text,labels
Admission,O
Date,O
:,O

2012-10-31,O

Discharge,O
Date,O
:,O

2012-11-07,O

Date,O
of,O
Birth,O
:,O

1941-03-23,O

Sex,O
:,O

M,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Nsaids/Anti-Inflammatory,B-TR
Classifier,I-TR
/,O
Vancomycin,B-TR

Attending,O
:,O

Kristie,O
R.,O
Hamby,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

CC,O
:,O
Antonio,O
M.,O
Z.,O
Eddings,O
",",O
M.D.,O

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

Mesenteric,B-TE
angiograpm,I-TE
w/,O
coil,B-TR
embolization,I-TR
of,O
bleeding,B-PR
vessel,I-PR
.,O

Sigmoidoscopy,B-TE
.,O

Colonoscopy,B-TE
.,O

History,O
of,O
Present,O
Illness,O
:,O

HPI:,O
Pt,O
is,O
a,O
71,O
y/o,O
male,O
with,O
h/o,O
dm2,B-PR
",",O
cad,B-PR
s/p,O
cabg,B-TR
",",O
DVT/PE,B-PR
on,O
long,B-TR
term,I-TR
anti-coagulation,I-TR
",",O
ulcerative,B-PR
colitis,I-PR
on,O
Asacol,B-TR
presents,O
with,O
brbpr,B-PR
starting,O
at,O
9am,O
of,O
the,O
morning,O
of,O
admission,O
.,O

He,O
'd,O
been,O
having,O
lower,B-PR
abdominal,I-PR
pain,I-PR
for,O
approximately,O
the,O
past,O
week,O
",",O
a,B-PR
symptom,I-PR
for,O
which,O
he,O
's,O
been,O
admitted,O
in,O
the,O
past,O
.,O

His,O
PCP,O
had,O
recently,O
started,O
ciprofloxacin,B-TR
for,O
a,B-PR
UTI,I-PR
.,O

At,O
9am,O
the,O
morning,O
of,O
admission,O
he,O
passed,O
a,B-PR
large,I-PR
",",I-PR
bloody,I-PR
bowel,I-PR
movement,I-PR
and,O
came,O
to,O
the,O
Michael,O
.,O
There,O
",",O
his,B-TE
vitals,I-TE
were,O
intially,O
stable,O
with,O
a,B-TE
hct,I-TE
of,O
36.7,O
",",O
though,O
he,O
was,O
felt,O
to,O
be,O
hypovolemic,B-PR
and,O
this,O
hemoconcentrated,B-PR
;,O
his,B-TE
previous,I-TE
hct,I-TE
was,O
39,O
about,O
five,O
months,O
ago,O
.,O

He,O
refused,O
an,B-TR
NG,I-TR
lavage,I-TR
.,O

Although,O
an,B-TE
initial,I-TE
DRE,I-TE
showed,O
only,O
clot,B-PR
",",O
he,O
later,O
passed,O
a,B-PR
large,I-PR
",",I-PR
bloody,I-PR
bowel,I-PR
movement,I-PR
",",O
and,O
his,B-TE
bp,I-TE
nadired,O
to,O
the,O
low,O
90's,O
but,O
rested,O
there,O
only,O
transiently,O
and,O
easily,O
rebounded,O
to,O
the,O
130's-140's,O
with,O
fluid,B-TR
;,O
he,O
then,O
went,O
to,O
angiography,O
for,O
a,B-TE
tagged,I-TE
RBC,I-TE
scan,I-TE
where,O
they,O
found,O
and,O
embolized,O
two,O
vessels,O
to,O
the,O
sigmoid,O
colon,O
.,O

His,B-TE
HCT,I-TE
had,O
dropped,O
from,O
36.7,O
to,O
30.8,O
despite,O
2U,B-TR
PRBC,I-TR
and,O
3,B-TR
U,I-TR
FFP,I-TR
.,O

Is,O
called,O
out,O
of,O
the,O
FICU,O
as,O
has,O
been,O
been,O
HD,O
and,O
stable,O
HCT,B-TE
.,O

Currently,O
denies,O
CP,B-PR
",",O
SOB,B-PR
",",O
abd,B-PR
pain,I-PR
or,O
continued,B-PR
BRBPR,I-PR
.,O

Past,O
Medical,O
History,O
:,O

PMH,O
:,O

1.),O
DM-2,B-PR

2.),O
CAD,B-PR
s/p,O
3v-CABG,B-TR
2003,O
and,O
subsequent,O
stenting,B-TR
of,O
SVG,B-TR
and,O
LIMA,O

3.),O
CHF,B-PR
with,O
EF,B-TE
30-35%,O
on,O
07-10,O
echo,B-TE

4.),O
Right,B-PR
parietal,I-PR
intracranial,I-PR
bleeding,I-PR
following,O
1996,O
cardiac,B-TE
cath,I-TE

5.),O
LBBB,B-PR

6.),O
Sinus,B-PR
node,I-PR
dysfunction,I-PR
s/p,O
pacemaker,B-TR

7.),O
H/O,O
DVT,B-PR
(,O
right,O
sided,O
),O
and,O
subsequent,O
PE,B-PR
",",O
put,O
onto,O
lifetime,O
warfarin,B-TR

8.),O
Ulcerative,B-PR
colitis,I-PR

PSH,O
:,O

1.),O
C4-7,B-TR
anterior,I-TR
discectomies,I-TR

2.),O
CABG,B-TR
2003,O

3.),O
R,B-TR
intracerebral,I-TR
hemorrhage,I-TR
drainage,I-TR

Social,O
History,O
:,O

SocHx,O
:,O
Mr,O
Peres,O
generally,O
lives,O
with,O
his,O
wife,O
but,O
has,O
spent,O
a,O
great,O
deal,O
of,O
time,O
recently,O
at,O
rehab,B-TR
.,O

He,O
has,O
no,O
h/o,O
ETOH/IVDA,O
but,O
quit,O
tob,O
15,O
years,O
ago,O
.,O

Family,O
History,O
:,O

Noncontributory,O
.,O

Physical,O
Exam,O
:,O

VS,B-TE
98.4,O
",",O
62,O
",",O
103/37,O
",",O
15,O
97%2L,O

gen,O
-,O
lying,O
in,O
bed,O
",",O
NAD,B-PR

heent,O
-,O
anicteric,B-PR
sclera,I-PR
",",O
op,O
clear,O
with,O
mmm,O

neck,O
-,O
jvd,B-PR
flat,O

cv,O
-,O
rrr,O
",",O
s1s2,O
",",O
no,O
m/r/g,B-PR

pul,O
-,O
CTAB,O
without,O
rales,B-PR

abd,O
-,O
soft,O
",",O
minimally,B-PR
distended,I-PR
",",O
nt,B-PR
",",O
no,O
rebound/guarding,B-PR
",",O
nabs,O

extrm,O
-,O
trace,B-PR
edema,I-PR
at,I-PR
ankles,I-PR
",",O
no,O
cyanosis,B-PR
",",O
warm/dry,O

Pertinent,O
Results,O
:,O

2012-10-31,O
05:47PM,O
URINE,O

COLOR,B-TE
-,O
Straw,O
APPEAR,B-TE
-,O
Clear,O
SP,O
Marquez,O
-,O
1.021,O

2012-10-31,O
05:47PM,O
URINE,O

BLOOD,O
-,O
LG,O
NITRITE,B-TE
-,O
NEG,O
PROTEIN,B-TE
-,O
NEG,O

GLUCOSE,B-TE
-,O
NEG,O
KETONE,B-TE
-,O
NEG,O
BILIRUBIN,B-TE
-,O
NEG,O
UROBILNGN,B-TE
-,O
NEG,O
PH,B-TE
-,O
7.0,O
LEUK,B-TE
-,O
NEG,O

2012-10-31,O
05:47PM,O
URINE,O

RBC-21-50*,B-TE
WBC-0-2,B-TE
BACTERIA,B-TE
-,O
FEW,O

YEAST,B-TE
-,O
NONE,O
EPI,B-TE
-,O
<1,O

2012-10-31,O
02:32PM,O

LACTATE,B-TE
-,O
1.8,O

2012-10-31,O
12:20PM,O

GLUCOSE,B-TE
-,O
197*,O
UREA,B-TE
N-25*,I-TE
CREAT,B-TE
-,O
0.8,O
SODIUM,B-TE
-,O
141,O

POTASSIUM,B-TE
-,O
3.7,O
CHLORIDE,B-TE
-,O
105,O
TOTAL,B-TE
CO2,I-TE
-,O
22,O
ANION,B-TE
GAP,I-TE
-,O
18,O

2012-10-31,O
12:20PM,O

WBC,B-TE
-,O
5.6,O
RBC,B-TE
-,O
4.35*,O
HGB,B-TE
-,O
12.6*,O
HCT,B-TE
-,O
36.7*,O
MCV,B-TE
-,O
84,O

MCH,B-TE
-,O
28.9,O
MCHC,B-TE
-,O
34.3,O
RDW,B-TE
-,O
15.7*,O

2012-10-31,O
12:20PM,O

NEUTS,B-TE
-,O
80.5*,O
LYMPHS,B-TE
-,O
13.1*,O
MONOS,B-TE
-,O
3.5,O
EOS,B-TE
-,O
2.5,O

BASOS,B-TE
-,O
0.4,O

2012-10-31,O
12:20PM,O

POIKILOCY,B-TE
-,O
1+,O
MICROCYT,B-TE
-,O
1+,O

2012-10-31,O
12:20PM,O

PLT,B-TE
COUNT,I-TE
-,O
102*,O

2012-10-31,O
12:20PM,O

PT,B-TE
-,O
20.5*,O
PTT,B-TE
-,O
29.4,O
INR(PT),B-TE
-,O
3.0,O

GI,B-TE
BLEEDING,I-TE
STUDY,I-TE

2012-10-31,O

IMPRESSION,O
:,O
Increased,B-PR
tracer,I-PR
activity,I-PR
demonstrated,O
within,O
the,O
left,O
lower,O
quadrant,O
",",O
most,O
likely,O
sigmoid,O
colonic,O
loops,O
of,O
bowel,O
",",O
consistent,O
with,O
active,B-PR
bleeding,I-PR
.,O

CT,B-TE
ABDOMEN,I-TE
W/CONTRAST,I-TE

2012-10-31,O
15:27,O

IMPRESSION,O
:,O

1.,O
No,O
evidence,O
of,O
colitis,B-PR
or,O
other,B-PR
bowel,I-PR
pathology,I-PR
present,O
to,O
explain,O
the,B-PR
patient,I-PR
's,I-PR
bright,I-PR
red,I-PR
blood,I-PR
per,I-PR
rectum,I-PR
.,O

2.,O
Stable,O
appearance,O
of,O
left,B-PR
adrenal,I-PR
fat-containing,I-PR
lesion,I-PR
consistent,O
with,O
a,B-PR
myelolipoma,I-PR
.,O

3.,O
Stable,O
appearance,O
of,O
hypodense,B-PR
lesion,I-PR
within,I-PR
the,I-PR
caudate,I-PR
lobe,I-PR
of,O
the,O
liver,O
",",O
too,O
small,O
to,O
fully,O
characterize,O
.,O

4.,O
Subcentimeter,B-PR
attenuation,I-PR
lesion,I-PR
within,I-PR
the,I-PR
lower,I-PR
pole,I-PR
of,O
the,O
right,O
kidney,O
",",O
too,O
small,O
to,O
characterize,O
.,O

5.,O
3-mm,B-PR
noncalcified,I-PR
pulmonary,I-PR
nodule,I-PR
within,I-PR
the,I-PR
right,I-PR
lower,I-PR
lobe,I-PR
.,O

If,O
the,O
patient,O
does,O
not,O
have,O
a,O
history,O
of,O
a,B-PR
primary,I-PR
malignancy,I-PR
",",O
followup,B-TE
CT,I-TE
of,I-TE
the,I-TE
chest,I-TE
in,O
1,O
year,O
is,O
recommended,O
to,O
evaluate,O
for,O
stability,O
of,O
this,O
finding,O
.,O

Brief,O
Hospital,O
Course,O
:,O

Initial,O
A/P,O
:,O

71,O
y/o,O
male,O
with,O
dm2,B-PR
",",O
cad,B-PR
",",O
chf,B-PR
",",O
uc,B-PR
presents,O
with,O
one,O
week,O
of,O
lower,B-PR
abdominal,I-PR
pain,I-PR
and,O
2,O
episodes,O
of,O
brpbr,B-PR
on,O
the,O
day,O
of,O
admission,O
.,O

#,O
BRBPR,B-PR
--,O
The,O
patient,O
was,O
in,O
the,O
intensive,O
care,O
unit,O
given,O
his,B-PR
lower,I-PR
GI,I-PR
bleed,I-PR
.,O

An,B-TE
angiography,I-TE
showed,O
bleeding,B-PR
in,I-PR
two,I-PR
vessels,I-PR
off,O
of,O
the,O
Minnie,O
supplying,O
the,O
sigmoid,O
that,O
were,O
succesfully,O
embolized,O
.,O

The,O
patient,O
was,O
transfused,O
from,O
a,B-TE
Hct,I-TE
29,O
to,O
34,O
on,O
the,O
day,O
of,O
discharge,O
.,O

His,B-TR
coumadin,I-TR
was,O
held,O
during,O
his,O
stay,O
given,O
his,B-PR
acute,I-PR
bleed,I-PR
but,O
restarted,O
per,O
his,O
PCP,O
with,O
the,O
guidance,O
of,O
GI,O
on,O
the,O
day,O
of,O
discharge,O
.,O

-,O
The,O
patient,O
underwent,O
a,B-TE
flex,I-TE
sigmoidoscopy,I-TE
on,O
Friday,O
",",O
11-02,O
",",O
which,O
showed,O
old,B-PR
blood,I-PR
in,I-PR
the,I-PR
rectal,I-PR
vault,I-PR
but,O
no,O
active,B-PR
source,I-PR
of,I-PR
bleeding,I-PR
.,O

Given,O
this,O
",",O
it,O
was,O
advised,O
that,O
the,O
patient,O
have,O
a,B-TE
colonoscopy,I-TE
to,O
rule,O
out,O
further,O
bleeding,B-PR
.,O

-,O
The,O
patient,O
had,O
a,B-TE
colonoscopy,I-TE
on,O
Monday,O
11-05,O
but,O
unfortunately,O
",",O
was,O
unable,O
to,O
complete,O
the,O
study,O
as,O
his,O
bowel,O

prep,O
was,O
inadequate,O
.,O

Therefore,O
",",O
he,O
had,O
a,B-TE
repeat,I-TE
colonoscopy,I-TE
on,O
11-06,O
which,O
showed,O
expected,O
mucosal,B-PR
signs,I-PR
of,O
moderate,B-PR
ulcerative,I-PR
colitis,I-PR
",",O
no,O
polyps,B-PR
",",O
w/,O
8,B-PR
mm,I-PR
ulcer,I-PR
at,I-PR
junction,I-PR
of,I-PR
distal,I-PR
descending,I-PR
colon,I-PR
and,I-PR
sigmoid,I-PR
colon,I-PR
.,O

-,O
Biopsies,B-TE
were,O
obtained,O
during,O
his,B-TE
colonoscopy,I-TE
and,O
he,O
should,O
follow,O
up,O
with,O
gastroenterology,O
for,O
the,O
results,O
.,O

#,O
Ulcerative,B-PR
colitis,I-PR
--,O
The,B-TR
patient,I-TR
's,I-TR
Asacol,I-TR
was,O
originally,O
held,O
but,O
restarted,O
the,O
day,O
prior,O
to,O
discharge,O
per,O
GI,O
.,O

#,O
CAD/CHF,B-PR
-,O
The,O
patient,O
was,O
restarted,O
on,O
his,B-TR
home,I-TR
regimen,I-TR
prior,O
to,O
discharge,O
as,O
it,O
was,O
held,O
temporarily,O
given,O
his,B-PR
acute,I-PR
GI,I-PR
bleed,I-PR
.,O

The,O
exception,O
is,O
that,O
per,O
his,O
PCP,O
",",O
Jason,O
aspirin,B-TR
will,O
be,O
held,O
for,O
2,O
weeks,O
given,O
that,O
he,O
was,O
restarted,O
on,O
coumadin,B-TR
with,O

his,B-PR
risk,I-PR
of,I-PR
bleeding,I-PR
.,O

#,O
DM-2,B-PR
--,O
The,O
patient,O
was,O
maintained,O
on,O
his,B-TR
home,I-TR
insulin,I-TR
regimen,I-TR
.,O

#,O
h/o,O
DVT/PE,B-PR
:,O

Coumadin,B-TR
was,O
initially,O
held,O
.,O

It,O
was,O
unclear,O
at,O
first,O
as,O
to,O
why,O
the,O
patient,O
required,O
life-long,B-TR
anticoagulation,I-TR
.,O

After,O
discussing,O
this,O
with,O
his,O
PCP,O
",",O
Leon,O
was,O
clear,O
that,O
the,O
patient,O
had,O
had,O
recurrent,B-PR
DVTs,I-PR
and,O
ultimately,O
a,B-PR
PE,I-PR
and,O
his,O
PCP,O
felt,O
strongly,O
that,O
he,O
required,O
long-term,B-TR
anticoagulation,I-TR
.,O

His,B-TE
goal,I-TE
INR,I-TE
should,O
be,O
1.6-2.0,O
.,O
If,O
bleeding,B-PR
continues,O
to,O
occur,O
",",O
consider,O
V.,B-TR
Winchester,I-TR
filter,I-TR
.,O

#,O
Access,O
--,O
2,B-TR
large,I-TR
bore,I-TR
PIV's,I-TR

#,O
Code,O
--,O
full,O

Medications,O
on,O
Admission,O
:,O

Meds,O
on,O
Admission,O
:,O

1.),O
Spironolactone/hctz,B-TR
25/25,O
daily,O

2.),O
Atenolol,B-TR
12.5mg,O
daily,O

3.),O
Insulin,B-TR
45N/8R,O
qAM,O
and,O
33N,O
qPM,O

4.),O
Furosemide,B-TR
10,O
mg,O
every,O
other,O
day,O

5.),O
Aspirin,B-TR
81,O
mg,O
daily,O

6.),O
Zoloft,B-TR
40,O
mg,O
qAM,O

7.),O
Flomax,B-TR

8.),O
Atorvastatin,B-TR
40,O
mg,O
daily,O

9.),O
Ritalin,B-TR
20,O
mg,O
daily,O

10.),O
Ramipril,B-TR
2.5,O
mg,O
daily,O

11.),O
Asacol,B-TR
400,O
mg,O
3,O
",",O
TID,O

12.),O
Carafate,B-TR
1,O
gm,O
bid,O

13.),O
Actos,B-TR
15,O
mg,O
daily,O

14.),O
Folate,B-TR
1,O
mg,O
daily,O

15.),O
Warfarin,B-TR
2,O
mg,O
daily,O

Discharge,O
Medications,O
:,O

1.,O
Tamsulosin,B-TR
0.4,O
mg,O
Capsule,O
",",O
Sust,O
.,O
Release,O
24HR,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
",",O
Sust,O
.,O
Release,O
24HR,O
PO,O
HS,O
(,O
at,O
bedtime,O
),O
.,O

2.,O
Atorvastatin,B-TR
40,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

3.,O
Methylphenidate,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

4.,O
Acetaminophen,B-TR
325,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
.,O

5.,O
Folic,B-TR
Acid,I-TR
1,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

6.,O
Atenolol,B-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
0.5,O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

7.,O
Spironolactone,B-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

8.,O
Ramipril,B-TR
1.25,O
mg,O
Capsule,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Capsule,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

9.,O
Hydrochlorothiazide,B-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

10.,O
Pioglitazone,B-TR
15,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
as,O
needed,O
for,O
DM,B-PR
.,O

11.,O
Mesalamine,B-TR
400,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
Three,O
(,O
3,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
as,O
needed,O
for,O
ulcerative,B-PR
colitis,I-PR
w/o,O
recent,O
severe,B-PR
flares,I-PR
.,O

12.,O
Insulin,B-TR
45,O
NPH,B-TR
in,O
am,O
with,O
33,O
NPH,B-TR
at,O
bedtime,O

Continue,O
Sliding,B-TR
scale,I-TR
insulin,I-TR
as,O
needed,O
.,O

13.,O
Sertraline,B-TR
20,O
mg/mL,O
Concentrate,O
Sig,O
:,O
Two,O
(,O
2,O
),O

14.,O
Coumadin,B-TR
2,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
once,O
a,O
day,O
.,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Facility,O
:,O

Oak,O
Bluffs,O
Of,O
Greenfield,O

Discharge,O
Diagnosis,O
:,O

Rectal,B-PR
bleeding,I-PR
from,I-PR
inferior,I-PR
mesenteric,I-PR
artery,I-PR
tributaries,I-PR
supplying,O
sigmoid,O
colon,O
.,O

Discharge,O
Condition,O
:,O
Good,O
.,O

Discharge,O
Instructions,O
:,O

Please,O
call,O
physician,O
if,O
you,O
develop,O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
weakness,B-PR
in,I-PR
your,I-PR
legs,I-PR
or,I-PR
arms,I-PR
",",O
sudden,B-PR
blurry,I-PR
vision,I-PR
or,O
slurred,B-PR
speech,I-PR
",",O
chest,B-PR
pain,I-PR
",",O
faintness,B-PR
",",O
or,O
significant,B-PR
unexplained,I-PR
weight,I-PR
loss,I-PR
.,O

Followup,O
Instructions,O
:,O

Provider,O
:,O
Lucio,O
Y.,O
Matthews,O
",",O
M.D.,O
Phone,O
:,O
(,O
967,O
),O
675,O
1641,O
Date/Time,O
:,O
2012-12-28,O
2:30,O

Provider,O
:,O

Provider,O
:,O
Lucio,O
F.,O
R.,O
Matthews,O
",",O
M.D.,O
Phone,O
:,O
(,O
967,O
),O
675,O
1641,O
Date/Time,O
:,O
2013-01-11,O
2:00,O

Please,O
call,O
White,O
",",O
Leslie,O
L.,O
at,O
(,O
602,O
),O
743,O
8709,O
to,O
schedule,O
an,O
appointment,O
with,O
him,O
in,O
1,O
week,O
.,O

Please,O
call,O
your,O
gastroenterologist,O
to,O
schedule,O
a,O
follow,O
up,O
appointment,O
in,O
2,O
weeks,O
.,O

Alan,O
John,O
MD,O
54-745,O

Completed,O
by,O
:,O
Bertha,O
Janice,O
Motta,O
MD,O
52-860,O
2012-11-07,O
@,O
1207,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Melody,O
PARKS,O
on:,O
WED,O
2012-11-21,O
6:22,O
PM,O

(,O
End,O
of,O
Report,O
),O

4668411,O

CTMC,O

68299235,O

763052,O

9/29/1993,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

09/29/1993,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

10/04/1993,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
28-year-old,O
woman,O
who,O
is,O
HIV,B-PR
positive,I-PR
for,O
two,O
years,O
.,O

She,O
presented,O
with,O
left,B-PR
upper,I-PR
quadrant,I-PR
pain,I-PR
as,O
well,O
as,O
nausea,B-PR
and,O
vomiting,B-PR
which,O
is,O
a,B-PR
long-standing,I-PR
complaint,I-PR
.,O

She,O
was,O
diagnosed,O
in,O
1991,O
during,O
the,O
birth,O
of,O
her,O
child,O
.,O

She,O
claims,O
she,O
does,O
not,O
know,O
why,O
she,O
is,O
HIV,B-PR
positive,I-PR
.,O

She,O
is,O
from,O
Maryland,O
",",O
apparently,O
had,O
no,O
blood,B-TR
transfusions,I-TR
before,O
the,O
birth,O
of,O
her,O
children,O
so,O
it,O
is,O
presumed,O
heterosexual,B-PR
transmission,I-PR
.,O

At,O
that,O
time,O
",",O
she,O
also,O
had,O
cat,B-PR
scratch,I-PR
fever,I-PR
and,O
she,O
had,O
resection,B-TR
of,O
an,B-PR
abscess,I-PR
in,I-PR
the,I-PR
left,I-PR
lower,I-PR
extremity,I-PR
.,O

She,O
has,O
not,O
used,O
any,B-TR
anti,I-TR
retroviral,I-TR
therapy,I-TR
since,O
then,O
",",O
because,O
of,O
pancytopenia,B-PR
and,O
vomiting,B-PR
on,O
DDI,B-TR
.,O

She,O
has,O
complaints,O
of,O
nausea,B-PR
and,O
vomiting,B-PR
as,O
well,O
as,O
left,B-PR
upper,I-PR
quadrant,I-PR
pain,I-PR
on,O
and,O
off,O
getting,O
progressively,O
worse,O
over,O
the,O
past,O
month,O
.,O

She,O
has,O
had,O
similar,B-PR
pain,I-PR
intermittently,O
for,O
last,O
year,O
.,O

She,O
described,O
the,B-PR
pain,I-PR
as,O
a,B-PR
burning,I-PR
pain,I-PR
which,O
is,O
positional,O
",",O
worse,O
when,O
she,O
walks,O
or,O
does,O
any,O
type,O
of,O
exercise,O
.,O

She,O
has,O
no,O
relief,O
from,O
antacids,B-TR
or,O
H2,B-TR
blockers,I-TR
.,O

In,O
10/92,O
",",O
she,O
had,O
a,B-TE
CT,I-TE
scan,I-TE
which,O
showed,O
fatty,B-PR
infiltration,I-PR
of,I-PR
her,I-PR
liver,I-PR
diffusely,I-PR
with,O
a,B-PR
1,I-PR
cm,I-PR
cyst,I-PR
in,I-PR
the,I-PR
right,I-PR
lobe,I-PR
of,I-PR
the,I-PR
liver,I-PR
.,O

She,O
had,O
a,O
normal,O
pancreas,O
at,O
that,O
time,O
",",O
however,O
",",O
hyperdense,B-PR
kidneys,I-PR
.,O

Her,B-TE
alkaline,I-TE
phosphatase,I-TE
was,O
slightly,B-PR
elevated,I-PR
but,O
otherwise,O
relatively,O
normal,O
.,O

Her,B-TE
amylase,I-TE
was,O
mildly,B-PR
elevated,I-PR
but,O
has,O
been,O
down,O
since,O
then,O
.,O

The,O
patient,O
has,O
had,O
progressive,B-PR
failure,I-PR
to,I-PR
thrive,I-PR
and,O
steady,B-PR
weight,I-PR
loss,I-PR
.,O

She,O
was,O
brought,O
in,O
for,O
an,B-TE
esophagogastroduodenoscopy,I-TE
on,O
9/26,O
but,O
she,O
basically,O
was,O
not,O
sufficiently,O
sedated,B-TR
and,O
readmitted,O
at,O
this,O
time,O
for,O
a,B-TE
GI,I-TE
work-up,I-TE
as,O
well,O
as,O
an,B-TE
evaluation,I-TE
of,O
new,B-PR
abscess,I-PR
in,I-PR
her,I-PR
left,I-PR
lower,I-PR
calf,I-PR
and,O
right,O
medial,O
lower,O
extremity,O
quadriceps,O
muscle,O
.,O

She,O
was,O
also,O
admitted,O
to,O
be,O
connected,O
up,O
with,O
social,O
services,O
for,O
HIV,B-PR
patients,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

As,O
above,O
.,O

ALLERGIES,O
:,O

BACTRIM,B-TR
.,O

MEDICATIONS,O
:,O

On,O
admission,O
included,O
Percocet,B-TR
",",O
Prinovil,B-TR
",",O
Dapsone,B-TR
",",O
Mycelex,B-TR
troches,I-TR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
was,O
recently,O
separated,O
from,O
her,O
husband,O
.,O

She,O
lives,O
with,O
her,O
daughter,O
.,O

She,O
does,O
not,O
drink,O
",",O
use,O
IV,O
drugs,O
or,O
smoke,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,O
revealed,O
a,O
cachetic,O
woman,O
in,O
no,O
acute,B-PR
distress,I-PR
with,O
stable,O
vital,O
signs,O
.,O

She,O
was,O
afebrile,B-PR
.,O

She,O
was,O
not,O
orthostatic,B-PR
.,O

Blood,B-TE
pressure,I-TE
110/80,O
.,O

HEENT,B-TE
exam,I-TE
was,O
within,O
normal,O
limits,O
.,O

Lungs,O
were,O
clear,O
to,O
auscultation,B-TE
and,O
percussion,B-TE
bilaterally,O
.,O

Cardiovascular,B-TE
exam,I-TE
revealed,O
a,O
regular,O
rate,O
and,O
rhythm,O
without,O
murmur,B-PR
.,O

Abdomen,O
was,O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
with,O
positive,O
bowel,O
sounds,O
.,O

There,O
was,O
no,O
hepatosplenomegaly,B-PR
.,O

Extremities,O
revealed,O
a,B-PR
2,I-PR
x,I-PR
3,I-PR
cm,I-PR
tender,I-PR
mass,I-PR
in,I-PR
the,I-PR
lateral,I-PR
left,I-PR
calf,I-PR
",",O
medial,B-PR
1,I-PR
cm,I-PR
mass,I-PR
above,I-PR
her,I-PR
knee,I-PR
.,O

There,O
was,O
no,O
evidence,O
of,O
edema,B-PR
.,O

LABORATORY,O
DATA,O
:,O

On,O
admission,O
included,O
BUN,B-TE
/,O
creatinine,B-TE
of,O
33/2.1,O
.,O

Sodium,B-TE
141,O
.,O

Potassium,B-TE
4.2,O
.,O

Hematocrit,B-TE
23,O
.,O

White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
was,O
2.1,O
with,O
56,B-TE
polys,I-TE
and,O
1,B-TE
band,I-TE
.,O

Platelet,B-TE
count,I-TE
"411,000",O
.,O

Amylase,B-TE
143,O
.,O

Lipase,B-TE
was,O
elevated,B-PR
to,O
600,O
.,O

ESR,B-TE
was,O
greater,O
than,O
140,O
.,O

Alkaline,B-TE
phosphatase,I-TE
190,O
.,O

ALT,B-TE
52,O
.,O

AST,B-TE
65,O
.,O

Beta,B-TE
hCG,I-TE
was,O
negative,O
.,O

Urinalysis,B-TE
was,O
positive,B-PR
for,I-PR
protein,I-PR
.,O

Bilirubin,B-TE
0.4,O
.,O

Chest,B-TE
x-ray,I-TE
revealed,O
clear,O
lung,O
fields,O
.,O

There,O
was,O
no,O
evidence,O
of,O
rib,B-PR
fracture,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
and,O
many,B-TE
cultures,I-TE
were,O
sent,O
which,O
were,O
all,O
negative,O
.,O

She,O
did,O
not,O
have,O
any,O
of,O
her,B-PR
pain,I-PR
in,O
the,O
hospital,O
.,O

On,O
the,O
third,O
hospital,O
day,O
",",O
she,O
did,O
have,O
some,B-PR
pain,I-PR
and,O
was,O
treated,O
with,O
Percocet,B-TR
.,O

She,O
went,O
for,O
a,B-TR
debridement,I-TR
of,O
her,B-PR
left,I-PR
calf,I-PR
lesion,I-PR
on,O
10/2/93,O
and,O
was,O
started,O
empirically,O
on,O
IV,B-TR
ceftriaxone,I-TR
which,O
was,O
changed,O
to,O
po,B-TR
doxycycline,I-TR
on,O
the,O
day,O
of,O
discharge,O
.,O

A,B-TE
follow-up,I-TE
CT,I-TE
scan,I-TE
was,O
done,O
which,O
did,O
not,O
show,O
any,O
evidence,O
for,O
splenomegaly,B-PR
or,O
hepatomegaly,B-PR
.,O

The,B-PR
1,I-PR
cm,I-PR
cyst,I-PR
which,O
was,O
seen,O
in,O
10/92,O
was,O
still,O
present,O
.,O

There,O
was,O
a,O
question,O
of,O
a,B-PR
cyst,I-PR
in,I-PR
her,I-PR
kidney,I-PR
with,O
a,B-PR
stone,I-PR
right,O
below,O
the,B-PR
cyst,I-PR
",",O
although,O
this,O
did,O
not,O
seem,O
to,O
be,O
clinically,O
significant,O
.,O

DISPOSITION,O
:,O

The,O
patient,O
was,O
discharged,O
to,O
home,O
in,O
stable,O
condition,O
.,O

Cultures,B-TE
were,O
pending,O
on,O
her,B-TE
aspirate,I-TE
and,O
will,O
be,O
treated,O
with,O
po,B-TR
doxycycline,I-TR
.,O

Dictated,O
By,O
:,O

JIMCHARL,O
B.,O
BUN,O
",",O
M.D.,O
OC33,O

Attending,O
:,O

I,O
BUN,O
",",O
M.D.,O
GR67,O
EF283/9675,O

Batch,O
:,O

2027,O

Index,O
No.,O
BOKMII88JZ,O

D,O
:,O

10/03/93,O

T,O
:,O

10/07/93,O

?Admission,O
Date,O
:,O

2016-12-24,O

Discharge,O
Date,O
:,O

2016-12-27,O

Date,O
of,O
Birth,O
:,O

1936-01-11,O

Sex:,O

F,O

Service,O
:,O

CMED,O
CSRU,O

CHIEF,O
COMPLAINT,O
:,O

Cough,B-PR
",",O
rhinorrhea,B-PR
",",O
dehydration,B-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
an,O
80,O
year,O
old,O
female,O
with,O
breast,B-PR
cancer,I-PR
",",O
status,O
post,O
lumpectomy,B-TR
/,O
radiation,B-TR
therapy,I-TR
/,O
Tamoxifen,B-TR
(,O
2000,O
),O
",",O
hypertension,B-PR
",",O
hyperlipidemia,B-PR
",",O
multiple,B-PR
urinary,I-PR
tract,I-PR
infections,I-PR
who,O
presents,O
with,O
a,O
four,O
day,O
prodrome,O
of,O
dry,B-PR
cough,I-PR
",",O
rhinorrhea,B-PR
",",O
coryza,B-PR
",",O
malaise,B-PR
",",O
chills,B-PR
",",O
headache,B-PR
",",O
decreased,B-PR
p.o.,I-PR
intake,I-PR
",",O
loose,B-PR
bowel,I-PR
movements,I-PR
with,O
diarrhea,B-PR
and,O
no,O
blood,B-PR
",",O
decreased,B-PR
urine,I-PR
output,I-PR
",",O
no,O
sick,O
contacts,O
",",O
had,O
flu,B-TR
shot,I-TR
this,O
year,O
.,O

In,O
the,O
Emergency,O
Department,O
",",O
she,O
had,O
labile,B-PR
blood,I-PR
pressure,I-PR
with,O
systolic,B-TE
blood,I-TE
pressure,I-TE
in,O
the,O
80,O
s,O
.,O

Her,O
usual,O
is,O
systolic,B-TE
blood,I-TE
pressure,I-TE
in,O
the,O
120,O
s,O
",",O
this,O
was,O
despite,O
two,B-TR
liters,I-TR
of,I-TR
intravenous,I-TR
fluids,I-TR
and,O
she,O
was,O
transferred,O
to,O
the,O
Medical,O
Intensive,O
Care,O
Unit,O
for,O
closer,O
monitoring,O
for,O
possible,O
early,B-PR
sepsis,I-PR
.,O

The,O
Intensive,O
Care,O
Unit,O
course,O
was,O
notable,O
for,O
initially,O
receiving,O
broad,B-TR
spectrum,I-TR
antibiotics,I-TR
as,O
well,O
as,O
a,B-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
of,O
11.0,O
with,O
15,O
bands,B-TE
.,O

She,O
was,O
ultimately,O
changed,O
to,O
Levaquin,B-TR
for,O
a,O
possible,O
early,B-PR
pneumonia,I-PR
pending,B-TE
cultures,I-TE
.,O

The,O
Intensive,O
Care,O
Unit,O
course,O
was,O
also,O
notable,O
for,O
negative,O
chest,O
x-ray,O
",",O
two,B-TR
units,I-TR
of,I-TR
packed,I-TR
red,I-TR
blood,I-TR
cells,I-TR
for,O
a,B-TE
hematocrit,I-TE
of,O
24.0,O
with,O
appropriate,O
bump,O
in,O
her,B-TE
hematocrit,I-TE
and,O
no,O
evidence,B-PR
of,I-PR
bleeding,I-PR
",",O
stable,O
blood,B-TE
pressure,I-TE
despite,O
a,B-TE
net,I-TE
fluid,I-TE
balance,I-TE
of,O
negative,O
2.5,O
liters,O
.,O

No,O
central,B-TR
access,I-TR
was,O
needed,O
.,O

The,B-TR
sepsis,I-TR
protocol,I-TR
was,O
aborted,O
.,O

Also,O
of,O
note,O
",",O
her,B-TE
liver,I-TE
function,I-TE
tests,I-TE
had,O
been,O
normal,O
.,O

Random,B-TE
cortisol,I-TE
was,O
17,O
and,O
her,B-TE
DFA,I-TE
was,O
positive,O
for,O
influenzae,B-PR
A,I-PR
with,O
a,B-TE
viral,I-TE
culture,I-TE
pending,O
at,O
the,O
time,O
of,O
discharge,O
.,O

Blood,B-TE
and,I-TE
urine,I-TE
cultures,I-TE
were,O
no,O
growth,O
at,O
the,O
time,O
of,O
discharge,O
as,O
well,O
.,O

She,O
also,O
had,O
a,B-TE
right,I-TE
lower,I-TE
extremity,I-TE
noninvasive,I-TE
ultrasound,I-TE
that,O
was,O
negative,O
for,O
deep,B-PR
venous,I-PR
thrombosis,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O
Breast,B-PR
cancer,I-PR
diagnosed,O
in,O
2010,O
",",O
Stage,O
I,O
",",O
status,B-TR
post,I-TR
left,I-TR
lumpectomy,I-TR
",",O
on,O
2012-05-08,O
",",O
and,O
repeat,B-TR
surgery,I-TR
with,O
sentinel,B-TR
node,I-TR
dissection,I-TR
on,O
2012-06-05,O
.,O

Invasive,B-PR
mucinous,I-PR
carcinoma,I-PR
with,O
estrogen,B-PR
receptor,I-PR
positivity,I-PR
and,O
HER2/NEU,B-PR
negative,O
.,O

Left,B-TR
chest,I-TR
radiation,I-TR
",",O
on,O
Tamoxifen,B-TR
therapy,I-TR
.,O

She,O
is,O
followed,O
by,O
Dr.,O
Alonso,O
Naugle,O
.,O

Question,O
of,O
vertebral,B-PR
basilar,I-PR
cerebrovascular,I-PR
accident,I-PR
in,O
2016-08-17,O
",",O
with,O
associated,O
limb,B-PR
ataxia,I-PR
.,O

Magnetic,B-TE
resonance,I-TE
imaging,I-TE
was,O
negative,O
except,O
for,O
some,B-PR
microvascular,I-PR
cerebral,I-PR
white,I-PR
matter,I-PR
changes,I-PR
.,O

Question,O
peripheral,B-PR
vertigo,I-PR
",",O
takes,O
Meclizine,B-TR
p.r.n.,O

Hypothyroidism,B-PR
.,O

Hypertension,B-PR
.,O

Hypercholesterolemia,B-PR
.,O

Glaucoma,B-PR
.,O

Cataract,B-PR
.,O

Osteopenia,B-PR
.,O

Left,B-PR
hip,I-PR
arthritis,I-PR
.,O

History,O
of,O
urinary,B-PR
tract,I-PR
infections,I-PR
.,O

Anemia,B-PR
",",O
with,O
a,B-TE
baseline,I-TE
hematocrit,I-TE
of,O
31.0,O
",",O
with,O
a,B-TE
TIBC,I-TE
that,O
was,O
low,B-PR
and,O
a,B-PR
high,I-PR
ferritin,I-PR
.,O

Echocardiogram,B-TE
in,O
2016-09-16,O
",",O
with,O
preserved,O
ejection,B-TE
fraction,I-TE
of,O
60,O
percent,O
with,O
trivial,B-PR
mitral,I-PR
regurgitation,I-PR
and,O
mild,B-PR
left,I-PR
atrial,I-PR
enlargement,I-PR
.,O

Cardiac,B-TE
stress,I-TE
test,I-TE
in,O
2016-03-17,O
",",O
that,O
was,O
negative,O
for,O
inducible,B-PR
ischemia,I-PR
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

1.,O
Evista,B-TR
60,O
mg,O
p.o.,O
daily,O
.,O

2.,O
Tamoxifen,B-TR
20,O
mg,O
p.o.,O
daily,O
.,O

3.,O
Lisinopril,B-TR
5,O
mg,O
p.o.,O
daily,O
.,O

4.,O
Triamterene/Hydrochlorothiazide,B-TR
37.5/25,O
mg,O
p.o.,O
daily,O
.,O

5.,O
Enteric,B-TR
Coated,I-TR
Aspirin,I-TR
325,O
mg,O
p.o.,O
daily,O
.,O

6.,O
Meclizine,B-TR
25,O
mg,O
q8hours,O
p.r.n.,O

7.,O
Aggrenox,B-TR
twice,O
a,O
day,O
",",O
the,O
dose,O
was,O
not,O
known,O
.,O

8.,O
Synthroid,B-TR
125,O
mcg,O
daily,O
.,O

SOCIAL,O
HISTORY,O
:,O

She,O
denies,O
tobacco,O
and,O
alcohol,O
abuse,O
.,O

She,O
is,O
a,O
professional,O
bowler,O
.,O

She,O
lives,O
alone,O
though,O
her,O
family,O
is,O
in,O
the,O
area,O
.,O

FAMILY,O
HISTORY,O
:,O

Breast,B-PR
cancer,I-PR
in,O
multiple,O
female,O
relatives,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

At,O
the,O
time,O
of,O
presentation,O
",",O
temperature,B-TE
100.8,O
",",O
heart,B-TE
rate,I-TE
89,O
",",O
blood,B-TE
pressure,I-TE
106,O
systolic,B-TE
",",O
respiratory,B-TE
rate,I-TE
18,O
",",O
oxygen,B-TE
saturation,I-TE
97,O
percent,O
in,O
room,O
air,O
.,O

Physical,B-TE
examination,I-TE
is,O
read,O
off,O
the,O
admitting,O
note,O
from,O
the,O
Intensive,O
Care,O
Unit,O
team,O
and,O
is,O
not,O
reflective,O
of,O
the,B-TE
examination,I-TE
by,O
this,O
dictator,O
.,O

General,O
-,O
The,O
patient,O
appears,O
stated,O
age,O
",",O
found,O
lying,O
flat,O
in,O
bed,O
",",O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

Head,O
",",O
eyes,O
",",O
ears,O
",",O
nose,O
and,O
throat,O
-,O
Sclera,B-PR
anicteric,I-PR
",",O
conjunctiva,B-PR
injected,I-PR
",",O
the,O
pupils,O
are,O
equal,O
",",O
round,O
and,O
reactive,O
to,O
light,O
and,O
accommodation,O
",",O
the,O
mucous,O
membranes,O
are,O
dry,B-PR
",",O
oropharynx,O
clear,O
.,O

Neck,O
-,O
No,O
jugular,B-PR
venous,I-PR
distention,I-PR
",",O
no,O
lymphadenopathy,B-PR
.,O

Cardiac,O
regular,O
rate,B-TE
and,O
rhythm,B-TE
",",O
normal,O
S1,O
and,O
S2,O
",",O
I/VI,B-PR
holosystolic,I-PR
murmur,I-PR
at,I-PR
the,I-PR
apex,I-PR
.,O

Chest,O
clear,O
to,O
percussion,B-TE
and,O
auscultation,B-TE
.,O

Abdomen,O
is,O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
",",O
no,O
hepatosplenomegaly,B-PR
.,O

Extremities,O
-,O
No,O
calf,B-PR
tenderness,I-PR
",",O
no,O
edema,B-PR
.,O

Neurologically,O
",",O
mental,B-TE
status,I-TE
examination,I-TE
is,O
normal,O
.,O

Cranial,B-TE
nerves,I-TE
II,I-TE
through,I-TE
XII,I-TE
are,O
intact,O
.,O

LABORATORY,O
DATA,O
:,O

On,O
admission,O
",",O
chest,B-TE
x-ray,I-TE
with,O
no,O
acute,B-PR
cardiopulmonary,I-PR
process,I-PR
.,O

Electrocardiogram,B-TE
notable,O
for,O
sinus,B-PR
tachycardia,I-PR
with,O
a,B-TE
rate,I-TE
of,O
104,O
beats,O
per,O
minute,O
",",O
normal,O
axis,O
",",O
normal,O
intervals,O
",",O
new,B-PR
T,I-PR
wave,I-PR
inversion,I-PR
in,I-PR
III,I-PR
and,O
old,B-PR
T,I-PR
wave,I-PR
inversions,I-PR
in,I-PR
aVL,I-PR
and,I-PR
V1,I-PR
.,O

This,O
was,O
not,O
significantly,O
changed,O
from,O
comparison,O
with,O
2016-03-17,O
.,O

On,O
admission,O
",",O
white,B-TE
blood,I-TE
cell,I-TE
count,I-TE
7.3,O
",",O
73,O
percent,O
neutrophils,B-TE
",",O
15,O
percent,O
bands,B-TE
",",O
6,O
percent,O
lymphocytes,B-TE
",",O
hematocrit,B-TE
30.4,O
",",O
platelet,B-TE
count,I-TE
"228,000",O
.,O

Sodium,B-TE
136,O
",",O
potassium,B-TE
3.5,O
",",O
chloride,B-TE
98,O
",",O
bicarbonate,B-TE
23,O
",",O
blood,B-TE
urea,I-TE
nitrogen,I-TE
16,O
",",O
creatinine,B-TE
0.8,O
",",O
glucose,B-TE
142,O
.,O

HOSPITAL,O
COURSE,O
:,O

This,O
is,O
an,O
80,O
year,O
old,O
female,O
with,O
a,O
history,O
of,O
Stage,B-PR
I,I-PR
breast,I-PR
cancer,I-PR
",",O
hypertension,B-PR
",",O
hyperlipidemia,B-PR
",",O
who,O
presents,O
with,O
a,B-PR
leukocytosis/bandemia,I-PR
",",O
hypotension,B-PR
in,O
the,O
setting,O
of,O
dehydration,B-PR
and,O
influenza,B-PR
.,O

After,O
a,O
short,O
Medical,O
Intensive,O
Care,O
Unit,O
course,O
where,O
she,O
remained,O
hemodynamically,O
stable,O
",",O
she,O
was,O
transferred,O
to,O
the,O
floor,O
.,O

Gerardi,O
problem,O
list,O
is,O
as,O
follows,O
:,O

Hypotension,B-PR
-,O
This,O
was,O
likely,O
secondary,O
to,O
volume,B-PR
depletion,I-PR
in,O
the,O
setting,O
of,O
a,B-PR
diarrheal,I-PR
and,I-PR
viral,I-PR
respiratory,I-PR
syndrome,I-PR
.,O

Her,B-TE
blood,I-TE
pressure,I-TE
was,O
stable,O
after,O
three,B-TR
liters,I-TR
of,I-TR
normal,I-TR
saline,I-TR
.,O

She,O
was,O
clinically,O
euvolemic,O
after,O
that,O
.,O

She,O
did,O
receive,O
two,B-TR
units,I-TR
of,I-TR
packed,I-TR
red,I-TR
blood,I-TR
cells,I-TR
.,O

There,O
is,O
no,O
evidence,O
of,O
gastrointestinal,B-PR
bleed,I-PR
or,O
adrenal,B-PR
insufficiency,I-PR
during,O
the,O
course,O
of,O
her,B-TE
evaluation,I-TE
.,O

Her,B-TR
antihypertensives,I-TR
were,O
initially,O
held,O
and,O
reinstated,O
upon,O
discharge,O
.,O

Influenza,B-PR
A,I-PR
-,O
DFA,B-TE
confirmed,O
",",O
the,B-TE
viral,I-TE
cultures,I-TE
were,O
pending,O
at,O
the,O
time,O
of,O
discharge,O
.,O

The,B-PR
initial,I-PR
bandemia,I-PR
would,O
not,O
have,O
been,O
consistent,O
with,O
a,B-PR
typical,I-PR
influenza,I-PR
presentation,I-PR
",",O
so,O
she,O
was,O
continued,O
on,O
a,O
fourteen,O
day,O
course,O
of,O
Levaquin,B-TR
to,O
eliminate,O
any,O
possibility,O
of,O
a,B-PR
bacterial,I-PR
superinfection,I-PR
or,O
early,B-PR
pneumonia,I-PR
.,O

Loose,B-PR
bowel,I-PR
movements,I-PR
-,O
This,O
problem,O
was,O
resolved,O
and,O
had,O
been,O
a,B-PR
viral,I-PR
syndrome,I-PR
on,O
presentation,O
.,O

There,O
was,O
no,O
evidence,O
of,O
diarrhea,B-PR
during,O
medical,O
Lawrence,O
Memorial,O
Hospital,O
stay,O
.,O

Anemia,B-PR
-,O
This,O
is,O
a,B-PR
chronic,I-PR
problem,I-PR
.,O

She,O
has,O
known,B-PR
iron,I-PR
deficiency,I-PR
.,O

There,O
was,O
no,O
evidence,B-PR
of,I-PR
bleeding,I-PR
.,O

She,O
was,O
guaiac,B-TE
negative,O
and,O
the,B-TE
Hemophilus,I-TE
panel,I-TE
was,O
negative,O
.,O

She,O
was,O
reinstated,O
on,O
iron,B-TR
at,O
discharge,O
and,O
her,B-TE
hematocrit,I-TE
was,O
stable,O
.,O

Hypothyroid,B-PR
-,O
She,O
was,O
continued,O
on,O
her,B-TR
Synthroid,I-TR
.,O

Osteopenia,B-PR
-,O
She,O
was,O
continued,O
on,O
Evista,B-TR
.,O

Fluids,B-TR
",",O
electrolytes,B-TR
and,O
nutrition,B-TR
-,O
She,O
was,O
tolerating,O
a,O
house,O
diet,O
upon,O
discharge,O
.,O

FOLLOW,O
UP,O
:,O

She,O
is,O
a,O
patient,O
of,O
Dr.,O
James,O
Deighan,O
and,O
will,O
follow-up,O
with,O
her,O
in,O
one,O
to,O
two,O
weeks,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

1.,O
Evista,B-TR
60,O
mg,O
p.o.,O
daily,O
.,O

2.,O
Tamoxifen,B-TR
20,O
mg,O
p.o.,O
daily,O
.,O

3.,O
Lisinopril,B-TR
5,O
mg,O
p.o.,O
daily,O
.,O

4.,O
Triamterene/Hydrochlorothiazide,B-TR
37.5/25,O
mg,O
p.o.,O
daily,O
.,O

5.,O
Enteric,B-TR
Coated,I-TR
Aspirin,I-TR
325,O
mg,O
p.o.,O
daily,O
.,O

6.,O
Meclizine,B-TR
25,O
mg,O
q8hours,O
p.r.n.,O

7.,O
Aggrenox,B-TR
twice,O
a,O
day,O
",",O
the,O
dose,O
was,O
not,O
known,O
.,O

8.,O
Synthroid,B-TR
125,O
mcg,O
daily,O
.,O

9.,O
Levofloxacin,B-TR
250,O
mg,O
p.o.,O
daily,O
to,O
complete,O
a,O
fourteen,O
day,O
course,O
.,O

She,O
was,O
given,O
a,O
prescription,O
for,O
ten,O
more,O
days,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

Influenza,B-PR
A,I-PR
.,O

Hypotension,B-PR
secondary,O
to,O
volume,B-PR
depletion,I-PR
.,O

Anemia,B-PR
.,O

Hypothyroidism,B-PR
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

The,O
patient,O
was,O
breathing,O
comfortably,O
in,O
room,O
air,O
.,O

She,O
was,O
normotensive,O
and,O
her,B-TE
hematocrit,I-TE
was,O
stable,O
at,O
her,O
baseline,O
upon,O
discharge,O
.,O

Linette,O
Randall,O
",",O
Mississippi,O
82499,O

Dictated,O
By,O
:,O
Jason,O
L,O
Parra,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O

2016-12-28,O
16:25,O

T,O
:,O

2016-12-28,O
20:11,O

Job,O
#,O
:,O

74466,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Wanda,O
PARKS,O
on,O
:,O
Yesenia,O
2017-01-10,O
6:50,O
PM,O

(,O
End,O
of,O
Report,O
),O

6544894,O

NVH,O

65104826,O

1/2/2004,O
12:00:00,O
AM,O

VT,B-PR
s/p,O
cardiac,B-TE
cath,I-TE
",",O
stent,B-TR
and,O
amp,O
;,O
amio,B-TR
loading,I-TR

DIS,O

Admission,O
Date,O
:,O

01/02/2004,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

01/07/2004,O

******,O
DISCHARGE,O
ORDERS,O
******,O

NERSLET,O
",",O
BERISS,O
665-07-74-6Q06,O

Room,O
:,O

89H-593,O

Service,O
:,O

CAR,O

DISCHARGE,O
PATIENT,O
ON,O
:,O

01/07/04,O
AT,O
02:00,O
PM,O

CONTINGENT,O
UPON,O
Not,O
Applicable,O

WILL,O
D,O
/,O
C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D,O
/,O
C,O
SUMMARY,O
:,O

YES,O

Attending,O
:,O

MOST,O
",",O
ANNETIFF,O
SIAYUDE,O
",",O
M.D.,O

DISPOSITION,O
:,O

Home,O

DISCHARGE,O
MEDICATIONS,O
:,O

AMIODARONE,B-TR
400,O
MG,O
PO,O
BID,O
Starting,O
Today,O
(,O
01/06,O
),O

Instructions,O
:,O

For,O
7,O
days,O

Alert,O
overridden,O
:,O

Override,O
added,O
on,O
01/03/04,O
by,O
TIKNEAV,O
",",O
JEFFCI,O
SUOT,O
A.,O
",",O
M.D.,O

SERIOUS,B-PR
INTERACTION,I-PR
:,O

DIGOXIN,B-TR
and,O
AMIODARONE,B-TR
HCL,I-TR

Reason,O
for,O
override,O
:,O

ok,O
ENTERIC,B-TR
COATED,I-TR
ASA,I-TR
(,I-TR
ASPIRIN,I-TR
ENTERIC,I-TR
COATED,I-TR
),I-TR
325,O
MG,O
PO,O
QD,O
DIGOXIN,B-TR
0.0625,O
MG,O
PO,O
QD,O

Override,O
Notice,O
:,O

Override,O
added,O
on,O
01/03/04,O
by,O
TIKNEAV,O
",",O
JEFFCI,O
SUOT,O
A.,O
",",O
M.D.,O
on,O
order,O
for,O
AMIODARONE,B-TR
PO,I-TR
(,O
ref,O
#,O
23731718,O
),O

SERIOUS,B-PR
INTERACTION,I-PR
:,O

DIGOXIN,B-TR
and,O
AMIODARONE,B-TR
HCL,I-TR

Reason,O
for,O
override,O
:,O

ok,O

Previous,O
override,O
information,O
:,O

Override,O
added,O
on,O
01/02/04,O
by,O
KOTESLENT,O
",",O
ANT,O
ODEWYJU,O
",",O
M.D.,O
on,O
order,O
for,O
AMIODARONE,B-TR
IV,I-TR
1,O
(,O
ref,O
#,O
45803793,O
),O

SERIOUS,B-PR
INTERACTION,I-PR
:,O

DIGOXIN,B-TR
and,O
AMIODARONE,B-TR
HCL,I-TR

Reason,O
for,O
override,O
:,O

will,O
follow,O

Previous,O
override,O
information,O
:,O

Override,O
added,O
on,O
01/02/04,O
by,O
KOTESLENT,O
",",O
ANT,O
ODEWYJU,O
",",O
M.D.,O

SERIOUS,B-PR
INTERACTION,I-PR
:,O

AMIODARONE,B-TR
HCL,I-TR
and,O
DIGOXIN,B-TR

Reason,O
for,O
override,O
:,O

will,O
follow,O

MVI,B-TR
THERAPEUTIC,I-TR
W,I-TR
/,I-TR
MINERALS,I-TR
(,I-TR
THERAP,I-TR
VITS,I-TR
/,I-TR
MINERALS,I-TR
),I-TR
1,O
TAB,O
PO,O
QD,O

Override,O
Notice,O
:,O

Override,O
added,O
on,O
01/02/04,O
by,O
KOTESLENT,O
",",O
ANT,O
ODEWYJU,O
",",O
M.D.,O
on,O
order,O
for,O
ZOCOR,B-TR
PO,I-TR
(,O
ref,O
#,O
71920299,O
),O

POTENTIALLY,O
SERIOUS,O
INTERACTION,O
:,O

NIACIN,B-TR
",",O
VIT,O
.,O

B-3,O
and,O
SIMVASTATIN,B-TR

Reason,O
for,O
override,O
:,O

wil,O
follow,O

ZOCOR,B-TR
(,I-TR
SIMVASTATIN,I-TR
),I-TR
40,O
MG,O
PO,O
QHS,O

Food,O
/,O
Drug,O
Interaction,O
Instruction,O

Avoid,O
grapefruit,O
unless,O
MD,O
instructs,O
otherwise,O
.,O

Alert,O
overridden,O
:,O

Override,O
added,O
on,O
01/02/04,O
by,O
KOTESLENT,O
",",O
ANT,O
ODEWYJU,O
",",O
M.D.,O

POTENTIALLY,O
SERIOUS,B-PR
INTERACTION,I-PR
:,O

NIACIN,B-TR
",",O
VIT,O
.,O

B-3,O
and,O
SIMVASTATIN,B-TR

Reason,O
for,O
override,O
:,O

wil,O
follow,O

TOPROL,B-TR
XL,I-TR
(,I-TR
METOPROLOL,I-TR
(,I-TR
SUST.,I-TR
REL.,I-TR
),I-TR
),I-TR
100,O
MG,O
PO,O
QD,O

Food,O
/,O
Drug,O
Interaction,O
Instruction,O

Take,O
consistently,O
with,O
meals,O
or,O
on,O
empty,O
stomach,O
.,O

Number,O
of,O
Doses,O
Required,O
(,O
approximate,O
),O
:,O

5,B-TR
PLAVIX,I-TR
(,I-TR
CLOPIDOGREL,I-TR
),I-TR
75,O
MG,O
PO,O
QD,O
Starting,O
Today,O
(,O
01/06,O
),O
KEFLEX,B-TR
(,I-TR
CEPHALEXIN,I-TR
),I-TR
500,O
MG,O
PO,O
QID,O
X,O
40,O
doses,O
AMIODARONE,B-TR
400,O
MG,O
PO,O
QD,O

Instructions,O
:,O

After,O
7,O
days,O

Alert,O
overridden,O
:,O

Override,O
added,O
on,O
01/07/04,O
by:,O

SERIOUS,B-PR
INTERACTION,I-PR
:,O

DIGOXIN,B-TR
and,O
AMIODARONE,B-TR
HCL,I-TR

Reason,O
for,O
override,O
:,O

ok,O

DIET,O
:,O

House,O
/,O
Low,O
chol,O
/,O
low,O
sat.,O
fat,O

ACTIVITY,O
:,O

Walking,O
as,O
tolerated,O
FOLLOW,O
UP,O
APPOINTMENT,O
(,O
S,O
),O
:,O

Dr.,O
Levels,O
(,O
Electrophysiology,O
),O
4,O
weeks,O
",",O
PCP,O
1-2,O
weeks,O
",",O

ALLERGY,O
:,O

NKA,B-PR

ADMIT,O
DIAGNOSIS,O
:,O

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O
Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O
VT,B-PR
s,O
/,O
p,O
cardiac,B-TE
cath,I-TE
",",O
stent,B-TR
and,O
amio,B-TR
loading,I-TR

OTHER,O
DIAGNOSIS,O
;,O
Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O
VT,B-PR
",",O
CAD,B-PR
s,O
/,O
p,O
MI,B-PR
ischemic,B-PR
cardiomyopathy,I-PR
bilateral,B-TR
knee,I-TR
replacement,I-TR

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O

Cardiac,B-TE
Cath,I-TE
1/6/0004,O

BRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

78,O
M,O
w/,O
longstanding,B-PR
CAD,I-PR
s,O
/,O
p,O
CABG,B-TR
'97,O
",",O
had,O
PPM,B-TR
and,O
AICD,B-TR
placed,O
in,O
'02,O
after,O
admitted,O
for,O
presyncope,B-PR
and,O
found,O
to,O
have,O
inducible,B-PR
VT,I-PR
.,O

in,O
USOH,O
until,O
this,O
am,O
when,O
felt,O
LH,B-PR
and,O
then,O
ICD,B-TR
discharge,I-TR
.,O

Subsequent,O
4,B-TR
ICD,I-TR
discharges,I-TR
at,O
rest,O
.,O

Denies,O
change,B-PR
in,I-PR
ET,I-PR
",",O
chest,B-PR
pain,I-PR
",",O
SOB,B-PR
.,O

Went,O
to,O
OSH,O
c,O
further,B-TR
ICD,I-TR
shocks,I-TR
",",O
VT,B-PR
on,O
monitor,B-TE
but,O
stable,O
VS,O
.,O

Given,O
amio,B-TR
bolu,I-TR
",",O
started,O
on,O
gtt,B-TR
and,O
transferred,O
to,O
NVH,O
for,O
further,B-TE
evaluation,I-TE
.,O

Exam,B-TE
remarkable,O
for,O
b,B-PR
/,I-PR
l,I-PR
carotid,I-PR
bruits,I-PR
",",O
soft,B-PR
murmur,I-PR
at,I-PR
L,I-PR
sternal,I-PR
border,I-PR
",",O
clear,O
chest,O
",",O
1+,B-PR
b,I-PR
/,I-PR
l,I-PR
edema,I-PR
.,O

Labs,B-TE
at,O
OSH,O
c,O
Cr,B-TE
:,O

1.9,O
",",O

Hct,B-TE
:,O

39.1,O
",",O

gluc,B-TE
:,O

214,O
",",O

CK,B-TE
:,O

130,O
",",O

MB,B-TE
:,O

2.6.,O

ECG,B-TE
is,O
AV,O
paced,O
but,O
prior,O
shower,B-PR
R,I-PR
on,I-PR
T,I-PR
VPB,I-PR
c,O
monomorphic,B-PR
VT,I-PR
then,O
overdrive,O
paced,O
.,O

****,O
Course,O

1),O
CV,O
(,O
R,O
),O
finished,O
amio,B-TR
IV,I-TR
load,I-TR
then,O
started,O
on,O
po,O
",",O
agressive,B-TR
lytes,I-TR
;,O
although,O
interrogation,B-TE
showed,O
>100,O
episodes,O
of,O
VT,B-PR
(,O
as,O
/,O
x,O
),O
",",O
pt,O
prefers,O
med,B-TR
therapy,I-TR
as,O
opposed,O
to,O
ablation,B-TR
(,O
I,O
),O
enzymes,B-TE
mildly,B-PR
elevated,I-PR
but,O
not,O
actively,B-PR
ischemic,I-PR
;,O
lipids,B-TE
",",O
ASA,B-TR
",",O
statin,B-TR
",",O
BB,B-TR
;,O
Adenosine,B-TE
thal,I-TE
1/4,O
and,O
echo,B-TE
1/4,O
to,O
look,O
for,O
signs,O
of,O
ischemia,B-PR
as,O
active,O
cause,O
for,O
VT,B-PR
(,O
P,O
),O
JVP,B-TE
at,O
angle,O
of,O
jaw,O
1/4,O
-->,O
giving,O
20,B-TR
Lasix,I-TR
;,O
dig,B-TE
level,I-TE
1/4,O
1.3,O
-->,O
1/2,O
dose,O
as,O
on,O
Amio,B-TR

2),O
Endo,O
:,O

elevated,B-PR
glu,I-PR
on,O
admit,O
BMP,B-TE
and,O
FSG,B-TE
also,O
concurring,O
-->,O
follow,O
and,O
Lispro,B-TR
;,O
will,O
probably,O
need,O
w,B-TE
/,I-TE
u,I-TE
as,O
outpt,O

3),O
Pulm,O
:,O

baseline,B-TE
PFTs,I-TE
as,O
staring,O
amio,B-TR

4),O
GI,O
:,O

baseline,B-TE
LFTs,I-TE
wnl,O
;,O
taking,O
cardiac,B-TR
/,I-TR
ADA,I-TR
diet,I-TR
as,O
glu,B-TE
remains,O
elevated,B-PR

5),O
Renal,O
:,O

baseline,B-TE
CRI,I-TE
(,O
1.2-1.6,O
),O
with,O
elevation,B-PR
at,O
admission,O
probably,O
prerenal,O
;,O
will,O
monitor,O
BUN,B-TE
/,O
Cr,B-TE
after,O
giving,O
Lasix,B-TR

6),O
Proph,O
:,O

PPI,B-TR
and,O
pneumoboots,B-TR

HOSPITAL,O
COURSE,O
and,O
OUTCOME,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
cardiology,O
service,O
and,O
commenced,O
amiodarone,B-TR
loading,I-TR
.,O

Adenosine,B-TE
stress,I-TE
MIBI,I-TE
revealed,O
a,B-PR
small,I-PR
reversible,I-PR
defect,I-PR
in,I-PR
the,I-PR
PDA,I-PR
territory,I-PR
and,O
the,O
patient,O
underwent,O
coronary,B-TE
catheterisation,I-TE
on,O
1/6/0004,O
which,O
revealed,O
a,B-PR
70%,I-PR
lesion,I-PR
in,I-PR
the,I-PR
SVG,I-PR
to,I-PR
PDA,I-PR
->,O
cypher,B-TR
stented,I-TR
successfully,O
.,O

He,O
had,O
occasional,B-PR
ventricular,I-PR
extopyon,I-PR
telemetry,B-TE
but,O
no,O
further,B-PR
recurrence,I-PR
of,O
ventricular,B-PR
tachycardia,I-PR
.,O

During,O
his,O
admission,O
",",O
his,B-TE
am,I-TE
fasting,I-TE
glucose,I-TE
levels,I-TE
were,O
intermittently,B-PR
elevated,I-PR
and,O
his,B-TE
HbA1C,I-TE
was,O
greater,O
than,O
7,O
.,O

I,O
have,O
explained,O
to,O
him,O
that,O
he,O
may,O
have,O
developed,O
some,B-PR
glucose,I-PR
intolerance,I-PR
and,O
that,O
",",O
in,O
the,O
first,O
instance,O
",",O
he,O
should,O
see,O
his,O
Primary,O
Care,O
Physician,O
and,O
attempt,O
dietary,B-TR
control,I-TR
.,O

On,O
the,O
day,O
prior,O
to,O
discharge,O
he,O
noticed,O
a,O
small,O
area,O
of,O
erythema,B-PR
surrounding,O
his,B-TR
R,I-TR
antecubital,I-TR
venous,I-TR
access,I-TR
site,I-TR
.,O

This,O
will,O
be,O
treated,O
empirically,O
with,O
a,O
10,O
day,O
course,O
of,O
Keflex,B-TR
.,O

I,O
have,O
instructed,O
him,O
to,O
see,O
his,O
PCP,O
if,O
it,O
does,O
not,O
improve,O
in,O
a,O
few,O
days,O
or,O
if,O
he,O
develops,O
fevers,B-PR
.,O

In,O
terms,O
of,O
his,B-TR
amiodarone,I-TR
",",O
he,O
will,O
be,O
discharged,O
on,O
400mg,O
po,O
bid,O
for,O
a,O
further,O
7,O
days,O
followed,O
by,O
400mg,O
qd,O
thereafter,O
.,O

He,O
will,O
followup,O
with,O
Dr.,O
Levels,O
in,O
device,O
clinic,O
in,O
4,O
weeks,O
.,O

I,O
have,O
advised,O
him,O
that,O
he,O
must,O
not,O
drive,O
until,O
he,O
is,O
seena,O
gain,O
in,O
clinic,O
and,O
his,B-TR
device,I-TR
interrogated,O
.,O

ADDITIONAL,O
COMMENTS,O
:,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O

TO,O
DO,O
/,O
PLAN,O
:,O

No,O
dictated,O
summary,O

ENTERED,O
BY,O
:,O

STENVERS,O
",",O
IMARL,O
",",O
M.D.,O
(,O
AW45,O
),O
01/07/04,O
02:14,O
PM,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

?Admission,O
Date,O
:,O

2015-10-10,O

Discharge,O
Date,O
:,O

2015-10-21,O

Date,O
of,O
Birth,O
:,O

1953-07-19,O

Sex,O
:,O

M,O

Service,O
:,O

CMED,O
CSRU,O

Allergies,O
:,O

Coumadin,B-TR

Attending,O
:,O
James,O
I,O
"Schultz,",O
M.D.,O

Chief,O
Complaint,O
:,O

fever,B-PR
",",O
left,B-PR
lower,I-PR
extremity,I-PR
redness,I-PR
",",O
dysuria,B-PR
",",O
inability,B-PR
to,I-PR
urinate,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

Transesophageal,B-TE
Echocardiogram,I-TE

History,O
of,O
Present,O
Illness,O
:,O

62,O
year-old,O
status-post,O
gastric,B-TR
bypass,I-TR
and,O
laprascopic,B-TR
cholecystectomy,I-TR
7,O
weeks,O
prior,O
to,O
admission,O
who,O
presented,O
with,O
fever,B-PR
",",O
chills,B-PR
",",O
and,O
left,B-PR
lower,I-PR
extemity,I-PR
redness,I-PR
.,O

The,O
patient,O
has,O
a,O
history,O
of,O
multiple,O
hospitalizations,O
for,O
lower,B-PR
extremity,I-PR
cellulitis,I-PR
and,O
noted,O
that,O
his,B-PR
symptoms,I-PR
and,O
the,O
appearance,O
of,O
his,O
left,O
leg,O
mirrored,O
previous,B-PR
episodes,I-PR
.,O

He,O
denied,O
recent,B-PR
trauma,I-PR
to,I-PR
the,I-PR
area,I-PR
or,O
travel,O
.,O

Review,B-TE
of,I-TE
systems,I-TE
was,O
significant,O
only,O
for,O
painful,B-PR
urination,I-PR
over,O
the,O
past,O
few,O
days,O
and,O
a,B-PR
reduction,I-PR
in,I-PR
urine,I-PR
output,I-PR
.,O

He,O
denied,O
chest,B-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
palpitations,B-PR
",",O
abdominal,B-PR
pain,I-PR
",",O
N/V,B-PR
",",O
penile,B-PR
discharge,I-PR
.,O

Past,O
Medical,O
History,O
:,O

1.,O
Morbid,B-PR
obesity,I-PR

2.,O
Frequent,B-PR
cellulitis,I-PR

3.,O
Lymphedema,B-PR
.,O

4.,O
CAD,B-PR
s/p,O
velocity,B-TR
stenting,I-TR
proximal,I-TR
LAD,I-TR
2002,O

5.,O
Osteoarthritis,B-PR
of,I-PR
the,I-PR
knees,I-PR

6.,O
Hypertension,B-PR

7.,O
Hypercholesterolemia,B-PR

8.,O
Obstructive,B-PR
sleep,I-PR
apnea,I-PR

9.,O
CVA,B-PR
x2,O
with,O
left-sided,B-PR
weakness,I-PR

10.,O
Gastric,B-TR
bypass,I-TR
surgery,I-TR
7,O
weeks,O
PTA,O

11.,O
Lap,B-TR
cholecystectomy,I-TR
7,O
weeks,O
PTA,O

Physical,O
Exam,O
:,O

VS,B-TE
T,O
101.4,O
BP,B-TE
85/50,O
HR,B-TE
130,O

RR,B-TE
20,O
O2,B-TE
Sat,I-TE
:,O
98%,O
RA,O

GEN,O
:,O
Obese,B-PR
male,O
",",O
AAOx3,O

HEENT,O
:,O
MM,B-PR
dry,I-PR
",",O
JVD,B-PR
cannot,O
be,O
assessed,O

CV,O
:,O
Irregularly,B-PR
irregular,I-PR
rhytmm,I-PR
",",O
no,O
m/r/g,B-PR

Chest,O
:,O
CTAB,O

ABD,O
:,O
Obese,B-PR
",",O
NT/ND,B-PR
",",O
no,O
rebound/guarding,B-PR

EXT,O
:,O
3+,B-PR
bilateral,I-PR
edema,I-PR
",",O
LLE,B-PR
edema,I-PR
and,O
erythema,B-PR
",",O
no,O
chords,B-PR
",",O
+,O
warmth,B-PR
",",O
+,O
chronic,B-PR
venous,I-PR
changes,I-PR
",",O
negative,O
Homens,O

Pertinent,O
Results,O
:,O

2015-10-10,O
02:16PM,O

WBC,B-TE
-,O
6.3,O
RBC,B-TE
-,O
4.90,O
HGB,B-TE
-,O
14.1,O
HCT,B-TE
-,O
41.0,O
MCV,B-TE
-,O
84,O
MCH,B-TE
-,O
28.7,O
MCHC,B-TE
-,O
34.4,O
RDW,B-TE
-,O
15.0,O

2015-10-10,O
02:16PM,O

NEUTS,B-TE
-,O
92,O
*,O
BANDS,B-TE
-,O
4,O
LYMPHS,B-TE
-,O
2,O
*,O
MONOS,B-TE
-,O
2,O
EOS,B-TE
-,O
0,O
BASOS,B-TE
-,O
0,O
ATYPS,B-TE
-,O
0,O
METAS,B-TE
-,O
0,O
MYELOS,B-TE
-,O
0,O

2015-10-10,O
02:16PM,O

PLT,B-TE
SMR,I-TE
-,O
NORMAL,O
PLT,B-TE
COUNT,I-TE
-,O
143,O
*#,O

2015-10-10,O
02:16PM,O
URINE,B-TE

BLOOD,B-TE
-,O
NEG,O
NITRITE,B-TE
-,O
NEG,O
PROTEIN,B-TE
-,O
NEG,O
GLUCOSE,B-TE
-,O
NEG,O
KETONE,B-TE
-,O
NEG,O
BILIRUBIN,B-TE
-,O
NEG,O
UROBILNGN,B-TE
-,O
NEG,O
PH,B-TE
-,O
5.0,O
LEUK,B-TE
-,O
SM,O

2015-10-10,O
02:16PM,O

CALCIUM,B-TE
-,O
9.6,O
PHOSPHATE,B-TE
-,O
0.8,O
*#,O
MAGNESIUM,B-TE
-,O
1.4,O
*,O

2015-10-10,O
02:16PM,O

CK-MB,B-TE
-,O
2,O
cTropnT,B-TE
-<,O
0.01,O

2015-10-10,O
02:16PM,O

CK(CPK),B-TE
-,O
109,O

2015-10-10,O
02:34PM,O

LACTATE,B-TE
-,O
2.4,O
*,O

2015-10-10,O
07:42PM,O

PT,B-TE
-,O
16.6,O
*,O
PTT,B-TE
-,O
32.2,O
INR(PT),B-TE
-,O
1.7,O

2015-10-10,O
07:42PM,O

ALBUMIN,B-TE
-,O
3.0,O
*,O
CALCIUM,B-TE
-,O
7.6,O
*,O
PHOSPHATE,B-TE
-,O
1.6,O
*,O
MAGNESIUM,B-TE
-,O
1.1,O
*,O

2015-10-10,O
07:42PM,O

ALT(SGPT),B-TE
-,O
28,O
AST(SGOT),B-TE
-,O
27,O
LD(LDH),B-TE
-,O
191,O
CK(CPK),B-TE
-,O
58,O
ALK,B-TE
PHOS,I-TE
-,O
63,O
AMYLASE,B-TE
-,O
27,O
TOT,B-TE
BILI,I-TE
-,O
0.9,O

2015-10-10,O
08:19PM,O

LACTATE,B-TE
-,O
1.9,O

Brief,O
Hospital,O
Course,O
:,O

This,O
62,O
year-old,O
obese,O
male,O
was,O
admitted,O
with,O
cellulitis,B-PR
and,O
presumed,O
bacteremia,B-PR
.,O

In,O
the,O
John,O
",",O
he,O
was,O
found,O
to,O
be,O
in,O
hypotensive,B-PR
atrial,I-PR
fibrillation,I-PR
.,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
Medical,O
ICU,O
where,O
his,B-PR
hypotension,I-PR
was,O
managed,O
with,O
IVF,B-TR
hydration,I-TR
and,O
he,O
was,O
maintained,O
on,O
a,B-TR
diltiazam,I-TR
drip,I-TR
for,O
atrial,B-PR
fibrillation,I-PR
.,O

After,O
his,B-TE
heart,I-TE
rate,I-TE
was,O
controlled,O
",",O
he,O
was,O
transitioned,O
to,O
oral,B-TR
medications,I-TR
and,O
transferred,O
to,O
the,O
medicine,O
service,O
.,O

1.,O
Cellulitis,B-PR
/,O
Bacteremia,B-PR

Review,O
of,O
the,O
medical,O
record,O
revealed,O
several,O
previous,O
admissions,O
for,O
cellulitis,B-PR
and,O
bacteremia,B-PR
.,O

Blood,B-TE
cultures,I-TE
on,O
this,O
admission,O
and,O
were,O
positive,O
for,O
Beta,B-PR
streptococcus,I-PR
Group,I-PR
B,I-PR
.,O

The,O
patient,O
had,O
previous,O
episodes,O
of,O
the,B-PR
same,I-PR
infection,I-PR
",",O
with,O
lower,B-PR
extremity,I-PR
cellulitis,I-PR
the,O
likely,O
source,O
.,O

A,B-TE
left,I-TE
lower,I-TE
extremity,I-TE
ultrasound,I-TE
was,O
negative,O
for,O
deep,B-PR
venous,I-PR
thrombosis,I-PR
.,O

The,O
patient,O
was,O
too,B-PR
large,I-PR
to,O
have,O
a,B-TE
CTA,I-TE
.,O

He,O
was,O
initially,O
treated,O
with,O
vancomycin,B-TR
and,O
zosyn,B-TR
while,O
awaiting,O
culture,B-TE
results,O
.,O

Once,O
the,B-PR
organism,I-PR
was,O
identified,O
",",O
he,O
was,O
transitioned,O
to,O
a,O
regimen,O
of,O
intravenous,B-TR
penicillin,I-TR
and,O
oral,B-TR
levofloxacin,I-TR
",",O
which,O
had,O
successfully,O
treated,O
the,B-PR
infection,I-PR
during,O
his,O
most,O
recent,O
admission,O
1,O
year,O
prior,O
.,O

He,O
completed,O
7,O
days,O
of,O
levofloxacin,B-TR
and,O
had,O
a,B-TR
PICC,I-TR
line,I-TR
placed,O
to,O
facilitate,O
a,O
2,O
week,O
course,O
of,O
IV,B-TR
Penicillin,I-TR
.,O

2.,O
Atrial,B-PR
fibrillation,I-PR

The,O
patient,O
's,O
development,O
of,O
atrial,B-PR
fibrillation,I-PR
was,O
believed,O
to,O
be,O
secondary,O
to,O
infection,B-PR
and,O
structural,B-PR
heart,I-PR
disease,I-PR
.,O

It,O
was,O
initially,O
managed,O
with,O
intravenous,B-TR
diltiazam,I-TR
",",O
and,O
it,O
was,O
later,O
managed,O
with,O
metoprolol,B-TR
and,O
anticoagulation,B-TR
.,O

A,B-TE
transthoracic,I-TE
echocardiogram,I-TE
showed,O
a,B-PR
mildly,I-PR
dilated,I-PR
and,I-PR
elongated,I-PR
left,I-PR
atrium,I-PR
",",O
with,O
a,B-PR
markedly,I-PR
dilated,I-PR
right,I-PR
atrium,I-PR
.,O

He,O
had,O
occasional,O
episodes,O
of,O
rapid,B-PR
atrial,I-PR
fibrillation,I-PR
that,O
were,O
controlled,O
with,O
responded,O
to,O
IV,B-TR
metoprolol,I-TR
.,O

However,O
",",O
his,B-TE
rate,I-TE
proved,O
difficult,O
to,O
control,O
despite,O
metoprolol,B-TR
and,O
diltiazam,B-TR
.,O

The,O
EP,O
service,O
was,O
consulted,O
and,O
recommended,O
transesophageal,B-TE
echocardiogram,I-TE
and,O
cardioversion,B-TR
.,O

The,B-TE
TEE,I-TE
was,O
negative,O
for,O
thrombus,B-PR
and,O
the,O
patient,O
was,O
successfully,O
cardioverted,O
to,O
normal,O
sinus,O
rhythm,O
with,O
ibutilide,B-TR
.,O

He,O
was,O
subsequently,O
started,O
on,O
amiodarone,B-TR
and,O
is,O
scheduled,O
to,O
complete,O
a,O
10,O
week,O
course,O
.,O

EKG,B-TE
before,O
discharge,O
showed,O
mild,B-PR
QT,I-PR
prolongation,I-PR
and,O
no,O
effect,O
from,O
amiodarone,B-TR
.,O

EKG,B-TE
and,O
LFTs,B-TE
should,O
be,O
monitored,O
by,O
his,O
PCP,O
",",O
William,O
given,O
the,O
high,O
dose,O
of,O
amiodarone,B-TR
he,O
will,O
receive,O
.,O

3.,O
FEN,O

He,O
was,O
followed,O
by,O
the,O
nutrition,O
team,O
throughout,O
his,O
admission,O
and,O
their,O
recommendations,O
were,O
followed,O
.,O

He,O
demonstrated,O
several,B-PR
asymptomatic,I-PR
electrolyte,I-PR
deficiecies,I-PR
;,O
these,O
were,O
likely,O
due,O
to,O
inadequate,B-PR
absorption,I-PR
following,O
his,B-TR
surgery,I-TR
and,O
he,O
responded,O
well,O
to,O
repletion,B-TR
.,O

Vitamin,B-TE
D,I-TE
and,O
parathyroid,B-TE
tests,I-TE
were,O
pending,O
at,O
the,O
time,O
of,O
discharge,O
.,O

The,O
patient,O
was,O
discharged,O
to,O
Kindred,O
Park,O
View,O
Specialty,O
Hospital,O
of,O
Springfield,O
Rehabilitation,O
Hospital,O
in,O
good,O
condition,O
.,O

He,O
was,O
sent,O
with,O
a,B-TE
King,I-TE
of,I-TE
Hearts,I-TE
monitor,I-TE
and,O
scheduled,O
for,O
follow-up,O
with,O
cardiology,O
and,O
his,O
primary,O
care,O
physician,O
.,O

Discharge,O
Medications,O
:,O

1.,O
Amiodarone,B-TR
HCl,I-TR
400,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
one,O
tid,O
for,O
2,O
weeks,O
",",O
then,O
1,O
qd,O
for,O
2,O
months,O
for,O
2,O
months,O
:,O
Please,O
take,O
1,O
tablet,O
3,O
times,O
per,O
day,O
for,O
2,O
weeks,O
",",O
then,O
take,O
1,O
tablet,O
per,O
day,O
for,O
2,O
months,O
.,O

Disp,O
:*,O
105,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

2.,O
Atorvastatin,B-TR
Calcium,I-TR
20,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
QD,O
(,O
once,O
a,O
day,O
).,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
1,O
*,O

3.,O
Zolpidem,B-TR
Tartrate,I-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
HS,O
(,O
at,O
bedtime,O
).,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

4.,O
Potassium,B-TR
&,I-TR
Sodium,I-TR
Phosphates,I-TR
(,O
875,O
),O
623,O
9797,O
mg,O
Packet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Packet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

Disp,O
:*,O
60,O
Packet,O
(s)*,O
Refills,O
:*,O
2,O
*,O

5.,O
Warfarin,B-TR
Sodium,I-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
HS,O
(,O
at,O
bedtime,O
).,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

6.,O
Penicillin,B-TR
G,I-TR
Pot,I-TR
in,I-TR
Dextrose,I-TR
"2,000,000",O
unit,O
/,O
50,O
mL,O
Piggyback,O
Sig,O
:,O
One,O
(,O
1,O
),O
Intravenous,O
Q4H,O
(,O
every,O
4,O
hours,O
).,O

Disp,O
:*,O
30,O
bags,O
*,O
Refills,O
:*,O
0,O
*,O

7.,O
Aspirin,B-TR
325,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
QD,O
(,O
once,O
a,O
day,O
).,O

8.,O
Acetaminophen,B-TR
325,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
.,O

9.,O
Pantoprazole,B-TR
Sodium,I-TR
40,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
Q24H,O
(,O
every,O
24,O
hours,O
).,O

10.,O
Calcium,B-TR
Carbonate,I-TR
500,O
mg,O
Tablet,O
",",O
Chewable,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Chewable,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

Disp,O
:*,O
60,O
Tablet,O
",",O
Chewable,O
(s)*,O
Refills,O
:*,O
2,O
*,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Facility,O
:,O

McLean,O
Hospital,O
&,O
Rehab,O
Center,O
-,O
Tewksbury,O
State,O
Hospital,O

Discharge,O
Diagnosis,O
:,O

Atrial,B-PR
fibrillation,I-PR
",",O
Cellulitis,B-PR
",",O
Bacteremia,B-PR

Discharge,O
Condition,O
:,O

Good,O

Discharge,O
Instructions,O
:,O

Please,O
take,O
all,O
over,O
your,B-TR
medications,I-TR
.,O

Please,O
make,O
a,O
follow-up,O
appointments,O
with,O
Dr.,O
Robinson,O
Dr.,O
Sturtevant,O
.,O

Return,O
to,O
the,O
Emergency,O
Department,O
if,O
you,O
develop,O
fevers,B-PR
",",O
chills,B-PR
",",O
chest,B-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
palpitations,B-PR
",",O
or,O
lightheadedness,B-PR
.,O

Followup,O
Instructions,O
:,O

Please,O
keep,O
your,O
appointment,O
with,O
Dr.,O
Ryan,O
on,O
Monday,O
",",O
12-07,O
at,O
11,O
AM,O
.,O

Please,O
call,O
Dr.,O
Pytel,O
(,O
760,O
),O
496-3627,O
and,O
make,O
a,O
follow-up,O
appointment,O
for,O
1,O
week,O
",",O
and,O
discuss,O
resuming,O
your,B-TR
other,I-TR
outpatient,I-TR
medications,I-TR
at,O
that,O
time,O
.,O

Janine,O
Karina,O
MD,O
98-439,O

Completed,O
by,O
:,O
Opal,O
Anne,O
MD,O
40-158,O
2015-10-22,O
@,O
1759,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Stephen,O
Williams,O
on,O
:,O
SAT,O
2015-10-24,O
9:46,O
AM,O

(,O
End,O
of,O
Report,O
),O

13496896,O

FIH,O

4925669,O

21983/7jk2,O

129165,O

02/22/1992,O
12:00:00,O
AM,O

LEFT,B-PR
CORONARY,I-PR
ARTERY,I-PR
STENOSIS,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

02/22/92,O

DISCHARGE,O
DATE,O
:,O

03/08/92,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

left,B-PR
coronary,I-PR
artery,I-PR
stenosis,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

diabetes,B-PR
mellitus,I-PR
with,O
diabetic,B-PR
renopathy,I-PR
",",O
renovascular,B-PR
occlusive,I-PR
disease,I-PR
",",O
with,O
thrombosis,B-PR
of,I-PR
the,I-PR
right,I-PR
renal,I-PR
artery,I-PR
",",O
hypertension,B-PR
",",O
probably,O
renal,O
vascular,O
",",O
hypertensive,B-PR
cardiac,I-PR
disease,I-PR
with,O
history,O
of,O
congestive,B-PR
heart,I-PR
failure,I-PR
",",O
chronic,B-PR
renal,I-PR
insufficiency,I-PR
",",O
coronary,B-PR
artery,I-PR
disease,I-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

03/03/92,O
-,O
left,B-TR
carotid,I-TR
endarterectomy,I-TR
with,O
continuous,B-TE
interoperative,I-TE
electroencephalogram,I-TE
monitoring,I-TE
and,O
saphenous,B-TR
vein,I-TR
patch,I-TR
closure,I-TR
.,O

ASSOCIATED,O
PROCEDURES,O
:,O

Sep/24/05,O
cardiac,B-TE
catheterization,I-TE
and,O
coronary,B-TE
angiography,I-TE
",",O
02/23/92,O
-,O
transfemoral,B-TE
aortogram,I-TE
",",O
bilateral,B-TE
carotid,I-TE
arteriogram,I-TE
",",O
abdominal,B-TE
aortogram,I-TE
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Patient,O
is,O
a,O
72,O
year,O
old,O
female,O
with,O
known,B-PR
carotid,I-PR
stenosis,I-PR
",",O
and,O
recent,B-TE
carotid,I-TE
noninvasives,I-TE
at,O
an,O
outside,O
hospital,O
",",O
which,O
showed,O
90%,B-PR
left,I-PR
sided,I-PR
stenosis,I-PR
.,O

She,O
has,O
not,O
had,O
a,B-PR
stroke,I-PR
",",O
or,O
transient,B-PR
ischemic,I-PR
attack,I-PR
.,O

She,O
was,O
recently,O
discharged,O
from,O
the,O
Per,O
Naplesspecrycet,O
Hospital,O
after,O
an,O
admission,O
for,O
congestive,B-PR
heart,I-PR
failure,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

As,O
noted,O
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

Significant,O
for,O
having,O
had,O
a,B-TR
cholecystectomy,I-TR
and,O
hysterectomy,B-TR
",",O
tonsillectomy,B-TR
and,O
adenoidectomy,B-TR
",",O
and,O
mastoidectomy,B-TR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Insulin,B-TR
44,O
units,O
NPH,B-TR
qam,O
;,O
8,O
units,O
qpm,O
;,O
Vasotec,B-TR
2.5,O
qd,O
;,O
Lasix,B-TR
40,O
qd,O
;,O
Mevacor,B-TR
40,O
qd,O
;,O
Cardizem,B-TR
CD,I-TR
180,O
qd,O
;,O
Ciprofloxacin,B-TR
for,O
urinary,B-PR
tract,I-PR
infection,I-PR
;,O
aspirin,B-TR
.,O

ALLERGIES,O
:,O

Seldane,B-TR
causes,O
gastrointestinal,B-PR
distress,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Clear,O
chest,O
.,O

Cardiac,O
:,O

regular,O
rate,O
and,O
rhythm,O
.,O

Extremities,O
:,O

revealed,O
2+,B-TE
carotid,I-TE
pulses,I-TE
with,O
bruits,B-PR
bilaterally,I-PR
",",O
2+,B-TE
radial,I-TE
",",O
2+,B-TE
femoral,I-TE
",",O
1+,B-TE
dorsalis,I-TE
pedis,I-TE
bilaterally,I-TE
.,O

LABORATORY,O
DATA,O
ON,O
ADMISSION,O
:,O

Significant,O
for,O
BUN,B-TE
and,O
creatinine,B-TE
33/2.4,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
Tau,O
Memorial,O
Hospital,O
.,O

She,O
was,O
seen,O
by,O
Dr.,O
Freiermthalskush,O
of,O
the,O
renal,O
service,O
for,O
management,B-TR
of,O
her,B-PR
chronic,I-PR
renal,I-PR
insufficiency,I-PR
.,O

On,O
02/22,O
",",O
she,O
underwent,O
angiography,B-TE
",",O
which,O
revealed,O
minimal,B-PR
right,I-PR
internal,I-PR
carotid,I-PR
artery,I-PR
disease,I-PR
",",O
and,O
proximal,B-PR
left,I-PR
internal,I-PR
carotid,I-PR
artery,I-PR
stenosis,I-PR
",",O
2,O
cm,O
in,O
length,O
for,O
the,O
1,O
mm,O
residual,O
lumen,O
.,O

The,O
left,O
anterior,O
communicating,O
artery,O
fell,O
from,O
the,O
right,O
.,O

She,O
was,O
also,O
seen,O
by,O
Cardiology,O
",",O
and,O
she,O
underwent,O
cardiac,B-TE
catheterization,I-TE
",",O
as,O
part,O
of,O
her,B-TE
preop,I-TE
evaluation,I-TE
",",O
which,O
revealed,O
normal,O
resting,O
hemodynamics,O
",",O
and,O
a,O
moderate,O
posterior,O
descending,O
artery,O
",",O
and,O
obtuse,B-PR
marginal,I-PR
stenoses,I-PR
.,O

She,O
was,O
",",O
therefore,O
",",O
cleared,O
for,O
the,O
operating,O
room,O
",",O
and,O
on,O
3/3/92,O
",",O
she,O
underwent,O
a,B-TR
left,I-TR
carotid,I-TR
endarterectomy,I-TR
",",O
with,O
continuous,B-TE
electroencephalogram,I-TE
monitoring,I-TE
and,O
vein,B-TR
patch,I-TR
angioplasty,I-TR
",",O
which,O
was,O
uneventful,O
.,O

Her,O
postoperative,O
course,O
was,O
marked,O
only,O
by,O
prolonged,B-PR
ileus,I-PR
",",O
perhaps,O
secondary,O
to,O
constipation,B-PR
",",O
with,O
persistent,B-PR
vomiting,I-PR
",",O
requiring,O
intravenous,B-TR
fluids,I-TR
",",O
however,O
",",O
on,O
03/07/92,O
",",O
she,O
had,O
a,O
large,O
bowel,O
movement,O
",",O
after,O
aggressive,B-TR
bowel,I-TR
regime,I-TR
",",O
felt,O
significantly,O
better,O
",",O
was,O
able,O
to,O
tolerate,O
PO,O
&apos;s,O
.,O

She,O
is,O
now,O
able,O
to,O
be,O
discharged,O
home,O
on,O
her,B-TR
admission,I-TR
medications,I-TR
",",O
with,O
the,O
exception,O
of,O
the,O
fact,O
that,O
Vasotec,B-TR
was,O
increased,O
to,O
10,O
mg,O
PO,O
bid,O
.,O

SHERMENE,O
JESCSELC,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

LENNI,O
BREUTZOLN,O
",",O
M.D.,O
.,O

TR,O
:,O

pv,O
/,O
bmot,O

DD,O
:,O

03/08/92,O

TD,O
:,O

03/10/92,O

CC,O
:,O

Dr.,O
Person,O

Admission,O
Date,O
:,O

2016-05-05,O

Discharge,O
Date,O
:,O

2016-06-15,O

Date,O
of,O
Birth,O
:,O

2016-05-05,O

Sex,O
:,O

F,O

Service,O
:,O

NEONATOLOGY,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
30,O
and,O
08-01,O
week,O
gestation,O
female,O
",",O
triplet,O
number,O
two,O
",",O
delivered,O
by,O
cesarean,B-TR
section,I-TR
due,O
to,O
progressive,B-PR
preterm,I-PR
labor,I-PR
and,O
triplet,B-PR
gestation,I-PR
.,O

PERINATAL,O
HISTORY,O
:,O

Mother,O
is,O
a,O
29,O
year-old,O
gravida,O
4,O
",",O
para,O
1,O
mother,O
",",O
Marian,O
Jane,O
conception,O
",",O
EDC,O
2016-07-08,O
.,O

Prenatal,B-TE
screen,I-TE
",",O
O,O
positive,O
",",O
antibody,B-TE
negative,O
",",O
RPR,B-TE
nonreactive,O
",",O
hepatitis,B-TE
B,I-TE
surface,I-TE
antigen,I-TE
negative,O
",",O
reportedly,O
GBS,B-TE
negative,O
",",O
Rubella,B-TE
immune,O
.,O

Pregnancy,O
complicated,O
by,O
gestational,B-PR
diabetes,I-PR
mellitus,I-PR
",",O
then,O
possible,O
preterm,B-PR
labor,I-PR
.,O

Mother,O
presented,O
with,O
abdominal,B-PR
discomfort,I-PR
and,O
vaginal,B-PR
pressure,I-PR
at,O
23,O
and,O
1/7,O
weeks,O
.,O

At,O
that,O
time,O
she,O
was,O
admitted,O
and,O
received,O
a,B-TR
full,I-TR
course,I-TR
of,I-TR
betamethasone,I-TR
at,O
24,O
weeks,O
and,O
remained,O
in,O
house,O
until,O
delivery,B-TR
.,O

Mother,O
presented,O
on,O
day,O
of,O
delivery,B-TR
with,O
preterm,B-PR
labor,I-PR
",",O
cervical,B-PR
dilation,I-PR
",",O
therefore,O
delivered,O
by,O
repeat,B-TR
cesarean,I-TR
section,I-TR
.,O

This,O
triplet,O
required,O
only,O
blow,B-TR
by,I-TR
oxygen,I-TR
and,O
routine,B-TR
care,I-TR
in,O
delivery,O
room,O
.,O

Apgars,B-TE
were,O
8,O
at,O
one,O
minute,O
and,O
9,O
at,O
five,O
minutes,O
.,O

Infant,O
demonstrated,O
mild,B-PR
increased,I-PR
work,I-PR
of,I-PR
breathing,I-PR
in,O
the,O
delivery,O
room,O
.,O

Infant,O
transported,O
to,O
Neonatal,O
Intensive,O
Care,O
Unit,O
on,O
facial,B-TR
CPAP,I-TR
.,O

PHYSICAL,O
EXAMINATION,O
ON,O
ADMISSION,O
:,O

Birth,B-TE
weight,I-TE
1455,O
grams,O
(,O
50th,O
percentile,O
"),",O
head,B-TE
circumference,I-TE
29.25,O
cm,O
(,O
50th,O
percentile,O
"),",O
length,B-TE
41.5,O
cm,O
(,O
50th,O
percentile,O
).,O

Nondysmorphic,B-PR
with,O
overall,O
appearance,O
consistent,O
with,O
gestational,O
age,O
.,O

Anterior,O
fontanel,O
soft,O
",",O
open,O
",",O
flat,O
",",O
red,B-TE
reflex,I-TE
present,O
bilaterally,O
",",O
palate,O
intact,O
.,O

Intermittent,B-PR
grunting,I-PR
",",O
moderate,B-PR
intercostal,I-PR
retractions,I-PR
",",O
diminished,B-PR
air,I-PR
entry,I-PR
",",O
regular,O
rate,O
and,O
rhythm,O
without,O
murmur,B-PR
",",O
2+,O
femoral,B-TE
pulses,I-TE
.,O

Abdomen,O
benign,O
with,O
no,O
hepatosplenomegaly,B-PR
or,O
masses,B-PR
.,O

No,O
external,O
female,O
genitalia,O
.,O

Normal,O
back,O
and,O
extremities,O
with,O
stable,O
hips,O
",",O
appropriate,O
tone,O
",",O
skin,O
pink,O
with,O
fair,O
perfusion,O
.,O

HOSPITAL,O
COURSE,O
:,O

1.,O
Pulmonary,O
:,O

On,O
admission,O
the,O
infant,O
required,O
CPAP,B-TR
6,O
cm,O
of,O
water,O
",",O
30%,B-TR
oxygen,I-TR
.,O

Initial,B-TE
capillary,I-TE
blood,I-TE
gas,I-TE
was,O
pH,B-TE
7.29,O
",",O
CO2,B-TE
47,O
.,O

Infant,O
was,O
intubated,B-TR
on,O
day,O
of,O
life,O
two,O
for,O
increased,B-PR
respiratory,I-PR
distress,I-PR
and,O
received,O
one,O
dose,O
of,O
surfactant,B-TR
.,O

Infant,O
was,O
extubated,B-TR
on,O
day,O
of,O
life,O
four,O
to,O
CPAP,B-TR
and,O
transitioned,O
to,O
room,O
air,O
on,O
day,O
of,O
life,O
six,O
.,O

The,O
infant,O
has,O
remained,O
in,O
room,O
air,O
throughout,O
the,O
hospitalization,O
.,O

Caffeine,B-TR
citrate,I-TR
was,O
started,O
on,O
day,O
of,O
life,O
six,O
and,O
was,O
discontinued,O
on,O
05-23,O
(,O
day,O
of,O
life,O
18,O
).,O

The,B-PR
last,I-PR
apnea,I-PR
and,O
bradycardia,B-PR
was,O
on,O
06-10,O
.,O

2.,O
Cardiovascular,O
:,O

The,O
infant,O
has,O
remained,O
hemodynamically,O
stable,O
throughout,O
this,O
hospitalization,O
",",O
no,O
murmur,B-PR
.,O

Heart,B-TE
rate,I-TE
150,O
to,O
160,O
",",O
mean,B-TE
blood,I-TE
pressure,I-TE
40,O
to,O
54,O
.,O

3.,O
Fluid,O
",",O
electrolytes,O
and,O
nutrition,O
:,O

Infant,O
was,O
initially,O
nothing,B-TR
by,I-TR
mouth,I-TR
receiving,O
80,O
cc,O
per,O
kilogram,O
per,O
day,O
of,O
D10W,B-TR
intravenously,I-TR
.,O

Infant,O
was,O
started,O
on,O
enteral,B-TR
feedings,I-TR
on,O
day,O
of,O
life,O
four,O
and,O
advanced,O
to,O
full,O
volume,O
feedings,O
of,O
150,O
cc,O
per,O
kilogram,O
per,O
day,O
by,O
day,O
of,O
life,O
seven,O
.,O

During,O
feeding,B-TR
advancement,I-TR
infant,O
was,O
given,O
parenteral,B-TR
nutrition,I-TR
and,O
intralipids,B-TR
.,O

The,O
infant,O
tolerated,O
feeding,B-TR
advancement,I-TR
without,O
difficulty,B-PR
.,O

Infant,O
was,O
advanced,O
to,O
maximum,O
caloric,O
density,O
of,O
breast,O
milk,O
or,O
premature,B-TR
Enfamil,I-TR
26,O
calories,O
per,O
ounce,O
with,O
ProMod,B-TR
by,O
day,O
of,O
life,O
11,O
.,O

Infant,O
is,O
currently,O
on,O
breast,O
milk,O
or,O
Enfamil,B-TR
24,O
calories,O
per,O
ounce,O
po,O
minimum,O
140,O
cc,O
per,O
kilogram,O
per,O
day,O
.,O

The,B-TE
most,I-TE
recent,I-TE
weight,I-TE
is,O
2525,O
g.,O

Head,B-TE
circumference,I-TE
24.5,O
cm,O
",",O
length,B-TE
45.5,O
cm,O
.,O

The,B-TE
most,I-TE
recent,I-TE
electrolytes,I-TE
on,O
day,O
of,O
life,O
five,O
were,O
sodium,B-TE
145,O
",",O
chloride,B-TE
115,O
",",O
potassium,B-TE
4,O
",",O
TCO2,B-TE
of,O
21,O
.,O

On,O
day,O
of,O
life,O
25,O
",",O
calcium,B-TE
10.1,O
",",O
phosphorus,B-TE
6.9,O
",",O
alkaline,B-TE
phosphatase,I-TE
341,O
.,O

4.,O
Gastrointestinal,O
:,O

Infant,O
was,O
started,O
on,O
double,B-TR
phototherapy,I-TR
on,O
day,O
of,O
life,O
two,O
for,O
a,B-TE
maximum,I-TE
bilirubin,I-TE
level,I-TE
of,O
8.1,O
with,O
a,B-TE
direct,I-TE
of,O
0.3,O
.,O

Infant,O
decreased,O
to,O
single,B-TR
phototherapy,I-TR
and,O
phototherapy,B-TR
was,O
discontinued,O
on,O
day,O
of,O
life,O
six,O
.,O

Rebound,B-TE
bilirubin,I-TE
level,I-TE
on,O
day,O
of,O
life,O
seven,O
was,O
5.3,O
with,O
a,B-TE
direct,I-TE
of,O
0.3,O
.,O

5.,O
Hematology,O
:,O

The,O
infant,O
did,O
not,O
receive,O
any,B-TR
blood,I-TR
transfusions,I-TR
this,B-TR
hospitalization,I-TR
.,O

The,B-TE
most,I-TE
recent,I-TE
hematocrit,I-TE
on,O
day,O
of,O
life,O
two,O
was,O
47%,O
.,O

CBC,B-TE
on,O
admission,O
white,B-TE
blood,I-TE
cell,I-TE
count,I-TE
8.9,O
",",O
hematocrit,B-TE
47%,O
",",O
platelets,B-TE
"243,000",O
",",O
6%,O
neutrophils,B-TE
",",O
0,O
bands,B-TE
.,O

Repeat,B-TE
CBC,I-TE
on,O
day,O
of,O
life,O
two,O
showed,O
a,B-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
of,O
8.4,O
",",O
platelets,B-TE
95,O
",",O
41%,O
neutrophils,B-TE
",",O
0,O
bands,B-TE
.,O

Repeat,B-TE
platelet,I-TE
count,I-TE
on,O
day,O
of,O
life,O
three,O
was,O
229,O
.,O

6.,O
Infectious,O
disease,O
:,O

The,O
infant,O
received,O
48,O
hours,O
of,O
ampicillin,B-TR
and,O
gentamicin,B-TR
for,O
rule,O
out,O
sepsis,B-PR
.,O

Blood,B-TE
cultures,I-TE
remained,O
negative,O
to,O
date,O
.,O

Infant,O
has,O
not,O
had,O
any,B-PR
issues,I-PR
with,I-PR
sepsis,I-PR
this,B-TR
hospitalization,I-TR
.,O

7.,O
Neurology,O
:,O

Head,B-TE
ultrasound,I-TE
on,O
day,O
of,O
life,O
seven,O
showed,O
no,O
intraventricular,B-PR
hemorrhage,I-PR
.,O

A,B-TE
repeat,I-TE
head,I-TE
ultrasound,I-TE
on,O
day,O
of,O
life,O
33,O
06-07,O
showed,O
a,B-PR
slight,I-PR
increase,I-PR
of,I-PR
echogenicity,I-PR
in,I-PR
the,I-PR
caudothalamic,I-PR
groove,I-PR
",",O
which,O
may,O
represent,O
tiny,B-PR
bilateral,I-PR
germinal,I-PR
matrix,I-PR
hemorrhages,I-PR
",",O
no,O
periventricular,B-PR
leukomalacia,I-PR
.,O

A,B-TE
repeat,I-TE
head,I-TE
ultrasound,I-TE
is,O
recommended,O
in,O
one,O
month,O
.,O

Normal,O
neurological,O
examination,O
.,O

Sensory,B-TE
",",I-TE
hearing,I-TE
screening,I-TE
was,O
performed,O
with,O
automated,O
auditory,O
brain,O
stem,O
responses,O
.,O

Infant,O
passed,O
both,O
ears,O
.,O

Ophthalmology,O
",",O
eyes,O
examined,O
most,O
recently,O
on,O
05-30,O
revealing,O
immaturity,B-PR
of,I-PR
the,I-PR
retinal,I-PR
vessels,I-PR
",",O
but,O
no,O
ROP,B-PR
as,O
of,O
yet,O
.,O

A,B-TE
follow,I-TE
up,I-TE
examination,I-TE
should,O
be,O
scheduled,O
for,O
the,O
week,O
of,O
06-20,O
.,O

Ophthalmologist,O
is,O
Dr.,O
Cruea,O
Franklin,O
.,O

8.,O
Psycho,O
/,O
social,O
:,O

Parents,O
involved,O
.,O

Triplet,O
number,O
one,O
is,O
still,O
in,O
the,O
Neonatal,O
Intensive,O
Care,O
Unit,O
and,O
triplet,O
number,O
three,O
is,O
home,O
with,O
family,O
and,O
there,O
is,O
also,O
a,O
2,O
year-old,O
sibling,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
on,O
room,O
air,O
.,O

DISCHARGE,O
DISPOSITION,O
:,O

Home,O
with,O
parents,O
.,O

NAME,O
OF,O
PRIMARY,O
PEDIATRICIAN,O
:,O

Dr.,O
Janetta,O
Burmaster,O
",",O
phone,O
number,O
(,O
262,O
),O
892,O
0330,O
",",O
fax,O
491-6171,O
.,O

CARE,O
AND,O
RECOMMENDATIONS,O
:,O

Feedings,O
breast,O
milk,O
or,O
Enfamil,B-TR
24,O
calories,O
per,O
ounce,O
",",O
breast,O
milk,O
mixed,O
with,O
4,O
calories,O
per,O
ounce,O
of,O
Enfamil,B-TR
powder,I-TR
",",O
minimum,O
of,O
140,O
cc,O
per,O
kilogram,O
per,O
day,O
po,O
.,O

MEDICATIONS,O
:,O

Ferrous,B-TR
sulfate,I-TR
25,O
mg,O
per,O
ml,O
",",O
2,O
mg,O
per,O
kilogram,O
per,O
day,O
.,O

Car,B-TE
seat,I-TE
position,I-TE
screening,I-TE
passed,O
on,O
06-07,O
.,O

Hearing,B-TE
screen,I-TE
passed,O
on,O
2016-06-07,O
.,O

State,B-TE
newborn,I-TE
screens,I-TE
were,O
sent,O
on,O
05-08,O
and,O
05-19,O
.,O

No,O
abnormal,B-PR
results,I-PR
have,O
been,O
reported,O
.,O

Immunizations,B-TR
",",O
the,O
infant,O
received,O
hepatitis,B-TR
B,I-TR
vaccine,I-TR
on,O
2016-06-02,O
.,O

Immunizations,B-TR
recommended,O
",",O
Synagis,B-TR
RSV,I-TR
prophylaxis,I-TR
should,O
be,O
considered,O
from,O
October,O
through,O
April,O
for,O
infants,O
who,O
meet,O
any,O
of,O
the,O
following,O
three,O
criteria,O
",",O
born,O
at,O
less,O
then,O
32,O
weeks,O
",",O
born,O
between,O
32,O
and,O
35,O
weeks,O
with,O
two,O
of,O
three,O
of,O
the,O
following,O
",",O
day,O
care,O
during,O
RSV,O
season,O
",",O
smoker,O
on,O
the,O
household,O
",",O
neuromuscular,B-PR
disease,I-PR
",",O
airway,B-PR
abnormalities,I-PR
or,O
school,O
age,O
siblings,O
or,O
with,O
chronic,B-PR
lung,I-PR
disease,I-PR
.,O

Influenza,B-TR
immunization,I-TR
is,O
recommended,O
annually,O
in,O
the,O
fall,O
for,O
all,O
infants,O
once,O
they,O
reach,O
six,O
months,O
of,O
age,O
.,O

Before,O
this,O
age,O
and,O
for,O
the,O
first,O
24,O
months,O
of,O
the,O
child,O
's,O
life,O
immunization,B-TR
against,O
influenza,B-PR
is,O
recommended,O
for,O
household,O
contacts,O
and,O
out,O
of,O
home,O
caregivers,O
.,O

FOLLOW,O
UP,O
APPOINTMENTS,O
:,O

1.,O
Primary,O
pediatrician,O
.,O

2.,O
Ophthalmology,O
Dr.,O
Wilson,O
.,O

3.,O
Visiting,O
Nurse,O
Association,O
early,O
intervention,O
program,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Prematurity,B-PR
triplet,O
number,O
two,O
.,O

2.,O
Status,O
post,O
respiratory,B-PR
distress,I-PR
.,O

3.,O
Status,O
post,O
rule,O
out,O
sepsis,B-PR
",",O
ruled,O
out,O
.,O

4.,O
Status,O
post,O
apnea,B-PR
of,I-PR
prematurity,I-PR
.,O

5.,O
Status,O
post,O
indirect,B-PR
hyperbilirubinemia,I-PR
.,O

Richard,O
Hartney,O
",",O
M.D.,O
02-219,O

Dictated,O
By,O
:,O
Leonard,O
J.,O
Pellegrino,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2016-06-14,O
11:22,O

T,O
:,O
2016-06-15,O
07:09,O

JOB,O
#:,O
47623,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Thomas,O
M.,O
Muth,O
on,O
:,O
WED,O
2016-06-15,O
9:49,O
AM,O

(,O
End,O
of,O
Report,O
),O

14894512,O

FIH,O

589930,O

86515/6878,O

801232,O

10/27/1993,O
12:00:00,O
AM,O

OSTEOCHONDROMATOSIS,B-PR
",",I-PR
RIGHT,I-PR
KNEE,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

10-27-93,O

DISCHARGE,O
DATE,O
:,O

11-1-93,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Osteochondromatosis,B-PR
",",I-PR
right,I-PR
knee,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
68,O
year,O
old,O
white,O
male,O
who,O
had,O
a,O
seven,O
to,O
eight,O
year,O
history,O
of,O
knee,B-PR
pain,I-PR
.,O

In,O
1984,O
",",O
he,O
had,O
the,O
right,O
knee,O
aspirated,O
and,O
was,O
noted,O
to,O
have,O
some,O
uric,B-PR
acid,I-PR
crystals,I-PR
",",O
although,O
serum,B-TE
uric,I-TE
acid,I-TE
was,O
normal,O
and,O
erythrocyte,B-TE
sedimentation,I-TE
rate,I-TE
.,O

He,O
continued,O
to,O
have,O
intermittent,B-PR
symptoms,I-PR
and,O
was,O
noted,O
to,O
have,O
some,B-PR
fullness,I-PR
in,I-PR
the,I-PR
suprapatellar,I-PR
pouch,I-PR
.,O

Plain,B-TE
films,I-TE
taken,O
by,O
his,O
orthopedist,O
in,O
Mongcana,O
Ster,O
Staarv,O
revealed,O
some,B-PR
soft,I-PR
tissue,I-PR
calcification,I-PR
within,O
the,O
medial,O
and,O
lateral,O
compartments,O
of,O
the,O
joint,O
.,O

an,B-TE
magnetic,I-TE
resonance,I-TE
imaging,I-TE
study,I-TE
demonstrated,O
calcification,B-PR
densities,I-PR
in,I-PR
the,I-PR
suprapatellar,I-PR
bursa,I-PR
region,I-PR
",",O
also,O
with,O
hypertrophia,B-PR
of,I-PR
the,I-PR
synovium,I-PR
.,O

It,O
was,O
felt,O
that,O
the,O
patient,O
had,O
synovial,B-PR
chondromatosis,I-PR
and,O
would,O
benefit,O
from,O
an,B-TR
open,I-TR
synovectomy,I-TR
and,O
debridement,B-TR
.,O

He,O
was,O
admitted,O
for,O
that,B-TR
procedure,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

He,O
had,O
tonsillectomy,B-TR
at,O
the,O
age,O
of,O
five,O
",",O
and,O
appendectomy,B-TR
in,O
1940,O
.,O

He,O
had,O
right,B-TR
knee,I-TR
aspirations,I-TR
done,O
in,O
1986,O
",",O
otherwise,O
",",O
he,O
does,O
not,O
suffer,O
from,O
any,B-PR
other,I-PR
medical,I-PR
problems,I-PR
.,O

ALLERGIES,O
:,O

He,O
has,O
no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

He,O
is,O
on,O
______________,O
2,O
tabs,O
PO,O
qd,O
.,O

SOCIAL,O
HISTORY,O
:,O

Married,O
and,O
lives,O
with,O
his,O
wife,O
in,O
Forda,O
Minsas,O
Ve,O
",",O
Wyoming,O
.,O

He,O
is,O
a,O
retired,O
school,O
teacher,O
by,O
profession,O
.,O

He,O
has,O
a,O
son,O
who,O
is,O
an,O
orthopedic,O
surgeon,O
.,O

SOCIAL,O
HISTORY,O
:,O

He,O
has,O
been,O
a,O
smoker,O
for,O
the,O
last,O
50,O
years,O
and,O
he,O
drinks,O
alcohol,O
occasionally,O
",",O
but,O
stopped,O
in,O
1987,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

He,O
is,O
healthy,O
looking,O
.,O

The,B-TE
general,I-TE
physical,I-TE
examination,I-TE
did,O
not,O
reveal,O
any,B-PR
abnormality,I-PR
.,O

Heart,B-TE
",",I-TE
chest,I-TE
",",I-TE
and,I-TE
abdominal,I-TE
examinations,I-TE
were,O
normal,O
.,O

The,B-TE
right,I-TE
knee,I-TE
examination,I-TE
showed,O
some,B-PR
effusion,I-PR
.,O

The,O
range,O
of,O
motion,O
was,O
15,O
to,O
120,O
degree,O
on,O
the,O
right,O
side,O
;,O
and,O
on,O
the,O
left,O
side,O
",",O
it,O
was,O
zero,O
to,O
135,O
.,O

There,O
was,O
normal,O
muscle,O
power,O
.,O

The,B-TE
peripheral,I-TE
pulses,I-TE
were,O
palpable,O
.,O

LABORATORY,O
DATA,O
:,O

His,B-TE
hematocrit,I-TE
was,O
44.4,O
",",O
with,O
white,B-TE
blood,I-TE
count,I-TE
of,O
11.9,O
",",O
and,O
platelet,B-TE
count,I-TE
of,O
410,O
.,O

His,B-TE
MCV,I-TE
was,O
92,O
",",O
MCH,B-TE
32.1,O
",",O
and,O
MCHE,B-TE
34.8,O
.,O

His,B-TE
chest,I-TE
X-ray,I-TE
did,O
not,O
reveal,O
any,B-PR
abnormality,I-PR
.,O

A,B-TE
electrocardiogram,I-TE
showed,O
nonspecific,B-PR
T-wave,I-PR
abnormalities,I-PR
",",O
otherwise,O
",",O
it,O
was,O
normal,O
.,O

HOSPITAL,O
COURSE,O
:,O

He,O
underwent,O
right,B-TR
knee,I-TR
open,I-TR
synovectomy,I-TR
and,O
debridement,B-TR
of,O
synovial,B-PR
chondromatosis,I-PR
on,O
10-28-93,O
.,O

Postoperatively,O
",",O
he,O
has,O
done,O
well,O
.,O

He,O
is,O
mobilized,O
with,O
the,O
help,O
of,O
physical,B-TR
therapy,I-TR
",",O
on,O
a,B-TR
continuous,I-TR
passive,I-TR
motion,I-TR
machine,I-TR
.,O

His,O
discharge,O
range,O
of,O
motion,O
is,O
from,O
zero,O
to,O
40,O
degrees,O
.,O

He,O
was,O
on,O
pain,B-TR
medication,I-TR
and,O
he,O
was,O
also,O
on,O
Percocet,B-TR
",",O
but,O
now,O
he,O
can,O
manage,O
without,O
the,O
Percocet,B-TR
.,O

He,O
is,O
on,O
Coumadin,B-TR
which,O
is,O
to,O
be,O
continued,O
for,O
six,O
weeks,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Percocet,B-TR
1-2,O
PO,O
q4h,O
prn,O
.,O

FOLLOW,O
UP,O
:,O

He,O
will,O
be,O
followed,O
up,O
in,O
Cesa,O
",",O
New,O
York,O
.,O

DISPOSITION,O
:,O

On,O
discharge,O
",",O
he,O
is,O
mobilized,O
",",O
partial,O
weight,O
bearing,O
with,O
the,O
help,O
of,O
a,B-TR
walker,I-TR
.,O

The,O
condition,O
on,O
discharge,O
is,O
good,O
.,O

STA,O
AGE,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

SHAA,O
STONGE,O
",",O
M.D.,O

TR,O
:,O

fu,O
/,O
bmot,O

DD,O
:,O

11-1-93,O

TD,O
:,O

11/01/93,O

CC,O
:,O

139391631,O

GH,O

97368061,O

7/20/1999,O
12:00:00,O
AM,O

NEUROPATHIC,B-PR
PAIN,I-PR

Signed,O

DIS,O

Admission,O
Date,O
:,O

07/20/1999,O

Report,O
Status,O
:,O

Signed,O
Discharge,O

Date,O
:,O

07/26/1999,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Post,B-PR
thoracotomy,I-PR
syndrome,I-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

The,O
patient,O
had,O
a,B-TR
spinal,I-TR
cord,I-TR
stimulator,I-TR
trial,I-TR
on,O
07/21/99,O
",",O
the,O
patient,O
had,O
an,B-TR
epidural,I-TR
trial,I-TR
on,O
07/24/99,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
65,O
year,O
old,O
female,O
with,O
post,B-PR
thoracotomy,I-PR
syndrome,I-PR
that,O
occurred,O
on,O
the,O
site,O
of,O
her,B-PR
thoracotomy,I-PR
incision,I-PR
.,O

She,O
had,O
a,B-PR
thoracic,I-PR
aortic,I-PR
aneurysm,I-PR
repaired,O
in,O
the,O
past,O
and,O
subsequently,O
developed,O
neuropathic,B-PR
pain,I-PR
at,O
the,B-PR
incision,I-PR
site,I-PR
.,O

She,O
is,O
currently,O
on,O
Vicodin,B-TR
",",O
one,O
to,O
two,O
tablets,O
every,O
four,O
hours,O
p.r.n.,O
",",O
Fentanyl,B-TR
patch,I-TR
25,O
mcg,O
an,O
hour,O
",",O
change,O
of,O
patch,O
every,O
72,O
hours,O
",",O
Elavil,B-TR
50,O
mgq,O
.h.s.,O
",",O
Neurontin,B-TR
600,O
mg,O
p.o.,O
t.i.d.,O
with,O
still,O
what,O
she,O
reports,O
as,O
stabbing,B-PR
left-sided,I-PR
chest,I-PR
pain,I-PR
that,O
can,O
be,O
as,O
severe,O
as,O
a,O
7/10.,O

She,O
has,O
failed,O
conservative,B-TR
therapy,I-TR
and,O
is,O
admitted,O
for,O
a,B-TR
spinal,I-TR
cord,I-TR
stimulator,I-TR
trial,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Hypertension,B-PR
.,O

2.,O
Hypothyroidism,B-PR
.,O

3.,O
Paraplegia,B-PR
status,O
post,O
thoracic,B-TR
aortic,I-TR
aneurysm,I-TR
repair,I-TR
.,O

4.,O
Left,B-PR
hemidiaphragmatic,I-PR
paralysis,I-PR
",",O
history,O
of,O
recurrent,B-PR
lung,I-PR
infections,I-PR
.,O

5.,O
Sacral,B-PR
decubitus,I-PR
ulcer,I-PR
.,O

6.,O
Home,B-TR
oxygen,I-TR
at,O
two,O
liters,O
a,O
minute,O
when,O
she,O
is,O
at,O
home,O
;,O
she,O
does,O
not,O
use,O
the,B-TR
oxygen,I-TR
when,O
she,O
is,O
in,O
a,B-TR
wheelchair,I-TR
or,O
is,O
out,O
of,O
the,O
house,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

1.,O
Atrovent,B-TR
nebulizers,I-TR
0.5,O
mg,O
mixed,O
with,O
albuterol,B-TR
",",O
nebulizer,B-TR
is,O
given,O
every,O
six,O
hours,O
.,O

2.,O
Norvasc,B-TR
2.5,O
mg,O
p.o.,O
q,O
day,O
.,O

3.,O
Colistin,B-TR
30,O
mg,O
nebulizer,O
twice,O
a,O
day,O
",",O
give,O
30,O
minutes,O
post,O
albuterol,B-TR
and,O
Atrovent,B-TR
.,O

4.,O
Pressure,B-TR
",",I-TR
dermal,I-TR
ulcer,I-TR
care,I-TR
b.i.d.,O
dressing,B-TR
change,I-TR
with,O
antibiotic,B-TR
solution,I-TR
.,O

5.,O
Neurontin,B-TR
600,O
mg,O
p.o.,O
t.i.d.,O

6.,O
Colace,B-TR
100,O
mg,O
p.o.,O
b.i.d.,O

7.,O
Albuterol,B-TR
neb,I-TR
2.5,O
mg,O
every,O
six,O
hours,O
",",O
30,O
minutes,O
before,O
Colistin,B-TR
.,O

8.,O
Amitriptyline,B-TR
50,O
mg,O
q.h.s.,O

9.,O
Vitamin,B-TR
C,I-TR
500,O
mg,O
p.o.,O
b.i.d.,O

10.,O
Calcium,B-TR
carbonate,I-TR
125.0,O
mg,O
t.i.d.,O

11.,O
Fentanyl,B-TR
patch,I-TR
25,O
mcg,O
an,O
hour,O
",",O
change,O
patch,B-TR
every,O
72,O
hours,O
.,O

12.,O
Folate,B-TR
1,O
mg,O
p.o.,O
q,O
day,O
.,O

13.,O
Synthroid,B-TR
50,O
mcg,O
p.o.,O
q,O
day,O
.,O

14.,O
Zinc,B-TR
sulfate,I-TR
220,O
mg,O
p.o.,O
q,O
day,O
.,O

15.,O
Multivitamin,B-TR
",",O
one,O
tablet,O
p.o.,O
q,O
day,O
.,O

16.,O
Hydrocodone,B-TR
5,O
mg,O
with,O
Tylenol,B-TR
",",O
one,O
to,O
two,O
tablets,O
every,O
four,O
hours,O
p.r.n.,O
pain,B-PR
.,O

17.,O
Milk,B-TR
of,I-TR
Magnesia,I-TR
30,O
cc,O
p.o.,O
q,O
day,O
constipation,B-PR
.,O

ALLERGIES,O
:,O

PENICILLIN,B-TR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
lives,O
in,O
Napro,O
with,O
her,O
husband,O
who,O
is,O
her,O
primary,O
caregiver,O
.,O

She,O
is,O
not,O
a,O
smoker,O
.,O

She,O
has,O
approximately,O
one,O
glass,O
of,O
wine,O
every,O
day,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,O
patient,O
is,O
well-appearing,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

Blood,B-TE
pressure,I-TE
is,O
150/90,O
",",O
heart,B-TE
rate,I-TE
of,O
90,O
",",O
respiratory,B-TE
rate,I-TE
20,O
with,O
saturation,B-TE
of,O
98%,O
.,O

HEENT,O
:,O

Pupils,O
are,O
equal,O
and,O
reactive,O
to,O
light,O
.,O

The,O
patient,O
wears,O
dentures,B-TR
.,O

Neck,O
:,O

Full,O
range,O
of,O
motion,O
with,O
no,O
lymphadenopathy,B-PR
.,O

Chest,O
:,O

Clear,O
to,O
auscultation,O
on,O
the,O
right,O
.,O

Decreased,B-PR
breath,I-PR
sounds,I-PR
on,I-PR
the,I-PR
left,I-PR
base,I-PR
with,O
coarse,B-PR
rales,I-PR
on,I-PR
the,I-PR
left,I-PR
base,I-PR
.,O

Cardiovascular,O
:,O

Regular,O
rate,O
and,O
rhythm,O
with,O
normal,O
S1,O
and,O
S2,O
.,O

Abdomen,O
:,O

Soft,O
",",O
nondistended,B-PR
",",O
nontender,B-PR
.,O

Positive,O
bowel,O
sounds,O
.,O

Back,O
:,O

Clear,O
.,O

Epidural,O
site,O
is,O
without,O
erythema,B-PR
",",O
drainage,B-PR
or,O
tenderness,B-PR
.,O

Left,O
buttock,O
area,O
has,O
a,B-TR
dressing,I-TR
over,O
the,B-PR
sacral,I-PR
decubitus,I-PR
ulcer,I-PR
.,O

Extremities,O
:,O

Well-profused,O
.,O

4/5,O
motor,O
strength,O
in,O
the,O
upper,O
extremities,O
bilaterally,O
.,O

Flaccid,B-PR
paralysis,I-PR
of,I-PR
bilateral,I-PR
lower,I-PR
extremities,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
on,O
07/20/99,O
for,O
a,O
history,O
of,O
left,B-PR
chest,I-PR
wall,I-PR
pain,I-PR
from,O
postthoracotomy,B-PR
syndrome,I-PR
.,O

The,O
patient,O
developed,O
the,B-PR
syndrome,I-PR
after,O
her,B-TR
thoracic,I-TR
aortic,I-TR
aneurysm,I-TR
repair,I-TR
.,O

The,O
patient,O
failed,O
the,B-TR
conservative,I-TR
therapy,I-TR
and,O
is,O
admitted,O
for,O
a,B-TR
spinal,I-TR
cord,I-TR
stimulator,I-TR
trial,I-TR
.,O

The,O
patient,O
had,O
a,B-TR
spinal,I-TR
cord,I-TR
stimulator,I-TR
placed,O
on,O
07/21/99,O
.,O

She,O
underwent,O
the,B-TR
procedure,I-TR
and,O
tolerated,O
the,B-TR
procedure,I-TR
very,O
well,O
.,O

The,B-TR
spinal,I-TR
cord,I-TR
stimulator,I-TR
was,O
programmed,O
with,O
setting,O
of,O
a,O
rate,O
of,O
80,O
",",O
power,O
450,O
and,O
4.0,O
amps,O
.,O

Channel,O
1,O
was,O
negative,O
",",O
2,O
was,O
neutral,O
",",O
3,O
was,O
neutral,O
",",O
4,O
was,O
positive,O
.,O

The,O
patient,O
the,O
next,O
two,O
days,O
did,O
not,O
notice,O
any,O
significant,O
change,O
in,O
her,B-PR
pain,I-PR
pattern,I-PR
.,O

The,O
patient,O
was,O
also,O
noted,O
to,O
have,O
a,O
lot,O
of,O
musculoskeletal,B-PR
component,I-PR
of,I-PR
her,I-PR
pain,I-PR
.,O

So,O
",",O
an,B-TR
epidural,I-TR
catheter,I-TR
was,O
placed,O
on,O
07/23/99,O
.,O

The,B-TR
epidural,I-TR
was,O
placed,O
in,O
the,O
L1-2,O
region,O
and,O
the,B-TR
catheter,I-TR
was,O
placed,O
in,O
the,O
T7,O
region,O
using,O
fluoroscope,B-TE
to,O
guide,O
the,B-TR
catheter,I-TR
.,O

Within,O
the,O
next,O
couple,O
of,O
days,O
",",O
the,O
patient,O
noticed,O
a,O
significant,O
improvement,O
in,O
her,B-PR
pain,I-PR
pattern,I-PR
.,O

The,B-PR
stabbing,I-PR
",",I-PR
sharp,I-PR
pain,I-PR
that,O
she,O
occasionally,O
has,O
on,O
the,O
left,O
chest,O
wall,O
was,O
significantly,O
diminished,O
and,O
she,O
also,O
noticed,O
periods,O
of,O
time,O
when,O
she,O
did,O
not,O
have,O
any,O
of,O
that,B-PR
pain,I-PR
.,O

The,B-TR
epidural,I-TR
catheter,I-TR
had,O
a,B-TR
morphine,I-TR
infusion,I-TR
initially,O
started,O
at,O
1,O
mg,O
a,O
day,O
and,O
increased,O
to,O
3,O
mg,O
a,O
day,O
in,O
a,O
period,O
of,O
three,O
days,O
.,O

The,B-TR
epidural,I-TR
was,O
discontinued,O
on,O
07/26/99,O
and,O
was,O
considered,O
a,B-TR
successful,I-TR
trial,I-TR
.,O

The,O
patient,O
will,O
schedule,O
with,O
the,O
Pain,O
Clinic,O
regarding,O
upcoming,B-TR
epidural,I-TR
pump,I-TR
placement,I-TR
.,O

During,O
her,O
hospitalization,O
",",O
the,O
patient,O
was,O
also,O
seen,O
by,O
the,O
Plastic,O
Service,O
.,O

Dr.,O
Falccouette,O
would,O
like,O
to,O
perform,O
an,B-TR
excision,I-TR
and,O
closure,B-TR
flap,I-TR
of,O
her,B-PR
left,I-PR
ischial,I-PR
decubitusin,I-PR
the,O
near,O
future,O
.,O

The,O
patient,O
was,O
discharged,O
in,O
stable,O
conditionand,O
will,O
follow,O
up,O
for,O
(,O
1,O
),O
sacral,B-TR
decubitus,I-TR
closure,I-TR
",",O
and,O
(,O
2,O
),O
placement,B-TR
of,I-TR
epidural,I-TR
pump,I-TR
in,O
the,O
future,O
.,O

DISCHARGE,O
INSTRUCTIONS,O
:,O

The,O
patient,O
will,O
have,O
SMH,O
Service,O
that,O
comes,O
to,O
her,O
home,O
once,O
a,O
day,O
for,O
adressing,B-TR
change,I-TR
.,O

The,O
patient,O
will,O
follow,O
up,O
with,O
Dr.,O
Kayschird,O
to,O
schedule,O
for,O
the,B-TR
epidural,I-TR
pump,I-TR
.,O

The,O
patient,O
will,O
follow,O
up,O
with,O
Dr.,O
Falccouette,O
to,O
schedule,O
for,O
excision,B-TR
and,O
closure,B-TR
of,O
her,B-PR
left,I-PR
ischial,I-PR
sacral,I-PR
decubitus,I-PR
.,O

Dictated,O
By,O
:,O

ECI,O
JESCSLAND,O
",",O
M.D.,O
OO63,O

Attending,O
:,O

FOMAIRE,O
KOTEKOTEJESCDREWE,O
",",O
M.D.,O
RY93,O
KE526/9219,O

Batch,O
:,O

37707,O

Index,O
No.,O

RWRF75BSI,O

D,O
:,O

07/26/99,O

T,O
:,O

07/26/99,O

CC,O
:,O

JOFREDD,O
N.,O
FALCCOUETTE,O
",",O
M.D.,O
SV7,O

[,O
report_end,O
],O

17480654,O

FIH,O

6160323,O

59147/s876,O

971818,O

2/15/1994,O
12:00:00,O
AM,O

CHRONIC,B-PR
MYELOMONOCYTIC,I-PR
LEUKEMIA,I-PR
",",O
WITHOUT,O
REMISSION,O
",",O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

2/15/94,O

DISCHARGE,O
DATE,O
:,O

2/28/94,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Chronic,B-PR
myelomonocytic,I-PR
leukemia,I-PR
",",O
without,O
remission,O
",",O
atrial,B-PR
fibrillation,I-PR
",",O
chronic,B-PR
airway,I-PR
obstruction,I-PR
",",O
hypopotassemia,B-PR
",",O
cellulitis,B-PR
",",O
orbital,B-PR
hemorrhage,I-PR
",",O
protein,B-PR
calorie,I-PR
malnutrition,I-PR
",",O
gastrointestinal,B-PR
hemorrhage,I-PR
",",O
pulmonary,B-PR
hemorrhage,I-PR
/,O
pneumonia,B-PR
",",O
hyperglycemia,B-PR
",",O
renal,B-PR
insufficiency,I-PR
",",O
hyperuricemia,B-PR
",",O
hypophosphatemia,B-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
75,O
year,O
old,O
male,O
had,O
been,O
noted,O
to,O
be,O
anemic,B-PR
with,O
an,B-PR
abnormal,I-PR
white,I-PR
blood,I-PR
count,I-PR
since,O
at,O
least,O
November,O
1993,O
",",O
while,O
he,O
was,O
living,O
in,O
Aersing,O
Rocuch,O
Sun,O
and,O
his,O
physicians,O
there,O
had,O
begun,O
to,O
manage,O
him,O
with,O
transfusions,B-TR
",",O
and,O
low,B-TR
dose,I-TR
hydroxyurea,I-TR
.,O

Apparently,O
",",O
a,B-TE
bone,I-TE
marrow,I-TE
biopsy,I-TE
at,O
the,O
time,O
confirmed,O
the,O
diagnosis,O
of,O
chronic,B-PR
myelomonocytic,I-PR
leukemia,I-PR
.,O

He,O
came,O
to,O
this,O
country,O
in,O
late,O
December,O
1994,O
to,O
live,O
with,O
his,O
son,O
for,O
a,O
few,O
months,O
and,O
was,O
referred,O
to,O
me,O
for,O
follow,O
up,O
.,O

He,O
had,O
been,O
noting,O
night,B-PR
sweats,I-PR
",",O
increasing,B-PR
fatigue,I-PR
",",O
anorexia,B-PR
",",O
and,O
dyspnea,B-PR
",",O
which,O
were,O
not,O
particularly,O
improved,O
by,O
increased,B-TR
transfusions,I-TR
or,O
alterations,O
of,O
hydroxy,B-TR
urea,I-TR
.,O

He,O
became,O
profoundly,B-PR
thrombocytopenic,I-PR
",",O
and,O
ultimately,O
was,O
admitted,O
to,O
the,O
hospital,O
on,O
2/15,O
with,O
headache,B-PR
and,O
weakness,B-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Significant,O
for,O
chronic,B-PR
atrial,I-PR
fibrillation,I-PR
",",O
managed,O
with,O
an,O
Italian,O
variation,O
of,O
Digoxin,B-TR
",",O
and,O
Amioadrone,B-TR
",",O
hypertension,B-PR
managed,O
with,O
an,B-TR
ACE,I-TR
inhibitor,I-TR
",",O
chronic,B-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
managed,O
with,O
a,B-TR
zanthine,I-TR
preparation,I-TR
and,O
low,B-TR
dose,I-TR
steroids,I-TR
",",O
as,O
well,O
as,O
an,B-TR
occasional,I-TR
inhaler,I-TR
.,O

Other,B-PR
medical,I-PR
problems,I-PR
included,O
chronic,B-PR
liver,I-PR
disease,I-PR
of,O
uncertain,O
etiology,O
",",O
for,O
which,O
he,O
had,O
been,O
advised,O
not,O
to,O
drink,O
any,O
alcohol,O
.,O

He,O
also,O
had,O
a,B-PR
penetrating,I-PR
injury,I-PR
to,I-PR
the,I-PR
right,I-PR
eye,I-PR
",",O
which,O
had,O
rendered,O
him,O
blind,B-PR
10,O
years,O
previously,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

He,O
was,O
a,O
chronically,O
ill,O
appearing,O
elderly,O
man,O
",",O
with,O
a,B-TE
respiratory,I-TE
rate,I-TE
of,O
30,O
",",O
temperature,B-TE
99.6,O
",",O
pulse,B-TE
100,O
",",O
and,O
irregularly,B-PR
irregular,I-PR
",",O
blood,B-TE
pressure,I-TE
148/71,O
.,O

He,O
had,O
some,B-PR
petechiae,I-PR
on,I-PR
his,I-PR
extremities,I-PR
",",O
as,O
well,O
as,O
in,O
his,O
mucosal,O
membranes,O
with,O
some,B-PR
hemorrhagic,I-PR
bullae,I-PR
.,O

There,O
were,O
bibasilar,B-PR
rales,I-PR
with,O
some,B-PR
wheezing,I-PR
.,O

He,O
had,O
no,O
cardiac,B-PR
murmur,I-PR
.,O

His,O
abdomen,O
was,O
distended,B-PR
with,O
massive,B-PR
hepatosplenomegaly,I-PR
",",O
which,O
was,O
somewhat,B-PR
tender,I-PR
.,O

The,B-TE
neurological,I-TE
examination,I-TE
aside,O
from,O
the,B-PR
blind,I-PR
right,I-PR
eye,I-PR
was,O
unremarkable,O
.,O

LABORATORY,O
DATA,O
:,O

Included,O
a,B-TE
white,I-TE
blood,I-TE
count,I-TE
of,O
"140,000",O
",",O
7%,B-TE
polys,I-TE
",",O
1%,B-TE
bands,I-TE
",",O
3%,B-TE
lymphs,I-TE
",",O
1%,B-TE
monos,I-TE
",",O
2,B-TE
basos,I-TE
",",O
4,B-TE
blasts,I-TE
",",O
76%,B-TE
pearl,I-TE
monocytes,I-TE
",",O
6%,B-TE
meta,I-TE
&apos;s,I-TE
",",O
3,B-TE
nucleated,I-TE
red,I-TE
blood,I-TE
cells,I-TE
.,O

There,O
were,O
some,O
oval,B-PR
tear,I-PR
drop,I-PR
cells,I-PR
and,O
target,B-PR
cells,I-PR
with,O
a,B-PR
few,I-PR
schistocytes,I-PR
.,O

The,B-TE
platelet,I-TE
count,I-TE
was,O
"9,000",O
",",O
hematocrit,B-TE
was,O
26.5,O
",",O
with,O
an,B-TE
mean,I-TE
corpuscular,I-TE
volume,I-TE
of,O
about,O
73,O
.,O

His,B-TE
prothrombin,I-TE
time,I-TE
and,O
partial,B-TE
thromboplastin,I-TE
time,I-TE
were,O
normal,O
.,O

His,B-TE
uric,I-TE
acid,I-TE
was,O
up,O
at,O
97,O
",",O
his,B-TE
total,I-TE
bilirubin,I-TE
was,O
up,O
at,O
1.8,O
",",O
his,B-TE
LDH,I-TE
was,O
428,O
",",O
his,B-TE
phosphorus,I-TE
was,O
1.2,O
",",O
calcium,B-TE
8.6,O
",",O
Digoxin,B-TE
level,I-TE
was,O
1.0,O
",",O
potassium,B-TE
on,O
admission,O
was,O
2.9,O
",",O
sodium,B-TE
135,O
",",O
BUN,B-TE
and,O
creatinine,B-TE
13/1.6,O
",",O
and,O
sugar,B-TE
of,O
267,O
.,O

A,B-TE
computerized,I-TE
tomography,I-TE
scan,I-TE
of,O
his,O
head,O
showed,O
no,O
signs,O
of,O
an,B-PR
acute,I-PR
bleed,I-PR
",",O
a,B-TE
chest,I-TE
X-ray,I-TE
showed,O
no,O
new,B-PR
infiltrates,I-PR
or,O
masses,B-PR
.,O

There,O
was,O
cardiomegaly,B-PR
with,O
prominent,B-PR
vascularity,I-PR
",",O
but,O
no,O
effusions,B-PR
.,O

An,B-TE
electrocardiogram,I-TE
was,O
consistent,O
with,O
atrial,B-PR
fibrillation,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
hospital,O
and,O
begun,O
on,O
high,B-TR
dose,I-TR
Hydroxyurea,I-TR
",",O
with,O
a,O
gradual,O
improvement,O
in,O
his,B-TE
white,I-TE
blood,I-TE
count,I-TE
over,O
the,O
next,O
few,O
days,O
.,O

He,O
did,O
spike,O
a,B-PR
fever,I-PR
and,O
began,O
Ancef,B-TR
and,O
Gentamicin,B-TR
",",O
although,O
cultures,B-TE
never,O
revealed,O
a,O
source,O
for,O
this,O
.,O

He,O
also,O
tried,O
Amicar,B-TR
and,O
continued,O
on,O
low,B-TR
dose,I-TR
Prednisone,I-TR
.,O

His,B-PR
headache,I-PR
improved,O
",",O
but,O
her,O
remained,O
profoundly,B-PR
weak,I-PR
and,O
intermittently,B-PR
febrile,I-PR
with,O
dyspnea,B-PR
.,O

There,O
was,O
hemoptysis,B-PR
and,O
intermittent,B-PR
gastrointestinal,I-PR
bleeding,I-PR
",",O
while,O
he,O
remained,O
profoundly,B-PR
thrombocytopenia,I-PR
.,O

Transfusions,B-TR
of,I-TR
platelets,I-TR
did,O
not,O
change,O
his,B-TE
platelet,I-TE
count,I-TE
",",O
presumably,O
because,O
of,O
sequestration,B-PR
and,O
a,B-PR
massive,I-PR
spleen,I-PR
.,O

Amicar,B-TR
was,O
of,O
uncertain,O
value,O
",",O
but,O
used,O
intermittently,O
.,O

A,B-TE
bone,I-TE
marrow,I-TE
biopsy,I-TE
revealed,O
the,O
transformation,O
of,O
his,B-PR
CMML,I-PR
to,O
acute,B-PR
myelogenous,I-PR
leukemia,I-PR
",",O
and,O
given,O
his,B-PR
other,I-PR
underlying,I-PR
medical,I-PR
problems,I-PR
",",O
we,O
chose,O
chemotherapy,B-TR
with,O
subcutaneous,B-TR
Cystosine,I-TR
Arabinoside,I-TR
and,O
6-Thioguanine,B-TR
",",O
which,O
he,O
tolerated,O
without,O
incident,O
and,O
this,O
brought,O
his,B-TE
white,I-TE
blood,I-TE
count,I-TE
down,O
to,O
below,O
"1,000",O
",",O
and,O
his,O
spleen,O
shrank,O
noticeably,O
",",O
but,O
he,O
still,O
could,O
not,O
maintain,O
a,O
bump,O
in,O
platelet,B-TE
count,I-TE
with,O
platelet,B-TR
transfusions,I-TR
.,O

He,O
was,O
intermittently,B-PR
congested,I-PR
limiting,O
our,O
ability,O
to,O
give,O
intravenous,B-TR
fluid,I-TR
",",O
for,O
his,B-TR
hydrea,I-TR
",",O
although,O
we,O
kept,O
him,O
on,O
Allopurinol,B-TR
.,O

The,O
renal,O
function,O
deteriorated,O
somewhat,O
",",O
hampering,O
our,O
ability,O
to,O
give,O
him,O
his,B-TR
Gentamicin,I-TR
.,O

The,O
family,O
maintained,O
an,O
extraordinary,O
vigil,O
over,O
the,O
days,O
of,O
his,O
hospitalization,O
",",O
providing,O
him,O
with,O
some,O
food,O
and,O
constant,O
attention,O
",",O
while,O
we,O
awaited,O
the,O
results,O
of,O
his,B-TR
chemotherapy,I-TR
and,O
treatment,B-TR
of,O
his,B-PR
infection,I-PR
.,O

He,O
was,O
intermittently,B-PR
restless,I-PR
and,O
somewhat,B-PR
confused,I-PR
",",O
and,O
as,O
his,O
respiratory,O
status,O
deteriorated,O
",",O
the,O
family,O
agreed,O
to,O
a,B-TR
low,I-TR
dose,I-TR
Morphine,I-TR
drip,I-TR
which,O
made,O
him,O
much,O
more,O
comfortable,O
.,O

They,O
agreed,O
with,O
a,O
do,O
not,O
resuscitate,O
status,O
early,O
on,O
in,O
the,O
hospitalization,O
and,O
in,O
the,O
course,O
of,O
being,O
maintain,O
on,O
low,B-TR
dose,I-TR
Morphine,I-TR
",",O
he,O
ultimately,O
expired,O
on,O
2/28/94,O
with,O
the,O
family,O
present,O
.,O

No,O
autopsy,B-TE
was,O
obtained,O
.,O

LENNI,O
BREUTZOLN,O
",",O
M.D.,O

TR,O
:,O

lj,O
/,O
bmot,O

DD,O
:,O

3/12/94,O

TD,O
:,O

03/13/94,O

CC,O
:,O

Dr.,O
Ca,O
Shuff,O
",",O
FIH,O
Oregon,O
Dr.,O
Ille,O
Kote,O

Admission,O
Date,O
:,O

2010-08-30,O

Discharge,O
Date,O
:,O

2010-09-06,O

Date,O
of,O
Birth,O
:,O

1946-01-08,O

Sex,O
:,O

M,O

Service,O
:,O

Cardiothoracic,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
64-year-old,O
man,O
with,O
a,O
history,O
of,O
coronary,B-PR
artery,I-PR
disease,I-PR
",",O
endocarditis,B-PR
status,O
post,O
coronary,B-TR
artery,I-TR
bypass,I-TR
grafting,I-TR
and,O
mitral,B-TR
valve,I-TR
replacement,I-TR
on,O
2010-08-13,O
.,O

He,O
was,O
transferred,O
to,O
Erich,O
Lindemann,O
Mental,O
Health,O
Center,O
from,O
the,O
rehabilitation,O
center,O
where,O
he,O
had,O
been,O
discharged,O
to,O
on,O
2010-08-25,O
following,O
his,B-TR
CABG/MVR,I-TR
.,O

At,O
the,O
rehabilitation,O
center,O
the,O
patient,O
developed,O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

A,B-TE
chest,I-TE
x-ray,I-TE
done,O
at,O
that,O
time,O
revealed,O
a,B-PR
left-sided,I-PR
infiltrate,I-PR
versus,O
effusion,B-PR
.,O

He,O
was,O
transferred,O
to,O
Mass.,O
Eye,O
&,O
Ear,O
Infirmary,O
for,O
treatment,B-TR
.,O

At,O
the,O
time,O
he,O
complained,O
of,O
no,O
chest,B-PR
pain,I-PR
",",O
weakness,B-PR
or,O
cough,B-PR
",",O
although,O
he,O
is,O
intermittently,B-PR
short,I-PR
of,I-PR
breath,I-PR
.,O

He,O
had,O
been,O
anticoagulated,B-TR
during,O
his,O
stay,O
at,O
rehabilitation,O
for,O
atrial,B-PR
fibrillation,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Significant,O
for,O
coronary,B-PR
artery,I-PR
disease,I-PR
status,O
post,O
CABG/MVR,B-TR
.,O

2.,O
Endocarditis,B-PR
.,O

3.,O
Rectal,B-PR
cancer,I-PR
.,O

4.,O
Atrial,B-PR
fibrillation,I-PR
.,O

ALLERGIES,O
:,O

The,O
patient,O
has,O
no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

MEDICATIONS,O
ON,O
TRANSFER,O
:,O

1.,O
Amiodarone,B-TR
200,O
mg,O
q.d.,O

2.,O
Lasix,B-TR
20,O
mg,O
b.i.d.,O

3.,O
Potassium,B-TR
chloride,I-TR
20,O
mEq,O
b.i.d.,O

4.,O
Ampicillin,B-TR
2,O
grams,O
q.,O
4,O
hours,O
.,O

5.,O
Albuterol,B-TR
and,O
Atrovent,B-TR
p.r.n.,O

6.,O
Aspirin,B-TR
325,O
q.d.,O

7.,O
Coumadin,B-TR
5,O
q.d.,O

8.,O
Nystatin,B-TR
swish,O
and,O
swallow,O
5,O
cc,O
t.i.d.,O

9.,O
Colace,B-TR
100,O
b.i.d.,O

10.,O
Percocet,B-TR
5/325,O
",",O
1-2,O
tablets,O
q.,O
4,O
hours,O
p.r.n.,O

LABORATORY,O
DATA,O
:,O

White,B-TE
count,I-TE
12.6,O
",",O
hematocrit,B-TE
28.9,O
",",O
platelet,B-TE
count,I-TE
259,O
",",O
PT,B-TE
21.4,O
",",O
PTT,B-TE
40.2,O
",",O
INR,B-TE
3.0,O
",",O
sodium,B-TE
137,O
",",O
potassium,B-TE
4.2,O
",",O
chloride,B-TE
100,O
",",O
CO2,B-TE
27,O
",",O
BUN,B-TE
26,O
",",O
creatinine,B-TE
1.3,O
",",O
glucose,B-TE
120,O
.,O

Chest,B-TE
x-ray,I-TE
shows,O
a,B-PR
large,I-PR
left,I-PR
pleural,I-PR
effusion,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,O
vital,B-TE
signs,I-TE
were,O
temperature,B-TE
100.1,O
",",O
heart,B-TE
rate,I-TE
83,O
and,O
sinus,O
rhythm,O
",",O
blood,B-TE
pressure,I-TE
108/50,O
",",O
respiratory,B-TE
rate,I-TE
25,O
",",O
oxygen,B-TE
saturation,I-TE
97%,O
on,O
three,B-TR
liters,I-TR
.,O

Generally,O
he,O
was,O
a,O
pleasant,O
man,O
with,O
mild,B-PR
respiratory,I-PR
distress,I-PR
.,O

Lungs,O
had,O
decreased,B-PR
breath,I-PR
sounds,I-PR
on,O
the,O
left,O
.,O

Cardiac,B-TE
examination,I-TE
showed,O
regular,O
rate,O
and,O
rhythm,O
",",O
S1,O
and,O
S2,O
.,O

Chest,B-PR
incision,I-PR
was,O
with,O
Steri-Strips,B-TR
",",O
open,O
to,O
air,O
",",O
clean,O
and,O
dry,O
.,O

Abdomen,O
was,O
soft,O
and,O
nontender,B-PR
",",O
nondistended,B-PR
",",O
with,O
positive,O
bowel,O
sounds,O
.,O

Extremities,O
had,O
bilateral,B-PR
pedal,I-PR
edema,I-PR
.,O

Right,B-PR
leg,I-PR
wound,I-PR
had,O
Steri-Strips,B-TR
",",O
open,O
to,O
air,O
",",O
clean,O
and,O
dry,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
Vencor,O
Hospital,O
.,O

He,O
was,O
given,O
fresh,B-TR
frozen,I-TR
plasma,I-TR
to,O
correct,O
his,B-TE
INR,I-TE
and,O
a,B-TR
left,I-TR
chest,I-TR
tube,I-TR
was,O
placed,O
.,O

Over,O
the,O
first,O
12,O
hours,O
the,B-TR
chest,I-TR
tube,I-TR
drained,O
"2,500",O
cc,O
.,O

On,O
hospital,O
day,O
two,O
the,O
patient,O
was,O
transferred,O
from,O
the,O
cardiac,O
surgery,O
recovery,O
unit,O
to,O
07-02,O
for,O
continuing,O
care,O
.,O

He,O
remained,O
hemodynamically,O
stable,O
.,O

His,B-PR
chest,I-PR
tube,I-PR
drainage,I-PR
reduced,O
significantly,O
after,O
the,O
first,O
24,O
hours,O
and,O
on,O
hospital,O
day,O
three,O
his,B-TR
chest,I-TR
tube,I-TR
was,O
discontinued,O
.,O

Over,O
the,O
next,O
several,O
days,O
the,O
patient,O
remained,O
in,O
the,O
hospital,O
to,O
reassess,O
for,O
recurrent,B-PR
pleural,I-PR
effusion,I-PR
.,O

On,O
09-02,O
it,O
was,O
decided,O
that,O
the,O
patient,O
was,O
stable,O
and,O
ready,O
to,O
be,O
transferred,O
back,O
to,O
rehabilitation,O
",",O
however,O
case,O
management,O
was,O
unable,O
to,O
get,O
authorization,O
from,O
the,O
patient,O
's,O
insurance,O
company,O
and,O
he,O
remained,O
in,O
the,O
hospital,O
throughout,O
the,O
holiday,O
weekend,O
awaiting,O
insurance,O
authorization,O
for,O
transfer,O
back,O
to,O
rehabilitation,O
.,O

At,O
this,O
time,O
the,B-TE
patient,I-TE
's,I-TE
physical,I-TE
examination,I-TE
is,O
as,O
follows,O
:,O

Vital,B-TE
signs,I-TE
were,O
temperature,B-TE
97.8,O
",",O
heart,B-TE
rate,I-TE
80,O
and,O
sinus,O
rhythm,O
",",O
blood,B-TE
pressure,I-TE
140/82,O
",",O
respiratory,B-TE
rate,I-TE
18,O
",",O

O2,B-TE
saturation,I-TE
96%,O
on,O
room,O
air,O
.,O

Weight,B-TE
on,I-TE
admission,I-TE
was,O
64,O
kg,O
",",O
at,O
discharge,O
was,O
51.6,O
kg,O
.,O

Laboratory,O
data,O
showed,O
an,B-TE
hematocrit,I-TE
of,O
31.6,O
",",O
PT,B-TE
13,O
",",O
INR,B-TE
1.2,O
",",O
potassium,B-TE
4.5,O
",",O
BUN,B-TE
18,O
",",O
creatinine,B-TE
0.9,O
.,O

He,O
was,O
alert,O
and,O
oriented,O
x,O
3,O
",",O
moved,O
all,O
extremities,O
",",O
followed,O
commands,O
.,O

Respiratory,B-TE
examination,I-TE
was,O
clear,O
to,O
auscultation,B-TE
bilaterally,I-TE
.,O

Cardiac,O
showed,O
a,O
regular,O
rate,O
and,O
rhythm,O
",",O
S1,O
and,O
S2,O
.,O

Sternum,O
was,O
stable,O
.,O

Incisions,B-PR
had,O
Steri-Strips,B-TR
",",O
open,O
to,O
air,O
",",O
clean,O
and,O
dry,O
.,O

Abdomen,O
was,O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
",",O
with,O
normal,O
active,O
bowel,O
sounds,O
.,O

Extremities,O
were,O
warm,O
and,O
well,O
perfused,O
with,O
no,O
edema,B-PR
.,O

Right,B-PR
lower,I-PR
extremity,I-PR
incision,I-PR
with,O
Steri-Strips,B-TR
",",O
open,O
to,O
air,O
",",O
clean,O
and,O
dry,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Colace,B-TR
100,O
mg,O
b.i.d.,O

2.,O
Aspirin,B-TR
325,O
mg,O
q.d.,O

3.,O
Nystatin,B-TR
swish,O
and,O
swallow,O
",",O
5,O
cc,O
q.,O
8,O
hours,O
.,O

4.,O
Ampicillin,B-TR
2,O
grams,O
IV,O
q.,O
6,O
through,O
09-08,O
.,O

5.,O
Amiodarone,B-TR
200,O
mg,O
q.d.,O

6.,O
Percocet,B-TR
5/325,O
",",O
1-2,O
tablets,O
q.,O
6,O
hours,O
p.r.n.,O

7.,O
Milk,B-TR
of,I-TR
Magnesia,I-TR
30,O
cc,O
q.h.s.,O
p.r.n.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Good,O
.,O

DISPOSITION,O
:,O

He,O
is,O
to,O
be,O
discharged,O
to,O
rehabilitation,O
.,O

FOHintonP,O
:,O

He,O
is,O
to,O
see,O
Dr.,O
les,O
Dina,O
in,O
one,O
month,O
",",O
Dr.,O
Bennett,O
in,O
one,O
month,O
and,O
Dr.,O
Duval,O
in,O
one,O
month,O
.,O

Russell,O
von,O
der,O
Hassler,O
",",O
M.D.,O

47-736,O

Dictated,O
By,O
:,O

Leonard,O
S.,O
Perdue,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O

2010-09-06,O

8:54,O

T,O
:,O

2010-09-06,O

9:17,O

JOB#,O
:,O

92751,O

Signed,O
electronically,O
by,O
:,O

DR.,O
Gene,O
au,O
Holden,O
on,O
:,O

FRI,O
2010-10-01,O
3:26,O
PM,O

(,O
End,O
of,O
Report,O
),O

25897906,O

CTMC,O

81515170,O

481064,O

06/11/1991,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

06/11/1991,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

06/22/1991,O

DISCHARGE,O
DIAGNOSIS,O
:,O

METASTATIC,B-PR
CERVICAL,I-PR
CARCINOMA,I-PR
.,O

SECONDARY,O
DIAGNOSES,O
INCLUDE,O
PERICARDIAL,B-PR
EFFUSION,I-PR
",",O
PULMONARY,B-PR
LYMPHANGITIC,I-PR
SPREAD,I-PR
",",O
AND,O
LIVER,B-PR
AND,I-PR
SPLEEN,I-PR
METASTASES,I-PR
.,O

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

Echocardiogram,B-TE
times,O
two,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Patient,O
is,O
a,O
28,O
year,O
old,O
gravida,O
IV,O
",",O
para,O
2,O
with,O
metastatic,B-PR
cervical,I-PR
cancer,I-PR
admitted,O
with,O
a,O
question,O
of,O
malignant,B-PR
pericardial,I-PR
effusion,I-PR
.,O

Patient,O
underwent,O
a,B-TR
total,I-TR
abdominal,I-TR
hysterectomy,I-TR
in,O
02/90,O
for,O
a,B-PR
4x3.6x2,I-PR
cm,I-PR
cervical,I-PR
mass,I-PR
felt,O
to,O
be,O
a,B-PR
fibroid,I-PR
at,O
Vanor,O
.,O

Pathology,B-TE
revealed,O
poorly,B-PR
differentiated,I-PR
squamous,I-PR
cell,I-PR
carcinoma,I-PR
of,I-PR
the,I-PR
cervix,I-PR
with,O
spots,O
of,O
vaginal,O
margins,O
and,O
metastatic,B-PR
squamous,I-PR
cell,I-PR
carcinoma,I-PR
in,I-PR
the,I-PR
cardinal,I-PR
ligaments,I-PR
with,O
extensive,B-PR
lymphatic,I-PR
invasion,I-PR
.,O

Patient,O
was,O
felt,O
to,O
have,O
stage,B-PR
2B,I-PR
disease,I-PR
and,O
post-operatively,O
",",O
she,O
was,O
treated,O
with,O
intracavitary,B-TR
and,I-TR
external,I-TR
beam,I-TR
radiation,I-TR
therapy,I-TR
and,O
low,B-TR
dose,I-TR
Cisplatin,I-TR
.,O

On,O
ultrasound,B-TE
in,O
02/91,O
",",O
the,O
patient,O
was,O
found,O
to,O
have,O
bilateral,B-PR
cystic,I-PR
adnexal,I-PR
masses,I-PR
confirmed,O
on,O
physical,B-TE
examination,I-TE
.,O

She,O
underwent,O
exploratory,B-TE
laparotomy,I-TE
and,O
had,O
a,B-TR
bilateral,I-TR
salpingo-oophorectomy,I-TR
and,O
appendectomy,B-TR
.,O

Pathology,B-TE
was,O
negative,O
for,O
tumor,B-PR
and,O
showed,O
peritubal,B-PR
and,I-PR
periovarian,I-PR
adhesions,I-PR
.,O

The,O
patient,O
now,O
presents,O
with,O
a,O
three,O
to,O
four,O
week,O
history,O
of,O
shortness,B-PR
of,I-PR
breath,I-PR
and,O
a,B-PR
dry,I-PR
non-productive,I-PR
cough,I-PR
.,O

She,O
was,O
evaluated,O
by,O
Dr.,O
Mielke,O
",",O
a,O
Pulmonologist,O
",",O
who,O
found,O
her,O
to,O
be,O
wheezing,B-PR
and,O
performed,O
pulmonary,B-TE
function,I-TE
tests,I-TE
which,O
showed,O
an,B-TE
FEV1,I-TE
of,O
1.1,O
and,O
an,B-TE
FVC,I-TE
of,O
1.8,O
.,O

She,O
was,O
admitted,O
to,O
Weekscook,O
University,O
Medical,O
Center,O
with,O
a,O
diagnosis,O
of,O
possible,O
asthma,B-PR
.,O

Room,B-TE
air,I-TE
arterial,I-TE
blood,I-TE
gas,I-TE
showed,O
a,B-TE
pO2,I-TE
of,O
56,O
",",O
a,B-TE
pCO2,I-TE
of,O
35,O
",",O
and,O
a,B-TE
pH,I-TE
of,O
7.52,O
.,O

EKG,B-TE
showed,O
sinus,B-PR
tachycardia,I-PR
at,O
100,O
and,O
echo,B-TE
revealed,O
pericardial,B-PR
effusion,I-PR
",",O
a,B-PR
10,I-PR
mm,I-PR
pulsus,I-PR
paradoxus,I-PR
was,O
noted,O
",",O
and,O
no,O
evidence,O
of,O
tamponade,B-PR
.,O

Given,O
the,O
patient,O
&apos;s,O
history,O
of,O
cervical,B-PR
cancer,I-PR
",",O
the,B-PR
pericardial,I-PR
effusion,I-PR
was,O
felt,O
most,O
likely,O
to,O
be,O
malignant,B-PR
.,O

She,O
was,O
therefore,O
transferred,O
to,O
the,O
Retelk,O
County,O
Medical,O
Center,O
for,O
further,B-TR
care,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

As,O
above,O
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

02/90,O
",",O
total,B-TR
abdominal,I-TR
hysterectomy,I-TR
complicated,O
by,O
ureteral,B-TR
transection,I-TR
with,O
right,B-TR
ureteral,I-TR
tube,I-TR
placed,O
for,O
six,O
weeks,O
",",O
stent,B-TR
tube,I-TR
placed,O
in,O
left,O
ureter,O
six,O
weeks,O
prior,O
to,O
admission,O
for,O
a,B-PR
hydronephrosis,I-PR
post,O
",",O
in,O
03/91,O
",",O
bilateral,B-TR
salpingo-oophorectomy,I-TR
and,O
appendectomy,B-TR
.,O

CURRENT,O
MEDICATIONS,O
:,O

Prednisone,B-TR
20,O
mg,O
p.o.,O
q.a.m.,O
with,O
10,O
mg,O
p.o.,O
q.p.m.,O
",",O
Uniphyl,B-TR
400,O
mg,O
p.o.,O
q.d.,O
",",O
Augmentin,B-TR
250,O
p.o.,O
t.i.d.,O
",",O
Estrase,B-TR
2,O
mg,O
p.o.,O
q.d.,O
",",O
MS,B-TR
Contin,I-TR
30,O
mg,O
q.12h.,O
",",O
and,O
Morphine,B-TR
p.r.n.,O

PHYSICAL,O
EXAMINATION,O
:,O

Emaciated,O
white,O
female,O
in,O
mild,B-PR
respiratory,I-PR
distress,I-PR
.,O

Temperature,B-TE
was,O
98.1,O
",",O
heart,B-TE
rate,I-TE
116,O
",",O
blood,B-TE
pressure,I-TE
120/68,O
",",O
and,O
room,B-TE
air,I-TE
O2,I-TE
saturation,I-TE
was,O
93%,O
.,O

HEENT,O
:,O

Dry,B-PR
mucous,I-PR
membranes,I-PR
and,O
myotic,B-PR
pupils,I-PR
.,O

NECK,O
:,O

No,O
lymphadenopathy,B-PR
.,O

CHEST,O
:,O

Few,B-PR
inspiratory,I-PR
wheezes,I-PR
and,O
no,O
rhonchi,B-PR
.,O

HEART,O
:,O

Regular,O
rate,O
and,O
rhythm,O
with,O
tachycardia,B-PR
and,O
no,O
rubs,B-PR
or,O
murmur,B-PR
.,O

ABDOMEN,O
:,O

Well,B-PR
healed,I-PR
Pfannenstiel,I-PR
scars,I-PR
and,O
no,O
masses,B-PR
.,O

PELVIC,O
:,O

No,O
masses,B-PR
.,O

RECTAL,O
:,O

No,O
masses,B-PR
and,O
guaiac,B-TE
negative,O
.,O

EXTREMITIES,O
:,O

No,O
edema,B-PR
or,O
cyanosis,B-PR
.,O

LABORATORY,O
EXAMINATION,O
:,O

Hematocrit,B-TE
was,O
40,O
",",O
white,B-TE
count,I-TE
was,O
21,O
",",O
and,O
platelet,B-TE
count,I-TE
of,O
"723,000",O
.,O

PT,B-TE
and,O
PTT,B-TE
were,O
12,O
and,O
26,O
.,O

Electrolytes,B-TE
were,O
within,O
normal,O
limits,O
",",O
liver,B-TE
function,I-TE
tests,I-TE
within,O
normal,O
limits,O
",",O
and,O
EKG,B-TE
showed,O
a,B-TE
heart,I-TE
rate,I-TE
of,O
128,O
",",O
axis,B-TE
73,O
",",O
and,O
possible,O
ectopic,B-PR
P,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
for,O
a,B-PR
new,I-PR
pericardial,I-PR
effusion,I-PR
which,O
was,O
felt,O
most,O
likely,O
to,O
be,O
secondary,O
to,O
metastatic,B-PR
cervical,I-PR
cancer,I-PR
.,O

There,O
was,O
no,O
evidence,O
of,O
tamponade,B-PR
.,O

An,B-TE
echocardiogram,I-TE
was,O
scheduled,O
and,O
Cardiology,O
was,O
consulted,O
.,O

Echocardiogram,B-TE
showed,O
moderate,B-PR
anterior,I-PR
pericardial,I-PR
effusion,I-PR
of,O
approximately,O
600,O
cc,O
with,O
diastolic,B-PR
indications,I-PR
of,I-PR
the,I-PR
right,I-PR
ventricle,I-PR
and,O
low,B-PR
velocity,I-PR
paradox,I-PR
.,O

Cardiology,O
did,O
not,O
feel,O
that,O
tamponade,B-PR
at,O
this,O
time,O
was,O
a,O
concern,O
and,O
that,O
a,B-TR
tap,I-TR
need,O
not,O
be,O
performed,O
.,O

She,O
continued,O
to,O
have,O
pulmonary,B-PR
wheezing,I-PR
",",O
unknown,O
origin,O
",",O
without,O
history,O
of,O
asthma,B-PR
.,O

Her,B-TR
steroids,I-TR
were,O
tapered,O
and,O
Pulmonary,O
was,O
consulted,O
who,O
recommended,O
a,B-TE
CT,I-TE
scan,I-TE
of,I-TE
the,I-TE
chest,I-TE
to,O
evaluate,O
the,O
lung,O
parenchyma,O
",",O
induce,O
sputum,O
for,O
CBC,B-TE
",",O
arterial,B-TE
blood,I-TE
gas,I-TE
",",O
continuing,O
of,O
the,B-TR
beta,I-TR
agonist,I-TR
inhalers,I-TR
",",O
and,O
trial,O
of,O
steroid,B-TR
inhalers,I-TR
.,O

They,O
felt,O
it,O
was,O
most,O
likely,O
a,B-PR
malignant,I-PR
lymphangitic,I-PR
spread,I-PR
with,O
pericardial,B-PR
involvement,I-PR
versus,O
infectious,B-PR
",",O
other,B-PR
cardiovascular,I-PR
causes,I-PR
",",O
or,O
viral,B-PR
bronchiolitis,I-PR
.,O

She,O
had,O
pulmonary,B-TE
function,I-TE
tests,I-TE
repeated,O
which,O
showed,O
an,B-TE
FEV1,I-TE
of,O
36%,O
of,O
predicted,O
and,O
FVC,B-TE
of,O
56%,O
of,O
predicted,O
.,O

Room,B-TE
air,I-TE
arterial,I-TE
blood,I-TE
gas,I-TE
showed,O
a,B-TE
pH,I-TE
of,O
7.45,O
",",O
pO2,B-TE
of,O
63,O
",",O
a,B-TE
pCO2,I-TE
of,O
41,O
",",O
and,O
fairly,B-PR
significant,I-PR
AA,I-PR
gradient,I-PR
.,O

She,O
was,O
continued,O
on,O
two,O
liters,O
of,O
oxygen,B-TR
awaiting,O
her,B-TE
CT,I-TE
scan,I-TE
on,O
06/14,O
and,O
she,O
developed,O
a,B-PR
new,I-PR
junctional,I-PR
rhythm,I-PR
with,O
a,O
question,O
of,O
a,B-PR
new,I-PR
rub,I-PR
versus,O
murmur,B-PR
on,O
examination,B-TE
.,O

Cardiology,O
felt,O
she,O
had,O
a,B-PR
rub,I-PR
and,O
her,B-TE
pulsus,I-TE
was,O
still,O
10,O
.,O

EKG,B-TE
showed,O
an,B-PR
ectopic,I-PR
low,I-PR
atrial,I-PR
P,I-PR
and,O
they,O
thought,O
she,O
was,O
still,O
stable,O
without,O
evidence,O
of,O
tamponade,B-PR
.,O

She,O
should,O
have,O
a,B-TE
follow-up,I-TE
echocardiogram,I-TE
.,O

Echocardiogram,B-TE
showed,O
left,O
ventricle,O
at,O
the,O
upper,O
limits,O
of,O
normal,O
for,O
size,O
",",O
low,B-PR
normal,I-PR
function,I-PR
",",O
moderate,B-PR
to,I-PR
mild,I-PR
effusion,I-PR
with,O
pericardial,B-TE
pressures,I-TE
exceeding,O
right,B-TE
atrial,I-TE
pressures,I-TE
",",O
and,O
right,B-TE
ventricular,I-TE
pressures,I-TE
at,O
various,O
points,O
of,O
patient,O
&apos;s,O
cycle,O
without,O
any,O
change,O
in,O
the,B-PR
effusion,I-PR
from,O
06/11,O
.,O

Thoracic,O
Surgery,O
was,O
also,O
consulted,O
and,O
they,O
felt,O
that,O
there,O
was,O
no,O
need,O
for,O
a,B-TR
pericardial,I-TR
window,I-TR
at,O
the,O
time,O
.,O

She,O
should,O
be,O
continued,O
with,O
pulmonary,B-TE
oximetry,I-TE
testing,I-TE
.,O

She,O
underwent,O
her,B-TE
CT,I-TE
scan,I-TE
.,O

This,O
showed,O
lymphangitic,B-PR
spread,I-PR
of,O
cancer,B-PR
in,I-PR
the,I-PR
chest,I-PR
",",O
question,O
of,O
pulmonary,B-PR
nodules,I-PR
in,I-PR
the,I-PR
chest,I-PR
",",O
pericardial,B-PR
effusion,I-PR
",",O
multiple,B-PR
liver,I-PR
metastases,I-PR
",",O
decreased,B-PR
function,I-PR
of,I-PR
the,I-PR
left,I-PR
kidney,I-PR
",",O
dilated,B-PR
left,I-PR
intrarenal,I-PR
collecting,I-PR
system,I-PR
and,I-PR
proximal,I-PR
ureter,I-PR
",",O
and,O
periaortic,B-PR
lymphadenopathy,I-PR
.,O

Pulmonary,O
felt,O
this,O
was,O
consistent,O
also,O
with,O
lymphangitic,B-PR
spread,I-PR
and,O
they,O
did,O
not,O
feel,O
that,O
a,B-TE
bronchoscopy,I-TE
would,O
be,O
of,O
any,O
assistance,O
at,O
this,O
time,O
.,O

Chemotherapy,B-TR
for,O
metastatic,B-PR
cervical,I-PR
cancer,I-PR
was,O
discussed,O
with,O
the,O
patient,O
and,O
she,O
was,O
started,O
on,O
5-FU,B-TR
800,O
mg,O
per,O
meter,O
squared,O
days,O
06/18,O
",",O
06/19,O
",",O
and,O
06/20,O
.,O

She,O
also,O
received,O
Cisplatin,B-TR
35,O
per,O
meter,O
squared,O
on,O
06/19,O
and,O
Ifex,B-TR
and,O
Mesna,B-TR
on,O
06/18,O
.,O

She,O
was,O
noted,O
",",O
on,O
06/16,O
",",O
to,O
have,O
numerous,B-PR
erythematous,I-PR
maculopapules,I-PR
on,I-PR
her,I-PR
back,I-PR
and,O
chest,O
.,O

Dermatology,O
was,O
consulted,O
and,O
they,O
felt,O
that,O
this,O
was,O
most,O
likely,O
steroid,B-PR
acne,I-PR
.,O

They,O
therefore,O
felt,O
a,B-TR
rapid,I-TR
steroid,I-TR
taper,I-TR
was,O
indicated,O
and,O
topical,B-TR
Erythromycin,I-TR
if,O
desired,O
by,O
the,O
patient,O
.,O

The,B-PR
patient,I-PR
&apos;s,I-PR
shortness,I-PR
of,I-PR
breath,I-PR
and,O
wheezing,B-PR
continued,O
but,O
without,O
change,O
.,O

Her,B-TE
cardiac,I-TE
examination,I-TE
remained,O
the,O
same,O
and,O
there,O
continued,O
to,O
be,O
no,O
evidence,O
of,O
tamponade,B-PR
.,O

Cardiology,O
felt,O
that,O
follow-up,B-TE
echo,I-TE
was,O
indicated,O
on,O
06/18,O
as,O
she,O
had,O
another,B-TE
echocardiogram,I-TE
which,O
showed,O
no,O
change,O
or,O
evidence,O
of,O
tamponade,B-PR
.,O

They,O
therefore,O
felt,O
that,O
she,O
could,O
be,O
continued,O
to,O
be,O
followed,O
by,O
examination,B-TE
.,O

She,O
had,O
some,B-PR
mental,I-PR
status,I-PR
changes,I-PR
with,O
confusion,B-PR
and,O
hallucinations,B-PR
on,O
06/18,O
originating,O
from,O
narcotics,B-TR
versus,O
decreased,B-PR
pO2,I-PR
.,O

The,B-TR
Ifex,I-TR
was,O
held,O
as,O
it,O
was,O
felt,O
that,O
it,O
could,O
have,O
precipitated,O
the,B-PR
mental,I-PR
status,I-PR
changes,I-PR
and,O
that,O
she,O
was,O
to,O
receive,O
no,O
further,B-TR
Ifex,I-TR
.,O

She,O
had,O
no,O
further,B-PR
hallucinations,I-PR
since,O
stopping,O
the,O
Ifex,B-TR
.,O

Psychiatry,O
was,O
also,O
consulted,O
to,O
help,O
her,O
with,O
the,O
changes,O
she,O
was,O
feeling,O
since,O
her,O
new,O
diagnosis,O
.,O

She,O
was,O
hooked,O
up,O
with,O
support,O
services,O
in,O
Collot,O
Ln,O
",",O
Dugo,O
",",O
Indiana,O
68961,O
for,O
further,B-TR
counselling,I-TR
and,O
given,O
Xanax,B-TR
for,O
symptoms,B-PR
of,O
anxiety,B-PR
.,O

She,O
continued,O
to,O
have,O
no,O
change,O
in,O
her,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
or,O
cardiac,B-TE
examination,I-TE
and,O
was,O
discharged,O
home,O
on,O
06/22/91,O
after,O
completing,O
her,B-TR
5-FU,I-TR
and,O
Cisplatin,B-TR
chemotherapy,I-TR
.,O

DISPOSITION,O
:,O

She,O
will,O
be,O
followed,O
by,O
Dr.,O
Mielke,O
and,O
home,O
care,O
services,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Premarin,B-TR
0.625,O
q.d.,O
",",O
Proventil,B-TR
Inhaler,I-TR
two,O
puffs,O
q.i.d.,O
",",O
Beclovent,B-TR
four,O
puffs,O
b.i.d.,O
",",O
Colace,B-TR
100,O
mg,O
p.o.,O
t.i.d.,O
",",O
MS,B-TR
Contin,I-TR
30,O
mg,O
p.o.,O
t.i.d.,O
",",O
Elavil,B-TR
25,O
mg,O
p.o.,O
q.h.s.,O
",",O
Trilisate,B-TR
750,O
mg,O
p.o.,O
b.i.d.,O
",",O
MS,B-TR
Elixir,I-TR
100,O
mg,O
p.o.,O
q.2h.,O
p.r.n.,O
",",O
Robitussin,B-TR
with,O
Codeine,B-TR
5,O
cc,O
p.o.,O
q.2h.,O
",",O
and,O
home,B-TR
O2,I-TR
two,I-TR
liters,I-TR
via,O
nasal,B-TR
prong,I-TR
with,O
increase,O
to,O
four,O
liters,O
as,O
needed,O
for,O
symptoms,B-PR
p.r.n.,O

ZQ233/5272,O
EARLLAMARG,O
S.,O
MIELKE,O
",",O
M.D.,O
RP75,O

D,O
:,O

07/17/91,O

Batch,O
:,O

8600,O

Report,O
:,O

J4678A87,O

T,O
:,O

07/21/91,O

Dicatated,O
By,O
:,O

SONRELLE,O
LOUELLPASCGACH,O
",",O
M.D.,O
EH41,O

Admission,O
Date,O
:,O

2014-04-14,O

Discharge,O
Date,O
:,O

2014-04-19,O

Date,O
of,O
Birth,O
:,O

2014-04-14,O

Sex,O
:,O

M,O

Service,O
:,O

CMED,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Baby,O
boy,O
Liles,O
is,O
the,O
2.985,O
kg,O
product,O
of,O
a,O
34,O
week,O
gestation,O
born,O
to,O
a,O
30-year-old,O
G3,O
",",O
P0,O
",",O
now,O
1,O
mother,O
.,O

Prenatal,B-TE
screens,I-TE
-,O
A,O
positive,O
",",O
antibody,B-TE
negative,O
",",O
hepatitis,B-TE
surface,I-TE
antigen,I-TE
negative,O
",",O
RPR,B-TE
nonreactive,O
",",O
rubella,B-TE
immune,O
",",O
GBS,B-TE
unknown,O
.,O

PAST,O
OBSTETRICAL,O
HISTORY,O
:,O

Remarkable,O
for,O
an,B-PR
intrauterine,I-PR
fetal,I-PR
demise,I-PR
at,O
30,O
weeks,O
gestation,O
.,O

This,O
pregnancy,O
complicated,O
by,O
hydramnios,B-PR
also,O
.,O

The,B-TE
baby,I-TE
's,I-TE
autopsy,I-TE
was,O
reported,O
to,O
be,O
normal,O
.,O

Dates,O
are,O
by,O
first,B-TE
trimester,I-TE
ultrasound,I-TE
.,O

Pregnancy,O
was,O
complicated,O
by,O
severe,B-PR
polyhydramnios,I-PR
with,O
an,B-TE
AFI,I-TE
of,O
45,O
just,O
prior,O
to,O
delivery,O
.,O

Mother,O
has,O
had,O
multiple,B-TE
ultrasounds,I-TE
and,O
fetal,B-TE
surveys,I-TE
at,O
17,O
and,O
21,O
weeks,O
that,O
had,O
been,O
unremarkable,O
.,O

Mother,O
was,O
transferred,O
to,O
the,O
Debbie-Monaco,O
from,O
Western,O
Mass.,O
Hospital,O
Hospital,O
in,O
the,O
middle,O
of,O
January,O
with,O
increasing,B-PR
polyhydramnios,I-PR
and,O
preterm,B-PR
labor,I-PR
.,O

She,O
received,O
a,B-TR
full,I-TR
course,I-TR
of,I-TR
betamethasone,I-TR
on,O
03-28,O
and,O
was,O
treated,O
with,O
magnesium,B-TR
sulfate,I-TR
until,O
04-12,O
.,O

She,O
was,O
given,O
1,O
dose,O
of,O
nifedipine,B-TR
2,O
days,O
ago,O
as,O
a,B-TR
tocolytic,I-TR
without,O
effect,O
.,O

Delivery,O
by,O
cesarean,B-TR
section,I-TR
was,O
prompted,O
by,O
ongoing,B-PR
labor,I-PR
.,O

Preterm,B-PR
labor,I-PR
with,O
new,O
onset,O
of,O
late,B-PR
decelerations,I-PR
and,O
breech,B-PR
presentation,I-PR
.,O

Nuchal,B-PR
cord,I-PR
was,O
noted,O
at,O
delivery,O
.,O

The,O
infant,O
cried,O
after,O
bulb,B-TR
suctioning,I-TR
and,O
stimulation,B-TR
.,O

Apgars,B-TE
were,O
8,O
and,O
8,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Weight,B-TE
2.985,O
kg,O
",",O
95th,O
percentile;,O
length,B-TE
48,O
cm,O
",",O
85th,O
percentile;,O
head,B-TE
circumference,I-TE
35,O
cm,O
",",O
greater,O
than,O
95th,O
percentile,O
.,O

Anterior,O
fontanel,O
soft,O
and,O
flat.,O
Head,O
shape,O
normal,O
with,O
mildly,B-PR
flattened,I-PR
on,I-PR
top,I-PR
consistent,O
with,O
breech,B-PR
positioning,I-PR
in,I-PR
utero,I-PR
.,O

Facies,O
nondysmorphic,B-PR
",",O
palate,O
intact,O
.,O

Mild,B-PR
intermittent,I-PR
grunting,I-PR
noted,O
with,O
mild,B-PR
subcostal,I-PR
retractions,I-PR
.,O

Good,O
air,O
entry,O
bilaterally,O
.,O

S1,O
and,O
S2,O
normal,O
intensity,O
.,O

No,O
murmur,B-PR
noted,O
.,O

Perfusion,O
good,O
.,O

Abdomen,O
soft,O
with,O
no,O
masses,B-PR
.,O

Three,O
vessel,O
cord,O
.,O

Normal,O
male,O
with,O
testes,O
palpable,O
bilaterally,O
.,O

Tone,B-PR
initially,I-PR
low,I-PR
normal,I-PR
but,O
improved,O
within,O
normal,O
limits,O
on,O
admission,O
.,O

Hips,O
increased,B-PR
lax,I-PR
knee,I-PR
but,O
no,O
obvious,B-PR
dislocation,I-PR
.,O

SUMMARY,O
OF,O
HOSPITAL,O
COURSE,O
BY,O
SYSTEMS,O
:,O

RESPIRATORY,O
:,O

Jacqueline,O
has,O
been,O
admitted,O
to,O
the,O
newborn,O
intensive,O
care,O
unit,O
and,O
has,O
been,O
stable,O
in,O
room,O
air,O
since,O
admission,O
.,O

CARDIOVASCULAR,O
:,O

Infant,O
has,O
an,B-PR
audible,I-PR
murmur,I-PR
.,O

Cardiology,O
consult,O
of,O
the,O
infant,O
on,O
04-18,O
.,O

Echocardiogram,B-TE
results,I-TE
were,O
within,O
normal,O
limits,O
revealing,O
a,B-PR
PPS,I-PR
murmur,I-PR
.,O

FLUIDS,O
",",O
ELECTROLYTES,O
AND,O
NUTRITION,O
:,O

Birth,B-TE
weight,I-TE
was,O
2.985,O
kg,O
.,O

Discharge,B-TE
weight,I-TE
..,O

The,O
infant,O
was,O
initially,O
started,O
on,O
60,O
cc,O
per,O
kg,O
per,O
day,O
of,O
D10W,B-TR
.,O

Enteral,B-TR
feedings,I-TR
were,O
initiated,O
on,O
day,O
of,O
life,O
No.1,O
.,O

The,O
infant,O
is,O
currently,O
on,O
a,O
120,O
cc,O
per,O
kg,O
per,O
day,O
of,O
premature,B-TR
Enfamil,I-TR
20,O
calorie,O
or,O
breast,O
milk,O
",",O
tolerating,O
feeds,O
well,O
.,O

Electrolytes,B-TE
on,O
day,O
of,O
life,O
1,O
showed,O
a,B-TE
sodium,I-TE
of,O
142,O
",",O
potassium,B-TE
of,O
5.1,O
",",O
chloride,B-TE
of,O
108,O
",",O
and,O
total,B-TE
CO2,I-TE
of,O
23,O
.,O

GASTROINTESTINAL,O
:,O

Bilirubin,B-TE
on,O
04-17,O
was,O
8.2/0.3,O
.,O

Surgery,O
was,O
consulted,O
to,O
rule,O
out,O
a,B-PR
TE,I-PR
fistula,I-PR
as,O
the,O
infant,O
had,O
an,B-PR
incidental,I-PR
pass,I-PR
of,O
a,B-TR
gavage,I-TR
tube,I-TR
into,O
his,O
right,O
bronchus,O
.,O

TEF,B-PR
was,O
primarily,O
ruled,O
out,O
as,O
Baker,O
was,O
passed,O
easily,O
to,O
stomach,O
and,O
x-ray,B-TE
revealed,O
good,O
position,O
.,O

HEMATOLOGY,O
:,O

Hematocrit,B-TE
on,I-TE
admission,I-TE
was,O
38.2,O
.,O

The,O
infant,O
has,O
not,O
required,O
any,B-TR
blood,I-TR
transfusions,I-TR
.,O

INFECTIOUS,O
DISEASE,O
:,O

CBC,B-TE
and,O
blood,B-TE
cultures,I-TE
were,O
obtained,O
on,O
admission,O
.,O

CBC,B-TE
was,O
benign,O
and,O
blood,B-TE
cultures,I-TE
remained,O
negative,O
at,O
48,O
hours,O
at,O
which,O
time,O
ampicillin,B-TR
and,O
gentamicin,B-TR
were,O
discontinued,O
.,O

Initial,B-TE
CBC,I-TE
had,O
a,B-TE
white,I-TE
count,I-TE
of,O
16,O
",",O
platelet,B-TE
count,I-TE
of,O
204,O
",",O
53,O
polys,B-TE
and,O
0,O
bands,B-TE
.,O

NEUROLOGY,O
:,O

Appropriate,O
for,O
gestational,O
age,O
.,O

MUSCULOSKELETAL,O
:,O

Of,O
note,O
incidental,O
finding,O
on,O
x-ray,B-TE
",",O
the,O
infant,O
has,O
a,B-PR
hemivertebra,I-PR
at,I-PR
T11,I-PR
.,O

AUDIOLOGY,O
:,O

Hearing,B-TE
screen,I-TE
has,O
not,O
been,O
done,O
but,O
should,O
be,O
done,O
prior,O
to,O
discharge,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
.,O

DISCHARGE,O
DISPOSITION,O
:,O

To,O
Western,O
Mass.,O
Hospital,O
Hospital,O
.,O

NAME,O
OF,O
PRIMARY,O
PEDIATRICIAN,O
:,O

Dr.,O
Joseph.,O

Telephone,O
No,O
.,O

208,O
1429,O
.,O

CARE,O
RECOMMENDATIONS:,O

1.,O
Continue,O
advancing,O
fluid,O
volume,O
to,O
support,O
infant,O
's,O
weight,O
gain,O
needs,O
.,O

2.,O
Medications,B-TR
:,O
Not,O
applicable,O
.,O

3.,O
Car,B-TE
Seat,I-TE
Position,I-TE
Screening,I-TE
has,O
not,O
been,O
performed,O
.,O

4.,O
State,B-TE
Newborn,I-TE
Screen,I-TE
was,O
sent,O
on,O
day,O
of,O
life,O
3,O
.,O

5.,O
Immunizations,B-TR
received:,O
The,O
infant,O
has,O
not,O
received,O
any,B-TR
immunizations,I-TR
at,O
this,O
time,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

Premature,O
infant,O
born,O
at,O
34,O
weeks,O
.,O

Rule,O
out,O
sepsis,B-PR
with,O
antibiotics,B-TR
.,O

Robert,O
Mincer,O
",",O
M.D.,O
50AHB,O

Dictated,O
By:Penny,O
K.,O
Mcbride,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O

2014-04-18,O
21:56,O

T,O
:,O

2014-04-18,O
22:38,O

Job#,O
:,O

44791,O

Signed,O
electronically,O
by,O
:,O

DR.,O
Kenneth,O
RHEIN,O
on,O
:,O

SAT,O
2014-04-19,O
10:03,O
AM,O

(,O
End,O
of,O
Report,O
),O

32890433,O

CTMC,O

75066875,O

828710,O

02/21/1991,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Unsigned,O

DIS,O

Admission,O
Date,O
:,O

02/21/1991,O

Report,O
Status,O
:,O

Unsigned,O

Discharge,O
Date,O
:,O

02/26/1991,O

DISCHARGE,O
DIAGNOSIS,O
:,O

LEFT,B-PR
RENAL,I-PR
MASS,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
was,O
a,O
63,O
year,O
old,O
female,O
with,O
long-standing,O
history,O
of,O
polycythemia,B-PR
vera,I-PR
",",O
managed,O
medically,O
",",O
who,O
on,O
a,B-TE
routine,I-TE
follow-up,I-TE
examination,I-TE
complained,O
of,O
left,B-PR
side,I-PR
pain,I-PR
and,O
had,O
an,B-TE
ultrasound,I-TE
that,O
demonstrated,O
a,B-PR
complex,I-PR
left,I-PR
renal,I-PR
mass,I-PR
.,O

A,B-TE
computerized,I-TE
tomography,I-TE
scan,I-TE
demonstrated,O
a,B-PR
contrast,I-PR
enhancing,I-PR
complex,I-PR
left,I-PR
renal,I-PR
mass,I-PR
.,O

Metastatic,B-TE
work-up,I-TE
was,O
negative,O
.,O

The,O
patient,O
presented,O
for,O
nephrectomy,B-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
included,O
polycythemia,B-PR
vera,I-PR
.,O

PAST,O
SURGICAL,O
HISTORY,O
included,O
appendectomy,B-TR
and,O
bunionectomy,B-TR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
were,O
Hydrea,B-TR
.,O

REVIEW,B-TE
OF,I-TE
SYSTEMS,I-TE
was,O
negative,O
in,O
detail,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,O
patient,O
was,O
a,O
robust,O
white,O
female,O
in,O
no,O
acute,B-PR
distress,I-PR
",",O
afebrile,B-PR
",",O
blood,B-TE
pressure,I-TE
165/80,O
.,O

Head,O
and,O
neck,O
were,O
unremarkable,O
.,O

Lungs,O
were,O
clear,O
.,O

Heart,O
had,O
regular,O
rate,O
and,O
rhythm,O
.,O

Abdomen,O
was,O
benign,O
.,O

Rectal,B-TE
examination,I-TE
was,O
guaiac,B-TE
negative,O
.,O

Extremities,B-TE
and,I-TE
neurological,I-TE
examinations,I-TE
were,O
unremarkable,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
taken,O
to,O
the,O
operating,O
room,O
by,O
Dr.,O
Suot,O
N.,O
Dragtente,O
on,O
02-21-91,O
",",O
where,O
a,B-TR
left,I-TR
radical,I-TR
nephrectomy,I-TR
was,O
performed,O
.,O

At,O
operation,B-TR
",",O
there,O
was,O
no,O
gross,B-PR
adenopathy,I-PR
or,O
renal,B-PR
vein,I-PR
involvement,I-PR
",",O
and,O
it,O
was,O
felt,O
that,O
the,B-PR
tumor,I-PR
was,O
completely,O
excised,O
.,O

The,O
patient,O
thereafter,O
had,O
a,O
benign,O
convalescence,O
",",O
and,O
was,O
discharged,O
on,O
the,O
5th,O
postoperative,O
day,O
.,O

The,O
oncology,O
fellows,O
from,O
Venbonlea,O
Health,O
followed,O
her,O
course,O
and,O
recommended,O
holding,O
off,O
on,O
her,B-TR
Hydrea,I-TR
while,O
she,O
is,O
hospitalized,O
",",O
and,O
they,O
will,O
follow,O
her,O
as,O
an,O
outpatient,O
and,O
restart,O
her,B-TR
Hydrea,I-TR
when,O
her,B-TE
hematocrit,I-TE
is,O
over,O
40%,O
.,O

DISPOSITION,O
:,O

The,O
patient,O
was,O
discharged,O
to,O
home,O
.,O

The,O
patient,O
was,O
discharged,O
on,O
a,O
regular,O
diet,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
was,O
stable,O
.,O

FOLLOW-UP,O
will,O
be,O
with,O
Dr.,O
Suot,O
N.,O
Dragtente,O
and,O
with,O
her,O
Venbonlea,O
Health,O
oncology,O
fellows,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
included,O
Percocet,B-TR
1,O
to,O
2,O
tablets,O
by,O
mouth,O
every,O
4,O
hours,O
as,O
needed,O
for,O
pain,B-PR
",",O
Colace,B-TR
100,O
milligrams,O
by,O
mouth,O
twice,O
a,O
day,O
.,O

PL926/1533,O
SUOT,O
N.,O
DRAGTENTE,O
",",O
M.D.,O
GJ7,O

D,O
:,O

02/26/91,O

Batch,O
:,O

8776,O

Report,O
:,O

P9055V6,O

T,O
:,O

03/02/91,O

Dicatated,O
By,O
:,O

ESPEXIINE,O
BRIZ,O
",",O
M.D.,O
XT67,O

cc,O
:,O

1.,O
VENBONLEA,O
HEALTH,O

Admission,O
Date,O
:,O

2015-09-14,O

Discharge,O
Date,O
:,O

2015-09-19,O

Date,O
of,O
Birth,O
:,O

2015-09-14,O

Sex,O
:,O

M,O

Service,O
:,O

NEONATOLOGY,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
3285,O
gm,O
infant,O
born,O
at,O
37,O
5/7,O
weeks,O
to,O
a,O
21,O
year,O
old,O
G3,O
P1,O
now,O
2,O
mother,O
with,O
prenatal,B-TE
screens,I-TE
as,O
follows,O
:,O

O,O
positive,O
",",O
antibody,B-TE
negative,O
",",O
hepatitis,B-TE
B,I-TE
surface,I-TE
antigen,I-TE
negative,O
",",O
RPR,B-TE
nonreactive,O
",",O
GBS,B-TE
negative,O
.,O

Unremarkable,O
pregnancy,O
except,O
for,O
minor,B-PR
fullness,I-PR
of,I-PR
the,I-PR
left,I-PR
renal,I-PR
pelvis,I-PR
reported,O
during,O
the,O
week,O
prior,O
to,O
delivery,B-TR
.,O

Past,O
OB,O
history,O
remarkable,O
for,O
postpartum,B-PR
depression,I-PR
.,O

Mother,O
was,O
admitted,O
in,O
labor,B-PR
.,O

Baby,O
was,O
delivered,O
by,O
repeat,B-TR
C-section,I-TR
with,O
rupture,B-TR
of,I-TR
membranes,I-TR
at,O
delivery,B-TR
.,O

Apgars,B-TE
were,O
8,O
and,O
9,O
.,O

CMED,O
CSRU,O
staff,O
was,O
called,O
about,O
30,O
minutes,O
of,O
age,O
for,O
grunting,B-PR
",",O
flaring,B-PR
and,O
retractions,B-PR
and,O
the,O
baby,O
was,O
admitted,O
to,O
the,O
CMED,O
CSRU,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Exam,B-TE
was,O
notable,O
for,O
a,O
term,O
infant,O
with,O
flat,O
anterior,O
fontanelle,O
",",O
pink,O
color,O
",",O
normal,O
facies,O
",",O
intact,O
palate,O
",",O
mild,B-PR
retractions,I-PR
",",O
good,O
air,O
entry,O
",",O
no,O
murmurs,B-PR
.,O

Femoral,B-TE
pulses,I-TE
present,O
.,O

Flat,O
",",O
soft,O
and,O
nontender,B-PR
abdomen,I-PR
without,O
hepatosplenomegaly,B-PR
.,O

Stable,O
hips,O
.,O

Normal,O
male,O
genitalia,O
.,O

Testes,O
scrotum,O
.,O

Normal,O
perfusion,O
.,O

Normal,O
tone,O
and,O
activity,O
.,O

LABORATORY,O
DATA,O
:,O

Initial,B-TE
white,I-TE
count,I-TE
19.4,O
thousand,O
",",O
64,O
polys,B-TE
",",O
3,O
bands,B-TE
",",O
hematocrit,B-TE
35.8,O
",",O
platelets,B-TE
"281,000",O
.,O

Chest,B-TE
x-ray,I-TE
revealed,O
streaky,B-PR
lung,I-PR
fields,I-PR
of,O
normal,O
situs,O
",",O
no,O
consolidation,B-PR
",",O
consistent,O
with,O
retained,B-PR
fetal,I-PR
lung,I-PR
fluid,I-PR
.,O

HOSPITAL,O
COURSE:,O

1.,O
Respiratory,O
.,O

The,O
Athol,O
Memorial,O
Hospital,O
hospital,O
course,O
was,O
initially,O
consistent,O
with,O
transient,B-PR
tachypnea,I-PR
of,I-PR
the,I-PR
newborn,I-PR
.,O

Chest,B-TE
x-ray,I-TE
revealed,O
mild,B-PR
streakiness,I-PR
of,I-PR
the,I-PR
lung,I-PR
fields,I-PR
.,O

He,O
was,O
initially,O
placed,O
on,O
nasal,B-TR
cannula,I-TR
with,O
subsequent,O
resolution,O
of,O
respiratory,B-PR
distress,I-PR
.,O

Nasal,B-TR
cannula,I-TR
was,O
weaned,O
off,O
on,O
day,O
of,O
life,O
3,O
and,O
he,O
initially,O
was,O
maintaining,O
O2,B-TE
sat,I-TE
above,O
94%,O
and,O
breathing,O
comfortably,O
.,O

He,O
was,O
subsequently,O
placed,O
back,O
on,O
nasal,B-TR
cannula,I-TR
for,O
mild,B-PR
oxygen,I-PR
desaturation,I-PR
and,O
was,O
requiring,O
25,O
c/min,O
flow,O
at,O
the,O
time,O
of,O
discharge,O
.,O

No,O
apneic,B-PR
or,I-PR
brady,I-PR
episodes,I-PR
.,O

2.,O
Cardiovascular,O
.,O

The,O
patient,O
's,O
cardiovascular,O
status,O
has,O
been,O
stable,O
throughout,O
his,O
CMED,O
CSRU,O
stay,O
.,O

No,O
murmur,B-PR
on,O
exam,B-TE
.,O

3.,O
FEN,O
.,O

The,O
patient,O
had,O
been,O
tolerating,O
oral,O
feeding,O
as,O
of,O
day,O
of,O
life,O
2,O
and,O
is,O
currently,O
taking,O
Enfamil,B-TR
20,O
p.o.,O
ad,O
lib,O
.,O

He,O
has,O
been,O
weaned,O
off,O
IV,B-TR
fluids,I-TR
and,O
has,O
been,O
maintaining,O
good,O
blood,O
glucose,O
.,O

His,B-TE
birth,I-TE
weight,I-TE
was,O
3285,O
gm,O
.,O

His,B-TE
weight,I-TE
is,O
3015,O
gm,O
on,O
day,O
of,O
life,O
5,O
.,O

4.,O
GI,O
.,O

The,B-TE
patient,I-TE
's,I-TE
bilirubin,I-TE
level,I-TE
at,O
24,O
hours,O
of,O
life,O
was,O
4.6.,O

No,O
phototherapy,B-TR
was,O
started,O
.,O

5.,O
ID,O
.,O

The,O
patient,O
was,O
not,O
started,O
on,O
antibiotics,B-TR
",",O
given,O
lack,O
of,O
sepsis,B-PR
risk,I-PR
factors,I-PR
.,O

His,B-TE
initial,I-TE
CBC,I-TE
showed,O
no,O
left,B-PR
shift,I-PR
.,O

Blood,B-TE
culture,I-TE
had,O
remained,O
no,O
growth,B-PR
to,O
date,O
.,O

6.,O
Heme,O
.,O

The,B-TE
patient,I-TE
's,I-TE
initial,I-TE
hematocrit,I-TE
was,O
35.8,O
.,O

No,O
transfusion,B-TR
during,O
this,B-TR
admission,I-TR
.,O

CONDITION,O
ON,O
TRANSFER,O
:,O

The,O
patient,O
has,O
been,O
doing,O
well,O
on,O
low,B-TR
flow,I-TR
nasal,I-TR
cannula.,I-TR
He,O
has,O
been,O
tolerating,O
p.o.,O
ad,O
lib,O
feeds,O
.,O

DISCHARGE,O
DISPOSITION,O
:,O

The,O
patient,O
is,O
to,O
be,O
transferred,O
to,O
the,O
Cambridge,O
Hospital,O
Hospital,O
Special,O
Care,O
Nursery,O
.,O

PRIMARY,O
PEDIATRICIAN,O
:,O

Dr.,O
Amanda,O
Hilton,O
of,O
Crown,O
Colony,O

Pediatrics,O
",",O
phone,O
number,O
353-5927,O
",",O
fax,O
number,O

(,O
853,O
),O
390,O
1387,O
.,O

CARE,O
AND,O
RECOMMENDATIONS:,O

1.,O
Feeds,O
at,O
discharge,O
:,O
Enfamil,B-TR
20,O
p.o.,O
ad,O
lib,O
.,O

2.,O
Medications,B-TR
:,O
none,O
.,O

3.,O
Car,O
seat,O
positioning,O
:,O
not,O
yet,O
done,O
.,O

4.,O
State,B-TE
newborn,I-TE
screening,I-TE
sent,O
.,O

5.,O
Immunizations,B-TR
:,O
received,O
hepatitis,B-TR
B,I-TR
on,O
09-16,O
.,O

DISCHARGE,O
DIAGNOSES:,O

1.,O
Prolonged,B-PR
Respiratory,I-PR
Transition,I-PR
.,O

1.,O
Hyaline,B-PR
Membrane,I-PR
Disease,I-PR
.,O

2.,O
Rule,O
out,O
sepsis,B-PR
without,O
antibiotics,B-TR
.,O

Kevin,O
F,O
Juliusson,O
",",O
M.D.,O

04-834,O

Dictated,O
By:Anita,O
X.,O
Duffy,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O

2015-09-17,O

13:45,O

T,O
:,O

2015-09-17,O

14:15,O

JOB#,O
:,O

24313,O

Signed,O
electronically,O
by,O
:,O

DR.,O
Vanessa,O
Riker,O
on,O
:,O

SAT,O
2015-09-19,O
2:01,O
PM,O

(,O
End,O
of,O
Report,O
),O

40076444,O

PUOMC,O

2267360,O

95601/1m70,O

602566,O

10/17/1995,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

10/17/95,O

DISCHARGE,O
DATE,O
:,O

10/20/95,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
73-year-old,O
man,O
with,O
squamous,B-PR
cell,I-PR
carcinoma,I-PR
of,I-PR
the,I-PR
lung,I-PR
",",O
status,O
post,O
lobectomy,B-TR
and,O
resection,B-TR
of,O
left,B-PR
cervical,I-PR
recurrence,I-PR
",",O
admitted,O
here,O
with,O
fever,B-PR
and,O
neutropenia,B-PR
.,O

Recently,O
he,O
had,O
been,O
receiving,O
a,O
combination,O
of,O
outpatient,B-TR
chemotherapy,I-TR
with,O
the,O
CAMP,O
Program,O
.,O

Other,B-PR
medical,I-PR
problems,I-PR
include,O
hypothyroidism,B-PR
",",O
hypercholesterolemia,B-PR
",",O
hypertension,B-PR
and,O
neuropathy,B-PR
from,O
Taxol,B-TR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

He,O
was,O
a,O
well-developed,O
",",O
well-nourished,O
man,O
who,O
was,O
breathing,O
comfortably,O
.,O

Temperature,B-TE
was,O
101.3,O
.,O

HEENT,O
were,O
normal,O
.,O

Neck,O
was,O
supple,O
.,O

Lungs,O
were,O
clear,O
to,O
percussion,B-TE
and,O
auscultation,B-TE
with,O
a,B-PR
few,I-PR
scattered,I-PR
rales,I-PR
",",O
left,O
greater,O
than,O
right,O
.,O

Abdominal,B-TE
examination,I-TE
was,O
normal,O
.,O

Extremities,O
were,O
normal,O
.,O

Neurological,B-TE
examination,I-TE
was,O
nonfocal,O
.,O

LABORATORY,O
DATA,O
:,O

The,B-TE
WBC,I-TE
was,O
0.9,O
",",O
the,B-TE
ANC,I-TE
was,O
540,O
",",O
platelets,B-TE
were,O
"156,000",O
.,O

HOSPITAL,O
COURSE,O
:,O

He,O
was,O
started,O
on,O
Neupogen,B-TR
",",O
400,O
mcg.,O
subq.,O
q.d.,O

He,O
was,O
initially,O
treated,O
with,O
antibiotic,B-TR
therapy,I-TR
.,O

Chest,B-TE
x-ray,I-TE
showed,O
questionable,O
nodule,B-PR
in,I-PR
the,I-PR
right,I-PR
lower,I-PR
lobe,I-PR
",",O
reasonably,O
stable,O
.,O

Calcium,B-TE
8.7,O
",",O
bilirubin,B-TE
0.3/1.3,O
",",O
creatinine,B-TE
1.1,O
",",O
glucose,B-TE
128,O
.,O

Hematocrit,B-TE
24.6,O
.,O

WBC,B-TE
rose,O
to,O
1.7,O
on,O
10/19,O
.,O

The,O
patient,O
had,O
some,B-PR
diarrhea,I-PR
.,O

There,O
was,O
no,O
diarrhea,B-PR
on,O
10/20,O
.,O

He,O
was,O
feeling,O
well,O
and,O
afebrile,B-PR
.,O

The,B-PR
neutropenia,I-PR
resolved,O
and,O
he,O
was,O
felt,O
to,O
be,O
in,O
satisfactory,O
condition,O
on,O
discharge,O
on,O
10/20/95,O
.,O

He,O
was,O
discharged,O
home,O
on,O
Neupogen,B-TR
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

Fever,B-PR
neutropenia,I-PR
",",O
metastatic,B-PR
squamous,I-PR
cell,I-PR
carcinoma,I-PR
of,I-PR
the,I-PR
lung,I-PR
",",O
hypertension,B-PR
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Include,O
Neupogen,B-TR
",",O
480,O
mcg.,O
subq.,O
q.d.,O
and,O
usual,B-TR
medications,I-TR
.,O

GUABENFRANDA,O
D.,O
PATCH,O
",",O
M.D.,O

TR,O
:,O

wl,O
/,O
bmot,O

DD,O
:,O

11/01/95,O

TD,O
:,O

11/02/95,O

CC,O
:,O

Admission,O
Date,O
:,O

2019-06-25,O

Discharge,O
Date,O
:,O

2019-07-01,O

Date,O
of,O
Birth,O
:,O

1950-04-19,O

Sex,O
:,O

M,O

Service,O
:,O

CARDIOTHORACIC,O

Allergies,O
:,O

Penicillins,B-TR
/,O
Norvasc,B-TR
/,O
Verapamil,B-TR

Attending,O
:,O
Christopher,O
Q,O
Thompson,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

preop,B-TE
w/,I-TE
for,O
knee,B-TR
surgery,I-TR
revealed,O
cardiac,B-PR
dz,I-PR
",",O
asymptomatic,B-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

CABGx4,B-TR
(,O
06-26,O
),O

History,O
of,O
Present,O
Illness,O
:,O

69yoM,O
with,O
OA,B-PR
having,O
workup,B-TE
for,O
knee,B-TR
replacements,I-TR
found,O
to,O
be,O
in,O
Afib,B-PR
",",O
had,O
stress,B-TE
test,I-TE
that,O
was,O
positive,O
followed,O
by,O
cardiac,B-TE
catheterization,I-TE
which,O
revealed,O
severe,B-PR
3VD,I-PR
.,O

Then,O
referred,O
for,O
CABG,B-TR

Past,O
Medical,O
History,O
:,O

HTN,B-PR

chol,B-PR

AFib,B-PR

OA,B-PR
needs,O
bilat,B-TR
arthroplasty,I-TR

CRI,B-PR

Social,O
History,O
:,O

Lives,O
with,O
wife,O
.,O

Remote,O
Timothy,O
",",O
quit,O
1990,O
.,O
+,O
ETOH,O
(,O
1-2,O
drinks,O
/,O
Rivero,O
),O

Family,O
History,O
:,O

Brother,O
died,O
64,O
/,O
MI,B-PR

Physical,O
Exam,O
:,O

Admission,O

VS,B-TE
T,B-TE
98,O

Gen,O
NAD,B-PR

Neuro,O
A&Ox3,O
",",O
nonfocal,O

Chest,O
CTA,O
bilat,O

CV,O
irreg-irreg,B-PR
",",O
no,O
M/R,B-PR

Abdn,O
soft,O
",",O
NT/ND/+BS,B-PR

Ext,O
warm,O
no,O
edema,B-PR

Discharge,O

T99.9,B-TE

Neuro,O
A&Ox3,O
MAE,O
",",O
non,B-TE
focal,I-TE
exam,I-TE

Pulm,O
CTAB,O

CV,O
irreg,B-PR
irreg,I-PR
",",O
sternum,B-PR
stable,I-PR
incision,I-PR
CDI,O

Abdm,O
soft,O
",",O
NT/ND/+BS,B-PR

Ext,O
warm,O
2+,B-PR
edema,I-PR

Pertinent,O
Results,O
:,O

2019-06-25,O
16:10,O

GLUCOSE,B-TE
-,O
97,O
UREA,B-TE
N,O
-,O
44,O
*,O
CREAT,B-TE
-,O
2.0,O
*,O
SODIUM,B-TE
-,O
143,O
POTASSIUM,B-TE
-,O
4.1,O
CHLORIDE,B-TE
-,O
107,O
TOTAL,B-TE
CO2,I-TE
-,O
27,O
ANION,B-TE
GAP,I-TE
-,O
13,O

2019-06-25,O
16:10,O

ALT(SGPT),B-TE
-,O
19,O
AST(SGOT),B-TE
-,O
19,O
LD(LDH),B-TE
-,O
153,O
ALK,B-TE
PHOS,I-TE
-,O
58,O
TOT,B-TE
BILI,I-TE
-,O
0.4,O

2019-06-25,O
16:10,O

ALBUMIN,B-TE
-,O
4.3,O

2019-06-25,O
16:10,O

%HbA1c,B-TE
-,O
5.7,O

2019-06-25,O
16:10,O

TSH,B-TE
-,O
1.2,O

2019-06-25,O
16:10,O

WBC,B-TE
-,O
7.0,O
RBC,B-TE
-,O
3.92,O
*,O
HGB,B-TE
-,O
12.6,O
*,O
HCT,B-TE
-,O
36.4,O
*,O
MCV,B-TE
-,O
93,O
MCH,B-TE
-,O
32.1,O
*,O
MCHC,B-TE
-,O
34.6,O
RDW,B-TE
-,O
13.6,O

2019-06-25,O
16:10,O

PLT,B-TE
COUNT,I-TE
-,O
207,O

2019-06-25,O
16:10,O

PT,B-TE
-,O
11.8,O
PTT,B-TE
-,O
22.4,O
INR(PT),B-TE
-,O
1.0,O

2019-07-01,O
07:30,O
AM,O
BLOOD,B-TE
WBC,B-TE
-,O
8.7,O
RBC,B-TE
-,O
3.18,O
*,O
Hgb,B-TE
-,O
10.4,O
*,O
Hct,B-TE
-,O
30.4,O
*,O
MCV,B-TE
-,O
96,O
MCH,B-TE
-,O
32.7,O
*,O
MCHC,B-TE
-,O
34.3,O
RDW,B-TE
-,O
13.5,O
Plt,B-TE
Ct,I-TE
-,O
303,O

2019-07-01,O
07:30,O
AM,O
BLOOD,B-TE
Plt,B-TE
Ct,I-TE
-,O
303,O

2019-07-01,O
07:30,O
AM,O
BLOOD,B-TE
PT,B-TE
-,O
14.4,O
*,O
PTT,B-TE
-,O
24.2,O
INR(PT)-,B-TE
1.3,O
*,O

2019-06-30,O
06:45,O
AM,O
BLOOD,B-TE
Glucose,B-TE
-,O
99,O
UreaN,B-TE
-,O
40,O
*,O
Creat,B-TE
-,O
1.9,O
*,O
Na,B-TE
-,O
137,O
K,O
-,O
4.1,O
Cl,B-TE
-,O
99,O
HCO3,B-TE
-,O
28,O
AnGap,B-TE
-,O
14,O

CHEST,B-TE
(,I-TE
PORTABLE,I-TE
A,I-TE
P),I-TE

2019-06-30,O
11:26,O

CHEST,B-TE
(,I-TE
PORTABLE,I-TE
AP,I-TE
),I-TE

Reason,O
:,O
Effusion,B-PR
?,O
Pntx,B-PR
?,O

UNDERLYING,O
MEDICAL,O
CONDITION,O
:,O

69,O
year,O
old,O
man,O
with,O
s/p,O
Off,B-TR
Pump,I-TR
CABG,I-TR

REASON,O
FOR,O
THIS,O
EXAMINATION,O
:,O

Effusion,B-PR
?,O
Pntx,B-PR
?,O

PORTABLE,B-TE
CHEST,I-TE
ON,O
2019-06-30,O
AT,O
11:39,O

INDICATION,O
:,O
CABG,B-TR
with,O
chest,B-TR
tube,I-TR
in,O
place,O
.,O

COMPARISON,O
:,O
2019-06-29,O
.,O

FINDINGS,O
:,O
Left,B-TR
chest,I-TR
tube,I-TR
remains,O
in,O
place,O
with,O
some,B-PR
density,I-PR
adjacent,I-PR
to,I-PR
the,I-PR
tip,I-PR
",",O
but,O
there,O
is,O
no,O
significant,B-PR
interval,I-PR
change,I-PR
vs,O
.,O
prior,O
.,O

Specifically,O
",",O
there,O
is,O
no,O
pneumothorax,B-PR
and,O
no,O
interval,B-PR
development,I-PR
of,I-PR
effusion,I-PR
.,O

Cardiac,O
silhouette,O
and,O
mediastinal,O
contours,O
are,O
stable,O
.,O

IMPRESSION,O
:,O
No,O
change,O
vs,O
.,O
prior,O
.,O

DR.,O
James,O
A,O
Roberts,O

Brief,O
Hospital,O
Course,O
:,O

69,O
yo,O
M,O
with,O
known,B-PR
Atrial,I-PR
fibrillation,I-PR
and,O
coronary,B-PR
artery,I-PR
disease,I-PR
admitted,O
preop,O
for,O
transition,O
fro,O
Coumadin,B-TR
to,O
Heparin,B-TR
.,O

Brought,O
to,O
the,O
OR,O
on,O
06-26,O
for,O
CABG,B-TR
",",O
please,O
see,O
OR,O
report,O
for,O
details,O
.,O

In,O
summary,O
pt,O
had,O
off,B-TR
pump,I-TR
CABGx4,I-TR
with,O
LIMA-LAD,B-TR
",",O
SVG,B-TR
OM-Y,I-TR
graft,I-TR
-,I-TR
Diag,I-TR
",",O
SVG-PDA,B-TR
.,O

Pt,O
tolerated,O
surgery,B-TR
well,O
and,O
was,O
transferred,O
to,O
CT,O
CMED,O
ICU,O
.,O

He,O
did,O
well,O
in,O
immediate,O
post-op,O
period,O
was,O
extubated,B-TR
and,O
on,O
POD1,O
he,O
was,O
transferred,O
to,O
the,O
step,O
down,O
floor,O
.,O

On,O
POD2,O
his,B-TR
chest,I-TR
tubes,I-TR
and,O
epicardial,B-TR
pacing,I-TR
wires,I-TR
were,O
removed,O
and,O
his,B-TR
Coumadin,I-TR
was,O
restarted,O
.,O

Over,O
the,O
next,O
several,O
days,O
his,O
activity,O
was,O
advanced,O
on,O
POD5,O
it,O
was,O
decided,O
he,O
was,O
stable,O
and,O
ready,O
to,O
be,O
discharged,O
home,O
with,O
visiting,O
nurses,O
.,O

Medications,O
on,O
Admission,O
:,O

Atenolol,B-TR
200,O
',O

HCTZ,B-TR
25,O
',O

Lisinopril,B-TR
20,O
',O

Ultram,B-TR
50,O
',O

Prilosec,B-TR
20,O
',O

Zocor,B-TR
40,O
',O

Levitra,B-TR
/,O
prn,O

Warfarin,B-TR
4,O
',O

Discharge,O
Medications,O
:,O

1.,O
Metoprolol,B-TR
Tartrate,I-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
Ellis,O
).,O

Disp,O
:*,O
60,O
Tablet,O
(s)*,O
Refills,O
:*,O
2,O
*,O

2.,O
Furosemide,B-TR
20,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
once,O
a,O
Leukhardt,O
for,O
2,O
weeks,O
.,O

Disp,O
:*,O
14,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

3.,O
Potassium,B-TR
Chloride,I-TR
10,O
mEq,O
Tablet,O
Sustained,O
Release,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
Sustained,O
Release,O
PO,O
once,O
a,O
Sine,O
for,O
2,O
weeks,O
.,O

Disp,O
:*,O
28,O
Tablet,O
Sustained,O
Release,O
(s)*,O
Refills,O
:*,O
0,O
*,O

4.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
Costa,O
).,O

Disp,O
:*,O
60,O
Capsule,O
(s)*,O
Refills,O
:*,O
2,O
*,O

5.,O
Aspirin,B-TR
81,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
)(s)*,O
Refills,O
:*,O
2,O
*,O

6.,O
Warfarin,B-TR
2,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
once,O
a,O
Avrett,O
:,O
target,B-TE
INR,I-TE
1.5-2,O
.,O

Disp,O
:*,O
60,O
Tablet,O
(s)*,O
Refills,O
:*,O
2,O
*,O

7.,O
Oxycodone,B-TR
-,I-TR
Acetaminophen,I-TR
5-325,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
every,O
4-6,O
hours,O
as,O
needed,O
for,O
pain,B-PR
.,O

Disp,O
:*,O
50,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

8.,O
Simvastatin,B-TR
40,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
2,O
*,O

9.,O
Prilosec,B-TR
20,O
mg,O
Capsule,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
once,O
a,O
Gray,O
.,O

10.,O
Ultram,B-TR
50,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q6,O
hrs,O
/,O
PRN,O
.,O

Discharge,O
Disposition,O
:,O

Home,O
with,O
Service,O

Discharge,O
Diagnosis,O
:,O

s/p,O
off,B-TR
pump,I-TR
CABGx4,I-TR
LIMA-LAD,B-TR
",Y",B-TR
"SVG-OM-Diag,",I-TR
SVG-PDA,B-TR
(,O
06-26,O
),O
PMH,O
:,O
HTN,B-PR
",",O
chol,B-PR
",",O
AF,B-PR
",",O
OA,B-PR
",",O
CRI,B-PR
",",O
s/p,O
bilat,B-TR
knee,I-TR
surgery,I-TR

Discharge,O
Condition,O
:,O

good,O

Discharge,O
Instructions,O
:,O

Keep,O
wounds,B-PR
clean,O
and,O
dry,O
.,O

OK,O
to,O
shower,O
",",O
no,O
bathing,O
or,O
swimming,O
.,O

Take,O
all,B-TR
medications,I-TR
as,O
prescribed,O

Call,O
for,O
any,O
fever,B-PR
",",O
redness,B-PR
or,O
drainage,B-PR
from,O
wounds,B-PR
.,O

Followup,O
Instructions,O
:,O

Wound,O
clinic,O
in,O
2,O
weeks,O

Dr,O
Anderson,O
in,O
2-3,O
weeks,O

Dr,O
Brown,O
in,O
4,O
weeks,O

Ada,O
Jordan,O
MD,O
62-102,O

Completed,O
by,O
:,O
MARK,O
Eugene,O
NP,O
80-AUO,O
2019-07-01,O
@,O
1417,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Elizabeth,O
P.,O
Fernandez,O
on,O
:,O
TUE,O
2019-07-30,O
8:03,O
AM,O

(,O
End,O
of,O
Report,O
),O

054478430,O
ELMVH,O

79660638,O

1835979,O

12/11/2005,O
12:00:00,O
AM,O

Right,B-PR
LE,I-PR
pain,I-PR

DIS,O

Admission,O
Date,O
:,O

12/11/2005,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

12/13/2005,O

******,O
FINAL,O
DISCHARGE,O
ORDERS,O
******,O

HIBBSKOTE,O
",",O
SIALIND,O
071-43-95-1,O
W78,O

Room,O
:,O

65Q-505,O

Service,O
:,O

ORT,O

DISCHARGE,O
PATIENT,O
ON,O
:,O

12/13/05,O
AT,O
12:00,O
PM,O

CONTINGENT,O
UPON,O

Not,O
Applicable,O

WILL,O
D,O
/,O
C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D,O
/,O
C,O
SUMMARY,O
:,O

YES,O

Attending,O
:,O

HEAD,O
",",O
SANTDEL,O
L.,O
",",O
M.D.,O

CODE,O
STATUS,O
:,O

Full,O
code,O

DISPOSITION,O
:,O

Home,O

DISCHARGE,O
MEDICATIONS,O
:,O

TYLENOL,B-TR
(,I-TR
ACETAMINOPHEN,I-TR
),I-TR
325-650,O
MG,O
PO,O
Q4H,O
PRN,O
Pain,B-PR
",",O
Headache,B-PR
",",O
Temperature,B-TE
greater,O
than,O
:,O

101,O
COLACE,B-TR
(,I-TR
DOCUSATE,I-TR
SODIUM,I-TR
),I-TR
100,O
MG,O
PO,O
BID,O
OXYCODONE,B-TR
10-25,O
MG,O
PO,O
Q3H,O
PRN,O
Pain,B-PR

HOLD,O
IF,O
:,O

excesive,B-PR
sedation,I-PR
RR,B-TE
&lt;,O
6,O
FLEXERIL,B-TR
(,I-TR
CYCLOBENZAPRINE,I-TR
HCL,I-TR
),I-TR
10,O
MG,O
PO,O
TID,O
PRN,O
Pain,B-PR

DIET,O
:,O

House,O
/,O
ADA,O
2100,O
cals,O
/,O
day,O
/,O
Low,O
saturated,O
fat,O
low,O
cholesterol,O
&lt;,O
FDI,O
&gt;,O

ACTIVITY,O
:,O

Walking,O
as,O
tolerated,O

FOLLOW,O
UP,O
APPOINTMENT,O
(,O
S,O
),O
:,O

Dr.,O
Maa,O
Bloch,O
(,O
WAMA,O
HEALTH,O
),O
Call,O
ASAP,O
to,O
schedule,O
in,O
1-2,O
days,O

Phoen,O
:,O

381-389-5852,O
",",O

Dr.,O
Santdel,O
Head,O
Call,O
ASAP,O
to,O
schedule,O
in,O
2,O
weeks,O
.,O

449-059-6882,O
",",O

ALLERGY,O
:,O

NKA,B-PR

ADMIT,O
DIAGNOSIS,O
:,O

R,B-PR
leg,I-PR
pain,I-PR

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O

Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O
Right,B-PR
LE,I-PR
pain,I-PR

OTHER,O
DIAGNOSIS,O
;,O

Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O

DM,B-PR

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

None,O

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O

PT,B-TE
Spien,I-TE
MRI,I-TE
Pelvis,B-TE
XR,I-TE
R,B-TE
hip,I-TE
Xray,I-TE

BRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

HPI,O
:,O

Hibbskote,O
has,O
severe,B-PR
low,I-PR
back,I-PR
pain,I-PR
radiating,O
down,O
the,O
right,O
leg,O
.,O

She,O
has,O
been,O
suffering,O
from,O
this,B-PR
problem,I-PR
for,O
the,O
last,O
few,O
weeks,O
.,O

A,O
week,O
and,O
half,O
ago,O
",",O
she,O
had,O
a,B-TR
steroid,I-TR
injection,I-TR
in,O
an,O
efforts,O
to,O
ameliorate,O
the,B-PR
pain,I-PR
.,O

She,O
presents,O
now,O
with,O
worsening,B-PR
low,I-PR
back,I-PR
pain,I-PR
radiating,O
down,O
the,O
right,O
leg,O
.,O

She,O
denies,O
numbness,B-PR
or,O
weakness,B-PR
in,O
any,O
part,O
of,O
the,O
body,O
.,O

She,O
denies,O
fever,B-PR
.,O

She,O
denies,O
nausea,B-PR
",",O
vomiting,B-PR
",",O
and,O
diarrhea,B-PR
.,O

She,O
denies,O
chest,B-PR
pain,I-PR
.,O

She,O
says,O
the,B-PR
pain,I-PR
is,O
sharp,O
in,O
character,O
",",O
and,O
radiates,O
with,O
a,B-PR
shock,I-PR
like,I-PR
intensity,I-PR
down,I-PR
the,I-PR
right,I-PR
leg,I-PR
.,O

She,O
says,O
that,O
oral,B-TR
analgesics,I-TR
have,O
been,O
of,O
little,O
help,O
.,O

On,O
detailed,B-TE
review,I-TE
of,I-TE
systems,I-TE
",",O
she,O
admitted,O
to,O
one,O
episode,O
of,O
urinary,B-PR
incontinence,I-PR
.,O

She,O
denied,O
any,B-PR
changes,I-PR
in,I-PR
bowel,I-PR
habits,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Non-insulin-requiring,B-PR
diabetes,I-PR
mellitus,I-PR
",",O
and,O
hypercholesterolemia,B-PR
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

As,O
given,O
above,O
.,O

SOCIAL,O
HISTORY,O
:,O

Negative,O
for,O
tobacco,O
",",O
drugs,O
",",O
or,O
domestic,O
violence,O
.,O

FAMILY,O
HISTORY,O
:,O

Negative,O
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

All,O
systems,O
were,O
reviewed,O
and,O
were,O
negative,O
except,O
as,O
given,O
above,O
.,O

MEDICATIONS,O
:,O

Metformin,B-TR
",",O
Zocor,B-TR
",",O
and,O
analgesics,B-TR
.,O

ALLERGIES,O
:,O

None,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Awake,O
",",O
alert,O
",",O
spontaneous,O
and,O
appropriate,O
",",O
and,O
somewhat,B-PR
uncomfortable,I-PR
due,O
to,O
pain,B-PR
but,O
looked,O
well,O
.,O

She,O
was,O
afebrile,B-PR
and,O
had,O
normal,O
vital,O
signs,O
.,O

The,B-TE
oxygen,I-TE
saturation,I-TE
was,O
normal,O
at,O
98%,O
on,O
room,O
air,O
.,O

There,O
was,O
no,O
evidence,O
of,O
head,B-PR
trauma,I-PR
.,O

There,O
was,O
no,O
scleral,B-PR
icterus,I-PR
.,O

The,O
oropharynx,O
was,O
clear,O
.,O

The,O
neck,O
was,O
supple,O
with,O
no,O
lymphadenopathy,B-PR
.,O

The,O
chest,O
was,O
clear,O
with,O
normal,O
excursion,O
.,O

Heart,O
was,O
regular,O
with,O
no,O
murmurs,B-PR
",",O
rubs,B-PR
",",O
or,O
gallops,B-PR
.,O

The,O
abdomen,O
was,O
soft,O
and,O
nontender,B-PR
with,O
no,O
masses,B-PR
",",O
no,O
organomegaly,B-PR
.,O

The,O
skin,O
and,O
extremities,O
were,O
normal,O
with,O
no,O
cyanosis,B-PR
",",O
clubbing,B-PR
",",O
edema,B-PR
",",O
lesions,B-PR
",",O
or,O
rashes,B-PR
.,O

Neurologic,B-TE
examination,I-TE
was,O
normal,O
.,O

Strength,O
",",O
sensation,O
",",O
coordination,O
and,O
cranial,O
nerve,O
function,O
were,O
all,O
normal,O
.,O

Straight,B-TE
leg,I-TE
raise,I-TE
test,I-TE
was,O
difficult,O
to,O
perform,O
due,O
to,O
pain,B-PR
but,O
seemed,O
to,O
be,O
positive,B-PR
on,O
the,O
right,O
.,O

Psychiatric,B-TE
examination,I-TE
was,O
normal,O
.,O

Examination,B-TE
of,I-TE
the,I-TE
back,I-TE
revealed,O
lumbar,B-PR
tenderness,I-PR
with,O
no,O
point,B-PR
tenderness,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

Patient,O
was,O
evaluated,O
by,O
the,O
orthopedic,O
service,O
.,O

An,B-TE
MRI,I-TE
of,I-TE
the,I-TE
spine,I-TE
showed,O
L4/5,B-PR
facet,I-PR
enhancement,I-PR
.,O

It,O
was,O
evaluated,O
by,O
the,O
IR,O
radiology,O
.,O

Thad,B-PR
lesion,I-PR
was,O
read,O
as,O
a,B-PR
facet,I-PR
hypertrophy,I-PR
and,O
not,O
an,B-PR
infectious,I-PR
process,I-PR
.,O

Patient,O
remained,O
afebrile,B-PR
.,O

ESR,B-TE
was,O
within,O
normal,O
limits,O
and,O
CPR,B-TE
was,O
mildly,B-PR
elevated,I-PR
.,O

An,B-TE
AP,I-TE
of,I-TE
pelvis,I-TE
and,O
R,B-TE
hip,I-TE
films,I-TE
were,O
unremarkable,O
.,O

Physical,B-TE
examination,I-TE
of,I-TE
the,I-TE
RLE,I-TE
showed,O
mild,B-PR
pain,I-PR
in,I-PR
right,I-PR
hip,I-PR
with,O
some,O
movements,O
.,O

When,O
patient,O
was,O
distracted,O
",",O
some,O
maneuvers,O
were,O
not,O
painful,B-PR
.,O

Patient,O
remained,O
cardiovascularly,O
stable,O
.,O

Patient,O
was,O
weaned,O
from,O
supplemental,B-TR
oxygen,I-TR
and,O
tolerated,O
a,O
regular,O
diet,O
prior,O
to,O
discharge,O
.,O

The,O
patient,O
received,O
pneumoboots,B-TR
and,O
lovenox,B-TR
for,O
DVT,B-TR
prophylaxis,I-TR
.,O
.,O

Patient,O
was,O
instructed,O
by,O
PT,O
on,O
the,O
correct,O
way,O
to,O
ambulate,O
",",O
weight,O
bearing,O
as,O
tolerated,O
in,O
the,O
RLE,O
.,O
.,O

Patient,O
was,O
able,O
to,O
void,O
and,O
ambulated,O
without,O
assistance,O
as,O
directed,O
by,O
P.T.,O

The,O
team,O
decided,O
that,O
the,O
patient,O
was,O
ready,O
for,O
discharge,O
.,O

Patient,O
should,O
follow,O
up,O
with,O
her,O
pain,O
doctor,O
",",O
Dr.,O
Maa,O
Bloch,O
381-389-5852,O
",",O
for,O
her,B-TR
chronic,I-TR
pain,I-TR
management,I-TR

ADDITIONAL,O
COMMENTS,O
:,O

Do,O
not,O
drive,O
or,O
drink,O
alcohol,O
while,O
taking,O
narcotics,B-TR
.,O

Resume,O
all,O
of,O
your,B-TR
home,I-TR
medications,I-TR
",",O
but,O
please,O
avoid,O
motrin,B-TR
/,I-TR
advil,I-TR
for,O
1,O
week,O
.,O

Call,O
449-059-6882,O
if,O
you,O
have,O
any,O
questions,O
.,O

If,O
you,O
have,O
fevers,B-PR
&gt;,O
101.5,O
F,O
",",O
vomiting,B-PR
",",O
or,O
increased,B-PR
redness,I-PR
",",O
swelling,B-PR
",",O
or,O
discharge,B-PR
from,O
your,B-PR
incision,I-PR
",",O
call,O
your,O
MD,O
or,O
go,O
to,O
the,O
nearest,O
ER,O
.,O

You,O
may,O
bear,O
weight,O
on,O
your,O
both,O
legs,O
.,O

Call,O
381-389-5852,O
to,O
schedule,O
an,O
apointment,O
with,O
your,O
pain,O
doctor,O
(,O
Dr.,O
Maa,O
Bloch,O
),O
ASAP,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O

TO,O
DO,O
/,O
PLAN,O
:,O

No,O
dictated,O
summary,O

ENTERED,O
BY,O
:,O

FLOMKOTEWIERST,O
",",O
NEENIE,O
LAURE,O
",",O
M.D.,O
(,O
DK739,O
),O
12/13/05,O
01:01,O
PM,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

Admission,O
Date,O
:,O

2018-04-23,O

Discharge,O
Date,O
:,O

2018-05-01,O

Date,O
of,O
Birth,O
:,O

1818-04-23,O

Sex,O
:,O

M,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Penicillins,B-TR

Attending,O
:,O

Crystal,O
GQ,O
Divers,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

respiratory,B-PR
distress,I-PR
",",O
hemoptysis,B-PR
transferred,O
from,O
OSH,O

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

debridement,B-TR
of,O
mass,B-PR
from,O
tracheal,O
lumen,O
by,O
interventional,O
pulmonary,O

History,O
of,O
Present,O
Illness,O
:,O

95,O
yo,O
male,O
with,O
PMH,O
large,B-PR
right,I-PR
thyroid,I-PR
cystic,I-PR
mass,I-PR
eroding,I-PR
into,O
trachea,O
",",O
who,O
presented,O
to,O
St.,O
Anne,O
's,O
Hospital,O
2018-04-22,O
with,O
hemoptysis,B-PR
and,O
respiratory,B-PR
distress,I-PR
",",O
now,O
diagnosed,O
with,O
anaplastic,B-PR
thyroid,I-PR
carcinoma,I-PR
.,O

.,O

Pt,O
reports,O
that,O
he,O
noticed,O
a,B-PR
right,I-PR
neck,I-PR
mass,I-PR
last,O
October,O
.,O

The,B-PR
mass,I-PR
grew,O
larger,O
",",O
to,O
the,O
size,O
of,O
a,O
baseball,O
.,O

It,O
appears,O
that,O
FNA,B-TE
was,O
performed,O
but,O
was,O
non-diagnostic,O
(,O
probably,O
because,O
anaplastic,B-PR
tumors,I-PR
tend,O
to,O
be,O
necrotic,O
),O
.,O

The,B-PR
mass,I-PR
appears,O
to,O
be,O
cystic,B-PR
in,O
nature,O
and,O
has,O
been,O
aspirated,O
at,O
least,O
3,O
times,O
",",O
which,O
decrease,O
in,O
size,O
each,O
time,O
.,O

Now,O
size,O
is,O
6.5cm*6.5cm,O
.,O

Plan,O
for,O
surgery,B-TR
in,O
Oct,O
was,O
deferred,O
04-05,O
syncope,B-PR
and,O
pacer,B-TR
placement,I-TR
for,O
SSS;,B-PR
again,O
deferred,O
2,O
weeks,O
ago,O
04-05,O
URI;,B-PR
was,O
planned,O
for,O
surgery,B-TR
this,O
Thurday,O
.,O

.,O

Pt,O
was,O
o/w,O
in,O
his,O
USOH,O
until,O
2-3,O
weeks,O
ago,O
when,O
he,O
developed,O
a,B-PR
URI,I-PR
with,O
symptoms,B-PR
of,O
dry,B-PR
cough;,I-PR
no,O
fever,B-PR
",",O
chills,B-PR
",",O
sore,B-PR
throat,I-PR
",",O
myalgias,B-PR
.,O

Pt,O
was,O
treated,O
with,O
3,O
days,O
of,O
an,B-TR
antibiotics,I-TR
",",O
followed,O
by,O
a,O
10,O
day,O
course,O
of,O
levaquin,B-TR
(,O
completed,O
2,O
days,O
PTA,O
),O
.,O

Per,O
pt,O
and,O
son,O
",",O
no,O
James,B-PR
pna,I-PR
.,O

2,O
days,O
prior,O
to,O
admission,O
",",O
pt,O
developed,O
hemoptysis;,B-PR
states,O
he,O
coughed,O
up,O
4,O
tsp,O
of,O
blood,B-PR
.,O

1,O
day,O
PTA,O
",",O
pt,O
developed,O
stridorous,B-PR
breathing,I-PR
and,O
respiratory,B-PR
distress,I-PR
.,O

Pt,O
was,O
initially,O
seen,O
at,O
Lahey,O
North,O
",",O
where,O
he,O
was,O
given,O
steroids,B-TR
",",O
with,O
improvement,O
in,O
respiratory,O
status,O
.,O

Pt,O
was,O
transferred,O
to,O
New,O
England,O
Baptist,O
Hospital,O
",",O
where,O
his,O
surgeon,O
is,O
located,O
.,O

There,O
he,O
was,O
admitted,O
to,O
the,O
CMED,O
.,O

Thyroid,B-PR
cyst,I-PR
was,O
aspirated,O
with,O
removal,O
of,O
300cc,O
of,O
fluid,O
.,O

Pt,O
was,O
given,O
racemic,B-TR
epinephrine,I-TR
and,O
Decadron,B-TR
10mg,O
IV,O
x1.,O
CT,B-TE
neck,I-TE
showed,O
tracheal,B-PR
mass,I-PR
per,O
nursing,O
s/o,O
(,O
pt,O
brought,O
CT,B-TE
),O
.,O

.,O

Pt,O
now,O
breathing,O
more,O
comfortably,O
.,O

He,O
has,O
not,O
had,O
fever,B-PR
and,O
night,B-PR
sweats,I-PR
but,O
reports,O
weakness,B-PR
and,O
weight,B-PR
loss,I-PR
for,O
several,O
months,O
recently,O
.,O

Past,O
Medical,O
History,O
:,O

R,B-PR
thyroid,I-PR
cyst,I-PR
(,O
as,O
above,O
),O

Goiter,B-PR

CRI,B-PR

HTN,B-PR

SSS,B-PR
(,O
s/p,O
pacer,B-TR
Michelle,O
Matthew,O
Mccaulley,O
),O
prostate,B-PR
cancer,I-PR
-dx,O
10,O
years,O
ago;,O
received,O
monthly,B-TR
shots,I-TR
which,O
were,O
discontinued,O
recently,O
.,O

anemia,B-PR
Afib,I-PR
(,O
19,O
episodes,O
since,O
2017-12-02,O
",",O
as,O
documented,O
on,O
pacer,B-TE
interogation,I-TE
2018-04-04,O
),O

Social,O
History,O
:,O

Was,O
living,O
alone,O
in,O
ALF,O
.,O

Walks,O
with,O
walker,O
.,O

Able,O
to,O
take,O
care,O
of,O
himself;,O
home,O
health,O
aide,O
visits,O
once,O
a,O
week,O
.,O

Denies,O
history,O
of,O
tobacco,O
",",O
etoh,O
",",O
drugs,O
.,O

Used,O
to,O
work,O
as,O
hat,O
manufacturer,O
.,O

Family,O
History:,O

No,O
history,O
of,O
thyroid,B-PR
disease,I-PR
.,O

Sister,O
with,O
lung,B-PR
ca,I-PR
.,O

Brother,O
with,O
gastric,B-PR
ca,I-PR
.,O

sister,O
with,O
unknown,B-PR
ca,I-PR
.,O

Father,O
with,O
stroke,B-PR
.,O

Physical,O
Exam:,O

VS,B-TE
:,O

T,B-TE
99.4,O
",",O
BP,B-TE
119/59,O
",",O
HR,B-TE
76,O
",",O
RR,B-TE
18,O
",",O
99%,O
RA,O

Gen,O
:,O

NAD,B-PR

HEENT,O
:,O

PERRL,O
",",O
EOMI,O
",",O
clear,O
OP,O
",",O
MMM,O

Neck,O
:,O

Large,B-PR
~6,I-PR
x,I-PR
6,I-PR
cm,I-PR
sized,I-PR
right,I-PR
thyroid,I-PR
mass,I-PR
",",O
soft,O
",",O
possibly,O
cystic,B-PR
",",O
non-tender.,B-PR

L,O
lobe,O
of,O
the,O
thyroid,O
gland,O
also,O
prominent,B-PR
.,O

CVS,O
:,O

RRR,O
",",O
nl,O
s1,O
s2,O
",",O
no,O
m/g/r,B-PR

Lungs,O
:,O
transmitted,B-PR
upper,I-PR
airway,I-PR
stridor;,I-PR
otherwise,O
clear,O

Abd,O
:,O
soft,O
",",O
NT,B-PR
",",O
ND,B-PR
",",O
+BS,O

Ext,O
:,O
no,O
edema,B-PR

Neuro,O
:,O

CN,B-TE
04-15,O
intact,O
",",O
07-06,O
bilateral,O
upper,O
and,O
lower,O
extremity,O
strength,O
.,O

Pertinent,O
Results,O
:,O

CT,B-TE
Neck,I-TE
-,O
IMPRESSION,O
:,O

1.,O
7-cm,B-PR
diameter,I-PR
right,I-PR
neck,I-PR
mass,I-PR
",",O
with,O
direct,B-PR
invasion,I-PR
of,I-PR
the,I-PR
subglottic,I-PR
",",I-PR
cervical,I-PR
and,I-PR
proximal,I-PR
thoracic,I-PR
trachea,I-PR
.,O

The,B-PR
mass,I-PR
is,O
reportedly,O
thyroid,O
in,O
origin,O
.,O

Differential,O
diagnosis,O
includes,O
primary,B-PR
head/neck,I-PR
cancer,I-PR
and,O
lymphoma,B-PR
.,O

2.,O
Left,B-PR
lobe,I-PR
thyroid,I-PR
enlargement,I-PR
with,O
heterogeneous,O
appearance,O
.,O

3.,O
Right,B-PR
upper,I-PR
paratracheal,I-PR
and,I-PR
prevascular,I-PR
lymphadenopathy,I-PR
as,O
well,O
as,O
additional,B-PR
nodes,I-PR
in,I-PR
the,I-PR
right,I-PR
side,I-PR
of,I-PR
the,I-PR
neck,I-PR
.,O

Dedicated,B-TE
MR,I-TE
of,I-TE
the,I-TE
neck,I-TE
may,O
be,O
helpful,O
for,O
more,B-TE
complete,I-TE
assessment,I-TE
of,O
the,B-PR
neck,I-PR
mass,I-PR
and,O
lymphadenopathy,B-PR
if,O
warranted,O
clinically,O
.,O

.,O

Pathology,O
:,O

The,B-PR
tumor,I-PR
is,O
composed,O
of,O
a,B-PR
relatively,I-PR
monotonous,I-PR
proliferation,I-PR
of,I-PR
spindle,I-PR
cells,I-PR
which,O
grow,O
in,O
sheets,O
with,O
a,O
prominent,O
vascular,O
pattern,O
.,O

Immunostains,B-TE
for,O
cytokeratin,B-TE
AE1/3,I-TE
and,O
CAM,B-TE
5.2,I-TE
",",O
CD-68,B-TE
",",O
CD-79a,B-TE
",",O
CD-138,B-TE
",",O
S-100,B-TE
",",O
LCA,B-TE
absorbed,I-TE
CEA,I-TE
",",O
EMA,B-TE
",",O
CD34,B-TE
",",O
CD31,B-TE
",",O
TTF-1,B-TE
",",O
actin,B-TE
",",O
desmin,B-TE
",",O
MNF-116,B-TE
",",O
calcitonin,B-TE
",",O
and,O
thyroglobulin,B-TE
are,O
negative,O
.,O

These,O
results,O
exclude,O
both,O
melanoma,B-PR
and,O
hematopoietic,B-PR
neoplasms,I-PR
.,O

The,O
differential,O
diagnosis,O
includes,O
",",O
but,O
is,O
not,O
limited,O
to,O
",",O
sarcoma,B-PR
",",O
spindle,B-PR
cell,I-PR
carcinomas,I-PR
(,O
sarcomatoid,B-PR
carcinoma,I-PR
of,I-PR
the,I-PR
upper,I-PR
aerodigestive,I-PR
tract,I-PR
and,O
anaplastic,B-PR
thyroid,I-PR
carcinoma,I-PR
),O
",",O
and,O
malignant,B-PR
salivary,I-PR
gland,I-PR
neoplasms,I-PR
.,O

Brief,O
Hospital,O
Course,O
:,O

Pt,O
was,O
transferred,O
here,O
for,O
further,B-TR
mgmt,I-TR
of,I-TR
airway,I-TR
and,O
large,B-PR
thyroid,I-PR
mass,I-PR
by,O
our,O
IP,O
team,O
.,O

IP,O
found,O
endotracheal,B-PR
obstructing,I-PR
tumor,I-PR
and,O
extrinsic,B-PR
compression,I-PR
of,I-PR
the,I-PR
high,I-PR
trachea,I-PR
by,O
thyroid,B-PR
mass,I-PR
.,O

After,O
rigid,B-TE
bronchoscopy,I-TE
with,O
removal,B-TR
of,O
the,B-PR
intratracheal,I-PR
tumor,I-PR
component,I-PR
on,O
2018-04-24,O
",",O
stat,B-TE
pathology,I-TE
showed,O
anaplastic,B-PR
tumor,I-PR
.,O

He,O
was,O
tranferred,O
to,O
the,O
CMED,O
.,O

Subsequently,O
extubated,O
and,O
his,O
respiratory,B-PR
Sx,I-PR
are,O
now,O
improved,O
.,O

Pt,O
was,O
seen,O
by,O
Rad,O
Onc,O
",",O
who,O
recommended,O
transfer,O
to,O
the,O
East,O
Campus,O
for,O
XRT,B-TR
.,O

On,O
the,O
morning,O
of,O
possible,B-TR
radiation,I-TR
",",O
patient,O
and,O
family,O
met,O
with,O
interventional,O
pulmonary,O
team,O
who,O
explained,O
that,O
the,B-TE
most,I-TE
recent,I-TE
CT,I-TE
showed,O
further,B-PR
invasion,I-PR
of,I-PR
the,I-PR
tumor,I-PR
into,O
the,O
trachea,O
.,O

After,O
a,O
long,O
discussion,O
",",O
patient,O
and,O
family,O
asked,O
to,O
be,O
made,O
CMO,B-TR
.,O

Patient,O
was,O
started,O
on,O
morphine,B-TR
drip,I-TR
and,O
palliative,O
care,O
team,O
was,O
consulted,O
with,O
recommendations,O
to,O
ensure,O
comfort,O
.,O

Mr,O
.,O
Davison,O
died,O
approximately,O
24,O
hours,O
after,O
decision,O
to,O
be,O
CMO,O
",",O
on,O
2018-05-01,O
.,O

Discharge,O
Disposition,O
:,O

Expired,O

Discharge,O
Diagnosis,O
:,O

NC,O

Discharge,O
Condition,O
:,O

NC,O

Discharge,O
Instructions,O
:,O

NC,O

Followup,O
Instructions,O
:,O

NC,O

John,O
Iris,O
MD,O
70-363,O

Completed,O
by,O
:,O

Patricia,O
Rojas,O
MD,O
73-701,O
2018-05-06,O
@,O
1434,O

Signed,O
electronically,O
by,O
:,O

DR.,O
John,O
J.,O
Booker,O
on,O
:,O

WED,O
2018-05-30,O
5:50,O
PM,O

(,O
End,O
of,O
Report,O
),O

060514276,O
SC,O

52175844,O

23928,O

2/17/2000,O
12:00:00,O
AM,O

ACUTE,B-PR
PANCREATITIS,I-PR

Signed,O

DIS,O

Admission,O
Date,O
:,O

02/17/2000,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

02/29/2000,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

ACUTE,B-PR
PANCREATITIS,I-PR
.,O

SECONDARY,O
DIAGNOSIS,O
:,O

GASTROESOPHAGEAL,B-PR
REFLUX,I-PR
DISEASE,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Ri,O
Strength,O
is,O
a,O
40,O
year,O
old,O
man,O
with,O
a,O
history,O
of,O
GERD,B-PR
",",O
who,O
presents,O
with,O
abdominal,B-PR
pain,I-PR
of,O
seven,O
days,O
duration,O
.,O

The,O
patient,O
was,O
in,O
general,O
good,O
health,O
until,O
seven,O
days,O
ago,O
(,O
2/11/00,O
),O
",",O
when,O
he,O
had,O
a,O
sudden,O
onset,O
of,O
sharp,B-PR
left,I-PR
flank,I-PR
pain,I-PR
with,O
radiation,B-PR
to,I-PR
the,I-PR
lower,I-PR
abdomen,I-PR
and,O
then,O
to,O
the,O
epigastrium,O
.,O

The,O
patient,O
described,O
the,B-PR
pain,I-PR
as,O
&quot;,O
knife-like,B-PR
&quot;,O
with,O
a,O
severity,O
of,O
1/25,O
at,O
its,O
worse,O
.,O

The,O
patient,O
was,O
exacerbated,O
when,O
eating,O
and,O
when,O
lying,O
flat,O
.,O

The,O
patient,O
also,O
reports,O
blood-streaked,B-PR
diarrhea,I-PR
for,O
two,O
days,O
.,O

He,O
denies,O
nausea,B-PR
and,O
vomiting,B-PR
.,O

He,O
has,O
had,O
no,O
fevers,B-PR
or,O
chills,B-PR
.,O

He,O
has,O
had,O
no,O
recent,B-PR
weight,I-PR
loss,I-PR
",",O
no,O
light-headedness,B-PR
or,O
dizziness,B-PR
.,O

He,O
denies,O
increased,B-PR
urinary,I-PR
frequent,I-PR
or,O
urgency,B-PR
.,O

The,O
patient,O
presented,O
to,O
the,O
Sloan-,O
Center,O
Emergency,O
Department,O
",",O
where,O
he,O
was,O
resuscitated,O
with,O
normal,B-TR
saline,I-TR
and,O
received,O
morphine,B-TR
for,O
pain,B-PR
.,O

He,O
was,O
then,O
transferred,O
to,O
the,O
general,O
medicine,O
service,O
for,O
further,B-TR
management,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

(1),O
GERD,B-PR
;,O
(2),O
Pneumonia,B-PR
with,O
partially,B-PR
collapsed,I-PR
lung,I-PR
in,O
1999,O
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

None,O
.,O

MEDICATIONS,O
:,O

Prilosec,B-TR
20,O
mg,O
p.o.,O
q.d.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

FAMILY,O
HISTORY,O
:,O

GERD,B-PR
and,O
PUD,B-PR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
currently,O
lives,O
in,O
Son,O
Wooda,O
with,O
his,O
wife,O
.,O

He,O
has,O
been,O
a,O
construction,O
worker,O
for,O
the,O
past,O
20,O
years,O
.,O

The,O
patient,O
admits,O
to,O
smoking,O
one,O
pack,O
of,O
cigarettes,O
per,O
day,O
.,O

The,O
patient,O
has,O
a,O
history,O
of,O
excessive,O
alcohol,O
use,O
.,O

He,O
currently,O
drinks,O
10,O
beers,O
every,O
other,O
day,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

VITAL,O
SIGNS,O
:,O

Temp,B-TE
98.5,O
",",O
heart,B-TE
rate,I-TE
74,O
",",O
BP,B-TE
140/90,O
",",O
respiratory,B-TE
rate,I-TE
18,O
",",O
O2,B-TE
sat,I-TE
98%,O
.,O

GENERAL,O
:,O

The,O
patient,O
was,O
alert,O
but,O
in,O
mild,B-PR
discomfort,I-PR
.,O

HEENT,O
:,O

PERRL,O
",",O
EOMI,O
",",O
oropharynx,O
clear,O
",",O
moist,O
buccal,O
mucosa,O
.,O

NECK,O
:,O

No,O
lymphadenopathy,B-PR
",",O
no,O
JVD,B-PR
.,O

LUNGS,O
:,O

Bibasilar,B-PR
crackles,I-PR
.,O

Breath,O
sounds,O
were,O
of,O
good,O
intensity,O
.,O

HEART,O
:,O

Regular,O
rate,O
and,O
rhythm,O
",",O
normal,O
S1,O
",",O
S2,O
",",O
no,O
murmurs,B-PR
",",O
rubs,B-PR
",",O
or,O
gallops,B-PR
.,O

ABDOMEN,O
:,O

Soft,O
",",O
non-distended,B-PR
.,O

Tender,B-PR
to,O
palpation,B-TE
at,I-TE
the,I-TE
left,I-TE
lower,I-TE
quadrant,I-TE
and,O
especially,O
at,O
the,O
epigastrium,O
.,O

There,O
was,O
no,O
splenomegaly,B-PR
or,O
hepatosplenomegaly,B-PR
.,O

Bowel,O
sounds,O
were,O
present,O
.,O

BACK,O
:,O

Point,B-PR
tenderness,I-PR
at,I-PR
the,I-PR
left,I-PR
costovertebral,I-PR
angle,I-PR
.,O

EXTREMITIES,O
:,O

Warm,O
to,O
touch,O
",",O
no,O
clubbing,B-PR
",",O
cyanosis,B-PR
",",O
or,O
edema,B-PR
.,O

NEURO,O
:,O

The,O
patient,O
was,O
alert,O
and,O
oriented,O
x3,O
.,O

Deep,B-TE
tendon,I-TE
reflexes,I-TE
were,O
equal,O
and,O
adequate,O
in,O
upper,O
and,O
lower,O
extremities,O
.,O

Cerebellar,O
function,O
was,O
intact,O
.,O

Sensation,O
was,O
intact,O
to,O
pain,B-PR
and,O
light,B-TE
touch,I-TE
.,O

LABORATORY,O
DATA,O
:,O

Chem-7,B-TE
-,O
Na,B-TE
139,O
",",O
K,B-TE
3.7,O
",",O
Cl,B-TE
99,O
",",O
bicarb,B-TE
28,O
",",O
BUN,B-TE
15,O
",",O
creatinine,B-TE
0.9,O
",",O
glucose,B-TE
89,O
.,O

Liver,B-TE
function,I-TE
tests,I-TE
were,O
significant,O
for,O
an,B-TE
ALT,I-TE
41,O
",",O
AST,B-TE
31,O
",",O
alk,B-TE
phos,I-TE
76,O
",",O
T.,B-TE
bili,I-TE
0.7,O
",",O
D.,B-TE
bili,I-TE
0.2,O
",",O
amylase,B-TE
345,O
",",O
lipase,B-TE
2510,O
",",O
T.,B-TE
protein,I-TE
8.1,O
",",O
albumin,B-TE
4.9,O
",",O
globulin,B-TE
3.2,O
",",O
Ca,B-TE
9.9,O
.,O

CBC,B-TE
-,O
White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
8.82,O
",",O
hemoglobin,B-TE
15.2,O
",",O
hematocrit,B-TE
43,O
",",O
and,O
platelets,B-TE
322,O
.,O

Imaging,B-TE
studies,I-TE
:,O

Abdominal,B-TE
CT,I-TE
scan,I-TE
on,O
2/21/00,O
-,O
Study,B-TE
revealed,O
a,B-PR
prominent,I-PR
pancreas,I-PR
with,O
associated,B-PR
mesenteric,I-PR
stranding,I-PR
.,O

No,O
abscess,B-PR
or,O
pseudocyst,B-PR
.,O

A,B-PR
small,I-PR
gallstone,I-PR
was,O
noted,O
in,O
the,O
gallbladder,O
neck,O
.,O

Bilateral,B-PR
pleural,I-PR
effusion,I-PR
were,O
seen,O
with,O
associated,B-PR
compression,I-PR
atelectasis,I-PR
.,O

Abdominal,B-TE
ultrasound,I-TE
on,O
2/23/00,O
-,O
This,B-TE
study,I-TE
revealed,O
gallbladder,B-PR
sludge,I-PR
but,O
no,O
cholelithiasis,B-PR
.,O

There,O
was,O
swelling,B-PR
of,I-PR
the,I-PR
body,I-PR
and,O
tail,O
of,O
the,O
pancreas,O
.,O

Portable,B-TE
chest,I-TE
on,O
2/23/00,O
-,O
Lungs,O
were,O
clear,O
.,O

Heart,O
was,O
normal,O
.,O

There,O
was,O
no,O
pleural,B-PR
effusion,I-PR
.,O

Chest,B-TE
(,I-TE
PA,I-TE
and,I-TE
lateral,I-TE
),I-TE
on,O
2/25/00,O
-,O
Lungs,O
were,O
clear,O
.,O

There,O
was,O
no,O
infiltrates,B-PR
or,O
consolidation,B-PR
.,O

HOSPITAL,O
COURSE,O
:,O

On,O
admission,O
",",O
the,O
patient,O
was,O
diagnosed,O
with,O
acute,B-PR
pancreatitis,I-PR
.,O

He,O
was,O
made,O
NPO,B-TR
and,O
was,O
resuscitated,O
with,O
IV,B-TR
fluids,I-TR
.,O

Pain,B-TR
control,I-TR
was,O
initiated,O
with,O
morphine,B-TR
but,O
was,O
then,O
changed,O
to,O
Demerol,B-TR
",",O
which,O
gave,O
the,O
patient,O
better,O
relief,O
of,O
his,B-PR
epigastric,I-PR
pain,I-PR
.,O

From,O
2/17/00,O
to,O
2/21/00,O
",",O
the,O
patient,O
complained,O
of,O
persistent,B-PR
and,I-PR
occasionally,I-PR
severe,I-PR
epigastric,I-PR
pain,I-PR
.,O

His,B-TR
pain,I-TR
medication,I-TR
was,O
then,O
changed,O
to,O
Dilaudid,B-TR
IV,I-TR
in,O
an,O
attempt,O
to,O
better,O
alleviate,O
his,B-PR
symptoms,I-PR
.,O

Dilaudid,B-TR
IV,I-TR
was,O
continued,O
for,O
the,O
remainder,O
of,O
the,O
patient,O
&apos;s,O
hospitalization,O
.,O

The,O
does,O
was,O
titrated,O
to,O
the,O
patient,O
&apos;s,O
need,O
for,O
comfort,O
and,O
was,O
eventually,O
tapered,O
.,O

The,O
severity,O
and,O
persistent,O
of,O
the,B-PR
patient,I-PR
&apos;s,I-PR
epigastric,I-PR
pain,I-PR
was,O
concerning,O
for,O
a,B-PR
pancreatic,I-PR
complication,I-PR
such,O
as,O
necrosis,B-PR
or,O
abscess,B-PR
.,O

The,O
patient,O
had,O
a,B-TE
CT,I-TE
scan,I-TE
",",O
which,O
revealed,O
a,B-PR
mass,I-PR
in,I-PR
the,I-PR
gallbladder,I-PR
neck,I-PR
",",O
but,O
no,O
biliary,B-PR
dilatation,I-PR
.,O

There,O
was,O
stranding,B-PR
along,I-PR
the,I-PR
pancreas,I-PR
",",O
but,O
no,O
necrosis,B-PR
",",O
abscess,B-PR
",",O
or,O
pseudocyst,B-PR
.,O

On,O
2/22/00,O
",",O
the,O
patient,O
had,O
fevers,B-PR
to,O
103.5,O
.,O

Blood,B-TE
and,I-TE
urine,I-TE
cultures,I-TE
were,O
sent,O
.,O

A,B-TE
chest,I-TE
x-ray,I-TE
was,O
done,O
",",O
which,O
revealed,O
no,O
infiltrate,B-PR
or,O
effusion,B-PR
.,O

The,O
patient,O
was,O
started,O
on,O
cefotaxime,B-TR
1,O
gm,O
IV,O
for,O
empiric,B-TR
antibiotic,I-TR
treatment,I-TR
.,O

All,B-TE
cultures,I-TE
were,O
negative,O
.,O

On,O
2/23/00,O
",",O
the,B-PR
high,I-PR
grade,I-PR
fever,I-PR
persisted,O
.,O

An,B-TE
ultrasound,I-TE
was,O
done,O
to,O
R,O
/,O
O,O
cholestasis,B-PR
or,O
cholangitis,B-PR
.,O

The,B-TE
ultrasound,I-TE
showed,O
biliary,B-PR
sludge,I-PR
and,O
swelling,B-PR
of,I-PR
the,I-PR
body,I-PR
and,O
tail,O
of,O
the,O
pancreas,O
.,O

No,O
other,B-PR
abnormalities,I-PR
were,O
noted,O
.,O

On,O
2/24/00,O
",",O
the,O
patient,O
had,O
an,O
episode,O
of,O
exacerbation,O
of,O
epigastric,B-PR
pain,I-PR
with,O
radiation,B-PR
to,I-PR
the,I-PR
left,I-PR
upper,I-PR
quadrant,I-PR
.,O

The,B-PR
pain,I-PR
was,O
subsequently,O
relieved,O
with,O
high,B-TR
dose,I-TR
Dilaudid,I-TR
.,O

The,O
patient,O
had,O
a,B-TE
follow-up,I-TE
chest,I-TE
x-ray,I-TE
",",O
which,O
was,O
essentially,O
unchanged,O
from,O
previously,O
",",O
showing,O
a,O
normal,O
heart,O
and,O
lungs,O
without,O
infiltrate,B-PR
.,O

From,O
2/25,O
-,O
2/27/00,O
",",O
the,B-PR
patient,I-PR
&apos;s,I-PR
fever,I-PR
defervesced,O
and,O
his,B-PR
abdominal,I-PR
pain,I-PR
gradually,O
subsided,O
.,O

The,B-TR
cefotaxime,I-TR
was,O
discontinued,O
since,O
no,O
infection,B-PR
was,O
identified,O
.,O

On,O
2/28/00,O
",",O
the,O
patient,O
&apos;s,O
diet,O
was,O
advanced,O
to,O
a,B-TR
low,I-TR
fat,I-TR
solids,I-TR
(,O
per,O
pancreatitis,B-TE
study,I-TE
),O
",",O
which,O
the,O
patient,O
tolerated,O
well,O
.,O

The,O
patient,O
was,O
discharged,O
home,O
on,O
2/29/00,O
",",O
with,O
much,O
improvement,O
of,O
his,B-PR
symptoms,I-PR
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Prilosec,B-TR
20,O
mg,O
p.o.,O
q.d.,O
;,O
Percocet,B-TR
1-2,O
tabs,O
p.o.,O
q.6-8h.,O
x5,O
days,O
;,O
MVI,B-TR
1,O
tab,O
p.o.,O
q.d.,O

DISCHARGE,O
FOLLOW-UP,O
:,O

The,O
patient,O
was,O
advised,O
to,O
follow-up,O
with,O
Dr.,O
Edwards,O
in,O
clinic,O
in,O
one,O
week,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
condition,O
.,O

DISCHARGE,O
DISPOSITION,O
:,O

The,O
patient,O
was,O
discharged,O
to,O
home,O
.,O

Dictated,O
By,O
:,O

SON,O
RHALT,O
",",O
SUBINTERN,O
.,O

Attending,O
:,O

MOPAIGEIT,O
S.,O
SOLID,O
",",O
M.D.,O
KP91,O
KX681/6848,O

Batch,O
:,O

52108,O

Index,O
No.,O
GAEHS07465,O

D,O
:,O

03/01/00,O

T,O
:,O

03/01/00,O

CC,O
:,O

1.,O
MOPAIGEIT,O
S.,O
SOLID,O
",",O
M.D.,O

Admission,O
Date,O
:,O

2012-11-21,O

Discharge,O
Date,O
:,O

2012-11-28,O

Date,O
of,O
Birth,O
:,O

1975-05-29,O

Sex,O
:,O

F,O

Service,O
:,O

Transplant,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
37-year-old,O
female,O
who,O
presents,O
on,O
an,O
elective,O
basis,O
for,O
a,B-TR
living-related,I-TR
kidney,I-TR
transplant,I-TR
.,O

The,O
patient,O
has,O
a,O
history,O
of,O
end-stage,B-PR
renal,I-PR
failure,I-PR
secondary,O
to,O
type,B-PR
1,I-PR
diabetes,I-PR
with,O
a,B-TE
baseline,I-TE
creatinine,I-TE
of,O
around,O
5,O
.,O

She,O
is,O
receiving,O
a,B-TR
kidney,I-TR
from,O
her,O
sister,O
.,O

The,O
patient,O
has,O
a,O
history,O
of,O
hypertension,B-PR
",",O
coronary,B-PR
artery,I-PR
disease,I-PR
",",O
and,O
insulin-dependent,B-PR
diabetes,I-PR
for,O
32,O
years,O
.,O

She,O
is,O
status,O
post,O
myocardial,B-PR
infarction,I-PR
in,O
April,O
of,O
this,O
year,O
and,O
subsequently,O
underwent,O
coronary,B-TR
artery,I-TR
bypass,I-TR
surgery,I-TR
.,O

She,O
present,O
electively,O
on,O
the,O
morning,O
of,O
her,B-TR
surgery,I-TR
with,O
no,O
recent,O
changes,O
in,O
her,B-PR
medical,I-PR
problems,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Sarcoidosis,B-PR
since,O
2001,O
.,O

2.,O
She,O
is,O
status,O
post,O
cholecystectomy,B-TR
.,O

3.,O
Status,O
post,O
tubal,B-TR
ligation,I-TR
.,O

4.,O
Status,O
post,O
left,B-TR
arteriovenous,I-TR
graft,I-TR
placement,I-TR
for,O
hemodialysis,B-TR
.,O

5.,O
Insulin-dependent,B-PR
diabetes,I-PR
mellitus,I-PR
times,O
32,O
years,O
.,O

6.,O
Hypertension,B-PR
.,O

7.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
",",O
status,O
post,O
myocardial,B-PR
infarction,I-PR
in,O
2012-05-06,O
.,O

8.,O
End-stage,B-PR
renal,I-PR
disease,I-PR
",",O
on,O
hemodialysis,B-TR
for,O
1.5,O
years,O
.,O

ALLERGIES,O
:,O

Allergies,B-PR
include,O
AMOXICILLIN,B-TR
and,O
CODEINE,B-TR
.,O

MEDICATIONS,O
ON,O
ADMISSION:,O

1.,O
Insulin,B-TR
by,O
sliding-scale,O
",",O
NPH,B-TR
insulin,I-TR
16,O
units,O
in,O
the,O
morning,O
and,O
6,O
units,O
in,O
the,O
evening,O
.,O

2.,O
Lipitor,B-TR
20,O
mg,O
p.o.,O
q.d.,O

3.,O
Zoloft,B-TR
50,O
mg,O
p.o.,O
t.i.d.,O

4.,O
Reglan,B-TR
10,O
mg,O
p.o.,O
t.i.d.,O

5.,O
Lopressor,B-TR
50,O
mg,O
p.o.,O
b.i.d.,O

6.,O
Aspirin,B-TR
81,O
mg,O
p.o.,O
q.d.,O

7.,O
Multivitamin,B-TR
1,O
p.o.,O
q.d.,O

8.,O
Remeron,B-TR
p.o.,O
q.d.,O

SOCIAL,O
HISTORY,O
:,O

She,O
is,O
a,O
half,O
to,O
one,O
pack,O
per,O
day,O
smoker,O
for,O
10,O
years,O
who,O
quit,O
approximately,O
one,O
week,O
prior,O
to,O
her,O
admission,O
.,O

She,O
denies,O
alcohol,O
use,O
.,O

PHYSICAL,O
EXAMINATION,O
ON,O
ADMISSION,O
:,O

Physical,B-TE
examination,I-TE
at,O
the,O
time,O
of,O
admission,O
revealed,O
she,O
was,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

Blood,B-TE
pressure,I-TE
was,O
150/79,O
",",O
a,B-TE
pulse,I-TE
of,O
81,O
.,O

She,O
is,O
legally,B-PR
blind,I-PR
.,O

She,O
was,O
without,O
any,B-PR
adenopathy,I-PR
.,O

Her,O
chest,O
was,O
clear,O
to,O
auscultation,B-TE
.,O

Heart,O
had,O
a,O
normal,O
S1,O
and,O
S2,O
",",O
with,O
no,O
murmurs,B-PR
",",O
gallops,B-PR
or,O
rubs,B-PR
.,O

Her,O
abdomen,O
was,O
soft,O
with,O
well-healed,B-PR
incisions,I-PR
.,O

There,O
was,O
no,O
organomegaly,B-PR
.,O

Extremities,O
were,O
without,O
edema,B-PR
.,O

She,O
had,O
a,B-PR
functioning,I-PR
arteriovenous,I-PR
fistula,I-PR
with,O
a,B-PR
thrill,I-PR
and,O
a,B-PR
bruit,I-PR
in,O
her,O
left,O
arm,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
preoperative,O
holding,O
area,O
and,O
taken,O
electively,O
to,O
the,O
operating,O
room,O
.,O

She,O
underwent,O
a,B-TR
living-related,I-TR
renal,I-TR
transplant,I-TR
in,I-TR
the,I-TR
right,I-TR
iliac,I-TR
fossa,I-TR
.,O

The,B-TR
operation,I-TR
was,O
somewhat,O
technically,O
difficult,O
secondary,O
to,O
a,B-PR
short,I-PR
segment,I-PR
of,I-PR
ureter,I-PR
which,O
was,O
anastomosed,O
over,O
a,B-TR
stent,I-TR
to,O
the,O
bladder,O
.,O

Otherwise,O
",",O
there,O
were,O
difficulties,B-PR
",",O
and,O
estimated,B-PR
blood,I-PR
loss,I-PR
was,O
minimal,O
.,O

She,O
was,O
taken,O
postoperatively,O
to,O
the,O
recovery,O
room,O
already,O
making,O
a,O
large,O
amount,O
of,O
urine,O
.,O

Intraoperatively,O
",",O
for,O
immunosuppression,B-TR
she,O
received,O
thymoglobulin,B-TR
and,O
Solu-Medrol,B-TR
.,O

She,O
was,O
started,O
on,O
Prograf,B-TR
and,O
CellCept,B-TR
in,O
the,O
postoperative,O
period,O
.,O

She,O
was,O
also,O
maintained,O
on,O
Bactrim,B-TR
postoperatively,O
and,O
did,O
not,O
require,O
ganciclovir,B-TR
",",O
as,O
she,O
and,O
her,O
sister,O
were,O
cytomegalovirus,B-PR
negative,O
.,O

The,O
patient,O
's,O
initial,O
postoperative,O
course,O
was,O
relatively,O
uneventful,O
.,O

Her,B-TE
creatinine,I-TE
",",O
which,O
was,O
5,O
initially,O
postoperatively,O
",",O
slowly,O
dropped,O
over,O
the,O
next,O
few,O
days,O
until,O
eventually,O
reaching,O
a,O
low,O
of,O
1,O
.,O

She,O
did,O
receive,O
pamidronate,B-TR
on,O
postoperative,O
day,O
one,O
and,O
received,O
a,O
total,O
of,O
four,O
doses,O
thymoglobulin,B-TR
.,O

Her,B-TR
steroid,I-TR
doses,I-TR
were,O
slowly,O
tapered,O
over,O
her,O
hospital,O
course,O
",",O
and,O
her,B-TE
Prograf,I-TE
level,I-TE
was,O
adjusted,O
to,O
maintain,O
therapeutic,O
values,O
between,O
10,O
and,O
15,O
.,O

She,O
continued,O
to,O
make,O
good,O
urine,O
over,O
the,O
first,O
few,O
days,O
and,O
had,O
her,O
urine,O
losses,O
replaced,O
with,O
intravenous,B-TR
fluids,I-TR
.,O

On,O
postoperative,O
day,O
three,O
",",O
the,O
patient,O
had,O
an,B-PR
episode,I-PR
of,I-PR
shortness,I-PR
of,I-PR
breath,I-PR
that,O
was,O
evaluated,O
by,O
both,O
the,O
Renal,O
and,O
surgical,O
residents,O
.,O

It,O
was,O
found,O
that,O
she,O
was,O
in,O
acute,B-PR
pulmonary,I-PR
edema,I-PR
and,O
required,O
transfer,O
to,O
the,O
Surgical,O
Intensive,O
Care,O
Unit,O
.,O

Her,B-TE
blood,I-TE
pressure,I-TE
at,O
the,O
time,O
of,O
this,O
incident,O
was,O
in,O
the,O
range,O
of,O
200/120,O
.,O

Her,B-TE
electrocardiogram,I-TE
showed,O
no,O
specific,B-PR
ST,I-PR
changes,I-PR
",",O
but,O
there,O
was,O
some,B-PR
loss,I-PR
of,I-PR
her,I-PR
R,I-PR
wave,I-PR
progression,I-PR
laterally,I-PR
.,O

Serial,B-TE
enzymes,I-TE
were,O
drawn,O
",",O
and,O
Cardiology,O
was,O
consulted,O
.,O

With,O
blood,B-TR
pressure,I-TR
control,I-TR
via,O
a,B-TR
nitroglycerin,I-TR
drip,I-TR
and,O
fluid,B-TR
restriction,I-TR
",",O
the,O
patient,O
quickly,O
improved,O
and,O
a,O
had,O
a,O
relatively,O
short,O
stay,O
in,O
the,O
Intensive,O
Care,O
Unit,O
.,O

Throughout,O
this,O
time,O
",",O
her,B-TE
creatinine,I-TE
continued,O
to,O
drop,O
",",O
and,O
there,O
was,O
no,O
apparent,B-PR
deleterious,I-PR
effect,I-PR
on,O
her,B-TR
transplant,I-TR
from,O
this,O
episode,O
.,O

Her,B-TR
beta,I-TR
blocker,I-TR
was,O
progressively,O
increased,O
",",O
and,O
her,B-TR
nitroglycerin,I-TR
drip,I-TR
was,O
weaned,O
down,O
.,O

Two,O
days,O
after,O
this,O
event,O
",",O
she,O
underwent,O
an,B-TE
echocardiogram,I-TE
which,O
was,O
significant,O
for,O
slightly,B-PR
depressed,I-PR
left,I-PR
ventricular,I-PR
systolic,I-PR
function,I-PR
with,O
severe,B-PR
posterior,I-PR
wall,I-PR
hypokinesis,I-PR
.,O

This,O
was,O
a,O
change,O
from,O
her,B-TE
prior,I-TE
echocardiogram,I-TE
and,O
demonstrated,O
evidence,O
of,O
a,B-PR
small,I-PR
myocardial,I-PR
infarction,I-PR
.,O

Clinically,O
",",O
she,O
did,O
much,O
better,O
and,O
her,B-TE
blood,I-TE
pressure,I-TE
was,O
optimized,O
prior,O
to,O
discharge,O
.,O

She,O
was,O
transferred,O
out,O
of,O
the,O
Intensive,O
Care,O
Unit,O
on,O
postoperative,O
day,O
five,O
and,O
was,O
stable,O
on,O
the,O
floor,O
for,O
the,O
next,O
two,O
days,O
.,O

DISCHARGE,O
DISPOSITION,O
:,O

She,O
was,O
set,O
to,O
be,O
discharged,O
to,O
home,O
on,O
11-28,O
",",O
on,O
postoperative,O
day,O
seven,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE:,O

1.,O
Prograf,B-TR
4,O
mg,O
p.o.,O
b.i.d.,O
(,O
this,O
may,O
change,O
depending,O
on,O
her,B-TE
most,I-TE
recent,I-TE
Prograf,I-TE
level,I-TE
which,O
will,O
be,O
drawn,O
on,O
the,O
morning,O
of,O
11-28,O
),O
.,O

2.,O
Prednisone,B-TR
20,O
mg,O
p.o.,O
q.d.,O

3.,O
CellCept,B-TR
1,O
mg,O
p.o.,O
b.i.d.,O

4.,O
Bactrim,B-TR
1,O
single-strength,O
tablet,O
p.o.,O
q.d.,O

5.,O
Zantac,B-TR
150,O
mg,O
p.o.,O
b.i.d.,O

6.,O
NPH,B-TR
insulin,I-TR
16,O
units,O
q.a.m.,O
and,O
6,O
units,O
q.p.m.,O

7.,O
Zoloft,B-TR
175,O
mg,O
p.o.,O
q.d.,O

8.,O
Colace,B-TR
100,O
mg,O
p.o.,O
b.i.d.,O

9.,O
Reglan,B-TR
10,O
mg,O
p.o.,O
t.i.d.,O

10.,O
Percocet,B-TR
one,O
to,O
two,O
tablets,O
p.o.,O
q.4-6h.,O
p.r.n.,O

11.,O
Lopressor,B-TR
125,O
mg,O
p.o.,O
b.i.d.,O

12.,O
Aspirin,B-TR
81,O
mg,O
p.o.,O
q.d.,O

13.,O
Cardizem-CD,B-TR
180,O
mg,O
p.o.,O
q.d.,O

DISCHARGE,O
FOLLOWUP,O
:,O

Follow-up,O
appointments,O
should,O
be,O
with,O
Dr.,O
Jones,O
and,O
Dr.,O
Yost,O
in,O
the,O
Transplant,O
Clinic,O
.,O

Furthermore,O
",",O
she,O
needs,O
a,O
follow-up,O
appointment,O
with,O
Dr.,O
Miller,O
of,O
Cardiology,O
within,O
the,O
next,O
two,O
weeks,O
.,O

DISCHARGE,O
STATUS,O
:,O

The,O
patient,O
was,O
discharged,O
to,O
home,O
.,O

CONDITION,O
AT,O
DISCHARGE,O
:,O

Condition,O
was,O
good,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

Status,O
post,O
living-related,B-TR
renal,I-TR
transplant,I-TR
with,O
perioperative,B-PR
small,I-PR
myocardial,I-PR
infarction,I-PR
.,O

Christina,O
Kinde,O
",",O
MD,O

46-131,O

Dictated,O
By:Lillian,O
U,O
Walley,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O

2012-11-27,O

18:32,O

T,O
:,O

2012-11-28,O

12:49,O

JOB#,O
:,O

9180,O

(,O
cclist,O
),O

Signed,O
electronically,O
by,O
:,O

DR.,O
Thomas,O
Rosier,O
on,O
:,O

FRI,O
2012-12-07,O
3:33,O
PM,O

(,O
End,O
of,O
Report,O
),O

60972300,O

NVH,O

58893318,O

2/1/2002,O
12:00:00,O
AM,O

CONGESTIVE,B-PR
HEART,I-PR
FAILURE,I-PR

Signed,O

DIS,O

Admission,O
Date,O
:,O

02/01/2002,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

02/08/2002,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Saujule,O
Study,O
is,O
a,O
77-year-old,O
woman,O
with,O
a,O
history,O
of,O
obesity,B-PR
and,O
hypertension,B-PR
who,O
presents,O
with,O
increased,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
x,O
5,O
days,O
.,O

Her,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
has,O
been,O
progressive,O
over,O
the,O
last,O
2-3,O
years,O
.,O

She,O
has,O
an,B-PR
associated,I-PR
dry,I-PR
cough,I-PR
but,O
no,O
fevers,B-PR
",",O
chills,B-PR
",",O
or,O
leg,B-PR
pain,I-PR
.,O

She,O
has,O
dyspnea,B-PR
on,O
exertion,O
.,O

She,O
ambulates,O
with,O
walker,B-TR
and,O
a,B-TR
cane,I-TR
secondary,O
to,O
osteoarthritis,B-PR
.,O

She,O
becomes,O
short,B-PR
of,I-PR
breath,I-PR
just,O
by,O
getting,O
up,O
from,O
her,O
chair,O
and,O
can,O
only,O
walk,O
2-3,O
steps,O
on,O
a,O
flat,O
surface,O
.,O

She,O
feels,O
light,B-PR
headed,I-PR
when,O
getting,O
up,O
.,O

Her,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
and,O
dyspnea,B-PR
on,O
exertion,O
has,O
been,O
progressive,O
for,O
the,O
past,O
several,O
years,O
.,O

It,O
has,O
not,O
been,O
sudden,O
or,O
acute,O
.,O

She,O
sleeps,O
in,O
a,O
chair,O
up,O
right,O
for,O
the,O
last,O
2,O
1/2,O
years,O
secondary,O
to,O
osteoarthritis,B-PR
.,O

She,O
has,O
orthopnea,B-PR
as,O
well,O
but,O
noparoxysmal,B-PR
nocturnal,I-PR
dyspnea,I-PR
.,O

She,O
occasionally,O
feels,O
chest,B-PR
twinges,I-PR
which,O
are,O
nonradiating,B-PR
but,O
are,O
sharp,B-PR
.,O

They,O
last,O
a,O
few,O
seconds,O
on,O
the,O
left,O
side,O
and,O
are,O
not,O
associated,O
with,O
sweating,B-PR
",",O
nausea,B-PR
",",O
vomiting,B-PR
or,O
syncope,B-PR
.,O

She,O
has,O
had,O
lower,B-PR
extremity,I-PR
edema,I-PR
for,O
thelast,O
several,O
years,O
with,O
multiple,O
episodes,O
of,O
cellulitis,B-PR
.,O

Her,B-PR
lower,I-PR
extremity,I-PR
edema,I-PR
has,O
increased,O
for,O
the,O
several,O
weeks,O
prior,O
to,O
admission,O
secondary,O
to,O
an,O
inability,O
to,O
elevate,O
her,O
legs,O
due,O
to,O
a,O
broken,O
chair,O
at,O
home,O
.,O

She,O
denies,O
any,B-PR
pleural,I-PR
chest,I-PR
pain,I-PR
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

Negative,O
for,O
headaches,B-PR
",",O
vision,B-PR
changes,I-PR
",",O
numbness,B-PR
",",O
tingling,B-PR
",",O
dyspnea,B-PR
",",O
hematuria,B-PR
",",O
abdominal,B-PR
pain,I-PR
",",O
diarrhea,B-PR
",",O
melena,B-PR
or,O
hematochezia,B-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Obesity,B-PR
",",O
hypertension,B-PR
",",O
lower,B-PR
extremity,I-PR
cellulitis,I-PR
and,O
edema,B-PR
",",O
breast,B-PR
cancer,I-PR
in,O
1988,O
treated,O
with,O
right,B-TR
lumpectomy,I-TR
and,O
XRT,B-TR
",",O
partial,B-TR
thyroidectomy,I-TR
in,O
1963,O
",",O
osteoarthritis,B-PR
with,O
right,B-PR
leg,I-PR
deformities,I-PR
",",O
hernia,B-TR
repair,I-TR
50,O
years,O
ago,O
",",O
bilateral,B-TR
cataract,I-TR
surgery,I-TR
.,O

ALLERGIES,O
:,O

Codeine,B-TR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Hydrochlorothiazide,B-TR
50,O
mg,O
p.o.,O
q,O
day,O
",",O
atenolol,B-TR
50,O
mg,O
p.o.,O
q,O
day,O
",",O
dicloxacillin,B-TR
started,O
on,O
December,O
29,O
",",O
2002,O
",",O
Naproxen,B-TR
500,O
mg,O
p.o.,O
t.i.d.,O
",",O
aspirin,B-TR
81,O
mg,O
p.o.,O
q,O
day,O
",",O
Tylenol,B-TR
p.r.n.,O

SOCIAL,O
HISTORY,O
:,O

Widowed,O
since,O
1972,O
",",O
no,O
tobacco,O
",",O
no,O
alcohol,O
",",O
lives,O
alone,O
.,O

Smoked,O
3,O
packs,O
per,O
day,O
x,O
17,O
years,O
.,O

FAMILY,O
HISTORY,O
:,O

Son,O
died,O
at,O
50,O
of,O
diabetes,B-PR
and,O
myocardial,B-PR
infarction,I-PR
.,O

PHYSICAL,O
EXAM,O
:,O

In,O
the,O
emergency,O
room,O
",",O
vitals,B-TE
were,O
temperature,B-TE
96.4,O
",",O
pulse,B-TE
40-50,O
",",O
blood,B-TE
pressure,I-TE
154-58,O
",",O
satting,O
86%,O
on,O
room,O
air,O
",",O
99%,O
on,O
3,O
liters,O
of,O
3,B-TR
liters,I-TR
cannula,I-TR
.,O

Rate,B-TE
28,O
.,O

HEENT,O
:,O

Anicteric,B-PR
.,O

Extraocular,O
movements,O
intact,O
.,O

2,B-TE
plus,I-TE
carotids,I-TE
.,O

No,O
delayed,B-PR
upstroke,I-PR
.,O

Oropharynx,O
is,O
clear,O
without,O
lymphadenopathyin,B-PR
the,I-PR
neck,I-PR
.,O

Jugular,B-PR
venous,I-PR
distention,I-PR
to,O
the,O
jaw,O
.,O

Positive,O
hepatojugular,O
reflexes,O
.,O

LUNGS,O
:,O

Crackles,B-PR
1/3,I-PR
up,I-PR
bilaterally,I-PR
.,O

CARDIAC,O
:,O

Regular,O
",",O
rate,O
and,O
rhythm,O
.,O

Normal,O
S1,O
and,O
S2,O
.,O

3/6,B-PR
crescendo,I-PR
decrescendo,I-PR
murmur,I-PR
at,I-PR
the,I-PR
right,I-PR
upper,I-PR
sternal,I-PR
border,I-PR
with,O
radiation,B-PR
to,I-PR
the,I-PR
carotids,I-PR
.,O

No,O
rubs,B-PR
or,O
gallops,B-PR
.,O

ABDOMEN,O
:,O

Soft,O
",",O
obese,B-PR
",",O
nontender,B-PR
",",O
nondistended,B-PR
",",O
normal,O
active,O
bowel,O
sounds,O
.,O

No,O
hepatosplenomegaly,B-PR
.,O

EXTREMITIES,O
:,O

3,B-PR
plus,I-PR
pitting,I-PR
edema,I-PR
to,I-PR
the,I-PR
knee,I-PR
bilaterally,I-PR
with,O
areas,O
of,O
darkened,B-PR
erythema,I-PR
which,O
is,O
crusted,B-PR
",",O
indented,B-PR
.,O

A,B-PR
shallow,I-PR
chronic,I-PR
ulcer,I-PR
in,I-PR
the,I-PR
right,I-PR
shin,I-PR
with,O
desquamation,B-PR
bilaterally,I-PR
around,I-PR
the,I-PR
ankle,I-PR
and,O
half,O
way,O
up,O
the,O
shin,O
.,O

1,B-PR
x,I-PR
2,I-PR
cm,I-PR
ulcer,I-PR
with,O
clean,O
sharp,O
borders,O
to,O
the,O
dermatome,O
on,O
the,O
left,O
posterior,O
thigh,O
.,O

NEUROLOGICAL,O
:,O

Alert,O
and,O
oriented,O
x,O
3,O
.,O

Cranial,O
nerves,O
II-XII,O
intact,O
.,O

4/5,O
lower,O
extremity,O
bilaterally,O
.,O

5/5,O
strength,O
upper,O
extremities,O
bilaterally,O
.,O

Unable,O
to,O
assess,O
reflexes,B-TE
due,O
to,O
the,B-PR
knee,I-PR
deformities,I-PR
.,O

2,B-TE
plus,I-TE
reflexes,I-TE
in,O
the,O
upper,O
extremities,O
symmetrically,O
bilaterally,O
.,O

Toes,O
downgoing,O
.,O

LABORATORY,O
DATA,O
ON,O
ADMISSION,O
:,O

Sodium,B-TE
134,O
",",O
potassium,B-TE
4.0,O
",",O
chloride,B-TE
91,O
",",O
bicarbonate,B-TE
33,O
",",O
BUN,B-TE
21,O
",",O
creatinine,B-TE
1.1,O
",",O
glucose,B-TE
99,O
",",O
CK,B-TE
22,O
",",O
troponin,B-TE
0,O
.,O

Calcium,B-TE
8.8,O
",",O
white,B-TE
blood,I-TE
cell,I-TE
count,I-TE
10.6,O
",",O
hematocrit,B-TE
37.1,O
",",O
platelets,B-TE
289,O
.,O

INR,B-TE
1.1,O
",",O
PTT,B-TE
30.3.Chest,B-TE
x-ray,I-TE
shows,O
cardiomegaly,B-PR
.,O

Small,B-PR
left,I-PR
effusion,I-PR
.,O

Lobular,B-PR
density,I-PR
at,I-PR
the,I-PR
right,I-PR
hilum,I-PR
.,O

No,O
pneumonia,B-PR
.,O

Electrocardiogram,B-TE
shows,O
normal,O
sinus,O
rhythm,O
at,O
50,O
.,O

Normal,O
axis,O
.,O

primary,B-PR
AV,I-PR
block,I-PR
.,O

Left,B-PR
ventricular,I-PR
hypertrophy,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
hospital,O
for,O
acute,B-PR
and,I-PR
chronic,I-PR
shortness,I-PR
of,I-PR
breath,I-PR
.,O

1.,O
Cardiovascular,O
:,O

The,O
patient,O
was,O
found,O
to,O
be,O
in,O
congestive,B-PR
heart,I-PR
failure,I-PR
and,O
thought,O
likely,O
secondary,O
to,O
diastolic,B-PR
dysfunction,I-PR
secondary,O
to,O
hypertension,B-PR
.,O

The,O
patient,O
was,O
also,O
found,O
to,O
have,O
pulmonary,B-PR
hypertension,I-PR
.,O

She,O
ruled,O
out,O
for,O
myocardial,B-PR
infarction,I-PR
with,O
3,O
negative,O
enzymes,O
.,O

On,O
admission,O
",",O
she,O
was,O
diuresed,O
with,O
Lasix,B-TR
and,O
was,O
negative,O
1-2,O
liters,O
per,O
day,O
for,O
several,O
days,O
.,O

The,B-TR
diuresis,I-TR
was,O
backed,O
off,O
when,O
her,B-TE
bicarbonate,I-TE
increased,O
from,O
36,O
to,O
39,O
.,O

She,O
was,O
restarted,O
on,O
20,O
mg,O
p.o.,O
q,O
day,O
prior,O
to,O
discharge,O
.,O

Her,B-TE
lipids,I-TE
were,O
checked,O
with,O
a,B-TE
total,I-TE
cholesterol,I-TE
of,O
110,O
",",O
triglycerides,B-TE
59,O
",",O
HDL32,B-TE
",",O
LDL,B-TE
64,O
.,O

The,O
patient,O
had,O
a,B-TE
D-dimer,I-TE
greater,O
than,O
1000,O
with,O
lower,B-TE
extremity,I-TE
non-invasive,I-TE
studies,I-TE
which,O
were,O
positive,O
for,O
a,B-PR
small,I-PR
right,I-PR
common,I-PR
femoral,I-PR
clot,I-PR
.,O

It,O
was,O
unclear,O
whether,O
this,O
was,O
old,O
or,O
new,O
.,O

A,B-TE
TTE,I-TE
showed,O
an,B-TE
ejection,I-TE
fraction,I-TE
of,O
60%,O
",",O
mild,B-PR
mitral,I-PR
regurgitation,I-PR
",",O
left,B-PR
atrial,I-PR
enlargement,I-PR
",",O
mild,B-PR
tricuspid,I-PR
regurgitation,I-PR
",",O
pulmonary,B-TE
artery,I-TE
pressures,I-TE
of,O
44,B-TE
plus,I-TE
right,I-TE
atrial,I-TE
pressure,I-TE
.,O

There,O
was,O
an,B-PR
intra-atrial,I-PR
shunt,I-PR
from,O
the,O
right,O
to,O
the,O
left,O
through,O
a,B-PR
patent,I-PR
foramen,I-PR
ovale,I-PR
.,O

Chest,B-TE
CT,I-TE
was,O
a,B-TE
poor,I-TE
study,I-TE
but,O
did,O
not,O
show,O
a,B-PR
pulmonary,I-PR
embolus,I-PR
.,O

The,O
patient,O
had,O
subsequent,B-TE
dobutamine,I-TE
MIBI,I-TE
which,O
was,O
positive,O
for,O
inducible,B-PR
ischemia,I-PR
in,O
the,O
distribution,O
of,O
posterior,O
descending,O
coronary,O
artery,O
and,O
posterolateral,O
coronary,O
artery,O
with,O
a,B-PR
small,I-PR
to,I-PR
medium,I-PR
perfusion,I-PR
defect,I-PR
in,O
the,O
inferolateral,O
wall,O
and,O
basal,O
inferior,O
wall,O
which,O
was,O
partially,O
reversible,O
.,O

The,O
cardiology,O
service,O
saw,O
the,O
patient,O
and,O
recommended,O
medical,O
management,O
only,O
without,O
catheterization,B-TE
.,O

Her,B-TE
blood,I-TE
pressure,I-TE
was,O
high,B-PR
so,O
Captopril,B-TR
was,O
titrated,O
up,O
to,O
50,O
mg,O
p.o.,O
t.i.d.,O
.,O

She,O
will,O
be,O
discharged,O
on,O
Lisinopril,B-TR
with,O
further,O
titration,O
as,O
an,O
outpatient,O
.,O

She,O
is,O
on,O
hydrochlorothiazide,B-TR
50,O
mg,O
p.o.,O
q,O
day,O
.,O

Her,B-TR
atenolol,I-TR
was,O
stopped,O
due,O
to,O
bradycardia,B-PR
on,O
admission,O
but,O
this,O
may,O
be,O
restarted,O
as,O
an,O
outpatient,O
in,O
gentle,B-TR
doses,I-TR
with,O
careful,O
monitoring,O
of,O
heart,B-TE
rate,I-TE
.,O

She,O
is,O
on,O
an,B-TR
aspirin,I-TR
.,O

She,O
will,O
be,O
discharged,O
on,O
Lasix,B-TR
20,O
mg,O
for,O
continued,O
control,O
of,O
her,B-PR
edema,I-PR
.,O

2.,O
Pulmonary,O
;,O

Pulmonary,B-PR
hypertension,I-PR
as,O
seen,O
on,O
echocardiogram,B-TE
.,O

Unclear,O
whether,O
there,O
are,O
chronic,B-PR
pulmonary,I-PR
embolus,I-PR
but,O
did,O
have,O
positive,O
test,O
for,O
deep,B-PR
venous,I-PR
thrombosis,I-PR
and,O
will,O
be,O
treated,O
with,O
Coumadin,B-TR
.,O

An,B-TE
ABG,I-TE
was,O
done,O
which,O
showed,O
pH,B-TE
7.34,O
",",O
pCO2,B-TE
78,O
",",O
pO2,B-TE
92,O
on,O
2,O
liters,O
.,O

Her,B-TE
bicarbonate,I-TE
peaked,O
at,O
39,O
and,O
generally,O
is,O
in,O
the,O
36-38,O
range,O
.,O

She,O
has,O
severe,B-PR
sleep,I-PR
apnea,I-PR
and,O
falls,O
asleep,O
midsentence,O
.,O

She,O
has,O
episodes,O
of,O
not,B-PR
breathing,I-PR
.,O

BIPAP,B-TR
was,O
attempted,O
for,O
3,O
nights,O
in,O
a,O
row,O
and,O
the,O
patient,O
did,O
not,O
tolerate,O
this,O
.,O

She,O
will,O
need,O
pulmonary,B-TE
function,I-TE
studies,I-TE
as,O
an,O
outpatient,O
as,O
these,O
were,O
not,O
done,O
in,O
the,O
hospital,O
.,O

The,O
pulmonary,O
team,O
saw,O
the,O
patient,O
and,O
only,O
recommended,O
the,B-TE
above,I-TE
testing,I-TE
.,O

She,O
needs,O
home,B-TR
oxygen,I-TR
and,O
is,O
currently,O
at,O
2,B-TR
liters,I-TR
nasal,I-TR
cannula,I-TR
oxygen,I-TR
.,O

3.,O
Infectious,B-PR
disease,I-PR
:,O

Evidence,O
for,O
cellulitis,B-PR
on,I-PR
her,I-PR
legs,I-PR
",",O
likely,O
due,O
to,O
distention,B-PR
from,O
edema,B-PR
and,O
poor,B-PR
perfusion,I-PR
.,O

She,O
was,O
originally,O
started,O
on,O
cefazolin,B-TR
which,O
was,O
then,O
changed,O
to,O
Keflex,B-TR
with,O
good,O
improvement,O
.,O

She,O
will,O
need,O
to,O
continue,O
for,O
at,O
least,O
10,O
more,O
days,O
or,O
as,O
clinically,O
indicated,O
by,O
the,O
course,O
of,O
her,B-PR
cellulitis,I-PR
.,O

4.,O
Hematology,O
:,O

D-dimer,B-TE
in,O
the,O
emergency,O
room,O
was,O
greater,O
than,O
1000,O
and,O
a,B-PR
right,I-PR
common,I-PR
femoral,I-PR
clot,I-PR
was,O
seen,O
.,O

This,B-PR
clot,I-PR
was,O
small,O
and,O
it,O
was,O
questionable,O
as,O
to,O
whether,O
it,O
was,O
old,O
or,O
new,O
.,O

She,O
was,O
started,O
on,O
anticoagulation,B-TR
given,O
the,B-PR
positive,I-PR
D-dimer,I-PR
.,O

Chest,B-TE
CT,I-TE
was,O
nondiagnostic,O
but,O
did,O
not,O
show,O
pulmonary,B-PR
embolus,I-PR
.,O

It,O
was,O
a,B-TE
poor,I-TE
study,I-TE
.,O

Heparin,B-TR
was,O
maintained,O
during,O
her,O
hospital,O
course,O
and,O
then,O
Lovenox,B-TR
was,O
started,O
.,O

Her,B-TR
dose,I-TR
was,O
increased,O
to,O
7.5,O
mg,O
q,O
day,O
the,O
day,O
prior,O
to,O
discharge,O
.,O

She,O
will,O
be,O
discharged,O
on,O
this,O
dose,O
in,O
addition,O
to,O
1,O
day,O
of,O
Lovenox,B-TR
.,O

Discharge,B-TE
INR,I-TE
1.8,O
.,O

Goal,B-TE
INR,I-TE
is,O
2.0-3.0,O
.,O

5.,O
Fluids,O
/,O
electrolytes,O
/,O
nutrition,O
:,O

Low,B-TR
salt,I-TR
diet,I-TR
.,O

Low,B-TR
cholesterol,I-TR
",",I-TR
low,I-TR
fat,I-TR
diet,I-TR
.,O

DISPOSITION,O
ON,O
DISCHARGE,O
:,O

To,O
rehabilitation,B-TR
.,O

DISCHARGE,O
INSTRUCTIONS,O
:,O

House,O
diet,O
.,O

No,O
added,O
salt,O
.,O

Low,O
saturated,O
fat,O
.,O

Low,O
cholesterol,O
.,O

ACTIVITY,O
:,O

As,O
tolerated,O
.,O

ADDITIONAL,O
COMMENTS,O
:,O

The,O
patient,O
needs,O
physical,B-TR
therapy,I-TR
to,O
increase,O
stability,O
in,O
mobilization,O
.,O

Need,O
to,O
try,O
to,O
control,O
blood,B-TE
pressure,I-TE
.,O

Can,O
increase,O
her,B-TR
Ace,I-TR
inhibitor,I-TR
as,O
tolerated,O
.,O

May,O
start,O
beta-blocker,B-TR
at,O
a,O
low,O
dose,O
given,O
mild,B-PR
bradycardia,I-PR
at,O
atenolol,B-TR
50,O
mg,O
p.o.,O
q,O
day,O
.,O

Need,O
to,O
continue,O
oxygen,B-TR
2,O
liters,O
via,O
nasal,B-TR
cannula,I-TR
.,O

Needs,O
anticoagulation,B-TR
for,O
6,O
months,O
for,O
right,B-PR
common,I-PR
femoral,I-PR
artery,I-PR
deep,I-PR
venous,I-PR
thrombosis,I-PR
.,O

Goal,B-TE
INR,I-TE
is,O
2.0-3.0,O
.,O

Should,O
continue,O
Keflex,B-TR
for,O
10,O
more,O
days,O
or,O
as,O
clinically,O
indicated,O
.,O

Need,O
to,O
follow,O
INR,B-TE
after,O
Keflex,B-TR
is,O
discontinued,O
as,O
expect,O
it,O
will,O
change,O
.,O

The,O
patient,O
has,O
severe,B-PR
sleep,I-PR
apnea,I-PR
and,O
stops,O
breathing,O
during,O
sleep,O
.,O

This,O
is,O
her,O
baseline,O
status,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Satisfactory,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Tylenol,B-TR
650,O
mg,O
p.o.,O
q,O
4-6,O
hours,O
p.r.n.,O
headache,B-PR
",",O
enteric,B-TR
coated,I-TR
aspirin,I-TR
325,O
mg,O
p.o.,O
q,O
day,O
",",O
calcium,B-TR
gluconate,I-TR
1000,O
mg,O
p.o.,O
b.i.d.,O
",",O
Colace,B-TR
100,O
mg,O
p.o.,O
b.i.d.,O
",",O
enema,B-TR
of,I-TR
choice,I-TR
and,O
laxative,B-TR
of,I-TR
choice,I-TR
p.o.,O
q,O
day,O
p.r.n.,O
constipation,B-PR
",",O
Lasix,B-TR
20,O
mg,O
p.o.,O
q,O
day,O
",",O
Coumadin,B-TR
7.5,O
mg,O
p.o.q.h.s.,O
for,O
goal,B-TE
INR,I-TE
of,O
2.0-3.0,O
.,O

Keflex,B-TR
500,O
mg,O
p.o.,O
q.i.d.,O
x,O
10,O
more,O
days,O
",",O
Miconazole,B-TR
2%,O
powder,O
topically,O
b.i.d.,O
apply,O
to,O
affected,O
areas,O
of,O
breasts,O
and,O
groins,O
b.i.d.,O
",",O
Lisinopril,B-TR
20,O
mg,O
p.o.,O
q,O
day,O
hold,O
of,O
systolic,B-TE
blood,I-TE
pressure,I-TE
less,O
than,O
110,O
",",O
Lovenox,B-TR
100,O
mg,O
subcutaneously,O
q,O
12,O
hours,O
x,O
2,O
doses,O
and,O
then,O
discontinued,O
",",O
atenolol,B-TR
12.5,O
mg,O
p.o.,O
q,O
day,O
hold,O
for,O
a,B-TE
systolic,I-TE
blood,I-TE
pressure,I-TE
of,O
less,O
than,O
110,O
",",O
heart,B-TE
rate,I-TE
less,O
than,O
55,O
.,O

Dictated,O
By,O
:,O

MONAHA,O
SCREEN,O
",",O
M.D.,O
YR61,O

Attending,O
:,O

CAR,O
APRUESS,O
",",O
M.D.,O
FS15,O
TX837/072487,O

Batch,O
:,O

3205,O

V2ZAS8884,O
J,O

D,O
:,O

2002-08-02,O

T,O
:,O

2002-08-02,O

Admission,O
Date,O
:,O

2018-12-04,O

Discharge,O
Date,O
:,O

2018-12-12,O

Date,O
of,O
Birth,O
:,O

1984-02-13,O

Sex,O
:,O

F,O

Service,O
:,O

OBSTETRICS/GYNECOLOGY,O

Allergies,O
:,O

Ciprofloxacin,B-TR
/,O
Flagyl,B-TR

Attending,O
:,O

Ana,O
K,O
Warren,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Pelvic,B-PR
organ,I-PR
prolapse,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

total,B-TR
vaginal,I-TR
hysterectomy;,I-TR
combined,O
anterior-posterior,B-TR
colporrhaphy,I-TR
with,O
posterior,B-TR
mesh;,I-TR
subpubic,B-TR
urethral,I-TR
sling;,I-TR
sacrospinous,B-TE
colpopexy,I-TE
exploratory,I-TE
laparotomy,I-TE

Reexploration,B-TE
of,I-TE
vaginal,I-TE
surgical,I-TE
area,I-TE
pelvic,I-TE
angiography,I-TE

History,O
of,O
Present,O
Illness,O
:,O

34,O
yo,O
G3P3,O
with,O
pelvic,B-PR
organ,I-PR
prolapse,I-PR
after,O
her,O
second,O
delivery;,O
after,O
her,O
third,O
delivery,O
it,O
became,O
much,B-PR
worse,I-PR
.,O

"She,O
feels,O
like,O
""everything,O
is,O
falling,O
out.""",O

She,O
urinates,O
frequently,O
",",O
but,O
occasionally,O
the,O
urine,O
is,O
very,B-PR
slow,I-PR
to,I-PR
start,I-PR
.,O

She,O
is,O
unable,O
to,O
run,O
without,O
losing,O
urine,O
.,O

The,B-PR
prolapse,I-PR
is,O
especailly,O
large,B-PR
and,I-PR
uncomfotable,I-PR
when,O
she,O
tries,O
to,O
move,O
her,O
bowels,O
and,O
it,O
is,O
easier,O
for,O
her,O
to,O
do,O
sowhile,O
standing,O
rather,O
than,O
sitting,O
.,O

She,O
has,O
deep,B-PR
pain,I-PR
in,O
intercourse,O
.,O

Past,O
Medical,O
History,O
:,O

Medical,O

Chronic,B-PR
back,I-PR
pain,I-PR
:,O
several,B-PR
discs,I-PR
and,O
spondylolisthesis,B-PR

Surgical,O

Left,B-TR
salpingo,I-TR
oophorectomy,I-TR
2002,O
for,O
torsion;,B-PR
coloposcopy,B-TE
and,O
cryotherapy,B-TR
2001;,O
appendectomy;,B-TR
T,B-TR
+,I-TR
A,I-TR

Ob,O

3,O
FTNDs,O

Social,O
History,O
:,O

Occasional,O
EtOH,O

1ppd,O
tobacco,O

Family,O
History,O
:,O

Mother,O
had,O
breast,B-PR
cancer,I-PR

Physical,O
Exam,O
:,O

112,O
#,O

138/94,O

Gen,O
:,O

NAD,B-PR

Heart,O
:,O

RRR,O
",",O
no,O
murmurs,B-PR

Lungs,O
:,O

Clear,O
to,O
percussion,B-TE
and,O
auscultation,B-TE

Breast,O
:,O

Negative,O

Abdomen,O
:,O

Negative,O

Pelvic,O

Ext,O
gen,O
:,O

negative,O

Support,O
:,O

Anterior,B-PR
wall,I-PR
prolapses,I-PR
3,O
cm,O
past,O
the,O
hymen,O
with,O
loss,B-PR
of,I-PR
urine,I-PR
on,I-PR
valsalva;,I-PR
cervix,O
1cm,O
above,O
the,O
hymen;,O
posterior,B-PR
prolapse,I-PR
only,O
to,O
the,O
hymen,O
but,O
3.4,O
cm,O
of,O
perineal,B-PR
descent,I-PR
.,O

Vagina,O
:,O

Negative,O

Cervix,O
:,O

Negative,O

Uterus,O
:,O

Anterior,O
",",O
tender,B-PR
on,O
motion,O

Adnexa,O
:,O

Right,O
not,O
palpable,O
",",O
left,O
absent,O

Rectal,O
:,O

Neg,O

Pertinent,O
Results,O
:,O

RADIOLABLED,B-TE
RED,I-TE
CELL,I-TE
STUDY,I-TE
12-05,O

IMPRESSION,O
:,O

No,O
evidence,O
of,O
acute,B-PR
bleed,I-PR
in,I-PR
the,I-PR
abdomen,I-PR
or,I-PR
pelvis,I-PR
.,O

PELVIC,B-TE
ARTEROGRAM,I-TE
12-05,O

FINDINGS,O
:,O

Images,O
demonstrate,O
diffusely,B-PR
small,I-PR
caliber,I-PR
vasculature,I-PR
consistent,O
with,O
shock,B-PR
.,O

There,O
is,O
luminal,B-PR
irregularity,I-PR
seen,O
in,O
segments,O
of,O
both,O
the,O
left,O
and,O
right,O
external,O
iliac,O
arteries,O
consistent,O
with,O
spasm,B-PR
.,O

Specifically,O
",",O
no,O
extravasation,B-PR
of,I-PR
contrast,I-PR
",",O
obstruction,B-PR
of,I-PR
blood,I-PR
flow,I-PR
",",O
AV,B-PR
fistulization,I-PR
or,O
intimal,B-PR
injury,I-PR
was,O
observed,O
.,O

Thus,O
",",O
no,O
embolotherapy,B-TR
was,O
embarked,O
upon,O
.,O

IMPRESSION,O
:,O

No,O
active,B-PR
bleeding,I-PR
was,O
observed,O
.,O

PATHOLOGY,O
uterus,O
",",O
tubes,O
",",O
ovaries,O
12-04,O

1.,O
Uterus,O
and,O
cervix,O
",",O
hysterectomy,B-TR
(,O
A-E,O
):,O

A.,O
Secretory,B-PR
endometrium,I-PR
.,O

B.,O
Cervix,O
with,O
squamous,B-PR
metaplasia,I-PR
.,O

C.,O
Unremarkable,O
myometrium,O
.,O

D.,O
One,B-TR
intrauterine,I-TR
device,I-TR
",",O
gross,O
description,O
.,O

2.,O
Vaginal,O
epithelium,O
(,O
F,O
):,O

Squamous,B-PR
mucosa,I-PR
and,O
skin,O
with,O
no,O
significant,B-PR
pathologic,I-PR
change,I-PR
.,O

2018-12-04,O
06:37PM,O
BLOOD,O

WBC,B-TE
-,O
20.0*,O
RBC,B-TE
-,O
3.31*,O
Hgb,B-TE
-,O
10.2*#,O
Hct,B-TE
-,O
31.2*,O

MCV,B-TE
-,O
95,O
MCH,B-TE
-,O
30.9,O
MCHC,B-TE
-,O
32.7,O
RDW,B-TE
-,O
13.6,O
Plt,B-TE
Ct,I-TE
-,O
297,O

2018-12-04,O
08:48PM,O
BLOOD,O

Hct,B-TE
-,O
19.5*#,O

2018-12-05,O
01:46AM,O
BLOOD,O

WBC,B-TE
-,O
20.0*,O
RBC,B-TE
-,O
3.96*,O
Hgb,B-TE
-,O
12.5,O
Hct,B-TE
-,O
34.4*#,O

MCV,B-TE
-,O
87#,O
MCH,B-TE
-,O
31.5,O
MCHC,B-TE
-,O
36.4*#,O
RDW,B-TE
-,O
13.6,O
Plt,B-TE
Ct,I-TE
-,O
89*#,O

2018-12-05,O
09:45AM,O
BLOOD,O

WBC,B-TE
-,O
12.7*,O
RBC,B-TE
-,O
3.17*,O
Hgb,B-TE
-,O
9.9*,O
Hct,B-TE
-,O
27.6*,O

MCV,B-TE
-,O
87,O
MCH,B-TE
-,O
31.3,O
MCHC,B-TE
-,O
35.9*,O
RDW,B-TE
-,O
14.2,O
Plt,B-TE
Ct,I-TE
-,O
104*,O

2018-12-06,O
04:09AM,O
BLOOD,O

WBC,B-TE
-,O
12.1*,O
RBC,B-TE
-,O
3.73*,O
Hgb,B-TE
-,O
11.3*,O
Hct,B-TE
-,O
31.5*,O

MCV,B-TE
-,O
84,O
MCH,B-TE
-,O
30.2,O
MCHC,B-TE
-,O
35.8*,O
RDW,B-TE
-,O
15.4,O
Plt,B-TE
Ct,I-TE
-,O
91*,O

2018-12-07,O
12:15AM,O
BLOOD,O

Hct,B-TE
-,O
28.7*,O

2018-12-08,O
06:30AM,O
BLOOD,O

Hct,B-TE
-,O
27.9*,O

2018-12-10,O
04:45AM,O
BLOOD,O

WBC,B-TE
-,O
12.6*,O
RBC,B-TE
-,O
3.53*,O
Hgb,B-TE
-,O
10.5*,O
Hct,B-TE
-,O
30.1*,O

MCV,B-TE
-,O
85,O
MCH,B-TE
-,O
29.8,O
MCHC,B-TE
-,O
35.0,O
RDW,B-TE
-,O
14.6,O
Plt,B-TE
Ct,I-TE
-,O
308#,O

2018-12-04,O
06:37PM,O
BLOOD,O

PT,B-TE
-,O
13.0,O
PTT,B-TE
-,O
26.1,O
INR,B-TE
(,O
PT,B-TE
),O
-,O
1.1,O

2018-12-05,O
02:03PM,O
BLOOD,O

PT,B-TE
-,O
13.2*,O
PTT,B-TE
-,O
24.2,O
INR,B-TE
(,O
PT,B-TE
),O
-,O
1.1,O

2018-12-06,O
04:09AM,O
BLOOD,O

PT,B-TE
-,O
11.6,O
PTT,B-TE
-,O
23.8,O
INR,B-TE
(,O
PT,B-TE
),O
-,O
1.0,O

2018-12-04,O
06:37PM,O
BLOOD,O

Glucose,B-TE
-,O
146*,O
UreaN,B-TE
-,O
12,O
Creat,B-TE
-,O
0.6,O
Na,B-TE
-,O
140,O

K,B-TE
-,O
4.1,O
Cl,B-TE
-,O
108,O
HCO3,B-TE
-,O
21*,O
AnGap,B-TE
-,O
15,O

2018-12-06,O
04:09AM,O
BLOOD,O

Glucose,B-TE
-,O
96,O
UreaN,B-TE
-,O
5*,O
Creat,B-TE
-,O
0.4,O
Na,B-TE
-,O
139,O

K,B-TE
-,O
3.1*,O
Cl,B-TE
-,O
108,O
HCO3,B-TE
-,O
26,O
AnGap,B-TE
-,O
8,O

2018-12-08,O
09:20PM,O
BLOOD,O

UreaN,B-TE
-,O
4*,O
Creat,B-TE
-,O
0.3*,O
Na,B-TE
-,O
140,O
K,B-TE
-,O
4.0,O
Cl,B-TE
-,O
108,O

HCO3,B-TE
-,O
27,O
AnGap,B-TE
-,O
9,O

2018-12-04,O
06:37PM,O
BLOOD,O

Calcium,B-TE
-,O
7.9*,O
Phos,B-TE
-,O
4.5,O
Mg,B-TE
-,O
1.5*,O

2018-12-06,O
01:03PM,O
BLOOD,O

Calcium,B-TE
-,O
7.3*,O
Phos,B-TE
-,O
2.3*,O
Mg,B-TE
-,O
1.7,O

2018-12-07,O
06:30AM,O
BLOOD,O

Calcium,B-TE
-,O
7.5*,O
Mg,B-TE
-,O
1.6,O

2018-12-08,O
09:20PM,O
BLOOD,O

Calcium,B-TE
-,O
7.5*,O
Phos,B-TE
-,O
2.7,O
Mg,B-TE
-,O
1.9,O

2018-12-04,O
10:53PM,O
BLOOD,O

Type,O
-,O
ART,O
pO2,B-TE
-,O
229*,O
pCO2,B-TE
-,O
44,O
pH,B-TE
-,O
7.26*,O
calTCO2,B-TE
-,O
21,O
Base,B-TE
XS,I-TE
-,O
-6,O
Intubat,O
-,O
INTUBATED,O
Vent,O
-,O
CONTROLLED,O

2018-12-05,O
09:09AM,O
BLOOD,O

Type,O
-,O
ART,O
Temp,B-TE
-,O
37.2,O
Rates,B-TE
-,O
/12,O
Tidal,B-TE
V,I-TE
-,O
560,O

PEEP,B-TE
-,O
5,O
FiO2,B-TE
-,O
50,O
pO2,B-TE
-,O
176*,O
pCO2,B-TE
-,O
42,O
pH,B-TE
-,O
7.35,O
calTCO2,B-TE
-,O
24,O
Base,B-TE
XS,I-TE
-,O
-2,O

Intubat,O
-,O
INTUBATED,O
Vent,O
-,O
SPONTANEOU,O

Brief,O
Hospital,O
Course,O
:,O

The,O
patient,O
was,O
taken,O
to,O
the,O
operating,O
room,O
on,O
2018-12-04,O
for,O
TVH,B-TR
",",O
sacrospinous,B-TR
fixation,I-TR
",",O
SPARC,B-TR
",",O
anterior,B-TR
and,I-TR
posterior,I-TR
repair,I-TR
with,I-TR
mesh,I-TR
",",O
cystoscopy;,B-TE
for,O
pelvic,B-PR
organ,I-PR
prolapse,I-PR
.,O

There,O
were,O
no,O
intraoperative,B-PR
complications,I-PR
and,O
the,O
surgical,O
field,O
was,O
hemostatic,O
at,O
the,O
conclusion,O
of,O
the,O
case,O
(,O
see,O
operative,O
report,O
for,O
full,O
description,O
),O
.,O

The,O
patient,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
and,O
was,O
stable,O
in,O
the,O
PACU,O
and,O
admitted,O
to,O
the,O
CMED,O
CCU,O
floor,O
for,O
routine,B-TR
care,I-TR
.,O

At,O
1645,O
12-04,O
",",O
the,O
patient,O
was,O
noted,O
to,O
be,O
hypotensive,B-PR
to,O
70/40,O

HR,B-TE
84,O
with,O
symptoms,B-PR
of,I-PR
lightheadedness,I-PR
while,O
lying,O
supine,O
.,O

There,O
was,O
no,O
active,B-PR
bleeding,I-PR
noted,O
at,O
the,O
surgical,O
site,O
on,O
examination,B-TE
.,O

A,B-TE
STAT,I-TE
HCT,I-TE
drawn,O
at,O
this,O
time,O
was,O
31.2,O
.,O

The,O
patient,O
was,O
re-evalutated,O
at,O
2000,O
and,O
was,O
found,O
to,O
be,O
tacchycardic,B-PR
to,O
115,O
with,O
BP,B-TE
104/50,O
using,O
a,O
manual,O
cuff,O
.,O

Urine,B-TE
output,I-TE
during,O
the,O
prior,O
two,O
hours,O
had,O
been,O
50cc,O
and,O
24cc,O
.,O

A,B-TE
STAT,I-TE
HCT,I-TE
drawn,O
at,O
this,O
time,O
was,O
19.5,O
.,O

The,O
clinical,O
picture,O
was,O
concerning,O
for,O
a,B-PR
post-operative,I-PR
hematoma,I-PR
.,O

The,O
ICU,O
was,O
alerted,O
to,O
the,O
patient,O
's,O
disposition,O
and,O
the,O
operating,O
room,O
was,O
activated,O
for,O
urgent,B-TE
re-exploration,I-TE
.,O

The,O
patient,O
was,O
taken,O
to,O
the,O
OR,O
on,O
POD#0,O
for,O
re-exploration,B-TE
with,I-TE
incision,I-TE
at,O
2243,O
.,O

Exploratory,B-TE
laparotomy,I-TE
revealed,O
hemoperitonium,B-PR
and,O
approximately,O
1,O
L,O
of,O
blood,B-PR
was,O
evacuated,O
.,O

There,O
was,O
approximately,O
500cc,O
of,O
retroperitoneal,B-PR
clot,I-PR
.,O

Despite,O
laparotomy,B-TE
and,O
re-exploration,B-TE
through,I-TE
the,I-TE
vaginal,I-TE
cuff,I-TE
",",O
no,O
source,O
for,O
the,B-PR
bleeding,I-PR
could,O
be,O
found,O
.,O

At,O
the,O
conclusion,O
of,O
the,O
case,O
",",O
the,O
patient,O
continued,O
to,O
bleed,O
",",O
allbeit,O
at,O
a,O
less,O
brisk,O
pace,O
.,O

The,B-TR
endotracheal,I-TR
tube,I-TR
was,O
left,O
in,O
place,O
.,O

Intraoperatively,O
",",O
the,O
patient,O
recieved,O
5u,O
PRBC,B-TR
.,O

IR,O
was,O
consulted,O
to,O
identify,O
the,B-PR
bleeding,I-PR
vessel,I-PR
with,O
angiography,B-TE
",",O
then,O
perform,O
embolization,B-TR
.,O

Tagged,B-TE
cell,I-TE
and,I-TE
angiographic,I-TE
studies,I-TE
performed,O
immediately,O
after,O
re-exploration,B-TE
on,O
12-05,O
did,O
not,O
indetify,O
active,B-PR
bleeding,I-PR
and,O
no,O
emobolization,B-TR
was,O
indicated,O
.,O

THe,O
patient,O
was,O
stable,O
and,O
remained,O
intubated,B-PR
.,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
ICU,O
for,O
further,B-TR
care,I-TR
.,O

The,O
patient,O
's,O
ICU,O
course,O
was,O
uneventful,O
.,O

There,O
was,O
no,O
evidence,O
of,O
continued,O
bleeding,B-PR
and,O
her,B-TE
HCT,I-TE
remained,O
stable,O
around,O
30,O
.,O

The,O
pt,O
self-extubated,O
on,O
POD,O
#1,O
.,O

The,O
patient,O
developed,O
a,B-PR
low,I-PR
grade,I-PR
fever,I-PR
to,O
100.1,O
on,O
POD#1,O
which,O
persisted,O
to,O
POD#2,O
and,O
imperic,B-TR
treatment,I-TR
with,O
gent/clinda,B-TR
was,O
started,O
.,O

The,O
patient,O
was,O
stable,O
for,O
transfer,O
to,O
the,O
CMED,O
floor,O
on,O
POD#3,O
.,O

Antibiotics,B-TR
were,O
discontinued,O
on,O
POD#8,O
and,O
pt,O
remained,O
afebrile,B-PR
thereafter,O
.,O

On,O
POD#9,O
",",O
the,O
patient,O
was,O
afebrile,B-PR
",",O
tolerating,O
a,O
regular,O
diet,O
",",O
ambultating,O
without,O
difficulty,B-PR
and,O
voiding,O
spontaneously,O
.,O

She,O
was,O
discharged,O
home,O
with,O
follow-up,O
in,O
two,O
weeks,O
.,O

Medications,O
on,O
Admission,O
:,O

Zoloft,B-TR
100mg,O
QD,O

Ritalin,B-TR
0.5mg,O
BID,O

Loraze3pam,B-TR
0.5mg,O
BID,O

Percocet,B-TR
5/325,O
QHS,O

Allergies,O
:,O

Cipro,B-TR
",",O
Flagyl,B-TR

Discharge,O
Medications,O
:,O

1.,O
Ibuprofen,B-TR
600,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q6H,O
(,O
every,O
6,O
hours,O
),O
as,O
needed,O
.,O

Disp,O
:,O
*60,O
Tablets*,O

Refills,O
:,O
*1*,O

2.,O
Oxycodone-Acetaminophen,B-TR
5-325,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
.,O

Disp,O
:,O
*60,O
Tablet(,O
s,O
)*,O

Refills,O
:,O
*0*,O

3.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

Disp,O
:,O
*60,O
Capsule(,O
s,O
)*,O

Refills,O
:,O
*2*,O

Continue,O
home,B-TR
meds,I-TR
.,O

Discharge,O
Disposition,O
:,O

Home,O

Discharge,O
Diagnosis,O
:,O

pelvic,B-PR
organ,I-PR
prolapse,I-PR
stress,B-PR
urinary,I-PR
incontinence,I-PR
retroperitoneal,B-PR
bleed,I-PR
hemoperitoneum,I-PR

Discharge,O
Condition,O
:,O

stable,O

Discharge,O
Instructions,O
:,O

No,O
heavy,O
lifting,O
for,O
6,O
weeks,O

No,O
abdominal,O
exercises,O
for,O
6,O
weeks,O

Nothing,O
in,O
the,O
vagina,O
for,O
6,O
weeks,O

Keep,O
stools,O
soft,O

Followup,O
Instructions,O
:,O

Please,O
call,O
Dr.,O
Lewis,O
office,O
for,O
an,O
appointment,O
in,O
2,O
weeks,O
.,O

Adam,O
Saundra,O
MD,O
46-863,O

Completed,O
by,O
:,O

Michael,O
KNIGHT,O
MD,O
21-317,O
2018-12-16,O
@,O
1245,O

Signed,O
electronically,O
by,O
:,O

DR.,O
Wanda,O
Detz,O
on,O
:,O

TUE,O
2018-12-18,O
8:13,O
AM,O

(,O
End,O
of,O
Report,O
),O

61486522,O

TGCHO,O

8946835,O

850116,O

12/19/2001,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O

KOTEFOOKS,O
",",O
DASHA,O

MRN,O
:,O

8946835,O

Age,O
:,O

89y,O

REGISTRATION,O
DATE,O
:,O

12/19/2001,O
01:44,O
AM,O

PRELIMINARY,O
REPORT,O

This,O
is,O
to,O
notify,O
you,O
that,O
your,O
patient,O
",",O
KOTEFOOKS,O
",",O
DASHA,O
arrived,O
in,O
the,O
Emergency,O
Department,O
at,O
Tecal,O
Galecounxopt,O
Community,O
Hospital,O
on,O
12/19/2001,O
01:44,O
AM,O
.,O

The,O
patient,O
presented,O
with,O
a,O
chief,O
complaint,O
of,O
S,O
/,O
P,O
FALL,O
/,O
WEAK,B-PR
.,O

Following,O
evaluation,B-TE
and,O
treatment,B-TR
",",O
the,O
patient,O
&apos;s,O
disposition,O
at,O
the,O
end,O
of,O
the,O
visit,O
was,O
ADMITTED,O
AS,O
AN,O
INPATIENT,O
TO,O
TECAL,O
GALENCOUNXOPT,O
COMMUNITY,O
HOSPITAL,O
.,O

The,O
patient,O
&apos;s,O
preliminary,O
admitting,O
physician,O
is,O
SHUFFCUCH,O
",",O
SEYSHARMSE,O
N,O
and,O
the,O
preliminary,O
diagnosis,O
is,O
HYPERGLYCEMIA,B-PR
.,O

Please,O
note,O
this,O
information,O
may,O
have,O
been,O
updated,O
on,O
the,O
inpatient,O
unit,O
.,O

If,O
you,O
need,O
additional,O
information,O
please,O
call,O
418-196-2156,O
.,O

PCP,O
Name,O
:,O

LETTE,O
",",O
VITA,O
N,O

Provider,O
Number,O
:,O

32325,O

Admission,O
Date,O
:,O

2011-03-06,O

Discharge,O
Date,O
:,O

2011-03-21,O

Date,O
of,O
Birth,O
:,O

1945-09-15,O

Sex,O
:,O

M,O

Service:,O

ADDENDUM,O
:,O

Addendum,O
to,O
hospital,O
course,O
.,O

The,O
patient,O
's,O
actual,O
date,O
of,O
discharge,O
was,O
2011-03-21,O
.,O

The,O
patient,O
will,O
be,O
discharged,O
to,O
rehabilitation,B-TR
in,O
Brain,O
Tree,O
Maryland,O
.,O

Service,O
is,O
actually,O
Medicine,O
",",O
Newburyport,O
Firm,O
not,O
C-CMED,O
.,O

The,O
Jewish,O
Memorial,O
Hospital,O
hospital,O
course,O
over,O
the,O
1-day,O
addendum,O
is,O
improving,O
.,O

The,O
patient,O
is,O
diuresing,O
well,O
",",O
negative,O
2,O
liters,O
again,O
per,O
day,O
.,O

The,O
patient,O
will,O
be,O
continued,O
on,O
medications,B-TR
per,O
Discharge,O
Summary,O
with,O
the,O
addition,O
of,O
captopril,B-TR
ACE,I-TR
inhibitor,I-TR
since,O
the,B-TE
patient,I-TE
's,I-TE
blood,I-TE
pressure,I-TE
is,O
stable,O
.,O

The,O
patient,O
with,O
no,O
new,B-PR
events,I-PR
.,O

The,O
patient,O
's,O
condition,O
on,O
discharge,O
was,O
stable,O
and,O
improved,O
.,O

The,O
patient,O
continues,O
to,O
improve,O
with,O
regard,O
to,O
his,B-PR
scrotal,I-PR
and,I-PR
lower,I-PR
extremity,I-PR
edema,I-PR
.,O

The,O
patient,O
has,O
no,O
lower,B-PR
extremity,I-PR
ulcers,I-PR
",",O
and,O
all,B-PR
former,I-PR
leg,I-PR
excoriations,I-PR
are,O
healing,O
well,O
.,O

The,O
patient,O
ambulating,O
three,O
to,O
four,O
times,O
per,O
day,O
and,O
able,O
to,O
get,O
out,O
of,O
bed,O
using,O
a,B-TR
walker,I-TR
.,O

The,O
patient,O
will,O
get,O
rehabilitation,B-TR
and,O
continue,O
to,O
get,O
care,O
for,O
his,B-PR
fluid,I-PR
status,I-PR
.,O

Shirley,O
H.Q.,O
Neller,O
",",O
M.D.,O

56-333,O

Dictated,O
By:Caroline,O
D,O
Dempsey,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O

2011-03-21,O

14:42,O

T,O
:,O

2011-03-23,O

13:01,O

JOB#,O
:,O

42266,O

Signed,O
electronically,O
by,O
:,O

DR.,O
Shirley,O
X,O
Schaack,O
on,O
:,O

Russell,O
2011-03-24,O
7:54,O
AM,O

(,O
End,O
of,O
Report,O
),O

62287942,O

PRGH,O

14021094,O

430901,O

12/22/2000,O
12:00:00,O
AM,O

SYNCOPE,B-PR

Signed,O

DIS,O

Admission,O
Date,O
:,O

12/22/2000,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

01/01/2001,O

PRINCIPAL,O
DIAGNOSES,O
:,O

1,O
),O
PRESYNCOPE,B-PR
.,O

2,O
),O
DIZZINESS,B-PR
.,O

SECONDARY,O
DIAGNOSES,O
:,O

1,O
),O
IRON,B-PR
DEFICIENCY,I-PR
ANEMIA,I-PR
",",O
COLONOSCOPY,B-TE
IN,O
1990,O
FOLLOWED,O
BY,O
HEMATOLOGY,O
ONCOLOGY,O
THROUGH,O
LYMPNANIER,O
HEALTH,O
SERVICES,O
",",O
DR.,O
NUMBER,O
.,O

2,O
),O
HISTORY,O
OF,O
DIASTOLIC,B-PR
DYSFUNCTION,I-PR
WITH,O
AN,B-TE
ECHOCARDIOGRAM,I-TE
IN,O
February,O
OF,O
1998,O
DEMONSTRATING,O
A,O
NORMAL,O
EJECTION,O
FRACTION,O
WITH,O
LEFT,B-PR
VENTRICULAR,I-PR
HYPERTROPHY,I-PR
",",O
STATUS,O
POST,O
ADMISSION,O
AT,O
LYMPNANIER,O
HEALTH,O
SERVICES,O
IN,O
January,O
OF,O
1999,O
FOR,O
DIASTOLIC,B-PR
CONGESTIVE,I-PR
HEART,I-PR
FAILURE,I-PR
REQUIRING,O
AN,O
ADMISSION,O
TO,O
THE,O
CORONARY,O
CARE,O
UNIT,O
.,O

3,O
),O
HYPOTHYROIDISM,B-PR
.,O

4,O
),O
RHEUMATOID,B-PR
ARTHRITIS,I-PR
/,O
CUTANEOUS,B-PR
LUPUS,I-PR
(,I-PR
MIXED,I-PR
CONNECTIVE,I-PR
TISSUE,I-PR
DISEASE,I-PR
),I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
an,O
80,O
female,O
with,O
a,O
history,O
of,O
diastolic,B-PR
function,I-PR
and,O
heart,B-PR
failure,I-PR
",",O
hypertension,B-PR
and,O
rheumatoid,B-PR
arthritis,I-PR
who,O
presents,O
from,O
an,O
outside,O
hospital,O
with,O
presyncope,B-PR
.,O

The,O
patient,O
reports,O
dizziness,B-PR
intermittently,I-PR
times,O
several,O
months,O
now,O
increasing,O
in,O
frequency,O
described,O
as,O
episodes,O
where,O
she,O
feels,O
faint,B-PR
.,O

The,O
room,O
spins,O
with,O
no,O
visual,B-PR
changes,I-PR
",",O
no,O
loss,B-PR
of,I-PR
consciousness,I-PR
",",O
no,O
palpitations,B-PR
or,O
chest,B-PR
pain,I-PR
",",O
no,O
shortness,B-PR
of,I-PR
breath,I-PR
or,O
diaphoresis,B-PR
.,O

On,O
the,O
day,O
of,O
admission,O
",",O
the,O
patient,O
was,O
with,O
some,O
friends,O
",",O
rose,O
from,O
a,O
chair,O
to,O
leave,O
and,O
felt,O
dizzy,B-PR
while,O
ambulating,O
",",O
fell,O
and,O
hit,O
elbow,O
with,O
minor,B-PR
head,I-PR
trauma,I-PR
.,O

The,O
patient,O
denied,O
loss,B-PR
of,I-PR
consciousness,I-PR
",",O
no,O
bowel,B-PR
or,I-PR
bladder,I-PR
incontinence,I-PR
.,O

The,O
patient,O
was,O
transferred,O
to,O
an,O
outside,O
hospital,O
where,O
she,O
was,O
noted,O
to,O
have,O
a,B-PR
50,I-PR
point,I-PR
discrepancy,I-PR
in,O
her,B-TE
upper,I-TE
extremity,I-TE
blood,I-TE
pressures,I-TE
",",O
right,O
greater,O
than,O
left,O
.,O

This,O
had,O
been,O
noted,O
in,O
the,O
outpatient,O
setting,O
approximately,O
one,O
to,O
two,O
years,O
prior,O
to,O
admission,O
.,O

The,O
patient,O
had,O
no,O
mediastinal,B-PR
widening,I-PR
on,O
chest,B-TE
x-ray,I-TE
",",O
but,O
was,O
transferred,O
to,O
Verg,O
Medical,O
Center,O
for,O
further,B-TE
evaluation,I-TE
.,O

In,O
the,O
emergency,O
room,O
",",O
the,B-TE
patient,I-TE
&apos;s,I-TE
temperature,I-TE
was,O
98.8,O
degrees,O
",",O
heart,B-TE
rate,I-TE
73,O
",",O
respiratory,B-TE
rate,I-TE
18,O
",",O
oxygen,B-TE
saturation,I-TE
98%,O
on,O
room,O
air,O
.,O

Blood,B-TE
pressure,I-TE
in,I-TE
the,I-TE
left,I-TE
arm,I-TE
demonstrated,O
125/89,O
",",O
blood,B-TE
pressure,I-TE
in,I-TE
the,I-TE
right,I-TE
arm,I-TE
was,O
177/119,O
.,O

The,O
patient,O
had,O
a,B-PR
systolic,I-PR
murmur,I-PR
3/6,O
that,O
radiated,O
to,O
the,O
carotids,O
with,O
a,B-PR
decreased,I-PR
left,I-PR
radial,I-PR
pulse,I-PR
per,O
the,O
emergency,O
room,O
.,O

The,O
patient,O
had,O
a,B-TE
chest,I-TE
CT,I-TE
scan,I-TE
demonstrating,O
no,O
dissection,B-PR
or,O
evidence,O
of,O
congestive,B-PR
heart,I-PR
failure,I-PR
.,O

She,O
received,O
Nitropaste,B-TR
",",O
aspirin,B-TR
",",O
laboratory,B-TE
studies,I-TE
and,O
was,O
taken,O
to,O
the,O
floor,O
for,O
further,O
management,O
.,O

The,O
patient,O
denies,O
melena,B-PR
",",O
bright,B-PR
red,I-PR
blood,I-PR
per,I-PR
rectum,I-PR
",",O
no,O
emesis,B-PR
",",O
or,O
fevers,B-PR
or,O
chills,B-PR
.,O

The,O
patient,O
has,O
a,O
history,O
of,O
anemia,B-PR
as,O
per,O
past,O
medical,O
history,O
above,O
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

Otherwise,O
negative,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Vital,O
signs,O
:,O

Heart,B-TE
rate,I-TE
62,O
",",O
respiratory,B-TE
rate,I-TE
16,O
",",O
blood,B-TE
pressure,I-TE
right,I-TE
arm,I-TE
205/84,O
",",O
oxygen,B-TE
saturation,I-TE
97%,O
on,O
two,B-TR
liters,I-TR
nasal,I-TR
cannula,I-TR
.,O

General,O
:,O

She,O
was,O
in,O
no,O
apparent,B-PR
distress,I-PR
",",O
tired,B-PR
",",O
easily,O
arousable,O
older,O
female,O
.,O

HEENT,B-TE
examination,I-TE
demonstrated,O
that,O
the,O
pupils,O
were,O
equal,O
",",O
round,O
and,O
reactive,O
to,O
light,O
.,O

Extraocular,O
movements,O
were,O
intact,O
.,O

There,O
was,O
a,B-PR
left,I-PR
cataract,I-PR
on,O
the,B-TE
fundoscopic,I-TE
examination,I-TE
.,O

Neck,O
was,O
supple,O
",",O
bilateral,B-PR
bruits,I-PR
",",O
although,O
possibly,O
radiating,O
from,O
cardiac,O
base,O
.,O

There,O
was,O
no,O
jugular,B-PR
venous,I-PR
distension,I-PR
.,O

Chest,O
demonstrated,O
bilateral,B-PR
holosystolic,I-PR
bruits,I-PR
over,I-PR
the,I-PR
subclavians,I-PR
",",O
left,O
greater,O
than,O
right,O
with,O
few,B-PR
bibasilar,I-PR
crackles,I-PR
.,O

Cardiovascular,B-TE
examination,I-TE
demonstrated,O
a,O
regular,O
rate,O
and,O
rhythm,O
with,O
2/6,B-PR
cresendo,I-PR
/,I-PR
descrecendo,I-PR
murmur,I-PR
heard,O
best,O
at,O
the,O
apex,O
with,O
preservation,O
of,O
the,O
second,O
heart,O
sound,O
",",O
no,O
S3,B-PR
or,O
S4,B-PR
.,O

Abdominal,B-TE
examination,I-TE
was,O
soft,O
",",O
non-tender,B-PR
",",O
non-distended,B-PR
",",O
positive,O
bowel,O
sounds,O
",",O
no,O
hepatosplenomegaly,B-PR
",",O
no,O
abdominal,B-PR
tenderness,I-PR
.,O

However,O
",",O
there,O
were,O
bilateral,B-PR
bilateral,I-PR
renal,I-PR
bruits,I-PR
and,O
femoral,B-PR
bruits,I-PR
.,O

The,O
patient,O
was,O
guaiac,B-TE
negative,O
per,O
the,O
emergency,O
room,O
.,O

Extremities,O
demonstrated,O
no,O
edema,B-PR
.,O

Extremity,B-TE
pulses,I-TE
revealed,O
a,B-TE
right,I-TE
radial,I-TE
of,O
2+,O
",",O
left,B-TE
radial,I-TE
of,O
1+,O
",",O
2+,B-TE
distal,I-TE
pulses,I-TE
in,I-TE
the,I-TE
lower,I-TE
extremities,I-TE
bilaterally,I-TE
.,O

Lower,B-TE
extremity,I-TE
blood,I-TE
pressures,I-TE
demonstrated,O
systolics,B-TE
of,O
205-210,O
.,O

LABORATORY,O
:,O

Laboratory,O
values,O
on,O
admission,O
included,O
a,B-TE
sodium,I-TE
of,O
142,O
",",O
potassium,B-TE
4.8,O
",",O
chloride,B-TE
106,O
",",O
bicarbonate,B-TE
27,O
",",O
BUN,B-TE
and,O
creatinine,B-TE
of,O
39,O
and,O
1.6,O
respectively,O
",",O
glucose,B-TE
113,O
.,O

Calcium,B-TE
was,O
9.6,O
.,O

CK,B-TE
was,O
62,O
.,O

Troponin,B-TE
was,O
0.2,O
.,O

White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
was,O
11.5,O
",",O
85,B-TE
polys,I-TE
",",O
5,B-TE
bands,I-TE
",",O
hematocrit,B-TE
37.6,O
",",O
platelet,B-TE
count,I-TE
328,O
.,O

Coagulation,B-TE
studies,I-TE
were,O
11.3/25.5/0.9,O
.,O

Urinalysis,B-TE
demonstrated,O
trace,B-PR
leukocyte,I-PR
esterase,I-PR
",",O
5-10,B-PR
white,I-PR
blood,I-PR
cells,I-PR
and,O
1+,B-PR
squamous,I-PR
epithelial,I-PR
cells,I-PR
.,O

EKG,B-TE
demonstrated,O
normal,O
sinus,O
rhythm,O
",",O
rate,B-TE
of,O
73,O
",",O
borderline,B-PR
left,I-PR
atrial,I-PR
enlargement,I-PR
",",O
axis,B-TE
of-28,O
",",O
T-wave,B-PR
inversions,I-PR
in,I-PR
V4,I-PR
through,O
V6,O
",",O
I,O
and,O
aVL,O
",",O
borderline,B-PR
left,I-PR
ventricular,I-PR
hypertrophy,I-PR
with,O
strain,B-PR
compared,O
to,O
earlier,O
this,O
AM,O
.,O

There,O
appeared,O
to,O
be,O
a,B-PR
new,I-PR
T-wave,I-PR
inversion,I-PR
in,O
V4,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

1,O
),O
Aspirin,B-TR
81,O
mg,O
p.o.,O
q.,O
day,O
.,O

2,O
),O
Os-Cal,B-TR
1250,O
mg,O
p.o.,O
three,O
times,O
a,O
day,O
.,O

3,O
),O
Lasix,B-TR
40,O
mg,O
p.o.,O
q.o.d.,O

4,O
),O
Plaquenil,B-TR
200,O
mg,O
p.o.,O
q.,O
day,O
.,O

5,O
),O
Ibuprofen,B-TR
400,O
mg,O
p.o.,O
t.i.d.,O

6,O
),O
Levoxyl,B-TR
100,O
mg,O
p.o.,O
q.,O
day,O
.,O

7,O
),O
Arava,B-TR
20,O
mg,O
p.o.,O
q.,O
day,O
.,O

8,O
),O
Zantac,B-TR
150,O
mg,O
p.o.,O
b.i.d.,O

9,O
),O
Isosorbide,B-TR
dinitrate,I-TR
unclear,O
dose,O
.,O

10,O
),O
Diltiazem,B-TR
240,O
mg,O
p.o.,O
q.,O
day,O
.,O

11,O
),O
Epogen,B-TR
q.,O
two,O
weeks,O
.,O

SOCIAL,O
HISTORY,O
:,O

Negative,O
for,O
tobacco,O
",",O
negative,O
for,O
alcohol,O
.,O

The,O
patient,O
lives,O
alone,O
",",O
but,O
in,O
a,O
senior,O
living,O
facility,O
adjacent,O
to,O
friends,O
.,O

HOSPITAL,O
COURSE,O
:,O

1,O
),O
Cardiovascular,O
:,O

The,O
patient,O
was,O
admitted,O
for,O
rule,O
out,O
myocardial,B-PR
infarction,I-PR
.,O

She,O
remained,O
on,O
telemetry,B-TE
for,O
greater,O
than,O
48,O
hours,O
which,O
demonstrated,O
no,O
dysrhythmia,B-PR
during,O
this,O
time,O
.,O

The,O
patient,O
underwent,O
an,B-TE
echocardiogram,I-TE
which,O
demonstrated,O
a,O
preserved,O
ejection,O
fraction,O
with,O
left,B-PR
ventricular,I-PR
hypertrophy,I-PR
and,O
no,O
significant,B-PR
valvular,I-PR
abnormalities,I-PR
.,O

The,O
patient,O
was,O
maintained,O
on,O
her,B-TR
aspirin,I-TR
and,O
Lasix,B-TR
.,O

The,B-TR
patient,I-TR
&apos;s,I-TR
Diltiazem,I-TR
was,O
stopped,O
due,O
to,O
her,B-PR
increased,I-PR
blood,I-PR
pressure,I-PR
and,O
was,O
started,O
on,O
Labetalol,B-TR
which,O
was,O
gradually,O
titrated,O
up,O
to,O
a,B-TE
target,I-TE
blood,I-TE
pressure,I-TE
of,O
160-170,B-TE
systolic,I-TE
in,O
her,O
right,O
arm,O
.,O

The,O
patient,O
also,O
underwent,O
an,B-TE
Adenosine,I-TE
MIBI,I-TE
stress,I-TE
test,I-TE
which,O
showed,O
only,O
mild,B-PR
lateral,I-PR
ischemia,I-PR
.,O

At,O
this,O
time,O
",",O
the,B-PR
patient,I-PR
&apos;s,I-PR
presyncopal,I-PR
symptoms,I-PR
were,O
not,O
felt,O
to,O
be,O
secondary,O
to,O
a,O
cardiovascular,O
etiology,O
.,O

2,O
),O
Neurological,O
/,O
vascular,O
:,O

The,B-PR
discrepancy,I-PR
in,O
the,B-TE
patient,I-TE
&apos;s,I-TE
pulses,I-TE
and,O
blood,B-TE
pressure,I-TE
was,O
felt,O
to,O
be,O
consistent,O
with,O
a,B-PR
subclavian,I-PR
artery,I-PR
stenosis,I-PR
.,O

The,O
patient,O
underwent,O
MRI,B-TE
/,I-TE
MRA,I-TE
of,I-TE
the,I-TE
head,I-TE
",",I-TE
neck,I-TE
and,I-TE
upper,I-TE
chest,I-TE
which,O
demonstrated,O
a,B-PR
proximal,I-PR
left,I-PR
subclavian,I-PR
artery,I-PR
stenosis,I-PR
",",O
proximal,O
to,O
the,O
take,O
off,O
of,O
the,O
left,O
vertebral,O
artery,O
.,O

The,O
left,O
vertebral,O
artery,O
had,O
a,B-PR
decreased,I-PR
flow,I-PR
consistent,O
with,O
either,O
native,B-PR
vessel,I-PR
disease,I-PR
or,O
some,B-PR
degree,I-PR
of,I-PR
retrograde,I-PR
flow,I-PR
with,O
subclavian,B-PR
steal,I-PR
phenomenon,I-PR
.,O

The,O
patient,O
had,O
patent,O
carotids,O
bilaterally,O
on,O
her,B-TE
neck,I-TE
MRA,I-TE
.,O

MRI,B-TE
of,I-TE
the,I-TE
head,I-TE
demonstrated,O
a,B-PR
small,I-PR
vessel,I-PR
disease,I-PR
and,O
was,O
likely,O
an,B-PR
old,I-PR
right,I-PR
cerebellar,I-PR
infarct,I-PR
.,O

The,O
patient,O
underwent,O
non-invasive,B-TE
carotid,I-TE
ultrasounds,I-TE
which,O
demonstrated,O
no,O
significant,B-PR
carotid,I-PR
disease,I-PR
.,O

The,O
patient,O
was,O
also,O
noted,O
to,O
have,O
antegrade,B-PR
flow,I-PR
in,O
both,O
of,O
her,O
vertebral,O
arteries,O
bilaterally,O
.,O

The,O
results,O
of,O
these,B-TE
studies,I-TE
suggested,O
that,O
the,B-PR
patient,I-PR
&apos;s,I-PR
symptoms,I-PR
were,O
not,O
due,O
to,O
subclavian,B-PR
steal,I-PR
phenomenon,I-PR
",",O
and,O
therefore,O
",",O
it,O
was,O
decided,O
that,O
the,O
patient,O
would,O
not,O
go,O
further,O
to,O
angio,B-TR
and,O
/,O
or,O
surgical,B-TR
or,I-TR
percutaneous,I-TR
intervention,I-TR
.,O

A,O
Neurology,O
consult,O
was,O
obtained,O
and,O
it,O
was,O
felt,O
that,O
the,B-TR
most,I-TR
valuable,I-TR
intervention,I-TR
that,O
could,O
be,O
done,O
for,O
the,B-PR
patient,I-PR
&apos;s,I-PR
intervascular,I-PR
disease,I-PR
would,O
be,O
adequate,O
control,O
of,O
her,B-TE
blood,I-TE
pressure,I-TE
.,O

3,O
),O
Orthopedic,O
:,O

The,O
patient,O
suffered,O
a,O
fall,O
at,O
home,O
with,O
her,O
initial,O
event,O
.,O

Outside,B-TE
hip,I-TE
films,I-TE
were,O
obtained,O
",",O
but,O
were,O
not,O
available,O
for,O
view,O
.,O

Repeat,B-TE
hip,I-TE
films,I-TE
demonstrated,O
a,B-PR
right,I-PR
sided,I-PR
pubic,I-PR
rami,I-PR
fracture,I-PR
",",O
likely,O
new,O
.,O

An,O
Orthopedics,O
consult,O
was,O
obtained,O
and,O
the,O
patient,O
was,O
encouraged,O
to,O
weight,O
bear,O
as,O
tolerated,O
with,O
Physical,B-TR
Therapy,I-TR
assistance,I-TR
.,O

A,B-TE
bone,I-TE
scan,I-TE
was,O
also,O
obtained,O
to,O
rule,O
out,O
an,B-PR
occult,I-PR
hip,I-PR
fracture,I-PR
which,O
was,O
negative,O
.,O

At,O
the,O
time,O
of,O
this,O
dictation,O
",",O
the,O
patient,O
was,O
able,O
to,O
bear,O
weight,O
with,O
the,O
assistance,O
of,O
Physical,O
Therapy,O
and,O
a,B-TR
walker,I-TR
.,O

Plans,O
were,O
made,O
for,O
the,O
patient,O
to,O
be,O
discharged,O
to,O
Dwardmegriff,O
Rehabilitation,O
for,O
rehabilitation,B-TR
of,O
her,B-PR
rami,I-PR
fracture,I-PR
.,O

4,O
),O
Gastrointestinal,O
:,O

The,O
patient,O
had,O
an,O
episode,O
of,O
her,B-PR
described,I-PR
vertigo,I-PR
while,O
lying,O
in,O
bed,O
and,O
on,O
the,B-TE
monitor,I-TE
during,O
which,O
no,O
dysrhythmia,B-PR
was,O
noted,O
.,O

The,O
patient,O
also,O
complained,O
of,O
frequent,B-PR
vomiting,I-PR
at,O
least,O
once,O
a,O
day,O
",",O
occasionally,O
associated,O
with,O
ingestion,O
of,O
her,B-TR
medications,I-TR
",",O
but,O
sometimes,O
associated,O
with,O
ambulation,O
.,O

The,O
patient,O
has,O
a,O
long-standing,O
history,O
of,O
spontaneous,B-PR
emesis,I-PR
due,O
to,O
overwhelming,O
stress,O
or,O
excitement,O
.,O

However,O
",",O
the,O
patient,O
reports,O
emesis,B-PR
in,O
the,O
hospital,O
more,O
frequently,O
.,O

The,B-PR
patient,I-PR
&apos;s,I-PR
emesis,I-PR
was,O
noted,O
to,O
be,O
bilious,B-PR
without,O
evidence,O
of,O
new,B-PR
or,I-PR
old,I-PR
blood,I-PR
.,O

The,O
etiology,O
of,O
the,B-PR
patient,I-PR
&apos;s,I-PR
nausea,I-PR
remained,O
unclear,O
as,O
she,O
demonstrated,O
ability,O
to,O
keep,O
down,O
many,O
of,O
her,O
meals,O
which,O
did,O
not,O
suggest,O
an,B-PR
anatomical,I-PR
lesion,I-PR
of,I-PR
her,I-PR
gastrointestinal,I-PR
tract,I-PR
.,O

The,O
patient,O
was,O
started,O
on,O
Meclizine,B-TR
on,O
December,O
31,O
",",O
2000,O
for,O
her,B-PR
nausea,I-PR
and,O
vertigo,B-PR
.,O

An,O
attempt,O
was,O
also,O
made,O
to,O
reduce,O
the,O
patient,O
&apos;s,O
large,O
number,O
of,O
medications,B-TR
and,O
the,B-TR
patient,I-TR
&apos;s,I-TR
Os-Cal,I-TR
",",O
multivitamin,B-TR
",",O
Lasix,B-TR
and,O
Colace,B-TR
were,O
discontinued,O
.,O

5,O
),O
Infectious,O
disease,O
:,O

The,O
patient,O
complained,O
of,O
some,B-PR
urinary,I-PR
incontinence,I-PR
and,O
difficulty,O
initiating,O
urine,O
on,O
December,O
30,O
",",O
2000,O
.,O

Urinalysis,B-TE
demonstrated,O
a,B-PR
likely,I-PR
urinary,I-PR
tract,I-PR
infection,I-PR
.,O

The,O
patient,O
was,O
started,O
on,O
Levofloxacin,B-TR
250,O
mg,O
p.o.,O
q.,O
day,O
times,O
seven,O
days,O
for,O
a,O
possible,O
nosocomial,B-PR
urinary,I-PR
tract,I-PR
infection,I-PR
.,O

The,B-TE
urine,I-TE
culture,I-TE
was,O
pending,O
at,O
the,O
time,O
of,O
this,O
dictation,O
.,O

6,O
),O
Fluids,O
",",O
electrolytes,O
and,O
nutrition,O
:,O

The,O
patient,O
had,O
a,B-PR
mild,I-PR
increase,I-PR
in,O
her,B-TE
BUN,I-TE
and,O
creatinine,B-TE
during,O
her,O
hospitalization,O
which,O
promptly,O
returned,O
to,O
her,O
baseline,O
levels,O
with,O
intravenous,B-TR
fluids,I-TR
.,O

The,O
patient,O
was,O
encouraged,O
to,O
increase,O
her,O
p.o.,O
intake,O
.,O

Dictated,O
By,O
:,O

BONE,O
A,O
",",O
M.D.,O
IQ35,O

Attending,O
:,O

LANAY,O
I.,O
IRON,O
",",O
M.D.,O
TJ93,O
YB914/4843,O

Batch,O
:,O

9056,O

Index,O
No.,O
FPOF6TO0Q7,O

D,O
:,O

New,O
Years,O
Eve,O

T,O
:,O

New,O
Years,O
Day,O

Admission,O
Date,O
:,O

2014-05-08,O

Discharge,O
Date,O
:,O

2014-05-19,O

Date,O
of,O
Birth,O
:,O

1946-01-06,O

Sex,O
:,O

F,O

Service,O
:,O

CARDIOTHORACIC,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,O
Drugs,B-TR

Attending,O
:,O

Jana,O
V,O
Pennington,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

lightheadedness,B-PR
",",O
slight,B-PR
DOE,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

2014-05-11,O

Redo,B-TR
AVR,I-TR
with,O
aortic,B-TR
root,I-TR
enlargement,I-TR
(,O

History,O
of,O
Present,O
Illness,O
:,O

68,O
yo,O
female,O
trasnferred,O
in,O
from,O
Catholic,O
CMED,O
CSRU.,O
Ctr.,O
with,O
periprosthetic,B-PR
aortic,I-PR
valve,I-PR
stenosis,I-PR
and,O
aortic,B-PR
valve,I-PR
thrombus,I-PR
.,O

No,O
cath,B-TE
done,O
",",O
but,O
echo,B-TE
05-07,O
showed,O
EF,B-TE
60-65%,O
",",O
stenotic,B-PR
mech.,I-PR
valve,I-PR
",",O
mean,B-TE
gradient,I-TE
33,O
mm,O
",",O
decreased,B-PR
disc,I-PR
motion,I-PR
",",O
mobile,B-PR
mass,I-PR
in,I-PR
LVOT,I-PR
",",O
mild,B-PR
AI,I-PR
",",O
mild,B-PR
to,I-PR
moderate,I-PR
MR,I-PR
",",O
trace,B-PR
TR.,I-PR
Referred,O
for,O
surgical,B-TE
evaluation,I-TE
.,O

Past,O
Medical,O
History,O
:,O

HTN,B-PR
elev.,B-PR
lipids,I-PR
hypothyroidism,B-PR
back,B-PR
pain,I-PR

GERD,B-PR

PSH,O
:,O

s/p,O
AVR,B-TR
2000,O
remote,B-TR
tonsillectomy/adenoidectomy,I-TR
partial,B-TR
thyroidectomy,I-TR
rem.,B-TR
right,I-TR
wrist,I-TR
ganglion,I-TR
cyst,I-TR
left,B-TR
foot,I-TR
bunionectomy,I-TR
breast,B-TE
biopsies,I-TE

Social,O
History,O
:,O

retired,O
",",O
lives,O
alone,O
",",O
widowed,O
quit,O
smoking,O
20+,O
years,O
ago,O
no,O
ETOH,O
use,O

Family,O
History,O
:,O

"father,O
died,O
at,O
57,O
of,O
heart,B-PR
problems,I-PR
brother,O
died,O
at,O
age,O
7,O
of,O
""leaky,B-PR
valve"",I-PR
sister,O
with,O
CAD/CABG",B-PR

Physical,O
Exam:,O

180/88,O

HR,B-TE
68,O

RR,B-TE
18,O

95%,O
sat,B-TE

"65.5""",O

87,O
kg,O

NAD,B-PR
skin/HEENT,O
unremarkable,O
neck,O
supple,O
",",O
murmur,B-PR
radiates,O
bilat.,O
to,O
carotids,O

CTAB,O

RRR,O
with,O
holosystolic,B-PR
murmur,I-PR
soft,O
",",O
NT,B-PR
",",O
ND,B-PR
",",O
+,O
BS,O
warm,O
",",O
well-perfused,O
",",O
no,O
edema,B-PR

2+,O
bil.,O
fem/,O
radials,O

1+,O
bil.,O
DP/PTs,O

Pertinent,O
Results,O
:,O

Cardiology,O
Report,O
ECHO,B-TE
Study,I-TE
Date,O
of,O
2014-05-11,O

POST-BYPASS,O
:,O

Pt,O
is,O
being,O
AV,O
paced,O
",",O
on,O
an,B-TR
infusion,I-TR
of,I-TR
phenylephrine,I-TR

1.,O
A,B-TR
bioprosthesis,I-TR
is,O
well,O
seated,O
in,O
the,O
aortic,O
position,O
",",O
leaflets,O
open,O
well,O
",",O
trace,B-PR
central,I-PR
AI,I-PR
is,O
seen,O
.,O

Trace,B-PR
AI,I-PR
is,O
also,O
noted,O
between,O
the,O
left,O
and,O
right,O
coronary,O
cusps,O
.,O

There,O
is,O
a,B-PR
small,I-PR
paravavluar,I-PR
leak,I-PR
in,O
the,O
area,O
adjacent,O
to,O
the,O
anterior,O
mitral,O
leaflet,O
",",O
resulting,O
in,O
some,B-PR
trace,I-PR
insuffiency,I-PR
outside,O
the,O
sewing,O
ring,O
.,O

2.,O
Mitral,B-PR
regurgitation,I-PR
is,O
unchanged,O
from,O
before,O
.,O

3.,O
Biventricular,O
systolic,O
function,O
is,O
unchanged,O
.,O

4.,O
Aorta,O
is,O
intact,O
post,O
decannulation,B-TR

5.,O
Other,O
findings,O
are,O
unchanged,O

6.,O
All,O
findings,O
discussed,O
with,O
surgeon,O
at,O
the,O
time,O
of,O
the,B-TE
exam,I-TE
.,O

2014-05-18,O
05:45AM,O
BLOOD,O

Hct,B-TE
-,O
29.2*,O

2014-05-17,O
04:40AM,O
BLOOD,O

WBC,B-TE
-,O
12.4*,O
RBC,B-TE
-,O
2.89*,O
Hgb,B-TE
-,O
9.0*,O
Hct,B-TE
-,O
26.0*,O

MCV,B-TE
-,O
90,O
MCH,B-TE
-,O
31.3,O
MCHC,B-TE
-,O
34.9,O
RDW,B-TE
-,O
13.5,O
Plt,B-TE
Ct,I-TE
-,O
262,O

2014-05-18,O
05:45AM,O
BLOOD,O

PT,B-TE
-,O
16.8*,O
PTT,B-TE
-,O
65.3*,O
INR,B-TE
(,O
PT,B-TE
),O
-,O
1.5*,O

2014-05-19,O
07:10AM,O
BLOOD,O

Glucose,B-TE
-,O
115*,O
UreaN,B-TE
-,O
20,O
Creat,B-TE
-,O
1.3*,O
Na,B-TE
-,O
137,O

K,B-TE
-,O
4.8,O
Cl,B-TE
-,O
96,O
HCO3,B-TE
-,O
34*,O
AnGap,B-TE
-,O
12,O

Brief,O
Hospital,O
Course,O
:,O

Admitted,O
05-08,O
to,O
cardiology,O
service,O
for,O
surgical,B-TE
work-up,I-TE
.,O

INR,B-TE
2.7,O
and,O
echo,B-TE
repeated,O
",",O
coumadin,B-TR
held,O
",",O
and,O
heparin,B-TR
drips,I-TR
started,O
.,O

Review,O
of,O
OSH,B-TE
echo,I-TE
revealed,O
peak,B-TE
gradient,I-TE
of,O
64mm,O
(,O

New,B-TE
echo,I-TE
showed,O
pannus,B-PR
involving,O
the,O
valve,O
and,O
?,O
thrombus,B-PR
.,O

Seen,O
by,O
Dr.,O
Laura,O
of,O
cardiac,O
surgery,O
and,O
underwent,O
redo,B-TR
AVR,I-TR
with,O
aortic,B-TR
root,I-TR
enlargement,I-TR
on,O
05-11,O
.,O

Transferred,O
to,O
the,O
CSRU,O
in,O
stable,O
condition,O
on,O
phenylephrine,B-TR
and,O
propofol,B-TR
drips,I-TR
.,O

Weaned,O
to,O
extubation,O
on,O
POD,O
#2,O
and,O
off,O
all,B-TR
drips,I-TR
.,O

Episode,B-PR
of,I-PR
AFib,I-PR
that,O
evening,O
treated,O
with,O
amiodarone,B-TR
and,O
converted,O
to,O
SR,O
.,O

Transferred,O
to,O
the,O
floor,O
on,O
POD,O
#3,O
to,O
begin,O
increasing,O
her,O
activity,O
level,O
.,O

Chest,B-TR
tubes,I-TR
and,O
wires,B-TR
removed,O
without,O
incident,B-PR
.,O

Cleared,O
for,O
discharge,O
to,O
home,O
with,O
services,O
.,O

Pt.,O
to,O
make,O
all,O
follow-up,O
appts.,O
per,O
discharge,O
instructions,O
.,O

Medications,O
on,O
Admission,O
:,O

synthroid,B-TR
75,O
mcg,O
daily,O

HCTZ,B-TR
37.5,O
mg,O
daily,O

MVI,B-TR
daily,O

Vit.C,B-TR
500,O
mg,O
daily,O
prevacid,B-TR
15,O
mg,O
daily,O
coumadin,B-TR
(,O

KCl,B-TR
12-27,O
mEq,O
daily,O
cozaar,B-TR
25,O
mg,O
daily,O

Discharge,O
Medications,O
:,O

1.,O
Metoprolol,B-TR
Tartrate,I-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
Three,O
(,O
3,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

Disp,O
:,O
*180,O
Tablet(,O
s,O
)*,O

Refills,O
:,O
*2*,O

2.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
for,O
1,O
months,O
.,O

Disp,O
:,O
*60,O
Capsule(,O
s,O
)*,O

Refills,O
:,O
*0*,O

3.,O
Aspirin,B-TR
81,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

Disp,O
:,O
*30,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
)(,O
s,O
)*,O

Refills,O
:,O
*2*,O

4.,O
Oxycodone-Acetaminophen,B-TR
5-325,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
Q4H,O
(,O
every,O
4,O
hours,O
),O
as,O
needed,O
for,O
pain,B-PR
.,O

Disp,O
:,O
*40,O
Tablet(,O
s,O
)*,O

Refills,O
:,O
*0*,O

5.,O
Levothyroxine,B-TR
75,O
mcg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

Disp,O
:,O
*30,O
Tablet(,O
s,O
)*,O

Refills,O
:,O
*2*,O

6.,O
Simvastatin,B-TR
40,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

Disp,O
:,O
*30,O
Tablet(,O
s,O
)*,O

Refills,O
:,O
*2*,O

7.,O
Pantoprazole,B-TR
40,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
Q24H,O
(,O
every,O
24,O
hours,O
),O
.,O

Disp,O
:,O
*30,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
)(,O
s,O
)*,O

Refills,O
:,O
*2*,O

8.,O
Amiodarone,B-TR
200,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
for,O
2,O
days,O
:,O
for,O
2,O
days,O
",",O
then,O
start,O
200,O
mg,O
daily,O
ongoing,O
on,O
05-20,O
.,O

Disp,O
:,O
*60,O
Tablet(,O
s,O
)*,O

Refills,O
:,O
*1*,O

9.,O
Potassium,B-TR
Chloride,I-TR
10,O
mEq,O
Capsule,O
",",O
Sustained,O
Release,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Capsule,O
",",O
Sustained,O
Release,O
PO,O
once,O
a,O
day,O
for,O
7,O
days,O
.,O

Disp,O
:,O
*14,O
Capsule,O
",",O
Sustained,O
Release(,O
s,O
)*,O

Refills,O
:,O
*0*,O

10.,O
Furosemide,B-TR
20,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
twice,O
a,O
day,O
for,O
7,O
days,O
.,O

Disp,O
:,O
*14,O
Tablet(,O
s,O
)*,O

Refills,O
:,O
*0*,O

Discharge,O
Disposition,O
:,O

Home,O
with,O
Service,O

Discharge,O
Diagnosis,O
:,O

prosthetic,B-PR
aortic,I-PR
valve,I-PR
stenosis,I-PR

HTN,B-PR
elev.,B-PR
lipds,I-PR
hypothyroidism,B-PR
back,B-PR
pain,I-PR

GERD,B-PR

A,B-PR
Fib,I-PR
s/p,O
AVR,B-TR
2000,O

Discharge,O
Condition,O
:,O

stable,O

Discharge,O
Instructions,O
:,O

no,O
driving,O
for,O
one,O
month,O
no,O
lifting,O
greater,O
than,O
10,O
pounds,O
for,O
10,O
weeks,O
no,O
lotions,O
",",O
creams,O
or,O
powders,O
on,O
any,O
incision,B-PR
may,O
shower,O
over,O
incisions,B-PR
and,O
pat,O
dry,O
call,O
for,O
fever,B-PR
greater,O
than,O
100.5,O
",",O
redness,B-PR
or,O
drainage,B-PR

Followup,O
Instructions,O
:,O

see,O
Dr.,O
Rodriguez,O
in,O
1-2,O
weeks,O
see,O
Dr.,O
Laura,O
in,O
4,O
weeks,O

(,O
944,O
),O
596,O
7247,O

Anthony,O
Louis,O
MD,O
43-293,O

Completed,O
by,O
:,O

Jerry,O
Pamela,O
NP,O
80-BXH,O
2014-05-19,O
@,O
1424,O

Signed,O
electronically,O
by,O
:,O

DR.,O
Andre,O
D.,O
Bruner,O
on,O
:,O

WED,O
2014-05-21,O
5:55,O
PM,O

(,O
End,O
of,O
Report,O
),O

82738817,O

CMC,O

19153629,O

6/3/1993,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

06/03/1993,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

06/06/1993,O

DISCHARGE,O
DIAGNOSIS,O
:,O

UTERINE,B-PR
PROLAPSE,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
70,O
year,O
old,O
gravida,O
IV,O
",",O
para,O
4,O
who,O
presented,O
for,O
a,B-TR
vaginal,I-TR
hysterectomy,I-TR
secondary,O
to,O
uterine,B-PR
prolapse,I-PR
and,O
also,O
presented,O
for,O
evaluation,B-TE
of,O
a,B-PR
suspicious,I-PR
lesion,I-PR
seen,O
on,O
a,B-TE
mammogram,I-TE
.,O

Patient,B-PR
&apos;s,I-PR
problem,I-PR
started,O
four,O
years,O
ago,O
when,O
she,O
first,O
experienced,O
a,B-PR
pushing,I-PR
forward,I-PR
of,I-PR
her,I-PR
uterus,I-PR
.,O

The,O
patient,O
described,O
this,O
sensation,O
as,O
uncomfortable,B-PR
and,O
becoming,O
more,O
prominent,O
over,O
the,O
following,O
three,O
years,O
with,O
increasing,B-PR
pressure,I-PR
and,O
pain,B-PR
.,O

Two,O
months,O
ago,O
",",O
the,O
patient,O
slipped,O
and,O
fell,O
with,O
valsalva,O
that,O
precipitated,O
an,O
exacerbation,O
of,O
her,B-PR
prolapse,I-PR
.,O

She,O
subsequently,O
could,O
not,O
urinate,O
and,O
was,O
in,O
pain,B-PR
secondary,O
to,O
her,B-PR
problem,I-PR
.,O

At,O
this,O
time,O
",",O
she,O
decided,O
that,O
she,O
needed,O
the,B-PR
prolapse,I-PR
fixed,O
and,O
actually,O
wrote,O
to,O
the,O
Norri,O
Hospital,O
to,O
try,O
and,O
find,O
a,O
Gynecologist,O
.,O

Her,O
letter,O
was,O
referred,O
to,O
Dr.,O
Earllamarg,O
Para,O
who,O
saw,O
her,O
in,O
the,O
office,O
and,O
recommended,O
vaginal,B-TR
hysterectomy,I-TR
.,O

Patient,O
has,O
never,O
had,O
a,B-TR
pessary,I-TR
and,O
refused,O
one,O
and,O
denies,O
nausea,B-PR
",",O
fever,B-PR
",",O
chills,B-PR
",",O
dysuria,B-PR
",",O
or,O
stress,B-PR
incontinence,I-PR
on,O
her,O
current,O
admission,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Significant,O
for,O
a,B-PR
lower,I-PR
left,I-PR
saphenous,I-PR
vein,I-PR
thrombosis,I-PR
diagnosed,O
with,O
lower,B-TE
extremity,I-TE
non-invasives,I-TE
and,O
on,O
May,O
2,O
",",O
1993,O
with,O
no,O
evidence,O
of,O
deep,B-PR
venous,I-PR
thrombosis,I-PR
and,O
clearance,O
by,O
Dr.,O
Ribreefcheampner,O
for,O
further,B-TR
intervention,I-TR
.,O

She,O
also,O
has,O
a,B-PR
heart,I-PR
murmur,I-PR
since,O
childhood,O
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

Negative,O
.,O

PAST,O
OBSTETRICAL,O
HISTORY,O
:,O

Significant,O
for,O
vaginal,O
deliveries,O
times,O
four,O
.,O

PAST,O
GYNECOLOGICAL,O
HISTORY,O
:,O

Last,O
menstrual,O
period,O
was,O
at,O
age,O
fifty,O
",",O
the,O
patient,O
is,O
not,O
on,O
hormonal,B-TR
replacement,I-TR
and,O
she,O
has,O
a,O
four,O
history,O
of,O
uterine,B-PR
prolapse,I-PR
.,O

CURRENT,O
MEDICATIONS,O
:,O

Aspirin,B-TR
one,O
per,O
day,O
which,O
the,O
patient,O
quit,O
taking,O
two,O
weeks,O
prior,O
to,O
admission,O
.,O

ALLERGIES,O
:,O

None,O
.,O

SOCIAL,O
HISTORY,O
:,O

Patient,O
lives,O
on,O
Sauxdo,O
Lo,O
with,O
her,O
husband,O
and,O
denies,O
alcohol,O
and,O
denies,O
drug,O
abuse,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

GENERAL,O
:,O

This,O
was,O
a,O
well-developed,O
",",O
well-nourished,O
female,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

Patient,O
had,O
a,B-TE
blood,I-TE
pressure,I-TE
of,O
128/72,O
",",O
a,B-TE
pulse,I-TE
of,O
84,O
that,O
was,O
regular,O
",",O
and,O
she,O
was,O
afebrile,B-PR
at,O
98.4,O
.,O

SKIN,O
:,O

Examination,B-TE
showed,O
right,B-PR
axillary,I-PR
and,I-PR
right,I-PR
posterior,I-PR
axillary,I-PR
skin,I-PR
tags,I-PR
and,O
crusted,B-PR
lesions,I-PR
.,O

HEENT,O
:,O

Pupils,O
were,O
equal,O
",",O
round,O
",",O
and,O
reactive,O
to,O
light,O
",",O
extraocular,O
muscles,O
were,O
intact,O
",",O
and,O
no,O
lymphadenopathy,B-PR
.,O

CARDIAC,O
:,O

Examination,B-TE
showed,O
regular,O
rate,O
and,O
rhythm,O
with,O
no,O
S3,B-PR
or,O
S4,B-PR
heard,O
and,O
a,B-PR
grade,I-PR
II/VI,I-PR
holosystolic,I-PR
murmur,I-PR
loudest,O
at,O
the,O
left,O
sternal,O
border,O
.,O

LUNGS,O
:,O

Examination,B-TE
was,O
clear,O
to,O
auscultation,B-TE
.,I-TE

BREASTS,O
:,O

Examination,B-TE
showed,O
a,B-PR
right,I-PR
upper,I-PR
mid,I-PR
small,I-PR
breast,I-PR
mass,I-PR
which,O
was,O
detected,O
actually,O
by,O
Dr.,O
Para,O
.,O

ABDOMEN,O
:,O

Soft,O
and,O
non-tender,B-PR
.,O

PELVIC,O
:,O

Deferred,O
until,O
the,O
Operating,O
Room,O
.,O

EXTREMITIES,O
:,O

She,O
had,O
left,B-PR
lower,I-PR
leg,I-PR
varicose,I-PR
veins,I-PR
",",O
no,O
venous,B-PR
cords,I-PR
",",O
and,O
bilateral,B-TE
2+,I-TE
pedal,I-TE
pulses,I-TE
.,O

LABORATORY,O
EXAMINATION,O
:,O

The,O
patient,O
had,O
a,B-TE
BUN,I-TE
and,O
creatinine,B-TE
of,O
12,O
and,O
1.2,O
",",O
a,B-TE
white,I-TE
count,I-TE
of,O
6.7,O
",",O
a,B-TE
hematocrit,I-TE
of,O
39.4,O
",",O
negative,O
urinalysis,O
",",O
and,O
a,B-TE
potassium,I-TE
of,O
4.6,O
.,O

Her,O
CA-125,B-TE
was,O
20,O
and,O
she,O
had,O
a,B-TE
chest,I-TE
X-Ray,I-TE
that,O
showed,O
no,O
infiltrates,B-PR
and,O
a,B-TE
mammogram,I-TE
that,O
showed,O
a,B-PR
left,I-PR
upper,I-PR
quadrant,I-PR
large,I-PR
calcified,I-PR
fibroadenoma,I-PR
and,O
right,B-PR
upper,I-PR
mid,I-PR
area,I-PR
of,I-PR
calcification,I-PR
.,O

She,O
had,O
an,B-TE
EKG,I-TE
that,O
showed,O
a,O
question,O
of,O
an,B-PR
old,I-PR
inferior,I-PR
myocardial,I-PR
infarction,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

Cardiology,O
was,O
consulted,O
to,O
evaluate,O
this,O
and,O
felt,O
that,O
the,B-PR
changes,I-PR
seen,O
on,O
the,B-TE
EKG,I-TE
were,O
not,O
significant,O
.,O

The,O
patient,O
was,O
also,O
seen,O
by,O
Dr.,O
Nusc,O
from,O
General,O
Surgery,O
for,O
evaluation,B-TE
of,O
micro,B-PR
calcifications,I-PR
in,I-PR
the,I-PR
right,I-PR
breast,I-PR
.,O

The,O
patient,O
refused,O
a,B-TE
biopsy,I-TE
for,O
this,O
admission,O
and,O
desires,O
follow-up,B-TE
mammograms,I-TE
.,O

She,O
is,O
to,O
be,O
followed,O
up,O
by,O
General,O
Surgery,O
.,O

The,O
patient,O
underwent,O
a,B-TR
total,I-TR
vaginal,I-TR
hysterectomy,I-TR
on,O
June,O
4,O
",",O
1993,O
which,O
she,O
tolerated,O
without,O
complications,B-PR
.,O

Her,O
post-operative,O
course,O
has,O
been,O
uncomplicated,O
.,O

She,O
remained,O
afebrile,B-PR
throughout,O
her,O
admission,O
tolerating,O
a,O
regular,O
diet,O
by,O
post-operative,O
day,O
two,O
and,O
was,O
discharged,O
on,O
June,O
6,O
",",O
1993,O
with,O
Percocet,B-TR
for,O
pain,B-PR
.,O

The,B-TR
Foley,I-TR
was,O
discontinued,O
and,O
the,O
patient,O
was,O
urinating,O
on,O
her,O
own,O
.,O

DISPOSITION,O
:,O

DISCHARGE,O
MEDICATIONS,O
:,O

Percocet,B-TR
one,O
to,O
two,O
tablets,O
p.o.,O
q.4-6h.,O
p.r.n.,O
",",O
Iron,B-TR
Sulfate,I-TR
325,O
mg,O
p.o.,O
b.i.d.,O
",",O
Colace,B-TR
100,O
mg,O
b.i.d.,O
",",O
and,O
one,O
Aspirin,B-TR
q.d.,O

She,O
is,O
to,O
follow-up,O
with,O
Dr.,O
Para,O
for,O
follow-up,O
.,O

Dictated,O
By,O
:,O

RIMARVNAA,O
D.,O
KUSHDREPS,O
",",O
M.D.,O
AV94,O

Attending,O
:,O

EARLLAMARG,O
S.,O
PARA,O
",",O
M.D.,O
FT99,O
OH475/4059,O

Batch,O
:,O

2446,O

Index,O
No.,O
LXAIB23C4,O
L,O

D,O
:,O

06/07/93,O

T,O
:,O

06/11/93,O

Admission,O
Date,O
:,O

2014-04-21,O

Discharge,O
Date,O
:,O

2014-04-24,O

Date,O
of,O
Birth,O
:,O

1960-10-27,O

Sex,O
:,O

M,O

Service,O
:,O

CARDIOTHORACIC,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,I-PR
Drugs,I-PR

Attending,O
:,O

Mary,O
X,O
Baxter,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

TIA/Palpitations,B-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

2014-04-21,O
-,O
PFO,B-TR
closure,I-TR
via,O
Right,B-TR
mini,I-TR
thoracotomy,I-TR

History,O
of,O
Present,O
Illness,O
:,O

This,O
53-year-old,O
with,O
a,O
history,O
of,O
multiple,B-PR
transient,I-PR
ischemic,I-PR
attacks,I-PR
in,O
the,O
past,O
was,O
investigated,O
and,O
was,O
found,O
to,O
have,O
a,B-PR
small,I-PR
patent,I-PR
foramen,I-PR
ovale,I-PR
",",O
and,O
he,O
was,O
electively,O
admitted,O
for,O
closure,B-TR
of,O
the,O
same,O
.,O

His,B-TE
preoperative,I-TE
investigations,I-TE
with,O
coronary,B-TE
angiogram,I-TE
showed,O
normal,O
coronary,O
arteries,O
.,O

His,O
left,O
ventricular,O
function,O
was,O
well,O
preserved,O
.,O

He,O
had,O
no,O
valvular,B-PR
disease,I-PR
.,O

Past,O
Medical,O
History,O
:,O

Right,B-PR
Upper,I-PR
lobe,I-PR
nodule,I-PR

TIA,B-PR
's,I-PR

Childhood,B-PR
skull,I-PR
fracture,I-PR

PFO,B-PR

Social,O
History,O
:,O

Lives,O
with,O
wife,O
.,O

1,O
ETO,O
drink,O
daily,O
.,O

Quit,O
smoking,O
30,O
years,O
ago,O
after,O
smoking,O
1ppd,O
.,O

Retired,O
.,O

Family,O
History,O
:,O

Brother,O
with,O
MI,B-PR
at,O
age,O
35,O

Father,O
with,O
MI/CABG,B-PR
died,O
at,O
age,O
60,O
.,O

Physical,O
Exam,O
:,O

Vitals,O
:,O

BP,B-TE
144/90,O
",",O
HR,B-TE
64,O
",",O
RR,B-TE
14,O

General,O
:,O

well,O
developed,O
male,O
in,O
no,O
acute,B-PR
distress,I-PR

HEENT,O
:,O

oropharynx,O
benign,O
",",O
poor,B-PR
dental,I-PR
health,I-PR

Neck,O
:,O

supple,O
",",O
no,O
JVD,B-PR

Heart,O
:,O

regular,O
rate,O
",",O
normal,O
s1s2,O
",",O
no,O
murmur,B-PR

Lungs,O
:,O

clear,O
bilaterally,O

Abdomen,O
:,O

soft,O
",",O
nontender,B-PR
",",O
normoactive,O
bowel,O
sounds,O

Ext,O
:,O

warm,O
",",O
no,O
edema,B-PR
",",O
no,O
varicosities,B-PR

Pulses,O
:,O

2+,O
distally,O

Neuro,O
:,O

nonfocal,O

Pertinent,O
Results:,O

2014-04-24,O
07:30AM,O
BLOOD,B-TE

Hct,B-TE
-,O
25.9*,O

2014-04-23,O
07:05AM,O
BLOOD,B-TE

WBC,B-TE
-,O
5.9,O
RBC,B-TE
-,O
2.72*,O
Hgb,B-TE
-,O
8.6*,O
Hct,B-TE
-,O
25.2*,O

MCV,B-TE
-,O
93,O
MCH,B-TE
-,O
31.5,O
MCHC,B-TE
-,O
34.0,O
RDW,B-TE
-,O
13.0,O
Plt,B-TE
Ct,I-TE
-,O
150,O

2014-04-23,O
07:05AM,O
BLOOD,B-TE

Plt,B-TE
Ct,I-TE
-,O
150,O

2014-04-24,O
07:30AM,O
BLOOD,B-TE

UreaN,B-TE
-,O
11,O
Creat,B-TE
-,O
0.8,O
K,O
-,O
4.4,O

2014-04-21,O
ECHO,B-TE

No,O
spontaneous,B-PR
echo,I-PR
contrast,I-PR
is,O
seen,O
in,O
the,O
body,O
of,O
the,O
left,O
atrium,O
.,O

No,O
mass/thrombus,B-PR
is,O
seen,O
in,O
the,O
left,O
atrium,O
or,O
left,O
atrial,O
appendage,O
.,O

No,O
spontaneous,B-PR
echo,I-PR
contrast,I-PR
is,O
seen,O
in,O
the,O
body,O
of,O
the,O
right,O
atrium,O
.,O

A,B-PR
patent,I-PR
foramen,I-PR
ovale/secundum,I-PR
ASD,I-PR
is,O
present,O
.,O

A,B-PR
left-to-right,I-PR
shunt,I-PR
across,I-PR
the,I-PR
interatrial,I-PR
septum,I-PR
is,O
seen,O
at,O
rest,O
.,O

A,B-PR
right-to-left,I-PR
shunt,I-PR
across,I-PR
the,I-PR
interatrial,I-PR
septum,I-PR
is,O
seen,O
at,O
rest,O
with,O
injection,B-TE
of,I-TE
agitated,I-TE
saline,I-TE
contrast,I-TE
.,O

The,O
inferior,O
vena,O
cava,O
is,O
dilated,B-PR
(,O
>2.5,O
cm,O
),O
.,O

Left,O
ventricular,O
wall,O
thickness,O
",",O
cavity,O
size,O
",",O
and,O
systolic,O
function,O
are,O
normal,O
(,O
LVEF,B-TE
>55%,I-TE
),O
.,O

Left,O
ventricular,O
wall,O
thicknesses,O
are,O
normal,O
.,O

Regional,O
left,O
ventricular,O
wall,O
motion,O
is,O
normal,O
.,O

Overall,O
left,O
ventricular,O
systolic,O
function,O
is,O
normal,O
(,O
LVEF>55%,B-TE
),O
.,O

Right,O
ventricular,O
chamber,O
size,O
and,O
free,O
wall,O
motion,O
are,O
normal,O
.,O

The,O
ascending,O
",",O
transverse,O
and,O
descending,O
thoracic,O
aorta,O
are,O
normal,O
in,O
diameter,O
and,O
free,O
of,O
atherosclerotic,B-PR
plaque,I-PR
.,O

The,O
aortic,O
valve,O
leaflets,O
(,O
3,O
),O
appear,O
structurally,O
normal,O
with,O
good,O
leaflet,O
excursion,O
and,O
no,O
aortic,B-PR
regurgitation,I-PR
.,O

No,O
aortic,B-PR
regurgitation,I-PR
is,O
seen,O
.,O

The,O
mitral,O
valve,O
appears,O
structurally,O
normal,O
with,O
trivial,B-PR
mitral,I-PR
regurgitation,I-PR
.,O

The,O
mitral,O
valve,O
leaflets,O
are,O
structurally,O
normal,O
.,O

There,O
is,O
no,O
pericardial,B-PR
effusion,I-PR
.,O

POST,O
BYPASS,B-TR

Flow,O
across,O
the,O
interatrial,O
septum,O
is,O
no,O
longer,O
visualized,O
with,O
color,B-TE
flow,I-TE
doppler,I-TE
or,O
with,O
injection,B-TE
of,I-TE
agitatated,I-TE
saline,I-TE
at,O
rest,O
or,O
with,O
valsalva,O
.,O

The,B-TE
study,I-TE
is,O
otherwise,O
unchanged,O
from,O
pre-bypass,B-TE
.,O

2014-04-22,O
CXR,B-TE

Previous,B-PR
right,I-PR
pneumothorax,I-PR
has,O
resolved,O
except,O
for,O
what,O
is,O
either,O
a,B-PR
small,I-PR
fissural,I-PR
component,I-PR
or,O
a,B-PR
bulla,I-PR
adjacent,O
to,O
the,O
minor,O
fissure,O
.,O

May,O
be,O
a,B-PR
small,I-PR
right,I-PR
pleural,I-PR
effusion,I-PR
.,O

Right,B-TR
apical,I-TR
pleural,I-TR
tube,I-TR
in,O
place,O
.,O

Left,O
lung,O
clear,O
from,O
basal,B-PR
atelectasis,I-PR
.,O

Paratracheal,B-PR
mediastinal,I-PR
hematoma,I-PR
is,O
resolving,O
.,O

Heart,O
size,O
is,O
normal,O
.,O

Tip,O
of,O
the,O
left,O
internal,O
jugular,O
line,O
projects,O
over,O
the,O
SVC,O
.,O

Brief,O
Hospital,O
Course,O
:,O

Mr.,O
Freeman,O
was,O
admitted,O
to,O
the,O
Nantucket,O
Cottage,O
Hospital,O
on,O
2014-04-21,O
for,O
surgical,B-TR
management,I-TR
of,O
his,B-PR
PFO,I-PR
.,O

He,O
was,O
taken,O
to,O
the,O
operating,O
room,O
where,O
he,O
underwent,O
a,B-TR
mini-thoracotomy,I-TR
with,O
closure,B-TR
of,O
his,B-PR
patent,I-PR
foramen,I-PR
ovale,I-PR
(,I-PR
PFO,I-PR
),I-PR
.,O

Postoperatively,O
he,O
was,O
taken,O
to,O
the,O
cardiac,O
surgical,O
intensive,O
care,O
unit,O
for,O
monitoring,O
.,O

Within,O
a,O
few,O
hours,O
",",O
he,O
woke,O
neurologically,O
intact,O
and,O
was,O
extubated,B-TR
.,O

Aspirin,B-TR
was,O
resumed.,O
On,O
postoperative,O
day,O
one,O
",",O
he,O
was,O
transferred,O
to,O
the,O
cardiac,O
surgical,O
step,O
down,O
unit,O
.,O

He,O
was,O
gently,O
diuresed,O
towards,O
his,O
preoperative,O
weight,O
.,O

The,O
physical,O
therapy,O
service,O
was,O
consulted,O
for,O
assistance,O
with,O
his,O
postoperative,O
strength,O
and,O
mobility,O
.,O

Iron,B-TR
and,O
vitamin,B-TR
C,I-TR
were,O
started,O
for,O
postoperative,B-PR
anemia,I-PR
.,O

Mr.,O
Freeman,O
maintained,O
stable,O
hemodynamics,O
with,O
a,O
normal,O
sinus,O
rhythm,O
throughout,O
his,O
postoperative,O
course,O
.,O

He,O
continued,O
to,O
make,O
steady,O
progress,O
and,O
was,O
discharged,O
home,O
on,O
postoperative,O
day,O
three,O
.,O

He,O
will,O
follow-up,O
with,O
Dr.,O
de,O
la,O
Cisneros,O
",",O
Dr.,O
Belt,O
",",O
his,O
cardiologist,O
and,O
his,O
primary,O
care,O
physician,O
as,O
an,O
outpatient,O
.,O

Medications,O
on,O
Admission,O
:,O

Plavix,B-TR
75mg,O
daily,O
aspirin,B-TR
81mg,O
daily,O

Discharge,O
Medications,O
:,O

1.,O
Potassium,B-TR
Chloride,I-TR
10,O
mEq,O
Capsule,O
",",O
Sustained,O
Release,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Capsule,O
",",O
Sustained,O
Release,O
PO,O
Q12H,O
(,O
every,O
12,O
hours,O
),O
for,O
5,O
days,O
.,O

Disp,O
:,O
*10,O
Capsule,O
",",O
Sustained,O
Release(,O
s,O
)*,O

Refills,O
:,O
*0*,O

2.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

Disp,O
:,O
*60,O
Capsule(,O
s,O
)*,O

Refills,O
:,O
*0*,O

3.,O
Aspirin,B-TR
81,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

Disp,O
:,O
*30,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
)(,O
s,O
)*,O

Refills,O
:,O
*2*,O

4.,O
Oxycodone-Acetaminophen,B-TR
5-325,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
every,O
4-6,O
hours,O
as,O
needed,O
for,O
pain,B-PR
.,O

Disp,O
:,O
*50,O
Tablet(,O
s,O
)*,O

Refills,O
:,O
*0*,O

5.,O
Ferrous,B-TR
Sulfate,I-TR
325,O
(,O
65,O
),O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
:,O
Take,O
for,O
one,O
month,O
then,O
stop,O
.,O

Disp,O
:,O
*30,O
Tablet(,O
s,O
)*,O

Refills,O
:,O
*0*,O

6.,O
Camphor-Menthol,B-TR
0.5-0.5,O
%,O
Lotion,O
Sig,O
:,O
One,O
(,O
1,O
),O
Appl,O
Topical,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
as,O
needed,O
.,O

Disp,O
:,O
*qs,O
qs*,O

Refills,O
:,O
*0*,O

7.,O
Ascorbic,B-TR
Acid,I-TR
500,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
:,O
Take,O
for,O
one,O
month,O
then,O
stop,O
.,O

Disp,O
:,O
*60,O
Tablet(,O
s,O
)*,O

Refills,O
:,O
*0*,O

8.,O
Furosemide,B-TR
20,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
for,O
5,O
days,O
.,O

Disp,O
:,O
*10,O
Tablet(,O
s,O
)*,O

Refills,O
:,O
*0*,O

Discharge,O
Disposition,O
:,O

Home,O
with,O
Service,O

Discharge,O
Diagnosis,O
:,O

PFO,B-PR

TIA,B-PR
lung,I-PR
nodule,I-PR
(,O
followed,O
by,O
Dr.,O
Belt,O
),O
s/p,O
fissurectomy/skull,B-PR
Fx,I-PR

Discharge,O
Condition,O
:,O

Good,O

Discharge,O
Instructions,O
:,O

1),O
Shower,O
",",O
wash,O
incisions,B-PR
with,O
mild,O
soap,O
and,O
water,O
and,O
pat,O
dry,O
.,O

No,O
lotions,B-TR
",",O
creams,B-TR
or,O
powders,B-TR
to,O
incisions,B-PR
.,O

2),O
Call,O
with,O
fever,B-PR
>101,I-PR
",",O
redness,B-PR
or,O
drainage,B-PR
from,I-PR
incision,I-PR
",",O
or,O
weight,B-PR
gain,I-PR
more,I-PR
than,I-PR
2,I-PR
pounds,I-PR
in,O
one,O
day,O
or,O
five,O
pounds,O
in,O
one,O
week,O
.,O

3),O
No,O
driving,O
while,O
on,O
narcotics,B-TR
.,O

4),O
Take,O
lasix,B-TR
twice,O
daily,O
with,O
potassium,B-TR
for,O
five,O
days,O
then,O
stop,O
.,O

5),O
Take,O
Vitamin,B-TR
C,I-TR
with,O
iron,B-TR
for,O
one,O
month,O
then,O
stop,O
.,O

6),O
Call,O
with,O
any,O
questions,O
or,O
concerns,O
.,O

Followup,O
Instructions:,O

Follow,O
up,O
with,O
Dr.,O
Heird,O
in,O
four,O
weeks,O
",",O
671,O
745,O
2553,O

Follow,O
up,O
with,O
Dr.,O
Knowlton,O
in,O
1-2,O
weeks,O
",",O
(246),O
828-4417,O

Follow,O
up,O
with,O
Dr.,O
Eckman,O
in,O
2-3,O
weeks,O
",",O
(506),O
946-4576,O

Call,O
all,O
providers,O
for,O
appointments,O
.,O

CAT,O
SCAN,O
Phone,O
:,O

(476),O
713,O
6117,O

Date/Time,O
:,O
2014-10-16,O
9:15,O

Edna,O
Arnold,O
",",O
MD,O

Phone,O
:,O
(300),O
922-6590,O

Date/Time,O
:,O
2014-10-16,O
2:30,O

Melonson,O
de,O
la,O
Donnelly,O
MD,O
08-301,O

Completed,O
by,O
:,O

Jeremy,O
N.,O
P.,O
Moschella,O
PA,O
80-BYE,O
2014-04-24,O
@,O
1103,O

Signed,O
electronically,O
by,O
:,O

DR.,O
Dorothy,O
au,O
Pratt,O
on,O
:,O

FRI,O
2014-06-06,O
10:27,O
AM,O

(,O
End,O
of,O
Report,O
),O

86326823,O

FIH,O

6708320,O

235967,O

594818,O

8/24/1998,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Report,O
Status,O
:,O

Signed,O

DISCHARGE,O
SUMMARY,O
NAME,O
:,O

RIEFF,O
",",O
ALB,O
P,O

UNIT,O
NUMBER,O
:,O

185-64-30,O

ADMISSION,O
DATE,O
:,O

08/24/1998,O

DISCHARGE,O
DATE,O
:,O

09/14/1998,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Sternal,B-PR
wound,I-PR
infection,I-PR
.,O

ASSOCIATED,O
DIAGNOSES,O
:,O

Infected,B-PR
aortic,I-PR
graft,I-PR
.,O

Hypertension,B-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

08/31/98,O
ascending,B-TR
aortic,I-TR
root,I-TR
replacement,I-TR
with,O
homograft,B-TR
with,O
omentopexy,B-TR
.,O

ASSOCIATED,O
PROCEDURES,O
:,O

09/02/98,O
sternal,B-TR
debridement,I-TR
.,O

Bilateral,B-TR
pectoralis,I-TR
major,I-TR
myocutaneous,I-TR
advancement,I-TR
flap,I-TR
.,O

Right,B-TR
superiorly,I-TR
based,I-TR
rectus,I-TR
abdominis,I-TR
flap,I-TR
.,O

Primary,B-TR
closure,I-TR
of,O
wound,B-PR
.,O

HISTORY,O
AND,O
REASON,O
FOR,O
HOSPITALIZATION,O
:,O

The,O
patient,O
is,O
a,O
79,O
year,O
old,O
gentleman,O
with,O
a,O
history,O
of,O
an,B-TR
ascending,I-TR
aortic,I-TR
graft,I-TR
replacement,I-TR
in,O
1991,O
for,O
aortic,B-PR
dissection,I-PR
.,O

At,O
that,O
time,O
the,O
patient,O
's,O
hospital,O
course,O
was,O
complicated,O
by,O
a,B-PR
sternal,I-PR
wound,I-PR
infection,I-PR
requiring,O
a,B-TR
sternal,I-TR
debridement,I-TR
and,O
subsequent,B-TR
abdominal,I-TR
flap,I-TR
.,O

The,O
patient,O
was,O
then,O
continued,O
by,O
report,O
on,O
Dicloxacillin,B-TR
for,O
approximately,O
one,O
year,O
following,O
that,B-TR
reconstructive,I-TR
operation,I-TR
.,O

The,O
patient,O
apparently,O
did,O
well,O
until,O
June,O
1998,O
when,O
he,O
noted,O
a,B-PR
bulge,I-PR
in,I-PR
his,I-PR
sternal,I-PR
area,I-PR
.,O

A,B-PR
ruptured,I-PR
aneurysm,I-PR
or,O
pseudoaneurysm,B-PR
at,O
the,O
junction,O
of,O
the,B-TR
graft,I-TR
and,O
arch,O
was,O
diagnosed,O
and,O
this,O
was,O
subsequently,O
repaired,O
.,O

The,O
patient,O
then,O
had,O
recurrent,B-PR
bleeding,I-PR
two,O
weeks,O
later,O
which,O
was,O
once,O
again,O
repaired,O
.,O

However,O
the,B-PR
same,I-PR
problem,I-PR
recurred,O
for,O
a,O
third,O
time,O
and,O
a,B-TE
computer,I-TE
tomogram,I-TE
scan,I-TE
at,O
an,O
outside,O
hospital,O
showed,O
an,B-PR
anterior,I-PR
hematoma,I-PR
.,O

By,O
report,O
the,O
patient,O
was,O
at,O
that,O
time,O
told,O
that,O
there,O
was,O
no,O
more,O
that,O
could,O
be,O
done,O
for,O
him,O
and,O
was,O
then,O
apparently,O
placed,O
on,O
comfort,B-TR
measures,I-TR
and,O
pain,B-TR
control,I-TR
at,O
the,O
outside,O
hospital,O
.,O

However,O
the,O
patient,O
was,O
then,O
subsequently,O
transferred,O
to,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
upon,O
request,O
of,O
the,O
family,O
on,O
8/24/98,O
for,O
further,B-TE
evaluation,I-TE
and,O
possible,O
intervention,B-TR
.,O

The,O
patient,O
was,O
evaluated,O
by,O
Dr.,O
Rhalt,O
of,O
Dentvailr.,O
Medical,O
Center,O
.,O

As,O
the,B-TE
patient,I-TE
's,I-TE
early,I-TE
evaluation,I-TE
the,O
patient,O
underwent,O
an,B-TE
aortogram,I-TE
which,O
showed,O
an,B-TR
ascending,I-TR
aortic,I-TR
graft,I-TR
with,O
bulging,B-PR
flaps,I-PR
and,O
a,B-PR
pseudoaneurysm,I-PR
at,O
the,O
anastomosis,O
of,O
the,B-TR
graft,I-TR
and,O
arch,O
just,O
below,O
the,O
great,O
vessels,O
.,O

There,O
was,O
no,O
evidence,O
for,O
a,B-PR
definite,I-PR
leak,I-PR
but,O
there,O
was,O
evidence,O
for,O
gas,B-PR
bubbles,I-PR
in,O
the,O
anterior,O
posterior,O
distal,O
ends,O
of,O
the,B-TR
grafts,I-TR
consistent,O
with,O
an,B-PR
infectious,I-PR
process,I-PR
.,O

At,O
the,O
same,O
time,O
the,O
patient,O
was,O
seen,O
in,O
consultation,O
by,O
the,O
Infectious,O
Disease,O
Service,O
who,O
upon,O
culturing,O
the,B-PR
patient,I-PR
's,I-PR
sternal,I-PR
drainage,I-PR
switched,O
the,O
patient,O
from,O
intravenous,B-TR
Unasyn,I-TR
to,O
Levofloxacin,B-TR
for,O
what,O
appeared,O
to,O
be,O
Citrobacter,B-PR
and,O
Diphtheroids,B-PR
in,O
the,B-TE
wound,I-TE
cultures,I-TE
.,O

Subsequent,O
to,O
starting,O
this,B-TR
antibiotic,I-TR
regimen,I-TR
the,B-PR
patient,I-PR
's,I-PR
wound,I-PR
drainage,I-PR
appeared,O
to,O
subside,O
.,O

Given,O
all,O
the,O
findings,O
on,O
the,B-TE
aortogram,I-TE
and,O
the,B-TE
subsequent,I-TE
chest,I-TE
computer,I-TE
tomogram,I-TE
scan,I-TE
it,O
was,O
discovered,O
that,O
the,O
patient,O
's,O
only,O
real,O
surgical,O
option,O
for,O
cure,O
was,O
a,B-TR
risky,I-TR
operation,I-TR
that,O
involved,O
removal,B-TR
and,I-TR
replacement,I-TR
of,I-TR
the,I-TR
aortic,I-TR
graft,I-TR
probably,O
with,O
homograft,B-TR
and,O
long,B-TR
term,I-TR
antibiotic,I-TR
coverage,I-TR
as,O
well,O
as,O
a,B-TR
plastic,I-TR
surgical,I-TR
reconstructive,I-TR
procedure,I-TR
.,O

The,O
patient,O
understood,O
the,O
risks,O
and,O
potential,O
benefits,O
of,O
the,B-TR
procedure,I-TR
and,O
was,O
willing,O
to,O
proceed,O
.,O

The,O
patient,O
otherwise,O
complained,O
of,O
no,O
angina,B-PR
",",O
no,O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
no,O
paroxysmal,B-PR
nocturnal,I-PR
dyspnea,I-PR
",",O
no,O
edema,B-PR
",",O
no,O
palpitations,B-PR
or,O
symptoms,O
of,O
syncope,B-PR
.,O

He,O
did,O
report,O
a,B-PR
20,I-PR
lbs,I-PR
weight,I-PR
loss,I-PR
over,O
the,O
last,O
several,O
months,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Thoracic,B-TR
aneurysm,I-TR
repair,I-TR
.,O

2.,O
Hypertension,B-PR
.,O

3.,O
Status,O
post,O
hernia,B-TR
repair,I-TR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

1.,O
Lopressor,B-TR
100,O
mg,O
po,O
three,O
times,O
a,O
day,O
.,O

2.,O
Captopril,B-TR
75,O
mg,O
po,O
three,O
times,O
a,O
day,O
.,O

3.,O
Prilosec,B-TR
20,O
mg,O
po,O
per,O
day,O
.,O

4.,O
Hydralazine,B-TR
12.5,O
mg,O
four,O
times,O
per,O
day,O
.,O

5.,O
Reglan,B-TR
10,O
mg,O
po,O
three,O
times,O
a,O
day,O
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

FAMILY,O
HISTORY,O
:,O

Noncontributory,O
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
was,O
married,O
and,O
denied,O
any,O
tobacco,O
or,O
alcohol,O
use,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,O
patient,O
was,O
afebrile,B-PR
",",O
vital,B-TE
signs,I-TE
were,O
stable,O
.,O

Head,B-TE
",",I-TE
eyes,I-TE
",",I-TE
ears,I-TE
",",I-TE
nose,I-TE
and,I-TE
throat,I-TE
exam,I-TE
:,O

negative,O
.,O

Neck,O
was,O
supple,O
.,O

There,O
was,O
no,O
jugular,B-PR
venous,I-PR
distention,I-PR
.,O

2+,B-TE
carotids,I-TE
without,O
bruits,B-PR
.,O

Cardiovascular,B-TE
exam,I-TE
:,O

regular,O
rate,O
and,O
rhythm,O
with,O
a,B-PR
2/6,I-PR
diastolic,I-PR
___,O
and,O
a,B-PR
1/6,I-PR
systolic,I-PR
ejection,I-PR
murmur,I-PR
.,O

His,O
lungs,O
were,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
without,O
any,O
evidence,O
for,O
crackles,B-PR
.,O

Extremities,O
:,O

the,O
patient,O
had,O
2+,B-TE
femoral,I-TE
pulses,I-TE
and,O
1+,B-TE
pedal,I-TE
pulses,I-TE
.,O

LABORATORY,O
AND,O
RADIOLOGIC,O
DATA,O
:,O

Sodium,B-TE
137,O
",",O
potassium,B-TE
4.0,O
",",O
blood,B-TE
urea,I-TE
nitrogen,I-TE
16,O
",",O
creatinine,B-TE
.9,O
",",O
white,B-TE
blood,I-TE
cell,I-TE
count,I-TE
4.9,O
",",O
hematocrit,B-TE
29.7,O
",",O
platelet,B-TE
count,I-TE
207,O
.,O

The,B-TE
patient,I-TE
's,I-TE
preoperative,I-TE
chest,I-TE
x-ray,I-TE
showed,O
bilateral,B-PR
effusions,I-PR
and,O
bibasilar,B-PR
atelectasis,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,B-PR
patient,I-PR
's,I-PR
sternal,I-PR
incision,I-PR
had,O
a,O
superior,O
edge,O
that,O
was,O
dehisced,B-PR
with,O
evidence,O
for,O
stay,B-TR
sutures,I-TR
and,O
some,O
superficial,B-TR
closure,I-TR
sutures,I-TR
exposed,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
initially,O
admitted,O
to,O
the,O
Cardiac,O
Surgical,O
Service,O
under,O
Dr.,O
Rhalt,O
.,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
Cardiac,O
Surgical,O
Intensive,O
Care,O
Unit,O
given,O
the,O
patient,O
's,O
precarious,O
condition,O
.,O

Over,O
the,O
next,O
several,O
hospital,O
days,O
the,O
patient,O
underwent,O
aortogram,B-TE
as,O
well,O
as,O
chest,B-TE
computer,I-TE
tomogram,I-TE
as,O
outlined,O
earlier,O
.,O

The,O
patient,O
was,O
also,O
seen,O
in,O
consultation,O
by,O
the,O
Infectious,O
Disease,O
Service,O
as,O
well,O
as,O
the,O
Cardiology,O
Service,O
who,O
assisted,O
in,O
managing,O
the,B-PR
patient,I-PR
's,I-PR
intermittent,I-PR
hypertension,I-PR
.,O

The,O
patient,O
was,O
also,O
seen,O
preoperatively,O
in,O
consultation,O
by,O
the,O
Plastic,O
Surgical,O
Service,O
for,O
potential,B-TR
sternal,I-TR
reconstruction,I-TR
.,O

After,O
lengthy,O
discussions,O
with,O
the,O
patient,O
and,O
the,O
patient,O
's,O
family,O
as,O
well,O
as,O
the,O
various,O
consultant,O
services,O
it,O
was,O
decided,O
that,O
the,O
patient,O
was,O
a,O
viable,O
candidate,O
for,O
aortic,B-TR
root,I-TR
replacement,I-TR
procedure,I-TR
using,O
homograft,B-TR
.,O

This,O
was,O
obtained,O
on,O
08/30/98,O
by,O
Dr.,O
Niste,O
Rhalt,O
of,O
the,O
Cardiac,O
Surgical,O
Service,O
.,O

The,O
patient,O
was,O
then,O
subsequently,O
taken,O
to,O
the,O
Operating,O
Room,O
on,O
08/31/98,O
with,O
the,O
preoperative,O
diagnosis,O
of,O
ascending,B-PR
aortic,I-PR
graft,I-PR
infection,I-PR
.,O

The,B-TR
procedure,I-TR
performed,O
was,O
homograft,B-TR
replacement,I-TR
of,I-TR
the,I-TR
ascending,I-TR
aorta,I-TR
with,O
omentopexy,B-TR
and,O
an,B-PR
open,I-PR
chest,I-PR
.,O

The,O
aortic,O
perfusions,O
were,O
via,O
the,O
femoral,O
artery,O
with,O
venous,O
return,O
by,O
the,O
femoral,O
vein,O
.,O

The,O
cardiopulmonary,O
bypass,O
time,O
was,O
one,O
hour,O
and,O
49,O
minutes,O
.,O

The,B-TR
graft,I-TR
used,O
was,O
a,B-TR
homograft,I-TR
.,O

The,O
patient,O
tolerated,O
the,B-TR
procedure,I-TR
fairly,O
well,O
and,O
was,O
transferred,O
intubated,B-TR
to,O
the,O
Cardiac,O
Surgical,O
Intensive,O
Care,O
Unit,O
with,O
his,B-PR
chest,I-PR
open,I-PR
.,O

The,O
immediate,O
postoperative,O
plans,O
were,O
for,O
a,O
short,O
Intensive,O
Care,O
Unit,O
stay,O
and,O
subsequent,B-TR
plastic,I-TR
surgical,I-TR
reconstruction,I-TR
of,I-TR
the,I-TR
patient,I-TR
's,I-TR
sternum,I-TR
.,O

The,O
patient,O
was,O
transferred,O
to,O
the,O
Cardiac,O
Surgical,O
Intensive,O
Care,O
Unit,O
in,O
stable,O
condition,O
.,O

There,O
he,O
continued,O
to,O
be,O
hemodynamically,O
stable,O
.,O

Of,O
note,O
",",O
intraoperatively,B-TE
multiple,I-TE
tissue,I-TE
cultures,I-TE
had,O
been,O
sent,O
.,O

In,O
the,O
Intensive,O
Care,O
Unit,O
the,O
patient,O
was,O
kept,O
intubated,B-TR
and,O
sedated,B-TR
until,O
09/02/98,O
which,O
was,O
postoperative,O
day,O
no.,O
1,O
following,O
the,B-TR
homograft,I-TR
replacement,I-TR
.,O

On,O
that,O
day,O
the,O
Plastic,O
Surgical,O
Service,O
performed,O
further,B-TR
sternal,I-TR
debridement,I-TR
and,O
subsequent,B-TR
reconstruction,I-TR
using,O
bilateral,B-TR
pectoralis,I-TR
major,I-TR
myocutaneous,I-TR
advancement,I-TR
flaps,I-TR
and,O
right,B-TR
superiorly,I-TR
rectus,I-TR
abdominis,I-TR
flap,I-TR
to,O
cover,O
the,B-PR
patient,I-PR
's,I-PR
sternal,I-PR
wound,I-PR
with,O
subsequent,B-TR
primary,I-TR
closure,I-TR
of,O
that,B-PR
wound,I-PR
.,O

The,O
patient,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
and,O
there,O
were,O
no,O
complications,B-PR
.,O

A,O
number,O
of,O
indwelling,B-TR
closed,I-TR
suction,I-TR
drains,I-TR
were,O
left,O
in,O
place,O
so,O
as,O
to,O
drain,O
the,O
bed,O
underneath,O
the,O
muscle,O
flaps,O
.,O

The,O
patient,O
was,O
then,O
transferred,O
back,O
to,O
the,O
Cardiac,O
Surgical,O
Intensive,O
Care,O
Unit,O
in,O
stable,O
condition,O
.,O

At,O
this,O
point,O
the,O
patient,O
continued,O
to,O
followed,O
by,O
Infectious,O
Disease,O
Service,O
and,O
continued,O
to,O
be,O
on,O
intravenous,B-TR
antibiotics,I-TR
which,O
included,O
Vancomycin,B-TR
and,O
Levofloxacin,B-TR
.,O

The,B-TE
Operating,I-TE
Room,I-TE
cultures,I-TE
at,O
that,O
point,O
were,O
positive,O
for,O
Crinobactermium,B-PR
with,O
sputum,B-TE
cultures,I-TE
being,O
sensitive,O
for,O
yeast,B-PR
and,O
gram,B-PR
positive,I-PR
cocci,I-PR
in,I-PR
clusters,I-PR
.,O

Over,O
the,O
next,O
postoperative,O
day,O
the,O
patient,O
was,O
awakened,O
and,O
weaned,O
to,O
extubate,O
without,O
significant,B-PR
difficulties,I-PR
.,O

The,O
patient,O
's,O
subsequent,O
postoperative,O
course,O
was,O
characterized,O
by,O
persistent,B-PR
hypertension,I-PR
which,O
required,O
a,O
significant,O
amount,O
of,O
antihypertensives,B-TR
including,O
Lopressor,B-TR
100,O
mg,O
po,O
three,O
times,O
a,O
day,O
",",O
Captopril,B-TR
100,O
mg,O
po,O
three,O
times,O
a,O
day,O
",",O
as,O
well,O
as,O
Procardia,B-TR
.,O

The,O
patient,O
otherwise,O
continued,O
to,O
do,O
well,O
and,O
was,O
becoming,O
more,O
oriented,O
as,O
time,O
went,O
on,O
and,O
as,O
his,B-TE
blood,I-TE
pressure,I-TE
was,O
brought,O
under,O
control,O
.,O

Subsequently,O
on,O
postoperative,O
day,O
no.,O
8,O
in,O
the,O
Intensive,O
Care,O
Unit,O
the,O
patient,O
was,O
felt,O
to,O
be,O
ready,O
for,O
transfer,O
to,O
the,O
Cardiac,O
Surgical,O
Inpatient,O
Service,O
.,O

The,O
patient,O
continued,O
to,O
be,O
followed,O
by,O
the,O
Infectious,O
Disease,O
Service,O
who,O
felt,O
that,O
the,B-TR
patient,I-TR
's,I-TR
Jackson,I-TR
Pratt,I-TR
drains,I-TR
needed,O
to,O
stay,O
in,O
as,O
there,O
was,O
still,O
some,B-PR
significant,I-PR
drainage,I-PR
from,O
them,O
.,O

As,O
per,O
the,O
Infectious,O
Disease,O
Service,O
the,O
patient,O
was,O
continued,O
on,O
Levofloxacin,B-TR
",",O
Vancomycin,B-TR
as,O
antibiotic,B-TR
coverage,I-TR
.,O

However,O
on,O
09/08/98,O
the,O
Infectious,O
Disease,O
Service,O
was,O
made,O
aware,O
that,O
the,B-TE
patient,I-TE
's,I-TE
intraoperative,I-TE
cultures,I-TE
had,O
also,O
grown,O
out,O
Mycoplasma,B-PR
humilius,I-PR
.,O

Given,O
this,O
finding,O
it,O
was,O
felt,O
that,O
the,O
patient,O
would,O
certainly,O
need,O
long,B-TR
term,I-TR
intravenous,I-TR
antibiotics,I-TR
to,O
include,O
at,O
least,O
six,O
weeks,O
of,O
Vancomycin,B-TR
and,O
then,O
subsequent,B-TR
Levofloxacin,I-TR
for,O
the,B-PR
Citrobacter,I-PR
and,O
Mycoplasma,B-PR
as,O
well,O
.,O

The,O
patient,O
was,O
scheduled,O
for,O
peripherally,B-TR
inserted,I-TR
central,I-TR
catheter,I-TR
line,I-TR
placement,I-TR
knowing,O
that,O
he,O
was,O
going,O
to,O
need,O
long,B-TR
term,I-TR
intravenous,I-TR
antibiotics,I-TR
.,O

This,O
was,O
placed,O
on,O
postoperative,O
day,O
no.,O
9,O
without,O
any,B-PR
difficulty,I-PR
.,O

At,O
the,O
same,O
time,O
the,O
patient,O
continued,O
to,O
be,O
stable,O
on,O
his,B-TR
antihypertensive,I-TR
regimen,I-TR
.,O

He,O
was,O
becoming,O
more,O
mobile,O
and,O
was,O
taking,O
a,B-TR
high,I-TR
protein,I-TR
high,I-TR
calories,I-TR
diet,I-TR
which,O
he,O
tolerated,O
well,O
.,O

He,O
continued,O
to,O
be,O
afebrile,B-PR
and,O
otherwise,O
very,O
stable,O
.,O

On,O
postoperative,O
day,O
no.,O
12,O
the,O
patient,O
was,O
noted,O
to,O
have,O
fallen,O
and,O
subsequently,O
dislocating,O
the,O
PIP,O
joint,O
of,O
his,O
left,O
middle,O
finger,O
.,O

Subsequent,B-TE
hand,I-TE
x-rays,I-TE
obtained,O
showed,O
no,O
evidence,O
of,O
fracture,B-PR
but,O
the,O
patient,O
was,O
seen,O
in,O
consultation,O
by,O
the,O
Plastic,O
Surgery,O
Hand,O
Service,O
.,O

The,O
patient,O
will,O
benefit,O
from,O
splinting,B-TR
of,I-TR
his,I-TR
finger,I-TR
while,O
the,B-PR
swelling,I-PR
subsided,O
and,O
subsequent,B-TR
early,I-TR
mobilization,I-TR
to,O
prevent,O
any,B-PR
rigidity,I-PR
in,I-PR
that,I-PR
joint,I-PR
.,O

The,O
patient,O
was,O
also,O
seen,O
subsequently,O
in,O
consultation,O
by,O
the,O
Plastic,O
Surgical,O
Service,O
who,O
discontinued,O
a,O
number,O
of,O
the,B-TR
patient,I-TR
's,I-TR
indwelling,I-TR
drains,I-TR
but,O
they,O
felt,O
that,O
others,O
needed,O
to,O
stay,O
while,O
the,O
patient,O
was,O
sent,O
to,O
rehabilitation,O
.,O

These,B-TR
drains,I-TR
will,O
then,O
be,O
subsequently,O
taken,O
out,O
by,O
Dr.,O
General,O
upon,O
his,O
followup,O
with,O
the,O
patient,O
.,O

Prior,O
to,O
discharge,O
the,O
patient,O
also,O
underwent,O
an,B-TE
audiogram,I-TE
as,O
a,B-TE
baseline,I-TE
hearing,I-TE
test,I-TE
while,O
the,O
patient,O
was,O
to,O
stay,O
on,O
long,B-TR
term,I-TR
intravenous,I-TR
antibiotics,I-TR
.,O

The,O
patient,O
otherwise,O
continued,O
to,O
be,O
hemodynamically,O
stable,O
making,O
good,O
progress,O
.,O

As,O
a,O
matter,O
of,O
fact,O
the,O
patient,O
made,O
remarkable,O
progress,O
given,O
the,O
severity,O
of,O
his,B-PR
disease,I-PR
condition,I-PR
prior,O
to,O
the,B-TR
operation,I-TR
.,O

The,O
patient,O
's,O
condition,O
continued,O
to,O
be,O
improved,O
.,O

Given,O
this,O
finding,O
the,O
patient,O
was,O
therefore,O
felt,O
to,O
be,O
ready,O
for,O
discharge,O
to,O
a,O
rehabilitation,O
facility,O
on,O
09/13/1998,O
.,O

In,O
consultation,O
with,O
the,O
Infectious,O
Disease,O
Service,O
the,O
patient,O
was,O
to,O
stay,O
on,O
long,B-TR
term,I-TR
intravenous,I-TR
antibiotics,I-TR
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Good,O
.,O

DISCHARGE,O
INSTRUCTIONS,O
:,O

Diet,O
:,O

High,B-TR
calorie,I-TR
",",I-TR
high,I-TR
protein,I-TR
.,O

The,B-TR
patient,I-TR
's,I-TR
treatment,I-TR
will,O
include,O
typical,B-TR
peripherally,I-TR
inserted,I-TR
central,I-TR
catheter,I-TR
line,I-TR
care,I-TR
with,O
frequent,B-TE
wound,I-TE
checks,I-TE
.,O

The,O
patient,O
prior,O
to,O
discharge,O
was,O
fitted,O
with,O
an,B-TR
orthoplast,I-TR
finger,I-TR
splint,I-TR
as,O
manufactured,O
by,O
Occupational,O
Therapy,O
Services,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
.,O

The,O
patient,O
was,O
also,O
instructed,O
in,O
range,B-TR
of,I-TR
motion,I-TR
exercises,I-TR
for,O
the,O
left,O
middle,O
finger,O
.,O

The,O
patient,O
on,O
discharge,O
is,O
to,O
have,O
twice,O
weekly,O
Vancomycin,B-TE
peak,I-TE
and,I-TE
trough,I-TE
levels,I-TE
while,O
he,O
continues,O
on,O
long,B-TR
term,I-TR
Vancomycin,I-TR
therapy,I-TR
.,O

The,O
patient,O
was,O
instructed,O
to,O
return,O
to,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
if,O
he,O
developed,O
any,O
signs,O
of,O
wound,B-PR
infection,I-PR
such,O
a,B-PR
erythema,I-PR
",",O
drainage,B-PR
",",O
or,O
increasing,B-PR
incisional,I-PR
pain,I-PR
.,O

The,O
patient,O
was,O
instructed,O
to,O
be,O
vigilant,O
for,O
any,B-PR
fevers,I-PR
or,O
chills,B-PR
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

1.,O
Vancomycin,B-TR
750,O
mg,O
intravenous,O
q,O
18h.,O

2.,O
Levofloxacin,B-TR
500,O
mg,O
po,O
per,O
day,O
.,O

3.,O
Prilosec,B-TR
20,O
mg,O
po,O
per,O
day,O
.,O

4.,O
Captopril,B-TR
100,O
mg,O
po,O
three,O
times,O
a,O
day,O
.,O

5.,O
Lopressor,B-TR
100,O
mg,O
po,O
three,O
times,O
a,O
day,O
.,O

6.,O
Albuterol,B-TR
nebulizers,I-TR
q6h,O
as,O
needed,O
.,O

7.,O
Atrovent,B-TR
nebulizers,I-TR
q6h,O
as,O
needed,O
.,O

8.,O
Lasix,B-TR
20,O
mg,O
po,O
per,O
day,O
.,O

9.,O
Kay-Ciel,B-TR
20,O
mEq,O
po,O
per,O
day,O
.,O

FOLLOWUP,O
:,O

The,O
patient,O
was,O
instructed,O
that,O
he,O
needed,O
to,O
followup,O
with,O
Dr.,O
Rhalt,O
by,O
calling,O
his,O
office,O
for,O
appointment,O
at,O
763-6361,O
subsequent,O
to,O
his,O
discharge,O
to,O
his,O
rehabilitation,O
facility,O
in,O
Oaksale,O
Lavalle,O
.,O

The,O
patient,O
was,O
also,O
instructed,O
to,O
followup,O
with,O
Dr.,O
Both,O
of,O
the,O
Cardiology,O
Service,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
following,O
his,O
discharge,O
so,O
that,O
his,B-TR
antihypertension,I-TR
medications,I-TR
could,O
be,O
appropriately,O
adjusted,O
.,O

The,O
patient,O
will,O
also,O
be,O
seen,O
in,O
followup,O
by,O
Dr.,O
Chpo,O
E.,O
Enla,O
General,O
of,O
the,O
Plastic,O
Surgery,O
Service,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
so,O
that,O
his,B-TR
indwelling,I-TR
Jackson,I-TR
Pratt,I-TR
drains,I-TR
be,O
appropriately,O
management,O
and,O
if,O
needed,O
be,O
discontinued,O
by,O
him,O
.,O

The,O
patient,O
will,O
also,O
be,O
followed,O
by,O
the,O
Infectious,O
Disease,O
Service,O
so,O
as,O
to,O
ascertain,O
the,O
exact,O
length,O
and,O
course,O
of,O
his,B-TR
antibiotic,I-TR
therapy,I-TR
.,O

The,O
patient,O
was,O
instructed,O
to,O
followup,O
with,O
Dr.,O
Naco,O
Mesprhalt,O
of,O
the,O
Infectious,O
Disease,O
Service,O
by,O
calling,O
her,O
office,O
for,O
an,O
appointment,O
at,O
094-902-2879,O
to,O
be,O
seen,O
in,O
approximately,O
four,O
weeks,O
following,O
the,O
patient,O
's,O
discharge,O
.,O

Dr.,O
Dau,O
's,O
recommendation,O
is,O
that,O
the,O
patient,O
is,O
to,O
stay,O
on,O
Vancomycin,B-TR
and,O
Levofloxacin,B-TR
for,O
approximately,O
six,O
weeks,O
following,O
discharge,O
and,O
then,O
subsequently,O
on,O
antibiotic,B-TR
regimen,I-TR
for,O
chronic,B-TR
suppression,I-TR
.,O

RYNA,O
DAU,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

NISTE,O
MA,O
RHALT,O
",",O
M.D.,O

TR,O
:,O

oq,O

DD,O
:,O

09/13/1998,O

TD,O
:,O

09/13/1998,O
7:18,O
A,O

cc,O
:,O

KEND,O
N,O
BOTH,O
",",O
M.D.,O
CARDIAC,O
FELLOWS,O
ROOM,O
LOLI,O
MEMORIAL,O
MEDICAL,O
CENTER,O
NACO,O
MESPRHALT,O
",",O
M.D.,O
INFECTIOUS,O
DISEASE,O
UNIT,O
CIL,O
HOSPITAL,O
RYNA,O
R,O
DAU,O
",",O
M.D.,O
SURGICAL,O
RESIDENT,O
SURG,O
AG,O
NISTE,O
MA,O
RHALT,O
",",O
M.D.,O
SURGERY,O
BROTROJEUNECOCK,O
HEALTH,O
CHPO,O
E,O
ENLA,O
GENERAL,O
",",O
M.D.,O
SURGERY,O
ON,O
HOSPITAL,O
STAT,O
EDITED,O
09/15/1998,O
RJ,O

Admission,O
Date,O
:,O

2016-05-10,O

Discharge,O
Date,O
:,O

2016-05-16,O

Date,O
of,O
Birth,O
:,O

1985-06-12,O

Sex,O
:,O

F,O

Service,O
:,O

MEDICINE,B-TR

Allergies,O
:,O

Zosyn,B-TR

Attending,O
:,O

Gayle,O
M,O
Whitener,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Transfer,O
from,O
Tewksbury,O
State,O
Hospital,O
Hospital,O
CMED,O
CCU,O
for,O
neurologic,B-PR
compromise,I-PR
",",O
at,O
request,O
of,O
family,O
for,O
second,O
opinion,O
.,O

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

None,O

History,O
of,O
Present,O
Illness,O
:,O

30-year-old,O
woman,O
with,O
metastatic,B-PR
squamous,I-PR
cell,I-PR
carcinoma,I-PR
of,O
unknown,O
primary,O
.,O

At,O
ChelseaWomens,O
',O
",",O
about,O
04-25,O
",",O
she,O
developed,O
pseudomonal,B-PR
urosepsis,I-PR
and,O
vaginal,B-PR
bleeding,I-PR
from,O
tumor,B-PR
extension/anti-coagulation,I-PR
.,O

She,O
was,O
transfered,O
to,O
AttleboroHospital,O
after,O
an,O
arrest,O
.,O

Her,O
course,O
was,O
complicated,O
by,O
post-hypotensive,B-PR
coma,I-PR
as,O
well,O
as,O
subarachnoid,B-PR
hemorrhages,I-PR
and,O
intraparenchymal,B-PR
bleeds,I-PR
.,O

Neurologists,O
at,O
RIH,O
felt,O
she,O
had,O
a,O
poor,O
prognosis,O
",",O
but,O
communication,O
between,O
the,O
medical,O
team,O
and,O
family,O
was,O
strained,O
and,O
transfer,O
was,O
arranged,O
to,O
Mediplex,O
Rehab,O
Hospital,O
for,O
a,O
second,O
opinion,O
.,O

Her,O
outside,O
course,O
in,O
more,O
detail:,O

Patient,O
transferred,O
from,O
Women,O
and,O
Infants,O
Hospital,O
to,O
RI,O
Hospital,O
2016-04-25,O
with,O
weaknes,B-PR
",",O
vag,B-PR
bleeding,I-PR
x,O
several,O
days,O
",",O
fever,B-PR
102.5,O
",",O
hypotension,B-PR
",",O
hypoxic,B-PR
84%,O
on,O
4L,B-TR
NC,I-TR
",",O
tachypnic,B-PR
to,O
30,O
",",O
with,O
labs,B-TE
significant,O
for,O
lactate,B-TE
6.3,O
",",O
wbc,B-TE
<1.0,O
",",O
plt,B-TE
9,O
",",O
hgb,B-TE
8.9,O
",",O
and,O
INR,B-TE
greater,O
than,O
lab,O
threshold,O
.,O

Intubated,B-TR
for,O
airway,B-TR
protection,I-TR
(,O
ABG,B-TE
7.39/26.5/73.6,O
),O
and,O
placed,O
on,O
levophed,B-TR
.,O

.,O

Placed,O
on,O
Reynolds/vanc/fluc/gentamicin,B-TR
for,O
neutropenic,B-PR
fever,I-PR
and,O
thrush,B-PR
initially,O
.,O

IVC,B-TR
filter,I-TR
placed,O
04-26,O
.,O

CT,B-TE
abdomen,I-TE
consistent,O
with,O
large,B-PR
necrotic,I-PR
pelvic,I-PR
mass,I-PR
-,O
not,O
sampled,O
02-12,O
coagulopathy,B-PR
.,O

04-27,O
results,O
from,O
Blood,B-TE
Cx,I-TE
from,O
W+I,O
:,O

04-24,O
PICC,B-TE
Bld,I-TE
Cx,I-TE
:,O
pseudomonas,B-PR
Diaz,O
to,O
zosyn,B-TR
",",O
cipro,B-TR
",",O
cefepime,B-TR
",",O
Tardugno,O
--,O
staph,B-PR
epi-,I-PR
Gray,O
to,O
vanc,B-TR

04-24,O
Peripheral,B-TE
Bld,I-TE
Cx,I-TE
:,O
pseudomonas,B-PR
as,O
above,O

04-24,O
Urine,B-TE
Cx,I-TE
:,O
pseudomonas,B-PR
as,O
above,O

Abx,B-TR
changed,O
to,O
vanc,B-TR
",",O
zosyn,B-TR
",",O
cipro,B-TR
",",O
fluc,B-TR
",",O
azith,B-TR
.,O

Pressors,B-TR
weaned,O
off,O
by,O
04-27,O
.,O

Completed,O
7,O
days,O
of,O
vanc/fluc,B-TR
",",O
13/14,O
days,O
of,O
cipro/zosyn,B-TR
.,O

Continued,O
to,O
have,O
recurrent,B-PR
fevers,I-PR
.,O

.,O

Seen,O
by,O
Urology,O
who,O
did,O
not,O
change,O
stents,B-TR
given,O
severe,B-PR
coagulopathy,I-PR
and,O
worsening,B-PR
renal,I-PR
function,I-PR
.,O

Found,O
to,O
be,O
in,O
DIC,B-PR
and,O
supported,O
with,O
daily,B-TR
blood,I-TR
products,I-TR
.,O

Seen,O
by,O
heme,O
and,O
GCSF,B-TR
started,O
.,O

Despite,O
aggressive,B-TR
blood,I-TR
product,I-TR
repletion,I-TR
patient,O
poorly,B-PR
responsive,I-PR
02-12,O
alloimmunization,B-PR
.,O

Plt,B-TE
count,I-TE
1,O
on,O
2016-04-29,O
.,O

Supported,O
on,O
TPN,B-TR
for,O
nutrition,O
then,O
switched,O
to,O
tube,B-TR
feeds,I-TR
.,O

Developed,O
renal,B-PR
failure,I-PR
with,O
Cr,B-TE
peak,I-TE
of,O
2.9.,O

Seen,O
by,O
renal,O
who,O
felt,O
was,O
c/w,O
ATN,B-PR
.,O

.,O

Head,B-TE
CT,I-TE
done,O
05-04,O
with,O
bilateral,B-PR
SAH,I-PR
and,O
L,B-PR
temporal,I-PR
parenchymal,I-PR
hematoma,I-PR
.,O

Also,O
with,O
multiple,B-PR
masses,I-PR
consistent,O
with,O
metastasis,B-PR
.,O

Placed,O
on,O
Dilantin,B-TR
.,O

Neurosurgery,O
consulted,O
.,O

Felt,O
secondary,O
to,O
low,B-PR
platelets,I-PR
with,O
no,O
surgical,B-TR
intervention,I-TR
indicated,O
.,O

.,O

Mult,O
family,O
meetings,O
given,O
poor,O
prognosis,O
.,O

Initially,O
decided,O
not,O
to,O
escilate,O
care,O
and,O
make,O
DNR,O
05-05,O
.,O

Then,O
progressed,O
to,O
withdrawal,O
of,O
care,O
05-06,O
with,O
plan,O
to,O
extubate,B-TR
05-07,O
.,O

However,O
there,O
was,O
dissent,O
among,O
neurologists,O
about,O
patient,O
's,O
ability,O
to,O
recover,O
from,O
the,B-PR
SAH,I-PR
while,O
awaiting,O
family,O
members,O
and,O
the,O
patient,O
was,O
changed,O
to,O
full,O
code,O
.,O

Given,O
48,O
hours,O
off,O
sedation,B-TR
with,O
out,O
change,B-PR
in,I-PR
mental,I-PR
status,I-PR
(,O
last,O
morphine,B-TR
was,O
2016-05-07,O
),O
.,O

Transferred,O
to,O
Mediplex,O
Rehab,O
Hospital,O
for,O
further,O
work,O
up,O
.,O

.,O

On,O
arrival,O
to,O
the,O
FICU,O
the,O
patient,O
was,O
intubated,B-TR
and,O
non-sedated,O
.,O

Past,O
Medical,O
History,O
:,O

12-15,O
",",O
s/p,O
XRT,B-TR
(,O
last,O
tx,O
2015-04-20,O
),O
",",O
s/p,O
cisplatin,B-TR
(,O
last,O
dose,O
3/22,O
),O

-,O
L,B-PR
hydroureter,I-PR
obstruction,I-PR
",",O
s/p,O
R,B-TR
ureteral,I-TR
stent,I-TR
2016-03-24,O

-,O
laser,B-TR
conization,I-TR
of,I-TR
cervix,I-TR
2004,O

Social,O
History,O
:,O

Lives,O
with,O
husband,O
and,O
4,O
y.o.,O
son,O
.,O

Family,O
History,O
:,O

Non-contributory,O

Physical,O
Exam,O
:,O

VS,B-TE
-,O
Tm,B-TE
101.7,O

Tc,B-TE
99.7,O
P,B-TE
123,O
BP,B-TE
137/75,O

Resp,O
-,O
PCV,B-TE
Pinsp,I-TE
26,O
R,B-TE
16,O
FiO2,B-TE
50%,O
Rate,B-TE
8,O
",",O
breathing,B-TE
20,O
",",O
Sat,B-TE
100%,O

Gen,O
-,O
lying,O
in,O
bed,O
unresponsive,B-PR

HEENT,O
-,O
OP,O
clear,O
",",O
PERRL,O

Neck,O
-,O
supple,O

Cor,O
-,O
RRR,O

Chest,O
-,O
diffuse,B-PR
ronchi,I-PR

Abd,O
-,O
Mass,B-PR
in,I-PR
LLQ,I-PR
",",O
nephrostomy,B-TR
with,O
yellow,O
clear,O
output,O

Ext,O
-,O
diffuse,B-PR
anasarca,I-PR
x,O
4,O
ext,O

Neuro,O
-,O
PERRL,O
",",O
corneal,O
reflex,O
",",O
gag,O
reflex,O
",",O
Dolls,B-PR
eyes,I-PR
",",O
spont,O
mvt,O
of,O
head,O
with,O
out,O
purpose,O
side,O
to,O
side,O

Pertinent,O
Results,O
:,O

2016-05-10,O
11:02PM,O

PT,B-TE
-,O
14.6*,O
PTT,B-TE
-,O
29.1,O
INR,B-TE
(,I-TE
PT,I-TE
),I-TE
-,O
1.3*,O

2016-05-10,O
11:02PM,O

PLT,B-TE
SMR,I-TE
-,O
LOW,B-PR
PLT,I-PR
COUNT,I-PR
-,O
86*,O

2016-05-10,O
11:02PM,O

WBC,B-TE
-,O
3.7*,O
RBC,B-TE
-,O
2.78*,O
HGB,B-TE
-,O
8.6,O
*,O
HCT,B-TE
-,O
25.8*,O
MCV,B-TE
-,O
93,O

MCH,B-TE
-,O
31.1,O
MCHC,B-TE
-,O
33.5,O
RDW,B-TE
-,O
14.9,O

2016-05-10,O
11:02PM,O

CALCIUM,B-TE
-,O
7.1*,O
PHOSPHATE,B-TE
-,O
5.1*,O
MAGNESIUM,B-TE
-,O
1.7,O

2016-05-10,O
11:02PM,O

ALT,B-TE
(,I-TE
SGPT,I-TE
),I-TE
-,O
23,O
AST,B-TE
(,I-TE
SGOT,I-TE
),I-TE
-,O
19,O
ALK,B-TE
PHOS,I-TE
-,O
101,O

2016-05-10,O
11:02PM,O

estGFR,B-TE
-,O
Using,O
this,O

2016-05-10,O
11:02PM,O

GLUCOSE,B-TE
-,O
96,O
UREA,B-TE
N,I-TE
-,O
113*,O
CREAT,B-TE
-,O
2.3*,O
SODIUM,B-TE
-,O
150*,O

POTASSIUM,B-TE
-,O
3.9,O
CHLORIDE,B-TE
-,O
110*,O
TOTAL,B-TE
CO2,I-TE
-,O
28,O
ANION,B-TE
GAP,I-TE
-,O
16,O

2016-05-15,O
06:02AM,O
BLOOD,B-TE

WBC,B-TE
-,O
9.5,O
RBC,B-TE
-,O
2.78*,O
Hgb,B-TE
-,O
8.8*,O
Hct,B-TE
-,O
25.7*,O

MCV,B-TE
-,O
93,O
MCH,B-TE
-,O
31.7,O
MCHC,B-TE
-,O
34.2,O
RDW,B-TE
-,O
14.6,O
Plt,B-TE
Ct,I-TE
-,O
26*,O

2016-05-11,O
04:30AM,O
BLOOD,B-TE

Neuts,B-TE
-,O
80.4*,O
Bands,B-TE
-,O
9.3*,O
Lymphs,B-TE
-,O
4.1*,O

Monos,B-TE
-,O
3.1,O
Eos,B-TE
-,O
1.0,O
Baso,B-TE
-,O
0,O
Atyps,B-TE
-,O
1.0*,O
Metas,B-TE
-,O
1.0*,O

2016-05-15,O
06:02AM,O
BLOOD,B-TE

Fibrino,B-TE
-,O
406*,O

2016-05-15,O
06:02AM,O
BLOOD,B-TE

Glucose,B-TE
-,O
120*,O
UreaN,B-TE
-,O
79*,O
Creat,B-TE
-,O
1.8*,O
Na,B-TE
-,O
144,O

K,B-TE
-,O
3.6,O
Cl,B-TE
-,O
110*,O
HCO3,B-TE
-,O
23,O
AnGap,B-TE
-,O
15,O

2016-05-11,O
04:30AM,O
BLOOD,B-TE

ALT,B-TE
-,O
19,O
AST,B-TE
-,O
18,O
LD,B-TE
(,I-TE
LDH,I-TE
),I-TE
-,O
313*,O
AlkPhos,B-TE
-,O
104,O

Amylase,B-TE
-,O
37,O
TotBili,B-TE
-,O
0.8,O

2016-05-15,O
06:02AM,O
BLOOD,O

Calcium,B-TE
-,O
7.4*,O
Phos,B-TE
-,O
3.6,O
Mg,B-TE
-,O
2.2,O

2016-05-11,O
04:30AM,O
BLOOD,B-TE

Albumin,B-TE
-,O
2.3,O

2016-05-13,O
08:32AM,O
BLOOD,B-TE

Type,O
-,O
ART,B-TE
Temp,I-TE
-,O
38.2,O
Tidal,B-TE
V,I-TE
-,O
500,O
PEEP,B-TE
-,O
5,O

FiO2,B-TE
-,O
40,O
pO2,B-TE
-,O
104,O
pCO2,B-TE
-,O
50*,O
pH,B-TE
-,O
7.36,O
calTCO2,B-TE
-,O
29,O
Base,B-TE
XS,I-TE
-,O
1,O

2016-05-11,O
02:08AM,O
BLOOD,B-TE

Lactate,B-TE
-,O
1.6,O

.,O

2016-05-11,O
MRI,B-TE
head:,I-TE

FINDINGS,O
:,O

The,B-TE
sagittal,I-TE
T1,I-TE
images,I-TE
demonstrate,O
several,O
areas,O
of,O
high,B-PR
signal,I-PR
along,I-PR
the,I-PR
sulci,I-PR
bilaterally,I-PR
which,O
could,O
be,O
secondary,O
to,O
subarachnoid,B-PR
hemorrhages,I-PR
.,O

There,O
are,O
several,O
areas,O
of,O
hyperintensities,B-PR
at,I-PR
the,I-PR
convexity,I-PR
which,O
could,O
be,O
intraaxial,O
and,O
could,O
be,O
related,O
to,O
hemorrhage,B-PR
within,I-PR
the,I-PR
metastatic,I-PR
lesions,I-PR
but,O
in,O
absence,O
of,O
gradient,B-TE
echo,I-TE
images,I-TE
",",O
this,O
could,O
not,O
be,O
further,O
confirmed,O
.,O

A,B-TE
CT,I-TE
would,O
help,O
for,O
further,O
assessment,O
if,O
indicated,O
.,O

There,O
is,O
increased,B-PR
signal,I-PR
seen,O
in,O
both,O
basal,O
ganglia,O
region,O
as,O
well,O
as,O
along,O
the,O
rolandic,O
region,O
bilaterally,O
which,O
is,O
suggestive,O
of,O
global,B-PR
hypoxic,I-PR
injury,I-PR
to,I-PR
the,I-PR
brain,I-PR
.,O

There,O
are,O
several,O
areas,O
of,O
brain,B-PR
edema,I-PR
identified,O
in,O
the,O
left,O
frontal,O
and,O
parietal,O
lobe,O
and,O
both,O
temporal,O
lobes,O
",",O
which,O
are,O
suspicious,O
for,O
areas,B-PR
of,I-PR
metastatic,I-PR
disease,I-PR
with,O
surrounding,B-PR
edema,I-PR
.,O

There,O
is,O
no,O
hydrocephalus,B-PR
or,O
midline,B-PR
shift,I-PR
seen,O
.,O

No,O
herniation,B-PR
is,O
identified,O
.,O

Images,B-TE
through,I-TE
the,I-TE
skull,I-TE
base,I-TE
demonstrate,O
soft,B-PR
tissue,I-PR
changes,I-PR
in,I-PR
the,I-PR
sphenoid,I-PR
sinus,I-PR
which,O
could,O
be,O
due,O
to,O
retained,B-PR
secretions,I-PR
from,O
intubation,B-TR
.,O

There,O
is,O
increased,B-PR
signal,I-PR
seen,O
along,O
the,O
sulci,O
on,O
FLAIR,B-TE
images,I-TE
at,O
the,O
convexity,O
which,O
could,O
be,O
secondary,O
to,O
subarachnoid,B-PR
hemorrhage,I-PR
.,O

A,B-TE
CT,I-TE
would,O
help,O
for,O
further,O
assessment,O
and,O
exclude,O
proteinaceous,B-PR
material,I-PR
within,I-PR
the,I-PR
sulci,I-PR
.,O

Gadolinium-enhanced,B-TE
MRI,I-TE
would,O
also,O
help,O
for,O
further,O
assessment,O
.,O

.,O

pCXR,B-TE
2016-05-11,O
5:01am:,O

FINDINGS,O
:,O

No,O
prior,O
comparisons,O
.,O

Tip,O
of,O
the,B-TR
ETT,I-TR
projects,O
roughly,O
5,O
cm,O
above,O
the,O
carina,O
.,O

A,B-TR
right,I-TR
IJ,I-TR
central,I-TR
venous,I-TR
line,I-TR
is,O
at,O
the,O
level,O
of,O
the,O
mid,O
SVC,O
.,O

Tip,O
of,O
the,B-TR
NGT,I-TR
is,O
below,O
the,O
edge,O
of,O
the,O
image,O
.,O

IVC,B-TR
filter,I-TR
and,O
probable,O
NU,B-TR
stent,I-TR
catheter,I-TR
on,I-TR
the,I-TR
left,I-TR
also,O
noted,O
.,O

Heart,O
and,O
mediastinum,O
are,O
unremarkable,O
allowing,O
for,O
technique,O
",",O
no,O
sizeable,B-PR
pneumothorax,I-PR
.,O

There,O
is,O
a,B-PR
somewhat,I-PR
wedge-shaped,I-PR
opacity,I-PR
at,I-PR
the,I-PR
right,I-PR
lung,I-PR
base,I-PR
which,O
could,O
represent,O
aspiration,B-PR
or,O
pneumonia,B-PR
.,O

No,O
other,B-PR
confluent,I-PR
infiltrates,I-PR
are,O
appreciated,O

.,O

pCXR,B-TE
2016-05-11.,O
1:46pm:,O

1.,O
Mild,B-PR
pulmonary,I-PR
edema,I-PR
.,O

2.,O
Vague,B-PR
right,I-PR
lower,I-PR
lobe,I-PR
opacity,I-PR
most,O
likely,O
represents,O
pulmonary,B-PR
edema,I-PR
though,O
if,O
opacity,B-PR
persistent,O
after,O
diuresis,B-TR
",",O
aspiration,B-PR
and,O
pneumonia,B-PR
will,O
become,O
considerations,O
.,O

3.,O
ETT,B-TR
4,O
cm,O
above,O
the,O
carina,O
with,O
NG,B-TR
tube,I-TR
advancement,O
into,O
the,O
stomach,O
.,O

.,O

EEG,B-TE
2016-05-12:,O

Abnormal,B-PR
portable,I-PR
EEG,I-PR
due,O
to,O
the,B-PR
slow,I-PR
and,I-PR
disorganized,I-PR
background,I-PR
and,O
bursts,B-PR
of,I-PR
generalized,I-PR
slowing,I-PR
.,O

These,O
findings,O
indicate,O
a,B-PR
widespread,I-PR
encephalopathy,I-PR
.,O

Medications,B-TR
",",O
metabolic,B-PR
disturbances,I-PR
",",O
and,O
infection,B-PR
are,O
among,O
the,O
most,O
common,O
causes,O
.,O

Subarachnoid,B-PR
hemorrhage,I-PR
is,O
another,O
possible,O
explanation,O
.,O

There,O
were,O
no,O
areas,O
of,O
prominent,B-PR
focal,I-PR
slowing,I-PR
",",O
and,O
there,O
were,O
no,O
epileptiform,B-PR
features,I-PR

.,O

Trans-thoracic,B-TE
echocardiogram,I-TE
2016-05-12,O
:,O

The,O
left,O
atrium,O
is,O
normal,O
in,O
size,O
.,O

Left,O
ventricular,O
wall,O
thickness,O
",",O
cavity,O
size,O
",",O
and,O
systolic,O
function,O
are,O
normal,O
(,O
LVEF>55%,B-TE
),O
.,O

Regional,O
left,O
ventricular,O
wall,O
motion,O
is,O
normal,O
.,O

Right,O
ventricular,O
chamber,O
size,O
and,O
free,O
wall,O
motion,O
are,O
normal,O
.,O

The,O
aortic,O
valve,O
leaflets,O
(,O
3,O
),O
appear,O
structurally,O
normal,O
with,O
good,O
leaflet,O
excursion,O
and,O
no,O
aortic,B-PR
regurgitation,I-PR
.,O

The,O
mitral,O
valve,O
appears,O
structurally,O
normal,O
with,O
trivial,B-PR
mitral,I-PR
regurgitation,I-PR
.,O

There,O
is,O
no,O
mitral,B-PR
valve,I-PR
prolapse,I-PR
.,O

The,B-TE
pulmonary,I-TE
artery,I-TE
systolic,I-TE
pressure,I-TE
could,O
not,O
be,O
determined,O
.,O

There,O
is,O
no,O
pericardial,B-PR
effusion,I-PR
.,O

IMPRESSION,O
:,O

Normal,O
global,O
and,O
regional,O
biventricular,O
systolic,O
function,O
.,O

No,O
pericardial,B-PR
effusion,I-PR
.,O

.,O

pCXR,B-TE
2016-05-13,O
:,O

Mild,B-PR
left,I-PR
lower,I-PR
perihilar,I-PR
opacification,I-PR
has,O
improved,O
",",O
probably,O
resolving,B-PR
edema,I-PR
.,O

There,O
is,O
more,B-PR
rightward,I-PR
mediastinal,I-PR
shift,I-PR
",",O
suggesting,O
new,B-PR
atelectasis,I-PR
in,I-PR
the,I-PR
right,I-PR
lung,I-PR
.,O

Enlargement,B-PR
of,I-PR
the,I-PR
right,I-PR
hilus,I-PR
could,O
represent,O
adenopathy,B-PR
.,O

Whether,O
to,O
pursue,O
this,O
would,O
depend,O
upon,O
clinical,O
circumstances,O
.,O

Heart,O
size,O
normal,O
.,O

ET,B-TR
tube,I-TR
in,O
standard,O
placement,O
.,O

Nasogastric,B-TR
tube,I-TR
passes,O
below,O
the,O
diaphragm,O
and,O
out,O
of,O
view,O
.,O

No,O
appreciable,B-PR
pneumothorax,I-PR
or,O
pleural,B-PR
effusions,I-PR

.,O

pCXR,B-TE
2016-05-14,O
:,O

Increasing,B-PR
opacification,I-PR
of,I-PR
the,I-PR
lungs,I-PR
could,O
be,O
due,O
to,O
mild,B-PR
pulmonary,I-PR
edema,I-PR
and,O
multiple,B-PR
micrometastases,I-PR
",",O
worsened,O
slightly,O
since,O
05-13,O
at,O
10:57,O
p.m.,O

Heart,O
size,O
is,O
normal,O
.,O

There,O
is,O
no,O
pleural,B-PR
effusion,I-PR
.,O

The,B-TR
ET,I-TR
tube,I-TR
and,O
right,B-TR
PICC,I-TR
line,I-TR
in,O
standard,O
placements,O
.,O

Nasogastric,B-TR
tube,I-TR
passes,O
below,O
the,O
diaphragm,O
and,O
out,O
of,O
view,O
.,O

No,O
pneumothorax,B-PR
.,O

.,O

Microbiology,O
:,O

05-11-,O
Blood,B-TE
cultures,I-TE
:,O
no,O
growth,B-PR
to,O
date,O
on,O
2/2,O
bottles,O

05-12-,O
Blood,B-TE
cultures,I-TE
:,O
no,O
growth,B-PR
to,O
date,O
on,O
6/6,O
bottles,O

05-14-,O
Blood,B-TE
cultures,I-TE
:,O
no,O
growth,B-PR
to,O
date,O
on,O
4/4,O
bottles,O

.,O

05-11-,O
Urine,B-TE
culture,I-TE
:,O
no,O
growth,B-PR
(,O
final,O
),O

05-12-,O
Urine,B-TE
culture,I-TE
:,O
no,O
growth,B-PR
(,O
final,O
),O

05-14-,O
Urine,B-TE
culture,I-TE
:,O
no,O
growth,B-PR
to,O
date,O

.,O

05-11-,O
Stool,B-TE
:,O
negative,O
for,O
Cdiff,B-PR
toxin,I-PR

05-12-,O
Stool,B-TE
:,O
negative,O
for,O
Cdiff,B-PR
toxin,I-PR

.,O

05-12-,O
Swab,B-TE
from,O
Nephrostomy,B-TR
:,O

GRAM,B-TE
STAIN,I-TE
(,O
Final,O
2016-05-12,O
),O
:,O

NO,O
POLYMORPHONUCLEAR,B-PR
LEUKOCYTES,I-PR
SEEN,O
.,O

NO,O
MICROORGANISMS,B-PR
SEEN,O
.,O

WOUND,B-TE
CULTURE,I-TE
(,O
Preliminary,O
),O
:,O

Due,O
to,O
mixed,B-PR
bacterial,I-PR
types,I-PR
(,O

STAPHYLOCOCCUS,B-PR
",",I-PR
COAGULASE,I-PR
NEGATIVE,O
.,O

RARE,B-PR
GROWTH,I-PR
.,O

CORYNEBACTERIUM,B-PR
SPECIES,I-PR
(,I-PR
DIPHTHEROIDS,I-PR
),I-PR
.,O

SPARSE,B-PR
GROWTH,I-PR
.,O

PSEUDOMONAS,B-PR
AERUGINOSA,I-PR
.,O

RARE,B-PR
GROWTH,I-PR
.,O

SENSITIVITIES,O
:,O

MIC,O
expressed,O
in,O

MCG/ML,O

_________________________________________________________,O

PSEUDOMONAS,B-PR
AERUGINOSA,I-PR

|,O

.,O

05-12-,O
Sputum,O
:,O

Source,O
:,O

Endotracheal,O
.,O

GRAM,B-TE
STAIN,I-TE
(,O
Final,O
2016-05-12,O
),O
:,O

11-03,O
PMNs,B-TE
and,O
<10,O
epithelial,O
cells/100X,O
field,O
.,O

NO,O
MICROORGANISMS,B-PR
SEEN,O
.,O

RESPIRATORY,B-TE
CULTURE,I-TE
(,O
Final,O
2016-05-14,O
),O
:,O

NO,O
GROWTH,B-PR
.,O

FUNGAL,B-TE
CULTURE,I-TE
(,O
Preliminary,O
),O
:,O

NO,O
FUNGUS,B-PR
ISOLATED,O
.,O

NOCARDIA,B-TE
CULTURE,I-TE
(,O
Preliminary,O
),O
:,O

NO,O
NOCARDIA,B-PR
ISOLATED,O
.,O

.,O

05-14-,O
Sputum,O
:,O

Source,O
Endotracheal,O
.,O

GRAM,B-TE
STAIN,I-TE
(,O
Final,O
2016-05-14,O
),O
:,O

>25,O
PMNs,B-TE
and,O
<10,O
epithelial,O
cells/100X,O
field,O
.,O

1+,O
(,O
<1,O
per,O
1000X,O
FIELD,O
),O
:,O

GRAM,B-PR
POSITIVE,I-PR
COCCI,I-PR
.,O

IN,O
PAIRS,O
AND,O
CLUSTERS,O
.,O

1+,O
(,O
<1,O
per,O
1000X,O
FIELD,O
),O
:,O

YEAST(,B-PR
S,I-PR
),I-PR
.,O

.,O

05-14-,O
Catheter,B-TR
tip,I-TR
(,I-TR
IV,I-TR
):,I-TR

WOUND,B-TE
CULTURE,I-TE
(,O
Final,O
2016-05-15,O
),O
:,O

No,O
significant,B-PR
growth,I-PR

Brief,O
Hospital,O
Course,O
:,O

30,O
yo,O
F,O
with,O
metastatic,B-PR
squamous,I-PR
cell,I-PR
carcinoma,I-PR
of,O
unknown,O
primary,O
who,O
presented,O
to,O
OSH,O
04-25,O
with,O
pseudomonal,B-PR
urosepsis,I-PR
",",O
vaginal,B-PR
bleeding,I-PR
from,O
tumor,B-PR
extension/anti-coagulation,I-PR
.,O

Course,O
complicated,O
by,O
sub,B-PR
arachnoid,I-PR
hemorrhages,I-PR
and,O
intraparenchymal,B-PR
bleeds,I-PR
as,O
well,O
as,O
potential,O
hypotensive,B-PR
brain,I-PR
injury,I-PR
with,O
poor,O
prognosis,O
per,O
neurology,O
.,O

Transferred,O
here,O
for,O
second,O
opinion,O
on,O
poor,O
prognosis,O
.,O

.,O

#,O
Neurologic,O
-,O
The,O
patient,O
was,O
seen,O
by,O
the,O
Neurology,O
consult,O
service,O
and,O
underwent,O
MRI,B-TE
head,I-TE
which,O
revealed,O
lesions,B-PR
suspicious,O
for,O
metastases,B-PR
",",O
possible,O
hemorrhages,B-PR
",",O
and,O
findings,O
consistent,O
with,O
hypoxic,B-PR
brain,I-PR
injury,I-PR
.,O

EEG,B-TE
was,O
performed,O
and,O
revealed,O
encephalopathy,B-PR
.,O

The,B-TE
patient,I-TE
's,I-TE
neurologic,I-TE
exam,I-TE
(,O
performed,O
after,O
sedation,B-TR
removed,O
>48,O
hours,O
),O
revealed,O
intact,O
brainstem,O
function,O
without,O
evidence,O
of,O
higher,O
cortical,O
activity,O
.,O

She,O
had,O
some,B-PR
metabolic,I-PR
abnormalities,I-PR
which,O
were,O
corrected,O
(,O
hypernatremia,B-PR
",",O
hyperphosphatemia,B-PR
),O
",",O
but,O
neurologic,B-TE
exam,I-TE
was,O
unchanged,O
.,O

A,O
family,O
meeting,O
on,O
2016-05-13,O
was,O
held,O
and,O
these,O
findings,O
communicated,O
with,O
the,O
patient,O
's,O
family,O
.,O

Final,B-TE
neurologic,I-TE
assessment,I-TE
was,O
that,O
the,O
patient,O
was,O
unlikely,O
to,O
regain,O
meaningful,O
neurologic,O
functioning,O
.,O

At,O
the,O
request,O
of,O
her,O
family,O
",",O
she,O
will,O
be,O
transferred,O
closer,O
to,O
her,O
home,O
in,O
Wyoming,O
",",O
to,O
Women,O
and,O

Infants,O
hospital,O
.,O

.,O

#,O
Respiratory,B-PR
Failure,I-PR
-,O
Pt,O
arrived,O
on,O
pressure,B-TR
support,I-TR
ventilation,I-TR
",",O
which,O
was,O
changed,O
to,O
Assist,B-TR
control,I-TR
to,O
make,O
patient,O
more,O
comfortable,O
.,O

She,O
was,O
originally,O
intubated,B-TR
for,O
airway,B-TR
protection,I-TR
",",O
and,O
it,O
is,O
felt,O
she,O
could,O
likely,O
be,O
weaned,O
from,O
the,B-TR
ventilator,I-TR
although,O
she,O
would,O
be,O
extremely,O
high,O
risk,O
for,O
aspiration,B-PR
.,O

Due,O
to,O
family,O
request,O
to,O
move,O
patient,O
to,O
a,O
hospital,O
closer,O
to,O
home,O
",",O
she,O
will,O
remain,O
intubated,B-TR
until,O
transfer,O
",",O
with,O
plan,O
to,O
extubate,B-TR
upon,O
arrival,O
to,O
Women,O
and,O
Infants,O
hospital,O
with,O
initiation,O
of,O
full,B-TR
palliative,I-TR
care,I-TR
and,O
compliance,O
of,O
DNI,O
status,O
.,O

.,O

#,O
Fevers/Infection,B-PR
-,O
Per,O
outside,O
hospital,O
records,O
",",O
the,O
patient,O
grew,O
pseudomonas,B-PR
from,O
blood,O
and,O
urine,O
.,O

At,O
OSH,O
",",O
she,O
was,O
treated,O
with,O
7,O
days,O
of,O
vancomycin,B-TR
",",O
as,O
well,O
as,O
13,O
days,O
(,O
of,O
14-day,O
planned,O
course,O
),O
of,O
Ciprofloxacin,B-TR
and,O
Zosyn,B-TR
.,O

She,O
was,O
intially,O
continued,O
on,O
Cipro/Zosyn,B-TR
.,O

CXR,B-TE
05-11,O
revealed,O
?,O
pneumonia,B-PR
vs,O
atelectasis,B-PR
at,I-PR
the,I-PR
R,I-PR
lung,I-PR
base,I-PR
.,O

Continues,O
to,O
spike,O
fever,B-PR
.,O

Could,O
have,O
still,O
seeding,O
of,O
nephrostomy,B-TR
tube,I-TR
.,O

Urology,O
at,O
OSH,O
against,O
pulling,O
tube,B-TR
because,O
coagulopathy,B-PR
and,O
may,O
not,O
be,O
able,O
to,O
replace,O
.,O

Fevers,B-PR
also,O
may,O
be,O
from,O
head,B-PR
bleed,I-PR
",",O
cancer,B-PR
",",O
or,O
drug,B-TR
.,O

She,O
was,O
continued,O
on,O
zosyn,B-TR
and,O
vancomycin,B-TR
to,O
complete,O
a,O
>14,O
day,O
course,O
.,O

She,O
continued,O
to,O
have,O
fevers,B-PR
.,O

Antibiotics,B-TR
were,O
discontinued,O
on,O
05-15,O
.,O

No,O
further,B-PR
infectious,I-PR
course,I-PR
was,O
identified,O
and,O
the,B-PR
fevers,I-PR
may,O
have,O
been,O
due,O
to,O
underlying,B-PR
malignant,I-PR
process,I-PR
.,O

.,O

#,O
Squamous,B-PR
Cell,I-PR
Cancer,I-PR
-,O
unknown,O
primary,O
.,O

The,O
patient,O
was,O
seen,O
by,O
the,O
oncology,O
consult,O
service,O
who,O
contacted,O
her,O
outside,O
hematologist,O
Dr.,O
Pauling,O
.,O

Upon,O
discussion,O
with,O
him,O
it,O
was,O
noted,O
that,O
the,O
patient,O
had,O
progression,O
of,O
her,B-PR
disease,I-PR
after,O
systemic,B-TR
therapy,I-TR
with,O
topotecan,B-TR
and,O
cisplatin,B-TR
.,O

She,O
then,O
proceed,O
to,O
XRT,B-TR
with,O
cisplatin,B-TR
which,O
she,O
was,O
unable,O
to,O
tolerate,O
this,O
secondary,O
to,O
thrombocytopenia,B-PR
(,O
40-50K,O
),O
.,O

Given,O
this,O
we,O
were,O
unable,O
to,O
offer,O
her,O
additional,B-TR
therapy.,I-TR
Hematology/Oncology,O
service,O
at,O
Mediplex,O
Rehab,O
Hospital,O
confirmed,O
her,O
grim,O
prognosis,O
and,O
expective,O
survival,O
in,O
terms,O
of,O
weeks,O
to,O
months,O
with,O
no,O
further,B-TR
available,I-TR
treatment,I-TR
.,O

.,O

#,O
h/o,O
DVT,B-PR
-,O
patient,O
with,O
head,B-PR
bleed,I-PR
which,O
is,O
contraindication,O
to,O
anti-coagulation,B-TR
.,O

IVC,B-TR
filter,I-TR
in,O
place,O
.,O

Patient,O
was,O
on,O
pneumoboots,B-TR
while,O
in,O
hospital,O
.,O

.,O

#,O
Hypernatremia,B-PR
-,O
Improved,O
from,O
OSH,O
.,O

Total,B-PR
body,I-PR
volume,I-PR
overloaded,I-PR
.,O

Water,O
Deficit,O
2.5,O
L,O
.,O

She,O
was,O
continued,O
on,O
free,B-TR
H20,I-TR
boluses,I-TR
and,O
D5,B-TR
1/2,I-TR
NS,I-TR
and,O
corrected,O
.,O

.,O

#,O
Acute,B-PR
Renal,I-PR
Failure,I-PR
-,O
stable,O
",",O
likely,O
02-12,O
hypotension,B-PR
leading,O
to,O
ATN,B-PR
that,O
is,O
slowly,O
improving,O
.,O

.,O

#,O
Access,O
-,O
R,B-TR
IJ,I-TR
changed,O
sterilly,O
over,O
wire,B-TR
05-01,O

.,O

#,O
FEN,O
-,O
tube,B-TR
feeds,I-TR
are,O
held,O
in,O
route,O
in,O
anticipation,O
of,O
extubation,O
.,O

.,O

.,O

#,O
Code,O
Status,O
:,O

After,O
multiple,O
discussion,O
with,O
family,O
and,O
the,O
doctor,O
accepting,O
the,O
patient,O
at,O
Women,O
and,O
Infants,O
Hospital(,O

She,O
was,O
made,O
DNR/DNI,O
and,O
the,O
plan,O
is,O
that,O
she,O
will,O
be,O
transferred,O
to,O
WIH,O
and,O
extubated,B-TR
there,O
upon,O
arrival,O
with,O
initiation,O
of,O
full,B-TR
palliative,I-TR
care,I-TR
.,O

The,O
family,O
understood,O
this;,O
all,O
questions,O
were,O
answered,O
and,O
they,O
wished,O
to,O
proceed,O
.,O

They,O
understand,O
that,O
there,O
is,O
no,O
ICU,O
at,O
WIH,O
and,O
no,O
further,O
advanced,B-TR
pulmonary,I-TR
support,I-TR
can,O
be,O
offered,O
.,O

Discharge,O
Medications,O
:,O

1.,O
Acetaminophen,B-TR
325,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
for,O
fever,B-PR
or,O
pain,B-PR
.,O

2.,O
Albuterol-Ipratropium,B-TR
103-18,O
mcg/Actuation,O
Aerosol,O
Sig,O
:,O
06-17,O
Puffs,O
Inhalation,O
Q2-4H,O
(,O
every,O
2,O
to,O
4,O
hours,O
),O
as,O
needed,O
.,O

3.,O
Calcium,B-TR
Acetate,I-TR
667,O
mg,O
Capsule,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Capsule,O
PO,O
TID,O
W/MEALS,O
(,O
3,O
TIMES,O
A,O
DAY,O
WITH,O
MEALS,O
),O
.,O

4.,O
Fentanyl,B-TR
Citrate,I-TR
(,O
PF,O
),O
0.05,O
mg/mL,O
Solution,O
Sig,O
:,O
25-100,O
mcg,O
Injection,O
Q2H,O
(,O
every,O
2,O
hours,O
),O
as,O
needed,O
for,O
comfort,O
.,O

5.,O
Insulin,B-TR
Regular,I-TR
Human,I-TR
100,O
unit/mL,O
Solution,O
Sig,O
:,O
2-10,O
units,O
Injection,O
ASDIR,O
(,O
AS,O
DIRECTED,O
),O
:,O
per,O
sliding,B-TR
scale,I-TR
for,O
blood,B-TE
sugars,I-TE
>,O
150mg/dl,O
.,O

6.,O
Midazolam,B-TR
1,O
mg/mL,O
Solution,O
Sig,O
:,O
1-2,O
mg,O
Injection,O
Q2H,O
(,O
every,O
2,O
hours,O
),O
as,O
needed,O
for,O
comfort,O
.,O

7.,O
Phenytoin,B-TR
Sodium,I-TR
50,O
mg/mL,O
Solution,O
Sig,O
:,O
One,O
95y,O
(,O
150,O
),O
mg,O
Intravenous,O
Q8H,O
(,O
every,O
8,O
hours,O
),O
.,O

8.,O
Ranitidine,B-TR
HCl,O
15,O
mg/mL,O
Syrup,O
Sig,O
:,O
One,O
95y,O
(,O
150,O
),O
mg,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

9.,O
Polyvinyl,B-TR
Alcohol-Povidone,I-TR
1.4-0.6,O
%,O
Dropperette,O
Sig,O
:,O
01-12,O
Drops,O
Ophthalmic,O
QID,O
(,O
4,O
times,O
a,O
day,O
),O
.,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Discharge,O
Diagnosis,O
:,O

1.,O
Hypoxic,B-PR
brain,I-PR
injury,I-PR

2.,O
Cranial,B-PR
hemorrages,I-PR
(,I-PR
sub,I-PR
arachnoid,I-PR
and,I-PR
parenchemal,I-PR
),I-PR

3.,O
Pseudomonal,B-PR
sepsis,I-PR
",",O
completed,O
antibiotic,B-TR
course,I-TR

4.,O
Metastatic,B-PR
Squamous,I-PR
cell,I-PR
carcinoma,I-PR
of,O
unknown,O
primary,O
.,O

5.,O
Thrombocytopenia,B-PR

6.,O
Blood,B-PR
loss,I-PR
anemia,I-PR

Discharge,O
Condition,O
:,O

Intubated,B-TR
",",O
stable,O

Discharge,O
Instructions,O
:,O

You,O
are,O
being,O
transferred,O
to,O
another,O
hospital,O
",",O
intubated,B-TR
",",O
with,O
the,O
plan,O
to,O
extubate,B-TR
upon,O
arrival,O
to,O
Women,O
's,O
and,O
Infants,O
hosptial,O
and,O
initiation,O
of,O
palliative,B-TR
care,I-TR
.,O

.,O

Your,B-TR
antibiotics,I-TR
were,O
stopped,O
2016-05-15,O
(,O
Vancomycin,B-TR
1000mg,O
q24,O
and,O
Aztreonam,B-TR
1000mg,O
q8,O
),O
as,O
your,O
micorbiology,B-TE
data,I-TE
has,O
been,O
negative,O
and,O
your,O
course,O
for,O
pseudomonal,B-PR
sepsis,I-PR
has,O
been,O
completed,O
.,O

If,O
you,O
continue,O
to,O
have,O
fevers,B-PR
",",O
blood,B-TE
cultures,I-TE
should,O
be,O
repeated,O
.,O

Followup,O
Instructions,O
:,O

As,O
directed,O
.,O

Jacque,O
John,O
MD,O
40-836,O

Completed,O
by,O
:,O

Marcy,O
Caroline,O
Latham,O
MD,O
51-251,O
2016-05-31,O
@,O
1628,O

Signed,O
electronically,O
by,O
:,O

DR.,O
Richard,O
Ronald,O
Lockett,O
on,O
:,O

MON,O
2016-08-01,O
3:08,O
PM,O

(,O
End,O
of,O
Report,O
),O

099147779,O
WGH,O

2346613,O

367017,O

2170984,O

11/17/2004,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Report,O
Status,O
:,O

Signed,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

BRENOCE,O
",",O
T,O
N,O

UNIT,O
NUMBER,O
:,O

254-05-39,O

ADMISSION,O
DATE,O
:,O

11/17/2004,O

DISCHARGE,O
DATE,O
:,O

11/26/2004,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Pneumonia,B-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

1.,O
Pill,B-PR
esophagitis,I-PR
.,O

2.,O
Right,B-PR
ventricular,I-PR
hypokinesis,I-PR
.,O

OPERATIONS,O
/,O
PROCEDURES,O
:,O

Dobutamine,B-TE
stress,I-TE
test,I-TE
",",O
cardiac,B-TE
ultrasound,I-TE
",",O
EGD,B-TE
",",O
chest,B-TE
x-ray,I-TE
",",O
PICC,B-TR
placement,I-TR
.,O

The,O
patient,O
is,O
a,O
62-year-old,O
female,O
with,O
a,O
history,O
of,O
diabetes,B-PR
mellitus,I-PR
",",O
hypertension,B-PR
",",O
COPD,B-PR
",",O
hypercholesterolemia,B-PR
",",O
depression,B-PR
and,O
CHF,B-PR
who,O
was,O
lying,O
in,O
bed,O
on,O
the,O
night,O
prior,O
to,O
admission,O
when,O
she,O
developed,O
left-sided,B-PR
chest,I-PR
pain,I-PR
located,O
in,O
the,O
mid-breast,O
region,O
with,O
some,B-PR
fluttering,I-PR
her,I-PR
chest,I-PR
.,O

The,O
patient,O
radiated,O
down,O
her,O
left,O
arm,O
associated,O
with,O
some,B-PR
nausea,I-PR
",",O
no,O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
cough,B-PR
",",O
vomiting,B-PR
",",O
diarrhea,B-PR
.,O

She,O
slept,O
through,O
the,O
night,O
",",O
woke,O
with,O
persistent,B-PR
pain,I-PR
.,O

She,O
went,O
with,O
her,O
sister,O
&apos;s,O
husband,O
to,O
La,O
Community,O
Hospital,O
where,O
she,O
was,O
given,O
sublingual,B-TR
nitroglycerin,I-TR
with,O
complete,O
relief,O
of,O
pain,B-PR
.,O

She,O
refused,O
ambulance,O
to,O
the,O
Emergency,O
Room,O
and,O
was,O
driven,O
to,O
Well,O
General,O
Hospital,O
Emergency,O
Room,O
by,O
her,O
sister,O
.,O

She,O
arrived,O
pain,B-PR
free,O
.,O

She,O
was,O
given,O
Aspirin,B-TR
",",O
Lopressor,B-TR
and,O
Insulin,B-TR
for,O
hyperglycemia,B-PR
.,O

EKG,B-TE
was,O
unchanged,O
compared,O
to,O
the,B-TE
prior,I-TE
EKG,I-TE
several,O
months,O
ago,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Insulin-dependent,B-PR
diabetes,I-PR
mellitus,I-PR
",",O
hypertension,B-PR
",",O
depression,B-PR
",",O
back,B-PR
pain,I-PR
",",O
COPD,B-PR
",",O
allergic,B-PR
rhinitis,I-PR
",",O
GERD,B-PR
",",O
obesity,B-PR
",",O
hyperlipidemia,B-PR
.,O

ALLERGIES,O
:,O

Codeine,B-TR
",",O
reaction,O
unknown,O
.,O

MEDICATIONS,O
:,O

Atrovent,B-TR
.,O

Aspirin,B-TR
.,O

Flonase,B-TR
.,O

Quinine,B-TR
Celebrex,B-TR
.,O

Compazine,B-TR
.,O

Oxybutynin,B-TR
Amitriptyline,B-TR
.,O

Zyrtec,B-TR
.,O

Prozac,B-TR
.,O

Trazodone,B-TR
.,O

Humulin,B-TR
70,O
units,O
bid,O
.,O

Albuterol,B-TR
.,O

Lasix,B-TR
40,O
PO,O
bid,O
.,O

Triamcinolone,B-TR
cream,I-TR
.,O

Miconazole,B-TR
cream,I-TR
Flovent,B-TR
.,O

Nifedipine,B-TR
ER,I-TR
60,O
daily,O
.,O

Lisinopril,B-TR
",",O
30,O
daily,O
.,O

KCl,B-TR
10,O
mEq,O
q,O
day,O
.,O

Protonix,B-TR
",",O
40,O
daily,O
.,O

Lipitor,B-TR
",",O
20,O
daily,O
.,O

Methadone,B-TR
10,O
bid,O
.,O

FAMILY,O
HISTORY,O
:,O

Non-contributory,O
.,O

HABITS,O
:,O

Tobacco,O
:,O

Quit,O
20,O
years,O
ago,O
.,O

Alcohol,O
:,O

Rare,O
drinks,O
per,O
week,O
.,O

SOCIAL,O
HISTORY,O
:,O

Lives,O
along,O
",",O
takes,O
care,O
of,O
herself,O
.,O

Retired,O
.,O

Used,O
to,O
work,O
in,O
fast,O
food,O
.,O

VITAL,O
SIGNS,O
:,O

On,O
admission,O
blood,B-TE
pressure,I-TE
165/70,O
.,O

temperature,B-TE
99.8,O
",",O
pulse,B-TE
86,O
",",O
respiratory,B-TE
rate,I-TE
18,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Obese,B-PR
",",O
no,O
acute,B-PR
distress,I-PR
.,O

Multiple,O
tattoos,O
.,O

Skin,O
normal,O
.,O

HEENT,O
",",O
ears,O
poor,B-PR
hearing,I-PR
.,O

Extraocular,O
movements,O
intact,O
.,O

Moist,O
mucous,O
membranes,O
.,O

No,O
lymphadenopathy,B-PR
.,O

Chest,O
",",O
lungs,O
clear,O
to,O
auscultation,B-TE
with,O
faint,B-PR
wheezes,I-PR
",",O
no,O
rales,B-PR
.,O

Cardiac,O
",",O
normal,O
S1,O
",",O
S2,O
",",O
no,O
murmurs,B-PR
",",O
rubs,B-PR
or,O
gallops,B-PR
.,O

Abdomen,O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
.,O

Positive,O
bowel,O
sounds,O
.,O

Neurologic,O
:,O

Alert,O
and,O
oriented,O
x3,O
.,O

Cranial,O
nerves,O
II,O
through,O
XII,O
intact,O
.,O

Motor,O
and,O
sensory,O
intact,O
.,O

Extremities,O
:,O

Feet,O
no,O
edema,B-PR
.,O

Pulses,O
2+,B-TE
PT,I-TE
and,O
DP,B-TE
.,O

LABORATORY,O
:,O

Unremarkable,O
with,O
normal,O
electrolytes,O
except,O
for,O
glucose,B-TE
of,O
328,O
.,O

CBC,B-TE
",",O
white,B-TE
count,I-TE
6.7,O
",",O
hematocrit,B-TE
37.4,O
",",O
platelets,B-TE
280,O
.,O

Chest,B-TE
x-ray,I-TE
was,O
low,B-PR
lung,I-PR
volumes,I-PR
",",O
no,O
consolidation,B-PR
.,O

EKG,B-TE
showed,O
sinus,B-PR
brady,I-PR
at,O
16,O
",",O
normal,O
axis,O
",",O
normal,O
intervals,O
",",O
no,O
STT,B-PR
wave,I-PR
abnormalities,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
Team,O
Four,O
for,O
cardiac,O
monitoring,O
and,O
ruling,O
out,O
for,O
MI,B-PR
.,O

Hospital,O
course,O
by,O
system,O
:,O

1.,O
Cardiovascular,O
:,O

The,O
patient,O
ruled,O
out,O
for,O
MI,B-PR
by,O
cardiac,B-TE
markers,I-TE
.,O

The,O
patient,O
was,O
set,O
to,O
go,O
for,O
a,B-TE
dobutamine,I-TE
stress,I-TE
test,I-TE
on,O
11/16/04,O
given,O
her,O
history,O
of,O
COPD,B-PR
",",O
but,O
the,B-TE
stress,I-TE
portion,I-TE
was,O
canceled,O
when,O
she,O
was,O
down,O
there,O
due,O
to,O
fever,B-PR
and,O
hypotension,B-PR
.,O

The,O
next,O
day,O
",",O
she,O
underwent,O
a,B-TE
cardiac,I-TE
echo,I-TE
(,I-TE
transthoracic,I-TE
echocardiogram,I-TE
),I-TE
.,O

This,B-TE
echo,I-TE
showed,O
LV,B-TE
ejection,I-TE
fraction,I-TE
of,O
50%,O
with,O
no,O
wall,B-PR
motion,I-PR
abnormality,I-PR
.,O

However,O
",",O
the,O
right,O
ventricular,O
was,O
diffusely,B-PR
hypokinetic,I-PR
.,O

It,O
was,O
suboptimally,O
imaged,O
",",O
so,O
there,O
was,O
no,O
RVSP,B-TE
given,O
.,O

The,O
patient,O
also,O
suffered,O
a,B-PR
hypotensive,I-PR
episode,I-PR
while,O
in,O
the,O
endoscopy,O
suite,O
for,O
her,B-TE
EGD,I-TE
on,O
11/17/04,O
.,O

This,O
responded,O
to,O
fluid,B-TR
bolus,I-TR
.,O

The,O
patient,O
was,O
then,O
transferred,O
to,O
Medicine,O
Team,O
D,O
given,O
her,B-PR
tenuous,I-PR
hemodynamic,I-PR
status,I-PR
.,O

The,O
patient,O
",",O
several,O
days,O
later,O
11/23,O
",",O
underwent,O
another,B-TE
dobutamine,I-TE
stress,I-TE
test,I-TE
.,O

This,B-TE
stress,I-TE
test,I-TE
",",O
although,O
complicated,O
by,O
hypotension,B-PR
again,O
",",O
to,O
the,O
60,O
&apos;s,O
or,O
70,O
&apos;s,O
was,O
completed,O
and,O
there,O
was,O
some,B-PR
mild,I-PR
anterior,I-PR
septal,I-PR
thinning,I-PR
",",O
but,O
no,O
evidence,O
of,O
ischemia,B-PR
and,O
an,B-TE
EF,I-TE
from,O
this,B-TE
test,I-TE
was,O
76%,O
.,O

Clearly,O
",",O
the,O
patient,O
&apos;s,O
hemodynamic,O
vascular,O
status,O
was,O
very,O
sensitive,O
to,O
dobutamine,B-TR
.,O

2.,O
Infectious,O
Disease,O
:,O

On,O
hospital,O
day,O
#2,O
",",O
the,O
patient,O
was,O
noted,O
to,O
have,O
increased,B-PR
dyspnea,I-PR
on,O
exertion,O
.,O

The,O
next,O
day,O
she,O
developed,O
a,B-PR
fever,I-PR
and,O
she,O
was,O
started,O
on,O
levofloxacin,B-TR
for,O
a,O
potential,O
UTI,B-PR
.,O

She,O
continued,O
to,O
have,O
low-grade,B-PR
fevers,I-PR
and,O
on,O
the,O
next,O
day,O
",",O
11/17/04,O
",",O
her,B-TE
chest,I-TE
x-ray,I-TE
showed,O
possible,O
new,B-PR
right,I-PR
upper,I-PR
lobe,I-PR
infiltrates,I-PR
.,O

She,O
was,O
then,O
started,O
on,O
ceftriaxone,B-TR
and,O
azithromycin,B-TR
.,O

Her,B-TE
urine,I-TE
legionella,I-TE
antigen,I-TE
was,O
negative,O
.,O

On,O
11/22/04,O
",",O
she,O
was,O
noted,O
to,O
have,O
gram-positive,B-PR
cocci,I-PR
in,O
her,O
sputum,O
.,O

She,O
was,O
started,O
on,O
vancomycin,B-TR
for,O
this,O
.,O

These,B-PR
bacteria,I-PR
turned,O
out,O
to,O
be,O
MRSA,B-PR
and,O
she,O
was,O
continued,O
on,O
her,B-TR
vancomycin,I-TR
.,O

She,O
had,O
PICC,B-TR
line,I-TR
placed,O
on,O
the,O
day,O
prior,O
to,O
discharge,O
for,O
home,B-TR
vancomycin,I-TR
administration,I-TR
.,O

3.,O
GI,O
:,O

The,O
patient,O
had,O
an,O
episode,O
of,O
nausea,B-PR
on,O
the,O
morning,O
of,O
11/16/04,O
associated,O
with,O
some,B-PR
cough,I-PR
",",O
apparent,B-PR
emesis,I-PR
.,O

GI,O
was,O
consulted,O
for,O
an,B-TE
EGD,I-TE
",",O
however,O
",",O
while,O
she,O
was,O
in,O
the,O
Endoscopy,O
Suite,O
",",O
as,O
mentioned,O
above,O
",",O
she,O
had,O
a,B-PR
hypotensive,I-PR
episode,I-PR
",",O
which,O
responded,O
to,O
some,B-TR
fluid,I-TR
boluses,I-TR
.,O

Finally,O
",",O
on,O
the,O
day,O
prior,O
to,O
discharge,O
",",O
she,O
was,O
stabilized,O
to,O
the,O
point,O
that,O
she,O
could,O
have,O
her,B-TE
EGD,I-TE
.,O

The,B-TE
EGD,I-TE
did,O
show,O
three,B-PR
esophageal,I-PR
ulcers,I-PR
that,O
were,O
localized,O
and,O
apparent,O
suggestion,O
of,O
pill,B-PR
esophagitis,I-PR
.,O

Her,O
stomach,O
and,O
duodenum,O
were,O
normal,O
and,O
it,O
was,O
suggested,O
that,O
she,O
change,O
her,B-TR
Nexium,I-TR
doses,I-TR
to,O
daily,O
and,O
that,O
she,O
also,O
drink,O
plenty,O
of,O
fluids,O
and,O
water,O
with,O
meals,O
",",O
sit,O
upright,O
when,O
she,O
would,O
eat,O
her,O
meals,O
to,O
decrease,O
the,O
chance,O
of,O
pills,B-TR
eroding,O
her,O
esophagus,O
.,O

4.,O
Shortness,B-PR
of,I-PR
breath,I-PR
:,O

As,O
mentioned,O
above,O
",",O
the,O
patient,O
did,O
develop,O
MRSA,B-PR
pneumonia,I-PR
that,O
was,O
started,O
to,O
be,O
treated,O
with,O
vancomycin,B-TR
and,O
she,O
did,O
also,O
develop,O
an,B-PR
oxygen,I-PR
requirement,I-PR
the,O
day,O
prior,O
to,O
discharge,O
.,O

At,O
most,O
",",O
her,B-PR
oxygen,I-PR
requirement,I-PR
was,O
4-5,O
liters,O
and,O
on,O
the,O
day,O
prior,O
to,O
discharge,O
",",O
she,O
was,O
satting,O
well,O
on,O
two,O
liters,O
of,O
nasal,B-TR
cannula,I-TR
.,O

This,O
was,O
thought,O
to,O
be,O
due,O
to,O
her,B-PR
pneumonia,I-PR
;,O
however,O
",",O
with,O
her,B-PR
right,I-PR
ventricular,I-PR
hypokinesis,I-PR
",",O
it,O
is,O
also,O
possible,O
that,O
she,O
may,O
have,O
an,O
element,O
of,O
pulmonary,B-PR
hypertension,I-PR
and,O
may,O
warrant,O
further,O
investigation,O
as,O
an,O
outpatient,O
",",O
for,O
example,O
",",O
with,O
chest,B-TE
CT,I-TE
.,O

5.,O
Derm,O
:,O

Several,O
days,O
prior,O
to,O
discharge,O
",",O
the,O
patient,O
developed,O
some,B-PR
erythematous,I-PR
rash,I-PR
under,O
her,O
left,O
breast,O
and,O
left,O
side,O
that,O
was,O
thought,O
to,O
be,O
due,O
to,O
yeast,B-PR
.,O

She,O
was,O
started,O
on,O
some,B-TR
Miconazole,I-TR
Cream,I-TR
.,O

The,B-PR
rash,I-PR
was,O
always,O
localized,O
to,O
her,O
left,O
side,O
",",O
sometimes,O
extending,O
down,O
to,O
her,O
leg,O
",",O
but,O
never,O
on,O
the,O
right,O
side,O
.,O

The,B-PR
rash,I-PR
appeared,O
to,O
be,O
resolving,O
by,O
the,O
time,O
of,O
discharge,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Tums,B-TR
",",O
500-1250,O
mg,O
PO,O
tid,O
.,O

Albuterol,B-TR
inhaler,I-TR
.,O

Lipitor,B-TR
",",O
20,O
daily,O
.,O

Prozac,B-TR
",",O
60,O
daily,O
.,O

Flovent,B-TR
inhaler,I-TR
",",O
220,O
mcg,O
bid,O
.,O

Atrovent,B-TR
",",O
two,O
puffs,O
qid,O
.,O

Ditropan,B-TR
",",O
5,O
mg,O
tid,O
.,O

Colace,B-TR
",",O
100,O
mg,O
tid,O
.,O

Aspirin,B-TR
",",O
325,O
mg,O
daily,O
.,O

Insulin,B-TR
NPH,I-TR
",",O
36,O
subcu,O
q,O
AM,O
",",O
30,O
subcu,O
q,O
PM,O
.,O

Nystatin,B-TR
Mouthwash,I-TR
Swish,O
and,O
Swallow,O
.,O

Nexium,B-TR
",",O
20,O
mg,O
PO,O
daily,O
.,O

Vancomycin,B-TR
1,O
gm,O
IV,O
q12h,O
.,O

The,O
patient,O
will,O
follow-up,O
with,O
her,O
primary,O
care,O
provider,O
",",O
Dr.,O
Na,O
Fongbain,O
at,O
the,O
Cord,O
Memorial,O
Hospital,O
.,O

IEVE,O
MANUAL,O
",",O
MD,O

DICTATING,O
FOR,O
:,O

Electronically,O
Signed,O
IEVE,O
MANUAL,O
",",O
MD,O
12/23/2004,O
11:19,O

_____________________________,O
IEVE,O
MANUAL,O
",",O
MD,O

TR,O
:,O

mm,O

DD,O
:,O

11/25/2004,O

TD,O
:,O

11/25/2004,O
8:49,O
P,O
367017,O

cc,O
:,O

IEVE,O
MANUAL,O
",",O
MD,O

Admission,O
Date,O
:,O

2011-06-14,O

Discharge,O
Date,O
:,O

2011-06-18,O

Date,O
of,O
Birth,O
:,O

1939-11-27,O

Sex,O
:,O

F,O

Service,O
:,O

FICU,O

CHIEF,O
COMPLAINT,O
:,O

Shortness,B-PR
of,I-PR
breath,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
71-year-old-female,O
with,O
asthma,B-PR
and,O
a,O
history,O
of,O
recent,B-PR
exacerbation,I-PR
of,O
lower,B-PR
extremity,I-PR
edema,I-PR
who,O
",",O
at,O
her,O
baseline,O
",",O
gets,O
short,B-PR
of,I-PR
breath,I-PR
walking,O
across,O
the,O
room,O
and,O
sleeps,O
on,O
four,O
pillows,O
times,O
several,O
years,O
.,O

She,O
has,O
reported,O
that,O
she,O
has,O
had,O
upper,B-PR
respiratory,I-PR
symptoms,I-PR
times,O
several,O
days,O
with,O
increasing,B-PR
dyspnea,I-PR
on,O
exertion,O
and,O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
eventually,O
at,O
rest,O
with,O
marked,B-PR
wheezing,I-PR
.,O

She,O
also,O
has,O
a,B-PR
cough,I-PR
with,O
a,O
small,O
amount,O
of,O
white,B-PR
sputum,I-PR
.,O

At,O
3,O
a.m.,O
on,O
the,O
day,O
of,O
admission,O
",",O
she,O
became,O
much,O
worse,O
and,O
after,O
several,O
days,O
of,O
increasing,O
her,B-TR
meter-dosed,I-TR
inhaler,I-TR
use,O
",",O
she,O
call,O
Emergency,O
Medical,O
Services,O
which,O
assessed,O
her,O
as,O
having,O
heart,B-PR
failure,I-PR
with,O
elevated,B-PR
jugular,I-PR
venous,I-PR
distention,I-PR
and,O
rales,B-PR
.,O

She,O
received,O
aspirin,B-TR
",",O
Lasix,B-TR
40,O
mg,O
intravenously,O
times,O
two,O
",",O
0.8,O
mg,O
of,O
nitroglycerin,B-TR
times,O
four,O
",",O
plus,O
morphine,B-TR
sulfate,I-TR
.,O

Her,B-TE
blood,I-TE
pressure,I-TE
was,O
noted,O
to,O
be,O
up,O
to,O
220/110,O
.,O

She,O
was,O
taken,O
to,O
the,O
The,O
Hospital,O
for,O
Orthopedics,O
Emergency,O
Room,O
where,O
she,O
was,O
assessed,O
as,O
having,O
asthma,B-PR
.,O

She,O
then,O
received,O
continuous,B-TR
nebulizer,I-TR
treatments,I-TR
for,O
approximately,O
eight,O
hours,O
with,O
minimal,O
improvement,O
.,O

She,O
did,O
receive,O
intravenous,B-TR
nitroglycerin,I-TR
in,O
the,O
Emergency,O
Room,O
for,O
blood,O
pressure,O
controlled,O
to,O
the,O
170s,O
.,O

She,O
initially,O
received,O
a,O
treatment,O
of,O
BiPAP,B-TR
on,O
arrival,O
as,O
she,O
was,O
barely,O
able,O
to,O
speak,O
.,O

She,O
also,O
received,O
80,B-TR
mg,I-TR
of,I-TR
Solu-Medrol,I-TR
in,O
the,O
Emergency,O
Department,O
.,O

She,O
was,O
never,O
hypoxic,B-PR
but,O
initially,O
her,B-TE
arterial,I-TE
blood,I-TE
gas,I-TE
showed,O
a,B-PR
respiratory,I-PR
acidosis,I-PR
with,O
a,B-TE
PCO2,I-TE
of,O
71,O
.,O

The,O
patient,O
does,O
have,O
a,O
vague,O
history,O
of,O
chronic,B-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
",",O
but,O
this,O
is,O
felt,O
to,O
be,O
inaccurate,O
.,O

She,O
also,O
received,O
captopril,B-TR
12.5,O
mg,O
times,O
one,O
.,O

Recently,O
",",O
the,O
patient,O
has,O
been,O
treated,O
with,O
several,B-TR
steroid,I-TR
tapers,I-TR
.,O

Depending,O
on,O
the,O
family,O
",",O
patient,O
",",O
and,O
the,O
OMR,O
records,O
",",O
the,O
exact,O
duration,O
of,O
the,O
most,O
recent,O
one,O
was,O
unclear,O
.,O

It,O
either,O
ended,O
in,O
2011-04-11,O
or,O
continued,O
through,O
2011-05-11,O
with,O
use,O
of,O
Augmentin,B-TR
;,O
and,O
",",O
by,O
report,O
",",O
lasted,O
until,O
06-07,O
.,O

However,O
",",O
the,O
family,O
said,O
the,O
patient,O
has,O
been,O
on,O
steroids,B-TR
for,O
several,O
weeks,O
.,O

The,O
patient,O
denies,O
any,O
exposure,O
to,O
smoke,O
",",O
animals,O
",",O
unusual,O
dust,O
or,O
vapors,O
",",O
or,O
other,O
asthma,O
triggers,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Asthma,B-PR
as,O
a,O
child,O
which,O
recurred,O
in,O
2001,O
.,O

She,O
takes,O
an,B-TR
albuterol,I-TR
and,O
Atrovent,B-TR
inhalers,I-TR
as,O
well,O
as,O
Serevent,B-TR
and,O
Flovent,B-TR
.,O

She,O
has,O
had,O
multiple,O
hospitalizations,O
and,O
has,O
never,O
been,O
intubated,B-TR
.,O

She,O
has,O
had,O
multiple,B-TR
prednisone,I-TR
tapers,I-TR
(,O
see,O
History,O
of,O
Present,O
Illness,O
),O
.,O

On,O
prednisone,B-TR
or,O
sometime,O
after,O
it,O
was,O
discontinued,O
",",O
depending,O
on,O
the,O
version,O
",",O
the,O
patient,O
developed,O
worsening,B-PR
lower,I-PR
extremity,I-PR
edema,I-PR
which,O
has,O
been,O
a,B-PR
Vega,I-PR
problem,I-PR
for,O
her,O
and,O
was,O
started,O
on,O
dyazide,B-TR
as,O
an,O
outpatient,O
.,O

Pulmonary,B-TE
function,I-TE
tests,I-TE
most,O
recently,O
in,O
2009-01-10,O
were,O
not,O
obstructive,O
.,O

They,O
showed,O
an,B-TE
FVC,I-TE
of,O
91%,O
of,O
predicted,O
",",O
and,O
a,B-TE
FEV1,I-TE
of,O
104%,O
of,O
predicted,O
",",O
with,O
a,B-TE
ratio,I-TE
of,O
114%,O
.,O

In,O
2003,O
",",O
there,O
was,O
19%,O
change,O
of,O
the,O
FEV1,O
and,O
an,O
11%,O
change,O
in,O
the,O
FVC,O
with,O
bronchodilators,B-TR
.,O

2.,O
Mild,B-PR
hypertension,I-PR
",",O
especially,O
on,O
prednisone,B-TR
.,O

3.,O
Hypoplastic,B-PR
left,I-PR
lower,I-PR
extremity,I-PR
and,O
hip,B-TR
repair,I-TR
at,O
the,O
age,O
of,O
five,O
.,O

4.,O
Polio,B-PR
.,O

5.,O
Status,O
post,O
cesarean,B-TR
section,I-TR
.,O

6.,O
History,O
of,O
zoster,B-PR
.,O

7.,O
Past,O
Discharge,O
Summary,O
mention,O
a,O
history,O
of,O
chronic,B-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
",",O
but,O
the,O
patient,O
has,O
never,O
smoked,O
.,O

8.,O
Incontinent,B-PR
of,I-PR
both,I-PR
stool,I-PR
and,I-PR
urine,I-PR
.,O

9.,O
Allergic,B-PR
rhinitis,I-PR
.,O

FAMILY,O
HISTORY,O
:,O

Brother,O
and,O
sister,O
both,O
have,O
asthma,B-PR
.,O

Brother,O
has,O
diabetes,B-PR
mellitus,I-PR
.,O

There,O
is,O
no,O
family,O
history,O
of,O
coronary,B-PR
artery,I-PR
disease,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
lives,O
on,O
the,O
first,O
floor,O
of,O
her,O
home,O
with,O
her,O
daughter,O
living,O
upstairs,O
.,O

There,O
are,O
several,O
foster,O
children,O
also,O
in,O
the,O
home,O
that,O
take,O
care,O
of,O
her,O
at,O
times,O
.,O

She,O
has,O
never,O
smoked,O
and,O
does,O
not,O
drink,O
.,O

She,O
does,O
not,O
use,O
drugs,O
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Dyazide,B-TR
25/37.5,O
p.o.,O
q.d.,O
",",O
as,O
well,O
as,O
Atrovent,B-TR
",",O
albuterol,B-TR
",",O
and,O
Flovent,B-TR
inhalers,I-TR
",",O
and,O
Swanson,B-TR
60,O
mg,O
p.o.,O
b.i.d.,O
",",O
and,O
Serevent,B-TR
2,O
puffs,O
q.12h.,O

MEDICATIONS,O
ON,O
TRANSFER,O
:,O

On,O
transfer,O
",",O
she,O
also,O
arrived,O
on,O
200,O
mcg,O
of,O
nitroglycerin,B-TR
and,O
reports,O
p.r.n.,O
Alka-Seltzer,B-TR
",",O
sinus,B-TR
and,O
NyQuil,B-TR
use,O
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

Review,B-TE
of,I-TE
systems,I-TE
were,O
notable,O
for,O
lower,B-PR
extremity,I-PR
edema,I-PR
which,O
worsened,O
in,O
May,O
.,O

She,O
says,O
she,O
has,O
had,O
this,O
intermittently,O
with,O
hot,O
summers,O
in,O
the,O
past,O
.,O

She,O
denies,O
chest,B-PR
pain,I-PR
.,O

She,O
does,O
have,O
chest,B-PR
tightness,I-PR
since,O
two,O
days,O
ago,O
",",O
coinciding,O
with,O
her,B-PR
wheezing,I-PR
.,O

She,O
had,O
paroxysms,B-PR
of,I-PR
cough,I-PR
and,O
shortness,B-PR
of,I-PR
breath,I-PR
which,O
resolves,O
with,O
water,O
and,O
sitting,O
up,O
.,O

This,O
is,O
worse,O
when,O
she,O
has,O
asthma,B-PR
flares,I-PR
.,O

She,O
denies,O
a,B-PR
rash,I-PR
and,O
any,B-PR
genitourinary,I-PR
symptoms,I-PR
.,O

She,O
has,O
had,O
a,B-PR
constant,I-PR
runny,I-PR
nose,I-PR
and,O
has,O
had,O
no,O
sick,O
contacts,O
.,O

PHYSICAL,O
EXAMINATION,O
ON,O
PRESENTATION,O
:,O

Physical,B-TE
examination,I-TE
revealed,O
afebrile,B-PR
",",O
respiratory,B-TE
rate,I-TE
of,O
23,O
",",O
heart,B-TE
rate,I-TE
of,O
113,O
",",O
blood,B-TE
pressure,I-TE
130s/90s,O
.,O

In,O
general,O
",",O
this,O
was,O
a,O
female,O
in,O
moderate,B-PR
distress,I-PR
secondary,O
to,O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
spoke,O
in,O
short,O
phrases,O
and,O
then,O
in,O
complete,O
sentences,O
as,O
the,O
night,O
went,O
on,O
.,O

Head,O
",",O
eyes,O
",",O
ears,O
",",O
nose,O
",",O
and,O
throat,O
revealed,O
oropharynx,O
was,O
moist,O
.,O

There,O
was,O
no,O
jugular,B-PR
venous,I-PR
distention,I-PR
.,O

There,O
was,O
no,O
HDR,B-PR
.,O

Sclerae,O
were,O
anicteric,B-PR
.,O

Cardiovascular,O
revealed,O
she,O
was,O
tachycardic,B-PR
with,O
a,O
regular,O
first,O
heart,O
sound,O
and,O
second,O
heart,O
sound,O
.,O

Pulmonary,O
revealed,O
she,O
had,O
diffuse,B-PR
wheezes,I-PR
.,O

There,O
were,O
no,O
rales,B-PR
.,O

She,O
had,O
reduced,B-PR
but,I-PR
adequate,I-PR
air,I-PR
movement,I-PR
.,O

The,O
abdomen,O
revealed,O
normal,O
active,O
bowel,O
sounds,O
",",O
soft,O
",",O
nontender,B-PR
",",O
obese,B-PR
",",O
and,O
nondistended,B-PR
.,O

Extremities,O
revealed,O
left,O
lower,O
extremity,O
was,O
hypoplastic,B-PR
.,O

There,O
was,O
pitting,B-PR
edema,I-PR
on,I-PR
both,I-PR
sides,I-PR
of,O
the,O
lower,O
extremities,O
.,O

The,O
right,O
ankle,O
was,O
somewhat,B-PR
tender,I-PR
from,O
this,B-PR
edema,I-PR
.,O

Neurologically,O
",",O
the,O
patient,O
was,O
oriented,O
to,O
person,O
",",O
place,O
",",O
and,O
time,O
;,O
however,O
",",O
she,O
was,O
somewhat,B-PR
drowsy,I-PR
and,O
at,O
times,O
was,O
difficult,O
to,O
keep,O
awake,O
during,O
conversations,O
.,O

PERTINENT,O
LABORATORY,O
DATA,O
ON,O
PRESENTATION,O
:,O

White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
was,O
10.2,O
",",O
hematocrit,B-TE
of,O
37.5,O
",",O
platelets,B-TE
of,O
236,O
.,O

INR,B-TE
of,O
1.3,O
",",O
PTT,B-TE
of,O
30.3,O
.,O

Urinalysis,B-TE
revealed,O
6,O
to,O
10,O
red,B-TE
blood,I-TE
cells,I-TE
",",O
0,O
to,O
2,O
white,B-TE
blood,I-TE
cells,I-TE
",",O
4,O
epithelial,B-TE
cells,I-TE
with,O
Foley,B-TR
in,O
place,O
.,O

Urine,B-TE
culture,I-TE
later,O
grew,O
out,O
contaminated,O
specimen,O
.,O

Differential,B-TE
with,O
72,O
polys,B-TE
",",O
16,O
lymphocytes,B-TE
",",O
4.6,O
monocytes,B-TE
",",O
6.3,O
eosinophils,B-TE
.,O

Chem-7,B-TE
was,O
notable,O
for,O
a,B-TE
bicarbonate,I-TE
of,O
31,O
and,O
a,B-TE
glucose,I-TE
of,O
156,O
.,O

Arterial,B-TE
blood,I-TE
gas,I-TE
was,O
7.24/71/227,O
.,O

Creatine,B-TE
kinase,I-TE
was,O
243,O
",",O
with,O
a,B-TE
MB,I-TE
of,O
9,O
",",O
and,O
a,B-TE
troponin,I-TE
of,O
less,O
than,O
0.3.,O

RADIOLOGY/IMAGING,O
:,O

Chest,B-TE
x-ray,I-TE
showed,O
low,B-PR
lung,I-PR
volumes,I-PR
but,O
no,O
evidence,O
of,O
congestive,B-PR
heart,I-PR
failure,I-PR
.,O

Electrocardiogram,B-TE
showed,O
sinus,B-PR
tachycardia,I-PR
at,O
115,O
with,O
a,O
normal,O
axis,O
",",O
intermittent,B-PR
Q,I-PR
wave,I-PR
in,I-PR
III;,I-PR
a,B-PR
wavy,I-PR
baseline,I-PR
.,O

The,O
patient,O
had,O
a,B-TE
stress,I-TE
echocardiogram,I-TE
with,O
a,O
normal,O
ejection,O
fraction,O
in,O
2007,O
.,O

HOSPITAL,O
COURSE,O
BY,O
SYSTEM:,O

1.,O
PULMONARY,O
:,O

She,O
was,O
treated,O
with,O
albuterol,B-TR
and,O
Atrovent,B-TR
continuous,I-TR
nebulizers,I-TR
and,O
was,O
weaned,O
then,O
to,O
intermittent,B-TR
nebulizer,I-TR
treatments,I-TR
and,O
then,O
to,O
her,B-TR
meter-dosed,I-TR
inhalers,I-TR
taking,O
them,O
q.4h.,O
at,O
the,O
time,O
of,O
discharge,O
.,O

She,O
was,O
continued,O
on,O
salmeterol,B-TR
and,O
Flovent,B-TR
.,O

She,O
was,O
continued,O
on,O
Solu-Medrol,B-TR
80,O
mg,O
q.8h.,O
then,O
converted,O
to,O
prednisone,B-TR
at,O
60,O
mg,O
p.o.,O
q.d.,O

She,O
was,O
started,O
on,O
Singulair,B-TR
10,O
mg,O
p.o.,O
q.d.,O

Serial,B-TE
arterial,I-TE
blood,I-TE
gases,I-TE
were,O
followed,O
after,O
an,B-TR
arterial,I-TR
line,I-TR
was,O
placed,O
.,O

Her,B-TE
PCO2,I-TE
gradually,O
declined,O
to,O
the,O
48,O
range,O
.,O

Despite,O
episodes,O
of,O
somnolence,B-PR
the,O
first,O
night,O
which,O
were,O
presumably,O
due,O
to,O
having,O
spent,O
the,O
entire,O
night,O
in,O
the,O
Emergency,O
Department,O
",",O
she,O
never,O
became,O
more,B-PR
hypercarbic,I-PR
",",O
and,O
her,B-TE
PCO2,I-TE
trended,O
to,O
48,O
by,O
the,O
time,O
the,B-TR
arterial,I-TR
line,I-TR
was,O
discontinued,O
.,O

On,O
the,O
night,O
of,O
admission,O
and,O
thereafter,O
",",O
she,O
was,O
noted,O
to,O
have,O
a,B-PR
very,I-PR
stridorous,I-PR
sounding,I-PR
breathing,I-PR
when,O
the,O
patient,O
was,O
asleep,O
.,O

This,O
would,O
disappear,O
whenever,O
she,O
was,O
awake,O
.,O

Her,O
case,O
was,O
discussed,O
with,O
Ear/Nose/Throat,O
and,O
the,O
Medical,O
Intensive,O
Care,O
Unit,O
attending,O
.,O

She,O
was,O
given,O
a,B-TR
trial,I-TR
of,I-TR
80/20,I-TR
mixed,I-TR
helium/oxygen,I-TR
to,O
decrease,O
the,B-PR
stridor,I-PR
but,O
had,O
minimal,O
effect,O
.,O

Ear/Nose/Throat,O
recommended,O
not,O
considering,O
this,O
an,B-PR
airway,I-PR
problem,I-PR
unless,O
she,O
was,O
stridorous,B-PR
while,I-PR
awake,I-PR
.,O

The,O
patient,O
was,O
to,O
arrange,O
for,O
Pulmonary,O
and,O
Medicine,O
followup,O
through,O
her,O
primary,O
care,O
physician,O
upon,O
discharge,O
as,O
she,O
has,O
not,O
been,O
seen,O
in,O
the,O
Pulmonary,O
Clinic,O
in,O
two,O
years,O
.,O

2.,O
CARDIOVASCULAR,O
:,O

The,O
patient,O
ruled,O
out,O
for,O
myocardial,B-PR
infarction,I-PR
with,O
serial,B-TE
creatine,I-TE
kinases,I-TE
",",O
although,O
these,O
did,O
rise,O
to,O
816,O
.,O

MB,B-TE
was,O
negative,O
.,O

She,O
was,O
treated,O
with,O
captopril,B-TR
for,O
hypertension,B-PR
",",O
and,O
this,O
was,O
switched,O
to,O
Norvasc,B-TR
7.5,O
mg,O
p.o.,O
q.d.,O
on,O
discharge,O
.,O

She,O
had,O
an,B-TE
echocardiogram,I-TE
which,O
showed,O
a,B-PR
hyperdynamic,I-PR
left,I-PR
ventricular,I-PR
of,O
normal,O
thickness,O
and,O
size,O
",",O
and,O
no,O
significant,B-PR
valvular,I-PR
disease,I-PR
.,O

She,O
apparently,O
did,O
not,O
have,O
a,O
cardiovascular,O
component,O
to,O
her,B-PR
wheezing,I-PR
or,O
shortness,B-PR
of,I-PR
breath,I-PR
;,O
however,O
",",O
she,O
was,O
to,O
go,O
home,O
on,O
Lasix,B-TR
20,O
mg,O
p.o.,O
q.d.,O
to,O
help,O
with,O
lower,B-PR
extremity,I-PR
edema,I-PR
",",O
as,O
she,O
experiences,O
discomfort,B-PR
with,O
this,O
",",O
and,O
the,O
team,O
felt,O
this,O
may,O
be,O
a,O
limiting,O
factor,O
with,O
her,B-TR
prednisone,I-TR
compliance,I-TR
.,O

3.,O
ENDOCRINE,O
:,O

She,O
was,O
treated,O
with,O
a,B-TR
sliding-scale,I-TR
of,I-TR
regular,I-TR
insulin,I-TR
while,O
she,O
was,O
in,O
house,O
.,O

She,O
was,O
given,O
500,O
mg,O
p.o.,O
q.d.,O
of,O
metformin,B-TR
to,O
treat,O
her,B-PR
steroid-induced,I-PR
diabetes,I-PR
on,O
discharge,O
.,O

This,O
should,O
be,O
followed,O
up,O
by,O
her,O
primary,O
care,O
physician,O
.,O

4.,O
INFECTIOUS,O
DISEASE,O
:,O

She,O
was,O
treated,O
briefly,O
with,O
levofloxacin,B-TR
because,O
of,O
the,B-PR
gram-positive,I-PR
cocci,I-PR
in,O
her,B-TE
sputum,I-TE
culture,I-TE
;,O
however,O
",",O
her,B-PR
symptoms,I-PR
were,O
felt,O
to,O
be,O
consistent,O
with,O
a,B-PR
viral,I-PR
upper,I-PR
respiratory,I-PR
infection,I-PR
",",O
and,O
levofloxacin,B-TR
was,O
continued,O
at,O
the,O
time,O
of,O
discharge,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE:,O

1.,O
Lasix,B-TR
20,O
mg,O
p.o.,O
q.d.,O

2.,O
Combivent,B-TR
meter-dosed,I-TR
inhaler,I-TR
2,O
puffs,O
q.4h.,O
weaning,O
to,O
albuterol,B-TR
meter-dosed,I-TR
inhaler,I-TR
2,O
puffs,O
q.4h.,O

3.,O
Salmeterol,B-TR
2,O
puffs,O
q.12h.,O

4.,O
Flovent,B-TR
220,O
mcg,O
2,O
puffs,O
q.12h.,O

5.,O
Prednisone,B-TR
40,O
mg,O
p.o.,O
q.d.,O
with,O
taper,O
.,O

6.,O
Fentress,B-TR
60,O
mg,O
p.o.,O
b.i.d.,O

7.,O
Singulair,B-TR
10,O
mg,O
p.o.,O
q.d.,O

8.,O
Univasc,B-TR
7.5,O
mg,O
p.o.,O
q.d.,O

9.,O
Metformin,B-TR
500,O
mg,O
p.o.,O
q.d.,O

Dyazide,B-TR
was,O
discontinued,O
.,O

DISCHARGE,O
STATUS,O
:,O

Discharge,O
services,O
included,O
visiting,O
nursing,O
which,O
was,O
to,O
assess,O
in,O
her,O
inhaler,O
technique,O
",",O
monitor,O
her,B-TE
fasting,I-TE
blood,I-TE
sugars,I-TE
",",O
as,O
well,O
as,O
her,B-TE
blood,I-TE
pressure,I-TE
",",O
monitor,O
her,B-TE
peak,I-TE
flows,I-TE
",",O
and,O
assess,O
her,O
mobility,O
and,O
activities,O
of,O
daily,O
living,O
at,O
home,O
.,O

DISCHARGE,O
FOLLOWUP,O
:,O

She,O
was,O
also,O
to,O
seek,O
the,O
next,O
available,O
appointment,O
with,O
Dr.,O
Jeanette,O
Barr,O
or,O
to,O
see,O
another,O
resident,O
in,O
the,O
Saint,O
Vincent,O
Hospital,O
Clinic,O
if,O
she,O
cannot,O
get,O
an,O
appointment,O
within,O
one,O
week,O
.,O

CONDITION,O
AT,O
DISCHARGE,O
:,O

Condition,O
on,O
discharge,O
was,O
good,O
..,O

CODE,O
STATUS,O
:,O

Full,O
code,O
.,O

DISCHARGE,O
DIAGNOSES:,O

1.,O
Asthma,B-PR
flare,I-PR
.,O

2.,O
Hypertension,B-PR
.,O

3.,O
Steroid-induced,B-PR
diabetes,I-PR
.,O

James,O
Z,O
Berg,O
",",O
M.D.,O

19-421,O

Dictated,O
By,O
:,O

Melanie,O
L.W.,O
Palevic,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O

2011-06-18,O

16:33,O

T,O
:,O

2011-06-21,O

15:34,O

JOB#,O
:,O

92012,O

Signed,O
electronically,O
by,O
:,O

DR.,O
Andrea,O
Trotter,O
on,O
:,O

Jose,O
2011-06-23,O
12:09,O
PM,O

(,O
End,O
of,O
Report,O
),O

100007275,O

OMH,O

4153022,O

539937,O

1/4/2001,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O

RHALTDEALBBREUTZ,O
",",O
STA,O

MRN,O
:,O

4153022,O

Age,O
:,O

94y,O

REGISTRATION,O
DATE,O
:,O

01/04/2001,O
07:21,O
PM,O

PRELIMINARY,O
REPORT,O

This,O
is,O
to,O
notify,O
you,O
that,O
your,O
patient,O
",",O
RHALTDEALBBREUTZ,O
",",O
STA,O
arrived,O
in,O
the,O
Emergency,O
Department,O
at,O
Oaksgekesser/,O
Memorial,O
Hospital,O
on,O
01/04/2001,O
07:21,O
PM,O
.,O

The,O
patient,O
presented,O
with,O
a,O
chief,O
complaint,O
of,O
PNEUMONIA,B-PR
.,O

Following,O
evaluation,B-TE
and,O
treatment,B-TR
",",O
the,O
patient,O
&apos;s,O
disposition,O
at,O
the,O
end,O
of,O
the,O
visit,O
was,O
ADMITTED,O
AS,O
AN,O
INPATIENT,O
TO,O
OAKSGEKESSER/,O
MEMORIAL,O
HOSPITAL,O
.,O

Your,O
patient,O
was,O
admitted,O
under,O
the,O
care,O
of,O
TUBBOLM,O
",",O
LISSWHITI,O
N,O
with,O
a,O
preliminary,O
diagnosis,O
of,O
PNEUMONIA,B-PR
.,O

If,O
you,O
need,O
additional,O
information,O
please,O
call,O
598-754-5083,O
.,O

PCP,O
Name,O
:,O

AJESC,O
",",O
DARLMA,O
MARGEA,O
L,O

Provider,O
Number,O
:,O

63669,O

Admission,O
Date,O
:,O

2017-06-28,O

Discharge,O
Date,O
:,O

2017-07-02,O

Date,O
of,O
Birth,O
:,O

1977-06-19,O

Sex,O
:,O

F,O

Service,O
:,O

CMED,O
CCU,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

A,O
40-year-old,O
female,O
with,O
history,O
of,O
non-ST-elevation,B-PR
myocardial,I-PR
infarction,I-PR
in,O
2016-09-30,O
with,O
stent,B-TR
to,I-TR
the,I-TR
LAD,I-TR
and,O
50%,O
to,O
the,O
mid,O
LAD,O
",",O
had,O
instent,B-PR
restenosis,I-PR
in,O
2017-04-02,O
and,O
then,O
underwent,O
brachytherapy,B-TR
to,I-TR
the,I-TR
RCA,I-TR
",",O
who,O
presented,O
to,O
Baldpate,O
Hospital,O
with,O
several,O
weeks,O
of,O
chest,B-PR
pain,I-PR
similar,O
to,O
her,B-PR
anginal,I-PR
equivalent,I-PR
and,O
MI,B-PR
in,O
the,O
past,O
.,O

It,O
started,O
at,O
rest,O
.,O

No,O
relief,O
with,O
nitroglycerin,B-TR
x3,O
.,O

Radiates,O
to,O
the,O
left,O
arm,O
.,O

Positive,O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

Troponins,B-TE
have,O
been,O
less,O
than,O
0.01.,O

With,O
history,O
",",O
will,O
go,O
for,O
cardiac,B-TE
catheterization,I-TE
evaluation,I-TE
.,O

Still,O
getting,O
chest,B-PR
pain,I-PR
intermittently,O
",",O
but,O
relieved,O
by,O
morphine,B-TR
sulfate,I-TR
.,O

Was,O
on,O
a,B-TR
Heparin,I-TR
and,O
nitroglycerin,B-TR
drip,I-TR
with,O
only,O
intermittent,O
relief,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Hypercholesterolemia,B-PR
.,O

2.,O
Obesity,B-PR
.,O

3.,O
Hypertension,B-PR
.,O

4.,O
Tobacco,O
history,O
.,O

5.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
:,O

2016-09-30,O
non-ST-elevation,B-PR
myocardial,I-PR
infarction,I-PR
",",O
100%,O
RCA,O
",",O
three,B-TR
stents,I-TR
",",O
50%,O
mid,O
LAD,O
.,O

2017-04-02,O
instent,B-PR
restenosis,I-PR
status,O
post,O
brachytherapy,B-TR
.,O

6.,O
GERD,B-PR
.,O

7.,O
Asthma,B-PR
.,O

8.,O
Sciatica,B-PR
.,O

9.,O
Degenerative,B-PR
joint,I-PR
disease,I-PR
.,O

10.,O
Glomerulosclerosis,B-PR
.,O

FAMILY,O
HISTORY,O
:,O

Brothers,O
with,O
William,B-PR
cancer,I-PR
and,O
a,B-PR
MI,I-PR
.,O

Father,O
with,O
emphysema,B-PR
.,O

Mother,O
with,O
lung,B-PR
cancer,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

Quit,O
tobacco,O
in,O
2016-09-30,O
.,O

Occasional,O
alcohol,O
.,O

Lives,O
with,O
her,O
6-year-old,O
daughter,O
.,O

ALLERGIES,O
:,O

Aspirin,B-TR
under,O
which,O
she,O
develops,O
worsening,O
of,O
her,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
and,O
asthma,B-PR
flare,I-PR
",",O
tetracycline,B-TR
",",O
sulfa,B-TR
",",O

Demerol,B-TR
.,O

MEDICATIONS:,O

1.,O
Diovan,B-TR
106,O
mg,O
q.d.,O

2.,O
Advair,B-TR
500/50,O
two,O
puffs,O
b.i.d.,O

3.,O
Plavix,B-TR
75,O
mg,O
q.d.,O

4.,O
Crestor,B-TR
20,O
mg,O
q.d.,O

5.,O
Neurontin,B-TR
300,O
mg,O
t.i.d.,O

6.,O
Prilosec,B-TR
20,O
mg,O
b.i.d.,O

7.,O
Vicodin,B-TR
as,O
needed,O
.,O

8.,O
Trazodone,B-TR
50,O
mg,O
q.d.,O

9.,O
Singulair,B-TR
10,O
mg,O
q.d.,O

10.,O
Flexeril,B-TR
10,O
mg,O
t.i.d.,O

11.,O
Lopressor,B-TR
75,O
mg,O
b.i.d.,O

12.,O
Humibid,B-TR
3600,O
b.i.d.,O

13.,O
Colace,B-TR
100,O
mg,O
b.i.d.,O

14.,O
Zetia,B-TR
10,O
mg,O
q.d.,O

15.,O
Benadryl,B-TR
as,O
needed,O
.,O

16.,O
Tricor,B-TR
106,O
mg,O
q.d.,O

17.,O
Premarin,B-TR
0.3,O
mg,O
q.d.,O

18.,O
Prozac,B-TR
40,O
mg,O
q.d.,O

19.,O
Omega-3,B-TR
fatty,I-TR
acids,I-TR
t.i.d.,O

PHYSICAL,O
EXAM,O
:,O

82,O
",",O
119/60,O
",",O
22,O
",",O
and,O
99%,O
on,O
room,O
air,O
.,O

Well,O
appearing,O
in,O
no,O
apparent,B-PR
distress,I-PR
.,O

Pupils,O
are,O
equal,O
",",O
round,O
",",O
and,O
reactive,O
to,O
light,O
.,O

Moist,O
mucous,O
membranes,O
.,O

No,O
JVD,B-PR
.,O

Regular,O
rate,O
and,O
rhythm,O
.,O

Positive,O
tenderness,B-PR
to,I-PR
sternum,I-PR
.,O

Chest,O
was,O
clear,O
to,O
auscultation,B-TE
bilaterally,I-TE
.,O

Abdomen,O
:,O

Obese,B-PR
",",O
soft,O
.,O

Extremities,O
show,O
no,O
edema,B-PR
",",O
2+,B-TE
dorsalis,I-TE
pedis,I-TE
",",O

1+,B-TE
femoral,I-TE
pulses,I-TE
.,O

LABORATORIES,O
:,O

Troponin-T,B-TE
less,O
than,O
0.01.,O

EKG,B-TE
:,O

Sinus,B-TE
",",O
84,O
",",O
normal,O
axis,O
",",O
QTc,B-TE
430,O
",",O
Q,B-PR
's,I-PR
in,I-PR
III,I-PR
and,I-PR
aVF,I-PR
",",O
no,O

ST,B-PR
changes,I-PR
as,O
compared,O
to,O
2017-05-01,O
EKG,B-TE
.,O

HOSPITAL,O
COURSE:,O

1.,O
Chest,B-PR
pain,I-PR
:,O

The,O
patient,O
ruled,O
out,O
for,O
myocardial,B-PR
infarction,I-PR
.,O

However,O
",",O
with,O
her,O
history,O
of,O
disease,B-PR
",",O
patient,O
underwent,O
a,B-TE
cardiac,I-TE
catheterization,I-TE
.,O

The,O
patient,O
was,O
found,O
at,O
cardiac,B-TE
catheterization,I-TE
to,O
have,O
mild,B-PR
diffuse,I-PR
instent,I-PR
restenosis,I-PR
in,I-PR
the,I-PR
mid,I-PR
stent,I-PR
",",O
otherwise,O
hemodynamically,O
normal,O
and,O
the,O
coronary,O
arteries,O
otherwise,O
were,O
without,O
flow-limiting,B-PR
stenoses,I-PR
.,O

The,O
patient,O
was,O
then,O
continued,O
on,O
her,B-TR
cardiac,I-TR
medications,I-TR
.,O

It,O
was,O
felt,O
that,O
if,O
we,O
attempted,O
aspirin,B-TR
desensitize,O
her,O
while,O
an,O
inpatient,O
",",O
then,O
she,O
would,O
benefit,O
from,O
the,O
use,O
of,O
aspirin,B-TR
and,O
Plavix,B-TR
.,O

The,O
patient,O
was,O
sent,O
to,O
the,O
CCU,O
and,O
underwent,O
aspirin,B-TR
desensitization,I-TR
protocol,I-TR
",",O
which,O
she,O
tolerated,O
well,O
.,O

She,O
had,O
mild,O
worsening,O
of,O
her,B-PR
asthma,I-PR
attacks,I-PR
",",O
which,O
was,O
relieved,O
by,O
Benadryl,B-TR
and,O
occasionally,O
albuterol,B-TR
.,O

The,O
patient,O
found,O
that,O
if,O
she,O
took,O
the,B-TR
aspirin,I-TR
in,O
the,O
evening,O
with,O
her,B-TR
Benadryl,I-TR
that,O
she,O
takes,O
for,O
sleep,O
",",O
that,O
the,B-PR
asthma,I-PR
exacerbation,I-PR
did,O
not,O
occur,O
.,O

Aspirin,B-TR
no,O
longer,O
should,O
be,O
considered,O
an,B-PR
allergy,I-PR
for,O
this,O
patient,O
",",O
and,O
she,O
is,O
going,O
to,O
take,O
this,O
as,O
an,O
outpatient,O
.,O

2.,O
Hyperlipidemia,B-PR
:,O

The,B-TR
patient,I-TR
's,I-TR
Lipitor,I-TR
was,O
increased,O
to,O
80,O
mg,O
q.d.,O

3.,O
Back,B-PR
pain,I-PR
:,O

This,O
is,O
a,B-PR
chronic,I-PR
issue,I-PR
and,O
was,O
controlled,O
with,O
Flexeril,B-TR
and,O
Vicodin,B-TR
.,O

DISPOSITION,O
:,O

To,O
home,O
.,O

DISCHARGE,O
STATUS,O
:,O

Patient,O
is,O
able,O
to,O
ambulate,O
without,O
any,B-PR
chest,I-PR
pain,I-PR
or,O
discomfort,B-PR
.,O

Can,O
carry,O
out,O
all,O
activities,O
of,O
daily,O
living,O
.,O

DISCHARGE,O
MEDICATIONS:,O

1.,O
Metoprolol,B-TR
100,O
mg,O
b.i.d.,O

2.,O
Plavix,B-TR
75,O
mg,O
q.d.,O

3.,O
Advair,B-TR
550,O
mcg,O
two,O
puffs,O
b.i.d.,O

4.,O
Neurontin,B-TR
300,O
mg,O
t.i.d.,O

5.,O
Protonix,B-TR
40,O
mg,O
q.d.,O

6.,O
Montelukast,B-TR
10,O
mg,O
q.d.,O

7.,O
Bethanechol,B-TR
25,O
mg,O
b.i.d.,O

8.,O
Docusate,B-TR
sodium,I-TR
100,O
mg,O
b.i.d.,O

9.,O
Zetia,B-TR
10,O
mg,O
q.d.,O

10.,O
Estrogen,B-TR
0.3,O
mg,O
q.d.,O

11.,O
Fluoxetine,B-TR
40,O
mg,O
q.d.,O

12.,O
Vicodin,B-TR
5-500,O
mg,O
tablets,O
q.4-6h.,O
as,O
needed,O
for,O
pain,B-PR
.,O

13.,O
Cyclobenzaprine,B-TR
10,O
mg,O
tablet,O
one,O
tablet,O
orally,O
t.i.d.,O

14.,O
Atorvastatin,B-TR
80,O
mg,O
q.d.,O

15.,O
Valsartan,B-TR
320,O
mg,O
q.d.,O

16.,O
Aspirin,B-TR
one,O
q.d.,O

17.,O
Benadryl,B-TR
as,O
needed,O
.,O

FOLLOWUP,O
:,O

The,O
patient,O
will,O
follow,O
up,O
with,O
her,O
primary,O
care,O
physician,O
",",O
Dr.,O
Benson,O
",",O
(,O
845,O
),O
253,O
6629,O
in,O
two,O
weeks,O
by,O
calling,O
to,O
schedule,O
an,O
appointment,O
.,O

DR.,O
"Luedeman,Melissa",O
69-853,O

Dictated,O
By,O
:,O

Andrew,O
C,O
Hoffman,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O

2017-07-02,O

11:35,O

T,O
:,O

2017-07-04,O

5:14,O

JOB#,O
:,O

19444,O

Signed,O
electronically,O
by,O
:,O

DR.,O
Andrew,O
X..,O
Dale,O
on,O
:,O

FRI,O
2017-09-22,O
9:13,O
AM,O

(,O
End,O
of,O
Report,O
),O

100469881,O
EH,O

989464,O

822862,O

06/09/1998,O
12:00:00,O
AM,O

OCCIPITAL,B-PR
CEREBROVASCULAR,I-PR
ACCIDENT,I-PR

Signed,O

DIS,O

Admission,O
Date,O
:,O

06/09/1998,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

06/12/1998,O

PRINCIPAL,O
DIAGNOSES,O
:,O

1),O
EXTENSIVE,B-PR
POSTERIOR,I-PR
CIRCULATION,I-PR
INFARCTION,I-PR
.,O

2),O
ASPIRATION,B-PR
PNEUMONIA,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
an,O
82,O
year-old,O
right,O
handed,O
gentleman,O
who,O
has,O
a,O
past,O
medical,O
history,O
of,O
hypertension,B-PR
and,O
tobacco,O
use,O
presented,O
to,O
the,O
emergency,O
room,O
with,O
acute,B-PR
change,I-PR
in,I-PR
mental,I-PR
status,I-PR
.,O

He,O
was,O
well,O
until,O
the,O
evening,O
prior,O
to,O
presentation,O
to,O
the,O
emergency,O
room,O
when,O
he,O
complained,O
of,O
headache,B-PR
across,I-PR
the,I-PR
forehead,I-PR
.,O

On,O
the,O
day,O
of,O
presentation,O
",",O
he,O
was,O
then,O
found,O
by,O
his,O
daughter,O
lying,O
on,O
his,O
bed,O
groaning,O
",",O
being,O
relatively,B-PR
unresponsive,I-PR
and,O
unable,O
to,O
speak,O
.,O

The,O
family,O
reported,O
one,O
episode,O
of,O
vomiting,B-PR
at,O
home,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,O
patient,O
was,O
afebrile,B-PR
",",O
heart,B-TE
rate,I-TE
73,O
",",O
blood,B-TE
pressure,I-TE
158/53,O
",",O
respiratory,B-TE
rate,I-TE
16-20,O
",",O
oxygen,B-TE
saturation,I-TE
97%,O
on,O
three,B-TR
liters,I-TR
.,O

General,O
:,O

The,O
patient,O
was,O
somnolent,B-PR
",",O
breathing,O
comfortably,O
",",O
occasionally,B-PR
coughing,I-PR
.,O

Neck,O
was,O
supple,O
with,O
full,O
range,O
of,O
motion,O
.,O

No,O
bruits,B-PR
were,O
heard,O
.,O

Chest,O
was,O
clear,O
to,O
auscultation,B-TE
but,O
with,O
poor,B-PR
air,I-PR
entry,I-PR
.,O

Heart,O
sounds,O
were,O
regular,O
with,O
one,B-PR
out,I-PR
of,I-PR
six,I-PR
holosystolic,I-PR
murmur,I-PR
at,O
the,O
left,O
lower,O
sternal,O
border,O
.,O

Abdomen,O
was,O
soft,O
",",O
non-tender,B-PR
",",O
bowel,O
sounds,O
present,O
.,O

Extremities,O
were,O
without,O
clubbing,B-PR
",",O
cyanosis,B-PR
or,O
edema,B-PR
.,O

Neurological,B-TE
examination,I-TE
revealed,O
a,O
patient,O
who,O
was,O
intermittently,B-PR
alert,I-PR
",",O
opening,O
eyes,O
to,O
voice,O
",",O
following,O
simple,O
commands,O
",",O
but,O
without,B-PR
any,I-PR
speech,I-PR
.,O

Pupils,O
were,O
4,O
mm,O
reactive,O
to,O
2,O
mm,O
bilaterally,O
.,O

There,O
was,O
no,O
pupillary,B-PR
defect,I-PR
.,O

Dolls,B-TE
eye,I-TE
was,O
negative,O
.,O

There,O
was,O
a,O
possible,O
right,B-PR
gaze,I-PR
preference,I-PR
and,O
the,O
patient,O
did,O
not,O
move,O
his,O
eyes,O
.,O

Corneals,B-TE
were,O
present,O
bilaterally,O
.,O

Gag,B-TE
was,O
present,O
weakly,O
.,O

Face,O
was,O
symmetrical,O
.,O

Tongue,O
was,O
midline,O
.,O

The,O
patient,O
was,O
moving,O
the,O
right,O
side,O
spontaneously,O
",",O
but,O
could,O
not,O
hold,O
arm,O
or,O
leg,O
up,O
for,O
any,O
length,O
of,O
time,O
.,O

There,O
was,O
only,O
minimal,B-PR
movement,I-PR
on,I-PR
the,I-PR
left,I-PR
side,I-PR
.,O

On,O
sensory,B-TE
testing,I-TE
",",O
the,O
patient,O
withdrew,O
all,O
extremities,O
to,O
pain,B-PR
.,O

Reflexes,B-TE
were,O
2+,O
and,O
symmetrical,O
all,O
over,O
.,O

The,O
left,O
toe,O
was,O
upgoing,B-PR
",",O
the,O
right,O
toe,O
was,O
downgoing,O
.,O

LABORATORY,O
:,O

Laboratory,O
data,O
revealed,O
a,B-TE
sodium,I-TE
of,O
139,O
",",O
potassium,B-TE
3.4,O
",",O
chloride,B-TE
101,O
",",O
bicarbonate,B-TE
28,O
",",O
BUN,B-TE
11,O
",",O
creatinine,B-TE
1.2,O
",",O
glucose,B-TE
151,O
.,O

AST,B-TE
was,O
20,O
",",O
ALT,B-TE
12,O
",",O
alkaline,B-TE
phosphatase,I-TE
80,O
",",O
bilirubin,B-TE
0.5.,O
CK,B-TE
was,O
113,O
.,O

Thyroid,B-TE
function,I-TE
tests,I-TE
were,O
normal,O
.,O

Troponin,B-TE
I,I-TE
was,O
0.05,O
.,O

Total,B-TE
protein,I-TE
was,O
8,O
",",O
albumin,B-TE
4.3,O
",",O
globulin,B-TE
3.7,O
",",O
calcium,B-TE
9.9,O
",",O
phosphate,B-TE
2.7,O
",",O
magnesium,B-TE
2.0.,O
White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
was,O
7,O
",",O
hemoglobin,B-TE
14.1,O
",",O
hematocrit,B-TE
43.6,O
",",O
platelet,B-TE
count,I-TE
241,O
.,O

Erythrocyte,B-TE
sedimentation,I-TE
rate,I-TE
was,O
41,O
.,O

PT,B-TE
was,O
12.3,O
",",O
PTT,B-TE
27.1.,O
An,B-TE
EKG,I-TE
showed,O
sinus,B-PR
bradycardia,I-PR
at,O
53,O
with,O
a,O
normal,O
axis,O
",",O
first,B-PR
degree,I-PR
atrioventricular,I-PR
block,I-PR
",",O
biphasic,B-PR
T-waves,I-PR
in,O
V1,O
to,O
V3,O
without,O
any,B-PR
acute,I-PR
changes,I-PR
.,O

A,B-TE
chest,I-TE
x-ray,I-TE
shows,O
left,B-PR
lower,I-PR
lobe,I-PR
consolidation,I-PR
.,O

The,B-TE
head,I-TE
CT,I-TE
scan,I-TE
revealed,O
a,B-PR
large,I-PR
right,I-PR
occipital,I-PR
infarct,I-PR
without,O
midline,B-PR
shift,I-PR
",",O
but,O
positive,B-PR
mass,I-PR
effect,I-PR
on,I-PR
the,I-PR
temporal,I-PR
horn,I-PR
",",O
on,O
the,O
right,O
ventricle,O
and,O
some,B-PR
effacement,I-PR
of,I-PR
the,I-PR
sulci,I-PR
in,O
the,O
right,O
parietal,O
area,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
a,O
telemetry,O
bed,O
and,O
started,O
on,O
heparin,B-TR
.,O

Around,O
4:00,O
AM,O
the,O
next,O
day,O
",",O
an,B-PR
acute,I-PR
decompensation,I-PR
in,I-PR
respiratory,I-PR
status,I-PR
was,O
noted,O
.,O

Lung,B-TE
examination,I-TE
at,O
that,O
point,O
showed,O
good,O
air,O
entry,O
",",O
no,O
wheezing,B-PR
",",O
coarse,B-PR
breath,I-PR
sounds,I-PR
throughout,I-PR
.,O

Neurologically,O
",",O
the,O
patient,O
was,O
not,O
following,O
commands,O
.,O

Eyes,O
were,O
closed,O
.,O

He,O
was,O
moving,O
the,O
right,O
arm,O
and,O
leg,O
spontaneously,O
",",O
though,O
less,O
than,O
before,O
.,O

Withdrawal,O
to,O
pain,B-TE
was,O
still,O
present,O
.,O

Both,O
plantars,O
were,O
upgoing,B-PR
.,O

A,B-TE
blood,I-TE
gas,I-TE
at,O
this,O
point,O
showed,O
a,B-TE
pH,I-TE
of,O
7.49,O
",",O
pO2,B-TE
61,O
",",O
pCO2,B-TE
of,O
33,O
on,O
100%,B-TR
non-rebreather,I-TR
mask,I-TR
.,O

EKG,B-TE
showed,O
sinus,B-PR
tachycardia,I-PR
.,O

The,B-TE
patient,I-TE
&apos;s,I-TE
temperature,I-TE
was,O
102,O
degrees,O
.,O

A,B-TE
repeat,I-TE
CAT,I-TE
scan,I-TE
of,I-TE
the,I-TE
head,I-TE
was,O
performed,O
.,O

This,O
showed,O
continued,O
evolution,O
of,O
the,B-PR
right,I-PR
posterior,I-PR
cerebral,I-PR
artery,I-PR
infarction,I-PR
now,O
extending,O
into,O
the,O
right,O
cerebellar,O
hemisphere,O
.,O

There,O
was,O
also,O
a,B-PR
high,I-PR
density,I-PR
adjacent,O
to,O
the,B-PR
right,I-PR
cerebellar,I-PR
infarction,I-PR
suggesting,O
the,O
presence,O
of,O
hemorrhage,B-PR
.,O

At,O
this,O
point,O
",",O
the,O
patient,O
was,O
transferred,O
to,O
the,O
intensive,O
care,O
unit,O
.,O

An,B-TE
MRI,I-TE
and,O
MRA,B-TE
of,I-TE
the,I-TE
head,I-TE
was,O
arranged,O
to,O
evaluate,O
the,O
extent,O
of,O
his,B-PR
stroke,I-PR
and,O
the,B-PR
posterior,I-PR
circulation,I-PR
.,O

The,B-TE
MRI,I-TE
showed,O
infarct,B-PR
of,I-PR
the,I-PR
cerebellar,I-PR
hemispheres,I-PR
bilaterally,I-PR
",",O
the,O
right,O
occipital,O
lobe,O
",",O
the,O
right,O
thalamus,O
and,O
bilateral,O
pons,O
.,O

The,B-TE
MRA,I-TE
of,I-TE
the,I-TE
intracranial,I-TE
circulation,I-TE
demonstrated,O
gross,B-PR
patency,I-PR
of,I-PR
the,I-PR
internal,I-PR
carotid,I-PR
arteries,I-PR
bilaterally,I-PR
and,I-PR
the,I-PR
basilar,I-PR
arteries,I-PR
.,O

The,O
left,O
vertebral,O
artery,O
was,O
not,O
visualized,O
.,O

There,O
was,O
a,O
dominant,O
right,O
vertebral,O
artery,O
.,O

There,O
was,O
mildly,B-PR
reduced,I-PR
flow,I-PR
in,O
the,O
branches,O
of,O
the,O
right,O
middle,O
cerebral,O
artery,O
compared,O
to,O
the,O
left,O
.,O

There,O
was,O
visualization,O
of,O
flow,O
within,O
both,O
posterior,O
cerebral,O
arteries,O
.,O

Clinically,O
",",O
the,O
patient,O
continued,O
to,O
deteriorate,O
.,O

Neurosurgery,O
was,O
consulted,O
",",O
however,O
the,O
neurosurgeons,O
felt,O
that,O
there,O
was,O
no,O
surgical,O
option,O
",",O
since,O
even,O
in,O
the,O
case,O
of,O
cerebellar,B-PR
swelling,I-PR
",",O
there,O
would,O
be,O
no,O
improvement,O
from,O
decompensation,B-PR
.,O

The,O
patient,O
was,O
therefore,O
treated,O
conservatively,O
with,O
fluid,B-TR
restriction,I-TR
and,O
blood,B-TR
pressure,I-TR
management,I-TR
.,O

Heparin,B-TR
was,O
discontinued,O
because,O
of,O
the,O
risk,O
of,O
intercerebral,B-PR
hemorrhage,I-PR
.,O

The,B-PR
aspiration,I-PR
pneumonia,I-PR
was,O
treated,O
with,O
Cefotaxime,B-TR
and,O
Metronidazole,B-TR
.,O

The,O
patient,O
&apos;s,O
family,O
was,O
involved,O
and,O
they,O
decided,O
to,O
opt,O
for,O
DNR,O
/,O
DNI,O
in,O
view,O
of,O
the,O
poor,O
prognosis,O
.,O

The,O
patient,O
passed,O
away,O
at,O
6:45,O
AM,O
on,O
June,O
12,O
",",O
1998,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Deceased,O
.,O

DISCHARGE,O
ORDERS,O
:,O

None,O
.,O

Dictated,O
By,O
:,O

GREGSIS,O
STREETS,O
",",O
M.D.,O
SQ51,O

Attending,O
:,O

CHLINO,O
B.,O
SHAM,O
",",O
M.D.,O
NI76,O
LN647/8356,O

Batch,O
:,O

57390,O

Index,O
No.,O
TCVBBUJ1Y,O

D,O
:,O

07/09/98,O

T,O
:,O

07/10/98,O

CC,O
:,O

1.,O
NATA,O
NELMI,O
PAIN,O
",",O
M.D.,O
",",O
Sonsantna,O
.,O

Admission,O
Date,O
:,O

2015-03-17,O

Discharge,O
Date,O
:,O

2015-03-23,O

Date,O
of,O
Birth,O
:,O

1992-12-06,O

Sex,O
:,O

M,O

Service:,O

ADDENDUM,O
:,O

The,O
initial,O
part,O
to,O
this,O
Discharge,O
Summary,O
confirmation,O
number,O
was,O
276836,O
(,O
I,O
believe,O
),O
.,O

Please,O
add,O
this,O
dictation,O
to,O
initial,O
dictation,O
done,O
on,O
2015-03-26,O
.,O

After,O
quoting,O
vital,O
signs,O
",",O
please,O
include,O
:,O

The,O
patient,O
was,O
alert,O
and,O
oriented,O
times,O
three,O
with,O
N.,B-TE
Ramirez,I-TE
Coma,I-TE
Scale,I-TE
of,O
15,O
on,O
arrival,O
.,O

He,O
was,O
following,O
all,O
commands,O
and,O
moving,O
all,O
extremities,O
.,O

The,O
pupils,O
were,O
equal,O
",",O
round,O
",",O
and,O
reactive,O
to,O
light,O
.,O

The,O
tympanic,O
membranes,O
were,O
clear,O
.,O

The,O
oropharynx,O
was,O
clear,O
.,O

The,O
extraocular,O
muscles,O
were,O
intact,O
.,O

Cardiovascular,B-TE
examination,I-TE
revealed,O
regular,O
rate,O
and,O
rhythm,O
.,O

Chest,O
was,O
clear,O
to,O
auscultation,B-TE
bilaterally,I-TE
.,O

Good,O
breath,O
sounds,O
.,O

No,O
crepitus,B-PR
.,O

Positive,O
tenderness,B-PR
over,O
the,O
distal,O
half,O
of,O
the,O
left,O
rib,O
cage,O
.,O

The,O
abdomen,O
was,O
tender,B-PR
in,I-PR
the,I-PR
left,I-PR
upper,I-PR
quadrant,I-PR
.,O

Positive,O
guarding,B-PR
.,O

The,O
pelvis,O
was,O
stable,O
.,O

No,O
deformities,B-PR
.,O

No,O
costovertebral,B-PR
angle,I-PR
tenderness,I-PR
bilaterally,I-PR
.,O

No,O
deformities,B-PR
",",O
stepoff,B-PR
",",O
or,O
tenderness,B-PR
of,I-PR
the,I-PR
cervical,I-PR
spine,I-PR
.,O

Rectal,B-TE
examination,I-TE
was,O
guaiac-negative,O
.,O

Good,O
tone,O
.,O

The,O
right,O
upper,O
extremity,O
was,O
positive,O
for,O
abrasions,B-PR
.,O

The,O
right,O
lower,O
extremity,O
was,O
positive,O
for,O
abrasions,B-PR
.,O

Left,O
upper,O
and,O
lower,O
extremities,O
revealed,O
no,O
deformities,B-PR
.,O

Strength,O
was,O
5/5,O
times,O
four,O
extremities,O
.,O

Good,O
pulses,O
throughout,O
.,O

The,O
patient,O
was,O
brought,O
to,O
the,O
operating,O
room,O
for,O
resuscitation,B-TR
.,O

The,O
patient,O
responded,O
to,O
aggressive,B-TR
resuscitation,I-TR
and,O
was,O
hemodynamically,O
stable,O
.,O

At,O
this,O
time,O
",",O
the,O
decision,O
to,O
treat,O
the,O
patient,O
nonoperatively,O
was,O
made,O
",",O
and,O
the,O
patient,O
was,O
admitted,O
to,O
the,O
Intensive,O
Care,O
Unit,O
for,O
close,O
monitoring,O
.,O

The,O
patient,O
was,O
kept,O
nothing,O
by,O
mouth,O
with,O
intravenous,B-TR
fluids,I-TR
",",O
bed,B-TR
rest,I-TR
",",O
every,B-TE
4-hour,I-TE
hematocrit,I-TE
checks,I-TE
",",O
and,O
serial,B-TE
abdominal,I-TE
examinations,I-TE
.,O

The,O
Athol,O
Memorial,O
Hospital,O
hospital,O
course,O
was,O
unremarkable,O
.,O

The,O
patient,O
remained,O
hemodynamically,O
stable,O
throughout,O
the,O
course,O
of,O
his,O
hospital,O
stay,O
",",O
and,O
his,B-TE
hematocrit,I-TE
was,O
relatively,O
stable,O
with,O
a,B-PR
gradual,I-PR
drop,I-PR
due,O
to,O
dilutional,B-PR
changes,I-PR
.,O

On,O
post,O
trauma,O
day,O
four,O
",",O
the,O
patient,O
remained,O
hemodynamically,O
stable,O
with,O
a,O
stable,O
hematocrit,O
and,O
a,O
soft,O
",",O
nontender,B-PR
",",O
and,O
nondistended,B-PR
abdomen,I-PR
.,O

The,O
patient,O
's,O
bed,O
rest,O
status,O
was,O
changed,O
to,O
out,O
of,O
bed,O
",",O
and,O
oral,O
intake,O
was,O
started,O
.,O

The,O
patient,O
tolerated,O
the,O
advancement,O
of,O
his,O
diet,O
without,O
problems,O
.,O

The,O
patient,O
ambulated,O
with,O
pain,B-PR
on,I-PR
the,I-PR
left,I-PR
lower,I-PR
extremity,I-PR
secondary,O
to,O
the,B-PR
left,I-PR
pubic,I-PR
rami,I-PR
fractures,I-PR
.,O

Physical,O
Therapy,O
was,O
consulted,O
",",O
and,O
crutches,B-TR
were,O
given,O
to,O
the,O
patient,O
.,O

Pain,B-PR
was,O
managed,O
with,O
a,B-TR
Fentanyl,I-TR
patch,I-TR
and,O
by,B-TR
mouth,I-TR
Dilaudid,I-TR
with,O
adequate,O
pain,B-TR
control,I-TR
on,O
discharge,O
.,O

DISCHARGE,O
STATUS,O
:,O

The,O
patient,O
was,O
discharged,O
to,O
home,O
.,O

DISCHARGE,O
DIAGNOSES:,O

1.,O
Grade,B-PR
3,I-PR
splenic,I-PR
laceration,I-PR
.,O

2.,O
Left,B-PR
rib,I-PR
8,I-PR
through,I-PR
12,I-PR
fractures,I-PR
.,O

3.,O
Left,B-PR
superior/inferior,I-PR
pubic,I-PR
rami,I-PR
fractures,I-PR
.,O

4.,O
Comorbidities,O
of,O
anxiety,B-PR
disorder/depression,I-PR
.,O

DISCHARGE,O
INSTRUCTIONS/FOLLOWUP:,O

1.,O
The,O
patient,O
was,O
asked,O
to,O
call,O
his,O
physician,O
if,O
he,O
experienced,O
any,B-PR
lightheadedness,I-PR
",",O
dizziness,B-PR
",",O
nausea,B-PR
",",O
vomiting,B-PR
",",O
fevers,B-PR
",",O
or,O
chills,B-PR
.,O

2.,O
The,O
patient,O
was,O
instructed,O
to,O
not,O
participate,O
in,O
contact,O
sports,O
for,O
six,O
weeks,O
.,O

3.,O
The,O
patient,O
was,O
instructed,O
to,O
follow,O
up,O
in,O
the,O
Trauma,O

Clinic,O
in,O
three,O
to,O
four,O
weeks,O
.,O

CONDITION,O
AT,O
DISCHARGE,O
:,O

The,O
patient,O
's,O
condition,O
on,O
discharge,O
was,O
stable,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

1.,O
Fentanyl,B-TR
75-mcg,O
per,O
hour,O
patch,O
q.72h.,O

2.,O
Zoloft,B-TR
50,O
mg,O
by,O
mouth,O
once,O
per,O
day,O
.,O

3.,O
Wellbutrin,B-TR
200,O
mg,O
by,O
mouth,O
twice,O
per,O
day,O
.,O

4.,O
Dilaudid,B-TR
one,O
to,O
two,O
tablets,O
by,O
mouth,O
q.4-6h.,O
as,O
needed,O
(,O
for,O
pain,B-PR
),O
.,O

Ernest,O
K.,O
Gardner,O
",",O
M.D.,O

09-697,O

Dictated,O
By,O
:,O

Sarah,O
Z,O
Stephens,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O

2015-03-26,O

18:08,O

T,O
:,O

2015-03-26,O

21:53,O

JOB#,O
:,O

81804,O

Signed,O
electronically,O
by,O
:,O

DR.,O
Billie,O
SCHNEIDER,O
on,O
:,O

FRI,O
2015-03-27,O
11:01,O
AM,O

(,O
End,O
of,O
Report,O
),O

116752045,O

CTMC,O

20515082,O

422603,O

12/23/1991,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

12/23/1991,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

01/02/1992,O

ADMISSION,O
DIAGNOSIS,O
:,O

ABDOMINAL,B-PR
AORTIC,I-PR
ANEURYSM,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Patient,O
is,O
a,O
64,O
year,O
old,O
white,O
male,O
with,O
a,O
past,O
medical,O
history,O
of,O
smoking,O
",",O
coronary,B-PR
artery,I-PR
disese,I-PR
",",O
hypertension,B-PR
",",O
and,O
hypercholesterolemia,B-PR
with,O
a,B-PR
l0,I-PR
cm,I-PR
abdominal,I-PR
aortic,I-PR
aneurysm,I-PR
.,O

Patient,O
presented,O
to,O
his,O
private,O
medical,O
doctor,O
in,O
Gewestster,O
with,O
transient,B-PR
calf,I-PR
pain,I-PR
on,O
walking,O
less,O
than,O
fifty,O
yards,O
.,O

Abdominal,B-PR
aortic,I-PR
aneurysm,I-PR
was,O
discovered,O
on,O
examination,B-TE
and,O
patient,O
was,O
referred,O
to,O
Retelk,O
County,O
Medical,O
Center,O
.,O

He,O
was,O
admitted,O
on,O
10/17/06,O
and,O
echocardiogram,B-TE
done,O
on,O
11/13/09,O
revealed,O
poor,B-PR
left,I-PR
ventricular,I-PR
function,I-PR
and,O
cardiac,B-TE
catheterization,I-TE
was,O
done,O
on,O
admission,O
which,O
showed,O
three,B-PR
vessel,I-PR
disease,I-PR
.,O

Patient,O
was,O
referred,O
to,O
Cardiology,O
and,O
underwent,O
a,B-TR
three,I-TR
vessel,I-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
on,O
11/25/09,O
.,O

His,O
post-operative,O
course,O
was,O
complicated,O
by,O
an,B-PR
E.,I-PR
coli,I-PR
urinary,I-PR
tract,I-PR
infection,I-PR
and,O
transient,B-PR
acute,I-PR
renal,I-PR
failure,I-PR
with,O
increasing,B-PR
creatinine,I-PR
.,O

Patient,B-TE
&apos;s,I-TE
renal,I-TE
function,I-TE
returned,O
to,O
normal,O
over,O
several,O
days,O
",",O
however,O
.,O

The,B-TE
patient,I-TE
&apos;s,I-TE
last,I-TE
ultrasound,I-TE
of,I-TE
his,I-TE
aorta,I-TE
revealed,O
a,B-PR
l0,I-PR
cm,I-PR
aneurysm,I-PR
and,O
he,O
presented,O
at,O
the,O
time,O
of,O
admission,O
for,O
an,B-TR
abdominal,I-TR
aortic,I-TR
aneurysm,I-TR
repair,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

As,O
above,O
.,O

Myocardial,B-PR
infarction,I-PR
also,O
in,O
l983,O
and,O
l988,O
",",O
congestive,B-PR
heart,I-PR
failure,I-PR
in,O
l989,O
",",O
diverticulitis,B-PR
in,O
l978,O
",",O
and,O
spontaneous,B-PR
pneumothorax,I-PR
in,O
l956,O
.,O

He,O
had,O
a,B-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
times,I-TR
three,I-TR
as,O
mentioned,O
above,O
.,O

CURRENT,O
MEDICATIONS,O
:,O

He,O
came,O
in,O
on,O
Carafate,B-TR
",",O
Enteric,B-TR
Coated,I-TR
Aspirin,I-TR
",",O
Albuterol,B-TR
Inhaler,I-TR
",",O
Atrovent,B-TR
Inhaler,I-TR
",",O
Procan,B-TR
SR,I-TR
",",O
Mevacor,B-TR
",",O
and,O
Digoxin,B-TR
.,O

ALLERGIES,O
:,O

He,O
is,O
allergic,B-PR
to,O
Penicillin,B-TR
",",O
Inderal,B-TR
",",O
and,O
also,O
to,O
Procan,B-TR
.,O

Patient,O
has,O
a,O
seventy,O
pack,O
year,O
history,O
of,O
smoking,O
which,O
he,O
quit,O
ten,O
years,O
ago,O
and,O
he,O
has,O
previously,O
had,O
problems,O
with,O
alcohol,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,O
was,O
remarkable,O
for,O
an,O
abdomen,O
which,O
was,O
soft,O
and,O
non-tender,B-PR
.,O

There,O
was,O
a,B-PR
pulsatile,I-PR
mass,I-PR
felt,O
in,O
the,O
right,O
upper,O
quadrant,O
near,O
the,O
midline,O
.,O

He,O
had,O
dopplerable,B-PR
lower,I-PR
extremity,I-PR
pulses,I-PR
on,I-PR
the,I-PR
left,I-PR
and,O
on,O
the,O
right,O
",",O
they,O
were,O
palpable,O
.,O

HOSPITAL,O
COURSE,O
:,O

Patient,O
was,O
admitted,O
and,O
taken,O
to,O
the,O
Operating,O
Room,O
the,O
next,O
day,O
on,O
12/24/09,O
where,O
patient,O
underwent,O
an,B-TR
abdominal,I-TR
aortic,I-TR
aneurysm,I-TR
repair,I-TR
.,O

In,O
his,O
post-operative,O
course,O
",",O
patient,O
was,O
sent,O
to,O
the,O
unit,O
and,O
was,O
put,O
on,O
perioperative,B-TR
Vancomycin,I-TR
.,O

Post-operatively,O
",",O
patient,O
was,O
found,O
to,O
have,O
frequent,B-PR
aberrant,I-PR
atrial,I-PR
premature,I-PR
beats,I-PR
and,O
some,B-PR
rare,I-PR
ventricular,I-PR
premature,I-PR
beats,I-PR
.,O

His,O
lungs,O
were,O
found,O
to,O
have,O
decreased,B-PR
breath,I-PR
sounds,I-PR
with,O
a,O
question,O
of,O
fluid,B-PR
overload,I-PR
.,O

There,O
was,O
a,O
question,O
of,O
whether,O
to,O
start,O
him,O
on,O
Quinidine,B-TR
versus,O
beta,B-TR
blockers,I-TR
.,O

An,B-TE
echocardiogram,I-TE
was,O
obtained,O
which,O
showed,O
moderate,B-PR
left,I-PR
ventricular,I-PR
dysfunction,I-PR
with,O
hypokinetic,B-PR
and,I-PR
akinetic,I-PR
areas,I-PR
throughout,I-PR
the,I-PR
left,I-PR
and,I-PR
right,I-PR
ventricle,I-PR
.,O

Patient,O
was,O
loaded,O
with,O
Quinidine,B-TR
and,O
then,O
started,O
on,O
a,B-TR
maintenance,I-TR
dose,I-TR
.,O

Patient,O
converted,O
to,O
normal,O
sinus,O
rhythm,O
once,O
on,O
Quinidine,B-TR
.,O

Patient,O
was,O
discharged,O
from,O
the,O
unit,O
on,O
12/30/09,O
and,O
was,O
sent,O
to,O
the,O
floor,O
.,O

His,B-TR
digoxin,I-TR
was,O
found,O
to,O
be,O
elevated,B-PR
so,O
his,B-TR
Digoxin,I-TR
was,O
held,O
for,O
four,O
days,O
while,O
levels,B-TE
slowly,O
came,O
down,O
.,O

Patient,O
was,O
restarted,O
on,O
Digoxin,B-TR
just,O
prior,O
to,O
discharge,O
.,O

Patient,O
also,O
was,O
found,O
to,O
have,O
elevated,B-PR
LDH,I-PR
",",I-PR
alkaline,I-PR
phosphatase,I-PR
",",I-PR
and,I-PR
amylase,I-PR
prior,O
to,O
admission,O
.,O

Lipase,B-TE
was,O
within,O
normal,O
limits,O
.,O

Ultrasound,B-TE
was,O
obtained,O
of,O
the,O
biliary,O
tree,O
which,O
demonstrated,O
no,O
abnormalities,B-PR
.,O

Patient,O
was,O
also,O
found,O
to,O
have,O
several,O
complaints,O
of,O
awaking,O
in,O
the,O
middle,O
of,O
the,O
night,O
with,O
tachypnea,B-PR
and,O
some,B-PR
bilateral,I-PR
chest,I-PR
pain,I-PR
associated,O
with,O
breathing,O
.,O

Serial,B-TE
EKG,I-TE
and,I-TE
CK,I-TE
were,O
obtained,O
which,O
were,O
negative,O
.,O

A,B-TE
chest,I-TE
X-Ray,I-TE
demonstrated,O
some,B-PR
pulmonary,I-PR
edema,I-PR
.,O

An,B-TE
arterial,I-TE
blood,I-TE
gas,I-TE
at,O
that,O
time,O
showed,O
pO2,B-TE
of,O
68,O
",",O
saturation,B-TE
of,O
95%,O
",",O
a,B-TE
pH,I-TE
of,O
7.5l,O
",",O
pCO2,B-TE
of,O
37,O
",",O
a,B-TE
bicarbonate,I-TE
of,O
37,O
",",O
and,O
a,B-TE
pCO2,I-TE
of,O
3l,O
with,O
a,B-TE
+7,I-TE
base,I-TE
.,O

Patient,B-TE
&apos;s,I-TE
chest,I-TE
X-Ray,I-TE
",",O
as,O
mentioned,O
above,O
",",O
showed,O
pulmonary,B-PR
edema,I-PR
.,O

Patient,O
was,O
aggressively,O
diuresed,O
with,O
resolution,O
of,O
symptoms,B-PR
.,O

DISPOSITION,O
:,O

DISCHARGE,O
MEDICATIONS,O
:,O

Patient,O
is,O
being,O
sent,O
home,O
on,O
Ecotrin,B-TR
one,O
q.d.,O
",",O
Digoxin,B-TR
0.l25,O
mg,O
every,O
three,O
days,O
",",O
Quinidine,B-TR
648,O
mg,O
q.a.m.,O
and,O
324,O
mg,O
q.p.m.,O
and,O
q.h.s.,O
",",O
Mevacor,B-TR
20,O
mg,O
p.o.,O
q.d.,O
",",O
Carafate,B-TR
one,O
gram,O
p.o.,O
q.i.d.,O
",",O
Colace,B-TR
l00,O
mg,O
p.o.,O
t.i.d.,O
",",O
Lasix,B-TR
80,O
mg,O
p.o.,O
q.d.,O
",",O
Potassium,B-TR
20,O
mEq,O
p.o.,O
q.d.,O
",",O
and,O
iron,B-TR
supplements,I-TR
.,O

Patient,O
has,O
follow-up,O
with,O
Dr.,O
Merkel,O
and,O
with,O
his,O
private,O
medical,O
doctor,O
.,O

EV956/4659,O
RISHAN,O
M.,O
MERKEL,O
",",O
M.D.,O
BS9,O

D,O
:,O

01/02/92,O

Batch,O
:,O

3669,O

Report,O
:,O

F6644X53,O

T,O
:,O

01/02/92,O

Dicatated,O
By,O
:,O

RAMA,O
R.,O
KOTEOBE,O
",",O
M.D.,O

cc,O
:,O

1.,O
DWAINCO,O
L.,O
MERKEL,O
",",O
M.D.,O

Admission,O
Date,O
:,O

2012-03-23,O

Discharge,O
Date,O
:,O

2012-03-26,O

Date,O
of,O
Birth,O
:,O

1972-06-27,O

Sex,O
:,O

M,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,O
Drugs,B-TR

Attending,O
:,O
George,O
XL,O
Patrick,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

mental,B-PR
status,I-PR
change,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

intubation,B-TR

History,O
of,O
Present,O
Illness,O
:,O

39,O
year,O
old,O
male,O
w/,O
h/o,O
low,B-PR
back,I-PR
pain,I-PR
on,O
chronic,B-TR
narcotics,I-TR
presents,O
after,O
being,O
found,O
unresponsive,B-PR
at,O
home,O
.,O

His,O
daughter,O
awoke,O
him,O
at,O
7,O
a.m.,O
",",O
reports,O
he,O
said,O
he,O
felt,O
"",O
cold,B-PR
and,O
shivery,B-PR
",""",O
vomited,O
several,O
times,O
",",O
then,O
drove,O
her,O
to,O
school,O
.,O

According,O
to,O
his,O
wife,O
",",O
he,O
came,O
home,O
and,O
went,O
to,O
sleep,O
.,O

When,O
she,O
tried,O
to,O
awaken,O
him,O
at,O
11,O
a.m.,O
",",O
she,O
was,O
unable,O
to,O
do,O
so,O
and,O
called,O
EMS,O
.,O

She,O
did,O
not,O
notice,O
any,B-PR
blood,I-PR
/,I-PR
urine,I-PR
/,I-PR
emesis,I-PR
/,I-PR
stool,I-PR
in,I-PR
the,I-PR
bed,I-PR
.,O

EMS,O
found,O
him,O
with,O
agonal,B-PR
respirations,I-PR
and,O
pinpoint,B-PR
pupils,I-PR
.,O

FS,B-TE
420,O
.,O

He,O
received,O
1,O
mg,O
IV,B-TR
Narcan,I-TR
(,O
numerous,O
bottles,O
of,O
oxycontin,B-TR
",",O
percocet,B-TR
were,O
found,O
in,O
room,O
);,O
his,O
pupils,O
dilated,O
to,O
~,O
8,O
mm,O
and,O
he,O
became,O
combative,B-PR
/,O
agitated,B-PR
.,O

He,O
was,O
then,O
intubated,O
for,O
airway,B-TR
protection,I-TR
(,O
etomidate,B-TR
/,O
succinate,B-TR
);,O
it,O
was,O
a,B-TR
traumatic,I-TR
intubation,I-TR

and,O
one,O
of,O
his,O
teeth,O
was,O
chipped,O
.,O

He,O
was,O
transported,O
to,O
Hallmark,O
Health,O
System,O
Monica,O
",",O
where,O
ABG,B-TE
7.14/82/44,O
while,O
bagging,O
on,O
100%,B-TR
FiO2,I-TR
.,O

Wife,O
reports,O
that,O
he,O
drank,O
a,O
large,O
amt,O
of,O
alcohol,O
(,O
12,O
bottles,O
of,O
beer,O
),O
night,O
PTA,O
.,O

For,O
2,O
days,O
PTA,O
",",O
he,O
has,O
expressed,O
a,O
wish,O
to,O
kill,O
himself,O
(,O
no,O
clear,O
plan,O
",",O
but,O
fixing,O
things,O
around,O
the,O
house,O
"",O
so,O
things,O
will,O
be,O
ready,O
when,O
I,O
'm,O
gone,O
"").,O

In,O
Monica,O
",",O
pt,O
received,O
charcoal,B-TR
",",O
500,O
mg,O
IV,B-TR
levofloxacin,I-TR
",",O
500,O
mg,O
IV,B-TR
metronidazole,I-TR
for,O
presumed,O
aspiration,B-PR
pna,I-PR
.,O

Past,O
Medical,O
History,O
:,O

chronic,B-PR
LBP,I-PR
",",O
HTN,B-PR
",",O
anxiety,B-PR
",",O
depression,B-PR
",",O
L,B-TR
arm,I-TR
surgeries,I-TR
(,O
hardware,B-TR
in,O
place,O
),O

Social,O
History,O
:,O

lives,O
with,O
wife,O
and,O
daughters,O
.,O

On,O
disability,O
secondary,O
to,O
work-related,B-PR
back,I-PR
injury,I-PR
.,O

Heavy,O
EtOH,O
(,O
12,O
beers,O
several,O
times,O
a,O
week,O
).,O

Smokes,O
~,O
1,O
pk,O
/,O
week,O
.,O

No,O
other,O
known,O
drug,O
use,O
other,O
than,O
Oxycontin,B-TR
/,O
percocet,B-TR
.,O

Family,O
History,O
:,O

No,O
family,O
history,O
of,O
heart,B-PR
disease,I-PR
or,O
cancer,B-PR

Physical,O
Exam,O
:,O

PE,O
:,O
Tc,B-TE
98.7,O
",",O
pc,B-TE
88,O
",",O
bpc,B-TE
120/60,O
",",O
AC,B-TE
600/20,O
",",O
FiO2,B-TE
100%,O
",",O
PEEP,B-TE
10,O

Gen,O
:,O
young,O
male,O
",",O
intubated,B-TR
",",O
sedated,B-TR
",",O
in,O
hard,B-TR
collar,I-TR
.,O

HEENT,O
:,O
Pupils,B-PR
pinpoint,I-PR
",",O
equal,O
",",O
anicteric,B-PR
",",O
normal,O
conjunctiva,O
",",O
intubated,B-TR
",",O
OGT,B-TR
in,O
place,O
",",O
OMMM,O
",",O
normocephalic,O
",",O
atraumatic,B-PR

Cardiac,O
:,O
RRR,O
",",O
I/VI,B-PR
SM,I-PR
at,I-PR
apex,I-PR
",",O
no,O
R/G,B-PR
appreciated,O

Pulm,O
:,O
coarse,B-PR
breath,I-PR
sounds,I-PR
throughout,I-PR

Abd,O
:,O
mildly,B-PR
distended,I-PR
",",O
hypoactive,B-PR
BS,I-PR
",",O
soft,O
",",O
no,O
HSM,B-PR

Ext,O
:,O
trace,B-PR
LE,I-PR
edema,I-PR
at,I-PR
ankles,I-PR
",",O
extremities,B-PR
cool,I-PR
w/,O
2+,O
radial,B-TE
",",O
1+,O
DP/PT,B-TE
pulses,I-TE
.,O

Well-healed,B-PR
scars,I-PR
over,I-PR
dorsal,I-PR
/,I-PR
lateral,I-PR
distal,I-PR
LUE,I-PR

Neuro,O
:,O
DTR,B-TE
3+,O
upper,O
and,O
lower,O
extremities,O
",",O
symmetric,O
bilaterally,O
.,O

Toes,O
equivocal,O
bilaterally,O
.,O

(+),O
gag,O

Pertinent,O
Results,O
:,O

EKG,B-TE
NSR,O
@,O
92,O
bpm,O
",",O
nl,O
axis,O
",",O
borderline,B-PR
QT,I-PR
(,O
QTc,B-TE
0.442,O
"),",O
J,B-PR
Pt,I-PR
elevtation,I-PR
V3,B-TE
",",O
TWF,B-TE
II,I-TE
",",O
III,B-TE
",",O
avF,B-TE
",",O
I,B-TE
",",O
avL,B-TE
(,O
no,O
prior,B-TE
EKG,I-TE
for,O
comparison,O
),O

2012-03-23,O
15:39,O

TYPE,O
-,O
ART,B-TE
PO2,I-TE
-,O
122,O
*,O
PCO2,B-TE
-,O
38,O
PH,B-TE
-,O
7.43,O
TOTAL,B-TE
CO2,I-TE
-,O
26,O
BASE,B-TE
XS,I-TE
-,O
1,O

2012-03-23,O
15:39,O

LACTATE,B-TE
-,O
2.0,O

2012-03-23,O
01:30,O
PM,O
URINE,B-TE

HOURS,O
-,O
RANDOM,O

2012-03-23,O
01:30,O
PM,O
URINE,B-TE

bnzodzpn,B-TE
-,O
POS,B-PR
barbitrt,B-TE
-,O
NEG,O
opiates,B-TE
-,O
NEG,O
cocaine,B-TE
-,O
NEG,O
amphetmn,B-TE
-,O
NEG,O
mthdone,B-TE
-,O
NEG,O

2012-03-23,O
01:30,O
PM,O
URINE,B-TE

COLOR,O
-,O
Straw,O
APPEAR,O
-,O
Clear,O
SP,B-TE
Barajas,I-TE
-,O
1.015,O

2012-03-23,O
01:30,O
PM,O
URINE,B-TE

BLOOD,B-TE
-,O
SM,O
NITRITE,B-TE
-,O
NEG,O
PROTEIN,B-TE
-,O
30,O
GLUCOSE,B-TE
-,O
1000,O
KETONE,B-TE
-,O
NEG,O
BILIRUBIN,B-TE
-,O
NEG,O
UROBILNGN,B-TE
-,O
NEG,O
PH,B-TE
-,O
6.0,O
LEUK,B-TE
-,O
NEG,O

2012-03-23,O
01:30,O
PM,O
URINE,B-TE

RBC,B-TE
-,O
03-10,O
*,O
WBC,B-TE
-,O
0-2,O
BACTERIA,B-TE
-,O
FEW,B-PR
YEAST,B-TE
-,O
NONE,O
EPI,B-TE
-,O
0,O

2012-03-23,O
01:30,O
PM,O
URINE,B-TE

MUCOUS,B-TE
-,O
FEW,O

2012-03-23,O
12:22,O

PO2,B-TE
-,O
44,O
*,O
PCO2,B-TE
-,O
82,O
*,O
PH,B-TE
-,O
7.14,O
*,O
TOTAL,B-TE
CO2,I-TE
-,O
30,O
BASE,B-TE
XS,I-TE
--,O
4,O

2012-03-23,O
12:22,O

GLUCOSE,B-TE
-,O
296,O
*,O
LACTATE,B-TE
-,O
4.8,O
*,O
NA+,B-TE
-,O
140,O
K+,B-TE
-,O
5.2,O
CL,B-TE
--,O
101,O

2012-03-23,O
12:20,O

UREA,B-TE
N,O
-,O
20,O
CREAT,B-TE
-,O
1.1,O

2012-03-23,O
12:20,O

ALT(SGPT),B-TE
-,O
30,O
AST(SGOT),B-TE
-,O
38,O
LD(LDH),B-TE
-,O
217,O
CK(CPK),B-TE
-,O
1152,O
*,O
ALK,B-TE
PHOS,I-TE
-,O
52,O
AMYLASE,B-TE
-,O
426,O
*,O
TOT,B-TE
BILI,I-TE
-,O
0.4,O

2012-03-23,O
12:20,O

LIPASE,B-TE
-,O
22,O

2012-03-23,O
12:20,O

CK-MB,B-TE
-,O
45,O
*,O
MB,B-TE
INDX,I-TE
-,O
3.9,O
cTropnT,B-TE
-<,O
0.01,O

2012-03-23,O
12:20,O

ALBUMIN,B-TE
-,O
4.4,O

2012-03-23,O
12:20,O

ASA,B-TE
-,O
NEG,O
ETHANOL,B-TE
-,O
NEG,O
ACETMNPHN,B-TE
-,O
NEG,O
bnzodzpn,B-TE
-,O
NEG,O
barbitrt,B-TE
-,O
NEG,O
tricyclic,B-TE
-,O
NEG,O

2012-03-23,O
12:20,O

WBC,B-TE
-,O
8.9,O
RBC,B-TE
-,O
3.93,O
*,O
HGB,B-TE
-,O
12.1,O
*,O
HCT,B-TE
-,O
36.7,O
*,O
MCV,B-TE
-,O
93,O
MCH,B-TE
-,O
30.8,O
MCHC,B-TE
-,O
33.0,O
RDW,B-TE
-,O
13.0,O

2012-03-23,O
12:20,O

NEUTS,B-TE
-,O
84.7,O
*,O
LYMPHS,B-TE
-,O
13.1,O
*,O
MONOS,B-TE
-,O
1.5,O
*,O
EOS,B-TE
-,O
0.3,O
BASOS,B-TE
-,O
0.4,O

2012-03-23,O
12:20,O

PLT,B-TE
COUNT,I-TE
-,O
227,O

2012-03-23,O
12:20,O

PT,B-TE
-,O
14.1,O
*,O
PTT,B-TE
-,O
21.0,O
*,O
INR(PT),B-TE
-,O
1.2,O

2012-03-23,O
12:20,O

FIBRINOGE,B-TE
-,O
375,O

2012-03-26,O
04:30,O
AM,O
BLOOD,B-TE
WBC,B-TE
-,O
6.9,O
RBC,B-TE
-,O
3.28,O
*,O
Hgb,B-TE
-,O
9.8,O
*,O
Hct,B-TE
-,O
29.0,O
*,O
MCV,B-TE
-,O
89,O
MCH,B-TE
-,O
29.7,O
MCHC,B-TE
-,O
33.6,O
RDW,B-TE
-,O
13.1,O
Plt,B-TE
Ct,I-TE
-,O
206,O

2012-03-26,O
04:30,O
AM,O
BLOOD,B-TE
Plt,B-TE
Ct,I-TE
-,O
206,O

2012-03-26,O
04:30,O
AM,O
BLOOD,B-TE
Glucose,B-TE
-,O
88,O
UreaN,B-TE
-,O
10,O
Creat,B-TE
-,O
0.7,O
Na,B-TE
-,O
143,O
K-3.6,B-TE
Cl,B-TE
-,O
108,O
HCO3,B-TE
-,O
28,O
AnGap,B-TE
-,O
11,O

2012-03-26,O
04:30,O
AM,O
BLOOD,B-TE
Calcium,B-TE
-,O
8.5,O
Phos,B-TE
-,O
3.1,O
Mg,B-TE
-,O
1.9,O

2012-03-25,O
04:00,O
AM,O
BLOOD,B-TE
calTIBC,B-TE
-,O
237,O
*,O
Ferritn,B-TE
-,O
534,O
*,O
TRF,B-TE
-,O
182,O
*,O

Brief,O
Hospital,O
Course,O
:,O

A,O
:,O
39,O
year,O
old,O
male,O
w/,O
HTN,B-PR
",",O
chronic,B-PR
LBP,I-PR
on,O
narcotics,B-TR
presents,O
after,O
being,O
found,O
unresponsive,B-PR
at,O
home,O
.,O

P,O
:,O

1),O
Unresponsiveness,B-PR
:,O
This,O
is,O
likely,O
due,O
todrug,B-PR
overdose,I-PR
(,O
known,O
oxycontin,B-TR
use,O
",",O
(+),B-PR
BNZ,I-PR
on,O
tox,B-TE
screen,I-TE
).,O

Ddx,O
:,O
cardiac,B-PR
ischemia,I-PR
(,O
no,O
ischemic,B-PR
EKG,I-PR
changes,I-PR
noted,O
"),",O
seizure,B-PR
w/,O
post-ictal,B-PR
state,I-PR
",",O
CVA,B-PR
(,O
head,B-TE
CT,I-TE
neg,O
).,O

His,B-TE
cardiac,I-TE
enzymes,I-TE
include,O
only,O
elevated,B-PR
CK,I-PR
",",O
but,O
not,O
Shaffer,O
",",O
Juan,O
he,O
ruled,O
out,O
for,O
MI,B-PR
.,O

His,O
mental,O
status,O
gradually,O
improved,O
from,O
03-23,O
to,O
03-24,O
.,O

He,O
was,O
able,O
to,O
communicate,O
appropriately,O
as,O
his,B-TE
level,I-TE
of,O
narcotic,B-TR
medications,I-TR
waned,O
in,O
his,B-TE
blood,I-TE
.,O

He,O
was,O
able,O
to,O
maintain,O
a,O
stable,O
mental,O
level,O
for,O
extubation,B-TR
on,O
03-24,O
.,O

As,O
of,O
3/21,O
",",O
he,O
was,O
alert,O
",",O
appropriate,O
and,O
answers,O
questions,O
and,O
follows,O
command,O
on,O
exam,B-TE
.,O

2),O
Pulmonary,B-PR
infiltrates,I-PR
:,O
THere,O
was,O
initially,O
concern,O
that,O
he,O
was,O
developing,O
ARDS,B-PR
from,O
aspiration,B-PR
pneumonia,I-PR
in,O
the,O
setting,O
of,O
being,O
found,O
unconscious,B-PR
.,O

He,O
was,O
intubated,O
and,O
was,O
on,O
mechanical,B-TR
ventilation,I-TR
from,O
9/13-10/11,O
",",O
but,O
he,O
was,O
started,O
on,O
levofloxacin,B-TR

and,O
flagyl,B-TR
for,O
total,O
of,O
4,O
days,O
.,O

ON,O
03-26,O
",",O
his,B-TR
antibiotics,I-TR
were,O
started,O
as,O
this,O
most,O
likely,O
represent,O
a,B-PR
transiet,I-PR
aspiration,I-PR
episode,I-PR
and,O
not,O
ARDS,B-PR
.,O

3),O
Airway,B-TR
protection,I-TR
:,O
He,O
was,O
intubated,B-TR
in,O
the,O
field,O
for,O
airway,B-TR
protection,I-TR

He,O
was,O
extubated,B-TR
on,O
03-24,O
and,O
was,O
weaned,O
off,O
oxygen,B-TR
slowly,O
from,O
03-24,O
to,O
03-26,O
without,O
significant,O
event,O
.,O

4),O
Hypertension,B-PR
:,O
He,O
was,O
restarted,O
on,O
his,B-TR
atenolol,I-TR
and,O
verapamil,B-TR
once,O
his,B-TE
blood,I-TE
pressure,I-TE
stabilized,O
on,O
03-25,O
.,O

5),O
Depression,B-PR
:,O
He,O
was,O
restarted,O
on,O
his,B-TR
paxil,I-TR
on,O
03-25,O
and,O
was,O
given,B-TR
1:1,I-TR
sitter,I-TR
for,O
suicidal,B-PR
ideation,I-PR
leading,O
up,O
to,O
his,O
suicide,O
leading,O
up,O
to,O
this,O
admission,O
.,O

He,O
has,O
not,O
had,O
further,B-PR
episodes,I-PR
while,O
he,O
was,O
in,O
the,O
hospital,O
.,O

6),O
Hyperglycemia,B-PR
:,O
Although,O
he,O
has,O
no,O
known,O
history,O
of,O

7),O
High,B-PR
amylase,I-PR
:,O
He,O
was,O
admitted,O
on,O
03-23,O
with,O
elevated,B-PR
amylase,I-PR
but,O
non-elevated,B-PR
lipase,I-PR
.,O

This,O
likely,O
is,O
not,O
concerning,O
of,O
pancreatic,O
process,O
.,O

His,B-TE
amylase,I-TE
trended,O
down,O
.,O

He,O
was,O
restarted,O
on,O
regular,O
diet,O
on,O
4/14-4/17,O
after,O
his,B-TR
extubation,I-TR

8),O
Anemia,B-PR
-,O
He,O
was,O
admitted,O
with,O
borderline,B-PR
anemia,I-PR
with,O
Fe,B-TE
studies,I-TE
suggestive,O
of,O
anemia,B-PR
of,I-PR
chronic,I-PR
disease,I-PR
and,O
his,B-TE
hct,I-TE
decreased,O
in,O
the,O
setting,O
fluid,B-TR
resucitation,I-TR
.,O

His,B-TE
hct,I-TE
has,O
stabilized,O
and,O
improved,O
to,O
close,O
to,O
30,O
at,O
the,O
time,O
of,O
3/21,O
.,O

He,O
reports,O
that,O
his,O
primary,O
physician,O
is,O
aware,O
of,O
his,B-PR
anemia,I-PR
and,O
was,O
in,O
the,O
process,O
of,O
followup,O
.,O

Medications,O
on,O
Admission,O
:,O

Oxycontin,B-TR

Percocet,B-TR

Paxil,B-TR

Gabapentin,B-TR

Atenolol,B-TR

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Discharge,O
Diagnosis,O
:,O

benzodiazipine,B-PR
overdose,I-PR

Discharge,O
Condition,O
:,O

stable,O

Discharge,O
Instructions,O
:,O

please,O
take,O
your,B-TR
medications,I-TR
and,O
call,O
your,O
doctor,O
if,O
you,O
experience,O
chest,B-PR
pain,I-PR
",",O
abdominal,B-PR
pain,I-PR
or,O
shortness,B-PR
of,I-PR
breath,I-PR
or,O
any,B-PR
thoughts,I-PR
of,I-PR
hurting,I-PR
yourself,I-PR
or,I-PR
anyone,I-PR
else,I-PR
.,O

Followup,O
Instructions,O
:,O

please,O
call,O
your,O
primary,O
doctor,O
Edmund,O
Starke,O
once,O
your,O
are,O
discharge,O
from,O
the,O
hospital,O

Clemmie,O
Shawn,O
MD,O
65-948,O

Completed,O
by,O
:,O
Michael,O
Melvin,O
Kinzer,O
MD,O
51-991,O
2012-03-26,O
@,O
1709,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Justin,O
Pappas,O
on:,O
MON,O
2012-05-07,O
4:52,O
PM,O

(,O
End,O
of,O
Report,O
),O

125667950,O

PRGH,O

10805085,O

360731,O

10/22/2000,O
12:00:00,O
AM,O

CHRONIC,B-PR
LYMPHOCYTIC,I-PR
LEUKEMIA,I-PR

Signed,O

DIS,O

Admission,O
Date,O
:,O

10/22/2000,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

11/17/2000,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

CHRONIC,B-PR
LYMPHOCYTIC,I-PR
LEUKEMIA,I-PR
.,O

OTHER,O
PROBLEMS,O
:,O

1.,O
FREQUENT,B-PR
HEADACHES,I-PR
.,O

2.,O
CHOLECYSTITIS,B-PR
.,O

3.,O
SPASTIC,B-PR
COLON,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
47-year-old,O
man,O
with,O
advanced,B-PR
stage,I-PR
chronic,I-PR
lymphocytic,I-PR
leukemia,I-PR
who,O
was,O
admitted,O
for,O
autologous,B-TR
bone,I-TR
marrow,I-TR
transplant,I-TR
as,O
per,O
protocol,O
94-055,O
of,O
the,O
Santusli,O
Hospital,O
.,O

The,O
patient,O
was,O
originally,O
diagnosed,O
in,O
06/98,O
during,O
a,B-TE
routine,I-TE
physical,I-TE
when,O
he,O
was,O
noted,O
to,O
have,O
a,B-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
of,O
"20,000",O
",",O
weight,B-PR
loss,I-PR
",",O
and,O
swelling,B-PR
in,I-PR
his,I-PR
neck,I-PR
and,I-PR
groin,I-PR
.,O

He,O
was,O
watched,O
after,O
his,B-PR
initial,I-PR
diagnosis,I-PR
",",O
but,O
six,O
months,O
later,O
he,O
developed,O
rapidly,B-PR
increasing,I-PR
leukocytosis,I-PR
and,O
he,O
became,O
more,B-PR
symptomatic,I-PR
.,O

After,O
treatment,B-TR
with,I-TR
three,I-TR
cycles,I-TR
of,I-TR
fludarabine,I-TR
he,O
had,O
90%,B-PR
involvement,I-PR
of,I-PR
his,I-PR
intratrabecular,I-PR
space,I-PR
.,O

He,O
was,O
therefore,O
treated,O
with,O
three,B-TR
cycles,I-TR
of,I-TR
fludarabine,I-TR
in,O
combination,O
with,O
cytoxan,B-TR
.,O

After,O
this,B-TR
therapy,I-TR
he,O
achieved,O
a,B-PR
protocol,I-PR
eligible,I-PR
minimal,I-PR
disease,I-PR
state,I-PR
.,O

However,O
",",O
he,O
did,O
have,O
relative,B-PR
pancytopenia,I-PR
following,O
this,B-TR
therapy,I-TR
.,O

He,O
was,O
taken,O
to,O
bone,B-TR
marrow,I-TR
harvest,I-TR
in,O
08/22,O
at,O
which,O
time,O
insufficient,B-PR
cells,I-PR
were,O
obtained,O
to,O
proceed,O
.,O

He,O
was,O
returned,O
previous,O
to,O
this,O
admission,O
for,O
repeat,B-TR
bone,I-TR
marrow,I-TR
harvest,I-TR
and,O
at,O
that,O
time,O
he,O
was,O
given,O
Neupogen,B-TR
prior,O
to,O
his,B-TR
harvest,I-TR
",",O
and,O
sufficient,O
cells,O
were,O
not,O
obtained,O
to,O
proceed,O
with,O
autologous,B-TR
bone,I-TR
marrow,I-TR
transplantation,I-TR
.,O

His,B-TE
most,I-TE
recent,I-TE
bone,I-TE
marrow,I-TE
biopsy,I-TE
revealed,O
less,B-PR
than,I-PR
5%,I-PR
of,I-PR
intratrabecular,I-PR
space,I-PR
involvement,I-PR
.,O

Recent,B-TE
CT,I-TE
scan,I-TE
showed,O
no,O
significant,B-PR
lymphadenopathy,I-PR
.,O

The,O
spleen,O
was,O
within,O
normal,O
limits,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Episode,O
of,O
pneumonia,B-PR
in,O
1996,O
.,O

2.,O
At,O
the,O
age,O
of,O
40,O
he,O
had,O
problems,O
with,O
frequent,B-PR
headaches,I-PR
.,O

3.,O
Episodes,O
of,O
cholecystitis,B-PR
and,O
spastic,B-PR
colon,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

No,O
medications,B-TR
upon,O
admission,O
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

He,O
works,O
as,O
an,O
airline,O
pilot,O
for,O
Vent,O

He,O
is,O
currently,O
flying,O
on,O
Hwy,O
routes,O
.,O

He,O
was,O
married,O
for,O
many,O
years,O
.,O

He,O
has,O
three,O
children,O
.,O

He,O
is,O
separated,O
and,O
has,O
a,O
very,O
supportive,O
new,O
partner,O
.,O

FAMILY,O
HISTORY,O
:,O

His,O
father,O
had,O
prostate,B-PR
cancer,I-PR
.,O

Mother,O
had,O
breast,B-PR
cancer,I-PR
.,O

Has,O
a,O
cousin,O
with,O
a,B-PR
brain,I-PR
tumor,I-PR
.,O

No,O
family,O
history,O
of,O
leukemia,B-PR
or,O
lymphoma,B-PR
.,O

He,O
has,O
one,O
sister,O
and,O
one,O
brother,O
who,O
are,O
alive,O
and,O
well,O
.,O

They,O
are,O
not,O
HLA,O
matched,O
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

On,O
admission,O
he,O
had,O
no,O
upper,B-PR
respiratory,I-PR
tract,I-PR
symptoms,I-PR
",",O
recent,B-PR
infections,I-PR
",",O
chest,B-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
nausea,B-PR
or,O
vomiting,B-PR
",",O
change,B-PR
in,I-PR
bowel,I-PR
habits,I-PR
or,O
abdomen,B-PR
pain,I-PR
.,O

He,O
did,O
complain,O
of,O
frequent,B-PR
headaches,I-PR
.,O

Following,O
his,B-TR
recent,I-TR
bone,I-TR
marrow,I-TR
harvest,I-TR
he,O
had,O
protracted,O
episodes,O
of,O
nausea,B-PR
and,O
vomiting,B-PR
.,O

All,O
other,O
systems,O
were,O
negative,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,O
.,O

GENERAL,O
:,O

He,O
was,O
well-appearing,O
and,O
in,O
no,O
apparent,B-PR
distress,I-PR
.,O

Performance,O
status,O
was,O
0,O
.,O

VITAL,O
SIGNS,O
:,O

Weight,B-TE
70.4,O
kilograms,O
",",O
temperature,B-TE
96.5,O
",",O
respiratory,B-TE
rate,I-TE
20,O
",",O
blood,B-TE
pressure,I-TE
105/60,O
",",O
pulse,B-TE
76,O
.,O

SKIN,O
:,O

Unremarkable,O
without,O
rashes,B-PR
or,O
lesions,B-PR
.,O

HEENT,O
:,O

Sclerae,B-PR
anicteric,I-PR
.,O

Pupils,O
equal,O
",",O
round,O
and,O
reactive,O
to,O
light,O
.,O

Oropharynx,O
",",O
lips,O
",",O
teeth,O
and,O
gums,O
were,O
without,O
lesions,B-PR
and,O
without,O
evidence,O
of,O
mucositis,B-PR
.,O

NECK,O
:,O

Supple,O
with,O
a,O
normal,O
thyroid,O
gland,O
.,O

No,O
cervical,B-PR
",",I-PR
supraclavicular,I-PR
or,I-PR
axillary,I-PR
adenopathy,I-PR
.,O

CHEST,O
:,O

Clear,O
.,O

HEART,O
:,O

Heart,B-TE
sounds,I-TE
normal,O
.,O

ABDOMEN,O
:,O

Soft,O
",",O
nontender,B-PR
",",O
without,O
any,B-PR
masses,I-PR
and,O
without,O
any,B-PR
hepatosplenomegaly,I-PR
.,O

GU,O
:,O

Normal,O
testes,O
and,O
penis,O
.,O

EXTREMITIES,O
:,O

Without,O
clubbing,B-PR
",",O
cyanosis,B-PR
or,O
edema,B-PR
.,O

NEURO,O
:,O

Normal,O
with,O
intact,O
cranial,O
nerves,O
",",O
deep,O
tendon,O
reflexes,O
and,O
normal,O
motor,O
/,O
sensory,O
exam,O
.,O

LABORATORY,O
DATA,O
:,O

Electrolytes,B-TE
were,O
within,O
normal,O
limits,O
.,O

Liver,B-TE
function,I-TE
tests,I-TE
were,O
within,O
normal,O
limits,O
.,O

White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
10.4,O
",",O
hemoglobin,B-TE
11.9,O
",",O
platelets,B-TE
124,O
",",O
PT,B-TE
and,O
PTT,B-TE
were,O
within,O
normal,O
limits,O
.,O

HOSPITAL,O
COURSE,O
:,O

1,O
),O
Oncology,O
:,O

The,O
patient,O
was,O
admitted,O
on,O
10/22/00,O
and,O
received,O
cytoxan,B-TR
and,O
total,B-TR
body,I-TR
irradiation,I-TR
per,O
protocol,O
.,O

Autologous,B-TR
bone,I-TR
marrow,I-TR
infusion,I-TR
occurred,O
on,O
10/29/00,O
and,O
was,O
uneventful,O
.,O

His,O
post-transplant,O
course,O
was,O
complicated,O
by,O
pain,B-PR
from,O
mucositis,B-PR
and,O
recalcitrant,B-PR
nausea,I-PR
and,I-PR
vomiting,I-PR
.,O

The,O
patient,O
did,O
not,O
tolerate,O
antiemetics,B-TR
well,O
and,O
it,O
was,O
subsequently,O
decided,O
to,O
avoid,O
phenothiazides,B-TR
secondary,O
to,O
jitteryness,B-PR
and,O
restless,B-PR
legs,I-PR
.,O

2,O
),O
Infectious,O
Disease,O
:,O

The,O
patient,O
remained,O
afebrile,B-PR
until,O
day,O
+11,O
when,O
he,O
spiked,O
and,O
was,O
started,O
on,O
ceftazidime,B-TR
.,O

Blood,B-TE
cultures,I-TE
and,O
urine,B-TE
cultures,I-TE
were,O
all,O
negative,O
.,O

3,O
),O
Heme,O
:,O

The,O
patient,O
acquired,O
intermittent,B-TR
transfusions,I-TR
for,O
pancytopenia,B-PR
.,O

4,O
),O
FEN,O
:,O

The,O
patient,O
was,O
unable,O
to,O
tolerate,O
adequate,O
p.o.&apos;s,O
in,O
the,O
last,O
several,O
days,O
.,O

He,O
was,O
well,O
nourished,O
so,O
TPN,B-TR
was,O
not,O
started,O
.,O

I,B-TE
&apos;s,I-TE
and,I-TE
O,I-TE
&apos;s,I-TE
were,O
balanced,O
and,O
maintained,O
with,O
IV,B-TR
fluids,I-TR
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Tylenol,B-TR
650,O
mg,O
p.o.,O
q.,O
4-6h,O
p.r.n.,O
headache,B-PR
or,O
pain,B-PR
;,O
acyclovir,B-TR
400,O
mg,O
p.o.,O
t.i.d.;,O
acyclovir,B-TR
topical,I-TR
t.i.d.,O
to,O
be,O
applied,O
to,O
lesion,B-PR
on,I-PR
corner,I-PR
of,I-PR
mouth,I-PR
;,O
Peridex,B-TR
15,O
ml,O
p.o.,O
b.i.d.;,O
Mycelex,B-TR
1,O
troche,O
p.o.,O
t.i.d.;,O
g-csf,O
404,O
mcg,O
subcu,O
q.d.;,O
folic,B-TR
acid,I-TR
1,O
mg,O
p.o.,O
q.d.;,O
lorazepam,B-TR
1-2,O
mg,O
p.o.,O
q.,O
4-6h,O
p.r.n.,O
nausea,B-PR
and,O
vomiting,B-PR
;,O
Miracle,B-TR
Cream,I-TR
topical,O
q.d.,O
p.r.n.,O
perianal,B-PR
irritation,I-PR
;,O
Eucerin,B-TR
Cream,I-TR
topical,O
b.i.d.;,O
Zantac,B-TR
150,O
mg,O
p.o.,O
b.i.d.;,O
Restoril,B-TR
15-30,O
mg,O
p.o.,O
q.,O
h.s.,O
p.r.n.,O
insomnia,B-PR
;,O
multivitamin,B-TR
1,O
tablet,O
p.o.,O
q.d.;,O
viscous,B-TR
lidocaine,I-TR
15,O
ml,O
p.o.,O
q.,O
3h,O
can,O

CONDITION,O
UPON,O
DISCHARGE,O
:,O

Stable,O
.,O

FOLLOWUP,O
:,O

Follow,O
up,O
appointment,O
with,O
Die,O
Anoort,O
and,O
Tomedankell,O
Care,O
on,O
11/18/00,O
at,O
9:30,O
a.m.,O
(,O
one,O
day,O
after,O
discharge,O
),O
.,O

The,O
patient,O
knows,O
to,O
go,O
to,O
Sper,O
Medical,O
Center,O
every,O
day,O
for,O
line,B-TR
care,I-TR
",",O
blood,B-TE
draws,I-TE
",",O
and,O
monitoring,B-TE
.,O

Dictated,O
By,O
:,O

CONRELLIE,O
KOTERUDES,O
",",O
M.D.,O
VJ31,O

Attending,O
:,O

SUOT,O
CARE,O
",",O
M.D.,O
OB89,O
RL958/5760,O

Batch,O
:,O

24769,O

Index,O
No.,O
GFNC2Z5N8Q,O

D,O
:,O

11/22/00,O

T,O
:,O

11/22/00,O

CC,O
:,O

1.,O
TOMEDANKELL,O
CARE,O
",",O
M.D.,O
RE04,O

Admission,O
Date,O
:,O

2014-11-29,O

Discharge,O
Date,O
:,O

2014-12-05,O

Date,O
of,O
Birth,O
:,O

1967-08-29,O

Sex,O
:,O

F,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Penicillins,B-TR
/,O
Estrogens,B-TR
/,O
Ancef,B-TR
/,O
Tegretol,B-TR
/,O
Keflex,B-TR

Attending,O
:,O

Mary,O
S.,O
Corral,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

hypotension,B-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure:,O

Nephrostomy,B-TR
tube,I-TR
placement,I-TR

History,O
of,O
Present,O
Illness,O
:,O

47,O
yo,O
F,O
w/,O
h/o,O
steroid-induced,B-PR
hyperglycemia,I-PR
",",O
SLE,B-PR
w/,O
h/o,O
pericarditis,B-PR
",",O
transverse,B-PR
myelitis,I-PR
w/,O
paraplegia,B-PR
and,O
neurogenic,B-PR
bladder,I-PR
s/p,B-TR
urostomy,I-TR
w/,O
ileal,B-TR
conduit,I-TR
",",O
h/o,O
ureteropelvic,B-PR
stone,I-PR
and,O
urosepsis,B-PR
",",O
and,O
h/o,O
RLE,B-PR
DVT,I-PR
a/w,O
F,O
2014-11-29,O
transferred,O
to,O
CMED,O
2014-11-30,O
for,O
hypotn,B-PR
resistant,O
to,O
IVFs,B-TR
and,O
stress,B-TR
steroids,I-TR
.,O

Patient,O
initially,O
p/w,O
c/o,O
sudden,B-PR
onset,I-PR
N/abd,I-PR
pain/chills,I-PR
w/,O
T,B-TE
103,O
at,O
NH,O
.,O

Rigors,B-PR
progressed,O
so,O
she,O
was,O
brought,O
to,O
Robert,O
.,O

She,O
reported,O
h/o,O
fatigue,B-PR
and,O
anorexia,B-PR
for,O
the,O
past,O
few,O
days,O
and,O
had,O
noticed,O
foul,B-PR
smelling,I-PR
urine,I-PR
and,O
some,O
abdominal,B-PR
distension,I-PR
",",O
similar,O
to,O
prior,O
episodes,O
of,O
pyelo,B-PR
.,O

She,O
also,O
c/o,O
LLQ,B-PR
and,I-PR
groin,I-PR
pain,I-PR
which,O
responded,O
to,O
tylenol,B-TR
.,O

She,O
denies,O
V,B-PR
or,O
D,B-PR
.,O

No,O
AMS,B-PR
.,O

No,O
c/o,O
CP,B-PR
.,O

On,O
arrival,O
to,O
Shirley,O
",",O
temperature,B-TE
was,O
101.2,O
.,O

CT,B-TE
abd,I-TE
showed,O
an,B-PR
8,I-PR
mm,I-PR
right,I-PR
proximal,I-PR
ureteral,I-PR
stone,I-PR
with,O
right-sided,B-PR
hydronephrosis,I-PR
and,O
inflammatory,B-PR
stranding,I-PR
",",O
in,O
addition,O
to,O
pyelonephritis,B-PR
of,I-PR
the,I-PR
left,I-PR
kidney,I-PR
without,O
left,B-PR
sided,I-PR
hydronephrosis,I-PR
.,O

Labs,B-TE
were,O
remarkable,O
for,O
wbc,B-TE
23.5,O
w/,O
1%,O
bands,B-TE
which,O
decreased,O
to,O
14,O
today,O
but,O
now,O
w/,O
15%,O
bands,B-TE
on,O
vanc,B-TR
(,O
h/o,O
MRSA,B-PR
urosepsis,I-PR
),O
and,O
gent,B-TR
(,O
mult,B-PR
drug,I-PR
allergies,I-PR
),O
.,O

AG,B-TE
on,O
admission,O
18,O
(,O
bicarb,B-TE
17,O
",",O
down,O
from,O
23,O
on,O
a,O
previous,O
admission,O
),O
",",O
down,O
to,O
AG,B-TE
15,O
this,O
AM,O
.,O

ABG,B-TE
prior,O
to,O
transfer,O
(,O
on,O
room,O
air,O
),O
:,O

7.43/24/69,O
w/,O
lactate,B-TE
1.3,O
(,O
down,O
from,O
1.4,O
on,O
the,O
prior,O
day,O
),O
.,O

Currently,O
",",O
03-14,O
blood,B-TE
cx,I-TE
are,O
growing,O
GNR,B-PR
in,O
both,O
anaerobic,O
bottles,O
.,O

Urine,B-TE
cx,I-TE
is,O
pending,O
.,O

Prior,O
to,O
transfer,O
",",O
patient,O
dropped,O
bp,B-TE
to,O
68/40s,O
.,O

BP,B-TE
did,O
not,O
improve,O
despite,O
2,O
L,O
NS,B-TR
and,O
100,O
mg,O
IV,B-TR
hydrocortisone,I-TR
.,O

A,B-TR
central,I-TR
line,I-TR
was,O
placed,O
and,O
she,O
was,O
sent,O
to,O
IR,O
for,O
a,B-TR
right,I-TR
nephrostomy,I-TR
tube,I-TR
.,O

Past,O
Medical,O
History,O
:,O

Recurrent,B-PR
transverse,I-PR
myelitis,I-PR
with,O
sequelae,O
of,O
paraplegia-exacerbation,B-PR
in,O
93,O
Recurrent,B-PR
bilateral,I-PR
optic,I-PR
neuritis,I-PR
with,O
legal,O

(,O
neurologist,O
:,O
Dr.,O
Heaton,O
",",O
UMass,O
Memorial,O
Medical,O
Center,O
),O
-,O
(,O
steroids,B-TR
increased,O
to,O
40,O
qd,O
in,O
Renee,O
for,O
concern,O
for,O
recurrent,B-PR
optic,I-PR
neuritis,I-PR
which,O
turned,O
out,O
to,O
be,O
capsular,B-PR
ossification,I-PR
),O

2014-11-03,O

Social,O
History,O
:,O

Retired,O
ICU,O
nurse,O
.,O

Thomas,O
Haas,O
x,O
15,O
yrs,O
but,O
maintains,O
her,O
certification,O
.,O

Lives,O
at,O
Lowell,O
Home,O
NH,O
x,O
11,O
yrs,O
due,O
to,O
chronic,B-PR
CMED,I-PR
issues,I-PR
.,O

Her,O
doctor,O
there,O
is,O
Dr.,O
Gerald,O
Jones,O
.,O

No,O
h/o,O
tobacco,O
",",O
alcohol,O
",",O
or,O
IVDA,O
.,O

Wheelchair,B-PR
dependent,I-PR
+,O
requires,O
Hoyer,B-TR
lift,I-TR
.,O

UE,B-TE
strength,I-TE
intact,O
but,O
poor,B-PR
motor,I-PR
movements,I-PR
due,O
to,O
loss,B-PR
of,I-PR
sensation,I-PR
.,O

Family,O
History,O
:,O

Mother,O
died,O
at,O
51,O
metastatic,B-PR
BCA,I-PR

Father,O
died,O
at,O
36,O
aplastic,B-PR
anemia,I-PR
only,O
child,O

Physical,O
Exam,O
:,O

T,B-TE
100.0,O
bp,B-TE
109/56,O

CVP,B-TE
11,O
hr,B-TE
113,O
rr,B-TE
16,O

O2,B-TE
95%,O
on,O
3L,B-TR
NC,I-TR
mixed,O
Quinn,O
82%,O
genrl,O
:,O
in,O
nad,B-PR
",",O
resting,O
comfortably,O
heent,O
:,O
perrla,O
(,O
4->3,O
mm,O
),O
bilaterally,O
",",O
blind,B-PR
in,I-PR
right,I-PR
visual,I-PR
field,I-PR
",",O
eomi,O
",",O
dry,B-PR
mm,I-PR
",",O
?,O
thrush,B-PR
neck,O
:,O
no,O
bruits,B-PR
cv,O
:,O
rrr,O
",",O
no,O
m/r/g,B-PR
",",O
faint,B-PR
s1/s2,I-PR
pulm,O
:,O
cta,O
bilaterally,O
abd,O
:,O
midline,B-PR
scar,I-PR
(,O
from,O
urostomy,B-TR
),O
",",O
nabs,O
",",O
soft,O
",",O
appears,O
distended,B-PR
but,O
patient,O
denies,O
",",O
ostomy,B-TR
RLQ,O
c/d/i,O
",",O
NT,B-PR
to,O
palpation,B-TE
back,O
:,O
right,B-TR
flank,I-TR
urostomy,I-TR
tube,I-TR
",",O
c/d/i,O
",",O
nt,B-PR
to,O
palpation,B-TE
extr,O
:,O
no,O
Gardner,B-TE
neuro,O
:,O
a,O
",",O

UE,O
and,O
LE,O

Pertinent,O
Results,O
:,O

2014-11-29,O
05:11PM,O

WBC,B-TE
-,O
23.5*#,O
RBC,B-TE
-,O
3.81*,O
HGB,B-TE
-,O
9.4*,O
HCT,B-TE
-,O
29.2*,O

MCV,B-TE
-,O
77*#,O
MCH,B-TE
-,O
24.6*#,O
MCHC,B-TE
-,O
32.1,O
RDW,B-TE
-,O
18.1*,O

2014-11-29,O
05:11PM,O

NEUTS,B-TE
-,O
93*,O
BANDS,B-TE
-,O
1,O
LYMPHS,B-TE
-,O
0,O
MONOS,B-TE
-,O
6,O
EOS,B-TE
-,O
0,O

BASOS,B-TE
-,O
0,O
ATYPS,B-TE
-,O
0,O
METAS,B-TE
-,O
0,O
MYELOS,B-TE
-,O
0,O

2014-11-29,O
05:11PM,O

GLUCOSE,B-TE
-,O
229*,O
UREA,B-TE
N,O
-,O
25*,O
CREAT,B-TE
-,O
0.8,O
SODIUM,B-TE
-,O
136,O

POTASSIUM,B-TE
-,O
5.3*,O
CHLORIDE,B-TE
-,O
101,O
TOTAL,B-TE
CO2,I-TE
-,O
17*,O
ANION,B-TE
GAP,I-TE
-,O
23*,O

2014-11-29,O
05:11PM,O

LD,B-TE
(,I-TE
LDH,I-TE
),I-TE
-,O
214,O

2014-11-29,O
06:41PM,O

LACTATE,B-TE
-,O
1.4,O

2014-11-29,O
05:11PM,O
URINE,B-TE

COLOR,B-TE
-,O
Straw,O
APPEAR,B-TE
-,O
Hazy,O
SP,O
Thibodeaux,B-TE
-,O
1.008,O

2014-11-29,O
05:11PM,O
URINE,B-TE

BLOOD,B-TE
-,O
LG,O
NITRITE,B-TE
-,O
NEG,O
PROTEIN,B-TE
-,O
TR,O

GLUCOSE,B-TE
-,O
NEG,O
KETONE,B-TE
-,O
NEG,O
BILIRUBIN,B-TE
-,O
NEG,O
UROBILNGN,B-TE
-,O
NEG,O
PH,B-TE
-,O
9.0*,O

LEUK,B-TE
-,O
SM,O

2014-11-29,O
05:11PM,O
URINE,B-TE

RBC,B-TE
-,O
21-50*,O
WBC,B-TE
-,O
04-12,O
BACTERIA,B-TE
-,O
MANY,O

YEAST,B-TE
-,O
NONE,O
EPI,B-TE
-,O
0-2,O

2014-11-29,O
05:11PM,O
URINE,B-TE

3PHOSPHAT,B-TE
-,O
OCC,O

2014-11-29,O
CT,B-TE
CAP,I-TE
:,O

1.,O
An,B-PR
8,I-PR
x,I-PR
7,I-PR
x,I-PR
7,I-PR
mm,I-PR
stone,I-PR
in,I-PR
the,I-PR
proximal,I-PR
right,I-PR
ureter,I-PR
with,O
associated,O
right,B-PR
hydronephrosis,I-PR
and,O
inflammatory,B-PR
perinephric,I-PR
stranding,I-PR
.,O

Additional,B-PR
smaller,I-PR
non-obstructing,I-PR
right,I-PR
renal,I-PR
stones,I-PR
.,O

2.,O
Left,B-PR
renal,I-PR
stones,I-PR
without,O
evidence,O
of,O
hydronephrosis,B-PR
.,O

Ileal,B-TR
conduit,I-TR
is,O
not,O
well,O
evaluated,O
.,O

3.,O
Right,B-PR
breast,I-PR
calcification,I-PR
.,O

Correlation,O
with,O
mammography,B-TE
is,O
suggested,O
.,O

.,O

2014-11-29,O
CXR,B-TE
:,O

No,O
evidence,O
of,O
pneumonia,B-PR
.,O

.,O

2014-11-29,O
CT,B-TE
AP,I-TE
#2,I-TE
(,I-TE
with,I-TE
contrast,I-TE
),I-TE
:,O

1.,O
Eight,B-PR
mm,I-PR
right,I-PR
proximal,I-PR
ureteral,I-PR
stone,I-PR
with,O
right-sided,B-PR
hydronephrosis,I-PR
and,O
inflammatory,B-PR
stranding,I-PR
.,O

Pyelonephritis,B-PR
of,I-PR
the,I-PR
left,I-PR
kidney,I-PR
without,O
left,B-PR
sided,I-PR
hydronephrosis,I-PR
.,O

2.,O
No,O
evidence,O
of,O
intraabdominal,B-PR
abscess,I-PR
or,O
of,O
diverticulitis,B-PR
.,O

3.,O
Bilateral,B-PR
round,I-PR
",",I-PR
hypodense,I-PR
renal,I-PR
lesions,I-PR
",",O
too,O
small,O
to,O
accurately,O
characterize,O
but,O
likely,O
representing,O
cysts,B-PR
.,O

4.,O
1.4,B-PR
cm,I-PR
hypodense,I-PR
lesion,I-PR
in,I-PR
right,I-PR
lobe,I-PR
of,I-PR
the,I-PR
liver,I-PR
is,O
incompletely,O
characterized,O
.,O

.,O

2014-11-30,O
CT,B-TE
CAP,I-TE
:,O

1.,O
Nephrostomy,B-TR
tube,I-TR
in,I-TR
the,I-TR
right,I-TR
kidney,I-TR
with,O
an,B-PR
8,I-PR
mm,I-PR
right,I-PR
ureteric,I-PR
stone,I-PR
.,O

2.,O
6,B-PR
mm,I-PR
nonobstructing,I-PR
calculus,I-PR
in,I-PR
the,I-PR
left,I-PR
kidney,I-PR
.,O

3.,O
Calcified,B-PR
focus,I-PR
and,O
a,B-PR
small,I-PR
hypodense,I-PR
lesion,I-PR
in,I-PR
the,I-PR
right,I-PR
lobe,I-PR
of,I-PR
the,I-PR
liver,I-PR
",",O
incompletely,O
characterized,O
.,O

4.,O
Bibasilar,B-PR
and,I-PR
dependent,I-PR
atelectasis,I-PR
.,O

.,O

2014-11-29,O
5:10,O
pm,O
BLOOD,B-TE
CULTURE,I-TE

2,O

**FINAL,O
REPORT,O
2014-12-04**,O

AEROBIC,B-TE
BOTTLE,I-TE
(,O
Final,O
2014-12-04,O
),O
:,O

KLEBSIELLA,B-PR
PNEUMONIAE,I-PR
.,O

IDENTIFICATION,B-TE
AND,O
SENSITIVITIES,B-TE
PERFORMED,O
FROM,O

ANAEROBIC,B-TE
BOTTLE,I-TE
.,O

OF,O
TWO,B-PR
COLONIAL,I-PR
MORPHOLOGIES,I-PR
.,O

ANAEROBIC,B-TE
BOTTLE,I-TE
(,O
Final,O
2014-12-04,O
),O
:,O

REPORTED,O
BY,O
PHONE,O
TO,O
Robert,O
BURGER,O
2014-11-30,O
10:35A,O
.,O

KLEBSIELLA,B-PR
PNEUMONIAE,I-PR
.,O

FINAL,B-TE
SENSITIVITIES,I-TE
.,O

Trimethoprim/Sulfa,B-TE
sensitivity,I-TE
testing,I-TE
available,O
on,O
request,O
.,O

KLEBSIELLA,B-PR
PNEUMONIAE,I-PR
.,O

FINAL,B-TE
SENSITIVITIES,I-TE
.,O

Trimethoprim/Sulfa,B-TE
sensitivity,I-TE
testing,I-TE
available,O
on,O
request,O
.,O

2ND,O
STRAIN,O
.,O

SENSITIVITIES,B-TE
:,O

MIC,B-TE
expressed,O
in,O
MCG/ML,O

_________________________________________________________,O

KLEBSIELLA,B-PR
PNEUMONIAE,I-PR

|,O

KLEBSIELLA,B-PR
PNEUMONIAE,I-PR

|,O

|,O

AMPICILLIN/SULBACTAM--,B-TR

=>32,O
R,O

=>32,O
R,O

CEFAZOLIN-------------,B-TR

<=4,O
S,O

<=4,O
S,O

CEFEPIME--------------,B-TR

<=1,O
S,O

<=1,O
S,O

CEFTAZIDIME-----------,B-TR

<=1,O
S,O

<=1,O
S,O

CEFTRIAXONE-----------,B-TR

<=1,O
S,O

<=1,O
S,O

CEFUROXIME------------,B-TR

4,O
S,O

4,O
S,O

CIPROFLOXACIN---------,B-TR

=>4,O
R,O

=>4,O
R,O

GENTAMICIN------------,B-TR

8,O
I,O

8,O
I,O

IMIPENEM--------------,B-TR

<=1,O
S,O

<=1,O
S,O

LEVOFLOXACIN----------,B-TR

=>8,O
R,O

=>8,O
R,O

MEROPENEM-------------,B-TR

<=0.25,O
S,O

<=0.25,O
S,O

PIPERACILLIN/TAZO-----,B-TR

<=4,O
S,O

<=4,O
S,O

TOBRAMYCIN------------,B-TR

4,O
S,O

8,O
I,O

.,O

2014-11-30,O
1:50,O
pm,O
"URINE,KIDNEY",O

PERC.,O
NEPH.,O
.,O

**FINAL,O
REPORT,O
2014-12-03**,O

FLUID,B-TE
CULTURE,I-TE
(,O
Final,O
2014-12-03,O
),O
:,O

Due,O
to,O
mixed,B-PR
bacterial,I-PR
types,I-PR
(,O

STAPH,B-PR
AUREUS,I-PR
COAG,I-PR
+,I-PR
.,O

">100,000",O
ORGANISMS/ML.,B-TE
.,O

OF,O
TWO,B-PR
COLONIAL,I-PR
MORPHOLOGIES,I-PR
.,O

Oxacillin,B-PR
RESISTANT,I-PR
Staphylococci,I-PR
MUST,O
be,O
reported,O
as,O
also,O
RESISTANT,O
to,O
other,O
penicillins,B-TR
",",O
cephalosporins,B-TR
",",O
carbacephems,B-TR
",",O
carbapenems,B-TR
",",O
and,O
beta-lactamase,B-TR
inhibitor,I-TR
combinations,I-TR
.,O

Rifampin,B-TR
should,O
not,O
be,O
used,O
alone,O
for,O
therapy,B-TR
.,O

GRAM,O
NEGATIVE,O
ROD(,O
S,O
),O
.,O

">100,000",O
ORGANISMS/ML.,B-TE
.,O

OF,O
TWO,B-PR
COLONIAL,I-PR
MORPHOLOGIES,I-PR
.,O

SENSITIVITIES,B-TE
:,O

MIC,B-TE
expressed,O
in,O

MCG/ML,O

_________________________________________________________,O

STAPH,B-PR
AUREUS,I-PR
COAG,I-PR
+,O

|,O

GENTAMICIN------------,B-TR

=>16,O
R,O

LEVOFLOXACIN----------,B-TR

=>8,O
R,O

NITROFURANTOIN--------,B-TR

<=16,O
S,O

OXACILLIN-------------,B-TR

=>4,O
R,O

PENICILLIN------------,B-TR

=>0.5,O
R,O

TETRACYCLINE----------,B-TR

=>16,O
R,O

VANCOMYCIN------------,B-TR

<=1,O
S,O

.,O

2014-12-03,O
BLOOD,B-TE
CULTURE,I-TE

AEROBIC,B-TE
BOTTLE,I-TE
-,O
PENDING,O
;,O
ANAEROBIC,B-TE
BOTTLE,I-TE
-,O
PENDING,O

2014-12-03,O
BLOOD,B-TE
CULTURE,I-TE

AEROBIC,B-TE
BOTTLE,I-TE
-,O
PENDING,O
;,O
ANAEROBIC,B-TE
BOTTLE,I-TE
-,O
PENDING,O

2014-12-02,O
URINE,B-TE

URINE,B-TE
CULTURE,I-TE
-,O
FINAL,O
No,O
Growth,O

2014-12-02,O
CATHETER,B-TR
TIP,I-TR
-,I-TR
IV,I-TR

WOUND,B-TE
CULTURE,I-TE
-,O
FINAL,O
No,O
Growth,O

2014-12-02,O
BLOOD,B-TE
CULTURE,I-TE

AEROBIC,B-TE
BOTTLE,I-TE
-,O
PENDING,O
;,O
ANAEROBIC,B-TE
BOTTLE,I-TE
-,O
PENDING,O

Brief,O
Hospital,O
Course,O
:,O

47,O
yo,O
F,O
w/,O
h/o,O
steroid-induced,B-PR
hyperglycemia,I-PR
",",O
SLE,B-PR
w/,O
h/o,O
pericarditis,B-PR
",",O
transverse,B-PR
myelitis,I-PR
w/,O
paraplegia,B-PR
and,O
neurogenic,B-PR
bladder,I-PR
s/p,O
urostomy,B-TR
w/,O
ileal,B-TR
conduit,I-TR
",",O
h/o,O
ureteropelvic,B-PR
stone,I-PR
and,O
urosepsis,B-PR
",",O
and,O
h/o,O
RLE,B-PR
DVT,I-PR
admitted,O
11-29,O
w/,O
left,B-PR
pyelo,I-PR
and,O
right,B-PR
8,I-PR
mm,I-PR
proximal,I-PR
ureteral,I-PR
stone,I-PR
w/,O
right,B-PR
hydro,I-PR
s/p,O
perc,B-TR
urostomy,I-TR
tube,I-TR
to,O
relieve,O
right,B-PR
hydro,I-PR
.,O

.,O

Upon,O
admission,O
",",O
pt,O
was,O
febrile,B-PR
to,O
101.2,O
with,O
U/A,B-TE
consistent,O
with,O
UTI,B-PR
.,O

A,B-TE
CT,I-TE
abd,I-TE
showed,O
8mm,B-PR
obstructing,I-PR
stone,I-PR
",",O
hydro,B-PR
with,O
stranding,B-PR
consistent,O
with,O
pylonephritis,B-PR
.,O

Her,O
presentation,O
was,O
thought,O
likely,O
due,O
to,O
urosepsis,B-PR
given,O
h/o,O
foul,B-PR
smelling,I-PR
urine,I-PR
and,O
in,O
setting,O
of,O
stone,B-PR
w/,O
hydro,B-PR
+,O
pyelo,B-PR
by,O
CT.,B-TE
The,O
patient,O
went,O
to,O
IR,O
on,O
2014-11-30,O
given,O
evidence,O
of,O
right,B-PR
hydronephrosis,I-PR
on,O
imaging,B-TE
for,O
decompression,B-TR
and,O
drainage.,B-TR
Upon,O
admission,O
",",O
she,O
was,O
treated,O
with,O
Vancomycin,B-TR
and,O
Gentamycin,B-TR
and,O
Flagyl,B-TR
.,O

She,O
was,O
started,O
on,O
the,B-TR
MUST,I-TR
protocol,I-TR
with,O
high,B-TR
dose,I-TR
steroids,I-TR
as,O
well,O
and,O
a,O
goal,O
SVO2,B-TE
>70%,O
.,O

She,O
was,O
hypoxic,B-PR
requiring,O
3L,B-TR
nasal,I-TR
cannula,I-TR
O2,I-TR
.,O

She,O
subsequently,O
developed,O
hypotension,B-PR
with,O
SBP,B-TE
in,O
the,O
70s,O
.,O

She,O
was,O
transferred,O
to,O
the,O
CMED,O
where,O
the,O
patient,O
was,O
continued,O
on,O
the,B-TR
MUST,I-TR
protocol,I-TR
with,O
goais,O
of,O
CVP,B-TE
10-12,O
",",O
SVO2,B-TE
greater,O
than,O
70%,O
.,O

The,O
patient,O
was,O
bolused,O
with,O
NS,B-TR
and,O
did,O
not,O
required,O
pressors,B-TR
.,O

On,O
the,O
day,O
after,O
admission,O
to,O
the,O
CMED,O
",",O
the,O
patient,O
was,O
noted,O
to,O
have,O
small,B-PR
oxygen,I-PR
requirement,I-PR
with,O
2L,B-TR
NC,I-TR
.,O

Repeat,B-TE
imaging,I-TE
revealed,O
evidence,O
of,O
mild,B-PR
pulmonary,I-PR
congestion,I-PR
which,O
was,O
thought,O
to,O
account,O
for,O
the,B-PR
patient,I-PR
's,I-PR
mild,I-PR
hypoxia,I-PR
.,O

Given,O
that,O
the,O
patient,O
had,O
been,O
maintaining,O
a,B-TE
MAP,I-TE
of,O
60,O
without,O
fluids,B-TR
or,O
pressors,B-TR
",",O
her,O
goal,O
CVP,B-TE
was,O
decreased,O
to,O
>8,O
to,O
avoid,O
fluid,B-PR
overload,I-PR
.,O

The,O
patient,O
was,O
continued,O
on,O
Vancomycin,B-TR
and,O
Gentamycin,B-TR
while,O
speciation,B-TE
and,O
sensitivities,B-TE
were,O
pending,O
.,O

Ciprofloxacin,B-TR
was,O
added,O
on,O
2014-12-01,O
for,O
synergy,O
when,O
surveillance,B-TE
cultures,I-TE
were,O
found,O
to,O
be,O
growing,O
again,O
GNR,B-PR
.,O

Gent,B-TR
and,O
Cipro,B-TR
were,O
then,O
discontinued,O
and,O
changed,O
to,O
meropenem,B-TR
when,O
blood,B-TE
culture,I-TE
sensitivities,I-TE
became,O
available,O
revealing,O
GNR,B-PR
sensitive,O
to,O
Jacoby,B-TR
but,O
resistant,O
to,O
both,O
Gent,B-TR
and,O
Cipro,B-TR
.,O

Additionaly,O
surveillance,B-TE
cultures,I-TE
were,O
drawn,O
daily,O
and,O
the,O
patient,O
was,O
transferred,O
back,O
to,O
the,O
floor,O
with,O
no,O
subsequent,B-PR
pressor,I-PR
requirement,I-PR
.,O

Blood,B-TE
cltures,I-TE
from,O
11-30,O
grew,O
KLEBSIELLA,B-PR
PNEUMONIAE,I-PR
and,O
12-01,O
grew,O
KLEBSIELLA,B-PR
PNEUMONIAE,I-PR
and,O
PROTEUS,B-PR
MIRABILIS,I-PR
both,O
sensitive,O
to,O
the,B-TR
Meropenam,I-TR
which,O
she,O
had,O
already,O
been,O
receiving,O
.,O

Urine,B-TE
cultures,I-TE
from,O
11-30,O
grew,O
STAPH,B-PR
AUREUS,I-PR
COAG,I-PR
+,O
",",O
and,O
GRAM,B-PR
NEGATIVE,I-PR
RODS,I-PR
of,O
two,O
morphologies,O
(,O
not,O
further,O
speciated,O
),O
.,O

She,O
defervesed,O
by,O
12-02,O
and,O
remained,O
clinically,O
stable,O
with,O
normal,O
blood,O
pressures,O
until,O
the,O
day,O
of,O
discharge,O
.,O

At,O
the,O
time,O
of,O
discharge,O
",",O
blood,B-TE
cultures,I-TE
from,O
12-02,O
and,O
12-03,O
have,O
no,O
growth,B-PR
to,O
date,O
.,O

She,O
received,O
a,B-TR
midline,I-TR
on,O
12-04,O
with,O
a,O
goal,O
of,O
16,O
days,O
of,O
further,B-TR
antibiotic,I-TR
treatment,I-TR
with,O
Meropenam,B-TR
(,O
for,O
a,O
total,O
of,O
3,O
weeks,O
),O
upon,O
discharge,O
back,O
to,O
the,O
nursing,O
home,O
where,O
she,O
lives,O
.,O

.,O

Given,O
right,B-PR
sided,I-PR
hydronephrosis,I-PR
and,O
GNR,B-PR
bactermeia,I-PR
",",O
a,B-TR
percutaneous,I-TR
nephrostomy,I-TR
tube,I-TR
was,O
placed,O
by,O
IR,O
2014-11-30,O
.,O

The,O
patient,O
put,O
out,O
1385,O
cc,O
urine,O
the,O
day,O
after,O
placement,O
",",O
950,O
cc,O
of,O
which,O
came,O
from,O
nephrostomy,B-TR
tube,I-TR
.,O

The,B-TR
tube,I-TR
appeared,O
to,O
be,O
functioning,O
well,O
",",O
draining,O
urine,O
with,O
occasional,B-PR
clot,I-PR
passage,I-PR
.,O

Urology,O
was,O
notified,O
about,O
the,B-PR
clots,I-PR
and,O
occasional,B-PR
blood,I-PR
tinged,I-PR
urine,I-PR
but,O
they,O
did,O
not,O
make,O
any,O
further,O
recommendations,O
.,O

Cultures,B-TE
from,I-TE
urine,I-TE
drawn,O
from,O
the,B-TR
nephrostomy,I-TR
tube,I-TR
are,O
currently,O
growing,O
>,O
100K,O
GNR,B-PR
",",O
possibly,O
of,O
two,B-PR
colony,I-PR
morphologies,I-PR
",",O
speciation,B-TE
and,O
sensitivity,B-TE
pending,O
.,O

.,O

On,O
admission,O
to,O
hospital,O
patient,O
had,O
Hct,B-TE
of,O
29.2,O
.,O

In,O
the,O
setting,O
of,O
Right,B-TR
sublavian,I-TR
line,I-TR
placement,I-TR
as,O
well,O
as,O
nephrostomy,B-TR
tube,I-TR
placement,I-TR
the,O
patient,O
was,O
noted,O
to,O
have,O
a,B-PR
drifting,I-PR
Hct,I-PR
",",O
concerning,O
for,O
bleed,B-PR
",",O
with,O
nadir,B-TE
of,O
22.8,O
on,O
2014-12-01,O
.,O

A,B-TE
CT,I-TE
abdomen,I-TE
was,O
performed,O
which,O
did,O
not,O
demonstrate,O
any,B-PR
retroperitoneal,I-PR
bleed,I-PR
.,O

Hct,B-TE
stabilized,O
to,O
24,O
for,O
three,O
days,O
prior,O
to,O
discharge,O
.,O

This,O
can,O
be,O
followed,O
as,O
an,O
outpatient,O
.,O

Anemia,B-TE
workup,I-TE
revealed,O
a,O
picture,O
of,O
anemia,B-PR
of,I-PR
chronic,I-PR
disease,I-PR
(,O
TIBC,B-TE
225,O
",",O
B12,B-TE
and,O
Folate,B-TE
normal,O
",",O
Hapto,B-TE
397,O
",",O
Ferritin,B-TE
51,O
",",O
TRF,B-TE
173,O
",",O
Iron,B-TE
35,O
),O
.,O

.,O

The,O
patient,O
on,O
admission,O
was,O
requiring,O
3,B-TR
L,I-TR
NC,I-TR
in,O
the,O
setting,O
of,O
receiving,O
2L,B-TR
NS,I-TR
and,O
chest,B-TE
film,I-TE
which,O
demonstrated,O
pulmonary,B-PR
congestion,I-PR
.,O

The,O
patient,O
was,O
not,O
diuresed,O
but,O
allowed,O
to,O
auto-diurese,O
any,O
additional,O
fluids,O
and,O
is,O
currently,O
with,O
O2,B-TE
sats,I-TE
97-98%,O
on,O
room,O
air,O
.,O

As,O
her,B-TE
BP,I-TE
remained,O
stable,O
she,O
did,O
not,O
receiving,O
any,B-TR
standing,I-TR
fluids,I-TR
but,O
was,O
be,O
bolused,B-TR
as,O
appropriate,O
for,O
a,B-TE
MAP,I-TE
<,O
60,O
or,O
CVP,B-TE
<,O
8,O
with,O
careful,O
monitoring,O
of,O
pulmonary,O
status,O
.,O

Patient,O
had,O
an,B-TE
echocardiogram,I-TE
in,O
2012,O
which,O
demonstrated,O
an,B-TE
EF,I-TE
of,O
60-65%,O
.,O

her,B-PR
O2,I-PR
requirement,I-PR
by,O
discharge,O
was,O
96%,O
on,O
room,O
air,O
with,O
no,O
SOB,B-PR
.,O

.,O

At,O
home,O
",",O
the,O
patient,O
received,O
metformin,B-TR
and,O
SSI,B-TR
.,O

The,B-TR
patient,I-TR
's,I-TR
metformin,I-TR
was,O
held,O
and,O
she,O
has,O
been,O
maintained,O
on,O
SSI,B-TR
qid,O
while,O
in,O
the,O
CMED,O
.,O

As,O
the,O
patient,O
appeared,O
to,O
be,O
clinically,O
stable,O
",",O
her,B-TR
stress,I-TR
dose,I-TR
steroids,I-TR
were,O
discontinued,O
and,O
the,O
patient,O
was,O
changed,O
back,O
to,O
her,O
home,O
dose,O
of,O
Prednisone,B-TR
40mg,O
PO,O
qd,O
for,O
maintenance,O
with,O
anticipated,O
decrease,O
in,O
her,B-TE
blood,I-TE
sugars,I-TE
.,O

Her,B-TR
Metformin,I-TR
was,O
re-added,O
2,O
days,O
prior,O
to,O
discharge,O
as,O
well,O
and,O
fingerstick,B-TE
glucoses,I-TE
on,O
the,O
day,O
of,O
discharge,O
were,O
93,O
and,O
156,O
",",O
respectively,O
.,O

.,O

Repeat,B-TE
TSH,I-TE
and,O
Free,B-TE
T4,I-TE
were,O
appropriate,O
on,O
current,B-TR
outpatient,I-TR
regimen.,I-TR
Patient,O
was,O
continued,O
on,O
Levothyroxine,B-TR
75mcg,O
po,O
qd,O
.,O

.,O

On,O
stress,B-TR
dose,I-TR
steroids,I-TR
originally,O
given,O
MUST,B-TR
protocol,I-TR
and,O
sepsis,B-PR
",",O
as,O
patient,O
clinically,O
stabilized,O
",",O
she,O
was,O
changed,O
back,O
to,O
home,O
dose,O
of,O
Prednisone,B-TR
40mg,O
pO,O
qd,O
.,O

.,O

Currently,O
no,O
sx,B-PR
of,I-PR
active,I-PR
disease,I-PR
.,O

No,O
manifestations,O
of,O
SLE,B-PR
during,O
this,O
admission,O
.,O

.,O

#,O
Osteoporosis,B-PR
-,O
We,O
continued,O
actonel/vit,B-TR
D,I-TR
",",O
Tums,B-TR

.,O

We,O
continued,O
CMED,B-TR
CSRU,I-TR
gtt,I-TR
.,O

.,O

She,O
had,O
a,B-PR
low,I-PR
bicarb,I-PR
likely,O
due,O
to,O
renal,B-PR
wasting,I-PR
but,O
there,O
is,O
an,B-PR
anion,I-PR
gap,I-PR
present,O
.,O

Serum,B-TE
acetone,I-TE
was,O
normal,O
.,O

We,O
followed,O
lactate,B-TE
while,O
she,O
was,O
in,O
the,O
CMED,O
which,O
was,O
normal,O
.,O

She,O
was,O
NPO,B-TR
periodically,O
but,O
maintained,O
a,O
normal,O
diet,O
prior,O
to,O
discharge,O
.,O

.,O

#,O
PPX,O
-,O
SQ,B-TR
Heparin,I-TR
during,O
this,O
admission,O
",",O
PPI,B-TR

.,O

.,O

To,O
nursing,O
home,O
for,O
follow,O
up,O
with,O
Dr.,O
Hipp,O
(,O
urology,O
),O
this,O
coming,O
Monday,O
",",O
12-08,O
at,O
1:30pm,O
and,O
with,O
her,O
PCP,O
at,O
the,O
nursing,O
home,O

Medications,O
on,O
Admission,O
:,O

Home,B-TR
Meds,I-TR
:,O

Ascorbic,B-TR
Acid,I-TR
500,O
TID,O

Cranberry,B-TR
Extract,I-TR
425,O
BID,O

Bisacodyl,B-TR
10mg,O

Senna,B-TR

Dephenhydramine,B-TR
50mg,O
prn,O
loperamide,B-TR
prn,O
famotidine,B-TR
20mg,O

KCL,B-TR
20mg,O
QD,O

Metformin,B-TR
1000,O
qd,O
tums,B-TR
1500,O
bid,O

MVI,B-TR

Timolol,B-TR
1,O
Drop,O
BID,O
0.5%,O
L,O
CMED,O
CSRU,O

Synthroid,B-TR
75,O
QD,O

Compro,B-TR
25mg,O
pr,O

Citrucel,B-TR

Vitamin,B-TR
D,I-TR
50k,O
Qmondays,O

Oxazepam,B-TR
15mg,O
qhs,O
tizamidine,B-TR
8mg,O
qhs,O
actonel,B-TR
35,O
qwed,O

Diovan,B-TR
80,O
qd,O
prednisone,B-TR
40,O
qd,O
bactrim,B-TR
ds,I-TR
qmwf,O
baclofen,B-TR
pump,I-TR
2-3yrs,O

Insulin,B-TR
SS,I-TR

.,O

Meds,O
on,O
transfer,O
:,O

Actonel,B-TR
35,O
mg,O
Oral,O
qwednesdays,O

Ascorbic,B-TR
Acid,I-TR
500,O
mg,O
PO,O
TID,O

Sodium,B-TR
Polystyrene,I-TR
Sulfonate,I-TR
15,O
gm,O
PO,O
ONCE,O
11-29,O
@,O
2201,O

Famotidine,B-TR
20,O
mg,O
PO,O
DAILY,O

Sulfameth/Trimethoprim,B-TR
DS,O
1,O
TAB,O
PO,O
QMOWEFR,O

Gentamicin,B-TR
80,O
mg,O
IV,O
Q8H,O

Timolol,B-TR
Maleate,I-TR
0.5%,O
1,O
DROP,O
OS,O
BID,O

Heparin,B-TR
5000,O
UNIT,O
SC,O
TID,O

Tizanidine,B-TR
HCl,I-TR
8,O
mg,O
PO,O
QHS,O

Hydrocortisone,B-TR
Na,I-TR
Succ.,I-TR
100,O
mg,O
IV,O
Q8H,O

11-30,O
@,O
0906,O

Valsartan,B-TR
80,O
mg,O
PO,O
DAILY,O

Insulin,B-TR
SC,I-TR
(,O
per,O
Insulin,O
Flowsheet,O
),O

Vancomycin,B-TR
HCl,I-TR
1000,O
mg,O
IV,O
Q,O
12H,O

Levothyroxine,B-TR
Sodium,I-TR
75,O
mcg,O
PO,O
DAILY,O

Vitamin,B-TR
D,I-TR
"50,000",O
UNIT,O
PO,O
QWEDNESDAYS,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Discharge,O
Diagnosis,O
:,O

GNR,B-PR
Sepsis,I-PR
;,O
Steroid,B-PR
induced,I-PR
hyperglycemia,I-PR
;,O
Hydronephrosis,B-PR
;,O
SLE,B-PR

Discharge,O
Condition,O
:,O

Stable,O

Discharge,O
Instructions,O
:,O

Pls,O
take,O
all,B-TR
meds,I-TR
as,O
prescribed,O
.,O

Call,O
your,O
doctor,O
immediately,O
if,O
any,B-PR
new,I-PR
symptoms,I-PR
develop,O
including,O
fevers,B-PR
",",O
rash,B-PR
",",O
increase,B-PR
in,I-PR
bloody,I-PR
urine,I-PR
in,O
nephrostomy,B-TR
or,O
urostomy,B-TR
bags,I-TR
",",O
etc,O
.,O

Follow,O
up,O
appointments,O
listed,O
below,O
.,O

Followup,O
Instructions,O
:,O

With,O
Dr.,O
Vivian,O
Hansen,O
",",O
UMass,O
Memorial,O
Medical,O
Center,O
",",O
3rd,O
floor,O
Morris,O
on,O
Monday,O
12-08,O
at,O
@,O
1:30pm,O
(,O
you,O
also,O
have,O
an,O
appointment,O
scheduled,O
with,O
Dr.,O
Hipp,O
for,O
01-14,O
),O
.,O

.,O

Provider,O
:,O

Sheena,O

Phone,O
:,O

361-438-6334,O

Date/Time,O
:,O
2015-01-07,O
8:30,O

Colleen,O
Thomas,O
MD,O
80-548,O

Completed,O
by,O
:,O

Edward,O
James,O
MD,O
50-497,O
2014-12-05,O
@,O
1042,O

Signed,O
electronically,O
by,O
:,O

DR.,O
Ronald,O
Z.,O
Thome,O
on,O
:,O

Robert,O
2015-01-15,O
5:13,O
PM,O

(,O
End,O
of,O
Report,O
),O

125721767,O

CTMC,O

34028893,O

597337,O

3/31/2001,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

03/31/2001,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

MYASTHENIA,B-PR
GRAVIS,I-PR
.,O

SECONDARY,O
DIAGNOSES,O
:,O

1.,O
HYPOTHYROIDISM,B-PR
.,O

2.,O
HISTORY,O
OF,O
THYMOMA,B-PR
",",O
STATUS,O
POST,O
RESECTION,B-TR
.,O

3.,O
HYPERTENSION,B-PR
.,O

4.,O
HISTORY,O
OF,O
COLON,B-PR
CANCER,I-PR
",",O
STATUS,O
POST,O
RESECTION,B-TR
.,O

5.,O
BENIGN,B-PR
PROSTATIC,I-PR
HYPERTROPHY,I-PR
.,O

6.,O
HYDROCELE,B-PR
.,O

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

ECHOCARDIOGRAM,B-TE
",",O
CARDIAC,B-TE
CATHETERIZATION,I-TE
",",O
EMG,B-TE
",",O
CT,B-TE
SCAN,I-TE
OF,I-TE
THE,I-TE
CHEST,I-TE
.,O

MEDICATIONS,O
:,O

Aspirin,B-TR
325,O
q.d.,O
;,O
albuterol,B-TR
nebs,I-TR
2.5,O
mg,O
q.,O
4h,O
;,O
Colace,B-TR
100,O
mg,O
b.i.d.,O
;,O
heparin,B-TR
"5,000",O
units,O
subcu,O
b.i.d.,O
;,O
Synthroid,B-TR
200,O
mcg,O
q.d.,O
;,O
Ocean,B-TR
Spray,I-TR
2,O
sprays,O
q.,O
i.d.,O
;,O
simvastatin,B-TR
10,O
mg,O
q.,O
h.s.,O
;,O
Flovent,B-TR
220,O
mcg,O
2,O
puffs,O
b.i.d.,O
;,O
Zantac,B-TR
150,O
b.i.d.,O
;,O
nystatin,B-TR
ointment,I-TR
to,O
the,O
gluteal,O
fold,O
b.i.d.,O
;,O
Lisinopril,B-TR
20,O
mg,O
q.d.,O
;,O
Mestinon,B-TR
controlled,I-TR
release,I-TR
180,O
q.,O
h.s.,O
;,O
Mestinon,B-TR
30,O
mg,O
q.,O
4h,O
while,O
awake,O
;,O
prednisone,B-TR
60,O
mg,O
p.o.,O
q.,O
IM,O
;,O
Atrovent,B-TR
nebs,I-TR
0.5,O
mg,O
q.,O
i.d.,O

DIET,O
:,O

No,O
restrictions,O
.,O

ACTIVITY,O
:,O

As,O
tolerated,O
.,O

HOSPITAL,O
COURSE,O
:,O

This,O
is,O
a,O
72-year-old,O
male,O
with,O
a,O
history,O
of,O
thymoma,B-PR
resected,O
in,O
1996,O
",",O
chronic,B-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
",",O
hypothyroidism,B-PR
who,O
was,O
transferred,O
from,O
Gobay,O
Hos,O
Memorial,O
Hospital,O
for,O
an,B-PR
myocardial,I-PR
infarction,I-PR
and,O
cardiac,B-TE
catheterization,I-TE
.,O

The,O
patient,O
developed,O
shortness,B-PR
of,I-PR
breath,I-PR
at,O
home,O
and,O
the,O
EMTs,O
were,O
called,O
and,O
the,O
patient,O
was,O
found,O
to,O
be,O
in,O
respiratory,B-PR
distress,I-PR
.,O

He,O
was,O
transferred,O
to,O
Gobay,O
Hos,O
Memorial,O
Hospital,O
where,O
chest,B-TE
x-ray,I-TE
showed,O
left,B-PR
lower,I-PR
lobe,I-PR
infiltrate,I-PR
and,O
cardiac,B-TE
enzymes,I-TE
were,O
elevated,B-PR
with,O
a,B-TE
CK,I-TE
of,O
297,O
",",O
MB,B-TE
fraction,I-TE
of,O
38,O
and,O
troponin,B-TE
of,O
12,O
.,O

The,O
patient,O
was,O
transferred,O
to,O
the,O
medicine,O
service,O
at,O
the,O
Retelk,O
County,O
Medical,O
Center,O
and,O
underwent,O
cardiac,B-TE
catheterization,I-TE
which,O
was,O
negative,O
for,O
disease,B-PR
.,O

He,O
continued,O
to,O
complain,O
of,O
shortness,B-PR
of,I-PR
breath,I-PR
with,O
an,O
episode,O
of,O
respiratory,B-PR
failure,I-PR
in,O
the,O
hospital,O
requiring,O
100%,B-TR
nonrebreather,I-TR
.,O

Neurology,O
was,O
consulted,O
for,O
difficulty,B-PR
lifting,I-PR
his,I-PR
arms,I-PR
.,O

On,O
consultation,O
the,O
patient,O
admitted,O
to,O
dysphasia,B-PR
and,O
periods,O
of,O
diplopia,B-PR
in,O
the,O
past,O
.,O

The,O
patient,O
was,O
found,O
to,O
have,O
weakness,B-PR
in,I-PR
the,I-PR
proximal,I-PR
muscles,I-PR
as,O
well,O
as,O
the,O
capability,O
of,O
the,O
muscles,O
.,O

He,O
was,O
started,O
on,O
IV,B-TR
ig,I-TR
and,O
IV,B-TR
Solu-Medrol,I-TR
for,O
a,O
diagnosis,O
of,O
myasthenia,B-PR
gravis,I-PR
given,O
his,O
past,O
history,O
of,O
thymoma,B-PR
.,O

He,O
markedly,O
improved,O
after,O
a,O
dose,O
of,O
Mestinon,B-TR
.,O

He,O
completed,O
a,O
five-day,O
course,O
of,O
IV,B-TR
ig,I-TR
.,O

His,B-TE
work,I-TE
up,I-TE
included,O
acetylcholine,B-TE
esterase,I-TE
",",O
receptor,B-TE
antibodies,I-TE
",",O
thyroglobulin,B-TE
antibody,I-TE
is,O
pending,O
.,O

An,B-TE
ANA,I-TE
and,O
rheumatoid,B-TE
factor,I-TE
were,O
negative,O
.,O

Sed,B-TE
rate,I-TE
was,O
58,O
and,O
repeat,O
75,O
.,O

EMG,B-TE
studies,I-TE
were,O
performed,O
",",O
the,O
result,O
is,O
pending,O
at,O
the,O
time,O
of,O
this,O
dictation,O
.,O

He,O
also,O
had,O
a,B-TE
repeat,I-TE
chest,I-TE
CT,I-TE
which,O
showed,O
a,O
question,O
of,O
recurrence,O
of,O
the,B-PR
thymoma,I-PR
.,O

Thoracic,O
Surgery,O
was,O
consulted,O
and,O
recommended,O
repeating,O
the,B-TE
CT,I-TE
scan,I-TE
in,O
six,O
weeks,O
as,O
an,O
outpatient,O
.,O

This,O
could,O
represent,O
either,O
recurrence,O
of,O
scar,B-PR
tissue,I-PR
.,O

The,O
patient,O
was,O
tapered,O
to,O
p.o.,B-TR
prednisone,I-TR
and,O
tolerated,O
Mestinon,B-TR
30,O
mg,O
q.,O
4h,O
with,O
180,O
mg,O
longacting,O
at,O
bedtime,O
.,O

Dictated,O
By,O
:,O

THYRNCINDE,O
BOTH,O
",",O
M.D.,O
VZ84,O

Attending,O
:,O

LENNI,O
E.,O
STENT,O
",",O
M.D.,O
UQ5,O
MX420/8849,O

Batch,O
:,O

85467,O

Index,O
No.,O
EJDFG7458J,O

D,O
:,O

2004-07-01,O

T,O
:,O

2004-10-01,O

Admission,O
Date,O
:,O

2010-09-06,O

Discharge,O
Date,O
:,O

2010-09-17,O

Date,O
of,O
Birth,O
:,O

1968-04-26,O

Sex,O
:,O

M,O

Service,O
:,O

ADDENDUM,O
:,O

The,O
patient,O
was,O
extubated,O
overnight,O
without,O
incident,B-PR
.,O

He,O
had,O
a,O
good,O
cardiac,O
index,O
off,O
all,B-TR
inotropic,I-TR
medications,I-TR
and,O
his,B-TR
Swan-Ganz,I-TR
catheter,I-TR
was,O
discontinued,O
.,O

The,O
patient,O
underwent,O
an,B-TR
exchange,I-TR
peritoneal,I-TR
dialysis,I-TR
.,O

The,O
Parrack,O
Diabetes,O
Center,O
was,O
consulted,O
to,O
help,O
manage,O
the,B-PR
patient,I-PR
's,I-PR
hyperglycemia,I-PR
.,O

By,O
postoperative,O
day,O
two,O
",",O
the,O
patient,O
had,O
remained,O
in,O
sinus,O
rhythm,O
and,O
his,B-TR
Lopressor,I-TR
was,O
increased,O
.,O

He,O
was,O
having,O
a,O
bit,O
of,O
a,B-PR
respiratory,I-PR
acidosis,I-PR
",",O
therefore,O
",",O
bicarbonate,B-TR
was,O
added,O
to,O
the,B-TR
dialysate,I-TR
.,O

His,B-TR
mediastinal,I-TR
chest,I-TR
tubes,I-TR
were,O
removed,O
",",O
however,O
",",O
his,B-TR
pleural,I-TR
chest,I-TR
tubes,I-TR
remained,O
in,O
place,O
.,O

On,O
postoperative,O
day,O
three,O
",",O
it,O
was,O
apparent,O
that,O
",",O
despite,O
an,B-TE
oxygen,I-TE
saturation,I-TE
of,O
99%,O
on,O
three,O
liters,O
",",O
that,O
the,O
patient,O
was,O
still,O
in,O
a,B-PR
respiratory,I-PR
acidosis,I-PR
",",O
and,O
he,O
received,O
aggressive,B-TR
pulmonary,I-TR
toilette,I-TR
.,O

His,B-TR
pleural,I-TR
chest,I-TR
tubes,I-TR
were,O
removed,O
.,O

On,O
postoperative,O
day,O
four,O
",",O
the,B-TR
patient,I-TR
Cordis,I-TR
was,O
removed,O
.,O

His,B-TR
Lopressor,I-TR
was,O
increased,O
another,O
increment,O
.,O

The,O
patient,O
was,O
subsequently,O
transferred,O
to,O
the,O
floor,O
on,O
postoperative,O
day,O
five,O
in,O
stable,O
and,O
good,O
condition,O
.,O

Once,O
on,O
the,O
floor,O
",",O
the,O
patient,O
had,O
an,O
uneventful,O
hospital,O
course,O
",",O
remaining,O
afebrile,B-PR
for,O
the,O
remainder,O
of,O
his,O
hospital,O
stay,O
.,O

The,O
patient,O
's,O
only,O
issue,O
was,O
his,B-PR
hypertension,I-PR
.,O

On,O
postoperative,O
day,O
seven,O
",",O
the,O
patient,O
had,O
a,B-TE
peak,I-TE
blood,I-TE
pressure,I-TE
of,O
210/100,O
.,O

The,O
decision,O
was,O
made,O
to,O
start,O
the,O
patient,O
on,O
lisinopril,B-TR
",",O
and,O
the,O
initial,O
dose,O
of,O
7.5,O
mg,O
was,O
increased,O
to,O
10,O
mg,O
daily,O
by,O
the,O
day,O
of,O
discharge,O
in,O
order,O
to,O
control,O
his,B-TE
pressure,I-TE
more,O
tightly,O
.,O

On,O
postoperative,O
day,O
seven,O
",",O
the,O
patient,O
was,O
refusing,O
to,O
be,O
discharged,O
to,O
a,O
rehabilitation,O
facility,O
despite,O
his,O
doctor,O
's,O
insistence,O
that,O
he,O
would,O
do,O
much,O
better,O
in,O
an,O
assisted,O
environment,O
.,O

Nevertheless,O
",",O
the,O
patient,O
was,O
adamant,O
about,O
going,O
home,O
.,O

The,O
patient,O
was,O
discharged,O
on,O
postoperative,O
day,O
seven,O
and,O
arrangements,O
were,O
made,O
to,O
have,O
physical,O
therapy,O
perform,O
a,B-TE
home,I-TE
safety,I-TE
evaluation,I-TE
for,O
the,O
patient,O
",",O
to,O
which,O
he,O
agreed,O
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

Coronary,B-PR
artery,I-PR
disease,I-PR
",",O
status,O
post,O
coronary,B-TR
artery,I-TR
bypass,I-TR
grafting,I-TR
times,O
three,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Lopressor,B-TR
100,O
mg,O
p.o.b.i.d.,O

Lisinopril,B-TR
10,O
mg,O
p.o.q.d.,O

Lipitor,B-TR
10,O
mg,O
p.o.q.d.,O

Aspirin,B-TR
81,O
mg,O
p.o.q.d.,O

Percocet,B-TR
one,O
to,O
two,O
tablets,O
p.o.q.,O
3-4,O
h.,O
p.r.n.,O
pain,B-PR
.,O

Colace,B-TR
100,O
mg,O
p.o.b.i.d.,O

DISCHARGE,O
PHYSICAL,O
EXAMINATION,O
:,O

The,O
patient,O
had,O
a,B-TE
temperature,I-TE
of,O
98.4,O
",",O
heart,B-TE
rate,I-TE
72,O
",",O
blood,B-TE
pressure,I-TE
154/89,O
",",O
respiratory,B-TE
rate,I-TE
18,O
and,O
oxygen,B-TE
saturation,I-TE
90%,O
in,O
room,O
air,O
.,O

He,O
was,O
alert,O
and,O
oriented,O
.,O

His,O
neck,O
was,O
supple,O
without,O
lymphadenopathy,B-PR
.,O

He,O
had,O
faint,B-PR
bibasilar,I-PR
crackles,I-PR
on,O
lung,B-TE
examination,I-TE
.,O

His,O
heart,O
had,O
a,O
regular,O
rate,O
and,O
rhythm,O
with,O
no,O
murmur,B-PR
",",O
rub,B-PR
or,O
gallop,B-PR
.,O

His,O
abdomen,O
was,O
soft,O
",",O
nontender,B-PR
and,O
nondistended,B-PR
with,O
a,B-PR
nonerythematous,I-PR
peritoneal,I-PR
dialysis,I-PR
insertion,I-PR
site,I-PR
.,O

Extremities,O
were,O
warm,O
and,O
well,O
perfused,O
.,O

DR,O
.,O
Kemp,O
",",O
Julie,O
R.,O
02-358,O

Dictated,O
By,O
:,O
Judy,O
Y,O
Carnevale,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2010-09-18,O
19:42,O

T,O
:,O
2010-09-22,O
11:10,O

JOB,O
#,O
:,O
34822,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Dalila,O
Talbot,O
on,O
:,O
Robert,O
2010-09-23,O
4:07,O
PM,O

(,O
End,O
of,O
Report,O
),O

126304158,O

PRGH,O

30872450,O

619542,O

2/10/1998,O
12:00:00,O
AM,O

CORONARY,B-PR
ARTERY,I-PR
DISEASE,I-PR

Unsigned,O

DIS,O

Admission,O
Date,O
:,O

02/10/1998,O

Report,O
Status,O
:,O

Unsigned,O

Discharge,O
Date,O
:,O

02/26/1998,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
69,O
year-old,O
white,O
gentleman,O
who,O
is,O
status,O
post,O
a,B-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
in,O
1985,O
with,O
a,B-PR
large,I-PR
anterior,I-PR
septal,I-PR
myocardial,I-PR
infarction,I-PR
intraoperatively,O
.,O

Two,O
years,O
after,O
this,B-TR
operation,I-TR
",",O
he,O
required,O
a,B-TR
pacer,I-TR
implantation,I-TR
for,O
sick,B-PR
sinus,I-PR
syndrome,I-PR
.,O

The,O
patient,O
presents,O
now,O
with,O
progressive,B-PR
dyspnea,I-PR
",",O
but,O
no,O
anginal,B-PR
pain,I-PR
.,O

Ejection,B-TE
fraction,I-TE
was,O
noted,O
to,O
be,O
20%,O
.,O

He,O
is,O
status,O
post,O
multiple,B-TR
angioplasty,I-TR
stents,I-TR
.,O

He,O
presents,O
now,O
for,O
possible,O
reoperative,B-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1,O
),O
Non-insulin,B-PR
dependent,I-PR
diabetes,I-PR
mellitus,I-PR
.,O

2,O
),O
Coronary,B-PR
artery,I-PR
disease,I-PR
",",O
status,O
post,O
coronary,B-TR
artery,I-TR
bypass,I-TR
graft,I-TR
",",O
status,O
post,O
anterior,B-PR
myocardial,I-PR
infarction,I-PR
",",O
sick,B-PR
sinus,I-PR
syndrome,I-PR
",",O
status,O
post,O
a,B-TR
VVI,I-TR
pacer,I-TR
placement,I-TR
.,O

Cardiac,B-TE
catheterization,I-TE
demonstrates,O
severe,B-PR
triple,I-PR
vessel,I-PR
coronary,I-PR
artery,I-PR
disease,I-PR
",",O
RCA,B-PR
100%,I-PR
occluded,I-PR
",",O
saphenous,B-TR
vein,I-TR
graft,I-TR
to,O
OM1,B-TR
graft,I-TR
was,O
100%,B-PR
occluded,I-PR
and,O
a,O
patent,O
LIMA,O
",",O
but,O
severely,B-PR
diseased,I-PR
LAD,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

1,O
),O
Enteric,B-TR
coated,I-TR
aspirin,I-TR
325,O
mg,O
p.o.,O
q.,O
day,O
.,O

2,O
),O
Capoten,B-TR
25,O
mg,O
p.o.,O
t.i.d.,O

3,O
),O
Lanoxin,B-TR
0.25,O
mg,O
p.o.,O
q.,O
day,O
.,O

4,O
),O
Cardizem,B-TR
125,O
mg,O
p.o.,O
q.,O
day,O
.,O

5,O
),O
Glucotrol,B-TR
XL,I-TR
10,O
mg,O
p.o.,O
b.i.d.,O

6,O
),O
Glucophage,B-TR
500,O
mg,O
p.o.,O
q.,O
day,O
.,O

7,O
),O
Amaryl,B-TR
2,O
mg,O
p.o.,O
q.h.s.,O

PHYSICAL,O
EXAMINATION,O
:,O

Physical,B-TE
examination,I-TE
revealed,O
that,O
the,B-TE
vital,I-TE
signs,I-TE
were,O
stable,O
.,O

Lungs,O
were,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

Heart,O
was,O
irregular,B-PR
with,O
no,O
murmurs,B-PR
palpated,O
.,O

Abdomen,O
was,O
benign,O
.,O

Pulses,B-TE
were,O
2+,O
throughout,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
Verg,O
Medical,O
Center,O
.,O

Subsequent,B-TE
exercise,I-TE
treadmill,I-TE
test,I-TE
demonstrated,O
no,O
evidence,O
of,O
ischemia,B-PR
by,O
EKG,B-TE
.,O

The,O
patient,O
was,O
subsequently,O
taken,O
to,O
the,O
operating,O
room,O
where,O
he,O
underwent,O
a,B-TR
reoperative,I-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
times,I-TR
three,I-TR
with,O
a,B-TR
subaortic,I-TR
proximal,I-TR
graft,I-TR
from,O
the,O
aorta,O
to,O
the,O
OM1,O
and,O
then,O
OM2,O
and,O
aorta,O
to,O
the,O
LAD,O
with,O
a,B-TR
wide,I-TR
graft,I-TR
per,O
Dr.,O
Lumar,O
Jongguild,O
.,O

Postoperatively,O
",",O
the,O
patient,O
was,O
ventilated,O
.,O

The,O
patient,O
was,O
weaned,O
off,O
an,B-TR
Epinephrine,I-TR
drip,I-TR
.,O

Rhythm,B-TE
became,O
more,O
stable,O
.,O

Balloon,B-TR
was,O
weaned,O
and,O
finally,O
discontinued,O
.,O

The,O
patient,O
was,O
extubated,O
.,O

His,B-TR
Melranon,I-TR
was,O
weaned,O
off,O
and,O
his,B-TR
ACE,I-TR
inhibitor,I-TR
began,O
.,O

The,O
patient,O
was,O
started,O
on,O
Amiodarone,B-TR
and,O
diuresed,O
.,O

The,O
patient,O
&apos;s,O
lower,O
extremities,O
began,O
to,O
swell,O
and,O
the,O
patient,O
was,O
begun,O
on,O
Hirudin,B-TR
for,O
deep,B-PR
venous,I-PR
thrombosis,I-PR
.,O

The,B-PR
patient,I-PR
&apos;s,I-PR
heparin,I-PR
induced,I-PR
thrombocytopenia,I-PR
became,O
positive,O
and,O
so,O
he,O
is,O
allergic,B-PR
to,O
heparin,B-TR
.,O

The,O
patient,O
was,O
begun,O
on,O
Coumadin,B-TR
and,O
he,O
stayed,O
several,O
days,O
for,O
Coumadinization,B-TR
and,O
was,O
finally,O
discharged,O
on,O
therapeutic,B-TR
Coumadin,I-TR
.,O

The,O
patient,O
tolerated,O
a,O
regular,O
diet,O
on,O
postoperative,O
day,O
number,O
thirteen,O
from,O
his,B-TR
reoperative,I-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

1,O
),O
Amiodarone,B-TR
400,O
mg,O
p.o.,O
q.,O
day,O
.,O

2,O
),O
Captopril,B-TR
50,O
mg,O
p.o.,O
t.i.d.,O

3,O
),O
Digoxin,B-TR
0.125,O
mg,O
p.o.,O
q.,O
day,O
.,O

4,O
),O
Colace,B-TR
100,O
mg,O
p.o.,O
t.i.d.,O

5,O
),O
Lasix,B-TR
80,O
mg,O
p.o.,O
b.i.d.,O

6,O
),O
Potassium,B-TR
chloride,I-TR
40,O
mEq,O
p.o.,O
b.i.d.,O

7,O
),O
Glucophage,B-TR
500,O
mg,O
p.o.,O
q.,O
day,O
.,O

8,O
),O
Glucotrol,B-TR
XL,I-TR
10,O
mg,O
p.o.,O
b.i.d.,O

9,O
),O
Coumadin,B-TR
5,O
mg,O
p.o.,O
q.,O
day,O
.,O

FOLLOW-UP,O
:,O

The,O
patient,O
was,O
instructed,O
to,O
follow-up,O
with,O
Dr.,O
Lumar,O
Jongguild,O
.,O

Dictated,O
By,O
:,O

RAMAG,O
TROISQUARCKAYS,O
",",O
M.D.,O
JB48,O

Attending,O
:,O

LUMAR,O
R.,O
JONGGUILD,O
",",O
M.D.,O
NJ48,O
RO267/6080,O

Batch,O
:,O

5076,O

Index,O
No.,O
KHQTW3FS3,O

D,O
:,O

04/26/98,O

T,O
:,O

04/27/98,O

Admission,O
Date,O
:,O

2016-03-31,O

Discharge,O
Date,O
:,O

2016-04-01,O

Date,O
of,O
Birth,O
:,O

1965-10-09,O

Sex,O
:,O

M,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Vicodin,B-TR

Attending,O
:,O
Richard,O
S.,O
Humphries,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O
chest,B-PR
pain,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

Cardiac,B-TE
Catheterization,I-TE

History,O
of,O
Present,O
Illness,O
:,O

50,O
yo,O
male,O
",",O
h/o,O
CAD,B-PR
s/p,O
stent,B-TR
to,I-TR
LAD,I-TR
in,O
2011,O
",",O
Hypercholesterolemia,B-PR
",",O
DM,B-PR
",",O
cocaine,O
abuse,O
",",O
presenting,O
with,O
chest,B-PR
pain,I-PR
.,O

He,O
states,O
he,O
had,O
onset,O
of,O
this,B-PR
pain,I-PR
today,O
;,O
described,O
as,O
anterior,B-PR
chest,I-PR
pain,I-PR
with,O
radiation,B-PR
to,I-PR
right,I-PR
shoulder,I-PR
",",O
09-26,O
",",O
was,O
increasing,O
over,O
the,O
course,O
of,O
45,O
minutes,O
to,O
1,O
hour,O
(,O
occurred,O
after,O
arrested,O
).,O

He,O
states,O
that,O
he,O
also,O
felt,O
SOB,B-PR
and,O
diaphoretic,B-PR
but,O
denies,O
n/v/palpitations,B-PR
.,O

He,O
reports,O
that,O
the,B-PR
pain,I-PR
was,O
increasing,O
in,O
intensity,O
.,O

He,O
was,O
brought,O
to,O
Providence,O
Behavioral,O
Health,O
Hospital,O
where,O
he,O
was,O
found,O
to,O
have,O
positive,O
urine,O
cocaine,O
",",O
EKG,B-TE
with,O
new,O
2-7392,O
W.,O
Second,O
Cr.,O
elevations,B-PR
in,I-PR
the,I-PR
anterior,I-PR
leads,I-PR
(,I-PR
v2-5,I-PR
),I-PR
and,O
some,B-PR
ST,I-PR
depressions,I-PR
in,I-PR
II,I-PR
",",I-PR
III,I-PR
",",I-PR
AvF,I-PR
.,O

He,O
was,O
given,O
lopressor,B-TR
5,O
mg,O
x,O
2,O
(,O
3rd,O
dose,O
given,O
by,O
medflight,O
",",O
5,O
mg,O
morphine,B-TR
",",O
ativan,B-TR
",",O
nitro,B-TR
gtt,I-TR
",",O
heparin,B-TR
",",O
and,O
integrillin,B-TR
.,O

Pain,B-PR
was,O
12-28,O
at,O
time,O
of,O
transfer,O
.,O

In,O
the,O
cath,O
lab,O
",",O
he,O
was,O
found,O
to,O
have,O
hazy,B-PR
plaque,I-PR
in,I-PR
LAD,I-PR
(,O
prior,B-TR
stent,I-TR
),O
",",O
80%,B-PR
hazy,I-PR
plaque,I-PR
in,I-PR
circumflex,I-PR
",",O
and,O
a,B-PR
totally,I-PR
occluded,I-PR
PLB,I-PR
(,I-PR
with,I-PR
collaterals,I-PR
),I-PR
.,O

1,B-TR
cypher,I-TR
stent,I-TR
was,O
place,O
in,O
the,O
LAD,O
while,O
2,O
were,O
placed,O
in,O
Lcx,O
.,O

Right,O
system,O
was,O
not,O
intervened,O
upon,O
",",O
for,O
the,O
PLB,O
was,O
unable,O
to,O
be,O
crossed,O
by,O
wire,B-TR
.,O

He,O
was,O
transferred,O
to,O
the,O
CCU,O
for,O
observation,B-TE
.,O

Past,O
Medical,O
History,O
:,O

1.,O
CAD,B-PR
",",O
s/p,O
MI,B-PR
in,O
2011,O
with,O
stenting,B-TR
of,I-TR
LAD,I-TR

2.,O
Hypercholesterolemia,B-PR

3.,O
DM,B-PR

Social,O
History,O
:,O

Lives,O
with,O
friend,O

History,O
of,O
cocaine,O
use,O
",",O
most,O
recent,O
use,O
day,O
of,O
admission,O

Etoh,O
use,O
",",O
01-21,O
drinks,O
/,O
day,O
",",O
most,O
recently,O
on,O
day,O
of,O
admission,O

Former,O
smoker,O
",",O
quit,O
4,O
yrs,O
ago,O
",",O
30,O
pack,O
year,O
history,O

Arrested,O
on,O
day,O
of,O
admission,O
for,O
soliciting,O
prostitute,O
(,O
undercover,O
police,O
officer,O
),O
",",O
currently,O
in,O
police,O
custody,O

Family,O
History,O
:,O

No,O
CAD,B-PR
in,O
1st,O
degree,O
relatives,O
.,O

Robert,O
sudden,B-PR
death,I-PR

Physical,O
Exam,O
:,O

VS,B-TE
:,O
94.1,O
130/81,O
71,O
21,O
99%,O
4L,B-TR
NC,I-TR

Gen,O
:,O
somnolent,B-PR
",",O
pleasant,O
male,O
",",O
lying,O
in,O
bed,O

HEENT,O
:,O
PERRL,O
",",O
some,B-PR
dried,I-PR
blood,I-PR
on,I-PR
lips,I-PR
",",I-PR
tongue,I-PR

Neck,O
:,O
no,O
LAD,B-PR
",",O
?,O
enlarged,B-PR
parotid,I-PR
glands,I-PR
bilaterally,I-PR

CV,O
:,O
RRR,O
",",O
nl,O
s1/s2,O
",",O
with,O
S4,B-PR
",",O
no,O
m/r,B-PR

Lungs,O
:,O
CTA,O
bilaterally,O
",",O
no,O
w/r/r,B-PR

Abdomen,O
:,O
protuberant,B-PR
",",O
nt/nd,B-PR
",",O
nabs,O

Right,O
groin,O
:,O
with,O
sheath,B-TR
in,O
place,O

Extr,O
:,O
DP/PT,B-TE
2+,O
bilaterally,O
",",O
no,O
c/c/e,B-PR

Pertinent,O
Results,O
:,O

Catheterization,B-TE
on,O
2016-03-31,O
:,O

HEMODYNAMICS,O
RESULTS,O
BODY,O
SURFACE,O
AREA,O
:,O

1.87,O
m2,O

HEMOGLOBIN,B-TE
:,O

14,O
gms,O
%,O

FICK,B-TE

**,O
PRESSURES,O

RIGHT,B-TE
ATRIUM,I-TE
{,O
a/v/m,O
},O
18/17/13,O

RIGHT,B-TE
VENTRICLE,I-TE
{,O
s/Ruben,O
},O
45/18,O

PULMONARY,B-TE
ARTERY,I-TE
{,O
s/d/m,O
},O
45/22,O

PULMONARY,B-TE
WEDGE,I-TE
{,O
a/v/m,O
},O
21/22/20,O

AORTA,B-TE
{,O
s/d/m,O
},O
97/66/81,O

**,O
CARDIAC,O
OUTPUT,O

HEART,B-TE
RATE,I-TE
{,O
beats/min,O
},O
88,O

RHYTHM,O
SINUS,O

O2,B-TE
CONS.,I-TE
IND,I-TE
{,O
ml/min/m2,O
},O
125,O

A-V,B-TE
O2,I-TE
DIFFERENCE,I-TE
{,O
ml/ltr,O
},O
32,O

CARD.,B-TE
OP/IND,I-TE
FICK,I-TE
{,O
l/mn/m2,O
},O
7.3/3.9,O

**,O
RESISTANCES,O

SYSTEMIC,B-TE
VASC.,I-TE
RESISTANCE,I-TE
745,O

**%,O
SATURATION,O
DATA,O
(,O
NL,O
),O

SVC,B-TE
LOW,I-TE
81,O

PA,B-TE
MAIN,I-TE
81,O

AO,B-TE
98,O

OTHER,O
HEMODYNAMIC,O
DATA,O
:,O

The,B-TE
oxygen,I-TE
consumption,I-TE
was,O
assumed,O
.,O

**,O
ARTERIOGRAPHY,O
RESULTS,O
MORPHOLOGY,O
%,O
STENOSIS,O
COLLAT.,O
FROM,O

**,O
RIGHT,O
CORONARY,O

1),O
PROXIMAL,B-TE
RCA,I-TE
:,O
NORMAL,O

2),O
MID,B-TE
RCA,I-TE
:,O
NORMAL,O

2A),O
ACUTE,B-TE
MARGINAL,I-TE
:,O
NORMAL,O

3),O
DISTAL,B-TE
RCA,I-TE
:,O
NORMAL,O

4),O
R-PDA,B-TE
:,O
NORMAL,O

4A),O
R-POST-LAT,B-TE
:,O
DISCRETE,O
100,O

4B),O
R-LV,B-TE
:,O
NORMAL,O

**,O
ARTERIOGRAPHY,O
RESULTS,O
MORPHOLOGY,O
%,O
STENOSIS,O
COLLAT.,O
FROM,O

**,O
LEFT,O
CORONARY,O

5),O
LEFT,B-TE
MAIN,I-TE
:,O
NORMAL,O

6),O
PROXIMAL,B-TE
LAD,I-TE
:,O
ULCERATED,B-PR

6A),O
SEPTAL-1,B-TE
:,O
NORMAL,O

7),O
MID-LAD,B-TE
:,O
NORMAL,O

8),O
DISTAL,B-TE
LAD,I-TE
:,O
NORMAL,O

9),O
DIAGONAL-1,B-TE
:,O
NORMAL,O

10),O
DIAGONAL-2,B-TE
:,O
NORMAL,O

12),O
PROXIMAL,B-TE
CX,I-TE
:,O
DISCRETE,O
80,O

13),O
MID,B-TE
CX,I-TE
:,O
NORMAL,O

13A),O
DISTAL,B-TE
CX,I-TE
:NORMAL,O

14),O
OBTUSE,B-TE
MARGINAL,I-TE
-,I-TE
1,I-TE
:,O
NORMAL,O

15),O
OBTUSE,B-TE
MARGINAL,I-TE
-,I-TE
2,I-TE
:,O
NORMAL,O

16),O
OBTUSE,B-TE
MARGINAL,I-TE
-,I-TE
3,I-TE
:,O
NORMAL,O

Proximal,O
LAD,O
with,O
hazy,B-PR
ulceration,I-PR
",",O
proximal,O
circumflex,O
with,O
80%,B-PR
hazy,I-PR
",",O
totally,B-PR
occluded,I-PR
PLB,I-PR
with,I-PR
collaterals,I-PR

1,B-TR
cypher,I-TR
stent,I-TR
placed,O
in,O
LAD,O
",",O
2,B-TR
cypher,I-TR
stents,I-TR
placed,O
in,O
Left,O

Circ,O

Echo,B-TE
:,O

2016-03-31,O
:,O

""",O
Conclusions,O
:",O

1.,O
The,O
left,O
ventricular,O
cavity,O
is,O
moderately,B-PR
dilated,I-PR
.,O

There,O
is,O
severe,B-PR
global,I-PR
left,I-PR
ventricular,I-PR
hypokinesis,I-PR
to,O
akinesis,B-PR
with,O
some,O
sparing,O
of,O
basal,O
wall,O
motion,O
.,O

Overall,B-TE
left,I-TE
ventricular,I-TE
systolic,I-TE
function,I-TE
is,O
severely,B-PR
depressed,I-PR
.,O

2.,O
The,O
mitral,O
valve,O
leaflets,O
are,O
mildly,B-PR
thickened,I-PR
.,O

"Trivial,B-PR
mitral,I-PR
regurgitation,I-PR
is,O
seen,O
.""",O

2016-03-31,O
22:40,O

GLUCOSE,B-TE
-,O
180,O
*,O
UREA,B-TE
N,I-TE
-,O
10,O
CREAT,B-TE
-,O
0.8,O
SODIUM,B-TE
-,O
142,O
POTASSIUM,B-TE
-,O
3.7,O
CHLORIDE,B-TE
-,O
104,O
TOTAL,B-TE
CO2,I-TE
-,O
30,O
*,O
ANION,B-TE
GAP,I-TE
-,O
12,O

2016-03-31,O
22:40,O

CK,B-TE
(,I-TE
CPK,I-TE
)-,I-TE
137,O

2016-03-31,O
22:40,O

CK-MB,B-TE
-,O
4,O
cTropnT,B-TE
-<,O
0.01,O

2016-03-31,O
22:40,O

CALCIUM,B-TE
-,O
8.6,O
PHOSPHATE,B-TE
-,O
3.4,O
MAGNESIUM,B-TE
-,O
1.7,O

2016-03-31,O
22:40,O

WBC,B-TE
-,O
9.1,O
RBC,B-TE
-,O
4.08,O
*,O
HGB,B-TE
-,O
12.7,O
*,O
HCT,B-TE
-,O
35.7,O
*,O
MCV,B-TE
-,O
88,O
MCH,B-TE
-,O
31.0,O
MCHC,B-TE
-,O
35.4,O
*,O
RDW,B-TE
-,O
12.7,O

2016-03-31,O
22:40,O

PLT,B-TE
COUNT,I-TE
-,O
253,O

Brief,O
Hospital,O
Course,O
:,O

1.,O
CAD,B-PR
:,O
presented,O
with,O
anginal,B-PR
symptoms,I-PR
and,O
EKG,B-PR
changes,I-PR
(,O
STEMI,B-PR
),O
",",O
with,O
cardiac,B-TE
catheterization,I-TE
revealing,O
lesions,B-PR
in,I-PR
LAD,I-PR
",",I-PR
LcX,I-PR
",",I-PR
and,I-PR
PLB,I-PR
.,O

Unclear,O
if,O
hazy,B-PR
lesions,I-PR
significant,O
or,O
if,O
this,O
was,O
cocaine,O
induced,O
vasospasm,O
.,O

LAD,O
and,O
LCX,O
were,O
stented,B-TR
",",O
but,O
PLB,O
could,O
not,O
be,O
crossed,O
by,O
guidewire,B-TR
(,O
were,O
collaterals,O
),O
.,O

-,O
continue,O
ASA,B-TR
",",O
statin,B-TR
",",O
Plavix,B-TR
;,O
will,O
hold,O
BB,B-TR
given,O
recent,O
cocaine,O
use,O
(,O
?,O
can,O
consider,O
labetalol,B-TR
if,O
necessary,O
),O
",",O
Integrillin,B-TR
for,O
18,O
hours,O

-,O
CK,B-TE
negative,O
.,O

TN,B-TE
WNL,O
.,O

2.,O
CHF,B-PR
:,O
EF,B-TE
25%,O
on,O
Echo,B-TE
",",O
states,O
he,O
takes,O
lasix,B-TR
at,O
home,O

-,O
Started,O
lisinopril,B-TR
.,O

-,O
Consider,O
repeat,B-TE
Echo,I-TE
in,O
1,O
month,O
and,O
Quincy,O
Medical,O
Center,O
-,O
V/ICD,B-TR
per,O
discretion,O
of,O
primary,O
cardiologist,O
.,O

-,O
Low,B-TR
Na,I-TR
diet,I-TR
with,O
1,B-TR
liter,I-TR
fluid,I-TR
restriction,I-TR

3.,O
Rhythm,B-TE
:,O
No,O
ectopy,B-PR
post,I-PR
cath/MI,I-PR

4.,O
DM,B-PR
:,O
on,O
metformin,B-TR
at,O
home,O
",",O
will,O
hold,O
given,O
cath,B-TR
/,I-TR
dye,I-TR
adn,O
cover,O
with,O
SSI,B-TR

5.,O
Cocaine,O
use,O
:,O
last,O
use,O
this,O
morning,O
",",O
no,O
BB,B-TR
given,O
this,O
;,O
considered,O
using,O
CCB,B-TR
/,O
phentolamine,B-TR
if,O
chest,B-PR
pain,I-PR
recurs,O
.,O

6.,O
EtOH,O
use,O
:,O
unclear,O
how,O
much,O
",",O
monitor,O
on,O
CIWA,B-TE
for,O
signs,O
of,O
withdrawal,B-PR
",",O
ativan,B-TR
prn,O

--,O
CIWAs,B-TE
were,O
0,O
throughout,O
admission,O

7.,O
Hyperlipidemia,B-PR
:,O
on,O
lipitor,B-TR
80,O
.,O

LDL,B-TE
79,O
",",O
HDL,B-TE
51,O

8.,O
Social,O
:,O
in,O
police,O
custody,O
",",O
with,O
24,O
hr,O
guard,O
",",O
handcuffed,O
to,O
bed,O

9.,O
FEN,O
:,O
cardiac,B-TR
diet,I-TR
",",O
watch,O
for,O
aspiration,B-PR
given,O
somnolent,B-PR
status,I-PR
at,O
this,O
time,O
",",O
ck,B-TE
and,O
replete,O
Mg/K/Ca,B-TR
aggressively,O

10.,O
Code,O
:,O
FULL,O

11.,O
Dispo,O
:,O
back,O
to,O
prison;,O
?,O
extradition,O
to,O
Hawaii,O

Medications,O
on,O
Admission,O
:,O

Lipitor,B-TR
80,O

Coreg,B-TR

ASA,B-TR
81,O
mg,O

Lasix,B-TR

Glucophage,B-TR

ALL,O
:,O
Vicodin,B-TR
-?,O
rash,B-PR

Discharge,O
Medications,O
:,O

1.,O
Please,O
continue,O
your,B-TR
previous,I-TR
diabetes,I-TR
medications,I-TR

2.,O
Aspirin,B-TR
325,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

3.,O
Clopidogrel,B-TR
Bisulfate,I-TR
75,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

4.,O
Multivitamin,B-TR
Capsule,I-TR
Sig,O
:,O
One,O
(,O
1,O
),O
Cap,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

5.,O
Pantoprazole,B-TR
Sodium,I-TR
40,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
Q24H,O
(,O
every,O
24,O
hours,O
),O
.,O

6.,O
Atorvastatin,B-TR
Calcium,I-TR
80,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

7.,O
Lisinopril,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Facility,O
:,O

Oak,O
BluffsCorrectional,O
Facility,O

Discharge,O
Diagnosis,O
:,O

Cocaine,O
Abuse,O

ST,B-PR
Elevation,I-PR
Myocardial,I-PR
Infarction,I-PR

Discharge,O
Condition,O
:,O

stable,O

Discharge,O
Instructions,O
:,O

Please,O
notify,O
nurses,O
",",O
doctors,O
Marilyn,O
Kristen,O
Layne,O
workers,O
of,O
chest,B-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
palpitations,B-PR
or,O
lightheadedness,B-PR
.,O

Cocaine,O
use,O
has,O
been,O
associated,O
with,O
an,O
increased,O
risk,O
of,O
heart,B-PR
attacks,I-PR
",",O
stroke,B-PR
and,O
death,B-PR
.,O

You,O
must,O
continue,O
to,O
take,O
plavix,B-TR
.,O

Please,O
discuss,O
the,O
use,O
of,O
beta-blockers,B-TR
with,O
your,O
cardiologist,O
.,O

Beta-blockers,B-TR
should,O
not,O
be,O
used,O
while,O
using,O
cocaine,O
.,O

Followup,O
Instructions,O
:,O

Please,O
follow-up,O
with,O
your,O
cardiologist,O
within,O
2,O
weeks,O
of,O
leaving,O
the,O
hospital,O
.,O

Please,O
follow-up,O
with,O
your,O
primary,O
doctor,O
within,O
2,O
weeks,O
of,O
leaving,O
the,O
hospital,O
.,O

Robert,O
Melissa,O
MD,O
41-790,O

Completed,O
by,O
:,O
William,O
Bennett,O
MD,O
47-894,O
2016-04-01,O
@,O
1501,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Evelyn,O
Paulk,O
on,O
:,O
Flora,O
2016-06-16,O
2:06,O
PM,O

(,O
End,O
of,O
Report,O
),O

129714460,O

CTMC,O

30735304,O

279659,O

8/31/1992,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

08/31/1992,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

09/07/1992,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
37-year-old,O
white,O
male,O
with,O
AIDS,B-PR
complicated,O
by,O
recurrent,B-PR
pseudomonas,I-PR
infections,I-PR
presently,O
on,O
Ceftazidime,B-TR
and,O
Aztrenam,B-TR
complicated,O
by,O
MAI,B-PR
who,O
comes,O
in,O
with,O
fever,B-PR
",",O
chills,B-PR
and,O
blood,B-TE
cultures,I-TE
positive,O
for,O
candida,B-PR
species,I-PR
.,O

The,O
patient,O
has,O
multiple,B-PR
AIDS,I-PR
illnesses,I-PR
including,O
MAI,B-PR
who,O
has,O
multiple,O
admissions,O
for,O
pseudomonas,B-PR
pneumonia,I-PR
.,O

His,O
most,O
recent,O
admission,O
was,O
on,O
08/23/92,O
to,O
08/25/92,O
with,O
fever,B-PR
and,O
chills,B-PR
.,O

He,O
was,O
again,O
treated,O
with,O
IV,B-TR
Ceftazidime,I-TR
for,O
presumed,O
pseudomonal,B-PR
pneumonia,I-PR
and,O
discharged,O
home,O
on,O
IV,B-TR
antibiotics,I-TR
which,O
he,O
is,O
presently,O
on,O
.,O

The,O
patient,O
did,O
well,O
at,O
home,O
with,O
decreasing,O
fever,O
and,O
good,O
appetite,O
until,O
the,O
night,O
prior,O
to,O
admission,O
when,O
he,O
developed,O
fever,B-PR
and,O
chills,B-PR
.,O

Concurrent,B-TE
blood,I-TE
cultures,I-TE
grew,O
out,O
candida,B-PR
species,I-PR
at,O
HCHP,O
.,O

The,B-TE
patient,I-TE
&apos;s,I-TE
baseline,I-TE
O2,I-TE
saturation,I-TE
is,O
92%,O
on,O
three,B-TR
liters,I-TR
.,O

He,O
has,O
a,B-TR
left,I-TR
arm,I-TR
graft,I-TR
placed,O
for,O
access,O
three,O
weeks,O
ago,O
which,O
is,O
used,O
for,O
blood,B-TR
drawing,I-TR
and,O
IV,B-TR
medications,I-TR
.,O

He,O
notes,O
no,O
tenderness,B-PR
",",O
erythema,B-PR
",",O
warmth,B-PR
or,O
exudate,B-PR
from,O
the,B-TR
passport,I-TR
site,I-TR
.,O

Medications,O
at,O
the,O
time,O
of,O
admission,O
include,O
Dapsone,B-TR
50,O
mg,O
p.o.,O
on,O
Monday,O
",",O
Wednesday,O
and,O
Friday,O
",",O
Ceftazidime,B-TR
1,O
gram,O
IV,O
q.,O
8,O
hours,O
",",O
Cipro,B-TR
750,O
mg,O
p.o.,O
b.i.d.,O
",",O
Acyclovir,B-TR
400,O
mg,O
p.o.,O
q.,O
day,O
",",O
Megastrol,B-TR
80,O
mg,O
p.o.,O
t.i.d.,O
and,O
G-CSF,B-TR
150,O
micrograms,O
subcu,O
b.i.d.,O

PHYSICAL,O
EXAMINATION,O
:,O

At,O
the,O
time,O
of,O
admission,O
",",O
his,B-TE
temperature,I-TE
was,O
101,O
",",O
blood,B-TE
pressure,I-TE
110/60,O
",",O
pulse,B-TE
96,O
",",O
respirations,B-TE
16,O
.,O

O2,B-TE
saturation,I-TE
on,O
three,B-TR
liters,I-TR
was,O
96%,O
.,O

HEENT,B-TE
exam,I-TE
was,O
unremarkable,O
.,O

The,O
neck,O
was,O
supple,O
.,O

No,O
lymphadenopathy,B-PR
or,O
thyromegaly,B-PR
.,O

Chest,O
revealed,O
bilateral,B-PR
basilar,I-PR
rales,I-PR
.,O

Cardiovascular,B-TE
exam,I-TE
has,O
a,O
normal,O
S1,O
and,O
S2,O
without,O
murmurs,B-PR
.,O

The,O
abdomen,O
was,O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
.,O

The,O
liver,O
was,O
approximately,O
8.0,O
cm,O
.,O

The,O
extremities,O
had,O
no,O
clubbing,B-PR
",",O
cyanosis,B-PR
or,O
edema,B-PR
.,O

Neurological,B-TE
exam,I-TE
was,O
alert,O
and,O
oriented,O
x,O
three,O
.,O

Nonfocal,O
.,O

LABORATORY,O
DATA,O
:,O

Notable,O
on,O
admission,O
were,O
BUN,B-TE
and,O
creatinine,B-TE
of,O
8.0,O
and,O
0.7,O
.,O

Sodium,B-TE
134,O
",",O
ALT,B-TE
18,O
",",O
AST,B-TE
27,O
",",O
LDH,B-TE
221,O
",",O
white,B-TE
count,I-TE
2.05,O
",",O
hematocrit,B-TE
23,O
",",O
platelet,B-TE
count,I-TE
"137,000",O
.,O

The,B-TE
differential,I-TE
showed,O
45,B-TE
polys,I-TE
",",O
6,B-TE
bands,I-TE
",",O
8,B-TE
lymphs,I-TE
",",O
32,B-TE
monos,I-TE
.,O

Urinalysis,B-TE
was,O
negative,O
.,O

Sputum,B-TE
gram,I-TE
stain,I-TE
showed,O
no,O
polys,B-PR
and,O
no,O
bacteria,B-PR
.,O

AFB,B-TE
stain,I-TE
was,O
negative,O
.,O

Chest,B-TE
X-ray,I-TE
was,O
consistent,O
with,O
an,B-TE
old,I-TE
chest,I-TE
X-ray,I-TE
on,O
08/08/92,O
showing,O
a,B-PR
resolving,I-PR
left,I-PR
lower,I-PR
lobe,I-PR
and,I-PR
lingular,I-PR
infiltrate,I-PR
and,O
resolution,O
of,O
the,B-PR
right,I-PR
mid,I-PR
lung,I-PR
infiltrate,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

By,O
problems,O
:,O

1.,O
Infectious,B-PR
Disease,I-PR
.,O

The,O
patient,O
was,O
started,O
on,O
Amphotericine,B-TR
at,O
.6,O
mg,O
/,O
kg,O
for,O
a,O
total,O
of,O
250,O
mg,O
for,O
positive,B-PR
blood,I-PR
cultures,I-PR
for,O
candida,B-PR
.,O

The,B-TR
passport,I-TR
in,I-TR
his,I-TR
left,I-TR
arm,I-TR
was,O
pulled,O
and,O
will,O
be,O
replaced,O
if,O
needed,O
after,O
the,B-TR
Amphotericine,I-TR
is,O
completed,O
.,O

The,O
patient,O
will,O
continue,O
on,O
his,B-TR
antibiotics,I-TR
for,O
pseudomonas,B-PR
pneumonia,I-PR
to,O
complete,O
the,O
fourteen,O
day,O
course,O
which,O
was,O
completed,O
on,O
09/06/92,O
.,O

The,O
patient,O
was,O
continued,O
on,O
his,B-TR
admission,I-TR
medications,I-TR
.,O

2.,O
Hematology,O
.,O

The,O
patient,O
was,O
continued,O
on,O
his,B-TR
G-CSF,I-TR
with,O
an,O
increase,O
in,O
his,B-TE
white,I-TE
count,I-TE
to,O
8,O
from,O
1.8,O
.,O

The,O
patient,O
required,O
multiple,B-TR
blood,I-TR
transfusions,I-TR
for,O
a,B-PR
low,I-PR
hematocrit,I-PR
.,O

DISPOSITION,O
:,O

MEDICATIONS,B-TR
at,O
the,O
time,O
of,O
discharge,O
are,O
G-CSF,B-TR
300,O
micrograms,O
subcu,O
q.,O
day,O
",",O
Acyclovir,B-TR
200,O
mg,O
p.o.,O
b.i.d.,O
",",O
Erythromycin,B-TR
500,O
mg,O
p.o.,O
b.i.d.,O
",",O
Dapsone,B-TR
50,O
mg,O
p.o.,O
Monday,O
",",O
Wednesday,O
and,O
Friday,O
",",O
Imodium,B-TR
1-2,O
tablets,O
p.o.,O
q.,O
6,O
hours,O
p.r.n.,O
",",O
Nystatin,B-TR
5,O
cc,O
swish,O
and,O
swallow,O
q.i.d.,O
",",O
Serax,B-TR
50,O
mg,O
p.o.,O
q.,O
6,O
hours,O
p.r.n.,O
and,O
Kay-Ceil,B-TR
40,O
mEq,O
p.o.,O
b.i.d.,O

The,O
patient,O
needs,O
to,O
have,O
his,B-TE
blood,I-TE
drawn,I-TE
the,O
day,O
after,O
discharge,O
to,O
check,O
a,B-TE
potassium,I-TE
and,O
magnesium,B-TE
which,O
he,O
has,O
been,O
wasting,O
secondary,O
to,O
Amphotericine,B-TR
.,O

He,O
will,O
probably,O
need,O
potassium,B-TR
and,O
magnesium,B-TR
replacement,I-TR
.,O

He,O
will,O
need,O
follow,B-TE
up,I-TE
lytes,I-TE
drawn,O
throughout,O
the,O
week,O
.,O

CR887/2594,O
TRANGCA,O
FERCI,O
CHIRDSTEN,O
",",O
M.D.,O
UO2,O

D,O
:,O

09/07/92,O

Batch,O
:,O

5346,O

Report,O
:,O

P4722W3,O

T,O
:,O

09/09/92,O

Dicatated,O
By,O
:,O

LANETTE,O
SC,O
",",O
M.D.,O

Admission,O
Date,O
:,O

2017-01-10,O

Discharge,O
Date,O
:,O

2017-01-16,O

Date,O
of,O
Birth,O
:,O

1963-12-23,O

Sex,O
:,O

F,O

Service,O
:,O

Medical,O
ICU,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Patient,O
is,O
a,O
53,O
-,O
year-old,O
female,O
found,O
down,O
in,O
hotel,O
room,O
by,O
EMS,O
with,O
change,B-PR
in,I-PR
mental,I-PR
status,I-PR
and,O
lethargy,B-PR
.,O

A,O
suicide,O
note,O
found,O
at,O
the,O
scene,O
referenced,O
multiple,B-PR
medical,I-PR
problems,I-PR
as,O
well,O
as,O
suggested,O
ingestion,O
of,O
beta,B-TR
blocker,I-TR
",",O
muscle,B-TR
relaxant,I-TR
",",O
and,O
Neurontin,B-TR
.,O

Vital,B-TE
signs,I-TE
were,O
stable,O
on,O
arrival,O
in,O
the,O
David,O
",",O
but,O
the,O
patient,O
was,O
minimally,B-PR
responsive,I-PR
and,O
subsequently,O
intubated,O
for,O
airway,B-TR
protection,I-TR
.,O

Patient,O
initially,O
given,O
2,O
mg,O
of,O
Narcan,B-TR
",",O
4,O
amps,O
of,O
sodium,B-TR
bicarb,I-TR
",",O
and,O
5,O
grams,O
of,O
activated,B-TR
charcoal,I-TR
.,O

Patient,B-TE
's,I-TE
blood,I-TE
pressures,I-TE
were,O
noted,O
to,O
decrease,B-PR
systolics,I-PR
to,O
the,O
80s,O
",",O
which,O
responded,O
to,O
IV,B-TR
fluids,I-TR
and,O
insulin,B-TR
/,O
glucose,B-TR
drips,I-TR
.,O

Also,O
noted,O
to,O
be,O
bradycardic,B-PR
to,O
the,O
50s,O
",",O
which,O
responded,O
to,O
atropine,B-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Hepatitis,B-PR
C,I-PR
.,O

2.,O
Hypertrophic,B-PR
cardiomyopathy,I-PR
.,O

3.,O
Lumbar,B-PR
and,I-PR
cervical,I-PR
degenerative,I-PR
disk,I-PR
disease,I-PR
.,O

4.,O
Sarcoid,B-PR
.,O

5.,O
Depression,B-PR
.,O

6.,O
Headaches,B-PR
.,O

MEDICATIONS,O
:,O

1.,O
Neurontin,B-TR
.,O

2.,O
Propanolol,B-TR
.,O

3.,O
Tylenol,B-TR
#3,I-TR
.,O

4.,O
Butalbital,B-TR
.,O

5.,O
Morphine,B-TR
.,O

6.,O
Protonix,B-TR
.,O

7.,O
Doxepin,B-TR
.,O

8.,O
Dilaudid,B-TR
.,O

9.,O
Inderal,B-TR
.,O

10.,O
Skelaxin,B-TR
.,O

11.,O
Zantac,B-TR
.,O

12.,O
Flexeril,B-TR
.,O

13.,O
MS,B-TR
Contin,I-TR
.,O

PHYSICAL,O
EXAM,O
:,O

Temperature,B-TE
96.8,O
",",O
heart,B-TE
rate,I-TE
81,O
",",O
blood,B-TE
pressure,I-TE
92/47,O
",",O
and,O
saturating,O
100%,O
on,O
40%,O
FIO2,B-TR
.,O

General,O
:,O

Patient,O
is,O
intubated,O
and,O
sedated,O
.,O

HEENT,O
:,O

Pupils,O
are,O
equal,O
",",O
round,O
",",O
and,O
reactive,O
to,O
light,O
.,O

Cardiovascular,O
:,O

Regular,O
rate,O
and,O
rhythm,O
",",O
no,O
murmurs,B-PR
.,O

Pulmonary,O
is,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

Abdomen,O
is,O
soft,O
",",O
nontender,B-PR
",",O
and,O
nondistended,B-PR
.,O

Extremities,O
:,O

No,O
edema,B-PR
.,O

LABORATORIES,O
:,O

White,B-TE
count,I-TE
20.0,O
",",O
hematocrit,B-TE
52,O
",",O
platelets,B-TE
439,O
.,O

Chem-7,B-TE
:,O

141,O
/,O
5.6,O
/,O
104,O
/,O
24,O
/,O
23,O
/,O
0.8,O
/,O
118,O
.,O

Urinalysis,B-TE
negative,O
except,O
for,O
large,B-PR
blood,I-PR
.,O

EKG,B-TE
:,O

Sinus,B-PR
bradycardia,I-PR
",",O
left,B-PR
bundle,I-PR
branch,I-PR
block,I-PR
",",O
prolonged,B-PR
QRS,I-PR
.,O

Urine,B-TE
tox,I-TE
positive,B-PR
for,I-PR
barbiturates,I-PR
",",I-PR
opiates,I-PR
",",I-PR
and,I-PR
methadone,I-PR
.,O

Serum,B-TE
Tylenol,I-TE
level,I-TE
is,O
8.3,O
.,O

Positive,B-PR
for,I-PR
serum,I-PR
barbiturates,I-PR
.,O

CK,B-TE
"15,000",O
.,O

ALT,B-TE
77,O
",",O
AST,B-TE
159,O
",",O
amylase,B-TE
153,O
",",O
alkaline,B-TE
phosphatase,I-TE
216,O
",",O
total,B-TE
bilirubin,I-TE
0.6,O
.,O

INR,B-TE
1.1,O
.,O

HOSPITAL,O
COURSE,O
:,O

In,O
summary,O
",",O
patient,O
is,O
a,O
53,O
-,O
year-old,O
female,O
with,O
multiple,B-PR
medical,I-PR
problems,I-PR
and,O
history,O
of,O
depression,B-PR
with,O
intentional,O
overdose,O
of,O
barbiturates,B-TR
",",O
opiates,B-TR
",",O
Tylenol,B-TR
",",O
and,O
beta,B-TR
blocker,I-TR
.,O

CMED,O
:,O

Patient,O
was,O
maintained,O
on,O
insulin,B-TR
",",O
D10,B-TR
and,O
glucagon,B-TR
drips,I-TR
to,O
maintain,O
her,O
hemodynamics,O
.,O

This,O
was,O
achieved,O
with,O
good,O
effect,O
",",O
and,O
they,O
were,O
subsequently,O
weaned,O
off,O
.,O

Patient,O
was,O
able,O
to,O
be,O
extubated,O
on,O
hospital,O
day,O
three,O
.,O

Psychiatry,O
was,O
consulted,O
after,O
the,O
patient,O
was,O
extubated,O
",",O
and,O
felt,O
that,O
patient,O
had,O
a,B-PR
high,I-PR
suicide,I-PR
risk,I-PR
",",O
and,O
plan,O
was,O
for,O
her,O
to,O
be,O
admitted,O
to,O
the,O
Psychiatry,O
service,O
once,O
medically,O
stable,O
.,O

Patient,O
's,O
renal,O
function,O
remained,O
stable,O
and,O
her,B-TE
CKs,I-TE
trended,O
down,O
gradually,O
.,O

Patient,O
remained,O
on,O
suicide,B-TR
precautions,I-TR
",",O
but,O
was,O
deemed,O
not,O
to,O
need,O
ICU,B-TE
level,I-TE
monitoring,I-TE
",",O
and,O
was,O
transferred,O
to,O
the,O
floor,O
on,O
01-11,O
.,O

In,O
the,O
a.m.,O
of,O
01/08,O
",",O
the,O
patient,O
experienced,O
episode,O
of,O
tongue,B-PR
biting,I-PR
",",O
unresponsiveness,B-PR
",",O
disorientation,B-PR
.,O

Was,O
loaded,O
on,O
Dilantin,B-TR
.,O

Became,O
progressively,O
hypoxic,B-PR
and,O
tachypneic,B-PR
throughout,O
the,O
day,O
with,O
respiratory,B-TE
rates,I-TE
of,O
30-40,O
with,O
a,B-TE
max,I-TE
respiratory,I-TE
rate,I-TE
of,O
116,O
",",O
tachycardia,B-PR
to,O
120s,O
.,O

Patient,O
subsequently,O
was,O
transferred,O
back,O
to,O
the,O
CMED,O
CCU,O
on,O
2017-01-13,O
for,O
further,B-TE
monitoring,I-TE
.,O

Patient,B-PR
's,I-PR
hypoxia,I-PR
was,O
felt,O
most,O
likely,O
to,O
be,O
caused,O
by,O
pneumonia,B-PR
.,O

She,O
was,O
started,O
on,O
appropriate,B-TR
antibiotics,I-TR
.,O

Etiology,O
of,O
patient,B-PR
's,I-PR
tachypnea,I-PR
was,O
unclear,O
.,O

Initially,O
",",O
the,O
patient,O
's,O
etiology,O
of,O
seizure,B-PR
was,O
not,O
quite,O
clear,O
",",O
but,O
thought,O
possibly,O
secondary,O
to,O
alcohol,B-PR
and,I-PR
benzodiazepine,I-PR
withdrawal,I-PR
.,O

She,O
received,O
EEG,B-TE
",",O
MRI,B-TE
",",O
LP,B-TE
.,O

Subsequently,O
EEG,B-TE
was,O
noted,O
to,O
have,O
no,O
seizure,B-PR
activity,I-PR
.,O

MRI,B-TE
was,O
suboptimal,O
due,O
to,O
motion,O
artifact,O
and,O
LP,B-TE
was,O
unremarkable,O
.,O

Despite,O
absence,O
of,O
seizure,B-PR
activity,I-PR
on,O
EEG,B-TE
",",O
patient,O
was,O
continued,O
on,O
Dilantin,B-TR
.,O

Her,B-PR
delirium,I-PR
was,O
felt,O
possibly,O
secondary,O
to,O
withdrawal,B-PR
versus,O
toxic,B-PR
metabolic,I-PR
",",O
but,O
gradually,O
improved,O
slowly,O
",",O
and,O
therefore,O
patient,O
did,O
not,O
receive,O
treatment,B-TR
for,O
barbiturate,B-PR
withdrawal,I-PR
.,O

Her,O
mental,O
status,O
",",O
tachypnea,B-PR
",",O
and,O
hypoxia,B-PR
all,O
improved,O
",",O
and,O
patient,O
was,O
subsequently,O
transferred,O
back,O
to,O
the,O
floor,O
medical,O
team,O
on,O
2017-01-15,O
.,O

While,O
on,O
the,O
floor,O
",",O
the,O
patient,O
's,O
mental,O
status,O
was,O
noted,O
to,O
be,O
improved,O
back,O
at,O
baseline,O
compared,O
to,O
that,O
back,O
to,O
the,O
CMED,O
CCU,O
",",O
and,O
she,O
exhibited,O
no,O
evidence,O
of,O
barbiturate,B-PR
withdrawal,I-PR
.,O

She,O
was,O
continued,O
on,O
suicide,B-TR
precautions,I-TR
with,O
a,B-TR
one-to-one,I-TR
sitter,I-TR
",",O
and,O
plan,O
was,O
for,O
psychiatric,O
admission,O
when,O
medical,B-PR
issues,I-PR
had,O
resolved,O
.,O

On,O
2017-01-16,O
",",O
the,O
night,O
float,O
intern,O
was,O
called,O
to,O
see,O
the,O
patient,O
as,O
she,O
was,O
unresponsive,B-PR
.,O

Patient,O
unresponsive,B-PR
to,O
verbal,B-TE
command,I-TE
",",O
sternal,B-TE
rub,I-TE
.,O

Pupils,O
were,O
fixed,B-PR
and,O
dilated,B-PR
.,O

Patient,O
noted,O
to,O
be,O
without,B-PR
corneal,I-PR
reflexes,I-PR
",",I-PR
spontaneous,I-PR
breathing,I-PR
",",I-PR
heart,I-PR
sounds,I-PR
",",I-PR
or,I-PR
palpable,I-PR
pulses,I-PR
.,O

Patient,O
was,O
pronounced,O
dead,O
at,O
6:15,O
a.m.,O
on,O
2017-01-16,O
.,O

Patient,O
's,O
family,O
was,O
notified,O
and,O
declined,O
autopsy,B-TE
.,O

Given,O
the,O
sudden,O
unexpected,O
nature,O
of,O
patient,O
's,O
death,O
",",O
the,O
medical,O
examiner,O
was,O
contacted,O
and,O
the,O
case,O
was,O
accepted,O
.,O

Of,O
note,O
at,O
time,O
of,O
death,O
",",O
patient,O
was,O
DNR,B-TR
/,O
DNI,B-TR
.,O

This,O
was,O
initiated,O
after,O
several,O
conversations,O
with,O
the,O
patient,O
's,O
mother,O
",",O
who,O
stated,O
that,O
the,O
patient,O
had,O
desired,O
to,O
be,O
DNR,B-TR
/,O
DNI,B-TR
for,O
many,O
years,O
",",O
not,O
just,O
in,O
the,O
recent,O
past,O
.,O

These,O
facts,O
were,O
confirmed,O
via,O
separate,O
conversations,O
with,O
both,O
the,O
patient,O
's,O
lawyer,O
and,O
her,O
primary,O
care,O
physician,O
.,O

Michael,O
N,O
Sawyer,O
",",O
M.D.,O

86-331,O

Dictated,O
By,O
:,O
Rebecca,O
S,O
Jefcoat,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2017-03-08,O
10:57,O

T,O
:,O
2017-03-10,O
07:01,O

JOB,O
#,O
:,O
53408,O

(,O
cclist,O
),O

***************************,O

Please,O
note,O
that,O
all,O
of,O
the,O
conversations,O
regarding,O
code,O
status,O
took,O
place,O
during,O
we,O
icu,O
admit,O
;,O
and,O
that,O
this,O
patient,O
passed,O
away,O
in,O
early,O
am,O
hours,O
of,O
night,O
she,O
was,O
called,O
back,O
out,O
to,O
the,O
medicine,O
floor,O
",",O
therefore,O
she,O
had,O
not,O
yet,O
been,O
re-evaluated,O
by,O
the,O
floor,O
medicine,O
attending,O
",",O
but,O
had,O
been,O
earlier,O
that,O
day,O
by,O
the,O
icu,O
attending,O
.,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Dorothy,O
Desalvo,O
on,O
:,O
WED,O
2017-04-26,O
7:22,O
AM,O

(,O
End,O
of,O
Report,O
),O

139391631,O

GH,O

97368061,O

7/20/1999,O
12:00:00,O
AM,O

NEUROPATHIC,B-PR
PAIN,I-PR

Signed,O

DIS,O

Admission,O
Date,O
:,O

07/20/1999,O

Report,O
Status,O
:,O

Signed,O
Discharge,O

Date,O
:,O

07/26/1999,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Post,B-PR
thoracotomy,I-PR
syndrome,I-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

The,O
patient,O
had,O
a,B-TE
spinal,I-TE
cord,I-TE
stimulator,I-TE
trial,I-TE
on,O
07/21/99,O
",",O
the,O
patient,O
had,O
an,B-TE
epidural,I-TE
trial,I-TE
on,O
07/24/99,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
65,O
year,O
old,O
female,O
with,O
post,B-PR
thoracotomy,I-PR
syndrome,I-PR
that,O
occurred,O
on,O
the,O
site,O
of,O
her,B-PR
thoracotomy,I-PR
incision,I-PR
.,O

She,O
had,O
a,B-PR
thoracic,I-PR
aortic,I-PR
aneurysm,I-PR
repaired,O
in,O
the,O
past,O
and,O
subsequently,O
developed,O
neuropathic,B-PR
pain,I-PR
at,O
the,B-PR
incision,I-PR
site,I-PR
.,O

She,O
is,O
currently,O
on,O
Vicodin,B-TR
",",O
one,O
to,O
two,O
tablets,O
every,O
four,O
hours,O
p.r.n.,O
",",O
Fentanyl,B-TR
patch,I-TR
25,O
mcg,O
an,O
hour,O
",",O
change,O
of,O
patch,O
every,O
72,O
hours,O
",",O
Elavil,B-TR
50,O
mgq,O
.h.s.,O
",",O
Neurontin,B-TR
600,O
mg,O
p.o.,O
t.i.d.,O
with,O
still,O
what,O
she,O
reports,O
as,O
stabbing,B-PR
left-sided,I-PR
chest,I-PR
pain,I-PR
that,O
can,O
be,O
as,O
severe,O
as,O
a,O
7/10.,O

She,O
has,O
failed,O
conservative,B-TR
therapy,I-TR
and,O
is,O
admitted,O
for,O
a,B-TE
spinal,I-TE
cord,I-TE
stimulator,I-TE
trial,I-TE
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Hypertension,B-PR
.,O

2.,O
Hypothyroidism,B-PR
.,O

3.,O
Paraplegia,B-PR
status,O
post,O
thoracic,B-TR
aortic,I-TR
aneurysm,I-TR
repair,I-TR
.,O

4.,O
Left,B-PR
hemidiaphragmatic,I-PR
paralysis,I-PR
",",O
history,O
of,O
recurrent,B-PR
lung,I-PR
infections,I-PR
.,O

5.,O
Sacral,B-PR
decubitus,I-PR
ulcer,I-PR
.,O

6.,O
Home,B-TR
oxygen,I-TR
at,O
two,O
liters,O
a,O
minute,O
when,O
she,O
is,O
at,O
home,O
;,O
she,O
does,O
not,O
use,O
the,B-TR
oxygen,I-TR
when,O
she,O
is,O
in,O
a,B-TR
wheelchair,I-TR
or,O
is,O
out,O
of,O
the,O
house,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

1.,O
Atrovent,B-TR
nebulizers,I-TR
0.5,O
mg,O
mixed,O
with,O
albuterol,B-TR
",",O
nebulizer,B-TR
is,O
given,O
every,O
six,O
hours,O
.,O

2.,O
Norvasc,B-TR
2.5,O
mg,O
p.o.,O
q,O
day,O
.,O

3.,O
Colistin,B-TR
30,O
mg,O
nebulizer,O
twice,O
a,O
day,O
",",O
give,O
30,O
minutes,O
post,O
albuterol,B-TR
and,O
Atrovent,B-TR
.,O

4.,O
Pressure,B-TR
",",I-TR
dermal,I-TR
ulcer,I-TR
care,I-TR
b.i.d.,O
dressing,B-TR
change,I-TR
with,O
antibiotic,B-TR
solution,I-TR
.,O

5.,O
Neurontin,B-TR
600,O
mg,O
p.o.,O
t.i.d.,O

6.,O
Colace,B-TR
100,O
mg,O
p.o.,O
b.i.d.,O

7.,O
Albuterol,B-TR
neb,I-TR
2.5,O
mg,O
every,O
six,O
hours,O
",",O
30,O
minutes,O
before,O
Colistin,B-TR
.,O

8.,O
Amitriptyline,B-TR
50,O
mg,O
q.h.s.,O

9.,O
Vitamin,B-TR
C,I-TR
500,O
mg,O
p.o.,O
b.i.d.,O

10.,O
Calcium,B-TR
carbonate,I-TR
125.0,O
mg,O
t.i.d.,O

11.,O
Fentanyl,B-TR
patch,I-TR
25,O
mcg,O
an,O
hour,O
",",O
change,O
patch,O
every,O
72,O
hours,O
.,O

12.,O
Folate,B-TR
1,O
mg,O
p.o.,O
q,O
day,O
.,O

13.,O
Synthroid,B-TR
50,O
mcg,O
p.o.,O
q,O
day,O
.,O

14.,O
Zinc,B-TR
sulfate,I-TR
220,O
mg,O
p.o.,O
q,O
day,O
.,O

15.,O
Multivitamin,B-TR
",",O
one,O
tablet,O
p.o.,O
q,O
day,O
.,O

16.,O
Hydrocodone,B-TR
5,I-TR
mg,I-TR
with,I-TR
Tylenol,I-TR
",",O
one,O
to,O
two,O
tablets,O
every,O
four,O
hours,O
p.r.n.,O
pain,B-PR
.,O

17.,O
Milk,B-TR
of,I-TR
Magnesia,I-TR
30,O
cc,O
p.o.,O
q,O
day,O
constipation,B-PR
.,O

ALLERGIES,O
:,O

PENICILLIN,B-TR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
lives,O
in,O
Napro,O
with,O
her,O
husband,O
who,O
is,O
her,O
primary,O
caregiver,O
.,O

She,O
is,O
not,O
a,O
smoker,O
.,O

She,O
has,O
approximately,O
one,O
glass,O
of,O
wine,O
every,O
day,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,O
patient,O
is,O
well-appearing,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

Blood,B-TE
pressure,I-TE
is,O
150/90,O
",",O
heart,B-TE
rate,I-TE
of,O
90,O
",",O
respiratory,B-TE
rate,I-TE
20,O
with,O
saturation,B-TE
of,O
98%,O
.,O

HEENT,O
:,O

Pupils,O
are,O
equal,O
and,O
reactive,O
to,O
light,O
.,O

The,O
patient,O
wears,O
dentures,B-TR
.,O

Neck,O
:,O

Full,O
range,O
of,O
motion,O
with,O
no,O
lymphadenopathy,B-PR
.,O

Chest,O
:,O

Clear,O
to,O
auscultation,B-TE
on,O
the,O
right,O
.,O

Decreased,B-PR
breath,I-PR
sounds,I-PR
on,I-PR
the,I-PR
left,I-PR
base,I-PR
with,O
coarse,B-PR
rales,I-PR
on,I-PR
the,I-PR
left,I-PR
base,I-PR
.,O

Cardiovascular,O
:,O

Regular,O
rate,O
and,O
rhythm,O
with,O
normal,O
S1,O
and,O
S2,O
.,O

Abdomen,O
:,O

Soft,O
",",O
nondistended,B-PR
",",O
nontender,B-PR
.,O

Positive,O
bowel,O
sounds,O
.,O

Back,O
:,O

Clear,O
.,O

Epidural,B-TR
site,I-TR
is,O
without,O
erythema,B-PR
",",O
drainage,B-PR
or,O
tenderness,B-PR
.,O

Left,O
buttock,O
area,O
has,O
a,B-TR
dressing,I-TR
over,O
the,B-PR
sacral,I-PR
decubitus,I-PR
ulcer,I-PR
.,O

Extremities,O
:,O

Well-profused,O
.,O

4/5,O
motor,O
strength,O
in,O
the,O
upper,O
extremities,O
bilaterally,O
.,O

Flaccid,B-PR
paralysis,I-PR
of,I-PR
bilateral,I-PR
lower,I-PR
extremities,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
on,O
07/20/99,O
for,O
a,O
history,O
of,O
left,B-PR
chest,I-PR
wall,I-PR
pain,I-PR
from,O
postthoracotomy,B-PR
syndrome,I-PR
.,O

The,O
patient,O
developed,O
the,B-PR
syndrome,I-PR
after,O
her,B-TR
thoracic,I-TR
aortic,I-TR
aneurysm,I-TR
repair,I-TR
.,O

The,O
patient,O
failed,O
the,B-TR
conservative,I-TR
therapy,I-TR
and,O
is,O
admitted,O
for,O
a,B-TE
spinal,I-TE
cord,I-TE
stimulator,I-TE
trial,I-TE
.,O

The,O
patient,O
had,O
a,B-TR
spinal,I-TR
cord,I-TR
stimulator,I-TR
placed,O
on,O
07/21/99,O
.,O

She,O
underwent,O
the,B-TR
procedure,I-TR
and,O
tolerated,O
the,B-TR
procedure,I-TR
very,O
well,O
.,O

The,B-TR
spinal,I-TR
cord,I-TR
stimulator,I-TR
was,O
programmed,O
with,O
setting,O
of,O
a,O
rate,O
of,O
80,O
",",O
power,O
450,O
and,O
4.0,O
amps,O
.,O

Channel,O
1,O
was,O
negative,O
",",O
2,O
was,O
neutral,O
",",O
3,O
was,O
neutral,O
",",O
4,O
was,O
positive,O
.,O

The,O
patient,O
the,O
next,O
two,O
days,O
did,O
not,O
notice,O
any,O
significant,O
change,O
in,O
her,B-PR
pain,I-PR
pattern,I-PR
.,O

The,O
patient,O
was,O
also,O
noted,O
to,O
have,O
a,O
lot,O
of,O
musculoskeletal,B-PR
component,I-PR
of,O
her,B-PR
pain,I-PR
.,O

So,O
",",O
an,B-TR
epidural,I-TR
catheter,I-TR
was,O
placed,O
on,O
07/23/99,O
.,O

The,B-TR
epidural,I-TR
was,O
placed,O
in,O
the,O
L1-2,O
region,O
and,O
the,B-TR
catheter,I-TR
was,O
placed,O
in,O
the,O
T7,O
region,O
using,O
fluoroscope,B-TR
to,O
guide,O
the,B-TR
catheter,I-TR
.,O

Within,O
the,O
next,O
couple,O
of,O
days,O
",",O
the,O
patient,O
noticed,O
a,O
significant,O
improvement,O
in,O
her,B-PR
pain,I-PR
pattern,I-PR
.,O

The,B-PR
stabbing,I-PR
",",I-PR
sharp,I-PR
pain,I-PR
that,O
she,O
occasionally,O
has,O
on,O
the,O
left,O
chest,O
wall,O
was,O
significantly,O
diminished,O
and,O
she,O
also,O
noticed,O
periods,O
of,O
time,O
when,O
she,O
did,O
not,O
have,O
any,O
of,O
that,B-PR
pain,I-PR
.,O

The,B-TR
epidural,I-TR
catheter,I-TR
had,O
a,B-TR
morphine,I-TR
infusion,I-TR
initially,O
started,O
at,O
1,O
mg,O
a,O
day,O
and,O
increased,O
to,O
3,O
mg,O
a,O
day,O
in,O
a,O
period,O
of,O
three,O
days,O
.,O

The,B-TR
epidural,I-TR
was,O
discontinued,O
on,O
07/26/99,O
and,O
was,O
considered,O
a,O
successful,O
trial,O
.,O

The,O
patient,O
will,O
schedule,O
with,O
the,O
Pain,O
Clinic,O
regarding,O
upcoming,O
epidural,B-TR
pump,I-TR
placement,I-TR
.,O

During,O
her,O
hospitalization,O
",",O
the,O
patient,O
was,O
also,O
seen,O
by,O
the,O
Plastic,O
Service,O
.,O

Dr.,O
Falccouette,O
would,O
like,O
to,O
perform,O
an,B-TR
excision,I-TR
and,O
closure,B-TR
flap,I-TR
of,O
her,B-PR
left,I-PR
ischial,I-PR
decubitusin,I-PR
the,O
near,O
future,O
.,O

The,O
patient,O
was,O
discharged,O
in,O
stable,O
conditionand,O
will,O
follow,O
up,O
for,O
(,O
1,O
),O
sacral,B-TR
decubitus,I-TR
closure,I-TR
",",O
and,O
(,O
2,O
),O
placement,B-TR
of,I-TR
epidural,I-TR
pump,I-TR
in,O
the,O
future,O
.,O

DISCHARGE,O
INSTRUCTIONS,O
:,O

The,O
patient,O
will,O
have,O
SMH,O
Service,O
that,O
comes,O
to,O
her,O
home,O
once,O
a,O
day,O
for,O
adressing,B-TR
change,I-TR
.,O

The,O
patient,O
will,O
follow,O
up,O
with,O
Dr.,O
Kayschird,O
to,O
schedule,O
for,O
the,B-TR
epidural,I-TR
pump,I-TR
.,O

The,O
patient,O
will,O
follow,O
up,O
with,O
Dr.,O
Falccouette,O
to,O
schedule,O
for,O
excision,B-TR
and,O
closure,B-TR
of,O
her,B-PR
left,I-PR
ischial,I-PR
sacral,I-PR
decubitus,I-PR
.,O

Dictated,O
By,O
:,O

ECI,O
JESCSLAND,O
",",O
M.D.,O
OO63,O

Attending,O
:,O

FOMAIRE,O
KOTEKOTEJESCDREWE,O
",",O
M.D.,O
RY93,O
KE526/9219,O

Batch,O
:,O

37707,O

Index,O
No.,O

RWRF75BSI,O

D,O
:,O

07/26/99,O

T,O
:,O

07/26/99,O

CC,O
:,O

JOFREDD,O
N.,O
FALCCOUETTE,O
",",O
M.D.,O
SV7,O

Admission,O
Date,O
:,O

2011-01-21,O

Discharge,O
Date,O
:,O

2011-02-23,O

Date,O
of,O
Birth,O
:,O

1988-10-20,O

Sex,O
:,O

M,O

Service,O
:,O

TRAUMA,O
SER,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
20,O
year,O
old,O
driver,O
was,O
in,O
a,O
major,O
motor,O
vehicle,O
accident,O
and,O
brought,O
to,O
the,O
Emergency,O
Saints,O
Medical,O
Center,O
following,O
this,O
",",O
with,O
multiple,B-PR
trauma,I-PR
.,O

The,O
patient,O
was,O
an,O
unrestrained,O
driver,O
in,O
a,O
car,O
versus,O
tree,O
.,O

He,O
was,O
involved,O
in,O
a,O
long,O
extrication,O
with,O
a,B-TE
blood,I-TE
pressure,I-TE
of,O
88,O
at,O
the,O
scene,O
.,O

Upon,O
extrication,O
from,O
the,O
vehicle,O
",",O
he,O
was,O
intubated,O
and,O
transported,O
to,O
the,O
Emergency,O
Room,O
.,O

He,O
was,O
tachycardic,B-PR
with,O
an,B-TE
initial,I-TE
blood,I-TE
pressure,I-TE
of,O
120,O
/,O
palpable,O
.,O

A,B-TR
groin,I-TR
line,I-TR
was,O
placed,O
and,O
the,O
patient,O
was,O
sedated,O
and,O
paralyzed,O
.,O

He,O
was,O
resuscitated,O
with,O
Crystalloid,B-TR
and,O
remained,O
hemodynamically,O
stable,O
.,O

He,O
had,O
a,B-PR
grossly,I-PR
deformed,I-PR
left,I-PR
lower,I-PR
extremity,I-PR
.,O

On,O
examination,B-TE
",",O
Belmont,B-TE
Coma,I-TE
Scale,I-TE
was,O
6T,O
;,O
blood,B-TE
pressure,I-TE
was,O
120,O
/,O
palpable,O
with,O
a,B-TE
heart,I-TE
rate,I-TE
of,O
122,O
.,O

The,O
trachea,O
was,O
midline,O
.,O

The,O
abdomen,O
was,O
soft,O
.,O

Rectal,O
was,O
heme,B-PR
positive,I-PR
with,O
normal,O
prostate,O
.,O

There,O
were,O
no,O
meatal,B-PR
blood,I-PR
.,O

The,O
left,O
femur,O
was,O
grossly,B-PR
deformed,I-PR
with,O
a,B-PR
pinhole,I-PR
opening,I-PR
in,I-PR
the,I-PR
lateral,I-PR
thigh,I-PR
.,O

His,O
left,O
forearm,O
was,O
also,O
grossly,B-PR
deformed,I-PR
.,O

There,O
is,O
no,O
step-off,B-PR
at,I-PR
the,I-PR
back,I-PR
.,O

Admission,B-TE
laboratories,I-TE
included,O
a,B-TE
hematocrit,I-TE
of,O
43.3,O
and,O
white,B-TE
blood,I-TE
cell,I-TE
count,I-TE
of,O
25.2,O
",",O
normal,O
electrolytes,O
and,O
amylase,B-TE
of,O
98,O
.,O

Arterial,B-TE
blood,I-TE
gas,I-TE
showed,O
a,B-PR
mild,I-PR
metabolic,I-PR
acidosis,I-PR
.,O

Additional,B-TE
assay,I-TE
shows,O
slight,B-PR
widening,I-PR
of,I-PR
the,I-PR
mediastinum,I-PR
on,O
chest,B-TE
x-ray,I-TE
.,O

The,B-TE
CT,I-TE
scan,I-TE
of,I-TE
the,I-TE
head,I-TE
and,I-TE
chest,I-TE
were,O
negative,O
.,O

There,O
was,O
a,B-PR
small,I-PR
liver,I-PR
laceration,I-PR
seen,O
on,O
the,B-TE
A/P,I-TE
pelvis,I-TE
.,O

There,O
was,O
a,B-PR
distal,I-PR
ulnar,I-PR
and,I-PR
radial,I-PR
fracture,I-PR
as,O
well,O
as,O
a,B-PR
left,I-PR
mid-shaft,I-PR
comminuted,I-PR
fracture,I-PR
of,I-PR
the,I-PR
femur,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
Intensive,O
Care,O
Unit,O
.,O

He,O
was,O
also,O
seen,O
by,O
the,O
Orthopedics,O
Service,O
and,O
Neurosurgical,O
Service,O
.,O

He,O
went,O
to,O
the,O
Operating,O
Room,O
quickly,O
and,O
had,O
an,B-TR
intramedullary,I-TR
rodding,I-TR
of,I-TR
the,I-TR
femur,I-TR
and,O
open,B-TR
reduction,I-TR
and,O
internal,B-TR
fixation,I-TR
of,I-TR
the,I-TR
radius,I-TR
and,I-TR
ulna,I-TR
.,O

He,O
was,O
evaluated,O
by,O
Neurosurgery,O
for,O
his,B-PR
head,I-PR
injury,I-PR
which,O
showed,O
multiple,B-PR
contusions,I-PR
in,I-PR
the,I-PR
frontal,I-PR
lobe,I-PR
.,O

He,O
was,O
extubated,O
on,O
postoperative,O
day,O
two,O
.,O

He,O
did,O
have,O
some,B-PR
blood,I-PR
loss,I-PR
anemia,I-PR
with,O
a,B-TE
hematocrit,I-TE
of,O
20.9,O
.,O

A,B-TE
repeat,I-TE
CT,I-TE
scan,I-TE
showed,O
no,O
change,O
.,O

He,O
was,O
begun,O
on,O
Physical,B-TR
Therapy,I-TR
but,O
remained,O
agitated,B-PR
.,O

He,O
was,O
discharged,O
to,O
the,O
Floor,O
.,O

His,B-TE
hematocrit,I-TE
remained,O
stable,O
.,O

His,O
cervical,O
spine,O
was,O
cleared,O
.,O

The,O
patient,O
was,O
seen,O
by,O
Psychiatry,O
due,O
to,O
some,B-PR
delirium,I-PR
and,O
question,O
of,O
suicidal,B-PR
ideation,I-PR
.,O

He,O
was,O
also,O
evaluated,O
by,O
the,O
Neuro-Rehabilitation,O
Service,O
who,O
thought,O
that,O
he,O
had,O
a,B-PR
post-head,I-PR
injury,I-PR
syndrome,I-PR
with,O
diffuse,B-PR
cognitive,I-PR
deficits,I-PR
.,O

He,O
continued,O
to,O
have,O
some,O
episodes,O
of,O
agitation,B-PR
which,O
were,O
treated,O
with,O
medication,B-TR
.,O

He,O
required,O
some,B-TR
sedation,I-TR
and,O
restraint,B-TR
and,O
was,O
begun,O
on,O
whatever,O
Physical,B-TR
Therapy,I-TR
he,O
could,O
have,O
given,O
his,B-PR
head,I-PR
injury,I-PR
.,O

He,O
was,O
continued,O
to,O
be,O
followed,O
by,O
Psychiatry,O
and,O
then,O
was,O
casted,O
by,O
Orthopedics,O
.,O

He,O
continued,O
to,O
have,O
episodes,O
of,O
confusion,B-PR
.,O

He,O
removed,O
the,B-TR
cast,I-TR
that,O
had,O
been,O
placed,O
and,O
then,O
a,B-TR
long-leg,I-TR
cast,I-TR
was,O
then,O
placed,O
so,O
it,O
would,O
be,O
difficult,O
for,O
him,O
to,O
remove,O
or,O
to,O
ambulate,O
on,O
his,O
leg,O
",",O
which,O
might,O
jeopardize,O
his,O
closure,O
.,O

It,O
continued,O
to,O
be,O
somewhat,O
difficult,O
to,O
control,O
his,O
activity,O
and,O
Rehabilitation,O
Screen,O
was,O
in,O
place,O
but,O
there,O
was,O
difficulty,O
finding,O
the,O
appropriate,O
facility,O
.,O

His,O
family,O
was,O
also,O
involved,O
in,O
his,O
care,O
and,O
orientation,O
.,O

He,O
does,O
of,O
BuSpar,B-TR
",",O
Trazodone,B-TR
and,O
Haldol,B-TR
were,O
continued,O
and,O
were,O
adjusted,O
by,O
Psychiatry,O
.,O

He,O
was,O
continued,O
on,O
observation,B-TE
and,O
sitters,O
and,O
finally,O
became,O
more,O
docile,O
and,O
cooperative,O
.,O

He,O
was,O
continued,O
on,O
Physical,B-TR
Therapy,I-TR
and,O
with,O
his,O
mother,O
present,O
",",O
he,O
began,O
to,O
follow,O
commands,O
much,O
more,O
appropriately,O
and,O
was,O
able,O
to,O
be,O
rehabilitated,B-TR
.,O

He,O
was,O
finally,O
sent,O
home,O
for,O
home,B-TR
rehabilitation,I-TR
on,O
2011-02-23,O
.,O

FINAL,O
DIAGNOSES,O
:,O

1.,O
Multiple,B-PR
trauma,I-PR
with,O
severe,B-PR
frontal,I-PR
head,I-PR
injury,I-PR
.,O

2.,O
Open,B-PR
fracture,I-PR
of,I-PR
the,I-PR
femur,I-PR
.,O

3.,O
Radial,B-PR
and,I-PR
ulnar,I-PR
fractures,I-PR
.,O

4.,O
Liver,B-PR
laceration,I-PR
.,O

SURGICAL,O
PROCEDURES,O
:,O

1.,O
Open,B-TR
reduction,I-TR
and,O
internal,B-TR
fixation,I-TR
of,I-TR
femur,I-TR
2011-01-21,O
.,O

2.,O
Open,B-TR
reduction,I-TR
and,O
internal,B-TR
fixation,I-TR
of,I-TR
radius,I-TR
and,I-TR
ulna,I-TR
2011-01-21,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Percocet,B-TR
",",O
one,O
p.o.,O
q.,O
four,O
hours,O
p.r.n.,O
pain,B-PR
.,O

2.,O
Haldol,B-TR
1,O
mg,O
p.o.,O
q.,O
four,O
to,O
six,O
hours,O
p.r.n.,O
agitation,B-PR
.,O

3.,O
Trazodone,B-TR
50,O
mg,O
p.o.,O
q.,O
h.s.,O

4.,O
Droperidol,B-TR
1.5,O
to,O
2.5,O
mg,O
p.r.n.,O
agitation,B-PR
.,O

DISPOSITION,O
:,O

The,O
patient,O
is,O
discharged,O
home,O
with,O
home,B-TR
rehabilitation,I-TR
.,O

DISCHARGE,O
INSTRUCTIONS,O
:,O

1.,O
The,O
patient,O
will,O
be,O
followed,O
by,O
Orthopedics,O
",",O
Dr.,O
Johnson,O
.,O

2.,O
To,O
be,O
followed,O
by,O
William,O
Scheidel,O
of,O
Neurological,O
Rehabilitation,O
.,O

Maria,O
L.,O
Bell,O
",",O
M.D.,O
05-084,O

Dictated,O
By,O
:,O
Michael,O
X.,O
Fisher,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2011-04-08,O
14:01,O

T,O
:,O
2011-04-10,O
08:09,O

JOB,O
#,O
:,O
48774,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Fredrick,O
Rossi,O
on,O
:,O
WED,O
2011-04-13,O
1:45,O
PM,O

(,O
End,O
of,O
Report,O
),O

139964603,O

NVH,O

40876531,O

11/17/2003,O
12:00:00,O
AM,O

PELVIC,B-PR
MASS,I-PR

Signed,O

DIS,O

Admission,O
Date,O
:,O

11/17/2003,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

12/22/2003,O

ATTENDING,O
:,O

DAY,O
SECOND,O
MD,O

This,O
dictation,O
goes,O
through,O
12/21/03,O
.,O

The,O
patient,O
received,O
care,O
on,O
the,O
Baydell,O
Medical,O
Center,O
.,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Pelvic,B-PR
mass,I-PR
.,O

PROBLEMS,O
:,O

Include,O
hypertension,B-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
57-year-old,O
female,O
status,O
post,O
ERT,B-TR
with,O
recurrence,O
of,O
a,B-PR
pelvic,I-PR
mass,I-PR
and,O
resection,B-TR
at,O
an,O
outside,O
hospital,O
in,O
06/22,O
.,O

Per,O
the,O
patient,O
",",O
the,B-PR
mass,I-PR
was,O
benign,O
.,O

The,O
patient,O
developed,O
severe,B-PR
left,I-PR
lower,I-PR
quadrant,I-PR
pain,I-PR
in,O
07/24,O
.,O

An,B-TE
MRI,I-TE
was,O
done,O
on,O
08/27/03,O
that,O
showed,O
an,B-PR
8,I-PR
cm,I-PR
left,I-PR
lower,I-PR
quadrant,I-PR
mass,I-PR
with,O
both,B-PR
cystic,I-PR
and,I-PR
solid,I-PR
components,I-PR
.,O

The,O
patient,O
was,O
started,O
on,O
Lupron,B-TR
on,O
10/18/03,O
",",O
but,O
pain,B-PR
was,O
not,O
affected,O
.,O

She,O
was,O
put,O
on,O
Vicodin,B-TR
ES,I-TR
and,O
Ultram,B-TR
with,O
minimal,O
relief,O
.,O

On,O
11/16/03,O
",",O
the,B-PR
patient,I-PR
&apos;s,I-PR
pain,I-PR
increased,O
and,O
she,O
presented,O
to,O
an,O
outside,O
hospital,O
with,O
nausea,B-PR
and,O
vomiting,B-PR
and,O
an,B-PR
inability,I-PR
to,I-PR
tolerate,I-PR
p.o.,I-PR
intake,I-PR
.,O

The,B-PR
left,I-PR
lower,I-PR
quadrant,I-PR
pain,I-PR
in,I-PR
the,I-PR
groin,I-PR
radiated,O
to,O
the,O
left,O
knee,O
.,O

No,O
fevers,B-PR
or,O
chills,B-PR
",",O
no,O
vaginal,B-PR
discharge,I-PR
or,O
bleeding,B-PR
.,O

Potassium,B-TE
at,O
the,O
outside,O
hospital,O
was,O
3.1,O
.,O

White,B-TE
count,I-TE
was,O
27.3,O
with,O
16%,B-TE
bands,I-TE
.,O

Hematocrit,B-TE
was,O
28.7,O
.,O

The,O
patient,O
was,O
transferred,O
to,O
NVH,O
after,O
receiving,O
intravenous,B-TR
fluid,I-TR
with,O
potassium,B-TR
",",O
Demerol,B-TR
for,O
pain,B-TR
control,I-TR
and,O
clindamycin,B-TR
",",O
Valium,B-TR
and,O
droperidol,B-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Hypothyroidism,B-PR
",",O
arthritis,B-PR
",",O
hypertension,B-PR
",",O
hypercholesterolemia,B-PR
",",O
anemia,B-PR
and,O
asthma,B-PR
.,O

SURGICAL,O
HISTORY,O
:,O

A,B-TR
TAH-BSO,I-TR
in,O
1980,O
and,O
an,B-TE
exploratory,I-TE
laparotomy,I-TE
with,O
resection,B-TR
of,O
a,B-PR
pelvic,I-PR
mass,I-PR
in,O
06/22,O
.,O

MEDICATIONS,O
AT,O
HOME,O
:,O

1.,O
Vicodin,B-TR
75/750,O
p.r.n.,O

2.,O
Ultram,B-TR
.,O

3.,O
Verapamil,B-TR
240,O
mg,O
b.i.d.,O

4.,O
Synthroid,B-TR
100,O
mcg,O
q.d.,O

5.,O
HCTZ,B-TR
25,O
mg,O
q.d.,O

6.,O
Arthrotec,B-TR
0.2,O
mg,O
b.i.d.,O

7.,O
Advair,B-TR
250/50,O
mcg,O
one,O
puff,O
q.a.m.,O

8.,O
Tofranil,B-TR
.,O

9.,O
Ambien,B-TR
10,O
mg,O
q.h.s.,O

10.,O
Trazadone,B-TR
150,O
mg,O
q.h.s.,O

11.,O
Ferrous,B-TR
sulfate,I-TR
325,O
mg,O
t.i.d.,O

12.,O
Colace,B-TR
.,O

ALLERGIES,O
:,O

Her,B-PR
allergies,I-PR
are,O
penicillin,B-TR
",",O
which,O
cause,O
throat,B-PR
edema,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

No,O
tobacco,O
",",O
alcohol,O
or,O
drug,O
use,O
.,O

The,O
patient,O
was,O
admitted,O
to,O
NVH,O
and,O
started,O
on,O
vancomycin,B-TR
",",O
levofloxacin,B-TR
and,O
Flagyl,B-TR
.,O

Cultures,B-TE
were,O
taken,O
.,O

Blood,B-TE
cultures,I-TE
were,O
done,O
for,O
a,O
possible,O
rectosigmoid,B-PR
mass,I-PR
or,O
fistula,B-PR
and,O
a,B-TE
CT,I-TE
showed,I-TE
questionable,O
abscess,B-PR
versus,O
tumor,B-PR
in,I-PR
the,I-PR
left,I-PR
lower,I-PR
quadrant,I-PR
.,O

Blood,B-TE
cultures,I-TE
done,O
on,O
11/17/03,O
grew,O
C.,B-PR
perfringens,I-PR
.,O

Other,B-TE
blood,I-TE
culture,I-TE
was,O
negative,O
.,O

On,O
11/20/03,O
",",O
a,B-TE
PE,I-TE
protocol,I-TE
CT,I-TE
was,O
negative,O
for,O
both,O
DVT,B-PR
and,O
PE,B-PR
.,O

The,O
patient,O
was,O
taken,O
to,O
the,O
operating,O
room,O
for,O
bilateral,B-TR
stent,I-TR
placement,I-TR
",",O
resection,B-TR
of,O
the,B-PR
pelvic,I-PR
mass,I-PR
",",O
lysis,B-TR
of,O
adhesions,B-PR
",",O
left,B-TR
ureterolysis,I-TR
",",O
rectosigmoid,B-TR
resection,I-TR
",",O
SBR,B-TR
",",O
removal,B-TR
of,O
a,B-PR
vaginal,I-PR
tumor,I-PR
",",O
omentectomy,B-TR
complicated,O
by,O
an,B-PR
enterotomy,I-PR
and,O
was,O
admitted,O
to,O
the,O
ICU,O
postoperatively,O
on,O
11/21/03,O
.,O

Postoperative,O
course,O
by,O
systems,O
is,O
as,O
follows,O
:,O

1.,O
Neuro,O
:,O

She,O
had,O
a,B-TR
PCEA,I-TR
for,O
pain,B-PR
",",O
then,O
a,B-TR
Dilaudid,I-TR
PCA,I-TR
.,O

The,O
patient,O
was,O
anxious,B-PR
with,O
depression,B-PR
poorly,I-PR
controlled,I-PR
until,O
12/14/03,O
.,O

The,O
patient,O
was,O
seen,O
by,O
Onc,O
Psychiatry,O
consult,O
",",O
who,O
recommended,O
imipramine,B-TR
75,O
mg,O
;,O
that,O
was,O
subsequently,O
increased,O
to,O
150,O
mg,O
p.o.,O
q.h.s.,O
",",O
trazadone,B-TR
100,O
mg,O
q.h.s.,O
and,O
Ambien,B-TR
10,O
mg,O
q.h.s.,O

2.,O
Cardiovascular,O
:,O

The,O
patient,O
has,O
baseline,B-PR
hypertension,I-PR
that,O
was,O
difficult,O
to,O
control,O
.,O

In,O
the,O
ICU,O
",",O
the,O
patient,O
was,O
on,O
enalapril,B-TR
",",O
hydralazine,B-TR
and,O
labetalol,B-TR
.,O

After,O
a,O
Cardiology,O
consulton,O
12/13/03,O
",",O
the,O
patient,O
was,O
started,O
on,O
metoprolol,B-TR
100,O
mg,O
p.o.,O
q.i.d.,O
",",O
lisinopril,B-TR
10,O
mg,O
q.d.,O
",",O
hydrochlorothiazide,B-TR
25,O
mg,O
q.d.,O
.,O

Hydralazine,B-TR
was,O
stopped,O
.,O

Blood,B-TE
pressure,I-TE
stayed,O
high,B-PR
with,O
an,B-TE
SBP,I-TE
in,O
the,O
170s,O
",",O
so,O
amlodipine,B-TR
10,O
mg,O
q.d.,O
was,O
added,O
and,O
that,B-TE
blood,I-TE
pressure,I-TE
was,O
still,B-PR
elevated,I-PR
.,O

At,O
the,O
time,O
of,O
transfer,O
to,O
the,O
________,O
Onc,O
Service,O
",",O
blood,B-TE
pressure,I-TE
was,O
within,O
the,O
normal,O
range,O
.,O

3.,O
Pulmonary,O
:,O

The,O
patient,O
was,O
extubated,O
on,O
11/22/03,O
.,O

Once,O
the,O
patient,O
was,O
extubated,O
",",O
after,O
the,B-TR
third,I-TR
surgery,I-TR
",",O
the,O
patient,O
could,O
not,O
be,O
weaned,O
off,O
2,B-TR
liters,I-TR
of,I-TR
nasal,I-TR
cannula,I-TR
and,O
was,O
to,O
______,O
to,O
20,O
breaths,O
per,O
minute,O
despite,O
nebulizer,B-TR
treatment,I-TR
.,O

The,O
patient,O
was,O
restarted,O
on,O
Advair,B-TR
and,O
by,O
12/15/03,O
",",O
was,O
weaned,O
to,O
room,O
air,O
likely,O
an,O
effective,O
Advair,B-TR
and,O
control,O
of,O
anxiety,B-PR
and,O
psychiatric,B-PR
issues,I-PR
.,O

4.,O
GI,O
:,O

On,O
postoperative,O
day,O
4,O
",",O
after,O
the,B-TR
initial,I-TR
surgery,I-TR
",",O
the,O
patient,O
had,O
increased,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
and,O
tachycardia,B-PR
with,O
abdominal,B-PR
pain,I-PR
.,O

A,B-TE
chest,I-TE
x-ray,I-TE
revealed,O
increased,B-PR
free,I-PR
air,I-PR
under,I-PR
the,I-PR
diaphragm,I-PR
.,O

A,B-TE
CT,I-TE
revealed,O
a,O
large,O
amount,O
of,O
free,B-PR
air,I-PR
.,O

The,O
patient,O
was,O
taken,O
to,O
the,O
OR,O
on,O
postop,O
day,O
5,O
for,O
emergent,B-TE
exploratory,I-TE
laparotomy,I-TE
that,O
disclosed,O
a,B-PR
small,I-PR
bowel,I-PR
enterotomy,I-PR
with,O
2,O
liters,O
of,O
bilious,B-PR
fluid,I-PR
within,I-PR
the,I-PR
peritoneum,I-PR
.,O

On,O
postop,O
day,O
9,O
",",O
the,O
patient,O
had,O
a,B-PR
similar,I-PR
increased,I-PR
abdominal,I-PR
pain,I-PR
episode,I-PR
and,O
was,O
taken,O
back,O
to,O
the,O
operating,O
room,O
for,O
another,B-TE
emergent,I-TE
exploratory,I-TE
laparotomy,I-TE
revealing,O
another,B-PR
peroration,I-PR
at,O
the,B-PR
site,I-PR
of,I-PR
previous,I-PR
repair,I-PR
.,O

Intraoperatively,B-TR
",",O
the,O
patient,O
suffered,O
hypotension,B-PR
with,O
induction,O
and,O
respiratory,B-PR
insufficiency,I-PR
.,O

The,O
patient,O
was,O
transferred,O
to,O
the,O
ICU,O
intubated,B-TR
with,O
stable,O
.,O

The,O
patient,O
was,O
kept,O
NPO,B-TR
with,O
an,B-TR
NG,I-TR
tube,I-TR
until,O
postop,O
day,O
14,O
and_____,O
started,O
on,O
clear,B-TR
sips,I-TR
with,O
TPN,B-TR
for,O
nutritional,B-TR
supplementation,I-TR
.,O

The,O
patient,O
intermittently,O
tolerated,O
diet,B-TR
advancement,I-TR
",",O
but,O
then,O
would,O
vomit,O
and,O
would,O
have,O
the,B-TR
NG,I-TR
tube,I-TR
replaced,O
.,O

The,O
patient,O
",",O
at,O
the,O
time,O
of,O
transfer,O
",",O
was,O
tolerating,O
clears,B-TR
with,O
low,B-PR
stoma,I-PR
output,I-PR
",",O
likely,O
to,O
tolerate,O
slow,O
advancement,O
.,O

The,O
patient,O
still,O
had,O
a,B-TR
PICC,I-TR
line,I-TR
at,O
the,O
time,O
",",O
although,O
TPN,B-TR
was,O
being,O
held,O
and,O
calorie,B-TR
counts,I-TR
were,O
done,O
to,O
evaluate,O
the,O
benefit,O
of,O
p.o.,O
nutrition,O
.,O

5.,O
GU,O
:,O

No,O
issues,O
.,O

The,O
patient,O
generally,O
had,O
good,O
urine,O
output,O
.,O

Presumably,O
",",O
should,O
follow,O
up,O
with,O
the,O
Urology,O
Clinic,O
for,O
removal,B-TR
of,I-TR
the,I-TR
ureteral,I-TR
stents,I-TR
at,O
some,O
point,O
.,O

6.,O
Infectious,B-PR
Disease,I-PR
:,O

Blood,B-TE
cultures,I-TE
mentioned,O
previously,O
were,O
positive,O
for,O
C.,B-PR
perfringens,I-PR
.,O

The,O
patient,O
was,O
started,O
on,O
empiricvancomycin,B-TR
",",O
levofloxacin,B-TR
and,O
Flagyl,B-TR
after,O
the,B-TE
second,I-TE
exploratory,I-TE
laparotomy,I-TE
.,O

She,O
was,O
started,O
on,O
vancomycin,B-TR
",",O
levofloxacin,B-TR
",",O
Flagyl,B-TR
",",O
doxycycline,B-TR
and,O
fluconazole,B-TR
.,O

Blood,B-TE
cultures,I-TE
drawn,O
on,O
12/01/03,O
were,O
negative,O
.,O

JP,B-TR
drain,I-TR
was,O
cultured,B-TE
on,O
12/11/03,O
along,O
with,O
aurine,B-TE
culture,I-TE
.,O

TLC,B-TE
",",O
TIB,B-TE
and,O
blood,B-TE
culture,I-TE
were,O
all,O
negative,O
.,O

These,O
were,O
cultured,O
because,O
the,B-TE
patient,I-TE
&apos;s,I-TE
white,I-TE
blood,I-TE
count,I-TE
was,O
increasing,O
to,O
the,O
mid,O
20s,O
without,O
fever,B-PR
or,O
other,B-PR
symptoms,I-PR
for,O
explanation,O
.,O

The,O
patient,O
",",O
at,O
the,O
time,O
of,O
transfer,O
",",O
to,O
the,O
Gyn,O
/,O
Onc,O
Service,O
was,O
not,O
antibiotics,B-TR
and,O
the,B-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
was,O
trending,O
down,O
.,O

7.,O
Heme,O
:,O

The,O
patient,O
was,O
stable,O
.,O

She,O
was,O
receiving,O
sub,B-TR
.q.,I-TR
heparin,I-TR
for,O
DVT,B-TR
prophylaxis,I-TR
postoperatively,O
.,O

On,O
postop,O
day,O
6,O
",",O
an,O
ID,O
consult,O
noted,O
erythema,B-PR
at,O
the,B-TR
right,I-TR
IJ,I-TR
line,I-TR
site,I-TR
.,O

On,O
postop,O
day,O
8,O
",",O
the,B-TR
right,I-TR
IJ,I-TR
line,I-TR
was,O
pulled,O
.,O

The,O
tip,O
was,O
cultured,O
with,O
no,O
growth,B-PR
.,O

On,O
postop,O
day,O
9,O
",",O
bilateral,B-TE
upper,I-TE
extremity,I-TE
Dopplers,I-TE
revealed,O
a,B-PR
right,I-PR
IJ,I-PR
clot,I-PR
.,O

The,O
patient,O
was,O
started,O
on,O
heparin,B-TR
.,O

The,O
patient,O
transitioned,O
to,O
Lovenox,B-TR
on,O
12/09/03,O
after,O
a,O
Cardiology,O
consult,O
indicated,O
increased,O
survival,O
with,O
Lovenox,B-TR
therapy,I-TR
.,O

8.,O
Endocrine,O
:,O

Has,O
a,O
history,O
of,O
hypothyroidism,B-PR
.,O

The,O
patient,O
was,O
on,O
home,B-TR
Synthroid,I-TR
dose,I-TR
during,O
her,O
hospitalization,O
",",O
insulin,B-TR
sliding,I-TR
scale,I-TR
with,O
q.6h.,O
fingersticks,B-TE
while,O
she,O
was,O
on,O
TPN,B-TR
.,O

The,O
patient,O
was,O
transferred,O
to,O
the,O
Gynecologic,O
Oncology,O
Service,O
on,O
12/21/03,O
.,O

The,O
rest,O
of,O
the,O
dictation,O
is,O
to,O
follow,O
.,O

eScription,O
document,O
:,O

2-9396725,O
JFDDaua,O
Tel,O

Dictated,O
By,O
:,O

FOORDRIG,O
",",O
LA,O
BOMA,O

Attending,O
:,O

SECOND,O
",",O
CA,O
Dictation,O
ID,O
0750210,O

D,O
:,O

12/24/03,O

T,O
:,O

12/24/03,O

Admission,O
Date,O
:,O

2015-05-13,O

Discharge,O
Date,O
:,O

2015-05-20,O

Date,O
of,O
Birth,O
:,O

1813-05-16,O

Sex,O
:,O

F,O

Service,O
:,O

CME,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
104,O
year,O
old,O
female,O
patient,O
with,O
a,O
history,O
of,O
chronic,B-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
",",O
coronary,B-PR
artery,I-PR
disease,I-PR
",",O
hypertension,B-PR
and,O
cerebrovascular,B-PR
accident,I-PR
who,O
presents,O
with,O
shortness,B-PR
of,I-PR
breath,I-PR
and,O
cough,B-PR
.,O

The,O
patient,O
states,O
that,O
she,O
has,O
no,O
idea,O
why,O
she,O
was,O
brought,O
to,O
the,O
Emergency,O
Department,O
and,O
denies,O
any,B-PR
symptoms,I-PR
.,O

"She,O
reports,O
an,B-PR
occasional,I-PR
nonproductive,I-PR
cough,I-PR
that,O
she,O
has,O
had,O
""for,O
years"",O
and,O
feels,O
that,O
she,O
has,O
been,O
experiencing,O
alternating,B-PR
chills,I-PR
and,I-PR
feeling,I-PR
hot,I-PR
.",O

A,O
progress,O
note,O
in,O
the,O
patient,O
's,O
chart,O
from,O
her,O
assisted,O
living,O
facility,O
indicates,O
that,O
the,O
patient,O
has,O
had,O
shortness,B-PR
of,I-PR
breath,I-PR
and,O
cough,B-PR
for,O
one,O
day,O
with,O
chills,B-PR
but,O
no,O
fever,B-PR
.,O

She,O
has,O
been,O
recently,O
evaluated,O
as,O
an,O
outpatient,O
for,O
bradycardia,B-PR
.,O

She,O
was,O
seen,O
by,O
her,O
cardiologist,O
",",O
Dr.,O
Clements,O
and,O
had,O
a,B-TE
Holter,I-TE
monitor,I-TE
on,O
2015-05-01,O
",",O
that,O
showed,O
first,B-PR
degree,I-PR
AV,I-PR
block,I-PR
with,O
a,B-TE
rate,I-TE
that,O
ranged,O
between,O
35,O
to,O
53,O
beats,O
per,O
minute,O
.,O

In,O
the,O
Emergency,O
Department,O
",",O
the,O
patient,O
was,O
given,O
nebulizer,B-TR
treatment,I-TR
",",O
started,O
on,O
antibiotics,B-TR
for,O
presumed,O
chronic,B-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
exacerbation,I-PR
.,O

She,O
was,O
noted,O
to,O
have,O
lateral,B-PR
ST,I-PR
depressions,I-PR
and,O
given,O
Aspirin,B-TR
.,O

She,O
continues,O
to,O
deny,O
chest,B-PR
pain,I-PR
",",O
palpitations,B-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
fevers,B-PR
",",O
nausea,B-PR
",",O
vomiting,B-PR
",",O
abdominal,B-PR
pain,I-PR
",",O
bright,B-PR
red,I-PR
blood,I-PR
per,I-PR
rectum,I-PR
",",O
melena,B-PR
",",O
dysuria,B-PR
",",O
urinary,B-PR
frequency,I-PR
and,I-PR
urgency,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Chronic,B-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
with,O
asthmatic,B-PR
component,I-PR
.,O

Hypothyroidism,B-PR
.,O

Gastroenteritis,B-PR
.,O

Anxiety,B-PR
.,O

Insomnia,B-PR
.,O

Hypertension,B-PR
.,O

Osteoporosis,B-PR
.,O

History,O
of,O
cerebrovascular,B-PR
accident,I-PR
with,O
residual,B-PR
right,I-PR
sided,I-PR
weakness,I-PR
.,O

Scoliosis,B-PR
.,O

Coronary,B-PR
artery,I-PR
disease,I-PR
.,O

History,O
of,O
kidney,B-PR
mass,I-PR
.,O

History,O
of,O
lower,B-PR
gastrointestinal,I-PR
bleed,I-PR
.,O

Status,O
post,O
total,B-TR
abdominal,I-TR
hysterectomy,I-TR
",",O
bilateral,B-TR
salpingo-,I-TR
oophorectomy,I-TR
.,O

Left,B-PR
cataract,I-PR
.,O

Bradycardia,B-PR
followed,O
by,O
outpatient,O
cardiologist,O
with,O
a,B-TE
Holter,I-TE
monitor,I-TE
on,O
2015-05-01,O
",",O
with,O
first,B-PR
degree,I-PR
AV,I-PR
block,I-PR
and,O
a,B-TE
heart,I-TE
rate,I-TE
ranging,O
between,O
35,O
to,O
53,O
beats,O
per,O
minute,O
.,O

ALLERGIES,O
:,O

Penicillin,B-TR
",",O
Erythromycin,B-TR
",",O
Valium,B-TR
",",O
Compazine,B-TR
",",O

Demerol,B-TR
",",O
Percodan,B-TR
.,O

MEDICATIONS,O
ON,O
ADMISSION:,O

1.,O
Levothyroxine,B-TR
50,O
mcg,O
p.o.,O
once,O
daily,O
.,O

2.,O
Combivent,B-TR
two,O
puffs,O
four,O
times,O
a,O
day,O
.,O

3.,O
Flovent,B-TR
two,O
puffs,O
four,O
times,O
a,O
day,O
.,O

4.,O
Protonix,B-TR
40,O
mg,O
once,O
daily,O
.,O

5.,O
Lisinopril,B-TR
5,O
mg,O
p.o.,O
once,O
daily,O
.,O

6.,O
Norvasc,B-TR
5,O
mg,O
twice,O
a,O
day,O
.,O

7.,O
Lasix,B-TR
40,O
mg,O
once,O
daily,O
.,O

8.,O
Senna,B-TR
one,O
once,O
daily,O
.,O

9.,O
Dulcolax,B-TR
10,O
mg,O
once,O
daily,O
p.r.n.,O

10,O
.,O

TUMS,B-TR
500,O
mg,O
twice,O
a,O
day,O
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
lives,O
at,O
Norwood,O
in,O
assisted,O
living,O
section,O
.,O

She,O
has,O
a,O
24,O
hour,O
caregiver,O
.,O

The,O
patient,O
quit,O
smoking,O
fifty,O
years,O
ago,O
but,O
previously,O
was,O
a,O
heavy,O
smoker,O
",",O
though,O
states,O
that,O
she,O
never,O
inhaled,O
.,O

The,O
patient,O
denies,O
use,O
of,O
alcohol,O
or,O
drugs,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Temperature,B-TE
98.1,O
",",O
blood,B-TE
pressure,I-TE

144/38,O
",",O
heart,B-TE
rate,I-TE
41,O
",",O
respiratory,B-TE
rate,I-TE
20,O
",",O
oxygen,B-TE
saturation,I-TE

94,O
percent,O
in,O
room,O
air,O
and,O
96,O
percent,O
on,O
three,O
liters,O
.,O

In,O
general,O
",",O
a,O
well,O
appearing,O
elderly,O
female,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

Skin,O
is,O
warm,O
and,O
dry,O
with,O
decreased,B-PR
skin,I-PR
turgor,I-PR
.,O

Head,B-TE
",",I-TE
eyes,I-TE
",",I-TE
ears,I-TE
",",I-TE
nose,I-TE
and,I-TE
throat,I-TE
examination,I-TE
-,O
The,O
pupils,O
are,O
equal,O
",",O
round,O
and,O
reactive,O
to,O
light,O
and,O
accommodation,O
.,O

Extraocular,O
movements,O
are,O
intact,O
.,O

Dry,B-PR
mucous,I-PR
membranes,I-PR
.,O

The,O
oropharynx,O
is,O
clear,O
.,O

Neck,O
is,O
supple,O
",",O
full,O
range,O
of,O
motion,O
",",O
no,O
jugular,B-PR
venous,I-PR
distension,I-PR
or,O
lymphadenopathy,B-PR
.,O

The,O
heart,O
was,O
bradycardic,B-PR
with,O
regular,O
rhythm,O
",",O
no,O
murmurs,B-PR
",",O
rubs,B-PR
or,O
gallops,B-PR
.,O

Lungs,O
-,O
diffuse,B-PR
expiratory,I-PR
wheezes,I-PR
with,O
bibasilar,B-PR
rales,I-PR
",",O
left,O
over,O
right,O
.,O

The,O
abdomen,O
revealed,O
normoactive,O
bowel,O
sounds,O
",",O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
.,O

Rectal,O
is,O
guaiac,B-PR
positive,I-PR
per,O
Emergency,O
Department,O
.,O

Extremities,O
-,O
no,O
cyanosis,B-PR
or,O
clubbing,B-PR
",",O
one,B-PR
plus,I-PR
bilateral,I-PR
lower,I-PR
extremity,I-PR
edema,I-PR
with,O
right,O
worse,O
than,O
left,O
.,O

Neurologically,O
",",O
the,O
patient,O
is,O
awake,O
",",O
alert,O
and,O
oriented,O
times,O
three,O
.,O

LABORATORY,O
DATA,O
:,O

White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
was,O
8.5,O
(,O
80,O
percent,O
neutrophils,B-TE
",",O
13,O
percent,O
lymphocytes,B-TE
),O
",",O
hematocrit,B-TE
27.4,O
",",O
platelet,B-TE
count,I-TE
"277,000",O
.,O

Sodium,B-TE
133,O
",",O
potassium,B-TE
4.8,O
",",O
chloride,B-TE

94,O
",",O
bicarbonate,B-TE
24,O
",",O
blood,B-TE
urea,I-TE
nitrogen,I-TE
39,O
",",O
creatinine,B-TE
2.0,O
",",O
glucose,B-TE
111,O
.,O

CK,B-TE
152,O
",",O
CK,B-TE
MB,I-TE
3.0,O
",",O
troponin,B-TE
0.04.,O

INR,B-TE
1.1.,O

Chest,B-TE
x-ray,I-TE
showed,O
equivocal,B-PR
retrocardiac,I-PR
opacity,I-PR
.,O

Electrocardiogram,B-TE
showed,O
sinus,B-PR
bradycardia,I-PR
at,O
40,O
beats,O
per,O
minute,O
.,O

First,B-PR
degree,I-PR
AV,I-PR
block,I-PR
with,O
PR,B-TE
interval,I-TE
220,O
",",O
left,B-PR
axis,I-PR
deviation,I-PR
",",O
right,B-PR
bundle,I-PR
branch,I-PR
block,I-PR
with,O
a,B-PR
left,I-PR
anterior,I-PR
fascicular,I-PR
block,I-PR
",",O
0.1103,O
N.,O
Fifth,O
Cir.,O
depressions,O
in,O

V4,O
through,O
V6,O
.,O

HOSPITAL,O
COURSE,O
:,O

Shortness,B-PR
of,I-PR
breath,I-PR
-,O
Though,O
the,O
patient,O
denied,O
shortness,B-PR
of,I-PR
breath,I-PR
on,O
admission,O
",",O
a,O
progress,O
note,O
from,O

Norwood,O
nursing,O
facility,O
suggested,O
that,O
the,O
patient,O
had,O
been,O
having,O
shortness,B-PR
of,I-PR
breath,I-PR
and,O
cough,B-PR
for,O
approximately,O
one,O
day,O
with,O
difficulty,B-PR
ambulating,I-PR
",",O
needing,O
to,O
travel,O
in,O
a,B-TR
wheelchair,I-TR
.,O

The,O
patient,O
was,O
afebrile,B-PR
on,O
admission,O
with,O
a,O
normal,O
white,O
blood,O
cell,O
count,O
but,O
had,O
significant,B-PR
wheezing,I-PR
and,O
rales,B-PR
on,O
physical,B-TE
examination,I-TE
with,O
a,O
possible,O
left,B-PR
lower,I-PR
lobe,I-PR
opacity,I-PR
seen,O
on,O
chest,B-TE
x-ray,I-TE
.,O

The,O
etiology,O
of,O
the,B-PR
patient,I-PR
's,I-PR
shortness,I-PR
of,I-PR
breath,I-PR
was,O
considered,O
a,O
likely,O
chronic,B-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
exacerbation,I-PR
and,O
the,O
patient,O
was,O
started,O
on,O
Albuterol,B-TR
and,O
Atrovent,B-TR
nebulizers,I-TR
.,O

The,O
patient,O
was,O
also,O
started,O
on,O
Doxycycline,B-TR
given,O
the,O
concern,O
for,O
pneumonia,B-PR
on,O
chest,B-TE
x-ray,I-TE
.,O

She,O
was,O
also,O
continued,O
on,O
steroids,B-TR
given,O
evidence,O
of,O
severe,B-PR
airway,I-PR
obstruction,I-PR
.,O

The,B-PR
patient,I-PR
's,I-PR
shortness,I-PR
of,I-PR
breath,I-PR
was,O
also,O
considered,O
possibly,O
related,O
to,O
a,B-PR
coronary,I-PR
event,I-PR
and,O
she,O
was,O
admitted,O
for,O
rule,O
out,O
myocardial,B-PR
infarction,I-PR
.,O

The,B-TE
patient,I-TE
's,I-TE
enzymes,I-TE
were,O
cycled,O
and,O
were,O
negative,O
.,O

The,B-TE
patient,I-TE
's,I-TE
electrocardiogram,I-TE
performed,O
on,O
hospital,O
day,O
number,O
two,O
was,O
concerning,O
for,O
2:1,B-PR
heart,I-PR
block,I-PR
and,O
the,O
cardiology,O
consult,O
service,O
was,O
contacted,O
for,O
evaluation,B-TE
.,O

The,O
patient,O
was,O
taken,O
to,O
the,O
Coronary,O
Care,O
Unit,O
late,O
on,O
hospital,O
day,O
number,O
two,O
and,O
received,O
a,B-TR
temporary,I-TR
wire,I-TR
.,O

The,O
following,O
day,O
the,O
patient,O
received,O
a,B-TR
permanent,I-TR
dual,I-TR
chamber,I-TR
rate,I-TR
responsive,I-TR
pacemaker,I-TR
.,O

The,O
patient,O
was,O
transferred,O
back,O
to,O
the,O
general,O
medicine,O
service,O
where,O
she,O
continued,O
to,O
exhibit,O
signs,O
of,O
chronic,B-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
exacerbation,I-PR
and,O
nebulizers,B-TR
",",O
steroids,B-TR
and,O
antibiotics,B-TR
were,O
continued,O
.,O

The,O
patient,O
's,O
respiratory,O
status,O
improved,O
throughout,O
the,O
remainder,O
of,O
her,O
hospitalization,O
and,O
oxygen,B-TR
was,O
eventually,O
weaned,O
.,O

Once,O
the,O
patient,O
was,O
transferred,O
out,O
of,O
the,O
Coronary,O
Care,O
Unit,O
",",O
she,O
appeared,O
to,O
have,O
an,B-PR
element,I-PR
of,I-PR
heart,I-PR
failure,I-PR
in,O
addition,O
to,O
her,B-PR
chronic,I-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
.,O

She,O
was,O
given,O
20,O
mg,O
of,O
intravenous,B-TR
Lasix,I-TR
with,O
impressive,O
urine,O
output,O
and,O
improvement,O
in,O
her,B-TE
overall,I-TE
fluid,I-TE
status,I-TE
.,O

The,O
patient,O
was,O
eventually,O
restarted,O
on,O
her,O
outpatient,O
dose,O
of,O
Lasix,B-TR
once,O
her,B-TE
renal,I-TE
function,I-TE
improved,O
to,O
baseline,O
and,O
remained,O
hemodynamically,O
stable,O
throughout,O
the,O
remainder,O
of,O
her,B-TR
hospitalization,I-TR
.,O

Heart,B-PR
block,I-PR
-,O
As,O
noted,O
previously,O
",",O
the,B-TE
patient,I-TE
's,I-TE
electrocardiogram,I-TE
was,O
significant,O
for,O
a,B-PR
2:1,I-PR
heart,I-PR
block,I-PR
and,O
cardiology,O
consult,O
service,O
was,O
contacted,O
for,O
evaluation,B-TE
.,O

The,O
patient,O
received,O
a,B-TR
temporary,I-TR
pacing,I-TR
wire,I-TR
on,O
the,O
evening,O
of,O
hospital,O
day,O
number,O
two,O
and,O
on,O
hospital,O
day,O
number,O
three,O
received,O
a,B-TR
dual,I-TR
chamber,I-TR
pacemaker,I-TR
.,O

Renal,O
-,O
The,O
patient,O
was,O
admitted,O
with,O
a,B-TE
creatinine,I-TE
of,O
1.8,O
",",O
considered,O
likely,O
secondary,O
to,O
hypovolemia,B-PR
.,O

Her,B-TE
calculated,I-TE
fractional,I-TE
excretion,I-TE
of,I-TE
sodium,I-TE
was,O
0.13,O
percent,O
suggesting,O
a,B-PR
prerenal,I-PR
cause,I-PR
.,O

The,B-TE
patient,I-TE
's,I-TE
creatinine,I-TE
improved,O
to,O
1.1,O
with,O
hydration,B-TR
.,O

Once,O
the,B-TE
patient,I-TE
's,I-TE
creatinine,I-TE
had,O
improved,O
to,O
baseline,O
",",O
her,B-TR
Lasix,I-TR
and,O
ace,B-TR
inhibitor,I-TR
were,O
restarted,O
and,O
the,B-TE
patient,I-TE
's,I-TE
creatinine,I-TE
was,O
noted,O
to,O
be,O
stable,O
.,O

Gastrointestinal,O
-,O
The,O
patient,O
was,O
admitted,O
with,O
a,O
history,O
of,O
gastrointestinal,B-PR
bleed,I-PR
with,O
guaiac,B-PR
positive,I-PR
stools,I-PR
on,O
admission,O
.,O

Her,B-TE
hematocrit,I-TE
was,O
noted,O
to,O
trend,O
down,O
after,O
transfusion,B-TR
of,O
one,O
unit,O
of,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
on,O
admission,O
.,O

Given,O
guaiac,B-PR
positive,I-PR
stools,I-PR
and,O
her,O
history,O
of,O
gastrointestinal,B-PR
bleed,I-PR
in,O
addition,O
to,O
use,O
of,O
steroids,B-TR
for,O
chronic,B-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
exacerbation,I-PR
",",O
the,O
gastroenterology,O
consult,O
service,O
was,O
contacted,O
.,O

The,O
results,O
of,O
that,O
consultation,O
and,O
potential,O
esophagogastroduodenoscopy,B-TE
are,O
pending,O
at,O
the,O
time,O
of,O
dictation,O
.,O

Hypertension,B-PR
-,O
The,O
patient,O
had,O
moderate,O
control,O
of,O
her,B-TE
blood,I-TE
pressure,I-TE
throughout,O
her,O
admission,O
.,O

Her,B-TR
calcium,I-TR
channel,I-TR
blocker,I-TR
and,O
ace,B-TR
inhibitor,I-TR
were,O
continued,O
.,O

Hematology,O
-,O
As,O
noted,O
previously,O
",",O
the,B-TE
patient,I-TE
's,I-TE
hematocrit,I-TE
was,O
noted,O
to,O
drop,O
after,O
transfusion,B-TR
with,O
one,O
unit,O
of,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
on,O
admission,O
.,O

Given,O
guaiac,B-PR
positive,I-PR
stools,I-PR
and,O
the,O
patient,O
's,O
history,O
of,O
gastrointestinal,B-PR
bleed,I-PR
",",O
gastroenterology,O
consult,O
service,O
was,O
contacted,O
for,O
possible,O
esophagogastroduodenoscopy,B-TE
and/or,O
colonoscopy,B-TE
.,O

The,O
results,O
of,O
this,O
consultation,O
are,O
pending,O
at,O
the,O
time,O
of,O
dictation,O
.,O

The,O
remainder,O
of,O
the,O
Hubbard,O
Regional,O
Hospital,O
hospital,O
course,O
",",O
discharge,O
diagnoses,O
",",O
medications,B-TR
and,O
follow-up,O
will,O
be,O
dictated,O
at,O
the,O
time,O
of,O
discharge,O
.,O

Justin,O
Q.,O
Yagi,O
",",O
M.D.,O
12AKK,O

Dictated,O
By:Miriam,O
H,O
Hines,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O

2015-05-18,O
11:24,O

T,O
:,O

2015-05-18,O
14:58,O

Job#,O
:,O

21080,O

Signed,O
electronically,O
by,O
:,O

DR.,O
Jose,O
M.,O
Rosales,O
on,O
:,O

MON,O
2015-07-27,O
9:58,O
AM,O

(,O
End,O
of,O
Report,O
),O

142995994,O
SC,O

54818584,O

976113,O

1/23/1992,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

01/23/1992,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

01/26/1992,O

DIAGNOSIS,O
ON,O
DISCHARGE,O
:,O

1.,O
STATUS,O
POST,O
MOTORVEHICLE,O
ACCIDENT,O
WITH,O
TRANSIENT,B-PR
PARAPLEGIA,I-PR
.,O

2.,O
RIGHT,B-PR
HYDRONEPHROSIS,I-PR
ON,O
CT,B-TE
SCAN,I-TE
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
20,O
year,O
old,O
black,O
female,O
who,O
was,O
a,O
pedestrian,O
when,O
struck,O
by,O
a,O
car,O
at,O
apparent,O
high,O
speed,O
.,O

There,O
was,O
apparent,B-PR
loss,I-PR
of,I-PR
consciousness,I-PR
at,O
the,O
scene,O
and,O
significant,O
deformity,O
of,O
the,O
anterior,O
portion,O
of,O
the,O
motorvehicle,O
with,O
positive,O
starring,O
of,O
the,O
windshield,O
.,O

The,O
patient,O
was,O
conscious,O
on,O
the,O
scene,O
when,O
evaluated,O
by,O
EMT,O
&apos;s,O
but,O
at,O
the,O
scene,O
",",O
the,O
patient,O
was,O
apparently,B-PR
paraplegic,I-PR
below,I-PR
the,I-PR
umbilicus,I-PR
with,O
absence,B-PR
of,I-PR
movement,I-PR
and,I-PR
sensation,I-PR
below,I-PR
the,I-PR
umbilicus,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

None,O
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

Status,O
post,O
laparotomy,B-TR
for,O
an,B-PR
ovarian,I-PR
cyst,I-PR
in,O
1988,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

None,O
.,O

ALLERGIES,O
:,O

None,O
.,O

She,O
denies,O
cigarette,O
use,O
and,O
ethanol,O
use,O
as,O
well,O
as,O
a,O
recreational,O
drug,O
use,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
initial,B-TE
exam,I-TE
",",O
her,O
left,O
shoulder,O
was,O
tender,B-PR
to,O
palpation,B-TE
over,O
the,O
proximal,O
humerus,O
with,O
decreased,B-PR
range,I-PR
of,I-PR
motion,I-PR
.,O

She,O
was,O
without,O
the,O
ability,O
to,O
move,O
her,O
left,O
lower,O
extremity,O
with,O
decreased,B-PR
sensation,I-PR
in,I-PR
the,I-PR
left,I-PR
leg,I-PR
.,O

The,O
right,O
leg,O
was,O
with,O
decreased,B-PR
range,I-PR
of,I-PR
motion,I-PR
of,O
thigh,O
flexion,O
and,O
extension,O
.,O

The,O
back,O
was,O
notable,O
for,O
tenderness,B-PR
at,O
the,O
level,O
of,O
L3-L5,O
.,O

LABORATORY,O
EXAMINATION,O
:,O

Initial,B-TE
radiologic,I-TE
evaluation,I-TE
showed,O
negative,O
C-spine,O
",",O
thoracic,O
spine,O
",",O
and,O
lumbosacral,O
spine,O
films,O
.,O

Abdominal,B-TE
CT,I-TE
was,O
negative,O
except,O
for,O
right,B-PR
hydronephrosis,I-PR
with,O
mild,B-PR
right,I-PR
hydroureter,I-PR
.,O

Back,B-TE
MRI,I-TE
was,O
negative,O
.,O

Film,B-TE
of,I-TE
the,I-TE
left,I-TE
humerus,I-TE
was,O
also,O
negative,O
.,O

HOSPITAL,O
COURSE,O
:,O

A,O
Neurosurgery,O
consultation,O
was,O
obtained,O
",",O
and,O
it,O
was,O
their,O
impression,O
that,O
the,B-PR
patient,I-PR
&apos;s,I-PR
paraplegia,I-PR
might,O
possibly,O
represent,O
a,B-PR
cord,I-PR
concussion,I-PR
",",O
and,O
recommended,O
treatment,B-TR
with,I-TR
intravenous,I-TR
steroids,I-TR
for,O
24,O
hours,O
.,O

The,B-PR
patient,I-PR
&apos;s,I-PR
paraplegia,I-PR
resolved,O
by,O
the,O
morning,O
of,O
her,O
second,O
hospital,O
day,O
",",O
and,O
she,O
maintained,O
5/5,O
motor,O
strength,O
in,O
all,O
groups,O
.,O

A,O
Urology,O
consultation,O
was,O
obtained,O
",",O
and,O
it,O
was,O
recommended,O
that,O
an,B-TE
IVP,I-TE
be,O
obtained,O
.,O

This,O
was,O
obtained,O
on,O
the,O
day,O
of,O
discharge,O
",",O
however,O
",",O
due,O
to,O
residual,B-PR
contrast,I-PR
in,I-PR
the,I-PR
colon,I-PR
from,O
the,B-TE
patient,I-TE
&apos;s,I-TE
prior,I-TE
abdominal,I-TE
CT,I-TE
scan,I-TE
",",O
the,B-TE
exam,I-TE
was,O
postponed,O
after,O
a,B-TE
scout,I-TE
film,I-TE
was,O
obtained,O
.,O

The,O
patient,O
fell,O
well,O
on,O
the,O
day,O
of,O
discharge,O
.,O

She,O
remained,O
afebrile,B-PR
throughout,O
her,O
hospital,O
course,O
.,O

Additionally,O
on,O
the,O
night,O
before,O
discharge,O
",",O
flexion,B-TE
and,I-TE
extension,I-TE
views,I-TE
of,I-TE
the,I-TE
lumbosacral,I-TE
spine,I-TE
were,O
obtained,O
",",O
and,O
showed,O
no,O
fracture,B-PR
or,O
instability,B-PR
.,O

DISPOSITION,O
:,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Good,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Tylenol,B-TR
650,O
mg,O
p.o.,O
q4,O
hours,O
p.r.n.,O
pain,B-PR
.,O

She,O
will,O
followup,O
in,O
the,O
Wardca,O
Presiew,O
Hospital,O
in,O
one,O
week,O
.,O

She,O
will,O
have,O
an,B-TE
IVP,I-TE
repeated,O
in,O
one,O
week,O
at,O
which,O
time,O
she,O
should,O
have,O
cleared,O
the,B-PR
residual,I-PR
contrast,I-PR
in,I-PR
her,I-PR
colon,I-PR
.,O

She,O
will,O
have,O
urology,O
followup,O
after,O
her,B-TE
IVP,I-TE
.,O

OP303/0134,O
NARI,O
BLACK,O
",",O
M.D.,O
SU1,O

D,O
:,O

01/26/92,O

Batch,O
:,O

7505,O

Report,O
:,O

K7798E74,O

T,O
:,O

01/27/92,O

Dictated,O
By,O
:,O

SHAZA,O
C.,O
SCHAUMANN,O
",",O
M.D.,O

Admission,O
Date,O
:,O

2013-11-01,O

Discharge,O
Date,O
:,O

2013-12-10,O

Date,O
of,O
Birth,O
:,O

2013-11-01,O

Sex,O
:,O

F,O

Service,O
:,O

Neonatology,O

HISTORY,O
:,O

Mychelia,O
Boyd,O
was,O
born,O
at,O
28-2/7,O
weeks,O
gestation,O
and,O
delivered,O
due,O
to,O
unstoppable,B-PR
premature,I-PR
labor,I-PR
.,O

Mother,O
is,O
an,O
18-year-old,O
prima,O
gravida,O
",",O
estimated,O
date,O
of,O
delivery,O
2014-01-22,O
.,O

Prenatal,B-TE
screens,I-TE
include,O
blood,B-TE
type,I-TE
O,O
negative,O
.,O

Other,B-TE
prenatal,I-TE
screens,I-TE
were,O
unknown,O
at,O
time,O
of,O
delivery,B-TR
.,O

Pregnancy,O
was,O
uncomplicated,O
until,O
the,O
day,O
of,O
delivery,B-TR
when,O
mother,O
presented,O
to,O
HealthSouth,O
New,O
England,O
Rehab,O
Hospital,O
Hospital,O
with,O
bleeding,B-PR
and,O
was,O
sent,O
home,O
.,O

She,O
then,O
presented,O
to,O
Jordan,O
Hospital,O
Hospital,O
where,O
she,O
was,O
noted,O
to,O
be,O
5,B-PR
cm,I-PR
dilated,I-PR
with,O
a,B-PR
transverse,I-PR
lie,I-PR
presentation,I-PR
.,O

She,O
was,O
given,O
betamethasone,B-TR
times,O
one,O
and,O
transferred,O
to,O
the,O
Nantucket,O
Cottage,O
Hospital,O
where,O
she,O
was,O
delivered,O
by,O
cesarean,B-TR
section,I-TR
with,O
rupture,B-PR
of,I-PR
membranes,I-PR
at,O
time,O
of,O
delivery,B-TR
notable,O
for,O
slight,B-PR
meconium,I-PR
stained,I-PR
amniotic,I-PR
fluid,I-PR
.,O

The,O
baby,O
emerged,O
with,O
spontaneous,O
cry,O
",",O
received,O
routine,B-TR
care,I-TR
and,O
then,O
was,O
intubated,O
in,O
the,O
Delivery,O
Room,O
due,O
to,O
inconsistent,B-PR
respiratory,I-PR
effort,I-PR
and,O
increased,B-PR
work,I-PR
of,I-PR
breathing,I-PR
.,O

Apgars,B-TE
were,O
6,O
at,O
one,O
minute,O
and,O
8,O
at,O
five,O
minutes,O
.,O

She,O
was,O
transferred,O
to,O
the,O
newborn,O
Intensive,O
Care,O
Unit,O
for,O
further,B-TR
management,I-TR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Her,B-TE
admission,I-TE
physical,I-TE
revealed,O
a,B-TE
birth,I-TE
weight,I-TE
of,O
901,O
gm,O
",",O
20th,O
percentile,O
;,O
length,B-TE
34,O
cm,O
",",O
25th,O
percentile,O
;,O
head,B-TE
circumference,I-TE
25,O
cm,O
",",O
25th,O
percentile,O
.,O

Anterior,O
fontanelle,O
open,O
",",O
soft,O
and,O
flat,O
.,O

Red,B-TE
reflex,I-TE
was,O
difficult,O
to,O
appreciate,O
bilaterally,O
.,O

Pupils,O
were,O
large,O
but,O
equal,O
and,O
reactive,O
.,O

Palate,O
deferred,O
due,O
to,O
oral,B-TR
intubation,I-TR
.,O

No,O
defect,B-PR
noted,O
during,O
procedure,B-TR
.,O

Increased,B-PR
work,I-PR
of,I-PR
breathing,I-PR
prior,O
to,O
intubation,B-TR
",",O
but,O
presently,O
comfortable,O
.,O

Breath,O
sounds,O
slightly,B-PR
crackly,I-PR
",",O
symmetric,O
equal,O
air,O
entry,O
.,O

Cardiovascular,O
regular,O
rate,O
and,O
rhythm,O
without,O
murmur,B-PR
.,O

Peripheral,B-TE
pulses,I-TE
plus,O
2,O
and,O
symmetric,O
.,O

Abdomen,O
soft,O
without,O
hepatosplenomegaly,B-PR
.,O

Three-vessel,O
cord,O
",",O
clamped,O
.,O

Normal,O
female,O
external,O
genitalia,O
.,O

Normal,O
back,O
and,O
hips,O
.,O

Skin,O
was,O
pink,O
and,O
well-perfused,O
.,O

Appropriate,O
tone,O
and,O
activity,O
.,O

HOSPITAL,O
COURSE,O
BY,O
SYSTEM,O
:,O

Respiratory,O
:,O

The,O
baby,O
was,O
intubated,O
in,O
the,O
Delivery,O
Room,O
",",O
received,O
two,O
doses,O
of,O
surfactant,B-TR
.,O

Radiograph,B-TE
revealed,O
bilateral,B-PR
diffuse,I-PR
granular,I-PR
pattern,I-PR
consistent,O
with,O
surfactant,B-PR
deficiency,I-PR
.,O

Maximum,B-TR
mechanical,I-TR
ventilation,I-TR
PIP,B-TR
26,O
",",O
PEEP,B-TR
6,O
",",O
rate,B-TR
of,O
25,O
",",O
maximum,B-TR
FIO2,I-TR
35,O
percent,O
.,O

Mychelia,O
was,O
extubated,O
to,O
a,B-TR
CPAP,I-TR
of,O
6,O
cm,O
on,O
day,O
of,O
life,O
two,O
where,O
she,O
remained,O
until,O
day,O
of,O
life,O
20,O
.,O

On,O
day,O
of,O
life,O
two,O
",",O
she,O
was,O
also,O
loaded,O
with,O
caffeine,B-TR
and,O
continues,O
on,O
caffeine,B-TR
at,O
time,O
of,O
transfer,O
.,O

She,O
was,O
transitioned,O
to,O
a,B-TR
nasal,I-TR
cannula,I-TR
on,O
day,O
of,O
life,O
20,O
and,O
remains,O
on,O
nasal,B-TR
cannula,I-TR
O2,I-TR
100,O
percent,O
at,O
13,O
cc,O
flow,O
.,O

She,O
averaged,O
2-3,O
apnea,B-PR
episodes,I-PR
a,O
day,O
with,O
bradycardia,B-PR
and,O
desaturations,B-PR
.,O

She,O
has,O
a,O
comfortable,O
respiratory,B-TE
rate,I-TE
and,O
good,O
air,O
exchange,O
.,O

Cardiovascular,O
:,O

She,O
received,O
a,B-TR
normal,I-TR
saline,I-TR
bolus,I-TR
times,O
one,O
initially,O
for,O
poor,B-PR
perfusion,I-PR
and,O
was,O
started,O
on,O
dopamine,B-TR
with,O
a,O
maximum,O
infusion,O
rate,O
of,O
6,O
mcg,O
per,O
kg,O
per,O
hour,O
.,O

This,O
was,O
discontinued,O
on,O
day,O
of,O
life,O
two,O
to,O
maintain,O
a,B-TE
mean,I-TE
arterial,I-TE
pressure,I-TE
of,O
greater,O
than,O
33,O
.,O

She,O
has,O
remained,O
hemodynamically,O
stable,O
during,O
the,O
remainder,O
of,O
her,O
hospitalization,O
here,O
.,O

Fluids,O
",",O
electrolytes,O
",",O
nutrition,O
:,O

Initially,O
maintained,O
NPO,B-TR
.,O

UAC,B-TR
and,I-TR
UVC,I-TR
lines,I-TR
were,O
placed,O
upon,O
admission,O
to,O
the,O
CMED,O
.,O

The,B-TR
UAC,I-TR
was,O
left,O
in,O
place,O
until,O
day,O
of,O
life,O
two,O
and,O
was,O
removed,O
after,O
wean,O
from,O
dopamine,B-TR
.,O

UVC,B-TR
remained,O
in,O
place,O
through,O
day,O
of,O
life,O
six,O
and,O
was,O
utilized,O
to,O
administer,O
parenteral,B-TR
nutrition,I-TR
.,O

Electrolytes,B-TE
and,O
glucose,B-TE
remained,O
in,O
the,O
normal,O
range,O
throughout,O
the,O
first,O
week,O
.,O

She,O
was,O
started,O
on,O
enteral,B-TR
feeds,I-TR
on,O
day,O
of,O
life,O
six,O
with,O
a,O
slow,O
advance,O
secondary,O
to,O
increased,B-PR
abdominal,I-PR
girth,I-PR
which,O
was,O
felt,O
to,O
be,O
due,O
to,O
CPAP,B-TR
.,O

She,O
passed,O
meconium,O
.,O

She,O
achieved,O
full,O
feeds,O
on,O
day,O
of,O
life,O
13,O
.,O

Calories,O
were,O
gradually,O
increased,O
to,O
breast,O
milk,O
30,O
calories,O
with,O
ProMod,B-TR
consisting,O
of,O
four,O
of,O
human,O
milk,O
fortifier,O
",",O
four,O
of,O
MCT,B-TR
and,O
two,O
of,O
Polycose,B-TR
with,O
a,O
12-28,O
teaspoon,O
of,O
ProMod,B-TR
per,O
50,O
ml,O
of,O
breast,O
milk,O
or,O
60,O
ml,O
of,O
formula,O
.,O

On,O
day,O
of,O
life,O
six,O
due,O
to,O
concerns,O
for,O
hyperglycemia,B-PR
and,O
abdominal,B-PR
distention,I-PR
",",O
sepsis,B-TE
evaluation,I-TE
was,O
obtained,O
.,O

She,O
was,O
noted,O
at,O
this,O
time,O
to,O
have,O
hyperglycemia,B-PR
requiring,O
two,O
subcutaneous,O
doses,O
of,O
insulin,B-TR
and,O
a,B-TR
decreased,I-TR
glucose,I-TR
infusion,I-TR
rate,I-TR
to,O
achieve,O
euglycemia,O
.,O

This,O
resolved,O
that,O
same,O
day,O
.,O

Urine,B-TE
output,I-TE
was,O
always,O
noted,O
to,O
be,O
of,O
sufficient,O
quantity,O
.,O

Gastrointestinal,O
:,O

Mychelia,O
demonstrated,O
slow,B-PR
gastrointestinal,I-PR
motility,I-PR
and,O
abdominal,B-PR
distention,I-PR
felt,O
to,O
be,O
due,O
to,O
CPAP,B-TR
.,O

She,O
was,O
slow,O
to,O
advance,O
on,O
enteral,O
feeds,O
and,O
gradually,O
attained,O
full,O
enteral,O
volume,O
on,O
day,O
of,O
life,O
13,O
.,O

On,O
day,O
of,O
life,O
15,O
",",O
she,O
was,O
made,O
NPO,B-TR
for,O
a,B-PR
distended,I-PR
abdomen,I-PR
and,O
a,B-PR
bilious,I-PR
spit,I-PR
.,O

Serial,B-TE
KUBs,I-TE
revealed,O
nonspecific,B-PR
changes,I-PR
with,O
dilated,B-PR
loops,I-PR
.,O

No,O
pneumatosis,B-PR
or,O
free,B-PR
air,I-PR
was,O
seen,O
.,O

She,O
was,O
noted,O
to,O
have,O
bluish,B-PR
discoloration,I-PR
thought,O
to,O
perhaps,O
be,O
a,B-PR
bruise,I-PR
on,I-PR
her,I-PR
left,I-PR
lower,I-PR
quadrant,I-PR
.,O

There,O
was,O
no,O
radiographic,O
correlation,O
with,O
this,O
.,O

Feeds,O
were,O
restarted,O
.,O

Again,O
",",O
she,O
was,O
advanced,O
to,O
full,O
volume,O
but,O
was,O
made,O
NPO,B-TR
on,O
day,O
of,O
life,O
20,O
for,O
abdominal,B-PR
distention,I-PR
.,O

This,B-TR
NPO,I-TR
was,O
temporary,O
for,O
that,O
day,O
and,O
she,O
then,O
resumed,O
feedings,O
and,O
has,O
been,O
tolerating,O
full,B-TR
enteral,I-TR
feeds,I-TR
well,O
",",O
improved,O
since,O
off,O
of,O
CPAP,B-TR
",",O
passing,O
normal,O
stools,O
",",O
guaiac,B-TE
negative,O
.,O

Mychelia,O
was,O
also,O
treated,O
for,O
physiologic,B-PR
jaundice,I-PR
.,O

She,O
was,O
started,O
under,O
phototherapy,B-TR
on,O
day,O
of,O
life,O
one,O
through,O
day,O
of,O
life,O
three,O
with,O
a,B-TE
peak,I-TE
serum,I-TE
bilirubin,I-TE
of,O
4.7/0.3,O
.,O

This,O
issue,O
resolved,O
.,O

Hematologic,O
and,O
Infectious,O
Disease,O
:,O

Initial,B-TE
CBC,I-TE
was,O
notable,O
for,O
a,B-TE
white,I-TE
count,I-TE
of,O
5.5,O
with,O
49,B-TE
polys,I-TE
",",O
1,B-TE
band,I-TE
and,O
47,B-TE
lymphs,I-TE
.,O

Initial,B-TE
hematocrit,I-TE
was,O
46.3,O
percent,O
and,O
platelets,B-TE
"320,000",O
.,O

Her,B-TE
initial,I-TE
blood,I-TE
culture,I-TE
remained,O
negative,O
and,O
she,O
received,O
48,O
hours,O
of,O
ampicillin,B-TR
and,O
gentamicin,B-TR
.,O

As,O
previously,O
noted,O
on,O
day,O
of,O
life,O
six,O
with,O
hyperglycemia,B-PR
",",O
abdominal,B-PR
distention,I-PR
",",O
a,B-TE
CBC,I-TE
and,O
blood,B-TE
culture,I-TE
were,O
again,O
obtained,O
revealing,O
a,B-TE
white,I-TE
count,I-TE
of,O
9.1,O
with,O
30,B-TE
polys,I-TE
",",O
0,B-TE
bands,I-TE
and,O
58,B-TE
lymphs,I-TE
.,O

Hematocrit,B-TE
at,O
that,O
time,O
was,O
noted,O
to,O
be,O
31,O
and,O
platelets,B-TE
"370,000",O
.,O

Blood,B-TE
culture,I-TE
grew,O
staph,B-PR
coagulase,I-PR
negative,I-PR
and,O
the,O
baby,O
received,O
seven,O
days,O
of,O
vancomycin,B-TR
and,O
gentamicin,B-TR
.,O

A,B-TE
lumbar,I-TE
puncture,I-TE
was,O
also,O
performed,O
to,O
rule,O
out,O
meningitis,B-PR
.,O

This,B-TE
culture,I-TE
remained,O
negative,O
with,O
normal,O
cell,O
counts,O
and,O
chemistries,O
.,O

Antibiotic,B-TE
levels,I-TE
were,O
monitored,O
and,O
doses,O
adjusted,O
accordingly,O
.,O

Mychelia,O
required,O
two,B-TR
transfusions,I-TR
during,O
her,O
hospital,O
stay,O
.,O

On,O
day,O
of,O
life,O
15,O
for,O
a,B-TE
hematocrit,I-TE
of,O
29,O
",",O
she,O
received,O
20,O
cc,O
of,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
.,O

She,O
started,O
on,O
iron,B-TR
and,O
vitamin,B-TR
E,I-TR
supplements,I-TR
on,O
day,O
of,O
life,O
25,O
and,O
continues,O
on,O
that,O
at,O
this,O
time,O
of,O
transfer,O
.,O

However,O
",",O
on,O
day,O
of,O
life,O
34,O
",",O
12-04,O
",",O
she,O
was,O
noted,O
to,O
be,O
pale,B-PR
and,O
less,B-PR
stress,I-PR
tolerant,I-PR
",",O
mottling,O
easily,O
with,O
care,O
.,O

A,B-TE
hematocrit,I-TE
and,O
reticulocyte,B-TE
count,I-TE
showed,O
a,B-TE
hematocrit,I-TE
of,O
23,O
percent,O
and,O
a,B-TE
reticulocyte,I-TE
count,I-TE
of,O
1.9,O
percent,O
.,O

Therefore,O
",",O
with,O
blood,B-TR
available,O
from,O
the,O
first,O
aliquot,O
",",O
a,O
second,O
20,O
cc,O
per,O
kg,O
of,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
were,O
infused,O
without,O
incident,O
.,O

Neurological,O
:,O

Initial,B-TE
head,I-TE
ultrasound,I-TE
on,O
day,O
of,O
life,O
seven,O
was,O
normal,O
.,O

At,O
one,O
month,O
of,O
age,O
",",O
on,O
12-03,O
",",O
she,O
was,O
noted,O
to,O
have,O
an,B-PR
absent,I-PR
septum,I-PR
pellucidum,I-PR
.,O

An,B-TE
MRI,I-TE
obtained,O
and,O
reviewed,O
by,O
the,O
Hallmark,O
Health,O
System,O
Radiology,O
Department,O
revealed,O
focal,B-PR
gyral,I-PR
morphology,I-PR
consistent,O
with,O
prematurity,B-PR
",",O
normal,O
midline,O
structures,O
",",O
normal,O
myelination,O
",",O
no,O
lesions,B-PR
",",O
no,O
signal,B-PR
abnormalities,I-PR
or,O
extracerebral,B-PR
collections,I-PR
.,O

The,O
cortical,O
ribbon,O
is,O
intact,O
.,O

The,O
major,O
vascular,O
structures,O
at,O
the,O
skull,O
base,O
are,O
normal,O
.,O

The,O
septal,O
leaflets,O
may,O
be,O
partially,B-PR
absent,I-PR
",",O
but,O
there,O
are,O
no,O
coronal,B-TE
images,I-TE
provided,O
for,O
confirmation,O
and,O
the,O
pituitary,O
stalk,O
is,O
present,O
.,O

An,O
Ophthalmology,O
consult,O
was,O
obtained,O
to,O
determine,O
the,O
presence,O
of,O
optic,O
nerves,O
.,O

These,O
were,O
both,O
determined,O
to,O
be,O
present,O
and,O
intact,O
.,O

Endocrine,O
was,O
also,O
consulted,O
.,O

Several,B-TE
labs,I-TE
were,O
ordered,O
.,O

Electrolytes,B-TE
and,O
thyroid,B-TE
studies,I-TE
were,O
noted,O
to,O
be,O
in,O
the,O
normal,O
range,O
with,O
serum,B-TE
sodium,I-TE
of,O
136,O
",",O
potassium,B-TE
4.7,O
",",O
chloride,B-TE
98,O
and,O
CO2,B-TE
34,O
.,O

She,O
had,O
a,B-TE
calcium,I-TE
of,O
10.3,O
",",O
a,B-TE
phosphorus,I-TE
of,O
4.8,O
and,O
alkaline,B-TE
phosphatase,I-TE
of,O
440,O
.,O

Thyroid,B-TE
function,I-TE
studies,I-TE
revealed,O
a,B-TE
TSH,I-TE
of,O
2.2,O
",",O
T4,B-TE
of,O
5.7,O
",",O
T3,B-TE
of,O
101,O
and,O
a,B-TE
cortisol,I-TE
level,I-TE
of,O
43,O
",",O
all,O
within,O
the,O
normal,O
range,O
.,O

A,B-TE
growth,I-TE
hormone,I-TE
was,O
sent,O
and,O
the,O
results,O
were,O
pending,O
at,O
time,O
of,O
transfer,O
.,O

In,O
addition,O
",",O
an,B-TE
FSH,I-TE
and,O
LH,B-TE
were,O
obtained,O
on,O
12-10,O
and,O
results,O
are,O
pending,O
at,O
time,O
of,O
transfer,O
.,O

Please,O
contact,O
lab,O
control,O
at,O
Mattapan,O
Community,O
Health,O
Center,O
for,O
results,O
:,O
(,O
409,O
),O
238-8236,O
.,O

The,B-TE
baby,I-TE
's,I-TE
neurologic,I-TE
examination,I-TE
is,O
appropriate,O
for,O
corrected,O
gestational,O
age,O
which,O
is,O
33,O
and,O
6/7,O
weeks,O
on,O
day,O
of,O
transfer,O
.,O

By,O
mother,O
's,O
report,O
",",O
a,O
maternal,O
cousin,O
also,O
has,O
an,B-PR
absent,I-PR
septum,I-PR
pellucidum,I-PR
.,O

Given,O
normal,O
pituitary,O
tests,O
thus,O
far,O
and,O
normal,O
optic,O
nerve,O
",",O
no,O
evidence,O
of,O
septic,B-PR
optic,I-PR
dysplasia,I-PR
.,O

Pediatrician,O
should,O
have,O
low,O
threshold,O
for,O
endocrinology,O
reconsult,O
if,O
any,B-PR
signs,I-PR
of,I-PR
pituitary,I-PR
problems,I-PR
.,O

Sensory,O
:,O

Audiology,O
hearing,O
has,O
not,O
yet,O
been,O
obtained,O
.,O

This,O
is,O
recommended,O
prior,O
to,O
discharge,O
from,O
hospital,O
to,O
home,O
.,O

Ophthalmology,O
:,O

Initial,B-TE
ROP,I-TE
screen,I-TE
was,O
done,O
on,O
12-02,O
and,O
revealed,O
immature,B-PR
retinas,I-PR
to,I-PR
zone,I-PR
2,I-PR
bilaterally,I-PR
.,O

They,O
recommended,O
follow-up,B-TE
examination,I-TE
due,O
on,O
the,O
week,O
of,O
12/20,O
.,O

Psychosocial,O
:,O

Gardner,O
State,O
Hospital,O
social,O
worker,O
has,O
assisted,O
in,O
working,O
with,O
this,O
family,O
.,O

The,O
contact,O
may,O
be,O
reached,O
at,O
(,O
754,O
),O
791,O
7976,O
.,O

Parents,O
have,O
been,O
very,O
involved,O
and,O
appropriate,O
with,O
infant,O
and,O
have,O
eagerly,O
learned,O
to,O
care,O
for,O
their,O
baby,O
.,O

Condition,O
at,O
time,O
of,O
transfer,O
is,O
good,O
.,O

Discharge,O
disposition,O
is,O
to,O
level,O
2,O
nursery,O
at,O
Jordan,O
Hospital,O
Hospital,O
.,O

Name,O
of,O
primary,O
pediatrician,O
is,O
Ashley,O
Daley,O
of,O
Village,O
Pediatrics,O
in,O
Stockbridge,O
.,O

Feedings,O
at,O
the,O
time,O
of,O
transfer,O
include,O
breast,O
milk,O
30,O
with,O
ProMod,B-TR
at,O
150,O
cc,O
per,O
kg,O
per,O
day,O
",",O
all,O
gavage,B-TR
given,O
over,O
one,O
hour,O
.,O

Medications,B-TR
include,O
Fer-In-Norman,B-TR
",",O
vitamin,B-TR
E,I-TR
5,O
international,O
units,O
each,O
day,O
and,O
caffeine,B-TR
citrate,I-TR
once,O
a,O
day,O
.,O

Car,B-TE
seat,I-TE
positioning,I-TE
screening,I-TE
has,O
not,O
been,O
obtained,O
.,O

Newborn,B-TE
state,I-TE
screens,I-TE
have,O
been,O
sent,O
per,O
protocol,O
.,O

Results,O
have,O
been,O
in,O
the,O
normal,O
range,O
.,O

IMMUNIZATIONS,O
RECEIVED,O
:,O

Mychelia,O
received,O
hepatitis,B-TR
B,I-TR
vaccine,I-TR
on,O
11-02,O
due,O
to,O
unknown,O
maternal,O
hepatitis,O
B,O
surface,O
antigen,O
status,O
.,O

She,O
also,O
received,O
hepatitis,B-TR
B,I-TR
immune,I-TR
globulin,I-TR
on,O
11-02,O
.,O

On,O
12-06,O
",",O
she,O
received,O
her,B-TR
second,I-TR
hepatitis,I-TR
B,I-TR
vaccine,I-TR
.,O

Her,B-TR
two,I-TR
month,I-TR
immunizations,I-TR
have,O
not,O
yet,O
been,O
given,O
.,O

IMMUNIZATIONS,O
RECOMMENDED,O
:,O

Synagis,B-TR
RSV,I-TR
prophylaxis,I-TR
should,O
be,O
considered,O
from,O
November,O
through,O
March,O
for,O
infants,O
who,O
meet,O
any,O
of,O
the,O
following,O
three,O
criteria,O
:,O

1),O
born,O
at,O
less,O
than,O
32,O
weeks,O
",",O

2),O
born,O
at,O
between,O
32,O
and,O
35,O
weeks,O
with,O
two,O
of,O
the,O
following,O
:,O

Daycare,O
during,O
RSV,O
season,O
",",O
a,O
smoker,O
in,O
the,O
household,O
",",O
neuromuscular,B-PR
disease,I-PR
",",O
airway,B-PR
abnormalities,I-PR
or,O
school,O
age,O
siblings,O
or,O

3),O
infants,O
with,O
chronic,B-PR
lung,I-PR
disease,I-PR
.,O

Influenza,B-TR
immunization,I-TR
is,O
recommended,O
annually,O
in,O
the,O
fall,O
for,O
all,O
infants,O
once,O
they,O
reach,O
6,O
months,O
of,O
age,O
.,O

Before,O
this,O
age,O
and,O
for,O
the,O
first,O
24,O
months,O
of,O
the,O
infant,O
's,O
life,O
",",O
immunization,B-TR
against,O
influenza,B-PR
is,O
recommended,O
for,O
household,O
contacts,O
and,O
out,O
of,O
home,O
caregivers,O
.,O

Follow-up,O
appointments,O
recommended,O
with,O
the,O
primary,O
pediatrician,O
",",O
Dr.,O
Marilyn,O
Daley,O
of,O
Stockbridge,O
",",O
Village,O
Pediatrics,O
",",O
Dr.,O
Lynn,O
Warren,O
of,O
Neurology,O
from,O
Emerson,O
Hospital,O
and,O
Ophthalmology,O
to,O
follow,O
her,O
ophthalmology,O
status,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Prematurity,B-PR
at,O
28-2/7,O
weeks,O
.,O

2.,O
Surfactant,B-PR
deficiency,I-PR
.,O

3.,O
Hypotension,B-PR
.,O

4.,O
Sepsis,B-PR
suspect,O
.,O

5.,O
Physiologic,B-PR
jaundice,I-PR
.,O

6.,O
Coagulase,B-PR
negative,I-PR
bacteremia,I-PR
.,O

7.,O
Anemia,B-PR
of,O
prematurity,B-PR
.,O

8.,O
Apnea,B-PR
of,O
prematurity,B-PR
.,O

9.,O
Absent,B-PR
septum,I-PR
pellucidum,I-PR
.,O

Rosalie,O
Gloria,O
",",O
North,O
Dakota,O
67177,O

Dictated,O
By,O
:,O
George,O
D,O
Gregory,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2013-12-10,O
12:41:22,O

T,O
:,O
2013-12-10,O
14:03:32,O

Job,O
#,O
:,O
48183,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Yolanda,O
Corona,O
on,O
:,O
WED,O
2013-12-11,O
11:46,O
AM,O

(,O
End,O
of,O
Report,O
),O

143484920,O

GH,O

57104201,O

7/10/1991,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Unsigned,O

DIS,O

Admission,O
Date,O
:,O

07/10/1991,O

Report,O
Status,O
:,O

Unsigned,O

Discharge,O
Date,O
:,O

07/18/1991,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

C.,B-PR
difficile,I-PR
colitis,I-PR
.,O

SECONDARY,O
DIAGNOSIS,O
:,O

1.,O
Chronic,B-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
.,O

2.,O
Chronic,B-PR
pleural,I-PR
effusion,I-PR
.,O

3.,O
History,O
of,O
ischemic,B-PR
bowel,I-PR
.,O

4.,O
Chronic,B-PR
renal,I-PR
insufficiency,I-PR
with,O
azotemia,B-PR
.,O

PROCEDURES,O
:,O

Thoracentesis,B-TR
was,O
performed,O
on,O
7-12-91,O
.,O

REASON,O
FOR,O
ADMISSION,O
:,O

The,O
patient,O
is,O
an,O
85-year-old,O
white,O
male,O
with,O
a,O
history,O
of,O
ischemic,B-PR
bowel,I-PR
status,O
post,O
recent,O
admission,O
for,O
urosepsis,B-PR
and,O
C.,B-PR
difficile,I-PR
colitis,I-PR
.,O

He,O
returns,O
from,O
the,O
nursing,O
home,O
with,O
fever,B-PR
",",O
leukocytosis,B-PR
",",O
and,O
azotemia,B-PR
.,O

PRESENT,O
ILLNESS,O
:,O

Briefly,O
",",O
the,O
patient,O
has,O
a,O
history,O
of,O
chronic,B-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
",",O
ethanol,O
abuse,O
",",O
chronic,B-PR
pleural,I-PR
effusions,I-PR
",",O
and,O
chronic,B-PR
renal,I-PR
insufficiency,I-PR
.,O

He,O
presented,O
to,O
Gaanvantsir,O
on,O
04-17-92,O
with,O
abdominal,B-PR
pain,I-PR
and,O
bloody,B-PR
diarrhea,I-PR
.,O

Workup,B-TE
revealed,O
ischemic,B-PR
bowel,I-PR
secondary,O
to,O
Celiac,B-PR
and,O
SMA,B-PR
stenoses,I-PR
.,O

The,O
patient,O
underwent,O
an,B-TR
angioplasty,I-TR
of,O
his,B-PR
SMA,I-PR
from,O
90-20%,O
residual,O
.,O

The,O
patient,O
was,O
also,O
found,O
to,O
have,O
gram,B-PR
negative,I-PR
rod,I-PR
sepsis,I-PR
with,O
blood,B-TE
cultures,I-TE
times,O
two,O
growing,O
E.,B-PR
coli,I-PR
and,O
B.,B-PR
fragilis,I-PR
.,O

The,O
patient,O
was,O
treated,O
with,O
ampicillin,B-TR
",",O
gentamicin,B-TR
",",O
and,O
Flagyl,B-TR
.,O

The,O
patient,O
was,O
readmitted,O
on,O
5-21-91,O
with,O
a,B-PR
falling,I-PR
hematocrit,I-PR
from,O
36,O
to,O
22,O
",",O
mild,B-PR
congestive,I-PR
heart,I-PR
failure,I-PR
",",O
and,O
guaiac,B-PR
positive,I-PR
stool,I-PR
.,O

The,B-TE
colonoscopy,I-TE
and,O
upper,B-TE
gastrointestinal,I-TE
series,I-TE
were,O
negative,O
.,O

The,O
patient,O
was,O
given,O
two,O
units,O
of,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
and,O
H2,B-TR
blockers,I-TR
.,O

His,B-TE
hematocrit,I-TE
was,O
31,O
on,O
discharge,O
.,O

His,B-TE
hematocrit,I-TE
was,O
31,O
on,O
discharge,O
.,O

On,O
6-12-91,O
the,O
patient,O
was,O
admitted,O
to,O
Ingtermst.gay,O
Health,O
Center,O
with,O
fever,B-PR
",",O
hypertension,B-PR
",",O
and,O
diarrhea,B-PR
.,O

The,B-TE
BUN,I-TE
and,O
creatinine,B-TE
equalled,O
128/8.6,O
",",O
CO2,B-TE
equaled,O
12,O
.,O

The,O
patient,O
was,O
treated,O
with,O
intravenous,B-TR
fluids,I-TR
",",O
Kefzol,B-TR
",",O
gentamicin,B-TR
",",O
Vancomycin,B-TR
",",O
and,O
he,O
was,O
transferred,O
to,O
Gaanvantsir,O
.,O

He,O
was,O
hospitalized,O
from,O
6-12-91,O
to,O
7-9-91,O
with,O
a,O
prolonged,O
course,O
notable,O
for,O
:,O

1),O
Serratia,B-PR
urosepsis,I-PR
treated,O
with,O
ceftizoxime,B-TR
.,O

2),O
Azotemia,B-PR
presumed,O
secondary,O
to,O
sepsis,B-PR
and,O
dehydration,B-PR
",",O
creatinine,B-TE
decreased,O
to,O
2.1,O
with,O
intravenous,B-TR
fluids,I-TR
and,O
antibiotics,B-TR
.,O

Renal,B-TE
ultrasound,I-TE
was,O
negative,O
for,O
abscess,B-PR
orhydronephrosis,I-PR
.,O

3),O
Loculated,B-PR
pleural,I-PR
effusions,I-PR
.,O

Thoracentesis,B-TE
revealed,O
a,B-TE
pH,I-TE
of,O
7.18,O
",",O
glucose,B-TE
52,O
",",O
white,B-TE
blood,I-TE
cell,I-TE
count,I-TE
200,O
;,O
evaluated,O
by,O
thoracic,O
surgery,O
",",O
no,O
chest,B-TR
tube,I-TR
placed,O
.,O

4),O
C.,B-PR
difficile,I-PR
colitis,I-PR
with,O
white,B-TE
blood,I-TE
cell,I-TE
count,I-TE
rising,O
to,O
"51,000",O
",",O
treated,O
with,O
intravenous,B-TR
and,I-TR
p.o.,I-TR
Flagyl,I-TR
.,O

C.,B-TE
difficile,I-TE
was,O
negative,O
times,O
three,O
prior,O
to,O
discharge,O
.,O

The,O
patient,O
went,O
to,O
his,O
nursing,O
home,O
on,O
7-9-91,O
but,O
the,O
next,O
day,O
he,O
developed,O
a,B-PR
temperature,I-PR
to,O
102.4,O
degrees,O
",",O
diarrhea,B-PR
",",O
and,O
orthostasis,B-PR
and,O
he,O
was,O
transferred,O
back,O
to,O
Gaanvantsir,O
.,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
medical,O
intensive,O
care,O
unit,O
with,O
question,O
of,O
sepsis,B-PR
.,O

White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
was,O
"40,000",O
with,O
left,B-PR
shift,I-PR
.,O

The,B-TE
BUN,I-TE
was,O
35,O
",",O
creatinine,B-TE
4.3,O
.,O

Urinalysis,B-TE
had,O
5-10,B-TE
white,I-TE
blood,I-TE
cells,I-TE
and,O
2+,B-TE
bacteria,I-TE
.,O

The,O
patient,O
underwent,O
thoracentesis,B-TE
without,O
evidence,O
of,O
empyema,B-PR
.,O

He,O
was,O
treated,O
with,O
intravenous,B-TR
fluids,I-TR
and,O
intravenous,B-TR
antibiotics,I-TR
with,O
ceftizoxime,B-TR
",",O
gentamicin,B-TR
",",O
and,O
Flagyl,B-TR
.,O

He,O
was,O
also,O
started,O
on,O
p.o.,B-TR
Vancomycin,I-TR
for,O
question,O
C.,B-PR
difficile,I-PR
colitis,I-PR
.,O

He,O
is,O
now,O
transferred,O
to,O
the,O
medicine,O
service,O
for,O
further,B-TR
care,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1),O
Alcohol,O
abuse,O
in,O
the,O
past,O
.,O

2),O
Chronic,B-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
.,O

3),O
Chronic,B-PR
pleural,I-PR
effusions,I-PR
.,O

4),O
Chronic,B-PR
renal,I-PR
insufficiency,I-PR
with,O
baseline,B-TE
creatinine,I-TE
1.8-2,O
.,O

5),O
Ischemic,B-PR
bowel,I-PR
status,O
post,O
SMA,B-TR
Percutaneous,I-TR
Transluminal,I-TR
Coronary,I-TR
Angioplasty,I-TR
.,O

6),O
Serratiaurosepsis,B-PR
.,O

7),O
Positive,B-PR
PPD,I-PR
.,O

8),O
Status,O
post,O
total,B-TR
hip,I-TR
replacement,I-TR
.,O

9),O
Right,B-PR
bundle,I-PR
branch,I-PR
block,I-PR
with,O
left,B-PR
anterior,I-PR
hemiblock,I-PR
on,O
electrocardiogram,B-TE
.,O

Allergies,B-PR
to,O
penicillin,B-TR
",",O
sulfa,B-TR
",",O
codeine,B-TR
",",O
morphine,B-TR
sulfate,I-TR
.Medications,B-TR
on,I-TR
transfer,I-TR
included,O
thiamine,B-TR
;,O
multivitamin,B-TR
;,O
Pepcid,B-TR
;,O
ceftizoxime,B-TR
1,O
gm,O
intravenously,O
q.,O
eight,O
hours,O
;,O
Flagyl,B-TR
500,O
mg,O
intravenously,O
q.,O
eight,O
hours,O
;,O
gentamicin,B-TR
80,O
mg,O
IV,O
q.,O
24,O
hours,O
;,O
Ventolin,B-TR
inhaler,I-TR
;,O
Lotrimin,B-TR
cream,I-TR
;,O
sliding,B-TR
scale,I-TR
nitro,I-TR
paste,I-TR
;,O
pyridium,B-TR
;,O
Vancomycin,B-TR
125,O
mg,O
p.o.,O
q.i.d.,O
;,O
and,O
calcium,B-TR
carbonate,I-TR
.,O

Habits,O
:,O

Positive,O
for,O
cigarettes,O
of,O
40,O
pack,O
/,O
years,O
quit,O
in,O
1990.,O

Positive,O
alcohol,O
abuse,O
in,O
the,O
distant,O
past,O
.,O

Family,O
history,O
is,O
positive,O
for,O
tuberculosis,B-PR
",",O
hypertension,B-PR
",",O
and,O
alcoholism,O
.,O

Social,O
history,O
:,O

Former,O
Vermont,O
blacksmith,O
.,O

He,O
has,O
one,O
son,O
and,O
lives,O
in,O
a,O
nursing,O
home,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

GENERAL,O
:,O

He,O
is,O
a,O
drowsy,O
",",O
elderly,O
white,O
male,O
lying,O
with,O
O2,B-TR
on,O
",",O
asking,O
to,O
be,O
scratched,O
.,O

Blood,B-TE
pressure,I-TE
110/50,O
",",O
pulse,B-TE
rate,I-TE
94,O
",",O
respiratory,B-TE
rate,I-TE
22,O
",",O
temperature,B-TE
maximum,I-TE
101,O
degrees,O
",",O
decreasing,O
to,O
99,O
degrees,O
.,O

SKIN,O
:,O

Without,O
rash,B-PR
or,O
petechiae,B-PR
.,O

HEENT,O
:,O

Dry,B-PR
mucous,I-PR
membranes,I-PR
.,O

NECK,O
:,O

Supple,O
.,O

LUNGS,O
:,O

Bibasilar,B-PR
crackles,I-PR
",",O
right,O
greater,O
than,O
left,O
",",O
no,O
wheezes,B-PR
.,O

CARDIAC,O
:,O

Regular,O
rate,O
and,O
rhythm,O
",",O
S1,O
",",O
S2,O
",",O
I,B-PR
/,I-PR
VI,I-PR
systolic,I-PR
ejection,I-PR
murmur,I-PR
.,O

ABDOMEN,O
:,O

Distended,B-PR
",",O
positive,O
bowel,O
sounds,O
",",O
soft,O
",",O
mild,B-PR
tenderness,I-PR
in,I-PR
the,I-PR
left,I-PR
lower,I-PR
quadrant,I-PR
",",O
no,O
rebound,B-PR
.,O

RECTAL,O
:,O

Tender,B-PR
",",O
external,B-PR
hemorrhoids,I-PR
",",O
guaiac,B-TE
negative,O
.,O

EXTREMITIES,O
:,O

Without,O
edema,B-PR
.,O

NEUROLOGIC,O
:,O

Alert,O
and,O
oriented,O
to,O
person,O
and,O
place,O
",",O
no,O
asterixis,B-PR
or,O
tremor,B-PR
.,O

LABORATORY,O
DATA,O
:,O

Significant,O
for,O
sodium,B-TE
140,O
",",O
potassium,B-TE
3,O
",",O
BUN,B-TE
35,O
",",O
creatinine,B-TE
3.6,O
",",O
liver,B-TE
function,I-TE
tests,I-TE
within,O
normal,O
limits,O
",",O
calcium,B-TE
6.6,O
",",O
albumin,B-TE
2,O
",",O
magnesium1.4,B-TE
",",O
PT,B-TE
14,O
",",O
white,B-TE
count,I-TE
30.1,O
with,O
77,O
polys,B-TE
",",O
13,O
bands,B-TE
",",O
5,O
lymphs,B-TE
",",O
and,O
5,O
monos,B-TE
.,O

Urine,B-TE
sodium,I-TE
is,O
75,O
",",O
urine,B-TE
creatinine,I-TE
143,O
",",O
urine,B-TE
osmose,I-TE
392,O
.,O

Pleural,B-TE
fluid,I-TE
pH,I-TE
is,O
7.29,O
",",O
glucose,B-TE
91,O
",",O
total,B-TE
protein3.1,I-TE
",",O
LDH,B-TE
296,O
",",O
70,B-TE
white,I-TE
blood,I-TE
cells,I-TE
",",O
50,B-TE
red,I-TE
blood,I-TE
cells,I-TE
.,O

HOSPITAL,O
COURSE,O
:,O

1.,O
Colitis,B-PR
.,O

The,O
patient,O
has,O
a,O
history,O
of,O
ischemic,B-PR
bowel,I-PR
status,O
post,O
SMA,B-TR
Percutaneous,I-TR
Transluminal,I-TR
Coronary,I-TR
Angioplasty,I-TR
with,O
recent,O
admission,O
for,O
gram,B-PR
negative,I-PR
rod,I-PR
urosepsis,I-PR
complicated,O
by,O
C.,B-PR
difficile,I-PR
colitis,I-PR
.,O

The,O
patient,O
received,O
a,B-TR
full,I-TR
course,I-TR
of,I-TR
Flagyl,I-TR
and,O
was,O
C.,B-TE
difficile,I-TE
toxin,I-TE
negative,O
times,O
three,O
prior,O
to,O
transfer,O
.,O

He,O
now,O
returns,O
with,O
fever,B-PR
",",O
rising,B-PR
white,I-PR
count,I-PR
",",O
diarrhea,B-PR
",",O
and,O
dehydration,B-PR
.,O

Initially,O
treated,O
with,O
intravenous,B-TR
ceftizoxime,I-TR
",",O
gentamicin,B-TR
",",O
and,O
Flagyl,B-TR
for,O
presumed,O
sepsis,B-PR
",",O
either,O
with,O
urine,O
or,O
bowel,O
source,O
.,O

He,O
was,O
also,O
started,O
on,O
p.o.,B-TR
Vancomycin,I-TR
.,O

Blood,B-TE
cultures,I-TE
and,O
urine,B-TE
cultures,I-TE
came,O
back,O
negative,O
.,O

Stool,B-TE
for,I-TE
C.,I-TE
difficile,I-TE
returned,O
positive,B-PR
.,O

The,O
diagnosis,O
",",O
therefore,O
",",O
was,O
relapsed,B-PR
C.,I-PR
difficile,I-PR
colitis,I-PR
.,O

Intravenous,B-TR
antibiotics,I-TR
were,O
discontinued,O
and,O
the,O
patient,O
was,O
continued,O
on,O
p.o.,B-TR
Vancomycin,I-TR
.,O

He,O
improved,O
clinically,O
with,O
defervescence,O
",",O
decreased,O
white,B-TE
blood,I-TE
cell,I-TE
count,I-TE
to,O
"10,000",O
with,O
resolution,O
of,O
left,B-PR
shift,I-PR
",",O
and,O
some,O
decrease,O
in,O
abdominal,B-PR
distention,I-PR
on,O
exam,B-TE
.,O

An,B-TE
abdominal,I-TE
CAT,I-TE
scan,I-TE
revealed,O
thickened,B-PR
bowel,I-PR
wall,I-PR
and,O
thumb,B-PR
printing,I-PR
",",O
primarily,O
involving,O
the,O
cecum,O
and,O
right,O
colon,O
greater,O
than,O
the,O
left,O
",",O
consistent,O
with,O
C.,B-PR
difficile,I-PR
colitis,I-PR
.,O

The,O
diagnosis,O
of,O
recurrent,B-PR
bowel,I-PR
ischemia,I-PR
",",O
however,O
",",O
was,O
not,O
ruled,O
out,O
and,O
this,O
will,O
continue,O
to,O
be,O
a,O
concern,O
in,O
the,O
future,O
.,O

The,O
patient,O
was,O
initially,O
n.p.o.,B-TR
and,O
was,O
then,O
advanced,O
to,O
clear,B-TR
liquids,I-TR
which,O
he,O
tolerated,O
.,O

He,O
will,O
be,O
advanced,O
to,O
soft,B-TR
solids,I-TR
prior,O
to,O
discharge,O
.,O

2.,O
Azotemia,B-PR
.,O

The,O
patient,O
has,O
chronic,B-PR
renal,I-PR
insufficiency,I-PR
with,O
baseline,B-TE
creatinine,I-TE
1.8-2,O
.,O

Creatinine,B-TE
had,O
risen,O
to,O
4.3,O
on,O
admission,O
presumed,O
secondary,O
to,O
sepsis,B-PR
and,O
dehydration,B-PR
.,O

With,O
intravenous,B-TR
hydration,I-TR
the,B-TE
BUN,I-TE
and,O
creatinine,B-TE
fell,O
to,O
12/1.9,O
which,O
is,O
within,O
normal,O
limits,O
for,O
this,O
patient,O
.,O

The,B-TE
abdominal,I-TE
CAT,I-TE
scan,I-TE
showed,O
no,O
evidence,O
of,O
hydronephrosis,B-PR
orrenal,B-PR
abscess,I-PR
.,O

3.,O
Mental,O
status,O
.,O

The,O
patient,O
was,O
alert,O
and,O
oriented,O
throughout,O
the,O
admission,O
;,O
however,O
",",O
by,O
personality,O
",",O
he,O
is,O
somewhat,O
cantankerous,O
and,O
demanding,O
of,O
the,O
nurses,O
.,O

He,O
was,O
written,O
for,O
Haldol,B-TR
1,O
mg,O
p.o.b.i.d.,O
p.r.n.,O
to,O
help,O
with,O
this,B-PR
problem,I-PR
.,O

DISCHARGE,O
DISPOSITION,O
:,O

Medications,B-TR
on,I-TR
transfer,I-TR
include,O
multivitamin,B-TR
1,O
tablet,O
p.o.,O
q.d.,O
;,O
Pepcid,B-TR
20,O
mg,O
p.o.,O
b.i.d.,O
;,O
Ventolin,B-TR
inhaler,I-TR
two,O
puffs,O
q.i.d.,O
;,O
Vancomycin,B-TR
125,O
mg,O
p.o.,O
q.i.d.,O
times,O
seven,O
days,O
;,O
calcium,B-TR
carbonate,I-TR
1250,O
mg,O
p.o.,O
b.i.d.,O
;,O
Lotrimin,B-TR
cream,I-TR
to,O
groin,O
b.i.d.,O
p.r.n.,O
;,O
O2,B-TR
at,O
four,O
liters,O
per,O
minute,O
;,O
and,O
Haldol,B-TR
1,O
mg,O
p.o.,O
b.i.d.,O
p.r.n.,O

Dictated,O
By,O
:,O

CA,O
NA,O
SHUFF,O
",",O
M.D.,O
SO92,O
VX072/9578,O

TRANGCA,O
CHIRDSTEN,O
",",O
M.D.,O
ZO84,O

D,O
:,O

07/17/91,O

T,O
:,O

07/17/91,O

Batch,O
:,O

T099,O

Report,O
:,O

XM487M32,O

Admission,O
Date,O
:,O

2018-08-04,O

Discharge,O
Date,O
:,O

2018-08-16,O

Date,O
of,O
Birth,O
:,O

1986-03-06,O

Sex,O
:,O

M,O

Service,O
:,O

SURGERY,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,I-PR
Drugs,I-PR

Attending,O
:,O
William,O
I.,O
Sundquist,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Abdominal,B-PR
pain,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O
pheresis,B-TE
renal,I-TE
biopsy,I-TE

History,O
of,O
Present,O
Illness,O
:,O

This,O
is,O
a,O
32,O
year,O
old,O
male,O
who,O
was,O
recently,O
discharged,O
from,O
Mediplex,O
Rehab,O
Hospital,O
and,O
presents,O
again,O
to,O
us,O
with,O
chief,O
complaint,O
of,O
abdominal,B-PR
pain,I-PR
(,O
sudden,B-PR
onset,I-PR
left-sided,I-PR
abdominal,I-PR
pain,I-PR
).,O

Of,O
note,O
",",O
he,O
had,O
a,B-TE
recent,I-TE
kidney,I-TE
biopsy,I-TE
on,O
2018-07-30,O
and,O
his,B-TE
Cr,I-TE
bumped,O
from,O
4.7,O
to,O
5.7,O
.,O

Also,O
",",O
HCT,B-TE
on,O
admission,O
21,O
from,O
25,O
.,O

Past,O
Medical,O
History,O
:,O

ESRD,B-PR
on,O
HD,B-TR
(,O
"M,W,F",O
),O
(,O
03-30,O
glomerulonephritis,B-PR
),O

HTN,B-PR

Hypercholesterolemia,B-PR

PSH,O
:,O

AVF,B-TR
-,I-TR
R,I-TR
radial,I-TR
-,I-TR
cephalic,I-TR

AVF,B-TR
-,I-TR
L,I-TR
aneurysm,I-TR
resection,I-TR

Tunneled,B-TR
L,I-TR
subclavian,I-TR
catheter,I-TR

Social,O
History,O
:,O
denies,O
tobacco,O
",",O
ETOH,O
",",O
drugs,O

Family,O
History,O
:,O
sister,O
who,O
is,O
26,O
also,O
has,O
ESRD,B-PR
on,O
HD,B-TR
(,O
?,O
etiology,O
),O

Physical,O
Exam,O
:,O

VS,B-TE
:,O
Afebrile,B-PR
",",O
HR,B-TE
:,O
70-80,O
",",O
99/70,O

Lungs,O
:,O
CTA,O
bilaterally,O

CV,O
:,O
RRR,O

Abd,O
:,O
Non-distended,B-PR
",",O
tender,B-PR
to,O
palpation,B-TE
LLQ,I-TE

Pertinent,O
Results,O
:,O

ADMISSION,O
LABS,O
-->,O
2018-08-04,O

WBC,B-TE
-,O
6.8,O
RBC,B-TE
-,O
2.50,O
*,O
Hgb,B-TE
-,O
6.8,O
*,O
Hct,B-TE
-,O
21.2,O
*,O
MCV,B-TE
-,O
85,O
MCH,B-TE
-,O
27.2,O
MCHC,B-TE
-,O
32.1,O
RDW,B-TE
-,O
18.0,O
*,O
Plt,B-TE
Ct,I-TE
-,O
149,O
*,O
PT,B-TE
-,O
11.9,O
PTT,B-TE
-,O
31.1,O
INR,B-TE
(,I-TE
PT,I-TE
),I-TE
-,O
1.0,O
Fibrinogen,B-TE
-,O
148,O
*,O
Glucose,B-TE
-,O
144,O
*,O
UreaN,B-TE
-,O
52,O
*,O
Creat,B-TE
-,O
5.7,O
*,O
Na,B-TE
-,O
138,O
K,B-TE
-,O
4.1,O
Cl,B-TE
-,O
107,O
HCO3,B-TE
-,O
17,O
*,O
AnGap,B-TE
-,O
18,O

2018-08-04,O
06:09,O
PM,O
BLOOD,B-TE
Calcium,B-TE
-,O
8.3,O
*,O
Phos,B-TE
-,O
5.0,O
*,O
Mg,B-TE
-,O
2.2,O

Discharge,O
Labs,O
:,O

2018-08-16,O

WBC,B-TE
-,O
5.7,O
RBC,B-TE
-,O
3.10,O
*,O
Hgb,B-TE
-,O
8.9,O
*,O
Hct,B-TE
-,O
26.2,O
*,O
MCV,B-TE
-,O
85,O
MCH,B-TE
-,O
28.7,O
MCHC,B-TE
-,O
33.9,O
RDW,B-TE
-,O
15.4,O
Plt,B-TE
Ct,I-TE
-,O
186,O
PT,B-TE
-,O
11.5,O
PTT,B-TE
-,O
25.6,O
INR,B-TE
(,I-TE
PT,I-TE
)-,I-TE
1.0,O
Fibrinogen,B-TE
-,O
443,O
*,O
Glucose,B-TE
-,O
104,O
UreaN,B-TE
-,O
60,O
*,O
Creat,B-TE
-,O
4.8,O
*,O
Na,B-TE
-,O
139,O
K,B-TE
-,O
4.3,O
Cl,B-TE
-,O
105,O
HCO3,B-TE
-,O
26,O
AnGap,B-TE
-,O
12,O
Calcium,B-TE
-,O
8.8,O
Phos,B-TE
-,O
5.0,O
*,O
Mg,B-TE
-,O
2.2,O

DISCHARGE,O
LABS,O
--->,O

2018-08-16,O
5:47,O

BLOOD,B-TE
WBC,B-TE
-,O
5.7,O
RBC,B-TE
-,O
3.10,O
*,O
Hgb,B-TE
-,O
8.9,O
*,O
Hct,B-TE
-,O
26.2,O
*,O
MCV,B-TE
-,O
85,O
MCH,B-TE
-,O
28.7,O
MCHC,B-TE
-,O
33.9,O
RDW,B-TE
-,O
15.4,O
Plt,B-TE
Ct,I-TE
-,O
186,O

2018-08-16,O
5:47,O

BLOOD,B-TE
Plt,B-TE
Ct,I-TE
-,O
186,O

2018-08-16,O
5:47,O

BLOOD,B-TE
PT,B-TE
-,O
11.5,O
PTT,B-TE
-,O
25.6,O
INR,B-TE
(,I-TE
PT,I-TE
)-,I-TE
1.0,O

2018-08-16,O
5:47,O

BLOOD,B-TE
Fibrino,B-TE
-,O
443,O
*,O

2018-08-16,O
5:47,O

BLOOD,B-TE
Glucose,B-TE
-,O
104,O
UreaN,B-TE
-,O
60,O
*,O
Creat,B-TE
-,O
4.8,O
*,O
Na,B-TE
-,O
139,O
K,B-TE
-,O
4.3,O
Cl,B-TE
-,O
105,O
HCO3,B-TE
-,O
26,O
AnGap,B-TE
-,O
12,O

2018-08-16,O
5:47,O

BLOOD,B-TE
Calcium,B-TE
-,O
8.8,O
Phos,B-TE
-,O
5.0,O
*,O
Mg,B-TE
-,O
2.2,O

Brief,O
Hospital,O
Course,O
:,O

This,O
patient,O
was,O
admitted,O
on,O
08-04,O
after,O
a,O
recent,O
discharge,O
from,O
the,O
hospital,O
for,O
sudden,O
onset,O
of,O
left,B-PR
sided,I-PR
abdominal,I-PR
pain,I-PR
.,O

In,O
the,O
emergency,O
room,O
",",O
his,B-TE
ultrasound,I-TE
showed,O
mild,B-PR
hydronephrosis,I-PR
with,O
new,B-PR
perinephric,I-PR
fluid,I-PR
surrounding,O
the,O
transplant,O
kidney,O
and,O
hence,O
",",O
underwent,O
a,B-TE
CT,I-TE
scan,I-TE
of,I-TE
his,I-TE
abdomen,I-TE
/,I-TE
pelvis,I-TE
which,O
showed,O
a,O
large,O
left-sided,O
of,O
retroperitoneal,B-PR
hemorrhage,I-PR
extending,O
down,O
to,O
the,O
level,O
of,O
the,B-TR
renal,I-TR
transplant,I-TR
possibly,O
related,O
to,O
recent,B-TE
transplant,I-TE
biopsy,I-TE
.,O

Renal,O
transplant,O
medicine,O
and,O
transplant,O
surgery,O
were,O
made,O
aware,O
and,O
the,O
pt,O
was,O
admitted,O
to,O
transplant,O

CMED,O
and,O
to,O
the,O
ICU,O
.,O

Serial,B-TE
hematocrits,I-TE
and,O
abdominal,B-TE
exams,I-TE
were,O
performed,O
.,O

He,O
was,O
not,O
taken,O
to,O
the,O
OR,O
.,O

On,O
08-06,O
",",O
he,O
received,O
2,O
units,O
of,O
pRBC,B-TR
and,O
underwent,O
plasmaphersis,B-TR
",",O
followed,O
by,O
10mg,O
of,O
IVIG,B-TR
.,O

He,O
received,O
another,B-TR
unit,I-TR
pRBC,I-TR
on,O
08-07,O
.,O

By,O
08-07,O
",",O
it,O
was,O
thought,O
there,O
was,O
improvement,O
of,O
his,B-TE
labs,I-TE
.,O

In,O
the,O
am,O
of,O
6/13,O
",",O
he,O
was,O
given,O
1,B-TR
unit,I-TR
pRBC,I-TR
for,O
a,B-TE
Hct,I-TE
of,O
21.8,O
.,O

His,B-TE
Hct,I-TE
was,O
stable,O
on,O
08-09,O
at,O
24.4,O
;,O
he,O
had,O
plasmapheresis,B-TR
on,O
08-09,O
(,O
followed,O
by,O
10,O
mg,O
IVIG,B-TR
).,O

He,O
was,O
transfered,O
to,O
the,O
floor,O
on,O
08-09,O
.,O

On,O
08-10,O
",",O
his,B-TE
am,I-TE
Hct,I-TE
was,O
21.9,O
",",O
hence,O
",",O
he,O
received,O
1,B-TR
unit,I-TR
pRBC,I-TR
.,O

On,O
08-10,O
class,B-TE
I,I-TE
and,I-TE
II,I-TE
antibody,I-TE
levels,I-TE
were,O
sent,O
.,O

He,O
had,O
plasmapheresis,B-TR
on,O
08-11,O
",",O
followed,O
by,O
10,B-TR
mg,I-TR
IVIG,I-TR
.,O

This,O
was,O
repeated,O
on,O
08-13,O
.,O

Hct,B-TE
remained,O
stable,O
.,O

On,O
08-15,O
",",O
he,O
went,O
for,O
pheresis,B-TR
/,O
IVIG,B-TR
.,O

No,O
new,B-PR
issues,I-PR
.,O

LLQ,B-PR
pain,I-PR
has,O
improved,O
over,O
the,O
course,O
of,O
this,O
hospitalization,O
.,O

He,O
is,O
eating,O
and,O
ambulating,O
w/o,O
difficulties,B-PR
.,O

Pheresis,B-TR
to,O
continue,O
as,O
an,O
outpatient,O
with,O
supervision,O
of,O
transplant,O
nephrology,O
on,O
08-17,O
",",O
08-20,O
and,O
08-22,O
.,O

Prograf,B-TR
was,O
increased,O
to,O
12,O
mg,O
bid,O
on,O
08-16,O
for,O
a,B-TE
trough,I-TE
level,I-TE
of,O
7.1,O
.,O

He,O
was,O
instructed,O
to,O
have,O
labs,B-TE
drawn,O
on,O
08-17,O
to,O
check,O
trough,B-TE
level,I-TE
of,I-TE
prograf,I-TE
as,O
well,O
as,O
cbc,B-TE
",",O
chem,B-TE
10,I-TE
",",O
coags,B-TE
.,O

Medications,O
on,O
Admission,O
:,O

Bactrim,B-TR
",",O
Valcyte,B-TR
",",O
MMF,B-TR
",",O
Prednisone,B-TR
",",O
FK,B-TR
",",O
Nifedipine,B-TR
",",O
Protonix,B-TR

Discharge,O
Medications,O
:,O

1.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

Disp,O
:*,O
60,O
Capsule,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

2.,O
Mycophenolate,B-TR
Mofetil,I-TR
500,O
mg,O
Tablet,O
Sig,O
:,O
Three,O
(,O
3,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

3.,O
Valganciclovir,B-TR
450,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q48H,O
(,O
every,O
48,O
hours,O
),O
.,O

4.,O
Trimethoprim,B-TR
-,O
Sulfamethoxazole,B-TR
80-400,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

5.,O
Nifedipine,B-TR
60,O
mg,O
Tablet,O
Sustained,O
Release,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
Sustained,O
Release,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

Disp,O
:*,O
60,O
Tablet,O
Sustained,O
Release,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

6.,O
Labetalol,B-TR
200,O
mg,O
Tablet,O
Sig,O
:,O
Four,O
(,O
4,O
),O
Tablet,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
.,O

Disp,O
:*,O
360,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

7.,O
Senna,B-TR
8.6,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

Disp,O
:*,O
60,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

8.,O
Oxycodone,B-TR
-,O
Acetaminophen,B-TR
5-325,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
.,O

Disp,O
:*,O
30,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
0,O
*,O

9.,O
Sevelamer,B-TR
800,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
.,O

10.,O
Pantoprazole,B-TR
40,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
Q12H,O
(,O
every,O
12,O
hours,O
),O
.,O

11.,O
Minoxidil,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
0.5,O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

Disp,O
:*,O
30,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

12.,O
Nystatin,B-TR
"100,000",O
unit,O
/,O
mL,O
Suspension,O
Sig,O
:,O
Five,O
(,O
5,O
),O
ML,O
PO,O
QID,O
(,O
4,O
times,O
a,O
day,O
),O
.,O

13.,O
Prednisone,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
Three,O
(,O
3,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

14.,O
Epogen,B-TR
"40,000",O
unit,O
/,O
mL,O
Solution,O
Sig,O
:,O
One,O
(,O
1,O
),O
ml,O
Injection,O
once,O
a,O
week,O
.,O

Disp,O
:*,O
8,O
*,O
Refills,O
:*,O
2,O
*,O

15.,O
syringes,B-TR
for,O
epogen,B-TR
q,O
week,O

1,O
box,O

refill,O
:,O
none,O

16.,O
Tacrolimus,B-TR
5,O
mg,O
Capsule,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Capsule,O
PO,O
Q12H,O
(,O
every,O
12,O
hours,O
),O
.,O

17.,O
Tacrolimus,B-TR
1,O
mg,O
Capsule,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Capsule,O
PO,O
twice,O
a,O
day,O
.,O

18.,O
Outpatient,B-TE
Lab,I-TE
Work,I-TE

Friday,O
08-17,O
and,O
Monday,O
08-20,O
cbc,B-TE
",",O
chem10,B-TE
",",O
pt/ptt/inr,B-TE
and,O
trough,B-TE
prograf,I-TE
level,I-TE
.,O

Discharge,O
Disposition,O
:,O

Home,O

Discharge,O
Diagnosis,O
:,O
humoral,B-PR
rejection,I-PR
of,I-PR
renal,I-PR
transplant,I-PR
perinephric,B-PR
transplant,I-PR
hemorrhage,I-PR

Discharge,O
Condition,O
:,O
good,O

Discharge,O
Instructions,O
:,O

Please,O
call,O
transplant,O
office,O
(,O
789,O
),O
583,O
5023,O
if,O
fevers,B-PR
",",O
chills,B-PR
",",O
nausea,B-PR
/,O
vomiting,B-PR
",",O
bleeding,B-PR
",",O
decreased,B-PR
urine,I-PR
output,I-PR
",",O
weight,B-PR
gain,I-PR
of,O
3,O
pounds,O
in,O
a,O
day,O
",",O
abdominal,B-PR
pain,I-PR
or,O
shortness,B-PR
of,I-PR
breath,I-PR

Pheresis,B-TR
Friday,O
08-17,O
then,O
Monday,O
08-20,O

Labwork,B-TE
every,O
Monday,O
and,O
Thursday,O
per,O
Transplant,O
clinic,O
:,O
CBC,B-TE
",",O
Chem,B-TE
7,I-TE
",",O
Ca,B-TE
",",O
Phos,B-TE
",",O
AST,B-TE
",",O
T,B-TE
Bili,I-TE
",",O
U/A,B-TE
and,O
Trough,B-TE
Prograf,I-TE
level,I-TE
.,O

Fax,O
results,O
to,O
326-955-2529,O

Followup,O
Instructions,O
:,O

PHERESIS,B-TR
",",O
BED,O
FIVE,O
PHERESIS,O
ROOMS,O
Date,O
/,O
Time,O
:,O
2018-08-17,O
9:15,O

PHERESIS,B-TR
",",O
BED,O
SIX,O
PHERESIS,O
ROOMS,O
Date,O
/,O
Time,O
:,O
2018-08-20,O
2:00,O

Vanessa,O
John,O
",",O
MD,O
Phone,O
:(,O
789,O
),O
583,O
5023,O
Date,O
/,O
Time,O
:,O
2018-08-21,O
9:50,O

Michael,O
Douglas,O
MD,O
87-106,O

Completed,O
by,O
:,O
Edwin,O
Marilyn,O
MD,O
50-613,O
2018-08-16,O
@,O
1456,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Brian,O
B.,O
B.,O
Chatterjee,O
on,O
:,O
MON,O
2018-09-10,O
1:21,O
PM,O

(,O
End,O
of,O
Report,O
),O

158656269,O

CTMC,O

2692537,O

322365,O

7/8/2000,O
12:00:00,O
AM,O

chest,B-PR
pain,I-PR

DIS,O

Admission,O
Date,O
:,O

07/08/2000,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

07/09/2000,O

******,O
DISCHARGE,O
ORDERS,O
******,O

CLOZLUIN,O
",",O
NOSHIN,O
699-77-12-2,O
K97,O

Room,O
:,O

18J-512,O

Service,O
:,O

MED,O

DISCHARGE,O
PATIENT,O
ON,O
:,O

07/09/00,O
AT,O
04:00,O
PM,O
CONTINGENT,O
UPON,O
Attending,B-TE
evaluation,I-TE

WILL,O
D/C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D/C,O
SUMMARY,O
:,O

YES,O

DISPOSITION,O
:,O

Home,O

DISCHARGE,O
MEDICATIONS,O
:,O

TYLENOL,B-TR
#3,I-TR
(,I-TR
ACETAMINOPHEN,I-TR
W,I-TR
/,I-TR
CODEINE,I-TR
30MG,O
),O
1-2,O
TAB,O
PO,O
Q4H,O
PRN,O
pain,B-PR
ALLOPURINOL,B-TR
300,O
MG,O
PO,O
QD,O
COLACE,B-TR
(,I-TR
DOCUSATE,I-TR
SODIUM,I-TR
),I-TR
100,O
MG,O
PO,O
BID,O
HYDROCHLOROTHIAZIDE,B-TR
25,O
MG,O
PO,O
QD,O
LEVOFLOXACIN,B-TR
500,O
MG,O
PO,O
QD,O
Starting,O
Today,O
(,O
07/09,O
),O

Instructions,O
:,O

continue,O
through,O
7/16/00,O

FLAGYL,B-TR
(,I-TR
METRONIDAZOLE,I-TR
),I-TR
500,O
MG,O
PO,O
TID,O

Instructions,O
:,O

through,O
7/16/00,O

Food,O
/,O
Drug,O
Interaction,O
Instruction,O

Give,O
with,O
meals,O

DIET,O
:,O

No,O
Restrictions,O
Activity,O
-,O
As,O
tolerated,O

RETURN,O
TO,O
WORK,O
:,O

Not,O
Applicable,O

FOLLOW,O
UP,O
APPOINTMENT,O
(,O
S,O
),O
:,O

dr.,O
mandessquarc,O
",",O
No,O
Known,B-PR
Allergies,I-PR

ADMIT,O
DIAGNOSIS,O
:,O

chest,B-PR
pain,I-PR
unclear,I-PR
etiology,I-PR

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O
Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O
chest,B-PR
pain,I-PR

OTHER,O
DIAGNOSIS,O
;,O
Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O

BRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

***,O
07/09/00,O
***,O

80,O
yo,O
woman,O
recently,O
diagnosed,O
with,O
metastatic,B-PR
squamous,I-PR
cell,I-PR
lung,I-PR
CA,I-PR
.,O

Mets,B-PR
to,I-PR
spine,I-PR
",",I-PR
femur,I-PR
.,O

On,O
XRT,B-TR
.,O

Tumor,B-PR
invasive,I-PR
of,I-PR
pleura,I-PR
and,I-PR
rib,I-PR
.,O

Admitted,O
after,O
acute,B-PR
onset,I-PR
left,I-PR
chest,I-PR
pain,I-PR
.,O

Transferred,O
today,O
from,O
Ez,O
Ephtro,O
Health,O
Center,O
on,O
LMWH,O
for,O
R,O
/,O
O,O
PE,B-PR
vs,O
pneumonia,B-PR
vs,O
tumor,B-PR
invasion,I-PR
.,O

Following,O
enzymes,B-TE
to,O
rule,O
out,O
unstable,B-PR
angina,I-PR
(,O
no,O
EKG,B-PR
changes,I-PR
),O
.,O

v,B-TE
/,I-TE
q,I-TE
at,O
outside,O
hospital,O
read,O
as,O
low,O
prob.,O
leni,O
&apos;s,O
here,O
neg.,O
d/c&apos;ed,O
on,O
levo,B-TR
/,O
flagyl,B-TR
for,O
presumed,O
post-obstructive,B-PR
pneumonia,I-PR
.,O

ADDITIONAL,O
COMMENTS,O
:,O

1.,O
Continue,O
with,O
medications,B-TR
as,O
prescribed,O
",",O
including,O
antibiotics,B-TR
(,O
levofloxacin,B-TR
/,O
flagyl,B-TR
),O
through,O
7/16/00,O
.,O

2.,O
If,O
you,O
have,O
further,B-PR
chest,I-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
fevers,B-PR
",",O
or,O
other,B-PR
symptoms,I-PR
which,O
concern,O
you,O
",",O
call,O
your,O
doctor,O
.,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O

TO,O
DO,O
/,O
PLAN,O
:,O

ENTERED,O
BY,O
:,O

ISNIFF,O
",",O
DALA,O
TAN,O
",",O
M.D.,O
(,O
EP01,O
),O

07/09/00,O
02:54,O
PM,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

Admission,O
Date,O
:,O

2013-09-22,O

Discharge,O
Date,O
:,O

2013-09-26,O

Date,O
of,O
Birth,O
:,O

1934-05-15,O

Sex,O
:,O

F,O

Service,O
:,O

SURGERY,O

Allergies,O
:,O

Iodine,B-TR

Attending,O
:,O
Ronald,O
B,O
Tekautz,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O
sp,O
cardiac,B-PR
arrest,I-PR
/,O
colitis,B-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

sp,O
Left,B-TR
subclavian,I-TR
CVL,I-TR
placement,I-TR

sp,O
Right,B-TR
femoral,I-TR
CVL,I-TR
placement,I-TR

History,O
of,O
Present,O
Illness,O
:,O

79F,O
Pmhx,O
"CHF,COPD",B-PR
",",O
found,O
down,O
at,O
home,O
",",O
pulseless,B-PR
-,O
CPR,B-TR
initiated,O
w/,O
conciousness,O
regained,O
on,O
scene,O
.,O

At,O
OSH,O
ABG,B-TE
7.19/94/110,O
",",O
BiPAP,B-TR
started,O
.,O

Pt,O
found,O
to,O
be,O
hypothermic,B-PR
w/,O
WBC,B-TE
17,O
(,O
pt,O
on,O
steroids,B-TR
),O
pnuemobilia,B-PR
and,O
thickening,B-PR
of,I-PR
sigmoid,I-PR
.,O

Currently,O
on,O
Nasal,B-TR
cannula,I-TR
02,I-TR
+,O
hemodymamically,O
stable,O
.,O

Past,O
Medical,O
History,O
:,O

CHF,B-PR
(,O
EF,B-TE
25%,O
",",O
mod,B-PR
"AS,AR",I-PR
",",O
mod,B-PR
MR,I-PR
",",O
"CAD,PAF",B-PR
",",O
angina,B-PR
",",O
COPD,B-PR
(,O
O2,B-PR
dependent,I-PR
-,O
2,O
L,O
),O
PVD,B-PR
",",O
recurrent,B-PR
UTI,I-PR
's,I-PR
",",O
Chronic,B-PR
bronchitis,I-PR
",",O
?,O
h/o,O

DM,B-PR
",",O
sp,O
L,B-TR
ax-bifem,I-TR
",",O
L,B-TR
fem-CMED,I-TR
",",O
ERCP,B-TR

Social,O
History,O
:,O
ex,O
tobacco,O
denies,O
ETOH,O
nursing,O
home,O
resident,O

Family,O
History,O
:,O

NC,O

Physical,O
Exam,O
:,O
thin,O
",",O
A&O,O
X,O
1,O

IRRR,B-PR

Decreased,B-PR
BS,I-PR
bilaterally,I-PR

soft,O
",",O
mild,B-PR
tenderness,I-PR
R,I-PR
and,I-PR
L,I-PR
lower,I-PR
quadrants,I-PR
-,O
not,O
reproducible,O

visible,B-TR
fem-fem,I-TR
graft,I-TR

ext,O
warm,O
",",O
+,B-PR
1,I-PR
edema,I-PR

Pertinent,O
Results,O
:,O

2013-09-22,O
04:20,O
AM,O
BLOOD,B-TE
WBC,B-TE
-,O
13.8,O
*,O
RBC,B-TE
-,O
3.17,O
*,O
Hgb,B-TE
-,O
8.9,O
*,O
Hct,B-TE
-,O
28.4,O
*,O
MCV,B-TE
-,O
90,O
MCH,B-TE
-,O
28.2,O
MCHC,B-TE
-,O
31.4,O
RDW,B-TE
-,O
15.0,O
Plt,B-TE
Ct,I-TE
-,O
185,O

2013-09-24,O
03:15,O
AM,O
BLOOD,B-TE
WBC,B-TE
-,O
6.8,O
RBC,B-TE
-,O
2.86,O
*,O
Hgb,B-TE
-,O
7.7,O
*,O
Hct,B-TE
-,O
25.9,O
*,O
MCV,B-TE
-,O
91,O
MCH,B-TE
-,O
27.0,O
MCHC,B-TE
-,O
29.9,O
*,O
RDW,B-TE
-,O
15.1,O
Plt,B-TE
Ct,I-TE
-,O
178,O

2013-09-25,O
02:41,O
AM,O
BLOOD,B-TE
WBC,B-TE
-,O
5.3,O
RBC,B-TE
-,O
2.94,O
*,O
Hgb,B-TE
-,O
8.2,O
*,O
Hct,B-TE
-,O
27.4,O
*,O
MCV,B-TE
-,O
93,O
MCH,B-TE
-,O
27.9,O
MCHC,B-TE
-,O
29.9,O
*,O
RDW,B-TE
-,O
15.0,O
Plt,B-TE
Ct,I-TE
-,O
194,O

2013-09-23,O
03:07,O
AM,O
BLOOD,B-TE
PT,B-TE
-,O
14.0,O
*,O
PTT,B-TE
-,O
30.1,O
INR,B-TE
(,I-TE
PT,I-TE
)-,I-TE
1.2,O
*,O

2013-09-22,O
04:20,O
AM,O
BLOOD,B-TE
Glucose,B-TE
-,O
86,O
UreaN,B-TE
-,O
18,O
Creat,B-TE
-,O
0.8,O
Na,B-TE
-,O
144,O
K,B-TE
-,O
3.7,O
Cl,B-TE
-,O
101,O
HCO3,B-TE
-,O
40,O
*,O
AnGap,B-TE
-,O
7,O
*,O

2013-09-24,O
09:36,O
AM,O
BLOOD,B-TE
Glucose,B-TE
-,O
202,O
*,O
UreaN,B-TE
-,O
25,O
*,O
Creat,B-TE
-,O
1.1,O
Na,B-TE
-,O
139,O
K,B-TE
-,O
3.9,O
Cl,B-TE
-,O
100,O
HCO3,B-TE
-,O
37,O
*,O
AnGap,B-TE
-,O
6,O
*,O

2013-09-25,O
02:41,O
AM,O
BLOOD,B-TE
Glucose,B-TE
-,O
122,O
*,O
UreaN,B-TE
-,O
31,O
*,O
Creat,B-TE
-,O
1.3,O
*,O
Na,B-TE
-,O
139,O
K,B-TE
-,O
4.1,O
Cl,B-TE
-,O
99,O
HCO3,B-TE
-,O
35,O
*,O
AnGap,B-TE
-,O
9,O

2013-09-22,O
04:20,O
AM,O
BLOOD,B-TE
ALT,B-TE
-,O
51,O
*,O
AST,B-TE
-,O
86,O
*,O
CK,B-TE
(,I-TE
CPK,I-TE
)-,I-TE
638,O
*,O
AlkPhos,B-TE
-,O
65,O
Amylase,B-TE
-,O
120,O
*,O
TotBili,B-TE
-,O
0.4,O

2013-09-22,O
12:38,O
PM,O
BLOOD,B-TE
CK,B-TE
(,I-TE
CPK,I-TE
)-,I-TE
1086,O
*,O

2013-09-22,O
09:45,O
PM,O
BLOOD,B-TE
CK,B-TE
(,I-TE
CPK,I-TE
)-,I-TE
972,O
*,O

2013-09-25,O
02:41,O
AM,O
BLOOD,B-TE
CK,B-TE
(,I-TE
CPK,I-TE
)-,I-TE
218,O
*,O

2013-09-22,O
04:20,O
AM,O
BLOOD,B-TE
cTropnT,B-TE
-,O
0.18,O
*,O

2013-09-22,O
12:38,O
PM,O
BLOOD,B-TE
CK-MB,B-TE
-,O
18,O
*,O
MB,B-TE
Indx,I-TE
-,O
1.7,O
cTropnT,B-TE
-,O
0.17,O
*,O

2013-09-22,O
09:45,O
PM,O
BLOOD,B-TE
CK-MB,B-TE
-14,O
*,O
MB,B-TE
Indx,I-TE
-,O
1.4,O

2013-09-23,O
04:26,O
AM,O
BLOOD,B-TE
CK-MB,B-TE
-,O
10,O
MB,B-TE
Indx,I-TE
-,O
1.4,O
cTropnT,B-TE
-,O
0.12,O
*,O

2013-09-25,O
02:41,O
AM,O
BLOOD,B-TE
CK-MB,B-TE
-,O
5,O
cTropnT,B-TE
-,O
0.10,O
*,O

2013-09-22,O
04:20,O
AM,O
BLOOD,B-TE
Calcium,B-TE
-,O
8.1,O
*,O
Phos,B-TE
-,O
3.2,O
Mg,B-TE
-,O
2.0,O

2013-09-25,O
02:41,O
AM,O
BLOOD,B-TE
Calcium,B-TE
-,O
8.2,O
*,O
Phos,B-TE
-,O
5.3,O
*,O
Mg,B-TE
-,O
1.9,O

2013-09-23,O
07:36,O
AM,O
BLOOD,B-TE
Vanco,B-TE
-,O
16.2,O
*,O

2013-09-24,O
10:26,O
AM,O
BLOOD,B-TE
Type,I-TE
-,O
ART,O
pO2,B-TE
-,O
105,O
pCO2,B-TE
-,O
95,O
*,O
pH,B-TE
-,O
7.19,O
*,O
calTCO2,B-TE
-,O
38,O
*,O
Base,B-TE
XS,I-TE
-,O
4,O

2013-09-24,O
11:05,O
AM,O
BLOOD,B-TE
Type,I-TE
-,O
May,O
pO2,B-TE
-,O
35,O
*,O
pCO2,B-TE
-,O
107,O
*,O
pH,B-TE
-,O
7.17,O
*,O
calTCO2,B-TE
-,O
41,O
*,O
Base,B-TE
XS,I-TE
-,O
5,O

2013-09-24,O
11:31,O
AM,O
BLOOD,B-TE
Type,I-TE
-,O
ART,O
pO2,B-TE
-,O
144,O
*,O
pCO2,B-TE
-,O
80,O
*,O
pH,B-TE
-,O
7.23,O
*,O
calTCO2,B-TE
-,O
35,O
*,O
Base,B-TE
XS,I-TE
-,O
3,O

2013-09-24,O
07:42,O
PM,O
BLOOD,B-TE
Type,I-TE
-,O
ART,O
pO2,B-TE
-,O
127,O
*,O
pCO2,B-TE
-,O
105,O
*,O
pH,B-TE
-,O
7.16,O
*,O
calTCO2,B-TE
-,O
40,O
*,O
Base,B-TE
XS,I-TE
-,O
4,O

2013-09-24,O
09:19,O
PM,O
BLOOD,B-TE
Type,I-TE
-,O
ART,O
pO2,B-TE
-,O
76,O
*,O
pCO2,B-TE
-,O
85,O
*,O
pH,B-TE
-,O
7.26,O
*,O
calTCO2,B-TE
-,O
40,O
*,O
Base,B-TE
XS,I-TE
-,O
7,O

2013-09-25,O
01:50,O
AM,O
BLOOD,B-TE
Type,I-TE
-,O
ART,O
pO2,B-TE
-,O
47,O
*,O
pCO2,B-TE
-,O
105,O
*,O
pH,B-TE
-,O
7.15,O
*,O
calTCO2,B-TE
-,O
39,O
*,O
Base,B-TE
XS,I-TE
-,O
3,O

2013-09-25,O
02:54,O
AM,O
BLOOD,B-TE
Type,I-TE
-,O
ART,O
pO2,B-TE
-,O
64,O
*,O
pCO2,B-TE
-,O
91,O
*,O
pH,B-TE
-,O
7.23,O
*,O
calTCO2,B-TE
-,O
40,O
*,O
Base,B-TE
XS,I-TE
-,O
6,O

CT,B-TE
CSpine,I-TE
:,O

No,O
evidence,O
of,O
cervical,B-PR
spine,I-PR
fracture,I-PR
.,O

Cervical,B-PR
spondylosis,I-PR
as,O
described,O
above,O
.,O

CXR,B-TE
post,O
CVL,B-TR
placement,I-TR
09-23,O
:,O

A,B-TR
left,I-TR
subclavian,I-TR
vascular,I-TR
catheter,I-TR
terminates,O
in,O
the,O
superior,O
vena,O
cava,O
.,O

Several,O
skin,O
folds,O
are,O
present,O
in,O
the,O
left,O
hemithorax,O
but,O
there,O
is,O
no,O
pneumothorax,B-PR
.,O

There,O
are,O
bilateral,B-PR
moderate,I-PR
pleural,I-PR
effusions,I-PR
",",O
both,O
of,O
which,O
have,O
increased,O
in,O
size,O
since,O
the,B-TE
previous,I-TE
study,I-TE
.,O

New,B-PR
perihilar,I-PR
and,I-PR
basilar,I-PR
opacities,I-PR
may,O
reflect,O
pulmonary,B-PR
edema,I-PR
sparing,O
the,O
upper,O
lobes,O
in,O
the,O
setting,O
of,O
emphysema,B-PR
",",O
but,O
it,O
is,O
difficult,O
to,O
exclude,O
underlying,B-PR
aspiration,I-PR
or,O
infectious,B-PR
pneumonia,I-PR
in,I-PR
the,I-PR
lung,I-PR
bases,I-PR
.,O

Surgical,B-TR
clips,I-TR
are,O
present,O
in,O
the,O
left,O
axilla,O
.,O

09-25,O
CXR,B-TE
:,O

Interval,O
development,O
of,O
large,B-PR
left,I-PR
pneumothorax,I-PR
with,O
almost,B-PR
complete,I-PR
collapse,I-PR
of,I-PR
the,I-PR
left,I-PR
lung,I-PR
.,O

Brief,O
Hospital,O
Course,O
:,O

79F,O
w/,O
a,O
multiple,B-PR
medical,I-PR
problems,I-PR
including,O
Sylvia,O
(,O
EF20%,B-TE
),O
",",O
COPD,B-PR
(,O
on,O
home,B-TR
O2,I-TR
),O
",",O
found,O
down,O
at,O
home,O
",",O
pulseless,B-PR
-,O
CPR,B-TR
initiated,O
w/conciousness,O
regained,O
on,O
scene,O
.,O

At,O
OSH,O
ABG,B-TE
7.19/94/110,O
",",O
BiPAP,B-TR
started,O
.,O

Pt,O
found,O
to,O
be,O
hypothermic,B-PR
w/,O
WBC,B-TE
17,O
(,O
pt,O
on,O
steroids,B-TR
),O
pnuemobilia,B-PR
and,O
thickening,B-PR
of,I-PR
sigmoid,I-PR
.,O

Pt,O
was,O
transferred,O
to,O
The,O
Hospital,O
for,O
Orthopedics,O
for,O
further,B-TR
management,I-TR
with,O
wishes,O
from,O
the,O
pt,O
and,O
family,O
to,O
reverse,O
DNR/DNI,O
status,O
if,O
surgery,B-TR
was,O
indicated,O
.,O

On,O
transfer,O
",",O
the,O
pt,O
had,O
VSS,O
with,O
a,B-PR
mildly,I-PR
tender,I-PR
abdomen,I-PR
without,O
peritoneal,O
signs,O
.,O

It,O
was,O
decided,O
to,O
treat,O
her,O
conservatively,O
with,O
bowel,B-TR
and,I-TR
IV,I-TR
antibiotics,I-TR
.,O

She,O
improved,O
and,O
was,O
tolerating,O
PO,O
's,O
without,O
difficulty,O
after,O
passing,O
a,B-TE
swallow,I-TE
study,I-TE
.,O

Her,O
Cpine,O
was,O
clearly,O
with,O
both,O
a,O
negative,O
CT,O
Cspine,O
and,O
clinical,B-TE
exam,I-TE
.,O

Her,B-TR
groin,I-TR
CVL,I-TR
was,O
DC,O
'd,O
after,O
a,B-TR
L,I-TR
SC,I-TR
SVL,I-TR
was,O
palced,O
.,O

CXR,B-TE
confirmed,O
good,O
position,O
and,O
no,O
PTx,B-PR
.,O

Overnight,O
on,O
HD,O
3,O
",",O
pt,O
became,O
mildly,B-PR
agitated,I-PR
and,O
an,B-TE
ABG,I-TE
was,O
drawn,O
which,O
showed,O
a,B-PR
severe,I-PR
resp,I-PR
acidosis,I-PR
and,O
BiPAP,B-TR
was,O
initiated,O
.,O

The,O
pt,O
subsequently,O
developed,O
severe,B-PR
hypoxia,I-PR
with,O
hypotension,B-PR
.,O

A,B-TE
CXR,I-TE
was,O
obtained,O
which,O
showed,O
complete,B-PR
collapse,I-PR
of,I-PR
the,I-PR
L,I-PR
lung,I-PR
thought,O
to,O
be,O
a,O
result,O
of,O
bursting,O
a,B-PR
bleb,I-PR
associated,O
with,O
her,B-PR
severe,I-PR
COPD,I-PR
.,O

Family,O
did,O
not,O
want,O
a,B-TR
chest,I-TR
tube,I-TR
placed,O
and,O
decided,O
to,O
make,O
the,O
pt,O
CMO,B-TR
measures,I-TR
.,O

On,O
HD,O
4,O
pt,O
continued,O
to,O
show,O
a,B-PR
severe,I-PR
respiratory,I-PR
acidosis,I-PR
",",O
was,O
continued,O
on,O
a,B-TR
morphine,I-TR
drip,I-TR
",",O
and,O
was,O
difficult,O
to,O
arouse,O
.,O

At,O
6pm,O
pt,O
's,O
respiratory,O
status,O
worsened,O
and,O
she,O
died,O
.,O

Medications,O
on,O
Admission,O
:,O

coreg,B-TR
6.25,O
"",O
",",O
captopril,B-TR
12.5,O
"",O
",",O
effexor,B-TR
150,O
',O
",",O
colace,B-TR
100,O
"",O
prn,O
",",O
calcium,B-TR
"",O
",",O
lasix,B-TR
40,O
',O
",",O
KCL,B-TR
20,O
',O
",",O
Pred,B-TR
5,O
',O
",",O
opscal,B-TR
',O
",",O
protonix,B-TR
40,O
',O
",",O
diamoxx,B-TR
250,O
',O
",",O
albuterol,B-TR
prn,O
",",O
darvocet,B-TR
prn,O
",",O
senekot,B-TR
",",O
trazadone,B-TR
25,O
',O

Discharge,O
Medications,O
:,O

NA,O

Discharge,O
Disposition,O
:,O

Expired,O

Discharge,O
Diagnosis,O
:,O
respiratory,B-PR
failure,I-PR

Discharge,O
Condition,O
:,O

NA,O

Discharge,O
Instructions,O
:,O

NA,O

Followup,O
Instructions,O
:,O

NA,O

Keith,O
Clint,O
MD,O
44-982,O

Completed,O
by,O
:,O
Christine,O
Mary,O
MD,O
00-155,O
2013-09-27,O
@,O
0902,O

Signed,O
electronically,O
by,O
:,O
DR.,O
William,O
Lawson,O
on,O
:,O
MON,O
2013-10-14,O
8:51,O
PM,O

(,O
End,O
of,O
Report,O
),O

164312247,O

NVH,O

47624330,O

1/19/2002,O
12:00:00,O
AM,O

Sepsis,B-PR
",",O
myocardial,B-PR
infarction,I-PR
",",O
ARDS,B-PR
",",O
pneumonia,B-PR

DIS,O

Admission,O
Date,O
:,O

01/19/2002,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

01/20/2002,O

******,O
DISCHARGE,O
ORDERS,O

TROSPROB,O
",",O
STYEES,O

650-29-95-3E45,O

Room,O
:,O

9V-851,O

Service,O
:,O

PUL,O

DISCHARGE,O
PATIENT,O
ON,O
:,O

01/20/02,O
AT,O
03:00,O
AM,O

CONTINGENT,O
UPON,O

Not,O
Applicable,O

WILL,O
D,O
/,O
C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D,O
/,O
C,O
SUMMARY,O
:,O

YES,O

Attending,O
:,O

GLOMOBESAP,O
",",O
BAMJET,O
ELLDAN,O
",",O
M.D.,O

CODE,O
STATUS,O
:,O

Other-Expired,O
.,O

DISPOSITION,O
:,O

Expired,O

DISCHARGE,O
MEDICATIONS,O
:,O

RETURN,O
TO,O
WORK,O
:,O

Not,O
Applicable,O

ALLERGY,O
:,O

Penicillins,B-TR

ADMIT,O
DIAGNOSIS,O
:,O

Sepsis,B-PR
",",O
ARDS,B-PR
",",O
Pneumonia,B-PR

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O
Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O
Sepsis,B-PR
",",O
myocardial,B-PR
infarction,I-PR
",",O
ARDS,B-PR
",",O
pneumonia,B-PR

OTHER,O
DIAGNOSIS,O
;,O
Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O
DM2,B-PR
",",O
s,O
/,O
p,O
splenectomy,B-TR
",",O
depression,B-PR

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

None,O
.,O

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O
None,O
.,O

BRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

Patient,O
received,O
as,O
transfer,O
from,O
outside,O
hospital,O
.,O

Patient,O
on,O
vent,B-TR
",",O
febrile,B-PR
",",O
hypotensive,B-PR
.,O

Developed,O
requirement,B-PR
for,O
multiple,B-TR
pressors,I-TR
",",O
then,O
arrhythmias,B-PR
.,O

Full,B-TR
code,I-TR
carried,O
out,O
.,O

Despite,O
extraordinary,B-TR
measures,I-TR
",",O
stable,O
sinus,O
rhythm,O
could,O
not,O
be,O
restored,O
.,O

Please,O
see,O
written,O
medical,O
record,O
for,O
complete,O
report,O
.,O

ADDITIONAL,O
COMMENTS,O
:,O

DISCHARGE,O
CONDITION,O
:,O

Expired,O

TO,O
DO,O
/,O
PLAN,O
:,O

No,O
dictated,O
summary,O

ENTERED,O
BY,O
:,O

NELLFYFE,O
",",O
SHATAYE,O
I,O
",",O
M.D.,O
",",O
PH.D.,O
(,O
IY150,O
),O

01/20/02,O
03:35,O
AM,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

Admission,O
Date,O
:,O

2011-09-24,O

Discharge,O
Date,O
:,O

2011-09-27,O

Date,O
of,O
Birth,O
:,O

1932-02-28,O

Sex,O
:,O

M,O

Service,O
:,O

ADMISSION,O
DIAGNOSIS,O
:,O

Subarachnoid,B-PR
hemorrhage,I-PR
",",I-PR
posttraumatic,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
was,O
a,O
79,O
-,O
year-old,O
gentleman,O
found,O
down,O
at,O
home,O
unresponsive,B-PR
by,O
his,O
wife,O
after,O
lunch,O
.,O

He,O
had,O
an,O
unwitnessed,O
fall,O
.,O

He,O
had,O
no,O
history,O
of,O
headaches,B-PR
or,O
recent,B-PR
illness,I-PR
.,O

He,O
remained,O
unresponsive,B-PR
when,O
the,O
ambulance,O
arrived,O
.,O

Systolic,B-TE
blood,I-TE
pressure,I-TE
was,O
reported,O
250,O
on,O
arrival,O
to,O
the,O
Mass.,O
Eye,O
&,O
Ear,O
Infirmary,O
Emergency,O
Department,O
.,O

He,O
was,O
intubated,O
and,O
given,O
Versed,B-TR
and,O
Fentanyl,B-TR
.,O

His,B-TE
GCS,I-TE
was,O
reported,O
as,O
3,O
on,O
arrival,O
to,O
the,O
Emergency,O
Department,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Hypertension,B-PR
.,O

Status,O
post,O
coronary,B-TR
artery,I-TR
bypass,I-TR
grafting,I-TR
.,O

Pacemaker,B-TR
implantation,I-TR
.,O

Atrial,B-PR
fibrillation,I-PR
.,O

Cerebrovascular,B-PR
accident,I-PR
.,O

Previous,B-PR
intracranial,I-PR
hemorrhage,I-PR
.,O

MEDICATIONS,O
:,O

Aspirin,B-TR
",",O
Folate,B-TR
",",O
Multivitamin,B-TR
",",O
Amiodarone,B-TR
",",O
Lasix,B-TR
",",O
Imdur,B-TR
",",O
Celexa,B-TR
",",O
Lipitor,B-TR
",",O
Potassium,B-TR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Vital,O
signs,O
:,O

He,O
was,O
afebrile,B-PR
",",O
blood,B-TE
pressure,I-TE
154/75,O
",",O
on,O
Nipride,B-TR
drip,I-TR
",",O
heart,B-TE
rate,I-TE
81,O
",",O
oxygen,B-TE
saturation,I-TE
97%,O
.,O

General,O
:,O

He,O
was,O
intubated,B-TR
and,O
sedated,B-TR
at,O
the,O
time,O
.,O

Neurological,O
:,O

Pinpoint,B-PR
pupils,I-PR
",",O
intact,O
corneal,O
reflexes,O
bilaterally,O
.,O

Doll,B-PR
's,I-PR
eyes,I-PR
.,O

He,O
withdrew,O
both,O
lower,O
extremities,O
to,O
peripheral,B-TE
stimulation,I-TE
",",O
as,O
well,O
as,O
his,O
upper,O
extremities,O
to,O
peripheral,B-TE
stimulation,I-TE
.,O

He,O
also,O
withdrew,O
his,O
left,O
upper,O
extremity,O
to,O
peripheral,B-TE
stimulation,I-TE
but,O
not,O
his,O
right,O
upper,O
extremity,O
.,O

His,B-TE
reflexes,I-TE
were,O
brisk,O
in,O
his,O
patellas,O
bilaterally,O
",",O
and,O
he,O
had,O
upgoing,B-PR
toes,I-PR
bilaterally,I-PR
.,O

IMAGING,O
:,O

Head,B-TE
CT,I-TE
showed,O
diffuse,B-PR
subarachnoid,I-PR
hemorrhage,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

He,O
was,O
admitted,O
to,O
the,O
Neuro,O
Surgical,O
Intensive,O
Care,O
Unit,O
for,O
close,O
monitoring,O
and,O
Neuro-checks,B-TE
.,O

A,B-TR
Vent,I-TR
drain,I-TR
was,O
placed,O
to,O
monitor,O
and,O
CP,O
and,O
relieved,O
fluid,O
.,O

He,O
received,O
12,O
U,O
of,O
platelets,B-TR
.,O

His,O
Intensive,O
Care,O
Unit,O
stay,O
was,O
unremarkable,O
.,O

His,B-TE
neurologic,I-TE
exam,I-TE
did,O
not,O
change,O
significantly,O
.,O

His,B-TE
ICPs,I-TE
were,O
in,O
the,O
range,O
of,O
11-22,O
",",O
and,O
he,O
was,O
weaned,O
off,O
the,B-TR
Nipride,I-TR
drip,I-TR
.,O

He,O
developed,O
extensive,B-PR
posturing,I-PR
.,O

A,B-TE
CTA,I-TE
showed,O
diffuse,B-PR
subarachnoid,I-PR
hemorrhage,I-PR
and,O
intraventricular,B-PR
blood,I-PR
but,O
no,O
evidence,O
of,O
an,B-PR
aneurysm,I-PR
.,O

A,B-TE
repeat,I-TE
CT,I-TE
on,O
09-26,O
showed,O
worsening,O
of,O
the,B-PR
diffuse,I-PR
subarachnoid,I-PR
hemorrhage,I-PR
and,O
a,B-PR
new,I-PR
cerebellar,I-PR
hemorrhage,I-PR
.,O

The,O
family,O
was,O
informed,O
of,O
the,O
patient,O
's,O
condition,O
and,O
repeat,B-TE
scan,I-TE
.,O

A,O
family,O
discussion,O
resulted,O
in,O
the,O
decision,O
to,O
make,O
the,O
patient,O
comfort,B-TR
measures,I-TR
only,I-TR
.,O

The,O
patient,O
was,O
placed,O
on,O
a,B-TR
Morphine,I-TR
drip,I-TR
and,O
extubated,O
and,O
passed,O
away,O
at,O
10:55,O
a.m.,O
on,O
2011-09-27,O
.,O

The,O
family,O
was,O
notified,O
of,O
the,O
patient,O
's,O
passing,O
.,O

The,O
medical,O
examiner,O
has,O
also,O
been,O
notified,O
of,O
the,O
passing,O
of,O
the,O
patient,O
.,O

Shawn,O
B,O
Crawford,O
",",O
M.D.,O

46-411,O

Dictated,O
By,O
:,O
Linda,O
P.F.,O
Clark,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2011-09-27,O
11:53,O

T,O
:,O
2011-09-27,O
12:41,O

JOB,O
#,O
:,O
63722,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Carlos,O
Warner,O
on,O
:,O
TUE,O
2011-09-27,O
3:42,O
PM,O

(,O
End,O
of,O
Report,O
),O

165342718,O

CTMC,O

79284819,O

181252,O

11/30/1993,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Unsigned,O

DIS,O

Admission,O
Date,O
:,O

11/30/1993,O

Report,O
Status,O
:,O

Unsigned,O

Discharge,O
Date,O
:,O

12/07/1993,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
40,O
year,O
old,O
woman,O
with,O
end,B-PR
stage,I-PR
renal,I-PR
disease,I-PR
",",O
on,O
hemodialysis,B-TR
since,O
12/91,O
.,O

This,O
was,O
secondary,O
to,O
polycystic,B-PR
kidneydisease,I-PR
",",O
which,O
was,O
noted,O
since,O
age,O
12,O
.,O

She,O
is,O
status,O
post,O
cadaveric,B-TR
renal,I-TR
allograft,I-TR
in,O
03/93,O
",",O
and,O
she,O
subsequently,O
underwent,O
an,B-TR
early,I-TR
postoperative,I-TR
transplant,I-TR
nephrectomy,I-TR
secondary,O
to,O
rupture,B-PR
.,O

He,O
has,O
been,O
having,O
difficult,B-PR
access,I-PR
problems,I-PR
and,O
now,O
has,O
a,B-TR
left,I-TR
upper,I-TR
arm,I-TR
PTFE,I-TR
.,O

She,O
had,O
been,O
placed,O
on,O
emergency,B-TR
transplant,I-TR
for,O
this,B-PR
difficult,I-PR
access,I-PR
problem,I-PR
.,O

Otherwise,O
",",O
she,O
has,O
been,O
healthy,O
and,O
her,B-TR
last,I-TR
hemodialysis,I-TR
was,O
the,O
day,O
prior,O
to,O
transplant,B-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Significant,O
for,O
hypertension,B-PR
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

Multiple,B-TR
angio,I-TR
accesses,I-TR
",",O
TAH,B-TR
at,O
age,O
18,O
",",O
cadaveric,B-TR
renal,I-TR
allograft,I-TR
in,O
03/93,O
",",O
reoperation,B-TR
for,O
bleed,B-PR
followed,O
by,O
transplant,B-TR
nephrectomy,I-TR
.,O

MEDICATIONS,O
ON,O
ADMIT,O
:,O

Iron,B-TR
",",O
Nephro-Caps,B-TR
",",O
calcium,B-TR
carbonate,I-TR
and,O
Valium,B-TR
.,O

HOSPITAL,O
COURSE,O
:,O

She,O
was,O
taken,O
to,O
the,O
Operating,O
Room,O
on,O
11/30/93,O
where,O
Dr.,O
Tiveloydherdes,O
performed,O
a,B-TR
cadaveric,I-TR
renal,I-TR
allograft,I-TR
to,I-TR
the,I-TR
left,I-TR
iliac,I-TR
fossa,I-TR
which,O
she,O
tolerated,O
well,O
.,O

Postoperative,O
course,O
was,O
unremarkable,O
.,O

She,O
was,O
started,O
on,O
her,B-TR
immunosuppressive,I-TR
agents,I-TR
as,O
per,O
protocol,O
.,O

Her,B-TE
creatinine,I-TE
fell,O
to,O
the,O
normal,O
range,O
early,O
.,O

Over,O
several,O
days,O
she,O
continued,O
to,O
make,O
good,O
amounts,O
or,O
urine,O
.,O

She,O
was,O
gradually,O
advanced,O
to,O
a,O
regular,O
diet,O
.,O

Her,B-TR
prednisone,I-TR
was,O
tapered,O
to,O
a,B-TR
stable,I-TR
dose,I-TR
.,O

DISPOSITION,O
:,O

Discharge,B-TR
medications,I-TR
were,O
prednisone,B-TR
30,O
q.d.,O
",",O
Imuran,B-TR
120,O
q.d.,O
",",O
cyclosporin,B-TR
400,O
b.i.d.,O
and,O
Pepcid,B-TR
20,O
b.i.d.,O
and,O
Colace,B-TR
100,O
b.i.d.,O

Dicatated,O
By,O
:,O

IA,O
A,O
",",O
M.D.,O
AX37,O

Attending,O
:,O

AE,O
Z.,O
TIVELOYDHERDES,O
",",O
M.D.,O
ZC5,O
GI592/4-03,O

Batch,O
:,O

6066,O

Index,O
No.,O
VQCUHL4S7Y,O

D,O
:,O

12/07/93,O

T,O
:,O

12/08/93,O

Admission,O
Date,O
:,O

2013-11-11,O

Discharge,O
Date,O
:,O

2013-11-13,O

Date,O
of,O
Birth,O
:,O

1938-06-09,O

Sex,O
:,O

M,O

Service,O
:,O

CMED,O

Allergies,O
:,O

No,O
Drug,B-PR
Allergy,I-PR
Information,O
on,O
File,O

Attending,O
:,O
Leroy,O
F,O
Stalnaker,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Left,B-PR
sided,I-PR
weakness,I-PR
",",O
slurred,B-PR
speech,I-PR
.,O

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

Intubation,B-TR
and,O
mechanical,B-TR
ventilation,I-TR
.,O

History,O
of,O
Present,O
Illness,O
:,O

Patient,O
is,O
a,O
75,O
year,O
old,O
right,O
handed,O
male,O
with,O
past,O
medical,O
history,O
of,O
coronary,B-PR
artery,I-PR
disease,I-PR
s/p,O
NQWMI,B-PR
02-25,O
",",O
s/p,O
LAD,B-TR
angioplasty,I-TR
and,O
stent,B-TR
05-26,O
",",O
dementia,B-PR
",",O
hyperlipidemia,B-PR
",",O
aortic,B-PR
stenosis,I-PR
",",O
atrial,B-PR
fibrillation,I-PR
on,O
coumadin,B-TR
who,O
presented,O
from,O
his,O
CMED,O
CSRU,O
doctor,O
's,O
office,O
wtih,O
acute,B-PR
onset,I-PR
left,I-PR
sided,I-PR
weakness,I-PR
and,O
dysarthria,B-PR
.,O

Patient,O
was,O
in,O
his,O
usual,O
state,O
of,O
health,O
until,O
around,O
12:15,O
on,O
day,O
of,O
admission,O
.,O

Was,O
at,O
this,O
doctor,O
's,O
office,O
and,O
complained,O
of,O
severe,B-PR
headache,I-PR
.,O

Thereafter,O
",",O
wife,O
noted,O
development,O
of,O
left,B-PR
sided,I-PR
weakness,I-PR
",",O
facial,B-PR
droop,I-PR
",",O
slurring,B-PR
of,I-PR
speech,I-PR
.,O

Sent,O
to,O
Hahnemann,O
General,O
Hospital,O
for,O
evaluation,B-TE
emergently,O
.,O

Tom,O
course,O
:,O

Arrived,O
at,O
Hahnemann,O
General,O
Hospital,O
at,O
12:30,O
.,O

Finger,B-TE
stick,I-TE
blood,I-TE
glucose,I-TE
120,O
.,O

Rest,O
of,O
vitals,B-TE
BP,B-TE
112/70,O
",",O
HR,B-TE
60,O
.,O

Blood,B-TE
pressure,I-TE
up,O
to,O
230,O
s,O
systolic,O
.,O

Seen,O
emergently,O
by,O
stroke,O
team,O
.,O

Initial,B-TE
NIH,I-TE
stroke,I-TE
scale,I-TE
of,O
33,O
.,O

Head,B-TE
CT,I-TE
showed,O
large,B-PR
right,I-PR
intracerebral,I-PR
hemorrhage,I-PR
.,O

Intubated,O
for,O
airway,B-TR
protection,I-TR
at,O
13:35,O
after,O
Fentanyl,B-TR
",",O
Etomidate,B-TR
",",O
Vecuronium,B-TR
and,O
Succhinylcholine,B-TR
given,O
.,O

Started,O
on,O
Labetalol,B-TR
and,O
then,O
Nipride,B-TR
drip,I-TR
for,O
BP,B-TR
control,I-TR
;,O
discontinued,O
as,O
goal,B-TE
BP,I-TE
in,O
130-160,O
s.,O

Received,O
10,B-TR
mg,I-TR
SC,I-TR
Vitamin,I-TR
K,I-TR
and,O
2,B-TR
units,I-TR
FFP,I-TR
while,O
in,O
Gary,O
.,O

Pupils,O
noted,O
to,O
be,O
fixed,B-PR
and,O
dilated,B-PR
at,O
14:10,O
.,O

Loaded,O
with,O
Dilantin,B-TR
and,O
50,B-TR
grams,I-TR
Mannitol,I-TR
.,O

Transferred,O
to,O
intensive,O
care,O
unit,O
.,O

Past,O
Medical,O
History,O
:,O

1.,O
Atrial,B-PR
fibrillation,I-PR
",",O
on,O
coumadin,B-TR

2.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
status,O
post,O
NQWMI,B-PR
02-25,O
",",O
s/p,O
LAD,B-TR
angioplasty,I-TR
and,O
stent,B-TR
05-26,O
.,O
Known,B-PR
non-dominant,I-PR
90%,I-PR
RCA,I-PR
lesion,I-PR
not,O
intervened,O
upon,O
.,O

3.,O
Dementia,B-PR

4.,O
Mild-moderate,B-PR
aortic,I-PR
stenosis,I-PR

5.,O
Hyperlipidemia,B-PR

6.,O
Colon,B-PR
cancer,I-PR

7.,O
Obstructive,B-PR
sleep,I-PR
apnea,I-PR

8.,O
Anxiety,B-PR

9.,O
Diabetes,B-PR
mellitus,I-PR
",",O
on,O
oral,B-TR
medications,I-TR

Social,O
History,O
:,O

Married,O
.,O

Lives,O
with,O
wife,O
.,O

One,O
son,O
",",O
in,O
area,O
.,O

Social,O
alcohol,O
.,O

No,O
tobacco,O
",",O
drug,O
use,O
.,O

Family,O
History,O
:,O

Non-contributory,O
.,O

Physical,O
Exam,O
:,O

PHYSICAL,B-TE
EXAM,I-TE
(,O
Examined,O
off,O
of,O
Propofol,B-TR
):,O

Tc,B-TE
:,O
96.7,O

BP,B-TE
:,O
120/48,O

HR,B-TE
:,O
61,O

RR,B-TE
:,O
14,O

O2Sat.,B-TE
:,O
100%,O
",",O
ventilated,B-TR
.,O

Gen,O
:,O
WD/WN,O
male,O
",",O
comfortable,O
appearing,O
",",O
intubated,B-TR
",",O
not,O
sedated,B-TR
.,O

HEENT,O
:,O
NC/AT,B-PR
.,O

Anicteric,B-PR
.,O

MMM,O
.,O

+Endotracheal,B-TR
tube,I-TR
.,O

Neck,O
:,O
Supple,O
.,O

No,O
masses,B-PR
or,O
LAD,B-PR
.,O

No,O
JVD,B-PR
.,O

No,O
thyromegaly,B-PR
.,O

No,O
carotid,B-PR
bruits,I-PR
.,O

Lungs,O
:,O
Coarse,B-PR
breath,I-PR
sounds,I-PR
anterolaterally,I-PR
.,O

Cardiac,O
:,O
Irregularly,B-PR
irregular,I-PR
.,O

S1/S2,O
.,O

No,O
M/R/G,B-PR
.,O

Abd,O
:,O
Soft,O
",",O
NT,B-PR
",",O
ND,B-PR
",",O
+NABS,O
.,O

No,O
rebound,B-PR
or,O
guarding,B-PR
.,O

No,O
HSM,B-PR
.,O

Extrem,O
:,O
Warm,O
and,O
well-perfused,O
.,O

No,O
C/C/E,B-PR
.,O

Neuro,O
:,O

Mental,O
status,O
:,O

No,B-PR
response,I-PR
to,I-PR
voice,I-PR
",",O
sternal,B-TE
rub,I-TE
.,O

Grimaces,O
to,O
nasal,B-TE
tickle,I-TE
.,O

Cranial,O
Nerves,O
:,O

Pupils,B-PR
fixed,I-PR
at,O
7,O
mm,O
bilaterally,O
.,O

Very,O
weak,O
flicker,O
of,O
inner,O
canthus,O
on,O
left,O
with,O
corneal,B-TE
stimulation,I-TE
.,O

No,B-PR
oculocephalic,I-PR
reflex,I-PR
.,O

Left,B-PR
facial,I-PR
droop,I-PR
.,O

No,B-PR
gag,I-PR
provoked,O
",",O
but,O
biting,O
ETT,B-TR
at,O
times,O
.,O

Tongue,O
midline,O
.,O

Motor,O
:,O

Normal,O
bulk,O
.,O

Increased,O
tone,O
x4,O
with,O
LEs,O
>,O
UEs,O
.,O

No,B-PR
withdrawal,I-PR
to,O
noxious,B-TE
stimuli,I-TE
.,O

Bilateral,O
feet,O
externally,O
rotated,O
.,O

Sensation,O
:,O

No,B-PR
withdrawal,I-PR
to,O
noxious,B-TE
stimuli,I-TE
.,O

Reflexes,B-TE
:,O

Absent,O
in,O
LUE,O
",",O
left,O
ankle,O
.,O

Striking,O
left,O
patellar,O
tendon,O
results,O
in,O
sustained,B-PR
clonus,I-PR
of,I-PR
left,I-PR
leg,I-PR
.,O

Toes,B-PR
upgoing,I-PR
bilaterally,I-PR
.,O

02-27,O
RUE,O
",",O
absent,O
right,O
ankle,O
.,O

Coordination,O
:,O

Unable,O
to,O
assess,O
.,O

Gait,O
:,O

Unable,O
to,O
assess,O
.,O

Pertinent,O
Results,O
:,O

2013-11-11,O
12:39,O

WBC,B-TE
-,O
9.1,O
RBC,B-TE
-,O
4.29,O
*,O
HGB,B-TE
-,O
14.1,O
HCT,B-TE
-,O
38.7,O
*,O
MCV,B-TE
-,O
90,O
MCH,B-TE
-,O
32.8,O
*,O
MCHC,B-TE
-,O
36.4,O
*,O
RDW,B-TE
-,O
14.7,O

2013-11-11,O
12:39,O

PLT,B-TE
COUNT,I-TE
-,O
147,O
*,O

2013-11-11,O
12:39,O

PT,B-TE
-,O
20.0,O
*,O
PTT,B-TE
-,O
32.4,O
INR,B-TE
(,I-TE
PT,I-TE
)-,I-TE
2.5,O

2013-11-11,O
12:39,O

GLUCOSE,B-TE
-,O
101,O
UREA,B-TE
N,I-TE
-,O
25,O
*,O
CREAT,B-TE
-,O
1.0,O
SODIUM,B-TE
-,O
142,O
POTASSIUM,B-TE
-,O
4.2,O
CHLORIDE,B-TE
-,O
106,O
TOTAL,B-TE
CO2,I-TE
-,O
27,O
ANION,B-TE
GAP,I-TE
-,O
13,O

2013-11-11,O
12:39,O

CK,B-TE
(,I-TE
CPK,I-TE
)-,I-TE
200,O
*,O

2013-11-11,O
12:39,O
PM,O
cTropnT,B-TE
-<,O
0.01,O

2013-11-11,O
12:39,O

CK-MB,B-TE
-,O
7,O

2013-11-11,O
21:45,O

CK,B-TE
(,I-TE
CPK,I-TE
)-,I-TE
196,O
*,O

2013-11-11,O
21:45,O

CK-MB,B-TE
-,O
3,O
cTropnT,B-TE
-<,O
0.01,O

2013-11-12,O
03:30,O
AM,O
BLOOD,B-TE
CK,B-TE
(,I-TE
CPK,I-TE
)-,I-TE
312,O
*,O

2013-11-12,O
03:30,O
AM,O
BLOOD,B-TE
CK-MB,B-TE
-,O
5,O
cTropnT,B-TE
-<,O
0.01,O

2013-11-11,O
01:55,O
PM,O
URINE,B-TE
BLOOD,B-TE
-,O
SM,O
NITRITE,B-TE
-,O
NEG,O
PROTEIN,B-TE
-,O
100,O
GLUCOSE,B-TE
-,O
NEG,O
KETONE,B-TE
-,O
NEG,O
BILIRUBIN,B-TE
-,O
NEG,O
UROBILNGN,B-TE
-,O
NEG,O
PH,B-TE
-,O
6.5,O
LEUK,B-TE
-,O
NEG,O

2013-11-12,O
11:16,O
AM,O
BLOOD,B-TE
ASA,B-TE
-,O
NEG,O
Ethanol,B-TE
-,O
NEG,O
Acetmnp,B-TE
-,O
NEG,O
Bnzodzp,B-TE
-,O
NEG,O
Barbitr,B-TE
-,O
NEG,O
Tricycl,B-TE
-,O
NEG,O

2013-11-12,O
10:17,O
AM,O
URINE,B-TE
bnzodzp,B-TE
-,O
NEG,O
barbitr,B-TE
-,O
NEG,O
opiates,B-TE
-,O
NEG,O
cocaine,B-TE
-,O
NEG,O
amphetm,B-TE
-,O
NEG,O
mthdone,B-TE
-,O
NEG,O

CT,B-TE
head,I-TE
without,I-TE
contrast,I-TE
2013-11-11,O
:,O

FINDINGS,O
:,O

There,O
is,O
a,O
large,O
region,O
of,O
high,B-PR
attenuation,I-PR
within,I-PR
the,I-PR
right,I-PR
frontal,I-PR
lobe,I-PR
and,O
the,O
region,O
of,O
the,O
right,O
basal,O
ganglia,O
.,O

This,O
is,O
consistent,O
with,O
intraparenchymal,B-PR
hemorrhage,I-PR
",",O
more,O
likely,O
hypertensive,B-PR
in,O
etiology,O
.,O

No,O
significant,B-PR
subarachnoid,I-PR
or,O
intraventricular,B-PR
hemorrhage,I-PR
is,O
appreciated,O
.,O

There,O
is,O
mass,B-PR
effect,I-PR
present,O
with,O
shift,B-PR
of,I-PR
the,I-PR
normally,I-PR
midline,I-PR
structures,I-PR
towards,O
the,O
left,O
.,O

There,O
is,O
also,O
left,B-PR
sided,I-PR
subfalcine,I-PR
herniation,I-PR
.,O

There,O
is,O
no,O
hydrocephalus,B-PR
.,O

The,O
visualized,O
osseous,O
structures,O
and,O
paranasal,O
sinuses,O
are,O
unremarkable,O
.,O

IMPRESSION,O
:,O

Large,B-PR
intraparenchymal,I-PR
hemorrhage,I-PR
within,I-PR
the,I-PR
right,I-PR
frontal,I-PR
lobe,I-PR
.,O

This,O
most,O
likely,O
relates,O
to,O
hypertensive,B-PR
hemorrhage,I-PR
",",O
as,O
opposed,O
to,O
a,B-PR
ruptured,I-PR
right,I-PR
middle,I-PR
cerebral,I-PR
artery,I-PR
aneurysm,I-PR
.,O

Brief,O
Hospital,O
Course,O
:,O

Patient,O
was,O
a,O
75,O
year,O
old,O
right,O
handed,O
male,O
with,O
past,O
medical,O
history,O
of,O
atrial,B-PR
fibrillation,I-PR
on,O
coumadin,B-TR
",",O
coronary,B-PR
artery,I-PR
disease,I-PR
",",O
hyperlipidemia,B-PR
",",O
dementia,B-PR
with,O
sudden,B-PR
onset,I-PR
left,I-PR
sided,I-PR
weakness,I-PR
",",O
dysarthria,B-PR
.,O

Head,B-TE
CT,I-TE
demonstrated,O
a,B-PR
large,I-PR
right,I-PR
intracerebral,I-PR
hemorrhage,I-PR
",",O
centered,O
around,O
basal,O
ganglia,O
and,O
putamen,O
.,O

We,O
felt,O
this,O
was,O
likely,O
secondary,O
to,O
hypertension,B-PR
.,O

While,O
still,O
in,O
the,O
emergency,O
department,O
",",O
he,O
had,O
rapid,B-PR
decompensation,I-PR
necessitating,O
intubation,B-TR
for,O
airway,B-TR
protection,I-TR
.,O

Examination,B-TE
post,O
intubation,B-TR
but,O
off,O
intubations,B-TR
showed,O
clinical,O
evidence,O
of,O
elevated,B-PR
intracranial,I-PR
pressure,I-PR
and,O
brainstem,B-PR
compression,I-PR
.,O

The,O
overall,O
prognosis,O
was,O
guarded,O
.,O

He,O
was,O
admitted,O
to,O
the,O
Neurology,O
/,O
Neurosurgery,O
ICU,O
.,O

He,O
was,O
loaded,O
with,O
Mannitol,B-TR
and,O
Dilantin,B-TR
in,O
the,O
emergency,O
room,O
.,O

He,O
was,O
evaluated,O
by,O
the,O
Neurosurgery,O
service,O
and,O
they,O
did,O
not,O
feel,O
a,B-TR
surgical,I-TR
intervention,I-TR
or,O
ventriculary,B-TR
drain,I-TR
was,O
warranted,O
.,O

After,O
arrival,O
in,O
the,O
ICU,O
",",O
patient,O
was,O
followed,O
with,O
neuro,B-TE
checks,I-TE
every,O
1,O
hour,O
.,O

Sedation,B-TR
was,O
held,O
to,O
allow,O
for,O
frequent,B-TE
exams,I-TE
.,O

Head,O
of,O
bed,O
was,O
kept,O
at,O
30,O
degrees,O
.,O

Labetalol,B-TR
continuous,I-TR
infusion,I-TR
was,O
titrated,O
for,O
systolic,B-TE
blood,I-TE
pressure,I-TE
of,O
130-160,O
.,O

Mannitol,B-TR
and,O
Dilantin,B-TR
were,O
continued,O
.,O

After,O
lengthy,O
discussion,O
",",O
the,O
patient,O
's,O
wife,O
opted,O
to,O
make,O
him,O
DNR,O
on,O
afternoon,O
of,O
2013-11-11,O
.,O

Overnight,O
",",O
fresh,B-TR
frozen,I-TR
plasma,I-TR
was,O
given,O
for,O
goal,B-TE
INR,I-TE
of,O
<,O
1.4,O
.,O

On,O
serial,B-TE
exams,I-TE
by,O
neurology,O
and,O
ICU,O
attendings,O
in,O
the,O
morning,O
on,O
2013-11-12,O
",",O
patient,O
had,O
no,B-PR
clinical,I-PR
signs,I-PR
of,I-PR
brainstem,I-PR
activity,I-PR
.,O

Namely,O
",",O
he,O
was,O
unresponsive,B-PR
.,O

Pupils,O
were,O
fixed,B-PR
and,O
dilated,B-PR
.,O

No,O
corneal,B-TE
",",I-TE
gag,I-TE
",",I-TE
oculocephalic,I-TE
",",I-TE
and,I-TE
oculovestibular,I-TE
reflexes,I-TE
were,O
elicited,O
.,O

He,O
was,O
not,O
overbreathing,O
his,B-TR
ventilator,I-TR
.,O

At,O
this,O
point,O
",",O
patient,O
was,O
felt,O
to,O
have,O
clinical,O
signs,O
consistent,O
with,O
brain,B-PR
death,I-PR
.,O

Plans,O
were,O
made,O
to,O
proceed,O
with,O
apnea,B-TE
testing,I-TE
.,O

However,O
",",O
after,O
discussion,O
with,O
patient,O
's,O
wife,O
",",O
this,O
was,O
postponed,O
with,O
test,B-TE
planned,O
on,O
2013-11-13,O
.,O

Full,B-TR
medical,I-TR
care,I-TR
and,O
managment,B-TR
continued,O
overnight,O
11/9-11/20/2002,O
.,O

At,O
approximately,O
06:00,O
on,O
2013-11-13,O
",",O
the,O
patient,O
became,O
bradycardic,B-PR
.,O

He,O
lapsed,O
first,O
into,O
a,B-PR
junctional,I-PR
rhythm,I-PR
and,O
then,O
had,O
very,B-PR
infrequent,I-PR
ventricular,I-PR
escape,I-PR
beats,I-PR
on,O
telemetry,B-TE
.,O

Finally,O
",",O
he,O
went,O
asystolic,B-PR
.,O

He,O
was,O
not,O
resuscitated,O
as,O
per,O
previous,O
conversations,O
with,O
his,O
wife,O
.,O

Ronald,O
was,O
pronounced,O
dead,B-PR
at,O
06:59,O
am,O
.,O

The,O
patient,O
's,O
wife,O
was,O
notified,O
.,O

The,O
attending,O
was,O
notified,O
as,O
well,O
.,O

Medications,O
on,O
Admission,O
:,O

1.,O
Coumadin,B-TR

2.,O
Lipitor,B-TR

3.,O
Toprol,B-TR
XL,I-TR

4.,O
ASA,B-TR

5.,O
Zoloft,B-TR

6.,O
Glucophage,B-TR

7.,O
Aricept,B-TR

8.,O
Namenda,B-TR

9.,O
Artificial,B-TR
Tears,I-TR

Discharge,O
Medications,O
:,O

Not,O
applicable,O
.,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Facility,O
:,O

Patient,O
deceased,O
.,O

Discharge,O
Diagnosis,O
:,O

Not,O
applicable;,O
patient,O
deceased,O
.,O

Discharge,O
Condition,O
:,O

Not,O
applicable,O
.,O

Discharge,O
Instructions,O
:,O

Not,O
applicable,O
.,O

Followup,O
Instructions,O
:,O

Not,O
applicable,O
.,O

William,O
William,O
MD,O
",",O
PHD,O
13-279,O

Completed,O
by,O
:,O
Barbara,O
Josephine,O
MD,O
21-547,O
2013-11-15,O
@,O
1413,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Exie,O
Culbreath,O
on,O
:,O
MON,O
2013-11-18,O
10:06,O
AM,O

(,O
End,O
of,O
Report,O
),O

166394283,O
PUMC,O

1991524,O

328713,O

95918,O

12/02/2002,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Report,O
Status,O
:,O

Signed,O

DISCHARGE,O
SUMMARY,O
NAME,O
:,O

KOTENORT,O
",",O
OAN,O
R,O

UNIT,O
NUMBER,O
:,O

105-24-06,O

ADMISSION,O
DATE,O
:,O

12/02/2002,O

DISCHARGE,O
DATE,O
:,O

12/04/2002,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Probably,O
sigmoid,B-PR
volvulus,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
an,O
81,O
year,O
old,O
female,O
with,O
a,O
history,O
of,O
cerebrovascular,B-PR
accident,I-PR
",",O
atrial,B-PR
fibrillation,I-PR
",",O
hypothyroidism,B-PR
and,O
dementia,B-PR
who,O
is,O
status,O
post,O
laparoscopic,B-TR
cholecystectomy,I-TR
one,O
week,O
ago,O
who,O
currently,O
presents,O
with,O
a,O
4,O
day,O
history,O
of,O
no,B-PR
bowel,I-PR
movement,I-PR
.,O

She,O
has,O
complaints,O
of,O
abdominal,B-PR
distention,I-PR
",",O
emesis,B-PR
",",O
and,O
constipation,B-PR
.,O

She,O
has,O
no,O
chest,B-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
or,O
fever,B-PR
.,O

She,O
has,O
no,O
nausea,B-PR
or,O
vomiting,B-PR
",",O
chills,B-PR
",",O
dysuria,B-PR
",",O
hematochezia,B-PR
",",O
or,O
melena,B-PR
.,O

She,O
was,O
discharged,O
from,O
the,O
hospital,O
on,O
11/28/02,O
to,O
a,O
short,O
term,O
rehabilitation,O
facility,O
.,O

She,O
was,O
found,O
to,O
have,O
normal,O
bowel,O
sounds,O
.,O

She,O
presented,O
to,O
the,O
"Ponta,itri-",O
University,O
Medical,O
Center,O
Emergency,O
Department,O
on,O
12/01/02,O
for,O
evaluation,B-TE
of,O
this,B-PR
constipation,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Cerebrovascular,B-PR
accident,I-PR
.,O

2.,O
Atrial,B-PR
fibrillation,I-PR
on,O
Coumadin,B-TR
.,O

3.,O
Diabetes,B-PR
mellitus,I-PR
type,I-PR
2,I-PR
.,O

4.,O
Hypothyroidism,B-PR
.,O

5.,O
Mild,B-PR
dementia,I-PR
.,O

6.,O
Proteinuria,B-PR
.,O

7.,O
Nephropathy,B-PR
.,O

8.,O
Anemia,B-PR
.,O

9.,O
Hearing,B-PR
impaired,I-PR
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

1.,O
Laparoscopic,B-TR
cholecystectomy,I-TR
as,O
above,O
.,O

2.,O
Total,B-TR
hip,I-TR
replacement,I-TR
in,O
2002,O
.,O

3.,O
Appendectomy,B-TR
.,O

4.,O
Diskectomy,B-TR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

1.,O
Digoxin,B-TR
.125,O
mg,O
qod,O
",",O
.25,O
mg,O
qod,O
.,O

2.,O
Colace,B-TR
100,O
mg,O
po,O
tid,O
.,O

3.,O
Levoxyl,B-TR
100,O
ugm,O
po,O
qd,O
.,O

4.,O
Prinivil,B-TR
20,O
mg,O
po,O
qd,O
.,O

5.,O
Zantac,B-TR
150,O
mg,O
po,O
bid,O
.,O

6.,O
Aspirin,B-TR
325,O
mg,O
qd,O
.,O

7.,O
Aricept,B-TR
5,O
mg,O
po,O
qd,O
.,O

8.,O
Glyburide,B-TR
1.25,O
mg,O
po,O
qam,O
.,O

9.,O
Oxybutynin,B-TR
5,O
mg,O
po,O
bid,O
.,O

10.,O
Coumadin,B-TR
7.5,O
mg,O
on,O
Sun,O
",",O
Tues,O
",",O
Wed,O
",",O
Fri,O
and,O
Sat,O
.,O

5,O
mg,O
on,O
Mon,O
and,O
Thurs,O
.,O

ALLERGIES,O
:,O

Fluoroquinolones,B-TR
.,O

SOCIAL,O
HISTORY,O
:,O

No,O
tobacco,O
",",O
alcohol,O
or,O
drugs,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Temperature,B-TE
96.7F,O
",",O
pulse,B-TE
63,O
",",O
respiratory,B-TE
rate,I-TE
20,O
",",O
blood,B-TE
pressure,I-TE
167/68,O
",",O
02,O
sat,O
99%,O
on,O
room,O
air,O
.,O

In,O
general,O
the,O
patient,O
is,O
in,O
no,O
apparent,B-PR
distress,I-PR
.,O

Head,B-TE
",",I-TE
eyes,I-TE
",",I-TE
ears,I-TE
",",I-TE
nose,I-TE
and,I-TE
throat,I-TE
exam,I-TE
is,O
within,O
normal,O
limits,O
.,O

Chest,O
clear,O
to,O
auscultation,O
bilaterally,O
.,O

Heart,O
regular,O
rate,O
and,O
rhythm,O
.,O

Abdomen,B-PR
grossly,I-PR
distended,I-PR
",",O
tympanitic,B-PR
",",O
plus,O
right,B-PR
upper,I-PR
quadrant,I-PR
tenderness,I-PR
and,O
no,O
rebound,B-PR
.,O

Rectal,O
had,O
normal,O
tone,O
",",O
empty,B-PR
rectal,I-PR
vault,I-PR
",",O
and,O
guaiac,B-TE
negative,O
.,O

Extremities,O
were,O
warm,O
and,O
well,O
perfused,O
.,O

LABORATORY,O
AND,O
RADIOLOGIC,O
DATA,O
:,O

On,O
admission,O
Digoxin,B-TR
7.3,O
",",O
sodium,B-TR
142,O
",",O
potassium,B-TR
2.8,O
(,O
was,O
supplemented,O
),O
",",O
blood,B-TR
urea,I-TR
nitrogen,I-TR
15,O
",",O
creatinine,B-TR
.9,O
",",O
calcium,B-TR
9.3,O
",",O
phosphorus,B-TR
1.9,O
",",O
magnesium,B-TR
1.8,O
.,O

Liver,B-TE
function,I-TE
tests,I-TE
were,O
within,O
normal,O
limits,O
.,O

Hematocrit,B-TE
36,O
",",O
white,B-TE
blood,I-TE
cell,I-TE
count,I-TE
8.3,O
",",O
platelets,B-TE
342,O
.,O

Electrocardiogram,B-TE
shows,O
sinus,B-PR
bradycardia,I-PR
with,O
Digitalis,B-PR
effect,I-PR
.,O

Urinalysis,B-TE
is,O
pending,O
.,O

Abdominal,B-TE
series,I-TE
showed,O
non-specific,B-PR
dilatation,I-PR
of,I-PR
the,I-PR
large,I-PR
bowel,I-PR
with,O
no,O
evidence,O
of,O
ileus,B-PR
.,O

CT,B-TE
of,I-TE
the,I-TE
abdomen,I-TE
and,I-TE
pelvis,I-TE
showed,O
dilated,B-PR
colon,I-PR
with,O
a,B-PR
large,I-PR
amount,I-PR
of,I-PR
fluid,I-PR
.,O

There,O
was,O
no,O
free,B-PR
air,I-PR
and,O
no,O
bowel,B-PR
wall,I-PR
thickening,I-PR
.,O

There,O
was,O
no,O
obstruction,B-PR
.,O

Normal,O
appearing,O
small,O
bowel,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
presented,O
to,O
the,O
operating,O
room,O
late,O
at,O
night,O
on,O
12/01/02,O
and,O
was,O
admitted,O
to,O
the,O
floor,O
early,O
on,O
the,O
morning,O
on,O
12/02/02,O
.,O

She,O
was,O
placed,O
on,O
a,B-TR
bowel,I-TR
regimen,I-TR
of,O
Dulcolax,B-TR
",",O
Fleet,B-TR
enema,I-TR
",",O
and,O
Colace,B-TR
.,O

On,O
12/03/02,O
the,O
patient,O
underwent,O
a,B-TE
repeat,I-TE
KUB,I-TE
which,O
was,O
suggestive,O
of,O
volvulus,B-PR
.,O

She,O
then,O
underwent,O
a,B-TE
CT,I-TE
scan,I-TE
which,O
showed,O
no,O
evidence,O
of,O
volvulus,B-PR
.,O

Rigid,B-TE
sigmoidoscopy,I-TE
revealed,O
no,O
obvious,B-PR
mucosal,I-PR
abnormalities,I-PR
but,O
during,O
the,O
time,O
of,O
the,O
procedure,O
22cc,O
of,O
mucous,B-PR
like,I-PR
stool,I-PR
was,O
evacuated,O
with,O
a,B-PR
large,I-PR
amount,I-PR
of,I-PR
gas,I-PR
.,O

Subsequent,O
to,O
that,O
the,O
patients,O
abdomen,O
was,O
significantly,B-PR
less,I-PR
distended,I-PR
and,O
her,B-PR
pain,I-PR
decreased,O
as,O
well,O
.,O

On,O
the,O
following,O
day,O
",",O
hospital,O
day,O
number,O
3,O
",",O
the,O
patient,O
was,O
doing,O
well,O
.,O

The,O
abdomen,O
was,O
again,O
far,B-PR
less,I-PR
distended,I-PR
.,O

She,O
was,O
tolerating,O
clear,B-TR
liquids,I-TR
ad,O
lib,O
.,O

She,O
was,O
afebrile,B-PR
with,O
stable,O
vital,O
signs,O
.,O

A,B-TE
repeat,I-TE
KUB,I-TE
was,O
performed,O
which,O
showed,O
no,O
evidence,O
of,O
volvulus,B-PR
.,O

She,O
was,O
discharged,O
back,O
to,O
a,O
rehabilitation,O
facility,O
in,O
good,O
condition,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

1.,O
Digoxin,B-TR
.125,O
mg,O
qod,O
",",O
.25,O
mg,O
qod,O
.,O

2.,O
Colace,B-TR
100,O
mg,O
po,O
tid,O
.,O

3.,O
Levoxyl,B-TR
100,O
ugm,O
po,O
qd,O
.,O

4.,O
Prinivil,B-TR
20,O
mg,O
po,O
qd,O
.,O

5.,O
Zantac,B-TR
150,O
mg,O
po,O
bid,O
.,O

6.,O
Aspirin,B-TR
325,O
mg,O
qd,O
.,O

7.,O
Aricept,B-TR
5,O
mg,O
po,O
qd,O
.,O

8.,O
Glyburide,B-TR
1.25,O
mg,O
po,O
qam,O
.,O

9.,O
Oxybutynin,B-TR
5,O
mg,O
po,O
bid,O
.,O

10.,O
Coumadin,B-TR
7.5,O
mg,O
on,O
Sun,O
",",O
Tues,O
",",O
Wed,O
",",O
Fri,O
and,O
Sat,O
.,O

5,O
mg,O
on,O
Mon,O
and,O
Thurs,O
.,O

ERIN,O
KENGEKOTE,O
",",O
MD,O

DICTATING,O
FOR,O
:,O

Electronically,O
Signed,O
MAENZET,O
HEAD,O
",",O
M.D.,O

12/25/2002,O
12:48,O

_____________________________,O
MAENZET,O
HEAD,O
",",O
M.D.,O

TR,O
:,O

su,O

DD,O
:,O

12/04/2002,O

TD,O
:,O

12/04/2002,O
2:34,O
P,O
328713,O

cc,O
:,O

ERIN,O
KENGEKOTE,O
",",O
MD,O
Surg,O
Obrh,O
ALBI,O
OSHASON,O
HEAD,O
",",O
M.D.,O
SURGERY,O
NIME,O
ETHILLBRID,O
HEALTHCARE,O
MAENZET,O
HEAD,O
",",O
M.D.,O
Ston,O
Community,O
Hospital,O
5223,O
Cannola,O
Creek,O
Rd,O
Granger,O
CO,O
78438,O
STAT,O

Admission,O
Date,O
:,O

2011-12-17,O

Discharge,O
Date,O
:,O

2012-01-14,O

Date,O
of,O
Birth,O
:,O

1932-12-18,O

Sex,O
:,O

M,O

Service,O
:,O

NEUROLOGY,O

Allergies,O
:,O

Bactrim,B-TR

Attending,O
:,O
Patricia,O
Q,O
Pendergrass,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O
altered,B-PR
metnal,I-PR
status,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O
bronchoscopy,B-TE

History,O
of,O
Present,O
Illness,O
:,O

79,O
-,O
year-old,O
M,O
recently,O
diagnosed,O
by,O
biopsy,B-TE
with,O
gliomatosis,B-PR
cerebri,I-PR
(,I-PR
grade,I-PR
II,I-PR
astrocytoma,I-PR
),I-PR
in,O
8/04,O
",",O
being,O
treated,O
with,O
XRT,B-TR
",",O
timidar,B-TR
.,O

She,O
is,O
currently,O
on,O
a,B-TR
decadron,I-TR
taper,I-TR
after,O
it,O
was,O
increased,O
several,O
months,O
ago,O
secondary,O
to,O
increasing,B-PR
ocular,I-PR
symptoms,I-PR
.,O

Seen,O
by,O
PMD,O
on,O
12-14,O
w/,O
symptoms,O
of,O
cough,B-PR
productive,O
of,O
yellow,B-PR
sputum,I-PR
",",O
which,O
wife,O
also,O
had,O
",",O
prescribed,O
zpak,B-TR
w/o,O
improvement,O
.,O

Pt,O
was,O
brought,O
to,O
the,O
Victor,O
for,O
increasing,B-PR
somnolence,I-PR
over,O
past,O
several,O
days-weeks,O
.,O

Over,O
the,O
past,O
two,O
weeks,O
",",O
pt,O
has,O
declined,O
in,O
status,O
.,O

He,O
is,O
confused,B-PR
",",O
has,O
had,O
hallucinations,B-PR
.,O

Family,O
believed,O
pt,O
was,O
becoming,O
dehydrated,B-PR
.,O

Also,O
",",O
pt,O
's,O
strength,O
has,O
been,O
declining,O
over,O
the,O
past,O
2,O
weeks,O
.,O

He,O
used,O
to,O
be,O
able,O
to,O
walk,O
with,O
a,B-TR
walker,I-TR
",",O
and,O
the,O
past,O
few,O
days,O
has,O
required,O
a,B-TR
wheelchair,I-TR
.,O

+,O
incontinence,B-PR
over,O
the,O
past,O
2,O
weeks,O
.,O

+,O
non-bloody,B-PR
diarrhea,I-PR
x,O
1,O
on,O
DOA,O
.,O

In,O
the,O
Deborah,O
VS,B-TE
on,O
arrival,O
were,O
T,B-TE
:,O
97.5,O
;,O
BP,B-TE
:,O
90/65,O
;,O
HR,B-TE
:,O
82,O
;,O
RR,B-TE
:,O
16,O
;,O
94,O
on,O
RA,O
.,O

CXR,B-TE
shows,O
diffuse,B-PR
b/l,I-PR
infiltrates,I-PR
R,I-PR
>,I-PR
L,I-PR
and,O
pt,O
was,O
found,O
to,O
have,O
a,B-PR
bandemia,I-PR
.,O

LDH,B-TE
was,O
511,O
.,O

Pt,O
received,O
bactrim,B-TR
500,O
mg,O
x,O
1,O
for,O
possible,O
PCP,B-PR
.,O

Lillian,O
R.,O
/,O
hypoxic,B-PR
respiratory,I-PR
distress,I-PR
.,O

During,O
admission,O
",",O
became,O
steadily,B-PR
more,I-PR
SOB,I-PR
",",O
increasing,B-PR
lethargy,I-PR
.,O

12-20,O
satting,O
initially,O
~,O
90%,O
on,O
40%,O
face,B-TR
mask,I-TR
.,O

ABG,B-TE
7.45/33/57,O
.,O

He,O
was,O
switched,O
to,O
a,B-TR
100%,I-TR
NRB,I-TR
mask,I-TR
and,O
ABG,B-TE
was,O
7.47/31/80,O
.,O

On,O
floor,O
on,O
day,O
of,O
transfer,O
7.25/50/70,O
on,O
100%,B-TR
NRB,I-TR
.,O

During,O
evaluation,B-TE
pt,O
responsive,O
to,O
sternal,B-TE
rub,I-TE
but,O
could,O
not,O
follow,O
commands,O
.,O

Intubated,O
for,O
failure,B-PR
to,I-PR
protect,I-PR
airway,I-PR
",",O
transferred,O
to,O
ICU,O
.,O

Past,O
Medical,O
History,O
:,O

PMHx,O
:,O

1.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
s/p,O
MI,B-PR
20,O
years,O
ago,O

2.,O
Hypertension,B-PR

3.,O
Hyperlipidemia,B-PR

4.,O
DJD,B-PR
in,I-PR
the,I-PR
C-spine,I-PR

5.,O
depression,B-PR

6.,O
h/o,O
DVT,B-PR

7.,O
Shingles,B-PR
recently,O
finished,O
treatment,B-TR

Social,O
History,O
:,O

Landfill,O
worker,O
-,O
retired,O

15-20,O
pky,O
h/o,O
smoking,O
",",O
quit,O
15,O
yrs,O
ago,O

Denies,O
etoh,O
/,O
drugs,O

Family,O
History,O
:,O
non-contributory,O
.,O

Physical,B-TE
Exam,I-TE
:,O
t,B-TE
98.9,O

Intubated,O
",",O
minimally,B-PR
responsive,I-PR
",",O
localized,O
pain,O
.,O

PERRL,O
.,O

OP,O
clear,O
.,O

MMM,O
.,O

JVD,B-PR
not,O
appreciated,O
03-07,O
to,O
deep,O
inspiratory,O
breaths,O
.,O

+,O
bs,O
.,O

Distended,B-PR
.,O

Soft,O
.,O

NT,B-PR
>,O

No,O
le,B-PR
edema,I-PR
.,O

Pertinent,O
Results,O
:,O

2011-12-23,O
07:54,O
PM,O
BLOOD,B-TE
WBC,B-TE
-,O
9.7,O
RBC,B-TE
-,O
3.02,O
*,O
Hgb,B-TE
-,O
10.0,O
*,O
Hct,B-TE
-,O
29.0,O
*,O
MCV,B-TE
-,O
96,O
MCH,B-TE
-,O
33.1,O
*,O
MCHC,B-TE
-,O
34.4,O
RDW,B-TE
-,O
17.7,O
*,O
Plt,B-TE
Ct,I-TE
-,O
307,O

2011-12-23,O
07:54,O
PM,O
BLOOD,B-TE
Neuts,B-TE
-,O
88,O
*,O
Bands,B-TE
-,O
0,O
Lymphs,B-TE
-,O
7,O
*,O
Monos,B-TE
-,O
3,O
Eos,B-TE
-,O
0,O
Baso,B-TE
-,O
0,O
Atyps,B-TE
-,O
0,O
Metas,B-TE
-,O
1,O
*,O
Myelos,B-TE
-,O
1,O
*,O

2011-12-23,O
07:54,O
PM,O
BLOOD,B-TE
PT,B-TE
-,O
16.0,O
*,O
PTT,B-TE
-,O
35.7,O
*,O
INR,B-TE
(,I-TE
PT,I-TE
)-,I-TE
1.6,O

Chem,B-TE
7,I-TE
:,O

2011-12-23,O
07:54,O
PM,O
BLOOD,B-TE
Glucose,B-TE
-,O
108,O
*,O
UreaN,B-TE
-,O
27,O
*,O
Creat,B-TE
-,O
1.9,O
*,O
Na,B-TE
-,O
132,O
*,O
K,B-TE
-,O
4.6,O
Cl,B-TE
-,O
102,O
HCO3,B-TE
-,O
20,O
*,O
AnGap,B-TE
-,O
15,O

2011-12-18,O
06:15,O
AM,O
BLOOD,B-TE
ALT,B-TE
-,O
29,O
AST,B-TE
-,O
25,O
LD,B-TE
(,I-TE
LDH,I-TE
)-,I-TE
400,O
*,O
AlkPhos,B-TE
-,O
52,O
TotBili,B-TE
-,O
0.3,O

2011-12-23,O
11:16,O
PM,O
BLOOD,B-TE
Type,B-TE
-,O
ART,O
pO2,B-TE
-,O
202,O
*,O
pCO2,B-TE
-,O
40,O
pH,B-TE
-,O
7.29,O
*,O
calHCO3,B-TE
-,O
20,O
*,O
Base,B-TE
XS,I-TE
--,O
6,O

2011-12-20,O
07:53,O
AM,O
BLOOD,B-TE
Lactate,B-TE
-,O
1.1,O

Brief,O
Hospital,O
Course,O
:,O

Impression,O
:,O

71,O
yo,O
m,O
w/,O
astrocytoma,B-PR
on,O
xrt,B-TR
and,O
chemotx,B-TR
",",O
who,O
p/w,O
1,O
wk,O
h/o,O
productive,B-PR
cough,I-PR
",",O
sick,O
contact,O
",",O
hypoxic,B-PR
",",O
now,O
intubated,O
",",O
w/,O
increasing,B-PR
infiltrates,I-PR
b/l,I-PR
.,O

1),O
Resp,B-PR
failure,I-PR
-,O
pt,O
admitted,O
w/,O
primarily,B-PR
hypoxic,I-PR
respiratory,I-PR
failure,I-PR
.,O

Following,O
admission,O
to,O
the,O
floor,O
the,O
pt,O
developed,O
increasing,B-PR
hypoxia,I-PR
and,O
somnolence,B-PR
",",O
requiring,O
intubation,B-TR
on,O
HD,O
5,O
.,O

Pulm,O
had,O
previously,O
been,O
consulted,O
and,O
felt,O
that,O
presentation,O
was,O
c/w,O
PCP,B-PR
",",O
Joann,O
started,O
on,O
Bactrim,B-TR
.,O

Previously,O
treated,O
for,O
CAP,B-PR
as,O
outpt,O
but,O
hypoxia,B-PR
continued,O
to,O
progress,O
.,O

Similar,O
lack,O
of,O
improvement,O
w/,O
additional,B-TR
broad,I-TR
spectrum,I-TR
coverage,I-TR
following,O
admission,O
.,O

Pt,O
underwent,O
bronchoscopy,B-TE
on,O
11-22,O
following,O
transfer,O
to,O
the,O
ICU,O
for,O
hypoxic,B-PR
respiratory,I-PR
failure,I-PR
and,O
intubation,B-TR
(,O
7.25/52/70,O
on,O
100%,B-TR
NRB,I-TR
),O
.,O

On,O
admission,O
to,O
the,O
ICU,O
the,B-TR
pt,I-TR
',I-TR
steroid,I-TR
dose,I-TR
was,O
increased,O
to,O
8,O
mg,O
bid,O
03-07,O
to,O
a,B-TE
dead,I-TE
space,I-TE
measurement,I-TE
of,O
50%,O
.,O

Pt,O
did,O
well,O
in,O
the,O
ICU,O
",",O
w/,O
his,O
respiratory,O
status,O
steadily,O
improving,O
and,O
was,O
extubated,O
on,O

01-03,O
.,O

He,O
was,O
subsequently,O
tranferred,O
to,O
the,O
floor,O
",",O
where,O
he,O
continued,O
to,O
have,O
a,B-PR
stable,I-PR
oxygen,I-PR
requirement,I-PR
.,O

Repeat,B-TE
CXR,I-TE
was,O
unchanged,O
from,O
previously,O
in,O
the,O
ICU,O
(,O
official,O
read,O
noted,O
mild,B-PR
CHF,I-PR
",",O
but,O
pt,O
was,O
continuing,O
to,O
autodiurese,O
and,O
has,O
remained,O
net,O
negative,O
everyday,O
while,O
on,O
the,O
floor,O
.,O

On,O
discharge,O
the,O
patient,O
has,O
stable,B-PR
O2,I-PR
req,I-PR
",",O
90%,O
on,O
RA,O
.,O

2),O
astrocytoma,B-PR
-,I-PR
grade,I-PR
II,I-PR
",",O
as,O
per,O
d/w,O
PMD,O
",",O
Dr.,O
Holscher,O
",",O
pt,O
has,O
poor,O
prognosis,O
",",O
but,O
reasonable,O
for,O
ongoing,B-TR
treatment,I-TR
.,O

Pt,O
has,O
had,O
two,O
recent,O
neg,O
head,O
CT,O
s,O
",",O
so,O
unlikely,O
the,O
etiology,O
of,O
the,B-PR
patient,I-PR
's,I-PR
MS,I-PR
change,I-PR
.,O

Pt,O
was,O
continued,O
on,O
keppra,B-TR
during,O
admission,O
for,O
sz,B-PR
px,I-PR
.,O

Initially,O
he,O
had,O
been,O
on,O
lamotrigine,B-TR
but,O
the,O
was,O
stopped,O
in,O
10/12,O
when,O
the,O
pt,O
was,O
noted,O
to,O
be,O
developing,O
a,B-PR
new,I-PR
rash,I-PR
.,O

Decadron,B-TR
has,O
been,O
steadily,O
tapered,O
since,O
arrival,O
on,O
the,O
floor,O
.,O

Now,O
continued,O
on,O
1,O
mg,O
BID,O
",",O
to,O
complete,O
a,O
7,O
day,O
course,O
",",O
which,O
will,O
be,O
tapered,O
to,O
1,O
mg,O
qday,O
on,O
01-15,O
",",O
and,O
subsequently,O
to,O
0.5,O
mg,O
qday,O
x,O
7,O
days,O
then,O
to,O
be,O
discontinued,O
.,O

The,B-TR
patient,I-TR
's,I-TR
keppra,I-TR
should,O
be,O
continued,O
for,O
sz,B-TR
prophylaxis,I-TR
.,O

3),O
MS,B-PR
change,I-PR
-,O
on,O
admission,O
pt,O
was,O
agitated,B-PR
",",O
requiring,O
restraints,B-TR
and,O
antipsychotics,B-TR
",",O
however,O
as,O
he,O
became,O
increasingly,B-PR
hypoxic,I-PR
he,O
became,O
somnolent,B-PR
.,O

In,O
the,O
ICU,O
the,O
pt,O
remained,O
stuporous,B-PR
",",O
responsive,O
to,O
painful,B-TE
stimuli,I-TE
.,O

On,O
the,O
floor,O
the,O
patient,O
intially,O
was,O
imporved,O
",",O
but,O
has,O
plateaued,O
",",O
responding,O
to,O
simple,O
commands,O
and,O
verbalizing,O
groans,O
but,O
no,B-PR
real,I-PR
speech,I-PR
.,O

Improvement,O
has,O
correlated,O
w/,O
tapering,O
of,O
steroids,B-TR
",",O
one,O
of,O
the,O
causes,O
in,O
the,B-TE
differential,I-TE
.,O

Pt,O
had,O
multiple,B-TE
head,I-TE
CT,I-TE
s,I-TE
which,O
ruled,O
out,O
progression,O
of,O
astrocytoma,B-PR
.,O

MRI,B-TE
has,O
been,O
deferred,O
given,O
that,O
the,O
pt,O
currently,O
would,O
not,O
tolerate,O
the,B-TE
procedure,I-TE
.,O

EEG,B-TE
was,O
w/o,O
evidence,O
of,O
epileptiform,B-PR
activity,I-PR
and,O
c/w,O
toxic,B-PR
encephalopathy,I-PR
.,O

Plan,O
to,O
continue,O
to,O
follow,O
MS,B-PR
",",O
expect,O
improvement,O
as,O
steroids,B-TR
are,O
continued,O
to,O
be,O
tapered,O
.,O

4),O
h/o,O
DVT,B-PR
-,O
cont,O
heparin,B-TR
",",O
previously,O
on,O
enoxaparin,B-TR
x10,O
days,O
at,O
treatment,O
dose,O
",",O
followed,O
by,O
prophylactic,B-TR
dose,I-TR
.,O

On,O
admission,O
",",O
the,O
pt,O
was,O
started,O
on,O
treatment,O
doses,O
of,O
enoxaparin,B-TR
.,O

Upon,O
transfer,O
to,O
the,O
Intensive,O
Care,O
Unit,O
the,O
pt,O
was,O
started,O
on,O
heparin,B-TR
gtt,I-TR
.,O

Course,O
was,O
c/b,O
one,O
episode,O
of,O
gross,B-PR
hematochezia,I-PR
on,O
12-28,O
",",O
w/,O
concomitant,B-PR
hct,I-PR
drop,I-PR
of,O
~,O
3,O
pts,O
.,O

B/L,B-TE
lower,I-TE
ext,I-TE
duplex,I-TE
us,I-TE
and,O
a,B-TE
cta,I-TE
were,O
performed,O
",",O
both,O
of,O
which,O
were,O
negative,O
.,O

Given,O
that,O
the,O
pt,O
was,O
w/o,O
evidence,O
of,O
DVT,B-PR
it,O
was,O
felt,O
that,O
the,O
risks,O
of,O
anticoagulation,B-TR
in,O
the,O
setting,O
of,O
gross,B-PR
GIB,I-PR
",",O
outweigh,O
the,O
risks,O
of,O
undetected,B-PR
deep,I-PR
vv,I-PR
thrombosis/pe,I-PR
.,O

Pt,O
was,O
continued,O
on,O
prophylactic,B-TR
heparin,I-TR
.,O

4),O
hypersensitivity,B-PR
reaction,I-PR
-,O
on,O
11-24,O
pt,O
was,O
noted,O
to,O
have,O
developing,O
rash,B-PR
of,I-PR
abdomen,I-PR
and,I-PR
anterior,I-PR
thighs,I-PR
.,O

Derm,O
initially,O
reviewed,O
and,O
thought,O
that,O
it,O
was,O
not,O
c/w,O
hypersensitivity,B-PR
rxn,I-PR
.,O

Over,O
the,O
next,O
the,B-PR
rash,I-PR
progressed,O
",",O
and,O
the,O
patient,O
subsequently,O
began,O
spiking,O
fevers,B-PR
to,O
approx,O
103,O
F,O
",",O
c/b,O
hypotension,B-PR
requiring,O
aggressive,B-TR
fluid,I-TR
repletion,I-TR
and,O
pressors,B-TR
",",O
and,O
tachycardia,B-PR
to,O
the,O

130s,O
.,O

The,O
patient,O
also,O
developed,O
elevated,B-PR
transaminases,I-PR
and,I-PR
pancreatic,I-PR
enzymes,I-PR
during,O
this,O
time,O
.,O

On,O
the,O
second,O
day,O
that,O
the,B-PR
rash,I-PR
had,O
been,O
noted,O
",",O
Derm,O
was,O
asked,O
to,O
see,O
again,O
",",O
felt,O
c/w,O
hypersensitivity,B-PR
",",O
bactrim,B-TR
was,O
switched,O
to,O
pentamidine,B-TR
",",O
and,O
lamictal,B-TR
was,O
held,O
.,O

Pt,O
continued,O
to,O
have,O
elev,B-PR
pancreatic,I-PR
enzymes,I-PR
and,O
pentamidine,B-TR
was,O
switched,O
to,O
clinda/primaquine,B-TR
.,O

Following,O
discontinuation,O
of,O
the,B-TR
bactrim,I-TR
the,O
patient,O
defervesced,O
",",O
and,O
remained,O
normotensive,O
.,O

He,O
received,O
one,O
dose,O
of,O
furosemide,B-TR
in,O
the,O
ICU,O
and,O
was,O
transferred,O
to,O
the,O
floor,O
the,O
next,O
day,O
.,O

On,O
arrival,O
to,O
the,O
floor,O
the,O
patient,O
was,O
noted,O
to,O
have,O
a,B-PR
lacy,I-PR
reticular,I-PR
rash,I-PR
of,I-PR
upper,I-PR
arms,I-PR
",",O
which,O
resolved,O
over,O
the,O
next,O
48h,O
.,O

Felt,O
likely,O
03-07,O
the,B-TR
sulfa,I-TR
moiety,O
of,O
the,B-TR
furosemide,I-TR
.,O

Plan,O
for,O
pt,O
to,O
complete,O
total,O
of,O
28,O
day,O
course,O
of,O
therapy,B-TR
for,O
PCP,B-PR
",",O
James,O
will,O
be,O
completed,O
on,O
01-16,O
.,O

5),O
Anemia,B-PR
-,O
previous,B-TE
w/u,I-TE
c/w,O
ACD,B-PR
(,O
elev,B-PR
ferritin,I-PR
",",O
low,B-PR
transferrin,I-PR
saturation,I-PR
),O
.,O

6),O
ARF,B-PR
-,O
Cr,B-TE
mildly,B-PR
elevated,I-PR
on,O
tx,O
to,O
ICU,O
",",O
u,B-TE
lytes,I-TE
c/w,O
prerenal,B-PR
azotemia,I-PR
",",O
which,O
resolved,O
w/,O
IVF,B-TR
.,O

7),O
hyponatremia,B-PR
-,O
also,O
hyponatremic,B-PR
on,O
transfer,O
",",O
resolved,O
w/,O
ivf,B-TR
.,O

8),O
CAD,B-PR
-,O
w/,O
abnl,B-PR
EF,I-PR
",",O
however,O
pt,O
tolerated,O
aggressive,B-TR
fluid,I-TR
resusciation,I-TR
w/o,O
significant,B-PR
hypoxia,I-PR
.,O

Continued,O
on,O
valsartan,B-TR
",",O
BB,B-TR
continued,O
",",O
statin,B-TR

9),O
Nutrition,O
-,O
pt,O
was,O
maintained,O
on,O
TFs,B-TR
via,O
post-pyloric,B-TR

10),O
Px,O
:,O
Heparin,B-TR
(,O
full,O
dose,O
),O
",",O
IV,B-TR
PPI,I-TR

11),O
Comm,O
:,O
Family,O
very,O
involved,O
at,O
bedside,O
",",O
evaluating,O
rehab,B-TR
today,O

17),O
DNR,O
",",O
but,O
may,O
intubate,O
for,O
reversible,O
causes,O

18),O
Restraint,B-TR

Medications,O
on,O
Admission,O
:,O

Meds,O
on,O
Transfer,O
:,O

Acyclovir,B-TR

Bactrim,B-TR

Zoloft,B-TR

Valsartan,B-TR

Metoprolol,B-TR

Keppra,B-TR

Lovenox,B-TR

Levofloxacin,B-TR

Ambisone,B-TR

Atrovent,B-TR
nebs,I-TR

Albuterol,B-TR
nebs,I-TR

Lasix,B-TR
10,O
mg,O
qd,O

Lipitor,B-TR

Haldol,B-TR
prn,O

Discharge,O
Medications,O
:,O

1.,O
Miconazole,B-TR
Nitrate,I-TR
2,O
%,O
Powder,O
Sig,O
:,O
One,O
(,O
1,O
),O
Appl,O
Topical,O
QID,O
(,O
4,O
times,O
a,O
day,O
),O
.,O

2.,O
Sertraline,B-TR
HCl,I-TR
50,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

3.,O
Albuterol,B-TR
Sulfate,I-TR
0.083,O
%,O
Solution,O
Sig,O
:,O
One,O
(,O
1,O
),O
Inhalation,O
Q4H,O
(,O
every,O
4,O
hours,O
),O
.,O

4.,O
Ipratropium,B-TR
Bromide,I-TR
0.02,O
%,O
Solution,O
Sig,O
:,O
One,O
(,O
1,O
),O
Inhalation,O
Q4H,O
(,O
every,O
4,O
hours,O
),O
.,O

5.,O
Senna,B-TR
8.6,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
as,O
needed,O
.,O

6.,O
Bisacodyl,B-TR
10,O
mg,O
Suppository,O
Sig,O
:,O
One,O
(,O
1,O
),O
Suppository,O
Rectal,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
as,O
needed,O
for,O
constipation,B-PR
.,O

7.,O
Levetiracetam,B-TR
500,O
mg,O
Tablet,O
Sig,O
:,O
Three,O
(,O
3,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

8.,O
Nystatin,B-TR
"100,000",O
unit,O
/,O
mL,O
Suspension,O
Sig,O
:,O
Five,O
(,O
5,O
),O
ML,O
PO,O
QID,O
(,O
4,O
times,O
a,O
day,O
),O
.,O

9.,O
Heparin,B-TR
Sodium,I-TR
(,I-TR
Porcine,I-TR
),I-TR
"5,000",O
unit,O
/,O
mL,O
Solution,O
Sig,O
:,O
One,O
(,O
1,O
),O
Injection,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
.,O

10.,O
Acetaminophen,B-TR
325,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
.,O

11.,O
Primaquine,B-TR
Phosphate,I-TR
26.3,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
for,O
3,O
days,O
.,O

12.,O
Metoprolol,B-TR
Tartrate,I-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

13.,O
Dexamethasone,B-TR
0.5,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
Q12H,O
(,O
every,O
12,O
hours,O
),O
:,O
Take,O
2,O
tablet,O
po,O
bid,O
for,O
four,O
days,O
",",O
then,O
2,O
tablet,O
po,O
qday,O
for,O
7,O
days,O
",",O
then,O
take,O
one,O
tablet,O
qday,O
for,O
7,O
days,O
.,O

Then,O
stop,O
taking,O
the,B-TR
medication,I-TR
.,O

14.,O
Acyclovir,B-TR
Sodium,I-TR
500,O
mg,O
Recon,O
Soln,O
Sig,O
:,O
200mg,O
Recon,O
Solns,O
Intravenous,O
Q12H,O
(,O
every,O
12,O
hours,O
),O
.,O

15.,O
Pantoprazole,B-TR
Sodium,I-TR
40,O
mg,O
Recon,O
Soln,O
Sig,O
:,O
One,O
(,O
1,O
),O
Recon,O
Soln,O
Intravenous,O
Q12H,O
(,O
every,O
12,O
hours,O
),O
.,O

16.,O
Clindamycin,B-TR
Phosphate,I-TR
in,O
D5W,B-TR
600,O
mg,O
/,O
50,O
mL,O
Piggyback,O
Sig,O
:,O
600,O
mg,O
Intravenous,O
Q8H,O
(,O
every,O
8,O
hours,O
),O
for,O
3,O
days,O
.,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Facility,O
:,O

Danvers,O
State,O
Hospital,O
&,O
Rehab,O
Center,O
-,O
Sterling,O
Medical,O
Center,O

Discharge,O
Diagnosis,O
:,O

1),O
PCP,B-PR
pna,I-PR

2),O
Astrocytoma,B-PR

3),O
Hypersensitivity,B-PR
to,O
Bactrim,B-TR

4),O
Hematochezia,B-PR

5),O
h/o,O
DVT,B-PR

Discharge,O
Condition,O
:,O

Good,O
",",O
still,O
w/,O
altered,B-PR
mental,I-PR
status,I-PR
but,O
improving,O
.,O

Discharge,O
Instructions,O
:,O

1),O
Take,O
your,O
medications,B-TR

2),O
Attend,O
follow,O
up,O
appointments,O

Followup,O
Instructions,O
:,O

Provider,O
:,O

Irene,O
FIELD,O
SCREENING,O
Where,O
:,O
Pembroke,O
Hospital,O

Winchester,O
Hospital,O
Phone,O
:(,O
217,O
),O
275,O
6206,O
Date,O
/,O
Time,O
:,O
2012-02-13,O
1:30,O

Provider,O
:,O
Annie,O
A.,O
Payne,O
",",O
M.D.,O
Where,O
:,O
Pembroke,O
Hospital,O

Winchester,O
Hospital,O
Phone,O
:(,O
217,O
),O
275,O
6206,O
Date,O
/,O
Time,O
:,O
2012-02-13,O
2:30,O

Alfonso,O
Daniel,O
MD,O
13-431,O

Completed,O
by,O
:,O
Bernadette,O
Sanders,O
MD,O
04-142,O
2012-01-14,O
@,O
0914,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Earnestine,O
Marsden,O
on,O
:,O
WED,O
2012-03-21,O
1:21,O
PM,O

(,O
End,O
of,O
Report,O
),O

169333047,O

FIH,O

4852999,O

72670/2ol1,O

131444,O

9/7/1993,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

09-07-93,O

DISCHARGE,O
DATE,O
:,O

09-08-93,O
PATIENT,O
DIED,O
ON,O
9/8/93,O
.,O

ADMISSION,O
DIAGNOSIS,O
:,O

Renal,B-PR
tubular,I-PR
acidosis,I-PR
distal,I-PR
type,I-PR
I,I-PR
;,O
shock,B-PR
;,O
seizure,B-PR
disorder,I-PR
;,O
severe,B-PR
acidosis,I-PR
and,O
severe,B-PR
electrolyte,I-PR
imbalance,I-PR
;,O
rule,O
out,O
sepsis,B-PR
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

Renal,B-PR
tubular,I-PR
acidosis,I-PR
distal,I-PR
type,I-PR
I,I-PR
;,O
shock,B-PR
;,O
severe,B-PR
acidosis,I-PR
and,O
severe,B-PR
electrolyte,I-PR
imbalance,I-PR
;,O
seizure,B-PR
disorder,I-PR
;,O
rule,O
out,O
sepsis,B-PR
",",O
varicella,B-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Date,O
of,O
birth,O
:,O

10/4/88,O
.,O

This,O
patient,O
is,O
a,O
5,O
year,O
old,O
white,O
female,O
with,O
a,O
history,O
of,O
type,B-PR
I,I-PR
renal,I-PR
tubular,I-PR
acidosis,I-PR
on,O
nephrocalcinosis,B-PR
who,O
was,O
admitted,O
to,O
Noughwell,O
Entanbon,O
Health,O
of,O
Washington,O
on,O
9/5/93,O
at,O
21:16,O
hours,O
with,O
a,O
2-3,O
day,O
history,O
of,O
chills,B-PR
",",O
fevers,B-PR
",",O
cough,B-PR
",",O
vomiting,B-PR
and,O
weakness,B-PR
(,O
unable,O
to,O
walk,O
),O
.,O

At,O
Noughwell,O
Entanbon,O
Health,O
",",O
her,B-TE
temperature,I-TE
was,O
101,O
",",O
pulse,B-TE
135,O
",",O
blood,B-TE
pressure,I-TE
94/74,O
",",O
respiratory,B-TE
rate,I-TE
20,O
.,O

Positive,O
findings,O
of,O
physical,B-TE
examination,I-TE
include,O
chicken,B-PR
pox,I-PR
lesions,I-PR
on,I-PR
thorax,I-PR
",",O
sunken,B-PR
eyes,I-PR
",",O
thick,B-PR
nasal,I-PR
discharge,I-PR
",",O
dry,B-PR
lips,I-PR
",",I-PR
tongue,I-PR
and,I-PR
mucous,I-PR
membranes,I-PR
",",O
red,B-PR
tonsils,I-PR
.,O

The,O
remainder,O
of,O
the,B-TE
physical,I-TE
examination,I-TE
was,O
considered,O
within,O
normal,O
limits,O
.,O

Admission,O
diagnosis,O
at,O
Ni,O
Hospital,O
&apos;s,O
:,O

vomiting,B-PR
and,O
dehydration,B-PR
",",O
hypokalemia,B-PR
",",O
hyponatremia,B-PR
",",O
tonsillitis,B-PR
.,O

A,B-TR
peripheral,I-TR
intravenous,I-TR
line,I-TR
was,O
started,O
on,O
Labor,O
Day,O
in,O
the,O
a.m.,O
No,O
respiratory,B-PR
distress,I-PR
was,O
noted,O
.,O

Oral,B-PR
cyanosis,I-PR
and,O
shallow,B-PR
respirations,I-PR
were,O
noted,O
on,O
9/7/93,O
at,O
2:45,O
a.m.,O

Therefore,O
the,O
patient,O
was,O
intubated,O
at,O
3:45,O
a.m.,O
on,O
9/7/93,O
.,O

Chest,B-TE
x-ray,I-TE
was,O
unremarkable,O
.,O

Cardiovascular,O
stable,O
",",O
significant,B-PR
hypertension,I-PR
was,O
noted,O
on,O
9/7/93,O
at,O
5:10,O
a.m.,O
and,O
therefore,O
10,B-TR
cc&apos;s,I-TR
per,I-TR
kilo,I-TR
albumin,I-TR
was,O
given,O
.,O

The,O
patient,O
was,O
admitted,O
was,O
started,O
on,O
clear,B-TR
fluids,I-TR
",",O
tolerated,O
",",O
with,O
D5,B-TR
normal,I-TR
saline,I-TR
plus,O
40,O
mEq,O
per,O
liter,O
of,O
KCL,B-TR
at,O
a,O
rate,O
of,O
50,O
cc,O
&apos;s,O
per,O
hour,O
for,O
9,O
hours,O
.,O
(,O
100,O
cc&apos;s,O
per,O
kilo,O
),O
.,O

Sodium,B-TE
and,O
potassium,B-TE
at,O
this,O
time,O
were,O
128/1.5,O
.,O

At,O
Labor,O
Day,O
",",O
9:30,O
a.m.,O
",",O
the,B-TR
fluids,I-TR
were,O
increased,O
to,O
100,O
cc&apos;s,O
per,O
hour,O
(,O
200,O
cc&apos;s,O
per,O
kilo,O
for,O
5,O
hours,O
),O
.,O

Electrolytes,B-TE
at,O
this,O
point,O
were,O
sodium,B-TE
132,O
",",O
potassium,B-TE
1.8,O
.,O

At,O
9/6/93,O
",",O
2:30,O
p.m.,O
",",O
fluids,B-TR
were,O
decreased,O
to,O
75,O
cc&apos;s,O
per,O
hour,O
",",O
150,O
cc&apos;s,O
per,O
kilo,O
",",O
40,O
mEq,O
of,O
K,B-TR
phosphate,I-TR
added,O
to,O
the,B-TR
intravenous,I-TR
fluids,I-TR
.,O

Electrolytes,B-TE
at,O
this,O
point,O
were,O
a,B-TE
sodium,I-TE
of,O
143,O
and,O
potassium,B-TE
1.7,O
.,O

On,O
9/6/93,O
",",O
22:00,O
",",O
fluids,B-TR
were,O
changed,O
to,O
D5,B-TR
normal,I-TR
saline,I-TR
plus,O
40,O
KCL,B-TR
and,O
40,O
K,B-TR
phosphate,I-TR
at,O
75,O
cc,O
&apos;s,O
per,O
hour,O
.,O

This,O
rate,O
was,O
maintained,O
for,O
11,O
hours,O
.,O

Electrolytes,B-TE
at,O
this,O
time,O
were,O
a,B-TE
sodium,I-TE
of,O
148,O
",",O
potassium,B-TE
1.7,O
.,O

At,O
9/7/93,O
",",O
1:00,O
a.m.,O
",",O
intravenous,B-TR
fluids,I-TR
rate,O
was,O
decreased,O
to,O
50,O
cc&apos;s,O
per,O
hour,O
",",O
total,B-TR
fluids,I-TR
given,O
during,O
the,O
first,O
24,O
hours,O
were,O
140,O
to,O
150,O
cc&apos;s,O
per,O
kilo,O
per,O
day,O
.,O

At,O
this,O
time,O
",",O
sodium,B-TE
was,O
147,O
",",O
potassium,B-TE
2.6,O
",",O
total,B-TR
sodium,I-TR
given,O
during,O
the,O
first,O
24,O
hours,O
20,O
mEq,O
per,O
kilo,O
per,O
day,O
.,O

On,O
9/7/93,O
at,O
4:00,O
a.m.,O
",",O
albumin,B-TR
bolus,I-TR
5%,O
10,O
cc&apos;s,O
per,O
kilo,O
was,O
given,O
",",O
a,O
total,O
of,O
120,O
cc&apos;s,O
",",O
electrolytes,B-TE
were,O
sodium,B-TE
155,O
",",O
potassium,B-TE
3.1,O
.,O

At,O
9/7/93,O
at,O
5:00,O
a.m.,O
",",O
sodium,B-TR
bicarbonate,I-TR
given,O
60,O
mEq,O
",",O
calcium,B-TR
bolus,I-TR
10,O
cc&apos;s,O
given,O
.,O

On,O
9/7,O
",",O
5:30,O
a.m.,O
",",O
D5,B-TR
quarter,I-TR
normal,I-TR
saline,I-TR
",",O
and,O
40,O
of,O
K,B-TR
phosphate,I-TR
at,O
100,O
cc&apos;s,O
per,O
hour,O
was,O
given,O
.,O

The,O
patient,O
was,O
taking,O
PO,O
initially,O
until,O
9/6/93,O
at,O
17:45,O
.,O

There,O
were,O
no,O
abnormal,B-PR
findings,I-PR
in,O
abdominal,B-TE
exam,I-TE
.,O

On,O
9/5/93,O
",",O
hematocrit,B-TE
48,O
",",O
white,B-TE
blood,I-TE
count,I-TE
11.2,O
",",O
neutrophiles,B-TE
67,O
",",O
bands,B-TE
14,O
",",O
lymphs,B-TE
11,O
",",O
monos,B-TE
6%,O
",",O
meta,B-TE
2%,O
",",O
platelets,B-TE
"220,000",O
.,O

Copious,B-PR
urine,I-PR
output,I-PR
",",O
BUN,B-TE
1.0,O
",",O
creatinine,B-TE
.8,O
.,O

Normal,O
neurologic,O
exam,O
on,O
admission,O
",",O
then,O
lethargic,B-PR
on,O
9/6/93,O
at,O
17:45,O
",",O
then,O
patient,O
became,O
unresponsive,B-PR
",",O
areflexic,B-PR
and,O
limp,B-PR
at,O
9/6/93,O
",",O
at,O
17:45,O
to,O
22:00,O
.,O

Patient,O
was,O
having,O
seizures,B-PR
",",O
twitching,B-PR
of,I-PR
face,I-PR
and,O
rapid,B-PR
movements,I-PR
of,I-PR
eyes,I-PR
.,O

Pupils,B-PR
dilated,I-PR
and,I-PR
sluggish,I-PR
.,O

Valium,B-TR
was,O
given,O
at,O
9/7/93,O
",",O
00:02,O
.,O

IV,B-TR
ampicillin,I-TR
",",O
chloramphenicol,B-TR
",",O
ceftriaxone,B-TR
",",O
and,O
culture,B-TE
were,O
sent,O
.,O

Finally,O
",",O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
transport,O
team,O
was,O
called,O
and,O
transport,O
team,O
arrived,O
on,O
9/7/93,O
",",O
6:30,O
a.m.,O
",",O
and,O
on,O
arrival,O
patient,O
was,O
seizing,O
with,O
rhythmic,B-PR
eye,I-PR
movement,I-PR
to,I-PR
left,I-PR
.,O

The,O
patient,O
was,O
unresponsive,B-PR
",",O
poor,B-PR
perfusion,I-PR
.,O

Temperature,B-TE
was,O
101.8,O
.,O

A,B-TR
second,I-TR
intravenous,I-TR
was,O
started,O
and,O
given,O
normal,B-TR
saline,I-TR
bolus,I-TR
",",O
change,O
in,O
intravenous,B-TR
fluids,I-TR
to,O
D5,B-TR
water,I-TR
with,O
80,O
mEq,O
of,O
bicarbonate,B-TR
",",O
plus,O
40,O
mEq,O
of,O
KCL,B-TR
at,O
45,O
cc&apos;s,O
per,O
hour,O
",",O
bicarbonate,B-TR
given,O
2,O
mEq,O
per,O
kilo,O
",",O
attempted,O
to,O
start,O
dopa,B-TR
for,O
poor,B-PR
perfusion,I-PR
but,O
worsening,B-PR
perfusion,I-PR
.,O

Therefore,O
",",O
dopa,B-TR
was,O
stopped,O
.,O

Total,O
volume,O
given,O
as,O
bolus,B-TR
50,O
cc&apos;s,O
per,O
kilo,O
",",O
sodium,B-TR
bicarbonate,I-TR
at,O
2,O
mEq,O
per,O
kilo,O
was,O
given,O
.,O

Last,O
ABG,B-TE
there,O
was,O
6.98,O
",",O
31,O
",",O
171,O
",",O
bicarbonate,B-TE
of,O
7,O
.,O

Phenobarbital,B-TR
and,O
Dilantin,B-TR
given,O
for,O
seizure,B-TR
control,I-TR
.,O

Electrolytes,B-TE
before,O
departure,O
for,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
was,O
a,B-TE
sodium,I-TE
of,O
176,O
",",O
potassium,B-TE
2.5,O
",",O
chloride,B-TE
140,O
",",O
bicarbonate,B-TE
14,O
",",O
calcium,B-TE
7.2,O
",",O
magnesium,B-TE
2.7,O
.,O

Admission,O
to,O
the,O
Pediatric,O
Intensive,O
Care,O
Unit,O
at,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
was,O
9/7/93,O
",",O
11:15,O
a.m.,O

Lines,B-TR
placed,O
were,O
a,B-TR
right,I-TR
femoral,I-TR
triple,I-TR
lumen,I-TR
",",O
endotracheal,B-TR
tube,I-TR
4.0,O
",",O
arterial,B-TR
line,I-TR
",",O
right,B-TR
radial,I-TR
line,I-TR
",",O
Foley,B-TR
placed,O
",",O
peripheral,B-TR
intravenous,I-TR
line,I-TR
",",O
nasogastric,B-TR
tube,I-TR
.,O

On,O
admission,O
to,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
",",O
temperature,B-TE
100.2,O
",",O
pulse,B-TE
149,O
",",O
respiratory,B-TE
rate,I-TE
50,O
",",O
blood,B-TE
pressure,I-TE
98/66,O
",",O
mean,B-TE
arterial,I-TE
pressure,I-TE
of,O
73,O
",",O
weight,B-TE
12,O
kilos,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

RTA,B-PR
diagnosed,O
at,O
14,O
months,O
of,O
age,O
",",O
she,O
had,O
a,O
history,O
of,O
scarlet,B-PR
fever,I-PR
at,O
14,O
months,O
of,O
age,O
.,O

She,O
also,O
had,O
a,O
recent,O
exposure,O
to,O
varicella,B-PR
.,O

Her,O
brother,O
had,O
developed,O
the,B-PR
typical,I-PR
rash,I-PR
on,O
9/3/93,O
.,O

ALLERGIES,O
:,O

None,O
known,O
.,O

SOCIAL,O
HISTORY,O
:,O

Mom,O
on,O
Medicaid,O
",",O
recovered,O
alcoholic,O
.,O

11,O
year,O
old,O
"brother,6",O
year,O
old,O
sister,O
",",O
healthy,O
.,O

Mom,O
separated,O
.,O

HOSPITAL,O
COURSE,O
:,O

On,O
admission,O
",",O
FI02,B-TR
was,O
50-60%,O
",",O
PID,B-TR
30-32/PEEP,B-TR
of,O
5.7,O
",",O
total,B-TE
volume,I-TE
was,O
between,O
140,O
to,O
210,O
during,O
Intensive,O
Care,O
Unit,O
stay,O
.,O

Chest,B-TE
x-ray,I-TE
showed,O
right,B-PR
upper,I-PR
lobe,I-PR
pneumonia,I-PR
.,O

Cardiovascular,O
:,O

CVP,B-TE
on,O
admission,O
was,O
1,O
cm,O
of,O
water,O
.,O

Then,O
during,O
the,O
Intensive,O
Care,O
Unit,O
stay,O
",",O
the,O
CVP,B-TE
remained,O
between,O
7,O
to,O
8,O
after,O
volume,B-TR
resuscitation,I-TR
.,O

Dopamine,B-TR
and,O
epinephrine,B-TR
given,O
for,O
cardiovascular,B-TR
support,I-TR
.,O

Her,B-TE
electrocardiogram,I-TE
findings,O
were,O
compatible,O
with,O
hypokalemia,B-PR
(,O
flattening,B-PR
T,I-PR
waves,I-PR
and,O
ST,B-PR
changes,I-PR
),O
.,O

Fluids,O
/,O
electrolytes/nutrition,O
:,O

On,O
admission,O
to,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
",",O
hypernatremia,B-PR
and,O
hypovolemic,B-PR
shock,I-PR
.,O

Fluids,B-TR
of,I-TR
D5,I-TR
water,I-TR
with,O
30,O
mEq,O
of,O
sodium,B-TR
acetate,I-TR
per,O
liter,O
",",O
30,O
ml,O
per,O
liter,O
of,O
phosphate,B-TR
",",O
and,O
30,O
mEq,O
of,O
K,B-TR
acetate,I-TR
per,O
liter,O
at,O
90,O
cc&apos;s,O
per,O
hour,O
was,O
given,O
.,O

Free,B-TR
water,I-TR
deficit,I-TR
over,O
48,O
hours,O
was,O
given,O
",",O
plus,O
maintenance,O
",",O
plus,O
adjusting,O
the,O
ongoing,O
losses,O
.,O

Pediatric,O
Nephrology,O
recommended,O
on,O
9/7/93,O
",",O
5:50,O
p.m.,O
",",O
10,O
cc,O
&apos;s,O
per,O
kilo,O
of,O
150,O
mEq,O
of,O
sodium,B-TR
bicarbonate,I-TR
per,O
liter,O
",",O
(,O
1.5,O
mEq,O
per,O
kilo,O
bicarbonate,B-TR
",",O
one,O
dose,O
of,O
Lasix,B-TR
and,O
volume,B-TR
as,O
needed,O
),O
.,O

The,O
patient,O
required,O
multiple,B-TR
boluses,I-TR
of,I-TR
albumin,I-TR
for,O
hypotension,B-PR
",",O
patient,O
also,O
required,O
multiple,B-TR
boluses,I-TR
of,I-TR
calcium,I-TR
because,O
of,O
hypocalcemia,B-PR
and,O
hypotension,B-PR
.,O

Magnesium,B-TR
2.0,O
mEq,O
per,O
liter,O
",",O
phosphate,B-TR
8,O
mg,O
/,O
dl,O
.,O

Gastrointestinal,O
:,O

Normal,O
.,O

NPO,B-TR
.,O

Albumin,B-TE
was,O
4.9,O
.,O

Globulin,B-TE
was,O
1.6,O
",",O
uric,B-TE
acid,I-TE
was,O
6.5,O
",",O
alkaline,B-TE
phosphatase,I-TE
150,O
",",O
SGPT,B-TE
11,O
",",O
SGOT,B-TE
85,O
",",O
LDH,B-TE
524,O
",",O
CK,B-TE
152,O
",",O
NH3,B-TE
81,O
.,O

Hematologic,O
:,O

White,B-TE
cell,I-TE
count,I-TE
9.4,O
",",O
hematocrit,B-TE
42,O
",",O
platelets,B-TE
"151,000",O
.,O

Differential,B-TE
was,O
polys,B-TE
59,O
",",O
bands,B-TE
3,O
",",O
lymphs,B-TE
25,O
.,O

Repeat,B-TE
white,I-TE
cell,I-TE
count,I-TE
6.4,O
",",O
hematocrit,B-TE
34,O
",",O
platelets,B-TE
103,O
.,O

PT,B-TE
11.6/10.1,O
",",O
repeat,B-TE
PT,I-TE
12.8/10.5,O
.,O

PTT,B-TE
36.4,O
",",O
repeat,B-TE
PTT,I-TE
50.9,O
.,O

Fibrinogen,B-TE
211,O
.,O

Renal,O
:,O

Urine,B-TE
output,I-TE
was,O
about,O
5,O
to,O
8,O
cc&apos;s,O
per,O
kilo,O
per,O
hour,O
.,O

Renal,B-TE
ultrasound,I-TE
was,O
scheduled,O
during,O
the,O
Intensive,O
Care,O
Unit,O
stay,O
.,O

Urinalysis,B-TE
showed,O
specific,B-TE
gravity,I-TE
1.005,O
",",O
pH,B-TE
8.0,O
",",O
positive,B-PR
proteins,I-PR
",",O
positive,B-PR
red,I-PR
blood,I-PR
cells,I-PR
",",O
negative,O
white,O
cell,O
count,O
",",O
positive,B-PR
glucose,I-PR
.,O

Neurologic,O
:,O

Patient,O
did,O
not,O
receive,O
sedation,B-TR
or,O
muscle,B-TR
relaxant,I-TR
since,O
admission,O
to,O
the,O
Pediatric,O
Intensive,O
Care,O
Unit,O
.,O

Phenobarbital,B-TE
levels,I-TE
were,O
31.4,O
",",O
30.2,O
",",O
and,O
50,O
.,O

Dilantin,B-TE
level,I-TE
was,O
22.6,O
",",O
20.2,O
",",O
20,O
.,O

Neurology,O
consultation,O
on,O
the,O
evening,O
of,O
9/7/93,O
revealed,O
supple,O
neck,O
",",O
no,B-PR
response,I-PR
to,O
external,B-TE
rub,I-TE
.,O

Pupils,O
were,O
3.5,O
OD,O
",",O
and,O
3.0,O
OS,O
",",O
irregular,B-PR
and,O
non,B-PR
reactive,I-PR
.,O

Corneal,B-TE
reflexes,I-TE
and,O
oculocephalic,B-TE
reflexes,I-TE
were,O
absent,B-PR
.,O

There,O
was,O
no,B-PR
gag,I-PR
.,O

Muscle,B-TE
tone,I-TE
was,O
increased,B-PR
throughout,I-PR
",",O
and,O
the,O
legs,O
were,O
both,B-PR
extended,I-PR
and,I-PR
internally,I-PR
rotated,I-PR
.,O

Deep,B-TE
tendon,I-TE
reflexes,I-TE
could,O
not,O
be,O
elicited,O
and,O
plantar,B-TE
responses,I-TE
were,O
silent,B-PR
.,O

Repeat,B-TE
neurological,I-TE
examination,I-TE
revealed,O
no,B-PR
spontaneous,I-PR
movement,I-PR
and,O
no,B-PR
response,I-PR
to,O
voice,B-TE
or,I-TE
noxious,I-TE
stimulation,I-TE
.,O

Pupils,O
were,O
dilated,B-PR
and,O
non,B-PR
reactive,I-PR
.,O

Disc,O
margins,O
appeared,O
blurred,B-PR
on,O
funduscopic,B-TE
exam,I-TE
.,O

A,B-TE
non,I-TE
contrast,I-TE
head,I-TE
CT,I-TE
scan,I-TE
was,O
obtained,O
and,O
CT,B-TE
revealed,O
severe,B-PR
cerebral,I-PR
edema,I-PR
with,O
thalamic,B-PR
mid,I-PR
brain,I-PR
",",I-PR
pons,I-PR
",",I-PR
medullar,I-PR
low,I-PR
attenuation,I-PR
",",O
diffuse,B-PR
cerebral,I-PR
edema,I-PR
",",O
loss,B-PR
of,I-PR
gray,I-PR
white,I-PR
matter,I-PR
differentiation,I-PR
.,O

Cerebral,B-TE
blood,I-TE
flow,I-TE
was,O
done,O
on,O
9/7/93,O
at,O
2:30,O
p.m.,O
",",O
revealed,O
complete,B-PR
absence,I-PR
of,I-PR
blood,I-PR
flow,I-PR
to,I-PR
brain,I-PR
.,O

There,O
was,O
a,B-PR
tiny,I-PR
region,I-PR
of,I-PR
activity,I-PR
in,O
what,O
appears,O
to,O
be,O
anterior,O
scalp,O
.,O

Infectious,O
Disease,O
:,O

Ampicillin,B-TR
and,O
chloramphenicol,B-TR
were,O
given,O
at,O
Noughwell,O
Entanbon,O
Health,O
",",O
and,O
ceftriaxone,B-TR
was,O
given,O
at,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
.,O

Acyclovir,B-TR
was,O
started,O
",",O
also,O
considering,O
the,B-PR
varicella,I-PR
at,O
120,O
mg,O
intravenously,O
every,O
8,O
hours,O
.,O

Urine,B-TE
cultures,I-TE
",",O
blood,B-TE
cultures,I-TE
and,O
sputum,B-TE
cultures,I-TE
were,O
sent,O
.,O

The,O
patient,O
finally,O
died,O
.,O

The,O
situation,O
of,O
the,O
patient,O
was,O
extensively,O
discussed,O
with,O
the,O
parents,O
",",O
and,O
the,O
attending,O
physician,O
from,O
Neurology,O
",",O
Dr.,O
Breunkote,O
",",O
and,O
the,O
attending,O
physician,O
from,O
Pediatric,O
Intensive,O
Care,O
Unit,O
",",O
Dr.,O
Boormcose,O
",",O
and,O
the,O
decision,O
was,O
finally,O
made,O
with,O
the,O
family,O
and,O
attendings,O
to,O
disconnect,O
the,O
patient,O
from,O
the,B-TR
mechanical,I-TR
ventilation,I-TR
due,O
to,O
severe,B-PR
neurological,I-PR
injury,I-PR
and,O
poor,B-PR
prognosis,I-PR
.,O

ZAKAY,O
COUGH,O
",",O
M.D.,O

TR,O
:,O

jx,O
/,O
bmot,O

DD,O
:,O

10-20-93,O

TD,O
:,O

10/21/93,O

CC,O
:,O

edited,O
10/24/93,O
rc,O

Admission,O
Date,O
:,O

2018-08-02,O

Discharge,O
Date,O
:,O

2018-08-08,O

Date,O
of,O
Birth,O
:,O

1941-03-03,O

Sex,O
:,O

F,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Penicillins,B-TR
/,O
Codeine,B-TR
/,O
Heparin,B-TR
Agents,I-TR
/,O
Levofloxacin,B-TR

Attending,O
:,O
Faye,O
B.,O
Jones,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O
rectal,B-PR
bleeding,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O
colonoscopy,B-TE
egd,B-TE

GI,B-TE
bleeding,I-TE
study,I-TE

History,O
of,O
Present,O
Illness,O
:,O

Patient,O
is,O
a,O
77,O
year,O
old,O
female,O
with,O
a,O
past,O
medical,O
history,O
significant,O
for,O
GI,B-PR
bleeding,I-PR
secondary,O
to,O
arteriovenous,B-PR
malformations,I-PR
",",O
who,O
presents,O
with,O
maroon,B-PR
stool,I-PR
and,O
a,B-PR
hematocrit,I-PR
drop,I-PR
.,O

Three,O
days,O
ago,O
began,O
to,O
develop,O
black,B-PR
stools,I-PR
.,O

There,O
was,O
no,O
clear,B-PR
blood,I-PR
in,O
the,O
toilet,O
bowl,O
.,O

In,O
addition,O
",",O
she,O
developed,O
nausea,B-PR
and,O
decreased,B-PR
PO,I-PR
intake,I-PR
.,O

She,O
had,O
a,B-PR
cough,I-PR
productive,O
of,O
white,B-PR
sputum,I-PR
and,O
felt,O
warm,O
",",O
although,O
she,O
did,O
not,O
record,O
her,B-TE
temperature,I-TE
.,O

At,O
dialysis,O
on,O
day,O
of,O
admission,O
",",O
she,O
related,O
these,O
symptoms,O
for,O
the,O
first,O
time,O
and,O
had,O
a,B-PR
bloody,I-PR
bowel,I-PR
movement,I-PR
.,O

Concerned,O
",",O
the,O
staff,O
sent,O
her,O
directly,O
to,O
the,O
Nantucket,O
Cottage,O
Hospital,O
.,O

In,O
the,O
Deanna,O
",",O
her,B-TE
temperature,I-TE
was,O
96.5,O
",",O
HR,B-TE
51,O
",",O
BP,B-TE
112/60,O
",",O
RR,B-TE
18,O
",",O
and,O
oxygen,B-TE
saturation,I-TE
was,O
98%,O
on,O
ambient,O
air,O
.,O

Her,B-TE
hematocrit,I-TE
was,O
measured,O
at,O
23.5,O
",",O
while,O
her,B-TE
baseline,I-TE
hematocrit,I-TE
is,O
in,O
the,O
low,O
30,O
s.,O

An,B-TE
NG,I-TE
lavage,I-TE
was,O
performed,O
and,O
there,O
was,O
bilious,B-PR
return,I-PR
.,O

Rectal,B-TE
examination,I-TE
was,O
notable,O
for,O
guiaiac,B-PR
positive,I-PR
maroon,I-PR
stool,I-PR
.,O

She,O
was,O
type,O
and,O
crossed,O
and,O
transfused,O
two,O
units,O
of,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
.,O

IV,B-TR
PPI,I-TR
was,O
given,O
and,O
the,O
GI,O
team,O
was,O
consulted,O
and,O
she,O
was,O
scheduled,O
for,O
colonoscopy,B-TE
and,O
EGD,B-TE
on,O
the,O
morning,O
of,O
6/8,O
.,O

She,O
was,O
transferred,O
to,O
the,O
CMED,O
CCU,O
for,O
observation,B-TE
.,O

Past,O
Medical,O
History,O
:,O

DM2,B-PR
on,O
insulin,B-TR

CRI,B-PR
03-30,O
HTN,B-PR
and,O
DM,B-PR
nephropathy,I-PR
",",O
with,O
baseline,B-TE
creatinine,I-TE
4-4.5,O

Chronic,B-PR
GI,I-PR
bleeding,I-PR
:,O
documented,B-PR
AVMs,I-PR

Anemia,B-PR
w/,O
baseline,B-TE
hct,I-TE
27-30,O

Thrombocytopenia,B-PR

Coagulopathy,B-PR
",",O
HIT,B-PR
in,O
2014,O

Cardiomyopathy,B-PR

MRSA,B-PR
endocardiitis,I-PR
(,O
01-28,O
),O

CAD,B-PR
;,O
status,O
post,O
coronary,B-TR
artery,I-TR
bypass,I-TR
graft,I-TR
times,O
two,O
and,O
status,O
post,O
myocardial,B-PR
infarction,I-PR
in,O
2001,O
and,O
2000,O
.,O

Asthma,B-PR

Hypothyroidism,B-PR

Osteoarthritis,B-PR

Paroxysmal,B-PR
atrial,I-PR
fibrillation,I-PR

PUD,B-PR
",",O
Barrett,B-PR
's,I-PR
Esophagus,I-PR

CHF,B-PR
EF,B-TE
50%,O

Social,O
History,O
:,O

Primarily,O
Togolese,O
speaking,O
",",O
wheelchair,B-PR
bound,I-PR
and,O
lives,O
alone,O
but,O
cared,O
for,O
entirely,O
by,O
her,O
daughter,O
.,O

She,O
denies,O
EtOH,O
",",O
tobacco,O
",",O
and,O
drugs,O
.,O

Patient,O
has,O
8,O
children,O
",",O
40,O
grandchildren,O
and,O
one,O
great-grandaughter,O
.,O

Family,O
History,O
:,O

CAD,B-PR
and,O
DM,B-PR

Physical,O
Exam,O
:,O

T,B-TE
:,O
97.2,O
BP,B-TE
:,O
127/57,O
HR,B-TE
:,O
68,O
RR,B-TE
:,O
11,O
O2saturation,B-TE
:,O
97%,O
on,O
ambient,O
air,O

Gen,O
:,O

Pleasant,O
",",O
well,O
appearing,O
heavy,O
set,O
woman,O
laying,O
in,O
bed,O
.,O

HEENT,O
:,O

Slight,B-PR
conjunctival,I-PR
pallor,I-PR
.,O

No,O
scleral,B-PR
icterus,I-PR
.,O

Slightly,B-PR
dry,I-PR
mucous,I-PR
membranes,I-PR
.,O

NECK,O
:,O

Supple,O
.,O

No,O
JVD,B-PR
.,O

CV,O
:,O

RRR,O
.,O

Systolic,B-PR
murmur,I-PR
in,I-PR
right,I-PR
upper,I-PR
sternal,I-PR
border,I-PR
.,O

Normal,O
S1,O
and,O
S2,O
.,O

No,O
rubs,B-PR
or,O
Andringa,B-PR
appreciated,O
.,O

LUNGS,O
:,O

Crackles,B-PR
in,I-PR
lower,I-PR
lung,I-PR
fields,I-PR
.,O

No,O
wheezes,B-PR
or,O
rhonci,B-PR
appreciated,O
.,O

ABD,O
:,O

Slightly,B-PR
hyperactive,I-PR
bowel,I-PR
sounds,I-PR
throughout,I-PR
.,O

Soft,O
.,O

Nontender,B-PR
and,O
nondistended,B-PR
.,O

No,O
guarding,B-PR
or,O
rebound,B-PR
.,O

Liver,O
edge,O
not,O
palpated,O
.,O

No,O
splenomegaly,B-PR
appreciated,O
.,O

Guaiac,B-PR
positive,I-PR
maroon,I-PR
stool,I-PR
in,O
Deanna,O
.,O

EXT,O
:,O

Warm,O
and,O
well,O
perfused,O
.,O

No,O
clubbing,B-PR
or,O
cyanosis,B-PR
.,O

No,O
lower,B-PR
extremity,I-PR
edema,I-PR
",",I-PR
bilaterally,I-PR
.,O

2+,B-TE
dorsalis,I-TE
pedis,I-TE
and,I-TE
radial,I-TE
pulse,I-TE
on,I-TE
left,I-TE
.,O

No,B-PR
radial,I-PR
pulse,I-PR
on,I-PR
right,I-PR
.,O

AV,B-TR
fistula,I-TR
on,O
right,O
.,O

Pertinent,O
Results,O
:,O

2018-08-07,O
12:56,O
AM,O
BLOOD,B-TE
WBC,B-TE
-,O
4.0,O
RBC,B-TE
-,O
3.54,O
*,O
Hgb,B-TE
-,O
11.6,O
*,O
Hct,B-TE
-,O
32.9,O
*,O
MCV,B-TE
-,O
93,O
MCH,B-TE
-,O
32.8,O
*,O
MCHC,B-TE
-,O
35.2,O
*,O
RDW,B-TE
-,O
18.5,O
*,O
Plt,B-TE
Ct,I-TE
-,O
65,O
*,O

2018-08-02,O
12:29,O
PM,O
BLOOD,B-TE
Hct,B-TE
-,O
23.5,O
*#,O

2018-08-02,O
04:40,O
PM,O
BLOOD,B-TE
WBC,B-TE
-,O
3.2,O
*,O
RBC,B-TE
-,O
2.49,O
*#,O
Hgb,B-TE
-,O
8.4,O
*#,O
Hct,B-TE
-,O
24.5,O
*#,O
MCV,B-TE
-,O
98,O
MCH,B-TE
-,O
33.7,O
*,O
MCHC,B-TE
-,O
34.3,O
RDW,B-TE
-,O
18.5,O
*,O
Plt,B-TE
Ct,I-TE
-,O
69,O
*,O

2018-08-06,O
04:52,O
AM,O
BLOOD,B-TE
PT,B-TE
-,O
14.7,O
*,O
PTT,B-TE
-,O
28.9,O
INR,B-TE
(,I-TE
PT,I-TE
)-,I-TE
1.3,O
*,O

2018-08-07,O
12:56,O
AM,O
BLOOD,B-TE
UreaN,B-TE
-,O
27,O
*,O
Creat,B-TE
-,O
4.1,O
*,O
Na,B-TE
-,O
130,O
*,O
K,B-TE
-,O
3.7,O
Cl,B-TE
-,O
94,O
*,O
HCO3,B-TE
-,O
27,O
AnGap,B-TE
-,O
13,O

2018-08-06,O
04:52,O
AM,O
BLOOD,B-TE
Glucose,B-TE
-,O
129,O
*,O
UreaN,B-TE
-,O
24,O
*,O
Creat,B-TE
-,O
3.4,O
*,O
Na,B-TE
-,O
134,O
K,B-TE
-,O
3.2,O
*,O
Cl,B-TE
-,O
96,O
HCO3,B-TE
-,O
29,O
AnGap,B-TE
-,O
12,O

2018-08-02,O
04:40,O
PM,O
BLOOD,B-TE
Glucose,B-TE
-,O
187,O
*,O
UreaN,B-TE
-,O
21,O
*,O
Creat,B-TE
-,O
2.0,O
*#,O
Na,B-TE
-,O
139,O
K,B-TE
-,O
3.2,O
*,O
Cl,B-TE
-,O
96,O
HCO3,B-TE
-,O
35,O
*,O
AnGap,B-TE
-,O
11,O

2018-08-07,O
12:56,O
AM,O
BLOOD,B-TE
Calcium,B-TE
-,O
8.0,O
*,O
Phos,B-TE
-,O
3.5,O
Mg,B-TE
-,O
1.8,O

Cardiology,O
Report,O
ECG,B-TE
Study,I-TE
Date,O
of,O
2018-08-02,O
5:40:48,O
PM,O

Sinus,B-PR
bradycardia,I-PR
with,O
markedly,B-PR
prolonged,I-PR
P-R,I-PR
interval,I-PR
and,O
Wenckebach,B-PR
type,I-PR

atrio-ventricular,B-PR
conduction,I-PR
delay,I-PR
.,O

Right,B-PR
bundle-branch,I-PR
block,I-PR
.,O

Indeterminate,B-PR
frontal,I-PR
plane,I-PR
QRS,I-PR
axis,I-PR
.,O

Compared,O
to,O
the,B-TE
previous,I-TE
tracing,I-TE
of,O
2017-10-12,O
multiple,B-PR
abnormalities,I-PR
as,O
previously,O
noted,O
persist,O
without,O
major,B-PR
change,I-PR
.,O

Read,O
by,O
:,O
Dunn,O
",",O
Rachel,O
Finch,O

Intervals,B-TE
Axes,I-TE

Rate,B-TE
PR,B-TE
QRS,B-TE
QT/QTc,B-TE
P,B-TE
QRS,B-TE
T,B-TE

57,O
0,O
154,O
670-32166,O
-37,O

2018-08-03,O
5:40,O
pm,O
SEROLOGY/BLOOD,B-TE

Source,O
:,O

Line-central,B-TR
.,O

**,O
FINAL,O
REPORT,O
2018-08-06,O
**,O

HELICOBACTER,B-TE
PYLORI,I-TE
ANTIBODY,I-TE
TEST,I-TE
(,O
Final,O
2018-08-06,O
),O
:,O

NEGATIVE,O
BY,O
EIA,O
.,O

(,O
Reference,O
Range-Negative,O
),O
.,O

GI,B-TE
bleed,I-TE
study,I-TE
-,O
IMPRESSION,O
:,O

Active,B-PR
radiotracer,I-PR
activity,I-PR
in,I-PR
the,I-PR
right,I-PR
lower,I-PR
quadrant,I-PR
in,O
a,O
serpingneous,O
f,O
fashion,O
suggestive,O
of,O
distal,O
small,O
bowel,O
.,O

EGD,B-TE
-,O
Impression,O
:,O

Angioectasias,B-PR
in,I-PR
the,I-PR
fundus,I-PR

Angioectasias,B-PR
in,I-PR
the,I-PR
antrum,I-PR

Angioectasias,B-PR
in,I-PR
the,I-PR
proximal,I-PR
jejunum,I-PR
and,I-PR
mid,I-PR
jejunum,I-PR

Angioectasia,B-PR
in,I-PR
the,I-PR
duodenum,I-PR

Otherwise,O
normal,O
small,O
bowel,O
enteroscopy,O
to,O
mid,O
jejunum,O

Recommendations,O
:,O

No,O
site,O
of,O
active,B-PR
bleeding,I-PR
was,O
seen,O
.,O

The,B-PR
fundal,I-PR
AVMs,I-PR
are,O
a,O
potential,O
site,O
of,O
bleeding,B-PR
although,O
do,O
not,O
explain,O
the,O
extent,O
of,O
bleeding,B-PR
.,O

Consider,O
endoscopic,B-TR
argon,I-TR
plasma,I-TR
therapy,I-TR

Proceed,O
with,O
colonoscopy,B-TE
.,O

Colonoscopy,B-TE
-,O

Impression,O
:,O

Blood,B-PR
in,I-PR
the,I-PR
colon,I-PR

Grade,B-PR
1,I-PR
external,I-PR
hemorrhoids,I-PR

Angioectasia,B-PR
in,I-PR
the,I-PR
colon,I-PR

Diverticulosis,B-PR
of,I-PR
the,I-PR
colon,I-PR

Otherwise,O
normal,O
colonoscopy,O
to,O
cecum,O

Brief,O
Hospital,O
Course,O
:,O

Blood,B-PR
loss,I-PR
anemia,I-PR
from,O
GI,B-PR
bleeding,I-PR
-,O
the,B-PR
bleeding,I-PR
was,O
likely,O
from,O
an,B-PR
AVM,I-PR
.,O

EGD,B-TE
",",O
colonoscopy,B-TE
and,O
tagged,B-TE
scan,I-TE
results,O
as,O
above,O
.,O

eventhough,O
uptake,O
was,O
noted,O
in,O
the,O
rt,O
LQ,O
",",O
no,O
clear,O
site,O
of,O
bleeding,B-PR
was,O
noticed,O
on,O
colonoscopy,B-TE
.,O

hence,O
",",O
no,O
intervention,B-TR
was,O
performed,O
.,O

she,O
was,O
transfused,O
with,O
5,O
units,O
of,O
PRBC,B-TR
in,O
the,O
ICU,O
andsent,O
to,O
the,O
Lahey,O
Clinic,O
-,O
North,O
Shore,O
.,O

Her,B-TE
hematocrit,I-TE
remained,O
stable,O
for,O
4,O
days,O
prior,O
to,O
discharge,O
.,O

No,O
further,B-PR
bleeding,I-PR
noted,O
.,O

GI,O
consult,O
team,O
followed,O
pt,O
in,O
hospital,O
.,O

On,O
discussion,O
with,O
Dr,O
Leigh,O
and,O
Dr,O
White,O
from,O
GI,O
-,O
they,O
recommended,O
that,O
she,O
follow,O
with,O
Dr.,O
Taylor,O
for,O
consideration,O
of,O
argon,B-TR
photocoagulation,I-TR
as,O
out-patient,O
.,O

Given,O
the,O
innumerable,O
number,O
of,O
AVM,B-PR
's,I-PR
",",O
it,O
is,O
diffcult,O
to,O
assess,O
which,O
the,B-PR
culprit,I-PR
lesion,I-PR
is,O
and,O
GI,O
may,O
start,O
APL,B-TR
from,I-TR
the,I-TR
fundus,I-TR
of,O
stomach,O
.,O

Patient,O
to,O
get,O
CBC,B-TE
checked,O
with,O
PCP,O
this,O
week,O
as,O
below,O
.,O

ASA,B-TR
was,O
held,O
and,O
may,O
be,O
restarted,O
if,O
Hct,B-TE
stable,O
in,O
clinic,O
at,O
the,O
PCP,O
's,O
discretion,O
.,O

Chronic,B-PR
thrombocytopenia,I-PR
was,O
noted,O
",",O
however,O
the,O
patient,O
did,O
not,O
require,O
platelet,B-TR
transfusions,I-TR
.,O

Has,O
a,O
h/o,O
HIT,B-PR
.,O

The,B-TR
metoprolol,I-TR
was,O
held,O
during,O
acute,B-PR
bleeding,I-PR
phase,I-PR
and,O
restarted,O
prior,O
to,O
discharge,O
as,O
her,B-TE
BP,I-TE
stabilized,O
.,O

Other,B-PR
medical,I-PR
problems,I-PR
stable,O
.,O

Dialysis,B-TR
was,O
continued,O
3,O
/,O
week,O
.,O

I,O
personally,O
talked,O
with,O
Dr,O
Pannell,O
at,O
the,O
time,O
of,O
discharge,O
to,O
update,O
him,O
with,O
the,O
hospital,O
events,O
.,O

Medications,O
on,O
Admission,O
:,O

-,O
Atorvastatin,B-TR
80,O
mg,O
QD,O

-,O
Hydroxyzine,B-TR
HCl,I-TR
25,O
mg,O
Tablet,O
PO,O
Q4-6H,O
PRN,O
for,O
itching,B-PR

-,O
Levothyroxine,B-TR
175,O
mcg,O
PO,O
qd,O

-,O
Albuterol,B-TR
90,O
mcg,O
1-2,O
Puffs,O
INH,O
q6hr,O
PRN,O

-,O
Nitroglycerin,B-TR
0.3,O
mg,O
Tablet,O
PRN,O

-,O
Metoprolol,B-TR
Tartrate,I-TR
12.5,O
mg,O
BID,O

-,O
B,B-TR
Complex,I-TR
-,O
Vitamin,B-TR
C,I-TR
-,O
Folic,B-TR
Acid,I-TR
1,O
mg,O
Capsule,O
QD,O

-,O
Insulin,B-TR
NPH,I-TR
75-25,O
20units,O
qAM,O
and,O
humalog,B-TR
sliding,I-TR
scale,I-TR

Discharge,O
Medications,O
:,O

1.,O
Atorvastatin,B-TR
80,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

2.,O
Albuterol,B-TR
90,O
mcg,O
/,O
Actuation,O
Aerosol,O
Sig,O
:,O
1-2,O
Puffs,O
Inhalation,O
Q6H,O
(,O
every,O
6,O
hours,O
),O
as,O
needed,O
.,O

3.,O
Levothyroxine,B-TR
175,O
mcg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

4.,O
Hydroxyzine,B-TR
HCl,I-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
.,O

5.,O
B-Complex,B-TR
with,O
Vitamin,B-TR
C,I-TR
Tablet,I-TR
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

6.,O
Menthol,B-TR
-,I-TR
Cetylpyridinium,I-TR
Cl,I-TR
2,O
mg,O
Lozenge,O
Sig,O
:,O
One,O
(,O
1,O
),O
Lozenge,O
Mucous,O
membrane,O
PRN,O
(,O
as,O
needed,O
),O
.,O

7.,O
Pantoprazole,B-TR
40,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
Q12H,O
(,O
every,O
12,O
hours,O
),O
.,O

8.,O
Nitroglycerin,B-TR
0.3,O
mg,O
Tablet,O
",",O
Sublingual,O
Sig,O
:,O
One,O
(,O
1,O
),O
Sublingual,O
as,O
needed,O
as,O
needed,O
for,O
chest,B-PR
pain,I-PR
.,O

9.,O
Insulin,B-TR

Continue,O
to,O
take,O
the,B-TR
insulin,I-TR
as,O
you,O
were,O
taking,O
prior,O
to,O
the,O
hospital,O
visit,O

10.,O
Outpatient,B-TE
Lab,I-TE
Work,I-TE

CBC,B-TE
(,O
to,O
be,O
checked,O
by,O
Dr,O
Pannell,O
444-1034,O
on,O
2018-08-10,O
),O

11.,O
Metoprolol,B-TR
Tartrate,I-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
0.5,O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

Discharge,O
Disposition,O
:,O

Home,O
with,O
Service,O

Discharge,O
Diagnosis,O
:,O

Acute,B-PR
blood,I-PR
loss,I-PR
anemia,I-PR
from,O
rectal,B-PR
bleeding,I-PR

Thrombocytopenia,B-PR
-,I-PR
chronic,I-PR

Secondary,O
diagnosis,O
-,O

HTN,B-PR

DM,B-PR
type,I-PR
1,I-PR

CKD,B-PR
stage,I-PR
5,I-PR

Hypothyroidism,B-PR

Asthma,B-PR

Coronary,B-PR
artery,I-PR
disease,I-PR

Discharge,O
Condition:,O
stable,O
.,O

Discharge,O
Instructions,O
:,O

Weigh,O
yourself,O
every,O
morning,O
",",O
call,O
MD,O
if,O
weight,B-PR
>,I-PR
3,I-PR
lbs,I-PR
.,O

Adhere,O
to,O
2,B-TR
gm,I-TR
sodium,I-TR
diet,I-TR

Do,O
not,O
take,O
the,B-TR
aspirin,I-TR
unless,O
you,O
see,O
Dr,O
Pannell,O
.,O

Continue,O
to,O
take,O
the,B-TR
insulin,I-TR
as,O
you,O
were,O
taking,O
prior,O
to,O
hospital,O
visit,O
.,O

Keep,O
your,O
appointments,O
.,O

Please,O
see,O
your,O
doctor,O
(,O
Dr,O
Pannell,O
),O
on,O
Friday,O
2018-08-10,O
for,O
a,B-TE
blood,I-TE
test,I-TE
(,O
cbc,B-TE
),O
.,O

He,O
has,O
asked,O
you,O
call,O
the,O
clinic,O
Friday,O
morning,O
for,O
a,O
same,O
day,O
appointment,O
.,O

Continue,O
the,B-TR
dialysis,I-TR
three,O
times,O
a,O
week,O
.,O

Return,O
to,O
the,O
hospital,O
if,O
you,O
notice,O
bleeding,B-PR
or,O
any,B-PR
other,I-PR
symptoms,I-PR
of,O
concern,O
to,O
you,O
.,O

Followup,O
Instructions,O
:,O

Provider,O
:,O

Kim,O
Phone,O
:,O
512,O
0199,O
Date,O
/,O
Time,O
:,O
2018-08-17,O
9:30,O

Gastroenterology,O
-,O
9092,O
N.,O
Eighth,O
Cir.,O
",",O
Wisecup,O
Rose,O
-,O
1st,O
floor,O
.,O

Provider,O
:,O
Michelle,O
Susan,O
",",O
MD,O
Phone,O
:,O
(,O
544,O
),O
439-6335,O
Date,O
/,O
Time,O
:,O
2018-08-14,O
8:20,O

Primary,O
doctor,O
-,O
Dr,O
Shirley,O
",",O
James,O
M.,O
444-1034,O
-,O
please,O
see,O
your,O
doctor,O
Mary,O
Powell,O
2018-08-10,O
for,O
a,B-TE
blood,I-TE
test,I-TE
(,O
cbc,B-TE
),O
.,O

Dialysis,B-TR
as,O
scheduled,O
.,O

Ruby,O
Charles,O
MD,O
75-829,O

Completed,O
by,O
:,O
William,O
Charles,O
MD,O
75-829,O
2018-08-08,O
@,O
0822,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Stoll,O
Delacy,O
on,O
:,O
Sandra,O
2018-08-09,O
4:36,O
PM,O

(,O
End,O
of,O
Report,O
),O

176318078,O

FIH,O

4189699,O

98761/1k47,O

867797,O

6/22/1994,O
12:00:00,O
AM,O

MITRAL,B-PR
STENOSIS,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

06/22/94,O

DISCHARGE,O
DATE,O
:,O

07/04/94,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Mitral,B-PR
stenosis,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

Tricuspid,B-PR
insufficiency,I-PR
",",O
atrial,B-PR
fibrillation,I-PR
",",O
congestive,B-PR
heart,I-PR
failure,I-PR
",",O
chronic,B-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
",",O
pulmonary,B-PR
hypertension,I-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

04/22/94,O
",",O
mitral,B-TR
valve,I-TR
replacement,I-TR
and,O
tricuspid,B-TR
valve,I-TR
reconstruction,I-TR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
68,O
year,O
old,O
female,O
had,O
rheumatic,B-PR
fever,I-PR
in,O
the,O
past,O
",",O
and,O
has,O
had,O
chronic,B-PR
atrial,I-PR
fibrillation,I-PR
.,O

She,O
has,O
had,O
progressive,B-PR
heart,I-PR
failure,I-PR
and,O
an,B-TE
evaluation,I-TE
demonstrated,O
worsening,B-PR
mitral,I-PR
stenosis,I-PR
with,O
severe,B-PR
pulmonary,I-PR
hypertension,I-PR
.,O

Because,O
of,O
her,O
deteriorating,O
status,O
",",O
she,O
underwent,O
prior,B-TE
cardiac,I-TE
catheterization,I-TE
",",O
which,O
confirmed,O
severe,B-PR
mitral,I-PR
stenosis,I-PR
with,O
secondary,B-PR
tricuspid,I-PR
valve,I-PR
regurgitation,I-PR
due,O
to,O
pulmonary,B-PR
hypertension,I-PR
.,O

She,O
was,O
referred,O
for,O
valve,B-TR
surgery,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
is,O
remarkable,O
for,O
chronic,B-PR
lung,I-PR
disease,I-PR
due,O
to,O
smoking,O
.,O

She,O
had,O
undergone,O
a,B-TR
previous,I-TR
nasal,I-TR
arterial,I-TR
embolization,I-TR
for,O
treatment,B-TR
of,O
recurrent,B-PR
epistaxis,I-PR
.,O

She,O
had,O
a,B-TR
partial,I-TR
gastrectomy,I-TR
in,O
1972,O
.,O

Her,B-TR
MEDICATIONS,I-TR
ON,I-TR
ADMISSION,I-TR
included,O
Coumadin,B-TR
",",O
digoxin,B-TR
",",O
0.125,O
",",O
qD,O
",",O
Lasix,B-TR
",",O
40,O
",",O
q.i.d.,O
",",O
and,O
Vanceril,B-TR
inhaler,I-TR
.,O

PERTINENT,B-TE
EXAMINATION,I-TE
demonstrated,O
mild,B-PR
elevation,I-PR
of,O
her,B-TE
jugular,I-TE
venous,I-TE
pulse,I-TE
",",O
with,O
prominent,B-PR
V-waves,I-PR
",",O
and,O
systolic,B-PR
and,I-PR
diastolic,I-PR
murmurs,I-PR
.,O

Peripheral,B-TE
pulses,I-TE
were,O
all,O
intact,O
",",O
and,O
there,O
was,O
venous,B-PR
stasis,I-PR
changes,I-PR
on,I-PR
her,I-PR
legs,I-PR
",",O
with,O
some,B-PR
edema,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
brought,O
to,O
the,O
Operating,O
Room,O
",",O
on,O
April,O
22,O
.,O

She,O
underwent,O
a,B-TR
mitral,I-TR
valve,I-TR
replacement,I-TR
",",O
utilizing,O
a,O
27,O
mm,O
.,O

St.,B-TR
Jude,I-TR
prosthesis,I-TR
",",O
and,O
tricuspid,B-TR
valve,I-TR
reconstruction,I-TR
by,O
ring,B-TR
anuloplasty,I-TR
.,O

She,O
weaned,O
from,O
cardiopulmonary,B-TR
bypass,I-TR
with,O
good,O
hemodynamics,O
.,O

She,O
initially,O
awoke,O
after,O
surgery,B-TR
",",O
with,O
good,O
hemodynamics,O
.,O

She,O
was,O
transiently,O
in,O
sinus,O
rhythm,O
",",O
but,O
atrial,B-PR
fibrillation,I-PR
recurred,O
.,O

She,O
was,O
extubated,O
on,O
the,O
third,O
postoperative,O
day,O
",",O
and,O
was,O
initially,B-PR
slightly,I-PR
agitated,I-PR
and,O
confused,B-PR
",",O
largely,O
due,O
to,O
an,B-PR
Intensive,I-PR
Care,I-PR
Unit,I-PR
psychosis,I-PR
.,O

She,O
continued,O
to,O
improve,O
",",O
with,O
mobilization,O
of,O
fluid,O
.,O

She,O
was,O
initially,O
noted,O
to,O
have,O
a,B-PR
slow,I-PR
ventricular,I-PR
response,I-PR
in,O
atrial,B-PR
fibrillation,I-PR
",",O
but,O
this,O
gradually,O
improved,O
over,O
time,O
.,O

She,O
was,O
initially,O
noted,O
to,O
be,O
somewhat,B-PR
anemic,I-PR
",",O
and,O
received,O
transfusions,B-TR
.,O

Coumadin,B-TR
was,O
restarted,O
",",O
and,O
her,B-TR
anticoagulation,I-TR
came,O
into,O
range,O
.,O

She,O
was,O
ultimately,O
discharged,O
with,O
a,B-TE
heart,I-TE
rate,I-TE
in,O
the,O
90,O
's,O
",",O
and,O
with,O
resolving,B-PR
edema,I-PR
and,O
a,O
clear,O
chest,O
.,O

Her,B-TR
MEDICATIONS,I-TR
ON,I-TR
DISCHARGE,I-TR
included,O
Lasix,B-TR
",",O
40,O
",",O
b.i.d.,O
",",O
potassium,B-TR
",",O
20,O
mEq.,O
",",O
b.i.d.,O
",",O
iron,B-TR
",",O
and,O
folic,B-TR
acid,I-TR
replacement,I-TR
",",O
and,O
Coumadin,B-TR
.,O

RIEMUND,O
C.,O
ALL,O
",",O
M.D.,O

TR,O
:,O

dun,O
/,O
bmot,O

DD,O
:,O

7/12/94,O

TD,O
:,O

07/13/94,O

CC,O
:,O

Dr.,O
Ca,O
Shuff,O
.,O

Admission,O
Date,O
:,O

2015-07-09,O

Discharge,O
Date,O
:,O

2015-07-17,O

Date,O
of,O
Birth,O
:,O

1947-06-29,O

Sex,O
:,O

F,O

Service:,O

ADDENDUM,O
:,O

Leona,O
Wheeler,O
had,O
continued,O
episodes,O
of,O
atrial,B-PR
fibrillation,I-PR
which,O
were,O
treated,O
with,O
intravenous,B-TR
Amiodarone,I-TR
and,O
later,O
intravenous,B-TR
Diltiazem,I-TR
.,O

Her,B-TR
Lopressor,I-TR
dose,I-TR
was,O
progressively,O
increased,O
to,O
100,O
mg,O
tid,O
.,O

Amiodarone,B-TR
400,O
mg,O
tid,O
was,O
continued,O
as,O
well,O
.,O

Due,O
to,O
this,B-PR
continued,I-PR
atrial,I-PR
fibrillation,I-PR
",",O
Leona,O
Wheeler,O
was,O
anticoagulated,O
with,O
intravenous,B-TR
Heparin,I-TR
.,O

Coumadin,B-TR
dose,I-TR
was,O
started,O
and,O
her,B-TE
INR,I-TE
were,O
followed,O
.,O

These,O
episodes,O
of,O
atrial,B-PR
fibrillation,I-PR
have,O
diminished,O
and,O
she,O
has,O
been,O
in,O
sinus,O
rhythm,O
for,O
over,O
24,O
hours,O
now,O
.,O

At,O
this,O
time,O
Leona,O
Wheeler,O
was,O
felt,O
stable,O
to,O
be,O
transferred,O
to,O
rehabilitation,O
facility,O
.,O

She,O
will,O
be,O
monitored,O
with,O
a,B-TE
King,I-TE
of,I-TE
Hearts,I-TE
monitor,I-TE
.,O

Changes,O
to,O
discharge,O
medications,O
:,O

Metoprolol,B-TR
100,O
mg,O
tid,O
",",O
Amiodarone,B-TR
400,O
mg,O
tid,O
times,O
7,O
days,O
",",O
then,O
bid,O
times,O
14,O
days,O
",",O
then,O
q,O
d,O
times,O
14,O
days,O
",",O
then,O
200,O
mg,O
q,O
d,O
.,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O
.,O

DISCHARGE,O
STATUS,O
:,O

Leona,O
Wheeler,O
is,O
to,O
be,O
transferred,O
on,O
2015-07-17,O
to,O
a,O
rehabilitation,O
facility,O
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

1.,O
Status,O
post,O
CABG,B-TR
times,O
four,O
.,O

Meghan,O
G.,O
Bardin,O
",",O
M.D.,O
43-132,O

Dictated,O
By,O
:,O
Louise,O
B.,O
Robertson,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2015-07-17,O
08:39,O

T,O
:,O
2015-07-22,O
10:29,O

JOB,O
#,O
:,O
72575,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Derek,O
Vildosola,O
on,O
:,O
WED,O
2015-07-29,O
1:15,O
PM,O

(,O
End,O
of,O
Report,O
),O

176318078_c,O

FIH,O

4189699,O

78088/7792,O

80216,O

8/21/1993,O
12:00:00,O
AM,O

EPISTAXIS,B-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

8/21/93,O

DISCHARGE,O
DATE,O
:,O

8/23/93,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Epistaxis,B-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

Mitral,B-PR
stenosis,I-PR
",",O
tricuspid,B-PR
regurgitation,I-PR
",",O
heart,B-PR
failure,I-PR
",",O
chronic,B-PR
atrial,I-PR
fibrillation,I-PR
",",O
chronic,B-PR
ventricular,I-PR
ectopy,I-PR
",",O
chronic,B-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
.,O

ADVERSE,O
DRUG,O
REACTIONS,O
:,O

Epistaxis,B-PR
on,O
Coumadin,B-TR
in,O
the,O
past,O
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

Partial,B-TR
embolization,I-TR
of,I-TR
blood,I-TR
supply,I-TR
to,O
nose,O
",",O
8/22,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
68,O
year,O
old,O
female,O
has,O
rheumatic,B-PR
heart,I-PR
disease,I-PR
.,O

Mitral,B-TR
and,I-TR
possibly,I-TR
tricuspid,I-TR
valve,I-TR
surgery,I-TR
is,O
scheduled,O
for,O
Labor,O
Day,O
by,O
Dr.,O
Riemund,O
C.,O
Kennedy,O
.,O

Her,O
history,O
is,O
detailed,O
in,O
the,O
discharge,O
summary,O
of,O
August,O
10,O
of,O
this,O
year,O
.,O

She,O
is,O
admitted,O
now,O
for,O
a,B-TR
neuro-interventional,I-TR
radiology,I-TR
procedure,I-TR
to,O
decrease,O
the,O
likelihood,O
of,O
epistaxis,B-PR
on,O
Coumadin,B-TR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Chest,O
was,O
clear,O
.,O

Right,B-PR
neck,I-PR
and,I-PR
right,I-PR
groin,I-PR
catheterization,I-PR
sites,I-PR
were,O
benign,O
.,O

No,O
edema,B-PR
.,O

Examination,B-TE
was,O
otherwise,O
unchanged,O
.,O

LABORATORY,O
DATA,O
:,O

Hematocrit,B-TE
was,O
42,O
",",O
PT,B-TE
was,O
10,O
",",O
potassium,B-TE
was,O
3.6,O
",",O
BUN,B-TE
was,O
29,O
",",O
creatinine,B-TE
was,O
1.4,O
",",O
blood,B-TE
sugar,I-TE
was,O
111,O
.,O

EKG,B-TE
showed,O
atrial,B-PR
fibrillation,I-PR
",",O
moderate,B-PR
ventricular,I-PR
response,I-PR
",",O
right,B-PR
ventricular,I-PR
hypertrophy,I-PR
",",O
right,B-PR
axis,I-PR
deviation,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,B-TR
interventional,I-TR
neuro-radiology,I-TR
procedure,I-TR
was,O
performed,O
by,O
Dr.,O
A,O
Skizeis,O
",",O
on,O
August,O
22,O
",",O
via,O
the,O
right,O
femoral,O
artery,O
.,O

The,O
right,O
internal,O
maxillary,O
artery,O
supply,O
to,O
the,O
nasal,O
mucosa,O
was,O
embolized,B-TR
.,O

The,O
left,O
external,O
carotid,O
artery,O
was,O
occluded,B-PR
at,O
its,O
origin,O
",",O
with,O
collaterals,O
from,O
the,O
internal,O
carotid,O
artery,O
.,O

Thus,O
",",O
embolization,B-TR
on,I-TR
the,I-TR
left,I-TR
side,I-TR
was,O
not,O
possible,O
.,O

The,O
patient,O
received,O
Coumadin,B-TR
",",O
10,O
mg.,O
",",O
on,O
the,O
evening,O
following,O
the,O
procedure,O
",",O
and,O
is,O
discharged,O
the,O
next,O
day,O
.,O

Her,B-TE
prothrombin,I-TE
time,I-TE
will,O
be,O
rechecked,O
on,O
August,O
27,O
by,O
her,O
primary,O
care,O
physician,O
",",O
Dr.,O
Naka,O
Gift,O
.,O

Once,O
her,B-TE
prothrombin,I-TE
time,I-TE
is,O
in,O
therapeutic,O
range,O
",",O
she,O
will,O
be,O
observed,O
for,O
epistaxis,B-PR
.,O

She,O
will,O
take,O
her,O
last,O
dose,O
of,O
Coumadin,B-TR
on,O
September,O
1,O
in,O
anticipation,O
of,O
cardiac,B-TR
surgery,I-TR
.,O

If,O
her,B-TE
prothrombin,I-TE
time,I-TE
does,O
not,O
come,O
into,O
therapeutic,O
range,O
promptly,O
",",O
then,O
surgery,B-TR
may,O
be,O
delayed,O
.,O

DISCHARGE,O
REGIMEN,O
:,O

Coumadin,B-TR
",",O
5,O
mg.,O
",",O
alternating,O
with,O
2.5,O
mg.,O
",",O
qD,O
",",O
digoxin,B-TR
",",O
0.125,O
mg.,O
",",O
qD,O
",",O
Lasix,B-TR
",",O
80,O
mg.,O
",",O
qAM,O
and,O
40,O
mg.,O
",",O
qPM,O
",",O
Vanceril,B-TR
",",O
3,O
puffs,O
",",O
b.i.d.,O

CA,O
N.,O
SHUFF,O
",",O
M.D.,O

TR,O
:,O

yqv,O
/,O
bmot,O

DD,O
:,O

8/23/93,O

TD,O
:,O

08/23/93,O

CC,O
:,O

A,O
copy,O
to,O
Dr.,O
Ca,O
Shuff,O
at,O
Valtawnprinceel,O
Community,O
Memorial,O
Hospital,O
",",O
a,O
copy,O
to,O
Dr.,O
A,O
Skizeis,O
",",O
a,O
copy,O
to,O
Dr.,O
Riemund,O
C.,O
Kennedy,O
",",O
and,O
three,O
copies,O
to,O
Dr.,O
Shuff,O
&apos;s,O
office,O
.,O

Admission,O
Date,O
:,O

2014-11-13,O

Discharge,O
Date,O
:,O

2014-12-05,O

Date,O
of,O
Birth,O
:,O

2014-11-13,O

Sex,O
:,O

M,O

Service,O
:,O

Neonatology,O

HISTORY,O
:,O

Baby,O
Boy,O
Timberlake,O
was,O
born,O
to,O
a,O
25,O
-,O
year-old,O
G-8,O
",",O
P-4,O
to,O
5,O
mom,O
with,O
Julie,O
type,O
B,O
positive,O
",",O
antibody,B-TE
negative,O
",",O
hepatitis,B-TE
B,I-TE
surface,I-TE
antigen,I-TE
negative,O
",",O
rubella,B-TE
immune,I-TE
",",O
RPR,B-TE
nonreactive,O
",",O
GBS,B-PR
positive,I-PR
with,O
a,O
history,O
of,O
infrequent,O
prenatal,O
care,O
since,O
28,O
weeks,O
time,O
and,O
preterm,B-PR
labor,I-PR
.,O

Mother,O
had,O
a,O
history,O
of,O
anxiety,B-PR
and,O
asthma,B-PR
as,O
well,O
as,O
moderate,O
cigarette,O
smoking,O
.,O

The,O
baby,O
was,O
delivered,O
through,O
normal,O
spontaneous,O
vaginal,O
delivery,O
with,O
brief,B-TR
blow,I-TR
by,I-TR
with,O
Apgars,B-TE
of,O
8,O
and,O
9,O
.,O

Father,O
of,O
baby,O
not,O
involved,O
at,O
this,O
time,O
.,O

The,O
patient,O
's,O
pediatrician,O
is,O
Wellesley,O
House,O
and,O
is,O
Dr,O
.,O
Shaw,O
.,O

The,O
patient,O
has,O
many,O
siblings,O
",",O
all,O
of,O
which,O
are,O
girls,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,O
",",O
the,B-TE
patient,I-TE
's,I-TE
birth,I-TE
weight,I-TE
was,O
1.705,O
kilograms,O
",",O
which,O
is,O
50th,O
percentile,O
.,O

Length,B-TE
was,O
40,O
cm,O
",",O
50th,O
percentile,O
.,O

Head,B-TE
circumference,I-TE
was,O
30,O
cm,O
",",O
50th,O
percentile,O
.,O

The,O
patient,O
was,O
born,O
at,O
32,O
and,O
4/7,O
weeks,O
gestation,O
and,O
brought,O
directly,O
to,O
the,O
CMED,O
CSRU,O
.,O

HOSPITAL,O
COURSE,O
:,O

By,O
systems,O
:,O

Respiratory,O
.,O

After,O
receiving,O
brief,B-TR
blow,I-TR
by,I-TR
oxygen,I-TR
in,O
the,O
delivery,O
room,O
",",O
the,O
patient,O
had,O
no,O
further,O
episodes,O
of,O
ventilatory,B-TR
assistance,I-TR
required,O
with,O
good,O
respiratory,O
rate,O
consistently,O
.,O

The,O
patient,O
was,O
never,O
placed,O
on,O
caffeine,B-TR
.,O

He,O
is,O
stable,O
in,O
room,O
air,O
at,O
this,O
time,O
.,O

Cardiovascular,O
.,O

No,O
active,O
issues,O
.,O

No,O
history,O
of,O
hypotension,B-PR
.,O

On,O
no,O
medications,B-TR
at,O
this,O
time,O
.,O

Notably,O
with,O
respect,O
to,O
apnea,B-PR
and,O
bradycardia,B-PR
of,O
prematurity,B-PR
",",O
the,O
patient,O
has,O
reached,O
5,O
days,O
without,O
significant,B-PR
apneic,I-PR
or,I-PR
bradycardic,I-PR
spells,I-PR
as,O
of,O
the,O
time,O
of,O
discharge,O
.,O

Fluids,O
",",O
electrolytes,O
and,O
nutrition,O
.,O

The,O
patient,O
reached,O
full,O
volume,O
feeds,O
by,O
day,O
of,O
life,O
6,O
and,O
had,O
calories,O
increased,O
to,O
maximum,O
of,O
26,O
kilocalories,O
per,O
ounce,O
of,O
Similac,B-TR
special,I-TR
care,I-TR
until,O
2014-12-03,O
",",O
at,O
which,O
point,O
this,O
was,O
weaned,O
to,O
24,O
kilocalories,O
per,O
ounce,O
of,O
straight,B-TR
Similac,I-TR
.,O

This,O
is,O
the,O
baby,O
's,O
discharge,O
feedings,O
and,O
he,O
is,O
p.o.,O
ad,O
lib,O
with,O
a,O
minimum,O
of,O
130,O
ml/kg/day,O
",",O
the,O
patient,O
has,O
taken,O
on,O
an,O
average,O
greater,O
than,O
150,O
ml/kg/day,O
ad,O
lib,O
over,O
each,O
of,O
the,O
past,O
5,O
days,O
.,O

GI,O
.,O

The,O
patient,O
with,O
peak,B-TE
bilirubin,I-TE
of,O
6.5,O
on,O
day,O
of,O
life,O
3,O
.,O

No,O
phototherapy,B-TR
was,O
required,O
.,O

Hematology,O
/,O
Infectious,O
Disease,O
.,O

The,B-TE
patient,I-TE
's,I-TE
hematocrit,I-TE
at,O
delivery,O
was,O
48,O
",",O
with,O
a,B-TE
white,I-TE
count,I-TE
of,O
11.2,O
and,O
platelets,B-TE
of,O
"301,000",O
.,O

Initial,B-TE
differential,I-TE
was,O
35,B-TE
polys,I-TE
and,O
zero,B-TE
bands,I-TE
",",O
not,O
suspicious,O
for,O
infectious,B-PR
condition,I-PR
.,O

The,O
patient,O
was,O
initially,O
treated,O
with,O
48,O
hours,O
of,O
ampicillin,B-TR
and,O
gentamicin,B-TR
until,O
blood,B-TE
cultures,I-TE
were,O
negative,O
.,O

The,O
infant,O
has,O
had,O
no,O
antibiotics,B-TR
since,O
that,O
time,O
.,O

Neurology,O
.,O

No,O
issues,O
.,O

Sensory,O
.,O

Hearing,B-TE
screen,I-TE
was,O
performed,O
with,O
automated,B-TE
auditory,I-TE
brainstem,I-TE
responses,I-TE
and,O
was,O
normal,O
on,O
2014-11-24,O
.,O

Ophthalmology,O
.,O

The,O
patient,O
did,O
not,O
qualify,O
for,O
routine,B-TE
ophthalmology,I-TE
exams,I-TE
due,O
to,O
his,O
gestational,O
age,O
at,O
birth,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
.,O

DISCHARGE,O
DISPOSITION,O
:,O

Home,O
.,O

PRIMARY,O
PEDIATRICIAN,O
:,O

Dr.,O
Shaw,O
at,O
Wellesley,O
House,O
.,O

CARE,O
RECOMMENDATIONS,O
:,O

1.,O
Feedings,O
at,O
discharge,O
-,O
Similac,B-TR
24,O
kilocalories,O
per,O
ounce,O
p.o.,O
ad,O
lib,O
.,O

If,O
the,O
patient,O
achieves,O
above,O
adequate,O
weight,O
gain,O
of,O
18-20,O
grams,O
per,O
kilogram,O
per,O
day,O
",",O
consider,O
decreasing,O
calories,O
to,O
standard,O
20,O
kilocalories,O
per,O
ounce,O
.,O

2.,O
Car,B-TE
seat,I-TE
positioning,I-TE
screening,I-TE
passed,O
.,O

3.,O
State,B-TE
newborn,I-TE
screening,I-TE
sent,O
per,O
protocol,O
and,O
no,O
abnormal,B-PR
reports,I-PR
have,O
been,O
received,O
.,O

4.,O
Immunizations,B-TR
received,O
:,O

Synagis,B-TR
RSV,I-TR
prophylaxis,I-TR
given,O
today,O
due,O
to,O
multiple,O
siblings,O
at,O
home,O
with,O
daycare,O
exposure,O
and,O
the,O
patient,O
being,O
between,O
32,O
and,O
35,O
weeks,O
.,O

Synagis,B-TR
RSV,I-TR
prophylaxis,I-TR
should,O
be,O
considered,O
in,O
general,O
from,O
November,O
through,O
March,O
for,O
infants,O
who,O
meet,O
any,O
of,O
the,O
following,O
3,O
criteria,O
:,O

1.,O
Born,O
at,O
less,O
than,O
32,O
weeks,O
",",O

2.,O
Born,O
between,O
32,O
and,O
35,O
weeks,O
with,O
2,O
of,O
the,O
following,O
:,O

Daycare,O
during,O
RSV,O
season,O
",",O
a,O
smoker,O
in,O
the,O
household,O
",",O
neuromuscular,B-PR
disease,I-PR
",",O
airway,B-PR
abnormalities,I-PR
or,O
school,O
age,O
sibling,O
",",O
or,O
3.,O
With,O
chronic,B-PR
lung,I-PR
disease,I-PR
.,O

Influenza,B-TR
immunization,I-TR
is,O
recommended,O
annually,O
in,O
the,O
fall,O
for,O
all,O
infants,O
once,O
they,O
reach,O
6,O
months,O
of,O
age,O
.,O

Before,O
this,O
age,O
and,O
for,O
the,O
first,O
24,O
months,O
of,O
the,O
child,O
's,O
life,O
",",O
immunization,B-TR
against,O
influenza,B-PR
is,O
recommended,O
for,O
household,O
contacts,O
and,O
out,O
of,O
home,O
caregivers,O
.,O

FOLLOW,O
UP,O
:,O

VNA,O
and,O
pediatric,O
primary,O
care,O
physician,O
appointments,O
to,O
be,O
scheduled,O
prior,O
to,O
discharge,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Prematurity,B-PR
.,O

2.,O
Apnea,B-PR
of,O
prematurity,B-PR
.,O

3.,O
Rule,O
out,O
sepsis,B-PR
.,O

Carol,O
Eddie,O
m.d,O
00-112,O

Dictated,O
By,O
:,O
John,O
KT,O
Bolling,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2014-12-05,O
15:53:11,O

T,O
:,O
2014-12-05,O
16:49:10,O

Job,O
#,O
:,O
28583,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Carol,O
Warren,O
on,O
:,O
MON,O
2014-12-08,O
11:49,O
AM,O

(,O
End,O
of,O
Report,O
),O

180414134,O

PUOMC,O

8987576,O

39627,O

936967,O

09/08/1996,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

PRUESSCHIRD,O
",",O
RIIE,O

UNIT,O
NUMBER,O
:,O

825-78-07,O

ADMISSION,O
DATE,O
:,O

09/08/96,O

DISCHARGE,O
DATE,O
:,O

09/17/96,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
82,O
year,O
old,O
retired,O
engineer,O
has,O
had,O
multiple,O
admissions,O
to,O
the,O
Ph,O
University,O
Of,O
Medical,O
Center,O
for,O
multiple,B-PR
strokes,I-PR
and,O
a,B-PR
spontaneous,I-PR
subdural,I-PR
hematoma,I-PR
and,O
prostatic,B-PR
hypertrophy,I-PR
.,O

He,O
has,O
been,O
managing,O
at,O
home,O
on,O
restricted,B-TR
activity,I-TR
but,O
able,O
to,O
get,O
around,O
with,O
a,B-TR
walker,I-TR
but,O
on,O
the,O
day,O
before,O
admission,O
he,O
became,O
increasing,B-PR
dyspneic,I-PR
and,O
on,O
the,O
day,O
of,O
admission,O
he,O
collapsed,O
and,O
was,O
unable,O
to,O
walk,O
to,O
his,O
bed,O
.,O

For,O
this,O
he,O
was,O
admitted,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,B-TE
physical,I-TE
examination,I-TE
the,O
patient,O
was,O
both,O
chronically,B-PR
and,I-PR
acutely,I-PR
ill,I-PR
",",O
dyspneic,B-PR
",",O
mildly,B-PR
febrile,I-PR
and,O
with,O
coarse,B-PR
rales,I-PR
in,I-PR
both,I-PR
bases,I-PR
.,O

He,O
was,O
in,O
chronic,B-PR
atrial,I-PR
fibrillation,I-PR
and,O
his,B-TE
vital,I-TE
signs,I-TE
were,O
otherwise,O
stable,O
.,O

His,O
abdomen,O
was,O
negative,O
.,O

His,B-PR
prostate,I-PR
enlarged,I-PR
and,O
he,O
had,O
no,O
peripheral,B-PR
edema,I-PR
.,O

LABORATORY,O
DATA,O
:,O

He,O
had,O
mild,B-PR
elevation,I-PR
of,O
the,B-TE
WBC,I-TE
intermittently,B-PR
grossly,I-PR
bloody,I-PR
urine,I-PR
.,O

No,O
cultures,B-TE
were,O
positive,B-PR
but,O
the,B-TE
chest,I-TE
x-ray,I-TE
showed,O
bilateral,B-PR
densities,I-PR
more,O
on,O
the,O
left,O
than,O
the,O
right,O
compatible,O
with,O
aspiration,B-PR
pneumonia,I-PR
.,O

There,O
were,O
no,O
radiographic,O
indications,O
of,O
congestive,B-PR
heart,I-PR
failure,I-PR
.,O

HOSPITAL,O
COURSE,O
AND,O
TREATMENT,O
:,O

The,O
patient,O
was,O
started,O
on,O
Clindamycin,B-TR
intravenous,I-TR
and,O
Cefuroxime,B-TR
intravenous,I-TR
with,O
clearing,O
of,O
his,B-PR
fever,I-PR
but,O
persistence,O
of,O
cough,B-PR
",",O
choking,B-PR
",",O
and,O
intermittently,B-PR
many,I-PR
coarse,I-PR
rales,I-PR
in,I-PR
his,I-PR
base,I-PR
with,O
no,O
clearing,O
by,B-TE
x-ray,I-TE
.,O

His,O
ambulation,O
was,O
minimal,O
and,O
always,O
with,O
assistance,O
but,O
he,O
had,O
a,B-TR
transurethral,I-TR
resection,I-TR
of,I-TR
the,I-TR
prostate,I-TR
on,O
09/14/96,O
.,O

He,O
is,O
transferred,O
to,O
Louline,O
Mauikings,O
Medical,O
Center,O
for,O
future,B-TR
rehabilitation,I-TR
and,O
hopeful,O
return,O
home,O
with,O
considerable,O
support,O
and,O
assistance,O
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

Aspiration,B-PR
pneumonia,I-PR
bilateral,I-PR
",",O
multiple,B-PR
strokes,I-PR
",",O
chronic,B-PR
atrial,I-PR
fibrillation,I-PR
",",O
prostatic,B-PR
hypertrophy,I-PR
with,O
gross,B-PR
hematuria,I-PR
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Digoxin,B-TR
0.25,O
mg,O
.,O

Hytrin,B-TR
2mg,O
at,O
bedtime,O
.,O

Ticlid,B-TR
0.25,O
g,O
po,O
bid,O
.,O

Bronchodilators,B-TR
as,O
needed,O
.,O

DOCTOR,O
&apos;S,O
DISCHARGE,O
ORDERS,O
:,O

Strict,B-TR
aspiration,I-TR
precautions,I-TR
with,O
avoidance,B-TR
of,I-TR
clear,I-TR
liquids,I-TR
and,O
all,O
other,O
liquids,O
thickened,O
.,O

Increased,O
ambulation,O
with,O
assistance,O
and,O
daily,B-TR
pulmonary,I-TR
physical,I-TR
therapy,I-TR
.,O

TOOB,O
OBESTIMEUPH,O
",",O
M.D.,O

TR,O
:,O

ua,O

DD,O
:,O

09/16/96,O

TD,O
:,O

09/16/96,O
4:10,O
P,O

cc,O
:,O

DOJE,O
EED,O
BOLMSHI,O
",",O
M.D.,O
TOOB,O
I,O
OBESTIMEUPH,O
",",O
M.D.,O
l1xk,O
STAT,O

Admission,O
Date,O
:,O

2010-02-05,O

Discharge,O
Date,O
:,O

2010-02-06,O

Date,O
of,O
Birth,O
:,O

1986-06-14,O

Sex,O
:,O

F,O

Service,O
:,O

TRAUMA,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
23,O
year,O
old,O
female,O
",",O
status,O
post,O
fall,O
from,O
standing,O
position,O
after,O
slipping,O
on,O
ice,O
.,O

She,O
had,O
no,O
loss,B-PR
of,I-PR
consciousness,I-PR
.,O

She,O
recalled,O
the,O
entire,O
event,O
.,O

She,O
was,O
found,O
by,O
family,O
and,O
friends,O
to,O
be,O
somewhat,B-PR
confused,I-PR
and,O
was,O
therefore,O
taken,O
to,O
Newton-Wellesley,O
Hospital,O
thereafter,O
.,O

Workup,B-TE
at,O
the,O
outside,O
hospital,O
included,O
a,B-TE
CT,I-TE
scan,I-TE
of,I-TE
the,I-TE
head,I-TE
revealing,O
a,O
possible,O
parietal,B-PR
subdural,I-PR
bleed,I-PR
on,I-PR
the,I-PR
right,I-PR
side,I-PR
.,O

The,B-TE
patient,I-TE
's,I-TE
GCS,I-TE
was,O
15,O
.,O

She,O
was,O
hemodynamically,O
stable,O
.,O

She,O
was,O
thereafter,O
transferred,O
to,O
Beverly,O
Hospital,O
for,O
further,B-TE
evaluation,I-TE
and,O
management,B-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Significant,O
for,O
depression,B-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

1.,O
Prozac,B-TR
.,O

2.,O
Tetracycline,B-TR
for,O
acne,B-PR
.,O

ALLERGIES,O
:,O

She,O
has,O
no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
presentation,O
",",O
her,B-TE
temperature,I-TE
was,O
98.8,O
with,O
a,B-TE
heart,I-TE
rate,I-TE
of,O
100,O
",",O
blood,B-TE
pressure,I-TE
110/65,O
",",O
respiratory,B-TE
rate,I-TE
18,O
",",O
and,O
she,O
was,O
saturating,O
at,O
100%,O
in,O
room,O
air,O
.,O

In,O
general,O
",",O
she,O
is,O
well,O
appearing,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

Head,B-TE
",",I-TE
eyes,I-TE
",",I-TE
ears,I-TE
",",I-TE
nose,I-TE
and,I-TE
throat,I-TE
examination,I-TE
-,O
The,O
pupils,O
are,O
equal,O
",",O
round,O
",",O
and,O
reactive,O
to,O
light,O
and,O
accommodation,O
.,O

Extraocular,O
movements,O
are,O
intact,O
.,O

The,O
oropharynx,O
is,O
negative,O
.,O

Face,O
is,O
stable,O
.,O

No,O
obvious,O
evidence,O
of,O
trauma,B-PR
.,O

She,O
is,O
normocephalic,O
otherwise,O
.,O

Trachea,O
was,O
midline,O
.,O

The,O
heart,O
was,O
regular,O
.,O

The,O
lungs,O
were,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

No,O
crepitus,B-PR
.,O

The,O
abdomen,O
was,O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
.,O

Extremities,O
with,O
no,O
evidence,O
of,O
step-off,B-PR
",",O
palpable,O
pulses,O
peripherally,O
.,O

She,O
had,O
brisk,O
capillary,O
refill,O
.,O

Rectal,B-TE
examination,I-TE
was,O
heme,B-TE
negative,O
with,O
normal,O
tone,O
.,O

Neurologic,B-TE
examination,I-TE
was,O
nonfocal,O
.,O

Neurosensory,O
was,O
intact,O
and,O
she,O
had,O
normal,O
motor,O
examination,O
with,O
5/5,O
strength,O
throughout,O
all,O
her,O
upper,O
and,O
lower,O
extremities,O
.,O

LABORATORY,O
DATA,O
:,O

Admission,B-TE
laboratories,I-TE
were,O
notable,O
for,O
a,B-TE
white,I-TE
count,I-TE
of,O
13.1,O
",",O
hematocrit,B-TE
34.0,O
",",O
platelet,B-TE
count,I-TE
"280,000",O
.,O

Chemistries,B-TE
were,O
notable,O
for,O
a,B-TE
sodium,I-TE
of,O
143,O
",",O
potassium,B-TE
3.2,O
",",O
chloride,B-TE
and,O
bicarbonate,B-TE
of,O
104,O
and,O
24,O
",",O
respectively,O
",",O
with,O
blood,B-TE
urea,I-TE
nitrogen,I-TE
and,O
creatinine,B-TE
of,O
7,O
and,O
0.4,O
",",O
respectively,O
.,O

Blood,B-TE
glucose,I-TE
was,O
116,O
.,O

Her,B-TE
admission,I-TE
coagulation,I-TE
studies,I-TE
were,O
notable,O
for,O
a,B-TE
prothrombin,I-TE
time,I-TE
INR,B-TE
of,O
11.8,O
and,O
0.9,O
",",O
respectively,O
with,O
a,B-TE
partial,I-TE
thromboplastin,I-TE
time,I-TE
of,O
25.2,O
.,O

Admission,B-TE
lactate,I-TE
was,O
0.8,O
.,O

Amylase,B-TE
was,O
87,O
.,O

Fibrinogen,B-TE
was,O
346,O
.,O

HCG,B-TE
was,O
negative,O
.,O

Serum,B-TE
toxicology,I-TE
and,O
urine,B-TE
toxicology,I-TE
were,O
negative,O
.,O

Urinalysis,B-TE
obtained,O
on,O
admission,O
was,O
additionally,O
negative,O
.,O

She,O
had,O
three,B-TE
views,I-TE
of,I-TE
the,I-TE
cervical,I-TE
spine,I-TE
that,O
were,O
negative,O
.,O

Chest,B-TE
x-ray,I-TE
was,O
negative,O
.,O

Pelvis,B-TE
film,I-TE
was,O
negative,O
.,O

Head,B-TE
CT,I-TE
from,O
the,O
outside,O
hospital,O
just,O
revealed,O
a,B-PR
small,I-PR
right,I-PR
parietal,I-PR
subdural,I-PR
blood,I-PR
.,O

She,O
was,O
evaluated,O
.,O

Her,O
cervical,O
spine,O
was,O
cleared,O
.,O

She,O
was,O
off,O
TLS,B-TR
precautions,I-TR
.,O

She,O
was,O
sent,O
to,O
the,O
Intensive,O
Care,O
Unit,O
for,O
monitoring,O
overnight,O
for,O
neural,B-TE
checks,I-TE
and,O
neurosurgical,O
consultation,O
was,O
obtained,O
.,O

Neurosurgical,B-TE
evaluation,I-TE
just,O
recommended,O
serial,B-TE
neurologic,I-TE
checks,I-TE
and,O
a,B-TE
repeat,I-TE
CAT,I-TE
scan,I-TE
on,O
the,O
second,O
day,O
of,O
admission,O
to,O
see,O
if,O
there,O
was,O
any,O
evidence,O
of,O
progression,O
of,O
the,B-PR
bleeding,I-PR
.,O

On,O
2010-02-05,O
",",O
the,O
patient,O
had,O
a,B-TE
repeat,I-TE
CAT,I-TE
scan,I-TE
of,I-TE
the,I-TE
head,I-TE
revealing,O
no,O
change,B-PR
in,I-PR
the,I-PR
subdural,I-PR
bleed,I-PR
.,O

Her,B-TE
neurologic,I-TE
examination,I-TE
remained,O
nonfocal,O
.,O

She,O
was,O
kept,O
in,O
the,O
hospital,O
for,O
an,O
additional,O
24,O
hours,O
for,O
further,B-TE
evaluation,I-TE
.,O

By,O
2010-02-06,O
",",O
which,O
would,O
correlate,O
with,O
hospital,O
day,O
number,O
two,O
",",O
the,O
patient,O
had,O
no,O
complaints,O
except,O
for,O
some,B-PR
small,I-PR
frontal,I-PR
pressure,I-PR
in,O
the,O
region,O
of,O
where,O
the,B-PR
bleed,I-PR
had,O
been,O
localized,O
on,O
the,O
right,O
side,O
.,O

She,O
remained,O
afebrile,B-PR
and,O
hemodynamically,O
.,O

She,O
was,O
tolerating,O
diet,O
and,O
able,O
to,O
ambulate,O
without,O
difficulty,O
.,O

She,O
had,O
no,O
other,O
complaints,O
by,O
examination,B-TE
.,O

Her,B-TE
neurologic,I-TE
examination,I-TE
remained,O
completely,O
nonfocal,O
and,O
otherwise,O
normal,O
.,O

She,O
was,O
seen,O
by,O
the,O
trauma,O
attending,O
with,O
Dr.,O
Walters,O
and,O
she,O
was,O
cleared,O
for,O
discharge,O
to,O
home,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

1.,O
Tylenol,B-TR
#3,I-TR
one,O
to,O
two,O
tablets,O
p.o.,O
q,O
4-6,O
hours,O
p.r.n.,O

2.,O
Motrin,B-TR
as,O
needed,O
.,O

3.,O
Prozac,B-TR
20,O
mg,O
p.o.,O
once,O
daily,O
.,O

4.,O
Tetracycline,B-TR
which,O
she,O
was,O
taking,O
for,O
her,B-PR
acne,I-PR
.,O

FOLLOW-UP,O
:,O

She,O
will,O
follow-up,O
with,O
Dr.,O
Langley,O
in,O
approximately,O
one,O
month,O
.,O

Her,O
trauma,O
clinic,O
follow-up,O
is,O
strictly,O
p.r.n.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Right,B-PR
parietal,I-PR
subdural,I-PR
bleed,I-PR
",",O
status,O
post,O
fall,O
from,O
standing,O
position,O
with,O
no,O
loss,B-PR
of,I-PR
consciousness,I-PR
and,O
no,O
neurologic,B-PR
deficits,I-PR
or,O
progression,B-PR
.,O

2.,O
Depression,B-PR
.,O

3.,O
Acne,B-PR
.,O

DISCHARGE,O
STATUS,O
:,O

The,O
patient,O
was,O
discharged,O
to,O
home,O
in,O
stable,O
condition,O
.,O

Charles,O
I.,O
.,O
Sanders,O
",",O
M.D.,O
76-364,O

Dictated,O
By,O
:,O
Hayden,O
Y.,O
Ferguson,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2010-02-06,O
08:59,O

T,O
:,O
2010-02-06,O
09:10,O

JOB,O
#:,O
73118,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Theresa,O
MOORMAN,O
on,O
:,O
FRI,O
2010-02-26,O
3:21,O
PM,O

(,O
End,O
of,O
Report,O
),O

186890029,O

SH,O

58809909,O

1/5/1994,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

01/05/1994,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

01/25/1994,O

PRINCIPLE,O
DIAGNOSIS,O
:,O

METASTATIC,B-PR
ADENOCARCINOMA,I-PR
OF,I-PR
THE,I-PR
BREAST,I-PR
.,O

OTHER,O
PROBLEMS,O
:,O

1.,O
HYPONATREMIA,B-PR
",",O
1-13-94,O
.,O

2.,O
PULMONARY,B-PR
EMBOLUS,I-PR
",",O
1-14-94,O
.,O

3.,O
DIARRHEA,B-PR
",",O
NAUSEA,B-PR
AND,O
VOMITING,B-PR
",",O
FEVER,B-PR
.,O

4.,O
HISTORY,O
OF,O
OVARIAN,B-TR
CYST,I-TR
RESECTION,I-TR
",",O
1975,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
49,O
year,O
old,O
woman,O
with,O
a,B-PR
metastatic,I-PR
adenocarcinoma,I-PR
of,I-PR
the,I-PR
breast,I-PR
who,O
is,O
status,O
post,O
high,B-TR
dose,I-TR
chemotherapy,I-TR
with,O
PBSE,B-TR
and,O
CCSS,B-TR
support,I-TR
ending,O
June,O
1994,O
.,O

She,O
was,O
admitted,O
on,O
1-5-94,O
for,O
fever,B-PR
",",O
chest,B-PR
wall,I-PR
ulceration,I-PR
",",O
cellulitis,B-PR
and,O
pain,B-TR
control,I-TR
.,O

The,O
patient,O
first,O
presented,O
in,O
October,O
1991,O
with,O
a,B-PR
tender,I-PR
right,I-PR
axillary,I-PR
mass,I-PR
.,O

A,B-TE
mammogram,I-TE
done,O
in,O
November,O
1990,O
was,O
negative,O
.,O

However,O
",",O
mammography,B-TE
repeated,O
in,O
October,O
1991,O
showed,O
bilateral,B-PR
breast,I-PR
masses,I-PR
",",O
suspicious,O
for,O
carcinoma,B-PR
.,O

Fine,B-TE
needle,I-TE
aspiration,I-TE
on,O
October,O
23,O
",",O
1991,O
demonstrated,O
atypical,B-PR
cells,I-PR
which,O
occurred,O
singly,O
and,O
in,O
clusters,O
.,O

Staging,B-TE
evaluation,I-TE
included,O
normal,O
liver,O
function,O
tests,O
",",O
normal,O
blood,O
counts,O
and,O
normal,O
chest,O
x-ray,O
.,O

Bone,B-TE
scan,I-TE
showed,O
degenerative,B-PR
joint,I-PR
disease,I-PR
in,I-PR
the,I-PR
shoulders,I-PR
and,I-PR
lumbar,I-PR
spine,I-PR
as,O
well,O
as,O
increased,B-PR
radio,I-PR
chaser,I-PR
uptake,I-PR
in,I-PR
the,I-PR
breast,I-PR
bilaterally,I-PR
.,O

Dr.,O
Berca,O
Gachfrum,O
performed,O
a,B-TR
right,I-TR
modified,I-TR
mastectomy,I-TR
and,O
left,B-TR
simple,I-TR
mastectomy,I-TR
on,O
November,O
4,O
",",O
1991,O
.,O

The,B-TR
right,I-TR
modified,I-TR
radical,I-TR
mastectomy,I-TR
contained,O
a,B-PR
5.5,I-PR
cm,I-PR
poorly,I-PR
differentiated,I-PR
",",I-PR
Grade,I-PR
III,I-PR
out,I-PR
of,I-PR
III,I-PR
infiltrating,I-PR
ductal,I-PR
carcinoma,I-PR
.,O

The,O
margins,O
were,O
free,O
of,O
tumor,B-PR
",",O
but,O
10,O
out,O
of,O
21,O
lymph,O
nodes,O
were,O
positive,O
for,O
metastatic,B-PR
carcinoma,I-PR
.,O

Furthermore,O
there,O
was,O
a,B-PR
mass,I-PR
on,I-PR
the,I-PR
right,I-PR
pectoralis,I-PR
muscle,I-PR
which,O
is,O
supposed,O
to,O
be,O
metastatic,B-PR
cancer,I-PR
.,O

The,B-TR
left,I-TR
simple,I-TR
mastectomy,I-TR
also,O
contained,O
5.5,B-PR
cm,I-PR
poorly,I-PR
differentiated,I-PR
infiltrating,I-PR
ductal,I-PR
and,I-PR
intraductal,I-PR
carcinoma,I-PR
with,O
extensive,B-PR
lymphatic,I-PR
vessel,I-PR
invasion,I-PR
.,O

Estrogen,B-TE
receptor,I-TE
was,O
0%,O
by,O
ERICA,O
.,O

The,O
patient,O
developed,O
a,B-PR
large,I-PR
hematoma,I-PR
requiring,O
surgical,B-TR
drainage,I-TR
.,O

Therefore,O
she,O
had,O
a,B-PR
Stage,I-PR
III-A,I-PR
adenocarcinoma,I-PR
of,I-PR
the,I-PR
breast,I-PR
.,O

Since,O
she,O
was,O
at,O
high,O
risk,O
for,O
both,O
local,B-PR
and,I-PR
metastatic,I-PR
recurrence,I-PR
of,O
her,B-PR
tumor,I-PR
",",O
she,O
received,O
both,O
systemic,B-TR
chemotherapy,I-TR
and,O
radiation,B-TR
therapy,I-TR
.,O

The,O
patient,O
was,O
treated,O
with,O
CMSAP,B-TR
",",O
which,O
is,O
Cytoxan,B-TR
",",O
Methotrexate,B-TR
",",O
Leukovoranrescue,B-TR
",",O
5-FU,B-TR
",",O
Adriamycin,B-TR
and,O
Prednisone,B-TR
for,O
four,O
cycles,O
.,O

There,O
were,O
no,O
dose,O
reductions,O
for,O
mucositis,B-PR
or,O
myelosuppression,B-PR
.,O

However,O
",",O
following,O
cycle,O
4,O
",",O
she,O
developed,O
a,B-PR
flu-like,I-PR
illness,I-PR
",",O
followed,O
by,O
fever,B-PR
",",O
nonproductive,B-PR
cough,I-PR
and,O
dyspnea,B-PR
on,O
exertion,O
.,O

ABGs,B-TE
showed,O
a,B-TE
pO2,I-TE
of,O
79,O
",",O
pH,B-TE
7.44,O
",",O
pO2,B-TE
33,O
.,O

Chest,B-TE
x-ray,I-TE
showed,O
diffuse,B-PR
interstitial,I-PR
infiltrates,I-PR
.,O

The,O
differential,O
diagnosis,O
included,O
viral,B-PR
pneumonitis,I-PR
",",O
Mycoplasma,B-PR
",",O
Chlamydia,B-PR
.,O

Basically,O
in,O
December,O
1993,O
",",O
she,O
returned,O
to,O
the,O
Hem,O
/,O
Onc,O
Clinic,O
with,O
chest,B-PR
wall,I-PR
nodules,I-PR
which,O
turned,O
out,O
to,O
be,O
tumor,B-PR
recurrences,I-PR
and,O
biopsied,O
.,O

Although,O
she,O
had,O
mediastinal,B-PR
recurrence,I-PR
",",O
bone,B-TE
scan,I-TE
",",O
head,B-TE
and,I-TE
liver,I-TE
CT,I-TE
were,O
negative,O
for,O
metastatic,B-PR
disease,I-PR
.,O

She,O
was,O
thus,O
started,O
on,O
a,O
Protocol,O
of,O
high,B-TR
dose,I-TR
chemotherapy,I-TR
with,O
GCSF,B-TR
and,O
peripheral,B-TR
stem,I-TR
cell,I-TR
support,I-TR
.,O

Complications,B-PR
has,O
mainly,O
included,O
myelosuppression,B-PR
and,O
mucositis,B-PR
.,O

She,O
also,O
developed,O
Klebsiella,B-PR
UTI,I-PR
after,O
the,O
second,O
cycle,O
of,O
high,B-TR
dose,I-TR
chemotherapy,I-TR
.,O

It,O
was,O
treated,O
with,O
gent,B-TR
and,O
Cipro,B-TR
.,O

Re-staging,B-TE
done,O
in,O
April,O
1993,O
showed,O
a,B-PR
decrease,I-PR
in,I-PR
the,I-PR
pretracheal,I-PR
nodes,I-PR
with,O
question,O
of,O
some,B-PR
lymphangitic,I-PR
spread,I-PR
versus,O
some,B-PR
pneumonitis,I-PR
.,O

In,O
May,O
1994,O
she,O
received,O
her,O
first,O
course,O
of,O
thiotepa,B-TR
and,O
Velban,B-TR
and,O
Methotrexate,B-TR
",",O
which,O
required,O
some,B-TR
red,I-TR
cell,I-TR
transfusions,I-TR
.,O

In,O
mid,O
May,O
she,O
was,O
admitted,O
for,O
fever,B-PR
and,O
neutropenia,B-PR
and,O
at,O
that,O
time,O
had,O
a,B-PR
UTI,I-PR
with,O
blood,B-PR
clots,I-PR
in,I-PR
the,I-PR
urine,I-PR
.,O

The,O
patient,O
presents,O
today,O
with,O
complaints,O
of,O
fever,B-PR
and,O
a,B-TE
temperature,I-TE
of,O
100,O
.,O

She,O
has,O
also,O
been,O
having,O
diarrhea,B-PR
since,O
November,O
and,O
her,O
other,O
complaints,O
of,O
admission,O
include,O
confusion,B-PR
",",O
nausea,B-PR
and,O
vomiting,B-PR
.,O

We,O
will,O
include,O
a,O
very,O
thorough,O
HPI,O
with,O
this,O
dictation,O
that,O
was,O
done,O
by,O
Dr.,O
Wedleung,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Significant,O
for,O
metastatic,B-PR
breast,I-PR
cancer,I-PR
",",O
complicated,O
by,O
fever,B-PR
and,O
neutropenia,B-PR
.,O

UTIs,B-PR
",",O
obstruction,B-PR
of,I-PR
the,I-PR
right,I-PR
subclavian,I-PR
vein,I-PR
and,I-PR
right,I-PR
brachial,I-PR
cephalic,I-PR
vein,I-PR
",",O
herpes,B-PR
zoster,I-PR
.,O

Status,O
post,O
ovarian,B-TR
cyst,I-TR
resection,I-TR
in,O
1975,O
.,O

She,O
had,O
menarche,O
at,O
age,O
15,O
.,O

She,O
used,O
the,B-TR
pill,I-TR
for,O
five,O
years,O
in,O
the,O
past,O
.,O

She,O
is,O
G,O
2,O
",",O
P,O
2,O
with,O
spontaneous,B-TR
vaginal,I-TR
deliveries,I-TR
.,O

She,O
has,O
a,O
history,O
of,O
easy,B-PR
bruis,I-PR
ability,I-PR
.,O

She,O
is,O
allergic,B-PR
to,O
Augmentin,B-TR
which,O
gives,O
her,O
a,B-PR
rash,I-PR
.,O

MEDICATIONS,O
:,O

MS,B-TR
Contin,I-TR
",",O
MSIR,B-TR
",",O
and,O
Percocet,B-TR
.,I-TR

FAMILY,O
HISTORY,O
:,O

Noncontributory,O
.,O

SOCIAL,O
HISTORY,O
:,O

Married,O
with,O
two,O
children,O
.,O

She,O
worked,O
as,O
an,O
occupational,O
therapist,O
at,O
a,O
professional,O
center,O
for,O
handicapped,O
children,O
.,O

She,O
denies,O
tobacco,O
and,O
drug,O
use,O
and,O
drinks,O
ethanol,O
socially,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

A,O
cachectic,O
white,O
female,O
.,O

T,B-TE
100.1,O
",",O
P,B-TE
104,O
",",O
blood,B-TE
pressure,I-TE
130/90,O
",",O
heart,B-TE
rate,I-TE
of,O
16,O
",",O
she,O
was,O
sating,B-TE
95%,O
on,O
room,O
air,O
.,O

HEENT,O
-,O
Pupils,O
were,O
miotic,B-PR
",",O
measuring,O
2,O
mm,O
but,O
responsive,O
to,O
light,O
.,O

Neck,O
-,O
Tender,B-PR
on,O
the,O
leftside,O
with,O
no,O
lymphadenopathy,B-PR
or,O
thyromegaly,B-PR
.,O

Lungs,O
were,O
clear,O
.,O

Chest,O
actually,O
had,O
a,B-PR
5,I-PR
x,I-PR
7,I-PR
cm,I-PR
necrotic,I-PR
area,I-PR
on,O
the,O
left,O
chest,O
wall,O
with,O
some,B-PR
pus,I-PR
.,O

Cardiovascular,O
-,O
Normal,O
.,O

Abdomen,O
-,O
Normal,O
.,O

There,O
was,O
no,O
HSM,B-PR
.,O

Extremities,O
-,O
Her,O
left,O
arm,O
was,O
very,B-PR
swollen,I-PR
.,O

It,O
was,O
tested,O
with,O
no,B-PR
voluntary,I-PR
movement,I-PR
except,O
at,O
the,O
finger,O
tips,O
.,O

There,O
was,O
no,O
edema,B-PR
elsewhere,O
in,O
her,O
extremities,O
",",O
only,O
the,O
left,O
arm,O
.,O

Neuro,O
-,O
The,O
patient,O
was,O
oriented,O
to,O
place,O
",",O
but,O
had,O
difficulty,B-PR
with,I-PR
recent,I-PR
memory,I-PR
.,O

She,O
also,O
had,O
mild,B-PR
weakness,I-PR
in,I-PR
the,I-PR
left,I-PR
extremities,I-PR
",",O
both,O
upper,O
and,O
lower,O
.,O

Cranial,O
nerves,O
II,O
-,O
XII,O
were,O
grossly,O
intact,O
.,O

Toes,O
were,O
downgoing,O
.,O

LABORATORY,O
DATA,O
:,O

Of,O
note,O
-,O
Na,B-TE
133,O
",",O
K,B-TE
4,O
",",O
WBC,B-TE
8.82,O
",",O
hematocrit,B-TE
35.1,O
",",O
platelets,B-TE
229,O
.,O

PT,B-TE
13.8,O
with,O
an,B-TE
INR,I-TE
of,O
1.3,O
",",O
PTT,B-TE
25.5,O
",",O
total,B-TE
protein,I-TE
was,O
6.2,O
",",O
albumin,B-TE
3.4,O
",",O
globulin,B-TE
of,O
2.8,O
",",O
calcium,B-TE
of,O
9.1,O
",",O
phos,B-TE
2.7,O
",",O
mag,B-TE
2.1,O
",",O
urea,B-TE
3.7,O
.,O

ALT,B-TE
was,O
elevated,B-PR
at,O
240,O
",",O
AST,B-TE
85,O
",",O
LDH,B-TE
305,O
",",O
alk,B-TE
phos,I-TE
85,O
",",O
total,B-TE
bilirubin,I-TE
was,O
1.3,O
",",O
direct,B-TE
bili,I-TE
was,O
.8,O
.,O

Cholesterol,B-TE
188,O
",",O
triglyceride,B-TE
was,O
127,O
.,O

UA,B-TE
-,O
trace,B-PR
protein,I-PR
",",O
trace,B-PR
ketones,I-PR
",",O
positive,B-PR
for,I-PR
bilirubin,I-PR
and,I-PR
nitrogen,I-PR
and,O
also,O
4,B-PR
to,I-PR
6,I-PR
wbcs,I-PR
with,O
1+,B-PR
bacteria,I-PR
.,O

Chest,B-TE
x-ray,I-TE
-,O
Showed,O
a,B-PR
left,I-PR
paratracheal,I-PR
adenopathy,I-PR
and,O
small,B-PR
left,I-PR
pleural,I-PR
effusion,I-PR
with,O
no,O
evidence,O
of,O
pneumonia,B-PR
.,O

In,O
summary,O
",",O
the,O
patient,O
is,O
a,O
49,O
year,O
old,O
woman,O
with,O
metastatic,B-PR
breast,I-PR
cell,I-PR
CA,I-PR
",",O
status,O
post,O
chemotherapy,B-TR
with,O
CMSAP,B-TR
and,O
PVSC,B-TR
and,O
XRT,B-TR
who,O
presented,O
with,O
fever,B-PR
",",O
four,O
days,O
of,O
diarrhea,B-PR
",",O
nausea,B-PR
and,O
vomiting,B-PR
and,O
had,O
been,O
on,O
Keflex,B-TR
for,O
an,B-PR
erythema,I-PR
on,I-PR
her,I-PR
left,I-PR
chest,I-PR
wall,I-PR
.,O

The,B-TR
Keflex,I-TR
was,O
stopped,O
when,O
she,O
developed,O
the,B-PR
diarrhea,I-PR
.,O

When,O
she,O
arrived,O
the,O
plan,O
was,O
to,O
go,O
ahead,O
and,O
treat,O
here,B-PR
rythematous,I-PR
induration,I-PR
and,O
possible,O
cellulitis,B-PR
with,O
IV,B-TR
antibiotics,I-TR
.,O

So,O
she,O
was,O
put,O
on,O
dicloxicillin,B-TR
and,O
we,O
did,O
local,B-TR
wound,I-TR
care,I-TR
with,O
an,B-TR
agent,I-TR
called,O
Santyl,B-TR
",",O
which,O
is,O
a,B-TR
collagenace,I-TR
ondebrided,I-TR
which,O
worked,O
very,O
well,O
for,O
her,O
.,O

Also,O
at,O
the,O
time,O
of,O
admission,O
we,O
were,O
also,O
considering,O
palliative,B-TR
Taxol,I-TR
chemotherapy,I-TR
",",O
which,O
the,O
patient,O
declined,O
.,O

She,O
refused,O
the,B-TR
Taxol,I-TR
therapy,I-TR
so,O
that,O
was,O
not,O
done,O
.,O

Another,O
major,O
issue,O
with,O
this,O
patient,O
was,O
pain,B-TR
control,I-TR
.,O

She,O
had,O
been,O
in,O
a,O
whole,O
lot,O
of,O
pain,B-PR
from,O
her,B-PR
left,I-PR
arm,I-PR
lesion,I-PR
.,O

So,O
pain,B-TR
control,I-TR
was,O
a,O
big,O
issue,O
so,O
she,O
was,O
on,O
MS,B-TR
Contin,I-TR
and,O
MSIR,B-TR
at,O
home,O
she,O
thought,O
that,O
clouded,O
her,O
thinking,O
",",O
so,O
we,O
tried,O
different,O
things,O
for,O
pain,B-TR
management,I-TR
.,O

One,O
of,O
them,O
was,O
to,O
do,O
a,B-TR
subarachnoid,I-TR
neurologic,I-TR
block,I-TR
at,I-TR
C6-C7,I-TR
interface,I-TR
on,O
1-6-94,O
.,O

After,O
that,O
the,O
patient,O
had,O
minimal,O
relief,O
of,O
pain,B-PR
.,O

However,O
",",O
she,O
declined,O
further,B-TR
blocks,I-TR
",",O
which,O
were,O
offered,O
to,O
her,O
.,O

So,O
accepted,O
to,O
be,O
on,O
dilaudid,B-TR
p.o.,I-TR
which,O
was,O
started,O
at,O
a,O
dosage,O
of,O
2-4,O
meg,O
but,O
since,O
then,O
we,O
have,O
tapered,O
it,O
up,O
.,O

She,O
is,O
now,O
getting,O
dilaudid,B-TR
8,O
mg,O
q2h,O
and,O
in,O
addition,O
she,O
has,O
been,O
on,O
fentanyl,B-TR
patch,I-TR
.,O

She,O
is,O
now,O
getting,O
75,O
micrograms,O
per,O
hour,O
of,O
the,B-TR
fentanyl,I-TR
patch,I-TR
which,O
is,O
changed,O
every,O
72,O
hours,O
.,O

We,O
can,O
go,O
up,O
by,O
25,O
mg,O
on,O
the,B-TR
fentanyl,I-TR
patch,I-TR
as,O
needed,O
to,O
control,O
her,B-PR
pain,I-PR
and,O
we,O
can,O
always,O
go,O
up,O
on,O
the,B-TR
dilaudid,I-TR
because,O
she,O
is,O
still,O
in,O
considerable,O
amount,O
of,O
pain,B-PR
.,O

Other,O
things,O
that,O
happened,O
during,O
this,O
admission,O
-,O
we,O
obtained,O
ahead,B-TE
CT,I-TE
for,O
her,O
on,O
the,O
8th,O
of,O
January,O
because,O
of,O
her,B-PR
clouded,I-PR
thinking,I-PR
and,O
altered,B-PR
mental,I-PR
status,I-PR
",",O
which,O
was,O
probably,O
due,O
to,O
the,B-TR
morphine,I-TR
that,O
she,O
was,O
taking,O
.,O

We,O
went,O
ahead,O
and,O
got,O
a,B-TE
head,I-TE
CT,I-TE
scanand,O
it,O
showed,O
no,O
enhancing,B-PR
lesions,I-PR
.,O

In,O
addition,O
her,B-TE
liver,I-TE
transaminases,I-TE
were,O
elevated,B-PR
",",O
we,O
thought,O
about,O
doing,O
further,B-TE
work-up,I-TE
",",O
but,O
that,O
was,O
deferred,O
because,O
the,O
patient,O
wanted,O
to,O
wait,O
on,O
that,O
.,O

That,O
has,O
been,O
stable,O
.,O

The,O
patient,O
on,O
January,O
13,O
became,O
hyponatremic,B-PR
.,O

Her,B-TE
sodium,I-TE
went,O
down,O
to,O
121,O
and,O
before,O
that,O
on,O
admission,O
she,O
was,O
133,O
.,O

A,O
renal,O
consult,O
was,O
obtained,O
and,O
their,B-TE
assessment,I-TE
was,O
that,O
this,O
was,O
probably,O
a,O
mixture,O
of,O
hypovolemia,B-PR
as,O
well,O
as,O
SIADH,B-PR
.,O

We,O
proceeded,O
to,O
do,O
for,O
her,B-PR
hyponatremia,I-PR
-,O
we,O
gave,O
her,O
some,B-TR
fluid,I-TR
and,O
her,B-TE
urine,I-TE
sodium,I-TE
became,O
higher,O
than,O
her,B-TE
serum,I-TE
sodium,I-TE
;,O
we,O
stopped,O
it,O
.,O

We,O
had,O
given,O
her,O
some,B-TR
normal,I-TR
saline,I-TR
and,O
then,O
we,O
proceeded,O
to,O
just,O
do,O
fluid,B-TR
restriction,I-TR
.,O

In,O
addition,O
we,O
gave,O
her,O
a,B-TR
sodium,I-TR
chloride,I-TR
one,O
gram,O
per,O
day,O
and,O
that,O
also,O
helped,O
",",O
so,O
that,O
now,O
at,O
the,O
time,O
of,O
discharge,O
",",O
the,B-TE
patient,I-TE
&apos;s,I-TE
sodium,I-TE
is,O
between,O
126,O
and,O
129,O
;,O
prior,O
to,O
that,O
it,O
had,O
gone,O
down,O
to,O
as,O
low,O
116.,O

So,O
that,O
has,O
really,O
improved,O
.,O

We,O
suggest,O
continuing,O
increased,B-TR
salt,I-TR
intake,I-TR
in,O
her,O
diet,O
and,O
also,O
continuing,O
with,O
the,B-TR
fluid,I-TR
restriction,I-TR
of,I-TR
free,I-TR
water,I-TR
intake,I-TR
to,O
one,O
liter,O
per,O
day,O
.,O

On,O
the,O
14th,O
of,O
January,O
",",O
the,O
patient,O
developed,O
increased,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
and,O
chest,B-TE
x-ray,I-TE
was,O
taken,O
showed,O
a,B-PR
wedge,I-PR
shaped,I-PR
infiltrate,I-PR
in,I-PR
the,I-PR
right,I-PR
upper,I-PR
lobe,I-PR
which,O
was,O
consistent,O
with,O
Hampton,B-PR
&apos;s,I-PR
hump,I-PR
.,O

Also,O
a,B-TE
VQ,I-TE
scan,I-TE
obtained,O
the,O
next,O
day,O
showed,O
high,O
probability,O
for,O
PE,B-PR
.,O

So,O
we,O
proceeded,O
to,O
put,O
her,O
on,O
heparin,B-TR
for,O
anticoagulation,B-TR
and,O
then,O
when,O
she,O
was,O
therapeutic,O
on,O
heparin,B-TR
",",O
we,O
went,O
ahead,O
and,O
started,O
her,O
on,O
coumadin,B-TR
and,O
she,O
is,O
currently,O
on,O
coumadin,B-TR
at,O
2.5,O
mg,O
q.h.s.,O

Her,B-TE
INR,I-TE
is,O
2.3,O
.,O

We,O
want,O
her,B-TE
INR,I-TE
to,O
remain,O
between,O
2,O
and,O
3,O
.,O

So,O
if,O
it,O
goes,O
much,O
lower,O
than,O
2,O
",",O
then,O
we,O
would,O
consider,O
increasing,O
it,O
to,O
perhaps,O
coumadin,B-TR
2.5,O
and,O
5,O
alternating,O
every,O
other,O
night,O
.,O

However,O
",",O
we,O
would,O
leave,O
it,O
at,O
2.5,O
for,O
now,O
.,O

Other,O
major,O
issues,O
-,O
As,O
a,O
result,O
of,O
all,O
the,O
things,O
happened,O
and,O
with,O
her,B-PR
hyponatremia,I-PR
and,O
also,O
the,B-PR
other,I-PR
problems,I-PR
",",O
her,B-TE
blood,I-TE
pressure,I-TE
was,O
elevated,B-PR
also,O
.,O

We,O
put,O
her,O
on,O
nifedipine,B-TR
IR,I-TR
",",O
SL,O
and,O
that,O
was,O
not,O
enough,O
to,O
control,O
her,B-TE
blood,I-TE
pressure,I-TE
which,O
was,O
in,O
the,O
200s,O
in,O
the,B-TE
systolic,I-TE
",",O
so,O
we,O
had,O
started,O
her,O
on,O
atenolol,B-TR
.,O

So,O
on,O
discharge,O
she,O
is,O
on,O
atenolol,B-TR
100,O
.,O

If,O
needed,O
to,O
you,O
can,O
give,O
her,O
some,B-TR
nifedipine,I-TR
SL,I-TR
to,O
decrease,O
her,B-TE
blood,I-TE
pressure,I-TE
.,O

The,O
patient,O
also,O
has,O
significant,B-PR
edema,I-PR
in,I-PR
both,I-PR
arms,I-PR
now,O
and,O
also,O
some,B-PR
mild,I-PR
edema,I-PR
in,I-PR
the,I-PR
lower,I-PR
extremities,I-PR
",",O
so,O
I,O
think,O
that,O
fluid,B-TR
restriction,I-TR
should,O
help,O
with,O
that,O
.,O

She,O
is,O
also,O
a,B-PR
little,I-PR
dry,I-PR
.,O

The,O
patient,O
is,O
on,O
oxygen,B-TR
.,O

Ever,O
since,O
the,B-PR
pulmonary,I-PR
embolus,I-PR
she,O
has,O
been,O
on,O
oxygen,B-TR
.,O

She,O
was,O
on,O
4,B-TR
liters,I-TR
;,O
now,O
she,O
is,O
on,O
5,B-TR
liters,I-TR
",",O
sating,B-TE
94,O
to,O
96%,O
on,O
5,B-TR
liters,I-TR
.,O

We,O
would,O
like,O
for,O
her,O
to,O
remain,O
on,O
the,B-TR
oxygen,I-TR
as,O
well,O
.,O

The,B-PR
complications,I-PR
that,O
I,O
have,O
listed,O
include,O
the,B-PR
hyponatremia,I-PR
",",O
pulmonary,B-PR
embolus,I-PR
and,O
also,O
the,B-PR
elevatd,I-PR
blood,I-PR
pressure,I-PR
.,O

DISPOSITION,O
:,O

Discharge,B-TR
medications,I-TR
-,O
Baclofen,B-TR
10,O
p.o.,O
t.i.d.,O
",",O
MVI,B-TR
one,O
tablet,O
p.o.,O
q.d.,O
",",O
Mycostatin,B-TR
powder,I-TR
TP,I-TR
q.d.,O
to,O
be,O
applied,O
to,O
the,B-PR
rash,I-PR
in,I-PR
her,I-PR
left,I-PR
groin,I-PR
area,I-PR
",",O
also,O
dilaudid,B-TR
8,O
mg,O
p.o.,O
q2h,O
",",O
Colace,B-TR
100,O
mg,O
p.o.,O
b.i.d.,O
",",O
coumadin,B-TR
2.5,O
mg,O
p.o.,O
q.h.s.,O
fentanyl,B-TR
patch,I-TR
75,O
micrograms,O
per,O
hour,O
topical,O
q72,O
hours,O
",",O
atenolol,B-TR
100,O
mg,O
p.o.,O
q.d.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Fair,O
.,O

She,O
remains,O
very,B-PR
weak,I-PR
and,O
will,O
most,O
likely,O
benefit,O
from,O
some,B-TR
physical,I-TR
therapy,I-TR
andshe,O
still,O
has,O
the,B-PR
bilateral,I-PR
edema,I-PR
.,O

She,O
is,O
to,O
go,O
to,O
the,O
Necsoncardel,O
Medical,O
Center,O
for,O
more,B-TR
chronic,I-TR
care,I-TR
.,O

Follow-up,O
is,O
with,O
Dr.,O
Wedleung,O
in,O
the,O
Hem,O
/,O
Onc,O
in,O
two,O
weeks,O
.,O

The,O
appointment,O
has,O
already,O
been,O
made,O
.,O

The,O
patient,O
is,O
very,O
limited,O
in,O
how,O
much,O
she,O
can,O
do,O
right,O
now,O
because,O
of,O
her,B-PR
pain,I-PR
primarily,O
and,O
her,B-PR
difficulty,I-PR
breathing,I-PR
.,O

Dictated,O
By,O
:,O

JEABRIHARL,O
FIGEFREIERMFOTHGRENDCAJAQUE,O
",",O
M.D.,O

Attending,O
:,O

LA,O
INEMACISTIN,O
PRONTMANDES,O
",",O
M.D.,O
HD45,O
SY882/1177,O

Batch,O
:,O

20,O

Index,O
No.,O

YJQI3J9VU6,O

D,O
:,O

01/25/94,O

T,O
:,O

01/25/94,O

Admission,O
Date,O
:,O

2014-04-19,O

Discharge,O
Date,O
:,O

2014-04-20,O

Date,O
of,O
Birth,O
:,O

2014-04-19,O

Sex,O
:,O

M,O

Service,O
:,O

CMED,O
CSRU,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Baby,O
Thomas,O
Moss,O
was,O
born,O
at,O
39,O
and,O
1/2,O
weeks,O
gestation,O
to,O
a,O
20-year-old,O
gravida,O
IV,O
",",O
para,O
III,O
",",O
now,O
IV,O
woman,O
.,O

The,B-TE
mother,I-TE
's,I-TE
prenatal,I-TE
screens,I-TE
were,O
blood,B-TE
type,I-TE
B,O
positive,O
",",O
antibody,B-TE
negative,O
",",O
rubella,B-TE
immune,O
",",O
RPR,B-TE
nonreactive,O
",",O
hepatitis,B-TE
surface,I-TE
antigen,I-TE
negative,O
and,O
group,B-TE
B,I-TE
strep,I-TE
negative,O
.,O

This,O
pregnancy,O
was,O
complicated,O
by,O
a,O
prenatal,O
diagnosis,O
of,O
a,B-PR
congenital,I-PR
cystic,I-PR
adenomatoid,I-PR
malformation,I-PR

(,O
CCAM,B-PR
).,O

The,O
mother,O
was,O
followed,O
in,O
the,O
Massachusetts,O
General,O
Hospital,O
Advanced,O
Fetal,O
Care,O
Center,O
and,O
was,O
followed,O
by,O
Dr.,O
Ralph,O
Wilson,O
.,O

The,O
mother,O
had,O
spontaneous,O
onset,O
of,O
labor,O
and,O
progressed,O
to,O
a,O
spontaneous,O
vaginal,O
delivery,O
.,O

The,O
infant,O
emerged,O
vigorous,O
with,O
Apgars,B-TE
of,O
9,O
at,O
one,O
and,O
five,O
minutes,O
.,O

His,B-TE
birth,I-TE
weight,I-TE
was,O
2905,O
grams,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Wt,B-TE
2905,O
gm,O

Length,B-TE
19,O
inches,O

HC,B-TE
34.5,O
cm,O

His,B-TE
admission,I-TE
physical,I-TE
exam,I-TE
reveals,O
a,B-PR
vigorous,I-PR
nondysmorphic,I-PR
term,O
infant,O
.,O

Anterior,O
fontanelle,O
open,O
and,O
flat,O
.,O

Palate,O
intact,O
.,O

Red,B-TE
reflex,I-TE
not,O
checked,O
.,O

Neck,O
supple,O
and,O
without,O
masses,B-PR
.,O

Clavicles,O
intact,O
.,O

Lungs,O
clear,O
bilaterally,O
with,O
slightly,B-PR
decreased,I-PR
breath,I-PR
sounds,I-PR
on,I-PR
the,I-PR
right,I-PR
but,O
symmetric,O
chest,O
rise,O
and,O
fall,O
.,O

Heart,O
was,O
regular,O
rate,O
and,O
rhythm,O
",",O
no,O
murmur,B-PR
.,O

Femoral,B-TE
pulses,I-TE
present,O
bilaterally,O
.,O

Abdomen,O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
",",O
active,O
bowel,O
sounds,O
.,O

Normal,O
male,O
genitalia,O
",",O
testes,O
descended,O
bilaterally,O
.,O

No,O
sacral,B-PR
anomalies,I-PR
.,O

Stable,O
hips,O
.,O

Patent,O
anus,O
.,O

Age,O
appropriate,O
tone,O
and,O
reflexes,O
.,O

CMED,O
CCU,O
:,O

By,O
systems,O
:,O

Respiratory,O
status,O
:,O

He,O
has,O
remained,O
in,O
room,O
air,O
well,O
saturated,O
with,O
comfortable,O
respirations,O
until,O
approximately,O
22,O
hours,O
of,O
age,O
when,O
he,O
started,O
with,O
increased,B-PR
work,I-PR
of,I-PR
breathing,I-PR
although,O
he,O
has,O
remained,O
well-saturated,O
in,O
room,O
air,O
.,O

His,B-TE
chest,I-TE
x-ray,I-TE
was,O
initially,O
remarkable,O
for,O
some,B-PR
mediastinal,I-PR
shift,I-PR
due,O
to,O
the,B-PR
right-sided,I-PR
lesion,I-PR
with,O
increasing,B-PR
shift,I-PR
present,O
on,O
the,B-TE
last,I-TE
x-ray,I-TE
.,O

Cardiovascular,O
status,O
:,O

He,O
has,O
remained,O
normotensive,O
throughout,O
his,O
CMED,O
stay,O
.,O

There,O
are,O
no,O
cardiovascular,B-PR
issues,I-PR
.,O

Fluid,O
",",O
electrolytes,O
and,O
nutrition,O
status,O
:,O

His,B-TE
weight,I-TE
at,O
the,O
time,O
of,O
transfer,O
is,O
2800,O
grams,O
.,O

He,O
has,O
been,O
breast,O
feeding,O
or,O
taking,O
20,O
calorie,O
per,O
ounce,O
formula,O
until,O
the,B-PR
increased,I-PR
respiratory,I-PR
distress,I-PR
so,O
that,O
at,O
the,O
time,O
of,O
transfer,O
he,O
is,O
NPO,B-TR
with,O
a,B-TR
peripheral,I-TR
IV,I-TR
with,O
total,B-TR
fluids,I-TR
of,O
150,O
ml,O
/,O
kg,O
/,O
day,O
of,O
10%,B-TR
dextrose,I-TR
with,O
electrolytes,B-TR
.,O

He,O
has,O
had,O
no,O
blood,B-TE
work,I-TE
except,O
for,O
blood,B-TE
glucose,I-TE
checks,I-TE
and,O
he,O
has,O
been,O
euglycemic,O
throughout,O
his,O
CMED,O
stay,O
with,O
his,B-TE
blood,I-TE
glucose,I-TE
being,O
in,O
the,O
70s,O
.,O

Gastrointestinal,O
status,O
:,O

He,O
has,O
passed,O
meconium,O
stool,O
and,O
is,O
voiding,O
with,O
each,O
diaper,O
change,O
.,O

He,O
has,O
not,O
had,O
a,B-TE
bilirubin,I-TE
checked,O
.,O

Hematology,O
:,O

He,O
has,O
not,O
had,O
any,B-TE
blood,I-TE
work,I-TE
done,O
.,O

Infectious,O
disease,O
:,O

He,O
has,O
had,O
no,O
antibiotic,B-TR
therapy,I-TR
or,O
blood,B-TE
cultures,I-TE
sent,O
.,O

Sensory,O
:,O

Audiology,O
:,O

Hearing,B-TE
screening,I-TE
is,O
recommended,O
prior,O
to,O
discharge,O
.,O

It,O
has,O
not,O
been,O
done,O
yet,O
.,O

Psychosocial,O
:,O

The,O
mother,O
has,O
3,O
older,O
children,O
who,O
are,O
alive,O
and,O
well,O
.,O

Her,O
own,O
mother,O
has,O
been,O
with,O
her,O
during,O
this,O
stay,O
.,O

The,O
infant,O
is,O
discharged,O
in,O
guarded,B-PR
condition,I-PR
.,O

He,O
is,O
being,O
transferred,O
to,O
Massachusetts,O
General,O
Hospital,O
Newborn,O
Intensive,O
Care,O
Unit,O
for,O
continuing,B-TR
care,I-TR
.,O

His,O
primary,O
pediatric,O
care,O
provider,O
will,O
be,O
Dr.,O
Schrader,O
at,O
Deaconess-Nashoba,O
Hospital,O
.,O

RECOMMENDATIONS,O
AFTER,O
DISCHARGE,O
:,O

1.,O
Feedings,O
:,O

The,O
infant,O
is,O
NPO,B-TR
.,O

2.,O
He,O
is,O
on,O
peripheral,B-TR
IV,I-TR
of,O
total,B-TR
fluids,I-TR
150,O
ml,O
/,O
kg,O
/,O
day,O
of,O
10%,O
dextrose,B-TR
with,O
2,O
mEq,O
of,O
sodium,B-TR
chloride,I-TR
per,O
100,O
ml,O
and,O
1,O
mEq,O
of,O
potassium,B-TR
chloride,I-TR
per,O
100,O
ml,O
.,O

3.,O
He,O
has,O
not,O
had,O
a,B-TE
car,I-TE
seat,I-TE
position,I-TE
screening,I-TE
test,I-TE
.,O

4.,O
A,B-TE
State,I-TE
newborn,I-TE
screen,I-TE
will,O
be,O
done,O
prior,O
to,O
transfer,O
.,O

5.,O
He,O
has,O
received,O
no,O
immunizations,B-TR
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Term,O
male,O
newborn,O
.,O

2.,O
Right-sided,B-PR
congenital,I-PR
cystic,I-PR
adenomatoid,I-PR
malformation,I-PR
.,O

Kathy,O
Hougland,O
",",O
M.D.,O
50AHB,O

Dictated,O
By,O
:,O
Gina,O
C.K.,O
Brantner,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2014-04-20,O
07:20:44,O

T,O
:,O
2014-04-20,O
10:08:45,O

Job,O
#:,O
07882,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Jaqueline,O
RHEIN,O
on,O
:,O
SUN,O
2014-04-20,O
8:13,O
PM,O

(,O
End,O
of,O
Report,O
),O

190510002,O

TGCHO,O

3067319,O

364639,O

3/16/2003,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O

KOTE,O
",",O
LYFRANKLAPALM,O

MRN,O
:,O

3067319,O

Age,O
:,O

56y,O

REGISTRATION,O
DATE,O
:,O

03/16/2003,O
05:16,O
PM,O

PRELIMINARY,O
REPORT,O

This,O
is,O
to,O
notify,O
you,O
that,O
your,O
patient,O
",",O
KOTE,O
",",O
LYFRANKLAPALM,O
arrived,O
in,O
the,O
Emergency,O
Department,O
at,O
Tecal,O
Galecounxopt,O
Community,O
Hospital,O
on,O
03/16/2003,O
05:16,O
PM,O
.,O

The,O
patient,O
presented,O
with,O
a,O
chief,O
complaint,O
of,O
INCREASED,B-PR
LETHARGY,I-PR
.,O

Following,O
evaluation,B-TE
and,O
treatment,B-TR
",",O
the,O
patient,O
&apos;s,O
disposition,O
at,O
the,O
end,O
of,O
the,O
visit,O
was,O
ADMITTED,O
AS,O
AN,O
INPATIENT,O
TO,O
TECAL,O
GALENCOUNXOPT,O
COMMUNITY,O
HOSPITAL,O
.,O

The,O
patient,O
&apos;s,O
preliminary,O
admitting,O
physician,O
is,O
SCIMEWHILDAJESC,O
",",O
LA,O
R,O
and,O
the,O
preliminary,O
diagnosis,O
is,O
DEHYDRATION,B-PR
..,O

Please,O
note,O
this,O
information,O
may,O
have,O
been,O
updated,O
on,O
the,O
inpatient,O
unit,O
.,O

If,O
you,O
need,O
additional,O
information,O
please,O
call,O
418-196-2156,O
.,O

PCP,O
Name,O
:,O

NONE,O
",",O
PHYSICIAN,O

Provider,O
Number,O
:,O

75055,O

Admission,O
Date,O
:,O

2019-03-29,O

Discharge,O
Date,O
:,O

2019-04-01,O

Date,O
of,O
Birth,O
:,O

1935-12-05,O

Sex,O
:,O

M,O

Service,O
:,O

NEUROLOGY,O

Allergies,O
:,O

Lorazepam,B-TR
/,O
Penicillins,B-TR
/,O
Prednisone,B-TR
/,O
Hydrochlorothiazide,B-TR
/,O
Ceftriaxone,B-TR
/,O
Phenytoin,B-TR

Attending,O
:,O
Derrick,O
Z,O
Wooster,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O
progressing,B-PR
slowing,I-PR
of,I-PR
mentation,I-PR
and,O
gait,B-PR
difficulties,I-PR
since,O
a,O
week,O
;,O
evaluation,B-TE
for,O
ICH,B-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

None,O

History,O
of,O
Present,O
Illness,O
:,O

The,O
patient,O
is,O
a,O
83,O
yo,O
R-handed,O
man,O
with,O
a,O
history,O
of,O
multiple,B-PR
intracranial,I-PR
hemorrhages,I-PR
during,O
the,O
last,O
few,O
years,O
",",O
pacemaker,B-TR
",",O
hyperlipidemia,B-PR
",",O
arrhythmia,B-PR
who,O
now,O
presents,O
with,O
gradual,B-PR
decline,I-PR
in,I-PR
gait,I-PR
and,O
slowing,B-PR
of,I-PR
mentation,I-PR
over,O
the,O
last,O
week,O
.,O

The,O
patient,O
had,O
a,O
fall,O
about,O
ten,O
days,O
ago,O
",",O
when,O
he,O
was,O
walking,O
the,O
dog,O
.,O

The,O
leash,O
got,O
wrapped,O
around,O
his,O
legs,O
.,O

According,O
to,O
his,O
wife,O
he,O
had,O
a,B-PR
small,I-PR
abrasion,I-PR
on,O
the,O
top,O
of,O
his,O
head,O
",",O
but,O
nothing,O
major,O
.,O

He,O
did,O
not,O
complain,O
about,O
a,B-PR
headache,I-PR
.,O

He,O
was,O
at,O
baseline,O
with,O
respect,O
to,O
his,O
gait,O
(,O
at,O
baseline,O
unsteady,B-PR
",",O
though,O
he,O
refuses,O
to,O
walk,O
with,O
a,B-TR
walker,I-TR
),O
and,O
his,O
mentation,O
(,O
at,O
baseline,O
difficulties,B-PR
with,I-PR
memory,I-PR
since,O
months,O
;,O
keeps,O
forgetting,O
appointments,O
).,O

Then,O
about,O
a,O
week,O
ago,O
",",O
the,O
patient,O
and,O
his,O
wife,O
noted,O
that,O
his,O
gait,O
became,O
even,B-PR
more,I-PR
unsteady,I-PR
",",O
though,O
he,O
did,O
not,O
fall,O
.,O

He,O
also,O
had,O
difficulties,B-PR
navigating,O
through,O
his,O
apartment,O
",",O
having,O
difficulties,B-PR
finding,O
the,O
fridge,O
for,O
example,O
.,O

They,O
were,O
concerned,O
that,O
the,O
fall,O
might,O
have,O
caused,O
another,B-PR
bleed,I-PR
",",O
as,O
had,O
happened,O
in,O
the,O
past,O
",",O
and,O
this,O
prompted,O
them,O
to,O
come,O
to,O
the,O
Deanna,O
.,O

No,O
headache,B-PR
",",O
neckpain,B-PR
",",O
nausea,B-PR
",",O
vomiting,B-PR
or,O
focal,B-PR
weakness,I-PR
/,O
numbness,B-PR
.,O

Review,O
of,O
systems,O
:,O
denies,O
any,B-PR
fever,I-PR
",",O
chills,B-PR
",",O
weight,B-PR
loss,I-PR
",",O
visual,B-PR
changes,I-PR
",",O
hearing,B-PR
changes,I-PR
",",O
dysphagia,B-PR
",",O
tingling,B-PR
",",O
numbness,B-PR
",",O
bowel-bladder,B-PR
dysfunction,I-PR
",",O
chest,B-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
abdominal,B-PR
pain,I-PR
",",O
dysuria,B-PR
",",O
hematuria,B-PR
",",O
or,O
bright,B-PR
red,I-PR
blood,I-PR
per,I-PR
rectum,I-PR
.,O

His,O
legs,O
have,O
been,O
feeling,O
weaker,B-PR
",",I-PR
bilaterally,I-PR
since,O
the,O
last,O
week,O
.,O

Past,O
Medical,O
History,O
:,O

1.,O
Previous,B-PR
interventricular,I-PR
hemorrhages,I-PR
:,O

06-30,O
resolved,O
as,O
of,O
repeat,B-TE
head,I-TE
CT,I-TE
one,O
month,O
later,O
",",O
no,O
residual,B-PR
deficits;,I-PR
03-03,O
:,O
ICH,B-PR
in,I-PR
3rd,I-PR
",",I-PR
4th,I-PR
",",I-PR
and,I-PR
L-lat,I-PR
ventricle,I-PR
;,O
no,O
aneurysm,B-PR
;,O
07-01,O
:,O
ICH,B-PR
in,I-PR
R-temporal,I-PR
lobe,I-PR
;,O
question,O
of,O
underlying,B-PR
mass,I-PR
at,O
that,O
time,O
per,O
contrast,B-TE
CT,I-TE
;,O
decided,O
to,O
follow,O
up,O
with,O
serial,B-TE
scans,I-TE
rather,O
than,O
to,O
biopsy,B-TE

2.,O
pacemaker,B-TR
placement,I-TR
for,O
arrhythmia,B-PR
",",O
Afibb,B-PR
;,O
during,O
last,O
hospitalization,O
episodes,O
of,O
NSVT,B-PR

3.,O
history,O
of,O
slowness,B-PR
of,I-PR
gait,I-PR
",",O
?,O
parkinsons,B-PR
?,O
and,O
possibly,O
dementia,B-PR
followed,O
by,O
Dr.,O
Ahern,O
(,O
Laurence,O
Eichorn,O
).,O

Sinemet,B-TR
was,O
stopped,O
during,O
last,O
admission,O
06-30,O
as,O
he,O
was,O
thought,O
to,O
NOT,O
have,O
PD,B-PR
.,O

4.,O
Depression,B-PR

5.,O
COPD,B-PR

6.,O
hyperlipidemia,B-PR

7.,O
bilateral,B-TR
cataract,I-TR
surgery,I-TR

8.,O
orthostatic,B-PR
hypotension,I-PR
",",O
on,O
midodrine,B-TR

Social,O
History,O
:,O

The,O
pt.,O
is,O
married,O
",",O
independent,O
in,O
ADLS,O
",",O
lives,O
with,O
wife,O
in,O
a,O
retirement,O
community,O
.,O

Significant,O
tobacco,O
history,O
x,O
40,O
yrs,O
x,O
1ppd,O
",",O
quit,O
20,O
yrs,O
ago,O
",",O

Reported,O
occassional,O
glass,O
of,O
wine,O
",",O
no,O
illicit,O
drugs,O

He,O
is,O
a,O
retired,O
architect,O
.,O

Wife,O
states,O
that,O
he,O
would,O
NOT,O
want,O
to,O
be,O
recussitated,O
",",O
and,O
that,O
OSH,O
placed,O
ETT,B-TR
before,O
asking,O
her,O
.,O

Family,O
History,O
:,O
no,O
kids,O
",",O
no,O
bleeds,B-PR
or,O
strokes,B-PR
in,O
other,O
family,O
members,O

Physical,O
Exam,O
:,O

Vitals,B-TE
:,O

96.7,O
HR60,B-TE
BP153/52,B-TE
",",O
later,O
178/85,O
RR,B-TE
18T,O
sO298%,B-TE
RA,I-TE

Gen,O
:,O

NAD,B-PR
",",O
in,O
bed,O

HEENT,O
:,O
mmm,O

Neck,O
:,O
no,O
LAD,B-PR
;,O
no,O
carotid,B-PR
bruits,I-PR
;,O
limited,B-PR
range,I-PR
neck,I-PR
movements,I-PR
bilaterally,I-PR

Lungs,O
:,O

Clear,O
to,O
auscultation,B-TE
bilaterally,O

Cardiovascular,O
:,O

Regular,O
rate,O
and,O
rhythm,O
",",O
normal,O
S1,O
and,O
S2,O
",",O
no,O
murmurs,B-PR
",",O
gallops,B-PR
and,O
rubs,B-PR
.,O

Abdomen,O
:,O
normal,O
bowel,O
sounds,O
",",O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR

Extremities,O
:,O
no,O
edema;,B-PR
cold,B-PR
feet,I-PR
bilaterally,I-PR

Mental,O
Status,O
:,O

Awake,O
and,O
alert,O
",",O
cooperative,O
with,O
exam,B-TE
",",O
normal,O
affect,O
;,O
facial,B-PR
expression,I-PR
somewhat,I-PR
sparse,I-PR
.,O

Oriented,O
to,O
place,O
and,O
person,O
",",O
not,O
date,O
1996,O
.,O

Attention,O
:,O

DOYbw,O
.,O

Memory,O
:,O

Registration,O
:,O

03-29,O
items,O
;,O
Recall,O
03-29,O
at,O
5,O
min,O
.,O

Language,O
:,O
fluent,O
;,O
repetition,O
:,O
intact,O
;,O
Naming,O
intact,O
;,O
Comprehension,O
intact,O
;,O
no,O
dysarthria,B-PR
",",O
no,O
paraphasic,B-PR
errors,I-PR
.,O

East,O
Sandwich,O
:,O
intact,O
;,O

3D-construction,O
:,O
poor,O
",",O
difficulties,B-PR
putting,I-PR
handles,I-PR
in,I-PR
clock,I-PR
;,O
No,O
Apraxia,B-PR
.,O

No,O
Neglect,B-PR
.,O

Unable,O
to,O
do,O
luria,O
.,O

Named,O
10,O
animals,O
in,O
1,O
minute,O
",",O
no,O
perseveration,O
",",O
but,O
no,O
further,O
animals,O
after,O
30,O
secs,O
.,O

Cranial,O
Nerves,O
:,O

II,O
:,O

Visual,O
fields,O
are,O
full,O
to,O
confrontation,O
",",O
pupils,O
equally,O
round,O
and,O
reactive,O
to,O
light,O
both,O
directly,O
and,O
consensually,O
",",O
2.5,O
-->,O
2,O
mm,O
bilaterally,O
.,O

III,O
",",O
IV,O
",",O
VI,O
:,O

Extraocular,O
movements,O
intact,O
with,O
few,O
beats,O
of,O
horizontal,B-PR
endgaze,I-PR
nystagmus,I-PR
.,O

Limited,B-PR
CMED,I-PR
CCU,I-PR
movements,I-PR
in,I-PR
upgaze,I-PR
.,O

Fixation,O
and,O
saccades,O
are,O
normal,O
.,O

V,O
:,O

Facial,O
sensation,O
intact,O
to,O
light,B-TE
touch,I-TE
and,O
pinprick,B-TE
.,O

VII,O
:,O

Facial,O
movement,O
symmetrical,O
;,O
no,O
facial,B-PR
droop,I-PR
.,O

VIII,O
:,O

Hearing,O
intact,O
to,O
finger,B-TE
rub,I-TE
bilaterally,O
.,O

IX,O
:,O

Palate,O
elevates,O
in,O
midline,O
.,O

XII,O
:,O

Tongue,O
protrudes,O
in,O
midline,O
",",O
no,O
fasciculations,B-PR
.,O

XI,O
:,O

Sternocleidomastoid,O
and,O
trapezius,O
normal,O
bilaterally,O
.,O

Motor,O
System,O
:,O

Decreased,B-PR
bulk,I-PR
throughout,I-PR
;,O
tone,O
normal,O
bilaterally,O
.,O

No,O
adventitious,B-PR
movements,I-PR
",",O
no,O
tremor,B-PR
",",O
no,O
asterixis,B-PR
.,O

Right,O

D,B-TE
-,O
5,O
;,O
T,B-TE
-,O
5,O
;,O
B,B-TE
-,O
5,O
;,O
WF,B-TE
-,O
5,O
;,O
WE,B-TE
-,O
5,O
;,O
FiF,B-TE
-,O
5,O
;,O
Bruner,B-TE
-,O
5,O
;,O
Ip,B-TE
-,O
5,O
;,O
Gl,B-TE
-,O
5,O
;,O
Q,B-TE
-,O
5-,O
;,O
H,B-TE
-,O
5,O
;,O
AF,B-TE
-,O
5,O
;,O
TF,B-TE
-,O
5,O
;,O
TE,B-TE
-,O
5,O

Left,O

D,B-TE
-,O
5,O
;,O
T,B-TE
-,O
5,O
;,O
B,B-TE
-,O
5,O
;,O
WF,B-TE
-,O
5,O
;,O
WE,B-TE
-,O
5,O
;,O
FiF,B-TE
-,O
5,O
;,O
Bruner,B-TE
-,O
5,O
;,O
Ip,B-TE
-,O
5,O
;,O
Gl,B-TE
-,O
5,O
;,O
Q,B-TE
-,O
5-,O
;,O
H,B-TE
-,O
5,O
;,O
AF,B-TE
-,O
5,O
;,O
TF,B-TE
-,O
5,O
;,O
TE,B-TE
-,O
5-,O

No,O
pronator,B-PR
drift,I-PR
.,O

No,O
rebound,B-PR
.,O

Sensory,O
system,O
:,O

Sensation,O
intact,O
to,O
light,B-TE
touch,I-TE
",",O
pin,B-TE
prick,I-TE
",",O
temperature,B-TE
(,I-TE
cold,I-TE
),I-TE
.,O

Decreased,B-PR
vibration,I-PR
in,I-PR
feet,I-PR
and,I-PR
ankles,I-PR
bilaterally,I-PR
",",O
some,O
in,O
knees,O
;,O
proprioception,B-PR
decreased,I-PR
in,I-PR
his,I-PR
feet,I-PR
bilaterally,I-PR
.,O

Reflexes,B-TE
:,O

Right,B-TE
B,I-TE
-,O
2,O
;,O
T,B-TE
-,O
2,O
;,O
Br,B-TE
-,O
2,O
;,O
Pa,B-TE
-,O
1,O
;,O
Pl,B-TE
-,O
0,O

Left,O

B,B-TE
-,O
2,O
;,O
T,B-TE
-,O
2,O
;,O
Br,B-TE
-,O
2,O
;,O
Pa,B-TE
-,O
1,O
;,O
Pl,B-TE
-,O
0,O
(,O
Less,O
brisk,O
than,O
on,O
R,O
",",O
but,O
exam,B-TE
limited,O
due,O
to,O
cuff,O
),O

Toes,O
:,O
mute,O
bilaterally,O
;,O
TFL,B-PR
contracted,I-PR
on,I-PR
the,I-PR
L,I-PR
.,O

Coordination,O
:,O

Normal,O
Correa,O
",",O
Kimberly,O
",",O
HTS,O
.,O

No,O
dysmetria,B-PR
or,O
pastpointing,B-PR
.,O

Gait,O
:,O
not,O
tested,O

(,O
later,O
tested,O
and,O
patient,O
markedly,B-PR
unstable,I-PR
on,I-PR
feet,I-PR
),O

Pertinent,O
Results,O
:,O

2019-03-29,O
22:59,O

GLUCOSE,B-TE
-,O
89,O

2019-03-29,O
22:59,O

CK,B-TE
(,I-TE
CPK,I-TE
)-,I-TE
128,O

2019-03-29,O
22:59,O

CK,B-TE
-,I-TE
MB,I-TE
-,O
6,O
cTropnT,B-TE
-<,O
0.01,O

2019-03-29,O
04:00,O
PM,O
URINE,B-TE

HOURS,O
-,O
RANDOM,O

2019-03-29,O
04:00,O
PM,O
URINE,B-TE

GR,B-TE
HOLD,O
-,O
HOLD,O

2019-03-29,O
04:00,O
PM,O
URINE,B-TE

COLOR,B-TE
-,O
Straw,O
APPEAR,B-TE
-,O
Clear,O
SP,B-TE
Stickney,I-TE
-,O
1.017,O

2019-03-29,O
04:00,O
PM,O
URINE,B-TE

BLOOD,B-TE
-,O
NEG,O
NITRITE,B-TE
-,O
NEG,O
PROTEIN,B-TE
-,O
NEG,O
GLUCOSE,B-TE
-,O
NEG,O
KETONE,B-TE
-,O
NEG,O
BILIRUBIN,B-TE
-,O
NEG,O
UROBILNGN,B-TE
-,O
NEG,O
PH,B-TE
-,O
7.0,O
LEUK,B-TE
-,O
NEG,O

2019-03-29,O
14:00,O

GLUCOSE,B-TE
-,O
72,O
UREA,B-TE
N,I-TE
-,O
17,O
CREAT,B-TE
-,O
0.8,O
SODIUM,B-TE
-,O
140,O
POTASSIUM,B-TE
-,O
4.4,O
CHLORIDE,B-TE
-,O
103,O
TOTAL,B-TE
CO2,I-TE
-,O
29,O
ANION,B-TE
GAP,I-TE
-,O
12,O

2019-03-29,O
14:00,O

WBC,B-TE
-,O
6.7,O
RBC,B-TE
-,O
4.53,O
*,O
HGB,B-TE
-,O
14.8,O
HCT,B-TE
-,O
44.6,O
MCV,B-TE
-,O
99,O
*,O
MCH,B-TE
-,O
32.8,O
*,O
MCHC,B-TE
-,O
33.3,O
RDW,B-TE
-,O
12.6,O

2019-03-29,O
14:00,O

NEUTS,B-TE
-,O
65.5,O
LYMPHS,B-TE
-,O
25.8,O
MONOS,B-TE
-,O
7.0,O
EOS,B-TE
-,O
1.4,O
BASOS,B-TE
-,O
0.2,O

2019-03-29,O
14:00,O

MACROCYT,B-TE
-,O
1+,O

2019-03-29,O
14:00,O

PLT,B-TE
COUNT,I-TE
-,O
213,O

2019-03-29,O
14:00,O

PT,B-TE
-,O
12.3,O
PTT,B-TE
-,O
24.5,O
INR,B-TE
(,I-TE
PT,I-TE
)-,I-TE
1.1,O

CT,B-TE
BRAIN,I-TE
(,I-TE
INITIAL,I-TE
),I-TE

FINDINGS,O
:,O

There,O
is,O
a,O
41,O
x,O
23,O
mm,O
area,O
of,O
hyperdensity,B-PR
within,I-PR
the,I-PR
right,I-PR
frontal,I-PR
lobe,I-PR
",",O
with,O
moderate,B-PR
surrounding,I-PR
vasogenic,I-PR
edema,I-PR

(,O
series,O
2,O
",",O
image,O
23,O
),O
",",O
compatible,O
with,O
acute,B-PR
intraparenchymal,I-PR
hemorrhage,I-PR
.,O

The,B-PR
chronic,I-PR
encephalomalacic,I-PR
changes,I-PR
at,I-PR
the,I-PR
adjacent,I-PR
right,I-PR
frontal,I-PR
lobe,I-PR
and,O
the,O
right,O
parietal,O
/,O
occipital,O
region,O
remain,O
stable,O
in,O
appearance,O
.,O

There,O
is,O
mild,B-PR
mass,I-PR
effect,I-PR
upon,I-PR
the,I-PR
anterior,I-PR
Mims,I-PR
of,O
the,O
right,O
lateral,O
ventricle,O
.,O

No,O
further,O
intraaxial,B-PR
or,I-PR
extraaxial,I-PR
fluid,I-PR
collections,I-PR
or,O
hematoma,B-PR
are,O
identified,O
.,O

There,O
is,O
no,O
displacement,B-PR
of,I-PR
the,I-PR
normally,I-PR
midline,I-PR
structures,I-PR
",",O
hydrocephalus,B-PR
",",O
or,O
effacement,B-PR
of,I-PR
the,I-PR
basal,I-PR
cisterns,I-PR
at,O
present,O
.,O

Review,B-TE
of,I-TE
bone,I-TE
windows,I-TE
demonstrates,O
no,O
skull,B-PR
bulge,I-PR
or,O
skull,B-PR
base,I-PR
fracture,I-PR
.,O

There,O
is,O
an,B-PR
air,I-PR
/,I-PR
fluid,I-PR
level,I-PR
within,I-PR
the,I-PR
right,I-PR
maxillary,I-PR
sinus,I-PR
-,O
?,O
acute,B-PR
sinusitis,I-PR
",",O
but,O
acute,B-PR
blood,I-PR
cannot,O
be,O
excluded,O
",",O
in,O
the,O
setting,O
of,O
acute,B-PR
trauma,I-PR
.,O

CONCLUSION,O
:,O

41,B-PR
x,I-PR
23,I-PR
mm,I-PR
acute,I-PR
intraparenchymal,I-PR
hematoma,I-PR
at,I-PR
the,I-PR
right,I-PR
frontal,I-PR
lobe,I-PR
",",O
causing,O
mild,B-PR
mass,I-PR
effect,I-PR
upon,I-PR
the,I-PR
ipsilateral,I-PR
lateral,I-PR
ventricle,I-PR
",",O
suspicious,O
of,O
hemorrhage,B-PR
secondary,O
to,O
congophilic,B-PR
angiopathy,I-PR
in,O
this,O
age,O
group,O
.,O

Chronic,B-PR
encephalomalacic,I-PR
changes,I-PR
at,I-PR
the,I-PR
right,I-PR
frontal,I-PR
lobe,I-PR
and,O
right,O
parietal,O
/,O
occipital,O
region,O
are,O
unchanged,O
in,O
appearance,O
since,O
2018-11-27,O
.,O

REPEAT,B-TE
HEAD,I-TE
CT,I-TE
03-30,O
:,O
no,O
significant,B-PR
change,I-PR
from,O
above,O
.,O

EKG,B-TE
:,O

Atrial,B-TR
pacing,I-TR
.,O

Since,O
the,B-TE
previous,I-TE
tracing,I-TE
of,O
2018-03-15,O
atrial,B-TR
pacing,I-TR
is,O
a,O
new,O
finding,O
.,O

The,B-TE
electrocardiogram,I-TE
is,O
otherwise,O
",",O
unchanged,O
and,O
continues,O
to,O
Weymouth,B-TR
voltage,I-TR
in,I-TR
the,I-TR
limb,I-TR
leads,I-TR
and,O
non-specific,B-PR
ST-T,I-PR
wave,I-PR
abnormalities,I-PR
.,O

Read,O
by,O
:,O

Stella,O
",",O
Kendra,O
B,O
.,O

Intervals,B-TE
Axes,I-TE

Rate,B-TE
60,O
PR,B-TE
188,O
QRS,B-TE
104,O
QT/QTc,B-TE
460/460,O
P,B-TE
85,O
QRS,B-TE
55,O
T,B-TE
75,O

Brief,O
Hospital,O
Course,O
:,O

The,O
patient,O
is,O
a,O
83,O
yo,O
man,O
with,O
a,O
history,O
of,O
past,B-PR
intracranial,I-PR
hemorrhages,I-PR
(,O
most,O
recent,O
07-01,O
with,O
R-frontal,B-PR
hemorrhage,I-PR
),O
who,O
presented,O
with,O
gradually,B-PR
slowing,I-PR
of,I-PR
mentation,I-PR
and,O
increased,B-PR
gait,I-PR
instability,I-PR
since,O
one,O
week,O
.,O

On,O
initial,B-TE
exam,I-TE
the,O
patient,O
was,O
not,B-PR
oriented,I-PR
to,I-PR
time,I-PR
",",O
seemed,O
somewhat,B-PR
slow,I-PR
",",O
and,O
had,O
difficulties,B-PR
generating,I-PR
a,I-PR
list,I-PR
of,I-PR
animals,I-PR
.,O

His,O
cranial,O
nerves,O
and,O
strength,O
were,O
full,O
",",O
and,O
the,B-TE
sensory,I-TE
exam,I-TE
showed,O
mildly,B-PR
decreased,I-PR
vibration,I-PR
and,I-PR
proprioception,I-PR
in,I-PR
both,I-PR
LE,I-PR
",",O
suggesting,O
peripheral,B-PR
neuropathy,I-PR
.,O

A,B-TE
CT,I-TE
was,O
performed,O
in,O
the,O
Deanna,O
that,O
showed,O
a,B-PR
new,I-PR
significant,I-PR
R-frontal,I-PR
intraparenchymal,I-PR
hemorrhage,I-PR
in,I-PR
the,I-PR
same,I-PR
location,I-PR
as,O
the,B-PR
prior,I-PR
bleed,I-PR
.,O

The,O
patient,O
was,O
seen,O
by,O
both,O
neurology,O
and,O
neurosurgery,O
",",O
and,O
the,O
two,O
teams,O
agreed,O
that,O
the,O
etiology,O
seemed,O
to,O
be,O
related,O
to,O
underlying,B-PR
amyloidosis,I-PR
.,O

During,O
the,O
last,O
admission,O
the,O
question,O
of,O
a,B-PR
mass,I-PR
underlying,O
a,B-PR
hemorrhage,I-PR
in,I-PR
the,I-PR
R-frontal,I-PR
region,I-PR
was,O
raised,O
.,O

The,O
location,O
of,O
the,B-PR
hemorrhage,I-PR
was,O
not,O
felt,O
to,O
be,O
typical,O
for,O
hypertensive,B-PR
bleed,I-PR
(,I-PR
cortical,I-PR
),I-PR
and,O
it,O
was,O
felt,O
to,O
be,O
unlikely,O
that,O
the,O
recent,O
fall,O
was,O
related,O
to,O
the,B-PR
bleed,I-PR
.,O

The,O
patient,O
could,O
not,O
undergo,O
an,B-TE
MRI,I-TE
due,O
to,O
his,B-TR
pacer,I-TR
.,O

He,O
was,O
admitted,O
to,O
the,O
neurology,O
ICU,O
for,O
closer,B-TE
monitoring,I-TE
and,O
was,O
stable,O
overnight,O
-,O
BP,B-TE
was,O
initially,B-PR
elevated,I-PR
and,O
required,O
a,B-TR
labetalol,I-TR
drip,I-TR
for,O
<,O
24,O
hours,O
",",O
then,O
stabilized,O
.,O

The,B-TE
goal,I-TE
SBP,I-TE
of,O
<,O
150,O
was,O
achieved,O
.,O

Coags,B-TE
and,O
UA,B-TE
were,O
checked,O
and,O
were,O
normal,O
.,O

For,O
the,O
question,O
of,O
seizure,B-PR
activity,I-PR
associated,O
with,O
a,B-PR
cortical,I-PR
bleed,I-PR
",",O
he,O
was,O
started,O
prophylactically,O
on,O
Keppra,B-TR
(,O
given,O
questionable,O
allergy,B-PR
to,O
dilantin,B-TR
),O
",",O
at,O
500,O
mg,O
bid,O
;,O
no,O
seizure,B-PR
activity,I-PR
was,O
seen,O
.,O

This,B-TR
medication,I-TR
should,O
be,O
continued,O
as,O
an,O
outpatient,O
at,O
least,O
while,O
the,B-PR
bleed,I-PR
has,O
time,O
to,O
clear,O
up,O
",",O
with,O
planned,O
titration,O
up,O
to,O
1000,O
mg,O
bid,O
on,O
04-05,O
.,O

Head,B-TE
CT,I-TE
repeated,O
on,O
03-30,O
was,O
unchanged,O
",",O
and,O
the,O
patient,O
remained,O
stable,O
with,O
only,O
very,O
suble,O
focal,O
exam,O
findings,O
(,O
very,B-PR
mild,I-PR
right,I-PR
pronator,I-PR
drift,I-PR
),O
as,O
well,O
as,O
his,B-PR
persistently,I-PR
poor,I-PR
memory,I-PR
related,O
to,O
dementia,B-PR
.,O

The,O
plan,O
after,O
24,O
hours,O
was,O
to,O
transfer,O
him,O
to,O
the,O
floor,O
",",O
but,O
the,O
hospital,O
was,O
full,O
and,O
he,O
never,O
got,O
a,O
bed,O
.,O

Cardiovascularly,O
",",O
lipitor,B-TR
and,O
amiodarone,B-TR
were,O
continued,O
.,O

He,O
could,O
not,O
get,O
an,B-TE
MRI,I-TE
due,O
to,O
his,B-TR
pacemaker,I-TR
.,O

There,O
were,O
no,O
telemetry,B-PR
events,I-PR
",",O
and,O
he,O
ruled,O
out,O
by,O
enzyme,B-TE
.,O

Pulmonlologically,O
",",O
his,B-TE
chest,I-TE
xray,I-TE
was,O
negative,O
and,O
he,O
complained,O
of,O
no,O
breathing,B-PR
problems,I-PR
.,O

Endocrinologically,O
",",O
BG,B-TE
was,O
monitored,O
to,O
improve,O
outcome,O
in,O
ICU,O
setting,O
though,O
he,O
had,O
no,O
history,O
of,O
DM,B-PR
.,O

Of,O
note,O
",",O
Hba1c,B-TE
done,O
03-04,O
was,O
slightly,B-PR
elevated,I-PR
(,O
"",O
borderline,B-PR
DM,I-PR
"",O
),O
at,O
6.3,O
;,O
this,O
was,O
repeated,O
and,O
was,O
still,O
pending,O
on,O
the,O
day,O
of,O
discharge,O
.,O

Ins,B-TE
/,I-TE
outs,I-TE
and,O
electrolytes,B-TE
were,O
monitored,O
and,O
were,O
not,O
abnormal,B-PR
;,O
he,O
was,O
on,O
a,B-TR
bowel,I-TR
regimen,I-TR
",",O
VD,B-TR
boots,I-TR
and,O
PUD,B-TR
prophylaxis,I-TR
with,O
protonix,B-TR
during,O
the,O
admission,O
.,O

Walking,O
was,O
assessed,O
later,O
and,O
the,O
patient,O
was,O
unstable,B-PR
on,I-PR
his,I-PR
feet,I-PR
.,O

PT,O
was,O
asked,O
to,O
see,O
him,O
for,O
this,B-PR
gait,I-PR
problem,I-PR
.,O

Brandon,O
felt,O
well,O
and,O
was,O
seen,O
by,O
PT,O
who,O
suggested,O
a,O
rehab/Hahnemann,O
Hospital,O
(,O
Worcester,O
),O
to,O
work,O
on,O
walking,O
with,O
the,O
eventual,O
goal,O
of,O
returning,O
to,O
assisted,O
living,O
with,O
his,O
wife,O
when,O
walking,O
improved,O
.,O

Follow-up,O
was,O
arranged,O
with,O
neurosurgery,O
in,O
5-6,O
weeks,O
with,O
repeat,B-TE
head,I-TE
ct,I-TE
to,O
be,O
arranged,O
by,O
neurosurgery,O
office,O
to,O
make,O
sure,O
blood,B-PR
has,O
cleared,O
",",O
and,O
if,O
indicated,O
",",O
to,O
look,O
for,O
a,O
possible,O
underlying,B-PR
lesion,I-PR
(,O
although,O
unlikely,O
),O
.,O

Medications,O
on,O
Admission,O
:,O

Amiodarone,B-TR
200,O
mg,O
Tablet,O
Sig,O
:,O
0.5,O
Tablet,O
PO,O
qod,O
-,O
in,O
March,O
",",O
should,O
be,O
on,O
odd,O
days,O
.,O

Donepezil,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
HS,O
(,O
at,O
bedtime,O
),O
.,O

Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

Multivitamin,B-TR
Capsule,I-TR
Sig,O
:,O
One,O
(,O
1,O
),O
Cap,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

Mirtazapine,B-TR
30,O
mg,O
Tablet,O
Sig,O
:,O
0.5,O
Tablet,O
PO,O
HS,O
(,O
at,O
bedtime,O
),O
.,O

Atorvastatin,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
at,O
bedtime,O
.,O

Ocuvite,B-TR
Tablet,I-TR
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
once,O
a,O
day,O
.,O

Artificial,B-TR
Tears,I-TR
Drops,I-TR
Sig,O
:,O
One,O
(,O
1,O
),O
drop,O
Ophthalmic,O
twice,O
a,O
day,O
:,O
ou,O
.,O

Ensure,B-TR
Liquid,I-TR
Sig,O
:,O
0.5,O
to,O
1,O
can,O
PO,O
three,O
times,O
a,O
day,O
.,O

Midodrine,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
1.5,O
Tablets,O
PO,O
twice,O
a,O
day,O
:,O
at,O
8am,O
and,O
noon,O
.,O

Ritalin,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
see,O
below,O
Tablet,O
PO,O
see,O
below,O
:,O
1.5,O
tablets,O
at,O
10am,O
(,O
7.5mg,O
),O
",",O
1,O
tablet,O
2pm,O
(,O
5mg,O
),O
.,O

Prilosec,B-TR
20,O
mg,O
Capsule,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
once,O
a,O
day,O
.,O

Guaifenesin,B-TR
100,O
mg,O
/,O
5,O
mL,O
Liquid,O
Sig,O
:,O
01-28,O
teaspoons,O
PO,O
every,O
six,O
(,O
6,O
),O
hours,O
as,O
needed,O
for,O
cold,B-PR
symptoms,I-PR
.,O

Discharge,O
Medications,O
:,O

1.,O
Amiodarone,B-TR
200,O
mg,O
Tablet,O
Sig,O
:,O
0.5,O
Tablet,O
PO,O
qod,O
-,O
in,O
March,O
",",O
should,O
be,O
on,O
odd,O
days,O
.,O

2.,O
Donepezil,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
HS,O
(,O
at,O
bedtime,O
),O
.,O

3.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

4.,O
Multivitamin,B-TR
Capsule,I-TR
Sig,O
:,O
One,O
(,O
1,O
),O
Cap,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

5.,O
Mirtazapine,B-TR
30,O
mg,O
Tablet,O
Sig,O
:,O
0.5,O
Tablet,O
PO,O
HS,O
(,O
at,O
bedtime,O
),O
.,O

6.,O
Atorvastatin,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
at,O
bedtime,O
.,O

7.,O
Levetiracetam,B-TR
500,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
:,O
on,O
04-05,O
",",O
please,O
increase,O
to,O
TWO,O
tablets,O
bid,O
(,O
1000,O
mg,O
bid,O
),O
.,O

8.,O
Ocuvite,B-TR
Tablet,I-TR
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
once,O
a,O
day,O
.,O

9.,O
Artificial,B-TR
Tears,I-TR
Drops,I-TR
Sig,O
:,O
One,O
(,O
1,O
),O
drop,O
Ophthalmic,O
twice,O
a,O
day,O
:,O
ou,O
.,O

10.,O
Ensure,B-TR
Liquid,I-TR
Sig,O
:,O
0.5,O
to,O
1,O
can,O
PO,O
three,O
times,O
a,O
day,O
.,O

11.,O
Midodrine,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
1.5,O
Tablets,O
PO,O
twice,O
a,O
day,O
:,O
at,O
8,O
am,O
and,O
noon,O
.,O

12.,O
Ritalin,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
see,O
below,O
Tablet,O
PO,O
see,O
below,O
:,O
1.5,O
tablets,O
at,O
10,O
am,O
(,O
7.5,O
mg,O
),O
",",O
1,O
tablet,O
2,O
pm,O
(,O
5,O
mg,O
),O
.,O

13.,O
Prilosec,B-TR
20,O
mg,O
Capsule,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
once,O
a,O
day,O
.,O

14.,O
Guaifenesin,B-TR
100,O
mg,O
/,O
5,O
mL,O
Liquid,O
Sig,O
:,O
01-28,O
teaspoons,O
PO,O
every,O
six,O
(,O
6,O
),O
hours,O
as,O
needed,O
for,O
cold,B-PR
symptoms,I-PR
.,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Discharge,O
Diagnosis,O
:,O

Right,B-PR
sided,I-PR
intraparenchymal,I-PR
cerebral,I-PR
hemorrhage,I-PR

Discharge,O
Condition,O
:,O

Stable,O
-,O
still,O
with,O
difficulty,B-PR
walking,I-PR
",",O
and,O
mental,B-TE
status,I-TE
exam,I-TE
with,O
memory,B-PR
loss,I-PR
c/w,O
dementia,B-PR
",",O
but,O
otherwise,O
no,O
focal,B-PR
weakness,I-PR
.,O

Discharge,O
Instructions,O
:,O

Please,O
call,O
MD,O
or,O
return,O
to,O
Deanna,O
if,O
new,O
symptoms,O
suggestive,O
of,O
stroke,B-PR
or,O
brain,B-PR
hemorrhage,I-PR
including,O
weakness,B-PR
",",O
numbness,B-PR
/,O
tingling,B-PR
",",O
facial,B-PR
droop,I-PR
",",O
visual,B-PR
changes,I-PR
",",O
vertigo,B-PR
",",O
loss,B-PR
of,I-PR
coordination,I-PR
",",O
or,O
worsened,B-PR
problems,I-PR
with,I-PR
walking,I-PR
.,O

Followup,O
Instructions,O
:,O

Please,O
f/u,O
with,O
Dr.,O
Hernandez,O
/,O
neurosurgery,O
in,O
6,O
weeks,O
-,O
patient,O
will,O
receive,O
a,O
call,O
from,O
the,O
neurosurgery,O
office,O
to,O
set,O
up,O
a,B-TE
repeat,I-TE
head,I-TE
CT,I-TE
prior,O
and,O
to,O
schedule,O
this,O
visit,O
.,O

Daniel,O
Laura,O
MD,O
",",O
PHD,O
13-279,O

Completed,O
by,O
:,O
Charles,O
Rodriguez,O
MD,O
38-818,O
2019-04-01,O
@,O
1518,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Stacie,O
Henry,O
on,O
:,O
MON,O
2019-05-06,O
12:14,O
PM,O

(,O
End,O
of,O
Report,O
),O

194830718,O
YC,O

29157608,O

520377,O

10/25/1997,O
12:00:00,O
AM,O

DIVERTICULITIS,B-PR
",",O
S,O
/,O
P,O
AORTIC,B-TR
VALVE,I-TR
REPLACEMENT,I-TR

Signed,O

DIS,O

Admission,O
Date,O
:,O

10/25/1997,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

11/03/1997,O

CHIEF,O
COMPLAINT,O
:,O

Diverticulitis,B-PR
",",O
presenting,O
for,O
sigmoid,B-TR
colectomy,I-TR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
67-year-old,O
woman,O
with,O
occasional,B-PR
abdominal,I-PR
pain,I-PR
in,I-PR
the,I-PR
right,I-PR
lower,I-PR
quadrant,I-PR
and,O
left,O
lower,O
quadrant,O
.,O

She,O
has,O
not,O
complained,O
of,O
any,B-PR
fever,I-PR
",",O
shaking,B-PR
",",O
or,O
chills,B-PR
.,O

No,O
nausea,B-PR
or,O
vomiting,B-PR
",",O
no,O
change,B-PR
in,I-PR
her,I-PR
bowel,I-PR
movements,I-PR
.,O

She,O
has,O
had,O
attacks,B-PR
treated,O
with,O
antibiotics,B-TR
in,O
the,O
past,O
notably,O
in,O
12/96,O
and,O
08/97,O
.,O

She,O
has,O
had,O
a,O
diagnosis,O
of,O
diverticulitis,B-PR
flairs,I-PR
and,O
baseline,B-PR
diverticulosis,I-PR
flairing,I-PR
in,O
09/96,O
.,O

Also,O
",",O
three,O
years,O
prior,O
in,O
1993,O
",",O
she,O
had,O
an,B-PR
attack,I-PR
of,I-PR
diverticulitis,I-PR
.,O

She,O
has,O
been,O
worked,O
up,O
with,O
barium,B-TE
enema,I-TE
in,O
09/97,O
which,O
showed,O
multiple,B-PR
diverticula,I-PR
throughout,I-PR
the,I-PR
colon,I-PR
",",O
but,O
mostly,O
in,O
the,O
sigmoid,O
.,O

At,O
this,O
time,O
",",O
there,O
was,O
diverticulosis,B-PR
with,O
no,O
acute,B-PR
diverticulitis,I-PR
.,O

There,O
was,O
also,O
no,O
obstruction,B-PR
.,O

The,O
patient,O
is,O
also,O
status,O
post,O
aortic,B-TR
valve,I-TR
replacement,I-TR
in,O
1996,O
",",O
and,O
presented,O
for,O
heparinization,B-TR
prior,O
to,O
her,B-TR
elective,I-TR
valve,I-TR
surgery,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

The,O
patient,O
has,O
hypothyroidism,B-PR
",",O
hypertension,B-PR
",",O
and,O
rheumatic,B-PR
fever,I-PR
age,O
6,O
with,O
aortic,B-PR
stenosis,I-PR
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

Aortic,B-TR
valve,I-TR
replacement,I-TR
in,O
11/96,O
with,O
a,B-TR
St.,I-TR
Jude,I-TR
valve,I-TR
and,O
chronic,B-TR
Coumadin,I-TR
therapy,I-TR
;,O
breast,B-TE
biopsy,I-TE
negative,O
in,O
1984,O
;,O
appendectomy,B-TR
age,O
15,O
;,O
tonsillectomy,B-TR
and,O
adenoidectomy,B-TR
age,O
6,O
;,O
hysterotomy,B-TR
age,O
30,O
;,O
C-section,B-TR
age,O
37,O
due,O
to,O
placenta,B-PR
previa,I-PR
.,O

MEDICATIONS,O
:,O

Lopressor,B-TR
50,O
mg,O
q.a.m.,O
",",O
25,O
mg,O
q.p.m.,O
",",O
and,O
25,O
mg,O
q.h.s.;,O
Synthroid,B-TR
88,O
mcg,O
q.d.;,O
Norvasc,B-TR
5,O
mg,O
q.d.;,O
Lescol,B-TR
20,O
mg,O
q.p.m.,O
with,O
meal,O
;,O
Coumadin,B-TR
is,O
usually,O
4,O
mg,O
p.o.,O
3x,O
a,O
week,O
and,O
3,O
mg,O
4x,O
a,O
week,O
.,O

It,O
was,O
held,O
the,O
day,O
prior,O
to,O
admission,O
.,O

ALLERGIES,O
:,O

Percodan,B-TR
and,O
codeine,B-TR
.,O

SOCIAL,O
HISTORY,O
:,O

Alcohol,O
and,O
tobacco,O
histories,O
are,O
negative,O
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

Negative,O
for,O
congestive,B-PR
heart,I-PR
failure,I-PR
",",O
positive,O
for,O
occasional,B-PR
dyspnea,I-PR
on,O
exertion,O
",",O
negative,O
for,O
dyspnea,B-PR
and,O
she,O
has,O
excellent,O
exercise,O
tolerance,O
.,O

There,O
is,O
occasional,B-PR
left,I-PR
chest,I-PR
tightening,I-PR
which,O
is,O
brief,O
.,O

No,O
bleeding,B-PR
in,I-PR
her,I-PR
urine,I-PR
or,I-PR
stool,I-PR
.,O

Occasional,B-PR
bleeding,I-PR
when,O
she,O
flosses,O
and,O
occasional,B-PR
dizziness,I-PR
secondary,O
to,O
a,B-PR
drop,I-PR
in,O
blood,B-TE
pressure,I-TE
transiently,O
at,O
home,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

VITAL,O
SIGNS,O
-,O
Temp,B-TE
98.8,O
",",O
pulse,B-TE
60,O
",",O
BP,B-TE
150/94,O
",",O
respiratory,B-TE
rate,I-TE
18,O
",",O
and,O
saturation,B-TE
96%,O
on,O
room,O
air,O
.,O

GENERAL,O
-,O
The,O
patient,O
is,O
a,O
pleasant,O
older,O
woman,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

HEENT,O
-,O
Normocephalic,O
",",O
atraumatic,B-PR
.,O

Oropharynx,O
is,O
not,O
injected,O
.,O

NECK,O
-,O
No,O
carotid,B-PR
bruits,I-PR
",",O
with,O
2+,B-TE
carotid,I-TE
pulses,I-TE
.,O

LUNGS,O
-,O
Clear,O
.,O

HEART,O
-,O
Regular,O
",",O
with,O
a,B-PR
III,I-PR
/,I-PR
VI,I-PR
murmur,I-PR
at,I-PR
the,I-PR
upper,I-PR
left,I-PR
sternal,I-PR
border,I-PR
.,O

ABDOMEN,O
-,O
There,O
is,O
a,O
soft,O
abdomen,O
with,O
a,O
question,O
of,O
eventful,B-PR
hernia,I-PR
.,O

RECTAL,O
-,O
Guaiac,B-TE
negative,O
with,O
normal,O
tone,O
.,O

EXTREMITIES,O
-,O
Bilateral,B-TE
radial,I-TE
",",O
dorsalis,B-TE
pedis,I-TE
",",O
posterior,B-TE
tibial,I-TE
",",O
and,O
femoral,B-TE
pulses,I-TE
are,O
all,O
2+,O
.,O

No,O
clubbing,B-PR
",",O
cyanosis,B-PR
",",O
or,O
edema,B-PR
of,I-PR
the,I-PR
extremities,I-PR
.,O

LABORATORY,O
DATA,O
:,O

Coagulation,B-TE
profile,I-TE
notable,O
for,O
a,B-TE
PT,I-TE
18,O
",",O
PTT,B-TE
36.7,O
and,O
an,B-TE
INR,I-TE
of,O
2.4,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
and,O
begun,O
on,O
cefotetan,B-TR
and,O
Flagyl,B-TR
",",O
as,O
well,O
as,O
heparin,B-TR
.,O

Her,B-TE
INR,I-TE
dropped,O
to,O
1.6,O
prior,O
to,O
surgery,B-TR
",",O
and,O
her,B-TE
PTT,I-TE
was,O
in,O
the,O
mid,O
80s,O
prior,O
to,O
surgery,B-TR
.,O

She,O
was,O
admitted,O
and,O
placed,O
on,O
a,B-TR
bowel,I-TR
prep,I-TR
two,O
days,O
before,O
surgery,B-TR
and,O
was,O
taken,O
to,O
the,O
Operating,O
Room,O
on,O
hospital,O
day,O
#,O
3,O
",",O
10/28/97,O
.,O

At,O
that,O
time,O
",",O
she,O
underwent,O
sigmoid,B-TR
colectomy,I-TR
and,O
ventral,B-TR
hernia,I-TR
repair,I-TR
.,O
(,O
A,O
full,O
account,O
of,O
this,B-TR
operation,I-TR
can,O
be,O
found,O
in,O
the,O
Operative,O
Note,O
),O
.,O

She,O
tolerated,O
this,B-TR
procedure,I-TR
without,O
complications,B-PR
initially,O
and,O
was,O
taken,O
to,O
the,O
Recovery,O
Room,O
in,O
stable,O
condition,O
.,O

Postoperatively,O
",",O
she,O
had,O
her,B-TR
heparin,I-TR
restarted,O
",",O
and,O
had,O
a,B-TE
PTT,I-TE
rising,O
to,O
142.8,O
and,O
then,O
down,O
to,O
92,O
.,O

Her,O
primary,O
postoperative,O
development,O
was,O
the,B-PR
passage,I-PR
of,I-PR
some,I-PR
blood,I-PR
clots,I-PR
and,O
blood,B-PR
per,I-PR
rectum,I-PR
on,O
postoperative,O
day,O
#,O
2,O
.,O

She,O
continued,O
to,O
pass,O
blood,B-PR
per,I-PR
rectum,I-PR
and,O
was,O
transfused,O
with,O
one,B-TR
unit,I-TR
of,I-TR
packed,I-TR
red,I-TR
blood,I-TR
cells,I-TR
.,O

Her,B-TE
preoperative,I-TE
hematocrit,I-TE
was,O
41,O
and,O
her,B-TE
hematocrit,I-TE
dropped,O
to,O
30.4,O
on,O
postoperative,O
day,O
#,O
2,O
.,O

This,O
was,O
a,O
drop,O
from,O
an,B-TE
immediate,I-TE
postoperative,I-TE
hematocrit,I-TE
of,O
35.4,O
.,O

Upon,O
receiving,O
the,B-TR
one,I-TR
unit,I-TR
of,I-TR
red,I-TR
blood,I-TR
cells,I-TR
",",O
her,B-TE
hematocrit,I-TE
returned,O
to,O
33,O
",",O
and,O
in,O
the,O
two,O
days,O
subsequent,O
to,O
the,B-TR
transfusion,I-TR
",",O
returned,O
to,O
34,O
.,O

Otherwise,O
",",O
her,O
postoperative,O
course,O
was,O
uneventful,O
with,O
gradual,O
resolution,O
of,O
the,O
passage,O
of,O
blood,B-PR
per,I-PR
rectum,I-PR
.,O

Her,B-TR
heparin,I-TR
was,O
discontinued,O
when,O
it,O
was,O
noted,O
that,O
she,O
was,O
bleeding,B-PR
per,I-PR
rectum,I-PR
and,O
her,B-TE
PTT,I-TE
drifted,O
to,O
a,O
normal,O
range,O
of,O
35,O
by,O
postoperative,O
day,O
#,O
3,O
.,O

On,O
postoperative,O
day,O
#,O
1,O
",",O
the,O
patient,O
was,O
restarted,O
on,O
2,O
mg,O
of,O
Coumadin,B-TR
.,O

However,O
",",O
due,O
to,O
the,O
episode,O
of,O
bleeding,B-PR
on,O
postoperative,O
day,O
#,O
2,O
",",O
the,B-TR
Coumadin,I-TR
was,O
held,O
for,O
two,O
consecutive,O
days,O
",",O
and,O
then,O
restarted,O
on,O
postoperative,O
day,O
#,O
4,O
.,O

At,O
this,O
time,O
",",O
she,O
is,O
given,O
3,O
mg,O
and,O
was,O
gradually,O
increased,O
to,O
her,B-TR
regular,I-TR
regimen,I-TR
of,O
4,O
mg,O
alternating,O
with,O
3,O
mg.,O

The,B-TE
patient,I-TE
&apos;s,I-TE
INR,I-TE
had,O
dropped,O
to,O
1.7,O
at,O
the,O
time,O
of,O
operation,B-TR
",",O
and,O
remained,O
in,O
this,O
range,O
initially,O
",",O
but,O
began,O
to,O
rise,O
to,O
2.0,O
with,O
her,B-TR
Coumadin,I-TR
dosing,I-TR
.,O

At,O
the,O
time,O
of,O
discharge,O
",",O
it,O
was,O
1.9,O
",",O
for,O
which,O
she,O
received,O
4,O
mg.,O

On,O
the,O
next,O
day,O
",",O
it,O
was,O
1.6,O
and,O
she,O
returned,O
to,O
a,B-TR
normal,I-TR
dosing,I-TR
of,O
4,O
mg,O
followed,O
by,O
outpatient,B-TE
draws,I-TE
to,O
determine,O
the,B-TR
further,I-TR
Coumadin,I-TR
dosing,I-TR
.,O

This,O
was,O
postoperative,O
day,O
#,O
6,O
",",O
at,O
which,O
time,O
she,O
is,O
ready,O
for,O
discharge,O
.,O

The,O
rest,O
of,O
her,O
hospital,O
course,O
was,O
unremarkable,O
",",O
with,O
perioperative,B-TR
ampicillin,I-TR
",",O
gentamicin,B-TR
and,O
Flagyl,B-TR
discontinued,O
on,O
postoperative,O
day,O
#,O
1,O
.,O

She,O
had,O
some,B-PR
initial,I-PR
nausea,I-PR
but,O
had,O
no,O
emesis,B-PR
.,O

Her,B-TR
nasogastric,I-TR
tube,I-TR
was,O
discontinued,O
on,O
postoperative,O
day,O
#,O
1,O
",",O
and,O
she,O
tolerated,O
a,O
regular,O
diet,O
by,O
postoperative,O
day,O
#,O
3,O
.,O

She,O
had,O
flatus,O
and,O
regular,O
bowel,O
movements,O
by,O
postoperative,O
day,O
#,O
5,O
.,O

She,O
also,O
complained,O
of,O
some,B-PR
slight,I-PR
dizziness,I-PR
upon,O
getting,O
up,O
.,O

For,O
this,O
reason,O
",",O
her,B-TR
normal,I-TR
Lopressor,I-TR
and,O
Norvasc,B-TR
were,O
held,O
.,O

It,O
was,O
felt,O
that,O
this,O
was,O
re-equalibration,O
after,O
being,O
sedentary,O
and,O
mostly,O
in,O
bed,O
following,O
the,B-TR
operation,I-TR
.,O

She,O
had,O
some,B-PR
slight,I-PR
headaches,I-PR
which,O
resolved,O
with,O
Tylenol,B-TR
",",O
and,O
the,B-PR
dizziness,I-PR
resolved,O
as,O
well,O
.,O

She,O
was,O
ready,O
for,O
discharge,O
on,O
postoperative,O
day,O
#,O
6,O
.,O

Her,B-PR
wound,I-PR
remained,O
benign,O
and,O
was,O
healing,O
nicely,O
at,O
the,O
time,O
of,O
discharge,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Lopressor,B-TR
50,O
mg,O
q.a.m.,O
",",O
25,O
mg,O
q.p.m.,O
",",O
and,O
25,O
mg,O
q.h.s.,O
",",O
Synthroid,B-TR
88,O
mcg,O
q.d.,O
",",O
Norvasc,B-TR
5,O
mg,O
q.d.,O
",",O
Lescol,B-TR
20,O
mg,O
q.p.m.,O
with,O
meal,O
",",O
Coumadin,B-TR
is,O
usually,O
4,O
mg,O
p.o.,O
3x,O
a,O
week,O
and,O
3,O
mg,O
4x,O
a,O
week,O
;,O
Percocet,B-TR
1-2,O
tabs,O
q.4h.,O
p.r.n.,O
pain,B-PR
.,O

DISCHARGE,O
FOLLOW-UP,O
:,O

Follow-up,O
with,O
Dr.,O
Jesc,O
in,O
the,O
office,O
.,O

DISCHARGE,O
DISPOSITION,O
:,O

Her,O
disposition,O
was,O
to,O
home,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
.,O

Estimated,O
disability,O
was,O
none,O
.,O

Dictated,O
By,O
:,O

BELL,O
REXBEATHEFARST,O
",",O
M.D.,O
NM82,O

Attending,O
:,O

LINEMASE,O
D.,O
JESC,O
",",O
M.D.,O
ZP2,O
SF477/5317,O

Batch,O
:,O

31967,O

Index,O
No.,O
PAWU09891C,O

D,O
:,O

11/07/97,O

T,O
:,O

11/07/97,O

Admission,O
Date,O
:,O

2019-12-28,O

Discharge,O
Date,O
:,O

2020-01-20,O

Date,O
of,O
Birth,O
:,O

2019-12-28,O

Sex,O
:,O

F,O

Service,O
:,O

CMED,O
CCU,O

HISTORY,O
:,O

Baby,O
Girl,O
Rizza-Gannaway,O
is,O
the,O
1515,O
gram,O
product,O
of,O
a,O
32,O
and,O
06-30,O
week,O
twin,O
gestation,O
born,O
to,O
a,O
37-year-old,O
G,O
-,O
2,O
",",O
P,O
-,O
0,O
",",O
now,O
2,O
",",O
mother,O
.,O

Prenatal,O
Edward,O
:,O

A,B-TE
negative,O
",",O
antibody,B-TE
negative,O
",",O
hepatitis,B-TE
surface,I-TE
antigen,I-TE
negative,O
",",O
RPR,B-TE
nonreactive,O
",",O
rubella,B-TE
immune,O
and,O
GBS,B-TE
negative,O
.,O

Pregnancy,O
was,O
IUI,O
assisted,O
for,O
di-di,O
twin,O
gestation,O
and,O
was,O
relatively,O
uncomplicated,B-PR
until,O
mother,O
presented,O
on,O
12-15,O
",",O
with,O
spontaneous,O
rupture,O
of,O
membranes,O
.,O

She,O
was,O
found,O
to,O
be,O
having,O
preterm,B-PR
contractions,I-PR
without,O
cervical,B-PR
change,I-PR
and,O
was,O
admitted,O
for,O
bedrest,B-TR
.,O

She,O
received,O
a,O
full,O
course,O
of,O
betamethasone,B-TR
complete,O
on,O
12-17,O
",",O
magnesium,B-TR
and,O
erythromycin,B-TR
for,O
latency,O
through,O
12-21,O
.,O

Intermittent,B-PR
maternal,I-PR
hypertension,I-PR
noted,O
but,O
without,O
proteinuria,B-PR
.,O

Ultrasounds,B-TE
have,O
been,O
reassuring,O
with,O
biophysicals,B-TE
8,O
out,O
of,O
8,O
x2,O
.,O

On,O
the,O
evening,O
of,O
12-27,O
",",O
monitoring,B-TE
noted,O
child,O
's,O
increased,B-PR
preterm,I-PR
contractions,I-PR
",",O
uterine,B-PR
tenderness,I-PR
and,O
mildly,B-PR
increased,I-PR
fetal,I-PR
heart,I-PR
rates,I-PR
",",O
due,O
to,O
concerns,O
of,O
possible,O
chorioamnionitis,B-PR
",",O
the,O
mother,O
was,O
taken,O
for,O
cesarean,B-TR
delivery,I-TR
.,O

The,O
infant,O
delivered,O
with,O
moderate,O
tone,O
and,O
respiratory,O
effort,O
responding,O
well,O
to,O
stimulation,B-TR
and,O
brief,B-TR
blow,I-TR
by,I-TR
O2,I-TR
.,O

Apgars,B-TE
were,O
8,O
and,O
8,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,O
",",O
weight,B-TE
1515,O
grams,O
",",O
10th,O
to,O
25th,O
percentile,O
",",O
head,B-TE
circumference,I-TE
30,O
cm,O
",",O
25th,O
to,O
50th,O
percentile,O
",",O
length,B-TE
41,O
cm,O
",",O
10th,O
to,O
25th,O
percentile,O
.,O

Warm,O
",",O
dry,O
",",O
premature,B-PR
infant,O
",",O
active,O
with,O
exam,B-TE
",",O
mild,B-PR
respiratory,I-PR
distress,I-PR
at,O
rest,O
.,O

Overall,O
appearance,O
consistent,O
with,O
estimated,O
gestational,O
age,O
.,O

Thin,O
",",O
warm,O
",",O
dry,O
",",O
pink,O
",",O
no,O
rashes,B-PR
.,O

Fontanelle,O
soft,O
and,O
flat,O
.,O

Ears,O
normal,O
.,O

Palate,O
intact,O
.,O

Nondysmorphic,B-PR
.,O

Positive,O
red,B-TE
reflex,I-TE
bilaterally,I-TE
.,O

Neck,O
supple,O
",",O
no,O
lesions,B-PR
.,O

Chest,O
moderately,O
aerated,O
.,O

Mild,B-PR
grunting,I-PR
.,O

Cardiovascular,O
:,O

Regular,O
rate,O
and,O
rhythm,O
",",O
no,O
murmur,B-PR
",",O
femoral,B-TE
pulses,I-TE
2+,O
.,O

Abdomen,O
soft,O
",",O
no,O
hepatosplenomegaly,B-PR
",",O
quiet,O
bowel,O
sounds,O
",",O
3,O
vessel,O
cord,O
.,O

CMED,O
CSRU,O
:,O

Normal,O
female,O
",",O
anus,O
patent,O
.,O

Hips,O
stable,O
.,O

Back,O
normal,O
.,O

No,O
lesions,B-PR
.,O

Appropriate,O
tone,O
and,O
activity,O
for,O
gestational,O
age,O
.,O

HOSPITAL,O
COURSE,O
:,O

By,O
systems,O
:,O

Respiratory,O
:,O

Pocasset,O
was,O
admitted,O
to,O
the,O
newborn,O
intensive,O
care,O
unit,O
with,O
mild,B-PR
respiratory,I-PR
distress,I-PR
.,O

Chest,B-TE
x-ray,I-TE
revealed,O
a,B-PR
left,I-PR
pneumothorax,I-PR
which,O
resolved,O
on,O
its,O
own,O
without,O
intervention,B-TR
.,O

The,O
infant,O
has,O
remained,O
in,O
room,O
air,O
throughout,O
her,O
hospital,O
course,O
with,O
occasional,B-PR
apnea,I-PR
and,O
bradycardia,B-PR
episodes,I-PR
",",O
the,O
last,O
being,O
documented,O
on,O
2020-01-14,O
.,O

Cardiovascular,O
:,O

Attleboro,O
has,O
been,O
stable,O
throughout,O
her,O
newborn,O
intensive,O
care,O
course,O
without,O
issue,O
.,O

Fluids,O
and,O
electrolytes,O
:,O

Birth,B-TE
weight,I-TE
was,O
1515,O
grams,O
.,O

She,O
was,O
initially,O
started,O
on,O
80,O
cc,O
per,O
kilo,O
per,O
day,O
of,O
D10W,B-TR
.,O

Enteral,B-TR
feedings,I-TR
were,O
initiated,O
on,O
day,O
of,O
life,O
#1,O
.,O

Full,B-TR
enteral,I-TR
feedings,I-TR
were,O
achieved,O
by,O
day,O
of,O
life,O
#7,O
.,O

The,O
infant,O
had,O
a,O
course,O
of,O
heme,B-PR
positive,I-PR
stools,I-PR
with,O
grossly,B-PR
bloody,I-PR
streaks,I-PR
and,O
mucus,B-PR
felt,O
to,O
be,O
protein,B-PR
allergy,I-PR
.,O

The,O
infant,O
is,O
now,O
receiving,O
breast,O
milk,O
with,O
Nutramigen,B-TR
powder,I-TR
concentrate,I-TR
to,O
24,O
calorie,O
.,O

Stools,O
have,O
been,O
negative,O
to,O
trace,B-PR
positive,I-PR
and,O
abdominal,B-TE
exam,I-TE
is,O
reassuring,O
.,O

Discharge,B-TE
weight,I-TE
is,O
2040,O
gm,O
",",O
the,B-TE
head,I-TE
circumference,I-TE
is,O
32,O
cm,O
and,O
the,B-TE
length,I-TE
is,O
46,O
cm.,O
.,O

GI,O
:,O

Peak,B-TE
bilirubin,I-TE
was,O
on,O
day,O
of,O
life,O
#2,O
of,O
4.8/0.3,O
.,O

Hematology,O
:,O

Hematocrit,B-TE
on,O
admission,O
was,O
41,O
.,O

The,O
infant,O
did,O
not,O
require,O
any,B-TR
blood,I-TR
transfusions,I-TR
during,O
this,O
hospital,O
course,O
.,O

Infectious,O
disease,O
:,O

CBC,B-TE
and,O
blood,B-TE
culture,I-TE
were,O
obtained,O
on,O
admission,O
.,O

White,B-TE
count,I-TE
was,O
4.8,O
",",O
7,B-TE
polys,I-TE
",",O
zero,B-TE
bands,I-TE
",",O
platelet,B-TE
count,I-TE
of,O
"316,000",O
.,O

ANC,B-TE
at,O
that,O
time,O
was,O
336,O
.,O

A,B-TE
24,I-TE
hour,I-TE
CBC,I-TE
was,O
obtained,O
.,O

White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
was,O
5.1,O
",",O
22,B-TE
polys,I-TE
",",O
zero,B-TE
bands,I-TE
with,O
a,B-TE
hematocrit,I-TE
of,O
39.3,O
and,O
platelets,B-TE
of,O
"313,000",O
.,O

The,O
infant,O
received,O
48,O
hours,O
of,O
ampicillin,B-TR
and,O
gentamicin,B-TR
which,O
were,O
discontinued,O
with,O
a,O
negative,O
blood,O
culture,O
.,O

Neurology,O
:,O

The,O
infant,O
has,O
been,O
appropriate,O
for,O
gestational,O
age,O
.,O

Sensory,O
:,O

Audiology,B-TE
hearing,I-TE
screen,I-TE
was,O
performed,O
with,O
automated,B-TE
auditory,I-TE
brainstem,I-TE
responses,I-TE
and,O
the,O
infant,O
passed,O
on,O
both,O
ears,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
.,O

DISCHARGE,O
DISPOSITION,O
:,O

To,O
home,O
.,O

PRIMARY,O
PEDIATRICIAN,O
:,O

Dr.,O
Donald,O
Carrion,O
",",O
telephone,O
number,O
(,O
861,O
),O
840,O
7928,O
.,O

CARE,O
RECOMMENDATIONS,O
:,O

1.,O
Continue,O
breast,O
milk,O
24,O
calories,O
of,O
Nutramigen,B-TR
for,O
concentration,O
.,O

2.,O
Medications,B-TR
:,O
The,O
infant,O
is,O
receiving,O
Fer-in-Phillip,B-TR
supplementation,I-TR
of,O
0.15,O
ml,O
p.o.,O
once,O
daily,O
.,O

3.,O
Car,B-TE
seat,I-TE
position,I-TE
screening,I-TE
was,O
performed,O
for,O
screening,O
and,O
the,O
infant,O
passed,O
.,O

4.,O
State,B-TE
newborn,I-TE
screens,I-TE
have,O
been,O
sent,O
per,O
protocol,O
",",O
most,O
recently,O
on,O
01-11,O
",",O
and,O
have,O
been,O
within,O
normal,O
limits,O
.,O

5.,O
Immunizations,B-TR
received,O
:,O
Hepatitis,B-TR
B,I-TR
vaccine,I-TR
on,O
2020-01-19,O
.,O

6.,O
Immunizations,B-TR
recommended,O
:,O

Synagis,B-TR
RSV,I-TR
prophylaxis,I-TR
should,O
be,O
considered,O
from,O
November,O
through,O
March,O
for,O
infants,O
who,O
meet,O
any,O
of,O
the,O
following,O
3,O
criteria,O
:,O

Born,O
at,O
less,O
than,O
32,O
weeks,O
",",O
born,O
between,O
32,O
and,O
35,O
weeks,O
with,O
2,O
of,O
the,O
following,O
:,O

Daycare,O
during,O
RSV,O
season,O
",",O
a,O
smoker,O
in,O
the,O
household,O
",",O
neuromuscular,B-PR
disease,I-PR
",",O
airway,B-PR
abnormalities,I-PR
or,O
school,O
age,O
sibling,O
",",O
or,O
3,O
with,O
chronic,B-PR
lung,I-PR
disease,I-PR
.,O

Influenza,B-TR
immunization,I-TR
is,O
recommended,O
annually,O
in,O
the,O
fall,O
for,O
all,O
infants,O
once,O
they,O
reach,O
6,O
months,O
of,O
age,O
.,O

Before,O
this,O
age,O
and,O
for,O
the,O
first,O
24,O
months,O
of,O
the,O
child,O
's,O
life,O
",",O
immunization,B-TR
against,O
influenza,B-PR
is,O
recommended,O
for,O
household,O
contacts,O
and,O
out,O
of,O
home,O
caregivers,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Premature,B-PR
twin,I-PR
#1,O
born,O
at,O
32,O
and,O
5/7,O
weeks,O
.,O

2.,O
Rule,O
out,O
sepsis,B-PR
with,O
antibiotics,B-TR
.,O

3.,O
Respiratory,B-PR
distress,I-PR
with,O
left,B-PR
pneumothorax,I-PR
resolved,O
.,O

4.,O
Mild,B-PR
hyperbilirubinemia,I-PR
.,O

5.,O
Mild,B-PR
apnea,I-PR
and,I-PR
bradycardia,I-PR
of,O
prematurity,B-PR
resolved,O
.,O

6.,O
Possible,O
milk,B-PR
proteine,I-PR
allergy,I-PR

FOLLOW,O
UP,O
:,O

Appointments,O
recommended,O
:,O

A,B-TE
hip,I-TE
ultrasound,I-TE
due,O
to,O
breech,B-PR
/,O
breech,B-PR
presentation,I-PR
of,I-PR
twins,I-PR
.,O

Tai,O
Pamela,O
Christopher,O
",",O
Oklahoma,O
05158,O

Dictated,O
By,O
:,O
John,O
T,O
Hall,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2020-01-19,O
02:52:47,O

T,O
:,O
2020-01-19,O
09:12:10,O

Job,O
#:,O
76780,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Charles,O
TRAN,O
on,O
:,O
MON,O
2020-01-20,O
8:22,O
AM,O

(,O
End,O
of,O
Report,O
),O

196768414,O
YC,O

36611261,O

5472577,O

5/7/2003,O
12:00:00,O
AM,O

SAVD,B-TR

DIS,O

Admission,O
Date,O
:,O

05/07/2003,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

05/09/2003,O

******,O
DISCHARGE,O
ORDERS,O
******,O

BOORMKAYSSCAJE,O
",",O
PA,O
A.,O
967-94-23-8,O
R21,O

Room,O
:,O

FISHIP,O
HOSPITAL,O

Service,O
:,O

OBS,O

DISCHARGE,O
PATIENT,O
ON,O
:,O

05/09/03,O
AT,O
10:00,O
AM,O

CONTINGENT,O
UPON,O

Not,O
Applicable,O

WILL,O
D,O
/,O
C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D,O
/,O
C,O
SUMMARY,O
:,O

YES,O

Attending,O
:,O

DOUETLEPSGISS,O
",",O
VALETO,O
",",O
M.D.,O

DISPOSITION,O
:,O

Home,O

DISCHARGE,O
MEDICATIONS,O
:,O

DIET,O
:,O

No,O
Restrictions,O

ACTIVITY,O
:,O

Resume,O
regular,O
exercise,O

FOLLOW,O
UP,O
APPOINTMENT,O
(,O
S,O
),O
:,O

dr.,O
kote,O
6,O
weeks,O
",",O
No,O
Known,B-PR
Allergies,I-PR

ADMIT,O
DIAGNOSIS,O
:,O

Spontaneous,B-PR
vaginal,I-PR
delivery,I-PR
Laceration,I-PR
2,O
degrees,O

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O

Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O
SAVD,B-TR

OTHER,O
DIAGNOSIS,O
;,O

Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O

SAVD,B-TR

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O

none,O

BRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

G3,O
T2,O
P0,O
A0,O
L2,O
Estimated,O

EDC,O
:,O

Maternal,O
transfer,O
:,O

No,O

ADDITIONAL,O
COMMENTS,O
:,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O

TO,O
DO,O
/,O
PLAN,O
:,O

No,O
dictated,O
summary,O

ENTERED,O
BY,O
:,O

DOUETLEPSGISS,O
",",O
VALETO,O
",",O
M.D.,O
(,O
MC71,O
),O
05/07/03,O
03:46,O
PM,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

Admission,O
Date,O
:,O

2014-01-26,O

Discharge,O
Date,O
:,O

2014-02-09,O

Date,O
of,O
Birth,O
:,O

1937-06-05,O

Sex,O
:,O

F,O

Service,O
:,O

NSU,O

ADDENDUM,O
:,O

Addendum,O
from,O
the,O
dates,O
of,O
2014-02-04,O
until,O
2014-02-09,O
.,O

The,O
patient,O
had,O
no,O
complications,B-PR
or,O
further,B-PR
events,I-PR
while,O
in,O
house,O
.,O

On,O
Thursday,O
-,O
2014-02-06,O
-,O
the,O
patient,O
did,O
have,O
two,O
episodes,O
of,O
chest,B-PR
discomfort,I-PR
;,O
for,O
which,O
he,O
was,O
given,O
nitroglycerin,B-TR
and,O
those,O
resolved,O
.,O

The,O
patient,O
did,O
have,O
an,O
evaluation,O
of,O
electrocardiogram,B-TE
done,O
by,O
Cardiology,O
which,O
was,O
negative,O
and,O
had,O
laboratory,B-TE
results,I-TE
for,O
rule,O
out,O
myocardial,B-PR
infarction,I-PR
which,O
were,O
also,O
negative,O
.,O

Cardiology,O
was,O
aware,O
of,O
the,O
patient,O
.,O

The,O
patient,O
had,O
no,O
further,O
episodes,O
of,O
chest,B-PR
discomfort,I-PR
and,O
remained,O
afebrile,B-PR
while,O
in,O
house,O
.,O

Per,O
Infectious,O
Disease,O
",",O
okay,O
for,O
the,O
patient,O
to,O
be,O
discharged,O
in,O
stable,O
condition,O
to,O
Waltham/Weston,O
Hospital,O
facility,O
.,O

Penny,O
Clayton,O
",",O
Texas,O
87120,O

Dictated,O
By,O
:,O
Eugene,O
F,O
Balboa,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2014-02-09,O
11:17:25,O

T,O
:,O
2014-02-09,O
17:20:17,O

Job,O
#:,O
66630,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Elizabeth,O
Fernandez,O
on,O
:,O
MON,O
2014-02-10,O
4:27,O
PM,O

(,O
End,O
of,O
Report,O
),O

207132235,O
SC,O

51203606,O

132775,O

9/20/2000,O
12:00:00,O
AM,O

ENDOMETRIAL,B-PR
CARCINOMA,I-PR

Signed,O

DIS,O

Admission,O
Date,O
:,O

09/20/2000,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

09/22/2000,O

ADMISSION,O
DIAGNOSIS,O
:,O

ENDOMETRIAL,B-PR
CANCER,I-PR
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

ENDOMETRIAL,B-PR
CANCER,I-PR
.,O

PROCEDURES,O
:,O

TOTAL,B-TR
ABDOMINAL,I-TR
HYSTERECTOMY,I-TR
AND,O
BILATERAL,B-TR
SALPINGO-OOPHORECTOMY,I-TR

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
48-year-old,O
G,O
3,O
P,O
3,O
who,O
presented,O
to,O
Dr.,O
Fuscmadril,O
&apos;s,O
clinic,O
after,O
having,O
an,B-PR
abnormal,I-PR
pap,I-PR
smear,I-PR
followed,O
by,O
an,B-TE
endometrial,I-TE
biopsy,I-TE
that,O
was,O
suggestive,O
of,O
grade,B-PR
1,I-PR
endometrial,I-PR
cancer,I-PR
.,O

This,O
is,O
a,O
patient,O
who,O
",",O
over,O
the,O
past,O
year,O
",",O
has,O
had,O
no,B-PR
menses,I-PR
and,O
thought,O
she,O
had,O
become,O
menopausal,B-PR
.,O

She,O
then,O
began,O
spotting,B-PR
for,O
several,O
months,O
with,O
some,B-PR
constant,I-PR
brown,I-PR
discharge,I-PR
.,O

A,B-TE
pap,I-TE
smear,I-TE
that,O
was,O
obtained,O
by,O
her,O
primary,O
care,O
physician,O
showed,O
an,B-PR
endometrial,I-PR
cell,I-PR
and,O
thus,O
she,O
was,O
referred,O
to,O
a,O
gynecologist,O
for,O
an,B-TE
endometrial,I-TE
biopsy,I-TE
.,O

The,B-TE
endometrial,I-TE
biopsy,I-TE
showed,O
grade,B-PR
1,I-PR
endometrial,I-PR
cancer,I-PR
.,O

A,O
decision,O
was,O
made,O
to,O
proceed,O
with,O
surgical,B-TR
management,I-TR
for,O
this,O
finding,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Migraines,B-PR
.,O

ALLERGIES,O
:,O

Penicillin,B-TR
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

Two,B-TR
cesarean,I-TR
sections,I-TR
.,O

PAST,O
GYN,O
HISTORY,O
:,O

Menarche,O
at,O
13,O
",",O
regular,O
menses,O
to,O
the,O
age,O
of,O
46,O
.,O

Then,O
becoming,O
irregular,B-PR
for,O
several,O
years,O
.,O

She,O
had,O
her,O
first,O
child,O
at,O
age,O
21,O
.,O

She,O
has,O
had,O
one,O
normal,B-TR
spontaneous,I-TR
vaginal,I-TR
delivery,I-TR
and,O
two,O
cesarean,B-TR
sections,I-TR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
was,O
a,O
prior,O
off-and-on,O
smoker,O
but,O
has,O
quit,O
in,O
01/19,O
.,O

She,O
is,O
married,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Imitrex,B-TR
;,O
Indocin,B-TR
;,O
Celebrex,B-TR
;,O
Verapamil,B-TR
for,O
migraines,B-PR
.,O

FAMILY,O
HISTORY,O
:,O

Mother,O
with,O
colonic,B-PR
polyps,I-PR
.,O

She,O
has,O
a,O
maternal,O
uncle,O
and,O
maternal,O
aunt,O
both,O
with,O
colon,B-PR
cancer,I-PR
who,O
have,O
passed,O
away,O
from,O
this,B-PR
disease,I-PR
.,O

There,O
was,O
no,O
additional,O
history,O
of,O
breast,B-PR
",",I-PR
ovarian,I-PR
or,I-PR
uterine,I-PR
cancer,I-PR
in,O
her,O
family,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

GENERAL,O
:,O

She,O
is,O
a,O
well-developed,O
",",O
well-nourished,O
female,O
.,O

She,O
is,O
5,O
foot,O
4,O
inches,O
and,O
159,O
pounds,O
.,O

BREASTS,O
:,O

No,O
masses,B-PR
.,O

LUNGS,O
:,O

Clear,O
to,O
auscultation,B-TE
.,O

HEART,O
:,O

Regular,O
rate,O
and,O
rhythm,O
.,O

ABDOMEN,O
:,O

Soft,O
",",O
mildly,B-PR
obese,I-PR
with,O
Pfannenstiel,B-PR
scar,I-PR
visualized,O
.,O

PELVIC,O
:,O

Normal,O
introitus,O
",",O
normal,O
appearing,O
cervix,O
",",O
a,O
small,O
",",O
mobile,O
uterus,O
.,O

No,O
additional,B-PR
masses,I-PR
or,O
nodules,B-PR
appreciated,O
on,O
exam,B-TE
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
on,O
the,O
day,O
of,O
her,B-TR
surgery,I-TR
which,O
was,O
09/20/00,O
.,O

She,O
underwent,O
a,B-TR
TAH-BSO,I-TR
which,O
was,O
uncomplicated,B-PR
.,O

Details,O
of,O
the,B-TR
procedure,I-TR
can,O
be,O
found,O
in,O
the,O
operative,O
dictation,O
.,O

In,O
short,O
",",O
frozen,B-TE
pathology,I-TE
from,I-TE
the,I-TE
uterus,I-TE
showed,O
that,O
there,O
was,O
a,B-PR
grade,I-PR
1,I-PR
cancer,I-PR
with,O
no,O
invasion,B-PR
of,I-PR
the,I-PR
myometrium,I-PR
.,O

There,O
was,O
no,O
nodal,B-TE
dissection,I-TE
done,O
at,O
that,O
time,O
.,O

The,O
patient,O
tolerated,O
the,B-TR
procedure,I-TR
extremely,O
well,O
and,O
did,O
well,O
during,O
her,O
postoperative,O
course,O
.,O

By,O
postoperative,O
day,O
#2,O
she,O
was,O
eating,O
",",O
ambulating,O
and,O
voiding,O
on,O
her,O
own,O
.,O

She,O
decided,O
to,O
now,O
be,O
discharged,O
home,O
at,O
this,O
time,O
.,O

She,O
was,O
discharged,O
home,O
with,O
the,B-TR
following,I-TR
medications,I-TR
:,O

DISCHARGE,O
MEDICATIONS,O
:,O

Percocet,B-TR
;,O
Colace,B-TR
.,O

FOLLOWUP,O
:,O

She,O
will,O
have,O
a,O
follow,O
up,O
appointment,O
with,O
Dr.,O
Fuscmadril,O
in,O
four,O
weeks,O
.,O

Dictated,O
By,O
:,O

ARL,O
STIREDELS,O
",",O
M.D.,O
ZJ05,O

Attending,O
:,O

EAN,O
L.,O
FUSCMADRIL,O
",",O
M.D.,O
RY2,O
JE898/7007,O

Batch,O
:,O

91309,O

Index,O
No.,O
DOABVQ3G8W,O

D,O
:,O

09/22/00,O

T,O
:,O

09/23/00,O

Admission,O
Date,O
:,O

2015-08-22,O

Discharge,O
Date,O
:,O

2015-08-26,O

Date,O
of,O
Birth,O
:,O

1946-09-05,O

Sex,O
:,O

M,O

Service,O
:,O

CMED,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,O
Drugs,B-TR

Attending,O
:,O
Leroy,O
F,O
Stalnaker,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Right-sided,B-PR
weakness,I-PR
and,O
difficulty,B-PR
speaking,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

TPA,B-TR
administration,I-TR

History,O
of,O
Present,O
Illness,O
:,O

68,O
year,O
old,O
right,O
handed,O
man,O
with,O
multiple,B-PR
vascular,I-PR
risk,I-PR
factors,I-PR
",",O
including,O
2,B-PR
previous,I-PR
strokes,I-PR
and,O
two,B-PR
myocardial,I-PR
infarctions,I-PR
",",O
hypertension,B-PR
and,O
hypercholesterolemia,B-PR
",",O
who,O
presents,O
with,O
acute,B-PR
onset,I-PR
right,I-PR
sided,I-PR
hemiplegia,I-PR
and,O
dysarthria,B-PR
.,O

He,O
went,O
to,O
the,O
bathroom,O
on,O
his,O
own,O
at,O
6:12,O
AM,O
and,O
then,O
called,O
for,O
help,O
at,O
6:15,O
AM,O
.,O

His,O
wife,O
found,O
him,O
with,O
weak,B-PR
right,I-PR
leg,I-PR
",",O
flaccid,B-PR
right,I-PR
arm,I-PR
",",O
and,O
severe,B-PR
dysarthria,I-PR
.,O

She,O
called,O
911,O
and,O
he,O
was,O
brought,O
to,O
Hahnemann,O
General,O
Hospital,O
Lydia,O
.,O

ROS,O
:,O

Wife,O
denies,O
any,B-PR
recent,I-PR
bleeding,I-PR
",",O
surgeries,B-TR
",",O
or,O
upper,B-PR
respiratory,I-PR
infection,I-PR
.,O

Past,O
Medical,O
History,O
:,O

1.,O
1992,O
anterior,B-PR
cerebellar,I-PR
infarction,I-PR

2.,O
Silent,B-PR
stroke,I-PR
affecting,O
anterior,O
part,O
of,O
brain,O

3.,O
2014-09-24,O
left,B-PR
MCA,I-PR
stroke,I-PR
leaving,O
him,O
with,O
right,B-PR
facial,I-PR
droop,I-PR

4.,O
CAD,B-PR
with,O
MI,B-PR
1999,O
and,O
CABG,B-TR

5.,O
hypercholesterolinemia,B-PR

6.,O
hypertension,B-PR

7.,O
remote,O
smoking,O
history,O

8.,O
depression,B-PR

9.,O
bipolar,B-PR
disorder,I-PR

Social,O
History,O
:,O

He,O
is,O
N.,O
Quinn,O
educated,O
retired,O
data,O
processor,O
who,O
lives,O
with,O
his,O
wife,O
.,O

Brian,O
quit,O
smoking,O
and,O
drinking,O
in,O
1980s,O
.,O

No,O
history,O
of,O
ivdu,O

Family,O
History,O
:,O

Patient,O
's,O
mother,O
died,O
of,O
stroke,B-PR
at,O
the,O
age,O
of,O
54,O
.,O

Physical,O
Exam,O
:,O

Vitals,B-TE
97.2,O
164/97,O
59,O
20,O
100%,O
room,O
air,O

General,B-TE
exam,I-TE
including,O
head,B-TE
",",I-TE
neck,I-TE
",",I-TE
heart,I-TE
",",I-TE
lung,I-TE
",",I-TE
abdominal,I-TE
and,I-TE
extremity,I-TE
exam,I-TE
",",O
was,O
normal,O
.,O

Neuro,O
exam,O
:,O

Awake,O
",",O
oriented,O
to,O
person,O
and,O
place,O

Nonfluent,B-PR
speech,I-PR
with,O
inability,O
to,O
repeat,O
.,O

"Intact,O
to,O
simple,O
comprehension,O
such,O
as,O
"",O
show,O
your,O
left,O
hand,O
"",O
but,O
not,O
"",O
show,O
your,O
left,O
thumb,O
"",O
.",O

No,O
neglect,B-PR

CN,O
-,O
Pupil,O
3,O
to,O
2,O
mm,O
reactive,O
bilaterally,O
.,O

EOMI,O
.,O

Visual,O
field,O
full,O
to,O
hand,B-TE
waving,I-TE
.,O

Right,B-PR
facial,I-PR
droop,I-PR
.,O

Motor,O
-,O
Decreased,B-PR
tone,I-PR
on,I-PR
right,I-PR
arm,I-PR
.,O

Unable,O
to,O
move,O
right,O
arm,O
but,O
able,O
to,O
lift,O
right,O
leg,O
antigravity,O
for,O
less,O
than,O
5,O
seconds,O

Sensory,O
-,O
Dense,B-PR
loss,I-PR
to,O
touch,B-TE
on,O
the,O
right,O
arm,O
and,O
leg,O

Reflex,B-TE
-,O
1+,O
/,O
4,O
in,O
upper,O
extremity,O
",",O
2+,O
/,O
4,O
at,O
patellar,O
",",O
trace,O
ankle,O
.,O

Toe,O
upgoing,O
on,O
right,O
only,O
.,O

Coordination,O
:,O

Intact,O
on,O
left,O
finger,B-TE
to,I-TE
nose,I-TE
but,O
limited,B-PR
on,O
right,O
due,O
to,O
weakness,B-PR

Pertinent,O
Results,O
:,O

Creatinine,B-PR
slightly,I-PR
elevated,I-PR
at,O
1.3,O
",",O
otherwise,O
CBC,B-TE
",",O
chemistries,B-TE
normal,O
.,O

Cardiac,B-TE
enzymes,I-TE
normal,O
.,O

Valproate,B-TE
level,I-TE
within,O
range,O
.,O

CT,B-TE
head,I-TE
:,O

Slight,B-PR
effacement,I-PR
of,I-PR
posterior,I-PR
insular,I-PR
cortex,I-PR
.,O

MRI,B-TE
head,I-TE
:,O

Restricted,B-PR
diffusion,I-PR
in,I-PR
left,I-PR
frontotemporal,I-PR
region,I-PR
in,O
the,O
distribution,O
of,O
the,O
right,O
middle,O
cerebral,O
artery,O
indicating,O
acute,B-PR
infarct,I-PR
.,O

Brain,B-PR
atrophy,I-PR
.,O

Changes,O
of,O
small,B-PR
vessel,I-PR
disease,I-PR
and,O
chronic,B-PR
lacunes,I-PR
bilaterally,I-PR
in,I-PR
basal,I-PR
ganglia,I-PR
.,O

Probable,O
chronic,B-PR
infarct,I-PR
in,I-PR
the,I-PR
right,I-PR
occipital,I-PR
cortex,I-PR
.,O

Also,O
a,B-PR
chronic,I-PR
infarction,I-PR
in,I-PR
the,I-PR
right,I-PR
cerebellum,I-PR
.,O

No,O
acute,B-PR
hemorrhage,I-PR
.,O

MRA,B-TE
:,O

Subtle,B-PR
decreased,I-PR
flow,I-PR
signal,I-PR
within,I-PR
the,I-PR
Sylvian,I-PR
branches,I-PR
of,O
the,O
left,O
middle,O
cerebral,O
artery,O
.,O

No,O
evidence,O
of,O
major,B-PR
vascular,I-PR
occlusion,I-PR
seen,O
.,O

Carotid,B-TE
ultrasound,I-TE
:,O

No,O
stenosis,B-PR

Echo,B-TE
:,O

Elongated,B-PR
left,I-PR
atrium,I-PR
.,O

LV,B-PR
cavity,I-PR
moderately,I-PR
dilated,I-PR
.,O

LVEF,B-TE
30-35%,O
.,O

No,O
masses,B-PR
or,O
thrombi,B-PR
are,O
seen,O
in,O
the,O
left,O
ventricle,O
.,O

Resting,B-PR
regional,I-PR
wall,I-PR
motion,I-PR
abnormalities,I-PR
include,O
apical,B-PR
dyskinesis,I-PR
and,O
distal,O
anterior,O
",",O
septal,O
",",O
mid,O
and,O
distal,B-PR
inferior,I-PR
and,I-PR
inferolateral,I-PR
wall,I-PR
akinesis,I-PR
.,O

Normal,O
RV,O
size,O
and,O
function,O
.,O

Mildly,B-PR
dilated,I-PR
aortic,I-PR
root,I-PR
and,I-PR
ascending,I-PR
aorta,I-PR
.,O

No,O
aortic,B-PR
or,I-PR
mitral,I-PR
regurgitation,I-PR
.,O

No,O
pericardial,B-PR
effusion,I-PR
.,O

Brief,O
Hospital,O
Course,O
:,O

Assessment,O
:,O

68M,O
with,O
multiple,B-PR
vascular,I-PR
risk,I-PR
factors,I-PR
presents,O
with,O
acute,B-PR
onset,I-PR
right-sided,I-PR
hemiparesis,I-PR
and,O
dysarthria,B-PR
",",O
aphasia,B-PR
concerning,O
for,O
acute,B-PR
left,I-PR
MCA,I-PR
infarct,I-PR
.,O

Patient,O
arrived,O
in,O
Daniel,O
within,O
3,O
hours,O
of,O
symptom,B-PR
onset,I-PR
and,O
head,B-TE
CT,I-TE
showed,O
no,O
evidence,O
of,O
bleed,B-PR
.,O

However,O
",",O
as,O
wife,O
had,O
not,O
seen,O
patient,O
before,O
he,O
became,O
symptomatic,B-PR
",",O
there,O
was,O
some,O
concern,O
that,O
he,O
had,O
symptoms,B-PR
earlier,O
than,O
6,O
am,O
",",O
and,O
therefore,O
would,O
be,O
outside,O
the,O
3,O
hour,O
window,O
for,O
TPA,B-TR
.,O

MRI,B-TE
was,O
performed,O
which,O
showed,O
diffusion,B-PR
abnormalities,I-PR
but,O
no,O
hyperintensity,B-PR
on,O
T2,B-TE
/,I-TE
FLAIR,I-TE
imaging,I-TE
supporting,O
the,O
acute,O
onset,O
.,O

Therefore,O
",",O
IV,B-TR
tpa,I-TR
thrombolytics,I-TR
were,O
administered,O
within,O
3,O
hours,O
of,O
symptom,B-PR
onset,I-PR
.,O

Within,O
minutes,O
the,O
patient,O
showed,O
decreased,B-PR
right,I-PR
sided,I-PR
weakness,I-PR
and,O
improved,O
from,O
a,B-PR
global,I-PR
aphasia,I-PR
to,O
an,B-PR
anterior,I-PR
aphasia,I-PR
picture,I-PR
.,O

Given,O
the,O
likely,O
embolic,B-PR
etiology,I-PR
of,O
infarct,B-PR
",",O
carotid,B-TE
doppler,I-TE
and,O
TTE,B-TE
were,O
performed,O
.,O

Doppler,B-TE
revealed,O
no,O
hemodynamically,B-PR
significant,I-PR
lesions,I-PR
bilaterally,I-PR
.,O

Echo,B-TE
did,O
not,O
reveal,O
potential,O
source,O
of,O
emboli,B-PR
",",O
but,O
showed,O
striking,B-PR
left,I-PR
ventricle,I-PR
akinesis,I-PR
and,O
hypokinesis,B-PR
presumbly,O
due,O
to,O
past,B-PR
MI,I-PR
x,O
2,O
.,O

Given,O
that,O
the,B-PR
stroke,I-PR
occurred,O
while,O
taking,O
aspirin,B-TR
and,O
plavix,B-TR
",",O
and,O
given,O
the,B-PR
severe,I-PR
akinesis,I-PR
of,I-PR
the,I-PR
left,I-PR
ventricle,I-PR
",",O
we,O
decided,O
to,O
initiate,O
anticoagulation,B-TR
with,O
warfarin,B-TR
to,O
help,O
prevent,O
future,B-PR
strokes,I-PR
.,O

Anticoagulation,B-TR
therapy,I-TR
was,O
initiated,O
with,O
heparin,B-TR
and,O
coumadin,B-TR
beginning,O
on,O
the,O
evening,O
of,O
2016-08-23,O
.,O

The,O
patient,O
and,O
his,O
wife,O
",",O
a,O
nurse,O
",",O
were,O
educated,O
on,O
low,B-TR
molecular,I-TR
wt,I-TR
heparin,I-TR
",",O
which,O
was,O
started,O
in,O
the,O
hospital,O
on,O
2015-08-26,O
with,O
close,O
follow-up,O
scheduled,O
with,O
Dr.,O
Demmert,O
of,O
the,O
Wareham,O
VA,O
primary,O
care,O
clinic,O
the,O
next,O
morning,O
.,O

His,B-TR
depakote,I-TR
was,O
continued,O
for,O
his,B-PR
bipolar,I-PR
disorder,I-PR
.,O

On,O
discharge,O
",",O
strength,O
was,O
nearly,O
intact,O
in,O
the,O
limbs,O
",",O
though,O
he,O
still,O
had,O
a,B-PR
right-sided,I-PR
facial,I-PR
droop,I-PR
.,O

Additionally,O
",",O
he,O
still,O
had,O
mild,B-PR
dysarthria,I-PR
and,O
mild,B-PR
anterior,I-PR
aphasia,I-PR
.,O

Additionally,O
",",O
risk,B-TR
factor,I-TR
modification,I-TR
was,O
continued,O
.,O

Lipid,B-TE
panel,I-TE
was,O
checked,O
and,O
showed,O
good,O
control,O
of,O
lipids,O
on,O
his,B-TR
home,I-TR
dose,I-TR
of,I-TR
zocor,I-TR
.,O

Patient,O
has,O
no,O
history,O
of,O
diabetes,B-PR
",",O
and,O
fasting,B-TE
glucose,I-TE
was,O
78,O
",",O
but,O
A1C,B-TE
was,O
slightly,B-PR
elevated,I-PR
at,O
5.9,O
.,O

He,O
may,O
need,O
further,B-TE
glucose,I-TE
monitoring,I-TE
in,O
the,O
future,O
.,O

His,B-TR
home,I-TR
hypertensive,I-TR
medications,I-TR
were,O
held,O
while,O
in,O
the,O
hospital,O
to,O
help,O
increase,O
cerebral,O
perfusion,O
and,O
prevent,O
further,B-PR
ischemia,I-PR
.,O

They,O
will,O
be,O
restarted,O
on,O
discharge,O
.,O

Speech,O
therapy,O
was,O
also,O
consulted,O
",",O
and,O
recommended,O
oupatient,B-TR
speech,I-TR
therapy,I-TR
.,O

Similarly,O
",",O
outpatient,B-TR
PT,I-TR
was,O
recommended,O
for,O
his,B-PR
gait,I-PR
difficulties,I-PR
from,O
his,B-PR
previous,I-PR
strokes,I-PR
.,O

Residual,B-PR
deficits,I-PR
include,O
right,B-PR
side,I-PR
facial,I-PR
droop,I-PR
from,O
previous,B-PR
stroke,I-PR
and,O
moderately,B-PR
severe,I-PR
dysarthria,I-PR
and,O
anterior,B-PR
aphasia,I-PR
with,O
word,B-PR
finding,I-PR
difficulties,I-PR
.,O

Medications,O
on,O
Admission,O
:,O

Captopril,B-TR
50,O
bid,O
",",O
asa,B-TR
81,O
",",O
plavix,B-TR
75,O
",",O
zocor,B-TR
40,O
",",O
imdur,B-TR
30,O
",",O
lasix,B-TR
10,O
",",O
prozac,B-TR
20,O
",",O
iron,B-TR
",",O
mvi,B-TR

Discharge,O
Medications,O
:,O

1.,O
Enoxaparin,B-TR
Sodium,I-TR
80,O
mg,O
/,O
0.8,O
mL,O
Syringe,O
Sig,O
:,O
One,O
(,O
1,O
),O
syringe,O
Subcutaneous,O
Q12H,O
(,O
every,O
12,O
hours,O
),O
:,O
May,O
discontinue,O
once,O
INR,B-TE
therapeutic,O
as,O
directed,O
by,O
your,O
physician,O
.,O

2.,O
Divalproex,B-TR
Sodium,I-TR
500,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

3.,O
Aspirin,B-TR
325,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
QD,O
(,O
once,O
a,O
day,O
),O
for,O
7,O
days,O
.,O

4.,O
Warfarin,B-TR
Sodium,I-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
HS,O
(,O
at,O
bedtime,O
),O
.,O

5.,O
Simvastatin,B-TR
40,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
once,O
a,O
day,O
.,O

6.,O
Prozac,B-TR
20,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
once,O
a,O
day,O
.,O

7.,O
Multivitamin,B-TR
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
once,O
a,O
day,O
.,O

8.,O
Captopril,B-TR
50,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
twice,O
a,O
day,O
.,O

9.,O
Imdur,B-TR
30,O
mg,O
Tablet,O
Sustained,O
Release,O
24,O
HR,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
Sustained,O
Release,O
24HR,O
PO,O
once,O
a,O
day,O
.,O

Discharge,O
Disposition,O
:,O

Home,O

Discharge,O
Diagnosis,O
:,O

Infarction,B-PR
of,I-PR
left,I-PR
middle,I-PR
cerebral,I-PR
artery,I-PR
inferior,I-PR
division,I-PR
",",O
s/p,O

TPA,B-TR
",",O
with,O
residual,B-PR
dysarthria,I-PR
and,O
aphasia,B-PR

Hypertension,B-PR

Hypercholesterolemia,B-PR

Coronary,B-PR
artery,I-PR
disease,I-PR

Discharge,O
Condition,O
:,O

Good,O
",",O
with,O
no,O
motor,B-PR
deficits,I-PR
",",O
mild,B-PR
dysarthria,I-PR
and,O
mild,B-PR
anterior,I-PR
aphasia,I-PR

Discharge,O
Instructions,O
:,O

Take,O
all,B-TR
medications,I-TR
as,O
directed,O
and,O
go,O
for,O
all,O
scheduled,O
appointments,O
for,O
anticoagulation,B-TE
monitoring,I-TE
.,O

If,O
problems,B-PR
with,I-PR
speech,I-PR
or,O
weakness,B-PR
worsen,O
",",O
go,O
immediately,O
to,O
an,O
emergency,O
room,O
for,O
evaluation,B-TE
.,O

Followup,O
Instructions,O
:,O

Dr.,O
Demmert,O
at,O
Wareham,O
Taunton,O
State,O
Hospital,O
Clinic,O
Thursday,O
2015-08-27,O
10:30am,O
and,O
follow-up,O
as,O
scheduled,O
by,O
the,O
VA,O
in,O
their,O
coumadin,O
clinic,O
.,O

Follow-up,O
with,O
Dr.,O
Robert,O
in,O
1-2,O
weeks,O
.,O

Call,O
his,O
office,O
for,O
an,O
appointment,O
.,O

Follow-up,O
with,O
Dr.,O
Tina,O
Phillips,O
in,O
Stroke,O
Clinic,O
in,O
about,O
2,O
months,O
.,O

Call,O
415,O
9374,O
to,O
schedule,O
an,O
appointment,O
.,O

William,O
William,O
MD,O
",",O
PHD,O
13-279,O

Completed,O
by,O
:,O
Patricia,O
Francis,O
MD,O
16-284,O
2015-08-26,O
@,O
1922,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Exie,O
Culbreath,O
on,O
:,O
SUN,O
2015-09-06,O
10:03,O
PM,O

(,O
End,O
of,O
Report,O
),O

210974938,O

FIH,O

4139381,O

98764/u6tl,O

722206,O

5/30/1993,O
12:00:00,O
AM,O

INTRAVENOUS,B-TR
CHEMOTHERAPY,I-TR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

5-30-93,O

DISCHARGE,O
DATE,O
:,O

6-2-93,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

INTRAVENOUS,B-TR
CHEMOTHERAPY,I-TR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

LEFT,B-PR
UPPER,I-PR
LOBE,I-PR
LARGE,I-PR
CELL,I-PR
CARCINOMA,I-PR
OF,I-PR
THE,I-PR
LUNG,I-PR
.,O

ADVERSE,O
DRUG,O
REACTIONS,O
:,O

None,O
.,O

CLINICAL,O
INFECTIONS,O
:,O

None,O

SPECIAL,O
PROCEDURES,O
AND,O
OPERATIONS,O
:,O

Intravenous,B-TR
chemotherapy,I-TR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
63,O
year,O
old,O
woman,O
with,O
a,O
history,O
of,O
mixed,B-PR
adenocarcinoma,I-PR
and,O
large,B-PR
cell,I-PR
carcinoma,I-PR
of,I-PR
the,I-PR
left,I-PR
upper,I-PR
lobe,I-PR
of,O
the,O
lung,O
who,O
is,O
being,O
admitted,O
for,O
Neoadjuvant,B-TR
chemotherapy,I-TR
with,O
Cisplatinum,B-TR
",",O
5-FU,B-TR
and,O
Velban,B-TR
.,O

Her,O
history,O
has,O
been,O
well,O
documented,O
in,O
her,O
previous,O
notes,O
.,O

Briefly,O
",",O
she,O
was,O
originally,O
diagnosed,O
in,O
April,O
1993,O
with,O
lung,B-PR
carcinoma,I-PR
.,O

Bronchoscopy,B-TE
and,O
mediastinoscopy,B-TE
revealed,O
an,B-PR
unresectable,I-PR
mediastinal,I-PR
tumor,I-PR
with,O
the,O
left,O
tracheobronchial,O
angle,O
node,O
positive,O
for,O
cancer,B-PR
",",O
and,O
the,O
right,O
paratracheal,O
node,O
positive,O
for,O
anthracosis,B-PR
.,O

Formal,B-TE
pathology,I-TE
revealed,O
a,B-PR
poorly,I-PR
differentiated,I-PR
adenocarcinoma,I-PR
with,O
focal,B-PR
giant,I-PR
cells,I-PR
.,O

Bone,B-TE
scan,I-TE
",",O
head,B-TE
CT,I-TE
and,O
other,B-TE
staging,I-TE
studies,I-TE
were,O
all,O
negative,O
for,O
evidence,O
of,O
metastatic,B-PR
disease,I-PR
.,O

The,O
patient,O
is,O
being,O
treated,O
with,O
preoperative,B-TR
neoadjuvant,I-TR
chemotherapy,I-TR
using,I-TR
5,I-TR
FU,I-TR
",",O
Vinblastine,B-TR
",",O
Cisplatinum,B-TR
and,O
concomitant,B-TR
radiation,I-TR
therapy,I-TR
.,O

She,O
is,O
now,O
admitted,O
for,O
her,B-TR
second,I-TR
course,I-TR
of,I-TR
that,I-TR
therapy,I-TR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

temperature,B-TE
98.9,O
",",O
pulse,B-TE
82,O
",",O
respirations,B-TE
20,O
.,O

HEENT,O
:,O

pupils,O
equal,O
",",O
round,O
",",O
reactive,O
to,O
light,O
and,O
accommodation,O
",",O
extra,O
ocular,O
movements,O
were,O
intact,O
.,O

Sclera,O
were,O
anicteric,B-PR
.,O

The,O
oropharynx,O
was,O
clear,O
.,O

The,O
neck,O
was,O
supple,O
without,O
JVD,B-PR
.,O

The,O
lungs,O
showed,O
decreased,B-PR
breath,I-PR
sounds,I-PR
at,I-PR
the,I-PR
right,I-PR
base,I-PR
",",O
otherwise,O
were,O
clear,O
.,O

The,B-TE
cardiac,I-TE
exam,I-TE
showed,O
a,O
regular,O
rate,O
and,O
rhythm,O
with,O
a,B-PR
I,I-PR
/,I-PR
VI,I-PR
systolic,I-PR
ejection,I-PR
murmur,I-PR
.,O

Abdomen,O
was,O
soft,O
and,O
nontender,B-PR
",",O
without,O
masses,B-PR
or,O
hepatosplenomegaly,B-PR
.,O

Rectal,B-TE
exam,I-TE
was,O
guaiac,B-TE
negative,O
.,O

Extremities,O
were,O
without,O
clubbing,B-PR
",",O
cyanosis,B-PR
or,O
edema,B-PR
.,O

Neurologic,B-TE
exam,I-TE
revealed,O
a,B-PR
resting,I-PR
tremor,I-PR
in,I-PR
the,I-PR
right,I-PR
arm,I-PR
and,I-PR
hand,I-PR
.,O

LABORATORY,O
DATA,O
:,O

white,B-TE
blood,I-TE
count,I-TE
6.2,O
",",O
hemoglobin,B-TE
12.4,O
",",O
hematocrit,B-TE
36.1,O
",",O
platelet,B-TE
count,I-TE
"265,000",O
.,O

The,B-TE
liver,I-TE
function,I-TE
tests,I-TE
were,O
within,O
normal,O
limits,O
.,O

BUN,B-TE
8,O
",",O
creatinine,B-TE
0.9,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
Oncology,O
Service,O
on,O
Founder,O
&apos;s,O
7,O
and,O
received,O
intravenous,B-TR
chemotherapy,I-TR
with,O
a,B-TR
72,I-TR
hour,I-TR
continuous,I-TR
infusion,I-TR
of,I-TR
5-FU,I-TR
",",O
Vinblastine,B-TR
on,O
day,O
1,O
and,O
day,O
3,O
",",O
and,O
Cisplatinum,B-TR
on,O
day,O
1,O
.,O

She,O
tolerated,O
the,B-TR
chemotherapy,I-TR
well,O
with,O
mild,B-PR
nausea,I-PR
and,O
vomiting,B-PR
.,O

She,O
had,O
mild,B-PR
increase,I-PR
in,O
her,B-PR
hypertension,I-PR
during,O
the,O
hospitalization,O
",",O
likely,O
secondary,O
to,O
fluid,B-PR
overload,I-PR
.,O

She,O
also,O
had,O
some,B-PR
modest,I-PR
anemia,I-PR
",",O
at,O
the,O
time,O
of,O
discharge,O
her,B-TE
hematocrit,I-TE
was,O
30.9,O
.,O

Overall,O
there,O
were,O
no,O
unanticipated,B-PR
side,I-PR
effects,I-PR
of,O
this,B-TR
chemotherapy,I-TR
.,O

Following,O
her,O
recovery,O
from,O
chemotherapy,B-TR
",",O
she,O
will,O
proceed,O
to,O
surgical,B-TR
resection,I-TR
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

Intravenous,B-TR
chemotherapy,I-TR
for,O
lung,B-PR
cancer,I-PR
.,O

DOCTORS,O
DISCHARGE,O
ORDERS,O
:,O

Slo-Mag,B-TR
one,O
tab,O
p.o.,O
b.i.d.,O
Stelazine,B-TR
2,O
mg.,O
p.o.,O
q.d.,O
Ativan,B-TR
1,O
mg,O
p.o.,O
or,O
s.l.,O
q.,O
4-6,O
hr.,O
p.r.n.,O
nausea,B-PR
.,O

WORK,O
DISABILITY,O
AND,O
PROBABLE,O
DURATION,O
",",O
COMPLETE,O
.,O

Followup,O
will,O
be,O
with,O
Dr.,O
Guabenfranda,O
Day,O
in,O
his,O
office,O
.,O

CA,O
SHUFF,O
",",O
M.D.,O

TR,O
:,O

ds,O
/,O
bmot,O

DD,O
:,O

6-2,O
93,O

TD,O
:,O

06/04/93,O

CC,O
:,O

GUABENFRANDA,O
DAY,O
",",O
M.D.,O

Admission,O
Date,O
:,O

2019-07-17,O

Discharge,O
Date,O
:,O

2019-07-27,O

Date,O
of,O
Birth,O
:,O

1980-01-29,O

Sex,O
:,O

F,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Cephalosporins,B-TR
/,O
Dilaudid,B-TR
/,O
Metoclopramide,B-TR

Attending,O
:,O
Bradley,O
A.,O
Goldware,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O
respiratory,B-PR
failure,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

Intubation,B-TR

Central,B-TR
line,I-TR
placement,I-TR

Bronchoscopy,B-TE

History,O
of,O
Present,O
Illness,O
:,O

This,O
is,O
a,O
39,O
year-old,O
female,O
with,O
a,O
history,O
of,O
diabetes,B-PR
type,I-PR
I,I-PR
on,O
an,B-TR
insulin,I-TR
pump,I-TR
",",O
anemia,B-PR
",",O
hypothyroidism,B-PR
",",O
gastroparesis,B-PR
",",O
GERD,B-PR
",",O
who,O
was,O
transferred,O
from,O
Mediplex,O
Rehab,O
Hospital,O
Hospital,O
for,O
further,B-TR
management,I-TR
of,O
hypoxic,B-PR
respiratory,I-PR
failure,I-PR
.,O

She,O
arrived,O
at,O
Mediplex,O
Rehab,O
Hospital,O
Hospital,O
on,O
07-01,O
for,O
1,O
day,O
of,O
nausea,B-PR
and,O
vomiting,B-PR
and,O
was,O
found,O
to,O
be,O
febrile,B-PR
to,O
99,O
at,O
that,O
time,O
.,O

She,O
was,O
admitted,O
for,O
likely,O
gastroparesis,B-PR
and,O
eventually,O
had,O
a,B-TE
complete,I-TE
fever,I-TE
work-up,I-TE
that,O
included,O
a,O
negative,O
chest,O
x-ray,O
",",O
blood,O
cultures,O
",",O
and,O
urine,O
culture,O
.,O

She,O
was,O
discharged,O
on,O
07-02,O
and,O
represented,O
that,O
day,O
with,O
continued,B-PR
nause,I-PR
",",O
vomiting,B-PR
",",O
and,O
fever,B-PR
.,O

She,O
was,O
readmitted,O
and,O
had,O
a,B-TE
complete,I-TE
febrile,I-TE
work-up,I-TE
that,O
included,O
CT,B-TE
abdomene,I-TE
/,I-TE
pelvis,I-TE
",",O
chest,B-TE
x-ray,I-TE
",",O
blood,B-TE
culture,I-TE
's,I-TE
",",O
urine,B-TE
cultures,I-TE
",",O
all,O
of,O
which,O
were,O
unremarkable,O
.,O

She,O
was,O
intubated,O
on,O
07-03,O
for,O
progressive,B-PR
respiratory,I-PR
failure,I-PR
.,O

Workup,B-TE
continued,O
to,O
be,O
negative,O
.,O

Extubation,B-TR
was,O
attempted,O
on,O
07-14,O
",",O
but,O
she,O
was,O
re-intubated,O
due,O
to,O
inspiratory,B-PR
stridor,I-PR
.,O

A,B-TE
CT,I-TE
neck,I-TE
showed,O
soft,B-PR
tissue,I-PR
swelling,I-PR
obliterating,O
the,O
airway,O
surrounding,O
the,B-TR
ETT,I-TR
tube,I-TR
.,O

She,O
was,O
transferred,O
to,O
Providence,O
Behavioral,O
Health,O
Hospital,O
for,O
further,O
management,O
.,O

Past,O
Medical,O
History,O
:,O

1.,O
Type,B-PR
I,I-PR
diabetes,I-PR
diagnosed,O
at,O
age,O
27,O
.,O

She,O
is,O
usually,O
managed,O
on,O
an,B-TR
insulin,I-TR
pump,I-TR
.,O

2.,O
Hashimoto,B-PR
's,I-PR
thyroiditis,I-PR
.,O

3.,O
Gastroparesis,B-PR

4.,O
History,O
of,O
bulemia,B-PR

5.,O
Anxiety,B-PR
on,O
clonazepam,B-TR

6.,O
History,O
of,O
diabetic,B-PR
foot,I-PR
ulcer,I-PR
.,O

Social,O
History,O
:,O

She,O
is,O
married,O
and,O
lives,O
with,O
her,O
husband,O
.,O

She,O
has,O
a,O
10,O
month,O
old,O
child,O
.,O

She,O
denies,O
any,O
alcohol,O
",",O
tobacco,O
",",O
or,O
other,O
drugs,O
.,O

Family,O
History,O
:,O

Non-contributory,O
.,O

Physical,O
Exam,O
:,O

Vitals,B-TE
:,O

Temperature,B-TE
:,O
98.8,O
Pulse,B-TE
:,O
79,O

Blood,B-TE
Pressure,I-TE
:,O
125/89,O

Respiratory,B-TE
Rate,I-TE
:,O
12,O

Oxygen,B-TE
Saturation,I-TE
:,O
100%,O
on,O
AC,B-TR
500x12,O
",",O
PEEP5,B-TR
",",O
50%,O

GENERAL,O
:,O

Intubated,B-TR
",",O
sedated,B-TR
",",O
not,B-PR
responsive,I-PR
to,O
command,B-TE
",",O
retracts,O
to,O
pain,B-TE

HEENT,O
:,O

Anicteric,B-PR
sclera,I-PR
bilat,I-PR
.,O

Pupils,B-PR
minimally,I-PR
reactive,I-PR

NECK,O
:,O

No,O
elevated,B-PR
JVP,I-PR
appreciated,O
.,O

CARDIAC,O
:,O

Regular,O
",",O
"s1,s2",O
.,O

No,O
murmurs,B-PR

RESPIRATORY,O
:,O

Clear,O
to,O
auscultation,B-TE
anteriorly,O
.,O

ABDOMEN,O
:,O

Soft,O
.,O

Nondistended,B-PR
.,O

No,O
hepatosplenomegally,B-PR
.,O

Mildly,B-PR
hypoactive,I-PR
bowelsounds,I-PR
.,O

EXTREMITIES,O
:,O

No,O
edema,B-PR
bilaterally,I-PR
.,O

Pulses,B-PR
diminished,I-PR
but,O
symmetric,O
.,O

NEURO,O
:,O

Sedated,B-TR
.,O

Retracts,O
to,O
painful,B-TE
stimuli,I-TE

SKIN,O
:,O

No,O
rashes,B-PR

Pertinent,O
Results,O
:,O

Hematology,O
:,O

WBC,B-TE
-,O
29.9,O
HGB,B-TE
-,O
8.5,O
HCT,B-TE
-,O
26.8,O
PLT,B-TE
COUNT,I-TE
-,O
323,O
NEUTS,B-TE
-,O
75,O
BANDS,B-TE
-,O
13,O
LYMPHS,B-TE
-,O
6,O
MONOS,B-TE
-,O
5,O
EOS,B-TE
-,O
1,O
BASOS,B-TE
-,O
0,O
ATYPS,B-TE
-,O
0,O
METAS,B-TE
-,O
0,O
MYELOS,B-TE
-,O
0,O

Chemistries,O
:,O

SODIUM,B-TE
-,O
137,O
POTASSIUM,B-TE
-,O
4.5,O
CHLORIDE,B-TE
-,O
106,O
TOTAL,B-TE
CO2,I-TE
-,O
22,O
UREA,B-TE
N,I-TE
-,O
41,O
*,O
CREAT,B-TE
-,O
1.3,O
GLUCOSE,B-TE
-,O
231,O
CALCIUM,B-TE
-,O
7.7,O
PHOSPHATE,B-TE
-,O
3.6,O
MAGNESIUM,B-TE
-,O
2.4,O

Liver,O
Function,O
:,O

ALT,B-TE
(,I-TE
SGPT,I-TE
)-,I-TE
249,O
AST,B-TE
(,I-TE
SGOT,I-TE
)-,I-TE
147,O
LD,B-TE
(,I-TE
LDH,I-TE
)-,I-TE
241,O
ALK,B-TE
PHOS,I-TE
-,O
230,O
AMYLASE,B-TE
-,O
28,O
TOT,B-TE
BILI,I-TE
-,O
0.9,O
LIPASE,B-TE
-,O
12,O
ALBUMIN,B-TE
-,O
2.6,O

Coagulation,O
:,O

PT,B-TE
-,O
13.8,O
PTT,B-TE
-,O
24.3,O
INR,B-TE
(,I-TE
PT,I-TE
)-,I-TE
1.2,O

Thyroid,O
:,O

TSH,B-TE
-,O
3.3,O

Imaging,O
:,O

1.,O
Nexk,B-TE
CT,I-TE
:,O

Increased,B-PR
soft,I-PR
tissues,I-PR
within,I-PR
the,I-PR
pharynx,I-PR
.,O

This,O
may,O
be,O
secondary,O
to,O
soft,B-PR
tissue,I-PR
swelling,I-PR
as,O
indicated,O
in,O
the,O
patient,O
's,O
history,O
",",O
and,O
some,O
may,O
be,O
secondary,O
to,O
secretions,B-PR
above,I-PR
the,I-PR
ETT,I-PR
balloon,I-PR
.,O

No,O
retropharyngeal,B-PR
fluid,I-PR
is,O
identified,O
.,O

Dependent,B-PR
atelectasis,I-PR
is,O
present,O
within,O
the,O
visualized,O
portions,O
of,O
the,O
lung,O
apices,O
.,O

2.,O
Chest,B-TE
CT,I-TE
:,O

Bilateral,B-PR
lower,I-PR
lobe,I-PR
consolidations,I-PR
mostly,O
in,O
dependent,O
portion,O
",",O
with,O
small,B-PR
pleural,I-PR
effusion,I-PR
and,O
diffuse,B-PR
ground-glass,I-PR
opacity,I-PR
in,I-PR
bilateral,I-PR
upper,I-PR
and,I-PR
lower,I-PR
lobes,I-PR
",",O
consistent,O
with,O
ARDS,B-PR
with,O
pulmonary,B-PR
edema,I-PR
given,O
the,O
history,O
.,O

Ground-glass,B-PR
opacity,I-PR
is,O
somewhat,O
more,O
prominent,O
in,O
right,O
upper,O
lobe,O
",",O
and,O
superimposed,B-PR
infection,I-PR
cannot,O
be,O
totally,O
excluded,O
.,O

Brief,O
Hospital,O
Course,O
:,O

This,O
is,O
a,O
39,O
year-old,O
female,O
with,O
diabetes,B-PR
type,I-PR
I,I-PR
",",O
hypothyroidism,B-PR
",",O
gastroparesis,B-PR
who,O
was,O
transfered,O
for,O
hypoxic,B-PR
respiratory,I-PR
failure,I-PR
.,O

1.,O
Hypoxic,B-PR
Rspiratory,I-PR
Failure,I-PR
:,O

She,O
arrived,O
intubated,B-TR
and,O
sedated,B-TR
from,O
Esteban,O
Hospital,O
.,O

On,O
arrival,O
a,B-TE
chest,I-TE
x-ray,I-TE
showed,O
perihilar,B-PR
and,I-PR
bibasilar,I-PR
opacities,I-PR
",",O
which,O
appeared,O
conistent,O
with,O
pulmonary,B-PR
edema,I-PR
but,O
also,O
possibly,O
consistent,O
with,O
a,B-PR
pneumonia,I-PR
.,O

There,O
was,O
no,O
evidence,O
of,O
ARDS,B-PR
.,O

She,O
was,O
known,O
to,O
have,O
gram-positive,B-PR
cocci,I-PR
in,I-PR
her,I-PR
sputum,I-PR
at,O
the,O
outside,O
hospital,O
.,O

A,B-TE
bronchoscopy,I-TE
with,O
BAL,B-TE
was,O
performed,O
and,O
a,B-TE
sputum,I-TE
sample,I-TE
eventually,O
grew,O
out,O
MRSA,B-PR
.,O

She,O
was,O
treated,O
with,O
vancomycin,B-TR
to,O
cover,O
her,B-PR
MRSA,I-PR
pneumonia,I-PR
.,O

A,B-TE
CT,I-TE
scan,I-TE
was,O
performed,O
on,O
07-17,O
to,O
evaluate,O
the,B-PR
soft,I-PR
tissue,I-PR
swelling,I-PR
seen,O
on,O
CT,B-TE
at,O
the,O
outside,O
hospital,O
.,O

The,B-TE
CT,I-TE
showed,O
increased,B-PR
soft,I-PR
tissues,I-PR
within,I-PR
the,I-PR
pharynx,I-PR
which,O
was,O
felt,O
to,O
be,O
secondary,O
to,O
prolonged,B-TR
intubation,I-TR
/,O
trauma,B-PR
.,O

She,O
was,O
treated,O
with,O
steroids,B-TR
for,O
this,B-PR
swelling,I-PR
at,O
the,O
outside,O
hospital,O
",",O
and,O
these,O
were,O
continued,O
.,O

It,O
was,O
decided,O
that,O
patient,O
should,O
receive,O
one,O
more,O
trial,O
off,O
the,B-TR
vent,I-TR
before,O
committing,O
her,O
to,O
a,B-TR
tracheotomy,I-TR
.,O

She,O
did,O
well,O
on,O
minimal,B-TR
vent,I-TR
settings,I-TR
but,O
it,O
was,O
decided,O
to,O
delay,O
extubating,O
the,O
patient,O
until,O
the,O
morning,O
of,O
6/2,O
.,O

Overnight,O
",",O
the,O
patient,O
became,O
hypoxic,B-PR
",",O
dropping,O
to,O
the,O
80,O
's,O
.,O

A,B-TE
chest,I-TE
x-ray,I-TE
showed,O
that,O
the,B-TR
ET,I-TR
tube,I-TR
was,O
displaced,B-PR
to,O
very,O
high,O
in,O
the,O
trachea,O
.,O

The,B-TR
cuff,I-TR
was,O
deflated,O
and,O
the,O
patient,O
was,O
extubated,O
.,O

She,O
was,O
placed,O
in,O
supplemental,B-TR
oxygen,I-TR
by,O
shovel,B-TR
mask,I-TR
and,O
her,B-TE
sats,I-TE
immediately,O
improved,O
.,O

She,O
was,O
weaned,O
down,O
until,O
she,O
was,O
maintaining,O
her,B-TE
oxygen,I-TE
saturation,I-TE
above,O
90%,O
on,O
6L,O
by,O
nasal,B-TR
cannuala,I-TR
.,O

As,O
she,O
was,O
doing,O
well,O
without,O
evidence,O
of,O
stridor,B-PR
",",O
the,B-TR
steroids,I-TR
were,O
stopped,O
.,O

She,O
did,O
well,O
and,O
was,O
weaned,O
from,O
supplemental,B-TR
oxygen,I-TR
.,O

At,O
the,O
time,O
of,O
discharge,O
",",O
she,O
was,O
oxygenating,O
well,O
on,O
room,O
air,O
.,O

She,O
Will,O
need,O
to,O
complete,O
a,O
14,O
day,O
course,O
of,O
vancomycin,B-TR
for,O
her,B-PR
MRSA,I-PR
pneumonia,I-PR
on,O
2019-07-30,O
.,O

2.,O
Enterobacter,B-PR
bacteremia,I-PR
:,O

She,O
was,O
initially,O
covered,O
broadly,O
with,O
vancomycin,B-TR
",",O
ciprofloxacin,B-TR
",",O
and,O
falgyl,B-TR
.,O

She,O
had,O
positive,B-PR
blood,I-PR
cultures,I-PR
at,O
Mediplex,O
Rehab,O
Hospital,O
Hospital,O
for,O
gram,B-PR
negative,I-PR
rods,I-PR
.,O

Subsequently,O
",",O
zosyn,B-TR
was,O
added,O
.,O

The,B-TE
cultures,I-TE
grew,O
out,O
enterobacter,B-PR
cloacae,I-PR
.,O

It,O
was,O
unclear,O
the,O
source,O
of,O
her,B-PR
bacteremia,I-PR
.,O

Her,B-TE
stool,I-TE
cultures,I-TE
were,O
negative,O
.,O

Her,B-TR
central,I-TR
line,I-TR
was,O
removed,O
and,O
the,B-TR
tip,I-TR
was,O
culture,O
negative,O
.,O

She,O
was,O
transitioned,O
to,O
on,O
levofloxacin,B-TR
for,O
her,B-PR
bacteremia,I-PR
.,O

She,O
had,O
no,O
positive,B-PR
cultures,I-PR
during,O
this,O
admission,O
.,O

Once,O
she,O
was,O
more,O
stable,O
",",O
an,B-TE
abdominal,I-TE
CT,I-TE
was,O
performed,O
to,O
look,O
for,O
an,B-PR
abscess,I-PR
.,O

This,B-TE
study,I-TE
was,O
negative,O
.,O

However,O
",",O
the,B-TE
study,I-TE
was,O
limited,O
due,O
to,O
inadequate,O
po,O
contrast,O
intake,O
by,O
the,O
patient,O
;,O
it,O
did,O
show,O
a,O
question,O
of,O
a,B-PR
cecal,I-PR
cystic,I-PR
lesion,I-PR
verse,O
normal,O
loop,O
of,O
bowel,O
.,O

This,B-TE
study,I-TE
will,O
need,O
to,O
be,O
repeated,O
once,O
she,O
is,O
tolerating,O
po,O
's,O
.,O

She,O
will,O
complete,O
a,O
14,O
day,O
course,O
of,O
levofloxacin,B-TR
for,O
her,B-PR
bacteremia,I-PR
on,O
2019-07-30,O
.,O

3.,O
Diabetes,B-PR
type,I-PR
I,I-PR
:,O

She,O
was,O
intially,O
maintained,O
on,O
an,B-TR
insulin,I-TR
drip,I-TR
for,O
tight,B-TR
glycemic,I-TR
control,I-TR
.,O

She,O
was,O
followed,O
by,O
Albano,O
during,O
the,O
admission,O
.,O

She,O
was,O
initially,O
maintained,O
on,O
D5W,B-TR
",",O
which,O
was,O
increased,O
to,O
D10W,B-TR
as,O
the,O
patient,O
was,O
persistently,B-PR
borderline,I-PR
hypoglycemic,I-PR
while,O
on,O
insulin,B-TR
drip,I-TR
.,O

Once,O
she,O
began,O
to,O
take,O
PO,O
's,O
",",O
the,B-TR
insulin,I-TR
drip,I-TR
was,O
stopped,O
and,O
patient,O
was,O
started,O
on,O
glargine,B-TR
with,O
a,B-TR
humalog,I-TR
sliding,I-TR
scale,I-TR
.,O

While,O
her,O
po,O
intake,O
was,O
minimal,O
she,O
was,O
maintained,O
on,O
supplemental,B-TR
IV,I-TR
dextrose,I-TR
to,O
suppress,O
ketosis,B-PR
.,O

While,O
she,O
was,O
on,O
the,B-TR
IV,I-TR
dextrose,I-TR
",",O
she,O
required,O
up,O
to,O
26,O
units,O
of,O
glargine,B-TR
for,O
glycemic,B-TR
control,I-TR
.,O

As,O
she,O
starting,O
taking,O
some,O
foods,O
",",O
her,B-TR
glargine,I-TR
was,O
decrease,O
.,O

At,O
the,O
time,O
of,O
discharge,O
her,B-TR
glargine,I-TR
was,O
10,O
.,O

Her,B-TE
blood,I-TE
glucose,I-TE
were,O
under,O
good,O
control,O
.,O

The,O
day,O
prior,O
to,O
discharge,O
",",O
she,O
was,O
nauseated,B-PR
and,O
not,O
taking,O
pos,O
.,O

Therefore,O
",",O
she,O
received,O
1L,O
of,O
D5,B-TR
",",O
and,O
her,B-TE
sugars,I-TE
were,O
elevated,B-PR
to,O
400,O
the,O
day,O
of,O
discharge,O
.,O

4.,O
Gastroparesis,B-PR
:,O

She,O
has,O
a,O
history,O
of,O
gastroparesis,B-PR
secondary,O
to,O
long-standing,B-PR
type,I-PR
I,I-PR
diabetes,I-PR
.,O

Once,O
she,O
was,O
extubated,O
",",O
she,O
was,O
nauseated,B-PR
with,O
emesis,B-PR
.,O

She,O
was,O
intially,O
treated,O
with,O
erythromycin,B-TR
for,O
pro-motility,O
as,O
she,O
had,O
a,B-PR
bad,I-PR
reaction,I-PR
to,O
reglan,B-TR
in,O
the,O
past,O
.,O

She,O
continued,O
to,O
remained,O
nauseated,B-PR
so,O
she,O
was,O
treated,O
with,O
phenergan,B-TR
",",O
anzemet,B-TR
",",O
zofran,B-TR
",",O
and,O
ativan,B-TR
.,O

She,O
intermittently,O
was,O
able,O
tolerate,O
pos,O
.,O

Her,B-PR
nausea,I-PR
was,O
accompanied,O
by,O
abdominal,B-PR
pain,I-PR
for,O
which,O
she,O
was,O
treated,O
with,O
morphine,B-TR
.,O

She,O
was,O
transitioned,O
to,O
a,B-TR
PCA,I-TR
for,O
better,B-TR
pain,I-TR
control,I-TR
.,O

She,O
continued,O
to,O
have,O
nausea,B-PR
despite,O
an,B-TR
agressive,I-TR
anti-emetic,I-TR
regimen,I-TR
.,O

It,O
was,O
felt,O
that,O
her,B-PR
symptoms,I-PR
were,O
secondary,O
to,O
gastroparesis,B-PR
.,O

However,O
",",O
other,O
causes,O
were,O
looked,O
for,O
including,O
adrenal,B-PR
insufficiency,I-PR
and,O
bowel,B-PR
obstruction,I-PR
.,O

She,O
had,O
a,O
normal,O
cortisol,O
stimulation,O
test,O
.,O

A,B-TE
abdominal,I-TE
plain,I-TE
film,I-TE
showed,O
non-specific,B-PR
bowel,I-PR
gas,I-PR
patterns,I-PR
that,O
may,O
represent,O
an,B-PR
early,I-PR
obstruction,I-PR
.,O

A,B-TR
NG,I-TR
tube,I-TR
was,O
placed,O
for,O
decompression,B-TR
given,O
the,O
signs,O
of,O
early,B-PR
obstruction,I-PR
the,O
day,O
of,O
transfer,O
.,O

The,O
GI,O
service,O
was,O
consulted,O
and,O
they,O
felt,O
that,O
her,B-PR
symptoms,I-PR
were,O
all,O
gastroparesis,B-PR
.,O

They,O
recommended,O
erythromycin,B-TR
and,O
zelnorm,B-TR
.,O

She,O
should,O
eventually,O
have,O
a,B-TE
tissue,I-TE
transglutaminase,I-TE
to,O
rule,O
out,O
celiac,B-PR
disease,I-PR
.,O

5.,O
Transaminitis,B-PR
:,O

Per,O
report,O
",",O
She,O
had,O
elevated,B-PR
LFTs,I-PR
at,O
the,O
outside,O
hospital,O
.,O

A,B-TE
right,I-TE
upper,I-TE
quadrant,I-TE
ultrasound,I-TE
was,O
performed,O
and,O
was,O
negative,O
for,O
any,B-PR
acute,I-PR
pathology,I-PR
.,O

Her,B-TE
LFTs,I-TE
trended,O
down,O
during,O
this,O
admission,O
.,O

6.,O
Hypothyroidism,B-PR
:,O

She,O
was,O
maintained,O
on,O
her,B-TR
levothyroxine,I-TR
.,O

While,O
she,O
was,O
not,O
taking,O
adequate,O
pos,O
",",O
she,O
was,O
on,O
IV,B-TR
levothyroxine,I-TR
.,O

7.,O
F/E/N,O
:,O

She,O
was,O
NPO,B-TR
while,O
intubated,B-TR
and,O
recived,O
tube,B-TR
feedings,I-TR
for,O
nutrition,O
.,O

After,O
extubation,B-TR
",",O
patient,O
was,O
started,O
on,O
sips,O
and,O
had,O
a,B-TE
speech,I-TE
and,I-TE
swallow,I-TE
evaluation,I-TE
.,O

She,O
was,O
cleared,O
to,O
advance,O
her,O
diet,O
as,O
tolerated,O
.,O

She,O
only,O
tolerated,O
some,O
clear,O
liquids,O
.,O

At,O
the,O
time,O
of,O
transfer,O
",",O
she,O
was,O
NPO,B-TR
given,O
her,B-TR
NG,I-TR
tube,I-TR
.,O

8.,O
Prophylaxis,B-TR
:,O

PPI,B-TR
",",O
Heparin,B-TR
SQ,I-TR
.,O

9.,O
Access,O
:,O

Her,B-TR
central,I-TR
line,I-TR
was,O
removed,O
given,O
the,O
concern,O
for,O
a,B-PR
line,I-PR
infection,I-PR
.,O

She,O
had,O
a,B-TR
double,I-TR
lumen,I-TR
PICC,I-TR
place,O
.,O

10.,O
CODE,O
:,O

FULL,B-TR

11.,O
Dispo,O
:,O

She,O
was,O
transfered,O
back,O
to,O
Mediplex,O
Rehab,O
Hospital,O
Hospital,O
per,O
the,O
patient,O
's,O
and,O
husband,O
's,O
request,O
so,O
that,O
she,O
would,O
be,O
closer,O
to,O
home,O
once,O
her,O
respiratory,O
status,O
was,O
stable,O
.,O

anti-GBM,B-TE
is,O
pending,O
.,O

Medications,O
on,O
Admission,O
:,O

Meds,O
:,O

Vitamin,B-TR
D,I-TR
50000,O
4662442,O
one,O
time,O
a,O
week,O

Cozaar,B-TR
25,O
mg,O
1,O
time,O
per,O
day,O

Procrit,B-TR
-,O
Multidose,O
20000,O
u,O
/,O
ml,O
"20,000",O
units,O
SQ,O
every,O
other,O
week,O

Levoxyl,B-TR
150,O
mcg,O
1,O
1,O
time,O
per,O
day,O

Iron,B-TR
325,O
(,O
65,O
),O
mg,O
twice,O
a,O
day,O

Zoloft,B-TR
100,O
mg,O
1,O
per,O
day,O
",",O
2,O
TABS,O

Freestyle,O
as,O
directed,O

Clonazepam,B-TR
0.5,O
mg,O

Humalog,B-TR
100,O
U,O
/,O
ml,O
1,O
as,O
directed,O
pump,O

Zofran,B-TR
8,O
mg,O
1,O
as,O
directed,O

Prevacid,B-TR
30,O
mg,O
1,O
1,O
time,O
per,O
day,O

Lorazepam,B-TR
0.5,O
mg,O
1,O
to,O
2,O
tablets,O
twice,O
daily,O
if,O
needed,O

on,O
transfer,O
:,O

"Cipro,B-TR
400,O
""",O

Vanco,B-TR
1,O
g,O
qD,O

Flagyl,B-TR
500,O
q8,O

Levophed,B-TR
gtt,I-TR

Propofol,B-TR
gtt,I-TR

Solumedrol,B-TR
40,O
q6,O

(,O
started,O
07-14,O
),O

Pepcid,B-TR

FeSo4,B-TR
325,O
',O

Insulin,B-TR
35,O
lantus,B-TR
qhs,O

Synthroid,B-TR
150,O
',O

Losartan,B-TR
25,O
',O

Zoloft,B-TR
200,O
',O

"Zelnorm,B-TR
6,O
""",O

MS,O
Lori,O
Harwood,O

Discharge,O
Medications,O
:,O

1.,O
Sertraline,B-TR
100,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

2.,O
Heparin,B-TR
(,I-TR
Porcine,I-TR
),O
"5,000",O
unit,O
/,O
mL,O
Solution,O
Sig,O
:,O
One,O
(,O
1,O
),O
Injection,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
.,O

3.,O
Acetaminophen,B-TR
500,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
as,O
needed,O
for,O
headache,B-PR
.,O

4.,O
Ondansetron,B-TR
HCl,I-TR
2,O
mg,O
/,O
mL,O
Solution,O
Sig,O
:,O
One,O
(,O
1,O
),O
ML,O
Intravenous,O
Q12H,O
(,O
every,O
12,O
hours,O
),O
as,O
needed,O
for,O
nausea,B-PR
.,O

5.,O
Pyridoxine,B-TR
50,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

6.,O
Olanzapine,B-TR
5,O
mg,O
Tablet,O
",",O
Rapid,O
Dissolve,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Rapid,O
Dissolve,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

7.,O
Insulin,B-TR
Glargine,I-TR
100,O
unit,O
/,O
mL,O
Cartridge,O
Sig,O
:,O
Ten,O
(,O
10,O
),O
units,O
Subcutaneous,O
once,O
a,O
day,O
.,O

8.,O
Humalog,B-TR
100,O
unit,O
/,O
mL,O
Cartridge,O
Sig,O
:,O
asdir,O
Subcutaneous,O
once,O
a,O
day,O
:,O
see,O
attached,O
sheet,O
for,O
sliding,O
scale,O
.,O

9.,O
Morphine,B-TR
2,O
mg,O
/,O
mL,O
Syringe,O
Sig,O
:,O
One,O
(,O
1,O
),O
Injection,O
Q4H,O
(,O
every,O
4,O
hours,O
),O
as,O
needed,O
.,O

10.,O
Tegaserod,B-TR
Hydrogen,I-TR
Maleate,I-TR
6,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
bid,O
(,O

11.,O
Levofloxacin,B-TR
500,O
mg,O
IV,O
Q24H,O

12.,O
Vancomycin,B-TR
HCl,O
750,O
mg,O
IV,O
Q,O
12H,O

13.,O
Dolasetron,B-TR
Mesylate,I-TR
25,O
mg,O
IV,O
Q8H,O
:,O
PRN,O
nausea,B-PR

14.,O
Promethazine,B-TR
HCl,I-TR
25,O
mg,O
IV,O
Q6H,O
:,O
PRN,O

15.,O
Lorazepam,B-TR
0.5-1,O
mg,O
IV,O
Q3-4H,O
:,O
PRN,O
anxiety,B-PR
",",O
nausea,B-PR
hold,O
for,O
sedation,B-PR
.,O

16.,O
Levothyroxine,B-TR
Sodium,I-TR
75,O
mcg,O
IV,O
DAILY,O

17.,O
Pantoprazole,B-TR
40,O
mg,O
IV,O
Q12H,O

18.,O
Erythromycin,B-TR
500,O
mg,O
IV,O
Q6H,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Discharge,O
Diagnosis,O
:,O

MRSA,B-PR
pneumonia,I-PR

Gastroparesis,B-PR

Enterobacter,B-PR
bacteremia,I-PR

Diabetes,B-PR
type,I-PR
I,I-PR

Hypothyroidism,B-PR

Discharge,O
Condition,O
:,O

Stable,O
.,O

She,O
was,O
oxygenating,O
well,O
on,O
room,O
air,O
.,O

She,O
continued,O
to,O
have,O
nausea,B-PR
and,O
vomiting,B-PR
.,O

She,O
was,O
unable,O
to,O
tolerate,O
pos,O
.,O

Discharge,O
Instructions,O
:,O

You,O
are,O
being,O
transfered,O
to,O
Mediplex,O
Rehab,O
Hospital,O
Hospital,O
for,O
further,O
care,O
as,O
you,O
have,O
requested,O
to,O
be,O
closer,O
to,O
home,O
.,O

Followup,O
Instructions,O
:,O

You,O
should,O
have,O
a,B-TE
anti-Tissue,I-TE
Transglutaminase,I-TE
Antibody,I-TE
",",O
IgA,B-TE
to,O
rule,O
out,O
celiac,B-PR
disease,I-PR
given,O
your,B-PR
abdominal,I-PR
symptoms,I-PR
.,O

Jayme,O
Gary,O
MD,O
57-021,O

Completed,O
by,O
:,O
Melvina,O
Holland,O
MD,O
20-010,O
2019-07-27,O
@,O
1645,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Melvin,O
N.I.,O
Lichtenberger,O
on,O
:,O
WED,O
2019-07-31,O
7:26,O
AM,O

(,O
End,O
of,O
Report,O
),O

216451163,O
PUMC,O

5642194,O

612016,O

23084,O

10/18/2001,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O
/,O
SUMMARY,O

ZEISRHALTPROT,O
",",O
QUETSHA,O

MRN,O
:,O

5642194,O

Age,O
:,O

40y,O

REGISTRATION,O
DATE,O
:,O

10/18/2001,O
09:18,O
AM,O

Provider,O
:,O

BIRI,O
WEERTLUC,O
PRELIMINARY,O
REPORT,O

Discharge,O
Date,O
/,O
Time,O
:,O

10/18/2001,O
10:09,O

Discharge,O
Status,O
:,O

Discharged,O

Condition,O
on,O
Discharge,O
:,O

Stable,O

Patient,O
States,O
Complaint,O
:,O

BACK,B-PR
PIAN,I-PR
Standardized,O

Discharge,O
Instructions,O
:,O

The,O
patient,O
was,O
given,O
printed,O
instructions,O
for,O
back,B-PR
pain,I-PR
(,O
English,O
),O
.,O

Diagnosis,O
:,O

back,B-PR
pain,I-PR

Treatment,O
Rendered,O
:,O

evaluation,B-TE

Discharge,O
Medications,O
:,O

ibuoprofen,B-TR
800,O
every,O
6-8,O
hrs,O
as,O
needed,O
skelaxin,B-TR
800mg,O
for,O
muscle,B-TR
relaxation,I-TR
vicodin,B-TR
1,O
tab,O
po,O
every,O
4-6,O
hrs,O
for,O
severe,B-PR
pain,I-PR

Follow,O
up,O
Service,O
:,O

please,O
call,O
your,O
primary,O
care,O
doctor,O
on,O
monday,O
for,O
follow,O
up,O
next,O
week,O
.,O

Disposition,O
",",O
Follow,O
up,O
and,O
Instructions,O
to,O
Patient,O
:,O

take,O
medication,B-TR
as,O
directed,O
",",O
return,O
for,O
severe,B-PR
or,I-PR
significantly,I-PR
worsening,I-PR
symptoms,I-PR
",",O
weakness,B-PR
or,O
loss,B-PR
of,I-PR
sensation,I-PR
work,O
restrictions,O
as,O
written,O
on,O
accompanying,O
form,O
.,O

PCP,O
Name,O
:,O

ASQUARCELMES,O
",",O
NOROBEBER,O

Provider,O
Number,O
:,O

20599,O

This,O
report,O
was,O
created,O
by,O
WEERTLUC,O
",",O
BIRI,O
10/18/2001,O
10:23,O
AM,O

Admission,O
Date,O
:,O

2017-06-12,O

Discharge,O
Date,O
:,O

2017-06-14,O

Date,O
of,O
Birth,O
:,O

1946-06-16,O

Sex,O
:,O

F,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Penicillins,B-TR
/,O
Keflex,B-TR
/,O
Sulfa,B-TR
(,I-TR
Sulfonamides,I-TR
),O
/,O
Nickel,O
/,O
Erythromycin,B-TR
Ethylsuccinate,I-TR

Attending,O
:,O
Michael,O
Y.,O
R.,O
Xiang,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Disconnected,B-PR
pigtail,I-PR
catheter,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

Removal,B-TR
of,I-TR
catheter,I-TR

History,O
of,O
Present,O
Illness,O
:,O

70,O
y/o,O
F,O
w/,O
tracheobronchomalacia,B-PR
",",O
COPD,B-PR
",",O
PMR,B-PR
",",O
recurrent,B-PR
pneumonias,I-PR
who,O
was,O
recently,O
discharged,O
from,O
Hallmark,O
Health,O
System,O
to,O
Pocasset,O
Mental,O
Health,O
Center,O

06-07,O
after,O
tracheobronchoplasty,B-TR
/,O
tracheostomy,B-TR
and,O
pigtail,B-TR
catheter,I-TR
placement,I-TR
for,O
pleural,B-PR
effusions,I-PR
.,O

Since,O
discharge,O
pt,O
has,O
continued,O
at,O
rehab,O
on,O
ps,B-TR
vent,I-TR
settings,I-TR
but,O
pigtail,B-TR
catheter,I-TR
fell,O
out,O
today,O
so,O
pt,O
was,O
referred,O
here,O
for,O
monitoring,O
.,O

On,O
ROS,B-TE
",",O
she,O
notes,O
feeling,O
poorly,B-PR
",",O
nausea,B-PR
",",O
and,O
diarrhea,B-PR
since,O
d/c,O
.,O

She,O
has,O
pleuritic,B-PR
chest,I-PR
pain,I-PR
which,O
she,O
has,O
had,O
since,O
she,O
arrested,O
during,O
her,O
admission,O
here,O
and,O
had,O
CPR,B-TR
.,O

Per,O
husband,O
she,O
has,O
no,O
cardiac,B-PR
history,I-PR
",",O
and,O
had,O
a,B-TE
stress,I-TE
test,I-TE
(,O
unclr,O
how,O
recent,O
),O
that,O
was,O
normal,O

Past,O
Medical,O
History,O
:,O

Past,O
CMED,O
Hx,O
:,O

Tracheobronchomalacia,B-PR

PMR,B-PR
s/p,O
TAH,B-TR

COPD,B-PR

AFib,B-PR
post,O
op,O

Recent,B-PR
UTI,I-PR
rx,O
w/aztreonam,B-TR

MRSA,B-PR
pna,I-PR
rx,O
w/vanc,B-TR

Anxiety,B-PR

Hx,O
resp,B-PR
arrest,I-PR
post-op,O

husb,O

Social,O
History,O
:,O

Soc,O
Hx,O
:,O
lives,O
in,O
Va,O
with,O
her,O
husband,O
",",O
has,O
been,O
up,O
here,O
since,O
April,O
s/p,O
month,O
long,O
hospitalization,O
",",O
no,O
tob/etoh,O

Family,O
History,O
:,O
nc,O

Physical,O
Exam,O
:,O

VS,B-TE
:,O

GEN,O
:,O

NAD,B-PR

HEENT,O
:,O

PERRLA,O
",",O
EOMI,O

RESP,O
:,O

CTA,O
-,O
ant,O

CV,O
:,O

RRR,O
",",O
nl,O
s1,O
",",O
s2,O
",",O
no,O
m/r/g,B-PR

abd,O
:,O
soft,O
",",O
"nt,nd",B-PR
",",O
nabs,O

extrem,O
:,O

1+,B-PR
edema,I-PR
blt,I-PR

Neuro,O
:,O

CNII,O
-,O
XII,O
intact,O

Pertinent,O
Results,O
:,O

ECG,B-TE
:,O
rate,B-TE
66,O
",",O
sinus,O
w/PAC,B-PR
's,I-PR
",",O
QT,B-TE
476,O
",",O
TWI,B-PR
in,I-PR
V1-6,I-PR
(,O
deep,O
in,O
v2-4,O
),O

CXR,B-TE
:,O

IMPRESSION,O
:,O

Interval,O
resolution,O
of,O
the,B-PR
right,I-PR
pleural,I-PR
effusion,I-PR
and,O
no,O
evidence,O
of,O
pneumothorax,B-PR
.,O

A,B-PR
small,I-PR
left,I-PR
pleural,I-PR
effusion,I-PR
?,O

No,O
changes,O
in,O
the,O
position,O
or,O
alignment,O
of,O
multiple,B-TR
lines,I-TR
and,O
tubes,B-TR

PATIENT,O
/,O
TEST,O
INFORMATION,O
:,O

Indication,O
:,O

Congestive,B-PR
heart,I-PR
failure,I-PR
.,O

Left,O
ventricular,O
function,O
.,O

Height,B-TE
:,O
(,O
in,O
),O
62,O

Weight,B-TE
(,O
lb,O
),O
:,O
180,O

BSA,B-TE
(,O
m2,O
),O
:,O
1.83,O
m2,O

BP,B-TE
(,O
mm,O
Hg,O
),O
:,O
115/48,O

HR,B-TE
(,O
bpm,O
),O
:,O
60,O

Status,O
:,O
Inpatient,O

Date,O
/,O
Time,O
:,O
2017-06-13,O
at,O
15:47,O

Test,O
:,O
TTE,B-TE
(,O
Complete,O
),O

Doppler,B-TE
:,O
Full,B-TE
doppler,I-TE
and,O
color,B-TE
doppler,I-TE

Contrast,O
:,O
None,O

Tape,O
Number,O
:,O
2005W251-0:21,O

Test,O
Location,O
:,O
West,O
Echo,O
Lab,O

Technical,O
Quality,O
:,O
Suboptimal,O

REFERRING,O
DOCTOR,O
:,O
DR.,O
Gregory,O
ERNST,O

DR.,O
Grace,O
ERNST,O

MEASUREMENTS,O
:,O

Left,B-TE
Atrium,I-TE
-,I-TE
Four,I-TE
Chamber,I-TE
Length,I-TE
:,O
5.1,O
cm,O
(,O
nl,O
<=,O
5.2,O
cm,O
),O

Right,B-TE
Atrium,I-TE
-,I-TE
Four,I-TE
Chamber,I-TE
Length,I-TE
:,O
*,O
6.2,O
cm,O
(,O
nl,O
<=,O
5.0,O
cm,O
),O

Left,B-TE
Ventricle,I-TE
-,I-TE
Septal,I-TE
Wall,I-TE
Thickness,I-TE
:,O
0.8,O
cm,O
(,O
nl,O
0.6,O
-,O
1.1,O
cm,O
),O

Left,B-TE
Ventricle,I-TE
-,I-TE
Inferolateral,I-TE
Thickness,I-TE
:,O
0.8,O
cm,O
(,O
nl,O
0.6,O
-,O
1.1,O
cm,O
),O

Left,B-TE
Ventricle,I-TE
-,I-TE
Diastolic,I-TE
Dimension,I-TE
:,O
5.3,O
cm,O
(,O
nl,O
<=,O
5.6,O
cm,O
),O

Left,B-TE
Ventricle,I-TE
-,I-TE
Ejection,I-TE
Fraction,I-TE
:,O
>=,O
40%,O
(,O
nl,O
>=,O
55%,O
),O

Aortic,B-TE
Valve,I-TE
-,I-TE
Peak,I-TE
Velocity,I-TE
:,O
1.4,O
m,O
/,O
sec,O
(,O
nl,O
<=,O
2.0,O
m,O
/,O
sec,O
),O

Mitral,B-TE
Valve,I-TE
-,I-TE
E,I-TE
Wave,I-TE
:,O
1.1,O
m,O
/,O
sec,O

Mitral,B-TE
Valve,I-TE
-,I-TE
A,I-TE
Wave,I-TE
:,O
1.0,O
m,O
/,O
sec,O

Mitral,B-TE
Valve,I-TE
-,I-TE
E/A,I-TE
Ratio,I-TE
:,O
1.10,O

TR,B-TE
Gradient,I-TE
(,I-TE
+,I-TE
RA,I-TE
=,I-TE
PASP,I-TE
),I-TE
:,O
*,O
36,O
mm,O
Hg,O
(,O
nl,O
<=,O
25,O
mm,O
Hg,O
),O

INTERPRETATION,O
:,O

Findings,O
:,O

This,B-TE
study,I-TE
was,O
compared,O
to,O
the,B-TE
prior,I-TE
study,I-TE
of,O
2017-06-01,O
.,O

LEFT,O
ATRIUM,O
:,O

Normal,O
LA,O
size,O
.,O

LEFT,O
VENTRICLE,O
:,O

Wall,B-TE
thickness,I-TE
and,O
cavity,B-TE
dimensions,I-TE
were,O
obtained,O
from,O
2D,B-TE
images,I-TE
.,O

Normal,O
LV,O
wall,O
thicknesses,O
and,O
cavity,O
size,O
.,O

Suboptimal,O
technical,O
quality,O
",",O
a,B-PR
focal,I-PR
LV,I-PR
wall,I-PR
motion,I-PR
abnormality,I-PR
cannot,O
be,O
fully,O
excluded,O
.,O

No,O
resting,O
LVOT,O
gradient,O
.,O

RIGHT,O
VENTRICLE,O
:,O

Normal,O
RV,O
chamber,O
size,O
and,O
free,O
wall,O
motion,O
.,O

AORTA,O
:,O

Normal,O
aortic,O
root,O
diameter,O
.,O

Focal,B-PR
calcifications,I-PR
in,I-PR
aortic,I-PR
root,I-PR
.,O

AORTIC,O
VALVE,O
:,O

Normal,O
aortic,O
valve,O
leaflets,O
.,O

No,O
AR,B-PR
.,O

MITRAL,O
VALVE,O
:,O

Normal,O
mitral,O
valve,O
leaflets,O
.,O

Mild,B-PR
(,I-PR
1+,I-PR
),I-PR
MR,I-PR
.,O

TRICUSPID,O
VALVE,O
:,O

Mild,B-PR
PA,I-PR
systolic,I-PR
hypertension,I-PR
.,O

PERICARDIUM,O
:,O

No,O
pericardial,B-PR
effusion,I-PR
.,O

GENERAL,O
COMMENTS,O
:,O

Suboptimal,O
image,O
quality,O
-,O
poor,O
echo,O
windows,O
.,O

Based,O
on,O
1997,O
AHA,O
endocarditis,O
prophylaxis,O
recommendations,O
",",O
the,O
echo,O
findings,O
indicate,O
a,O
low,O
risk,O
(,O
prophylaxis,B-TR
not,O
recommended,O
).,O

Clinical,O
decisions,O
regarding,O
the,O
need,O
for,O
prophylaxis,B-TR
should,O
be,O
based,O
on,O
clinical,O
and,O
echocardiographic,O
data,O
.,O

Conclusions,O
:,O

The,O
left,O
atrium,O
is,O
normal,O
in,O
size,O
.,O

Left,B-TE
ventricular,I-TE
wall,I-TE
thicknesses,I-TE
and,O
cavity,B-TE
size,I-TE
are,O
normal,O
.,O

Due,O
to,O
suboptimal,O
technical,O
quality,O
",",O
a,B-PR
focal,I-PR
wall,I-PR
motion,I-PR
abnormality,I-PR
cannot,O
be,O
fully,O
excluded,O
.,O

Overall,B-TE
systolic,I-TE
function,I-TE
is,O
good,O
(,O
LVEF,B-TE
>,O
40%,O
).,O

Right,B-TE
ventricular,I-TE
chamber,I-TE
size,I-TE
and,O
free,B-TE
wall,I-TE
motion,I-TE
are,O
normal,O
.,O

The,O
aortic,O
valve,O
leaflets,O
appear,O
structurally,O
normal,O
with,O
good,O
leaflet,O
excursion,O
.,O

No,O
aortic,B-PR
regurgitation,I-PR
is,O
seen,O
.,O

The,O
mitral,O
valve,O
leaflets,O
are,O
structurally,O
normal,O
.,O

Mild,B-PR
(,I-PR
1+,I-PR
),I-PR
mitral,I-PR
regurgitation,I-PR
is,O
seen,O
.,O

There,O
is,O
mild,B-PR
pulmonary,I-PR
artery,I-PR
systolic,I-PR
hypertension,I-PR
.,O

There,O
is,O
no,O
pericardial,B-PR
effusion,I-PR
.,O

IMPRESSION,O
:,O

Good,O
global,O
biventricular,O
systolic,O
function,O
.,O

Mild,B-PR
mitral,I-PR
regurgitation,I-PR
.,O

The,B-TE
prior,I-TE
study,I-TE
of,O
2017-06-01,O
(,O
tape,O
reviewed,O
),O
was,O
of,O
very,O
suboptimal,O
technical,O
quality,O
and,O
not,O
directly,O
comparable,O
to,O
the,B-TE
current,I-TE
study,I-TE
.,O

If,O
more,O
definitive,O
information,O
regarding,O
ventricualr,O
fuynction,O
is,O
needed,O
",",O
a,B-TE
cardiac,I-TE
MRI,I-TE
(,O
(,O
951,O
),O
247-0244,O
),O
or,O
radionuclide,B-TE
study,I-TE
is,O
suggested,O
.,O

Based,O
on,O
1997,O
AHA,O
endocarditis,O
prophylaxis,O
recommendations,O
",",O
the,O
echo,O
findings,O
indicate,O
a,B-PR
low,I-PR
risk,I-PR
(,O
prophylaxis,B-TR
not,O
recommended,O
).,O

Clinical,O
decisions,O
regarding,O
the,O
need,O
for,O
prophylaxis,B-TR
should,O
be,O
based,O
on,O
clinical,O
and,O
echocardiographic,O
data,O
.,O

Electronically,O
signed,O
by,O
Lisa,O
John,O
",",O
MD,O
on,O
2017-06-13,O
18:41,O
.,O

Oak,O
Bluffs,O
PHYSICIAN,O
:,O
"Gregory,Domingo",O
J,O
.,O

Brief,O
Hospital,O
Course:,O

Pleural,B-PR
effusion,I-PR
:,O
s/p,O
pigtail,B-TR
cath,I-TR
drain,I-TR
.,O

Imaging,B-TE
indicated,O
that,O
the,B-PR
pleural,I-PR
effusions,I-PR
had,O
resolved,O
.,O

Thoracics,O
agreed,O
to,O
no,O
need,O
for,O
pigtail,B-TR
placement,I-TR
.,O

CHF,B-PR
:,O

Patient,O
was,O
seen,O
by,O
CHF,O
(,O
echo,O
results,O
are,O
detailed,O
above,O
),O
.,O

They,O
recommended,O
continuing,O
beta-blocker,B-TR
and,O
titarting,O
ace,B-TR
as,O
tolerated,O
.,O

Patient,O
should,O
be,O
kept,O
euvolemic,O
once,O
peripheral,B-PR
edema,I-PR
resolves,O
(,O
may,O
use,O
lasix,B-TR
to,O
decrease,O
edema,B-PR
).,O

She,O
will,O
need,O
a,B-TE
repeat,I-TE
echo,I-TE
in,O
3-6,O
months,O
(,O
since,O
this,B-TE
echo,I-TE
showed,O
a,O
question,O
of,O
focal,B-PR
wall,I-PR
motion,I-PR
abnormality,I-PR
).,O

Also,O
",",O
patient,O
was,O
started,O
on,O
amiodarone,B-TR
and,O
digoxin,B-TR
was,O
held,O
secondary,O
to,O
high,B-PR
levels,I-PR
(,O
please,O
restart,O
when,O
level,B-TE
less,O
than,O
2,O
),O

Diarrhea,B-PR
:,O

Stool,B-TE
c.,I-TE
diff,I-TE
neg,O
x1,O
.,O

She,O
will,O
need,O
two,B-TE
more,I-TE
specimens,I-TE
.,O

COPD,B-PR
:,O
cont,O
nebs,B-TR
.,O

PAF,B-PR
:,O
started,O
on,O
amio,B-TR
",",O
cont,O
b-blocker,B-TR
",",O
and,O
patient,O
was,O
started,O
on,O
coumadin,B-TR
-,O
levels,B-TE
(,I-TE
inr,I-TE
),I-TE
should,O
be,O
monitored,O
.,O

Nutrition,O
:,O

Patient,O
should,O
be,O
started,O
on,O
tube,B-TR
feeds,I-TR
at,O
rehab,O

Rash,B-PR
:,O

Patient,O
developed,O
a,B-PR
diffuse,I-PR
erythematous,I-PR
rash,I-PR
",",O
though,O
to,O
be,O
an,B-PR
ID,I-PR
reaction,I-PR
to,O
a,B-PR
recent,I-PR
fungal,I-PR
infection,I-PR
.,O

She,O
has,O
been,O
satrted,O
on,O
benadryl,B-TR
and,O
hydrocort,B-TR
for,O
sx,O
relief,O
.,O

Please,O
monitor,O
this,O
(,O
may,O
need,O
dermatology,O
consult,O
).,O

Also,O
a,B-PR
drug,I-PR
reaction,I-PR
is,O
in,O
the,O
ddx,O
but,O
unlikely,O
as,O
rash,B-PR
started,O
at,O
rehab,O
prior,O
to,O
receiving,O
drugs,B-TR
here,O
.,O

Medications,O
on,O
Admission,O
:,O

Meds,B-TR
at,O
Pocasset,O
Mental,O
Health,O
Center,O
:,O

SQ,B-TR
heparin,I-TR
",",O
MVI,B-TR
",",O
nystatin,B-TR
",",O
colace,B-TR
",",O
albuterol,B-TR
",",O
atrovent,B-TR
",",O
amiodarone,B-TR
400,O
bid,O
",",O
pulmicort,B-TR
",",O
digoxin,B-TR
",",O
metoprolol,B-TR
12.5,O
tid,O
",",O
reglan,B-TR

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Discharge,O
Diagnosis,O
:,O
tracheobronchomalecia,B-PR
chf,B-PR

PAF,B-PR

COPD,B-PR

Discharge,O
Condition,O
:,O
deconditioned,B-PR
but,O
stable,O

Discharge,O
Instructions,O
:,O

Please,O
call,O
your,O
doctor,O
or,O
come,O
to,O
Robert,O
if,O
you,O
develop,O
fevers,B-PR
",",O
chills,B-PR
",",O
cp,B-PR
",",O
nausea,B-PR
or,O
vomiting,B-PR
",",O
or,O
any,B-PR
other,I-PR
concerning,I-PR
sx,I-PR

Followup,O
Instructions,O
:,O

Call,O
Dr.,O
Pederson,O
office,O
for,O
appointment,O
in,O
2-3,O
weeks,O
-(,O
869,O
),O
263-1570.,O

you,O
will,O
need,O
a,B-TE
repeat,I-TE
echo,I-TE
within,O
3-6,O
months,O

Please,O
call,O
your,O
PCP,O
for,O
an,O
appointment,O
within,O
1,O
week,O
-,O
number,O
to,O
call,O
is,O
(,O
489,O
),O
489,O
0229,O
ext,O
7499,O

ARMIN,O
ERNST,O
MD,O
57-915,O

Completed,O
by,O
:,O
Neva,O
Rhonda,O
MD,O
77-523,O
2017-06-14,O
@,O
1112,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Rhonda,O
ERNST,O
on,O
:,O
FRI,O
2017-06-16,O
1:44,O
PM,O

(,O
End,O
of,O
Report,O
),O

220536305,O

CMC,O

82863580,O

10/8/1994,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

10/08/1994,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

10/18/1994,O

The,O
patient,O
was,O
scheduled,O
for,O
discharge,O
to,O
rehab,O
.,O

It,O
was,O
noted,O
on,O
10/8/94,O
that,O
she,O
had,O
a,B-PR
decreased,I-PR
range,I-PR
of,I-PR
motion,I-PR
in,O
both,O
her,O
knees,O
with,O
flexion,O
to,O
approximately,O
40,O
degrees,O
with,O
maximum,O
physical,B-TR
therapy,I-TR
.,O

It,O
was,O
decided,O
to,O
postpone,O
her,O
discharge,O
to,O
rehab,O
and,O
take,O
her,O
back,O
to,O
the,O
operating,O
room,O
for,O
a,B-TR
manipulation,I-TR
under,O
anesthesia,B-TR
.,O

On,O
10/9/94,O
",",O
she,O
was,O
taken,O
back,O
to,O
the,O
operating,O
room,O
.,O

Dictated,O
By,O
:,O

NA,O
BENGSTEN,O
",",O
M.D,O
",",O
HM72,O

Attending,O
:,O

LUPEVICKETTE,O
L.,O
MELENA,O
",",O
M.D.,O
YL7,O
TD803/0252,O

Batch,O
:,O

473,O

Index,O
No.,O
KRUQ8L9,O
GVZ,O

D,O
:,O

10/17/94,O

T,O
:,O

10/18/94,O

880410,O

Admission,O
Date,O
:,O

2013-07-23,O

Discharge,O
Date,O
:,O

2013-08-01,O

Date,O
of,O
Birth,O
:,O

2013-07-23,O

Sex,O
:,O

F,O

Service,O
:,O

CMED,O
CSRU,O

HISTORY,O
:,O

Baby,O
Girl,O
Kathryn,O
Frazier,O
",",O
triplet,O
III,O
",",O
delivered,O
at,O
32,O
-,O
5/7,O
weeks,O
gestation,O
was,O
admitted,O
to,O
the,O
newborn,O
intensive,O
care,O
unit,O
for,O
management,B-TR
of,O
prematurity,B-PR
.,O

Birth,B-TE
weight,I-TE
was,O
1630,O
grams,O
.,O

The,O
mother,O
is,O
a,O
31,O
-,O
year-old,O
Gravida,O
5,O
",",O
para,O
1,O
",",O
now,O
4,O
woman,O
with,O
estimated,O
date,O
of,O
delivery,O
2013-09-12,O
.,O

Prenatal,B-TE
screens,I-TE
included,O
blood,B-TE
type,I-TE
A+,O
",",O
antibody,B-TE
screen,I-TE
negative,O
",",O
rubella,B-TE
immune,O
",",O
RPR,B-TE
nonreactive,O
.,O

Hepatitis,B-TE
B,I-TE
surface,I-TE
antigen,I-TE
negative,O
",",O
cystic,B-TE
fibrosis,I-TE
negative,O
",",O
and,O
Group,B-TE
B,I-TE
strep,I-TE
unknown,O
.,O

Mother,O
's,O
medical,O
history,O
was,O
notable,O
for,O
depression,B-PR
treated,O
with,O
Zoloft,B-TR
.,O

OB,O
history,O
notable,O
for,O
infertility,B-PR
treated,O
with,O
Clomid,B-TR
.,O

This,O
pregnancy,O
was,O
complicate,O
by,O
triplet,B-PR
gestation,I-PR
",",O
cervical,B-PR
shortening,I-PR
",",O
and,O
pregnancy,B-PR
induced,I-PR
hypertension,I-PR
.,O

Delivery,O
was,O
by,O
cesarean,B-TR
section,I-TR
under,O
spinal,B-TR
anesthesia,I-TR
for,O
pre-eclampsia,B-PR
.,O

There,O
was,O
no,O
labor,B-PR
or,I-PR
maternal,I-PR
fever,I-PR
.,O

Membranes,O
were,O
ruptured,O
at,O
delivery,O
for,O
clear,O
fluid,O
.,O

Mother,O
did,O
not,O
receive,O
any,B-TR
antibiotics,I-TR
prior,O
to,O
delivery,O
.,O

The,O
infant,O
emerged,O
vigorous,O
",",O
was,O
dried,O
",",O
bulb,O
suctioned,O
and,O
given,O
free,B-TR
flow,I-TR
oxygen,I-TR
.,O

Apgar,B-TE
scores,I-TE
were,O
7,O
at,O
one,O
minute,O
and,O
8,O
at,O
5,O
minutes,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,O
birth,B-TE
weight,I-TE
1630,O
grams,O
(,O
50th,O
percentile,O
),O
",",O
length,B-TE
43.5,O
cm,O
(,O
50th,O
percentile,O
),O
",",O
head,B-TE
circumference,I-TE
31.5,O
cm,O
(,O
75th,O
percentile,O
).,O

Infant,O
with,O
non-,B-PR
dysmorphic,I-PR
facies,I-PR
",",O
palate,O
intact,O
.,O

Anterior,O
fontanel,O
soft,O
and,O
flat,O
",",O
moderate,B-PR
nasal,I-PR
flaring,I-PR
.,O

Chest,O
with,O
moderate,B-PR
intercostal,I-PR
retractions,I-PR
",",O
fair,O
breath,O
sounds,O
bilaterally,O
",",O
no,O
crackles,B-PR
.,O

Cardiovascular,O
is,O
well,O
perfused,O
with,O
regular,O
rate,O
and,O
rhythm,O
and,O
normal,O
S1,O
and,O
S2,O
",",O
no,O
murmur,B-PR
",",O
normal,O
pulses,O
and,O
perfusion,O
.,O

Abdomen,O
soft,O
",",O
not,O
distended,B-PR
.,O

No,O
organomegaly,B-PR
or,O
masses,B-PR
.,O

Bowel,O
sounds,O
are,O
active,O
",",O
patent,O
anus,O
",",O
three,O
vessel,O
umbilical,O
cord,O
.,O

Genitourinary,O
normal,O
female,O
genitalia,O
.,O

Skin,O
without,O
rashes,B-PR
or,O
lesions,B-PR
.,O

Spine,O
intact,O
.,O

Hips,O
stable,O
.,O

Active,O
",",O
alert,O
",",O
responding,O
to,O
stimulation,B-TE
.,O

Tone,B-PR
decreased,I-PR
slightly,I-PR
in,O
symmetric,O
distribution,O
",",O
moves,O
all,O
extremities,O
equally,O
.,O

Suck,O
and,O
gag,O
present,O
.,O

Grasp,O
symmetric,O
.,O

SUMMARY,O
OF,O
HOSPITAL,O
COURSE,O
BY,O
SYSTEMS,O
:,O

Initially,O
was,O
placed,O
on,O
continuous,B-TR
positive,I-TR
airway,I-TR
pressure,I-TR
40%,B-TR
oxygen,I-TR
.,O

Due,O
to,O
increasing,B-PR
respiratory,I-PR
distress,I-PR
was,O
intubated,O
",",O
placed,O
on,O
conventional,B-TR
ventilation,I-TR
and,O
pressures,B-TR
of,O
24/6,O
",",O
rate,B-TR
of,O
25,O
.,O

She,O
received,O
one,O
dose,O
of,O
Survanta,B-TR
and,O
then,O
weaned,O
well,O
on,O
ventilator,B-TR
settings,I-TR
.,O

She,O
was,O
extubated,O
to,O
room,O
air,O
at,O
13,O
hours,O
of,O
age,O
.,O

Has,O
remained,O
in,O
room,O
air,O
since,O
with,O
comfortable,O
work,O
of,O
breathing,O
",",O
respiratory,B-TE
rates,I-TE
in,O
the,O
40,O
's,O
to,O
70,O
's.,O

No,O
apnea,B-PR
.,O

Cardiovascular,O
has,O
been,O
hemodynamically,O
stable,O
throughout,O
hospital,O
stay,O
.,O

Heart,B-TE
rates,I-TE
range,O
in,O
the,O
140,O
to,O
160,O
's,O
",",O
no,O
heart,B-PR
murmur,I-PR
.,O

Recent,B-TE
blood,I-TE
pressure,I-TE
71/31,O
with,O
a,O
mean,O
of,O
48,O
.,O

Fluids,O
",",O
electrolytes,O
",",O
nutrition,O
:,O

Was,O
initially,O
NPO,B-TR
on,O
receiving,O
D10-W,B-TR
by,O
peripheral,O
intravenous,O
.,O

Enteral,B-TR
feeds,I-TR
were,O
started,O
on,O
day,O
of,O
life,O
one,O
and,O
she,O
advanced,O
to,O
full,B-TR
volume,I-TR
feeds,I-TR
of,O
breast,O
milk,O
or,O
special,B-TR
care,I-TR
formula,I-TR
on,O
day,O
of,O
life,O
six,O
(,O
2013-07-29,O
),O
without,O
problems,B-PR
.,O

She,O
is,O
presently,O
receiving,O
breast,O
milk,O
or,O
special,B-TR
care,I-TR
formula,I-TR
24,O
cal,O
at,O
150,O
mls,O
per,O
kilo,O
per,O
day,O
with,O
tolerance,O
.,O

Voiding,O
and,O
stooling,O
appropriately,O
.,O

Most,B-TE
recent,I-TE
electrolytes,I-TE
done,O
on,O
day,O
of,O
life,O
one,O
showed,O
a,B-TE
sodium,I-TE
of,O
132,O
",",O
potassium,B-TE
6.1,O
",",O
chloride,B-TE
100,O
",",O
Co2,B-TE
20,O
.,O

Discharge,B-TE
weight,I-TE
is,O
1700,O
grams,O
up,O
15,O
grams,O
..,O

Gastrointestinal,O
:,O

Received,O
phototherapy,B-TR
from,O
07-27,O
to,O
2013-07-28,O
for,O
a,B-TE
peak,I-TE
bilirubin,I-TE
of,O
8.1,O
.,O

Phototherapy,B-TR
was,O
discontinued,O
when,O
bilirubin,B-TE
was,O
a,B-TE
total,I-TE
of,O
4.7,O
.,O

Most,B-TE
recent,I-TE
bilirubin,I-TE
on,O
2013-07-29,O
total,B-TE
of,O
4.2,O
",",O
direct,B-TE
.4,O
.,O

Hematology,O
:,O

Hematocrit,B-TE
on,O
admission,O
47%,O
.,O

No,O
transfusions,B-TR
given,O
.,O

Infectious,O
Disease,O
:,O

Received,O
48,O
hours,O
of,O
Ampicillin,B-TR
and,O
gentamicin,B-TR
for,O
rule,O
out,O
sepsis,B-PR
.,O

CBC,B-TE
on,O
admission,O
showed,O
a,B-TE
white,I-TE
count,I-TE
of,O
9.3,O
with,O
37,B-TE
polys,I-TE
",",O
0,B-TE
bands,I-TE
",",O
platelets,B-TE
"399,000",O
.,O

The,B-TE
blood,I-TE
culture,I-TE
was,O
negative,O
.,O

Neurology,O
:,O

Head,B-TE
ultrasound,I-TE
not,O
indicated,O
.,O

Sensory,O
:,O

A,B-TE
hearing,I-TE
screening,I-TE
has,O
not,O
been,O
performed,O
",",O
will,O
need,O
prior,O
to,O
discharge,O
home,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
7,O
day,O
old,O
former,O
32-5/7,O
week,O
and,O
now,O
33-5/7,O
weeks,O
age,O
.,O

DISPOSITION,O
:,O

Saint,O
Vincent,O
Hospital,O
Hospital,O
.,O

PEDIATRICIAN,O
:,O

Dr.,O
Manuel,O
Burke,O
",",O
1,O
Parkway,O
",",O
Fall,O
River,O
",",O
New,O
Mexico,O
57362,O
.,O

CARE,O
AND,O
RECOMMENDATIONS,O
:,O

1.,O
Feeds,O
.,O

Breast,O
milk,O
or,O
special,B-TR
care,I-TR
formula,I-TR
24,O
calories,O
per,O
ounce,O
at,O
150,O
mls,O
per,O
kilo,O
per,O
day,O
with,O
plans,O
to,O
advance,O
calories,O
.,O

2.,O
Medications,O
:,O

Currently,O
on,O
no,O
medications,B-TR
.,O

3.,O
State,B-TE
newborn,I-TE
screen,I-TE
was,O
sent,O
on,O
2013-07-26,O
and,O
is,O
pending,O
.,O

4.,O
Has,O
not,O
received,O
any,B-TR
immunization,I-TR
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

1.,O
AGA,O
32-5/7,O
week,O
pre-term,O
female,O
.,O

2.,O
Triplet,O
#3,O

3.,O
Respiratory,B-PR
distress,I-PR
syndrome,I-PR
resolved,O
.,O

4.,O
Physiologic,B-PR
jaundice,I-PR
.,O

5.,O
Perinatal,B-PR
sepsis,I-PR
ruled,O
out,O
.,O

Joseph,O
Clarence,O
",",O
Oklahoma,O
91525,O

Dictated,O
By,O
:,O
Doris,O
Q.,O
Marszalek,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2013-07-29,O
17:28:46,O

T,O
:,O
2013-07-29,O
18:39:50,O

Job,O
#,O
:,O
97834,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Lance,O
GRAY,O
on,O
:,O
Maxine,O
2013-08-01,O
12:50,O
PM,O

(,O
End,O
of,O
Report,O
),O

225281111,O

GH,O

59035229,O

7/4/1999,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

07/04/1999,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

07/09/1999,O

ADMISSION,O
DIAGNOSIS,O
:,O

ABDOMINAL,B-PR
PAIN,I-PR
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

PARTIAL,B-PR
SMALL,I-PR
BOWEL,I-PR
OBSTRUCTION,I-PR
.,O

HISTORY,O
OF,O
THE,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
49,O
year-old,O
male,O
with,O
a,O
history,O
of,O
a,B-TR
low,I-TR
anterior,I-TR
resection,I-TR
in,O
May,O
of,O
1998,O
and,O
a,B-PR
recurrence,I-PR
of,O
metastasis,B-PR
with,O
asleeve,O
of,O
section,O
of,O
left,B-TR
colon,I-TR
diverting,I-TR
ileostomy,I-TR
for,O
recurrent,B-PR
metastasis,I-PR
later,O
in,O
May,O
of,O
1999,O
who,O
presents,O
with,O
anterior,B-PR
midepigastric,I-PR
abdominal,I-PR
pain,I-PR
.,O

The,O
patient,O
states,O
that,O
the,B-PR
pain,I-PR
began,O
at,O
10:30,O
on,O
the,O
day,O
of,O
admission,O
with,O
increase,O
during,O
the,O
day,O
of,O
admission,O
with,O
positive,O
nausea,B-PR
and,O
vomiting,B-PR
",",O
no,O
diarrhea,B-PR
",",O
decreased,B-PR
output,I-PR
from,I-PR
the,I-PR
ostomy,I-PR
",",O
and,O
the,B-PR
pain,I-PR
was,O
radiating,O
to,O
the,O
back,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

As,O
above,O
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

As,O
above,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Percocet,B-TR
and,O
Naprosyn,B-TR
.,O

ALLERGIES,O
:,O

Demerol,B-TR
.,O

SOCIAL,O
HISTORY,O
:,O

No,O
tobacco,O
and,O
no,O
alcohol,O
use,O
.,O

PHYSICAL,O
EXAMINATION,O
ON,O
ADMISSION,O
:,O

Temperature,B-TE
98.8,O
",",O
heart,B-TE
rate,I-TE
68,O
",",O
blood,B-TE
pressure,I-TE
107/82,O
",",O
and,O
oxygen,B-TE
saturation,I-TE
99%,O
on,O
room,O
air,O
.,O

CHEST,O
:,O

Clear,O
to,O
auscultation,B-TE
.,O

HEART,O
:,O

Regular,O
rate,O
and,O
rhythm,O
with,O
no,O
murmurs,B-PR
.,O

ABDOMEN,O
:,O

Soft,O
",",O
mildly,B-PR
distended,I-PR
",",O
and,O
tympanic,B-PR
with,O
midepigastric,B-PR
tenderness,I-PR
to,O
palpation,B-TE
and,O
no,O
rebound,B-PR
.,O

The,B-TR
ostomy,I-TR
was,O
pink,O
with,O
minimal,O
fluid,O
in,O
the,B-TR
ostomy,I-TR
bag,I-TR
.,O

It,O
was,O
guaiac,B-TE
negative,O
.,O

EXTREMITIES,O
:,O

No,O
signs,O
of,O
edema,B-PR
and,O
the,O
patient,O
had,O
warm,O
and,O
palpable,O
pulses,O
distally,O
.,O

HOSPITAL,O
COURSE,O
:,O

Assessment,B-TE
was,O
continued,O
with,O
laboratory,B-TE
studies,I-TE
which,O
showed,O
the,O
patient,O
to,O
have,O
a,O
white,B-TE
blood,I-TE
cell,I-TE
count,I-TE
of,O
9,O
",",O
hematocrit,B-TE
39,O
",",O
and,O
platelets,B-TE
470,O
.,O

The,O
patient,O
had,O
a,O
normal,O
amylase,O
and,O
lipase,B-TE
",",O
and,O
a,O
normal,O
basic,O
metabolic,O
panel,O
.,O

The,O
patient,O
had,O
KUB,B-TE
that,O
showed,O
multiple,B-PR
dilated,I-PR
loops,I-PR
of,I-PR
small,I-PR
bowel,I-PR
and,O
was,O
admitted,O
for,O
a,O
partial,B-PR
small,I-PR
bowel,I-PR
obstruction,I-PR
.,O

An,B-TR
nasogastric,I-TR
tube,I-TR
was,O
placed,O
and,O
had,O
an,B-TR
H2,I-TR
blocker,I-TR
started,O
",",O
and,O
was,O
admitted,O
for,O
bowel,B-TR
rest,I-TR
and,O
decompression,B-TR
.,O

The,O
patient,O
tolerated,O
the,B-TR
nasogastric,I-TR
tube,I-TR
well,O
.,O

The,B-TR
nasogastric,I-TR
tube,I-TR
was,O
removed,O
on,O
hsp,O
day,O
#,O
3,O
.,O

The,B-PR
pain,I-PR
improved,O
quickly,O
and,O
the,O
patient,O
was,O
started,O
on,O
a,O
clear,B-TR
liquid,I-TR
diet,I-TR
which,O
was,O
advanced,O
as,O
tolerated,O
.,O

On,O
7/9/99,O
",",O
the,O
patient,O
was,O
tolerating,O
a,O
house,O
diet,O
.,O

The,O
patient,O
had,O
some,B-PR
minimal,I-PR
back,I-PR
pain,I-PR
that,O
occurred,O
after,O
food,O
but,O
with,O
negative,O
urinalysis,O
and,O
negative,O
fever,B-PR
spikes,I-PR
over,O
the,O
entire,O
course,O
of,O
this,O
stay,O
.,O

The,O
patient,O
will,O
be,O
discharged,O
home,O
on,O
Zantac,B-TR
",",O
Simethicone,B-TR
",",O
and,O
preoperative,B-TR
medications,I-TR
with,O
follow-up,O
with,O
Dr.,O
Ur,O
in,O
two,O
weeks,O
.,O

Dictated,O
By,O
:,O

NISTE,O
BLOCKER,O
",",O
M.D.,O
AQ36,O

Attending,O
:,O

STIE,O
FYFE,O
",",O
M.D.,O
BW3,O
BL436/5666,O

Batch,O
:,O

85114,O

Index,O
No.,O

FNQXCX58,O
EM,O

D,O
:,O

07/09/99,O

T,O
:,O

07/09/99,O
HP8,O

Admission,O
Date,O
:,O

2015-06-29,O

Discharge,O
Date,O
:,O

2015-07-09,O

Date,O
of,O
Birth,O
:,O

1941-01-16,O

Sex,O
:,O

M,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,O
Drugs,B-TR

Attending,O
:,O
Pedro,O
D.,O
Anderson,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Chest,B-PR
Pain,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O
persantine,B-TE
MIBI,I-TE
cardiac,I-TE
stress,I-TE
test,I-TE
thoracentesis,B-TE

Chest,B-TR
Tube,I-TR

History,O
of,O
Present,O
Illness,O
:,O

74,O
yo,O
M,O
with,O
lung,B-PR
cancer,I-PR
DVT,B-PR
who,O
presents,O
with,O
1,O
day,O
of,O
substernal,B-PR
chest,I-PR
pain,I-PR
.,O

Patient,O
developed,O
chest,B-PR
pain,I-PR
the,O
night,O
prior,O
to,O
admission,O
.,O

The,B-PR
pain,I-PR
was,O
substernal,O
07-08,O
",",O
did,O
not,O
radiate,O
.,O

He,O
reports,O
that,O
the,B-PR
pain,I-PR
was,O
similar,O
to,O
his,B-PR
prior,I-PR
MI,I-PR
.,O

The,O
patient,O
had,O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

In,O
the,O
Amanda,O
the,B-PR
patients,I-PR
pain,I-PR
resolved,O
with,O
NTG,B-TR
and,O
morphine,B-TR
.,O

he,O
was,O
given,O
ASA,B-TR
and,O
bblocker,B-TR
.,O

At,O
time,O
of,O
my,B-TE
evaluation,I-TE
",",O
the,O
patient,O
denied,O
nausea,B-PR
",",O
vomitting,B-PR
",",O
abdominal,B-PR
pain,I-PR
",",O
dysuria,B-PR
",",O
dizziness,B-PR
",",O
changes,B-PR
in,I-PR
vision,I-PR
/hearing,I-PR

Past,O
Medical,O
History,O
:,O

-,O
Lung,B-PR
cancer,I-PR
-,O
Non-small,B-PR
cell,I-PR
lung,I-PR
cancer,I-PR
stage,I-PR
IIIA,I-PR
",",O
status,O
post,O
weekly,B-TR
carboplatin,I-TR
and,O
Taxol,B-TR
chemotherapy,I-TR
with,O
XRT,B-TR
for,O
seven,O
weeks,O
followed,O
by,O
surgery,B-TR
on,O
2015-04-14,O
.,O

-,O
CAD,B-PR
-,O
s/p,O
inferior,B-PR
STEMI,I-PR
12-03,O
",",O
stent,B-TR
to,I-TR
L,I-TR
Cx,I-TR

-,O
CHF,B-PR
(,O
EF,B-TE
55%,O
on,O
05-04,O
),O

Social,O
History,O
:,O
non-smoker,O
",",O
occasional,O
etoh,O
",",O
no,O
drugs,O

Family,O
History,O
:,O
father,O
and,O
mother,O
with,O
CAD,B-PR

Physical,O
Exam,O
:,O

VS,B-TE
-,O
98.0,O
67,O
140/63,O
22,O
99%,O
on,O
RA,O

Gen,O
-,O
A+Ox3,O
",",O
NAD,B-PR

HEENT,O
-,O
EOMI,O
",",O
OP,O
clear,O

Neck,O
-,O
supple,O
",",O
no,O
LAD,B-PR
",",O
no,O
JVD,B-PR

Cor,O
-,O
RRR,O
no,O
murmurs,B-PR

Chest,O
-,O
R,O
base,O
with,O
poor,B-PR
excursion,I-PR
and,O
poor,B-PR
breath,I-PR
sounds,I-PR
.,O

Clear,O
otherwise,O
.,O

Abd,O
-,O
s/nt/nd,B-PR
+BS,O

Ext,O
-,O
w/wp,O
",",O
no,O
edema,B-PR
",",O
R,B-PR
leg,I-PR
swollen,I-PR
compared,O
to,O
left,O

Pertinent,O
Results,O

2015-06-29,O
05:15PM,O

CK,B-TE
(,I-TE
CPK,I-TE
)-,I-TE
67,O

2015-06-29,O
05:15PM,O

CK,B-TE
-,I-TE
MB,I-TE
-,O
NotDone,O
cTropnT,B-TE
-<,O
0.01,O

2015-06-29,O
9:55,O

GLUCOSE,B-TE
-,O
159,O
*,O
UREA,B-TE
N,I-TE
-,O
17,O
CREAT,B-TE
-,O
1.0,O
SODIUM,B-TE
-,O
137,O
POTASSIUM,B-TE
-,O
3.6,O
CHLORIDE,B-TE
-,O
100,O
TOTAL,B-TE
CO2,I-TE
-,O
27,O
ANION,B-TE
GAP,I-TE
-,O
14,O

2015-06-29,O
9:55,O

CK,B-TE
(,I-TE
CPK,I-TE
)-,I-TE
76,O

2015-06-29,O
09:55,O
AM,O
cTropnT,B-TE
-<,O
0.01,O

2015-06-29,O
9:55,O

CK,B-TE
-,I-TE
MB,I-TE
-,O
NotDone,O

2015-06-29,O
9:55,O

WBC,B-TE
-,O
10.4,O
RBC,B-TE
-,O
4.41,O
*#,O
HGB,B-TE
-,O
12.8,O
*#,O
HCT,B-TE
-,O
38.2,O
*#,O
MCV,B-TE
-,O
87,O
MCH,B-TE
-,O
29.0,O
MCHC,B-TE
-,O
33.5,O
RDW,B-TE
-,O
15.9,O
*,O

2015-06-29,O
9:55,O

NEUTS,B-TE
-,O
86.1,O
*,O
LYMPHS,B-TE
-,O
5.4,O
*,O
MONOS,B-TE
-,O
5.7,O
EOS,B-TE
-,O
2.2,O
BASOS,B-TE
-,O
0.6,O

2015-06-29,O
9:55,O

MICROCYT,B-TE
-,O
1+,O

2015-06-29,O
9:55,O

PLT,B-TE
COUNT,I-TE
-,O
372,O

2015-06-29,O
09:50,O
AM,O
URINE,B-TE

HOURS,O
-,O
RANDOM,O

2015-06-29,O
09:50,O
AM,O
URINE,B-TE

GR,O
HOLD,O
-,O
HOLD,O

2015-06-29,O
9:50,O

PT,B-TE
-,O
20.4,O
*,O
PTT,B-TE
-,O
28.6,O
INR,B-TE
(,I-TE
PT,I-TE
)-,I-TE
2.0,O
*,O

2015-06-29,O
09:50,O
AM,O
URINE,B-TE

COLOR,B-TE
-,O
Yellow,O
APPEAR,O
-,O
Clear,O
SP,B-TE
Dickson,I-TE
-,O
1.013,O

2015-06-29,O
09:50,O
AM,O
URINE,B-TE

BLOOD,B-TE
-,O
MOD,O
NITRITE,B-TE
-,O
NEG,O
PROTEIN,B-TE
-,O
NEG,O
GLUCOSE,B-TE
-,O
NEG,O
KETONE,B-TE
-,O
NEG,O
BILIRUBIN,B-TE
-,O
NEG,O
UROBILNGN,B-TE
-,O
NEG,O
PH,B-TE
-,O
6.0,O
LEUK,O
-,O
NEG,O

2015-06-29,O
09:50,O
AM,O
URINE,B-TE

RBC,B-TE
-,O
05-03,O
*,O
WBC,B-TE
-,O
0,O
BACTERIA,B-TE
-,O
NONE,O
YEAST,B-TE
-,O
NONE,O
EPI,B-TE
-<,O
1,O

CXR,B-TE
-,O
Increased,B-PR
right,I-PR
pleural,I-PR
effusion,I-PR
and,O
partial,B-PR
collapse,I-PR
of,I-PR
the,I-PR
right,I-PR
upper,I-PR
lung,I-PR
.,O

EKG,B-TE
-,O
NSR,O
70,O
",",O
nl,O
axis,O
",",O
nl,O
int,O
",",O
old,B-PR
TWI,I-PR
III,I-PR
",",O
F,O
;,O
old,B-PR
J,I-PR
pointing,I-PR
V,I-PR
04-04,O

07-03,O
CT,B-TE

CT,B-TE
CHEST,I-TE
:,O

The,O
heart,O
",",O
pericardium,O
",",O
and,O
great,O
vessels,O
are,O
stable,O
.,O

There,O
is,O
a,O
small,O
amount,O
of,O
pericardial,B-PR
fluid,I-PR
.,O

No,O
definite,B-PR
axillary,I-PR
",",I-PR
mediastinal,I-PR
",",I-PR
or,I-PR
hilar,I-PR
lymphadenopathy,I-PR
is,O
seen,O
.,O

Again,O
seen,O
is,O
a,B-PR
moderate,I-PR
-,I-PR
to,I-PR
large,I-PR
-,I-PR
sized,I-PR
right,I-PR
pleural,I-PR
effusion,I-PR
.,O

There,O
has,O
been,O
interval,O
development,O
of,O
moderate,O
amount,O
of,O
high-attenuation,B-PR
fluid,I-PR
within,O
the,B-PR
effusion,I-PR
consistent,O
with,O
hemorrhage,B-PR
.,O

Patchy,B-PR
consolidation,I-PR
of,I-PR
the,I-PR
right,I-PR
lung,I-PR
is,O
stable,O
.,O

Hazy,B-PR
patchy,I-PR
opacities,I-PR
are,O
noted,O
in,O
the,O
left,O
lung,O
field,O
but,O
no,O
frank,B-PR
consolidation,I-PR
is,O
seen,O
.,O

CT,B-TE
ABDOMEN,I-TE
:,O

Within,O
the,O
limits,O
of,O
this,B-TE
non-contrast,I-TE
study,I-TE
",",O
the,O
liver,O
",",O
gallbladder,O
",",O
pancreas,O
",",O
spleen,O
",",O
adrenal,O
glands,O
",",O
kidneys,O
",",O
stomach,O
",",O
and,O
small,O
bowel,O
loops,O
are,O
within,O
normal,O
limits,O
.,O

There,O
is,O
colonic,B-PR
diverticulosis,I-PR
most,O
prominent,O
at,O
the,O
hepatic,O
flexure,O
.,O

There,O
is,O
no,O
free,B-PR
air,I-PR
or,O
free,B-PR
fluid,I-PR
.,O

No,O
mesenteric,B-PR
or,I-PR
retroperitoneal,I-PR
lymphadenopathy,I-PR
is,O
identified,O
.,O

An,B-TR
IVC,I-TR
filter,I-TR
is,O
seen,O
.,O

CT,B-TE
PELVIS,I-TE
:,O

The,O
bladder,O
is,O
unremarkable,O
.,O

The,O
patient,O
appears,O
to,O
be,O
status,O
post,O
prostatectomy,B-TR
.,O

The,O
rectum,O
is,O
unremarkable,O
.,O

There,O
is,O
no,O
free,B-PR
fluid,I-PR
and,O
no,O
pelvic,B-PR
or,I-PR
inguinal,I-PR
lymphadenopathy,I-PR
.,O

BONE,O
WINDOWS,O
:,O

A,B-PR
lytic,I-PR
area,I-PR
is,O
again,O
seen,O
in,O
the,O
L5,O
vertebral,O
body,O
but,O
unchanged,O
from,O
prior,B-TE
examination,I-TE
.,O

Several,B-PR
subacute,I-PR
or,I-PR
chronic,I-PR
rib,I-PR
fractures,I-PR
are,O
identified,O
on,O
the,O
right,O
.,O

IMPRESSION,O
:,O

1.,O
Interval,O
development,O
of,O
a,O
moderate,O
amount,O
of,O
hemorrhage,B-PR
within,O
the,B-PR
right,I-PR
pleural,I-PR
effusion,I-PR
.,O

2.,O
No,O
acute,B-PR
intra-abdominal,I-PR
abnormalities,I-PR
identified,O
.,O

07-01,O
Stress,B-TE
MIBI,I-TE

New,B-PR
moderate,I-PR
and,I-PR
fixed,I-PR
inferior,I-PR
myocardial,I-PR
wall,I-PR
perfusion,I-PR
defect,I-PR
.,O

Mild,B-PR
inferior,I-PR
wall,I-PR
hypokinesis,I-PR
.,O

Calculated,B-TE
LVEF,I-TE
42%,O
.,O

Brief,O
Hospital,O
Course,O
:,O

A/P,O
74,O
yo,O
M,O
with,O
lung,B-PR
cancer,I-PR
",",O
DVT,B-PR
",",O
CAD,B-PR
s/p,O
MI,B-PR
presents,O
with,O
chest,B-PR
pain,I-PR
shortness,B-PR
of,I-PR
breath,I-PR
.,O

#,O
Chest,B-PR
Pain,I-PR
/,O
Ischemia,B-PR
-,O
Patient,O
with,O
history,O
of,O
CAD,B-PR
a/p,O
MI,B-PR
.,O

Now,O
with,O
an,O
episode,O
of,O
pain,B-PR
consistent,O
with,O
his,B-PR
anginal,I-PR
equivalent,I-PR
.,O

No,O
changes,B-PR
on,O
EKG,B-TE
but,O
not,O
in,O
pain,B-PR
at,O
time,O
of,O
EKG,B-TE
.,O

Patient,O
was,O
ruled,O
out,O
by,O
enzymes,B-TE
.,O

He,O
also,O
had,O
a,B-TE
stress,I-TE
test,I-TE
which,O
revealed,O
an,B-PR
irreversible,I-PR
deficit,I-PR
from,O
his,B-PR
prior,I-PR
known,I-PR
IMI,I-PR
.,O

Continued,O
on,O
asa,B-TR
",",O
bblocker,B-TR
",",O
Hicks,B-TR
",",O
statin,B-TR
",",O
plavix,B-TR
.,O

BP,B-TR
meds,I-TR
held,O
while,O
was,O
unstable,B-PR
.,O

ASA,B-TR
",",O
plavix,B-TR
held,O
during,O
hemothorax,B-PR
.,O

#,O
CHF,B-PR
-,O
patient,O
does,O
not,O
seem,O
volume,B-PR
overloaded,I-PR
at,O
this,O
time,O
.,O

He,O
has,O
no,O
JVD,B-PR
",",O
no,O
edema,B-PR
in,I-PR
legs,I-PR
(,O
other,O
than,O
swelling,B-PR
from,O
DVT,B-PR
),O
.,O

Last,B-TE
Echo,I-TE
with,O
EF,B-TE
55%,O
.,O

Does,O
have,O
increased,B-PR
effusion,I-PR
although,O
loculated,O
.,O

Continued,O
on,O
lasix,B-TR
",",O
bblocker,B-TR
Robertson,O
.,O

BP,B-TR
meds,I-TR
held,O
while,O
unstable,B-PR
.,O

#,O
Afib,B-PR
-,O
In,O
sinus,O
during,O
admission,O
.,O

Patients,B-TR
anticoag,I-TR
held,O
during,O
hemothorax,B-PR
.,O

#,O
Shortness,B-PR
of,I-PR
Breath,I-PR
/,O
loculated,B-PR
Effusion,I-PR
-,O
patient,O
with,O
increaing,B-PR
loculated,I-PR
pleural,I-PR
effusion,I-PR
.,O

Has,O
chronic,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
which,O
has,O
worsened,O
over,O
the,O
past,O
few,O
days,O
.,O

No,O
sign,O
of,O
infeciton,B-PR
at,O
this,O
time,O
.,O

Had,O
thoracentesis,B-TE
by,O
interventional,O
pumonology,O
on,O
2015-07-01,O
revealing,O
almost,O
2,O
L,O
of,O
serous,B-PR
exudative,I-PR
fluid,I-PR
.,O

Patient,O
had,O
improved,O
breathing,O
.,O

Cytology,B-TE
was,O
negative,O
.,O

However,O
on,O
07-02,O
Hct,B-TE
dropped,O
.,O

CT,B-TE
revealed,O
hemothorax,B-PR
.,O

All,B-TR
anticoagulation,I-TR
stopped,O
despite,O
the,O
risk,O
of,O
DVT,B-PR
",",O
afib,B-PR
.,O

Risk,O
discussed,O
with,O
family,O
.,O

Thoracics,O
consulted,O
and,O
chest,B-TR
tube,I-TR
placed,O
.,O

Frank,B-PR
blood,I-PR
was,O
taken,O
out,O
.,O

Patient,O
continued,O
to,O
bleed,O
in,O
and,O
around,O
the,B-TR
tube,I-TR
.,O

Patient,O
sent,O
to,O
CMED,O
for,O
observation,B-TE
after,O
Hct,B-TE
continued,O
to,O
drop,O
.,O

Patient,O
spontaneously,O
stablized,O
and,O
output,B-TE
of,O
CT,B-TE
became,O
more,O
serous,O
.,O

Output,B-TE
resent,O
for,O
cytology,B-TE
which,O
was,O
pending,O
at,O
time,O
of,O
discharge,O
.,O

When,O
output,B-TE
became,O
<,O
100,O
cc,O
the,B-TR
tube,I-TR
was,O
removed,O
.,O

Patient,O
follwed,O
with,O
serial,B-TE
CXR,I-TE
that,O
did,O
not,O
demonstrate,O
reaccumulation,B-PR
.,O

Hct,B-TE
also,O
remained,O
stable,O
.,O

#,O
DVT,B-PR
-,O
patient,O
therapeutic,O
on,O
heparin,B-TR
.,O

Improving,O
clots,B-PR
on,O
LENI,B-TR
.,O

CTA,B-TE
neg,O
for,O
PE,B-PR
.,O

Anticoagulaiton,B-TR
held,O
during,O
hemothorax,B-PR
.,O

Patient,O
restarted,O
on,O
coumadin,B-TR
and,O
will,O
be,O
discharged,O
on,O
3mg,O
coumadin,B-TR
qday,O
.,O

#,O
Lung,B-PR
Cancer,I-PR
-,O
patient,O
currently,O
with,O
no,O
evidence,O
of,O
disease,B-PR
.,O

s/p,O
neoadjuvant,B-TR
chemo/XRT,I-TR
now,O
s/p,O
surgery,B-TR
.,O

1st,B-TE
cytology,I-TE
negative,O
.,O

2ng,B-TE
cytology,I-TE
pending,O
.,O

WIll,O
follow,O
up,O
tih,O
outpatient,O
oncologist,O
.,O

Contacts,O
-,O
son,O
506-1596,O

Medications,O
on,O
Admission,O
:,O

Lipitor,B-TR
80,O
mg,O
qday,O

Asa,B-TR
81,O
mg,O
qday,O

bowel,B-TR
reg,I-TR

percocet,B-TR
prn,O

plavix,B-TR
75,O
mg,O
qday,O

losartan,B-TR
25,O
mg,O
qday,O

coumadin,B-TR
3,O
mg,O
qday,O

lasix,B-TR
20,O
mg,O
qday,O

atenolol,B-TR
25,O
mg,O
qday,O

Discharge,O
Medications,O
:,O

1.,O
Atorvastatin,B-TR
80,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

2.,O
Aspirin,B-TR
325,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

3.,O
Senna,B-TR
8.6,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
as,O
needed,O
for,O
constipation,B-PR
.,O

Disp,O
:*,O
30,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
0,O
*,O

4.,O
Bisacodyl,B-TR
5,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
DAILY,O
(,O
Daily,O
),O
as,O
needed,O
for,O
constipation,B-PR
.,O

Disp,O
:*,O
30,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
)(,O
s,O
)*,O
Refills,O
:*,O
0,O
*,O

5.,O
Oxycodone,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q4H,O
(,O
every,O
4,O
hours,O
),O
as,O
needed,O
.,O

Disp,O
:*,O
100,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
0,O
*,O

6.,O
Clopidogrel,B-TR
75,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

7.,O
Furosemide,B-TR
20,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

8.,O
Nitroglycerin,B-TR
0.3,O
mg,O
Tablet,O
",",O
Sublingual,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Sublingual,O
Sublingual,O
PRN,O
(,O
as,O
needed,O
),O
.,O

9.,O
Atenolol,B-TR
50,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
once,O
a,O
day,O
.,O

Disp,O
:*,O
30,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

10.,O
Losartan,B-TR
50,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

Disp,O
:*,O
30,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

11.,O
Benzonatate,B-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
as,O
needed,O
for,O
cough,B-PR
.,O

Disp,O
:*,O
60,O
Capsule,O
(,O
s,O
)*,O
Refills,O
:*,O
3,O
*,O

12.,O
Acetaminophen,B-TR
325,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
Q6H,O
(,O
every,O
6,O
hours,O
),O
as,O
needed,O
for,O
pain,B-PR
.,O

13.,O
Oxycodone,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q4H,O
(,O
every,O
4,O
hours,O
),O
as,O
needed,O
.,O

Disp,O
:*,O
50,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
0,O
*,O

14.,O
Codeine,B-TR
-,O
Guaifenesin,B-TR
10-100,O
mg,O
/,O
5,O
mL,O
Syrup,O
Sig,O
:,O
5-10,O
MLs,O
PO,O
Q6H,O
(,O
every,O
6,O
hours,O
),O
as,O
needed,O
.,O

Disp,O
:*QS,O
1,O
month,O
ML,O
(,O
s,O
)*,O
Refills,O
:*,O
0,O
*,O

15.,O
Coumadin,B-TR
3,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
once,O
a,O
day,O
.,O

Disp,O
:*,O
30,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

Discharge,O
Disposition,O
:,O

Home,O
with,O
Service,O

Discharge,O
Diagnosis,O
:,O

Angina,B-PR

Pleural,B-PR
Effusion,I-PR

Secondary,O

HTN,B-PR

Non,B-PR
small,I-PR
cell,I-PR
lung,I-PR
cancer,I-PR

CAD,B-PR

DVT,B-PR
h/o,O
afib,B-PR

Discharge,O
Condition,O
:,O
stable,O
",",O
eating,O
",",O
on,O
room,O
air,O

Discharge,O
Instructions,O
:,O

Please,O
take,O
all,B-TR
medications,I-TR
as,O
listed,O
in,O
the,O
discharge,O
paperwork,O
.,O

Please,O
make,O
all,O
appointments,O
listed,O
in,O
the,O
discharge,O
paperwork,O
.,O

If,O
you,O
have,O
chest,B-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
abdominal,B-PR
pain,I-PR
",",O
nausea,B-PR
or,O
other,B-PR
concerning,I-PR
symptoms,I-PR
please,O
call,O
your,O
MD,O
or,O
come,O
to,O
the,O
emergency,O
room,O
.,O

I,O
have,O
changed,O
some,O
of,O
your,B-TR
blood,I-TR
pressure,I-TR
meds,I-TR
.,O

Your,B-TR
atenolol,I-TR
has,O
increased,O
to,O
50,O
mg,O
a,O
day,O
.,O

Your,B-TR
losartan,I-TR
has,O
increased,O
to,O
50,O
mg,O
a,O
day,O
.,O

Followup,O
Instructions,O
:,O

Provider,O
:,O

Kathleen,O
Shirley,O
",",O
MD,O
Phone,O
:(,O
870,O
),O
559-0424,O

Date,O
/,O
Time,O
:,O
2015-08-06,O
9:00,O

You,O
should,O
call,O
Dr.,O
Worden,O
to,O
also,O
see,O
him,O
again,O
sooner,O
09-07,O
days,O
.,O

(,O
870,O
),O
559-0424,O
.,O

Please,O
see,O
Dr.,O
Holbrook,O
(,O
984,O
),O
452,O
0816,O
on,O
monday,O
and,O
have,O
your,B-TE
coumadin,I-TE
level,I-TE
checked,O
.,O

Merle,O
Shirley,O
MD,O
87-502,O

Completed,O
by,O
:,O
Nannie,O
Brenda,O
MD,O
13-326,O
2015-07-10,O
@,O
1534,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Shanta,O
PARKS,O
on,O
:,O
TUE,O
2015-07-14,O
9:08,O
AM,O

(,O
End,O
of,O
Report,O
),O

258418598,O

FIH,O

2044357,O

81841/8e23,O

715555,O

4/9/1992,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

04-09-92,O

DISCHARGE,O
DATE,O
:,O

04-20-92,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Mr.,O
Kacholera,O
Junk,O
was,O
a,O
34,O
year,O
old,O
gentleman,O
with,O
no,O
significant,O
past,O
medical,O
history,O
except,O
for,O
a,O
history,O
of,O
of,O
intravenous,O
drug,O
abuse,O
.,O

He,O
was,O
status,O
post,O
a,B-TR
rehabilitation,I-TR
hospitalization,I-TR
at,O
the,O
Raya,O
Ma,O
Den,O
Erinmarg,O
Hospital,O
with,O
a,O
recent,O
recrudescence,O
of,O
his,O
drug,O
abuse,O
.,O

He,O
was,O
admitted,O
to,O
the,O
Sephsandpot,O
Center,O
on,O
the,O
morning,O
of,O
4/9,O
and,O
was,O
subsequently,O
transferred,O
to,O
the,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
for,O
further,B-TR
care,I-TR
.,O

The,O
patient,O
was,O
apparently,O
well,O
until,O
one,O
day,O
prior,O
to,O
admission,O
.,O

His,O
family,O
reports,O
that,O
he,O
had,O
worked,O
that,O
day,O
.,O

He,O
relates,O
using,O
large,O
doses,O
of,O
Cocaine,O
and,O
Heroin,O
early,O
in,O
the,O
morning,O
on,O
the,O
day,O
of,O
admission,O
.,O

At,O
3:00,O
a.m.,O
on,O
the,O
day,O
of,O
admission,O
he,O
was,O
found,O
by,O
the,O
emergency,O
medical,O
technicians,O
&quot;,O
crawling,O
on,O
all,O
fours,O
&quot;,O
",",O
confused,B-PR
",",O
and,O
combative,B-PR
outside,O
his,O
home,O
.,O

He,O
gave,O
an,O
equivocal,O
history,O
of,O
fevers,B-PR
and,O
chills,B-PR
on,O
the,O
days,O
prior,O
to,O
admission,O
.,O

Bystanders,O
report,O
that,O
he,O
was,O
assaulted,O
about,O
20,O
minutes,O
earlier,O
and,O
the,O
nature,O
of,O
the,O
assault,O
was,O
not,O
known,O
.,O

He,O
was,O
taken,O
to,O
the,O
Sephsandpot,O
Center,O
where,O
he,O
was,O
hypotensive,B-PR
with,O
a,B-TE
blood,I-TE
pressure,I-TE
of,O
105/85,O
",",O
tachycardic,B-PR
with,O
a,B-TE
heart,I-TE
rate,I-TE
to,O
186,O
",",O
aneuric,B-PR
",",O
hyperthermic,B-PR
",",O
with,O
a,B-TE
temperature,I-TE
to,O
105,O
degrees,O
F,O
",",O
and,O
progressively,B-PR
more,I-PR
confused,I-PR
.,O

His,B-TE
chest,I-TE
x-ray,I-TE
was,O
clear,O
.,O

He,O
was,O
treated,O
with,O
Dopamine,B-TR
for,O
hypertension,B-PR
and,O
Inderal,B-TR
for,O
tachycardia,B-PR
.,O

He,O
received,O
two,O
amps,O
of,O
Narcan,B-TR
.,O

He,O
received,O
one,O
gram,O
of,O
Ceftriaxone,B-TR
intravenously,O
after,O
blood,B-TE
cultures,I-TE
were,O
drawn,O
.,O

His,B-TE
initial,I-TE
arterial,I-TE
blood,I-TE
gas,I-TE
at,O
the,O
Sephsandpot,O
Center,O
revealed,O
a,B-TE
p02,I-TE
of,O
76,O
",",O
pC02,B-TE
14,O
",",O
and,O
a,B-TE
pH,I-TE
of,O
7.44,O
on,O
room,O
air,O
.,O

He,O
was,O
then,O
transferred,O
via,O
Med,O
Flight,O
to,O
the,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
.,O

He,O
denied,O
any,O
history,O
of,O
recent,O
travel,O
.,O

Toxicology,B-TE
screen,I-TE
at,O
Sephsandpot,O
Center,O
revealed,O
Cocaine,O
and,O
Quinine,B-TR
.,O

Shortly,O
after,O
his,O
arrival,O
to,O
that,O
hospital,O
he,O
had,O
been,O
intubated,O
for,O
a,B-TE
respiratory,I-TE
rate,I-TE
of,O
60,O
.,O

He,O
required,O
medical,B-TR
paralysis,I-TR
for,O
this,O
.,O

He,O
was,O
reported,O
to,O
have,O
a,B-PR
seizure,I-PR
",",O
although,O
the,O
nature,O
of,O
this,O
was,O
unclear,O
",",O
and,O
received,O
Valium,B-TR
for,O
this,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

None,O
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

He,O
is,O
status,O
post,O
recent,B-TR
left,I-TR
knee,I-TR
surgery,I-TR
",",O
status,O
post,O
left,B-TR
carpal,I-TR
tunnel,I-TR
release,I-TR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

His,B-TR
meds,I-TR
on,O
transfer,O
to,O
FIH,O
were,O
Levophed,B-TR
",",O
Dopamine,B-TR
",",O
and,O
Ceftriaxone,B-TR
.,O

FAMILY,O
HISTORY,O
:,O

The,O
patient,O
is,O
divorced,O
with,O
no,O
children,O
.,O

His,O
mother,O
and,O
father,O
are,O
alive,O
and,O
well,O
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
works,O
as,O
a,O
welder,O
.,O

He,O
has,O
a,O
history,O
of,O
intravenous,O
drug,O
abuse,O
",",O
no,O
alcohol,O
abuse,O
or,O
tobacco,O
abuse,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Revealed,O
an,O
obtunded,O
white,O
muscular,O
man,O
who,O
was,O
intubated,B-TR
and,O
sedated,B-TR
.,O

The,B-TE
vital,I-TE
signs,I-TE
showed,O
a,B-TE
blood,I-TE
pressure,I-TE
of,O
69,O
",",O
pulse,B-TE
80,O
",",O
respirations,B-TE
14,O
",",O
and,O
temperature,B-TE
99.8,O
.,O

There,O
is,O
a,B-PR
contusion,I-PR
over,I-PR
the,I-PR
right,I-PR
eye,I-PR
but,O
no,O
laceration,B-PR
",",O
abrasion,B-PR
of,I-PR
her,I-PR
left,I-PR
shoulder,I-PR
",",O
no,O
flank,B-PR
discoloration,I-PR
",",O
blanching,B-PR
papules,I-PR
over,I-PR
the,I-PR
knees,I-PR
bilaterally,I-PR
without,O
central,B-PR
necrosis,I-PR
.,O

He,O
had,O
multiple,O
tattoos,O
.,O

Lymphatic-he,O
had,O
shotty,B-PR
cervical,I-PR
adenopathy,I-PR
.,O

The,B-TE
head,I-TE
",",I-TE
eyes,I-TE
",",I-TE
ears,I-TE
",",I-TE
nose,I-TE
",",I-TE
throat,I-TE
exam,I-TE
was,O
normocephalic,O
",",O
with,O
trauma,B-PR
as,O
described,O
",",O
pupils,O
were,O
2,O
mm,O
bilaterally,O
which,O
were,O
minimally,B-PR
reactive,I-PR
",",O
fundi,O
was,O
not,O
seen,O
",",O
conjunctivae,O
without,O
erythema,B-PR
",",O
sclerae,O
anicteric,B-PR
",",O
positive,O
corneal,B-TE
reflexes,I-TE
noted,O
.,O

Ears-the,O
tympanic,O
membranes,O
were,O
clear,O
with,O
no,O
hemorrhage,B-PR
at,O
the,O
time,O
of,O
admission,O
.,O

Nose-no,O
sinus,B-PR
discharge,I-PR
",",O
no,O
hemorrhage,B-PR
.,O

The,O
oropharynx,O
was,O
intubated,B-TR
.,O

Lungs-clear,O
with,O
good,O
air,O
movement,O
bilaterally,O
.,O

He,O
had,O
scattered,B-PR
wheezes,I-PR
following,O
a,B-TR
3,I-TR
liter,I-TR
bolus,I-TR
for,O
hypotension,B-PR
.,O

No,O
effusion,B-PR
or,O
rub,B-PR
was,O
heard,O
.,O

The,B-TE
cardiac,I-TE
exam,I-TE
showed,O
point,O
of,O
maximal,O
impulse,O
was,O
not,O
displaced,O
",",O
regular,O
rate,O
and,O
rhythm,O
with,O
normal,O
S1,O
",",O
S2,O
",",O
no,O
S3,B-PR
or,O
S4,B-PR
",",O
a,B-PR
grade,I-PR
II,I-PR
/,I-PR
VI,I-PR
systolic,I-PR
murmur,I-PR
was,O
heard,O
at,O
the,O
left,O
upper,O
sternal,O
border,O
without,O
radiation,B-PR
",",O
likely,O
representing,O
a,B-PR
flow,I-PR
murmur,I-PR
.,O

No,O
peripheral,B-PR
edema,I-PR
was,O
noted,O
.,O

The,B-TE
jugular,I-TE
venous,I-TE
pressure,I-TE
was,O
not,O
assessed,O
secondary,O
to,O
cervical,B-TR
collar,I-TR
being,O
in,O
place,O
.,O

The,B-TE
carotid,I-TE
pulses,I-TE
were,O
brisk,O
bilaterally,O
.,O

The,B-TE
vascular,I-TE
exam,I-TE
showed,O
normal,O
pulses,O
bilaterally,O
without,O
bruits,B-PR
.,O

The,O
abdomen,O
was,O
soft,O
",",O
bowel,O
sounds,O
of,O
normal,O
character,O
",",O
and,O
there,O
was,O
mild,B-PR
percussion,I-PR
tenderness,I-PR
and,O
tenderness,B-PR
to,O
modest,B-TE
palpation,I-TE
in,I-TE
all,I-TE
four,I-TE
quadrants,I-TE
.,O

It,O
was,O
unclear,O
whether,O
this,O
was,O
due,O
to,O
superficial,B-PR
tenderness,I-PR
or,O
abdominal,B-PR
tenderness,I-PR
.,O

He,O
had,O
marked,B-PR
voluntary,I-PR
guarding,I-PR
without,O
rigidity,B-PR
and,O
no,O
masses,B-PR
were,O
felt,O
.,O

The,B-TE
genitourinary,I-TE
exam,I-TE
showed,O
normal,O
penis,O
with,O
normal,O
testicles,O
which,O
were,O
nontender,B-PR
.,O

There,O
was,O
no,O
urethritis,B-PR
",",O
no,O
balinitis,B-PR
",",O
normal,O
prostate,O
",",O
nontender,B-PR
.,O

There,O
was,O
tan,B-PR
guaiac,I-PR
positive,I-PR
stool,I-PR
with,O
no,O
masses,B-PR
.,O

The,B-TE
musculoskeletal,I-TE
exam,I-TE
showed,O
well,O
developed,O
",",O
symmetrical,O
muscular,O
development,O
with,O
no,O
fasciculations,B-PR
",",O
no,O
joint,B-PR
erythema,I-PR
",",O
no,O
effusions,B-PR
.,O

Neuro,B-TE
exam-the,I-TE
Mental,B-TE
Status,I-TE
Exam,I-TE
was,O
variable,O
",",O
intermittently,B-PR
responsive,I-PR
",",O
unable,B-PR
to,O
follow,O
commands,B-TE
.,O

He,O
nods,O
appropriately,O
and,O
was,O
able,O
to,O
confirm,O
known,O
history,O
.,O

The,O
cranial,O
nerves,O
II-XII,O
grossly,O
intact,O
",",O
bilaterally,O
symmetric,O
.,O

The,B-TE
motor,I-TE
exam-moves,I-TE
all,O
four,O
extremities,O
easily,O
and,O
on,O
command,O
.,O

The,B-TE
sensory,I-TE
exam,I-TE
revealed,O
no,O
focal,B-PR
deficits,I-PR
to,O
limited,B-TE
exam,I-TE
.,O

Reflexes,B-TE
were,O
trace,O
in,O
the,O
upper,O
extremities,O
and,O
absent,B-PR
in,I-PR
the,I-PR
knees,I-PR
with,O
downgoing,O
toes,O
bilaterally,O
.,O

LABORATORY,O
DATA,O
:,O

On,O
admission,O
the,B-TE
sodium,I-TE
was,O
144,O
",",O
potassium,B-TE
2.6,O
",",O
chloride,B-TE
114,O
",",O
bicarbonate,B-TE
12.3,O
",",O
BUN,B-TE
30,O
",",O
creatinine,B-TE
4.0,O
",",O
glucose,B-TE
89,O
.,O

The,B-TE
SGOT,I-TE
was,O
994,O
",",O
LDH,B-TE
"1,888",O
",",O
alkaline,B-TE
phosphatase,I-TE
92,O
",",O
total,B-TE
bilirubin,I-TE
2.9,O
and,O
direct,B-TE
bilirubin,I-TE
11.2,O
.,O

Lactate,B-TE
was,O
6.3,O
",",O
acetone,B-TE
negative,O
",",O
ammonia,B-TE
26,O
",",O
uric,B-TE
acids,I-TE
26.9,O
",",O
albumin,B-TE
4.0,O
",",O
globulin,B-TE
3.0,O
",",O
amylase,B-TE
259,O
",",O
lipase,B-TE
34,O
",",O
magnesium,B-TE
3.5,O
",",O
phosphorus,B-TE
1.9,O
",",O
calcium,B-TE
9.4.,O
The,B-TE
white,I-TE
blood,I-TE
count,I-TE
was,O
19.7,O
with,O
89%,O
polys,B-TE
",",O
7%,O
bands,B-TE
",",O
4%,O
lymphs,B-TE
",",O
with,O
toxic,B-PR
granulations,I-PR
.,O

Hematocrit,B-TE
was,O
45.2,O
with,O
a,B-TE
platelet,I-TE
count,I-TE
of,O
"132,000",O
",",O
falling,O
rapidly,O
to,O
"24,000",O
.,O

The,B-TE
MCV,I-TE
is,O
88,O
.,O

The,B-TE
prothrombin,I-TE
time,I-TE
is,O
27.7,O
",",O
partial,B-TE
thromboplastin,I-TE
time,I-TE
is,O
greater,O
than,O
100,O
.,O

The,B-TE
urinalysis,I-TE
revealed,O
a,B-TE
specific,I-TE
gravity,I-TE
of,O
1.15,O
",",O
pH,B-TE
5.0,O
",",O
and,O
4+,B-PR
albumin,I-PR
",",O
positive,B-PR
occult,I-PR
blood,I-PR
",",O
with,O
0-5,B-PR
granular,I-PR
casts,I-PR
and,O
5-10,B-PR
RBCs,I-PR
and,O
3-5,B-PR
WBCs,I-PR
.,O

The,B-TE
CK,I-TE
was,O
"17,890",O
with,O
0.6%,O
MB,B-TE
.,O

The,B-TE
urine,I-TE
sodium,I-TE
was,O
147,O
.,O

The,B-TE
serum,I-TE
toxicology,I-TE
was,O
positive,B-PR
for,O
Cocaine,O
on,O
admission,O
to,O
the,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
as,O
well,O
as,O
the,O
Sephsandpot,O
Center,O
.,O

The,B-TE
electrocardiogram,I-TE
revealed,O
normal,O
sinus,O
rhythm,O
at,O
85,O
with,O
a,B-PR
prolonged,I-PR
QT,I-PR
at,O
0.572,O
.,O

An,B-TE
I-head,I-TE
CT,I-TE
revealed,O
left,O
sphenoid,O
and,O
left,B-PR
maxillary,I-PR
sinusitis,I-PR
with,O
mild,B-PR
cerebral,I-PR
edema,I-PR
and,O
no,O
focal,B-PR
hemorrhages,I-PR
.,O

The,B-TE
abdominal,I-TE
CT,I-TE
revealed,O
mesenteric,B-PR
adenopathy,I-PR
",",O
normal,O
bowels,O
",",O
hepatosplenomegaly,B-PR
",",O
and,O
?,O
fatty,B-PR
liver,I-PR
.,O

Chest,B-TE
x-ray,I-TE
revealed,O
early,B-PR
interstitial,I-PR
edema,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
with,O
the,O
diagnosis,O
of,O
Cocaine,B-PR
induced,I-PR
rhabdomyolysis,I-PR
",",O
renal,B-PR
failure,I-PR
",",O
disseminated,B-PR
intravascular,I-PR
coagulation,I-PR
",",O
shock,B-PR
",",O
hepatic,B-PR
failure,I-PR
",",O
pancreatitis,B-PR
",",O
and,O
thrombocytopenia,B-PR
in,O
the,O
setting,O
of,O
Cocaine,O
intoxication,O
.,O

He,O
was,O
accepted,O
at,O
the,O
Vo,O
Yd,O
Burgsygu,O
Hospital,O
Center,O
Intensive,O
Care,O
Unit,O
and,O
his,O
hospital,O
course,O
will,O
be,O
reviewed,O
by,O
problems,O
.,O

1-Rhabdomyolysis,B-PR
.,O

The,O
patient,O
had,O
massive,B-PR
Cocaine,I-PR
induced,I-PR
rhabdomyolysis,I-PR
.,O

This,O
resulted,O
in,O
tremendous,B-PR
third,I-PR
spacing,I-PR
of,I-PR
fluid,I-PR
and,O
persistent,B-PR
intervascular,I-PR
hypovolemia,I-PR
.,O

The,B-TE
patient,I-TE
&apos;s,I-TE
creatinine,I-TE
______________,I-TE
kinase,I-TE
peaked,O
at,O
"56,160",O
with,O
negative,O
MB,B-TE
percentages,I-TE
.,O

The,B-TE
aldolase,I-TE
was,O
positive,O
at,O
142,O
.,O

This,O
was,O
further,O
complicated,O
by,O
hypocalcemia,B-PR
which,O
resulted,O
in,O
mild,B-PR
electrocardiographic,I-PR
abnormalities,I-PR
.,O

The,O
patient,O
&apos;s,O
urine,O
was,O
alkalinized,B-TR
with,O
intravenous,B-TR
bicarbonate,I-TR
to,O
maximize,O
the,O
myoglobin,O
secretion,O
.,O

The,B-TE
patient,I-TE
&apos;s,I-TE
urine,I-TE
output,I-TE
was,O
further,O
augmented,O
by,O
adding,O
Dopamine,B-TR
.,O

Nevertheless,O
",",O
the,B-PR
patient,I-PR
&apos;s,I-PR
renal,I-PR
failure,I-PR
continued,O
to,O
progress,O
.,O

Over,O
the,O
course,O
of,O
the,O
hospitalization,O
his,B-TE
CK,I-TE
fell,O
in,O
the,O
serum,O
.,O

Much,O
of,O
his,B-PR
diffuse,I-PR
pain,I-PR
was,O
felt,O
to,O
be,O
due,O
to,O
this,B-PR
massive,I-PR
rhabdomyolysis,I-PR
.,O

2-Renal,B-PR
failure,I-PR
.,O

The,B-TE
creatinine,I-TE
was,O
4.4,O
on,O
admission,O
and,O
peaked,O
at,O
10.5,O
on,O
the,O
15th,O
.,O

The,B-TE
urinalysis,I-TE
revealed,O
4+,B-PR
albumin,I-PR
with,O
marked,B-PR
occult,I-PR
blood,I-PR
.,O

Peritoneal,B-TR
dialysis,I-TR
was,O
instituted,O
on,O
4/11,O
after,O
a,B-TR
Tenckhoff,I-TR
catheter,I-TR
was,O
placed,O
by,O
Drs.,O
Freierm,O
",",O
Le,O
",",O
and,O
Round,O
.,O

Subsequently,O
his,B-TE
creatinine,I-TE
rose,O
for,O
three,O
days,O
and,O
then,O
stabilized,O
at,O
10,O
.,O

He,O
continued,O
to,O
make,O
minimal,B-PR
urine,I-PR
throughout,O
the,O
hospitalization,O
.,O

3-Disseminated,B-PR
intravascular,I-PR
coagulation,I-PR
.,O

On,O
admission,O
the,B-TE
patient,I-TE
&apos;s,I-TE
prothrombin,I-TE
time,I-TE
was,O
27.7,O
with,O
a,B-TE
partial,I-TE
thromboplastin,I-TE
time,I-TE
of,O
greater,O
than,O
100,O
and,O
a,B-TE
d-dimer,I-TE
positive,O
at,O
8,O
with,O
a,B-TE
fibrinogen,I-TE
of,O
69,O
.,O

He,O
went,O
on,O
to,O
develop,O
profound,B-PR
thrombocytopenia,I-PR
complicated,O
by,O
hemorrhage,B-PR
.,O

The,O
patient,O
was,O
supported,O
with,O
abundant,O
use,O
of,O
fresh,B-TR
frozen,I-TR
plasma,I-TR
",",O
cryoprecipitate,B-TR
",",O
platelets,B-TR
",",O
and,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
.,O

His,B-PR
DIC,I-PR
was,O
further,O
complicated,O
by,O
hepatic,B-PR
failure,I-PR
which,O
resulted,O
in,O
poor,B-PR
endogenous,I-PR
production,I-PR
of,I-PR
clotting,I-PR
factors,I-PR
and,O
he,O
remained,O
fresh,B-PR
frozen,I-PR
plasma,I-PR
dependent,I-PR
.,O

4-Septic,B-PR
shock,I-PR
.,O

The,O
patient,O
remained,O
pressor,B-PR
dependent,I-PR
throughout,O
his,O
hospitalization,O
.,O

He,O
was,O
maintained,O
variously,O
on,O
Levophed,B-TR
",",O
Dobutamine,B-TR
",",O
Dopamine,B-TR
",",O
and,O
ultimately,O
Epinephrine,B-TR
for,O
blood,B-TR
pressure,I-TR
support,I-TR
.,O

Hemodynamic,B-TE
monitoring,I-TE
revealed,O
low,B-PR
systemic,I-PR
vascular,I-PR
resistance,I-PR
and,O
high,B-PR
cardiac,I-PR
output,I-PR
.,O

He,O
had,O
multiple,O
sources,O
of,O
infection,B-PR
including,O
his,O
sinuses,O
",",O
lungs,O
",",O
and,O
multiple,B-TR
lines,I-TR
.,O

This,O
will,O
be,O
discussed,O
below,O
.,O

Further,O
he,O
had,O
massive,B-PR
muscle,I-PR
necrosis,I-PR
and,O
hepatic,B-PR
failure,I-PR
.,O

An,B-TE
echocardiogram,I-TE
on,O
4/12,O
revealed,O
a,B-PR
dilated,I-PR
left,I-PR
ventricle,I-PR
which,O
was,O
diffusely,B-PR
mildly,I-PR
hypokinetic,I-PR
with,O
no,O
vegetations,B-PR
.,O

His,B-TE
ejection,I-TE
fraction,I-TE
was,O
55%,O
.,O

On,O
4/16,O
the,B-TE
pulmonary,I-TE
artery,I-TE
catheter,I-TE
was,O
placed,O
which,O
revealed,O
a,B-TE
wedge,I-TE
pressure,I-TE
of,O
8,O
",",O
cardiac,B-TE
index,I-TE
of,O
4.5,O
",",O
and,O
an,B-TE
SVR,I-TE
of,O
5.8,O
.,O

5-Hepatic,B-PR
failure,I-PR
.,O

His,B-TE
SGPT,I-TE
on,O
admission,O
was,O
"2,520",O
with,O
a,O
peak,O
at,O
"7,680",O
on,O
hospital,O
day,O
two,O
.,O

He,O
had,O
complete,B-PR
loss,I-PR
of,I-PR
synthetic,I-PR
and,I-PR
conjugation,I-PR
function,I-PR
of,O
the,O
liver,O
with,O
rising,B-PR
bilirubin,I-PR
and,O
falling,B-PR
albumin,I-PR
with,O
dependence,B-PR
on,I-PR
transfusion,I-PR
for,O
support,O
of,O
his,B-TE
prothrombin,I-TE
time,I-TE
.,O

He,O
was,O
seen,O
in,O
consultation,O
by,O
the,O
GI,O
Service,O
and,O
the,O
Liver,O
Transplantation,O
Service,O
.,O

Given,O
his,B-PR
multiple,I-PR
other,I-PR
medical,I-PR
problems,I-PR
",",O
the,O
direness,O
of,O
his,O
situation,O
",",O
and,O
his,O
ongoing,O
substance,O
abuse,O
at,O
the,O
time,O
of,O
admission,O
he,O
was,O
deemed,O
not,O
to,O
be,O
a,O
candidate,O
for,O
a,B-TR
liver,I-TR
transplantation,I-TR
.,O

6-Cocaine,O
intoxication,O
.,O

Serum,B-TE
Cocaine,I-TE
was,O
positive,B-PR
6-12,O
hours,O
ingestion,O
at,O
the,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
.,O

Further,O
",",O
at,O
Ceanotsit,O
Ortgold,O
Center,O
his,B-TE
serum,I-TE
toxicology,I-TE
screens,I-TE
were,O
positive,B-PR
.,O

This,O
is,O
thought,O
to,O
be,O
the,O
insighting,O
cause,O
of,O
his,B-PR
massive,I-PR
rhabdomyolysis,I-PR
and,O
hepatic,B-PR
failure,I-PR
.,O

7-Pneumonia,B-PR
.,O

The,O
patient,O
developed,O
two,B-PR
pneumonias,I-PR
with,O
two,B-PR
separate,I-PR
organisms,I-PR
.,O

The,O
first,O
was,O
Acinetobacter,B-PR
calcoaceticus,I-PR
subspecies,I-PR
anitratus,I-PR
",",O
treated,O
with,O
Ciprofloxacin,B-TR
and,O
Gentamicin,B-TR
.,O

He,O
subsequently,O
developed,O
a,B-PR
staphylococcus,I-PR
aureus,I-PR
pneumonia,I-PR
which,O
was,O
treated,O
with,O
Vancomycin,B-TR
",",O
dosed,O
to,O
levels,O
appropriate,O
for,O
his,B-PR
renal,I-PR
failure,I-PR
.,O

He,O
was,O
seen,O
in,O
consultation,O
by,O
the,O
Infectious,O
Disease,O
Service,O
who,O
advised,O
us,O
on,O
antibiotic,B-TR
choices,I-TR
daily,O
.,O

8-Pancreatitis,B-PR
.,O

The,B-TE
amylase,I-TE
on,O
admission,O
was,O
279,O
with,O
a,B-TE
lipase,I-TE
of,O
161,O
.,O

Although,O
not,O
fully,O
this,O
may,O
have,O
contributed,O
to,O
his,B-PR
hypocalcemia,I-PR
and,O
volume,B-PR
requirements,I-PR
.,O

9-Catheter,B-PR
tip,I-PR
infections,I-PR
.,O

The,O
patient,O
grew,O
out,O
coagulase,B-PR
negative,I-PR
staphylococcus,I-PR
from,O
the,B-TR
femoral,I-TR
lines,I-TR
which,O
were,O
placed,O
during,O
his,B-PR
profound,I-PR
hypertension,I-PR
.,O

These,O
were,O
treated,O
with,O
Vancomycin,B-TR
.,O

10-Anemia,B-PR
.,O

The,B-TE
patient,I-TE
&apos;s,I-TE
hematocrit,I-TE
was,O
33%,O
on,O
admission,O
and,O
fell,O
to,O
28,O
requiring,O
4,O
units,O
of,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
over,O
the,O
course,O
of,O
his,O
hospitalization,O
.,O

11-Coma,B-PR
.,O

The,O
patient,O
",",O
although,O
initially,O
minimally,B-PR
responsive,I-PR
",",O
went,O
on,O
to,O
develop,O
a,B-PR
deep,I-PR
comatose,I-PR
state,I-PR
.,O

A,B-TE
CT,I-TE
scan,I-TE
on,O
admission,O
revealed,O
no,O
evidence,O
of,O
hemorrhage,B-PR
though,O
he,O
did,O
have,O
sphenoid,B-PR
sinusitis,I-PR
.,O

The,B-TE
lumbar,I-TE
puncture,I-TE
and,O
sinus,B-TE
exploration,I-TE
were,O
unable,O
to,O
be,O
performed,O
given,O
the,B-PR
patient,I-PR
&apos;s,I-PR
persistent,I-PR
coagulopathy,I-PR
.,O

The,O
patient,O
was,O
treated,O
empirically,O
with,O
Nafcillin,B-TR
and,O
Ceftriaxone,B-TR
for,O
meningitis,B-PR
and,O
sinusitis,B-PR
.,O

Further,O
complicating,O
this,O
was,O
his,B-PR
profound,I-PR
liver,I-PR
failure,I-PR
with,O
rising,B-PR
ammonias,I-PR
and,O
hepatic,B-PR
encephalopathy,I-PR
.,O

Despite,O
maximal,B-TR
supports,I-TR
the,O
patient,O
continued,O
to,O
be,O
hypotensive,B-PR
.,O

Mid-way,O
through,O
his,O
hospital,O
course,O
he,O
developed,O
trilobar,B-PR
pneumonia,I-PR
and,O
this,O
was,O
probably,O
complicated,O
further,O
by,O
adult,B-PR
respiratory,I-PR
distress,I-PR
syndrome,I-PR
and,O
the,B-PR
multi-organ,I-PR
system,I-PR
failure,I-PR
syndrome,I-PR
.,O

The,O
patient,O
remained,O
mechanically,B-TR
ventilated,I-TR
throughout,O
his,O
hospitalization,O
.,O

Nevertheless,O
",",O
he,O
developed,O
refractory,B-PR
hypoxemia,I-PR
",",O
hypotension,B-PR
",",O
and,O
ultimately,O
the,O
patient,O
died,O
despite,O
total,B-TR
life,I-TR
support,I-TR
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

Cocaine,O
intoxication,O
",",O
rhabdomyolysis,B-PR
",",O
renal,B-PR
failure,I-PR
",",O
disseminated,B-PR
intravascular,I-PR
coagulation,I-PR
",",O
septic,B-PR
shock,I-PR
",",O
hepatic,B-PR
failure,I-PR
",",O
pneumonia,B-PR
",",O
pancreatitis,B-PR
",",O
catheter,B-PR
tip,I-PR
infection,I-PR
",",O
anemia,B-PR
",",O
coma,B-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

Peritoneal,B-TR
dialysis,I-TR
catheter,I-TR
placement,I-TR
",",O
peritoneal,B-TR
dialysis,I-TR
",",O
arterial,B-TR
catheterization,I-TR
",",O
venous,B-TR
catheterization,I-TR
",",O
continuous,B-TR
mechanical,I-TR
ventilation,I-TR
",",O
and,O
parenteral,B-TR
nutrition,I-TR
.,O

COMPLICATIONS,O
DURING,O
ADMISSION,O
:,O

Neck,B-PR
hematoma,I-PR
secondary,O
to,O
pulmonary,B-TR
artery,I-TR
line,I-TR
placement,I-TR
requiring,O
transfusion,B-TR
",",O
catheter,B-PR
tip,I-PR
infection,I-PR
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

None,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

The,O
patient,O
was,O
discharged,O
to,O
Samfer,O
Street,O
with,O
no,O
autopsy,O
.,O

LENNI,O
HEAD,O
",",O
M.D.,O

TR,O
:,O

be,O
/,O
bmot,O

DD,O
:,O

09-05-92,O

TD,O
:,O

09/07/92,O

CC,O
:,O

Admission,O
Date,O
:,O

2010-03-11,O

Discharge,O
Date,O
:,O

2010-03-28,O

Date,O
of,O
Birth,O
:,O

1946-10-26,O

Sex,O
:,O

M,O

Service:,O

ADMISSION,O
DIAGNOSIS:,O

1.,O
Unstable,B-PR
angina,I-PR
.,O

2.,O
Non-ST,B-PR
elevation,I-PR
myocardial,I-PR
infarction,I-PR
.,O

3.,O
Atrial,B-PR
fibrillation,I-PR
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

1.,O
Persistent,B-PR
atrial,I-PR
fibrillation,I-PR
.,O

2.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
.,O

3.,O
Coronary,B-TR
artery,I-TR
bypass,I-TR
grafting,I-TR
times,O
two,O
.,O

HISTORY,O
OF,O
THE,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
63,O
-,O
year-old,O
man,O
with,O
a,O
history,O
of,O
hypertension,B-PR
and,O
prior,O
history,O
of,O
atrial,B-PR
fibrillation,I-PR
secondary,O
to,O
hyperthyroidism,B-PR
who,O
presented,O
to,O
an,O
outside,O
hospital,O
with,O
a,O
history,O
of,O
left-sided,B-PR
chest,I-PR
pain,I-PR
at,O
rest,O
.,O

The,O
patient,O
awoke,O
with,O
chest,B-PR
pressure,I-PR
radiating,O
to,O
the,O
right,O
chest,O
associated,O
with,O
diaphoresis,B-PR
.,O

The,O
patient,O
was,O
found,O
to,O
have,O
a,B-TE
blood,I-TE
pressure,I-TE
of,O
170/108,O
with,O
atrial,B-PR
fibrillation,I-PR
and,O
rapid,B-PR
ventricular,I-PR
response,I-PR
to,O
a,B-TE
heart,I-TE
rate,I-TE
of,O
140s,O
.,O

The,O
patient,O
was,O
rate,O
controlled,O
and,O
transferred,O
to,O
the,O
Stillman,O
Infirmary,O
for,O
emergent,B-TE
cardiac,I-TE
catheterization,I-TE
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Atrial,B-PR
fibrillation,I-PR
secondary,O
to,O
hyperthyroidism,B-PR
",",O
initially,O
diagnosed,O
in,O
2005,O
.,O

2.,O
Status,O
post,O
current,O
cardioversion,B-TR
times,O
four,O
.,O

3.,O
Hyperthyroidism,B-PR
",",O
status,O
post,O
radioactive,B-TR
iodine,I-TR
ablation,I-TR
.,O

4.,O
Status,O
post,O
carpal,B-TR
tunnel,I-TR
release,I-TR
.,O

5.,O
Status,O
post,O
umbilical,B-TR
hernia,I-TR
repair,I-TR
.,O

6.,O
Hypertension,B-PR
.,O

MEDICATIONS,O
AT,O
HOME,O
:,O

1.,O
Accupril,B-TR
40,O
mg,O
q.d.,O

2.,O
Aspirin,B-TR
325,O
mg,O
q.d.,O

3.,O
Clonidine,B-TR
0.1,O
mg,O
b.i.d.,O

PHYSICAL,O
EXAMINATION,O
ON,O
ADMISSION,O
:,O

General,O
:,O

The,O
patient,O
was,O
in,O
no,O
acute,B-PR
distress,I-PR
",",O
well,O
developed,O
.,O

Vital,O
signs,O
:,O

Stable,O
",",O
afebrile,B-PR
.,O

HEENT,O
:,O

Normocephalic,O
",",O
atraumatic,B-PR
.,O

PERRL,O
",",O
anicteric,B-PR
",",O
EOMI,O
.,O

The,O
throat,O
was,O
clear,O
.,O

Neck,O
:,O

Supple,O
",",O
midline,O
",",O
without,O
masses,B-PR
or,O
lymphadenopathy,B-PR
.,O

No,O
bruit,B-PR
or,O
JVD,B-PR
.,O

Cardiovascular,O
:,O

Irregularly,B-PR
/,I-PR
irregular,I-PR
without,O
murmurs,B-PR
",",O
rubs,B-PR
",",O
or,O
gallops,B-PR
.,O

Chest,O
:,O

Clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

Abdomen,O
:,O

Soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
",",O
without,O
masses,B-PR
or,O
organomegaly,B-PR
.,O

Extremities,O
:,O

Warm,O
",",O
noncyanotic,B-PR
",",O
nonedematous,B-PR
times,O
four,O
.,O

Neurological,O
:,O

Grossly,O
intact,O
.,O

ADMISSION,O
LABORATORY,O
DATA,O
:,O

CBC,B-TE
11.3,O
/,O
15.7,O
/,O
44.6,O
/,O
183,O
.,O

PT,B-TE
14,O
",",O
INR,B-TE
1.3,O
",",O
PTT,B-TE
115,O
.,O

Chemistries,B-TE
:,O

137,O
/,O
4.3,O
/,O
104,O
/,O
22,O
/,O
14,O
/,O
0.7,O
/,O
155,O
.,O

ALT,B-TE
27,O
",",O
AST,B-TE
21,O
",",O
alkaline,B-TE
phosphatase,I-TE
72,O
",",O
total,B-TE
bilirubin,I-TE
1.2,O
",",O
amylase,B-TE
47,O
.,O

The,B-TE
U/A,I-TE
was,O
negative,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
transferred,O
for,O
cardiac,B-TE
catheterization,I-TE
.,O

Emergent,B-TE
cardiac,I-TE
catheterization,I-TE
revealed,O
an,B-TE
ejection,I-TE
fraction,I-TE
of,O
45%,O
",",O
right,B-PR
dominant,I-PR
coronary,I-PR
artery,I-PR
system,I-PR
with,O
occlusive,B-PR
single,I-PR
vessel,I-PR
disease,I-PR
of,I-PR
the,I-PR
LAD,I-PR
.,O

Multiple,B-TR
wires,I-TR
were,O
used,O
to,O
attempt,O
to,O
cross,O
the,B-PR
total,I-PR
occlusion,I-PR
",",O
but,O
were,O
ultimately,O
unsuccessful,O
.,O

The,O
patient,O
was,O
continued,O
on,O
a,B-TR
heparin,I-TR
drip,I-TR
for,O
atrial,B-PR
fibrillation,I-PR
.,O

Cardiothoracic,O
Surgery,O
consultation,O
was,O
obtained,O
and,O
the,O
patient,O
was,O
taken,O
to,O
the,O
Operating,O
Room,O
on,O
2010-03-12,O
for,O
coronary,B-TR
artery,I-TR
bypass,I-TR
grafting,I-TR
times,O
two,O
;,O
LIMA,O
to,O
the,O
LAD,O
",",O
saphenous,B-TR
vein,I-TR
graft,I-TR
to,I-TR
the,I-TR
diagonal,I-TR
artery,I-TR
.,O

Subsequent,O
to,O
this,O
",",O
the,O
patient,O
was,O
transferred,O
to,O
the,O
CRSU,O
for,O
closer,O
monitoring,O
.,O

He,O
was,O
deemed,O
to,O
be,O
too,B-PR
lethargic,I-PR
and,O
sleepy,B-PR
to,O
be,O
extubated,O
on,O
postoperative,O
day,O
number,O
zero,O
.,O

The,O
patient,O
was,O
extubated,O
early,O
on,O
postoperative,O
day,O
number,O
one,O
without,O
significant,B-PR
complication,I-PR
.,O

He,O
remained,O
in,O
atrial,B-PR
fibrillation,I-PR
.,O

The,O
EP,O
Service,O
was,O
consulted,O
regarding,O
the,B-PR
patient,I-PR
's,I-PR
atrial,I-PR
fibrillation,I-PR
.,O

This,O
was,O
his,B-PR
main,I-PR
issue,I-PR
in,O
the,O
postoperative,O
course,O
.,O

He,O
was,O
attempted,O
on,O
multiple,B-TR
different,I-TR
drugs,I-TR
including,O
Procainamide,B-TR
",",O
Diltiazem,B-TR
",",O
Esmolol,B-TR
",",O
Sotalol,B-TR
",",O
Amiodarone,B-TR
.,O

The,O
patient,O
was,O
kept,O
therapeutically,B-TR
anticoagulated,I-TR
throughout,O
this,O
period,O
.,O

The,O
patient,O
was,O
also,O
started,O
on,O
digoxin,B-TR
.,O

Ultimately,O
",",O
the,O
patient,O
was,O
transferred,O
to,O
the,O
floor,O
and,O
anticoagulation,B-TR
with,O
Coumadin,B-TR
was,O
begun,O
.,O

The,O
patient,O
arrived,O
on,O
the,O
floor,O
with,O
medications,B-TR
as,O
follows,O
:,O

Sotalol,B-TR
180,O
mg,O
b.i.d.,O
",",O
Diltiazem,B-TR
90,O
mg,O
q.i.d.,O
",",O
digoxin,B-TR
0.125,O
mg,O
q.d.,O

While,O
the,O
patient,O
was,O
awaiting,O
therapeutic,B-TR
anticoagulation,I-TR
with,O
Coumadin,B-TR
",",O
he,O
spontaneously,O
converted,O
into,O
normal,O
sinus,O
rhythm,O
.,O

The,O
patient,O
was,O
found,O
to,O
have,O
a,B-TE
resting,I-TE
heart,I-TE
rate,I-TE
of,O
approximately,O
50,O
subsequent,O
to,O
this,O
.,O

In,O
consultation,O
with,O
the,O
EP,O
Service,O
",",O
Diltiazem,B-TR
was,O
stopped,O
.,O

After,O
approximately,O
24,O
hours,O
",",O
the,O
patient,O
converted,O
back,O
into,O
atrial,B-PR
fibrillation,I-PR
and,O
Diltiazem,B-TR
was,O
restarted,O
at,O
60,O
mg,O
q.i.d.,O

The,O
patient,O
then,O
had,O
one,B-PR
more,I-PR
episode,I-PR
where,O
he,O
was,O
converted,O
to,O
normal,O
sinus,O
rhythm,O
but,O
this,O
lasted,O
only,O
a,O
few,O
hours,O
before,O
reverting,O
back,O
to,O
atrial,B-PR
fibrillation,I-PR
.,O

The,O
patient,O
was,O
ultimately,O
discharged,O
on,O
postoperative,O
day,O
number,O
16,O
",",O
tolerating,O
a,O
regular,O
diet,O
",",O
and,O
adequate,O
pain,O
control,O
on,O
p.o.,B-TR
pain,I-TR
medications,I-TR
",",O
having,O
no,O
anginal,B-PR
symptoms,I-PR
and,O
with,O
an,B-TE
INR,I-TE
of,O
2.0,O
.,O

The,O
patient,O
failed,O
multiple,O
attempts,O
at,O
cardioversion,B-TR
.,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O
.,O

INR,B-TE
2.0.,O

DISPOSITION,O
:,O

To,O
home,O
.,O

DIET,O
:,O

Cardiac,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Percocet,B-TR
5/325,O
mg,O
one,O
to,O
two,O
q.,O
four,O
hours,O
p.r.n.,O

2.,O
Aspirin,B-TR
325,O
mg,O
q.d.,O

3.,O
Colace,B-TR
100,O
mg,O
b.i.d.,O

4.,O
Coumadin,B-TR
5,O
mg,O
q.d.,O

5.,O
Sotalol,B-TR
180,O
mg,O
b.i.d.,O

6.,O
Digoxin,B-TR
0.125,O
mg,O
q.d.,O

7.,O
Diltiazem,B-TR
60,O
mg,O
q.i.d.,O

8.,O
Ambien,B-TR
5-10,O
mg,O
q.h.s.,O
p.r.n.,O

DISCHARGE,O
INSTRUCTIONS,O
:,O

The,O
patient,O
should,O
follow-up,O
with,O
his,O
cardiologist,O
in,O
one,O
to,O
two,O
weeks,O
.,O

He,O
will,O
also,O
go,O
home,O
with,O
VNA,O
for,O
INRs,B-TE
twice,O
weekly,O
with,O
the,O
results,O
reported,O
to,O
his,O
PCP,O
or,O
cardiologist,O
for,O
Coumadin,B-TR
adjustment,I-TR
.,O

The,O
patient,O
should,O
follow-up,O
with,O
Dr.,O
Halcomb,O
in,O
six,O
weeks,O
time,O
.,O

Octavia,O
W.,O
Levitre,O
",",O
M.D.,O
05-383,O

Dictated,O
By,O
:,O
James,O
Q.,O
Mitchell,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2010-03-28,O
10:15,O

T,O
:,O
2010-03-28,O
10:46,O

JOB,O
#,O
:,O
41466,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Janice,O
Carpenter,O
on,O
:,O
Andrea,O
2010-04-01,O
8:20,O
AM,O

(,O
End,O
of,O
Report,O
),O

260257442,O
DH,O

145802,O

292408,O

9739205,O

2/11/2003,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O
/,O
SUMMARY,O

DUHETLAND,O
",",O
RIE,O

MRN,O
:,O

145802,O

Age,O
:,O

29y,O

REGISTRATION,O
DATE,O
:,O

02/11/2003,O
02:42,O
PM,O

Provider,O
:,O

AMINE,O
GUAYTREFTSCOST,O

PRELIMINARY,O
REPORT,O

PCP,O
notified,O
by,O
MD,O
:,O

Yes,O
-,O
Direct,O
contact,O
with,O
PCP,O

Discharge,O
Date,O
/,O
Time,O
:,O

02/11/2003,O
16:52,O

Discharge,O
Status,O
:,O

Discharged,O

Condition,O
on,O
Discharge,O
:,O

Stable,O

Patient,O
States,O
Complaint,O
:,O

BACK,B-PR
PAIN,I-PR

Standardized,O
Discharge,O
Instructions,O
:,O

The,O
patient,O
was,O
given,O
printed,O
instructions,O
for,O
back,B-PR
pain,I-PR
(,O
English,O
),O
.,O

Diagnosis,O
:,O

Back,B-PR
pain,I-PR

Disposition,O
",",O
Follow,O
up,O
and,O
Instructions,O
to,O
Patient,O
:,O

Call,O
your,O
doctor,O
in,O
the,O
morning,O
for,O
an,O
appointment,O
with,O
the,O
pain,O
clinic,O
.,O

If,O
you,O
have,O
any,O
bladder,B-PR
incontinence,I-PR
",",O
bowel,B-PR
incontinence,I-PR
",",O
worse,B-PR
numbness,I-PR
",",O
any,B-PR
weakness,I-PR
",",O
or,O
any,O
other,B-PR
concerns,I-PR
",",O
call,O
your,O
doctor,O
or,O
return,O
to,O
the,O
emergency,O
department,O
immediately,O
.,O

PCP,O
Name,O
:,O

PULESHUFF,O
",",O
SACA,O
G,O

Provider,O
Number,O
:,O

79863,O

This,O
report,O
was,O
created,O
by,O
GUAYTREFTSCOST,O
",",O
AMINE,O
02/11/2003,O
04:53,O
PM,O

Admission,O
Date,O
:,O

2012-05-13,O

Discharge,O
Date,O
:,O

2012-05-22,O

Date,O
of,O
Birth,O
:,O

2012-05-13,O

Sex,O
:,O

M,O

Service,O
:,O

Neonatology,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Fred,O
Grauman,O
is,O
the,O
former,O
2.252,O
kg,O
product,O
of,O
a,O
35-1/7,O
week,O
gestation,O
pregnancy,O
born,O
to,O
a,O
37-year-old,O
G4,O
P3-5,O
woman,O
.,O

Prenatal,O
screens,O
:,O

Blood,B-TE
type,I-TE
O+,O
",",O
antibody,B-TE
negative,O
",",O
rubella,B-TE
immune,O
",",O
RPR,B-TE
nonreactive,O
",",O
hepatitis,B-TE
B,I-TE
surface,I-TE
antigen,I-TE
negative,O
",",O
group,B-PR
beta,I-PR
Strep,I-PR
positive,I-PR
.,O

The,O
pregnancy,O
was,O
complicated,O
by,O
anemia,B-PR
.,O

Mother,O
has,O
a,O
prior,O
history,O
of,O
mitral,B-PR
valve,I-PR
prolapse,I-PR
.,O

She,O
had,O
a,B-TR
prior,I-TR
cesarean,I-TR
section,I-TR
done,O
",",O
two,O
vaginal,O
births,O
after,O
cesarean,B-TR
section,I-TR
.,O

She,O
presented,O
in,O
labor,O
on,O
the,O
day,O
of,O
delivery,O
.,O

These,O
infants,O
were,O
delivered,O
by,O
repeat,B-TR
cesarean,I-TR
section,I-TR
",",O
this,O
twin,O
emerged,O
with,O
good,O
tone,O
",",O
color,O
",",O
and,O
cry,O
.,O

Apgars,B-TE
were,O
eight,O
at,O
one,O
minute,O
and,O
nine,O
at,O
five,O
minutes,O
.,O

He,O
was,O
admitted,O
to,O
the,O
Neonatal,O
Intensive,O
Care,O
Unit,O
for,O
treatment,B-TR
of,O
prematurity,B-PR
.,O

PHYSICAL,O
EXAMINATION,O
UPON,O
ADMISSION,O
TO,O
THE,O
NEONATAL,O
INTENSIVE,O
CARE,O
UNIT,O
:,O

Weight,B-TE
2.252,O
kg,O
",",O
65th,O
percentile;,O
length,B-TE
46,O
cm,O
",",O
50th,O
percentile,O
;,O
head,B-TE
circumference,I-TE
33,O
cm,O
75th,O
percentile,O
.,O

General,O
:,O

A,O
nondysmorphic,O
preterm,O
35,O
week,O
gestation,O
male,O
.,O

Skin,O
:,O

Color,O
pink,O
in,O
room,O
air,O
.,O

Head,O
",",O
eyes,O
",",O
ears,O
",",O
nose,O
",",O
and,O
throat,O
:,O

Anterior,O
fontanel,O
open,O
",",O
level,O
and,O
soft,O
.,O

Sutures,O
are,O
proximated,O
.,O

Positive,O
red,O
reflex,O
bilaterally,O
.,O

Palate,O
intact,O
.,O

Chest,O
:,O

Mild,B-PR
retractions,I-PR
",",O
occasional,B-PR
grunting,I-PR
.,O

Breath,B-TE
sounds,I-TE
equal,O
with,O
good,O
aeration,O
.,O

Cardiovascular,O
:,O

Regular,O
",",O
rate,O
",",O
and,O
rhythm,O
",",O
no,O
murmur,B-PR
.,O

Pulses,B-TE
+2,O
.,O

Abdomen,O
is,O
soft,O
",",O
nontender,B-PR
",",O
no,O
masses,B-PR
",",O
and,O
no,O
hepatosplenomegaly,B-PR
.,O

Genitourinary,O
:,O

Normal,O
male,O
",",O
testes,O
descended,O
.,O

Extremities,O
:,O

Hips,O
stable,O
",",O
moving,O
all,O
.,O

Spine,O
intact,O
.,O

Neurologic,O
:,O

Appropriate,O
tone,O
and,O
reflexes,O
.,O

HOSPITAL,O
COURSE,O
BY,O
SYSTEMS,O
INCLUDING,O
PERTINENT,O
LABORATORY,O
DATA:,O

1.,O
Respiratory,O
:,O

Raymond,O
required,O
some,B-TR
intermittent,I-TR
blow-by,I-TR
oxygen,I-TR
for,O
the,O
first,O
two,O
hours,O
of,O
birth,O
.,O

He,O
has,O
remained,O
in,O
room,O
air,O
since,O
that,O
time,O
.,O

The,B-PR
grunting,I-PR
noted,O
on,O
admission,O
resolved,O
within,O
the,O
first,O
few,O
hours,O
after,O
birth,O
.,O

He,O
did,O
not,O
have,O
any,O
episodes,O
of,O
spontaneous,B-PR
apnea,I-PR
or,O
bradycardia,B-PR
.,O

2.,O
Cardiovascular,O
:,O

No,O
murmurs,B-PR
were,O
noted,O
",",O
although,O
normal,O
heart,O
rates,O
and,O
blood,O
pressures,O
.,O

3.,O
Fluids,O
",",O
electrolytes,O
",",O
and,O
nutrition,O
:,O

Enteral,B-TR
feeds,I-TR
were,O
started,O
on,O
the,O
date,O
of,O
birth,O
and,O
gradually,O
advanced,O
to,O
full,O
volume,O
.,O

He,O
required,O
some,B-TR
gavage,I-TR
feeds,I-TR
through,O
day,O
of,O
life,O
#4,O
",",O
and,O
has,O
been,O
all,O
po,O
since,O
day,O
of,O
life,O
#5,O
.,O

At,O
the,O
time,O
of,O
discharge,O
",",O
he,O
is,O
taking,O
Enfamil,B-TR
20,I-TR
calories,I-TR
/,I-TR
ounce,I-TR
with,I-TR
iron,I-TR
.,O

Discharge,B-TE
weight,I-TE
is,O
2.37,O
kg,O
",",O
head,B-TE
circumference,I-TE
32,O
cm,O
",",O
length,B-TE
47,O
cm,O
.,O

4.,O
Infectious,O
Disease,O
:,O

Due,O
to,O
the,B-PR
unknown,I-PR
group,I-PR
B,I-PR
Strep,I-PR
status,I-PR
and,O
prematurity,B-PR
",",O
Raymond,O
was,O
evaluated,O
for,O
sepsis,B-PR
.,O

A,B-TE
complete,I-TE
blood,I-TE
count,I-TE
had,O
a,B-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
of,O
"13,800",O
with,O
17%,B-TE
polys,I-TE
",",O
0%,B-TE
bands,I-TE
.,O

A,O
repeat,O
on,O
day,O
of,O
life,O
two,O
",",O
had,O
a,B-TE
white,I-TE
count,I-TE
of,O
"13,000",O
with,O
50%,B-TE
polys,I-TE
",",O
0%,B-TE
bands,I-TE
.,O

A,B-TE
blood,I-TE
culture,I-TE
obtained,O
prior,O
to,O
starting,O
antibiotics,B-TR
was,O
no,O
growth,B-PR
at,O
48,O
hours,O
.,O

5.,O
Gastrointestinal,O
:,O

Peak,B-TE
serum,I-TE
bilirubin,I-TE
occurred,O
on,O
day,O
of,O
life,O
#4,O
",",O
a,B-TE
total,I-TE
of,O
10.0/0.3,O
direct,B-TE
.,O

A,B-TE
repeat,I-TE
bilirubin,I-TE
on,O
2012-05-19,O
was,O
8.0/0.3,O
direct,B-TE
.,O

6.,O
Hematological,O
:,O

Hematocrit,B-TE
at,O
birth,O
was,O
43.8%.,O

Raymond,O
did,O
not,O
receive,O
any,B-TR
transfusions,I-TR
of,I-TR
blood,I-TR
products,I-TR
during,O
admission,O
.,O

7.,O
Neurology,O
:,O

Raymond,O
has,O
maintained,O
normal,O
neurological,O
examination,O
throughout,O
admission,O
and,O
there,O
were,O
no,O
concerns,O
at,O
the,O
time,O
of,O
discharge,O
.,O

8.,O
Sensory,O
:,O

Audiology,B-TE
hearing,I-TE
screening,I-TE
was,O
performed,O
with,O
automated,O
auditory,O
brain,O
stem,O
responses,O
.,O

Raymond,O
passed,O
in,O
both,O
ears,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Good,O
.,O

DISCHARGE,O
/,O
DISPOSITION,O
:,O

Home,O
with,O
parents,O
.,O

PRIMARY,O
PEDIATRICIAN,O
:,O

Dr.,O
Timothy,O
Alexander,O
",",O
Gloucester,O

Pediatric,O
Associate,O
",",O
8219,O
W.,O
Eighth,O
Rd.,O
",",O
Terry,O
",",O
Illinois,O
72097,O
",",O
phone,O
482-5289,O
.,O

CARE,O
AND,O
RECOMMENDATIONS,O
AT,O
THE,O
TIME,O
OF,O
DISCHARGE,O
:,O

1.,O
Feeding,O
:,O

Adlib,O
po,B-TR
Enfamil,I-TR
with,I-TR
iron,I-TR
.,O

2.,O
No,O
medications,B-TR
.,O

3.,O
Car,B-TE
seat,I-TE
position,I-TE
screening,I-TE
was,O
performed,O
successfully,O
.,O

4.,O
State,B-TE
Newborn,I-TE
Screen,I-TE
was,O
sent,O
on,O
day,O
of,O
life,O
#3,O
.,O

A,O
report,O
of,O
an,B-PR
elevated,I-PR
17-OH,I-PR
was,O
called,O
to,O
the,O
CMED,O
CCU,O
.,O

A,B-TE
subsequent,I-TE
sample,I-TE
was,O
done,O
(,O
05-21,O
),O
and,O
results,O
are,O
pending,O
.,O

Newborn,O
State,O
Screen,O
phone,O
number,O
#(,O
822,O
),O
923-2683,O
.,O

5.,O
Immunizations,B-TR
received,O
:,O

Hepatitis,B-TR
B,I-TR
vaccine,I-TR
was,O
administered,O
at,O
the,O
time,O
of,O
birth,O
on,O
2012-05-13,O
.,O

IMMUNIZATIONS,O
RECOMMENDED,O
:,O

1.,O
Synagis,B-TR
RSV,I-TR
prophylaxis,I-TR
should,O
be,O
considered,O
from,O
October,O
through,O
April,O
for,O
infants,O
who,O
meet,O
any,O
of,O
the,O
following,O
three,O
criteria,O
:,O

1),O
Born,O
at,O
less,O
than,O
32,O
weeks,O
",",O

2),O
born,O
between,O
32,O
and,O
35,O
weeks,O
with,O
plans,O
for,O
daycare,O
during,O
RSV,O
season,O
",",O
with,O
a,O
smoker,O
in,O
the,O
household,O
",",O
or,O
with,O
preschool,O
siblings,O
",",O
or,O

3),O
with,O
chronic,B-PR
lung,I-PR
disease,I-PR
.,O

2.,O
Influenza,B-TR
immunization,I-TR
should,O
be,O
considered,O
annually,O
in,O
the,O
fall,O
for,O
preterm,B-PR
infants,I-PR
with,O
chronic,B-PR
lung,I-PR
disease,I-PR
once,O
they,O
reach,O
six,O
months,O
of,O
age,O
.,O

Before,O
this,O
age,O
",",O
the,O
family,O
and,O
other,O
caregivers,O
should,O
be,O
considered,O
for,O
immunization,B-TR
against,O
influenza,B-PR
to,O
protect,O
the,O
infant,O
.,O

FOLLOW-UP,O
APPOINTMENT,O
:,O

Primary,O
pediatrician,O
recommended,O
within,O
three,O
days,O
of,O
discharge,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
A,O
35-1/7,O
week,O
gestation,O
.,O

2.,O
Twin,O
#2,O
of,O
twin,O
gestation,O
.,O

3.,O
Transitional,B-PR
respiratory,I-PR
distress,I-PR
.,O

4.,O
Suspicion,O
for,O
sepsis,B-PR
ruled,O
out,O
.,O

DR.,O
Gloria,O
",",O
Lonnie,O
55-454,O

Dictated,O
By,O
:,O
John,O
Z.,O
Toledo,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2012-05-22,O
07:06,O

T,O
:,O
2012-05-22,O
07:17,O

JOB,O
#,O
:,O
35651,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Freddy,O
King,O
on,O
:,O
WED,O
2012-05-23,O
9:05,O
AM,O

(,O
End,O
of,O
Report,O
),O

268157859,O
YC,O

35980943,O

4198660,O

5/30/2005,O
12:00:00,O
AM,O

s,O
/,O
p,O
total,B-TR
thyoidectomy,I-TR

DIS,O

Admission,O
Date,O
:,O

05/30/2005,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

05/31/2005,O

******,O
DISCHARGE,O
ORDERS,O
******,O

KOTEBITZWEERTS,O
",",O
LIXYNA,O
N,O

306-08-68-0,O
K78,O

Room,O
:,O

58W-275,O

Service,O
:,O

GGI,O

DISCHARGE,O
PATIENT,O
ON,O
:,O

05/31/05,O
AT,O
02:00,O
PM,O

CONTINGENT,O
UPON,O

Not,O
Applicable,O

WILL,O
D,O
/,O
C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D,O
/,O
C,O
SUMMARY,O
:,O

YES,O

Attending,O
:,O

TLAND,O
",",O
JR,O
",",O
VOTRIBRENDEVE,O
N.,O
",",O
M.D.,O

DISPOSITION,O
:,O

Home,O

DISCHARGE,O
MEDICATIONS,O
:,O

ROCALTROL,B-TR
(,I-TR
CALCITRIOL,I-TR
),I-TR
0.5,O
MCG,O
PO,O
QD,O
Starting,O
Today,O
(,O
05/31,O
),O

Instructions,O
:,O

Start,O
on,O
day,O
of,O
surgery,B-TR
and,O
continue,O
throughout,O
hospitalization,O
.,O

SYNTHROID,B-TR
(,I-TR
LEVOTHYROXINE,I-TR
SODIUM,I-TR
),I-TR
125,O
MCG,O
PO,O
QD,O

Instructions,O
:,O

(,O
typical,O
dose,O
is,O
1,O
mcg,O
per,O
lb.,O
),O

OXYCODONE,B-TR
5-10,O
MG,O
PO,O
Q4H,O
PRN,O
Pain,B-PR
ADVAIR,B-TR
DISKUS,I-TR
100/50,O
(,O
FLUTICASONE,B-TR
PROPIONATE/...,I-TR
),O
1,O
PUFF,O
INH,O
BID,O
CALCIUM,B-TR
CARBONATE,I-TR
"2,400",O
MG,O
PO,O
QID,O
Starting,O
Today,O
(,O
05/31,O
),O

DIET,O
:,O

No,O
Restrictions,O

ACTIVITY,O
:,O

Resume,O
regular,O
exercise,O

FOLLOW,O
UP,O
APPOINTMENT,O
(,O
S,O
),O
:,O

Dr.,O
Tland,O
",",O
462-352-5678,O
1-2,O
weeks,O
please,O
call,O
for,O
appointment,O
if,O
not,O
made,O
",",O

ALLERGY,O
:,O

NKA,B-PR
ADMIT,O
DIAGNOSIS,O
:,O

total,B-TR
thyroidectomy,I-TR

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O

Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O
s,O
/,O
p,O
total,B-TR
thyoidectomy,I-TR

OTHER,O
DIAGNOSIS,O
;,O

Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O
asthma,B-PR

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

05/30/05,O
TLAND,O
",",O
JR,O
",",O
VOTRIBRENDEVE,O
N.,O
",",O
M.D.,O
TOTAL,B-TR
THYROIDECTOMY,I-TR

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O

none,O

BRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

40F,O
with,O
hurtle,B-PR
cell,I-PR
tumor,I-PR
of,I-PR
thyroid,I-PR
had,O
total,B-TR
thyroidectomy,I-TR
without,O
complication,B-PR
.,O

POD#,O
1,O
pt,O
was,O
tolerating,O
regular,O
diet,O
",",O
ambulating,O
",",O
afebrile,B-PR
",",O
and,O
calcium,B-TE
was,O
stable,O
.,O

Incicsion,B-PR
was,O
clean,O
dry,O
and,O
intact,O
and,O
pt,O
was,O
discharged,O
home,O
in,O
stable,O
condition,O

ADDITIONAL,O
COMMENTS,O
:,O

Keep,O
incision,B-PR
clean,O
and,O
dry,O
",",O
may,O
shower,O
Wed,O
.,O

Do,O
not,O
drive,O
if,O
taking,O
narcotics,B-TR
Call,O
doctor,O
if,O
fever,B-PR
&gt;,O
101.5,O
",",O
worsening,B-PR
pain,I-PR
",",O
swelling,B-PR
",",O
or,O
redness,B-PR
of,I-PR
wound,I-PR
",",O
numbness,B-PR
or,I-PR
tingling,I-PR
in,I-PR
extremities,I-PR
or,O
face,O
or,O
any,O
other,O
concerns,O
.,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O

TO,O
DO,O
/,O
PLAN,O
:,O

No,O
dictated,O
summary,O

ENTERED,O
BY,O
:,O

LILLETLANDTRIEV,O
",",O
ROSEEN,O
ERTONDON,O
(,O
BZ30,O
),O
05/31/05,O
09:05,O
AM,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

Admission,O
Date,O
:,O

2017-05-08,O

Discharge,O
Date,O
:,O

2017-05-16,O

Date,O
of,O
Birth,O
:,O

1931-10-04,O

Sex,O
:,O

M,O

Service,O
:,O

CARDIOTHORACIC,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,O
Drugs,B-TR

Attending,O
:,O
Walter,O
G,O
Gaines,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O
worsening,B-PR
chest,I-PR
pain,I-PR
and,O
shortness,B-PR
of,I-PR
breath,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

Coronary,B-TR
artery,I-TR
bypass,I-TR
graft,I-TR
x,O
2,O
/,O
Aortic,B-TR
valve,I-TR
replacement,I-TR
05-08,O

History,O
of,O
Present,O
Illness,O
:,O

Mr.,O
Williams,O
is,O
an,O
85,O
yo,O
gentleman,O
who,O
has,O
a,B-PR
known,I-PR
cardiac,I-PR
history,I-PR
and,O
has,O
had,O
a,O
h/o,O
worsening,B-PR
chest,I-PR
pain,I-PR
and,O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

He,O
had,O
an,B-TE
echocardiogram,I-TE
which,O
showed,O
an,B-TE
EF,I-TE
40-45%,O
and,O
severe,B-PR
aortic,I-PR
stenosis,I-PR
.,O

He,O
underwent,O
cardiac,B-TE
catheterization,I-TE
which,O
showed,O
an,B-PR
80%,I-PR
LAD,I-PR
lesion,I-PR
",",O
chronically,B-PR
occluded,I-PR
RCA,I-PR
",",O
anneurysmal,B-PR
mid,I-PR
LCX,I-PR
w/50%,B-PR
lesion,I-PR
.,O

He,O
was,O
refered,O
to,O
Dr.,O
Barber,O
for,O
surgical,B-TR
treatment,I-TR
.,O

Past,O
Medical,O
History,O
:,O

s/p,O
MI,B-PR
1992,O

AS,B-PR

h/o,O
prostate,B-PR
CA,I-PR
s/p,O
brachytherapy,B-TR
and,O
hormone,B-TR
treatment,I-TR

hyperlipidemia,B-PR

HTN,B-PR

PAF,B-PR
h/o,O
rectal,B-PR
bleeding,I-PR
s/p,O
cauterization,B-TR

cholelithiasis,B-PR

s/p,O
AAA,B-TR
repair,I-TR

s/p,O
bilateral,B-TR
hernia,I-TR
repair,I-TR

s/p,O
R,B-TR
lung,I-TR
surgery,I-TR

CRI,B-PR

chronic,B-PR
lung,I-PR
disease,I-PR

Pertinent,O
Results:,O

2017-05-16,O
06:20,O
AM,O
BLOOD,B-TE
WBC,B-TE
-,O
8.0,O
RBC,B-TE
-,O
3.35,O
*,O
Hgb,B-TE
-,O
10.3,O
*,O
Hct,B-TE
-,O
31.0,O
*,O
MCV,B-TE
-,O
93,O
MCH,B-TE
-,O
30.7,O
MCHC,B-TE
-,O
33.1,O
RDW,B-TE
-,O
13.0,O
Plt,B-TE
Ct,I-TE
-,O
201,O

2017-05-16,O
06:20,O
AM,O
BLOOD,B-TE
Plt,B-TE
Ct,I-TE
-,O
201,O

2017-05-16,O
06:20,O
AM,O
BLOOD,B-TE
PT,B-TE
-,O
19.0,O
*,O
INR,B-TE
(,I-TE
PT,I-TE
)-,O
2.3,O

2017-05-16,O
09:50,O
AM,O
BLOOD,B-TE
Glucose,B-TE
-,O
118,O
*,O
UreaN,B-TE
-,O
18,O
Creat,B-TE
-,O
1.6,O
*,O
Na,B-TE
-,O
137,O
K,B-TE
-,O
5.1,O
Cl,B-TE
-,O
98,O
HCO3,B-TE
-,O
29,O
AnGap,B-TE
-,O
15,O

Brief,O
Hospital,O
Course,O
:,O

Mr.,O
Williams,O
was,O
admitted,O
to,O
Hallmark,O
Health,O
System,O
on,O
05-08,O
and,O
taken,O
to,O
the,O
operating,O
room,O
with,O
Dr.,O
Barber,O
for,O
a,B-TR
CABGx2,I-TR
and,O
AVR,B-TR
w/,O
25,B-TR
mm,I-TR
pericardial,I-TR
valve,I-TR
.,O

Please,O
see,O
operative,O
note,O
for,O
full,O
details,O
.,O

He,O
was,O
transfered,O
to,O
the,O
ICU,O
in,O
stable,O
condition,O
.,O

He,O
was,O
weaned,O
and,O
extubated,O
from,O
mechanical,B-TR
ventillation,I-TR
on,O
POD#1,O
without,O
difficulty,B-PR
.,O

He,O
was,O
transfered,O
to,O
the,O
regular,O
part,O
of,O
the,O
hospital,O
on,O
POD#2,O
",",O
where,O
he,O
began,O
working,O
with,O
physical,O
therapy,O
.,O

He,O
developed,O
atrial,B-PR
fibrillation,I-PR
on,O
POD#2,O
with,O
well,O
controlled,O
rate,O
and,O
hemodynamically,O
stable,O
.,O

He,O
was,O
started,O
on,O
heparin,B-TR
and,O
coumadin,B-TR
for,O
anticoagulation,B-TR
on,O
POD#5,O
.,O

On,O
POD#7,O
he,O
was,O
cleared,O
for,O
discharge,O
to,O
home,O
by,O
physical,O
therapy,O
and,O
on,O
POD#8,O
he,O
was,O
discharged,O
.,O

Medications,O
on,O
Admission,O
:,O

lasix,B-TR
40,O
mg,O
q,O
M-W-F,O

Klorcon,B-TR
10,O
mEq,O
q,O
M-W-F,O

Pepcid,B-TR
40,O
mg,O
qd,O

colexa,B-TR
10,O
mg,O
qd,O

metoprolol,B-TR
50,O
mg,O
bid,O

lipitor,B-TR
20,O
mg,O
qd,O

aspirin,B-TR
325,O
mg,O
qd,O

flovent,B-TR
110,O
mcg,O
inhaler,O
bid,O

atrovent,B-TR
inhaler,I-TR
tid,O

Discharge,O
Medications,O
:,O

1.,O
Aspirin,B-TR
81,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

Disp,O
:*,O
30,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
)(,O
s,O
)*,O
Refills,O
:*,O
0,O
*,O

2.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

Disp,O
:*,O
60,O
Capsule,O
(,O
s,O
)*,O
Refills,O
:*,O
0,O
*,O

3.,O
Fluticasone,B-TR
Propionate,I-TR
110,O
mcg,O
/,O
Actuation,O
Aerosol,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Puff,O
Inhalation,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

Disp,O
:*,O
1,O
canister,O
*,O
Refills,O
:*,O
0,O
*,O

4.,O
Oxycodone,B-TR
-,I-TR
Acetaminophen,I-TR
5-325,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
every,O
4-6,O
hours,O
as,O
needed,O
for,O
pain,B-PR
.,O

Disp,O
:*,O
40,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
0,O
*,O

5.,O
Ipratropium,B-TR
Bromide,I-TR
18,O
mcg,O
/,O
Actuation,O
Aerosol,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Puff,O
Inhalation,O
QID,O
(,O
4,O
times,O
a,O
day,O
),O
.,O

Disp,O
:*,O
1,O
canister,O
*,O
Refills,O
:*,O
0,O
*,O

6.,O
Pantoprazole,B-TR
Sodium,I-TR
40,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
Q24H,O
(,O
every,O
24,O
hours,O
),O
.,O

Disp,O
:*,O
30,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
)(,O
s,O
)*,O
Refills,O
:*,O
0,O
*,O

7.,O
Metoprolol,B-TR
Tartrate,I-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

Disp,O
:*,O
60,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
0,O
*,O

8.,O
Lipitor,B-TR
20,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
once,O
a,O
day,O
.,O

Disp,O
:*,O
30,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:,O
*,O
0,O
*,O

9.,O
Bacitracin,B-TR
Zinc,I-TR
500,O
unit,O
/,O
g,O
Ointment,O
Sig,O
:,O
One,O
(,O
1,O
),O
Appl,O
Topical,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

Disp,O
:*,O
1,O
tube,O
*,O
Refills,O
:*,O
0,O
*,O

10.,O
Celexa,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
once,O
a,O
day,O
.,O

Tablet,O
(,O
s,O
),O

11.,O
Warfarin,B-TR
Sodium,I-TR
1,O
mg,O
Tablet,O
Sig,O
:,O
Five,O
(,O
5,O
),O
Tablet,O
PO,O
once,O
a,O
day,O
:,O
Take,O
5,O
mg,O
on,O
04-18,O
.,O

MD,O
to,O
dose,O
daily,O
.,O

Disp,O
:*,O
150,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

12.,O
Lasix,B-TR
40,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
q,O
M-W-F,O
.,O

Disp,O
:*,O
30,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
0,O
*,O

13.,O
Potassium,B-TR
Chloride,I-TR
10,O
mEq,O
Capsule,O
",",O
Sustained,O
Release,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
",",O
Sustained,O
Release,O
PO,O
q,O
M-W-F,O
.,O

Disp,O
:*,O
30,O
Capsule,O
",",O
Sustained,O
Release,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

14.,O
Coumadin,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
once,O
a,O
day,O
:,O
as,O
directed,O
for,O
goal,B-TE
INR,I-TE
2.0-2.5.,O

Disp,O
:*,O
30,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
0,O
*,O

Discharge,O
Disposition,O
:,O

Home,O
with,O
Service,O

Discharge,O
Diagnosis,O
:,O

Coronary,B-PR
artery,I-PR
disease,I-PR
.,O

Aortic,B-PR
stenosis,I-PR
.,O

Hyperlipidemia,B-PR
.,O

Atrial,B-PR
fibrillation,I-PR
.,O

Chronic,B-PR
renal,I-PR
insufficiency,I-PR

Discharge,O
Condition,O
:,O

Good,O
.,O

Discharge,O
Instructions,O
:,O

Shower,O
daily,O
and,O
wash,O
incisions,B-PR
with,O
soap,O
and,O
water,O
.,O

Rinse,O
well,O
.,O

Do,O
not,O
apply,O
any,O
creams,O
",",O
lotions,O
",",O
powders,O
",",O
or,O
ointments,O
.,O

No,O
bathing,O
in,O
tub,O
or,O
swimming,O
.,O

No,O
heavy,O
lifting,O
",",O
greater,O
than,O
10,O
pounds,O
.,O

No,O
driving,O
for,O
6,O
weeks,O
.,O

Followup,O
Instructions,O
:,O

Make,O
follow-appointment,O
with,O
Dr.,O
Barber,O
in,O
4-6,O
weeks,O
.,O

Make,O
follow-up,O
appointment,O
with,O
Dr.,O
Jo,O
in,O
1-2,O
weeks,O
.,O

Dustin,O
Elmer,O
MD,O
22-708,O

Completed,O
by,O
:,O
Ann,O
J.,O
Haley,O
PA,O
80-AXP,O
2017-05-17,O
@,O
1251,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Jackie,O
Mcafee,O
on,O
:,O
TUE,O
2017-07-11,O
8:43,O
AM,O

(,O
End,O
of,O
Report,O
),O

277175072,O

NVH,O

87686746,O

1/3/1997,O
12:00:00,O
AM,O

10%,B-PR
BODY,I-PR
BURNS,I-PR

Signed,O

DIS,O

Admission,O
Date,O
:,O

01/03/1997,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

01/07/1997,O

FINAL,O
DIAGNOSIS,O
:,O

(1),O
THIRD,B-PR
DEGREE,I-PR
BURN,I-PR
TO,I-PR
RIGHT,I-PR
HAND,I-PR
AND,I-PR
FOREARM,I-PR

(2),O
SECOND,B-PR
DEGREE,I-PR
BURN,I-PR
TO,I-PR
FACE,I-PR
PROCEDURE,O
:,O

(1),O
1/5/97,O
:,O

DEBRIDEMENT,B-TR
OF,O
BURN,B-PR
AND,O
APPLICATION,B-TR
OF,I-TR
ARTIFICIAL,I-TR
SKIN,I-TR

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
59,O
year,O
old,O
gentleman,O
who,O
experienced,O
a,B-PR
flash,I-PR
burn,I-PR
from,O
grease,O
while,O
working,O
on,O
a,O
stove,O
on,O
the,O
night,O
prior,O
to,O
admission,O
.,O

The,O
patient,O
at,O
that,O
time,O
treated,O
himself,O
symptomatically,O
at,O
home,O
but,O
presented,O
to,O
Roing,O
Hospital,O
on,O
the,O
day,O
after,O
the,O
event,O
and,O
was,O
transferred,O
to,O
the,O
Nimaconwood,O
Valley,O
Hospital,O
immediately,O
for,O
evaluation,B-TE
because,O
of,O
his,B-PR
extensive,I-PR
burns,I-PR
.,O

The,O
patient,O
was,O
walking,O
",",O
talking,O
",",O
and,O
was,O
breathing,O
without,O
difficulty,B-PR
on,O
arrival,O
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

No,O
significant,O
history,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Only,O
significant,O
for,O
excessive,O
alcohol,O
use,O
.,O

MEDICATIONS,O
:,O

None,O
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

99%,O
saturation,B-TE
on,O
room,O
air,O
.,O

Heart,B-TE
rate,I-TE
76,O
",",O
blood,B-TE
pressure,I-TE
169/100,O
.,O

Other,B-TE
vital,I-TE
signs,I-TE
were,O
within,O
normal,O
limits,O
.,O

The,O
patient,O
was,O
not,O
anxious,O
or,O
ill-appearing,B-PR
.,O

HEENT,O
:,O

Extensive,B-PR
first,I-PR
degree,I-PR
and,I-PR
second,I-PR
degree,I-PR
burns,I-PR
around,I-PR
the,I-PR
face,I-PR
",",O
superficial,O
in,O
nature,O
",",O
with,O
no,O
blistering,B-PR
.,O

His,O
oropharynx,O
was,O
wide,O
open,O
with,O
no,O
evidence,O
of,O
burn,B-PR
.,O

Lungs,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

Heart,O
:,O

Regular,O
.,O

Abdomen,O
:,O

Soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
.,O

Extremities,O
:,O

Good,O
pulses,O
bilaterally,O
.,O

Skin,O
:,O

Third,B-PR
degree,I-PR
burn,I-PR
on,I-PR
dorsum,I-PR
of,O
forearm,O
and,O
on,O
dorsum,O
of,O
hand,O
with,O
extensive,B-PR
second,I-PR
degree,I-PR
burn,I-PR
around,O
the,O
remainder,O
of,O
his,O
hand,O
circumferentially,O
and,O
on,O
his,O
forearm,O
.,O

Pulses,O
were,O
intact,O
.,O

No,O
evidence,O
of,O
compartment,B-PR
syndrome,I-PR
.,O

Evaluation,B-TE
in,O
the,O
emergency,O
room,O
revealed,O
the,O
patient,O
to,O
be,O
stable,O
and,O
he,O
was,O
evaluated,O
by,O
ophthalmology,O
who,O
also,O
felt,O
that,O
the,O
patient,O
had,O
no,O
injury,B-PR
to,I-PR
his,I-PR
eyes,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
taken,O
from,O
the,O
emergency,O
room,O
and,O
transferred,O
to,O
the,O
Surgical,O
Intensive,O
Care,O
Unit,O
for,O
airway,B-TE
observation,I-TE
.,O

He,O
was,O
given,O
three,O
liters,O
of,O
IV,B-TR
hydration,I-TR
with,O
good,O
urine,O
output,O
response,O
.,O

His,B-PR
wounds,I-PR
were,O
dressed,O
with,O
antiointment,B-TR
and,O
Xeroform,B-TR
with,O
the,O
plan,O
to,O
take,O
him,O
to,O
the,O
operating,O
room,O
for,O
debridement,B-TR
under,O
general,B-TR
anesthesia,I-TR
and,O
application,B-TR
of,I-TR
artificial,I-TR
skin,I-TR
.,O

The,O
patient,O
remained,O
hemodynamically,O
stable,O
with,O
good,O
urine,O
output,O
.,O

While,O
in,O
the,O
Intensive,O
Care,O
Unit,O
the,O
patient,O
was,O
put,O
on,O
delirium,B-TR
tremons,I-TR
prophylaxis,I-TR
with,O
Serax,B-TR
around,O
the,O
clock,O
.,O

There,O
was,O
no,O
evidence,O
while,O
in,O
the,O
hospital,O
.,O

The,O
patient,O
was,O
taken,O
to,O
the,O
operating,O
room,O
on,O
1/5/97,O
.,O

At,O
that,O
time,O
the,O
patient,O
underwent,O
debridement,B-TR
of,O
his,B-PR
facial,I-PR
wounds,I-PR
and,O
debridement,B-TR
of,I-TR
his,I-TR
right,I-TR
hand,I-TR
and,I-TR
forearm,I-TR
with,O
application,B-TR
of,I-TR
artificial,I-TR
skin,I-TR
which,O
is,O
the,O
dermagraft,B-TR
TC,I-TR
.,O

The,O
patient,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
.,O

There,O
were,O
no,O
complications,B-PR
.,O

Postoperatively,O
the,O
patient,O
was,O
transferred,O
out,O
of,O
the,O
Intensive,O
Care,O
Unit,O
to,O
the,O
burn,O
floor,O
where,O
he,O
received,O
dressing,B-TR
changes,I-TR
p.r.n.,O

The,O
patient,O
remained,O
afebrile,B-PR
and,O
other,B-TE
vital,I-TE
signs,I-TE
were,O
within,O
normal,O
limits,O
.,O

On,O
the,O
day,O
of,O
discharge,O
the,B-TR
patient,I-TR
&apos;s,I-TR
dressing,I-TR
was,O
taken,O
down,O
completely,O
and,O
evaluation,B-TE
of,O
the,B-TR
derma,I-TR
graft,I-TR
was,O
made,O
.,O

At,O
that,O
time,O
it,O
appeared,O
well,O
adhered,O
to,O
the,O
underlying,O
skin,O
.,O

There,O
was,O
no,O
evidence,O
of,O
infection,B-PR
.,O

The,O
patient,O
was,O
screened,O
by,O
the,O
rehabilitation,O
facility,O
and,O
felt,O
to,O
be,O
an,O
acceptable,O
candidate,O
.,O

The,O
patient,O
and,O
his,O
family,O
agreed,O
to,O
transfer,O
from,O
Nimaconwood,O
Valley,O
Hospital,O
to,O
Ianehutche,O
Medical,O
Center,O
.,O

DISPOSITION,O
:,O

DISCHARGE,O
MEDICATIONS,O
:,O

Colace,B-TR
100,O
mg,O
p.o.,O
b.i.d.,O
",",O
Folate,B-TR
1,O
mg,O
q.d.,O
",",O
Artificial,B-TR
Tears,I-TR
2,O
drops,O
each,O
eye,O
b.i.d.,O
and,O
p.r.n.,O
",",O
Serax,B-TR
15,O
mg,O
p.o.,O
q6h,O
-,O
hold,O
if,O
patient,O
excessively,B-PR
sleepy,I-PR
",",O
Thiamine,B-TR
100,O
mg,O
p.o.,O
q.d.,O
",",O
MS,B-TR
-,I-TR
Contin,I-TR
30,O
mg,O
p.o.b.i.d.,O
",",O
multivitamin,B-TR
q.d.,O
",",O
MSIR,B-TR
15,O
mg,O
p.o.,O
q3-4h,O
p.r.n.,O
pain,B-PR
",",O
and,O
Axid,B-TR
150,O
mg,O
p.o.,O
b.i.d.,O

The,O
patient,O
is,O
to,O
undergo,O
dry,B-TR
dressing,I-TR
changes,I-TR
and,O
splint,B-TR
to,I-TR
his,I-TR
right,I-TR
arm,I-TR
q.d.,O

DIET,O
:,O

Regular,O
.,O

FOLLOWUP,O
:,O

The,O
patient,O
is,O
to,O
be,O
seen,O
in,O
the,O
burn,O
clinic,O
two,O
days,O
after,O
discharge,O
.,O

The,O
patient,O
was,O
discharged,O
in,O
stable,O
condition,O
.,O

Dictated,O
By,O
:,O

TELSHEY,O
K.,O
PAP,O
",",O
M.D.,O
IK06,O

Attending,O
:,O

TELSHEY,O
K.,O
PAP,O
",",O
M.D.,O
BH2,O
MC084/4189,O

Batch,O
:,O

9441,O

Index,O
No.,O

YROINI4,O
PGM,O

D,O
:,O

01/07/97,O

T,O
:,O

01/07/97,O

CC,O
:,O

1.,O
ERFIBOULDNON,O
VALLEY,O
MEMORIAL,O
HOSPITAL,O

Admission,O
Date,O
:,O

2013-10-21,O

Discharge,O
Date,O
:,O

2013-10-31,O

Date,O
of,O
Birth,O
:,O

1928-10-14,O

Sex,O
:,O

F,O

Service,O
:,O

CARDIOTHORACIC,O

Allergies,O
:,O

Codeine,B-TR
/,O
Shellfish,O
/,O
Ciprofloxacin,B-TR

Attending,O
:,O
Pamela,O
I,O
Wickman,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Exertional,B-PR
angina,I-PR
and,O
dyspnea,B-PR
on,O
exertion,O

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

2013-10-21,O
CABG,B-TR
x,O
3,O
(,O
LIMA,O
->,O
LAD,O
",",O
SVG,O
->,O
OM,O
",",O
SVG,O
->,O
PDA,O
),O

History,O
of,O
Present,O
Illness,O
:,O

This,O
is,O
an,O
85,O
year,O
old,O
female,O
with,O
prior,O
history,O
of,O
non-hodgkins,B-PR
lymphoma,I-PR
",",O
s/p,O
Cytoxan,B-TR
in,O
2003,O
a,O
with,O
recurrence,B-PR
in,O
2009,O
.,O

Follow,B-TE
up,I-TE
examinations,I-TE
have,O
found,O
a,B-PR
suspicious,I-PR
left,I-PR
lower,I-PR
lobe,I-PR
finding,I-PR
.,O

Cardiac,B-TE
workup,I-TE
prior,O
to,O
left,B-TR
lower,I-TR
lobe,I-TR
resection,I-TR
led,O
to,O
cardiac,B-TE
catheterization,I-TE
which,O
found,O
severe,B-PR
three,I-PR
vessel,I-PR
disease,I-PR
with,O
04-05+,B-PR
mitral,I-PR
regurgitation,I-PR
.,O

She,O
now,O
present,O
for,O
surgical,B-TR
intervention,I-TR
.,O

Past,O
Medical,O
History,O
:,O

Non-hodgkins,B-PR
lymphoma,I-PR
-,O
s/p,O
Cytoxan,B-TR
in,O
2003,O
and,O
2001,O
",",O
History,O
of,O
Varicella,B-PR
Zoster,I-PR
with,O
opthalmic,B-PR
lesions,I-PR
",",O
History,O
of,O
Menieres,B-PR
Disease,I-PR
",",O
GERD,B-PR
",",O
Glaucoma,B-PR
",",O
History,O
of,O
chronic,B-PR
sinusitis,I-PR
",",O
s/p,O
cataract,B-TR
surgery,I-TR
",",O
s/p,O
TAH,B-TR
and,O
BSO,B-TR
",",O
s/p,O
appendectomy,B-TR
",",O
s/p,O
bilateral,B-TR
breast,I-TR
reduction,I-TR

Social,O
History,O
:,O

Retired,O
RN,O
.,O

Lives,O
alone,O
but,O
family,O
is,O
close,O
.,O

Denies,O
tobacco,O
and,O
ETOH,O
.,O

Family,O
History,O
:,O

Daughter,O
died,O
of,O
MI,B-PR
at,O
age,O
49,O
.,O

Physical,O
Exam,O
:,O

Vitals,B-TE
:,O

BP,B-TE
160-170/80-84,O
",",O
HR,B-TE
82,O
",",O
Resp,B-TE
20,O

General,O
:,O

Elderly,O
female,O
in,O
no,O
acute,B-PR
distress,I-PR

HEENT,O
:,O

Oropharynx,O
benign,O

Neck,O
:,O

Supple,O
",",O
no,O
JVD,B-PR
",",O
no,O
carotid,B-PR
bruits,I-PR

Chest,O
:,O

Lungs,O
CTA,O
bilaterally,O

Heart,O
:,O

Regular,O
rate,O
",",O
04-07,O
holosystolic,B-PR
murmur,I-PR

Abdomen,O
:,O

Soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR

Ext,O
:,O

Warm,O
",",O
no,O
edema,B-PR

Pulses,B-TE
:,O

2+,O
distally,O

Neuro,O
:,O

Nonfocal,O

Pertinent,O
Results,O
:,O

2013-10-29,O
06:10,O
AM,O
BLOOD,B-TE
WBC,B-TE
-,O
10.9,O
RBC,B-TE
-,O
3.99,O
*,O
Hgb,B-TE
-,O
12.6,O
Hct,B-TE
-,O
37.9,O
MCV,B-TE
-,O
95,O
MCH,B-TE
-,O
31.5,O
MCHC,B-TE
-,O
33.2,O
RDW,B-TE
-,O
13.9,O
Plt,B-TE
Ct,I-TE
-,O
330,O
#,O

2013-10-29,O
06:10,O
AM,O
BLOOD,B-TE
Glucose,B-TE
-,O
76,O
UreaN,B-TE
-,O
12,O
Creat,B-TE
-,O
0.9,O
Na,B-TE
-,O
141,O
K,B-TE
-,O
3.5,O
Cl,B-TE
-,O
104,O
HCO3,B-TE
-,O
26,O
AnGap,B-TE
-,O
15,O

2013-10-30,O
06:28,O
AM,O
BLOOD,B-TE
Phenyto,B-TE
-,O
5.5,O
*,O

Brief,O
Hospital,O
Course,O
:,O

Mrs.,O
Mandelbaum,O
was,O
admitted,O
and,O
underwent,O
three,B-TR
vessel,I-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
grafting,I-TR
by,O
Dr.,O
Larry,O
Mckinney,O
.,O

Of,O
note,O
",",O
intraoperative,B-TE
transesophageal,I-TE
echocardiogram,I-TE
evaluation,I-TE
showed,O
only,O
mild,B-PR
mitral,I-PR
regurgitation,I-PR
",",O
so,O
no,O
repair/replacement,B-TR
was,O
indicated,O
.,O

Following,O
the,B-TR
operation,I-TR
",",O
she,O
was,O
brought,O
to,O
the,O
CSRU,O
.,O

On,O
postoperative,O
day,O
one,O
",",O
she,O
was,O
noted,O
to,O
be,O
largely,B-PR
unresponsive,I-PR
with,O
left,B-PR
hemiparesis,I-PR
.,O

Restlessness,B-PR
with,O
body,B-PR
tremors,I-PR
were,O
also,O
noted,O
.,O

A,B-TE
stat,I-TE
MRI,I-TE
was,O
notable,O
for,O
multiple,B-PR
abnormal,I-PR
foci,I-PR
consistent,O
with,O
systemic,B-PR
emboli,I-PR
.,O

These,O
were,O
found,O
in,O
the,O
right,O
cerebellar,O
",",O
occipital,O
and,O
anterior,O
parietal,O
lobes,O
.,O

The,O
neurology,O
service,O
was,O
consulted,O
and,O
attributed,O
these,O
findings,O
to,O
cholesterol,B-PR
emboli,I-PR
.,O

Due,O
to,O
seizure,B-PR
activity,I-PR
",",O
Dilantin,B-TR
was,O
started,O
.,O

Anticoagulation,B-TR
was,O
not,O
recommended,O
.,O

Over,O
the,O
next,O
several,O
days,O
",",O
her,O
neurological,O
status,O
slowly,O
improved,O
.,O

She,O
was,O
eventually,O
extubated,O
without,O
incident,B-PR
.,O

She,O
went,O
on,O
to,O
experience,O
paroxysmal,B-PR
atrial,I-PR
fibrillation,I-PR
which,O
was,O
initially,O
treated,O
with,O
intravenous,B-TR
Amiodarone,I-TR
.,O

She,O
concomitantly,O
had,O
loose,B-PR
stools,I-PR
which,O
were,O
C.,B-TE
diff,I-TE
negative,O
.,O

Her,O
clinical,O
status,O
stablized,O
and,O
she,O
transferred,O
to,O
the,O
step,O
down,O
unit,O
on,O
postoperative,O
day,O
six,O
.,O

She,O
remained,O
mostly,O
in,O
a,O
normal,O
sinus,O
rhythm,O
and,O
transitioned,O
to,O
oral,B-TR
Amiodarone,I-TR
which,O
will,O
need,O
to,O
continue,O
for,O
three,O
months,O
postop,O
.,O

She,O
tolerated,O
beta,B-TR
blockade,I-TR
which,O
was,O
slowly,O
advanced,O
as,O
tolerated,O
.,O

She,O
worked,O
daily,O
with,O
physical,O
and,O
occupational,O
therapy,O
.,O

Her,O
neurological,O
status,O
continued,O
to,O
improve,O
.,O

Acyclovir,B-TR
was,O
eventually,O
increased,O
from,O
her,B-TR
maintenance,I-TR
dose,I-TR
for,O
a,B-PR
herpes,I-PR
zoster,I-PR
breakout,I-PR
on,I-PR
her,I-PR
right,I-PR
upper,I-PR
back,I-PR
.,O

In,O
addition,O
",",O
she,O
was,O
empirically,O
started,O
on,O
Flagyl,B-TR
for,O
persistent,B-PR
diarrhea,I-PR
(,O
despite,O
negative,O
C.,O
diff,O
cultures,O
),O
",",O
however,O
she,O
developed,O
an,B-PR
additional,I-PR
rash,I-PR
on,I-PR
her,I-PR
buttocks,I-PR
after,O
the,O
first,O
dose,O
of,O
flagyl,B-TR
",",O
so,O
the,B-TR
flagyl,I-TR
was,O
discontinued,O
.,O

She,O
developed,O
a,B-PR
urinary,I-PR
tract,I-PR
infection,I-PR
for,O
which,O
she,O
was,O
started,O
on,O
Bactrim,B-TR
.,O

A,B-TR
foley,I-TR
catheter,I-TR
was,O
inserted,O
given,O
her,O
mutiple,O
episodes,O
of,O
incontinence,B-PR
that,O
were,O
adding,O
to,O
skin,B-PR
irritation,I-PR
.,O

On,O
insertion,B-TR
she,O
was,O
found,O
to,O
be,O
retaining,O
1400,O
cc,O
of,O
urine,O
",",O
so,O
the,B-TR
foley,I-TR
catheter,I-TR
was,O
left,O
in,O
.,O

She,O
continued,O
to,O
make,O
clinical,O
improvements,O
and,O
was,O
cleared,O
for,O
discharge,O
to,O
rehab,O
on,O
postoperative,O
day,O
10,O
.,O

Medications,O
on,O
Admission,O
:,O

Acyclovir,B-TR
800,O
qd,O
",",O
Nexium,B-TR
40,O
qd,O
",",O
Lipitor,B-TR
40,O
qd,O
",",O
Coreg,B-TR
6.25,O
bid,O
",",O
Asa,B-TR
81,O
qd,O
",",O
Timolol,B-TR
CMED,I-TR
CSRU,I-TR
gtts,I-TR
",",O
Calcium,B-TR
",",O
MVI,B-TR
",",O
Vitamin,B-TR
C,I-TR

Discharge,O
Medications,O
:,O

1.,O
Acetaminophen,B-TR
325,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
Q4H,O
(,O
every,O
4,O
hours,O
),O
as,O
needed,O
for,O
fever,B-PR
or,O
pain,B-PR
.,O

Tablet,O
(,O
s,O
),O

2.,O
Metoprolol,B-TR
Tartrate,I-TR
50,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

3.,O
Phenytoin,B-TR
Sodium,I-TR
Extended,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
.,O

4.,O
Furosemide,B-TR
20,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

Tablet,O
(,O
s,O
),O

5.,O
Pantoprazole,B-TR
40,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
Q24H,O
(,O
every,O
24,O
hours,O
),O
.,O

6.,O
Amiodarone,B-TR
200,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
once,O
a,O
day,O
for,O
7,O
days,O
:,O
400,O
mg,O
PO,O
daily,O
for,O
1,O
week,O
",",O
then,O
decrease,O
to,O
200,O
mg,O
PO,O
daily,O
.,O

Tablet,O
(,O
s,O
),O

7.,O
Aspirin,B-TR
81,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

8.,O
Acyclovir,B-TR
800,O
mg,O
Tablet,O
Sig,O
:,O
0.5,O
Tablet,O
PO,O
5X/D,O
(,O
5,O
times,O
a,O
day,O
),O
for,O
5,O
days,O
:,O
Then,O
decrease,O
dose,O
to,O
800,O
mg,O
PO,O
daily,O
.,O

9.,O
Lipitor,B-TR
40,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
once,O
a,O
day,O
.,O

10.,O
Potassium,B-TR
Chloride,I-TR
20,O
mEq,O
Packet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Packet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

11.,O
Trimethoprim,B-TR
-,I-TR
Sulfamethoxazole,I-TR
160-800,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

12.,O
Miconazole,B-TR
Nitrate,I-TR
2,O
%,O
Powder,O
Sig,O
:,O
One,O
(,O
1,O
),O
Appl,O
Topical,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
as,O
needed,O
.,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Discharge,O
Diagnosis,O
:,O

Coronary,B-PR
artery,I-PR
disease,I-PR
-,O
s/p,O
CABG,B-TR

Varicella,B-PR
Zoster,I-PR

Postop,B-PR
CVA,I-PR

Postop,B-PR
Atrial,I-PR
fibrillation,I-PR

Discharge,O
Condition,O
:,O

Good,O
.,O

Discharge,O
Instructions,O
:,O

Follow,O
medications,B-TR
on,O
discharge,O
instructions,O
.,O

Do,O
not,O
lift,O
more,O
than,O
10,O
lbs.,O
for,O
2,O
months,O
.,O

Do,O
not,O
drive,O
for,O
4,O
weeks,O
.,O

Call,O
our,O
office,O
for,O
sternal,B-PR
drainage,I-PR
",",O
temp,B-PR
>,O
101.5,O

No,O
lotions,O
",",O
creams,O
",",O
or,O
powders,O
on,O
wounds,B-PR
.,O

Followup,O
Instructions,O
:,O

Make,O
an,O
appointment,O
with,O
Dr.,O
Madden,O
for,O
1-2,O
weeks,O
.,O

Make,O
an,O
appointment,O
with,O
Dr.,O
Murray,O
for,O
4,O
weeks,O
.,O

Make,O
an,O
appointment,O
with,O
Dr.,O
Mclaughlin,O
in,O
neurology,O
clinic,O
for,O
4,O
weeks,O
.,O

Briley,O
von,O
der,O
Ross,O
MD,O
67-576,O

Completed,O
by,O
:,O
Ann,O
Kenneth,O
NP,O
80-BXH,O
2013-10-31,O
@,O
1005,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Santos,O
von,O
der,O
Ross,O
on,O
:,O
TUE,O
2013-11-05,O
7:12,O
AM,O

(,O
End,O
of,O
Report,O
),O

280594741,O

FIH,O

7060363,O

70349/v957,O

68215,O

7/2/1993,O
12:00:00,O
AM,O

SEVERE,B-PR
BLUNT,I-PR
ABDOMINAL,I-PR
TRAUMA,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

7-2-93,O

DISCHARGE,O
DATE,O
:,O

7-30-93,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Severe,B-PR
blunt,I-PR
abdominal,I-PR
trauma,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

1.,O
Grade,B-PR
II,I-PR
/,I-PR
V,I-PR
laceration,I-PR
of,I-PR
liver,I-PR
",",O

2.,O
rupture,B-PR
of,I-PR
left,I-PR
renal,I-PR
vein,I-PR
",",O

3.,O
tear,B-PR
of,I-PR
transverse,I-PR
mesocolon,I-PR
",",O

4.,O
serosal,B-PR
tear,I-PR
of,I-PR
transverse,I-PR
colon,I-PR
",",O

5.,O
blunt,B-PR
fracture,I-PR
of,O
the,O
neck,O
of,O
the,O
pancreas,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
AND,O
HOSPITAL,O
COURSE,O
:,O

Mr.,O
Breath,O
was,O
a,O
32,O
year,O
old,O
previously,O
healthy,O
unbelted,O
driver,O
whose,O
car,O
was,O
hit,O
at,O
high,O
speed,O
by,O
a,O
vehicle,O
driven,O
by,O
an,O
intoxicated,O
driver,O
.,O

The,O
patient,O
was,O
ejected,O
and,O
his,O
vehicle,O
rolled,O
over,O
",",O
possibly,O
over,O
him,O
.,O

He,O
was,O
found,O
awake,O
at,O
the,O
scene,O
",",O
complaining,O
of,O
abdominal,B-PR
pain,I-PR
.,O

He,O
had,O
a,B-TE
blood,I-TE
pressure,I-TE
of,O
60,O
systolic,O
upon,O
arrival,O
of,O
the,O
Giles,O
Min,O
General,O
Hospital,O
crew,O
.,O

Intravenous,B-TR
fluids,I-TR
was,O
given,O
.,O

He,O
was,O
paralyzed,B-PR
and,O
endotracheally,O
intubated,O
",",O
and,O
a,B-TR
14,I-TR
gauge,I-TR
catheter,I-TR
was,O
inserted,O
in,O
his,O
left,O
chest,O
because,O
of,O
poor,B-PR
breath,I-PR
sounds,I-PR
.,O

He,O
arrived,O
at,O
the,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
at,O
02:30,O
with,O
a,B-TE
blood,I-TE
pressure,I-TE
of,O
86,O
and,O
a,B-TE
heart,I-TE
rate,I-TE
of,O
170,O
.,O

Large,B-TR
bore,I-TR
cannulas,I-TR
were,O
inserted,O
into,O
the,O
femoral,O
veins,O
",",O
bilateral,B-TR
chest,I-TR
tubes,I-TR
were,O
placed,O
",",O
and,O
his,B-TE
blood,I-TE
pressure,I-TE
rose,O
to,O
110,O
systolic,O
after,O
two,O
liters,O
of,O
crystalloid,B-TR
.,O

He,O
had,O
an,B-PR
ecchymosis,I-PR
over,O
the,O
medial,O
right,O
costal,O
margin,O
and,O
his,O
abdomen,O
was,O
distended,B-PR
.,O

His,B-TE
hematocrit,I-TE
was,O
36,O
",",O
and,O
creatinine,B-TE
1.6,O
.,O

The,B-TE
abdominal,I-TE
tap,I-TE
was,O
grossly,B-PR
positive,I-PR
for,I-PR
blood,I-PR
.,O

His,B-TE
blood,I-TE
pressure,I-TE
fell,O
to,O
60,O
systolic,O
as,O
he,O
was,O
being,O
transferred,O
to,O
the,O
computerized,O
tomography,O
scan,O
table,O
;,O
the,B-TE
scan,I-TE
was,O
aborted,O
and,O
he,O
was,O
taken,O
directly,O
to,O
the,O
operating,O
room,O
at,O
03:00,O
.,O

At,O
laparotomy,B-TR
",",O
there,O
was,O
a,O
liter,O
of,O
blood,B-PR
in,I-PR
the,I-PR
peritoneal,I-PR
cavity,I-PR
.,O

There,O
was,O
a,B-PR
class,I-PR
II,I-PR
laceration,I-PR
of,I-PR
the,I-PR
left,I-PR
liver,I-PR
at,O
the,O
falciform,O
ligament,O
which,O
was,O
actively,O
bleeding,O
",",O
a,B-PR
tear,I-PR
of,I-PR
the,I-PR
transverse,I-PR
mesocolon,I-PR
from,O
its,O
base,O
to,O
the,O
bowel,O
wall,O
with,O
active,B-PR
bleeding,I-PR
",",O
a,B-PR
7,I-PR
cm,I-PR
serosal,I-PR
tear,I-PR
of,I-PR
the,I-PR
adjacent,I-PR
transverse,I-PR
colon,I-PR
",",O
and,O
a,B-PR
large,I-PR
central,I-PR
retroperitoneal,I-PR
hematoma,I-PR
.,O

Control,O
of,O
the,O
super-celiac,O
aorta,O
was,O
obtained,O
",",O
and,O
both,O
left,B-TR
and,I-TR
right,I-TR
sided,I-TR
&quot;,I-TR
Mattox,I-TR
&quot;,I-TR
maneuvers,I-TR
were,O
performed,O
.,O

The,O
retroperitoneum,O
was,O
opened,O
",",O
with,O
vigorous,B-PR
bleeding,I-PR
resulting,O
.,O

This,O
was,O
controlled,O
",",O
necessitating,O
ten,O
minutes,O
of,O
aortic,B-TR
clamping,I-TR
and,O
found,O
to,O
have,O
originated,O
from,O
the,B-PR
rupture,I-PR
of,I-PR
the,I-PR
left,I-PR
renal,I-PR
vein,I-PR
one,O
centimeter,O
from,O
its,O
junction,O
with,O
the,O
inferior,O
vena,O
cava,O
.,O

The,O
vein,O
was,O
divided,O
and,O
suture,B-TR
ligated,O
.,O

Bleeding,B-PR
from,I-PR
the,I-PR
liver,I-PR
was,O
controlled,O
with,O
sutures,B-TR
.,O

The,B-PR
tears,I-PR
in,I-PR
the,I-PR
transverse,I-PR
mesocolon,I-PR
and,I-PR
colon,I-PR
serosa,I-PR
were,O
repaired,O
.,O

The,B-TE
examination,I-TE
of,O
the,O
remainder,O
of,O
the,O
abdominal,O
contents,O
revealed,O
no,O
other,B-PR
injury,I-PR
;,O
in,O
particular,O
",",O
the,O
entire,O
anterior,O
surface,O
and,O
the,O
immediately,O
juxtaduodenal,O
posterior,O
surface,O
of,O
the,O
pancreas,O
were,O
normal,O
.,O

The,O
patient,O
was,O
now,O
very,O
stable,O
",",O
and,O
he,O
was,O
taken,O
to,O
the,O
Respiratory,O
Intensive,O
Care,O
Unit,O
.,O

The,O
patient,O
had,O
received,O
ten,O
units,O
of,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
",",O
five,O
units,O
of,O
fresh,B-TR
frozen,I-TR
plasma,I-TR
",",O
seven,O
units,O
of,O
platelets,B-TR
",",O
and,O
nine,O
liters,O
of,O
Ringer,B-TR
&apos;s,I-TR
lactate,I-TR
.,O

An,B-TE
intracranial,I-TE
pressure,I-TE
monitoring,I-TE
bolt,I-TE
had,O
been,O
placed,O
by,O
the,O
Neurosurgery,O
Service,O
staff,O
during,O
the,B-TR
laparotomy,I-TR
.,O

Intracranial,B-TE
pressures,I-TE
were,O
normal,O
.,O

That,O
day,O
",",O
cranial,B-TE
computerized,I-TE
tomography,I-TE
scan,I-TE
and,O
cervical,B-TE
spine,I-TE
films,I-TE
were,O
normal,O
.,O

An,B-TE
arch,I-TE
aortogram,I-TE
was,O
normal,O
.,O

Over,O
the,O
ensuing,O
twenty-four,O
hours,O
",",O
bilateral,B-PR
infiltrates,I-PR
on,O
chest,B-TE
X-ray,I-TE
with,O
poor,B-PR
oxygenation,I-PR
and,O
labile,B-PR
blood,I-PR
pressure,I-PR
requiring,O
PA,B-TR
line,I-TR
guided,I-TR
fluid,I-TR
and,O
pressors,B-TR
developed,O
.,O

The,O
patient,O
had,O
a,B-PR
large,I-PR
fluid,I-PR
requirement,I-PR
with,O
total,B-PR
body,I-PR
capillary,I-PR
leak,I-PR
",",O
decreasing,B-PR
SVR,I-PR
",",O
oliguria,B-PR
unresponsive,O
to,O
Lasix,B-TR
/,O
Mannitol,B-TR
accompanied,O
by,O
a,B-PR
rise,I-PR
in,O
creatinine,B-TE
to,O
3.2,O
",",O
worsening,B-PR
ARDS,I-PR
",",O
a,B-PR
rise,I-PR
in,O
temperature,B-TE
to,O
103,O
",",O
and,O
a,B-TE
serum,I-TE
amylase,I-TE
of,O
1265,O
.,O

He,O
was,O
returned,O
to,O
the,O
operating,O
room,O
on,O
July,O
4,O
.,O

Three,O
liters,O
of,O
clear,B-PR
green,I-PR
fluid,I-PR
were,O
found,O
in,O
the,O
abdominal,O
cavity,O
.,O

Exploration,B-TE
of,I-TE
the,I-TE
pancreas,I-TE
revealed,O
a,B-PR
posterior,I-PR
fracture,I-PR
a,I-PR
the,I-PR
superior,I-PR
mesenteric,I-PR
vessels,I-PR
.,O

Because,O
of,O
the,B-PR
intense,I-PR
diffuse,I-PR
inflammatory,I-PR
reaction,I-PR
that,O
had,O
already,O
set,O
in,O
",",O
it,O
was,O
decided,O
that,O
neither,O
distal,B-TR
pancreatic,I-TR
resection,I-TR
nor,O
Roux-en-Y,B-TR
drainage,I-TR
was,O
feasible,O
.,O

Four,B-TR
large,I-TR
flat,I-TR
Jackson-Pratt,I-TR
drains,I-TR
were,O
placed,O
",",O
and,O
gastrostomy,B-TR
",",O
jejunostomy,B-TR
",",O
and,O
cholecystostomy,B-TR
tubes,I-TR
",",O
as,O
well,O
as,O
a,B-TR
right,I-TR
subclavian,I-TR
Quinton,I-TR
catheter,I-TR
were,O
placed,O
.,O

The,O
patient,O
&apos;s,O
hemodynamics,O
had,O
improved,O
markedly,O
with,O
the,B-TR
evacuation,I-TR
of,O
the,B-PR
peritoneal,I-PR
pancreatic,I-PR
fluid,I-PR
",",O
so,O
that,O
he,O
was,O
no,O
longer,O
on,O
pressors,B-TR
.,O

However,O
",",O
upon,O
transfer,O
from,O
the,O
operating,O
room,O
table,O
to,O
the,O
RICU,O
bed,O
",",O
he,O
suffered,O
a,B-PR
cardiac,I-PR
arrest,I-PR
",",O
which,O
upon,O
investigation,B-TE
was,O
a,B-PR
primary,I-PR
respiratory,I-PR
arrest,I-PR
;,O
the,B-TE
initial,I-TE
arterial,I-TE
blood,I-TE
gas,I-TE
was,O
32/88/6.92,O
.,O

He,O
was,O
successfully,O
resuscitated,O
after,O
fifteen,O
minutes,O
of,O
cardiopulmonary,B-TR
resuscitation,I-TR
and,O
he,O
was,O
taken,O
to,O
the,O
RICU,O
.,O

Continuous,B-TR
venovenous,I-TR
hemodialysis,I-TR
was,O
started,O
on,O
July,O
5,O
",",O
and,O
continued,O
for,O
most,O
of,O
the,O
remainder,O
of,O
the,O
patient,O
&apos;s,O
course,O
.,O

Vancomycin,B-TR
",",O
Flagyl,B-TR
",",O
and,O
Aztreonam,B-TR
were,O
given,O
for,O
gram,B-PR
negative,I-PR
Coccobacilli,I-PR
(,O
later,O
identified,O
as,O
Bacteroides,B-PR
),O
that,O
had,O
grown,O
in,O
his,B-TE
blood,I-TE
cultures,I-TE
and,O
gram,B-PR
negative,I-PR
rods,I-PR
(,I-PR
Enterobacter,I-PR
),I-PR
in,O
his,B-TE
peritoneal,I-TE
fluid,I-TE
.,O

He,O
was,O
kept,O
sedated,B-TR
and,O
paralyzed,B-TR
because,O
of,O
his,B-PR
severe,I-PR
adult,I-PR
respiratory,I-PR
distress,I-PR
syndrome,I-PR
.,O

Total,B-TR
parenteral,I-TR
nutrition,I-TR
was,O
started,O
on,O
July,O
5,O
.,O

Initial,O
improvement,O
was,O
followed,O
by,O
recurrence,O
of,O
low,B-PR
SVR,I-PR
",",O
high,B-PR
cardiac,I-PR
output,I-PR
",",O
ongoing,B-PR
acidosis,I-PR
",",O
requiring,O
norepinephrine,B-TR
infusion,I-TR
in,O
the,O
30,O
to,O
40,O
mcg,O
per,O
minute,O
range,O
;,O
drainage,B-PR
from,O
the,B-TR
Jackson-Pratt,I-TR
drains,I-TR
were,O
minimal,O
despite,O
irrigation,B-TR
and,O
manipulation,B-TR
.,O

The,O
patient,O
was,O
returned,O
to,O
the,O
operating,O
room,O
on,O
July,O
10,O
",",O
where,O
several,B-PR
loculated,I-PR
thin,I-PR
fluid,I-PR
collections,I-PR
were,O
drained,O
and,O
obviously,B-PR
necrotic,I-PR
tissue,I-PR
was,O
debrided,O
.,O

It,O
was,O
decided,O
to,O
place,O
more,B-TR
drains,I-TR
and,O
pack,O
the,O
lesser,O
sac,O
with,O
Adaptic,B-TR
and,O
laparotomy,B-TR
pads,I-TR
.,O

The,O
abdomen,O
was,O
left,O
open,O
",",O
with,O
the,B-PR
wound,I-PR
margins,I-PR
connected,O
by,O
a,O
sheet,O
of,O
Marlex,B-TR
mesh,I-TR
to,O
prevent,O
evisceration,B-PR
.,O

He,O
was,O
returned,O
to,O
the,O
operating,O
room,O
on,O
July,O
12,O
",",O
13,O
",",O
16,O
",",O
19,O
",",O
21,O
",",O
and,O
23,O
for,O
packing,B-TR
change,I-TR
",",O
irrigation,B-TR
and,O
debridement,B-TR
.,O

Tracheostomy,B-TR
was,O
also,O
performed,O
on,O
July,O
17,O
.,O

There,O
was,O
severe,B-PR
diffuse,I-PR
peritonitis,I-PR
with,O
intense,B-PR
inflammation,I-PR
",",O
infection,B-PR
",",O
and,O
patchy,B-PR
necrosis,I-PR
of,I-PR
peritoneal,I-PR
surfaces,I-PR
and,O
of,O
the,O
distal,O
pancreas,O
.,O

The,O
subsequent,O
overall,O
course,O
was,O
a,O
slow,O
downhill,O
one,O
",",O
with,O
ongoing,B-PR
extreme,I-PR
hyperdynamic,I-PR
(,O
cardiac,B-TE
output,I-TE
12,O
to,O
15,O
liters,O
per,O
minute,O
),O
and,O
catabolic,B-PR
state,I-PR
.,O

On,O
July,O
26,O
",",O
abdominal,B-TR
irrigation,I-TR
and,O
debridement,B-TR
was,O
performed,O
in,O
the,O
RICU,O
;,O
this,O
was,O
repeated,O
daily,O
for,O
the,O
next,O
three,O
days,O
.,O

On,O
July,O
29,O
",",O
the,B-PR
septic,I-PR
state,I-PR
with,O
low,B-PR
SVR,I-PR
and,O
acidosis,B-PR
accelerated,O
beyond,O
the,O
control,O
of,O
maximal,B-TR
support,I-TR
.,O

His,B-TE
blood,I-TE
pressure,I-TE
gradually,O
fell,O
",",O
and,O
he,O
died,O
early,O
on,O
July,O
30,O
",",O
1993,O
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

Severe,B-PR
blunt,I-PR
abdominal,I-PR
trauma,I-PR
with,O
rupture,B-PR
of,I-PR
liver,I-PR
",",I-PR
left,I-PR
renal,I-PR
vein,I-PR
",",I-PR
pancreas,I-PR
",",I-PR
and,I-PR
transverse,I-PR
mesocolon,I-PR
.,O

SPECIAL,O
PROCEDURES,O
AND,O
OPERATIONS,O
:,O

1.,O
7-2-93,O
",",O
emergency,O
room,O
exploratory,B-TE
laparotomy,I-TE
",",O
repair,B-TR
of,O
liver,B-PR
laceration,I-PR
",",O
repair,B-TR
of,O
torn,B-PR
transverse,I-PR
mesocolon,I-PR
",",O
repair,B-TR
of,O
serosal,B-PR
tear,I-PR
of,I-PR
transverse,I-PR
colon,I-PR
",",O
ligation,B-TR
and,O
division,B-TR
of,O
ruptured,B-PR
left,I-PR
renal,I-PR
vein,I-PR
",",O
exploration,B-TE
of,I-TE
pancreas,I-TE
",",O

2.,O
7-4-93,O
",",O
exploratory,B-TE
laparotomy,I-TE
",",O
irrigation,B-TR
and,O
debridement,B-TR
",",O
pancreatic,B-TR
drainage,I-TR
placement,I-TR
",",O
gastrostomy,B-TR
tube,I-TR
",",O
jejunostomy,B-TR
",",O
cholecystostomy,B-TR
",",O
placement,B-TR
of,I-TR
right,I-TR
subclavian,I-TR
Quinton,I-TR
catheter,I-TR
",",O

3.,O
7-10-93,O
",",O
abdominal,B-TR
irrigation,I-TR
and,O
debridement,B-TR
and,O
packing,B-TR
of,I-TR
pancreas,I-TR
",",O

4.,O
7-12-93,O
",",O
7-14,O
",",O
7-20,O
",",O
7-22,O
",",O
and,O
7-24,O
",",O
were,O
the,O
same,O
as,O
7-10-93,O
",",O
and,O
7-17,O
was,O
the,O
same,O
with,O
the,O
addition,O
of,O
tracheostomy,B-TR
were,O
same,O
as,O
7-10,O
",",O

COMPLICATIONS,O
:,O

Severe,B-PR
necrotizing,I-PR
pancreatitis,I-PR
and,O
diffuse,B-PR
peritonitis,I-PR
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

N,O
/,O
A.,O

DOCTORS,O
DISCHARGE,O
ORDERS,O
:,O

N,O
/,O
A.,O

ESTIMATED,O
DISABILITY,O
AND,O
PROBABLE,O
DURATION,O
:,O

N,O
/,O
A.,O

DISPOSITION,O
:,O

Mason,O
Street,O
.,O

RISSPA,O
BREATH,O
",",O
M.D.,O

TR,O
:,O

un,O
/,O
bmot,O

DD,O
:,O

08-07-93,O

TD,O
:,O

08/08/93,O

CC,O
:,O

Admission,O
Date,O
:,O

2011-09-18,O

Discharge,O
Date,O
:,O

2011-09-26,O

Date,O
of,O
Birth,O
:,O

1962-05-08,O

Sex,O
:,O

F,O

Service,O
:,O

CMED,O
CCU,O

Allergies,O
:,O

Sulfonamides,B-TR
/,O
Zithromax,B-TR
/,O
Floxin,B-TR
/,O
Penicillins,B-TR
/,O
Neurontin,B-TR
/,O
Demerol,B-TR
/,O
Morphine,B-TR
Sulfate,I-TR
/,O
Ativan,B-TR

Attending,O
:,O
James,O
I,O
Schultz,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O
see,O
dc,O
summary,O

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O
see,O
dc,O
summary,O

History,O
of,O
Present,O
Illness,O
:,O
see,O
dc,O
summary,O

Past,O
Medical,O
History,O
:,O
see,O
dc,O
summary,O

Social,O
History,O
:,O
see,O
dc,O
summary,O

Family,O
History,O
:,O
see,O
dc,O
summary,O

Physical,O
Exam,O
:,O
see,O
dc,O
summary,O

Pertinent,O
Results,O
:,O
see,O
dc,O
summary,O

Brief,O
Hospital,O
Course,O
:,O
see,O
dc,O
summary,O

Medications,O
on,O
Admission,O
:,O
see,O
dc,O
summary,O

Discharge,O
Medications,O
:,O

Change,O
:,O

Pyridium,B-TR
200,O
mg,O
po,O
three,O
times,O
a,O
day,O
for,O
UTI,B-PR
symptoms,I-PR
x,O
2,O
days,O
.,O

Discharge,O
Disposition,O
:,O

Home,O
with,O
Service,O

Discharge,O
Diagnosis,O
:,O
see,O
dc,O
summary,O

Discharge,O
Condition,O
:,O
see,O
dc,O
summary,O

Discharge,O
Instructions,O
:,O
see,O
dc,O
summary,O

Followup,O
Instructions,O
:,O
see,O
dc,O
summary,O

Janine,O
Karina,O
MD,O
98-439,O

Completed,O
by,O
:,O

Harvey,O
Aaron,O
MD,O
37-052,O
2011-09-26,O
@,O
1232,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Stephen,O
Williams,O
on,O
:,O
SAT,O
2011-10-08,O
9:45,O
AM,O

(,O
End,O
of,O
Report,O
),O

285864187,O

OMH,O

7792851,O

920021,O

1/1/1998,O
12:00:00,O
AM,O

1),O
STAPH,B-PR
.,O

SEPSIS,B-PR
RELATED,O
TO,O
PICC,B-TR
LINE,I-TR
.,O

2),O
PREVIOUS,B-PR
ANOXIC,I-PR

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

DISCHARGE,O
SUMMARY,O
NAME,O
:,O

GACH,O
",",O
CH,O

UNIT,O
NUMBER,O
:,O

397-72-29,O

ADMISSION,O
DATE,O
:,O

01/01/98,O

DISCHARGE,O
DATE,O
:,O

01/07/98,O

DIAGNOSES,O
:,O

1),O
Staph.,B-PR
sepsis,I-PR
related,O
to,O
PICC,B-TR
line,I-TR
.,O

2),O
Previous,B-PR
anoxicbrain,I-PR
damage,I-PR
.,O

3),O
Previous,B-PR
myocardial,I-PR
infarction,I-PR
.,O

4),O
coronary,B-PR
artery,I-PR
disease,I-PR
.,O

5),O
status,O
post,O
CABG,B-TR
surgery,I-TR
in,O
11/97,O
.,O

6),O
paroxysmal,B-PR
atrial,I-PR
fibrillation,I-PR
.,O

7),O
mild,B-PR
chronic,I-PR
renal,I-PR
insufficiency,I-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

None,O
.,O

CLINICAL,O
INFECTION,O
:,O

Positive,B-PR
blood,I-PR
cultures,I-PR
with,O
Staph.,B-PR
aureus,I-PR
sensitiveto,O
Methicillin,B-TR
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Hydralazine,B-TR
10,O
mgs,O
PO,O
t.i.d.,O
",",O
Digoxin,B-TR
0.125,O
mgs,O
PO,O
q.d.,O
",",O
thiamine,B-TR
100,O
mgs,O
PO,O
q.d.,O
",",O
multi-vitamin,B-TR
1,O
tab.,O
PO,O
q.d.,O
",",O
Peri,B-TR
-,I-TR
Colace,I-TR
100,O
mgs,O
PO,O
t.i.d.,O
",",O
folate,B-TR
1,O
mg,O
PO,O
q.d.,O
",",O
Norvasc,B-TR
2.5,O
mgs,O
PO,O
q.HS,O
",",O
Ritalin,B-TR
10,O
mgs,O
PO,O
b.i.d.,O
",",O
Trazodone,B-TR
25,O
mgs,O
PO,O
q.HS,O
",",O
Nafcillin,B-TR
2,O
gramsIV,O
q.4H,O
which,O
wil,O
conclude,O
at,O
the,O
end,O
of,O
the,O
day,O
on,O
1/16/98,O
",",O
Atroventnebulizer,B-TR
PRN,O
",",O
Albuterol,B-TR
nebulizer,I-TR
PRN,O
",",O
Tylenol,B-TR
650,O
mgs,O
PO,O
q.4H,O
PRN,O
pain,B-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Mr.,O
Gach,O
is,O
an,O
80,O
year,O
old,O
man,O
with,O
aprevious,O
history,O
of,O
coronary,B-PR
artery,I-PR
disease,I-PR
who,O
was,O
transferred,O
from,O
Linghs,O
County,O
Medical,O
Center,O
to,O
Oaksgekesser/,O
Memorial,O
Hospital,O
because,O
of,O
an,B-PR
apparent,I-PR
infected,I-PR
wound,I-PR
",",O
including,O
the,B-TR
PICC,I-TR
line,I-TR
in,O
his,O
right,O
elbow,O
and,O
positive,B-PR
blood,I-PR
cultures,I-PR
for,O
Staph.,B-PR
aureus,I-PR
associated,O
with,O
fever,B-PR
.,O

He,O
has,O
a,O
history,O
of,O
myocardial,B-PR
infarctions,I-PR
in,O
1981,O
",",O
1992,O
and,O
08/97,O
with,O
thelast,O
episode,O
complicated,O
by,O
anoxic,B-PR
encephalopathy,I-PR
.,O

He,O
gradually,O
improved,O
but,O
had,O
recurrent,B-PR
angina,I-PR
requiring,O
cardiac,B-TE
catheterization,I-TE
",",O
demonstrating,O
90%,O
left,O
main,O
",",O
95%,O
ostial,O
LAD,O
and,O
30,O
to,O
40%,O
mid-LAD,O
with,O
an,B-PR
occluded,I-PR
RCA,I-PR
.,O

CABG,B-TR
surgery,I-TR
with,O
two,B-TR
vessel,I-TR
bypass,I-TR
was,O
done,O
on,O
11/18/97,O
.,O

He,O
was,O
then,O
transferred,O
to,O
Linghs,O
County,O
Medical,O
Center,O
.,O

A,B-TR
PICC,I-TR
line,I-TR
was,O
placed,O
in,O
his,O
left,O
antecubital,O
fossa,O
and,O
on,O
the,O
day,O
of,O
New,O
Years,O
Eve,O
he,O
developed,O
a,B-PR
fever,I-PR
of,O
102,O
and,O
became,O
lethargic,B-PR
.,O

The,B-TR
PICC,I-TR
line,I-TR
site,I-TR
was,O
erythematous,B-PR
.,O

Blood,B-TE
cultures,I-TE
grew,O
out,O
4,O
out,O
of,O
4,O
bottles,O
for,O
gram,B-PR
positive,I-PR
cocci,I-PR
",",O
which,O
thereafter,O
proved,O
to,O
be,O
Staph.,B-PR
aureus,I-PR
Methicillin,B-TR
sensitive,O
.,O

He,O
had,O
no,O
chest,B-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
or,O
diarrhea,B-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Includes,O
ischemic,B-PR
cardiomyopathy,I-PR
with,O
an,B-TE
echocardiogram,I-TE
done,O
on,O
11/13/97,O
showing,O
an,B-TE
ejection,I-TE
fraction,I-TE
of,O
28%,O
and,O
LV,O
that,O
is,O
diffusely,B-PR
hypokinetic,I-PR
.,O

OTHER,O
MEDICAL,O
PROBLEMS,O
:,O

1),O
Dementia,B-PR
",",O

2),O
paroxysmal,B-PR
atrial,I-PR
"fibrillation,",I-PR

3),O
hypertension,B-PR
",",O

4),O
peripheral,B-PR
vascular,I-PR
disease,I-PR
with,O
previous,B-TR
left,I-TR
femoral,I-TR
popliteal,I-TR
bypass,I-TR
",",O

5),O
diabetes,B-PR
mellitus,I-PR
",",O

6),O
chronic,B-PR
renal,I-PR
"insufficiency,",I-PR

7),O
COPD,B-PR
",",O

8),O
previous,B-TR
abdominal,I-TR
aortic,I-TR
aneurysm,I-TR
repair,I-TR
in,O
1981,O
",",O

9),O
benign,B-PR
prostatic,I-PR
hypertrophy,I-PR
status,O
post,O
TURP,B-TR
surgery,I-TR
in,O
1982,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Aspirin,B-TR
325,O
mgs,O
PO,O
q.d.,O
",",O
Prilosec,B-TR
20,O
mgs,O
PO,O
q.d.,O
",",O
Azmacort,B-TR
2,O
puffs,O
q.i.d.,O
PRN,O
",",O
Atrovent,B-TR
2,O
puffs,O
q.i.d.,O
PRN,O
",",O
heparin,B-TR
"5,000",O
units,O
subcu.,O
b.i.d.,O
",",O
Digoxin,B-TR
0.125,O
mgs,O
PO,O
q.d.,O
",",O
Wellbutrin,B-TR
37.5,O
mgs,O
PO,O
b.i.d.,O
",",O
Kaopectate,B-TR
PRN,O
",",O
Betoptic,B-TR
0.25%,O
OU,O
q.d.,O
",",O
Ritalin,B-TR
10,O
mgs,O
PO,O
q.a.m.,O
and,O
at,O
noon,O
time,O
",",O
Norvasc,B-TR
2.5,O
mgs,O
PO,O
q.d.,O

The,O
patient,O
reported,O
disorientation,B-PR
with,O
Ambien,B-TR
and,O
Halcyon,B-TR
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

No,O
other,B-PR
medical,I-PR
problems,I-PR
other,O
than,O
stated,O
above,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Elderly,O
white,O
male,O
who,O
was,O
somnolent,B-PR
",",O
looking,O
his,O
stated,O
age,O
.,O

His,B-TE
temperature,I-TE
was,O
97.5,O
",",O
pulse,B-TE
90,O
",",O
respiratory,B-TE
rate,I-TE
20,O
",",O
blood,B-TE
pressure,I-TE
104/60,O
",",O
o2,B-TE
sat.,I-TE
97%.,O

Eyes,O
-,O
pupils,O
equal,O
",",O
round,O
",",O
reactive,O
to,O
light,O
",",O
sclera,O
non-icteric,B-PR
.,O

Neck,O
-,O
supple,O
without,O
masses,B-PR
or,O
thyromegaly,B-PR
.,O

Lungs,O
-,O
clear,O
to,O
percussion,B-TE
and,O
auscultation,B-TE
on,O
both,O
sides,O
.,O

Cardiovascular,O
examination,O
-,O
normal,O
jugular,O
venous,O
pressure,O
",",O
normal,O
carotid,O
upstrokes,O
with,O
bruits,B-PR
",",O
there,O
are,O
distant,B-PR
heart,I-PR
sounds,I-PR
",",O
S1,O
and,O
S2,O
are,O
normal,O
",",O
there,O
are,O
no,O
murmurs,B-PR
detected,O
.,O

Abdomen,O
-,O
soft,O
",",O
non-tender,B-PR
without,O
organomegaly,B-PR
or,O
masses,B-PR
.,O

Extremities,O
-,O
without,O
cyanosis,B-PR
or,O
edema,B-PR
.,O

Neurologic,B-TE
examination,I-TE
-,O
somnolent,B-PR
",",O
awake,O
",",O
arousable,O
to,O
commands,O
",",O
though,O
he,O
falls,O
asleep,O
rapidly,O
.,O

Deep,B-TE
tendon,I-TE
reflexes,I-TE
are,O
2+,O
and,O
symmetric,O
",",O
toes,O
were,O
up,B-PR
going,I-PR
bilaterally,I-PR
.,O

LABORATORY,O
DATA,O
:,O

Sodium,B-TE
131,O
",",O
potassium,B-TE
4.5,O
",",O
BUN,B-TE
45,O
",",O
creatinine,B-TE
2.0,O
",",O
glucose,B-TE
134,O
",",O
bilirubin,B-TE
0.4.,O
Blood,B-TE
gas,I-TE
on,O
5,B-TR
liters,I-TR
nasal,I-TR
o2,I-TR
-,O
PO2,B-TE
106,O
",",O
PCO227,B-TE
",",O
pH,B-TE
7.41,O
.,O

Blood,B-TE
cultures,I-TE
were,O
obtained,O
",",O
urine,B-TE
cultures,I-TE
were,O
obtained,O
.,O

Chest,B-TE
x-ray,I-TE
-,O
low,B-PR
lung,I-PR
volumes,I-PR
",",O
bibasilar,B-PR
opacities,I-PR
",",O
no,O
evidence,O
of,O
heart,B-PR
failure,I-PR
.,O

EKG,B-TE
-,O
technically,O
poor,O
tracing,O
with,O
what,O
appears,O
to,O
be,O
normal,O
sinus,O
rhythm,O
with,O
very,B-PR
small,I-PR
P,I-PR
waves,I-PR
",",O
there,O
are,O
Q-waves,B-PR
in,I-PR
leads,I-PR
V1,I-PR
and,I-PR
V2,I-PR
",",O
as,O
well,O
as,O
in,O
V3,O
.,O

There,O
are,O
non-specific,B-PR
ST,I-PR
T,I-PR
wave,I-PR
changes.,I-PR

The,B-TE
blood,I-TE
cultures,I-TE
at,O
Linghs,O
County,O
Medical,O
Center,O
grew,O
out,O
Staph.,B-PR
aureus,I-PR
sensitive,O
to,O
methicillin,B-TR
.,O

The,B-TE
blood,I-TE
cultures,I-TE
obtained,O
a,O
Oaksgekesser/,O
Memorial,O
Hospital,O
were,O
negative,O
.,O

An,B-TE
echocardiogram,I-TE
obtained,O
at,O
Oaksgekesser/,O
Memorial,O
Hospital,O
obtained,O
as,O
a,B-TE
transthoracic,I-TE
echocardiogram,I-TE
showed,O
an,B-TE
ejection,I-TE
fraction,I-TE
of,O
33%,O
",",O
wall,B-TE
thickness,I-TE
12,O
mms,O
at,O
the,O
septum,O
",",O
posterior,B-TE
wall,I-TE
11,O
mms.,O
",",O
left,B-TE
atrial,I-TE
size,I-TE
40,O
mms,O
.,O

There,O
is,O
anteroseptal,B-PR
hypokinesis,I-PR
with,O
mid,B-PR
and,I-PR
apical,I-PR
akinesis,I-PR
.,O

HOSPITAL,O
COURSE,O
AND,O
TREATMENT,O
:,O

The,O
patient,O
was,O
treated,O
with,O
intravenous,B-TR
antibiotics,I-TR
.,O

A,B-TE
lumbar,I-TE
puncture,I-TE
was,O
obtained,O
which,O
showed,O
normal,O
pressure,O
and,O
no,O
cells,B-PR
.,O

The,B-TE
CSF,I-TE
culture,I-TE
was,O
negative,O
.,O

A,B-TE
stool,I-TE
assay,I-TE
was,O
taken,O
for,O
Clostridium,B-PR
difficile,I-PR
which,O
was,O
negative,O
.,O

The,O
patient,O
gradually,O
improved,O
on,O
the,B-TR
current,I-TR
therapy,I-TR
and,O
was,O
quite,O
awake,O
and,O
alert,O
",",O
though,O
still,O
appeared,O
to,O
have,O
some,O
evidence,O
of,O
dementia,B-PR
and,O
disorientation,B-PR
.,O

He,O
was,O
encouraged,O
to,O
eat,O
and,O
it,O
was,O
decided,O
not,O
to,O
place,O
either,O
a,B-TR
feeding,I-TR
tube,I-TR
or,O
to,O
start,O
TPN,B-TR
.,O

Dr.,O
Rhalttland,O
was,O
called,O
at,O
Sondi,O
Memorial,O
to,O
update,O
him,O
on,O
the,O
patient,O
&apos;s,O
condition,O
.,O

He,O
still,O
needs,O
much,B-TR
intensive,I-TR
rehabilitation,I-TR
",",O
encouragement,O
to,O
eat,O
and,O
encouragement,O
to,O
get,O
out,O
of,O
bed,O
to,O
use,O
the,O
bathroom,O
rather,O
than,O
abed,B-TR
pain,I-TR
or,O
a,B-TR
diaper,I-TR
.,O

He,O
is,O
being,O
transferred,O
to,O
Linghs,O
County,O
Medical,O
Center,O
for,O
further,B-TR
care,I-TR
.,O

CONDITION,O
:,O

Stable,O
and,O
improved,O
.,O

LAKO,O
C.,O
WARM,O
",",O
M.D.,O
STAT,O

TR,O
:,O

lv,O

DD,O
:,O

01/06/98,O

TD,O
:,O

01/06/98,O
7:41,O

Pcc,O
:,O

LAKO,O
C,O
WARM,O
",",O
M.D.,O

Admission,O
Date,O
:,O

2013-08-26,O

Discharge,O
Date,O
:,O

2013-09-17,O

Date,O
of,O
Birth,O
:,O

1945-02-07,O

Sex,O
:,O

M,O

Service:,O

NOTE,O
:,O

The,O
Discharge,O
Date,O
of,O
2013-09-17,O
is,O
pending,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Briefly,O
",",O
this,O
68,O
year,O
old,O
male,O
with,O
a,O
history,O
of,O
coronary,B-PR
artery,I-PR
disease,I-PR
",",O
diabetes,B-PR
mellitus,I-PR
",",O
peripheral,B-PR
vascular,I-PR
disease,I-PR
",",O
was,O
admitted,O
originally,O
to,O
the,O
Podiatry,O
Service,O
for,O
a,B-PR
left,I-PR
patellar,I-PR
mid-foot,I-PR
ulcer,I-PR
.,O

He,O
underwent,O
angiogram,B-TE
on,O
2013-08-28,O
",",O
to,O
evaluate,O
his,O
circulation,O
and,O
found,O
at,O
that,O
time,O
that,O
the,O
patient,O
had,O
a,B-PR
poor,I-PR
circulation,I-PR
to,I-PR
the,I-PR
left,I-PR
leg,I-PR
.,O

The,O
patient,O
was,O
transferred,O
to,O
the,O
Vascular,O
Surgery,O
Service,O
for,O
bilateral,B-TR
iliac,I-TR
stenting,I-TR
at,O
that,O
time,O
.,O

The,O
patient,O
also,O
at,O
that,O
time,O
was,O
followed,O
by,O
Cardiology,O
and,O
for,O
preoperative,B-TE
evaluation,I-TE
had,O
a,B-TE
stress,I-TE
test,I-TE
which,O
was,O
positive,B-PR
and,O
he,O
became,O
diaphoretic,B-PR
but,O
denied,O
any,B-PR
chest,I-PR
pain,I-PR
.,O

Atropine,B-TR
was,O
given,O
and,O
heart,B-TE
rate,I-TE
returned,O
to,O
the,O
70s,O
and,O
his,B-TE
blood,I-TE
pressure,I-TE
returned,O
to,O
the,O
120s,O
over,O
80s,O
.,O

The,O
patient,O
denied,O
any,O
orthopnea,B-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
chest,B-PR
pain,I-PR
",",O
paroxysmal,B-PR
nocturnal,I-PR
dyspnea,I-PR
or,O
cough,B-PR
.,O

He,O
had,O
occasional,B-PR
leg,I-PR
swelling,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY:,O

1,O
.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
status,O
post,O
myocardial,B-PR
infarction,I-PR
in,O
2006,O
and,O
1997,O
and,O
status,O
post,O
percutaneous,B-TR
transluminal,I-TR
coronary,I-TR
angioplasty,I-TR
times,O
two,O
.,O

2.,O
Diabetes,B-PR
mellitus,I-PR
type,I-PR
2,I-PR
since,O
age,O
25,O
;,O
now,O
currently,O
on,O
insulin,B-TR
",",O
which,O
is,O
complicated,O
by,O
peripheral,B-PR
neuropathy,I-PR
",",O
nephropathy,B-PR
and,O
Charcot,B-PR
's,I-PR
foot,I-PR
.,O

3.,O
Chronic,B-PR
renal,I-PR
insufficiency,I-PR
.,O

4.,O
Peripheral,B-PR
vascular,I-PR
disease,I-PR
status,O
post,O
left,B-TR
iliac,I-TR
stent,I-TR
and,O
right,B-TR
femoral,I-TR
stent,I-TR
.,O

5.,O
Hypertension,B-PR
.,O

6.,O
High,B-PR
cholesterol,I-PR
.,O

7.,O
Question,O
of,O
tendonitis,B-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

1.,O
Insulin,B-TR
70/30,O
",",O
40,O
units,O
q.,O
a.m.,O
and,O
40,O
units,O
q.,O
p.m.,O

2.,O
Diovan,B-TR
160,O
mg,O
p.o.,O
q.,O
day,O
.,O

3.,O
Nortriptyline,B-TR
25,O
mg,O
p.o.,O
q.,O
h.s.,O

4.,O
Norvasc,B-TR
10,O
mg,O
p.o.,O
q.,O
day,O
.,O

5.,O
Metoprolol,B-TR
50,O
mg,O
p.o.,O
twice,O
a,O
day,O
.,O

6.,O
Hydrochlorothiazide,B-TR
",",O
15,O
mg,O
p.o.,O
q.,O
day,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,O
patient,O
was,O
afebrile,B-PR
;,O
his,B-TE
vital,I-TE
signs,I-TE
were,O
stable,O
.,O

His,O
neck,O
was,O
supple,O
;,O
he,O
had,O
no,O
jugular,B-PR
venous,I-PR
distention,I-PR
.,O

His,O
carotids,O
were,O
two,O
plus,O
bilaterally,O
without,O
bruits,B-PR
.,O

His,O
lungs,O
were,O
clear,O
.,O

His,O
heart,O
was,O
regular,O
rate,O
and,O
rhythm,O
with,O
no,O
murmurs,B-PR
",",O
rubs,B-PR
or,O
gallops,B-PR
.,O

His,O
abdomen,O
was,O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
.,O

Bowel,O
sounds,O
are,O
present,O
.,O

He,O
had,O
bilateral,B-PR
femoral,I-PR
bruits,I-PR
and,O
he,O
had,O
one,B-TE
plus,I-TE
popliteal,I-TE
pulses,I-TE
.,O

His,B-TE
pedal,I-TE
pulses,I-TE
are,O
absent,B-PR
.,O

LABORATORY,O
:,O

On,O
admission,O
",",O
his,B-TE
BUN,I-TE
was,O
13,O
",",O
creatinine,B-TE
1.7,O
",",O
hematocrit,B-TE
43,O
and,O
the,B-TE
cholesterol,I-TE
was,O
208,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
is,O
admitted,O
to,O
this,O
hospital,O
through,O
the,O
Podiatry,O
Service,O
;,O
however,O
",",O
the,B-TE
stress,I-TE
test,I-TE
showed,O
multi-vessel,B-PR
disease,I-PR
.,O

Podiatry,O
continued,O
to,O
follow,O
for,O
evaluation,B-TE
of,O
his,B-PR
left,I-PR
foot,I-PR
ulcer,I-PR
.,O

At,O
the,O
time,O
of,O
discharge,O
",",O
he,O
was,O
having,O
acetic,B-TR
acid,I-TR
wet-to-dry,I-TR
dressing,I-TR
changes,I-TR
",",O
0.25%,O
q.,O
day,O
.,O

Vascular,O
Surgery,O
was,O
following,O
at,O
the,O
same,O
time,O
and,O
decided,O
that,O
bilateral,B-TR
iliac,I-TR
stenting,I-TR
would,O
be,O
the,B-TR
most,I-TR
optimum,I-TR
treatment,I-TR
currently,O
and,O
suggested,O
that,O
the,O
patient,O
should,O
be,O
worked,O
up,O
for,O
cardiac,B-PR
disease,I-PR
prior,O
to,O
re-vascularization,B-TR
.,O

Medicine,O
was,O
also,O
consulted,O
at,O
that,O
time,O
for,O
high,B-PR
blood,I-PR
pressure,I-PR
and,O
for,O
the,B-PR
biceps,I-PR
pain,I-PR
.,O

While,O
having,O
angiography,B-TE
",",O
he,O
had,O
a,B-PR
transient,I-PR
increase,I-PR
in,O
his,B-TE
blood,I-TE
pressure,I-TE
and,O
became,O
diaphoretic,B-PR
and,O
thus,O
precipitated,O
the,B-TE
evaluation,I-TE
for,O
cardiac,B-PR
disease,I-PR
.,O

Cardiology,O
was,O
consulted,O
at,O
that,O
time,O
to,O
evaluate,O
his,O
heart,O
.,O

The,O
patient,O
was,O
managed,O
on,O
the,O
Medical,O
Service,O
for,O
his,B-PR
drop,I-PR
in,O
blood,B-TE
pressure,I-TE
and,O
cardiac,B-TE
evaluation,I-TE
.,O

He,O
was,O
also,O
followed,O
by,O
Podiatry,O
and,O
Vascular,O
Surgery,O
.,O

He,O
was,O
taken,O
to,O
the,O
Cardiac,O
Catheterization,O
Laboratory,O
which,O
showed,O
multi-vessel,B-PR
disease,I-PR
and,O
Cardiothoracic,O
Surgery,O
was,O
consulted,O
.,O

The,O
patient,O
was,O
taken,O
to,O
the,O
Operating,O
Room,O
on,O
2013-09-04,O
",",O
where,O
a,B-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
times,O
four,O
was,O
performed,O
",",O
left,B-TR
internal,I-TR
mammary,I-TR
artery,I-TR
to,I-TR
left,I-TR
anterior,I-TR
descending,I-TR
",",O
saphenous,B-TR
vein,I-TR
graft,I-TR
to,I-TR
diagonal,I-TR
",",O
saphenous,B-TR
vein,I-TR
graft,I-TR
to,I-TR
obtuse,I-TR
marginal,I-TR
and,O
saphenous,B-TR
vein,I-TR
graft,I-TR
to,I-TR
PC,I-TR
by,O
Dr.,O
Wright,O
.,O

The,O
patient,O
was,O
transferred,O
to,O
the,O
CSRU,O
postoperatively,O
where,O
he,O
did,O
well,O
.,O

He,O
was,O
slowly,O
weaned,O
from,O
his,B-TR
ventilator,I-TR
and,O
was,O
able,O
to,O
be,O
extubated,O
.,O

The,O
patient,O
was,O
able,O
to,O
be,O
weaned,O
to,O
six,B-TR
liters,I-TR
nasal,I-TR
cannula,I-TR
after,O
extubation,B-TR
",",O
however,O
",",O
it,O
was,O
noted,O
on,O
chest,B-TE
x-ray,I-TE
that,O
he,O
had,O
a,B-PR
small,I-PR
apical,I-PR
pneumothorax,I-PR
.,O

A,B-TE
repeat,I-TE
chest,I-TE
x-ray,I-TE
showed,O
resolution,O
of,O
that,B-PR
pneumothorax,I-PR
.,O

The,O
patient,O
was,O
continued,O
on,O
an,B-TR
insulin,I-TR
drip,I-TR
for,O
his,B-PR
diabetes,I-PR
mellitus,I-PR
but,O
continued,O
to,O
improve,O
.,O

His,B-TR
chest,I-TR
tube,I-TR
was,O
in,O
place,O
for,O
a,B-PR
high,I-PR
chest,I-PR
tube,I-PR
output,I-PR
.,O

His,B-TR
Foley,I-TR
catheter,I-TR
was,O
removed,O
and,O
the,O
patient,O
was,O
transferred,O
to,O
the,O
Floor,O
.,O

Physical,O
Therapy,O
was,O
consulted,O
in,O
order,O
to,O
assess,O
the,O
patient,O
's,O
ambulation,O
and,O
mobility,O
",",O
however,O
",",O
with,O
his,B-PR
foot,I-PR
infection,I-PR
and,O
associated,B-PR
pain,I-PR
",",O
it,O
was,O
difficult,O
to,O
assess,O
at,O
that,O
time,O
.,O

After,O
arriving,O
on,O
the,O
Floor,O
",",O
the,O
patient,O
had,O
an,O
episode,O
of,O
rapid,B-PR
atrial,I-PR
fibrillation,I-PR
which,O
was,O
treated,O
with,O
amiodarone,B-TR
and,O
Lopressor,B-TR
.,O

The,O
patient,O
resolved,O
",",O
however,O
",",O
Lasix,B-TR
was,O
also,O
given,O
due,O
to,O
some,B-PR
pulmonary,I-PR
edema,I-PR
and,O
increasing,B-PR
oxygen,I-PR
need,I-PR
.,O

The,O
patient,O
continued,O
to,O
have,O
episodes,O
of,O
rapid,B-PR
atrial,I-PR
fibrillation,I-PR
while,O
on,O
the,O
Floor,O
",",O
which,O
required,O
continued,O
diuresis,B-TR
as,O
well,O
as,O
intravenous,B-TR
Lopressor,I-TR
.,O

His,B-TR
chest,I-TR
tube,I-TR
and,O
Foley,B-TR
catheter,I-TR
were,O
removed,O
on,O
postoperative,O
day,O
number,O
three,O
",",O
and,O
the,O
patient,O
had,O
aggressive,B-TR
chest,I-TR
Physical,I-TR
Therapy,I-TR
and,O
nebulizer,B-TR
treatments,I-TR
.,O

His,B-TR
dressing,I-TR
changes,I-TR
for,I-TR
his,I-TR
foot,I-TR
continued,O
per,O
the,O
Podiatry,O
Service,O
and,O
his,B-PR
leg,I-PR
ulcer,I-PR
was,O
noted,O
to,O
be,O
slowly,O
healing,O
.,O

The,O
patient,O
had,O
multiple,O
episodes,O
of,O
rapid,B-PR
atrial,I-PR
fibrillation,I-PR
which,O
again,O
required,O
intravenous,B-TR
Lopressor,I-TR
.,O

Amiodarone,B-TR
boluses,I-TR
were,O
given,O
and,O
the,O
patient,O
was,O
started,O
on,O
400,O
three,O
times,O
a,O
day,O
of,O
p.o.,B-TR
amiodarone,I-TR
",",O
aggressive,B-TR
pulmonary,I-TR
toilet,I-TR
and,O
continued,B-TR
diuresis,I-TR
was,O
done,O
",",O
however,O
",",O
the,O
patient,O
continued,O
to,O
have,O
respiratory,B-PR
difficulties,I-PR
when,O
in,O
rapid,B-PR
atrial,I-PR
fibrillation,I-PR
.,O

The,O
patient,O
was,O
evaluated,O
on,O
postoperative,O
day,O
number,O
five,O
and,O
it,O
was,O
decided,O
at,O
that,O
time,O
that,O
the,O
patient,O
should,O
be,O
transferred,O
back,O
to,O
the,O
Intensive,O
Care,O
Unit,O
for,O
respiratory,B-PR
difficulties,I-PR
.,O

He,O
was,O
transferred,O
back,O
to,O
the,O
Surgical,O
Intensive,O
Care,O
Unit,O
where,O
he,O
was,O
aggressively,O
diuresed,O
as,O
well,O
as,O
his,B-TE
rate,I-TE
was,O
controlled,O
and,O
chest,B-TR
Physical,I-TR
Therapy,I-TR
and,O
nebulizer,B-TR
treatments,I-TR
were,O
done,O
.,O

The,O
patient,O
improved,O
slowly,O
.,O

Also,O
",",O
his,B-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
was,O
found,O
to,O
rise,O
to,O
32.0,O
;,O
this,O
was,O
most,O
likely,O
due,O
to,O
a,B-PR
secondary,I-PR
infection,I-PR
of,I-PR
his,I-PR
foot,I-PR
and,O
Zosyn,B-TR
was,O
started,O
.,O

The,O
patient,O
continued,O
to,O
do,O
well,O
and,O
his,B-PR
recurrent,I-PR
atrial,I-PR
fibrillation,I-PR
slowly,O
improved,O
;,O
p.o.,O
doses,O
of,O
Lopressor,B-TR
slowly,O
increased,O
to,O
get,O
better,O
control,O
of,O
his,B-TE
rate,I-TE
and,O
the,O
patient,O
was,O
able,O
to,O
be,O
controlled,O
with,O
a,B-TE
heart,I-TE
rate,I-TE
in,O
the,O
50s,O
to,O
60s,O
with,O
Lopressor,B-TR
.,O

Following,O
initiation,O
of,O
his,B-TR
Zosyn,I-TR
",",O
the,B-TE
white,I-TE
count,I-TE
continued,O
to,O
improve,O
and,O
the,O
patient,O
was,O
planned,O
for,O
a,B-TR
PICC,I-TR
line,I-TR
for,O
long-term,B-TR
intravenous,I-TR
antibiotics,I-TR
.,O

The,O
patient,O
was,O
started,O
on,O
Lopressor,B-TR
75,O
mg,O
p.o.,O
twice,O
a,O
day,O
with,O
good,O
control,O
with,O
a,B-TE
heart,I-TE
rate,I-TE
of,O
50s,O
to,O
60s,O
.,O

He,O
is,O
in,O
sinus,O
rhythm,O
.,O

He,O
was,O
also,O
started,O
on,O
his,B-TR
preoperative,I-TR
medications,I-TR
of,O
Amlodipine,B-TR
and,O
Losartan,B-TR
with,O
improvement,O
of,O
his,B-TE
blood,I-TE
pressure,I-TE
.,O

The,O
patient,O
was,O
also,O
reduced,O
to,O
400,O
mg,O
q.,O
day,O
of,O
amiodarone,B-TR
.,O

Pulmonary,O
was,O
consulted,O
at,O
this,O
time,O
for,O
this,B-PR
difficulty,I-PR
of,I-PR
diuresis,I-PR
and,O
pulmonary,B-PR
edema,I-PR
.,O

They,O
continued,O
to,O
agree,O
with,O
the,O
management,O
of,O
the,O
patient,O
and,O
with,O
aggressive,B-TR
pulmonary,I-TR
toilet,I-TR
as,O
well,O
as,O
diuresis,B-TR
and,O
nebulizer,B-TR
treatment,I-TR
.,O

The,O
patient,O
was,O
transferred,O
back,O
from,O
the,O
Intensive,O
Care,O
Unit,O
on,O
2013-09-13,O
",",O
and,O
upon,O
arriving,O
on,O
the,O
floor,O
",",O
he,O
continued,O
to,O
do,O
well,O
.,O

Pulmonary,B-TR
toilet,I-TR
and,O
aggressive,B-TR
chest,I-TR
Physical,I-TR
Therapy,I-TR
was,O
continued,O
and,O
the,O
patient,O
was,O
able,O
to,O
be,O
weaned,O
from,O
his,B-TR
oxygen,I-TR
.,O

Furthermore,O
",",O
his,B-TR
Foley,I-TR
catheter,I-TR
was,O
removed,O
and,O
he,O
was,O
started,O
on,O
anti-coagulation,B-TR
for,O
his,O
episodes,O
of,O
atrial,B-PR
fibrillation,I-PR
.,O

He,O
had,O
been,O
started,O
on,O
heparin,B-TR
in,O
the,O
Intensive,O
Care,O
Unit,O
and,O
that,O
was,O
continued,O
.,O

Coumadin,B-TR
was,O
then,O
begun,O
with,O
a,B-TE
goal,I-TE
INR,I-TE
of,O
2.0,O
to,O
3.0,O
.,O

At,O
that,O
time,O
he,O
was,O
stabilized,O
from,O
a,O
cardiac,O
perspective,O
.,O

Podiatry,O
and,O
Vascular,O
Surgery,O
were,O
reconsulted,O
to,O
assess,O
the,O
patient,O
's,O
needs,O
for,O
revascularization,B-TR
and,O
for,O
his,B-PR
foot,I-PR
ulcer,I-PR
.,O

It,O
was,O
decided,O
at,O
that,O
time,O
that,O
the,O
patient,O
could,O
be,O
discharged,O
in,O
follow-up,O
with,O
Vascular,O
Surgery,O
for,O
revascularization,B-TR
and,O
Podiatry,O
thereafter,O
.,O

On,O
2013-08-28,O
",",O
the,O
patient,O
had,O
a,B-TR
PICC,I-TR
line,I-TR
placed,O
for,O
a,O
six,O
week,O
course,O
of,O
intravenous,B-TR
Zosyn,I-TR
for,O
his,B-PR
foot,I-PR
ulcer,I-PR
and,O
his,B-TR
Coumadin,I-TR
was,O
also,O
continued,O
.,O

The,O
patient,O
did,O
well,O
and,O
was,O
discharged,O
to,O
a,O
rehabilitation,O
facility,O
at,O
that,O
time,O
.,O

His,O
discharge,O
date,O
is,O
pending,O
.,O

CURRENT,O
DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Regular,B-TR
insulin,I-TR
sliding,I-TR
scale,I-TR
.,O

2.,O
Coumadin,B-TR
7.5,O
mg,O
p.o.,O
q.d.,O
for,O
an,B-TE
INR,I-TE
goal,I-TE
of,O
2.0,O
to,O
3.0,O
and,O
adjust,O
the,O
dose,O
accordingly,O
.,O

3.,O
Acetic,B-TR
acid,I-TR
0.25%,O
wet-to-dry,B-TR
dressing,I-TR
changes,I-TR
q.,O
day,O
for,O
his,B-PR
left,I-PR
foot,I-PR
ulcer,I-PR
.,O

4.,O
Amiodarone,B-TR
400,O
mg,O
q.,O
day,O
.,O

5.,O
Albuterol,B-TR
nebulizers,I-TR
q.,O
four,O
hours,O
and,O
q.,O
two,O
hours,O
p.r.n.,O

6.,O
Losartan,B-TR
50,O
mg,O
p.o.,O
q.,O
day,O
.,O

7.,O
Iron,B-TR
325,O
mg,O
p.o.,O
q.,O
day,O
.,O

8.,O
Albuterol,B-TR
ipratropium,B-TR
two,O
puffs,O
four,O
times,O
a,O
day,O
.,O

9.,O
Zosyn,B-TR
4.5,O
grams,O
intravenously,O
q.,O
six,O
hours,O
times,O
six,O
weeks,O
;,O
started,O
on,O
09-10,O
.,O

10.,O
Lipitor,B-TR
10,O
mg,O
p.o.,O
q.,O
day,O
.,O

11.,O
Amlodipine,B-TR
10,O
mg,O
p.o.,O
q.,O
day,O
.,O

12.,O
Nortriptyline,B-TR
25,O
mg,O
p.o.,O
q.,O
h.s.,O

13.,O
Mecsazopam,B-TR
15,O
to,O
30,O
mg,O
p.o.,O
q.,O
h.s.,O
p.r.n.,O

14.,O
Dulcolax,B-TR
10,O
mg,O
p.o.,O
or,O
p.r.,O
q.,O
day,O
p.r.n.,O

15.,O
Milk,B-TR
of,I-TR
Magnesia,I-TR
30,O
cc,O
",",O
p.o.,O
q.,O
h.s.,O
p.r.n.,O

16.,O
Percocet,B-TR
one,O
to,O
two,O
tablets,O
p.o.,O
q.,O
four,O
hours,O
p.r.n.,O

17.,O
Zantac,B-TR
150,O
p.o.,O
twice,O
a,O
day,O
.,O

18.,O
Colace,B-TR
100,O
mg,O
p.o.,O
twice,O
a,O
day,O
.,O

19.,O
Alexandria,O
Daly,O
20,O
mEq,O
p.o.,O
twice,O
a,O
day,O
.,O

20.,O
Lasix,B-TR
20,O
mg,O
intravenous,O
twice,O
a,O
day,O
.,O

21.,O
Lopressor,B-TR
75,O
mg,O
p.o.,O
twice,O
a,O
day,O
.,O

DISCHARGE,O
STATUS,O
:,O

The,O
patient,O
is,O
discharged,O
to,O
rehabilitation,O
.,O

CONDITION,O
AT,O
DISCHARGE,O
:,O

Stable,O
condition,O
.,O

DISCHARGE,O
INSTRUCTIONS:,O

1.,O
He,O
is,O
instructed,O
to,O
follow-up,O
with,O
Dr.,O
Holloway,O
in,O
four,O
weeks,O
.,O

2.,O
He,O
is,O
to,O
follow-up,O
with,O
his,O
primary,O
care,O
physician,O
in,O
one,O
to,O
two,O
weeks,O
.,O

3.,O
Follow-up,O
with,O
Cardiologist,O
in,O
four,O
weeks,O
.,O

4.,O
He,O
is,O
also,O
instructed,O
to,O
follow-up,O
with,O
Vascular,O
Surgery,O
and,O
Podiatry,O
for,O
revascularization,B-TR
at,O
the,O
appropriate,O
time,O
frame,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
status,O
post,O
myocardial,B-PR
infarction,I-PR
status,O
post,O
percutaneous,B-TR
transluminal,I-TR
coronary,I-TR
angioplasty,I-TR
",",O
status,O
post,O
coronary,B-TR
artery,I-TR
bypass,I-TR
graft,I-TR
.,O

2.,O
Diabetes,B-PR
mellitus,I-PR
type,I-PR
2,I-PR
",",O
now,O
currently,O
on,O
insulin,B-TR
.,O

3.,O
Chronic,B-PR
renal,I-PR
insufficiency,I-PR
.,O

4.,O
Peripheral,B-PR
vascular,I-PR
disease,I-PR
status,O
post,O
bilateral,B-TR
iliac,I-TR
stenting,I-TR
.,O

5.,O
Hypertension,B-PR
.,O

6.,O
High,B-PR
cholesterol,I-PR
.,O

7.,O
Question,O
tendonitis,B-PR
with,O
left,B-PR
biceps,I-PR
pain,I-PR
.,O

8.,O
Left,B-PR
foot,I-PR
ulcer,I-PR
status,O
post,O
debridement,B-TR
.,O

PLEASE,O
SEE,O
ADDENDUM,O
FOR,O
ANY,O
CHANGE,O
IN,O
MEDICATIONS,O
AND,O
DISCHARGE,O
DATE,O
.,O

Donna,O
B.,O
Christensen,O
",",O
M.D.,O
31-932,O

Dictated,O
By,O
:,O
Ervin,O
Y.,O
Nobles,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2013-09-16,O
16:00,O

T,O
:,O
2013-09-16,O
16:11,O

JOB,O
#,O
:,O
82277,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Kenneth,O
Din,O
on,O
:,O
TUE,O
2013-09-17,O
11:14,O
AM,O

(,O
End,O
of,O
Report,O
),O

289724916,O

HLGMC,O

51811,O

56075/pu8n,O

6/30/1992,O
12:00:00,O
AM,O

CARCINOMA,B-PR
OF,I-PR
THE,I-PR
KIDNEY,I-PR
",",O
HYPOVOLEMIA,B-PR
",",O
METASTATIC,B-PR
LIVER,I-PR

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

6-30-92,O

DISCHARGE,O
DATE,O
:,O

7-1-92,O
(,O
SOUTHOBASSKING&apos;S,O
VILLEMARG,O
HOSPITAL,O
),O

PRINCIPAL,O
DIAGNOSIS,O
:,O

carcinoma,B-PR
of,I-PR
the,I-PR
kidney,I-PR
",",O
hypovolemia,B-PR
",",O
metastatic,B-PR
liver,I-PR
disease,I-PR
and,O
intrathoracic,B-PR
lymphadenopathy,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
history,O
of,O
this,O
49,O
year,O
old,O
male,O
is,O
provided,O
in,O
detail,O
in,O
the,O
typed,O
admission,O
note,O
dated,O
June,O
30,O
",",O
1992,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

(,O
at,O
time,O
of,O
admission,O
),O
the,B-TE
blood,I-TE
pressure,I-TE
100/65,O
;,O

head,O
",",O
eyes,O
",",O
ears,O
",",O
nose,O
",",O
throat,O
:,O

no,O
masses,B-PR
",",O
neck,O
revealed,O
lymphadenopathy,B-PR
.,O

The,O
lungs,O
were,O
clear,O
",",O
heart,O
normal,O
.,O

Abdomen,O
:,O

liver,B-PR
massively,I-PR
enlarged,I-PR
down,O
15,O
cm,O
.,O

Extremities,O
:,O

normal,O
;,O

neurological,B-TE
examination,I-TE
:,O

generally,O
intact,O
.,O

LABORATORY,O
DATA,O
:,O

(,O
at,O
time,O
of,O
admission,O
),O
hematocrit,B-TE
32.7,O
;,O
white,B-TE
blood,I-TE
count,I-TE
"9,000",O
;,O
platelet,B-TE
count,I-TE
"336,000",O
;,O
sodium,B-TE
126,O
",",O
potassium,B-TE
4.3,O
",",O
chloride,B-TE
93,O
",",O
CO2,B-TE
19,O
",",O
BUN,B-TE
36,O
",",O
creatinine,B-TE
1.5,O
",",O
blood,B-TE
sugar,I-TE
84,O
",",O
calcium,B-TE
11.7,O
;,O
the,B-TE
chest,I-TE
X-ray,I-TE
normal,O
.,O

KUB,B-TE
:,O

consistent,O
with,O
adynamic,B-PR
ileus,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
worsened,O
rapidly,O
following,O
admission,O
and,O
it,O
was,O
clear,O
to,O
his,O
family,O
and,O
to,O
his,O
physician,O
that,O
he,O
was,O
pre-terminal,O
.,O

All,O
efforts,O
were,O
directed,O
to,O
his,O
comfort,O
and,O
he,O
died,O
on,O
July,O
1,O
",",O
1992,O
.,O

Autopsy,O
permission,O
was,O
declined,O
by,O
the,O
family,O
.,O

NU,O
L.,O
GALL,O
",",O
M.D.,O

TR,O
:,O

vb,O
/,O
bmot,O

DD,O
:,O

7-30-92,O

TD,O
:,O

08/03/92,O

CC,O
:,O

DR.,O
VERD,O
CHURLAUNT,O

DR.,O
NU,O
L.,O
GALL,O
",",O
LI,O
HOSPITAL,O

Admission,O
Date,O
:,O

2016-12-15,O

Discharge,O
Date,O
:,O

2016-12-21,O

Date,O
of,O
Birth,O
:,O

1980-08-17,O

Sex,O
:,O

F,O

Service,O
:,O

OBSTETRICS,O
/,O
GYNECOLOGY,O

Allergies,O
:,O

Sulfonamides,B-TR

Attending,O
:,O
Melissa,O
P,O
Lowery,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Term,O
pregnancy,O

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

SVD,B-TR

D&C,B-TR

Supracervical,B-TR
hysterectomy,I-TR

Reexploration,B-TE
with,O
vaginal,B-TR
artery,I-TR
ligation,I-TR

Multiple,B-TR
transfusions,I-TR

History,O
of,O
Present,O
Illness,O
:,O

36,O
yo,O
G3P2,O
at,O
38+5,O
weeks,O
GA,O
presented,O
to,O
L&D,O
for,O
elective,B-TR
induction,I-TR
of,I-TR
labor,I-TR
.,O

Antenatal,O
course,O
benign,O
.,O

Past,O
Medical,O
History,O
:,O

PMHx,O
:,O

Narcolepsy,B-PR
.,O

R,B-PR
inguinal,I-PR
hernia,I-PR
.,O

ObHx,O
:,O

SVDX2,B-TR

Social,O
History,O
:,O

Married,O
.,O

No,O
T/E/D,O

Family,O
History,O
:,O

NC,O

Physical,O
Exam,O
:,O

Vital,B-TE
signs,I-TE
stable,O
on,O
admission,O
.,O

Heart,O
RRR,O

Lungs,O
CTAB,O

Abd,B-PR
Gravid,I-PR
",",O
NT,B-PR

Ext,O
without,O
edema,B-PR

Cervix,O
1,O
cm,O
dilated,O
.,O

Pertinent,O
Results,O
:,O

2016-12-15,O
03:31,O
PM,O
BLOOD,B-TE
WBC,B-TE
-,O
6.2,O
RBC,B-TE
-,O
3.82,O
*,O
Hgb,B-TE
-,O
12.2,O
Hct,B-TE
-,O
34.5,O
*,O
MCV,B-TE
-,O
91,O
MCH,B-TE
-,O
32.0,O
MCHC,B-TE
-,O
35.4,O
*,O
RDW,B-TE
-,O
12.7,O
Plt,B-TE
Ct,I-TE
-,O
246,O

2016-12-21,O
07:45,O
AM,O
BLOOD,B-TE
WBC,B-TE
-,O
6.6,O
RBC,B-TE
-,O
2.79,O
*,O
Hgb,B-TE
-,O
8.5,O
*,O
Hct,B-TE
-,O
23.9,O
*,O
MCV,B-TE
-,O
86,O
MCH,B-TE
-,O
30.5,O
MCHC,B-TE
-,O
35.7,O
*,O
RDW,B-TE
-,O
16.9,O
*,O
Plt,B-TE
Ct,I-TE
-,O
222,O
#,O

Brief,O
Hospital,O
Course,O
:,O

After,O
admission,O
to,O
L&D,O
",",O
the,O
patient,O
was,O
administered,O
Pitocin,B-TR
for,O
elective,B-TR
induction,I-TR
of,I-TR
labor,I-TR
and,O
progressed,O
uneventfully,O
and,O
went,O
on,O
to,O
deliver,O
a,O
viable,O
female,O
infant,O
",",O
weight,B-TE
3595,O
g,O
",",O
Apgars,B-TE
11-11,O
.,O

EBL,B-PR
during,O
delivery,O
was,O
300,O
cc,O
.,O

Patient,O
was,O
transferred,O
to,O
the,O
PP,O
floor,O
in,O
stable,O
condition,O
.,O

Soon,O
after,O
transfer,O
",",O
patient,O
had,O
a,B-PR
large,I-PR
post,I-PR
partum,I-PR
hemorrhage,I-PR
.,O

This,O
was,O
treated,O
with,O
transfer,O
back,O
to,O
L&D,O
",",O
bimanual,B-TR
massage,I-TR
",",O
administration,O
of,O
various,B-TR
uterotonics,I-TR
",",O
namely,O
pitocin,B-TR
100,O
U,O
",",O
Methergine,B-TR
x,O
1,O
",",O
Hemabate,B-TR
x,O
1,O
",",O
and,O
cytotec,B-TR
1000,O
mcgs,O
with,O
minimal,O
response,O
.,O

Patient,O
underwent,O
suction,B-TR
curettage,I-TR
and,O
finally,O
a,B-TR
supercervical,I-TR
hysterectomy,I-TR
.,O

EBL,B-PR
4000,O
cc,O
;,O
IVF,B-TR
6000,O
cc,O
crystalloid,B-TR
;,O
U/O,B-TE
3500,O
cc,O
.,O

Products,O
:,O

8,B-TR
units,I-TR
RBC,I-TR
",",O
6FFP,B-TR
",",O
1,B-TR
cryo,I-TR
",",O
1,B-TR
pack,I-TR
plt,I-TR
.,O

After,O
this,B-TR
procedure,I-TR
",",O
the,O
patient,O
again,O
hemorrhaged,O
in,O
the,O
ICU,O
and,O
was,O
taken,O
back,O
to,O
the,O
OR,O
for,O
reexploration,B-TE
and,O
ligation,B-TR
of,O
a,B-PR
bleeding,I-PR
vaginal,I-PR
artery,I-PR
.,O

EBL,B-PR
3500,O
;,O
IVF,B-TR
4000,O
;,O
UO,B-TE
45,O
;,O
RBC,B-TR
9U,O
;,O
Plt,B-TR
12,O
pack,O
;,O
1u,B-TR
Cryo,I-TR
;,O
6U,B-TR
FFP,I-TR
.,O

For,O
details,O
of,O
these,B-TR
procedures,I-TR
",",O
please,O
see,O
op,O
notes,O
dictated,O
by,O
Dr.,O
Day,O
on,O
2016-12-16,O
.,O

Overall,O
",",O
the,O
pt,O
maintained,O
good,O
BP,B-TE
throughout,O
and,O
was,O
on,O
pressors,B-TR
only,O
briefly,O
.,O

Hct,B-TE
was,O
maintained,O
in,O
stable,O
range,O
with,O
product,B-TR
transfusions,I-TR
.,O

Patient,O
did,O
well,O
and,O
was,O
extubated,O
uneventfully,O
on,O
12-17,O
.,O

She,O
was,O
transferred,O
from,O
the,O
ICU,O
back,O
to,O
the,O
PP,O
floor,O
on,O
12-19,O
.,O

There,O
",",O
she,O
made,O
great,O
progress,O
.,O

Her,B-TE
vital,I-TE
signs,I-TE
were,O
stable,O
",",O
she,O
remained,O
afebrile,B-PR
off,O
antibiotics,B-TR
.,O

Her,B-PR
pain,I-PR
was,O
controlled,O
with,O
percocet,B-TR
and,O
motrin,B-TR
.,O

Her,B-TR
foley,I-TR
was,O
removed,O
and,O
she,O
voided,O
without,O
problems,B-PR
.,O

She,O
John,O
",",O
tolerated,O
a,O
regular,O
diet,O
",",O
and,O
was,O
discharged,O
home,O
in,O
good,O
condition,O
on,O
12-21,O
.,O

Medications,O
on,O
Admission,O
:,O

Cylert,B-TR
.,O

Discharge,O
Medications,O
:,O

1.,O
Ibuprofen,B-TR
600,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q6H,O
(,O
every,O
6,O
hours,O
),O
as,O
needed,O
.,O

Disp,O
:*,O
25,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:,O
*,O
0,O
*,O

2.,O
Oxycodone,B-TR
-,I-TR
Acetaminophen,I-TR
5-325,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
.,O

Disp,O
:*,O
30,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
0,O
*,O

Discharge,O
Disposition,O
:,O

Home,O

Discharge,O
Diagnosis,O
:,O

Full,O
term,O
pregnancy,O
",",O
s/p,O
SVD,B-TR

Uterine,B-PR
atony,I-PR
",",O
postpartum,B-PR
hemorrhage,I-PR

Severe,B-PR
anemia,I-PR

Discharge,O
Condition,O
:,O

Stable,O

Discharge,O
Instructions,O
:,O

Follow,O
printed,O
instructions,O

Followup,O
Instructions,O
:,O

6,O
wks,O
for,O
postpartum,B-TE
exam,I-TE

MOnday,O
for,O
staple,B-TR
removal,I-TR
.,O

James,O
Tricia,O
MD,O
61-345,O

Completed,O
by,O
:,O
Greg,O
Allen,O
MD,O
53-372,O
2016-12-22,O
@,O
1825,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Katherine,O
Beaulieu,O
Brush,O
on,O
:,O
WED,O
2017-01-25,O
12:05,O
AM,O

(,O
End,O
of,O
Report,O
),O

291181306,O

FIH,O

231078,O

718719,O

9555422,O

03/11/2002,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Report,O
Status,O
:,O

Signed,O

DISCHARGE,O
SUMMARY,O
NAME,O
:,O

GETZZOCHTLAND,O
",",O
SYNNANI,O
F,O

UNIT,O
NUMBER,O
:,O

451-52-66,O

ADMISSION,O
DATE,O
:,O

03/11/2002,O

DISCHARGE,O
DATE,O
:,O

03/14/2002,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Right,B-PR
hip,I-PR
osteoarthritis,I-PR
.,O

ASSOCIATED,O
DIAGNOSES,O
:,O

Asthma,B-PR
",",O
gastroesophageal,B-PR
reflux,I-PR
disease,I-PR
",",O
and,O
constipation,B-PR
.,O

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

Right,B-TR
total,I-TR
hip,I-TR
arthroplasty,I-TR
.,O

CHIEF,O
COMPLAINT,O
:,O

Right,B-PR
hip,I-PR
pain,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
62-year-old,O
hospice,O
chaplain,O
who,O
was,O
referred,O
by,O
Dr.,O
Tomedankell,O
Flowayles,O
and,O
Dr.,O
Es,O
Oarekote,O
for,O
evaluation,B-TE
of,O
his,B-PR
right,I-PR
hip,I-PR
pain,I-PR
.,O

He,O
states,O
that,O
his,B-PR
pain,I-PR
has,O
been,O
of,O
seven,O
to,O
eight,O
durations,O
",",O
and,O
rated,O
as,O
moderate,O
to,O
severe,O
(,O
7/10,O
),O
.,O

He,O
does,O
limp,O
.,O

He,O
does,O
not,O
use,O
a,B-TR
cane,I-TR
and,O
he,O
requires,O
a,O
bannister,O
for,O
going,O
up,O
and,O
down,O
stairs,O
.,O

He,O
has,O
trouble,O
with,O
his,O
shoes,O
and,O
socks,O
.,O

He,O
uses,O
a,B-TR
walker,I-TR
.,O

He,O
can,O
walk,O
about,O
a,O
quarter,O
of,O
a,O
mile,O
without,O
stopping,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Asthma,B-PR
",",O
history,O
of,O
atrial,B-PR
fibrillation,I-PR
",",O
non-small-cell,B-PR
lung,I-PR
cancer,I-PR
removed,O
from,O
his,O
right,O
lung,O
by,O
Dr.,O
Vital,O
four,O
years,O
prior,O
to,O
admission,O
",",O
status,O
post,O
chemotherapy,B-TR
and,O
radiation,B-TR
for,O
the,B-PR
non-small-cell,I-PR
lung,I-PR
cancer,I-PR
",",O
gastroesophageal,B-PR
reflux,I-PR
disease,I-PR
",",O
and,O
history,O
of,O
constipation,B-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Prilosec,B-TR
",",O
20,O
mg.,O
PO,O
q.day,O
;,O
Singulair,B-TR
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

He,O
is,O
5,O
feet,O
",",O
9,O
inches,O
",",O
225,O
pounds,O
.,O

He,O
walks,O
with,O
a,B-PR
limp,I-PR
related,O
to,O
his,O
right,O
hip,O
.,O

His,O
right,O
hip,O
is,O
irritable,B-PR
with,O
a,B-PR
10-degree,I-PR
fixed,I-PR
flexion,I-PR
contracture,I-PR
.,O

He,O
is,O
able,O
to,O
flex,O
his,O
right,O
hip,O
to,O
100,O
degrees,O
.,O

He,O
has,O
10,O
degrees,O
of,O
internal,O
and,O
external,O
rotation,O
.,O

He,O
has,O
intact,O
distal,O
pulses,O
and,O
5/5,O
muscle,O
strength,O
in,O
all,O
major,O
muscle,O
groups,O
.,O

His,B-TE
X-rays,I-TE
show,O
advanced,B-PR
osteoarthritis,I-PR
of,I-PR
his,I-PR
right,I-PR
hip,I-PR
.,O

IMPRESSION,O
AND,O
PLAN,O
:,O

This,O
is,O
a,O
62-year-old,O
male,O
with,O
severe,B-PR
osteoarthritis,I-PR
of,I-PR
the,I-PR
right,I-PR
hip,I-PR
who,O
after,O
discussion,O
",",O
including,O
the,O
nature,O
",",O
risks,O
",",O
benefits,O
and,O
alternative,O
treatment,O
plans,O
",",O
signed,O
informed,O
consent,O
for,O
a,B-TR
right,I-TR
total,I-TR
hip,I-TR
replacement,I-TR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
taken,O
to,O
the,O
operating,O
room,O
on,O
March,O
11,O
",",O
2002,O
",",O
and,O
underwent,O
an,B-TR
uncomplicated,I-TR
right,I-TR
total,I-TR
hip,I-TR
replacement,I-TR
.,O

The,O
patient,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
and,O
was,O
transferred,O
to,O
the,O
Post,O
Anesthesia,O
Care,O
Unit,O
and,O
then,O
to,O
the,O
floor,O
in,O
stable,O
condition,O
.,O

On,O
postoperative,B-TE
check,I-TE
",",O
he,O
was,O
doing,O
well,O
.,O

He,O
was,O
afebrile,B-PR
and,O
his,B-TE
vital,I-TE
signs,I-TE
were,O
stable,O
.,O

He,O
was,O
neurovascularly,O
intact,O
.,O

His,B-TE
hematocrit,I-TE
was,O
34.7,O
.,O

He,O
was,O
started,O
on,O
Coumadin,B-TR
for,O
DVT,B-TR
prophylaxis,I-TR
and,O
Ancef,B-TR
for,O
routine,B-TR
antimicrobial,I-TR
coverage,I-TR
.,O

He,O
was,O
made,O
partial,O
weight-bearing,O
for,O
his,O
right,O
lower,O
extremity,O
.,O

He,O
was,O
placed,O
on,O
posterior,B-TR
hip,I-TR
dislocation,I-TR
precautions,I-TR
and,O
was,O
out,O
of,O
bed,O
with,O
physical,O
therapy,O
and,O
occupational,O
therapy,O
.,O

On,O
postoperative,O
day,O
one,O
",",O
there,O
were,O
no,O
active,O
issues,O
.,O

He,O
was,O
afebrile,B-PR
.,O

His,B-TE
vital,I-TE
signs,I-TE
were,O
stable,O
.,O

He,O
was,O
neurovascularly,O
intact,O
.,O

On,O
postoperative,O
day,O
two,O
",",O
he,O
was,O
afebrile,B-PR
",",O
vital,B-TE
signs,I-TE
were,O
stable,O
.,O

His,B-PR
incision,I-PR
was,O
clean,O
",",O
dry,O
and,O
intact,O
with,O
no,O
erythema,B-PR
.,O

He,O
remained,O
neurovascularly,O
intact,O
.,O

His,B-TE
hematocrit,I-TE
was,O
34.8,O
.,O

On,O
postoperative,O
day,O
three,O
",",O
lower,B-TE
extremity,I-TE
noninvasive,I-TE
ultrasounds,I-TE
were,O
performed,O
",",O
which,O
showed,O
no,O
evidence,O
of,O
deep,B-PR
venous,I-PR
thrombosis,I-PR
in,I-PR
the,I-PR
lower,I-PR
extremities,I-PR
.,O

The,O
remainder,O
of,O
his,O
hospitalization,O
was,O
uncomplicated,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Folic,B-TR
acid,I-TR
",",O
1,O
mg.,O
PO,O
q.d.;,O
multivitamin,B-TR
",",O
one,O
capsule,O
PO,O
q.day,O
;,O

ferrous,B-TR
sulfate,I-TR
",",O
325,O
mg.,O
PO,O
t.i.d.;,O

Colace,B-TR
",",O
100,O
mg.,O
PO,O
t.i.d.;,O

Tylenol,B-TR
",",O
650,O
mg.,O
PO,O
q.4,O
hours,O
",",O
p.r.n.,O
pain,B-PR
;,O

Milk,B-TR
of,I-TR
Magnesia,I-TR
",",O
30,O
ml.,O
PO,O
q.day,O
",",O
p.r.n.,O
constipation,B-PR
;,O

Coumadin,B-TR
",",O
2.5,O
mg.,O
PO,O
q.p.m.,O
",",O
dose,O
to,O
vary,O
per,O
INR,B-TE
level,I-TE
;,O

Percocet,B-TR
5/325,O
mg.,O
s,O
",",O
one,O
to,O
two,O
tablets,O
PO,O
q.4,O
to,O
6,O
hours,O
p.r.n.,O
pain,B-PR
;,O

Singulair,B-TR
",",O
10,O
mg.,O
PO,O
q.h.s.;,O

Nexium,B-TR
",",O
10,O
mg.,O
PO,O
q.day,O
;,O

Metamucil,B-TR
instant,I-TR
mix,I-TR
",",O
one,O
teaspoon,O
PO,O
q.day,O
;,O

Peri-Colace,B-TR
",",O
two,O
capsules,O
PO,O
b.i.d.;,O
Dulcolax,B-TR
",",O
10,O
mg.,O
PR,O
q.day,O
",",O
p.r.n.,O
constipation,B-PR
.,O

DISCHARGE,O
INSTRUCTIONS,O
:,O

The,O
patient,O
is,O
to,O
follow-up,O
with,O
Dr.,O
Class,O
six,O
weeks,O
from,O
the,O
date,O
of,O
surgery,B-TR
.,O

His,B-TR
staples,I-TR
should,O
be,O
removed,O
10,O
to,O
14,O
days,O
from,O
the,O
date,O
of,O
surgery,B-TR
.,O

If,O
his,B-PR
wound,I-PR
is,O
dry,O
",",O
he,O
may,O
shower,O
.,O

He,O
is,O
to,O
ambulate,O
with,O
crutches,B-TR
or,O
a,B-TR
walker,I-TR
and,O
be,O
on,O
posterior,B-TR
hip,I-TR
dislocation,I-TR
precautions,I-TR
for,O
three,O
months,O
following,O
the,O
date,O
of,O
surgery,B-TR
.,O

He,O
should,O
be,O
on,O
Coumadin,B-TR
for,O
anticoagulation,B-TR
for,O
three,O
weeks,O
from,O
the,O
date,O
of,O
surgery,B-TR
with,O
twice,O
weekly,O
blood,B-TE
draws,I-TE
for,O
INR,B-TE
with,O
a,O
goal,O
of,O
1.5,O
to,O
2.0,O
.,O

He,O
is,O
to,O
call,O
Dr.,O
Class,O
&apos;s,O
office,O
with,O
any,O
questions,O
or,O
concerns,O
.,O

LENNI,O
E.,O
BREUTZOLN,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

Electronically,O
Signed,O
LI,O
RIJARRED,O
CLASS,O
",",O
M.D.,O
03/27/2002,O
12:39,O
_____________________________,O
LI,O
RIJARRED,O
CLASS,O
",",O
M.D.,O

TR,O
:,O

jt,O

DD,O
:,O

03/13/2002,O

TD,O
:,O

03/13/2002,O
10:05,O
P,O
718719,O

cc,O
:,O

LI,O
RIJARRED,O
CLASS,O
",",O
M.D.,O
STAT,O

Admission,O
Date,O
:,O

2013-08-24,O

Discharge,O
Date,O
:,O

2013-08-27,O

Date,O
of,O
Birth,O
:,O

1987-09-08,O

Sex,O
:,O

M,O

Service,O
:,O

Trauma,O
Surgery,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
25,O
-,O
year-old,O
gentleman,O
who,O
is,O
status,O
post,O
a,O
motor,O
vehicle,O
accident,O
in,O
which,O
he,O
was,O
the,O
unrestrained,O
driver,O
and,O
struck,O
a,O
telephone,O
pole,O
.,O

He,O
was,O
ejected,O
from,O
the,O
car,O
and,O
landed,O
on,O
his,O
face,O
.,O

Extreme,O
damage,O
was,O
reported,O
to,O
the,O
vehicle,O
by,O
first,O
responders,O
.,O

It,O
was,O
presumed,O
high-speed,O
motor,O
vehicle,O
collision,O
.,O

The,O
patient,O
was,O
CMED-flighted,O
to,O
Quincy,O
Medical,O
Center,O
",",O
and,O
he,O
was,O
intubated,O
upon,O
arrival,O
in,O
the,O
Emergency,O
Department,O
.,O

After,O
initial,B-TE
trauma,I-TE
assessment,I-TE
and,O
initiation,O
of,O
resuscitation,B-TR
",",O
a,B-TE
CT,I-TE
scan,I-TE
was,O
performed,O
.,O

Images,B-TE
of,I-TE
his,I-TE
head,I-TE
",",I-TE
abdomen,I-TE
",",I-TE
and,I-TE
thorax,I-TE
were,O
obtained,O
.,O

His,B-PR
injuries,I-PR
included,O
bilateral,B-PR
zygomal,I-PR
and,I-PR
orbital,I-PR
rim,I-PR
fractures,I-PR
",",O
a,B-PR
right,I-PR
temporal,I-PR
fracture,I-PR
",",O
bilateral,B-PR
frontal,I-PR
contusions,I-PR
",",O
and,O
a,B-PR
right,I-PR
temporal,I-PR
epidural,I-PR
versus,O
subdural,B-PR
hematoma,I-PR
.,O

The,O
anterior,O
and,O
posterior,O
of,O
the,O
frontal,O
sinus,O
was,O
fractured,B-PR
with,O
communication,B-PR
with,I-PR
the,I-PR
ethmoid,I-PR
air,I-PR
cells,I-PR
",",O
presumably,O
caused,O
air,B-PR
in,I-PR
the,I-PR
orbit,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Denies,O
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

Denies,O
.,O

SOCIAL,O
HISTORY,O
:,O

Denies,O
.,O

ALLERGIES,O
:,O

Denies,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Denies,O
.,O

PHYSICAL,O
EXAMINATION,O
ON,O
PRESENTATION,O
:,O

Initial,B-TE
examination,I-TE
revealed,O
the,O
patient,O
had,O
a,B-TE
heart,I-TE
rate,I-TE
in,O
the,O
80s,O
",",O
with,O
a,B-TE
blood,I-TE
pressure,I-TE
of,O
150/80s,O
.,O

He,O
was,O
intubated,B-TR
with,O
multiple,B-PR
abrasions,I-PR
",",O
and,O
severe,B-PR
swelling,I-PR
and,O
contusions,B-PR
of,I-PR
his,I-PR
face,I-PR
.,O

He,O
was,O
not,O
following,O
commands,O
.,O

His,B-TE
Boston,I-TE
Coma,I-TE
Scale,I-TE
was,O
16,O
.,O

His,O
pupils,O
were,O
reactive,O
on,O
the,O
right,O
going,O
from,O
3,O
mm,O
to,O
2,O
mm,O
of,O
light,O
.,O

The,B-TE
response,I-TE
was,O
brisk,O
.,O

On,O
the,O
left,O
",",O
his,O
pupils,O
went,O
from,O
2.5,O
mm,O
to,O
2,O
mm,O
",",O
also,O
brisk,O
.,O

Initial,B-TE
evaluation,I-TE
revealed,O
corticate,B-PR
posturing,I-PR
was,O
noted,O
by,O
the,O
trauma,O
team,O
.,O

He,O
withdrew,O
equally,O
and,O
purposefully,O
after,O
20,O
minutes,O
in,O
the,O
trauma,O
bay,O
.,O

He,O
withdrew,O
to,O
noxious,B-TE
stimuli,I-TE
equally,O
and,O
purposefully,O
after,O
20,O
minutes,O
in,O
the,O
trauma,O
bay,O
.,O

HOSPITAL,O
COURSE,O
BY,O
SYSTEM,O
:,O

1.,O
NEUROLOGY,O
:,O

Mr.,O
Roach,O
was,O
transported,O
to,O
Intensive,O
Care,O
Unit,O
from,O
the,O
trauma,O
bay,O
.,O

Upon,O
arrival,O
",",O
Neurosurgery,O
promptly,O
placed,O
V.,B-TR
Holtzen,I-TR
bolt,I-TR
.,O

This,O
allowed,O
continuous,B-TE
monitoring,I-TE
of,I-TE
intracranial,I-TE
pressure,I-TE
.,O

Notably,O
",",O
intracranial,B-TE
pressure,I-TE
was,O
17,O
when,O
the,B-TR
bolt,I-TR
was,O
placed,O
.,O

During,O
his,O
hospitalization,O
",",O
his,B-TE
intracranial,I-TE
pressure,I-TE
was,O
monitored,O
very,O
closely,O
and,O
maintained,O
to,O
a,O
level,O
of,O
less,O
than,O
20,O
.,O

To,O
do,O
this,O
",",O
mannitol,B-TR
25,O
mg,O
q.,O
6h.,O
was,O
used,O
.,O

While,O
using,O
mannitol,B-TR
",",O
his,B-TE
serum,I-TE
osmolalities,I-TE
were,O
followed,O
closely,O
.,O

In,O
addition,O
",",O
to,O
monitoring,O
his,B-TE
intracranial,I-TE
pressure,I-TE
",",O
his,B-TE
systemic,I-TE
blood,I-TE
pressures,I-TE
were,O
maintained,O
in,O
such,O
a,O
manner,O
that,O
his,B-TE
cerebral,I-TE
perfusion,I-TE
pressure,I-TE
was,O
maintained,O
at,O
70,O
mmHg,O
.,O

A,B-TE
parameter,I-TE
monitor,I-TE
for,O
his,O
neurologic,O
status,O
PaCO2,B-TE
which,O
was,O
maintained,O
between,O
35,O
and,O
40,O
during,O
his,O
hospitalization,O
.,O

Mr.,O
Roach,O
was,O
kept,O
sedated,B-TR
with,O
propofol,B-TR
and,O
was,O
given,O
Fentanyl,B-TR
and,O
/,O
or,O
morphine,B-TR
boluses,I-TR
for,O
pain,B-PR
.,O

Neurologic,B-TE
checks,I-TE
were,O
followed,O
initially,O
every,O
one,O
hour,O
and,O
then,O
every,O
two,O
hours,O
to,O
monitor,O
for,O
change,B-PR
in,I-PR
neurologic,I-PR
examination,I-PR
.,O

During,O
his,O
hospitalization,O
",",O
two,O
subsequent,O
CAT,B-TE
scans,I-TE
were,O
obtained,O
;,O
one,O
on,O
hospital,O
day,O
two,O
.,O

This,B-TE
CAT,I-TE
scan,I-TE
revealed,O
possible,O
worsening,O
and,O
was,O
read,O
as,O
epidural,B-PR
versus,O
subdural,B-PR
bleed,I-PR
.,O

After,O
a,O
discussion,O
with,O
both,O
Radiology,O
and,O
Neurosurgery,O
",",O
the,O
decision,O
was,O
made,O
that,O
the,O
worsening,O
did,O
not,O
appear,O
significant,O
",",O
and,O
this,O
was,O
not,O
accompanied,O
by,O
a,B-PR
change,I-PR
in,I-PR
his,I-PR
clinical,I-PR
condition,I-PR
.,O

His,B-TE
intracranial,I-TE
pressure,I-TE
remained,O
stable,O
",",O
and,O
his,B-TE
clinical,I-TE
examination,I-TE
was,O
unchanged,O
.,O

An,B-TE
additional,I-TE
CT,I-TE
scan,I-TE
was,O
obtained,O
on,O
hospital,O
day,O
three,O
.,O

This,B-TE
examination,I-TE
was,O
unchanged,O
from,O
the,B-TE
previous,I-TE
examination,I-TE
.,O

Again,O
",",O
his,B-TE
intracranial,I-TE
pressure,I-TE
and,O
neurologic,B-TE
examination,I-TE
remained,O
the,O
same,O
",",O
and,O
conservative,B-TR
treatment,I-TR
was,O
opted,O
for,O
.,O

2.,O
CARDIOVASCULAR,O
:,O

As,O
described,O
in,O
previous,O
section,O
",",O
Neo-Synephrine,B-TR
and,O
eventually,O
Levophed,B-TR
were,O
used,O
to,O
maintain,O
a,B-TE
coronary,I-TE
perfusion,I-TE
pressure,I-TE
of,O
greater,O
than,O
70,O
.,O

A,B-TR
pulmonary,I-TR
artery,I-TR
catheter,I-TR
was,O
placed,O
on,O
hospital,O
day,O
four,O
.,O

This,B-TR
catheter,I-TR
was,O
placed,O
when,O
the,O
patient,O
started,O
to,O
demonstrate,O
septic,B-PR
physiology,I-PR
and,O
for,O
increasing,O
pressor,B-TR
support,I-TR
.,O

Please,O
see,O
Infectious,O
Disease,O
section,O
for,O
more,O
details,O
.,O

3.,O
GASTROINTESTINAL,O
:,O

Mr.,O
Roach,O
was,O
n.p.o.,B-TR
from,O
the,O
time,O
of,O
his,O
admission,O
.,O

A,B-TR
orogastric,I-TR
tube,I-TR
was,O
passed,O
.,O

Initially,O
during,O
admission,O
",",O
carafate,B-TR
was,O
given,O
down,O
the,B-TR
orogastric,I-TR
tube,I-TR
.,O

However,O
",",O
on,O
a,B-TE
routine,I-TE
chest,I-TE
x-ray,I-TE
shot,O
on,O
hospital,O
day,O
three,O
",",O
a,B-PR
mediastinum,I-PR
was,O
noted,O
.,O

This,O
raised,O
the,O
question,O
of,O
potential,O
esophageal,B-PR
rupture,I-PR
.,O

Gastroenterology,O
was,O
consulted,O
for,O
this,O
.,O

Gastroenterology,O
was,O
consulted,O
to,O
assist,O
in,O
creating,O
the,O
most,O
appropriate,O
diagnostic,O
rhythm,O
given,O
his,O
intubated,O
and,O
sedated,O
status,O
.,O

At,O
this,O
point,O
",",O
his,B-TR
carafate,I-TR
was,O
switched,O
to,O
intravenous,B-TR
Protonix,I-TR
and,O
he,O
was,O
strictly,B-TR
n.p.o.,I-TR

4.,O
HEMATOLOGY,O
:,O

Throughout,O
Mr.,O
Richard,O
admission,O
",",O
his,B-TE
hematocrit,I-TE
remained,O
stable,O
in,O
the,O
low,O
30s,O
.,O

As,O
will,O
be,O
discussed,O
in,O
the,O
Infectious,O
Disease,O
section,O
",",O
he,O
developed,O
an,O
episode,O
of,O
what,O
appeared,O
to,O
be,O
sepsis,B-PR
",",O
and,O
his,B-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
peaked,O
at,O
23,O
.,O

Mr.,O
Roach,O
was,O
on,O
Pneumo,B-TR
boots,I-TR
spontaneous,I-TR
compression,I-TR
devices,I-TR
for,O
deep,B-TR
venous,I-TR
thrombosis,I-TR
prophylaxis,I-TR
.,O

He,O
was,O
not,O
a,O
candidate,O
for,O
subcutaneous,B-TR
heparin,I-TR
as,O
we,O
were,O
concerned,O
of,O
an,B-PR
intracranial,I-PR
hemorrhage,I-PR
.,O

An,B-TR
inferior,I-TR
vena,I-TR
cava,I-TR
filter,I-TR
was,O
considered,O
but,O
was,O
deferred,O
",",O
as,O
it,O
was,O
felt,O
that,O
Mr.,O
Roach,O
was,O
too,B-PR
unstable,I-PR
to,O
undergo,O
the,B-TR
procedure,I-TR
.,O

5.,O
ENDOCRINE,O
:,O

Mr.,O
Marian,O
blood,B-TE
sugar,I-TE
was,O
maintained,O
under,O
tight,O
control,O
from,O
100,O
to,O
130,O
using,O
a,B-TR
regular,I-TR
insulin,I-TR
sliding-scale,I-TR
.,O

6.,O
INFECTIOUS,O
DISEASE,O
:,O

Mr.,O
Roach,O
had,O
a,B-PR
spike,I-PR
in,I-PR
white,I-PR
blood,I-PR
cell,I-PR
count,I-PR
and,O
developed,O
fevers,B-PR
.,O

His,O
blood,O
urine,O
and,O
sputum,O
were,O
all,O
cultured,O
.,O

Blood,B-TE
cultures,I-TE
were,O
pertinent,O
for,O
one,O
bottle,O
of,O
gram,B-PR
-,I-PR
positive,I-PR
coagulase,I-PR
-,I-PR
negative,I-PR
Staphylococcus,I-PR
which,O
grew,O
from,O
08-25,O
.,O

His,B-TE
preliminary,I-TE
cultures,I-TE
including,O
sputum,O
from,O
08-25,O
grew,O
Escherichia,B-PR
coli,I-PR
.,O

Sputum,B-TE
from,O
08-27,O
grew,O
gram-negative,B-PR
rods,I-PR
",",O
not,O
yet,O
speciated,O
",",O
and,O
from,O
08-27,O
a,B-TE
bronchoalveolar,I-TE
lavage,I-TE
grew,O
1+,B-PR
gram-negative,I-PR
rods,I-PR
and,O
4+,B-PR
polymorphonuclear,I-PR
lymphocytes,I-PR
.,O

Throughout,O
this,O
time,O
",",O
Mr.,O
Richard,O
temperature,B-TE
continued,O
to,O
increase,O
and,O
was,O
such,O
that,O
on,O
hospital,O
day,O
four,O
",",O
his,B-TE
temperature,I-TE
maximum,I-TE
was,O
42.2,O
degrees,O
centigrade,O
.,O

During,O
his,O
hospitalization,O
",",O
his,O
was,O
treated,O
with,O
vancomycin,B-TR
for,O
his,B-PR
gram-negative,I-PR
rods,I-PR
",",O
imipenem,B-TR
",",O
and,O
Flagyl,B-TR
.,O

Initially,O
",",O
he,O
had,O
been,O
placed,O
on,O
clindamycin,B-TR
to,O
cover,O
his,B-TR
drain,I-TR
",",O
but,O
his,B-TE
cultures,I-TE
became,O
positive,B-PR
",",O
and,O
his,B-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
increased,O
.,O

He,O
was,O
switched,O
from,O
clindamycin,B-TR
to,O
the,B-TR
imipenem,I-TR
and,O
Flagyl,B-TR
.,O

Vancomycin,B-TR
was,O
added,O
when,O
we,O
had,O
the,B-PR
positive,I-PR
blood,I-PR
culture,I-PR
.,O

With,O
a,B-PR
fever,I-PR
of,O
102,O
",",O
up,O
to,O
42,O
degrees,O
centigrade,O
",",O
aggressive,B-TR
measures,I-TR
including,O
cooling,B-TR
blankets,I-TR
",",O
alcohol,B-TR
swabs,I-TR
",",O
and,O
fans,B-TR
were,O
used,O
in,O
an,O
attempt,O
to,O
bring,O
his,B-TE
body,I-TE
temperature,I-TE
down,O
.,O

Hypercarbia,B-PR
would,O
result,O
and,O
increase,O
in,O
cerebral,O
perfusion,O
",",O
paralysis,B-TR
was,O
initiated,O
to,O
decrease,O
genesis,O
of,O
carbon,O
dioxide,O
secreted,O
during,O
shivering,B-PR
.,O

7.,O
PULMONARY,O
:,O

As,O
discussed,O
in,O
the,O
Infectious,O
Disease,O
section,O
",",O
Mr.,O
Roach,O
developed,O
a,B-PR
pneumonia,I-PR
likely,O
from,O
gram-negative,B-PR
organisms,I-PR
",",O
but,O
most,O
likely,O
from,O
Escherichia,B-PR
coli,I-PR
.,O

For,O
this,B-PR
pneumonia,I-PR
",",O
he,O
was,O
placed,O
empirically,O
on,O
imipenem,B-TR
",",O
vancomycin,B-TR
",",O
and,O
Flagyl,B-TR
.,O

On,O
hospital,O
day,O
three,O
",",O
Mr.,O
Roach,O
had,O
developed,O
an,O
episode,O
of,O
tachycardia,B-PR
and,O
tachypnea,B-PR
.,O

For,O
this,O
",",O
a,B-TE
CT,I-TE
angiogram,I-TE
was,O
obtained,O
which,O
demonstrated,O
no,O
pulmonary,B-PR
embolism,I-PR
.,O

On,O
hospital,O
day,O
four,O
",",O
a,B-TE
routine,I-TE
chest,I-TE
x-ray,I-TE
revealed,O
a,B-PR
left-sided,I-PR
pneumothorax,I-PR
.,O

For,O
this,O
",",O
a,B-TR
left,I-TR
#34,I-TR
Caucasian,I-TR
chest,I-TR
tube,I-TR
was,O
placed,O
.,O

On,O
the,O
evening,O
of,O
hospital,O
day,O
four,O
",",O
Mr.,O
Roach,O
had,O
an,B-PR
acute,I-PR
episode,I-PR
whereby,O
his,B-TE
central,I-TE
venous,I-TE
pressure,I-TE
rose,O
sharply,O
and,O
immediately,O
followed,O
by,O
a,O
period,O
of,O
asystole,B-PR
.,O

Urgent,B-TR
resuscitation,I-TR
measures,I-TR
were,O
initiated,O
.,O

The,B-TR
measures,I-TR
included,O
attempts,O
at,O
pacing,B-TR
.,O

Epinephrine,B-TR
and,O
atropine,B-TR
were,O
administered,O
as,O
were,O
bicarbonate,B-TR
and,O
calcium,B-TR
.,O

He,O
had,O
a,O
differential,O
diagnosis,O
of,O
asystole,B-PR
preceded,O
by,O
an,B-PR
acute,I-PR
rise,I-PR
in,I-PR
central,I-PR
venous,I-PR
pressure,I-PR
included,O
attention,B-PR
pneumothorax,I-PR
",",O
cardiac,B-PR
tamponade,I-PR
",",O
and,O
pulmonary,B-PR
embolism,I-PR
.,O

During,O
the,B-TR
resuscitation,I-TR
afterwards,O
",",O
it,O
was,O
noted,O
that,O
a,B-TR
patent,I-TR
left,I-TR
chest,I-TR
tube,I-TR
was,O
present,O
in,O
the,O
left,O
chest,O
",",O
so,O
initially,O
neo-decompression,B-TR
was,O
attempted,O
in,O
the,O
right,O
chest,O
.,O

There,O
was,O
no,O
sign,O
of,O
attention,B-PR
pneumothorax,I-PR
with,O
decompression,B-TR
",",O
and,O
a,B-TR
right,I-TR
chest,I-TR
tube,I-TR
was,O
placed,O
.,O

During,O
this,O
time,O
",",O
a,B-TE
needle,I-TE
aspiration,I-TE
of,O
what,O
was,O
felt,O
to,O
be,O
the,O
pericardium,O
was,O
performed,O
revealing,O
bloody,B-PR
fluid,I-PR
coming,O
back,O
.,O

A,B-TR
left,I-TR
anterior,I-TR
thoracotomy,I-TR
was,O
made,O
by,O
the,O
Cardiac,O
Surgery,O
fellow,O
who,O
was,O
present,O
.,O

After,O
30,O
minutes,O
of,O
active,B-TR
resuscitation,I-TR
including,O
internal,B-TR
cardiac,I-TR
massage,I-TR
",",O
there,O
was,O
no,O
evidence,O
of,O
return,O
of,O
vital,B-TE
signs,I-TE
or,O
electric,B-TE
activity,I-TE
to,I-TE
the,I-TE
heart,I-TE
as,O
noted,O
on,O
electrocardiogram,B-TE
monitors,I-TE
.,O

Resuscitation,B-TR
was,O
terminated,O
at,O
1914,O
on,O
08-27,O
.,O

After,O
the,O
termination,O
of,O
resuscitation,B-TR
",",O
both,O
the,O
anesthesia,O
Intensive,O
Care,O
Unit,O
attending,O
and,O
the,O
surgical,O
attending,O
were,O
present,O
to,O
discuss,O
the,O
proceedings,O
events,O
with,O
the,O
patient,O
's,O
family,O
members,O
including,O
his,O
next,O
of,O
kin,O
",",O
his,O
mother,O
.,O

Permission,O
for,O
a,B-TE
postmortem,I-TE
examination,I-TE
was,O
granted,O
.,O

Matthew,O
M.,O
Barnett,O
",",O
M.D.,O
78-102,O

Dictated,O
By,O
:,O
Mark,O
D.,O
Eng,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2013-08-28,O
00:21,O

T,O
:,O
2013-09-03,O
11:11,O

JOB,O
#,O
:,O
24887,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Katherin,O
Toth,O
on,O
:,O
MON,O
2013-10-14,O
3:05,O
PM,O

(,O
End,O
of,O
Report,O
),O

300423900,O

PUOMC,O

7191549,O

32395/a42u,O

265407,O

12/4/1995,O
12:00:00,O
AM,O

MAINTENANCE,B-TR
CHEMOTHERAPY,I-TR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

12/4/95,O

DISCHARGE,O
DATE,O
:,O

12/8/95,O

His,O
date,O
of,O
birth,O
is,O
11/7/32,O
.,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

maintenance,B-TR
chemotherapy,I-TR
.,O

ASSOCIATED,O
DIAGNOSES,O
:,O

malignant,B-PR
fibrous,I-PR
histiocytoma,I-PR
of,I-PR
duodenum,I-PR
",",O
metastases,B-PR
to,I-PR
liver,I-PR
",",O
anemia,B-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

intravenous,B-TR
chemotherapy,I-TR
12/4/95,O
through,O
12/8/95,O
.,O

DISCHARGE,O
ORDERS,O
:,O

Ativan,B-TR
1,O
mg,O
or,O
Trilafon,B-TR
4,O
mg,O
q,O
4,O
hours,O
prn,O
nausea,B-PR
",",O
Carafate,B-TR
one,O
gram,O
q.i.d.,O

PRESENT,O
ILLNESS,O
:,O

This,O
63-year-old,O
man,O
had,O
a,B-PR
mass,I-PR
in,I-PR
the,I-PR
duodenum,I-PR
",",O
discovered,O
in,O
02/95,O
.,O

A,B-PR
leiomyosarcoma,I-PR
was,O
resected,B-TR
after,O
embolization,B-TR
of,I-TR
the,I-TR
splenic,I-TR
artery,I-TR
.,O

However,O
",",O
it,O
could,O
not,O
be,O
completely,O
excised,O
",",O
moreover,O
the,B-PR
tumor,I-PR
metastasized,O
to,O
the,O
liver,O
was,O
discovered,O
on,O
follow,B-TE
up,I-TE
scan,I-TE
in,O
06/95,O
.,O

He,O
has,O
been,O
receiving,O
chemotherapy,B-TR
since,O
then,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

He,O
generally,O
looks,O
well,O
.,O

Vital,B-TE
signs,I-TE
are,O
normal,O
.,O

The,O
skin,O
is,O
intact,O
.,O

His,O
head,O
",",O
eyes,O
",",O
ears,O
",",O
nose,O
",",O
throat,O
is,O
clear,O
.,O

The,O
neck,O
is,O
without,O
adenopathy,B-PR
.,O

Chest,O
clear,O
.,O

Heart,O
without,O
gallop,B-PR
.,O

Abdomen,O
without,O
mass,B-PR
.,O

Extremities,O
without,O
edema,B-PR
.,O

Neurological,B-TE
examination,I-TE
intact,O
.,O

LABORATORY,O
EXAMINATION,O
:,O

hematocrit,B-TE
33,O
",",O
white,B-TE
count,I-TE
4.4,O
",",O
with,O
28%,O
monos,B-TE
and,O
30%,O
polys,B-TE
and,O
bands,B-TE
.,O

Platelets,B-TE
253,O
thousand,O
.,O

Creatinine,B-TE
0.6,O
",",O
SGOT,B-TE
52,O
",",O
bilirubin,B-TE
0.5,O
.,O

COURSE,O
IN,O
HOSPITAL,O
:,O

The,O
patient,O
was,O
hydrated,O
well,O
and,O
given,O
Adriamycin,B-TR
27,O
mg,O
and,O
DTIC,B-TR
450,O
mg,O
daily,O
for,O
four,O
days,O
.,O

He,O
also,O
got,O
ifosfamide,B-TR
3.6,O
grams,O
a,O
day,O
with,O
mesna,B-TR
.,O

He,O
tolerated,O
treatment,B-TR
well,O
and,O
was,O
discharged,O
in,O
good,O
condition,O
.,O

FOLLOWUP,O
:,O

by,O
private,O
physician,O
.,O

LENNI,O
BREUTZOLN,O
",",O
M.D.,O

TR,O
:,O

by,O
/,O
bmot,O

DD,O
:,O

12/10/95,O

TD,O
:,O

12/13/95,O

CC,O
:,O

Admission,O
Date,O
:,O

2019-10-10,O

Discharge,O
Date,O
:,O

2019-10-19,O

Date,O
of,O
Birth,O
:,O

1994-01-10,O

Sex,O
:,O

M,O

Service,O
:,O

ORTHOPAEDICS,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,O
Drugs,B-TR

Attending,O
:,O
George,O
G,O
Lindsey,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O
s/p,O
fall,O
with,O
Left,B-PR
arm,I-PR
pain,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

2019-10-11,O
:,O

ORIF,B-TR
Left,B-PR
distal,I-PR
radius,I-PR
fracture,I-PR

History,O
of,O
Present,O
Illness,O
:,O

Mr.,O
Steadman,O
is,O
a,O
25,O
year,O
old,O
man,O
who,O
was,O
locked,O
out,O
of,O
his,O
apartment,O
and,O
tried,O
to,O
enter,O
by,O
climbing,O
up,O
two,O
stories,O
to,O
get,O
in,O
by,O
a,O
window,O
.,O

He,O
fell,O
15-20,O
feet,O
onto,O
concrete,O
",",O
denies,O
any,O
loss,B-PR
of,I-PR
consiousness,I-PR
.,O

Past,O
Medical,O
History,O
:,O
denies,O

Social,O
History,O
:,O

+ETOH,O
",",O
had,O
12,O
cans,O
of,O
beer,O
prior,O
to,O
accident,O

Family,O
History,O
:,O
n/a,O

Physical,O
Exam,O
:,O

Upon,O
admission,O
:,O

Alert,O
and,O
oriented,O

Cardiac,O
:,O

Tachycardiac,B-PR
120-140,O
",",O
regular,O

Chest,O
:,O

Clear,O
to,O
auscultation,B-TE

Abdomen,O
:,O

Soft,O
non-tender,B-PR
non-distended,B-PR

Extremities,O
:,O

Left,B-PR
elbow,I-PR
",",I-PR
gross,I-PR
deformity,I-PR
swelling,I-PR
over,I-PR
dorsal,I-PR
forearm,I-PR
",",O
gross,B-PR
deformity,I-PR
left,I-PR
wrist,I-PR
",",O
no,O
skin,B-PR
lacerations,I-PR
.,O

SILT,O

R/U/M,O
LUE,O

Bilateral,O
lower,O
extremities,O
:,O

Brief,O
Hospital,O
Course,O
:,O

Mr.,O
Steadman,O
is,O
a,O
25,O
year,O
old,O
man,O
who,O
presented,O
to,O
the,O
The,O
Hospital,O
for,O
Orthopedics,O
on,O

2019-10-10,O
via,O
ambulance,O
after,O
falling,O
15-20,O
feet,O
onto,O
concrete,O
.,O

He,O
was,O
evaluated,O
by,O
the,O
trauma,O
surgery,O
department,O
and,O
the,O
orthopaedic,O
surgery,O
department,O
.,O

He,O
was,O
intoxicated,O
and,O
tachycardic,B-PR
in,O
the,O
trauma,O
bay,O
.,O

His,B-PR
injuries,I-PR
were,O
identified,O
as,O
a,B-PR
left,I-PR
elbow,I-PR
disloaction,I-PR
with,O
was,O
reduced,O
and,O
splinted,O
.,O

Also,O
a,B-PR
left,I-PR
distal,I-PR
radius,I-PR
fracture,I-PR
with,O
was,O
reduced,O
and,O
splinted,O
.,O

Also,O
a,B-PR
Left,I-PR
non,I-PR
displaced,I-PR
sacral,I-PR
wing,I-PR
fracture,I-PR
and,O
left,B-PR
inferior,I-PR
pubic,I-PR
ramus,I-PR
fx,I-PR
extending,O
the,O
to,O
inferior,O
acetabulum,O
.,O

He,O
was,O
admitted,O
to,O
the,O
trauma,O
intensive,O
care,O
unit,O
due,O
to,O
his,B-PR
tachycardia,I-PR
which,O
was,O
not,O
resolved,O
with,O
pain,B-TR
medication,I-TR
.,O

On,O
2019-10-11,O
he,O
was,O
started,O
on,O
lopressor,B-TR
for,O
his,B-PR
tachycardia,I-PR
which,O
had,O
good,O
effect,O
.,O

He,O
was,O
then,O
transfered,O
to,O
the,O
floor,O
in,O
the,O
care,O
of,O
the,O
orthopaedic,O
surgery,O
service,O
.,O

Also,O
on,O
2019-10-11,O
he,O
was,O
taken,O
to,O
the,O
operating,O
room,O
for,O
an,B-TR
ORIF,I-TR
of,O
his,B-PR
left,I-PR
distal,I-PR
radius,I-PR
fracture,I-PR
.,O

His,B-PR
pelvis,I-PR
fracture,I-PR
are,O
closed,O
treated,O
and,O
he,O
can,O
be,O
weight,O
bearing,O
as,O
tolerated,O
on,O
his,O
right,O
leg,O
and,O
and,O
nonweight,O
bearing,O
on,O
his,O
left,O
leg,O
.,O

He,O
tolerated,O
the,B-TR
procedure,I-TR
without,O
difficulty,B-PR
.,O

He,O
begain,O
to,O
work,O
with,O
physical,O
therapy,O
to,O
improve,O
his,O
strenght,O
and,O
mobility,O
.,O

His,B-TE
heart,I-TE
rate,I-TE
continued,O
to,O
be,O
well,O
controlled,O
with,O
his,B-TR
lopressor,I-TR
.,O

Throught,O
the,O
stay,O
his,B-TE
labs,I-TE
remained,O
normal,O
and,O
his,B-PR
pain,I-PR
controlled,O
.,O

He,O
was,O
discharged,O
home,O
in,O
stable,O
conditions,O
.,O

He,O
was,O
instructed,O
to,O
follow,O
up,O
with,O
Dr.,O
Conway,O
in,O
2,O
weeks,O
and,O
an,O
appointment,O
was,O
made,O
on,O
11-15,O
for,O
him,O
at,O
the,O
Louis,O
Schubert,O
Community,O
Health,O
Center,O
to,O
follow,O
his,B-TE
heart,I-TE
rate,I-TE
and,O
continued,O
need,O
for,O
lopressor,B-TR
.,O

Medications,O
on,O
Admission,O
:,O
none,O

Discharge,O
Medications,O
:,O

1.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

Disp,O
:*,O
60,O
Capsule,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

2.,O
Enoxaparin,B-TR
30,O
mg,O
/,O
0.3,O
mL,O
Syringe,O
Sig,O
:,O
One,O
(,O
1,O
),O
30,O
mg,O
syringe,O
Subcutaneous,O
Q12H,O
(,O
every,O
12,O
hours,O
),O
for,O
4,O
weeks,O
.,O

Disp,O
:*,O
56,O
30,O
mg,O
syringe,O
*,O
Refills,O
:*,O
0,O
*,O

3.,O
Oxycodone,B-TR
-,O
Acetaminophen,B-TR
5-325,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
.,O

Disp,O
:*,O
90,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
0,O
*,O

4.,O
Metoprolol,B-TR
Tartrate,I-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
0.5,O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

Disp,O
:*,O
30,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
0,O
*,O

Discharge,O
Disposition,O
:,O

Home,O

Discharge,O
Diagnosis,O
:,O
s/p,O
fall,O
from,O
15-20,O
feet,O

Discharge,O
Condition,O
:,O

Stable,O

Discharge,O
Instructions,O
:,O

Continue,O
to,O
be,O
non-weight,O
bearing,O
on,O
your,O
left,O
leg,O

Continue,O
to,O
wear,O
your,B-TR
left,I-TR
arm,I-TR
splint,I-TR
",",O
but,O
take,O
it,O
off,O
daily,O
to,O
inspect,O
your,O
skin,O

Continue,O
your,B-TR
Lovenox,I-TR
injections,I-TR
as,O
instructed,O

If,O
you,O
notice,O
any,O
increase,B-PR
in,I-PR
swelling,I-PR
or,O
erythemia,B-PR
at,O
the,B-PR
incisions,I-PR
",",O
or,O
if,O
you,O
become,O
short,B-PR
of,I-PR
breath,I-PR
or,O
if,O
you,O
have,O
a,B-TE
temperature,I-TE
greater,O
than,O
101.4,O
please,O
call,O
the,O
office,O
or,O
go,O
to,O
the,O
emergency,O
room,O

Physical,O
Therapy,O
:,O

Activity,O
:,O

Activity,O
as,O
tolerated,O

Left,O
upper,O
extremity,O
:,O

Non,O
weight,O
bearing,O

Non-weight,O
bearing,O
left,O
leg,O

Treatments,O
Frequency,O
:,O
splint,B-TR
to,I-TR
left,I-TR
arm,I-TR

Followup,O
Instructions,O
:,O

Please,O
follow,O
up,O
with,O
Dr.,O
Bergeron,O
in,O
clinic,O
in,O
2,O
weeks,O
",",O
please,O
call,O
953,O
6923,O
to,O
Posada,O
that,O
appointment,O
.,O

An,O
appointment,O
has,O
been,O
made,O
for,O
you,O
with,O
Nurse,O
Daniel,O
Crump,O
at,O
the,O
Loretta,O
Schubert,O
Community,O
Health,O
Center,O
on,O
Friday,O
Novemeber,O
24,O
at,O
2pm,O
.,O

It,O
is,O
located,O
at,O
2249,O
S.,O
Lincoln,O
Ave.,O
in,O
Nantucket,O
Cottage,O
Hospital,O
the,O
phone,O
to,O
the,O
clinic,O
is,O
(,O
451,O
),O
376-3200,O
.,O

They,O
will,O
monitor,O
your,B-TE
blood,I-TE
pressure,I-TE
and,O
heart,B-TE
rate,I-TE
and,O
lopressor,B-TR
.,O

Gregory,O
Robert,O
MD,O
06-807,O

Completed,O
by,O
:,O
Genevieve,O
Gehlert,O
PA,O
80-BZQ,O
2019-10-19,O
@,O
1248,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Ron,O
Scott,O
on,O
:,O
WED,O
2019-11-27,O
7:42,O
AM,O

(,O
End,O
of,O
Report,O
),O

303694252,O
EH,O

14027692,O

97370,O

08/05/2001,O
12:00:00,O
AM,O

erosive,B-PR
esophagitis,I-PR

DIS,O

Admission,O
Date,O
:,O

08/05/2001,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

08/08/2001,O

******,O
DISCHARGE,O
ORDERS,O
******,O

RHALTHEAGLE,O
",",O
LEELO,O
506-20-55-6,O
K40,O

Room,O
:,O

89N-803,O

Service,O
:,O

MED,O

DISCHARGE,O
PATIENT,O
ON,O
:,O

08/08/01,O
AT,O
04:00,O
PM,O

CONTINGENT,O
UPON,O

SNF,O
/,O
rehab,O

WILL,O
D,O
/,O
C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D,O
/,O
C,O
SUMMARY,O
:,O

YES,O

Attending,O
:,O

GRENDZISKLEEB,O
",",O
FACISA,O
TIELO,O
",",O
M.D.,O

CODE,O
STATUS,O
:,O

No,O
CPR,B-TR
/,O
No,O
defib,B-TR
/,O

DISPOSITION,O
:,O

No-,O
Ter,O
Chipold,O
Medical,O
Center,O

DISCHARGE,O
MEDICATIONS,O
:,O

ROBITUSSIN,B-TR
(,I-TR
GUAIFENESIN,I-TR
),I-TR
10,O
MILLILITERS,O
PO,O
Q4H,O
PRN,O
cough,B-PR
FLAGYL,B-TR
(,I-TR
METRONIDAZOLE,I-TR
),I-TR
500,O
MG,O
PO,O
TID,O
X,O
5,O
Days,O
Starting,O
Today,O
(,O
08/08,O
),O
NITROGLYCERIN,B-TR
1/150,O
(,O
0.4,O
MG,O
),O
1,O
TAB,O
SL,O
q5min,O
x,O
3,O
PRN,O
chest,B-PR
pain,I-PR

HOLD,O
IF,O
:,O

SBP,B-TE
&lt;,O
100,O
AMBIEN,B-TR
(,I-TR
ZOLPIDEM,I-TR
TARTRATE,I-TR
),I-TR
5,O
MG,O
PO,O
QHS,O
PRN,O
insomnia,B-PR

Food,O
/,O
Drug,O
Interaction,O
Instruction,O

Give,O
on,O
an,O
empty,O
stomach,O
(,O
give,O
1hr,O
before,O
or,O
2hr,O
after,O
food,O
),O

Number,O
of,O
Doses,O
Required,O
(,O
approximate,O
),O
:,O

5,B-TR
LEVOFLOXACIN,I-TR
250,O
MG,O
PO,O
QD,O
X,O
5,O
Days,O
Starting,O
Today,O
(,O
08/08,O
),O

Alert,O
overridden,O
:,O

Override,O
added,O
on,O
08/08/01,O
by,O
:,O

POTENTIALLY,O
SERIOUS,B-PR
INTERACTION,I-PR
:,O

HALOPERIDOL,B-TR
and,O
LEVOFLOXACIN,B-TR

POTENTIALLY,O
SERIOUS,B-PR
INTERACTION,I-PR
:,O

HALOPERIDOL,B-TR
and,O
LEVOFLOXACIN,B-TR

Reason,O
for,O
override,O
:,O

aware,O

Previous,O
Override,O
Notice,O

Override,O
added,O
on,O
08/07/01,O
by,O
ZISKFUSCJALK,O
",",O
ACRI,O
",",O
M.D.,O
on,O
order,O
for,O
HALDOL,B-TR
IM,I-TR
(,O
ref,O
#,O
09647807,O
),O

POTENTIALLY,O
SERIOUS,B-PR
INTERACTION,I-PR
:,O

LEVOFLOXACIN,B-TR
and,O
HALOPERIDOL,B-TR

Reason,O
for,O
override,O
:,O

awre,O

Previous,O
override,O
information,O
:,O

Override,O
added,O
on,O
08/07/01,O
by,O
ZISKFUSCJALK,O
",",O
ACRI,O
",",O
M.D.,O
on,O
order,O
for,O
HALDOL,B-TR
PO,I-TR
(,O
ref,O
#,O
60739147,O
),O

POTENTIALLY,O
SERIOUS,B-PR
INTERACTION,I-PR
:,O

LEVOFLOXACIN,B-TR
and,O
HALOPERIDOL,B-TR

Reason,O
for,O
override,O
:,O

aware,O

OMEPRAZOLE,B-TR
40,O
MG,O
PO,O
BID,O
X,O
45,O
Days,O
ATENOLOL,B-TR
25,O
MG,O
PO,O
BID,O

Food,O
/,O
Drug,O
Interaction,O
Instruction,O

Take,O
consistently,O
with,O
meals,O
or,O
on,O
empty,O
stomach,O
.,O

RETURN,O
TO,O
WORK,O
:,O

Not,O
Applicable,O

FOLLOW,O
UP,O
APPOINTMENT,O
(,O
S,O
),O
:,O

Dr.,O
Scaher,O
Grend,O
",",O
RAMMCO,O
8/20,O
",",O
3:30pm,O
scheduled,O
",",O
No,O
Known,B-PR
Allergies,I-PR

ADMIT,O
DIAGNOSIS,O
:,O

hematemesis,B-PR

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O

Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O
erosive,B-PR
esophagitis,I-PR

OTHER,O
DIAGNOSIS,O
;,O

Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O
right,B-PR
scrotal,I-PR
hydrocele,I-PR
bph,B-PR
(,I-PR
benign,I-PR
prostatic,I-PR
hypertrophy,I-PR
),I-PR
?,O
nph,B-PR
(,O
?,O
hydrocephalus,B-PR
),O
dementia,B-PR
(,I-PR
dementia,I-PR
),I-PR

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O

Esophagogastroduodenoscopy,B-TR

BRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

86,O
yo,O
male,O
with,O
one,O
day,O
of,O
hematemesis,B-PR
(,O
history,O
unclear,O
),O
.,O

No,O
known,O
TB,B-PR
or,O
CA,B-PR
history,O
.,O

No,O
SOB,B-PR
",",O
?,O
fever,B-PR
at,O
home,O
.,O

No,O
known,O
dysphagia,B-PR
.,O

Also,O
c,O
/,O
o,O
chest,B-PR
pain,I-PR
",",O
substernal,B-PR
discomfort,I-PR
for,O
past,O
few,O
days,O
.,O

Brought,O
in,O
from,O
assisted,O
living,O
facility,O
.,O

In,O
ED,O
HR,B-TE
70,O
",",O
BP,B-TE
130/80,O
",",O
O2sat,B-TE
96%,O
.,O

Hct,B-TE
44,O
.,O

CXR,B-TE
notable,O
for,O
RLL,B-PR
infiltrate,I-PR
with,O
old,B-PR
B,I-PR
upper,I-PR
lung,I-PR
field,I-PR
granulomas,I-PR
.,O

Chest,B-TE
CT,I-TE
notable,O
for,O
esophageal,B-PR
diverticulum,I-PR
and,O
thickened,B-PR
distal,I-PR
1/3,I-PR
of,I-PR
esophagus,I-PR
",",O
suspicious,O
for,O
malignancy,B-PR
.,O

+,O
alveolar,B-PR
opacities,I-PR
c,O
/,O
w,O
alveolar,B-PR
hemorrhage,I-PR
or,O
aspirated,B-PR
blood,I-PR
.,O

Also,O
with,O
multiple,B-PR
cystic,I-PR
hypodensities,I-PR
in,I-PR
liver,I-PR
seen,O
in,O
previous,O
scans,B-TE
.,O

1,O
),O
GI,O
:,O

Throughout,O
admission,O
",",O
hematemesis,B-PR
flow,O
decreased,O
while,O
on,O
PPI,B-TR
and,O
clear,B-TR
liquids,I-TR
.,O

EGD,B-TE
08/08/01,O
showed,O
mulitple,B-PR
non-bleeding,I-PR
linear,I-PR
erosions,I-PR
with,O
an,B-PR
irregular,I-PR
circumfrencial,I-PR
ulcer,I-PR
at,I-PR
the,I-PR
GE,I-PR
junction,I-PR
.,O

Tolerated,O
advancement,O
to,O
a,B-TR
soft,I-TR
mechanical,I-TR
diet,I-TR
well,O
.,O

Started,O
on,O
omeprazole,B-TR
40,O
mg,O
po,O
bid,O
x6,O
wks,O
.,O

2,O
),O
CV,O
:,O

CP,B-PR
",",O
low,O
prob,O
with,O
atypical,B-PR
chest,I-PR
pain,I-PR
",",O
CK,B-TE
&apos;s,O
x3,O
flat,O
",",O
and,O
no,O
further,O
episodes,O
of,O
CP,B-PR
during,O
the,O
admission,O
.,O

BP,B-TE
remained,O
stable,O
throughout,O
the,O
admission,O
;,O
initially,O
",",O
BP,B-TR
meds,I-TR
were,O
held,O
",",O
but,O
as,O
VS,B-TE
remai,O
ned,O
stable,O
and,O
bleeding,B-PR
subsided,O
",",O
lopressor,B-TR
was,O
titrated,O
up,O
to,O
25,O
mg,O
po,O
tid,O
.,O

He,O
was,O
switched,O
back,O
to,O
his,O
home,O
dose,O
of,O
atenolol,B-TR
25,O
mg,O
po,O
bid,O

3,O
),O
ID,O
:,O

Levo,B-TR
and,O
flagyl,B-TR
for,O
presumed,O
aspiration,B-PR
pneumonia,I-PR
/,O
pneuomonitis,B-PR
.,O

4,O
),O
GU,O
:,O

h,O
/,O
o,O
obstructive,B-PR
uropathy,I-PR
--,O
UOP,B-TE
was,O
erratic,O
",",O
but,O
no,O
foley,B-TR
was,O
needed,O
.,O

Bun,B-TE
/,O
Cr,B-TE
were,O
stable,O
.,O

5,O
),O
FEN,O
:,O

Started,O
on,O
clear,B-TR
liquids,I-TR
.,O

Once,O
bleed,B-PR
ing,I-PR
stopped,O
",",O
advanced,O
diet,O
to,O
soft-mechanical,B-TR
.,O

CODE,O
:,O

DNR,B-TR
",",O
NO,O
CPR,B-TR
",",O
may,O
intubate,O
for,O
airway,B-TR
protection,I-TR
",",O
call,O
son,O
.,O

Disposition,O
Plans,O
:,O

Will,O
follow-up,O
with,O
his,O
PMD,O
;,O
biopsy,O
results,O
to,O
be,O
followed,O
closely,O
.,O

If,O
biopsy,O
results,O
abnormal,B-PR
",",O
will,O
need,O
follow-up,B-TE
intra-esophageal,I-TE
ultrasound,I-TE
by,O
GI,O
service,O
.,O

ADDITIONAL,O
COMMENTS,O
:,O

You,O
have,O
been,O
admitted,O
for,O
evaluation,B-TE
of,O
an,B-PR
esophageal,I-PR
bleed,I-PR
.,O

You,O
have,O
some,B-PR
erosions,I-PR
in,I-PR
the,I-PR
esophagus,I-PR
which,O
are,O
no,O
longer,O
bleeding,B-PR
.,O

You,O
will,O
need,O
to,O
continue,O
to,O
take,O
special,B-TR
medications,I-TR
for,O
these,B-PR
erosions,I-PR
.,O

If,O
you,O
experience,O
further,B-PR
bleeding,I-PR
or,O
increasing,B-PR
discomfort,I-PR
with,O
swallowing,O
",",O
you,O
must,O
tell,O
your,O
nurse,O
and,O
call,O
your,O
doctor,O
right,O
away,O
.,O

Please,O
follow-up,O
the,O
biopsy,O
results,O
with,O
your,O
doctor,O
.,O

You,O
may,O
need,O
to,O
have,O
further,B-TE
studies,I-TE
at,O
a,O
later,O
date,O
.,O

Continue,O
all,O
your,B-TR
previous,I-TR
medications,I-TR
as,O
directed,O
.,O

DISCHARGE,O
CONDITION,O
:,O

Satisfactory,O

TO,O
DO,O
/,O
PLAN,O
:,O

1,O
),O
Follow-up,O
esophageal,O
biopsy,O
results,O

2,O
),O
Schedule,O
GI,O
follow-up,O
if,O
biopsy,O
results,O
abnormal,B-PR
or,O
if,O
continued,B-PR
bleeding,I-PR
.,O

3,O
),O
Consider,O
oncology,O
follow-up,O
if,O
biopsies,B-TE
suggestive,O
of,O
malignancy,B-PR

4,O
),O
Omeprazole,B-TR
40,O
mg,O
po,O
bid,O
x6,O
wks,O
.,O

No,O
dictated,O
summary,O

ENTERED,O
BY,O
:,O

ZISKFUSCJALK,O
",",O
ACRI,O
",",O
M.D.,O
(,O
AN36,O
),O

2008-08-01,O
15:06,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

Admission,O
Date,O
:,O

2014-03-05,O

Discharge,O
Date,O
:,O

2014-04-04,O

Date,O
of,O
Birth,O
:,O

1942-08-15,O

Sex,O
:,O

M,O

Service,O
:,O

CARDIOTHORACIC,O
SURGERY,O

HISTORY,O
OF,O
THE,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
71,O
-,O
year-old,O
gentleman,O
who,O
was,O
admitted,O
to,O
the,O
St.,O
Anne,O
's,O
Hospital,O
as,O
a,O
transfer,O
from,O
the,O
Kindred,O
Park,O
View,O
Specialty,O
Hospital,O
of,O
Springfield,O
.,O

Prior,O
to,O
admission,O
",",O
he,O
had,O
a,O
long,O
and,O
complicated,O
hospital,O
course,O
at,O
the,O
outside,O
hospital,O
.,O

His,O
hospital,O
course,O
began,O
on,O
2014-02-13,O
when,O
he,O
underwent,O
a,B-TR
right,I-TR
carotid,I-TR
endarterectomy,I-TR
for,O
95%,B-PR
stenosis,I-PR
of,I-PR
the,I-PR
carotid,I-PR
artery,I-PR
.,O

His,O
postoperative,O
course,O
was,O
complicated,O
by,O
nonspecific,B-PR
T,I-PR
wave,I-PR
changes,I-PR
consistent,O
with,O
myocardial,B-PR
infarction,I-PR
postoperatively,O
as,O
well,O
as,O
hematoma,B-PR
formation,I-PR
.,O

The,B-PR
hematoma,I-PR
formation,I-PR
was,O
rapidly,O
expanding,O
and,O
he,O
received,O
an,B-TR
emergent,I-TR
surgical,I-TR
airway,I-TR
in,O
the,O
Intensive,O
Care,O
Unit,O
.,O

This,B-TR
emergent,I-TR
cricothyroidotomy,I-TR
was,O
converted,O
then,O
to,O
a,B-TR
formal,I-TR
tracheostomy,I-TR
.,O

During,O
his,O
subsequent,O
hospital,O
course,O
",",O
he,O
had,O
an,B-PR
additional,I-PR
CHF,I-PR
exacerbation,I-PR
.,O

He,O
was,O
medically,O
managed,O
and,O
eventually,O
his,B-TR
tracheostomy,I-TR
was,O
decannulated,O
.,O

However,O
",",O
just,O
prior,O
to,O
admission,O
to,O
Mass.,O
Eye,O
&,O
Ear,O
Infirmary,O
he,O
had,O
another,B-PR
acute,I-PR
decompensation,I-PR
with,O
CHF,B-PR
exacerbation,I-PR
.,O

This,O
necessitated,O
emergent,B-TR
intubation,I-TR
.,O

With,O
EKG,B-PR
changes,I-PR
consistent,O
with,O
myocardial,B-PR
infarction,I-PR
",",O
he,O
was,O
transferred,O
to,O
the,O
Mass.,O
Eye,O
&,O
Ear,O
Infirmary,O
for,O
further,O
management,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Diabetes,B-PR
type,I-PR
2,I-PR
treated,O
with,O
oral,B-TR
medication,I-TR
.,O

2.,O
Cerebrovascular,B-PR
disease,I-PR
",",O
status,O
post,O
left,B-TR
carotid,I-TR
endarterectomy,I-TR
in,O
2008,O
.,O

3.,O
Status,O
post,O
right,B-PR
cerebrovascular,I-PR
accident,I-PR
in,O
2009,O
with,O
residual,B-PR
left-sided,I-PR
weakness,I-PR
.,O

4.,O
Status,O
post,O
right,B-TR
carotid,I-TR
endarterectomy,I-TR
on,O
2014-02-13,O
.,O

5.,O
Fall,O
from,O
standing,O
on,O
2014-01-29,O
with,O
resultant,O
displaced,B-PR
radial,I-PR
fracture,I-PR
which,O
was,O
reduced,O
",",O
closed,O
",",O
and,O
casted,O
.,O

6.,O
Hypertension,B-PR
.,O

7.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
.,O

No,O
history,O
of,O
catheterization,B-TE
prior,O
to,O
admission,O
to,O
the,O
Saint,O
Vincent,O
Hospital,O
.,O

8.,O
Chronic,B-PR
renal,I-PR
insufficiency,I-PR
with,O
a,B-TE
baseline,I-TE
creatinine,I-TE
of,O
2.0,O
to,O
2.7.,O

MEDICATIONS,O
ON,O
TRANSFER,O
THE,O
Stillman,O
Infirmary,O
:,O

1.,O
Lovenox,B-TR
1,O
mg,O
per,O
kilogram,O
subcutaneously,O
b.i.d.,O

2.,O
Aspirin,B-TR
81,O
mg,O
p.o.,O
q.d.,O

3.,O
Lopressor,B-TR
50,O
mg,O
p.o.,O
b.i.d.,O

4.,O
Lansoprazole,B-TR
30,O
mg,O
p.o.,O
q.d.,O

5.,O
Regular,B-TR
insulin,I-TR
sliding,I-TR
scale,I-TR
.,O

6.,O
Captopril,B-TR
6.25,O
mg,O
q.i.d.,O

7.,O
Lasix,B-TR
drip,I-TR
at,O
2,O
per,O
hour,O
.,O

8.,O
Versed,B-TR
drip,I-TR
.,O

9.,O
TPN,B-TR
.,O

PHYSICAL,O
EXAMINATION,O
ON,O
ADMISSION,O
:,O

This,O
is,O
a,O
gentleman,O
who,O
is,O
intubated,B-TR
",",O
comfortable,O
",",O
with,O
minimal,B-TR
sedation,I-TR
.,O

He,O
was,O
afebrile,B-PR
with,O
a,B-TE
temperature,I-TE
of,O
99.1,O
.,O

His,B-TE
pulse,I-TE
was,O
in,O
the,O
70s,O
",",O
blood,B-TE
pressure,I-TE
119/58,O
.,O

He,O
was,O
breathing,O
12,O
per,O
minute,O
and,O
saturating,O
98%,O
.,O

His,B-TE
CVP,I-TE
is,O
ranging,O
from,O
07-27,O
.,O

He,O
was,O
intubated,O
and,O
has,O
a,B-TR
nasogastric,I-TR
tube,I-TR
.,O

His,O
neck,O
has,O
a,B-PR
well-healed,I-PR
right,I-PR
carotid,I-PR
endarterectomy,I-PR
scar,I-PR
.,O

There,O
is,O
also,O
a,B-PR
well-healing,I-PR
tracheostomy,I-PR
scar,I-PR
.,O

The,O
lungs,O
were,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

The,O
heart,O
was,O
regular,O
with,O
an,O
S1,O
and,O
S2,O
.,O

The,O
abdomen,O
was,O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
with,O
normoactive,O
bowel,O
sounds,O
.,O

The,O
extremities,O
were,O
without,O
edema,B-PR
.,O

The,O
left,O
arm,O
was,O
in,O
a,B-TR
cast,I-TR
.,O

HOSPITAL,O
COURSE,O
:,O

Mr.,O
Knueppel,O
was,O
admitted,O
to,O
the,O
CCU,O
at,O
the,O
Mass.,O
Eye,O
&,O
Ear,O
Infirmary,O
.,O

Upon,O
admission,O
",",O
he,O
was,O
treated,O
for,O
his,B-PR
pneumonia,I-PR
.,O

He,O
was,O
medically,O
managed,O
for,O
CHF,B-PR
and,O
underwent,O
a,B-TE
cardiac,I-TE
catheterization,I-TE
on,O
2014-03-06,O
.,O

His,B-TE
catheterization,I-TE
revealed,O
70%,B-PR
stenosis,I-PR
of,I-PR
the,I-PR
distal,I-PR
left,I-PR
main,I-PR
coronary,I-PR
artery,I-PR
",",O
90%,B-PR
stenosis,I-PR
of,I-PR
the,I-PR
LAD,I-PR
",",O
80%,B-PR
stenosis,I-PR
of,I-PR
the,I-PR
circumflex,I-PR
",",O
90%,B-PR
stenosis,I-PR
of,I-PR
OM2,I-PR
and,O
a,B-PR
proximally,I-PR
occluded,I-PR
right,I-PR
coronary,I-PR
artery,I-PR
.,O

After,O
reviewing,O
cardiac,B-TE
catheterization,I-TE
data,I-TE
",",O
a,O
consultation,O
was,O
made,O
with,O
Cardiothoracic,O
Surgery,O
who,O
deemed,O
that,O
he,O
was,O
a,O
good,O
candidate,O
for,O
coronary,B-TR
artery,I-TR
bypass,I-TR
grafting,I-TR
.,O

Over,O
the,O
ensuing,O
days,O
",",O
Mr.,O
Nina,O
CHF,B-PR
was,O
managed,O
by,O
the,O
CCU,O
Team,O
and,O
he,O
received,O
treatment,B-TR
for,O
what,O
was,O
now,O
determined,O
to,O
be,O
a,B-PR
Klebsiella,I-PR
pneumonia,I-PR
.,O

He,O
was,O
treated,O
with,O
a,O
full,O
course,O
of,O
Zosyn,B-TR
.,O

On,O
2014-03-11,O
",",O
Mr.,O
Knueppel,O
went,O
to,O
the,O
Operating,O
Room,O
with,O
Dr.,O
Streeter,O
.,O

He,O
underwent,O
a,B-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
of,I-TR
four,I-TR
vessels,I-TR
.,O

He,O
had,O
a,B-TR
saphenous,I-TR
vein,I-TR
graft,I-TR
to,I-TR
his,I-TR
LAD,I-TR
and,I-TR
diagonal,I-TR
in,O
a,O
sequential,O
fashion,O
",",O
saphenous,B-TR
vein,I-TR
graft,I-TR
to,I-TR
his,I-TR
PDA,I-TR
and,O
a,B-TR
saphenous,I-TR
vein,I-TR
graft,I-TR
to,I-TR
his,I-TR
OM,I-TR
.,O

The,B-TR
procedure,I-TR
was,O
performed,O
by,O
Dr.,O
Streeter,O
and,O
assisted,O
by,O
Dr,O
.,O
.....................,O

The,O
patient,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
without,O
complication,B-PR
and,O
was,O
transferred,O
to,O
the,O
Cardiac,O

Surgery,O
Recovery,O
Unit,O
without,O
complication,B-PR
.,O

Please,O
see,O
the,O
previously,O
dictated,O
operative,O
note,O
for,O
more,O
details,O
.,O

Mr.,O
Knueppel,O
had,O
a,O
long,O
postoperative,O
course,O
.,O

His,O
postoperative,O
course,O
was,O
complicated,O
by,O
hypertension,B-PR
which,O
was,O
managed,O
medically,O
.,O

During,O
his,O
postoperative,O
course,O
",",O
he,O
did,O
not,O
suffer,O
from,O
any,B-PR
arrhythmias,I-PR
nor,O
did,O
he,O
have,O
any,O
episode,O
of,O
hypotension,B-PR
.,O

At,O
the,O
time,O
of,O
discharge,O
",",O
he,O
was,O
on,O
a,B-TR
stable,I-TR
antihypertensive,I-TR
regimen,I-TR
appropriate,O
for,O
someone,O
with,O
a,B-PR
decreased,I-PR
ejection,I-PR
fraction,I-PR
.,O

Mr.,O
Knueppel,O
had,O
had,O
a,O
long,O
protracted,O
period,O
of,O
intubation,B-TR
prior,O
to,O
the,O
operation,B-TR
.,O

The,O
status,O
of,O
Mr.,O
Nina,O
pulmonary,O
system,O
necessitated,O
a,B-TR
prolonged,I-TR
postoperative,I-TR
intubation,I-TR
.,O

After,O
a,O
very,O
slow,O
wean,O
from,O
ventilatory,B-TR
support,I-TR
",",O
Mr.,O
Knueppel,O
was,O
successfully,O
extubated,O
on,O
postoperative,O
day,O
number,O
nine,O
.,O

He,O
continued,O
to,O
be,O
very,O
tenuous,O
from,O
a,O
pulmonary,O
point,O
of,O
view,O
and,O
required,O
frequent,B-TR
chest,I-TR
PT,I-TR
.,O

For,O
this,O
reason,O
",",O
Mr.,O
Knueppel,O
was,O
kept,O
in,O
the,O
Intensive,O
Care,O
Unit,O
where,O
very,O
close,O
monitoring,O
could,O
be,O
performed,O
.,O

In,O
addition,O
",",O
he,O
had,O
chest,B-TR
PT,I-TR
performed,O
at,O
very,O
regular,O
intervals,O
by,O
the,O
ICU,O
staff,O
.,O

His,O
pulmonary,O
status,O
was,O
so,O
tenuous,O
that,O
we,O
were,O
unable,O
to,O
transfer,O
him,O
to,O
the,O
regular,O
patient,O
care,O
floor,O
during,O
his,O
hospitalization,O
.,O

Mr.,O
Knueppel,O
had,O
an,B-TR
emergent,I-TR
cricothyroidotomy,I-TR
followed,O
by,O
a,B-TR
formal,I-TR
tracheostomy,I-TR
at,O
the,O
outside,O
hospital,O
.,O

There,O
is,O
much,B-PR
scarring,I-PR
surrounding,I-PR
his,I-PR
larynx,I-PR
.,O

Such,O
a,O
situation,O
frequently,O
makes,O
it,O
very,O
difficult,O
to,O
swallow,O
without,O
aspirating,O
.,O

As,O
is,O
expected,O
",",O
Mr.,O
Knueppel,O
failed,O
a,B-TE
swallowing,I-TE
study,I-TE
early,O
on,O
in,O
his,O
Boston,O
Regional,O
Medical,O
Centerr,O
hospital,O
course,O
.,O

The,B-TE
study,I-TE
was,O
repeated,O
and,O
yet,O
again,O
Mr.,O
Knueppel,O
was,O
unable,O
to,O
swallow,O
without,O
evidence,O
of,O
aspiration,B-PR
.,O

After,O
a,O
prolonged,O
period,O
of,O
being,O
fed,O
via,O
nasogastric,B-TR
tube,I-TR
",",O
Mr.,O
Knueppel,O
finally,O
had,O
a,B-TR
formal,I-TR
percutaneous,I-TR
endoscopic,I-TR
gastrostomy,I-TR
tube,I-TR
placed,O
in,O
the,O
Intensive,O
Care,O
Unit,O
.,O

This,O
was,O
performed,O
on,O
2014-04-01,O
",",O
postoperative,O
day,O
number,O
21,O
.,O

This,B-TR
procedure,I-TR
was,O
performed,O
by,O
Dr.,O
Kevin,O
Taussig,O
and,O
assisted,O
by,O
Dr.,O
Carla,O
Solan,O
.,O

The,B-TR
procedure,I-TR
was,O
performed,O
under,O
endoscopic,B-TR
guidance,I-TR
in,O
the,O
Intensive,O
Care,O
Unit,O
without,O
complication,B-PR
.,O

Please,O
see,O
the,O
previously,O
dictated,O
operative,O
note,O
for,O
more,O
details,O
.,O

Mr.,O
Knueppel,O
Robertson,O
a,B-PR
distal,I-PR
radius,I-PR
fracture,I-PR
prior,O
to,O
arriving,O
to,O
the,O
hospital,O
.,O

This,B-PR
injury,I-PR
had,O
been,O
reduced,O
and,O
casted,O
at,O
the,O
outside,O
institution,O
.,O

Postoperatively,O
",",O
there,O
was,O
much,B-PR
edema,I-PR
associated,O
in,O
the,O
postoperative,O
course,O
from,O
coronary,B-TR
artery,I-TR
bypass,I-TR
grafting,I-TR
.,O

His,B-TR
cast,I-TR
was,O
removed,O
by,O
the,O
Orthopedic,O
Service,O
in,O
anticipation,O
of,O
this,B-PR
edema,I-PR
and,O
to,O
avoid,O
compartment,B-PR
syndrome,I-PR
.,O

The,B-TR
cast,I-TR
was,O
replaced,O
by,O
a,B-TR
plaster,I-TR
splint,I-TR
.,O

Mr.,O
Knueppel,O
should,O
follow-up,O
with,O
his,O
orthopedic,O
surgeon,O
in,O
the,O
Worcester,O
State,O
Hospital,O
for,O
reassessment,B-TE
of,O
his,B-PR
injury,I-PR
and,O
possible,O
removal,B-TR
of,O
the,B-TR
splint,I-TR
.,O

By,O
postoperative,O
day,O
number,O
23,O
",",O
Mr.,O
Nina,O
pulmonary,O
status,O
was,O
deemed,O
sufficiently,O
stable,O
.,O

His,B-PR
hypertension,I-PR
was,O
well,O
controlled,O
and,O
he,O
was,O
tolerating,O
tube,B-TR
feeds,I-TR
.,O

At,O
this,O
point,O
",",O
he,O
was,O
ready,O
to,O
be,O
discharged,O
to,O
rehabilitation,O
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

1.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
",",O
status,O
post,O
coronary,B-TR
artery,I-TR
bypass,I-TR
graft,I-TR
",",I-TR
four,I-TR
vessels,I-TR
.,O

2.,O
Congestive,B-PR
heart,I-PR
failure,I-PR
.,O

3.,O
Klebsiella,B-PR
pneumonia,I-PR
.,O

4.,O
Failed,B-PR
swallow,I-PR
study,I-PR
status,O
post,O
percutaneous,B-TR
endoscopic,I-TR
gastrostomy,I-TR
tube,I-TR
placement,I-TR
.,O

5.,O
Central,B-TE
line,I-TE
culture,I-TE
positive,O
for,O
coagulase,B-PR
-,I-PR
negative,I-PR
Staphylococcus,I-PR
aureus,I-PR
",",O
status,O
post,O
a,B-TR
14,I-TR
day,I-TR
treatment,I-TR
with,O
vancomycin,B-TR
and,O
removal,B-TR
of,O
the,B-TR
line,I-TR
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

1.,O
Methylphenidate,B-TR
5,O
mg,O
p.o.,O
q.d.,O

2.,O
Lasix,B-TR
40,O
mg,O
p.o.,O
b.i.d.,O

3.,O
Captopril,B-TR
50,O
mg,O
p.o.,O
t.i.d.,O

4.,O
Glyburide,B-TR
10,O
mg,O
p.o.,O
b.i.d.,O

5.,O
Miconazole,B-TR
powder,I-TR
2%,O
",",O
apply,O
q.i.d.,O
p.r.n.,O

6.,O
Paxil,B-TR
20,O
mg,O
p.o.,O
q.d.,O

7.,O
Albuterol,B-TR
nebulizer,I-TR
solution,I-TR
one,O
nebulizer,O
q.,O
four,O
hours,O
.,O

8.,O
Metoprolol,B-TR
100,O
mg,O
p.o.,O
t.i.d.,O

9.,O
Heparin,B-TR
"5,000",O
units,O
subcutaneously,O
q.,O
12,O
hours,O
.,O

10.,O
Amlodipine,B-TR
5,O
mg,O
p.o.,O
b.i.d.,O

11.,O
Percocet,B-TR
one,O
to,O
two,O
tablets,O
p.o.,O
q.,O
four,O
hours,O
p.r.n.,O
pain,B-PR
.,O

12.,O
Colace,B-TR
100,O
mg,O
p.o.,O
b.i.d.,O

13.,O
Aspirin,B-TR
325,O
mg,O
p.o.,O
q.d.,O

14.,O
Tube,B-TR
feedings,I-TR
;,O
Mr.,O
Knueppel,O
is,O
to,O
be,O
discharged,O
on,O
tube,B-TR
feeds,I-TR
",",O
Promote,B-TR
",",I-TR
with,I-TR
fiber,I-TR
full-strength,I-TR
at,O
80,O
cc,O
per,O
hour,O
around,O
the,O
clock,O
.,O

His,B-TR
PEG,I-TR
tube,I-TR
should,O
be,O
flushed,O
with,O
30,O
cc,O
of,O
water,O
after,O
every,O
use,O
.,O

ACTIVITY,O
:,O

Mr.,O
Nina,O
activity,O
is,O
ad,O
lib,O
.,O

He,O
is,O
also,O
to,O
be,O
strict,B-TR
n.p.o.,I-TR

He,O
should,O
be,O
n.p.o.,B-TR
until,O
he,O
has,O
a,B-TE
repeat,I-TE
swallow,I-TE
evaluation,I-TE
which,O
demonstrates,O
his,O
ability,O
to,O
swallow,O
without,O
aspiration,B-PR
.,O

FOLLOW-UP,O
:,O

The,O
patient,O
will,O
follow-up,O
with,O
Dr.,O
Streeter,O
in,O
his,O
office,O
in,O
four,O
to,O
six,O
weeks,O
.,O

The,O
patient,O
should,O
follow-up,O
with,O
his,O
primary,O
care,O
physician,O
within,O
one,O
week,O
.,O

The,O
patient,O
should,O
follow-up,O
with,O
his,O
orthopedic,O
surgeon,O
at,O
the,O
next,O
convenient,O
time,O
to,O
determine,O
the,O
length,O
of,O
duration,O
of,O
his,B-TR
casting,I-TR
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
.,O

PHYSICAL,O
EXAMINATION,O
ON,O
DISCHARGE,O
:,O

Mr.,O
Knueppel,O
is,O
afebrile,B-PR
with,O
a,B-TE
temperature,I-TE
of,O
97.1,O
",",O
pulse,B-TE
77,O
",",O
sinus,O
rhythm,O
.,O

His,B-TE
blood,I-TE
pressure,I-TE
was,O
142/68,O
",",O
breathing,O
21,O
breaths,O
per,O
minute,O
",",O
94%,O
on,O
2,B-TR
liters,I-TR
nasal,I-TR
cannula,I-TR
.,O

His,O
pupils,O
were,O
equal,O
",",O
round,O
",",O
and,O
reactive,O
.,O

Extraocular,O
muscles,O
intact,O
.,O

His,O
head,O
was,O
normocephalic,O
",",O
atraumatic,B-PR
.,O

The,O
lungs,O
were,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

The,O
heart,O
revealed,O
a,O
regular,O
rate,O
and,O
rhythm,O
.,O

The,O
abdomen,O
was,O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
.,O

He,O
had,O
a,B-TR
PEG,I-TR
tube,I-TR
in,I-TR
his,I-TR
left,I-TR
upper,I-TR
quadrant,I-TR
.,O

The,B-PR
site,I-PR
was,O
clean,O
and,O
dry,O
.,O

There,O
was,O
no,O
evidence,O
of,O
necrosis,B-PR
",",O
erythema,B-PR
or,O
exudate,B-PR
at,O
the,B-PR
site,I-PR
.,O

The,O
extremities,O
were,O
warm,O
and,O
well,O
perfuse,O
.,O

There,O
was,O
trace,B-PR
edema,I-PR
in,I-PR
both,I-PR
lower,I-PR
extremities,I-PR
.,O

His,O
right,O
lower,O
extremity,O
has,O
ecchymosis,B-PR
related,O
to,O
a,B-PR
saphenectomy,I-PR
site,I-PR
.,O

This,B-PR
ecchymosis,I-PR
is,O
much,O
improved,O
from,O
previous,B-TE
examinations,I-TE
.,O

There,O
was,O
no,O
increased,B-PR
warmth,I-PR
over,O
this,O
area,O
nor,O
is,O
there,O
any,B-PR
exudate,I-PR
from,O
his,B-PR
wounds,I-PR
.,O

All,O
of,O
his,B-PR
wounds,I-PR
including,O
sternotomy,B-PR
wound,I-PR
were,O
clean,O
",",O
dry,O
",",O
and,O
intact,O
.,O

Timothy,O
M,O
Geibel,O
",",O
M.D.,O
92-534,O

Dictated,O
By,O
:,O
Melinda,O
U,O
Yantis,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2014-04-04,O
02:23,O

T,O
:,O
2014-04-04,O
15:35,O

JOB,O
#,O
:,O
79430,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Timothy,O
B.,O
Chew,O
on,O
:,O
TUE,O
2014-06-03,O
4:10,O
PM,O

(,O
End,O
of,O
Report,O
),O

305265793_b,O

FIH,O

2833679,O

44807/072t,O

458891,O

5/14/1992,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

5/14/92,O

DISCHARGE,O
DATE,O
:,O

5/19/92,O

CHIEF,O
COMPLAINT,O
:,O

Right,B-PR
foot,I-PR
pain,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
71,O
year,O
old,O
white,O
female,O
with,O
metastatic,B-PR
ovarian,I-PR
carcinoma,I-PR
",",O
who,O
recently,O
underwent,O
an,B-TE
exploratory,I-TE
laparotomy,I-TE
on,O
5/2,O
by,O
Dr.,O
Korcblinknud,O
.,O

She,O
was,O
found,O
to,O
have,O
widely,B-PR
metastatic,I-PR
ovarian,I-PR
carcinoma,I-PR
.,O

There,O
was,O
sigmoid,B-PR
narrowing,I-PR
near,O
a,B-PR
large,I-PR
left,I-PR
ovarian,I-PR
mass,I-PR
",",O
and,O
distal,B-PR
ileal,I-PR
narrowing,I-PR
by,O
a,B-PR
right,I-PR
ovarian,I-PR
mass,I-PR
.,O

The,O
patient,O
had,O
an,B-TR
ileostomy,I-TR
performed,O
and,O
had,O
had,O
her,O
first,O
course,O
of,O
chemotherapy,B-TR
and,O
later,O
debulking,B-TR
operation,I-TR
by,O
Dr.,O
Median,O
.,O

She,O
was,O
well,O
at,O
home,O
until,O
8:30,O
p.m.,O
on,O
the,O
day,O
of,O
admission,O
",",O
when,O
she,O
developed,O
acute,O
onset,O
of,O
right,B-PR
foot,I-PR
pain,I-PR
",",O
which,O
was,O
worse,O
with,O
walking,O
.,O

She,O
complained,O
of,O
increased,B-PR
numbness,I-PR
of,I-PR
the,I-PR
right,I-PR
foot,I-PR
over,O
time,O
",",O
and,O
was,O
seen,O
at,O
Sephsandpot,O
Center,O
",",O
where,O
she,O
was,O
found,O
to,O
have,O
palpable,O
right,O
femoral,O
and,O
popliteal,O
pulses,O
",",O
and,O
no,B-PR
pedal,I-PR
pulses,I-PR
.,O

The,O
patient,O
was,O
transferred,O
to,O
the,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
.,O

She,O
had,O
previous,O
history,O
of,O
claudication,B-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Significant,O
for,O
glaucoma,B-PR
",",O
right,B-TR
knee,I-TR
arthroscopic,I-TR
surgery,I-TR
in,O
1988,O
",",O
appendectomy,B-TR
",",O
dilation,B-TR
and,I-TR
curettage,I-TR
times,O
two,O
",",O
and,O
a,B-PR
hiatus,I-PR
hernia,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Lorazepam,B-TR
1,O
mg.,O
PO,O
q6,O
hours,O
PRN,O
",",O
and,O
Timoptic,B-TR
0.5%,O
1,O
drop,O
b.i.d.,O

ALLERGIES,O
:,O

Iodine,B-TR
and,O
shellfish,O
cause,O
throat,B-PR
tightening,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

No,O
history,O
of,O
smoking,O
and,O
ethanol,O
use,O
.,O

She,O
lives,O
with,O
her,O
husband,O
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

Negative,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Showed,O
a,O
71,O
year,O
old,O
white,O
female,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

The,B-TE
vital,I-TE
signs,I-TE
were,O
blood,B-TE
pressure,I-TE
155/82,O
",",O
pulse,B-TE
88,O
",",O
temperature,B-TE
96.0.,O

Her,O
right,O
foot,O
was,O
without,B-PR
capillary,I-PR
refill,I-PR
",",O
with,O
a,B-PR
marked,I-PR
change,I-PR
of,O
temperature,B-TE
at,O
a,O
level,O
of,O
the,O
mid,O
calf,O
.,O

There,O
was,O
decreased,B-PR
sensation,I-PR
to,O
touch,B-TE
over,O
the,O
entire,O
foot,O
.,O

She,O
was,O
able,O
to,O
move,O
her,O
foot,O
and,O
toes,O
.,O

Radial,B-TE
",",I-TE
carotid,I-TE
and,I-TE
femoral,I-TE
pulses,I-TE
were,O
symmetric,O
and,O
strong,O
.,O

The,B-TE
popliteal,I-TE
pulse,I-TE
on,I-TE
the,I-TE
right,I-TE
side,I-TE
was,O
diminished,B-PR
.,O

There,O
was,O
no,B-PR
dorsal,I-PR
",",I-PR
pedal,I-PR
pulse,I-PR
on,I-PR
the,I-PR
right,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

ON,O
5/14/92,O
",",O
the,O
patient,O
received,O
an,B-TE
arteriogram,I-TE
which,O
demonstrated,O
an,B-PR
embolus,I-PR
in,I-PR
the,I-PR
right,I-PR
profunda,I-PR
/,I-PR
femoral,I-PR
artery,I-PR
.,O

There,O
was,O
an,B-PR
occlusion,I-PR
in,I-PR
the,I-PR
proximal,I-PR
calf,I-PR
",",O
of,O
the,O
peroneal,O
and,O
anterior,O
tibial,O
arteries,O
.,O

There,O
was,O
an,B-PR
occlusion,I-PR
of,I-PR
posterior,I-PR
tibial,I-PR
artery,I-PR
at,O
the,O
ankle,O
.,O

She,O
was,O
taken,O
urgently,O
to,O
the,O
operating,O
room,O
",",O
where,O
she,O
underwent,O
embolectomy,B-TR
of,I-TR
the,I-TR
profunda,I-TR
superficial,I-TR
femoral,I-TR
vessels,I-TR
.,O

The,B-TE
estimated,I-TE
blood,I-TE
loss,I-TE
was,O
200,O
cc.,O
and,O
she,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
.,O

Postoperatively,O
",",O
she,O
was,O
again,O
noted,O
to,O
have,O
a,B-PR
cold,I-PR
right,I-PR
lower,I-PR
extremity,I-PR
with,O
diminished,B-PR
pulses,I-PR
and,O
was,O
again,O
taken,O
to,O
the,O
operating,O
room,O
",",O
where,O
she,O
underwent,O
a,B-TE
right,I-TE
popliteal,I-TE
exploration,I-TE
and,O
thrombectomy,B-TR
.,O

She,O
again,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
and,O
did,O
well,O
postoperatively,O
.,O

On,O
5/19,O
",",O
she,O
had,O
an,B-TE
echocardiogram,I-TE
done,O
which,O
was,O
to,O
be,O
evaluated,O
as,O
an,O
out,O
patient,O
.,O

By,O
discharge,O
she,O
was,O
walking,O
and,O
taking,O
PO&apos;s,O
without,O
problem,O
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

Thromboembolus,B-PR
to,I-PR
the,I-PR
right,I-PR
profunda,I-PR
femoris,I-PR
",",I-PR
and,I-PR
right,I-PR
superficial,I-PR
femoral,I-PR
artery,I-PR
.,O

MA,O
JAMTLANDBRANTESSLIGH,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

COR,O
TLAND,O
",",O
M.D.,O

TR,O
:,O

qa,O
/,O
bmot,O

DD,O
:,O

07/02/92,O

TD,O
:,O

07/07/92,O

CC,O
:,O

Admission,O
Date,O
:,O

2013-02-18,O

Discharge,O
Date,O
:,O

2013-02-27,O

Date,O
of,O
Birth,O
:,O

1934-03-07,O

Sex,O
:,O

F,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,O
Drugs,B-TR

Attending,O
:,O
Karen,O
U.O.,O
Berliner,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O
abdominal,B-PR
pain,I-PR
/,O
nausea,B-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

Intubation,B-TR

IR,B-TR
guided,I-TR
nephrostomy,I-TR
placement,I-TR

History,O
of,O
Present,O
Illness,O
:,O

The,O
patient,O
is,O
a,O
78,O
y/o,O
WF,O
w/a,O
PMH,O
significant,O
for,O
HTN,B-PR
and,O
afib,B-PR
who,O
presented,O
to,O
an,O
OSH,O
w/,O
complaints,O
of,O
abd,B-PR
pain,I-PR
and,O
nausea,B-PR
.,O

She,O
was,O
found,O
to,O
have,O
a,B-PR
R,I-PR
ureteral,I-PR
stone,I-PR
w/,O
resultant,O
hydronephrosis,B-PR
and,O
was,O
transferred,O
to,O
Nantucket,O
Cottage,O
Hospital,O
for,O
ureteral,B-TR
stent,I-TR
placement,I-TR
.,O

Her,B-TE
INR,I-TE
was,O
found,O
to,O
be,O
elevated,B-PR
when,O
admitted,O
and,O
",",O
in,O
the,O
course,O
of,O
waiting,O
for,O
this,O
to,O
normalize,O
",",O
the,O
patient,O
spiked,O
a,B-TE
temperature,I-TE
to,O
105,O
and,O
became,O
hypotensive,B-PR
to,O
the,O
70s,O
.,O

She,O
was,O
bolused,O
w/out,O
effect,O
and,O
had,O
little,O
response,O
to,O
neo,B-TR
so,O
she,O
was,O
changed,O
to,O
levophed,B-TR
",",O
given,O
doses,O
of,O
cipro,B-TR
/,O
vanco,B-TR
/,O
gent,B-TR
and,O
transferred,O
to,O
the,O
CMED,O
CSRU,O
for,O
management,O
.,O

In,O
the,O
CMED,O
",",O
urology,O
was,O
consulted,O
and,O
the,O
patient,O
received,O
a,B-TR
R,I-TR
nephrostomy,I-TR
tube,I-TR
.,O

However,O
",",O
tube,B-TR
placement,I-TR
was,O
complicated,O
by,O
renal,B-PR
artery,I-PR
puncture,I-PR
",",O
afib,B-PR
",",O
and,O
increased,B-PR
dyspnea,I-PR
.,O

She,O
was,O
intubated,O
for,O
this,B-PR
hypoxia,I-PR
and,O
treated,O
with,O
lasix,B-TR
",",O
metoprolol,B-TR
",",O
and,O
diltiazem,B-TR
.,O

She,O
was,O
weaned,O
off,O
her,B-TR
pressors,I-TR
on,O
02-21,O
and,O
maintained,O
her,O
pressure,O
w/out,O
additional,B-TR
fluid,I-TR
boluses,I-TR
.,O

Her,B-TR
sedation,I-TR
was,O
weaned,O
down,O
and,O
she,O
was,O
successfully,O
extubated,O
shortly,O
thereafter,O
.,O

UCx,B-TE
grew,O
proteus,B-PR
and,O
her,B-TR
abx,I-TR
were,O
changed,O
to,O
levaquin,B-TR
alone,O
and,O
she,O
remained,O
afebrile,B-PR
for,O
>,O
24,O
hr,O
on,O
this,B-TR
regimen,I-TR
.,O

She,O
continued,O
to,O
have,O
trouble,O
with,O
afib,B-PR
and,O
required,O
a,B-TR
dilt,I-TR
gtt,I-TR
on,O
the,O
day,O
prior,O
to,O
call-out,O
to,O
control,O
this,O
rhythm,O
but,O
she,O
was,O
transitioned,O
to,O
PO,B-TR
diltiazem,I-TR
and,O
has,O
been,O
in,O
NSR,O
since,O
this,O
time,O
.,O

She,O
was,O
restarted,O
on,O
heparin,B-TR
prior,O
to,O
d/c,O
as,O
a,O
bridge,O
to,O
therapeutic,B-TR
coumadin,I-TR
anticoagulation,I-TR
.,O

Past,O
Medical,O
History,O
:,O

1.,O
HTN,B-PR

2.,O
A.fib,B-PR
on,O
Coumadin,B-TR

3.,O
Cataract,B-PR
disease,I-PR

4.,O
01-22,O
closed,B-PR
fracture,I-PR
of,I-PR
radius,I-PR
s/p,O
closed,B-TR
reduction,I-TR

5.,O
MV,B-PR
",",I-PR
AV,I-PR
",",I-PR
TV,I-PR
insufficiency,I-PR

Social,O
History,O
:,O

Single,O
",",O
lives,O
with,O
her,O
daughter,O
",",O
doesn,O
't,O
smoke,O
",",O
doesn,O
't,O
drink,O
",",O
worked,O
for,O
bag,O
company,O

Family,O
History,O
:,O

"Brother,O
with,O
"",O
heart,B-PR
trouble,I-PR
"",O
.",O

Physical,O
Exam,O
:,O

140/66,O
",",O
92,O
",",O
18,O
",",O
96%,O
2L,O

Gen,O
:,O

Pleasant,O
obese,O
female,O
in,O
NAD,B-PR
",",O
in,O
wrist,B-TR
restraints,I-TR

HEENT,O
:,O

EOMI,O
",",O
PERRLA,O
",",O
MM,B-PR
dry,I-PR
",",O
O/P,O
clear,O

Lungs,O
:,O
clear,O
anteriorly,O

CV,O
:,O

RRR,O
",",O
S1/S2,O
intact,O
",",O
3/6,B-PR
SEM,I-PR
at,I-PR
the,I-PR
USB,I-PR

Abd,O
:,O

S/NT/ND,B-PR
",",O
obese,B-PR
",",O
+BS,O

Back,O
:,O

R,B-TR
nephrostomy,I-TR
tube,I-TR
in,O
place,O
and,O
draining,O

Ext,O
:,O
brace,B-TR
on,I-TR
L,I-TR
wrist,I-TR
",",O
2+,B-PR
LE,I-PR
edema,I-PR

Neuro,O
:,O
CN,O
03-31,O
grossly,O
intact,O
",",O
strength,O
5/5,O
bilaterally,O
",",O
AAO,O
to,O
person,O
",",O
place,O
(,O
hospital,O
in,O
Burlington,O
),O
",",O
and,O
time,O
(,O
1997-02-23,O
),O

Pertinent,O
Results,O
:,O

CXR,B-TE
2013-02-21,O
:,O

Right,B-TR
subclavian,I-TR
CV,I-TR
line,I-TR
overlies,O
proximal,O
SVC,O
.,O

There,O
is,O
cardiomegaly,B-PR
and,O
tortuosity,B-PR
of,I-PR
the,I-PR
thoracic,I-PR
aorta,I-PR
with,O
small,B-PR
bilateral,I-PR
pleural,I-PR
effusions,I-PR
consistent,O
with,O
CHF,B-PR
.,O

No,O
pneumothorax,B-PR
.,O

Overall,O
appearances,O
are,O
essentially,O
unchanged,O
since,O
the,B-TE
prior,I-TE
film,I-TE
of,O
2013-02-20,O
",",O
apart,O
from,O
removal,B-TR
of,O
the,B-TR
ET,I-TR
tube,I-TR
.,O

CT,B-TE
Abd,I-TE
2013-02-18,O
:,O

1),O
Moderate,B-PR
to,I-PR
severe,I-PR
right,I-PR
hydroureteronephrosis,I-PR
with,O
two,B-PR
obstructing,I-PR
distal,I-PR
right,I-PR
ureteral,I-PR
stones,I-PR
",",O
8,O
mm,O
and,O
6,O
mm,O
respectively,O
.,O

2),O
Probable,O
obstructing,B-PR
5,I-PR
mm,I-PR
right,I-PR
mid,I-PR
ureteral,I-PR
calculus,I-PR
causing,O
mild,B-PR
hydroureter,I-PR
",",O
though,O
it,O
is,O
difficult,O
to,O
tell,O
definitively,O
if,O
this,B-PR
stone,I-PR
is,O
within,O
or,O
just,O
medial,O
to,O
the,O
right,O
ureter,O
on,O
this,B-TE
CT,I-TE
without,I-TE
IV,I-TE
contrast,I-TE
.,O

3),O
Small,B-PR
bilateral,I-PR
pleural,I-PR
effusions,I-PR
.,O

4),O
Coronary,B-PR
artery,I-PR
calcification,I-PR
.,O

ECHO,B-TE
2013-02-19,O
:,O

1.,O
The,O
left,O
atrium,O
is,O
mildly,B-PR
dilated,I-PR
.,O

2.,O
The,B-TE
left,I-TE
ventricular,I-TE
cavity,I-TE
size,I-TE
is,O
normal,O
.,O

Due,O
to,O
suboptimal,O
technical,O
quality,O
",",O
a,B-PR
focal,I-PR
wall,I-PR
motion,I-PR
abnormality,I-PR
cannot,O
be,O
fully,O
excluded,O
.,O

Overall,B-TE
left,I-TE
ventricular,I-TE
systolic,I-TE
function,I-TE
is,O
normal,O
LVEF,B-TE
>,O
55%,O
),O
.,O

3.,O
The,O
right,O
ventricular,O
cavity,O
is,O
dilated,B-PR
.,O

Right,B-TE
ventricular,I-TE
systolic,I-TE
function,I-TE
appears,O
depressed,B-PR
.,O

4.,O
The,O
aortic,O
valve,O
leaflets,O
(,O
3,O
),O
are,O
mildly,B-PR
thickened,I-PR
.,O

There,O
is,O
mild,B-PR
aortic,I-PR
valve,I-PR
stenosis,I-PR
.,O

5.,O
The,O
mitral,O
valve,O
leaflets,O
are,O
mildly,B-PR
thickened,I-PR
.,O

There,O
is,O
severe,B-PR
mitral,I-PR
annular,I-PR
calcification,I-PR
.,O

Trivial,B-PR
mitral,I-PR
regurgitation,I-PR
is,O
present,O
.,O

6.,O
Moderate,B-PR
to,I-PR
severe,I-PR
[,I-PR
3+,I-PR
],I-PR
tricuspid,I-PR
regurgitation,I-PR
is,O
seen,O
.,O

There,O
is,O
moderate,B-PR
pulmonary,I-PR
artery,I-PR
systolic,I-PR
hypertension,I-PR
.,O

2013-02-18,O
05:49,O
PM,O
BLOOD,B-TE
WBC,B-TE
-,O
36.6,O
*,O
RBC,B-TE
-,O
4.29,O
Hgb,B-TE
-,O
13.4,O
Hct,B-TE
-,O
38.8,O
MCV,B-TE
-,O
91,O
MCH,B-TE
-,O
31.3,O
MCHC,B-TE
-,O
34.6,O
RDW,B-TE
-,O
13.2,O
Plt,B-TE
Ct,I-TE
-,O
132,O
*,O

2013-02-27,O
05:17,O
AM,O
BLOOD,B-TE
WBC,B-TE
-,O
11.8,O
*,O
RBC,B-TE
-,O
3.61,O
*,O
Hgb,B-TE
-,O
10.8,O
*,O
Hct,B-TE
-,O
32.2,O
*,O
MCV,B-TE
-,O
89,O
MCH,B-TE
-,O
29.8,O
MCHC,B-TE
-,O
33.5,O
RDW,B-TE
-,O
13.2,O
Plt,B-TE
Ct,I-TE
-,O
346,O

2013-02-18,O
05:49,O
PM,O
BLOOD,B-TE
PT,B-TE
-,O
20.6,O
*,O
PTT,B-TE
-,O
31.6,O
INR,B-TE
(,I-TE
PT,I-TE
)-,I-TE
3.0,O

2013-02-27,O
05:17,O
AM,O
BLOOD,B-TE
PT,B-TE
-,O
15.5,O
*,O
PTT,B-TE
-,O
75.0,O
*,O
INR,B-TE
(,I-TE
PT,I-TE
)-,I-TE
1.6,O

2013-02-18,O
05:49,O
PM,O
BLOOD,B-TE
Glucose,B-TE
-,O
127,O
*,O
UreaN,B-TE
-,O
26,O
*,O
Creat,B-TE
-,O
1.7,O
*,O
Na,B-TE
-,O
136,O
K,B-TE
-,O
3.9,O
Cl,B-TE
-,O
103,O
HCO3,B-TE
-,O
20,O
*,O
AnGap,B-TE
-,O
17,O

2013-02-27,O
05:17,O
AM,O
BLOOD,B-TE
Glucose,B-TE
-,O
97,O
UreaN,B-TE
-,O
14,O
Creat,B-TE
-,O
1.2,O
*,O
Na,B-TE
-,O
144,O
K,B-TE
-,O
3.9,O
Cl,B-TE
-,O
106,O
HCO3,B-TE
-,O
29,O
AnGap,B-TE
-,O
13,O

2013-02-22,O
03:00,O
AM,O
BLOOD,B-TE
ALT,B-TE
-,O
52,O
*,O
AST,B-TE
-,O
50,O
*,O
LD,B-TE
(,I-TE
LDH,I-TE
)-,I-TE
300,O
*,O
CK,B-TE
(,I-TE
CPK,I-TE
)-,I-TE
41,O
AlkPhos,B-TE
-,O
280,O
*,O
TotBili,B-TE
-,O
0.8,O

2013-02-18,O
05:49,O
PM,O
BLOOD,B-TE
Calcium,B-TE
-,O
7.7,O
*,O
Phos,B-TE
-,O
3.3,O
Mg,B-TE
-,O
1.1,O
*,O

2013-02-27,O
05:17,O
AM,O
BLOOD,B-TE
Calcium,B-TE
-,O
8.7,O
Phos,B-TE
-,O
4.0,O
Mg,B-TE
-,O
1.9,O

Brief,O
Hospital,O
Course,O
:,O

A/P,O
:,O

78,O
year,O
old,O
female,O
with,O
history,O
of,O
HTN,B-PR
",",O
a.fib,B-PR
presenting,O
with,O
ureteral,B-PR
stone,I-PR
",",O
hydronephrosis,B-PR
",",O
and,O
urosepsis,B-PR
.,O

She,O
originally,O
had,O
hypotension,B-PR
and,O
a,B-PR
leukocytosis,I-PR
in,O
the,O
ER,O
and,O
was,O
admitted,O
to,O
the,O
CMED,O
CCU,O
.,O

In,O
the,O
CMED,O
",",O
urology,O
was,O
consulted,O
and,O
the,O
patient,O
received,O
a,B-TR
R,I-TR
nephrostomy,I-TR
tube,I-TR
.,O

However,O
",",O
tube,B-TR
placement,I-TR
was,O
complicated,O
by,O
renal,B-PR
artery,I-PR
puncture,I-PR
",",O
afib,B-PR
",",O
and,O
increased,B-PR
dyspnea,I-PR
.,O

She,O
was,O
intubated,O
for,O
this,B-PR
hypoxia,I-PR
and,O
treated,O
with,O
lasix,B-TR
",",O
metoprolol,B-TR
",",O
and,O
diltiazem,B-TR
.,O

She,O
was,O
weaned,O
off,O
her,B-TR
pressors,I-TR
on,O
02-21,O
and,O
maintained,O
her,B-TE
pressure,I-TE
w/out,O
additional,B-TR
fluid,I-TR
boluses,I-TR
.,O

Her,B-TR
sedation,I-TR
was,O
weaned,O
down,O
and,O
she,O
was,O
successfully,O
extubated,O
shortly,O
thereafter,O
.,O

UCx,B-TE
grew,O
proteus,B-PR
and,O
her,B-TR
abx,I-TR
were,O
changed,O
to,O
levaquin,B-TR
alone,O
and,O
she,O
remained,O
afebrile,B-PR
for,O
>,O
24hr,O
on,O
this,B-TR
regimen,I-TR
.,O

She,O
continued,O
to,O
have,O
trouble,O
with,O
afib,B-PR
and,O
required,O
a,B-TR
dilt,I-TR
gtt,I-TR
on,O
the,O
day,O
prior,O
to,O
call-out,O
to,O
control,O
this,O
rhythm,O
but,O
she,O
was,O
transitioned,O
to,O
PO,B-TR
diltiazem,I-TR
on,O
the,O
day,O
of,O
call-out,O
.,O

1.,O
Sepsis,B-PR
-,O
The,O
patient,O
was,O
septic,B-PR
in,O
the,O
ER,O
and,O
her,B-TE
blood,I-TE
cultures,I-TE
eventually,O
grew,O
proteus,B-PR
.,O

Her,B-TE
Bcx,I-TE
remained,O
negative,O
throughout,O
her,O
stay,O
.,O

She,O
was,O
treated,O
with,O
levaquin,B-TR
on,O
the,O
floor,O
and,O
will,O
complete,O
a,O
14d,O
course,O
at,O
rehab,O
.,O

She,O
has,O
been,O
afebrile,B-PR
since,O
she,O
was,O
called,O
out,O
to,O
the,O
floor,O
.,O

2.,O
Ureteral,B-PR
stone,I-PR
-,O
The,O
patient,O
had,O
a,B-TR
nephrostomy,I-TR
tube,I-TR
placed,O
by,O
IR,O
to,O
relieve,O
her,B-PR
hydronephrosis,I-PR
.,O

She,O
was,O
followed,O
by,O
urology,O
during,O
her,O
stay,O
and,O
will,O
see,O
them,O
again,O
2,O
wk,O
after,O
d/c,O
for,O
definitive,B-TR
treatment,I-TR
of,O
her,B-PR
nephrolithiasis,I-PR
.,O

At,O
this,O
time,O
",",O
urology,O
will,O
coordinate,O
removal,B-TR
of,O
her,B-TR
nephrostomy,I-TR
tube,I-TR
with,O
IR,O
.,O

Her,B-TR
nephrostomy,I-TR
tube,I-TR
was,O
draining,O
clear,O
yellow,O
urine,O
at,O
the,O
time,O
of,O
d/c,O
.,O

3.,O
a.fib,B-PR
-,O
The,O
patient,O
has,O
a,O
history,O
of,O
atrial,B-PR
fibrillation,I-PR
controlled,O
with,O
beta,B-TR
blockers,I-TR
at,O
home,O
.,O

She,O
was,O
treated,O
in,O
the,O
CMED,O
as,O
above,O
.,O

Once,O
on,O
the,O
floor,O
",",O
the,O
patient,O
had,O
one,O
episode,O
of,O
afib,B-PR
w/,O
RVR,B-PR
that,O
responded,O
immediately,O
to,O
IV,B-TR
metoprolol,I-TR
.,O

Because,O
of,O
this,O
",",O
the,B-TR
patient,I-TR
's,I-TR
diltiazem,I-TR
was,O
stopped,O
and,O
she,O
was,O
started,O
on,O
tid,B-TR
metoprolol,I-TR
.,O

After,O
this,O
",",O
the,O
patient,O
had,O
no,O
further,B-PR
problems,I-PR
with,O
her,B-TR
rate,I-TR
control,I-TR
.,O

She,O
was,O
maintained,O
on,O
a,B-TR
heparin,I-TR
gtt,I-TR
for,O
bridge,O
to,O
coumadin,B-TR
while,O
on,O
the,O
floor,O
after,O
this,O
was,O
cleared,O
by,O
IR,O
and,O
urology,O
.,O

She,O
will,O
be,O
d/c,O
w/out,O
her,B-TR
heparin,I-TR
as,O
she,O
is,O
trending,O
upwards,O
with,O
her,B-TE
INR,I-TE
and,O
has,O
no,O
MR,B-PR
Paul,I-PR
Paquettec,I-PR
heart,I-PR
disease,I-PR
.,O

She,O
will,O
continue,O
her,B-TR
coumadin,I-TR
at,O
rehab,O
to,O
achieve,O
an,B-TE
INR,I-TE
between,O
03-22,O
.,O

4.,O
delirium,B-PR
-,O
The,O
patient,O
had,O
troubles,O
with,O
agitation,B-PR
while,O
in,O
the,O
CMED,O
CCU,O
.,O

She,O
received,O
prn,B-TR
haldol,I-TR
w/,O
little,O
effect,O
and,O
improved,O
as,O
her,B-PR
infection,I-PR
cleared,O
.,O

Medications,O
on,O
Admission,O
:,O
toprol,B-TR
(,O
unknown,O
dose,O
),O
coumadin,B-TR
1,O
mg,O
qhs,O

Discharge,O
Medications,O
:,O

1.,O
Bisacodyl,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
as,O
needed,O
for,O
constipation,B-PR
.,O

2.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

3.,O
Levofloxacin,B-TR
500,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q24H,O
(,O
every,O
24,O
hours,O
),O
for,O
7,O
days,O
.,O

4.,O
Warfarin,B-TR
1,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
HS,O
(,O
at,O
bedtime,O
),O
.,O

5.,O
Miconazole,B-TR
Nitrate,I-TR
2,O
%,O
Powder,O
Sig,O
:,O
One,O
(,O
1,O
),O
Appl,O
Topical,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
.,O

6.,O
Ipratropium,B-TR
Bromide,I-TR
0.02,O
%,O
Solution,O
Sig,O
:,O
One,O
(,O
1,O
),O
neb,O
Inhalation,O
Q6H,O
(,O
every,O
6,O
hours,O
),O
as,O
needed,O
.,O

7.,O
Metoprolol,B-TR
Tartrate,I-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
.,O

8.,O
Polyvinyl,B-TR
Alcohol,I-TR
1.4,O
%,O
Drops,O
Sig,O
:,O
1-2,O
Drops,O
Ophthalmic,O
PRN,O
(,O
as,O
needed,O
),O
.,O

9.,O
Acetaminophen,B-TR
325,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
.,O

10.,O
Outpatient,B-TE
Lab,I-TE
Work,I-TE
please,O
have,O
your,B-TE
INR,I-TE
checked,O
at,O
the,O
rehab,O
center,O
with,O
a,O
goal,O
of,O
03-22,O
.,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Facility,O
:,O

Danvers,O
State,O
Hospital,O
&,O
Rehab,O
Center,O
-,O
Beverly,O

Discharge,O
Diagnosis,O
:,O

Urosepsis,B-PR

Nephrolithiasis,B-PR

Atrial,B-PR
fibrillation,I-PR

Discharge,O
Condition,O
:,O

Good,O

Discharge,O
Instructions,O
:,O

Please,O
take,O
your,B-TR
medications,I-TR
as,O
directed,O

Please,O
keep,O
your,O
follow-up,O
appointments,O

Followup,O
Instructions,O
:,O

Dr.,O
Emma,O
Attar,O
2013-03-26,O
10:15,O
AM,O

George,O
Yvonne,O
",",O
MD,O
Phone,O
:,O
440-401-5366,O
Date,O
/,O
Time,O
:,O
2013-03-19,O
10:40,O

Deborah,O
Walter,O
MD,O
17-478,O

Completed,O
by,O
:,O
Richard,O
LYNCH,O
MD,O
72-568,O
2013-02-27,O
@,O
1558,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Brenda,O
BELL,O
on,O
:,O
WED,O
2013-04-17,O
3:18,O
PM,O

(,O
End,O
of,O
Report,O
),O

305265793_g,O

FIH,O

2833679,O

74738/2av5,O

543247,O

09/21/1992,O
12:00:00,O
AM,O

STAGE,B-PR
3C,I-PR
PAPILLARY,I-PR
SEROUS,I-PR
CARCINOMA,I-PR
OF,I-PR
THE,I-PR
OVARY,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

09/21/92,O

DISCHARGE,O
DATE,O
:,O

09/24/92,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Stage,B-PR
3C,I-PR
papillary,I-PR
serous,I-PR
carcinoma,I-PR
of,I-PR
the,I-PR
ovary,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

Patient,O
was,O
admitted,O
to,O
the,O
GYN,O
Oncology,O
SErvice,O
in,O
1980,O
by,O
Dr.,O
Slaineaee,O
Ganz,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
seventy-one,O
year,O
old,O
white,O
female,O
with,O
stenotic,B-PR
area,I-PR
on,I-PR
her,I-PR
mid,I-PR
sigmoid,I-PR
",",O
noticed,O
on,O
barium,B-TE
enema,I-TE
.,O

The,B-TE
ultrasound,I-TE
showed,O
ascites,B-PR
and,O
question,O
of,O
pelvic,B-PR
mass,I-PR
.,O

The,O
patient,O
was,O
explored,O
by,O
General,O
surgery,O
",",O
who,O
saw,O
the,B-PR
3C,I-PR
ovarian,I-PR
carcinoma,I-PR
.,O

The,O
patient,O
also,O
had,O
an,B-TR
omentectomy,I-TR
and,O
ileostomy,B-TR
.,O

The,O
patient,O
was,O
admitted,O
for,O
one,O
cycle,O
of,O
Cytoxan,B-TR
and,O
Cisplatin,B-TR
",",O
and,O
subsequently,O
underwent,O
debulking,B-TR
in,O
June,O
1992,O
",",O
as,O
well,O
as,O
a,B-TR
total,I-TR
abdominal,I-TR
hysterectomy/,I-TR
bilateral,B-TR
salpingo-oophorectomy,I-TR
",",O
omentectomy,B-TR
",",O
splenectomy,B-TR
",",O
rectosigmoid,B-TR
resection,I-TR
with,O
a,B-TR
take,I-TR
down,I-TR
of,I-TR
the,I-TR
ileostomy,I-TR
.,O

Also,O
ileal,B-TR
cecal,I-TR
resection,I-TR
",",O
MDR,B-TE
showed,O
that,O
Cisplatin,B-TR
and,O
VP,B-TR
16,I-TR
were,O
more,O
effective,O
.,O

The,O
patient,O
now,O
presents,O
for,O
line,O
1,O
",",O
cycle,O
4,O
to,O
15,O
of,O
VP,B-TR
16,I-TR
and,I-TR
Cisplatin,I-TR
chemotherapy,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

The,O
patient,O
&apos;s,O
past,O
medical,O
history,O
is,O
unremarkable,O
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

As,O
above,O
",",O
including,O
an,B-TR
embolectomy,I-TR
in,O
June,O
1992,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Coumadin,B-TR
2.5,O
mg.,O
five,O
times,O
a,O
week,O
",",O
Ativan,B-TR
and,O
Lomotil,B-TR
prn,O
.,O

ADVERSE,O
DRUG,O
REACTIONS,O
:,O

no,O
known,B-PR
drug,I-PR
allergies,I-PR
",",O
but,O
has,O
shellfish,B-PR
allergy,I-PR
",",O
and,O
question,O
of,O
an,B-PR
Iodine,I-PR
allergy,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
physical,B-TE
exam,I-TE
the,O
patient,O
is,O
a,O
well,O
appearing,O
",",O
elderly,O
white,O
female,O
",",O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

The,B-TE
blood,I-TE
pressure,I-TE
is,O
120/82,O
",",O
heart,B-TE
rate,I-TE
88,O
",",O
weight,B-TE
125,O
pounds,O
.,O

The,B-TE
head,I-TE
",",I-TE
eyes,I-TE
",",I-TE
ears,I-TE
",",I-TE
nose,I-TE
",",I-TE
throat,I-TE
exam,I-TE
was,O
notable,O
for,O
alopecia,B-PR
",",O
otherwise,O
unremarkable,O
.,O

Chest,O
was,O
clear,O
",",O
bilateral,B-TE
cardiac,I-TE
exam,I-TE
showed,O
regular,O
rate,O
and,O
rhythm,O
",",O
abdomen,O
was,O
soft,O
",",O
nontender,B-PR
",",O
except,O
for,O
mild,B-PR
left,I-PR
upper,I-PR
quadrant,I-PR
tenderness,I-PR
with,O
a,B-PR
well,I-PR
healed,I-PR
",",I-PR
midline,I-PR
abdominal,I-PR
scar,I-PR
.,O

No,O
other,B-PR
lower,I-PR
quadrant,I-PR
tenderness,I-PR
.,O

Extremities,O
were,O
unremarkable,O
.,O

Neurological,O
:,O

exam,B-TE
was,O
nonfocal,O
",",O
and,O
there,O
was,O
no,O
significant,B-PR
lymphadenopathy,I-PR
.,O

LABORATORY,O
DATA,O
:,O

Notable,O
for,O
a,B-TE
white,I-TE
blood,I-TE
cell,I-TE
of,O
9.5,O
",",O
ANC,B-TE
7.7,O
",",O
hematocrit,B-TE
26,O
",",O
platelets,B-TE
of,O
248,O
",",O
BUN,B-TE
and,O
creatinine,B-TE
12.,O
and,O
1.2,O
respectively,O
",",O
magnesium,B-TE
1.1,O
",",O
calcium,B-TE
8.7,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
hospital,O
and,O
received,O
two,O
units,O
of,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
for,O
her,B-TE
hematocrit,I-TE
of,O
26,O
",",O
and,O
had,O
a,B-TR
magnesium,I-TR
repleted,O
.,O

The,O
patient,O
received,O
three,O
days,O
of,O
chemotherapy,B-TR
",",O
consisting,O
of,O
45,O
mg.,O
of,O
Cisplatin,B-TR
160,O
mg.,O
of,O
VP,B-TR
16,I-TR
",",O
and,O
tolerated,O
chemotherapy,B-TR
resonably,O
well,O
.,O

Serial,B-TE
PTs,I-TE
were,O
obtained,O
",",O
and,O
the,O
patient,O
was,O
noted,O
to,O
have,O
an,B-TE
initial,I-TE
PT,I-TE
of,O
10.9,O
on,O
admission,O
",",O
despite,O
Coumadin,B-TR
at,O
home,O
.,O

She,O
was,O
given,O
10,O
mg.,O
on,O
hospital,O
day,O
#,O
1,O
",",O
and,O
5,O
mg.,O
on,O
hospital,O
day,O
2,O
",",O
and,O
back,O
to,O
2.5,O
qhs,O
.,O

The,B-TE
patient,I-TE
&apos;s,I-TE
pro,I-TE
time,I-TE
bumped,O
to,O
19.5,O
on,O
hospital,O
day,O
#,O
3,O
",",O
and,O
the,O
patient,O
was,O
instructed,O
to,O
continue,O
with,O
2,O
1/2,O
mg.,O
qhs,O
and,O
is,O
to,O
followup,O
with,O
Anticoagulation,O
Clinic,O
in,O
one,O
week,O
for,O
further,B-TE
pro,I-TE
time,I-TE
checks,I-TE
and,O
adjustments,B-TR
.,O

The,O
patient,O
did,O
develop,O
some,B-PR
hypertension,I-PR
during,O
infusion,B-TR
of,I-TR
her,I-TR
VP,I-TR
16,I-TR
to,O
the,O
170/100,O
range,O
",",O
which,O
apparently,O
happened,O
during,O
her,B-TR
prior,I-TR
chemotherapy,I-TR
.,O

The,O
patient,O
was,O
instructed,O
to,O
followup,O
with,O
her,O
internist,O
regarding,O
further,B-TE
evaluation,I-TE
of,O
her,B-PR
hypertension,I-PR
",",O
and,O
should,O
be,O
assessed,O
regarding,O
further,B-TR
management,I-TR
",",O
as,O
an,O
inpatient,O
",",O
or,O
while,O
receiving,O
chemotherapy,B-TR
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

The,O
patient,O
was,O
discharged,O
home,O
on,O
Coumadin,B-TR
2.5,O
mg.,O
po,O
q,O
d,O
",",O
and,O
Ativan,B-TR
and,O
Lomotil,B-TR
prn,O
.,O

The,O
patient,O
is,O
to,O
followup,O
with,O
Dr.,O
Slaineaee,O
Ganz,O
and,O
was,O
discharged,O
home,O
in,O
good,O
condition,O
.,O

TOMEDANKELL,O
FLOWAYLES,O
",",O
M.D.,O
DICTATING,O
FOR,O
;,O
SLAINEAEE,O
GANZ,O
",",O
M.D.,O

TR,O
:,O

qo,O
/,O
bmot,O

DD,O
:,O

09/24/92,O

TD,O
:,O

09/27/92,O

CC,O
:,O

Admission,O
Date,O
:,O

2017-04-26,O

Discharge,O
Date,O
:,O

2017-05-01,O

Date,O
of,O
Birth,O
:,O

1955-02-25,O

Sex,O
:,O

M,O

Service,O
:,O

CARD,O
CMED,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
62,O
year,O
old,O
gentleman,O
who,O
underwent,O
an,B-TE
exercise,I-TE
treadmill,I-TE
test,I-TE
for,O
screening,B-TE
through,O
the,O
Beth,O
Israel,O
Deaconess,O
Hospital-Needham,O
Clinic,O
.,O

The,B-TE
test,I-TE
was,O
positive,O
for,O
EKG,B-PR
changes,I-PR
and,O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

The,O
patient,O
has,O
no,O
history,O
of,O
chest,B-PR
pain;,I-PR
no,O
history,O
of,O
myocardial,B-PR
infarction,I-PR
.,O

The,O
patient,O
was,O
referred,O
to,O
Cambridge,O
Health,O
Alliance,O
for,O
cardiac,B-TE
catheterization,I-TE
.,O

Cardiac,B-TE
catheterization,I-TE
showed,O
an,B-TE
ejection,I-TE
fraction,I-TE
of,O
50%,O
",",O
left,B-TE
ventricular,I-TE
end,I-TE
diastolic,I-TE
pressure,I-TE
of,O
20,O
",",O
90%,B-PR
left,I-PR
anterior,I-PR
descending,I-PR
lesion,I-PR
",",O
80%,B-PR
left,I-PR
circumflex,I-PR
lesion,I-PR
",",O
80%,B-PR
mid,I-PR
right,I-PR
coronary,I-PR
artery,I-PR
lesion,I-PR
and,O
80%,B-PR
distal,I-PR
right,I-PR
coronary,I-PR
artery,I-PR
lesion,I-PR
.,O

The,O
patient,O
was,O
referred,O
to,O
Dr.,O
Rota,O
for,O
coronary,B-TR
artery,I-TR
bypass,I-TR
grafting,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Hypertension,B-PR
.,O

2.,O
Type,B-PR
2,I-PR
diabetes,I-PR
mellitus,I-PR
.,O

3.,O
Hypercholesterolemia,B-PR
.,O

4.,O
Thirty,O
pack,O
year,O
tobacco,O
history,O
",",O
quit,O
one,O
month,O
ago,O
.,O

5.,O
Gout,B-PR
.,O

6.,O
Gastroesophageal,B-PR
reflux,I-PR
disease,I-PR
.,O

7.,O
History,O
of,O
salivary,B-TR
gland,I-TR
removal,I-TR
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

PREOPERATIVE,O
MEDICATIONS,O
:,O

1.,O
Glucophage,B-TR
XR,O
1000,O
mg,O
p.o.,O
q.,O
day,O
.,O

2.,O
Avandia,B-TR
4,O
mg,O
p.o.,O
q.,O
day,O
.,O

3.,O
Diovan,B-TR
160,O
mg,O
p.o.,O
q.,O
day,O
.,O

4.,O
Atenolol,B-TR
25,O
mg,O
p.o.,O
q.,O
day,O
.,O

5.,O
Lipitor,B-TR
10,O
mg,O
p.o.,O
q.,O
day,O
.,O

6.,O
Niaspan,B-TR
500,O
mg,O
p.o.,O
q.,O
day,O
.,O

7.,O
Enteric-coated,B-TR
aspirin,I-TR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
Saint,O
Vincent,O
Hospital,O
on,O
2017-04-26,O
and,O
underwent,O
a,B-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
times,O
four,O
with,O
left,B-TR
internal,I-TR
mammary,I-TR
artery,I-TR
to,I-TR
left,I-TR
anterior,I-TR
descending,I-TR
",",O
saphenous,B-TR
vein,I-TR
graft,I-TR
to,I-TR
right,I-TR
coronary,I-TR
artery,I-TR
",",O
saphenous,B-TR
vein,I-TR
graft,I-TR
to,I-TR
PDA,I-TR
and,O
saphenous,B-TR
vein,I-TR
graft,I-TR
to,I-TR
obtuse,I-TR
marginal,I-TR
with,O
Dr.,O
Rota,O
.,O

Please,O
see,O
the,O
Operative,O
Note,O
for,O
further,O
details,O
.,O

The,O
patient,O
was,O
transferred,O
to,O
the,O
Intensive,O
Care,O
Unit,O
in,O
stable,O
condition,O
on,O
Neo-Synephrine,B-TR
infusion,I-TR
.,O

The,O
patient,O
was,O
weaned,O
the,O
next,O
day,O
from,O
mechanical,B-TR
ventilation,I-TR
on,O
his,O
first,O
postoperative,O
night,O
.,O

Postoperative,O
days,O
one,O
and,O
two,O
",",O
the,O
patient,O
continued,O
to,O
require,O
Neo-Synephrine,B-TR
to,O
maintain,O
systolic,B-TE
blood,I-TE
pressures,I-TE
greater,O
than,O
100,O
.,O

On,O
postoperative,O
day,O
two,O
",",O
the,B-TE
patient,I-TE
's,I-TE
hematocrit,I-TE
was,O
noted,O
to,O
be,O
23.1,O
;,O
he,O
was,O
transfused,O
one,O
unit,O
of,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
as,O
well,O
as,O
given,O
a,O
dose,O
of,O
Lasix,B-TR
.,O

The,B-TR
Neo-Synephrine,I-TR
was,O
weaned,O
off,O
by,O
postoperative,O
day,O
number,O
three,O
.,O

The,B-TR
patient,I-TR
's,I-TR
chest,I-TR
tubes,I-TR
were,O
removed,O
on,O
postoperative,O
day,O
three,O
without,O
incident,B-PR
.,O

The,O
patient,O
was,O
started,O
on,O
low,B-TR
dose,I-TR
Lasix,I-TR
and,O
Lopressor,B-TR
which,O
he,O
tolerated,O
well,O
.,O

On,O
postoperative,O
day,O
number,O
four,O
",",O
the,O
patient,O
was,O
transferred,O
from,O
the,O
Intensive,O
Care,O
Unit,O
to,O
the,O
regular,O
part,O
of,O
the,O
hospital,O
where,O
he,O
began,O
working,O
with,O
Physical,O
Therapy,O
and,O
on,O
his,O
first,O
session,O
he,O
was,O
able,O
to,O
ambulate,O
500,O
feet,O
and,O
climb,O
one,O
flight,O
of,O
stairs,O
while,O
remaining,O
hemodynamically,O
stable,O
without,O
requiring,O
any,B-TR
oxygen,I-TR
.,O

On,O
postoperative,O
day,O
number,O
five,O
",",O
the,O
patient,O
continued,O
to,O
remain,O
hemodynamically,O
stable,O
.,O

The,B-TR
patient,I-TR
's,I-TR
epicardial,I-TR
pacing,I-TR
wires,I-TR
were,O
removed,O
without,O
incident,B-PR
and,O
the,O
patient,O
was,O
cleared,O
for,O
discharge,O
to,O
home,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Temperature,B-TE
maximum,I-TE
99.8,O
F.,O
;,O
pulse,B-TE
76,O
and,O
sinus,O
rhythm,O
;,O
blood,B-TE
pressure,I-TE
107/61,O
;,O
respiratory,B-TE
rate,I-TE
18,O
;,O
room,B-TE
air,I-TE
oxygen,I-TE
saturation,I-TE
95%,O
.,O

The,B-TE
patient,I-TE
's,I-TE
weight,I-TE
on,O
05-01,O
was,O
101.4,O
.,O

The,O
patient,O
weighed,O
100,O
kilograms,O
preoperatively,O
.,O

LABORATORY,O
DATA,O
:,O

White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
5.8,O
",",O
hematocrit,B-TE
23.5,O
",",O
platelet,B-TE
count,I-TE
118,O
.,O

Sodium,B-TE
140,O
",",O
potassium,B-TE
3.9,O
",",O
chloride,B-TE
103,O
",",O
bicarbonate,B-TE
18,O
",",O
BUN,B-TE
11,O
",",O
creatinine,B-TE
0.8,O
",",O
glucose,B-TE
144,O
.,O

PT,B-TE
29,O
",",O
INR,B-TE
1.1,O
and,O
PTT,B-TE
22.9,O
.,O

Neurologically,O
",",O
the,O
patient,O
is,O
alert,O
and,O
oriented,O
times,O
three,O
",",O
anxious,O
.,O

Neurological,B-TE
examination,I-TE
is,O
non-focal,O
.,O

Heart,O
is,O
regular,O
rate,O
and,O
rhythm,O
without,O
rub,B-PR
or,O
murmur,B-PR
.,O

Respiratory,B-TE
breath,I-TE
sounds,I-TE
are,O
clear,O
bilaterally,O
",",O
decreased,B-PR
at,I-PR
the,I-PR
bases,I-PR
.,O

Abdomen,O
with,O
positive,O
bowel,O
sounds,O
",",O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
",",O
tolerating,O
a,O
regular,O
diet,O
.,O

Sternal,B-TR
incision,I-TR
staples,I-TR
are,O
intact,O
and,O
open,O
to,O
air,O
.,O

Incision,B-PR
is,O
clean,O
and,O
dry,O
.,O

There,O
is,O
no,O
erythema,B-PR
and,O
sternum,O
is,O
stable,O
.,O

Right,B-PR
lower,I-PR
extremity,I-PR
vein,I-PR
harvest,I-PR
site,I-PR
has,O
a,O
moderate,O
amount,O
of,O
ecchymosis,B-PR
at,O
the,O
very,O
distal,O
portion,O
of,O
the,B-PR
incision,I-PR
at,I-PR
the,I-PR
ankle,I-PR
.,O

There,O
is,O
a,O
minimum,O
amount,O
of,O
serosanguinous,B-PR
drainage,I-PR
.,O

There,O
is,O
no,O
erythema,B-PR
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
.,O

2.,O
Status,O
post,O
coronary,B-TR
artery,I-TR
bypass,I-TR
graft,I-TR
times,O
four,O
.,O

3.,O
Type,B-PR
2,I-PR
diabetes,I-PR
mellitus,I-PR
.,O

4.,O
Postoperative,B-PR
anemia,I-PR
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Atenolol,B-TR
25,O
mg,O
p.o.,O
q.,O
day,O
.,O

2.,O
Lasix,B-TR
20,O
mg,O
p.o.,O
q.,O
day,O
times,O
seven,O
days,O
.,O

3.,O
Potassium,B-TR
chloride,I-TR
20,O
mEq,O
p.o.,O
q.,O
day,O
times,O
seven,O
days,O
.,O

4.,O
Niferex,B-TR
150,O
mg,O
p.o.,O
q.,O
day,O
times,O
one,O
month,O
.,O

5.,O
Vitamin,B-TR
C,I-TR
500,O
mg,O
p.o.,O
twice,O
a,O
day,O
times,O
one,O
month,O
.,O

6.,O
Multivitamin,B-TR
one,O
p.o.,O
q.,O
day,O
times,O
one,O
month,O
.,O

7.,O
Ambien,B-TR
5,O
mg,O
p.o.,O
q.,O
h.s.,O
p.r.n.,O

8.,O
Colace,B-TR
100,O
mg,O
p.o.,O
twice,O
a,O
day,O
.,O

9.,O
Avandia,B-TR
4,O
mg,O
p.o.,O
q.,O
day,O
.,O

10.,O
Glucophage,B-TR
500,O
mg,O
p.o.,O
twice,O
a,O
day,O
.,O

11.,O
Lipitor,B-TR
20,O
mg,O
p.o.,O
q.,O
day,O
.,O

12.,O
Zantac,B-TR
150,O
mg,O
p.o.,O
twice,O
a,O
day,O
.,O

13.,O
Niaspan,B-TR
500,O
mg,O
p.o.,O
q.,O
day,O
.,O

14.,O
Percocet,B-TR
5/325,O
one,O
to,O
two,O
p.o.,O
q.,O
four,O
to,O
six,O
hours,O
p.r.n.,O

DISPOSITION,O
:,O

The,O
patient,O
is,O
to,O
be,O
discharged,O
to,O
home,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
condition,O
.,O

DISCHARGE,O
INSTRUCTIONS,O
:,O

1.,O
The,O
patient,O
is,O
to,O
follow-up,O
with,O
Dr.,O
Neri,O
in,O
one,O
to,O
two,O
weeks,O
.,O

2.,O
The,O
patient,O
is,O
to,O
follow-up,O
with,O
Dr.,O
Rota,O
in,O
three,O
to,O
four,O
weeks,O
.,O

3.,O
The,O
patient,O
is,O
to,O
return,O
to,O
Smith,O
on,O
or,O
about,O
05-17,O
to,O
have,O
his,B-TR
staples,I-TR
removed,O
.,O

Gabriela,O
E.,O
D.,O
Castillo,O
",",O
M.D.,O
05-025,O

Dictated,O
By,O
:,O
Julia,O
Q,O
Mcafee,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2017-05-01,O
15:06,O

T,O
:,O
2017-05-01,O
15:37,O

JOB,O
#,O
:,O
59432,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Kathy,O
Brendel,O
on,O
:,O
TUE,O
2017-05-02,O
8:08,O
AM,O

(,O
End,O
of,O
Report,O
),O

313251236,O
WGH,O

1429918,O

816995,O

854768,O

5/1/2004,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O

KATESJESC,O
",",O
RAI,O

MRN,O
:,O

1429918,O

Age,O
:,O

60y,O

REGISTRATION,O
DATE,O
:,O

05/01/2004,O
06:30,O
PM,O

PRELIMINARY,O
REPORT,O

This,O
is,O
to,O
notify,O
you,O
that,O
your,O
patient,O
",",O
KATESJESC,O
",",O
RAI,O
arrived,O
in,O
the,O
Emergency,O
Department,O
at,O
Well,O
General,O
Hospital,O
on,O
05/01/2004,O
06:30,O
PM,O
.,O

The,O
patient,O
presented,O
with,O
a,O
chief,O
complaint,O
of,O
SSCP,B-PR
.,O

Following,O
evaluation,B-TE
and,O
treatment,B-TR
",",O
the,O
patient,O
&apos;s,O
disposition,O
at,O
the,O
end,O
of,O
the,O
visit,O
was,O
ADMITTED,O
AS,O
AN,O
INPATIENT,O
TO,O
WELL,O
GENERAL,O
HOSPITAL,O
.,O

The,O
patient,O
&apos;s,O
preliminary,O
admitting,O
physician,O
is,O
REKE,O
",",O
ATOTA,O
S,O
and,O
the,O
preliminary,O
diagnosis,O
is,O
ACS,B-PR
..,O

Please,O
note,O
this,O
information,O
may,O
have,O
been,O
updated,O
on,O
the,O
inpatient,O
unit,O
.,O

If,O
you,O
need,O
additional,O
information,O
please,O
call,O
366-686-5449,O
.,O

PCP,O
Name,O
:,O

REKE,O
",",O
ATOTA,O
S,O

Provider,O
Number,O
:,O

36860,O

488076,O

Admission,O
Date,O
:,O

2015-07-12,O

Discharge,O
Date,O
:,O

2015-07-19,O

Date,O
of,O
Birth,O
:,O

1970-05-06,O

Sex,O
:,O

F,O

Service,O
:,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
48,O
-,O
year-old,O
woman,O
who,O
was,O
transferred,O
from,O
Shaugnessy-Kaplan,O
Rehab,O
Hospital,O
.,O

The,O
patient,O
originally,O
presented,O
to,O
her,O
PCP,O
approximately,O
one,O
week,O
prior,O
to,O
admission,O
here,O
with,O
increasing,B-PR
cough,I-PR
",",O
dyspnea,B-PR
and,O
fatigue,B-PR
.,O

She,O
was,O
given,O
a,B-TR
Z-Pak,I-TR
for,O
treatment,B-TR
along,O
with,O
albuterol,B-TR
.,O

Despite,O
this,O
",",O
she,O
continued,O
to,O
worsen,O
and,O
became,O
febrile,B-PR
.,O

So,O
",",O
she,O
was,O
admitted,O
to,O
Shaugnessy-Kaplan,O
Rehab,O
Hospital,O
on,O
2015-07-10,O
.,O

At,O
the,O
hospital,O
",",O
she,O
was,O
started,O
on,O
Rocephin,B-TR
and,O
Levaquin,B-TR
for,O
a,B-PR
right,I-PR
lower,I-PR
lobe,I-PR
pneumonia,I-PR
seen,O
on,O
chest,B-TE
x-ray,I-TE
.,O

She,O
continued,O
to,O
have,O
increasing,B-PR
respiratory,I-PR
distress,I-PR
with,O
hypoxia,B-PR
.,O

She,O
was,O
also,O
significantly,B-PR
tachypneic,I-PR
.,O

At,O
this,O
time,O
",",O
repeat,B-TE
chest,I-TE
x-ray,I-TE
showed,O
bilateral,B-PR
diffuse,I-PR
infiltrates,I-PR
consistent,O
with,O
ARDS,B-PR
.,O

The,O
patient,O
was,O
intubated,O
and,O
then,O
transferred,O
to,O
Hahnemann,O
General,O
Hospital,O
CMED,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Hypothyroidism,B-PR
.,O

Depression,B-PR
.,O

Anxiety,B-PR
disorder,I-PR
.,O

MEDICATIONS,O
:,O

1.,O
Levoxyl,B-TR
112,O
mcg,O
q.d.,O

2.,O
Prozac,B-TR
.,O

3.,O
Codeine,B-TR
for,O
cough,B-PR
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
is,O
unemployed,O
.,O

She,O
smokes,O
approximately,O
one,O
pack,O
per,O
day,O
.,O

She,O
drinks,O
alcohol,O
socially,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,O
",",O
vital,B-TE
signs:,I-TE

Temperature,B-TE
101.4,O
",",O
blood,B-TE
pressure,I-TE
101/62,O
",",O
pulse,B-TE
80,O
",",O
respiratory,B-TE
rate,I-TE
19,O
on,O
a,B-TR
ventilator,I-TR
with,O
settings,O
of,O
assist,B-TR
control,I-TR
at,O
500/12,O
and,O
a,B-TR
PEEP,I-TR
of,O
5,O
.,O

General,O
:,O

The,O
patient,O
is,O
intubated,B-TR
and,O
sedated,B-TR
",",O
but,O
easily,O
arousable,O
.,O

HEENT,O
:,O

Pupils,O
equally,O
round,O
and,O
reactive,O
to,O
light,O
.,O

Sclerae,O
are,O
anicteric,B-PR
.,O

ET,B-TR
tube,I-TR
is,O
in,O
place,O
.,O

Neck,O
:,O

Soft,O
and,O
supple,O
.,O

Cardiovascular,O
:,O

Normal,O
.,O

Chest,O
:,O

Faint,B-PR
scattered,I-PR
wheezes,I-PR
bilaterally,I-PR
.,O

Abdomen,O
:,O

Benign,O
.,O

Extremities,O
:,O

Warm,O
with,O
good,O
distal,O
pulses,O
.,O

There,O
is,O
no,O
edema,B-PR
.,O

Neurologic,O
:,O

Able,O
to,O
follow,O
simple,O
commands,O
.,O

LABORATORY,O
DATA,O
:,O

Labs,B-TE
on,O
admission,O
from,O
outside,O
hospital,O
",",O
CBC,B-TE
notable,O
for,O
a,B-TE
white,I-TE
count,I-TE
of,O
21.9,O
with,O
hematocrit,B-TE
of,O
36.3,O
and,O
normal,O
platelets,O
.,O

Chem-7,B-TE
notable,O
for,O
potassium,B-TE
of,O
3.2,O
and,O
bicarbonate,B-TE
of,O
30,O
.,O

LFTs,B-TE
show,O
an,B-PR
elevated,I-PR
ALT,I-PR
of,O
52,O
and,O
AST,B-TE
of,O
101,O
with,O
normal,O
alkaline,O
phosphatase,O
and,O
total,B-TE
bilirubin,I-TE
.,O

Latest,B-TE
arterial,I-TE
blood,I-TE
gas,I-TE
with,O
pH,B-TE
of,O
7.45,O
",",O
pCO2,B-TE
43,O
and,O
pO2,B-TE
155,O
on,O
100,B-TR
percent,I-TR
oxygen,I-TR
via,O
ventilator,B-TR
.,O

RADIOGRAPHIC,O
STUDIES,O
:,O

Chest,B-TE
x-ray,I-TE
shows,O
right,B-PR
middle,I-PR
lobe,I-PR
",",I-PR
right,I-PR
lower,I-PR
lobe,I-PR
",",I-PR
and,I-PR
left,I-PR
lower,I-PR
lobe,I-PR
infiltrates,I-PR
.,O

EKG,B-TE
shows,O
normal,O
sinus,O
rhythm,O
at,O
70,O
beats,O
per,O
minute,O
with,O
normal,O
axis,O
and,O
intervals,O
",",O
borderline,B-PR
LVH,I-PR
.,O

SUMMARY,O
OF,O
HOSPITAL,O
COURSE,O
:,O

Respiratory,O
:,O

On,O
admission,O
",",O
the,O
patient,O
had,O
what,O
appeared,O
to,O
be,O
acute,B-PR
respiratory,I-PR
distress,I-PR
syndrome,I-PR
secondary,O
to,O
community,B-PR
-,I-PR
acquired,I-PR
pneumonia,I-PR
.,O

She,O
was,O
maintained,O
on,O
a,B-TR
ventilator,I-TR
and,O
ventilated,O
according,O
to,O
ARDSNet,O
protocol,O
.,O

For,O
antibiotic,B-TR
coverage,I-TR
of,O
her,B-PR
pneumonia,I-PR
",",O
she,O
was,O
started,O
on,O
Levaquin,B-TR
",",O
ceftriaxone,B-TR
",",O
and,O
vancomycin,B-TR
.,O

Over,O
the,O
next,O
two,O
days,O
after,O
admission,O
",",O
the,B-TR
patient,I-TR
's,I-TR
vent,I-TR
settings,I-TR
were,O
gradually,O
weaned,O
",",O
and,O
she,O
was,O
extubated,O
two,O
days,O
after,O
being,O
transferred,O
to,O
this,O
hospital,O
.,O

After,O
extubation,B-TR
",",O
the,O
patient,O
was,O
oxygenating,O
well,O
on,O
face,B-TR
mask,I-TR
.,O

She,O
did,O
continue,O
to,O
have,O
a,B-PR
persistent,I-PR
fairly,I-PR
severe,I-PR
cough,I-PR
;,O
however,O
",",O
her,B-PR
cough,I-PR
was,O
weak,B-PR
due,O
to,O
abdominal,B-PR
muscle,I-PR
pain,I-PR
from,O
repeated,B-PR
coughing,I-PR
.,O

The,B-PR
cough,I-PR
was,O
mostly,B-PR
nonproductive,I-PR
.,O

The,O
patient,O
was,O
breathing,O
comfortably,O
.,O

As,O
there,O
was,O
no,O
identified,B-PR
bacterial,I-PR
pathogen,I-PR
on,O
any,B-TE
cultures,I-TE
",",O
the,O
patient,O
was,O
continued,O
on,O
the,B-TR
triple,I-TR
antibiotics,I-TR
for,O
first,O
several,O
days,O
of,O
the,O
hospitalization,O
.,O

She,O
was,O
also,O
on,O
round-the-clock,B-TR
Atrovent,I-TR
and,O
albuterol,B-TR
nebulizers,I-TR
.,O

Once,O
the,O
patient,O
was,O
transferred,O
out,O
of,O
the,O
ICU,O
and,O
after,O
extubation,B-TR
",",O
the,B-TR
antibiotics,I-TR
were,O
gradually,O
narrowed,O
.,O

The,B-TR
vancomycin,I-TR
and,O
Levaquin,B-TR
were,O
discontinued,O
after,O
approximately,O
four,O
days,O
in,O
the,O
hospital,O
.,O

The,B-TR
ceftriaxone,I-TR
was,O
discontinued,O
after,O
four,O
days,O
in,O
the,O
hospital,O
",",O
and,O
the,O
patient,O
was,O
to,O
continue,O
on,O
Levaquin,B-TR
.,O

The,O
patient,O
had,O
gradual,O
improvement,O
in,O
her,B-TE
oxygenation,I-TE
.,O

Pain,B-TR
control,I-TR
:,O

The,O
patient,O
had,O
fairly,B-PR
significant,I-PR
abdominal,I-PR
pain,I-PR
secondary,O
to,O
persistent,B-PR
cough,I-PR
.,O

She,O
was,O
started,O
on,O
a,O
regimen,O
of,O
MS,B-TR
Contin,I-TR
with,O
oxycodone,B-TR
for,O
breakthrough,B-PR
pain,I-PR
.,O

This,O
helped,O
her,O
somewhat,O
though,O
she,O
has,O
continued,O
to,O
have,O
difficulty,B-PR
coughing,I-PR
due,O
to,O
the,B-PR
pain,I-PR
.,O

Tylenol,B-TR
and,O
ibuprofen,B-TR
were,O
also,O
added,O
for,O
better,O
control,O
.,O

Transaminitis,B-PR
:,O

The,O
patient,O
was,O
noted,O
to,O
have,O
mild,B-PR
transaminitis,I-PR
on,O
admission,O
.,O

However,O
",",O
this,O
was,O
felt,O
to,O
be,O
due,O
to,O
her,B-PR
significant,I-PR
infection,I-PR
.,O

This,O
should,O
continue,O
to,O
be,O
followed,O
as,O
an,O
outpatient,O
to,O
assure,O
that,O
it,O
returns,O
back,O
to,O
normal,O
.,O

Anemia,B-PR
:,O

The,B-TE
patient,I-TE
's,I-TE
reticulocyte,I-TE
count,I-TE
showed,O
inadequate,B-PR
production,I-PR
.,O

Iron,B-TE
studies,I-TE
showed,O
a,O
mixed,O
picture,O
with,O
decreased,B-PR
iron,I-PR
and,O
decreased,B-PR
iron,I-PR
to,I-PR
TIBC,I-PR
ratio,I-PR
suggestive,O
of,O
iron-deficiency,B-PR
anemia,I-PR
",",O
but,O
also,O
normal,O
to,O
high,B-PR
MCV,I-PR
.,O

B12,B-TE
was,O
noted,O
to,O
be,O
low,B-PR
and,O
the,O
patient,O
was,O
given,O
an,O
injection,O
of,O
IM,B-TR
B12,I-TR
while,O
in,O
the,O
hospital,O
.,O

She,O
was,O
also,O
started,O
on,O
iron,B-TR
supplementation,I-TR
.,O

Hypothyroidism,B-PR
:,O

The,O
patient,O
was,O
continued,O
on,O
Synthroid,B-TR
for,O
her,B-PR
chronic,I-PR
hypothyroidism,I-PR
.,O

DISCHARGE,O
STATUS,O
:,O

The,O
patient,O
was,O
discharged,O
home,O
with,O
services,O
.,O

DISCHARGE,O
CONDITION,O
:,O

Good,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

Community-acquired,B-PR
pneumonia,I-PR
.,O

Acute,B-PR
respiratory,I-PR
distress,I-PR
syndrome,I-PR
.,O

Iron-deficiency,B-PR
anemia,I-PR
.,O

Hypothyroidism,B-PR
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Levothyroxine,B-TR
75,O
mcg,O
q.d.,O

2.,O
Prozac,B-TR
40,O
mg,O
q.d.,O

3.,O
Levaquin,B-TR
500,O
mg,O
q.d.,O
for,O
7,O
days,O
after,O
discharge,O
.,O

4.,O
Guaifenesin,B-TR
syrup,I-TR
p.r.n.,O
cough,B-PR
.,O

5.,O
Oxycodone,B-TR
10,O
mg,O
q.4,O
h.,O
p.r.n.,O
for,O
pain,B-PR
.,O

6.,O
Colace,B-TR
100,O
mg,O
b.i.d.,O

7.,O
MS,B-TR
Contin,I-TR
30,O
mg,O
b.i.d.,O

8.,O
Ibuprofen,B-TR
800,O
mg,O
q.8,O
h,O
.,O

9.,O
Albuterol,B-TR
1,O
to,O
2,O
puffs,O
q.6,O
h.,O
p.r.n.,O

10.,O
Atrovent,B-TR
1,O
puff,O
q.6,O
h.,O
p.r.n.,O

DISCHARGE,O
INSTRUCTIONS,O
:,O

Follow-up,O
Plans,O
:,O

The,O
patient,O
was,O
instructed,O
to,O
call,O
her,O
PCP,O
",",O
Dr.,O
Ruby,O
Godfrey,O
",",O
to,O
follow,O
up,O
the,O
week,O
of,O
discharge,O
.,O

She,O
is,O
also,O
to,O
call,O
her,O
PCP,O
if,O
she,O
has,O
increasing,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
or,O
fevers,B-PR
.,O

Richard,O
Wanita,O
",",O
Washington,O
30778,O

Dictated,O
By,O
:,O
Christopher,O
QX,O
Morse,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2015-09-14,O
17:19:48,O

T,O
:,O
2015-09-15,O
00:27:21,O

Job,O
#,O
:,O
18355,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Phillip,O
Garcia,O
on,O
:,O
WED,O
2015-09-16,O
5:10,O
PM,O

(,O
End,O
of,O
Report,O
),O

316810105,O

BH,O

5442905,O

550393,O

03/17/2003,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O

KAYSLANCE,O
",",O
ICEROYLN,O

MRN,O
:,O

5442905,O

Age,O
:,O

58y,O

REGISTRATION,O
DATE,O
:,O

03/17/2003,O
02:52,O
AM,O

PRELIMINARY,O
REPORT,O

This,O
is,O
to,O
notify,O
you,O
that,O
your,O
patient,O
",",O
KAYSLANCE,O
",",O
ICEROYLN,O
arrived,O
in,O
the,O
Emergency,O
Department,O
at,O
Bri,O
Health,O
on,O
03/17/2003,O
02:52,O
AM,O
.,O

The,O
patient,O
presented,O
with,O
a,O
chief,O
complaint,O
of,O
LEFT,B-PR
LEG,I-PR
FX,I-PR
HIP,I-PR
.,O

Following,O
evaluation,B-TE
and,O
treatment,B-TR
",",O
the,O
patient,O
&apos;s,O
disposition,O
at,O
the,O
end,O
ofthe,O
visit,O
was,O
ADMITTED,O
AS,O
AN,O
INPATIENT,O
TO,O
BRI,O
HEALTH,O
.,O

The,O
patient,O
&apos;s,O
preliminary,O
admitting,O
physician,O
is,O
HEAGLEINCHIRD,O
",",O
JEANSIA,O
S,O
and,O
the,O
preliminary,O
diagnosis,O
is,O
HIP,B-PR
FRACTURE,I-PR
.,O

Please,O
note,O
this,O
information,O
may,O
have,O
been,O
updated,O
on,O
the,O
inpatient,O
unit,O
.,O

If,O
you,O
need,O
additional,O
information,O
please,O
call,O
442-025-0303,O
.,O

PCP,O
Name,O
:,O

NONE,O
",",O
PHYSICIAN,O

Provider,O
Number,O
:,O

27715,O

Admission,O
Date,O
:,O

2017-09-13,O

Discharge,O
Date,O
:,O

2017-09-15,O

Date,O
of,O
Birth,O
:,O

1972-05-09,O

Sex,O
:,O

F,O

Service,O
:,O

NSU,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
45,O
-,O
year-old,O
female,O
here,O
for,O
a,B-TE
diagnostic,I-TE
cerebral,I-TE
angiogram,I-TE
with,O
coiling,B-TR
.,O

HOSPITAL,O
COURSE,O
:,O

On,O
admission,O
",",O
the,B-TE
patient,I-TE
's,I-TE
vital,I-TE
signs,I-TE
were,O
stable,O
.,O

Her,B-TE
blood,I-TE
pressure,I-TE
was,O
102/82,O
.,O

Her,B-TE
heart,I-TE
rate,I-TE
was,O
71,O
.,O

Her,B-TE
SPO2,I-TE
was,O
98,O
percent,O
on,O
room,O
air,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

1.,O
Plavix,B-TR
75,O
mg,O
times,O
6,O
doses,O
.,O

2.,O
Xanax,B-TR
q.d.,O

3.,O
Prozac,B-TR
20,O
mg,O
q.d.,O

4.,O
Cyclobenzaprine,B-TR
10,O
mg,O
q.d.,O

5.,O
Aspirin,B-TR
325,O
mg,O
times,O
3,O
doses,O
.,O

6.,O
Vitamin,B-TR
E,I-TR
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

Tubal,B-TR
ligation,I-TR
",",O
1986,O
.,O

Cystectomy,B-TR
",",O
1992,O
and,O
1998,O
.,O

Breast,B-TR
lesion,I-TR
excision,I-TR
",",O
1989,O
.,O

ALLERGIES,O
:,O

TETRACYCLINE,B-TR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
uses,O
alcohol,O
socially,O
;,O
was,O
a,O
smoker,O
",",O
used,O
tobacco,O
",",O
she,O
quit,O
4,O
years,O
ago,O
;,O
denies,O
using,O
recreational,O
drug,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

The,O
patient,O
had,O
complaint,O
of,O
headaches,B-PR
in,O
the,O
past,O
.,O

She,O
has,O
fibromyalgia,B-PR
and,O
a,O
history,O
of,O
slurred,B-PR
speech,I-PR
.,O

Her,O
last,O
menstrual,O
period,O
was,O
on,O
2017-08-29,O
.,O

HOSPITAL,O
COURSE,O
:,O

On,O
2017-09-13,O
",",O
the,O
patient,O
was,O
brought,O
to,O
the,O
operating,O
room,O
and,O
underwent,O
a,B-TR
coiling,I-TR
with,O
stent,B-TR
placement,I-TR
of,O
the,B-PR
left,I-PR
carotid,I-PR
ophthalmic,I-PR
aneurysm,I-PR
.,O

The,O
patient,O
underwent,O
coiling,B-TR
and,O
stent,B-TR
placement,I-TR
without,O
complications,B-PR
.,O

She,O
was,O
discharged,O
to,O
the,O
PACU,O
in,O
stable,O
condition,O
.,O

Postoperative,B-TE
check,I-TE
",",O
the,B-TE
patient,I-TE
's,I-TE
vital,I-TE
signs,I-TE
were,O
stable,O
.,O

Her,B-TE
temperature,I-TE
was,O
96.3,O
degrees,O
",",O
blood,B-TE
pressure,I-TE
was,O
128/63,O
.,O

Her,B-TE
pulse,I-TE
was,O
61,O
",",O
respirations,B-TE
12,O
",",O
and,O
her,B-TE
O2,I-TE
saturation,I-TE
was,O
98,O
percent,O
on,O
room,O
air,O
.,O

Her,B-TE
labs,I-TE
showed,O
a,B-TE
white,I-TE
blood,I-TE
count,I-TE
of,O
7.7,O
",",O
hematocrit,B-TE
of,O
33.3,O
",",O
and,O
platelets,B-TE
were,O
305,O
.,O

Her,B-TE
coags,I-TE
",",O
her,B-TE
PT,I-TE
was,O
14.5,O
",",O
PTT,B-TE
was,O
143.4,O
",",O
and,O
her,B-TE
INR,I-TE
was,O
1.3,O
.,O

Her,B-TE
electrolytes,I-TE
were,O
all,O
within,O
normal,O
limits,O
.,O

On,O
physical,B-TE
exam,I-TE
",",O
the,O
patient,O
was,O
awake,O
",",O
alert,O
",",O
and,O
oriented,O
times,O
3,O
.,O

She,O
had,O
a,O
symmetric,O
smile,O
.,O

Her,O
extraocular,O
movements,O
were,O
full,O
.,O

Her,O
pupils,O
were,O
3,O
to,O
2,O
bilaterally,O
",",O
briskly,O
reactive,O
.,O

The,O
visual,O
fields,O
were,O
intact,O
.,O

Her,O
strength,O
was,O
05-31,O
throughout,O
except,O
for,O
right,O
was,O
not,O
tested,O
due,O
to,O
the,B-PR
angiocele,I-PR
in,I-PR
her,I-PR
groin,I-PR
.,O

Angiocele,B-PR
was,O
intact,O
without,O
hematoma,B-PR
",",O
and,O
she,O
exhibited,O
strong,O
pedal,O
pulses,O
on,O
the,O
right,O
side,O
.,O

The,B-TE
assessment,I-TE
at,O
that,O
time,O
was,O
she,O
was,O
neurologically,O
stable,O
.,O

The,O
plan,O
was,O
q.,O
1-hour,O
neuro,B-TE
checks,I-TE
.,O

She,O
was,O
started,O
on,O
a,B-TR
heparin,I-TR
drip,I-TR
at,O
800,O
per,O
hour,O
.,O

Her,B-TE
PTT,I-TE
goes,O
50,O
to,O
60,O
at,O
that,O
time,O
.,O

She,O
was,O
cleared,O
to,O
take,O
sips,O
of,O
clear,O
fluids,O
and,O
was,O
to,O
remain,O
flat,O
for,O
4,O
hours,O
.,O

On,O
postoperative,O
day,O
1,O
",",O
the,O
patient,O
was,O
alert,O
and,O
oriented,O
times,O
3,O
.,O

She,O
exhibited,O
no,O
drift,B-PR
.,O

Her,B-TE
IPs,I-TE
were,O
full,O
at,O
5/5,O
.,O

She,O
had,O
no,O
hematoma,B-PR
in,I-PR
her,I-PR
groin,I-PR
site,I-PR
.,O

Visual,O
fields,O
were,O
full,O
",",O
her,O
pupils,O
were,O
round,O
and,O
reactive,O
bilaterally,O
.,O

Her,B-TE
vital,I-TE
signs,I-TE
were,O
stable,O
with,O
a,B-TE
temperature,I-TE
of,O
97.8,O
degrees,O
",",O
blood,B-TE
pressure,I-TE
was,O
104,O
to,O
121,O
over,O
50s,O
.,O

Pulse,B-TE
was,O
60,O
to,O
70,O
.,O

Respirations,B-TE
were,O
15,O
",",O
and,O
she,O
was,O
saturating,O
at,O
96,O
percent,O
on,O
room,O
air,O
.,O

Her,B-TE
PTT,I-TE
at,O
that,O
time,O
was,O
67.8,O
.,O

She,O
was,O
started,O
on,O
aspirin,B-TR
325,O
mg,O
q.d.,O
and,O
Plavix,B-TR
75,O
mg,O
q.d.,O

On,O
2017-09-14,O
",",O
she,O
was,O
transferred,O
to,O
the,O
regular,O
floor,O
at,O
Far,O
5,O
.,O

Postoperative,O
day,O
2,O
",",O
the,O
patient,O
was,O
stable,O
without,O
events,O
",",O
all,B-TE
vital,I-TE
signs,I-TE
were,O
stable,O
.,O

She,O
was,O
moving,O
all,O
extremities,O
and,O
exhibiting,O
good,O
strength,O
.,O

Her,O
visual,O
fields,O
were,O
intact,O
.,O

Her,O
extraocular,O
movements,O
were,O
full,O
.,O

Angio,B-PR
site,I-PR
was,O
clean,O
",",O
dry,O
",",O
and,O
intact,O
without,O
bleeding,B-PR
or,O
drainage,B-PR
.,O

She,O
was,O
to,O
be,O
discharged,O
today,O
and,O
encouraged,O
to,O
ambulate,O
on,O
her,O
own,O
.,O

Discharge,O
condition,O
for,O
this,O
patient,O
was,O
good,O
.,O

She,O
was,O
ambulating,O
on,O
her,O
own,O
and,O
tolerating,O
a,O
p.o.,O
diet,O
.,O

She,O
was,O
discharged,O
to,O
home,O
in,O
stable,O
condition,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

1.,O
Plavix,B-TR
75,O
mg,O
q.d.,O

2.,O
Aspirin,B-TR
325,O
mg,O
q.d.,O

DISCHARGE,O
INSTRUCTIONS,O
:,O

She,O
is,O
to,O
continue,O
taking,O
medications,B-TR
as,O
prescribed,O
.,O

She,O
is,O
to,O
undergo,O
no,O
strenuous,O
activity,O
until,O
follow-up,O
in,O
2,O
weeks,O
.,O

FINAL,O
DIAGNOSIS,O
:,O

She,O
is,O
status,O
post,O
coiling,B-TR
with,O
stent,B-TR
placement,I-TR
for,O
left,B-PR
carotid,I-PR
ophthalmic,I-PR
aneurysm,I-PR
.,O

RECOMMENDED,O
FOLLOW-UP,O
:,O

She,O
is,O
following,O
up,O
with,O
Dr.,O
Mcmaster,O
on,O
2017-09-29,O
at,O
11:30,O
a.m.,O

She,O
is,O
also,O
to,O
follow,O
up,O
with,O
her,O
primary,O
care,O
physician,O
to,O
review,O
her,B-TR
hypertensive,I-TR
medications,I-TR
.,O

SURGICAL,O
INTERVENTION,O
:,O

Coiling,B-TR
with,O
a,B-TR
stent,I-TR
placement,I-TR
for,O
left,B-PR
carotid,I-PR
artery,I-PR
aneurysm,I-PR
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

She,O
is,O
neurologically,O
stable,O
.,O

Helen,O
Cynthia,O
",",O
New,O
York,O
10969,O

Dictated,O
By,O
:,O
Scott,O
T,O
Little,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2017-09-15,O
09:28:45,O

T,O
:,O
2017-09-15,O
15:37:05,O

Job,O
#,O
:,O
23470,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Mae,O
Behlmer,O
on,O
:,O
MON,O
2017-10-09,O
5:18,O
AM,O

(,O
End,O
of,O
Report,O
),O

325924358,O

FIH,O

7061594,O

795820,O

418796,O

08/15/1998,O
12:00:00,O
AM,O

CORONARY,B-PR
ARTERY,I-PR
DISEASE,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

DISCHARGE,O
SUMMARY,O
NAME,O
:,O

TLANDRAC,O
",",O
NI,O

UNIT,O
NUMBER,O
:,O

388-23-03,O

ADMISSION,O
DATE,O
:,O

08/15/1998,O

DISCHARGE,O
DATE,O
:,O

08/22/1998,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Coronary,B-PR
artery,I-PR
disease,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

Failed,B-PR
coronary,I-PR
artery,I-PR
bypass,I-PR
graft,I-PR
",",O
prior,B-PR
myocardial,I-PR
infarction,I-PR
",",O
hypertension,B-PR
",",O
elevated,B-PR
cholesterol,I-PR
",",O
renal,B-PR
insufficiency,I-PR
",",O
congestive,B-PR
heart,I-PR
failure,I-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

08/20/98,O
dual,B-TR
chamber,I-TR
pacemaker,I-TR
generator,I-TR
change,I-TR
(,O
CPI,O
1276,O
Meridian,O
DR,O
),O
.,O

ASSOCIATED,O
PROCEDURES,O
:,O

08/15/98,O
bilateral,B-TE
heart,I-TE
catheterization,I-TE
;,O
08/15/98,O
left,B-TE
ventriculography,I-TE
;,O
08/15/98,O
bilateral,B-TE
coronary,I-TE
angiography,I-TE
;,O
08/15/98,O
bypass,B-TE
graft,I-TE
angiography,I-TE
;,O
08/15/98,O
internal,B-TE
mammary,I-TE
artery,I-TE
angiography,I-TE
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Aspirin,B-TR
325,O
mg.,O
PO,O
q.d.,O

Lipitor,B-TR
80,O
mg.,O
PO,O
q.d.,O

Toprol,B-TR
XL,I-TR
50,O
mg.,O
PO,O
q.d.,O

Lasix,B-TR
80,O
mg.,O
q.a.m.,O
and,O
40,O
mg.,O
q.p.m.,O

Potassium,B-TR
chloride,I-TR
20,O
mEq.,O
PO,O
b.i.d.,O

Citracal,B-TR
1,O
packet,O
q.d.,O

Imdur,B-TR
60,O
mg.,O
PO,O
q.d.,O

Vitamin,B-TR
E,I-TR
400,O
international,O
units,O
q.d.,O

Prilosec,B-TR
20,O
mg.,O
PO,O
q.d.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Breunlinke,O
is,O
a,O
70-year-old,O
patient,O
of,O
Dr.,O
Brendniungand,O
Asilbekote,O
in,O
California,O
.,O

She,O
is,O
referred,O
for,O
progressive,B-PR
angina,I-PR
.,O

She,O
had,O
rheumatoid,B-PR
fever,I-PR
as,O
a,O
child,O
and,O
a,B-PR
heart,I-PR
murmur,I-PR
noted,O
but,O
no,O
further,B-TE
testing,I-TE
.,O

She,O
has,O
used,O
antibiotic,B-TR
prophylaxis,I-TR
since,O
1980,O
.,O

In,O
1980,O
she,O
had,O
quadruple,B-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
surgery,I-TR
by,O
Dr.,O
Elks,O
at,O
Feargunwake,O
Otacaa,O
Community,O
Hospital,O
and,O
did,O
well,O
until,O
1988,O
when,O
she,O
had,O
exertional,B-PR
angina,I-PR
and,O
a,B-PR
positive,I-PR
stress,I-PR
test,I-PR
and,O
found,O
that,O
three,B-TR
or,I-TR
four,I-TR
grafts,I-TR
were,O
occluded,B-PR
.,O

In,O
October,O
",",O
1989,O
",",O
Dr.,O
No,O
re-did,O
her,B-TR
bypass,I-TR
operation,I-TR
.,O

She,O
had,O
a,B-TR
left,I-TR
internal,I-TR
mammary,I-TR
artery,I-TR
graft,I-TR
to,I-TR
the,I-TR
left,I-TR
anterior,I-TR
descending,I-TR
",",O
saphenous,B-TR
vein,I-TR
graft,I-TR
to,I-TR
the,I-TR
obtuse,I-TR
marginal,I-TR
1,I-TR
and,O
a,B-TR
saphenous,I-TR
vein,I-TR
graft,I-TR
to,I-TR
the,I-TR
obtuse,I-TR
marginal,I-TR
2,I-TR
.,O

In,O
1993,O
she,O
had,O
a,B-TR
DDD,I-TR
pacemaker,I-TR
for,O
complete,B-PR
heart,I-PR
block,I-PR
.,O

She,O
had,O
exertional,B-PR
angina,I-PR
at,O
that,O
time,O
.,O

In,O
November,O
",",O
1997,O
she,O
had,O
a,B-PR
small,I-PR
myocardial,I-PR
infarction,I-PR
as,O
was,O
transferred,O
to,O
Ona,O
Hospital,O
where,O
a,B-TE
cardiac,I-TE
catheterization,I-TE
showed,O
a,B-PR
tight,I-PR
left,I-PR
internal,I-PR
mammary,I-PR
artery,I-PR
to,O
left,B-PR
anterior,I-PR
descending,I-PR
stenosis,I-PR
",",O
high,O
grade,O
saphenous,O
vein,O
graft,O
to,O
obtuse,B-PR
marginal,I-PR
1,I-PR
stenosis,I-PR
and,O
patent,O
obtuse,O
marginal,O
2,O
graft,O
.,O

She,O
had,O
normal,O
left,O
ventricular,O
function,O
with,O
apical,B-PR
tip,I-PR
akinesis,I-PR
.,O

Since,O
that,O
time,O
she,O
has,O
continued,O
to,O
have,O
exertional,B-PR
left,I-PR
chest,I-PR
burning,I-PR
",",O
radiating,O
to,O
the,O
left,O
neck,O
and,O
arm,O
",",O
relieved,O
by,O
nitroglycerin,B-TR
.,O

She,O
was,O
turned,O
down,O
for,O
re-do,B-TR
surgery,I-TR
at,O
that,O
time,O
and,O
did,O
not,O
have,O
a,B-TR
percutaneous,I-TR
transluminal,I-TR
coronary,I-TR
angioplasty,I-TR
.,O

Because,O
these,B-PR
symptoms,I-PR
have,O
been,O
increasing,O
",",O
particularly,O
at,O
cardiac,O
rehabilitation,O
",",O
she,O
was,O
referred,O
here,O
.,O

In,O
May,O
",",O
1998,O
she,O
had,O
an,B-TE
exercise,I-TE
tolerance,I-TE
test,I-TE
in,O
which,O
her,B-TE
heart,I-TE
rate,I-TE
went,O
to,O
112,O
and,O
her,B-TE
blood,I-TE
pressure,I-TE
fell,O
to,O
95,O
systolic,O
.,O

She,O
had,O
diffuse,B-PR
ischemic,I-PR
ST,I-PR
segment,I-PR
changes,I-PR
and,O
increased,B-PR
lung,I-PR
uptake,I-PR
and,O
a,B-PR
reversible,I-PR
anterior,I-PR
and,I-PR
lateral,I-PR
defect,I-PR
.,O

She,O
has,O
had,O
no,O
syncope,B-PR
.,O

Her,O
cardiac,O
risk,O
factors,O
are,O
hypertension,B-PR
and,O
elevated,B-PR
cholesterol,I-PR
.,O

She,O
has,O
a,O
very,O
strong,O
family,O
history,O
of,O
coronary,B-PR
artery,I-PR
disease,I-PR
with,O
a,O
mother,O
",",O
sister,O
and,O
brother,O
dying,O
of,O
myocardial,B-PR
infarction,I-PR
.,O

She,O
is,O
a,O
remote,O
cigarette,O
smoker,O
.,O

She,O
also,O
has,O
a,O
history,O
of,O
lactose,B-PR
intolerance,I-PR
",",O
peptic,B-PR
ulcer,I-PR
disease,I-PR
",",O
with,O
a,B-PR
remote,I-PR
gastrointestinal,I-PR
bleed,I-PR
and,O
multiple,B-PR
ectopic,I-PR
pregnancies,I-PR
and,O
mid,B-PR
term,I-PR
miscarriages,I-PR
.,O

She,O
has,O
had,O
a,B-TR
total,I-TR
abdominal,I-TR
hysterectomy,I-TR
.,O

SOCIAL,O
HISTORY,O
:,O

She,O
is,O
a,O
widow,O
for,O
20,O
years,O
and,O
retired,O
18,O
years,O
from,O
Palmci,O

She,O
lives,O
alone,O
.,O

Her,O
son,O
",",O
Nertland,O
is,O
nearby,O
and,O
he,O
works,O
at,O
the,O
Em,O
Nysonken,O
Medical,O
Center,O
on,O
Verville,O
.,O

They,O
live,O
in,O
Ohio,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

She,O
is,O
a,O
healthy,O
appearing,O
female,O
",",O
5,O
foot,O
120,O
pounds,O
.,O

Her,B-TE
blood,I-TE
pressure,I-TE
was,O
120/70,O
",",O
pulse,B-TE
60,O
and,O
regular,O
.,O

Neck,O
veins,O
are,O
not,O
distended,B-PR
.,O

Respiratory,B-TE
rate,I-TE
12,O
.,O

Carotids,O
:,O

no,O
bruits,B-PR
.,O

Lungs,O
were,O
clear,O
.,O

Cardiac,O
:,O

1/6,B-PR
systolic,I-PR
ejection,I-PR
murmur,I-PR
.,O

Abdomen,O
was,O
benign,O
.,O

Peripheral,B-TE
pulses,I-TE
intact,O
.,O

Neurological,B-TE
examination,I-TE
non-focal,O
.,O

LABORATORY,O
DATA,O
:,O

On,O
admission,O
",",O
includes,O
an,B-TE
electrocardiogram,I-TE
that,O
shows,O
DDD,B-TR
pacing,I-TR
.,O

Hematocrit,B-TE
39,O
percent,O
",",O
white,B-TE
blood,I-TE
cell,I-TE
count,I-TE
4500,O
",",O
PT,B-TE
and,O
PTT,B-TE
normal,O
.,O

Sodium,B-TE
140,O
",",O
potassium,B-TE
4.2,O
",",O
chloride,B-TE
105,O
",",O
carbon,B-TE
dioxide,I-TE
30,O
",",O
BUN,B-TE
24,O
",",O
creatinine,B-TE
1.0,O
.,O

HOSPITAL,O
COURSE,O
AND,O
TREATMENT,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
Cardiac,O
Catheterization,O
Laboratory,O
.,O

There,O
",",O
her,B-TE
pulmonary,I-TE
wedge,I-TE
pressure,I-TE
was,O
12,O
and,O
her,B-TE
right,I-TE
atrial,I-TE
pressure,I-TE
was,O
4,O
and,O
pulmonary,B-TE
artery,I-TE
pressure,I-TE
44/17,O
.,O

Her,B-TE
left,I-TE
ventricular,I-TE
contraction,I-TE
showed,O
akinesis,B-PR
of,I-PR
the,I-PR
anterior,I-PR
wall,I-PR
with,O
dyskinesis,B-PR
of,I-PR
the,I-PR
apex,I-PR
.,O

She,O
had,O
preserved,O
inferior,O
contraction,O
and,O
basal,O
contraction,O
.,O

Her,O
native,O
right,O
and,O
left,O
anterior,O
descending,O
vessels,O
were,O
occluded,B-PR
as,O
was,O
an,O
obtuse,O
marginal,O
branch,O
.,O

The,O
saphenous,O
vein,O
to,O
the,O
high,O
diagonal,O
or,O
high,O
obtuse,O
marginal,O
was,O
occluded,B-PR
.,O

The,O
left,O
internal,O
mammary,O
artery,O
to,O
the,O
left,O
anterior,O
descending,O
was,O
also,O
occluded,B-PR
.,O

The,B-TR
saphenous,I-TR
vein,I-TR
graft,I-TR
to,I-TR
the,I-TR
second,I-TR
obtuse,I-TR
marginal,I-TR
was,O
open,O
with,O
no,O
significant,B-PR
stenosis,I-PR
",",O
but,O
there,O
was,O
an,B-PR
outflow,I-PR
lesion,I-PR
in,I-PR
the,I-PR
obtuse,I-PR
marginal,I-PR
2,I-PR
as,O
well,O
as,O
severe,B-PR
distal,I-PR
lesion,I-PR
as,O
the,O
obtuse,O
marginal,O
2,O
fed,O
the,O
posterior,O
descending,O
artery,O
.,O

This,O
was,O
considered,O
her,B-PR
culprit,I-PR
lesion,I-PR
.,O

This,O
was,O
considered,O
too,O
high,O
risk,O
for,O
angioplasty,B-TR
because,O
of,O
the,B-PR
severe,I-PR
disease,I-PR
in,O
the,B-TR
graft,I-TR
.,O

In,O
addition,O
",",O
it,O
was,O
noted,O
that,O
she,O
had,O
saphenous,O
vein,O
harvested,O
from,O
both,O
thighs,O
.,O

Her,O
left,O
internal,O
mammary,O
artery,O
was,O
also,O
unused,O
.,O

It,O
was,O
also,O
noted,O
that,O
she,O
had,O
failure,O
to,O
sense,O
with,O
the,O
atrial,O
lead,O
.,O

She,O
would,O
not,O
sense,O
the,O
atrial,O
contraction,O
and,O
the,O
fire,O
and,O
this,O
occasionally,O
led,O
to,O
competition,B-PR
of,I-PR
firing,I-PR
.,O

This,O
was,O
intermittent,O
.,O

The,B-TE
P,I-TE
wave,I-TE
amplitude,I-TE
was,O
.6,O
and,O
this,O
could,O
not,O
be,O
totally,O
sensed,O
.,O

The,O
patient,O
was,O
admitted,O
for,O
management,B-TR
of,O
her,B-PR
coronary,I-PR
artery,I-PR
disease,I-PR
and,O
evaluation,B-TE
of,O
her,B-TR
pacemaker,I-TR
.,O

It,O
was,O
noted,O
that,O
she,O
became,O
very,B-PR
symptomatic,I-PR
when,O
she,O
was,O
not,O
on,O
a,B-TR
beta,I-TR
blocker,I-TR
but,O
that,O
on,O
a,B-TR
beta,I-TR
blocker,I-TR
she,O
had,O
significant,B-PR
pacemaker,I-PR
failure,I-PR
.,O

Her,B-TR
pacemaker,I-TR
was,O
set,O
to,O
a,O
VVI,O
mode,O
which,O
sensed,O
appropriately,O
.,O

She,O
was,O
in,O
sinus,O
rhythm,O
with,O
most,O
of,O
the,O
time,O
.,O

When,O
her,B-TR
pacemaker,I-TR
was,O
in,O
a,O
sinus,O
rhythm,O
without,O
a,B-TR
beta,I-TR
blocker,I-TR
",",O
she,O
had,O
significant,B-PR
angina,I-PR
.,O

Carotid,B-TE
non-invasive,I-TE
testing,I-TE
was,O
unremarkable,O
.,O

The,O
situation,O
was,O
reviewed,O
with,O
Dr.,O
Niste,O
Graft,O
.,O

He,O
felt,O
the,O
patient,O
was,O
not,O
a,O
coronary,O
artery,O
bypass,O
graft,O
candidate,O
because,O
of,O
the,B-PR
lack,I-PR
of,I-PR
conduit,I-PR
and,O
because,O
of,O
the,O
presence,O
of,O
a,B-PR
large,I-PR
anterior,I-PR
myocardial,I-PR
infarction,I-PR
.,O

For,O
this,O
reason,O
",",O
it,O
was,O
decided,O
to,O
maximize,O
her,B-TR
beta,I-TR
blockers,I-TR
and,O
nitrates,B-TR
.,O

The,O
situation,O
was,O
reviewed,O
with,O
Dr.,O
No,O
of,O
the,O
Pacemaker,O
Service,O
.,O

On,O
August,O
20,O
",",O
under,O
local,B-TR
anesthesia,I-TR
the,O
right,O
pectoral,O
region,O
was,O
explored,O
and,O
the,O
leads,O
disconnected,O
and,O
the,B-TR
pulse,I-TR
generator,I-TR
changed,O
to,O
a,B-TR
CPI,I-TR
unit,I-TR
in,O
which,O
the,O
sensitivity,O
could,O
be,O
adjusted,O
to,O
.15,O
mm.,O
",",O
which,O
permitted,O
appropriate,O
atrial,O
sensing,O
.,O

There,O
was,O
nothing,O
wrong,O
with,O
the,B-TR
prior,I-TR
generator,I-TR
and,O
nothing,O
wrong,O
with,O
the,B-TR
leads,I-TR
.,O

It,O
just,O
needed,O
a,O
unit,O
that,O
could,O
have,O
more,O
sensitivity,O
in,O
the,O
atrial,O
mode,O
.,O

She,O
tolerated,O
this,O
well,O
.,O

Her,B-TR
medications,I-TR
were,O
resumed,O
.,O

She,O
ambulated,O
without,O
difficulty,O
and,O
was,O
discharged,O
to,O
home,O
to,O
be,O
followed,O
medically,O
for,O
her,B-PR
coronary,I-PR
artery,I-PR
disease,I-PR
following,O
two,B-TR
failed,I-TR
bypass,I-TR
graft,I-TR
procedure,I-TR
by,O
Dr.,O
Brendniungand,O
Asilbekote,O
in,O
Bi,O
Masase,O
",",O
KS,O
.,O

ACHASTHA,O
N.,O
GRAFT,O
",",O
M.D.,O

TR,O
:,O

hfr,O

DD,O
:,O

08/22/1998,O

TD,O
:,O

08/27/1998,O
3:56,O
P,O

cc,O
:,O

ACHASTHA,O
NICEMAEN,O
GRAFT,O
",",O
M.D.,O
GITTETUMN,O
DARNNAMAN,O
NO,O
",",O
M.D.,O

Admission,O
Date,O
:,O

2017-07-12,O

Discharge,O
Date,O
:,O

2017-07-17,O

Date,O
of,O
Birth,O
:,O

1959-10-16,O

Sex,O
:,O

F,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Clindamycin,B-TR
/,O
Erythromycin,B-TR
Base,I-TR
/,O
Amoxicillin,B-TR
/,O
Keflex,B-TR
/,O
Wellbutrin,B-TR

Attending,O
:,O
Jerry,O
R,O
Morris,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O
syncope,B-PR
and,O
hypotension,B-PR
on,O
Heywood,O
Memorial,O
Hospital,O
4,O

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

Central,B-TR
line,I-TR
attempted,O
but,O
never,O
placed,O

History,O
of,O
Present,O
Illness,O
:,O

57,O
y/o,O
F,O
with,O
multiple,B-PR
medical,I-PR
problems,I-PR
including,O
polyendocrine,B-PR
deficiency,I-PR
comprised,O
of,O
adrenal,B-PR
insufficiency,I-PR
",",O
DM,B-PR
",",O
premature,B-PR
ovarian,I-PR
failure,I-PR
",",O
hypoparathyroidism,B-PR
",",O
addison,B-PR
's,I-PR
disease,I-PR
and,O
also,O
breast,B-PR
CA,I-PR
and,O
depression,B-PR
with,O
multiple,O
suicide,O
attempts,O
in,O
the,O
past,O
who,O
originally,O
presented,O
s/p,O
tylenol,B-PR
with,I-PR
codeine,I-PR
overdose,I-PR
and,O
hypotension,B-PR
",",O
was,O
intubated,O
and,O
admitted,O
to,O
the,O
FICU,O
.,O

She,O
was,O
eventually,O
stabilized,O
and,O
transfered,O
out,O
of,O
the,O
ICU,O
to,O
the,O
medical,O
Mary,O
Lane,O
Hospital,O
.,O

Subsequently,O
",",O
she,O
was,O
transfered,O
to,O
the,O
psychiatric,O
Mary,O
Lane,O
Hospital,O
in,O
Boston,O
Medical,O
Center,O
4,O
for,O
further,B-TE
psychiatric,I-TE
w/u,I-TE
.,O

This,O
morning,O
",",O
2017-07-12,O
",",O
Ms.,O
Gallegos,O
King,O
feeling,O
weaker,B-PR
than,I-PR
usual,I-PR
.,O

She,O
noted,O
that,O
she,O
had,O
increased,B-PR
pain,I-PR
in,I-PR
her,I-PR
lower,I-PR
back,I-PR
",",O
which,O
she,O
attributed,O
to,O
her,B-PR
arthritis,I-PR
.,O

She,O
ate,O
a,O
normal,O
breakfast,O
of,O
cereal,O
and,O
milk,O
.,O

Later,O
that,O
am,O
",",O
she,O
stood,O
from,O
her,B-TR
wheelchair,I-TR
",",O
had,O
a,B-PR
prodrome,I-PR
of,I-PR
LH,I-PR
and,O
then,O
reports,O
LOC,B-PR
and,O
fall,O
.,O

She,O
denies,O
any,B-PR
tunnel,I-PR
vision,I-PR
",",O
darkened,B-PR
vision,I-PR
",",O
or,O
focal,B-PR
weakness,I-PR
this,O
morning,O
.,O

No,O
bowel,B-PR
/,I-PR
bladder,I-PR
incont,I-PR
",",O
no,O
aura,B-PR
",",O
no,O
postictal,B-PR
state,I-PR
.,O

She,O
does,O
not,O
recall,O
falling,O
",",O
but,O
does,O
recall,O
waking,O
up,O
with,O
people,O
surrounding,O
her,O
.,O

During,O
the,O
fall,O
she,O
hit,O
her,O
nose,O
and,O
her,O
R,O
knee,O
.,O

She,O
does,O
not,O
recall,O
hitting,O
her,O
head,O
.,O

She,O
does,O
not,O
describe,O
decreased,B-PR
PO,I-PR
intake,I-PR
from,O
her,O
norm,O
this,O
morning,O
",",O
but,O
did,O
feel,O
dehydrated,B-PR
at,O
the,O
time,O
of,O
her,O
fall,O
.,O

LOC,B-PR
was,O
unwitnessed,O
.,O

Early,O
this,O
morning,O
before,O
breakfast,O
her,B-TE
BS,I-TE
was,O
reportedly,O
145,O
",",O
and,O
after,O
LOC,B-PR
",",O
her,B-TE
BS,I-TE
was,O
reportedly,O
207,O
.,O

She,O
reports,O
that,O
her,B-TE
BP,I-TE
was,O
read,O
at,O
60/48,O
after,O
her,O
fall,O
.,O

Her,B-TE
systolic,I-TE
BP,I-TE
measurements,I-TE
have,O
been,O
running,O
around,O
100-110,O
over,O
the,O
past,O
few,O
weeks,O
.,O

Ms.,O
Cassata,O
has,O
a,O
history,O
of,O
"",O
passing,O
out,O
"",O
in,O
August,O
of,O
2004,O
",",O
(,O
?,O
7,O
hours,O
),O
",",O
and,O
reports,O
that,O
this,O
episode,O
did,O
not,O
feel,O
similar,O
.,O

ROS,O
:,O

She,O
denies,O
any,B-PR
recent,I-PR
nausea,I-PR
",",O
but,O
had,O
an,O
episode,O
of,O
vomiting,B-PR
last,O
week,O
.,O

She,O
denies,O
any,B-PR
pain,I-PR
with,I-PR
urination,I-PR
or,O
incontinence,B-PR
.,O

She,O
also,O
denies,O
any,B-PR
recent,I-PR
cough,I-PR
",",O
chest,B-PR
pain,I-PR
",",O
chest,B-PR
palpitations,I-PR
",",O
heart,B-PR
racing,I-PR
.,O

She,O
reports,O
2,O
nights,O
with,O
soaking,B-PR
NS,I-PR
.,O

Denies,O
subj,B-PR
/,I-PR
obj,I-PR
fevers,I-PR
or,O
chills,B-PR
.,O

She,O
describes,O
her,O
mood,O
as,O
depressed,B-PR
",",O
however,O
she,O
denies,O
suicidal,B-PR
ideation,I-PR
at,O
this,O
time,O
.,O

She,O
reports,O
that,O
she,O
took,O
all,B-TR
her,I-TR
medications,I-TR
as,O
usual,O
this,O
morning,O
",",O
with,O
no,O
changes,O
.,O

Past,O
Medical,O
History,O
:,O

1),O
Polyendocrine,B-PR
deficiency,I-PR
syndrome,I-PR
Type,I-PR
I,I-PR
which,O
is,O
comprised,O
of,O
the,O
following,O
:,O

a),O
Hypoparathyroidism,B-PR
",",O
dxed,O
1954,O

b),O
Addison,B-PR
's,I-PR
disease,I-PR
",",O
dxed,O
1960,O

c),O
Premature,B-PR
ovarian,I-PR
failure,I-PR
",",O
dxed,O
1967,O

d),O
Alopecia,B-PR
areata,I-PR
and,I-PR
totalis,I-PR
",",O
dxed,O
1970s,O

e),O
mucocutaneous,B-PR
candidiasis,I-PR

f),O
Diabetes,B-PR
type,I-PR
I,I-PR

2),O
colonic,B-PR
dysfunction,I-PR
alternating,O
with,O
diarrhea,B-PR
and,O
constipation,B-PR

3),O
?,O
unstable,B-PR
serum,I-PR
calcium,I-PR
since,O
1999,O

4),O
Generalized,B-PR
osteoarthritis,I-PR

5),O
depression,B-PR
requiring,O
ECT,B-TR
therapy,I-TR
in,O
the,O
past,O

6),O
bilateral,B-PR
Neuropathy,I-PR
of,I-PR
lower,I-PR
extremities,I-PR

7),O
Bilateral,B-PR
cataracts,I-PR

8),O
PVD,B-PR

9),O
Spontaneous,B-PR
dislocation,I-PR
of,I-PR
left,I-PR
hip,I-PR
in,O
2014,O

10),O
GERD,B-PR

11),O
Low,B-PR
grade,I-PR
anemia,I-PR

12),O
Elevated,B-PR
liver,I-PR
enzymes,I-PR

13),O
h/o,O
amputation,B-TR
of,I-TR
right,I-TR
2nd,I-TR
toe,I-TR
secondary,O
to,O
osteomyelitis,B-PR
in,O
2005,O

14),O
h/o,O
hemorrhoidectomy,B-TR
in,O
2007,O

15),O
h/o,O
left,B-TR
hip,I-TR
joint,I-TR
replacement,I-TR
in,O
2008,O

16),O
h/o,O
total,B-TR
hysterectomy,I-TR
in,O
2009,O

17),O
h/o,O
breast,B-PR
CA,I-PR
s/p,O
mastectomies,B-TR

18),O
recent,O
suicide,O
attempt,O
with,O
tylenol,B-TR
#3,I-TR
requiring,O
CMED,O
admission,O
but,O
relatively,O
Jennifer,O
transaminitis,B-PR
with,O
full,O
recovery,O

PCP,O
at,O
Cynthia,O
(,O
656,O
),O
302,O
4444,O
Dr.,O
Mosier,O
.,O

Has,O
been,O
hospitalized,O
at,O
Pocasset,O
Mental,O
Health,O
Center,O
and,O
Children,O
's,O
Hospital,O
Boston,O
numerous,O
times,O
.,O

Social,O
History,O
:,O
lives,O
in,O
VA,O
Hospital,O
Northampton,O
.,O

Denies,O
etoh,O
",",O
illicits,O
.,O

Multiple,O
past,O
suicide,O
attempts,O
.,O

Medically,O
savvy,O
-,O
has,O
spent,O
much,O
of,O
her,O
life,O
in,O
the,O
hospital,O
with,O
her,B-PR
multiple,I-PR
medical,I-PR
problems,I-PR
.,O

Family,O
History,O
:,O
father,O
with,O
history,O
of,O
liver,B-PR
cancer,I-PR
at,O
a,O
late,O
age,O

Physical,O
Exam,O
:,O

T,B-TE
98.4,O
RR,B-TE
20,O
Sat,B-TE
100%,O
RA,O
",",O
P,B-TE
100,O
in,O
bed,O
&,O
same,O
standing,O
",",O
BP,B-TE
=,O
120/65,O
in,O
bed,O
",",O
same,O
standing,O
.,O

Gen,O
:,O

NAD,B-PR
",",O
cooperative,O
and,O
conversant,O
",",O
able,O
to,O
ambulate,O
independently,O
around,O
room,O
using,O
crutches,B-TR

HEENT,O
:,O

NCAT,B-PR
",",O
no,O
tenderness,B-PR
to,O
palpation,B-TE
of,I-TE
scalp,I-TE
",",O
PERRL,O
",",O
EOMI,O
",",O
alopecia,B-PR
",",O
no,O
scleral,B-PR
icterus,I-PR
",",O
mucus,B-PR
membranes,I-PR
moderately,I-PR
dry,I-PR
",",O
slight,O
amount,O
of,O
crusted,B-PR
blood,I-PR
on,I-PR
tip,I-PR
of,O
R,O
nostril,O
from,O
fall,B-PR
injury,I-PR

Neck,O
:,O
supple,O
",",O
no,O
supraclavicular,B-PR
LAD,I-PR
",",O
no,O
JVD,B-PR

CV,O
:,O
tachycardic,B-PR
",",O
regular,O
rhythm,O
",",O
III/VI,B-PR
systolic,I-PR
",",O
crescendo-decrescendo,B-PR
at,I-PR
USB,I-PR
bilaterally,I-PR
.,O

Harsher,B-PR
holosystolic,I-PR
murmur,I-PR
at,I-PR
the,I-PR
apex,I-PR
heard,O
best,O
with,O
bell,O
.,O

Pulm,O
:,O

CTAB,O
aside,O
from,O
slightly,B-PR
dull,I-PR
breath,I-PR
sounds,I-PR
at,I-PR
the,I-PR
bases,I-PR

Abd,O
:,O
soft,O
",",O
slightly,B-PR
obese,I-PR
",",O
nondistended,B-PR
",",O
+BS,O

Ext,O
:,O
no,O
edema,B-PR
/,O
cyanosis,B-PR
",",O
2+,B-TE
peripheral,I-TE
pulses,I-TE
",",O
small,B-PR
1,I-PR
cm,I-PR
abrasion,I-PR
on,I-PR
R,I-PR
knee,I-PR
",",O
no,O
active,B-PR
bleeding,I-PR
",",O
no,O
brusing,B-PR
",",O
no,O
limited,O

ROM,B-PR
",",O
no,O
signs,O
of,O
effusion,B-PR

Neuro,O
:,O

A&Ox3,O
",",O
no,O
asterixis,B-PR
",",O
strength,O
4+,O
/,O
5,O
equal,O
throughout,O
",",O
sensation,O
light,O
touch,O
intact,O
",",O
toes,O
upgoing,O
bilaterally,O
",",O
no,O
pronator,B-PR
drift,I-PR
.,O

Gait,O
does,O
not,O
appear,O
unsteady,B-PR
",",O
uses,O
crutches,B-TR
for,O
support,O
.,O

Pertinent,O
Results,O
:,O

ADMISSION,O
LABS,O
:,O

2017-07-12,O
10:40,O
AM,O
BLOOD,B-TE
WBC,B-TE
-,O
17.1,O
*,O
RBC,B-TE
-,O
3.37,O
*,O
Hgb,B-TE
-,O
10.1,O
*,O
Hct,B-TE
-,O
30.1,O
*,O
MCV,B-TE
-,O
89,O
MCH,B-TE
-,O
30.0,O
MCHC,B-TE
-,O
33.6,O
RDW,B-TE
-,O
18.8,O
*,O
Plt,B-TE
Ct,I-TE
-,O
526,O
*,O

2017-07-12,O
10:40,O
AM,O
BLOOD,B-TE
Neuts,B-TE
-,O
86,O
*,O
Bands,B-TE
-,O
5,O
Lymphs,B-TE
-,O
4,O
*,O
Monos,B-TE
-,O
5,O
Eos,B-TE
-,O
0,O
Baso,B-TE
-,O
0,O
Atyps,B-TE
-,O
0,O
Metas,B-TE
-,O
0,O
Myelos,B-TE
-,O
0,O

2017-07-12,O
10:40,O
AM,O
BLOOD,B-TE
Plt,B-TE
Smr,I-TE
-,O
HIGH,B-PR
Plt,I-PR
Ct,I-PR
-,O
526,O
*,O

2017-07-13,O
05:30,O
AM,O
BLOOD,B-TE
PT,B-TE
-,O
11.3,O
PTT,B-TE
-,O
24.9,O
INR,B-TE
(,I-TE
PT,I-TE
)-,I-TE
1.0,O

2017-07-11,O
08:00,O
AM,O
BLOOD,B-TE
Glucose,B-TE
-,O
137,O
*,O
UreaN,B-TE
-,O
19,O
Creat,B-TE
-,O
1.0,O
Na,B-TE
-,O
142,O
K,B-TE
-,O
4.0,O
Cl,B-TE
-,O
105,O
HCO3,B-TE
-,O
29,O
AnGap,B-TE
-,O
12,O

2017-07-13,O
05:30,O
AM,O
BLOOD,B-TE
ALT,B-TE
-,O
85,O
*,O
AST,B-TE
-,O
238,O
*,O
LD,B-TE
(,I-TE
LDH,I-TE
)-,I-TE
316,O
*,O
CK,B-TE
(,I-TE
CPK,I-TE
)-,I-TE
55,O
AlkPhos,B-TE
-,O
122,O
*,O
Amylase,B-TE
-,O
65,O
TotBili,B-TE
-,O
0.3,O

2017-07-13,O
05:30,O
AM,O
BLOOD,B-TE
Lipase,B-TE
-,O
35,O

2017-07-14,O
05:20,O
AM,O
BLOOD,B-TE
CK,B-TE
-,I-TE
MB,I-TE
-,O
NotDone,O
cTropnT,B-TE
-<,O
0.01,O

2017-07-13,O
01:12,O
PM,O
BLOOD,B-TE
CK,B-TE
-,I-TE
MB,I-TE
-,O
2,O
cTropnT,B-TE
-<,O
0.01,O

2017-07-13,O
05:30,O
AM,O
BLOOD,B-TE
CK,B-TE
-,I-TE
MB,I-TE
-,O
NotDone,O
cTropnT,B-TE
-<,O
0.01,O

2017-07-11,O
08:00,O
AM,O
BLOOD,B-TE
Albumin,B-TE
-,O
3.4,O
Calcium,B-TE
-,O
8.0,O
*,O
Phos,B-TE
-,O
5.0,O
*,O
Mg,B-TE
-,O
1.6,O

2017-07-13,O
01:12,O
PM,O
BLOOD,B-TE
HBsAg,B-TE
-,O
NEGATIVE,O
HBsAb,B-TE
-,O
NEGATIVE,O
HBcAb,B-TE
-,O
NEGATIVE,O

2017-07-13,O
05:30,O
AM,O
BLOOD,B-TE
Acetmnp,B-TE
-,O
NEG,O

2017-07-13,O
01:12,O
PM,O
BLOOD,B-TE
HCV,B-TE
Ab,I-TE
-,O
NEGATIVE,O

2017-07-13,O
08:40,O
AM,O
BLOOD,B-TE
Type,B-TE
-,O
ART,O
pO2,B-TE
-,O
72,O
*,O
pCO2,B-TE
-,O
34,O
*,O
pH,B-TE
-,O
7.46,O
*,O
calHCO3,B-TE
-,O
25,O
Base,B-TE
XS,I-TE
-,O
0,O

2017-07-13,O
08:40,O
AM,O
BLOOD,B-TE
Lactate,B-TE
-,O
2.0,O

2017-07-13,O
08:40,O
AM,O
BLOOD,B-TE
freeCa,B-TE
-,O
0.90,O
*,O

STUDIES,O
:,O

EKG,B-TE
:,O

2017-07-12,O
NSR,O
",",O
normal,O
axis,O
",",O
likely,O
V1,B-PR
and,I-PR
V2,I-PR
reversal,I-PR
",",O
TWI,B-PR
in,I-PR
V2,I-PR
",",O
?,O
ST,B-PR
depr,I-PR
<,O
0.5,O
mm,O
in,O
II,O
and,O
V5/6,O
-,O
repeat,B-TE
EKG,I-TE
without,O
these,B-PR
changes,I-PR
.,O

No,O
change,O
from,O
prior,B-TE
EKG,I-TE
.,O

CXR,B-TE
2017-07-12,O
:,O

Heart,O
normal,O
in,O
size,O
",",O
mediastinal,O
and,O
hilar,O
contours,O
are,O
normal,O
.,O

Pulmonary,O
vascularity,O
is,O
normal,O
",",O
lungs,O
are,O
clear,O
.,O

No,O
effusions,B-PR
or,O
pneumothorax,B-PR
.,O

Multiple,B-PR
healed,I-PR
bilateral,I-PR
rib,I-PR
fractures,I-PR
are,O
demonstrated,O
.,O

Clips,B-TR
in,I-TR
the,I-TR
left,I-TR
axilla,I-TR
demonstrate,O
prior,B-TR
lymph,I-TR
node,I-TR
dissection,I-TR
.,O

Overall,O
",",O
no,O
acute,B-PR
cardiopulmonary,I-PR
abnormality,I-PR
.,O

2017-07-13,O
CXR,B-TE
:,O

UPRIGHT,O
AP,O
VIEW,O
OF,O
THE,O
CHEST,O
:,O

Aside,O
from,O
low,B-PR
lung,I-PR
volumes,I-PR
",",O
the,O
lungs,O
are,O
clear,O
.,O

The,O
heart,O
size,O
",",O
and,O
mediastinal,O
and,O
hilar,O
contours,O
are,O
normal,O
.,O

The,O
pleurae,O
are,O
normal,O
.,O

Clips,B-TR
in,I-TR
the,I-TR
left,I-TR
axilla,I-TR
denote,O
prior,B-TR
lymph,I-TR
node,I-TR
dissection,I-TR
.,O

Multiple,B-PR
bilateral,I-PR
healed,I-PR
rib,I-PR
fractures,I-PR
are,O
present,O
.,O

2017-07-13,O
RUQ,B-TE
U/S,I-TE
:,O

IMPRESSION,O
:,O

1.,O
Normal,O
liver,O
.,O

No,O
evidence,O
of,O
bile,B-PR
duct,I-PR
dilatation,I-PR
.,O

2.,O
Gallbladder,B-PR
polyp,I-PR
and,O
possible,O
tiny,B-PR
stones,I-PR
.,O

No,O
cholecystitis,B-PR
.,O

2017-07-14,O
ECHO,B-TE
:,O

Conclusions,O
:,O

The,O
left,O
atrium,O
is,O
normal,O
in,O
size,O
.,O

There,O
is,O
mild,B-PR
symmetric,I-PR
left,I-PR
ventricular,I-PR
hypertrophy,I-PR
.,O

The,B-TE
left,I-TE
ventricular,I-TE
cavity,I-TE
size,I-TE
is,O
normal,O
.,O

Overall,B-TE
left,I-TE
ventricular,I-TE
systolic,I-TE
function,I-TE
is,O
normal,O
(,O
LVEF,B-TE
>,O
55%,O
).,O

Right,B-TE
ventricular,I-TE
chamber,I-TE
size,I-TE
and,O
free,O
wall,O
motion,O
are,O
normal,O
.,O

The,O
aortic,O
valve,O
leaflets,O
are,O
moderately,B-PR
thickened,I-PR
.,O

There,O
is,O
mild,B-PR
aortic,I-PR
valve,I-PR
stenosis,I-PR
.,O

Trace,B-PR
aortic,I-PR
regurgitation,I-PR
is,O
seen,O
.,O

The,O
mitral,O
valve,O
leaflets,O
are,O
mildly,B-PR
thickened,I-PR
.,O

No,O
mitral,B-PR
regurgitation,I-PR
is,O
seen,O
.,O

There,O
is,O
a,B-PR
small,I-PR
pericardial,I-PR
effusion,I-PR
.,O

There,O
are,O
no,O
echocardiographic,O
signs,O
of,O
tamponade,B-PR
.,O

Compared,O
with,O
the,O
report,O
of,O
the,B-TE
prior,I-TE
study,I-TE
(,O
images,O
unavailable,O
for,O
review,O
),O
of,O
2017-06-13,O
",",O
there,O
is,O
no,O
significant,B-PR
change,I-PR
.,O

DISCHARGE,O
LABS,O
:,O

2017-07-17,O
04:50,O
AM,O
BLOOD,B-TE
WBC,B-TE
-,O
7.2,O
RBC,B-TE
-,O
2.69,O
*,O
Hgb,B-TE
-,O
8.0,O
*,O
Hct,B-TE
-,O
24.0,O
*,O
MCV,B-TE
-,O
89,O
MCH,B-TE
-,O
29.7,O
MCHC,B-TE
-,O
33.3,O
RDW,B-TE
-,O
18.7,O
*,O
Plt,B-TE
Ct,I-TE
-,O
363,O

2017-07-17,O
04:50,O
AM,O
BLOOD,B-TE
Plt,B-TE
Ct,I-TE
-,O
363,O

2017-07-17,O
04:50,O
AM,O
BLOOD,B-TE
Glucose,B-TE
-,O
60,O
*,O
UreaN,B-TE
-,O
13,O
Creat,B-TE
-,O
0.9,O
Na,B-TE
-,O
147,O
*,O
K,B-TE
-,O
3.0,O
*,O
Cl,B-TE
-,O
109,O
*,O
HCO3,B-TE
-,O
29,O
AnGap,B-TE
-,O
12,O

2017-07-17,O
04:50,O
AM,O
BLOOD,B-TE
ALT,B-TE
-,O
73,O
*,O
AST,B-TE
-,O
50,O
*,O
LD,B-TE
(,I-TE
LDH,I-TE
)-,O
195,O
AlkPhos,B-TE
-,O
112,O
TotBili,B-TE
-,O
0.3,O

2017-07-15,O
06:47,O
AM,O
BLOOD,B-TE
Lipase,B-TE
-,O
17,O

2017-07-17,O
04:50,O
AM,O
BLOOD,B-TE
Calcium,B-TE
-,O
8.2,O
*,O
Phos,B-TE
-,O
3.2,O
Mg,B-TE
-,O
1.5,O
*,O

2017-07-13,O
01:12,O
PM,O
BLOOD,B-TE
HBsAg,B-TE
-,O
NEGATIVE,O
HBsAb,B-TE
-,O
NEGATIVE,O
HBcAb,B-TE
-,O
NEGATIVE,O

2017-07-13,O
05:30,O
AM,O
BLOOD,B-TE
Acetmnp,B-TE
-,O
NEG,O

2017-07-13,O
01:12,O
PM,O
BLOOD,B-TE
HCV,B-TE
Ab,I-TE
-,O
NEGATIVE,O

Brief,O
Hospital,O
Course,O
:,O

BRIEF,O
OVERVIEW,O
:,O

57,O
yo,O
F,O
with,O
h/o,O
polyglandular,B-PR
autoimmune,I-PR
syndrome,I-PR
initially,O
admitted,O
in,O
May,O
to,O
FICU,O
for,O
suicide,B-PR
overdose,I-PR
then,O
transferred,O
to,O
Whittier,O
Rehab,O
Hospital,O
4,O
for,O
depression,B-PR
",",O
who,O
was,O
transferred,O
to,O
the,O
medical,O
floor,O
for,O
a,B-PR
syncopal,I-PR
episode,I-PR
and,O
hypotension,B-PR
to,O
60,B-TE
systolic,I-TE
that,O
returned,O
to,O
baseline,O
with,O
2.5L,O
IVF,B-TR
who,O
was,O
subsequently,O
transferred,O
to,O
the,O
CMED,O
CSRU,O
for,O
a,O
recurrent,O
episode,O
of,O
hypotension,B-PR
",",O
fevers,B-PR
and,O
concern,O
for,O
sepsis,B-PR
.,O

Initially,O
when,O
she,O
arrived,O
to,O
the,O
floor,O
she,O
was,O
afebrile,B-PR
",",O
normotensive,O
without,O
signs,O
of,O
orthostasis,B-PR
",",O
had,O
a,O
negative,O
UA,O
",",O
a,O
clear,O
chest,O
xray,O
and,O
no,O
signs,O
/,O
symptoms,O
of,O
a,B-PR
fever,I-PR
.,O

She,O
was,O
slightly,B-PR
tachycardic,I-PR
.,O

She,O
was,O
initially,O
not,O
started,O
on,O
antibiotics,B-TR
.,O

She,O
was,O
given,O
a,B-TR
standing,I-TR
IVF,I-TR
order,I-TR
.,O

Overnight,O
she,O
became,O
febrile,B-PR
to,O
102.3,O
",",O
increasingly,B-PR
tachycardic,I-PR
to,O
125,O
",",O
and,O
hypotensive,B-PR
to,O
80,B-TE
systolic,I-TE
.,O

She,O
was,O
started,O
on,O
stress,B-TR
dose,I-TR
steroids,I-TR
and,O
levo,B-TR
",",O
flagyl,B-TR
",",O
and,O
vanco,B-TR
.,O

She,O
was,O
given,O
4L,O
of,O
fluid,B-TR
boluses,I-TR
and,O
transfered,O
to,O
the,O
CMED,O
CSRU,O
.,O

In,O
the,O
CMED,O
CSRU,O
",",O
repeated,O
attempts,O
to,O
place,O
lines,B-TR
were,O
unsuccessful,O
.,O

The,B-TR
above,I-TR
treatments,I-TR
were,O
continued,O
.,O

Urine,B-TE
cultures,I-TE
returned,O
with,O
"10-100,000",O
organisms,B-PR
coag,O
negative,O
staph,B-PR
.,O

Blood,B-TE
cultures,I-TE
remained,O
negative,O
.,O

Vital,B-TE
signs,I-TE
stabilized,O
and,O
she,O
was,O
transfered,O
back,O
to,O
the,O
medical,O
floor,O
after,O
2,O
days,O
in,O
the,O
ICU,O
.,O

Stress,B-TR
dose,I-TR
steroids,I-TR
were,O
planned,O
for,O
a,O
7,O
day,O
course,O
",",O
antibiotics,B-TR
were,O
peeled,O
back,O
to,O
levofloxacin,B-TR
alone,O
",",O
and,O
a,B-TE
R,I-TE
hip,I-TE
film,I-TE
revealed,O
no,O
loosening,B-PR
nor,O
inflammation,B-PR
.,O

Echo,B-TE
showed,O
normal,O
function,O
",",O
trace,B-PR
AR,I-PR
",",O
and,O
no,O
MR,B-PR
.,O

She,O
had,O
a,O
normal,O
RUQ,O
US,O
",",O
as,O
well,O
.,O

On,O
the,O
floor,O
the,O
patient,O
remained,O
stable,O
hemodynamically,O
without,O
recurrent,B-PR
fever,I-PR
and,O
was,O
stable,O
for,O
transfer,O
back,O
to,O
Franciscan,O
Children,O
's,O
Hospital,O
&,O
Rehab,O
Center,O
4,O
.,O

At,O
the,O
time,O
of,O
discharge,O
",",O
her,B-TE
potassium,I-TE
had,O
been,O
low,B-PR
despite,O
repletion,B-TR
",",O
Na,B-TE
was,O
elevated,B-PR
",",O
as,O
was,O
blood,B-TE
pressure,I-TE
.,O

On,O
recommendation,O
from,O
endocrine,O
",",O
her,B-TR
fludrocortisone,I-TR
was,O
decreased,O
from,O
0.2,O
to,O
0.1,O
(,O
higher,O
than,O
required,O
doses,O
of,O
fludrocort,B-TR
can,O
cause,O
these,B-PR
symptoms,I-PR
.,O
),O
.,O

1.,O
Hypotension,B-PR
:,O

Patient,O
presented,O
after,O
episode,O
of,O
hypotension,B-PR
and,O
syncope,B-PR
on,O
Mass.,O
Mental,O
Health,O
Center,O
5,O
.,O

Initially,O
it,O
was,O
felt,O
that,O
this,O
was,O
a,O
result,O
of,O
poor,B-PR
PO,I-PR
intake,I-PR
.,O

She,O
was,O
afebrile,B-PR
without,O
orthostatic,B-PR
vital,I-PR
signs,I-PR
nor,O
hypotension,B-PR
.,O

She,O
had,O
no,O
symptoms,O
of,O
infectious,B-PR
source,I-PR
",",O
normal,O
UA,O
",",O
normal,O
chest,O
xray,O
",",O
and,O
no,O
symptoms,O
nor,O
signs,O
of,O
injury,B-PR
after,O
her,O
fall,O
with,O
syncope,B-PR
.,O

Neuro,B-TE
exam,I-TE
was,O
normal,O
.,O

Subsequently,O
overnight,O
",",O
she,O
developed,O
a,B-PR
fever,I-PR
to,O
102.3,O
and,O
recurrent,B-PR
hypotension,I-PR
in,O
the,O
setting,O
of,O
fevers,B-PR
and,O
tachycardia,B-PR
that,O
was,O
concerning,O
for,O
an,B-PR
infectious,I-PR
source,I-PR
.,O

She,O
still,O
had,O
no,O
localizing,O
signs,O
of,O
infection,B-PR
and,O
culture,B-TE
data,I-TE
was,O
negative,O
to,O
be,O
negative,O
.,O

RUQ,B-TE
US,I-TE
was,O
ordered,O
and,O
returned,O
without,O
signs,O
of,O
infection,B-PR
later,O
.,O

She,O
was,O
started,O
on,O
stress,B-TR
dose,I-TR
steroids,I-TR
.,O

She,O
had,O
cultures,B-TE
drawn,O
",",O
was,O
given,O
tylenol,B-TR
(,O
tylenol,B-TE
screen,I-TE
prior,O
to,O
this,O
dose,O
was,O
negative,O
",",O
as,O
was,O
a,B-TE
urine,I-TE
tox,I-TE
),O
",",O
was,O
started,O
on,O
levofloxacin,B-TR
",",O
metronidazole,B-TR
",",O
and,O
vancomycin,B-TR
to,O
cover,O
emperically,O
for,O
hospital,B-PR
aquired,I-PR
pneumonia,I-PR
",",O
GI,B-PR
sources,I-PR
",",O
and,O
a,O
potential,O
hip,B-PR
infection,I-PR
.,O

Her,B-TE
transaminases,I-TE
were,O
slightly,B-PR
elevated,I-PR
",",O
which,O
was,O
later,O
attributed,O
to,O
shock,B-PR
liver,I-PR
as,O
a,O
result,O
of,O
her,O
period,O
of,O
hypotension,B-PR
.,O

Lipase,B-TE
and,O
amylase,B-TE
remained,O
normal,O
.,O

In,O
the,O
ICU,O
she,O
also,O
received,O
an,B-TE
echo,I-TE
that,O
revealed,O
normal,O
function,O
and,O
little,B-PR
valvular,I-PR
disease,I-PR
(,O
she,O
has,O
two,B-PR
loud,I-PR
systolic,I-PR
murmurs,I-PR
on,O
exam,B-TE
),O
",",O
and,O
a,B-TE
hip,I-TE
film,I-TE
revealing,O
no,O
inflammation,B-PR
nor,O
loosening,B-PR
.,O

Urine,B-TE
culture,I-TE
twice,O
grew,O
"10-100,000",O
coag,B-PR
negative,O
staph,B-PR
.,O

A,B-TR
line,I-TR
could,O
not,O
be,O
placed,O
for,O
technical,O
reasons,O
",",O
however,O
after,O
4L,O
NS,B-TR
on,O
the,O
floor,O
and,O
01-30,O
more,O
in,O
the,O
ICU,O
via,O
peripheral,B-TR
IV,I-TR
's,I-TR
she,O
was,O
stable,O
.,O

She,O
remained,O
hemodynamically,O
stable,O
with,O
good,O
UOP,O
in,O
the,O
setting,O
of,O
being,O
started,O
on,O
abx,B-TR
and,O
stress,B-TR
dose,I-TR
steroids,I-TR
.,O

The,B-TR
steroids,I-TR
were,O
thought,O
to,O
have,O
helped,O
significantly,O
in,O
in,O
the,O
setting,O
of,O
Addison,B-PR
's,I-PR
with,O
possibely,O
superimposed,B-PR
infection,I-PR
.,O

The,O
patient,O
was,O
planned,O
for,O
a,O
7,O
day,O
course,O
of,O
stress,B-TR
dose,I-TR
steroids,I-TR
followed,O
by,O
a,O
return,O
to,O
her,B-TR
basal,I-TR
predinisone,I-TR
/,O
fludrocortisone,B-TR
dose,I-TR
.,O

2.,O
Elevated,B-PR
LFTs,I-PR
:,O

LFTs,B-TE
wre,O
elevated,B-PR
at,O
presentation,O
.,O

Initially,O
the,O
differential,O
was,O
thought,O
to,O
include,O
shock,B-PR
liver,I-PR
from,O
hypotension,B-PR
",",O
hepatitis,B-PR
",",O
cholangitis,B-PR
or,O
choledocholithiasis,B-PR
.,O

Hepatitis,B-TE
serologies,I-TE
were,O
negative,O
and,O
the,O
pt,O
was,O
eventually,O
felt,O
to,O
have,O
had,O
shock,B-PR
liver,I-PR
from,O
her,B-PR
hypotensive,I-PR
episode,I-PR
as,O
the,B-PR
transaminitis,I-PR
resolved,O
over,O
time,O
.,O

3.,O
Hypoparathyroidism,B-PR
:,O

This,O
is,O
a,B-PR
chronic,I-PR
problem,I-PR
.,O

calcium,B-TE
levels,I-TE
were,O
followed,O
with,O
a,O
goal,O
to,O
keep,O
them,O
around,O
8.0,O
by,O
continuing,O
Calcium,B-TR
carbonate,I-TR
",",O
calcitriol,B-TR
.,O

The,O
pt,O
required,O
calcium,B-TR
gluconate,I-TR
x1,O
the,O
day,O
prior,O
to,O
discharge,O
.,O

Per,O
endocrine,O
at,O
the,O
time,O
of,O
discharge,O
",",O
the,O
pt,O
may,O
need,O
an,O
increase,O
in,O
calcium,B-TR
PO,I-TR
",",O
but,O
at,O
this,O
time,O
they,O
recommended,O
no,O
change,O
.,O

It,O
will,O
need,O
to,O
be,O
monitored,O
over,O
time,O
.,O

4.,O
Addison,B-PR
's-,I-PR
The,O
patient,O
is,O
on,O
basal,B-TR
prednisone,I-TR
/,O
fludrocortisone,B-TR
.,O

These,O
were,O
initially,O
continued,O
as,O
above,O
and,O
later,O
",",O
when,O
she,O
became,O
hypotensive,B-PR
and,O
febrile,B-PR
",",O
stress,B-TR
dose,I-TR
steroids,I-TR
were,O
started,O
and,O
planned,O
for,O
a,O
7,O
day,O
course,O
followed,O
by,O
a,O
return,O
to,O
her,O
prior,O
dose,O
of,O
prednisone,B-TR
.,O

At,O
the,O
time,O
of,O
discharge,O
",",O
her,B-TE
potassium,I-TE
had,O
been,O
low,B-PR
despite,O
repletion,B-TR
",",O

Na,B-TE
was,O
elevated,B-PR
",",O
as,O
was,O
blood,B-TE
pressure,I-TE
.,O

On,O
recommendation,O
from,O
endocrine,O
",",O
her,B-TR
fludrocortisone,I-TR
was,O
decreased,O
from,O
0.2,O
to,O
0.1,O
(,O
higher,O
than,O
required,O
doses,O
of,O
fludrocort,B-TR
can,O
cause,O
these,B-PR
symptoms.,I-PR
),O
.,O

5.,O
DM,B-PR
:,O

Light,O
followed,O
the,O
patient,O
.,O

She,O
was,O
continued,O
on,O
her,O
prior,O
dose,O
of,O
steroids,B-TR
with,O
sliding,B-TR
scale,I-TR
per,O
patient,O
using,O
a,B-TR
1:15,I-TR
carb,I-TR
counting,I-TR
scheme,I-TR
with,O
a,B-TR
1:30,I-TR
correction,I-TR
factor,I-TR
.,O

On,O
the,O
day,O
of,O
discharge,O
her,B-TR
glargine,I-TR
was,O
decreased,O
by,O
one,O
unit,O
because,O
her,B-TE
glucose,I-TE
remained,O
somewhat,B-PR
low,I-PR
in,O
the,O
mornings,O
.,O

6.,O
R,B-PR
Hip,I-PR
pain,I-PR
:,O

Later,O
in,O
her,O
hospital,O
course,O
",",O
the,O
pt,O
complained,O
of,O
hip,B-PR
pain,I-PR
.,O

A,B-TE
R,I-TE
hip,I-TE
film,I-TE
was,O
negative,O
for,O
pathology,B-PR
or,O
failure,B-PR
of,O
her,B-TR
hip,I-TR
replacement,I-TR
.,O

Pain,B-PR
was,O
controlled,O
with,O
tylenol,B-TR
and,O
the,O
pt,O
was,O
reassured,O
.,O

PT,O
was,O
consulted,O
.,O

The,O
pt,O
uses,O
a,B-TR
wheelchair,I-TR
often,O
at,O
baseline,O
due,O
to,O
pain,B-PR
from,O
arthritis,B-PR
.,O

7.,O
Depression,B-PR
:,O

The,O
pt,O
was,O
being,O
treated,O
at,O
Mediplex,O
Rehab,O
Hospital,O
4,O
for,O
suicidal,B-PR
ideation,I-PR
and,O
a,O
suicide,O
attempt,O
on,O
original,O
admission,O
with,O
tylenol,B-TR
and,O
oxycodone,B-TR
.,O

She,O
had,O
planned,O
this,O
attempt,O
carefully,O
without,O
the,O
knowledge,O
of,O
those,O
close,O
to,O
her,O
and,O
very,O
much,O
expected,O
her,O
attempt,O
to,O
work,O
.,O

She,O
had,O
been,O
depressed,B-PR
for,O
some,O
time,O
but,O
her,O
loved,O
ones,O
were,O
very,O
surprised,O
at,O
her,O
attempt,O
.,O

She,O
remained,O
very,B-PR
depressed,I-PR
at,O
her,O
inpatient,O
admission,O
and,O
refractory,B-PR
to,O
treatment,B-TR
.,O

One,O
day,O
prior,O
to,O
her,O
transfer,O
to,O
the,O
medical,O
floor,O
she,O
was,O
sectioned,O
to,O
initiate,O
ECT,B-TR
",",O
which,O
she,O
had,O
previously,O
refused,O
.,O

As,O
a,O
result,O
",",O
she,O
was,O
maintained,O
on,O
her,B-TR
ativan,I-TR
",",O
mirtazapine,B-TR
",",O
risperidone,B-TR
",",O
duloxetine,B-TR
.,O

She,O
did,O
not,O
exhibit,O
psychotic,B-PR
symptoms,I-PR
.,O

She,O
had,O
a,O
1:1,O
sitter,O
at,O
all,O
times,O
.,O

She,O
denied,O
any,B-PR
suicidality,I-PR
but,O
did,O
endorse,O
depression,B-PR
.,O

She,O
denied,O
HI,B-PR
",",O
SI,B-PR
",",O
and,O
illusions,B-PR
/,O
hallucinations,B-PR
.,O

Her,O
mood,O
appeared,O
stable,O
throughout,O
her,O
hospitalization,O
.,O

She,O
was,O
followed,O
by,O
psychiatry,O
in,O
consultation,O
while,O
she,O
was,O
on,O
the,O
medical,O
floor,O
.,O

The,O
patient,O
did,O
have,O
heparin,B-TR
subcutaneously,I-TR
while,O
on,O
the,O
medical,O
floor,O
and,O
in,O
the,O
ICU,O
.,O

She,O
remained,O
full,B-TR
code,I-TR
throughout,O
the,O
hospitalization,O
.,O

As,O
on,O
prior,O
hospitalization,O
",",O
her,O
HCP,O
was,O
shared,O
by,O
Dianne,O
White,O
.,O

Medications,O
on,O
Admission,O
:,O

Meds,O
on,O
transfer,O
:,O

Fludrocortisone,B-TR
Acetate,I-TR
0.2,O
mg,O
PO,O
DAILY,O
07-12,O
@,O
1033,O

Acetaminophen,B-TR
650,O
mg,O
PO,O
BID,O
07-11,O
@,O
1503,O
View,O

Ibuprofen,B-TR
400,O
mg,O
PO,O
BID,O
07-11,O
@,O
1503,O
View,O

Ibuprofen,B-TR
400,O
mg,O
PO,O
Q8H,O
:,O
PRN,O
07-11,O
@,O
1503,O
View,O

Insulin,B-TR
SC,I-TR
(,O
per,O
Insulin,O
Flowsheet,O
),O

Risperidone,B-TR
1,O
mg,O
PO,O
HS,O
07-10,O
@,O
1135,O
View,O

Risperidone,B-TR
0.5,O
mg,O
PO,O
DAILY,O
07-10,O
@,O
1135,O
View,O

Potassium,B-TR
Chloride,I-TR
20,O
mEq,O
PO,O
BID,O

Calcium,B-TR
Carbonate,I-TR
1500,O
mg,O
PO,O
TID,O
07-04,O
@,O
1126,O
View,O

Mirtazapine,B-TR
15,O
mg,O
PO,O
HS,O
07-03,O
@,O
1220,O
View,O

Duloxetine,B-TR
30,O
mg,O
PO,O
BID,O
Start,O
:,O
In,O
am,O
07-03,O
@,O
1214,O

Psyllium,B-TR
1,O
PKT,O
PO,O
TID,O
:,O
PRN,O
06-30,O
@,O
1248,O
View,O

Memantine,B-TR
*,O
N,O
F*,O
10,O
mg,O
Oral,O
daily,O
06-27,O
@,O
1124,O
View,O

Calcitriol,B-TR
0.25,O
mcg,O
PO,O
EVERY,O
OTHER,O
DAY,O
t/th/s/s,O

Calcitriol,B-TR
0.5,O
mcg,O
PO,O
EVERY,O
OTHER,O
DAY,O
06-27,O
@,O
1051,O

Lorazepam,B-TR
2,O
mg,O
PO,O
HS,O
06-23,O
@,O
1215,O
View,O

Alendronate,B-TR
Sodium,I-TR
70,O
mg,O
PO,O
QSUN,O
06-22,O
@,O
1106,O
View,O

Lactulose,B-TR
60,O
ml,O
PO,O
QTHUR,O
06-21,O
@,O
1600,O
View,O

Milk,B-TR
of,I-TR
Magnesia,I-TR
60,O
ml,O
PO,O
QTHUR,O
06-21,O
@,O
1600,O
View,O

Arimidex,B-TR
*,O
N,O
F*,O
1,O
mg,O
Oral,O
daily,O
06-21,O
@,O
1414,O
View,O

Magnesium,B-TR
Oxide,I-TR
400,O
mg,O
PO,O
BID,O
06-20,O
@,O
2017,O
View,O

Atorvastatin,B-TR
20,O
mg,O
PO,O
DAILY,O
06-20,O
@,O
2017,O
View,O

Docusate,B-TR
Sodium,I-TR
100,O
mg,O
PO,O
TID,O
06-20,O
@,O
2017,O
View,O

Pantoprazole,B-TR
40,O
mg,O
PO,O
Q24H,O
06-20,O
@,O
2017,O
View,O

Prednisone,B-TR
2.5,O
mg,O
PO,O
Q3PM,O
06-20,O
@,O
2017,O
View,O

Prednisone,B-TR
5,O
mg,O
PO,O
QAM,O
06-20,O
@,O
2017,O
View,O

Chlorothiazide,B-TR
500,O
mg,O
PO,O
DAILY,O
06-20,O
@,O
2017,O
View,O

Aspirin,B-TR
81,O
mg,O
PO,O
DAILY,O

Multivitamins,B-TR
1,O
CAP,O
PO,O
DAILY,O

Allergies,O
:,O

Clindamycin,B-TR
/,O
Erythromycin,B-TR
Base,I-TR
/,O
Amoxicillin,B-TR
/,O
Keflex,B-TR
/,O
Wellbutrin,B-TR

Discharge,O
Medications,O
:,O

1.,O
Risperidone,B-TR
0.5,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
HS,O
(,O
at,O
bedtime,O
),O
.,O

2.,O
Risperidone,B-TR
0.5,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

3.,O
Mirtazapine,B-TR
15,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
HS,O
(,O
at,O
bedtime,O
),O
.,O

4.,O
Duloxetine,B-TR
30,O
mg,O
Capsule,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

5.,O
Calcitriol,B-TR
0.25,O
mcg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
EVERY,O
OTHER,O
DAY,O
(,O
Every,O
Other,O
Day,O
),O
.,O

6.,O
Calcitriol,B-TR
0.5,O
mcg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
EVERY,O
OTHER,O
DAY,O
(,O
Every,O
Other,O
Day,O
),O
.,O

7.,O
Alendronate,B-TR
70,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
QSUN,O
(,O
every,O
Sunday,O
),O
.,O

8.,O
Lactulose,B-TR
10,O
g,O
/,O
15,O
mL,O
Syrup,O
Sig,O
:,O
Sixty,O
(,O
60,O
),O
ML,O
PO,O
EVERY,O
THURSDAY,O
(,O

9.,O
Magnesium,B-TR
Hydroxide,I-TR
400,O
mg,O
/,O
5,O
mL,O
Suspension,O
Sig,O
:,O
Thirty,O
(,O
30,O
),O
ML,O
PO,O
Q6H,O
(,O
every,O
6,O
hours,O
),O
as,O
needed,O
.,O

10.,O
Anastrozole,B-TR
1,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
daily,O
(,O

11.,O
Atorvastatin,B-TR
20,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

12.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
.,O

13.,O
Pantoprazole,B-TR
40,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
Q24H,O
(,O
every,O
24,O
hours,O
),O
.,O

14.,O
Aspirin,B-TR
81,O
mg,O
Tablet,O
",",O
Chewable,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Chewable,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

15.,O
Multivitamin,B-TR
Capsule,I-TR
Sig,O
:,O
One,O
(,O
1,O
),O
Cap,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

16.,O
Ibuprofen,B-TR
400,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

17.,O
Ferrous,B-TR
Sulfate,I-TR
325,O
(,O
65,O
),O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

18.,O
Maalox,B-TR
200-200-20,O
mg,O
/,O
5,O
mL,O
Suspension,O
Sig,O
:,O
Fifteen,O
(,O
15,O
),O
ML,O
PO,O
PRN,O
(,O
as,O
needed,O
),O
.,O

19.,O
Levofloxacin,B-TR
500,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q24H,O
(,O
every,O
24,O
hours,O
),O
for,O
2,O
days,O
.,O

20.,O
Calcium,B-TR
Carbonate,I-TR
500,O
mg,O
Tablet,O
",",O
Chewable,O
Sig,O
:,O
Three,O
(,O
3,O
),O
Tablet,O
",",O
Chewable,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
.,O

21.,O
Calcium,B-TR
Carbonate,I-TR
500,O
mg,O
Tablet,O
",",O
Chewable,O
Sig,O
:,O
Three,O
(,O
3,O
),O
Tablet,O
",",O
Chewable,O
PO,O
QID,O
(,O
4,O
times,O
a,O
day,O
),O
.,O

22.,O
Heparin,B-TR
(,I-TR
Porcine,I-TR
),I-TR
"5,000",O
unit,O
/,O
mL,O
Solution,O
Sig,O
:,O
5000,O
(,O
5000,O
),O
units,O
Injection,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
.,O

23.,O
Prednisone,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

24.,O
Prednisone,B-TR
2.5,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q,O
3PM,O
(,O

25.,O
Chlorothiazide,B-TR
250,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

26.,O
Fludrocortisone,B-TR
0.1,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

27.,O
Potassium,B-TR
Chloride,I-TR
10,O
mEq,O
Capsule,O
",",O
Sustained,O
Release,O
Sig,O
:,O
Four,O
(,O
4,O
),O
Capsule,O
",",O
Sustained,O
Release,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

28.,O
Lorazepam,B-TR
1,O
mg,O
Tablet,O
Sig,O
:,O
0.5,O
Tablet,O
PO,O
Q6H,O
(,O
every,O
6,O
hours,O
),O
as,O
needed,O
.,O

29.,O
Memantine,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
daily,O
(,O

30.,O
Insulin,B-TR
Glargine,I-TR
100,O
unit,O
/,O
mL,O
Solution,O
Sig,O
:,O
AS,O
INSTRUCTED,O
Subcutaneous,O
twice,O
a,O
day,O
:,O
7,O
units,O
in,O
the,O
morning,O
",",O
18,O
units,O
in,O
the,O
evening,O
.,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Facility,O
:,O

Quincy,O
Medical,O
Center,O
4,O

Discharge,O
Diagnosis,O
:,O

Hypotension,B-PR

Early,B-PR
Sepsis,I-PR

Adrenal,B-PR
Insufficiency,I-PR

Diabetes,B-PR
I,I-PR

Hypocalcemia,B-PR
(,O
Hypoparathyroidism,B-PR
),O

Depression,B-PR

Transaminitis,B-PR

Discharge,O
Condition,O
:,O

Stable,O
vitals,O
",",O
depressed,B-PR
.,O

Discharge,O
Instructions,O
:,O

You,O
were,O
admitted,O
with,O
a,B-PR
low,I-PR
blood,I-PR
pressure,I-PR
and,O
developed,O
a,B-PR
fever,I-PR
.,O

You,O
are,O
finishing,O
a,O
course,O
of,O
antibiotics,B-TR
and,O
have,O
been,O
stable,O
for,O
days,O
.,O

If,O
you,O
lose,O
consciousness,O
",",O
develop,O
a,B-PR
low,I-PR
BP,I-PR
",",O
have,O
lightheadedness,B-PR
with,O
standing,O
",",O
develop,O
a,B-PR
fever,I-PR
",",O
or,O
have,O
other,B-PR
worrisome,I-PR
symptoms,I-PR
",",O
please,O
seek,O
medical,B-TR
care,I-TR
.,O

Followup,O
Instructions,O
:,O

As,O
planned,O
-,O
continued,O
consultation,O
by,O
Light,O
and,O
Endocrine,O

Vivian,O
LIEN,O
MD,O
88-143,O

Completed,O
by,O
:,O
Mildred,O
BERRY,O
MD,O
38-748,O
2017-07-18,O
@,O
0548,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Edith,O
LIEN,O
on,O
:,O
MON,O
2017-07-24,O
1:03,O
PM,O

(,O
End,O
of,O
Report,O
),O

333145593,O

FIH,O

9229891,O

50096/c65m,O

571634,O

12/5/1993,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

12/05/93,O

DISCHARGE,O
DATE,O
:,O

12/17/93,O

CAUSE,O
OF,O
DEATH,O
:,O

Cardiogenic,B-PR
shock,I-PR
.,O

CAUSATIVE,O
FACTORS,O
:,O

Including,O
cardiomyopathy,B-PR
",",O
aortic,B-PR
stenosis,I-PR
",",O
status,O
post,O
aortic,B-TR
valve,I-TR
replacement,I-TR
",",O
coronary,B-PR
artery,I-PR
disease,I-PR
status,O
post,O
coronary,B-TR
artery,I-TR
bypass,I-TR
grafting,I-TR
with,O
congestive,B-PR
heart,I-PR
failure,I-PR
and,O
pulmonary,B-PR
edema,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
65,O
year,O
old,O
male,O
who,O
sustained,O
a,B-PR
small,I-PR
myocardial,I-PR
infarction,I-PR
first,O
in,O
1978,O
",",O
with,O
course,O
thereafter,O
including,O
a,B-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
by,O
Dr.,O
Wierst,O
______________at,O
Noughwell,O
Entanbon,O
Health,O
in,O
1986,O
.,O

In,O
1991,O
he,O
presented,O
with,O
congestive,B-PR
heart,I-PR
failure,I-PR
and,O
he,O
underwent,O
porcine,B-TR
aortic,I-TR
valve,I-TR
replacement,I-TR
.,O

In,O
the,O
seven,O
to,O
eight,O
months,O
preceding,O
admission,O
",",O
he,O
developed,O
recurrent,B-PR
angina,I-PR
with,O
dyspnea,B-PR
on,O
exertion,O
.,O

The,O
patient,O
was,O
admitted,O
for,O
cardiac,B-TE
catheterization,I-TE
in,O
early,O
December,O
",",O
1993,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Significant,O
for,O
vertebrobasilar,B-PR
insufficiency,I-PR
",",O
bipolar,B-PR
mood,I-PR
disorder,I-PR
",",O
and,O
hypercholesterolemia,B-PR
",",O
as,O
well,O
as,O
some,B-PR
baseline,I-PR
renal,I-PR
insufficiency,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Procardia,B-TR
sustained,I-TR
release,I-TR
60,O
mg.,O
po,O
q.day,O
",",O
Digoxin,B-TR
.25,O
mg.,O
po,O
q.day,O
",",O
Lasix,B-TR
30,O
mg.,O
(,O
interval,O
unspecified,O
),O
",",O
Prozac,B-TR
40,O
mg.,O
po,O
q.day,O
",",O
Lovestatin,B-TR
20,O
mg.,O
po,O
bid,O
",",O
aspirin,B-TR
q.,O
day,O
and,O
supplemental,B-TR
potassium,I-TR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Remarkable,O
for,O
an,O
oriented,O
",",O
alert,O
male,O
in,O
no,O
acute,B-PR
distress,I-PR
with,O
decreased,B-PR
breath,I-PR
sounds,I-PR
at,I-PR
the,I-PR
right,I-PR
base,I-PR
consistent,O
with,O
effusion,B-PR
and,O
a,B-PR
3/6,I-PR
systolic,I-PR
murmur,I-PR
consistent,O
with,O
aortic,B-PR
stenosis,I-PR
.,O

His,B-TE
pulse,I-TE
exam,I-TE
was,O
intact,O
.,O

Cardiac,B-TE
catheterization,I-TE
demonstrated,O
elevated,B-PR
right,I-PR
and,I-PR
left-sided,I-PR
filling,I-PR
pressures,I-PR
at,O
rest,O
",",O
with,O
pulmonary,B-PR
hypertension,I-PR
and,O
normal,O
cardiac,O
index,O
.,O

There,O
was,O
severe,B-PR
aortic,I-PR
stenosis,I-PR
of,O
70,O
millimeter,O
peak,O
gradient,O
",",O
native,B-PR
three,I-PR
vessel,I-PR
disease,I-PR
with,O
patent,B-TR
left,I-TR
internal,I-TR
mammary,I-TR
artery,I-TR
graft,I-TR
to,I-TR
the,I-TR
left,I-TR
circumflex,I-TR
",",O
dissection,B-PR
of,I-PR
the,I-PR
left,I-PR
main,I-PR
was,O
induced,O
by,O
the,B-TR
catheter,I-TR
tip,I-TR
.,O

A,B-TR
patent,I-TR
right,I-TR
internal,I-TR
mammary,I-TR
artery,I-TR
to,I-TR
the,I-TR
left,I-TR
anterior,I-TR
descending,I-TR
artery,I-TR
and,I-TR
diagonal,I-TR
was,O
noted,O
",",O
and,O
a,B-TR
patent,I-TR
saphenous,I-TR
vein,I-TR
graft,I-TR
to,I-TR
the,I-TR
posterior,I-TR
descending,I-TR
artery,I-TR
was,O
present,O
.,O

Also,O
of,O
note,O
",",O
pulmonary,B-PR
edema,I-PR
was,O
induced,O
by,O
dye,B-TR
and,O
anxiety,B-PR
and,O
treated,O
with,O
Lasix,B-TR
",",O
Morphine,B-TR
",",O
oxygen,B-TR
and,O
nitroglycerin,B-TR
.,O

Post-procedure,O
he,O
was,O
admitted,O
to,O
the,O
CCU,O
because,O
of,O
the,O
history,O
of,O
left,B-PR
main,I-PR
dissection,I-PR
.,O

He,O
remained,O
hemodynamically,O
stable,O
but,O
of,O
note,O
",",O
would,O
not,O
tolerate,O
a,B-TE
transesophageal,I-TE
echo,I-TE
because,O
of,O
anxiety-he,B-PR
would,O
not,O
swallow,O
the,B-TR
probe,I-TR
.,O

Transthoracic,B-TE
echo,I-TE
demonstrated,O
gradients,O
of,O
100,O
peak,O
and,O
65,O
mean,O
across,O
the,O
aortic,O
valve,O
and,O
there,O
was,O
mild,B-PR
aortic,I-PR
insufficiency,I-PR
and,O
ejection,B-TE
fraction,I-TE
was,O
noted,O
to,O
be,O
18%,O
with,O
global,B-PR
hypokinesis,I-PR
.,O

The,O
next,O
several,O
days,O
were,O
remarkable,O
for,O
events,O
in,O
which,O
the,O
patient,O
was,O
quite,B-PR
agitated,I-PR
and,O
was,O
evaluated,O
by,O
Psychiatry,O
and,O
treated,O
with,O
Ativan,B-TR
.,O

The,O
patient,O
was,O
then,O
evaluated,O
by,O
Cardiac,O
Surgery,O
for,O
probable,O
re-do,B-TR
aortic,I-TR
valve,I-TR
replacement,I-TR
and,O
possible,O
re-do,B-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
grafting,I-TR
.,O

In,O
the,O
course,O
of,O
preoperative,B-TE
workup,I-TE
",",O
Mr.,O
Has,O
was,O
evaluated,O
completely,O
by,O
Psychiatry,O
with,O
diagnoses,O
including,O
underlying,B-PR
chronic,I-PR
depression,I-PR
well-controlled,O
on,O
Prozac,B-TR
",",O
underlying,B-PR
organ,I-PR
brain,I-PR
vulnerability,I-PR
of,O
unclear,O
etiology,O
",",O
possibly,O
microvascular,B-PR
infarct,I-PR
",",O
acute,B-PR
paranoid,I-PR
and,I-PR
belligerent,I-PR
behavior,I-PR
",",O
possibly,O
due,O
to,O
medications,B-TR
.,O

On,O
December,O
12,O
the,O
patient,O
underwent,O
surgery,B-TR
",",O
including,O
a,B-TR
re-do,I-TR
aortic,I-TR
valve,I-TR
replacement,I-TR
with,O
#,B-TR
25,I-TR
St.,I-TR
Jude,I-TR
and,O
re-do,B-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
grafting,I-TR
times,I-TR
one,I-TR
;,O
saphenous,B-TR
vein,I-TR
graft,I-TR
to,I-TR
the,I-TR
posterior,I-TR
descending,I-TR
artery,I-TR
as,O
a,B-TR
veno-venous,I-TR
jump,I-TR
graft,I-TR
.,O

The,O
total,O
bypass,O
time,O
:,O

2,O
hours,O
25,O
minutes,O
.,O

Total,O
crossclamp,O
time,O
:,O

1,O
hour,O
and,O
48,O
minutes,O
.,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
Surgical,O
Intensive,O
Care,O
Unit,O
postoperatively,O
with,O
stable,O
hemodynamics,O
on,O
Lidocaine,B-TR
at,O
one,O
",",O
Dobutamine,B-TR
at,O
200,O
and,O
Nipride,B-TR
.,O

The,O
patient,O
was,O
extubated,O
by,O
postoperative,O
day,O
#,O
1,O
but,O
was,O
noted,O
to,O
be,O
relatively,B-PR
hypoxemic,I-PR
with,O
high,B-PR
oxygen,I-PR
requirement,I-PR
.,O

Chest,B-TE
x-ray,I-TE
demonstrating,O
pulmonary,B-PR
edema,I-PR
.,O

Aggressive,B-TR
diuresis,I-TR
was,O
undertaken,O
and,O
the,O
patient,O
responded,O
",",O
albeit,O
sluggishly,O
.,O

In,O
addition,O
",",O
he,O
remained,O
agitated,B-PR
.,O

This,O
was,O
attributed,O
to,O
mild,B-PR
hypoxia,I-PR
and,O
/,O
or,O
his,B-PR
underlying,I-PR
psychiatric,I-PR
diagnoses,I-PR
and,O
he,O
was,O
treated,O
with,O
Haldol,B-TR
appropriately,O
.,O

On,O
day,O
#,O
2,O
the,O
patient,O
continued,O
to,O
diurese,O
and,O
this,O
was,O
maintained,O
with,O
the,B-TR
Lasix/,I-TR
Mannitol,I-TR
infusion,I-TR
.,O

His,B-TE
urine,I-TE
output,I-TE
remained,O
at,O
150,O
to,O
200,O
cc.,O
an,O
hour,O
.,O

Despite,O
this,O
",",O
his,B-TE
chest,I-TE
x-ray,I-TE
continued,O
to,O
show,O
severe,B-PR
pulmonary,I-PR
edema,I-PR
and,O
the,O
clinical,O
picture,O
correlated,O
.,O

He,O
required,O
anti-hypertensive,B-TR
therapy,I-TR
initially,O
with,O
Nipride,B-TR
which,O
was,O
changed,O
to,O
Hydralazine,B-TR
to,O
avoid,O
shunting,B-PR
.,O

He,O
received,O
several,O
units,O
of,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
to,O
increase,O
his,B-TE
hematocrit,I-TE
and,O
oncotic,B-TE
pressure,I-TE
.,O

Very,O
early,O
in,O
the,O
morning,O
on,O
postoperative,O
day,O
#,O
3,O
",",O
the,O
patient,O
became,O
acutely,B-PR
hypoxic,I-PR
after,O
several,O
hours,O
of,O
marginal,B-PR
oxygenation,I-PR
with,O
respiratory,B-TE
rates,I-TE
in,O
the,O
thirties,O
and,O
the,O
patient,O
was,O
urgently,O
intubated,O
",",O
without,O
complication,B-PR
.,O

With,O
positive,B-TR
pressure,I-TR
ventilation,I-TR
and,O
continued,B-TR
diuresis,I-TR
",",O
his,B-TE
arterial,I-TE
blood,I-TE
gases,I-TE
improved,O
.,O

Throughout,O
this,O
he,O
remained,O
hemodynamically,O
stable,O
.,O

Exception,O
was,O
a,O
ten,O
beat,O
run,O
of,O
ventricular,B-PR
tachycardia,I-PR
which,O
was,O
thought,O
to,O
be,O
ischemic,B-PR
in,O
origin,O
and,O
treated,O
with,O
nitrates,B-TR
and,O
Lidocaine,B-TR
.,O

His,B-TE
chest,I-TE
x-ray,I-TE
blossomed,O
to,O
demonstrate,O
pulmonary,B-PR
infiltrate,I-PR
and,O
the,O
patient,O
began,O
to,O
produce,O
sputum,B-PR
.,O

Infectious,O
Disease,O
consultation,O
was,O
obtained,O
for,O
evaluation,B-TE
of,O
his,B-PR
purulent,I-PR
sputum,I-PR
and,O
the,O
patient,O
was,O
covered,O
with,O
Vancomycin,B-TR
",",O
Ceftazidime,B-TR
and,O
Gentamicin,B-TR
.,O

Cardiology,B-TE
evaluation,I-TE
commented,O
on,O
the,B-PR
patient,I-PR
&apos;s,I-PR
increasing,I-PR
ventricular,I-PR
ectopy,I-PR
and,O
suggested,O
that,O
these,O
were,O
due,O
to,O
an,B-PR
R,I-PR
and,I-PR
T,I-PR
phenomenon,I-PR
from,O
his,B-TR
pacer,I-TR
in,O
the,O
setting,O
of,O
prolonged,B-PR
QT,I-PR
interval,I-PR
.,O

Consequently,O
his,B-TR
Pronestyl,I-TR
was,O
discontinued,O
.,O

In,O
addition,O
",",O
the,O
patient,O
was,O
given,O
magnesium,B-TR
to,O
bring,O
his,B-TE
level,I-TE
above,O
2,O
.,O

On,O
the,O
evening,O
of,O
the,O
18th,O
",",O
the,O
patient,O
continued,O
to,O
remain,O
hemodynamically,O
stable,O
",",O
although,O
his,B-TE
oxygenation,I-TE
was,O
clearly,O
deteriorating,O
and,O
more,O
marginal,O
.,O

On,O
60%,O
FIO2,B-TR
his,O
pO2,B-TE
was,O
63,O
.,O

It,O
was,O
increased,O
to,O
65%,O
with,O
pO2,B-TE
of,O
81,O
.,O

At,O
approximately,O
7:50,O
a.m.,O
",",O
house,O
officer,O
was,O
called,O
to,O
the,O
room,O
for,O
blood,B-TE
pressure,I-TE
of,O
70/40,O
with,O
falling,B-PR
oxygen,I-PR
saturations,I-PR
.,O

The,O
patient,O
was,O
immediately,O
given,O
400,O
mg.,O
of,O
Calcium,B-TR
Chloride,I-TR
i.v.,I-TR
push,I-TR
and,O
ventilator,B-TR
disconnected,O
and,O
the,O
patient,O
manually,B-TR
ventilated,I-TR
.,O

Within,O
one,O
minute,O
",",O
the,O
patient,O
lost,O
his,B-TE
blood,I-TE
pressure,I-TE
and,O
CPR,B-TR
was,O
initiated,O
and,O
code,O
was,O
called,O
.,O

The,O
patient,O
initially,O
continued,O
to,O
have,O
rhythm,O
consistent,O
with,O
EMV,B-PR
and,O
he,O
was,O
bolused,O
with,O
Levophed,B-TR
and,O
given,O
some,O
volume,O
while,O
compressions,B-TR
continued,O
.,O

The,B-TE
patient,I-TE
&apos;s,I-TE
prothrombin,I-TE
time,I-TE
had,O
been,O
23,O
early,O
the,O
same,O
morning,O
and,O
tamponade,B-PR
was,O
considered,O
and,O
thoracotomy,B-TR
instruments,I-TR
obtained,O
.,O

The,O
chest,O
was,O
opened,O
partially,O
and,O
through,O
sub-xyphoid,O
area,O
it,O
was,O
determined,O
that,O
there,O
was,O
no,O
evidence,O
of,O
tamponade,B-PR
.,O

Compressions,B-TR
were,O
continued,O
and,O
adequate,O
pulse,O
was,O
felt,O
and,O
arterial,B-TE
blood,I-TE
gases,I-TE
demonstrated,O
adequate,O
oxygenation,O
and,O
perfusion,O
.,O

The,B-TE
patient,I-TE
&apos;s,I-TE
rhythm,I-TE
degenerated,O
to,O
ventricular,B-PR
tachycardia,I-PR
and,O
he,O
was,O
shocked,O
",",O
initially,O
without,O
response,O
but,O
after,O
several,O
doses,O
of,O
Epinephine,B-TR
",",O
one-half,O
mg.,O
of,O
Atropine,B-TR
and,O
a,O
bolus,O
of,O
Lidocaine,B-TR
we,O
were,O
able,O
to,O
obtain,O
a,B-TE
blood,I-TE
pressure,I-TE
and,O
rhythm,B-TE
only,O
briefly,O
",",O
and,O
quickly,O
deteriorated,O
back,O
to,O
ventricular,B-PR
fibrillation,I-PR
.,O

Further,O
attempts,O
at,O
resuscitation,B-TR
were,O
unsuccessful,O
and,O
the,O
patient,O
was,O
pronounced,O
dead,O
at,O
8:30,O
a.m.,O

The,O
family,O
has,O
been,O
notified,O
and,O
autopsy,O
consent,O
has,O
been,O
obtained,O
.,O

LENNI,O
BREUTZOLN,O
",",O
M.D.,O

TR,O
:,O

bp,O
/,O
bmot,O

DD,O
:,O

12/17/93,O

TD,O
:,O

12/18/93,O

CC,O
:,O

G,O
Hemp,O
",",O
M.D.,O
Taarnna,O
Has,O
",",O
M.D.,O

Admission,O
Date,O
:,O

2020-01-20,O

Discharge,O
Date,O
:,O

2020-01-21,O

Date,O
of,O
Birth,O
:,O

1977-11-23,O

Sex,O
:,O

M,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Lipitor,B-TR
/,O
Codeine,B-TR

Attending,O
:,O
Sam,O
M,O
Ennis,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

GIB,B-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

Endoscopy,B-TE
2020-01-20,O

History,O
of,O
Present,O
Illness,O
:,O

42,O
yom,O
with,O
PMH,O
of,O
HTN,B-PR
",",O
hyperchol,B-PR
admitted,O
to,O
OSH,O
1,O
day,O
ago,O
with,O
black,B-PR
tarry,I-PR
stools,I-PR
X,O
2,O
days,O
.,O

Patient,O
states,O
that,O
he,O
had,O
chronically,O
had,O
loose,B-PR
stools,I-PR
but,O
over,O
2,O
preeceeding,O
days,O
noticed,O
the,O
stool,O
to,O
be,O
dark,B-PR
and,O
tarry,B-PR
.,O

+,O
Epigastric,B-PR
discomfort,I-PR
",",O
gurgling,B-PR
gas-like,I-PR
pain,I-PR
",",O
no,O
association,O
with,O
food,O
.,O

+,O
lightheadedness,B-PR
when,O
he,O
stood,O
up,O
prompting,O
him,O
to,O
go,O
to,O
OSH,O
Nellie,O
.,O

He,O
states,O
that,O
he,O
takes,O
ASA,B-TR
daily,O
and,O
takes,O
motrin,B-TR
800,O
mg,O
tid,O
sometimes,O
for,O
pain,B-PR
",",O
last,O
use,O
2,O
wks,O
PTA,O
.,O

Denies,O
BRBPR,B-PR
",",O
n/v/d,B-PR
.,O

Denies,O
recent,B-PR
fevers,I-PR
",",O
chills,B-PR
.,O

Denies,O
any,B-PR
hemetemesis,I-PR
.,O

At,O
OSH,O
initial,B-TE
Hct,I-TE
=,O
26,O
",",O
and,O
22,O
upon,O
repeat,O
.,O

He,O
was,O
also,O
orthostatic,B-PR
given,O
3,O
units,O
PRBC,B-TR
and,O
IVF,B-TR
.,O

EGD,B-TE
attempted,O
but,O
pt,O
unable,O
to,O
tolerate,O
.,O

He,O
is,O
now,O
transferred,O
to,O
Mediplex,O
Rehab,O
Hospital,O
for,O
futher,B-TE
workup,I-TE
and,O
Rx,B-TR
.,O

On,O
transfer,O
pt,O
denies,O
any,O
complaints,O
.,O

States,O
that,O
lightheadedness,B-PR
is,O
resolved,O
.,O

Past,O
Medical,O
History,O
:,O

HTN,B-PR

Hyperchol,B-PR
h/o,O
A.,B-PR
fib,I-PR
6,O
yrs,O
ago,O
->,O
cardioverted,O
.,O

Social,O
History,O
:,O

Social,O
Hx,O
:,O

Works,O
as,O
a,O
police,O
oficer,O
",",O
married,O
",",O
denies,O
smoking,O
",",O
etoh,O
.,O

Family,O
History,O
:,O

Family,O
Hx,O
:,O
father,O
with,O
lung,B-PR
ca,I-PR
.,O

Physical,O
Exam,O
:,O

Physical,O
Exam,O
:,O

Vitals,O
:,O

T,B-TE
:,O
98,O

P,B-TE
:,O
66,O

R,B-TE
:,O
15,O

BP,B-TE
:,O
122/51,O

SaO2,B-TE
:,O
100%,O
RA,O

General,O
:,O
young,O
male,O
in,O
nad,B-PR
",",O
awake,O
alert,O
oriented,O

HEENT,O
:,O

MMM,O
",",O
eomi,O
",",O
OP,O
clear,O

Neck,O
:,O
supple,O
",",O
no,O
JVD,B-PR

Pulmonary,O
:,O

Lungs,O
CTA,O
bilaterally,O
without,O
R/R/W,B-PR

Cardiac,O
:,O

RRR,O
",",O
nl.,O
S1S2,O
",",O
no,O
M/R/G,B-PR
noted,O

Abdomen,O
:,O
obese,B-PR
",",O
soft,O
",",O
mild,B-PR
epigastric,I-PR
tenderness,I-PR
",",O
NABS,O

Extremities,O
:,O

No,O
C/C/E,B-PR
bilaterally,I-PR
",",O
2+,B-TE
radial,I-TE
",",I-TE
DP,I-TE
and,I-TE
PT,I-TE
pulses,I-TE
b/l,I-TE
.,O

Rectal,O
:,O
no,O
hemrroiids,B-PR
",",O
guiac,B-PR
positive,I-PR
brown,I-PR
stool,I-PR
.,O

Pertinent,O
Results,O
:,O

OSH,O
27.5,O
hct,B-TE
at,O
2:50,O
AM,O
01-20,O
.,O

EKG,B-TE
:,O

OSH,O
-,O
sinus,B-PR
tach,I-PR
at,O
108,O
",",O
nl,O
axis,O
",",O
nl,O
intevals,O
.,O

No,O
st-t,B-PR
abnormalities,I-PR
.,O

2020-01-20,O
6:17,O

PT,B-TE
-,O
13.2,O
*,O
PTT,B-TE
-,O
27.2,O
INR,B-TE
(,I-TE
PT,I-TE
)-,I-TE
1.1,O

2020-01-20,O
6:17,O

PLT,B-TE
COUNT,I-TE
-,O
259,O

2020-01-20,O
6:17,O

WBC,B-TE
-,O
9.3,O
RBC,B-TE
-,O
3.21,O
*,O
HGB,B-TE
-,O
9.6,O
*,O
HCT,B-TE
-,O
27.3,O
*,O
MCV,B-TE
-,O
85,O
MCH,B-TE
-,O
29.9,O
MCHC,B-TE
-,O
35.2,O
*,O
RDW,B-TE
-,O
15.6,O
*,O

2020-01-20,O
21:50,O

WBC,B-TE
-,O
8.0,O
RBC,B-TE
-,O
3.20,O
*,O
HGB,B-TE
-,O
9.6,O
*,O
HCT,B-TE
-,O
27.8,O
*,O
MCV,B-TE
-,O
87,O
MCH,B-TE
-,O
30.1,O
MCHC,B-TE
-,O
34.7,O
RDW,B-TE
-,O
15.7,O
*,O

2020-01-20,O
21:50,O

PLT,B-TE
COUNT,I-TE
-,O
264,O

2020-01-20,O
12:38,O

WBC,B-TE
-,O
7.4,O
RBC,B-TE
-,O
3.38,O
*,O
HGB,B-TE
-,O
10.1,O
*,O
HCT,B-TE
-,O
29.2,O
*,O
MCV,B-TE
-,O
86,O
MCH,B-TE
-,O
29.8,O
MCHC,B-TE
-,O
34.5,O
RDW,B-TE
-,O
15.5,O

Brief,O
Hospital,O
Course,O
:,O

Assessment,O
and,O
Plan,O
:,O

42,O
yom,O
with,O
h/o,O
NSAID,B-TR
use,O
transferred,O
from,O
OSH,O
with,O
black,B-PR
tarry,I-PR
stools,I-PR
at,O
home,O
.,O

Patient,O
was,O
admitted,O
to,O
CMED,O
CCU,O
with,O
tid,O
Hct,B-TE
check,I-TE
.,O

GI,O
was,O
consulted,O
and,O
performed,O
Endoscopy,B-TE
under,O
general,B-TR
anesthesia,I-TR
which,O
revealed,O
a,B-PR
non,I-PR
bleeding,I-PR
ulcer,I-PR
and,O
gastritis,B-PR
.,O

Patient,O
was,O
continued,O
on,O
BID,O
PPI,B-TR
",",O
H,B-TR
.,O

Pylori,B-TE
serology,I-TE
checked,O
(,O
pending,O
at,O
time,O
of,O
discharge,O
),O
.,O

His,B-TR
antihypertensives,I-TR
were,O
held,O
given,O
concern,O
for,O
GI,B-PR
bleed,I-PR
and,O
should,O
be,O
restarted,O
at,O
follow,O
up,O
appointment,O
with,O
PCP,O
.,O

Marie,O
was,O
discharged,O
with,O
goal,B-TR
PPI,I-TR
twice,O
day,O
for,O
1,O
month,O
followed,O
by,O
once,O
a,O
day,O
.,O

He,O
is,O
scheduled,O
to,O
follow,O
up,O
with,O
daughter,O
in,O
2,O
days,O
.,O

Medications,O
on,O
Admission,O
:,O

Medications,B-TR
on,O
transfer,O
:,O
esmopreazole,B-TR
40,O
mg,O
iv,O
bid,O
hydrochlorthiazide,B-TR
25,O
mg,O
daily,O
lisinopril,B-TR
5,O
mg,O
daily,O
loratadine,B-TR
10,O
mg,O
daily,O
metprolol,B-TR
150,O
mg,O
daily,B-TR
multivitamin,I-TR
niacin,I-TR
500,O
mg,O
daily,O

Medications,O
at,O
home,O
:,O

ASA,B-TR
325,O
mg,O
daily,O

motrin,B-TR
800,O
mg,O
tid,O

lisinopril,B-TR
5,O
mg,O
daily,O

hydrochlorthiazide,B-TR
25,O
mg,O
daily,O

toprol,B-TR
xl,I-TR
150,O
mg,O
daily,O

niaspan,B-TR
500,O
mg,O
daily,O

loratidine,B-TR
10,O
mg,O
daily,O
.,O

Discharge,O
Medications,O
:,O

1.,O
Niacin,B-TR
500,O
mg,O
Capsule,O
",",O
Sustained,O
Release,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
",",O
Sustained,O
Release,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

2.,O
Pantoprazole,B-TR
40,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
Q12H,O
(,O
every,O
12,O
hours,O
),O
:,O

Twice,O
a,O
day,O
for,O
one,O
month,O
",",O
followed,O
by,O
one,O
tablet,O
per,O
day,O
.,O

Disp,O
:*,O
60,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
)(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

Discharge,O
Disposition,O
:,O

Home,O

Discharge,O
Diagnosis,O
:,O

GI,B-PR
Bleeding,I-PR

Peptic,B-PR
Ulcer,I-PR
disease,I-PR

Gastritis,B-PR

Hypertension,B-PR

Hypercholestrolemia,B-PR

Discharge,O
Condition,O
:,O

Good,O

Discharge,O
Instructions,O
:,O

Please,O
continue,O
to,O
take,O
all,B-TR
your,I-TR
medicaitons,I-TR
and,O
follow,O
up,O
with,O
your,O
appointments,O
as,O
below,O
.,O

You,O
should,O
avoid,O
aspirin,B-TR
",",O
motrin,B-TR
or,O
any,B-TR
other,I-TR
nonsteroidal,I-TR
antiinflammatory,I-TR
agents,I-TR
.,O

You,O
should,O
restart,O
your,B-TR
BP,I-TR
medications,I-TR
after,O
you,O
see,O
your,O
PCP,O
.,O

If,O
you,O
have,O
any,B-PR
further,I-PR
black,I-PR
stools,I-PR
",",O
bleeding,B-PR
",",O
lightheadedness,B-PR
or,O
any,B-PR
other,I-PR
concerning,I-PR
symptoms,I-PR
please,O
contact,O
your,O
PCP,O
or,O
return,O
to,O
the,O
emergency,O
room,O
.,O

Followup,O
Instructions,O
:,O

Please,O
call,O
your,O
PCP,O
X.,O
Neuse,O
at,O
(,O
536,O
),O
671-1515,O
to,O
set,O
up,O
an,O
appointment,O
by,O
Friday,O
this,O
week,O
.,O

Richard,O
Campbell,O
MD,O
99-028,O

Completed,O
by,O
:,O

James,O
Monique,O
MD,O
11-259,O
2020-01-21,O
@,O
1445,O

Signed,O
electronically,O
by,O
:,O
DR.,O
William,O
Dunbar,O
on,O
:,O
FRI,O
2020-09-25,O
1:30,O
PM,O

(,O
End,O
of,O
Report,O
),O

339460011,O

PUOMC,O

5569091,O

946797,O

6020656,O

4/14/2004,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O

AKOTE,O
",",O
RALPRI,O

MRN,O
:,O

5569091,O

Age,O
:,O

77y,O

REGISTRATION,O
DATE,O
:,O

04/14/2004,O
02:47,O
PM,O

PRELIMINARY,O
REPORT,O

This,O
is,O
to,O
notify,O
you,O
that,O
your,O
patient,O
",",O
AKOTE,O
",",O
RALPRI,O
arrived,O
in,O
the,O
Emergency,O
Department,O
at,O
Ph,O
University,O
Of,O
Medical,O
Center,O
on,O
04/14/2004,O
02:47,O
PM,O
.,O

The,O
patient,O
presented,O
with,O
a,O
chief,O
complaint,O
of,O
SOB,B-PR
",",O
FEVER,B-PR
.,O

Following,O
evaluation,B-TE
and,O
treatment,B-TR
",",O
the,O
patient,O
&apos;s,O
disposition,O
at,O
the,O
end,O
of,O
the,O
visit,O
was,O
ADMITTED,O
AS,O
AN,O
INPATIENT,O
TO,O
PH,O
UNIVERSITY,O
OF,O
MEDICAL,O
CENTER,O
.,O

The,O
patient,O
&apos;s,O
preliminary,O
admitting,O
physician,O
is,O
CHIRD,O
",",O
GRAJORD,O
C,O
and,O
the,O
preliminary,O
diagnosis,O
is,O
PNA,B-PR
.,O

Please,O
note,O
this,O
information,O
may,O
have,O
been,O
updated,O
on,O
the,O
inpatient,O
unit,O
.,O

If,O
you,O
need,O
additional,O
information,O
please,O
call,O
639-873-2993,O
.,O

PCP,O
Name,O
:,O

FTLOYD,O
",",O
LETTE,O
D,O

Provider,O
Number,O
:,O

49622,O

Admission,O
Date,O
:,O

2012-07-17,O

Discharge,O
Date,O
:,O

2012-07-22,O

Date,O
of,O
Birth,O
:,O

1953-12-04,O

Sex,O
:,O

F,O

Service,O
:,O

SURGERY,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,O
Drugs,B-TR

Attending,O
:,O
Steve,O
M.,O
Estes,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

ABDOMENAL,B-PR
PAIN,I-PR
AND,O
NAUSEA,B-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

SMALL,B-TR
BOWEL,I-TR
RESECTION,I-TR

History,O
of,O
Present,O
Illness,O
:,O

58,O
YEAR-OLD,O
FEMALE,O
S/P,O
GASTRIC,B-TR
BYPASS,I-TR
03-01,O
WITHOUT,O
COMPLICATIONS,B-PR
POST-OPERATIVELY,O
",",O
NOW,O
PRESENTS,O
WITH,O
ABOMENAL,B-PR
AND,I-PR
AND,I-PR
ASCOCIATED,I-PR
NAUSEA,I-PR
SINCE,O
THE,O
NIGHT,O
BEFORE,O
ADMISSION,O
.,O

PAIN,B-PR
IS,O
DIFFUSED,O
",",O
06-05,O
OUT,O
OF,O
10,O
IN,O
INTENSITY,O
",",O
AND,O
HAS,O
NOT,O
IMPROVED,O
OVERNIGHT,O
.,O

NO,O
FLATUS,B-PR
X,O
1,O
DAY,O
.,O

Past,O
Medical,O
History,O
:,O

OBESITY,B-PR

HYPERTENSION,B-PR

GERD,B-PR

HYPERLIPIDEMIA,B-PR

APPENDECTOMY,B-TR

OVARIAN,B-PR
CYST,I-PR

Physical,O
Exam,O
:,O

AFEBRILE,B-PR
",",O
PULSE,B-TE
70-80,O
'S,O
",",O
VITAL,B-TE
STABLE,O
AND,O
WITHIN,O
NORMAL,O
LIMITS,O

GENERAL,O
:,O

ALERT,O
",",O
ANICTERUS,B-PR
",",O
OROPHARYNX,O
CLEAR,O

NO,O
LYMPHANOPATHY,B-PR

LUNGS,O
CLEAR,O
TO,O
ASCULTATION,B-TE

HEART,O
REGULAR,O
RATE,O
RHYTHM,O

ABDOMEN,O
SOFT,O
",",O
NON-DISTENDED,B-PR
",",O
DIFFUSE,B-PR
TENDERNESS,I-PR
",",O
NO,O
PERITOMEAL,B-PR

SIGNS,O

EXTREMITIES,O
NO,O
EDEMA,B-PR

Pertinent,O
Results,O
:,O

CT,B-TE
PELVIS,I-TE
(,O
07-17,O
),O
An,B-PR
abnormal,I-PR
loop,I-PR
of,O
slightly,B-PR
dilated,I-PR
small,I-PR
bowel,I-PR
with,O
fecalization,B-PR
and,O
possible,O
bowel,B-PR
wall,I-PR
thickening,I-PR
.,O

A,O
clear,O
transit,O
point,O
is,O
not,O
visualized,O
.,O

This,B-PR
small,I-PR
bowel,I-PR
obstruction,I-PR
is,O
likely,O
secondary,O
to,O
closed,B-PR
loop,I-PR
obstruction,I-PR
.,O

This,O
could,O
be,O
due,O
to,O
internal,B-PR
hernia,I-PR
or,O
could,O
be,O
stricture,B-PR
related,O
.,O

Other,O
differential,O
includes,O
ischemia,B-PR
.,O

Infectious,B-PR
etiology,I-PR
is,O
less,O
likely,O
due,O
to,O
the,O
focal,O
nature,O
of,O
the,O
involvement,O
.,O

Brief,O
Hospital,O
Course,O
:,O

UPON,O
PRESENTATION,O
TO,O
THE,O
HOSPITAL,O
AND,O
INTIAL,B-TE
WORK-UP,I-TE
",",O
THE,O
PATIENT,O
WAS,O
IMMEDIATELY,O
TAKEN,O
TO,O
THE,O
OPERATING,O
ROOM,O
FOR,O
AN,B-TE
EXPLORATORY,I-TE
LAPORATOMY,I-TE
.,O

INTRAOPERATIVELY,O
",",O
THE,O
PATIENT,O
WAS,O
FOUND,O
TO,O
HAVE,O
SMALL,B-PR
BOWEL,I-PR
OBSTRUCTION,I-PR
WITH,O
ISCHEMIC,B-PR
SMALL,I-PR
BOWEL,I-PR
.,O

PORTIONS,O
OF,O
THE,O
SMALL,O
BOWEL,O
WERE,O
RESECTED,O
.,O

SHE,O
TOLERATED,O
THE,B-TR
PROCEDURE,I-TR
AND,O
WAS,O
ADMITTED,O
TO,O
THE,O
INTENSIVE,O
CARE,O
UNIT,O
.,O

SHE,O
DID,O
WELL,O
IN,O
THE,O
ICU,O
AND,O
WAS,O
SUBSEQUENTLY,O
TRANSFERED,O
TO,O
THE,O
FLOOR,O
.,O

SHE,O
HAS,O
BEEN,O
AFEBRILE,B-PR
POST-OPERATIVELY,O
",",O
MAKING,O
GOOD,O
URINE,O
",",O
AMBULATING,O
",",O
EATING,O
A,O
REGULAR,O
DIET,O
WITHOUT,O
ANY,B-PR
COMPLICATIONS,I-PR
.,O

SHE,O
WILL,O
BE,O
DISCHARGED,O
IN,O
GOOD,O
CONDITION,O
.,O

Discharge,O
Medications,O
:,O

1.,O
Oxycodone-Acetaminophen,B-TR
5-325,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
.,O

Disp,O
:*,O
40,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
0,O
*,O

2.,O
Metoprolol,B-TR
Tartrate,I-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
0.5,O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

Discharge,O
Disposition,O
:,O

Home,O

Discharge,O
Diagnosis,O
:,O

SMALL,B-PR
BOWEL,I-PR
OBSTRUCTION,I-PR

ISCHEMIC,B-PR
SMALL,I-PR
BOWEL,I-PR

Discharge,O
Condition,O
:,O

GOOD,O

Discharge,O
Instructions,O
:,O

PLEASE,O
TAKE,O
MEDICATIONS,B-TR
AS,O
PRESCRIBED,O
AND,O
READ,O
WARNING,O
LABELS,O
CAREFULLY,O
.,O

IF,O
SIGNS,O
AND,O
SYMPTOMS,O
OF,O
WOUND,B-PR
INFECTION,I-PR
",",O
SUCH,O
AS,O
SUDDEN,B-PR
FEVER,I-PR
",",O
INCREASED,B-PR
PAIN,I-PR
",",O
NAUSEA,B-PR
/,O
VOMITING,B-PR
",",O
PURULENT,B-PR
DISCHARGE,I-PR
",",O
PLEASE,O
GO,O
TO,O
THE,O
EMERGENCY,O
ROOM,O
OR,O
CALL,O
.,O

MAY,O
SHOWER,O
",",O
NO,O
BATHS,O
.,O

PAD,O
DRY,O
--,O
DO,O
NOT,O
SCRUB,O
WOUND,B-PR
.,O

Followup,O
Instructions,O
:,O

PLEASE,O
CALL,O
DR.,O
Barnett,O
OFFICE,O
(,O
(,O
443,O
),O
316,O
6447,O
FOR,O
A,O
FOLLOW-UP,O
APPOINTMENT,O
IN,O
1-2,O
WEEKS,O
.,O

Ruby,O
John,O
MD,O
54-596,O

Completed,O
by,O
:,O

Thomas,O
Louis,O
MD,O
12-223,O
2012-07-22,O
@,O
1423,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Edgar,O
SCHNEIDER,O
on,O
:,O
SUN,O
2012-07-22,O
2:47,O
PM,O

(,O
End,O
of,O
Report,O
),O

341909688,O
EH,O

48646747,O

6988856,O

2/14/2003,O
12:00:00,O
AM,O

s,O
/,O
p,O
ventral,B-TR
hernia,I-TR
repair,I-TR

DIS,O

Admission,O
Date,O
:,O

02/14/2003,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

02/15/2003,O

******,O
DISCHARGE,O
ORDERS,O
******,O

KAYSKUDZ,O
",",O
NARO,O
307-36-32-7,O
E32,O

Room,O
:,O

80A-171,O

Service,O
:,O

GGI,O

DISCHARGE,O
PATIENT,O
ON,O
:,O

02/15/03,O
AT,O
02:00,O
PM,O

CONTINGENT,O
UPON,O

Not,O
Applicable,O

WILL,O
D,O
/,O
C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D,O
/,O
C,O
SUMMARY,O
:,O

YES,O

Attending,O
:,O

GRENDWIERST,O
",",O
SONLYN,O
R.,O
",",O
M.D.,O

DISPOSITION,O
:,O

Home,O

DISCHARGE,O
MEDICATIONS,O
:,O

COLACE,B-TR
(,I-TR
DOCUSATE,I-TR
SODIUM,I-TR
),I-TR
100,O
MG,O
PO,O
BID,O
PERCOCET,B-TR
1-2,O
TAB,O
PO,O
Q4H,O
PRN,O
pain,B-PR

DIET,O
:,O

No,O
Restrictions,O

ACTIVITY,O
:,O

Avoid,O
any,O
heavy,O
lifting,O

FOLLOW,O
UP,O
APPOINTMENT,O
(,O
S,O
),O
:,O

Dr.,O
Grendwierst,O
1-2,O
weeks,O
",",O
No,O
Known,B-PR
Allergies,I-PR

ADMIT,O
DIAGNOSIS,O
:,O

s,O
/,O
p,O
ventral,B-TR
hernia,I-TR
repair,I-TR

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O

Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O
s,O
/,O
p,O
ventral,B-TR
hernia,I-TR
repair,I-TR

OTHER,O
DIAGNOSIS,O
;,O

Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O
s,O
/,O
p,O
Roux,B-TR
en,I-TR
Y,I-TR
gastric,I-TR
bypass,I-TR
.,O

s,O
/,O
p,O
c-section,B-TR
B12,B-PR
deficiency,I-PR
Anemia,I-PR

GERD,B-TR
OPERATIONS,I-TR
AND,O
PROCEDURES,B-TR
:,O

02/14/03,O
GRENDWIERST,O
",",O
SONLYN,O
R.,O
",",O
M.D.,O
VENTRAL,B-TR
HERNIA,I-TR
REPAIR,I-TR
W,I-TR
/,I-TR
MESH,I-TR

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O

None,O

BRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

This,O
is,O
a,O
39,O
year,O
old,O
female,O
",",O
s,O
/,O
p,O
Roux-en-Y,B-TR
gastric,I-TR
bypass,I-TR
in,O
09/06,O
who,O
is,O
admitted,O
for,O
elective,B-TR
repair,I-TR
of,O
a,B-PR
ventral,I-PR
hernia,I-PR
.,O

The,O
patient,O
went,O
to,O
the,O
operating,O
room,O
on,O
2/14/03,O
for,O
repair,B-TR
of,O
the,B-PR
hernia,I-PR
.,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
hospital,O
overnight,O
for,O
pai,B-TR
n,I-TR
management,I-TR
in,O
the,O
setting,O
of,O
a,B-PR
large,I-PR
incision,I-PR
with,O
large,O
amounts,O
of,O
dissection,B-PR
during,O
the,B-TR
procedure,I-TR
.,O

She,O
did,O
well,O
overnight,O
with,O
minimal,B-PR
pain,I-PR
medication,I-PR
requirements,I-PR
.,O

She,O
voided,O
on,O
the,O
morning,O
of,O
POD,O
#,O
1,O
.,O

She,O
had,O
no,O
complaints,O
of,O
nausea,B-PR
or,O
vomiting,B-PR
and,O
was,O
tolerating,O
PO&apos;s,O
well,O
.,O

ADDITIONAL,O
COMMENTS,O
:,O

No,O
heavy,O
lifting,O
x,O
3,O
weeks,O
.,O

Keep,O
the,B-TR
dressing,I-TR
on,O
and,O
dry,O
for,O
48,O
hours,O
after,O
the,B-TR
surgery,I-TR
.,O

You,O
can,O
shower,O
when,O
you,O
get,O
home,O
.,O

Avoid,O
getting,O
the,B-PR
incision,I-PR
soaking,O
wet,O
.,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O

TO,O
DO,O
/,O
PLAN,O
:,O

You,O
should,O
follow-up,O
with,O
Dr.,O
Grendwierst,O
.,O

Call,O
his,O
office,O
to,O
make,O
an,O
appointment,O
.,O

Take,O
the,B-TR
pain,I-TR
medication,I-TR
as,O
prescribed,O
.,O

You,O
can,O
take,O
regular,O
tylenol,B-TR
or,O
motrin,B-TR
for,O
pain,B-PR
and,O
use,O
the,B-TR
percocet,I-TR
for,O
breakthrough,B-PR
pain,I-PR
.,O

REturn,O
to,O
the,O
ER,O
or,O
call,O
your,O
doctor,O
if,O
you,O
develop,O
fevers,B-PR
",",O
notice,O
pus,B-PR
from,O
the,B-PR
incision,I-PR
",",O
develop,O
surrounding,B-PR
redness,I-PR
",",O
have,O
abdominal,B-PR
pain,I-PR
",",O
have,O
vomiting,B-PR
where,O
you,O
can,O
&apos;t,O
keep,O
anything,O
down,O
or,O
develop,O
any,B-PR
symptoms,I-PR
that,O
concern,O
you,O
.,O

No,O
dictated,O
summary,O

ENTERED,O
BY,O
:,O

MSSHUFFBREUN,O
",",O
RERE,O
N.,O
",",O
M.D.,O
(,O
KX79,O
),O

02/15/03,O
01:29,O
PM,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

Admission,O
Date,O
:,O

2018-12-29,O

Discharge,O
Date,O
:,O

2019-01-04,O

Date,O
of,O
Birth,O
:,O

2018-12-29,O

Sex,O
:,O

M,O

Service,O
:,O

Neonatology,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Baby,O
Davis,O
is,O
the,O
3.160,O
kilogram,O
product,O
of,O
a,O
term,O
pregnancy,O
.,O

He,O
was,O
born,O
to,O
a,O
38,O
-,O
year-old,O
gravida,O
I,O
",",O
para,O
0,O
(,O
now,O
1,O
),O
mother,O
at,O
37,O
and,O
1/7,O
weeks,O
.,O

The,O
pregnancy,O
was,O
benign,O
with,O
an,O
EDC,O
of,O
2019-01-18,O
.,O

Prenatal,B-TE
screens,I-TE
were,O
O,O
positive,O
",",O
antibody,B-TE
negative,O
",",O
hepatitis,B-TE
surface,I-TE
antigen,I-TE
negative,O
",",O
rapid,B-TE
plasma,I-TE
reagent,I-TE
nonreactive,O
",",O
rubella,B-TE
immune,O
",",O
group,B-TE
B,I-TE
strep,I-TE
negative,O
.,O

The,O
infant,O
delivered,O
by,O
spontaneous,O
vaginal,O
delivery,O
with,O
Apgar,B-TE
scores,I-TE
of,O
8,O
at,O
one,O
minute,O
and,O
8,O
at,O
five,O
minutes,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,O
",",O
the,O
Baby,O
Lucas,O
is,O
well,O
appearing,O
",",O
no,O
jaundice,B-PR
.,O

He,O
has,O
bilateral,O
breath,O
sounds,O
that,O
are,O
clear,O
and,O
equal,O
.,O

The,B-TE
heart,I-TE
rate,I-TE
is,O
regular,O
without,O
murmur,B-PR
.,O

Pulses,B-TE
are,O
2+,O
and,O
symmetrical,O
.,O

The,O
abdomen,O
is,O
soft,O
and,O
nontender,B-PR
with,O
no,O
hepatosplenomegaly,B-PR
.,O

His,B-TE
weight,I-TE
is,O
3.160,O
kilograms,O
(,O
7,O
pounds,O
3,O
ounces,O
),O
at,O
birth,O
.,O

He,O
is,O
circumcised,O
with,O
testes,O
descended,O
bilaterally,O
.,O

His,O
hips,O
are,O
stable,O
.,O

His,O
tone,O
is,O
normal,O
.,O

Normal,O
neonatal,O
reflexes,O
.,O

He,O
is,O
tolerating,O
his,O
feedings,O
well,O
.,O

HOSPITAL,O
COURSE,O
:,O

1.,O
Respiratory,O
.,O

Without,O
issues,O
on,O
this,O
admission,O
.,O

Breath,O
sounds,O
are,O
clear,O
and,O
equal,O
.,O

2.,O
Cardiovascular,O
.,O

Without,O
issues,O
on,O
this,O
admission,O
.,O

He,O
had,O
a,O
regular,O
heart,O
rate,O
and,O
rhythm,O
",",O
no,O
murmur,B-PR
",",O
pulses,B-TE
were,O
2+,O
and,O
symmetric,O
.,O

3.,O
Fluids,O
",",O
electrolytes,O
and,O
nutrition,O
.,O

The,B-TE
baby,I-TE
's,I-TE
weight,I-TE
was,O
3.160,O
kilograms,O
(,O
7,O
pounds,O
3,O
ounces,O
).,O

He,O
is,O
breast,O
and,O
bottle,O
feeding,O
every,O
3,O
hours,O
with,O
expressed,O
breast,O
milk,O
and,O
/,O
or,O
Enfamil,B-TR
.,O

He,O
is,O
feeding,O
well,O
.,O

His,B-TE
discharge,I-TE
weight,I-TE
is,O
3025,O
gm,O
",",O
and,O
has,O
been,O
stable,O
for,O
past,O
2,O
days,O
.,O

4.,O
Gastrointestinal,O
.,O

The,B-TE
baby,I-TE
's,I-TE
bilirubin,I-TE
on,O
2018-12-31,O
",",O
was,O
15.5,O
/,O
0.5,O
at,O
which,O
time,O
double,B-TR
phototherapy,I-TR
was,O
started,O
.,O

On,O
01-01,O
",",O
his,B-TE
bilirubin,I-TE
was,O
17.3,O
/,O
0.4,O
at,O
which,O
time,O
triple,B-TR
phototherapy,I-TR
was,O
started,O
and,O
then,O
his,B-TE
subsequent,I-TE
bilirubins,I-TE
are,O
16.5,O
/,O
0.4,O
on,O
2019-01-01,O
",",O
and,O
16.2,O
/,O
0.5,O
on,O
2019-01-02,O
.,O

Phototherapy,B-TR
was,O
discontinued,O
on,O
2019-01-04,O
for,O
a,B-TE
bilirubin,I-TE
of,O
12.1,O
",",O
and,O
a,B-TE
rebound,I-TE
bilirubin,I-TE
will,O
be,O
checked,O
on,O
01-05,O
.,O

5.,O
Hematology,O
.,O

The,B-TE
hematocrit,I-TE
on,O
01-02,O
",",O
was,O
61,O
with,O
a,B-TE
reticulocyte,I-TE
of,O
2.6%,O
.,O

His,B-TE
blood,I-TE
type,I-TE
is,O
A+,O
",",O
Coombs,B-TE
negative,O
.,O

6.,O
Infectious,O
disease,O
.,O

No,O
issues,O
on,O
this,O
admission,O
.,O

7.,O
Neurological,O
.,O

The,O
baby,O
has,O
been,O
appropriate,O
for,O
gestational,O
age,O
with,O
normal,O
newborn,O
reflexes,O
.,O

8.,O
Sensory,O
.,O

Auditory,B-TE
hearing,I-TE
screening,I-TE
was,O
performed,O
with,O
automated,O
brainstem,O
responses,O
.,O

The,O
infant,O
passed,O
both,O
ears,O
on,O
2018-12-30,O
.,O

9.,O
Psychosocial,O
.,O

The,O
family,O
is,O
invested,O
and,O
involved,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
.,O

DISCHARGE,O
DISPOSITION,O
:,O

Home,O
.,O

PRIMARY,O
PEDIATRIC,O
CARE,O
:,O

Source,O
of,O
primary,O
pediatric,O
care,O
is,O
David,O
Bull,O
at,O
1899,O
S.,O
Fifth,O
Rd.,O
",",O
Salem,O
",",O
Florida,O
92564,O
.,O

Phone,O
is,O
(,O
(,O
256,O
),O
348-3764,O
.,O

CARE,O
RECOMMENDATIONS,O
:,O

1.,O
Continue,O
breast,O
feeding,O
with,O
post-feed,B-TR
supplemental,I-TR
EBM,I-TR
.,O

2.,O
Follow-up,B-TE
bilirubin,I-TE
in,O
1,O
day,O
;,O
f/u,O
with,O
PMD,O
in,O
1-3,O
days,O
.,O

3.,O
Medications,O
:,O

Not,O
applicable,O
.,O

4.,O
Car,B-TE
seat,I-TE
position,I-TE
and,I-TE
screening,I-TE
:,O
Not,O
applicable,O
.,O

5.,O
State,B-TE
newborn,I-TE
screens,I-TE
were,O
sent,O
on,O
2018-12-31,O
",",O
and,O
the,O
results,O
are,O
pending,O
.,O

6.,O
Immunizations,B-TR
received,O
:,O
Hepatitis,B-TR
B,I-TR
vaccine,I-TR
on,O
12-31,O
",",O
2006,O
.,O

7.,O
Immunization,B-TR
recommended,O
:,O

Influenza,B-TR
immunization,I-TR
is,O
recommended,O
annually,O
in,O
the,O
fall,O
for,O
all,O
infants,O
once,O
they,O
reach,O
6,O
months,O
of,O
age,O
.,O

Before,O
this,O
age,O
(,O
and,O
for,O
the,O
first,O
24,O
months,O
of,O
the,O
child,O
's,O
life,O
),O
",",O
immunization,B-TR
against,O
influenza,B-PR
is,O
recommended,O
for,O
all,O
household,O
contacts,O
and,O
out,O
of,O
home,O
caregivers,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Term,O
(,O
37,O
and,O
1/7,O
weeks,O
),O
appropriate,O
for,O
gestational,O
age,O
male,O
neonate,O
.,O

2.,O
Exaggerated,B-PR
physiologic,I-PR
hyperbilirubinemia,I-PR
responsive,O
to,O
phototherapy,B-TR
.,O

Nicole,O
Monica,O
",",O
MD,O
48-041,O

Dictated,O
By,O
:,O
Michelle,O
A,O
Sweeney,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2019-01-02,O
12:16:10,O

T,O
:,O
2019-01-02,O
13:00:35,O

Job,O
#,O
:,O
38170,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Victoria,O
Cox,O
on,O
:,O
FRI,O
2019-01-04,O
11:25,O
AM,O

(,O
End,O
of,O
Report,O
),O

348983165,O

FIH,O

4912803,O

97509/32z1,O

28205,O

4/14/1994,O
12:00:00,O
AM,O

SELF,B-PR
INFLICTED,I-PR
GUNSHOT,I-PR
WOUND,I-PR
TO,I-PR
THE,I-PR
HEAD,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

4/14/94,O

DISCHARGE,O
DATE,O
:,O

4/20/94,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Self,B-PR
inflicted,I-PR
gunshot,I-PR
wound,I-PR
to,I-PR
the,I-PR
head,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

hypertension,B-PR
",",O
poor,B-PR
dentition,I-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

Suture,B-TR
of,O
right,B-PR
temporal,I-PR
head,I-PR
wound,I-PR
",",O
performed,O
on,O
April,O
14,O
",",O
1994,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Mr.,O
Le,O
is,O
a,O
seventy,O
three,O
year,O
old,O
male,O
who,O
presents,O
to,O
the,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
",",O
following,O
a,B-PR
self,I-PR
inflicted,I-PR
gunshot,I-PR
wound,I-PR
to,I-PR
the,I-PR
head,I-PR
.,O

Mr.,O
Le,O
was,O
found,O
in,O
bed,O
with,O
a,O
32,O
caliber,O
revolver,O
at,O
his,O
side,O
.,O

The,O
patient,O
was,O
apparently,O
alone,O
at,O
home,O
",",O
his,O
neighbors,O
heard,O
a,O
single,O
shot,O
",",O
and,O
the,O
paramedics,O
were,O
called,O
.,O

Upon,O
arrival,O
",",O
they,O
found,O
the,O
patient,O
in,O
bed,O
",",O
with,O
notes,O
nearby,O
",",O
listing,O
his,O
funeral,O
home,O
preferences,O
and,O
information,O
on,O
his,O
next,O
of,O
kin,O
.,O

The,O
patient,O
indicates,O
that,O
his,O
neighbors,O
were,O
making,O
excessive,O
noise,O
upstairs,O
from,O
his,O
dwelling,O
",",O
and,O
he,O
found,O
it,O
unbearable,O
.,O

He,O
therefore,O
decided,O
to,O
take,O
his,O
life,O
with,O
a,O
gun,O
which,O
he,O
had,O
found,O
in,O
the,O
house,O
.,O

Apparently,O
",",O
the,O
gun,O
belonged,O
to,O
his,O
father,O
.,O

On,O
further,O
questioning,O
",",O
the,O
patient,O
described,O
that,O
his,O
father,O
passed,O
away,O
approximately,O
forty,O
to,O
fifty,O
years,O
prior,O
to,O
his,O
admission,O
",",O
and,O
the,O
gun,O
was,O
found,O
in,O
a,O
box,O
in,O
their,O
home,O
.,O

The,O
patient,O
expressed,O
concern,O
that,O
he,O
had,O
several,O
utility,O
bills,O
that,O
he,O
was,O
unable,O
to,O
pay,O
.,O

The,O
patient,O
&apos;s,O
sister,O
died,O
eight,O
years,O
prior,O
to,O
the,O
patient,O
&apos;s,O
admission,O
of,O
leukemia,B-PR
",",O
and,O
he,O
otherwise,O
has,O
no,O
next,O
of,O
kin,O
with,O
the,O
exception,O
of,O
one,O
brother,O
in,O
Washington,O
",",O
with,O
whom,O
his,O
relationship,O
is,O
tenuous,O
.,O

On,O
initial,O
questioning,O
",",O
however,O
",",O
the,O
patient,O
denies,O
any,O
recent,O
losses,O
.,O

On,O
admission,O
",",O
the,O
patient,O
denies,O
any,B-PR
suicidal,I-PR
or,I-PR
homicidal,I-PR
ideation,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
hypertension,B-PR
",",O

2.,O
poor,B-PR
dentition,I-PR
.,O

ADVERSE,O
DRUG,O
REACTIONS,O
:,O

no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

NOne,O
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
is,O
retired,O
employee,O
of,O
the,O
City,O
of,O
Avi,O
Den,O
",",O
Hawaii,O
",",O
lives,O
on,O
a,O
pension,O
and,O
Social,O
Security,O
.,O

The,O
patient,O
has,O
never,O
been,O
married,O
and,O
has,O
no,O
children,O
.,O

He,O
has,O
a,O
sixty,O
to,O
seventy,O
five,O
pack,O
year,O
smoking,O
history,O
and,O
drinks,O
alcohol,O
approximately,O
one,O
time,O
per,O
week,O
.,O

He,O
denies,O
any,O
ilicit,O
drug,O
use,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,O
patient,O
is,O
an,O
obese,O
male,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

The,B-TE
vital,I-TE
signs,I-TE
temperature,B-TE
98.0,O
",",O
heart,B-TE
rate,I-TE
78,O
",",O
blood,B-TE
pressure,I-TE
186/69,O
",",O
respirations,B-TE
18,O
.,O

The,B-TE
head,I-TE
",",I-TE
eyes,I-TE
",",I-TE
ears,I-TE
",",I-TE
nose,I-TE
",",I-TE
throat,I-TE
examination,I-TE
revealed,O
an,B-PR
entry,I-PR
wound,I-PR
approximately,O
1,O
1/2,O
inches,O
above,O
the,O
right,O
ear,O
",",O
which,O
is,O
approximately,O
1,O
cm.,O
in,O
length,O
and,O
surrounded,O
by,O
powder,B-PR
burn,I-PR
.,O

There,O
is,O
a,B-PR
lump,I-PR
in,I-PR
the,I-PR
right,I-PR
parietal,I-PR
region,I-PR
",",O
which,O
corresponds,O
with,O
the,O
bullet,O
seen,O
on,O
the,B-TE
computerized,I-TE
tomography,I-TE
scan,I-TE
.,O

There,O
is,O
no,O
bruising,B-PR
about,I-PR
the,I-PR
eyes,I-PR
or,I-PR
mastoid,I-PR
sinuses,I-PR
",",O
and,O
there,O
is,O
no,O
fluid,B-PR
from,I-PR
the,I-PR
nose,I-PR
or,I-PR
ears,I-PR
.,O

The,O
neck,O
was,O
supple,O
",",O
and,O
without,O
adenopathy,B-PR
.,O

The,O
lungs,O
are,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

The,B-TE
heart,I-TE
sounds,I-TE
are,O
regular,O
rate,O
and,O
rhythm,O
and,O
no,O
murmur,B-PR
",",O
rub,B-PR
or,O
gallop,B-PR
are,O
appreciated,O
.,O

The,O
abdomen,O
is,O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
",",O
without,O
hepatosplenomegaly,B-PR
.,O

There,O
are,O
no,O
masses,B-PR
and,O
the,B-TE
bowel,I-TE
sounds,I-TE
are,O
present,O
.,O

The,O
extremities,O
are,O
well,O
perfused,O
and,O
there,O
is,O
no,O
clubbing,B-PR
",",O
cyanosis,B-PR
or,O
edema,B-PR
.,O

Neurological,O
:,O

examination,B-TE
revealed,O
a,O
patient,O
who,O
was,O
alert,O
and,O
oriented,O
X,O
3,O
",",O
with,O
short,O
term,O
recall,O
of,O
2/3,O
objects,O
at,O
five,O
minutes,O
and,O
fluent,O
speech,O
.,O

The,O
patient,O
remembers,O
the,O
presidents,O
as,O
Carter-Bush-Regan-Truman-Roosevelt,O
.,O

The,O
patient,O
was,O
able,O
to,O
spell,O
world,O
backwards,O
on,O
the,O
third,O
attempt,O
.,O

He,O
performed,O
serial,O
7,O
&apos;s,O
accurately,O
.,O

He,O
demonstrated,O
poor,B-PR
ability,I-PR
for,I-PR
abstract,I-PR
thinking,I-PR
.,O

Cranial,O
nerves,O
II-XII,O
were,O
grossly,O
intact,O
.,O

The,O
pupils,O
equal,O
",",O
round,O
",",O
reactive,O
to,O
light,O
and,O
accommodation,O
",",O
and,O
the,B-TE
extra,I-TE
ocular,I-TE
movements,I-TE
are,O
intact,O
.,O

The,O
fundi,O
are,O
benign,O
and,O
the,O
discs,O
are,O
sharp,O
.,O

The,O
patient,O
&apos;s,O
strength,O
is,O
5/5,O
throughout,O
and,O
the,O
sensorium,O
is,O
intact,O
.,O

The,B-TE
deep,I-TE
tendon,I-TE
reflexes,I-TE
are,O
2+,O
and,O
symmetrical,O
throughout,O
.,O

LABORATORY,O
DATA,O
:,O

A,B-TE
panel,I-TE
of,I-TE
serum,I-TE
electrolytes,I-TE
is,O
normal,O
.,O

The,B-TE
white,I-TE
blood,I-TE
count,I-TE
is,O
9.4,O
",",O
hematocrit,B-TE
47.1,O
",",O
and,O
the,B-TE
platelets,I-TE
"253,000",O
.,O

Blood,B-TE
coagulation,I-TE
times,I-TE
are,O
normal,O
.,O

Serum,B-TE
toxic,I-TE
screen,I-TE
is,O
negative,O
.,O

Leukocyte,B-TE
differential,I-TE
count,I-TE
reveals,O
64,B-TE
neutrophils,I-TE
",",O
24%,B-TE
lymphocytes,I-TE
",",O
8%,B-TE
monocytes,I-TE
",",O
2%,B-TE
eosinophils,I-TE
",",O
and,O
2%,B-TE
basophils,I-TE
.,O

A,B-TE
panel,I-TE
of,I-TE
serum,I-TE
enzymes,I-TE
suggest,O
normal,O
hepatic,O
function,O
.,O

A,B-TE
computerized,I-TE
tomography,I-TE
scan,I-TE
of,I-TE
the,I-TE
head,I-TE
reveals,O
a,B-PR
small,I-PR
external,I-PR
skull,I-PR
fracture,I-PR
",",O
approximately,O
1-2,O
millemeters,O
in,O
size,O
",",O
near,O
the,O
right,O
frontoparietal,O
apex,O
.,O

A,B-PR
right,I-PR
parietal,I-PR
contusion,I-PR
is,O
also,O
identified,O
",",O
with,O
blood,O
tracking,O
into,O
the,O
middle,O
focus,O
.,O

Standard,B-TE
12,I-TE
lead,I-TE
electrocardiogram,I-TE
revealed,O
normal,O
sinus,O
rhythm,O
at,O
a,B-TE
rate,I-TE
of,O
85,O
",",O
with,O
poor,B-PR
R,I-PR
wave,I-PR
progression,I-PR
in,O
leads,O
V1,O
through,O
V3,O
suggesting,O
the,O
possibility,O
of,O
an,B-PR
old,I-PR
anteroseptal,I-PR
myocardial,I-PR
infarction,I-PR
.,O

Nonspecific,B-PR
ST,I-PR
segment,I-PR
and,I-PR
T,I-PR
wave,I-PR
abnormalities,I-PR
are,O
present,O
as,O
well,O
.,O

Otherwise,O
",",O
the,O
axis,O
is,O
normal,O
and,O
the,O
intervals,O
are,O
normal,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
",",O
on,O
the,O
Neurological,O
Surgery,O
Service,O
of,O
Lupevickette,O
L.,O
Ca,O
",",O
M.D.,O

Prior,O
to,O
his,O
admission,O
",",O
the,B-PR
patient,I-PR
&apos;s,I-PR
gunshot,I-PR
wound,I-PR
was,O
sutured,O
close,O
in,O
the,O
emergency,O
room,O
.,O

The,O
patient,O
was,O
placed,O
on,O
suicide,B-TR
precautions,I-TR
",",O
and,O
was,O
hydrated,O
with,O
an,B-TR
infusion,I-TR
of,I-TR
intravenous,I-TR
fluid,I-TR
.,O

The,O
patient,O
was,O
seen,O
in,O
consultation,O
by,O
the,O
Psychiatry,O
Service,O
",",O
who,O
began,O
a,O
battery,O
of,O
testing,B-TE
",",O
which,O
continues,O
at,O
the,O
time,O
of,O
discharge,O
.,O

The,O
Consulting,O
Psychiatrist,O
recommended,O
a,O
minimum,O
of,O
2,B-TR
point,I-TR
restraints,I-TR
at,O
all,O
times,O
",",O
and,O
recommended,O
the,O
patient,O
be,O
monitored,O
by,O
a,O
sitter,O
.,O

Allowing,O
the,O
patient,O
to,O
ambulate,O
was,O
not,O
recommended,O
.,O

From,O
a,O
medical,O
standpoint,O
",",O
the,O
patient,O
did,O
well,O
.,O

He,O
was,O
initially,O
admitted,O
to,O
the,O
Neurological,O
Intensive,O
Care,O
Unit,O
where,O
he,O
was,O
closely,O
monitored,O
during,O
the,O
first,O
two,O
days,O
of,O
his,O
hospitalization,O
.,O

The,O
chief,O
obstacle,O
was,O
bringing,O
his,B-TE
blood,I-TE
pressure,I-TE
under,O
control,O
and,O
this,O
was,O
ultimately,O
achieved,O
with,O
a,O
combination,O
of,O
Captopril,B-TR
and,O
Nifedipine,B-TR
.,O

After,O
his,B-TE
blood,I-TE
pressure,I-TE
had,O
stabilized,O
",",O
the,O
patient,O
was,O
transferred,O
to,O
the,O
Neurology,O
Ward,O
.,O

Close,B-TE
monitoring,I-TE
demonstrated,O
his,B-TE
blood,I-TE
pressure,I-TE
to,O
be,O
stable,O
and,O
within,O
an,O
acceptable,O
rang,O
on,O
his,B-TR
dosage,I-TR
regimen,I-TR
.,O

The,O
Psychiatry,O
Service,O
followed,O
up,O
extensively,O
with,O
the,O
patient,O
",",O
and,O
his,O
Psychiatric,O
progress,O
is,O
detailed,O
in,O
the,O
Psychiatry,O
transfer,O
note,O
.,O

By,O
the,O
7th,O
hospital,O
day,O
",",O
the,O
patient,O
was,O
medically,O
stable,O
.,O

He,O
had,O
undergone,O
full,B-TE
Psychiatric,I-TE
evaluation,I-TE
",",O
and,O
was,O
prepared,O
for,O
transfer,O
to,O
a,O
Psychiatric,O
Hospital,O
.,O

Therefore,O
",",O
because,O
of,O
his,O
need,O
for,O
intense,B-TR
psychiatric,I-TR
care,I-TR
",",O
the,O
patient,O
is,O
discharged,O
to,O
the,O
Vo,O
Black,O
Doylestrictshore,O
Ft.,O
Clinics,O
Medical,O
Center,O
on,O
the,O
7th,O
hospital,O
day,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Improved,O
.,O

DOCTORS,O
DISCHARGE,O
ORDERS,O
:,O

Discharged,O
to,O
Sonpathcermu,O
Jords,O
Hospital,O
.,O

2.,O
diet,O
as,O
tolerated,O
.,O

3.,O
Activity,O
ad,O
lib,O
",",O
with,O
restrictions,O
as,O
indicated,O
by,O
the,O
Psychiatry,O
Transfer,O
Note,O
.,O

4.,O
Followup,O
with,O
Dr.,O
Rourdrick,O
in,O
four,O
weeks,O
time,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Dilantin,B-TR
100,O
mg.,O
po,O
tid,O
",",O
Mylanta,B-TR
30,O
cc.,O
po,O
q,O
4,O
hours,O
prn,O
",",O
Dyspepsia,B-PR
",",O
Milk,B-TR
of,I-TR
Magnesia,I-TR
30,O
cc.,O
po,O
q,O
4,O
hours,O
prn,O
constipation,B-PR
",",O
Cimetidine,B-TR
400,O
mg.,O
po,O
bid,O
",",O
Haloperidol,B-TR
1,O
mg.,O
po,O
or,O
IM,O
q,O
3,O
hours,O
prn,O
agitation,B-PR
.,O

Colace,B-TR
100,O
mg.,O
po,O
bid,O
",",O
Captopril,B-TR
50,O
mg.,O
po,O
tid,O
",",O
Nifedipine,B-TR
20,O
mg.,O
po,O
q,O
6,O
hours,O
and,O
Nifedipine,B-TR
20,O
mg.,O
po,O
or,O
sublingual,O
q,O
3,O
hours,O
prn,O
systolic,B-PR
blood,I-PR
pressure,I-PR
greater,I-PR
than,I-PR
160,I-PR
millemeters,I-PR
of,I-PR
Mercury,I-PR
.,O

LUPEVICKETTE,O
CA,O
",",O
M.D.,O

TR,O
:,O

yz,O
/,O
bmot,O

DD,O
:,O

4/19/94,O

TD,O
:,O

04/19/94,O

CC,O
:,O

stat,O

Admission,O
Date,O
:,O

2017-05-14,O

Discharge,O
Date,O
:,O

2017-06-26,O

Date,O
of,O
Birth,O
:,O

2017-05-14,O

Sex,O
:,O

F,O

Service,O
:,O

CMED,O
CCU,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Jadiara,O
Harrison,O
is,O
twin,O
#1,O
born,O
to,O
a,O
17,O
year-old,O
primiparous,O
mother,O
at,O
31,O
weeks,O
gestation,O
.,O

Mother,O
was,O
admitted,O
to,O
the,O
Nantucket,O
Cottage,O
Hospital,O
from,O
Lawrence,O
General,O
Hospital,O
Hospital,O
on,O
05-01,O
with,O
cervical,O
effacement,O
and,O
preterm,B-PR
labor,I-PR
.,O

She,O
was,O
treated,O
with,O
magnesium,B-TR
sulfate,I-TR
.,O

She,O
had,O
previously,O
been,O
admitted,O
here,O
at,O
the,O
24th,O
week,O
after,O
a,O
motor,O
vehicle,O
accident.,O
She,O
was,O
treated,O
with,O
tocolysis,B-TR
and,O
betamethasone,B-TR
at,O
that,O
time,O
.,O

Due,O
to,O
progressing,O
labor,O
and,O
presentation,O
of,O
twins,O
",",O
delivery,O
was,O
by,O
Cesarean,B-TR
section,I-TR
.,O

Prenatal,B-TE
screens,I-TE
were,O
notable,O
for,O
blood,B-TE
type,I-TE
0,O
positive,O
",",O
antibody,B-TE
negative,O
",",O
hepatitis,B-TE
B,I-TE
surface,I-TE
antigen,I-TE
negative,O
",",O
RPR,B-TE
nonreactive,O
.,O

Rubella,B-TE
status,I-TE
was,O
not,O
documented,O
.,O

Group,B-TE
B,I-TE
strep,I-TE
status,I-TE
was,O
unknown,O
.,O

Infant,O
emerged,O
from,O
the,B-PR
breech,I-PR
position,I-PR
.,O

She,O
was,O
vigorous,O
.,O

She,O
was,O
given,O
blow-by,B-TR
oxygen,I-TR
and,O
stimulation,B-TR
.,O

Her,B-TE
Apgars,I-TE
were,O
7,O
at,O
1,O
minute,O
and,O
9,O
at,O
5,O
minutes,O
.,O

She,O
was,O
brought,O
to,O
the,O
CMED,O
CSRU,O
for,O
further,B-TE
evaluation,I-TE
.,O

PHYSICAL,O
EXAMINATION,O
:,O

ON,O
admission,O
",",O
physical,B-TE
examination,I-TE
reveals,O
a,B-PR
non,I-PR
dysmorphic,I-PR
infant,I-PR
",",O
well,O
saturated,O
and,O
perfused,O
with,O
multiple,B-PR
bruises,I-PR
noted,O
over,O
the,O
upper,O
legs,O
",",O
left,O
arm,O
and,O
chest,O
.,O

No,O
bony,B-PR
abnormalities,I-PR
or,O
petechiae,B-PR
noted,O
.,O

She,O
was,O
moving,O
all,O
joints,O
and,O
extremities,O
well,O
.,O

HEENT,O
:,O

Within,O
normal,O
limits,O
.,O

CV,O
:,O

Normal,O
S1,O
and,O
S2,O
without,O
a,B-PR
murmur,I-PR
.,O

Lungs,O
were,O
clear,O
.,O

Abdomen,O
was,O
benign,O
.,O

Genitalia,O
normal,O
.,O

Premature,O
female,O
.,O

Neuro,O
:,O

Non,O
focal,O
and,O
age,O
appropriate,O
.,O

Hips,O
normal,O
",",O
held,O
in,O
the,O
breech,O
position,O
.,O

Anus,O
patent,O
.,O

Spine,O
intact,O
.,O

HOSPITAL,O
COURSE,O
:,O

Respiratory,O
:,O

On,O
admission,O
",",O
infant,O
did,O
not,O
require,O
supplemental,B-TR
oxygen,I-TR
or,O
respiratory,B-TR
support,I-TR
.,O

Since,O
that,O
time,O
",",O
Jadiara,O
has,O
always,O
been,O
in,O
room,O
air,O
without,O
requiring,O
supplemental,B-TR
oxygen,I-TR
.,O

She,O
was,O
noted,O
to,O
have,O
apnea,B-PR
of,I-PR
prematurity,I-PR
",",O
treated,O
with,O
caffeine,B-TR
until,O
2017-06-04,O
.,O

Since,O
that,O
time,O
",",O
she,O
has,O
had,O
very,B-PR
rare,I-PR
spells,I-PR
",",O
with,O
none,O
for,O
over,O
one,O
week,O
by,O
the,O
time,O
of,O
discharge,O
.,O

Cardiovascular,O
:,O

She,O
was,O
hemodynamically,O
stable,O
upon,O
admission,O
with,O
normal,O
blood,O
pressures,O
and,O
heart,O
rate,O
.,O

On,O
day,O
of,O
life,O
15,O
",",O
she,O
was,O
noted,O
to,O
have,O
a,B-PR
murmur,I-PR
",",O
eventually,O
prompting,O
evaluation,B-TE
by,I-TE
ECHO,I-TE
.,O

The,B-TE
ECHO,I-TE
revealed,O
an,B-PR
anomalous,I-PR
left,I-PR
coronary,I-PR
",",O
with,O
one,O
end,O
entering,O
the,O
right,O
ventricular,O
outflow,O
tract,O
and,O
the,O
other,O
end,O
not,O
clearly,O
defined,O
.,O

It,O
was,O
unable,O
to,O
be,O
delineated,O
whether,O
this,O
represented,O
an,B-PR
anomalous,I-PR
left,I-PR
coronary,I-PR
artery,I-PR
arising,I-PR
from,I-PR
the,I-PR
pulmonary,I-PR
artery,I-PR
(,I-PR
LCAPA,I-PR
),I-PR
or,O
a,B-PR
left,I-PR
coronary,I-PR
artery,I-PR
fistula,I-PR
to,I-PR
the,I-PR
pulmonar,I-PR
artery,I-PR
.,O

The,O
right,O
coronary,O
was,O
prominent,O
",",O
and,O
there,O
appeared,O
to,O
be,O
coronary,B-PR
artery,I-PR
collateral,I-PR
vessels,I-PR
in,I-PR
the,I-PR
posterior,I-PR
apical,I-PR
myocardium,I-PR
.,O

A,B-PR
small,I-PR
apical,I-PR
muscular,I-PR
VSD,I-PR
was,O
also,O
noted,O
.,O

Several,B-TE
additional,I-TE
ECHOs,I-TE
were,O
performed,O
",",O
including,O
an,B-TE
ECHO,I-TE
in,O
the,O
cardiology,O
department,O
at,O
HealthSouth,O
Rehab,O
Hospital,O
of,O
Western,O
Mass.,O
",",O
but,O
the,O
anatomy,O
of,O
the,O
left,O
coronary,O
artery,O
could,O
not,O
be,O
further,O
defined,O
.,O

Due,O
to,O
the,O
risks,O
of,O
coronary,B-PR
ischemia,I-PR
if,O
this,O
represented,O
an,B-PR
LCAPA,I-PR
",",O
the,O
infant,O
was,O
followed,O
with,O
regular,B-TE
ECHOs,I-TE
and,O
EKGs,B-TE
during,O
the,O
remainder,O
of,O
hospitalization,O
",",O
with,O
no,O
evidence,O
of,O
ischemia,B-PR
",",O
valvular,B-PR
regurgitation,I-PR
",",O
or,O
compromised,B-PR
ventricular,I-PR
function,I-PR
.,O

She,O
will,O
be,O
continued,O
to,O
be,O
followed,O
closely,O
by,O
cardiology,O
as,O
an,O
outpatient,O
",",O
with,O
likely,O
plans,O
for,O
cardiac,B-TE
catheterization,I-TE
and,O
surgical,B-TR
repair,I-TR
when,O
she,O
grows,O
to,O
3.5,O
to,O
4,O
kg,O
.,O

Fluids,O
",",O
electrolytes,O
and,O
nutrition,O
:,O

The,O
infant,O
was,O
initially,O
maintained,O
on,O
IVF,B-TR
",",O
with,O
introduction,O
of,O
enteral,B-TR
feeds,I-TR
on,O
day,O
of,O
life,O
2,O
.,O

She,O
was,O
advanced,O
to,O
full,B-TR
volume,I-TR
enteral,I-TR
feeds,I-TR
by,O
day,O
of,O
life,O
7,O
",",O
and,O
then,O
to,O
a,B-TR
maximum,I-TR
caloric,I-TR
density,I-TR
of,O
28,O
cals,O
/,O
oz,O
.,O

Oral,O
feedings,O
were,O
introduced,O
as,O
tolerated,O
.,O

By,O
the,O
time,O
of,O
discharge,O
",",O
infant,O
is,O
feedign,O
BM,O
or,O
enfamil,B-TR
24,O
cals,O
/,O
oz,O
PO,O
ad,O
lib,O
",",O
with,O
adequate,O
intake,O
and,O
adequate,O
weight,O
gain,O
.,O

Last,B-TE
nutrition,I-TE
labs,I-TE
were,O
on,O
06-20,O
with,O
AP,B-TE
of,O
208,O
",",O
Ca,B-TE
10.8,O
",",O
and,O
Phos,B-TE
7.4.,O

Gastrointestinal,O
:,O

The,O
infant,O
required,O
phototherapy,B-TR
for,O
hyperbilirubinemia,B-PR
through,O
day,O
of,O
life,O
7,O
",",O
with,O
peak,B-TE
bilirubin,I-TE
of,O
7,O
/,O
0.3,O
on,O
day,O
of,O
life,O
3,O
",",O
and,O
last,B-TE
bilirubin,I-TE
of,O
4.9,O
/,O
0.3,O
on,O
day,O
of,O
life,O
9,O
.,O

Hematologic,O
/,O
Infectious,O
disease,O
:,O

CBC,B-TE
and,O
blood,B-TE
culture,I-TE
were,O
obtained,O
upon,O
admission,O
revealing,O
a,B-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
of,O
9.0,O
with,O
25,B-TE
polys,I-TE
and,O
0,B-TE
bands,I-TE
;,O
hematocrit,B-TE
was,O
46.9%,O
and,O
platelets,B-TE
of,O
"222,000",O
.,O

Baby,O
received,O
48,O
hours,O
of,O
Ampicillin,B-TR
and,O
Gentamycin,B-TR
with,O
negative,O
cultures,O
and,O
a,O
stable,O
clinical,O
course,O
.,O

Infant,O
was,O
treated,O
with,O
supplemental,B-TR
iron,I-TR
",",O
and,O
did,O
not,O
receive,O
any,B-TR
blood,I-TR
transfusions,I-TR
.,O

Last,B-TE
Hct,I-TE
was,O
30.6,O
on,O
06-20,O
with,O
a,B-TE
reticulocyte,I-TE
count,I-TE
of,O
6.5%.,O

Neurologic,O
:,O

Baby,O
has,O
been,O
appropriate,O
for,O
gestational,O
age,O
.,O

Social,O
:,O

Mother,O
is,O
17,O
years,O
old,O
",",O
and,O
has,O
been,O
accompanied,O
on,O
the,O
majority,O
of,O
her,O
visits,O
by,O
her,O
parents,O
",",O
both,O
of,O
whom,O
are,O
students,O
.,O

The,O
infant,O
's,O
maternal,O
grandparents,O
have,O
been,O
very,O
involved,O
in,O
her,O
care,O
.,O

Sensory,O
:,O

Initial,B-TE
opthalmologic,I-TE
exam,I-TE
on,O
06-05,O
revealed,O
immature,B-PR
retinas,I-PR
in,O
zone,O
3,O
",",O
and,O
repeat,B-TE
exam,I-TE
on,O
06-26,O
revealed,O
mature,O
retinas,O
bilaterally,O
.,O

Infant,O
passed,O
hearing,B-TE
screen,I-TE
prior,O
to,O
discharge,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Good,O
.,O

DISCHARGE,O
DISPOSITION,O
:,O

To,O
home,O
.,O

PRIMARY,O
PEDIATRICIAN,O
:,O

Dr.,O
Robinson,O
",",O
Lawrence,O
General,O
Hospital,O
Hospital,O

Pediatrics,O
",",O
4952,O
Washington,O
St.,O
in,O
Dr.,O
John,O
C.,O
Corrigan,O
Mental,O
Health,O
Center,O
.,O

(,O
589,O
),O
690-3703,O
.,O

CARE,O
RECOMMENDATIONS,O
:,O

Diet,O
:,O

Enfamil,B-TR
or,O
breast,O
milk,O
24,O
calories,O
per,O
oz,O
",",O
with,O
enfamil,O
powder,O
.,O

Medications,O
:,O

Ferinsol,B-TR
0.2,O
mL,O
po,O
qd,O
.,O

Newborn,B-TE
screen,I-TE
:,O

Sent,O
as,O
per,O
protocol;,O
one,B-TE
specimen,I-TE
from,O
2017-05-28,O
returned,O
with,O
borderline,B-PR
low,I-PR
thyroxine,I-PR
",",O
but,O
repeat,B-TE
was,O
within,O
normal,O
limits,O
.,O

Immunizations,O
:,O

Hepatitis,B-TR
B,I-TR
vaccine,I-TR
given,O
06-17,O
.,O

Car,O
seat,O
:,O

Car,B-TE
seat,I-TE
safety,I-TE
screening,I-TE
passed,O
prior,O
to,O
discharge,O
.,O

Follow-up,O
:,O

Infant,O
will,O
follow-up,O
with,O
primary,O
pediatrician,O
within,O
2,O
days,O
of,O
discharge,O
",",O
and,O
will,O
see,O
Dr.,O
Dale,O
Merkel,O
of,O
Pediatric,O
Cardiology,O
in,O
Dr.,O
John,O
C.,O
Corrigan,O
Mental,O
Health,O
Center,O
on,O
2017-07-07,O
at,O
1:30,O
pm,O
.,O

Due,O
to,O
breech,B-PR
presentation,I-PR
",",O
a,B-TE
hip,I-TE
ultrasound,I-TE
can,O
be,O
considered,O
in,O
2-4,O
weeks,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Prematurity,B-PR
at,O
31,O
weeks,O
",",O
twin,O
#1,O
.,O

2.,O
Breech,B-PR
presentation,I-PR
.,O

3.,O
Sepsis,B-PR
suspect,O
ruled,O
out,O
with,O
antibiotics,B-TR
.,O

4.,O
Physiologic,B-PR
jaundice,I-PR
.,O

5.,O
Apnea,B-PR
of,I-PR
prematurity,I-PR
.,O

6.,O
Anemia,B-PR
of,I-PR
prematurity,I-PR
.,O

7.,O
Aberrant,B-PR
left,I-PR
coronary,I-PR
artery,I-PR
.,O

8.,O
Muscular,B-PR
ventricular,I-PR
septal,I-PR
defect,I-PR
.,O

Lisa,O
Annie,O
",",O
MD,O
50ABQ,O

Dictated,O
By,O
:,O
Ehtel,O
Z,O
Ebert,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2017-06-02,O
03:49:08,O

T,O
:,O
2017-06-02,O
05:32:26,O

Job,O
#,O
:,O
12559,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Ann,O
Nguyen,O
on,O
:,O
TUE,O
2017-06-27,O
8:40,O
AM,O

(,O
End,O
of,O
Report,O
),O

356529973_a,O

FIH,O

2102647,O

14892/3n8v,O

481088,O

7/9/1993,O
12:00:00,O
AM,O

OVARIAN,B-PR
MASS,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

7-9-93,O

DISCHARGE,O
DATE,O
:,O

7-15-93,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Ovarian,B-PR
mass,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

Papanicolaou,B-TE
smear,I-TE
positive,O
for,O
somomabodies,B-PR
",",O
incontinence,B-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

Total,B-TR
abdominal,I-TR
hysterectomy,I-TR
",",O
bilateral,B-TR
salpingo-oophorectomy,I-TR
",",O
lysis,B-TR
of,O
adhesions,B-PR
",",O
open,B-TR
laparoscopy,I-TR
",",O
Birch,B-TR
procedure,I-TR
",",O
suprapubic,B-TR
bladder,I-TR
catheter,I-TR
placement,I-TR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
52,O
year,O
old,O
female,O
with,O
gravida,O
3,O
para,O
3,O
who,O
presents,O
with,O
complains,O
of,O
abdominal,B-PR
pain,I-PR
and,O
enlarged,B-PR
ovary,I-PR
by,O
ultrasound,B-TE
.,O

The,O
patient,O
is,O
also,O
complaining,O
of,O
several,B-PR
years,I-PR
urinary,I-PR
incontinence,I-PR
.,O

The,O
patient,O
&apos;s,O
recent,O
history,O
is,O
also,O
notable,O
for,O
a,B-TE
Papanicolaou,I-TE
smear,I-TE
which,O
revealed,O
somomabodies,B-PR
.,O

The,O
patient,O
also,O
had,O
vaginal,B-PR
bleeding,I-PR
in,O
April,O
1992,O
following,O
radiation,B-TR
therapy,I-TR
.,O

The,O
patient,O
initially,O
presented,O
with,O
hypercalcemia,B-PR
and,O
underwent,O
a,B-TR
parathyroidectomy,I-TR
on,O
June,O
22,O
",",O
1993,O
.,O

It,O
was,O
at,O
that,O
time,O
that,O
her,B-TE
abnormal,I-TE
Papanicolaou,I-TE
smear,I-TE
was,O
obtained,O
.,O

The,O
patient,O
is,O
now,O
admitted,O
for,O
exploratory,B-TE
laparotomy,I-TE
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

The,O
past,O
medical,O
history,O
is,O
notable,O
for,O
lymphosarcoma,B-PR
in,O
1970,O
.,O

She,O
was,O
treated,O
with,O
radiation,B-TR
therapy,I-TR
.,O

In,O
1980,O
",",O
the,O
patient,O
had,O
a,B-PR
left,I-PR
axillary,I-PR
recurrence,I-PR
that,O
was,O
treated,O
with,O
radiation,B-TR
therapy,I-TR
.,O

The,O
patient,O
also,O
has,O
a,O
history,O
of,O
hyperparathyroidism,B-PR
secondary,O
to,O
papillary,B-PR
thyroid,I-PR
cancer,I-PR
.,O

The,O
history,O
is,O
also,O
notable,O
for,O
gallstones,B-PR
",",O
kidney,B-PR
stones,I-PR
",",O
episodic,B-PR
tachycardia,I-PR
",",O
chronic,B-PR
pancreatitis,I-PR
.,O

Of,O
note,O
",",O
the,O
patient,O
also,O
has,O
a,O
history,O
of,O
incontinence,B-PR
.,O

The,O
patient,O
also,O
has,O
hypothyroidism,B-PR
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

The,O
patient,O
&apos;s,O
past,O
surgical,O
history,O
is,O
notable,O
for,O
the,B-TR
removal,I-TR
of,O
a,B-PR
thyroid,I-PR
nodule,I-PR
in,O
February,O
1989,O
.,O

This,O
revealed,O
papillary,B-PR
thyroid,I-PR
cancer,I-PR
and,O
the,O
patient,O
received,O
radioactive,B-TR
iodine,I-TR
ablation,I-TR
.,O

In,O
June,O
1993,O
",",O
the,O
patient,O
had,O
a,B-TR
parathyroidectomy,I-TR
and,O
also,O
of,O
note,O
",",O
in,O
September,O
1992,O
",",O
the,O
patient,O
had,O
an,B-TE
exploratory,I-TE
laparotomy,I-TE
for,O
pain,B-PR
and,O
chronic,B-PR
pancreatitis,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Include,O
Librax,B-TR
1,O
PO,O
before,O
meals,O
",",O
Pancrease,B-TR
2,O
tabs,O
before,O
meals,O
",",O
Synthroid,B-TR
0.125,O
mg,O
PO,O
qd,O
.,O

Tenormin,B-TR
50,O
mg,O
bid,O
",",O
Valium,B-TR
5,O
mg,O
bid,O
to,O
tid,O
",",O
Premarin,B-TR
0.625,O
mg,O
qd,O
",",O
Provera,B-TR
2.5,O
mg,O
qod,O
",",O
Desyrel,B-TR
50,O
mg,O
qhs,O
.,O

ALLERGIES,O
:,O

The,B-PR
patient,I-PR
&apos;s,I-PR
allergies,I-PR
include,O
Septra,B-TR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
&apos;s,O
social,O
history,O
is,O
notable,O
for,O
a,O
heavy,O
smoking,O
history,O
.,O

She,O
is,O
interested,O
in,O
quitting,O
smoking,O
.,O

The,O
patient,O
has,O
no,O
history,O
of,O
alcohol,O
abuse,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,B-TE
patient,I-TE
&apos;s,I-TE
preoperative,I-TE
examination,I-TE
is,O
notable,O
for,O
normal,O
breasts,O
",",O
normal,O
heart,O
and,O
lungs,O
.,O

The,B-TE
pelvic,I-TE
examination,I-TE
is,O
normal,O
except,O
for,O
the,O
presence,O
of,O
a,B-PR
full,I-PR
right,I-PR
ovary,I-PR
.,O

The,B-TE
rectovaginal,I-TE
examination,I-TE
is,O
normal,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
judged,O
to,O
be,O
at,O
risk,O
secondary,O
to,O
her,O
history,O
of,O
somomabodies,B-PR
and,O
vaginal,B-PR
bleeding,I-PR
.,O

Her,O
differential,O
diagnosis,O
included,O
ovarian,B-PR
cancer,I-PR
.,O

The,O
patient,O
was,O
admitted,O
on,O
July,O
9,O
to,O
the,O
operating,O
room,O
.,O

She,O
underwent,O
an,B-TR
open,I-TR
laparoscopy,I-TR
",",O
total,B-TR
abdominal,I-TR
hysterectomy,I-TR
",",O
bilateral,B-TR
salpingo-oophorectomy,I-TR
",",O
lysis,B-TR
of,O
adhesions,B-PR
",",O
Birch,B-TR
procedure,I-TR
",",O
and,O
suprapubic,B-TR
Foley,I-TR
catheter,I-TR
placement,I-TR
and,O
Jackson-Pratt,B-TR
drain,I-TR
placement,I-TR
.,O

The,B-TE
estimated,I-TE
blood,I-TE
loss,I-TE
was,O
300,O
cc,O
.,O

There,O
were,O
no,O
complications,B-PR
during,O
the,B-TR
procedure,I-TR
and,O
the,O
patient,O
returned,O
to,O
the,O
recovery,O
room,O
in,O
stable,O
condition,O
.,O

Postoperatively,O
",",O
the,O
patient,O
did,O
well,O
.,O

Her,B-TE
calcium,I-TE
was,O
followed,O
daily,O
and,O
repleted,O
as,O
needed,O
.,O

Her,B-TR
Jackson-Pratt,I-TR
drain,I-TR
was,O
removed,O
on,O
postoperative,O
day,O
number,O
two,O
.,O

The,O
patient,O
had,O
a,B-TE
temperature,I-TE
of,O
101.6,O
on,O
postoperative,O
day,O
two,O
.,O

Her,O
lungs,O
revealed,O
coarse,B-PR
breath,I-PR
sounds,I-PR
.,O

She,O
was,O
encouraged,O
to,O
ambulate,O
and,O
deep,O
breath,O
.,O

The,O
patient,O
was,O
started,O
on,O
nebulizer,B-TR
treatment,I-TR
.,O

The,O
patient,O
did,O
well,O
and,O
her,B-TR
suprapubic,I-TR
tube,I-TR
was,O
clamped,B-TR
starting,O
on,O
postoperative,O
day,O
four,O
.,O

The,O
patient,O
voided,O
spontaneously,O
.,O

Clamping,O
continued,O
until,O
postoperative,O
day,O
six,O
.,O

At,O
this,O
time,O
",",O
her,B-TE
post-void,I-TE
residuals,I-TE
range,O
from,O
2,O
cc,O
to,O
25,O
cc,O
.,O

The,B-TR
suprapubic,I-TR
tube,I-TR
was,O
therefore,O
discontinued,O
.,O

By,O
postoperative,O
day,O
six,O
",",O
the,O
patient,O
was,O
also,O
tolerating,O
a,O
regular,O
diet,O
and,O
passing,O
flatus,O
.,O

A,B-TE
chest,I-TE
X-ray,I-TE
was,O
performed,O
secondary,O
to,O
the,B-PR
patient,I-PR
&apos;s,I-PR
coarse,I-PR
breath,I-PR
sounds,I-PR
",",O
however,O
",",O
the,B-TE
chest,I-TE
X-ray,I-TE
was,O
clear,O
except,O
for,O
a,O
small,O
amount,O
of,O
atelectasis,B-PR
.,O

The,O
patient,O
was,O
discharged,O
home,O
.,O

final,B-TE
pathology,I-TE
revealed,O
right,O
Fallopian,O
tube,O
and,O
ovary,O
with,O
benign,B-PR
paratubal,I-PR
cysts,I-PR
and,O
adhesions,B-PR
.,O

The,O
cervix,O
revealed,O
squamous,B-PR
metaplasia,I-PR
.,O

The,O
patient,O
was,O
discharged,O
home,O
on,O
admission,B-TR
medications,I-TR
.,O

In,O
addition,O
",",O
she,O
will,O
take,O
Ciprofloxacin,B-TR
for,O
nine,O
more,O
days,O
.,O

She,O
will,O
also,O
take,O
Percocet,B-TR
.,O

DISPOSITION,O
:,O

The,O
patient,O
is,O
discharged,O
to,O
home,O
and,O
is,O
to,O
follow,O
up,O
with,O
Dr.,O
Cancer,O
",",O
as,O
well,O
as,O
Dr.,O
Kotefold,O
and,O
Dr.,O
Cancer,O
.,O

KITRI,O
CURB,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

EARNRA,O
CANCER,O
",",O
M.D.,O

TR,O
:,O

nx,O
/,O
bmot,O

DD,O
:,O

07-15-93,O

TD,O
:,O

07/16/93,O

CC,O
:,O

Dr.,O
Ertca,O
Cancer,O
",",O
Dr.,O
Kotefold,O

648746074,O

CTMC,O

84164942,O

960919,O

9/7/1992,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

09/07/1992,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

09/12/1992,O

ADMISSION,O
DIAGNOSES,O
:,O

1.,O
STAGE,B-PR
IV,I-PR
ENDOMETRIAL,I-PR
CANCER,I-PR

2.,O
STAGE,B-PR
III-C,I-PR
OVARIAN,I-PR
CANCER,I-PR

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
STAGE,B-PR
IV,I-PR
ENDOMETRIAL,I-PR
CANCER,I-PR

2.,O
STAGE,B-PR
III-C,I-PR
OVARIAN,I-PR
CANCER,I-PR

TREATMENTS,O
:,O

Chemotherapy,B-TR
of,O
IFEX,B-TR
",",O
MESNA,B-TR
and,O
VP-16,B-TR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
31,O
year,O
old,O
gravida,O
0,O
with,O
stage,B-PR
IV,I-PR
endometrial,I-PR
cancer,I-PR
and,O
stage,B-PR
III-C,I-PR
ovarian,I-PR
cancer,I-PR
vs,O
metastatic,B-PR
endometrial,I-PR
cancer,I-PR
for,O
line,O
2,O
",",O
cycle,B-TR
1,I-TR
chemotherapy,I-TR
.,O

The,O
patient,O
presented,O
in,O
10-90,O
",",O
with,O
heavy,B-PR
bleeding,I-PR
per,I-PR
vagina,I-PR
.,O

D,B-TE
and,I-TE
C,I-TE
showed,O
grade,B-PR
II-III,I-PR
adenocarcinoma,I-PR
with,O
squamous,B-PR
differentiation,I-PR
at,O
Wellla,O
Uxinny,O
:,O
mount,O
Medical,O
Center,O
in,O
Com,O
St.,O
",",O
Tton,O
",",O
Arkansas,O
32167,O
.,O

The,O
patient,O
underwent,O
TAH,B-TR
/,O
BSO,B-TR
",",O
partial,B-TR
omentectomy,I-TR
at,O
CTMC,O
in,O
10-90,O
.,O

At,O
that,O
time,O
",",O
tumor,B-PR
was,O
found,O
to,O
be,O
studding,B-PR
on,I-PR
the,I-PR
right,I-PR
diaphragm,I-PR
",",O
gross,B-PR
tumor,I-PR
in,I-PR
the,I-PR
omentum,I-PR
and,I-PR
large,I-PR
bowel,I-PR
",",O
tumor,B-PR
through,I-PR
the,I-PR
uterine,I-PR
serosa,I-PR
.,O

Pathology,B-TE
showed,O
grade,B-PR
II-III,I-PR
papillary,I-PR
adenocarcinoma,I-PR
of,I-PR
the,I-PR
endometrium,I-PR
with,O
squamous,B-PR
differentiation,I-PR
which,O
was,O
focally,B-PR
invasive,I-PR
and,O
superficial,B-PR
myometrium,I-PR
.,O

The,O
ovary,O
showed,O
papillary,B-PR
serous,I-PR
adeno,I-PR
with,O
omental,B-PR
involvement,I-PR
consistent,O
with,O
an,B-PR
endometroid,I-PR
adenocarcinoma,I-PR
.,O

The,O
question,O
was,O
whether,O
or,O
not,O
whether,O
she,O
had,O
two,B-PR
primaries,I-PR
vs,O
metastatic,B-PR
endometrial,I-PR
cancer,I-PR
.,O

The,O
patient,O
underwent,O
6,O
cycles,O
of,O
CAP,B-TR
in,O
Pemrancetul,O
Tonsst.,O
.,O

However,O

Her,B-TE
CA-125,I-TE
on,O
6-27-91,O
",",O
was,O
249,O
and,O
on,O
8-29-91,O
",",O
was,O
734,O
.,O

In,O
05-92,O
",",O
the,O
patient,O
was,O
admitted,O
to,O
Wellla,O
Uxinny,O
:,O
mount,O
Medical,O
Center,O
with,O
left,B-PR
leg,I-PR
DVT,I-PR
and,O
started,O
on,O
Heparin,B-TR
therapy,I-TR
.,O

She,O
was,O
discharged,O
from,O
there,O
on,O
Coumadin,B-TR
therapy,I-TR
.,O

On,O
admission,O
",",O
the,O
patient,O
has,O
no,O
complaints,O
except,O
anxiety,B-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Negative,O
except,O
as,O
above,O
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

Negative,O
except,O
as,O
above,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Coumadin,B-TR
5,O
mg,O
po,O
q,O
d,O
",",O
Tagamet,B-TR
400,O
mg,O
po,O
q,O
d,O
",",O
Amoxicillin,B-TR
which,O
was,O
started,O
on,O
Labor,O
Day,O
",",O
for,O
a,B-PR
sore,I-PR
throat,I-PR
and,O
Ativan,B-TR
1,O
mg,O
po,O
prn,O
nausea,B-PR
/,O
anxiety,B-PR
.,O

ALLERGIES,O
:,O

The,O
patient,O
gets,O
hives,B-PR
to,O
aspirin,B-TR
and,O
tomatoes,O
also,O
cause,O
her,O
hives,B-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,B-TE
temp,I-TE
was,O
99.4,O

She,O
was,O
an,O
anxious,O
female,O
",",O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

HEENT,B-TE
exam,I-TE
showed,O
PERRLA,O
",",O
EOMI,O
",",O
oropharynx,O
benign,O
.,O

The,O
lungs,O
were,O
clear,O
to,O
auscultation,B-TE
.,O

CV,O
was,O
regular,O
rate,O
and,O
rhythm,O
without,O
murmurs,B-PR
.,O

The,O
abdomen,O
was,O
soft,O
",",O
positive,O
bowel,O
sounds,O
",",O
non,B-PR
tender,I-PR
",",O
large,B-PR
",",I-PR
hard,I-PR
mass,I-PR
occupying,O
the,O
lower,O
abdomen,O
and,O
left,O
upper,O
quadrant,O
.,O

The,O
extremities,O
were,O
non,B-PR
tender,I-PR
without,O
edema,B-PR
.,O

LABORATORY,O
DATA,O
:,O

On,O
admission,O
",",O
the,B-TE
sodium,I-TE
was,O
136,O
",",O
potassium,B-TE
3.0,O
",",O
chloride,B-TE
98,O
",",O
CO2,B-TE
20,O
",",O
BUN,B-TE
8,O
",",O
creatinine,B-TE
0.8,O
and,O
glucose,B-TE
94,O
",",O
ALT,B-TE
5,O
",",O
AST,B-TE
10,O
",",O
LDH,B-TE
166,O
",",O
alkaline,B-TE
phosphatase,I-TE
81,O
",",O
total,B-TE
bili,I-TE
0.6,O
",",O
direct,B-TE
bili,I-TE
.3,O
",",O
albumin,B-TE
3.3,O
",",O
calcium,B-TE
8.8,O
and,O
uric,B-TE
acid,I-TE
3.1,O
.,O

She,O
had,O
CA-125,B-TE
which,O
was,O
pending,O
at,O
the,O
time,O
of,O
discharge,O
.,O

Her,B-TE
hematocrit,I-TE
was,O
31.1,O
",",O
WBC,B-TE
11.6,O
and,O
"151,000",O
platelets,B-TE
.,O

PLAN,O
:,O

The,O
patient,O
is,O
thus,O
stage,B-PR
IV,I-PR
endometrial,I-PR
and,O
stage,B-PR
III-C,I-PR
ovarian,I-PR
vs,O
metastatic,B-PR
endometrial,I-PR
for,I-PR
line,I-PR
II,I-PR
",",O
cycle,B-TR
I,I-TR
chemotherapy,I-TR
IFEX,B-TR
",",O
MESNA,B-TR
and,O
VP-16,B-TR
.,O

The,O
plan,O
was,O
for,O
urinalysis,B-TE
q,O
d,O
.,O

With,O
the,O
history,O
of,O
DVT,B-PR
",",O
we,O
plan,O
Coumadin,B-TR
and,O
check,O
her,B-TE
coags,I-TE
.,O

The,O
patient,O
was,O
tachycardiac,B-PR
on,O
admission,O
and,O
it,O
was,O
felt,O
she,O
was,O
dehydrated,B-PR
and,O
/,O
or,O
anxious,B-PR
at,O
the,O
time,O
of,O
her,B-TE
initial,I-TE
evaluation,I-TE
.,O

EKG,B-TE
showed,O
sinus,B-PR
tachycardia,I-PR
and,O
incomplete,B-PR
right,I-PR
bundle,I-PR
branch,I-PR
block,I-PR
.,O

When,O
compared,O
with,O
ECG,B-TE
of,O
11-06-90,O
",",O
there,O
was,O
borderline,O
criteria,O
for,O
anterior,B-PR
MI,I-PR
although,O
the,O
patient,O
denied,O
any,B-PR
chest,I-PR
pain,I-PR
at,O
any,O
point,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
underwent,O
chemotherapy,B-TR
on,O
the,O
following,O
doses,O
:,O

IFEX,B-TR
1.2,O
grams,O
per,O
meter,O
squared,O
x,O
3,O
days,O
",",O
MESNA,B-TR
1.2,O
grams,O
per,O
meter,O
squared,O
x,O
3,O
days,O
continuous,B-TR
IV,I-TR
infusion,I-TR
.,O

She,O
had,O
VP-16,B-TR
mixed,O
with,O
250,O
cc,O
IV,B-TR
fluid,I-TR
given,O
over,O
1,O
hour,O
each,O
day,O
for,O
3,O
days,O
.,O

She,O
also,O
had,O
MESNA,B-TR
dose,I-TR
of,O
.6,O
grams,O
per,O
meter,O
squared,O
after,O
her,B-TR
IFEX,I-TR
/,O
MESNA,B-TR
were,O
completed,O
.,O

The,B-TE
patient,I-TE
's,I-TE
urinalysis,I-TE
on,O
admission,O
was,O
significant,O
for,O
red,B-PR
blood,I-PR
cells,I-PR
which,O
were,O
TNTC,O
as,O
well,O
as,O
uric,B-TE
acid,I-TE
.,O

Because,O
it,O
was,O
felt,O
the,O
patient,O
was,O
bleeding,O
and,O
the,O
patient,O
was,O
contaminated,O
",",O
she,O
received,O
her,O
IFEX,B-TR
/,O
MESNA,B-TR
.,O

A,B-TE
repeat,I-TE
straight,I-TE
cath,I-TE
was,O
negative,O
for,O
RBC,B-PR
's,I-PR
.,O

After,O
1,O
day,O
of,O
chemotherapy,B-TR
",",O
the,O
patient,O
had,O
8-10,B-PR
RBC,I-PR
's,I-PR
in,I-PR
her,I-PR
urine,I-PR
but,O
by,O
the,O
second,O
day,O
of,O
her,B-TR
IFEX,I-TR
infusion,I-TR
",",O
she,O
had,O
50-80,B-PR
RBC,I-PR
's,I-PR
in,I-PR
her,I-PR
urine,I-PR
as,O
well,O
as,O
a,B-PR
few,I-PR
transitional,I-PR
epithelial,I-PR
cells,I-PR
.,O

Because,O
of,O
this,O
finding,O
",",O
her,B-TR
IFEX,I-TR
was,O
stopped,O
before,O
completion,O
of,O
her,O
second,O
day,O
of,O
infusion,B-TR
.,O

Her,B-TR
MESNA,I-TR
alone,O
was,O
continued,O
at,O
that,O
time,O
for,O
IV,B-TR
infusion,I-TR
.,O

She,O
did,O
receive,O
her,B-TR
VP-16,I-TR
without,O
complication,B-PR
.,O

Other,O
significant,O
issues,O
were,O
the,B-TE
patient,I-TE
's,I-TE
hematocrit,I-TE
on,O
admission,O
at,O
31.1,O
which,O
dwindled,O
down,O
to,O
26.2,O
by,O
9-10,O

The,O
patient,O
was,O
counselled,O
and,O
received,O
2,O
units,O
of,O
packed,B-TR
RBC,I-TR
's,I-TR
at,O
that,O
time,O

However,O
",",O
the,B-TE
patient,I-TE
's,I-TE
hematocrit,I-TE
bumped,O
only,O
to,O
28.1,O
and,O
a,O
repeat,O
later,O
on,O
9-11,O
",",O
showed,O
hematocrit,B-TE
of,O
27.6,O
.,O

At,O
this,O
time,O
",",O
an,O
additional,O
2,O
units,O
of,O
packed,B-TR
RBC,I-TR
's,I-TR
were,O
transfused,O
.,O

The,O
third,O
issue,O
was,O
that,O
her,B-TR
anticoagulation,I-TR
was,O
grossly,O
out,O
of,O
control,O
on,O
admission,O
with,O
PT,B-TE
of,O
25.6,O
and,O
PTT,B-TE
of,O
42.2,O
.,O

Her,O
repeat,O
on,O
9-8,O
",",O
was,O
36.0,O
/,O
68.2,O
and,O
her,B-TR
Coumadin,I-TR
was,O
held,O
.,O

She,O
received,O
no,O
Coumadin,B-TR
during,O
her,O
admission,O
and,O
by,O
the,O
time,O
of,O
discharge,O
",",O
her,B-TE
PT,I-TE
was,O
down,O
to,O
16.2,O
.,O

She,O
was,O
restarted,O
on,O
Coumadin,B-TR
2.5,O
mg,O
per,O
day,O
.,O

The,B-TE
patient,I-TE
's,I-TE
hematocrit,I-TE
on,O
the,O
day,O
of,O
discharge,O
was,O
35.6,O
showing,O
significant,O
bump,O
in,O
her,B-TE
count,I-TE
after,O
her,O
second,O
two,O
units,O
of,O
packed,B-TR
RBC,I-TR
's,I-TR
.,O

Her,B-TE
PT,I-TE
on,O
the,O
day,O
of,O
discharge,O
was,O
13.2,O
and,O
she,O
was,O
started,O
on,O
Coumadin,B-TR
2.5,O
mg,O
po,O
q,O
d,O
as,O
mentioned,O
.,O

The,O
patient,O
was,O
discharged,O
on,O
9-12-92,O
",",O
with,O
the,O
approval,O
of,O
her,O
attending,O
physiciana,O
",",O
Dr.,O
Porriede,O
Friednantflirt,O
.,O

FOLLOW,O
UP,O
CARE,O
:,O

On,O
9-28-92,O
",",O
the,O
patient,O
will,O
return,O
for,O
chemotherapy,B-TR
and,O
she,O
will,O
follow,O
up,O
with,O
her,O
primary,O
doctor,O
",",O
Dr.,O
Jescspald,O
",",O
for,O
repeat,B-TE
PT,I-TE
and,O
Coumadin,B-TR
dosing,I-TR
on,O
Monday,O
",",O
9-14-02,O
.,O

LT503/7456,O
LAKO,O
C.,O
SCARVTWI,O
",",O
M.D.,O
TH0,O

D,O
:,O
09/14/92,O

Batch,O
:,O
3799,O

Report,O
:,O
V1670V4,O

T,O
:,O
09/15/92,O

Dicatated,O
By,O
:,O
GRA,O
A.,O
SPARDBOUILLNAPPS,O
",",O
M.D.,O
AM57,O

[,O
report,O
_,O
end,O
],O

359487751,O

PUOMC,O

9075321,O

7676,O

21768,O

12/7/1996,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

ELKSCHIRD,O
",",O
EBERTA,O
R,O

UNIT,O
NUMBER,O
:,O

882-95-20,O

ADMISSION,O
DATE,O
:,O

12/07/96,O

DISCHARGE,O
DATE,O
:,O

12/14/96,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

76-year-old,O
male,O
with,O
right,B-PR
hip,I-PR
pain,I-PR
X,O
five,O
years,O
.,O

The,B-PR
pain,I-PR
is,O
often,O
severely,O
and,O
increasing,O
at,O
night,O
especially,O
when,O
he,O
is,O
lying,O
on,O
the,O
right,O
side,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Tonsillectomy,B-TR
.,O

History,O
of,O
high,B-PR
blood,I-PR
pressure,I-PR
",",O
enlarged,B-PR
heart,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Zantac,B-TR
.,O

Furosemide,B-TR
.,O

Aerobid,B-TR
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR

PHYSICAL,O
EXAMINATION,O
:,O

The,O
head,O
",",O
eyes,O
",",O
ears,O
",",O
nose,O
and,O
throat,O
unremarkable,O
.,O

The,O
lungs,O
were,O
clear,O
.,O

Heart,O
:,O

regular,O
rate,O
and,O
rhythm,O
.,O

The,O
abdomen,O
was,O
soft,O
and,O
non-tender,B-PR
.,O

Left,O
hip,O
shows,O
flexion,B-TE
and,O
extension,B-TE
40,O
.,O

Right,B-TE
hip,I-TE
flexion,I-TE
and,O
extension,B-TE
40,O
and,O
0,O
.,O

IMPRESSION,O
:,O

Right,B-PR
hip,I-PR
pain,I-PR
degenerative,B-PR
joint,I-PR
disease,I-PR
for,O
right,B-TR
total,I-TR
hip,I-TR
replacement,I-TR
.,O

HOSPITAL,O
COURSE,O
AND,O
TREATMENT,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
hospital,O
as,O
a,O
postoperative,O
admit,O
on,O
December,O
7,O
for,O
total,B-TR
hip,I-TR
replacement,I-TR
.,O

For,O
further,O
details,O
of,O
this,B-TR
procedure,I-TR
see,O
operative,O
note,O
.,O

Postoperatively,O
he,O
did,O
well,O
initially,O
in,O
the,O
first,O
12,O
hours,O
.,O

However,O
he,O
had,O
a,O
report,O
of,O
emesis,B-PR
of,I-PR
coffee,I-PR
grounds,I-PR
on,O
postoperative,O
night,O
#1,O
.,O

This,O
with,O
no,O
electrocardiogram,B-PR
changes,I-PR
.,O

Due,O
to,O
this,O
GI,O
was,O
consulted,O
and,O
felt,O
that,O
he,O
would,O
be,O
a,O
candidate,O
for,O
esophagogastroduodenoscopy,B-TE
.,O

He,O
was,O
placed,O
nothing,B-TR
by,I-TR
mouth,I-TR
and,O
the,B-TE
esophagogastroduodenoscopy,I-TE
was,O
done,O
by,O
the,O
GI,O
Service,O
.,O

Findings,O
showed,O
a,B-PR
Mallory,I-PR
Weiss,I-PR
tear,I-PR
",",O
nonspecific,B-PR
duodenitis,I-PR
.,O

He,O
was,O
placed,O
on,O
Zantac,B-TR
150,O
mg.,O
PO,O
b.i.d.,O
and,O
H,B-TE
Pylori,I-TE
serology,I-TE
was,O
sent,O
.,O

Post,O
EGD,B-TE
his,O
diet,O
was,O
advanced,O
slowly,O
and,O
he,O
did,O
exceptionally,O
well,O
.,O

At,O
the,O
time,O
of,O
discharge,O
he,O
was,O
tolerating,O
a,O
full,O
diet,O
",",O
out,O
of,O
bed,O
with,O
pain,B-PR
",",O
tolerated,O
on,O
po.,B-TR
medications,I-TR
.,O

His,B-PR
wound,I-PR
was,O
intact,O
with,O
no,O
evidence,O
of,O
infection,B-PR
.,O

Distal,O
neurovascular,O
status,O
was,O
intact,O
.,O

There,O
was,O
no,O
calf,B-PR
tenderness,I-PR
and,O
lower,B-TE
extremity,I-TE
arterial,I-TE
non-invasive,I-TE
studies,I-TE
were,O
negative,O
.,O

He,O
was,O
generally,O
well,O
in,O
all,O
regards,O
.,O

The,B-TE
physical,I-TE
examination,I-TE
was,O
unremarkable,O
and,O
he,O
had,O
no,O
recurrent,O
symptoms,O
of,O
coffee,B-PR
ground,I-PR
emesis,I-PR
.,O

He,O
was,O
doing,O
exceptionally,O
well,O
at,O
discharge,O
with,O
plans,O
to,O
follow,O
up,O
with,O
Dr.,O
Rhalttland,O
.,O

Discharge,O
instructions,O
have,O
been,O
given,O
.,O

ROYNEO,O
WALLA,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

LI,O
RHALTTLAND,O
",",O
M.D.,O

TR,O
:,O

hbq,O

DD,O
:,O

12/12/96,O

TD,O
:,O

12/12/96,O
9:00,O
A,O

cc,O
:,O

LI,O
RIJARRED,O
RHALTTLAND,O
",",O
M.D.,O
ROYNEO,O
MAMAIRE,O
WALLA,O
",",O
M.D.,O

Admission,O
Date,O
:,O

2012-04-27,O

Discharge,O
Date,O
:,O

2012-04-30,O

Date,O
of,O
Birth,O
:,O

1933-02-05,O

Sex,O
:,O

F,O

Service,O
:,O

Neurosurgery,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Patient,O
is,O
a,O
79,O
-,O
year-old,O
female,O
with,O
a,O
history,O
of,O
cataracts,B-PR
",",O
glaucoma,B-PR
",",O
and,O
diabetes,B-PR
",",O
who,O
fell,O
and,O
tripped,O
over,O
a,O
wheelchair,O
of,O
a,O
friend,O
with,O
no,O
loss,B-PR
of,I-PR
consciousness,I-PR
",",O
no,O
dizziness,B-PR
",",O
no,O
chest,B-PR
pain,I-PR
",",O
and,O
no,O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

PHYSICAL,O
EXAM,O
:,O

She,O
was,O
afebrile,B-PR
.,O

Heart,B-TE
rate,I-TE
was,O
77,O
.,O

Blood,B-TE
pressure,I-TE
132/48,O
.,O

Respiratory,B-TE
rate,I-TE
was,O
17,O
.,O

Sats,B-TE
96%,O
on,O
room,O
air,O
.,O

Her,B-TE
temperature,I-TE
was,O
97.6,O
.,O

She,O
neurologically,O
",",O
she,O
had,O
a,O
nonfocal,O
neurologic,O
examination,O
.,O

Her,O
cardiovascular,O
was,O
regular,O
rate,O
and,O
rhythm,O
.,O

Her,O
pulmonary,O
:,O

Chest,O
was,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

Extremities,O
:,O

No,O
cyanosis,B-PR
",",O
clubbing,B-PR
",",O
or,O
edema,B-PR
.,O

Head,B-TE
CT,I-TE
showed,O
a,B-PR
front,I-PR
focal,I-PR
hemorrhage,I-PR
in,I-PR
the,I-PR
left,I-PR
occipital,I-PR
lobe,I-PR
adjacent,O
to,O
the,O
falx,O
with,O
intraparenchymal,B-PR
hemorrhage,I-PR
or,O
epidural,B-PR
or,I-PR
subdural,I-PR
hemorrhage,I-PR
near,I-PR
the,I-PR
falx,I-PR
with,O
no,O
shift,B-PR
.,O

CT,B-TE
of,I-TE
the,I-TE
C,I-TE
spine,I-TE
was,O
negative,O
and,O
her,O
cervical,O
spine,O
was,O
cleared,O
.,O

HOSPITAL,O
COURSE,O
:,O

She,O
was,O
admitted,O
to,O
the,O
ICU,O
for,O
close,B-TE
neurosurgical,I-TE
and,I-TE
neurological,I-TE
observation,I-TE
.,O

She,O
remained,O
neurologically,O
stable,O
.,O

Repeat,B-TE
head,I-TE
CT,I-TE
showed,O
stable,B-PR
bleed,I-PR
.,O

The,O
patient,O
was,O
transferred,O
to,O
the,O
regular,O
floor,O
.,O

She,O
was,O
out,O
of,O
bed,O
ambulating,O
",",O
tolerating,O
a,O
regular,O
diet,O
",",O
voiding,O
spontaneously,O
.,O

She,O
will,O
be,O
discharged,O
to,O
home,O
with,O
followup,O
with,O
Dr.,O
Wilson,O
in,O
two,O
weeks,O
with,O
a,B-TE
repeat,I-TE
head,I-TE
CT,I-TE
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

1.,O
Levofloxacin,B-TR
250,O
mg,O
p.o.,O
q.24h.,O
x3,O
days,O
.,O

2.,O
Dilantin,B-TR
100,O
mg,O
p.o.,O
t.i.d.,O

3.,O
Colace,B-TR
100,O
mg,O
p.o.,O
b.i.d.,O

4.,O
Timoptic,B-TR
0.25,O
one,O
drop,O
O.U.,O
b.i.d.,O

5.,O
Lantoprost,B-TR
0.005,O
ophthalmic,O
solution,O
one,O
drop,O
O.U.,O
q.h.s.,O

6.,O
Zantac,B-TR
150,O
mg,O
p.o.,O
b.i.d.,O

7.,O
Insulin-sliding,B-TR
scale,I-TR
as,O
well,O
as,O
40,O
units,O
of,O
Humalog,B-TR
in,O
the,O
a.m.,O
and,O
20,O
at,O
night,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
.,O

FOLLOW-UP,O
INSTRUCTIONS,O
:,O

She,O
will,O
follow,O
up,O
with,O
Dr.,O
Perez,O
in,O
two,O
weeks,O
with,O
repeat,B-TE
head,I-TE
CT,I-TE
.,O

Danvers,O
T,O
Sharp,O
",",O
M.D.,O

16-530,O

Dictated,O
By,O
:,O
David,O
GA,O
Crane,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2012-04-30,O
11:30,O

T,O
:,O
2012-05-01,O
08:13,O

JOB,O
#:,O
10027,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Margarita,O
Martin,O
on,O
:,O
TUE,O
2012-06-05,O
8:08,O
AM,O

(,O
End,O
of,O
Report,O
),O

369195584,O

CTMC,O

26248578,O

130467,O

3/10/1992,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

03/10/1992,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

03/22/1992,O

DISCHARGE,O
DIAGNOSIS,O
:,O

1.,O
Prostate,B-PR
cancer,I-PR
.,O

2.,O
Alzheimer,B-PR
's,I-PR
disease,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

The,O
patient,O
is,O
an,O
87-year-old,O
male,O
with,O
stage,B-PR
D,I-PR
prostate,I-PR
was,O
cancer,B-PR
",",O
was,O
admitted,O
for,O
fluid,B-TR
hydration,I-TR
on,O
the,O
10th,O
of,O
March,O
.,O

The,O
patient,O
was,O
initially,O
diagnosed,O
with,O
prostate,B-PR
cancer,I-PR
in,O
August,O
of,O
1989,O
.,O

He,O
presented,O
with,O
gross,B-PR
hematuria,I-PR
at,O
that,O
time,O
.,O

Subsequent,B-TE
prostatic,I-TE
biopsy,I-TE
revealed,O
a,B-PR
Gleason,I-PR
's,I-PR
IV,I-PR
",",I-PR
plus,I-PR
V,I-PR
tumor,I-PR
and,O
the,B-TE
CT,I-TE
showed,O
an,B-PR
irregular,I-PR
large,I-PR
prostate,I-PR
with,O
tumor,B-PR
invasion,I-PR
into,I-PR
the,I-PR
bladder,I-PR
and,O
evidence,O
of,O
bilateral,B-PR
retroperitoneal,I-PR
lymph,I-PR
node,I-PR
spread,I-PR
.,O

There,O
was,O
also,O
evidence,O
of,O
bone,B-PR
metastasis,I-PR
at,O
that,O
time,O
.,O

The,O
patient,O
was,O
admitted,O
in,O
October,O
of,O
1991,O
for,O
urinary,B-PR
retention,I-PR
and,O
acute,B-PR
renal,I-PR
failure,I-PR
and,O
was,O
treated,O
with,O
fluid,B-TR
rehydration,I-TR
and,O
Foley,B-TR
catheter,I-TR
placement,I-TR
.,O

Over,O
the,O
past,O
one,O
month,O
prior,O
to,O
admission,O
",",O
the,O
patient,O
's,O
wife,O
has,O
noticed,O
a,B-PR
marked,I-PR
decrease,I-PR
in,I-PR
p.o.,I-PR
intake,I-PR
and,O
also,O
noted,O
a,B-PR
weight,I-PR
loss,I-PR
of,O
approximately,O
ten,O
pounds,O
in,O
the,O
preceding,O
two,O
weeks,O
.,O

The,O
patient,O
has,O
been,O
lethargic,B-PR
and,O
bed,B-PR
ridden,I-PR
for,O
the,O
past,O
two,O
weeks,O
",",O
although,O
there,O
was,O
no,O
evidence,O
of,O
fever,B-PR
or,O
chills,B-PR
over,O
this,O
time,O
.,O

The,O
patient,O
is,O
now,O
admitted,O
for,O
fluid,B-TR
rehydration,I-TR
therapy,I-TR
and,O
observation,B-TE
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

As,O
above,O
.,O

MEDICATIONS,O
:,O

None,O
currently,O
.,O

ALLERGIES,O
:,O

None,O
.,O

HABITS,O
:,O

No,O
history,O
of,O
cigarette,O
smoking,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,O
patient,O
is,O
afebrile,B-PR
with,O
a,B-TE
recumbent,I-TE
blood,I-TE
pressure,I-TE
of,O
128/16,O
",",O
pulse,B-TE
of,O
76,O
",",O
and,O
standing,B-TE
blood,I-TE
pressure,I-TE
of,O
110/60,O
with,O
a,B-TE
pulse,I-TE
of,O
88,O
.,O

Respirations,B-TE
are,O
unlabored,B-PR
at,O
16,O
.,O

HEENT,O
:,O

Noted,O
for,O
nonicteric,B-PR
sclerae,I-PR
and,O
lungs,O
that,O
are,O
clear,O
to,O
auscultation,B-TE
.,O

No,O
CVA,B-PR
tenderness,I-PR
was,O
appreciated,O
in,O
the,O
heart,O
and,O
the,O
heart,O
appears,O
to,O
be,O
in,O
regular,O
rate,O
and,O
rhythm,O
.,O

EXTREMITIES,O
:,O

Without,O
cyanosis,B-PR
or,O
edema,B-PR
.,O

ABDOMEN,O
:,O

Soft,O
and,O
nontender,B-PR
.,O

SKIN,O
:,O

Decreased,B-PR
turgor,I-PR
with,O
dry,B-PR
mucous,I-PR
membranes,I-PR
.,O

LABORATORY,O
DATA,O
:,O

White,B-TE
count,I-TE
of,O
7.75,O
",",O
hematocrit,B-TE
of,O
46.2%,O
",",O
sodium,B-TE
144,O
",",O
potassium,B-TE
3.9,O
",",O
creatinine,B-TE
25,O
",",O
and,O
BUN,B-TE
was,O
1.4,O
with,O
a,B-TE
blood,I-TE
sugar,I-TE
of,O
88,O
.,O

Urinalysis,B-TE
demonstrated,O
30-50,B-PR
white,I-PR
blood,I-PR
cells,I-PR
with,O
red,B-PR
blood,I-PR
cells,I-PR
too,O
numerous,O
to,O
count,O
and,O
2+,B-PR
bacteria,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
with,O
a,O
diagnosis,O
of,O
prostate,B-PR
CA,I-PR
",",O
for,O
fluid,B-TR
rehydration,I-TR
.,O

Initially,O
",",O
the,O
patient,O
was,O
begun,O
on,O
Bactrim,B-TR
for,O
presumptive,O
urinary,B-PR
tract,I-PR
infection,I-PR
and,O
the,O
initial,O
course,O
of,O
his,O
hospitalization,O
",",O
he,O
took,O
p.o.',O
s,O
poorly,O
.,O

The,O
patient,O
remained,O
afebrile,B-PR
",",O
however,O
",",O
and,O
his,B-TE
electrolytes,I-TE
were,O
within,O
normal,O
limits,O
.,O

By,O
hospital,O
day,O
number,O
six,O
",",O
however,O
",",O
the,O
patient,O
became,O
febrile,B-PR
to,O
100.7,O
and,O
repeat,B-TE
urinalysis,I-TE
showed,O
20-30,B-PR
white,I-PR
blood,I-PR
cells,I-PR
and,O
1+,B-PR
bacteria,I-PR
.,O

Antibiotics,B-TR
were,O
switched,O
to,O
IV,B-TR
Ciprofloxacin,I-TR
and,O
the,O
patient,O
defervesced,O
;,O
however,O
",",O
by,O
hospital,O
day,O
number,O
seven,O
",",O
the,O
patient,O
was,O
found,O
to,O
be,O
passing,O
very,O
little,O
urine,O
through,O
his,B-TR
condom,I-TR
catheter,I-TR
and,O
electrolyte,B-TE
screen,I-TE
and,O
electrolytes,B-TE
from,O
hospital,O
day,O
number,O
seven,O
showed,O
a,B-TE
BUN,I-TE
of,O
27,O
and,O
a,B-TE
creatinine,I-TE
of,O
2.7,O
.,O

The,O
patient,O
was,O
vigorously,B-TR
fluid,I-TR
rehydrated,I-TR
;,O
however,O
",",O
by,O
hospital,O
day,O
number,O
nine,O
",",O
BUN,B-TE
was,O
22,O
",",O
creatinine,B-TE
was,O
3.5,O
.,O

A,B-TR
Foley,I-TR
catheter,I-TR
was,O
placed,O
at,O
that,O
time,O
with,O
the,O
recovery,O
of,O
approximately,O
800,O
cc,O
of,O
urine,O
.,O

Subsequently,O
",",O
the,O
patient,O
began,O
vigorously,O
diuresing,O
with,O
4,O
liters,O
urine,O
recovered,O
the,O
following,O
hospital,O
day,O
.,O

Blood,B-TE
electrolytes,I-TE
were,O
remarkable,O
for,O
a,B-TE
sodium,I-TE
of,O
148,O
and,O
a,B-TE
potassium,I-TE
of,O
5.1,O
.,O

The,B-TR
patient,I-TR
's,I-TR
fluid,I-TR
hydration,I-TR
from,O
D5,B-TR
one-half,I-TR
normal,I-TR
saline,I-TR
with,O
20,O
mEq,O
of,O
K,B-TR
to,O
D5W,B-TR
and,O
acuchecks,B-TE
from,O
this,O
time,O
showed,O
blood,B-TE
sugars,I-TE
routinely,O
between,O
20,O
and,O
50,O
.,O

The,O
patient,O
was,O
given,O
one,O
Amp,O
of,O
D50,B-TR
for,O
each,B-TE
acucheck,I-TE
for,O
blood,B-TE
sugars,I-TE
of,O
less,O
than,O
40,O
.,O

Gradually,O
over,O
the,O
course,O
of,O
the,O
following,O
days,O
",",O
the,B-TE
patient,I-TE
's,I-TE
electrolytes,I-TE
again,O
normalized,O
;,O
however,O
",",O
as,O
the,O
patient,O
continues,O
to,O
take,O
p.o.',O
s,O
poorly,O
",",O
the,O
patient,O
remained,O
on,O
IV,B-TR
hydration,I-TR
therapy,I-TR
.,O

On,O
hospital,O
day,O
number,O
fourteen,O
",",O
electrolytes,B-TE
were,O
sodium,B-TE
of,O
140,O
",",O
potassium,B-TE
3.9,O
",",O
BUN,B-TE
of,O
11,O
",",O
creatinine,B-TE
1.3,O
with,O
a,B-TE
blood,I-TE
sugar,I-TE
of,O
125,O
and,O
a,B-TE
magnesium,I-TE
of,O
1.9,O
.,O

The,O
patient,O
was,O
taking,O
470,O
cc,O
of,O
liquid,O
p.o.,O
and,O
is,O
now,O
in,O
stable,O
condition,O
and,O
ready,O
for,O
transfer,O
to,O
El,O
Hospital,O
to,O
continue,O
his,O
recovery,O
.,O

DISPOSITION,O
:,O

The,O
patient,O
is,O
transferred,O
to,O
El,O
Hospital,O
",",O
still,O
receiving,O
IV,B-TR
hydration,I-TR
at,O
a,O
rate,O
currently,O
of,O
50,O
cc,O
an,O
hour,O
of,O
D5,B-TR
one-half,I-TR
normal,I-TR
with,O
20,O
mEq,O
of,O
K,B-TR
.,O

Should,O
the,O
patient,O
's,O
p.o.,O
intake,O
drop,O
to,O
below,O
500,O
",",O
the,O
patient,O
should,O
be,O
hydrated,O
at,O
75,O
cc/hour,O
.,O

If,O
the,O
patient,O
's,O
p.o.,O
intake,O
drop,O
below,O
300,O
cc,O
per,O
day,O
",",O
the,O
patient,O
should,O
be,O
hydrated,O
at,O
100,O
cc,O
an,O
hour,O
.,O

The,B-TR
Foley,I-TR
catheter,I-TR
was,O
in,O
place,O
and,O
the,B-TR
Bacitracin,I-TR
ointment,I-TR
should,O
be,O
applied,O
to,O
the,O
urethral,O
meatus,O
twice,O
a,O
day,O
.,O

Periodic,B-TE
urinalysis,I-TE
should,O
be,O
conducted,O
to,O
monitor,O
the,O
development,O
of,O
possible,O
urinary,B-PR
tract,I-PR
infection,I-PR
.,O

It,O
should,O
be,O
noted,O
that,O
while,O
in,O
the,O
hospital,O
",",O
the,O
patient,O
received,O
an,B-TE
abdominal,I-TE
ultrasound,I-TE
which,O
is,O
significant,O
for,O
a,B-PR
grossly,I-PR
enlarged,I-PR
liver,I-PR
with,O
multiple,B-PR
foci,I-PR
of,I-PR
cancer,I-PR
.,O

The,O
patient,O
is,O
discharged,O
on,O
Mylanta,B-TR
30,O
cc,O
with,O
meals,O
",",O
Carafate,B-TR
1,O
gm,O
q.,O
6,O
",",O
Heparin,B-TR
5000,O
units,O
subcutaneous,O
b.i.d.,O
until,O
the,O
patient,O
regains,O
full,O
activity,O
and,O
IV,B-TR
hydration,I-TR
.,O

The,B-TR
Foley,I-TR
should,O
be,O
in,O
place,O
until,O
a,O
follow-up,O
appointment,O
with,O
Dr.,O
Aarhalt,O
can,O
be,O
scheduled,O
in,O
approximately,O
one,O
to,O
two,O
weeks,O
at,O
which,O
time,O
a,O
decision,O
regarding,O
the,O
status,O
of,O
the,B-PR
patient,I-PR
's,I-PR
urinary,I-PR
obstruction,I-PR
will,O
be,O
addressed,O
.,O

Dictated,O
By,O
:,O

CHIEROBEBREUTZ,O
",",O
M.D.,O
AA578/3804,O
CONRELLIE,O
S.,O
KOTERUDES,O
",",O
M.D.,O
KQ9,O

D,O
:,O

03/22/92,O

T,O
:,O

03/22/92,O

Batch,O
:,O

S541,O

Report,O
:,O

FS984Q01,O

Admission,O
Date,O
:,O

2013-02-11,O

Discharge,O
Date,O
:,O

2013-02-26,O

Date,O
of,O
Birth,O
:,O

1932-07-08,O

Sex,O
:,O

M,O

Service,O
:,O

KURLIND,O

ADDENDUM,O
:,O

The,O
patient,O
was,O
discharged,O
to,O
Milton/Haverhill,O
per,O
family,O
request,O
for,O
pain,B-PR
and,O
comfort,B-TR
(,I-TR
hospice,I-TR
),I-TR
management,I-TR
.,O

Please,O
refer,O
to,O
full,O
discharge,O
summary,O
for,O
details,O
.,O

Patricia,O
E.,O
Burnett,O
",",O
M.D.,O

54-256,O

Dictated,O
By,O
:,O
Sarah,O
G,O
Sheahan,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2013-05-01,O
10:33,O

T,O
:,O
2013-05-01,O
12:59,O

JOB,O
#:,O
23157,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Edward,O
Larue,O
on,O
:,O
TUE,O
2013-05-14,O
5:11,O
AM,O

(,O
End,O
of,O
Report,O
),O

383938711,O
ELMVH,O

8236772,O

6307693,O

10/30/2006,O
12:00:00,O
AM,O

s,O
/,O
p,O
Multiple,O
falls,O

DIS,O

Admission,O
Date,O
:,O

10/30/2006,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

11/03/2006,O

******,O
FINAL,O
DISCHARGE,O
ORDERS,O
******,O

TROUITSA,O
",",O
WIN,O

509-64-03-7,O
E03,O

Room,O
:,O

40R-480,O

Service,O
:,O

RNM,O

DISCHARGE,O
PATIENT,O
ON,O
:,O

11/03/06,O
AT,O
10:45,O
AM,O

CONTINGENT,O
UPON,O

Not,O
Applicable,O

WILL,O
D,O
/,O
C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D,O
/,O
C,O
SUMMARY,O
:,O

YES,O

Attending,O
:,O

FYFE,O
",",O
NAAN,O
ACANDEA,O
",",O
M.D.,O

CODE,O
STATUS,O
:,O

Full,O
code,O

DISPOSITION,O
:,O

Home,O
w/,O
services,O

DISCHARGE,O
MEDICATIONS,O
:,O

TYLENOL,B-TR
(,I-TR
ACETAMINOPHEN,I-TR
),I-TR
650,O
MG,O
PO,O
Q4H,O
Starting,O
Today,O
(,O
11/02,O
),O
PRN,O
Headache,B-PR

Instructions,O
:,O

Do,O
not,O
take,O
more,O
than,O
4gm,O
/,O
day,O
ACETYLSALICYLIC,B-TR
ACID,I-TR
325,O
MG,O
PO,O
DAILY,O
PHOSLO,B-TR
(,I-TR
CALCIUM,I-TR
ACETATE,I-TR
(,O
1,O
GELCAP,O
=,O
667,O
MG,O
),O
),O
"1,334",O
MG,O
PO,O
TID,O

Instructions,O
:,O

Please,O
give,O
with,O
meals,O
FLOVENT,B-TR
HFA,I-TR
(,I-TR
FLUTICASONE,I-TR
PROPIONATE,I-TR
),I-TR
44,O
MCG,O
INH,O
BID,O
LABETALOL,B-TR
HCL,I-TR
300,O

MG,O
PO,O
BID,O

HOLD,O
IF,O
:,O

SBP,B-TE
&lt;,O
100,O
or,O
HR,B-TE
&lt;,O
55,O

Food,O
/,O
Drug,O
Interaction,O
Instruction,O

Take,O
consistently,O
with,O
meals,O
or,O
on,O
empty,O
stomach,O
.,O

COZAAR,B-TR
(,I-TR
LOSARTAN,I-TR
),I-TR
50,O

MG,O
PO,O
DAILY,O
HOLD,O
IF,O
:,O

SBP,B-TE
&lt;,O
100,O

Number,O
of,O
Doses,O
Required,O
(,O
approximate,O
),O
:,O

3,O

NEPHROCAPS,B-TR
(,I-TR
NEPHRO-VIT,I-TR
RX,I-TR
),I-TR
1,O
TAB,O
PO,O
DAILY,O

Alert,O
overridden,O
:,O

Override,O
added,O
on,O
10/30/06,O
by,O
FELSAPPRYDEFUSC,O
",",O
ERI,O
N.,O
",",O
M.D.,O

POTENTIALLY,O
SERIOUS,B-PR
INTERACTION,I-PR
:,O

SIMVASTATIN,B-TR
and,O
NIACIN,B-TR
",",O
VIT.,B-TR
B-3,I-TR

Reason,O
for,O
override,O
:,O

will,O
monitor,O

ZOCOR,B-TR
(,I-TR
SIMVASTATIN,I-TR
),I-TR
40,O
MG,O
PO,O
BEDTIME,O

Food,O
/,O
Drug,O
Interaction,O
Instruction,O

Avoid,O
grapefruit,O
unless,O
MD,O
instructs,O
otherwise,O
.,O

Override,O
Notice,O
:,O

Override,O
added,O
on,O
10/30/06,O
by,O
FELSAPPRYDEFUSC,O
",",O
ERI,O
N.,O
",",O
M.D.,O
on,O
order,O
for,O
NEPHROCAPS,B-TR
PO,I-TR
(,O
ref,O
#,O
581988585,O
),O

POTENTIALLY,O
SERIOUS,B-PR
INTERACTION,I-PR
:,O

SIMVASTATIN,B-TR
and,O
NIACIN,B-TR
",",O
VIT,B-TR
.,I-TR

B-3,B-TR

Reason,O
for,O
override,O
:,O

will,O
monitor,O

DIET,O
:,O

House,O
/,O
2,O
gm,O
Na,O
/,O
Low,O
saturated,O
fat,O
low,O
cholesterol,O
/,O
2,O
gram,O
K+,O
",",O
Renal,B-TR
diet,I-TR
&lt;,O
I,O
&gt;,O
&lt;,O
FDI,O
&gt;,O

ACTIVITY,O
:,O

Walking,O
as,O
tolerated,O

FOLLOW,O
UP,O
APPOINTMENT,O
(,O
S,O
),O
:,O

Hemodialysis,B-TR
MWF,O
",",O
Dr.,O
Gaetz,O
220-871-6906,O
1-2,O
weeks,O
",",O
Dr.,O
Clow,O
836-771-4924,O
1,O
week,O
",",O
Cardiology,O
Clinic,O
452-860-1428,O
",",O
please,O
call,O
to,O
make,O
an,O
appointment,O
in,O
1-2,O
weeks,O
with,O
a,O
cardiology,O
fellow,O
",",O

ALLERGY,O
:,O

NKA,B-PR

ADMIT,O
DIAGNOSIS,O
:,O

s,O
/,O
p,O
Multiple,O
falls,O

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O

Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O
s,O
/,O
p,O
Multiple,O
falls,O

OTHER,O
DIAGNOSIS,O
;,O

Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O

IHSS,B-PR
AF,B-PR
ESRD,B-PR
on,O
HD,B-TR
",",O
IgA,B-PR
nephropathy,I-PR
on,O
transplant,O
list,O
",",O
COPD,B-PR
",",O
s,O
/,O
p,O
pacemaker,B-TR
for,O
afib,B-PR
",",O
BPH,B-PR
s,O
/,O
p,O
TURP,B-TR
",",O
HTN,B-PR
",",O
hypothyroidism,B-PR
",",O
gout,B-PR
",",O
h,O
/,O
o,O
positive,B-PR
PPD,I-PR
MR,B-PR

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

None,O

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O

Hemodialysis,B-TR
s,O
/,O
p,O
abdominal,B-TE
fat,I-TE
pad,I-TE
biopsy,I-TE
11/2/06,O

BRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

cc,O
:,O

falls,O

HPI,O
:,O

62,O
yo,O
m,O
w,O
/,O
IgA,B-PR
nephropathy,I-PR
",",O
developmental,B-PR
delay,I-PR
",",O
began,O
HD,B-TR
7/31,O
.,O

Was,O
seen,O
in,O
dialysis,O
on,O
day,O
of,O
admission,O
and,O
was,O
seen,O
to,O
have,O
&quot;,B-PR
raccoon,I-PR
eyes,I-PR
&quot;,I-PR
and,O
HD,O
staff,O
was,O
worried,O
about,O
sending,O
home,O
.,O

Head,B-TE
CT,I-TE
w,O
/,O
o,O
bleed,B-PR
.,O

Trauma,B-TE
series,I-TE
normal,O
.,O

Pt,O
denies,O
abuse,O
or,O
loc,B-PR
associated,O
w,O
/,O
fall,O
",",O
but,O
has,O
noticed,O
several,O
recent,O
falls,O
.,O

Recent,B-TE
neuro,I-TE
w,I-TE
/,I-TE
u,I-TE
including,O
EEG,B-TE
",",O
carotid,B-TE
u,I-TE
/,I-TE
s,I-TE
",",O
head,B-TE
ct,I-TE
(,O
old,B-PR
stroke,I-PR
),O
",",O
dobutamine-MIBI,B-TE
(,O
fixed,B-PR
defect,I-PR
and,O
small,B-PR
inferolateral,I-PR
reversible,I-PR
),O
were,O
all,O
negative,O
.,O

Notable,O

PMH,O
:,O

ESRD,B-PR
from,O
IgA,B-PR
",",O
s,O
/,O
p,O
PPI,B-TR
after,O
nodal,B-TR
ablation,I-TR
",",O
HTN,B-PR
",",O
COPD,B-PR
",",O
hypothyroid,B-PR
",",O
hypertrophic,B-PR

CM,O
PE,O
:,O

T,B-TE
96.5,O
",",O
BP,B-TE
145/97,O
",",O
p,B-TE
70,O
",",O
Pox,B-TE
98%,O
Gen,O
AO,O
x,O
3,O
",",O
raccoon,B-PR
eyes,I-PR
",",O
large,B-PR
forehead,I-PR
hematoma,I-PR

Lungs,O
:,O

clear,O

Abd,O
:,O

soft,O
",",O
NT,B-PR

Ext,O
:,O

1+,B-PR
edema,I-PR
b,I-PR
/,I-PR
l,I-PR

Skin,O
:,O

warm,O
",",O
smooth,O
",",O
no,O
rashes,B-PR

Access,O
site,O
:,O

clean,O
w,O
/,O
o,O
inflammation,B-PR

Labs,O
:,O

K,B-TE
3.5,O
",",O
Creat,B-TE
3.8,O
",",O
Trop-I,B-TE
0.45,O
",",O
INR,B-TE
1.6,O

HOSPITAL,O
COURSE,O
:,O

1.,O
Falls-A,O
PT,O
consult,O
was,O
obtained,O
to,O
assist,O
with,O
ambulation,O
.,O

A,O
social,O
work,O
consult,O
was,O
also,O
obtained,O
and,O
deemed,O
that,O
the,O
patient,O
has,O
appropriate,O
support,O
at,O
home,O
and,O
is,O
safe,O
at,O
home,O
.,O

The,O
patient,O
was,O
placed,O
on,O
telemetry,B-TE
and,O
had,O
no,O
telemetry,B-PR
events,I-PR
while,O
an,O
inpatient,O
.,O

He,O
was,O
also,O
seen,O
by,O
the,O
Electrophysiology,O
service,O
",",O
his,B-TR
pacemaker,I-TR
was,O
interrogated,O
and,O
working,O
fine,O
",",O
with,O
no,O
signs,O
of,O
recent,B-PR
ventricular,I-PR
arrhythmia,I-PR
.,O

The,O
patient,O
his,O
undergoing,O
a,B-TE
TTE,I-TE
prior,O
to,O
discharge,O
to,O
rule,O
out,O
a,B-PR
thrombus,I-PR
.,O

His,B-TE
TTE,I-TE
showed,O
EF,B-TE
45-50%,O
",",O
moderate,B-PR
cLVH,I-PR
",",O
abnormal,B-PR
diastolic,I-PR
function,I-PR
",",O
moderate,B-PR
MR,I-PR
",",O
moderate,B-PR
TR,I-PR
and,O
severe,B-PR
LAE,I-PR
.,O

THere,O
was,O
a,O
question,O
of,O
ionfiltrative,B-PR
cardiomyopathy,I-PR
",",O
and,O
the,O
patient,O
underwent,O
abdominal,B-TE
fat,I-TE
pad,I-TE
biopsy,I-TE
to,O
assess,O
for,O
amyloidosis,B-PR
.,O

He,O
also,O
currently,O
has,O
an,B-TE
SPEP,I-TE
/,O
UPEP/Beta,B-TE
2,I-TE
microglobulin,I-TE
/,O
ACE,B-TE
test,I-TE
that,O
are,O
currently,O
pending,O
.,O

These,O
should,O
be,O
followed,O
up,O
as,O
an,O
outaptient,O
.,O

He,O
had,O
carotid,B-TE
ultrasound,I-TE
studies,I-TE
3,O
months,O
ago,O
that,O
were,O
normal,O
without,O
evidence,O
for,O
stenosis,B-PR
.,O

2.,O
Renal,O
-,O
cont,O
MWF,O
HD,B-TR
;,O
electrolytes,B-TE
have,O
been,O
stable,O
.,O

Perhaps,O
his,O
recent,O
falls,O
are,O
related,O
to,O
orthostatic,B-PR
hypotension,I-PR
after,O
dialysis,B-TR
.,O

3.,O
CV,O
-The,O
pt,O
has,O
a,O
small,O
area,O
of,O
reversible,B-PR
ischemia,I-PR
on,O
recent,B-TE
MIBI,I-TE
",",O
and,O
has,O
troponins,B-PR
persistently,I-PR
elevated,I-PR
in,O
the,O
setting,O
of,O
his,B-PR
renal,I-PR
disease,I-PR
.,O

His,B-TE
troponins,I-TE
remained,O
lower,O
than,O
his,O
baseline,O
levels,O
and,O
there,O
was,O
no,O
suspicion,O
of,O
ACS,B-PR
causing,O
syncope,B-PR
.,O

He,O
continued,O
on,O
his,B-TR
zocor,I-TR
",",O
cozaar,B-TR
and,O
labetalol,B-TR
.,O

We,O
will,O
now,O
hold,O
his,B-TR
coumadin,I-TR
given,O
his,O
recent,O
falls,O
and,O
bleeding,B-PR
risk,I-PR
.,O

His,B-TR
aspirin,I-TR
was,O
restarted,O
prior,O
to,O
discharge,O
.,O

4.,O
Endo,O
-,O
TSH,B-TE
was,O
4.7,O
and,O
normal,O
.,O

5.,O
Heme,O
:,O

The,O
patient,O
has,O
a,B-PR
macrocytosis,I-PR
.,O

His,B-TE
B12,I-TE
level,I-TE
was,O
418,O
and,O
normal,O
.,O

He,O
does,O
have,O
a,O
history,O
of,O
B12,B-PR
deficiency,I-PR
in,O
the,O
past,O
",",O
and,O
evidence,O
for,O
peripheral,B-PR
neuropathy,I-PR
BLE,I-PR
which,O
may,O
also,O
be,O
contributing,O
to,O
his,O
recent,O
falls,O
.,O
?,O
EtOH,O

6.,O
Psych,O
:,O

watch,O
for,O
EtOH,B-PR
WD,I-PR
.,O

THe,O
patient,O
had,O
no,O
signs,O
of,O
alcohol,B-PR
withdrawal,I-PR
.,O

His,B-TE
serum,I-TE
toxicology,I-TE
screen,I-TE
was,O
negative,O
.,O

7.,O
Pulm,O
:,O

COPD,B-PR
and,O
R,B-PR
pleural,I-PR
effusion,I-PR
",",O
off,O
oxygen,B-TR
and,O
stable,O
.,O

8.,O
GU,O
:,O

R,B-PR
complex,I-PR
renal,I-PR
cyst,I-PR
",",O
bladder,B-PR
diverticula,I-PR
.,O

THe,O
patient,O
will,O
need,O
a,B-TE
follow,I-TE
up,I-TE
ultrasound,I-TE
to,O
further,O
evaluate,O
these,B-PR
incidental,I-PR
findings,I-PR
seen,O
on,O
imaging,B-TE
upon,O
admission,O
.,O

9.,O
ID,O
:,O

The,B-TE
patient,I-TE
&apos;s,I-TE
urinalysis,I-TE
was,O
normal,O
.,O

He,O
had,O
no,O
fecal,B-PR
leukocytes,I-PR
.,O

A,B-TE
c.difficile,I-TE
test,I-TE
is,O
negative,O
on,O
prelim,O
read,O
",",O
however,O
very,O
low,O
suspicion,O
given,O
no,O
recent,B-TR
antibiotic,I-TR
use,I-TR
.,O

ADDITIONAL,O
COMMENTS,O
:,O

Please,O
return,O
to,O
the,O
hospital,O
if,O
you,O
have,O
falls,B-PR
",",O
headache,B-PR
",",O
visual,B-PR
changes,I-PR
",",O
muscle,B-PR
weakness,I-PR
",",O
chest,B-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O

TO,O
DO,O
/,O
PLAN,O
:,O

1),O
Hemodialysis,B-TR

2),O
Please,O
do,O
not,O
take,O
coumadin,B-TR
.,O

3),O
Please,O
follow,O
up,O
with,O
PCP,O
to,O
have,O
ultrasound,B-TE
of,I-TE
right,I-TE
kidney,I-TE
and,I-TE
bladder,I-TE
to,O
assess,O
right,B-PR
kidney,I-PR
cyst,I-PR
and,O
bladder,B-PR
diverticula,I-PR
seen,O
incidentally,O

4),O
Please,O
follow,O
up,O
with,O
Dr.,O
Clow,O
to,O
follow,O
up,O
results,O
of,O
abdominal,B-TE
fat,I-TE
pad,I-TE
biopsy,I-TE
and,O
blood,B-TE
tests,I-TE
to,O
assess,O
for,O
amyloid,B-PR
.,O

No,O
dictated,O
summary,O

ENTERED,O
BY,O
:,O

FELSAPPRYDEFUSC,O
",",O
ERI,O
N.,O
",",O
M.D.,O
(,O
NT717,O
),O
11/03/06,O
10:51,O
AM,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

Admission,O
Date,O
:,O

2018-05-12,O

Discharge,O
Date,O
:,O

2018-05-14,O

Date,O
of,O
Birth,O
:,O

2018-05-07,O

Sex,O
:,O

M,O

Service,O
:,O

Neonatology,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Melba,O
Barnett,O
is,O
the,O
3.710,O
-,O
kg,O
(,O
8,O
-,O
pound,O
3,O
-,O
ounce,O
),O
product,O
of,O
a,O
term,O
gestation,O
.,O

He,O
was,O
born,O
to,O
a,O
35,O
-,O
year-old,O
gravida,O
2,O
",",O
para,O
1,O
(,O
now,O
2,O
),O
mother,O
.,O

Readmitted,O
for,O
hyperbilirubinemia,B-PR
on,O
day,O
of,O
life,O
#5,O
.,O

The,O
pregnancy,O
was,O
benign,O
with,O
an,O
EDC,O
of,O
2018-05-07,O
.,O

Prenatal,B-TE
screens,I-TE
were,O
O+,O
",",O
antibody,B-TE
negative,O
",",O
hepatitis,B-TE
surface,I-TE
antigen,I-TE
negative,O
",",O
rapid,B-TE
plasma,I-TE
reagin,I-TE
nonreactive,O
",",O
rubella,B-TE
immune,O
",",O
group,B-TE
B,I-TE
strep,I-TE
positive,O
.,O

The,O
infant,O
delivered,O
vaginally,O
with,O
Apgar,B-TE
scores,I-TE
of,O
9,O
at,O
one,O
minute,O
and,O
9,O
at,O
five,O
minutes,O
.,O

Alleyne,B-TE
blood,I-TE
type,I-TE
is,O
O+,O
/,O
Coombs,B-TE
negative,O
.,O

He,O
was,O
readmitted,O
for,O
phototherapy,B-TR
on,O
day,O
of,O
life,O
#5,O
for,O
a,B-TE
bilirubin,I-TE
of,O
23.3,O
.,O

PHYSICAL,O
EXAMINATION,O
ON,O
ADMISSION,O
:,O

On,O
admission,O
",",O
Thomas,O
was,O
well-appearing,O
though,O
slightly,B-PR
sleepy,I-PR
with,O
jaundice,B-PR
.,O

He,O
had,O
bilateral,O
breath,O
sounds,O
that,O
were,O
clear,O
and,O
equal,O
.,O

The,B-TE
heart,I-TE
rate,I-TE
was,O
regular,O
without,O
murmur,B-PR
",",O
and,O
pulses,B-TE
were,O
2+,O
and,O
symmetrical,O
.,O

The,O
abdomen,O
was,O
soft,O
and,O
nontender,B-PR
with,O
no,O
hepatosplenomegaly,B-PR
.,O

His,B-TE
weight,I-TE
was,O
3.505,O
(,O
7,O
pounds,O
/,O
12,O
ounces,O
),O
on,O
readmission,O
.,O

He,O
had,O
normal,O
male,O
genitalia,O
with,O
bilaterally,O
descended,O
testes,O
.,O

His,O
hips,O
were,O
stable,O
.,O

His,B-TE
tone,I-TE
was,O
normal,O
with,O
normal,O
neonatal,O
reflexes,O
.,O

He,O
is,O
tolerating,O
his,O
feedings,O
well,O
.,O

SUMMARY,O
OF,O
HOSPITAL,O
COURSE,O
:,O

RESPIRATORY,O
:,O

Without,O
issues,O
on,O
this,O
admission,O
.,O

Breath,B-TE
sounds,I-TE
are,O
clear,O
and,O
equal,O
.,O

CARDIOVASCULAR,O
:,O

Without,O
issues,O
on,O
this,O
admission,O
.,O

He,O
had,O
a,O
regular,O
heart,O
rate,O
and,O
rhythm,O
",",O
no,O
murmur,B-PR
",",O
and,O
pulses,B-TE
were,O
2+,O
and,O
symmetric,O
.,O

FLUIDS,O
",",O
ELECTROLYTES,O
AND,O
NUTRITION,O
:,O

Alleyne,O
birth,B-TE
weight,I-TE
was,O
3.710,O
kg,O
(,O
8,O
pounds,O
/,O
3,O
ounces,O
).,O

His,B-TE
weight,I-TE
on,O
this,O
admission,O
was,O
3.505,O
kg,O
(,O
7,O
pounds,O
/,O
12,O
ounces,O
).,O

Linda,O
is,O
breast,O
feeding,O
every,O
3,O
hours,O
and,O
supplementing,O
with,O
expressed,O
breast,O
milk,O
.,O

He,O
is,O
feeding,O
well,O
.,O

His,B-TE
discharge,I-TE
weight,I-TE
is,O
3585,O
grams,O
(,O
7,O
pounds,O
13,O
ounces,O
),O
.,O

GASTROINTESTINAL,O
:,O

Alleyne,O
bilirubin,B-TE
on,O
2018-05-09,O
was,O
10.4,O
;,O
at,O
which,O
time,O
he,O
was,O
discharged,O
to,O
home,O
.,O

At,O
the,O
primary,O
pediatrician,O
's,O
office,O
on,O
2018-05-12,O
his,B-TE
bilirubin,I-TE
had,O
been,O
23,O
",",O
at,O
which,O
time,O
he,O
was,O
readmitted,O
to,O
the,O
HealthSouth,O
Rehab,O
Hospital,O
of,O
Western,O
Mass.,O
and,O
double,B-TR
phototherapy,I-TR
was,O
started,O
.,O

His,B-TE
bilirubin,I-TE
on,O
05-13,O
was,O
18.4,O
;,O
and,O
on,O
05-14,O
it,O
was,O
14.7,O
.,O

Phototherapy,B-TR
was,O
discontinued,O
on,O
2018-05-14,O
",",O
and,O
a,B-TE
rebound,I-TE
bilirubin,I-TE
will,O
be,O
checked,O
in,O
the,O
pediatrician,O
's,O
office,O
.,O

HEMATOLOGY,O
:,O

The,B-TE
hematocrit,I-TE
on,O
05-12,O
was,O
48.7,O
with,O
a,B-TE
reticulocyte,I-TE
count,I-TE
of,O
1.9,O
",",O
and,O
his,B-TE
blood,I-TE
type,I-TE
is,O
O+,O
/,O
Coombs,B-TE
negative,O
.,O

INFECTIOUS,O
DISEASE,O
:,O

No,O
issues,O
on,O
this,O
admission,O
.,O

NEUROLOGICAL,O
:,O

The,O
infant,O
has,O
been,O
appropriate,O
for,O
gestational,O
age,O
.,O

SENSORY,O
:,O

Auditory,B-TE
hearing,I-TE
screening,I-TE
was,O
performed,O
with,O
automated,O
auditory,O
brain,O
stem,O
responses,O
",",O
and,O
the,O
infant,O
passed,O
both,O
ears,O
on,O
his,O
previous,O
admission,O
.,O

Hearing,B-TE
screens,I-TE
were,O
repeated,O
on,O
2018-05-13,O
and,O
he,O
passed,O
both,O
ears,O
.,O

PSYCHOSOCIAL,O
:,O

Family,O
is,O
invested,O
and,O
involved,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
.,O

DISCHARGE,O
DISPOSITION,O
:,O

To,O
home,O
.,O

SOURCE,O
OF,O
PRIMARY,O
PEDIATRIC,O
CARE,O
:,O

South,O
Cove,O
Community,O
Health,O
Center,O
at,O
5368,O
W.,O
Sixth,O
Rd.,O
",",O
Burlington,O
",",O
Oregon,O
55832,O
;,O
telephone,O
number,O
(,O
391-5273,O
.,O

CARE,O
RECOMMENDATIONS,O
:,O

1.,O
Continue,O
ad,O
lib,O
feeding,O
.,O

2.,O
Follow,O
up,O
with,O
pediatrician,O
at,O
SCCHC,O
on,O
Tuesday,O
2018-05-15,O
.,O

3.,O
Medications,O
:,O

Not,O
applicable,O
.,O

4.,O
Car,B-TE
seat,I-TE
positioning,I-TE
screen,I-TE
:,O

Not,O
applicable,O
.,O

5.,O
State,B-TE
newborn,I-TE
screens,I-TE
were,O
sent,O
on,O
2018-05-09,O
;,O
and,O
results,O
are,O
pending,O
.,O

On,O
his,O
previous,O
admission,O
",",O
Terrance,O
received,O
hepatitis,B-TR
B,I-TR
vaccine,I-TR
on,O
2018-05-09,O
.,O

6.,O
Immunization,B-TR
recommended,O
:,O

Influenza,B-TR
immunization,I-TR
is,O
recommended,O
annually,O
in,O
the,O
Fall,O
for,O
all,O
infants,O
once,O
they,O
reach,O
6,O
months,O
of,O
age,O
.,O

Before,O
this,O
age,O
(,O
and,O
for,O
the,O
first,O
24,O
months,O
of,O
the,O
child,O
's,O
life,O
),O
immunization,B-TR
against,O
influenza,B-PR
is,O
recommended,O
for,O
household,O
contacts,O
and,O
out,O
of,O
home,O
caregivers,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Term,O
",",O
appropriate,O
for,O
gestational,O
age,O
",",O
male,O
neonate,O
.,O

2.,O
Exaggerated,B-PR
physiologic,I-PR
hyperbilirubinemia,I-PR
responsive,O
to,O
phototherapy,B-TR

Jennifer,O
Martin,O
",",O
North,O
Dakota,O
07287,O

Dictated,O
By,O
:,O
Jean,O
TE,O
Fletcher,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2018-05-13,O
13:07:31,O

T,O
:,O
2018-05-13,O
14:24:41,O

Job,O
#:,O
75582,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Deloris,O
O.,O
Williams,O
on,O
:,O
MON,O
2018-05-14,O
9:37,O
AM,O

(,O
End,O
of,O
Report,O
),O

385215362,O

CTMC,O

47531332,O

8504886,O

11/17/2003,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

11/17/2003,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

PROGRESSIVE,B-PR
ACANTHAMOEBA,I-PR
INFECTION,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
65-year-old,O
man,O
with,O
refractory,B-PR
CLL,I-PR
",",O
status,O
post,O
non-myeloblative,B-TR
stem,I-TR
cell,I-TR
transplant,I-TR
approximately,O
nine,O
months,O
prior,O
to,O
admission,O
",",O
and,O
status,O
post,O
prolonged,O
recent,O
Retelk,O
County,O
Medical,O
Center,O
stay,O
for,O
Acanthamoeba,B-PR
infection,I-PR
of,I-PR
skin,I-PR
and,O
sinuses,O
",",O
complicated,O
by,O
ARS,B-PR
due,O
to,O
medication,B-PR
toxicity,I-PR
",",O
as,O
well,O
as,O
GVHD,B-PR
and,O
recent,B-PR
CMV,I-PR
infection,I-PR
",",O
readmitted,O
for,O
new,B-PR
fever,I-PR
",",O
increasing,B-PR
creatinine,I-PR
",",O
hepatomegaly,B-PR
and,O
fluid,B-PR
surge,I-PR
spacing,I-PR
",",O
in,O
the,O
setting,O
of,O
hyponatremia,B-PR
.,O

Patient,O
initially,O
presented,O
in,O
1991,O
with,O
cervical,B-PR
lymphadenopathy,I-PR
",",O
was,O
treated,O
with,O
MACE,B-TR
/,O
CytaBOM,B-TR
",",O
and,O
did,O
well,O
until,O
1997,O
",",O
when,O
he,O
received,O
six,O
cycles,O
of,O
fludarabine,B-TR
for,O
progressive,B-PR
disease,I-PR
.,O

In,O
November,O
",",O
2001,O
",",O
he,O
progressed,O
to,O
leukemic,B-PR
phase,I-PR
",",O
received,O
Rituxan,B-TR
and,O
CVP,B-TR
.,O

Started,O
Campath,B-TR
in,O
July,O
",",O
2001,O
",",O
complicated,O
by,O
lymphopenia,B-PR
/,O
neutropenia,B-PR
and,O
CMV,B-PR
infection,I-PR
",",O
and,O
underwent,O
MUD,B-TR
stem,I-TR
cell,I-TR
transplant,I-TR
in,O
December,O
",",O
2002,O
.,O

The,O
patient,O
had,O
bone,B-TE
marrow,I-TE
biopsy,I-TE
",",O
August,O
",",O
2003,O
",",O
for,O
persistent,B-PR
pancytopenia,I-PR
",",O
revealing,O
mild,B-PR
hypercelluarity,I-PR
with,O
80%,B-PR
leukemic,I-PR
cells,I-PR
.,O

He,O
was,O
again,O
treated,O
with,O
Campath,B-TR
",",O
had,O
recurrent,B-PR
fever,I-PR
in,O
association,O
with,O
sinus,B-PR
symptoms,I-PR
",",O
with,O
CT,B-TE
scan,I-TE
showing,O
left,B-PR
maxillary,I-PR
sinusitis,I-PR
in,O
association,O
with,O
new,B-PR
skin,I-PR
nodules,I-PR
on,I-PR
right,I-PR
elbow,I-PR
and,I-PR
buttocks,I-PR
.,O

Patient,O
was,O
hospitalized,O
September,O
26,O
to,O
November,O
11,O
for,O
what,O
was,O
diagnosed,O
by,O
skin,B-TE
biopsy,I-TE
and,O
sinus,B-TE
washings,I-TE
as,O
Acanthamoeba,B-PR
infection,I-PR
of,I-PR
skin,I-PR
and,O
sinuses,O
",",O
without,O
any,O
progression,O
to,O
neurologic,B-PR
infection,I-PR
(,O
as,O
assessed,O
by,O
head,B-TE
CT,I-TE
and,O
MRI,B-TE
),O
.,O

ID,O
consult,O
was,O
obtained,O
and,O
he,O
was,O
initially,O
treated,O
with,O
azithromycin,B-TR
",",O
itraconazole,B-TR
",",O
and,O
pentamidine,B-TR
",",O
with,O
progression,O
of,O
skin,B-PR
infection,I-PR
.,O

Subsequent,O
discontinuance,O
of,O
azithromycin,B-TR
",",O
trial,B-TR
of,I-TR
5-FC,I-TR
",",O
with,O
increasing,B-PR
neutropenia,I-PR
requiring,O
discontinuance,O
",",O
change,O
if,O
itraconazole,B-TR
to,O
voriconazole,B-TR
",",O
given,O
continued,B-PR
neutropenia,I-PR
",",O
and,O
trial,O
of,O
sulfadiazine,B-TR
",",O
discontinued,O
for,O
increasing,B-PR
ARS,I-PR
.,O

Patient,O
was,O
maintained,O
on,O
p.o.,B-TR
voriconazole,I-TR
and,O
IV,B-TR
pentamidine,I-TR
",",O
with,O
pentamidine,B-TR
nasal,I-TR
washings,I-TR
",",O
with,O
re-CT,B-TE
of,I-TE
sinuses,I-TE
near,O
end,O
of,O
stay,O
showing,O
no,O
change,O
in,O
disease,B-PR
burden,I-PR
.,O

He,O
has,O
had,O
recurrent,B-PR
CMB,I-PR
infection,I-PR
in,O
the,O
setting,O
of,O
Campath,B-TR
therapy,I-TR
",",O
requiring,O
IV,B-TR
Foscarnet,I-TR
therapy,I-TR
during,O
stay,O
",",O
with,O
inability,O
to,O
tolerate,O
valganciclovir,B-TR
maintenance,I-TR
suppression,I-TR
subsequently,O
due,O
to,O
increasing,B-PR
ARS,I-PR
.,O

Hypercapture,B-TE
near,O
end,O
of,O
stay,O
was,O
negative,O
.,O

Patient,O
experienced,O
acute,B-PR
renal,I-PR
failure,I-PR
on,O
chronic,B-PR
renal,I-PR
insufficiency,I-PR
",",O
with,O
previous,B-TE
baseline,I-TE
creatinine,I-TE
1.6,O
",",O
felt,O
to,O
be,O
due,O
to,O
medication,B-PR
toxicity,I-PR
",",O
requiring,O
Kayexalate,B-TR
and,O
Phoslo,B-TR
to,O
manage,O
electrolytes,B-TE
",",O
but,O
never,O
any,O
need,O
for,O
hemodialysis,B-TR
",",O
with,O
mild,O
improvement,O
of,O
creatinine,B-TE
by,O
discharge,O
",",O
with,O
peak,B-TE
creatinine,I-TE
3.4,O
",",O
discharge,B-TE
creatinine,I-TE
2.6,O
.,O

Patient,O
struggled,O
with,O
GVHD,B-PR
",",O
with,O
extensive,B-PR
skin,I-PR
involvement,I-PR
",",O
taking,O
Cellcept,B-TR
",",O
prednisone,B-TR
and,O
cyclosporine,B-TR
at,O
time,O
of,O
last,O
admission,O
.,O

Cellcept,B-TR
was,O
discontinued,O
in,O
the,O
setting,O
of,O
infection,B-PR
",",O
but,O
attempts,O
to,O
decrease,O
prednisone,B-TR
or,O
cyclosporine,B-TR
were,O
unsuccessful,O
.,O

Patient,O
returns,O
from,O
rehabilitation,B-TR
after,O
discharge,O
on,O
November,O
11,O
",",O
with,O
new,B-PR
fever,I-PR
up,O
to,O
102.0,O
in,O
DSCI,O
clinic,O
",",O
increasing,B-PR
hepatomegaly,I-PR
as,O
assessed,O
by,O
examination,B-TE
in,O
clinic,O
",",O
and,O
increasing,B-PR
creatinine,I-PR
.,O

Patient,O
reports,O
no,O
significant,O
changes,O
in,O
how,O
he,O
feels,O
over,O
the,O
past,O
week,O
.,O

Denies,O
cough,B-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
chest,B-PR
pain,I-PR
",",O
nausea,B-PR
",",O
vomiting,B-PR
",",O
diarrhea,B-PR
",",O
dysuria,B-PR
",",O
neck,B-PR
stiffness,I-PR
",",O
new,B-PR
skin,I-PR
lesions,I-PR
",",O
worsening,B-PR
red,I-PR
petechiae,I-PR
",",O
or,O
increasing,B-PR
sinus,I-PR
symptoms,I-PR
.,O

Patient,O
reports,O
persistent,B-PR
mild,I-PR
right,I-PR
upper,I-PR
quadrant,I-PR
discomfort,I-PR
",",O
recent,B-PR
poor,I-PR
appetite,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Refractory,B-PR
CLL,I-PR
with,O
bone,B-PR
marrow,I-PR
involvement,I-PR
",",O
status,O
post,O
MUD,B-TR
",",I-TR
mini-allo,I-TR
stem,I-TR
cell,I-TR
transplant,I-TR
",",O
December,O
",",O
2002,O
",",O
Acanthamoeba,B-PR
infection,I-PR
of,I-PR
skin,I-PR
and,I-PR
sinuses,I-PR
",",O
recently,O
treated,O
with,O
IV,B-TR
pentamidine,I-TR
and,O
p.o.,B-TR
voriconazole,I-TR
",",O
history,O
of,O
recurrent,B-PR
CMB,I-PR
infection,I-PR
",",O
recent,B-PR
ARS,I-PR
on,O
CRI,B-PR
",",O
thought,O
due,O
to,O
medication,B-PR
toxicity,I-PR
(,O
creatinine,B-TE
on,O
discharge,O
from,O
Retelk,O
County,O
Medical,O
Center,O
on,O
October,O
16,O
was,O
2.6),O
.,O

No,O
history,O
of,O
hemodialysis,B-TR
.,O

Graft,B-PR
versus,I-PR
host,I-PR
disease,I-PR
",",O
recently,O
on,O
cyclosporine,B-TR
50,O
b.i.d.,O
and,O
prednisone,B-TR
60,O
q.d.,O

History,O
of,O
SVT,B-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Pentamidine,B-TR
300,O
mg,O
IV,O
q.,O
36,O
hours,O
",",O
Pentamidine,B-TR
nasal,I-TR
wash,I-TR
60,O
mg,O
per,O
6,O
ml,O
of,O
sterile,B-TR
water,I-TR
q.d.,O
",",O
voriconazole,B-TR
200,O
mg,O
p.o.,O
b.i.d.,O
",",O
acyclovir,B-TR
400,O
mg,O
p.o.,O
b.i.d.,O
",",O
cyclosporine,B-TR
50,O
mg,O
p.o.,O
b.i.d.,O
",",O
prednisone,B-TR
60,O
mg,O
p.o.,O
q.d.,O
",",O
GCSF,B-TR
480,O
mcg,O
IV,O
q.d.,O
",",O
Epogen,B-TR
"40,000",O
units,O
subcu,O
q.,O
week,O
",",O
Protonix,B-TR
40,O
mg,O
q.d.,O
",",O
Simethicone,B-TR
80,O
mg,O
p.o.,O
q.,O
8,O
",",O
nitroglycerin,B-TR
paste,I-TR
1,O
&quot;,O
q.,O
4,O
h.,O
p.r.n.,O
",",O
flunisolide,B-TR
nasal,I-TR
inhaler,I-TR
",",O
2,O
puffs,O
q.,O
8,O
",",O
OxyCodone,B-TR
10-15,O
mg,O
p.o.,O
q.,O
6,O
p.r.n.,O
",",O
Sudafed,B-TR
30,O
mg,O
q.,O


ALLERGIES,O
:,O

BACTRIM,B-TR
(,O
SEVERE,B-PR
RASH,I-PR
),O
",",O
GANCICLOVIR,B-TR
(,O
RASH,B-PR
",",O
HAS,O
BEEN,O
DESENSITIZED,O
),O
.,O

SOCIAL,O
HISTORY,O
:,O

Patient,O
works,O
formerly,O
as,O
a,O
structural,O
engineer,O
",",O
has,O
not,O
been,O
employed,O
over,O
the,O
last,O
two,O
years,O
.,O

Patient,O
is,O
married,O
",",O
an,O
immigrant,O
from,O
Mondca,O
",",O
South,O
Carolina,O
who,O
lived,O
close,O
to,O
Scond,O
at,O
time,O
of,O
nuclear,O
disaster,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

VITAL,O
SIGNS,O
:,O

98.6,O
",",O
85,O
",",O
130/80,O
",",O
20,O
",",O
97%,O
on,O
room,O
air,O
",",O
82.2,O
kg,O
.,O

GENERAL,O
:,O

Comfortable,O
",",O
conversational,O
",",O
appears,O
same,O
as,O
week,O
prior,O
",",O
no,O
apparent,B-PR
distress,I-PR
.,O

HEENT,O
:,O

Pupils,O
were,O
equal,O
",",O
round,O
",",O
reactive,O
to,O
light,O
",",O
anicteric,B-PR
.,O

Oropharynx,O
clear,O
.,O

CARDIOVASCULAR,O
:,O

Regular,O
",",O
normal,O
S1,O
and,O
S2,O
",",O
no,O
murmurs,B-PR
",",O
gallops,B-PR
or,O
rubs,B-PR
.,O

JVP,B-TE
flat,O
.,O

RESPIRATORY,O
:,O

Lungs,O
clear,O
to,O
auscultation,B-TE
bilaterally,I-TE
.,O

ABDOMEN,O
:,O

Normoactive,O
bowel,O
sounds,O
",",O
soft,O
",",O
mild,B-PR
right,I-PR
upper,I-PR
quadrant,I-PR
tenderness,I-PR
",",O
not,O
dissimilar,O
from,O
week,O
prior,O
",",O
pronounced,B-PR
hepatomegaly,I-PR
with,O
liver,O
edge,O
7,O
cm,O
below,O
costal,O
margin,O
",",O
midclavicular,O
line,O
",",O
no,O
splenomegaly,B-PR
",",O
no,O
CVA,B-PR
tenderness,I-PR
.,O

EXTREMITIES,O
:,O

Slightly,B-PR
cool,I-PR
",",O
3-4+,B-PR
edema,I-PR
bilaterally,I-PR
.,O

DERMATOLOGY,O
:,O

Erythematous,B-PR
eruption,I-PR
on,O
80%,O
of,O
body,O
",",O
not,O
much,O
change,O
from,O
week,O
prior,O
.,O

Erythematous,B-PR
nodules,I-PR
on,I-PR
arms,I-PR
at,O
elbows,O
and,O
on,O
right,O
thigh,O
",",O
as,O
previous,O
.,O

NEUROLOGIC,O
:,O

Alert,O
and,O
appropriate,O
.,O

ADMISSION,O
LABORATORY,O
DATA,O
:,O

Sodium,B-TE
129,O
",",O
creatinine,B-TE
3.0,O
",",O
BUN,B-TE
70,O
",",O
potassium,B-TE
5.0,O
",",O
bicarbonate,B-TE
23,O
",",O
chloride,B-TE
99,O
",",O
ALT,B-TE
36,O
",",O
AST,B-TE
30,O
",",O
alkaline,B-TE
phosphatase,I-TE
215,O
",",O
total,B-TE
bilirubin,I-TE
1.1,O
",",O
albumin,B-TE
2.6,O
",",O
white,B-TE
blood,I-TE
cell,I-TE
count,I-TE
2.0,O
",",O
hematocrit,B-TE
30.5,O
",",O
platelets,B-TE
60,O
.,O

HOSPITAL,O
COURSE,O
:,O

Patient,O
was,O
admitted,O
for,O
diagnosis,O
and,O
treatment,B-TR
of,O
new,B-PR
fever,I-PR
.,O

Workup,B-TE
on,I-TE
admission,I-TE
included,O
a,B-TE
chest,I-TE
x-ray,I-TE
negative,O
for,O
pneumonia,B-PR
",",O
an,B-TE
MRI,I-TE
of,I-TE
the,I-TE
liver,I-TE
to,O
investigate,O
for,O
focal,B-PR
lesion,I-PR
",",O
with,O
no,O
evidence,O
for,O
abscess,B-PR
or,O
focal,B-PR
lesion,I-PR
on,O
report,O
.,O

Blood,B-TE
and,I-TE
urine,I-TE
cultures,I-TE
with,O
only,O
positive,O
culture,O
a,B-TE
blood,I-TE
culture,I-TE
on,O
November,O
20,O
",",O
with,O
one,O
of,O
two,O
bottles,O
positive,O
for,O
coagulase,B-PR
negative,I-PR
Staphylococcus,I-PR
.,O

A,B-TE
repeat,I-TE
CMV,I-TE
hypercapture,I-TE
",",O
negative,O
for,O
presence,O
of,O
CMV,B-PR
.,O

A,B-TE
repeat,I-TE
CAT,I-TE
scan,I-TE
of,I-TE
the,I-TE
sinuses,I-TE
with,O
finding,O
of,O
progressive,B-PR
thickening,I-PR
of,I-PR
the,I-PR
left,I-PR
maxillary,I-PR
sinus,I-PR
and,O
both,O
sets,O
of,O
ethmoid,O
air,O
cells,O
since,O
prior,O
study,O
of,O
November,O
9,O
",",O
indicating,O
progressive,B-PR
infection,I-PR
of,I-PR
Acanthamoeba,I-PR
and,O
any,O
possible,O
superinfection,B-PR
with,O
bacterial,B-PR
sinusitis,I-PR
.,O

In,O
the,O
days,O
following,O
admission,O
",",O
there,O
was,O
clear,O
evidence,O
for,O
progression,O
of,O
erythematous,B-PR
nodules,I-PR
over,I-PR
both,I-PR
arms,I-PR
and,O
right,O
thigh,O
at,O
foci,O
of,O
Acanthamoeba,B-PR
infection,I-PR
",",O
suggesting,O
progressive,B-PR
skin,I-PR
involvement,I-PR
with,O
Acanthamoeba,B-PR
.,O

Infectious,O
disease,O
consult,O
was,O
obtained,O
and,O
recommendation,O
was,O
to,O
switch,O
from,O
voriconazole,B-TR
to,O
itraconazole,B-TR
",",O
on,O
which,O
there,O
was,O
more,O
existing,O
data,O
on,O
treatment,B-TR
of,O
Acanthamoeba,B-PR
infection,I-PR
.,O

Pentamidine,B-TR
intravenous,I-TR
and,I-TR
nasal,I-TR
washings,I-TR
were,O
continued,O
.,O

Clinical,O
progression,O
of,O
skin,B-PR
and,I-PR
sinus,I-PR
infection,I-PR
on,O
maximal,B-TR
antimicrobial,I-TR
therapy,I-TR
continued,O
",",O
with,O
emergence,O
on,O
November,O
20,O
of,O
a,B-PR
new,I-PR
right-sided,I-PR
ptosis,I-PR
in,O
association,O
with,O
a,B-PR
left,I-PR
homonymous,I-PR
hemianopsia,I-PR
",",O
and,O
fleeting,B-PR
confusion,I-PR
while,O
febrile,B-PR
",",O
prompting,O
head,B-TE
MRI,I-TE
which,O
revealed,O
a,O
large,O
5,O
x,O
2,O
x,O
4.3,O
cm,O
region,O
in,O
the,O
right,O
occipital,O
lobe,O
of,O
hemorrhage,B-PR
and,O
edema,B-PR
",",O
with,O
dural,B-PR
and,I-PR
",",I-PR
likely,I-PR
",",I-PR
leptomeningeal,I-PR
enhancement,I-PR
in,O
association,O
with,O
small,B-PR
foci,I-PR
in,I-PR
the,I-PR
right,I-PR
cerebellum,I-PR
and,O
pons,O
",",O
concerning,O
for,O
early,B-PR
lesions,I-PR
of,O
similar,O
type,O
.,O

Idiosyncratic,B-PR
reaction,I-PR
to,O
cyclosporine,B-TR
was,O
considered,O
as,O
cause,O
for,O
cerebritis,B-PR
",",O
and,O
cyclosporine,B-TR
was,O
discontinued,O
.,O

However,O
",",O
much,O
more,O
likely,O
explanation,O
is,O
progressive,B-PR
infection,I-PR
of,O
Acanthamoeba,B-PR
with,O
new,B-PR
neurologic,I-PR
involvement,I-PR
.,O

Most,O
likely,O
source,O
of,O
fevers,B-PR
was,O
judged,O
to,O
be,O
progressive,B-PR
Acanthamoeba,I-PR
infection,I-PR
",",O
even,O
on,O
maximal,B-TR
antimicrobial,I-TR
therapy,I-TR
.,O

A,B-TE
single,I-TE
blood,I-TE
culture,I-TE
positive,O
for,O
coagulase,B-PR
negative,I-PR
Staphylococcus,I-PR
was,O
treated,O
with,O
a,O
course,O
of,O
vancomycin,B-TR
in,O
the,O
setting,O
of,O
a,B-TR
PICC,I-TR
line,I-TR
and,O
a,B-TE
chest,I-TE
x-ray,I-TE
on,O
November,O
20,O
indicating,O
possible,O
developing,B-PR
pneumonia,I-PR
",",O
resulted,O
in,O
a,O
course,O
of,O
levofloxacin,B-TR
",",O
for,O
both,O
possible,O
pneumonia,B-PR
",",O
as,O
well,O
as,O
treatment,B-TR
of,O
any,B-PR
bacterial,I-PR
superinfection,I-PR
of,O
Acanthamoeba,B-PR
sinusitis,I-PR
.,O

Patient,O
experienced,O
steady,O
decline,O
",",O
with,O
persistent,B-PR
fevers,I-PR
despite,O
all,B-TR
above,I-TR
measures,I-TR
",",O
progressive,O
areas,O
of,O
skin,B-PR
infection,I-PR
",",O
more,O
frequent,O
episodes,O
of,O
confusion,B-PR
",",O
and,O
decreasing,B-PR
oxygen,I-PR
saturation,I-PR
in,O
the,O
setting,O
of,O
bilateral,B-PR
effusion,I-PR
",",O
in,O
the,O
setting,O
of,O
fluid,B-PR
surge,I-PR
spacing,I-PR
.,O

On,O
November,O
30,O
",",O
a,O
family,O
meeting,O
with,O
patient,O
&apos;s,O
daughter,O
and,O
spouse,O
",",O
along,O
with,O
primary,O
oncologist,O
",",O
Dr.,O
Tomedankell,O
Bile,O
",",O
attending,O
physician,O
",",O
Dr.,O
Mellerny,O
Close,O
",",O
and,O
house,O
staff,O
",",O
was,O
held,O
to,O
discuss,O
patient,B-PR
&apos;s,I-PR
critical,I-PR
condition,I-PR
and,O
inability,O
to,O
prevent,O
progression,O
of,O
skin,B-PR
",",I-PR
sinus,I-PR
and,I-PR
neurological,I-PR
Acanthamoeba,I-PR
infection,I-PR
on,O
maximal,B-TR
antimicrobial,I-TR
therapy,I-TR
.,O

Decision,O
was,O
made,O
to,O
withdraw,O
aggressive,B-TR
measures,I-TR
of,I-TR
care,I-TR
",",O
with,O
priority,O
on,O
patient,O
&apos;s,O
comfort,O
.,O

Pentamidine,B-TR
",",O
itraconazole,B-TR
",",O
Levaquin,B-TR
",",O
acyclovir,B-TR
and,O
GCSF,B-TR
were,O
discontinued,O
",",O
along,O
with,O
other,B-TR
medications,I-TR
nonessential,O
to,O
patient,O
&apos;s,O
comfort,O
.,O

DNR,O
/,O
DNI,O
status,O
initially,O
established,O
early,O
during,O
hospital,O
stay,O
remained,O
in,O
effect,O
.,O

The,O
patient,O
was,O
made,O
comfortable,O
with,O
morphine,B-TR
for,O
pain,B-PR
and,O
for,O
air,B-PR
hunger,I-PR
",",O
and,O
sinus,B-TR
suctioning,I-TR
was,O
continued,O
to,O
relieve,O
congestion,B-PR
",",O
in,O
conjunction,O
with,O
continuation,O
of,O
nasal,B-TR
sprays,I-TR
.,O

Tylenol,B-TR
was,O
continued,O
to,O
control,O
fevers,B-PR
and,O
prednisone,B-TR
was,O
continued,O
to,O
control,O
inflammation,B-PR
and,O
prevent,O
precipitation,O
of,O
adrenal,B-PR
insufficiency,I-PR
.,O

Such,O
measures,O
have,O
been,O
continued,O
through,O
December,O
3,O
",",O
and,O
patient,O
remains,O
comfortable,O
through,O
this,O
time,O
.,O

This,O
interim,O
dictation,O
to,O
be,O
followed,O
by,O
an,O
addendum,O
detailing,O
end,O
of,O
hospital,O
course,O
.,O

Dictated,O
By,O
:,O

SHAA,O
KACHOLERA,O
STONGE,O
",",O
M.D.,O
LN00,O

Attending,O
:,O

LA,O
K.,O
SKI,O
",",O
M.D.,O
OF1,O
WS584/564649,O

Batch,O
:,O

2235,O

Index,O
No.,O
UWHS3TCPJ2,O

D,O
:,O

2012-03-03,O

T,O
:,O

2012-04-03,O

Admission,O
Date,O
:,O

2014-12-29,O

Discharge,O
Date,O
:,O

2015-01-20,O

Date,O
of,O
Birth,O
:,O

1944-09-05,O

Sex,O
:,O

M,O

Service,O
:,O

SURGERY,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,O
Drugs,B-TR

Attending,O
:,O
Patricia,O
H,O
Leonard,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

End,B-PR
stage,I-PR
liver,I-PR
disease,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

Piggyback,B-TR
orthotopic,I-TR
liver,I-TR
transplant,I-TR

Liver,B-TE
biopsy,I-TE

History,O
of,O
Present,O
Illness,O
:,O

Mr.,O
Reese,O
is,O
a,O
70,O
-,O
year-old,O
gentleman,O
with,O
end,B-PR
stage,I-PR
liver,I-PR
disease,I-PR
secondary,O
to,O
alcoholic,B-PR
cirrhosis,I-PR
.,O

Of,O
note,O
",",O
he,O
underwent,O
radiofrequency,B-TR
ablation,I-TR
of,I-TR
two,I-TR
small,I-TR
liver,I-TR
nodules,I-TR
",",O
one,O
in,O
segment,O
VI,O
and,O
the,O
other,O
in,O
the,O
caudate,O
lobe,O
.,O

Both,O
are,O
less,O
than,O
2,O
cm,O
.,O

Cytology,B-TE
on,O
these,B-PR
nodules,I-PR
was,O
suspicious,O
for,O
hepatocellular,B-PR
carcinoma,I-PR
.,O

The,B-TR
ablation,I-TR
was,O
done,O
on,O
2013-12-04,O
.,O

He,O
had,O
decompensation,O
of,O
his,B-PR
cirrhosis,I-PR
in,O
2011,O
with,O
ascites,B-PR
and,O
SBP,B-PR
.,O

He,O
also,O
had,O
encephalopathy,B-PR
during,O
that,O
period,O
.,O

The,O
liver,O
was,O
from,O
a,O
62,O
year-old,O
gentleman,O
who,O
had,O
died,O
from,O
CVA,B-PR
with,O
normal,O
liver,O
function,O
.,O

He,O
has,O
no,O
history,O
of,O
a,B-PR
GI,I-PR
bleed,I-PR
or,O
varices,B-PR
by,O
endoscopy,B-TE
.,O

His,O
last,O
drink,O
was,O
in,O
2009-11-11,O
.,O

Prior,O
to,O
this,O
",",O
he,O
drank,O
a,O
bottle,O
of,O
wine,O
a,O
day,O

Past,O
Medical,O
History,O
:,O

His,O
past,O
medical,O
history,O
is,O
also,O
remarkable,O
for,O
non-insulin,B-PR
dependent,I-PR
diabetes,I-PR
and,O
hypertension,B-PR
.,O

He,O
has,O
coronary,B-PR
artery,I-PR
disease,I-PR
and,O
underwent,O
a,B-TR
CABG,I-TR
in,O
1998,O
.,O

He,O
has,O
a,O
history,O
of,O
gastroesophageal,B-PR
reflux,I-PR
disease,I-PR
and,O
anemia,B-PR
.,O

He,O
also,O
has,O
had,O
a,B-TR
prior,I-TR
inguinal,I-TR
hernia,I-TR
repair,I-TR
.,O

Social,O
History,O
:,O

The,O
patient,O
obtained,O
a,O
degree,O
in,O
law,O
.,O

He,O
worked,O
for,O
the,O
attorney,O
general,O
's,O
office,O
early,O
in,O
his,O
career,O
but,O
eventually,O
started,O
his,O
own,O
business,O
in,O
foreign,O
currency,O
exchange,O
from,O
which,O
he,O
retired,O
in,O
2009,O
.,O

He,O
does,O
not,O
smoke,O
",",O
and,O
there,O
is,O
no,O
history,O
of,O
IV,O
drug,O
abuse,O
.,O

Physical,O
Exam,O
:,O

On,O
pre-operative,B-TE
exam,I-TE
",",O
he,O
was,O
awake,O
",",O
alert,O
",",O
and,O
oriented,O
x3,O
.,O

He,O
was,O
not,O
in,O
any,B-PR
apparent,I-PR
distress,I-PR
.,O

He,O
was,O
afebrile,B-PR
with,O
normal,O
vitals,O
.,O

He,O
is,O
6,O
feet,O
1,O
inches,O
tall,O
and,O
has,O
a,B-TE
pre-op,I-TE
weight,I-TE
of,O
181,O
pounds,O
.,O

He,O
had,O
no,O
pallor,B-PR
or,O
obvious,B-PR
jaundice,I-PR
.,O

He,O
had,O
no,O
asterixis,B-PR
.,O

He,O
had,O
palmar,B-PR
erythema,I-PR
.,O

There,O
was,O
no,O
clubbing,B-PR
.,O

He,O
had,O
no,O
lymphadenopathy,B-PR
.,O

His,O
chest,O
was,O
clear,O
to,O
ascultation,B-TE
.,O

His,B-TE
heart,I-TE
sounds,I-TE
were,O
regular,O
rate,O
rhythm,O
.,O

His,O
abdomen,O
is,O
soft,O
and,O
nontender,B-PR
.,O

No,O
masses,B-PR
or,O
viscera,B-PR
was,O
felt,O
.,O

He,O
had,O
good,O
femoral,O
pulses,O
bilaterally,O
.,O

He,O
had,O
no,O
pedal,B-PR
edema,I-PR
or,O
lower,B-PR
extremity,I-PR
lesions,I-PR
.,O

His,B-TE
neurological,I-TE
exam,I-TE
was,O
intact,O
.,O

Pertinent,O
Results,O
:,O

2014-12-30,O
10:34,O
AM,O
BLOOD,B-TE
ALT,B-TE
-,O
699,O
*,O
AST,B-TE
-,O
1434,O
*,O
AlkPhos,B-TE
-,O
65,O
Amylase,B-TE
-,O
46,O
TotBili,B-TE
-,O
5.9,O
*,O

2015-01-01,O
11:46,O
AM,O
BLOOD,B-TE
ALT,B-TE
-,O
1423,O
*,O
AST,B-TE
-,O
1066,O
*,O
AlkPhos,B-TE
-,O
72,O
TotBili,B-TE
-,O
6.2,O
*,O

2015-01-19,O
04:47,O
AM,O
BLOOD,B-TE
ALT,B-TE
-,O
355,O
*,O
AST,B-TE
-,O
90,O
*,O
AlkPhos,B-TE
-,O
352,O
*,O
TotBili,B-TE
-,O
3.2,O
*,O

Brief,O
Hospital,O
Course,O
:,O

Mr.,O
Reese,O
Jones,O
the,B-TR
procedure,I-TR
well,O
.,O

Post-operatively,O
",",O
he,O
was,O
slow,O
to,O
recover,O
but,O
did,O
progressed,O
nicely,O
.,O

Within,O
the,O
fist,O
few,O
days,O
after,O
the,B-TR
surgery,I-TR
",",O
his,B-TE
liver,I-TE
function,I-TE
tests,I-TE
were,O
elevated,B-PR
to,O
as,O
high,O
as,O
1484,O
for,O
ALT,B-TE
",",O
915,O
for,O
AST,B-TE
",",O
and,O
7.6,O
for,O
total,B-TE
bilirubin,I-TE
.,O

His,B-TE
Alk,I-TE
Phos,I-TE
were,O
inititially,O
low,B-PR
a,O
few,O
days,O
after,O
the,B-TR
operation,I-TR
",",O
but,O
it,O
rised,O
up,O
to,O
422,O
two,O
weeks,O
after,O
",",O
but,O
down-trended,O
",",O
as,O
with,O
the,O
rest,O
of,O
his,B-TE
liver,I-TE
function,I-TE
test,I-TE
by,O
the,O
time,O
he,O
left,O
the,O
hospital,O
.,O

Several,O
tests,O
",",O
including,O
Duplex,B-TE
Ultrasound,I-TE
",",O
CT,B-TE
of,I-TE
the,I-TE
Abdomen,I-TE
",",O
and,O
Abdominal,B-TE
A-gram,I-TE
all,O
showed,O
patent,O
right,O
and,O
left,O
hepatic,O
arteries,O
arising,O
from,O
the,O
celiac,O
trunk,O
.,O

An,B-TE
ERCP,I-TE
was,O
also,O
done,O
",",O
showing,O
a,B-PR
filling,I-PR
defect,I-PR
from,O
a,B-PR
narrowed,I-PR
donor,I-PR
duct,I-PR
",",O
but,O
no,O
strictures,B-PR
.,O

A,B-TR
sphincterotomy,I-TR
wss,O
done,O
to,O
drain,O
the,B-PR
sludge,I-PR
from,I-PR
the,I-PR
central,I-PR
common,I-PR
duct,I-PR
.,O

There,O
was,O
a,B-PR
small,I-PR
bleed,I-PR
resulting,O
from,O
the,B-TR
sphincterotomy,I-TR
",",O
but,O
it,O
was,O
controlled,O
by,O
epinepherine,B-TR
injections,I-TR
.,O

Initial,B-TE
biopsy,I-TE
of,I-TE
the,I-TE
allograft,I-TE
three,O
days,O
after,O
the,B-TR
operation,I-TR
was,O
consistent,O
with,O
preservation,B-PR
/,I-PR
ischemic,I-PR
injury,I-PR
.,O

Result,O
of,O
a,B-TE
second,I-TE
biopsy,I-TE
",",O
which,O
was,O
done,O
three,O
weeks,O
after,O
the,B-TR
operation,I-TR
",",O
is,O
still,O
pending,O
.,O

During,O
his,O
hospital,O
stay,O
",",O
his,B-TE
blood,I-TE
glucose,I-TE
were,O
elevated,B-PR
and,O
labile,B-PR
ranging,O
from,O
below,B-PR
normal,I-PR
values,I-PR
[,O
40-60,O
's],O
to,O
the,O
200-300,O
's,O
.,O

He,O
was,O
completely,O
assymptomatic,B-PR
while,O
below,B-PR
normal,I-PR
values,I-PR
.,O

At,O
one,O
point,O
",",O
he,O
had,O
to,O
be,O
on,O
an,B-TR
insulin,I-TR
drip,I-TR
.,O

However,O
with,O
the,O
help,O
of,O
Albano,O
",",O
his,B-TE
blood,I-TE
glucose,I-TE
began,O
to,O
normalize,O
.,O

He,O
has,O
also,O
been,O
working,O
with,O
Physical,O
Therapy,O
to,O
regain,O
his,O
strength,O
.,O

He,O
has,O
been,O
ambulating,O
on,O
his,O
own,O
several,O
times,O
a,O
day,O
.,O

Also,O
",",O
he,O
has,O
been,O
afebrile,B-PR
with,O
stable,O
vitals,O
",",O
tolerating,O
a,O
regular,O
diet,O
",",O
producing,O
good,O
urine,O
and,O
adequate,O
stool,O
.,O

Furthermore,O
",",O
he,O
has,O
had,O
no,O
complaints,B-PR
",",O
including,O
pain,B-PR
",",O
while,O
his,B-TE
lab,I-TE
values,I-TE
are,O
normalizing,O
.,O

He,O
will,O
be,O
discharged,O
to,O
home,O
",",O
in,O
good,O
condition,O
",",O
with,O
very,O
specific,O
intructions,O
to,O
follow,O
up,O
with,O
Albano,O
for,O
his,B-TR
diabetic,I-TR
care,I-TR
and,O
the,O
Transplant,O
Clinic,O
for,O
his,B-TR
transplant,I-TR
care,I-TR
.,O

Discharge,O
Medications,O
:,O

1.,O
Trimethoprim,B-TR
-,I-TR
Sulfamethoxazole,I-TR
80-400,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

Disp,O
:*,O
30,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

2.,O
Pantoprazole,B-TR
40,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
Q24H,O
(,O
every,O
24,O
hours,O
),O
.,O

Disp,O
:*,O
30,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
)(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

3.,O
Mycophenolate,B-TR
Mofetil,I-TR
500,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

Disp,O
:*,O
120,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

4.,O
Prednisone,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
Three,O
(,O
3,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

Disp,O
:*,O
30,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

5.,O
Valganciclovir,B-TR
450,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

Disp,O
:*,O
60,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

6.,O
Ursodiol,B-TR
300,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
.,O

7.,O
Metoprolol,B-TR
Tartrate,I-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
1.5,O
Tablets,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

8.,O
Acetaminophen,B-TR
325,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
.,O

9.,O
Fluconazole,B-TR
200,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
Q24H,O
(,O
every,O
24,O
hours,O
),O
.,O

Disp,O
:*,O
60,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

10.,O
Insulin,B-TR
SS,I-TR
and,O
fixed,B-TR
dose,I-TR

Fingerstick,B-TE
QACHS,O
",",O
3,O
AM,O
Insulin,B-TR
SC,I-TR
Fixed,I-TR
Dose,I-TR
Orders,O

Breakfast,O

NPH,O

17,O
Units,O

Insulin,B-TR
SC,I-TR
Sliding,I-TR
Scale,I-TR

Breakfast,O
Lunch,O
Dinner,O
Bedtime,O

Regular,O
Regular,O
Regular,O
Regular,O

Glucose,O
Insulin,O
Dose,O
Insulin,O
Dose,O
Insulin,O
Dose,O
Insulin,O
Dose,O

0-60,O
mg,O
/,O
dL,O
4,O
oz.,O
Juice,O
4,O
oz.,O
Juice,O
4,O
oz.,O
Juice,O
4,O
oz.,O
Juice,O

61-120,O
mg,O
/,O
dL,O
1,O
Units,O
0,O
Units,O
0,O
Units,O
0,O
Units,O

121-160,O
mg,O
/,O
dL,O
2,O
Units,O
0,O
Units,O
1,O
Units,O
0,O
Units,O

161-200,O
mg,O
/,O
dL,O
3,O
Units,O
4,O
Units,O
2,O
Units,O
0,O
Units,O

201-240,O
mg,O
/,O
dL,O
5,O
Units,O
6,O
Units,O
4,O
Units,O
0,O
Units,O

241-280,O
mg,O
/,O
dL,O
6,O
Units,O
7,O
Units,O
5,O
Units,O
1,O
Units,O

281-320,O
mg,O
/,O
dL,O
7,O
Units,O
8,O
Units,O
6,O
Units,O
2,O
Units,O

321-360,O
mg,O
/,O
dL,O
9,O
Units,O
10,O
Units,O
8,O
Units,O
3,O
Units,O

361-400,O
mg,O
/,O
dL,O
11,O
Units,O
11,O
Units,O
10,O
Units,O
4,O
Units,O

>,O
400,O
mg,O
/,O
dL,O
Notify,O
M.D.,O
Notify,O
M.D.,O
Notify,O
M.D.,O
Notify,O
M.D.,O

11.,O
Tacrolimus,B-TR
0.5,O
mg,O
Capsule,O
Sig,O
:,O
Three,O
(,O
3,O
),O
Capsule,O
PO,O
twice,O
a,O
day,O
.,O

Disp,O
:*,O
180,O
Capsule,O
(,O
s,O
)*,O
Refills,O
:*,O
0,O
*,O

12.,O
Insulin,B-TR
NPH,I-TR
Human,I-TR
Recomb,I-TR
100,O
unit,O
/,O
mL,O
Cartridge,O
Sig,O
:,O
One,O
(,O
1,O
),O
Subcutaneous,O
at,O
breakfast,O
:,O
Please,O
take,O
as,O
prescribed,O
by,O
Albano,O
/,O
Transplant,O
Team,O
.,O

Disp,O
:*,O
10,O
*,O
Refills,O
:*,O
2,O
*,O

13.,O
Insulin,B-TR
Regular,I-TR
Human,I-TR
300,O
unit,O
/,O
3,O
mL,O
Insulin,O
Pen,O
Sig,O
:,O
One,O
(,O
1,O
),O
Subcutaneous,O
four,O
times,O
a,O
day,O
:,O
Please,O
take,O
as,O
prescribed,O
by,O
Albano,O
/,O
Transplant,O
team,O
.,O

Disp,O
:*,O
10,O
*,O
Refills,O
:*,O
2,O
*,O

14.,O
Insulin,B-TR
Syringe,I-TR
Needless,I-TR
(,O
Disp,O
),O
1,O
mL,O
Syringe,O
Sig,O
:,O
One,O
(,O
1,O
),O
Miscell.,O
as,O
directed,O
by,O
Albano,O
/,O
Trasplant,O
.,O

Disp,O
:*,O
150,O
*,O
Refills,O
:*,O
2,O
*,O

Discharge,O
Disposition,O
:,O

Home,O
with,O
Service,O

Discharge,O
Diagnosis,O
:,O

End,B-PR
stage,I-PR
liver,I-PR
disease,I-PR

Discharge,O
Condition,O
:,O

Good,O

Discharge,O
Instructions,O
:,O

Please,O
take,O
medications,B-TR
as,O
prescribed,O
and,O
read,O
warning,O
labels,O
carefully,O
.,O

If,O
symptoms,O
such,O
as,O
fever,B-PR
/,O
chills,B-PR
",",O
nausea,B-PR
/,O
vomiting,B-PR
",",O
increasing,B-PR
pain,I-PR
/,O
redness,B-PR
/,O
purulent,B-PR
discharge,I-PR
from,O
incision,B-PR
",",O
increasing,B-PR
jaundice,I-PR
",",O
please,O
call,O
or,O
go,O
to,O
the,O
emergency,O
room,O
immediately,O
.,O

Remember,O
to,O
call,O
for,O
a,O
follow,O
up,O
appointment,O
(,O
bellow,O
),O
.,O

Light,O
activities,O
until,O
seen,O
in,O
clinic,O
.,O

May,O
eat,O
regular,O
food,O
.,O

May,O
shower,O
but,O
no,O
baths,O
.,O

Pat,O
incision,B-PR
wounds,I-PR
dry,O
",",O
do,O
not,O
scrub,O
wound,B-PR
when,O
showering,O
.,O

Absolutely,O
no,O
smoking,O
.,O

Followup,O
Instructions,O
:,O

Provider,O
:,O

Francis,O
Britni,O
",",O
MD,O
Phone,O
:(,O
646,O
),O
444-8240,O

Date,O
/,O
Time,O
:,O
2015-01-22,O
10:40,O

Provider,O
:,O

Francis,O
Britni,O
",",O
MD,O
Phone,O
:(,O
646,O
),O
444-8240,O

Date,O
/,O
Time,O
:,O
2015-01-29,O
10:40,O

Provider,O
:,O

Francis,O
Britni,O
",",O
MD,O
Phone,O
:(,O
646,O
),O
444-8240,O

Date,O
/,O
Time,O
:,O
2015-02-05,O
9:20,O

Please,O
follow,O
up,O
with,O
Albano,O
",",O
as,O
direct,O
by,O
them,O
",",O
a,O
few,O
days,O
after,O
discharge,O
from,O
the,O
hospital,O
(,O
(,O
371,O
),O
400,O
5776,O
.,O

Francis,O
Britni,O
MD,O
34-902,O

Completed,O
by,O
:,O
Wayne,O
Chris,O
MD,O
18-062,O
2015-01-20,O
@,O
1208,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Francis,O
VU,O
Vila,O
on,O
:,O
MON,O
2015-01-26,O
6:12,O
PM,O

(,O
End,O
of,O
Report,O
),O

387946944,O

FIH,O

6652087,O

713765,O

7284844,O

9/21/2003,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O

DOUETTWIDOUET,O
",",O
TAROBY,O

MRN,O
:,O

6652087,O

Age,O
:,O

80y,O

REGISTRATION,O
DATE,O
:,O

09/21/2003,O
06:51,O
PM,O

PRELIMINARY,O
REPORT,O

This,O
is,O
to,O
notify,O
you,O
that,O
your,O
patient,O
",",O
DOUETTWIDOUET,O
",",O
TAROBY,O
arrived,O
in,O
the,O
Emergency,O
Department,O
at,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
on,O
09/21/2003,O
06:51,O
PM,O
.,O

The,O
patient,O
presented,O
with,O
a,O
chief,O
complaint,O
of,O
WEAK,B-PR
.,O

Following,O
evaluation,B-TE
and,O
treatment,B-TR
",",O
the,O
patient,O
&apos;s,O
disposition,O
at,O
the,O
end,O
of,O
the,O
visit,O
was,O
ADMITTED,O
AS,O
AN,O
INPATIENT,O
TO,O
FAIRM,O
OF,O
IJORDCOMPMAC,O
HOSPITAL,O
.,O

The,O
patient,O
&apos;s,O
preliminary,O
admitting,O
physician,O
is,O
SAPSCLYSS,O
",",O
LEO,O
R,O
and,O
the,O
preliminary,O
diagnosis,O
is,O
WEAKNESS,B-PR
.,O

Please,O
note,O
this,O
information,O
may,O
have,O
been,O
updated,O
on,O
the,O
inpatient,O
unit,O
.,O

If,O
you,O
need,O
additional,O
information,O
please,O
call,O
834-226-3369,O
.,O

PCP,O
Name,O
:,O

ROSORB,O
",",O
ASALEYSEAN,O
I,O

Provider,O
Number,O
:,O

80629,O

Admission,O
Date,O
:,O

2017-06-16,O

Discharge,O
Date,O
:,O

2017-07-27,O

Date,O
of,O
Birth,O
:,O

1959-03-24,O

Sex,O
:,O

M,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,O
Drugs,B-TR

Attending,O
:,O
Andre,O
K.,O
Young,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Fever,B-PR
",",O
tachycardia,B-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

None,O

History,O
of,O
Present,O
Illness,O
:,O

Patient,O
is,O
a,O
58,O
year,O
old,O
male,O
with,O
a,O
recent,O
admission,O
for,O
abdominal,B-PR
pain,I-PR
s/p,O
negative,O
exploratory,O
laparotomy,O
for,O
suspected,O
intussuception,B-PR
now,O
returns,O
on,O
day,O
of,O
discharge,O
with,O
fever,B-PR
and,O
tachycardia,B-PR
.,O

Patient,O
has,O
a,O
history,O
for,O
terrible,B-PR
vasculopathy,I-PR
s/p,O
recent,B-TR
right,I-TR
BKA,I-TR
with,O
dry,B-PR
gangrene,I-PR
of,I-PR
the,I-PR
distal,I-PR
stump,I-PR
.,O

Patient,O
's,O
last,O
admission,O
was,O
significant,O
for,O
a,O
negative,O
ex-lap,O
.,O

Post-operatively,O
",",O
his,O
course,O
was,O
complicated,O
by,O
respiratory,B-PR
distress,I-PR
necessitating,O
an,O
urgent,O
return,O
to,O
the,O
ICU,O
and,O
was,O
intubated,O
.,O

After,O
multuple,O
failed,O
attempts,O
at,O
extubation,B-TR
",",O
the,O
patient,O
was,O
trached,O
.,O

Patient,O
then,O
did,O
well,O
on,O
a,B-TR
trach,I-TR
mask,I-TR
and,O
was,O
transferred,O
to,O
rehab,O
on,O
the,O
day,O
of,O
admission,O
but,O
now,O
returns,O
with,O
tachycardia,B-PR
to,O
the,O
120,O
's,O
",",O
and,O
fever,B-PR
to,O
102,O
degrees,O
F,O
.,O

Past,O
Medical,O
History,O
:,O

PVD,B-PR
s/p,O
multiple,B-PR
failed,I-PR
femoral,I-PR
distal,I-PR
bypass,I-PR

Diabetes,B-PR
mellitus,I-PR

CAD,B-PR
s/p,O
CABG,B-TR
2003,O
s/p,O

ex,B-TE
lap,I-TE
05-23,O

Physical,O
Exam,O
:,O

T,B-TE
101,O
HR,B-TE
120,O
BP,B-TE
144/90,O
RR,B-TE
18,O
SpO2,B-TE
99%,O
on,O
70%,O
TM,B-TR

Moderately,B-PR
distressed,I-PR

Coarse,B-PR
breath,I-PR
sounds,I-PR
b/l,I-PR

Tachycardic,B-PR
",",O
nl,O
S1,O
and,O
S2,O

Abd,O
soft,O
",",O
NT/ND,B-PR

Right,B-PR
AKA,I-PR
stump,I-PR
with,O
dry,B-PR
gangrene,I-PR

Left,O
lower,O
extremity,O
warm,O
and,O
well-perfused,O

Pertinent,O
Results,O
:,O

MRI,B-TE
HEAD,I-TE
:,O

The,O
diffusion,O
images,O
demonstrate,O
no,O
evidence,O
of,O
slow,B-PR
diffusion,I-PR
to,O
indicate,O
acute,B-PR
infarct,I-PR
.,O

There,O
is,O
moderate,B-PR
prominence,I-PR
of,I-PR
ventricles,I-PR
and,I-PR
sulci,I-PR
",",O
inappropriate,O
for,O
the,O
patient,O
's,O
age,O
.,O

There,O
is,O
no,O
midline,B-PR
shift,I-PR
",",O
mass,B-PR
effect,I-PR
",",O
hydrocephalus,B-PR
",",O
or,O
territorial,B-PR
infarct,I-PR
.,O

Following,O
gadolinium,B-TE
",",O
no,O
evidence,O
of,O
abnormal,B-PR
parenchymal,I-PR
",",I-PR
vascular,I-PR
",",I-PR
or,I-PR
meningeal,I-PR
enhancement,I-PR
seen,O
.,O

Gastric,B-TE
biopsy,I-TE
:,O
negative,O
for,O
H.,B-PR
pylori,I-PR
.,O

Brief,O
Hospital,O
Course,O
:,O

The,O
patient,O
was,O
re-admitted,O
to,O
the,O
surgical,O
service,O
and,O
taken,O
to,O
the,O
CMED,O
.,O

A,B-TE
chest,I-TE
x-ray,I-TE
on,O
admission,O
showed,O
effusions,B-PR
consistent,O
with,O
CHF,B-PR
along,O
with,O
overlying,B-PR
pnumonia,I-PR
.,O

Urine,B-TE
cultures,I-TE
were,O
significant,O
for,O
Klebsiella,B-PR
UTI,I-PR
and,O
sputum,B-TE
cultures,I-TE
were,O
significant,O
for,O
MRSA,B-PR
.,O

He,O
was,O
placed,O
on,O
vancomycin,B-TR
",",O
levofloxacin,B-TR
and,O
fluconazole,B-TR
.,O

He,O
underwent,O
PICC,B-TR
line,I-TR
placement,I-TR
on,O
06-18,O
.,O

A,B-TR
trach,I-TR
collar,I-TR
was,O
placed,O
on,O
06-19,O
.,O

GI,O
was,O
consulted,O
for,O
colonoscopy,B-TE
.,O

Patient,O
was,O
transferred,O
to,O
the,O
floor,O
on,O
06-20,O
.,O

He,O
was,O
seen,O
by,O
respiratory,O
therapy,O
and,O
suctioned,O
continually,O
throughout,O
his,O
hospital,O
course,O
.,O

His,O
respiratory,O
status,O
improved,O
.,O

He,O
tolerated,O
his,B-TR
trach,I-TR
collar,I-TR
",",O
and,O
tube,B-TR
feeds,I-TR
at,O
goal,O
.,O

The,B-TR
fluconazole,I-TR
was,O
discontinued,O
.,O

On,O
06-21,O
the,O
patient,O
was,O
seen,O
by,O
physical,O
therapy,O
.,O

A,O
nutrition,O
consult,O
was,O
obtained,O
on,O
06-22,O
.,O

He,O
underwent,O
a,B-PR
failed,I-PR
bedside,I-PR
swallow,I-PR
study,I-PR
.,O

Based,O
on,O
a,B-TE
chest,I-TE
x-ray,I-TE
that,O
showed,O
a,B-PR
small,I-PR
hydro-pneumothorax,I-PR
on,I-PR
the,I-PR
left,I-PR
lower,I-PR
lobe,I-PR
of,O
the,O
lung,O
",",O
a,O
thoracic,O
surgery,O
consult,O
was,O
obtained,O
",",O
though,O
no,O
specific,B-TR
interventions,I-TR
were,O
warranted,O
at,O
the,O
time,O
.,O

On,O
06-23,O
the,B-TR
patient,I-TR
's,I-TR
tube,I-TR
feed,I-TR
were,O
changed,O
from,O
Respalor,B-TR
to,O
Deliver,B-TR
2.0,I-TR
to,O
give,O
increased,O
calories,O
.,O

On,O
06-25,O
",",O
urine,B-TE
cultures,I-TE
grew,O
out,O
VRE,B-PR
",",O
and,O
a,B-TE
C,I-TE
diff,I-TE
was,O
negative,O
.,O

He,O
experienced,O
low,B-PR
grade,I-PR
fevers,I-PR
.,O

He,O
was,O
pan-cultured,O
on,O
06-26,O
for,O
continued,B-PR
fevers,I-PR
.,O

On,O
06-27,O
",",O
his,B-TR
nutrition,I-TR
regimen,I-TR
was,O
changed,O
to,O
Deliver,B-TR
2.0,I-TR
at,O
70,O
cc,O
/,O
hr,O
with,O
15,O
g,O
ProMod,B-TR
.,O

On,O
06-28,O
",",O
the,O
patient,O
experienced,O
PVC,B-PR
's,I-PR
.,O

An,B-TE
EKG,I-TE
showed,O
ST,B-PR
segment,I-PR
depression,I-PR
along,O
the,O
lateral,O
pre-cordial,O
leads,O
.,O

Serial,B-TE
enzymes,I-TE
showed,O
mild,B-PR
elevation,I-PR
of,O
troponins,B-TE
.,O

A,O
cardiology,O
consult,O
was,O
obtained,O
.,O

The,O
cardiology,O
service,O
simply,O
recommended,O
increasing,O
the,B-TR
beta-blockade,I-TR
and,O
maximizing,O
the,O
patient,O
's,O
electrolyte,O
status,O
.,O

On,O
06-29,O
",",O
the,O
patient,O
was,O
transferred,O
to,O
the,O
medical,O
service,O
.,O

Pt,B-TR
's,I-TR
vancomycin,I-TR
was,O
stopped,O
after,O
14,O
days,O
of,O
treatment,B-TR
.,O

HIV,B-TE
test,I-TE
was,O
found,O
to,O
be,O
negative,O
.,O

MRI,B-TE
head,I-TE
was,O
obtained,O
to,O
further,O
w/u,O
patient,B-PR
's,I-PR
apparent,I-PR
cognitive,I-PR
decline,I-PR
.,O

MRI,B-TE
showed,O
prominent,B-PR
sulci,I-PR
and,O
enlarged,B-PR
ventricles,I-PR
abnormal,O
for,O
the,O
patient,O
's,O
age,O
.,O

Due,O
to,O
concerns,O
for,O
dementia,B-PR
",",O
neurology,O
consult,O
was,O
obtained,O
.,O

Neurology,O
felt,O
that,O
the,B-PR
patient,I-PR
's,I-PR
cognitive,I-PR
symptoms,I-PR
were,O
consistent,O
w/,O
metabolic,B-PR
encephalopathy,I-PR
due,O
to,O
his,B-PR
multiple,I-PR
medical,I-PR
problems,I-PR
.,O

They,O
felt,O
that,O
his,O
mental,O
status,O
would,O
improve,O
as,O
his,O
health,O
improved,O
.,O

Underlying,B-PR
dementia,I-PR
was,O
possible,O
but,O
difficult,O
to,O
assess,O
with,O
an,B-PR
overlying,I-PR
delerium,I-PR
.,O

The,O
patient,O
continued,O
to,O
pull,O
out,O
his,B-TR
doboff,I-TR
tube,I-TR
.,O

Pt,O
had,O
EGD,B-TE
performed,O
to,O
evaluate,O
his,B-PR
poor,I-PR
nutritional,I-PR
status,I-PR
.,O

He,O
was,O
found,O
to,O
have,O
a,B-PR
large,I-PR
gastric,I-PR
ulcer,I-PR
and,O
high,B-TR
dose,I-TR
PPI,I-TR
was,O
started,O
.,O

The,B-TE
gastric,I-TE
biopsy,I-TE
and,O
the,B-TE
serology,I-TE
were,O
both,O
negative,O
for,O
H.,B-PR
pylori,I-PR
.,O

PEG,B-TR
placement,I-TR
was,O
unsuccessful,O
by,O
GI,O
due,O
to,O
the,O
patient,O
's,O
anantomy,O
.,O

07-05,O
the,O
patient,O
had,O
a,B-TR
J,I-TR
tube,I-TR
placed,O
in,O
interventional,O
radiology,O
for,O
nutritional,B-TR
support,I-TR
.,O

He,O
was,O
re-started,O
on,O
tube,B-TR
feeds,I-TR
.,O

07-06,O
patient,O
failed,O
a,B-TE
repeat,I-TE
swallow,I-TE
evaluation,I-TE
due,O
to,O
discoordinated,B-PR
swallow,I-PR
.,O

07-07,O
the,O
patient,O
was,O
taken,O
for,O
colonoscopy,B-TE
and,O
found,O
to,O
have,O
a,O
normal,O
colon,O
to,O
cecum,O
.,O

07-12,O
the,O
patient,O
was,O
found,O
to,O
be,O
C,B-PR
diff,I-PR
positive,I-PR
and,O
was,O
started,O
on,O
14,O
day,O
course,O
of,O
Flagyl,B-TR
.,O

On,O
07-18,O
",",O
as,O
his,O
mental,O
status,O
improved,O
",",O
he,O
did,O
well,O
at,O
the,B-TE
bed,I-TE
side,I-TE
swall,I-TE
evaluation,I-TE
.,O

On,O
07-19,O
",",O
he,O
underwent,O
video,B-TE
swallow,I-TE
evaluation,I-TE
and,O
was,O
able,O
to,O
tolerate,O
ground,B-TR
consistent,I-TR
food,I-TR
and,O
thin,B-TR
liquids,I-TR
.,O

His,B-TR
meds,I-TR
should,O
be,O
crushed,O
and,O
mixed,O
with,O
puree,B-TR
thick,I-TR
liquid,I-TR
.,O

He,O
has,O
gained,O
30,B-PR
lb,I-PR
since,O
the,B-TR
tubefeed,I-TR
was,O
initiated,O
(,O
70,O
lb,O
to,O
100,O
lb,O
),O
during,O
this,O
admission,O
.,O

He,O
will,O
still,O
need,O
to,O
be,O
on,O
tubefeed,B-TR
to,O
support,O
his,O
nutrition,O
until,O
he,O
is,O
cleared,O
by,O
a,O
nutritionist,O
.,O

In,O
terms,O
of,O
his,O
mental,O
status,O
",",O
he,O
continued,O
to,O
improve,O
steadily,O
over,O
the,O
last,O
few,O
weeks,O
of,O
his,O
hospital,O
stay,O
.,O

He,O
was,O
more,O
alert,O
and,O
engaged,O
with,O
activity,O
.,O

He,O
did,O
much,O
better,O
with,O
PT,B-TR
and,O
OT,B-TR
at,O
the,O
end,O
after,O
his,O
mental,O
status,O
improved,O
.,O

As,O
noted,O
above,O
",",O
his,B-PR
mental,I-PR
status,I-PR
change,I-PR
was,O
likely,O
toxic-metabolic,B-PR
from,O
acute,B-PR
infection,I-PR
.,O

He,O
started,O
to,O
develop,O
more,B-PR
pain,I-PR
around,I-PR
the,I-PR
right,I-PR
stump,I-PR
since,O
07-17,O
.,O

He,O
was,O
seen,O
by,O
the,O
vascular,O
surgery,O
who,O
felt,O
that,O
he,O
is,O
too,O
medically,B-PR
sick,I-PR
and,O
malnourished,B-PR
to,O
have,O
surgery,B-TR
at,O
this,O
time,O
.,O

He,O
will,O
follow,O
up,O
with,O
Dr.,O
Javier,O
as,O
outpatient,O
.,O

Initially,O
",",O
his,B-PR
pain,I-PR
was,O
controlled,O
with,O
titrating,O
up,O
the,B-TR
Oxycontin,I-TR
.,O

However,O
",",O
it,O
was,O
titrated,O
too,O
quickly,O
from,O
10,O
mg,O
bid,O
to,O
30,O
mg,O
bid,O
.,O

He,O
then,O
developed,O
urinary,B-PR
retention,I-PR
requiring,O
foley,B-TR
placement,I-TR
.,O

After,O
he,O
passed,O
the,B-TE
video,I-TE
swallowing,I-TE
",",O
he,O
was,O
tolerating,O
ground,B-TR
consistent,I-TR
solids,I-TR
.,O

On,O
07-24,O
",",O
he,O
had,O
an,B-PR
emesis,I-PR
x,O
1,O
",",O
and,O
had,O
aspiration,B-PR
pneumonia,I-PR
(,O
+,O
interstital,B-PR
markings,I-PR
on,O
the,O
left,O
on,O
CXR,B-TE
",",O
fever,B-PR
",",O
leukocytosis,B-PR
),O
.,O

His,B-TR
Flagyl,I-TR
course,I-TR
was,O
extended,O
",",O
and,O
Vanc,B-TR
/,O
Levo,B-TR
were,O
added,O
.,O

His,B-TE
sputum,I-TE
showed,O
many,B-PR
GPC,I-PR
which,O
later,O
grew,O
Staph,B-PR
aureus,I-PR
.,O

Given,O
his,B-PR
recent,I-PR
MRSA,I-PR
pneumonia,I-PR
",",O
he,O
will,O
be,O
treated,O
with,O
2,O
week,O
course,O
of,O
Vanc,B-TR
/,O
Levo,B-TR
/,O
Flagyl,B-TR
.,O

He,O
was,O
seen,O
by,O
the,O
pain,O
service,O
who,O
recommended,O
to,O
discontinue,O
Oxycontin,B-TR
",",O
and,O
start,O
Neurontin,B-TR
",",O
MSIR,B-TR
",",O
and,O
lidocaine,B-TR
patch,I-TR
in,O
addition,O
to,O
the,B-TR
standing,I-TR
Tylenol,I-TR
.,O

On,O
07-25,O
",",O
his,B-TR
J-tube,I-TR
was,O
noted,O
to,O
be,O
obstructed,B-PR
but,O
was,O
able,O
to,O
be,O
flushed,O
by,O
IR,O
on,O
07-26,O
.,O

Tubefeed,B-TR
was,O
resumed,O
without,O
any,B-PR
difficulty,I-PR
since,O
.,O

Since,O
oxycontin,B-TR
was,O
discontinued,O
",",O
the,B-TR
foley,I-TR
was,O
removed,O
on,O
07-27,O
and,O
was,O
able,O
to,O
void,O
without,O
any,B-PR
difficulty,I-PR
.,O

Medications,O
on,O
Admission,O
:,O

Lopressor,B-TR
50,O
mg,O
BID,O

percocet,B-TR

nebulizer,B-TR

lipitor,B-TR

klonopin,B-TR
0.5,O
mg,O
TID,O

RISS,B-TR

heparin,B-TR
sc,I-TR

lasix,B-TR
40,O
mg,O
TID,O

prevacid,B-TR

milk,B-TR
of,I-TR
mag,I-TR

multivitamin,B-TR

papain,B-TR

zinc,B-TR

Discharge,O
Medications,O
:,O

1.,O
Albuterol,B-TR
-,O
Ipratropium,B-TR
103-18,O
mcg,O
/,O
Actuation,O
Aerosol,O
Sig,O
:,O
02-19,O
Puffs,O
Inhalation,O
Q6H,O
(,O
every,O
6,O
hours,O
),O
as,O
needed,O
.,O

2.,O
Multivitamins,B-TR
Tablet,I-TR
",",O
Chewable,O
Sig,O
:,O
One,O
(,O
1,O
),O
Cap,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

3.,O
Magnesium,B-TR
Hydroxide,I-TR
400,O
mg,O
/,O
5,O
mL,O
Suspension,O
Sig,O
:,O
Thirty,O
(,O
30,O
),O
ML,O
PO,O
Q6H,O
(,O
every,O
6,O
hours,O
),O
as,O
needed,O
.,O

4.,O
Ipratropium,B-TR
Bromide,I-TR
0.02,O
%,O
Solution,O
Sig,O
:,O
One,O
(,O
1,O
),O
Inhalation,O
Q6H,O
(,O
every,O
6,O
hours,O
),O
.,O

5.,O
Heparin,B-TR
Sodium,I-TR
(,I-TR
Porcine,I-TR
),I-TR
"5,000",O
unit,O
/,O
mL,O
Solution,O
Sig,O
:,O
One,O
(,O
1,O
),O
Injection,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
.,O

6.,O
Atorvastatin,B-TR
Calcium,I-TR
20,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

7.,O
Papain,B-TR
-,I-TR
Urea,I-TR
"830,000-10",O
unit,O
-%,O
Spray,O
",",O
Non-Aerosol,O
Sig,O
:,O
One,O
(,O
1,O
),O
Appl,O
Topical,O
DAILY,O
(,O
Daily,O
),O
.,O

8.,O
Insulin,B-TR
Regular,I-TR
Human,I-TR
100,O
unit,O
/,O
mL,O
Solution,O
Sig,O
:,O
Sliding,B-TR
scale,I-TR
Injection,I-TR
ASDIR,O
(,O
AS,O
DIRECTED,O
),O
:,O
See,O
the,B-TR
sliding,I-TR
scale,I-TR
.,O

9.,O
Zinc,B-TR
Sulfate,I-TR
220,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

10.,O
Ascorbic,B-TR
Acid,I-TR
500,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

11.,O
Metoprolol,B-TR
Tartrate,I-TR
50,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

12.,O
Aspirin,B-TR
81,O
mg,O
Tablet,O
",",O
Chewable,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Chewable,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

13.,O
Clopidogrel,B-TR
Bisulfate,I-TR
75,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

14.,O
Metronidazole,B-TR
500,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
for,O
6,O
days,O
:,O
Last,O
day,O
2017-07-25,O
.,O

15.,O
Acetaminophen,B-TR
325,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
Q6H,O
(,O
every,O
6,O
hours,O
),O
.,O

16.,O
Olanzapine,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
as,O
needed,O
for,O
confusion,B-PR
.,O

17.,O
Protonix,B-TR
40,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
twice,O
a,O
day,O
.,O

18.,O
Morphine,B-TR
Sulfate,I-TR
15,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
.,O

19.,O
Levofloxacin,B-TR
500,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q24H,O
(,O
every,O
24,O
hours,O
),O
:,O
Last,O
day,O
08-07,O
.,O

20.,O
Vancomycin,B-TR
HCl,I-TR
in,O
Dextrose,B-TR
1,O
g,O
/,O
200,O
mL,O
Piggyback,O
Sig,O
:,O
One,O
(,O
1,O
),O
Intravenous,O
Q,O
12H,O
(,O
Every,O
12,O
Hours,O
),O
:,O
Last,O
day,O
08-07,O
.,O

21.,O
Gabapentin,B-TR
300,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
.,O

22.,O
Lidocaine,B-TR
5,O
%(,O
700,O
mg,O
/,O
patch,O
),O
Adhesive,O
Patch,O
",",O
Medicated,O
Sig,O
:,O
One,O
(,O
1,O
),O
Adhesive,O
Patch,O
",",O
Medicated,O
Topical,O
QD,O
(,O

23.,O
Morphine,B-TR
Sulfate,I-TR
2,O
mg,O
/,O
mL,O
Syringe,O
Sig,O
:,O
02-19,O
Injection,O
Q12H,O
(,O
every,O
12,O
hours,O
),O
as,O
needed,O
.,O

24.,O
Prochlorperazine,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q6H,O
(,O
every,O
6,O
hours,O
),O
as,O
needed,O
.,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Facility,O
:,O

Mediplex,O
Rehab,O
Hospital,O
-,O
Lawrence,O

Discharge,O
Diagnosis,O
:,O

Primary,O
:,O

1),O
Gangrenous,B-PR
leg,I-PR

2),O
Urinary,B-PR
tract,I-PR
infection,I-PR

3),O
MRSA,B-PR
pneumonia,I-PR

4),O
Failure,B-PR
to,I-PR
thrive,I-PR
and,O
weight,B-PR
loss,I-PR

5),O
Altered,B-PR
mental,I-PR
status,I-PR

6),O
Gastric,B-PR
ulcer,I-PR

7),O
C.diff,B-PR
colitis,I-PR

Secondary,O
:,O

1),O
Coronary,B-PR
artery,I-PR
disease,I-PR

2),O
Anemia,B-PR

3),O
Congestive,B-PR
heart,I-PR
failure,I-PR

4),O
Peripheral,B-PR
vascular,I-PR
disease,I-PR

5),O
Diabetes,B-PR
mellitus,I-PR

6),O
Hypertension,B-PR

Discharge,O
Condition,O
:,O

Hemodynamically,O
stable,O
",",O
pt,O
doing,O
much,O
better,O
with,O
physical,B-TR
therapy,I-TR
",",O
passed,O
video,B-TE
swallow,I-TE
evaluation,I-TE
tolerating,O
po,O
.,O

Discharge,O
Instructions,O
:,O

Patient,O
needs,O
to,O
take,O
all,O
of,O
the,B-TR
medications,I-TR
as,O
directed,O
.,O

Patient,O
needs,O
to,O
continue,O
the,B-TR
tube,I-TR
feed,I-TR
nutrition,I-TR
until,O
re-assessed,O
by,O
the,O
nutrionist,O
.,O

He,O
can,O
also,O
take,O
oral,O
food,O
as,O
directed,O
below,O
.,O

He,O
needs,O
to,O
seek,O
medical,O
attention,O
if,O
he,O
develops,O
fever,B-PR
",",O
chills,B-PR
",",O
nausea,B-PR
",",O
vomiting,B-PR
",",O
worsening,B-PR
pain,I-PR
",",O
worsening,B-PR
wound,I-PR
",",O
or,O
any,B-PR
other,I-PR
concerning,I-PR
symptoms,I-PR
.,O

Followup,O
Instructions,O
:,O

Please,O
follow,O
up,O
with,O
Dr.,O
Cynthia,O
Kabzinski,O
(,O
672-3879,O
),O
on,O
2017-08-08,O

10:45,O

Provider,O
:,O

Sarah,O
",",O
Santo,O
S.,O
Isom,O

SURGERY,O

Where,O
:,O

VASCULAR,O
SURGERY,O

Date,O
/,O
Time,O
:,O
2017-08-08,O
10:45,O

Vernon,O
Karen,O
MD,O
28-960,O

Completed,O
by,O
:,O
Marquita,O
Sherry,O
MD,O
09-161,O
2017-07-27,O
@,O
1440,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Frank,O
Z.K.,O
Delgado,O
on,O
:,O
Maxine,O
2017-07-27,O
3:37,O
PM,O

(,O
End,O
of,O
Report,O
),O

389977469,O

SH,O

30431630,O

12/19/2004,O
12:00:00,O
AM,O

abdominal,B-PR
pain,I-PR

DIS,O

Admission,O
Date,O
:,O

12/19/2004,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

12/23/2004,O

******,O
DISCHARGE,O
ORDERS******,O

MEEDHEYSKUDZRO,O
",",O
LEENLEE,O
C,O

360-93-28-7P31,O

Room,O
:,O

3M-963,O

Service,O
:,O

PUL,O

DISCHARGE,O
PATIENT,O
ON,O
:,O

12/23/04,O
AT,O
05:00,O
PM,O

CONTINGENT,O
UPON,O
Not,O
Applicable,O

WILL,O
D,O
/,O
C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D,O
/,O
C,O
SUMMARY,O
:,O

YES,O

Attending,O
:,O

SADDCHIRD,O
",",O
ALINE,O
CHPIE,O
",",O
M.D.,O

CODE,O
STATUS,O
:,O

No,O
CPR,B-TR
/,O
No,O
defib,B-TR
/,O
No,O
intubation,B-TR
/,O
No,O
pressors,B-TR

/DISPOSITION,O
:,O

Home,O
w/,O
services,O

DISCHARGE,O
MEDICATIONS,O
:,O

ALBUTEROL,B-TR
INHALER,I-TR
2,O
PUFF,O
INH,O
QID,O
PRN,O
Shortness,B-PR
of,I-PR
Breath,I-PR
",",O
Wheezing,B-PR
VITAMIN,B-TR
C,I-TR
(,I-TR
ASCORBIC,I-TR
ACID,I-TR
),I-TR
500,O
MG,O
PO,O
BID,O
MIACALCIN,B-TR
(,I-TR
CALCITONIN,I-TR
-,I-TR
SALMON,I-TR
),I-TR
1,O
SPRAY,O
INH,O
QD,O

Number,O
of,O
Doses,O
Required,O
(,O
approximate,O
),O
:,O

1MAG,B-TR
CITRATE,I-TR
(,I-TR
CITRATE,I-TR
OF,I-TR
MAGNESIA,I-TR
),I-TR
300,O
MILLILITERS,O
PO,O
QD,O
PRN,O
Constipation,B-PR
COLACE,B-TR
(,I-TR
DOCUSATE,I-TR
SODIUM,I-TR
),I-TR
100,O
MG,O
PO,O
TID,O
GLYBURIDE,B-TR
5,O
MG,O
PO,O
BID,O
Starting,O
IN,O
AM,O
on,O
12/21/04,O
LACTULOSE,B-TR
30,O
MILLILITERS,O
PO,O
Q6,O

HOLD,O
IF,O
:,O

diarrhea,B-PR

SENNA,B-TR
TABLETS,I-TR
2,O
TAB,O
PO,O
BID,O
SIMETHICONE,B-TR
160,O
MG,O
PO,O
QID,O
Starting,O
Today,O
(,O
12/23,O
),O
PRN,O

Other,O
:,O

gas,B-PR
",",O
upset,B-PR
stomach,I-PR
.,O

TAMOXIFEN,B-TR
20,O
MG,O
PO,O
QD,O

Override,O
Notice,O
:,O

Override,O
added,O
on,O
12/19/04,O
by,O
SAPMOORES,O
",",O
NELL,O
RILET,O
",",O
M.D.,O
on,O
order,O
for,O
LEVOFLOXACIN,B-TR
PO,I-TR
(,O
ref,O
#,O
88006031,O
),O

POTENTIALLY,O
SERIOUS,B-PR
INTERACTION,I-PR
:,O

TAMOXIFEN,B-TR
CITRATE,I-TR
and,O
LEVOFLOXACIN,B-TR

Reason,O
for,O
override,O
:,O

aware,O
MVI,B-TR
THERAPEUTIC,I-TR
W,I-TR
/,I-TR
MINERALS,I-TR
(,I-TR
THERAP,I-TR
VITS,I-TR
/,I-TR
MINERALS,I-TR
),I-TR
1,O
TAB,O
PO,O
QD,O
PILOCARPINE,B-TR
4%,I-TR
SOLUTION,I-TR
1,O
DROP,O
OS,O
QID,O
FLONASE,B-TR
(,I-TR
FLUTICASONE,I-TR
NASAL,I-TR
SPRAY,I-TR
),I-TR
2,O
SPRAY,O
INH,O
BID,O

Number,O
of,O
Doses,O
Required,O
(,O
approximate,O
),O
:,O

2,B-TR
ALPHAGAN,I-TR
(,I-TR
BRIMONIDINE,I-TR
TARTRATE,I-TR
),I-TR
1,O
DROP,O
OS,O
BID,O

Number,O
of,O
Doses,O
Required,O
(,O
approximate,O
),O
:,O

2,B-TR
LEVOFLOXACIN,I-TR
250,O
MG,O
PO,O
QD,O
X,O
1,O
Days,O
Starting,O
Today,O
(,O
12/21,O
),O

Food,O
/,O
Drug,O
Interaction,O
Instruction,O

Administer,O
iron,B-TR
products,I-TR
a,O
minimum,O
of,O
2,O
hours,O
before,O
or,O
after,O
a,B-TR
levofloxacin,I-TR
or,O
ciprofloxacin,B-TR
dose,O
dose,O

If,O
on,O
tube,B-TR
feeds,I-TR
",",O
please,O
cycle,O
(,O
hold,O
1,O
hr,O
before,O
to,O
2,O
hr,O
after,O
),O

Take,O
2,O
hours,O
before,O
or,O
2,O
hours,O
after,O
dairy,O
products,O
.,O

Alert,O
overridden,O
:,O

Override,O
added,O
on,O
12/19/04,O
by,O
SAPMOORES,O
",",O
NELL,O
RILET,O
",",O
M.D.,O

POTENTIALLY,O
SERIOUS,B-PR
INTERACTION,I-PR
:,O

TAMOXIFEN,B-TR
CITRATE,I-TR
and,O
LEVOFLOXACIN,B-TR

Reason,O
for,O
override,O
:,O

aware,O

CELEXA,B-TR
(,I-TR
CITALOPRAM,I-TR
),I-TR
20,O
MG,O
PO,O
QD,O
CALCIUM,B-TR
CARB,I-TR
+,I-TR
D,I-TR
(,O
600MG,O
ELEM,B-TR
CA,I-TR
+,I-TR
VIT,I-TR
D/200,I-TR
IU,O
),O
1,O
TAB,O
PO,O
BID,O
LUMIGAN,B-TR
(,I-TR
BIMATOPROST,I-TR
0.03%,I-TR
),I-TR
1,O
DROP,O
OU,O
QHS,O

DIET,O
:,O

No,O
Restrictions,O

ACTIVITY,O
:,O

as,O
tolerated,O

FOLLOW,O
UP,O
APPOINTMENT,O
(,O
S,O
),O
:,O

Dr.,O
Faleschird,O
",",O
Dr.,O
Cuchbreunjesc,O
",",O
Dr.,O
Roziesc,O
",",O

ALLERGY,O
:,O

CEFUROXIME,B-TR
AXETILADMIT,O
DIAGNOSIS,O
:,O

abdominal,B-PR
pain,I-PR

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O

Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O
abdominal,B-PR
pain,I-PR

OTHER,O
DIAGNOSIS,O
;,O

Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O
Allergies,B-PR
-,O
PCN,B-TR
-,O
rash,B-PR
-,O
Bactrim,B-TR
-,O
hives,B-PR
-,O
Erythro,B-TR
-,O
nausea,B-PR
-,O
Ceclor,B-TR
-,O
nausea,B-PR
-,O
Clarythro,B-TR
=,O
rash,B-PR

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

None,O
.,O

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O

NONEBRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

67,O
y/o,O
F,O
w/,O
hx,O
poliomyelitis,B-PR
",",O
breast,B-PR
CA,I-PR
stable,O
on,O
tamoxifen,B-TR
",",O
vent,B-PR
dependent,I-PR
in,O
an,B-TR
iron,I-TR
lung,I-TR
admitted,O
w/,O
1,O
day,O
hx,O
of,O
abdominal,B-PR
pain,I-PR
.,O

Pt,O
was,O
recently,O
admitted,O
1,O
week,O
ago,O
w/,O
epigastric,B-PR
pain,I-PR
.,O

Pain,B-PR
worse,O
with,O
movement,O
.,O

She,O
denies,O
any,B-PR
fever,I-PR
",",O
BRBPR,B-PR
",",O
melena,B-PR
",",O
dysuria,B-PR
.,O

On,O
admision,O
",",O
T,B-TE
97.5,O
",",O
HR,B-TE
86,O
",",O
BP,B-TE
111/47,O
",",O
R,B-TE
20,O
.,O

Sat,B-TE
94%,O
on,O
4L,B-TR
.,O

Exam,B-TE
notable,O
for,O
hyperactive,B-PR
bowel,I-PR
sounds,I-PR
with,O
abd,B-PR
distention,I-PR
and,O
tenderness,B-PR
to,O
palpation,B-TE
at,I-TE
LLQ,I-TE
and,O
RLQ,O
.,O

No,O
rebound,B-PR
or,O
guarding,B-PR
.,O

Abd,B-TE
CT,I-TE
showed,O
stable,O
findings,O
compared,O
to,O
12/10/04,O
except,O
for,O
distended,B-PR
right,I-PR
colon,I-PR
consistent,O
with,O
ileus,B-PR
.,O

Hospital,O
course,O
:,O

GI,O
:,O

pt,O
&apos;s,O
clinical,O
picture,O
was,O
consistent,O
with,O
constipation-related,B-PR
abdominal,I-PR
pain,I-PR
.,O

pt,O
was,O
started,O
on,O
bowel,B-TR
regimen,I-TR
with,O
Senna,B-TR
",",O
magcitrate,B-TR
and,O
Lactulose,B-TR
.,O

Several,O
loose,O
bowel,O
movements,O
were,O
induced,O
with,O
above,O
regimen,O
.,O

Her,B-PR
abd,I-PR
distention,I-PR
and,O
tenderness,B-PR
improved,O
after,O
bowel,O
movement,O
.,O

ID,O
:,O

pt,O
was,O
Levo,B-TR
250mg,O
x,O
3,O
days,O
for,O
UTI,B-PR
(,O
pyuria,B-PR
on,O
admisstion,O
),O
.,O

Pulm,O
:,O

pt,O
has,O
been,O
using,O
iron,B-TR
lung,I-TR
for,O
breathing,O
and,O
has,O
been,O
satting,O
well,O
duing,O
her,O
hospital,O
course,O
.,O

Code,O
:,O

DNR,O
/,O
DNI,O
.,O

ADDITIONAL,O
COMMENTS,O
:,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O

TO,O
DO,O
/,O
PLAN,O
:,O

1.,O
Please,O
follow,O
up,O
with,O
Dr.,O
Faleschird,O
",",O
Dr.,O
Cuchbreunjesc,O
and,O
Dr.,O
Roziesc,O
.,O

No,O
dictated,O
summary,O

ENTERED,O
BY,O
:,O

LEESEPLASSBREAN,O
",",O
RIDELT,O
",",O
M.D.,O
(,O
FR98,O
),O

12/23/04,O
04:37,O
PM,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

Admission,O
Date,O
:,O

2014-05-12,O

Discharge,O
Date:,O

Date,O
of,O
Birth,O
:,O

Sex,O
:,O

Service,O
:,O

ADMISSION,O
DIAGNOSES,O
:,O

1.,O
Congestive,B-PR
heart,I-PR
failure,I-PR
.,O

2.,O
Dilated,B-PR
cardiomyopathy,I-PR
.,O

3.,O
A,O
27,O
week,O
intrauterine,B-PR
pregnancy,I-PR
.,O

4.,O
Chronic,B-PR
hypertension,I-PR
.,O

5.,O
Asthma,B-PR
.,O

6.,O
History,O
of,O
atrioseptal,B-PR
defect,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
28,O
-,O
year-old,O
",",O
gravida,O
3,O
",",O
para,O
1,O
",",O
at,O
approximately,O
27,O
weeks,O
gestation,O
",",O
who,O
was,O
admitted,O
on,O
2014-05-12,O
due,O
to,O
increasing,O
symptoms,O
of,O
congestive,B-PR
heart,I-PR
failure,I-PR
.,O

She,O
has,O
known,B-PR
dilated,I-PR
cardiomyopathy,I-PR
with,O
a,B-TE
baseline,I-TE
ejection,I-TE
fraction,I-TE
of,O
approximately,O
25%,O
.,O

She,O
had,O
been,O
managed,O
as,O
an,O
outpatient,O
during,O
her,O
pregnancy,O
and,O
was,O
on,O
multiple,B-TR
medications,I-TR
including,O
Lasix,B-TR
40,O
mg,O
daily,O
",",O
Hydralazine,B-TR
25,O
mg,O
daily,O
",",O
Toprol,B-TR
XL,I-TR
100,O
mg,O
daily,O
",",O
digoxin,B-TR
0.5,O
mg,O
daily,O
and,O
Lovenox,B-TR
40,O
mg,O
twice,O
daily,O
subcutaneously,O
.,O

She,O
also,O
took,O
albuterol,B-TR
on,O
a,O
p.r.n.,O
basis,O
for,O
her,B-PR
asthma,I-PR
.,O

She,O
has,O
known,B-PR
allergy,I-PR
to,O
penicillin,B-TR
",",O
vancomycin,B-TR
and,O
erythromycin,B-TR
.,O

She,O
was,O
evaluated,O
upon,O
presentation,O
by,O
the,O
Maternal,O
Fetal,O
Medicine,O
attending,O
on,O
call,O
as,O
well,O
as,O
by,O
Cardiology,O
.,O

She,O
was,O
found,O
to,O
have,O
symptoms,O
of,O
congestive,B-PR
heart,I-PR
failure,I-PR
as,O
well,O
as,O
decreased,B-PR
fetal,I-PR
movement,I-PR
.,O

Fetal,B-TE
monitoring,I-TE
initially,O
on,O
admission,O
was,O
appropriate,O
for,O
gestational,O
age,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
physical,B-TE
exam,I-TE
",",O
she,O
was,O
noted,O
to,O
have,O
bilateral,B-PR
lower,I-PR
extremity,I-PR
edema,I-PR
",",O
mildly,B-PR
elevated,I-PR
pressures,I-PR
in,O
the,O
140,O
to,O
150/90,O
range,O
",",O
and,O
jugular,B-PR
venous,I-PR
distension,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

After,O
consultation,O
with,O
Cardiology,O
as,O
well,O
as,O
Anesthesia,O
on,O
call,O
that,O
evening,O
",",O
it,O
was,O
decided,O
to,O
transfer,O
the,O
patient,O
to,O
the,O
ICU,O
for,O
intensive,B-TE
monitoring,I-TE
.,O

Central,B-TR
IV,I-TR
access,I-TR
was,O
obtained,O
.,O

The,O
patient,O
was,O
carefully,O
diuresed,O
over,O
the,O
next,O
48,O
hours,O
.,O

Symptoms,O
of,O
congestive,B-PR
heart,I-PR
failure,I-PR
gradually,O
abated,O
over,O
the,O
next,O
48,O
to,O
72,O
hours,O
.,O

The,O
patient,O
was,O
given,O
antenatal,B-TR
corticosteroids,I-TR
for,O
fetal,O
lung,O
maturity,O
.,O

A,O
Neonatology,O
consultation,O
was,O
obtained,O
during,O
the,O
course,O
of,O
the,O
hospitalization,O
.,O

After,O
discussion,O
",",O
it,O
was,O
decided,O
to,O
attempt,O
to,O
obtain,O
28,O
weeks,O
gestation,O
and,O
then,O
deliver,O
electively,O
by,O
cesarean,B-TR
section,I-TR
given,O
the,B-PR
decompensation,I-PR
in,O
the,O
third,O
trimester,O
.,O

The,O
patient,O
underwent,O
primary,B-TR
low,I-TR
transverse,I-TR
cesarean,I-TR
section,I-TR
on,O
2014-05-19,O
at,O
approximately,O
28,O
weeks,O
gestation,O
.,O

The,B-TR
cesarean,I-TR
section,I-TR
was,O
performed,O
on,O
the,O
West,O
Campus,O
in,O
the,O
Cardiothoracic,O
Surgical,O
Suite,O
.,O

This,O
was,O
performed,O
in,O
this,O
location,O
in,O
case,O
any,B-PR
acute,I-PR
cardiac,I-PR
decompensation,I-PR
occurred,O
during,O
the,O
time,O
of,O
cesarean,B-TR
section,I-TR
.,O

Cardiothoracic,O
Surgery,O
was,O
on,O
standby,O
during,O
the,B-TR
surgery,I-TR
.,O

The,O
patient,O
went,O
to,O
the,O
cardiac,O
Intensive,O
Care,O
Unit,O
on,O
the,O
West,O
Campus,O
postoperatively,O
.,O

She,O
did,O
well,O
during,O
the,O
postoperative,O
period,O
.,O

She,O
required,O
several,O
episodes,O
of,O
diuresis,B-TR
due,O
to,O
increasing,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
on,O
postoperative,O
day,O
#1,O
and,O
postoperative,O
day,O
#2,O
due,O
to,O
worsening,O
symptoms,O
of,O
shortness,B-PR
of,I-PR
breath,I-PR
from,O
fluid,B-PR
shifts,I-PR
that,O
normally,O
occur,O
during,O
the,O
postpartum,O
period,O
.,O

The,O
patient,O
was,O
transferred,O
to,O
the,O
West,O
Campus,O
on,O
postoperative,O
day,O
#2,O
in,O
stable,O
condition,O
.,O

She,O
did,O
well,O
during,O
the,O
remainder,O
of,O
her,O
postoperative,O
course,O
and,O
was,O
continued,O
on,O
her,B-TR
medication,I-TR
regimen,I-TR
that,O
she,O
had,O
been,O
on,O
during,O
the,O
antepartum,O
period,O
.,O

She,O
was,O
discharged,O
to,O
home,O
on,O
postoperative,O
day,O
#4,O
.,O

She,O
was,O
to,O
followup,O
with,O
Maternal,O
Fetal,O
Medicine,O
in,O
5,O
to,O
7,O
days,O
.,O

She,O
had,O
followup,O
with,O
her,O
primary,O
cardiologist,O
in,O
Shaugnessy-Kaplan,O
Rehab,O
Hospital,O
scheduled,O
for,O
1,O
week,O
postoperatively,O
.,O

Of,O
note,O
",",O
the,O
patient,O
also,O
underwent,O
tubal,B-TR
ligation,I-TR
at,O
the,O
time,O
of,O
cesarean,B-TR
section,I-TR
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Toprol,B-TR
XL,I-TR
100,O
mg,O
daily,O
",",O
Hydralazine,B-TR
25,O
mg,O
daily,O
",",O
Lasix,B-TR
40,O
mg,O
twice,O
a,O
day,O
",",O
digoxin,B-TR
0.75,O
mg,O
daily,O
",",O
Lovenox,B-TR
40,O
mg,O
twice,O
daily,O
subcutaneously,O
and,O
albuterol,B-TR
p.r.n.,O

Peter,O
Richard,O
",",O
MD,O

Dictated,O
By,O
:,O
Michael,O
O.,O
Tucker,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2016-01-29,O
09:07:27,O

T,O
:,O
2016-01-29,O
09:49:48,O

Job,O
#:,O
72842,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Homer,O
Peterson,O
on,O
:,O
FRI,O
2016-01-29,O
11:36,O
AM,O

(,O
End,O
of,O
Report,O
),O

395715290,O

PUOMC,O

2681723,O

64704/9r71,O

946667,O

4/6/1995,O
12:00:00,O
AM,O

ACUTE,B-PR
MYOCARDIAL,I-PR
INFARCTION,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

4/6/95,O

DISCHARGE,O
DATE,O
:,O

4/16/95,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Acute,B-PR
myocardial,I-PR
infarction,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

status,O
post,O
aortic,B-TR
valve,I-TR
replacement,I-TR
",",O
status,O
post,O
coronary,B-TR
artery,I-TR
bypass,I-TR
grafting,I-TR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

Percutaneous,B-TR
angioplasty,I-TR
of,I-TR
the,I-TR
right,I-TR
coronary,I-TR
artery,I-TR
",",O
4/9/95,O
.,O

OTHER,O
PROCEDURES,O
:,O

directional,B-TR
angioplasty,I-TR
of,I-TR
the,I-TR
right,I-TR
coronary,I-TR
artery,I-TR
",",I-TR
left,I-TR
main,I-TR
and,I-TR
left,I-TR
anterior,I-TR
descending,I-TR
vessels,I-TR
.,O

4/11/95,O
.,O

DOCTORS,O
DISCHARGE,O
ORDERS,O
:,O

Lanoxin,B-TR
0.375,O
mg.,O
daily,O
.,O

Coumadin,B-TR
as,O
adjusted,O
by,O
Prothrombin,B-TE
times,I-TE
",",O
Isordil,B-TR
20,O
mg.,O
tid,O
",",O
Micronase,B-TR
1.25,O
mg.,O
daily,O
",",O
aspirin,B-TR
81,O
mg.,O
daily,O
",",O
nitroglycerin,B-TR
0.3,O
mg.,O
SL,O
prn,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
seventy,O
two,O
year,O
old,O
man,O
who,O
a,O
number,O
of,O
years,O
ago,O
underwent,O
coronary,B-TR
bypass,I-TR
surgery,I-TR
at,O
another,O
institution,O
.,O

This,O
took,O
place,O
in,O
1983,O
.,O

In,O
1992,O
he,O
underwent,O
redo,B-TR
surgery,I-TR
and,O
aortic,B-TR
valve,I-TR
replacement,I-TR
.,O

In,O
April,O
1994,O
he,O
presented,O
with,O
an,B-PR
acute,I-PR
inferior,I-PR
myocardial,I-PR
infarction,I-PR
and,O
was,O
given,O
Streptokinase,B-TR
.,O

He,O
had,O
recurrent,B-PR
pain,I-PR
and,O
went,O
to,O
the,O
Catheter,O
Laboratory,O
where,O
a,B-PR
proximal,I-PR
right,I-PR
coronary,I-PR
artery,I-PR
lesion,I-PR
was,O
angioplastied,O
.,O

A,O
relook,O
several,O
days,O
later,O
led,O
to,O
a,B-TR
repeat,I-TR
percutaneous,I-TR
transluminal,I-TR
coronary,I-TR
angioplasty,I-TR
.,O

He,O
has,O
has,O
stable,B-PR
",",I-PR
mild,I-PR
angina,I-PR
",",O
subsequently,O
",",O
mostly,O
in,O
the,O
setting,O
of,O
stress,B-PR
.,O

Slightly,O
increased,O
in,O
recent,O
months,O
.,O

On,O
the,O
day,O
of,O
admission,O
",",O
he,O
was,O
involved,O
in,O
a,O
minor,O
motor,O
vehicle,O
accident,O
",",O
and,O
there,O
was,O
some,O
apparent,O
controversy,O
with,O
the,O
driver,O
of,O
the,O
other,O
vehicle,O
",",O
during,O
the,O
course,O
of,O
which,O
he,O
developed,O
substernal,B-PR
chest,I-PR
pain,I-PR
radiating,O
to,O
the,O
left,O
arm,O
and,O
shoulder,O
.,O

This,O
waxed,O
and,O
waned,O
for,O
thirty,O
to,O
sixty,O
minutes,O
",",O
and,O
he,O
took,O
a,O
number,O
of,O
nitroglycerins,B-TR
.,O

After,O
returning,O
home,O
after,O
conferring,O
with,O
his,O
wife,O
",",O
and,O
the,B-PR
pain,I-PR
lasted,O
another,O
half,O
hour,O
",",O
he,O
came,O
to,O
the,O
emergency,O
room,O
.,O

His,B-TE
electrocardiogram,I-TE
showed,O
increased,B-PR
T,I-PR
wave,I-PR
inversions,I-PR
in,I-PR
V3,I-PR
and,O
V4,O
and,O
1,O
mm,O
.,O

ST,B-PR
segment,I-PR
depression,I-PR
in,I-PR
V3,I-PR
through,O
V6,O
.,O

His,B-TE
examination,I-TE
was,O
largely,O
benign,O
after,O
he,O
was,O
made,O
pain,B-PR
free,O
.,O

The,B-TE
pulse,I-TE
was,O
75,O
",",O
blood,B-TE
pressure,I-TE
120/80,O
",",O
respirations,B-TE
18,O
",",O
and,O
he,O
was,O
afebrile,B-PR
.,O

The,O
jugular,O
veins,O
were,O
not,O
distended,B-PR
",",O
the,B-TE
carotid,I-TE
volume,I-TE
was,O
diminished,B-PR
.,O

The,O
chest,O
was,O
clear,O
and,O
the,O
cardiac,O
rhythm,O
was,O
regular,O
.,O

There,O
were,O
normal,B-TR
prothetic,I-TR
valves,I-TR
.,O

There,O
was,O
a,B-PR
grade,I-PR
II-II,I-PR
apical,I-PR
and,I-PR
systolic,I-PR
murmur,I-PR
.,O

The,O
abdomen,O
was,O
negative,O
and,O
there,O
was,O
no,O
edema,B-PR
of,I-PR
the,I-PR
feet,I-PR
.,O

The,B-TE
electrocardiogram,I-TE
demonstrated,O
normal,O
sinus,O
rhythm,O
with,O
poor,B-PR
R,I-PR
wave,I-PR
progression,I-PR
",",O
left,B-PR
atrial,I-PR
enlargement,I-PR
and,O
T,B-PR
wave,I-PR
inversion,I-PR
in,I-PR
leads,I-PR
V,I-PR
4,I-PR
",",I-PR
5,I-PR
",",O
and,O

Admission,O
Date,O
:,O

2020-05-23,O

Discharge,O
Date,O
:,O

2020-05-29,O

Date,O
of,O
Birth,O
:,O

1955-11-14,O

Sex,O
:,O

F,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,O
Drugs,B-TR

Attending,O
:,O
Sabrina,O
Q.,O
G.,O
King,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O
change,B-PR
in,I-PR
mental,I-PR
status,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

Intubation,B-TR

Central,B-TR
line,I-TR
placement,I-TR

History,O
of,O
Present,O
Illness,O
:,O

64,O
F,O
with,O
breast,B-PR
CA,I-PR
s/p,O
mastectomy,B-TR
17,O
y,O
ago,O
with,O
local,B-PR
recurrence,I-PR
leading,O
to,O
paralysis,B-PR
of,I-PR
L,I-PR
arm,I-PR
~,O
5-6,O
y,O
ago,O
.,O

Now,O
declining,O
gradually,O
since,O
January,O
(,O
30,B-PR
lbs,I-PR
weight,I-PR
loss,I-PR
",",O
becoming,O
more,B-PR
confused,I-PR
",",O
decreased,B-PR
appetite,I-PR
).,O

Patient,O
declined,O
workup,B-TE
/,O
imaging,B-TE
for,O
mets,B-PR
as,O
outpatient,O
.,O

Moving,O
toward,O
home,O
hospice,O
.,O

Over,O
the,O
last,O
2,O
weeks,O
",",O
husband,O
reports,O
patient,O
becoming,O
increasingly,B-PR
weak,I-PR
",",O
unable,O
to,O
leave,O
bed,O
",",O
confused,B-PR
",",O
unable,O
to,O
feed,O
herself,O
.,O

Seen,O
by,O
VNA,O
and,O
noted,O
to,O
be,O
tachycardic,B-PR
and,O
sent,O
to,O
Middleboroughfor,O
evaluation,B-TE
.,O

Now,O
sent,O
in,O
to,O
Amesbury,O
by,O
VNA,O
because,O
of,O
asymptomatic,B-PR
sinus,I-PR
tachycardia,I-PR
.,O

Transferred,O
here,O
for,O
workup,B-TE
for,O
CNS,B-PR
mets,I-PR
and,O
admission,O
.,O

In,O
John,O
",",O
VS,B-TE
-,O
99.6,O
",",O
135,O
",",O
122/65,O
",",O
20,O
.,O

Neurology,O
evaluated,O
pt,O
and,O
felt,O
to,O
have,O
intact,O
brainstem,O
reflexes,O
but,O
poor,O
prognosis,O
.,O

Neurosurg,O
evaluated,O
pt,O
and,O
felt,O
to,O
not,O
be,O
surgical,O
candidate,O
;,O
recommended,O
dilantin,B-TR
load,I-TR
and,O
decadron,B-TR
.,O

Received,O
lorazepam,B-TR
prior,O
to,O
CT,B-TE
scan,I-TE
.,O

Intubated,O
for,O
MS,B-PR
changes,I-PR
and,O
lethargy,B-PR
and,O
concern,O
for,O
airway,B-TR
protection,I-TR
.,O

Post,O
intubation,B-TR
",",O
hypotensive,B-PR
and,O
started,O
on,O
dopamine,B-TR
and,O
transitioned,O
to,O
levophed,B-TR
.,O

Received,O
vancomycin,B-TR
/,O
levafloxacin,B-TR
at,O
OSH,O
.,O

Received,O
metronidazole,B-TR
at,O
Ricky,O
in,O
Mediplex,O
Rehab,O
Hospital,O
.,O

In,O
CMED,O
CCU,O
",",O
pt.,O
responsive,O
to,O
noxious,B-TE
stimuli,I-TE
only,O
.,O

History,O
obtained,O
from,O
husband,O
as,O
above,O
.,O

Past,O
Medical,O
History,O
:,O

PMHx,O
:,O

1.,O
Left,O
breast,O
status,O
post,O
radical,B-TR
mastectomy,I-TR
in,O
2002,O
with,O
adjuvant,B-TR
Tamoxifen,I-TR
for,O
five,O
years,O
.,O

This,O
was,O
followed,O
by,O
later,O
development,O
of,O
lymphedema,B-PR
and,O
left,B-PR
arm,I-PR
(,I-PR
distal,I-PR
>,I-PR
proximal,I-PR
),I-PR
weakness,I-PR
due,O
to,O
metastatic,B-PR
disease,I-PR
in,I-PR
left,I-PR
axilla,I-PR
ensheathing,I-PR
nerve,I-PR
plexus,I-PR
.,O

Treated,O
with,O
course,O
of,O
local,B-TR
XRT,I-TR
in,O
Springfield,O
Municipal,O
Hospital,O
and,O
Tamoxifen,B-TR
.,O

Switched,O
to,O
Arimedex,B-TR
in,O
2019-02-10,O
due,O
to,O
vaginal,B-PR
bleeding,I-PR
on,O
Tamoxifen,B-TR
.,O

Self,O
discontinued,O
Arimedex,B-TR
last,O
month,O
.,O

No,O
prior,O
history,O
of,O
intracranial,B-PR
disease,I-PR
.,O

2.,O
Metastatic,B-PR
disease,I-PR
in,I-PR
left,I-PR
arm,I-PR
",",I-PR
brachial,I-PR
plexus,I-PR
resulting,O
in,O
left,B-PR
arm,I-PR
paresis,I-PR
",",O
as,O
above,O

Social,O
History,O
:,O

Married,O
",",O
lives,O
with,O
husband,O
.,O

Victoria,O
't,O
worked,O
since,O
2008,O
",",O
prior,O
to,O
that,O
worked,O
in,O
a,O
school,O
cafeteria,O
.,O

+,O
children,O
(,O
husband,O
Gracia,O
't,O
quantify,O
).,O

Social,O
smoker,O
in,O
her,O
youth,O
.,O

Distant,O
smoking,O
history,O
.,O

Occasional,O
alcohol,O
use,O
.,O

Family,O
History,O
:,O

Maternal,O
aunt,O
with,O
breast,B-PR
cancer,I-PR
.,O

Mother,O
aged,O
85,O
",",O
alive,O
and,O
well,O
.,O

Three,O
healthy,O
siblings,O
.,O

Father,O
deceased,O
from,O
complications,B-PR
from,O
MS,B-PR
.,O

Physical,O
Exam,O
:,O

T,B-TE
99.8,O

HR,B-TE
124,O

SBP,B-TE
135/58,O

RR,B-TE
16,O

Ox,B-TE
100,O

Gen,O
:,O

Cachectic,B-PR
",",O
lays,O
with,O
eyes,O
closed,O
.,O

HEENT,O
:,O

Temporal,B-PR
wasting,I-PR
.,O

NC/AT,B-PR
.,O

Anicteric,B-PR
.,O

Mucosa,B-PR
dry,I-PR
.,O

Neck,O
:,O

Supple,O
.,O

Lungs,O
:,O

Clear,O
anterolaterally,O
.,O

No,O
R/R/W,B-PR
.,O

Cardiac,O
:,O

Tachycardic,B-PR
",",O
regular,O
.,O

S1/S2,O
.,O

No,O
M/R/G,B-PR
.,O

Abd,O
:,O

Soft,O
",",O
NT,B-PR
",",O
ND,B-PR
",",O
+,O
NABS,O
.,O

No,O
rebound,B-PR
or,O
guarding,B-PR
.,O

No,O
HSM,B-PR
.,O

Extrem,O
:,O

Wasted,B-PR
.,O

Legs,O
are,O
rigid,B-PR
.,O

Pertinent,O
Results,O
:,O

Head,B-TE
CT,I-TE
There,O
is,O
diffuse,B-PR
metastatic,I-PR
disease,I-PR
.,O

Three,B-PR
discrete,I-PR
lesions,I-PR
are,O
seen,O
within,O
the,O
left,O
frontal,O
",",O
right,O
occipital,O
",",O
and,O
left,O
parietal,O
lobes,O
with,O
significant,B-PR
surrounding,I-PR
vasogenic,I-PR
edema,I-PR
.,O

The,B-PR
largest,I-PR
single,I-PR
lesion,I-PR
measures,O
3.7,O
x,O
3.4,O
cm,O
.,O

There,O
is,O
moderate,B-PR
surrounding,I-PR
edema,I-PR
with,O
10,O
mm,O
rightward,B-PR
shift,I-PR
of,I-PR
the,I-PR
normally,I-PR
midline,I-PR
structures,I-PR
with,O
associated,B-PR
mass,I-PR
effect,I-PR
on,I-PR
the,I-PR
lateral,I-PR
ventricles,I-PR
.,O

The,O
basilar,O
cistern,O
is,O
preserved,O
and,O
there,O
is,O
no,O
uncal,B-PR
herniation,I-PR
.,O

The,O
osseous,O
structures,O
are,O
unremarkable,O
.,O

The,O
paranasal,O
sinuses,O
and,O
mastoid,O
air,O
cells,O
are,O
well,O
aerated,O
.,O

CT,B-TE
torso,I-TE

1.,O
Right,B-PR
middle,I-PR
lobe,I-PR
lung,I-PR
nodule,I-PR
",",O
suspicious,O
for,O
metastatic,B-PR
disease,I-PR
.,O

2.,O
Right,B-PR
upper,I-PR
lobe,I-PR
lung,I-PR
opacities,I-PR
which,O
appear,O
confluent,B-PR
",",O
most,O
suggestive,O
of,O
infectious,B-PR
etiology,I-PR
",",O
however,O
",",O
cannot,O
entirely,O
exclude,O
metastatic,B-PR
lesions,I-PR
.,O

Recommend,O
follow,B-TE
up,I-TE
CT,I-TE
to,O
ensure,O
resolution,O
.,O

3.,O
Multiple,B-PR
hypodense,I-PR
liver,I-PR
lesions,I-PR
which,O
are,O
mildly,B-PR
enhancing,I-PR
",",O
most,O
consistent,O
with,O
metastatic,B-PR
disease,I-PR
.,O

4.,O
Bilateral,B-PR
small,I-PR
pleural,I-PR
effusion,I-PR
",",O
which,O
certainly,O
could,O
be,O
malignant,B-PR
given,O
today,B-TE
's,I-TE
findings,I-TE
and,O
history,O
of,O
breast,B-PR
cancer,I-PR
.,O

5.,O
No,O
evidence,O
of,O
bony,B-PR
metastases,I-PR
.,O

6.,O
Uterine,O
cavity,O
fluid,O
of,O
unclear,O
etiology,O
.,O

Brief,O
Hospital,O
Course,O
:,O

Metastatic,B-PR
breast,I-PR
CA,I-PR
-,O
Large,B-PR
brain,I-PR
mets,I-PR
with,O
midline,B-PR
shift,I-PR
.,O

Intubated,O
for,O
airway,B-TR
protection,I-TR
.,O

Treated,O
with,O
IV,B-TR
dilantin,I-TR
and,O
decadron,B-TR
.,O

Patient,O
mental,O
status,O
improved,O
slightly,O
.,O

After,O
discussion,O
with,O
primary,O
oncologist,O
goals,O
of,O
care,O
where,O
change,O
to,O
comfort,O
.,O

Dilantin,B-TR
was,O
stopped,O
.,O

Will,O
go,O
home,O
with,O
prn,O
morphine,B-TR
",",O
ativan,B-TR
",",O
and,O
PR,B-TR
decadron,I-TR
.,O

Pnuemonia,B-PR
-,O
Possible,O
aspiration,B-PR
.,O

Completed,O
a,O
7,O
day,O
course,O
of,O
vancomycin,B-TR
and,O
levofloxacin,B-TR
.,O

Medications,O
on,O
Admission,O
:,O
none,O

Discharge,O
Medications,O
:,O

1.,O
Morphine,B-TR
Concentrate,I-TR
20,O
mg,O
/,O
mL,O
Solution,O
Sig,O
:,O
2.5-20,O
mg,O
PO,O
Q1-2H,O
(,O

Disp,O
:*,O
30,O
ml,O
*,O
Refills,O
:*,O
0,O
*,O

2.,O
Lorazepam,B-TR
0.5,O
mg,O
Tablet,O
Sig,O
:,O
0.5-2,O
mg,O
PO,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
for,O
aggitation,B-PR
/,O
seizure,B-PR
:,O
Please,O
dispense,O
liquid,O
.,O

Disp,O
:*,O
50,O
ml,O
*,O
Refills,O
:*,O
0,O
*,O

3.,O
Dexamethasone,B-TR
4,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
Q8H,O
(,O
every,O
8,O
hours,O
),O
:,O
please,O
give,O
8,O
mg,O
suppository,O
.,O

Disp,O
:*,O
90,O
suppository,O
*,O
Refills,O
:*,O
0,O
*,O

Discharge,O
Disposition,O
:,O

Home,O
with,O
Service,O

Discharge,O
Diagnosis,O
:,O

Breast,B-PR
cancer,I-PR

Discharge,O
Condition,O
:,O

Stable,O

Discharge,O
Instructions,O
:,O

Please,O
call,O
hospice,O
for,O
questions,O
.,O

Followup,O
Instructions,O
:,O
as,O
needed,O

Ramirez,O
Mary,O
Lenora,O
MD,O
74-114,O

Completed,O
by,O
:,O
Tony,O
Cervantes,O
MD,O
43-424,O
2020-05-29,O
@,O
0951,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Patricia,O
Noland,O
on,O
:,O
SAT,O
2020-05-30,O
9:10,O
AM,O

(,O
End,O
of,O
Report,O
),O

399210956,O

FIH,O

6954426,O

59986/3015,O

71004,O

08/27/1992,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

08-27-92,O

DISCHARGE,O
DATE,O
:,O

09-05-92,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
75,O
year,O
old,O
Hispanic,O
male,O
with,O
insulin,B-PR
dependent,I-PR
diabetes,I-PR
mellitus,I-PR
",",O
status,O
post,O
a,B-TR
right,I-TR
above-knee,I-TR
amputation,I-TR
about,O
five,O
years,O
ago,O
",",O
who,O
reportedly,O
approximately,O
four,O
months,O
ago,O
",",O
he,O
developed,O
a,B-PR
small,I-PR
ulceration,I-PR
in,I-PR
the,I-PR
left,I-PR
great,I-PR
toe,I-PR
",",O
which,O
progressively,O
worsened,O
.,O

He,O
was,O
seen,O
by,O
a,O
doctor,O
in,O
Arizona,O
and,O
treated,O
with,O
dressing,B-TR
changes,I-TR
and,O
debridement,B-TR
until,O
approximately,O
six,O
weeks,O
ago,O
",",O
when,O
antibiotics,B-TR
were,O
started,O
with,O
Ciprofloxacin,B-TR
.,O

The,O
patient,O
was,O
seen,O
and,O
it,O
was,O
suggested,O
that,O
he,O
should,O
have,O
an,B-TR
amputation,I-TR
and,O
he,O
decided,O
to,O
come,O
to,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
for,O
further,B-TE
evaluation,I-TE
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

insulin,B-PR
dependent,I-PR
diabetes,I-PR
mellitus,I-PR
for,O
fifteen,O
years,O
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

right,B-TR
above-knee,I-TR
amputation,I-TR
five,O
years,O
ago,O
",",O
status,O
post,O
motor,O
vehicle,O
accident,O
.,O

He,O
sustained,O
left,B-PR
humerus,I-PR
fracture,I-PR
and,O
left,B-PR
tib-fib,I-PR
fracture,I-PR
.,O

ALLERGIES,O
:,O

The,O
patient,O
has,O
no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Tylenol,B-TR
",",O
Ciprofloxacin,B-TR
and,O
Insulin,B-TR
",",O
about,O
16,O
units,O
of,O
NPH,B-TR
qa.m.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

On,O
review,B-TE
of,I-TE
systems,I-TE
",",O
denies,O
fevers,B-PR
",",O
has,O
pain,B-PR
in,I-PR
the,I-PR
left,I-PR
foot,I-PR
",",O
no,O
shortness,B-PR
of,I-PR
breath,I-PR
or,O
chest,B-PR
pain,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,B-TE
physical,I-TE
examination,I-TE
reveals,O
him,O
to,O
be,O
an,O
elderly,O
gentleman,O
who,O
is,O
alert,O
and,O
oriented,O
and,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

The,B-TE
head,I-TE
",",I-TE
eyes,I-TE
",",I-TE
ears,I-TE
",",I-TE
nose,I-TE
",",I-TE
throat,I-TE
examination,I-TE
was,O
unremarkable,O
.,O

Chest,O
was,O
clear,O
to,O
auscultation,B-TE
and,O
percussion,B-TE
.,O

Cardiovascular,O
exam,O
:,O

regular,O
rate,O
and,O
rhythm,O
.,O

The,O
abdomen,O
was,O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
",",O
no,O
visceromegaly,B-PR
.,O

The,B-TE
rectal,I-TE
examination,I-TE
showed,O
normal,O
prostate,O
",",O
guaiac,B-TE
negative,O
.,O

His,B-TE
neurological,I-TE
examination,I-TE
was,O
nonfocal,O
.,O

Pulses,B-TE
remained,O
",",O
aside,O
from,O
the,B-TR
above-knee,I-TR
amputation,I-TR
on,I-TR
the,I-TR
right,I-TR
side,I-TR
",",O
they,O
remained,O
symmetrical,O
bilaterally,O
with,O
3+,B-TE
carotid,I-TE
",",O
2+,B-TE
brachial,I-TE
",",O
1+,B-TE
radial,I-TE
",",O
3+,B-TE
femoral,I-TE
.,O

LABORATORY,O
DATA,O
:,O

significant,O
for,O
a,B-TE
white,I-TE
blood,I-TE
count,I-TE
of,O
6.0,O
",",O
hematocrit,B-TE
35.9,O
",",O
electrolytes,B-TE
within,O
normal,O
limits,O
",",O
BUN,B-TE
and,O
creatinine,B-TE
of,O
13,O
and,O
0.8,O
",",O
amylase,B-TE
of,O
56,O
.,O

The,O
patient,O
had,O
an,B-TE
electrocardiogram,I-TE
which,O
showed,O
no,O
acute,B-PR
ischemic,I-PR
change,I-PR
.,O

His,B-TE
chest,I-TE
X-ray,I-TE
ruled,O
out,O
acute,B-PR
cardiopulmonary,I-PR
process,I-PR
.,O

Left,B-PR
foot,I-PR
changes,I-PR
consistent,O
with,O
osteomyelitis,B-PR
of,I-PR
the,I-PR
left,I-PR
great,I-PR
toe,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
for,O
intravenous,B-TR
antibiotics,I-TR
and,O
a,O
question,O
of,O
evaluation,B-TE
of,I-TE
circulation,I-TE
to,O
the,O
left,O
great,O
toe,O
and,O
also,O
possible,O
debridement,B-TR
and,O
possibly,O
a,B-TR
toe,I-TR
amputation,I-TR
.,O

The,O
patient,O
had,O
the,O
following,O
radiological,O
studies,O
:,O

08-27-92,O
",",O
left,B-TE
foot,I-TE
film,I-TE
",",O
correlation,O
",",O
patient,O
consistent,O
with,O
osteomyelitis,B-PR
involving,I-PR
the,I-PR
first,I-PR
digit,I-PR
and,O
possibly,O
the,O
second,O
digit,O
of,O
the,O
left,O
foot,O
.,O

The,B-TE
chest,I-TE
X-ray,I-TE
reveals,O
no,O
evidence,O
of,O
acute,B-PR
disease,I-PR
.,O

The,O
patient,O
had,O
lower,B-TE
extremity,I-TE
arterial,I-TE
non-invasive,I-TE
study,I-TE
which,O
showed,O
good,O
arterial,O
hemodynamics,O
of,O
the,O
left,O
lower,O
extremity,O
",",O
perfusion,O
to,O
the,O
TM,O
level,O
",",O
but,O
there,O
was,O
evidence,O
of,O
diabetic,B-PR
small,I-PR
vessel,I-PR
disease,I-PR
and,O
spasm,B-PR
of,I-PR
his,I-PR
digits,I-PR
.,O

The,O
arterial,O
circulation,O
is,O
adequate,O
for,O
healing,O
of,O
his,B-PR
left,I-PR
great,I-PR
toe,I-PR
ulcer,I-PR
",",O
noncompressible,B-PR
left,I-PR
thigh,I-PR
and,I-PR
calf,I-PR
pressures,I-PR
highly,B-PR
calcified,I-PR
arterial,I-PR
system,I-PR
.,O

On,O
09-03-92,O
",",O
patient,O
underwent,O
a,B-TR
left,I-TR
great,I-TR
toe,I-TR
buttontoe,I-TR
amputation,I-TR
under,O
regional,B-TR
ankle,I-TR
block,I-TR
for,O
chronic,B-PR
ulcer,I-PR
and,O
osteomyelitis,B-PR
of,I-PR
the,I-PR
left,I-PR
great,I-PR
toe,I-PR
.,O

The,O
patient,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
.,O

There,O
were,O
no,O
complications,B-PR
during,O
the,B-TR
procedure,I-TR
.,O

There,O
was,O
a,B-TR
small,I-TR
Penrose,I-TR
drain,I-TR
postoperatively,O
that,O
was,O
placed,O
intraoperatively,O
and,O
discontinued,O
on,O
approximately,O
postoperative,O
day,O
number,O
three,O
.,O

The,O
patient,O
was,O
preoperatively,O
treated,O
with,O
about,O
a,O
seven,O
day,O
course,O
of,O
intravenous,B-TR
Unasyn,I-TR
and,O
postoperatively,O
treated,O
for,O
approximately,O
four,O
days,O
of,O
intravenous,B-TR
Unasyn,I-TR
.,O

The,O
patient,O
was,O
discharged,O
home,O
in,O
stable,O
condition,O
on,O
postoperative,O
day,O
number,O
five,O
",",O
without,O
any,B-PR
complications,I-PR
.,O

The,B-PR
incision,I-PR
from,O
buttontoe,B-TR
amputation,I-TR
of,I-TR
the,I-TR
left,I-TR
foot,I-TR
healing,O
well,O
",",O
without,O
any,O
further,B-PR
complications,I-PR
.,O

FOLLOWUP,O
:,O

The,O
patient,O
is,O
to,O
follow,O
up,O
in,O
clinic,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Included,O
his,B-TR
pre-admission,I-TR
medications,I-TR
.,O

A,O
HAS,O
",",O
M.D.,O

TR,O
:,O

yy,O
/,O
bmot,O

DD,O
:,O

10-21-92,O

TD,O
:,O

10/22/92,O

CC,O
:,O

Admission,O
Date,O
:,O

2010-06-07,O

Discharge,O
Date,O
:,O

2010-06-12,O

Date,O
of,O
Birth,O
:,O

1955-03-30,O

Sex,O
:,O

M,O

Service,O
:,O

CARDIOTHORACIC,O
SURGERY,O

HISTORY,O
OF,O
THE,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
55,O
-,O
year-old,O
male,O
with,O
critical,B-PR
aortic,I-PR
stenosis,I-PR
who,O
was,O
referred,O
to,O
Dr.,O
Brenda,O
Hummer,O
for,O
discussion,O
for,O
surgical,B-TR
options,I-TR
to,O
free,O
this,B-PR
condition,I-PR
.,O

The,O
patient,O
reportedly,O
had,O
been,O
experiencing,O
increasing,B-PR
fatigue,I-PR
and,O
dyspnea,B-PR
with,O
exertion,O
for,O
the,O
year,O
prior,O
to,O
his,O
admission,O
.,O

The,O
patient,O
reported,O
increasingly,O
frequent,O
episodes,O
of,O
dizziness,B-PR
and,O
shortness,B-PR
of,I-PR
breath,I-PR
accompanied,O
with,O
coughing,B-PR
spells,I-PR
after,O
walking,O
approximately,O
a,O
half,O
a,O
mile,O
or,O
climbing,O
three,O
flights,O
of,O
stairs,O
.,O

On,O
2010-05-27,O
",",O
an,B-TE
echocardiogram,I-TE
was,O
done,O
which,O
revealed,O
critical,B-PR
fibrocalcific,I-PR
aortic,I-PR
stenosis,I-PR
with,O
a,B-TE
peak,I-TE
gradient,I-TE
of,O
125,O
mmHg,O
",",O
a,B-TE
mean,I-TE
gradient,I-TE
of,O
74,O
mmHg,O
",",O
an,B-TE
Oak,I-TE
Bluffs,I-TE
of,O
0.44,O
",",O
and,O
1+,B-PR
aortic,I-PR
and,I-PR
mitral,I-PR
insufficiency,I-PR
.,O

The,O
patient,O
subsequently,O
underwent,O
a,B-TE
cardiac,I-TE
catheterization,I-TE
on,O
2010-06-01,O
",",O
which,O
demonstrated,O
no,O
hemodynamically,B-PR
significant,I-PR
coronary,I-PR
artery,I-PR
disease,I-PR
",",O
but,O
critical,B-PR
aortic,I-PR
stenosis,I-PR
consistent,O
with,O
his,B-TE
echocardiogram,I-TE
study,I-TE
results,I-TE
.,O

The,O
patient,O
was,O
subsequently,O
scheduled,O
for,O
a,B-TR
mechanical,I-TR
aortic,I-TR
valve,I-TR
replacement,I-TR
procedure,I-TR
with,O
aortic,B-TR
replacement,I-TR
on,O
2010-06-07,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Diabetes,B-PR
.,O

2.,O
Hypertension,B-PR
.,O

3.,O
Seasonal,B-PR
allergies,I-PR
.,O

4.,O
Arthritis,B-PR
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

Negative,O
.,O

AT,O
-,O
HOME,O
MEDICATIONS,O
:,O

1.,O
Metformin,B-TR
.,O

2.,O
Celexa,B-TR
.,O

3.,O
Lipitor,B-TR
.,O

4.,O
Aspirin,B-TR
.,O

5.,O
Toprol,B-TR
XL,I-TR
.,O

ALLERGIES,O
:,O

The,O
patient,O
is,O
allergic,B-PR
to,O
penicillin,B-TR
and,O
shell,O
fish,O
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
is,O
married,O
with,O
two,O
children,O
and,O
is,O
currently,O
unemployed,O
.,O

The,O
patient,O
denied,O
any,O
tobacco,O
or,O
alcohol,O
history,O
.,O

HOSPITAL,O
COURSE,O
:,O

On,O
2010-06-07,O
",",O
the,O
patient,O
underwent,O
a,B-TR
mechanical,I-TR
aortic,I-TR
valve,I-TR
replacement,I-TR
with,O
a,B-TR
23,I-TR
mm,I-TR
Carbomedics,I-TR
mechanical,I-TR
valve,I-TR
and,O
a,B-TR
Supra,I-TR
coronary,I-TR
aortic,I-TR
graft,I-TR
with,O
gelweave,B-TR
28,O
mm,O
.,O

The,O
patient,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
with,O
a,B-TR
bypass,I-TR
time,I-TR
of,O
155,O
minutes,O
and,O
a,B-TR
crossclamp,I-TR
time,I-TR
of,O

130,O
minutes,O
",",O
and,O
a,O
rest,O
time,O
of,O
16,O
minutes,O
.,O

The,O
patient,O
's,O
pericardium,O
was,O
left,O
open,O
;,O
lines,B-TR
placed,O
included,O
a,B-TR
right,I-TR
radial,I-TR
line,I-TR
and,O
a,B-TR
right,I-TR
IJ,I-TR
line,I-TR
;,O
both,O
ventricular,B-TR
and,I-TR
atrial,I-TR
wires,I-TR
were,O
placed,O
;,O
two,B-TR
mediastinal,I-TR
tubes,I-TR
were,O
placed,O
.,O

The,O
patient,O
was,O
subsequently,O
transferred,O
to,O
the,O
Cardiac,O
Surgery,O
Recovery,O
Unit,O
",",O
intubated,B-TR
",",O
for,O
further,B-TE
evaluation,I-TE
and,O
management,O
.,O

On,O
transfer,O
",",O
the,B-TE
patient,I-TE
's,I-TE
mean,I-TE
arterial,I-TE
pressure,I-TE
was,O
76,O
",",O
CVP,B-TE
12,O
",",O
PAD,B-TE
17,O
",",O
and,O
his,B-TE
Bennie,I-TE
was,O
25,O
.,O

The,O
patient,O
was,O
AV,B-TR
paced,I-TR
at,O
a,O
rate,O
of,O
88,O
beats,O
per,O
minute,O
.,O

Active,B-TR
drips,I-TR
included,O
milrinone,B-TR
",",O
Levophed,B-TR
",",O
propofol,B-TR
",",O
and,O
insulin,B-TR
.,O

On,O
postoperative,O
day,O
number,O
one,O
",",O
the,O
patient,O
was,O
successfully,O
weaned,O
and,O
extubated,O
without,O
complication,B-PR
.,O

The,O
patient,O
was,O
then,O
advanced,O
to,O
oral,O
intake,O
which,O
he,O
tolerated,O
without,O
complication,B-PR
.,O

On,O
postoperative,O
day,O
number,O
two,O
",",O
the,B-TR
patient,I-TR
's,I-TR
chest,I-TR
tubes,I-TR
were,O
removed,O
without,O
complication,B-PR
and,O
the,O
patient,O
was,O
subsequently,O
cleared,O
for,O
transfer,O
to,O
the,O
floor,O
.,O

The,O
patient,O
was,O
subsequently,O
admitted,O
to,O
the,O
cardiothoracic,O
service,O
under,O
the,O
direction,O
of,O
Dr.,O
Brenda,O
Hummer,O
.,O

Postoperatively,O
",",O
the,O
patient,O
's,O
clinical,O
course,O
was,O
largely,O
unremarkable,O
.,O

The,O
patient,O
was,O
evaluated,O
by,O
Physical,O
Therapy,O
",",O
who,O
declared,O
him,O
a,O
suitable,O
candidate,O
for,O
discharge,O
directly,O
to,O
home,O
following,O
resolution,O
of,O
his,B-TR
medical,I-TR
therapy,I-TR
.,O

The,O
patient,O
was,O
advanced,O
to,O
a,O
full,O
regular,O
diet,O
",",O
which,O
he,O
tolerated,O
without,O
complication,B-PR
",",O
and,O
had,O
adequate,B-TR
pain,I-TR
control,I-TR
provided,O
via,O
oral,B-TR
pain,I-TR
medications,I-TR
.,O

The,O
patient,O
was,O
begun,O
on,O
anticoagulation,B-TR
therapy,I-TR
for,O
a,B-TE
target,I-TE
INR,I-TE
of,O
2.5,O
.,O

On,O
the,O
evening,O
of,O
postoperative,O
day,O
number,O
four,O
",",O
the,O
patient,O
had,O
a,O
transient,O
episode,O
of,O
disorientation,B-PR
and,O
confusion,B-PR
which,O
subsequently,O
resolved,O
spontaneously,O
.,O

By,O
postoperative,O
day,O
number,O
five,O
",",O
the,O
patient,O
was,O
noted,O
to,O
be,O
afebrile,B-PR
and,O
stable,O
.,O

His,B-PR
incision,I-PR
was,O
noted,O
to,O
be,O
clean,O
",",O
dry,O
",",O
and,O
intact,O
with,O
no,O
evidence,O
of,O
cellulitis,B-PR
or,O
purulent,B-PR
drainage,I-PR
.,O

The,O
patient,O
was,O
noted,O
to,O
be,O
independently,O
ambulatory,O
and,O
was,O
productive,O
of,O
adequate,O
amounts,O
of,O
urine,O
.,O

The,O
patient,O
was,O
tolerant,O
of,O
a,O
full,O
regular,O
diet,O
and,O
had,O
his,B-PR
pain,I-PR
well,O
controlled,O
via,O
oral,B-TR
pain,I-TR
medications,I-TR
.,O

The,B-TE
patient,I-TE
's,I-TE
INR,I-TE
was,O
noted,O
to,O
be,O
2.3,O
.,O

The,O
patient,O
was,O
subsequently,O
cleared,O
for,O
discharge,O
to,O
home,O
with,O
instructions,O
for,O
follow-up,O
on,O
postoperative,O
day,O
number,O
five,O
",",O
2010-06-12,O
.,O

CONDITION,O
AT,O
DISCHARGE,O
:,O

The,O
patient,O
is,O
to,O
be,O
discharged,O
to,O
home,O
with,O
instructions,O
for,O
follow-up,O
.,O

STATUS,O
AT,O
DISCHARGE,O
:,O

Stable,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Lopressor,B-TR
25,O
mg,O
p.o.,O
b.i.d.,O

2.,O
Lasix,B-TR
20,O
mg,O
p.o.,O
q.,O
12,O
hours,O
times,O
seven,O
days,O
.,O

3.,O
Potassium,B-TR
chloride,I-TR
20,O
mEq,O
p.o.,O
q.,O
12,O
hours,O
times,O
seven,O
days,O
.,O

4.,O
Colace,B-TR
100,O
mg,O
p.o.,O
b.i.d.,O

5.,O
Metformin,B-TR
500,O
mg,O
p.o.,O
b.i.d.,O

6.,O
Percocet,B-TR
5/325,O
one,O
to,O
two,O
tablets,O
p.o.,O
q.,O
four,O
to,O
six,O
hours,O
p.r.n.,O

7.,O
Celexa,B-TR
20,O
mg,O
p.o.,O
q.d.,O

8.,O
Lipitor,B-TR
20,O
mg,O
p.o.,O
q.d.,O

9.,O
Warfarin,B-TR
5,O
mg,O
p.o.,O
q.d.,O
times,O
four,O
days,O
",",O
after,O
which,O
point,O
the,O
patient,O
's,O
dosage,O
schedule,O
is,O
to,O
be,O
coordinated,O
by,O
his,O
PCP,O
",",O
Dr.,O
Jerold,O
Esqueda,O
.,O

DISCHARGE,O
INSTRUCTIONS,O
:,O

The,O
patient,O
is,O
to,O
maintain,O
his,B-PR
incisions,I-PR
clean,O
and,O
dry,O
at,O
all,O
times,O
.,O

The,O
patient,O
may,O
shower,O
but,O
should,O
pat,O
dry,O
incisions,B-PR
afterwards,O
;,O
no,O
bathing,O
or,O
swimming,O
until,O
further,O
notice,O
.,O

The,O
patient,O
may,O
resume,O
a,B-TR
Heart,I-TR
Healthy,I-TR
Diet,I-TR
.,O

The,O
patient,O
had,O
been,O
advised,O
to,O
limit,O
his,O
physical,O
exercise,O
;,O
no,O
heavy,O
exertion,O
.,O

No,O
driving,O
while,O
taking,O
prescription,B-TR
pain,I-TR
medications,I-TR
.,O

The,O
patient,O
is,O
to,O
have,O
his,B-TR
Coumadin,I-TR
managed,O
by,O
his,O
primary,O
care,O
provider,O
",",O
Dr.,O
Jerold,O
Esqueda,O
",",O
for,O
a,B-TE
target,I-TE
INR,I-TE
of,O
2.5,O
.,O

The,O
patient,O
is,O
to,O
report,O
to,O
Dr.,O
Jones,O
office,O
on,O
2010-06-14,O
for,O
an,B-TE
initial,I-TE
blood,I-TE
draw,I-TE
and,O
subsequent,B-TR
Coumadin,I-TR
titration,I-TR
;,O
Coumadin,B-TE
levels,I-TE
are,O
to,O
be,O
monitored,O
per,O
his,O
PCP,O
David,O
.,O

The,O
patient,O
is,O
to,O
follow-up,O
with,O
Dr.,O
Leanne,O
Larimore,O
in,O
Cardiology,O
within,O
two,O
to,O
three,O
weeks,O
following,O
discharge,O
.,O

The,O
patient,O
is,O
to,O
follow-up,O
with,O
Dr.,O
Brenda,O
Hummer,O
four,O
weeks,O
following,O
discharge,O
.,O

The,O
patient,O
is,O
to,O
call,O
to,O
schedule,O
all,O
appointments,O
.,O

Tracy,O
X.,O
Carmen,O
",",O
M.D.,O

76-050,O

Dictated,O
By,O
:,O
Gerald,O
R.,O
Quiroz,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2010-06-12,O
02:00,O

T,O
:,O
2010-06-12,O
14:21,O

JOB,O
#:,O
47222,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Tiffany,O
D.,O
Picklesimer,O
on,O
:,O
WED,O
2010-07-28,O
4:41,O
PM,O

(,O
End,O
of,O
Report,O
),O

405728860,O

FIH,O

7150860,O

05849/1xpu,O

994032,O

1/3/1994,O
12:00:00,O
AM,O

MEDIASTINAL,B-PR
TUMOR,I-PR
MASS,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

1-3-94,O

DISCHARGE,O
DATE,O
:,O

1-9-94,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Mediastinal,B-PR
tumor,I-PR
mass,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

History,O
of,O
colon,B-PR
cancer,I-PR
",",O
chronic,B-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
",",O
obesity,B-PR
",",O
hypertension,B-PR
",",O
history,O
of,O
myocardial,B-PR
infarction,I-PR
.,O

SPECIAL,O
PROCEDURES,O
AND,O
OPERATIONS,O
:,O

January,O
3,O
",",O
1994,O
",",O
median,B-TE
sternotomy,I-TE
with,O
mediastinal,B-TE
exploration,I-TE
",",O
radical,B-TR
resection,I-TR
of,O
tumor,B-PR
and,O
aortopulmonary,B-PR
window,I-PR
;,O
partial,B-TR
resection,I-TR
of,I-TR
adjacent,I-TR
lung,I-TR
",",O
en,B-TR
bloc,I-TR
resection,I-TR
of,I-TR
vagus,I-TR
and,I-TR
phrenic,I-TR
nerves,I-TR
;,O
partial,B-TR
pericardectomy,I-TR
;,O
fiberoptic,B-TE
bronchoscopy,I-TE
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
66,O
year,O
old,O
white,O
female,O
with,O
metastatic,B-PR
colon,I-PR
carcinoma,I-PR
with,O
a,B-PR
mass,I-PR
in,I-PR
the,I-PR
left,I-PR
superhilar,I-PR
region,I-PR
",",O
who,O
presents,O
for,O
bronchoscopy,B-TE
",",O
mediastinal,B-TE
exploration,I-TE
and,O
resection,B-TR
.,O

The,O
patient,O
was,O
in,O
her,O
usual,O
state,O
of,O
health,O
until,O
she,O
experienced,O
the,O
onset,O
of,O
abdominal,B-PR
pain,I-PR
in,O
early,O
1992,O
.,O

In,O
December,O
of,O
1992,O
",",O
she,O
underwent,O
a,B-TR
transverse,I-TR
colectomy,I-TR
for,O
colon,B-PR
carcinoma,I-PR
which,O
was,O
Duke,B-PR
&apos;s,I-PR
grade,I-PR
B-II,I-PR
",",O
lymph,O
nodes,O
were,O
negative,O
.,O

She,O
received,O
postoperative,B-TR
chemotherapy,I-TR
.,O

In,O
September,O
of,O
1992,O
",",O
she,O
underwent,O
an,B-TE
exploratory,I-TE
laparotomy,I-TE
because,O
of,O
an,B-PR
increased,I-PR
level,I-PR
of,I-PR
CEA,I-PR
in,O
her,B-TE
blood,I-TE
with,O
the,O
presence,O
of,O
a,B-PR
liver,I-PR
abnormality,I-PR
on,O
computerized,B-TE
tomography,I-TE
scan,I-TE
.,O

The,B-TE
exploratory,I-TE
laparotomy,I-TE
was,O
negative,O
.,O

She,O
continued,O
to,O
have,O
a,B-PR
rise,I-PR
in,O
her,B-TE
CEA,I-TE
level,I-TE
which,O
prompted,O
a,B-TE
further,I-TE
work,I-TE
up,I-TE
.,O

In,O
September,O
of,O
1993,O
",",O
an,B-TE
abdominal,I-TE
and,I-TE
pelvic,I-TE
computerized,I-TE
tomography,I-TE
scan,I-TE
was,O
negative,O
and,O
in,O
June,O
of,O
1993,O
",",O
she,O
had,O
a,B-TE
negative,I-TE
bone,I-TE
scan,I-TE
.,O

In,O
December,O
of,O
1994,O
",",O
a,B-TE
thoracic,I-TE
computerized,I-TE
tomography,I-TE
scan,I-TE
showed,O
a,B-PR
four,I-PR
centimeter,I-PR
soft,I-PR
tissue,I-PR
mass,I-PR
on,I-PR
the,I-PR
left,I-PR
suprahilar,I-PR
region,I-PR
",",O
adjacent,O
to,O
the,B-PR
aortopulmonary,I-PR
window,I-PR
.,O

She,O
also,O
experienced,O
increased,B-PR
hoarseness,I-PR
over,O
the,O
preceding,O
months,O
",",O
which,O
was,O
due,O
to,O
left,B-PR
vocal,I-PR
cord,I-PR
paralysis,I-PR
.,O

She,O
also,O
complains,O
of,O
increased,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
for,O
the,O
preceding,O
month,O
and,O
now,O
presents,O
for,O
mediastinal,B-TE
exploration,I-TE
and,O
resection,B-TR
of,O
her,O
probable,O
metastatic,B-PR
mass,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

The,O
patient,O
has,O
a,O
history,O
of,O
hypertension,B-PR
",",O
coronary,B-PR
artery,I-PR
disease,I-PR
",",O
previous,B-PR
myocardial,I-PR
infarction,I-PR
in,O
1983,O
",",O
hypothyroidism,B-PR
",",O
history,O
of,O
breast,B-PR
cancer,I-PR
and,O
history,O
of,O
colon,B-PR
cancer,I-PR
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

The,O
past,O
surgical,O
history,O
is,O
notable,O
for,O
a,O
1971,O
mastectomy,B-TR
on,I-TR
the,I-TR
right,I-TR
",",O
1937,O
appendectomy,B-TR
",",O
1991,O
cholecystectomy,B-TR
",",O
1992,O
transverse,B-TR
colectomy,I-TR
",",O
1992,O
exploratory,B-TE
laparotomy,I-TE
",",O
1991,O
bilateral,B-TR
cataract,I-TR
surgery,I-TR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Levoxine,B-TR
0.125,O
mg,O
PO,O
q.day,O
",",O
Vasotec,B-TR
10,O
mg,O
PO,O
b.i.d.,O
",",O
Maxzide,B-TR
75/50,O
",",O
30,O
mg,O
PO,O
q.day,O
.,O

ALLERGIES,O
:,O

The,O
patient,O
is,O
allergic,B-PR
to,O
sulfa,B-TR
.,O

HABITS,O
:,O

50,O
pack,O
year,O
smoking,O
history,O
",",O
still,O
smoking,O
currently,O
.,O

Ethanol,O
:,O

none,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
physical,B-TE
examination,I-TE
",",O
she,O
is,O
an,O
obese,O
white,O
female,O
in,O
no,O
acute,B-PR
distress,I-PR
with,O
a,B-PR
hoarse,I-PR
voice,I-PR
.,O

The,B-TE
head,I-TE
",",I-TE
eyes,I-TE
",",I-TE
ears,I-TE
",",I-TE
nose,I-TE
",",I-TE
throat,I-TE
examination,I-TE
shows,O
that,O
she,O
is,O
normocephalic,O
",",O
atraumatic,B-PR
",",O
extra,O
ocular,O
movements,O
are,O
intact,O
",",O
pupils,O
equal,O
",",O
round,O
",",O
reactive,O
to,O
light,O
and,O
accommodation,O
",",O
and,O
the,O
oropharynx,O
was,O
clear,O
",",O
neck,O
was,O
supple,O
without,O
lymphadenopathy,B-PR
",",O
either,O
axillary,O
or,O
supraclavicular,O
.,O

Chest,O
is,O
clear,O
with,O
decreased,B-PR
breath,I-PR
sounds,I-PR
at,I-PR
the,I-PR
left,I-PR
base,I-PR
.,O

She,O
has,O
a,B-TR
previous,I-TR
right,I-TR
mastectomy,I-TR
.,O

Cardiovascular,O
exam,O
:,O

regular,O
rate,O
and,O
rhythm,O
",",O
without,O
murmur,B-PR
",",O
rub,B-PR
or,O
gallop,B-PR
.,O

Abdomen,O
:,O

obese,B-PR
with,O
multiple,B-PR
well,I-PR
healed,I-PR
surgical,I-PR
incisions,I-PR
",",O
positive,O
bowel,O
sounds,O
.,O

The,B-TE
rectal,I-TE
examination,I-TE
is,O
guaiac,B-TE
negative,O
without,O
masses,B-PR
.,O

Extremities,O
:,O

no,O
clubbing,B-PR
",",O
cyanosis,B-PR
or,O
edema,B-PR
.,O

The,B-TE
neurological,I-TE
examination,I-TE
is,O
nonfocal,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
.,O

The,O
patient,O
was,O
brought,O
to,O
the,O
Operating,O
Room,O
on,O
January,O
3,O
",",O
1994,O
where,O
she,O
underwent,O
a,B-TR
median,I-TR
sternotomy,I-TR
with,O
removal,B-TR
of,O
her,B-PR
mediastinal,I-PR
mass,I-PR
.,O

This,B-PR
mass,I-PR
was,O
situated,O
in,O
the,B-PR
aortopulmonary,I-PR
window,I-PR
and,O
was,O
sent,O
to,O
pathology,O
.,O

The,B-TE
frozen,I-TE
section,I-TE
analysis,I-TE
revealed,O
this,O
to,O
be,O
adenocarcinoma,B-PR
",",O
metastatic,B-PR
disease,I-PR
from,I-PR
the,I-PR
colon,I-PR
most,O
likely,O
.,O

She,O
had,O
a,B-TR
chest,I-TR
tube,I-TR
placed,O
intraoperatively,O
and,O
another,O
placed,O
postoperatively,O
in,O
the,O
recovery,O
room,O
",",O
for,O
what,O
was,O
presumed,O
to,O
be,O
a,B-PR
left,I-PR
pleural,I-PR
effusion,I-PR
.,O

This,B-TR
tube,I-TR
drained,O
only,O
a,O
small,O
amount,O
of,O
fluid,O
and,O
it,O
was,O
likely,O
that,O
the,B-PR
effusion,I-PR
was,O
made,O
to,O
look,O
more,O
severe,O
in,O
the,O
presence,O
of,O
left,B-PR
hemidiaphragm,I-PR
elevation,I-PR
.,O

This,B-TR
additional,I-TR
chest,I-TR
tube,I-TR
was,O
removed,O
the,O
following,O
day,O
.,O

Her,B-TE
postoperative,I-TE
hematocrit,I-TE
was,O
31,O
",",O
compared,O
to,O
a,B-TE
preoperative,I-TE
level,I-TE
of,O
43,O
.,O

Her,O
postoperative,O
recovery,O
was,O
really,O
quite,O
remarkable,O
.,O

Mediastinal,B-TR
chest,I-TR
tube,I-TR
was,O
removed,O
on,O
postoperative,O
day,O
three,O
.,O

The,O
patient,O
was,O
discharged,O
home,O
in,O
stable,O
condition,O
on,O
postoperative,O
day,O
six,O
.,O

DOCTORS,O
DISCHARGE,O
ORDERS,O
:,O

Percocet,B-TR
for,O
pain,B-PR
.,O

Follow,O
up,O
with,O
Dr.,O
Fede,O
Duhenile,O
.,O

She,O
will,O
have,O
a,O
home,O
health,O
aide,O
to,O
visit,O
and,O
help,O
her,O
with,O
meals,O
.,O

CA,O
SHUFF,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

FEDE,O
LEVEL,O
",",O
M.D.,O

TR,O
:,O

kw,O
/,O
bmot,O

DD,O
:,O

1-9-94,O

TD,O
:,O

01/10/94,O

CC,O
:,O

Admission,O
Date,O
:,O

2016-02-14,O

Discharge,O
Date,O
:,O

Date,O
of,O
Birth,O
:,O

1952-03-27,O

Sex,O
:,O

M,O

Service,O
:,O

ADMISSION,O
DIAGNOSIS,O
:,O

Coronary,B-PR
artery,I-PR
disease,I-PR
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
.,O

2.,O
Status,O
post,O
off,B-TR
pump,I-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
times,O
three,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
63,O
year,O
old,O
gentleman,O
who,O
had,O
initially,O
presented,O
with,O
exertional,B-PR
chest,I-PR
pressure,I-PR
several,O
weeks,O
prior,O
to,O
this,O
admission,O
that,O
would,O
resolve,O
with,O
rest,O
.,O

Stress,B-TE
echocardiogram,I-TE
demonstrated,O
an,B-TE
ejection,I-TE
fraction,I-TE
of,O
40%,O
",",O
hypokinesis,B-PR
of,I-PR
distal,I-PR
anterior,I-PR
wall,I-PR
",",O
akinesis,B-PR
of,I-PR
distal,I-PR
inferior,I-PR
wall,I-PR
and,I-PR
apex,I-PR
.,O

The,O
patient,O
had,O
a,B-TE
cardiac,I-TE
catheterization,I-TE
which,O
revealed,O
three,B-PR
vessel,I-PR
disease,I-PR
and,O
the,O
patient,O
now,O
presents,O
for,O
elective,B-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
grafting,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Hypertension,B-PR
.,O

2.,O
Hypercholesterolemia,B-PR
.,O

3.,O
Diabetes,B-PR
mellitus,I-PR
.,O

4.,O
End,B-PR
stage,I-PR
renal,I-PR
disease,I-PR
.,O

5.,O
Status,O
post,O
cadaveric,B-TR
kidney,I-TR
transplant,I-TR
in,O
2012-09-21,O
.,O

6.,O
Chronic,B-PR
allograft,I-PR
nephropathy,I-PR
.,O

7.,O
Chronic,B-PR
anemia,I-PR
.,O

8.,O
History,O
of,O
upper,B-PR
gastrointestinal,I-PR
bleed,I-PR
.,O

9.,O
Depression,B-PR
.,O

10.,O
Gout,B-PR
.,O

11.,O
Question,O
of,O
transient,B-PR
ischemic,I-PR
attack,I-PR
.,O

12.,O
Status,O
post,O
left,B-TR
AV,I-TR
fistula,I-TR
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

1.,O
Aspirin,B-TR
325,O
mg,O
p.o.,O
once,O
daily,O
.,O

2.,O
Neoral,B-TR
25,O
mg,O
three,O
times,O
a,O
day,O
.,O

3.,O
Diltiazem,B-TR
240,O
mg,O
once,O
daily,O
.,O

4.,O
Allopurinol,B-TR
100,O
mg,O
p.o.,O
once,O
daily,O
.,O

5.,O
Hydralazine,B-TR
100,O
mg,O
twice,O
a,O
day,O
.,O

6.,O
Enalapril,B-TR
10,O
mg,O
p.o.,O
twice,O
a,O
day,O
.,O

7.,O
Avandia,B-TR
4,O
mg,O
once,O
daily,O
.,O

8.,O
Lipitor,B-TR
10,O
mg,O
once,O
daily,O
.,O

9.,O
Bactrim,B-TR
double,I-TR
strength,I-TR
once,O
daily,O
.,O

10.,O
Hydrochlorothiazide,B-TR
25,O
mg,O
once,O
daily,O
.,O

11.,O
Toprol,B-TR
XL,I-TR
25,O
mg,O
once,O
daily,O
.,O

12.,O
Prednisone,B-TR
5,O
mg,O
once,O
daily,O
.,O

LABORATORY,O
DATA,O
:,O

Preoperative,O
laboratory,O
values,O
showed,O
white,B-TE
blood,I-TE
cell,I-TE
count,I-TE
6.8,O
",",O
hematocrit,B-TE
33.3,O
",",O
platelet,B-TE
count,I-TE

"283,000",O
.,O

INR,B-TE
1.1,O
.,O

Chem7,B-TE
showed,O
sodium,B-TE
138,O
",",O
potassium,B-TE
4.1,O
",",O
chloride,B-TE
107,O
",",O
bicarbonate,B-TE
20,O
",",O
blood,B-TE
urea,I-TE
nitrogen,I-TE
49,O
",",O
creatinine,B-TE
2.5,O
",",O
glucose,B-TE
156,O
.,O

Calcium,B-TE
9.2,O
",",O
magnesium,B-TE
1.8,O
",",O
and,O
phosphorus,B-TE
4.2,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,O
",",O
in,O
general,O
",",O
the,O
patient,O
was,O
in,O
no,O
acute,B-PR
distress,I-PR
",",O
comfortable,O
.,O

Vital,B-TE
signs,I-TE
showed,O
temperature,B-TE
96.3,O
",",O
pulse,B-TE
64,O
",",O
blood,B-TE
pressure,I-TE
170/70,O
",",O
respiratory,B-TE
rate,I-TE
20,O
",",O
oxygen,B-TE
saturation,I-TE
98%,O
in,O
room,O
air,O
.,O

Head,B-TE
",",I-TE
eyes,I-TE
",",I-TE
ears,I-TE
",",I-TE
nose,I-TE
and,I-TE
throat,I-TE
examination,I-TE
is,O
normocephalic,O
and,O
atraumatic,B-PR
.,O

Extraocular,O
movements,O
are,O
intact,O
.,O

The,O
pupils,O
are,O
equal,O
",",O
round,O
",",O
and,O
reactive,O
to,O
light,O
and,O
accommodation,O
.,O

Anicteric,B-PR
.,O

Throat,O
is,O
clear,O
.,O

The,O
chest,O
is,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

Neck,O
was,O
supple,O
with,O
no,O
lymphadenopathy,B-PR
.,O

Cardiovascular,O
shows,O
grade,B-PR
II/VI,I-PR
systolic,I-PR
ejection,I-PR
murmur,I-PR
",",O
regular,O
rate,O
and,O
rhythm,O
.,O

The,O
abdomen,O
is,O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
",",O
with,O
a,B-PR
small,I-PR
umbilical,I-PR
hernia,I-PR
.,O

Extremities,O
are,O
warm,O
",",O
noncyanotic,B-PR
and,O
nonedematous,B-PR
times,O
four,O
.,O

There,O
is,O
no,O
peripheral,B-PR
edema,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
initially,O
admitted,O
to,O
the,O
medical,O
service,O
for,O
optimization,O
prior,O
to,O
his,B-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
.,O

The,O
patient,O
was,O
given,O
stress,B-TR
dose,I-TR
steroids,I-TR
on,O
the,O
day,O
prior,O
to,O
his,B-TR
surgery,I-TR
.,O

He,O
was,O
closely,O
followed,O
from,O
his,O
admission,O
through,O
to,O
his,O
discharge,O
by,O
the,O
renal,O
service,O
for,O
his,B-PR
transplant,I-PR
issues,I-PR
.,O

On,O
2016-02-15,O
",",O
the,O
patient,O
was,O
taken,O
to,O
the,O
operating,O
room,O
and,O
had,O
an,B-TR
off,I-TR
pump,I-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
performed,O
with,O
the,B-TR
left,I-TR
internal,I-TR
mammary,I-TR
artery,I-TR
to,I-TR
the,I-TR
left,I-TR
anterior,I-TR
descending,I-TR
",",O
saphenous,B-TR
vein,I-TR
graft,I-TR
to,I-TR
obtuse,I-TR
marginal,I-TR
and,O
posterior,O
descending,O
artery,O
.,O

For,O
details,O
of,O
this,B-TR
operation,I-TR
",",O
please,O
see,O
the,O
previously,O
dictated,O
operative,O
note,O
.,O

Postoperatively,O
",",O
the,O
patient,O
was,O
transferred,O
to,O
the,O
CSRU,O
for,O
close,B-TE
monitoring,I-TE
.,O

On,O
the,O
evening,O
of,O
postoperative,O
day,O
number,O
zero,O
",",O
the,O
patient,O
had,O
decreased,B-PR
urine,I-PR
output,I-PR
and,O
was,O
placed,O
on,O
a,B-TR
Lasix,I-TR
drip,I-TR
for,O
diuresis,B-TR
.,O

The,O
patient,O
tolerated,O
this,O
well,O
.,O

The,O
renal,O
service,O
continued,O
to,O
follow,O
close,B-TR
management,I-TR
of,O
his,B-TR
immunosuppression,I-TR
.,O

On,O
postoperative,O
day,O
number,O
one,O
",",O
the,O
patient,O
was,O
extubated,O
and,O
awakened,O
from,O
sedation,B-TR
.,O

He,O
did,O
well,O
on,O
this,O
and,O
his,B-TR
Levophed,I-TR
drip,I-TR
was,O
weaned,O
to,O
off,O
as,O
tolerated,O
.,O

Over,O
the,O
course,O
of,O
his,O
Intensive,O
Care,O
Unit,O
stay,O
",",O
the,O
patient,O
received,O
six,O
units,O
of,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
for,O
a,B-PR
low,I-PR
hematocrit,I-PR
.,O

He,O
otherwise,O
had,O
a,O
fairly,O
uncomplicated,O
postoperative,O
course,O
.,O

On,O
postoperative,O
day,O
number,O
three,O
",",O
the,O
patient,O
was,O
transferred,O
to,O
the,O
floor,O
.,O

On,O
postoperative,O
day,O
number,O
four,O
",",O
the,O
patient,O
was,O
noted,O
to,O
have,O
a,B-PR
low,I-PR
platelet,I-PR
level,I-PR
of,O
"43,000",O
.,O

Heparin,B-TE
induced,I-TE
thrombocytopenia,I-TE
antibody,I-TE
panel,I-TE
was,O
sent,O
.,O

Other,O
than,O
this,O
",",O
the,O
patient,O
did,O
very,O
well,O
.,O

Chest,B-TR
tubes,I-TR
were,O
removed,O
when,O
output,B-TE
was,O
low,O
.,O

Pacing,B-TR
wires,I-TR
were,O
removed,O
.,O

Physical,O
therapy,O
saw,O
the,O
patient,O
and,O
cleared,O
the,O
patient,O
for,O
discharge,O
.,O

Ultimately,O
",",O
the,O
patient,O
was,O
discharged,O
on,O
postoperative,O
day,O
number,O
six,O
tolerating,O
a,O
regular,O
diet,O
",",O
adequate,O
pain,B-TR
control,I-TR
on,O
p.o.,B-TR
pain,I-TR
medications,I-TR
",",O
and,O
ambulating,O
well,O
with,O
clearance,O
of,O
physical,O
therapy,O
.,O

DISPOSITION,O
:,O

To,O
home,O
.,O

DIET,O
:,O

Cardiac,B-TR
and,I-TR
diabetic,I-TR
diet,I-TR
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
.,O

PHYSICAL,O
EXAMINATION,O
ON,O
DISCHARGE,O
:,O

The,O
chest,O
is,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
without,O
sternal,B-PR
click,I-PR
or,O
discharge,B-PR
.,O

Cardiovascular,O
is,O
regular,O
rate,O
and,O
rhythm,O
.,O

The,O
abdomen,O
is,O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
.,O

Extremities,O
are,O
warm,O
",",O
noncyanotic,B-PR
",",O
minimal,B-PR
peripheral,I-PR
edema,I-PR
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

1.,O
Percocet,B-TR
5/325,O
one,O
to,O
two,O
q4hours,O
p.r.n.,O

2.,O
Plavix,B-TR
75,O
mg,O
once,O
daily,O
.,O

3.,O
Aspirin,B-TR
325,O
mg,O
once,O
daily,O
.,O

4.,O
Bactrim,B-TR
double,I-TR
strength,I-TR
one,O
tablet,O
once,O
daily,O
.,O

5.,O
Prednisone,B-TR
5,O
mg,O
once,O
daily,O
.,O

6.,O
Lipitor,B-TR
10,O
mg,O
once,O
daily,O
.,O

7.,O
Lopressor,B-TR
25,O
mg,O
twice,O
a,O
day,O
.,O

8.,O
Hydralazine,B-TR
75,O
mg,O
q6hours,O
.,O

9.,O
Cyclosporin,B-TR
75,O
mg,O
twice,O
a,O
day,O
.,O

10.,O
Rosiglitazone,B-TR
4,O
mg,O
once,O
daily,O
.,O

DISCHARGE,O
INSTRUCTIONS,O
:,O

The,O
patient,O
is,O
to,O
follow-up,O
with,O
Dr.,O
Herrick,O
in,O
four,O
weeks,O
time,O
.,O

He,O
should,O
follow-up,O
with,O
his,O
cardiologist,O
in,O
one,O
to,O
two,O
weeks,O
for,O
optimization,O
of,O
his,B-TR
medications,I-TR
.,O

The,O
patient,O
should,O
return,O
or,O
contact,O
the,O
office,O
if,O
he,O
has,O
a,B-PR
fever,I-PR
",",O
sternal,B-PR
discharge,I-PR
or,O
other,B-PR
significant,I-PR
chest,I-PR
pain,I-PR
.,O

Ellen,O
Z,O
Neher,O
",",O
M.D.,O

65-969,O

Dictated,O
By,O
:,O
Ann,O
C,O
Vinson,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2016-02-21,O
11:42,O

T,O
:,O
2016-02-21,O
13:33,O

JOB,O
#:,O
94475,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Georgia,O
K.,O
Dover,O
on,O
:,O
FRI,O
2016-03-18,O
3:35,O
PM,O

(,O
End,O
of,O
Report,O
),O

421179499,O

BH,O

940729,O

770923,O

3/30/1997,O
12:00:00,O
AM,O

ASPIRATION,B-PR
PNEUMONIA,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

DISCHARGE,O
SUMMARY,O
NAME,O
:,O

STRAPEFREIRE,O
",",O
VATALY,O
C,O

UNIT,O
NUMBER,O
:,O

972-02-46,O

ADMISSION,O
DATE,O
:,O

03/30/97,O

DISCHARGE,O
DATE,O
:,O

04/01/97,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Aspiration,B-PR
pneumonia,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

Dementia,B-PR
;,O
congestive,B-PR
heart,I-PR
failure,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
AND,O
REASON,O
FOR,O
HOSPITALIZATION,O
:,O

The,O
patient,O
was,O
a,O
108-year-old,O
nursing,O
home,O
resident,O
",",O
who,O
was,O
admitted,O
with,O
a,O
two-day,O
history,O
of,O
increased,B-PR
respiratory,I-PR
secretions,I-PR
and,O
a,O
24-hour,O
history,O
of,O
elevated,B-PR
fever,I-PR
.,O

Despite,O
Augmentin,B-TR
",",O
the,B-PR
patient,I-PR
&apos;s,I-PR
delirium,I-PR
worsened,O
in,O
the,O
24,O
hours,O
prior,O
to,O
admission,O
",",O
and,O
her,B-TE
temperature,I-TE
was,O
up,O
to,O
102,O
.,O

She,O
was,O
refusing,O
to,O
take,O
p.o.&apos;s,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Recurrent,B-PR
urinary,I-PR
tract,I-PR
infections,I-PR
",",O
most,O
recently,O
on,O
2/23/97,O
;,O
recurrent,B-PR
aspiration,I-PR
pneumonias,I-PR
",",O
most,O
recently,O
on,O
2/21/97,O
;,O
multi-infarct,B-PR
dementia,I-PR
with,O
associated,B-PR
dysphasia,I-PR
;,O
mitral,B-PR
regurgitation,I-PR
;,O
history,O
of,O
congestive,B-PR
heart,I-PR
failure,I-PR
;,O
pernicious,B-PR
anemia,I-PR
;,O
chronic,B-PR
venous,I-PR
stasis,I-PR
;,O
status,O
post,O
left,B-PR
femoral,I-PR
neck,I-PR
fracture,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Augmentin,B-TR
500,O
mg,O
t.i.d.,O

Senokot,B-TR
one,O
q.h.s.,O

Sertraline,B-TR
75,O
mg,O
q.day,O
.,O

Aspirin,B-TR
81,O
mg,O
q.day,O
.,O

Vitamin,B-TR
B12,I-TR
100,O
mcg,O
IM,O
q.month,O
.,O

Urecholine,B-TR
25,O
mg,O
t.i.d.,O
Colace,B-TR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
resides,O
in,O
the,O
"Pcaer,ter",O
Medical,O
Center,O
",",O
is,O
nonambulatory,B-PR
",",O
and,O
her,O
code,O
status,O
is,O
do,O
not,O
resuscitate,O
/,O
do,O
not,O
intubate,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,O
patient,O
was,O
nonverbal,B-PR
",",O
but,O
was,O
able,O
to,O
open,O
her,O
eyes,O
and,O
nod,O
.,O

No,O
respiratory,B-PR
distress,I-PR
.,O

Her,B-TE
temperature,I-TE
was,O
102.2,O
;,O
blood,B-TE
pressure,I-TE
135/64,O
;,O
pulse,B-TE
rate,I-TE
108,O
;,O
respirations,B-TE
24,O
;,O
oxygen,B-TE
saturations,I-TE
on,I-TE
room,I-TE
air,I-TE
94%,O
.,O

The,B-TE
head,I-TE
",",I-TE
eyes,I-TE
",",I-TE
ears,I-TE
",",I-TE
nose,I-TE
and,I-TE
throat,I-TE
examination,I-TE
revealed,O
no,O
ocular,B-PR
abnormalities,I-PR
.,O

Neck,O
-,O
no,O
lymphadenopathy,B-PR
;,O
no,O
carotid,B-PR
bruits,I-PR
;,O
jugular,B-TE
venous,I-TE
pressure,I-TE
not,O
elevated,B-PR
;,O
no,O
goiter,B-PR
.,O

Chest,O
-,O
reduced,B-PR
breath,I-PR
sounds,I-PR
at,I-PR
the,I-PR
bases,I-PR
with,O
faint,B-PR
inspiratory,I-PR
rhonchi,I-PR
anteriorly,I-PR
.,O

Cardiac,O
-,O
regular,O
rate,O
and,O
rhythm,O
with,O
frequent,B-PR
premature,I-PR
beats,I-PR
and,O
a,B-PR
2/6,I-PR
systolic,I-PR
ejection,I-PR
murmur,I-PR
at,I-PR
the,I-PR
apex,I-PR
.,O

The,O
abdomen,O
was,O
non-tender,B-PR
",",O
nondistended,B-PR
",",O
no,O
hepatomegaly,B-PR
",",O
normal,O
bowel,O
sounds,O
.,O

Extremities,O
-,O
1+,B-PR
edema,I-PR
;,O
2+,B-TE
pulses,I-TE
.,O

Skin,O
-,O
intact,O
with,O
diaper,B-TR
.,O

LABORATORY,O
DATA,O
:,O

The,B-TE
sodium,I-TE
was,O
142,O
;,O
potassium,B-TE
4.5,O
;,O
chloride,B-TE
105,O
;,O
bicarbonate,B-TE
27,O
;,O
BUN,B-TE
and,O
creatinine,B-TE
31,O
and,O
1.3,O
;,O
glucose,B-TE
107,O
;,O
total,B-TE
protein,I-TE
7.7,O
;,O
albumin,B-TE
3.2,O
;,O
globulin,B-TE
4.5,O
;,O
uric,B-TE
acid,I-TE
4.2,O
;,O
alkaline,B-TE
phosphatase,I-TE
114,O
;,O
serum,B-TE
glutamic,I-TE
oxaloacetic,I-TE
transaminase,I-TE
46,O
;,O
lactic,B-TE
acid,I-TE
dehydrogenase,I-TE
370,O
;,O
white,B-TE
blood,I-TE
count,I-TE
"11,000",O
with,O
83,O
polymorphonuclear,B-TE
leukocytes,I-TE
;,O
hematocrit,B-TE
42,O
;,O
platelet,B-TE
count,I-TE
"227,000",O
.,O

A,B-TE
chest,I-TE
x-ray,I-TE
showed,O
consolidation,B-PR
bilateral,I-PR
lyin,I-PR
the,I-PR
lower,I-PR
lobes,I-PR
.,O

HOSPITAL,O
COURSE,O
AND,O
TREATMENT,O
:,O

The,O
patient,O
was,O
admitted,O
for,O
treatment,B-TR
of,O
a,O
presumed,O
aspiration,B-PR
pneumonia,I-PR
and,O
for,O
rehydration,B-TR
.,O

She,O
was,O
started,O
on,O
Clindamycin,B-TR
and,O
Ofloxacin,B-TR
at,O
renal,O
dose,O
to,O
cover,O
the,B-PR
aspiration,I-PR
pneumonia,I-PR
and,O
positive,B-PR
urine,I-PR
culture,I-PR
",",O
which,O
subsequently,O
came,O
back,O
.,O

She,O
had,O
some,B-PR
wheezing,I-PR
",",O
which,O
responded,O
well,O
to,O
Albuterol,B-TR
nebulizers,I-TR
.,O

She,O
was,O
generally,O
doing,O
well,O
with,O
resolution,O
of,O
her,B-TE
temperature,I-TE
until,O
4/1/97,O
at,O
9:20,O
P.M.,O
",",O
when,O
she,O
was,O
noted,O
to,O
be,O
unresponsive,B-PR
with,O
fixed,B-PR
dilated,I-PR
pupils,I-PR
.,O

She,O
was,O
certified,O
dead,O
at,O
9:20,O
P.M.,O

MI,O
CUCHSLI,O
",",O
M.D.,O

TR,O
:,O

vgo,O

DD,O
:,O

05/11/97,O

TD,O
:,O

05/15/97,O
8:26,O

Acc,O
:,O

MI,O
CUCHSLI,O
",",O
M.D.,O

cc,O
:,O

Nursing,O
Director,O
"Pcaer,ter",O
Medical,O
Center,O
Sco,O
",",O
Ohio,O

Admission,O
Date,O
:,O

2018-05-26,O

Discharge,O
Date,O
:,O

2018-06-13,O

Date,O
of,O
Birth,O
:,O

1966-02-20,O

Sex,O
:,O

M,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,O
Drugs,B-TR

Attending,O
:,O
Collette,O
C.,O
Higa,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Altered,B-PR
Mental,I-PR
Status,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

Intubatation,B-TR

Central,B-TR
line,I-TR
placement,I-TR

History,O
of,O
Present,O
Illness,O
:,O

52,O
y.o.,O
male,O
with,O
ESLD,B-PR
due,O
to,O
HCV,B-PR
/,O
EtOH,B-PR
Cirrhosis,I-PR
now,O
with,O
delta,B-PR
MS,I-PR
.,O

Recently,O
d/c,O
'd,O
on,O
05-15,O
after,O
admission,O
for,O
hepatic,B-PR
encephalopathy,I-PR
versus,O
opiate,B-PR
abuse,I-PR
.,O

Brought,O
in,O
by,O
family,O
for,O
ams,B-PR
.,O

No,O
hx,O
available,O
at,O
Youville,O
Hospital,O
Katherine,O
",",O
except,O
for,O
abdominal,B-PR
pain,I-PR
.,O

Increasing,B-PR
tachypnea,I-PR
and,O
tachycardia,B-PR
in,O
Leola,O
",",O
cxr,B-TE
with,O
likely,O
aspiration,B-PR
pna,I-PR
versus,O
chf,B-PR
",",O
intubated,B-TR
.,O

Started,O
on,O
levo,B-TR
/,O
flagyl,B-TR
/,O
ceftriaxone,B-TR
and,O
lasix,B-TR
for,O
sbp,B-PR
and,O
questionable,O
meningitis,B-PR
.,O

Past,O
Medical,O
History,O
:,O

1.,O
HCV/ETOH,B-PR
Cirrhosis,I-PR

2.,O
H/O,O
SBP,B-PR

3.,O
Esoph,B-PR
Varices,I-PR
(,I-PR
Grade,I-PR
I,I-PR
),I-PR

4.,O
Depression,B-PR

5.,O
H/O,O
IVDU,O
(,O
Heroin,O
),O

6.,O
Recurrent,B-PR
ARF,I-PR

7.,O
H/O,O
Seizure,B-PR

8.,O
Chronic,B-PR
LBP,I-PR

9.,O
Anemia,B-PR

Social,O
History,O
:,O

The,O
patient,O
lives,O
with,O
his,O
two,O
sons,O
.,O

Charles,O
quit,O
using,O
Cocaine,O
",",O
ETOH,O
",",O
and,O
IV,O
Heroin,O
two,O
years,O
ago,O
",",O
and,O
his,O
son,O
is,O
unaware,O
of,O
any,O
relapses,O
.,O

He,O
currently,O
smokes,O
",",O
about,O
1,O
ppd,O
.,O

Family,O
History,O
:,O

His,O
father,O
had,O
Hemochromatosis,B-PR
and,O
DMII,B-PR
.,O

Physical,O
Exam,O
:,O

101.8,O
",",O
100,O
",",O
144/92,O
",",O
18,O
",",O
98%,O
3lnc,O
lying,O
in,O
bed,O
",",O
oriented,O
hospital,O
only,O
scleral,B-PR
icterus,I-PR
tachy,B-PR
but,O
reg,B-PR
diffusely,I-PR
ttp,I-PR
and,O
guaiac,B-TE
negative,O
non-pitting,B-PR
brawny,I-PR
edema,I-PR
with,O
lichenification,B-PR

Pertinent,O
Results,O
:,O
wbc,B-TE
6.7,O
46%,O
pmn,O
40%,O
bands,B-TE
",",O
na,B-TE
128,O
tbili,B-TE
9.1,O
",",O
alb,B-TE
2.3,O
",",O
inr,B-TE
2.1,O
",",O
lactate,B-TE
4.4,O
ecg,B-TE
unremarkable,O

1st,B-TE
cxr,I-TE
normal,O
;,O
2nd,O
prior,O
to,O
intubation,B-TR
?,O
rll,B-PR
opacity,I-PR
(,O
mild,B-PR
chf,I-PR
?,O
),O
ascites,B-PR
:,O

2900,B-TE
wbc,I-TE
98%,O
pmn,O
",",O
suspcious,O
for,O
intra,B-PR
/,I-PR
extracellular,I-PR
bact,I-PR

Brief,O
Hospital,O
Course,O
:,O

SBP,B-PR
:,O

Pt,O
admitted,O
with,O
E,B-PR
coli,I-PR
SPB,I-PR
and,O
bacteremia,B-PR
.,O

Was,O
treated,O
with,O
ceftriaxone,B-TR
2,O
gm,O
IV,O
daily,O
with,O
multiple,B-TR
repeat,I-TR
paracenteses,I-TR
.,O

Repeat,B-TE
taps,I-TE
did,O
not,O
revealed,O
evidence,O
of,O
infection,B-PR
.,O

Patient,O
was,O
treated,O
with,O
14,O
days,O
of,O
levoflox,B-TR
.,O

Resp,B-PR
failure,I-PR
:,O

Unclear,O
etiology,O
",",O
but,O
likely,O
aspiration,B-PR
event,I-PR
in,O
Monica,O
.,O

Treated,O
aspiration,B-PR
pneumonia,I-PR
.,O

Weaning,O
and,O
potential,B-TR
extubation,I-TR
complicated,O
by,O
mechanical,B-PR
disadvantage,I-PR
from,O
large,B-PR
ascites,I-PR
as,O
well,O
as,O
continued,B-PR
somnolence,I-PR
(,O
off,O
sedation,B-TR
).,O

we,O
Performed,O
frequent,B-TR
large,I-TR
vol,I-TR
taps,I-TR
and,O
attempted,O
to,O
give,O
diuretics,B-TR
",",O
but,O
were,O
limited,O
by,O
renal,B-PR
failure,I-PR
.,O

The,B-PR
ascites,I-PR
quickly,O
accumulated,O
after,O
each,B-TR
tap,I-TR
.,O

Patient,O
was,O
not,O
a,O
TIPS,O
candidate,O
.,O

Cirrhosis,B-PR
:,O

End-stage,B-PR
cirrhosis,I-PR
with,O
refractory,B-PR
ascites,I-PR
.,O

Each,O
time,O
we,O
have,O
initiated,O
diuretics,B-TR
",",O
creatinine,B-TE
rose,O
.,O

Patient,O
was,O
continued,O
on,O
nadolol,B-TR
(,O
as,O
bp,B-TE
tolerated,O
),O
and,O
lactulose,B-TR
),O

Renal,B-PR
failure,I-PR
:,O

Creatinine,B-PR
elevation,I-PR
appears,O
to,O
be,O
related,O
to,O
both,O
elevated,B-PR
abdominal,I-PR
pressures,I-PR
from,O
ascites,B-PR
as,O
well,O
as,O
to,O
attempts,O
at,O
diuresis,B-TR
.,O

AMS,B-PR
:,O

Likely,O
hepatic,B-PR
encepholopathy,I-PR
initially,O
",",O
and,O
later,O
likely,O
related,O
to,O
sedation,B-TR
and,O
delayed,B-PR
clearance,I-PR
from,O
liver,B-PR
disease,I-PR
.,O

Patient,O
became,O
increasingly,O
hypotensive,B-PR
with,O
a,B-PR
rising,I-PR
cr,I-PR
",",O
eventually,O
becoming,O
pressor,B-PR
dependent,I-PR
.,O

Family,O
meeting,O
was,O
held,O
to,O
discuss,O
grave,O
prognosis,O
",",O
and,O
patient,O
was,O
made,O
cmo,B-TR
.,O

He,O
passed,O
away,O
shortly,O
thereafter,O
.,O

Medications,O
on,O
Admission,O
:,O
patient,O
passed,O
away,O

Discharge,O
Medications,O
:,O
patient,O
passed,O
away,O

Discharge,O
Disposition,O
:,O

Expired,O

Discharge,O
Diagnosis,O
:,O
patient,O
passed,O
away,O

Discharge,O
Condition,O
:,O
patient,O
passed,O
away,O

Discharge,O
Instructions,O
:,O
patient,O
passed,O
away,O

Followup,O
Instructions,O
:,O
patient,O
passed,O
away,O

Efrain,O
Zavala,O
MD,O
02-024,O

Completed,O
by,O
:,O
Marcel,O
L,O
Beatty,O
",",O
M.D.,O

435216075,O
YC,O

93004953,O

1966777,O

5/26/2005,O
12:00:00,O
AM,O

Atypical,B-PR
chest,I-PR
pain,I-PR

DIS,O

Admission,O
Date,O
:,O

05/26/2005,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

05/27/2005,O

******,O
DISCHARGE,O
ORDERS,O
******,O

CHEAMPBUR,O
",",O
STEENRA,O
R.,O

789-41-40-5,O
N56,O

Room,O
:,O

0W-320,O

Service,O
:,O

CAR,O

DISCHARGE,O
PATIENT,O
ON,O
:,O

05/27/05,O
AT,O
05:30,O
PM,O

CONTINGENT,O
UPON,O

Not,O
Applicable,O

WILL,O
D,O
/,O
C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D,O
/,O
C,O
SUMMARY,O
:,O

YES,O

Attending,O
:,O

SEISE,O
",",O
JR,O
",",O
EJAKE,O
L.,O
",",O
M.D.,O

CODE,O
STATUS,O
:,O

Full,O
code,O

DISPOSITION,O
:,O

Home,O

DISCHARGE,O
MEDICATIONS,O
:,O

ECASA,B-TR
(,I-TR
ASPIRIN,I-TR
ENTERIC,I-TR
COATED,I-TR
),I-TR
81,O
MG,O
PO,O
QD,O
LEVOXYL,B-TR
(,I-TR
LEVOTHYROXINE,I-TR
SODIUM,I-TR
),I-TR
25,O
MCG,O
PO,O
QD,O
SYNAREL,B-TR
(,I-TR
NAFARELIN,I-TR
ACETATE,I-TR
),I-TR
1,O
PUFF,O
NA,O
BID,O
NITROGLYCERIN,B-TR
1/150,O
(,O
0.4,O
MG,O
),O
1,O
TAB,O
SL,O
Q5MIN,O
X,O
3,O
doses,O
PRN,O
Chest,B-PR
Pain,I-PR
MULTIVITAMIN,B-TR
THERAPEUTIC,I-TR
(,I-TR
THERAPEUTIC,I-TR
MULTIVI,I-TR
...,I-TR
),I-TR
1,O
TAB,O
PO,O
QD,O

Alert,O
overridden,O
:,O

Override,O
added,O
on,O
05/26/05,O
by,O
SAGELYSS,O
",",O
TYTUMZE,O
V.,O
",",O
M.D.,O

POTENTIALLY,O
SERIOUS,B-PR
INTERACTION,I-PR
:,O

SIMVASTATIN,B-TR
and,O
NIACIN,B-TR
",",O
VIT,O
.,O

B-3,O
Reason,O
for,O
override,O
:,O

ok,O
TOPROL,B-TR
XL,I-TR
(,I-TR
METOPROLOL,I-TR
(,I-TR
SUST.,I-TR
REL.,I-TR
),I-TR
),O
200,O
MG,O
PO,O
QD,O

Food,O
/,O
Drug,O
Interaction,O
Instruction,O

Take,O
consistently,O
with,O
meals,O
or,O
on,O
empty,O
stomach,O
.,O

Number,O
of,O
Doses,O
Required,O
(,O
approximate,O
),O
:,O

8,O
PLAVIX,B-TR
(,I-TR
CLOPIDOGREL,I-TR
),I-TR
75,O
MG,O
PO,O
QD,O
LIPITOR,B-TR
(,I-TR
ATORVASTATIN,I-TR
),I-TR
40,O
MG,O
PO,O
QD,O

Alert,O
overridden,O
:,O

Override,O
added,O
on,O
05/27/05,O
by,O
:,O

POTENTIALLY,O
SERIOUS,B-PR
INTERACTION,I-PR
:,O

NIACIN,B-TR
",",O
VIT,O
.,O

B-3,O
and,O
ATORVASTATIN,B-TR
CALCIUM,I-TR

Reason,O
for,O
override,O
:,O

ok,O

DIET,O
:,O

House,O
/,O
Low,O
saturated,O
fat,O
low,O
cholesterol,O
&lt;,O
FDI,O
&gt;,O

ACTIVITY,O
:,O

Resume,O
regular,O
exercise,O

FOLLOW,O
UP,O
APPOINTMENT,O
(,O
S,O
),O
:,O

Follow,O
up,O
with,O
your,O
PCP,O
within,O
2,O
wks,O
",",O

ALLERGY,O
:,O

Morphine,B-TR
",",O

LEUPROLIDE,B-TR
ADMIT,O
DIAGNOSIS,O
:,O

Chest,B-PR
Pain,I-PR

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O

Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O
Atypical,B-PR
chest,I-PR
pain,I-PR

OTHER,O
DIAGNOSIS,O
;,O

Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O

s,O
/,O
p,O
inferior,B-PR
STEMI,I-PR
(,O
2/17,O
),O
with,O
stent,B-TR
to,I-TR
RCA,I-TR
;,O
TTE,B-TE
(,O
2/17,O
),O
-,O
LVEF,B-TE
55-60%,O
",",O
inferobasal,B-PR
HK,I-PR
;,O
cervical,B-PR
spinal,I-PR
stenosis,I-PR
;,O
hypothyroidism,B-PR
;,O
GERD,B-PR
;,O
endometriosis,B-PR
s,O
/,O
p,O
laparotomy,B-TE
and,O
L,B-TR
oophorectomy,I-TR
.,O

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

none,O

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O

ETT,B-TE
-,O
MIBI,B-TE
5/27/05,O
-,O
normal,O
",",O
no,O
e,O
/,O
o,O
ischemia,B-PR
.,O

BRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

45,O
yo,O
F,O
s,O
/,O
p,O
recent,B-PR
inferior,I-PR
STEMI,I-PR
(,O
2/17,O
),O
w/,O
100%,O
RCA,O
stented,O
-&gt;,O
0%,O
",",O
and,O
residual,B-PR
LAD,I-PR
/,I-PR
Diag1/LCx,I-PR
/,I-PR
OM2,I-PR
disease,I-PR
.,O

Developed,O
burning,B-PR
chest,I-PR
pain,I-PR
before,O
bedtime,O
the,O
night,O
PTA,O
.,O

NO,O
associated,O
sxs,B-PR
/,O
radiation,B-PR
.,O

Slept,O
well,O
",",O
but,O
on,O
the,O
am,O
of,O
admission,O
had,O
same,B-PR
burning,I-PR
across,I-PR
chest,I-PR
(,O
&quot;,O
deeper,O
than,O
heartburn,B-PR
&quot;,O
),O
so,O
went,O
to,O
her,O
MD,O
&apos;s,O
office,O
.,O

Transient,B-PR
diaphoresis,I-PR
in,O
MD,O
&apos;s,O
office,O
that,O
patient,O
attributed,O
to,O
heat,O
in,O
room,O
.,O

Patient,O
says,O
pain,B-PR
is,O
similar,O
in,O
location,O
and,O
quality,O
to,O
the,B-PR
pain,I-PR
she,O
had,O
with,O
her,B-PR
MI,I-PR
",",O
although,O
with,O
her,B-PR
MI,I-PR
the,B-PR
pain,I-PR
was,O
much,O
more,O
intense,O
(,O
20x,O
worse,O
),O
.,O

This,O
is,O
1st,B-PR
pain,I-PR
since,O
MI,B-PR
(,O
though,O
patient,O
reports,O
chronic,B-PR
baseline,I-PR
chest,I-PR
tightness,I-PR
x8-10,O
years,O
of,O
unclear,O
etiology,O
),O
.,O

CP,B-PR
/,O
burning,B-PR
lasted,O
several,O
hours,O
and,O
was,O
relieved,O
after,O
she,O
received,O
Maalox,B-TR
",",O
lidocaine,B-TR
",",O
and,O
NTG,B-TR
in,O
the,O
ED,O
.,O

She,O
reports,O
compliance,O
with,O
her,B-TR
ASA,I-TR
+,O
plavix,B-TR
.,O

She,O
is,O
active,O
at,O
baseline,O
",",O
participating,O
in,O
cardiac,B-TR
rehab,I-TR
for,O
2,O
hrs,O
/,O
week,O
and,O
running,O
up,O
and,O
down,O
stairs,O
at,O
home,O
without,O
CP,B-PR
/,O
SOB,B-PR
.,O

IN,O
ED,O
vitals,B-TE
p86,B-TE
bp,B-TE
127/88,O
sat,B-TE
100%,O
.,O

NAD,B-PR
.,O

No,O
JVD,B-PR
.,O

CTAB.,O
nl,O
s1s2,O
",",O
reg,O
",",O
no,O
m,B-PR
/,O
r.,B-PR
no,O
chest,B-PR
tenderness,I-PR
.,O

abd,O
soft,O
",",O
NT,B-PR
/,O
ND,B-PR
",",O
NABS.,O
ext,O
wwp,O
",",O
no,O
c,B-PR
/,O
c/e,B-PR
",",O
2+DP,B-TE
&apos;s,O
b,O
/,O
l.,O

labs,O
:,O

A,O
set,O
:,O

trop,B-TE
&lt;,I-TE
assay,I-TE
",",O
CK,B-TE
67,O
",",O
MB,B-TE
0.2,O
.,O

EKG,B-TE
-,O
old,B-PR
TWI,I-PR
III,I-PR
.,O

A,O
/,O
P,B-TE
:,O

45F,O
with,O
recent,B-PR
inferior,I-PR
STEMI,I-PR
s,O
/,O
p,O
stent,B-TR
to,I-TR
RCA,I-TR
.,O

1.,O
CV,O
:,O

(,O
I,O
),O
ROMI,B-TE
negative,O
.,O

ETT,B-TE
MIBI,B-TE
4/14,O
without,O
e,O
/,O
o,O
ischemia,B-PR
.,O
?,O

GERD,B-PR
as,O
etiology,O
of,O
her,B-PR
chest,I-PR
burning,I-PR
.,O

cont,O
asa,B-TR
",",O
statin,B-TR
",",O
plavix,B-TR
",",O
bblkr,B-TR
.,O

(,O
P,O
),O
Most,O
recent,O
echo,B-TE
:,O

EF,B-TE
55%,O
and,O
inf,B-PR
/,I-PR
post,I-PR
HK,I-PR
.,O

(,O
R,O
),O
Patient,O
had,O
no,O
events,O
on,O
tele,B-TE
.,O

2.,O
ENDO,O
:,O

continue,O
levoxyl,B-TR
for,O
hypothyroidism,B-PR
",",O
synarel,B-TR
for,O
endometriosis,B-PR
.,O

3.,O
MSK,O
:,O

cervical,B-PR
spondylosis,I-PR
",",O
tylenol,B-TR
for,O
pain,B-PR
.,O

4.,O
GI,O
:,O

h,O
/,O
o,O
GERD-,B-PR
nexium,B-TR
.,O

FULL,O
CODE,O
ADDITIONAL,O
COMMENTS,O
:,O

If,O
you,O
develop,O
recurrent,B-PR
chest,I-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
or,O
any,B-PR
other,I-PR
concerning,I-PR
symptoms,I-PR
",",O
call,O
your,O
doctor,O
or,O
return,O
to,O
the,O
hospital,O
.,O

Continue,O
taking,O
all,O
of,O
your,B-TR
regular,I-TR
home,I-TR
medications,I-TR
.,O

Follow,O
up,O
with,O
Dr.,O
Koteskismanhout,O
in,O
July,O
.,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O

TO,O
DO,O
/,O
PLAN,O
:,O

No,O
dictated,O
summary,O

ENTERED,O
BY,O
:,O

SAGELYSS,O
",",O
TYTUMZE,O
V.,O
",",O
M.D.,O
(,O
FS69,O
),O
05/27/05,O
05:33,O
PM,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

Admission,O
Date,O
:,O

2012-05-24,O

Discharge,O
Date,O
:,O

2012-06-19,O

Date,O
of,O
Birth,O
:,O

1954-07-01,O

Sex,O
:,O

M,O

Service,O
:,O

NEUROSURGERY,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,O
Drugs,B-TR

Attending,O
:,O
Joyce,O
V.,O
Seidel,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Right,B-PR
parietal,I-PR
wound,I-PR
dehiscence,I-PR
.,O

CSF,B-PR
leak,I-PR
.,O

Perforated,B-PR
diverticulitis,I-PR
.,O

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

Lumbar,B-TR
drain,I-TR
placement,I-TR
2012-05-24,O

Exploratory,B-TE
laparotomy,I-TE
2012-05-26,O

Abdominal,B-TR
washtou,I-TR
2012-05-26,O

Sigmoid,B-TR
colectomy,I-TR
and,O
Hartmans,B-TR
pouch,I-TR
2012-05-26,O

Lumbar,B-TR
drain,I-TR
placement,I-TR
2012-05-29,O

CT-guided,B-TR
aspiration,I-TR
06-01,O
for,O
pelvic,B-PR
abscess,I-PR

Reveision,B-TR
Right,I-TR
craniotomy,I-TR
06-03,O

revsion,B-TR
of,I-TR
bone,I-TR
flap,I-TR
06-03,O

Emergent,B-TR
intubation,I-TR
06-04,O

PICC,B-TR
line,I-TR
placement,I-TR
2012-06-08,O

History,O
of,O
Present,O
Illness,O
:,O

57,O
yo,O
right,O
handed,O
male,O
with,O
seizure,B-PR
history,I-PR
since,O
1988,O
",",O
s/p,O
craniotomies,B-TR
x,O
3,O
(,O
most,O
recently,O
05-05,O
),O
for,O
oligodendroglioma,B-PR
.,O

The,O
patient,O
began,O
having,O
generalized,B-PR
tonic,I-PR
-,I-PR
clonic,I-PR
seizures,I-PR
in,O
1988,O
",",O
which,O
at,O
the,O
time,O
were,O
thought,O
to,O
be,O
related,O
to,O
asthma,B-TR
medications,I-TR
.,O

At,O
this,O
time,O
",",O
his,B-TE
head,I-TE
CT,I-TE
was,O
negative,O
",",O
and,O
he,O
was,O
treated,O
with,O
Dilantin,B-TR
and,O
Phenobarbital,B-TR
.,O

However,O
",",O
he,O
continued,O
to,O
have,O
left,B-PR
arm,I-PR
focal,I-PR
motor,I-PR
seizures,I-PR
and,O
problems,B-PR
thinking,I-PR
.,O

In,O
2001-08-31,O
he,O
stopped,O
his,B-TR
medication,I-TR
and,O
had,O
a,B-PR
generalized,I-PR
tonic,I-PR
-,I-PR
clonic,I-PR
seizure,I-PR
in,O
12/94,O
.,O

He,O
was,O
diagnosed,O
by,O
biopsy,B-TE
with,O
oligodendroglioma,B-PR
",",O
and,O
gross,B-TR
total,I-TR
resection,I-TR
by,O
Dr.,O
Redner,O
in,O

95,O
revealed,O
a,B-PR
low-grade,I-PR
oligodendroglioma,I-PR
.,O

He,O
was,O
followed,O
by,O
Dr.,O
Gregory,O
Dumas,O
",",O
with,O
serial,B-TE
MRI,I-TE
's.,I-TE

In,O
2011-05-02,O
",",O
he,O
was,O
requiring,O
more,B-TR
ativan,I-TR
to,O
control,O
his,B-PR
seizures,I-PR
",",O
and,O
was,O
increasingly,B-PR
disoriented,I-PR
and,O
forgetful,B-PR
with,O
headaches,B-PR
.,O

He,O
had,O
a,B-TR
repeat,I-TR
total,I-TR
resection,I-TR
in,O
4/04,O
by,O
Dr.,O
Peter,O
Hoadley,O
at,O
Hallmark,O
Health,O
System,O
which,O
revealed,O
anaplastic,B-PR
oligodendroglioma,I-PR
grade,I-PR
III,I-PR
.,O

He,O
had,O
radiation,B-TR
following,O
the,B-TR
resection,I-TR
and,O
was,O
doing,O
well,O
on,O
monthly,B-TR
Temodar,I-TR
until,O
2012-04-23,O
when,O
he,O
had,O
a,B-PR
marked,I-PR
change,I-PR
in,I-PR
behavior,I-PR
",",O
his,O
balance,O
was,O
off,O
",",O
speech,B-PR
slurred,I-PR
",",O
and,O
he,O
had,O
difficulty,B-PR
using,I-PR
the,I-PR
computer,I-PR
.,O

A,B-TE
head,I-TE
MRI,I-TE
on,O
2012-04-24,O
revealed,O
increasing,B-PR
tumor,I-PR
infiltration,I-PR
with,O
increased,B-PR
edema,I-PR
and,O
mass,B-PR
effect,I-PR
.,O

He,O
underwent,O
a,B-TR
right,I-TR
craniotomy,I-TR
with,O
resection,B-TR
and,O
gliadel,B-TR
wafers,I-TR
on,O
2012-05-02,O
at,O
Hallmark,O
Health,O
System,O
by,O
Dr.,O
Ackley,O
.,O

Came,O
for,O
neurosurgery,O
follow,O
up,O
on,O
05-21,O
",",O
and,O
had,O
been,O
having,O
clear,B-PR
fluid,I-PR
leaking,O
from,O
his,B-PR
incision,I-PR
",",O
as,O
well,O
as,O
frontal,B-PR
headache,I-PR
",",O
imbalance,B-PR
",",O
bumping,O
into,O
things,O
with,O
his,O
left,O
leg,O
and,O
worsening,B-PR
tremors,I-PR
.,O

He,O
was,O
admitted,O
for,O
Lumbar,B-TR
drain,I-TR
placement,I-TR

Past,O
Medical,O
History,O
:,O

Right,B-PR
parietal,I-PR
oligodendroglioma,I-PR
",",O
as,O
above,O
status,O
post,O
craniotomy,B-TR
x,O
3,O
(,O

hernia,B-TR
surgery,I-TR
x,O
3,O

right,B-PR
hand,I-PR
ganglion,I-PR
cyst,I-PR
removed,O

asthma,B-PR

Social,O
History,O
:,O

Lives,O
w,O
wife,O
",",O
has,O
home,O
health,O
assistance,O
.,O

Employment,O
:,O
on,O
short,O
term,O
disability,O
",",O
has,O
boat,O
which,O
he,O
enjoys,O
as,O
hobby,O

Physical,O
Exam,O
:,O

RRR,O

CTA,O

Abdomen,O
soft,O
Nontender,B-PR
and,O
nondistended,B-PR

Alert,O
and,O
oriented,O
times,O
3,O

Speech,O
fluent,O
",",O
comprehension,O
intact,O

Pupils,O
equal,O
round,O
and,O
reactive,O
to,O
light,O
",",O
extraocular,O
movements,O
intact,O

Face,O
symmetric,O

Tongue,O
midline,O

No,O
pronator,B-PR
drift,I-PR

Strength,B-TE
5/5,O
throughout,O

Normal,O
tone,O

2+,B-TE
reflexes,I-TE
throughout,O

Toes,O
downgoing,O
bilaterally,O

No,O
dysmetria,B-PR

Pertinent,O
Results,O
:,O

Admission,O
labs,O
:,O

2012-05-24,O

WBC,B-TE
-,O
6.3,O
RBC,B-TE
-,O
4.17,O
*,O
Hgb,B-TE
-,O
13.7,O
*,O
Hct,B-TE
-,O
40.2,O
MCV,B-TE
-,O
96,O
MCH,B-TE
-,O
32.7,O
*,O
MCHC,B-TE
-,O
34.0,O
RDW,B-TE
-,O
13.6,O
Plt,B-TE
Ct,I-TE
-,O
143,O
*,O
PT,B-TE
-,O
11.9,O
PTT,B-TE
-,O
21.1,O
*,O
INR,B-TE
(,I-TE
PT,I-TE
)-,I-TE
0.9,O
Glucose,B-TE
-,O
207,O
*,O
UreaN,B-TE
-,O
17,O
Creat,B-TE
-,O
0.9,O
Na,B-TE
-,O
134,O
K,B-TE
-,O
4.6,O
Cl,B-TE
-,O
93,O
*,O
HCO3,B-TE
-,O
35,O
*,O
AnGap,B-TE
-,O
11,O
Calcium,B-TE
-,O
8.3,O
*,O
Phos,B-TE
-,O
1.8,O
*#,O
Mg,B-TE
-,O
2.1,O

Discharge,O
labs,O
:,O

2012-06-18,O

WBC,B-TE
-,O
6.5,O
RBC,B-TE
-,O
3.20,O
*,O
Hgb,B-TE
-,O
10.5,O
*,O
Hct,B-TE
-,O
30.7,O
*,O
MCV,B-TE
-,O
96,O
MCH,B-TE
-,O
32.8,O
*,O
MCHC,B-TE
-,O
34.2,O
RDW,B-TE
-,O
14.3,O
Plt,B-TE
Ct,I-TE
-,O
227,O
PT,B-TE
-,O
13.4,O
PTT,B-TE
-,O
24.6,O
INR,B-TE
(,I-TE
PT,I-TE
)-,I-TE
1.1,O
Glucose,B-TE
-,O
117,O
*,O
UreaN,B-TE
-,O
12,O
Creat,B-TE
-,O
0.6,O
Na,B-TE
-,O
140,O
K,B-TE
-,O
4.2,O
Cl,B-TE
-,O
102,O
HCO3,B-TE
-,O
32,O
*,O
AnGap,B-TE
-,O
10,O
Calcium,B-TE
-,O
9.0,O
Phos,B-TE
-,O
3.9,O
Mg,B-TE
-,O
2.0,O

Pathology,O
:,O

Sigmoid,O
colon,O
:,O

Diverticular,B-PR
disease,I-PR
of,I-PR
the,I-PR
colon,I-PR
:,O

1.,O
Multiple,B-PR
diverticula,I-PR
.,O

2.,O
Rupture,B-PR
of,I-PR
diverticulum,I-PR
with,O
pericolic,B-PR
abscess,I-PR
.,O

CT,B-TE
head,I-TE
2012-06-11,O
:,O

IMPRESSION,O
:,O

1),O
Overall,O
",",O
a,O
slight,O
decrease,O
in,O
the,B-PR
mass,I-PR
effect,I-PR
and,O
edema,B-PR
associated,O
with,O
the,O
postoperative,O
changes,O
.,O

2),O
Slight,O
increase,O
in,O
epidural,B-PR
fluid,I-PR
collection,I-PR
adjacent,O
to,O
the,B-PR
craniotomy,I-PR
site,I-PR
.,O

CT,B-TE
abdomen,I-TE
2012-06-18,O
:,O

IMPRESSION,O
:,O

Small,B-PR
residual,I-PR
collection,I-PR
anterior,O
to,O
the,O
rectum,O
",",O
smaller,O
than,O
on,O
the,B-TE
prior,I-TE
study,I-TE
",",O
and,O
without,O
substantial,B-PR
fluid,I-PR
components,I-PR
to,O
allow,O
drainage,B-TR
.,O

WOUND,B-TE
CULTURE,I-TE
(,O
Final,O
2012-06-05,O
),O
:,O

(,O
PELVIC,B-PR
ABSCESS,I-PR
),O

Due,O
to,O
mixed,B-PR
bacterial,I-PR
types,I-PR
(,O

ENTEROCOCCUS,B-PR
SP.,I-PR

SPARSE,B-PR
GROWTH,I-PR
.,O

PSEUDOMONAS,B-PR
AERUGINOSA,I-PR
.,O

SPARSE,B-PR
GROWTH,I-PR
.,O

CORYNEBACTERIUM,B-PR
SPECIES,I-PR
(,I-PR
DIPHTHEROIDS,I-PR
),I-PR
.,O

SPARSE,B-PR
GROWTH,I-PR
.,O

SENSITIVITIES,O
:,O

MIC,O
expressed,O
in,O

MCG/ML,O

_________________________________________________________,O

ENTEROCOCCUS,B-PR
SP,I-PR
.,O

|,O

PSEUDOMONAS,B-PR
AERUGINOSA,I-PR

|,O

|,O

AMPICILLIN------------,B-TR

<=2,O
S,O

CEFEPIME--------------,B-TR

2,O
S,O

CEFTAZIDIME-----------,B-TR

4,O
S,O

CIPROFLOXACIN---------,B-TR

<=0.25,O
S,O

GENTAMICIN------------,B-TR

2,O
S,O

IMIPENEM--------------,B-TR

8,O
I,O

LEVOFLOXACIN----------,B-TR

1,O
S,O

MEROPENEM-------------,B-TR

4,O
S,O

PENICILLIN------------,B-TR

2,O
S,O

PIPERACILLIN----------,B-TR

8,O
S,O

PIPERACILLIN/TAZO-----,B-TR

8,O
S,O

TOBRAMYCIN------------,B-TR

<=1,O
S,O

VANCOMYCIN------------,B-TR

<=1,O
S,O

WOUND,B-TE
CULTURE,I-TE
(,O
Final,O
2012-06-05,O
),O
:,O

(,O
from,O
OR,B-TR
revision,I-TR
craniotomy,I-TR
),O

STAPH,B-PR
AUREUS,I-PR
COAG,I-PR
+,O
.,O

SPARSE,B-PR
GROWTH,I-PR
.,O

Oxacillin,B-PR
RESISTANT,I-PR
Staphylococci,I-PR
MUST,O
be,O
reported,O
as,O
also,O
RESISTANT,B-PR
to,O
other,O
penicillins,B-TR
",",O
cephalosporins,B-TR
",",O
carbacephems,B-TR
",",O
carbapenems,B-TR
",",O
and,O
beta-lactamase,B-TR
inhibitor,I-TR
combinations,I-TR
.,O

Rifampin,B-TR
should,O
not,O
be,O
used,O
alone,O
for,O
therapy,B-TR
.,O

Please,O
contact,O
the,O
Microbiology,O
Laboratory,O
(,O
2313-08-31,O
),O
immediately,O
if,O
sensitivity,O
to,O
clindamycin,B-TR
is,O
required,O
on,O
this,O
patient,O
's,O
isolate,O
.,O

SENSITIVITIES,O
:,O

MIC,O
expressed,O
in,O

MCG/ML,O

_________________________________________________________,O

STAPH,B-PR
AUREUS,I-PR
COAG,I-PR
+,O

|,O

ERYTHROMYCIN----------,B-TR

=>8,O
R,O

GENTAMICIN------------,B-TR
<=0.5,O
S,O

LEVOFLOXACIN----------,B-TR

=>8,O
R,O

OXACILLIN-------------,B-TR

=>4,O
R,O

PENICILLIN------------,B-TR
=>0.5,O
R,O

RIFAMPIN--------------,B-TR
<=0.5,O
S,O

TETRACYCLINE----------,B-TR

<=1,O
S,O

VANCOMYCIN------------,B-TR

<=1,O
S,O

Brief,O
Hospital,O
Course,O
:,O
patient,O
was,O
admitted,O
on,O
2012-05-24,O
after,O
having,O
drainage,B-PR
from,O
his,B-PR
incision,I-PR
for,O
the,O
last,O
couple,O
of,O
days,O
.,O

He,O
was,O
seen,O
in,O
the,O
brain,O
tumor,O
clinic,O
on,O
05-21,O
and,O
stitches,B-TR
were,O
placed,O
in,O
the,B-PR
incision,I-PR
",",O
however,O
it,O
continued,O
to,O
leak,O
.,O

He,O
had,O
a,B-TR
lumbar,I-TR
drain,I-TR
placed,O
.,O

He,O
c/o,O
of,O
abd,B-PR
pain,I-PR
and,O
distension,B-PR
on,O
05-25,O
he,O
had,O
a,B-TE
kub,I-TE
done,O
which,O
was,O
negative,O
.,O

on,O
05-26,O
he,O
continued,O
to,O
c/o,O
of,O
epigastric,B-PR
pain,I-PR
had,O
a,B-TE
chest,I-TE
x-ray,I-TE
done,O
to,O
due,O
to,O
decreased,B-PR
lung,I-PR
sounds,I-PR
.,O

The,B-TE
Chest,I-TE
x-ray,I-TE
showed,O
free,B-PR
air,I-PR
.,O

general,O
surgery,O
was,O
consulted,O
and,O
the,O
patient,O
was,O
taken,O
to,O
the,O
OR,O
for,O
exploratory,B-TE
laproratomy,I-TE
.,O

he,O
was,O
found,O
to,O
have,O
a,B-PR
perforated,I-PR
sigmoid,I-PR
diverticulum,I-PR
.,O

He,O
had,O
a,B-TR
colostomy,I-TR
and,O
partial,B-TR
colectomy,I-TR
.,O

patient,O
recovered,O
well,O
from,O
colocetomy,B-TR
.,O

He,O
was,O
found,O
to,O
have,O
an,B-PR
abd,I-PR
abcess,I-PR
which,O
was,O
drained,O
via,O
CT,B-TE
guidance,I-TE
on,O
06-01,O
.,O

On,O
06-02,O
his,B-TR
lumbar,I-TR
drain,I-TR
pulled,O
out,O
.,O

he,O
had,O
to,O
have,O
it,O
replaced,O
",",O
however,O
",",O
because,O
his,B-PR
head,I-PR
incision,I-PR
began,O
to,O
leak,O
again,O
.,O

On,O
06-03,O
he,O
was,O
taken,O
back,O
to,O
the,O
OR,O
for,O
debridement,B-TR
of,O
his,B-PR
head,I-PR
wound,I-PR
with,O
removal,B-TR
of,O
the,B-PR
remaining,I-PR
gliadel,I-PR
waffers,I-PR
.,O

He,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
",",O
postop,O
however,O
he,O
had,O
a,B-PR
grand,I-PR
mal,I-PR
seizure,I-PR
and,O
was,O
intubated,O
and,O
sent,O
to,O
the,O
ICU,O
.,O

ID,O
was,O
consulted,O
for,O
both,O
the,B-PR
abd,I-PR
abcess,I-PR
and,O
possible,O
meningitis,B-PR
given,O
the,B-PR
large,I-PR
amount,I-PR
of,I-PR
wbc,I-PR
in,O
the,B-TE
csf,I-TE
cultures,I-TE
.,O

Patient,O
was,O
placed,O
on,O
vancomycin,B-TR
1,O
gm,O
IV,O
q12,O
and,O
zosyn,B-TR
.,O

He,O
was,O
kept,O
on,O
antibiotics,B-TR
until,O
06-17,O
.,O

Neurologically,O
he,O
slowly,O
woke,O
up,O
after,O
the,B-PR
seizures,I-PR
and,O
was,O
extubated,O
on,O
06-03,O
.,O

He,O
was,O
transfered,O
to,O
the,O
step,O
down,O
unit,O
and,O
had,O
his,B-TR
lumbar,I-TR
drain,I-TR
slowly,O
weaned,O
.,O

The,B-TR
lumbar,I-TR
drain,I-TR
was,O
d/ced,O
on,O
06-14,O
.,O

He,O
had,O
a,B-TE
head,I-TE
Ct,I-TE
which,O
remains,O
stable,O
and,O
head,B-PR
wound,I-PR
remain,O
dry,O
.,O

Neurologically,O
he,O
is,O
awake,O
and,O
alert,O
and,O
oriented,O
x,O
3,O
he,O
is,O
07-05,O
in,O
all,O
muscle,O
group,O
bilat,O
.,O

He,O
follows,O
commands,O
",",O
he,O
is,O
out,O
of,O
bed,O
ambulating,O
with,O
max,O
assist,O
.,O

PT,O
and,O
OT,O
are,O
recommending,O
rehab,B-TR
.,O

He,O
will,O
follow,O
up,O
with,O
Dr,O
Fisher,O
the,O
general,O
surgeon,O
in,O
two,O
weeks,O
and,O
follow,O
up,O
in,O
the,O
brain,O
tumor,O
clinic,O
in,O
two,O
weeks,O
for,O
stitch,B-TR
removal,I-TR
.,O

H,O
ewas,O
switched,O
to,O
oral,B-TR
CIpro,I-TR
for,O
the,B-PR
pelvic,I-PR
abcess,I-PR
and,O
will,O
continue,O
it,O
until,O
he,O
has,O
his,O
followup,O
with,O
infectious,O
disease,O
in,O
2,O
weeks,O
.,O

Medications,O
on,O
Admission,O
:,O

Neurontin,B-TR
",",O
Keppra,B-TR
",",O
Lamictal,B-TR
",",O
decadron,B-TR
",",O
multivitamin,B-TR
",",O
Murray,O
",",O
Calcium,B-TR

Discharge,O
Medications,O
:,O

1.,O
Heparin,B-TR
Sodium,I-TR
(,I-TR
Porcine,I-TR
),I-TR
"5,000",O
unit,O
/,O
mL,O
Solution,O
Sig,O
:,O
One,O
(,O
1,O
),O
Injection,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
.,O

2.,O
Diphenhydramine,B-TR
HCl,I-TR
25,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
Q6H,O
(,O
every,O
6,O
hours,O
),O
as,O
needed,O
.,O

3.,O
Albuterol,B-TR
-,I-TR
Ipratropium,I-TR
103-18,O
mcg,O
/,O
Actuation,O
Aerosol,O
Sig,O
:,O
03-04,O
Puffs,O
Inhalation,O
Q4H,O
(,O
every,O
4,O
hours,O
),O
as,O
needed,O
.,O

4.,O
Acetaminophen,B-TR
325,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
.,O

5.,O
Fluticasone,B-TR
-,I-TR
Salmeterol,I-TR
250-50,O
mcg,O
/,O
Dose,O
Disk,O
with,O
Device,O
Sig,O
:,O
One,O
(,O
1,O
),O
Disk,O
with,O
Device,O
Inhalation,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

6.,O
Lamotrigine,B-TR
100,O
mg,O
Tablet,O
Sig,O
:,O
1.5,O
Tablets,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

7.,O
Levetiracetam,B-TR
500,O
mg,O
Tablet,O
Sig,O
:,O
Three,O
(,O
3,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

8.,O
Ibuprofen,B-TR
400,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
Q8H,O
(,O
every,O
8,O
hours,O
),O
as,O
needed,O
.,O

9.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

10.,O
Pantoprazole,B-TR
Sodium,I-TR
40,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
Q24H,O
(,O
every,O
24,O
hours,O
),O
.,O

11.,O
Ciprofloxacin,B-TR
500,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q12H,O
(,O
every,O
12,O
hours,O
),O
for,O
2,O
weeks.,O
Tablet,O
(,O
s,O
),O

12.,O
Metoprolol,B-TR
Tartrate,I-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
0.5,O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

13.,O
Lorazepam,B-TR
1,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
HS,O
(,O
at,O
bedtime,O
),O
as,O
needed,O
.,O

14.,O
Dexamethasone,B-TR
2,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q12H,O
(,O
every,O
12,O
hours,O
),O
.,O

15.,O
Insulin,B-TR
Regular,I-TR
Human,I-TR
100,O
unit,O
/,O
mL,O
Solution,O
Sig,O
:,O
One,O
(,O
1,O
),O
Injection,O
ASDIR,O
(,O
AS,O
DIRECTED,O
),O
:,O
51-150,O
0,O
Units,O

151-200,O
2,O
Units,O

201-250,O
4,O
Units,O

251-300,O
6,O
Units,O

301-350,O
8,O
Units,O

351-400,O
10,O
Units,O

>,O
400,O
Bessie,O
MD,O

16.,O
Hydralazine,B-TR
HCl,I-TR
20,O
mg,O
/,O
mL,O
Solution,O
Sig,O
:,O
0.5,O
syringe,O
Injection,O
Q4HR,O
(,O

Disp,O
:*,O
qs,O
syringe,O
*,O
Refills,O
:*,O
0,O
*,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Discharge,O
Diagnosis,O
:,O

Cerebrospinal,B-PR
fluid,I-PR
leak,I-PR

Chronic,O
steroid,O
use,O
wound,B-PR
infection,I-PR

Perforated,B-PR
sigmoid,I-PR
diverticulum,I-PR
status,O
post,O
exploratory,B-TE
laparotomy,I-TE

Status,O
post,O
sigmoid,B-TR
colectomy,I-TR
",",O
hartmans,B-TR
pouch,I-TR
and,O
washout,B-TR

Post,B-PR
operative,I-PR
fever,I-PR
fever,B-PR
status,O
post,O
Reveision,B-TR
Right,I-TR
craniotomy,I-TR
and,O
revsion,B-TR
of,I-TR
bone,I-TR
flap,I-TR
change,B-PR
in,I-PR
mental,I-PR
status,I-PR

Seizure,B-PR

Conant,B-PR
palsy,I-PR
with,O
Left,B-PR
sided,I-PR
weakness,I-PR

Respiratory,B-PR
failure,I-PR
requiring,O
intubation,B-TR

Methicillin,B-PR
resistant,I-PR
staph,I-PR
aureus,I-PR
infection,I-PR
of,I-PR
central,I-PR
nervous,I-PR
system,I-PR

Pelvic,B-PR
abscess,I-PR
oligodendroglioma,B-PR

Asthma,B-PR

S/p,O
craniotomy,B-TR
x,O
3,O

Hernia,B-TR
Surgery,I-TR
x,O
3,O

Discharge,O
Condition,O
:,O

Good,O

Discharge,O
Instructions,O
:,O

Call,O
with,O
any,B-PR
spiking,I-PR
fevers,I-PR
",",O
leakage,B-PR
from,O
your,B-PR
head,I-PR
wound,I-PR
",",O
increase,B-PR
in,I-PR
headaches,I-PR
",",O
confusion,B-PR
",",O
blurry,B-PR
vision,I-PR
severe,B-PR
neck,I-PR
stiffness,I-PR
",",O
redness,B-PR
",",O
swelling,B-PR
",",O
or,O
discharge,B-PR
around,O
your,B-PR
wound,I-PR
site,I-PR

Call,O
your,O
general,O
surgeon,O
if,O
you,O
experience,O
increased,B-PR
abdominal,I-PR
pain,I-PR
",",O
vomiting,B-PR
",",O
decreased,B-PR
or,I-PR
increased,I-PR
ostomy,I-PR
output,I-PR
.,O

Followup,O
Instructions,O
:,O

1.,O
Dr.,O
Martha,O
Lopez,O
or,O
Dr.,O
Henson,O
in,O
infectious,O
disese,O
in,O
2,O
weeks,O
.,O

Call,O
for,O
an,O
appointment,O
(,O
724,O
),O
875,O
5043,O

2.,O
Dr,O
Fisher,O
in,O
General,O
surgery,O
",",O
1,O
week,O
",",O
call,O
his,O
office,O
for,O
an,O
appointment,O
.,O

515-3442,O

3.,O
Follow,O
up,O
in,O
1,O
week,O
at,O
brain,O
tumor,O
clinic,O
.,O

Call,O
for,O
an,O
appointment,O
908-6508,O

Cherrie,O
Celeste,O
MD,O
44-924,O

Completed,O
by,O
:,O
Angie,O
Irene,O
MD,O
36-512,O
2012-06-19,O
@,O
0950,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Charles,O
Mcwilliams,O
on,O
:,O
Daniel,O
2012-07-05,O
3:09,O
PM,O

(,O
End,O
of,O
Report,O
),O

456424011,O

PUOMC,O

4107358,O

541797,O

858595,O

4/7/1997,O
12:00:00,O
AM,O

CORONARY,B-PR
ARTERY,I-PR
DISEASE,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

VESSELS,O
",",O
TISTIE,O
D,O

UNIT,O
NUMBER,O
:,O

125-10-86,O

ADMISSION,O
DATE,O
:,O

04/07/97,O

DISCHARGE,O
DATE,O
:,O

04/08/97,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

coronary,B-PR
artery,I-PR
disease,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

Ischemic,B-PR
cardiomyopathy,I-PR
",",O
orthotopic,B-TR
heart,I-TR
transplantation,I-TR
",",O
hyperlipidemia,B-PR
",",O
hypertension,B-PR
",",O
coronary,B-PR
graft,I-PR
disease,I-PR
",",O
medical,B-PR
noncompliance,I-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

Cardiac,B-TE
echocardiogram,I-TE
.,O

OTHER,O
PROCEDURES,O
:,O

None,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Mr.,O
Vessels,O
is,O
a,O
49-year-old,O
man,O
status,O
post,O
orthotopic,B-TR
heart,I-TR
transplantation,I-TR
in,O
1991,O
at,O
Dautenorwe,O
Stuart,O
Erec,O
Hillpa,O
Of,O
Hospital,O
who,O
is,O
admitted,O
with,O
dyspnea,B-PR
and,O
severe,B-PR
heart,I-PR
failure,I-PR
.,O

Mr.,O
Vessels,O
&apos;s,O
postoperative,O
course,O
has,O
been,O
marked,O
by,O
CMV,B-PR
infection,I-PR
",",O
hypertension,B-PR
",",O
poorly,B-PR
controlled,I-PR
lipids,I-PR
",",O
peripheral,B-PR
vascular,I-PR
disease,I-PR
",",O
and,O
chronic,B-PR
renal,I-PR
insufficiency,I-PR
with,O
a,B-TE
creatinine,I-TE
of,O
1.8,O
or,O
so,O
.,O

Recently,O
he,O
had,O
documented,O
coronary,B-TE
angiography,I-TE
based,O
on,O
a,B-TE
catheterization,I-TE
performed,O
in,O
January,O
1996,O
with,O
moderate,B-PR
to,I-PR
diffuse,I-PR
atherosclerosis,I-PR
.,O

A,B-TE
repeat,I-TE
angiogram,I-TE
performed,O
a,O
year,O
later,O
showed,O
marked,O
progression,O
of,O
coronary,B-PR
allograft,I-PR
disease,I-PR
.,O

A,B-TE
biopsy,I-TE
at,O
that,O
time,O
revealed,O
grade,B-PR
1B,I-PR
rejection,I-PR
with,O
endothelialitis,B-PR
and,O
eosinophils,B-PR
.,O

He,O
was,O
treated,O
with,O
pulsed,B-TR
IV,I-TR
steroids,I-TR
and,O
Imuran,B-TR
",",O
was,O
augmented,O
with,O
mycophenolate,B-TR
Mofetil,I-TR
.,O

Chest,B-TE
x-ray,I-TE
showed,O
cariogenic,B-PR
pulmonary,I-PR
edema,I-PR
and,O
he,O
was,O
faring,O
poorly,O
.,O

Prior,O
to,O
admission,O
he,O
was,O
seen,O
approximately,O
1,O
week,O
in,O
the,O
office,O
with,O
mild,B-PR
congestive,I-PR
heart,I-PR
failure,I-PR
.,O

An,B-TE
echocardiogram,I-TE
then,O
revealed,O
an,B-TE
ejection,I-TE
fraction,I-TE
of,O
40%,O
and,O
an,B-TE
endomyocardial,I-TE
biopsy,I-TE
revealed,O
no,O
ejection,B-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Notable,O
for,O
coronary,B-PR
artery,I-PR
disease,I-PR
",",O
coronary,B-PR
allograft,I-PR
vasculopathy,I-PR
",",O
hyperlipidemia,B-PR
",",O
peripheral,B-PR
vascular,I-PR
disease,I-PR
",",O
CMV,B-PR
infection,I-PR
",",O
hypertension,B-PR
",",O
depression,B-PR
",",O
and,O
tricuspid,B-PR
regurgitation,I-PR
.,O

Examination,B-TE
revealed,O
a,O
tired,O
",",O
fatigued,O
man,O
with,O
cool,B-PR
extremities,I-PR
.,O

His,B-TE
blood,I-TE
pressure,I-TE
is,O
130/80,O
and,O
heart,B-TE
rate,I-TE
was,O
100.,O
jugular,B-TE
venous,I-TE
pressure,I-TE
was,O
increasing,O
.,O

Carotids,B-TE
were,O
2+,O
.,O

Crackles,B-PR
were,O
increased,O
1/4,O
of,O
the,O
way,O
up,O
.,O

There,O
was,O
a,B-PR
left,I-PR
ventricular,I-PR
heave,I-PR
and,O
an,B-PR
S3,I-PR
galop,I-PR
.,O

The,O
abdomen,O
was,O
soft,O
and,O
nontender,B-PR
with,O
a,O
palpable,O
liver,O
edge,O
and,O
the,B-TE
pulses,I-TE
were,O
diminished,O
.,O

LABORATORY,O
DATA,O
:,O

Revealed,O
a,B-TE
sodium,I-TE
136,O
",",O
potassium,B-TE
4.5,O
",",O
BUN,B-TE
47,O
",",O
creatinine,B-TE
2.4,O
",",O
glucose,B-TE
136.,O
hematocrit,B-TE
40%,O
.,O

The,B-TE
electrocardiogram,I-TE
revealed,O
poor,B-PR
R,I-PR
wave,I-PR
progression,I-PR
and,O
marked,B-PR
decrease,I-PR
in,I-PR
all,I-PR
volts,I-PR
.,O

chest,B-TE
x-ray,I-TE
revealed,O
prominent,B-PR
pulmonary,I-PR
vessels,I-PR
and,O
enlarged,B-PR
heart,I-PR
.,O

HOSPITAL,O
COURSE,O
AND,O
TREATMENT,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
hospital,O
via,O
the,O
emergency,O
room,O
where,O
a,B-TE
bedside,I-TE
echocardiogram,I-TE
was,O
performed,O
.,O

The,B-TE
echocardiogram,I-TE
revealed,O
no,O
pericardial,B-PR
effusion,I-PR
",",O
an,B-TE
ejection,I-TE
fraction,I-TE
of,O
30%,O
and,O
worsening,B-PR
systolic,I-PR
dysfunction,I-PR
.,O

Hydrocortisone,B-TR
was,O
given,O
1,O
g,O
in,O
an,O
attempt,O
to,O
reverse,O
what,O
was,O
thought,O
to,O
be,O
aggressive,B-PR
coronary,I-PR
allograft,I-PR
vasculopathy,I-PR
.,O

The,O
patient,O
diuresed,O
and,O
responded,O
to,O
Lasix,B-TR
100,O
mg,O
administered,O
in,O
the,O
emergency,O
room,O
and,O
was,O
admitted,O
to,O
a,O
monitored,O
bed,O
.,O

At,O
4:30,O
AM,O
the,O
following,O
morning,O
the,O
patient,O
was,O
found,O
in,O
cardiac,B-PR
arrest,I-PR
.,O

Despite,O
intravenous,B-TR
fluids,I-TR
",",O
intravenous,B-TR
epinephrine,I-TR
",",O
and,O
multiple,O
attempts,O
at,O
defibrillation,B-TR
",",O
the,O
patient,O
was,O
unable,O
to,O
be,O
resuscitated,O
.,O

Upon,O
arrival,O
of,O
the,O
covering,O
access,O
physician,O
the,O
patient,O
was,O
being,O
ventilated,O
mechanically,O
and,O
CPR,B-TR
was,O
being,O
performed,O
.,O

The,B-TE
rhythm,I-TE
revealed,O
sinus,B-PR
tachycardia,I-PR
with,O
no,O
palpable,O
or,O
measurable,B-TE
blood,I-TE
pressure,I-TE
.,O

There,O
were,O
also,O
runs,O
of,O
ventricular,B-PR
tachycardia,I-PR
which,O
generated,O
into,O
ventricular,B-PR
fibrillation,I-PR
that,O
was,O
refractory,O
to,O
multiple,B-TR
cardioversions,I-TR
.,O

A,B-TE
pericardiocentesis,I-TE
was,O
attempted,O
with,O
no,O
yield,O
of,O
pericardial,O
fluid,O
.,O

A,B-TR
transvenous,I-TR
pacing,I-TR
wire,I-TR
was,O
attempted,O
and,O
a,O
pacing,O
rhythm,O
was,O
obtained,O
but,O
with,O
no,O
palpable,B-TE
blood,I-TE
pressure,I-TE
.,O

In,O
total,O
",",O
the,O
patient,O
was,O
defibrillated,O
10,O
times,O
",",O
given,O
5,O
courses,O
of,O
intravenous,B-TR
epinephrine,I-TR
",",O
one,O
course,O
of,O
intravenous,B-TR
Atropine,I-TR
and,O
intravenous,B-TR
calcium,I-TR
x,O
1,O
in,O
addition,O
to,O
an,B-TR
amp,I-TR
of,I-TR
bicarbonate,I-TR
.,O

The,B-TR
resuscitation,I-TR
efforts,I-TR
were,O
discontinued,O
at,O
4:15,O
AM,O
and,O
were,O
begun,O
at,O
3:38,O
AM,O
.,O

The,O
patient,O
was,O
pronounced,O
dead,O
.,O

Patient,O
&apos;s,O
mother,O
was,O
informed,O
by,O
Dr.,O
Vessels,O
.,O

An,B-TE
autopsy,I-TE
permission,O
was,O
granted,O
.,O

DOCTOR,O
&apos;S,O
DISCHARGE,O
ORDERS,O
:,O

None,O
.,O

AKA,O
MAM,O
",",O
M.D.,O

TR,O
:,O

ok,O

DD,O
:,O

05/14/97,O

TD,O
:,O

05/17/97,O
9:40,O
A,O

cc,O
:,O

AKA,O
G,O
MAM,O
",",O
M.D.,O

Admission,O
Date,O
:,O

2016-11-02,O

Discharge,O
Date,O
:,O

2016-11-15,O

Date,O
of,O
Birth,O
:,O

1938-06-17,O

Sex,O
:,O

M,O

Service,O
:,O

CARDIOTHORACIC,O
SURGERY,O

ADDENDUM,O
:,O

The,O
patient,O
had,O
INR,B-TE
of,O
3.2,O
that,O
came,O
back,O
on,O
date,O
of,O
discharge,O
.,O

Please,O
hold,O
dose,O
of,O
warfarin,B-TR
on,O
the,O
night,O
of,O
the,O
16,O
",",O
and,O
please,O
recheck,O
INR,B-TE
on,O
2016-11-16,O
and,O
dose,O
warfarin,B-TR
appropriately,O
for,O
INR,B-TE
of,O
2,O
to,O
2.5.,O

Dolly,O
K.,O
Reyes,O
",",O
M.D.,O

04-100,O

Dictated,O
By,O
:,O
Todd,O
N.,O
Brannon,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2016-11-15,O
11:54,O

T,O
:,O
2016-11-15,O
11:02,O

JOB,O
#:,O
75150,O

Signed,O
electronically,O
by,O
:,O

DR.,O
Dolly,O
N,O
Wardlaw,O
on,O
:,O
TUE,O
2016-12-27,O
5:21,O
PM,O

(,O
End,O
of,O
Report,O
),O

466217945,O

BH,O

568574,O

158979,O

3/7/2002,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Report,O
Status,O
:,O

Signed,O

DISCHARGE,O
SUMMARY,O
NAME,O
:,O

JESCOBEJESC,O
",",O
SON,O

UNIT,O
NUMBER,O
:,O

485-03-93,O

ADMISSION,O
DATE,O
:,O

03/07/2002,O

DISCHARGE,O
DATE,O
:,O

03/13/2002,O

PRIMARY,O
DIAGNOSIS,O
:,O

Wound,B-PR
infection,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

None,O
.,O

PRINCIPAL,O
PROCEDURES,O
:,O

Incision,B-TR
and,O
drainage,B-TR
of,O
wound,B-PR
infection,I-PR
on,O
3/7/02,O
.,O

Abdominal,B-TE
pelvic,I-TE
CT,I-TE
scan,I-TE
on,O
3/10/02,O
.,O

Fistulogram,B-TE
on,O
3/11/02,O
.,O

Intravenous,B-TR
antibiotics,I-TR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
79-year-old,O
man,O
status,O
postradical,B-TR
cystoprostatectomy,I-TR
with,I-TR
ileal,I-TR
loop,I-TR
for,O
locally,B-PR
invasive,I-PR
prostate,I-PR
cancer,I-PR
.,O

This,B-TR
operation,I-TR
was,O
performed,O
2/11/02,O
by,O
Dr.,O
Doje,O
Para,O
.,O

The,O
postoperative,O
course,O
was,O
complicated,O
by,O
atrial,B-PR
fibrillation,I-PR
with,O
transfer,O
to,O
the,O
Cardiac,O
Step-Down,O
Unit,O
.,O

This,O
transfer,O
occurred,O
around,O
postoperative,O
day,O
8,O
for,O
anticoagulation,B-TR
and,O
amiodarone,B-TR
load,I-TR
.,O

The,B-TR
anticoagulation,I-TR
was,O
stopped,O
due,O
to,O
concern,O
for,O
postoperative,B-PR
bleeding,I-PR
.,O

The,O
patient,O
complained,O
of,O
fevers,B-PR
.,O

The,O
patient,O
presented,O
to,O
the,O
emergency,O
room,O
on,O
3/7/02,O
",",O
complaining,O
of,O
fevers,B-PR
since,O
Monday,O
3/2/02,O
.,O

He,O
developed,O
erythema,B-PR
around,O
the,B-PR
wound,I-PR
on,O
Wednesday,O
and,O
was,O
seen,O
by,O
Dr.,O
Para,O
",",O
who,O
started,O
Keflex,B-TR
and,O
obtained,O
a,B-TE
CT,I-TE
scan,I-TE
which,O
demonstrated,O
a,B-PR
fluid,I-PR
collection,I-PR
at,O
the,O
site,O
of,O
erythema,B-PR
.,O

The,B-PR
fevers,I-PR
continued,O
as,O
high,O
as,O
102.5,O
degrees,O
F,O
with,O
chills,B-PR
on,O
the,O
morning,O
of,O
admission,O
.,O

He,O
was,O
draining,O
pus,B-PR
from,O
the,B-PR
wound,I-PR
site,I-PR
with,O
subsequent,O
relief,O
of,O
discomfort,B-PR
at,O
the,O
site,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Hypertension,B-PR
",",O
atrial,B-PR
fibrillation,I-PR
",",O
gout,B-PR
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

Cystoprostatectomy,B-TR
",",O
bilateral,B-TR
inguinal,I-TR
hernia,I-TR
repair,I-TR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Keflex,B-TR
500,O
mg,O
qid,O
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
ON,O
ADMISSION,O
:,O

On,O
presentation,O
",",O
temperature,B-TE
99.3,O
degrees,O
F,O
",",O
other,B-TE
vital,I-TE
signs,I-TE
were,O
within,O
normal,O
limits,O
.,O

He,O
was,O
in,O
no,O
acute,B-PR
distress,I-PR
",",O
non-toxic,B-PR
.,O

Cardiovascular,O
:,O

Regular,O
rate,O
and,O
rhythm,O
.,O

Pulmonary,O
:,O

Clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

Abdomen,O
soft,O
and,O
there,O
was,O
wound,B-PR
erythema,I-PR
with,O
three,B-PR
areas,I-PR
of,I-PR
dehiscence,I-PR
draining,O
foul-smelling,B-PR
",",I-PR
purulent,I-PR
fluid,I-PR
.,O

The,O
fascia,O
appeared,O
intact,O
by,O
probing,B-TE
.,O

The,B-TR
stoma,I-TR
was,O
pink,O
and,O
functional,O
.,O

The,B-PR
wound,I-PR
was,O
a,B-PR
midline,I-PR
incision,I-PR
for,O
his,B-TR
radical,I-TR
cystoprostatectomy,I-TR
.,O

LABORATORY,O
DATA,O
:,O

White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
16.9,O
",",O
hematocrit,B-TE
32.2,O
",",O
platelet,B-TE
count,I-TE
418,O
",",O
sodium,B-TE
131,O
",",O
potassium,B-TE
3.4,O
",",O
chloride,B-TE
102,O
",",O
bicarbonate,B-TE
21.4,O
",",O
BUN27,B-TE
",",O
creatinine,B-TE
1.4,O
",",O
glucose,B-TE
150,O
.,O

RADIOLOGIC,O
STUDIES,O
:,O

CT,B-TE
scan,I-TE
3/5/02,O
:,O

A,B-PR
fluid,I-PR
collection,I-PR
external,I-PR
to,I-PR
the,I-PR
fascia,I-PR
consistent,O
with,O
site,O
of,O
erythema,B-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
Urology,O
.,O

After,O
the,B-PR
wound,I-PR
was,O
further,O
opened,O
",",O
he,O
was,O
started,O
on,O
ampicillin,B-TR
",",O
Gentamicin,B-TR
",",O
and,O
Flagyl,B-TR
antibiotics,I-TR
and,O
he,O
was,O
placed,O
on,O
a,B-TR
bid,I-TR
dressing,I-TR
change,I-TR
and,O
packing,B-TR
.,O

On,O
hospital,O
day,O
2,O
",",O
the,O
patient,O
had,O
no,O
complaints,O
.,O

He,O
was,O
afebrile,B-PR
with,O
stable,O
vital,O
signs,O
and,O
good,O
urine,O
output,O
.,O

The,B-PR
wound,I-PR
erythema,I-PR
was,O
improving,O
and,O
the,B-PR
wound,I-PR
was,O
packed,O
twice,O
a,O
day,O
.,O

Wound,B-TE
cultures,I-TE
remained,O
negative,O
at,O
that,O
time,O
.,O

We,O
continued,O
his,B-TR
ampicillin,I-TR
",",O
Gentamicin,B-TR
",",O
and,O
Flagyl,B-TR
.,O

By,O
hospital,O
day,O
4,O
",",O
he,O
remained,O
afebrile,B-PR
throughout,O
his,O
hospital,O
course,O
.,O

The,B-TE
wound,I-TE
cultures,I-TE
demonstrated,O
gram-positive,B-PR
cocci,I-PR
in,I-PR
clusters,I-PR
and,O
gram-negative,B-PR
rods,I-PR
.,O

Blood,B-TE
cultures,I-TE
remained,O
negative,O
.,O

The,O
patient,O
was,O
continued,O
on,O
antibiotics,B-TR
and,O
we,O
obtained,O
a,B-TE
CT,I-TE
scan,I-TE
to,O
check,O
for,O
an,B-PR
enterocutaneous,I-PR
fistula,I-PR
.,O

We,O
discontinued,O
his,B-TR
Flagyl,I-TR
on,O
that,O
day,O
.,O

We,O
contacted,O
the,O
patient,O
&apos;s,O
primary,O
care,O
physician,O
",",O
Dr.,O
Aslinke,O
______,O
",",O
regarding,O
his,B-TR
cardiac,I-TR
medication,I-TR
management,I-TR
.,O

We,O
agreed,O
that,O
he,O
should,O
resume,O
his,B-TR
atenolol,I-TR
.,O

He,O
was,O
started,O
on,O
2.5,O
mg,O
PO,O
qd,O
.,O

He,O
was,O
continued,O
on,O
his,B-TR
dressing,I-TR
changes,I-TR
.,O

We,O
changed,O
the,B-TR
dressings,I-TR
tid,O
instead,O
of,O
bid,O
for,O
continued,B-PR
drainage,I-PR
.,O

The,B-TE
CT,I-TE
scan,I-TE
that,O
was,O
obtained,O
on,O
3/10/02,O
demonstrated,O
no,O
connection,O
between,O
bowel,O
and,O
the,B-PR
wound,I-PR
.,O

The,B-PR
drainage,I-PR
had,O
been,O
decreasing,O
and,O
the,O
patient,O
continued,O
to,O
be,O
afebrile,B-PR
.,O

On,O
the,O
following,O
day,O
",",O
3/11/02,O
",",O
a,B-TE
fistulogram,I-TE
was,O
obtained,O
which,O
was,O
negative,O
for,O
a,B-PR
fistula,I-PR
from,I-PR
the,I-PR
bowel,I-PR
to,O
the,B-PR
wound,I-PR
.,O

The,O
patient,O
was,O
continued,O
on,O
ampicillin,B-TR
and,O
Gentamicin,B-TR
.,O

Her,O
remained,O
afebrile,B-PR
with,O
stable,O
vital,O
signs,O
.,O

He,O
was,O
comfortable,O
and,O
erythema,B-PR
continued,O
to,O
decrease,O
with,O
improvemeent,O
in,O
the,O
appearance,O
of,O
the,B-PR
wound,I-PR
.,O

In,O
consultation,O
with,O
Infectious,O
Disease,O
",",O
it,O
was,O
agreed,O
to,O
discharge,O
the,O
patient,O
on,O
Augmentin,B-TR
for,O
coverage,O
.,O

We,O
obtained,O
sensitivities,B-TE
of,O
his,B-PR
wound,I-PR
bacteria,I-PR
.,O

His,B-TR
intravenous,I-TR
antibiotics,I-TR
were,O
discontinued,O
.,O

He,O
remaineda,O
febrile,B-PR
with,O
daily,O
improvement,O
in,O
the,O
appearance,O
of,O
his,B-PR
wound,I-PR
.,O

On,O
hospital,O
day,O
7,O
",",O
the,O
patient,O
remained,O
afebrile,B-PR
with,O
stable,O
vital,O
signs,O
.,O

His,B-PR
wound,I-PR
demonstrated,O
no,O
erythema,B-PR
with,O
moderate,B-PR
dark,I-PR
drainage,I-PR
.,O

The,O
patient,O
will,O
be,O
discharged,O
with,O
WH,O
and,O
continued,B-TR
dressing,I-TR
changes,I-TR
bid,O
.,O

DISCHARGE,O
INSTRUCTIONS,O
:,O

1.,O
The,O
patient,O
will,O
be,O
sent,O
home,O
on,O
7,O
days,O
of,O
Augmentin,B-TR
PO,I-TR
.,O

2.,O
The,O
patient,O
will,O
have,O
follow-up,O
with,O
Dr.,O
Para,O
in,O
three,O
weeks,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Percocet,B-TR
as,O
needed,O
for,O
pain,B-PR
.,O

Norvasc,B-TR
2.5,O
mg,O
PO,O
qd,O
.,O

Augmentin,B-TR
500/125,O
1,O
tab,O
PO,O
tid,O
x,O
7,O
days,O
.,O

LAKO,O
C,O
SCARVTWI,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

Electronically,O
Signed,O

DOJE,O
EED,O
PARA,O
",",O
M.D.,O

04/21/2002,O
10:49,O

_____________________________,O
DOJE,O
EED,O
PARA,O
",",O
M.D.,O

TR,O
:,O

yh,O

DD,O
:,O

03/13/2002,O

TD,O
:,O

03/13/2002,O
9:24,O
A,O
158979,O

cc,O
:,O

DOJE,O
EED,O
PARA,O
",",O
M.D.,O

Admission,O
Date,O
:,O

2019-02-28,O

Discharge,O
Date,O
:,O

2019-03-26,O

Date,O
of,O
Birth,O
:,O

1943-06-17,O

Sex,O
:,O

M,O

Service,O
:,O

CARDIOTHORACIC,O

Allergies,O
:,O

Morphine,B-TR
Sulfate,I-TR
/,O
Codeine,B-TR
/,O
Keflex,B-TR
/,O
Sudafed,B-TR

Attending,O
:,O
Willa,O
D,O
Garcia,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Fever,B-PR
/,O
+,O
BC,B-PR
w/,O
h/o,O
MV,B-PR
endocarditis,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

Mitral,B-TR
Valve,I-TR
Replacement,I-TR
with,O
31,B-TR
mm,I-TR
SJM,I-TR
Biocor,I-TR
Tissue,I-TR
valve,I-TR
/,I-TR
della,I-TR

Copeland,B-TR
resection,I-TR
on,O
2019-03-19,O

History,O
of,O
Present,O
Illness,O
:,O

Mr.,O
Pizano,O
is,O
a,O
75,O
y/o,O
man,O
who,O
has,O
a,O
PMHx,O
significant,O
for,O
Enterococcus,B-PR
mitral,I-PR
valve,I-PR
endocarditis,I-PR
which,O
has,O
been,O
treated,O
since,O
09-19,O
.,O

He,O
has,O
had,O
2,O
6,O
week,O
courses,O
of,O
antibiotics,B-TR
with,O
recurrent,B-PR
bacteremia,I-PR
.,O

He,O
had,O
a,B-TE
TEE,I-TE
on,O
2019-01-22,O
which,O
revealed,O
thickened,B-PR
mitral,I-PR
leaflets,I-PR
with,O
small,B-PR
vegetations,I-PR
on,I-PR
both,I-PR
anterior,I-PR
and,I-PR
posterior,I-PR
leaflets,I-PR
with,O
moderate,B-PR
to,I-PR
severe,I-PR
mitral,I-PR
regurgitation,I-PR
.,O

He,O
has,O
preserved,O
LV,O
systolic,O
function,O
with,O
mild,B-PR
TR,I-PR
and,O
AR,B-PR
and,O
LAE,B-PR
without,O
abscess,B-PR
.,O

He,O
had,O
a,B-TE
repeat,I-TE
TEE,I-TE
on,O
02-19,O
which,O
revealed,O
4,B-PR
+,I-PR
MR,I-PR
.,O

Thomasine,O
was,O
tranferred,O
from,O
MWMC,O
(,O
where,O
he,O
was,O
admitted,O
on,O
02-15,O
with,O
fevers,B-PR
and,O
positive,B-PR
blood,I-PR
cultures,I-PR
),O
to,O
IDMC,O
for,O
further,B-TR
treatment,I-TR
and,O
possibly,O
MVR,B-TR
.,O

Past,O
Medical,O
History,O
:,O
h/o,O
Mitral,B-PR
Valve,I-PR
Endocarditis,I-PR

Hypertension,B-PR

h/o,O
CVA,B-PR

Spinal,B-PR
Stenosis,I-PR
s/p,O
Lumbar,B-TR
Laminectomy,I-TR
x,O
3,O

Parkinson,B-PR
's,I-PR
disease,I-PR

h/o,O
paranoid,B-PR
delusions,I-PR

MGUS,B-PR
vs,O
MM,B-PR

Social,O
History,O
:,O

Lives,O
in,O
nursing,O
home,O
.,O

Quit,O
smoking,O
3.5,O
years,O
ago,O
.,O

Denies,O
ETOH,O
.,O

Family,O
History,O
:,O

Non-contributory,O

Physical,O
Exam,O
:,O

Preop,O

General,O
:,O

Elderly,O
man,O
in,O
NAD,B-PR
",",O
VSS,O

HEENT,O
:,O

NC/AT,B-PR
",",O
PERRLA,O
",",O
EOMI,O
",",O
poor,B-PR
dentition,I-PR

Neck,O
:,O

Supple,O
",",O
FROM,O
",",O
-,O
thyromegaly,B-PR
",",O
-,O
lymphadenopathy,B-PR
",",O
Carotids,B-TE
2,O
+,O

Bilat,O
w/out,O
bruits,B-PR

Lungs,O
:,O

CTAB,O
-,O
w/r/r,B-PR

Heart,O
:,O

RRR,O
",",O
+,O
S1S2,O
",",O
02-18,O
mumrmur,B-PR

Abd,O
:,O

Soft,O
NT/ND,B-PR
",",O
+,O
BS,O
without,O
masses,B-PR
or,O
hepatomegaly,B-PR
/,O
splenomegaly,B-PR

Ext,O
:,O

Warm,O
",",O
dry,O
-,O
c/c/e,B-PR
",",O
pulses,B-TE
2+,O
throughout,O

Neuro,O
:,O

Non-focal,O
",",O
MAE,O

Skin,O
:,O
well-healed,B-PR
surgical,I-PR
scars,I-PR
on,I-PR
lower,I-PR
back,I-PR

Discharge,O

Gen,O
:,O

NAD,B-PR
/,O
VSS,O

Neuro,O
:,O

Alert,O
",",O
non,O
focal,O
exam,O

Pulm,O
:,O

CTA,O
bilat,O

Card,O
:,O

RRR,O
",",O
sternum,O
stable,O
",",O
incision,B-PR
clean,O
and,O
dry,O
",",O
no,O
erythema,B-PR
/,O
drainage,B-PR

Abdm,O
:,O
soft,O
",",O
NT,B-PR
/,O
ND,B-PR
/,O
NABS,B-PR

Ext,O
:,O
warm,O
well,O
perfused,O
",",O
no,O
C/C/E,B-PR

Pertinent,O
Results,O
:,O

2019-02-28,O
19:30,O

GLUCOSE,B-TE
-,O
94,O
UREA,B-TE
N,I-TE
-,O
21,O
*,O
CREAT,B-TE
-,O
1.3,O
*,O
SODIUM,B-TE
-,O
138,O
POTASSIUM,B-TE
-,O
5.0,O
CHLORIDE,B-TE
-,O
105,O
TOTAL,B-TE
CO2,I-TE
-,O
25,O
ANION,B-TE
GAP,I-TE
-,O
13,O

2019-02-28,O
19:30,O

ALT,B-TE
(,I-TE
SGPT,I-TE
)-,I-TE
6,O
AST,B-TE
(,I-TE
SGOT,I-TE
)-,I-TE
20,O
LD,B-TE
(,I-TE
LDH,I-TE
)-,I-TE
255,O
*,O
ALK,B-TE
PHOS,I-TE
-,O
134,O
*,O
TOT,B-TE
BILI,I-TE
-,O
0.4,O

2019-02-28,O
19:30,O

CALCIUM,B-TE
-,O
9.3,O
PHOSPHATE,B-TE
-,O
3.7,O
MAGNESIUM,B-TE
-,O
2.3,O

2019-02-28,O
19:30,O

WBC,B-TE
-,O
4.9,O
RBC,B-TE
-,O
4.27,O
*,O
HGB,B-TE
-,O
11.3,O
*,O
HCT,B-TE
-,O
35.1,O
*,O
MCV,B-TE
-,O
82,O
MCH,B-TE
-,O
26.4,O
*,O
MCHC,B-TE
-,O
32.2,O
RDW,B-TE
-,O
17.4,O
*,O

2019-02-28,O
19:30,O

NEUTS,B-TE
-,O
66.3,O
LYMPHS,B-TE
-,O
25.0,O
MONOS,B-TE
-,O
5.7,O
EOS,B-TE
-,O
0.1,O
BASOS,B-TE
-,O
2.9,O
*,O

2019-02-28,O
19:30,O

PLT,B-TE
COUNT,I-TE
-,O
187,O

2019-02-28,O
19:30,O

PT,B-TE
-,O
13.1,O
PTT,B-TE
-,O
30.1,O
INR,B-TE
(,I-TE
PT,I-TE
)-,I-TE
1.1,O

2019-02-28,O
06:27,O
PM,O
URINE,B-TE

COLOR,B-TE
-,O
Amber,O
APPEAR,B-TE
-,O
Clear,O
SP,B-TE
Stickney,I-TE
-,O
1.015,O

2019-03-23,O
05:31,O
AM,O
BLOOD,B-TE

WBC,B-TE
-,O
8.6,O
RBC,B-TE
-,O
3.43,O
*,O
Hgb,B-TE
-,O
9.9,O
*,O
Hct,B-TE
-,O
28.7,O
*,O
MCV,B-TE
-,O
84,O
MCH,B-TE
-,O
28.9,O
MCHC,B-TE
-,O
34.5,O
RDW,B-TE
-,O
17.8,O
*,O
Plt,B-TE
Ct,I-TE
-,O
120,O
*,O

2019-03-25,O
01:53,O
AM,O
BLOOD,B-TE

Glucose,B-TE
-,O
95,O
UreaN,B-TE
-,O
35,O
*,O
Creat,B-TE
-,O
1.4,O
*,O
Na,B-TE
-,O
136,O
K,B-TE
-,O
4.9,O
Cl,B-TE
-,O
105,O
HCO3,B-TE
-,O
21,O
*,O
AnGap,B-TE
-,O
15,O

2019-03-25,O
04:47,O
PM,O
BLOOD,B-TE
PT,B-TE
-,O
14.1,O
*,O
PTT,B-TE
-,O
29.4,O
INR,B-TE
(,I-TE
PT,I-TE
)-,O
1.3,O
*,O

Brief,O
Hospital,O
Course,O
:,O

As,O
mentioned,O
in,O
the,O
HPI,O
",",O
Mr.,O
Mcculley,O
was,O
transferred,O
from,O
MWMC,O
to,O
Nantucket,O
Cottage,O
Hospital,O
for,O
ongoing,O
care,O
(,O
?,O
MVR,B-TR
).,O

And,O
Infectious,O
disease,O
consult,O
was,O
immediately,O
made,O
.,O

IV,B-TR
Daptomycin,I-TR
was,O
continued,O
via,O
PICC,B-TR
line,I-TR
which,O
was,O
inserted,O
on,O
02-20,O
at,O
MWMC,O
.,O

Mr,O
Stutts,O
had,O
an,B-TE
extensive,I-TE
preop,I-TE
evaluation,I-TE
including,O
cardiology,O
",",O
infectious,O
diseases,O
",",O
orthopedics,O
",",O
psychiatry,O
and,O
ethics,O
services,O
.,O

He,O
ultimately,O
was,O
brought,O
to,O
the,O
operating,O
room,O
on,O
03-19,O
.,O

At,O
that,O
time,O
he,O
had,O
a,B-TR
Mitral,I-TR
Valve,I-TR
replacement,I-TR
",",O
aortoomy,B-TR
",",O
and,O
left,B-TR
atrial,I-TR
appendage,I-TR
resection,I-TR
.,O

His,B-TR
bypass,I-TR
time,I-TR
was,O
103,O
minutes,O
/,O
crossclamp,B-TR
89,O
mins,O
.,O

Please,O
see,O
OR,O
report,O
for,O
full,O
details,O
.,O

He,O
tolerated,O
the,B-TR
surgery,I-TR
well,O
and,O
was,O
transferred,O
from,O
the,O
OR,O
to,O
the,O
CSRU,O
on,O
Epinephrinne,B-TR
and,O
Propofol,B-TR
infusions,I-TR
.,O

He,O
did,O
well,O
in,O
immediate,O
postoperative,O
period,O
.,O

Following,O
surgery,B-TR
his,B-TR
anesthesia,I-TR
was,O
reversed,O
",",O
he,O
was,O
weaned,O
from,O
ventilator,B-TR
and,O
successfully,O
extubated,O
.,O

His,B-TR
iv,I-TR
medications,I-TR
were,O
also,O
weaned,O
to,O
off,O
.,O

On,O
POD1,O
His,B-TR
PA,I-TR
line,I-TR
and,O
chest,B-TR
tubes,I-TR
were,O
removed,O
",",O
he,O
was,O
also,O
started,O
on,O
Beta,B-TR
blockers,I-TR
and,O
diuretics,B-TR
.,O

On,O
POD2,O
the,O
patient,O
remained,O
hemodynamically,O
stable,O
and,O
was,O
transferred,O
from,O
the,O
ICU,O
to,O
F2,O
for,O
continued,O
postop,O
care,O
.,O

Over,O
the,O
next,O
several,O
days,O
with,O
the,O
assisstance,O
of,O
the,O
nursing,O
staff,O
and,O
physical,O
therapy,O
the,O
patients,O
activity,O
level,O
was,O
advanced,O
",",O
he,O
was,O
transitioned,O
to,O
all,B-TR
oral,I-TR
medications,I-TR
with,O
the,O
exception,O
of,O
his,B-TR
antibiotics,I-TR
.,O

On,O
POD7,O
it,O
was,O
decided,O
that,O
the,O
pt,O
was,O
stable,O
and,O
ready,O
for,O
discharge,O
to,O
rehabilitation,O
.,O

It,O
should,O
be,O
noted,O
that,O
the,O
patient,O
did,O
have,O
episodes,O
of,O
postoperative,B-PR
atrial,I-PR
fibrillation,I-PR
",",O
he,O
was,O
seen,O
by,O
the,O

Electrophysiology,O
service,O
",",O
started,O
on,O
Procainamide,B-TR
and,O
Coumadin,B-TR
.,O

Medications,O
on,O
Admission,O
:,O

Aricept,B-TR
10,O
mg,O
qd,O
",",O
Aspirin,B-TR
81,O
mg,O
qd,O
",",O
Folic,B-TR
acid,I-TR
",",O
Gabapentin,B-TR
200,O
mg,O
tid,O
",",O
Lopressor,B-TR
12.5,O
mg,O
bid,O
",",O
Lisinopril,B-TR
5,O
mg,O
qd,O
",",O
Daptomycin,B-TR
420,O
mg,O
IV,O
qd,O
",",O
Protonix,B-TR
40,O
mg,O
qd,O
",",O
Seroquel,B-TR
50,O
mg,O
tid,O
",",O
Heparin,B-TR
5000,O
units,O
SQ,O
tid,O
",",O
Colace,B-TR
100,O
mg,O
bid,O
",",O
Lactulose,B-TR
15,O
mg,O
bid,O
",",O
Comtan,B-TR
200,O
mg,O
qd,O
",",O
Mirapex,B-TR
1.5,O
mg,O
tid,O
",",O
Sinemet,B-TR
50,O
/,O
200,O
mg,O
tid,O

Discharge,O
Medications,O
:,O

1.,O
Furosemide,B-TR
20,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
once,O
a,O
day,O
for,O
2,O
weeks,O
.,O

2.,O
Potassium,B-TR
Chloride,I-TR
20,O
mEq,O
Packet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Packet,O
PO,O
once,O
a,O
day,O
for,O
2,O
weeks,O
.,O

3.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

4.,O
Pantoprazole,B-TR
40,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
Q24H,O
(,O
every,O
24,O
hours,O
),O
.,O

5.,O
Aspirin,B-TR
81,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

6.,O
Magnesium,B-TR
Hydroxide,I-TR
400,O
mg,O
/,O
5,O
mL,O
Suspension,O
Sig,O
:,O
Thirty,O
(,O
30,O
),O
ML,O
PO,O
HS,O
(,O
at,O
bedtime,O
),O
as,O
needed,O
for,O
constipation,B-PR
.,O

7.,O
Entacapone,B-TR
200,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
.,O

8.,O
Pramipexole,B-TR
0.25,O
mg,O
Tablet,O
Sig,O
:,O
Six,O
(,O
6,O
),O
Tablet,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
.,O

9.,O
Carbidopa,B-TR
-,I-TR
Levodopa,I-TR
50,O
-,O
200,O
mg,O
Tablet,O
Sustained,O
Release,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
.,O

10.,O
Quetiapine,B-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

11.,O
Procainamide,B-TR
250,O
mg,O
Capsule,O
Sig,O
:,O
Three,O
(,O
3,O
),O
Capsule,O
PO,O
Q6H,O
(,O
every,O
6,O
hours,O
),O
:,O
x,O
6,O
weeks,O
.,O

12.,O
Acetaminophen,B-TR
-,I-TR
Codeine,I-TR
300-30,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q4H,O
(,O
every,O
4,O
hours,O
),O
as,O
needed,O
.,O

13.,O
Warfarin,B-TR
1,O
mg,O
Tablet,O
Sig,O
:,O
as,O
directed,O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

14.,O
Daptomycin,B-TR
500,O
mg,O
Recon,O
Soln,O
Sig,O
:,O
Four,O
90y,O
(,O
480,O
),O
mg,O
Intravenous,O
Q24H,O
(,O
every,O
24,O
hours,O
),O
:,O
thru,O
05-02,O
.,O

Discharge,O
Disposition,O
:,O

Extended,B-TR
Care,I-TR

Discharge,O
Diagnosis,O
:,O
mitral,B-PR
valve,I-PR
endocarditis,I-PR
s/p,O
MV,B-TR
replacement,I-TR

HTN,B-PR

s/p,O
CVA,B-PR

Spinal,B-PR
stenosis,I-PR
s/p,O
Lumbar,B-TR
Laminectomy,I-TR

Parkingson,B-PR
's,I-PR

h/o,O
paranoid,B-PR
delusions,I-PR

MGUS,B-PR
vs,O
MM,B-PR

Discharge,O
Condition,O
:,O
good,O

Discharge,O
Instructions,O
:,O

May,O
take,O
shower,O
.,O

Wash,O
incisions,B-PR
with,O
warm,O
water,O
and,O
gentle,O
soap,O
.,O

Do,O
no,O
take,O
bath,O
or,O
swim,O
.,O

Do,O
not,O
apply,O
lotions,B-TR
",",O
creams,B-TR
",",O
ointments,B-TR
or,O
powders,B-TR
to,O
incision,B-PR
.,O

Do,O
not,O
drive,O
for,O
1,O
month,O
.,O

Do,O
not,O
lift,O
more,O
than,O
10,O
pounds,O
for,O
2,O
months,O
.,O

Please,O
contact,O
office,O
if,O
you,O
develop,O
a,B-PR
fever,I-PR
more,O
than,O
101.5,O
or,O
notice,O
drainage,B-PR
from,O
chest,B-PR
incision,I-PR
.,O

Followup,O
Instructions,O
:,O

Dr.,O
Portsche,O
in,O
4,O
weeks,O

Dr.,O
Bravo,O
(,O
PCP,O
),O
in,O
1-2,O
weeks,O

Infectious,O
disease,O
Provider,O
:,O

Marsha,O
Harriet,O
",",O
MD,O

Phone,O
:,O
574-5036,O

Date,O
/,O
Time,O
:,O
2019-04-29,O
10:00,O

Jeffrey,O
Everett,O
MD,O
23-815,O

Completed,O
by,O
:,O
MARK,O
Carolyn,O
NP,O
80-AUO,O
2019-03-26,O
@,O
1033,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Millard,O
Fornataro,O
on,O
:,O
FRI,O
2019-03-29,O
4:45,O
PM,O

(,O
End,O
of,O
Report,O
),O

468211586,O

PUOMC,O

9651828,O

14540,O

719527,O

1/4/1996,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

RALNMOTTEFUH,O
",",O
AEEN,O

UNIT,O
NUMBER,O
:,O

363-79-23,O

ADMISSION,O
DATE,O
:,O

01/04/96,O

DISCHARGE,O
DATE,O
:,O

01/10/96,O

FINAL,O
DIAGNOSIS,O
:,O

Cervical,B-PR
carcinoma,I-PR
;,O
bilateral,B-PR
ureteral,I-PR
obstruction,I-PR
secondary,O
to,O
the,B-PR
cancer,I-PR
.,O

Uremia,B-PR
.,O

Ileus,B-PR
.,O

OPERATION,O
:,O

Bilateral,B-TR
ureteral,I-TR
stent,I-TR
placement,I-TR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
78-year-old,O
woman,O
had,O
stage,B-PR
IIIB,I-PR
carcinoma,I-PR
of,I-PR
the,I-PR
cervix,I-PR
and,O
she,O
has,O
known,B-PR
periaortic,I-PR
and,I-PR
splenic,I-PR
metastases,I-PR
.,O

She,O
was,O
discharged,O
from,O
the,O
hospital,O
about,O
18,O
days,O
prior,O
to,O
her,O
admission,O
",",O
following,O
a,O
month,O
long,O
stay,O
.,O

When,O
her,B-PR
cancer,I-PR
was,O
diagnosed,O
",",O
she,O
underwent,O
total,B-TR
abdominal,I-TR
hysterectomy,I-TR
and,O
bilateral,B-TR
salpingo-oophorectomy,I-TR
and,O
pelvic,B-TR
lymphadenectomy,I-TR
.,O

She,O
had,O
extensive,B-PR
disease,I-PR
of,I-PR
the,I-PR
uterus,I-PR
",",I-PR
ovarian,I-PR
tubes,I-PR
",",I-PR
omentum,I-PR
and,I-PR
the,I-PR
periaortic,I-PR
lymph,I-PR
nodes,I-PR
.,O

Postoperatively,O
",",O
she,O
developed,O
ileus,B-PR
",",O
then,O
finally,O
she,O
recovered,O
and,O
she,O
was,O
discharged,O
to,O
the,O
nursing,O
home,O
.,O

She,O
was,O
readmitted,O
because,O
of,O
a,O
problem,O
with,O
uremia,B-PR
and,O
high,B-PR
BUN,I-PR
and,I-PR
creatinine,I-PR
when,O
she,O
seen,O
in,O
the,O
office,O
and,O
the,B-TE
BUN,I-TE
and,O
creatinine,B-TE
was,O
ordered,O
.,O

The,B-TE
BUN,I-TE
was,O
70,O
and,O
creatinine,B-TE
was,O
4.6,O
and,O
for,O
this,O
reason,O
she,O
had,O
ultrasound,B-TE
of,I-TE
the,I-TE
kidney,I-TE
which,O
showed,O
bilateral,B-PR
hydronephrosis,I-PR
.,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
hospital,O
for,O
ureteral,B-TR
stent,I-TR
placement,I-TR
.,O

On,O
the,O
day,O
of,O
admission,O
",",O
she,O
was,O
generally,O
stable,O
and,O
she,O
had,O
no,O
evidence,O
of,O
disease,B-PR
in,I-PR
the,I-PR
pelvis,I-PR
",",O
no,O
bleeding,B-PR
and,O
no,O
other,B-PR
abnormality,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

Dr.,O
Jescdrig,O
was,O
called,O
and,O
a,O
consultation,O
was,O
done,O
and,O
he,O
placed,O
bilateral,B-TR
ureteral,I-TR
stents,I-TR
in,I-TR
her,I-TR
kidneys,I-TR
.,O

Postoperatively,O
",",O
she,O
diuresed,O
very,O
well,O
.,O

She,O
had,O
dropped,O
her,B-TE
BUN,I-TE
and,O
creatinine,B-TE
to,O
normal,O
and,O
she,O
was,O
found,O
to,O
have,O
may,O
be,O
metastatic,B-PR
disease,I-PR
to,I-PR
her,I-PR
skin,I-PR
on,O
the,O
right,O
paraumbilical,O
area,O
.,O

Because,O
of,O
her,O
age,O
and,O
mental,O
condition,O
and,O
the,O
fact,O
that,O
she,O
had,O
cerebral,B-PR
atrophy,I-PR
",",O
the,O
decision,O
was,O
made,O
for,O
comfort,O
unless,O
she,O
has,O
any,B-PR
further,I-PR
problem,I-PR
and,O
no,O
further,O
chemotherapy,B-TR
or,O
treatment,B-TR
will,O
be,O
given,O
.,O

The,O
possibility,O
that,O
she,O
may,O
need,O
to,O
receive,O
radiation,B-TR
therapy,I-TR
to,O
this,O
area,O
to,O
prevent,O
her,O
from,O
getting,O
further,B-PR
obstruction,I-PR
was,O
also,O
brought,O
up,O
.,O

Her,O
family,O
felt,O
that,O
at,O
the,O
present,O
time,O
",",O
because,O
her,O
condition,O
was,O
no,O
good,O
",",O
they,O
would,O
like,O
to,O
just,O
take,O
her,O
home,O
so,O
that,O
she,O
could,O
enjoy,O
the,O
quality,O
of,O
life,O
.,O

Indeed,O
",",O
at,O
the,O
time,O
of,O
discharge,O
she,O
was,O
conscious,O
and,O
she,O
was,O
cooperative,O
and,O
she,O
was,O
able,O
to,O
communicate,O
very,O
nicely,O
with,O
everyone,O
including,O
her,O
family,O
",",O
except,O
for,O
the,B-PR
mental,I-PR
instability,I-PR
that,O
she,O
had,O
because,O
of,O
her,B-PR
cerebral,I-PR
atrophy,I-PR
due,O
to,O
senility,B-PR
.,O

FOLLOW-UP,O
:,O

She,O
will,O
be,O
followed,O
in,O
the,O
Centu,O
Fairgmer,O
Queen,O
Medical,O
Center,O
.,O

AZEL,O
U.,O
HIBBSKAYS,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

EARNRA,O
HAWNSPANTKOTE,O
",",O
M.D.,O

TR,O
:,O

yq,O

DD,O
:,O

01/26/96,O

TD,O
:,O

01/30/96,O
12:18,O
P,O

cc,O
:,O

AZEL,O
USANNE,O
HIBBSKAYS,O
",",O
M.D.,O
EARNRA,O
HAWNSPANTKOTE,O
",",O
M.D.,O

Admission,O
Date,O
:,O

2016-03-22,O

Discharge,O
Date,O
:,O

2016-04-04,O

Date,O
of,O
Birth,O
:,O

1940-06-17,O

Sex,O
:,O

F,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Morphine,B-TR

Attending,O
:,O
Michael,O
I.,O
Miller,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O
s/p,O
Fall,O

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O
s/p,O
right,B-TR
hip,I-TR
ORIF,I-TR

s/p,O
intubation,B-TR

History,O
of,O
Present,O
Illness,O
:,O

75,O
yo,O
F,O
with,O
CAD,B-PR
s/p,O
MI,B-PR
x4,O
(,O
s/p,O
LAD,B-TR
stent,I-TR

Per,O
daughter,O
",",O
pt,O
was,O
in,O
her,O
USOH,O
until,O
two,O
days,O
prior,O
to,O
admission,O
when,O
she,O
was,O
noted,O
to,O
have,O
a,B-PR
superficial,I-PR
ulcerations,I-PR
on,I-PR
her,I-PR
foot,I-PR
with,O
erythema,B-PR
.,O

Pt,O
was,O
taken,O
to,O
Bridgewater,O
Chelsea,O
Soldier,O
's,O
Home,O
Hospital,O
and,O
started,O
on,O
unasyn,B-TR
IV,I-TR
.,O

Pt,O
awoke,O
later,O
that,O
night,O
and,O
felt,O
unsteady,B-PR
on,I-PR
her,I-PR
feet,I-PR
and,O
sustained,O
a,O
mechanical,O
fall,O
.,O

Per,O
daughter,O
",",O
pt,O
did,O
not,O
note,O
chest,B-PR
pain,I-PR
",",O
tachycardia,B-PR
",",O
had,O
a,O
good,O
PO,O
intake,O
and,O
no,O
noted,B-PR
seizure,I-PR
activity,I-PR
.,O

"Pt,O
was,O
in,O
severe,B-PR
"",I-PR
back,I-PR
pain,I-PR
"",I-PR
as,O
per,O
daughter,O
which,O
was,O
treated,O
with,O
dilaudid,B-TR
.",O

CT,B-TE
of,I-TE
the,I-TE
neck,I-TE
revealed,O
a,O
possible,O
C1,B-PR
fracture,I-PR
and,O
the,B-TE
X-ray,I-TE
at,O
the,O
OSH,O
revealed,O
intratrochanteric,B-PR
fracture,I-PR
of,I-PR
the,I-PR
right,I-PR
femur,I-PR
.,O

Pt,O
was,O
subsequently,O
transferred,O
to,O
Hallmark,O
Health,O
System,O
for,O
orthopaedic,B-TE
evaluation,I-TE
.,O

In,O
Monica,O
at,O
Hallmark,O
Health,O
System,O
",",O
pt,O
was,O
seen,O
by,O
the,O
Trauma,O
service,O
where,O
a,B-TE
CT,I-TE
of,I-TE
the,I-TE
neck,I-TE
revealed,O
no,O
fracture,B-PR
(,O
however,O
",",O
the,B-TR
c-collar,I-TR
was,O
maintained,O
secondary,O
to,O
pain,B-PR
),O
.,O

The,O
orthopaedic,O
service,O
recommended,O
emergent,B-TR
repair,I-TR
of,O
the,B-PR
intratrochanteric,I-PR
fracture,I-PR
secondary,O
to,O
instability,B-PR
.,O

The,O
Monica,O
stay,O
was,O
complicated,O
by,O
runs,O
of,O
afib,B-PR
to,O
133,O
requiring,O
IV,B-TR
lopressor,I-TR
.,O

ROS,O
:,O

Pt,O
is,O
very,B-PR
SOB,I-PR
at,O
baseline,O
",",O
not,O
on,O
home,B-TR
ox,I-TR
",",O
no,O
CP,B-PR
at,O
rest,O
",",O
no,O
LE,B-PR
edema,I-PR
",",O
no,O
PND,B-PR
",",O
stable,B-PR
orthopnea,I-PR
(,O
2,O
pillows,O
),O
.,O

Pt,O
ambulates,O
10,O
feet,O
with,O
significant,B-PR
fatigue,I-PR
as,O
per,O
daughter,O
.,O

(,O
?,O
dec,B-PR
in,I-PR
exercise,I-PR
tolerance,I-PR
),O
.,O

CMED,O
CCU,O
change,O
include,O
discontinuation,O
of,O
coumadin,B-TR
secondary,O
to,O
inc,O
risk,O
of,O
upper,B-PR
GI,I-PR
bleed,I-PR
.,O

Digoxin,B-TR
",",O
Norvasc,B-TR
and,O
Imdur,B-TR
was,O
also,O
discontinued,O
.,O

HPI,O
:,O

75,O
yo,O
F,O
with,O
CAD,B-PR
s/p,O
stenting,B-TR
",",O
VT,B-PR
",",O
SSS,B-PR
s/p,O
pacer,B-TR
",",O
COPD,B-PR
",",O
presented,O
to,O
OSH,O
2016-03-21,O
with,O
foot,B-PR
ulceration,I-PR
.,O

Started,O
on,O
unasyn,B-TR
",",O
in,O
hospital,O
suffered,O
mech.,O
fall,O
with,O
hip,B-PR
fx,I-PR
.,O

Transferred,O
to,O
Hallmark,O
Health,O
System,O
03-22,O
.,O

Medically,B-TE
eval,I-TE
not,O
high,B-TR
risk,I-TR
surgery,I-TR
",",O
preop,B-TR
beta,I-TR
blocker,I-TR
given,O
.,O

ORIF,B-TR
with,O
repair,B-TR
of,O
neck,B-PR
fracture,I-PR
2016-03-23,O
.,O

Expected,B-TR
prolonged,I-TR
extubation,I-TR
course,I-TR
given,O
COPD,B-PR
history,I-PR
",",O
as,O
with,O
colon,B-TR
CA,I-TR
resection,I-TR
surgery,I-TR
.,O

In,O
PM,O
extubated,O
",",O
transferred,O
to,O
floor,O
2016-03-23,O
.,O

Late,O
03-23,O
found,O
with,O
afib,B-PR
and,O
RVR,B-PR
",",O
given,O
beta,B-TR
blocker,I-TR
with,O
min.,O
response,O
",",O
started,O
dilt.,B-TR
drip,I-TR
.,O

Received,O
2,B-TR
mg,I-TR
dilaudid,I-TR
for,O
pain,B-PR
o/n,O
.,O

This,O
AM,O
with,O
respiratory,B-PR
failure,I-PR
",",O
continued,B-PR
tachycardia,I-PR
on,O
dilt.,B-TR
gtt,I-TR
.,O

Transferred,O
to,O
unit,O
and,O
urgently,O
intubated,O
(,O
labs,B-TE
below.,O
),O

Of,O
note,O
",",O
a,B-TR
NGT,I-TR
by,O
Xray,B-TE
was,O
not,O
in,O
correct,O
position,O
?,O
lungs,O
->,O
possibly,O
used,O
for,O
medication,B-TR
administration,I-TR
this,O
AM,O
.,O

Past,O
Medical,O
History,O
:,O

1.,O
CAD,B-PR
s/p,O
LAD,B-TR
stent,I-TR
in,O
',O
98,O
+,O
RCA,B-TR
stet,I-TR
in,O
',O
00,O
with,O
repeat,B-TR
RCA,I-TR
stent,I-TR
in,O
',O
04,O
.,O

Last,B-TE
cath,I-TE
in,O
9-04,O

2.,O
PAF,B-PR

3.,O
DM,B-PR

4.,O
Sick,B-PR
sinus,I-PR
syndrome,I-PR
s/p,O
pacer,B-TR
placement,I-TR
in,O
',O
98,O

5.,O
Depression,B-PR

6.,O
COPD,B-PR
(,O
no,O
PFT,B-TE
available,O
),O

7.,O
Chronic,B-PR
restrictive,I-PR
lung,I-PR
disease,I-PR
(,O
no,O
PFT,B-TE
available,O
),O

8.,O
HTN,B-PR

9.,O
Hyperlipidemia,B-PR

10.,O
Obesity,B-PR

11.,O
s/p,O
TAH,B-TR

12.,O
s/p,O
colonic,B-TR
resection,I-TR
secondary,O
to,O
perforation,B-PR
s/p,O
polypectomy,B-TR

13.,O
Inducible,B-PR
Vtach,I-PR
on,O
EP,B-TE
study,I-TE
with,O
AICD,B-TR
placement,I-TR
11-01,O

14.,O
CHF,B-PR

15.,O
Upper,B-PR
GI,I-PR
bleed,I-PR

Physical,O
Exam,O
:,O

VS,B-TE
:,O

HR,B-TE
:,O
133,O

BP,B-TE
:,O
110/80,O

Gen,O
:,O
sedated,B-TR
but,O
A+O,O
x3,O

HEENT,O
:,O
cervical,B-TR
collar,I-TR
in,O
place,O

CV,O
:,O
tachycardia,B-PR

Chest,O
:,O
CTA,O
bilaterally,O

Abd,O
:,O
+,O
BS,O
",",O
soft,O
",",O
NT,B-PR
",",O
ND,B-PR
",",O
BS,O
+,O

Ext,O
:,O
no,O
peripheral,B-PR
edema,I-PR
",",O
R,B-PR
leg,I-PR
shortened,I-PR
and,I-PR
rotated,I-PR
",",O
+,O
cellulitis,B-PR

Pertinent,O
Results,O
:,O

2016-03-22,O
2:45,O

WBC,B-TE
-,O
12.7,O
*,O
RBC,B-TE
-,O
4.32,O
HGB,B-TE
-,O
10.5,O
*,O
HCT,B-TE
-,O
33.2,O
*,O
MCV,B-TE
-,O
77,O
*,O
MCH,B-TE
-,O
24.2,O
*,O
MCHC,B-TE
-,O
31.5,O
RDW,B-TE
-,O
15.4,O

2016-03-22,O
2:45,O

NEUTS,B-TE
-,O
90.5,O
*,O
LYMPHS,B-TE
-,O
5.1,O
*,O
MONOS,B-TE
-,O
3.7,O
EOS,B-TE
-,O
0.6,O
BASOS,B-TE
-,O
0.2,O

2016-03-22,O
2:45,O

HYPOCHROM,B-TE
-,O
3+,O
POIKILOCY,B-TE
-,O
1+,O
MICROCYT,B-TE
-,O
2+,O

2016-03-22,O
2:45,O

PLT,B-TE
COUNT,I-TE
-,O
324,O

2016-03-22,O
2:45,O

PT,B-TE
-,O
13.6,O
PTT,B-TE
-,O
25.2,O
INR,B-TE
(,I-TE
PT,I-TE
)-,I-TE
1.2,O

2016-03-22,O
2:45,O

GLUCOSE,B-TE
-,O
191,O
*,O
UREA,B-TE
N,I-TE
-,O
14,O
CREAT,B-TE
-,O
0.6,O
SODIUM,B-TE
-,O
141,O
POTASSIUM,B-TE
-,O
3.5,O
CHLORIDE,B-TE
-,O
101,O
TOTAL,B-TE
CO2,I-TE
-,O
28,O
ANION,B-TE
GAP,I-TE
-,O
16,O

2016-03-22,O
2:45,O

CALCIUM,B-TE
-,O
8.8,O
PHOSPHATE,B-TE
-,O
4.4,O
MAGNESIUM,B-TE
-,O
1.9,O

2016-03-22,O
11:25,O
AM,O
URINE,B-TE

COLOR,B-TE
-,O
Yellow,O
APPEAR,B-TE
-,O
Clear,O
SP,B-TE
Barajas,I-TE
-,O
1.020,O

2016-03-22,O
11:25,O
AM,O
URINE,B-TE

BLOOD,B-TE
-,O
LG,B-TE
NITRITE,I-TE
-,O
NEG,O
PROTEIN,B-TE
-,O
NEG,O
GLUCOSE,B-TE
-,O
250,O
KETONE,B-TE
-,O
NEG,O
BILIRUBIN,B-TE
-,O
NEG,O
UROBILNGN,B-TE
-,O
NEG,O
PH,B-TE
-,O
6.5,O

LEUK,B-TE
-,O
NEG,O

2016-03-22,O
11:25,O
AM,O
URINE,B-TE

RBC,B-TE
-,O
0-2,O
WBC,B-TE
-,O
04-02,O
BACTERIA,B-TE
-,O
OCC,B-TE
YEAST,I-TE
-,O
NONE,O
EPI,B-TE
-,O
0,O

2016-03-22,O
11:25,O
AM,O
URINE,B-TE

HYALINE,B-TE
-,O
3,O
*,O

2016-03-22,O
11:25,O

CK,B-TE
(,I-TE
CPK,I-TE
)-,I-TE
178,O
*,O

2016-03-22,O
11:25,O

CK-MB,B-TE
-,O
7,O

2016-03-22,O
16:45,O

D-DIMER,B-TE
-,O
1748,O
*,O

2016-03-22,O
16:45,O

CK,B-TE
(,I-TE
CPK,I-TE
)-,I-TE
153,O
*,O

2016-03-22,O
16:45,O

CK-MB,B-TE
-,O
5,O
cTropnT,B-TE
-<,O
0.01,O

',O
00,O
TTE,B-TE
:,O

EF,B-TE
50-55%,O
;,O
mild,B-PR
to,I-PR
moderate,I-PR
MR,I-PR
",",O
left,O
atrium,O
is,O
moderately,B-PR
dilated,I-PR
",",O
trace,B-PR
AR,I-PR

10-02,O
:,O

Cardiac,B-TE
catheterization,I-TE
:,O
inferior,B-PR
",",I-PR
posterobasilar,I-PR
hypokinesis,I-PR
",",O
1,B-PR
+,I-PR
MR,I-PR
",",O
EF,B-TE
48%,O
",",O
mid,O
RCA,O
50%,O
",",O
distal,O
RCA,O
40%,O
",",O
mid,O
LAD,O
50%,O
",",O
OM3,B-PR
diffusely,I-PR
diseased,I-PR
s/p,O
stenting,B-TR
of,I-TR
RCA,I-TR
with,O
drug,B-TR
eluting,I-TR
stent,I-TR
with,O
10%,B-TE
residual,I-TE
flow,I-TE
.,O

2016-03-22,O
CXR,B-TE
:,O
moderate,B-PR
cardiomegaly,I-PR
without,O
CHF,B-PR
",",O
no,O
effusions,B-PR
",",O
left,B-PR
retrocardiac,I-PR
opacity,I-PR
consistent,O
with,O
atelectasis,B-PR
vs.,O
consolidation,B-PR

2016-03-22,O
CT,B-TE
c-spine,I-TE
:,O

1),O
No,O
evidence,O
of,O
fracture,B-PR
of,I-PR
the,I-PR
cervical,I-PR
spine,I-PR
.,O

No,O
definite,B-PR
fracture,I-PR
of,I-PR
C1,I-PR
is,O
identified,O
to,O
correlate,O
with,O
the,O
history,O
of,O
questioned,O
C1,B-PR
fracture,I-PR
from,O
outside,O
hospital,O
.,O

"2),O
Extensive,B-PR
degenerative,I-PR
change,I-PR
of,I-PR
the,I-PR
cervical,I-PR
spine,I-PR
.""",O

2016-03-22,O
Femur,B-TE
&,I-TE
R,I-TE
knee,I-TE
X-ray,I-TE
:,O

1),O
Comminuted,B-PR
intertrochanteric,I-PR
fracture,I-PR
of,I-PR
the,I-PR
right,I-PR
femur,I-PR
",",O
with,O
avulsion,B-PR
of,I-PR
the,I-PR
lesser,I-PR
trochanter,I-PR
",",O
displacement,B-PR
and,O
angulation,B-PR
.,O

"2),O
No,O
other,B-PR
definite,I-PR
fractures,I-PR
identified.,O
degenerative,B-PR
changes,I-PR
of,I-PR
the,I-PR
lumbosacral,I-PR
spine,I-PR
.""",O

2016-04-01,O
Flexion,B-TE
extension,I-TE
xrays,I-TE
of,I-TE
cervical,I-TE
spine,I-TE
:,O

Mild,O
degree,O
of,O
instability,B-PR
at,I-PR
level,I-PR
C3-C4,I-PR
as,O
described,O
.,O

Possibility,O
of,O
arch,B-PR
element,I-PR
in,I-PR
this,I-PR
region,I-PR
cannot,O
be,O
excluded,O
.,O

Brief,O
Hospital,O
Course,O
:,O

A/P,O
:,O

75,O
yo,O
F,O
s/p,O
MIx4,B-PR
",",O
numerous,B-TE
cath,I-TE
",",O
PAF,B-PR
",",O
Inducible,B-PR
VTach,I-PR
s/p,O
AICD,B-TR
and,O
pacer,B-TR
with,O
severe,B-PR
COPD,I-PR
/,O
restrictive,B-PR
lung,I-PR
disease,I-PR
s/p,O
fall,O
with,O
intertrochanteric,B-PR
fracture,I-PR
.,O

As,O
per,O
CMED,O
CCU,O
",",O
pt,O
requires,O
emergent,B-TR
repair,I-TR
of,O
intertrochanteric,B-PR
fracture,I-PR
to,O
preserve,O
neurovascular,O
function,O
.,O

Pt,O
is,O
a,O
moderate,O
risk,O
for,O
a,B-TR
needed,I-TR
emergent,I-TR
non-cardiac,I-TR
procedure,I-TR
.,O

Pt,O
is,O
medically,O
cleared,O
for,O
procedure,B-TR

1.,O
Cards,O
:,O

---,O
No,O
real,O
utility,O
in,O
MIBI,B-TR
/,O
cath,B-TE
prior,O
to,O
procedure,B-TR
gien,O
previous,B-TE
caths,I-TE
with,O
no,O
significant,B-PR
lesions,I-PR
to,O
be,O
intervened,O
on,O
.,O

---,O
V-Tach,B-PR
:,O
pt,O
has,O
AICD,B-TR
in,O
place,O
",",O
however,O
b-blocker,B-TR
should,O
contorl,O
Vtach,B-PR
for,O
now,O
.,O

2.,O
COPD,B-PR
/,O
Restrictive,B-PR
lung,I-PR
disease,I-PR
:,O

3.,O
Hip,B-PR
fracture,I-PR
:,O

4.,O
Anemia,B-PR
:,O

5.,O
Hypokalemia,B-PR
:,O

---,O
60IV,B-TR
K,I-TR
now,O

6.,O
Cellulitis,B-PR
:,O

7.,O
DM,B-PR
:,O

8.,O
PPx,B-TR
:,O

---,O
Protonix,B-TR
",",O
Lovenox,B-TR
",",O
R,B-TR
boot,I-TR
as,O
per,O
CMED,O
CCU,O

9.,O
Diet,O
:,O

NPO,B-TR

10.,O
Code,O
:,O

Full,O
-->,O
DNR,O
/,O
DNI,O

CMED,O
course,O
:,O

ORIF,B-TR
with,O
repair,B-TR
of,O
neck,B-PR
fracture,I-PR
2016-03-23,O
.,O

Had,O
expected,O
prolonged,B-PR
post-op,I-PR
extubation,I-PR
in,O
PACU,O
given,O
COPD,B-PR
history,I-PR
",",O
as,O
with,O
colon,B-TR
CA,I-TR
resection,I-TR
surgery,I-TR
.,O

In,O
PM,O
extubated,O
",",O
transferred,O
to,O
floor,O
2016-03-23,O
.,O

Late,O
03-23,O
found,O
with,O
afib,B-PR
and,O
RVR,B-PR
",",O
given,O
beta,B-TR
blocker,I-TR
with,O
min.,O
response,O
",",O
started,O
dilt.,B-TR
drip,I-TR
.,O

Received,O
2,B-TR
mg,I-TR
dilaudid,I-TR
for,O
pain,B-PR
o/n,O
.,O

On,O
03-24,O
AM,O
p/w,O
with,O
respiratory,B-PR
failure,I-PR
",",O
continued,B-PR
tachycardia,I-PR
on,O
dilt.,B-TR
gtt.,I-TR

Transferred,O
to,O
unit,O
and,O
urgently,O
intubated,O
.,O

Of,O
note,O
",",O
there,O
was,O
a,O
question,O
of,O
misplaced,B-PR
NGT,I-PR
.,O

When,O
NGT,B-TR
tube,I-TR
was,O
pulled,O
out,O
",",O
it,O
was,O
noted,O
to,O
have,O
respiratory-like,O
secretions,O
.,O

Concern,O
for,O
aspiration,B-PR
of,O
mediations,B-TR
to,O
lungs,O
.,O

However,O
",",O
evaluation,O
of,O
CXR,B-TE
revealed,O
NGT,B-PR
coiled,I-PR
in,I-PR
esophagus,I-PR
.,O

Pt,B-PR
's,I-PR
respiratory,I-PR
distress,I-PR
is,O
most,O
likely,O
on,O
setting,O
of,O
aspiration,B-PR
pneumonia,I-PR
vs.,O
pneumonitis,B-PR
in,O
the,O
setting,O
of,O
depressed,B-PR
mental,I-PR
status,I-PR
secondary,O
to,O
post-operative,B-TR
narcotics,I-TR
.,O

Pt,O
was,O
pan-cultured,O
and,O
switched,O
from,O
unasyn,B-TR
(,O
started,O
at,O
OSH,O
for,O
foot,B-PR
ulcer,I-PR
),O
to,O
zosyn,B-TR
.,O

Vanco,B-TR
was,O
added,O
for,O
possible,O
nosocomial,B-PR
infection,I-PR
.,O

CTA,B-TE
was,O
performed,O
which,O
was,O
negative,O
for,O
PE,B-PR
",",O
but,O
revealed,O
bilateral,B-PR
patchy,I-PR
ground,I-PR
glass,I-PR
opacities,I-PR
c/w,O
aspiration,B-PR
vs.,O
pneumonia,B-PR
vs.,O
edema,B-PR
.,O

Pt,O
was,O
weaned,O
down,O
on,O
ventilator,B-TR
",",O
minimal,B-PR
secretions,I-PR
noted,O
.,O

On,O
03-27,O
",",O
pt,O
was,O
noted,O
to,O
have,O
depressed,B-PR
mental,I-PR
status,I-PR
off,O
all,B-TR
sedating,I-TR
medications,I-TR
;,O
mental,O
status,O
improved,O
over,O
the,O
course,O
of,O
the,O
day,O
.,O

Pt,O
was,O
diuresed,O
.,O

Atrial,B-PR
fibrillation,I-PR
was,O
rate-controlled,O
on,O
dilt,B-TR
drip,I-TR
.,O

Dilt,B-TR
drip,I-TR
was,O
discontinued,O
and,O
metoprolol,B-TR
titrated,O
up,O
.,O

Cardiac,B-TE
enzymes,I-TE
were,O
cycled,O
in,O
setting,O
of,O
rapid,B-PR
AF,I-PR
and,O
were,O
flat,O
.,O

Initially,O
",",O
pt,O
was,O
noted,O
to,O
be,O
dry,B-PR
with,O
low,B-PR
FeNa,I-PR
and,O
given,O
IVF,B-TR
.,O

Then,O
",",O
noted,O
to,O
be,O
volume,B-PR
overloaded,I-PR
and,O
diuresed,O
with,O
lasix,B-TR
.,O

Pt,O
had,O
depressed,B-PR
mental,I-PR
status,I-PR
on,O
transfer,O
to,O
CMED,O
in,O
setting,O
of,O
narcotics,B-TR
.,O

She,O
was,O
then,O
started,O
on,O
propofol,B-TR
while,O
intubated,B-TR
.,O

Head,B-TE
CT,I-TE
was,O
negative,O
for,O
acute,B-PR
bleed,I-PR
",",O
mass,B-PR
effect,I-PR
",",O
or,O
stroke,B-PR
.,O

Mental,O
status,O
improved,O
during,O
times,O
when,O
propofol,B-TR
was,O
held,O
.,O

On,O
03-27,O
",",O
pt,O
was,O
noted,O
to,O
have,O
significantly,B-PR
depressed,I-PR
M.S.,I-PR
off,O
propol,B-TR
improved,O
off,O
sedation,B-TR
.,O

All,B-TR
sedating,I-TR
medications,I-TR
including,O
prn,B-TR
narcotics,I-TR
were,O
held,O
and,O
mental,O
status,O
cleared,O
somewhat,O
.,O

s/p,O
hip,B-TR
fx,I-TR
repair,I-TR
:,O
started,O
on,O
lovenox,B-TR
for,O
anti-coagulation,B-TR
.,O

Given,O
standing,B-TR
NSAID,I-TR
",",O
tylenol,B-TR
for,O
pain,B-TR
control,I-TR
.,O

opiates,B-TR
used,O
very,O
sparingly,O
in,O
setting,O
of,O
MS,B-PR
change,I-PR

On,O
transfer,O
to,O
floor,O
team,O
from,O
CMED,O
active,O
issues,O
and,O
plan,O
included,O
:,O

Resp,B-PR
failure,I-PR
/,O
COPD,B-PR
:,O

Initially,O
got,O
steroids,B-TR
upon,O
intubation,B-TR
.,O

Off,O
for,O
days,O
now,O
.,O

Extubated,O
on,O
03-31,O
.,O

Still,O
tachypneic,B-PR
and,O
hypoxic,B-PR
on,O
room,O
air,O
.,O

Lung,O
sounds,O
fairly,O
clear,O
.,O

?,O
COPD,B-PR
vs,O
atelectasis,B-PR
as,O
cause,O
of,O
hypoxia,B-PR
.,O

On,O
Blake,O
",",O
Nancy,O
pe,O
less,O
likely,O

-,O
atrovent,B-TR
standing,O
.,O

prn,O
albuterol,B-TR
only,O
given,O
A,B-PR
fib,I-PR
with,O
RVR,B-PR

Fever,B-PR
:,O

In,O
the,O
ICU,O
.,O

Had,O
received,O
unasyn,B-TR
",",O
vanc,B-TR
",",O
zosyn,B-TR
during,O
hospital,O
course,O
for,O
cellulitis,B-PR
and,O
other,O
unclear,O
reasons,O
",",O
including,O
possible,O
vent,B-PR
associated,I-PR
pna,I-PR
.,O

No,O
true,O
source,O
found,O
.,O

Afebrile,B-PR
>,O
24,O
hours,O
off,O
abx,B-TR
.,O

-,O
culture,B-TE
if,O
spikes,O
.,O

No,O
abx,B-TR
unless,O
source,O
found,O

a.fib,B-PR
with,O
RVR,B-PR
-,O
Has,O
ppm,B-TR
",",O
so,O
can,O
have,O
lot,O
of,O
nodal,B-TR
agents,I-TR
.,O

Now,O
rate,O
controlled,O
on,O
metop,B-TR
125,O
tid,O
and,O
dilt,B-TR
.,O

30,O
QID,O
.,O

Titrate,O
prn,O
.,O

CAD,B-PR
:,O
on,O
asa,B-TR
",",O
b,B-TR
blocker,I-TR
",",O
ace,B-TR
.,O

No,O
statin,B-TR
.,O

need,O
to,O
clear,O
with,O
family,O

Heme,O
-,O
anemic,B-PR
.,O

Unclear,O
baseline,O
.,O

Possible,O
anemia,B-PR
03-02,O
operative,B-PR
blood,I-PR
loss,I-PR
.,O

Follow,O
hct,B-TE
daily,O
Goal,O
>,O
28,O

Neck,O
:,O
never,O
had,O
c,O
spine,O
cleared,O
by,O
neurosurg,O
.,O

Had,O
fall,O
pta,O
with,O
?,O
fx,B-PR
on,O
initial,B-TE
CT,I-TE
",",O
neg,O
fx,B-PR
on,O
f/u,B-TE
ct,I-TE
.,O

Overnight,O
on,O
pt,O
's,O
first,O
evening,O
on,O
the,O
floor,O
",",O
she,O
had,O
episode,O
of,O
desaturation,B-PR
with,O
inc,B-PR
O2,I-PR
requirement,I-PR
(,O
4L,O
->,O
6L,O
->,O
sating,B-TE
91%,O
on,O
NRB,B-TR
),O
-,O
CXR,B-TE
with,O
worsening,B-PR
-,O
non,O
responsive,O
to,O
lasix,B-TR
.,O

Family,O
meeting,O
held,O
and,O
pt,O
made,O
clear,O
wishes,O
after,O
extubation,B-TR
that,O
she,O
does,O
not,O
want,O
to,O
be,O
intubated,O
again,O
and,O
made,O
DNR,B-TR
/,O
DNI,B-TR
.,O

No,O
BIPAP,B-TR
.,O

Now,O
pt,O
lethargic,B-PR
and,O
min,B-PR
responsive,I-PR
.,O

All,O
four,O
children,O
in,O
pts,O
room,O
and,O
agree,O
on,O
CMO,B-TR
-,O
want,O
to,O
d/c,O
c-collar,B-TR
and,O
start,O
morphine,B-TR
ggt,I-TR
.,O

Discussed,O
with,O
night,O
float,O
cover,O
Dr.,O
Dennis,O
COmmander,O
and,O
Dr.,O
Mike,O
French,O
.,O

Although,O
Dr.,O
Ray,O
will,O
be,O
covering,O
pt,O
today,O
",",O
Dr.,O
Stephanie,O
Wilson,O
spoke,O
with,O
family,O
this,O
morning,O
and,O
has,O
noted,O
that,O
pt,O
is,O
CMO,B-TR
.,O

EP,O
was,O
called,O
to,O
deactivate,O
pt,O
dual,B-TR
chamber,I-TR
ICD,I-TR
as,O
per,O
family,O
wishes,O
.,O

On,O
exam,B-TE
",",O
pt,O
lethargic,B-PR
",",O
responsive,O
to,O
pain,B-PR
but,O
not,O
voice,O
",",O
with,O
NRB,B-TR
in,O
place,O
;,O
obvious,B-PR
inc,I-PR
wob,I-PR
.,O

IV,B-TR
in,I-TR
R,I-TR
foot,I-TR
for,O
access,O
.,O

Family,O
at,O
bedside,O
.,O

afebrile,B-PR
;,O

BP,B-TE
:,O
159-161-139-98,O
(,O
after,O
morphine,B-TR
)/,O
69,O
HR,B-TE
:,O
148,O
-->,O
88,O
;,O
rr,B-TE
:,O
28-40,O
O2,B-TE
:,O
94%,O
NRB,B-TR

As,O
above,O
",",O
made,O
CMO,B-TR
after,O
meeting,O
with,O
NF,O
team,O
and,O
family,O
and,O
reconfirmed,O
with,O
primary,O
medical,O
team,O
on,O
04-02,O
.,O

Start,O
morphine,B-TR
ggt,I-TR
and,O
titrate,O
to,O
comfort,O
.,O

D/c,O
'ed,O
all,B-TE
lab,I-TE
draws,I-TE
/,O
vitals,B-TE
.,O

Prn,B-TR
nebs,I-TR
for,O
comfort,O
.,O

Family,O
at,O
bedside,O
and,O
aware,O
and,O
in,O
agreement,O
of,O
plan,O
.,O

Morhpine,B-TR
ggt,I-TR
titrated,O
up,O
to,O
18,O
mg,O
/,O
hr,O
by,O
monday,O
morning,O
and,O
pt,O
expired,O
04-04,O
at,O
7:40,O
am,O
.,O

Medications,O
on,O
Admission,O
:,O

MEDICATION,O
:,O

1.,O
Coumadin,B-TR
2,O
mg,O
once,O
daily,O
(,O
stopped,O
recently,O
due,O
to,O
risk,O
of,O
GI,B-PR
bleed,I-PR
),O

2.,O
Zoloft,B-TR
100,O
mg,O
once,O
daily,O

3.,O
Toprol,B-TR
100,O
mg,O
BID,O

4.,O
Lasix,B-TR
40,O
mg,O
BID,O

5.,O
AS,B-TR
81,O
mg,O
once,O
daily,O

6.,O
Plavix,B-TR
75,O
mg,O
once,O
daily,O

7.,O
KCl,B-TR
40,O
mEq,O
once,O
daily,O

8.,O
Prandin,B-TR
0.5,O
mg,O
once,O
daily,O

9.,O
Unasyn,B-TR
3,O
gIV,O
Q8hours,O

ALLERGIES,O
:,O

Morphine,B-TR
->,O
confusion,B-PR
/,O
delerium,B-PR
.,O

Discharge,O
Disposition,O
:,O

Expired,O

Discharge,O
Diagnosis,O
:,O
n/a,O

Discharge,O
Condition,O
:,O
n/a,O

Discharge,O
Instructions,O
:,O
n/a,O

Followup,O
Instructions,O
:,O
n/a,O

Ruby,O
Eric,O
MD,O
73-490,O

Completed,O
by,O
:,O
Verna,O
Richard,O
MD,O
01-822,O
2016-04-04,O
@,O
2005,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Brandon,O
Mangum,O
on,O
:,O
WED,O
2016-04-13,O
3:17,O
PM,O

(,O
End,O
of,O
Report,O
),O

478767824,O

OMH,O

1644158,O

248222,O

4/27/1998,O
12:00:00,O
AM,O

ADULT,B-PR
RESPIRATORY,I-PR
DISTRESS,I-PR
SYNDROME,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

WYNDEALB,O
",",O
AUALE,O

UNIT,O
NUMBER,O
:,O

309-82-41,O

ADMISSION,O
DATE,O
:,O

04/27/1998,O

DISCHARGE,O
DATE,O
:,O

05/02/1998,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

adult,B-PR
respiratory,I-PR
distress,I-PR
syndrome,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

acute,B-PR
renal,I-PR
insufficiency,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
72,O
year,O
old,O
white,O
male,O
with,O
a,O
history,O
of,O
coronary,B-PR
artery,I-PR
disease,I-PR
",",O
status,O
post,O
a,B-TR
four,I-TR
vessel,I-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
in,O
1983,O
",",O
pulmonary,B-PR
hypertension,I-PR
",",O
hepatitis,B-PR
C,I-PR
positive,O
cirrhosis,B-PR
history,O
with,O
history,O
of,O
portal,B-PR
hypertension,I-PR
and,O
status,O
post,O
an,B-PR
upper,I-PR
gastrointestinal,I-PR
bleed,I-PR
on,O
4-10-98,O
",",O
who,O
presents,O
from,O
Sondi,O
Memorial,O
for,O
work,B-TE
up,I-TE
of,O
pulmonary,B-PR
infiltrates,I-PR
",",O
acute,B-PR
renal,I-PR
failure,I-PR
and,O
pulmonary,B-PR
hypertension,I-PR
.,O

The,O
patient,O
presented,O
to,O
Sondi,O
Memorial,O
on,O
4-10-98,O
with,O
fatigue,B-PR
and,O
fall,O
",",O
found,O
to,O
have,O
a,B-TE
hematocrit,I-TE
of,O
29,O
",",O
baseline,O
37,O
.,O

The,O
patient,O
was,O
transfused,O
two,B-TR
units,I-TR
and,O
an,B-TE
esophagogastroduodenoscopy,I-TE
done,O
where,O
it,O
showed,O
gastritis,B-PR
",",O
candidal,B-PR
esophagitis,I-PR
and,O
portal,B-PR
hypertensive,I-PR
gastropathy,I-PR
without,O
varices,B-PR
.,O

A,B-TE
colonoscopy,I-TE
showed,O
anteriordysplasia,B-PR
",",O
no,O
bleeding,B-PR
was,O
seen,O
.,O

The,O
patient,O
was,O
discharged,O
after,O
one,O
week,O
on,O
iron,B-TR
sulfate,I-TR
.,O

On,O
4-24,O
",",O
the,O
patient,O
was,O
seen,O
again,O
at,O
Sondi,O
Memorial,O
when,O
he,O
experienced,O
at,O
home,O
a,O
fall,O
",",O
no,O
loss,B-PR
of,I-PR
consciousness,I-PR
",",O
positive,O
substernal,B-PR
chest,I-PR
pain,I-PR
",",O
pleuritic,B-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
and,O
cough,B-PR
.,O

He,O
went,O
to,O
Sondi,O
Memorial,O
where,O
he,O
ruled,O
out,O
for,O
myocardial,B-PR
infarction,I-PR
and,O
was,O
found,O
to,O
have,O
a,B-PR
left,I-PR
lower,I-PR
lobe,I-PR
infiltrate,I-PR
/,O
pneumonia,B-PR
",",O
started,O
on,O
cefuroxime,B-TR
.,O

His,O
respiratory,O
condition,O
continued,O
to,O
deteriorate,O
despite,O
aggressive,B-TR
chest,I-TR
physical,I-TR
therapy,I-TR
for,O
possible,O
blood,O
",",O
given,O
Lasix,B-TR
for,O
congestive,B-PR
heart,I-PR
failure,I-PR
",",O
became,O
hypotensive,B-PR
",",O
hypoxic,B-PR
and,O
intubated,B-TR
.,O

The,O
patient,O
was,O
found,O
to,O
have,O
expanding,B-PR
pulmonary,I-PR
infiltrates,I-PR
on,O
chest,B-TE
x-ray,I-TE
",",O
developed,O
acute,B-PR
renal,I-PR
insufficiency,I-PR
with,O
minimal,B-PR
urine,I-PR
output,I-PR
",",O
less,O
than,O
10,O
cc,O
an,O
hour,O
",",O
started,O
on,O
dopamine,B-TR
for,O
hemodynamic,B-PR
instability,I-PR
.,O

An,B-TE
echocardiogram,I-TE
was,O
obtained,O
on,O
4-26,O
which,O
showed,O
concentric,B-PR
left,I-PR
ventricular,I-PR
hypertrophy,I-PR
with,O
normal,O
_____,O
left,O
ventricular,O
function,O
",",O
severe,B-PR
right,I-PR
ventricular,I-PR
dilatation,I-PR
with,O
septal,B-PR
hypokinesis,I-PR
and,I-PR
flattening,I-PR
with,O
a,O
question,O
of,O
right,B-PR
ventricular,I-PR
apical,I-PR
clot,I-PR
raised,O
with,O
mild,B-PR
aortic,I-PR
stenosis,I-PR
",",O
severe,B-PR
tricuspid,I-PR
regurgitation,I-PR
and,O
increased,B-PR
pulmonary,I-PR
artery,I-PR
pressure,I-PR
of,O
approximately,O
70,O
millimeters,O
",",O
consistent,O
with,O
fairly,B-PR
severe,I-PR
pulmonary,I-PR
hypertension,I-PR
.,O

Blood,B-TE
cultures,I-TE
x,O
two,O
sent,O
off,O
with,O
no,O
growth,B-PR
.,O

The,O
patient,O
ruled,O
out,O
for,O
myocardial,B-PR
infarction,I-PR
with,O
flat,O
creatine,B-TE
kinases,I-TE
and,O
he,O
was,O
sent,O
to,O
Oaksgekesser/,O
Memorial,O
Hospital,O
for,O
further,B-TE
work,I-TE
up,I-TE
.,O

HOSPITAL,O
COURSE,O
AND,O
TREATMENT,O
:,O

At,O
the,O
Oaksgekesser/,O
Memorial,O
Hospital,O
he,O
was,O
quite,B-PR
hypotensive,I-PR
",",O
requiring,O
dopamine,B-TR
at,O
"1,000",O
",",O
Levo,B-TR
at,O
12,O
.,O

His,B-TE
chest,I-TE
x-ray,I-TE
showed,O
diffuse,B-PR
patchy,I-PR
infiltrates,I-PR
on,I-PR
left,I-PR
lung,I-PR
with,O
left,B-PR
upper,I-PR
lung,I-PR
patchy,I-PR
infiltrates,I-PR
and,O
right,B-PR
hemidiaphragm,I-PR
elevated,I-PR
",",O
consistent,O
with,O
adult,B-PR
respiratory,I-PR
distress,I-PR
syndrome,I-PR
from,O
possible,O
pneumonia,B-PR
.,O

A,B-TE
urinalysis,I-TE
was,O
obtained,O
which,O
showed,O
blood,B-PR
",",O
urine,B-PR
sediment,I-PR
was,O
active,B-PR
with,O
positive,O
dysmorphic,B-PR
cells,I-PR
",",O
red,B-PR
cell,I-PR
casts,I-PR
",",O
and,O
1+,B-PR
albumin,I-PR
with,O
mild,B-PR
protein,I-PR
uria,I-PR
.,O

The,O
patient,O
had,O
ANCA,B-TE
",",O
anti-GBM,B-TE
",",O
anti-streptolycin,B-TE
",",O
ANA,B-TE
",",O
UPEP,B-TE
",",O
SPEP,B-TE
",",O
renal,B-TE
ultrasound,I-TE
",",O
hepatitis,B-TE
C,I-TE
cryoglobulin,I-TE
sent,O
out,O
.,O

He,O
had,O
a,B-TE
bronchoscopy,I-TE
immediately,O
done,O
which,O
showed,O
no,O
fresh,B-PR
blood,I-PR
",",O
just,O
old,B-PR
clot,I-PR
and,O
a,B-TR
pulmonary,I-TR
arterial,I-TR
line,I-TR
placed,O
in,O
the,O
right,O
internal,O
jugular,O
vein,O
.,O

Question,O
of,O
pulmonary-renal,B-PR
syndrome,I-PR
was,O
raised,O
.,O

The,O
patient,O
subsequently,O
deteriorated,O
over,O
time,O
",",O
was,O
started,O
on,O
CVVH,B-TR
and,O
suffered,O
significant,B-PR
complications,I-PR
without,O
improvement,O
of,O
his,O
pulmonary,O
/,O
renal,O
situation,O
.,O

A,O
family,O
meeting,O
was,O
held,O
on,O
5-2-98,O
and,O
it,O
was,O
decided,O
that,O
the,O
patient,O
should,O
be,O
made,O
comfort,B-TR
care,I-TR
only,O
.,O

All,O
CVVH,B-TR
and,O
the,B-TR
ventilator,I-TR
was,O
removed,O
and,O
the,O
patient,O
spontaneously,O
passed,O
away,O
on,O
5-2-98,O
",",O
at,O
4:55,O
p.m.,O

Family,O
and,O
primary,O
carephysician,O
informed,O
.,O

________________________,O
SONRIELA,O
RED,O
",",O
M.D.,O

TR,O
:,O

xbr,O

DD,O
:,O

07/12/1998,O

TD,O
:,O

07/27/1998,O
12:36,O

Pcc,O
:,O

Admission,O
Date,O
:,O

2011-10-17,O

Discharge,O
Date,O
:,O

2011-10-31,O

Date,O
of,O
Birth,O
:,O

1955-09-01,O

Sex,O
:,O

M,O

Service,O
:,O

Cardiothor,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
56,O
year-old,O
gentleman,O
with,O
severe,B-PR
aortic,I-PR
stenosis,I-PR
",",O
reports,O
having,O
been,O
told,O
he,O
had,O
a,B-PR
heart,I-PR
murmur,I-PR
many,O
years,O
ago,O
but,O
just,O
recently,O
diagnosed,O
with,O
aortic,B-PR
stenosis,I-PR
.,O

He,O
has,O
had,O
mild,B-PR
dyspnea,I-PR
on,O
exertion,O
increasing,O
over,O
the,O
past,O
couple,O
of,O
months,O
prior,O
to,O
admission,O
.,O

An,B-TE
echocardiogram,I-TE
in,O
2011-09-05,O
revealed,O
a,B-TE
left,I-TE
ventricular,I-TE
ejection,I-TE
fraction,I-TE
of,O
20,O
to,O
25%,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Cigarette,O
smoking,O
.,O

2.,O
Insulin,B-PR
dependent,I-PR
diabetes,I-PR
mellitus,I-PR
.,O

3.,O
Proteinuria,B-PR
.,O

4.,O
Aortic,B-PR
stenosis,I-PR
.,O

5.,O
Cellulitis,B-PR
.,O

6.,O
Gangrene,B-PR
of,I-PR
his,I-PR
left,I-PR
second,I-PR
toe,I-PR
in,O
2010-06-06,O
followed,O
by,O
an,B-TR
amputation,I-TR
.,O

7.,O
Left,B-TR
common,I-TR
femoral,I-TR
dorsalis,I-TR
pedis,I-TR
bypass,I-TR
graft,I-TR
.,O

8.,O
Right,B-TR
leg,I-TR
bypass,I-TR
graft,I-TR
in,O
1999,O
.,O

9.,O
Right,B-TR
below,I-TR
the,I-TR
knee,I-TR
amputation,I-TR
in,O
2008,O
.,O

ALLERGIES,O
:,O

The,O
patient,O
states,O
he,O
has,O
no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

MEDICATIONS,O
:,O

1.,O
Aspirin,B-TR
325,O
mg,O
po,O
q,O
day,O
.,O

2.,O
Vasotec,B-TR
7.5,O
mg,O
po,O
q,O
day,O
.,O

3.,O
Humalog,B-TR
insulin,I-TR
sliding,I-TR
scale,I-TR
with,O
meals,O
and,O
at,O
bedtime,O
.,O

4.,O
Humulin,B-TR
Walters,I-TR
insulin,I-TR
24,O
units,O
subcutaneous,O
q,O
A.M.,O
and,O
8,O
to,O
16,O
in,O
the,O
evening,O
depending,O
upon,O
where,O
his,B-TE
blood,I-TE
sugar,I-TE
has,O
been,O
.,O

Preoperative,B-TE
laboratory,I-TE
values,I-TE
were,O
unremarkable,O
.,O

The,O
patient,O
underwent,O
cardiac,B-TE
catheterization,I-TE
on,O
2011-10-17,O
which,O
revealed,O
a,B-PR
20%,I-PR
left,I-PR
vein,I-PR
osteal,I-PR
lesion,I-PR
as,O
well,O
as,O
70%,B-PR
LAD,I-PR
lesion,I-PR
and,O
an,B-PR
80%,I-PR
right,I-PR
coronary,I-PR
.,O

The,O
patient,O
was,O
taken,O
to,O
the,O
operating,O
room,O
on,O
2011-10-18,O
where,O
he,O
underwent,O
an,B-TR
aortic,I-TR
valve,I-TR
replacement,I-TR
with,O
#23,B-TR
mm,I-TR
pericardial,I-TR
valve,I-TR
as,O
well,O
as,O
coronary,B-TR
artery,I-TR
bypass,I-TR
graft,I-TR
times,O
two,O
with,O
a,O
LIMA,O
to,O
the,O
LAD,O
and,O
saphenous,O
vein,O
to,O
the,O
acute,O
marginal,O
.,O

Postoperatively,O
the,O
patient,O
was,O
transported,O
to,O
the,O
cardiac,O
surgery,O
recovery,O
unit,O
on,O
Milrinone,B-TR
",",O
Neo-Synephrine,B-TR
and,O
Levophed,B-TR
drip,I-TR
.,O

The,O
patient,O
was,O
weaned,O
from,O
mechanical,B-TR
ventilation,I-TR
and,O
subsequently,O
extubated,O
on,O
the,O
night,O
of,O
surgery,B-TR
.,O

He,O
remained,O
on,O
Levophed,B-TR
",",O
Milrinone,B-TR
and,O
Neo-Synephrine,B-TR
drips,I-TR
and,O
was,O
hemodynamically,O
stable,O
.,O

N.,O
Saez,O
clinic,O
consult,O
was,O
obtained,O
due,O
to,O
hyperglycemia,B-PR
and,O
the,O
need,O
for,O
insulin,B-TR
drip,I-TR
in,O
the,O
Intensive,O
Care,O
Unit,O
.,O

On,O
postoperative,O
day,O
the,B-TR
Milrinone,I-TR
was,O
weaned,O
down,O
.,O

The,B-TR
Levophed,I-TR
had,O
been,O
discontinued,O
as,O
the,B-TR
Neo-Synephrine,I-TR
and,O
the,O
patient,O
was,O
beginning,O
to,O
progress,O
hemodynamically,O
.,O

Upon,O
discontinuation,O
of,O
the,B-TR
Milrinone,I-TR
the,B-TE
patient,I-TE
's,I-TE
SV02,I-TE
had,O
dropped,O
significantly,O
in,O
the,O
low,O
50,O
s.,O

The,O
patient,O
had,O
decreased,B-PR
exercise,I-PR
tolerance,I-PR
and,O
therefore,O
was,O
placed,O
back,O
on,O
his,B-TR
milrinone,I-TR
to,O
keep,O
his,B-TE
cardiac,I-TE
index,I-TE
greater,O
than,O
2.0,O
.,O

Over,O
the,O
next,O
couple,O
of,O
days,O
it,O
was,O
very,O
slowly,O
decreased,O
as,O
his,B-TR
Ace,I-TR
inhibitors,I-TR
were,O
increased,O
orally,O
.,O

The,O
patient,O
ultimately,O
was,O
weaned,O
off,O
the,B-TR
Milrinone,I-TR
",",O
transitioned,O
to,O
Captopril,B-TR
on,O
postoperative,O
day,O
five,O
and,O
remained,O
hemodynamically,O
stable,O
.,O

Once,O
the,O
patient,O
had,O
remained,O
off,O
of,O
inotropics,B-TR
for,O
approximately,O
24,O
hours,O
",",O
he,O
had,O
been,O
given,O
diuretics,B-TR
and,O
Ace,B-TR
inhibitors,I-TR
and,O
remained,O
hemodynamically,O
stable,O
he,O
was,O
transferred,O
from,O
the,O
Intensive,O
Care,O
Unit,O
to,O
the,O
Telemetry,O
floor,O
on,O
postoperative,O
day,O
six,O
.,O

A,B-TE
physical,I-TE
therapy,I-TE
evaluation,I-TE
was,O
obtained,O
for,O
assistance,O
and,O
mobility,O
.,O

Cardiac,B-TR
rehabilitation,I-TR
was,O
initiated,O
at,O
that,O
time,O
.,O

On,O
2011-10-24,O
postoperative,O
day,O
six,O
consultation,O
heart,O
failure,O
cardiology,O
service,O
was,O
obtained,O
.,O

It,O
was,O
their,O
recommendation,O
to,O
continue,O
Ace,B-TR
inhibitors,I-TR
",",O
to,O
continue,O
daily,B-TE
weights,I-TE
",",O
to,O
switch,O
the,O
patient,O
to,O
a,B-TR
long,I-TR
acting,I-TR
beta-blocker,I-TR
and,O
to,O
enroll,O
the,O
patient,O
in,O
postoperative,B-TR
cardiac,I-TR
rehabilitation,I-TR
as,O
well,O
as,O
to,O
make,O
sure,O
the,O
patient,O
was,O
on,O
statin,B-TR
drugs,I-TR
.,O

These,O
measures,O
were,O
all,O
instituted,O
.,O

The,O
patient,O
continued,O
to,O
progress,O
from,O
cardiac,O
rehabilitation,O
and,O
physical,O
therapy,O
standpoint,O
while,O
on,O
the,O
floor,O
.,O

The,O
patient,O
remained,O
hemodynamically,O
stable,O
over,O
the,O
next,O
few,O
days,O
",",O
continued,O
to,O
increase,O
with,O
physical,B-TR
therapy,I-TR
and,O
ambulation,O
.,O

His,B-TE
blood,I-TE
sugars,I-TE
were,O
followed,O
by,O
the,O
Cape,O
Cod,O
Hospital,O
Clinic,O
service,O
and,O
insulin,B-TR
has,O
been,O
adjusted,O
accordingly,O
.,O

Today,O
",",O
2011-10-31,O
",",O
postoperative,O
day,O
13,O
the,O
patient,O
remains,O
stable,O
and,O
ready,O
for,O
discharge,O
to,O
home,O
.,O

The,O
patient,O
's,O
condition,O
today,O
is,O
as,O
follows,O
:,O

Temperature,B-TE
96.9,O
F,O
",",O
pulse,B-TE
84,O
",",O
respiratory,B-TE
rate,I-TE
18,O
",",O
blood,B-TE
pressure,I-TE
106/59,O
.,O

Most,B-TE
recent,I-TE
laboratory,I-TE
values,I-TE
are,O
from,O
2011-10-25,O
which,O
revealed,O
a,B-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
8.4000,O
",",O
hematocrit,B-TE
35,O
",",O
platelet,B-TE
count,I-TE
"202,000.",O
Sodium,B-TE
133,O
",",O
potassium,B-TE
4.4,O
",",O
chloride,B-TE
93,O
",",O
CO2,B-TE
30,O
",",O
BUN,B-TE
24,O
",",O
creatinine,B-TE
0.7,O
",",O
glucose,B-TE
198,O
.,O

The,B-TE
patient,I-TE
's,I-TE
finger,I-TE
stick,I-TE
blood,I-TE
glucose,I-TE
levels,I-TE
range,O
from,O
151,O
to,O
390,O
over,O
the,O
past,O
24,O
hours,O
and,O
his,B-TR
insulin,I-TR
scale,I-TR
has,O
been,O
adjusted,O
upward,O
to,O
compensate,O
for,O
that,O
.,O

Neurologically,O
the,O
patient,O
is,O
grossly,O
intact,O
.,O

Pulmonary,B-TE
exam,I-TE
he,O
is,O
clear,O
upper,O
lobes,O
",",O
diminished,B-PR
bilateral,I-PR
bases,I-PR
left,O
greater,O
than,O
right,O
.,O

Coronary,B-TE
exam,I-TE
is,O
regular,O
rate,O
and,O
rhythm,O
.,O

His,O
abdomen,O
is,O
benign,O
.,O

His,O
sternum,O
is,O
stable.,O
His,B-PR
incision,I-PR
is,O
clean,O
and,O
dry,O
Steri,B-TR
Strips,I-TR
intact,O
.,O

His,O
extremities,O
are,O
warm,O
and,O
well,O
perfused,O
with,O
minimal,B-PR
edema,I-PR
of,I-PR
his,I-PR
left,I-PR
foot,I-PR
as,O
well,O
as,O
his,O
right,O
stump,O
.,O

He,O
is,O
able,O
to,O
apply,O
his,B-TR
prosthesis,I-TR
and,O
ambulate,O
as,O
well,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Lasix,B-TR
40,O
mg,O
po,O
bid,O
.,O

2.,O
Potassium,B-TR
Chloride,I-TR
20,O
milliequivalents,O
po,O
bid,O
.,O

3.,O
Colace,B-TR
100,O
mg,O
po,O
bid,O
.,O

4.,O
Zantac,B-TR
150,O
mg,O
po,O
bid,O
.,O

5.,O
Aspirin,B-TR
325,O
mg,O
po,O
qd,O
.,O

6.,O
Captopril,B-TR
25,O
mg,O
po,O
tid,O
.,O

7.,O
Digoxin,B-TR
0.25,O
mg,O
po,O
q,O
day,O
.,O

8.,O
Atorvastatin,B-TR
10,O
mg,O
po,O
q,O
day,O
.,O

9.,O
Toprol,B-TR
XL,I-TR
100,O
mg,O
po,O
q,O
day,O
.,O

10.,O
Bollin,B-TR
insulin,I-TR
18,O
units,O
subcutaneous,O
q,O
A.M.,O
",",O
Richard,B-TR
insulin,I-TR
14,O
units,O
subcutaneous,O
q,O
P.M.,O

11.,O
Sliding,B-TR
scale,I-TR
Humalog,I-TR
regular,I-TR
insulin,I-TR
for,O
breakfast,O
is,O
blood,B-TE
glucose,I-TE
of,O
151,O
to,O
200,O
equal,O
4,O
units,O
",",O
201,O
to,O
250,O
equal,O
6,O
units,O
",",O
251,O
to,O
350,O
equal,O
12,O
units,O
",",O
greater,O
than,O
350,O
equals,O
15,O
units,O
.,O

For,O
lunch,O
blood,B-TE
glucose,I-TE
of,O
101,O
to,O
150,O
equals,O
4,O
units,O
",",O
151,O
to,O
200,O
equals,O
7,O
units,O
",",O
201,O
to,O
250,O
equals,O
8,O
units,O
",",O
251,O
to,O
350,O
equals,O
12,O
units,O
",",O
greater,O
than,O
350,O
equals,O
15,O
units,O
.,O

Dinner,O
blood,B-TE
glucose,I-TE
101,O
to,O
150,O
equals,O
2,O
units,O
",",O
151,O
to,O
200,O
equals,O
3,O
units,O
",",O
201,O
to,O
250,O
equals,O
6,O
units,O
",",O
251,O
to,O
350,O
equals,O
12,O
units,O
",",O
greater,O
than,O
350,O
equals,O
15,O
units,O
.,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

1.,O
Aortic,B-PR
stenosis,I-PR
.,O

2.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
.,O

3.,O
Type,B-PR
I,I-PR
diabetes,I-PR
mellitus,I-PR
.,O

4.,O
Peripheral,B-PR
vascular,I-PR
disease,I-PR
.,O

FOLLOW,O
UP,O
:,O

Dr.,O
Lloyd,O
van,O
de,O
Clark,O
in,O
approximately,O
one,O
month,O
postoperative,O
.,O

Please,O
call,O
the,O
office,O
at,O
(,O
854,O
),O
787-3243,O
for,O
an,O
appointment,O
.,O

The,O
patient,O
is,O
also,O
to,O
follow,O
up,O
with,O
his,O
primary,O
care,O
physician,O
for,O
diabetes,B-TR
management,I-TR
.,O

He,O
is,O
to,O
follow,O
up,O
with,O
Dr.,O
East,O
here,O
at,O
the,O
Heart,O
Failure,O
Clinic,O
to,O
continue,O
follow,O
up,O
with,O
cardiac,B-TR
rehabilitation,I-TR
and,O
heart,B-TR
failure,I-TR
management,I-TR
.,O

Brown,O
des,O
Stone,O
",",O
M.D.,O

07-760,O

Dictated,O
By,O
:,O
Anthony,O
O,O
Carreno,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2011-10-31,O
10:25,O

T,O
:,O
2011-10-31,O
10:45,O

JOB,O
#:,O
02527,O

Signed,O
electronically,O
by,O
:,O
DR.,O
John,O
della,O
Hopper,O
on,O
:,O
WED,O
2011-11-16,O
7:16,O
PM,O

(,O
End,O
of,O
Report,O
),O

487110437,O

TGCHO,O

1128447,O

662727,O

10/15/1999,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Report,O
Status,O
:,O

Signed,O

DISCHARGE,O
SUMMARY,O
NAME,O
:,O

FACTOR,O
",",O
REBEM,O

UNIT,O
NUMBER,O
:,O

333-33-75,O

ADMISSION,O
DATE,O
:,O

10/15/1999,O

DISCHARGE,O
DATE,O
:,O

10/18/1999,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Acute,B-PR
inferior,I-PR
myocardial,I-PR
infarction,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

Hypertension,B-PR
.,O

Gout,B-PR
.,O

SPECIAL,O
PROCEDURES,O
AND,O
OPERATIONS,O
:,O

Stent,B-TR
placement,I-TR
of,I-TR
the,I-TR
RCA,I-TR
on,O
October,O
15,O
",",O
1999,O
.,O

OTHER,O
PROCEDURES,O
:,O

Right,B-TE
heart,I-TE
catheterization,I-TE
and,O
coronary,B-TE
angiography,I-TE
on,O
October,O
15,O
",",O
1999,O
.,O

DOCTOR,O
&apos;,O
S,O
DISCHARGE,O
ORDERS,O
:,O

Aspirin,B-TR
325,O
mg.,O
qday,O
.,O

Plavix,B-TR
75,O
mg.,O
qday,O
for,O
four,O
weeks,O
.,O

Atenolol,B-TR
50,O
mg.,O
qday,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Mr.,O
Factor,O
is,O
a,O
76,O
year,O
old,O
white,O
male,O
with,O
acute,B-PR
inferior,I-PR
myocardial,I-PR
infarction,I-PR
",",O
who,O
was,O
urgently,O
transferred,O
by,O
Dr.,O
Lenni,O
Factor,O
for,O
cardiac,B-TE
catheterization,I-TE
and,O
possible,O
angioplasty,B-TR
.,O

His,O
only,O
cardiac,O
risk,O
factor,O
includes,O
hypertension,B-PR
.,O

The,O
night,O
of,O
Oct,O
14,O
",",O
1999,O
the,O
patient,O
developed,O
chest,B-PR
discomfort,I-PR
associated,O
with,O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

On,O
October,O
15,O
",",O
1999,O
at,O
6,O
AM,O
the,O
patient,O
was,O
admitted,O
to,O
No,O
Verlmerver,O
Medical,O
Center,O
.,O

An,B-TE
electrocardiogram,I-TE
showed,O
acute,B-PR
inferior,I-PR
myocardial,I-PR
infarction,I-PR
.,O

Due,O
to,O
unknown,O
duration,O
of,O
the,B-PR
chest,I-PR
pain,I-PR
the,O
patient,O
wastransferred,O
urgently,O
to,O
the,O
TGCHO,O
for,O
cardiac,B-TE
catheterization,I-TE
.,O

Shortly,O
after,O
Aggrastat,B-TR
was,O
started,O
",",O
the,O
patient,O
became,O
pain,B-PR
free,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Hypertension,B-PR
and,O
gout,B-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Blood,B-TE
pressure,I-TE
115/77,O
.,O

The,B-TE
heart,I-TE
rate,I-TE
64,O
.,O

JVP,B-TE
6,O
cm,O
.,O

H20,O
.,O

Carotid,B-TE
upstroke,I-TE
was,O
normal,O
.,O

There,O
was,O
an,B-PR
S4,I-PR
.,O

The,O
lungs,O
were,O
clear,O
.,O

Abdomen,O
was,O
benign,O
.,O

Femoral,B-TE
and,I-TE
distal,I-TE
pulses,I-TE
were,O
full,O
.,O

There,O
was,O
no,O
pedaledema,B-PR
.,O

The,B-TE
neurological,I-TE
examination,I-TE
was,O
nonfocal,O
.,O

The,B-TE
electrocardiogram,I-TE
normal,O
sinus,O
rhythm,O
at,O
62,O
beats,O
per,O
minute,O
",",O
small,B-PR
Qwaves,I-PR
in,I-PR
3,I-PR
and,I-PR
F,I-PR
",",O
ST,B-PR
elevation,I-PR
in,I-PR
2,I-PR
",",I-PR
3,I-PR
",",I-PR
and,I-PR
F.,I-PR
ST,B-PR
Depression,I-PR
in,I-PR
1,I-PR
",",I-PR
L,I-PR
and,I-PR
V2,I-PR
and,I-PR
3,I-PR
.,O

LABORATORY,O
DATA,O
:,O

Peak,B-TE
CPK,I-TE
1117,O
.,O

Total,B-TE
cholesterol,I-TE
142,O
.,O

LDL,B-TE
56,O
.,O

HDL,B-TE
30,O
.,O

Triglycerides,B-TE
281,O
.,O

HOSPITAL,O
COURSE,O
AND,O
TREATMENT,O
:,O

The,O
patient,O
was,O
directly,O
admitted,O
to,O
the,O
cardiac,O
catheterization,O
laboratory,O
.,O

Coronary,B-TE
angiography,I-TE
",",O
right,B-TE
heart,I-TE
catheterization,I-TE
and,O
percutaneous,B-TR
intervention,I-TR
of,I-TR
the,I-TR
RCA,I-TR
were,O
performed,O
from,O
the,O
right,O
groin,O
without,O
complications,B-PR
.,O

The,O
proximal,O
RCA,O
was,O
totally,B-PR
occluded,I-PR
with,O
good,O
left,O
to,O
right,O
collaterals,O
.,O

The,O
LAD,O
showed,O
a,B-PR
40%,I-PR
stenosis,I-PR
in,I-PR
the,I-PR
proximal,I-PR
segment,I-PR
.,O

The,O
circumflex,O
showed,O
mild,B-PR
atherosclerotic,I-PR
.,O

The,B-PR
RCA,I-PR
occlusion,I-PR
was,O
successfully,O
dilated,O
and,O
sent,O
using,O
a,B-TR
3.0,I-TR
X,I-TR
23,I-TR
mm,I-TR
Duet,I-TR
with,O
post,B-TR
stent,I-TR
dilatation,I-TR
up,O
to,O
16,O
atmospheres,O
.,O

Following,O
intervention,B-TR
right,B-TE
heart,I-TE
catheterization,I-TE
was,O
performed,O
to,O
rule,O
out,O
RV,B-PR
infarct,I-PR
.,O

The,B-TE
RA,I-TE
was,O
5,O
.,O

PA,B-TE
was,O
19/7,O
with,O
a,B-TE
mean,I-TE
of,O
13,O
.,O

PCW,B-TE
was,O
11,O
.,O

Of,O
note,O
there,O
was,O
a,B-PR
clear,I-PR
A,I-PR
wave,I-PR
in,O
the,B-TE
RV,I-TE
tracing,I-TE
",",O
suggestive,O
of,O
RV,B-PR
infarct,I-PR
.,O

The,O
next,O
day,O
the,O
patient,O
was,O
quite,B-PR
confused,I-PR
and,O
disoriented,B-PR
",",O
which,O
gradually,O
disappeared,O
.,O

An,B-TE
echocardiogram,I-TE
was,O
performed,O
to,O
evaluate,O
the,B-TE
LV,I-TE
function,I-TE
",",O
which,O
showed,O
an,B-TE
ejection,I-TE
fraction,I-TE
of,O
53%,O
with,O
inferoposteriorakinesis,B-PR
/,O
hypokinesis,B-PR
.,O

The,O
next,O
day,O
the,O
patient,O
&apos;s,O
mental,O
status,O
came,O
back,O
to,O
baseline,O
and,O
he,O
remained,O
free,O
of,O
angina,B-PR
.,O

ASHEE,O
SHOULTSNER,O
",",O
M.D.,O

Electronically,O
Signed,O
ASHEE,O
SHOULTSNER,O
",",O
M.D.,O

11/07/1999,O
11:06,O

TR,O
:,O

ghu,O

DD,O
:,O

10/18/1999,O

TD,O
:,O

10/18/1999,O
10:59,O

Acc,O
:,O

ASHEE,O
SHOULTSNER,O
",",O
M.D.,O
Dr.,O
Lenni,O
Factor,O
No,O
Verlmerver,O
Medical,O
Center,O
Dr.,O
Tomedankell,O
Flowayles,O
No,O
Verlmerver,O
Medical,O
Center,O
STAT,O

Admission,O
Date,O
:,O

2017-02-04,O

Discharge,O
Date,O
:,O

2017-03-04,O

Date,O
of,O
Birth,O
:,O

1958-07-29,O

Sex,O
:,O

M,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Betalactams,B-TR
/,O
Levofloxacin,B-TR

Attending,O
:,O
Cayla,O
R,O
Turner,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O
respiratory,B-PR
distress,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O
s/p,O
intracranial,B-TR
pressure,I-TR
bolt,I-TR
placement,I-TR

History,O
of,O
Present,O
Illness,O
:,O

The,O
patient,O
is,O
a,O
58,O
-,O
year-old,O
man,O
with,O
history,O
of,O
IDDM,B-PR
",",O
PVD,B-PR
",",O
status,O
post,O
toe,B-TR
amputations,I-TR
",",O
diabetic,B-PR
neuropathy,I-PR
",",O
and,O
retinopathy,B-PR
recently,O
admitted,O
to,O
McLean,O
Hospital,O
from,O
2017-01-13,O
",",O
through,O
2017-01-18,O
",",O
with,O
a,O
diagnosis,O
of,O
right,B-PR
heel,I-PR
diabetic,I-PR
ulcer,I-PR
with,O
MSSA,B-PR
osteomyelitis,I-PR
of,I-PR
the,I-PR
calcaneus,I-PR
",",O
MSSA,B-PR
bacteremia,I-PR
",",O
acute,B-PR
interstitial,I-PR
nephritis,I-PR
secondary,O
to,O
oxacillin,B-TR
",",O
and,O
RLL,B-PR
pna,I-PR
.,O

He,O
was,O
sent,O
home,O
with,O
a,B-TR
PICC,I-TR
line,I-TR
and,O
IV,B-TR
antibiotics,I-TR
.,O

He,O
returned,O
to,O
the,O
Wing,O
Memorial,O
&,O
Medical,O
Center,O
intubated,B-TR
from,O
an,O
outside,O
hospital,O
on,O
2017-02-04,O
",",O
for,O
respiratory,B-PR
failure,I-PR
and,O
was,O
sent,O
to,O
CMED,O
CSRU,O
.,O

Prior,O
to,O
his,O
re-admission,O
",",O
his,O
sister,O
had,O
noted,O
that,O
he,O
was,O
having,O
some,B-PR
shaking,I-PR
chills,I-PR
and,O
heavy,B-PR
breathing,I-PR
.,O

When,O
he,O
came,O
back,O
to,O
Faulkner,O
Hospital,O
Hospital,O
for,O
confusion,B-PR
and,O
diaphoresis,B-PR
",",O
his,B-TE
initial,I-TE
oxygen,I-TE
sat,I-TE
was,O
only,O
80%,O
with,O
a,B-TE
fingerstick,I-TE
of,O
29,O
.,O

He,O
was,O
given,O
D50,B-TR
",",O
but,O
continued,O
to,O
have,O
progressive,B-PR
respiratory,I-PR
failure,I-PR
",",O
was,O
therefore,O
intubated,O
and,O
transferred,O
to,O
the,O
Austen,O
Riggs,O
Center,O
where,O
he,O
was,O
noted,O
to,O
have,O
multifocal,B-PR
pneumonia,I-PR
and,O
bacteremia,B-PR
with,O
enterobacter,B-PR
and,O
MSSA,B-PR
.,O

Past,O
Medical,O
History,O
:,O
diabetes,B-PR
type,I-PR
1,I-PR
since,O
age,O
24,O
after,O
pancreatic,B-PR
trauma,I-PR

diabetic,B-PR
retinopathy,I-PR

direct,B-PR
neuropathy,I-PR

PVD,B-PR

status,O
post,O
multiple,B-TR
toe,I-TR
amputations,I-TR

recent,B-PR
right,I-PR
heel,I-PR
osteomyelitis,I-PR

recent,B-PR
MSSA,I-PR
bacteremia,I-PR

multifocal,B-PR
pneumonia,I-PR

acute,B-PR
interstitial,I-PR
nephritis,I-PR

cataract,B-TR
surgery,I-TR
.,O

Social,O
History,O
:,O
divorced,O
truck,O
driver,O

tobacco,O
:,O
16,O
pack,O
year,O
hx,O
;,O
quit,O
24,O
years,O
ago,O

ETOH,O
:,O
occasional,O
beer,O

Family,O
History,O
:,O

NC,O

Physical,O
Exam,O
:,O

On,O
transfer,O
to,O
the,O
floor,O
from,O
the,O
CMED,O
CSRU,O
on,O
2017-02-15,O
temp,B-TE
:,O

97.4,O
HR,B-TE
:,O

78,O
BP,B-TE
:,O

141/64,O
RR,B-TE
:,O

20,O
O2sat,B-TE
:,O

94-95%,O
on,O
3L,B-TR
NC,I-TR

Gen,O
:,O
somnolent,B-PR
but,O
arousable,O
to,O
voice,O

HEENT,O
:,O

MM,O
moist,O
",",O
PERRLA,O

CV,O
:,O

RRR,O
",",O
no,O
m/r/g,B-PR

Lungs,O
:,O
crackles,B-PR
bibasilar,I-PR

Abd,O
:,O
soft,O
",",O
slightly,B-PR
distended,I-PR
",",O
nontender,B-PR
",",O
+BS,O

Ext,O
:,O

2+,B-PR
pitting,I-PR
edema,I-PR
B,I-PR
LE,I-PR
to,I-PR
knee,I-PR
",",O
nonpitting,B-PR
edema,I-PR
in,I-PR
B,I-PR
hands,I-PR
and,I-PR
arms,I-PR
.,O

1+,B-TE
DP,I-TE
pulses,I-TE
bilaterally,I-TE
.,O

Missing,B-PR
R,I-PR
1st,I-PR
toe,I-PR
and,I-PR
L,I-PR
2nd,I-PR
toe,I-PR
.,O

Wound,B-TR
vac,I-TR
in,O
place,O
on,O
R,O
foot,O
.,O

Access,O
:,O

L,B-TR
PICC,I-TR
(,O

Neuro,O
:,O
arousable,O
.,O

States,O
he,O
is,O
at,O
home,O
",",O
name,O
is,O
"",O
Henry,O
"",O
and,O
year,O
is,O
1992,O
.,O

Not,O
answering,O
other,O
questions,O
.,O

Not,O
following,O
commands,O
but,O
moves,O
UE,O
's,O
to,O
try,O
to,O
pull,O
out,O
NG,B-TR
tube,I-TR
.,O

Pertinent,O
Results,O
:,O

CT,B-TE
chest,I-TE
2017-02-06,O

IMPRESSION,O
:,O

1.,O
Extensive,B-PR
bilateral,I-PR
diffuse,I-PR
ground,I-PR
glass,I-PR
and,O
more,O
confluent,O
areas,O
of,O
consolidation,B-PR
in,I-PR
both,I-PR
lungs,I-PR
consistent,O
with,O
the,B-TE
recent,I-TE
chest,I-TE
x-ray,I-TE
.,O

This,B-PR
non,I-PR
-,I-PR
specific,I-PR
pattern,I-PR
could,O
represent,O
diffuse,B-PR
pneumonia,I-PR
complicated,O
by,O
ARDS,B-PR
.,O

This,O
would,O
likely,O
less,O
represent,O
asymmetric,B-PR
pulmonary,I-PR
edema,I-PR
.,O

2.,O
Small,B-PR
bilateral,I-PR
pleural,I-PR
effusions,I-PR
.,O

Echo,B-TE
2018-02-06,O

Conclusions,O
:,O

1.,O
No,O
spontaneous,B-PR
echo,I-PR
contrast,I-PR
or,O
thrombus,B-PR
is,O
seen,O
in,O
the,O
body,O
of,O
the,O
left,O
atrium,O
or,O
left,O
atrial,O
appendage,O
.,O

No,O
atrial,B-PR
septal,I-PR
defect,I-PR
is,O
seen,O
by,O
2D,B-TE
or,I-TE
color,I-TE
Doppler,I-TE
.,O

2.,O
Left,B-TE
ventricular,I-TE
wall,I-TE
thickness,I-TE
",",O
cavity,B-TE
size,I-TE
",",O
and,O
systolic,B-TE
function,I-TE
are,O
normal,O
(,O
LVEF,B-TE
>,O
55%,O
),O
.,O

3.,O
Right,B-TE
ventricular,I-TE
chamber,I-TE
size,I-TE
and,O
free,B-TE
wall,I-TE
motion,I-TE
are,O
normal,O
.,O

4.,O
The,O
ascending,O
",",O
transverse,O
and,O
descending,O
thoracic,O
aorta,O
are,O
normal,O
in,O
diameter,O
and,O
free,O
of,O
atherosclerotic,B-PR
plaque,I-PR
.,O

5.,O
The,O
aortic,O
valve,O
leaflets,O
(,O
3,O
),O
appear,O
structurally,O
normal,O
with,O
good,O
leaflet,O
excursion,O
.,O

No,O
masses,B-PR
or,O
vegetations,B-PR
are,O
seen,O
on,O
the,O
aortic,O
valve,O
.,O

Trace,B-PR
aortic,I-PR
regurgitation,I-PR
is,O
seen,O
.,O

6.,O
The,O
mitral,O
valve,O
appears,O
structurally,O
normal,O
with,O
trivial,B-PR
mitral,I-PR
regurgitation,I-PR
.,O

No,O
mass,B-PR
or,O
vegetation,B-PR
is,O
seen,O
on,O
the,O
mitral,O
valve,O
.,O

7.,O
No,O
vegetation,B-PR
/,O
mass,B-PR
is,O
seen,O
on,O
the,O
pulmonic,O
valve,O
.,O

8.,O
There,O
is,O
a,O
trivial,O
/,O
physiologic,B-PR
pericardial,I-PR
effusion,I-PR
.,O

Head,B-TE
CT,I-TE
2017-02-08,O

FINDINGS,O
:,O

No,O
intracranial,B-PR
hemorrhage,I-PR
is,O
identified,O
.,O

There,O
is,O
no,O
mass,B-PR
effect,I-PR
or,O
shift,B-PR
of,I-PR
the,I-PR
normally,I-PR
midline,I-PR
structures,I-PR
.,O

No,O
major,B-PR
vascular,I-PR
territorial,I-PR
infarction,I-PR
is,O
identified,O
.,O

The,O
ventricles,O
and,O
sulci,O
are,O
normal,O
in,O
size,O
and,O
symmetrical,O
.,O

No,O
osseous,B-PR
lesions,I-PR
are,O
seen,O
.,O

IMPRESSION,O
:,O

No,O
intracranial,B-PR
hemorrhage,I-PR
or,O
CT,B-TE
evidence,O
of,O
acute,B-PR
infarction,I-PR
.,O

EEG,B-TE
2017-02-10,O

IMPRESSION,O
:,O

This,O
is,O
an,B-PR
abnormal,I-PR
EEG,I-PR
due,O
to,O
the,O
presence,O
of,O
a,B-PR
low,I-PR
voltage,I-PR
and,O
slow,B-PR
background,I-PR
consistent,O
with,O
a,B-PR
severe,I-PR
encephalopathy,I-PR
of,O
toxic,O
",",O
metabolic,O
",",O
or,O
anoxic,O
etiology,O
.,O

Note,O
that,O
with,O
the,O
documented,O
movements,O
of,O
the,O
patient,O
's,O
head,O
and,O
mouth,O
",",O
no,O
change,O
on,O
the,B-TE
EEG,I-TE
was,O
seen,O
.,O

No,O
evidence,O
of,O
ongoing,B-PR
seizures,I-PR
was,O
seen,O
.,O

Cultures,B-TE
:,O

Urine,B-TE
:,O

2017-02-04,O
and,O
2017-02-07,O
and,O
2017-02-11,O
:,O
yeast,B-PR

Sputum,B-TE
2017-02-04,O

ENTEROBACTER,B-PR
CLOACAE,I-PR

IV,B-TR
catheter,I-TR
tip,I-TR
2017-02-05:,O

STAPHYLOCOCCUS,B-PR
",",I-PR
COAGULASE,I-PR
NEGATIVE,I-PR
sensitive,O
to,O
vanc,B-TR

Blood,B-TE
:,O

2017-02-04,O

ENTEROBACTER,B-PR
CLOACAE,I-PR

ENTEROCOCCUS,B-PR
FAECIUM,I-PR
.,O

STAPHYLOCOCCUS,B-PR
",",I-PR
COAGULASE,I-PR
NEGATIVE,I-PR
.,O

ISOLATED,O
FROM,O
ONE,O
SET,O
ONLY,O
.,O

Stool,B-TE
2017-02-07,O
:,O
c.,B-PR
diff,I-PR
negative,O

Brief,O
Hospital,O
Course,O
:,O

1),O
Respiratory,B-PR
failure,I-PR
:,O

On,O
admission,O
",",O
this,O
was,O
felt,O
to,O
be,O
likely,O
03-15,O
worsening,B-PR
PNA,I-PR
.,O

Pt,O
remained,O
intubated,B-TR
until,O
2017-02-14,O
.,O

He,O
had,O
difficulty,O
weaning,O
from,O
the,B-TR
vent,I-TR
due,O
to,O
difficulties,B-PR
with,I-PR
neurological,I-PR
status,I-PR
(,O
he,O
remained,O
drowsy,B-PR
and,O
unresponsive,B-PR
for,O
many,O
days,O
),O
but,O
eventually,O
awoke,O
enough,O
and,O
was,O
extubated,O
without,O
difficulty,O
and,O
remained,O
stable,O
on,O
3L,B-TR
NC,I-TR
.,O

He,O
was,O
transferred,O
to,O
the,O
floor,O
but,O
a,O
few,O
days,O
later,O
began,O
to,O
show,O
signs,O
of,O
respiratory,B-PR
distress,I-PR
and,O
was,O
transferred,O
back,O
to,O
the,O
CMED,O
CSRU,O
for,O
reintubation,B-TR
for,O
likely,O
aspiration,B-PR
event,I-PR
leading,O
to,O
worsening,B-PR
pneumonia,I-PR
as,O
well,O
as,O
some,O
component,O
of,O
pulm,B-PR
edema,I-PR
.,O

He,O
was,O
extubated,O
a,O
few,O
days,O
later,O
and,O
transferred,O
back,O
to,O
the,O
floor,O
where,O
his,O
pulm,O
status,O
improved,O
dramatically,O
with,O
lasix,B-TR
and,O
continued,B-TR
nebulizer,I-TR
treatments,I-TR
.,O

The,O
patient,O
was,O
prepared,O
for,O
discharge,O
on,O
05-29,O
",",O
when,O
he,O
was,O
sat,O
',O
ing,O
in,O
the,O
high,O
90,O
's,O
on,O
room,O
air,O
.,O

However,O
",",O
on,O
2017-03-01,O
at,O
6,O
am,O
the,O
pt,O
was,O
found,O
with,O
labored,B-PR
respirations,I-PR
(,O
rr,B-TE
=,O
24,O
),O
and,O
SaO2,B-TE
89%,O
",",O
which,O
improved,O
to,O
only,O
SaO290,B-TE
-,O
91%,O
on,O
100%,O
NRB,B-TR
.,O

ABG,B-TE
(,O
7.42,O
/,O
38,O
/,O
88,O
),O
was,O
performed,O
",",O
80,O
mg,O
lasix,B-TR
was,O
given,O
and,O
the,O
patietn,O
had,O
foley,B-TR
placed,O
and,O
had,O
good,O
urine,O
output,O
and,O
good,O
mentation,O
.,O

He,O
was,O
also,O
given,O
nebulizers,B-TR
without,O
improvement,O
.,O

His,B-TE
chest,I-TE
radiograph,I-TE
had,O
fluffy,B-PR
bilateral,I-PR
infiltrates,I-PR
.,O

Although,O
the,O
pt,O
was,O
w/o,O
fever,B-PR
",",O
he,O
had,O
chills,B-PR
.,O

He,O
was,O
readmitted,O
tot,O
he,O
CMED,O
CSRU,O
for,O
respiratory,B-PR
distress,I-PR
likely,O
secondary,O
to,O
a,B-PR
recurrent,I-PR
aspiration,I-PR
event,I-PR
.,O

He,O
was,O
continued,O
on,O
meropenem,B-TR
",",O
started,O
on,O
BiPAP,B-TR
and,O
aggressively,O
suctioned,O
in,O
an,O
attempt,O
to,O
avoid,O
intubation,B-TR
.,O

On,O
03-02,O
at,O
10,O
am,O
",",O
the,O
patient,O
had,O
an,B-PR
acutechange,I-PR
in,I-PR
mental,I-PR
status,I-PR
with,O
bradycardia,B-PR
",",O
hypertension,B-PR
",",O
pinpoint,B-PR
pupils,I-PR
",",O
decerebrate,B-PR
posturing,I-PR
and,O
increased,B-PR
tone,I-PR
in,I-PR
bilateral,I-PR
upper,I-PR
extremities,I-PR
and,O
unresponsiveness,B-PR
.,O

The,O
patient,O
was,O
brought,O
to,O
CT,O
immediately,O
for,O
stat,B-TE
scan,I-TE
and,O
was,O
found,O
to,O
have,O
a,B-PR
massive,I-PR
occipital,I-PR
spontaneous,I-PR
hemorrhage,I-PR
into,I-PR
the,I-PR
L,I-PR
ventricle,I-PR
requiring,O
ventricular,B-TR
drainage,I-TR
.,O

Neurosurgery,O
was,O
immediately,O
called,O
for,O
an,B-TR
EVD,I-TR
and,O
anesthesia,O
was,O
called,O
STAT,O
to,O
the,O
bedside,O
for,O
intubation,B-TR
at,O
10:45,O
am,O
in,O
order,O
to,O
assist,O
in,O
hyperventilation,B-TR
.,O

After,O
endotracheal,B-TR
intubation,I-TR
",",O
MAPs,B-TE
were,O
maintained,O
between,O
70,O
and,O
90,O
",",O
dilantin,B-TR
was,O
dose,O
to,O
maintain,O
an,O
appropriate,O
level,O
.,O

L,B-TR
frontal,I-TR
ICP,I-TR
bolt,I-TR
was,O
placed,O
by,O
neurosurgery,O
under,O
sterile,O
conditions,O
on,O
antibiotics,B-TR
.,O

Mannitol,B-TR
75,O
mg,O
iv,O
x,O
1,O
then,O
50,O
gm,O
iv,O
tid,O
was,O
begun,O
to,O
maintain,O
serum,B-TE
osm,I-TE
>,O
320,O
and,O
Na,B-TE
>,O
147,O
.,O

The,O
patient,O
was,O
hyperventilated,B-TR
to,O
goal,B-TE
PCO2,I-TE
30-35,O
with,O
ICP,B-TE
improvement,O
.,O

Serial,B-TE
head,I-TE
CT,I-TE
studies,I-TE
and,O
neurologic,B-TE
exams,I-TE
were,O
performed,O
but,O
the,O
patient,O
was,O
unchaged,O
",",O
unresponsive,B-PR
with,O
posturing,B-PR
and,O
no,B-PR
spontaneous,I-PR
movement,I-PR
despite,O
ICP,B-TE
being,O
maintained,O
in,O
good,O
range,O
(,O
<,O
20,O
).,O

On,O
2017-03-03,O
",",O
a,O
family,O
meeting,O
resulted,O
in,O
the,O
patient,O
's,O
code,O
being,O
changed,O
to,O
comfort,B-TR
measures,I-TR
only,I-TR
.,O

The,O
patient,O
was,O
terminally,O
extubated,O
on,O
a,B-TR
morphine,I-TR
drip,I-TR
and,O
ativan,B-TR
titrated,O
for,O
agonal,B-PR
breathing,I-PR
and,O
discomfort,B-PR
;,O
scopolamine,B-TR
was,O
used,O
as,O
an,O
adjunct,O
to,O
control,O
secretions,B-PR
and,O
appeared,O
comfortable,O
when,O
he,O
died,O
at,O
12:27,O
pm,O
on,O
2017-03-04,O
.,O

The,O
family,O
refused,O
autopsy,B-TE
or,O
post-mortem,B-TE
examination,I-TE
to,O
deduce,O
secondary,O
causes,O
of,O
death,O
.,O

2.,O
ID,O
-,O
Bacteremia,B-PR
and,O
PNA,B-PR
:,O

Pt,B-TR
's,I-TR
triple,I-TR
lumen,I-TR
catheter,I-TR
was,O
found,O
to,O
be,O
growing,O
coag,B-PR
neg,I-PR
staph,I-PR
.,O
and,O
PICC,B-TR
tip,I-TR
and,O
sputum,B-TE
growing,O
enterobacter,B-PR
cloacae,I-PR
.,O

The,B-TR
PICC,I-TR
was,O
d/c,O
'ed,O
and,O
pt,O
was,O
continued,O
on,O
vancomycin,B-TR
(,O
for,O
course,O
of,O
6,O
weeks,O
),O
and,O
meropenem,B-TR
was,O
added,O
on,O
02-09,O
(,O
for,O
3,O
week,O
course,O
).,O

TEE,B-TE
was,O
negative,O
.,O

Pt,O
finished,O
the,O
3,O
week,O
course,O
of,O
meropenem,B-TR
while,O
in,O
house,O
and,O
was,O
discharged,O
to,O
rehab,O
on,O
day,O
34/42,O
of,O
the,B-TR
vancomycin,I-TR
.,O

3),O
AIN,B-PR
:,O

Pt,O
received,O
oxacillin,B-TR
during,O
his,O
prior,O
hospitalization,O
and,O
had,O
AIN,B-PR
from,O
this,B-TR
medication,I-TR
.,O

On,O
this,O
admission,O
he,O
was,O
continued,O
on,O
prednisone,B-TR
taper,I-TR
.,O

Fluoroquinolones,B-TR
and,O
other,O
renal,O
toxins,O
were,O
avoided,O
.,O

Renal,O
function,O
gradually,O
improved,O
and,O
Cr,B-TE
trended,O
down,O
from,O
peak,O
of,O
7.6,O
to,O
1.4,O
.,O

Before,O
the,O
patient,O
acutely,O
decompensated,O
as,O
above,O
",",O
the,O
plan,O
was,O
for,O
steroid,B-TR
taper,I-TR
:,O

60,O
mg,O
x,O
10,O
days,O
(,O
already,O
completed,O
),O
",",O
40,O
mg,O
x,O
14,O
d,O
(,O
already,O
completed,O
),O
",",O
20,O
mg,O
x,O
14,O
d,O
(,O
now,O
day,O
11-24,O
),O
",",O
10,O
mg,O
x,O
10,O
d,O
",",O
5,O
mg,O
x,O
10,O
d,O
.,O

4),O
Foot,B-PR
ulcer,I-PR
:,O
The,O
pt,O
was,O
followed,O
by,O
podiatry,O
and,O
had,O
several,B-TR
further,I-TR
debridement,I-TR
of,O
his,B-PR
R,I-PR
heel,I-PR
wound,I-PR
.,O

on,O
abx,B-TR
",",O
podiatry,O
following,O
",",O
changed,O
vac,B-TR
q3,O
days,O
.,O

5),O
Encephalopathy,B-PR
:,O
It,O
was,O
unclear,O
why,O
the,O
pt,O
's,O
mental,O
status,O
initially,O
did,O
not,O
improve,O
more,O
quickly,O
after,O
all,B-TR
sedatives,I-TR
were,O
removed,O
and,O
he,O
was,O
extubated,O
.,O

His,O
MS,O
waxed,O
and,O
waned,O
for,O
many,O
days,O
and,O
uremia,B-PR
vs.,O
failure,B-PR
to,I-PR
clear,I-PR
sedatives,I-PR
were,O
considered,O
(,O
although,O
pt,O
was,O
making,O
urine,O
and,O
LFT,B-TE
's,I-TE
are,O
wnl,O
).,O

The,O
pt,O
had,O
an,B-TE
EEG,I-TE
and,O
2,B-TE
head,I-TE
CT,I-TE
's,I-TE
which,O
did,O
not,O
show,O
anoxic,B-PR
brain,I-PR
injury,I-PR
or,O
bleeding,B-PR
.,O

He,O
gradually,O
improved,O
and,O
was,O
A&Ox3,O
and,O
near,O
baseline,O
before,O
Amesbury,O
Hospital,O
transferred,O
to,O
the,O
CMED,O
CSRU,O
in,O
respiratory,B-PR
distress,I-PR
.,O

6),O
DM,B-PR
:,O

Pt,O
was,O
maintained,O
on,O
SSI,B-TR
with,O
small,O
amount,O
of,O
standing,B-TR
insulin,I-TR
while,O
he,O
was,O
NPO,B-TR
and,O
then,O
his,B-TR
dose,I-TR
was,O
gradually,O
increased,O
as,O
he,O
received,O
tube,B-TR
feeds,I-TR
.,O

7),O
FEN,O
:,O

The,O
pt,O
had,O
an,B-TR
NG,I-TR
tube,I-TR
placed,O
and,O
received,O
tube,B-TR
feeds,I-TR
for,O
the,O
majority,O
of,O
his,B-TR
hospitalization,I-TR
.,O

Upon,O
extubation,B-TR
and,O
transfer,O
to,O
the,O
floor,O
he,O
pulled,O
out,O
the,B-TR
NG,I-TR
tube,I-TR
time,O
several,O
times,O
and,O
required,O
restraints,B-TR
.,O

Albumin,B-TE
was,O
very,B-PR
low,I-PR
and,O
pt,O
had,O
significant,B-PR
edema,I-PR
likely,O
03-15,O
this,O
.,O

A,O
few,O
days,O
before,O
decompensating,O
",",O
his,O
mental,O
status,O
improved,O
to,O
the,O
degree,O
that,O
he,O
was,O
able,O
to,O
eat,O
normal,O
food,O
without,O
aspirating,O
.,O

8),O
CV,O
:,O

Pump,O
/,O
HTN,B-PR
:,O
pt,O
had,O
episodes,O
of,O
both,O
hypertension,B-PR
and,O
hypotension,B-PR
during,O
his,O
stay,O
.,O

He,O
was,O
managed,O
with,O
Metoprolol,B-TR
",",O
Hydralazine,B-TR
",",O
and,O
Amlodipine,B-TR
.,O

Near,O
discharge,O
his,B-TE
BP,I-TE
was,O
controlled,O
with,O
Metoprolol,B-TR
only,O
.,O

9),O
Hypernatremia,B-PR
-,O
While,O
in,O
the,O
CMED,O
CSRU,O
the,O
pt,O
developed,O
hypernatremia,B-PR
.,O

This,O
was,O
felt,O
to,O
be,O
likely,O
03-15,O
intravascular,B-PR
volume,I-PR
depletion,I-PR
since,O
the,B-TE
pt,I-TE
's,I-TE
albumin,I-TE
was,O
so,B-PR
low,I-PR
and,O
he,O
was,O
third,O
spacing,O
all,O
of,O
his,O
fluid,O
.,O

He,O
was,O
volume,O
resuscitated,O
and,O
managed,O
with,O
D5W,B-TR
and,O
lasix,B-TR
as,O
well,O
as,O
receving,O
FW,B-TR
boluses,I-TR
with,O
his,B-TR
NG,I-TR
tube,I-TR
feeds,I-TR
.,O

The,B-PR
hypernatremia,I-PR
fully,O
resolved,O
when,O
he,O
resumed,O
eating,O
on,O
his,O
own,O
and,O
had,O
access,O
to,O
free,O
water,O
.,O

10),O
Anemia,B-PR
:,O

Pt,B-TE
's,I-TE
Hct,I-TE
trended,O
down,O
slowly,O
throughout,O
his,O
hospitalization,O
.,O

Labs,B-TE
were,O
consistent,O
with,O
anemia,B-PR
of,O
chronic,B-PR
disease,I-PR
.,O

He,O
was,O
transfused,O
3,B-TR
units,I-TR
pRBC,I-TR
's,I-TR
near,O
the,O
end,O
of,O
his,O
hospitalization,O
and,O
had,O
an,O
appropriate,O
bump,O
.,O

11),O
CMED,O
CCU,O
:,O

When,O
the,O
pt,O
's,O
MS,O
improved,O
to,O
near,O
baseline,O
before,O
again,O
decompensating,O
",",O
he,O
became,O
extremely,B-PR
tearful,I-PR
and,O
expressed,O
feelings,O
of,O
depression,B-PR
after,O
being,O
in,O
the,O
hospital,O
for,O
so,O
long,O
.,O

He,O
expressed,O
interest,O
in,O
taking,O
an,B-TR
anti-depressant,I-TR
for,O
a,O
short,O
time,O
while,O
he,O
was,O
recovering,O
and,O
was,O
started,O
on,O
Celexa,B-TR
.,O

Medications,O
on,O
Admission,O
:,O
vancomycin,B-TR
1g,O
IV,O
q48,O

MVI,B-TR

Neurontin,B-TR
300,O
qd,O

RISS,B-TR

Prednisone,B-TR
taper,I-TR
60,O
qd,O

Prilosec,B-TR
20,O
qd,O

Metoprolol,B-TR
25,O
bid,O

Lantus,B-TR
480,O
qd,O

Calcium,B-TR
Carbonate,I-TR
tid,O
with,O
meals,O

Discharge,O
Medications,O
:,O
n/a,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Discharge,O
Diagnosis,O
:,O
subarachnoid,B-PR
hemorrhage,I-PR

Diabetes,B-PR
Mellitis,I-PR
(,O
Pancreatic,B-PR
Trauma,I-PR
),O

Acute,B-PR
Interstitial,I-PR
Nephritis,I-PR
(,O
Oxacillin,B-TR
),O

Peripheral,B-PR
Neuropathy,I-PR

Peripheral,B-PR
Vascular,I-PR
Disease,I-PR

Digital,B-PR
Necrosis,I-PR

Multiple,B-TR
Toe,I-TR
Amputations,I-TR

Diabetic,B-PR
Nephropathy,I-PR

Hypertension,B-PR

MSSA,B-PR
Bacteremia,I-PR

Enterococcal,B-PR
Bacteremia,I-PR

Enterbactor,B-PR
Cloacae,I-PR
Bacteremia,I-PR

Multifocal,B-PR
Pneumonia,I-PR

Respiratory,B-PR
Failure,I-PR

MSSA,B-PR
osteomyelitis,I-PR
of,I-PR
Calcaneous,I-PR

Toxic,B-PR
/,I-PR
Metabolic,I-PR
Encephalopathy,I-PR

Hypernatremia,B-PR

Discharge,O
Condition,O
:,O

Deceased,O

Sims,O
Kenneth,O
Jason,O
MD,O
95-149,O

Completed,O
by,O
:,O
Michael,O
Sulzer,O
ROSENTHAL,O
MD,O
58-540,O
2017-05-24,O
@,O
2309,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Cheryl,O
James,O
on,O
:,O
Larry,O
2017-05-25,O
2:28,O
PM,O

(,O
End,O
of,O
Report,O
),O

506243692_b,O

FIH,O

6305145,O

963632,O

439524,O

11/4/2000,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Report,O
Status,O
:,O

Signed,O

DISCHARGE,O
SUMMARY,O
NAME,O
:,O

STATE,O
",",O
ELRO,O

UNIT,O
NUMBER,O
:,O

413-18-46,O

ADMISSION,O
DATE,O
:,O

11/04/2000,O

DISCHARGE,O
DATE,O
:,O

11/09/2000,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Pulmonary,B-PR
edema,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

Congestive,B-PR
heart,I-PR
failure,I-PR
",",O
coronary,B-PR
artery,I-PR
disease,I-PR
",",O
mediastinal,B-PR
mass,I-PR
",",O
inferior,B-PR
myocardial,I-PR
infarction,I-PR
",",O
bronchiectasis,B-PR
.,O

ADVERSE,O
DRUG,O
REACTIONS,O
:,O

None,O
.,O

CLINICAL,O
INFECTIONS,O
:,O

None,O
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

Cardiac,B-TE
catheterization,I-TE
.,O

ASSOCIATED,O
PROCEDURES,O
:,O

VQ,B-TE
scan,I-TE
",",O
lower,B-TE
extremities,I-TE
noninvasive,I-TE
Doppler,I-TE
studies,I-TE
and,O
overnight,B-TE
oximetry,I-TE
saturation,I-TE
monitoring,I-TE
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Mr.,O
State,O
is,O
an,O
81-year-old,O
man,O
with,O
a,O
history,O
of,O
restrictive,B-PR
and,I-PR
obstructive,I-PR
lung,I-PR
disease,I-PR
",",O
dilated,B-PR
cardiomyopathy,I-PR
",",O
inferior,B-PR
myocardial,I-PR
infarction,I-PR
",",O
and,O
anterior,B-PR
mediastinal,I-PR
masses,I-PR
admitted,O
with,O
acute,O
onset,O
of,O
pulmonary,B-PR
edema,I-PR
.,O

In,O
the,O
setting,O
of,O
inadvertently,O
decreasing,O
Lasix,B-TR
from,O
80,O
mg.,O
po,O
40,O
mg.,O
a,O
day,O
Mr.,O
State,O
had,O
sudden,B-PR
onset,I-PR
dyspnea,I-PR
after,O
approximate,O
day,O
and,O
a,O
half,O
prodrome,B-PR
culminating,O
in,O
severe,B-PR
dyspnea,I-PR
.,O

Upon,O
arrival,O
in,O
the,O
Emergency,O
Room,O
Mr.,B-TE
State,I-TE
&apos;s,I-TE
saturations,I-TE
were,O
in,O
the,O
mid,O
80s,O
and,O
he,O
was,O
promptly,O
rendered,O
more,O
comfortable,O
with,O
high,B-TR
flow,I-TR
oxygen,I-TR
",",O
morphine,B-TR
",",O
and,O
nitrates,B-TR
and,O
intravenous,B-TR
Lasix,I-TR
.,O

Chest,B-TE
x-ray,I-TE
was,O
relatively,O
unrevealing,O
for,O
interstitial,B-PR
or,I-PR
alveolar,I-PR
edema,I-PR
and,O
with,O
clinical,O
improvement,O
ensued,O
with,O
the,O
immediate,B-TR
therapy,I-TR
in,O
the,O
Emergency,O
Room,O
as,O
noted,O
.,O

The,O
patient,O
denied,O
angina,B-PR
",",O
syncope,B-PR
",",O
preceding,B-PR
worsening,I-PR
orthopnea,I-PR
",",O
paroxysmal,B-PR
nocturnal,I-PR
dyspnea,I-PR
",",O
palpitations,B-PR
",",O
chest,B-PR
pain,I-PR
",",O
hematemesis,B-PR
or,O
melena,B-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Is,O
notable,O
for,O
an,B-PR
inferior,I-PR
myocardial,I-PR
infarction,I-PR
",",O
restrictive,B-PR
and,I-PR
obstructive,I-PR
lung,I-PR
disease,I-PR
with,O
an,B-TE
FEV1,I-TE
of,O
.9,O
and,O
FVC,B-TE
of,O
1.34,O
and,O
a,O
moderate,O
at,O
best,O
response,O
to,O
bronchodilators,B-TR
",",O
and,O
a,O
negative,O
sestamibi,O
scan,O
in,O
May,O
",",O
1999,O
apart,O
from,O
a,B-PR
severe,I-PR
fixed,I-PR
inferolateral,I-PR
defect,I-PR
",",O
systolic,B-PR
dysfunction,I-PR
with,O
recent,B-TE
echocardiography,I-TE
revealing,O
an,B-TE
LVID,I-TE
of,O
62,O
mm.,O
and,O
ejection,B-TE
fraction,I-TE
of,O
28,O
percent,O
",",O
moderate,B-PR
mitral,I-PR
regurgitation,I-PR
and,O
mild-to-moderate,B-PR
aortic,I-PR
stenosis,I-PR
with,O
a,B-TE
peak,I-TE
gradient,I-TE
of,O
33,O
and,O
a,B-TE
mean,I-TE
gradient,I-TE
of,O
19,O
and,O
a,B-TE
valve,I-TE
area,I-TE
of,O
1.4,O
cm.,O
squared,O
.,O

In,O
addition,O
",",O
Mr.,O
State,O
has,O
an,B-PR
anterior,I-PR
mediastinal,I-PR
mass,I-PR
2x2x1.7,O
cm.,O
by,O
recent,B-TE
computerized,I-TE
tomography,I-TE
scan,I-TE
without,O
surrounding,B-PR
or,I-PR
adjacent,I-PR
adenopathy,I-PR
or,O
parenchymal,B-PR
lung,I-PR
disease,I-PR
apart,O
from,O
bronchiectasis,B-PR
.,O

His,B-TE
cardiomyopathy,I-TE
work,I-TE
up,I-TE
entailed,O
a,O
negative,O
ANA,O
",",O
negative,O
SPEP,O
",",O
UPEP,B-TE
and,O
Benz-Jones,B-TE
proteins,I-TE
",",O
normal,O
ferritin,O
",",O
thyroid,B-TE
stimulating,I-TE
hormone,I-TE
and,O
a,B-TE
recent,I-TE
work,I-TE
up,I-TE
for,O
possible,O
bimomatous,B-PR
associated,O
myasthenia,B-PR
gravis,I-PR
that,O
was,O
negative,O
.,O

The,O
patient,O
lives,O
on,O
Quelene,O
with,O
his,O
wife,O
.,O

He,O
is,O
a,O
non-smoker,O
and,O
drinks,O
rare,O
alcohol,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,O
patient,O
was,O
a,O
very,O
pleasant,O
man,O
who,O
appeared,O
his,O
stated,O
age,O
.,O

Blood,B-TE
pressure,I-TE
was,O
155/60,O
",",O
heart,B-TE
rate,I-TE
70,O
with,O
occasional,B-PR
premature,I-PR
ventricular,I-PR
contractions,I-PR
",",O
respirations,B-TE
14,O
.,O

Mr.,O
State,O
was,O
dyspneic,B-PR
speaking,O
in,O
short,O
sentences,O
initially,O
on,O
high,B-TR
flow,I-TR
oxygen,I-TR
.,O

Jugular,B-TE
venous,I-TE
pressure,I-TE
was,O
8,O
with,O
a,B-PR
brisk,I-PR
inspiratory,I-PR
descent,I-PR
.,O

There,O
was,O
no,O
thyromegaly,B-PR
.,O

Carotids,B-TE
were,O
2+,O
.,O

Breath,O
sounds,O
were,O
decreased,B-PR
at,I-PR
the,I-PR
bases,I-PR
only,O
with,O
distant,B-PR
heart,I-PR
sounds,I-PR
and,O
a,B-PR
2,I-PR
out,I-PR
of,I-PR
6,I-PR
systolic,I-PR
ejection,I-PR
murmur,I-PR
consistent,O
with,O
aortic,B-PR
stenosis,I-PR
with,O
Gallavardin,B-PR
like,I-PR
radiation,I-PR
to,I-PR
the,I-PR
apex,I-PR
.,O

Abdomen,O
:,O

soft,O
",",O
nontender,B-PR
with,O
hepatosplenomegaly,B-PR
",",O
or,O
hepatojugular,B-PR
reflex,I-PR
",",O
bruits,B-PR
or,O
pulsations,B-PR
.,O

There,O
was,O
no,O
rash,B-PR
and,O
no,O
edema,B-PR
and,O
the,B-TE
neurological,I-TE
examination,I-TE
was,O
non-focal,O
.,O

LABORATORY,O
DATA,O
:,O

Notable,O
for,O
a,B-TE
sodium,I-TE
of,O
145,O
",",O
potassium,B-TE
3.6,O
",",O
BUN,B-TE
23,O
",",O
creatinine,B-TE
1.3,O
",",O
glucose,B-TE
104,O
",",O
hematocrit,B-TE
42,O
",",O
white,B-TE
count,I-TE
8.7,O
",",O
platelet,B-TE
count,I-TE
235,O
and,O
a,B-TE
PT,I-TE
of,O
12.9,O
seconds,O
.,O

The,B-TE
urinalysis,I-TE
was,O
negative,O
.,O

The,B-TE
Troponin,I-TE
I,I-TE
was,O
less,O
than,O
.4,O
and,O
the,B-TE
creatine,I-TE
kinase,I-TE
was,O
114,O
.,O

Chest,B-TE
x-ray,I-TE
revealed,O
moderate,B-PR
cardiomegaly,I-PR
with,O
no,O
clear,B-PR
interstitial,I-PR
or,I-PR
alveolar,I-PR
pulmonary,I-PR
edema,I-PR
and,O
chronic,B-PR
atelectasis,I-PR
and,O
/,O
or,O
scarring,B-PR
at,I-PR
both,I-PR
lung,I-PR
bases,I-PR
.,O

The,B-TE
electrocardiogram,I-TE
revealed,O
normal,O
sinus,O
rhythm,O
with,O
premature,B-PR
atrial,I-PR
complexes,I-PR
and,O
right,B-PR
bundle,I-PR
branch,I-PR
block,I-PR
with,O
left,B-PR
anterior,I-PR
hemiblock,I-PR
and,O
old,B-PR
anterior,I-PR
myocardial,I-PR
infarction,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
Hospital,O
and,O
underwent,O
an,B-TR
approximate,I-TR
1.5,I-TR
liter,I-TR
diuresis,I-TR
within,O
the,O
first,O
24,O
hours,O
with,O
improvement,O
in,O
his,B-PR
symptoms,I-PR
and,O
improvement,O
in,O
his,B-TE
oxygen,I-TE
saturations,I-TE
.,O

After,O
a,O
long,O
discussion,O
with,O
the,O
patient,O
and,O
his,O
family,O
it,O
was,O
determined,O
that,O
a,B-TE
cardiac,I-TE
catheterization,I-TE
would,O
be,O
prudent,O
.,O

Prior,O
to,O
catheterization,B-TE
a,B-TE
VQ,I-TE
scan,I-TE
was,O
performed,O
which,O
revealed,O
a,O
moderate,O
probability,O
for,O
PE,B-PR
with,O
a,B-PR
subsegmental,I-PR
defect,I-PR
in,I-PR
the,I-PR
lingular,I-PR
on,O
the,O
left,O
lung,O
.,O

Subsequent,B-TE
lower,I-TE
extremities,I-TE
noninvasive,I-TE
studies,I-TE
and,O
D-dimer,B-TE
test,I-TE
were,O
both,O
negative,O
rendering,O
the,O
probability,O
of,O
acute,B-PR
pulmonary,I-PR
embolism,I-PR
less,O
than,O
2,O
percent,O
.,O

It,O
was,O
not,O
felt,O
that,O
the,O
patient,O
would,O
be,O
in,O
need,O
of,O
chronic,B-TR
Coumadin,I-TR
therapy,I-TR
in,O
lieu,O
of,O
this,O
low,O
probability,O
findings,O
in,O
toto,O
.,O

Coronary,B-TE
angiography,I-TE
revealed,O
occlusion,B-PR
of,I-PR
the,I-PR
right,I-PR
coronary,I-PR
artery,I-PR
proximally,I-PR
with,O
insignificant,B-PR
plaquing,I-PR
in,I-PR
the,I-PR
left,I-PR
anterior,I-PR
descending,I-PR
artery,I-PR
and,O
circumflex,O
arteries,O
.,O

After,O
a,B-TR
approximate,I-TR
3,I-TR
liter,I-TR
total,I-TR
diuresis,I-TR
the,B-TE
right,I-TE
atrial,I-TE
pressure,I-TE
was,O
5,O
",",O
pulmonary,B-TE
capillary,I-TE
wedge,I-TE
pressure,I-TE
14,O
",",O
pulmonary,B-TE
vacuolar,I-TE
resistance,I-TE
353,O
and,O
the,B-TE
cardiac,I-TE
output,I-TE
depressed,O
at,O
2.95,O
liters,O
per,O
minute,O
",",O
or,O
a,B-TE
cardiac,I-TE
index,I-TE
of,O
1.7,O
liters,O
per,O
minute,O
.,O

Based,O
upon,O
these,O
findings,O
it,O
was,O
felt,O
that,O
Mr.,O
State,O
most,O
likely,O
has,O
multi-factorial,B-PR
dyspnea,I-PR
owing,O
to,O
both,O
his,B-PR
ventilatory,I-PR
limitation,I-PR
and,O
to,O
a,B-PR
chronic,I-PR
low,I-PR
output,I-PR
state,I-PR
.,O

In,O
Hospital,O
he,O
was,O
seen,O
by,O
both,O
Speech,O
Therapy,O
",",O
physical,O
therapy,O
",",O
and,O
the,O
Uspend,O
Harmemewood,O
Medical,O
Center,O
Congestive,O
Heart,O
Failure,O
Nurse,O
Practitioner,O
Program,O
.,O

His,B-TR
Isordil,I-TR
was,O
increased,O
in,O
Hospital,O
and,O
blood,B-TR
pressure,I-TR
control,I-TR
was,O
relative,O
episodic,O
with,O
systolic,B-TE
pressures,I-TE
ranging,O
between,O
100,O
and,O
160,O
.,O

Future,O
adjustments,O
will,O
be,O
made,O
at,O
home,O
pending,O
his,B-TE
blood,I-TE
pressure,I-TE
measures,I-TE
.,O

At,O
a,O
goal,O
weight,B-TE
of,O
142,O
pounds,O
",",O
Mr.,B-TE
State,I-TE
&apos;s,I-TE
filling,I-TE
pressures,I-TE
appeared,O
ideal,O
with,O
a,B-TE
wedge,I-TE
pressure,I-TE
of,O
14,O
and,O
his,O
goal,O
weight,O
range,O
will,O
be,O
between,O
142,O
and,O
44,O
pounds,O
at,O
home,O
.,O

The,O
patient,O
will,O
be,O
followed,O
by,O
Dr.,O
State,O
within,O
a,O
week,O
of,O
discharge,O
and,O
by,O
Nieie,O
Naebrand,O
Freierm,O
of,O
the,O
Dyathenslycha,O
Medical,O
Center,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Imdur,B-TR
120,O
mg.,O
PO,O
q.d.,O
Captopril,B-TR
100mg.,O
PO,O
t.i.d.,O
Lasix,B-TR
80,O
mg.,O
PO,O
q.d.,O
Potassium,B-TR
chloride,I-TR
40,O
mEq.,O
PO,O
q.d.,O
Coreg,B-TR
12.5,O
mg.,O
b.i.d.,O
Cozaar,B-TR
100,O
mg.,O
b.i.d.,O
Plavix,B-TR
75,O
mg.,O
q.d.,O
Allopurinol,B-TR
300,O
mg.,O
q.d.,O
Pulmacort,B-TR
and,O
Serevent,B-TR
inhalers,I-TR
2,O
puffs,O
b.i.d.,O
Zocor,B-TR
20,O
mg.,O
q.d.,O
Prilosec,B-TR
20,O
mg.,O
q.d.,O
Colace,B-TR
100,O
mg.,O
t.i.d.,O

FOLLOW,O
UP,O
:,O

The,O
patient,O
will,O
see,O
Dr.,O
State,O
",",O
as,O
noted,O
",",O
in,O
follow,O
up,O
.,O

AKA,O
G,O
STATE,O
",",O
M.D.,O
CARDIAC,O
TRANSPLANT,O
STEMSTRICTALLE,O
MEDICAL,O
CENTER,O
Electronically,O
Signed,O
AKA,O
G,O
STATE,O
",",O
M.D.,O
11/17/2000,O
12:46,O
_____________________________,O
??,O

TR,O
:,O

rij,O

DD,O
:,O

11/09/2000,O

TD,O
:,O

11/14/2000,O
1:09,O
P,O

cc,O
:,O

AKA,O
G,O
STATE,O
",",O
M.D.,O
AMAN,O
SCKOLLMINEVUILLE,O
",",O
M.D.,O
FA,O
HEN,O
KNOTTIPPSFYFE,O
",",O
M.D.,O

Admission,O
Date,O
:,O

2012-03-01,O

Discharge,O
Date,O
:,O

2012-03-13,O

Date,O
of,O
Birth,O
:,O

1985-11-02,O

Sex,O
:,O

F,O

Service,O
:,O

CMED,O
CCU,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Patient,O
is,O
a,O
26,O
-,O
year-old,O
female,O
with,O
a,O
past,O
medical,O
history,O
significant,O
for,O
nonischemic,B-PR
dilated,I-PR
cardiomyopathy,I-PR
with,O
an,B-TE
ejection,I-TE
fraction,I-TE
of,O
15-20%,O
",",O
who,O
presents,O
with,O
a,O
one-week,O
history,O
of,O
progressive,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
.,O

She,O
reports,O
orthopnea,B-PR
with,O
an,B-PR
increasing,I-PR
pillow,I-PR
requirement,I-PR
of,O
2-4,O
with,O
paroxysmal,B-PR
nocturnal,I-PR
dyspnea,I-PR
.,O

Patient,O
also,O
reports,O
a,B-PR
6-pound,I-PR
weight,I-PR
gain,I-PR
over,O
the,O
last,O
four,O
days,O
with,O
associated,O
lower,B-PR
extremity,I-PR
edema,I-PR
.,O

She,O
also,O
reports,O
positional,B-PR
chest,I-PR
pain,I-PR
",",O
which,O
is,O
worse,O
with,O
lying,O
down,O
and,O
relieved,O
with,O
sitting,O
up,O
.,O

She,O
denies,O
any,B-PR
pain,I-PR
with,O
activity,O
.,O

She,O
also,O
reports,O
a,B-PR
cough,I-PR
productive,O
of,O
green,B-PR
sputum,I-PR
for,O
approximately,O
one,O
week,O
.,O

She,O
does,O
report,O
chills,B-PR
",",O
but,O
no,O
fevers,B-PR
.,O

In,O
the,O
Emergency,O
Department,O
",",O
she,O
was,O
started,O
on,O
a,B-TR
nesiritide,I-TR
drip,I-TR
and,O
responded,O
well,O
with,O
2000,O
cc,O
urine,O
output,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Nonischemic,B-PR
dilated,I-PR
cardiomyopathy,I-PR
with,O
an,B-TE
ejection,I-TE
fraction,I-TE
of,O
15-20%,O
.,O

2.,O
Status,O
post,O
cardiac,B-TE
catheterization,I-TE
in,O
2011-11-19,O
which,O
showed,O
normal,O
coronaries,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

1.,O
Toprol,B-TR
.,O

2.,O
Lasix,B-TR
.,O

3.,O
Digoxin,B-TR
.,O

4.,O
Coumadin,B-TR
.,O

5.,O
Flovent,B-TR
.,O

6.,O
Albuterol,B-TR
.,O

7.,O
Lisinopril,B-TR
.,O

ALLERGIES,O
:,O

She,O
has,O
no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

She,O
is,O
a,O
positive,O
tobacco,O
user,O
.,O

She,O
smoked,O
a,O
half,O
pack,O
a,O
day,O
for,O
eight,O
years,O
and,O
quit,O
in,O
2011-11-19,O
.,O

She,O
denies,O
any,O
alcohol,O
or,O
drug,O
use,O
.,O

She,O
has,O
a,O
5-year-old,O
son,O
.,O

FAMILY,O
HISTORY,O
:,O

There,O
is,O
no,O
family,O
history,O
of,O
coronary,B-PR
artery,I-PR
disease,I-PR
.,O

VITALS,O
ON,O
ADMISSION,O
:,O

She,O
had,O
a,B-TE
temperature,I-TE
of,O
98.1,O
",",O
blood,B-TE
pressure,I-TE
of,O
130/99,O
",",O
pulse,B-TE
of,O
111,O
",",O
respiratory,B-TE
rate,I-TE
of,O
16,O
.,O

She,O
was,O
saturating,O
100%,O
on,O
room,O
air,O
.,O

PHYSICAL,O
EXAM,O
:,O

General,O
:,O

She,O
is,O
in,O
no,O
apparent,B-PR
distress,I-PR
.,O

She,O
is,O
obese,B-PR
.,O

She,O
is,O
slightly,B-PR
tachypneic,I-PR
.,O

HEENT,O
:,O

Pupils,O
are,O
equal,O
",",O
round,O
",",O
and,O
reactive,O
to,O
light,O
.,O

Her,O
oropharynx,O
is,O
clear,O
.,O

Mucous,O
membranes,O
are,O
moist,O
.,O

Neck,O
:,O

She,O
has,O
JVD,B-PR
to,O
angle,O
of,O
the,O
jaw,O
",",O
no,O
bruits,B-PR
.,O

Chest,O
:,O

She,O
has,O
got,O
bilateral,B-PR
basilar,I-PR
crackles,I-PR
",",O
no,O
wheezing,B-PR
.,O

Cardiac,B-TE
examination,I-TE
:,O

She,O
had,O
a,O
normal,O
S1,O
",",O
S2,O
with,O
a,B-PR
2/6,I-PR
systolic,I-PR
ejection,I-PR
murmur,I-PR
at,I-PR
the,I-PR
left,I-PR
upper,I-PR
sternal,I-PR
border,I-PR
.,O

She,O
had,O
a,O
positive,O
S4,B-PR
.,O

Her,O
abdomen,O
was,O
obese,B-PR
",",O
soft,O
",",O
nontender,B-PR
.,O

Extremities,O
:,O

2+,B-PR
edema,I-PR
to,I-PR
the,I-PR
knees,I-PR
.,O

LABORATORIES,O
ON,O
ADMISSION,O
:,O

She,O
had,O
a,B-TE
white,I-TE
count,I-TE
of,O
9.3,O
",",O
hematocrit,B-TE
of,O
37.7,O
",",O
platelets,B-TE
of,O
293,O
.,O

She,O
had,O
a,B-TE
CK,I-TE
of,O
212,O
and,O
MB,B-TE
of,O
21,O
",",O
and,O
a,B-TE
troponin,I-TE
of,O
0.56,O
.,O

She,O
had,O
a,B-TE
Chem-7,I-TE
which,O
was,O
normal,O
.,O

She,O
had,O
an,B-TE
INR,I-TE
of,O
1.5,O
on,O
her,B-TR
Coumadin,I-TR
.,O

Chest,B-TE
x-ray,I-TE
showed,O
right,B-PR
patchy,I-PR
opacity,I-PR
with,O
a,B-PR
right,I-PR
effusion,I-PR
.,O

EKG,B-TE
showed,O
sinus,B-PR
tachycardia,I-PR
",",O
borderline,B-PR
left,I-PR
axis,I-PR
",",O
normal,O
intervals,O
",",O
LVH,B-PR
",",O
left,B-PR
atrial,I-PR
enlargement,I-PR
",",O
no,O
Q,B-PR
waves,I-PR
",",O
no,O
P-R,B-PR
depressions,I-PR
",",O
no,O
ST,B-PR
segment,I-PR
elevations,I-PR
or,O
depression,B-PR
.,O

HOSPITAL,O
COURSE,O
:,O

1.,O
Congestive,B-PR
heart,I-PR
failure,I-PR
:,O

Patient,O
was,O
diuresed,O
effectively,O
with,O
nesiritide,B-TR
and,O
Lasix,B-TR
.,O

Patient,B-TE
's,I-TE
weight,I-TE
on,O
admission,O
was,O
250,O
pounds,O
",",O
and,O
on,O
the,O
day,O
of,O
discharge,O
was,O
244,O
pounds,O
which,O
was,O
back,O
to,O
her,B-TE
dry,I-TE
weight,I-TE
.,O

She,O
had,O
lost,O
the,O
6,O
pounds,O
that,O
she,O
reported,O
gaining,O
in,O
the,O
four,O
days,O
prior,O
to,O
her,O
hospitalization,O
.,O

Patient,O
was,O
continued,O
on,O
her,B-TR
Toprol,I-TR
",",O
her,B-TR
lisinopril,I-TR
",",O
and,O
her,B-TR
digoxin,I-TR
.,O

Patient,B-TR
's,I-TR
Coumadin,I-TR
was,O
held,O
for,O
right,B-TE
heart,I-TE
catheterization,I-TE
and,O
biopsy,B-TE
",",O
and,O
then,O
EP,B-TE
study,I-TE
with,O
ICD,B-TR
placement,I-TR
.,O

Patient,O
did,O
have,O
Woodrow,O
Betty,O
",",O
SPEP,B-TE
",",O
and,O
anticardiolipin,B-TE
antibody,I-TE
sent,O
for,O
further,B-TE
workup,I-TE
of,O
the,O
etiology,O
of,O
her,B-PR
cardiomyopathy,I-PR
.,O

The,O
Courtney,O
",",O
SPEP,B-TE
",",O
and,O
anticardiolipin,B-TE
antibody,I-TE
were,O
all,O
negative,O
.,O

Her,B-TE
CKs,I-TE
did,O
trend,O
down,O
over,O
the,O
course,O
of,O
her,O
hospital,O
stay,O
",",O
and,O
in,O
the,O
setting,O
of,O
her,O
known,O
clean,O
coronaries,O
on,O
cardiac,B-TE
catheterization,I-TE
in,O
2011-11-19,O
",",O
it,O
was,O
believed,O
that,O
a,B-PR
myocarditis,I-PR
might,O
be,O
the,O
cause,O
of,O
her,B-PR
elevated,I-PR
cardiac,I-PR
enzymes,I-PR
and,O
also,O
could,O
have,O
exacerbated,O
her,B-PR
congestive,I-PR
heart,I-PR
failure,I-PR
.,O

Patient,O
did,O
receive,O
a,B-TE
right,I-TE
heart,I-TE
catheterization,I-TE
",",O
which,O
showed,O
elevated,B-PR
wedge,I-PR
pressures,I-PR
and,O
biopsy,B-TE
specimens,I-TE
were,O
obtained,O
of,O
the,O
right,O
ventricle,O
.,O

The,O
results,O
of,O
these,B-TE
biopsies,I-TE
are,O
still,O
pending,O
in,O
pathology,O
.,O

Post,O
right,B-TE
heart,I-TE
catheterization,I-TE
and,O
right,B-TE
ventricular,I-TE
biopsy,I-TE
",",O
the,O
patient,O
was,O
sent,O
to,O
the,O
CCU,O
for,O
a,B-TR
Swan,I-TR
-,I-TR
guided,I-TR
therapy,I-TR
in,O
the,O
setting,O
of,O
her,B-PR
elevated,I-PR
wedge,I-PR
pressures,I-PR
and,O
low,B-PR
cardiac,I-PR
output,I-PR
.,O

In,O
the,O
CCU,O
",",O
she,O
was,O
put,O
on,O
milrinone,B-TR
with,O
good,O
results,O
.,O

Patient,O
was,O
also,O
seen,O
by,O
the,O
Pulmonary,O
service,O
here,O
and,O
had,O
pulmonary,B-TE
function,I-TE
tests,I-TE
done,O
as,O
part,O
of,O
a,B-TE
pretransplant,I-TE
workup,I-TE
.,O

There,O
is,O
no,O
pulmonary,O
process,O
to,O
exclude,O
her,O
from,O
the,O
transplant,O
list,O
as,O
noted,O
by,O
the,O
Pulmonary,O
service,O
.,O

Patient,O
did,O
receive,O
an,B-TR
ICD,I-TR
during,O
this,O
hospital,O
admission,O
without,O
complication,B-PR
.,O

Patient,O
was,O
in,O
bigeminy,B-PR
during,O
the,O
course,O
of,O
her,O
hospital,O
stay,O
",",O
and,O
did,O
have,O
frequent,O
runs,O
of,O
ectopy,B-PR
as,O
noted,O
on,O
telemetry,B-TE
.,O

2.,O
Her,B-PR
right,I-PR
lower,I-PR
lobe,I-PR
infiltrate,I-PR
:,O

Patient,O
did,O
report,O
a,B-PR
cough,I-PR
productive,O
of,O
green,B-PR
sputum,I-PR
on,O
admission,O
.,O

She,O
received,O
a,O
full,O
course,O
of,O
azithromycin,B-TR
for,O
this,O
with,O
resolution,O
of,O
her,B-PR
cough,I-PR
and,O
sputum,B-PR
production,I-PR
.,O

On,O
discharge,O
",",O
the,O
patient,O
was,O
restarted,O
on,O
her,B-TR
Coumadin,I-TR
",",O
which,O
was,O
held,O
for,O
her,B-TE
right,I-TE
heart,I-TE
catheterization,I-TE
",",O
and,O
her,B-TE
biopsy,I-TE
",",O
and,O
her,B-TR
ICD,I-TR
placement,I-TR
.,O

She,O
was,O
also,O
continued,O
on,O
all,B-TR
her,I-TR
heart,I-TR
failure,I-TR
medications,I-TR
including,O
her,B-TR
Toprol,I-TR
",",O
her,B-TR
lisinopril,I-TR
",",O
her,B-TR
digoxin,I-TR
",",O
and,O
her,B-TR
Lasix,I-TR
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Good,O
.,O

DISCHARGE,O
STATUS,O
:,O

To,O
home,O
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

Nonischemic,B-PR
dilated,I-PR
cardiomyopathy,I-PR
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

1.,O
Digoxin,B-TR
375,O
mcg,O
and,O
250,O
mcg,O
alternating,O
doses,O
each,O
day,O
.,O

2.,O
Lisinopril,B-TR
40,O
mg,O
p.o.,O
q.d.,O

3.,O
Toprol,B-TR
XL,I-TR
75,O
mg,O
p.o.,O
q.d.,O

4.,O
Flovent,B-TR
110,O
mcg,O
two,O
puffs,O
b.i.d.,O

5.,O
Albuterol,B-TR
1-2,O
puffs,O
q.6h.,O
prn,O
.,O

6.,O
Coumadin,B-TR
10,O
mg,O
p.o.,O
q.h.s.,O

7.,O
Lasix,B-TR
40,O
mg,O
p.o.,O
q.d.,O

8.,O
Keflex,B-TR
500,O
mg,O
x6,O
doses,O
.,O

FOLLOW-UP,O
INSTRUCTIONS,O
:,O

The,O
patient,O
will,O
follow,O
up,O
in,O
EP,O
Clinic,O
on,O
2012-03-19,O
.,O

She,O
will,O
also,O
be,O
seen,O
in,O
the,O
Heart,O
Failure,O
Clinic,O
on,O
2012-03-28,O
.,O

Patient,O
will,O
also,O
followup,O
with,O
her,O
primary,O
care,O
provider,O
",",O
Dr.,O
Sandra,O
Lamar,O
for,O
check,O
of,O
her,B-TE
INR,I-TE
in,O
one,O
week,O
's,O
time,O
.,O

Felix,O
Weiss,O
",",O
M.D.,O

95-771,O

Dictated,O
By,O
:,O
Randy,O
EB,O
Brooks,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2012-03-13,O
12:25,O

T,O
:,O
2012-03-13,O
14:00,O

JOB,O
#:,O
15824,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Felix,O
Willis,O
on,O
:,O
FRI,O
2012-06-22,O
12:49,O
PM,O

(,O
End,O
of,O
Report,O
),O

513119146,O

PUOMC,O

2186824,O

425597,O

704384,O

4/16/2001,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O

FALMDREPSGREND,O
",",O
LINE,O

MRN,O
:,O

2186824,O

Age,O
:,O

40y,O

REGISTRATION,O
DATE,O
:,O

04/16/2001,O
03:46,O
PM,O

PRELIMINARY,O
REPORT,O

This,O
is,O
to,O
notify,O
you,O
that,O
your,O
patient,O
",",O
FALMDREPSGREND,O
",",O
LINE,O
arrived,O
in,O
the,O
Emergency,O
Department,O
at,O
Ph,O
University,O
Of,O
Medical,O
Center,O
on,O
04/16/2001,O
03:46,O
PM,O
.,O

The,O
patient,O
presented,O
with,O
a,O
chief,O
complaint,O
of,O
PAIN,B-PR
/,O
ASSAULT,O
.,O

Following,O
evaluation,B-TE
and,O
treatment,B-TR
",",O
the,O
patient,O
&apos;s,O
disposition,O
at,O
the,O
end,O
of,O
the,O
visit,O
was,O
ADMITTED,O
TO,O
OBSERVATION,O
AT,O
PH,O
UNIVERSITY,O
OF,O
MEDICAL,O
CENTER,O
.,O

Your,O
patient,O
was,O
admitted,O
under,O
the,O
care,O
of,O
SHUFFCUCH,O
",",O
SEYSHARMSE,O
N,O
with,O
a,O
preliminary,O
diagnosis,O
of,O
VERTEBRAL,B-PR
FRACTURES,I-PR
.,O

If,O
you,O
need,O
additional,O
information,O
please,O
call,O
639-873-2993,O
.,O

PCP,O
Name,O
:,O

RALLSVERSGACH,O
",",O
DWAINCO,O

Provider,O
Number,O
:,O

91361,O

Admission,O
Date,O
:,O

2014-01-20,O

Discharge,O
Date,O
:,O

2014-01-21,O

Date,O
of,O
Birth,O
:,O

1928-01-02,O

Sex,O
:,O

M,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,O
Drugs,B-TR

Attending,O
:,O
Michael,O
V.,O
Hamlett,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Hypoxia,B-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O
none,O

History,O
of,O
Present,O
Illness,O
:,O

CC,O
:,O
dyspnea,B-PR

HPI,O
:,O

86,O
yo,O
man,O
with,O
h/o,O
CVA,B-PR
",",O
CHF,B-PR
",",O
recent,O
episodes,O
of,O
aspiration,B-PR
pneumonia,I-PR
",",O
who,O
p/w,O
dyspnea,B-PR
from,O
his,O
NH,O
.,O

Per,O
the,O
pt,O
's,O
daughter,O
",",O
the,O
patient,O
has,O
had,O
2-3,O
episodes,O
of,O
asp,B-PR
pna,I-PR
in,O
the,O
last,O
2,O
months,O
",",O
for,O
which,O
he,O
has,O
received,O
IV,B-TR
abx,I-TR
at,O
the,O
NH,O
with,O
apparent,O
resolution,O
of,O
symptoms,B-PR
.,O

The,O
daughter,O
says,O
that,O
on,O
the,O
day,O
PTA,O
",",O
when,O
she,O
visited,O
the,O
patient,O
at,O
the,O
NH,O
",",O
he,O
was,O
"",O
having,O
a,O
good,O
day,O
",""",O
more,O
interactive,O
than,O
usual,O
and,O
in,O
good,O
spirits,O
.,O

She,O
was,O
called,O
at,O
430,O
am,O
today,O
from,O
the,O
NH,O
with,O
the,O
news,O
that,O
the,O
pt,O
was,O
not,O
doing,O
well,O
",",O
and,O
she,O
came,O
to,O
the,O
Deanna,O
to,O
meet,O
up,O
with,O
her,O
father,O
.,O

Of,O
note,O
",",O
the,O
patient,O
's,O
daughter,O
and,O
son-in-law,O
confirm,O
his,O
desire,O
to,O
be,O
DNR/DNI,B-TR
",",O
stating,O
that,O
they,O
want,O
him,O
to,O
be,O
comfortable,O
.,O

However,O
",",O
when,O
asked,O
if,O
she,O
thinks,O
he,O
would,O
want,O
comfort,B-TR
measures,I-TR
even,O
if,O
it,O
meant,O
that,O
his,O
respiratory,O
status,O
would,O
worsen,O
",",O
the,O
pt,O
's,O
daughter,O
says,O
that,O
he,O
would,O
not,O
.,O

In,O
particular,O
",",O
she,O
feels,O
that,O
the,O
pt,O
would,O
not,O
want,O
a,B-TR
morphine,I-TR
drip,I-TR
if,O
it,O
would,O
negatively,O
impact,O
his,O
respiratory,O
function,O
.,O

ROS,O
:,O
patient,O
unable,O
to,O
communicate,O
at,O
current,O
time,O

Past,O
Medical,O
History,O
:,O

PMH,O
:,O

-,O
CVA,B-PR
x,O
2,O
",",O
1970,O
and,O
1996,O

-,O
renal,B-PR
cell,I-PR
ca,I-PR
",",O
s/p,O
left,B-TR
nephrectomy,I-TR
1992,O

-,O
dementia,B-PR
",",O
since,O
2000,O
",",O
baseline,B-TE
MMSE,I-TE
21/29,O

-,O
moderate,B-PR
R,I-PR
sided,I-PR
macular,I-PR
degeneration,I-PR

Social,O
History,O
:,O

Social,O
hx,O
:,O
came,O
to,O
the,O
States,O
10,O
yrs,O
ago,O
with,O
his,O
wife,O
.,O

Robert,O
a,O
daughter,O
who,O
lives,O
in,O
Wareham,O
.,O

Used,O
to,O
work,O
as,O
an,O
engineer,O
at,O
an,O
automobile,O
plant,O
.,O

World,O
War,O
II,O
veteran,O
.,O

Currently,O
living,O
at,O
Beth,O
Israel,O
Deaconess,O
Hospital-Needham,O
Rehab,O
.,O

Asian-speaking,O
only,O
.,O

Family,O
History,O
:,O
noncontributory,O

Physical,O
Exam,O
:,O

Vitals,O
:,O

T,B-TE
102.8,O

HR,B-TE
113,O

BP,B-TE
157/85,O

RR,B-TE
35,O

Sat,B-TE
97%,O
on,O
BIPAP,B-TR

10,O
23,


Gen,O
:,O
frail,B-PR
",",O
elderly,O
caucasian,O
man,O
lying,O
in,O
stretcher,O
",",O
HOB,O
at,O
45,O
degrees,O
",",O
breathing,O
in,O
moderate,B-PR
distress,I-PR
with,O
accessory,B-PR
muscle,I-PR
use,I-PR

HEENT,O
:,O

BIPAP,B-TR
mask,I-TR
in,O
place,O
with,O
no,O
apparent,B-PR
leak,I-PR
",",O
eyes,O
closed,O
",",O
mouth,O
open,O
",",O
no,O
rhinorhea,B-PR
or,O
oral,B-PR
discharge,I-PR
visible,O

Neck,O
:,O

JVP,B-TE
flat,O

CV,O
:,O
difficult,O
to,O
assess,O
heart,O
sounds,O
over,O
respiratory,O
sounds,O
",",O
but,O
appears,O
to,O
have,O
RRR,O
",",O
nl,O
s1,O
s2,O
",",O
no,O
murmurs,B-PR

Lungs,O
:,O

R,O
lower,O
01-20,O
with,O
coarse,B-PR
BS,I-PR
and,O
rales,B-PR
;,O
L,O
side,O
clear,O
;,O
no,O
wheezing,B-PR

Abd,O
:,O
thin,O
",",O
nd,B-PR
",",O
nt,B-PR
",",O
soft,O
",",O
no,O
masses,B-PR
palpable,O

Ext,O
:,O
thin,O
",",O
no,O
edema,B-PR
",",O
multiple,B-PR
old,I-PR
well-healed,I-PR
scars,I-PR
on,I-PR
R,I-PR
leg,I-PR

Skin,O
:,O
warm,O
and,O
dry,O
",",O
no,O
rash,B-PR
or,O
breakdown,B-PR
noted,O
though,O
could,O
not,O
examine,O
sacrum,O

Neuro,O
:,O
reactive,O
to,O
pain,B-TE
",",O
otherwise,O

Pertinent,O
Results,O
:,O

2014-01-20,O
05:30,O
AM,O
BLOOD,B-TE
WBC,B-TE
-,O
10.9,O
RBC,B-TE
-,O
4.63,O
Hgb,B-TE
-,O
13.6,O
*,O
Hct,B-TE
-,O
40.3,O
#,O
MCV,B-TE
-,O
87,O
MCH,B-TE
-,O
29.3,O
MCHC,B-TE
-,O
33.7,O
RDW,B-TE
-,O
14.0,O
Plt,B-TE
Ct,I-TE
-,O
393,O
#,O

2014-01-20,O
05:30,O
AM,O
BLOOD,B-TE
Neuts,B-TE
-,O
82.6,O
*,O
Lymphs,B-TE
-,O
14.5,O
*,O
Monos,B-TE
-,O
2.2,O
Eos,B-TE
-,O
0.2,O
Baso,B-TE
-,O
0.4,O

2014-01-20,O
02:08,O
PM,O
BLOOD,B-TE
PT,B-TE
-,O
13.2,O
PTT,B-TE
-,O
27.4,O
INR,B-TE
(,I-TE
PT,I-TE
)-,I-TE
1.2,O

2014-01-20,O
05:30,O
AM,O
BLOOD,B-TE
Plt,B-TE
Ct,I-TE
-,O
393,O
#,O

2014-01-20,O
05:30,O
AM,O
BLOOD,B-TE
Glucose,B-TE
-,O
334,O
*,O
UreaN,B-TE
-,O
22,O
*,O
Creat,B-TE
-,O
0.9,O
Na,B-TE
-,O
144,O
K,B-TE
-,O
5.0,O
Cl,B-TE
-,O
108,O
HCO3,B-TE
-,O
25,O
AnGap,B-TE
-,O
16,O

2014-01-20,O
02:08,O
PM,O
BLOOD,B-TE
CK,B-TE
(,I-TE
CPK,I-TE
)-,I-TE
275,O
*,O

2014-01-20,O
05:30,O
AM,O
BLOOD,B-TE
ALT,B-TE
-,O
15,O
AST,B-TE
-,O
22,O
LD,B-TE
(,I-TE
LDH,I-TE
)-,I-TE
254,O
*,O
CK,B-TE
(,I-TE
CPK,I-TE
)-,I-TE
398,O
*,O
AlkPhos,B-TE
-,O
125,O
*,O
TotBili,B-TE
-,O
0.5,O

2014-01-20,O
02:08,O
PM,O
BLOOD,B-TE
CK-MB,B-TE
-,O
9,O
cTropnT,B-TE
-,O
0.08,O
*,O

2014-01-20,O
05:30,O
AM,O
BLOOD,B-TE
cTropnT,B-TE
-,O
0.05,O
*,O

2014-01-20,O
05:30,O
AM,O
BLOOD,B-TE
CK-MB,B-TE
-,O
7,O

2014-01-20,O
05:30,O
AM,O
BLOOD,B-TE
Albumin,B-TE
-,O
3.2,O
*,O
Calcium,B-TE
-,O
9.3,O
Phos,B-TE
-,O
4.2,O
Mg,B-TE
-,O
1.8,O

ABG,B-TE
s:,I-TE

2014-01-20,O
10:46,O
PM,O
BLOOD,B-TE
Type,O
-,O
ART,B-TE
pO2,B-TE
-,O
148,O
*,O
pCO2,B-TE
-,O
129,O
*,O
pH,B-TE
-,O
7.03,O
*,O
calHCO3,B-TE
-,O
37,O
*,O
Base,B-TE
XS,I-TE
-,O
-1,O

2014-01-20,O
11:49,O
AM,O
BLOOD,B-TE
Type,O
-,O
ART,B-TE
PEEP,B-TR
-,O
5,O
FiO2,B-TR
-,O
60,O
pO2,B-TE
-,O
75,O
*,O
pCO2,B-TE
-,O
56,O
*,O
pH,B-TE
-,O
7.29,O
*,O
calHCO3,B-TE
-,O
28,O
Base,B-TE
XS,I-TE
-,O
0,O
Intubat,O
-,O
NOT,O
INTUBA,O
Comment,O
-,O
BIPAP,B-TR

2014-01-20,O
10:46,O
PM,O
BLOOD,B-TE
Glucose,B-TE
-,O
114,O
*,O
Lactate,B-TE
-,O
1.8,O
K,B-TE
-,O
4.8,O

2014-01-20,O
11:49,O
AM,O
BLOOD,B-TE
Lactate,B-TE
-,O
3.0,O
*,O
K,B-TE
-,O
5.1,O

2014-01-20,O
11:49,O
AM,O
BLOOD,B-TE
freeCa,B-TE
-,O
1.19,O

CXR,B-TE
:,O

IMPRESSION,O
:,O

Focal,B-PR
consolidation,I-PR
in,I-PR
the,I-PR
medial,I-PR
aspect,I-PR
of,O
the,O
right,O
lower,O
lung,O

Brief,O
Hospital,O
Course,O
:,O

This,O
86,O
yo,O
man,O
with,O
h/o,O
CVA,B-PR
",",O
CHF,B-PR
",",O
recent,O
episodes,O
of,O
aspiration,B-PR
pneumonia,I-PR
",",O
presented,O
with,O
dyspnea,B-PR
from,O
his,O
NH,O
",",O
likely,O
from,O
new,O
RLL,B-PR
pneumonia,I-PR
.,O

He,O
was,O
started,O
on,O
Zosyn,B-TR
and,O
Vanco,B-TR
for,O
his,B-PR
presumed,I-PR
aspiration,I-PR
",",O
"",B-PR
hospital,I-PR
"",I-PR
aquired,I-PR
PNA,I-PR
.,O

PE,B-PR
was,O
considered,O
but,O
less,O
likely,O
given,O
his,B-PR
fevers,I-PR
and,O
clear,B-PR
pneumonia,I-PR
on,O
CXR,B-TE
.,O

He,O
was,O
supported,O
on,O
BIPAP,B-TR
for,O
his,O
respiratory,O
status,O
.,O

An,B-TE
ABG,I-TE
was,O
attempted,O
in,O
the,O
Deanna,O
however,O
it,O
was,O
limited,O
by,O
pt,B-PR
discomfort,I-PR
.,O

ABG,B-TE
on,O
arrival,O
to,O
the,O
ICU,O
was,O
7.29/56/75,O
.,O

He,O
was,O
continued,O
on,O
BIPAP,B-TR
.,O

Blood,B-TE
cultures,I-TE
and,O
sputum,B-TE
cultures,I-TE
were,O
sent,O
.,O

Over,O
the,O
course,O
of,O
the,O
day,O
he,O
continued,O
to,O
decline,O
.,O

He,O
was,O
given,O
some,B-TR
prn,I-TR
Morphine,I-TR
for,O
comfort,O
.,O

In,O
the,O
evening,O
of,O
the,O
day,O
of,O
admission,O
he,O
was,O
noted,O
to,O
be,O
increasingly,B-PR
somnolent,I-PR
.,O

A,B-TE
repeat,I-TE
ABG,I-TE
was,O
performed,O
which,O
was,O
7.03/129/148,O
.,O

His,O
family,O
was,O
notified,O
that,O
he,O
was,O
doing,O
worse,O
and,O
came,O
in,O
to,O
visit,O
him,O
.,O

It,O
was,O
his,O
family,O
's,O
wish,O
that,O
he,O
be,O
made,O
comfortable,O
.,O

Based,O
upon,O
this,O
wish,O
the,B-TR
BIPAP,I-TR
was,O
removed,O
and,O
he,O
was,O
placed,O
on,O
nasal,B-TR
cannula,I-TR
.,O

He,O
was,O
written,O
for,O
a,B-TR
morphine,I-TR
drip,I-TR
however,O
he,O
expired,O
before,O
this,O
could,O
be,O
initiated,O
.,O

Secondary,O
issues,O

Elevated,B-PR
lactate,I-PR
:,O

This,O
was,O
concerning,O
for,O
early,B-PR
sepsis,I-PR
given,O
RLL,B-PR
PNA,I-PR
.,O

His,B-TE
blood,I-TE
pressures,I-TE
remained,O
elevated,B-PR
and,O
he,O
was,O
hydrated,O
with,O
NS,B-TR
conservatively,O
",",O
given,O
h/o,O
CHF,B-PR
and,O
dyspnea,B-PR
.,O

DM2,B-PR
:,O

He,O
was,O
covered,O
with,O
a,B-TR
Insulin,I-TR
drip,I-TR
while,O
unstable,O

CV,O
:,O

CAD,B-PR
:,O

He,O
was,O
not,O
taking,O
any,B-TR
PO,I-TR
medications,I-TR
per,O
Hunt,O
Center,O
Rehab,O
so,O
all,B-TR
medications,I-TR
were,O
held,O
.,O

Medications,O
on,O
Admission,O
:,O

Meds,O
:,O

Discharge,O
Disposition,O
:,O

Expired,O

Discharge,O
Diagnosis,O
:,O

Pneumonia,B-PR

Discharge,O
Condition,O
:,O
expired,O

Discharge,O
Instructions,O
:,O

N/A,O

Followup,O
Instructions,O
:,O

N/A,O

Daniel,O
Monica,O
MD,O
55-804,O

Completed,O
by,O
:,O
Sheri,O
John,O
MD,O
30-456,O
2014-01-21,O
@,O
0659,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Meredith,O
Davis,O
on,O
:,O
Sandra,O
2014-03-13,O
1:53,O
PM,O

(,O
End,O
of,O
Report,O
),O

525602122,O
EH,O

25951463,O

363878,O

12/05/1997,O
12:00:00,O
AM,O

BILATERAL,B-PR
LUNG,I-PR
NODULES,I-PR

Signed,O

DIS,O

Admission,O
Date,O
:,O

12/05/1997,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

12/07/1997,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
50,O
year-old,O
female,O
with,O
a,O
history,O
of,O
bilateral,B-PR
lung,I-PR
nodules,I-PR
dating,O
back,O
to,O
the,O
July,O
of,O
1995,O
discovered,O
on,O
a,B-TE
work-up,I-TE
for,O
an,B-PR
adrenal,I-PR
abnormality,I-PR
.,O

Diffuse,B-PR
adenopathy,I-PR
was,O
noted,O
at,O
that,O
time,O
and,O
an,O
attempt,O
was,O
made,O
at,O
axillary,B-TE
node,I-TE
biopsy,I-TE
which,O
was,O
aborted,O
secondary,O
to,O
positioning,O
difficulty,O
and,O
difficult,B-PR
intubation,I-PR
.,O

She,O
was,O
since,O
then,O
lost,O
to,O
follow-up,B-TE
with,O
a,O
recently,O
re-establish,O
primary,O
care,O
practitioner,O
contact,O
.,O

Follow-up,B-TE
chest,I-TE
CT,I-TE
on,O
October,O
26,O
",",O
1997,O
at,O
the,O
Ver,O
Medical,O
Center,O
showed,O
multiple,B-PR
pulmonary,I-PR
nodules,I-PR
in,O
abundant,O
number,O
",",O
very,B-PR
small,I-PR
nodes,I-PR
seen,O
in,O
the,O
mediastinum,O
but,O
no,O
hilar,B-PR
adenopathy,I-PR
",",O
no,O
hepatosplenomegaly,B-PR
or,O
adrenal,B-PR
mass,I-PR
was,O
noted,O
.,O

Chest,B-TE
x-ray,I-TE
on,O
August,O
6,O
",",O
1997,O
revealed,O
multiple,B-PR
pulmonary,I-PR
nodules,I-PR
increasing,O
in,O
size,O
since,O
July,O
22,O
",",O
1995,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

She,O
denies,O
any,B-PR
hypertension,I-PR
",",O
coronary,B-PR
artery,I-PR
disease,I-PR
",",O
chest,B-PR
pain,I-PR
",",O
myocardial,B-PR
infarction,I-PR
or,O
diabetes,B-PR
mellitus,I-PR
.,O

She,O
is,O
status,O
post,O
an,B-TR
open,I-TR
cholecystectomy,I-TR
in,O
1968,O
",",O
status,O
post,O
hysterectomy,B-TR
and,O
axillary,B-TE
node,I-TE
biopsy,I-TE
which,O
failed,O
.,O

She,O
has,O
a,O
history,O
of,O
hiatal,B-PR
hernia,I-PR
and,O
umbilical,B-TR
hernia,I-TR
repair,I-TR
.,O

She,O
also,O
has,O
a,O
history,O
of,O
an,B-PR
adrenal,I-PR
disorder,I-PR
treated,O
with,O
Prednisone,B-TR
in,O
the,O
past,O
",",O
but,O
not,O
currently,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

1),O
Spironolactone,B-TR
50,O
mg,O
p.o.,O
b.i.d.,O

2),O
Advil,B-TR
p.r.n.,O

3),O
Topical,B-TR
steroids,I-TR
for,O
eczema,B-PR
p.r.n.,O

ALLERGIES,O
:,O

The,O
patient,O
had,O
no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
quit,O
smoking,O
approximately,O
fourteen,O
years,O
ago,O
after,O
a,O
four,O
pack,O
per,O
year,O
history,O
.,O

She,O
is,O
a,O
single,O
female,O
who,O
lives,O
in,O
Mifayston,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Vital,O
signs,O
:,O

Blood,B-TE
pressure,I-TE
140/80,O
",",O
heart,B-TE
rate,I-TE
86,O
.,O

She,O
is,O
a,O
pleasant,O
",",O
obese,O
",",O
black,O
female,O
in,O
no,O
apparent,B-PR
distress,I-PR
.,O

There,O
is,O
no,O
lymphadenopathy,B-PR
.,O

Her,O
skin,O
is,O
intact,O
without,O
lesions,B-PR
.,O

Her,B-TE
HEENT,I-TE
examination,I-TE
is,O
benign,O
.,O

Her,O
neck,O
is,O
slightly,B-PR
tender,I-PR
with,O
a,B-PR
firm,I-PR
thyroid,I-PR
",",O
but,O
no,O
masses,B-PR
or,O
bruits,B-PR
.,O

Her,O
lungs,O
have,O
decreased,B-PR
sounds,I-PR
bilaterally,I-PR
in,I-PR
the,I-PR
upper,I-PR
lung,I-PR
fields,I-PR
.,O

Her,O
heart,O
is,O
regular,O
rate,O
and,O
rhythm,O
.,O

She,O
has,O
a,B-PR
well,I-PR
healed,I-PR
umbilical,I-PR
hernia,I-PR
scar,I-PR
for,I-PR
approximately,I-PR
2,I-PR
1/2,I-PR
cm,I-PR
.,O

She,O
has,O
no,O
clubbing,B-PR
",",O
cyanosis,B-PR
or,O
edema,B-PR
on,I-PR
her,I-PR
extremities,I-PR
.,O

LABORATORY,O
:,O

Pulmonary,B-TE
function,I-TE
tests,I-TE
on,O
September,O
27,O
",",O
1997,O
revealed,O
an,B-TE
FVC,I-TE
of,O
2.7,O
which,O
is,O
112%,O
and,O
FEV1,B-TE
of,O
2.23,O
which,O
is,O
123%,O
.,O

Her,O
admission,O
laboratory,O
data,O
includes,O
serum,B-TE
chemistries,I-TE
with,O
a,B-TE
sodium,I-TE
of,O
144,O
",",O
potassium,B-TE
4.1,O
",",O
chloride,B-TE
101,O
",",O
bicarbonate,B-TE
28,O
",",O
BUN,B-TE
10,O
",",O
creatinine,B-TE
0.9,O
and,O
glucose,B-TE
of,O
93,O
.,O

White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
is,O
7.65,O
",",O
hematocrit,B-TE
of,O
42,O
and,O
platelets,B-TE
of,O
345,O
.,O

Her,B-TE
urinalysis,I-TE
shows,O
2+,B-PR
bacteria,I-PR
and,O
2+,B-PR
squamous,I-PR
epithelium,I-PR
with,O
greater,B-PR
than,I-PR
"10,000",I-PR
mixed,I-PR
bacteria,I-PR
.,O

Chest,B-TE
x-ray,I-TE
on,O
August,O
6,O
",",O
1997,O
revealed,O
multiple,B-PR
pulmonary,I-PR
nodules,I-PR
increased,O
in,O
size,O
as,O
previously,O
mentioned,O
.,O

PT,B-TE
was,O
11.7,O
",",O
PTT,B-TE
26.7,O
and,O
INR,B-TE
of,O
0.9,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
on,O
December,O
5,O
",",O
1997,O
and,O
underwent,O
left,B-TR
lung,I-TR
wedge,I-TR
thoracoscopic,I-TR
resection,I-TR
and,O
bronchoscopy,B-TR
.,O

She,O
was,O
transferred,O
to,O
the,O
Post,O
Anesthesia,O
Care,O
Unit,O
postoperatively,O
in,O
stable,O
condition,O
.,O

Her,B-TR
chest,I-TR
tube,I-TR
was,O
pulled,O
on,O
postoperative,O
day,O
number,O
one,O
and,O
the,O
patient,O
did,O
quite,O
well,O
and,O
remained,O
inhouse,O
for,O
observation,B-TE
until,O
December,O
7,O
",",O
1997,O
and,O
the,O
patient,O
was,O
discharged,O
to,O
home,O
in,O
stable,O
condition,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

1),O
Lac-Hydrin,B-TR
12%,O
topically,O
b.i.d.,O

2),O
Colace,B-TR
100,O
mg,O
p.o.,O
t.i.d.,O

3),O
Tylenol,B-TR
#,I-TR
3,I-TR
tablets,O
rather,O
than,O
Percocet,B-TR
",",O
1-2,O
tablets,O
p.o.,O
q.4-6h.,O
p.r.n.,O
pain,B-PR
.,O

4),O
Spironolactone,B-TR
50,O
mg,O
p.o.,O
b.i.d.,O

DIET,O
:,O

No,O
restrictions,O
.,O

ACTIVITY,O
:,O

No,O
restrictions,O
.,O

FOLLOW-UP,O
:,O

The,O
patient,O
is,O
to,O
follow-up,O
with,O
Dr.,O
Prus,O
and,O
she,O
should,O
call,O
for,O
an,O
appointment,O
.,O

DISPOSITION,O
:,O

The,O
patient,O
was,O
discharged,O
to,O
stay,O
with,O
her,O
family,O
until,O
returning,O
home,O
and,O
will,O
be,O
screened,O
for,O
house,O
safety,O
upon,O
moving,O
from,O
the,O
family,O
&apos;s,O
house,O
.,O

Dictated,O
By,O
:,O

BURLTIS,O
SHOULDER,O
",",O
M.D.,O
UU24,O

Attending,O
:,O

LASHAUND,O
PRUS,O
",",O
M.D.,O
HY9,O
ZG840/5307,O

Batch,O
:,O

47331,O

Index,O
No.,O
HRMNNB82LK,O

D,O
:,O

12/07/97,O

T,O
:,O

12/09/97,O

?Admission,O
Date,O
:,O

2016-03-30,O

Discharge,O
Date,O
:,O

2016-04-03,O

Date,O
of,O
Birth,O
:,O

1951-08-19,O

Sex,O
:,O

F,O

Service,O
:,O

CCU,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
64-year-old,O
female,O
with,O
a,O
history,O
of,O
hypertension,B-PR
",",O
hypercholesterolemia,B-PR
",",O
diabetes,B-PR
mellitus,I-PR
",",O
and,O
dilated,B-PR
cardiomyopathy,I-PR
(,O
with,O
a,B-TE
transthoracic,I-TE
echocardiogram,I-TE
in,O
2016-01-13,O
showing,O
an,B-TE
ejection,I-TE
fraction,I-TE
of,O
40%,O
",",O
posterior,B-PR
and,I-PR
inferior,I-PR
apical,I-PR
akinesis,I-PR
",",O
and,O
large,B-PR
left,I-PR
ventricular,I-PR
thrombus,I-PR
).,O

The,O
patient,O
was,O
admitted,O
from,O
2016-01-21,O
to,O
2016-02-03,O
;,O
at,O
which,O
time,O
she,O
was,O
ruled,O
out,O
for,O
a,B-PR
myocardial,I-PR
infarction,I-PR
.,O

She,O
had,O
a,B-TE
cardiac,I-TE
catheterization,I-TE
which,O
revealed,O
3-vessel,B-PR
disease,I-PR
with,O
normal,O
left,O
main,O
",",O
mid,O
left,O
anterior,O
descending,O
artery,O
60%,O
",",O
diffuse,B-PR
90%,I-PR
mid,I-PR
distal,I-PR
stenosis,I-PR
at,O
the,O
origin,O
of,O
the,O
diagonal,O
",",O
serial,O
70%,O
and,O
90%,B-PR
left,I-PR
circumflex,I-PR
lesions,I-PR
",",O
and,O
90%,O
first,O
obtuse,O
marginal,O
",",O
and,O
mid,O
right,O
coronary,O
artery,O
60%,O
.,O

During,O
initial,B-TE
evaluation,I-TE
for,O
a,B-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
",",O
80%,O
to,O
90%,O
of,O
the,B-PR
right,I-PR
coronary,I-PR
artery,I-PR
stenosis,I-PR
was,O
found,O
;,O
for,O
which,O
she,O
underwent,O
a,B-TR
right,I-TR
internal,I-TR
carotid,I-TR
artery,I-TR
stent,I-TR
.,O

She,O
was,O
discharged,O
on,O
Coumadin,B-TR
for,O
a,O
goal,O
INR,B-TE
of,O
2.5,O
to,O
3,O
.,O

She,O
was,O
then,O
admitted,O
again,O
on,O
2016-03-30,O
for,O
an,B-TR
elective,I-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
.,O

At,O
surgery,B-TR
",",O
the,O
descending,O
aorta,O
was,O
noted,O
to,O
be,O
calcified,B-PR
",",O
and,O
an,B-TE
intraoperative,I-TE
transesophageal,I-TE
echocardiogram,I-TE
revealed,O
an,B-PR
irregular,I-PR
intra-aortic,I-PR
pedunculated,I-PR
lesion,I-PR
.,O

Given,O
the,B-PR
elevated,I-PR
stroke,I-PR
risk,I-PR
of,O
aortic,B-TR
cross-clamping,I-TR
in,O
the,O
setting,O
of,O
this,O
finding,O
",",O
the,O
plan,O
for,O
a,B-TR
bypass,I-TR
graft,I-TR
was,O
aborted,O
.,O

The,O
patient,O
was,O
then,O
transferred,O
to,O
the,O
Coronary,O
Care,O
Unit,O
Service,O
for,O
medical,O
management,O
in,O
anticipation,O
of,O
possible,O
percutaneous,B-TR
coronary,I-TR
intervention,I-TR
later,O
in,O
the,O
admission,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Diabetes,B-PR
mellitus,I-PR
.,O

2.,O
Hypertension,B-PR
.,O

3.,O
Hypercholesterolemia,B-PR
.,O

4.,O
Asthma,B-PR
.,O

5.,O
Chronic,B-PR
low,I-PR
back,I-PR
pain,I-PR
.,O

6.,O
Cholelithiasis,B-PR
.,O

7.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
(,O
as,O
noted,O
previously,O
).,O

8.,O
Dilated,B-PR
cardiomyopathy,I-PR
(,O
also,O
as,O
noted,O
above,O
).,O

MEDICATIONS,O
ON,O
TRANSFER,O
:,O

1.,O
Dopamine,B-TR
drip,I-TR
at,O
3,O
.,O

2.,O
Insulin,B-TR
drip,I-TR
at,O
2,O
.,O

3.,O
Regular,B-TR
10,O
units,O
intravenously,O
q.6h.,O
as,O
needed,O
.,O

4.,O
Percocet,B-TR
as,O
needed,O
.,O

5.,O
Sucralfate,B-TR
1,O
g,O
via,O
nasogastric,O
tube,O
q.6h.,O

6.,O
Aspirin,B-TR
325,O
mg,O
p.o.,O
once,O
per,O
day,O
.,O

7.,O
Colace,B-TR
100,O
mg,O
p.o.,O
twice,O
per,O
day,O
.,O

8.,O
Flonase,B-TR
2,O
puffs,O
twice,O
per,O
day,O
.,O

9.,O
Lipitor,B-TR
10,O
mg,O
p.o.,O
once,O
per,O
day,O
.,O

10.,O
Protonix,B-TR
40,O
mg,O
p.o.,O
once,O
per,O
day,O
.,O

11.,O
Plavix,B-TR
75,O
mg,O
p.o.,O
once,O
per,O
day,O
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

Social,O
history,O
is,O
positive,O
for,O
smoking,O
.,O

PHYSICAL,O
EXAMINATION,O
ON,O
PRESENTATION,O
:,O

Physical,B-TE
examination,I-TE
revealed,O
temperature,B-TE
was,O
99.3,O
",",O
heart,B-TE
rate,I-TE
was,O
66,O
in,O
a,O
normal,O
sinus,O
rhythm,O
",",O
blood,B-TE
pressure,I-TE
was,O
132/51,O
",",O
respiratory,B-TE
rate,I-TE
was,O
22,O
",",O
and,O
oxygen,B-TE
saturation,I-TE
was,O
100%,O
on,O
3,B-TR
liters,I-TR
nasal,I-TR
cannula,I-TR
.,O

Swan,B-TE
showed,O
a,B-TE
PA,I-TE
of,O
29/11,O
",",O
SVR,B-TE
of,O
14/9,O
",",O
cardiac,B-TE
output,I-TE
of,O
3.86,O
",",O
cardiac,B-TE
index,I-TE
of,O
2.14,O
.,O

Urine,B-TE
output,I-TE
of,O
30,O
cc,O
to,O
100,O
cc,O
per,O
hour,O
over,O
the,O
last,O
four,O
hours,O
.,O

Chest,B-TR
tube,I-TR
showed,O
30,O
cc,O
per,O
hour,O
over,O
the,O
last,O
four,O
hours,O
.,O

In,O
general,O
",",O
the,O
patient,O
was,O
alert,O
and,O
oriented,O
times,O
three,O
.,O

In,O
no,O
apparent,B-PR
distress,I-PR
and,O
denied,O
pain,B-PR
.,O

Head,B-TE
",",I-TE
eyes,I-TE
",",I-TE
ears,I-TE
",",I-TE
nose,I-TE
",",I-TE
and,I-TE
throat,I-TE
examination,I-TE
was,O
without,O
bruits,B-PR
.,O

Lungs,O
were,O
clear,O
to,O
auscultation,B-TE
anteriorly,O
.,O

Heart,O
was,O
regular,O
in,O
rate,B-TE
and,O
rhythm,B-TE
.,O

Normal,O
first,B-TE
heart,I-TE
sounds,I-TE
and,O
second,B-TE
heart,I-TE
sounds,I-TE
.,O

No,O
audible,B-PR
murmurs,I-PR
.,O

The,O
abdomen,O
was,O
soft,O
",",O
nontender,B-PR
",",O
and,O
nondistended,B-PR
with,O
active,O
bowel,O
sounds,O
.,O

Extremities,O
were,O
without,O
edema,B-PR
.,O

Neurologic,B-TE
examination,I-TE
was,O
nonfocal,O
.,O

Lines,B-TR
included,O
a,B-TR
right,I-TR
antecubital,I-TR
peripheral,I-TR
intravenous,I-TR
.,O

Chest,B-TR
tube,I-TR
was,O
in,O
place,O
in,O
left,O
internal,O
jugular,O
an,B-TR
pulmonary,I-TR
artery,I-TR
catheter,I-TR
.,O

PERTINENT,O
LABORATORY,O
VALUES,O
ON,O
PRESENTATION,O
:,O

Laboratories,B-TE
revealed,O
white,B-TE
blood,I-TE
cell,I-TE
count,I-TE
was,O
12.7,O
",",O
hematocrit,B-TE
was,O
32.4,O
",",O
platelets,B-TE
were,O
140,O
",",O
and,O
mean,B-TE
cell,I-TE
volume,I-TE
was,O
80,O
.,O

Patient,O
was,O
4.4,O
",",O
blood,B-TE
urea,I-TE
nitrogen,I-TE
was,O
14,O
",",O
creatinine,B-TE
was,O
0.6,O
",",O
and,O
glucose,B-TE
was,O
147,O
.,O

INR,B-TE
was,O
1.2,O
",",O
partial,B-TE
thromboplastin,I-TE
time,I-TE
was,O
23.7,O
",",O
and,O
prothrombin,B-TE
time,I-TE
was,O
13.4,O
.,O

Free,B-TE
calcium,I-TE
was,O
0.95,O
on,O
03-30,O
.,O

Phosphate,B-TE
was,O
3.6,O
and,O
magnesium,B-TE
was,O
2.2,O
.,O

Arterial,B-TE
blood,I-TE
gas,I-TE
at,O
3,O
a.m.,O
demonstrated,O
7.4/45/125,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
is,O
a,O
64-year-old,O
female,O
with,O
3-vessel,B-PR
disease,I-PR
who,O
was,O
admitted,O
to,O
the,O
Coronary,O
Care,O
Unit,O
Service,O
for,O
Western,O
Mass,O
.,O

Hospital,O
medical,O
optimization,O
and,O
management,O
following,O
an,B-TR
aborted,I-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
when,O
a,B-PR
mobile,I-PR
aortic,I-PR
atheroma,I-PR
was,O
noted,O
.,O

The,O
patient,O
was,O
continued,O
on,O
aspirin,B-TR
",",O
Plavix,B-TR
",",O
and,O
statin,B-TR
.,O

Once,O
the,O
patient,O
was,O
titrated,O
off,O
dopamine,B-TR
",",O
the,B-TR
beta,I-TR
blocker,I-TR
and,O
ACE,B-TR
inhibitor,I-TR
were,O
restarted,O
.,O

With,O
regard,O
to,O
the,B-PR
left,I-PR
ventricular,I-PR
thrombus,I-PR
",",O
her,O
goal,O
INR,B-TE
remained,O
2.5,O
to,O
3,O
;,O
and,O
the,O
goal,O
was,O
to,O
start,O
heparin,B-TR
once,O
the,O
patient,O
was,O
stable,O
from,O
a,B-TR
thoracotomy,I-TR
and,O
chest,B-TR
tube,I-TR

standpoint,O
.,O

The,O
patient,O
remained,O
comfortable,O
.,O

By,O
04-01,O
",",O
on,O
postoperative,O
day,O
two,O
",",O
the,O
patient,O
was,O
doing,O
well,O
and,O
the,B-TR
chest,I-TR
tube,I-TR
was,O
discontinued,O
.,O

The,O
patient,O
still,O
had,O
transcutaneous,B-TR
pacing,I-TR
wires,I-TR
in,O
place,O
.,O

Likewise,O
",",O
on,O
04-01,O
",",O
the,O
patient,O
was,O
weaned,O
off,O
surgery,B-TR
without,O
difficulty,O
.,O

Thus,O
",",O
the,B-TR
beta,I-TR
blocker,I-TR
and,O
ACE,B-TR
inhibitor,I-TR
were,O
started,O
to,O
be,O
titrated,O
up,O
.,O

In,O
addition,O
",",O
the,O
patient,O
was,O
started,O
on,O
Wellbutrin,B-TR
for,O
smoking,O
cessation,O
.,O

At,O
this,O
point,O
",",O
it,O
was,O
determined,O
that,O
the,O
patient,O
would,O
not,O
receive,O
percutaneous,B-TR
coronary,I-TR
intervention,I-TR
on,O
this,O
admission,O
and,O
would,O
likely,O
be,O
discharged,O
to,O
the,O
floor,O
for,O
stabilization,O
with,O
followup,O
.,O

The,O
patient,O
did,O
well,O
and,O
was,O
transferred,O
to,O
the,O
floor,O
on,O
04-02,O
.,O

After,O
evaluation,B-TE
and,O
a,O
discussion,O
with,O
Dr.,O
Gunter,O
",",O
it,O
was,O
determined,O
that,O
the,O
patient,O
no,O
longer,O
needed,O
anticoagulation,B-TR
since,O
there,O
was,O
no,O
aortic,B-PR
thrombus,I-PR
but,O
only,O
an,B-PR
aortic,I-PR
plaque,I-PR
",",O
and,O
there,O
was,O
no,O
anterior/apical,B-PR
akinesis,I-PR
noted,O
.,O

At,O
this,O
point,O
",",O
the,B-PR
left,I-PR
ventricular,I-PR
thrombus,I-PR
(,O
for,O
which,O
she,O
was,O
initially,O
started,O
therapy,B-TR
for,O
),O
was,O
no,O
longer,O
present,O
.,O

The,O
patient,O
was,O
noted,O
to,O
have,O
a,B-PR
slight,I-PR
hematocrit,I-PR
drop,I-PR
and,O
was,O
transfused,O
one,B-TR
unit,I-TR
of,I-TR
packed,I-TR
red,I-TR
blood,I-TR
cells,I-TR
for,O
a,O
goal,O
hematocrit,B-TE
of,O
greater,O
than,O
30,O
.,O

By,O
04-03,O
",",O
captopril,B-TR
and,O
atenolol,B-TR
were,O
started,O
",",O
and,O
the,B-TR
patient,I-TR
's,I-TR
leg,I-TR
bandage,I-TR
from,O
the,B-TR
vein,I-TR
harvest,I-TR
was,O
removed,O
.,O

The,O
patient,O
continued,O
to,O
do,O
well,O
on,O
the,B-TR
medical,I-TR
regimen,I-TR
and,O
was,O
without,O
chest,B-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
or,O
any,B-PR
other,I-PR
symptoms,I-PR
.,O

DISCHARGE,O
DISPOSITION,O
:,O

Thus,O
",",O
the,O
patient,O
was,O
discharged,O
to,O
home,O
.,O

DISCHARGE,O
INSTRUCTIONS/FOLLOWUP,O
:,O

The,O
patient,O
was,O
to,O
follow,O
up,O
with,O
her,O
primary,O
care,O
physician,O
(,O
Dr.,O
Desmet,O
),O
",",O
as,O
well,O
as,O

with,O
Dr.,O
Gunter,O
for,O
an,B-TR
eventual,I-TR
percutaneous,I-TR
coronary,I-TR
intervention,I-TR
",",O
and,O
her,O
surgeon,O
(,O
Dr.,O
Halcomb,O
),O
following,O
her,B-TR
thoracotomy,I-TR
.,O

DISCHARGE,O
DIAGNOSES:,O

1.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
;,O
3-vessel,B-PR
disease,I-PR
.,O

2.,O
Status,B-TR
post,I-TR
aborted,I-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
due,O
to,O
mobile,B-PR
aortic,I-PR
atheroma,I-PR
.,O

3.,O
Diabetes,B-PR
.,O

4.,O
Hypertension,B-PR
.,O

CONDITION,O
AT,O
DISCHARGE,O
:,O

Condition,O
on,O
discharge,O
was,O
stable,O
and,O
asymptomatic,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

1.,O
Aspirin,B-TR
325,O
mg,O
p.o.,O
once,O
per,O
day,O
.,O

2.,O
Docusate,B-TR
100,O
mg,O
p.o.,O
twice,O
per,O
day,O
.,O

3.,O
Fluticasone,B-TR
2,O
puffs,O
inhaled,O
twice,O
per,O
day,O
.,O

4.,O
Protonix,B-TR
40,O
mg,O
p.o.,O
once,O
per,O
day,O
.,O

5.,O
Plavix,B-TR
75,O
mg,O
p.o.,O
once,O
per,O
day,O
.,O

6.,O
Pravastatin,B-TR
20,O
mg,O
p.o.,O
once,O
per,O
day,O
.,O

7.,O
Bupropion,B-TR
100,O
mg,O
p.o.,O
twice,O
per,O
day,O
(,O
for,O
smoking,O
cessation,O
).,O

8.,O
Atenolol,B-TR
25,O
mg,O
p.o.,O
once,O
per,O
day,O
.,O

9.,O
Lisinopril,B-TR
5,O
mg,O
p.o.,O
once,O
per,O
day,O
.,O

Miriam,O
C,O
Hebert,O
",",O
M.D.,O

05-383,O

Dictated,O
By,O
:,O
Barbara,O
B.,O
Phillips,O
",",O
M.D.,O

MEDQUIST36,O

D:,O
2016-06-15,O

21:48,O

T:,O
2016-06-19,O

10:46,O

JOB,O
#:,O

26532,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Kevin,O
Sineath,O
on,O
:,O
Andrea,O
2016-06-30,O
1:09,O
PM,O

(,O
End,O
of,O
Report,O
),O

534644131,O

FIH,O

9393835,O

24529/65a4,O

204379,O

4/28/1993,O
12:00:00,O
AM,O

RIGHT,B-PR
THYROID,I-PR
PAPILLARY,I-PR
CARCINOMA,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

4/28/93,O

DISCHARGE,O
DATE,O
:,O

5/15/93,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Right,B-PR
thyroid,I-PR
papillary,I-PR
carcinoma,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

1.,O
Pulmonary,B-PR
and,I-PR
right,I-PR
iliac,I-PR
bone,I-PR
metastases,I-PR
.,O

2.,O
Eosinophilia,B-PR
.,O

3.,O
Chronic,B-PR
leg,I-PR
edema,I-PR
.,O

4.,O
Atrial,B-PR
fibrillation,I-PR
.,O

5.,O
Congestive,B-PR
heart,I-PR
failure,I-PR
.,O

6.,O
Left,B-PR
subclavian,I-PR
vein,I-PR
thrombosis,I-PR
.,O

7.,O
Urinary,B-PR
tract,I-PR
infection,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
74,O
year,O
old,O
female,O
with,O
metastatic,B-PR
papillary,I-PR
carcinoma,I-PR
of,I-PR
the,I-PR
thyroid,I-PR
who,O
presented,O
to,O
the,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
on,O
4/28/93,O
with,O
progressive,B-PR
weakness,I-PR
",",O
weight,B-PR
loss,I-PR
and,O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

The,O
patient,O
was,O
in,O
a,O
good,O
state,O
of,O
health,O
until,O
January,O
of,O
1993,O
when,O
she,O
developed,O
a,B-PR
serious,I-PR
upper,I-PR
respiratory,I-PR
tract,I-PR
infection,I-PR
associated,O
with,O
weakness,B-PR
and,O
fatigue,B-PR
.,O

She,O
had,O
also,O
reported,O
a,B-PR
weight,I-PR
loss,I-PR
of,I-PR
15,I-PR
pounds,I-PR
over,O
the,O
past,O
two,O
months,O
.,O

Although,O
her,B-PR
upper,I-PR
respiratory,I-PR
tract,I-PR
infection,I-PR
seemed,O
to,O
be,O
resolving,O
",",O
her,B-PR
weakness,I-PR
persisted,O
.,O

A,B-TE
work,I-TE
up,I-TE
begun,O
by,O
her,O
internist,O
",",O
Dr.,O
Brain,O
",",O
revealed,O
a,B-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
of,O
"49,000",O
with,O
50%,B-TE
eosinophils,I-TE
.,O

She,O
was,O
admitted,O
to,O
Box,O
Memorial,O
Hospital,O
Nursing,O
Home,O
for,O
further,B-TE
evaluation,I-TE
.,O

Data,O
collected,O
there,O
included,O
a,B-TE
chest,I-TE
x-ray,I-TE
which,O
was,O
unremarkable,O
.,O

The,B-TE
liver,I-TE
function,I-TE
tests,I-TE
showed,O
an,B-TE
alkaline,I-TE
phosphatase,I-TE
of,O
303,O
",",O
LDH,B-TE
310,O
",",O
SGOT,B-TE
66,O
",",O
albumin,B-TE
2.5,O
.,O

A,B-TE
peripheral,I-TE
blood,I-TE
smear,I-TE
showed,O
mature,O
eosinophils,O
in,O
increased,B-PR
numbers,I-PR
.,O

Chromosomal,B-TE
studies,I-TE
were,O
negative,O
.,O

A,B-TE
bone,I-TE
scan,I-TE
showed,O
increased,B-PR
uptake,I-PR
at,I-PR
the,I-PR
manubrium,I-PR
at,O
the,O
site,O
of,O
an,B-PR
old,I-PR
fracture,I-PR
",",O
as,O
well,O
as,O
in,O
the,O
right,O
supraclavicular,O
area,O
.,O

A,B-TE
thyroid,I-TE
ultrasound,I-TE
showed,O
an,B-PR
inferior,I-PR
thyroid,I-PR
mass,I-PR
.,O

This,O
was,O
followed,O
by,O
an,B-TE
abdominal,I-TE
CT,I-TE
which,O
showed,O
an,B-PR
enlarged,I-PR
spleen,I-PR
",",O
a,B-PR
lytic,I-PR
lesion,I-PR
on,I-PR
the,I-PR
right,I-PR
iliac,I-PR
bone,I-PR
and,O
a,B-PR
benign,I-PR
renal,I-PR
cyst,I-PR
.,O

Biopsy,B-TE
of,I-TE
the,I-TE
lytic,I-TE
lesion,I-TE
was,O
consistent,O
with,O
metastases,B-PR
papillary,I-PR
carcinoma,I-PR
of,I-PR
the,I-PR
thyroid,I-PR
.,O

An,B-TE
upper,I-TE
gastrointestinal,I-TE
was,O
unremarkable,O
.,O

The,B-TE
small,I-TE
bowel,I-TE
follow,I-TE
through,I-TE
was,O
within,O
normal,O
limits,O
.,O

A,B-TE
thyroid,I-TE
scan,I-TE
revealed,O
decreased,B-PR
function,I-PR
and,O
displacement,B-PR
of,I-PR
the,I-PR
thyroid,I-PR
by,O
a,B-PR
cold,I-PR
mass,I-PR
located,O
inferiorly,O
with,O
calcifications,B-PR
on,I-PR
the,I-PR
right,I-PR
side,I-PR
.,O

A,B-TE
chest,I-TE
CT,I-TE
also,O
revealed,O
a,B-PR
small,I-PR
pulmonary,I-PR
nodule,I-PR
with,O
a,B-PR
necrotic,I-PR
mass,I-PR
involving,O
the,O
right,O
lung,O
posteriorly,O
.,O

The,O
patient,O
was,O
subsequently,O
referred,O
to,O
the,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
under,O
the,O
service,O
of,O
Dr.,O
Brain,O
.,O

She,O
continued,O
to,O
have,O
profound,B-PR
weakness,I-PR
",",O
a,B-PR
decreased,I-PR
appetite,I-PR
and,O
weight,B-PR
loss,I-PR
.,O

She,O
also,O
developed,O
lower,B-PR
extremity,I-PR
edema,I-PR
as,O
well,O
as,O
left,B-PR
upper,I-PR
extremity,I-PR
swelling,I-PR
associated,O
with,O
increased,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
on,O
exertion,O
.,O

A,B-TE
needle,I-TE
biopsy,I-TE
of,I-TE
the,I-TE
right,I-TE
thyroid,I-TE
nodule,I-TE
showed,O
papillary,B-PR
thyroid,I-PR
carcinoma,I-PR
.,O

The,O
patient,O
reports,O
no,O
history,O
of,O
radiation,B-PR
exposure,I-PR
",",O
no,O
family,O
history,O
of,O
thyroid,B-PR
carcinoma,I-PR
",",O
no,O
recent,O
travels,O
or,O
exposure,B-PR
to,I-PR
tuberculosis,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Includes,O
a,O
history,O
of,O
atrial,B-PR
fibrillation,I-PR
with,O
good,O
heart,B-TR
rate,I-TR
control,I-TR
on,O
Digoxin,B-TR
.,O

She,O
reports,O
no,O
prior,O
surgical,O
history,O
.,O

The,O
patient,O
also,O
reports,O
no,O
known,B-PR
drug,I-PR
allergy,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
lives,O
alone,O
in,O
Leschle,O
Drive,O
",",O
Sonpo,O
",",O
and,O
does,O
not,O
report,O
a,O
smoking,O
or,O
alcohol,O
history,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Lanoxin,B-TR
",",O
0.25,O
mg,O
po,O
qd,O
;,O
Lasix,B-TR
",",O
20,O
mg,O
po,O
qd,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,O
patient,O
is,O
a,O
pleasant,O
",",O
elderly,O
female,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

Her,B-TE
vital,I-TE
signs,I-TE
showed,O
a,B-TE
blood,I-TE
pressure,I-TE
of,O
126/72,O
",",O
pulse,B-TE
84,O
",",O
respirations,B-TE
22,O
",",O
temperature,B-TE
98.6,O
.,O

She,O
had,O
a,B-PR
3,I-PR
x,I-PR
4,I-PR
cm,I-PR
firm,I-PR
",",I-PR
nontender,I-PR
right,I-PR
thyroid,I-PR
mass,I-PR
that,O
seemed,O
to,O
be,O
fixed,O
to,O
the,O
trachea,O
.,O

She,O
had,O
no,O
jugular,B-PR
venous,I-PR
distention,I-PR
or,O
bruits,B-PR
.,O

The,O
lungs,O
exhibited,O
right,B-PR
basilar,I-PR
dullness,I-PR
one,O
quarter,O
of,O
the,O
way,O
up,O
.,O

She,O
had,O
no,O
definite,B-PR
S3,I-PR
.,O

The,O
liver,O
edge,O
was,O
palpable,O
to,O
6,O
cm,O
below,O
the,O
right,O
costal,O
margin,O
.,O

Her,O
spleen,O
could,O
not,O
be,O
palpated,O
.,O

She,O
had,O
4+,B-PR
edema,I-PR
to,I-PR
the,I-PR
knees,I-PR
bilaterally,I-PR
.,O

LABORATORY,O
DATA,O
:,O

On,O
admission,O
the,B-TE
white,I-TE
blood,I-TE
count,I-TE
was,O
67.3,O
with,O
a,B-TE
differential,I-TE
of,O
21%,B-TE
polys,I-TE
",",O
16%,B-TE
bands,I-TE
",",O
3%,B-TE
lymphocytes,I-TE
",",O
2%,B-TE
monocytes,I-TE
",",O
57%,B-TE
eosinophils,I-TE
and,O
1%,B-TE
myelocytes,I-TE
.,O

Her,B-TE
hematocrit,I-TE
was,O
38.8,O
",",O
hemoglobin,B-TE
13.7,O
",",O
platelet,B-TE
count,I-TE
"155,000",O
",",O
PT,B-TE
12.7/10.1,O
",",O
PTT,B-TE
33.9,O
",",O
erythrocyte,B-TE
sedimentation,I-TE
rate,I-TE
18,O
",",O
calcium,B-TE
7.5,O
",",O
phosphorus,B-TE
3.5,O
",",O
sodium,B-TE
136,O
",",O
potassium,B-TE
3.7,O
",",O
BUN,B-TE
15,O
",",O
total,B-TE
protein,I-TE
5.9,O
",",O
albumin,B-TE
2.3,O
",",O
globulin,B-TE
3.6,O
",",O
alkaline,B-TE
phosphatase,I-TE
379,O
",",O
SGOT,B-TE
37,O
",",O
Digoxin,B-TE
level,I-TE
0.7,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
Dr.,O
Shatermivaet,O
S,O
Brain,O
on,O
4/28/93,O
with,O
a,O
history,O
of,O
papillary,B-PR
carcinoma,I-PR
of,I-PR
the,I-PR
thyroid,I-PR
with,O
bone,B-PR
involvement,I-PR
and,O
possible,O
lung,B-PR
involvement,I-PR
.,O

Work,B-TE
up,I-TE
was,O
begun,O
for,O
the,O
possible,O
myeloproliferative,B-PR
/,I-PR
myelodysplastic,I-PR
disorder,I-PR
associated,O
with,O
the,B-PR
hyper-eosinophilic,I-PR
syndrome,I-PR
.,O

Accordingly,O
",",O
an,O
Oncology,O
consult,O
was,O
called,O
on,O
4/29/93,O
and,O
a,B-TE
bone,I-TE
marrow,I-TE
aspirate,I-TE
biopsy,I-TE
was,O
performed,O
.,O

This,O
revealed,O
maturation,O
of,O
leukocytes,O
to,O
all,O
stages,O
with,O
markedly,B-PR
increased,I-PR
eosinophilic,I-PR
proliferation,I-PR
.,O

A,B-TE
lung,I-TE
biopsy,I-TE
was,O
performed,O
on,O
4/30/93,O
without,O
definitive,O
results,O
.,O

During,O
this,O
time,O
the,O
patient,O
&apos;s,O
coagulation,O
status,O
had,O
improved,O
with,O
Vitamin,B-TR
K,I-TR
therapy,I-TR
with,O
PTs,B-TE
normalizing,O
.,O

ANCA,O
serum,O
results,O
were,O
negative,O
.,O

ANA,O
results,O
were,O
also,O
nonsuggestive,O
.,O

The,O
patient,O
continued,O
to,O
suffer,O
from,O
edema,B-PR
of,I-PR
the,I-PR
left,I-PR
upper,I-PR
extremity,I-PR
and,O
a,O
Vascular,O
Radiology,O
consult,O
revealed,O
a,B-PR
thrombosis,I-PR
of,I-PR
the,I-PR
left,I-PR
subclavian,I-PR
vein,I-PR
extending,O
into,O
the,O
axillary,O
vein,O
.,O

There,O
was,O
some,B-PR
thrombosis,I-PR
of,I-PR
the,I-PR
left,I-PR
internal,I-PR
jugular,I-PR
vein,I-PR
as,O
well,O
.,O

A,B-TE
head,I-TE
CT,I-TE
was,O
performed,O
and,O
was,O
completely,O
negative,O
for,O
any,B-PR
metastatic,I-PR
process,I-PR
involving,O
the,O
brain,O
.,O

Thus,O
",",O
a,B-TR
heparin,I-TR
sliding,I-TR
scale,I-TR
was,O
begun,O
.,O

Meanwhile,O
",",O
the,B-PR
patient,I-PR
&apos;s,I-PR
eosinophilia,I-PR
was,O
treated,O
with,O
a,B-TR
trial,I-TR
of,I-TR
prednisone,I-TR
.,O

She,O
also,O
developed,O
a,B-PR
mild,I-PR
urinary,I-PR
tract,I-PR
infection,I-PR
which,O
responded,O
to,O
Bactrim,B-TR
",",O
but,O
which,O
was,O
subsequently,O
stopped,O
because,O
of,O
diarrhea,B-PR
.,O

The,O
conclusions,O
at,O
this,O
time,O
of,O
the,O
thyroid,O
cytologist,O
",",O
as,O
well,O
as,O
the,O
bone,O
pathologist,O
",",O
were,O
that,O
the,O
findings,O
were,O
diagnostic,O
of,O
papillary,B-PR
thyroid,I-PR
carcinoma,I-PR
with,O
pulmonary,B-PR
metastases,I-PR
.,O

Dr.,O
Trial,O
was,O
subsequently,O
consulted,O
on,O
5/5,O
for,O
surgical,B-TR
intervention,I-TR
.,O

On,O
5/6/93,O
the,O
patient,O
underwent,O
a,B-TR
right,I-TR
thyroidectomy,I-TR
with,O
sacrifice,O
of,O
the,O
right,O
recurrent,O
laryngeal,O
nerve,O
as,O
well,O
as,O
the,O
right,O
sternothyroid,O
muscle,O
and,O
lower,O
parathyroid,O
gland,O
.,O

She,O
underwent,O
autotransplantation,B-TR
of,I-TR
the,I-TR
right,I-TR
upper,I-TR
parathyroid,I-TR
gland,I-TR
",",O
as,O
well,O
as,O
repair,B-TR
of,O
a,B-TR
right,I-TR
posterior,I-TR
membranous,I-TR
tracheotomy,I-TR
.,O

She,O
was,O
received,O
in,O
the,O
Respiratory,O
Intensive,O
Care,O
Unit,O
immediately,O
postoperatively,O
in,O
stable,O
condition,O
.,O

Her,B-TE
rate,I-TE
was,O
well,O
controlled,O
on,O
Digoxin,B-TR
.,O

The,O
patient,O
was,O
transferred,O
to,O
the,O
floor,O
on,O
5/7,O
.,O

On,O
the,O
ward,O
she,O
continued,O
a,B-TR
gentle,I-TR
diuresis,I-TR
as,O
well,O
as,O
Solu-Medrol,B-TR
therapy,I-TR
.,O

Calcium,B-TE
levels,I-TE
remained,O
7.2,O
to,O
7.5,O
postoperatively,O
.,O

She,O
continued,O
to,O
improve,O
with,O
a,B-PR
slight,I-PR
hoarseness,I-PR
in,I-PR
her,I-PR
voice,I-PR
that,O
was,O
expected,O
.,O

She,O
continued,O
to,O
exhibit,O
asymptomatic,B-PR
atrial,I-PR
fibrillation,I-PR
.,O

Anticoagulation,B-TR
was,O
begun,O
on,O
the,O
third,O
postoperative,O
day,O
with,O
Coumadin,B-TR
.,O

She,O
was,O
effectively,B-TR
anticoagulated,I-TR
with,O
a,B-TE
PT,I-TE
in,O
the,O
range,O
between,O
15,O
and,O
17,O
over,O
a,O
control,O
of,O
10,O
.,O

She,O
also,O
received,O
a,O
Radiation,O
Therapy,O
consult,O
for,O
local,B-TR
control,I-TR
of,O
her,B-PR
invasive,I-PR
carcinoma,I-PR
.,O

She,O
did,O
well,O
on,O
the,O
ward,O
and,O
was,O
discharged,O
on,O
her,O
ninth,O
postoperative,O
day,O
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

Metastatic,B-PR
papillary,I-PR
thyroid,I-PR
carcinoma,I-PR
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Coumadin,B-TR
",",O
5,O
mg,O
po,O
alternating,O
with,O
2.5,O
mg,O
po,O
;,O
prednisolone,B-TR
",",O
30,O
mg,O
po,O
bid,O
;,O
hydrochlorothiazide,B-TR
",",O
50,O
mg,O
po,O
bid,O
;,O
potassium,B-TR
chloride,I-TR
",",O
40,O
mEq,O
po,O
bid,O
;,O
Augmentin,B-TR
",",O
500,O
mg,O
po,O
tid,O
;,O
Digoxin,B-TR
",",O
0.125,O
mg,O
po,O
qd,O
;,O
Tylenol,B-TR
",",O
650,O
mg,O
po,O
q4h,O
prn,O
;,O
Carafate,B-TR
",",O
1,O
gram,O
po,O
bid,O
;,O
Synthroid,B-TR
",",O
0.125,O
mg,O
po,O
qd,O
.,O

DISPOSITION,O
:,O

The,O
patient,O
was,O
discharged,O
home,O
with,O
Terchestlumnesamp,O
Medical,O
Center,O
referral,O
for,O
weekly,B-TE
blood,I-TE
tests,I-TE
",",O
potassium,B-TE
and,O
PT,B-TE
.,O

The,O
patient,O
is,O
also,O
to,O
keep,O
her,B-TR
left,I-TR
arm,I-TR
elevated,I-TR
and,O
to,O
remain,O
on,O
a,B-TR
low,I-TR
sodium,I-TR
diet,I-TR
.,O

She,O
will,O
be,O
maintained,O
on,O
a,B-TE
PT,I-TE
between,O
15,O
and,O
17,O
with,O
Coumadin,B-TR
.,O

Arrangements,O
will,O
be,O
made,O
for,O
radiation,B-TR
therapy,I-TR
to,I-TR
the,I-TR
right,I-TR
neck,I-TR
and,I-TR
right,I-TR
iliac,I-TR
crest,I-TR
.,O

The,O
prognosis,O
for,O
rehabilitation,O
potential,O
is,O
guarded,O
.,O

LENNI,O
BRAIN,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

ERTCA,O
TRIAL,O
",",O
M.D.,O

TR,O
:,O

ak,O
/,O
bmot,O

DD,O
:,O

05/15/93,O

TD,O
:,O

05/15/93,O

CC,O
:,O

Dr.,O
Trial,O
",",O
Ertca,O
Dirk,O
",",O
Dr.,O
Lenni,O
Brain,O

Admission,O
Date,O
:,O

2015-09-30,O

Discharge,O
Date,O
:,O

2015-10-02,O

Date,O
of,O
Birth,O
:,O

1958-01-16,O

Sex,O
:,O

F,O

Service,O
:,O

MEDICAL,O
ICU,O

CHIEF,O
COMPLAINT,O
:,O

Change,B-PR
in,I-PR
mental,I-PR
status,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
57-year-old,O
nursing,O
home,O
resident,O
female,O
",",O
who,O
had,O
been,O
in,O
her,O
usual,O
state,O
of,O

health,O
until,O
about,O
three,O
weeks,O
ago,O
when,O
the,O
daughter,O
noted,O
she,O
was,O
sleeping,O
more,O
.,O

Per,O
record,O
",",O
she,O
has,O
had,O
multiple,O
episodes,O
in,O
the,O
last,O
week,O
of,O
changes,B-PR
in,I-PR
mental,I-PR
status,I-PR
.,O

EMTs,O
called,O
many,O
times,O
.,O

The,O
patient,O
would,O
awake,O
prior,O
to,O
arrival,O
and,O
not,O
need,O
transfer,O
.,O

The,O
patient,O
was,O
seen,O
at,O
the,O
Leonard,O
Morse/Metrowest,O
Medical,O
Center,O
on,O
09-28,O
.,O

No,O
localizing,O
etiology,O
of,O
delta,B-PR
MS,I-PR
.,O

That,O
evening,O
she,O
was,O
unresponsive,B-PR
and,O
the,O
patient,O
was,O
brought,O
to,O
Amesbury,O
Hospital,O
Hospital,O
.,O

There,O
her,B-TE
oxygen,I-TE
she,O
was,O
sating,O
65%,O
on,O
room,O
air,O
",",O
increased,O
to,O
98%,O
with,O
a,B-TR
nonrebreather,I-TR
mask,I-TR
.,O

There,O
an,B-TE
ABG,I-TE
was,O
done,O
which,O
showed,O
an,B-TE
ABG,I-TE
of,O
7.42,O
",",O
62,O
",",O
and,O
55,O
.,O

She,O
had,O
a,B-TE
head,I-TE
CT,I-TE
that,O
was,O
negative,O
.,O

Chest,B-TE
x-ray,I-TE
that,O
was,O
questionable,O
left,B-PR
lower,I-PR
lobe,I-PR
infiltrate,I-PR
.,O

Lumbar,B-TE
puncture,I-TE
was,O
performed,O
and,O
the,B-TE
micro,I-TE
cultures,I-TE
are,O
still,O
pending,O
.,O

She,O
was,O
seen,O
by,O
Psychiatry,O
at,O
the,O
outside,O
hospital,O
",",O
but,O
noted,O
there,O
was,O
no,O
psychoses,B-PR
",",O
but,O
delirium,B-PR
.,O

The,O
patient,O
's,O
mental,O
status,O
waxed,O
and,O
waned,O
there,O
.,O

She,O
also,O
had,O
a,B-TE
K,I-TE
of,O
6.0,O
and,O
given,O
30,O
of,O
Kayexalate,B-TR
",",O
5,O
of,O
Haldol,B-TR
",",O
2,O
mg,O
of,O
Ativan,B-TR
given,O
for,O

agitation,B-PR
",",O
and,O
2,O
mg,O
of,O
ceftriaxone,B-TR
was,O
given,O
for,O
a,B-TE
temperature,I-TE
of,O
101.3,O
with,O
a,O
concern,O
for,O
meningitis,B-PR
as,O
a,B-TE
LP,I-TE
was,O
done,O
prior,O
.,O

Patient,O
was,O
transferred,O
to,O
the,O
Kindred,O
Hospital,O
Melendez,O
the,O
patient,O
's,O
primary,O
care,O
provider,O
was,O
here,O
.,O

She,O
is,O
currently,O
being,O
seen,O
by,O
Addison,O
Gilbert,O
Hospital,O
Group,O
.,O

On,O
arrival,O
to,O
Mass.,O
Eye,O
&,O
Ear,O
Infirmary,O
",",O
she,O
was,O
unresponsive,B-PR
with,O
an,B-TE
oxygen,I-TE
saturation,I-TE
of,O
72%,O
on,O
6,B-TR
liters,I-TR
.,O

She,O
was,O
placed,O
on,O
50%,B-TR
vent,I-TR
mask,I-TR
",",O
which,O
improved,O
her,B-TE
oxygenation,I-TE
to,O
97%,O
.,O

Patient,O
was,O
placed,O
on,O
BiPAP,B-TR
.,O

Original,B-TE
ABG,I-TE
here,O
before,O
BiPAP,B-TR
was,O
7.19,O
",",O
102,O
",",O
and,O
92,O
.,O

After,O
being,O
placed,O
on,O
BiPAP,B-TR
",",O
her,B-TE
blood,I-TE
pressure,I-TE
decreased,B-PR
to,O
the,O
80s,O
.,O

She,O
responded,O
to,O
1,O
liter,O
of,O
IV,B-TR
fluids,I-TR
",",O
normal,B-TR
saline,I-TR
and,O
blood,B-TE
pressure,I-TE
remained,O
stable,O
.,O

Patient,O
had,O
peripheral,B-TR
IV,I-TR
x1,O
placed,O
and,O
right,B-TR
femoral,I-TR
line,I-TR
placed,O
in,O
the,O
Matthew,O
.,O

When,O
laying,O
flat,O
",",O
her,B-TE
sats,I-TE
decreased,B-PR
to,O
50%,O
on,O
30%,O
FIO2,B-TR
",",O
PEEP,B-TR
of,O
10,O
",",O
and,O
pressure,B-TR
support,I-TR
of,O
5,O
.,O

Her,B-TE
ABG,I-TE
at,O
the,O
time,O
was,O
7.24,O
",",O
91,O
",",O
and,O
38,O
.,O

Once,O
the,O
patient,O
sat,O
up,O
",",O
her,B-TE
sats,I-TE
improved,O
and,O
her,O
airway,O
was,O
no,O
longer,O
obstructed,O
.,O

After,O
a,O
history,O
on,O
BiPAP,B-TR
about,O
a,O
half,O
an,O
hour,O
",",O
her,B-TE
ABG,I-TE
was,O
7.29,O
",",O
79,O
",",O
and,O
106,O
on,O
30%,O
pressure,B-TR
support,I-TR
of,O
5,O
and,O
PEEP,B-TR
of,O
10,O
.,O

Patient,O
was,O
intermittently,O
awaking,O
.,O

She,O
denied,O
any,O
pain,B-PR
and,O
was,O
not,O
answering,O
questions,O
at,O
the,O
time,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Obstructive-sleep,B-PR
apnea,I-PR
?,O

2.,O
Morbid,B-PR
obesity,I-PR
.,O

3.,O
Congestive,B-PR
heart,I-PR
failure,I-PR
",",O
unknown,O
EF,B-TE
.,O

4.,O
Hypertension,B-PR
.,O

5.,O
Diabetes,B-PR
mellitus,I-PR
.,O

6.,O
Depression,B-PR
.,O

7.,O
Nursing,O
home,O
resident,O
.,O

8.,O
Dyspnea,B-PR
on,O
exertion,O
.,O

9.,O
History,O
of,O
fibroids,B-PR
.,O

10.,O
Hypercholesterolemia,B-PR
.,O

SOCIAL,O
HISTORY,O
:,O

She,O
is,O
a,O
nursing,O
home,O
resident,O
.,O

Does,O
not,O
ambulate,O
.,O

Denies,O
alcohol,O
or,O
tobacco,O
use,O
.,O

MEDICATIONS,O
ON,O
TRANSFER,O
FROM,O
NURSING,O
HOME,O
:,O

1.,O
Lasix,B-TR
40,O
q.d.,O

2.,O
Senna,B-TR
two,O
tablets,O
q.6h.,O

3.,O
Metoprolol,B-TR
25,O
mg,O
b.i.d.,O

4.,O
Metformin,B-TR
"1,000",O
mg,O
b.i.d.,O

5.,O
Colace,B-TR
.,O

6.,O
Niferex,B-TR
one,O
tablet,O
b.i.d.,O

7.,O
Cozaar,B-TR
25,O
mg,O
q.d.,O

8.,O
Ranitidine,B-TR
150,O
mg,O
p.o.,O
q.d.,O

9.,O
Peroxetine,B-TR
40,O
mg,O
p.o.,O
q.d.,O

10.,O
Insulin,B-TR
:,O

NPH,B-TR
70,O
units,O
q.a.m.,O
",",O
50,O
units,O
q.p.m.,O
",",O
regular,B-TR
insulin-sliding,I-TR
scale,I-TR
.,O

11.,O
SubQ,B-TR
Heparin,I-TR
"5,000",O
q.8h.,O

12.,O
Lactulose,B-TR
.,O

13.,O
Multivitamins,B-TR
.,O

14.,O
Albuterol,B-TR
inhalers,I-TR
prn,O
.,O

ALLERGIES,O
:,O

Penicillin,B-TR
:,O

Shortness,B-PR
of,I-PR
breath,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Vital,O
signs,O
:,O

Heart,B-TE
rate,I-TE
108,O
",",O
blood,B-TE
pressure,I-TE
140/82,O
",",O
oxygen,B-TE
saturation,I-TE
96%,O
",",O
respiratory,B-TE
rate,I-TE
of,O
22,O
on,O
BiPAP,B-TR
5/10/30%,O
.,O

In,O
general,O
",",O
sleepy,B-PR
but,O
arousable,O
.,O

Arousable,O
intermittently,O
to,O
voice,B-TE
.,O

HEENT,O
:,O

Pupils,B-TE
3,O
mm,O
reactive,O
.,O

Neck,O
:,O

Obese,B-PR
",",O
unable,O
to,O
assess,O
lymphadenopathy,B-PR
or,O
jugular,B-PR
venous,I-PR
distention,I-PR
.,O

Lungs,O
:,O

Poor,B-PR
effort,I-PR
",",O
no,O
wheezes,B-PR
",",O
rales,B-PR
",",O
or,O
rhonchi,B-PR
.,O

Cardiovascular,O
:,O

Distant,B-PR
heart,I-PR
sounds,I-PR
",",O
tachycardia,B-PR
",",O
regular,O
rhythm,B-TE
.,O

Abdomen,O
is,O
obese,B-PR
",",O
nontender,B-PR
",",O
decreased,B-PR
bowel,I-PR
sounds,I-PR
.,O

Extremities,O
:,O

Obese,B-PR
",",O
no,O
edema,B-PR
",",O
2+,O
pulses,B-TE
.,O

Neurologic,O
:,O

Responding,O
to,O
commands,O
.,O

Moving,O
all,O
extremities,O
well,O
.,O

Toes,O
are,O
downgoing,O
.,O

PERTINENT,O
LABORATORIES,O
:,O

White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
12.8,O
(,O
79%,O
polys,B-TE
",",O
13%,O
lymphocytes,B-TE
",",O
8,O
monocytes,B-TE
",",O
nucleated,B-TE
RBCs,I-TE
1%,O
"),hematocrit",B-TE
31.7,O
.,O

Potassium,B-TE
5.2,O
",",O
creatinine,B-TE
1.3,O
",",O
BUN,B-TE
35,O
",",O
glucose,B-TE
152,O
",",O
D,B-TE
dimer,I-TE
1636,O
",",O
INR,B-TE
1.3,O
.,O

Urinalysis,B-TE
:,O

Moderate,B-TE
leukocytes,I-TE
",",O
06-09,O
RBCs,B-TE
",",O
21-50,O
lymphocytes,B-TE
",",O
many,B-PR
bacteria,I-PR
",",O
06-09,O
epithelial,B-TE
cells,I-TE
.,O

Tox,B-TE
screen,I-TE
negative,O
.,O

Urine,B-TE
cultures,I-TE
pending,O
.,O

LABORATORIES,O
AT,O
OUTSIDE,O
HOSPITAL,O
:,O

White,B-TE
count,I-TE
11.8,O
(,O
90%,O
polys,B-TE
",",O
4%,O
lymphocytes,B-TE
",",O
5%,O
monocytes,B-TE
",",O
1%,O
basophils,B-TE
",",O
3%,O
nucleated,B-TE
RBCs,I-TE
).,O

Potassium,B-TE
6.6,O
",",O
creatinine,B-TE
1.4,O
",",O
alkaline,B-TE
phosphatase,I-TE
302,O
",",O
T,B-TE
bilirubin,I-TE
0.6,O
",",O
AST,B-TE
25,O
",",O
ALT,B-TE
84,O
",",O
CK,B-TE
of,O
15,O
",",O
troponin,B-TE
0.01,O
.,O

Chest,B-TE
x-ray,I-TE
:,O

Left,B-PR
lower,I-PR
lobe,I-PR
basal,I-PR
opacity,I-PR
.,O

EKG,B-TE
:,O

Sinus,B-PR
tachycardia,I-PR
at,O
106,O
beats,B-TE
per,I-TE
minute,I-TE
",",O
left,B-PR
axis,I-PR
deviation,I-PR
",",O
T-wave,B-PR
inversions,I-PR
in,I-PR
leads,I-PR
I,I-PR
and,I-PR
aVL,I-PR
that,O
are,O
old,O
.,O

No,O
QRS,B-PR
widening,I-PR
and,O
no,O
peak,B-PR
T,I-PR
waves,I-PR
.,O

This,O
is,O
in,O
comparison,O
to,O
2015-09-27,O
EKG,B-TE
.,O

Chest,B-TE
x-ray,I-TE
rotated,O
low,B-PR
lung,I-PR
volumes,I-PR
",",O
hazy,B-PR
opacities,I-PR
at,I-PR
bases,I-PR
.,O

Echocardiogram,B-TE
in,O
2010,O
:,O

Mild-to-moderate,B-PR
MR,I-PR
",",O
TR,B-PR
.,O

HOSPITAL,O
COURSE,O
:,O

1.,O
Hypercarbic,B-PR
respiratory,I-PR
failure,I-PR
issues,I-PR
:,O

The,O
patient,O
presented,O
with,O
changes,B-PR
in,I-PR
mental,I-PR
status,I-PR
",",O
pCO2,B-TE
of,O
100,O
",",O
pH,B-TE
of,O
7.19,O
",",O
decreasing,B-PR
sats,I-PR
on,O
arrival,O
likely,O
element,O
of,O
obstructive-sleep,B-PR
apnea,I-PR
.,O

She,O
was,O
monitored,O
overnight,O
.,O

She,O
had,O
admitted,O
to,O
the,O
CMED,O
and,O
had,O
multiple,O
episodes,O
of,O
apnea,B-PR
throughout,O
the,O
night,O
.,O

She,O
was,O
placed,O
on,O
pressure,B-TR
support,I-TR
",",O
which,O
improved,O
her,B-TE
saturations,I-TE
and,O
decreased,O
her,B-PR
hypercarbia,I-PR
.,O

Patient,O
improved,O
that,O
her,B-TE
mental,I-TE
status,I-TE
with,O
improvement,O
of,O
her,B-TE
oxygenation,I-TE
and,O
ventilation,O
as,O
well,O
as,O
for,O
correction,O
of,O
her,B-PR
respiratory,I-PR
acidosis,I-PR
.,O

Patient,O
was,O
eventually,O
placed,O
on,O
BiPAP,B-TR
on,O
hospital,O
day,O
three,O
",",O
on,O
the,O
date,O
prior,O
to,O
discharge,O
of,O
BiPAP,B-TR
settings,O
of,O
12/8/5,B-TR
liters,I-TR
of,I-TR
oxygen,I-TR
with,O
saturations,B-TE
of,O
96%,O
with,O
a,B-TE
gas,I-TE
of,O
7.38,O
",",O
67,O
",",O
and,O
91,O
with,O
an,O
aim,O
of,O
a,O
goal,O
pCO2,B-TE
of,O
67,O
.,O

She,O
only,O
had,O
one,O
episode,O
of,O
apnea,B-PR
on,O
the,O
day,O
prior,O
to,O
discharge,O
.,O

2.,O
Delta,B-PR
MS/mental,I-PR
status,I-PR
issues,I-PR
:,O

Most,O
likely,O
her,B-PR
waxing,I-PR
and,I-PR
waning,I-PR
mental,I-PR
status,I-PR
and,O
hypercarbia/hypoxia,B-PR
compounded,O
by,O
infection,B-PR
of,I-PR
pneumonia,I-PR
and,O
UTI,B-PR
.,O

With,O
improvements,O
of,O
her,B-TE
ventilation,I-TE
and,O
oxygenation,B-TE
and,O
treatment,B-TR
with,O
levofloxacin,B-TR
of,O
her,B-PR
UTI,I-PR
and,O
pneumonia,B-PR
",",O
her,O
mental,O
status,O
greatly,O
improved,O
on,O
hospital,O
day,O
two,O
without,O
further,B-PR
waxing,I-PR
and,I-PR
waning,I-PR
.,O

Her,O
daughters,O
came,O
by,O
and,O
visited,O
her,O
",",O
and,O
reported,O
that,O
she,O
was,O
at,O
her,O
baseline,O
mental,O
status,O
on,O
the,O
day,O
prior,O
to,O
discharge,O
.,O

B12,B-TE
",",O
folate,B-TE
",",O
RPR,B-TE
were,O
all,O
sent,O
that,O
were,O
unremarkable,O
as,O
causes,O
for,O
delta,B-PR
MS,I-PR
.,O

We,O
are,O
awaiting,O
results,O
of,O
the,B-TE
lumbar,I-TE
puncture,I-TE
from,O
the,O
outside,O
hospital,O
",",O
but,O
on,O
hospital,O
day,O
two,O
.,O

Those,B-TE
cultures,I-TE
are,O
still,O
pending,O
at,O
the,O
time,O
.,O

Patient,O
was,O
also,O
given,O
multivites,B-TR
.,O

3.,O
Fever,B-PR
issues,I-PR
:,O

The,O
patient,O
initially,O
presented,O
with,O
T,B-TE
max,I-TE
of,O
101.3,O
at,O
outside,O
hospital,O
with,O
increasing,B-PR
white,I-PR
blood,I-PR
cell,I-PR
counts,I-PR
and,O
a,O
positive,O
urinalysis,B-PR
.,O

A,B-TE
chest,I-TE
x-ray,I-TE
with,O
bilateral,B-PR
patchy,I-PR
infiltrates,I-PR
likely,O
pneumonia,B-PR
and,O
UTI,B-PR
.,O

Upon,O
calling,O
the,O
outside,O
hospital,O
",",O
the,O
urine,O
was,O
growing,O
out,O
Klebsiella,B-PR
",",O
and,O
patient,O
was,O
given,O
a,O
10,O
day,O
course,O
of,O
levofloxacin,B-TR
to,O
cover,O
both,O
the,B-PR
pneumonia,I-PR
and,O
UTI,B-PR
.,O

Blood,B-TE
cultures,I-TE
and,O
urine,B-TE
cultures,I-TE
are,O
still,O
pending,O
at,O
this,O
hospital,O
visit,O
and,O
the,O
CSF,B-TE
fluid,I-TE
from,O
Whitter,O
Rehabilitation,O
Hospital,O
needs,O
to,O
be,O
further,O
evaluated,O
.,O

Patient,O
on,O
the,O
day,O
of,O
discharge,O
was,O
afebrile,B-PR
with,O
a,B-PR
decreasing,I-PR
white,I-PR
count,I-PR
x48,O
hours,O
.,O

4.,O
Acute,B-PR
renal,I-PR
failure,I-PR
issues,I-PR
:,O

Creatinine,B-TE
initially,O
presented,O
at,O
1.3,O
.,O

Patient,O
is,O
known,O
to,O
have,O
a,O
baseline,O
of,O
1.0,O
",",O
most,O
likely,O
hypovolemia,B-PR
and,O
prerenal,O
.,O

A,B-TE
FENa,I-TE
was,O
sent,O
",",O
was,O
0.3%,O
.,O

Patient,O
was,O
gently,O
hydrated,O
and,O
IV,B-TR
fluids,I-TR
started,O
up,O
on,O
a,B-TR
p.o.,I-TR
diet,I-TR
regimen,I-TR
.,O

On,O
hospital,O
day,O
two,O
",",O
her,B-TE
creatinine,I-TE
returned,O
to,O
0.8,O
",",O
and,O
she,O
remained,O
with,O
a,B-TE
creatinine,I-TE
of,O
0.8,O
for,O
the,O
remainder,O
of,O
her,O
hospital,O
stay,O
.,O

Patient's,B-TE
K,I-TE
was,O
followed,O
",",O
and,O
trended,O
back,O
down,O
to,O
normal,O
on,O
the,O
day,O
of,O
discharge,O
at,O
3.9,O
.,O

5.,O
Elevated,B-PR
transaminases,I-PR
:,O

Patient,O
had,O
no,O
right,B-PR
upper,I-PR
quadrant,I-PR
pain,I-PR
.,O

Stewart,B-TE
sign,I-TE
was,O
negative,O
.,O

A,B-TE
right,I-TE
upper,I-TE
quadrant,I-TE
ultrasound,I-TE
was,O
performed,O
that,O
showed,O
no,O
hepatic,B-PR
or,I-PR
biliary,I-PR
pathology,I-PR
likely,O
due,O
to,O
acute,B-PR
phase,I-PR
stress,I-PR
changes,I-PR
given,O
the,O
fact,O
that,O
she,O
had,O
no,O
clinical,B-PR
symptoms,I-PR
.,O

There,O
is,O
no,O
need,O
to,O
followup,O
these,B-TE
transaminases,I-TE
.,O

6.,O
Congestive,B-PR
heart,I-PR
failure,I-PR
history,O
:,O

Patient,O
was,O
stable,O
without,O
evidence,O
of,O
CHF,B-PR
on,O
chest,B-TE
x-ray,I-TE
.,O

Followed,O
her,B-TE
sats,I-TE
likely,O
due,O
to,O
obstructive-sleep,B-PR
apnea,I-PR
and,O
hypoventilation,B-PR
.,O

Patient,O
was,O
restarted,O
on,O
her,B-TR
beta,I-TR
blocker,I-TR
and,O
.......-,O
receptor,B-TR
blocker,I-TR
on,O
hospital,O
day,O
two,O
given,O
that,O
her,B-TE
creatinine,I-TE
had,O
stabilized,O
.,O

Patient,O
had,O
no,O
further,B-PR
cardiac,I-PR
issues,I-PR
at,O
this,O
time,O
.,O

She,O
was,O
on,O
telemetry,B-TE
without,O
any,O
episodes,O
of,O
any,B-PR
rhythm,I-PR
abnormalities,I-PR
.,O

7.,O
CMED,O
CCU,O
:,O

The,O
patient,O
had,O
some,B-PR
vaginal,I-PR
bleeding,I-PR
x2,O
days,O
.,O

Patient,O
had,O
a,O
history,O
of,O
fibroids,B-PR
during,O
this,O
hospitalization,O
.,O

Followed,O
her,B-TE
examination,I-TE
.,O

Her,B-TE
hematocrit,I-TE
remained,O
stable,O
throughout,O
this,O
course,O
.,O

Patient,O
is,O
strongly,O
encouraged,O
to,O
followup,O
with,O
her,O
outside,O
primary,O
care,O
provider,O
to,O
followup,O
for,O
the,B-PR
vaginal,I-PR
bleeding,I-PR
given,O
her,O
history,O
of,O
fibroids,B-PR
and,O
question,O
metaplasia,B-PR
of,I-PR
the,I-PR
endometrium,I-PR
.,O

8.,O
Heme,O
:,O

Her,B-TE
hematocrit,I-TE
remained,O
stable,O
.,O

She,O
had,O
a,O
history,O
of,O
nucleated,B-PR
RBCs,I-PR
likely,O
secondary,O
to,O
stress,B-PR
and,O
hypoxia,B-PR
during,O
this,O
admission,O
.,O

Hemolysis,B-TE
laboratories,I-TE
were,O
negative,O
.,O

Patient,O
was,O
restarted,O
on,O
her,B-TR
iron,I-TR
supplementation,I-TR
.,O

Reticulocyte,B-TE
count,I-TE
was,O
performed,O
that,O
was,O
negative,O
.,O

9.,O
FEN,O
:,O

She,O
was,O
NPO,B-TR
with,O
a,B-PR
decrease,I-PR
in,I-PR
her,I-PR
mental,I-PR
status,I-PR
.,O

We,O
slowly,O
advanced,O
her,O
diet,O
as,O
her,O
mental,O
status,O
improved,O
and,O
repleted,O
her,B-TE
electrolytes,I-TE
",",O
and,O
started,O
on,O
her,B-TR
p.o.,I-TR
medications,I-TR
on,O
hospital,O
day,O
two,O
.,O

10.,O
Diabetes,B-PR
:,O

Patient,O
had,O
q.i.d.,O
fingersticks,B-TE
with,O
a,B-TR
Humalog,I-TR
sliding,I-TR
scale,I-TR
and,O
NPH,B-TR
doses,I-TR
were,O
cut,O
in,O
half,O
while,O
she,O
was,O
NPO,B-TR
",",O
and,O
they,O
were,O
brought,O
back,O
to,O
her,B-TR
normal,I-TR
doses,I-TR
on,O
the,O
day,O
of,O
discharge,O
with,O
a,O
full,O
diet,O
.,O

11.,O
Code,O
status,O
:,O

Full,O
.,O

Two,O
daughters,O
came,O
by,O
and,O
requested,O
to,O
be,O
health,O
care,O
proxies,O
as,O
patient,O
approved,O
.,O

Documentation,O
is,O
in,O
her,O
medical,O
chart,O
.,O

12.,O
Prophylaxis,B-TR
:,O

The,O
patient,O
was,O
on,O
subQ,B-TR
Heparin,I-TR
for,O
DVT,B-PR
and,O
ranitidine,B-TR
for,O
GI,B-TR
prophylaxis,I-TR
.,O

DISPOSITION:,O

The,O
patient,O
is,O
to,O
be,O
discharged,O
today,O
to,O
Lahey,O
Clinic,O
-,O
North,O
Shore,O
Hospital,O
for,O
long-term,B-TR
pulmonary,I-TR
........,I-TR
therapy,I-TR
and,O
further,O
evaluation,B-TE
of,O
her,B-PR
obstructive-sleep,I-PR
apnea,I-PR
.,O

DISCHARGE,O
CONDITION,O
:,O

Patient,O
was,O
stable,O
with,O
complete,O
clearance,O
of,O
her,O
mental,O
status,O
",",O
advancement,O
of,O
her,O
diet,O
",",O

blood,B-TE
pressure,I-TE
",",O
and,O
heart,B-TE
rate,I-TE
remained,O
stable,O
",",O
and,O
her,B-TE
oxygen,I-TE
saturations,I-TE
were,O
well,O
above,O
90%,O
during,O
the,O
daytime,O
on,O
2,B-TR
liters,I-TR
nasal,I-TR
cannula,I-TR
and,O
at,O
night,O
on,O
the,B-TR
BiPAP,I-TR
settings,O

described,O
above,O
.,O

Physical,O
Therapy,O
consult,O
is,O
pending,O
today,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
NPH,B-TR
70,O
units,O
q.a.m.,O
",",O
50,O
units,O
q.p.m.,O

2.,O
Humalog,B-TR
sliding,I-TR
scale,I-TR
.,O

3.,O
SubQ,B-TR
Heparin,I-TR
"5,000",O
units,O
t.i.d.,O

4.,O
Ranitidine,B-TR
150,O
mg,O
p.o.,O
b.i.d.,O

5.,O
Multivitamin,B-TR
x1,O
.,O

6.,O
Losartan,B-TR
25,O
mg,O
p.o.,O
q.d.,O

7.,O
Iron,B-TR
supplementation,I-TR
150,O
mg,O
p.o.,O
q.d.,O

8.,O
Levofloxacin,B-TR
day,O
four,O
of,O
10,O
to,O
be,O
completed,O
for,O
a,O
full,O
10-day,O
course,O
",",O
500,O
mg,O
p.o.,O
q.d.,O

9.,O
Metoprolol,B-TR
25,O
mg,O
p.o.,O
b.i.d.,O

10.,O
Colace,B-TR
100,O
mg,O
p.o.,O
b.i.d.,O

Mark,O
Nibbe,O
",",O
M.D.,O

87-896,O

Dictated,O
By,O
:,O
Jeffrey,O
N.,O
Elvington,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O

2015-10-02,O
8:19,O

T,O
:,O

2015-10-02,O
8:20,O

JOB,O
#,O
:,O

15790,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Mark,O
Nibbe,O
on,O
:,O
TUE,O
2015-10-06,O
9:46,O
PM,O

(,O
End,O
of,O
Report,O
),O

537167143,O

FIH,O

1543338,O

75053/sqyo,O

326247,O

12/3/1993,O
12:00:00,O
AM,O

PAPILLARY,B-PR
ADENOCARCINOMA,I-PR
OF,I-PR
THE,I-PR
LUNG,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

12-3-93,O

DISCHARGE,O
DATE,O
:,O

12-10-93,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Papillary,B-PR
adenocarcinoma,I-PR
of,I-PR
the,I-PR
lung,I-PR
.,O

SPECIAL,O
PROCEDURES,O
AND,O
OPERATIONS,O
:,O

A,B-TE
flexible,I-TE
bronchoscopy,I-TE
and,O
extrapleural-pleural,B-TR
lobectomy,I-TR
on,O
12-4-93,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
47,O
year,O
old,O
white,O
male,O
with,O
a,O
history,O
of,O
emphysema,B-PR
who,O
presents,O
for,O
admission,O
with,O
a,O
diagnosis,O
of,O
broncho-alveolar,B-PR
carcinoma,I-PR
and,O
is,O
scheduled,O
for,O
flexible,B-TE
bronchoscopy,I-TE
",",O
mediastinoscopy,B-TE
and,O
thoracotomy,B-TR
with,O
questionable,O
pneumonectomy,B-TR
by,O
Dr.,O
An,O
on,O
12-4-93,O
.,O

The,O
patient,O
is,O
a,O
native,O
of,O
Nahuter,O
with,O
a,O
70+,O
pack,O
year,O
smoking,O
history,O
(,O
2,O
1/2-3,O
pack,O
per,O
day,O
x,O
35,O
years,O
),O
whose,O
symptoms,O
began,O
last,O
12/92,O
when,O
he,O
had,O
a,B-PR
persistent,I-PR
cough,I-PR
and,O
fever,B-PR
.,O

In,O
six,O
months,O
",",O
he,O
was,O
hospitalized,O
for,O
pneumonia,B-PR
x,O
four,O
.,O

He,O
has,O
had,O
worsening,B-PR
dyspnea,I-PR
and,O
paroxysmal,B-PR
nocturnal,I-PR
dyspnea,I-PR
",",O
though,O
denies,O
orthopnea,B-PR
.,O

No,O
hemoptysis,B-PR
",",O
no,O
fevers,B-PR
",",O
chills,B-PR
",",O
sweats,B-PR
",",O
when,O
pneumonia,B-PR
resolved,O
.,O

The,O
patient,O
also,O
noticed,O
a,B-PR
loss,I-PR
of,I-PR
weight,I-PR
of,O
approximately,O
25,O
pounds,O
over,O
a,O
few,O
months,O
with,O
increased,B-PR
fatigue,I-PR
and,O
lower,B-PR
extremity,I-PR
weakness,I-PR
.,O

A,B-PR
&quot;,I-PR
spot,I-PR
&quot;,I-PR
in,I-PR
the,I-PR
left,I-PR
lower,I-PR
lobe,I-PR
on,O
chest,B-TE
X-ray,I-TE
was,O
noted,O
in,O
October,O
of,O
1993,O
",",O
after,O
his,B-PR
pneumonia,I-PR
cleared,O
.,O

A,B-TE
follow,I-TE
up,I-TE
chest,I-TE
computerized,I-TE
tomography,I-TE
scan,I-TE
led,O
to,O
a,B-TE
tissue,I-TE
biopsy,I-TE
via,O
flexible,B-TE
bronchoscopy,I-TE
in,O
07/93,O
.,O

Tissue,O
returned,O
well,B-PR
differentiated,I-PR
adenocarcinoma,I-PR
.,O

The,O
patient,O
was,O
told,O
nothing,O
could,O
be,O
done,O
until,O
he,O
was,O
referred,O
to,O
Dr.,O
An,O
.,O

His,O
appetite,O
has,O
been,O
good,O
and,O
he,O
has,O
only,O
complained,O
of,O
occasional,B-PR
sharp,I-PR
pain,I-PR
under,I-PR
his,I-PR
rib,I-PR
cage,I-PR
",",O
right,O
greater,O
than,O
left,O
.,O

ALLERGIES,O
:,O

The,O
patient,O
is,O
allergic,B-PR
to,O
Percodan,B-TR
",",O
which,O
gives,O
him,O
itchiness,B-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Triamcinolone,B-TR
",",O
one,O
tablet,O
PO,O
b.i.d.,O
",",O
dosage,O
unknown,O
",",O
Xanax,B-TR
one,O
tablet,O
PO,O
t.i.d.,O
",",O
prn,O
anxiety,B-PR
",",O
dosage,O
unknown,O
",",O
MS,B-TR
Contin,I-TR
prn,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Distant,B-PR
peptic,I-PR
ulcer,I-PR
disease,I-PR
",",O
thumb,B-PR
and,I-PR
middle,I-PR
finger,I-PR
lost,I-PR
secondary,O
to,O
lawnmower,O
accident,O
at,O
age,O
five,O
years,O
",",O
no,O
peripheral,B-PR
vascular,I-PR
disease,I-PR
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

The,O
patient,O
is,O
status,O
post,O
partial,B-TR
gastrectomy,I-TR
for,O
peptic,B-PR
ulcer,I-PR
disease,I-PR
in,O
1965,O
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

The,B-TE
review,I-TE
of,I-TE
systems,I-TE
was,O
notable,O
for,O
anxiety,B-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
physical,B-TE
examination,I-TE
",",O
he,O
is,O
a,O
cachectic,O
white,O
male,O
looking,O
older,O
than,O
his,O
stated,O
age,O
",",O
who,O
is,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

The,B-TE
head,I-TE
",",I-TE
eyes,I-TE
",",I-TE
ears,I-TE
",",I-TE
nose,I-TE
",",I-TE
throat,I-TE
examination,I-TE
was,O
within,O
normal,O
limits,O
.,O

The,O
neck,O
showed,O
a,B-PR
1,I-PR
x,I-PR
1,I-PR
centimeter,I-PR
submaxillary,I-PR
right,I-PR
lymph,I-PR
node,I-PR
.,O

It,O
was,O
otherwise,O
supple,O
",",O
with,O
no,O
thyromegaly,B-PR
.,O

His,O
chest,O
and,O
axillae,O
showed,O
no,O
supraclavicular,B-PR
or,I-PR
axillary,I-PR
adenopathy,I-PR
.,O

The,O
lung,O
sounds,O
were,O
rhonchorous,B-PR
",",O
otherwise,O
clear,O
to,O
auscultation,B-TE
and,O
percussion,B-TE
.,O

Cardiovascular,B-TE
exam,I-TE
:,O

regular,O
rate,O
and,O
rhythm,O
",",O
normal,O
Sl,O
and,O
S2,O
",",O
no,O
murmur,B-PR
",",O
rub,B-PR
or,O
gallop,B-PR
.,O

Abdomen,O
:,O

scaphoid,O
",",O
positive,O
bowel,O
sounds,O
",",O
no,O
palpable,B-PR
masses,I-PR
",",O
with,O
a,B-PR
parasagittal,I-PR
scar,I-PR
right,O
of,O
the,O
midline,O
.,O

Extremities,O
:,O

Pulses,B-TE
were,O
2+,O
and,O
symmetrical,O
",",O
no,O
clubbing,B-PR
",",O
cyanosis,B-PR
or,O
edema,B-PR
.,O

The,B-TE
neurological,I-TE
examination,I-TE
was,O
nonfocal,O
.,O

LABORATORY,O
DATA,O
:,O

Admission,B-TE
sodium,I-TE
of,O
136,O
",",O
potassium,B-TE
3.8,O
",",O
chloride,B-TE
99,O
",",O
bicarbonate,B-TE
27.3,O
",",O
BUN,B-TE
and,O
creatinine,B-TE
of,O
13,O
and,O
0.6,O
",",O
glucose,B-TE
86,O
",",O
calcium,B-TE
9.3,O
",",O
liver,B-TE
function,I-TE
tests,I-TE
notable,O
for,O
an,O
albumin,B-TE
of,O
2.5,O
",",O
globulin,B-TE
4.5,O
.,O

The,B-TE
complete,I-TE
blood,I-TE
count,I-TE
on,I-TE
admission,I-TE
showed,O
a,B-TE
white,I-TE
blood,I-TE
count,I-TE
of,O
14.5,O
",",O
hematocrit,B-TE
31.0,O
",",O
hemoglobin,B-TE
10.3,O
and,O
platelet,B-TE
count,I-TE
"478,000",O
.,O

The,B-TE
arterial,I-TE
blood,I-TE
gases,I-TE
on,O
room,O
air,O
were,O
7.46/70/41,O
.,O

The,B-TE
pulmonary,I-TE
function,I-TE
tests,I-TE
revealed,O
an,B-TE
FEV1,I-TE
of,O
1.51,O
",",O
FVC,B-TE
2.72,O
",",O
and,O
FEV1/FVC,B-TE
ratio,I-TE
of,O
56%,O
.,O

DLCO,B-TE
was,O
2,O
",",O
or,O
19%,O
of,O
predicted,O
.,O

HOSPITAL,O
COURSE,O
:,O

A,B-TE
quantitative,I-TE
V,I-TE
/,I-TE
Q,I-TE
scan,I-TE
was,O
also,O
done,O
preoperatively,O
and,O
Pulmonary,O
consult,O
was,O
obtained,O
preoperatively,O
.,O

Pulmonary,O
recommended,O
that,O
he,O
just,O
be,O
started,O
on,O
Albuterol,B-TR
and,O
Atrovent,B-TR
metered,I-TR
dose,I-TR
inhalers,I-TR
",",O
2,O
puffs,O
q6h,O
",",O
prior,O
to,O
surgery,B-TR
.,O

The,O
patient,O
underwent,O
his,B-TR
procedure,I-TR
on,O
12-4-93,O
",",O
without,O
complications,B-PR
.,O

Findings,O
included,O
thickened,B-PR
pleura,I-PR
with,O
multiple,B-PR
adhesions,I-PR
and,O
an,B-PR
abscess,I-PR
near,I-PR
the,I-PR
margin,I-PR
major,I-PR
fissure,I-PR
.,O

He,O
had,O
a,B-PR
firm,I-PR
nodule,I-PR
in,I-PR
the,I-PR
left,I-PR
lower,I-PR
lobe,I-PR
.,O

The,O
patient,O
was,O
transferred,O
to,O
the,O
Respiratory,O
Intensive,O
Care,O
Unit,O
in,O
stable,O
condition,O
and,O
had,O
an,O
uneventful,O
stay,O
there,O
.,O

He,O
had,O
oxygen,B-TE
saturations,I-TE
of,O
99%,O
with,O
an,B-TE
Fi02,I-TE
of,O
40%,O
and,O
had,O
no,O
complaints,O
.,O

He,O
was,O
transferred,O
to,O
the,O
floor,O
on,O
postoperative,O
day,O
number,O
one,O
and,O
tolerated,O
his,O
PO&apos;s,O
well,O
.,O

His,B-TE
left,I-TE
lower,I-TE
lobe,I-TE
micro,I-TE
results,O
revealed,O
alpha,B-PR
hemolytic,I-PR
Streptococcus,I-PR
on,O
culture,B-TE
and,O
he,O
was,O
then,O
switched,O
to,O
penicillin,B-TR
and,O
Gentamicin,B-TR
after,O
being,O
started,O
on,O
triples,O
of,O
Flagyl,B-TR
",",O
Ampicillin,B-TR
",",O
and,O
Gentamicin,B-TR
.,O

He,O
had,O
low,B-PR
grade,I-PR
temperatures,I-PR
",",O
though,O
did,O
not,O
spike,O
a,B-PR
high,I-PR
temperature,I-PR
during,O
his,O
hospital,O
course,O
.,O

His,O
hospital,O
course,O
was,O
otherwise,O
uneventful,O
and,O
the,O
patient,O
was,O
discharged,O
in,O
stable,O
condition,O
on,O
postoperative,O
day,O
",",O
afebrile,B-PR
.,O

The,B-TE
chest,I-TE
X-ray,I-TE
on,O
the,O
morning,O
of,O
discharge,O
was,O
unchanged,O
from,O
the,O
previous,O
day,O
",",O
with,O
slight,B-PR
increase,I-PR
in,I-PR
left,I-PR
pleural,I-PR
fluid,I-PR
.,O

He,O
had,O
completed,O
six,O
days,O
of,O
penicillin,B-TR
and,O
Gentamicin,B-TR
and,O
was,O
discharged,O
on,O
Ciprofloxacin,B-TR
and,O
Flagyl,B-TR
for,O
the,O
next,O
seven,O
days,O
.,O

He,O
stayed,O
at,O
the,O
local,O
Comfort,O
Inn,O
before,O
his,O
return,O
back,O
to,O
Aujer,O
Cin,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Tylenol,B-TR
#,I-TR
3,I-TR
",",O
Xanax,B-TR
",",O
Ciprofloxacin,B-TR
",",O
Flagyl,B-TR
.,O

TVI,O
POST,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

REG,O
V.,O
POST,O
",",O
M.D.,O

TR,O
:,O

xr,O
/,O
bmot,O

DD,O
:,O

1-4-94,O

TD,O
:,O

01/05/94,O

CC,O
:,O

Admission,O
Date,O
:,O

2009-03-27,O

Discharge,O
Date,O
:,O

2009-04-03,O

Date,O
of,O
Birth,O
:,O

1960-03-06,O

Sex,O
:,O

F,O

Service,O
:,O

GYNECOLOGY,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
49-year-old,O
gravida,O
III,O
",",O
para,O
II,O
",",O
who,O
was,O
sent,O
from,O
her,O
primary,O
care,O
physician,O
's,O
office,O
secondary,O
to,O
lower,B-PR
abdominal,I-PR
pain,I-PR
.,O

The,O
patient,O
is,O
status,O
post,O
uterine,B-TR
artery,I-TR
embolization,I-TR
on,O
2009-01-07,O
secondary,O
to,O
fibroids,B-PR
.,O

She,O
has,O
had,O
continuing,B-PR
vaginal,I-PR
discharge,I-PR
",",O
and,O
was,O
diagnosed,O
with,O
bacterial,B-PR
vaginosis,I-PR
one,O
day,O
prior,O
to,O
admission,O
",",O
and,O
was,O
given,O
a,O
prescription,O
for,O
Flagyl,B-TR
.,O

She,O
noted,O
increasing,B-PR
abdominal,I-PR
pain,I-PR
two,O
days,O
prior,O
to,O
admission,O
",",O
which,O
became,O
more,O
severe,O
on,O
the,O
day,O
prior,O
to,O
admission,O
.,O

She,O
went,O
to,O
her,O
primary,O
care,O
physician,O
's,O
office,O
on,O
the,O
day,O
of,O
admission,O
complaining,O
of,O
abdominal,B-PR
pain,I-PR
",",O
which,O
she,O
stated,O
was,O
constant,O
but,O
intermittently,O
sharper,O
at,O
times,O
.,O

The,O
location,O
was,O
variable,O
.,O

She,O
also,O
complained,O
of,O
some,B-PR
loose,I-PR
stools,I-PR
on,O
the,O
day,O
of,O
admission,O
",",O
no,O
nausea,B-PR
or,O
vomiting,B-PR
.,O

Her,B-TE
temperature,I-TE
was,O
100.4,O
in,O
the,O
office,O
",",O
and,O
she,O
had,O
no,O
chills,B-PR
.,O

She,O
was,O
sent,O
for,O
a,B-TE
CT,I-TE
scan,I-TE
of,I-TE
her,I-TE
abdomen,I-TE
",",O
which,O
revealed,O
fluid,B-PR
and,O
question,O
of,O
gas,B-PR
in,I-PR
the,I-PR
endometrial,I-PR
cavity,I-PR
",",O
and,O
she,O
was,O
sent,O
to,O
Pinewood,O
",",O
Norfolk,O
for,O
treatment,B-TR
and,O
admission,B-TR
.,O

PAST,O
OBSTETRICAL,O
HISTORY,O
:,O

Cesarean,B-TR
section,I-TR
x,O
2,O
",",O
spontaneous,B-PR
abortion,I-PR
x,O
1,O
.,O

PAST,O
GYNECOLOGIC,O
HISTORY,O
:,O

Last,O
menstrual,O
period,O
2009-02-21,O
.,O

Some,B-PR
spotting,I-PR
on,O
the,O
day,O
prior,O
to,O
admission,O
",",O
but,O
not,O
a,O
normal,O
period,O
.,O

Periods,O
regular,O
.,O

Lupron,B-TR
x,O
three,O
months,O
prior,O
to,O
embolization,B-TR
.,O

Fibroid,B-PR
uterus,I-PR
status,O
post,O
embolization,B-TR
on,O
2009-01-07,O
.,O

Dilatation,B-TR
and,I-TR
curettage,I-TR
x,O
1,O
for,O
SAB,B-PR
.,O

History,O
of,O
herpes,B-PR
simplex,I-PR
virus,I-PR
",",O
last,O
outbreak,O
in,O
2000,O
.,O

No,O
history,O
of,O
abnormal,B-PR
Pap,I-PR
smears,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

None,O
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

Cesarean,B-TR
section,I-TR
x,O
2,O
",",O
dilatation,B-TR
and,I-TR
curettage,I-TR
x,O
1,O
",",O
neck,B-TR
fusion,I-TR
after,O
motor,O
vehicle,O
accident,O
",",O
shoulder,B-TR
surgery,I-TR
after,O
motor,O
vehicle,O
accident,O
.,O

MEDICATIONS,O
:,O

Flagyl,B-TR
.,O

ALLERGIES,O
:,O

None,O
.,O

SOCIAL,O
HISTORY,O
:,O

No,O
smoking,O
",",O
alcohol,O
or,O
drugs,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Temperature,B-TE
100.4,O
",",O
pulse,B-TE
108,O
",",O
respirations,B-TE
20,O
",",O
blood,B-TE
pressure,I-TE
110/70,O
",",O
oxygen,B-TE
saturation,I-TE
100%,O
on,O
room,O
air,O
.,O

In,O
general,O
",",O
she,O
was,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

Her,O
abdomen,O
was,O
notable,O
for,O
voluntary,B-PR
guarding,I-PR
but,O
no,O
involuntary,B-PR
guarding,I-PR
or,O
rebound,B-PR
",",O
mild,B-PR
right,I-PR
lower,I-PR
quadrant,I-PR
tenderness,I-PR
greater,O
than,O
left,O
lower,O
quadrant,O
",",O
nondistended,B-PR
.,O

Her,B-TE
pelvic,I-TE
examination,I-TE
was,O
notable,O
for,O
some,B-PR
brownish,I-PR
discharge,I-PR
.,O

Her,O
uterus,O
and,O
adnexa,O
were,O
difficult,O
to,O
assess,O
secondary,O
to,O
voluntary,B-PR
tensing,I-PR
of,I-PR
her,I-PR
abdomen,I-PR
.,O

ASSESSMENT,O
:,O

This,O
is,O
a,O
49-year-old,O
gravida,O
III,O
",",O
para,O
II,O
",",O
status,B-TR
post,I-TR
uterine,I-TR
artery,I-TR
embolization,I-TR
on,O
2009-01-07,O
due,O
to,O
uterine,B-PR
fibroids,I-PR
",",O
with,O
continued,B-PR
abdominal,I-PR
pain,I-PR
and,O
CT,B-TE
scan,I-TE
revealing,O
fluid,B-PR
and,I-PR
gas,I-PR
in,I-PR
the,I-PR
endometrial,I-PR
cavity,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
and,O
was,O
initially,O
started,O
on,O
intravenous,B-TR
ampicillin,I-TR
",",O
gentamicin,B-TR
and,O
clindamycin,B-TR
.,O

Her,B-TE
initial,I-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
was,O
11.3,O
",",O
with,O
a,O
normal,O
differential,O
.,O

Her,B-TE
sedimentation,I-TE
rate,I-TE
was,O
elevated,B-PR
at,O
110,O
.,O

Her,B-TE
electrolytes,I-TE
were,O
within,O
normal,O
limits,O
.,O

She,O
was,O
maintained,O
on,O
intravenous,B-TR
antibiotics,I-TR
.,O

On,O
hospital,O
day,O
number,O
three,O
",",O
her,B-TE
blood,I-TE
cultures,I-TE
came,O
back,O
positive,B-PR
in,O
the,B-TE
anaerobic,I-TE
culture,I-TE
for,O
gram-positive,B-PR
cocci,I-PR
in,I-PR
pairs,I-PR
and,I-PR
clusters,I-PR
.,O

Further,B-TE
identification,I-TE
revealed,O
staphylococcus,B-PR
coag-negative,I-PR
",",O
which,O
was,O
sensitive,O
to,O
gentamicin,B-TR
and,O
clindamycin,B-TR
.,O

She,O
was,O
continued,O
on,O
her,B-TR
antibiotics,I-TR
",",O
and,O
was,O
afebrile,B-PR
until,O
hospital,O
day,O
number,O
five,O
",",O
when,O
she,O
had,O
a,B-PR
temperature,I-PR
spike,I-PR
to,O
102.3,O
.,O

Repeat,B-TE
blood,I-TE
cultures,I-TE
were,O
sent,O
.,O

Her,B-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
was,O
12.8,O
",",O
with,O
a,O
normal,O
differential,O
.,O

At,O
this,O
time,O
",",O
an,O
Infectious,O
Disease,O
consult,O
was,O
obtained,O
",",O
and,O
the,O
recommendation,O
was,O
to,O
discontinue,O
the,B-TR
ampicillin,I-TR
",",O
gentamicin,B-TR
and,O
clindamycin,B-TR
",",O
and,O
start,O
her,O
on,O
intravenous,B-TR
Unasyn,I-TR
.,O

She,O
underwent,O
a,B-TE
pelvic,I-TE
ultrasound,I-TE
and,O
an,B-TE
abdomen,I-TE
and,I-TE
pelvis,I-TE
CT,I-TE
",",O
which,O
revealed,O
continued,B-PR
air,I-PR
in,I-PR
the,I-PR
endometrial,I-PR
cavity,I-PR
vs.,O
in,O
the,B-PR
fundal,I-PR
fibroid,I-PR
.,O

Discussion,O
was,O
had,O
at,O
this,O
time,O
with,O
the,O
patient,O
regarding,O
whether,O
or,O
not,O
this,O
represented,O
an,B-PR
infected,I-PR
abscess,I-PR
vs.,O
post-surgical,B-PR
change,I-PR
.,O

Extensive,O
discussion,O
was,O
held,O
",",O
and,O
second,O
opinion,O
was,O
obtained,O
regarding,O
the,O
need,O
for,O

possible,O
drainage,B-TR
of,O
the,B-PR
abscess,I-PR
vs.,O
hysterectomy,B-TR
.,O

The,O
patient,O
requested,O
an,O
outside,O
second,O
opinion,O
",",O
as,O
she,O
was,O
reluctant,O
to,O
undergo,O
hysterectomy,B-TR
at,O
this,O
time,O
.,O

She,O
was,O
discharged,O
to,O
home,O
on,O
hospital,O
day,O
number,O
eight,O
",",O
on,O
oral,B-TR
antibiotics,I-TR
.,O

The,O
patient,O
was,O
to,O
have,O
a,B-TE
repeat,I-TE
CT,I-TE
scan,I-TE
in,O
one,O
week,O
.,O

She,O
was,O
also,O
to,O
obtain,O
a,O
second,O
opinion,O
regarding,O
the,O
question,O
of,O
possible,O
surgical,B-TR
management,I-TR
.,O

Claude,O
U,O
Bolanos,O
",",O
M.D.,O

95-182,O

Dictated,O
By,O
:,O
William,O
MP,O
Lajoie,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2009-04-02,O
22:09,O

T,O
:,O
2009-04-03,O
01:26,O

JOB,O
#:,O

61261,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Suzanne,O
Simpson,O
on,O
:,O
FRI,O
2009-04-24,O
12:48,O
PM,O

(,O
End,O
of,O
Report,O
),O

551969782,O

HLGMC,O

2743471,O

05215/8895,O

3/26/1993,O
12:00:00,O
AM,O

POST-INFARCTION,B-PR
UNSTABLE,I-PR
ANGINA,I-PR
PECTORIS,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

3-26-93,O

DISCHARGE,O
DATE,O
:,O

4-3-93,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Post-infarction,B-PR
unstable,I-PR
angina,I-PR
pectoris,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

Inferior,B-PR
wall,I-PR
myocardial,I-PR
infarction,I-PR
",",O
ventricular,B-PR
fibrillation,I-PR
arrest,I-PR
",",O
congestive,B-PR
heart,I-PR
failure,I-PR
",",O
paroxysmal,B-PR
atrial,I-PR
tachycardia,I-PR
",",O
coronary,B-PR
artery,I-PR
disease,I-PR
",",O
psychosis,B-PR
.,O

SPECIAL,O
PROCEDURES,O
AND,O
OPERATIONS,O
:,O

3-27-93,O
",",O
cardiac,B-TE
catheterization,I-TE
and,O
coronary,B-TE
and,I-TE
left,I-TE
ventricular,I-TE
angiography,I-TE
;,O
4-2-93,O
",",O
exercise,B-TE
tolerance,I-TE
test,I-TE
with,I-TE
Thallium,I-TE
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Vasotec,B-TR
5,O
mg,O
PO,O
b.i.d.,O
",",O
Isordil,B-TR
10,O
mg,O
PO,O
q.i.d.,O
",",O
Ticlopidine,B-TR
50,O
mg,O
PO,O
b.i.d.,O
",",O
Metoprolol,B-TR
50,O
mg,O
PO,O
b.i.d.,O
",",O
Ciprofloxacin,B-TR
500,O
mg,O
PO,O
q12h,O
x,O
seven,O
days,O
",",O
nitroglycerin,B-TR
0.3,O
mg,O
sublingually,O
prn,O
chest,B-PR
pain,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
73,O
year,O
old,O
female,O
who,O
was,O
transferred,O
for,O
cardiac,B-TE
catheterization,I-TE
after,O
ventricular,B-PR
fibrillation,I-PR
arrest,I-PR
in,O
the,O
setting,O
of,O
an,B-PR
acute,I-PR
inferior,I-PR
myocardial,I-PR
infarction,I-PR
and,O
a,B-PR
urinary,I-PR
tract,I-PR
infection,I-PR
.,O

The,O
patient,O
was,O
admitted,O
on,O
3-16-93,O
to,O
Diy,O
Hospital,O
for,O
an,B-PR
E.,I-PR
coli,I-PR
urinary,I-PR
tract,I-PR
infection,I-PR
.,O

The,O
patient,O
was,O
readmitted,O
on,O
3-20-93,O
because,O
of,O
fever,B-PR
",",O
chills,B-PR
and,O
a,O
sudden,O
onset,O
of,O
ventricular,B-PR
fibrillation,I-PR
arrest,I-PR
",",O
successfully,O
cardioverted,O
back,O
to,O
rapid,B-PR
atrial,I-PR
fibrillation,I-PR
and,O
finally,O
to,O
sinus,O
rhythm,O
",",O
where,O
an,B-TE
electrocardiogram,I-TE
then,O
showed,O
ST,B-PR
elevation,I-PR
in,I-PR
inferior,I-PR
leads,I-PR
.,O

Peak,B-TE
CPK,I-TE
was,O
2494,O
with,O
18%,B-TE
MB,I-TE
's,I-TE
.,O

She,O
required,O
intubation,B-TR
for,O
mild,B-PR
to,I-PR
moderate,I-PR
congestive,I-PR
heart,I-PR
failure,I-PR
",",O
treated,O
with,O
diuretics,B-TR
",",O
intravenous,B-TR
nitroglycerin,I-TR
and,O
heparin,B-TR
.,O

She,O
had,O
post-infarction,B-PR
angina,I-PR
",",O
was,O
transferred,O
here,O
for,O
angiography,B-TE
and,O
possible,O
percutaneous,B-TR
transluminal,I-TR
coronary,I-TR
angioplasty,I-TR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
physical,B-TE
examination,I-TE
",",O
blood,B-TE
pressure,I-TE
is,O
130/80,O
",",O
pulse,B-TE
74,O
and,O
regular,O
",",O
respirations,B-TE
14,O
.,O

Her,O
chest,O
demonstrated,O
bibasilar,B-PR
crackles,I-PR
.,O

Cardiovascular,O
exam,O
:,O

the,B-TE
jugular,I-TE
venous,I-TE
pressure,I-TE
was,O
seven,O
centimeters,O
",",O
carotid,B-TE
upstroke,I-TE
normal,O
.,O

The,B-TE
heart,I-TE
exam,I-TE
revealed,O
a,O
normal,O
Sl,O
and,O
S2,O
was,O
normally,O
split,O
.,O

There,O
was,O
an,B-PR
S4,I-PR
",",O
no,O
S3,B-PR
",",O
grade,B-PR
II/VI,I-PR
apical,I-PR
murmur,I-PR
in,I-PR
systole,I-PR
",",O
no,O
rubs,B-PR
.,O

The,O
abdomen,O
was,O
benign,O
",",O
unremarkable,O
.,O

Extremities,O
:,O

no,O
calf,B-PR
tenderness,I-PR
or,O
peripheral,B-PR
edema,I-PR
.,O

Peripheral,B-TE
pulses,I-TE
were,O
2+,O
and,O
symmetrical,O
bilaterally,O
.,O

HOSPITAL,O
COURSE,O
:,O

On,O
3-27-93,O
",",O
patient,O
underwent,O
cardiac,B-TE
catheterization,I-TE
",",O
coronary,B-TE
and,I-TE
left,I-TE
ventricular,I-TE
angiography,I-TE
without,O
complications,B-PR
.,O

Review,O
of,O
these,B-TE
angiograms,I-TE
demonstrated,O
a,O
dominant,O
right,O
coronary,O
artery,O
with,O
a,B-PR
focal,I-PR
50%,I-PR
stenosis,I-PR
in,I-PR
the,I-PR
mid-portion,I-PR
.,O

The,O
left,O
main,O
coronary,O
artery,O
was,O
clear,O
.,O

The,O
left,O
anterior,O
descending,O
had,O
moderate,B-PR
plaques,I-PR
with,O
a,B-PR
50%,I-PR
proximal,I-PR
stenosis,I-PR
of,I-PR
the,I-PR
right,I-PR
anterior,I-PR
oblique,I-PR
caudal,I-PR
view,O
.,O

The,O
proximal,O
diagonal,O
D1,O
had,O
a,B-PR
50%,I-PR
stenosis,I-PR
.,O

The,O
circumflex,O
had,O
a,B-PR
long,I-PR
30%,I-PR
stenosis,I-PR
proximally,O
and,O
an,B-PR
80%,I-PR
stenosis,I-PR
at,O
the,O
origin,O
of,O
the,O
second,O
major,O
marginal,O
artery,O
.,O

The,B-TE
left,I-TE
ventricular,I-TE
angiogram,I-TE
showed,O
akinesis,B-PR
of,I-PR
the,I-PR
posterobasal,I-PR
walls,I-PR
",",O
severe,B-PR
hypokinesis,I-PR
of,I-PR
the,I-PR
diaphragmatic,I-PR
wall,I-PR
and,O
trace,B-PR
mitral,I-PR
regurgitation,I-PR
.,O

The,O
patient,O
was,O
maintained,O
on,O
heparin,B-TR
anticoagulation,I-TR
.,O

An,B-TE
exercise,I-TE
tolerance,I-TE
test,I-TE
with,I-TE
Thallium,I-TE
was,O
to,O
be,O
performed,O
in,O
order,O
to,O
assess,O
myocardial,O
viability,O
in,O
the,B-PR
infarct,I-PR
zone,I-PR
.,O

The,B-PR
right,I-PR
coronary,I-PR
artery,I-PR
lesion,I-PR
was,O
complex,O
and,O
there,O
was,O
severe,B-PR
stenosis,I-PR
in,I-PR
the,I-PR
obtuse,I-PR
marginal,I-PR
1,I-PR
.,O

The,O
patient,O
had,O
no,O
further,B-PR
angina,I-PR
.,O

On,O
4-2-93,O
",",O
she,O
underwent,O
a,B-TE
Persantine,I-TE
Thallium,I-TE
study,I-TE
.,O

This,O
showed,O
no,O
diagnostic,B-PR
electrocardiogram,I-PR
changes,I-PR
for,O
ischemia,B-PR
and,O
no,O
angina,B-PR
pectoris,I-PR
.,O

The,B-TE
thallium,I-TE
images,I-TE
showed,O
a,B-PR
large,I-PR
region,I-PR
of,I-PR
persistently,I-PR
reduced,I-PR
blood,I-PR
flow,I-PR
involving,O
the,O
apex,O
and,O
inferoposterior,O
segments,O
of,O
the,O
left,O
ventricular,O
wall,O
.,O

This,O
was,O
consistent,O
with,O
scar,B-PR
.,O

There,O
was,O
no,O
definite,B-PR
perfusion,I-PR
abnormality,I-PR
in,I-PR
the,I-PR
circumflex,I-PR
zone,I-PR
.,O

In,O
view,O
of,O
these,O
findings,O
",",O
it,O
was,O
elected,O
to,O
discharge,O
her,O
on,O
her,O
present,O
medical,O
program,O
.,O

The,O
patient,O
is,O
to,O
return,O
to,O
the,O
follow,O
up,O
care,O
of,O
Dr.,O
Ko,O
Kollciem,O
at,O
the,O
Diy,O
Hospital,O
.,O

CHPO,O
E.,O
JESCOBEA,O
",",O
M.D.,O

TR,O
:,O

sq,O
/,O
bmot,O

DD,O
:,O

06-13-93,O

TD,O
:,O

06/15/93,O

CC,O
:,O

Dr.,O
Ko,O
Kollciem,O
",",O
Retchard,O
Healthcare,O
to,O
Dr.,O
Wall,O

Admission,O
Date,O
:,O

2013-09-06,O

Discharge,O
Date,O
:,O

2013-09-18,O

Date,O
of,O
Birth,O
:,O

1927-08-07,O

Sex,O
:,O

F,O

Service,O
:,O

NEUROLOGIC,O
MEDICINE,O

DISCHARGE,O
DIAGNOSIS,O
:,O

Large,B-PR
left,I-PR
middle,I-PR
cerebral,I-PR
artery,I-PR
stroke,I-PR
along,O
with,O
posterior,B-PR
cerebral,I-PR
artery,I-PR
strokes,I-PR
bilaterally,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
an,O
86,O
year,O
old,O
woman,O
who,O
has,O
a,O
history,O
of,O
atrial,B-PR
fibrillation,I-PR
",",O
peripheral,B-PR
vascular,I-PR
disease,I-PR
",",O
and,O
a,O
history,O
of,O
atrial,B-PR
emboli,I-PR
who,O
was,O
admitted,O
on,O
2013-09-06,O
",",O
to,O
the,O
Neurologic,O
Intensive,O
Care,O
Unit,O
service,O
after,O
collapsing,O
at,O
home,O
at,O
8:30,O
p.m,O
.,O

She,O
was,O
found,O
to,O
have,O
right,B-PR
sided,I-PR
weakness,I-PR
and,O
was,O
noted,O
by,O
her,O
husband,O
to,O
have,O
vomited,O
.,O

She,O
was,O
found,O
comatose,B-PR
at,O
home,O
by,O
EMS,O
and,O
was,O
brought,O
to,O
the,O
Emergency,O
Department,O
.,O

On,O
arrival,O
to,O
the,O
Emergency,O
Department,O
",",O
she,O
was,O
noted,O
to,O
have,O
a,B-TE
temperature,I-TE
of,O
98.2,O
",",O
blood,B-TE
pressure,I-TE
164/110,O
",",O
respiratory,B-TE
rate,I-TE
28,O
",",O
and,O
heart,B-TE
rate,I-TE
of,O
74,O
.,O

She,O
was,O
found,O
to,O
be,O
responsive,B-PR
only,I-PR
to,I-PR
painful,I-PR
stimuli,I-PR
at,O
this,O
time,O
.,O

She,O
was,O
intubated,O
for,O
airway,B-TR
protection,I-TR
and,O
received,O
multiple,B-TR
medications,I-TR
prior,O
to,O
her,B-TE
initial,I-TE
neurologic,I-TE
examination,I-TE
.,O

She,O
was,O
also,O
noted,O
to,O
have,O
a,B-PR
cold,I-PR
distal,I-PR
left,I-PR
upper,I-PR
extremity,I-PR
which,O
was,O
operated,O
on,O
and,O
she,O
is,O
now,O
status,O
post,O
left,B-TR
brachial,I-TR
artery,I-TR
embolectomy,I-TR
.,O

Throughout,O
her,O
course,O
on,O
the,O
Intensive,O
Care,O
Unit,O
service,O
",",O
she,O
has,O
remained,O
unresponsive,B-PR
with,O
imaging,B-TE
studies,I-TE
consistent,O
with,O
a,O
large,O
left,O
middle,O
cerebral,O
artery,O
and,O
posterior,B-PR
cerebral,I-PR
artery,I-PR
distribution,I-PR
cerebral,I-PR
infarction,I-PR
with,O
mass,B-PR
effect,I-PR
and,O
midline,B-PR
shift,I-PR
.,O

There,O
is,O
evidence,O
of,O
bilateral,B-PR
occipital,I-PR
and,I-PR
cerebellar,I-PR
infarctions,I-PR
as,O
well,O
.,O

Discussion,O
with,O
the,O
patient,O
's,O
family,O
by,O
the,O
Intensive,O
Care,O
Unit,O
service,O
has,O
resulted,O
in,O
focusing,O
on,O
her,B-TR
comfort,I-TR
care,I-TR
.,O

This,O
decision,O
was,O
made,O
after,O
an,O
extensive,O
discussion,O
with,O
her,O
husband,O
and,O
family,O
as,O
the,O
likelihood,O
of,O
significant,O
meaningful,O
recovery,O
is,O
extremely,O
low,O
.,O

Based,O
on,O
this,O
",",O
she,O
is,O
transferred,O
to,O
the,O
Neurology,O
service,O
for,O
focus,O
on,O
comfort,B-TR
care,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Breast,B-PR
cancer,I-PR
",",O
status,O
post,O
lumpectomy,B-TR
.,O

2.,O
Mitral,B-TR
commissurectomy,I-TR
.,O

3.,O
Atrial,B-PR
fibrillation,I-PR
.,O

4.,O
Peripheral,B-PR
vascular,I-PR
disease,I-PR
.,O

5.,O
Arterial,B-PR
emboli,I-PR
",",I-PR
left,I-PR
femoral,I-PR
artery,I-PR
.,O

6.,O
Congestive,B-PR
heart,I-PR
failure,I-PR
.,O

MEDICATIONS,O
ON,O
TRANSFER,O
:,O

1.,O
Lopressor,B-TR
intravenous,I-TR
q,O
6,O
hours,O
.,O

2.,O
Morphine,B-TR
Sulfate,I-TR
1,O
mg,O
intravenous,O
p.r.n.,O

ALLERGIES,O
:,O

Penicillin,B-TR
",",O
Sulfa,B-TR
and,O
Quinidine,B-TR
.,O

SOCIAL,O
HISTORY,O
:,O

She,O
lived,O
with,O
her,O
husband,O
caring,O
for,O
him,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
the,O
date,O
of,O
transfer,O
",",O
temperature,B-TE
98.5,O
",",O
heart,B-TE
rate,I-TE
80,O
and,O
irregular,B-PR
",",O
blood,B-TE
pressure,I-TE
140/60,O
",",O
oxygen,B-TE
saturation,I-TE
100%,O
in,O
room,O
air,O
.,O

in,O
general,O
",",O
the,O
patient,O
is,O
minimally,B-PR
responsive,I-PR
woman,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

Head,O
and,O
neck,O
-,O
normocephalic,O
",",O
supple,O
",",O
no,O
lymphadenopathy,B-PR
.,O

Cardiovascular,O
-,O
irregular,B-PR
rhythm,I-PR
",",O
normal,O
rate,O
.,O

Pulmonary,O
-,O
Good,O
air,O
movement,O
",",O
but,O
occasional,B-PR
rhonchi,I-PR
.,O

Abdomen,O
reveals,O
positive,O
bowel,O
sounds,O
",",O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
.,O

Extremities,O
-,O
no,O
edema,B-PR
.,O

Neurologic,O
-,O
The,O
patient,O
is,O
unresponsive,B-PR
to,O
verbal,B-TE
stimuli,I-TE
",",O
withdrawals,O
the,O
left,O
extremities,O
to,O
noxious,B-TE
stimulation,I-TE
.,O

The,O
right,O
side,O
does,O
not,O
move,O
.,O

Tone,O
is,O
increased,O
on,O
the,O
right,O
.,O

Toes,O
are,O
upgoing,O
on,O
the,O
right,O
.,O

Cranial,O
nerves,O
-,O
The,O
pupils,O
are,O
equal,O
and,O
reactive,O
to,O
light,O
and,O
accommodation,O
.,O

There,O
is,O
a,B-PR
left,I-PR
gaze,I-PR
preference,I-PR
.,O

The,O
fundi,O
Belmont,O
difficult,O
to,O
visualize,O
but,O
there,O
is,O
no,O
evidence,O
of,O
papilledema,B-PR
.,O

Reflexes,B-TE
are,O
down,B-PR
on,I-PR
the,I-PR
right,I-PR
side,I-PR
.,O

Normal,O
reflexes,O
on,O
the,O
left,O
side,O
.,O

LABORATORY,O
DATA,O
:,O

White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
11.5,O
",",O
hematocrit,B-TE
31.0,O
",",O
platelet,B-TE
count,I-TE
"290,000",O
.,O

INR,B-TE
3.0,O
.,O

Potassium,B-TE
was,O
3.0,O
",",O
glucose,B-TE
131,O
.,O

MR,B-TE
studies,I-TE
revealed,O
a,B-PR
large,I-PR
left,I-PR
middle,I-PR
cerebral,I-PR
artery,I-PR
infarction,I-PR
with,O
multiple,B-PR
smaller,I-PR
posterior,I-PR
circulation,I-PR
infarctions,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
's,O
course,O
up,O
to,O
the,O
date,O
of,O
transfer,O
to,O
Neurology,O
has,O
been,O
outlined,O
above,O
.,O

Briefly,O
",",O
she,O
is,O
an,O
86,O
year,O
old,O
woman,O
who,O
has,O
suffered,O
multiple,B-PR
cardioembolic,I-PR
cerebral,I-PR
infarctions,I-PR
in,I-PR
multiple,I-PR
arterial,I-PR
territories,I-PR
.,O

She,O
has,O
remained,O
unresponsive,B-PR
throughout,O
the,O
hospitalization,O
and,O
currently,O
only,O
withdraws,O
to,O
pain,B-PR
.,O

After,O
extensive,O
discussion,O
with,O
her,O
family,O
",",O
her,O
care,O
was,O
focused,O
on,O
comfort,O
.,O

A,B-TR
low,I-TR
dose,I-TR
Morphine,I-TR
drip,I-TR
was,O
initiated,O
after,O
further,O
serious,O
discussion,O
with,O
her,O
husband,O
and,O
nieces,O
and,O
nephews,O
.,O

The,O
patient,O
passed,O
away,O
peacefully,O
on,O
2013-09-18,O
.,O

The,O
family,O
did,O
not,O
want,O
postmortem,B-TE
examination,I-TE
.,O

Michael,O
P,O
Galuszka,O
",",O
M.D.,O

46-348,O

Dictated,O
By,O
:,O
Melissa,O
U,O
Sangi,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2013-11-11,O
18:47,O

T,O
:,O
2013-11-11,O
19:46,O

JOB,O
#:,O

93375,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Ryann,O
W.,O
U.,O
Galuszka,O
on,O
:,O
TUE,O
2013-11-19,O
12:45,O
PM,O

(,O
End,O
of,O
Report,O
),O

559197012_a,O

FIH,O

4469096,O

80486/8ays,O

271958,O

9/2/1994,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

9-2-94,O

DISCHARGE,O
DATE,O
:,O

9-18-94,O

ADMISSION,O
DIAGNOSIS,O
:,O

Coronary,B-PR
artery,I-PR
disease,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

Non-insulin,B-PR
dependent,I-PR
diabetes,I-PR
mellitus,I-PR
",",O
history,O
of,O
gastric,B-PR
ulcer,I-PR
",",O
and,O
history,O
of,O
ETOH,O
abuse,O
.,O

SPECIAL,O
PROCEDURES,O
AND,O
OPERATIONS,O
:,O

September,O
11,O
",",O
1994,O
",",O
coronary,B-TR
artery,I-TR
bypass,I-TR
surgery,I-TR
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Coumadin,B-TR
5,O
mg,O
PO,O
q.day,O
",",O
Digoxin,B-TR
0.25,O
mg,O
PO,O
q.day,O
",",O
Metoprolol,B-TR
25,O
mg,O
PO,O
b.i.d.,O
",",O
Baby,B-TR
aspirin,I-TR
80,O
mg,O
PO,O
q.day,O
.,O

The,O
patient,O
will,O
be,O
followed,O
by,O
the,O
Anticoagulation,O
Clinic,O
for,O
prothrombin,B-TE
time,I-TE
level,I-TE
evaluations,I-TE
and,O
appropriate,B-TR
Coumadin,I-TR
doses,I-TR
.,O

IDENTIFYING,O
DATA,O
:,O

The,O
patient,O
is,O
a,O
66,O
year,O
old,O
Portuguese,O
speaking,O
gentleman,O
with,O
a,O
history,O
of,O
hypertension,B-PR
",",O
diabetes,B-PR
mellitus,I-PR
",",O
increasing,B-PR
cholesterol,I-PR
",",O
and,O
history,O
of,O
tobacco,O
use,O
",",O
who,O
is,O
status,O
post,O
myocardial,B-PR
infarction,I-PR
in,O
September,O
of,O
1993,O
and,O
February,O
of,O
1993,O
",",O
who,O
presented,O
with,O
new,O
onset,O
of,O
left,B-PR
chest,I-PR
pain,I-PR
and,O
arm,B-PR
pain,I-PR
for,O
two,O
days,O
.,O

Apparently,O
",",O
patient,O
was,O
in,O
his,O
usual,O
state,O
of,O
health,O
until,O
two,O
days,O
prior,O
to,O
admission,O
when,O
he,O
noted,O
new,O
onset,O
of,O
chest,B-PR
pain,I-PR
and,O
arm,B-PR
pain,I-PR
",",O
confined,O
to,O
his,O
left,O
side,O
.,O

The,B-PR
chest,I-PR
pain,I-PR
was,O
considered,O
mild,O
but,O
persistent,O
with,O
episodes,O
lasting,O
twenty,O
minutes,O
.,O

He,O
came,O
to,O
the,O
emergency,O
room,O
with,O
chest,B-PR
pain,I-PR
on,O
July,O
22,O
",",O
1994,O
",",O
relieved,O
with,O
sublingual,B-TR
nitroglycerin,I-TR
.,O

No,O
history,O
of,O
nausea,B-PR
and,O
vomiting,B-PR
or,O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

Denies,O
fevers,B-PR
",",O
pleuritic,B-PR
chest,I-PR
pain,I-PR
or,O
cough,B-PR
.,O

The,B-TE
electrocardiogram,I-TE
showed,O
pseudonormalization,B-PR
of,I-PR
T,I-PR
waves,I-PR
in,O
V1,O
through,O
V6,O
and,O
Q,B-PR
waves,I-PR
in,I-PR
V1,I-PR
through,O
V3,O
.,O

The,O
patient,O
&apos;s,O
past,O
cardiac,O
history,O
is,O
significant,O
for,O
an,B-PR
anterior,I-PR
myocardial,I-PR
infarction,I-PR
in,O
September,O
of,O
1993,O
and,O
a,B-PR
non-Q,I-PR
wave,I-PR
myocardial,I-PR
infarction,I-PR
in,O
February,O
of,O
1993,O
.,O

The,O
patient,O
in,O
September,O
of,O
1993,O
had,O
3-4,B-PR
millimeter,I-PR
ST,I-PR
segment,I-PR
elevation,I-PR
in,I-PR
V1,I-PR
through,O
V4,O
and,O
depression,B-PR
in,I-PR
II,I-PR
",",I-PR
III,I-PR
",",I-PR
and,I-PR
AVF,I-PR
.,O

At,O
the,O
time,O
",",O
patient,O
had,O
bright,B-PR
red,I-PR
blood,I-PR
per,I-PR
rectum,I-PR
as,O
well,O
and,O
patient,O
had,O
cardiac,B-TE
catheterization,I-TE
at,O
the,O
time,O
which,O
showed,O
95%,O
left,O
anterior,O
descending,O
",",O
which,O
was,O
percutaneous,O
transluminal,O
coronary,O
angioplastied,O
and,O
had,O
intra-aortic,B-TR
balloon,I-TR
pump,I-TR
placement,I-TR
.,O

He,O
had,O
a,B-TE
CPK,I-TE
of,O
over,O
5000,O
with,O
MB,B-TE
fraction,I-TE
of,O
26.7,O
.,O

The,B-TE
echocardiogram,I-TE
showed,O
a,B-TE
44%,I-TE
ejection,I-TE
fraction,I-TE
with,O
anterior,B-PR
akinesis,I-PR
and,O
septal,B-PR
hypokinesis,I-PR
.,O

He,O
had,O
a,B-PR
positive,I-PR
exercise,I-PR
tolerance,I-PR
test,I-PR
with,O
Thallium,O
and,O
repeat,B-TE
cardiac,I-TE
catheterization,I-TE
showed,O
left,O
anterior,O
descending,O
being,O
patent,O
and,O
distal,B-PR
posterior,I-PR
descending,I-PR
artery,I-PR
lesion,I-PR
with,O
circumflex,B-PR
lesion,I-PR
after,I-PR
the,I-PR
obtuse,I-PR
marginal,I-PR
1,I-PR
.,O

In,O
February,O
of,O
1993,O
",",O
patient,O
again,O
presented,O
with,O
chest,B-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
ruled,O
in,O
for,O
a,B-PR
non-Q,I-PR
wave,I-PR
myocardial,I-PR
infarction,I-PR
with,O
CPK,B-TE
peak,I-TE
of,O
219,O
and,O
MB,B-TE
of,O
20.9,O
.,O

Repeat,B-TE
cardiac,I-TE
catheterization,I-TE
showed,O
re-stenosis,B-PR
of,I-PR
proximal,I-PR
left,I-PR
anterior,I-PR
descending,I-PR
that,O
had,O
been,O
percutaneous,O
transluminal,O
coronary,O
angioplastied,O
and,O
a,B-PR
lesion,I-PR
in,I-PR
the,I-PR
first,I-PR
obtuse,I-PR
marginal,I-PR
and,O
a,B-PR
moderate,I-PR
to,I-PR
severe,I-PR
left,I-PR
circumflex,I-PR
lesion,I-PR
after,O
the,O
third,O
obtuse,O
marginal,O
.,O

He,O
also,O
had,O
an,B-PR
akinetic,I-PR
anterolateral,I-PR
and,I-PR
apical,I-PR
ventricle,I-PR
.,O

CARDIAC,O
RISK,O
FACTORS,O
:,O

Again,O
",",O
patient,O
&apos;s,O
cardiac,O
risk,O
factors,O
include,O
hypertension,B-PR
",",O
diabetes,B-PR
mellitus,I-PR
",",O
increasing,B-PR
cholesterol,I-PR
and,O
a,O
positive,O
family,O
history,O
and,O
tobacco,O
use,O
.,O

In,O
the,O
past,O
",",O
patient,O
had,O
been,O
noted,O
to,O
be,O
non-compliant,B-PR
with,O
cardiac,B-TR
medications,I-TR
and,O
continues,O
to,O
smoke,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

The,O
patient,O
has,O
a,O
history,O
of,O
hypertension,B-PR
",",O
non-insulin,B-PR
dependent,I-PR
diabetes,I-PR
mellitus,I-PR
",",O
diet-controlled,O
",",O
status,O
post,O
myocardial,B-PR
infarctions,I-PR
x,O
two,O
as,O
mentioned,O
above,O
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

The,O
patient,O
is,O
status,O
post,O
appendectomy,B-TR
.,O

Lower,B-PR
gastrointestinal,I-PR
bleed,I-PR
in,O
February,O
of,O
1993,O
which,O
was,O
not,O
worked,O
up,O
due,O
to,O
patient,O
deferment,O
.,O

ALLERGIES,O
:,O

The,O
patient,O
is,O
allergic,B-PR
to,O
penicillin,B-TR
",",O
develops,O
a,B-PR
rash,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Metoprolol,B-TR
50,O
mg,O
PO,O
b.i.d.,O
",",O
Isordil,B-TR
20,O
mg,O
PO,O
t.i.d.,O
",",O
Ecotrin,B-TR
aspirin,I-TR
q.day,O
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
smokes,O
one,O
pack,O
per,O
day,O
.,O

He,O
used,O
to,O
be,O
a,O
heavy,O
drinker,O
in,O
the,O
past,O
",",O
no,O
drugs,O
.,O

The,O
patient,O
lives,O
in,O
Hou,O
with,O
wife,O
and,O
daughter,O
.,O

He,O
is,O
a,O
retired,O
taxi,O
driver,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,B-TE
physical,I-TE
examination,I-TE
revealed,O
him,O
to,O
be,O
afebrile,B-PR
",",O
blood,B-TE
pressure,I-TE
of,O
130/80,O
with,O
a,B-TE
pulse,I-TE
rate,I-TE
of,O
56,O
and,O
respirations,B-TE
of,O
24,O
.,O

In,O
general,O
",",O
he,O
is,O
a,O
well,O
developed,O
",",O
well,O
nourished,O
man,O
breathing,O
easily,O
",",O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

Skin,O
:,O

multiple,B-PR
stigmata,I-PR
of,O
burns,B-PR
on,I-PR
the,I-PR
left,I-PR
arm,I-PR
and,I-PR
chest,I-PR
.,O

On,O
head,B-TE
",",I-TE
eyes,I-TE
",",I-TE
ears,I-TE
",",I-TE
nose,I-TE
",",I-TE
throat,I-TE
examination,I-TE
",",O
pupils,O
equal,O
",",O
round,O
",",O
reactive,O
to,O
light,O
and,O
accommodation,O
",",O
fundus,O
was,O
sharp,O
",",O
oral,O
mucosa,O
was,O
clear,O
.,O

Neck,O
:,O

no,O
jugular,B-PR
venous,I-PR
distention,I-PR
at,O
five,O
centimeters,O
",",O
neck,O
was,O
supple,O
",",O
full,O
range,O
of,O
movement,O
",",O
no,O
bruits,B-PR
",",O
no,O
adenopathy,B-PR
.,O

Lungs,O
had,O
bibasilar,B-PR
rales,I-PR
1/4,O
of,O
the,O
way,O
up,O
bilaterally,O
",",O
otherwise,O
clear,O
.,O

Cardiovascular,O
exam,O
:,O

II,B-PR
/,I-PR
VI,I-PR
systolic,I-PR
ejection,I-PR
murmur,I-PR
at,I-PR
left,I-PR
sternal,I-PR
border,I-PR
",",O
positive,O
S3,B-PR
",",O
question,O
of,O
S4,B-PR
",",O
otherwise,O
point,O
of,O
maximal,B-TE
impulse,I-TE
was,O
laterally,B-PR
displaced,I-PR
.,O

Abdomen,O
:,O

surgical,B-PR
midline,I-PR
incision,I-PR
and,O
previous,B-TR
surgery,I-TR
for,O
history,O
of,O
gastric,B-PR
ulcer,I-PR
.,O

The,O
abdomen,O
was,O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
",",O
mildly,B-PR
obese,I-PR
with,O
liver,O
edge,O
two,O
centimeters,O
below,O
the,O
right,O
costal,O
margin,O
.,O

Extremities,O
:,O

no,O
evidence,O
of,O
clubbing,B-PR
",",O
cyanosis,B-PR
or,O
edema,B-PR
.,O

The,B-TE
rectal,I-TE
examination,I-TE
was,O
trace,B-PR
guaiac,I-PR
positive,I-PR
.,O

The,O
patient,O
had,O
pulses,B-TE
distally,I-TE
",",O
1+,B-TE
femorals,I-TE
",",O
1+,B-TE
dorsalis,I-TE
pedis,I-TE
.,O

The,B-TE
neurological,I-TE
examination,I-TE
was,O
otherwise,O
nonfocal,O
with,O
mentioned,O
left,O
upper,O
extremity,O
3/5,O
strength,O
with,O
pain,B-PR
and,O
5/5,O
on,O
the,O
left,O
lower,O
extremity,O
.,O

LABORATORY,O
DATA,O
:,O

Admission,B-TE
hematocrit,I-TE
44,O
",",O
BUN,B-TE
and,O
creatinine,B-TE
of,O
13,O
and,O
0.9,O
",",O
prothrombin,B-TE
time,I-TE
and,O
partial,B-TE
thromboplastin,I-TE
time,I-TE
normal,O
.,O

The,O
patient,O
had,O
a,B-TE
chest,I-TE
X-ray,I-TE
which,O
showed,O
mild,B-PR
pulmonary,I-PR
edema,I-PR
.,O

The,B-TE
electrocardiogram,I-TE
showed,O
Q,B-PR
waves,I-PR
in,I-PR
V1,I-PR
through,O
V6,O
",",O
T,B-PR
wave,I-PR
pseudonormalization,I-PR
in,I-PR
V1,I-PR
through,O
V6,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
for,O
rule,O
out,O
myocardial,B-PR
infarction,I-PR
.,O

The,O
patient,O
ruled,O
in,O
for,O
myocardial,B-PR
infarction,I-PR
with,O
CPK,B-TE
maximum,O
on,O
hospital,O
day,O
number,O
one,O
peak,B-TE
of,O
186,O
and,O
iso,B-TE
of,O
23.8,O
and,O
index,B-TE
of,O
12.8,O
on,O
September,O
2,O
",",O
1994,O
.,O

The,O
patient,O
was,O
seen,O
in,O
consultation,O
by,O
Dr.,O
Signs,O
for,O
Dr.,O
Churlaunt,O
of,O
Cardiology,O
.,O

The,O
patient,O
received,O
the,B-TR
appropriate,I-TR
protocol,I-TR
for,O
myocardial,B-PR
infarction,I-PR
",",O
intravenous,B-TR
heparin,I-TR
",",O
aspirin,B-TR
",",O
and,O
beta,B-TR
blockers,I-TR
for,O
rate,B-TR
and,I-TR
blood,I-TR
pressure,I-TR
control,I-TR
.,O

The,O
patient,O
on,O
the,O
date,O
of,O
September,O
5,O
",",O
1994,O
had,O
cardiac,B-TE
catheterization,I-TE
which,O
showed,O
normal,O
resting,O
hemodynamics,O
.,O

The,O
patient,O
has,O
a,O
small,O
non-dominant,O
right,O
coronary,O
artery,O
",",O
left,O
anterior,O
descending,O
showed,O
severe,B-PR
proximal,I-PR
lesion,I-PR
with,O
more,B-PR
distal,I-PR
lesions,I-PR
of,I-PR
diagonal,I-PR
one,I-PR
.,O

The,O
left,O
circumflex,O
was,O
dominant,O
with,O
severe,B-PR
disease,I-PR
of,I-PR
obtuse,I-PR
marginal,I-PR
one,I-PR
",",O
with,O
moderate,B-PR
mid-circumflex,I-PR
stenosis,I-PR
and,O
moderate,B-PR
posterior,I-PR
descending,I-PR
artery,I-PR
lesion,I-PR
.,O

The,B-TE
left,I-TE
ventriculography,I-TE
shows,O
anterior,B-PR
akinesis,I-PR
and,O
apical,B-PR
severe,I-PR
hypokinesis,I-PR
with,O
a,B-PR
moderately,I-PR
depressed,I-PR
ejection,I-PR
fraction,I-PR
",",O
cardiac,B-TE
output,I-TE
of,O
3.9,O
",",O
index,B-TE
of,O
2.0,O
.,O

The,O
patient,O
was,O
seen,O
in,O
consultation,O
by,O
Cardiac,O
Surgery,O
for,O
evaluation,B-TE
of,O
coronary,B-TR
artery,I-TR
bypass,I-TR
grafting,I-TR
.,O

The,O
patient,O
had,O
stable,B-TE
hematocrit,I-TE
of,O
38%,O
on,O
intravenous,B-TR
heparin,I-TR
.,O

The,B-TE
carotid,I-TE
noninvasives,I-TE
preoperatively,O
were,O
negative,O
.,O

Dental,B-TE
consult,I-TE
was,O
negative,O
.,O

On,O
the,O
date,O
of,O
September,O
11,O
",",O
1994,O
",",O
patient,O
underwent,O
a,B-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
grafting,I-TR
with,O
saphenous,B-TR
vein,I-TR
graft,I-TR
to,I-TR
the,I-TR
posterior,I-TR
descending,I-TR
artery,I-TR
",",O
circumflex,B-TR
and,I-TR
diagonal,I-TR
and,I-TR
left,I-TR
internal,I-TR
mammary,I-TR
artery,I-TR
to,I-TR
the,I-TR
left,I-TR
anterior,I-TR
descending,I-TR
.,O

The,O
patient,O
had,O
a,O
bypass,O
time,O
of,O
one,O
hour,O
and,O
fifty,O
minutes,O
with,O
good,O
urine,O
output,O
and,O
pre-bypass,B-TE
cardiac,I-TE
output,I-TE
of,O
4.0,O
",",O
post-chest,B-TE
closure,I-TE
5.3,O
",",O
arrived,O
to,O
the,O
Surgical,O
Intensive,O
Care,O
Unit,O
on,O
Nipride,B-TR
",",O
Lidocaine,B-TR
of,O
1,O
and,O
Fentanyl/,B-TR
Versed,B-TR
of,O
10,O
.,O

The,B-TE
postoperative,I-TE
hematocrit,I-TE
was,O
26%,O
.,O

The,O
patient,O
had,O
a,O
routine,O
postoperative,O
course,O
in,O
the,O
Surgical,O
Intensive,O
Care,O
Unit,O
with,O
a,B-TE
postoperative,I-TE
BUN,I-TE
and,O
creatinine,B-TE
of,O
11,O
and,O
1.2,O
with,O
good,O
urine,O
output,O
of,O
over,O
100,O
an,O
hour,O
and,O
patient,O
received,O
two,O
units,O
of,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
",",O
fresh,B-TR
frozen,I-TR
plasma,I-TR
and,O
platelets,B-TR
for,O
increasing,B-PR
chest,I-PR
tube,I-PR
drainage,I-PR
.,O

The,O
patient,O
on,O
the,O
date,O
of,O
postoperative,O
day,O
number,O
one,O
",",O
September,O
13,O
",",O
1994,O
",",O
was,O
transferred,O
from,O
the,O
Surgical,O
Intensive,O
Care,O
Unit,O
up,O
to,O
the,O
FIH,O
18,O
floor,O
.,O

The,O
patient,O
&apos;s,O
only,O
post-Surgical,O
Intensive,O
Care,O
Unit,O
course,O
was,O
remarkable,O
for,O
hypertension,B-PR
requiring,O
Nipride,B-TR
and,O
bleeding,B-PR
which,O
was,O
controlled,O
with,O
fresh,B-TR
frozen,I-TR
plasma,I-TR
",",O
platelets,B-TR
.,O

The,O
patient,O
had,O
a,B-TE
stable,I-TE
hematocrit,I-TE
of,O
30%,O
with,O
CPK,B-TE
&apos;s,I-TE
postoperatively,O
maximum,B-TE
MB,I-TE
fraction,I-TE
of,O
78,O
.,O

On,O
postoperative,O
day,O
number,O
three,O
",",O
patient,O
went,O
into,O
atrial,B-PR
fibrillation,I-PR
",",O
which,O
was,O
treated,O
appropriately,O
with,O
metoprolol,B-TR
and,O
digoxin,B-TR
and,O
converted,O
back,O
to,O
sinus,O
rhythm,O
.,O

The,O
patient,O
continued,O
to,O
need,O
diuresis,B-TR
.,O

The,B-TR
postoperative,I-TR
medications,I-TR
up,O
on,O
FIH,O
were,O
Coumadin,B-TR
",",O
baby,B-TR
aspirin,I-TR
",",O
Isordil,B-TR
10,O
PO,O
t.i.d.,O
",",O
Digoxin,B-TR
.25,O
q.day,O
",",O
metoprolol,B-TR
25,O
PO,O
b.i.d.,O
______________,O

Chest,B-TR
tubes,I-TR
and,O
wires,B-TR
were,O
all,O
discontinued,O
according,O
to,O
protocol,B-TR
on,O
postoperative,O
day,O
number,O
four,O
.,O

The,B-TR
Isordil,I-TR
was,O
also,O
discontinued,O
.,O

The,B-PR
patient,I-PR
&apos;s,I-PR
incisions,I-PR
sternal,O
and,O
right,O
leg,O
were,O
clean,O
and,O
healing,O
well,O
",",O
normal,O
sinus,O
rhythm,O
at,O
70-80,O
",",O
with,O
blood,B-TE
pressure,I-TE
98-110/60,O
and,O
patient,O
was,O
doing,O
well,O
",",O
recovering,O
",",O
ambulating,O
",",O
tolerating,O
regular,O
diet,O
and,O
last,B-TE
hematocrit,I-TE
prior,O
to,O
discharge,O
was,O
39%,O
with,O
a,B-TE
BUN,I-TE
and,O
creatinine,B-TE
of,O
15,O
and,O
1.0,O
",",O
prothrombin,B-TE
time,I-TE
level,I-TE
of,O
13.8,O
",",O
chest,B-TE
X-ray,I-TE
prior,O
to,O
discharge,O
showed,O
small,B-PR
bilateral,I-PR
effusions,I-PR
with,O
mild,B-PR
cardiomegaly,I-PR
and,O
subsegmental,B-PR
atelectasis,I-PR
bibasilar,I-PR
and,O
electrocardiogram,B-TE
showed,O
normal,O
sinus,O
rhythm,O
with,O
left,B-PR
atrial,I-PR
enlargement,I-PR
and,O
no,O
acute,B-PR
ischemic,I-PR
changes,I-PR
on,O
electrocardiogram,B-TE
.,O

Note,O
:,O

patient,O
needs,O
anticoagulation,B-TR
for,O
large,B-TR
saphenous,I-TR
vein,I-TR
graft,I-TR
to,O
prevent,O
any,O
possibility,O
of,O
thrombosis,B-PR
.,O

The,O
patient,O
was,O
discharged,O
home,O
in,O
stable,O
condition,O
and,O
will,O
follow,O
up,O
with,O
his,O
cardiologist,O
and,O
will,O
follow,O
up,O
with,O
Dr.,O
Hemp,O
and,O
Dr.,O
Signs,O
.,O

A,O
NECESSARY,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

G,O
HEMP,O
",",O
M.D.,O

TR,O
:,O

ee,O
/,O
bmot,O

DD,O
:,O

9-18-94,O

TD,O
:,O

09/19/94,O

CC,O
:,O

Dr.,O
Signs,O

?Admission,O
Date,O
:,O

2010-07-15,O

Discharge,O
Date,O
:,O

2010-07-18,O

Date,O
of,O
Birth,O
:,O

1978-01-25,O

Sex,O
:,O

F,O

Service,O
:,O

KULAND,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
32-year-old,O
white,O
female,O
with,O
history,O
of,O
diabetes,B-PR
type,I-PR
1,I-PR
and,O
migraines,B-PR
who,O
presented,O
with,O
complaints,O
of,O
nausea,B-PR
",",O
diarrhea,B-PR
and,O
vomiting,B-PR
for,O
24,O
hours,O
.,O

Patient,O
states,O
she,O
was,O
unable,O
to,O
take,O
her,B-TR
usual,I-TR
insulin,I-TR
regimen,I-TR
because,O
she,O
was,O
vomiting,B-PR
.,O

The,O
patient,O
denied,O
any,O
fevers,B-PR
",",O
chills,B-PR
",",O
chest,B-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
or,O
dysuria,B-PR
but,O
does,O
state,O
she,O
had,O
her,B-PR
usual,I-PR
migraine,I-PR
headache,I-PR
the,O
night,O
prior,O
to,O
admission,O
.,O

The,B-TE
patient,I-TE
's,I-TE
arterial,I-TE
blood,I-TE
gases,I-TE
in,O
the,O
Emergency,O
Department,O
were,O
7.19,O
",",O
22,O
and,O
109,O
with,O
a,B-TE
bicarbonate,I-TE
of,O
9,O
and,O
a,B-TE
fingerstick,I-TE
of,O
greater,O
than,O
500,O
.,O

Patient,O
was,O
given,O
two,B-TR
boluses,I-TR
of,I-TR
15,I-TR
units,I-TR
of,I-TR
regular,I-TR
insulin,I-TR
and,O
was,O
started,O
on,O
an,B-TR
insulin,I-TR
drip,I-TR
of,O
one,O
unit,O
per,O
hour,O
and,O
given,O
a,B-TR
total,I-TR
of,I-TR
five,I-TR
liters,I-TR
of,I-TR
normal,I-TR
saline,I-TR
.,O

Her,B-TE
fingersticks,I-TE
decreased,O
with,O
the,B-TR
insulin,I-TR
drip,I-TR
and,O
the,B-TR
intravenous,I-TR
fluids,I-TR
.,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
Intensive,O
Care,O
Unit,O
for,O
an,B-TR
insulin,I-TR
drip,I-TR
and,O
frequent,B-TE
blood,I-TE
sugar,I-TE
monitoring,I-TE
and,O
Chem-7,B-TE
monitoring,I-TE
.,O

The,O
patient,O
did,O
well,O
overnight,O
in,O
the,O
Medical,O
Intensive,O
Care,O
Unit,O
.,O

Her,B-TE
anion,I-TE
gap,I-TE
closed,O
and,O
her,B-TE
fingersticks,I-TE
were,O
less,O
than,O
200,O
.,O

Her,B-TR
NPH,I-TR
and,O
a,B-TR
regular,I-TR
sliding,I-TR
scale,I-TR
were,O
started,O
and,O
her,B-TR
drip,I-TR
was,O
discontinued,O
.,O

The,O
patient,O
denied,O
any,B-PR
more,I-PR
gastrointestinal,I-PR
symptoms,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Includes,O
diabetes,B-PR
",",O
diagnosed,O
at,O
age,O
14,O
.,O

Multiple,O
episodes,O
of,O
diabetic,B-PR
ketoacidosis,I-PR
in,O
the,O
past,O
",",O
migraine,B-PR
headaches,I-PR
and,O
attention,B-PR
deficit,I-PR
disorder,I-PR
.,O

MEDICATIONS,O
AT,O
HOME,O
:,O

Included,O
Wellbutrin,B-TR
",",O
Imitrex,B-TR
",",O
Tylenol,B-TR
",",O
Humalog,B-TR
sliding,I-TR
scale,I-TR
and,O
NPH,B-TR
insulin,I-TR
two,O
units,O
in,O
the,O
morning,O
",",O
7,O
units,O
at,O
noon,O
and,O
13,O
units,O
at,O
bedtime,O
.,O

ALLERGIES,O
:,O

Patient,O
has,O
allergies,B-PR
to,O
penicillin,B-TR
.,O

She,O
gets,O
hives,B-PR
.,O

Bactrim,B-TR
",",O
she,O
gets,O
hives,B-PR
.,O

Percocet,B-TR
and,O
erythromycin,B-TR
",",O
she,O
gets,O
gastrointestinal,B-PR
upset,I-PR
and,O
Keflex,B-TR
she,O
gets,O
hives,B-PR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
lives,O
with,O
mother,O
and,O
father,O
.,O

She,O
had,O
a,O
recent,O
pregnancy,O
with,O
a,O
five,O
month,O
stay,O
at,O
Erich,O
Lindemann,O
Mental,O
Health,O
Center,O
.,O

Patient,O
had,O
a,B-TR
cesarean,I-TR
section,I-TR
at,O
eight,O
months,O
.,O

The,O
baby,O
is,O
now,O
healthy,O
",",O
about,O
four,O
months,O
old,O
.,O

Tobacco,O
history,O
",",O
three,O
cigarettes,O
a,O
week,O
.,O

Denies,O
alcohol,O
or,O
drugs,O
.,O

FAMILY,O
HISTORY,O
:,O

Hypertension,B-PR
.,O

PHYSICAL,O
EXAM,O
ON,O
ADMISSION,O
:,O

Includes,O
a,B-TE
temperature,I-TE
of,O
99.9,O
.,O

Pulse,B-TE
of,O
94,O
.,O

Blood,B-TE
pressure,I-TE
of,O
138/49,O
.,O

Patient,O
was,O
generally,B-PR
ill-appearing,I-PR
and,O
nauseated,B-PR
",",O
but,O
alert,O
and,O
oriented,O
times,O
three,O
.,O

Head,O
",",O
eyes,O
",",O
ears,O
",",O
nose,O
and,O
throat,O
exam,O
:,O

Pupils,O
equal,O
",",O
round,O
and,O
reactive,O
to,O
light,O
.,O

Oropharynx,O
clear,O
.,O

Dry,O
mucous,O
membranes,O
.,O

Neck,O
supple,O
",",O
no,O
lymphadenopathy,B-PR
.,O

Chest,O
clear,O
to,O
auscultation,B-TE
.,O

Heart,O
regular,O
.,O

Abdomen,O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
.,O

Extremities,O
:,O

No,O
edema,B-PR
.,O

Neurological,B-TE
exam,I-TE
:,O

Alert,O
and,O
oriented,O
times,O
three,O
.,O

Cranial,B-TE
nerves,I-TE
II,I-TE
through,I-TE
XII,I-TE
are,O
intact,O
",",O
nonfocal,O
",",O
moving,O
all,O
extremities,O
.,O

LABORATORY,O
ON,O
ADMISSION,O
:,O

White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
of,O
22.8,O
",",O
hematocrit,B-TE
of,O
42.1,O
.,O

Sodium,B-TE
of,O
136,O
",",O
chloride,B-TE
96,O
",",O
bicarbonate,B-TE
8,O
",",O
BUN,B-TE
25,O
",",O
creatinine,B-TE
1.2,O
",",O
glucose,B-TE
720,O
.,O

Arterial,B-TE
blood,I-TE
gases,I-TE
showed,O
a,B-TE
pH,I-TE
of,O
7.19,O
",",O
pCO2,B-TE
of,O
22,O
and,O
PO2,B-TE
of,O
102,O
and,O
a,B-TE
potassium,I-TE
of,O
3.9,O
.,O

Chest,B-TE
x-ray,I-TE
was,O
negative,O
for,O
infiltrate,B-PR
.,O

Electrocardiogram,B-TE
was,O
normal,O
sinus,O
rhythm,O
with,O
a,B-PR
T,I-PR
wave,I-PR
inversion,I-PR
in,I-PR
V2,I-PR
",",O
but,O
no,O
ST,B-PR
segment,I-PR
elevations,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

As,O
above,O
",",O
and,O
once,O
transferred,O
to,O
the,O
floor,O
",",O
patient,O
had,O
fingersticks,B-TE
monitored,O
every,O
four,O
hours,O
with,O
a,B-TR
sliding,I-TR
scale,I-TR
.,O

Patient,O
reached,O
goal,O
of,O
fingersticks,B-TE
between,O
50,O
and,O
300,O
",",O
which,O
is,O
what,O
she,O
maintains,O
at,O
home,O
.,O

Sliding,B-TR
scale,I-TR
was,O
adjusted,O
as,O
necessary,O
.,O

Patient,O
was,O
continued,O
on,O
intravenous,B-TR
fluids,I-TR
until,O
taking,O
good,O
po,O
.,O

Infectious,O
Disease,O
:,O

The,O
patient,O
had,O
an,B-PR
elevated,I-PR
white,I-PR
count,I-PR
upon,O
admission,O
",",O
however,O
",",O
white,B-TE
count,I-TE
came,O
down,O
to,O
7.1,O
and,O
prior,O
to,O
discharge,O
",",O
patient,O
was,O
afebrile,B-PR
and,O
no,O
clear,O
etiology,O
for,O
elevated,B-PR
white,I-PR
blood,I-PR
cell,I-PR
on,O
admission,O
",",O
questionably,O
secondary,O
to,O
short,B-PR
gastrointestinal,I-PR
infection,I-PR
",",O
however,O
",",O
patient,O
is,O
completely,O
symptom,O
free,O
upon,O
discharge,O
.,O

Fluid,O
",",O
electrolytes,O
and,O
nutrition,O
:,O

The,B-TE
patient,I-TE
's,I-TE
electrolytes,I-TE
were,O
repleted,O
as,O
necessary,O
.,O

Potassium,B-TR
was,O
given,O
with,O
her,B-TR
intravenous,I-TR
fluids,I-TR
and,O
phosphate,B-TR
will,O
be,O
repleted,O
as,O
patient,O
increases,O
her,O
po,O
intake,O
.,O

CONDITION,O
OF,O
DISCHARGE,O
:,O

Good,O
.,O

DISCHARGE,O
STATUS,O
:,O

To,O
home,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Diabetic,B-PR
ketoacidosis,I-PR
.,O

2.,O
Viral,B-PR
gastroenteritis,I-PR
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Includes,O
her,B-TR
regular,I-TR
insulin,I-TR
sliding,I-TR
scale,I-TR
and,O
her,B-TR
NPH,I-TR
fixed,O
scale,O
of,O
7,O
units,O
in,O
the,O
morning,O
",",O
2,O
units,O
at,O
noon,O
and,O
13,O
units,O
at,O
bedtime,O
.,O

Patient,O
was,O
instructed,O
to,O
decrease,O
her,B-TR
evening,I-TR
dose,I-TR
if,O
she,O
does,O
not,O
continue,O
to,O
take,O
good,O
po,O
.,O

Patient,O
will,O
also,O
continue,O
on,O
her,B-TR
Wellbutrin,I-TR
and,O
Imitrex,B-TR
as,O
needed,O
for,O
migraines,B-PR
.,O

FOLLOW-UP,O
PLANS,O
:,O

The,O
patient,O
is,O
to,O
follow-up,O
with,O
her,O
endocrinologist,O
at,O
the,O
Mahoney,O
",",O
as,O
well,O
as,O
her,O
primary,O
care,O
physician,O
.,O

Diane,O
Sands,O
",",O
M.D.,O

11-089,O

Dictated,O
By,O
:,O
Pamela,O
F.,O
Williams,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2010-07-20,O
21:01,O

T,O
:,O
2010-07-20,O
21:01,O

JOB,O
#:,O

65230,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Timothy,O
Clemons,O
on,O
:,O
MON,O
2010-07-26,O
11:01,O
AM,O

(,O
End,O
of,O
Report,O
),O

559197012_b,O

FIH,O

4469096,O

64024/p16e,O

909222,O

10/24/1993,O
12:00:00,O
AM,O

NON-Q,B-PR
WAVE,I-PR
MYOCARDIAL,I-PR
INFARCTION,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

10-24-93,O

DISCHARGE,O
DATE,O
:,O

11-2-93,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Non-Q,B-PR
wave,I-PR
myocardial,I-PR
infarction,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

Status,O
post,O
anterior,B-PR
myocardial,I-PR
infarction,I-PR
in,O
05-93,O
",",O
status,O
post,O
percutaneous,B-TR
transluminal,I-TR
coronary,I-TR
angioplasty,I-TR
of,I-TR
left,I-TR
anterior,I-TR
descending,I-TR
in,O
05-93,O
",",O
hypertension,B-PR
",",O
diabetes,B-PR
mellitus,I-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

Coronary,B-TR
angiography,I-TR
",",O
exercise,B-TE
tolerance,I-TE
test,I-TE
with,I-TE
Thallium,I-TE
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Metoprolol,B-TR
50,O
mg,O
PO,O
bid,O
",",O
Isordil,B-TR
20,O
mg,O
PO,O
tid,O
",",O
enteric,B-TR
coated,I-TR
aspirin,I-TR
1,O
PO,O
qd,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
65,O
year,O
old,O
Portuguese,O
male,O
with,O
a,O
history,O
of,O
an,B-PR
anterior,I-PR
myocardial,I-PR
infarction,I-PR
i,O
May,O
1993,O
and,O
is,O
status,O
post,O
a,B-TR
percutaneous,I-TR
transluminal,I-TR
coronary,I-TR
angioplasty,I-TR
of,I-TR
the,I-TR
LAD,I-TR
who,O
presented,O
on,O
10-24-93,O
with,O
crushing,B-PR
substernal,I-PR
chest,I-PR
pain,I-PR
and,O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

He,O
had,O
no,O
prior,O
cardiac,O
history,O
until,O
May,O
1993,O
when,O
on,O
5-24,O
he,O
had,O
crushing,B-PR
chest,I-PR
pain,I-PR
which,O
radiated,O
to,O
his,O
left,O
arm,O
.,O

He,O
was,O
found,O
at,O
that,O
time,O
to,O
have,O
3-4,B-PR
mm,I-PR
ST,I-PR
segment,I-PR
elevations,I-PR
in,I-PR
V1,I-PR
through,O
V4,O
at,O
Pre,O
Health,O
.,O

The,O
patient,O
was,O
transferred,O
to,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
and,O
had,O
4-7,B-PR
mm,I-PR
ST,I-PR
segment,I-PR
elevations,I-PR
across,I-PR
the,I-PR
precordium,I-PR
with,O
Q&apos;s,B-PR
in,I-PR
V1,I-PR
and,I-PR
V2,I-PR
",",O
2,B-PR
mm,I-PR
ST,I-PR
elevation,I-PR
in,I-PR
AVL,I-PR
",",O
and,O
1-2,B-PR
mm,I-PR
reciprocal,I-PR
ST,I-PR
depression,I-PR
in,I-PR
II,I-PR
",",I-PR
III,I-PR
",",I-PR
and,I-PR
F.,I-PR

On,O
physical,B-TE
examination,I-TE
at,O
that,O
time,O
he,O
had,O
bright,B-PR
red,I-PR
blood,I-PR
per,I-PR
rectum,I-PR
and,O
therefore,O
lysis,B-TR
was,O
deferred,O
and,O
he,O
was,O
taken,O
directly,O
to,O
the,O
cardiac,O
catheterization,O
lab,O
.,O

The,O
cardiac,O
catheterization,O
results,O
at,O
that,O
time,O
revealed,O
a,B-TE
right,I-TE
atrial,I-TE
pressure,I-TE
of,O
7,O
",",O
pulmonary,B-TE
artery,I-TE
pressure,I-TE
of,O
29/16,O
",",O
RV,B-TE
33/8,O
",",O
pulmonary,B-TE
capillary,I-TE
wedge,I-TE
pressure,I-TE
of,O
16,O
.,O

He,O
had,O
a,B-PR
95%,I-PR
proximal,I-PR
left,I-PR
anterior,I-PR
descending,I-PR
lesion,I-PR
which,O
was,O
PTCA,O
&apos;d,O
to,O
a,O
residual,O
of,O
30%,O
and,O
an,B-TR
intra-aortic,I-TR
balloon,I-TR
pump,I-TR
was,O
placed,O
.,O

He,O
also,O
had,O
some,B-PR
mild,I-PR
to,I-PR
moderate,I-PR
disease,I-PR
at,O
the,O
OM1,O
noted,O
at,O
that,O
time,O
.,O

The,O
patient,O
was,O
transferred,O
to,O
the,O
Cardiac,O
Care,O
Unit,O
where,O
he,O
had,O
a,B-TE
peak,I-TE
CPK,I-TE
of,O
"5,042",O
and,O
26.7%,O
MB&apos;s,B-TE
.,O

His,B-TR
intra-aortic,I-TR
balloon,I-TR
pump,I-TR
was,O
weaned,O
without,O
problems,B-PR
.,O

He,O
had,O
hypotension,B-PR
with,O
beta,B-TR
blockers,I-TR
and,O
therefore,O
they,O
were,O
not,O
started,O
.,O

On,O
day,O
six,O
",",O
an,B-TE
echocardiogram,I-TE
showed,O
an,B-TE
ejection,I-TE
fraction,I-TE
of,O
44%,O
with,O
anterior,B-PR
akinesis,I-PR
and,O
septal,B-PR
hypokinesis,I-PR
.,O

On,O
day,O
nine,O
",",O
he,O
had,O
a,B-TE
low,I-TE
level,I-TE
exercise,I-TE
tolerance,I-TE
test,I-TE
with,I-TE
Thallium,I-TE
which,O
was,O
positive,O
for,O
2.5,B-PR
mm,I-PR
horizontal,I-PR
depressions,I-PR
in,I-PR
II,I-PR
",",I-PR
III,I-PR
",",I-PR
and,I-PR
AVF,I-PR
",",O
and,O
1.5,B-PR
mm,I-PR
downsloping,I-PR
ST,I-PR
depressions,I-PR
in,I-PR
V5,I-PR
and,I-PR
V6,I-PR
",",O
as,O
well,O
as,O
some,B-PR
anteroseptal,I-PR
redistribution,I-PR
on,O
Thallium,B-TR
.,O

Therefore,O
",",O
he,O
went,O
to,O
repeat,B-TE
cardiac,I-TE
catheterization,I-TE
which,O
revealed,O
that,O
the,O
left,O
anterior,O
descending,O
site,O
was,O
patent,O
and,O
revealed,O
a,B-PR
distal,I-PR
PDA,I-PR
lesion,I-PR
and,O
a,B-PR
circumflex,I-PR
lesion,I-PR
after,O
the,O
OM,O
.,O

The,O
patient,O
was,O
discharged,O
to,O
home,O
and,O
is,O
supposed,O
to,O
follow,O
up,O
with,O
Dr.,O
Shuffburle,O
of,O
Gastroenterology,O
for,O
work,B-TE
up,I-TE
of,O
his,B-PR
bright,I-PR
red,I-PR
blood,I-PR
per,I-PR
rectum,I-PR
and,O
is,O
supposed,O
to,O
follow,O
up,O
with,O
Dr.,O
Amesin,O
of,O
Cardiology,O
and,O
Dr.,O
Shuffpasc,O
of,O
Dingclearf,O
Alllirefaith,O
Memorial,O
Hospital,O
.,O

However,O
",",O
he,O
did,O
not,O
keep,O
any,O
of,O
these,O
appointments,O
.,O

He,O
went,O
home,O
and,O
did,O
not,O
take,O
any,O
of,O
his,B-TR
medications,I-TR
and,O
smoked,O
and,O
drank,O
heavily,O
throughout,O
the,O
several,O
months,O
.,O

On,O
the,O
a.m.,O
of,O
10-24-93,O
",",O
the,O
patient,O
developed,O
crushing,B-PR
substernal,I-PR
chest,I-PR
pain,I-PR
and,O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

He,O
came,O
to,O
the,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
Emergency,O
Ward,O
where,O
he,O
was,O
noted,O
to,O
be,O
ashen,B-PR
and,O
diaphoretic,B-PR
.,O

He,O
was,O
treated,O
with,O
oxygen,B-TR
",",O
aspirin,B-TR
",",O
five,B-TR
sublingual,I-TR
nitroglycerins,I-TR
",",O
heparin,B-TR
",",O
and,O
was,O
eventually,O
made,O
pain,O
free,O
with,O
that,B-TR
regimen,I-TR
.,O

CARDIAC,O
RISK,O
FACTORS,O
:,O

His,O
cardiac,O
risk,O
factors,O
included,O
hypertension,B-PR
",",O
diabetes,B-PR
mellitus,I-PR
",",O
hypercholesterolemia,B-PR
",",O
cigarette,O
smoking,O
",",O
and,O
a,O
positive,O
family,O
history,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

His,O
past,O
medical,O
history,O
included,O
hypertension,B-PR
and,O
non-insulin,B-PR
diabetes,I-PR
mellitus,I-PR
which,O
is,O
diet,O
controlled,O
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

His,O
past,O
surgical,O
history,O
had,O
included,O
gastric,B-TR
ulcer,I-TR
surgery,I-TR
and,O
appendectomy,B-TR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

On,O
admission,O
",",O
he,O
was,O
on,O
Isordil,B-TR
10,O
tid,O
and,O
enteric,B-TR
coated,I-TR
aspirin,I-TR
",",O
but,O
he,O
was,O
not,O
taking,O
either,O
of,O
these,B-TR
medications,I-TR
.,O

HABITS,O
:,O

The,O
patient,O
smokes,O
one,O
pack,O
per,O
day,O
and,O
has,O
a,O
history,O
of,O
heavy,O
alcohol,O
use,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,B-TE
physical,I-TE
examination,I-TE
on,I-TE
admission,I-TE
revealed,O
a,B-TE
blood,I-TE
pressure,I-TE
of,O
110/70,O
",",O
a,B-TE
heart,I-TE
rate,I-TE
of,O
66,O
",",O
respirations,B-TE
of,O
24,O
",",O
temperature,B-TE
of,O
98,O
.,O

The,B-TE
HEENT,I-TE
exam,I-TE
revealed,O
the,O
extra,O
ocular,O
movements,O
intact,O
.,O

The,O
pupils,O
equal,O
",",O
round,O
",",O
reactive,O
to,O
light,O
.,O

The,O
oropharynx,O
was,O
clear,O
and,O
the,O
fundi,O
were,O
normal,O
.,O

There,O
were,O
no,O
hypertensive,B-PR
or,I-PR
diabetic,I-PR
changes,I-PR
.,O

The,O
neck,O
was,O
suppled,O
",",O
with,O
no,O
lymphadenopathy,B-PR
and,O
no,O
jugular,B-PR
venous,I-PR
distention,I-PR
.,O

The,B-TE
carotids,I-TE
were,O
1+,O
without,O
bruits,B-PR
.,O

The,O
heart,O
was,O
regular,O
rate,O
and,O
rhythm,O
",",O
S4,O
",",O
S1,O
",",O
S2,O
",",O
with,O
a,B-PR
I,I-PR
/,I-PR
VI,I-PR
systolic,I-PR
murmur,I-PR
at,I-PR
the,I-PR
left,I-PR
lower,I-PR
sternal,I-PR
border,I-PR
.,O

The,O
lungs,O
were,O
clear,O
",",O
except,O
for,O
a,B-PR
few,I-PR
dry,I-PR
crackles,I-PR
bibasilarly,I-PR
.,O

The,O
abdomen,O
revealed,O
a,B-PR
midline,I-PR
scar,I-PR
and,O
a,B-PR
right,I-PR
lower,I-PR
quadrant,I-PR
scar,I-PR
",",O
and,O
it,O
was,O
soft,O
and,O
nontender,B-PR
wit,O
positive,O
bowel,O
sounds,O
.,O

The,O
liver,O
edge,O
was,O
2,O
cm,O
below,O
the,O
right,O
costal,O
margin,O
",",O
but,O
smooth,O
and,O
nontender,B-PR
.,O

There,O
was,O
no,O
splenomegaly,B-PR
.,O

The,B-TE
femoral,I-TE
pulses,I-TE
were,O
diminished,B-PR
.,O

He,O
had,O
bilateral,B-PR
intertrigo,I-PR
in,I-PR
his,I-PR
femoral,I-PR
region,I-PR
as,O
well,O
as,O
his,O
axillae,O
.,O

The,O
extremities,O
revealed,O
no,O
clubbing,B-PR
",",O
cyanosis,B-PR
or,O
edema,B-PR
.,O

The,B-TE
pulses,I-TE
were,O
1+,O
bilaterally,O
.,O

The,B-TE
skin,I-TE
exam,I-TE
revealed,O
changes,O
consistent,O
with,O
vitiligo,B-PR
.,O

The,B-TE
rectal,I-TE
examination,I-TE
was,O
guaiac,B-TE
negative,O
.,O

LABORATORY,O
DATA,O
:,O

The,O
laboratory,O
data,O
revealed,O
normal,O
electrolytes,O
",",O
BUN,O
and,O
creatinine,O
",",O
normal,O
liver,O
function,O
tests,O
",",O
a,B-TE
first,I-TE
CPK,I-TE
of,O
140,O
",",O
and,O
a,B-TE
hematocrit,I-TE
of,O
43.1,O
.,O

The,B-TE
portable,I-TE
chest,I-TE
X-ray,I-TE
showed,O
clear,O
lungs,O
",",O
slight,B-PR
enlarged,I-PR
heart,I-PR
",",O
and,O
a,B-PR
mildly,I-PR
elevated,I-PR
hemidiaphragm,I-PR
.,O

The,B-TE
electrocardiogram,I-TE
was,O
normal,O
sinus,O
rhythm,O
at,O
81,O
",",O
with,O
normal,O
intervals,O
and,O
normal,O
axis,O
",",O
had,O
poor,B-PR
R-wave,I-PR
progression,I-PR
consistent,O
with,O
an,B-PR
old,I-PR
anterior,I-PR
myocardial,I-PR
infarction,I-PR
",",O
had,O
flipped,B-PR
T-waves,I-PR
in,I-PR
V1,I-PR
through,O
V5,O
",",O
which,O
were,O
of,O
no,O
significant,B-PR
change,I-PR
since,O
his,B-TE
last,I-TE
EKG,I-TE
on,O
5-25-93,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
Step,O
Down,O
Unit,O
for,O
a,O
rule,O
out,O
MI,B-TR
protocol,I-TR
.,O

He,O
was,O
treated,O
with,O
aspirin,B-TR
",",O
heparin,B-TR
",",O
and,O
intravenous,B-TR
nitroglycerin,I-TR
.,O

No,O
beta,B-TR
blockers,I-TR
was,O
started,O
because,O
of,O
his,O
history,O
of,O
hypertension,B-PR
with,O
beta,B-TR
blockers,I-TR
and,O
because,O
his,B-TE
blood,I-TE
pressure,I-TE
of,O
only,O
110/70,O
.,O

The,O
patient,O
ruled,O
in,O
for,O
myocardial,B-PR
infarction,I-PR
with,O
a,B-TE
peak,I-TE
CPK,I-TE
of,O
219,O
and,O
20.9%,B-TE
MB,I-TE
fraction,I-TE
.,O

This,O
was,O
a,B-PR
non-Q,I-PR
wave,I-PR
myocardial,I-PR
infarction,I-PR
as,O
there,O
were,O
no,O
diagnostic,B-PR
electrocardiogram,I-PR
changes,I-PR
.,O

on,O
10-27-93,O
",",O
the,O
patient,O
went,O
to,O
the,O
cath,O
lab,O
which,O
revealed,O
a,O
small,O
nondominant,O
right,O
coronary,O
artery,O
without,O
any,B-PR
lesions,I-PR
",",O
a,B-PR
restenosis,I-PR
of,I-PR
the,I-PR
proximal,I-PR
left,I-PR
anterior,I-PR
descending,I-PR
lesion,I-PR
that,O
had,O
been,O
PTCA,B-TR
&apos;d,I-TR
",",O
a,B-PR
lesion,I-PR
in,I-PR
the,I-PR
first,I-PR
OM,I-PR
",",O
and,O
a,B-PR
moderately,I-PR
severe,I-PR
left,I-PR
circumflex,I-PR
lesion,I-PR
after,I-PR
the,I-PR
OM3,I-PR
.,O

The,B-TE
left,I-TE
ventriculogram,I-TE
revealed,O
an,B-PR
akinetic,I-PR
anterolateral,I-PR
and,I-PR
apical,I-PR
ventricle,I-PR
.,O

Given,O
the,O
results,O
of,O
this,B-TE
cardiac,I-TE
catheterization,I-TE
",",O
which,O
were,O
not,O
significantly,O
changed,O
from,O
his,B-TE
previous,I-TE
cardiac,I-TE
catheterization,I-TE
prior,O
to,O
the,B-TR
PTCA,I-TR
",",O
it,O
was,O
elected,O
to,O
attempt,O
to,O
medically,O
manage,O
the,O
patient,O
.,O

He,O
was,O
ambulated,O
progressively,O
on,O
the,O
floor,O
.,O

A,B-TR
beta,I-TR
blocker,I-TR
was,O
started,O
with,O
Metoprolol,B-TR
initially,O
at,O
25,O
mg,O
PO,O
bid,O
and,O
eventually,O
increased,O
to,O
50,O
mg,O
PO,O
bid,O
.,O

The,O
patient,O
ambulated,O
extensively,O
on,O
the,O
FIH,O
20,O
floor,O
each,O
day,O
without,O
any,O
episodes,O
of,O
chest,B-PR
pain,I-PR
or,O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

On,O
11-2-93,O
",",O
the,O
patient,O
underwent,O
a,B-TE
low,I-TE
level,I-TE
treadmill,I-TE
exercise,I-TE
test,I-TE
with,O
Thallium,B-TE
imaging,I-TE
.,O

This,B-TE
treadmill,I-TE
test,I-TE
was,O
done,O
on,O
medications,B-TR
",",O
including,O
beta,B-TR
blockers,I-TR
",",O
in,O
hopes,O
to,O
assess,O
an,O
amount,O
of,O
ischemia,B-PR
on,O
treatment,B-TR
.,O

The,O
patient,O
was,O
able,O
to,O
exercise,O
for,O
approximately,O
nine,O
minutes,O
on,O
a,B-TR
modified,I-TR
Bruce,I-TR
protocol,I-TR
",",O
however,O
",",O
he,O
did,O
not,O
reach,O
his,O
predicted,O
maximal,O
heart,O
rate,O
while,O
he,O
was,O
on,O
the,B-TR
beta,I-TR
blockade,I-TR
.,O

There,O
were,O
no,O
diagnostic,B-PR
electrocardiogram,I-PR
changes,I-PR
during,O
the,B-TE
treadmill,I-TE
exercise,I-TE
test,I-TE
",",O
although,O
he,O
did,O
have,O
0.5,B-PR
to,I-PR
1,I-PR
mm,I-PR
ST,I-PR
depression,I-PR
in,I-PR
II,I-PR
",",I-PR
III,I-PR
",",I-PR
and,I-PR
AVF,I-PR
.,O

The,B-TE
study,I-TE
was,O
halted,O
for,O
shortness,B-PR
of,I-PR
breath,I-PR
and,O
there,O
was,O
no,O
chest,B-PR
pain,I-PR
.,O

Thallium,B-TE
images,I-TE
revealed,O
a,B-PR
moderate,I-PR
sized,I-PR
region,I-PR
of,I-PR
ischemic,I-PR
but,I-PR
viable,I-PR
myocardium,I-PR
involving,O
the,O
anteroseptal,O
and,O
lateral,O
segments,O
of,O
the,O
left,O
ventricle,O
.,O

There,O
was,O
also,O
some,O
evidence,O
of,O
left,B-PR
ventricular,I-PR
dysfunction,I-PR
during,O
the,B-TE
test,I-TE
.,O

These,B-TE
images,I-TE
were,O
essentially,O
unchanged,O
compared,O
with,O
the,B-TE
previous,I-TE
Thallium,I-TE
images,I-TE
in,O
May,O
1993,O
.,O

After,O
extensive,O
discussion,O
between,O
myself,O
",",O
Dr.,O
Amesin,O
",",O
and,O
Dr.,O
Scgach,O
",",O
it,O
was,O
elected,O
to,O
discharge,O
the,O
patient,O
to,O
home,O
with,O
medical,B-TR
management,I-TR
.,O

The,O
patient,O
was,O
extremely,O
reluctant,O
to,O
undergo,O
surgery,B-TR
",",O
although,O
he,O
understands,O
that,O
this,O
may,O
become,O
necessary,O
in,O
the,O
future,O
.,O

Dr.,O
Amesin,O
had,O
a,O
long,O
discussion,O
with,O
the,O
patient,O
&apos;s,O
daughters,O
revolving,O
primarily,O
around,O
issues,O
of,O
the,O
patient,O
&apos;s,O
compliance,O
.,O

Previously,O
he,O
had,O
not,O
taken,O
any,O
of,O
his,B-TR
medicines,I-TR
and,O
smoked,O
heavily,O
on,O
the,O
outside,O
and,O
not,O
kept,O
any,O
of,O
his,O
appointments,O
.,O

The,O
importance,O
of,O
quitting,O
smoking,O
as,O
well,O
as,O
continuing,O
to,O
follow,O
his,B-TR
medical,I-TR
regimen,I-TR
was,O
emphasized,O
to,O
the,O
daughter,O
and,O
to,O
the,O
patient,O
.,O

She,O
will,O
be,O
actively,O
involved,O
in,O
encouraging,O
the,O
patient,O
to,O
comply,O
with,O
this,B-TR
medical,I-TR
regimen,I-TR
and,O
also,O
to,O
follow,O
up,O
with,O
Dr.,O
Amesin,O
as,O
well,O
as,O
Dr.,O
Lfsquarc,O
on,O
the,O
outside,O
.,O

The,O
patient,O
remained,O
guaiac,B-TE
negative,O
throughout,O
the,O
entire,O
hospitalization,O
.,O

Despite,O
being,O
on,O
heparin,B-TR
for,O
a,O
short,O
time,O
",",O
his,B-TE
hematocrit,I-TE
remained,O
very,O
stable,O
with,O
only,O
a,B-PR
small,I-PR
dip,I-PR
after,O
the,B-TR
catheterization,I-TR
was,O
done,O
.,O

He,O
will,O
need,O
to,O
be,O
followed,O
up,O
as,O
an,O
out,O
patient,O
for,O
guaiac,B-PR
positive,I-PR
stools,I-PR
and,O
possibly,O
worked,O
up,O
for,O
this,O
in,O
the,O
future,O
.,O

CAGHALA,O
UINTEELE,O
",",O
M.D.,O

TR,O
:,O

yf,O
/,O
bmot,O

DD,O
:,O

11-3-93,O

TD,O
:,O

11/04/93,O

CC,O
:,O

Dr.,O
Telshey,O
Swatlleebtik,O
Dr.,O
Eri,O
Lfsquarc,O

Admission,O
Date,O
:,O

2013-09-05,O

Discharge,O
Date,O
:,O

2013-09-12,O

Date,O
of,O
Birth,O
:,O

1934-08-29,O

Sex,O
:,O

M,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,O
Drugs,B-TR

Attending,O
:,O
Mary,O
N,O
Major,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

change,B-PR
in,I-PR
mental,I-PR
status,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

None,O

History,O
of,O
Present,O
Illness,O
:,O

HPI,O
:,O
This,O
is,O
a,O
79,O
y/o,O
M,O
with,O
h/o,O
of,O
HTN,B-PR
",",O
DM,B-PR
",",O
recent,B-PR
CVA,I-PR
Theresa,O
",",O
chronic,B-PR
respiratory,I-PR
failure,I-PR
on,O
vent,B-TR
",",O
trached,B-TR
",",O
ESRD,B-PR
on,O
HD,B-TR
who,O
was,O
sent,O
from,O
rehab,O
facility,O
for,O
worsening,B-PR
mental,I-PR
status,I-PR
.,O

Per,O
refferal,O
notes,O
",",O
he,O
went,O
to,O
hemodyalisis,B-TR
today,O
in,O
the,O
morning,O
.,O

1,O
L,O
was,O
removed,O
.,O

At,O
about,O
2:30,O
pm,O
",",O
he,O
was,O
found,O
to,O
have,O
worsening,B-PR
mental,I-PR
status,I-PR
.,O

In,O
that,O
setting,O
he,O
was,O
hypotensive,B-PR
down,O
to,O
the,O
92/45,O
",",O
and,O
was,O
given,O
1,B-TR
L,I-TR
NS,I-TR
.,O

Fs,B-TE
was,O
also,O
checked,O
179,O
.,O

At,O
that,O
time,O
",",O
it,O
seems,O
that,O
he,O
had,O
been,O
on,O
T,B-TR
peace,I-TR
since,O
4,O
am,O
today,O
.,O

At,O
2:30,O
he,O
was,O
also,O
found,O
with,O
sats,B-TE
in,O
the,O
90%,O
.,O

ABG,B-TE
done,O
7.1,O
",",O
89/72,O
-,O
he,O
was,O
placed,O
on,O
AC,B-TR
600,O
/,O
0.4,O
and,O
6,O
PEEP,B-TR
-,O
sats,B-TE
up,O
to,O
94%,O
.,O

Given,O
persistent,B-PR
lethargy,I-PR
",",O
patient,O
was,O
sent,O
to,O
Falkener,O
Amanda,O
.,O

Of,O
note,O
",",O
after,O
interview,O
with,O
HCP,O
",",O
at,O
around,O
07-23,O
",",O
patient,O
started,O
having,O
episodes,O
of,O
dizziness,B-PR
",",O
and,O
had,O
unstable,B-PR
gait,I-PR
.,O

he,O
was,O
taken,O
to,O
Williams,O
ICU,O
until,O
08-09,O
when,O
he,O
was,O
discharged,O
to,O
Waltham/Weston,O
Hospital,O
Rehab,O
.,O

he,O
had,O
a,B-TR
peg,I-TR
tube,I-TR
and,O
tracheostomy,B-TR
prior,O
to,O
d/c,O
.,O

He,O
had,O
been,O
chronicallyl,B-PR
vent,I-PR
dependent,I-PR
.,O

His,O
companion,O
states,O
that,O
they,O
have,O
been,O
trying,O
to,O
wean,O
him,O
down,O
at,O
rehab,O
.,O

his,O
basline,O
mental,O
staus,O
apparently,O
responds,O
with,O
his,O
head,O
shaking,O
",",O
and,O
also,O
try,O
to,O
write,O
sentences,O
.,O

In,O
the,O
Amanda,O
:,O
VS,B-TE
T,B-TE
103,O
rectal,O
BP90/44,B-TE
HR,B-TE
:,O
84,O
RR,B-TE
16,O
Sats,B-TE
:,O
98,O
+,B-PR
guiac,I-PR
stool,I-PR
.,O

He,O
received,O
tylenol,B-TR
",",O
levofloxacin,B-TR
500,O
mg,O
IV,O
",",O
Flagyl,B-TR
500,O
mg,O
and,O
Vancomycin,B-TR
and,O
I,B-TR
L,I-TR
NS,I-TR
.,O

ROS,O
:,O
difficult,O
to,O
obtain,O
2x2,O
to,O
patient,O
mental,O
status,O
baselin,O

Past,O
Medical,O
History,O
:,O

CVA,B-PR
Theresa,O
/,O
2006,O

HTN,B-PR

DM,B-PR

CRI,B-PR
on,O
HD,B-TR
since,O
Theresa,O
(,O
"Tu,",O
"Thurs,",O
Sat,O
),O

Neuropathy,B-PR
right,I-PR
leg,I-PR

s/p,O
cCY,B-TR

Social,O
History,O
:,O

Uset,O
to,O
be,O
truck,O
driver,O
.,O

Retired,O
15,O
years,O
ago,O
.,O

He,O
has,O
1,O
son,O
",",O
two,O
grandson,O
.,O

smoking,O
"(-),",O
alcohol,O
-,O

Family,O
History,O
:,O

brother,O
died,O
cerebral,B-PR
aneurysm,I-PR

Brother,O
Sabina,B-PR
cancer,I-PR

brother,O
prostate,B-PR
cancer,I-PR

father,O
Randall,O

Physical,O
Exam,O
:,O

Physical,O
Exam,O
:,O

Vitals,B-TE
:,O
T,B-TE
:,O
99,O
P,B-TE
:,O
84,O
BP,B-TE
:,O
145/62,O
AC,B-TR
:,O
600,O
",",O
x,O
12,O
/,O
0.5,O
/,O
5,O
SaO2,B-TE
:,O
100%,O

General,O
:,O
Awake,O
",",O
alert,O
",",O
responding,O
to,O
voice,O
.,O

HEENT,O
:,O
PEERLA,O
",",O
no,O
JVD,B-PR
.,O
+,O
tracheostomy,B-TR

Pulmonary,O
:,O
clear,O
anteriorly,O
.,O

decrease,B-PR
breath,I-PR
sounds,I-PR
bases,I-PR
.,O

Cardiac,O
:,O
RRR,O
",",O
nl,O
.,O
S1S2,O
",",O
soft,B-PR
holosytolic,I-PR
murmur,I-PR
apex,I-PR

Abdomen,O
:,O
soft,O
",",O
NT/ND,B-PR
",",O
normoactive,O
bowel,O
sounds,O
",",O
no,O
masses,B-PR
or,O
organomegaly,B-PR
noted,O
.,O

Extremities,O
:,O
Left,B-TR
arm,I-TR
AVF,I-TR

1+,B-PR
trace,I-PR
edemalymphadenopathy,I-PR
noted,O
.,O

Skin,O
:,O
no,O
rashes,B-PR
",",O
small,B-PR
decubit,I-PR
in,I-PR
the,I-PR
back,I-PR
.,O

Neurologic,O
:,O
alert,O
",",O
awake,O
",",O
partially,O
interacting,O
and,O
responding,O
to,O
comands,O
.,O

decreased,B-PR
reflexes,I-PR
Lower,I-PR
extremities,I-PR
.,O

bilaterally,O
.,O

spastic,O
right,O

upper,O
extremity,O
.,O

Pertinent,O
Results,O
:,O

141,O
103,O
53,O
167,O

AGap,B-TE
=,O
14,O

------------->,O

5.7,O
30,O
3.6,O

CK,B-TE
:,O
29,O
MB,B-TE
:,O
Notdone,O
Trop,B-TE
-*,O
T,O
*:,O
0.44,O

Comments,O
:,O
Notified,O
Glenn,O
Shives,O
2013-09-05,O
6:50,O
p,O

Ctropnt,B-TE
>,O
0.10,O
Ng,O
/,O
Ml,O
Suggests,O
Acute,B-PR
Mi,I-PR

Ca,B-TE
:,O
8.6,O
Mg,B-TE
:,O
2.4,O
P,B-TE
:,O
5.0,O

Other,O
Blood,O
Chemistry,O
:,O

proBNP,B-TE
:,O
11065,O

WBC,B-TE
15.2,O
Plat,B-TE
395,O

HCT,B-TE
:,O
28.4,O

N,B-TE
:,O
89.8,O
Band,B-TE
:,O
0,O
L,B-TE
:,O
5.8,O
M,B-TE
:,O
4.1,O
E,B-TE
:,O
0.3,O
Bas,B-TE
:,O
0.1,O
PT,B-TE
:,O
12.1,O
PTT,B-TE
:,O
37.5,O
INR,B-TE
:,O
1.0,O

2013-09-05,O

5:04,O
PM,O

Green,O
Top,O

K,B-TE
:,O
5.5,O
Lactate,B-TE
:,O
1.3,O

Brief,O
Hospital,O
Course,O
:,O

Assessment,O
and,O
Plan,O
:,O

This,O
is,O
a,O
79,O
y/o,O
M,O
with,O
h/o,O
HTN,B-PR
",",O
DM,B-PR
",",O
recent,B-PR
CVA,I-PR
",",O
chronic,B-PR
ventilatory,I-PR
failure,I-PR
",",O
CRI,B-PR
on,O
HD,B-TR
who,O
presents,O
with,O
change,B-PR
in,I-PR
MS,I-PR
and,O
febrile,B-PR
in,O
the,O
Amanda,O
",",O
admitted,O
to,O
CMED,O
.,O

#,O
Altered,B-PR
mental,I-PR
status,I-PR
:,O
Ct,B-TE
scan,I-TE
with,O
no,O
evidence,O
of,O
new,B-PR
intracraneal,I-PR
bleeding,I-PR
.,O

Patient,O
febrile,B-PR
in,O
the,O
Amanda,O
.,O

High,B-PR
WBC,I-PR
.,O

It,O
was,O
thought,O
that,O
it,O
could,O
have,O
been,O
a,O
combination,O
of,O
hypotension,B-PR
",",O
hypercapnia,B-PR
and,O
infection,B-PR
.,O

He,O
was,O
initially,O
started,O
on,O
broad,B-TR
spectrum,I-TR
antibiotics,I-TR
.,O

Despite,O
having,O
a,B-PR
profund,I-PR
limitation,I-PR
communicating,I-PR
given,O
his,B-PR
neurological,I-PR
status,I-PR
",",O
his,B-PR
mental,I-PR
changes,I-PR
seemed,O
to,O
improved,O
initially,O
.,O

However,O
later,O
on,O
during,O
his,O
course,O
",",O
his,O
mental,O
status,O
deteriorated,O
",",O
being,O
even,O
less,B-PR
responsive,I-PR
.,O

#,O
ID,O
:,O

Patient,O
febrile,B-PR
and,O
with,O
a,B-PR
high,I-PR
WBC,I-PR
on,O
admission,O
.,O

After,O
starting,O
broad,B-TR
spectrum,I-TR
antibiotics,I-TR
-,O
cefepime,B-TR
-,O
vancomycin,B-TR
and,O
flagyl,B-TR
(,O
for,O
initial,O
concern,O
of,O
aspiration,B-PR
pneumonia,I-PR
"),",O
he,O
responded,O
clinically,O
.,O

Urine,B-TE
cx,I-TE
from,O
Rehab,O
showed,O
gram,B-PR
negative,I-PR
rods,I-PR
>,B-PR
100,I-PR
K,I-PR
enterobacter,I-PR
cloacae,I-PR
.,O

Urine,B-TE
Cx,I-TE
in,O
house,O
grew,O
Citrobacter,B-PR
Freundi,I-PR
and,O
his,B-TE
sputum,I-TE
grew,O
Acinetobacter,B-PR
Baummani,I-PR
.,O

Since,O
there,O
was,O
no,O
more,O
evidence,O
of,O
gram,B-PR
positive,I-PR
infections,I-PR
",",O
vancomycin,B-TR
was,O
discontinued,O
and,O
cefepime,B-TR
was,O
kept,O
.,O

#,O
Fevers,B-PR
:,O
in,O
the,O
Amanda,O
",",O
high,B-PR
WBC,I-PR
",",O
possible,O
pneumonia,B-PR
.,O

Also,O
possible,O
source,O
sinus,B-PR
infections,I-PR
given,O
findings,O
on,O
intial,B-TE
CT,I-TE
(,O
see,O
summary,O
in,O
significant,O
studies,O
).,O
He,O
did,O
not,O
spike,O
any,O
fevers,B-PR
after,O
being,O
transfer,O
to,O
the,O
CMED,O
from,O
the,O
Amanda,O
.,O

#,O
Resp,O
:,O
Patient,O
was,O
intermitentely,O
switched,O
from,O
AC,B-TR
to,O
Pressure,B-TR
support,I-TR
trials,I-TR
.,O

However,O
",",O
after,O
Patient,O
did,O
well,O
.,O

Then,O
trach,B-TR
mask,I-TR
trials,I-TR
were,O
done,O
.,O

He,O
tolerated,O
this,O
well,O
",",O
although,O
he,O
required,O
PS,B-TR
overnight,O
.,O

#,O
ESRD,B-PR
on,O
hemodyalisis,B-TR
:,O
Renal,O
service,O
was,O
consulted,O
and,O
HD,B-TR
was,O
continued,O
.,O

#,O
CV,O
:,O

Rhythm,B-TE
:,O
NSR,O
",",O
not,O
tachycardic,B-PR
.,O

Pump,B-TE
:,O
With,O
trace,O
of,O
lower,B-PR
extremity,I-PR
edema,I-PR
.,O

X,B-TE
ray,I-TE
suggested,O
some,B-PR
pulmonary,I-PR
edema,I-PR
on,O
admission,O
.,O

Despite,O
this,O
findings,O
",",O
he,O
was,O
supported,O
with,O
40%,B-TR
FIO2,I-TR
most,O
of,O
the,O
time,O
.,O

CAD,B-PR
:,O
On,O
admission,O
Ck,B-TE
low,O
normal,O
",",O
MB,B-TE
not,O
done,O
.,O

Troponin,B-TE
0.44.,O

It,O
was,O
more,O
likely,O
due,O
to,O
CRI,B-PR
.,O

Second,O
set,O
12,O
hours,O
apart,O
",",O
showed,O
no,O
changes,B-PR
.,O

s/p,O
stroke,B-PR
:,O
continue,O
aspirin,B-TR
",",O
statin,B-TR
",",O
plavix,B-TR

#,O
Hypotension,B-PR
:,O
per,O
referral,O
form,O
.,O

Intially,O
concern,O
for,O
sepsis,B-PR
in,O
the,O
setting,O
of,O
fevers,B-PR
and,O
high,B-PR
blood,I-PR
count,I-PR
.,O

His,B-TR
BP,I-TR
medications,I-TR
were,O
held,O
on,O
admission,O
.,O

Patient,O
did,O
not,O
require,O
pressors,B-TR
.,O

His,B-TE
blood,I-TE
pressure,I-TE
remained,O
stable,O
and,O
BP,B-TR
meds,I-TR
were,O
restarted,O
.,O

#,O
FEN,O
:,O

Tube,B-TR
feedings,I-TR
were,O
started,O
thorugh,O
peg,B-TR
tube,I-TR
.,O

On,O
2013-09-08,O
",",O
patient,O
pulled,O
out,O
peg,B-TR
tube,I-TR
.,O

Temporary,B-TR
foley,I-TR
was,O
placed,O
and,O
on,O
2013-09-11,O
",",O

On,O
2013-09-12,O
after,O
deterioration,B-PR
of,I-PR
his,I-PR
mental,I-PR
status,I-PR
and,I-PR
also,I-PR
of,I-PR
his,I-PR
blood,I-PR
pressure,I-PR
",",O
goals,O
of,O
care,O
were,O
discussed,O
with,O
his,O
HCP,O
.,O

It,O
was,O
decided,O
to,O
direct,O
goals,O
of,O
care,O
towards,O
confort,B-TR
care,I-TR
.,O

Patient,O
passed,O
away,O
accompanied,O
by,O
his,O
significant,O
other,O
.,O

Medications,O
on,O
Admission,O
:,O

Novolin,B-TR
16,O
U,O
q,O
12h,O

Aranesp,B-TR
40,O
mcg,O
sc,O

Prozac,B-TR
liquid,I-TR
20,O
mg,O
q,O
am,O

Heparin,B-TR
3000,O
U,O
tu,O
",",O
thursday,O
saturday,O

Norvasc,B-TR
10,O
mg,O
daily,O
GT,O

Tylenol,B-TR
PRN,O

Reglan,B-TR
5,O
mg,O
q,O
6h,O
",",O

fergon,B-TR
300,O
mg,O
BID,O

Plavix,B-TR
75,O
mg,O
GT,O

nephrocaps,B-TR
1,O
daily,O

novolin,B-TR
Sliding,I-TR
scale,I-TR

heparin,B-TR
sc,O
5000,O
q,O
8h,O

Protonix,B-TR
40,O
mg,O
daily,O
GT,O

Combivent,B-TR
2,O
puff,O
qid,O
inh,O

zocor,B-TR
10,O
mg,O
Tab,O
/,O
day,O
GT,O

aspirin,B-TR
325,O
mg,O
tab,O

Ferrlecit,B-TR
Sodium,I-TR
ferric,I-TR
gluconate,I-TR
Mo-We,O
Fr,O
IV,O

Discharge,O
Medications,O
:,O

n/a,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Discharge,O
Diagnosis,O
:,O

1.,O
Change,B-PR
in,I-PR
Mental,I-PR
status,I-PR

2.,O
Urinary,B-PR
tract,I-PR
Infection,I-PR

3.,O
Chronic,B-PR
respiratory,I-PR
failure,I-PR

Secondary,O
:,O

1.,O
Hypertension,B-PR

2.,O
Diabetes,B-PR
Mellitus,I-PR

3.,O
End,B-PR
stage,I-PR
renal,I-PR
disease,I-PR
on,O
HD,B-TR

Discharge,O
Condition,O
:,O

expired,O

Discharge,O
Instructions,O
:,O

n/a,O

Followup,O
Instructions,O
:,O

n/a,O

Z.,O
Mcbride,O
WEISS,O
MD,O
51-615,O

Completed,O
by,O
:,O
Martha,O
Fairley,O
MD,O
53-063,O
2013-11-12,O
@,O
2057,O

Signed,O
electronically,O
by,O
:,O
DR.,O
V,O
Osterman,O
WEISS,O
on,O
:,O
WED,O
2013-11-13,O
8:40,O
AM,O

(,O
End,O
of,O
Report,O
),O

570922581,O

CTMC,O

93618376,O

16906,O

1/11/1996,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

01/11/1996,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

01/19/1996,O

IDENTIFICATION,O
:,O

Ms.,O
Less,O
was,O
initially,O
admitted,O
to,O
the,O
Vascular,O
Surgery,O
Service,O
for,O
Dr.,O
Scosthuang,O
and,O
was,O
recently,O
transferred,O
to,O
the,O
Neurosurgery,O
Service,O
under,O
the,O
care,O
of,O
Dr.,O
Pae,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Ms.,O
Less,O
is,O
a,O
79,O
year,O
old,O
white,O
female,O
with,O
history,O
of,O
non,B-PR
small,I-PR
cell,I-PR
lung,I-PR
cancer,I-PR
diagnosed,O
in,O
02/95,O
.,O

She,O
underwent,O
a,B-TR
resection,I-TR
for,O
stage,B-PR
I,I-PR
in,O
10/95,O
and,O
treated,O
with,O
XRT,B-TR
.,O

She,O
presented,O
to,O
the,O
hospital,O
with,O
a,B-PR
numb,I-PR
right,I-PR
leg,I-PR
this,O
morning,O
and,O
underwent,O
an,B-TR
emergent,I-TR
embolectomy,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Coronary,B-PR
artery,I-PR
disease,I-PR
status,O
post,O
myocardial,B-PR
infarction,I-PR
in,O
1990,O
",",O
peptic,B-PR
ulcer,I-PR
disease,I-PR
and,O
hypertension,B-PR
.,O

MEDICATIONS,O
:,O

Medications,B-TR
on,I-TR
admission,I-TR
were,O
Coumadin,B-TR
",",O
Digoxin,B-TR
Synthroid,B-TR
",",O
Lopressor,B-TR
and,O
Zantac,B-TR
.,O

On,O
1/14/96,O
",",O
she,O
had,O
a,B-TR
dialysis,I-TR
catheter,I-TR
.,O

On,O
1/18/96,O
",",O
she,O
had,O
an,B-PR
acute,I-PR
change,I-PR
in,I-PR
mental,I-PR
status,I-PR
and,O
underwent,O
an,B-TE
emergent,I-TE
head,I-TE
CT,I-TE
scan,I-TE
which,O
showed,O
a,B-PR
massive,I-PR
subarachnoid,I-PR
hemorrhage,I-PR
with,O
bleeding,B-PR
in,I-PR
the,I-PR
subarachnoid,I-PR
space,I-PR
",",O
and,O
throughout,O
the,O
ventricles,O
.,O

She,O
also,O
had,O
significant,B-PR
hydrocephalus,I-PR
.,O

Follow,B-TE
up,I-TE
CT,I-TE
scan,I-TE
showed,O
worsening,O
of,O
her,B-PR
hydrocephalus,I-PR
and,O
she,O
had,O
a,B-TR
ventriculostomy,I-TR
placed,O
in,O
the,O
Intensive,O
Care,O
Unit,O
.,O

She,O
failed,O
to,O
improve,O
following,O
placement,O
of,O
the,B-TR
ventriculostomy,I-TR
and,O
her,O
poor,O
prognosis,O
was,O
discussed,O
with,O
the,O
family,O
.,O

The,O
family,O
at,O
that,O
point,O
considering,O
the,O
multiple,O
system,O
involvement,O
of,O
her,B-PR
diseases,I-PR
",",O
decided,O
to,O
make,O
the,O
patient,O
DNR,B-TR
and,O
withdraw,O
care,B-TR
.,O

The,O
patient,O
expired,O
on,O
1/19/96,O
at,O
11:35,O
p.m.,O

The,O
medical,O
examiner,O
was,O
called,O
and,O
the,O
case,O
was,O
discussed,O
",",O
and,O
he,O
declined,O
autopsy,B-TE
of,O
the,O
case,O
.,O

The,O
family,O
was,O
informed,O
and,O
all,O
questions,O
were,O
answered,O
.,O

Dictated,O
By,O
:,O

RORIEZAILA,O
FERNE,O
KOTEKAYSKOTEKAYSCOA,O
",",O
M.D.,O
AV9,O

Attending,O
:,O

NAREA,O
L.,O
RUDESTHIR,O
",",O
M.D.,O
XS62,O
RS286/0162,O

Batch,O
:,O

2998,O

Index,O
No.,O
WLDOVN4PV4,O

D,O
:,O

01/19/96,O

T,O
:,O

01/19/96,O

420033129,O
YC,O

87142319,O

129591,O

12/12/1996,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

12/12/1996,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

12/16/1996,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

STATUS,O
POST,O
TOTAL,B-TR
ABDOMINAL,I-TR
HYSTERECTOMY,I-TR
AND,O
BILATERAL,B-TR
SALPINGO-OOPHORECTOMY,I-TR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

1),O
MENORRHAGIA,B-PR
.,O

2),O
PELVIC,B-PR
PAIN,I-PR
.,O

3),O
ENDOMETRIOSIS,B-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

TAH-BSO,B-TR
.,O

HISTORY,O
/,O
REASON,O
FOR,O
HOSPITALIZATION,O
:,O

The,O
patient,O
is,O
a,O
42,O
year,O
old,O
gravida,O
II,O
",",O
para,O
I,O
female,O
with,O
a,O
long,O
history,O
of,O
menorrhagia,B-PR
and,O
pelvic,B-PR
pain,I-PR
.,O

She,O
also,O
has,O
a,O
history,O
of,O
endometriosis,B-PR
that,O
is,O
symptomatic,B-PR
.,O

She,O
used,O
Danocrine,B-TR
for,O
approximately,O
nine,O
months,O
and,O
was,O
pain,B-PR
free,O
",",O
but,O
was,O
unable,O
to,O
tolerate,O
the,B-PR
side,I-PR
effects,I-PR
.,O

She,O
is,O
status,O
post,O
several,B-TE
laparoscopies,I-TE
in,O
the,O
past,O
with,O
which,O
she,O
was,O
diagnosed,O
with,O
endometriosis,B-PR
.,O

She,O
has,O
recently,O
been,O
on,O
Depo-Provera,B-TR
and,O
has,O
had,O
episodes,O
of,O
break-through,B-PR
bleeding,I-PR
for,O
six,O
weeks,O
at,O
a,O
time,O
.,O

She,O
desired,O
surgical,B-TR
therapy,I-TR
.,O

HOSPITAL,O
COURSE,O
:,O

On,O
12/12/96,O
she,O
had,O
an,B-TR
uncomplicated,I-TR
total,I-TR
abdominal,I-TR
hysterectomy,I-TR
and,O
bilateral,B-TR
salpingo-oophorectomy,I-TR
.,O

Estimated,B-PR
blood,I-PR
loss,I-PR
was,O
100,O
cc,O
and,O
she,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
.,O

On,O
postop,O
day,O
number,O
one,O
she,O
was,O
afebrile,B-PR
and,O
doing,O
well,O
with,O
a,B-TR
PCA,I-TR
for,O
pain,B-TR
control,I-TR
.,O

On,O
postop,O
day,O
number,O
two,O
she,O
was,O
also,O
afebrile,B-PR
and,O
had,O
not,O
passed,O
any,B-PR
flatus,I-PR
yet,O
.,O

She,O
was,O
ambulating,O
frequently,O
.,O

Her,B-TE
hematocrit,I-TE
was,O
34.2,O
and,O
stable,O
from,O
her,O
preoperative,O
value,O
.,O

On,O
postop,O
day,O
number,O
three,O
her,O
abdomen,O
was,O
noted,O
to,O
be,O
distended,B-PR
with,O
a,B-TE
few,I-TE
bowel,I-TE
sounds,I-TE
and,O
she,O
still,O
had,O
not,O
passed,O
gas,B-PR
.,O

The,O
patient,O
decreased,O
the,O
amount,O
of,O
Demerol,B-TR
she,O
was,O
using,O
and,O
supplemented,O
with,O
Tylenol,B-TR
and,O
continued,O
her,O
frequent,O
ambulation,O
.,O

On,O
postop,O
day,O
number,O
four,O
she,O
had,O
passed,O
flatus,B-PR
and,O
was,O
feeling,O
much,O
better,O
.,O

She,O
was,O
discharged,O
to,O
home,O
in,O
good,O
condition,O
on,O
the,B-TR
following,I-TR
medications,I-TR
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Demerol,B-TR
for,O
pain,B-PR
.,O

Motrin,B-TR
for,O
pain,B-PR
.,O

Colace,B-TR
stool,I-TR
softener,I-TR
.,O

DISPOSITION,O
:,O

The,O
patient,O
should,O
follow-up,O
with,O
Dr.,O
Side,O
in,O
two,O
weeks,O
.,O

Dictated,O
By,O
:,O

IEDEARC,O
SIDE,O
",",O
M.D.,O
LB28,O

Attending,O
:,O

MITERY,O
D.,O
LOSS,O
",",O
M.D.,O
CB51,O
II795/2112,O

Batch,O
:,O

42100,O

Index,O
No.,O
ZMFX3O4G1,O

D,O
:,O

01/04/97,O

T,O
:,O

01/06/97,O

CC,O
:,O

1.,O
MITERY,O
D.,O
LOSS,O
",",O
M.D.,O
NT11,O

[,O
report,O
_,O
end,O
],O

573620996,O

FIH,O

7728564,O

87294/8g15,O

879796,O

6/26/1994,O
12:00:00,O
AM,O

MIXED,B-PR
MESODERMAL,I-PR
CANCER,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

06/26/94,O

DISCHARGE,O
DATE,O
:,O

06/30/94,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

mixed,B-PR
mesodermal,I-PR
cancer,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

(,O
1,O
),O
status,O
post,O
hysterectomy,B-TR
and,O
bilateral,B-TR
oophorectomy,I-TR
.,O

(,O
2,O
),O
abdominal,B-PR
wall,I-PR
hernia,I-PR
.,O

(,O
3,O
),O
hypertension,B-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

On,O
June,O
26,O
",",O
1994,O
tumor,B-TR
debulking,I-TR
",",O
pelvic,B-TR
lymph,I-TR
node,I-TR
dissection,I-TR
",",O
lysis,B-TR
of,O
adhesions,B-PR
",",O
abdominal,B-TR
wall,I-TR
hernia,I-TR
repair,I-TR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
an,O
81,O
year,O
old,O
female,O
",",O
G2,O
",",O
P2,O
",",O
who,O
status,O
post,O
total,B-TR
abdominal,I-TR
hysterectomy-bilateral,I-TR
salpingo-oophorectomy,I-TR
one,O
years,O
ago,O
for,O
a,B-PR
mixed,I-PR
mesodermal,I-PR
cancer,I-PR
who,O
presents,O
with,O
vaginal,B-PR
apex,I-PR
recurrence,I-PR
.,O

She,O
had,O
a,O
normal,O
pelvic,O
examination,O
and,O
CT,B-TE
scan,I-TE
in,O
February,O
of,O
1993,O
but,O
one,O
month,O
prior,O
to,O
this,O
admission,O
starting,O
bleeding,B-PR
per,I-PR
vagina,I-PR
.,O

An,B-TE
examination,I-TE
revealed,O
an,B-PR
apicovaginal,I-PR
lesion,I-PR
consistent,O
with,O
recurrent,B-PR
tumor,I-PR
.,O

A,B-TE
computerized,I-TE
tomography,I-TE
scan,I-TE
was,O
performed,O
which,O
showed,O
a,B-PR
central,I-PR
recurrence,I-PR
and,O
biopsy,B-TE
of,O
this,B-PR
lesion,I-PR
was,O
positive,O
.,O

She,O
presents,O
now,O
for,O
excision,B-TR
of,O
her,B-PR
local,I-PR
cancer,I-PR
recurrence,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Is,O
as,O
above,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Halcion,B-TR
0.25,O
mg.,O
P.O.,O
q.h.s.,O
",",O

Valium,B-TR
5,O
mg.,O
P.O.,O
p.r.n,O
and,O
methyclothiazide,B-TR
5,O
mg.,O
q.d.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Her,B-TE
temperature,I-TE
is,O
97.9,O
",",O
blood,B-TE
pressure,I-TE
160/80,O
",",O
heart,B-TE
rate,I-TE
92,O
",",O
her,B-TE
HEENT,I-TE
examination,I-TE
reveals,O
anicteric,B-PR
sclerae,I-PR
and,O
her,O
left,O
eye,O
has,O
slightly,B-PR
relaxed,I-PR
inferoorbital,I-PR
wall,I-PR
.,O

Her,O
chest,O
is,O
clear,O
to,O
auscultation,B-TE
.,O

Her,O
heart,O
has,O
regular,O
rate,O
and,O
rhythm,O
with,O
I,B-PR
/,I-PR
VI,I-PR
systolic,I-PR
ejection,I-PR
murmur,I-PR
at,I-PR
the,I-PR
base,I-PR
.,O

Abdomen,O
is,O
obese,B-PR
",",O
soft,O
",",O
non-tender,B-PR
",",O
and,O
without,O
palpable,B-PR
masses,I-PR
.,O

Extremities,O
two,B-TE
plus,I-TE
pulses,I-TE
bilaterally,I-TE
and,O
nonpitting,B-PR
edema,I-PR
up,I-PR
to,I-PR
the,I-PR
knees,I-PR
in,O
both,O
legs,O
.,O

Neurologic,O
examination,O
:,O

is,O
unremarkable,O
.,O

LABORATORY,O
DATA,O
:,O

sodium,B-TE
142,O
",",O
potassium,B-TE
3.3,O
",",O
chloride,B-TE
98,O
",",O
bicarbonate,B-TE
34,O
",",O
BUN,B-TE
and,O
creatinine,B-TE
14/0.9,O
.,O

Her,B-TE
alkaline,I-TE
phosphatase,I-TE
is,O
77,O
",",O
white,B-TE
blood,I-TE
count,I-TE
12.5,O
",",O
hematocrit,B-TE
42.6,O
",",O
platelet,B-TE
count,I-TE
268,O
.,O

IN,O
SUMMARY,O
:,O

This,O
is,O
a,O
patient,O
with,O
recurrence,O
of,O
a,B-PR
mixed,I-PR
mesodermal,I-PR
cancer,I-PR
at,I-PR
the,I-PR
vaginal,I-PR
apex,I-PR
who,O
presents,O
for,O
local,B-TR
excision,I-TR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
GYN,O
/,O
Oncology,O
Service,O
under,O
the,O
care,O
of,O
Dr.,O
Top,O
on,O
June,O
26,O
",",O
1994,O
.,O

On,O
that,O
day,O
she,O
was,O
taken,O
to,O
the,O
operating,O
room,O
where,O
she,O
underwent,O
an,B-TE
exam,I-TE
under,O
anesthesia,B-TR
",",O
an,B-TE
exploratory,I-TE
laparotomy,I-TE
with,O
lysis,B-TR
of,O
adhesions,B-PR
",",O
tumor,B-TR
debulking,I-TR
and,O
bilateral,B-TR
pelvic,I-TR
lymph,I-TR
node,I-TR
dissection,I-TR
.,O

An,B-PR
abdominal,I-PR
wall,I-PR
hernia,I-PR
was,O
also,O
repaired,O
.,O

The,O
patient,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
without,O
any,B-PR
complications,I-PR
.,O

Her,O
postoperative,O
course,O
was,O
unremarkable,O
.,O

Her,B-TR
vaginal,I-TR
pack,I-TR
was,O
removed,O
on,O
the,O
second,O
postoperative,O
day,O
as,O
well,O
as,O
the,B-TR
Foley,I-TR
catheter,I-TR
.,O

By,O
postoperative,O
day,O
three,O
she,O
had,O
return,O
of,O
normal,O
bowel,O
function,O
and,O
was,O
able,O
to,O
tolerate,O
a,O
regular,O
diet,O
without,O
any,B-PR
difficulty,I-PR
.,O

Her,B-TR
Jackson-Pratt,I-TR
drain,I-TR
was,O
removed,O
on,O
June,O
30,O
",",O
1994,O
",",O
postoperative,O
day,O
four,O
.,O

On,O
that,O
day,O
she,O
was,O
feeling,O
well,O
enough,O
",",O
eating,O
well,O
",",O
and,O
voiding,O
without,O
difficulty,B-PR
.,O

As,O
a,O
result,O
she,O
was,O
able,O
to,O
be,O
discharged,O
home,O
on,O
June,O
30,O
",",O
1994,O
.,O

FOLLOW-UP,O
:,O

She,O
will,O
follow,O
up,O
with,O
Dr.,O
Top,O
in,O
his,O
office,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Her,B-TR
only,I-TR
additional,I-TR
medication,I-TR
on,O
discharge,O
is,O
Percocet,B-TR
as,O
needed,O
for,O
pain,B-PR
.,O

In,O
addition,O
Dr.,O
Blincarour,O
from,O
Radiation,O
Oncology,O
saw,O
the,O
patient,O
and,O
recommended,O
pelvic,B-TR
radiation,I-TR
therapy,I-TR
.,O

She,O
wishes,O
to,O
get,O
her,B-TR
radiation,I-TR
in,O
O,O
and,O
has,O
spoken,O
to,O
her,O
primary,O
care,O
physician,O
regarding,O
this,O
.,O

Of,O
note,O
the,O
pelvic,O
lymph,O
nodes,O
which,O
were,O
dissected,O
were,O
positive,O
for,O
tumor,B-PR
by,O
frozen,B-TE
section,I-TE
analysis,I-TE
.,O

The,B-TE
permanent,I-TE
pathology,I-TE
sections,I-TE
are,O
still,O
pending,O
.,O

DOLL,O
GRENDBLY,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

SLAINEAEE,O
S.,O
NIET,O
TOP,O
",",O
M.D.,O

TR,O
:,O

egi,O
/,O
bmot,O

DD,O
:,O

06/30/94,O

TD,O
:,O

07/01/94,O

CC,O
:,O

Dr.,O
Top,O
Dr.,O
Grendbly,O

Admission,O
Date,O
:,O

2009-06-23,O

Discharge,O
Date,O
:,O

2009-07-12,O

Date,O
of,O
Birth,O
:,O

1926-02-07,O

Sex,O
:,O

M,O

Service,O
:,O

CMI,O
;,O
then,O
to,O
Medcine,O
;,O
then,O
transferred,O
to,O
CCU,O

CHIEF,O
COMPLAINT,O
:,O

Renal,B-PR
failure,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
an,O
83-year-old,O
male,O
with,O
a,O
history,O
of,O
diabetes,B-PR
mellitus,I-PR
",",O
steroid-treated,B-PR
polymyalgia,I-PR
rheumatica,I-PR
",",O
hypertension,B-PR
",",O
benign,B-PR
prostatic,I-PR
hypertrophy,I-PR
",",O
and,O
high,B-PR
cholesterol,I-PR
who,O
presented,O
for,O
a,B-TE
lower,I-TE
extremity,I-TE
peripheral,I-TE
angiography,I-TE
for,O
bilateral,B-PR
foot,I-PR
ulcers,I-PR
",",O
and,O
he,O
was,O
found,O
to,O
an,B-PR
evaluated,I-PR
blood,I-PR
urea,I-PR
nitrogen,I-PR
",",I-PR
and,I-PR
creatinine,I-PR
",",I-PR
and,I-PR
potassium,I-PR
.,O

The,O
patient,O
notes,O
he,O
developed,O
worsening,B-PR
foot,I-PR
pain,I-PR
and,O
ulcers,B-PR
four,O
months,O
ago,O
.,O

Due,O
to,O
his,B-PR
worsening,I-PR
blood,I-PR
glucose,I-PR
",",O
he,O
was,O
started,O
on,O
insulin,B-TR
.,O

His,B-PR
foot,I-PR
ulcers,I-PR
continued,O
to,O
develop,O
",",O
and,O
the,O
patient,O
complained,O
of,O
pain,B-PR
in,I-PR
his,I-PR
feet,I-PR
;,O
primarily,O
at,O
night,O
.,O

The,O
patient,O
was,O
referred,O
to,O
for,O
Vascular,O
consultation,O
because,O
of,O
the,B-PR
ulcerations,I-PR
and,O
pain,B-PR
and,O
scheduled,O
for,O
a,O
lower,O

extremity,B-TE
angiography,I-TE
on,O
the,O
day,O
of,O
admission,O
",",O
but,O
due,O
to,O
his,B-PR
renal,I-PR
failure,I-PR
the,O
procedure,O
was,O
cancelled,O
.,O

The,O
patient,O
showed,O
peaked,B-PR
T,I-PR
waves,I-PR
on,O
electrocardiogram,B-TE
",",O
and,O
he,O
was,O
transferred,O
to,O
Medicine,O
.,O

The,O
patient,O
denied,O
any,O
oliguria,B-PR
",",O
hematuria,B-PR
",",O
dysuria,B-PR
",",O
foamy,B-PR
urine,I-PR
",",O
flank,B-PR
pain,I-PR
",",O
abdominal,B-PR
pain,I-PR
",",O
or,O
urinary,B-PR
hesitancy,I-PR
.,O

He,O
has,O
complained,O
of,O
fatigue,B-PR
",",O
anorexia,B-PR
",",O
and,O
a,B-PR
10-pound,I-PR
weight,I-PR
loss,I-PR
in,O
the,O
last,O
four,O
months,O
.,O

He,O
gets,O
short,B-PR
of,I-PR
breath,I-PR
with,O
one,O
flight,O
of,O
stairs,O
.,O

He,O
denies,O
any,B-PR
fevers,I-PR
",",O
chills,B-PR
",",O
recent,B-PR
infections,I-PR
",",O
chest,B-PR
pain,I-PR
",",O
orthopnea,B-PR
",",O
nausea,B-PR
",",O
vomiting,B-PR
",",O
diarrhea,B-PR
",",O
hematemesis,B-PR
",",O
melena,B-PR
",",O
or,O
hematochezia,B-PR
.,O

The,O
patient,O
also,O
notes,O
he,O
has,O
had,O
hoarseness,B-PR
for,O
the,O
last,O
two,O
to,O
three,O
weeks,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Diabetes,B-PR
mellitus,I-PR
times,O
four,O
years,O
;,O
recently,O
started,O
insulin,B-TR
and,O
metformin,B-TR
due,O
to,O
his,B-TR
concurrent,I-TR
steroid,I-TR
use,I-TR
.,O

Last,O
hemoglobin,B-TE
A1c,I-TE
was,O
11.4,O
.,O

2.,O
Polymyalgia,B-PR
rheumatica,I-PR
diagnosed,O
four,O
years,O
ago,O
;,O
on,O
steroids,B-TR
.,O

3.,O
Benign,B-PR
prostatic,I-PR
hypertrophy,I-PR
",",O
status,O
post,O
transurethral,B-TR
resection,I-TR
of,I-TR
prostate,I-TR
.,O

4.,O
Hypertension,B-PR
.,O

5.,O
High,B-PR
cholesterol,I-PR
.,O

6.,O
Lower,B-PR
extremity,I-PR
edema,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Methylprednisolone,B-TR
4,O
mg,O
q.,O
a.m.,O
and,O
2,O
mg,O
p.o.,O
q.h.s.,O
",",O
spironolactone,B-TR
50,O
mg,O
p.o.,O
q.d.,O
",",O
metformin,B-TR
1500,O
mg,O
p.o.,O
q.h.s.,O
",",O
Pravastatin,B-TR
10,O
mg,O
p.o.,O
q.h.s.,O
",",O
lisinopril,B-TR
20,O
mg,O
p.o.,O
q.,O
a.m.,O
",",O
Lasix,B-TR
80,O
mg,O
p.o.,O
q.,O
a.m.,O
",",O
Tylenol,B-TR
as,O
needed,O
",",O
insulin,B-TR
regular,I-TR
22,O
units,O
in,O
the,O
morning,O
and,O
12,O
units,O
at,O
night,O
(,O
lispro,B-TR
regular,I-TR
).,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

FAMILY,O
HISTORY,O
:,O

Type,B-PR
1,I-PR
diabetes,I-PR
in,O
twin,O
brother,O
",",O
type,B-PR
2,I-PR
diabetes,I-PR
in,O
mother,O
and,O
brother,O
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
is,O
a,O
former,O
smoker,O
;,O
he,O
quit,O
50,O
years,O
ago,O
.,O

He,O
drinks,O
one,O
glass,O
of,O
wine,O
per,O
night,O
.,O

He,O
is,O
married,O
and,O
lives,O
with,O
his,O
wife,O
.,O

John,O
was,O
in,O
the,O
Army,O
during,O
World,O
War,O
II,O
.,O

PHYSICAL,O
EXAMINATION,O
ON,O
PRESENTATION,O
:,O

On,O
admission,O
",",O
temperature,B-TE
was,O
98.1,O
",",O
blood,B-TE
pressure,I-TE
was,O
140/70,O
",",O
pulse,B-TE
was,O
95,O
",",O
respiratory,B-TE
rate,I-TE
was,O
18,O
",",O
oxygen,B-TE
saturation,I-TE
was,O
98%,O
on,O
room,O
air,O
.,O

In,O
general,O
",",O
the,O
patient,O
was,O
a,O
thin,O
white,O
male,O
",",O
lying,O
in,O
bed,O
",",O
in,O
no,O
acute,B-PR
distress,I-PR
",",O
with,O
a,B-PR
hoarse,I-PR
voice,I-PR
.,O

Head,O
",",O
eyes,O
",",O
ears,O
",",O
nose,O
",",O
and,O
throat,O
revealed,O
pupils,O
were,O
equally,O
round,O
and,O
reactive,O
to,O
light,O
and,O
accommodation,O
.,O

Extraocular,O
movements,O
were,O
intact,O
.,O

Sclerae,O
were,O
anicteric,B-PR
.,O

Mucous,O
membranes,O
were,O
moist,O
.,O

Neck,O
revealed,O
no,O
lymphadenopathy,B-PR
.,O

No,O
thyromegaly,B-PR
.,O

No,O
jugular,B-PR
venous,I-PR
distention,I-PR
.,O

Cardiovascular,B-TE
examination,I-TE
revealed,O
a,O
regular,O
rate,O
and,O
rhythm,O
.,O

Normal,O
first,O
heart,O
sound,O
and,O
second,O
heart,O
sound,O
.,O

A,B-PR
2/6,I-PR
systolic,I-PR
murmur,I-PR
at,I-PR
the,I-PR
upper,I-PR
sternal,I-PR
border,I-PR
.,O

Lungs,O
were,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
with,O
faint,B-PR
lower,I-PR
lobe,I-PR
crackles,I-PR
on,I-PR
the,I-PR
left,I-PR
.,O

Back,O
revealed,O
no,O
costovertebral,B-PR
angle,I-PR
tenderness,I-PR
.,O

The,O
abdomen,O
was,O
soft,O
and,O
nontender,B-PR
.,O

No,O
rebound,B-PR
or,O
guarding,B-PR
.,O

No,O
hepatosplenomegaly,B-PR
.,O

Extremities,O
revealed,O
2+,B-TE
femoral,I-TE
pulses,I-TE
bilaterally,I-TE
",",O
1+,B-TE
dorsalis,I-TE
pedis,I-TE
pulses,I-TE
bilaterally,I-TE
.,O

No,O
lower,B-PR
extremity,I-PR
edema,I-PR
.,O

Left,O
foot,O
with,O
a,B-PR
dry,I-PR
crusted,I-PR
ulcer,I-PR
over,O
the,O
medial,O
aspect,O
of,O
the,O
first,O
metatarsal,O
head,O
and,O
the,O
lateral,O
posterior,O
heel,O
.,O

On,O
the,B-PR
right,I-PR
foot,I-PR
dry,I-PR
crusted,I-PR
ulcer,I-PR
over,O
the,O
medial,O
aspect,O
of,O
the,O
first,O
metatarsal,O
head,O
and,O
medial,O
posterior,O
heel,O
.,O

Neurologic,B-TE
examination,I-TE
was,O
grossly,O
intact,O
.,O

PERTINENT,O
LABORATORY,O
DATA,O
ON,O
PRESENTATION,O
:,O

On,O
admission,O
",",O
white,B-TE
blood,I-TE
cell,I-TE
count,I-TE
was,O
11,O
",",O
hematocrit,B-TE
was,O
30,O
",",O
platelets,B-TE
were,O
269,O
.,O

Sodium,B-TE
was,O
139,O
",",O
potassium,B-TE
was,O
6.1,O
",",O
chloride,B-TE
was,O
102,O
",",O
bicarbonate,B-TE
was,O
18,O
",",O
blood,B-TE
urea,I-TE
nitrogen,I-TE
was,O
100,O
",",O
creatinine,B-TE
was,O
2.3,O
",",O
and,O
blood,B-TE
glucose,I-TE
was,O
189,O
.,O

FENa,B-TE
was,O
0.37,O
.,O

RADIOLOGY,O
/,O
IMAGING,O
:,O

Renal,B-TE
ultrasound,I-TE
was,O
normal,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
is,O
an,O
83,O
-,O
year-old,O
male,O
with,O
a,O
history,O
of,O
diabetes,B-PR
",",O
steroid-treated,B-PR
polymyalgia,I-PR
rheumatica,I-PR
",",O
hypertension,B-PR
",",O
benign,B-PR
prostatic,I-PR
hypertrophy,I-PR
",",O
and,O
high,B-PR
cholesterol,I-PR
without,O
presented,O
to,O
the,O
hospital,O
for,O
lower,B-TE
extremity,I-TE
angiograph,I-TE
;,O
however,O
",",O
that,O
was,O
deferred,O
due,O
to,O
new,B-PR
onset,I-PR
renal,I-PR
failure,I-PR
.,O

1.,O
RENAL,B-PR
FAILURE,I-PR
:,O

The,O
patient,O
was,O
initially,O
thought,O
to,O
be,O
prerenal,B-PR
",",O
and,O
his,O
renal,O
status,O
improved,O
after,O
hydration,B-TR
and,O
increased,B-TR
oral,I-TR
intake,I-TR
.,O

He,O
did,O
have,O
a,B-TE
magnetic,I-TE
resonance,I-TE
angiography,I-TE
of,I-TE
his,I-TE
kidneys,I-TE
which,O
showed,O
mild,B-PR
right-sided,I-PR
renal,I-PR
artery,I-PR
stenosis,I-PR
.,O

His,O
renal,O
function,O
fluctuated,O
throughout,O
his,O
hospital,O
stay,O
",",O
and,O
when,O
he,O
was,O
in,O
the,O
Medical,O
Intensive,O
Care,O
Unit,O
he,O
did,O
have,O
decreased,B-PR
urine,I-PR
output,I-PR
in,O
the,O
setting,O
of,O
cardiogenic,B-PR
shock,I-PR
.,O

2.,O
CARDIOVASCULAR,O
:,O

The,O
patient,O
with,O
severe,B-PR
peripheral,I-PR
vascular,I-PR
disease,I-PR
.,O

During,O
his,O
hospital,O
stay,O
",",O
he,O
developed,O
some,B-PR
nonsustained,I-PR
ventricular,I-PR
tachycardia,I-PR
.,O

He,O
also,O
became,O
hypotensive,B-PR
on,O
07-02,O
in,O
the,O
setting,O
of,O
infection,B-PR
.,O

The,O
patient,O
had,O
a,B-TR
central,I-TR
line,I-TR
placed,O
and,O
went,O
into,O
sustained,B-PR
ventricular,I-PR
tachycardia,I-PR
that,O
was,O
treated,O
with,O
lidocaine,B-TR
.,O

After,O
being,O
treated,O
with,O
lidocaine,B-TR
",",O
the,O
patient,O
became,O
apneic,B-PR
requiring,O
intubation,B-TR
and,O
transfer,O
to,O
the,O
Coronary,O
Care,O
Unit,O
.,O

His,B-PR
nonsustained,I-PR
ventricular,I-PR
tachycardia,I-PR
was,O
treated,O
with,O
a,B-TR
lidocaine,I-TR
drip,I-TR
.,O

It,O
was,O
found,O
that,O
he,O
had,O
elevated,B-PR
troponins,I-PR
and,O
likely,O
an,B-PR
ischemic,I-PR
event,I-PR
on,O
the,O
07-02,O
.,O

A,B-TE
repeat,I-TE
echocardiogram,I-TE
showed,O
a,B-PR
decreased,I-PR
ejection,I-PR
fraction,I-PR
from,O
prior,O
.,O

He,O
had,O
a,B-TE
cardiac,I-TE
catheterization,I-TE
which,O
revealed,O
3-vessel,B-PR
disease,I-PR
.,O

Cardiothoracic,O
Surgery,O
was,O
consulted,O
",",O
and,O
due,O
to,O
the,B-PR
patient,I-PR
's,I-PR
acute,I-PR
illness,I-PR
",",O
they,O
wanted,O
to,O
re-evaluate,O
after,O
the,O
patient,O
was,O
extubated,O
.,O

The,O
patient,O
continued,O
to,O
have,O
intermittent,O
episodes,O
of,O
ventricular,B-PR
tachycardia,I-PR
.,O

He,O
was,O
continued,O
on,O
lidocaine,B-TR
and,O
eventually,O
changed,O
over,O
to,O
amiodarone,B-TR
.,O

He,O
was,O
noted,O
to,O
be,O
cardiogenic,B-PR
shock,I-PR
requiring,O
pressors,B-TR
.,O

Of,O
note,O
",",O
he,O
likely,O
suffered,O
a,B-PR
second,I-PR
ischemic,I-PR
event,I-PR
during,O
his,O
Coronary,O
Care,O
Unit,O
stay,O
.,O

The,O
patient,O
did,O
have,O
a,B-TE
Swan-Ganz,I-TE
catheter,I-TE
in,O
place,O
and,O
had,O
a,B-PR
low,I-PR
cardiac,I-PR
output,I-PR
.,O

The,O
patient,O
's,O
family,O
eventually,O
decided,O
to,O
withdraw,O
care,O
",",O
and,O
the,O
patient,O
was,O
extubated,O
and,O
passed,O
away,O
on,O
2009-07-12,O
.,O

2.,O
INFECTIOUS,O
DISEASE,O
:,O

The,O
patient,O
was,O
initially,O
treated,O
with,O
levofloxacin,B-TR
for,O
a,B-PR
left,I-PR
lower,I-PR
lobe,I-PR
infiltrate,I-PR
and,O
a,B-PR
urinary,I-PR
tract,I-PR
infection,I-PR
.,O

He,O
then,O
developed,O
positive,B-PR
blood,I-PR
cultures,I-PR
with,O
Staphylococcus,B-PR
aureus,I-PR
sensitive,O
to,O
levofloxacin,B-TR
",",O
and,O
that,O
was,O
continued,O
.,O

When,O
the,O
patient,O
became,O
hypotensive,B-PR
and,O
required,O
intubation,B-TR
and,O
pressors,B-TR
",",O
his,B-TR
antibiotics,I-TR
were,O
broadened,O
",",O
and,O
he,O
was,O
put,O
on,O
stress-dose,B-TR
steroids,I-TR
.,O

He,O
was,O
found,O
to,O
have,O
bilateral,B-PR
Staphylococcus,I-PR
pneumonia,I-PR
.,O

3.,O
PULMONARY,O
:,O

The,O
patient,O
required,O
intubation,B-TR
in,O
the,O
setting,O
of,O
hypotension,B-PR
and,O
ventricular,B-PR
tachycardia,I-PR
.,O

He,O
was,O
actually,O
extubated,O
on,O
07-09,O
",",O
but,O
then,O
reintubated,O
one,O
hour,O
later,O
due,O
to,O
hypoxia,B-PR
.,O

He,O
was,O
also,O
found,O
to,O
have,O
a,B-PR
bilateral,I-PR
Staphylococcus,I-PR
pneumonia,I-PR
.,O

DISCHARGE,O
DISPOSITION,O
:,O

On,O
07-12,O
",",O
after,O
and,O
extensive,O
family,O
meeting,O
",",O
the,O
family,O
decided,O
to,O
extubate,O
the,O
patient,O
and,O
make,O
him,O
comfortable,O
",",O
and,O
he,O
passed,O
away,O
at,O
5:20,O
on,O
2009-07-12,O
.,O

Hattie,O
L,O
Breaux,O
",",O
M.D.,O

33-679,O

Dictated,O
By,O
:,O
Larry,O
W.,O
Nagy,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2009-12-03,O
09:18,O

T,O
:,O
2009-12-08,O
10:47,O

JOB,O
#:,O

32151,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Stephanie,O
Francis,O
on,O
:,O
TUE,O
2009-12-08,O
4:59,O
PM,O

(,O
End,O
of,O
Report,O
),O

599923748,O

PUOMC,O

79427,O

25598/1879,O

538465,O

5/8/1995,O
12:00:00,O
AM,O

RIGHT,B-PR
OCCIPITAL,I-PR
",",I-PR
CEREBRAL,I-PR
INFARCTION,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

05/08/95,O

DISCHARGE,O
DATE,O
:,O

05/14/95,O

DATE,O
OF,O
BIRTH,O
:,O

01-Apr-23,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Right,B-PR
occipital,I-PR
",",I-PR
cerebral,I-PR
infarction,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

Old,B-PR
inferior,I-PR
wall,I-PR
myocardial,I-PR
infarction,I-PR
in,O
1984,O
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

Head,B-TE
magnetic,I-TE
resonance,I-TE
imaging,I-TE
study,I-TE
and,O
magnetic,B-TE
resonance,I-TE
imaging,I-TE
angiogram,I-TE
with,I-TE
and,I-TE
without,I-TE
gadolinium,I-TE
.,O

ASSOCIATED,O
PROCEDURES,O
:,O

Head,B-TE
computerized,I-TE
tomography,I-TE
scan,I-TE
",",O
echocardiogram,B-TE
",",O
transcranial,B-TE
Dopplers,I-TE
",",O
carotid,B-TE
noninvasives,I-TE
",",O
Holter,B-TE
electrocardiogram,I-TE
",",O
electroencephalogram,B-TE
",",O
and,O
visual,B-TE
field,I-TE
testing,I-TE
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
72-year-old,O
right-handed,O
gentleman,O
with,O
a,O
history,O
of,O
coronary,B-PR
artery,I-PR
disease,I-PR
status,O
post,O
myocardial,B-PR
infarction,I-PR
in,O
1984,O
.,O

Also,O
with,O
a,O
history,O
of,O
noninsulin,B-PR
dependent,I-PR
diabetes,I-PR
mellitus,I-PR
",",O
now,O
presenting,O
with,O
acute,B-PR
blurry,I-PR
vision,I-PR
on,I-PR
the,I-PR
left,I-PR
side,I-PR
",",O
which,O
is,O
homonymous,O
.,O

The,O
patient,O
woke,O
up,O
as,O
usual,O
on,O
May,O
8,O
",",O
1995,O
.,O

At,O
8,O
a.m.,O
the,O
patient,O
was,O
looking,O
at,O
his,O
wife,O
with,O
the,O
background,O
outside,O
a,O
large,O
window,O
.,O

The,O
patient,O
had,O
sudden,O
onset,O
of,O
blurred,B-PR
vision,I-PR
",",O
where,O
the,O
right,O
side,O
of,O
his,O
wife,O
&apos;s,O
face,O
looked,O
blurred,O
.,O

The,O
patient,O
did,O
not,O
notice,O
change,B-PR
of,I-PR
vision,I-PR
in,O
the,O
background,O
.,O

The,B-PR
blurred,I-PR
vision,I-PR
was,O
homonymous,O
",",O
which,O
he,O
had,O
blurred,O
in,O
each,O
eye,O
in,O
the,O
left,O
visual,O
field,O
.,O

The,B-PR
same,I-PR
blurred,I-PR
vision,I-PR
was,O
also,O
noticed,O
later,O
when,O
the,O
patient,O
was,O
watching,O
television,O
and,O
also,O
when,O
he,O
was,O
reading,O
.,O

The,O
patient,O
was,O
seen,O
at,O
the,O
Ochtuheihugh,O
Put,O
University,O
Medical,O
Center,O
and,O
then,O
he,O
was,O
referred,O
to,O
the,O
Purckecation,O
Balpoingdelt,O
Pabarnes-,O
Campa,O
Memorial,O
Hospital,O
.,O

At,O
8,O
p.m.,O
the,O
patient,O
seen,O
at,O
the,O
Purckecation,O
Balpoingdelt,O
Pabarnes-,O
Campa,O
Memorial,O
Hospital,O
and,O
was,O
examined,O
and,O
assessed,O
.,O

The,O
patient,O
was,O
referred,O
to,O
Ph,O
University,O
Of,O
Medical,O
Center,O
for,O
rule,O
out,O
transient,B-PR
ischemic,I-PR
attack,I-PR
and,O
rule,O
out,O
stroke,B-PR
.,O

The,O
patient,O
denies,O
any,B-PR
nausea,I-PR
",",O
vomiting,B-PR
",",O
ataxia,B-PR
",",O
motor,B-PR
deficits,I-PR
",",O
speech,B-PR
deficits,I-PR
or,O
sensory,B-PR
deficits,I-PR
.,O

The,O
patient,O
lightly,O
bumped,O
his,O
head,O
on,O
the,O
top,O
three,O
times,O
on,O
the,O
previous,O
night,O
and,O
the,O
patient,O
had,O
frontal,B-PR
headaches,I-PR
and,O
a,B-PR
tight,I-PR
neck,I-PR
.,O

One,O
hour,O
after,O
he,O
had,O
physical,O
activity,O
on,O
the,O
previously,O
night,O
as,O
well,O
.,O

ALLERGIES,O
:,O

The,O
patient,O
denies,O
any,B-PR
drug,I-PR
allergies,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

is,O
significant,O
for,O
a,B-PR
myocardial,I-PR
infarction,I-PR
in,O
1984,O
.,O

The,O
patient,O
has,O
been,O
on,O
cardiac,B-TR
medications,I-TR
since,O
and,O
has,O
had,O
no,O
new,B-PR
episodes,I-PR
.,O

The,O
patient,O
has,O
been,O
diagnosed,O
with,O
diabetes,B-PR
mellitus,I-PR
since,O
1991,O
and,O
has,O
been,O
maintained,O
on,O
Glipizide,B-TR
.,O

In,O
1992,O
",",O
the,O
patient,O
has,O
been,O
diagnosed,O
with,O
bladder,B-PR
papilloma,I-PR
and,O
has,O
been,O
cystoscoped,O
seven,O
times,O
.,O

The,O
most,O
recent,O
was,O
done,O
on,O
May,O
4,O
",",O
1995,O
.,O

FAMILY,O
HISTORY,O
:,O

The,O
patient,O
has,O
a,O
family,O
history,O
of,O
prostate,B-PR
cancer,I-PR
and,O
stroke,B-PR
but,O
no,O
history,O
of,O
migraines,B-PR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
stopped,O
smoking,O
10,O
years,O
ago,O
and,O
works,O
as,O
a,O
lawyer,O
20,O
hours,O
per,O
week,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Lopressor,B-TR
25,O
mg,O
PO,O
b.i.d.,O
",",O
Cardizem,B-TR
30,O
mg,O
po,O
q.i.d.,O
",",O
Zantac,B-TR
150,O
mg,O
po,O
qd,O
",",O
Isordil,B-TR
60,O
mg,O
po,O
q,O
a.m.,O
",",O
60,O
mg,O
po,O
q,O
noon,O
",",O
30,O
mg,O
po,O
q,O
p.m.,O
and,O
30,O
mg,O
po,O
q,O
hs,O
",",O
Glipizide,B-TR
po,O
5,O
mg,O
q,O
a.m.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,O
patient,O
was,O
afebrile,B-PR
with,O
stable,O
vital,O
signs,O
.,O

The,B-TE
head,I-TE
",",I-TE
eyes,I-TE
",",I-TE
ears,I-TE
",",I-TE
nose,I-TE
",",I-TE
throat,I-TE
examination,I-TE
was,O
unremarkable,O
.,O

The,O
neck,O
was,O
supple,O
and,O
no,O
goiter,B-PR
was,O
noticed,O
",",O
no,O
bruit,B-PR
was,O
noticed,O
.,O

The,O
lungs,O
were,O
clear,O
.,O

The,O
heart,O
had,O
normal,O
rate,O
and,O
rhythm,O
",",O
with,O
normal,O
Sl,O
and,O
S2,O
and,O
no,O
significant,B-PR
heart,I-PR
murmur,I-PR
was,O
heard,O
.,O

The,O
abdomen,O
was,O
soft,O
",",O
flat,O
",",O
nontender,B-PR
",",O
with,O
normal,O
bowel,O
sounds,O
and,O
no,O
hepatosplenomegaly,B-PR
was,O
noticed,O
.,O

No,O
mass,B-PR
was,O
noticed,O
.,O

Capillary,B-TE
refill,I-TE
was,O
normal,O
and,O
there,O
was,O
no,O
edema,B-PR
.,O

The,O
calves,O
were,O
nontender,B-PR
.,O

On,O
neurological,B-TE
examination,I-TE
",",O
the,O
patient,O
was,O
alert,O
",",O
oriented,O
to,O
time,O
",",O
place,O
and,O
person,O
.,O

The,O
memory,O
was,O
intact,O
for,O
retention,O
and,O
long-term,O
memory,O
.,O

Fort,O
short-term,O
memory,O
the,O
patient,O
was,O
able,O
to,O
recall,O
one,O
object,O
out,O
of,O
thee,O
at,O
five,O
minute,O
",",O
two,O
out,O
of,O
three,O
with,O
clues,O
and,O
three,O
out,O
of,O
three,O
with,O
multiple,O
choice,O
.,O

The,O
reading,O
",",O
writing,O
",",O
drawing,O
clock,O
and,O
copying,O
cubes,O
were,O
all,O
intact,O
.,O

The,O
speech,O
was,O
fluent,O
and,O
repetition,O
was,O
normal,O
.,O

The,O
pattern,O
recognition,O
was,O
intact,O
.,O

Insight,O
",",O
abstract,O
thinking,O
and,O
______________,O
test,O
were,O
all,O
intact,O
.,O

The,O
patient,O
had,O
mild,O
errors,O
in,O
sequential,O
substracting,O
sevens,O
from,O
100,O
test,O
.,O

The,O
patient,O
was,O
able,O
to,O
follow,O
complex,O
commands,O
of,O
three,O
parts,O
involving,O
right,O
and,O
left,O
side,O
.,O

For,O
cranial,O
nerves,O
the,O
patient,O
had,O
minimal,B-PR
blurred,I-PR
vision,I-PR
in,I-PR
left,I-PR
upper,I-PR
quadrant,I-PR
.,O

The,O
optic,O
fundi,O
was,O
normal,O
.,O

The,B-TE
extra,I-TE
ocular,I-TE
movements,I-TE
were,O
full,O
with,O
mild,B-PR
terminal,I-PR
nystagmus,I-PR
",",O
2-3,O
beats,O
",",O
in,O
the,O
right,O
lateral,O
gaze,O
.,O

The,B-TE
light,I-TE
reflex,I-TE
was,O
slightly,B-PR
slow,I-PR
but,O
equal,O
and,O
intact,O
direct,O
and,O
indirectly,O
.,O

The,O
pupils,O
were,O
bilaterally,O
4.5,O
mm,O
and,O
had,O
been,O
dilated,O
at,O
the,O
Purckecation,O
Balpoingdelt,O
Pabarnes-,O
Campa,O
Memorial,O
Hospital,O
.,O

The,O
pupils,O
were,O
round,O
and,O
regular,O
.,O

The,O
nasolabial,O
fold,O
",",O
the,O
wrinkling,O
of,O
forehead,O
and,O
the,O
eye,O
closure,O
were,O
all,O
symmetric,O
and,O
normal,O
.,O

The,O
patient,O
had,O
conduction,B-PR
hearing,I-PR
on,I-PR
the,I-PR
left,I-PR
side,I-PR
",",O
which,O
had,O
been,O
old,O
.,O

The,O
tongue,O
was,O
midline,O
and,O
uvula,O
was,O
midline,O
as,O
well,O
.,O

The,O
gag,O
reflex,O
was,O
intact,O
.,O

The,O
sternocleidomastoid,O
and,O
the,O
trapezius,O
muscles,O
were,O
both,O
intact,O
.,O

The,B-TE
motor,I-TE
examination,I-TE
",",O
the,O
tone,O
and,O
bulk,O
were,O
normal,O
.,O

The,O
patient,O
had,O
no,O
pronator,B-PR
drift,I-PR
.,O

The,O
patient,O
had,O
mild,B-PR
weakness,I-PR
on,I-PR
the,I-PR
left,I-PR
side,I-PR
with,O
the,B-TE
strength,I-TE
of,O
5,O
minus,O
on,O
the,O
upper,O
and,O
lower,O
extremities,O
",",O
distally,O
and,O
proximally,O
.,O

The,O
coordination,O
was,O
intact,O
for,O
finger-nose-finger,B-TE
test,I-TE
",",O
rapid,O
alternating,O
hand,O
movements,O
.,O

The,B-TE
heel-shin-test,I-TE
was,O
slightly,B-PR
clumsy,I-PR
bilaterally,I-PR
but,O
the,O
knee,O
tapping,O
was,O
normal,O
bilaterally,O
.,O

Sensory,B-TE
examination,I-TE
:,O

The,O
patient,O
had,O
decreased,B-PR
vibratory,I-PR
sense,I-PR
in,I-PR
the,I-PR
distal,I-PR
lower,I-PR
extremities,I-PR
",",O
worse,O
on,O
the,O
left,O
side,O
.,O

The,O
touch,O
",",O
pain,O
",",O
and,O
position,O
sense,O
were,O
all,O
intact,O
.,O

The,O
patient,O
had,O
reflexes,O
of,O
two-plus,O
bilaterally,O
in,O
the,O
radials,O
",",O
the,O
biceps,O
",",O
the,O
triceps,O
and,O
the,O
knee,O
jerk,O
.,O

The,O
ankle,O
jerks,O
were,O
one-plus,O
bilaterally,O
.,O

The,B-TE
Babinski,I-TE
&apos;s,I-TE
were,O
negative,O
bilaterally,O
.,O

The,B-TE
cross,I-TE
extension,I-TE
reflex,I-TE
was,O
positive,O
on,O
the,O
left,O
.,O

The,O
gait,O
was,O
intact,O
and,O
the,O
tandem,O
gait,O
was,O
intact,O
as,O
well,O
.,O

LABORATORY,O
DATA,O
:,O

Complete,B-TE
blood,I-TE
count,I-TE
:,O

white,B-TE
blood,I-TE
cells,I-TE
7,O
",",O
hematocrit,B-TE
42.7%,O
",",O
hemoglobin,B-TE
14.3,O
",",O
platelets,B-TE
161,O
.,O

Differential,O
:,O

69%,B-TE
polys,I-TE
",",O
60%,B-TE
lymphs,I-TE
",",O
10%,B-TE
monos,I-TE
",",O
5%,B-TE
eos,I-TE
.,O

Prothrombin,B-TE
time,I-TE
11.7,O
",",O
partial,B-TE
thromboplastin,I-TE
time,I-TE
30.4,O
.,O

Urinalysis,O
:,O

over,B-TE
100,I-TE
red,I-TE
blood,I-TE
cells,I-TE
per,O
high,O
powered,O
field,O
",",O
20-50,B-TE
white,I-TE
blood,I-TE
cells,I-TE
per,O
high,O
powered,O
field,O
.,O

Sodium,B-TE
139,O
",",O
potassium,B-TE
4.7,O
",",O
chloride,B-TE
106,O
",",O
bicarbonate,B-TE
21.6,O
",",O
BUN,B-TE
22,O
",",O
creatinine,B-TE
1.6,O
",",O
glucose,B-TE
107,O
",",O
amylase,B-TE
120,O
",",O
calcium,B-TE
8.7,O
",",O
phosphorus,B-TE
3.3,O
",",O
magnesium,B-TE
1.9,O
",",O
total,B-TE
protein,I-TE
7.5,O
",",O
albumin,B-TE
3.9,O
",",O
globulin,B-TE
3.6,O
",",O
uric,B-TE
acid,I-TE
5.6,O
",",O
alkaline,B-TE
phosphatase,I-TE
43,O
",",O
GOT,B-TE
42,O
",",O
LDH,B-TE
549,O
with,O
hemolyzed,B-TE
sample,I-TE
.,O

Chest,B-TE
x-ray,I-TE
revealed,O
no,O
pneumonia,B-PR
",",O
no,O
congestive,B-PR
heart,I-PR
failure,I-PR
.,O

Electrocardiogram,B-TE
revealed,O
Q-waves,B-PR
in,I-PR
leads,I-PR
II,I-PR
",",I-PR
III,I-PR
and,I-PR
AVF,I-PR
.,O

A,B-TE
computerized,I-TE
tomography,I-TE
scan,I-TE
revealed,O
right,B-PR
lower,I-PR
occipital,I-PR
low-density,I-PR
area,I-PR
.,O

Head,B-TE
magnetic,I-TE
resonance,I-TE
imaging,I-TE
study,I-TE
and,O
magnetic,B-TE
resonance,I-TE
imaging,I-TE
angiogram,I-TE
obtained,O
on,O
May,O
11,O
",",O
1995,O
",",O
revealed,O
subacute,B-PR
right,I-PR
lateral,I-PR
occipital,I-PR
lobe,I-PR
infarction,I-PR
and,O
decreased,B-PR
flow,I-PR
related,I-PR
enhancement,I-PR
in,I-PR
the,I-PR
left,I-PR
posterior,I-PR
communicating,I-PR
artery,I-PR
with,O
respect,O
to,O
that,O
on,O
the,O
right,O
.,O

The,O
right,O
suggested,O
decreased,B-PR
flow,I-PR
.,O

Carotid,B-TE
noninvasives,I-TE
revealed,O
minimal,B-PR
carotid,I-PR
disease,I-PR
.,O

Transcranial,B-TE
Dopplers,I-TE
:,O

normal,O
posterior,O
and,O
anterior,O
circulation,O
.,O

Holter,B-TE
electrocardiogram,I-TE
:,O

no,O
significant,B-PR
arrhythmias,I-PR
.,O

Electroencephalogram,B-TE
:,O

normal,O
study,O
.,O

Visual,B-TE
field,I-TE
testing,I-TE
:,O

small,B-PR
wedge-shaped,I-PR
visual,I-PR
field,I-PR
defect,I-PR
in,I-PR
right,I-PR
eye,I-PR
",",O
suggesting,O
retinal,B-PR
lesion,I-PR
.,O

Echocardiogram,B-TE
revealing,O
segmental,B-PR
left,I-PR
ventricular,I-PR
dysfunction,I-PR
involving,O
inferoseptal,O
",",O
inferior,O
and,O
posterior,O
segments,O
at,O
the,O
base,O
and,O
mid,O
ventricular,O
level,O
.,O

Overall,B-TE
left,I-TE
ventricle,I-TE
systolic,I-TE
function,I-TE
moderately,B-PR
impaired,I-PR
with,O
and,B-TE
estimated,I-TE
ejection,I-TE
fraction,I-TE
of,O
35%,O
.,O

Otherwise,O
",",O
there,O
was,O
pulmonary,B-PR
insufficiency,I-PR
",",O
tricuspid,B-PR
insufficiency,I-PR
",",O
mitral,B-PR
insufficiency,I-PR
and,O
aortic,B-PR
insufficiency,I-PR
.,O

There,O
were,O
no,O
clots,B-PR
seen,O
on,O
the,B-TE
echocardiogram,I-TE
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
with,O
a,B-PR
right,I-PR
occipital,I-PR
cerebral,I-PR
infarction,I-PR
.,O

The,O
patient,O
was,O
started,O
on,O
intravenous,B-TR
heparin,I-TR
and,O
had,O
the,B-TE
studies,I-TE
as,O
described,O
above,O
for,O
rule,O
out,O
source,O
of,O
embolic,B-PR
strokes,I-PR
including,O
carotid,B-TE
noninvasives,I-TE
",",O
transcranial,B-TE
Dopplers,I-TE
",",O
Holter,B-TE
electrocardiogram,I-TE
and,O
echocardiogram,B-TE
.,O

The,O
patient,O
also,O
had,O
serial,B-TE
electrocardiogram,I-TE
",",O
which,O
showed,O
no,O
change,O
.,O

The,O
patient,O
also,O
had,O
serial,B-TE
creatinine,I-TE
kinase,I-TE
with,I-TE
MB,I-TE
fractions,I-TE
studied,O
",",O
which,O
revealed,O
MB,B-TE
fraction,I-TE
too,B-PR
low,I-PR
to,O
be,O
tested,O
.,O

The,O
patient,O
also,O
experienced,O
a,O
feeling,O
of,O
moving,O
back,O
and,O
forth,O
when,O
lying,O
down,O
with,O
neck,O
extended,O
during,O
the,B-TE
magnetic,I-TE
resonance,I-TE
imaging,I-TE
study,I-TE
and,O
also,O
in,O
bed,O
.,O

This,B-PR
moving,I-PR
sense,I-PR
",",O
with,O
normal,O
electroencephalogram,O
",",O
was,O
thought,O
to,O
be,O
a,B-PR
mild,I-PR
vestibular,I-PR
dysfunction,I-PR
or,O
from,O
the,O
acute,O
episode,O
of,O
the,B-PR
stroke,I-PR
.,O

The,O
patient,O
will,O
have,O
these,B-PR
symptoms,I-PR
only,O
when,O
the,O
eyes,O
are,O
closed,O
.,O

Our,O
opinion,O
was,O
not,O
to,O
intervene,O
or,O
have,O
any,B-TE
further,I-TE
studies,I-TE
for,O
acute,O
period,O
and,O
to,O
continued,O
to,O
observe,O
.,O

The,O
patient,O
did,O
have,O
a,B-PR
hypotensive,I-PR
episode,I-PR
and,O
the,B-TE
systolic,I-TE
blood,I-TE
pressure,I-TE
was,O
80,O
",",O
after,O
the,O
patient,O
received,O
his,B-TR
regular,I-TR
cardiac,I-TR
medications,I-TR
.,O

The,O
patient,O
had,O
been,O
off,O
his,B-TR
regular,I-TR
medications,I-TR
since,O
during,O
the,O
admission,O
and,O
will,O
be,O
discharged,O
off,O
his,B-TR
medications,I-TR
.,O

Otherwise,O
",",O
there,O
were,O
no,O
further,O
episodes,O
of,O
blurred,B-PR
vision,I-PR
.,O

The,O
patient,O
was,O
stable,O
with,O
an,O
unchanged,O
neurological,B-TE
and,I-TE
physical,I-TE
examination,I-TE
and,O
was,O
discharged,O
on,O
aspirin,B-TR
325,O
mg,O
po,O
qd,O
",",O
on,O
May,O
14,O
",",O
1995,O
.,O

The,O
patient,O
will,O
be,O
randomized,O
on,O
the,O
Wars,O
study,O
early,O
next,O
week,O
by,O
the,O
Stroke,O
Service,O
at,O
Ph,O
University,O
Of,O
Medical,O
Center,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

The,O
patient,O
was,O
stable,O
with,O
the,B-TE
physical,I-TE
examination,I-TE
as,O
described,O
above,O
.,O

DISCHARGE,O
ORDERS,O
:,O

Medications,B-TR
-,O
aspirin,B-TR
325,O
mg,O
po,O
qd,O
",",O
Glipizide,B-TR
25,O
mg,O
po,O
qd,O
.,O

The,O
patient,O
will,O
be,O
discharged,O
home,O
without,O
his,B-TR
regular,I-TR
cardiac,I-TR
medications,I-TR
.,O

The,O
patient,O
will,O
be,O
followed,O
by,O
Dr.,O
Ketyvi,O
Liftjesc,O
of,O
the,O
Neurology,O
Service,O
at,O
Ph,O
University,O
Of,O
Medical,O
Center,O
on,O
May,O
17,O
",",O
1995,O
",",O
for,O
randomization,O
on,O
the,O
Wars,O
study,O
.,O

The,O
patient,O
will,O
be,O
also,O
followed,O
by,O
Dr.,O
Joseet,O
Gelineau,O
of,O
the,O
Neurology,O
Service,O
at,O
Ph,O
University,O
Of,O
Medical,O
Center,O
.,O

The,O
patient,O
will,O
also,O
be,O
followed,O
by,O
Dr.,O
Margmimaui,O
Gelineau,O
",",O
his,O
primary,O
care,O
physician,O
at,O
Ochtuheihugh,O
Put,O
University,O
Medical,O
Center,O
within,O
one,O
week,O
after,O
discharge,O
.,O

The,O
patient,O
will,O
also,O
be,O
followed,O
by,O
his,O
regular,O
Urologist,O
at,O
Ochtuheihugh,O
Put,O
University,O
Medical,O
Center,O
within,O
one,O
week,O
after,O
discharge,O
for,O
his,B-PR
continuing,I-PR
hematuria,I-PR
.,O

JOSEET,O
GELINEAU,O
",",O
M.D.,O

TR,O
:,O

lj,O
/,O
bmot,O

DD,O
:,O

05/13/95,O

TD,O
:,O

05/17/95,O

CC,O
:,O

Dr.,O
Besti,O
Kotebreun,O
",",O
Neurology,O
Service,O
Dr.,O
Margmimaui,O
Gelineau,O
",",O
Ochtuheihugh,O
Put,O
University,O
Medical,O
Center,O

Admission,O
Date,O
:,O

2013-08-05,O

Discharge,O
Date,O
:,O

2013-08-15,O

Date,O
of,O
Birth,O
:,O

1949-01-18,O

Sex,O
:,O

M,O

Service,O
:,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

In,O
brief,O
",",O
the,O
patient,O
is,O
a,O
64,O
-,O
year-old,O
male,O
with,O
a,O
significant,O
history,O
for,O
coronary,B-PR
artery,I-PR
disease,I-PR
",",O
status,O
post,O
three,B-PR
myocardial,I-PR
infarctions,I-PR
and,O
also,O
status,O
post,O
five,B-TR
vessel,I-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
in,O
',O
89,O
and,O
status,O
post,O
multiple,B-TR
percutaneous,I-TR
transluminal,I-TR
coronary,I-TR
angioplasties,I-TR
who,O
recently,O
had,O
a,B-TE
catheterization,I-TE
done,O
in,O
Mississippi,O
and,O
stent,B-TR
placed,O
in,O
2013-03-24,O
.,O

The,O
patient,O
did,O
well,O
until,O
approximately,O
three,O
to,O
four,O
weeks,O
prior,O
to,O
presentation,O
when,O
he,O
began,O
to,O
experience,O
increased,B-PR
dyspnea,I-PR
on,O
exertion,O
.,O

One,O
week,O
prior,O
to,O
presentation,O
",",O
he,O
had,O
chest,B-PR
pain,I-PR
leading,O
to,O
a,B-TE
repeat,I-TE
catheterization,I-TE
at,O
Springfield,O
on,O
07-30,O
which,O
showed,O
narrowing,B-PR
of,O
the,B-TR
stent,I-TR
and,O
an,B-TE
ejection,I-TE
fraction,I-TE
of,O
approximately,O
20%,O
.,O

No,O
intervention,B-TR
was,O
done,O
at,O
that,O
point,O
.,O

On,O
the,O
evening,O
prior,O
to,O
admission,O
",",O
the,O
patient,O
was,O
awoken,O
with,O
chest,B-PR
pressure,I-PR
radiating,O
to,O
the,O
neck,O
anginal,O

equivalent,O
which,O
was,O
relieved,O
by,O
sublingual,B-TR
nitroglycerin,I-TR
.,O

This,O
episode,O
happened,O
three,O
times,O
that,O
night,O
and,O
finally,O
on,O
the,O
fourth,O
re-awakening,O
",",O
the,O
patient,O
presented,O
to,O
the,O
Emergency,O
Department,O
at,O
Springfield,O
and,O
was,O
transferred,O
to,O
the,O
Faulkner,O
Hospital,O
for,O
coronary,B-TR
revascularization,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Coronary,B-PR
artery,I-PR
disease,I-PR

2.,O
Myocardial,B-PR
infarction,I-PR
x3,I-PR

3.,O
Coronary,B-TR
artery,I-TR
bypass,I-TR
graft,I-TR

4.,O
Systemic,B-PR
lupus,I-PR
erythematosus,I-PR
in,O
remission,O

HOME,O
MEDICATIONS,O
:,O

1.,O
Coreg,B-TR
6.25,O
mg,O
po,O
bid,O

2.,O
Lasix,B-TR
25,O
mg,O
po,O
qd,O

3.,O
Imdur,B-TR
30,O
mg,O
po,O
qd,O

4.,O
K-Dur,B-TR
10,O
milliequivalents,O
po,O
qd,O

5.,O
Zestril,B-TR
2.5,O
mg,O
po,O
bid,O

6.,O
Multivitamin,B-TR

7.,O
Folate,B-TR

ALLERGIES,O
:,O

He,O
has,O
no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

PHYSICAL,O
EXAM,O
:,O

VITAL,O
SIGNS,O
:,O

He,O
was,O
afebrile,B-PR
with,O
stable,O
vital,O
signs,O

HEART,O
:,O

Regular,O
rate,O
and,O
rhythm,O
with,O
a,B-PR
2,I-PR
out,I-PR
of,I-PR
6,I-PR
systolic,I-PR
ejection,I-PR
murmur,I-PR
heard,O
loudest,O
at,O
the,O
apex,O
.,O

LUNGS,O
:,O

Clear,O
to,O
auscultation,B-TE
.,O

ABDOMEN,O
:,O

Soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
.,O

EXTREMITIES,O
:,O

No,O
cyanosis,B-PR
",",O
clubbing,B-PR
or,O
edema,B-PR
.,O

Palpable,O
DP,O
s,O
bilaterally,O
.,O

PERTINENT,O
LABS,O
:,O

His,B-TE
hematocrit,I-TE
was,O
44,O
.,O

White,B-TE
count,I-TE
was,O
8,O
.,O

Potassium,B-TE
was,O
3.9,O
.,O

BUN,B-TE
and,O
creatinine,B-TE
was,O
18,O
and,O
0.9,O
.,O

His,B-TE
troponin,I-TE
was,O
29.7,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
medically,O
managed,O
initially,O
and,O
then,O
underwent,O
on,O
2013-08-09,O
",",O
coronary,B-TR
artery,I-TR
bypass,I-TR
grafting,I-TR
x2,O
and,O
a,B-TR
mitral,I-TR
valve,I-TR
annuloplasty,I-TR
with,O
placement,B-TR
of,I-TR
intra-aortic,I-TR
balloon,I-TR
pump,I-TR
.,O

He,O
was,O
transferred,O
to,O
the,O
Intensive,O
Care,O
Unit,O
in,O
relatively,O
stable,O
condition,O
.,O

On,O
postoperative,O
day,O
#1,O
",",O
his,B-TR
balloon,I-TR
pump,I-TR
was,O
weaned,O
and,O
the,O
patient,O
was,O
transferred,O
at,O
2,B-TR
units,I-TR
of,I-TR
packed,I-TR
red,I-TR
blood,I-TR
cells,I-TR
.,O

He,O
also,O
began,O
to,O
wean,O
off,O
the,B-TR
ventilator,I-TR
.,O

On,O
postoperative,O
day,O
#1,O
in,O
the,O
evening,O
",",O
the,O
patient,O
was,O
noted,O
to,O
go,O
into,O
atrial,B-PR
fibrillation,I-PR
",",O
for,O
which,O
he,O
was,O
controlled,O
and,O
started,O
on,O
amiodarone,B-TR
",",O
after,O
which,O
he,O
converted,O
again,O
to,O
normal,O
sinus,O
rhythm,O
.,O

He,O
was,O
extubated,O
during,O
postoperative,O
day,O
#1,O
.,O

On,O
postoperative,O
day,O
#2,O
",",O
the,O
patient,O
was,O
noted,O
to,O
be,O
relatively,O
stable,O
.,O

His,B-TR
balloon,I-TR
pump,I-TR
had,O
already,O
been,O
removed,O
and,O
on,O
postoperative,O
day,O
#3,O
",",O
he,O
was,O
transferred,O
to,O
the,O
floor,O
on,O
Lopressor,B-TR
and,O
amiodarone,B-TR
in,O
normal,O
sinus,O
rhythm,O
.,O

On,O
the,O
floor,O
",",O
the,O
patient,O
was,O
noted,O
to,O
do,O
extremely,O
well,O
.,O

Physical,O
therapy,O
was,O
consulted,O
and,O
the,O
patient,O
was,O
ambulating,O
extremely,O
well,O
with,O
minimal,O
assistance,O
.,O

On,O
postoperative,O
day,O
#4,O
",",O
he,O
remained,O
afebrile,B-PR
with,O
stable,O
vital,O
signs,O
on,O
Lopressor,B-TR
at,O
25,O
mg,O
po,O
bid,O
and,O
an,B-TR
amiodarone,I-TR
dose,I-TR
.,O

His,B-TR
left,I-TR
chest,I-TR
tube,I-TR
was,O
discontinued,O
at,O
this,O
time,O
and,O
his,B-TR
right,I-TR
chest,I-TR
tube,I-TR
was,O
removed,O
the,O
following,O
day,O
on,O

postoperative,O
day,O
#5,O
.,O

Currently,O
",",O
the,O
patient,O
is,O
postoperative,O
day,O
#6,O
.,O

He,O
remains,O
afebrile,B-PR
with,O
stable,O
vital,O
signs,O
and,O
the,O
patient,O
is,O
ambulating,O
to,O
a,O
level,O
5,O
with,O
physical,B-TR
therapy,I-TR
and,O
wishes,O
to,O
be,O
discharged,O
home,O
today,O
.,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Coronary,B-PR
artery,I-PR
disease,I-PR

2.,O
Mitral,B-PR
valve,I-PR
regurgitation,I-PR
",",O
status,O
post,O
coronary,B-TR
artery,I-TR
bypass,I-TR
graft,I-TR
x2,O
and,O
mitral,B-TR
valve,I-TR
annuloplasty,I-TR

SECONDARY,O
DIAGNOSES,O
:,O

1.,O
Coronary,B-PR
artery,I-PR
disease,I-PR

2.,O
Myocardial,B-PR
infarction,I-PR
x3,O

3.,O
Coronary,B-TR
artery,I-TR
bypass,I-TR
graft,I-TR

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Lopressor,B-TR
25,O
mg,O
po,O
bid,O

2.,O
Amiodarone,B-TR
taper,I-TR
400,O
mg,O
po,O
tid,O
x4,O
days,O
",",O
then,O
bid,O
x7,O
days,O
",",O
qd,O
x7,O
days,O
",",O
then,O
200,O
mg,O
po,O
qd,O

3.,O
Lasix,B-TR
20,O
mg,O
po,O
qd,O

4.,O
K-Dur,B-TR
20,O
milliequivalents,O
po,O
qd,O

5.,O
Aspirin,B-TR
81,O
mg,O
po,O
qd,O

6.,O
Percocet,B-TR
1,O
to,O
2,O
po,O
q,O
4,O
to,O
6,O
hours,O
prn,O

7.,O
Colace,B-TR
100,O
mg,O
po,O
bid,O

8.,O
Percocet,B-TR

9.,O
Protonix,B-TR
20,O
mg,O
po,O
qd,O

DIGrimmE,O
INSTRUCTIONS,O
:,O

The,O
patient,O
should,O
follow,O
up,O
with,O
Dr.,O
von,O
Diamond,O
in,O
approximately,O
three,O
weeks,O
.,O

The,O
patient,O
should,O
also,O
follow,O
up,O
with,O
his,O
primary,O
care,O
doctor,O
",",O
Dr.,O
Beals,O
",",O
in,O
approximately,O
three,O
weeks,O
.,O

Briley,O
von,O
der,O
Ross,O
",",O
M.D.,O

67-576,O

Dictated,O
By,O
:,O
Julie,O
H.,O
Bullock,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2013-08-15,O
07:55,O

T,O
:,O
2013-08-15,O
09:01,O

JOB,O
#:,O

15357,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Santos,O
von,O
der,O
Ross,O
on,O
:,O
WED,O
2013-08-21,O
2:56,O
PM,O

(,O
End,O
of,O
Report,O
),O

600720722,O
SC,O

86426538,O

5408181,O

9/17/2005,O
12:00:00,O
AM,O

pp,O

DIS,O

Admission,O
Date,O
:,O

09/17/2005,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

09/20/2005,O

******,O
FINAL,O
DISCHARGE,O
ORDERS,O
******,O

CRASSBELBKOTE,O
",",O
NEE,O
537-39-30-6,O
T83,O

Room,O
:,O

EIZ0-059,O

Service,O
:,O

OBS,O

DISCHARGE,O
PATIENT,O
ON,O
:,O

09/20/05,O
AT,O
10:00,O
AM,O

CONTINGENT,O
UPON,O

HO,B-TE
evaluation,I-TE

WILL,O
D,O
/,O
C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D,O
/,O
C,O
SUMMARY,O
:,O

YES,O

Attending,O
:,O

GIENGPRATLSHUFF,O
",",O
QUASARZELL,O
KATECHEL,O
",",O
M.D.,O
",",O
PH.D.,O

DISPOSITION,O
:,O

Home,O

DISCHARGE,O
MEDICATIONS,O
:,O

DIET,O
:,O

No,O
Restrictions,O

ACTIVITY,O
:,O

Resume,O
regular,O
exercise,O

FOLLOW,O
UP,O
APPOINTMENT,O
(,O
S,O
),O
:,O

QH,O
2/6wks,O
",",O

ALLERGY,O
:,O

NKA,B-PR

ADMIT,O
DIAGNOSIS,O
:,O

pp,B-PR
/,O
pps,B-PR

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O
Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O
pp,B-PR

OTHER,O
DIAGNOSIS,O
;,O
Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O
pp,B-PR

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

Primary,O
Anesthesia,O
:,O

Epidural,B-TR

Secondary,O
Anesthesia,O
:,O

Local,O
Procedures,O
:,O

PPS,B-PR
",",O

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O

bilateral,B-TR
tubal,I-TR
ligation,I-TR

BRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

G3,O
T3,O
P0,O
A0,O
L3,O

Estimated,O
EDC,O
:,O

Maternal,O
transfer,O
:,O

No,O

ADDITIONAL,O
COMMENTS,O
:,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O

TO,O
DO,O
/,O
PLAN,O
:,O

No,O
dictated,O
summary,O

ENTERED,O
BY,O
:,O

JOAS,O
",",O
CENI,O
",",O
C.N.M.,O
(,O
FJ992,O
),O
09/19/05,O
09:50,O
AM,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

Admission,O
Date,O
:,O

2015-11-22,O

Discharge,O
Date,O
:,O

2015-11-27,O

Date,O
of,O
Birth,O
:,O

1942-03-04,O

Sex,O
:,O

M,O

Service,O
:,O

CMED,O
CCU-GREEN,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
73,O
year,O
old,O
male,O
with,O
a,O
recent,O
history,O
of,O
paroxysmal,B-PR
atrial,I-PR
fibrillation,I-PR
and,O
hypercholesterolemia,B-PR
who,O
presented,O
to,O
the,O
Emergency,O
Department,O
with,O
the,O
chief,O
complaint,O
of,O
syncope,B-PR
.,O

The,O
patient,O
was,O
discharged,O
from,O
The,O
Hospital,O
for,O
Orthopedics,O
with,O
the,O
diagnosis,O
of,O
pulmonary,B-PR
embolism,I-PR
about,O
six,O
months,O
prior,O
to,O
the,O
current,O
admission,O
and,O
was,O
started,O
on,O
Warfarin,B-TR
.,O

One,O
month,O
prior,O
to,O
this,O
admission,O
",",O
the,O
patient,O
reports,O
not,O
feeling,O
well,O
with,O
worsening,B-PR
gastric,I-PR
distress,I-PR
.,O

A,O
few,O
weeks,O
prior,O
to,O
admission,O
",",O
he,O
fell,O
down,O
on,O
his,O
back,O
and,O
started,O
taking,O
ibuprofen,B-TR
1000,O
mg,O
once,O
a,O
day,O
for,O
pain,B-PR
and,O
Vioxx,B-TR
in,O
addition,O
to,O
his,B-TR
aspirin,I-TR
and,O
Coumadin,B-TR
regimen,I-TR
.,O

The,O
night,O
prior,O
to,O
admission,O
",",O
he,O
was,O
found,O
by,O
his,O
wife,O
on,O
the,O
bathroom,O
floor,O
in,O
a,O
pool,O
of,O
urine,O
",",O
unresponsive,B-PR
without,O
any,O
body,O
movements,O
",",O
post-ictal,B-PR
state,I-PR
.,O

EMS,O
was,O
activated,O
",",O
however,O
",",O
the,O
patient,O
refused,O
to,O
go,O
to,O
the,O
hospital,O
.,O

A,O
similar,O
episode,O
happened,O
at,O
2,O
a.m.,O
the,O
same,O
night,O
and,O
at,O
07:45,O
on,O
the,O
day,O
of,O
admission,O
",",O
the,O
patient,O
lost,O
consciousness,O
once,O
again,O
when,O
he,O
was,O
trying,O
to,O
sit,O
up,O
.,O

He,O
was,O
then,O
transferred,O
to,O
The,O
Hospital,O
for,O
Orthopedics,O
.,O

The,O
patient,O
reports,O
some,B-PR
nausea,I-PR
and,O
epigastric,B-PR
pressure,I-PR
which,O
is,O
post-prandial,O
.,O

He,O
denies,O
any,O
emesis,B-PR
",",O
melena,B-PR
",",O
diarrhea,B-PR
or,O
constipation,B-PR
.,O

He,O
describes,O
the,O
room,O
spinning,O
with,O
attempts,O
to,O
sit,O
upright,O
.,O

No,O
history,O
of,O
previous,O
episodes,O
was,O
noted,O
.,O

Denies,O
incontinence,B-PR
.,O

He,O
does,O
have,O
diaphoresis,B-PR
and,O
weakness,B-PR
with,O
orthostatic,O
changes,O
.,O

In,O
the,O
Emergency,O
Department,O
",",O
stool,B-TE
guaiac,I-TE
was,O
trace,B-PR
positive,I-PR
.,O

Hematocrit,B-TE
was,O
24.8,O
",",O
with,O
a,O
baseline,O
of,O
46,O
.,O

Gastric,B-TR
lavage,I-TR
was,O
grossly,O
positive,O
for,O
coffee,B-PR
ground,I-PR
material,I-PR
.,O

His,B-TE
INR,I-TE
was,O
found,O
to,O
be,O
4.4,O
.,O

He,O
was,O
given,O
Vitamin,B-TR
K,I-TR
10,O
mg,O
subcutaneously,O
",",O
2.5,O
liters,O
of,O
normal,B-TR
saline,I-TR
",",O
two,O
units,O
of,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
and,O
two,O
units,O
of,O
fresh,B-TR
frozen,I-TR
plasma,I-TR
and,O
transferred,O
to,O
the,O
Medical,O
Intensive,O
Care,O
Unit,O
for,O
further,O
management,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Hyperthyroid,B-PR
disease,I-PR
status,O
post,O
radioactive,B-TR
iodine,I-TR
ablation,I-TR
",",O
now,O
hypothyroid,B-PR
on,O
Levoxyl,B-TR
.,O

2.,O
History,O
of,O
pulmonary,B-PR
embolism,I-PR
",",O
etiology,O
unknown,O
.,O

It,O
was,O
thought,O
to,O
be,O
induced,O
by,O
frequent,O
flying,O
to,O
California,O
.,O

The,O
patient,O
was,O
started,O
on,O
Coumadin,B-TR
five,O
months,O
prior,O
to,O
this,O
admission,O
.,O

3.,O
Hypercholesterolemia,B-PR
.,O

Well,O
controlled,O
on,O
Lipitor,B-TR
.,O

Last,B-TE
total,I-TE
cholesterol,I-TE
was,O
168,O
in,O
2015-08-24,O
.,O

4.,O
Paroxysmal,B-PR
atrial,I-PR
fibrillation,I-PR
in,O
the,O
setting,O
of,O
pulmonary,B-PR
embolism,I-PR
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

1.,O
Only,O
significant,O
for,O
a,B-TR
right,I-TR
inguinal,I-TR
hernia,I-TR
repair,I-TR
.,O

ALLERGIES,O
:,O

Penicillin,B-TR
.,O

OUTPATIENT,O
MEDICATIONS,O
:,O

1.,O
Lipitor,B-TR
10,O
mg,O
three,O
times,O
a,O
week,O
.,O

2.,O
Aspirin,B-TR
81,O
.,O

3.,O
Propranolol,B-TR
10,O
mg,O
three,O
times,O
a,O
day,O
.,O

4.,O
Coumadin,B-TR
6.25,O
mg,O
once,O
a,O
day,O
.,O

5.,O
Levoxyl,B-TR
100,O
mEq,O
q.,O
day,O
.,O

6.,O
Ambien,B-TR
p.r.n.,O

7.,O
Vitamins,B-TR
.,O

8.,O
Vioxx,B-TR
times,O
three,O
weeks,O
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
quit,O
smoking,O
20,O
years,O
ago,O
;,O
ethanol,O
one,O
glass,O
of,O
wine,O
a,O
day,O
.,O

He,O
is,O
a,O
retired,O
elementary,O
school,O
principal,O
and,O
now,O
works,O
in,O
Johnson,O
management,O
.,O

FAMILY,O
HISTORY,O
:,O

Significant,O
for,O
mother,O
who,O
has,O
hypertension,B-PR
and,O
stroke,B-PR
at,O
the,O
age,O
of,O
70,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Temperature,B-TE
was,O
100.3,O
F.,O
;,O
heart,B-TE
rate,I-TE
was,O
115,O
.,O

In,O
general,O
",",O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

Alert,O
and,O
oriented,O
times,O
three,O
.,O

HEENT,O
:,O

Extraocular,O
movements,O
are,O
intact,O
.,O

Pupils,O
equally,O
round,O
and,O
reactive,O
to,O
light,B-TE
and,O
accommodation,B-TE
bilaterally,O
.,O

Oropharynx,O
clear,O
.,O

Mucosal,O
membranes,O
are,O
moist,O
.,O

Cardiovascular,O
:,O

Regular,O
rate,O
and,O
rhythm,O
",",O
normal,O
S1,O
",",O
S2,O
",",O
no,O
murmurs,B-PR
",",O
rubs,B-PR
or,O
gallops,B-PR
.,O

Pulmonary,O
clear,O
to,O
auscultation,B-TE
anteriorly,O
.,O

Abdomen,O
soft,O
",",O
mildly,B-PR
distended,I-PR
",",O
nontender,B-PR
",",O
positive,O
bowel,O
sounds,O
.,O

Extremities,O
with,O
no,O
edema,B-PR
",",O
one,O
to,O
two,O
pulses,O
in,O
all,O
four,O
extremities,O
.,O

LABORATORY,O
:,O

Sodium,B-TE
141,O
",",O
potassium,B-TE
4.4,O
",",O
chloride,B-TE
108,O
",",O
bicarbonate,B-TE
23,O
",",O
BUN,B-TE
57,O
",",O
creatinine,B-TE
0.7,O
",",O
glucose,B-TE
115,O
.,O

White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
11.0,O
",",O
differential,B-TE
with,O
76,O
neutrophils,B-TE
",",O
2,O
monos,B-TE
",",O
21,O
lymphocytes,B-TE
",",O
and,O
no,O
eosinophils,B-TE
.,O

Hematocrit,B-TE
24.8,O
",",O
platelets,B-TE
223,O
",",O
INR,B-TE
2.4,O
",",O
CK,B-TE
234,O
.,O

CT,B-TE
scan,I-TE
of,I-TE
the,I-TE
head,I-TE
showed,O
no,O
hemorrhage,B-PR
or,O
edema,B-PR
.,O

EKG,B-TE
showed,O
normal,O
sinus,O
rhythm,O
at,O
90,O
with,O
normal,O
intervals,O
and,O
ST,B-PR
wave,I-PR
inversions,I-PR
and,O
early,B-PR
R,I-PR
wave,I-PR
progression,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
transferred,O
to,O
Medical,O
Intensive,O
Care,O
Unit,O
for,O
further,O
management,O
for,O
acute,B-PR
GI,I-PR
bleed,I-PR
.,O

1.,O
Gastrointestinal,B-PR
bleed,I-PR
:,O

The,O
patient,O
continued,O
to,O
receive,O
blood,B-TR
transfusions,I-TR
on,O
the,O
floor,O
and,O
serial,B-TE
hematocrits,I-TE
with,O
serial,B-TE
INR,I-TE
checks,I-TE
were,O
drawn,O
.,O

As,O
he,O
was,O
receiving,O
his,O
third,O
unit,O
of,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
",",O
the,O
patient,O
became,O
tachycardic,B-PR
and,O
short,B-PR
of,I-PR
breath,I-PR
.,O

His,B-TE
temperature,I-TE
raised,O
from,O
98.6,O
F.,O
",",O
to,O
101.0,O
F.,O

He,O
was,O
shown,O
to,O
have,O
rigors,B-PR
.,O

The,B-TR
transfusion,I-TR
was,O
stopped,O
and,O
the,O
patient,O
was,O
given,O
Tylenol,B-TR
1,O
mg,O
with,O
epinephrine,B-TR
",",O
100,O
mg,O
of,O
hydrocortisone,B-TR
",",O
25,O
mg,O
of,O
Benadryl,B-TR
and,O
Demerol,B-TR
15,I-TR
as,O
well,O
as,O
Pepcid,B-TR
.,O

He,O
had,O
emesis,B-PR
times,O
three,O
of,O
75,O
cc,O
of,O
coffee,B-PR
ground,I-PR
material,I-PR
.,O

The,O
patient,O
also,O
desaturated,O
to,O
the,O
low,O
80,O
s,O
and,O
was,O
started,O
on,O
a,B-TR
non-rebreather,I-TR
mask,I-TR
.,O

His,B-TE
saturations,I-TE
improved,O
quickly,O
on,O
100%,B-TR
non-rebreather,I-TR
mask,I-TR
within,O
15,O
to,O
20,O
minutes,O
.,O

Shortly,O
after,O
his,O
mental,O
status,O
changed,O
;,O
he,O
became,O
disoriented,B-PR
and,O
euphoric,B-PR
and,O
continued,O
to,O
be,O
in,O
this,O
state,O
for,O
two,O
more,O
hours,O
.,O

After,O
that,O
period,O
of,O
time,O
",",O
his,O
mental,O
status,O
gradually,O
improved,O
and,O
he,O
continued,O
to,O
receive,O
his,B-TR
blood,I-TR
transfusions,I-TR
requiring,O
a,O
total,O
of,O
ten,O
units,O
of,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
and,O
four,O
units,O
of,O
fresh,B-TR
frozen,I-TR
plasma,I-TR
to,O
reach,O
a,B-TE
hematocrit,I-TE
of,O
30.0,O
",",O
which,O
remained,O
stable,O
for,O
the,O
duration,O
of,O
his,O
stay,O
.,O

On,O
admission,O
",",O
the,O
patient,O
was,O
started,O
on,O
high,B-TR
dose,I-TR
proton,I-TR
pump,I-TR
inhibitors,I-TR
for,O
prophylaxis,B-TR
.,O

On,O
Wednesday,O
",",O
11-25,O
",",O
an,B-TE
esophagogastroduodenoscopy,I-TE
was,O
performed,O
and,O
was,O
significant,O
for,O
the,O
following,O
findings,O
:,O

Medium,B-PR
hiatal,I-PR
hernia,I-PR
",",O
Barrett's,B-PR
esophagus,I-PR
",",O
erosion,B-PR
of,I-PR
the,I-PR
gastroesophageal,I-PR
junction,I-PR
",",O
granularity,B-PR
",",O
erythema,B-PR
and,O
congestion,B-PR
of,I-PR
the,I-PR
antrum,I-PR
in,O
the,O
pre-pyloric,O
region,O
compatible,O
with,O
gastritis,B-PR
.,O

Erosions,B-PR
in,I-PR
the,I-PR
antrum,I-PR
and,I-PR
pre-pyloric,I-PR
region,I-PR
",",O
granularity,B-PR
",",O
erythema,B-PR
and,O
congestion,B-PR
of,I-PR
the,I-PR
anterior,I-PR
bulb,I-PR
and,I-PR
posterior,I-PR
bulb,I-PR
compatible,O
with,O
duodenitis,B-PR
.,O

It,O
was,O
recommended,O
by,O
Gastroenterology,O
that,O
the,O
patient,O
is,O
to,O
stay,O
off,O
aspirin,B-TR
for,O
at,O
least,O
four,O
to,O
six,O
weeks,O
at,O
discharge,O
to,O
prevent,O
further,B-PR
bleeding,I-PR
.,O

2.,O
Cardiovascular,O
:,O

During,O
transfusion,B-PR
reaction,I-PR
episode,I-PR
",",O
the,O
patient,O
had,O
an,O
episode,O
of,O
tachycardia,B-PR
ranging,O
from,O
134,O
to,O
158,O
",",O
for,O
one,O
to,O
two,O
hours,O
.,O

EKG,B-TE
during,O
this,O
episode,O
was,O
taken,O
and,O
showed,O
sinus,B-PR
tachycardia,I-PR
;,O
however,O
",",O
serial,B-TE
enzymes,I-TE
were,O
significant,O
for,O
CK,B-TE
peaking,O
at,O
1075,O
",",O
MB,B-TE
peaking,O
at,O
114,O
and,O
MB,B-TE
index,I-TE
peaking,O
at,O
10.8,O
",",O
consistent,O
with,O
myocardial,B-PR
damage,I-PR
.,O

The,O
day,O
following,O
this,O
episode,O
",",O
EKG,B-TE
showed,O
loss,B-PR
of,I-PR
R,I-PR
wave,I-PR
progression,I-PR
in,O
anterior,O
leads,O
and,O
Q,B-PR
waves,I-PR
in,I-PR
leads,I-PR
III,I-PR
and,O
AVF,B-PR
consistent,O
with,O
anteroseptal,B-PR
myocardial,I-PR
infarction,I-PR
.,O

The,B-TE
patient,I-TE
's,I-TE
blood,I-TE
pressures,I-TE
remained,O
stable,O
during,O
his,O
stay,O
.,O

He,O
had,O
no,O
episodes,O
of,O
arrhythmia,B-PR
on,O
Telemetry,B-TE
.,O

Cardiology,O
consultation,O
was,O
obtained,O
.,O

The,B-PR
myocardial,I-PR
infarction,I-PR
was,O
attributed,O
to,O
demand,B-PR
ischemia,I-PR
secondary,O
to,O
acute,B-PR
hematocrit,I-PR
drop,I-PR
exacerbated,O
by,O
tachycardia,B-PR
secondary,O
to,O
blood,B-PR
transfusion,I-PR
reaction,I-PR
.,O

Further,B-TE
Cardiologic,I-TE
work-up,I-TE
was,O
suggested,O
as,O
an,O
outpatient,O
at,O
four,O
to,O
six,O
weeks,O
post,O
discharge,O
.,O

The,O
patient,O
was,O
started,O
on,O
Lopressor,B-TR
",",O
Lipitor,B-TR
and,O
Lisinopril,B-TR
.,O

3.,O
After,O
ten,O
units,O
of,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
and,O
four,O
units,O
of,O
fresh,B-TR
frozen,I-TR
plasma,I-TR
transfusions,I-TR
",",O
the,B-TE
patient,I-TE
's,I-TE
hematocrit,I-TE
remained,O
stable,O
at,O
above,O
30,O
.,O

His,B-TE
INR,I-TE
decreased,O
to,O
1.3,O
at,O
the,O
time,O
of,O
discharge,O
.,O

He,O
required,O
no,O
blood,B-TR
transfusions,I-TR
for,O
four,O
days,O
prior,O
to,O
discharge,O
.,O

4.,O
History,O
of,O
pulmonary,B-PR
embolism,I-PR
likely,O
secondary,O
to,O
frequent,O
flying,O
.,O

The,O
need,O
for,O
further,B-TR
anti-coagulation,I-TR
was,O
discussed,O
with,O
the,O
patient,O
's,O
attending,O
",",O
Dr.,O
Coleman,O
",",O
and,O
it,O
was,O
decided,O
not,O
to,O
continue,O
anti-coagulation,B-TR
due,O
to,O
increased,O
risk,B-PR
of,I-PR
gastrointestinal,I-PR
bleeding,I-PR
.,O

The,O
patient,O
remained,O
symptom,O
free,O
during,O
his,O
stay,O
in,O
the,O
hospital,O
",",O
saturating,O
well,O
in,O
room,O
air,O
.,O

5.,O
Endocrine,O
:,O

The,O
patient,O
was,O
restarted,O
on,O
Levothyroxine,B-TR
soon,O
after,O
admission,O
.,O

His,B-TE
hemoglobin,I-TE
A1C,I-TE
was,O
sent,O
and,O
it,O
was,O
pending,O
at,O
the,O
time,O
of,O
discharge,O
.,O

6.,O
Single,B-PR
mental,I-PR
status,I-PR
change,I-PR
times,O
two,O
hours,O
during,O
episode,O
of,O
blood,B-PR
transfusion,I-PR
reaction,I-PR
.,O

Was,O
most,O
likely,O
due,O
to,O
multiple,B-TR
drugs,I-TR
administered,O
during,O
the,O
episode,O
including,O
Demerol,B-TR
.,O

After,O
this,O
episode,O
",",O
the,O
patient,O
's,O
mental,O
status,O
remained,O
clear,O
for,O
the,O
rest,O
of,O
the,O
duration,O
of,O
his,O
stay,O
.,O

7.,O
Prophylaxis,B-TR
:,O

The,O
patient,O
was,O
sent,O
home,O
on,O
proton,B-TR
pump,I-TR
inhibitors,I-TR
.,O

His,B-TE
Helicobacter,I-TE
pylori,I-TE
serology,I-TE
was,O
sent,O
and,O
was,O
pending,O
at,O
the,O
time,O
of,O
discharge,O
.,O

CONDITION,O
AT,O
DISCHARGE,O
:,O

Good,O
.,O

DISPOSITION,O
:,O

The,O
patient,O
was,O
discharged,O
to,O
home,O
on,O
the,B-TR
following,I-TR
medications,I-TR
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Lisinopril,B-TR
5,O
mg,O
p.o.,O
q.,O
day,O
.,O

2.,O
Metoprolol,B-TR
37.5,O
mg,O
p.o.,O
twice,O
a,O
day,O
.,O

3.,O
Lipitor,B-TR
10,O
mg,O
p.o.,O
q.,O
day,O
.,O

4.,O
Pantoprazole,B-TR
40,O
mg,O
p.o.,O
q.,O
day,O
.,O

5.,O
Levothyroxine,B-TR
100,O
micrograms,O
p.o.,O
q.,O
day,O
.,O

DISCHARGE,O
INSTRUCTIONS,O
:,O

1.,O
The,O
patient,O
was,O
to,O
arrange,O
his,O
follow-up,O
with,O
his,O
primary,O
care,O
physician,O
",",O
Bryan,O
Smith,O
.,O

2.,O
To,O
follow-up,O
with,O
his,O
Cardiologist,O
",",O
Dr.,O
Delores,O
Padilla,O
within,O
one,O
to,O
two,O
weeks,O
of,O
discharge,O
.,O

Tammy,O
Thompson,O
",",O
M.D.,O

40-318,O

Dictated,O
By,O
:,O
Randolph,O
Q,O
Barber,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2015-11-26,O
15:15,O

T,O
:,O
2015-11-26,O
16:10,O

JOB,O
#:,O

90402,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Tammy,O
Thompson,O
on,O
:,O
FRI,O
2015-11-27,O
8:46,O
PM,O

(,O
End,O
of,O
Report,O
),O

625433852,O

FIH,O

3767370,O

25103/5cy1,O

160996,O

10/1/1994,O
12:00:00,O
AM,O

METASTATIC,B-PR
CANCER,I-PR
TO,I-PR
THE,I-PR
LIVER,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

10-01-94,O

DISCHARGE,O
DATE,O
:,O

10-10-94,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Metastatic,B-PR
cancer,I-PR
to,I-PR
the,I-PR
liver,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

diabetes,B-PR
mellitus,I-PR
",",O
peripheral,B-PR
neuropathy,I-PR
",",O
rectal,B-PR
carcinoma,I-PR
",",O
premature,B-PR
ventricular,I-PR
contractions,I-PR
",",O
right,B-PR
hemidiaphragmatic,I-PR
paralysis,I-PR
.,O

SPECIAL,O
PROCEDURES,O
AND,O
OPERATIONS,O
:,O

10-02-94,O
left,B-TR
hepatectomy,I-TR
",",O
10-01-94,O
celiac,B-TE
and,I-TE
superior,I-TE
mesenteric,I-TE
angiogram,I-TE
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
60,O
year,O
old,O
diabetic,O
who,O
underwent,O
an,B-TR
APR,I-TR
in,O
1989,O
for,O
rectal,B-PR
carcinoma,I-PR
and,O
has,O
been,O
doing,O
following,O
radiation,B-TR
therapy,I-TR
and,O
5FU,B-TR
.,O

He,O
recently,O
developed,O
fatigue,B-PR
and,O
dyspnea,B-PR
and,O
workup,B-TE
disclosed,O
a,B-PR
large,I-PR
liver,I-PR
mass,I-PR
which,O
was,O
biopsied,O
and,O
revealed,O
to,O
be,O
poorly,B-PR
differentiated,I-PR
neoplasm,I-PR
most,O
consistent,O
with,O
metastatic,B-PR
rectal,I-PR
discontinued,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

remarkable,O
for,O
diabetes,B-PR
mellitus,I-PR
",",O
premature,B-PR
ventricular,I-PR
contractions,I-PR
",",O
rectal,B-PR
carcinoma,I-PR
",",O
diabetic,B-PR
neuropathy,I-PR
both,O
peripherally,O
and,O
involving,O
the,O
right,O
diaphragm,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Diabeta,B-TR
10,O
mg.,O
po.,O
bid,O
.,O

Serax,B-TR
20,O
mg.,O
po.,O
qhs,O
.,O

Sudafed,B-TR
30,O
mg.,O
po.,O
bid,O
.,O

Theo-dur,B-TR
300,O
mg.,O
po.,O
bid,O
.,O

Betoptic,B-TR
0.5%,O
one,O
drop,O
OU,O
bid,O
",",O
Propene,B-TR
0.1%,O
one,O
drop,O
OU,O
bid,O
",",O
Pred-Forte,B-TR
1%,O
one,O
drop,O
OS,O
bid,O
",",O
Percocet,B-TR
two,O
tabs.,O
po.,O
q4hours,O
prn,O
.,O

Proventil,B-TR
2,O
puffs,O
q6hours,O
prn,O
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

includes,O
and,O
abdominoperineal,B-TR
resection,I-TR
in,O
1989,O
.,O

ALLERGIES,O
:,O

no,O
known,B-PR
drug,I-PR
allergies,I-PR

PHYSICAL,O
EXAMINATION,O
:,O

demonstrated,O
an,O
obese,O
man,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

The,B-TE
blood,I-TE
pressure,I-TE
140/75,O
",",O
pulse,B-TE
90,O
and,O
irregular,B-PR
",",O
respirations,B-TE
20,O
.,O

The,B-TE
head,I-TE
",",I-TE
eyes,I-TE
",",I-TE
ears,I-TE
",",I-TE
nose,I-TE
",",I-TE
throat,I-TE
and,I-TE
neck,I-TE
examinations,I-TE
were,O
unremarkable,O
.,O

Cardiac,B-TE
examination,I-TE
was,O
remarkable,O
for,O
frequent,B-PR
ectopic,I-PR
beats,I-PR
.,O

The,B-TE
lung,I-TE
examination,I-TE
was,O
clear,O
but,O
breath,B-TE
sounds,I-TE
were,O
more,O
pronounced,O
on,O
the,O
left,O
than,O
the,O
right,O
.,O

Abdomen,O
:,O

soft,O
",",O
obese,B-PR
with,O
mild,B-PR
epigastric,I-PR
and,I-PR
right,I-PR
upper,I-PR
quadrant,I-PR
tenderness,I-PR
.,O

An,B-TR
intact,I-TR
colostomy,I-TR
was,O
present,O
.,O

No,O
masses,B-PR
could,O
be,O
palpated,O
secondary,O
to,O
the,B-PR
patient,I-PR
&apos;s,I-PR
extreme,I-PR
obesity,I-PR
.,O

Extremities,O
:,O

unremarkable,O
.,O

The,B-TE
neurological,I-TE
examination,I-TE
was,O
remarkable,O
for,O
a,B-PR
peripheral,I-PR
neuropathy,I-PR
including,O
decreased,B-PR
sensation,I-PR
in,I-PR
the,I-PR
lower,I-PR
extremities,I-PR
with,O
decreased,B-PR
strength,I-PR
in,I-PR
the,I-PR
upper,I-PR
and,I-PR
lower,I-PR
extremities,I-PR
most,O
pronounced,O
in,O
the,O
legs,O
and,O
feet,O
.,O

A,B-TE
chest,I-TE
X-ray,I-TE
demonstrated,O
right,B-PR
hemidiaphragmatic,I-PR
elevation,I-PR
.,O

The,B-TE
electrocardiogram,I-TE
was,O
remarkable,O
for,O
trigeminy,B-PR
at,O
91,O
per,O
minute,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
and,O
underwent,O
celiac,B-TE
and,I-TE
superior,I-TE
mesenteric,I-TE
artery,I-TE
angiography,I-TE
which,O
demonstrated,O
a,O
patent,O
celiac,O
and,O
superior,O
mesenteric,O
artery,O
with,O
normal,O
branching,O
pattern,O
.,O

His,B-TE
preoperative,I-TE
workup,I-TE
was,O
completed,O
and,O
included,O
a,O
normal,O
white,O
count,O
",",O
hematocrit,B-TE
42,O
.,O

normal,O
electrolytes,O
",",O
normal,O
coags,O
and,O
normal,O
renal,O
function,O
.,O

On,O
10-02-94,O
the,O
patient,O
was,O
brought,O
to,O
the,O
operating,O
room,O
where,O
he,O
underwent,O
exploratory,B-TE
laparotomy,I-TE
and,O
left,B-TR
hepatectomy,I-TR
and,O
cholecystectomy,B-TR
by,O
Dr.,O
Duhenile,O
.,O

The,O
patient,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
with,O
a,B-PR
2000,I-PR
cc.,I-PR
blood,I-PR
loss,I-PR
and,O
was,O
autotransfused,O
two,O
units,O
of,O
blood,B-TR
.,O

In,O
the,O
postoperative,O
course,O
Mr.,O
Fyfe,O
did,O
surprisingly,O
well,O
given,O
his,B-PR
underlying,I-PR
medical,I-PR
condition,I-PR
.,O
",",O

He,O
did,O
require,O
two,O
units,O
of,O
transfused,B-TR
blood,I-TR
but,O
otherwise,O
did,O
quite,O
well,O
and,O
was,O
extubated,O
on,O
the,O
night,O
of,O
surgery,O
.,O

He,O
remained,O
in,O
the,O
Intensive,O
Care,O
Unit,O
for,O
two,O
days,O
but,O
was,O
hemodynamically,O
stable,O
throughout,O
.,O

He,O
continued,O
to,O
manifest,O
occasional,B-PR
premature,I-PR
ventricular,I-PR
contractions,I-PR
",",O
but,O
these,O
were,O
unchanged,O
from,O
preoperatively,O
and,O
the,O
patient,O
otherwise,O
did,O
well,O
.,O

His,B-TR
nasogastric,I-TR
tube,I-TR
was,O
discontinued,O
and,O
he,O
was,O
begun,O
on,O
clear,B-TR
liquids,I-TR
and,O
subsequently,O
advanced,O
to,O
a,O
regular,O
diet,O
without,O
difficulty,O
.,O

Both,O
of,O
his,B-TR
Jackson-Pratt,I-TR
drains,I-TR
were,O
removed,O
without,O
incident,O
.,O

By,O
postoperative,O
day,O
#,O
7,O
",",O
Mr.,O
Fyfe,O
was,O
tolerating,O
a,B-TR
regular,I-TR
ADA,I-TR
1800,I-TR
kilocalorie,I-TR
diet,I-TR
without,O
difficulty,O
with,O
all,O
of,O
his,B-TR
tubes,I-TR
and,O
drains,B-TR
removed,O
.,O

His,B-PR
wound,I-PR
was,O
noted,O
to,O
be,O
healing,O
well,O
and,O
his,B-TR
colostomy,I-TR
functioning,O
appropriately,O
without,O
significant,O
difficulty,O
.,O

He,O
is,O
being,O
transferred,O
back,O
to,O
the,O
Per,O
Naplesspecrycet,O
Hospital,O
in,O
stable,O
condition,O
on,O
the,B-TR
same,I-TR
medications,I-TR
which,O
he,O
was,O
on,O
preoperatively,O
.,O

These,O
include,O
Diabeta,B-TR
10,O
mg.,O
po.,O
bid,O
.,O

Serax,B-TR
20,O
mg.,O
po.,O
qhs,O
.,O

Sudafed,B-TR
30,O
po.,O
bid,O
.,O

Theo-dur,B-TR
300,O
mg.,O
po.,O
bid,O
.,O

Betoptic,B-TR
0.5%,O
one,O
drop,O
OU,O
bid,O
",",O
Propene,B-TR
0.1%,O
one,O
drop,O
OU,O
bid,O
.,O

Pred-Forte,B-TR
1%,O
one,O
drop,O
OS,O
bid,O
.,O

Percocet,B-TR
two,O
tabs,O
po.,O
q4h,O
prn,O
.,O

Proventil,B-TR
2,O
puffs,O
q6hours,O
prn,O
..,O

The,O
patient,O
will,O
followup,O
with,O
Dr.,O
Fede,O
Duhenile,O
in,O
two,O
weeks,O
in,O
Dr.,O
Duhenile,O
&apos;s,O
office,O
.,O

LENNI,O
BREUTZOLN,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

FEDE,O
A.,O
DUHENILE,O
",",O
M.D.,O

TR,O
:,O

eb,O
/,O
bmot,O

DD,O
:,O

10-10-94,O

TD,O
:,O

10/09/94,O

CC,O
:,O

STAT,O

?Admission,O
Date,O
:,O

2012-05-08,O

Discharge,O
Date,O
:,O

2012-05-18,O

Date,O
of,O
Birth,O
:,O

2012-05-08,O

Sex,O
:,O

M,O

Service,O
:,O

Neonatology,O

HISTORY,O
:,O

Baby,O
Barbara,O
Stead,O
is,O
a,O
term,O
infant,O
admitted,O
with,O
increasing,B-PR
head,I-PR
circumference,I-PR
and,O
bruising,B-PR
.,O

He,O
was,O
born,O
to,O
a,O
31-year-old,O
G1,O
P0,O
now,O
1,O
mother,O
with,O
unremarkable,O
prenatal,O
screens,O
as,O
follows,O
:,O

O,B-TE
positive,O
",",O
antibody,B-TE
negative,O
",",O
hepatitis,B-TE
B,I-TE
surface,I-TE
antigen,I-TE
negative,O
",",O
RPR,B-TE
nonreactive,O
",",O
rubella,B-TE
immune,I-TE

PREGNANCY,O
HISTORY,O
:,O

Estimated,O
date,O
of,O
delivery,O
was,O
2012-05-14,O
for,O
estimated,O
gestational,O
age,O
of,O
39-1/7,O
weeks,O
.,O

Pregnancy,O
was,O
complicated,O
by,O
oligohydramnios,B-PR
with,O
an,B-TE
AFI,I-TE
of,O
3.5,O
and,O
by,O
multiple,B-TE
evaluations,I-TE
for,O
decreased,B-PR
fetal,I-PR
movement,I-PR
.,O

There,O
was,O
spontaneous,B-PR
onset,I-PR
of,I-PR
labor,I-PR
progressing,O
through,O
vacuum,B-TR
assisted,I-TR
vaginal,I-TR
delivery,I-TR
under,O
epidural,B-TR
anesthesia,I-TR
.,O

clear,O
amniotic,O
fluid,O
",",O
no,O
antepartum,B-PR
maternal,I-PR
fever,I-PR
or,O
fetal,B-PR
tachycardia,I-PR
",",O
no,O
antepartum,B-TR
antibiotic,I-TR
prophylaxis,I-TR
.,O

Baby,O
was,O
vigorous,O
at,O
delivery,O
",",O
was,O
bulb,B-TR
suction,I-TR
",",O
dried,O
",",O
and,O
had,O
free,B-TR
flow,I-TR
oxygen,I-TR
administered,O
briefly,O
.,O

Apgars,B-TE
were,O
nine,O
and,O
nine,O
.,O

In,O
the,O
Newborn,O
Nursery,O
",",O
he,O
initially,O
had,O
a,B-PR
caput,I-PR
which,O
increased,O
in,O
the,O
amount,O
of,O
swelling,B-PR
and,O
bruising,B-PR
in,O
the,O
subsequent,O
24,O
hours,O
.,O

He,O
was,O
then,O
referred,O
to,O
the,O
CMED,O
CCU,O
for,O
assessment,B-TE
and,O
management,B-TR
of,O
the,B-PR
increased,I-PR
bleeding,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
UPON,O
ADMISSION,O
TO,O
THE,O
CMED,O
CCU,O
:,O

Birth,B-TE
weight,I-TE
was,O
3850,O
grams,O
.,O

Head,B-TE
circumference,I-TE
was,O
41,O
cm,O
.,O

HEENT,B-TE
was,O
significant,O
for,O
swelling,B-PR
of,I-PR
the,I-PR
scalp,I-PR
tissue,I-PR
in,O
generalized,O
distribution,O
with,O
ecchymosis,B-PR
extending,O
from,O
the,O
occiput,O
to,O
the,O
posterior,O
auricular,O
area,O
and,O
dorsal,O
aspect,O
of,O
the,O
neck,O
to,O
the,O
mid,O
cervical,O
level,O
.,O

Ears,O
were,O
displaced,O
forward,O
.,O

Eyes,O
were,O
normal,O
.,O

Neck,O
and,O
mouth,O
were,O
normal,O
.,O

No,O
nasal,B-PR
flaring,I-PR
.,O

Chest,O
:,O

No,O
retractions,B-PR
",",O
good,O
breath,O
sounds,O
bilaterally,O
",",O
no,O
crackles,B-PR
.,O

Cardiovascular,O
:,O

Regular,O
",",O
rate,O
",",O
and,O
rhythm,O
.,O

Femoral,B-TE
pulses,I-TE
normal,O
",",O
S1,O
",",O
S2,O
were,O
normal,O
.,O

There,O
was,O
a,B-PR
1/6,I-PR
systolic,I-PR
ejection,I-PR
murmur,I-PR
in,O
the,O
upper,O
left,O
sternal,O
border,O
without,O
radiation,B-PR
.,O

Abdomen,O
was,O
soft,O
",",O
nontender,B-PR
",",O
no,O
organomegaly,B-PR
",",O
no,O
masses,B-PR
.,O

Bowel,B-TE
sounds,I-TE
are,O
active,O
and,O
patent,O
.,O

CNS,O
active,O
",",O
responsive,O
to,O
stimulation,B-TE
.,O

Pupils,O
are,O
reactive,O
to,O
light,O
.,O

Tone,B-TE
is,O
normal,O
",",O
moving,O
all,O
limbs,O
symmetrically,O
",",O
irritable,B-PR
with,O
palpation,B-TE
of,I-TE
the,I-TE
scalp,I-TE
.,O

Suck,B-TE
",",O
root,B-TE
",",O
gag,B-TE
",",O
grasp,B-TE
",",O
and,O
morrow,B-TE
were,O
normal,O
.,O

Skin,O
:,O

Pale,O
as,O
above,O
",",O
nonicteric,B-PR
.,O

Musculoskeletal,O
:,O

Normal,O
spine,O
",",O
hip,O
",",O
clavicles,O
",",O
small,B-PR
mass,I-PR
at,O
the,O
site,O
of,O
previous,B-TR
right,I-TR
quadriceps,I-TR
intramuscular,I-TR
injection,I-TR
.,O

An,B-TE
initial,I-TE
head,I-TE
CT,I-TE
scan,I-TE
had,O
revealed,O
extracranial,B-PR
soft,I-PR
tissue,I-PR
swelling,I-PR
most,O
prominently,O
at,O
the,O
right,O
frontal-parietal-occipital,O
area,O
extending,O
to,O
the,O
left,O
and,O
to,O
the,O
upper,O
cervical,O
region,O
.,O

Ventricles,O
were,O
symmetrical,O
and,O
not,O
compressed,O
.,O

No,O
gross,B-PR
intraparenchymal,I-PR
hemorrhage,I-PR
.,O

But,O
upon,O
further,O
radiology,O
attending,O
Stoughton,O
",",O
there,O
was,O
a,B-PR
small,I-PR
bilateral,I-PR
occipital,I-PR
subdural,I-PR
hemorrhage,I-PR
noted,O
.,O

The,B-TE
initial,I-TE
hematocrit,I-TE
was,O
21.2,O
",",O
platelets,B-TE
186,O
.,O

PT,B-TE
was,O
14.6,O
",",O
PTT,B-TE
77,O
with,O
an,B-TE
INR,I-TE
of,O
1.4,O
.,O

Fibrinogen,B-TE
was,O
192,O
.,O

D-dimer,B-TE
was,O
negative,O
.,O

ASSESSMENT,O
:,O

This,O
is,O
a,O
term,O
infant,O
with,O
significant,B-PR
subgaleal,I-PR
hematoma,I-PR
with,O
apparent,O
extension,O
over,O
the,O
past,O
six,O
hours,O
.,O

There,O
was,O
also,O
elevation,B-PR
of,O
the,B-TE
PTT,I-TE
suggesting,O
possible,O
inborn,B-PR
coagulopathy,I-PR
.,O

There,O
is,O
also,O
critical,B-PR
anemia,I-PR
secondary,O
to,O
the,B-PR
subgaleal,I-PR
hemorrhage,I-PR
.,O

He,O
was,O
admitted,O
to,O
the,O
CMED,O
CCU,O
for,O
further,B-TR
management,I-TR
.,O

SUMMARY,O
OF,O
HOSPITAL,O
COURSE,O
BY,O
SYSTEMS,O
:,O

1.,O
Respiratory,O
:,O

Patient,O
has,O
been,O
on,O
room,O
air,O
maintaining,O
sats,B-TE
above,O
95%,O
.,O

No,O
apnea,B-PR
or,O
bradycardia,B-PR
.,O

2.,O
Cardiovascular,O
:,O

There,O
was,O
an,B-PR
initial,I-PR
murmur,I-PR
on,O
admission,O
likely,O
secondary,O
to,O
severe,B-PR
anemia,I-PR
which,O
has,O
since,O
resolved,O
.,O

He,O
remained,O
hemodynamically,O
stable,O
throughout,O
this,O
admission,O
.,O

3.,O
FEN,O
:,O

Patient,O
was,O
restarted,O
on,O
po,O
feeds,O
as,O
of,O
day,O
of,O
life,O
three,O
after,O
the,B-PR
bleeding,I-PR
had,O
stabilized,O
.,O

He,O
has,O
been,O
taking,O
breast,O
milk,O
or,O
Enfamil,O
20,O
po,O
adlib,O
.,O

His,B-TE
admission,I-TE
weight,I-TE
was,O
3850,O
grams,O
.,O

His,B-TE
weight,I-TE
on,I-TE
discharge,I-TE
was,O
4055,O
.,O

4.,O
GI,O
:,O

Given,O
the,O
significant,O
amount,O
of,O
bleeding,B-PR
",",O
baby,O
was,O
started,O
prophylactically,O
on,O
phototherapy,B-TR
.,O

His,B-TE
bilirubin,I-TE
peaked,O
on,O
day,O
of,O
life,O
three,O
at,O
5.4,O
with,O
a,B-TE
subsequent,I-TE
bilirubin,I-TE
of,O
4.6,O
at,O
which,O
time,O
phototherapy,B-TR
was,O
discontinued,O
.,O

5.,O
Hematology,O
:,O

Given,O
the,O
rapid,O
extension,O
of,O
the,B-PR
subgaleal,I-PR
bleed,I-PR
",",O
coagulopathy,B-TE
workup,I-TE
was,O
initiated,O
revealing,O
an,B-PR
elevated,I-PR
PTT,I-PR
level,I-PR
of,O
77,O
as,O
well,O
as,O
factor,B-TE
8,I-TE
level,I-TE
that,O
was,O
below,O
detection,O
in,O
the,O
presence,O
of,O
normal,O
factors,O
5,O
",",O
9,O
",",O
10,O
",",O
and,O
11,O
.,O

He,O
was,O
started,O
on,O
a,B-TR
50,I-TR
units,I-TR
/,I-TR
kg,I-TR
bolus,I-TR
of,I-TR
factor,I-TR
8,I-TR
followed,O
by,O
continuous,B-TR
factor,I-TR
8,I-TR
infusions,I-TR
at,O
50,O
units,O
/,O
kg,O
/,O
day,O
divided,O
until,O
hourly,O
infusion,O
rates,O
at,O
05-10,O
.,O

Subsequent,B-TE
factor,I-TE
8,I-TE
levels,I-TE
varied,O
with,O
an,B-TE
initial,I-TE
factor,I-TE
8,I-TE
level,I-TE
of,O
18,O
after,O
the,B-TR
bolus,I-TR
with,O
which,O
he,O
received,O
another,O
bolus,O
of,O
factor,B-TR
8,I-TR
of,O
50,O
units,O
/,O
kg,O
and,O
increased,B-TR
factor,I-TR
8,I-TR
infusion,I-TR
rate,I-TR
to,O
65,O
units,O
/,O
kg,O
/,O
day,O
.,O

As,O
of,O
05-17,O
",",O
he,O
was,O
switched,O
over,O
to,O
bolus,B-TR
infusion,I-TR
in,O
preparation,O
of,O
continued,B-TR
home,I-TR
factor,I-TR
8,I-TR
administration,I-TR
.,O

His,B-TE
peak,I-TE
level,I-TE
after,O
a,O
bolus,O
of,O
75,O
units,O
/,O
kg,O
of,O
factor,B-TR
8,I-TR
was,O
131,O
.,O

A,B-TE
trough,I-TE
level,I-TE
at,O
20,O
hours,O
after,O
the,B-TR
bolus,I-TR
on,O
day,O
of,O
discharge,O
was,O
29,O
.,O

He,O
will,O
continue,O
to,O
receive,O
factor,B-TR
8,I-TR
bolus,I-TR
q,O
day,O
for,O
a,O
total,O
of,O
2-3,O
weeks,O
in,O
light,O
of,O
the,B-PR
intracranial,I-PR
hemorrhage,I-PR
",",O
and,O
will,O
be,O
followed,O
by,O
Hematology,O
visiting,O
nurse,O
Michael,O
Edwards,O
level,O
checks,O
at,O
home,O
.,O

Currently,O
",",O
the,B-TR
infusion,I-TR
of,O
factor,B-TR
8,I-TR
are,O
going,O
through,O
a,B-TR
jugular,I-TR
Broviac,I-TR
which,O
was,O
placed,O
on,O
05-15,O
for,O
administration,O
of,O
factor,B-TR
.,O

His,B-TE
last,I-TE
PTT,I-TE
on,O
05-16,O
was,O
68.3,O
.,O

The,B-TE
last,I-TE
hematocrit,I-TE
was,O
on,O
05-16,O
of,O
54.5,O
.,O

6.,O
Neurology,O
:,O

Baby,O
Mary,O
Stead,O
initially,O
presented,O
with,O
significant,B-PR
subgaleal,I-PR
bleed,I-PR
as,O
well,O
as,O
a,B-PR
small,I-PR
subdural,I-PR
hemorrhage,I-PR
.,O

A,B-TE
repeat,I-TE
head,I-TE
CT,I-TE
scan,I-TE
on,O
05-15,O
had,O
shown,O
the,O
resolution,O
of,O
the,B-PR
subdural,I-PR
hematoma,I-PR
and,O
significant,O
improvement,O
of,O
the,B-PR
subgaleal,I-PR
bleed,I-PR
.,O

His,B-TE
head,I-TE
ultrasound,I-TE
on,O
05-14,O
reveals,O
no,O
interventricular,B-PR
hemorrhage,I-PR
.,O

He,O
had,O
remained,O
neurologically,O
stable,O
.,O

His,B-TE
head,I-TE
circumference,I-TE
on,O
05-18,O
was,O
36.5,O
cm,O
with,O
a,B-TE
maximum,I-TE
head,I-TE
circumference,I-TE
on,O

admission,O
of,O
40.5,O
cm,O
.,O

7.,O
Social,O
:,O

Both,O
parents,O
are,O
very,O
involved,O
in,O
the,O
care,O
of,O
Baby,O
Norman,O
Stead,O
.,O

They,O
have,O
been,O
informed,O
up,O
to,O
date,O
on,O
his,O
needs,O
",",O
discharge,O
from,O
the,O
hospital,O
.,O

Teaching,O
has,O
been,O
completed,O
on,O
the,O
care,O
of,O
the,B-TR
Boviak,I-TR
as,O
well,O
as,O
administration,O
of,O
factor,B-TR
8,I-TR
.,O

8.,O
Sensory,O
:,O

Audiology,O
:,O

Hearing,B-TE
screen,I-TE
was,O
performed,O
automated,O
auditory,O
brain,O
stem,O
responses,O
and,O
Baby,O
David,O
Stead,O

passed,O
bilaterally,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Baby,O
Julian,O
Stead,O
had,O
been,O
stable,O
with,O
improvement,O
of,O
the,B-PR
subgaleal,I-PR
bleed,I-PR
and,O
good,O
peak,O
and,O
trough,O
factor,O
8,O
levels,O
after,O
the,B-TR
bolus,I-TR
infusion,I-TR
.,O

DISPOSITION,O
:,O

Baby,O
Corine,O
Stead,O
is,O
to,O
be,O
discharged,O
home,O
with,O
parents,O
with,O
close,O
Hematology,O
VNA,O
followup,O
.,O

NAME,O
OF,O
PRIMARY,O
PEDIATRICIAN,O
:,O

Dr.,O
Pearly,O
Reilly,O
",",O
208-4200,O
.,O

CARE,O
AND,O
RECOMMENDATIONS,O
:,O

1.,O
Feeds,O
at,O
discharge,O
:,O

Breast,O
milk,O
Enfamil,O
20,O
po,O
adlib,O
as,O
tolerated,O
.,O

2.,O
Medications,O
:,O

Factor,B-TR
8,I-TR
boluses,I-TR
at,O
75,O
units,O
/,O
kg,O
/,O
day,O
.,O

3.,O
Car,B-TE
seat,I-TE
position,I-TE
screening,I-TE
passed,O
.,O

4.,O
State,B-TE
Newborn,I-TE
Screen,I-TE
sent,O
.,O

5.,O
Immunizations,O
:,O

Received,O
hepatitis,B-TR
B,I-TR
vaccination,I-TR
on,O
05-16,O
.,O

FOLLOW-UP,O
APPOINTMENT,O
:,O

Scheduled,O
for,O
05-21,O
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

1.,O
Factor,B-PR
8,I-PR
deficiency,I-PR
.,O

2.,O
Subgaleal,B-PR
hemorrhage,I-PR
",",O
resolved,O
.,O

3.,O
Small,B-PR
occipital,I-PR
subdural,I-PR
hemorrhage,I-PR
",",O
resolved,O

Reviewed,O
By,O
:,O
Mavis,O
W.,O
"Mobley,",O
M.D.,O

21-114,O

Dictated,O
By,O
:,O
William,O
A.,O
Hunter,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2012-05-18,O
13:58,O

T,O
:,O
2012-05-18,O
14:22,O

JOB,O
#:,O

93716,O

Signed,O
electronically,O
by,O
:,O
DR.,O
George,O
Sherwood,O
on,O
:,O
MON,O
2012-05-21,O
11:57,O
AM,O

(,O
End,O
of,O
Report,O
),O

649917202,O
DH,O

8205558,O

997074,O

322941,O

3/25/2001,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Report,O
Status,O
:,O

Signed,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

DULDKOTE,O
",",O
EI,O
N,O

UNIT,O
NUMBER,O
:,O

904-33-96,O

ADMISSION,O
DATE,O
:,O

03/25/2001,O

DISCHARGE,O
DATE,O
:,O

03/26/2001,O

CHIEF,O
COMPLAINT,O
:,O

Right,B-PR
shoulder,I-PR
instability,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
30-year-old,O
right,O
hand,O
dominant,O
gentleman,O
who,O
pleasant,O
Software,O
Engineer,O
.,O

In,O
1989,O
the,O
patient,O
was,O
dunking,O
a,O
basketball,O
and,O
injured,O
his,O
right,O
shoulder,O
with,O
abduction,B-PR
external,I-PR
rotation,I-PR
injury,I-PR
.,O

He,O
has,O
had,O
persistent,B-PR
pain,I-PR
over,O
the,O
years,O
which,O
has,O
worsened,O
in,O
the,O
past,O
several,O
months,O
including,O
inability,B-PR
to,I-PR
sleep,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Is,O
unremarkable,O
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

Knee,B-TR
surgery,I-TR
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

None,O
.,O

SOCIAL,O
HISTORY,O
:,O

Occasional,O
alcohol,O
",",O
does,O
not,O
smoke,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

In,O
Clinic,O
his,B-TE
cervical,I-TE
spine,I-TE
examination,I-TE
was,O
benign,O
.,O

Shoulder,B-TE
elevation,I-TE
is,O
170,O
degrees,O
with,O
70,O
degrees,O
of,O
external,O
rotation,O
and,O
internal,O
rotation,O
of,O
the,O
right,O
shoulder,O
to,O
T9,O
vertebra,O
versus,O
T7,O
on,O
the,O
left,O
.,O

Rotator,O
cuff,O
measures,O
4-5,O
on,O
the,O
right,O
and,O
5,O
out,O
of,O
5,O
on,O
the,O
left,O
.,O

Mild,B-PR
pain,I-PR
with,O
resistive,B-TE
test,I-TE
and,O
his,B-TE
Pigott,I-TE
sign,I-TE
is,O
mildly,O
positive,O
on,O
the,O
right,O
",",O
negative,O
on,O
the,O
left,O
.,O

There,O
is,O
1,O
cm.,O
sulcus,O
sign,O
bilaterally,O
.,O

Laxity,B-PR
is,O
noted,O
as,O
well,O
as,O
markedly,B-PR
positive,I-PR
apprehension,I-PR
sign,I-PR
on,I-PR
the,I-PR
right,I-PR
.,O

Biceps,O
are,O
normal,O
.,O

HOSPITAL,O
COURSE,O
AND,O
TREATMENT,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
Hospital,O
and,O
was,O
taken,O
to,O
the,O
operating,O
room,O
for,O
an,B-TR
open,I-TR
Bankart,I-TR
procedure,I-TR
with,O
biceps,B-TR
tenodesis,I-TR
(,O
Please,O
see,O
the,O
operative,O
note,O
for,O
full,O
details,O
),O
.,O

Postoperatively,O
",",O
the,O
patient,O
did,O
very,O
well,O
and,O
was,O
neurovascularly,O
intact,O
.,O

His,B-PR
wound,I-PR
was,O
intact,O
",",O
clean,O
and,O
dry,O
and,O
it,O
was,O
covered,O
with,O
perioperative,B-TR
antibiotics,I-TR
.,O

He,O
was,O
discharged,O
to,O
home,O
on,O
Percocet,B-TR
.,O

He,O
was,O
given,O
strict,O
instructions,O
to,O
limit,O
his,O
external,O
rotation,O
no,O
more,O
than,O
30,O
degrees,O
.,O

He,O
was,O
seen,O
by,O
physical,O
therapy,O
prior,O
to,O
discharge,O
.,O

FOLLOW,O
UP,O
:,O

He,O
is,O
to,O
follow,O
up,O
with,O
Dr.,O
Rach,O
Breutznedeaisscarvwierst,O
in,O
Clinic,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Percocet,B-TR
1-2,O
tablets,O
PO,O
q.4-6,O
hours,O
prn,O
pain,B-PR
.,O

MA,O
ANSHI,O
PIERNREUKOTEFILLE,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

Electronically,O
Signed,O
RACH,O
HY,O
BREUTZNEDEAISSCARVWIERST,O
",",O
M.D.,O
05/20/2001,O
18:29,O

_____________________________,O
RACH,O
HY,O
BREUTZNEDEAISSCARVWIERST,O
",",O
M.D.,O

TR,O
:,O

wlk,O

DD,O
:,O

03/26/2001,O

TD,O
:,O

03/31/2001,O
10:13,O
A,O

cc,O
:,O

RACH,O
HY,O
BREUTZNEDEAISSCARVWIERST,O
",",O
M.D.,O

?Admission,O
Date,O
:,O

1989-03-20,O

Discharge,O
Date,O
:,O

2015-12-31,O

Date,O
of,O
Birth,O
:,O

1931-12-09,O

Sex,O
:,O

M,O

Service,O
:,O

This,O
is,O
an,O
addendum,O
to,O
the,O
discharge,O
summary,O
that,O
was,O
dictated,O
earlier,O
this,O
morning,O
.,O

Continuing,O
throughout,O
his,O
course,O
he,O
had,O
multiple,B-PR
infectious,I-PR
disease,I-PR
issues,I-PR
.,O

He,O
developed,O
zoster,B-PR
for,O
which,O
he,O
received,O
a,B-TR
course,I-TR
of,I-TR
acyclovir,I-TR
.,O

His,B-TE
cultures,I-TE
came,O
back,O
as,O
noted,O
with,O
Klebsiella,B-PR
ultimately,O
in,O
his,B-PR
chest,I-PR
wound,I-PR
",",O
MRSA,B-PR
in,O
his,O
sputum,O
.,O

He,O
had,O
multiple,B-PR
sources,I-PR
of,I-PR
yeast,I-PR
.,O

Currently,O
his,B-PR
only,I-PR
yeast,I-PR
source,I-PR
is,O
urine,O
.,O

Negative,O
blood,O
cultures,O
at,O
this,O
point,O
.,O

Also,O
in,O
the,O
course,O
of,O
the,O
month,O
that,O
he,O
was,O
in,O
the,O
ICU,O
he,O
had,O
a,B-TR
left,I-TR
chest,I-TR
tube,I-TR
placed,O
for,O
fluid,B-PR
and,O
then,O
a,B-TR
right,I-TR
chest,I-TR
tube,I-TR
placed,O
ultimately,O
for,O
fluid,B-PR
.,O

He,O
received,O
O.T.,O
and,O
P.T.,O
consults,O
.,O

He,O
developed,O
another,O
round,O
of,O
acute,B-PR
renal,I-PR
failure,I-PR
with,O
ATN,B-PR
and,O
casts,B-PR
in,I-PR
his,I-PR
urine,I-PR
.,O

On,O
11-18,O
a,O
DNR,O
order,O
was,O
put,O
into,O
place,O
.,O

He,O
also,O
started,O
treatment,B-TR
for,O
gallstones,B-PR
with,O
cholestasis,B-PR
on,O
the,O
medication,O
ursodiol,B-TR
.,O

He,O
received,O
a,O
course,O
of,O
cefepime,B-TR
also,O
.,O

He,O
continued,O
to,O
have,O
multiple,B-TR
dressing,I-TR
changes,I-TR
after,O
his,B-TR
split,I-TR
thickness,I-TR
skin,I-TR
grafts,I-TR
",",O
which,O
he,O
does,O
to,O
this,O
day,O
.,O

In,O
early,O
November,O
he,O
started,O
dialysis,B-TR
after,O
a,B-TR
PermCath,I-TR
was,O
placed,O
.,O

His,B-TR
Dobbhoff,I-TR
tube,I-TR
was,O
removed,O
.,O

He,O
was,O
able,O
to,O
use,O
a,B-TR
Passy-Muir,I-TR
valve,I-TR
intermittently,O
for,O
his,B-TR
trach,I-TR
.,O

On,O
12-23,O
he,O
went,O
back,O
to,O
the,O
operating,O
room,O
for,O
open,B-PR
jejunostomy,I-PR
tube,I-PR
dehiscence,I-PR
site,I-PR
.,O

His,B-TR
J,I-TR
tube,I-TR
is,O
now,O
functioning,O
.,O

This,O
was,O
repaired,O
and,O
stay,B-TR
sutures,I-TR
are,O
in,O
place,O
.,O

This,O
was,O
done,O
on,O
11-23,O
.,O

On,O
11-24,O
he,O
received,O
a,B-TR
permanent,I-TR
DDD,I-TR
pacemaker,I-TR
with,O
a,B-TR
lead,I-TR
that,O
was,O
externally,O
placed,O
on,O
his,O
chest,O
wall,O
due,O
to,O
his,O
healing,O
and,O
infected,B-PR
chest,I-PR
wound,I-PR
.,O

From,O
the,O
point,O
of,O
discharge,O
today,O
on,O
12-31,O
his,B-TE
most,I-TE
recent,I-TE
labs,I-TE
are,O
as,O
follows,O
.,O

White,B-TE
count,I-TE
13.9,O
",",O
hematocrit,B-TE
35.9,O
",",O
platelet,B-TE
count,I-TE
"81,000",O
.,O

Sodium,B-TE
139,O
",",O
K,B-TE
4.8,O
",",O
chloride,B-TE
109,O
",",O
CO2,B-TE
31,O
",",O
BUN,B-TE
33,O
",",O
creatinine,B-TE
2.2,O
",",O
blood,B-TE
sugar,I-TE
164,O
.,O

Albumin,B-TE
2.5,O
.,O

Vancomycin,B-TE
level,I-TE
was,O
21,O
.,O

To,O
go,O
by,O
systems,O
",",O
currently,O
he,O
is,O
neurologically,O
alert,O
and,O
follows,O
commands,O
.,O

He,O
occasionally,O
gets,O
agitated,B-PR
.,O

From,O
a,O
cardiac,O
point,O
of,O
view,O
",",O
he,O
is,O
in,O
sinus,O
rhythm,O
today,O
.,O

He,O
does,O
have,O
his,B-TR
pacing,I-TR
lead,I-TR
with,O
his,B-TR
external,I-TR
pacemaker,I-TR
DDD,I-TR
available,O
to,O
him,O
and,O
is,O
being,O
followed,O
by,O
the,O
EP,O
service,O
and,O
Dr.,O
Janet,O
Gutkin,O
for,O
further,O
outpatient,O
treatment,O
of,O
this,O

in,O
the,O
future,O
.,O

From,O
a,O
respiratory,O
point,O
of,O
view,O
",",O
he,O
is,O
on,O
CPAP,B-TR
and,O
pressure,B-TR
support,I-TR
at,O
5,O
and,O
5,O
at,O
40%,O
.,O

He,O
does,O
use,O
the,B-TR
Passy-Muir,I-TR
valve,I-TR
intermittently,O
for,O
his,B-TR
trach,I-TR
.,O

He,O
is,O
on,O
a,B-TR
trach,I-TR
collar,I-TR
this,O
week,O
during,O
the,O
day,O
only,O
and,O
rested,O
on,O
the,B-TR
ventilator,I-TR
at,O

night,O
.,O

Abdominally,O
",",O
he,O
does,O
have,O
his,B-PR
midabdominal,I-PR
incision,I-PR
with,O
good,O
approximated,O
margins,O
and,O
stay,B-TR
sutures,I-TR
in,O
place,O
.,O

From,O
a,O
GI,O
point,O
of,O
view,O
",",O
he,O
is,O
receiving,O
Promote,B-TR
tube,I-TR
feeds,I-TR
through,O
his,B-TR
jejunostomy,I-TR
tube,I-TR
.,O

His,B-PR
chest,I-PR
incision,I-PR
is,O
granulating,O
in,O
well,O
.,O

He,O
currently,O
receives,O
saline,B-TR
washes,I-TR
and,O
Adaptic,B-TR
dressing,I-TR
changes,I-TR
twice,O
a,O
day,O
.,O

From,O
a,O
CMED,O
CCU,O
point,O
of,O
view,O
",",O
he,O
gets,O
straight,B-TR
cathed,I-TR
every,O
other,O
day,O
.,O

He,O
has,O
a,B-TR
left,I-TR
subclavian,I-TR
PermCath,I-TR
access,O
for,O
his,B-TR
dialysis,I-TR
which,O
takes,O
place,O
on,O
Monday,O
",",O
Wednesday,O
and,O
Friday,O
.,O

Hematology,O
.,O

He,O
is,O
HITT,B-TE
negative,O
.,O

He,O
has,O
received,O
no,O
transfusions,B-TR
in,O
the,O
past,O
week,O
or,O
so,O
.,O

His,B-TE
hematocrit,I-TE
has,O
been,O
stable,O
in,O
the,O
mid-30s,O
.,O

He,O
has,O
a,B-TR
PICC,I-TR
line,I-TR
in,O
place,O
for,O
his,B-TR
antibiotics,I-TR
which,O
are,O
as,O
follows,O
.,O

The,B-TR
PICC,I-TR
line,I-TR
was,O
placed,O
on,O
12-29,O
.,O

His,B-TR
antibiotics,I-TR
currently,O
are,O
vancomycin,B-TR
",",O
ceftazidime,B-TR
",",O
fluconazole,B-TR
and,O
caspofungin,B-TR
.,O

I,O
will,O
give,O
doses,O
and,O
administration,O
information,O
in,O
his,O
list,O
of,O
discharge,B-TR
medications,I-TR
.,O

In,O
addition,O
",",O
his,B-TE
albumin,I-TE
today,O
is,O
2.5,O
.,O

He,O
is,O
being,O
covered,O
by,O
regular,B-TR
insulin,I-TR
sliding,I-TR
scale,I-TR
.,O

Exam,B-TE
today,O
shows,O
he,O
is,O
neurologically,O
alert,O
.,O

Heart,O
was,O
regular,O
rate,O
and,O
rhythm,O
.,O

He,O
had,O
coarse,B-PR
respiratory,I-PR
sounds,I-PR
.,O

Abdomen,O
was,O
soft,O
.,O

His,B-TR
graft,I-TR
is,O
granulating,O
in,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Docusate,B-TR
sodium,I-TR
100,O
mg,O
p.o.,O
b.i.d.,O

2.,O
Ursodiol,B-TR
300,O
mg,O
p.o.,O
b.i.d.,O

3.,O
Ascorbic,B-TR
acid,I-TR
500,O
mg,O
p.o.,O
q.d.,O

4.,O
Zinc,B-TR
sulfate,I-TR
220,O
mg,O
p.o.,O
q.d.,O

5.,O
Lansoprazole,B-TR
oral,I-TR
solution,I-TR
30,O
mg,O
per,O
gastric,O
tube,O
q.d.,O

6.,O
Caspofungin,B-TR
acetate,I-TR
50,O
mg,O
IV,O
q.d.,O
",",O
day,O
23,O
of,O
treatment,B-TR
and,O
patient,O
should,O
remain,O
on,O
it,O
indefinitely,O
.,O

7.,O
Nephrocaps,B-TR
one,O
cap,O
p.o.,O
q.d.,O

If,O
on,O
"dialysis,",B-TR
please,O
take,O
after,O
dialysis,B-TR
treatment,I-TR
.,O

8.,O
Metoclopramide,B-TR
5,O
mg,O
p.o.,O
b.i.d.,O
",",O
take,O
30,O
minutes,O
before,O
meals,O
.,O

9.,O
Fluconazole,B-TR
200,O
mg,O
p.o.,O
q.h.d.,O

Patient,O
should,O
remain,O
on,O
this,O
medication,B-TR
.,O

10.,O
Magnesium,B-TR
sulfate,I-TR
2,O
gm,O
in,O
100,O
ml,O
of,O
D5W,B-TR
IV,O
as,O
needed,O
for,O
repletion,O
p.r.n.,O

11.,O
Miconazole,B-TR
powder,I-TR
2%,O
one,O
application,O
t.p.,O
t.i.d.,O
p.r.n.,O

12.,O
Acetaminophen,B-TR
325,O
mg,O
to,O
650,O
mg,O
p.o.,O
q.four,O
to,O
six,O
hours,O
p.r.n.,O

13.,O
Albuterol,B-TR
one,O
to,O
two,O
puffs,O
inhaled,O
q.,O
six,O
hours,O
p.r.n.,O

14.,O
Bisacodyl,B-TR
10,O
mg,O
per,O
rectum,O
h.s.,O
as,O
needed,O
p.r.n.,O

15.,O
Hydralazine,B-TR
hydrochloride,I-TR
10,O
mg,O
IV,O
q.,O
six,O
hours,O
p.r.n.,O
systolic,B-TE
blood,I-TE
pressure,I-TE
greater,O
than,O
140,O
.,O

16.,O
Vancomycin,B-TR
1,O
gm,O
IV,O
as,O
needed,O
for,O
vancomycin,B-TE
level,I-TE
less,O
than,O
15,O
.,O

This,O
is,O
day,O
23,O
of,O
treatment,B-TR
for,O
an,O
approximate,O
six,O
week,O
course,O
.,O

17.,O
Ceftazidime,B-TR
1,O
gm,O
IV,O
q.h.d.,O
after,O
dialysis,B-TR
.,O

18.,O
Alteplase,B-TR
for,O
catheter,O
clearance,O
2,O
mg,O
IV,O
once,O
times,O
one,O
dose,O
for,O
indwelling,B-TR
PermCath,I-TR
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Status,O
post,O
aortic,B-TR
valve,I-TR
replacement,I-TR
and,O
coronary,B-TR
artery,I-TR
bypass,I-TR
grafting,I-TR
times,O
four,O
.,O

2.,O
Status,O
post,O
sternal,B-TR
debridement,I-TR
.,O

3.,O
Status,O
post,O
skin,B-TR
graft,I-TR
to,O
chest,B-PR
incision,I-PR
.,O

4.,O
Status,O
post,O
open,B-TR
jejunostomy,I-TR
tube,I-TR
placement,I-TR
",",O
open,B-TR
left,I-TR
subclavian,I-TR
PermCath,I-TR
placement,I-TR
.,O

5.,O
Status,O
post,O
DDD,B-TR
pacer,I-TR
placement,I-TR
with,O
external,B-TR
generator,I-TR
.,O

6.,O
Status,O
post,O
abdominal,B-TR
repair,I-TR
of,O
wound,B-PR
dehiscence,I-PR
of,I-PR
jejunostomy,I-PR
site,I-PR
.,O

7.,O
Status,O
post,O
percutaneous,B-TR
tracheostomy,I-TR
.,O

8.,O
Status,O
post,O
acute,B-PR
renal,I-PR
failure,I-PR
.,O

9.,O
Status,O
post,O
myocardial,B-PR
infarction,I-PR
.,O

10.,O
Hypertension,B-PR
.,O

11.,O
Hypercholesterolemia,B-PR
.,O

12.,O
Asthma,B-PR
.,O

13.,O
Peptic,B-PR
ulcer,I-PR
disease,I-PR
status,O
post,O
gastrectomy,B-TR
30,O
years,O
ago,O
.,O

14.,O
Colon,B-PR
cancer,I-PR
status,O
post,O
colectomy,B-TR
with,O
XRT,B-TR
four,O
years,O
ago,O
.,O

15.,O
Peripheral,B-PR
vascular,I-PR
disease,I-PR
with,O
history,O
of,O
bilateral,B-PR
lower,I-PR
extremity,I-PR
claudication,I-PR
.,O

16.,O
COPD,B-PR
with,O
asbestosis,B-PR
on,O
chest,B-TE
CT,I-TE
scan,I-TE
.,O

The,O
patient,O
is,O
discharged,O
on,O
Thursday,O
",",O
12-31,O
",",O
to,O
a,O
rehabilitation,O
facility,O
",",O
on,O
postoperative,O
day,O
93,O
",",O
in,O
stable,O
condition,O
",",O
from,O
the,O
cardiac,O
surgery,O
recovery,O
unit,O
.,O

Perry,O
G.,O
Ozuna,O
",",O
M.D.,O

83-390,O

Dictated,O
By,O
:,O
Keith,O
E.,O
Shafer,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2015-12-31,O
11:12,O

T,O
:,O
2015-12-31,O
11:19,O

JOB,O
#:,O

4648,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Kelsey,O
MOORMAN,O
on,O
:,O
FRI,O
2016-01-08,O
9:29,O
PM,O

(,O
End,O
of,O
Report,O
),O

649953363_c,O

FIH,O

8723483,O

824333,O

5999,O

5/12/2000,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Report,O
Status,O
:,O

Signed,O

DISCHARGE,O
SUMMARY,O
NAME,O
:,O

UPH,O
",",O
JIM,O

UNIT,O
NUMBER,O
:,O

089-44-01,O

ADMISSION,O
DATE,O
:,O

05/12/2000,O

DISCHARGE,O
DATE,O
:,O

05/20/2000,O

REASON,O
FOR,O
ADMISSION,O
:,O

Small,B-PR
cell,I-PR
lung,I-PR
cancer,I-PR
.,O

Chemotherapy,B-TR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Provided,O
in,O
the,O
house,O
staff,O
note,O
from,O
the,O
admission,O
date,O
.,O

Briefly,O
this,O
is,O
a,O
Hispanic,O
patient,O
with,O
history,O
of,O
advanced,B-PR
lung,I-PR
cancer,I-PR
",",O
small,O
cell,O
in,O
histology,O
.,O

The,O
patient,O
presented,O
with,O
almost,B-PR
a,I-PR
stridor,I-PR
and,O
a,B-PR
large,I-PR
mediastinal,I-PR
mass,I-PR
with,O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

He,O
was,O
transferred,O
to,O
the,O
Oncology,O
Service,O
after,O
discussions,O
about,O
the,O
utility,O
of,O
chemotherapy,B-TR
.,O

HOSPITAL,O
COURSE,O
:,O

In,O
the,O
Oncology,O
Floor,O
he,O
received,O
Carboplatin,B-TR
and,O
Etoposide,B-TR
to,O
which,O
he,O
reacted,O
well,O
.,O

There,O
were,O
no,O
major,O
issues,O
and,O
he,O
was,O
discharged,O
home,O
on,O
5/20/00,O
.,O

________________________,O

MAREN,O
TLANDFLENT,O
",",O
M.D.,O

Electronically,O
Signed,O

MAREN,O
STEA,O
TLANDFLENT,O
",",O
M.D.,O

07/15/2000,O
21:36,O

TR,O
:,O

se,O

DD,O
:,O

07/06/2000,O

TD,O
:,O

07/11/2000,O
12:44,O
P,O

cc,O
:,O

MAREN,O
STEA,O
TLANDFLENT,O
",",O
M.D.,O

Admission,O
Date,O
:,O

2011-06-10,O

Discharge,O
Date,O
:,O

2011-06-13,O

Date,O
of,O
Birth,O
:,O

1976-04-17,O

Sex,O
:,O

M,O

Service,O
:,O

CMED,O
CSRU,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
35-year-old,O
gentleman,O
with,O
HIV,B-PR
on,O
HAART,B-TR
with,O
last,B-TE
CD4,I-TE
count,I-TE
of,O
268,O
and,O
undetectable,O
viral,B-TE
load,I-TE
who,O
was,O
referred,O
to,O
the,O
emergency,O
room,O
via,O
his,O
PCP,O
for,O
progressive,B-PR
throat,I-PR
pain,I-PR
and,O
edema,B-PR
.,O

His,B-PR
throat,I-PR
pain,I-PR
began,O
2,O
to,O
3,O
days,O
prior,O
to,O
admission,O
",",O
initially,O
treated,O
with,O
ibuprofen,B-TR
",",O
seen,O
in,O
an,O
outside,O
hospital,O
emergency,O
room,O
day,O
prior,O
to,O
admission,O
where,O
he,O
received,O
IV,B-TR
penicillin,I-TR
and,O
was,O
sent,O
home,O
.,O

In,O
clinic,O
today,O
",",O
the,O
patient,O
desaturated,O
to,O
low,O
90,O
s,O
with,O
ambulation,O
and,O
also,O
had,O
complaints,O
of,O
progressive,B-PR
swelling,I-PR
"",O
like,O
my,O
throat,O
is,O
going,O
to,O
close,O
up,O
"",O
with,O
increasing,B-PR
drooling,I-PR
",",O
unable,O
to,O
swallow,O
the,B-TR
HIV,I-TR
medications,I-TR
.,O

Also,O
noted,O
to,O
have,O
low-grade,B-PR
temperature,I-PR
of,O
99,O
to,O
100,O
degrees,O
with,O
productive,B-PR
cough,I-PR
and,O
yellow,B-PR
sputum,I-PR
times,O
1,O
day,O
with,O

right,B-PR
ear,I-PR
pain,I-PR
.,O

No,O
subjective,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
.,O

The,O
patient,O
describes,O
whole,B-PR
body,I-PR
numbness,I-PR
.,O

He,O
currently,O
notes,O
improvement,O
in,O
his,B-PR
throat,I-PR
pain,I-PR
after,O
some,B-TR
Decadron,I-TR
and,O
clindamycin,B-TR
.,O

He,O
was,O
seen,O
by,O
CMED,O
CSRU,O
in,O
the,O
emergency,O
room,O
and,O
the,B-TE
exam,I-TE
was,O
consistent,O
with,O
supraglottitis,B-PR
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

Review,B-TE
of,I-TE
systems,I-TE
was,O
negative,O
for,O
history,O
of,O
opportunistic,B-PR
infections,I-PR
or,O
prior,O
hospitalizations,O
.,O

Of,O
note,O
",",O
his,B-TE
CD4,I-TE
count,I-TE
was,O
less,O
than,O
200,O
last,O
winter,O
.,O

He,O
believes,O
he,O
is,O
up-to-date,O
on,O
all,O
his,B-TR
vaccines,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

HIV,B-PR
times,O
13,O
years,O
.,O

Last,B-TE
CD4,I-TE
count,I-TE
of,O
268,O
",",O
viral,B-TE
load,I-TE
undetectable,O
",",O
followed,O
at,O
the,O
Boston,O
Regional,O
Medical,O
Centerr,O
Clinic,O
by,O
Dr.,O
Taylor,O
.,O

History,O
of,O
anal,B-PR
warts,I-PR
and,O
rectal,B-PR
abscesses,I-PR
and,O
fistula,B-PR
.,O

FAMILY,O
HISTORY,O
:,O

Positive,O
for,O
diabetes,B-PR
.,O

Negative,O
for,O
CAD,B-PR
.,O

Mother,O
with,O
throat,B-PR
cancer,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

Works,O
in,O
a,O
restaurant,O
.,O

Lives,O
with,O
his,O
partner,O
.,O

Negative,O
Barbara,O
.,O

Positive,O
occasional,O
alcohol,O
use,O
",",O
occasional,O
pot,O
and,O
crystal,O
meth,O
",",O
but,O
negative,O
IV,O
drug,O
use,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

1.,O
Atazanavir,B-TR
300,O
mg,O
q.d.,O

2.,O
Ritonavir,B-TR
100,O
mg,O
q.d.,O

3.,O
Tenofovir,B-TR
300,O
mg,O
q.d.,O

4.,O
Didanosine,B-TR
250,O
mg,O
q.d.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Vital,B-TE
Signs,I-TE
:,O

Temperature,B-TE
100.1,O
degrees,O
",",O
blood,B-TE
pressure,I-TE
134/79,O
",",O
pulse,B-TE
100,O
",",O
respiratory,B-TE
rate,I-TE
17,O
",",O
and,O
saturations,B-TE
95,O
percent,O
on,O
room,O
air,O
.,O

General,O
:,O

He,O
is,O
awake,O
",",O
alert,O
",",O
and,O
oriented,O
times,O
3,O
and,O
pleasant,O
.,O

HEENT,O
:,O
Positive,O
hoarse,B-PR
whisper,I-PR
.,O

Positive,O
drooling,B-PR
.,O

Negative,O
trismus,B-PR
or,O
stridor,B-PR
.,O

Bilateral,B-PR
tonsillar,I-PR
hypertrophy,I-PR
.,O

No,O
white,B-PR
exudate,I-PR
.,O

Right,O
external,O
auditory,O
canal,O
was,O
occluded,B-PR
bycerumen,I-PR
and,O
left,O
external,O
auditory,O
canal,O
clear,O
with,O
tympanic,O
membrane,O
intact,O
.,O

Positive,O
anterior,B-PR
cervical,I-PR
lymphadenopathy,I-PR
.,O

Cardiovascular,O
:,O

Regular,O
and,O
tachycardic,B-PR
.,O

Normal,O
S1,O
and,O
S2,O
.,O

Lungs,O
:,O

Bilateral,B-PR
coarse,I-PR
breath,I-PR
sounds,I-PR
.,O

Negative,O
rhonchi,B-PR
",",O
rales,B-PR
",",O
or,O
wheezes,B-PR
.,O

Abdomen,O
:,O

Soft,O
and,O
nontender,B-PR
.,O

Extremities,O
:,O

Warm,O
",",O
well,O
perfused,O
.,O

No,O
edema,B-PR
.,O

Neuro,O
Exam,O
:,O

Cranial,O
nerves,O
II,O
through,O
XII,O
are,O
intact,O
.,O

Muscles,O
are,O
05-04,O
in,O
all,O
extremities,O
with,O
good,O
sensation,O
to,O
light,O
touch,O
.,O

LABORATORY,O
DATA,O
ON,O
ADMISSION,O
:,O

White,B-TE
count,I-TE
18.3,O
",",O
neutrophils,B-TE
89,O
percent,O
",",O
hematocrit,B-TE
41,O
",",O
platelets,B-TE
261,O
",",O
INR,B-TE
1.2,O
",",O
and,O
chem-7,B-TE
otherwise,O
normal,O
.,O

Chest,B-TE
x-ray,I-TE
was,O
negative,O
for,O
effusions,B-PR
",",O
pneumonia,B-PR
",",O
or,O
pneumothorax,B-PR
.,O

Neck,O
with,O
soft,B-PR
tissue,I-PR
prominence,I-PR
of,I-PR
the,I-PR
epiglottitis,I-PR
and,I-PR
uvula,I-PR
consistent,O
with,O
epiglottitis,B-PR
.,O

Fiberoptic,B-TE
scope,I-TE
showed,O
swelling,B-PR
of,I-PR
the,I-PR
right,I-PR
epiglottitis,I-PR
extending,O
down,O
to,O
the,O
right,O
aryepiglottic,O
fold,O
obscuring,O
view,O
of,O
the,O
right,O
vocal,O
cord,O
.,O

Left,O
vocal,O
cord,O
with,O
glottic,O
airway,O
visible,O
but,O
narrow,B-PR
.,O

Positive,O
edema,B-PR
of,I-PR
the,I-PR
left,I-PR
supraglottitis,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

This,O
is,O
a,O
35-year-old,O
gentleman,O
with,O
HIV,B-PR
on,O
HAART,B-TR
",",O
last,B-TE
CD4,I-TE
count,I-TE
268,O
with,O
undetectable,O
viral,B-TE
load,I-TE
who,O
was,O
initially,O
admitted,O
to,O
the,O
CMED,O
CSRU,O
for,O
supraglottitis,B-PR
with,O
significant,B-PR
edema,I-PR
.,O

PROBLEM,O
LIST,O
:,O

1.,O
Epiglottitis,B-PR
/,O
supraglottitis,B-PR
.,O

The,O
patient,O
was,O
observed,O
in,O
the,O
CMED,O
CSRU,O
for,O
48,O
hours,O
and,O
noted,O
to,O
have,O
decrease,O
in,O
swelling,B-PR
on,O
serial,B-TE
exams,I-TE
.,O

He,O
was,O
followed,O
by,O
the,O
CMED,O
CSRU,O
Service,O
and,O
was,O
started,O
on,O
IV,B-TR
Decadron,I-TR
initially,O
in,O
addition,O
to,O
IV,B-TR
Unasyn,I-TR
",",O
which,O
he,O
tolerated,O
well,O
.,O

His,B-PR
edema,I-PR
was,O
improving,O
and,O
was,O
starting,O
to,O
tolerate,O
p.o.,O

His,O
airway,O
and,O
symptoms,B-PR
continued,O
to,O
improve,O
and,O
remained,O
stable,O
.,O

The,O
patient,O
was,O
stable,O
for,O
transfer,O
to,O
the,O
floor,O
",",O
was,O
treated,O
with,O
over,O
72,O
hours,O
of,O
IV,B-TR
Unasyn,I-TR
",",O
and,O
then,O
transitioned,O
to,O
oral,O
regimen,O
of,O
Augmentin,B-TR
to,O
be,O
continued,O
as,O
an,O
outpatient,O
.,O

Eventually,O
",",O
his,B-TR
IV,I-TR
steroids,I-TR
were,O
transitioned,O
to,O
a,B-TR
p.o.,I-TR
steroid,I-TR
taper,I-TR
",",O
which,O
he,O
tolerated,O
well,O
",",O
and,O
was,O
discharged,O
on,O
a,B-TR
steroid,I-TR
taper,I-TR
also,O
with,O
CMED,O
CSRU,O
follow-up,O
as,O
an,O
outpatient,O
.,O

His,O
oxygenation,O
and,O
symptoms,B-PR
remained,O
stable,O
and,O
again,O
tolerated,O
p.o.,O
without,O
difficulty,O
.,O

Eventually,O
",",O
as,O
the,O
patient,O
remained,O
hemodynamically,O
stable,O
",",O
his,O
airway,O
remained,O
stable,O
",",O
and,O
he,O
was,O
tolerating,O
PO,O
"s,",O
he,O
was,O
transitioned,O
to,O
the,O
floor,O
where,O
he,O
remained,O
otherwise,O
stable,O
and,O
asymptomatic,B-PR
.,O

His,O
voice,O
improved,O
during,O
the,O
course,O
of,O
his,O
stay,O
and,O
was,O
talking,O
clearly,O
by,O
the,O
time,O
of,O
discharge,O
.,O

He,O
remained,O
afebrile,B-PR
during,O
the,O
course,O
of,O
his,O
stay,O
after,O
transfer,O
to,O
the,O
floor,O
and,O
per,O
CMED,O
CSRU,O
was,O
to,O
be,O
discharged,O
on,O
a,O
2-week,O
course,O
of,O
Augmentin,B-TR
with,O
follow-up,O
with,O
Dr.,O
Thibodeau,O
in,O
2,O
weeks,O
',O
time,O
in,O
addition,O
to,O
a,B-TR
Medrol,I-TR
Dosepak,I-TR
.,O

1.,O
HIV,B-PR
.,O

Once,O
",",O
the,O
patient,O
was,O
tolerating,O
p.o.,O
",",O
the,O
patient,O
was,O
restarted,O
on,O
his,B-TR
HAART,I-TR
regimen,I-TR
and,O
remained,O
stable,O
from,O
that,O
perspective,O
.,O

DISCHARGE,O
CONDITION,O
:,O

Good,O
.,O

The,O
patient,O
ambulating,O
without,O
difficulty,O
",",O
tolerating,O
p.o.,O
",",O
stable,O
oxygen,O
saturation,O
",",O
and,O
stable,O
voice,O
by,O
the,O
time,O
of,O
discharge,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

Epiglottitis,B-PR
/,O
supraglottitis,B-PR
.,O

HIV,B-PR
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Menthol,B-TR
-,I-TR
Cetylpyridinium,I-TR
lozenges,I-TR
1,O
as,O
needed,O
.,O

2.,O
Tenofovir,B-TR
300,O
mg,O
p.o.,O
q.d.,O

3.,O
Didanosine,B-TR
250,O
mg,O
p.o.,O
q.d.,O

4.,O
Atazanavir,B-TR
300,O
mg,O
p.o.,O
q.d.,O

5.,O
Ritonavir,B-TR
100,O
mg,O
p.o.,O
q.d.,O

6.,O
Calcium,B-TR
carbonate,I-TR
500,O
mg,O
p.o.,O
q.d.,O

7.,O
Methylprednisolone,B-TR
4,O
mg,O
tablets,O
per,O
taper,O
regimen,O
.,O

The,O
patient,O
was,O
to,O
take,O
one,O
4,O
mg,O
tablet,O
dinner,O
and,O
at,O
bedtime,O
the,O
day,O
of,O
discharge,O
",",O
then,O
the,O
next,O
day,O
take,O
one,O
4,O
mg,O
tablet,O
in,O
the,O
morning,O
",",O
lunch,O
time,O
",",O
and,O
with,O
dinner,O
and,O
then,O
at,O
bedtime,O
",",O
then,O
the,O
third,O
day,O
to,O
take,O
4,O
mg,O
tablet,O
in,O
the,O
morning,O
",",O
lunch,O
",",O
and,O
bedtime,O
",",O
the,O
fourth,O
day,O
to,O
take,O
one,O
tablet,O
in,O
the,O
morning,O
and,O
dinner,O
",",O
and,O
in,O
the,O
last,O
day,O
take,O
one,O
4,O
mg,O
tablet,O
in,O
the,O
morning,O
.,O

He,O
was,O
also,O
discharged,O
on,O
Augmentin,B-TR
XR,I-TR
1000,O
mg,O
/,O
62.5,O
mg,O
sustained,O
release,O
1,O
tablet,O
q.,O
12h,O
.,O
for,O
2,O
weeks,O
.,O

FOLLOW-UP,O
:,O

The,O
patient,O
was,O
to,O
follow,O
up,O
with,O
his,O
PCP,O
A.,O
L.,O
.,O
Taylor,O
in,O
7,O
to,O
10,O
days,O
",",O
and,O
the,O
patient,O
was,O
to,O
call,O
Dr.,O
Thibodeau,O
",",O
CMED,O
CSRU,O
doctor,O
to,O
follow,O
up,O
in,O
2,O
weeks,O
',O
time,O
.,O

Teddy,O
Stephen,O
",",O
Louisiana,O
32870,O

Dictated,O
By,O
:,O
Judy,O
J,O
Johnston,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2011-07-12,O
15:55:31,O

T,O
:,O
2011-07-13,O
11:14:52,O

Job,O
#:,O

79962,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Ruth,O
Gibson,O
on,O
:,O
MON,O
2011-07-18,O
7:48,O
AM,O

(,O
End,O
of,O
Report,O
),O

649953363_e,O

FIH,O

8723483,O

249112,O

912397,O

12/19/2000,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O
/,O
SUMMARY,O

UPH,O
",",O
JIM,O

MRN,O
:,O

8723483,O

Age,O
:,O

57y,O

REGISTRATION,O
DATE,O
:,O

12/19/2000,O
02:48,O
PM,O

Provider,O
:,O

Asha,O
Vengloan,O

PRELIMINARY,O
REPORT,O

Benefits,O
Assigned,O
:,O

Y,O

Discharge,O
Date,O
/,O
Time,O
:,O

12/19/00,O
6:13:06,O
PM,O

Discharge,O
Status,O
:,O

Discharged,O

Patient,O
States,O
Complaint,O
:,O

SOB,B-PR

Diagnosis,O
:,O

COPD,B-PR
exacerbation,I-PR
(,I-PR
emphysema,I-PR
),I-PR

Treatment,O
Rendered,O
:,O

Prednisone,B-TR
",",O
nebulizers,B-TR
.,O

Chest,B-TE
x-ray,I-TE
shows,O
question,O
of,O
a,B-PR
pulmonary,I-PR
nodule,I-PR
in,I-PR
the,I-PR
right,I-PR
lower,I-PR
lobe,I-PR
which,O
may,O
be,O
cancer,B-PR
.,O

Discharge,O
Medications,O
:,O

Prednisone,B-TR
60,O
mg,O
daily,O
for,O
4,O
days,O
.,O

Continue,O
inhalers,B-TR
as,O
prescribed,O
.,O

Disposition,O
",",O
Follow,O
up,O
and,O
Instructions,O
to,O
Patient,O
:,O

Call,O
Dr.,O
Linketerf,O
tomorrow,O
and,O
make,O
an,O
appointment,O
for,O
follow-up,O
on,O
the,B-PR
lung,I-PR
nodule,I-PR
.,O

THIS,O
IS,O
VERY,O
IMPORTANT,O
.,O

This,O
report,O
was,O
created,O
by,O
Vengloan,O
",",O
Asha,O
12/19/2000,O
06:15,O
PM,O

Admission,O
Date,O
:,O

2014-12-03,O

Discharge,O
Date,O
:,O

2014-12-18,O

Date,O
of,O
Birth,O
:,O

1962-09-23,O

Sex,O
:,O

F,O

Service,O
:,O

Medicine,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
52,O
-,O
year-old,O
female,O
with,O
no,O
known,B-PR
cardiopulmonary,I-PR
history,I-PR
who,O
presented,O
with,O
a,O
chief,O
complaint,O
of,O
dyspnea,B-PR
on,O
exertion,O
as,O
well,O
as,O
exertional,B-PR
chest,I-PR
tightness,I-PR
which,O
was,O
acute-on-chronic,O
.,O

The,O
patient,O
stated,O
her,B-PR
symptoms,I-PR
began,O
in,O
2011,O
and,O
have,O
increased,O
in,O
intensity,O
and,O
frequency,O
every,O
since,O
then,O
.,O

She,O
reports,O
dyspnea,B-PR
on,O
exertion,O
and,O
chest,B-PR
tightness,I-PR
daily,O
which,O
worsened,O
significantly,O
one,O
day,O
prior,O
to,O
admission,O
.,O

Says,O
that,O
she,O
could,O
not,O
walk,O
a,O
few,O
yards,O
without,O
developing,O
symptoms,B-PR
.,O

She,O
describes,O
the,B-PR
chest,I-PR
tightness,I-PR
as,O
substernal,O
and,O
epigastric,O
.,O

She,O
denied,O
any,B-PR
associated,I-PR
nausea,I-PR
",",O
vomiting,B-PR
",",O
diaphoresis,B-PR
",",O
lightheadedness,B-PR
",",O
or,O
dizziness,B-PR
.,O

She,O
does,O
have,O
radiation,B-PR
of,I-PR
the,I-PR
pain,I-PR
to,O
her,O
neck,O
and,O
jaw,O
bilaterally,O
.,O

She,O
also,O
describes,O
a,B-PR
fast,I-PR
heart,I-PR
rate,I-PR
and,O
palpitations,B-PR
.,O

She,O
stated,O
her,B-PR
symptoms,I-PR
improved,O
with,O
rest,O
",",O
and,O
she,O
denied,O
any,B-PR
symptoms,I-PR
beginning,O
when,O
she,O
was,O
at,O
rest,O
.,O

The,O
patient,O
reports,O
a,B-TE
previous,I-TE
workup,I-TE
which,O
included,O
a,O
negative,O
exercise,O
treadmill,O
test,O
",",O
a,O
normal,O
MIBI,O
in,O
2011-04-10,O
",",O
and,O
a,O
normal,O
echocardiogram,O
in,O
2012,O
(,O
except,O
some,B-PR
borderline,I-PR
mild,I-PR
pulmonary,I-PR
hypertension,I-PR
),O
with,O
an,B-TE
ejection,I-TE
fraction,I-TE
of,O
55%,O
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

Review,B-TE
of,I-TE
systems,I-TE
was,O
significant,O
for,O
menopausal,B-PR
symptoms,I-PR
(,O
for,O
which,O
she,O
has,O
attempted,O
hormone,B-TR
replacement,I-TR
therapy,I-TR
",",O
discontinued,O
in,O
2014,O
).,O

She,O
also,O
reports,O
difficulty,B-PR
sleeping,I-PR
",",O
daytime,B-PR
sleepiness,I-PR
.,O

She,O
sleeps,O
on,O
elevated,B-TR
pillows,I-TR
secondary,O
to,O
her,B-PR
gastroesophageal,I-PR
reflux,I-PR
disease,I-PR
.,O

Occasional,B-PR
paroxysmal,I-PR
nocturnal,I-PR
dyspnea,I-PR
in,O
the,O
past,O
but,O
none,O
recently,O
.,O

Occasional,B-PR
lower,I-PR
extremity,I-PR
edema,I-PR
",",O
left,O
greater,O
than,O
right,O
.,O

No,O
abdominal,B-PR
or,I-PR
urinary,I-PR
complaints,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Gastroesophageal,B-PR
reflux,I-PR
disease,I-PR
.,O

2.,O
Grave's,B-PR
",",O
status,O
post,O
radiation,B-TR
resulting,O
in,O
hypothyroidism,B-PR
.,O

3.,O
Migraines,B-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Synthroid,B-TR
",",O
Prilosec,B-TR
20,O
mg,O
p.o.,O
",",O
Fioricet,B-TR
",",O
Celebrex,B-TR
.,O

ALLERGIES,O
:,O

PENICILLIN,B-TR
causes,O
a,B-PR
rash,I-PR
.,O

FAMILY,O
HISTORY,O
:,O

Diabetes,B-PR
",",O
Grave's,B-PR
disease,I-PR
",",O
but,O
no,O
history,O
of,O
cardiopulmonary,B-PR
disease,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
lives,O
with,O
her,O
husband,O
",",O
and,O
they,O
have,O
no,O
children,O
.,O

She,O
denies,O
any,O
tobacco,O
or,O
alcohol,O
history,O
.,O

She,O
does,O
use,O
herbal,B-TR
remedies,I-TR
including,O
Primrose,B-TR
oil,I-TR
",",O
Siberian,B-TR
ginseng,I-TR
",",O
and,O
has,O
a,O
history,O
of,O
use,O
of,O
wallerian,B-TR
root,I-TR
.,O

PHYSICAL,O
EXAMINATION,O
ON,O
PRESENTATION,O
:,O

Vital,B-TE
signs,I-TE
were,O
temperature,B-TE
of,O
98.4,O
",",O
heart,B-TE
rate,I-TE
74,O
",",O
blood,B-TE
pressure,I-TE
130/91,O
",",O
respiratory,B-TE
rate,I-TE
21,O
",",O
satting,O
98%,O
on,O
room,O
air,O
.,O

HEENT,O
revealed,O
pupils,O
were,O
equally,O
round,O
and,O
reactive,O
to,O
light,O
.,O

The,O
oropharynx,O
was,O
clear,O
.,O

Neck,O
was,O
supple,O
",",O
no,O
lymphadenopathy,B-PR
",",O
no,O
thyromegaly,B-PR
",",O
no,O
jugular,B-PR
venous,I-PR
distention,I-PR
",",O
and,O
no,O
bruits,B-PR
.,O

Lungs,O
had,O
scant,B-PR
crackles,I-PR
at,I-PR
the,I-PR
left,I-PR
base,I-PR
and,I-PR
middle,I-PR
field,I-PR
;,O
otherwise,O
clear,O
.,O

Cardiovascular,O
had,O
a,O
regular,O
rate,O
and,O
rhythm,O
.,O

No,O
murmurs,B-PR
.,O

No,O
fourth,O
heart,O
sound,O
or,O
third,O
heart,O
sound,O
.,O

No,O
parasternal,B-PR
heave,I-PR
.,O

Gastrointestinal,O
revealed,O
soft,O
",",O
nontender,B-PR
",",O
and,O
nondistended,B-PR
.,O

No,O
hepatosplenomegaly,B-PR
.,O

No,O
masses,B-PR
.,O

No,O
bruits,B-PR
.,O

Normal,O
active,O
bowel,O
sounds,O
.,O

Extremities,O
had,O
no,O
edema,B-PR
",",O
2+,B-TE
distal,I-TE
pedis,I-TE
.,O

Neurologically,O
",",O
grossly,O
nonfocal,O
.,O

LABORATORY,O
DATA,O
ON,O
PRESENTATION,O
:,O

At,O
the,O
time,O
of,O
admission,O
",",O
white,B-TE
blood,I-TE
cell,I-TE
count,I-TE
11.1,O
",",O
hematocrit,B-TE
37.7,O
",",O
platelets,B-TE
326,O
.,O

Sodium,B-TE
140,O
",",O
potassium,B-TE
4,O
",",O
chloride,B-TE
105,O
",",O
bicarbonate,B-TE
28,O
",",O
BUN,B-TE
17,O
",",O
creatinine,B-TE
0.8,O
",",O
glucose,B-TE
76,O
.,O

Creatine,B-TE
kinase,I-TE
100,O
",",O
MB,B-TE
4,O
",",O
troponin,B-TE
of,O
less,O
than,O
0.3,O
.,O

RADIOLOGY,O
/,O
IMAGING,O
:,O

Electrocardiogram,B-TE
revealed,O
left,B-PR
atrial,I-PR
hypertrophy,I-PR
",",O
right,B-PR
ventricular,I-PR
hypertrophy,I-PR
",",O
and,O
poor,B-PR
R,I-PR
wave,I-PR
progression,I-PR
which,O
were,O
new,O
.,O

Also,O
",",O
T,B-PR
wave,I-PR
inversions,I-PR
in,I-PR
II,I-PR
",",I-PR
III,I-PR
",",I-PR
aVF,I-PR
",",I-PR
V1,I-PR
through,I-PR
V5,I-PR
;,O
new,B-PR
evolving,I-PR
right,I-PR
bundle-branch,I-PR
block,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
is,O
a,O
52,O
-,O
year-old,O
female,O
with,O
no,O
known,O
history,O
of,O
cardiac,B-PR
disease,I-PR
presenting,O
with,O
dyspnea,B-PR
on,O
exertion,O
and,O
chest,B-PR
tightness,I-PR
",",O
who,O
was,O
admitted,O
for,O
evaluation,B-TE
and,O
management,B-TR
of,O
her,B-PR
symptoms,I-PR
.,O

1.,O
CARDIOVASCULAR,O
:,O

The,O
patient,O
was,O
admitted,O
for,O
complaints,O
of,O
dyspnea,B-PR
on,O
exertion,O
and,O
chest,B-PR
pressure,I-PR
which,O
could,O
be,O
consistent,O
with,O
angina,B-PR
.,O

However,O
",",O
given,O
the,O
long,O
duration,O
of,O
the,B-PR
symptoms,I-PR
and,O
negative,O
workup,O
in,O
the,O
past,O
",",O
it,O
was,O
thought,O
to,O
be,O
unlikely,O
.,O

However,O
",",O
the,O
patient,O
was,O
started,O
on,O
an,B-TR
aspirin,I-TR
as,O
well,O
as,O
a,B-TR
beta,I-TR
blocker,I-TR
",",O
and,O
a,B-TE
rule,I-TE
out,I-TE
myocardial,I-TE
infarction,I-TE
protocol,I-TE
was,O
initiated,O
.,O

A,B-TE
stress,I-TE
thallium,I-TE
was,O
planned,O
for,O
the,O
day,O
following,O
admission,O
.,O

However,O
",",O
on,O
the,O
night,O
of,O
admission,O
the,O
patient,O
was,O
found,O
lying,O
in,O
her,O
bed,O
diaphoretic,B-PR
and,O
obtunded,B-PR
",",O
and,O
a,O
code,O
was,O
called,O
.,O

Further,B-TE
examination,I-TE
revealed,O
a,O
strong,O
palpable,O
pulse,O
with,O
a,B-TE
systolic,I-TE
blood,I-TE
pressure,I-TE
in,O
the,O
130,O
s,O
and,O
a,B-TE
heart,I-TE
rate,I-TE
in,O
the,O
80,O
s.,O

Over,O
the,O
course,O
of,O
the,O
next,O
few,O
minutes,O
the,O
patient,O
became,O
increasingly,O
more,O
responsive,O
.,O

She,O
was,O
treated,O
with,O
a,B-TR
fluid,I-TR
bolus,I-TR
.,O

The,O
patient,O
quickly,O
responded,O
to,O
a,B-TR
fluid,I-TR
bolus,I-TR
and,O
became,O
interactive,O
.,O

She,O
reported,O
that,O
she,O
was,O
sitting,O
on,O
the,O
commode,O
urinating,O
and,O
began,O
to,O
feel,O
nauseous,B-PR
and,O
presyncopal,B-PR
.,O

She,O
was,O
able,O
to,O
get,O
to,O
bed,O
at,O
which,O
point,O
she,O
passed,O
out,O
.,O

She,O
denied,O
any,B-PR
chest,I-PR
pain,I-PR
or,O
pressure,B-PR
",",O
and,O
no,O
shortness,B-PR
of,I-PR
breath,I-PR
during,O
this,O
event,O
.,O

A,B-TE
rhythm,I-TE
check,I-TE
obtained,O
during,O
the,O
time,O
of,O
this,O
event,O
demonstrated,O
a,B-PR
pause,I-PR
of,I-PR
six,I-PR
seconds,I-PR
followed,O
by,O
a,B-PR
junctional,I-PR
escape,I-PR
rhythm,I-PR
.,O

An,B-TE
electrocardiogram,I-TE
obtained,O
after,O
the,O
code,O
demonstrated,O
no,O
acute,B-PR
changes,I-PR
.,O

Her,B-PR
acute,I-PR
bradycardic,I-PR
event,I-PR
was,O
felt,O
likely,O
secondary,O
to,O
her,B-TR
new,I-TR
beta,I-TR
blocker,I-TR
in,O
conjunction,O
with,O
a,B-PR
vagal,I-PR
response,I-PR
.,O

It,O
was,O
determined,O
to,O
stop,O
the,B-TR
beta,I-TR
blocker,I-TR
",",O
and,O
atropine,B-TR
was,O
placed,O
at,O
the,O
bedside,O
.,O

On,O
the,O
following,O
day,O
the,O
patient,O
underwent,O
an,B-TE
echocardiogram,I-TE
which,O
demonstrated,O
dilated,B-PR
right,I-PR
ventricle,I-PR
secondary,O
to,O
chronic,B-PR
dysfunction,I-PR
and,O
a,B-TE
pulmonary,I-TE
artery,I-TE
pressure,I-TE
of,O
greater,O
than,O
100,O
.,O

Her,B-TE
stress,I-TE
test,I-TE
was,O
cancelled,O
.,O

A,B-TE
CT,I-TE
angiogram,I-TE
was,O
ordered,O
to,O
evaluate,O
for,O
chronic,B-PR
thromboembolic,I-PR
disease,I-PR
as,O
a,O
potential,O
cause,O
of,O
her,B-PR
pulmonary,I-PR
hypertension,I-PR
.,O

She,O
was,O
ruled,O
out,O
for,O
myocardial,B-PR
infarction,I-PR
with,O
three,O
sets,O
of,O
normal,O
enzymes,O
and,O
continued,O
to,O
be,O
monitored,O
on,O
telemetry,B-TE
.,O

A,O
Pulmonary,O
consultation,O
was,O
obtained,O
to,O
evaluate,O
for,O
possible,O
etiology,O
of,O
the,B-PR
patient,I-PR
's,I-PR
hypotension,I-PR
.,O

There,O
was,O
little,O
evidence,O
to,O
suggest,O
any,B-PR
cardiac,I-PR
disease,I-PR
",",O
and,O
given,O
the,B-PR
patient,I-PR
's,I-PR
Grave's,I-PR
disease,I-PR
an,B-PR
autoimmune,I-PR
process,I-PR
was,O
felt,O
to,O
be,O
possible,O
.,O

In,O
addition,O
",",O
consideration,O
was,O
given,O
to,O
sarcoidosis,B-PR
",",O
human,B-PR
immunodeficiency,I-PR
virus,I-PR
",",O
and,O
drug-induced,O
given,O
her,O
history,O
of,O
herbal,B-TR
medication,I-TR
use,O
.,O

It,O
was,O
recommended,O
that,O
the,O
patient,O
begin,O
anticoagulation,B-TR
given,O
the,O
severity,O
of,O
her,B-PR
pulmonary,I-PR
hypertension,I-PR
.,O

It,O
was,O
also,O
planned,O
to,O
undergo,O
a,B-TE
right,I-TE
heart,I-TE
catheterization,I-TE
with,O
a,B-TE
vasodilation,I-TE
trial,I-TE
by,O
the,O
catheterization,O
laboratory,O
.,O

A,B-TE
right,I-TE
heart,I-TE
catheterization,I-TE
was,O
performed,O
on,O
2014-12-05,O
.,O

A,B-TE
pharmacologic,I-TE
pulmonary,I-TE
vasodilator,I-TE
challenge,I-TE
was,O
performed,O
with,O
a,O
positive,O
response,O
.,O

In,O
addition,O
",",O
a,B-TE
CT,I-TE
angiogram,I-TE
of,I-TE
the,I-TE
chest,I-TE
with,O
pulmonary,B-TE
embolism,I-TE
protocol,I-TE
showed,O
no,O
intravascular,B-PR
filling,I-PR
defect,I-PR
but,O
did,O
show,O
a,B-PR
right,I-PR
upper,I-PR
lobe,I-PR
ground-glass,I-PR
and,O
scattered,B-PR
adenopathy,I-PR
.,O

Therefore,O
",",O
in,O
the,O
end,O
left,B-PR
atrial,I-PR
hypertension,I-PR
was,O
essentially,O
ruled,O
out,O
as,O
a,O
primary,O
cause,O
.,O

Chronic,B-PR
pulmonary,I-PR
embolus,I-PR
was,O
less,O
likely,O
given,O
her,O
negative,O
CT,O
angiogram,O
.,O

Chronic,B-PR
lung,I-PR
disease,I-PR
was,O
unlikely,O
given,O
the,O
patient,O
's,O
normal,O
pulmonary,O
function,O
tests,O
and,O
DLCO,B-TE
in,O
2012,O
as,O
well,O
as,O
a,O
normal,O
CT,O
angiogram,O
.,O

Collagen,B-PR
vascular,I-PR
disease,I-PR
could,O
not,O
be,O
definitively,O
ruled,O
out,O
;,O
however,O
",",O
given,O
the,O
patient,O
's,O
lack,O
of,O
connective,B-PR
tissue,I-PR
disorder,I-PR
stigmata,I-PR
it,O
was,O
thought,O
to,O
be,O
less,O
likely,O
",",O
and,O
the,B-TE
patient,I-TE
's,I-TE
human,I-TE
immunodeficiency,I-TE
virus,I-TE
test,I-TE
was,O
negative,O
.,O

Therefore,O
",",O
it,O
was,O
felt,O
that,O
the,O
patient,O
was,O
most,O
likely,O
experiencing,O
a,B-PR
primary,I-PR
pulmonary,I-PR
hypertension,I-PR
.,O

Consideration,O
was,O
given,O
to,O
treating,O
the,O
patient,O
with,O
a,O
course,O
of,O
calcium,B-TR
channel,I-TR
blocker,I-TR
;,O
however,O
",",O
given,O
the,O
patient,O
's,O
poor,O
response,O
to,O
Lopressor,B-TR
",",O
it,O
was,O
determined,O
that,O
this,O
would,O
not,O
be,O
optimal,O
treatment,O
for,O
the,B-PR
patient,I-PR
's,I-PR
pulmonary,I-PR
hypertension,I-PR
.,O

Therefore,O
",",O
her,O
insurance,O
company,O
was,O
contacted,O
regarding,O
the,O
potential,O
of,O
Flolan,B-TR
as,O
a,O
treatment,O
.,O

Plans,O
were,O
made,O
for,O
placement,O
of,O
a,B-TR
Hickman,I-TR
catheter,I-TR
and,O
initiation,O
of,O
Flolan,B-TR
treatment,I-TR
.,O

However,O
",",O
on,O
12-07,O
",",O
the,O
patient,O
once,O
again,O
experienced,O
an,O
episode,O
of,O
unresponsiveness,B-PR
.,O

Upon,O
arrival,O
by,O
the,O
physician,O
the,O
patient,O
was,O
awake,O
",",O
alert,O
",",O
and,O
oriented,O
with,O
a,B-TE
pulse,I-TE
in,O
the,O
80,O
"s,",O
with,O
pressure,B-TE
in,O
the,O
80,O
"s,",O
and,O
satting,O
100%,O
on,O
room,O
air,O
.,O

She,O
described,O
this,O
episode,O
as,O
an,B-PR
uncomfortable,I-PR
feeling,I-PR
in,I-PR
her,I-PR
chest,I-PR
.,O

The,O
patient,O
was,O
treated,O
with,O
2,O
liters,O
of,O
intravenous,B-TR
fluids,I-TR
with,O
a,O
bump,O
in,O
her,B-TE
systolic,I-TE
blood,I-TE
pressure,I-TE
to,O
the,O
90,O
s.,O

Review,O
of,O
telemetry,B-TE
revealed,O
an,O
8,O
to,O
9,O
beat,O
episode,O
of,O
nonsustained,B-PR
ventricular,I-PR
tachycardia,I-PR
followed,O
by,O
an,O
episode,O
of,O
bradycardia,B-PR
to,O
60,O
beats,O
per,O
minute,O
.,O

The,O
etiology,O
of,O
these,B-PR
cardiovascular,I-PR
episodes,I-PR
was,O
unclear,O
",",O
but,O
was,O
felt,O
likely,O
secondary,O
to,O
the,B-PR
patient,I-PR
's,I-PR
tenuous,I-PR
cardiovascular,I-PR
status,I-PR
given,O
the,O
fact,O
that,O
she,O
had,O
clear,B-PR
pulmonary,I-PR
hypertension,I-PR
",",O
was,O
very,B-PR
preload,I-PR
dependent,I-PR
",",O
and,O
had,O
an,O
intact,O
left,O
ventricular,O
function,O
but,O
with,O
cardiac,B-PR
output,I-PR
limited,I-PR
due,O
to,O
left,B-PR
ventricular,I-PR
compression,I-PR
by,O
a,B-PR
dilated,I-PR
left,I-PR
ventricle,I-PR
.,O

Given,O
the,B-PR
patient,I-PR
's,I-PR
persistent,I-PR
hypotensive,I-PR
episodes,I-PR
",",O
and,O
decreased,B-PR
urine,I-PR
output,I-PR
",",O
she,O
was,O
transferred,O
back,O
to,O
the,O
Medical,O
Intensive,O
Care,O
Unit,O
for,O
management,O
prior,O
to,O
initiation,O
of,O
Flolan,B-TR
therapy,I-TR
.,O

On,O
12-08,O
",",O
the,B-TR
Hickman,I-TR
catheter,I-TR
was,O
placed,O
in,O
preparation,O
of,O
Flolan,B-TR
administration,O
.,O

During,O
the,O
Mass.,O
Mental,O
Health,O
Center,O
Medical,O
Intensive,O
Care,O
Unit,O
stay,O
",",O
the,O
patient,O
was,O
found,O
to,O
exquisitely,B-PR
preload,I-PR
dependent,I-PR
and,O
responded,O
well,O
to,O
aggressive,B-TR
fluids,I-TR
as,O
needed,O
to,O
maintain,O
her,B-TE
blood,I-TE
pressure,I-TE
with,O
a,B-TE
systolic,I-TE
of,O
greater,O
than,O
90,O
.,O

She,O
had,O
no,O
further,O
episodes,O
of,O
bradycardia,B-PR
during,O
her,O
Medical,O
Intensive,O
Care,O
Unit,O
stay,O
.,O

In,O
addition,O
",",O
the,B-TE
patient,I-TE
's,I-TE
urine,I-TE
output,I-TE
improved,O
dramatically,O
with,O
hydration,B-TR
therapy,I-TR
",",O
suggesting,O
her,B-PR
low,I-PR
urine,I-PR
output,I-PR
was,O
secondary,O
to,O
decreased,B-PR
cardiac,I-PR
output,I-PR
secondary,O
to,O
low,B-PR
preload,I-PR
.,O

The,O
patient,O
continued,O
to,O
be,O
followed,O
by,O
the,O
Electrophysiology,O
Service,O
",",O
who,O
determined,O
that,O
the,O
patient,O
was,O
demonstrating,O
severe,B-PR
vasal,I-PR
sensitivity,I-PR
with,O
bradycardia,B-PR
necessitating,O
pacemaker,B-TR
placement,I-TR
.,O

This,O
was,O
to,O
be,O
deferred,O
until,O
after,O
the,O
patient,O
had,O
her,B-TR
Hickman,I-TR
in,O
place,O
.,O

Because,O
the,B-TE
patient,I-TE
's,I-TE
pulmonary,I-TE
pressures,I-TE
responded,O
so,O
well,O
to,O
adenosine,B-TR
during,O
right,B-TE
heart,I-TE
catheterization,I-TE
",",O
it,O
was,O
thought,O
that,O
the,O
patient,O
would,O
be,O
a,O
good,O
candidate,O
for,O
Flolan,B-TR
therapy,I-TR
.,O

Flolan,B-TR
was,O
initiated,O
on,O
12-08,O
at,O
5,O
nanograms,O
per,O
kilogram,O
per,O
minute,O
.,O

The,O
patient,O
was,O
monitored,O
for,O
symptoms,B-PR
of,O
Flolan,B-TR
therapy,I-TR
including,O
nausea,B-PR
",",O
vomiting,B-PR
",",O
first,B-PR
bite,I-PR
jaw,I-PR
claudication,I-PR
",",O
or,O
hypotension,B-PR
.,O

Over,O
the,O
course,O
of,O
the,O
hospital,O
stay,O
the,B-TR
patient,I-TR
's,I-TR
Flolan,I-TR
dose,I-TR
was,O
titrated,O
to,O
receive,O
maximum,O
benefit,O
without,O
precipitating,O
symptoms,O
of,O
Flolan,B-PR
overdose,I-PR
.,O

The,O
patient,O
was,O
felt,O
to,O
be,O
stable,O
on,O
her,B-TR
current,I-TR
Flolan,I-TR
dose,I-TR
and,O
was,O
therefore,O
transferred,O
back,O
to,O
the,O
floor,O
.,O

A,B-TE
high,I-TE
resolution,I-TE
CT,I-TE
was,O
requested,O
to,O
further,O
evaluate,O
for,O
possible,O
secondary,O
cause,O
of,O
her,B-PR
primary,I-PR
pulmonary,I-PR
hypertension,I-PR
;,O
however,O
",",O
the,O
patient,O
refused,O
it,O
at,O
this,O
time,O
.,O

Plans,O
for,O
placement,O
of,O
a,B-TR
pacemaker,I-TR
were,O
initiated,O
.,O

However,O
",",O
on,O
the,O
night,O
prior,O
to,O
the,O
planned,O
surgical,O
date,O
the,O
patient,O
suffered,O
an,O
episode,O
of,O
bleeding,B-PR
from,O
her,B-TR
Hickman,I-TR
catheter,I-TR
site,O
.,O

Surgery,O
was,O
notified,O
and,O
pressure,B-TR
was,O
applied,O
;,O
however,O
",",O
it,O
did,O
not,O
stop,O
oozing,O
.,O

A,B-TR
surgicel,I-TR
dressing,I-TR
was,O
placed,O
and,O
prolonged,B-TR
pressure,I-TR
resulted,O
in,O
resolution,O
of,O
the,B-PR
bleeding,I-PR
.,O

In,O
addition,O
",",O
an,B-TR
extra,I-TR
stitch,I-TR
was,O
placed,O
in,O
an,O
effort,O
to,O
stop,O
the,B-PR
bleeding,I-PR
.,O

"Following,O
this,O
episode,O
the,O
patient,O
felt,O
like,O
she,O
was,O
"",O
too,B-PR
stressed,I-PR
"",O
for,O
pacemaker,B-TR
placement,I-TR
.",O

Therefore,O
",",O
she,O
was,O
monitored,O
over,O
the,O
next,O
few,O
days,O
for,O
any,B-PR
further,I-PR
bleeding,I-PR
events,I-PR
.,O

Over,O
the,O
course,O
of,O
the,O
next,O
few,O
days,O
the,O
patient,O
became,O
more,O
accustomed,O
to,O
her,B-TR
Flolan,I-TR
",",O
and,O
Flolan,B-TR
teaching,O
was,O
continued,O
.,O

She,O
continued,O
to,O
have,O
occasional,O
episodes,O
of,O
dizziness,B-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
and,O
hypotension,B-PR
whenever,O
the,O
alarm,O
sounded,O
suggesting,O
that,O
the,B-TR
Flolan,I-TR
bag,I-TR
needed,O
to,O
be,O
changed,O
.,O

However,O
",",O
over,O
the,O
course,O
of,O
the,O
hospital,O
stay,O
these,O
decreased,O
both,O
in,O
frequency,O
and,O
severity,O
.,O

On,O
12-15,O
",",O
the,O
patient,O
went,O
for,O
placement,O
of,O
a,B-TR
pacemaker,I-TR
.,O

She,O
had,O
dual-mode,B-TR
",",I-TR
dual-pacing,I-TR
",",I-TR
dual-sensing,I-TR
pacemaker,I-TR
placed,O
with,O
a,B-TE
lower,I-TE
rate,I-TE
at,O
60,O
ppm,O
",",O
and,O
upper,B-TE
rate,I-TE
of,O
120,O
ppm,O
with,O
a,B-TE
paced,I-TE
AV,I-TE
of,O
150,O
msec,O
.,O

The,O
patient,O
recovered,O
well,O
from,O
her,B-TR
surgery,I-TR
for,O
pacemaker,B-TR
placement,I-TR
.,O

At,O
the,O
time,O
of,O
discharge,O
",",O
the,O
patient,O
was,O
tolerating,O
her,B-TR
Flolan,I-TR
therapy,I-TR
well,O
.,O

She,O
had,O
received,O
a,O
full,O
course,O
of,O
Flolan,B-TR
teaching,I-TR
and,O
reported,O
that,O
she,O
and,O
her,O
husband,O
felt,O
comfortable,O
with,O
the,O
administration,O
of,O
the,B-TR
medication,I-TR
at,O
home,O
.,O

She,O
was,O
set,O
up,O
with,O
a,B-TR
primary,I-TR
pulmonary,I-TR
hypertension,I-TR
support,I-TR
group,I-TR
",",O
and,O
home,B-TR
services,I-TR
were,O
arranged,O
to,O
help,O
her,O
in,O
the,O
initiation,O
of,O
Flolan,B-TR
therapy,I-TR
.,O

Following,O
pacemaker,B-TR
placement,I-TR
the,O
patient,O
had,O
no,O
further,O
episodes,O
of,O
bradycardia,B-PR
on,O
telemetry,B-TE
",",O
and,O
therefore,O
she,O
was,O
discharged,O
in,O
satisfactory,O
condition,O
.,O

2.,O
INFECTIOUS,O
DISEASE,O
:,O

The,O
patient,O
had,O
no,O
signs,O
or,O
symptoms,O
of,O
infection,B-PR
at,O
the,O
time,O
of,O
admission,O
.,O

However,O
",",O
she,O
was,O
noted,O
to,O
have,O
a,B-PR
relatively,I-PR
elevated,I-PR
white,I-PR
blood,I-PR
cell,I-PR
count,I-PR
that,O
remained,O
stable,O
over,O
the,O
course,O
of,O
her,O
hospital,O
stay,O
.,O

However,O
",",O
near,O
the,O
end,O
of,O
her,O
hospitalization,O
the,O
patient,O
began,O
describing,O
increased,B-PR
urinary,I-PR
frequency,I-PR
which,O
persisted,O
once,O
her,B-TR
Foley,I-TR
catheter,I-TR
was,O
removed,O
.,O

A,B-TE
urinalysis,I-TE
was,O
positive,B-PR
and,O
urine,B-TE
culture,I-TE
grew,O
enterococcus,B-PR
which,O
was,O
pan,O
sensitive,O
.,O

Therefore,O
",",O
the,O
patient,O
was,O
started,O
on,O
levofloxacin,B-TR
therapy,I-TR
to,O
complete,O
a,O
10,O
-,O
day,O
course,O
.,O

Following,O
initiation,O
of,O
the,B-TR
antibiotic,I-TR
the,B-TE
patient,I-TE
's,I-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
quickly,O
came,O
down,O
",",O
and,O
she,O
remained,O
afebrile,B-PR
.,O

At,O
the,O
time,O
of,O
discharge,O
",",O
the,O
patient,O
still,O
had,O
a,B-PR
mildly,I-PR
elevated,I-PR
white,I-PR
blood,I-PR
cell,I-PR
count,I-PR
but,O
was,O
asymptomatic,B-PR
with,O
a,O
normal,O
temperature,O
.,O

She,O
will,O
complete,O
two,O
more,O
days,O
of,O
Levaquin,B-TR
therapy,I-TR
as,O
an,O
outpatient,O
.,O

3.,O
RENAL,O
:,O

The,B-TE
patient,I-TE
's,I-TE
BUN,I-TE
and,O
creatinine,B-TE
were,O
followed,O
over,O
the,O
course,O
of,O
her,O
hospital,O
stay,O
.,O

These,O
remained,O
stable,O
and,O
within,O
normal,O
limits,O
.,O

It,O
was,O
felt,O
that,O
the,B-PR
decreased,I-PR
urine,I-PR
output,I-PR
was,O
secondary,O
to,O
her,B-PR
preload,I-PR
dependence,I-PR
",",O
and,O
that,O
her,B-TE
urine,I-TE
output,I-TE
increased,O
significantly,O
when,O
she,O
was,O
adequately,O
hydrated,O
in,O
the,O
Medical,O
Intensive,O
Care,O
Unit,O
.,O

4.,O
GASTROINTESTINAL,O
:,O

The,O
patient,O
has,O
a,O
history,O
of,O
gastroesophageal,B-PR
reflux,I-PR
disease,I-PR
.,O

She,O
was,O
continued,O
on,O
Protonix,B-TR
over,O
the,O
course,O
of,O
her,O
hospital,O
stay,O
and,O
had,O
no,O
further,B-PR
gastrointestinal,I-PR
issues,I-PR
.,O

5.,O
HEMATOLOGY,O
:,O

The,B-TE
patient,I-TE
's,I-TE
hematocrit,I-TE
remained,O
stable,O
over,O
the,O
course,O
of,O
her,O
hospital,O
stay,O
.,O

Despite,O
bleeding,B-PR
from,O
the,B-TR
Hickman,I-TR
site,I-TR
",",O
she,O
did,O
not,O
require,O
any,B-TR
transfusion,I-TR
therapy,I-TR
.,O

6.,O
FLUIDS,O
/,O
ELECTROLYTES,O
/,O
NUTRITION,O
:,O

The,O
patient,O
tolerated,O
a,O
regular,O
diet,O
throughout,O
the,O
course,O
of,O
her,O
hospital,O
stay,O
.,O

Her,B-TE
electrolytes,I-TE
were,O
checked,O
on,O
a,O
daily,O
basis,O
and,O
remained,O
within,O
normal,O
limits,O
",",O
being,O
replaced,O
as,O
needed,O
.,O

She,O
was,O
discharged,O
to,O
home,O
on,O
a,O
regular,O
diet,O
.,O

7.,O
ENDOCRINE,O
:,O

The,O
patient,O
with,O
a,O
history,O
of,O
hypothyroidism,B-PR
.,O

She,O
was,O
continued,O
on,O
her,B-TR
regular,I-TR
Synthroid,I-TR
dose,I-TR
.,O

She,O
will,O
need,O
a,B-TE
TSH,I-TE
and,O
T4,B-TE
checked,O
as,O
an,O
outpatient,O
.,O

8.,O
CODE,O
STATUS,O
:,O

The,O
patient,O
is,O
a,B-TR
full,I-TR
code,I-TR
.,O

9.,O
FLOLAN,B-TR
ADMINISTRATION,I-TR
:,O

At,O
the,O
time,O
of,O
discharge,O
",",O
the,O
patient,O
was,O
tolerating,O
a,B-TR
Flolan,I-TR
dose,I-TR
of,O
5,O
nanograms,O
per,O
kilogram,O
per,O
minute,O
.,O

A,O
Physical,O
Therapy,O
consultation,O
was,O
obtained,O
to,O
initiate,O
a,B-TE
6,I-TE
-,I-TE
minute,I-TE
walk,I-TE
test,I-TE
.,O

On,O
room,O
air,O
",",O
the,B-TE
patient,I-TE
's,I-TE
oxygen,I-TE
saturation,I-TE
was,O
95%,O
and,O
dropped,O
to,O
88%,O
following,O
a,O
6,O
-,O
minute,O
walk,O
.,O

The,O
patient,O
was,O
discharged,O
to,O
home,O
with,O
appropriate,O
Flolan,B-TR
teaching,I-TR
and,O
supplies,O
.,O

She,O
was,O
to,O
follow,O
up,O
with,O
Dr.,O
Savage,O
in,O
the,O
Clinic,O
the,O
following,O
week,O
.,O

CONDITION,O
AT,O
DISCHARGE,O
:,O

The,O
patient,O
was,O
stable,O
.,O

DISCHARGE,O
STATUS,O
:,O

She,O
was,O
discharged,O
to,O
home,O
.,O

DISCHARGE,O
FOLLOWUP,O
:,O

She,O
has,O
follow,O
up,O
with,O
Dr.,O
Schwartz,O
in,O
the,O
Clinic,O
on,O
Monday,O
",",O
12-22,O
",",O
at,O
2:30,O
p.m.,O
to,O
check,O
her,B-TE
INR,I-TE
and,O
digoxin,B-TE
level,I-TE
.,O

She,O
also,O
has,O
follow,O
up,O
with,O
Dr.,O
Savage,O
in,O
the,O
Pulmonary,O
Clinic,O
on,O
12-25,O
at,O
12:15,O
p.m.,O
for,O
management,B-TR
of,O
her,B-PR
pulmonary,I-PR
hypertension,I-PR
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

1.,O
Coumadin,B-TR
2,O
mg,O
p.o.,O
q.6h.,O

2.,O
Tylenol,B-TR
No.,I-TR
3,I-TR
one,O
to,O
two,O
tablets,O
p.o.,O
q.4h.,O
p.r.n.,O
for,O
pain,B-PR
.,O

3.,O
Digoxin,B-TR
0.125,O
mg,O
p.o.,O
q.d.,O

4.,O
Levofloxacin,B-TR
500,O
mg,O
p.o.,O
t.i.d.,O
times,O
two,O
days,O
.,O

5.,O
Protonix,B-TR
40,O
mg,O
p.o.,O
q.d.,O

6.,O
Tylenol,B-TR
650,O
mg,O
p.o.,O
q.4-6h.,O
p.r.n.,O
for,O
fever,B-PR
or,O
pain,B-PR
.,O

7.,O
Synthroid,B-TR
125,O
mcg,O
p.o.,O
q.d.,O

8.,O
Colace,B-TR
100,O
mg,O
p.o.,O
q.d.,O

9.,O
Lactulose,B-TR
30,O
cc,O
p.o.,O
q.6h.,O
p.r.n.,O
for,O
constipation,B-PR
.,O

10.,O
Flolan,B-TR
5,O
nanograms,O
per,O
kilograms,O
per,O
minute,O
",",O
continuous,O
infusion,O
.,O

11.,O
Oxygen,B-TR
per,O
nasal,B-TR
cannula,I-TR
as,O
needed,O
.,O

Alan,O
Q.,O
Steckelberg,O
",",O
M.D.,O

54-745,O

Dictated,O
By,O
:,O
Roy,O
C,O
Ali,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2014-12-18,O
18:32,O

T,O
:,O
2014-12-21,O
10:44,O

JOB,O
#:,O

60351,O

(,O
cclist,O
),O

Signed,O
electronically,O
by,O
:,O
DR.,O
Melody,O
PARKS,O
on,O
:,O
TUE,O
2014-12-23,O
6:28,O
AM,O

(,O
End,O
of,O
Report,O
),O

656225945,O
YC,O

76593195,O

2774375,O

01/19/2003,O
12:00:00,O
AM,O

cellulitis,B-PR

DIS,O

Admission,O
Date,O
:,O

01/19/2003,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

01/24/2003,O

******,O
DISCHARGE,O
ORDERS,O
******,O

MONG,O
",",O
RISHRIELI,O

156-02-38-0,O
P22,O

Room,O
:,O

15L-305,O

Service,O
:,O

MED,O

DISCHARGE,O
PATIENT,O
ON,O
:,O

01/24/03,O
AT,O
02:00,O
PM,O

CONTINGENT,O
UPON,O

Attending,B-TE
evaluation,I-TE

WILL,O
D,O
/,O
C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D,O
/,O
C,O
SUMMARY,O
:,O

YES,O

Attending,O
:,O

SHONESGANS,O
",",O
AH,O
B.,O
",",O
M.D.,O

DISPOSITION,O
:,O

Home,O

DISCHARGE,O
MEDICATIONS,O
:,O

LEVOFLOXACIN,B-TR
500,O
MG,O
PO,O
QD,O
X,O
14,O
Days,O

Food,O
/,O
Drug,O
Interaction,O
Instruction,O

Administer,O
iron,B-TR
products,I-TR
a,O
minimum,O
of,O
2,O
hours,O
before,O
or,O
after,O
a,B-TR
levofloxacin,I-TR
or,O
ciprofloxacin,B-TR
dose,I-TR
dose,O
If,O
on,O
tube,B-TR
feeds,I-TR
",",O
please,O
cycle,O
(,O
hold,O
1,O
hr,O
before,O
to,O
2,O
hr,O
after,O
),O
Take,O
2,O
hours,O
before,O
or,O
2,O
hours,O
after,O
dairy,O
products,O
.,O

DIET,O
:,O

No,O
Restrictions,O

ACTIVITY,O
:,O

Resume,O
regular,O
exercise,O

FOLLOW,O
UP,O
APPOINTMENT,O
(,O
S,O
),O
:,O

Ica,O
Gachcienne,O
-,O
in,O
PCP,O
office,O
01/26/03,O
",",O

ALLERGY,O
:,O

Penicillins,B-TR

ADMIT,O
DIAGNOSIS,O
:,O

Cellulitis,B-PR

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O

Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O
cellulitis,B-PR

OTHER,O
DIAGNOSIS,O
;,O

Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O
cellulitis,B-PR

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

None,O

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O

CT,B-TE
of,I-TE
neck,I-TE
with,I-TE
contrast,I-TE

BRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

Pt,O
is,O
22,O
y,O
/,O
o,O
female,O
with,O
hx,O
of,O
HIV,B-PR
and,O
CD4,B-TE
ct,I-TE
of,O
297,O
who,O
presented,O
to,O
ED,O
on,O
01/14,O
with,O
sebaceous,B-PR
cyst,I-PR
that,O
was,O
infected,B-PR
.,O

Cyst,B-PR
was,O
drained,O
and,O
pt,O
was,O
sent,O
home,O
with,O
Duracef,B-TR
.,O

She,O
did,O
not,O
fill,O
script,B-TR
for,O
2,O
days,O
and,O
even,O
then,O
was,O
not,B-PR
compliant,I-PR
with,O
her,B-TR
meds,I-TR
.,O

She,O
now,O
returns,O
to,O
ED,O
with,O
pain,B-PR
and,O
erythema,B-PR
from,I-PR
the,I-PR
midline,I-PR
posterior,I-PR
neck,I-PR
to,O
her,O
submental,O
area,O
and,O
2-3,O
d,O
of,O
intermittent,B-PR
fevers,I-PR
and,O
chills,B-PR
.,O
+,O
nausea,B-PR
.,O

No,O
dysphagia,B-PR
",",O
trouble,O
hearing,O
.,O

PMH,O
:,O

HIV,B-PR
",",O
viral,B-TE
load,I-TE
954,O
",",O
7/03,O
-,O
H.,B-PR
Pylori,I-PR
pos.,O
",",O
asthma,B-PR

FHX,O
/,O
SHX,O
:,O

Lives,O
with,O
boyfriend,O
in,O
apt,O
.,O

Smokes,O
2-3,O
cig,O
/,O
day,O
",",O
occ,O
etoh,O
",",O
and,O
no,O
drugs,O
except,O
marijuana,O
Exam,B-TE
:,O

98.6,O
54,O
119/59,O
18,O
100%,O
RA,O
.,O

Exam,B-TE
sig.,O
for,O
erthyema,B-PR
as,O
described,O
previously,O
and,O
tenderness,B-PR
to,O
minimal,B-TE
palpation,I-TE
.,O

Data,O
:,O

Neck,B-TE
CT,I-TE
neg,O
for,O
abcess,B-PR
.,O

Pt,O
with,O
WBC,B-TE
of,O
15.4,O
with,O
70%,B-TE
seg,I-TE
.,O

Plan,O
:,O

(1),O
ID,O
-,O
Pt,O
received,O
Clinda,B-TR
and,O
Ancef,B-TR
in,O
ED,O
.,O

Will,O
cont,O
Ancef,B-TR
1q8,O
overnight,O
and,O
trans,O
to,O
Keflex,B-TR
.,O

CD4,B-TE
ct,I-TE
.,O

Bacitracin,B-TR
oint,I-TR
.,O

Percocet,B-TR
and,O
morphine,B-TR
sulfate,I-TR
for,O
pain,B-PR
.,O

(2),O
GI,O
-,O
Nexium,B-TR

(3),O
FEN,O
-,O
NS,B-TR
overnight,O

(4),O
Pulm,O
-,O
Albuterol,B-TR
inhalers,I-TR
prn,O
Patient,O
seems,O
to,O
be,O
improving,O
and,O
afebrile,B-PR
and,O
resting,O
comfortably,O
.,O

The,B-PR
erythematous,I-PR
region,I-PR
is,O
retreating,O
and,O
the,B-PR
wound,I-PR
cleaned,O
.,O

She,O
is,O
ready,O
to,O
be,O
sent,O
home,O
with,O
antibiotics,B-TR
.,O

Repeat,B-TE
CT,I-TE
was,O
neg.,O
for,O
abcess,B-PR
or,O
fascitis,B-PR
.,O

ADDITIONAL,O
COMMENTS,O
:,O

1,O
-,O
be,O
sure,O
to,O
finish,O
all,O
antibiotic,B-TR
even,O
if,O
pain,B-PR
subsides,O
adn,O
inflammation,B-PR
goes,O
down,O
.,O

2,O
-,O
clean,O
wound,B-PR

3,O
-,O
Follow,O
up,O
with,O
PCP,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O

TO,O
DO,O
/,O
PLAN,O
:,O

1,O
-,O
Fill,O
Rx,O
for,O
antibiotics,B-TR
today,O
and,O
take,O
until,O
finished,O
even,O
if,O
neck,B-PR
pain,I-PR
subsides,O
x,O
14,O
days,O

2,O
-,O
Clean,O
wound,B-PR

3,O
-,O
Return,O
to,O
ED,O
or,O
call,O
PCP,O
if,O
neck,B-PR
inflammation,I-PR
and,O
red,B-PR
swollen,I-PR
area,I-PR
does,O
not,O
continue,O
to,O
get,O
better,O
or,O
if,O
temperature,B-PR
returns,O
.,O

4,O
-,O
Visit,O
PCP,O
on,O
Monday,O
at,O
2:30,O
No,O
dictated,O
summary,O

ENTERED,O
BY,O
:,O

DRIN,O
",",O
FONDT,O
L.,O
",",O
M.D.,O
(,O
CR90,O
),O
01/24/03,O
12:48,O
PM,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

Admission,O
Date,O
:,O

2014-08-07,O

Discharge,O
Date,O
:,O

2014-08-09,O

Date,O
of,O
Birth,O
:,O

1958-03-14,O

Sex,O
:,O

M,O

Service,O
:,O

NEUROSURG,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
56,O
-,O
year-old,O
man,O
without,O
any,O
significant,O
past,O
medical,O
history,O
who,O
presented,O
to,O
the,O
emergency,O
room,O
after,O
the,O
sudden,O
onset,O
of,O
headache,B-PR
while,O
he,O
was,O
riding,O
a,O
bicycle,O
.,O

He,O
characterized,O
this,B-PR
headache,I-PR
as,O
the,B-PR
worst,I-PR
headache,I-PR
of,O
his,O
life,O
and,O
had,O
associated,O
nausea,B-PR
and,O
vomiting,B-PR
times,O
one,O
.,O

He,O
also,O
complained,O
of,O
dizziness,B-PR
at,O
the,O
time,O
of,O
headache,B-PR
onset,O
.,O

He,O
presented,O
to,O
the,O
Edith,O
Nourse,O
Rogers,O
Memorial,O
VA,O
Hospital,O
emergency,O
room,O
",",O
where,O
an,B-TE
initial,I-TE
head,I-TE
CT,I-TE
scan,I-TE
was,O
read,O
as,O
negative,O
.,O

However,O
",",O
a,B-TE
lumbar,I-TE
puncture,I-TE
was,O
done,O
",",O
in,O
which,O
tube,O
1,O
showed,O
4800,B-TE
red,I-TE
blood,I-TE
cells,I-TE
and,O
tube,O
4,O
showed,O
4000,B-TE
red,I-TE
blood,I-TE
cells,I-TE
.,O

The,O
patient,O
was,O
sent,O
for,O
an,B-TE
MRI,I-TE
of,I-TE
the,I-TE
head,I-TE
",",O
which,O
raised,O
the,O
question,O
of,O
a,B-PR
right,I-PR
posterior,I-PR
cerebral,I-PR
artery,I-PR
aneurysm,I-PR
.,O

The,B-TE
CT,I-TE
scan,I-TE
was,O
revealed,O
and,O
",",O
on,O
second,O
analysis,O
",",O
it,O
was,O
thought,O
that,O
it,O
was,O
suspicious,O
for,O
a,B-PR
subarachnoid,I-PR
hemorrhage,I-PR
in,I-PR
the,I-PR
suprasellar,I-PR
cistern,I-PR
.,O

The,O
patient,O
was,O
then,O
admitted,O
for,O
further,B-TE
evaluation,I-TE
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

"The,O
past,O
medical,O
history,O
was,O
significant,O
for,O
left,B-TR
shoulder,I-TR
surgery,I-TR
in,O
2014-03-06,O
for,O
repair,B-TR
of,O
a,B-PR
"",I-PR
minor,I-PR
rotator,I-PR
cuff,I-PR
tear,I-PR
"",O
and,O
removal,B-TR
of,O
osteophytes,B-PR
.",O

Otherwise,O
",",O
the,O
past,O
medical,O
history,O
was,O
insignificant,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

The,O
patient,O
was,O
on,O
no,O
medications,B-TR
.,O

ALLERGIES,O
:,O

There,O
were,O
no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

FAMILY,O
HISTORY,O
:,O

The,O
father,O
had,O
leukemia,B-PR
and,O
the,O
mother,O
had,O
gastrointestinal,B-PR
cancer,I-PR
.,O

There,O
was,O
no,O
family,O
history,O
of,O
aneurysms,B-PR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
was,O
a,O
nonsmoker,O
and,O
used,O
no,O
ethanol,O
.,O

He,O
was,O
married,O
",",O
with,O
children,O
",",O
and,O
was,O
a,O
church,O
minister,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
physical,B-TE
examination,I-TE
",",O
the,O
patient,O
was,O
resting,O
comfortably,O
when,O
seen,O
",",O
slightly,B-PR
sleepy,I-PR
at,O
first,O
but,O
readily,O
arousable,O
",",O
awake,O
",",O
alert,O
",",O
oriented,O
and,O
conversant,O
.,O

Of,O
note,O
",",O
the,O
patient,O
had,O
been,O
given,O
2,O
mg,O
of,O
Ativan,B-TR
before,O
the,B-TE
examination,I-TE
.,O

The,O
face,O
was,O
symmetric,O
.,O

The,O
tongue,O
was,O
midline,O
.,O

The,O
neck,O
was,O
supple,O
with,O
full,O
range,O
of,O
motion,O
.,O

There,O
was,O
no,O
rigidity,B-PR
",",O
but,O
the,O
neck,O
was,O
slightly,B-PR
painful,I-PR
at,O
extreme,B-TE
flexion,I-TE
.,O

The,B-TE
general,I-TE
examination,I-TE
was,O
essentially,O
unremarkable,O
",",O
as,O
per,O
previous,O
notes,O
.,O

On,O
examination,B-TE
of,I-TE
the,I-TE
extremities,I-TE
",",O
the,O
patient,O
moved,O
all,O
extremities,O
and,O
had,O
strength,O
of,O
5/5,O
in,O
all,O
of,O
the,O
muscle,O

groups,O
tested,O
in,O
the,O
upper,O
and,O
lower,O
extremities,O
.,O

The,B-TE
sensory,I-TE
examination,I-TE
was,O
intact,O
to,O
light,B-TE
touch,I-TE
.,O

There,O
was,O
a,B-PR
very,I-PR
slight,I-PR
inward,I-PR
pronator,I-PR
drift,I-PR
of,I-PR
the,I-PR
left,I-PR
hand,I-PR
.,O

Finger,B-TE
-,I-TE
nose,I-TE
-,I-TE
finger,I-TE
testing,I-TE
and,O
heel,B-TE
-,I-TE
to,I-TE
-,I-TE
shin,I-TE
testing,I-TE
were,O
normal,O
.,O

Rapid,O
alternating,O
movement,O
was,O
normal,O
.,O

The,O
toes,O
were,O
downgoing,O
bilaterally,O
.,O

Gait,O
was,O
reported,O
to,O
be,O
normal,O
",",O
as,O
per,O
the,O
emergency,O
room,O
staff,O
.,O

There,O
was,O
no,O
ataxia,B-PR
noted,O
.,O

LABORATORY,O
:,O

Laboratory,B-TE
values,I-TE
were,O
as,O
per,O
the,O
History,O
of,O
Present,O
Illness,O
.,O

RADIOLOGY,O
:,O

Neurological,B-TE
imaging,I-TE
data,O
was,O
as,O
per,O
the,O
History,O
of,O
Present,O
Illness,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
surgical,O
intensive,O
care,O
unit,O
",",O
where,O
a,B-TE
continued,I-TE
cerebral,I-TE
angiogram,I-TE
was,O
done,O
that,O
was,O
essentially,O
normal,O
",",O
without,O
evidence,O
of,O
any,B-PR
obvious,I-PR
aneurysm,I-PR
.,O

The,O
patient,O
was,O
observed,O
for,O
two,O
days,O
with,O
a,B-TE
repeat,I-TE
CT,I-TE
scan,I-TE
showing,O
no,O
changes,B-PR
from,O
the,B-TE
previous,I-TE
examination,I-TE
.,O

The,B-PR
headache,I-PR
stabilized,O
after,O
the,O
patient,O
was,O
transferred,O
to,O
the,O
floor,O
.,O

The,O
patient,O
continued,O
to,O
do,O
well,O
and,O
the,O
decision,O
was,O
made,O
to,O
discharge,O
him,O
.,O

DISCHARGE,O
INSTRUCTIONS,O
:,O

The,O
patient,O
was,O
discharged,O
with,O
strict,O
instructions,O
to,O
return,O
to,O
the,O
emergency,O
room,O
",",O
should,O
there,O
be,O
an,O
exacerbation,O
of,O
symptoms,B-PR
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

Ruled,O
out,O
subarachnoid,B-PR
hemorrhage,I-PR
.,O

Michael,O
Lawrence,O
",",O
M.D.,O

41-707,O

Dictated,O
By,O
:,O
Lena,O
D.,O
Mannie,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2014-08-09,O
14:04,O

T,O
:,O
2014-08-09,O
15:27,O

JOB,O
#:,O

45402,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Michael,O
Jackson,O
on,O
:,O
FRI,O
2014-09-05,O
11:39,O
AM,O

(,O
End,O
of,O
Report,O
),O

662179752,O

PUOMC,O

9175227,O

22849/871n,O

818603,O

7/30/1993,O
12:00:00,O
AM,O

CORONARY,B-PR
ARTERY,I-PR
DISEASE,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

07-30-93,O

DISCHARGE,O
DATE,O
:,O

08-10-93,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Coronary,B-PR
artery,I-PR
disease,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

1.,O
Congestive,B-PR
heart,I-PR
failure,I-PR
.,O

2.,O
Ventricular,B-PR
ectopy,I-PR
.,O

3.,O
Pulmonary,B-PR
hypertension,I-PR
.,O

4.,O
Cardiomegaly,B-PR
.,O

5.,O
Sinus,B-PR
tachycardia,I-PR
.,O

6.,O
Diabetes,B-PR
mellitus,I-PR
.,O

7.,O
Paraphimosis,B-PR
.,O

8.,O
Right,B-PR
bundle,I-PR
branch,I-PR
block,I-PR
.,O

9.,O
Pericarditis,B-PR
.,O

ADVERSE,O
DRUG,O
REACTIONS,O
:,O

Heparin,B-TR
",",O
consisting,O
of,O
thrombocytopenia,B-PR
;,O
Pronestyl,B-TR
",",O
consisting,O
of,O
nausea,B-PR
.,O

SPECIAL,O
PROCEDURES,O
AND,O
OPERATIONS,O
:,O

08/02/93,O
:,O

coronary,B-TR
artery,I-TR
bypass,I-TR
grafting,I-TR
x,I-TR
3,I-TR
.,O

08/02/93,O
:,O

left,O
internal,O
mammary,O
artery,O
to,O
anterior,O
descending,O
artery,O
x,O
1,O
.,O

08/02/93,O
:,O

Insertion,B-TR
of,I-TR
intra-aortic,I-TR
balloon,I-TR
pump,I-TR
.,O

07/30/93,O
:,O

bilateral,B-TE
cardiac,I-TE
catheterization,I-TE
.,O

07/30/93,O
:,O

Left,B-TE
ventriculography,I-TE
.,O

07/30/93,O
:,O

bilateral,B-TE
coronary,I-TE
angiography,I-TE
.,O

08/02/93,O
:,O

Signal,B-TE
average,I-TE
EKG,I-TE
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Digoxin,B-TR
",",O
.25,O
mg,O
PO,O
QD,O
;,O
Ecotrin,B-TR
",",O
325,O
mg,O
QD,O
;,O
Coumadin,B-TR
",",O
2.5,O
mg,O
PO,O
QD,O
;,O
Lisinopril,B-TR
",",O
2.5,O
mg,O
PO,O
QD,O
;,O
Micronase,B-TR
",",O
5,O
mg,O
PO,O
BID,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
47,O
year,O
old,O
patient,O
of,O
Dr.,O
Laymie,O
Fournier,O
and,O
Dr.,O
Leebjescobe,O
in,O
Co,O
In,O
Saorlirv,O
Frea,O
",",O
West,O
Virginia,O
who,O
was,O
well,O
until,O
a,O
bout,O
of,O
double,B-PR
pneumonia,I-PR
in,O
May,O
1992,O
",",O
at,O
which,O
time,O
he,O
was,O
hospitalized,O
at,O
Centdick,O
Naco,O
Hospital,O
Medical,O
Center,O
.,O

He,O
also,O
has,O
a,O
history,O
of,O
hypertension,B-PR
and,O
diabetes,B-PR
mellitus,I-PR
.,O

He,O
had,O
a,O
transient,O
episode,O
of,O
headache,B-PR
and,O
disorientation,B-PR
at,O
that,O
time,O
.,O

A,B-TE
CT,I-TE
and,O
MRI,B-TE
scan,I-TE
corroborated,O
multiple,B-PR
cerebral,I-PR
infarcts,I-PR
.,O

He,O
was,O
started,O
on,O
aspirin,B-TR
.,O

He,O
has,O
a,O
family,O
history,O
of,O
hypertension,B-PR
as,O
well,O
.,O

He,O
was,O
also,O
placed,O
on,O
Vasotec,B-TR
.,O

A,B-TE
Holter,I-TE
monitor,I-TE
showed,O
ventricular,B-PR
ectopy,I-PR
.,O

A,B-TE
thallium,I-TE
stress,I-TE
test,I-TE
showed,O
tachycardia,B-PR
and,O
severe,B-PR
dyspnea,I-PR
as,O
well,O
as,O
a,B-PR
fall,I-PR
in,I-PR
blood,I-PR
pressure,I-PR
with,O
low,O
level,O
exercise,O
.,O

An,B-TE
echocardiogram,I-TE
showed,O
global,B-PR
hypokinesis,I-PR
.,O

Accordingly,O
he,O
was,O
referred,O
for,O
further,B-TE
evaluation,I-TE
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Blood,B-TE
pressure,I-TE
140/100,O
",",O
phosphorus,B-TE
94,O
",",O
weight,B-TE
181,O
lb,O
.,O

Head,O
",",O
neck,O
:,O

unremarkable,O
.,O

Lungs,O
clear,O
.,O

Carotids,O
normal,O
.,O

Cardiac,O
:,O

Loud,B-PR
S4,I-PR
and,O
a,B-PR
II,I-PR
/,I-PR
VI,I-PR
regurgitant,I-PR
murmur,I-PR
.,O

Abdomen,O
was,O
benign,O
.,O

Peripheral,B-TE
pulses,I-TE
intact,O
.,O

Neurological,O
:,O

Nonfocal,O
.,O

LABORATORY,O
DATA,O
:,O

Sodium,B-TE
140,O
",",O
potassium,B-TE
4.0,O
",",O
chloride,B-TE
104,O
",",O
CO2,B-TE
28,O
",",O
BUN,B-TE
14,O
",",O
creatinine,B-TE
1.1,O
",",O
glucose,B-TE
243,O
.,O

Cholesterol,B-TE
197,O
",",O
triglycerides,B-TE
118,O
",",O
HDL,B-TE
31,O
",",O
LDL,B-TE
142,O
",",O
total,B-TE
protein,I-TE
6.2,O
",",O
bilirubin,B-TE
1.0,O
",",O
alkaline,B-TE
phosphatase,I-TE
72,O
",",O
SGOT,B-TE
23,O
.,O

Hematocrit,B-TE
on,O
admission,O
was,O
43%,O
with,O
a,B-TE
white,I-TE
blood,I-TE
count,I-TE
of,O
6600,O
.,O

MCV,B-TE
was,O
85,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
taken,O
to,O
the,O
cardiac,O
catheterization,O
laboratory,O
",",O
where,O
he,O
was,O
noted,O
initially,O
to,O
have,O
a,B-TE
pulmonary,I-TE
wedge,I-TE
pressure,I-TE
of,O
45,O
with,O
a,B-TE
pulmonary,I-TE
artery,I-TE
pressure,I-TE
of,O
82/40,O
.,O

This,O
lowered,O
with,O
IV,B-TR
nitroglycerin,I-TR
.,O

Selective,B-TE
coronary,I-TE
angiography,I-TE
showed,O
an,B-PR
occluded,I-PR
right,I-PR
coronary,I-PR
artery,I-PR
in,I-PR
its,I-PR
midportion,I-PR
.,O

He,O
had,O
an,O
80%,O
distal,O
left,O
main,O
",",O
a,O
90%,O
proximal,O
circumflex,O
",",O
and,O
multiple,B-PR
significant,I-PR
lesions,I-PR
in,I-PR
the,I-PR
LAD,I-PR
.,O

His,O
left,O
ventricle,O
ejection,O
showed,O
diffuse,B-PR
hypokinesis,I-PR
.,O

The,O
situation,O
was,O
reviewed,O
with,O
his,O
wife,O
",",O
Sligh,O
.,O

She,O
noted,O
that,O
he,O
was,O
actively,O
working,O
full,O
time,O
and,O
was,O
a,O
sales,O
representative,O
at,O
the,O
Leigh,O
and,O
lives,O
at,O
home,O
with,O
her,O
and,O
his,O
daughter,O
",",O
age,O
18,O
.,O

It,O
was,O
felt,O
that,O
",",O
because,O
of,O
the,O
evidence,O
of,O
congestive,B-PR
heart,I-PR
failure,I-PR
and,O
the,B-PR
critical,I-PR
left,I-PR
main,I-PR
lesion,I-PR
",",O
he,O
should,O
be,O
admitted,O
for,O
further,B-TE
evaluation,I-TE
.,O

Indeed,O
",",O
he,O
was,O
treated,O
with,O
diuretics,B-TR
and,O
nitrates,B-TR
along,O
with,O
cessation,O
of,O
his,B-TR
aspirin,I-TR
",",O
and,O
he,O
was,O
put,O
on,O
IV,B-TR
Heparin,I-TR
.,O

He,O
stabilized,O
over,O
the,O
weekend,O
.,O

He,O
was,O
noted,O
to,O
have,O
some,B-PR
ventricular,I-PR
ectopy,I-PR
on,O
Holter,B-TE
monitor,I-TE
.,O

He,O
developed,O
epigastric,B-PR
pain,I-PR
on,O
07/31,O
which,O
previously,O
had,O
been,O
ignored,O
but,O
in,O
retrospect,O
was,O
probably,O
his,B-PR
anginal,I-PR
equivalent,I-PR
.,O

He,O
also,O
had,O
multifocal,B-PR
ventricular,I-PR
ectopy,I-PR
at,O
that,O
time,O
.,O

He,O
had,O
some,B-PR
further,I-PR
anterolateral,I-PR
ST,I-PR
segment,I-PR
changes,I-PR
.,O

Therefore,O
",",O
he,O
did,O
have,O
unstable,B-PR
angina,I-PR
with,O
his,B-PR
critical,I-PR
coronary,I-PR
anatomy,I-PR
.,O

The,O
patient,O
was,O
seen,O
in,O
consultation,O
by,O
the,O
Electrophysiology,O
service,O
",",O
Dr.,O
Slusslashgodle,O
",",O
who,O
said,O
that,O
he,O
had,O
no,O
indication,O
for,O
patch,B-TR
placement,I-TR
at,O
the,O
time,O
of,O
surgery,B-TR
.,O

On,O
08/02/93,O
",",O
an,B-TR
intra-aortic,I-TR
balloon,I-TR
pump,I-TR
was,O
placed,O
;,O
then,O
",",O
Dr.,O
Thorebreutz,O
took,O
him,O
to,O
the,O
operating,O
room,O
",",O
where,O
he,O
had,O
quadruple,B-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
grafting,I-TR
.,O

He,O
had,O
a,B-TR
left,I-TR
internal,I-TR
mammary,I-TR
artery,I-TR
graft,I-TR
of,I-TR
the,I-TR
LAD,I-TR
",",O
a,O
single,O
saphenous,O
vein,O
to,O
the,O
right,O
coronary,O
artery,O
with,O
280,O
cc,O
per,O
minute,O
flow,O
",",O
and,O
a,B-TR
saphenous,I-TR
vein,I-TR
snake,I-TR
graft,I-TR
to,I-TR
the,I-TR
diagonal,I-TR
and,O
circumflex,O
with,O
150,O
cc,O
per,O
minute,O
flow,O
.,O

A,B-PR
paraphimosis,I-PR
was,O
noted,O
and,O
treated,O
by,O
Dr.,O
Ryna,O
Jescdrig,O
.,O

After,O
surgery,B-TR
he,O
had,O
a,B-PR
ongoing,I-PR
sinus,I-PR
tachycardia,I-PR
.,O

He,O
was,O
able,O
to,O
be,O
rapidly,O
weaned,O
and,O
extubated,O
.,O

He,O
had,O
good,O
hemodynamics,O
.,O

He,O
had,O
occasional,B-PR
atrial,I-PR
and,I-PR
ventricular,I-PR
premature,I-PR
beats,I-PR
.,O

His,B-TR
intra-aortic,I-TR
balloon,I-TR
pump,I-TR
was,O
weaned,O
the,O
following,O
day,O
and,O
he,O
was,O
transferred,O
out,O
of,O
the,O
Surgical,O
Intensive,O
Care,O
Unit,O
.,O

He,O
was,O
seen,O
in,O
consultation,O
by,O
the,O
Nutrition,O
Service,O
",",O
who,O
followed,O
him,O
for,O
dietary,O
management,O
of,O
his,B-PR
diabetes,I-PR
mellitus,I-PR
.,O

On,O
08/05,O
it,O
was,O
noted,O
that,O
his,B-TE
platelet,I-TE
count,I-TE
had,O
fallen,O
from,O
"171,000",O
to,O
"54,000",O
;,O
this,O
was,O
thought,O
to,O
be,O
associated,O
with,O
intravenous,B-TR
Heparin,I-TR
and,O
indeed,O
",",O
when,O
Heparin,B-TR
was,O
discontinued,O
",",O
since,O
it,O
had,O
been,O
restarted,O
after,O
surgery,O
",",O
his,B-TE
platelet,I-TE
count,I-TE
rebounded,O
to,O
normal,O
.,O

Therefore,O
",",O
he,O
does,O
have,O
a,B-PR
thrombocytopenic,I-PR
reaction,I-PR
to,O
Heparin,B-TR
.,O

He,O
remained,O
in,O
normal,O
sinus,O
rhythm,O
.,O

He,O
did,O
have,O
runs,O
of,O
nonsustained,B-PR
ventricular,I-PR
tachycardia,I-PR
",",O
which,O
were,O
clinically,O
stable,O
.,O

He,O
had,O
a,B-PR
right,I-PR
bundle,I-PR
branch,I-PR
block,I-PR
.,O

He,O
is,O
at,O
increased,O
risk,O
for,O
future,O
events,O
because,O
of,O
his,B-PR
low,I-PR
left,I-PR
ventricular,I-PR
ejection,I-PR
fraction,I-PR
",",O
but,O
he,O
is,O
clinically,O
stable,O
on,O
ACE,B-TR
inhibitors,I-TR
",",O
Digoxin,B-TR
",",O
Coumadin,B-TR
",",O
and,O
aspirin,B-TR
.,O

Therefore,O
he,O
was,O
able,O
to,O
be,O
discharged,O
home,O
.,O

He,O
understands,O
that,O
he,O
does,O
have,O
significant,B-PR
left,I-PR
ventricle,I-PR
dysfunction,I-PR
and,O
requires,O
monitoring,B-TE
of,I-TE
his,I-TE
prothrombin,I-TE
times,I-TE
and,I-TE
his,I-TE
arrhythmias,I-TE
;,O
these,O
will,O
be,O
done,O
in,O
Grovea,O
Co,O
Terburgperv,O
Portnew,O
.,O

ACHASTHA,O
N.,O
DAIZSMAELLILLE,O
",",O
M.D.,O

TR,O
:,O

ssx,O
/,O
bmot,O

DD,O
:,O

08-09-93,O

TD,O
:,O

08/10/93,O

CC,O
:,O

Dr.,O
Thorebreutz,O
",",O
E,O
2,O

Admission,O
Date,O
:,O

2015-09-20,O

Discharge,O
Date,O
:,O

2015-09-30,O

Date,O
of,O
Birth,O
:,O

1961-09-28,O

Sex,O
:,O

F,O

Service,O
:,O

NEUROLOGY,O

Allergies,O
:,O

Lamictal,B-TR
/,O
Keflex,B-TR
/,O
Navane,B-TR
/,O
Inderal,B-TR
/,O
Depakote,B-TR

Attending,O
:,O
Cindy,O
U.,O
Kelly,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

transfer,O
from,O
OSH,O
",",O
seizure,B-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

Lumbar,B-TE
puncture,I-TE

History,O
of,O
Present,O
Illness,O
:,O

Ms.,O
Swanson,O
is,O
a,O
53,O
yo,O
woman,O
with,O
PMH,O
significant,O
for,O
seizure,B-PR
disorder,I-PR
",",O
brain,B-PR
injury,I-PR
",",O
and,O
?,O
atypical,B-PR
multiple,I-PR
sclerosis,I-PR
who,O
presents,O
with,O
right,B-PR
face,I-PR
twitch,I-PR
and,O
right,B-PR
arm,I-PR
shaking,I-PR
.,O

History,O
is,O
obtained,O
from,O
her,O
sister,O
",",O
William,O
from,O
Lawrence,O
General,O
Hospital,O
",",O
and,O
from,O
her,O
primary,O
neurologist,O
",",O
Dr.,O
Brian,O
.,O

She,O
lives,O
in,O
an,O
assisted,O
living,O
",",O
and,O
was,O
noted,O
yesterday,O
to,O
have,O
generalized,B-PR
tonic-clonic,I-PR
activity,I-PR
beginning,O
on,O
the,O
right,O
side,O
and,O
lasting,O
90,O
minutes,O
.,O

EMS,O
gave,O
her,O
valium,B-TR
5,O
mg,O
pr,O
at,O
the,O
facility,O
and,O
brought,O
her,O
to,O
Barnstable,O
County,O
Hospital,O
.,O

She,O
persisted,O
with,O
right,B-PR
sided,I-PR
seizure,I-PR
activity,I-PR
there,O
and,O
was,O
given,O
valium,B-TR
10,O
mg,O
and,O
ativan,B-TR
1,O
mg,O
",",O
as,O
well,O
as,O
loaded,O
with,O
dilantin,B-TR
1000,O
mg,O
.,O

She,O
was,O
transferred,O
to,O
the,O
Providence,O
Behavioral,O
Health,O
Hospital,O
CMED,O
.,O

Here,O
she,O
was,O
given,O
an,B-TR
additional,I-TR
valium,I-TR
5,O
mg,O
x,O
2,O
and,O
ativan,B-TR
1,O
mg,O
x,O
3,O
for,O
persistent,B-PR
twitching,I-PR
in,I-PR
her,I-PR
face,I-PR
and,I-PR
right,I-PR
hand,I-PR
.,O

Since,O
the,B-TR
ativan,I-TR
",",O
her,B-PR
facial,I-PR
twitching,I-PR
has,O
apparently,O
improved,O
",",O
but,O
she,O
continues,O
to,O
have,O
hand,B-PR
twitches,I-PR
.,O

She,O
also,O
had,O
an,B-TE
EEG,I-TE
",",O
which,O
showed,O
left,B-PR
sided,I-PR
slowing,I-PR
on,O
preliminary,O
read,O
.,O

Apparently,O
she,O
has,O
a,O
long,O
history,O
of,O
seizure,B-PR
disorder,I-PR
",",O
possibly,O
from,O
a,O
history,O
of,O
traumatic,B-PR
brain,I-PR
injury,I-PR
(,O
though,O
per,O
Dr.,O
Paula,O
",",O

records,O
from,O
that,O
hospitalization,O
indicate,O
she,O
may,O
have,O
only,O
had,O
a,B-PR
very,I-PR
mild,I-PR
injury,I-PR
),O
and,O
has,O
been,O
managed,O
on,O
dilantin,B-TR
and,O
keppra,B-TR
.,O

Since,O
she,O
has,O
seen,O
Dr.,O
Ollie,O
",",O
she,O
has,O
had,O
at,O
least,O
two,O
episodes,O
of,O
status,B-PR
epilepticus,I-PR
and,O
one,B-PR
generalized,I-PR
seizure,I-PR
",",O
as,O
well,O
as,O
some,B-PR
less,I-PR
significant,I-PR
seizures,I-PR
which,O
are,O
characterized,O
by,O
left,B-PR
gaze,I-PR
preference,I-PR
and,O
left,B-PR
sided,I-PR
tonic-clonic,I-PR
activity,I-PR
.,O

Her,B-TE
dilantin,I-TE
levels,I-TE
had,O
been,O
somewhat,O
difficult,O
to,O
control,O
.,O

He,O
tried,O
adding,O
lamictal,B-TR
",",O
but,O
this,O
caused,O
a,B-PR
rash,I-PR
.,O

At,O
the,O
time,O
of,O
her,O
last,O
visit,O
(,O
2015-03-18,O
),O
Dr.,O
Bradley,O
had,O
discussed,O
the,O
addition,O
of,O
a,B-TR
third,I-TR
Castelluccio,I-TR
",",O
possibly,O
zonegran,B-TR
(,O
less,O
likely,O
topamax,B-TR
"),",O
to,O
the,B-TR
dilantin,I-TR
200,O
mg,O
bid,O
and,O
keppra,B-TR
1500,O
mg,O
bid,O
.,O

Her,O
sister,O
had,O
wanted,O
to,O
keep,O
the,O
current,O
course,O
because,O
she,O
felt,O
she,O
was,O
doing,O
well,O
where,O
she,O
was,O
living,O
and,O
did,O
not,O
want,O
to,O
upset,O
that,O
.,O

However,O
",",O
she,O
had,O
several,B-TE
dilantin,I-TE
levels,I-TE
drawn,O
since,O
her,O
last,O
visit,O
",",O
with,O
15.4,O
in,O
05,O
-,O
23.5,O
in,O
Theresa,O
",",O
and,O
3.09,O
-,O
18,O
.,O

Her,O
sister,O
reports,O
that,O
the,B-TR
medication,I-TR
dose,I-TR
had,O
been,O
changed,O
to,O
200,O
mg,O
qam,O
and,O
100,O
mg,O
qpm,O
in,O
Theresa,O
",",O
and,O
a,O
review,O
of,O
her,O
Union,O
Hospital,O
-,O
North,O
Shore,O
Medical,O
Center,O
records,O
indicates,O
that,O
this,O
may,O
have,O
occurred,O
in,O
an,O
urgent,O
care,O
appointment,O
secondary,O
to,O
slurred,B-PR
speech,I-PR
and,O
a,O
recent,O
fall,O
and,O
a,B-PR
non-trough,I-PR
level,I-PR
of,O
15.9,O
.,O

According,O
to,O
her,O
sister,O
",",O
the,O
patient,O
has,O
no,B-PR
short-term,I-PR
memory,I-PR
.,O

She,O
has,O
been,O
living,O
in,O
an,O
assisted,O
living,O
facility,O
and,O
frequently,O
calls,O
her,O
even,O
right,O
after,O
she,O
has,O
left,O
without,O
remembering,O
her,O
visit,O
.,O

The,O
patient,O
walks,O
with,O
a,B-TR
walker,I-TR
at,O
baseline,O
and,O
goes,O
out,O
for,O
dinner,O
and,O
shopping,O
with,O
her,O
sister,O
.,O

Ms.,O
Swanson,O
also,O
carries,O
a,O
diagnosis,O
of,O
"",O
atypical,B-PR
MS,I-PR
""",",O
which,O
she,O
brought,O
with,O
her,O
to,O
Dr.,O
Billie,O
.,O

According,O
to,O
Dr.,O
Nicole,O
",",O
she,O
has,O
had,O
stable,B-PR
deficits,I-PR
for,O
many,O
years,O
without,O
any,B-PR
flare-like,I-PR
episodes,I-PR
.,O

She,O
had,O
an,B-TE
MRI,I-TE
in,O
2014,O
that,O
showed,O
multiple,B-PR
plaque-like,I-PR
lesions,I-PR
",",O
but,O
these,O
were,O
entirely,O
stable,O
since,O
2010,O
.,O

She,O
is,O
not,O
undergoing,O
any,B-TR
treatment,I-TR
.,O

Reportedly,O
she,O
has,O
been,O
evaluated,O
at,O
Shriner's,O
Hospital,O
for,O
Crippled,O
Children,O
",",O
HealthSouth,O
Braintree,O
Rehab,O
Hospital,O
",",O
and,O
possibly,O
St.,O
Elizabeth's,O
Medical,O
Center,O
of,O
Boston,O
.,O

She,O
has,O
not,O
had,O
an,B-TE
LP,I-TE
as,O
far,O
as,O
Dr.,O
Ginger,O
knows,O
.,O

Past,O
Medical,O
History,O
:,O

h/o,O
head,B-PR
trauma,I-PR

atypical,B-PR
MS,I-PR

seizures,B-PR

depression,B-PR

hypercholesterolemia,B-PR

Social,O
History,O
:,O

lives,O
in,O
assisted,O
living,O
.,O

Sister,O
Andrew,O
is,O
HCP,O

Family,O
History,O
:,O

not,O
elicited,O

Physical,O
Exam,O
:,O

ICU,O
exam,O
:,O

VS,B-TE
:,O
T99.5,O
",",O
BP,B-TE
126/72,O
",",O
HR,B-TE
99,O
",",O
RR,B-TE
15,O
",",O
SaO2,B-TE
99%,O
/,O
RA,O

Genl,O
:,O
lying,O
in,O
bed,O
",",O
right,O
hand,O
moving,O
rhythmically,O
",",O
NGT,B-TR
in,O
place,O

MS,O
:,O
not,B-PR
following,I-PR
commands,I-PR
",",O
withdraws,O
to,O
noxious,B-TE
stimuli,I-TE
",",O
making,O
incomprehensible,B-PR
vocalizations,I-PR

CN,O
:,O
PERRL,O
",",O
corneal,O
reflex,O
intact,O
",",O
nasal,O
tickle,O
intact,O
",",O
face,O
symmetric,O
.,O

Motor,O
:,O
moving,O
right,O
hand,O
rhythmically,O
with,O
occasional,B-PR
right,I-PR
face,I-PR
twitching,I-PR
as,O
well,O
.,O

Moves,O
all,O
extremities,O
to,O
stimuli,B-TE
",",O
L,O
>,O
R,O

Sensation,O
:,O
intact,O
to,O
noxious,B-TE
stimuli,I-TE
in,O
all,O
four,O
extremities,O

Reflexes,O
:,O
3+,O
throughout,O
",",O
both,O
toes,O
upgoing,O

Recent,O
exam,O
:,O

Afebrile,B-PR
",",O
VSS,O

Following,O
commands,O
",",O
oriented,O
to,O
name,O
",",O
place,O
.,O

Able,O
to,O
carry,O
on,O
simple,O
conversation,O
.,O

No,O
dysarthria,B-PR
",",O
speech,O
fluent,O
.,O

CN,O
:,O
PEERL,O
",",O
EOM,O
full,O
",",O
tongue,O
midline,O

Motor,O
:,O
moves,O
all,O
extremities,O
with,O
some,O
"strength,",O
improved,O
bilaterally,O

Reflexes,O
:,O
as,O
above,O

Pertinent,O
Results,O
:,O

Admission,O
labs,O
:,O

2015-09-20,O
03:54,O
AM,O
BLOOD,B-TE
WBC,B-TE
-,O
11.4,O
*#,O
RBC,B-TE
-,O
3.96,O
*,O
Hgb,B-TE
-,O
12.1,O
Hct,B-TE
-,O
35.1,O
*,O
MCV,B-TE
-,O
88,O
MCH,B-TE
-,O
30.6,O
MCHC,B-TE
-,O
34.6,O
RDW,B-TE
-,O
13.1,O
Plt,B-TE
Ct,I-TE
-,O
152,O

2015-09-28,O
07:50,O
AM,O
BLOOD,B-TE
Neuts,B-TE
-,O
83.3,O
*,O
Lymphs,B-TE
-,O
10.1,O
*,O
Monos,B-TE
-,O
5.3,O
Eos,B-TE
-,O
1.1,O
Baso,B-TE
-,O
0.2,O

2015-09-20,O
03:54,O
AM,O
BLOOD,B-TE
PT,B-TE
-,O
12.3,O
PTT,B-TE
-,O
26.7,O
INR(PT),B-TE
-,O
1.1,O

2015-09-20,O
03:54,O
AM,O
BLOOD,B-TE
Glucose,B-TE
-,O
97,O
UreaN,B-TE
-,O
12,O
Creat,B-TE
-,O
0.4,O
Na,B-TE
-,O
137,O
K,B-TE
-,O
3.8,O
Cl,B-TE
-,O
101,O
HCO3,B-TE
-,O
26,O
AnGap,B-TE
-,O
14,O

2015-09-20,O
03:54,O
AM,O
BLOOD,B-TE
Albumin,B-TE
-,O
4.0,O
Calcium,B-TE
-,O
8.0,O
*,O
Phos,B-TE
-,O
2.9,O
Mg,B-TE
-,O
2.0,O

2015-09-20,O
03:54,O
AM,O
BLOOD,B-TE
ALT,B-TE
-,O
14,O
AST,B-TE
-,O
18,O
AlkPhos,B-TE
-,O
92,O
TotBili,B-TE
-,O
0.3,O

2015-09-20,O
03:54,O
AM,O
BLOOD,B-TE
Phenyto,B-TE
-,O
18.4,O

Discharge,O
labs,O
:,O

2015-09-29,O
07:25,O
AM,O
BLOOD,B-TE
Phenyto,B-TE
-,O
5.1,O
*,O

U/A,O
:,O

2015-09-22,O
03:04,O
PM,O
URINE,B-TE
Color,B-TE
-,O
Straw,O
Appear,B-TE
-,O
Clear,O
Sp,O
Dixon,B-TE
-,O
1.010,O

2015-09-22,O
03:04,O
PM,O
URINE,B-TE
Blood,B-TE
-,O
SM,O

2015-09-22,O
03:04,O
PM,O
URINE,B-TE
RBC,B-TE
-,O
6,O
*,O
WBC,B-TE
-,O
29,O
*,O
Bacteri,B-TE
-,O
OCC,B-TE
Yeast,I-TE
-,O
NONE,O
Epi,B-TE
-,O
<,O
1,O

2015-09-28,O
03:04,O
PM,O
URINE,B-TE
Color,B-TE
-,O
Yellow,O
Appear,B-TE
-,O
Clear,O
Sp,B-TE
Brown,I-TE
-,O
1.015,O

2015-09-28,O
03:04,O
PM,O
URINE,B-TE
Blood,B-TE
-,O
LG,B-TE
Nitrite,I-TE
-,O
NEG,O
Protein,B-TE
-,O
TR,O
Glucose,B-TE
-,O
NEG,O
Ketone,B-TE
-,O
NEG,O
Bilirub,B-TE
-,O
NEG,O
Urobiln,B-TE
-,O
0.2,O
pH,B-TE
-,O
6.5,O
Leuks,B-TE
-,O
NEG,O

2015-09-28,O
03:04,O
PM,O
URINE,B-TE
RBC,B-TE
-,O
01-04,O
*,O
WBC,B-TE
-,O
04-19,O
Bacteri,B-TE
-,O
FEW,O
Yeast,B-TE
-,O
NONE,O
Epi,B-TE
-,O
0-2,O

CSF,O
:,O

2015-09-25,O
02:20,O
PM,O
CEREBROSPINAL,B-TE
FLUID,I-TE
(,I-TE
CSF,I-TE
),O
WBC,B-TE
-,O
6,O
RBC,B-TE
-,O
2,O
*,O
Polys,B-TE
-,O
0,O
Lymphs,B-TE
-,O
92,O
Monos,B-TE
-,O
8,O

2015-09-25,O
02:20,O
PM,O
CEREBROSPINAL,B-TE
FLUID,I-TE
(,I-TE
CSF,I-TE
),O
WBC,B-TE
-,O
6,O
RBC,B-TE
-,O
0,O
Polys,B-TE
-,O
0,O
Lymphs,B-TE
-,O
95,O
Monos,B-TE
-,O
5,O

2015-09-25,O
02:20,O
PM,O
CEREBROSPINAL,B-TE
FLUID,I-TE
(,I-TE
CSF,I-TE
),O
TotProt,B-TE
-,O
56,O
*,O
Glucose,B-TE
-,O
77,O

2015-09-25,O
02:20,O
PM,O
CEREBROSPINAL,B-TE
FLUID,I-TE
(,I-TE
CSF,I-TE
),O
ANGIOTENSIN,B-TE
1,I-TE
CONVERTING,I-TE
ENZYME,I-TE
-,O
PND,O

2015-09-25,O
02:20,O
PM,O
CEREBROSPINAL,B-TE
FLUID,I-TE
(,I-TE
CSF,I-TE
),O
VDRL,B-TE
-,O
PND,O

2015-09-25,O
02:20,O
PM,O
CEREBROSPINAL,B-TE
FLUID,I-TE
(,I-TE
CSF,I-TE
),O
Ernest,B-TE
VIRUS,I-TE
(,I-TE
JCV,I-TE
),I-TE
DNA,I-TE
DETECTION,I-TE
BY,I-TE
POLYMERASE,I-TE
CHAIN,I-TE
REACTION,I-TE
(,I-TE
PCR,I-TE
)-,O
PND,O

2015-09-25,O
02:20,O
PM,O
CEREBROSPINAL,B-TE
FLUID,I-TE
(,I-TE
CSF,I-TE
),O
VARICELLA,B-TE
DNA,I-TE
(,I-TE
PCR,I-TE
)-,O
PND,O

2015-09-25,O
02:20,O
PM,O
CEREBROSPINAL,B-TE
FLUID,I-TE
(,I-TE
CSF,I-TE
),O
HERPES,B-TE
SIMPLEX,I-TE
VIRUS,I-TE
PCR,I-TE
-,O
PND,O

2015-09-25,O
02:20,O
PM,O
CEREBROSPINAL,B-TE
FLUID,I-TE
(,I-TE
CSF,I-TE
),O
EBV,B-TE
-,I-TE
PCR,I-TE
-,O
PND,O

2015-09-25,O
02:20,O
PM,O
CEREBROSPINAL,B-TE
FLUID,I-TE
(,I-TE
CSF,I-TE
),I-TE
CYTOMEGALOVIRUS,B-TE
-,I-TE
PCR,I-TE
-,O
negative,O

Other,O
:,O

cryptococcus,B-PR
:,O
negative,O

CSF,B-TE
negative,O

blood,B-TE
cx,I-TE
NGTD,O

urine,B-TE
cx,I-TE
lactobacillus,B-PR

CSF,B-TE
cytology,I-TE
:,O
NEGATIVE,O
FOR,O
MALIGNANT,B-PR
CELLS,I-PR
.,O

Reactive,B-PR
lymphoid,I-PR
cells,I-PR
.,O

immunotyping,B-TE
negative,O
.,O

CXR,B-TE
09-28,O
:,O
No,O
evidence,O
for,O
pneumonia,B-PR
.,O

No,O
change,O
since,O
prior,B-TE
study,I-TE
of,O
2015-09-24,O
.,O

CT,B-TE
HEAD,I-TE
FINDINGS,O
:,O
There,O
is,O
moderately,B-PR
severe,I-PR
",",I-PR
confluent,I-PR
periventricular,I-PR
white,I-PR
matter,I-PR
hypodensity,I-PR
surrounding,O
the,O
frontal,O
horns,O
",",O
posterior,O
horns,O
",",O
and,O
more,O
superiorly,O
",",O
involving,O
the,O
centra,O
semiovale,O
.,O

These,O
findings,O
are,O
unchanged,O
from,O
prior,B-TE
studies,I-TE
",",O
and,O
may,O
relate,O
to,O
the,B-PR
"",I-PR
atypical,I-PR
"",I-PR
demyelinating,I-PR
process,I-PR
",",O
suggested,O
in,O
the,O
indication,O
on,O
the,B-TE
prior,I-TE
MRI,I-TE
;,O
however,O
",",O
they,O
are,O
non-specific,O
.,O

There,O
is,O
no,O
evidence,O
of,O
acute,B-PR
intra,I-PR
-,I-PR
or,I-PR
extra,I-PR
-,I-PR
axial,I-PR
hemorrhage,I-PR
.,O

There,O
is,O
no,O
shift,B-PR
of,I-PR
normally,I-PR
midline,I-PR
structures,I-PR
.,O

The,O
ventricles,O
are,O
mildly,B-PR
prominent,I-PR
",",O
but,O
are,O
unchanged,O
from,O
the,B-TE
prior,I-TE
study,I-TE
.,O

There,O
is,O
no,O
interval,B-PR
loss,I-PR
of,I-PR
focal,I-PR
gray,I-PR
-,I-PR
white,I-PR
matter,I-PR
differentiation,I-PR
to,O
suggest,O
acute,B-PR
infarction,I-PR
",",O
though,O
CT,B-TE
is,O
not,O
sensitive,O
in,O
the,O
early,O
stages,O
.,O

No,O
focal,B-PR
masses,I-PR
is,O
seen,O
.,O

IMPRESSION,O
:,O

1),O
No,O
intracranial,B-PR
hemorrhage,I-PR
or,O
mass,B-PR
effect,I-PR
;,O
no,O
significant,B-PR
interval,I-PR
change,I-PR
from,O
CT,B-TE
of,O
2015-07-20,O
.,O

2),O
Diffuse,B-PR
",",I-PR
confluent,I-PR
periventricular,I-PR
white,I-PR
matter,I-PR
hypodensity,I-PR
",",O
which,O
may,O
relate,O
to,O
an,B-PR
underlying,I-PR
demyelinating,I-PR
process,I-PR
(,O
as,O
suggested,O
in,O
the,O
indication,O
provided,O
for,O
the,B-TE
prior,I-TE
MRI,I-TE
).,O

The,B-PR
markedly,I-PR
low,I-PR
-,I-PR
attenation,I-PR
(,O
14-15,O
HU,O
),O
centered,O
within,O
this,O
process,O
suggests,O
either,O
irreversible,B-PR
demyelination,I-PR
with,O
cavitation,B-PR
("",I-PR
black,I-PR
hole,I-PR
"""),",O
or,O
lacunar,B-PR
infarction,I-PR
on,I-PR
a,I-PR
vascular,I-PR
basis,I-PR
.,O

Generalized,O
and,O
marked,B-PR
callosal,I-PR
atrophy,I-PR
(,O
on,O
the,B-TE
MR,I-TE
),O
also,O
suggest,O
advanced,B-PR
",",I-PR
irreversible,I-PR
disease,I-PR
.,O

3),O
No,O
mass,B-PR
is,O
appreciated,O
on,O
this,B-TE
limited,I-TE
non-contrast,I-TE
study,I-TE
;,O
if,O
clinically,O
concerned,O
",",O
an,B-TE
MRI,I-TE
with,I-TE
gadolinium,I-TE
is,O
recommended,O
.,O

MRI,B-TE
:,O
There,O
is,O
a,O
similar,O
configuration,O
of,O
increased,B-PR
T2,I-PR
signal,I-PR
in,O
the,O
periventricular,O
white,O
matter,O
of,O
both,O
cerebral,O
hemispheres,O
",",O
suggesting,O
demyelinating,B-PR
disease,I-PR
.,O

As,O
previously,O
noted,O
",",O
there,O
is,O
associated,B-PR
volume,I-PR
loss,I-PR
",",O
thinning,B-PR
of,I-PR
the,I-PR
corpus,I-PR
callosum,I-PR
",",O
and,O
slight,B-PR
widening,I-PR
of,I-PR
the,I-PR
ventricles,I-PR
.,O

On,O
post-contrast,B-TE
images,I-TE
",",O
there,O
is,O
a,O
probably,O
stable,O
appearance,O
of,O
a,B-PR
5,I-PR
mm,I-PR
linear,I-PR
",",I-PR
focal,I-PR
area,I-PR
of,I-PR
enhancement,I-PR
in,I-PR
the,I-PR
left,I-PR
centrum,I-PR
semiovale,I-PR
",",O
of,O
uncertain,O
etiology,O
.,O

Also,O
ehancing,O
is,O
3,B-PR
mm,I-PR
linear,I-PR
lesion,I-PR
in,I-PR
the,I-PR
left,I-PR
hippocampal,I-PR
cortex,I-PR
anteriorly,I-PR
",",O
not,O
seen,O
on,O
the,O
08-20,O
MR,B-TE
",",O
but,O
that,B-TE
study,I-TE
was,O
very,O
motion,O
-,O
degraded,O
.,O

The,O
hippocampus,O
would,O
be,O
a,O
most,O
unusual,O
site,O
for,O
involvement,O
by,O
multiple,B-PR
sclerosis,I-PR
.,O

There,O
is,O
no,O
apparent,B-PR
mass,I-PR
lesion,I-PR
or,O
mass,B-PR
effect,I-PR
.,O

No,O
changes,B-PR
in,I-PR
the,I-PR
overall,I-PR
morphology,I-PR
of,O
the,O
brain,O
are,O
identified,O
.,O

The,O
surrounding,O
osseous,O
and,O
soft,O
tissue,O
structures,O
are,O
unremarkable,O
.,O

The,O
major,O
vascular,O
flow,O
patterns,O
are,O
normal,O
.,O

IMPRESSION,O
:,O

1.,O
Stable,O
appearance,O
of,O
confluent,O
areas,O
of,O
increased,B-PR
T2,I-PR
signal,I-PR
in,I-PR
the,I-PR
periventricular,I-PR
white,I-PR
matter,I-PR
",",O
consistent,O
with,O
severe,B-PR
demyelinating,I-PR
disease,I-PR
.,O

2.,O
Enhancing,B-PR
lesions,I-PR
in,I-PR
the,I-PR
left,I-PR
centrum,I-PR
semiovale,I-PR
and,O
also,O
left,O
hippocampal,O
cortex,O
.,O

This,B-PR
former,I-PR
lesion,I-PR
was,O
evident,O
on,O
MR,B-TE
dating,O
back,O
to,O
2014-08-15,O
",",O
though,O
is,O
more,O
prominent,O
at,O
this,O
time,O
",",O
likely,O
due,O
to,O
less,O
motion,O
degradation,O
of,O
the,B-TE
current,I-TE
scan,I-TE
.,O

Etiology,O
of,O
these,B-PR
enhancing,I-PR
lesions,I-PR
is,O
uncertain,O
",",O
but,O
could,O
be,O
atypical,B-PR
manifestations,I-PR
of,I-PR
demyelination,I-PR
.,O

EEG,B-TE
:,O

ABNORMALITY,O
#1:,O
Throughout,O
the,O
recording,O
there,O
were,O
frequent,O
bursts,O
of,O
generalized,B-PR
theta,I-PR
and,I-PR
delta,I-PR
slowing,I-PR
.,O

Facial,B-PR
twitching,I-PR
was,O
described,O
by,O
the,O
technologist,O
and,O
seen,O
on,O
the,B-TE
video,I-TE
.,O

This,O
is,O
primarily,O
right-sided,B-PR
",",I-PR
facial,I-PR
movement,I-PR
clinically,O
and,O
did,O
not,O
appear,O
to,O
involve,O
the,O
forehead,O
or,O
CMED,O
CSRU,O
.,O

There,O
were,O
no,O
clear,O
EEG,B-TE
correlate,O
.,O

ABNORMALITY,O
#2:,O
The,B-TE
background,I-TE
voltages,I-TE
were,O
occasionally,B-PR
lower,I-PR
on,O
the,O
left,O
side,O
",",O
and,O
there,O
were,O
additional,B-PR
bursts,I-PR
of,I-PR
delta,I-PR
slowing,I-PR

ABNORMALITY,O
#3:,O
The,O
background,O
rhythms,O
were,O
dominated,O
by,O
much,B-PR
faster,I-PR
beta,I-PR
rhythm,I-PR
.,O

They,O
appeared,O
to,O
reach,O
an,O
8,O
Hz,O
frequency,O
on,O
the,O
right,O
at,O
times,O
",",O
though,O
the,O
background,O
was,O
disorganized,O
and,O
slow,O
on,O
both,O
sides,O
for,O

much,O
of,O
the,O
recording,O
.,O

It,O
was,O
of,O
much,O
lower,O
voltage,O
on,O
the,O
left,O
.,O

HYPERVENTILATION,B-TR
:,O
Could,O
not,O
be,O
performed,O
.,O

INTERMITTENT,B-TE
PHOTIC,I-TE
STIMULATION,I-TE
:,O
Could,O
not,O
be,O
performed,O
.,O

SLEEP,O
:,O
No,O
normal,O
waking,O
or,O
sleeping,O
morphologies,O
were,O
seen,O
.,O

CARDIAC,B-TE
MONITOR,I-TE
:,O
Showed,O
a,O
generally,O
regular,O
rhythm,O
.,O

IMPRESSION,O
:,O
Abnormal,B-PR
portable,I-PR
EEG,I-PR
due,O
to,O
the,B-PR
bursts,I-PR
of,I-PR
generalized,I-PR
slowing,I-PR
and,O
additional,B-PR
left-sided,I-PR
slowing,I-PR
and,O
voltage,B-PR
dimunition,I-PR
",",O
along,O
with,O
some,B-PR
slowing,I-PR
of,I-PR
the,I-PR
background,I-PR
.,O

The,O
generalized,O
and,O
background,O
features,O
indicate,O
a,B-PR
wide-spread,I-PR
encephalopathy,I-PR
.,O

The,B-PR
left,I-PR
sided,I-PR
slowing,I-PR
and,O
voltage,B-PR
reduction,I-PR
surpassed,O
an,B-PR
additional,I-PR
dysfunction,I-PR
on,I-PR
the,I-PR
left,I-PR
side,I-PR
",",O
possibly,O
wide-spread,B-PR
cortical,I-PR
dysfunction,I-PR
.,O

There,O
is,O
a,O
possibility,O
of,O
a,B-PR
structural,I-PR
lesion,I-PR
on,I-PR
the,I-PR
left,I-PR
",",O
but,O
the,B-PR
encephalopathy,I-PR
dominated,O
the,O
overall,O
picture,O
.,O

There,O
were,O
no,O
clear,B-PR
epileptiform,I-PR
discharges,I-PR
.,O

No,O
EEG,O
correlate,O
was,O
established,O
for,O
the,B-PR
facial,I-PR
twitching,I-PR
.,O

The,O
lack,O
of,O
EEG,O
correlate,O
to,O
the,B-PR
facial,I-PR
twitching,I-PR
does,O
not,O
exclude,O
a,O
central,O
cause,O
(,O
and,O
",",O
indeed,O
",",O
this,O
appeared,O
most,O
likely,O
based,O
on,O
the,O
clinical,O
and,O
video,B-TE
observations,I-TE
).,O

Brief,O
Hospital,O
Course,O
:,O

53,O
yo,O
woman,O
with,O
h/o,O
seizure,B-PR
disorder,I-PR
",",O
demyelinating,B-PR
disease,I-PR
",",O
and,O
brain,B-PR
injury,I-PR
",",O
presents,O
with,O
prolonged,B-PR
seizure,I-PR
",",O
now,O
unresponsive,B-PR
with,O
persistent,B-PR
twitching,I-PR
of,I-PR
right,I-PR
arm,I-PR
and,I-PR
face,I-PR
.,O

This,O
is,O
most,O
consistent,O
with,O
complex,B-PR
partial,I-PR
seizures,I-PR
with,O
a,O
focus,O
in,O
the,O
left,O
hemisphere,O
",",O
most,O
likely,O
the,O
motor,O
strip,O
.,O

In,O
the,O
past,O
",",O
her,B-PR
seizures,I-PR
were,O
on,O
the,O
left,O
side,O
",",O
which,O
implies,O
that,O
she,O
now,O
has,O
a,O
new,O
focus,O
.,O

It,O
is,O
possible,O
that,O
this,O
is,O
secondary,O
to,O
her,B-PR
underlying,I-PR
demyelinating,I-PR
disease,I-PR
",",O
but,O
per,O
report,O
this,O
has,O
not,O
been,O
very,O
active,O
.,O

Other,O
possibilities,O
include,O
infection,B-PR
",",O
including,O
her,B-PR
UTI,I-PR
.,O

It,O
is,O
likely,O
that,O
these,B-PR
seizures,I-PR
began,O
due,O
to,O
subtherapeutic,B-PR
dilantin,I-PR
levels,I-PR
on,O
her,B-TR
new,I-TR
dose,I-TR
of,O
200,O
mg,O
/,O
100,O
mg,O
.,O

Her,B-TR
seizure,I-TR
management,I-TR
is,O
difficult,O
",",O
given,O
the,B-TR
higher,I-TR
doses,I-TR
were,O
causing,O
her,O
to,O
fall,O
and,O
slur,O
her,O
speech,O
.,O

Discussed,O
with,O
Dr.,O
Joaquin,O
the,O
addition,O
of,O
an,B-TR
alternate,I-TR
Castelluccio,I-TR
with,O
the,O
possibility,O
of,O
tapering,O
down,O
the,B-TR
dilantin,I-TR
in,O
the,O
future,O
",",O
and,O
he,O
agreed,O
that,O
she,O
may,O
benefit,O
from,O
zonegran,B-TR
.,O

Cannot,O
use,O
lamictal,B-TR
or,O
depakote,B-TR
due,O
to,O
reactions,B-PR
.,O

Topamax,B-TR
is,O
another,O
possibility,O
",",O
but,O
not,O
ideal,O
in,O
a,O
patient,O
with,O
preexisting,B-PR
cognitive,I-PR
deficits,I-PR
.,O

She,O
was,O
started,O
on,O
zonegran,B-TR
at,O
50,O
mg,O
daily,O
with,O
plans,O
to,O
increase,O
by,O
50,O
mg,O
every,O
other,O
week,O
to,O
a,O
goal,O
dose,O
of,O
200,O
mg,O
/,O
day,O
;,O
she,O
was,O
on,O
100,O
mg,O
daily,O
at,O
discharge,O
and,O
should,O
have,O
her,O
dose,O
increased,O
on,O
10-12,O
and,O
again,O
on,O
10-26,O
.,O

She,O
was,O
continued,O
on,O
keppra,B-TR
and,O
dilantin,B-TR
with,O
trough,B-TE
checked,O
frequently,O
and,O
adjustment,O
as,O
needed,O
.,O

Ativan,B-TR
was,O
used,O
for,O
breakthrough,B-PR
seizures,I-PR
(,O
facial,B-PR
twitching,I-PR
).,O

MRI/MRA,B-TE
showed,O
new,B-PR
temporal,I-PR
lesions,I-PR
",",O
but,O
it,O
is,O
unclear,O
if,O
these,O
are,O
the,O
cause,O
or,O
effect,O
of,O
her,B-PR
seizures,I-PR
.,O

She,O
will,O
need,O
to,O
have,O
a,B-TE
repeat,I-TE
MRI,I-TE
in,O
several,O
months,O
for,O
further,B-TE
evaluation,I-TE
.,O

LP,B-TE
was,O
done,O
and,O
had,O
no,O
changes,O
to,O
suggest,O
a,O
different,O
etiology,O
(,O
ie,O
negative,O
cytology,O
and,O
negative,O
immunophenotyping,O
).,O

Oligoclonal,B-TE
bands,I-TE
were,O
not,O
assessed,O
as,O
there,O
was,O
not,O
enough,O
CSF,B-TE
per,O
the,O
laboratory,O
.,O

She,O
will,O
need,O
repeated,B-TE
dilantin,I-TE
troughs,I-TE
with,O
one,O
time,O
dose,O
when,O
trough,O
is,O
subtherapeutic,O
.,O

Pending,O
tests,O
:,O

ANGIOTENSIN,B-TE
1,I-TE
CONVERTING,I-TE
ENZYME,I-TE

EBV-PCR,B-TE

HERPES,B-TE
SIMPLEX,I-TE
VIRUS,I-TE
PCR,I-TE

Ernest,B-TE
VIRUS,I-TE
(,I-TE
JCV,I-TE
),I-TE
DNA,B-TE
PCR,I-TE

LYME,B-TE
",",O
TOTAL,B-TE
EIA,I-TE
WITH,O
REFLEX,B-TE
TO,I-TE
CSF,I-TE
RATIO,I-TE

VARICELLA,B-TE
DNA,I-TE
(,I-TE
PCR,I-TE
),I-TE

VDRL,B-TE

2.,O
atypical,B-PR
MS,I-PR
:,O
discussed,O
with,O
her,O
outpt,O
neurologist,O
(,O
Dr.,O
Ford,O
in,O
Boston,O
Medical,O
Center,O
);,O
no,O
current,O
role,O
for,O
MS,B-TR
medications,I-TR
.,O

MRI,B-TE
was,O
performed,O
and,O
showed,O
new,B-PR
lesions,I-PR
vs,O
sz,B-PR
effects,I-PR
in,I-PR
the,I-PR
left,I-PR
temporal,I-PR
lobe,I-PR
.,O

She,O
also,O
had,O
a,B-PR
new,I-PR
lesion,I-PR
on,O
her,B-TE
last,I-TE
MRI,I-TE
in,O
the,O
centrum,O
semiovale,O
.,O

LP,B-TE
was,O
done,O
to,O
evaluate,O
for,O
malignancy,B-PR
",",O
and,O
no,O
malignant,B-PR
cells,I-PR
were,O
seen,O
.,O

Immunotyping,B-TE
was,O
negative,O
as,O
well,O
(,O
per,O
verbal,O
report,O
).,O

Unfortunately,O
",",O
oligoclonal,B-TE
bands,I-TE
could,O
not,O
be,O
sent,O
from,O
the,O
CSF,O
(,O
lab,O
sent,O
CSF,O
for,O
other,B-TE
studies,I-TE
and,O
there,O
was,O
not,O
enough,O
left,O
over,O
for,O
OCB,B-TE
s).,I-TE

This,O
was,O
relayed,O
to,O
the,O
family,O
(,O
Kirk,O
).,O

Given,O
that,O
she,O
does,O
have,O
new,B-PR
lesions,I-PR
on,O
MRI,B-TE
",",O
if,O
OCB,B-TE
s,I-TE
were,O
sent,O
this,O
would,O
have,O
weighed,O
in,O
in,O
her,O
dx,O
of,O
MS,B-PR
",",O
and,O
it's,O
possible,O
she,O
could,O
benefit,O
from,O
MS,B-TR
therapy,I-TR
.,O

This,O
was,O
relayed,O
to,O
the,O
family,O
",",O
and,O
they,O
will,O
readdress,O
this,O
with,O
Dr.,O
Ford,O
(,O
MS,O
Hoyos,O
).,O

The,O
family,O
is,O
confident,O
in,O
any,O
decision,O
Dr.,O
Ford,O
would,O
make,O
re,O
:,O
therapy,B-TR
for,O
her,B-PR
MS,I-PR
.,O

3.,O
fevers,B-PR
on,O
admission,O
:,O
Pt,O
w/,O
positive,B-PR
U/A,I-PR
",",O
treated,O
with,O
bactrim,B-TR
x,O
3,O
days,O
with,O
defervescence,O
.,O

4.,O
depression,B-PR
:,O
continue,O
escitalopram,B-TR
;,O
assess,O
need,O
to,O
change,O
medication,B-TR
as,O
an,O
outpatient,O
.,O

5.,O
FEN,O
:,O
NGT,B-TR
was,O
placed,O
given,O
her,B-PR
altered,I-PR
mental,I-PR
status,I-PR
",",O
and,O
she,O
has,O
been,O
unable,O
to,O
pass,O
a,B-TE
swallow,I-TE
evaluation,I-TE
",",O
but,O
has,O
improved,O
.,O

This,O
should,O
be,O
repeated,O
in,O
several,O
days,O
as,O
her,O
mental,O
status,O
continues,O
to,O
clear,O
.,O

Commun,O
:,O
Sister,O
Andrew,O
is,O
HCP,O
.,O
(,O
780,O
),O
970-0261,O

Dispo,O
:,O
PT/OT,O
worked,O
with,O
patient,O
during,O
admission,O

Medications,O
on,O
Admission,O
:,O

Dilantin,B-TR
200/100,O

Keppra,B-TR
1500,O
mg,O
bid,O

Lexapro,B-TR
20,O
mg,O
q,O
day,O

Folate,B-TR
1,O
mg,O
q,O
day,O

Calcium,B-TR
1,O
tab,O
bid,O

Discharge,O
Medications,O
:,O

1.,O
Zonisamide,B-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
DAILY,O
(,O
Daily,O
):,O
Increase,O
by,O
50,O
mg,O
every,O
other,O
week,O
(,O
next,O
increase,O
2015-10-12,O
).,O

2.,O
Phenytoin,B-TR
50,O
mg,O
Tablet,O
",",O
Chewable,O
Sig,O
:,O
Four,O
(,O
4,O
),O
Tablet,O
",",O
Chewable,O
PO,O
QAM,O
(,O
once,O
a,O
day,O
(,O
in,O
the,O
morning,O
)).,O

3.,O
Phenytoin,B-TR
50,O
mg,O
Tablet,O
",",O
Chewable,O
Sig,O
:,O
Three,O
(,O
3,O
),O
Tablet,O
",",O
Chewable,O
PO,O
QPM,O
(,O
once,O
a,O
day,O
(,O
in,O
the,O
evening,O
)).,O

4.,O
Phenytoin,B-TR
50,O
mg,O
Tablet,O
",",O
Chewable,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Chewable,O
PO,O
EVERY,O
OTHER,O
DAY,O
(,O
Every,O
Other,O
Day,O
).,O

5.,O
Levetiracetam,B-TR
500,O
mg,O
Tablet,O
Sig,O
:,O
Four,O
(,O
4,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

6.,O
Escitalopram,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

7.,O
Folic,B-TR
Acid,I-TR
1,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

8.,O
Lansoprazole,B-TR
30,O
mg,O
Tablet,O
",",O
Rapid,O
Dissolve,O
",",O
DR,O
Turner,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Rapid,O
Dissolve,O
",",O
DR,O
Hughes,O
DAILY,O
(,O
Daily,O
).,O

9.,O
Docusate,B-TR
Sodium,I-TR
150,O
mg,O
/,O
15,O
mL,O
Liquid,O
Sig,O
:,O
One,O
Hundred,O
(,O
100,O
),O
mg,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

10.,O
Senna,B-TR
8.6,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

11.,O
Bisacodyl,B-TR
10,O
mg,O
Suppository,O
Sig,O
:,O
One,O
(,O
1,O
),O
Suppository,O
Rectal,O
DAILY,O
(,O
Daily,O
),O
as,O
needed,O
for,O
constipation,B-PR
.,O

12.,O
Heparin,B-TR
(,I-TR
Porcine,I-TR
),O
"5,000",O
unit,O
/,O
mL,O
Solution,O
Sig,O
:,O
5000,O
(,O
5000,O
),O
units,O
Injection,O
TID,O
(,O
3,O
times,O
a,O
day,O
).,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Facility,O
:,O

L.F.,O
Quigley,O
Memorial,O
Hospital,O
&,O
Rehab,O
Center,O
-,O
Berkshire,O
Medical,O
Center,O

Discharge,O
Diagnosis,O
:,O

Seizure,B-PR

History,O
of,O
atypical,B-PR
multiple,I-PR
sclerosis,I-PR

Memory,B-PR
loss,I-PR

Status,O
post,O
brain,B-PR
injury,I-PR

Urinary,B-PR
tract,I-PR
infection,I-PR

Discharge,O
Condition,O
:,O

Stable,O
",",O
much,O
improved,O
from,O
admission,O
",",O
and,O
almost,O
at,O
baseline,O
.,O

Discharge,O
Instructions,O
:,O

Take,O
all,B-TR
medications,I-TR
as,O
prescribed,O
.,O

Please,O
increase,O
zonegran,B-TR
dose,I-TR
by,O
50,O
every,O
other,O
week,O
until,O
it,O
reaches,O
200,O
mg,O
daily,O
",",O
with,O
first,O
dose,O
change,O
10-12,O
to,O
150,O
mg,O
daily,O
and,O
second,O
dose,O
change,O
10-26,O
to,O
200,O
mg,O
daily,O
.,O

Follow,O
up,O
with,O
Dr.,O
Pilcher,O
",",O
Dr.,O
Donnie,O
",",O
and,O
Dr.,O
Harris,O
upon,O
discharge,O
.,O

Call,O
the,O
doctor,O
or,O
go,O
to,O
the,O
emergency,O
room,O
with,O
increased,B-PR
seizure,I-PR
frequency,I-PR
",",O
unresponsiveness,B-PR
",",O
new,B-PR
weakness,I-PR
or,O
numbness,B-PR
",",O
or,O
any,B-PR
other,I-PR
concerning,I-PR
symptoms,I-PR
.,O

Followup,O
Instructions,O
:,O

Please,O
follow,O
up,O
with,O
a,B-TE
repeat,I-TE
MRI,I-TE
in,O
several,O
months,O
to,O
evaluate,O
new,B-PR
lesions,I-PR
in,I-PR
the,I-PR
brain,I-PR
.,O

Follow,O
up,O
with,O
:,O

Dr.,O
Harris,O
(,O
859-847-5149,O
),O
on,O
2015-10-05,O
at,O
915,O
am,O
.,O

Dr.,O
Alejandro,O
((,O
211,O
),O
394-5801,O
),O
on,O
2015-10-20,O
at,O
145,O
pm,O
.,O

Dr.,O
Sheets,O
((,O
506,O
),O
858,O
7552),O
on,O
2015-10-26,O
at,O
10,O
am,O
.,O

Wayne,O
Deloris,O
MD,O
55-122,O

Completed,O
by,O
:,O
Meghan,O
Mark,O
MD,O
99-323,O
2015-09-30,O
@,O
1502,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Sheila,O
SHEEN,O
on,O
:,O
WED,O
2015-09-30,O
4:59,O
PM,O

(,O
End,O
of,O
Report,O
),O

669952543,O

CTMC,O

98431395,O

329475,O

2/8/1990,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Unsigned,O

DIS,O

Admission,O
Date,O
:,O

02/08/1990,O

Report,O
Status,O
:,O

Unsigned,O

Discharge,O
Date,O
:,O

02/13/1990,O

ADMISSION,O
DIAGNOSIS,O
:,O

VULVAR,B-PR
CANCER,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
43-year-old,O
gravida,O
II,O
para,O
II,O
white,O
female,O
referred,O
by,O
Dr.,O
Ca,O
Shuff,O
for,O
evaluation,B-TE
.,O

She,O
was,O
in,O
her,O
usual,O
state,O
of,O
good,O
health,O
until,O
December,O
when,O
she,O
was,O
seen,O
emergently,O
for,O
treatment,B-TR
of,O
a,B-PR
perforated,I-PR
colon,I-PR
cancer,I-PR
.,O

That,O
area,O
was,O
resected,O
with,O
no,O
evidence,O
of,O
metastatic,B-PR
disease,I-PR
.,O

She,O
has,O
had,O
subsequent,B-TE
CEA&apos;s,I-TE
and,O
scans,B-TE
which,O
were,O
negative,O
.,O

A,B-PR
tumor,I-PR
was,O
noted,O
on,O
her,O
vulva,O
which,O
was,O
biopsied,O
and,O
revealed,O
squamous,B-PR
cell,I-PR
carcinoma,I-PR
in,I-PR
situ,I-PR
.,O

ALLERGIES,O
:,O

NO,O
KNOWN,B-PR
DRUG,I-PR
ALLERGIES,I-PR
.,O

MEDICATIONS,O
:,O

None,O
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

As,O
above,O
with,O
colostomy,B-TR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,O
included,O
HEENT,B-TE
exam,I-TE
which,O
was,O
normal,O
.,O

Chest,O
was,O
clear,O
.,O

Heart,O
revealed,O
a,O
regular,O
rate,O
and,O
rhythm,O
.,O

Abdomen,O
was,O
soft,O
and,O
nontender,B-PR
.,O

Vulva,O
and,O
right,O
labia,O
replaced,O
by,O
reddish,B-PR
lesion,I-PR
",",O
somewhat,O
raised,O
in,O
the,O
center,O
extending,O
from,O
adjacent,O
to,O
the,O
cuterus,O
to,O
the,O
posterior,O
forchette,O
.,O

Otherwise,O
",",O
her,B-TE
pelvic,I-TE
exam,I-TE
was,O
negative,O
.,O

IMPRESSION,O
:,O

STAGE,B-PR
II,I-PR
SQUAMOUS,I-PR
CELL,I-PR
CARCINOMA,I-PR
OF,I-PR
THE,I-PR
VULVA,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
plan,O
was,O
for,O
right,B-TR
radical,I-TR
vulvectomy,I-TR
.,O

1.,O
Vulvectomy,B-TR
:,O

The,O
patient,O
on,O
2/8/90,O
underwent,O
a,B-TR
right,I-TR
radical,I-TR
vulvectomy,I-TR
with,O
excellent,O
results,O
and,O
negative,O
margins,O
on,O
frozen,B-TE
section,I-TE
.,O

Her,O
postoperative,O
course,O
was,O
unremarkble,O
.,O

She,O
was,O
kept,O
on,O
bedrest,B-TR
for,O
two,O
days,O
and,O
then,O
was,O
ambulating,O
and,O
voiding,O
well,O
without,O
trouble,O
on,O
postoperative,O
day,O
number,O
three,O
when,O
the,B-TR
Foley,I-TR
catheter,I-TR
was,O
discontinued,O
.,O

She,O
has,O
been,O
doing,O
Betadine,B-TR
paint,I-TR
and,O
blow,O
drying,O
the,O
area,O
several,O
times,O
a,O
day,O
and,O
after,O
each,O
bowel,O
movement,O
and,O
urine,O
without,O
incident,O
.,O

DISPOSITION,O
:,O

The,O
discharge,O
is,O
to,O
home,O
.,O

The,O
patient,O
will,O
follow-up,O
with,O
Dr.,O
Friednantflirt,O
.,O

She,O
will,O
have,O
AH,O
for,O
support,O
.,O

________________________________,O
YT844/9769,O
LAKO,O
SCARVTWI,O
",",O
M.D.,O
TH0,O

D,O
:,O

02/12/90,O

Batch,O
:,O

7753,O

Report,O
:,O

Y6201H2,O

T,O
:,O

02/13/90,O

Dicatated,O
By,O
:,O

RORIEZAILA,O
KOTEKAYSKOTEKAYSCOA,O
",",O
M.D.,O
SE85,O

Admission,O
Date,O
:,O

2014-04-17,O

Discharge,O
Date,O
:,O

2014-04-25,O

Date,O
of,O
Birth,O
:,O

1953-07-04,O

Sex,O
:,O

M,O

Service,O
:,O

CARDIOTHORACIC,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,O
Drugs,B-TR

Attending,O
:,O
Christopher,O
Q,O
Thompson,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Chest,B-PR
pain,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

2014-04-18,O
Off,B-TR
Pump,I-TR
Coronary,I-TR
Artery,I-TR
Bypass,I-TR
Grafting,I-TR
utilizing,O
the,O
left,O
internal,O
mammary,O
artery,O
to,O
left,O
anterior,O
descending,O
artery,O
",",O
free,O
right,O
internal,O
mammary,O
to,O
obtuse,O
marginal,O
and,O
vein,B-TR
graft,I-TR
to,I-TR
diagonal,I-TR
.,O

History,O
of,O
Present,O
Illness,O
:,O

This,O
is,O
a,O
60,O
year,O
old,O
male,O
with,O
new,B-PR
onset,I-PR
chest,I-PR
pain,I-PR
.,O

Nuclear,B-TE
myocardial,I-TE
perfusion,I-TE
study,I-TE
was,O
notable,O
for,O
a,B-PR
moderate,I-PR
fixed,I-PR
defect,I-PR
within,I-PR
the,I-PR
inferior,I-PR
wall,I-PR
and,O
cardiac,O
apex,O
.,O

His,B-TE
ejection,I-TE
fraction,I-TE
however,O
appeared,O
preserved,O
at,O
73%,O
with,O
mild,B-PR
inferior,I-PR
wall,I-PR
hypokinesis,I-PR
.,O

Subsequent,B-TE
cardiac,I-TE
catheterization,I-TE
at,O
Nantucket,O
Cottage,O
Hospital,O
Hospital,O
on,O
2014-04-16,O
was,O
significant,O
for,O
severe,B-PR
two,I-PR
vessel,I-PR
coronary,I-PR
artery,I-PR
disease,I-PR
.,O

Angiography,B-TE
revealed,O
a,B-PR
right,I-PR
dominant,I-PR
system,I-PR
with,O
a,B-PR
40%,I-PR
lesion,I-PR
in,I-PR
the,I-PR
distal,I-PR
left,I-PR
"main,",I-PR
several,B-PR
tight,I-PR
lesions,I-PR
in,I-PR
the,I-PR
proximal,I-PR
and,I-PR
mid,I-PR
left,I-PR
anterior,I-PR
descending,I-PR
artery,I-PR
",",O
and,O
a,B-PR
90%,I-PR
stenosis,I-PR
in,I-PR
the,I-PR
proximal,I-PR
circumflex,I-PR
.,O

The,O
right,O
coronary,O
artery,O
had,O
mild,B-PR
diffuse,I-PR
plaquing,I-PR
but,O
no,O
evidence,O
of,O
focal,B-PR
stenosis,I-PR
.,O

Based,O
upon,O
the,O
above,O
results,O
",",O
he,O
was,O
transferred,O
to,O
the,O
Mediplex,O
Rehab,O
Hospital,O
for,O
surgical,B-TR
revascularization,I-TR
.,O

Past,O
Medical,O
History,O
:,O

Asthma,B-PR

Benign,B-PR
Prostatic,I-PR
Hypertrophy,I-PR

History,O
of,O
Nephrolithiasis,B-PR

Hemorrhoids,B-PR

Social,O
History,O
:,O

Denies,O
tobacco,O
history,O
.,O

Admits,O
to,O
03-08,O
ETOH,O
drinks,O
per,O
week,O
.,O

He,O
works,O
as,O
an,O
accountant,O
.,O

Family,O
History,O
:,O

Mother,O
suffer,O
MI,B-PR
in,O
her,O
50,O
"'s,",O
died,O
at,O
age,O
59,O
.,O

Father,O
died,O
from,O
MI,B-PR
at,O
age,O
72,O
.,O

Physical,O
Exam,O
:,O

Vitals,B-TE
:,O
T,B-TE
98.9,O
",",O
BP,B-TE
148/70,O
",",O
HR,B-TE
57,O
",",O
RR,B-TE
20,O
",",O
SAT,B-TE
95,O
on,O
room,O
air,O

General,O
:,O
well,O
developed,O
male,O
in,O
no,O
acute,B-PR
distress,I-PR

HEENT,O
:,O
oropharynx,O
benign,O
",",O

Neck,O
:,O
supple,O
",",O
no,O
JVD,B-PR
",",O

Heart,O
:,O
regular,O
rate,O
",",O
normal,O
s1s2,O
",",O
no,O
murmur,B-PR
or,O
rub,B-PR

Lungs,O
:,O
clear,O
bilaterally,O

Abdomen,O
:,O
soft,O
",",O
nontender,B-PR
",",O
normoactive,O
bowel,O
sounds,O

Ext,O
:,O
warm,O
",",O
no,O
edema,B-PR
",",O
no,O
varicosities,B-PR

Pulses,B-TE
:,O
2+,O
distally,O
",",O
no,O
carotid,B-PR
or,I-PR
femoral,I-PR
bruits,I-PR

Neuro,O
:,O
nonfocal,O

Pertinent,O
Results,O
:,O

2014-04-17,O
03:58,O
PM,O
BLOOD,B-TE
WBC,B-TE
-,O
6.3,O
RBC,B-TE
-,O
4.60,O
Hgb,B-TE
-,O
15.4,O
Hct,B-TE
-,O
42.9,O
MCV,B-TE
-,O
93,O
MCH,B-TE
-,O
33.4,O
*,O
MCHC,B-TE
-,O
35.8,O
*,O
RDW,B-TE
-,O
12.8,O
Plt,B-TE
Ct,I-TE
-,O
168,O

2014-04-17,O
03:58,O
PM,O
BLOOD,B-TE
PT,B-TE
-,O
13.2,O
*,O
PTT,B-TE
-,O
30.3,O
INR(PT),B-TE
-,O
1.2,O
*,O

2014-04-17,O
03:58,O
PM,O
BLOOD,B-TE
Glucose,B-TE
-,O
92,O
UreaN,B-TE
-,O
15,O
Creat,B-TE
-,O
1.3,O
*,O
Na,B-TE
-,O
142,O
K,B-TE
-,O
4.5,O
Cl,B-TE
-,O
104,O
HCO3,B-TE
-,O
26,O
AnGap,B-TE
-,O
17,O

2014-04-17,O
03:58,O
PM,O
BLOOD,B-TE
ALT,B-TE
-,O
18,O
AST,B-TE
-,O
20,O
AlkPhos,B-TE
-,O
53,O
Amylase,B-TE
-,O
98,O
TotBili,B-TE
-,O
0.6,O

2014-04-17,O
03:58,O
PM,O
BLOOD,B-TE
%HbA1c,B-TE
-,O
5.8,O
[Hgb],B-TE
-,O
DONE,O
[A1c],B-TE
-,O
DONE,O

2014-04-22,O
07:10,O
AM,O
BLOOD,B-TE
WBC,B-TE
-,O
6.5,O
RBC,B-TE
-,O
2.89,O
*,O
Hgb,B-TE
-,O
9.3,O
*,O
Hct,B-TE
-,O
26.4,O
*,O
MCV,B-TE
-,O
92,O
MCH,B-TE
-,O
32.3,O
*,O
MCHC,B-TE
-,O
35.2,O
*,O
RDW,B-TE
-,O
13.8,O
Plt,B-TE
Ct,I-TE
-,O
155,O

2014-04-22,O
07:10,O
AM,O
BLOOD,B-TE
Glucose,B-TE
-,O
97,O
UreaN,B-TE
-,O
11,O
Creat,B-TE
-,O
1.3,O
*,O
Na,B-TE
-,O
142,O
K,B-TE
-,O
4.4,O
Cl,B-TE
-,O
103,O
HCO3,B-TE
-,O
34,O
*,O
AnGap,B-TE
-,O
9,O

2014-04-22,O
07:10,O
AM,O
BLOOD,B-TE
Mg,B-TE
-,O
2.0,O

2014-04-22,O
Chest,B-TE
x-ray,I-TE
:,O
No,O
evidence,O
of,O
pneumothorax,B-PR
.,O

Persistent,B-PR
bibasilar,I-PR
atelectasis,I-PR
and,O
tiny,B-PR
pleural,I-PR
effusions,I-PR
.,O

Stable,B-PR
postoperative,I-PR
cardiac,I-PR
and,I-PR
mediastinal,I-PR
widening,I-PR
.,O

2014-04-24,O
06:35,O
AM,O
BLOOD,B-TE
WBC,B-TE
-,O
6.7,O
RBC,B-TE
-,O
2.96,O
*,O
Hgb,B-TE
-,O
9.1,O
*,O
Hct,B-TE
-,O
28.0,O
*,O
MCV,B-TE
-,O
94,O
MCH,B-TE
-,O
30.9,O
MCHC,B-TE
-,O
32.7,O
RDW,B-TE
-,O
13.6,O
Plt,B-TE
Ct,I-TE
-,O
234,O
#,O

2014-04-25,O
06:45,O
AM,O
BLOOD,B-TE
Glucose,B-TE
-,O
93,O
UreaN,B-TE
-,O
13,O
Creat,B-TE
-,O
1.4,O
*,O
Na,B-TE
-,O
141,O
K,B-TE
-,O
4.6,O
Cl,B-TE
-,O
102,O
HCO3,B-TE
-,O
31,O
AnGap,B-TE
-,O
13,O

2014-04-24,O
06:35,O
AM,O
BLOOD,B-TE
Glucose,B-TE
-,O
96,O
UreaN,B-TE
-,O
13,O
Creat,B-TE
-,O
1.4,O
*,O
Na,B-TE
-,O
143,O
K,B-TE
-,O
4.8,O
Cl,B-TE
-,O
104,O
HCO3,B-TE
-,O
33,O
*,O
AnGap,B-TE
-,O
11,O

Brief,O
Hospital,O
Course,O
:,O

Mr.,O
Chester,O
was,O
admitted,O
to,O
the,O
cardiac,O
surgical,O
service,O
and,O
underwent,O
routine,B-TE
preoperative,I-TE
evaluation,I-TE
.,O

He,O
remained,O
pain,B-PR
free,O
on,O
medical,B-TR
therapy,I-TR
.,O

Workup,B-TE
was,O
unremarkable,O
and,O
he,O
was,O
cleared,O
for,O
surgery,B-TR
.,O

On,O
04-18,O
",",O
Dr.,O
Oneill,O
performed,O
off,B-TR
pump,I-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
grafting,I-TR
.,O

For,O
surgical,O
details,O
",",O
please,O
see,O
seperate,O
dictated,O
operative,O
note,O
.,O

Following,O
the,B-TR
operation,I-TR
",",O
he,O
was,O
brought,O
to,O
the,O
CSRU,O
for,O
invasive,B-TE
monitoring,I-TE
.,O

Within,O
24,O
hours,O
",",O
he,O
awoke,O
neurologically,O
intact,O
and,O
was,O
extubated,O
without,O
incident,O
.,O

Given,O
hypotension,B-PR
and,O
bradycardia,B-PR
",",O
he,O
was,O
slow,B-PR
to,I-PR
wean,I-PR
from,O
Neosynephrine,B-TR
.,O

Low,B-TR
dose,I-TR
beta,I-TR
blockade,I-TR
was,O
eventually,O
resumed,O
.,O

Chest,B-TR
tubes,I-TR
and,O
pacing,B-TR
wires,I-TR
were,O
removed,O
without,O
complication,B-PR
.,O

On,O
postoperative,O
day,O
three,O
",",O
he,O
transferred,O
to,O
the,O
SDU,O
.,O

He,O
maintained,O
a,O
normal,O
sinus,O
rhythm,O
without,O
atrial,B-PR
or,I-PR
ventricular,I-PR
arrhythmias,I-PR
.,O

He,O
remained,O
in,O
sinus,B-PR
bradycardia,I-PR
(,O
rate,O
50-60,O
),O
and,O
tolerated,O
low,B-TR
dose,I-TR
beta,I-TR
blockade,I-TR
.,O

On,O
POD,O
#6,O
his,B-TE
creatinine,I-TE
became,O
slightly,B-PR
elevated,I-PR
at,O
1.4,O
",",O
his,B-TR
lasix,I-TR
was,O
discontinued,O
and,O
the,O
following,O
day,O
his,B-TE
creatinine,I-TE
was,O
stable,O
at,O
1.4,O
.,O

He,O
continued,O
to,O
progress,O
and,O
was,O
eventually,O
cleared,O
for,O
discharge,O
to,O
home,O
on,O
postoperative,O
day,O
7,O
.,O

His,B-TE
discharge,I-TE
chest,I-TE
x-ray,I-TE
showed,O
persistent,B-PR
bibasilar,I-PR
atelectasis,I-PR
with,O
only,O
tiny,B-PR
pleural,I-PR
effusions,I-PR
.,O

Of,O
note,O
",",O
he,O
will,O
need,O
to,O
remain,O
on,O
Plavix,B-TR
for,O
three,O
months,O
postop,O
given,O
the,B-TR
off,I-TR
pump,I-TR
procedure,I-TR
.,O

In,O
addition,O
",",O
he,O
will,O
need,O
to,O
remain,O
on,O
Imdur,B-TR
given,O
use,O
of,O
his,O
right,O
internal,O
mammary,O
artery,O
as,O
a,B-TR
"",I-TR
free,I-TR
"",I-TR
arterial,I-TR
graft,I-TR
in,O
preventing,O

vasospasm,B-PR
.,O

Medications,O
on,O
Admission,O
:,O

Lopressor,B-TR
?,O
dose,O

Aspirin,B-TR
325,O
qd,O

Zocor,B-TR
40,O
qd,O

IV,B-TR
Heparin,I-TR

Discharge,O
Medications,O
:,O

1.,O
Furosemide,B-TR
20,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
once,O
a,O
day,O
for,O
5,O
days,O
.,O

Disp,O
:*,O
5,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

2.,O
Potassium,B-TR
Chloride,I-TR
10,O
mEq,O
Capsule,O
",",O
Sustained,O
Release,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Capsule,O
",",O
Sustained,O
Release,O
PO,O
once,O
a,O
day,O
for,O
5,O
days,O
.,O

Disp,O
:*,O
10,O
Capsule,O
",",O
Sustained,O
Release,O
(s)*,O
Refills,O
:*,O
0,O
*,O

3.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

Disp,O
:*,O
60,O
Capsule,O
(s)*,O
Refills,O
:*,O
0,O
*,O

4.,O
Aspirin,B-TR
81,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
)(s)*,O
Refills,O
:*,O
0,O
*,O

5.,O
Oxycodone,B-TR
-,I-TR
Acetaminophen,I-TR
5-325,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
every,O
4-6,O
hours,O
as,O
needed,O
for,O
pain,B-PR
.,O

Disp,O
:*,O
50,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

6.,O
Simvastatin,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
60,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

7.,O
Fluticasone,B-TR
-,I-TR
Salmeterol,I-TR
250-50,O
mcg,O
/,O
Dose,O
Disk,O
with,O
Device,O
Sig,O
:,O
One,O
(,O
1,O
),O
Disk,O
with,O
Device,O
Inhalation,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

Disp,O
:*,O
1,O
Disk,O
with,O
Device,O
(s)*,O
Refills,O
:*,O
0,O
*,O

8.,O
Isosorbide,B-TR
Mononitrate,I-TR
30,O
mg,O
Tablet,O
Sustained,O
Release,O
24,O
hr,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
Sustained,O
Release,O
24,O
hr,O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Tablet,O
Sustained,O
Release,O
24,O
hr,O
(s)*,O
Refills,O
:*,O
2,O
*,O

9.,O
Clopidogrel,B-TR
75,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
2,O
*,O

10.,O
Metoprolol,B-TR
Succinate,I-TR
25,O
mg,O
Tablet,O
Sustained,O
Release,O
24,O
hr,O
Sig,O
:,O
0.5,O
(,O
half,O
),O
Tablet,O
Sustained,O
Release,O
24,O
hr,O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Tablet,O
Sustained,O
Release,O
24,O
hr,O
(s)*,O
Refills,O
:*,O
0,O
*,O

Discharge,O
Disposition,O
:,O

Home,O
with,O
Service,O

Discharge,O
Diagnosis,O
:,O

Coronary,B-PR
artery,I-PR
disease,I-PR
-,O
s/p,O
Off,B-TR
Pump,I-TR
CABG,I-TR

Sinus,B-PR
Bradycardia,I-PR

Asthma,B-PR

BPH,B-PR

Nephrolithiasis,B-PR

Discharge,O
Condition,O
:,O

Good,O

Discharge,O
Instructions,O
:,O

Follow,O
medications,B-TR
on,O
discharge,O
instructions,O
.,O

Do,O
not,O
drive,O
for,O
4,O
weeks,O
.,O

Do,O
not,O
lift,O
more,O
than,O
10,O
lbs,O
for,O
2,O
months,O
.,O

Shower,O
daily,O
",",O
let,O
water,O
flow,O
over,O
wounds,B-PR
",",O
pat,O
dry,O
with,O
a,O
towel,O
.,O

Do,O
not,O
use,O
creams,O
",",O
lotions,O
",",O
or,O
powders,O
on,O
wounds,B-PR
.,O

Call,O
our,O
office,O
for,O
sternal,B-PR
drainage,I-PR
",",O
temp,B-PR
.>,O
101.5,O

Followup,O
Instructions,O
:,O

Make,O
an,O
appointment,O
with,O
Dr.,O
Aguirre,O
for,O
1-2,O
weeks,O
.,O

Make,O
an,O
appointment,O
with,O
Dr.,O
Keller,O
for,O
4-5,O
weeks,O
.,O

Alice,O
Jordan,O
MD,O
62-102,O

Completed,O
by,O
:,O
Kitty,O
Pamela,O
NP,O
80-BXH,O
2014-04-25,O
@,O
0955,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Bessie,O
R.,O
Conners,O
on,O
:,O
WED,O
2014-05-21,O
9:31,O
AM,O

(,O
End,O
of,O
Report,O
),O

676650879,O
RWH,O

8529404,O

689059,O

5100093,O

10/16/2005,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O

DOUETNOUNBREUNKOLL,O
",",O
STENRESLYSE,O

MRN,O
:,O

8529404,O

Age,O
:,O

55y,O

REGISTRATION,O
DATE,O
:,O

10/16/2005,O
10:38,O
AM,O

PRELIMINARY,O
REPORT,O

This,O
is,O
to,O
notify,O
you,O
that,O
your,O
patient,O
",",O
DOUETNOUNBREUNKOLL,O
",",O
STENRESLYSE,O
arrived,O
in,O
the,O
Emergency,O
Department,O
at,O
Ro,O
Woodma,O
Healthcare,O
on,O
10/16/2005,O
10:38,O
AM,O
.,O

The,O
patient,O
presented,O
with,O
a,O
chief,O
complaint,O
of,O
RLQ,B-PR
PAIN,I-PR
.,O

Following,O
evaluation,B-TE
and,O
treatment,B-TR
",",O
the,O
patient,O
&apos;s,O
disposition,O
at,O
the,O
end,O
of,O
the,O
visit,O
was,O
admitted,O
as,O
an,O
inpatient,O
to,O
Ro,O
Woodma,O
Healthcare,O
.,O

The,O
patient,O
&apos;s,O
preliminary,O
admitting,O
physician,O
is,O
DALEJESC,O
",",O
OIE,O
and,O
the,O
preliminary,O
admitting,O
diagnosis,O
is,O
CHOLECYSTITIS,B-PR
.,O

Please,O
note,O
this,O
information,O
may,O
have,O
been,O
updated,O
on,O
the,O
inpatient,O
unit,O
.,O

If,O
you,O
need,O
additional,O
information,O
please,O
call,O
662-747-1199,O
.,O

PCP,O
Name,O
:,O

BREUTZFREIERM,O
",",O
VIENNEE,O

Provider,O
Number,O
:,O

98704,O

?Admission,O
Date,O
:,O

2014-07-30,O

Discharge,O
Date,O
:,O

2014-08-04,O

Date,O
of,O
Birth,O
:,O

1930-08-11,O

Sex,O
:,O

F,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Penicillins,B-TR

Attending,O
:,O
William,O
Q.,O
Williams,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

dyspnea,B-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

None,O

History,O
of,O
Present,O
Illness,O
:,O

This,O
is,O
an,O
83,O
y/o,O
female,O
with,O
moderate,B-PR
AS,I-PR
",",O
s/p,O
MVR,B-TR
27,O
years,O
ago,O
",",O
s/p,O
PPM,B-TR
",",O
DM,B-PR
",",O
CHF,B-PR
",",O
p/w,O
dsypnea,B-PR
and,O
increased,B-PR
work,I-PR
of,I-PR
breathing,I-PR
x,O
4-5,O
days,O
.,O

Per,O
family,O
",",O
the,O
patient,O
has,O
had,O
worsening,B-PR
CHF/volume,I-PR
overload,I-PR
over,O
the,O
last,O
several,O
weeks,O
",",O
requiring,O
supplemental,B-TR
O2,I-TR
at,O
rehab,O
.,O

Over,O
the,O
last,O
few,O
days,O
",",O
she,O
has,O
been,O
noted,O
to,O
be,O
more,B-PR
short,I-PR
of,I-PR
breath,I-PR
and,O
having,O
sats,B-TE
to,O
60%,O
on,O
RA,O
.,O

Her,B-TR
lasix,I-TR
was,O
increased,O
to,O
60,O
mg,O
bid,O
.,O

Beginning,O
today,O
",",O
she,O
was,O
noted,O
to,O
be,O
in,O
hypoxic,B-PR
respiratory,I-PR
distress,I-PR
",",O
87-91%,O
on,O
2L/NC,B-TR
.,O

She,O
was,O
increased,O
to,O
5L,O
",",O
with,O
her,B-TE
sats,I-TE
going,O
up,O
to,O
97%,O
.,O

She,O
was,O
also,O
noted,O
to,O
be,O
more,B-PR
confused,I-PR
over,O
the,O
last,O
few,O
days,O
and,O
especially,O
today,O
.,O

She,O
was,O
given,O
lasix,B-TR
and,O
2,B-TR
mg,I-TR
IV,I-TR
morphine,I-TR
at,O
New,O
England,O
Sinai,O
Hospital,O
&,O
Rehab,O
Center,O
Rehab,O
",",O
and,O
sent,O
to,O
Nantucket,O
Cottage,O
Hospital,O
for,O
further,B-TE
evaluation,I-TE
.,O

En,O
route,O
",",O
she,O
was,O
given,O
additional,B-TR
lasix,I-TR
of,O
60,O
mg,O
IV,O
and,O
nitro,B-TR
spray,I-TR
x,O
2,O
.,O

In,O
the,O
Deanna,O
",",O
her,B-TE
VS,I-TE
were,O
Tc,B-TE
97.2,O
",",O
BP,B-TE
146/25,O
",",O
HR,B-TE
70,O
",",O
RR,B-TE
27,O
",",O
SaO2,B-TE
95%/NRB,B-TR
.,O

Foley,B-TR
was,O
placed,O
in,O
Deanna,O
.,O

She,O
was,O
given,O
40,O
mg,O
IV,B-TR
lasix,I-TR
and,O
325,O
mg,O
ASA,B-TR
.,O

She,O
was,O
placed,O
on,O
BiPAP,B-TR
for,O
comfort,O
at,O
30%,O
FiO2,B-TR
",",O
5,O
PEEP,B-TR
",",O
12,O
PS,B-TR
.,O

Admitted,O
to,O
the,O
CMED,O
CSRU,O
for,O
further,B-TR
management,I-TR
.,O

Per,O
family,O
",",O
besides,O
the,B-PR
dyspnea,I-PR
and,O
SOB,B-PR
",",O
the,O
patient,O
has,O
had,O
no,O
other,B-PR
symptoms,I-PR
",",O
including,O
f/c/s,B-PR
",",O
CP,B-PR
",",O
palpitations,B-PR
",",O
abd,B-PR
pain,I-PR
",",O
n/v/diarrhea,B-PR
.,O

She,O
has,O
had,O
decreased,B-PR
appetite,I-PR
over,O
the,O
last,O
few,O
days,O
in,O
the,O
context,O
of,O
increasing,B-PR
confusion,I-PR
.,O

Past,O
Medical,O
History,O
:,O

1.,O
Moderate,B-PR
AS,I-PR

2.,O
s/p,O
MVR,B-TR

3.,O
s/p,O
PPM,B-TR

4.,O
A,B-PR
fib,I-PR

5.,O
DM,B-PR
2,I-PR
on,O
insulin,B-TR

6.,O
Hypercholesterolemia,B-PR

7.,O
Gout,B-PR

8.,O
Depression,B-PR

9.,O
?,O
Pulmonary,B-PR
fibrosis,I-PR

10.,O
CHF/CAD,B-PR
",",O
last,B-TE
EF,I-TE
55%,O
4/06,O

Social,O
History,O
:,O

Lives,O
at,O
Salem,O
Hospital,O
-,O
North,O
Shore,O
Medical,O
Center,O
Rehab,O
.,O

Prior,O
h/o,O
heavy,O
tobacco,O
use,O
.,O

Ambulates,O
at,O
baseline,O
.,O

Family,O
History,O
:,O

Mother,O
with,O
h/o,O
emphysema,B-PR
",",O
CAD,B-PR

Physical,O
Exam,O
:,O

General,O
:,O
Asleep,O
",",O
easily,O
arousable,O
.,O

On,O
BiPAP,B-TR
",",O
NAD,B-PR

HEENT,O
:,O
NC/AT,O
",",O
PERRL,O
",",O
EOMI,O
.,O

MMM,O
",",O
OP,O
clear,O

Neck,O
:,O
+,O
elevated,B-PR
JVD,I-PR
to,O
earlobe,O
",",O
supple,O

Chest,O
:,O
decreased,B-PR
BS,I-PR
at,O
bases,O
with,O
few,B-PR
crackles,I-PR
b/l,I-PR

CV,O
:,O
RRR,O
3/6,O
HSM,B-PR
",",O
loudest,O
at,O
LUSB,O

Abd,O
:,O
soft,O
",",O
NT/ND,B-PR
",",O
NABS,O

Ext,O
:,O
2,O
+,O
pitting,B-PR
edema,I-PR
b/l,I-PR
",",O
warm,O
with,O
faint,O
DP,O

Pertinent,O
Results,O
:,O

2014-07-30,O
01:30PM,O

WBC,B-TE
-,O
9.6,O
RBC,B-TE
-,O
4.02,O
*,O
HGB,B-TE
-,O
11.4,O
*,O
HCT,B-TE
-,O
36.3,O
MCV,B-TE
-,O
90,O
MCH,B-TE
-,O
28.4,O
MCHC,B-TE
-,O
31.4,O
RDW,B-TE
-,O
17.8,O
*,O

2014-07-30,O
01:30PM,O

NEUTS,B-TE
-,O
87.0,O
*,O
LYMPHS,B-TE
-,O
6.7,O
*,O
MONOS,B-TE
-,O
5.0,O
EOS,B-TE
-,O
0.9,O
BASOS,B-TE
-,O
0.4,O

2014-07-30,O
01:30PM,O

PLT,B-TE
COUNT,I-TE
-,O
161,O

2014-07-30,O
01:30PM,O

PT,B-TE
-,O
23.2,O
*,O
INR,B-TE
(,O
PT,O
),O
-,O
2.3,O
*,O

2014-07-30,O
01:30PM,O

cTropnT,B-TE
-,O
0.08,O
*,O

2014-07-30,O
01:30PM,O

CK,B-TE
(,I-TE
CPK,I-TE
),I-TE
-,O
37,O

2014-07-30,O
01:30PM,O

cTropnT,B-TE
-,O
0.08,O
*,O

2014-07-30,O
01:30PM,O

CK-MB,B-TE
-,O
NotDone,O
proBNP,B-TE
-,O
5313,O
*,O

2014-07-30,O
01:30PM,O

GLUCOSE,B-TE
-,O
173,O
*,O
UREA,B-TE
N,I-TE
-,O
52,O
*,O
CREAT,B-TE
-,O
1.5,O
*,O
SODIUM,B-TE
-,O
145,O
POTASSIUM,B-TE
-,O
4.8,O
CHLORIDE,B-TE
-,O
100,O
TOTAL,B-TE
CO2,I-TE
-,O
40,O
*,O
ANION,B-TE
GAP,I-TE
-,O
10,O

2014-07-30,O
01:45PM,O

TYPE,O
-,O
ART,B-TE
PO2,I-TE
-,O
249,O
*,O
PCO2,B-TE
-,O
99,O
*,O
PH,B-TE
-,O
7.28,O
*,O
TOTAL,B-TE
CO2,I-TE
-,O
49,O
*,O
BASE,B-TE
XS,I-TE
-,O
15,O
INTUBATED,O
-,O
NOT,O
INTUBA,O

2014-07-30,O
06:20PM,O

TYPE,O
-,O
ART,B-TE
TEMP,I-TE
-,O
37.0,O
O2-90,O
O2,B-TR
FLOW,I-TR
-,O
5,O
PO2,B-TE
-,O
63,O
*,O
PCO2,B-TE
-,O
81,O
*,O
PH,B-TE
-,O
7.39,O
TOTAL,B-TE
CO2,I-TE
-,O
51,O
*,O
BASE,B-TE
XS,I-TE
-,O
19,O
AADO2,B-TE
-,O
513,O
REQ,B-TE
O2,I-TE
-,O
84,O

INTUBATED,O
-,O
NOT,O
INTUBA,O
COMMENTS,O
-,O
NASAL,O
Harper,O

Echo,B-TE
:,O
The,O
left,O
atrium,O
is,O
mildly,B-PR
dilated,I-PR
.,O

There,O
is,O
mild,B-PR
symmetric,I-PR
left,I-PR
ventricular,I-PR
hypertrophy,I-PR
.,O

The,B-TE
left,I-TE
ventricular,I-TE
cavity,I-TE
size,I-TE
is,O
normal,O
.,O

Overall,B-TE
left,I-TE
ventricular,I-TE
systolic,I-TE
function,I-TE
is,O
normal,O
(,O
LVEF,B-TE
70%,O
).,O

There,O
is,O
no,O
ventricular,B-PR
septal,I-PR
defect,I-PR
.,O

The,O
right,O
ventricular,O
free,O
wall,O
is,O
hypertrophied,B-PR
.,O

The,O
right,O
ventricular,O
cavity,O
is,O
dilated,B-PR
.,O

Right,B-TE
ventricular,I-TE
systolic,I-TE
function,I-TE
appears,O
depressed,B-PR
.,O

The,O
aortic,O
arch,O
is,O
mildly,B-PR
dilated,I-PR
.,O

There,O
are,O
focal,B-PR
calcifications,I-PR
in,I-PR
the,I-PR
aortic,I-PR
arch,I-PR
.,O

There,O
are,O
three,B-PR
aortic,I-PR
valve,I-PR
leaflets,I-PR
.,O

The,O
aortic,O
valve,O
leaflets,O
are,O
moderately,B-PR
thickened,I-PR
.,O

There,O
is,O
at,O
least,O
moderate,B-PR
aortic,I-PR
valve,I-PR
stenosis,I-PR
.,O

A,B-TR
bileaflet,I-TR
mitral,I-TR
valve,I-TR
prosthesis,I-TR
is,O
present,O
.,O

The,B-TE
gradients,I-TE
are,O
higher,O
than,O
expected,O
for,O
this,O
type,O
of,O
prosthesis,B-TR
.,O

The,O
tricuspid,O
valve,O
leaflets,O
are,O
mildly,B-PR
thickened,I-PR
.,O

There,O
is,O
moderate,B-PR
pulmonary,I-PR
artery,I-PR
systolic,I-PR
hypertension,I-PR
.,O

The,B-TE
end-diastolic,I-TE
pulmonic,I-TE
regurgitation,I-TE
velocity,I-TE
is,O
increased,B-PR
suggesting,O
pulmonary,B-PR
artery,I-PR
diastolic,I-PR
hypertension,I-PR
.,O

There,O
is,O
no,O
pericardial,B-PR
effusion,I-PR
.,O

Compared,O
with,O
the,O
findings,O
of,O
the,B-TE
prior,I-TE
study,I-TE
(,O
images,O
reviewed,O
),O
of,O
2013-06-18,O
",",O
the,B-TE
pressure,I-TE
gradient,I-TE
across,O
the,B-TR
mitral,I-TR
valve,I-TR
prosthesis,I-TR
is,O
increased,B-PR
.,O

IMPRESSION,O
:,O
AP,B-TE
chest,I-TE
compared,O
to,O
07-30,O
through,O
26,O
:,O
Mild,B-PR
pulmonary,I-PR
edema,I-PR
is,O
unchanged,O
.,O

Bilateral,B-PR
pleural,I-PR
effusion,I-PR
small,O
on,O
the,O
right,O
and,O
moderate,O
on,O
the,O
left,O
is,O
stable,O
.,O

Severe,B-PR
cardiomegaly,I-PR
and,O
left,B-PR
lower,I-PR
lobe,I-PR
atelectasis,I-PR
unchanged,O
.,O

No,O
pneumothorax,B-PR
.,O

Transvenous,B-TR
right,I-TR
ventricular,I-TR
pacer,I-TR
lead,I-TR
in,O
standard,O
placement,O
.,O

ECG,B-TE
:,O
Ventricular,O
paced,O
rhythm,O
.,O

Compared,O
to,O
the,B-TE
previous,I-TE
tracing,I-TE
of,O
2014-07-30,O
no,O
significant,O
change,O
.,O

Intervals,O
Axes,O

Rate,B-TE
PR,B-TE
QRS,B-TE
QT/QTc,B-TE
P,B-TE
QRS,B-TE
T,B-TE
70,O
0,O
160,O
466/486.42,O
0,O
-71,O
112,O

Brief,O
Hospital,O
Course,O
:,O

A/P,O
-,O
83yo,O
F,O
with,O
valvular,B-PR
disorder,I-PR
",",O
AF,B-PR
",",O
and,O
h/o,O
CAD,B-PR
a/w,O
hypercarbic,B-PR
respiratory,I-PR
failure,I-PR
.,O

#,O
Respiratory,B-PR
failure,I-PR
-,O
She,O
was,O
admitted,O
to,O
the,O
CMED,O
CSRU,O
for,O
her,B-PR
repiratory,I-PR
failure,I-PR
which,O
was,O
thought,O
to,O
be,O
secondary,O
to,O
CHF,B-PR
.,O

Pt,O
was,O
diuresed,O
with,O
iv,B-TR
lasix,I-TR
/,O
acetazolamide,B-TR
and,O
given,O
iv,B-TR
morphine,I-TR
/,O
prn,O
for,O
respiratory,B-PR
distress,I-PR
and,O
BIPAP,B-TR
was,O
tried,O
.,O

However,O
",",O
hypercarbia,B-PR
(,O
04-11,O
metabolic,B-PR
alkalosis,I-PR
),O
remained,O
in,O
the,O
90s,O
.,O

Pt,O
was,O
mentating,O
okay,O
",",O
having,O
conversations,O
with,O
intermittent,B-PR
somnolence,I-PR
despite,O
hypercarbia,B-PR
.,O

TTE,B-TE
showed,O
preserved,O
EF,O
with,O
moderate,B-PR
AS,I-PR
and,O
moderate,B-PR
MS,I-PR
and,O
mod,B-PR
pulm,I-PR
HTN,I-PR
.,O

Cardiology,O
was,O
consulted,O
and,O
thought,O
MS,B-PR
Harold,O
Holcomb,O
to,O
her,B-PR
pulm,I-PR
edema,I-PR
and,O
pulm,B-PR
HTN,I-PR
.,O

Cardiology,O
recommended,O
d/cing,O
digoxin,B-TR
and,O
starting,O
amiodarone,B-TR
.,O

Family,O
declined,O
valvuloplasty,B-TR
.,O

For,O
possible,O
COPD,B-PR
",",O
pt,O
was,O
started,O
on,O
steroids,B-TR
and,O
nebs,B-TR
on,O
08-03,O
.,O

Pt,O
is,O
currently,O
satting,B-TE
90s,O
on,O
1,O
L,O
NC,B-TR
while,O
sitting,O
in,O
a,O
chair,O
but,O
needs,O
more,B-TR
O2,I-TR
when,O
supine,O
.,O

Pt,O
is,O
a,O
mouth,O
breather,O
and,O
occasionally,O
needs,O
a,B-TR
face,I-TR
mask,I-TR
.,O

Pt,O
will,O
need,O
I/Os,B-TE
monitored,O
to,O
goal,O
even,O
to,O
slightly,O
negative,O
as,O
she,O
was,O
diursed,O
4.8,O
L,O
during,O
her,O
CMED,O
stay,O
.,O

Depending,O
on,O
her,B-TE
I/O,I-TE
",",O
lasix,B-TR
and,O
acetazolamide,B-TR
can,O
be,O
decreased,O
or,O
discontinued,O
.,O

If,O
she,O
were,O
to,O
decompensate,O
at,O
the,O
rehab,O
",",O
goals,O
of,O
care,O
will,O
need,O
to,O
be,O
readdressed,O
.,O

#,O
h/o,O
CAD,B-PR
-,O
There,O
were,O
new,O
changes,O
on,O
EKG,B-TE
but,O
pt,O
was,O
ruled,O
out,O
with,O
3,O
sets,O
of,O
negative,O
cardiac,O
enzymes,O
.,O

Pt,O
was,O
continued,O
on,O
BB,B-TR
",",O
ASA,B-TR
",",O
and,O
nitrates,B-TR
.,O

#,O
Acid,O
/,O
base,O
status,O
-,O
Respiratory,B-PR
acidosis,I-PR
with,O
metabolic,O
compensation,O
.,O

Appears,O
to,O
be,O
chronic,O
in,O
nature,O
given,O
degree,O
of,O
metabolic,O
compensation,O
with,O
acute,O
component,O
earlier,O
today,O
.,O

Pt,O
failed,O
BIPAP,B-TR
and,O
pCO2,B-TE
remained,O
in,O
the,O
90s,O
but,O
maintaining,O
mentation,O
.,O

#,O
Renal,B-PR
insufficiency,I-PR
-,O
baseline,B-TE
Cr,I-TE
unknown,O
",",O
may,O
have,O
CRI,B-PR
from,O
DM,B-PR
.,O

Creatinine,B-TE
stayed,O
stable,O
from,O
1.3-1.5,O
.,O

Will,O
need,O
to,O
renally,O
dose,O
all,B-TR
medications,I-TR
.,O

#,O
A,B-PR
fib,I-PR
-,O
continued,O
BB,B-TR
.,O

Per,O
cardiology,O
consult,O
recs,O
",",O
discontinued,O
digoxin,B-TR
and,O
started,O
amiodarone,B-TR
.,O

Due,O
to,O
elevated,B-PR
INR,I-PR
",",O
coumadin,B-TR
was,O
held,O
.,O

Pt,O
is,O
also,O
paced,O
.,O

Pt,O
needs,O
to,O
be,O
on,O
amiodarone,B-TR
400mg,O
BID,O
x,O
7,O
days,O
(,O
loading,O
dose,O
),O
and,O
then,O
400mg,O
daily,O
for,O
maintenance,O
.,O

#,O
DM,B-PR
-,O
insulin,B-TR
standing,O
+,O
HISS,O
",",O
FS,O
qid,O

#,O
Depression,B-PR
-,O
continued,B-TR
home,I-TR
regimen,I-TR

#,O
F/E/N,O
-,O
NPO,O
initially,O
while,O
on,O
BIPAP,B-TR
and,O
now,O
low,B-TR
sodium,I-TR
cardiac,I-TR
diet,I-TR
.,O

#,O
PPx,O
-,O
supratherpeutic,B-PR
INR,I-PR

#,O
Access,O
-,O
PIV,B-TR

#,O
Code,O
-,O
DNR/DNI,O
.,O

No,O
pressors,B-TR
or,O
central,B-TR
line,I-TR
per,O
HCP,O
.,O

If,O
she,O
were,O
to,O
decompensate,O
at,O
the,O
rehab,O
",",O
goals,O
of,O
care,O
will,O
need,O
to,O
be,O
readressed,O
.,O

#,O
Communication,O
-,O
Evelyn,O
Matos,O
(,O
niece,O
),O
492,O
-,O
9977,O
",",O
cell,O
(,O
921,O
),O
815,O
-,O
7040,O

Medications,O
on,O
Admission,O
:,O

Coumadin,B-TR
2.5,O
mg,O
/,O
3,O
mg,O

Insulin,B-TR
-,O
Humulin,B-TR
N,I-TR
36,O
U,O
daily,O
/,O
14,O
U,O
qhs,O

Lasix,B-TR
40,O
mg,O
bid,O

Venlafaxine,B-TR
XR,O
75,O
mg,O
qd,O

Sorbitol,B-TR

Metoprolol,B-TR
25,O
mg,O
bid,O

Imdur,B-TR
30,O
mg,O
qd,O

Hydralazine,B-TR
50,O
mg,O
bid,O

Digoxin,B-TR
0.125,O
qd,O

Oscal,B-TR
250,O
mg,O
+,O
D,O

Tylenol,B-TR
prn,O

Morphine,B-TR
sulfate,I-TR
4,O
mg,O
q2,O
hrs,O
prn,O

Discharge,O
Medications,O
:,O

1.,O
NPH,B-TR

18,O
units,O
qam,O
and,O
7,O
units,O
qhs,O

2.,O
Humalog,B-TR

Per,O
sliding,O
scale,O
q,O
breakfast,O
",",O
lunch,O
",",O
and,O
dinner,O

3.,O
Venlafaxine,B-TR
37.5,O
mg,O
Capsule,O
",",O
Sust,O
.,O
Release,O
24,O
hr,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
",",O
Sust,O
.,O
Release,O
24,O
hr,O
PO,O
DAILY,O
(,O
Daily,O
).,O

4.,O
Aspirin,B-TR
325,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

5.,O
Isosorbide,B-TR
Mononitrate,I-TR
30,O
mg,O
Tablet,O
Sustained,O
Release,O
24,O
hr,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
Sustained,O
Release,O
24,O
hr,O
PO,O
DAILY,O
(,O
Daily,O
).,O

6.,O
Metoprolol,B-TR
Tartrate,I-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

7.,O
Albuterol,B-TR
Sulfate,I-TR
0.083,O
%,O
(,O
0.83,O
mg,O
/,O
mL,O
),O
Solution,O
Sig,O
:,O
One,O
(,O
1,O
),O
Inhalation,O
Q6H,O
(,O
every,O
6,O
hours,O
).,O

8.,O
Ipratropium,B-TR
Bromide,I-TR
0.02,O
%,O
Solution,O
Sig,O
:,O
One,O
(,O
1,O
),O

9.,O
Albuterol,B-TR
Sulfate,I-TR
0.083,O
%,O
(,O
0.83,O
mg,O
/,O
mL,O
),O
Solution,O
Sig,O
:,O
One,O
(,O
1,O
),O
Inhalation,O
Q2H,O
(,O
every,O
2,O
hours,O
),O
as,O
needed,O
.,O

10.,O
Prednisone,B-TR
20,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
for,O
4,O
days,O
.,O

11.,O
Furosemide,B-TR
10,O
mg,O
/,O
mL,O
Solution,O
Sig,O
:,O
Forty,O
(,O
40,O
),O
mg,O
Injection,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

12.,O
Acetazolamide,B-TR
Sodium,I-TR
500,O
mg,O
Recon,O
Soln,O
Sig,O
:,O
Two,O
Hundred,O
Fifty,O
(,O
250,O
),O
Recon,O
Soln,O
Injection,O
Q12H,O
(,O
every,O
12,O
hours,O
).,O

13.,O
Morphine,B-TR
2,O
mg,O
/,O
mL,O
Syringe,O
Sig,O
:,O
1-2,O
mg,O
Injection,O
Q4H,O
(,O
every,O
4,O
hours,O
),O
as,O
needed,O
.,O

14.,O
Amiodarone,B-TR
200,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
for,O
7,O
days,O
.,O

15.,O
Amiodarone,B-TR
400,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
once,O
a,O
day,O
:,O
after,O
finishing,O
400mg,O
BID,O
x,O
6,O
days,O
.,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Facility,O
:,O

Whidden,O
Memorial,O
Hospital,O
for,O
the,O
Aged,O
-,O
LTC,O

Discharge,O
Diagnosis,O
:,O

Primary,O
diagnoses,O
:,O

Diastolic,B-PR
congestive,I-PR
heart,I-PR
failure,I-PR

Aortic,B-PR
stenosis,I-PR

Mitral,B-PR
stenosis,I-PR

Possible,O
chronic,B-PR
obstructive,I-PR
lung,I-PR
disease,I-PR

Secondary,O
diagnoses,O
:,O

Coronary,B-PR
artery,I-PR
disease,I-PR

Chronic,B-PR
kidney,I-PR
disease,I-PR

Depression,B-PR

Diabetes,B-PR
mellitus,I-PR

Discharge,O
Condition,O
:,O

Stable,O
",",O
satting,O
98%,O
on,O
1L,B-TR
via,I-TR
NC,I-TR
",",O
sitting,O
up,O
in,O
a,O
chair,O

Discharge,O
Instructions,O
:,O

Please,O
call,O
your,O
doctor,O
at,O
the,O
rehabilitation,O
if,O
you,O
develop,O
any,O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
chest,B-PR
pain,I-PR
",",O
nausea,B-PR
",",O
vomiting,B-PR
",",O
or,O
any,B-PR
other,I-PR
concerning,I-PR
symptoms,I-PR
.,O

Please,O
take,O
medications,B-TR
as,O
instructed,O
.,O

Keep,O
all,O
your,O
follow-up,O
appointments,O
.,O

Followup,O
Instructions,O
:,O

Provider,O
:,O
David,O
Phone,O
:,O
912-6800-0569,O
Date,O
/,O
Time,O
:,O
2014-08-11,O
1:00,O

Jim,O
Stanley,O
MD,O
78-708,O

Completed,O
by,O
:,O
Junko,O
Alpha,O
MD,O
22-842,O
2014-08-04,O
@,O
1725,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Jane,O
B.,O
Hardy,O
on,O
:,O
Sandra,O
2014-08-07,O
11:10,O
AM,O

(,O
End,O
of,O
Report,O
),O

677051476,O

FIH,O

4871976,O

46286/a787,O

826393,O

1/11/1992,O
12:00:00,O
AM,O

GASTRIC,B-PR
CARCINOMA,I-PR

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

01-11-92,O

DISCHARGE,O
DATE,O
:,O

01-22-92,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Gastric,B-PR
carcinoma,I-PR

ASSOCIATED,O
DIAGNOSIS,O
:,O

hypothyroidism,B-PR
following,O
near,B-TR
total,I-TR
thyroidectomy,I-TR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

On,O
1/12/92,O
near,B-TR
total,I-TR
gastrectomy,I-TR
with,O
retrocolic,B-TR
Bill-Roth,I-TR
II,I-TR
gastrojejunostomy,I-TR
",",O
portal,B-TR
node,I-TR
dissection,I-TR
",",O
repair,B-TR
of,O
ventral,B-PR
hernia,I-PR
",",O
and,O
needle,B-TR
jejunostomy,I-TR
tube,I-TR
placement,I-TR
.,O

OTHER,O
PROCEDURES,O
:,O

None,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Ms.,O
Tikrhalt,O
is,O
an,O
86,O
year,O
old,O
female,O
",",O
previously,O
healthy,O
",",O
who,O
presents,O
with,O
a,O
3,O
month,O
history,O
of,O
dysphagia,B-PR
.,O

A,B-TE
subsequent,I-TE
workup,I-TE
including,O
upper,B-TE
gastrointestinal,I-TE
series,I-TE
and,O
abdominal,B-TE
computerized,I-TE
tomography,I-TE
scan,I-TE
suggested,O
the,O
presence,O
of,O
a,B-PR
gastric,I-PR
mass,I-PR
.,O

Endoscopy,B-TE
with,O
biopsy,B-TE
revealed,O
gastric,B-PR
carcinoma,I-PR
",",O
poorly,O
differentiated,O
",",O
within,O
the,O
body,O
of,O
the,O
stomach,O
along,O
the,O
greater,O
curvature,O
.,O

She,O
was,O
subsequently,O
referred,O
to,O
Dr.,O
Ko,O
for,O
a,O
possible,O
resection,B-TR
of,O
this,B-PR
carcinoma,I-PR
.,O

She,O
reports,O
a,B-PR
10,I-PR
pound,I-PR
weight,I-PR
loss,I-PR
over,O
the,O
past,O
several,O
months,O
.,O

She,O
denies,O
any,B-PR
abdominal,I-PR
pain,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Significant,O
for,O
an,B-TR
appendectomy,I-TR
in,O
the,O
distant,O
past,O
",",O
cholecystectomy,B-TR
in,O
the,O
past,O
",",O
history,O
of,O
of,O
Cesarean,B-TR
section,I-TR
in,O
the,O
past,O
and,O
a,O
history,O
of,O
near,B-TR
total,I-TR
thyroidectomy,I-TR
for,O
nodular,B-PR
goiter,I-PR
in,O
the,O
past,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Her,B-TR
only,I-TR
medication,I-TR
is,O
Thyrolar,B-TR
for,O
her,B-PR
relative,I-PR
hypothyroidism,I-PR
following,O
resection,B-TR
.,O

There,O
is,O
a,O
question,O
of,O
an,B-PR
allergy,I-PR
to,O
Tylenol,B-TR
.,O

She,O
denies,O
any,O
history,O
of,O
hypertension,B-PR
",",O
diabetes,B-PR
mellitus,I-PR
",",O
coronary,B-PR
artery,I-PR
disease,I-PR
or,O
peptic,B-PR
ulcer,I-PR
disease,I-PR
.,O

Interestingly,O
",",O
she,O
reports,O
that,O
both,O
her,O
mother,O
and,O
father,O
died,O
of,O
stomach,B-PR
carcinoma,I-PR
.,O

She,O
is,O
a,O
former,O
smoker,O
",",O
and,O
drinks,O
alcohol,O
occasionally,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
physical,B-TE
examination,I-TE
she,O
is,O
an,O
elderly,O
but,O
spry,O
white,O
female,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

Her,O
sclera,O
were,O
nonicteric,B-PR
.,O

Her,O
oropharynx,O
was,O
clear,O
.,O

Her,O
neck,O
was,O
supple,O
without,O
masses,B-PR
or,O
bruits,B-PR
noted,O
.,O

Her,O
lungs,O
were,O
clear,O
to,O
auscultation,B-TE
.,O

Her,B-TE
cardiac,I-TE
examination,I-TE
was,O
unremarkable,O
.,O

Examination,B-TE
of,I-TE
her,I-TE
abdomen,I-TE
revealed,O
a,B-PR
flat,I-PR
nontender,I-PR
abdomen,I-PR
without,O
palpable,B-PR
masses,I-PR
.,O

There,O
were,O
multiple,B-PR
well,I-PR
healed,I-PR
surgical,I-PR
scars,I-PR
.,O

She,O
was,O
guaiac,B-TE
negative,O
.,O

There,O
was,O
no,O
cva,B-PR
tenderness,I-PR
or,O
spinal,B-PR
tenderness,I-PR
noted,O
.,O

Her,B-TE
pulses,I-TE
were,O
intact,O
throughout,O
.,O

LABORATORY,O
DATA,O
:,O

Sodium,B-TE
139,O
",",O
potassium,B-TE
3.7,O
and,O
BUN,B-TE
of,O
19,O
.,O

Her,B-TE
hematocrit,I-TE
was,O
37.2,O
with,O
a,B-TE
white,I-TE
blood,I-TE
count,I-TE
of,O
6.6,O
.,O

Her,B-TE
Bilirubin,I-TE
direct,I-TE
and,O
total,B-TE
were,O
0.1,O
and,O
0.3,O
respectively,O
.,O

Her,B-TE
alkaline,I-TE
phosphatase,I-TE
was,O
134,O
.,O

Her,B-TE
electrocardiogram,I-TE
demonstrated,O
normal,O
sinus,O
rhythm,O
without,O
acute,B-PR
ischemic,I-PR
changes,I-PR
.,O

Chest,B-TE
X-Ray,I-TE
was,O
unremarkable,O
.,O

The,B-TE
assessment,I-TE
at,O
the,O
time,O
of,O
admission,O
was,O
that,O
of,O
an,O
86,O
year,O
old,O
female,O
with,O
poorly,B-PR
differentiated,I-PR
gastric,I-PR
adenocarcinoma,I-PR
",",O
admitted,O
for,O
resection,B-TR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
Service,O
of,O
Dr.,O
Fede,O
A.,O
Duhenile,O
.,O

On,O
1/12/92,O
she,O
was,O
taken,O
to,O
the,O
operating,O
room,O
where,O
she,O
underwent,O
a,B-TR
neart,I-TR
total,I-TR
gastrectomy,I-TR
with,O
a,B-TR
retrocolic,I-TR
Bill-Roth,I-TR
II,I-TR
gastrojejunostomy,I-TR
reconstruction,I-TR
.,O

In,O
addition,O
a,B-PR
small,I-PR
ventral,I-PR
hernia,I-PR
was,O
noted,O
upon,O
abdominal,B-TE
exploration,I-TE
within,O
a,B-TR
previous,I-TR
surgical,I-TR
incision,I-TR
.,O

This,O
was,O
repaired,B-TR
.,O

A,B-TR
needle,I-TR
jejunostomy,I-TR
catheter,I-TR
was,O
placed,O
at,O
the,O
time,O
of,O
her,B-TR
operation,I-TR
to,O
facilitate,O
postoperative,B-TR
nutrition,I-TR
.,O

With,O
regards,O
to,O
the,B-PR
cancer,I-PR
",",O
there,O
was,O
a,B-PR
large,I-PR
mass,I-PR
along,O
the,O
greater,O
curvature,O
in,O
the,O
body,O
of,O
the,O
stomach,O
",",O
and,O
several,O
perigastric,O
lymph,O
nodes,O
which,O
were,O
taken,O
with,O
the,B-TE
specimen,I-TE
.,O

In,O
addition,O
",",O
there,O
were,O
at,O
least,O
two,O
lymph,O
nodes,O
within,O
the,O
porta,O
hepatis,O
which,O
were,O
dissected,B-TR
free,I-TR
and,O
taken,O
en,O
bloc,O
with,O
the,B-TE
specimen,I-TE
.,O

The,O
remainder,O
of,O
her,O
abdomen,O
was,O
unremarkable,O
without,O
evidence,O
of,O
metastatic,B-PR
spread,I-PR
elsewhere,O
",",O
including,O
the,O
liver,O
.,O

The,O
patient,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
and,O
was,O
taken,O
to,O
the,O
recovery,O
room,O
in,O
good,O
condition,O
.,O

The,O
patient,O
's,O
postoperative,O
course,O
was,O
for,O
the,O
most,O
part,O
unremarkable,O
.,O

Her,B-PR
wounds,I-PR
healed,O
well,O
without,O
incident,O
and,O
the,B-TR
needle,I-TR
jejunostomy,I-TR
tube,I-TR
was,O
utilized,O
on,O
the,O
first,O
postoperative,O
day,O
right,O
up,O
until,O
the,O
time,O
of,O
discharge,O
",",O
infusing,O
Vivonex,B-TR
T.E.N.,I-TR

The,O
patient,O
tolerated,O
this,O
without,O
difficulty,B-PR
.,O

The,B-TR
patient,I-TR
's,I-TR
nasogastric,I-TR
tube,I-TR
was,O
removed,O
on,O
the,O
3rd,O
postoperative,O
day,O
",",O
and,O
with,O
the,O
passage,O
of,O
flatus,O
and,O
good,O
bowel,O
sounds,O
noted,O
",",O
she,O
was,O
started,O
on,O
a,B-TR
liquid,I-TR
diet,I-TR
which,O
was,O
advanced,O
slowly,O
.,O

She,O
was,O
seen,O
by,O
the,O
dietician,O
and,O
was,O
advised,O
with,O
regard,O
to,O
needing,O
numerous,O
small,O
meals,O
during,O
the,O
day,O
rather,O
than,O
3,O
larger,O
meals,O
as,O
she,O
previously,O
was,O
used,O
to,O
.,O

Her,O
ambulation,O
and,O
mobilization,O
increased,O
gradually,O
and,O
by,O
the,O
time,O
of,O
discharge,O
she,O
was,O
walking,O
in,O
the,O
halls,O
without,O
assistance,O
.,O

As,O
mentioned,O
",",O
her,B-PR
wounds,I-PR
healed,O
well,O
without,O
incident,O
and,O
the,B-TR
staples,I-TR
were,O
removed,O
on,O
the,O
10th,O
postoperative,O
day,O
just,O
prior,O
to,O
discharge,O
.,O

She,O
had,O
some,B-PR
difficulties,I-PR
with,O
confusion,B-PR
in,O
the,O
early,O
postoperative,O
period,O
which,O
were,O
attributable,O
to,O
her,O
advanced,O
age,O
and,O
a,B-PR
sundowning,I-PR
effect,I-PR
.,O

These,O
problems,O
resolved,O
by,O
the,O
4th,O
or,O
5th,O
postoperative,O
day,O
and,O
she,O
remained,O
lucid,O
and,O
alert,O
for,O
the,O
remainder,O
of,O
her,O
hospital,O
stay,O
.,O

Surgical,O
pathology,O
report,O
was,O
completed,O
prior,O
to,O
discharge,O
which,O
revealed,O
poorly,B-PR
differentiated,I-PR
adenocarcinoma,I-PR
ulcerating,O
and,O
extending,O
through,O
the,O
wall,O
into,O
the,O
serosa,O
of,O
the,O
stomach,O
.,O

Metastatic,B-PR
carcinoma,I-PR
was,O
present,O
in,O
3,O
of,O
3,O
lymph,O
nodes,O
.,O

The,O
gastric,O
resection,O
margins,O
were,O
free,O
of,O
carcinoma,B-PR
.,O

The,O
patient,O
was,O
set,O
for,O
discharge,O
on,O
the,O
11th,O
postoperative,O
day,O
doing,O
well,O
.,O

On,O
the,O
day,O
prior,O
to,O
discharge,O
she,O
complained,O
of,O
some,B-PR
dysuria,I-PR
",",O
a,B-TE
urine,I-TE
specimen,I-TE
was,O
obtained,O
",",O
which,O
showed,O
numerous,B-PR
white,I-PR
cells,I-PR
consistent,O
with,O
a,B-PR
urinary,I-PR
tract,I-PR
infection,I-PR
.,O

She,O
was,O
started,O
empirically,O
on,O
Bactrim,B-TR
",",O
while,O
culture,B-TE
and,O
sensitivity,B-TE
results,O
were,O
pending,O
and,O
remained,O
pending,O
at,O
the,O
time,O
of,O
this,O
dictation,O
.,O

She,O
will,O
be,O
discharged,O
to,O
home,O
and,O
will,O
be,O
seen,O
in,O
follow-up,O
by,O
her,O
regular,O
physicians,O
as,O
well,O
as,O
Dr.,O
Ko,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Bactrim,B-TR
",",I-TR
single,I-TR
strength,I-TR
",",O
one,O
p.o.,O
b.i.d.,O
times,O
10,O
days,O
",",O
initiated,O
9/27/92,O
",",O
Synthroid,B-TR
0.1,O
mg,O
p.o.,O
q.day,O
",",O
Ferrous,B-TR
Gluconate,I-TR
300,O
mg,O
p.o.,O
t.i.d.,O
and,O
Folate,B-TR
1,O
mg,O
p.o.,O
q.,O
day,O
.,O

She,O
will,O
be,O
seen,O
by,O
Visiting,O
Nurses,O
Association,O
to,O
help,O
with,O
general,O
aspects,O
of,O
daily,O
living,O
as,O
well,O
as,O
adequate,O
diet,O
planning,O
following,O
her,B-TR
gastric,I-TR
resection,I-TR
.,O

TOMEDANKELL,O
FLOWAYLES,O
",",O
M.D.,O

TR,O
:,O

cdw,O
/,O
bmot,O

DD,O
:,O

01-21-92,O

TD,O
:,O

01/22/92,O

CC,O
:,O

Dr.,O
Ko,O

Admission,O
Date,O
:,O

2019-04-06,O

Discharge,O
Date,O
:,O

2019-04-15,O

Date,O
of,O
Birth,O
:,O

1938-02-19,O

Sex,O
:,O

M,O

Service,O
:,O
ORTHOPAEDICS,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,I-PR
Drugs,I-PR

Attending,O
:,O
Woodrow,O
Y,O
Williams,O
",",O
M.D.,O

Addendum,O
:,O

On,O
2019-04-12,O
he,O
was,O
transfused,O
with,O
2,O
units,O
of,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
due,O
to,O
post-operative,B-PR
anemia,I-PR
.,O

Mr.,O
Minton,O
did,O
not,O
get,O
his,B-TR
IVIG,I-TR
until,O
2019-04-14,O
.,O

The,B-TR
infusion,I-TR
was,O
completed,O
without,O
incidence,O
.,O

He,O
remained,O
stable,O
with,O
his,B-TE
vital,I-TE
signs,I-TE
and,O
lab,B-TE
data,I-TE
within,O
normal,O
limits,O
.,O

Chief,O
Complaint,O
:,O

see,O
below,O

Pertinent,O
Results,O
:,O

2019-04-15,O
09:25,O
AM,O
BLOOD,B-TE
WBC,I-TE
-,O
3.8,O
*,O
RBC,B-TE
-,O
2.88,O
*,O
Hgb,B-TE
-,O
8.9,O
*,O
Hct,B-TE
-,O
25.9,O
*,O
MCV,B-TE
-,O
90,O
MCH,B-TE
-,O
30.9,O
MCHC,B-TE
-,O
34.3,O
RDW,B-TE
-,O
16.4,O
*,O
Plt,B-TE
Ct,I-TE
-,O
194,O

2019-04-14,O
08:50,O
AM,O
BLOOD,B-TE
WBC,I-TE
-,O
6.5,O
RBC,B-TE
-,O
3.02,O
*,O
Hgb,B-TE
-,O
9.4,O
*,O
Hct,B-TE
-,O
27.1*,O
MCV,B-TE
-,O
90,O
MCH,B-TE
-,O
31.0,O
MCHC,B-TE
-,O
34.6,O
RDW,B-TE
-,O
16.3,O
*,O
Plt,B-TE
Ct,I-TE
-,O
169,O

2019-04-13,O
08:40,O
AM,O
BLOOD,B-TE
WBC,I-TE
-,O
6.7,O
RBC,B-TE
-,O
3.07,O
*,O
Hgb,B-TE
-,O
9.3,O
*,O
Hct,B-TE
-,O
27.1,O
*,O
MCV,B-TE
-,O
88,O
MCH,B-TE
-,O
30.4,O
MCHC,B-TE
-,O
34.5,O
RDW,B-TE
-,O
16.2,O
*,O
Plt,B-TE
Ct,I-TE
-,O
144,O
*,O

2019-04-12,O
08:00,O
PM,O
BLOOD,B-TE
Hct,I-TE
-,O
26.5,O
*,O

2019-04-12,O
06:35,O
AM,O
BLOOD,B-TE
Hct,I-TE
-,O
23.6,O
*,O

2019-04-11,O
12:55,O
PM,O
BLOOD,B-TE
Hct,I-TE
-,O
27.1,O
*,O

2019-04-11,O
09:50,O
AM,O
BLOOD,B-TE
WBC,I-TE
-,O
4.8,O
RBC,B-TE
-,O
3.02,O
*,O
Hgb,B-TE
-,O
9.5,O
*,O
Hct,B-TE
-,O
26.7,O
*,O
MCV,B-TE
-,O
89,O
MCH,B-TE
-,O
31.4,O
MCHC,B-TE
-,O
35.5,O
*,O
RDW,B-TE
-,O
15.2,O
Plt,B-TE
Ct,I-TE
-,O
103,O
*,O

2019-04-11,O
06:27,O
AM,O
BLOOD,B-TE
WBC,I-TE
-,O
4.4,O
RBC,B-TE
-,O
3.03,O
*,O
Hgb,B-TE
-,O
9.5,O
*,O
Hct,B-TE
-,O
26.7,O
*,O
MCV,B-TE
-,O
88,O
MCH,B-TE
-,O
31.2,O
MCHC,B-TE
-,O
35.4,O
*,O
RDW,B-TE
-,O
14.7,O
Plt,B-TE
Ct,I-TE
-,O
94,O
*,O

2019-04-10,O
06:30,O
AM,O
BLOOD,B-TE
WBC,I-TE
-,O
4.6,O
RBC,B-TE
-,O
2.81,O
*,O
Hgb,B-TE
-,O
8.9,O
*,O
Hct,B-TE
-,O
24.8,O
*,O
MCV,B-TE
-,O
88,O
MCH,B-TE
-,O
31.7,O
MCHC,B-TE
-,O
36.0,O
*,O
RDW,B-TE
-,O
15.2,O
Plt,B-TE
Ct,I-TE
-,O
95,O
*,O

2019-04-09,O
06:45,O
AM,O
BLOOD,B-TE
WBC,I-TE
-,O
5.0,O
RBC,B-TE
-,O
3.33,O
*,O
Hgb,B-TE
-,O
10.4,O
*,O
Hct,B-TE
-,O
29.2,O
*,O
MCV,B-TE
-,O
88,O
MCH,B-TE
-,O
31.2,O
MCHC,B-TE
-,O
35.5,O
*,O
RDW,B-TE
-,O
15.0,O
Plt,B-TE
Ct,I-TE
-,O
72,O
*,O

2019-04-08,O
12:27,O
AM,O
BLOOD,B-TE
WBC,I-TE
-,O
4.9,O
RBC,B-TE
-,O
3.11,O
*,O
Hgb,B-TE
-,O
9.9,O
*,O
Hct,B-TE
-,O
27.1,O
*,O
MCV,B-TE
-,O
87,O
MCH,B-TE
-,O
32.0,O
MCHC,B-TE
-,O
36.6,O
*,O
RDW,B-TE
-,O
15.5,O
Plt,B-TE
Ct,I-TE
-,O
107,O
*,O

2019-04-07,O
04:53,O
PM,O
BLOOD,B-TE
WBC,I-TE
-,O
4.4,O
RBC,B-TE
-,O
2.92,O
*,O
Hgb,B-TE
-,O
9.6,O
*#,O
Hct,B-TE
-,O
25.8,O
*,O
MCV,B-TE
-,O
88,O
MCH,B-TE
-,O
32.8,O
*,O
MCHC,B-TE
-,O
37.1,O
*,O
RDW,B-TE
-,O
14.9,O
Plt,B-TE
Ct,I-TE
-,O
81,O
*,O

2019-04-07,O
11:00,O
AM,O
BLOOD,B-TE
WBC,I-TE
-,O
4.4,O
RBC,B-TE
-,O
2.34,O
*#,O
Hgb,B-TE
-,O
7.5,O
*,O
Hct,B-TE
-,O
21.2,O
*#,O
MCV,B-TE
-,O
91,O
MCH,B-TE
-,O
32.1,O
*,O
MCHC,B-TE
-,O
35.4,O
*,O
RDW,B-TE
-,O
14.5,O
Plt,B-TE
Ct,I-TE
-,O
94,O
*,O

2019-04-07,O
06:00,O
AM,O
BLOOD,B-TE
WBC,I-TE
-,O
3.2,O
*#,O
RBC,B-TE
-,O
3.14,O
*,O
Hgb,B-TE
-,O
10.0,O
*,O
Hct,B-TE
-,O
28.9,O
*,O
MCV,B-TE
-,O
92,O
MCH,B-TE
-,O
32.0,O
MCHC,B-TE
-,O
34.8,O
RDW,B-TE
-,O
14.1,O
Plt,B-TE
Ct,I-TE
-,O
82,O
*#,O

2019-04-06,O
10:40,O
AM,O
BLOOD,B-TE
WBC,I-TE
-,O
2.1,O
*,O
RBC,B-TE
-,O
3.51,O
*,O
Hgb,B-TE
-,O
10.9,O
*,O
Hct,B-TE
-,O
31.7,O
*,O
MCV,B-TE
-,O
90,O
MCH,B-TE
-,O
31.1,O
MCHC,B-TE
-,O
34.5,O
RDW,B-TE
-,O
14.3,O
Plt,B-TE
Ct,I-TE
-,O
50,O
*,O

2019-04-15,O
09:25,O
AM,O
BLOOD,B-TE
Plt,I-TE
Ct,I-TE
-,O
194,O

2019-04-14,O
08:50,O
AM,O
BLOOD,B-TE
Plt,I-TE
Ct,I-TE
-,O
169,O

2019-04-14,O
08:50,O
AM,O
BLOOD,B-TE
PT,I-TE
-,O
12.0,O
INR(PT),B-TE
-,O
1.0,O

2019-04-15,O
09:25,O
AM,O
BLOOD,B-TE
Glucose,I-TE
-,O
134,O
*,O
UreaN,B-TE
-,O
19,O
Creat,B-TE
-,O
0.8,O
Na,B-TE
-,O
135,O
K,B-TE
-,O
3.5,O
Cl,B-TE
-,O
100,O
HCO3,B-TE
-,O
28,O
AnGap,B-TE
-,O
11,O

Discharge,O
Medications,O
:,O

1.,O
Cholecalciferol,B-TR
(,I-TR
Vitamin,I-TR
D3,I-TR
),I-TR
400,O
unit,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

2.,O
Pantoprazole,B-TR
40,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
Q24H,O
(,O
every,O
24,O
hours,O
).,O

3.,O
Lorazepam,B-TR
0.5,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
as,O
needed,O
for,O
anxiety,B-PR
.,O

4.,O
Acetaminophen,B-TR
325,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
Q4H,O
(,O
every,O
4,O
hours,O
).,O

5.,O
Lisinopril,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

6.,O
Senna,B-TR
8.6,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
as,O
needed,O
.,O

7.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

8.,O
Enoxaparin,B-TR
30,O
mg,O
/,O
0.3,O
mL,O
Syringe,O
Sig,O
:,O
One,O
(,O
1,O
),O

9.,O
Oxycodone,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
.,O

10.,O
Bisacodyl,B-TR
5,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
DAILY,O
(,O
Daily,O
),O
as,O
needed,O
.,O

11.,O
Magnesium,B-TR
Hydroxide,I-TR
400,O
mg,O
/,O
5,O
mL,O
Suspension,O
Sig,O
:,O
Thirty,O
(,O
30,O
),O
ML,O
PO,O
Q6H,O
(,O
every,O
6,O
hours,O
),O
as,O
needed,O
.,O

12.,O
Trazodone,B-TR
50,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
HS,O
(,O
at,O
bedtime,O
),O
as,O
needed,O
for,O
insomnia,B-PR
.,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Facility,O
:,O

Lemuel,O
Shattuck,O
Hospital,O
-,O
Malden,O

Michelle,O
Franklin,O
MD,O
31-164,O

Completed,O
by,O
:,O
Celia,O
Gloria,O
NP,O
80-CCZ,O
2019-04-15,O
@,O
1049,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Michelle,O
K.,O
Partin,O
on,O
:,O
WED,O
2019-04-17,O
1:13,O
PM,O

(,O
End,O
of,O
Report,O
),O

693519617,O

PUOMC,O

2328487,O

769151,O

388371,O

12/16/1997,O
12:00:00,O
AM,O

END-STAGE,B-PR
RENAL,I-PR
DISEASE,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

LESS,O
",",O
LIESEANALE,O

UNIT,O
NUMBER,O
:,O

589-25-50,O

ADMISSION,O
DATE,O
:,O

12/16/97,O

DISCHARGE,O
DATE,O
:,O

01/16/98,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

End-stage,B-PR
renal,I-PR
disease,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

1.,O
Right,B-TR
nephrectomy,I-TR
.,O

2.,O
Cadaveric,B-TR
renal,I-TR
transplant,I-TR
.,O

3.,O
Acute,B-PR
thrombosis,I-PR
.,O

4.,O
Transplant,B-TR
nephrectomy,I-TR
.,O

5.,O
Pulmonary,B-PR
emboli,I-PR
.,O

6.,O
Hypertension,B-PR
.,O

7.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
.,O

8.,O
Chronic,B-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
.,O

9.,O
Hypercoagulable,B-PR
state,I-PR
.,O

10.,O
Perforated,B-PR
viscus,I-PR
.,O

11.,O
Abdominal,B-PR
abscesses,I-PR
.,O

12.,O
Sepsis,B-PR
.,O

13.,O
Respiratory,B-PR
failure,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
was,O
a,O
53-year-old,O
male,O
with,O
a,O
longstanding,O
history,O
of,O
renal,B-PR
disease,I-PR
with,O
multiple,B-PR
complications,I-PR
and,O
problems,B-PR
related,O
to,O
vascular,O
access,O
and,O
hypercoagulable,B-PR
state,I-PR
.,O

These,O
culminated,O
in,O
an,B-TR
attempted,I-TR
cadaveric,I-TR
kidney,I-TR
transplant,I-TR
undertaken,O
on,O
12/16/97,O
",",O
which,O
was,O
complicated,O
by,O
thrombosis,B-PR
and,O
necrosis,B-PR
of,I-PR
the,I-PR
cadaveric,I-PR
renal,I-PR
vein,I-PR
within,O
24,O
hours,O
.,O

This,O
required,O
a,B-TR
transplant,I-TR
nephrectomy,I-TR
.,O

HOSPITAL,O
COURSE,O
AND,O
TREATMENT,O
:,O

The,O
patient,O
&apos;s,O
course,O
was,O
subsequently,O
characterized,O
by,O
recurrent,B-PR
pneumonias,I-PR
",",O
possibly,O
due,O
to,O
aspiration,B-PR
",",O
and,O
by,O
hemodynamic,B-PR
instability,I-PR
.,O

He,O
was,O
transferred,O
to,O
the,O
Medical,O
Intensive,O
Care,O
Unit,O
from,O
the,O
Transplant,O
Service,O
for,O
ventilatory,B-TR
management,I-TR
in,O
the,O
setting,O
of,O
hypotension,B-PR
.,O

On,O
transfer,O
",",O
the,O
patient,O
was,O
not,O
sedated,B-TR
",",O
but,O
was,O
unresponsive,B-PR
and,O
extremely,B-PR
dyssynchronous,I-PR
with,O
the,B-TR
ventilator,I-TR
.,O

The,O
patient,O
was,O
found,O
to,O
have,O
substantial,B-PR
auto,I-PR
PEEP,I-PR
with,O
an,B-PR
elevated,I-PR
dead,I-PR
space,I-PR
.,O

A,B-TE
pulmonary,I-TE
arteriogram,I-TE
on,O
01/03/98,O
demonstrated,O
multiple,B-PR
pulmonary,I-PR
emboli,I-PR
",",O
likely,O
less,O
than,O
one,O
week,O
old,O
",",O
possibly,O
introduced,O
at,O
the,O
time,O
of,O
the,B-PR
renal,I-PR
vein,I-PR
thrombosis,I-PR
of,O
12/19/97,O
.,O

An,B-TR
inferior,I-TR
vena,I-TR
cava,I-TR
filter,I-TR
was,O
placed,O
;,O
lower,B-TE
extremity,I-TE
noninvasive,I-TE
studies,I-TE
were,O
negative,O
.,O

The,O
patient,O
required,O
high,B-TR
pressures,I-TR
to,O
ventilate,O
adequately,O
",",O
possibly,O
related,O
to,O
an,B-PR
abdominal,I-PR
compartment,I-PR
syndrome,I-PR
.,O

The,O
patient,O
had,O
undergone,O
two,B-TR
abdominal,I-TR
procedures,I-TR
following,O
explantation,O
.,O

The,O
physiology,O
at,O
the,O
time,O
of,O
transfer,O
to,O
the,O
Medical,O
Intensive,O
Care,O
Unit,O
was,O
consistent,O
with,O
a,B-PR
septic,I-PR
process,I-PR
.,O

CT,B-TE
scan,I-TE
demonstrated,O
retroperitoneal,B-PR
collection,I-PR
containing,O
both,O
free,B-PR
air,I-PR
and,O
extravasated,B-PR
contrast,I-PR
material,I-PR
.,O

For,O
the,O
concern,O
of,O
a,B-PR
perforated,I-PR
viscus,I-PR
",",O
the,O
patient,O
was,O
taken,O
to,O
exploratory,B-TE
laparotomy,I-TE
on,O
01/06/98,O
",",O
during,O
which,O
the,O
bowel,O
was,O
run,O
without,O
evidence,O
of,O
perforation,B-PR
.,O

The,O
patient,O
remained,O
unstable,B-PR
.,O

He,O
was,O
taken,O
to,O
fluoroscopy,B-TE
",",O
where,O
oral,B-TE
contrast,I-TE
was,O
demonstrated,O
to,O
be,O
extravasating,O
through,O
a,O
posterior,O
duodenum,O
.,O

For,O
this,O
reason,O
",",O
he,O
was,O
taken,O
again,O
to,O
the,O
operating,O
room,O
on,O
01/08/98,O
",",O
at,O
which,O
time,O
a,B-TR
gastrojejunostomy,I-TR
was,O
performed,O
with,O
stapling,B-TR
across,I-TR
the,I-TR
gastroduodenal,I-TR
junction,I-TR
",",O
introduction,O
of,O
five,B-TR
Jackson-Pratt,I-TR
drains,I-TR
into,O
the,B-PR
retroperitoneal,I-PR
mass,I-PR
",",O
cholecystotomy,B-TR
tube,I-TR
",",O
gastrostomy,B-TR
tube,I-TR
",",O
and,O
jejunostomy,B-TR
tube,I-TR
.,O

The,O
patient,O
had,O
an,B-PR
extensive,I-PR
estimated,I-PR
blood,I-PR
loss,I-PR
requiring,O
multiple,B-TR
blood,I-TR
products,I-TR
and,O
fluid,B-TR
resuscitation,I-TR
therapy,I-TR
.,O

Accompanying,O
this,O
during,O
this,O
period,O
were,O
elevations,B-PR
in,O
liver,B-TE
function,I-TE
studies,I-TE
and,O
amylase,B-TE
and,O
lipase,B-TE
consistent,O
with,O
pancreatic,B-PR
inflammation,I-PR
.,O

The,O
patient,O
was,O
aggressively,O
treated,O
with,O
fluid,B-TR
resuscitation,I-TR
and,O
pressors,B-TR
for,O
his,B-PR
septic,I-PR
physiology,I-PR
.,O

There,O
was,O
no,O
evidence,O
of,O
cardiac,B-PR
tamponade,I-PR
or,O
specific,B-PR
underlying,I-PR
coronary,I-PR
dysfunction,I-PR
.,O

He,O
was,O
treated,O
with,O
appropriate,B-TR
antibiotics,I-TR
for,O
his,B-PR
Serratia,I-PR
pneumonia,I-PR
",",O
as,O
well,O
as,O
for,O
his,B-PR
abdominal,I-PR
process,I-PR
.,O

The,O
patient,O
was,O
felt,O
to,O
have,O
an,B-PR
underlying,I-PR
hypercoagulable,I-PR
state,I-PR
",",O
thought,O
to,O
be,O
the,O
source,O
for,O
the,B-PR
repeated,I-PR
clots,I-PR
.,O

Because,O
of,O
the,B-PR
bleeding,I-PR
problems,I-PR
",",O
however,O
",",O
it,O
was,O
felt,O
that,O
full,B-TR
heparinization,I-TR
would,O
not,O
be,O
prudent,O
",",O
and,O
the,O
patient,O
was,O
treated,O
with,O
pneumo-boots,B-TR
and,O
subcutaneous,B-TR
heparin,I-TR
.,O

Attention,O
was,O
paid,O
to,O
a,O
variety,O
of,O
metabolic,B-PR
and,I-PR
electrolyte,I-PR
abnormalities,I-PR
",",O
which,O
were,O
corrected,O
appropriately,O
.,O

Nonetheless,O
",",O
Mr.,O
Less,O
continued,O
to,O
remain,O
critically,B-PR
ill,I-PR
with,O
only,O
very,O
transient,O
mild,O
improvement,O
with,O
drainage,B-TR
of,O
additional,B-PR
retroperitoneal,I-PR
fluid,I-PR
.,O

He,O
remained,O
pressor,B-PR
dependent,I-PR
",",O
as,O
well,O
as,O
dependent,B-PR
upon,O
mechanical,B-TR
ventilatory,I-TR
assistance,I-TR
.,O

His,O
course,O
was,O
complicated,O
by,O
atrial,B-PR
fibrillation,I-PR
requiring,O
cardioversion,B-TR
.,O

He,O
had,O
an,B-PR
ongoing,I-PR
requirement,I-PR
for,O
high,B-TR
volume,I-TR
resuscitation,I-TR
and,O
was,O
persistently,B-PR
acidotic,I-PR
despite,O
CV-VVH,B-TR
in,O
the,O
face,O
of,O
bicarbonate,B-TR
replenishment,I-TR
.,O

The,O
patient,O
also,O
appeared,O
to,O
have,O
stool,O
from,O
his,B-PR
Jackson-Pratt,I-PR
site,I-PR
and,O
right,B-PR
oblique,I-PR
incision,I-PR
.,O

Bloody,B-PR
drainage,I-PR
from,O
his,B-PR
increasingly,I-PR
distended,I-PR
abdomen,I-PR
was,O
noted,O
.,O

Extensive,O
discussions,O
were,O
carried,O
out,O
with,O
Mrs.,O
Less,O
condition,O
was,O
irretrievable,O
.,O

It,O
was,O
felt,O
that,O
the,O
patient,O
had,O
continued,O
massive,B-PR
retroperitoneal,I-PR
contamination,I-PR
and,O
probable,O
multiple,B-PR
enteric,I-PR
fistulae,I-PR
from,O
an,B-PR
ischemic,I-PR
bowel,I-PR
.,O

Dr.,O
Cantsleddjesc,O
felt,O
that,O
no,O
surgical,B-TR
approach,I-TR
to,O
this,B-PR
problem,I-PR
or,O
further,B-TR
intervention,I-TR
or,O
radiologic,B-TR
procedures,I-TR
would,O
be,O
helpful,O
.,O

All,O
physicians,O
and,O
the,O
family,O
were,O
in,O
agreement,O
that,O
the,O
most,O
appropriate,O
approach,O
was,O
to,O
institute,O
comfort,B-TR
measures,I-TR
.,O

This,O
was,O
done,O
",",O
and,O
the,O
patient,O
appeared,O
to,O
be,O
comfortable,O
at,O
the,O
time,O
of,O
death,O
with,O
his,O
family,O
at,O
his,O
side,O
on,O
1/16/98,O
.,O

I,O
L.,O
STERPSKOLK,O
",",O
M.D.,O

TR,O
:,O

vcp,O

DD,O
:,O

05/25/98,O

TD,O
:,O

05/30/98,O
8:30,O
A,O

cc,O
:,O

LE,O
FREIERM,O
",",O
JR,O
",",O
M.D.,O
KIVERL,O
NA,O
CANTSLEDDJESC,O
",",O
M.D.,O
I,O
LYNIN,O
STERPSKOLK,O
",",O
M.D.,O
ETI,O
CHAELKA,O
MULKEVI,O
",",O
M.D.,O

cc,O
:,O

Dr.,O
Less,O

Admission,O
Date,O
:,O

2013-03-27,O

Discharge,O
Date,O
:,O

2013-04-01,O

Date,O
of,O
Birth,O
:,O

1954-08-12,O

Sex,O
:,O

F,O

Service,O
:,O
NEUROSURGERY,O

Allergies,O
:,O

Shellfish,O

Attending,O
:,O
Sam,O
K.,O
Laudato,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

s/p,O
MVC,O

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

none,O

History,O
of,O
Present,O
Illness,O
:,O

58,O
yo,O
female,O
s/p,O
high,O
speed,O
MVC,O
.,O

She,O
lost,O
contaol,O
of,O
her,O
car,O
",",O
she,O
hit,O
the,O
Barnes,O
rails,O
then,O
the,O
car,O
stopped,O
.,O

Another,O
car,O
was,O
coming,O
behind,O
her,O
did,O
not,O
see,O
her,O
car,O
",",O
hit,O
again,O
",",O
the,O
person,O
checked,O
the,O
car,O
",",O
she,O
was,O
not,O
inside,O
.,O

+LOC,B-PR
",",O
GCS:14,B-TE
.,O

She,O
ejected,O
.,O

She,O
brought,O
by,O
EMS,O
to,O
Nantucket,O
Cottage,O
Hospital,O
for,O
furher,B-TE
evaluation,I-TE
.,O

Past,O
Medical,O
History,O
:,O

1.,O
EtOH,O
addiction,O
in,O
past,O

2.,O
h/o,O
depression,B-PR

3.,O
?,O
h/o,O
hypomania,B-PR

4.,O
L5-S1,B-PR
spondylolisthesis,I-PR

all,O
:,O
no,O
known,B-PR
drug,I-PR
allergies,I-PR

Social,O
History,O
:,O

divorced,O
twice,O
.,O

smokes,O
1ppd,O
for,O
many,O
years,O
",",O
no,O
EtOH,O
or,O
illicit,O
drug,O
use,O
.,O

Family,O
History,O
:,O

brother,O
who,O
was,O
alcoholic,O

Physical,O
Exam,O
:,O

O,O
:,O
T,B-TE
:,O
100.1,O
BP,B-TE
:,O
162/84,O
HR,B-TE
:,O
80,O
RR,B-TE
:,O
20,O
O2Sats,B-TE
:,O
100,O

Gen,O
:,O
lying,O
in,O
strecther,O
",",O
NAD,B-PR
",",O
shaking,B-PR
om,I-PR
bilateral,I-PR
lower,I-PR
extremities,I-PR
.,O

HEENT,O
:,O
Neck,O
Supple,O
",",O
right,O
CMED,O
CCU,O
ecchymotic,B-PR
and,O
edematous,B-PR
",",O
c-collor,B-TR
in,O
place,O
.,O

Lungs,O
:,O
CTA,O
bilaterally,O
.,O

Cardiac,O
:,O
RRR,O
.,O

S1/S2,O
.,O

Abd,O
:,O
Soft,O
",",O
NT,B-PR
",",O
BS+,O

Extrem,O
:,O
Cool,O
",",O
No,O
C/C/E,B-PR
.,O

Neuro,O
:,O

Mental,O
status,O
:,O
Awake,O
and,O
alert,O
",",O
cooperative,O
with,O
exam,B-TE
",",O
normal,O
affect,O
.,O

Orientation,O
:,O
Oriented,O
to,O
person,O
",",O
place,O
",",O
and,O
date,O
.,O

Language,O
:,O
Speech,O
fluent,O
with,O
good,O
comprehension,O
and,O
repetition,O
.,O

Naming,O
intact,O
.,O

No,O
dysarthria,B-PR
or,O
paraphasic,B-PR
errors,I-PR
.,O

Cranial,O
Nerves,O
:,O

I:,O
Not,O
tested,O

II:,O
Pupils,O
equally,O
round,O
and,O
reactive,O
to,O
light,O
",",O
3to,O
2,O
mm,O
bilaterally,O
.,O

Visual,O
fields,O
are,O
full,O
to,O
confrontation,B-TE
.,O

III,O
",",O
IV,O
",",O
VI:,O
Extraocular,O
movements,O
intact,O
bilaterally,O
without,O
nystagmus,B-PR
.,O

V,O
",",O
VII:,O
Facial,O
strength,O
and,O
sensation,O
intact,O
and,O
symmetric,O
.,O

VIII:,O
Hearing,O
intact,O
to,O
finger,B-TE
rub,I-TE
bilaterally,O
.,O

IX,O
",",O
X:,O
Palatal,O
elevation,O
symmetrical,O
.,O

XI:,O
Sternocleidomastoid,O
and,O
trapezius,O
normal,O
bilaterally,O
.,O

XII:,O
Tongue,O
midline,O
without,O
fasciculations,B-PR
.,O

Motor,O
:,O
Normal,O
bulk,O
and,O
tone,O
bilaterally,O
.,O

No,O
abnormal,B-PR
movements,I-PR
",",O
tremors,B-PR
.,O

Strength,B-TE
full,O
power,O
05-31,O
execept,O
Right,O
Dubord,O
03-31,O
.,O

No,O
pronator,B-PR
drift,I-PR

Sensation,B-TE
:,O
Intact,O
to,O
light,B-TE
touch,I-TE
",",O
propioception,B-TE
",",O
pinprick,B-TE
execept,O
decreased,B-PR
sensation,I-PR
L5-S1,I-PR
distrubution,I-PR
.,O

Reflexes,B-TE
:,O

Right,O
:,O
B,B-TE
-,O
2,O
;,O
T,B-TE
-,O
2,O
;,O
Br,B-TE
-,O
2,O
;,O
Pa,B-TE
-,O
2,O
;,O
Ac,B-TE
-,O
2,O

Left,O
:,O
B,B-TE
-,O
2,O
;,O
T,B-TE
-,O
2,O
;,O
Br,B-TE
-,O
2,O
;,O
Pa,B-TE
-,O
2,O
;,O
Ac,B-TE
-,O
2,O

Toes,O
downgoing,O
bilaterally,O

Coordination,O
:,O
normal,O
finger-nose-finger,B-TE

Pertinent,O
Results,O
:,O

2013-03-27,O
12:59,O
AM,O
URINE,B-TE
COLOR,I-TE
-,O
Yellow,O
APPEAR,B-TE
-,O
Clear,O
SP,B-TE
Stickney,I-TE
-,O
1.032,O

2013-03-27,O
12:59,O
AM,O
URINE,B-TE
BLOOD,I-TE
-,O
NEG,O
NITRITE,B-TE
-,O
NEG,O
PROTEIN,B-TE
-,O
TR,O
GLUCOSE,B-TE
-,O
NEG,O
KETONE,B-TE
-,O
50,O
BILIRUBIN,B-TE
-,O
NEG,O
UROBILNGN,B-TE
-,O
1,O
PH,B-TE
-,O
7.0,O
LEUK,B-TE
-,O
NEG,O

2013-03-27,O
12:59,O
AM,O
URINE,B-TE
RBC-,I-TE
0-2,O
WBC,B-TE
-,O
0,O
BACTERIA,B-TE
-,O
NONE,O
YEAST,B-TE
-,O
NONE,O
EPI,B-TE
-,O
0-2,O

2013-03-27,O
12:59,O
AM,O
WBC,B-TE
-,O
5.0,O
RBC,B-TE
-,O
4.23,O
HGB,B-TE
-,O
13.4,O
HCT,B-TE
-,O
38.5,O
MCV,B-TE
-,O
91,O
MCH,B-TE
-,O
31.8,O
MCHC,B-TE
-,O
34.9,O
RDW,B-TE
-,O
12.7,O

2013-03-27,O
12:59,O
AM,O
PLT,B-TE
COUNT,I-TE
-,O
213,O

2013-03-27,O
12:59,O
AM,O
URINE,B-TE
bnzodzpn,I-TE
-,O
NEG,O
barbitrt,B-TE
-,O
NEG,O
opiates,B-TE
-,O
NEG,O
cocaine,B-TE
-,O
NEG,O
amphetmn,B-TE
-,O
POS,O
mthdone,B-TE
-,O
NEG,O

2013-03-27,O
01:09,O
AM,O
HGB,B-TE
-,O
13.4,O
calcHCT,B-TE
-,O
40,O
O2,B-TE
SAT,I-TE
-,O
95,O
CARBOXYHB,B-TE
-,O
1.2,O
MET,B-TE
HGB,I-TE
-,O
0.2,O

2013-03-27,O
12:59,O
AM,O
UREA,B-TE
N,I-TE
-,O
21,O
*,O
CREAT,B-TE
-,O
0.8,O

2013-03-27,O
02:25,O
AM,O
PT,B-TE
-,O
13.2,O
*,O
PTT,B-TE
-,O
22.9,O
INR(PT),B-TE
-,O
1.2,O
*,O

Brief,O
Hospital,O
Course,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
Nantucket,O
Cottage,O
Hospital,O
on,O
2013-03-27,O
following,O
a,O
motor,O
vehicle,O
crash,O
as,O
described,O
previously,O
.,O

Chest,B-TE
and,I-TE
pelvis,I-TE
X-rays,I-TE
were,O
negative,O
for,O
fractures,B-PR
.,O

A,B-TE
CT,I-TE
of,I-TE
her,I-TE
head,I-TE
demonstrated,O
intraparenchymal,B-PR
and,I-PR
extraaxial,I-PR
blood,I-PR
(,I-PR
mostly,I-PR
subarachnoid,I-PR
),I-PR
in,I-PR
bilateral,I-PR
cerebral,I-PR
hemispheres,I-PR
",",O
right,O
greater,O
than,O
left,O
",",O
in,O
a,O
pattern,O
indicating,O
contrecoup,B-PR
injury,I-PR
.,O

A,B-TE
CT,I-TE
of,I-TE
her,I-TE
C-spine,I-TE
revealed,O
a,O
possible,O
fracture,B-PR
of,I-PR
right,I-PR
C7,I-PR
pedicle,I-PR
.,O

A,B-TE
CT,I-TE
of,I-TE
her,I-TE
chest,I-TE
revealed,O
bliateral,B-PR
lung,I-PR
nodules,I-PR
and,O
a,B-PR
right,I-PR
thyroid,I-PR
nodule,I-PR
.,O

A,B-TE
CT,I-TE
of,I-TE
her,I-TE
sinues,I-TE
revealed,O
no,O
fractures,B-PR
.,O

X-rays,B-TE
of,I-TE
her,I-TE
right,I-TE
lower,I-TE
extremity,I-TE
were,O
negative,O
for,O
any,B-PR
acute,I-PR
injury,I-PR
.,O

A,O
neurosurgery,O
consult,O
was,O
obtained,O
.,O

Our,O
recommendations,O
were,O
to,O
load,O
her,O
with,O
Dilantin,B-TR
and,O
then,O
continue,O
at,O
100,O
mg,O
PO,O
TID,O
.,O

The,O
orthopedics,O
spine,O
service,O
saw,O
her,O
and,O
put,O
her,O
in,O
a,B-TR
C-collar,I-TR
.,O

She,O
was,O
admitted,O
to,O
the,O
trauma,O
ICU,O
.,O

A,B-TE
repeat,I-TE
head,I-TE
CT,I-TE
12,O
hours,O
after,O
the,O
first,O
was,O
largely,O
unchanged,O
.,O

She,O
was,O
transferred,O
to,O
step,O
down,O
.,O

"She,O
was,O
having,O
some,B-PR
pain,I-PR
issues,I-PR
and,O
morphine,B-TR
was,O
making,O
her,O
"",O
jittery,B-PR
.""",O

On,O
HD,O
2,O
she,O
was,O
switched,O
to,O
Fioricet,B-TR
",",O
which,O
helped,O
with,O
her,B-PR
headaches,I-PR
.,O

A,B-TE
repeact,I-TE
head,I-TE
CT,I-TE
was,O
unchanged,O
.,O

An,B-TE
MRI,I-TE
of,I-TE
her,I-TE
C-spine,I-TE
was,O
done,O
to,O
evaluate,O
for,O
ligamentous,B-PR
injury,I-PR
",",O
but,O
this,O
was,O
extremely,B-TE
limited,I-TE
examination,I-TE
due,O
to,O
patient,O
motion,O
and,O
the,O
signal,O
in,O
the,O
spinal,O
cord,O
could,O
not,O
be,O
adequately,O
assessed,O
for,O
edema,B-PR
.,O

As,O
per,O
CMED,O
CSRU,O
spine,O
",",O
the,O
patient,O
was,O
instructed,O
to,O
follow-up,O
in,O
2,O
weeks,O
for,O
repeat,B-TE
X-rays,I-TE
.,O

On,O
discharge,O
she,O
was,O
awake,O
",",O
alert,O
and,O
orientated,O
X3,O
with,O
c/o,O
mild,B-PR
headache,I-PR
.,O

She,O
had,O
full,B-TE
strength,I-TE
motor,I-TE
exam,I-TE
",",O
no,O
pronator,B-PR
drift,I-PR
and,O
PERRLA,O
with,O
full,O
EOM,O
s.,O

She,O
was,O
ambulating,O
without,O
difficulties,B-PR
.,O

On,O
04-01,O
she,O
was,O
seen,O
by,O
physical,B-TR
therapy,I-TR
was,O
thought,O
to,O
benefit,O
from,O
acute,B-TR
rehabilitation,I-TR
.,O

She,O
had,O
a,B-TE
head,I-TE
CT,I-TE
prior,O
to,O
discharge,O
that,O
showed,O
resolution,O
of,O
the,B-PR
subarachnoid,I-PR
hemorrhage,I-PR
.,O

Follow-up,O
in,O
1,O
month,O
with,O
neurosurgery,O
for,O
a,B-TE
repeat,I-TE
head,I-TE
CT,I-TE
was,O
arranged,O
.,O

She,O
was,O
discharged,O
on,O
fioricet,B-TR
and,O
dilantin,B-TR
.,O

She,O
was,O
counseled,O
to,O
follow-up,O
with,O
her,O
PCP,O
F,O
6-12,O
months,O
regading,O
the,B-PR
right,I-PR
thyroid,I-PR
nodule,I-PR
and,O
the,B-PR
bilateral,I-PR
small,I-PR
lung,I-PR
nodules,I-PR
seen,O
on,O
her,B-TE
chest,I-TE
CT,I-TE
.,O

Medications,O
on,O
Admission,O
:,O

1.,O
celexa,B-TR

2.,O
premarin,B-TR

3.,O
trazodone,B-TR

4.,O
6-MP,B-TR

5.,O
Prednisone,B-TR

Discharge,O
Medications,O
:,O

1.,O
Phenytoin,B-TR
Sodium,I-TR
Extended,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
for,O
1,O
months,O
.,O

Disp,O
:*,O
90,O
Capsule,O
(s)*,O
Refills,O
:*,O
0,O
*,O

2.,O
Acetaminophen,B-TR
-,O
Caff,B-TR
-,O
Butalbital,B-TR
504-61-78,O
mg,O
Capsule,O
Sig,O
:,O
01-28,O
Tablets,O
PO,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
for,O
1,O
months,O
.,O

Disp,O
:*,O
60,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

3.,O
Citalopram,B-TR
20,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

4.,O
Metoprolol,B-TR
Tartrate,I-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

5.,O
Hydromorphone,B-TR
2,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
Q4H,O
(,O
every,O
4,O
hours,O
),O
as,O
needed,O
for,O
pain,B-PR
.,O

Disp,O
:*,O
40,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

6.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
):,O
Use,O
while,O
taking,O
narcotics,B-TR
.,O

7.,O
Phenytoin,B-TR
Sodium,I-TR
Extended,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
).,O

Disp,O
:*,O
90,O
Capsule,O
(s)*,O
Refills,O
:*,O
0,O
*,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Facility,O
:,O

St.,O
Anne's,O
Hospital,O
-,O
Burlington,O

Discharge,O
Diagnosis,O
:,O

Head,B-PR
trauma,I-PR
with,O
subarachnoid,B-PR
hemorrhage,I-PR

C7,B-PR
fracture,I-PR

Discharge,O
Condition,O
:,O

neurologically,O
stable,O

Discharge,O
Instructions,O
:,O

Call,O
for,O
severe,B-PR
headache,I-PR
or,O
any,B-PR
other,I-PR
problems,I-PR
.,O

Please,O
take,O
Fioricet,B-TR
as,O
directed,O
for,O
headaches,B-PR
.,O

Please,O
do,O
not,O
drive,O
while,O
on,O
this,B-TR
medication,I-TR
.,O

Please,O
continue,O
to,O
wear,O
your,B-TR
C-collar,I-TR
at,O
all,O
times,O
.,O

Please,O
continue,O
Dilantin,B-TR
as,O
directed,O
for,O
seizure,B-TR
prophylaxis,I-TR
.,O

Followup,O
Instructions,O
:,O

Follow,O
up,O
with,O
Dr.,O
Kelley,O
in,O
4,O
weeks,O
with,O
head,B-TE
CT,I-TE
-,O
call,O
716,O
3268,O

Please,O
also,O
follow-up,O
with,O
Dr.,O
Obrecht,O
of,O
CMED,O
CCU,O
spine,O
in,O
2,O
weeks,O
for,O
flexion,B-TE
/,I-TE
extension,I-TE
X-rays,I-TE
((,O
228,O
),O
411-7660,O
),O

Please,O
follow-up,O
with,O
your,O
PCP,O
N,O
6-12,O
months,O
reguading,O
the,B-PR
right,I-PR
thyroid,I-PR
nodule,I-PR
and,O
the,B-PR
bilateral,I-PR
small,I-PR
lung,I-PR
nodules,I-PR
seen,O
on,O
your,B-TE
chest,I-TE
CT,I-TE
.,O

Vernia,O
Diana,O
MD,O
76-016,O

Completed,O
by,O
:,O
Sonya,O
Ramona,O
NP,O
80-AKY,O
2013-04-01,O
@,O
1453,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Shirley,O
Bennett,O
on,O
:,O
Sandra,O
2013-05-02,O
4:53,O
PM,O

(,O
End,O
of,O
Report,O
),O

694467643,O

FIH,O

7327698,O

47130/04v4,O

120605,O

06/29/1992,O
12:00:00,O
AM,O

HEPATOCELLULAR,B-PR
CARCINOMA,I-PR
",",O
AND,O
HEPATITIS,B-PR
C,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

06/29/92,O

DISCHARGE,O
DATE,O
:,O

07/27/92,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Hepatocellular,B-PR
carcinoma,I-PR
",",O
and,O
hepatitis,B-PR
C,I-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

Liver,B-TR
transplant,I-TR
.,O

Native,B-TR
hepatectomy,I-TR
.,O

Re-exploration,B-TE
for,O
bleeding,B-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Mr.,O
Villesatelkscurb,O
is,O
a,O
fifty,O
year,O
old,O
black,O
gentleman,O
with,O
a,O
long,O
history,O
of,O
hepatitis,B-PR
C,I-PR
",",O
believed,O
to,O
be,O
contracted,O
during,O
transfusions,B-TR
in,O
a,B-PR
previous,I-PR
trauma,I-PR
.,O

The,O
patient,O
had,O
recently,O
prior,O
to,O
this,O
admission,O
",",O
had,O
a,B-PR
rise,I-PR
in,I-PR
his,I-PR
alpha,I-PR
feta,I-PR
protein,I-PR
and,O
a,B-TE
biopsy,I-TE
of,I-TE
his,I-TE
liver,I-TE
had,O
shown,O
hepatocellular,B-PR
carcinoma,I-PR
.,O

The,O
patient,O
was,O
admitted,O
for,O
liver,B-TE
transplant,I-TE
workup,I-TE
and,O
to,O
await,O
liver,B-TR
transplant,I-TR
.,O

PAST,O
MEDICAL,O
and,O

SURGICAL,O
HISTORY,O
:,O

Significant,O
for,O
motor,O
vehicle,O
accident,O
in,O
1966,O
",",O
requiring,O
exploratory,B-TE
laparotomy,I-TE
and,O
splenectomy,B-TR
",",O
tonsillectomy,B-TR
as,O
a,O
child,O
",",O
pneumonia,B-PR
in,O
the,O
past,O
",",O
hepatitis,B-PR
C,I-PR
and,O
recent,O
diagnosis,O
of,O
hepatocellular,B-PR
carcinoma,I-PR
.,O

ADVERSE,O
DRUG,O
REACTIONS,O
:,O

no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

On,O
admission,O
medications,B-TR
included,O
Lasix,B-TR
and,O
iron,B-TR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Significant,O
for,O
normal,O
head,O
",",O
eyes,O
",",O
ears,O
",",O
nose,O
",",O
throat,O
exam,O
with,O
no,O
scleral,B-PR
icterus,I-PR
.,O

Heart,O
regular,O
rate,O
and,O
rhythm,O
",",O
his,O
lungs,O
were,O
clear,O
.,O

He,O
had,O
no,O
appreciable,B-PR
ascites,I-PR
.,O

He,O
did,O
have,O
clubbing,B-PR
and,O
palmar,B-PR
erythema,I-PR
with,O
bilateral,B-PR
ankle,I-PR
edema,I-PR
.,O

He,O
was,O
Neurologically,O
intact,O
.,O

LABORATORY,O
DATA,O
:,O

bilirubin,B-TE
to,O
be,O
.6,O
.,O

SGOT,B-TE
of,O
80,O
.,O

HOSPITAL,O
COURSE,O
:,O

Preoperatively,O
",",O
the,O
patient,O
underwent,O
chemo-embolization,B-TR
for,O
his,B-PR
hepatocellular,I-PR
carcinoma,I-PR
.,O

The,O
remainder,O
of,O
his,O
preoperative,O
course,O
was,O
benign,O
.,O

On,O
July,O
15,O
",",O
1992,O
",",O
a,O
liver,O
became,O
available,O
",",O
and,O
the,O
patient,O
underwent,O
hepatectomy,B-TR
and,O
orthotopic,B-TR
liver,I-TR
transplant,I-TR
.,O

His,B-TR
operation,I-TR
was,O
complicated,O
by,O
severe,B-PR
coagulopathy,I-PR
requiring,O
fifty-nine,O
units,O
of,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
",",O
64,O
units,O
of,O
FFP,B-TR
and,O
34,O
units,O
of,O
platelets,B-TR
.,O

Postoperatively,O
",",O
the,O
patient,O
continued,O
to,O
have,O
a,B-PR
coagulopathy,I-PR
requiring,O
re-exploration,B-TE
on,O
postoperatively,O
day,O
2,O
",",O
with,O
findings,O
only,O
of,O
hematoma,B-PR
and,O
no,O
active,B-PR
bleeding,I-PR
.,O

Initially,O
",",O
the,O
patient,O
did,O
well,O
in,O
the,O
Intensive,O
Care,O
Unit,O
",",O
mentally,O
alert,O
",",O
and,O
oriented,O
",",O
however,O
",",O
he,O
continued,O
to,O
be,O
coagulopathic,B-PR
and,O
was,O
requiring,O
large,B-TR
amounts,I-TR
of,I-TR
blood,I-TR
and,O
FFP,B-TR
transfusions,I-TR
",",O
with,O
a,B-PR
resultant,I-PR
pulmonary,I-PR
edema,I-PR
.,O

He,O
developed,O
renal,B-PR
failure,I-PR
felt,O
to,O
be,O
ATN,B-PR
secondary,O
to,O
ischemia,B-PR
of,I-PR
his,I-PR
kidneys,I-PR
.,O

The,O
patient,O
remained,O
intubated,B-TR
in,O
the,O
Intensive,O
Care,O
Unit,O
for,O
twelve,O
days,O
prior,O
to,O
his,O
death,O
.,O

He,O
had,O
daily,B-TR
transfusions,I-TR
of,O
FFP,B-TR
and,O
blood,B-TR
",",O
and,O
continued,O
coagulopathy,B-PR
.,O

He,O
also,O
developed,O
thrombocytopenia,B-PR
",",O
requiring,O
persistent,B-TR
platelet,I-TR
transfusions,I-TR
on,O
a,O
daily,O
basis,O
.,O

His,B-TR
immunosuppression,I-TR
was,O
OKT3,B-TR
and,O
Solu,B-TR
Medrol,I-TR
",",O
and,O
he,O
underwent,O
hemodialysis,B-TR
and,O
ultra,B-TR
filtration,I-TR
to,O
remove,O
fluid,O
.,O

While,O
in,O
the,O
ICU,O
he,O
developed,O
seizures,B-PR
",",O
requiring,O
large,B-TR
amounts,I-TR
of,I-TR
intravenous,I-TR
Valium,I-TR
to,O
break,O
his,B-PR
seizures,I-PR
",",O
and,O
he,O
was,O
maintained,O
on,O
Tegretol,B-TR
and,O
Dilantin,B-TR
.,O

However,O
",",O
he,O
became,O
progressively,O
more,O
mentally,B-PR
obtunded,I-PR
.,O

During,O
the,B-PR
seizure,I-PR
",",O
he,O
bit,O
his,O
tongue,O
",",O
resulting,O
in,O
a,B-PR
large,I-PR
bleed,I-PR
from,I-PR
his,I-PR
tongue,I-PR
",",O
which,O
was,O
sutured,B-TR
by,O
the,O
ENT,O
Service,O
",",O
however,O
",",O
his,B-PR
continued,I-PR
coagulopathy,I-PR
resulted,O
in,O
bleeding,B-PR
from,I-PR
his,I-PR
nasopharynx,I-PR
",",O
which,O
could,O
never,O
be,O
identified,O
",",O
and,O
also,O
upper,B-PR
gastrointestinal,I-PR
bleeding,I-PR
.,O

Endoscopy,B-TE
never,O
revealed,O
specific,O
sources,O
of,O
bleeding,B-PR
",",O
although,O
he,O
appeared,O
to,O
have,O
a,B-PR
diffuse,I-PR
duodenitis,I-PR
.,O

He,O
was,O
started,O
on,O
Pitressin,B-TR
to,O
try,O
to,O
control,O
the,B-PR
gastrointestinal,I-PR
bleeding,I-PR
",",O
but,O
he,O
continued,O
to,O
have,O
severe,B-PR
bleeding,I-PR
",",O
and,O
became,O
progressively,B-PR
hypotensive,I-PR
",",O
with,O
eventual,B-PR
bradycardia,I-PR
and,O
cardiac,B-PR
arrest,I-PR
.,O

He,O
was,O
pronounced,O
dead,O
at,O
3:49,O
PM,O
on,O
July,O
15,O
",",O
1992,O
.,O

STA,O
TITCHEGRIESESC,O
",",O
M.D.,O
DICTATING,O
FOR,O
;,O
KIVERL,O
NA,O
CANTSLEDDJESC,O
",",O
M.D.,O

TR,O
:,O

wj,O
/,O
bmot,O

DD,O
:,O

07/28/92,O

TD,O
:,O

07/28/92,O

CC,O
:,O

Admission,O
Date,O
:,O

2015-08-10,O

Discharge,O
Date,O
:,O

2015-08-15,O

Date,O
of,O
Birth,O
:,O

1954-12-08,O

Sex,O
:,O

M,O

Service,O
:,O

CT,O
CMED,O
CSRU,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Mr.,O
Bruno,O
is,O
a,O
60,O
year,O
old,O
gentleman,O
who,O
initially,O
presented,O
with,O
hematemesis,B-PR
",",O
hemoptysis,B-PR
and,O
on,O
work-up,B-TE
was,O
found,O
to,O
have,O
a,B-PR
left,I-PR
lower,I-PR
lobe,I-PR
mass,I-PR
.,O

He,O
previously,O
underwent,O
bronchoscopy,B-TE
with,I-TE
washings,I-TE
which,O
showed,O
to,O
be,O
negative,O
for,O
malignant,B-PR
cells,I-PR
and,O
showed,O
atypical,B-PR
bronchial,I-PR
epithelial,I-PR
cells,I-PR
",",O
likely,O
to,O
be,O
reactive,B-TE
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Rectal,B-PR
fissure,I-PR
.,O

2.,O
Lumpectomy,B-TR
of,O
the,B-PR
left,I-PR
breast,I-PR
nodule,I-PR
.,O

3.,O
Knee,B-TR
surgery,I-TR
.,O

4.,O
Hand,B-TR
surgery,I-TR
.,O

ALLERGIES,O
:,O

The,O
patient,O
has,O
no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

MEDICATIONS,O
:,O

The,O
patient,O
had,O
no,O
home,B-TR
medications,I-TR
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

The,B-TE
review,I-TE
of,I-TE
systems,I-TE
was,O
essentially,O
negative,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,O
",",O
showed,O
a,O
gentleman,O
in,O
no,O
acute,B-PR
distress,I-PR
;,O
afebrile,B-PR
.,O

Chest,O
was,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

Heart,O
has,O
a,O
regular,O
rate,O
and,O
rhythm,O
.,O

Abdomen,O
is,O
benign,O
",",O
no,O
mass,B-PR
.,O

Extremities,O
were,O
well,O
perfused,O
and,O
warm,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
taken,O
to,O
the,O
Operating,O
Room,O
the,O
day,O
of,O
admission,O
.,O

He,O
underwent,O
a,B-TR
left,I-TR
bronchoscopy,I-TR
and,O
lower,B-TR
lobectomy,I-TR
of,I-TR
the,I-TR
left,I-TR
side,I-TR
.,O

The,B-TR
operation,I-TR
was,O
subsequently,O
complicated,O
by,O
a,B-PR
postoperative,I-PR
bleeding,I-PR
.,O

The,O
patient,O
had,O
to,O
be,O
taken,O
back,O
to,O
the,O
Operating,O
Room,O
where,O
a,B-TR
repair,I-TR
of,I-TR
the,I-TR
left,I-TR
pulmonary,I-TR
artery,I-TR
was,O
performed,O
.,O

The,O
patient,O
was,O
then,O
transferred,O
to,O
the,O
CSRU,O
",",O
intubated,O
",",O
in,O
stable,O
condition,O
.,O

Vascular,O
Surgery,O
Service,O
was,O
also,O
consulted,O
.,O

During,O
the,B-TR
operation,I-TR
",",O
the,O
patient,O
received,O
13,O
units,O
of,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
",",O
four,O
units,O
of,O
fresh,B-TR
frozen,I-TR
plasma,I-TR
and,O
one,O
unit,O
of,O
platelets,B-TR
with,O
an,B-PR
estimated,I-PR
blood,I-PR
loss,I-PR
of,O
1500,O
cc,O
.,O

The,O
patient,O
remained,O
to,O
be,O
stable,O
on,O
the,O
floor,O
with,O
subsequent,O
monitoring,O
of,O
hematocrit,B-TE
within,O
a,O
normal,O
stable,O
range,O
.,O

He,O
is,O
successfully,O
extubated,O
on,O
08-12,O
and,O
hypertension,B-PR
transferred,O
to,O
the,O
floor,O
in,O
stable,O
condition,O
where,O
the,O
Pain,O
Service,O
is,O
managing,O
his,B-TR
epidural,I-TR
with,O
very,O
good,O
effect,O
and,O
he,O
is,O
tolerating,O
a,O
regular,O
p.o.,O
diet,O
and,O
is,O
making,O
adequate,O
amount,O
of,O
urine,O
.,O

His,O
recovery,O
was,O
essentially,O
unremarkable,O
.,O

His,B-TR
epidural,I-TR
was,O
successfully,O
discontinued,O
and,O
he,O
is,O
discharged,O
to,O
home,O
on,O
08-15,O
with,O
instructions,O
to,O
follow-up,O
with,O
Dr.,O
Cordova,O
in,O
the,O
office,O
within,O
the,O
next,O
one,O
to,O
two,O
weeks,O
.,O

He,O
is,O
discharged,O
to,O
home,O
with,O
pain,B-TR
medication,I-TR
which,O
is,O
percocet,B-TR
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
.,O

DISCHARGE,O
STATUS,O
:,O

To,O
home,O
without,O
service,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

Left,B-PR
lung,I-PR
mass,I-PR
status,O
post,O
resection,B-TR
.,O

Harriet,O
D.,O
Buffington,O
",",O
M.D.,O
51-721,O

Dictated,O
By,O
:,O
Steven,O
L.,O
Ibarra,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2015-08-17,O
10:50,O

T,O
:,O
2015-08-21,O
16:28,O

JOB,O
#:,O
00413,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Natasha,O
Toth,O
on,O
:,O
TUE,O
2015-10-06,O
5:11,O
PM,O

(,O
End,O
of,O
Report,O
),O

704319103,O
PUMC,O

6340505,O

274938,O

7752547,O

10/14/2004,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O
/,O
SUMMARY,O

A,O
",",O
MIFER,O

MRN,O
:,O

6340505,O

Age,O
:,O

41y,O

REGISTRATION,O
DATE,O
:,O

10/14/2004,O
03:51,O
PM,O

Provider,O
:,O

KOTEJESCZUK,O
",",O
M.D.,O
STOCKADALELEEFNATHE,O

PRELIMINARY,O
REPORT,O

PCP,O
notified,O
by,O
MD,O
:,O

E-mail,O
PCP,O

Benefits,O
Assigned,O
:,O

Y,O

Discharge,O
Date,O
/,O
Time,O
:,O

10/14/2004,O
21:17,O

Discharge,O
Status,O
:,O

Discharged,O

Condition,O
on,O
Discharge,O
:,O

Stable,O

Patient,O
States,O
Complaint,O
:,O

CP,B-PR
Standardized,I-PR

Discharge,O
Instructions,O
:,O

The,O
patient,O
was,O
given,O
printed,O
instructions,O
for,O
chest,B-PR
pain,I-PR
(,O
English,O
),O
.,O

Diagnosis,O
:,O

lt,B-PR
arm/,I-PR
chest,I-PR
pain,I-PR

Treatment,O
Rendered,O
:,O

ekg,B-TE
=,O
normal,O
",",O
cxr,B-TE
normal,O
",",O
ddimer,B-TE
/,O
cardiac,B-TE
enzymes,I-TE
negative,O

Discharge,O
Medications,O
:,O

ibuprofen,B-TR
as,O
needed,O

Follow,O
up,O
Service,O
:,O

call,O
dr,O
koorskote,O
&apos;s,O
office,O
tomorrow,O

PCP,O
Name,O
:,O

KOORSKOTE,O
",",O
SHARA,O
G,O

Provider,O
Number,O
:,O

708,O

This,O
report,O
was,O
created,O
by,O
STOCKADALELEEFNATHE,O
",",O
LISHE,O
",",O
M.D.,O
10/14/2004,O
09:35,O
PM,O

Admission,O
Date,O
:,O

2016-02-15,O

Discharge,O
Date,O
:,O

2016-02-21,O

Date,O
of,O
Birth,O
:,O

2016-02-15,O

Sex,O
:,O

M,O

Service,O
:,O

NEONATOLOGY,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
infant,O
is,O
a,O
32,O
and,O
03-05,O
week,O
male,O
",",O
twin,O
A,O
",",O
who,O
was,O
admitted,O
to,O
the,O
Neonatal,O
Intensive,O
Care,O
Unit,O
for,O
management,B-TR
of,O
prematurity,B-PR
.,O

The,O
infant,O
was,O
born,O
to,O
a,O
38,O
year,O
old,O
",",O
gravida,O
V,O
",",O
para,O
III,O
",",O
woman,O
.,O

Serologies,B-TE
:,O

A,O
positive,O
",",O
antibody,B-TE
negative,O
",",O
hepatitis,B-TE
B,I-TE
surface,I-TE
antigen,I-TE
negative,O
",",O
RPR,B-TE
nonreactive,O
",",O
rubella,B-TE
immune,O
",",O
GBS,B-TE
unknown,O
.,O

Pregnancy,B-PR
notable,O
for:,O

1.,O
Gestational,O
carrier,O
for,O
brother,O
and,O
his,O
wife,O
(,O
donor,O
eggs,O
).,O

2.,O
IVF,B-TR
with,O
diamniotic,O
",",O
dichorionic,O
twins,O
.,O

3.,O
At,O
29-30,O
week,O
gestation,O
concern,O
for,O
fetal,B-PR
decelerations,I-PR
of,O
twin,O
A,O
",",O
admitted,O
to,O
Cambridge,O
Health,O
Alliance,O
",",O
completed,O
a,O
course,O
of,O
Betamethasone,B-TR
",",O
discharged,O
to,O
home,O
.,O

4.,O
Elevated,B-PR
one,I-PR
hour,I-PR
glucose,I-PR
tolerance,I-PR
test,I-PR
",",O
normal,O
three,O
hour,O
glucose,O
tolerance,O
test,O
.,O

5.,O
Declined,O
triple,B-TE
screen,I-TE
and,O
amniocentesis,B-TE
.,O

Gestational,O
carrier,O
for,O
brother,O
and,O
sister-in-law,O
as,O
noted,O
above,O
.,O

Presented,O
with,O
spontaneous,B-PR
",",I-PR
premature,I-PR
rupture,I-PR
of,I-PR
membranes,I-PR
.,O

No,O
maternal,B-PR
fever,I-PR
.,O

Clear,O
fluid,O
.,O

Delivery,B-TR
by,I-TR
cesarean,I-TR
section,I-TR
secondary,O
to,O
twin,B-PR
B,I-PR
breech,I-PR
presentation,I-PR
.,O

Apgars,B-TE
eight,O
at,O
one,O
minute,O
and,O
eight,O
at,O
five,O
minutes,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Birth,B-TE
weight,I-TE
1865,O
grams,O
.,O

HOSPITAL,O
COURSE,O
:,O

1.,O
Respiratory,O
-,O
The,O
infant,O
has,O
remained,O
in,O
room,O
air,O
throughout,O
this,O
hospitalization,O
with,O
respiratory,B-TE
rates,I-TE
40,O
s,O
to,O
50,O
"s,",O
oxygen,B-TE
saturation,I-TE
greater,O
than,O
94%,O
.,O

One,B-PR
apnea,I-PR
and,I-PR
bradycardia,I-PR
event,I-PR
which,O
was,O
self,O
resolved,O
on,O
day,O
of,O
life,O
four,O
.,O

2.,O
Cardiovascular,O
-,O
The,O
infant,O
was,O
noted,O
on,O
CR-monitor,B-TE
to,O
have,O
premature,B-PR
ventricular,I-PR
contractions,I-PR
which,O
resolved,O
spontaneously,O
.,O

A,B-TE
twelve,I-TE
lead,I-TE
electrocardiogram,I-TE
was,O
recommended,O
if,O
this,O
persists,O
.,O

No,O
murmur,B-PR
.,O

Heart,B-TE
rates,I-TE
140,O
s,O
to,O
150,O
s.,O

Mean,B-TE
blood,I-TE
pressure,I-TE
has,O
been,O
46,O
to,O
54,O
.,O

3.,O
Fluid,O
",",O
electrolytes,O
and,O
nutrition,O
-,O
The,O
infant,O
was,O
started,O
on,O
enteral,B-TR
feedings,I-TR
on,O
day,O
of,O
life,O
one,O
and,O
advanced,O
to,O
full,B-TR
volume,I-TR
feedings,I-TR
by,O
day,O
of,O
life,O
four,O
.,O

The,O
infant,O
was,O
initially,O
started,O
on,O
80,O
cc,O
/,O
kg,O
/,O
day,O
of,O
intravenous,B-TR
fluid,I-TR
D10W,I-TR
and,O
advanced,O
to,O
150,O
cc,O
/,O
kg,O
/,O
day,O
by,O
day,O
of,O
life,O
four,O
.,O

The,O
infant,O
tolerated,O
feeding,O
advancement,O
without,O
difficulty,O
.,O

The,O
infant,O
did,O
not,O
receive,O
parenteral,B-TR
nutrition,I-TR
.,O

The,B-TE
most,I-TE
recent,I-TE
electrolytes,I-TE
on,O
day,O
of,O
life,O
two,O
showed,O
a,B-TE
sodium,I-TE
of,O
145,O
",",O
chloride,B-TE
111,O
",",O
potassium,B-TE
3.8,O
",",O
bicarbonate,B-TE
21,O
.,O

The,O
infant,O
is,O
currently,O
receiving,O
breast,O
milk,O
22,O
calories,O
per,O
ounce,O
or,O
premature,O
Enfamil,O
22,O
calories,O
per,O
ounce,O
",",O
150,O
cc,O
/,O
kg,O
/,O
day,O
p.o.,O
and,O
gavage,B-TR
.,O

The,B-TE
most,I-TE
recent,I-TE
weight,I-TE
today,O
is,O
1810,O
grams,O
which,O
was,O
no,O
change,O
from,O
the,O
previous,O
day,O
.,O

4.,O
Gastrointestinal,O
-,O
The,O
infant,O
was,O
started,O
on,O
single,B-TR
phototherapy,I-TR
on,O
day,O
of,O
life,O
two,O
for,O
a,B-TE
maximum,I-TE
bilirubin,I-TE
level,I-TE
of,O
9.1,O
with,O
a,B-TE
direct,I-TE
of,O
0.3,O
.,O

Phototherapy,B-TR
was,O
discontinued,O
on,O
day,O
of,O
life,O
five,O
and,O
the,B-TE
rebound,I-TE
bilirubin,I-TE
level,I-TE
on,O
day,O
of,O
life,O
six,O
is,O
7.7,O
with,O
a,B-TE
direct,I-TE
of,O
0.2,O
.,O

5.,O
Hematology,O
-,O
The,B-TE
most,I-TE
recent,I-TE
hematocrit,I-TE
on,O
day,O
of,O
life,O
two,O
was,O
45.8%,O
.,O

Hematocrit,B-TE
on,I-TE
admission,I-TE
was,O
54.0%,O
.,O

The,O
infant,O
has,O
not,O
received,O
any,B-TR
blood,I-TR
transfusions,I-TR
this,O
hospitalization,O
.,O

6.,O
Infectious,O
disease,O
-,O
The,O
infant,O
received,O
48,O
hours,O
of,O
Ampicillin,B-TR
and,O
Gentamicin,B-TR
for,O
rule,O
out,O
sepsis,B-PR
.,O

The,B-TE
complete,I-TE
blood,I-TE
count,I-TE
on,I-TE
admission,I-TE
showed,O
a,B-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
of,O
8.0,O
",",O
hematocrit,B-TE
54.0%,O
",",O
platelet,B-TE
count,I-TE
"190,000",O
",",O
11,O

neutrophils,B-TE
",",O
0,O
bands,B-TE
.,O

A,B-TE
repeat,I-TE
complete,I-TE
blood,I-TE
count,I-TE
on,O
day,O
of,O
life,O
two,O
showed,O
a,B-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
of,O
6.3,O
",",O
hematocrit,B-TE
45.8%,O
",",O
platelet,B-TE
count,I-TE
"199,000",O
",",O
37,O
neutrophils,B-TE
",",O
0,O
bands,B-TE
",",O
53,O
lymphocytes,B-TE
.,O

Blood,B-TE
cultures,I-TE
remained,O
negative,O
to,O
date,O
.,O

7.,O
Neurology,O
-,O
Normal,O
neurologic,O
examination,O
.,O

The,O
infant,O
does,O
not,O
meet,O
criteria,O
for,O
head,B-TE
ultrasound,I-TE
.,O

8.,O
Sensory,O
-,O
Hearing,B-TE
screening,I-TE
is,O
recommended,O
prior,O
to,O
discharge,O
.,O

9.,O
Psychosocial,O
-,O
As,O
noted,O
above,O
",",O
paternal,O
aunt,O
was,O
the,O
gestational,O
carrier,O
.,O

The,O
infants,O
are,O
legally,O
under,O
the,O
parents,O
',O
names,O
and,O
they,O
are,O
involved,O
with,O
the,B-TR
infant,I-TR
's,I-TR
care,I-TR
.,O

The,O
gestational,O
carrier,O
is,O
not,O
involved,O
.,O

Noted,O
in,O
the,O
chart,O
are,O
legal,O
documents,O
.,O

The,O
contact,O
social,O
worker,O
can,O
be,O
reached,O
at,O
(,O
756,O
),O
599-4849,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

32,O
and,O
4/7,O
weeks,O
",",O
now,O
day,O
of,O
life,O
six,O
",",O
stable,O
in,O
room,O
air,O
.,O

DISCHARGE,O
DISPOSITION,O
:,O

To,O
nursery,O
at,O
VA,O
Hospital,O
Jamaica,O
Plain,O
Hospital,O
.,O

PRIMARY,O
PEDIATRICIAN,O
:,O

Dr.,O
James,O
Ramos,O
",",O
telephone,O
(,O
346,O
),O
741,O
2728,O
.,O

FEEDINGS,O
AT,O
DISCHARGE,O
:,O

150,O
cc,O
/,O
kg,O
/,O
day,O
of,O
breast,O
milk,O
22,O
calories,O
or,O
premature,O
Enfamil,O
22,O
calories,O
per,O
ounce,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

None,O
.,O

CAR,B-TE
SEAT,I-TE
POSITION,I-TE
SCREENING,I-TE
:,O

Recommended,O
prior,O
to,O
discharge,O
.,O

STATE,B-TE
NEWBORN,I-TE
SCREEN,I-TE
:,O

Screens,B-TE
have,O
been,O
sent,O
and,O
results,O
are,O
pending,O
.,O

IMMUNIZATIONS,B-TR
:,O

The,O
infant,O
has,O
not,O
received,O
any,B-TR
immunizations,I-TR
this,O
hospitalization,O
.,O

IMMUNIZATIONS,O
RECOMMENDED,O
:,O

Synagis,B-TR
RSV,I-TR
prophylaxis,I-TR
should,O
be,O
considered,O
from,O
October,O
through,O
April,O
for,O
infants,O
who,O
meet,O
any,O
of,O
the,O
following,O
three,O
criteria,O
:,O

1.,O
Born,O
at,O
less,O
than,O
32,O
weeks,O
.,O

2.,O
Born,O
between,O
32,O
and,O
35,O
weeks,O
with,O
two,O
of,O
the,O
following,O
:,O

a.,O
Day,O
Care,O
during,O
RSV,O
season,O
.,O

b.,O
A,O
smoker,O
in,O
the,O
household,O
",",O

c.,O
neuromuscular,B-PR
disease,I-PR
",",O

d.,O
airway,B-PR
abnormalities,I-PR
or,O

e.,O
a,O
school,O
age,O
sibling,O
.,O

3.,O
With,O
chronic,B-PR
lung,I-PR
disease,I-PR
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Prematurity,B-PR
32,I-PR
and,I-PR
4/7,I-PR
weeks,I-PR
",",O
Twin,O
#1,O
.,O

2.,O
Rule,O
out,O
sepsis,B-PR
",",O
ruled,O
out,O
.,O

3.,O
Apnea,B-PR
of,I-PR
prematurity,I-PR
.,O

4.,O
Indirect,B-PR
hyperbilirubinemia,I-PR
.,O

Gregory,O
R,O
Godfrey,O
",",O
M.D.,O
28-526,O

Dictated,O
By,O
:,O
Crystal,O
K.,O
Carter,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2016-02-21,O
09:53,O

T,O
:,O
2016-02-21,O
10:12,O

JOB,O
#:,O
02200,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Cynthia,O
Short,O
on,O
:,O
MON,O
2016-02-22,O
8:16,O
AM,O

(,O
End,O
of,O
Report,O
),O

708632336,O
YC,O

32343989,O

527629,O

10/14/2004,O
12:00:00,O
AM,O

PELVIC,B-PR
MASS,I-PR

Signed,O

DIS,O

Admission,O
Date,O
:,O

10/14/2004,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

10/17/2004,O

ATTENDING,O
:,O

NAEELV,O
CRUTCH,O
MD,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Pelvic,B-PR
mass,I-PR
",",O
benign,B-PR
mucinous,I-PR
cystadenoma,I-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

Total,B-TR
abdominal,I-TR
hysterectomy,I-TR
",",O
right,B-TR
lymph,I-TR
node,I-TR
dissection,I-TR
",",O
appendectomy,B-TR
",",O
omental,B-TE
biopsy,I-TE
",",O
and,O
pelvic,B-TR
washings,I-TR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
56-year-old,O
menopausal,O
female,O
G3,O
",",O
P3,O
who,O
presented,O
initially,O
for,O
evaluation,B-TE
of,O
a,B-PR
pelvic,I-PR
mass,I-PR
while,O
recently,O
vacationing,O
in,O
An,O
Saintcafield,O
Terland,O
.,O

She,O
had,O
a,B-TE
physical,I-TE
over,O
there,O
",",O
and,O
the,B-TE
evaluation,I-TE
included,O
an,B-TE
ultrasound,I-TE
which,O
showed,O
an,B-PR
ovarian,I-PR
mass,I-PR
.,O

She,O
was,O
seen,O
in,O
the,O
emergency,O
room,O
here,O
on,O
08/31/04,O
where,O
they,O
performed,O
an,B-TE
abdominal,I-TE
CT,I-TE
that,O
showed,O
a,B-PR
14,I-PR
x,I-PR
14,I-PR
x,I-PR
10,I-PR
cm,I-PR
pelvic,I-PR
mass,I-PR
with,O
multiple,B-PR
enlarged,I-PR
lymph,I-PR
nodes,I-PR
.,O

The,O
patient,O
was,O
thus,O
sent,O
to,O
GYN,O
for,O
further,B-TE
workup,I-TE
and,O
is,O
now,O
here,O
for,O
surgical,B-TR
management,I-TR
of,O
pelvic,B-PR
mass,I-PR
.,O

Her,B-TE
CA-125,I-TE
is,O
9,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

None,O
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

Tubal,B-TR
ligation,I-TR
.,O

PAST,O
OBSTETRICAL,O
HISTORY,O
:,O

G3,O
",",O
P3,O
",",O
spontaneous,B-TR
vaginal,I-TR
delivery,I-TR
x3,O
.,O

MEDICATIONS,O
:,O

None,O
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

Denies,O
tobacco,O
",",O
alcohol,O
or,O
drug,O
use,O
.,O

Married,O
",",O
lives,O
with,O
husband,O
",",O
denies,O
domestic,O
violence,O
.,O

FAMILY,O
HISTORY,O
:,O

No,O
history,O
of,O
GYN,B-PR
",",O
cancers,B-PR
",",O
or,O
breast,B-PR
cancer,I-PR
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

Negative,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
taken,O
to,O
the,O
operating,O
room,O
on,O
hospital,O
day,O
#,O
1,O
where,O
she,O
underwent,O
an,B-TR
uncomplicated,I-TR
total,I-TR
abdominal,I-TR
hysterectomy,I-TR
",",O
bilateral,B-TR
salpingo-oophorectomy,I-TR
",",O
right,B-TR
lymph,I-TR
node,I-TR
dissection,I-TR
",",O
appendectomy,B-TR
",",O
omental,B-TE
biopsy,I-TE
",",O
pelvic,B-TR
washings,I-TR
",",O
and,O
Pap,B-TR
of,I-TR
the,I-TR
diaphragm,I-TR
.,O

An,B-PR
estimated,I-PR
blood,I-PR
loss,I-PR
was,O
100,O
cc,O
.,O

At,O
the,O
time,O
of,O
surgery,B-TR
",",O
frozen,B-TE
section,I-TE
revealed,O
benign,B-PR
mucinous,I-PR
cystadenoma,I-PR
.,O

By,O
postoperative,O
day,O
#3,O
",",O
the,O
patient,O
was,O
tolerating,O
p.o.&apos;,O
s,O
",",O
tolerating,O
oral,B-TR
pain,I-TR
medications,I-TR
",",O
ambulating,O
",",O
passing,O
flatus,O
",",O
and,O
having,O
a,O
bowel,O
movement,O
.,O

She,O
was,O
voiding,O
without,O
difficulty,O
.,O

Her,B-TE
hematocrit,I-TE
preoperatively,O
was,O
36,O
and,O
postoperatively,O
was,O
33,O
and,O
then,O
32,O
.,O

The,O
patient,O
did,O
have,O
some,B-PR
tachycardia,I-PR
postoperatively,I-PR
;,O
however,O
",",O
her,B-TE
hematocrit,I-TE
remained,O
stable,O
.,O

She,O
was,O
asymptomatic,B-PR
",",O
and,O
her,B-TE
EKG,I-TE
was,O
within,O
normal,O
limits,O
.,O

Her,B-PR
tachycardia,I-PR
improved,O
.,O

Throughout,O
this,O
time,O
",",O
she,O
had,O
normal,O
vital,O
signs,O
with,O
a,O
normal,O
O2,O
saturation,O
.,O

DISPOSITION,O
AND,O
DISCHARGE,O
MEDICATIONS,O
:,O

She,O
was,O
discharged,O
home,O
in,O
stable,O
condition,O
with,O
prescriptions,O
for,O
Colace,B-TR
",",O
Motrin,B-TR
and,O
Percocet,B-TR
as,O
needed,O
.,O

FOLLOW,O
UP,O
:,O

She,O
will,O
follow,O
up,O
with,O
Dr.,O
Crutch,O
in,O
two,O
weeks,O
.,O

She,O
was,O
again,O
discharged,O
home,O
in,O
stable,O
condition,O
.,O

eScription,O
document,O
:,O

2-8707232,O
WEBCtug,O
Tel,O

Dictated,O
By,O
:,O

JAQUENATHE,O
",",O
MYA,O

Attending,O
:,O

CRUTCH,O
",",O
NAEELV,O
Dictation,O
ID,O
8975259,O

D,O
:,O

10/17/04,O

T,O
:,O

10/17/04,O

Admission,O
Date,O
:,O

2013-01-03,O

Discharge,O
Date,O
:,O

2013-01-09,O

Date,O
of,O
Birth,O
:,O

1954-07-20,O

Sex,O
:,O

F,O

Service,O
:,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
58,O
-,O
year-old,O
woman,O
who,O
was,O
transferred,O
from,O
Shaugnessy-Kaplan,O
Rehab,O
Hospital,O
Hospital,O
for,O
cardiac,B-TE
catheterization,I-TE
.,O

The,O
patient,O
had,O
a,O
long,O
history,O
of,O
hypertension,B-PR
",",O
hypercholesterolemia,B-PR
",",O
tobacco,O
abuse,O
",",O
and,O
family,O
history,O
of,O
coronary,B-PR
artery,I-PR
disease,I-PR
",",O
who,O
was,O
in,O
the,O
usual,O
state,O
of,O
health,O
until,O
Saturday,O
previous,O
to,O
admission,O
when,O
she,O
experienced,O
bilateral,B-PR
arm,I-PR
and,I-PR
chest,I-PR
discomfort,I-PR
while,O
carrying,O
groceries,O
.,O

Her,B-PR
symptoms,I-PR
resolved,O
with,O
rest,B-TR
.,O

The,B-PR
same,I-PR
symptoms,I-PR
occurred,O
again,O
the,O
same,O
evening,O
with,O
exertion,O
and,O
then,O
were,O
again,O
relieved,O
with,O
rest,B-TR
.,O

The,O
patient,O
presented,O
to,O
the,O
outside,O
hospital,O
Emergency,O
Room,O
where,O
she,O
was,O
started,O
on,O
Aspirin,B-TR
",",O
Lovenox,B-TR
and,O
beta,B-TR
blocker,I-TR
.,O

She,O
ruled,O
out,O
for,O
myocardial,B-PR
infarction,I-PR
by,O
CPK,B-TE
and,O
troponin,B-TE
and,O
had,O
non,B-PR
diagnostic,I-PR
EKG,I-PR
changes,I-PR
.,O

She,O
is,O
being,O
transferred,O
to,O
Arbour-Fuller,O
Hospital,O
for,O
cardiac,B-TE
catheterization,I-TE
.,O

Results,O
of,O
the,B-TE
catheterization,I-TE
indicated,O
the,O
patient,O
had,O
three,B-PR
vessel,I-PR
disease,I-PR
and,O
was,O
a,O
candidate,O
for,O
coronary,B-TR
artery,I-TR
bypass,I-TR
graft,I-TR
.,O

The,O
patient,O
went,O
to,O
the,O
operating,O
room,O
",",O
was,O
admitted,O
to,O
go,O
to,O
the,O
operating,O
room,O
on,O
2013-01-04,O
.,O

Her,O
risk,O
factors,O
:,O
Hypertension,B-PR
",",O
tobacco,O
abuse,O
(,O
one,O
pack,O
per,O
day,O
times,O
45,O
years,O
"),",O
family,O
history,O
(,O
father,O
diagnosed,O
with,O
coronary,B-PR
artery,I-PR
disease,I-PR
in,O
his,O
50,O
"'s,",O
patient,O
's,O
mother,O
had,O
coronary,B-PR
artery,I-PR
disease,I-PR
",",O
patient,O
's,O
brother,O
has,O
coronary,B-PR
artery,I-PR
disease,I-PR
).,O

Hypercholesterolemia,B-PR
(,O
total,B-TE
cholesterol,I-TE
on,O
admission,O
300,O
's,O
several,O
years,O
ago,O
).,O

The,O
patient,O
denies,O
any,O
history,O
of,O
diabetes,B-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Status,O
post,O
CVA,B-PR
times,O
two,O
in,O
2010,O
",",O
arthritis,B-PR
",",O
hypertension,B-PR
",",O
hypercholesterolemia,B-PR
",",O
status,O
post,O
remote,B-PR
pneumonia,I-PR
",",O
status,O
post,O
remote,B-PR
pleurisy,I-PR
",",O
psoriasis,B-PR
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

Status,O
post,O
tubal,B-TR
ligation,I-TR
.,O

MEDICATIONS,O
:,O

At,O
home,O
",",O
Aggrenox,B-TR
250,O
mg,O
po,O
q,O
day,O
.,O

ALLERGIES,O
:,O

Sulfa,B-TR
causes,O
rash,B-PR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
lives,O
alone,O
and,O
works,O
full,O
time,O
doing,O
secretarial,O
work,O
.,O

She,O
has,O
a,O
son,O
who,O
is,O
mentally,B-PR
handicapped,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,O
vital,B-TE
signs,I-TE
",",O
heart,B-TE
rate,I-TE
71,O
",",O
blood,B-TE
pressure,I-TE
134/75,O
",",O
respiratory,B-TE
rate,I-TE
20,O
.,O

Neck,O
",",O
no,O
jugulovenous,B-PR
distension,I-PR
",",O
carotids,B-PR
",",O
no,O
bruit,B-PR
in,I-PR
either,I-PR
right,I-PR
or,I-PR
left,I-PR
carotid,I-PR
artery,I-PR
.,O

Lungs,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

Heart,O
",",O
S1,B-TE
and,O
S2,B-TE
appreciated,O
",",O
no,O
murmurs,B-PR
",",O
rubs,B-PR
or,O
gallops,B-PR
.,O

Abdomen,O
soft,O
",",O
non,B-PR
distended,I-PR
",",O
nontender,B-PR
.,O

There,O
is,O
ecchymosis,B-PR
in,I-PR
mid,I-PR
abdomen,I-PR
",",O
left,O
of,O
midline,O
",",O
likely,O
secondary,O
to,O
Lovenox,B-TR
injections,I-TR
.,O

Extremities,O
",",O
no,O
bruit,B-PR
at,I-PR
the,I-PR
left,I-PR
or,I-PR
right,I-PR
femoral,I-PR
arteries,I-PR
.,O

DP,B-TE
and,I-TE
PT,I-TE
pulses,I-TE
are,O
2+,O
bilaterally,O
.,O

There,O
is,O
no,O
pedal,B-PR
edema,I-PR
but,O
there,O
is,O
evidence,O
of,O
some,B-PR
psoriasis,I-PR
of,I-PR
the,I-PR
lower,I-PR
extremities,I-PR
",",O
right,O
greater,O
than,O
left,O
.,O

LABORATORY,O
DATA,O
:,O

Cardiac,B-TE
catheterization,I-TE
performed,O
on,O
2013-01-03,O
:,O
Three,B-PR
vessel,I-PR
disease,I-PR
in,I-PR
the,I-PR
right,I-PR
dominant,I-PR
system,I-PR
.,O

Left,O
main,O
coronary,O
artery,O
with,O
short,O
vessel,O
without,O
significant,B-PR
lesions,I-PR
.,O

The,B-PR
LAD,I-PR
diffusely,I-PR
diseased,I-PR
proximal,I-PR
section,I-PR
up,O
to,O
50%,O
with,O
focal,O
70%,B-PR
mid,I-PR
segment,I-PR
lesion,I-PR
.,O

D1,O
was,O
mildly,B-PR
diseased,I-PR
diffusely,I-PR
.,O

Left,O
circumflex,O
had,O
80%,B-PR
stenosis,I-PR
in,I-PR
a,I-PR
large,I-PR
OM1,I-PR
branch,I-PR
.,O

The,O
right,O
coronary,O
artery,O
was,O
diffusely,B-PR
diseased,I-PR
in,I-PR
the,I-PR
mid,I-PR
segment,I-PR
with,O
serial,B-PR
80-90%,I-PR
stenosis,I-PR
.,O

Limited,B-TE
hemodynamics,I-TE
showed,O
elevated,B-PR
LV,I-PR
and,I-PR
diastolic,I-PR
pressure,I-PR
(,O
21,O
mmHg,O
).,O

Left,B-TE
ventriculogram,I-TE
demonstrates,O
a,B-PR
mild,I-PR
mitral,I-PR
regurgitation,I-PR
and,O
left,B-TE
ventricular,I-TE
ejection,I-TE
fraction,I-TE
of,O
58%,O
with,O
normal,O
regional,B-TE
wall,I-TE
motion,I-TE
.,O

HOWeaver,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
Edith,O
Nourse,O
Rogers,O
Memorial,O
VA,O
Hospital,O
and,O
brought,O
to,O
the,O
operating,O
room,O
on,O
2013-01-04,O
by,O
Dr.,O
van,O
der,O
Talbot,O
where,O
she,O
received,O
a,B-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
times,O
three,O
.,O

She,O
had,O
an,B-TR
anastomosis,I-TR
between,I-TR
the,I-TR
left,I-TR
internal,I-TR
mammary,I-TR
artery,I-TR
and,I-TR
the,I-TR
left,I-TR
anterior,I-TR
descending,I-TR
artery,I-TR
",",O
saphenous,B-TR
vein,I-TR
graft,I-TR
to,I-TR
RCA,I-TR
",",O
saphenous,B-TR
vein,I-TR
graft,I-TR
to,I-TR
OM,I-TR
.,O

The,O
patient,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
and,O
was,O
transported,O
to,O
the,O
cardiac,O
surgery,O
recovery,O
room,O
.,O

The,O
patient,O
was,O
extubated,O
on,O
arrival,O
in,O
the,O
cardiac,O
surgery,O
recovery,O
room,O
but,O
was,O
on,O
no,O
drips,B-TR
.,O

The,O
patient,O
's,O
postoperative,O
course,O
was,O
uncomplicated,O
and,O
she,O
was,O
extubated,O
on,O
the,O
first,O
postoperative,O
day,O
.,O

On,O
the,O
first,O
postoperative,O
day,O
her,O
diet,O
was,O
advanced,O
as,O
tolerated,O
and,O
she,O
was,O
transferred,O
to,O
the,O
patient,O
care,O
floor,O
.,O

On,O
postoperative,O
day,O
#2,O
her,B-TR
Foley,I-TR
catheter,I-TR
and,O
chest,B-TR
tubes,I-TR
were,O
discontinued,O
.,O

By,O
postoperative,O
day,O
#3,O
she,O
began,O
ambulating,O
with,O
some,B-PR
great,I-PR
hesitancy,I-PR
.,O

Foley,B-TR
catheter,I-TR
was,O
removed,O
.,O

By,O
postoperative,O
day,O
#5,O
she,O
was,O
ambulating,O
at,O
level,O
IV,O
",",O
was,O
tolerating,O
po,O
",",O
was,O
able,O
to,O
void,O
and,O
felt,O
comfortable,O
to,O
go,O
to,O
rehab,B-TR
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
.,O

DISCHARGE,O
STATUS,O
:,O

Discharged,O
to,O
rehab,O
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

1.,O
Status,O
post,O
coronary,B-TR
artery,I-TR
bypass,I-TR
graft,I-TR
times,O
three,O
on,O
2013-01-04,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Toprol,B-TR
75,O
mg,O
po,O
bid,O
",",O
Furosemide,B-TR
20,O
mg,O
po,O
bid,O
times,O
one,O
week,O
",",O
potassium,B-TR
chloride,I-TR
20,O
mEq,O
po,O
bid,O
while,O
on,O
Lasix,B-TR
",",O
Colace,B-TR
100,O
mg,O
po,O
bid,O
while,O
on,O
Percocet,B-TR
",",O
enteric,B-TR
coated,I-TR
Aspirin,I-TR
325,O
mg,O
po,O
q,O
day,O
",",O
Indocin,B-TR
25,O
mg,O
po,O
bid,O
",",O
Sarna,B-TR
cream,I-TR
applied,O
to,O
affected,O
area,O
prn,O
",",O
Percocet,B-TR
1-2,O
tabs,O
po,O
q,O
4-6,O
hours,O
prn,O
",",O
Ibuprofen,B-TR
400,O
mg,O
po,O
q,O
6,O
hours,O
prn,O
",",O
Tylenol,B-TR
650,O
mg,O
po,O
q,O
4-6,O
hours,O
prn,O
",",O
Ativan,B-TR
0.5,O
mg,O
po,O
q,O
8,O
hours,O
prn,O
.,O

FOAnterP,O
:,O

The,O
patient,O
will,O
follow-up,O
in,O
the,O
wound,O
care,O
clinic,O
in,O
two,O
weeks,O
.,O

The,O
patient,O
will,O
also,O
follow-up,O
with,O
Dr.,O
Fairchild,O
",",O
her,O
primary,O
care,O
physician,O
in,O
three,O
weeks,O
.,O

The,O
patient,O
will,O
follow-up,O
with,O
Dr.,O
vel,O
Diaz,O
in,O
3-4,O
weeks,O
.,O

Briley,O
von,O
der,O
"Ross,",O
M.D.,O
67-576,O

Dictated,O
By,O
:,O
Emily,O
O,O
Ennis,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2013-01-08,O
16:46,O

T,O
:,O
2013-01-08,O
17:08,O

JOB,O
#:,O
67252,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Santos,O
von,O
der,O
Ross,O
on,O
:,O
Elizabeth,O
2013-02-21,O
3:05,O
PM,O

(,O
End,O
of,O
Report,O
),O

712282401,O

OMH,O

5834580,O

96137,O

10/24/1996,O
12:00:00,O
AM,O

RIGHT,B-PR
MIDDLE,I-PR
CEREBRAL,I-PR
ARTERY,I-PR
INFARCT,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

FINGER,O
",",O
ASHA,O

UNIT,O
NUMBER,O
:,O

424-76-57,O

ADMISSION,O
DATE,O
:,O

10/24/96,O

DISCHARGE,O
DATE,O
:,O

Halloween,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Right,B-PR
middle,I-PR
cerebral,I-PR
artery,I-PR
infarct,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

Urinary,B-PR
tract,I-PR
infection,I-PR
.,O

CLINICAL,O
INFECTIONS,O
:,O

Urinary,B-PR
tract,I-PR
infection,I-PR
",",O
E.,B-PR
Coli,I-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

MRI,B-TE
/,O
MRA,B-TE
.,O

OTHER,O
PROCEDURES,O
:,O

Echocardiogram,B-TE
",",O
neurovascular,B-TE
ultrasound,I-TE
.,O

HISTORY,O
:,O

Patient,O
is,O
a,O
73-year-old,O
retired,O
cook,O
with,O
a,O
history,O
of,O
cervical,B-PR
myelopathy,I-PR
",",O
who,O
is,O
admitted,O
for,O
new,B-PR
left,I-PR
hemiparesis,I-PR
.,O

He,O
had,O
undergone,O
C-spine,B-TR
surgery,I-TR
for,O
spinal,B-PR
stenosis,I-PR
with,O
a,O
question,O
of,O
myelopathy,B-PR
and,O
radiculopathy,B-PR
in,O
1992,O
with,O
residual,B-PR
spastic,I-PR
paresis,I-PR
and,O
monoparesis,B-PR
of,I-PR
the,I-PR
left,I-PR
upper,I-PR
extremity,I-PR
",",O
but,O
was,O
ambulatory,O
until,O
a,O
day,O
prior,O
to,O
admission,O
.,O

At,O
his,O
baseline,O
",",O
he,O
was,O
able,O
to,O
perform,O
limited,O
tasks,O
with,O
his,O
left,O
upper,O
extremity,O
",",O
and,O
was,O
clearly,O
able,O
to,O
move,O
his,O
hand,O
and,O
able,O
to,O
ambulate,O
.,O

He,O
also,O
at,O
baseline,O
has,O
had,O
urinary,B-PR
and,I-PR
fecal,I-PR
urgencies,I-PR
/,O
incontinence,B-PR
.,O

His,O
history,O
is,O
now,O
that,O
he,O
has,O
had,O
a,O
week,O
of,O
progressive,B-PR
left,I-PR
upper,I-PR
extremity,I-PR
weakness,I-PR
",",O
to,O
the,O
point,O
of,O
being,O
unable,O
to,O
move,O
the,O
left,O
hand,O
and,O
one,O
day,O
of,O
being,O
unable,O
to,O
walk,O
secondary,O
to,O
left,B-PR
leg,I-PR
weakness,I-PR
with,O
a,O
marked,O
tendency,O
to,O
fall,O
leftward,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Notable,O
for,O
anemia,B-PR
",",O
hypercholesterolemia,B-PR
",",O
narcolepsy,B-PR
for,O
the,O
past,O
6,O
years,O
on,O
Dexedrine,B-TR
",",O
impotence,B-PR
with,O
decreased,B-PR
testosterone,I-PR
",",O
status,O
post,O
implant,B-TR
",",O
peptic,B-PR
ulcer,I-PR
disease,I-PR
",",O
status,O
post,O
duodenal,B-TR
resection,I-TR
",",O
cervical,B-PR
stenosis,I-PR
",",O
status,O
post,O
decompression,B-TR
&apos;92,O
",",O
hernia,B-PR
",",O
status,O
post,O
herniorrhaphy,B-TR
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

MEDICATIONS,B-TR
ON,O
ADMISSION,O
:,O

Dexedrine,B-TR
5,O
mg,O
per,O
day,O
and,O
Motrin,B-TR
600,O
mg,O
tid,O
.,O

PHYSICAL,B-TE
EXAMINATION,I-TE
:,O

On,O
admission,O
",",O
older,O
",",O
black,O
gentleman,O
in,O
no,O
acute,B-PR
distress,I-PR
with,O
left,B-TE
upper,I-TE
extremity,I-TE
flex,I-TE
across,O
his,O
chest,O
.,O

His,B-TE
temperatureis,I-TE
98.9,O
.,O

His,B-TE
pressure,I-TE
is,O
150/90,O
.,O

Rate,B-TE
76,O
.,O

Respirations,B-TE
16,O
.,O

He,O
was,O
edentulous,B-PR
.,O

He,O
had,O
mild,B-PR
copper,I-PR
wiring,I-PR
.,O

He,O
has,O
a,B-PR
I,I-PR
/,I-PR
VI,I-PR
systolic,I-PR
murmur,I-PR
at,I-PR
the,I-PR
right,I-PR
upper,I-PR
sternal,I-PR
border,I-PR
.,O

Heart,B-TE
sounds,I-TE
were,O
normal,O
and,O
regular,O
.,O

Breath,B-TE
sounds,I-TE
were,O
equal,O
bilaterally,O
with,O
course,B-PR
rhonchi,I-PR
.,O

He,O
had,O
a,B-PR
midline,I-PR
abdominal,I-PR
scar,I-PR
and,O
a,B-PR
reducible,I-PR
umbilical,I-PR
hernia,I-PR
.,O

Abdomen,O
was,O
otherwise,O
soft,O
and,O
nontender,B-PR
.,O

He,O
had,O
2+,B-TE
carotids,I-TE
",",O
no,O
bruits,B-PR
.,O

He,O
had,O
gynecomastia,B-PR
.,O

Rectal,O
was,O
guaiac,O
negative,O
with,O
brown,O
stool,O
",",O
good,O
tone,O
but,O
unable,O
to,O
squeeze,O
.,O

Extremities,O
:,O

1+,B-TE
right,I-TE
posterior,I-TE
tibialis,I-TE
",",O
2+,B-TE
left,I-TE
posterior,I-TE
tibialis,I-TE
",",O
no,O
edema,B-PR
",",O
ichthyotic,B-PR
changes,I-PR
were,O
present,O
.,O

He,O
had,O
0,O
left,O
wrist,O
flexion,O
or,O
extension,O
while,O
his,O
left,O
proximal,O
muscles,O
were,O
4,O
including,O
his,O
biceps,O
and,O
triceps,O
.,O

His,O
right,O
arm,O
muscles,O
were,O
also,O
in,O
the,O
range,O
of,O
4/5.,O

His,B-TE
hip,I-TE
flexion,I-TE
was,O
4+,O
on,O
the,O
right,O
and,O
4-,O
on,O
the,O
left,O
;,O
extension,B-TE
5,O
on,O
the,O
right,O
",",O
4+,O
on,O
the,O
left,O
;,O
knee,B-TE
flexion,I-TE
evidently,O
trace,O
on,O
the,O
right,O
and,O
4-,O
on,O
the,O
left,O
with,O
knee,B-TE
extension,I-TE
5-,O
on,O
the,O
left,O
",",O
5,O
on,O
the,O
right,O
;,O
knee,B-TE
flexion,I-TE
4-,O
on,O
the,O
left,O
",",O
trace,O
on,O
the,O
right,O
;,O
ankle,B-TE
dorsi,I-TE
flexion,I-TE
4-,O
on,O
the,O
left,O
",",O
trace,O
on,O
the,O
right,O
.,O

Reflexes,B-TE
4+,O
overall,O
in,O
the,O
upper,O
extremities,O
and,O
3+,O
overall,O
in,O
the,O
lower,O
extremities,O
",",O
an,O
upgoing,O
left,O
toe,O
and,O
a,O
down,O
going,O
right,O
toe,O
.,O

His,O
tone,O
was,O
increased,O
on,O
the,O
left,O
side,O
and,O
he,O
had,O
diminished,O
pin,O
prick,O
and,O
light,O
touch,O
in,O
his,O
left,O
upper,O
extremity,O
and,O
slightly,O
in,O
his,O
left,O
lower,O
extremity,O
with,O
a,O
similar,O
finding,O
for,O
vibratory,O
sense,O
",",O
but,O
in,O
an,O
unreliable,O
pattern,O
.,O

He,O
occasionally,O
had,O
extinction,O
in,O
his,O
left,O
upper,O
",",O
greater,O
than,O
lower,O
extremity,O
",",O
but,O
this,O
was,O
fluctuating,O
.,O

Mental,O
state,O
:,O

He,O
was,O
awake,O
",",O
occasionally,O
sleepy,O
but,O
easily,O
aroused,O
",",O
oriented,O
to,O
self,O
",",O
Oaksgekesser/,O
Memorial,O
Hospital,O
and,O
the,O
date,O
.,O

He,O
was,O
mildly,B-PR
perseverative,I-PR
and,O
inattentive,B-PR
.,O

Coordination,O
:,O

his,O
fine,O
finger,O
movements,O
and,O
rapid,O
alternating,O
movements,O
were,O
within,O
normal,O
limits,O
.,O

He,O
was,O
unable,O
to,O
stand,O
without,O
extensive,O
assistance,O
.,O

LABORATORY,B-TE
DATA,I-TE
:,O

Sodium,B-TE
141,O
",",O
potassium,B-TE
3.6,O
",",O
BUN,B-TE
14,O
",",O
creatinine,B-TE
1.1,O
",",O
hematocrit,B-TE
37%,O
",",O
platelets,B-TE
177,O
",",O
white,B-TE
blood,I-TE
count,I-TE
4.1,O
.,O

Chest,B-TE
x-ray,I-TE
showed,O
degenerative,B-PR
joint,I-PR
disease,I-PR
",",O
an,B-PR
ill,I-PR
defined,I-PR
left,I-PR
hemi-diaphragm,I-PR
without,O
air,B-PR
space,I-PR
disease,I-PR
.,O

On,O
the,O
lateral,O
view,O
",",O
surgical,B-TR
clips,I-TR
in,I-TR
the,I-TR
abdomen,I-TR
.,O

EKG,B-TE
showed,O
normal,O
sinus,O
rhythm,O
",",O
no,O
ST,B-PR
or,I-PR
T,I-PR
wave,I-PR
changes,I-PR
.,O

HOSPITAL,O
COURSE,O
AND,O
TREATMENT,B-TR
:,O

Mr.,O
Finger,O
was,O
admitted,O
for,O
what,O
appeared,O
to,O
be,O
a,B-PR
stroke,I-PR
syndrome,I-PR
involving,O
his,O
left,O
middle,O
cerebral,O
artery,O
territory,O
.,O

He,O
underwent,O
neurovascular,B-TE
doppler,I-TE
studies,I-TE
which,O
showed,O
no,O
significant,O
change,O
in,O
either,O
common,O
carotid,O
or,O
in,O
the,O
left,O
common,O
internal,O
ophthalmic,O
system,O
.,O

However,O
",",O
there,O
were,O
hemodynamic,B-PR
changes,I-PR
which,O
raised,O
the,O
question,O
of,O
right,B-PR
siphon,I-PR
disease,I-PR
.,O

He,O
had,O
normal,O
cervical,O
vertebral,O
arteries,O
.,O

Transcranial,B-TE
dopplers,I-TE
showed,O
no,O
abnormalities,B-PR
in,I-PR
the,I-PR
ophthalmic,I-PR
siphon,I-PR
systems,I-PR
",",O
distal,O
vertebrals,O
",",O
or,O
proximal,O
basilar,O
artery,O
.,O

The,O
proximal,O
",",O
middle,O
",",O
anterior,O
and,O
posterior,O
cerebral,O
arteries,O
",",O
however,O
",",O
could,O
not,O
be,O
insinuated,O
.,O

Over,O
the,O
course,O
of,O
the,O
first,O
hospital,O
day,O
",",O
the,B-TE
patient,I-TE
&apos;s,I-TE
exam,I-TE
deteriorated,O
in,O
a,O
manner,O
that,O
appeared,O
to,O
be,O
blood,O
pressure,O
dependent,O
.,O

He,O
had,O
been,O
started,O
on,O
Heparin,B-TR
from,O
the,O
time,O
of,O
his,O
admission,O
.,O

A,B-TE
computerized,I-TE
tomography,I-TE
scan,I-TE
had,O
showed,O
multiple,B-PR
lacunes,I-PR
",",O
right,O
greater,O
than,O
left,O
",",O
and,O
the,O
deep,O
gray,O
and,O
white,O
matters,O
suspicious,O
for,O
proximal,B-PR
middle,I-PR
cerebral,I-PR
artery,I-PR
stem,I-PR
occlusion,I-PR
or,O
stenosis,B-PR
.,O

MRI,B-TE
/,O
MRA,B-TE
was,O
performed,O
with,O
diffusion,O
weighted,O
images,O
",",O
showing,O
subcortical,B-PR
white,I-PR
matter,I-PR
and,O
basal,B-PR
ganglia,I-PR
infarcts,I-PR
",",O
but,O
preserved,O
middle,O
cerebral,O
artery,O
territory,O
cortex,O
.,O

Because,O
of,O
his,B-TE
blood,I-TE
pressure,I-TE
",",O
dependence,O
of,O
his,O
left,O
sided,O
extremities,O
",",O
the,O
lower,O
leg,O
specifically,O
",",O
he,O
was,O
transferred,O
to,O
the,O
Intensive,O
Care,O
Unit,O
where,O
he,O
underwent,O
hypertensive,B-TR
therapy,I-TR
for,O
several,O
days,O
.,O

His,B-TE
systolic,I-TE
blood,I-TE
pressure,I-TE
goal,O
was,O
initially,O
170-190,O
",",O
which,O
he,O
was,O
able,O
to,O
achieve,O
spontaneously,O
for,O
the,O
most,O
part,O
.,O

However,O
",",O
due,O
to,O
the,O
absence,O
of,O
clear,O
benefit,O
at,O
this,O
level,O
",",O
and,O
further,B-PR
deterioration,I-PR
in,I-PR
his,I-PR
left,I-PR
sided,I-PR
strength,I-PR
",",O
this,O
goal,O
was,O
increased,O
and,O
Neo-Synephrine,B-TR
was,O
added,O
to,O
his,O
regimen,O
to,O
achieve,O
mean,B-TE
arterial,I-TE
pressures,I-TE
in,O
the,O
110-120,O
range,O
.,O

This,O
strategy,O
and,O
its,O
incumbent,O
risks,O
",",O
particularly,O
in,O
a,O
patient,O
on,O
Heparin,B-TR
",",O
were,O
discussed,O
at,O
length,O
with,O
both,O
the,O
patient,O
and,O
his,O
family,O
",",O
who,O
were,O
very,O
clear,O
in,O
wanting,O
to,O
proceed,O
with,O
all,O
possible,O
efforts,O
to,O
save,O
the,O
use,O
of,O
his,O
left,O
leg,O
.,O

While,O
in,O
the,O
Intensive,O
Care,O
Unit,O
",",O
his,O
strength,O
deteriorated,O
from,O
being,O
able,O
to,O
hold,O
his,O
left,O
leg,O
off,O
the,O
bed,O
up,O
to,O
several,O
inches,O
to,O
loosing,O
virtually,O
all,O
distal,O
extremity,O
strength,O
",",O
and,O
having,O
a,O
2-3/5,O
power,O
in,O
his,O
proximal,O
left,O
leg,O
groups,O
.,O

He,O
also,O
",",O
as,O
Neo-Synephrinewas,B-TR
tapered,O
",",O
developed,O
mild,B-PR
sensory,I-PR
findings,I-PR
",",O
in,O
particular,O
diminished,B-PR
large,I-PR
fiber,I-PR
sensibility,I-PR
in,I-PR
his,I-PR
left,I-PR
hand,I-PR
",",O
although,O
he,O
at,O
times,O
",",O
including,O
near,O
the,O
end,O
of,O
his,O
Intensive,O
Care,O
Unit,O
stay,O
had,O
a,B-PR
right,I-PR
gaze,I-PR
preference,I-PR
.,O

In,O
terms,O
of,O
exploring,O
his,O
visual,O
space,O
",",O
he,O
was,O
able,O
to,O
look,O
to,O
the,O
left,O
",",O
and,O
it,O
was,O
not,O
possible,O
to,O
elicit,O
clear,O
evidence,O
for,O
a,B-PR
field,I-PR
deficit,I-PR
.,O

He,O
was,O
followed,O
by,O
speech,O
and,O
swallowing,O
service,O
",",O
who,O
assisted,O
in,O
the,B-TR
management,I-TR
of,I-TR
po,I-TR
intake,I-TR
which,O
gradually,O
improved,O
",",O
although,O
he,O
clearly,O
had,O
problems,O
with,O
manipulation,O
of,O
food,O
in,O
the,O
left,O
side,O
of,O
his,O
mouth,O
and,O
would,O
tend,O
to,O
accumulate,O
a,O
pouch,O
of,O
food,O
in,O
his,O
left,O
cheek,O
.,O

I,O
should,O
mention,O
that,O
his,B-TR
blood,I-TR
pressure,I-TR
therapy,I-TR
was,O
at,O
times,O
limited,O
by,O
a,B-PR
severe,I-PR
headache,I-PR
",",O
although,O
he,O
also,O
had,O
this,O
off,O
the,B-TR
pressor,I-TR
.,O

He,O
had,O
several,B-TE
repeat,I-TE
imaging,I-TE
studies,I-TE
during,O
his,O
Intensive,O
Care,O
Unit,O
stay,O
which,O
showed,O
further,B-PR
demarcation,I-PR
",",O
but,O
not,O
extension,B-PR
of,I-PR
his,I-PR
prior,I-PR
infarct,I-PR
",",O
both,O
on,O
computerized,B-TE
tomography,I-TE
scan,I-TE
and,O
DWI,B-TE
images,I-TE
.,O

Additionally,O
",",O
he,O
had,O
a,B-TE
perfusion,I-TE
",",I-TE
diffusion,I-TE
MR,I-TE
study,I-TE
earlier,O
on,O
",",O
which,O
suggested,O
the,O
presence,O
of,O
viable,B-PR
penumbra,I-PR
",",O
including,O
the,O
overlying,O
cortex,O
.,O

He,O
was,O
transferred,O
to,O
the,O
regular,O
neurology,O
floor,O
once,O
it,O
became,O
clear,O
that,O
he,O
was,O
not,O
receiving,O
any,O
significant,O
benefit,O
from,O
hypertensive,B-TR
therapy,I-TR
.,O

At,O
this,O
time,O
",",O
his,B-TE
neurologic,I-TE
exam,I-TE
is,O
notable,O
for,O
hemiplegia,B-PR
of,I-PR
his,I-PR
left,I-PR
arm,I-PR
",",O
severe,B-PR
hemiparesis,I-PR
of,I-PR
his,I-PR
left,I-PR
leg,I-PR
",",O
mild,B-PR
large,I-PR
fiber,I-PR
sensory,I-PR
loss,I-PR
in,I-PR
his,I-PR
left,I-PR
arm,I-PR
",",O
and,O
otherwise,O
fairly,O
intact,O
mental,O
status,O
",",O
cranial,O
nerve,O
function,O
",",O
and,O
right,O
sided,O
motor,O
and,O
sensory,O
function,O
.,O

We,O
anticipate,O
that,O
he,O
represents,O
a,O
good,O
rehab,O
potential,O
.,O

He,O
will,O
be,O
discharged,O
to,O
rehab,O
on,O
a,O
regimen,O
of,O
Coumadin,B-TR
5,O
mg,O
po,O
today,O
then,O
daily,O
for,O
an,O
INR,B-TE
goal,O
of,O
2-3,O
",",O
Ofloxacin,B-TR
400,O
mg,O
po,O
bid,O
to,O
be,O
discontinued,O
on,O
11/05/96,O
",",O
Dexedrine,B-TR
5,O
mg,O
po,O
qd,O
",",O
Omeprazole,B-TR
20mg,O
po,O
qd,O
",",O
Erythromycin,B-TR
eye,I-TR
ointment,I-TR
OU,O
bid,O
",",O
Heparin,B-TR
at,O
its,O
present,O
rate,O
adjusting,O
per,O
partial,B-TE
thromboplastin,I-TE
time,I-TE
bid,O
",",O
and,O
discontinuing,O
when,O
the,B-TR
Coumadin,I-TR
is,O
therapeutic,O
",",O
Tylenol,B-TR
650,O
mg,O
po,O
q4,O
prn,O
",",O
Colace,B-TR
100,O
mg,O
po,O
bid,O
.,O

Follow,O
up,O
will,O
be,O
with,O
Dr.,O
Tvi,O
Fine,O
of,O
Neurology,O
",",O
and,O
Dr.,O
Doll,O
Grendbly,O
of,O
internal,O
medicine,O
and,O
primary,O
care,O
",",O
shortly,O
after,O
discharge,O
from,O
rehab,O
.,O

BETHTATCHA,O
W,O
R,O
NEW,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

TVI,O
SHANEL,O
WASHING,O
",",O
M.D,O
",",O
PhD,O
.,O

TR,O
:,O

tu,O

DD,O
:,O

Halloween,O

TD,O
:,O

10/31/96,O
2:55,O

Pcc,O
:,O

LASDAJENA,O
WASHING,O
",",O
M.D.,O
TELSHEY,O
KO,O
SWATLLEEBTIK,O
",",O
JR,O
",",O
M.D.,O
TVI,O
SHANEL,O
WASHING,O
",",O
M.D.,O
",",O
Ph.D.,O
DOLL,O
MAO,O
GRENDBLY,O
",",O
M.D.,O
BETHTATCHA,O
W,O
R,O
NIQUE,O
DOUETMONES,O
",",O
III,O
",",O
M.D.,O
STAT,O

?Admission,O
Date,O
:,O

2014-07-24,O

Discharge,O
Date,O
:,O

2014-08-09,O

Date,O
of,O
Birth,O
:,O

1946-08-07,O

Sex,O
:,O

F,O

Service,O
:,O

BLUE,O
GENERAL,O
SURGERY,O

HISTORY,O
OF,O
THE,O
PRESENT,O
ILLNESS,O
:,O

Mrs.,O
Gonzalez,O
is,O
a,O
patient,O
with,O
a,O
prior,O
medical,O
history,O
including,O
hypothyroidism,B-PR
",",O
iron-deficiency,B-PR
anemia,I-PR
",",O
osteoporosis,B-PR
",",O
increased,B-PR
cholesterol,I-PR
",",O
peptic,B-PR
ulcer,I-PR
disease,I-PR
",",O
chronic,B-PR
constipation,I-PR
",",O
and,O
status,O
post,O
appendectomy,B-TR
as,O
well,O
as,O
status,O
post,O
hysterectomy,B-TR
and,O
bilateral,B-TR
salpingo-oophorectomy,I-TR
.,O

She,O
was,O
transferred,O
from,O
an,O
outside,O
hospital,O
for,O
evaluation,B-TE
and,O
treatment,B-TR
of,O
adenocarcinoma,B-PR
involving,O
the,O
transverse,O
colon,O
and,O
gallbladder,O
.,O

At,O
the,O
outside,O
hospital,O
the,O
patient,O
had,O
already,O
seemed,O
some,B-TE
workup,I-TE
for,O
a,O
couple,O
weeks,O
duration,O
of,O
bilateral,B-PR
upper,I-PR
quadrant,I-PR
pain,I-PR
which,O
occasionally,O
radiated,O
to,O
her,O
back,O
.,O

She,O
was,O
also,O
complaining,O
of,O
fatigue,B-PR
for,O
two,O
weeks,O
but,O
a,O
good,O
appetite,O
and,O
the,O
patient,O
denied,O
weight,B-PR
loss,I-PR
",",O
melena,B-PR
",",O
or,O
bright,B-PR
red,I-PR
blood,I-PR
per,I-PR
rectum,I-PR
.,O

A,B-TE
CAT,I-TE
scan,I-TE
of,I-TE
the,I-TE
abdomen,I-TE
showed,O
air-fluid,B-PR
levels,I-PR
in,I-PR
the,I-PR
gallbladder,I-PR
.,O

It,O
also,O
showed,O
a,B-PR
thickened,I-PR
gallbladder,I-PR
wall,I-PR
as,O
well,O
as,O
a,B-PR
dilated,I-PR
common,I-PR
bile,I-PR
duct,I-PR
.,O

Incidentally,O
",",O
it,O
also,O
showed,O
diverticulosis,B-PR
.,O

A,B-TE
HIDA,I-TE
scan,I-TE
at,O
the,O
other,O
hospital,O
did,O
not,O
show,O
filling,B-PR
of,I-PR
the,I-PR
gallbladder,I-PR
indicating,O
some,O
sort,O
of,O

cystic,B-PR
duct,I-PR
obstruction,I-PR
.,O

The,B-TE
first,I-TE
imaging,I-TE
study,I-TE
that,O
was,O
done,O
at,O
Hahnemann,O
General,O
Hospital,O
was,O
a,B-TE
MRCP,I-TE
which,O
revealed,O
an,B-PR
enhanced,I-PR
thickened,I-PR
gallbladder,I-PR
wall,I-PR
consistent,O
with,O
chronic,B-PR
cholecystitis,I-PR
.,O

A,O
differential,O
according,O
to,O
the,B-TE
imaging,I-TE
included,O
a,B-PR
fistula,I-PR
with,O
adjacent,B-PR
inflammatory,I-PR
change,I-PR
but,O
also,O
carcinoma,B-PR
or,O
adenomatosis,B-PR
.,O

In,O
"addition,",O
also,O
the,B-TE
MRCP,I-TE
showed,O
a,B-PR
mass,I-PR
near,O
the,O
region,O
of,O
the,O
neck,O
of,O
the,O
gallbladder,O
.,O

Of,O
note,O
",",O
at,O
the,O
outside,O
hospital,O
",",O
an,B-TE
endoscopy,I-TE
and,O
colonoscopy,B-TE
were,O
performed,O
.,O

The,B-TE
colonoscopy,I-TE
showed,O
two,B-PR
polyps,I-PR
and,O
also,O
a,O
region,O
in,O
the,O
transverse,O
colon,O
that,O
was,O
biopsied,O
.,O

This,B-TE
biopsy,I-TE
came,O
back,O
as,O
positive,O
for,O
adenocarcinoma,B-PR
.,O

The,O
diagnosis,O
of,O
adenocarcinoma,B-PR
was,O
already,O
established,O
prior,O
to,O
her,O
admission,O
at,O
this,O
hospital,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
scheduled,O
for,O
an,O
operative,O
date,O
on,O
2014-07-29,O
and,O
over,O
the,O
next,O
few,O
days,O
she,O
was,O

given,O
a,B-TR
low-residual,I-TR
diet,I-TR
.,O

She,O
had,O
her,O
belly,O
cleaned,O
with,O
Hibiclens,B-TR
one,O
a,O
day,O
and,O
once,O
an,B-TE
adequate,I-TE
preoperative,I-TE
evaluation,I-TE
was,O
performed,O
",",O
she,O
was,O
given,O
a,B-TR
bowel,I-TR
prep,I-TR
on,O
Monday,O
afternoon,O
and,O
evening,O
in,O
preparation,O
for,O
an,O

exploratory,B-TE
laparotomy,I-TE
on,O
Tuesday,O
",",O
2014-07-29,O
.,O

On,O
the,O
morning,O
of,O
2014-07-29,O
",",O
the,O
patient,O
was,O
taken,O
to,O
the,O
Operating,O
Room,O
and,O
underwent,O
a,B-TR
cholecystectomy,I-TR
",",O
partial,B-TR
hepatectomy,I-TR
",",O
partial,B-TR
lymph,I-TR
node,I-TR
dissection,I-TR
",",O
a,B-TR
colocolostomy,I-TR
",",O
partial,B-TR
colectomy,I-TR
",",O
and,O
in,O
addition,O
a,B-TR
gastrostomy,I-TR
and,O
a,B-TR
feeding,I-TR
jejunostomy,I-TR
were,O
also,O
put,O
in,O
place,O
.,O

Please,O
refer,O
to,O
the,O
previously,O
dictated,O
operative,O
notes,O
for,O
the,O
details,O
of,O
this,B-TR
surgery,I-TR
.,O

Briefly,O
",",O
the,B-TR
surgery,I-TR
on,O
2014-07-29,O
revealed,O
a,B-PR
carcinoma,I-PR
of,I-PR
the,I-PR
gallbladder,I-PR
with,O
a,B-PR
cholecystocolonic,I-PR
fistula,I-PR
which,O
crossed,O
into,O
the,O
liver,O
as,O
well,O
as,O
metastatic,B-PR
adenopathy,I-PR
around,I-PR
the,I-PR
portal,I-PR
nodes,I-PR
as,O
well,O
as,O
retroperitoneal,B-PR
nodes,I-PR
around,I-PR
the,I-PR
inferior,I-PR
vena,I-PR
cava,I-PR
and,I-PR
the,I-PR
hepatic,I-PR
artery,I-PR
.,O

In,O
addition,O
to,O
the,B-TR
gastrostomy,I-TR
and,O
feeding,B-TR
jejunostomy,I-TR
tube,I-TR
",",O
two,B-TR
Belmont-Gardner,I-TR
drains,I-TR
were,O
placed,O
.,O

The,B-PR
patient,I-PR
's,I-PR
pain,I-PR
postoperatively,O
was,O
controlled,O
with,O
an,B-TR
epidural,I-TR
catheter,I-TR
.,O

However,O
",",O
the,B-TR
epidural,I-TR
had,O
the,O
consequence,O
of,O
causing,O
a,O
bit,O
of,O
a,B-PR
hypotension,I-PR
in,O
the,O
patient,O
and,O
the,O
patient,O
was,O
admitted,O
to,O
the,O
Surgical,O
ICU,O
for,O
the,O
first,O
postoperative,O
day,O
.,O

In,O
addition,O
",",O
the,O
patient,O
had,O
low,B-PR
hematocrits,I-PR
which,O
required,O
a,B-TR
transfusion,I-TR
of,I-TR
packed,I-TR
red,I-TR
blood,I-TR
cells,I-TR
.,O

In,O
addition,O
",",O
on,O
postoperative,O
day,O
number,O
two,O
",",O
the,O
patient,O
was,O
transferred,O
out,O
to,O
the,O
floor,O
and,O
she,O
was,O
doing,O
better,O
in,O
terms,O
of,O
pain,B-TR
control,I-TR
on,O
a,B-TR
Dilaudid,I-TR
PCA,I-TR
machine,I-TR
.,O

On,O
postoperative,O
day,O
number,O
two,O
",",O
interestingly,O
",",O
the,O
patient,O
was,O
complaining,O
of,O
sensitivity,B-PR
to,I-PR
light,I-PR
from,O
an,O
unknown,O
etiology,O
.,O

The,O
patient,O
's,O
postoperative,O
course,O
was,O
unremarkable,O
aside,O
from,O
the,B-PR
photophobia,I-PR
.,O

On,O
postoperative,O
day,O
number,O
two,O
",",O
an,O
Oncology,O
consult,O
with,O
Dr.,O
Natalie,O
Mcalister,O
was,O
obtained,O
and,O

follow-up,O
appointments,O
were,O
scheduled,O
with,O
him,O
as,O
an,O
outpatient,O
.,O

Following,O
that,O
",",O
the,O
patient,O
was,O
slowly,O
advanced,O
to,O
clear,B-TR
liquids,I-TR
and,O
to,O
a,O
regular,O
diet,O
once,O
her,O
bowels,O
began,O
working,O
when,O
she,O
began,O
having,O
flatus,O
.,O

Her,O
bowel,O
function,O
was,O
slow,O
to,O
develop,O
and,O
she,O
needed,O
to,O
remain,O
n.p.o.,B-TR
until,O
postoperative,O
day,O
number,O
six,O
.,O

The,O
patient,O
was,O
also,O
given,O
supplemental,B-TR
tube,I-TR
feedings,I-TR
to,O
supplement,O
her,O
calories,O
and,O
caloric,O
intake,O
.,O

On,O
postoperative,O
day,O
number,O
seven,O
",",O
the,O
patient,O
was,O
tolerating,O
her,B-TR
clear,I-TR
liquid,I-TR
diet,I-TR
and,O
her,B-TR
tube,I-TR
feeds,I-TR
.,O

She,O
was,O
started,O
on,O
p.o.,B-TR
medicines,I-TR
and,O
her,B-TR
first,I-TR
Belmont-Gardner,I-TR
drain,I-TR
was,O
pulled,O
due,O
to,O
scant,O
output,O
.,O

By,O
2014-08-09,O
",",O
the,O
patient,O
was,O
tolerating,O
a,O
full,O
solid,O
diet,O
as,O
well,O
as,O
her,B-TR
tube,I-TR
feeds,I-TR
.,O

Between,O
the,O
two,O
of,O
those,O
",",O
her,O
caloric,O
intake,O
was,O
sufficient,O
for,O
her,O
to,O
sustain,O
herself,O
.,O

She,O
was,O
discharged,O
to,O
home,O
with,O
services,O
including,O
tube,B-TR
feedings,I-TR
for,O
her,O
home,O
care,O
.,O

Therefore,O
",",O
she,O
was,O
discharged,O
on,O
2014-08-09,O
in,O
good,O
condition,O
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

1.,O
Metastatic,B-PR
gallbladder,I-PR
cancer,I-PR
.,O

2.,O
Status,O
post,O
cholecystectomy,B-TR
.,O

3.,O
Status,O
post,O
transverse,B-TR
colectomy,I-TR
with,O
anastomosis,B-PR
.,O

4.,O
G,B-TR
tube,I-TR
placement,I-TR
.,O

5.,O
Feeding,B-TR
jejunostomy,I-TR
.,O

6.,O
Hypothyroidism,B-PR
.,O

7.,O
Blood,B-PR
loss,I-PR
requiring,O
transfusion,B-TR
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Levothyroxine,B-TR
100,O
micrograms,O
orally,O
once,O
a,O
day,O
.,O

2.,O
Pantoprazole,B-TR
one,O
tablet,O
once,O
a,O
day,O
.,O

3.,O
Ambien,B-TR
10,O
mg,O
orally,O
before,O
bed,O
.,O

4.,O
Tylenol,B-TR
#,O
3,O
one,O
tablet,O
every,O
four,O
hours,O
as,O
needed,O
for,O
pain,B-PR
.,O

5.,O
Reglan,B-TR
10,O
mg,O
four,O
times,O
a,O
day,O
before,O
meals,O
and,O
at,O
bedtime,O
.,O

6.,O
Colace,B-TR
100,O
mg,O
twice,O
a,O
day,O
.,O

DISCHARGE,O
INSTRUCTIONS,O
:,O

Follow-up,O
with,O
the,O
Visiting,O
Nurses,O
Association,O
to,O
arrange,O
assistance,O
with,O
her,B-TR
tube,I-TR
feeding,I-TR
and,O

her,O
activities,O
of,O
daily,O
living,O
.,O

The,O
patient,O
is,O
also,O
scheduled,O
for,O
an,O
appointment,O
with,O
Dr.,O
Patterson,O
approximately,O
two,O
weeks,O
after,O
her,O
discharge,O
from,O
the,O
hospital,O
.,O

Heather,O
FISCHER,O
",",O
M.D.,O

91-657,O

Dictated,O
By,O
:,O
Raymond,O
Q.,O
Martinez,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2014-08-16,O
01:23,O

T,O
:,O
2014-08-16,O
13:25,O

JOB,O
#:,O

23786,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Brian,O
S,O
Heath,O
on,O
:,O
Danielle,O
2014-08-28,O
2:52,O
PM,O

(,O
End,O
of,O
Report,O
),O

736743101,O

PUOMC,O

2427050,O

19324/7383,O

418074,O

4/17/1995,O
12:00:00,O
AM,O

NECROTIZING,B-PR
PANCREATITIS,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

4/17/95,O

DISCHARGE,O
DATE,O
:,O

07/16/95,O

DATE,O
OF,O
BIRTH,O
:,O

7/2/1928,O
.,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Necrotizing,B-PR
pancreatitis,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

1.,O
Wegener,B-PR
&apos;s,I-PR
granulomatosis,I-PR
.,O

2.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
",",O
status,O
post,O
anterior,B-PR
myocardial,I-PR
infarction,I-PR
in,O
1993,O
.,O

3.,O
Left,B-PR
ventricular,I-PR
aneurysm,I-PR
.,O

4.,O
Dementia,B-PR
.,O

5.,O
Gallstone,B-PR
pancreatitis,I-PR
.,O

6.,O
Fungal,B-PR
cystitis,I-PR
.,O

7.,O
Intra-abdominal,B-PR
infection,I-PR
.,O

8.,O
Total,B-PR
parenteral,I-PR
nutrition,I-PR
dependent,I-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

Exploratory,B-TE
laparotomy,I-TE
",",O
left,B-TR
colectomy,I-TR
",",O
end-transverse,B-TR
colostomy,I-TR
",",O
drainage,B-TR
of,O
pancreatic,B-PR
necrosis,I-PR
.,O

Date,O
of,O
operation,O
:,O

4/28/95,O
.,O

HISTORY,O
AND,O
REASON,O
FOR,O
ADMISSION,O
:,O

Mr.,O
Mass,O
was,O
a,O
56,O
year,O
old,O
white,O
male,O
who,O
was,O
transferred,O
from,O
Vassdiysey,O
Medical,O
Center,O
for,O
rule,O
out,O
pancreatic,B-PR
pseudocyst,I-PR
.,O

Mr.,O
Mass,O
had,O
a,O
past,O
medical,O
history,O
which,O
included,O
Wegener,B-PR
&apos;s,I-PR
granulomatosis,I-PR
",",O
history,O
of,O
an,B-PR
anterior,I-PR
myocardial,I-PR
infarction,I-PR
",",O
and,O
gallstone,B-PR
pancreatitis,I-PR
.,O

He,O
was,O
admitted,O
to,O
Vassdiysey,O
Medical,O
Center,O
with,O
severe,B-PR
recurrent,I-PR
pancreatitis,I-PR
",",O
nausea,B-PR
",",O
vomiting,B-PR
",",O
and,O
abdominal,B-PR
pain,I-PR
.,O

His,B-TE
amylase,I-TE
on,O
admission,O
there,O
was,O
"1,961",O
.,O

The,O
patient,O
had,O
two,O
recent,O
admissions,O
for,O
pancreatitis,B-PR
in,O
January,O
1994,O
",",O
and,O
August,O
1994,O
.,O

On,O
his,O
current,O
admission,O
",",O
the,O
patient,O
was,O
admitted,O
to,O
Free,O
Medical,O
Center,O
.,O

His,B-TE
amylase,I-TE
decreased,O
to,O
51,O
",",O
and,O
the,O
increased,O
back,O
to,O
151,O
on,O
hospital,O
day,O
#10,O
.,O

At,O
that,O
time,O
",",O
he,O
spiked,O
a,B-TE
temperature,I-TE
to,O
103,O
.,O

He,O
also,O
became,O
increasingly,B-PR
confused,I-PR
.,O

A,B-TE
computerized,I-TE
tomography,I-TE
scan,I-TE
done,O
on,O
4/16/95,O
showed,O
a,B-PR
large,I-PR
&quot;,I-PR
pseudocyst,I-PR
&quot;,I-PR
.,O

He,O
was,O
transferred,O
to,O
Ph,O
University,O
Of,O
Medical,O
Center,O
for,O
further,B-TE
surgical,I-TE
evaluation,I-TE
.&apos;,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
As,O
above,O
.,O

2.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
",",O
status,O
post,O
anterior,B-PR
myocardial,I-PR
infarction,I-PR
",",O
in,O
1993,O
.,O

Ejection,B-TE
fraction,I-TE
was,O
felt,O
to,O
be,O
35%,O
in,O
1993,O
.,O

Recent,B-TE
echocardiogram,I-TE
suggests,O
ejection,B-TE
fraction,I-TE
of,O
15%,O
.,O

3.,O
Wegener,B-PR
&apos;s,I-PR
granulomatosis,I-PR
",",O
with,O
associated,B-PR
chronic,I-PR
renal,I-PR
insufficiency,I-PR
.,O

4.,O
Mild,B-PR
dementia,I-PR
.,O

MEDICATIONS,O
:,O

Vitamin,B-TR
K,I-TR
",",O
10,O
mg.,O
",",O
IM,O
",",O
q-week,O
.,O

2.,O
Pepcid,B-TR
",",O
20,O
mg.,O
",",O
intravenously,O
",",O
q12h.,O

3.,O
Digoxin,B-TR
",",O
0.125,O
mg.,O
",",O
intravenously,O
",",O
qD,O
.,O

4.,O
Imipenem,B-TR
",",O
500,O
mg.,O
",",O
intravenously,O
",",O
q6h.,O

5.,O
Nitropaste,B-TR
",",O
one-half,O
inch,O
to,O
chest,O
wall,O
",",O
q6h.,O

6.,O
Vasotec,B-TR
.,O

7.,O
Alterajel,B-TR
.,O

8.,O
Lasix,B-TR
",",O
20,O
mg.,O
",",O
po,O
",",O
qD,O
.,O

9.,O
Haldol,B-TR
.,O

10.,O
Demerol,B-TR
",",O
prn,O
.,O

ALLERGIES,O
:,O

Ativan,B-TR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

In,O
general,O
",",O
confused,O
white,O
man,O
",",O
in,O
mild,B-PR
distress,I-PR
.,O

Vital,O
signs,O
:,O

Temperature,B-TE
was,O
102,O
",",O
heart,B-TE
rate,I-TE
was,O
110,O
",",O
respiratory,B-TE
rate,I-TE
was,O
22,O
",",O
blood,B-TE
pressure,I-TE
was,O
113/63,O
.,O

His,O
head,O
",",O
eyes,O
",",O
ears,O
",",O
nose,O
",",O
throat,O
was,O
benign,O
.,O

His,O
neck,O
was,O
supple,O
.,O

Lungs,O
:,O

Rales,B-PR
at,I-PR
the,I-PR
right,I-PR
base,I-PR
",",O
bilateral,B-PR
decreased,I-PR
breath,I-PR
sounds,I-PR
at,I-PR
the,I-PR
bases,I-PR
.,O

Cor,O
:,O

Regular,O
rate,O
and,O
rhythm,O
",",O
S1,O
and,O
S2,O
",",O
no,O
extra,B-PR
heart,I-PR
sounds,I-PR
",",O
abdomen,B-PR
distended,I-PR
with,O
an,B-PR
epigastric,I-PR
mass,I-PR
noted,O
",",O
mildly,B-PR
tender,I-PR
to,O
palpation,B-TE
",",O
no,O
guarding,B-PR
.,O

Bowel,O
sounds,O
were,O
present,O
.,O

The,B-TE
neurological,I-TE
examination,I-TE
was,O
nonfocal,O
.,O

LABORATORY,O
DATA,O
:,O

White,B-TE
count,I-TE
was,O
14.4,O
",",O
hematocrit,B-TE
was,O
36.2,O
",",O
platelet,B-TE
count,I-TE
was,O
217,O
",",O
sodium,B-TE
was,O
135,O
",",O
potassium,B-TE
was,O
3.3,O
",",O
chloride,B-TE
was,O
99,O
",",O
bicarbonate,B-TE
was,O
25,O
",",O
BUN,B-TE
was,O
40,O
",",O
creatinine,B-TE
was,O
1.9,O
",",O
glucose,B-TE
was,O
124,O
",",O
urinalysis,B-TE
was,O
negative,O
",",O
PT,B-TE
was,O
12.2,O
",",O
PTT,B-TE
was,O
24.5,O
",",O
calcium,B-TE
was,O
7.8,O
",",O
phosphorus,B-TE
was,O
3.7,O
",",O
albumin,B-TE
was,O
2.3,O
",",O
total,B-TE
bilirubin,I-TE
was,O
1.3,O
",",O
alkaline,B-TE
phosphatase,I-TE
was,O
202,O
",",O
SGPT,B-TE
was,O
32,O
",",O
SGOT,B-TE
was,O
64,O
",",O
LDH,B-TE
was,O
998,O
",",O
amylase,B-TE
was,O
150,O
.,O

EKG,B-TE
revealed,O
sinus,B-PR
tachycardia,I-PR
at,O
107,O
beats,O
per,O
minute,O
.,O

Evidence,O
of,O
old,B-PR
left,I-PR
anterior,I-PR
septal,I-PR
infarct,I-PR
.,O

Chest,B-TE
X-ray,I-TE
:,O

Large,B-PR
left,I-PR
ventricle,I-PR
",",O
bilateral,B-PR
atelectasis,I-PR
or,O
effusion,B-PR
.,O

Abdominal,B-TE
computerized,I-TE
tomography,I-TE
scan,I-TE
:,O

Pancreatitis,B-PR
",",O
fluid,B-PR
collection,I-PR
in,I-PR
the,I-PR
lesser,I-PR
sac,I-PR
.,O

A,B-PR
perisplenic,I-PR
effusion,I-PR
was,O
noted,O
which,O
appeared,O
to,O
communicate,O
with,O
the,B-PR
lesser,I-PR
sac,I-PR
collection,I-PR
.,O

Gallbladder,O
was,O
visualized,O
with,O
stones,B-PR
.,O

IN,O
SUMMARY,O
",",O
the,O
patient,O
was,O
considered,O
to,O
have,O
severe,B-PR
necrotizing,I-PR
pancreatitis,I-PR
",",O
with,O
severe,B-PR
cardiac,I-PR
disease,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
",",O
placed,O
on,O
intravenous,B-TR
fluids,I-TR
.,O

He,O
was,O
continued,O
on,O
his,B-TR
imipenem,I-TR
",",I-TR
intravenously,I-TR
.,O

The,O
patient,O
was,O
started,O
on,O
total,B-TR
parenteral,I-TR
nutrition,I-TR
.,O

On,O
4/17/95,O
",",O
GI,O
Interventional,O
Radiology,O
performed,O
drainage,B-TR
of,O
the,B-PR
peripancreatic,I-PR
fluid,I-PR
collection,I-PR
.,O

Approximately,O
one,O
liter,O
of,O
brownish,B-PR
fluid,I-PR
was,O
obtained,O
and,O
sent,O
for,O
culture,B-TE
.,O

The,B-TR
drainage,I-TR
catheter,I-TR
was,O
left,O
in,O
a,B-PR
pseudocyst,I-PR
.,O

The,O
patient,O
was,O
evaluated,O
by,O
Cardiology,O
.,O

A,B-TE
Persantine,I-TE
Thallium,I-TE
study,I-TE
demonstrated,O
a,B-PR
large,I-PR
infarct,I-PR
",",O
involving,O
the,O
posteroseptal,O
",",O
anteroseptal,O
areas,O
.,O

Left,B-PR
ventricular,I-PR
aneurysm,I-PR
was,O
also,O
noted,O
;,O
however,O
",",O
no,O
ischemia,B-PR
was,O
seen,O
.,O

An,B-TE
echocardiogram,I-TE
was,O
done,O
.,O

The,B-TE
echocardiogram,I-TE
showed,O
terrible,B-PR
left,I-PR
ventricular,I-PR
function,I-PR
",",O
with,O
left,B-PR
ventricular,I-PR
aneurysm,I-PR
.,O

The,O
right,O
ventricle,O
appeared,O
to,O
be,O
acceptable,O
.,O

The,B-TR
percutaneous,I-TR
drainage,I-TR
catheter,I-TR
continued,O
to,O
have,O
high,O
output,O
.,O

The,O
fluid,O
was,O
sent,O
for,O
amylase,B-TE
",",O
which,O
came,O
back,O
"53,230",O
.,O

On,O
4/28/95,O
",",O
the,O
patient,O
had,O
new,O
onset,O
of,O
abdominal,B-PR
pain,I-PR
.,O

His,B-TE
white,I-TE
count,I-TE
had,O
bumped,O
from,O
8.3,O
on,O
admission,O
to,O
18.5,O
",",O
on,O
4/27,O
.,O

A,B-TE
computerized,I-TE
tomography,I-TE
scan,I-TE
of,I-TE
the,I-TE
abdomen,I-TE
was,O
performed,O
.,O

Approximately,O
100,O
cc.&apos;s,O
of,O
thick,B-PR
brownish,I-PR
material,I-PR
was,O
aspirated,O
through,O
the,B-TR
indwelling,I-TR
catheter,I-TR
.,O

The,B-TE
computerized,I-TE
tomography,I-TE
scan,I-TE
showed,O
the,B-TR
catheter,I-TR
tip,I-TR
in,O
good,O
position,O
.,O

Because,O
of,O
the,B-PR
patient,I-PR
&apos;s,I-PR
deteriorating,I-PR
state,I-PR
",",O
the,O
patient,O
was,O
brought,O
to,O
the,O
operating,O
room,O
on,O
4/28/95,O
.,O

An,B-TE
exploratory,I-TE
laparotomy,I-TE
was,O
performed,O
.,O

The,O
splenic,O
flexure,O
had,O
a,B-PR
purulent,I-PR
exudative,I-PR
process,I-PR
along,I-PR
the,I-PR
antimesenteric,I-PR
surface,I-PR
.,O

Thus,O
",",O
the,O
splenic,O
flexure,O
and,O
a,O
portion,O
of,O
the,O
descending,O
colon,O
were,O
resected,B-TR
.,O

The,O
patient,O
underwent,O
a,B-TR
left,I-TR
colectomy,I-TR
with,O
end,B-TR
transverse,I-TR
colostomy,I-TR
",",O
and,O
oversewing,B-TR
of,I-TR
the,I-TR
descending,I-TR
colon,I-TR
.,O

Drainage,B-TR
of,O
the,B-PR
pancreatic,I-PR
necrosis,I-PR
was,O
also,O
done,O
.,O

The,O
patient,O
tolerated,O
the,B-TR
procedure,I-TR
fairly,O
well,O
",",O
and,O
was,O
transferred,O
to,O
the,O
Intensive,O
Care,O
Unit,O
.,O

In,O
the,O
Intensive,O
Care,O
Unit,O
",",O
the,O
patient,O
had,O
a,O
prolonged,O
course,O
.,O

The,O
patient,O
was,O
then,O
extubated,O
on,O
postoperative,O
day,O
#2,O
",",O
but,O
remained,O
pressor-dependent,B-PR
.,O

He,O
remained,O
on,O
imipenem,B-TR
",",O
and,O
Vancomycin,B-TR
was,O
also,O
started,O
.,O

Thereafter,O
",",O
the,O
patient,O
had,O
a,B-PR
long,I-PR
and,I-PR
complicated,I-PR
postoperative,I-PR
course,I-PR
.,O

He,O
was,O
eventually,O
transferred,O
to,O
the,O
floor,O
",",O
where,O
he,O
remained,O
meta-stable,O
.,O

He,O
had,O
repeated,O
episodes,O
of,O
hypotension,B-PR
to,O
80-90,B-TE
systolic/40-50,I-TE
diastolic,I-TE
.,O

These,O
resolved,O
without,O
incident,O
.,O

He,O
also,O
had,O
repeated,B-PR
temperature,I-PR
spikes,I-PR
.,O

After,O
repeated,B-TE
work,I-TE
ups,I-TE
",",O
it,O
was,O
felt,O
that,O
these,O
were,O
probably,O
due,O
to,O
remaining,B-PR
infection,I-PR
in,I-PR
the,I-PR
peripancreatic,I-PR
area,I-PR
.,O

His,B-TR
drainage,I-TR
tube,I-TR
from,I-TR
the,I-TR
peripancreatic,I-TR
area,I-TR
was,O
gradually,O
advanced,O
",",O
and,O
eventually,O
discontinued,O
.,O

Mr.,O
Mass,O
was,O
placed,O
on,O
multiple,O
courses,O
of,O
antibiotics,B-TR
.,O

Most,O
recently,O
",",O
he,O
was,O
on,O
a,O
28,O
day,O
course,O
of,O
Vancomycin,B-TR
",",O
ofloxacin,B-TR
",",O
and,O
Flagyl,B-TR
",",O
for,O
blood,B-TE
cultures,I-TE
that,O
were,O
positive,O
for,O
gram,B-PR
positive,I-PR
cocci,I-PR
and,O
enteric,B-PR
and,I-PR
non-enteric,I-PR
gram,I-PR
negative,I-PR
rods,I-PR
.,O

This,B-TR
28,I-TR
day,I-TR
course,I-TR
was,O
completed,O
on,O
07/15/95,O
.,O

The,O
patient,O
was,O
also,O
treated,O
initially,O
with,O
amphotericin-B,B-TR
and,O
then,O
with,O
fluconazole,B-TR
for,O
a,B-TE
computerized,I-TE
tomography,I-TE
guided,I-TE
aspirate,I-TE
of,O
a,B-PR
small,I-PR
fluid,I-PR
collection,I-PR
around,I-PR
his,I-PR
pancreas,I-PR
",",O
which,O
grew,O
Candida,B-PR
albicans,I-PR
.,O

The,O
patient,O
also,O
had,O
several,O
episodes,O
of,O
fungal,B-PR
cystitis,I-PR
with,O
Torulopsis,B-PR
glabrata,I-PR
",",O
going,O
from,O
his,B-TE
urine,I-TE
.,O

He,O
was,O
treated,O
with,O
amphotericin-B,B-TR
bladder,I-TR
washes,I-TR
for,O
this,O
.,O

Mr.,O
Mass,O
was,O
initially,O
anticoagulated,B-TR
for,O
his,B-PR
left,I-PR
ventricular,I-PR
aneurysm,I-PR
.,O

He,O
remained,O
stable,O
from,O
a,O
cardiac,O
fashion,O
.,O

He,O
did,O
have,O
problems,B-PR
with,O
po,O
intake,O
.,O

He,O
had,O
repeated,O
bouts,O
of,O
small-volume,B-PR
emesis,I-PR
that,O
may,O
have,O
been,O
secondary,O
to,O
reflux,B-PR
.,O

He,O
was,O
treated,O
with,O
a,O
variety,O
of,O
anti-emetics,B-TR
",",O
most,O
recently,O
Granisetron,B-TR
",",O
with,O
only,O
mild,O
success,O
.,O

He,O
remained,O
total,B-PR
parenteral,I-PR
nutrition-dependent,I-PR
throughout,O
his,O
hospital,O
course,O
.,O

By,O
the,O
end,O
of,O
June,O
",",O
it,O
became,O
clear,O
that,O
Mr.,O
Mass,O
would,O
require,O
aggressive,B-TR
surgical,I-TR
intervention,I-TR
in,O
order,O
to,O
eradicate,O
his,B-PR
intra-abdominal,I-PR
bursts,I-PR
of,I-PR
intermittent,I-PR
sepsis,I-PR
;,O
however,O
",",O
long,O
discussions,O
with,O
the,O
patient,O
and,O
his,O
wife,O
",",O
who,O
was,O
his,O
health-care,O
proxy,O
",",O
revealed,O
that,O
they,O
felt,O
that,O
no,O
further,B-TR
aggressive,I-TR
intervention,I-TR
be,O
attempted,O
.,O

The,O
patient,O
had,O
been,O
made,O
a,O
do,O
not,O
resuscitate,O
do,O
not,O
intubate,O
patient,O
earlier,O
in,O
his,O
hospital,O
stay,O
.,O

Multiple,O
discussions,O
were,O
held,O
between,O
Dr.,O
Mass,O
",",O
the,O
rest,O
of,O
the,O
surgical,O
team,O
",",O
and,O
the,O
patient,O
&apos;s,O
wife,O
",",O
with,O
this,O
same,O
result,O
.,O

After,O
discussion,O
with,O
the,O
patient,O
&apos;s,O
primary,O
doctor,O
",",O
Dr.,O
Douet,O
at,O
Vassdiysey,O
Medical,O
Center,O
",",O
it,O
was,O
felt,O
that,O
the,O
patient,O
and,O
his,O
family,O
would,O
be,O
best,O
served,O
if,O
the,O
patient,O
were,O
transferred,O
to,O
Vassdiysey,O
Medical,O
Center,O
.,O

Of,O
note,O
",",O
given,O
the,O
patient,O
&apos;s,O
do,O
not,O
resuscitate,O
status,O
and,O
the,B-PR
risk,I-PR
for,I-PR
bleeding,I-PR
",",O
the,B-TR
patient,I-TR
&apos;s,I-TR
Coumadin,I-TR
was,O
stopped,O
without,O
incident,O
several,O
weeks,O
before,O
transfer,O
.,O

DOCTORS,O
DISCHARGE,O
INSTRUCTIONS,O
:,O

MEDICATIONS,O
:,O

1.,O
Heparin,B-TR
",",O
"5,000",O
units,O
",",O
sc.,O
",",O
b.i.d.,O

2.,O
Lisinopril,B-TR
",",O
20,O
mg.,O
",",O
po,O
",",O
qD,O
.,O

3.,O
Isordil,B-TR
",",O
10,O
mg.,O
",",O
po,O
",",O
t.i.d.,O

4.,O
Nitropaste,B-TR
",",O
1,O
inch,O
to,O
chest,O
wall,O
",",O
q8h.,O

5.,O
Carafate,B-TR
",",O
one,O
gram,O
",",O
po,O
or,O
per,O
nasogastric,B-TR
tube,I-TR
",",O
q.i.d.,O
",",O
Cardizem,B-TR
",",O
30,O
mg.,O
",",O
po,O
",",O
q6h,O
",",O
digoxin,B-TR
",",O
0.25,O
mg.,O
",",O
po,O
or,O
intravenously,O
",",O
qD,O
",",O
fluconazole,B-TR
",",O
200,O
mg.,O
",",O
qD,O
",",O
for,O
five,O
more,O
days,O
",",O
after,O
transfer,O
",",O
for,O
a,O
total,O
of,O
a,O
14,O
day,O
course,O
",",O
total,B-TR
parenteral,I-TR
nutrition,I-TR
to,O
meet,O
the,O
patient,O
&apos;s,O
nutritional,O
needs,O
.,O

The,O
patient,O
has,O
an,B-TR
ostomy,I-TR
appliance,I-TR
around,O
the,O
former,O
site,O
of,O
his,B-TR
pancreatic,I-TR
fistula,I-TR
drain,I-TR
.,O

This,O
area,O
has,O
continued,O
to,O
drain,O
and,O
it,O
is,O
felt,O
that,O
it,O
could,O
be,O
best,O
managed,O
by,O
an,B-TR
ostomy,I-TR
appliance,I-TR
and,O
stoma,B-TR
care,I-TR
.,O

The,O
patient,O
is,O
also,O
treated,O
with,O
shots,B-TR
of,I-TR
morphine,I-TR
for,O
intermittent,B-PR
pain,I-PR
.,O

I,O
DRAIN,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

LIASUN,O
L.,O
MASS,O
",",O
M.D.,O

TR,O
:,O

aet,O
/,O
bmot,O

DD,O
:,O

07/16/95,O

TD,O
:,O

07/15/95,O

CC,O
:,O

STAT,O
discharge,O
summary,O
.,O

Copies,O
to,O
Dr.,O
Liasun,O
Mass,O
",",O
Dr.,O
Tomedankell,O
New,O
of,O
Cardiology,O
",",O
and,O
Dr.,O
Scosthuang,O
of,O
Vassdiysey,O
Medical,O
Center,O
.,O

Please,O
have,O
a,O
copy,O
in,O
the,O
chart,O
;,O
the,O
patient,O
will,O
be,O
leaving,O
on,O
the,O
morning,O
of,O
07/16/95,O
.,O

Admission,O
Date,O
:,O

2014-03-22,O

Discharge,O
Date,O
:,O

2014-03-28,O

Date,O
of,O
Birth,O
:,O

1983-03-15,O

Sex,O
:,O

M,O

Service,O
:,O

ORT,O

ADDENDUM,O
:,O

Mr.,O
Olander,O
had,O
acute,B-PR
blood,I-PR
loss,I-PR
anemia,I-PR
from,O
the,O
combination,O
of,O
the,B-PR
gunshot,I-PR
wound,I-PR
to,I-PR
the,I-PR
right,I-PR
distal,I-PR
femur,I-PR
as,O
well,O
as,O
requirements,O
for,O
urgent,B-TR
open,I-TR
reduction,I-TR
",",O
internal,B-TR
fixation,I-TR
.,O

His,B-TE
hematocrit,I-TE
dropped,O
down,O
to,O
the,O
level,O
of,O
20,O
.,O

Although,O
he,O
remained,O
hemodynamically,O
stable,O
",",O
we,O
elected,O
to,O
move,O
ahead,O
and,O
transfuse,O
him,O
with,O
nonautologous,B-TR
PRBC,I-TR
.,O

Bertha,O
Patrick,O
",",O
MD,O
20AAQ,O

Dictated,O
By,O
:,O
Rose,O
D.,O
Bordelon,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2014-04-11,O
13:18:08,O

T,O
:,O
2014-04-12,O
09:36:49,O

Job,O
#:,O
32074,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Josefa,O
V.,O
Wynn,O
on,O
:,O
WED,O
2014-04-16,O
2:19,O
PM,O

(,O
End,O
of,O
Report,O
),O

745232329,O

PUOMC,O

9543139,O

96458/7hv1,O

139846,O

9/14/1993,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

9/14/93,O

DISCHARGE,O
DATE,O
:,O

9/15/93,O

CHIEF,O
COMPLAINT,O
:,O

left,B-TR
axillary,I-TR
node,I-TR
dissection,I-TR
",",O
status,O
post,O
breast,B-PR
carcinoma,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Patient,O
is,O
a,O
49,O
year,O
old,O
previously,O
healthy,O
female,O
",",O
who,O
was,O
diagnosed,O
in,O
June,O
",",O
1992,O
",",O
with,O
a,B-PR
breast,I-PR
carcinoma,I-PR
",",O
after,O
she,O
presented,O
with,O
some,B-PR
breast,I-PR
discomfort,I-PR
on,I-PR
the,I-PR
left,I-PR
side,I-PR
.,O

She,O
underwent,O
a,B-TR
wide,I-TR
resection,I-TR
of,O
a,B-PR
left,I-PR
breast,I-PR
mass,I-PR
by,O
Dr.,O
Ausguall,O
on,O
8/17/93,O
.,O

Pathology,B-TE
of,O
this,B-TR
resection,I-TR
revealed,O
a,B-PR
Grade,I-PR
III,I-PR
/,I-PR
III,I-PR
infiltrating,I-PR
ductal,I-PR
carcinoma,I-PR
.,O

She,O
now,O
presents,O
for,O
left,B-TR
axillary,I-TR
node,I-TR
dissection,I-TR
",",O
to,O
complete,O
her,O
staging,O
.,O

She,O
has,O
no,O
complaints,O
at,O
the,O
time,O
of,O
presentation,O
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

noncontributory,O
",",O
her,O
last,O
menstrual,O
period,O
was,O
regular,O
",",O
and,O
last,O
week,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

:w,O

:q,O

none,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Noncontributory,O
.,O

ALLERGIES,O
:,O

no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

Denies,O
cigarette,O
",",O
or,O
alcohol,O
use,O
",",O
she,O
is,O
married,O
and,O
has,O
one,O
child,O
.,O

FAMILY,O
HISTORY,O
:,O

Is,O
negative,O
",",O
there,O
is,O
no,O
breast,B-PR
carcinoma,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Patient,O
is,O
a,O
pleasant,O
female,O
",",O
in,O
no,O
apparent,B-PR
distress,I-PR
.,O

Her,B-TE
vital,I-TE
signs,I-TE
are,O
stable,O
",",O
she,O
is,O
afebrile,B-PR
.,O

head,O
",",O
eyes,O
",",O
ears,O
",",O
nose,O
",",O
throat,O
:,O

reveals,O
no,O
adenopathy,B-PR
",",O
extra,O
ocular,O
movements,O
intact,O
",",O
pupils,O
equal,O
",",O
round,O
",",O
reactive,O
to,O
light,O
and,O
accommodation,O
.,O

Throat,O
:,O

benign,O
.,O

Cardiac,O
:,O

regular,O
rate,O
and,O
rhythm,O
",",O
normal,O
first,O
and,O
second,O
heart,O
sounds,O
",",O
no,O
murmur,B-PR
",",O
rub,B-PR
or,O
gallop,B-PR
.,O

The,O
lungs,O
were,O
clear,O
to,O
auscultation,B-TE
and,O
percussion,B-TE
.,O

Abdomen,O
:,O

soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
",",O
positive,O
bowel,O
sounds,O
",",O
there,O
is,O
no,O
hepatosplenomegaly,B-PR
.,O

Chest,O
:,O

reveals,O
a,B-PR
well,I-PR
healed,I-PR
incision,I-PR
in,I-PR
the,I-PR
left,I-PR
side,I-PR
",",O
there,O
are,O
no,O
axillary,O
lymph,O
nodes,O
palpable,O
on,O
both,O
sides,O
.,O

Extremities,O
:,O

reveal,O
no,O
clubbing,B-PR
",",O
cyanosis,B-PR
or,O
edema,B-PR
.,O

Motor,O
:,O

5/5,O
throughout,O
.,O

Sensory,O
:,O

intact,O
.,O

LABORATORY,O
DATA,O
:,O

sodium,B-TE
140,O
",",O
potassium,B-TE
4.4,O
",",O
BUN,B-TE
and,O
creatinine,B-TE
14/.9,O
",",O
glucose,B-TE
95,O
",",O
prothrombin,B-TE
time,I-TE
10.0,O
",",O
with,O
a,O
control,O
of,O
10.2,O
",",O
partial,B-TE
thromboplastin,I-TE
time,I-TE
26.9,O
",",O
urinalysis,B-TE
negative,O
",",O
white,B-TE
blood,I-TE
count,I-TE
5.8,O
",",O
hematocrit,B-TE
37.5,O
",",O
hemoglobin,B-TE
13.4,O
",",O
platelet,B-TE
count,I-TE
"274,000",O
.,O

The,B-TE
electrocardiogram,I-TE
reveals,O
normal,O
sinus,O
rhythm,O
at,O
66,O
beats,O
per,O
minute,O
",",O
with,O
no,O
ST,B-PR
changes,I-PR
",",O
there,O
is,O
R,B-PR
wave,I-PR
progression,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
on,O
9/14/93,O
",",O
and,O
underwent,O
on,O
that,O
same,O
day,O
",",O
a,B-TR
left,I-TR
axillary,I-TR
lymph,I-TR
nodes,I-TR
dissection,I-TR
",",O
by,O
Dr.,O
Ausguall,O
.,O

The,O
patient,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
",",O
there,O
were,O
no,O
complications,B-PR
.,O

Postoperative,O
course,O
was,O
unremarkable,O
.,O

The,O
patient,O
was,O
discharged,O
home,O
on,O
9/15/93,O
.,O

At,O
that,O
time,O
her,B-TR
JP,I-TR
was,O
still,O
in,O
place,O
.,O

DISPOSITION,O
:,O

Patient,O
will,O
follow,O
up,O
with,O
Dr.,O
Ausguall,O
",",O
in,O
about,O
4-5,O
days,O
",",O
at,O
which,O
time,O
the,B-TR
JP,I-TR
drain,I-TR
will,O
be,O
removed,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Percocet,B-TR
1-2,O
tablets,O
PO,O
q3-4,O
prn,O
.,O

BESTI,O
KOTEBREUN,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

WILFTAM,O
AUSGUALL,O
",",O
M.D.,O

TR,O
:,O

th,O
/,O
bmot,O

DD,O
:,O

9/14/93,O

TD,O
:,O

09/15/93,O

CC,O
:,O

Dr.,O
Ausguall,O

Admission,O
Date,O
:,O

2019-02-01,O

Discharge,O
Date,O
:,O

2019-02-09,O

Date,O
of,O
Birth,O
:,O

1940-04-28,O

Sex,O
:,O

M,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,O
Drugs,B-TR

Attending,O
:,O
Nicholas,O
E.,O
E.,O
Collard,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Abdominal,B-PR
pain,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

Intubation,B-TR

ERCP,B-TE
with,O
stent,B-TR

Blood,B-TR
transfusion,I-TR

History,O
of,O
Present,O
Illness,O
:,O

Pt,O
is,O
a,O
78,O
yo,O
male,O
with,O
h/o,O
A,B-PR
fib,I-PR
",",O
s/p,O
multiple,B-PR
CVA,I-PR
"s,",I-PR
CHF,B-PR
",",O
HTN,B-PR
",",O
DM2,B-PR
admitted,O
to,O
Mediplex,O
Rehab,O
Hospital,O
Robert,O
on,O
02-01,O
with,O
abdominal,B-PR
pain,I-PR
and,O
n/v,B-PR
since,O
that,O
morning,O
.,O

Pt,B-TE
's,I-TE
vitals,I-TE
on,O
admission,O
wer,O
significant,O
for,O
T,B-TE
104,O
",",O
SBP,B-TE
100,O
"s,",O
HR,B-TE
in,O
the,O
120,O
s.,O

RUQ,B-TE
U/s,I-TE
demonstrated,O
multiple,B-PR
small,I-PR
gallstones,I-PR
with,O
sludges,B-PR
without,O
evidence,O
of,O
pericholecystic,B-PR
fluid,I-PR
or,O
significant,B-PR
dilatation,I-PR
of,I-PR
the,I-PR
gallbladder,I-PR
.,O

Surgery,O
was,O
consulted,O
for,O
concern,O
of,O
cholangitis,B-PR
with,O
probable,O
sepsis,B-PR
.,O

Pt,O
was,O
admitted,O
to,O
the,O
CMED,O
CCU,O
",",O
intubated,B-TR
overnight,O
for,O
ERCP,B-TE
procedure,I-TE
and,O
fluid,B-TR
resuscitation,I-TR
.,O

The,O
patient,O
was,O
placed,O
on,O
zosyn,B-TR
.,O

Pt,B-TE
's,I-TE
INR,I-TE
was,O
eleveted,B-PR
as,O
he,O
was,O
on,O
home,B-TR
coumadin,I-TR
.,O

He,O
was,O
given,O
4,B-TR
units,I-TR
FFP,I-TR
in,O
anticipation,O
of,O
ERCP,B-TE
the,O
following,O
day,O
.,O

On,O
02-02,O
ERCP,B-TE
demonstrated,O
a,B-PR
large,I-PR
filling,I-PR
defect,I-PR
in,I-PR
the,I-PR
distal,I-PR
duct,I-PR
representing,O
a,B-PR
stone,I-PR
with,O
CBD,B-PR
dilatation,I-PR
.,O

A,B-TR
biliary,I-TR
stent,I-TR
was,O
placed,O
after,O
the,B-TR
removal,I-TR
of,O
the,B-PR
stone,I-PR
.,O

Pt,O
was,O
extubated,O
the,O
next,O
day,O
.,O

He,O
was,O
then,O
transferred,O
to,O
the,O
medicine,O
service,O
.,O

Past,O
Medical,O
History,O
:,O

1),O
Atrial,B-PR
fibrillation,I-PR

2),O
s/p,O
MVR,B-TR
(,I-TR
mechanical,I-TR
),I-TR

3),O
CHF,B-PR
EF,B-TE
15%,O

4),O
HTN,B-PR

5),O
multiple,B-PR
CVA,I-PR
s,I-PR
(,O
last,O
1998,O
),O

6),O
Hypercholesterolemia,B-PR

7),O
Type,B-PR
II,I-PR
DM,I-PR

8),O
Multiple,B-PR
prior,I-PR
UTI,I-PR

Social,O
History,O
:,O

Lives,O
in,O
Danvers,O
with,O
wife,O
",",O
denies,O
Timothy,O
or,O
alcohol,O
.,O

Family,O
History,O
:,O

NC,O

Physical,O
Exam,O
:,O

upon,O
tx,O
to,O
medicine,O
service,O

T,B-TE
:,O
99.0,O
;,O
BP,B-TE
142/61,O
;,O
Pulse,B-TE
65,O
;,O
Resp,B-TE
20,O
;,O
O2,B-TE
sat,I-TE
96%,O
RA,O

Gen,O
-,O
Alert,O
",",O
no,O
acute,B-PR
distress,I-PR

HEENT,O
-,O
mucous,B-PR
membranes,I-PR
slightly,I-PR
dry,I-PR

Neck,O
-,O
no,O
JVD,B-PR
",",O
no,O
cervical,B-PR
lymphadenopathy,I-PR

Chest,O
-,O
CTA,O
b/l,O
with,O
good,O
air,O
entry,O

CV,O
-,O
Normal,O
S1/S2,O
",",O
irreg,B-PR
irreg,I-PR

Abd,O
-,O
Soft,O
",",O
nontender,B-PR
",",O
mild,B-PR
distension,I-PR
",",O
normoactive,O
bowel,O
sounds,O

Extr,O
-,O
No,O
edema,B-PR
.,O

2+,O
DP,B-TE
pulses,I-TE
bilaterally,O

Neur,O
:,O
A,O
&,O
O,O
X3,O
",",O
dysarthric,B-PR
speech,I-PR
",",O

CN,O
:,O
mild,B-PR
left,I-PR
facial,I-PR
droop,I-PR
",",O
o/w,O
appears,O
intact,O
;,O
4/5,O
strength,O
on,O
flex,O
at,O
elbows,O
b/l,O
",",O
legs,O
06-22,O
strength,O
",",O
DTR,O
s,O
intact,O
",",O
sensation,O
intact,O

Skin,O
-,O
No,O
rash,B-PR

Pertinent,O
Results,O
:,O

ERCP,O
report,O
:,O
Four,B-TE
fluoroscopic,I-TE
images,I-TE
and,O
ERCP,B-TE
are,O
provided,O
.,O

A,B-PR
large,I-PR
filling,I-PR
defect,I-PR
is,O
seen,O
in,O
the,O
distal,O
duct,O
representing,O
a,B-PR
stone,I-PR
.,O

The,O
common,O
duct,O
is,O
dilated,B-PR
.,O

Subsequent,B-TR
biliary,I-TR
stent,I-TR
was,O
placed,O
after,O
the,B-TR
removal,I-TR
of,O
the,B-PR
stone,I-PR
.,O

Blood,B-TE
cultures,I-TE
:,O

2019-02-01,O
(,O
4,O
of,O
4,O
bottles,O
),O
E.coli,B-PR

CXR,B-TE
:,O
Pulmonary,B-PR
edema,I-PR
.,O

ECHO,B-TE
:,O

The,O
left,O
atrium,O
is,O
markedly,B-PR
dilated,I-PR
.,O

There,O
is,O
mild,B-PR
symmetric,I-PR
left,I-PR
ventricular,I-PR

The,O
left,O
ventricular,O
cavity,O
is,O
moderately,B-PR
dilated,I-PR
.,O

There,O
is,O

Overall,O
left,O
ventricular,O
systolic,O
function,O
is,O
moderately,B-PR
depressed,I-PR
.,O

Right,B-TE
ventricular,I-TE
chamber,I-TE
size,I-TE
and,O
free,O
wall,O
motion,O
are,O
normal,O
.,O

Right,B-TE
ventricular,I-TE
systolic,I-TE
function,I-TE
is,O
normal,O
.,O

[,O
Intrinsic,B-TE
right,I-TE
ventricular,I-TE
systolic,I-TE
function,I-TE
is,O
likely,O
more,B-PR
depressed,I-PR
given,O
the,O
severity,O
of,O
tricuspid,B-PR
regurgitation,I-PR
.],O

The,O
aortic,O
valve,O
leaflets,O
(,O
3,O
),O
are,O
mildly,B-PR
thickened,I-PR
.,O

There,O
is,O
no,O
aortic,B-PR
valve,I-PR
stenosis,I-PR
.,O

Mild,B-PR
(,I-PR
1+,I-PR
),I-PR
aortic,I-PR
regurgitation,I-PR
is,O
seen,O
.,O

A,B-TR
bileaflet,I-TR
mitral,I-TR
valve,I-TR
prosthesis,I-TR
is,O
present,O
.,O

The,B-TE
transmitral,I-TE
gradient,I-TE
is,O
normal,O
for,O
this,B-TR
prosthesis,I-TR
.,O

No,O
mitral,B-PR
regurgitation,I-PR
is,O
seen,O
.,O

Mild,B-PR
(,I-PR
1+,I-PR
),I-PR
mitral,I-PR
regurgitation,I-PR
is,O
seen,O
.,O

[,O
Due,O
to,O
acoustic,O
shadowing,O
",",O
the,O
severity,O
of,O
mitral,B-PR
regurgitation,I-PR
may,O
be,O
significantly,O
UNDERestimated,O
.],O

The,O
tricuspid,O
valve,O
leaflets,O
are,O
mildly,B-PR
thickened,I-PR
.,O

Moderate,B-PR
[,I-PR
2+,I-PR
],I-PR
tricuspid,I-PR
regurgitation,I-PR
is,O
seen,O
.,O

There,O
is,O
mild,B-PR
pulmonary,I-PR
artery,I-PR
systolic,I-PR
hypertension,I-PR
.,O

There,O
is,O
no,O
pericardial,B-PR
effusion,I-PR
.,O

Labs,O
on,O
admission,O
:,O

2019-02-01,O
03:20,O
PM,O
BLOOD,B-TE
WBC,B-TE
-,O
11.7,O
*#,O
RBC,B-TE
-,O
4.72,O
Hgb,B-TE
-,O
14.1,O
Hct,B-TE
-,O
42.7,O
MCV,B-TE
-,O
91,O
MCH,B-TE
-,O
29.9,O
MCHC,B-TE
-,O
33.1,O
RDW,B-TE
-,O
14.9,O
Plt,B-TE
Ct,I-TE
-,O
91,O
*,O

2019-02-01,O
03:20,O
PM,O
BLOOD,B-TE
Neuts,B-TE
-,O
94.6,O
*,O
Bands,B-TE
-,O
0,O
Lymphs,B-TE
-,O
2.7,O
*,O
Monos,B-TE
-,O
1.9,O
*,O
Eos,B-TE
-,O
0.4,O
Baso,B-TE
-,O
0.4,O

2019-02-01,O
03:20,O
PM,O
BLOOD,B-TE
PT,B-TE
-,O
28.0,O
*,O
PTT,B-TE
-,O
26.7,O
INR(PT),B-TE
-,O
2.9,O
*,O

2019-02-01,O
03:20,O
PM,O
BLOOD,B-TE
Glucose,B-TE
-,O
202,O
*,O
UreaN,B-TE
-,O
31,O
*,O
Creat,B-TE
-,O
1.3,O
*,O
Na,B-TE
-,O
141,O
K,B-TE
-,O
4.0,O
Cl,B-TE
-,O
102,O
HCO3,B-TE
-,O
27,O
AnGap,B-TE
-,O
16,O

2019-02-01,O
03:20,O
PM,O
BLOOD,B-TE
ALT,B-TE
-,O
167,O
*,O
AST,B-TE
-,O
218,O
*,O
AlkPhos,B-TE
-,O
108,O
Amylase,B-TE
-,O
117,O
*,O
TotBili,B-TE
-,O
3.6,O
*,O

2019-02-02,O
03:54,O
PM,O
BLOOD,B-TE
Lipase,B-TE
-,O
992,O
*,O

2019-02-01,O
03:20,O
PM,O
BLOOD,B-TE
Albumin,B-TE
-,O
4.8,O
Calcium,B-TE
-,O
9.4,O
Phos,B-TE
-,O
1.9,O
*,O
Mg,B-TE
-,O
2.0,O

2019-02-01,O
04:15,O
PM,O
BLOOD,B-TE
Digoxin,B-TE
-,O
0.3,O
*,O

2019-02-01,O
11:43,O
PM,O
BLOOD,B-TE
Type,I-TE
-,O
ART,O
Temp,B-TE
-,O
38.3,O
PEEP,B-TR
-,O
5,O
pO2,B-TE
-,O
115,O
*,O
pCO2,B-TE
-,O
36,O
pH,B-TE
-,O
7.33,O
*,O
calTCO2,B-TE
-,O
20,O
*,O
Base,B-TE
XS,I-TE
-,O
-6,O
Intubat,O
-,O
INTUBATED,B-TR

2019-02-01,O
04:06,O
PM,O
BLOOD,B-TE
Lactate,B-TE
-,O
3.4,O
*,O

2019-02-01,O
08:00,O
PM,O
BLOOD,B-TE
Lactate,B-TE
-,O
6.4,O
*,O

Labs,O
on,O
discharge,O
:,O

2019-02-06,O
06:30,O
AM,O
BLOOD,B-TE
WBC,B-TE
-,O
7.4,O
RBC,B-TE
-,O
3.82,O
*,O
Hgb,B-TE
-,O
11.3,O
*,O
Hct,B-TE
-,O
34.7,O
*,O
MCV,B-TE
-,O
91,O
MCH,B-TE
-,O
29.5,O
MCHC,B-TE
-,O
32.5,O
RDW,B-TE
-,O
15.1,O
Plt,B-TE
Ct,I-TE
-,O
92,O
*,O

2019-02-09,O
04:45,O
AM,O
BLOOD,B-TE
PT,B-TE
-,O
19.6,O
*,O
PTT,B-TE
-,O
74.9,O
*,O
INR(PT),B-TE
-,O
1.9,O
*,O

2019-02-07,O
09:00,O
AM,O
BLOOD,B-TE
Glucose,B-TE
-,O
124,O
*,O
UreaN,B-TE
-,O
26,O
*,O
Creat,B-TE
-,O
1.2,O
Na,B-TE
-,O
140,O
K,B-TE
-,O
3.7,O
Cl,B-TE
-,O
102,O
HCO3,B-TE
-,O
29,O
AnGap,B-TE
-,O
13,O

2019-02-07,O
09:00,O
AM,O
BLOOD,B-TE
ALT,B-TE
-,O
62,O
*,O
AST,B-TE
-,O
45,O
*,O
AlkPhos,B-TE
-,O
105,O
TotBili,B-TE
-,O
2.2,O
*,O

2019-02-04,O
02:40,O
AM,O
BLOOD,B-TE
Lipase,B-TE
-,O
74,O
*,O

2019-02-07,O
09:00,O
AM,O
BLOOD,B-TE
Mg,B-TE
-,O
2.0,O

2019-02-04,O
02:50,O
AM,O
BLOOD,B-TE
Lactate,B-TE
-,O
1.0,O

Brief,O
Hospital,O
Course,O
:,O

Pt,O
is,O
a,O
78,O
yo,O
male,O
with,O
atrial,B-PR
fibrillation,I-PR
",",O
s/p,O
multiple,B-PR
CVA,I-PR
"s,",I-PR
CHF,B-PR
",",O
HTN,B-PR
",",O
DM2,B-PR
transferred,O
from,O
the,O
CMED,O
CCU,O
s/p,O
intervention,B-TR
for,O
cholangitis,B-PR
.,O

1),O
Acute,B-PR
cholangitis,I-PR
:,O
Pt,O
was,O
admitted,O
to,O
the,O
ICU,O
",",O
intubated,O
",",O
and,O
ERCP,B-TE
performed,O
",",O
likely,O
stone,B-PR
obstructing,O
CBD,O
.,O

Stent,B-TR
was,O
placed,O
and,O
patient,O
was,O
treated,O
with,O
antibiotics,B-TR
(,O
Zosyn,B-TR
-,O
>,O
Ciprofloxacin,B-TR
).,O

Per,O
ERCP,O
fellow,O
",",O
plan,O
is,O
for,O
patient,O
to,O
return,O
in,O
four,O
weeks,O
to,O
see,O
Dr.,O
Suzanne,O
Davis,O
",",O
at,O
which,O
time,O
he,O
will,O
likely,O
have,O
repeat,B-TE
cholangiogram,I-TE
and,O
removal,B-TR
of,O
stent,B-TR
and,O
stone,B-PR
.,O

If,O
this,O
is,O
still,O
problematic,O
",",O
pt,O
may,O
also,O
need,O
a,B-TR
sphincterotomy,I-TR
.,O

Dr.Demby,O
secretary,O
will,O
contact,O
patient,O
at,O
home,O
the,O
week,O
after,O
discharge,O
to,O
schedule,O
this,O
for,O
the,O
end,O
of,O
January,O
.,O

Pt,O
is,O
to,O
continue,O
ciprofloxacin,B-TR
for,O
a,O
complete,O
14,O
day,O
course,O
.,O

2),O
Mechanical,B-TR
mitral,I-TR
valve,I-TR
:,O
Anticoagulation,B-TR
was,O
reversed,O
for,O
ERCP,B-TE
.,O

After,O
this,O
he,O
was,O
anticoagulated,O
with,O
heparin,B-TR
drip,I-TR
.,O

INR,B-TE
was,O
1.9,O
on,O
discharge,O
.,O

He,O
was,O
given,O
sc,B-TR
lovenox,I-TR
x,O
1,O
and,O
will,O
continue,O
this,O
the,O
day,O
after,O
discharge,O
bid,O
for,O
one,O
day,O
.,O

VNA,O
will,O
check,O
his,B-TE
INR,I-TE
at,O
home,O
and,O
page,O
his,O
PCP,O
with,O
the,O
results,O
.,O

3),O
Atrial,B-PR
fibrillation,I-PR
:,O
Rate,O
controlled,O
and,O
on,O
warfarin,B-TR
.,O

While,O
in,O
the,O
hospital,O
he,O
had,O
several,O
episodes,O
of,O
pauses,B-PR
",",O
none,O
longer,O
than,O
2.5,O
seconds,O
.,O

His,B-TR
digoxin,I-TR
was,O
held,O
and,O
his,B-TR
metoprolol,I-TR
was,O
titrated,O
down,O
from,O
his,B-TR
home,I-TR
dose,I-TR
.,O

Once,O
the,B-TR
digoxin,I-TR
was,O
no,O
longer,O
having,O
effect,O
",",O
metoprolol,B-TR
was,O
titrated,O
back,O
to,O
home,O
dose,O
.,O

4),O
CHF,B-PR
:,O
Pt,O
was,O
oxygen,B-PR
dependent,I-PR
for,O
most,O
of,O
the,O
hospital,O
course,O
",",O
CXR,B-TE
was,O
consistent,O
with,O
pulmonary,B-PR
edema,I-PR
.,O

He,O
was,O
diuresed,O
with,O
lasix,B-TR
with,O
good,O
effect,O
.,O

Volume,B-PR
overload,I-PR
likely,O
ocurred,O
in,O
the,O
setting,O
of,O
IV,B-TR
fluids,I-TR
given,O
in,O
the,O
ICU,O
.,O

Did,O
not,O
require,O
lasix,B-TR
on,O
discharge,O
.,O

5),O
E.,B-PR
coli,I-PR
bacteremia,I-PR
/,O
sepsis,B-PR
:,O
Source,O
of,O
acute,B-PR
cholangitis,I-PR
as,O
above,O
.,O

Pt,O
required,O
3,O
day,O
stay,O
in,O
the,O
surgical,O
ICU,O
and,O
intubation,B-TR
as,O
above,O
.,O

6),O
Intubation,B-TR
:,O
Pt,O
was,O
97%,O
on,O
room,O
air,O
on,O
arrival,O
to,O
Cindy,O
",",O
developed,O
rapid,B-PR
ventricular,I-PR
reponse,I-PR
to,O
a,B-PR
fib,I-PR
which,O
was,O
treated,O
",",O
but,O
after,O
that,O
period,O
of,O
time,O
required,O
oxygen,B-TR
",",O
presumably,O
for,O
pulmonary,B-PR
edema,I-PR
.,O

In,O
the,O
Lori,O
pt,O
was,O
given,O
3L,B-TR
NS,I-TR
as,O
well,O
as,O
1,O
unit,O
of,O
FFP,B-TR
",",O
and,O
oxygen,B-PR
requirements,I-PR
contimued,O
to,O
climb,O
.,O

In,O
the,O
CMED,O
CCU,O
pt,O
was,O
intubated,O
for,O
ERCP,B-TE
procedure,I-TE
.,O

He,O
was,O
extubated,O
the,O
next,O
morning,O
.,O

Medications,O
on,O
Admission,O
:,O

Lisinopril,B-TR
2.5,O
qday,O
",",O
Buspiron,B-TR
20,O
mg,O
po,O
qday,O
",",O
Digoxin,B-TR
",",O
Doxasozin,B-TR
8,O
mg,O
qhs,O
",",O
Glyburide,B-TR
2.5,O
mg,O
qday,O
",",O
metoprolol,B-TR
bid,O
",",O
atorvastatin,B-TR
20,O
mg,O
qday,O
",",O
warfarin,B-TR
5,O
mg,O
qday,O

Discharge,O
Medications,O
:,O

1.,O
Ciprofloxacin,B-TR
500,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q12H,O
(,O
every,O
12,O
hours,O
),O
for,O
6,O
days,O
.,O

Disp,O
:*,O
12,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

2.,O
Medications,B-TR

Continue,O
all,B-TR
other,I-TR
home,I-TR
medications,I-TR
EXCEPT,O
do,O
not,O
take,O
digoxin,B-TR
.,O

Discharge,O
Disposition,O
:,O

Home,O
with,O
Service,O

Discharge,O
Diagnosis,O
:,O

Primary,O
diagnosis,O
:,O

acute,B-PR
cholangitis,I-PR

Secondary,O
diagnosis,O
:,O

anticoagulation,B-TR
with,O
a,B-TR
mechanical,I-TR
valve,I-TR

Atrial,B-PR
fibrillation,I-PR

Diabetes,B-PR
Mellitus,I-PR

Congestive,B-PR
heart,I-PR
failure,I-PR

Discharge,O
Condition,O
:,O

stable,O
",",O
will,O
work,O
with,O
home,O
PT,O

Discharge,O
Instructions,O
:,O

Please,O
continue,O
Ciprofloxacin,B-TR
antibiotic,I-TR
until,O
2019-02-14,O
.,O

Dr.,O
Mcfarlane,O
is,O
the,O
doctor,O
who,O
performed,O
the,B-TR
procedure,I-TR
to,O
place,O
a,B-TR
stent,I-TR
in,I-TR
your,I-TR
bile,I-TR
duct,I-TR
(,O
a,O
tube,O
that,O
drains,O
the,O
liver,O
).,O

His,O
nurse,O
is,O
going,O
to,O
contact,O
you,O
at,O
home,O
to,O
schedule,O
a,O
time,O
for,O
a,B-TR
repeat,I-TR
procedure,I-TR
to,O
remove,O
that,B-TR
stent,I-TR
.,O

You,O
will,O
have,O
your,O
blood,O
drawn,O
tomorrow,O
(,O
2019-02-10,O
),O
by,O
VNA,O
.,O

It,O
will,O
be,O
called,O
in,O
to,O
Dr.,O
Hamasaki,O
office,O
and,O
he,O
will,O
call,O
you,O
to,O
see,O
how,O
to,O
change,O
your,B-TR
coumadin,I-TR
.,O

You,O
will,O
also,O
take,O
lovenox,B-TR
subcutaneous,I-TR
injections,I-TR
tomorrow,O
",",O
2019-02-10,O
.,O

You,O
will,O
take,O
one,O
if,O
the,O
morning,O
and,O
one,O
at,O
night,O
.,O

Continue,O
all,O
of,O
your,B-TR
medications,I-TR
except,O
for,O
digoxin,B-TR
.,O

Followup,O
Instructions,O
:,O

Dr.,O
Mcfarlane,O
is,O
the,O
doctor,O
who,O
performed,O
the,B-TR
procedure,I-TR
to,O
place,O
a,B-TR
stent,I-TR
in,I-TR
your,I-TR
bile,I-TR
duct,I-TR
(,O
a,O
tube,O
that,O
drains,O
the,O
liver,O
).,O

His,O
nurse,O
is,O
going,O
to,O
contact,O
you,O
at,O
home,O
to,O
schedule,O
a,O
time,O
for,O
a,B-TR
repeat,I-TR
procedure,I-TR
to,O
remove,O
that,B-TR
stent,I-TR
.,O

Before,O
you,O
have,O
the,B-TR
procedure,I-TR
with,O
Dr.,O
Morris,O
you,O
will,O
need,O
to,O
talk,O
to,O
Dr.,O
Moya,O
to,O
see,O
if,O
you,O
need,O
to,O
stop,O
your,B-TR
coumadin,I-TR
/,O
warfarin,B-TR
for,O
a,O
few,O
days,O
.,O

Shirley,O
Anthony,O
MD,O
56-333,O

Completed,O
by,O
:,O
Donald,O
Beverly,O
MD,O
74-194,O
2019-02-09,O
@,O
1644,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Shirley,O
V,O
Usher,O
on,O
:,O
SAT,O
2019-02-09,O
5:32,O
PM,O

(,O
End,O
of,O
Report,O
),O

747495092,O

CTMC,O

91057356,O

183023,O

7/3/1998,O
12:00:00,O
AM,O

AMPULLARY,B-PR
ADENOCARCINOMA,I-PR

Signed,O

DIS,O

Admission,O
Date,O
:,O

07/03/1998,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

07/10/1998,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

AMPULLARY,B-PR
ADENOCARCINOMA,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
50,O
year,O
old,O
man,O
in,O
his,O
usual,O
state,O
of,O
health,O
until,O
two,O
weeks,O
prior,O
to,O
admission,O
when,O
the,O
patient,O
developed,O
epigastric,B-PR
pain,I-PR
after,O
meals,O
.,O

The,O
next,O
morning,O
",",O
the,O
patient,O
felt,O
dizzy,B-PR
and,O
went,O
to,O
his,O
private,O
medical,O
doctor,O
at,O
Eifro,O
Medical,O
Center,O
",",O
and,O
was,O
found,O
to,O
have,O
elevated,B-PR
bilirubins,I-PR
",",I-PR
alkaline,I-PR
phosphatase,I-PR
",",I-PR
and,I-PR
transaminases,I-PR
.,O

The,O
patient,O
reported,O
fatigue,B-PR
and,O
nausea,B-PR
",",O
as,O
well,O
as,O
noted,O
coca,B-PR
cola,I-PR
colored,I-PR
urine,I-PR
.,O

The,O
patient,O
has,O
been,O
constipated,B-PR
with,O
hard,B-PR
stool,I-PR
",",O
but,O
no,O
bright,B-PR
red,I-PR
blood,I-PR
per,I-PR
rectum,I-PR
.,O

The,O
patient,O
also,O
reported,O
an,B-PR
18,I-PR
lb,I-PR
weight,I-PR
loss,I-PR
over,O
the,O
last,O
4-5,O
months,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Significant,O
only,O
for,O
history,O
of,O
hypertension,B-PR
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

None,O
.,O

MEDICATIONS,O
:,O

Serax,B-TR
p.r.n.,O
insomnia,B-PR
;,O
iron,B-TR
;,O
MVI,B-TR
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

VITAL,O
SIGNS,O
:,O

BP,B-TE
120/80,O
",",O
temp,B-TE
96,O
",",O
pulse,B-TE
78,O
",",O
respiratory,B-TE
rate,I-TE
18,O
.,O

GENERAL,O
:,O

No,O
acute,B-PR
distress,I-PR
.,O

SKIN,O
:,O

The,O
skin,O
is,O
jaundiced,B-PR
.,O

NODES,O
:,O

No,O
lymph,O
nodes,O
palpated,O
.,O

HEENT,O
:,O

Notable,O
for,O
scleral,B-PR
icterus,I-PR
.,O

LUNGS,O
:,O

Clear,O
to,O
auscultation,B-TE
bilaterally,I-TE
",",O
no,O
wheezes,B-PR
",",O
rales,B-PR
",",O
or,O
rhonchi,B-PR
.,O

HEART,O
:,O

Regular,O
rate,O
and,O
rhythm,O
",",O
no,O
murmur,B-PR
.,O

ABDOMEN,O
:,O

Soft,O
",",O
bowel,O
sounds,O
present,O
",",O
tenderness,B-PR
present,O
in,O
epigastrium,O
to,O
moderate,B-TE
palpation,I-TE
.,O

There,O
was,O
no,O
rebound,B-PR
and,O
no,O
hepatosplenomegaly,B-PR
.,O

No,O
incisional,B-PR
scars,I-PR
.,O

EXTREMITIES,O
:,O

Warm,O
",",O
with,O
no,O
edema,B-PR
and,O
palpable,O
pulses,O
bilaterally,O
.,O

LABORATORY,O
DATA,O
:,O

Na,B-TE
134,O
",",O
K,B-TE
4.2,O
",",O
Cl,B-TE
98,O
",",O
bicarb,B-TE
26,O
",",O
BUN,B-TE
11,O
",",O
creatinine,B-TE
0.5,O
",",O
glucose,B-TE
119,O
.,O

CBC,B-TE
-,O
White,B-TE
count,I-TE
7.5,O
",",O
hematocrit,B-TE
28.5,O
",",O
platelets,B-TE
452,O
.,O

PT,B-TE
16.2,O
",",O
PTT,B-TE
34.7,O
",",O
INR,B-TE
1.8,O
.,O

LDH,B-TE
254,O
",",O
amylase,B-TE
727,O
",",O
lipase,B-TE
8600,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
preoperatively,O
for,O
surgery,B-TR
on,O
7/4/98,O
.,O

The,B-TE
patient,I-TE
&apos;s,I-TE
workup,I-TE
up,I-TE
until,O
that,O
time,O
included,O
a,O
diagnosis,O
of,O
periampullary,B-PR
adenocarcinoma,I-PR
",",O
which,O
was,O
proven,O
by,O
EGD,B-TE
directed,I-TE
biopsy,I-TE
",",O
and,O
a,B-PR
left,I-PR
renal,I-PR
mass,I-PR
",",O
which,O
was,O
biopsied,O
and,O
found,O
to,O
be,O
an,B-PR
oncocytoma,I-PR
.,O

On,O
7/4/98,O
",",O
the,O
patient,O
underwent,O
a,B-TR
Whipple,I-TR
procedure,I-TR
",",O
which,O
proceeded,O
without,O
complications,B-PR
.,O

Postoperatively,O
",",O
the,O
patient,O
did,O
extremely,O
well,O
and,O
was,O
extubated,O
the,O
following,O
morning,O
.,O

The,B-TR
NG,I-TR
tube,I-TR
was,O
D/C&apos;d,O
on,O
postoperative,O
day,O
#2,O
.,O

The,O
patient,O
was,O
to,O
be,O
transferred,O
to,O
the,O
floor,O
on,O
postoperative,O
day,O
#2,O
",",O
however,O
",",O
due,O
to,O
the,O
lack,O
of,O
beds,O
",",O
he,O
remained,O
in,O
the,O
ICU,O
until,O
postoperative,O
day,O
#3,O
.,O

On,O
postoperative,O
day,O
#4,O
",",O
the,O
patient,O
began,O
tolerating,O
clear,B-TR
liquids,I-TR
and,O
his,O
diet,O
was,O
advanced,O
as,O
tolerated,O
by,O
postoperative,O
day,O
#6,O
and,O
7,O
.,O

The,O
patient,O
was,O
out,O
of,O
bed,O
",",O
doing,O
fine,O
",",O
and,O
tolerating,O
a,O
regular,O
diet,O
on,O
7/10/98,O
.,O

The,O
patient,O
is,O
to,O
be,O
discharged,O
to,O
home,O
with,O
services,O
and,O
in,O
stable,O
condition,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Sandostatin,B-TR
100,O
mcg,O
subcu.,O
b.i.d.,O
;,O
Percocet,B-TR
1-2,O
tabs,O
q.3-4h.,O
p.r.n.,O
pain,B-PR
;,O
Axid,B-TR
150,O
mg,O
p.o.,O
b.i.d.,O
;,O
Colace,B-TR
100,O
mg,O
p.o.,O
b.i.d.,O

DISCHARGE,O
FOLLOW-UP,O
:,O

The,O
patient,O
has,O
been,O
instructed,O
to,O
follow-up,O
with,O
Dr.,O
Red,O
in,O
one,O
week,O
and,O
in,O
the,O
Urology,O
Clinic,O
in,O
three,O
weeks,O
.,O

DISCHARGE,O
DISPOSITION,O
:,O

The,O
patient,O
is,O
discharged,O
to,O
home,O
on,O
7/10/98,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
condition,O
.,O

Dictated,O
By,O
:,O

MALICHARLEAR,O
KROENER,O
",",O
M.D.,O
EB85,O

Attending,O
:,O

LEAND,O
L.,O
KROENER,O
",",O
M.D.,O
QW18,O
FO508/6558,O

Batch,O
:,O

54270,O

Index,O
No.,O
YCCYST5DG2,O

D,O
:,O

07/10/98,O

T,O
:,O

07/12/98,O

CC,O
:,O

1.,O
LEAND,O
L.,O
KROENER,O
",",O
M.D.,O

Admission,O
Date,O
:,O

2012-06-20,O

Discharge,O
Date,O
:,O

2012-06-29,O

Date,O
of,O
Birth,O
:,O

1958-02-28,O

Sex,O
:,O

F,O

Service,O
:,O

FICU,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
54,O
year-old,O
female,O
with,O
a,O
history,O
of,O
breast,B-PR
cancer,I-PR
with,O
known,B-PR
brain,I-PR
mets,I-PR
",",O
history,O
of,O
PE,B-PR
",",O
recent,B-TR
radiation,I-TR
therapy,I-TR
and,O
steroids,B-TR
who,O
presented,O
in,O
2012-04-23,O
with,O
myopathy,B-PR
presumed,O
secondary,O
to,O
sterids,B-TR
",",O
which,O
have,O
been,O
given,O
for,O
her,B-PR
brain,I-PR
mets,I-PR
.,O

She,O
was,O
later,O
sent,O
to,O
rehab,O
",",O
but,O
returned,O
early,O
in,O
April,O
with,O
increased,B-PR
cough,I-PR
with,O
exertion,O
with,O
fever,B-PR
to,O
101,O
.,O

She,O
was,O
treated,O
with,O
Levaquin,B-TR
given,O
her,B-TE
temperatures,I-TE
and,O
differential,O
diagnosis,O
of,O
increased,B-PR
PE,I-PR
burden,I-PR
load,I-PR
",",O
infections,B-PR
or,O
pneumonia,B-PR
and,O
questionable,O
lymphangitic,B-PR
spread,I-PR
of,O
her,B-PR
cancer,I-PR
.,O

The,O
patient,O
did,O
not,O
experience,O
improvement,O
in,O
her,B-PR
symptoms,I-PR
and,O
was,O
readmitted,O
on,O
06-11,O
with,O
continued,B-PR
dyspnea,I-PR
and,O
fevers,B-PR
.,O

Review,O
of,O
CTA,B-TE
showed,O
no,O
PE,B-PR
",",O
but,O
there,O
was,O
ground,B-PR
glass,I-PR
opacities,I-PR
on,O
CT,B-TE
",",O
so,O
PCP,B-PR
was,O
considered,O
highly,O
unlikely,O
given,O
her,O
recent,O
history,O
of,O
steroid,B-TR
use,I-TR
.,O

Her,B-TE
induced,I-TE
sputum,I-TE
was,O
negative,O
and,O
BOL,B-TE
was,O
done,O
and,O
also,O
negative,O
.,O

Sputum,B-TE
cultures,I-TE
were,O
negative,O
.,O

She,O
was,O
given,O
Bactrim,B-TR
and,O
she,O
had,O
improvement,O
in,O
the,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
after,O
her,B-TR
Bactrim,I-TR
was,O
started,O
and,O
improved,O
room,O
air,O
sats,O
and,O
was,O
sent,O
home,O
on,O
Bactrim,B-TR
.,O

She,O
then,O
continued,O
to,O
do,O
poorly,O
and,O
then,O
returned,O
on,O
06-19,O
.,O

She,O
presented,O
on,O
clinic,O
on,O
06-20,O
with,O
hypotension,B-PR
for,O
which,O
she,O
was,O
given,O
intravenous,B-TR
fluids,I-TR
.,O

She,O
spiked,O
a,B-PR
fever,I-PR
to,O
103,O
with,O
blood,B-TE
pressures,I-TE
hypertensive,B-PR
into,O
the,B-TE
systolic,I-TE
80,O
s,O
and,O
with,O
rigors,B-PR
.,O

Chest,B-TE
x-ray,I-TE
showed,O
a,O
question,O
of,O
left,B-PR
lung,I-PR
opacity,I-PR
.,O

The,O
patient,O
was,O
given,O
Vancomycin,B-TR
and,O
a,O
gram,O
of,O
intravenous,B-TR
fluids,I-TR
.,O

Today,O
",",O
the,O
patient,O
was,O
found,O
in,O
the,O
bathroom,O
and,O
became,O
hypoxic,B-PR
with,O
saturations,B-TE
in,O
the,O
80,O
s,O
and,O
was,O
responsive,O
to,O
oxygen,B-TR
",",O
but,O
was,O
still,O
tachypneic,B-PR
without,O
improvement,O
and,O
was,O
placed,O
on,O
nonrebreather,B-TR
.,O

Currently,O
the,O
patient,O
is,O
admitted,O
to,O
the,O
Intensive,O
Care,O
Unit,O
for,O
further,B-TR
medical,I-TR
care,I-TR
.,O

Currently,O
the,O
patient,O
is,O
short,B-PR
of,I-PR
breath,I-PR
without,O
chest,B-PR
pain,I-PR
or,O
dysphagia,B-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Breast,B-PR
cancer,I-PR
left,I-PR
side,I-PR
diagnosed,O
in,O
1982,O
status,O
post,O
1995,O
mastectomy,B-TR
with,O
5,O
out,O
of,O
9,O
positive,B-PR
lymph,I-PR
nodes,I-PR
.,O

She,O
was,O
treated,O
with,O
chemotherapy,B-TR
and,O
bone,B-TR
marrow,I-TR
transplant,I-TR
and,O
then,O
later,O
with,O
Tamoxifen,B-TR
from,O
2004,O
to,O
2001,O
.,O

In,O
2011,O
she,O
had,O
mediastinal,B-PR
lymphadenopathy,I-PR
treated,O
with,O
Taxol,B-TR
and,O
changed,O
to,O
Navelbine,B-TR
on,O
03-28,O
.,O

She,O
had,O
diagnosed,O
brain,B-PR
mets,I-PR
in,O
2012-03-25,O
right,O
side,O
cerebella,O
and,O
parietal,O
for,O
which,O
she,O
was,O
treated,O
with,O
chemotherapy,B-TR
",",O
radiation,B-TR
therapy,I-TR
and,O
Decadron,B-TR
.,O

2.,O
History,O
of,O
pulmonary,B-PR
embolism,I-PR
in,O
2012-04-23,O
treated,O
with,O
only,O
aspirin,B-TR
secondary,O
to,O
brain,B-PR
mets,I-PR
.,O

3.,O
Asthma,B-PR
.,O

4.,O
Gastritis,B-PR
.,O

5.,O
Questionable,O
history,O
of,O
_______________.,O

MEDICATIONS,O
ON,O
TRANSFER,O
:,O

1.,O
Protonix,B-TR
40,O
mg,O
q,O
day,O
.,O

2.,O
Megace,B-TR
400,O
q,O
day,O
.,O

3.,O
Colace,B-TR
200,O
b.i.d.,O

4.,O
Aspirin,B-TR
.,O

5.,O
Heparin,B-TR
subq.,O

6.,O
Prednisone,B-TR
40,O
q,O
day,O
.,O

7.,O
___________,O
30,O
q,O
day,O
.,O

8.,O
Clindamycin,B-TR
900,O
q,O
8,O
.,O

9.,O
Levaquin,B-TR
500,O
q,O
day,O
.,O

ALLERGIES,O
:,O

Penicillin,B-TR
.,O

SOCIAL,O
HISTORY,O
:,O

She,O
is,O
an,O
emergency,O
room,O
physician,O
at,O
the,O
Pauline,O
.,O

She,O
is,O
married,O
with,O
three,O
children,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
examination,B-TE
on,O
transfer,O
to,O
the,O
Intensive,O
Care,O
Unit,O
she,O
is,O
febrile,B-PR
with,O
a,B-PR
low,I-PR
grade,I-PR
temperature,I-PR
of,O
100.1,O
",",O
tachycardic,B-PR
to,O
110,O
",",O
hypotensive,B-PR
85/49,O
",",O
tachypneic,B-PR
into,O
the,O
50,O
s,O
and,O
60,O
"s,",O
95%,O
on,O
nonrebreather,B-TR
.,O

In,O
general,O
",",O
she,O
is,O
extremely,B-PR
tachypneic,I-PR
",",O
difficulty,B-PR
in,I-PR
speaking,I-PR
words,I-PR
.,O

Her,O
heart,O
is,O
regular,O
without,O
murmurs,B-PR
",",O
rubs,B-PR
or,O
gallops,B-PR
",",O
slightly,B-PR
tachycardic,I-PR
.,O

Her,B-TE
pulmonary,I-TE
examination,I-TE
shows,O
she,O
has,O
bronchial,O
breath,O
sounds,O
with,O
dry,B-PR
crackles,I-PR
at,I-PR
the,I-PR
bases,I-PR
.,O

Abdominal,B-TE
examination,I-TE
was,O
benign,O
.,O

Extremities,O
no,O
clubbing,B-PR
",",O
cyanosis,B-PR
or,O
edema,B-PR
.,O

She,O
is,O
alert,O
and,O
following,O
commands,O
.,O

LABORATORY,O
:,O

White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
3.2,O
",",O
hematocrit,B-TE
26.6,O
",",O
platelets,B-TE
130,O
",",O
chemistry,B-TE
is,O
131,O
",",O
potassium,B-TE
3.0,O
",",O
chloride,B-TE
105,O
",",O
bicarb,B-TE
17,O
",",O
BUN,B-TE
10,O
",",O
creatinine,B-TE
0.5,O
",",O
glucose,B-TE
105,O
.,O

Calcium,B-TE
7.3,O
",",O
phos,B-TE
1.8,O
",",O
magnesium,B-TE
1.5,O
.,O

She,O
had,O
a,B-TE
gas,I-TE
showing,O
7.36,O
",",O
31,O
",",O
96,O
.,O

She,O
had,O
a,B-TE
CT,I-TE
from,O
the,O
29th,O
of,O
her,O
abdomen,O
and,O
pelvis,O
showing,O
marked,B-PR
increased,I-PR
consolidations,I-PR
at,I-PR
the,I-PR
left,I-PR
lung,I-PR
base,I-PR
and,O
question,O
of,O
new,B-PR
left,I-PR
sided,I-PR
pleural,I-PR
effusion,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

1.,O
Pulmonary,O
:,O

The,O
patient,O
was,O
transferred,O
to,O
the,O
Intensive,O
Care,O
Unit,O
for,O
respiratory,B-PR
distress,I-PR
and,O
febrile,B-PR
hypotension,I-PR
with,O
a,O
question,O
of,O
a,B-PR
new,I-PR
infiltrate,I-PR
on,O
her,B-TE
chest,I-TE
x-ray,I-TE
.,O

The,O
exact,O
etiology,O
of,O
the,B-PR
patient,I-PR
's,I-PR
respiratory,I-PR
distress,I-PR
was,O
presumed,O
to,O
be,O
questionable,O
multifactorial,O
.,O

There,O
was,O
concern,O
about,O
possible,O
pneumonia,B-PR
.,O

Also,O
she,O
had,O
a,O
history,O
of,O
PE,B-PR
and,O
also,O
there,O
was,O
concern,O
about,O
possible,O
lymphangitic,B-PR
spread,I-PR
of,O
her,B-PR
breast,I-PR
CA,I-PR
.,O

Given,O
her,B-PR
fevers,I-PR
and,O
shortness,B-PR
of,I-PR
breath,I-PR
the,O
patient,O
was,O
treated,O
with,O
broad,B-TR
spectrum,I-TR
antibiotics,I-TR
initially,O
started,O
on,O
Ceptaz,B-TR
",",O
Levaquin,B-TR
and,O
__________,O
and,O
Clindamycin,B-TR
.,O

Lab,O
two,B-TR
antibiotics,I-TR
were,O
added,O
considering,O
the,O
patient,O
was,O
thought,O
to,O
be,O
a,O
relatively,O
high,O
risk,O
for,O
PCP,B-PR
Douglas,O
.,O

The,O
patient,O
was,O
initially,O
trialed,O
on,O
BiPAP,B-TR
",",O
but,O
the,O
patient,O
was,O
increasingly,B-PR
dyspneic,I-PR
",",O
increased,B-PR
respiratory,I-PR
stress,I-PR
and,O
ultimately,O
needed,O
to,O
be,O
intubated,O
on,O
06-22,O
.,O

Earlier,O
during,O
her,O
Intensive,O
Care,O
Unit,O
course,O
she,O
underwent,O
bronchoscopy,B-TE
",",O
which,O
was,O
sent,O
for,O
cytology,B-TE
and,O
multiple,B-PR
bacterial,I-PR
pathogens,I-PR
all,O
of,O
which,O
were,O
negative,O
.,O

Ultimately,O
her,O
Intensive,O
Care,O
Unit,O
course,O
continued,O
and,O
she,O
began,O
to,O
defervesce,O
and,O
her,B-TE
bacterial,I-TE
studies,I-TE
particulaly,O
from,O
BAL,B-TE
lavage,I-TE
were,O
found,O
to,O
be,O
negative,O
.,O

The,O
patient,O
had,O
multiple,B-TR
antibiotics,I-TR
withdrawn,O
.,O

Clindamycin,B-TR
and,O
_______________,O
was,O
discontinued,O
early,O
in,O
hospital,O
course,O
.,O

Her,B-TE
PCP,I-TE
was,O
thought,O
to,O
be,O
negative,O
.,O

In,O
addition,O
",",O
Vancomycin,B-TR
",",O
Levaquin,B-TR
were,O
also,O
discontinued,O
.,O

She,O
was,O
later,O
continued,O
on,O
Ceftazidine,B-TR
and,O
Clindamycin,B-TR
for,O
possible,O
gram,B-PR
negative,I-PR
infection,I-PR
and,O
also,O
for,O
possible,O
post,B-PR
obstructive,I-PR
picture,I-PR
that,O
she,O
would,O
be,O
at,O
risk,O
for,O
given,O
her,O
pulmonary,O
anatomy,O
.,O

As,O
the,O
Hubbard,O
Regional,O
Hospital,O
hospital,O
course,O
went,O
on,O
the,O
patient,O
's,O
respiratory,O
did,O
not,O
show,O
mild,O
improvement,O
on,O
the,B-TR
ventilator,I-TR
.,O

She,O
was,O
able,O
to,O
oxygenate,O
originally,O
.,O

Unfortunately,O
her,O
mental,O
status,O
failed,O
to,O
improve,O
despite,O
having,O
been,O
off,O
all,B-TR
sedative,I-TR
medications,I-TR
for,O
several,O
days,O
.,O

Later,O
in,O
her,O
Intensive,O
Care,O
Unit,O
course,O
family,O
meetings,O
took,O
place,O
and,O
given,O
the,O
patient,O
's,O
overall,O
poor,O
prognosis,O
with,O
decreased,B-PR
mental,I-PR
status,I-PR
it,O
was,O
decided,O
that,O
the,O
patient,O
would,O
become,O
CMO,B-TR
.,O

Subsequently,O
she,O
was,O
extubated,O
on,O
06-28,O
.,O

The,O
patient,O
continues,O
to,O
actually,O
ventilate,O
well,O
off,O
of,O
the,O
respiratory,O
.,O

However,O
",",O
she,O
is,O
CMO,B-TR
and,O
will,O
not,O
be,O
intubated,O
for,O
respiratory,B-PR
distress,I-PR
.,O

2.,O
Cardiovascular,O
:,O

The,O
patient,O
was,O
initially,O
transferred,O
to,O
the,O
Intensive,O
Care,O
Unit,O
thought,O
to,O
be,O
exhibiting,O
septic,B-PR
physiology,I-PR
",",O
respiratory,B-PR
distress,I-PR
and,O
hypotensive,B-PR
.,O

She,O
required,O
aggressive,B-TR
intravenous,I-TR
fluids,I-TR
and,O
later,O
required,O
pressor,B-TR
support,I-TR
with,O
neo-synephrine,B-TR
.,O

Later,O
during,O
her,O
Intensive,O
Care,O
Unit,O
course,O
she,O
was,O
felt,O
to,O
be,O
somewhat,B-PR
overloaded,I-PR
and,O
intravenous,B-TR
fluids,I-TR
were,O
cut,O
back,O
.,O

It,O
was,O
quite,O
difficult,O
weaning,O
her,O
off,O
of,O
neo-synephrine,B-TR
.,O

She,O
was,O
also,O
given,O
stress,B-TR
dose,I-TR
steroids,I-TR
.,O

Later,O
in,O
her,O
hospital,O
course,O
she,O
also,O
had,O
an,B-TE
echocardiogram,I-TE
for,O
question,O
of,O
new,O
ECG,O
findings,O
in,O
her,O
inferior,O
leads,O
.,O

Her,B-TE
echocardiogram,I-TE
",",O
however,O
",",O
was,O
essentially,O
normal,O
with,O
an,B-TE
ejection,I-TE
fraction,I-TE
of,O
55%,O
without,O
any,B-PR
gross,I-PR
wall,I-PR
motion,I-PR
abnormalities,I-PR
or,O
valvular,B-PR
pathology,I-PR
.,O

As,O
mentioned,O
above,O
the,O
patient,O
's,O
hemodynamic,O
status,O
was,O
tenuous,B-PR
throughout,O
her,O
hospital,O
course,O
as,O
it,O
was,O
difficult,O
to,O
wean,O
the,O
patient,O
off,O
of,O
neo-synephrine,B-TR
.,O

By,O
06-28,O
",",O
however,O
",",O
the,O
patient,O
had,O
been,O
off,O
of,O
neo-synephrine,B-TR
",",O
but,O
at,O
this,O
time,O
as,O
mentioned,O
above,O
the,O
patient,O
was,O
deemed,O
to,O
be,O
CMO,B-TR
per,O
discussion,O
with,O
physicians,O
and,O
her,O
husband,O
/,O
health,O
care,O
proxy,O
.,O

3.,O
Hematology,O
:,O

Patient,O
with,O
a,O
history,O
of,O
known,B-PR
malignancy,I-PR
and,O
also,O
a,O
history,O
of,O
pulmonary,B-PR
embolisms,I-PR
from,O
2012-04-23,O
.,O

Earlier,O
in,O
her,O
Intensive,O
Care,O
Unit,O
course,O
the,O
team,O
was,O
concerned,O
about,O
possible,O
pulmonary,B-PR
embolisms,I-PR
as,O
a,O
possible,O
source,O
of,O
the,B-PR
patient,I-PR
's,I-PR
respiratory,I-PR
decompensation,I-PR
.,O

However,O
",",O
the,O
patient,O
also,O
had,O
brain,B-PR
metastasis,I-PR
and,O
at,O
this,O
point,O
anticoagulation,B-TR
was,O
thought,O
to,O
be,O
a,O
contraindication,O
given,O
risk,O
for,O
hemorrhage,B-PR
into,O
these,B-PR
tumors,I-PR
.,O

She,O
did,O
have,O
lower,B-TE
extremity,I-TE
doppler,I-TE
ultrasounds,I-TE
",",O
which,O
were,O
negative,O
.,O

4.,O
Infectious,O
disease,O
:,O

As,O
mentioned,O
above,O
patient,O
initially,O
hypotension,B-PR
",",O
febrile,B-PR
and,O
in,O
respiratory,B-PR
distress,I-PR
presumed,O
to,O
be,O
septic,B-PR
source,I-PR
likely,O
pulmonary,O
.,O

Initially,O
the,O
patient,O
was,O
treated,O
with,O
broad,B-TR
spectrum,I-TR
antibiotics,I-TR
including,O
Vancomycin,B-TR
",",O
Ceptaz,B-TR
",",O
Levaquin,B-TR
",",O
Clindamycin,B-TR
and,O
_________.,O

All,O
of,O
her,B-TE
cultures,I-TE
are,O
negative,O
to,O
date,O
.,O

She,O
was,O
negative,O
for,O
PCP,B-PR
and,O
subsequently,O
_____________,O
was,O
continued,O
and,O
Clindamycin,B-TR
was,O
changed,O
for,O
anaerobic,B-TR
coverage,I-TR
.,O

In,O
addition,O
her,B-TR
Vancomycin,I-TR
and,O
Levaquin,B-TR
were,O
also,O
discontinued,O
.,O

The,O
patient,O
remained,O
afebrile,B-PR
during,O
the,O
majority,O
of,O
her,O
hospital,O
course,O
.,O

By,O
virtue,O
of,O
discussions,O
on,O
06-28,O
the,O
patient,O
was,O
deemed,O
to,O
be,O
CMO,B-TR
and,O
all,B-TR
antibiotics,I-TR
were,O
withdrawn,O
at,O
this,O
point,O
.,O

5.,O
Gastroenterology,O
:,O

The,O
patient,O
had,O
an,B-TE
abdominal,I-TE
CT,I-TE
earlier,O
in,O
her,O
Intensive,O
Care,O
Unit,O
course,O
",",O
which,O
was,O
essentially,O
negative,O
for,O
an,B-PR
intraabdominal,I-PR
pathology,I-PR
.,O

She,O
was,O
initially,O
supported,O
with,O
tube,B-TR
feeds,I-TR
during,O
her,O
Intensive,O
Care,O
Unit,O
course,O
",",O
but,O
at,O
this,O
point,O
the,O
patient,O
is,O
CMO,B-TR
and,O
tube,B-TR
feeds,I-TR
have,O
been,O
subsequently,O
discontinued,O
.,O

DISPOSITION,O
:,O

The,O
patient,O
's,O
attending,O
physician,O
was,O
in,O
constant,O
communication,O
with,O
the,O
patient,O
's,O
health,O
care,O
proxy,O
her,O
husband,O
.,O

As,O
her,O
Intensive,O
Care,O
Unit,O
course,O
continued,O
and,O
the,O
patient,O
showed,O
minimal,O
signs,O
of,O
meaningful,O
improvement,O
",",O
continued,O
discussions,O
were,O
had,O
with,O
the,O
family,O
about,O
possibly,O
changing,O
code,O
status,O
.,O

Ultimately,O
it,O
was,O
decided,O
by,O
06-28,O
that,O
the,O
patient,O
had,O
shown,O
minimal,O
improvement,O
and,O
minimal,O
evidence,O
of,O
improvement,O
status,O
",",O
it,O
was,O
decided,O
at,O
this,O
point,O
for,O
the,O
patient,O
to,O
be,O
extubated,O
and,O
to,O
move,O
toward,O
CMO,B-TR
care,I-TR
.,O

Subsequently,O
all,B-TR
antibiotics,I-TR
",",O
blood,B-TE
draws,I-TE
and,O
supportive,B-TR
blood,I-TR
pressure,I-TR
medications,I-TR
were,O
withdrawn,O
.,O

Currently,O
she,O
is,O
comfortable,O
with,O
morphine,B-TR
and,O
Ativan,B-TR
prn.,O

Currently,O
plans,O
are,O
in,O
the,O
making,O
for,O
arranging,O
for,O
the,O
patient,O
to,O
have,O
home,B-TR
hospice,I-TR
care,I-TR
.,O

Please,O
see,O
discharge,O
addendum,O
for,O
further,O
developments,O
in,O
the,O
patient,O
's,O
care,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Metastatic,B-PR
breast,I-PR
cancer,I-PR
end,I-PR
stage,I-PR
.,O

2.,O
Respiratory,B-PR
failure,I-PR
unclear,O
etiology,O
",",O
presumed,O
secondary,O
to,O
possible,O
pneumonia,B-PR
",",O
questionable,O
lymphangitic,B-PR
spread,I-PR
.,O

3.,O
Sepsis,B-PR
presumed,O
pulmonary,O
source,O
.,O

DISCHARGE,O
CONDITION,O
:,O

Grim,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Morphine,B-TR
prn,O
.,O

2.,O
Ativan,B-TR
prn,O
.,O

3.,O
Tylenol,B-TR
prn,O
.,O

4.,O
Albuterol,B-TR
and,O
Atrovent,B-TR
nebs,I-TR
prn,O
.,O

Rice,O
S.F.,O
Thrash,O
",",O
M.D.,O
15-419,O

Dictated,O
By,O
:,O
Brett,O
E.X.,O
Im,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2012-06-29,O
01:15,O

T,O
:,O
2012-06-29,O
05:47,O

JOB,O
#:,O
44693,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Vicki,O
Baker,O
on,O
:,O
TUE,O
2012-07-03,O
8:23,O
AM,O

(,O
End,O
of,O
Report,O
),O

763970014,O

CMC,O

85905567,O

04/21/1994,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

04/21/1994,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

04/29/1994,O

DISCHARGE,O
DIAGNOSIS,O
:,O

LEFT,B-PR
PARIETAL,I-PR
GLIOBLASTOMA,I-PR
MULTIFORME,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Patient,O
is,O
an,O
88,O
year,O
old,O
female,O
with,O
fatigue,B-PR
and,O
decreased,B-PR
short,I-PR
term,I-PR
memory,I-PR
for,O
the,O
past,O
six,O
months,O
.,O

The,O
past,O
six,O
weeks,O
",",O
she,O
has,O
also,O
been,O
complaining,O
of,O
hot,B-PR
sensation,I-PR
and,O
tingling,B-PR
sensation,I-PR
in,I-PR
the,I-PR
hands,I-PR
bilaterally,I-PR
.,O

For,O
the,O
past,O
five,O
weeks,O
",",O
the,O
patient,O
has,O
experienced,O
dragging,B-PR
of,I-PR
the,I-PR
right,I-PR
leg,I-PR
with,O
weakness,B-PR
throughout,O
that,O
side,O
.,O

Head,B-TE
CT,I-TE
was,O
done,O
which,O
patient,O
reported,O
demonstrated,O
three,B-PR
lesions,I-PR
in,I-PR
the,I-PR
left,I-PR
parietal,I-PR
region,I-PR
of,O
the,O
brain,O
.,O

Bone,B-TE
scan,I-TE
",",O
CT,B-TE
of,I-TE
the,I-TE
abdomen,I-TE
",",O
chest,B-TE
X-Ray,I-TE
",",O
and,O
mammogram,B-TE
were,O
all,O
negative,O
.,O

Patient,O
noted,O
the,B-PR
foot,I-PR
dragging,I-PR
to,O
have,O
worsened,O
over,O
the,O
past,O
few,O
weeks,O
but,O
improved,O
since,O
on,O
Decadron,B-TR
the,O
past,O
week,O
before,O
admission,O
.,O

Patient,O
is,O
now,O
admitted,O
for,O
elective,B-TE
left,I-TE
parietal,I-TE
stereotactic,I-TE
biopsy,I-TE
of,O
the,B-PR
tumor,I-PR
.,O

PAST,O
MEDICAL,O
/,O
SURGICAL,O
HISTORY,O
:,O

Significant,O
for,O
a,O
history,O
of,O
hypertension,B-PR
",",O
basal,B-PR
cell,I-PR
carcinoma,I-PR
of,I-PR
the,I-PR
nose,I-PR
six,O
years,O
ago,O
",",O
cataracts,B-PR
",",O
and,O
a,B-TR
hysterectomy,I-TR
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

CURRENT,O
MEDICATIONS,O
:,O

Hydrochlorothiazide,B-TR
25,O
mg,O
q.d.,O
and,O
Decadron,B-TR
25,O
mg,O
b.i.d.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,O
demonstrated,O
a,O
well-developed,O
",",O
well-nourished,O
female,O
in,O
no,O
apparent,B-PR
distress,I-PR
dragging,O
her,O
right,O
foot,O
.,O

HEENT,O
:,O

Head,O
was,O
atraumatic,B-PR
and,O
normocephalic,O
with,O
pupils,O
equal,O
",",O
round,O
",",O
and,O
reactive,O
to,O
light,O
.,O

LUNGS,O
:,O

Clear,O
to,O
auscultation,B-TE
.,O

HEART,O
:,O

Examination,B-TE
demonstrated,O
a,O
regular,O
rate,O
and,O
rhythm,O
without,O
any,B-PR
murmurs,I-PR
noted,O
.,O

ABDOMEN,O
:,O

Benign,O
with,O
a,B-PR
hysterectomy,I-PR
scar,I-PR
which,O
was,O
well,O
healed,O
.,O

NEUROLOGICAL,O
:,O

Examination,B-TE
showed,O
that,O
the,O
patient,O
was,O
noted,O
to,O
be,O
alert,O
and,O
oriented,O
times,O
three,O
",",O
short,O
term,O
memory,O
was,O
deficient,B-PR
",",O
patient,O
remembered,O
zero,O
out,O
of,O
three,O
things,O
to,O
remember,O
at,O
one,O
minute,O
",",O
speech,O
was,O
noted,O
to,O
be,O
fluent,O
",",O
and,O
cranial,O
nerves,O
II-XII,O
were,O
intact,O
.,O

On,O
motor,B-TE
examination,I-TE
",",O
patient,O
was,O
noted,O
to,O
be,O
of,O
normal,O
motor,O
function,O
throughout,O
except,O
for,O
a,B-PR
slight,I-PR
weakness,I-PR
of,I-PR
the,I-PR
right,I-PR
dorsi,I-PR
flexion,I-PR
and,I-PR
plantar,I-PR
flexion,I-PR
",",O
both,O
noted,O
to,O
be,O
about,O
4/5,O
and,O
sensory,B-TE
examination,I-TE
was,O
intact,O
throughout,O
.,O

Patient,O
's,O
gait,O
was,O
noted,O
to,O
have,O
a,B-PR
right,I-PR
foot,I-PR
drag,I-PR
as,O
well,O
as,O
right,B-PR
foot,I-PR
drop,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

Patient,O
was,O
taken,O
to,O
the,O
Operating,O
Room,O
on,O
April,O
21,O
where,O
patient,O
underwent,O
a,B-TE
left,I-TE
parietal,I-TE
stereotactic,I-TE
guided,I-TE
brain,I-TE
biopsy,I-TE
.,O

Patient,O
tolerated,O
the,B-TE
procedure,I-TE
well,O
without,O
any,B-PR
complications,I-PR
and,O
was,O
taken,O
to,O
the,O
Recovery,O
Room,O
awake,O
and,O
stable,O
then,O
subsequently,O
transferred,O
to,O
the,O
floor,O
.,O

Patient,O
did,O
well,O
post-operatively,O
",",O
continued,O
to,O
have,O
a,B-PR
right,I-PR
sided,I-PR
deficit,I-PR
",",O
and,O
Physical,O
Therapy,O
and,O
Occupational,O
Therapy,O
visited,O
the,O
patient,O
",",O
worked,O
with,O
the,O
patient,O
",",O
and,O
determined,O
that,O
patient,O
needed,O
rehabilitation,B-TR
with,O
Physical,O
Therapy,O
.,O

The,O
patient,O
was,O
evaluated,O
by,O
Doing,O
and,O
was,O
subsequently,O
accepted,O
into,O
that,O
program,O
.,O

Patient,O
is,O
now,O
discharged,O
to,O
Harl,O
Wa,O
Healthcare,O
Network,O
on,O
April,O
29,O
",",O
1994,O
in,O
stable,O
condition,O
.,O

DISPOSITION,O
:,O

She,O
is,O
to,O
receive,O
rehabilitation,B-TR
to,O
increase,O
her,O
mobility,O
and,O
strength,O
",",O
rehabilitation,B-TR
potential,O
is,O
good,O
",",O
and,O
she,O
is,O
to,O
receive,O
the,O
following,O
medications,O
at,O
that,O
facility,O
:,O

Decadron,B-TR
3,O
mg,O
p.o.,O
q.6h.,O
times,O
one,O
week,O
then,O
2,O
mg,O
p.o.q.6h.,O
thereafter,O
",",O
Colace,B-TR
100,O
mg,O
b.i.d.,O
",",O
Heparin,B-TR
5000,O
units,O
subcutaneously,O
b.i.d.,O
until,O
ambulating,O
well,O
",",O
Hydrochlorothiazide,B-TR
25mg,O
q.d.,O
",",O
Dilantin,B-TR
100,O
mg,O
p.o.,O
b.i.d.,O
",",O
Zantac,B-TR
150,O
mg,O
b.i.d.,O
",",O
and,O
Percocet,B-TR
p.r.n.,O

Patient,O
is,O
to,O
be,O
subsequently,O
followed,O
up,O
by,O
Dr.,O
Memory,O
.,O

Pathology,O
of,O
the,B-TE
biopsy,I-TE
demonstrated,O
glioblastoma,B-PR
multiforme,I-PR
",",I-PR
grade,I-PR
IIi/III,I-PR
.,O

Radiation,O
Oncology,O
saw,O
the,O
patient,O
while,O
in,O
the,O
hospital,O
and,O
is,O
to,O
follow,O
her,O
over,O
at,O
Colning,O
.,O

Dictated,O
By,O
:,O

TELSHEY,O
MEMORY,O
",",O
M.D.,O

Attending,O
:,O

BESTI,O
T.,O
DROP,O
",",O
M.D.,O
ND32,O
UZ561/2906,O

Batch,O
:,O

349,O

Index,O
No.,O
WZGE1,O
XNHQ,O

D,O
:,O

04/29/94,O

T,O
:,O

04/29/94,O

Admission,O
Date,O
:,O

2016-09-05,O

Discharge,O
Date,O
:,O

2016-09-14,O

Date,O
of,O
Birth,O
:,O

1940-08-17,O

Sex,O
:,O

M,O

Service,O
:,O

CSU,O

CHIEF,O
COMPLAINT,O
:,O

Chest,B-PR
pain,I-PR
and,O
back,B-PR
pain,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Mr.,O
Hohlt,O
is,O
a,O
76,O
-,O
year-old,O
man,O
with,O
a,O
history,O
of,O
hypertension,B-PR
",",O
hyperlipidemia,B-PR
and,O
prior,B-PR
myocardial,I-PR
infarction,I-PR
with,O
a,B-TR
percutaneous,I-TR
transluminal,I-TR
coronary,I-TR
angioplasty,I-TR
of,I-TR
the,I-TR
right,I-TR
coronary,I-TR
artery,I-TR
in,O
2005,O
at,O
the,O
Cambridge,O
Health,O
Alliance,O
.,O

He,O
states,O
that,O
he,O
has,O
experienced,O
pain,B-PR
and,O
tightness,B-PR
in,I-PR
his,I-PR
back,I-PR
radiating,O
into,O
both,O
shoulders,O
starting,O
on,O
2016-09-02,O
.,O

The,O
patient,O
denies,O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
dizziness,B-PR
",",O
diaphoresis,B-PR
",",O
or,O
nausea,B-PR
.,O

The,B-PR
pain,I-PR
lasted,O
for,O
30,O
seconds,O
following,O
pushing,O
a,O
wheelbarrow,O
and,O
resolved,O
with,O
rest,O
.,O

The,O
patient,O
denied,O
any,O
prior,O
episodes,O
of,O
pain,B-PR
or,O
any,O
since,O
2005,O
following,O
the,O
initial,O
episode,O
of,O
pain,B-PR
.,O

The,O
patient,O
informs,O
his,O
primary,O
care,O
provider,O
who,O
referred,O
him,O
to,O
the,O
emergency,O
room,O
.,O

He,O
then,O
presented,O
to,O
Mass.,O
Mental,O
Health,O
Center,O
where,O
he,O
was,O
ruled,O
out,O
for,O
an,B-PR
myocardial,I-PR
infarction,I-PR
by,O
enzymes,B-TE
and,O
electrocardiograms,B-TE
.,O

The,O
patient,O
also,O
underwent,O
a,O
negative,O
evaluation,O
for,O
dissecting,B-PR
aortic,I-PR
aneurysm,I-PR
.,O

On,O
2016-09-03,O
",",O
the,O
patient,O
began,O
experiencing,O
continuing,B-PR
chest,I-PR
pain,I-PR
of,O
increasing,O
intensity,O
.,O

He,O
was,O
treated,O
with,O
nitroglycerin,B-TR
paste,I-TR
and,O
IV,B-TR
Integrelin,I-TR
as,O
well,O
as,O
Plavix,B-TR
.,O

At,O
that,O
time,O
",",O
he,O
ruled,O
in,O
for,O
an,B-PR
NST,I-PR
EMI,I-PR
with,O
a,B-TE
peak,I-TE
CK,I-TE
of,O
412,O
and,O
a,B-TE
troponin,I-TE
of,O
6.23,O
.,O

Electrocardiograms,B-TE
progressed,O
to,O
inverted,B-PR
T,I-PR
waves,I-PR
in,I-PR
V5,I-PR
and,I-PR
V6,I-PR
.,O

The,O
patient,O
is,O
now,O
transferred,O
to,O
Cambridge,O
Health,O
Alliance,O
for,O
cardiac,B-TE
catheterization,I-TE
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Hypertension,B-PR
",",O
hyperlipidemia,B-PR
",",O
IMI,B-PR
in,O
2005,O
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

Partial,B-TR
thyroidectomy,I-TR
",",O
herniorrhaphy,B-TR
",",O
percutaneous,B-TR
transluminal,I-TR
coronary,I-TR
angioplasty,I-TR
of,I-TR
the,I-TR
RCA,I-TR
in,O
2005,O
",",O
left,B-TR
knee,I-TR
surgery,I-TR
as,O
well,O
as,O
tonsil,B-TR
and,I-TR
adenoid,I-TR
surgery,I-TR
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

MEDICATIONS,O
AT,O
HOME,O
:,O

1.,O
Flomax,B-TR
0.4,O
q.d.,O

2.,O
Aspirin,B-TR
325,O
q.d.,O

3.,O
Lipitor,B-TR
10,O
q.d.,O

4.,O
Naproxen,B-TR
p.r.n.,O
as,O
well,O
as,O
several,B-TR
vitamins,I-TR
and,O
supplements,B-TR
.,O

5.,O
Zestoretic,B-TR
with,O
an,O
unknown,O
dose,O
.,O

MEDICATIONS,O
ON,O
TRANSFER,O
:,O

1.,O
Captopril,B-TR
25,O
t.i.d.,O

2.,O
Protonix,B-TR
q.d.,O
40,O
.,O

3.,O
Nitroglycerin,B-TR
paste,I-TR
1,O
inch,O
q.,O
6,O
hours,O
.,O

4.,O
Lopressor,B-TR
25,O
b.i.d.,O

5.,O
Plavix,B-TR
75,O
q.d.,O

6.,O
Lovenox,B-TR
90,O
b.i.d.,O

7.,O
Aspirin,B-TR
325,O
q.d.,O

8.,O
Lipitor,B-TR
10,O
q.d.,O

SOCIAL,O
HISTORY,O
:,O

Married,O
",",O
retired,O
accountant,O
with,O
six,O
children,O
.,O

He,O
denies,O
any,O
tobacco,O
use,O
",",O
2,O
to,O
3,O
alcohol,O
drinks,O
per,O
week,O
.,O

FAMILY,O
HISTORY,O
:,O

Father,O
died,O
in,O
his,O
80,O
's,O
of,O
pacemaker,B-PR
failure,I-PR
",",O
also,O
had,O
a,B-PR
myocardial,I-PR
infarction,I-PR
in,O
his,O
70,O
's.,O

PHYSICAL,O
EXAMINATION,O
:,O

Vital,O
signs,O
:,O

Heart,B-TE
rate,I-TE
is,O
55,O
",",O
blood,B-TE
pressure,I-TE
is,O
129/79,O
",",O
Respiratory,B-TE
rate,I-TE
is,O
22,O
",",O
O2,B-TE
sat,I-TE
is,O
96,O
percent,O
on,O
2,B-TR
liters,I-TR
.,O

In,O
general,O
",",O
well-appearing,O
man,O
",",O
lying,O
on,O
a,O
stretcher,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

Neck,O
:,O

2,B-TE
plus,I-TE
carotids,I-TE
with,O
no,O
jugular,B-PR
venous,I-PR
distention,I-PR
and,O
no,O
bruits,B-PR
and,O
no,O
thyromegaly,B-PR
.,O

Lungs,O
:,O

Fine,B-PR
crackles,I-PR
in,I-PR
the,I-PR
bases,I-PR
",",O
otherwise,O
clear,O
.,O

Cardiovascular,O
:,O

Regular,O
rate,O
and,O
rhythm,O
",",O
S1,O
and,O
S2,O
with,O
no,O
murmurs,B-PR
",",O
rubs,B-PR
or,O
gallops,B-PR
.,O

Abdomen,O
:,O
Soft,O
and,O
nontender,B-PR
and,O
nondistended,B-PR
",",O
normal,O
active,O
bowel,O
sounds,O
and,O
no,O
bruits,B-PR
.,O

Pulses,B-TE
are,O
2,O
plus,O
femoral,O
bilaterally,O
",",O
2,O
plus,O
dorsalis,O
pedis,O
as,O
well,O
as,O
posterior,O
tibial,O
bilaterally,O
.,O

No,O
edema,B-PR
.,O

Neurological,O
:,O

Alert,O
and,O
oriented,O
times,O
3,O
.,O

Chest,B-TE
CT,I-TE
done,O
at,O
the,O
outside,O
hospital,O
showed,O
no,O
gallstones,B-PR
.,O

Left,O
kidney,O
with,O
a,B-PR
small,I-PR
cyst,I-PR
splenic,I-PR
lesion,I-PR
and,O
no,O
triple,B-PR
A,I-PR
.,O

Electrocardiogram,B-TE
has,O
sinus,O
rhythm,O
with,O
Q,B-PR
wave,I-PR
in,I-PR
2,I-PR
",",I-PR
3,I-PR
",",I-PR
and,I-PR
F,I-PR
",",O
flattened,B-PR
T,I-PR
waves,I-PR
in,I-PR
the,I-PR
lateral,I-PR
leads,I-PR
",",O
sinus,O
rhythm,O
at,O
a,O
rate,O
of,O
56,O
.,O

LABORATORY,O
DATA,O
:,O

White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
is,O
8.3,O
",",O
hematocrit,B-TE
42.7,O
",",O
platelets,B-TE
180,O
",",O
INR,B-TE
was,O
1.1,O
",",O
sodium,B-TE
135,O
",",O
potassium,B-TE
4.0,O
",",O
chloride,B-TE
99,O
",",O
CO2,B-TE
33,O
",",O
BUN,B-TE
13,O
",",O
creatinine,B-TE
1.0,O
",",O
glucose,B-TE
96,O
.,O

While,O
on,O
transfer,O
",",O
the,O
patient,O
underwent,O
cardiac,B-TE
catheterization,I-TE
.,O

Please,O
see,O
cathed,O
report,O
for,O
full,O
details,O
.,O

In,O
summary,O
",",O
the,B-TE
catheterization,I-TE
showed,O
left,O
main,O
with,O
no,O
obstructive,B-PR
disease,I-PR
",",O
LAD,O
with,O
70,B-PR
percent,I-PR
serial,I-PR
lesion,I-PR
",",O
left,O
circumflex,O
with,O
70,O
percent,O
proximal,O
",",O
OM1,O
and,O
OM2,O
both,O
70,B-PR
percent,I-PR
lesions,I-PR
",",O
RCA,O
with,O
nonobstructive,B-PR
disease,I-PR
and,O
ejection,O

fraction,B-TE
of,O
25,O
percent,O
.,O

The,O
patient,O
was,O
referred,O
to,O
CT,O
surgery,O
who,O
was,O
seen,O
and,O
accepted,O
for,O
coronary,B-TR
artery,I-TR
bypass,I-TR
grafting,I-TR
.,O

On,O
09-06,O
",",O
he,O
was,O
brought,O
to,O
the,O
Operating,O
Room,O
",",O
please,O
see,O
the,O
Operating,O
Room,O
report,O
for,O
full,O
details,O
.,O

In,O
summary,O
",",O
he,O
had,O
a,B-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
times,O
4,O
with,O
a,B-TR
LIMA,I-TR
to,I-TR
the,I-TR
LAD,I-TR
",",O
saphenous,B-TR
vein,I-TR
graft,I-TR
OM1,I-TR
",",O
saphenous,B-TR
vein,I-TR
graft,I-TR
OM2,I-TR
and,O
saphenous,B-TR
vein,I-TR
graft,I-TR
of,I-TR
the,I-TR
diagonal,I-TR
.,O

His,O
bypass,O
time,O
was,O
105,O
minutes,O
with,O
a,O
cross,O
clamp,O
time,O
of,O
87,O
minutes,O
.,O

He,O
tolerated,O
the,B-TR
operation,I-TR
well,O
and,O
was,O
transferred,O
from,O
the,O
Operating,O
Room,O
to,O
the,O
cardiothoracic,O
ICU,O
.,O

At,O
the,O
time,O
of,O
transfer,O
",",O
he,O
was,O
AV,B-TR
paced,I-TR
at,O
a,O
rate,O
of,O
88,O
beats,O
per,O
minute,O
.,O

He,O
had,O
Propofol,B-TR
at,O
30,O
mc,O
per,O
kg,O
per,O
minute,O
and,O
Neo-Synephrine,B-TR
to,O
maintain,O
his,B-TE
blood,I-TE
pressure,I-TE
.,O

The,O
patient,O
did,O
well,O
in,O
the,O
immediate,O
postoperative,O
period,O
.,O

His,B-TR
anesthesia,I-TR
was,O
reversed,O
.,O

He,O
was,O
weaned,O
from,O
the,B-TR
ventilator,I-TR
and,O
successfully,O
extubated,O
.,O

He,O
remained,O
hemodynamically,O
stable,O
throughout,O
the,O
remainder,O
of,O
his,O
operative,O
day,O
.,O

On,O
postoperative,O
day,O
1,O
",",O
the,O
patient,O
remained,O
hemodynamically,O
stable,O
on,O
a,B-TR
Neo-Synephrine,I-TR
drip,I-TR
to,O
maintain,O
an,O
adequate,O
blood,O

pressure,O
.,O

He,O
remained,O
in,O
the,O
Intensive,O
Care,O
Unit,O
as,O
he,O
was,O
unable,O
to,O
be,O
weaned,O
off,O
of,O
his,B-TR
Neo-Synephrine,I-TR
drip,I-TR
.,O

On,O
postoperative,O
day,O
1,O
",",O
his,B-TR
Swan-Ganz,I-TR
catheter,I-TR
was,O
removed,O
as,O
well,O
.,O

On,O
postoperative,O
day,O
2,O
",",O
another,O
attempt,O
was,O
made,O
to,O
wean,O
the,O
patient,O
off,O
of,O
Neo-Synephrine,B-TR
unsuccessfully,O
.,O

His,B-TR
chest,I-TR
tubes,I-TR
were,O
removed,O
.,O

However,O
",",O
because,O
he,O
could,O
not,O
be,O
weaned,O
from,O
the,B-TR
Neo-Synephrine,I-TR
",",O
he,O
again,O
remained,O
in,O
the,O
Intensive,O
Care,O
Unit,O
.,O

On,O
postoperative,O
day,O
3,O
",",O
an,O
additional,O
attempt,O
was,O
made,O
to,O
wean,O
the,O
patient,O
from,O
his,B-TR
Neo-Synephrine,I-TR
unsuccessfully,O
.,O

The,O
patient,O
also,O
received,O
a,B-TR
unit,I-TR
of,I-TR
packed,I-TR
red,I-TR
blood,I-TR
cells,I-TR
in,O
an,O
additional,O
attempt,O
to,O
wean,O
from,O
Neo-Synephrine,B-TR
.,O

This,O
also,O
did,O
not,O
help,O
in,O
the,O
attempt,O
to,O
wean,O
from,O
Neo-Synephrine,B-TR
.,O

His,B-TR
Foley,I-TR
catheter,I-TR
was,O
removed,O
and,O
he,O
remained,O
again,O
in,O
the,O
ICU,O
.,O

On,O
postoperative,O
day,O
4,O
",",O
additional,O
attempts,O
were,O
made,O
to,O
wean,O
the,O
patient,O
off,O
of,O
his,B-TR
Neo-Synephrine,I-TR
",",O
however,O
",",O
he,O
continued,O
to,O
drop,O
his,B-TE
blood,I-TE
pressure,I-TE
whenever,O
an,O
attempt,O
was,O
made,O
.,O

Other,O
than,O
that,O
",",O
the,O
patient,O
remained,O
completely,O
stable,O
.,O

On,O
postoperative,O
day,O
5,O
",",O
the,O
patient,O
was,O
finally,O
weaned,O
off,O
of,O
his,B-TR
Neo-Synephrine,I-TR
and,O
diuresis,B-TR
was,O
begun,O
.,O

He,O
remained,O
in,O
the,O
Intensive,O
Care,O
Unit,O
for,O
an,O
additional,O
day,O
to,O
monitor,O
his,O
hemodynamics,O
.,O

On,O
postoperative,O
day,O
6,O
",",O
the,O
patient,O
remained,O
hemodynamically,O
stable,O
and,O
he,O
was,O
transferred,O
to,O
the,O
floor,O
for,O
continuing,B-TR
postoperative,I-TR
care,I-TR
and,O
cardiac,B-TR
rehabilitation,I-TR
.,O

Over,O
the,O
next,O
two,O
days,O
",",O
the,O
patient,O
had,O
an,O
uneventful,O
hospitalization,O
.,O

His,O
activity,O
level,O
was,O
increased,O
with,O
the,O
assistance,O
of,O
physical,O
therapy,O
department,O
and,O
the,O
nursing,O
staff,O
.,O

On,O
postoperative,O
day,O
7,O
",",O
it,O
was,O
decided,O
that,O
the,O
patient,O
would,O
be,O
stable,O
and,O
ready,O
to,O
be,O
discharged,O
to,O
home,O
on,O
the,O
following,O
day,O
.,O

At,O
the,O
time,O
of,O
this,O
dictation,O
",",O
the,B-TE
patient,I-TE
's,I-TE
physical,I-TE
examination,I-TE
is,O
as,O
follows,O
:,O
Vital,B-TE
signs,I-TE
were,O
temperature,B-TE
99,O
",",O
heart,B-TE
rate,I-TE
84,O
in,O
sinus,O
rhythm,O
",",O
blood,B-TE
pressure,I-TE
was,O
114/63,O
",",O
Respiratory,B-TE
rate,I-TE
was,O
18,O
",",O
O2,B-TE
sat,I-TE
was,O
94,O
percent,O
on,O
room,O
air,O
.,O

Weight,B-TE
preoperatively,O
was,O
88.5,O
kilos,O
",",O
at,O
discharge,O
was,O
90.4,O
kilos,O
.,O

LABORATORY,O
DATA,O
:,O

White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
8.8,O
",",O
hematocrit,B-TE
29.7,O
",",O
platelets,B-TE
367,O
",",O
sodium,B-TE
139,O
",",O
potassium,B-TE
4.7,O
",",O
chloride,B-TE
102,O
",",O
CO2,B-TE
27,O
",",O
BUN,B-TE
17,O
",",O
creatinine,B-TE
1.1,O
",",O
glucose,B-TE
95,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Neurological,O
:,O
Alert,O
and,O
oriented,O
times,O
3,O
.,O

Moves,O
all,O
extremities,O
and,O
follows,O
commands,O
.,O

Respiratory,O
:,O

Clear,O
to,O
auscultation,B-TE
bilaterally,I-TE
.,O

Cardiovascular,O
:,O
Regular,O
rate,O
and,O
rhythm,O
",",O
S1,O
and,O
S2,O
.,O

No,O
murmurs,B-PR
.,O

Sternum,O
is,O
stable,O
",",O
incision,B-PR
with,O
staples,B-TR
",",O
opened,O
to,O
air,O
",",O
clean,O
and,O
dry,O
.,O

Abdomen,O
:,O
Soft,O
and,O
nontender,B-PR
",",O
nondistended,B-PR
with,O
positive,O
bowel,O
sounds,O
.,O

Extremities,O
:,O

Warm,O
and,O
well,O
profuse,O
with,O
1,B-PR
to,I-PR
2,I-PR
plus,I-PR
edema,I-PR
.,O

Right,B-PR
saphenous,I-PR
vein,I-PR
graft,I-PR
site,I-PR
with,O
Steri-strips,B-TR
",",O
open,O
to,O
air,O
",",O
clean,O
and,O
dry,O
.,O

The,O
patient,O
's,O
condition,O
at,O
discharge,O
is,O
good,O
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

1.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
",",O
status,O
post,O
coronary,B-TR
artery,I-TR
bypass,I-TR
grafting,I-TR
times,O
4,O
with,O
LIMA,B-TR
to,I-TR
the,I-TR
LAD,I-TR
",",O
saphenous,B-TR
vein,I-TR
graft,I-TR
to,I-TR
OM1,I-TR
",",O
saphenous,B-TR
vein,I-TR
graft,I-TR
to,I-TR
OM2,I-TR
and,O
saphenous,B-TR
vein,I-TR
graft,I-TR
to,I-TR
the,I-TR
diagonal,I-TR
.,O

2.,O
Hypertension,B-PR
.,O

3.,O
Hypercholesterolemia,B-PR
.,O

4.,O
Status,O
post,O
partial,B-TR
thyroidectomy,I-TR
.,O

5.,O
Status,O
post,O
hernia,B-TR
repair,I-TR
.,O

6.,O
Status,O
post,O
left,B-TR
knee,I-TR
surgery,I-TR
.,O

7.,O
Status,O
post,O
tonsil,B-TR
and,I-TR
adenoid,I-TR
surgery,I-TR
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Atorvastatin,B-TR
10,O
mg,O
q.d.,O

2.,O
Plavix,B-TR
75,O
mg,O
q.d.,O
times,O
3,O
months,O
.,O

3.,O
Aspirin,B-TR
325,O
mg,O
q.d.,O

4.,O
Lasix,B-TR
20,O
mg,O
q.d.,O
times,O
two,O
weeks,O
.,O

5.,O
Potassium,B-TR
chloride,I-TR
20,O
mEq,O
q.d.,O
times,O
two,O
weeks,O
.,O

6.,O
Metoprolol,B-TR
12.5,O
mg,O
b.i.d.,O

7.,O
Percocet,B-TR
1,O
to,O
2,O
tabs,O
q.,O
4,O
hours,O
p.r.n.,O

The,O
patient,O
is,O
to,O
be,O
discharged,O
home,O
with,O
visiting,O
nurses,O
.,O

He,O
is,O
to,O
have,O
follow,O
up,O
in,O
the,O
wound,O
clinic,O
in,O
two,O
weeks,O
and,O
follow,O
up,O
with,O
Dr.,O
Brewster,O
in,O
two,O
to,O
three,O
weeks,O
and,O
follow,O
up,O
with,O
Dr.,O
Rota,O
in,O
4,O
weeks,O
.,O

Herbert,O
Jesus,O
",",O
Georgia,O
01835,O

Dictated,O
By,O
:,O
Scott,O
OK,O
Astarita,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2016-09-14,O
12:52:27,O

T,O
:,O
2016-09-14,O
13:28:05,O

Job,O
#:,O
15604,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Richard,O
Gomez,O
on,O
:,O
FRI,O
2016-09-16,O
7:05,O
AM,O

(,O
End,O
of,O
Report,O
),O

766212923,O
ELMVH,O

70097548,O

1264110,O

11/9/2003,O
12:00:00,O
AM,O

GASTROINTESTINAL,B-PR
BLEEDING,I-PR

Signed,O

DIS,O

Admission,O
Date,O
:,O

11/09/2003,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

11/16/2003,O

ATTENDING,O
:,O

GROSRIANNE,O
SISANDLEE,O
JERGJESC,O
M.D.,O

SERVICE,O
:,O

GMS,O
1,O
Medical,O
Service,O
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

GI,B-PR
bleed,I-PR
.,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O
.,O

HOSPITAL,O
COURSE,O
:,O

Patient,O
&apos;s,O
hospital,O
course,O
is,O
as,O
follows,O
:,O

Patient,O
is,O
an,O
84-year-old,O
male,O
who,O
was,O
transferred,O
from,O
an,O
outside,O
hospital,O
with,O
a,B-PR
low,I-PR
hematocrit,I-PR
of,O
21,O
and,O
with,O
guaiac-positive,B-PR
stool,I-PR
.,O

The,O
day,O
prior,O
to,O
admission,O
",",O
he,O
experienced,O
dyspnea,B-PR
on,O
exertion,O
",",O
and,O
on,O
the,O
day,O
of,O
admission,O
he,O
collapsed,O
and,O
complained,O
of,O
substantial,B-PR
weakness,I-PR
.,O

He,O
denied,O
any,B-PR
melana,I-PR
",",O
any,B-PR
hematemesis,I-PR
",",O
nausea,B-PR
or,O
vomiting,B-PR
.,O

He,O
was,O
taken,O
to,O
an,O
outside,O
hospital,O
at,O
the,O
time,O
at,O
which,O
time,O
it,O
was,O
found,O
that,O
his,B-TE
hematocrit,I-TE
was,O
21,O
",",O
blood,B-TE
pressure,I-TE
90/60,O
",",O
and,O
his,B-TE
INR,I-TE
was,O
3.3,O
.,O

Of,O
note,O
",",O
he,O
is,O
anti-coagulated,B-TR
for,O
an,B-TR
artificial,I-TR
heart,I-TR
valve,I-TR
.,O

He,O
was,O
at,O
that,O
point,O
given,O
1,B-TR
unit,I-TR
of,I-TR
packed,I-TR
red,I-TR
blood,I-TR
cells,I-TR
.,O

On,O
further,O
questioning,O
",",O
the,O
patient,O
reported,O
that,O
he,O
started,O
to,O
feel,O
&quot;,O
different,O
&quot;,O
several,O
days,O
ago,O
with,O
slowing,B-PR
and,I-PR
difficult,I-PR
ambulation,I-PR
progressing,O
to,O
complete,O
inability,O
to,O
ambulate,O
.,O

He,O
was,O
also,O
short,B-PR
of,I-PR
breath,I-PR
with,O
ambulation,O
",",O
but,O
he,O
does,O
have,O
baseline,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
with,O
exertion,O
.,O

He,O
denied,O
any,B-PR
chest,I-PR
pain,I-PR
",",O
dysuria,B-PR
",",O
loss,B-PR
of,I-PR
consciousness,I-PR
",",O
fevers,B-PR
",",O
chills,B-PR
or,O
any,O
history,O
of,O
myocardial,B-PR
infarction,I-PR
.,O

Patient,O
was,O
last,O
admitted,O
to,O
Padrugmoff,O
Hospital,O
with,O
a,B-TE
hematocrit,I-TE
of,O
24.5,O
",",O
and,O
was,O
asymptomatic,B-PR
prior,O
to,O
admission,O
.,O

At,O
that,O
time,O
",",O
he,O
had,O
guaiac-positive,B-PR
and,O
had,O
a,B-TE
small,I-TE
bowel,I-TE
follow,I-TE
through,I-TE
which,O
was,O
negative,O
.,O

He,O
was,O
transfused,O
4,B-TR
units,I-TR
during,O
that,O
admission,O
and,O
discharged,O
with,O
a,B-TE
hematocrit,I-TE
of,O
34,O
on,O
vitamin,B-TR
C,I-TR
and,O
iron,B-TR
sulfate,I-TR
.,O

EXAM,O
ON,O
ARRIVAL,O
IN,O
THE,O
LO,O
HOSPITAL,O
EMERGENCY,O
ROOM,O
:,O

On,O
arrival,O
at,O
the,O
Lo,O
Hospital,O
Emergency,O
Room,O
:,O

He,O
was,O
found,O
to,O
have,O
a,B-TE
temperature,I-TE
of,O
97.4,O
",",O
heart,B-TE
rate,I-TE
65,O
",",O
pressure,B-TE
107/52,O
",",O
respiratory,B-TE
rate,I-TE
22,O
and,O
saturating,B-TE
100%,O
on,O
2,O
L,O
of,O
a,B-TR
nasal,I-TR
cannula,I-TR
.,O

General,B-TE
exam,I-TE
at,O
the,O
time,O
was,O
notable,O
for,O
pale,B-PR
mucous,I-PR
membranes,I-PR
",",O
left,B-PR
lateral,I-PR
eye,I-PR
deviation,I-PR
",",O
clear,O
lungs,O
",",O
2/6,B-PR
holosystolic,I-PR
murmur,I-PR
",",O
best,O
heard,O
at,O
the,O
apex,O
",",O
abdomen,O
was,O
mildly,B-PR
distended,I-PR
but,O
was,O
soft,O
and,O
nontender,B-PR
and,O
his,O
extremities,O
were,O
without,O
edema,B-PR
and,O
skin,O
without,O
any,B-PR
rashes,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Is,O
as,O
follows,O
:,O

History,O
of,O
coronary,B-PR
artery,I-PR
disease,I-PR
with,O
status,O
post,O
two-vessel,B-TR
CABG,I-TR
in,O
1986,O
",",O
also,O
he,O
was,O
treated,O
for,O
congestive,B-PR
heart,I-PR
failure,I-PR
",",O
hypertension,B-PR
",",O
aortic,B-TR
valve,I-TR
replacement,I-TR
",",O
and,O
mitral,B-TR
valve,I-TR
replacement,I-TR
with,O
St.,B-TR
Jude,I-TR
&apos;s,I-TR
valve,I-TR
in,O
09/2001,O
",",O
atrial,B-PR
fibrillation,I-PR
",",O
history,O
of,O
prior,B-PR
GI,I-PR
bleed,I-PR
requiring,O
blood,B-TR
transfusions,I-TR
during,O
which,O
he,O
also,O
had,O
a,B-TE
colonoscopy,I-TE
on,O
05/2003,O
which,O
demonstrated,O
no,O
neoplasia,B-PR
and,O
scattered,B-PR
diverticuli,I-PR
.,O

The,O
patient,O
also,O
",",O
following,O
his,B-PR
first,I-PR
GI,I-PR
bleed,I-PR
",",O
had,O
an,B-TE
EEG,I-TE
done,O
in,O
07/2003,O
which,O
showed,O
gastritis,B-PR
with,O
oozing,B-PR
and,O
evidence,O
of,O
a,B-PR
recent,I-PR
bleed,I-PR
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

MEDICATIONS,O
:,O

Included,O
Lasix,B-TR
",",O
Lopressor,B-TR
",",O
Coumadin,B-TR
",",O
Diovan,B-TR
",",O
torsemide,B-TR
",",O
Flomax,B-TR
",",O
Protonix,B-TR
",",O
Senekot,B-TR
",",O
potassium,B-TR
",",O
vitamin,B-TR
C,I-TR
",",O
iron,B-TR
",",O
and,O
a,B-TR
multivitamin,I-TR
.,O

SOCIAL,O
HISTORY,O
:,O

Notable,O
for,O
no,O
tobacco,O
",",O
no,O
alcohol,O
.,O

He,O
has,O
a,O
wife,O
with,O
Alzheimer,B-PR
&apos;s,I-PR
who,O
lives,O
in,O
a,O
skilled-nursing,O
facility,O
.,O

LABORATORY,O
DATA,O
:,O

Notable,O
for,O
a,B-TE
BUN,I-TE
and,O
creatinine,B-TE
of,O
78,O
",",O
1.7,O
;,O
for,O
a,B-TE
sodium,I-TE
",",O
potassium,B-TE
139,O
and,O
3.6,O
;,O
chloride,B-TE
and,O
bicarb,B-TE
108,O
",",O
21,O
.,O

White,B-TE
count,I-TE
7,O
",",O
hematocrit,B-TE
24.2,O
",",O
platelet,B-TE
count,I-TE
was,O
183,O
.,O

His,B-TE
INR,I-TE
was,O
also,O
3.4,O
.,O

PTT,B-TE
was,O
55,O
.,O

His,B-TE
EKG,I-TE
was,O
notable,O
for,O
right,B-PR
bundle,I-PR
branch,I-PR
block,I-PR
",",O
left,B-PR
axis,I-PR
deviation,I-PR
",",O
but,O
was,O
in,O
sinus,O
rhythm,O
.,O

His,B-TE
UA,I-TE
had,O
10-17,B-PR
white,I-PR
blood,I-PR
cells,I-PR
;,O
trace,B-PR
leukocyte,I-PR
esterase,I-PR
hyaline,B-PR
casts,I-PR
numbering,O
60-70,O
.,O

His,B-TE
chest,I-TE
x-ray,I-TE
was,O
notable,O
for,O
clear,O
lungs,O
with,O
no,O
edema,B-PR
or,O
infiltrates,B-PR
and,O
small,B-PR
bilateral,I-PR
effusions,I-PR
.,O

OTHER,O
NOTALBE,O
LABS,O
:,O

Patient,O
was,O
found,O
to,O
have,O
a,B-TE
troponin,I-TE
of,O
0.71,O
on,O
admission,O
with,O
a,B-TE
CK,I-TE
of,O
46,O
and,O
CKMB,B-TE
of,O
3.4,O
.,O

ASSESSMENT,O
:,O

At,O
that,O
time,O
",",O
it,O
was,O
felt,O
that,O
the,O
patient,O
was,O
likely,O
having,O
a,B-PR
repeat,I-PR
GI,I-PR
bleed,I-PR
and,O
while,O
he,O
was,O
hemodynamically,O
stable,O
",",O
he,O
had,O
evidently,O
lost,O
a,O
substantial,O
amount,O
of,O
blood,O
.,O

HOSPITAL,O
COURSE,O
:,O

1.,O
GI,O
:,O

Patient,O
was,O
transfused,O
2,B-TR
units,I-TR
of,I-TR
packed,I-TR
red,I-TR
blood,I-TR
cells,I-TR
overnight,O
",",O
the,O
first,O
night,O
after,O
admission,O
and,O
his,B-TE
hematocrit,I-TE
bumped,O
up,O
appropriately,O
.,O

He,O
remained,O
hemodynamically,O
stable,O
throughout,O
his,O
admission,O
.,O

He,O
was,O
continued,O
on,O
a,B-TR
proton,I-TR
pump,I-TR
inhibitor,I-TR
and,O
on,O
iron,B-TR
sulfate,I-TR
and,O
vitamin,B-TR
C,I-TR
.,O

His,B-TR
Coumadin,I-TR
was,O
held,O
at,O
the,O
time,O
given,O
the,B-PR
bleeding,I-PR
",",O
even,O
though,O
it,O
was,O
important,O
to,O
keep,O
his,B-TE
INR,I-TE
2.5-3.5,O
",",O
given,O
his,B-TR
artificial,I-TR
valve,I-TR
it,O
was,O
felt,O
that,O
the,O
risk,O
of,O
continued,B-PR
bleeding,I-PR
was,O
to,O
great,O
to,O
continue,O
the,B-TR
Coumadin,I-TR
.,O

He,O
was,O
subsequently,O
seen,O
by,O
the,O
GI,O
team,O
who,O
performed,O
an,B-TE
upper,I-TE
endoscopy,I-TE
which,O
demonstrated,O
the,O
following,O
:,O

In,O
the,O
esophagus,O
",",O
there,O
was,O
a,B-PR
small,I-PR
hiatal,I-PR
hernia,I-PR
and,O
in,O
the,O
stomach,O
there,O
is,O
evidence,O
of,O
erosive,B-PR
gastritis,I-PR
of,I-PR
the,I-PR
body,I-PR
of,O
the,O
stomach,O
and,O
the,O
antrum,O
",",O
the,O
mucous,O
appeared,O
edematous,B-PR
.,O

A,B-PR
small,I-PR
polyp,I-PR
was,O
found,O
in,O
the,O
fundus,O
which,O
stigmata,B-PR
of,O
old,B-PR
bleeding,I-PR
;,O
an,B-TR
Endoclip,I-TR
was,O
applied,O
to,O
this,O
.,O

Another,B-PR
polyp,I-PR
was,O
found,O
in,O
the,O
antrum,O
and,O
cold,B-TE
biopsies,I-TE
were,O
obtained,O
there,O
.,O

In,O
the,O
duodenum,O
",",O
a,B-PR
small,I-PR
AVM,I-PR
was,O
noted,O
in,O
the,O
second,O
portion,O
of,O
the,O
duodenum,O
and,O
was,O
cauterized,O
.,O

The,B-TE
biopsy,I-TE
subsequently,O
demonstrated,O
a,B-PR
hyperplastic,I-PR
polyp,I-PR
with,O
acute,B-PR
and,I-PR
chronic,I-PR
inflammation,I-PR
and,O
erosion,B-PR
and,O
reactive,B-PR
epithelial,I-PR
changes,I-PR
but,O
no,O
dysplasia,B-PR
.,O

Also,O
of,O
note,O
",",O
prior,O
to,O
the,B-TE
upper,I-TE
endoscopy,I-TE
",",O
the,O
patient,O
received,O
fresh,B-TR
frozen,I-TR
plasma,I-TR
to,O
reverse,O
his,B-TR
anticoagulation,I-TR
.,O

Patient,O
remained,O
hemodynamically,O
stable,O
during,O
and,O
after,O
the,B-TE
upper,I-TE
endoscopy,I-TE
and,O
his,B-TE
hematocrit,I-TE
remained,O
above,O
30,O
following,O
this,O
until,O
the,O
point,O
of,O
discharge,O
.,O

His,B-TE
last,I-TE
recorded,I-TE
hematocrit,I-TE
on,O
discharge,O
was,O
31.3,O
.,O

His,B-TE
last,I-TE
BUN,I-TE
and,O
creatinine,B-TE
were,O
42,O
and,O
1.5,O
with,O
an,B-TE
INR,I-TE
of,O
2.5,O
.,O

Consideration,O
was,O
given,O
to,O
performing,O
a,B-TE
repeat,I-TE
colonoscopy,I-TE
.,O

This,O
was,O
discussed,O
with,O
the,O
GI,O
Service,O
who,O
felt,O
that,O
this,O
was,O
not,O
necessary,O
given,O
the,B-TE
recent,I-TE
colonoscopy,I-TE
that,O
he,O
had,O
had,O
in,O
05/2003,O
.,O

2.,O
Cardiovascular,O
:,O

A,O
:,O

Ischemia,B-PR
:,O

Patient,B-PR
&apos;s,I-PR
troponin,I-PR
bump,I-PR
was,O
found,O
to,O
be,O
likely,O
to,O
demand,B-PR
ischemia,I-PR
in,O
the,O
setting,O
of,O
his,B-PR
GI,I-PR
bleed,I-PR
",",O
it,O
was,O
not,O
felt,O
that,O
he,O
was,O
having,O
acute,B-PR
coronary,I-PR
syndrome,I-PR
.,O

On,O
discharge,O
",",O
he,O
was,O
continued,O
on,O
his,B-TR
aspirin,I-TR
",",O
simvastatin,B-TR
and,O
his,B-TR
Lopressor,I-TR
which,O
was,O
initially,O
held,O
",",O
and,O
subsequently,O
restarted,O
.,O

B,O
:,O

Rhythm,O
:,O

Patient,O
continued,O
to,O
be,O
in,O
A-fib.,B-PR
throughout,O
the,O
admission,O
and,O
was,O
restarted,O
on,O
his,B-TR
Coumadin,I-TR
concurrently,O
with,O
heparin,B-TR
.,O

Heparin,B-TR
was,O
subsequently,O
DCd,O
once,O
his,B-TE
INR,I-TE
reached,O
a,O
therapeutic,O
level,O
between,O
2.5-3.5,O
.,O

His,B-TE
last,I-TE
reported,I-TE
INR,I-TE
on,O
discharge,O
was,O
2.5,O
.,O

C,O
:,O

Valves,O
:,O

Patient,O
had,O
",",O
as,O
noted,O
above,O
",",O
his,B-TR
anticoagulation,I-TR
was,O
initially,O
reversed,O
despite,O
his,O
having,O
artificial,B-TR
valves,I-TR
.,O

However,O
",",O
his,B-TR
Coumadin,I-TR
was,O
subsequently,O
restarted,O
and,O
he,O
achieved,O
therapeutic,O
INR,B-TE
levels,I-TE
before,O
discharge,O
.,O

D,O
:,O

Pump,O
:,O

Patient,O
",",O
during,O
this,O
hospital,O
course,O
",",O
became,O
hypervolemic,B-PR
likely,O
due,O
to,O
his,B-TR
diuretics,I-TR
being,O
held,O
and,O
due,O
to,O
his,O
receiving,O
blood,B-TR
products,I-TR
.,O

He,O
was,O
diuresed,O
initially,O
with,O
one,O
dose,O
of,O
Lasix,B-TR
and,O
subsequently,O
with,O
one,O
dose,O
of,O
torsemide,B-TR
after,O
it,O
was,O
discovered,O
that,O
he,O
developed,O
thrombocytopenia,B-PR
on,O
a,O
prior,O
admission,O
in,O
reaction,O
to,O
Lasix,B-TR
.,O

He,O
subsequently,O
was,O
diuresed,O
to,O
a,O
euvolemic,O
state,O
.,O

Of,O
note,O
",",O
he,O
did,O
not,O
become,O
thrombocytopenic,B-PR
on,O
this,O
admission,O
.,O

DISPOSITION,O
:,O

Was,O
discharged,O
on,O
11/16/2003,O
in,O
stable,O
condition,O
with,O
the,B-TE
last,I-TE
recorded,I-TE
hematocrit,I-TE
of,O
31.3,O
.,O

He,O
was,O
asked,O
to,O
continue,O
on,O
his,B-TR
Nexium,I-TR
",",O
iron,B-TR
and,O
vitamin,B-TR
C,I-TR
and,O
was,O
continued,O
on,O
his,B-TR
other,I-TR
home,I-TR
medications,I-TR
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

His,B-TR
final,I-TR
medications,I-TR
on,O
discharge,O
were,O
as,O
follows,O
:,O

Aspirin,B-TR
325,O
",",O
he,O
was,O
restarted,O
on,O
a,B-TR
PPI,I-TR
",",O
also,O
on,O
iron,B-TR
",",O
vitamin,B-TR
C,I-TR
",",O
Lopressor,B-TR
12.5,O
b.i.d,O
.,O

Of,O
note,O
",",O
this,O
was,O
at,O
a,O
decreased,O
dose,O
compared,O
to,O
that,O
which,O
he,O
came,O
in,O
on,O
",",O
Coumadin,B-TR
7.5,O
",",O
mg,O
",",O
torsemide,B-TR
100,O
q.d.,O
",",O
sucralfate,B-TR
",",O
simvastatin,B-TR
",",O
Diovan,B-TR
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

He,O
was,O
discharged,O
in,O
stable,O
condition,O
with,O
instructions,O
to,O
follow,O
up,O
with,O
his,O
PCP,O
as,O
well,O
as,O
to,O
follow,O
up,O
with,O
the,O
Anticoagulation,O
Clinic,O
and,O
Dr.,O
Gilbert,O
.,O

eScription,O
document,O
:,O

4-9918752,O
IEEHttd,O
Tel,O

Dictated,O
By,O
:,O

NETPEAKE,O
",",O
SHIRLH,O

Attending,O
:,O

JERGJESC,O
",",O
GROSRIANNE,O
SISANDLEE,O
Dictation,O
ID,O
4535172,O

D,O
:,O

12/22/03,O

T,O
:,O

12/22/03,O

Admission,O
Date,O
:,O

2013-04-25,O

Discharge,O
Date,O
:,O

2013-05-11,O

Date,O
of,O
Birth,O
:,O

1963-05-10,O

Sex,O
:,O

M,O

Service,O
:,O

CMED,O
CSRU,O

CHIEF,O
COMPLAINT,O
:,O

Cardiac,B-PR
arrest,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
49,O
year,O
old,O
man,O
who,O
was,O
admitted,O
to,O
the,O
Medical,O
Intensive,O
Care,O
Unit,O
status,O
post,O
cardiac,B-PR
arrest,I-PR
.,O

History,O
was,O
obtained,O
per,O
the,O
Emergency,O
Department,O
report,O
as,O
well,O
as,O
from,O
the,O
patient,O
's,O
family,O
.,O

Information,O
was,O
very,O
limited,O
regarding,O
the,O
circumstances,O
of,O
his,B-PR
cardiac,I-PR
arrest,I-PR
.,O

Reportedly,O
",",O
the,O
patient,O
was,O
at,O
a,O
local,O
restaurant,O
where,O
he,O
was,O
noted,O
to,O
be,O
unresponsive,B-PR
.,O

EMS,O
was,O
called,O
and,O
reported,O
to,O
arrive,O
on,O
scene,O
within,O
three,O
minutes,O
.,O

The,O
patient,O
was,O
asystolic,B-PR
but,O
regained,O
a,O
perfusing,O
rhythm,O
after,O
2,O
mg,O
of,O
Epinephrine,B-TR
and,O
2,O
mg,O
of,O
Atropine,B-TR
.,O

He,O
was,O
intubated,O
in,O
the,O
field,O
and,O
brought,O
to,O
the,O
Emergency,O
Department,O
.,O

He,O
remained,O
unresponsive,B-PR
despite,O
the,O
administration,O
of,O
Narcan,B-TR
.,O

CT,B-TE
examinations,I-TE
of,I-TE
the,I-TE
head,I-TE
",",I-TE
chest,I-TE
",",I-TE
abdomen,I-TE
and,I-TE
pelvis,I-TE
were,O
all,O
unremarkable,O
.,O

Initial,B-TE
chest,I-TE
x-ray,I-TE
showed,O
a,B-PR
left,I-PR
retrocardiac,I-PR
opacity,I-PR
and,O
prominent,B-PR
interstitium,I-PR
though,O
his,O
lung,O
volumes,O
were,O
low,B-PR
.,O

Subsequent,B-TE
chest,I-TE
x-ray,I-TE
showed,O
right,B-TR
main,I-TR
stem,I-TR
intubation,I-TR
with,O
left,B-PR
lung,I-PR
collapse,I-PR
which,O
had,O
corrected,O
with,O
withdrawal,B-TR
of,I-TR
the,I-TR
endotracheal,I-TR
tube,I-TR
.,O

The,O
patient,O
was,O
then,O
transferred,O
to,O
the,O
Medical,O
Intensive,O
Care,O
Unit,O
for,O
induced,B-TR
hypothermia,I-TR
given,O
his,O
hemodynamic,O
stability,O
",",O
ongoing,B-PR
unresponsiveness,I-PR
and,O
recent,B-PR
out,I-PR
of,I-PR
hospital,I-PR
cardiac,I-PR
arrest,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1),O
Hypertension,B-PR
.,O

2),O
Chronic,B-PR
low,I-PR
back,I-PR
pain,I-PR
",",O
s/p,O
lumbar,B-TR
discectomy,I-TR
x,O
2,O
.,O

3),O
Cirrhosis,B-PR
.,O

4),O
h/o,O
stab,B-PR
wound,I-PR
complicated,O
by,O
pneumothorax,B-PR
.,O

5),O
h/o,O
lower,B-PR
extremity,I-PR
cellulitis,I-PR
.,O

6),O
s/p,O
cholecystectomy,B-TR
.,O

7),O
Peripheral,B-PR
neuropathy,I-PR
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

According,O
to,O
his,O
pharmacy,O
",",O
he,O
was,O
on,O
:,O

1.,O
OxyContin,B-TR
40,O
mg,O
p.o.,O
q,O
12hours,O
.,O

2.,O
Percocet,B-TR
.,O

3.,O
Nortriptyline,B-TR
.,O

4.,O
Neurontin,B-TR
1800,O
mg,O
four,O
times,O
a,O
day,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
is,O
divorced,O
.,O

His,O
son,O
is,O
a,O
policeman,O
working,O
in,O
Ludlow,O
.,O

He,O
drinks,O
greater,O
than,O
one,O
case,O
of,O
beer,O
per,O
day,O
.,O

He,O
has,O
a,O
history,O
of,O
abuse,O
of,O
Percocet,B-TR
according,O
to,O
his,O
brother,O
.,O

James,O
is,O
currently,O
homeless,O
.,O

He,O
was,O
recently,O
arrested,O
for,O
altering,O
a,O
prescription,O
according,O
to,O
his,O
pharmacy,O
.,O

He,O
had,O
recently,O
filled,O
a,O
prescription,O
for,O
560,O
tablets,O
of,O
Percocet,B-TR
as,O
well,O
as,O
60,O
tablets,O
of,O
OxyContin,B-TR
early,O
last,O
month,O
.,O

FAMILY,O
HISTORY,O
:,O

Negative,O
for,O
any,O
history,O
of,O
sudden,B-PR
death,I-PR
or,O
coronary,B-PR
artery,I-PR
disease,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,O
",",O
temperature,B-TE
was,O
96.2,O
",",O
blood,B-TE
pressure,I-TE
150/80,O
",",O
heart,B-TE
rate,I-TE
92,O
",",O
respiratory,B-TE
rate,I-TE
16,O
.,O

In,O
general,O
",",O
he,O
was,O
unarousible,B-PR
",",O
intubated,B-TR
",",O
not,O
on,O
any,B-TR
sedation,I-TR
.,O

Head,O
",",O
eyes,O
",",O
ears,O
",",O
nose,O
and,O
throat,O
-,O
His,O
pupils,O
were,O
equal,O
and,O
three,O
millimeters,O
.,O

They,O
were,O
minimally,B-PR
reactive,I-PR
.,O

His,O
sclerae,O
were,O
anicteric,B-PR
.,O

The,B-TE
cardiac,I-TE
examination,I-TE
was,O
unremarkable,O
without,O
murmurs,B-PR
.,O

The,O
lungs,O
were,O
clear,O
to,O
auscultation,B-TE
bilaterally,I-TE
.,O

His,O
abdomen,O
had,O
normal,O
bowel,O
sounds,O
",",O
soft,O
and,O
nontender,B-PR
.,O

Extremities,O
had,O
multiple,B-PR
bilateral,I-PR
lower,I-PR
extremity,I-PR
excoriations,I-PR
.,O

Neurologic,B-TE
examination,I-TE
-,O
he,O
was,O
unarousible,B-PR
and,O
without,O
sedation,B-TR
.,O

He,O
had,O
no,B-PR
spontaneous,I-PR
movements,I-PR
.,O

Flaccid,B-PR
.,O

Extremities,O
-,O
Babinski,B-TE
reflex,I-TE
was,O
equivocal,O
bilaterally,O
.,O

LABORATORY,O
DATA,O
:,O

At,O
the,O
time,O
of,O
admission,O
",",O
laboratories,B-TE
were,O
remarkable,O
for,O
a,B-TE
partial,I-TE
thromboplastin,I-TE
time,I-TE
of,O
31.7,O
",",O
INR,B-TE
1.4,O
",",O
potassium,B-TE
3.2,O
",",O
glucose,B-TE
182,O
",",O
lactate,B-TE
was,O
initially,O
6.6,O
.,O

Urine,B-TE
toxicology,I-TE
screen,I-TE
was,O
negative,O
.,O

Serum,B-TE
toxicology,I-TE
screen,I-TE
was,O
positive,O
for,O
TCA,B-TR
s.,I-TR

Tylenol,B-TE
level,I-TE
was,O
15,O
.,O

Alcohol,B-TE
level,I-TE
was,O
199,O
.,O

Initial,B-TE
blood,I-TE
gas,I-TE
was,O
7.31/46/500/77,O
.,O

HOSPITAL,O
COURSE,O
:,O

Cardiac,B-PR
arrest,I-PR
-,O
His,B-PR
arrest,I-PR
was,O
of,O
unknown,O
etiology,O
at,O
the,O
time,O
of,O
admission,O
.,O

No,O
further,O
history,O
was,O
ever,O
gained,O
about,O
his,B-PR
cardiac,I-PR
arrest,I-PR
throughout,O
his,O
hospitalization,O
.,O

CT,B-TE
angiogram,I-TE
had,O
been,O
negative,O
for,O
pulmonary,B-PR
embolism,I-PR
.,O

The,O
patient,O
had,O
an,B-TE
echocardiogram,I-TE
on,O
2013-04-26,O
",",O
which,O
showed,O
a,O
normal,O
ejection,O
fraction,O
and,O
trivial,B-PR
mitral,I-PR
regurgitation,I-PR
;,O
otherwise,O
no,O
obvious,B-PR
abnormalities,I-PR
were,O
seen,O
.,O

Given,O
the,O
patient,O
had,O
an,B-PR
out,I-PR
of,I-PR
hospital,I-PR
arrest,I-PR
",",O
remained,O
unresponsive,B-PR
despite,O
hemodynamic,O
stability,O
",",O
he,O
was,O
treated,O
with,O
induced,B-TR
hypothermia,I-TR
and,O
with,O
cold,B-TR
packs,I-TR
and,O
a,B-TR
cooling,I-TR
blanket,I-TR
were,O
placed,O
with,O
goals,O
of,O
reducing,O
his,B-TE
core,I-TE
body,I-TE
temperature,I-TE
to,O
32,O
degrees,O
Celsius,O
for,O
a,O
period,O
of,O
twelve,O
hours,O
at,O
which,O
point,O
he,O
would,O
be,O
rewarmed,O
over,O
the,O
subsequent,O
six,O
hours,O
.,O

This,O
was,O
done,O
",",O
however,O
",",O
as,O
in,O
problem,O
number,O
two,O
below,O
",",O
we,O
were,O
not,O
successful,O
in,O
any,O
neurologic,O
recovery,O
.,O

Neurology,O
-,O
The,O
patient,O
remained,O
unresponsive,B-PR
after,O
the,B-TR
induced,I-TR
hypothermia,I-TR
",",O
the,O
patient,O
was,O
noticed,O
to,O
develop,O
myoclonic,B-PR
jerks,I-PR
and,O
occasional,O
fluttering,O
of,O
his,O
eyelids,O
.,O

Electroencephalogram,B-TE
revealed,O
the,O
patient,O
was,O
experiencing,O
persistent,B-PR
seizure,I-PR
activity,I-PR
.,O

Neurology,O
was,O
consulted,O
and,O
the,O
patient,O
was,O
treated,O
very,O
aggressively,O
",",O
loaded,O
with,O
multiple,B-TR
drugs,I-TR
",",O
including,O
Ativan,B-TR
and,O
Propofol,B-TR
drips,I-TR
.,O

The,O
patient,O
continued,O
to,O
demonstrate,O
seizure,B-PR
activity,I-PR
despite,O
this,O
.,O

He,O
was,O
loaded,O
with,O
Dilantin,B-TR
and,O
ultimately,O
was,O
treated,O
with,O
a,B-TR
Pentobarb,I-TR
coma,I-TR
.,O

After,O
multiple,O
attempts,O
of,O
weaning,O
the,B-TR
Pentobarb,I-TR
",",O
the,O
patient,O
was,O
continually,O
reverting,O
to,O
status,B-PR
epilepticus,I-PR
which,O
was,O
never,O
able,O
to,O
be,O
suppressed,O
.,O

Infectious,O
disease,O
-,O
Over,O
the,O
course,O
of,O
his,O
hospital,O
stay,O
",",O
the,B-TE
patient,I-TE
's,I-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
rose,O
to,O
a,O
peak,O
of,O
17,O
.,O

Multiple,B-TE
cultures,I-TE
were,O
done,O
and,O
the,O
patient,O
was,O
ultimately,O
found,O
to,O
have,O
methicillin,B-PR
resistant,I-PR
Staphylococcus,I-PR
aureus,I-PR
bacteremia,I-PR
",",O
pneumonia,B-PR
",",O
and,O
urinary,B-PR
tract,I-PR
infection,I-PR
.,O

For,O
all,O
these,B-PR
infections,I-PR
",",O
the,O
patient,O
was,O
treated,O
with,O
Vancomycin,B-TR
and,O
he,O
was,O
also,O
on,O
Levofloxacin,B-TR
and,O
Flagyl,B-TR
for,O
presumed,O
aspiration,B-PR
pneumonia,I-PR
at,O
the,O
time,O
of,O
his,O
admission,O
.,O

Blood,B-TE
cultures,I-TE
cleared,O
by,O
2013-05-03,O
.,O

Sputum,B-TE
culture,I-TE
as,O
late,O
as,O
2013-05-10,O
",",O
however,O
was,O
still,O
positive,O
for,O
coagulase,B-PR
positive,I-PR
Staphylococcus,I-PR
which,O
was,O
methicillin,B-PR
resistant,I-PR
Staphylococcus,I-PR
aureus,I-PR
.,O

The,O
patient,O
remained,O
gravely,B-PR
ill,I-PR
throughout,O
his,O
hospital,O
stay,O
and,O
had,O
multiple,O
meetings,O
were,O
held,O
with,O
his,O
family,O
with,O
his,O
son,O
being,O
his,O
next,O
of,O
kin,O
.,O

Ultimately,O
it,O
was,O
decided,O
that,O
the,O
patient,O
's,O
wishes,O
would,O
be,O
to,O
not,O
be,O
maintained,O
in,O
a,O
vegetative,O
state,O
and,O
given,O
his,O
poor,O
prognosis,O
ultimately,O
the,O
decision,O
was,O
made,O
to,O
pursue,O
comfort,B-TR
measures,I-TR
only,O
.,O

With,O
these,O
goals,O
of,O
care,O
",",O
the,O
patient,O
expired,O
on,O
2013-05-11,O
.,O

The,O
family,O
did,O
consent,O
to,O
a,B-TE
postmortem,I-TE
examination,I-TE
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

Cardiac,B-PR
arrest,I-PR
.,O

Anoxic,B-PR
brain,I-PR
injury,I-PR

Status,B-PR
epilepticus,I-PR

Methicillin,B-PR
resistant,I-PR
Staphylococcus,I-PR
aureus,I-PR
pneumonia,I-PR
.,O

MRSA,B-PR
urinary,I-PR
tract,I-PR
infection,I-PR
.,O

MRSA,B-PR
Bacteremia,I-PR
.,O

Steven,O
Welch,O
",",O
Montana,O
61528,O

Dictated,O
By,O
:,O
Julie,O
DD,O
George,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2013-12-24,O
13:55:05,O

T,O
:,O
2013-12-24,O
20:47:07,O

Job,O
#:,O
52892,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Patricia,O
Henley,O
on,O
:,O
Maxine,O
2014-01-02,O
10:45,O
AM,O

(,O
End,O
of,O
Report,O
),O

768768524,O

PRGH,O

91287406,O

57469,O

6/19/1998,O
12:00:00,O
AM,O

RESPIRATORY,B-PR
DISTRESS,I-PR

Signed,O

DIS,O

Admission,O
Date,O
:,O

06/19/1998,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

08/01/1998,O

PRINCIPAL,O
DIAGNOSES,O
:,O

1,O
),O
THROMBOTIC,B-PR
THROMBOCYTOPENIC,I-PR
PURPURA,I-PR
.,O

2,O
),O
BRONCHIOLITIS,B-PR
OBLITERANS,I-PR
ORGANIZING,I-PR
PNEUMONIA,I-PR
.,O

3,O
),O
RENAL,B-PR
FAILURE,I-PR
REQUIRING,O
CHRONIC,B-TR
DIALYSIS,I-TR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
63,O
year-old,O
woman,O
transferred,O
from,O
Pre,O
Health,O
on,O
June,O
19,O
",",O
1998,O
to,O
the,O
Verg,O
Medical,O
Center,O
Intensive,O
Care,O
Unit,O
for,O
evaluation,B-TE
of,O
thrombotic,B-PR
thrombocytopenic,I-PR
purpura,I-PR
and,O
bronchiolitis,B-PR
obliterans,I-PR
organizing,I-PR
pneumonia,I-PR
.,O

On,O
May,O
12,O
",",O
1998,O
",",O
the,O
patient,O
presented,O
to,O
Pre,O
Health,O
with,O
fever,B-PR
",",O
cough,B-PR
",",O
dyspnea,B-PR
and,O
a,B-TE
chest,I-TE
x-ray,I-TE
revealing,O
a,B-PR
patchy,I-PR
infiltrate,I-PR
in,I-PR
the,I-PR
right,I-PR
lung,I-PR
.,O

She,O
was,O
treated,O
with,O
Clindamycin,B-TR
and,O
Erythromycin,B-TR
which,O
were,O
changed,O
to,O
Trovan,B-TR
and,O
then,O
transferred,O
to,O
A,O
Hospital,O
.,O

On,O
May,O
27,O
",",O
1998,O
",",O
the,O
patient,O
desaturated,O
to,O
40%,O
with,O
a,B-TE
temperature,I-TE
of,O
100.5,O
degrees,O
.,O

Her,B-TE
oxygen,I-TE
saturations,I-TE
improved,O
to,O
only,O
92%,O
on,O
100%,B-TR
face,I-TR
mask,I-TR
and,O
she,O
was,O
admitted,O
to,O
Pre,O
Health,O
Intensive,O
Care,O
Unit,O
.,O

Chest,B-TE
x-ray,I-TE
there,O
revealed,O
bilateral,B-PR
pulmonary,I-PR
infiltrates,I-PR
with,O
increasing,B-PR
pleural,I-PR
effusion,I-PR
.,O

A,B-TE
VQ,I-TE
scan,I-TE
was,O
high,O
probability,O
",",O
but,O
no,O
pulmonary,B-TE
angiogram,I-TE
was,O
done,O
and,O
an,B-TE
echocardiogram,I-TE
revealed,O
a,O
normal,O
left,O
ventricle,O
with,O
no,O
wall,B-PR
motion,I-PR
abnormality,I-PR
and,O
an,B-TE
ejection,I-TE
fraction,I-TE
of,O
75%,O
.,O

On,O
May,O
24,O
",",O
1998,O
",",O
the,O
patient,O
had,O
a,B-TE
CT,I-TE
scan,I-TE
of,I-TE
the,I-TE
chest,I-TE
which,O
revealed,O
diffuse,B-PR
alveolar,I-PR
infiltrates,I-PR
at,I-PR
the,I-PR
right,I-PR
base,I-PR
",",O
mediastinal,B-PR
lymphadenopathy,I-PR
and,O
bilateral,B-PR
pleural,I-PR
effusions,I-PR
.,O

At,O
this,O
point,O
",",O
a,O
diagnosis,O
of,O
lupus,B-PR
was,O
considered,O
and,O
her,B-TE
ANA,I-TE
was,O
1:640,O
and,O
her,B-TE
rheumatoid,I-TE
factor,I-TE
and,O
ANCA,B-TE
were,O
negative,O
.,O

She,O
was,O
started,O
on,O
a,B-TR
steroid,I-TR
trial,I-TR
at,O
that,O
point,O
.,O

Her,O
pleural,O
fluid,O
was,O
tapped,O
and,O
it,O
was,O
negative,O
for,O
malignancy,B-PR
.,O

On,O
June,O
11,O
",",O
1998,O
",",O
the,O
patient,O
had,O
a,B-TE
video,I-TE
assisted,I-TE
thoracoscopic,I-TE
study,I-TE
of,I-TE
the,I-TE
right,I-TE
lung,I-TE
which,O
revealed,O
chronic,B-PR
interstitial,I-PR
pneumonitis,I-PR
with,O
a,B-PR
bronchiolitis,I-PR
obliterans,I-PR
organizing,I-PR
pneumonia-like,I-PR
reaction,I-PR
and,O
a,B-TR
chest,I-TR
tube,I-TR
was,O
placed,O
.,O

The,O
patient,O
was,O
then,O
started,O
on,O
40,O
mg,O
of,O
Prednisone,B-TR
q.,O
day,O
.,O

From,O
May,O
27,O
",",O
1998,O
through,O
June,O
19,O
",",O
1998,O
",",O
the,O
patient,O
had,O
a,O
decline,O
in,O
her,B-TE
platelets,I-TE
from,O
394,O
to,O
28,O
with,O
a,O
stable,O
hematocrit,O
of,O
32,O
to,O
33,O
and,O
a,B-PR
rise,I-PR
in,O
creatinine,B-TE
from,O
1.0,O
to,O
3.8,O
.,O

On,O
June,O
19,O
",",O
1998,O
",",O
she,O
was,O
transferred,O
to,O
the,O
Verg,O
Medical,O
Center,O
Medical,O
Intensive,O
Care,O
Unit,O
for,O
evaluation,B-TE
of,O
possible,O
thrombotic,B-PR
thrombocytopenic,I-PR
purpura,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1,O
),O
Cerebrovascular,B-PR
accident,I-PR
in,O
1995,O
in,O
the,O
pontine,O
region,O
secondary,O
to,O
hypertension,B-PR
.,O

2,O
),O
Hypertension,B-PR
.,O

3,O
),O
Status,O
post,O
hysterectomy,B-TR
.,O

4,O
),O
Status,O
post,O
appendectomy,B-TR
.,O

MEDICATIONS,O
ON,O
TRANSFER,O
:,O

1,O
),O
Albuterol,B-TR
inhaler,I-TR
4,O
puffs,O
q.i.d.,O

2,O
),O
Lasix,B-TR
p.r.n.,O

3,O
),O
Prednisone,B-TR
40,O
mg,O
p.o.,O
q.,O
day,O
.,O

4,O
),O
Inderal,B-TR
40,O
mg,O
p.o.,O
q.i.d.,O

5,O
),O
Thiamine,B-TR
.,O

6,O
),O
Lasix,B-TR
p.r.n.,O

7,O
),O
Atrovent,B-TR
inhaler,I-TR
4,O
puffs,O
q.i.d.,O

8,O
),O
Folic,B-TR
acid,I-TR
.,O

9,O
),O
Premarin,B-TR
0.625,O
mg,O
p.o.,O
q.,O
day,O
.,O

10,O
),O
Omeprazole,B-TR
20,O
mg,O
p.o.,O
q.,O
day,O
.,O

11,O
),O
Insulin,B-TR
sliding,I-TR
scale,I-TR
.,O

ALLERGIES,O
:,O

The,O
patient,O
had,O
no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
is,O
divorced,O
.,O

She,O
has,O
two,O
children,O
.,O

She,O
recently,O
retired,O
as,O
a,O
clerical,O
worker,O
.,O

She,O
denies,O
any,O
tobacco,O
.,O

She,O
has,O
only,O
social,O
alcohol,O
use,O
.,O

FAMILY,O
HISTORY,O
:,O

Father,O
died,O
at,O
age,O
56,O
of,O
coronary,B-PR
artery,I-PR
disease,I-PR
.,O

Mother,O
died,O
at,O
age,O
68,O
of,O
pancreatic,B-PR
carcinoma,I-PR
.,O

Brother,O
has,O
coronary,B-PR
artery,I-PR
disease,I-PR
.,O

There,O
is,O
no,O
family,O
history,O
of,O
hematologic,B-PR
problems,I-PR
.,O

LABORATORY,O
:,O

Laboratory,B-TE
studies,I-TE
on,O
admission,O
were,O
notable,O
for,O
a,B-TE
sodium,I-TE
of,O
131,O
",",O
potassium,B-TE
6.2,O
",",O
BUN,B-TE
111,O
",",O
creatinine,B-TE
3.9,O
",",O
white,B-TE
blood,I-TE
cell,I-TE
count,I-TE
23,O
",",O
hematocrit,B-TE
27,O
with,O
2+,B-PR
schistocytes,I-PR
and,O
2+,B-PR
spherocytes,I-PR
on,O
the,B-TE
smear,I-TE
",",O
platelet,B-TE
count,I-TE
92,O
and,O
LDH,B-TE
496,O
.,O

HOSPITAL,O
COURSE,O
:,O

1,O
),O
Bronchiolitis,B-PR
obliterans,I-PR
organizing,I-PR
pneumonia,I-PR
:,O

The,B-TE
video,I-TE
assisted,I-TE
thoracoscopic,I-TE
study,I-TE
at,O
the,O
outside,O
hospital,O
was,O
consistent,O
with,O
bronchiolitis,B-PR
obliterans,I-PR
organizing,I-PR
pneumonia,I-PR
.,O

The,O
patient,O
was,O
continued,O
on,O
steroids,B-TR
throughout,O
the,O
course,O
of,O
her,O
stay,O
.,O

This,O
was,O
changed,O
to,O
Solu-Medrol,B-TR
part,O
way,O
through,O
the,O
course,O
due,O
to,O
her,B-PR
hematologic,I-PR
problems,I-PR
",",O
see,O
below,O
.,O

By,O
discharge,O
",",O
she,O
was,O
returned,O
to,O
40,O
mg,O
of,O
Prednisone,B-TR
q.,O
day,O
times,O
one,O
month,O
to,O
be,O
followed,O
by,O
a,B-TR
slow,I-TR
taper,I-TR
.,O

The,B-PR
patient,I-PR
&apos;s,I-PR
bronchiolitis,I-PR
obliterans,I-PR
organizing,I-PR
pneumonia,I-PR
appeared,O
to,O
improve,O
slowly,O
throughout,O
her,O
hospital,O
course,O
",",O
however,O
on,O
July,O
12,O
",",O
1998,O
",",O
after,O
starting,O
dialysis,B-TR
(,O
see,O
below,O
),O
",",O
the,O
patient,O
desaturated,O
and,O
required,O
supplemental,B-TR
oxygen,I-TR
.,O

Repeat,B-TE
chest,I-TE
x-rays,I-TE
and,O
chest,B-TE
CT,I-TE
scans,I-TE
appeared,O
consistent,O
with,O
pulmonary,B-PR
edema,I-PR
from,O
volume,B-PR
overload,I-PR
given,O
her,B-PR
renal,I-PR
failure,I-PR
and,O
eventually,O
",",O
the,O
patient,O
&apos;s,O
pulmonary,O
status,O
did,O
improve,O
after,O
significant,B-TR
volume,I-TR
removal,I-TR
with,O
dialysis,B-TR
for,O
several,O
weeks,O
.,O

At,O
the,O
time,O
of,O
her,O
discharge,O
",",O
the,O
patient,O
was,O
still,O
requiring,O
two,O
liters,O
of,O
supplemental,B-TR
oxygen,I-TR
to,O
maintain,O
her,B-TE
oxygen,I-TE
saturations,I-TE
in,O
the,O
mid,O
90%,O
.,O

2,O
),O
Thrombotic,B-PR
thrombocytopenic,I-PR
purpura,I-PR
:,O

The,O
patient,O
was,O
initially,O
admitted,O
with,O
platelet,B-TE
count,I-TE
of,O
28,O
",",O
hematocrit,B-TE
of,O
32,O
",",O
LDH,B-TE
of,O
496,O
with,O
2+,B-PR
schistocytes,I-PR
and,O
2+,B-PR
spherocytes,I-PR
on,O
her,B-TE
smear,I-TE
.,O

This,O
was,O
felt,O
to,O
be,O
consistent,O
with,O
thrombotic,B-PR
thrombocytopenic,I-PR
purpura,I-PR
and,O
on,O
June,O
20,O
",",O
1998,O
",",O
she,O
was,O
started,O
on,O
daily,B-TR
plasma,I-TR
exchange,I-TR
which,O
continued,O
through,O
July,O
27,O
",",O
1999,O
.,O

She,O
was,O
also,O
changed,O
to,O
intravenous,B-TR
Solu-Medrol,I-TR
50,O
mg,O
q.,O
day,O
which,O
was,O
changed,O
back,O
to,O
40,O
mg,O
of,O
Prednisone,B-TR
prior,O
to,O
discharge,O
.,O

Her,B-TE
platelet,I-TE
count,I-TE
initially,O
rose,O
to,O
a,O
maximum,O
of,O
159,O
on,O
July,O
3,O
",",O
1998,O
",",O
then,O
they,O
steadily,O
fell,O
to,O
a,O
low,O
of,O
60,O
on,O
July,O
20,O
",",O
1999,O
.,O

Her,B-TE
LDH,I-TE
which,O
peaked,O
at,O
1255,O
decreased,O
to,O
the,O
mid,O
200s,O
",",O
but,O
remained,O
elevated,B-PR
.,O

She,O
continued,O
to,O
have,O
a,B-PR
few,I-PR
schistocytes,I-PR
on,O
her,B-TE
smear,I-TE
",",O
but,O
it,O
was,O
much,O
decreased,O
.,O

The,O
patient,O
also,O
required,O
red,B-TR
blood,I-TR
cell,I-TR
transfusions,I-TR
",",O
approximately,O
two,O
units,O
every,O
seven,O
to,O
ten,O
days,O
to,O
maintain,O
her,B-TE
hematocrit,I-TE
.,O

Eventually,O
",",O
her,B-TR
plasma,I-TR
exchange,I-TR
was,O
tapered,O
to,O
a,O
smaller,O
and,O
smaller,O
dose,O
each,O
day,O
and,O
then,O
discontinued,O
altogether,O
after,O
July,O
27,O
",",O
1999,O
.,O

After,O
this,O
",",O
the,B-TE
patient,I-TE
&apos;s,I-TE
platelet,I-TE
count,I-TE
rose,O
to,O
a,O
maximum,O
of,O
177,O
on,O
discharge,O
.,O

It,O
is,O
felt,O
that,O
the,B-PR
patient,I-PR
&apos;s,I-PR
thrombotic,I-PR
thrombocytopenic,I-PR
purpura,I-PR
has,O
resolved,O
.,O

She,O
will,O
continue,O
on,O
her,B-TR
Prednisone,I-TR
for,O
one,O
month,O
as,O
above,O
for,O
the,B-PR
bronchiolitis,I-PR
obliterans,I-PR
organizing,I-PR
pneumonia,I-PR
with,O
a,B-TR
very,I-TR
slow,I-TR
taper,I-TR
.,O

3,O
),O
Renal,O
:,O

The,O
patient,O
presented,O
in,O
acute,B-PR
renal,I-PR
failure,I-PR
with,O
a,B-TE
BUN,I-TE
of,O
101,O
and,O
a,B-TE
creatinine,I-TE
of,O
3.7,O
.,O

Throughout,O
the,O
month,O
of,O
June,O
",",O
she,O
had,O
a,B-PR
rising,I-PR
Potassium,I-PR
phosphate,I-PR
and,O
increasing,B-PR
volume,I-PR
overload,I-PR
with,O
decreasing,O
response,O
to,O
diuretics,B-TR
and,O
she,O
was,O
finally,O
initiated,O
on,O
dialysis,B-TR
with,O
ultrafiltration,B-TR
on,O
July,O
12,O
",",O
1998,O
.,O

The,O
opinion,O
of,O
the,O
Renal,O
consult,O
was,O
that,O
this,O
was,O
permanent,B-PR
and,I-PR
non-reversible,I-PR
renal,I-PR
failure,I-PR
since,O
it,O
did,O
not,O
improve,O
with,O
dialysis,B-TR
and,O
the,O
patient,O
will,O
continue,O
on,O
dialysis,B-TR
three,O
times,O
per,O
week,O
.,O

She,O
required,O
approximately,O
five,O
liters,O
of,O
ultrafiltration,B-TR
fluid,I-TR
removal,I-TR
at,O
each,O
dialysis,O
session,O
due,O
to,O
her,B-PR
significant,I-PR
volume,I-PR
overload,I-PR
.,O

During,O
the,O
course,O
of,O
her,B-TR
dialysis,I-TR
",",O
she,O
had,O
a,O
great,O
improvement,O
in,O
her,B-PR
lower,I-PR
extremity,I-PR
edema,I-PR
and,O
her,B-TE
oxygen,I-TE
saturation,I-TE
.,O

4,O
),O
Infectious,O
disease,O
:,O

The,O
patient,O
had,O
multiple,B-PR
line,I-PR
infections,I-PR
during,O
her,O
admission,O
including,O
a,B-PR
confirmed,I-PR
coag.,I-PR
negative,I-PR
Staphylococcus,I-PR
line,I-PR
infection,I-PR
with,O
positive,B-PR
blood,I-PR
cultures,I-PR
on,O
June,O
23,O
",",O
1998,O
",",O
July,O
4,O
",",O
1998,O
",",O
July,O
8,O
",",O
1998,O
and,O
July,O
9,O
",",O
1998,O
.,O

The,O
patient,O
eventually,O
had,O
a,B-TR
left,I-TR
subclavian,I-TR
Tesio,I-TR
catheter,I-TR
placed,O
and,O
a,B-TR
right,I-TR
brachial,I-TR
PICC,I-TR
line,I-TR
placed,O
on,O
July,O
10,O
",",O
1998,O
which,O
remained,O
patent,O
and,O
uninfected,B-PR
.,O

She,O
received,O
a,B-TR
full,I-TR
three,I-TR
week,I-TR
course,I-TR
of,I-TR
Vancomycin,I-TR
and,O
also,O
received,O
a,B-TR
three,I-TR
week,I-TR
course,I-TR
of,I-TR
Ceftazidime,I-TR
.,O

In,O
addition,O
",",O
she,O
had,O
a,B-PR
fungal,I-PR
urinary,I-PR
tract,I-PR
infection,I-PR
treated,O
with,O
Amphojel,B-TR
bladder,I-TR
irrigation,I-TR
",",O
which,O
was,O
followed,O
by,O
a,B-PR
Klebsiella,I-PR
urinary,I-PR
tract,I-PR
infection,I-PR
for,O
which,O
she,O
received,O
Levofloxacin,B-TR
times,O
fourteen,O
days,O
.,O

She,O
also,O
received,O
a,B-TR
fourteen,I-TR
day,I-TR
course,I-TR
of,I-TR
Acyclovir,I-TR
which,O
was,O
begun,O
on,O
June,O
21,O
",",O
1998,O
for,O
perianal,B-PR
lesions,I-PR
consistent,O
with,O
herpes,B-PR
simplex,I-PR
virus,I-PR
.,O

She,O
was,O
also,O
on,O
Fluconazole,B-TR
for,O
some,B-PR
oral,I-PR
thrush,I-PR
which,O
was,O
inadvertently,O
continued,O
for,O
a,O
total,O
of,O
thirty,O
days,O
.,O

The,O
patient,O
was,O
also,O
started,O
on,O
Bactrim,B-TR
one,I-TR
double,I-TR
strength,I-TR
tablet,O
q.o.d.,O
as,O
prophylaxis,O
for,O
Pneumocystis,B-PR
carinii,I-PR
pneumonia,I-PR
while,O
on,O
her,B-TR
high,I-TR
dose,I-TR
steroids,I-TR
.,O

5,O
),O
Rheumatology,O
:,O

The,O
patient,O
was,O
admitted,O
with,O
a,O
question,O
of,O
lupus,B-PR
given,O
her,B-TE
ANA,I-TE
of,O
1:640,O
although,O
her,B-TE
rheumatoid,I-TE
factor,I-TE
and,O
ANCA,B-TE
were,O
negative,O
.,O

Unfortunately,O
throughout,O
her,O
admission,O
",",O
we,O
were,O
unable,O
to,O
test,O
any,B-TE
more,I-TE
titers,I-TE
since,O
she,O
was,O
receiving,O
daily,B-TR
plasma,I-TR
exchange,I-TR
.,O

A,B-TE
repeat,I-TE
ANA,I-TE
",",O
rheumatoid,B-TE
factor,I-TE
and,O
ANCA,B-TE
may,O
be,O
repeated,O
as,O
an,O
outpatient,O
.,O

FOLLOW-UP,O
:,O

1,O
),O
The,O
patient,O
will,O
follow-up,O
with,O
her,O
primary,O
care,O
physician,O
",",O
Dr.,O
Tamarg,O
Study,O
",",O
in,O
Arvus,O
after,O
she,O
is,O
discharged,O
from,O
rehabilitation,B-TR
.,O

2,O
),O
The,O
patient,O
is,O
being,O
discharged,O
to,O
A,O
Hospital,O
where,O
she,O
will,O
receive,O
onsite,B-TR
hemodialysis,I-TR
three,O
times,O
per,O
week,O
on,O
Monday,O
",",O
Wednesday,O
and,O
Friday,O
.,O

The,O
nephrologist,O
who,O
will,O
follow,O
her,O
there,O
is,O
Dr.,O
Study,O
.,O

3,O
),O
The,O
patient,O
will,O
continue,O
to,O
have,O
her,B-TE
CBC,I-TE
",",O
LDH,B-TE
",",O
bilirubin,B-TE
",",O
chem-7,B-TE
and,O
magnesium,B-TE
and,O
calcium,B-TE
checked,O
with,O
each,B-TR
dialysis,I-TR
and,O
the,O
results,O
will,O
be,O
faxed,O
to,O
Dr.,O
Ian,O
Zineisfreierm,O
",",O
the,O
hematology,O
attending,O
at,O
fax,O
number,O
751-329-8840,O
.,O

4,O
),O
The,O
patient,O
will,O
eventually,O
need,O
a,B-TR
permanent,I-TR
dialysis,I-TR
fistula,I-TR
.,O

The,B-TR
left,I-TR
subclavian,I-TR
Tesio,I-TR
which,O
she,O
has,O
in,O
place,O
will,O
last,O
for,O
several,O
months,O
in,O
the,O
mean,O
time,O
.,O

She,O
would,O
like,O
to,O
arrange,O
to,O
have,O
her,B-TR
fistula,I-TR
placed,O
at,O
Pre,O
Health,O
and,O
the,O
vascular,O
surgeons,O
there,O
should,O
be,O
contacted,O
regarding,O
this,O
.,O

5,O
),O
The,O
patient,O
will,O
need,O
packed,B-TR
red,I-TR
blood,I-TR
cell,I-TR
transfusions,I-TR
with,O
dialysis,B-TR
when,O
her,B-TE
hematocrit,I-TE
falls,O
below,O
26,O
.,O

6,O
),O
The,O
patient,O
will,O
continue,O
her,B-TR
Prednisone,I-TR
at,O
40,O
mg,O
p.o.,O
q.,O
day,O
times,O
one,O
month,O
(,O
this,O
was,O
started,O
on,O
July,O
27,O
",",O
1999,O
),O
and,O
then,O
she,O
will,O
begin,O
a,B-TR
slow,I-TR
taper,I-TR
as,O
guided,O
by,O
Pulmonary,O
.,O

7,O
),O
The,O
patient,O
has,O
a,O
follow-up,O
appointment,O
in,O
the,O
Pulmonary,O
Clinic,O
with,O
Dr.,O
Cedwi,O
Stone,O
at,O
336-2931,O
on,O
August,O
30,O
",",O
1999,O
at,O
1:40,O
PM,O
.,O

8,O
),O
The,O
patient,O
has,O
a,O
follow-up,O
appointment,O
with,O
Dr.,O
Ian,O
Zineisfreierm,O
at,O
the,O
We,O
Erthunt,O
Hospital,O
at,O
180-0455,O
on,O
August,O
15,O
",",O
1999,O
at,O
12:30,O
PM,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

1,O
),O
Calcitriol,B-TR
0.25,O
mcg,O
p.o.,O
q.,O
day,O
.,O

2,O
),O
TUMS,B-TR
1250,O
mg,O
p.o.,O
t.i.d.,O

3,O
),O
Premarin,B-TR
0.625,O
mg,O
p.o.,O
q.,O
day,O
.,O

4,O
),O
Colace,B-TR
100,O
mg,O
p.o.,O
b.i.d.,O

5,O
),O
Humulin,B-TR
sliding,I-TR
scale,I-TR
q.a.c.,O
and,O
q.h.s.,O

6,O
),O
Labetalol,B-TR
400,O
mg,O
p.o.,O
t.i.d.,O

7,O
),O
Omeprazole,B-TR
20,O
mg,O
p.o.,O
q.,O
day,O
.,O

8,O
),O
Serax,B-TR
15,O
mg,O
p.o.,O
q.h.s.,O
p.r.n.,O
insomnia,B-PR
.,O

9,O
),O
Prednisone,B-TR
40,O
mg,O
p.o.,O
q.,O
day,O
times,O
thirty,O
days,O
beginning,O
on,O
July,O
27,O
",",O
1999,O
to,O
be,O
followed,O
by,O
a,B-TR
slow,I-TR
taper,I-TR
as,O
directed,O
by,O
the,O
pulmonologist,O
.,O

10,O
),O
Metamucil,B-TR
one,O
packet,O
p.o.,O
q.,O
day,O
.,O

11,O
),O
Amlodipine,B-TR
10,O
mg,O
p.o.,O
q.,O
day,O
.,O

12,O
),O
Bactrim,B-TR
Double,I-TR
Strength,I-TR
one,O
tablet,O
p.o.,O
q.o.d.,O

13,O
),O
Nephrocaps,B-TR
one,O
tablet,O
p.o.,O
q.,O
day,O
.,O

14,O
),O
Epogen,B-TR
"1,000",O
units,O
subcutaneously,O
three,O
times,O
per,O
week,O
.,O

15,O
),O
Iron,B-TR
sulfate,I-TR
300,O
mg,O
p.o.,O
t.i.d.,O

Dictated,O
By,O
:,O

CHELA,O
FYFENEIGH,O
",",O
M.D.,O
NY5,O

Attending,O
:,O

LENNI,O
E.,O
NECESSARY,O
",",O
M.D.,O
BE1,O
IZ845/6789,O

Batch,O
:,O

7665,O

Index,O
No.,O
YQGKGG4LST,O

D,O
:,O

08/01/98,O

T,O
:,O

08/01/98,O

CC,O
:,O

CEDWI,O
STONE,O
",",O
MD,O
",",O
BMH,O
PULMONARY,O
CLINIC,O
TAMARG,O
STUDY,O
",",O
MD,O
",",O
Port,O
O,O
",",O
PHONE,O
912-434-8561,O
A,O
HOSPITAL,O
",",O
Sburgbuff,O

?Admission,O
Date,O
:,O

2016-03-18,O

Discharge,O
Date,O
:,O

2016-04-01,O

Date,O
of,O
Birth,O
:,O

1929-07-27,O

Sex,O
:,O

M,O

Service,O
:,O

SURGERY,B-TR

Allergies,O
:,O

Tetracycline,B-TR

Attending,O
:,O
Samuel,O
A.,O
Brown,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Transfer,O
from,O
Lewis,O
to,O
Hallmark,O
Health,O
System,O
CMED,O
CSRU,O

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

s/p,O
I&D,B-TR
(,O
03-17,O
),O

s/p,O
Debridement,B-TR
(,O
03-18,O
),O

History,O
of,O
Present,O
Illness,O
:,O

Mr.,O
Morton,O
is,O
a,O
86,O
yo,O
male,O
transferred,O
from,O
Kindred,O
Park,O
View,O
Specialty,O
Hospital,O
of,O
Springfield-Sample,O
.,O

He,O
developed,O
right,B-PR
foot,I-PR
pain,I-PR
the,O
Sunday,O
prior,O
to,O
admission,O
and,O
was,O
seen,O
by,O
his,O
Podiatrist,O
",",O
who,O
diagnosed,O
him,O
with,O
gout,B-PR
.,O

He,O
was,O
given,O
colchicine,B-TR
and,O
prednisone,B-TR
.,O

Mr.,O
Morton,O
then,O
developed,O
more,B-PR
pain,I-PR
and,O
warmth,B-PR
to,I-PR
his,I-PR
right,I-PR
foot,I-PR
later,O
in,O
the,O
week,O
and,O
presented,O
to,O
the,O
Youville,O
Hospital,O
-,O
Woody,O
Monica,O
.,O

At,O
this,O
hospital,O
he,O
underwent,O
an,B-TR
I&D,I-TR
(,O
03-17,O
),O
of,O
a,B-PR
right,I-PR
foot,I-PR
infection,I-PR
and,O
subsequently,O
underwent,O

re-exploration,B-TE
(,O
03-18,O
),O
for,O
developing,B-PR
necrotizing,I-PR
fascitis,I-PR
.,O

He,O
was,O
transferred,O
to,O
Hallmark,O
Health,O
System,O
for,O
further,O
care,O
.,O

Past,O
Medical,O
History,O
:,O

PMH,O
:,O
Prostate,B-PR
Ca,I-PR
",",O
Glaucoma,B-PR

PSH,O
:,O
RIH,B-TR
repair,I-TR
",",O
s/p,O
TURP,B-TR
",",O
s/p,O
thyroid,B-TR
excision,I-TR

Social,O
History,O
:,O

EtOH,O

Physical,O
Exam,O
:,O

98.9,O
",",O
93,O
",",O
137/78,O
",",O
16,O
",",O
98%,O

GEN,O
:,O
NAD,O

HEENT,O
:,O
EOMI,O
",",O
"anicteric,",B-PR
OP,O
pink,O

NECK,O
:,O
no,O
masses,B-PR
",",O
supple,O

CV,O
:,O
RRR,O
",",O
no,O
m/r,B-PR

RESP,O
:,O
clear,O

GI,O
:,O
soft/NT/ND,B-PR

EXT,O
:,O
R,O
foot,O
with,O
erythema,B-PR
/,O
swelling,B-PR
;,O
muscle,O
and,O
tendons,O
exposed,O
",",O
with,O
necrotic,B-PR
edges,I-PR
",",O
some,B-PR
fibrinous,I-PR
exudate,I-PR

NEURO,O
:,O
AxOx3,O

Pertinent,O
Results,O
:,O

MRI,B-TE
RLE,I-TE
03-21,O

"",O
1.,B-PR
7,I-PR
cm,I-PR
linear,I-PR
fluid,I-PR
collection,I-PR
running,O
between,O
the,O
anterior,O
and,O
lateral,O
muscle,O
compartments,O
",",O
extending,O
from,O
a,O
large,O
area,O
of,O
soft,B-PR
tissue,I-PR
loss,I-PR
seen,O
in,O
the,O
distal,O
lateral,O
foreleg,O
to,O
roughly,O
the,O
mid,O
tibia,O
/,O
fibula,O
",",O
18,O
cm,O
distal,O
to,O
the,O
knee,O
joint,O
line,O
.,O

The,B-PR
collection,I-PR
is,O
largest,O
at,O
its,O
most,O
proximal,O
extent,O
",",O
measuring,O
1.4,O
x,O
0.7,O
cm,O
in,O
the,O
transverse,O
dimension,O
.,O

2.,O
Non-specific,B-PR
myositis,I-PR
involving,O
multiple,O
muscle,O
groups,O
in,O
the,O
foreleg,O
",",O
most,O
severe,O
in,O
the,O
anterior,O
",",O
lateral,O
",",O
and,O
posterior,O
deep,O
compartments,O
.,O

3.,O
Tendinosis,B-PR
of,O
the,O
posterior,O
tibialis,O
and,O
peroneus,O
brevis,O
tendons,O
.,O

No,O
tendon,B-PR
tear,I-PR
.,O

"4.,O
No,O
evidence,O
of,O
abnormal,B-PR
bone,I-PR
marrow,I-PR
signal,I-PR
intensity,I-PR
or,O
intraosseous,B-PR
abscess,I-PR
.""",O

RLE,B-TE
Angio,I-TE
03-21,O

"",O
1.,O
Mild,B-PR
but,I-PR
multifocal,I-PR
atherosclerotic,I-PR
disease,I-PR
involving,O
the,O
infrarenal,O
aorta,O
and,O
iliac,O
arteries,O
",",O
with,O
no,O
significant,B-PR
pressure,I-PR
gradient,I-PR
associated,O
.,O

2.,O
Significant,B-PR
segmental,I-PR
stenosis,I-PR
(,O
approx.,O
5-6,O
cm,O
long,O
),O
in,O
the,O
mid,O
right,O
superficial,O
femoral,O
artery,O
.,O

3.,O
High,B-PR
bifurcation,I-PR
of,I-PR
the,I-PR
popliteal,I-PR
artery,I-PR
at,O
the,O
knee,O
level,O
.,O

4.,O
In,O
the,O
proximal,O
calf,O
",",O
severe,B-PR
stenosis,I-PR
or,O
occlusion,B-PR
of,I-PR
the,I-PR
two,I-PR
terminal,I-PR
branches,I-PR
arising,O
from,O
this,O
popliteal,O
bifurcation,O
(,O
likely,O
the,O
anterior,O
tibial,O
and,O
the,O
peroneal,O
arteries,O
).,O

Two,B-PR
significant,I-PR
focal,I-PR
stenoses,I-PR
of,I-PR
the,I-PR
distal,I-PR
right,I-PR
anterior,I-PR
tibial,I-PR
artery,I-PR
.,O

Right,O
posterior,O
tibial,O
artery,O
completely,B-PR
occluded,I-PR
.,O

5.,O
Patent,O
medial,O
and,O
lateral,O
plantar,O
arteries,O
",",O
filled,O
through,O
collaterals,O
arising,O
mostly,O
from,O
the,O
peroneal,O
artery,O
.,O

"Dorsalis,O
pedis,O
artery,O
not,O
seen,O
.""",O

Brief,O
Hospital,O
Course,O
:,O

Mr.,O
Morton,O
was,O
admitted,O
to,O
the,O
TSICU,O
.,O

He,O
was,O
placed,O
on,O
Penicillin,B-TR
G,I-TR
",",O
Clindamycin,B-TR
",",O
for,O
empiric,B-TR
coverage,I-TR
of,O
his,B-PR
wound,I-PR
",",O
with,O
Group,B-PR
A,I-PR
strep,I-PR
growth,I-PR
from,O
the,B-TE
New,I-TE
England,I-TE
Baptist,I-TE
Hospital-Bryce,I-TE
cultures,I-TE
.,O

He,O
was,O
transferred,O
to,O
the,O
floor,O
on,O
HD#2,O
.,O

He,O
continued,O
to,O
undergo,O
BID,B-TR
dressing,I-TR
changes,I-TR
.,O

Plastic,O
surgery,O
was,O
asked,O
to,O
evaluate,O
the,O
patient,O
.,O

Per,O
their,O
recommendations,O
",",O
silvadine,B-TR
was,O
applied,O
to,O
the,O
tendons,O
to,O
prevent,O
dessication,B-PR
.,O

Vascular,O
surgery,O
was,O
also,O
asked,O
to,O
evaluate,O
the,O
patient,O
's,O
right,O
lower,O
extremity,O
blood,O
flow,O
.,O

An,B-TE
angiogram,I-TE
on,O
HD#4,O
showed,O
severe,B-PR
tibial,I-PR
disease,I-PR
and,O
moderate,B-PR
SFA,I-PR
disease,I-PR
",",O
no,O
DP,O
artery,O
was,O
seen,O
.,O

The,O
vascular,O
team,O
recommended,O
a,B-TR
femoral-peroneal,I-TR
bypass,I-TR
for,O
revascularization,B-TR
and,O
performed,O
this,B-TR
operation,I-TR
on,O
HD#5,O
.,O

He,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
",",O
please,O
see,O
Dr.,O
Allgood,O
Operative,O
Note,O
for,O
detail,O
.,O

On,O
POD#1,O
",",O
Mr.,O
Morton,O
received,O
2,O
units,O
of,O
pRBCs,B-TR
for,O
post-op,B-PR
anemia,I-PR
(,O
Hct,B-TE
25,O
).,O

Mr.,O
Morton,O
continued,O
to,O
be,O
followed,O
by,O
Infectious,O
Disease,O
",",O
whose,O
recommendations,O
were,O
to,O
complete,O
a,O
01-28,O
week,O
course,O
of,O
Penicillin,B-TR
G,I-TR
and,O
Clindamycin,B-TR
after,O
the,O
foot,O
was,O
completely,O
debrided,O
and,O
the,B-TR
skin,I-TR
flaps,I-TR
completed,O
.,O

His,B-PR
wound,I-PR
continued,O
to,O
heal,O
well,O
and,O
by,O
POD,O
#6,O
a,B-TR
VAC,I-TR
dressing,I-TR
was,O
placed,O
.,O

He,O
received,O
a,B-TR
PICC,I-TR
on,O
POD#7,O
for,O
his,B-TR
long-term,I-TR
antibiotic,I-TR
therapy,I-TR
.,O

At,O
the,O
time,O
of,O
discharge,O
",",O
Mr.,O
Morton,O
had,O
good,O
pain,O
control,O
",",O
was,O
tolerating,O
a,O
regular,O
diet,O
",",O
had,O
a,B-PR
well-healing,I-PR
wound,I-PR
treated,O
with,O
a,B-TR
VAC,I-TR
dressing,I-TR
",",O
and,O
was,O
to,O
continue,O
his,B-TR
IV,I-TR
PCN,I-TR
G,I-TR
and,O
Clindamycin,B-TR
.,O

He,O
was,O
discharged,O
to,O
a,O
rehab,O
facility,O
in,O
fair,O
condition,O
.,O

Medications,O
on,O
Admission,O
:,O

Timolol,B-TR
.5%,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Discharge,O
Diagnosis,O
:,O

Right,B-PR
lower,I-PR
extremity,I-PR
necrosing,I-PR
fascitis,I-PR
history,O
of,O
prostate,B-PR
cancer,I-PR
s/p,O
TURP,B-TR
glaucoma,B-PR

Discharge,O
Condition,O
:,O

Fair,O

Discharge,O
Instructions,O
:,O

If,O
you,O
have,O
any,B-PR
fevers/chills,I-PR
",",O
nausea/vomiting,B-PR
",",O
chest,B-PR
pain,I-PR
",",O
foot,B-PR
pain,I-PR
",",O
please,O
seek,O
medical,O
attention,O
.,O

Followup,O
Instructions,O
:,O

Please,O
follow,O
up,O
with,O
Dr.,O
Mallard,O
in,O
one,O
week,O
",",O
call,O
421-3721,O
for,O
an,O
appointment,O
.,O

Follow,O
up,O
with,O
Dr.,O
Adner,O
in,O
2,O
weeks,O
",",O
call,O
763-9180,O
for,O
an,O
appointment,O
.,O

Mark,O
William,O
MD,O
19-081,O

Completed,O
by,O
:,O
Shane,O
Gabrielle,O
MD,O
73-971,O
2016-04-01,O
@,O
0836,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Robert,O
Howell,O
on:,O
WED,O
2016-05-18,O
5:18,O
PM,O

(,O
End,O
of,O
Report,O
),O

770828516,O

OMH,O

9357991,O

58511/2j86,O

12/28/1995,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

12/28/95,O

DISCHARGE,O
DATE,O
:,O

New,O
Years,O
Eve,O

ADDENDUM,O
:,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Mevacor,B-TR
20,O
mg,O
p.o.,O
q.d.,O
;,O
Colace,B-TR
100,O
t.i.d.,O
;,O
Carafate,B-TR
1,O
gram,O
q.i.d.,O
;,O
Serax,B-TR
15,O
mg,O
p.o.,O
q.6.h.,O
to,O
hold,O
for,O
somnolence,B-PR
;,O
thiamine,B-TR
100,O
mg,O
IM,O
q.d.,O
",",O
folate,B-TR
1,O
mg,O
q.d.,O
",",O
Multivitamin,B-TR
1,O
q.d.,O
",",O
Percocet,B-TR
1-2,O
tabs,O
p.o.,O
q.4.h.,O
p.r.n.,O
pain,B-PR
",",O
Dulcolax,B-TR
2,O
tabs,O
p.o.,O
q.d.,O
",",O
p.r.n.,O
no,B-PR
stool,I-PR
x,O
48,O
hours,O
;,O
Tylenol,B-TR
650,O
p.o.,O
q.4.h.,O
p.r.n.,O
and,O
heparin,B-TR
7500,O
units,O
subcu.,O
b.i.d.,O

STA,O
TITCHEGRIESESC,O
",",O
M.D.,O

TR,O
:,O

kk,O
/,O
bmot,O

DD,O
:,O

12-30-95,O

TD,O
:,O

01/02/96,O

CC,O
:,O

Admission,O
Date,O
:,O

2009-11-10,O

Discharge,O
Date,O
:,O

2009-11-12,O

Date,O
of,O
Birth,O
:,O

1948-10-16,O

Sex,O
:,O

M,O

Service,O
:,O

CCU,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
61,O
-,O
year-old,O
white,O
male,O
with,O
a,O
history,O
of,O
coronary,B-PR
artery,I-PR
disease,I-PR
",",O
status,O
post,O
5-vessel,B-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
on,O
2009-09-11,O
",",O
who,O
presents,O
for,O
elective,B-TE
right,I-TE
heart,I-TE
catheterization,I-TE
and,O
pericardiocentesis,B-TR
.,O

The,O
patient,O
did,O
well,O
after,O
his,B-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
.,O

On,O
10-14,O
",",O
the,O
patient,O
had,O
a,B-TE
transthoracic,I-TE
echocardiogram,I-TE
which,O
revealed,O
a,B-PR
new,I-PR
",",I-PR
moderate-to-large,I-PR
sized,I-PR
pericardial,I-PR
effusion,I-PR
.,O

The,O
patient,O
was,O
asymptomatic,B-PR
at,O
this,O
time,O
",",O
and,O
the,O
decision,O
was,O
made,O
to,O
monitor,O
him,O
and,O
to,O
start,O
him,O
on,O
Lasix,B-TR
.,O

The,O
patient,O
had,O
follow-up,B-TE
transthoracic,I-TE
echocardiogram,I-TE
on,O
11-04,O
which,O
revealed,O
a,B-PR
slightly,I-PR
large,I-PR
effusion,I-PR
.,O

A,O
few,O
days,O
later,O
",",O
on,O
11-07,O
",",O
the,O
patient,O
began,O
to,O
develop,O
dyspnea,B-PR
on,O
exertion,O
with,O
normal,O
activity,O
.,O

He,O
also,O
noted,O
a,B-PR
new,I-PR
two,I-PR
to,I-PR
three-pillow,I-PR
orthopnea,I-PR
and,O
paroxysmal,B-PR
nocturnal,I-PR
dyspnea,I-PR
.,O

On,O
11-08,O
",",O
he,O
had,O
an,O
episode,O
of,O
acute,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
with,O
chest,B-PR
pressure,I-PR
which,O
he,O
describes,O
as,O
different,O
from,O
his,B-PR
typical,I-PR
angina,I-PR
with,O
minimal,O
exertion,O
.,O

The,O
patient,O
spoke,O
with,O
his,O
cardiologist,O
who,O
referred,O
him,O
for,O
pericardiocentesis,B-TR
for,O
persistent,B-PR
and,I-PR
symptomatic,I-PR
pericardial,I-PR
effusion,I-PR
.,O

On,O
right,B-TE
heart,I-TE
catheterization,I-TE
",",O
the,O
patient,O
was,O
noted,O
to,O
have,O
elevated,B-PR
right-sided,I-PR
and,I-PR
left-sided,I-PR
filling,I-PR
pressures,I-PR
with,O
a,B-TE
pulmonary,I-TE
capillary,I-TE
wedge,I-TE
pressure,I-TE
of,O
19,O
and,O
a,B-TE
right,I-TE
atrial,I-TE
pressure,I-TE
of,O
16,O
.,O

After,O
600,O
cc,O
of,O
serosanguineous,B-PR
pericardial,I-PR
fluid,I-PR
was,O
removed,O
",",O
the,O
patient,O
was,O
noted,O
to,O
have,O
a,B-TE
pulmonary,I-TE
capillary,I-TE
wedge,I-TE
pressure,I-TE
of,O
9,O
and,O
a,B-TE
right,I-TE
atrial,I-TE
pressure,I-TE
of,O
2,O
;,O
indicating,O
resolution,O
of,O
tamponade,B-PR
physiology,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
",",O
status,O
post,O
5-vessel,B-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
on,O
2009-09-11,O
.,O

Left,O
internal,O
mammary,O
artery,O
to,O
left,O
anterior,O
descending,O
artery,O
",",O
saphenous,B-TR
vein,I-TR
graft,I-TR
to,O
left,O
anterior,O
descending,O
artery,O
to,O
diagonal,O
",",O
saphenous,B-TR
vein,I-TR
graft,I-TR
to,O
right,O
posterior,O
descending,O
artery,O
",",O
and,O
saphenous,B-TR
vein,I-TR
graft,I-TR
to,O
first,O
obtuse,O
marginal,O
.,O

2.,O
Type,B-PR
1,I-PR
diabetes,I-PR
mellitus,I-PR
for,O
50,O
years,O
.,O

3.,O
Hypercholesterolemia,B-PR
.,O

4.,O
Hypertension,B-PR
.,O

5.,O
Chronic,B-PR
renal,I-PR
insufficiency,I-PR
with,O
a,B-TE
baseline,I-TE
creatinine,I-TE
of,O
1.1,O
to,O
1.4,O
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
has,O
a,O
positive,O
tobacco,O
history,O
",",O
but,O
he,O
quit,O
smoking,O
over,O
20,O
years,O
ago,O
.,O

He,O
is,O
married,O
and,O
lives,O
in,O
Burbank,O
Hospital,O
.,O

He,O
has,O
retired,O
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Atenolol,B-TR
50,O
mg,O
p.o.,O
q.d.,O
",",O
Lipitor,B-TR
10,O
mg,O
p.o.,O
q.d.,O
",",O
baby,B-TR
aspirin,I-TR
81,O
mg,O
p.o.,O
q.d.,O
",",O
iron,B-TR
sulfate,I-TR
81,O
mg,O
p.o.,O
q.d.,O
",",O
Lasix,B-TR
40,O
mg,O
p.o.,O
q.d.,O
",",O
Accupril,B-TR
40,O
mg,O
p.o.,O
q.d.,O
",",O
hydrochlorothiazide,B-TR
12.5,O
mg,O
p.o.,O
q.d.,O
",",O
NPH,B-TR
insulin,I-TR
18,O
units,O
q.a.m.,O
and,O
10,O
units,O
q.p.m.,O
",",O
Humalog,B-TR
sliding-scale,I-TR
q.a.m.,O
and,O
q.p.m.,O

PHYSICAL,O
EXAMINATION,O
ON,O
PRESENTATION,O
:,O

The,O
patient,O
had,O
a,B-TE
temperature,I-TE
of,O
100.9,O
.,O

He,O
had,O
a,B-TE
blood,I-TE
pressure,I-TE
of,O
148,O
to,O
162/45,O
to,O
54,O
.,O

He,O
had,O
a,B-TE
heart,I-TE
rate,I-TE
of,O
85,O
to,O
87,O
",",O
breathing,O
at,O
17,O
to,O
23,O
",",O
satting,O
100%,O
on,O
room,O
air,O
.,O

In,O
general,O
",",O
he,O
was,O
alert,O
and,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

His,O
neck,O
was,O
supple,O
without,O
any,B-PR
jugular,I-PR
venous,I-PR
distention,I-PR
.,O

HEENT,B-TE
examination,I-TE
revealed,O
his,O
pupils,O
were,O
equal,O
",",O
round,O
",",O
and,O
reactive,O
to,O
light,O
.,O

His,O
extraocular,O
movements,O
were,O
intact,O
.,O

His,O
sclerae,O
were,O
anicteric,B-PR
.,O

His,O
mucous,O
membranes,O
were,O
moist,O
.,O

His,O
oropharynx,O
was,O
benign,O
.,O

Cardiovascular,O
revealed,O
a,O
regular,O
rate,O
and,O
rhythm,O
",",O
heart,B-PR
sounds,I-PR
muffled,I-PR
",",O
no,O
murmurs,B-PR
.,O

Respiratory,O
revealed,O
bibasilar,B-PR
rales,I-PR
.,O

Abdomen,O
was,O
soft,O
",",O
nontender,B-PR
",",O
and,O
nondistended,B-PR
",",O
positive,O
bowel,O
sounds,O
.,O

Extremities,O
revealed,O
trace,B-PR
lower,I-PR
extremity,I-PR
edema,I-PR
",",O
right,O
greater,O
than,O
left,O
",",O
2+,B-TE
dorsalis,I-TE
pedis,I-TE
and,I-TE
posterior,I-TE
tibialis,I-TE
pulses,I-TE
.,O

He,O
had,O
2+,B-TE
femoral,I-TE
pulses,I-TE
bilaterally,O
.,O

No,O
hematomas,B-PR
were,O
noted,O
",",O
but,O
a,B-PR
soft,I-PR
right,I-PR
femoral,I-PR
bruit,I-PR
was,O
heard,O
.,O

LABORATORY,O
DATA,O
ON,O
PRESENTATION,O
:,O

The,O
patient,O
had,O
a,B-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
of,O
9.5,O
",",O
a,B-TE
hematocrit,I-TE
of,O
34.5,O
",",O
a,B-TE
platelet,I-TE
count,I-TE
of,O
194,O
.,O

His,B-TE
Chem-7,I-TE
revealed,O
sodium,B-TE
of,O
132,O
",",O
potassium,B-TE
of,O
43,O
",",O
chloride,B-TE
of,O
97,O
",",O
bicarbonate,B-TE
of,O
28,O
",",O
BUN,B-TE
of,O
25,O
",",O
creatinine,B-TE
of,O
1.3,O
",",O
glucose,B-TE
of,O
220,O
.,O

He,O
had,O
an,B-TE
INR,I-TE
of,O
1.1,O
.,O

A,B-TE
calcium,I-TE
of,O
8.4,O
",",O
phosphate,B-TE
of,O
2.5,O
",",O
magnesium,B-TE
of,O
1.9,O
.,O

Pericardial,B-TE
fluid,I-TE
analysis,I-TE
was,O
consistent,O
with,O
an,B-PR
exudative,I-PR
etiology,I-PR
.,O

RADIOLOGY,O
/,O
IMAGING,O
:,O

The,O
patient,O
had,O
an,B-TE
electrocardiogram,I-TE
with,O
normal,O
sinus,O
rhythm,O
at,O
70,O
",",O
normal,O
axis,O
",",O
normal,O
intervals,O
",",O
low,B-PR
voltage,I-PR
in,I-PR
the,I-PR
limb,I-PR
leads,I-PR
.,O

Chest,B-TE
x-ray,I-TE
on,O
admission,O
revealed,O
a,B-PR
large,I-PR
left,I-PR
pleural,I-PR
effusion,I-PR
.,O

The,O
patient,O
had,O
an,B-TE
echocardiogram,I-TE
on,O
11-10,O
which,O
revealed,O
the,O
following,O
:,O

Global,B-TE
left,I-TE
ventricular,I-TE
systolic,I-TE
function,I-TE
appeared,O
grossly,O
preserved,O
.,O

Due,O
to,O
technical,O
quality,O
a,B-PR
focal,I-PR
wall,I-PR
motion,I-PR
abnormality,I-PR
could,O
not,O
be,O
fully,O
excluded,O
.,O

The,O
aortic,O
valve,O
leaflets,O
were,O
mildly,B-PR
thickened,I-PR
.,O

The,O
mitral,O
valve,O
leaflets,O
were,O
mildly,B-PR
thickened,I-PR
.,O

There,O
was,O
a,B-PR
large,I-PR
pericardial,I-PR
effusion,I-PR
(,O
up,O
to,O
greater,O
than,O
6,O
cm,O
wide,O
anterior,O
to,O
the,O
right,O
ventricle,O
).,O

The,O
right,O
ventricle,O
was,O
compressed,B-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
transferred,O
to,O
the,O
Coronary,O
Care,O
Unit,O
after,O
his,B-TR
therapeutic,I-TR
pericardiocentesis,I-TR
.,O

He,O
was,O
hemodynamically,O
stable,O
and,O
without,O
any,O
complaints,O
.,O

He,O
was,O
continued,O
on,O
his,B-TR
home,I-TR
cardiac,I-TR
regimen,I-TR
",",O
but,O
was,O
started,O
on,O
indomethacin,B-TR
for,O
post,B-PR
pericardiotomy,I-PR
syndrome,I-PR
.,O

Over,O
the,O
course,O
of,O
the,O
night,O
the,O
patient,O
drained,O
an,O
additional,O
400,O
cc,O
of,O
serosanguineous,B-PR
fluid,I-PR
from,O
his,B-TR
pericardial,I-TR
drain,I-TR
pouch,I-TR
.,O

By,O
the,O
next,O
morning,O
",",O
the,O
degree,O
of,O
drainage,B-PR
had,O
decreased,O
considerably,O
with,O
only,O
60,O
cc,O
drained,O
over,O
six,O
hours,O
.,O

The,O
patient,O
had,O
a,B-TE
repeat,I-TE
transthoracic,I-TE
echocardiogram,I-TE
prior,O
to,O
drain,B-TR
removal,I-TR
which,O
revealed,O
the,O
following,O
:,O

A,B-PR
trivial,I-PR
/,I-PR
physiologic,I-PR
pericardial,I-PR
effusion,I-PR
one,O
day,O
post,O
pericardiocentesis,B-TR
with,O
no,O
change,O
from,O
the,B-TE
study,I-TE
immediately,O
post,O
pericardiocentesis,B-TR
.,O

The,B-TR
pericardial,I-TR
drain,I-TR
was,O
removed,O
without,O
any,B-PR
difficulty,I-PR
.,O

The,B-TR
pericardial,I-TR
fluid,I-TR
bag,I-TR
was,O
removed,O
without,O
any,B-PR
difficulty,I-PR
with,O
the,O
decision,O
to,O
monitor,O
the,O
patient,O
overnight,O
and,O
repeat,O
the,B-TE
echocardiogram,I-TE
prior,O
to,O
discharge,O
.,O

The,O
patient,O
had,O
an,B-PR
enlarged,I-PR
left,I-PR
pleural,I-PR
effusion,I-PR
which,O
was,O
noted,O
to,O
layer,O
on,O
a,B-TE
lateral,I-TE
decubitus,I-TE
film,I-TE
.,O

We,O
decided,O
to,O
perform,O
a,B-TR
therapeutic,I-TR
thoracentesis,I-TR
.,O

The,O
patient,O
was,O
prepped,O
and,O
draped,O
in,O
a,O
sterile,O
fashion,O
",",O
and,O
1150,O
cc,O
of,O
fluid,B-PR
were,O
drained,B-TR
.,O

A,B-TE
chest,I-TE
x-ray,I-TE
was,O
obtained,O
post,O
thoracentesis,B-TR
which,O
revealed,O
a,O
significant,O
decrease,O
in,O
the,O
size,O
of,O
the,B-PR
left,I-PR
pleural,I-PR
effusion,I-PR
.,O

No,O
evidence,O
of,O
pneumothorax,B-PR
.,O

On,O
the,O
morning,O
of,O
admission,O
the,O
patient,O
had,O
a,B-TE
markedly,I-TE
improved,I-TE
lung,I-TE
examination,I-TE
with,O
increased,O
air,O
movement,O
in,O
the,O
left,O
base,O
.,O

He,O
denied,O
any,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
and,O
had,O
oxygen,B-TE
saturations,I-TE
in,O
the,O
90,O
s,O
on,O
room,O
air,O
.,O

He,O
had,O
a,B-TE
repeat,I-TE
echocardiogram,I-TE
which,O
revealed,O
a,B-PR
trivial,I-PR
/,I-PR
physiologic,I-PR
pericardial,I-PR
effusion,I-PR
.,O

The,O
patient,O
was,O
without,O
any,O
complaints,O
and,O
remained,O
stable,O
.,O

CONDITION,O
AT,O
DISCHARGE,O
:,O

Condition,O
on,O
discharge,O
was,O
stable,O
.,O

DISCHARGE,O
STATUS,O
:,O

The,O
patient,O
was,O
to,O
be,O
discharged,O
to,O
home,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Post,B-PR
pericardiotomy,I-PR
syndrome,I-PR
.,O

2.,O
Status,O
post,O
pericardiocentesis,B-TR
.,O

3.,O
Status,O
post,O
thoracentesis,B-TR
.,O

4.,O
Type,B-PR
1,I-PR
diabetes,I-PR
mellitus,I-PR
for,O
50,O
years,O
.,O

5.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
.,O

6.,O
Hypercholesterolemia,B-PR
.,O

7.,O
Hypertension,B-PR
.,O

8.,O
Chronic,B-PR
renal,I-PR
insufficiency,I-PR
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O
(,O
Discharge,O
medications,O
include,O
),O

1.,O
Indomethacin,B-TR
25,O
mg,O
p.o.,O
t.i.d.,O
for,O
seven,O
days.,O

2.,O
Atenolol,B-TR
50,O
mg,O
p.o.,O
q.d.,O

3.,O
Lipitor,B-TR
10,O
mg,O
p.o.,O
q.d.,O

4.,O
Baby,B-TR
aspirin,I-TR
81,O
mg,O
p.o.,O
q.d.,O

5.,O
Iron,B-TR
sulfate,I-TR
81,O
mg,O
p.o.,O
q.d.,O

6.,O
Accupril,B-TR
40,O
mg,O
p.o.,O
q.d.,O

7.,O
Hydrochlorothiazide,B-TR
12.5,O
mg,O
p.o.,O
q.d.,O

8.,O
NPH,B-TR
insulin,I-TR
18,O
units,O
q.a.m.,O
and,O
10,O
units,O
q.p.m.,O

9.,O
Humalog,B-TR
sliding-scale,I-TR
q.a.m.,O
and,O
q.p.m.,O

DISCHARGE,O
FOLLOWUP,O
:,O

The,O
patient,O
was,O
to,O
follow,O
up,O
with,O
his,O
primary,O
cardiologist,O
",",O
Dr.,O
Thomas,O
",",O
within,O
one,O
week,O
.,O

David,O
Archibald,O
",",O
M.D.,O
11-989,O

Dictated,O
By,O
:,O
Dorothy,O
Y.,O
Madore,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2009-11-12,O
12:02,O

T,O
:,O
2009-11-12,O
17:44,O

JOB,O
#:,O
33199,O

(,O
cclist,O
),O

Signed,O
electronically,O
by,O
:,O
DR.,O
Susan,O
O.,O
G.,O
Aviles,O
on,O
:,O
Robert,O
2010-01-14,O
7:23,O
PM,O

(,O
End,O
of,O
Report,O
),O

782836641,O
DH,O

9369592,O

1111,O

974771,O

3/15/2002,O
12:00:00,O
AM,O

OB,O
Discharge,O
Summary,O

Signed,O

DIS,O

Report,O
Status,O
:,O

Signed,O
OB,O
EMR,O
L,O
and,O
D,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

XIEACASS,O
BETHCONRI,O
BALLOON,O

UNIT,O
NUMBER,O
:,O

242-36-71,O

ADMISSION,O
DATE,O
:,O

20020315,O

DISCHARGE,O
DATE,O
:,O

20020318,O

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
:,O

Vaginal,B-TR
Delivery,I-TR
With,O
First,B-PR
Degree,I-PR
Laceration,I-PR

ASSOCIATED,O
DIAGNOSES,O
:,O

Advanced,B-PR
Maternal,I-PR
Age,I-PR
;,O
Depression,B-PR
",",O
history,O
of,O
;,O
Hepatitis,B-PR
C,I-PR
Antibody,I-PR
Positive,I-PR
;,O
Polyneuropathy,B-PR
",",O
history,O
of,O
;,O
Problems,O
With,O
Abuse,O
",",O
history,O
of,O
;,O
Rh,O
Nonsensitization,O
;,O
Stopped,O
Smoking,O
This,O
Pregnancy,O
",",O
history,O
of,O

PRINCIPAL,O
PROCEDURE,O
OR,O
OPERATION,O
:,O

Spontaneous,B-TR
Vertex,I-TR
Vaginal,I-TR
Delivery,I-TR

ASSOCIATED,O
PROCEDURES,O
OR,O
OPERATIONS,O
:,O

POSTPARTUM,O
DIAGNOSTIC,O
PROCEDURES,O
:,O

None,O

POSTPARTUM,O
THERAPEUTIC,O
PROCEDURES,O
:,O

None,O

HISTORY,O
AND,O
REASON,O
FOR,O
HOSPITALIZATION,O
:,O

Active,B-PR
Labor,I-PR

PHYSICAL,O
EXAMINATION,O
:,O

HEIGHT,B-TE
NORMAL,O
66,O
HEENT,O
NORMAL,O
MOUTH,O
NORMAL,O
NECK,O
NORMAL,O
BREASTS,O
NORMAL,O
NIPPLES,O
NORMAL,O
CHEST,O
NORMAL,O
COR,O
NORMAL,O
ABDOMEN,O
NORMAL,O
EXTREM,O
NORMAL,O
SKIN,B-PR
mottled,I-PR
on,I-PR
both,I-PR
lower,I-PR
extremities,I-PR
.,O

NODES,O
NORMAL,O
VULVA,O
NORMAL,O
VAGINA,O
NORMAL,O
CERVIX,O
NORMAL,O
OS,O
NORMAL,O
ADNEXAE,O
NORMAL,O
UTERUS,O
NORMAL,O
UTERINE,B-TE
SIZE,I-TE
IN,O
WEEKS,O
15,O
HOSPITAL,O
COURSE,O
(,O
include,O
complications,O
if,O
any,O
),O
:,O

This,O
42,O
year,O
old,O
Gravida,O
3,O
Para,O
2002,O
was,O
admitted,O
to,O
the,O
Naliheall,O
County,O
Memorial,O
Hospital,O
Obstetrical,O
service,O
on,O
03/15/2002,O
at,O
10:04,O
pm,O
for,O
the,O
indication,O
(,O
s,O
),O
:,O

active,B-PR
labor,I-PR
.,O

She,O
delivered,O
a,O
2809,O
gram,O
male,O
infant,O
on,O
03/16/2002,O
at,O
02:50,O
am,O
with,O
apgar,B-TE
scores,I-TE
of,O
7,O
and,O
9,O
at,O
one,O
and,O
five,O
minutes,O
respectively,O
at,O
38.0,O
weeks,O
gestation,O
via,O
spontaneous,B-TR
vertex,I-TR
vaginal,I-TR
delivery,I-TR
.,O

During,O
her,O
labor,O
she,O
encountered,O
the,O
following,O
complication,O
(,O
s,O
),O
:,O

none,O
.,O

During,O
her,O
delivery,O
she,O
encountered,O
the,O
following,O
complication,O
(,O
s,O
),O
:,O

.,O
Postpartum,O
she,O
encountered,O
the,O
following,O
complication,O
(,O
s,O
),O
:,O

depression,B-PR
.,O

She,O
was,O
discharged,O
on,O
03/18/2002,O
at,O
12:45,O
pm,O
in,O
good,O
condition,O
.,O

DISCHARGE,O
ORDERS,O
(,O
medications,O
instructions,O
to,O
patient,O
",",O
follow-up,O
care),O
:,O

DISCHARGE,O
ACTIVITY,O
:,O

No,O
Restrictions,O

DISCHARGE,O
DIET,O
:,O

No,O
Restrictions,O

POSTPARTUM,O
DISPOSITION,O
:,O

Home,O
Under,O
Care,O
Of,O
Shingle,O
Geabell,O
Hospital,O

POSTPARTUM,O
CARE,O
SITE,O
:,O

Dh,O
Ob,O

POSTPARTUM,O
RETURN,O
APPOINTMENT,O
(,O
DAYS,O
),O
:,O

42,O

BREAST,O
FEEDING,O
AT,O
DISCHARGE,O
:,O

No,O

POSTPARTUM,B-TR
RH,I-TR
IMMUNE,I-TR
GLOBULIN,I-TR
:,O

Given,O

POSTPARTUM,B-TR
MEASLES,I-TR
/,I-TR
MUMPS/RUBELLA,I-TR
VACCINE,I-TR
:,O

Not,O
Indicated,O

MEDICATION,O
(,O
S,O
),O
ON,O
DISCHARGE,O
:,O

Multivitamins,B-TR
And,O
Folate,B-TR
(,O
Stuart,B-TR
Prenatal,I-TR
With,O
Folate,B-TR
),O
;,O
Fluoxetine,B-TR
(,I-TR
Prozac,I-TR
),I-TR

Electronically,O
Signed,O
:,O

Polle,O
",",O
Nella,O
O,O
03/18/2002,O
9:01:18,O
PM,O

Admission,O
Date,O
:,O

2015-04-16,O

Discharge,O
Date,O
:,O

2015-04-24,O

Date,O
of,O
Birth,O
:,O

1937-04-06,O

Sex,O
:,O

F,O

Service,O
:,O

SURGERY,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,I-PR
Drugs,I-PR

Attending,O
:,O
Mattie,O
R.,O
A.,O
Hamilton,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Altered,B-PR
mental,I-PR
status,I-PR

Diaphoresis,B-PR

Abdominal,B-PR
pain,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

Lap,B-TR
converted,O
to,O
open,B-TR
cholecystectomy,I-TR

History,O
of,O
Present,O
Illness,O
:,O

This,O
78,O
year,O
old,O
Mexican,O
speaking,O
female,O
presented,O
to,O
the,O
emergency,O
department,O
on,O
2015-04-16,O
.,O

Her,O
family,O
memebers,O
stated,O
that,O
she,O
was,O
found,O
at,O
home,O
with,O
altered,B-PR
mental,I-PR
status,I-PR
and,O
diaphoresis,B-PR
.,O

She,O
is,O
diabetic,B-PR
.,O

Mental,O
status,O
improved,O
after,O
binasal,B-TR
cannula,I-TR
oxygen,I-TR
applied,O
",",O
at,O
which,O
time,O
she,O
localized,O
right,B-PR
upper,I-PR
quadrant,I-PR
pain,I-PR
.,O

She,O
developed,O
leukocytosis,B-PR
and,O
transaminasemia,B-PR
.,O

Past,O
Medical,O
History,O
:,O

DM,B-PR
on,O
insulin,B-TR

HTN,B-PR

gerd,B-PR

pvd,B-PR

osteo-arthritis,B-PR

osteoporosis,B-PR

anemia,B-PR

cholelithiasis,B-PR

left,B-PR
humeral,I-PR
fracture,I-PR

b/l,B-PR
cataracts,I-PR
s/p,O
surgery,B-TR

s/p,O
uterine,B-TR
myomectomy,I-TR

Social,O
History,O
:,O

distant,O
tobacco,O

drinks,O
often,O
-,O
including,O
vodka,O

walks,O
without,O
cane,B-TR

trained,O
engineer,O
in,O
Papua,O
New,O
Guinea,O

Has,O
brother,O
",",O
nephew,O
and,O
daughter,O
in,O
law,O
near,O
by,O
.,O

Family,O
History,O
:,O

denies,O
cad,B-PR

Physical,O
Exam,O
:,O

T,B-TE
:,O
99.2,O
HR,B-TE
97,O
BP,B-TE
131/68,O
RR,B-TE
:,O
20,O
Spo2,B-TE
100%,O
on,O
RA,O

Constitutional,O
:,O
alert,O
&,O
oriented,O
x,O
3,O
.,O

Head,O
/,O
eyes,O
:,O
EOMI,O
",",O
PERRL,O

Chest,O
/,O
respiratory,O
:,O
clear,O
to,O
auscultation,O
bilaterally,O

Cardiovascular,O
:,O
Regular,O
rate,O
&,O
rhythm,O
+,O
S1/S2,O
.,O

No,O
Mumur,B-PR
/,O
regurgiation,B-PR
/,O
gallop,B-PR

GI,O
/,O
Abdomen,O
:,O
soft,O
.,O

+,O
Haskell,B-TE
sign,I-TE
",",O
right,B-PR
upper,I-PR
quadrant,I-PR
tenderness,I-PR
.,O

Nondistended,B-PR
.,O

No,O
rebounding,B-PR

Musculoskeletal,O
:,O
5/5,O
strength,O
all,O
extremities,O

Skin,O
:,O
no,O
C/C/E,B-PR

Neuro,O
:,O
CN,O
II-XII,O
intact,O
",",O
no,O
dysdiadokinesis,B-PR
.,O

decreased,B-PR
Babinski,I-PR
's,I-PR

Pertinent,O
Results,O
:,O

2015-04-16,O
07:10,O
PM,O
BLOOD,B-TE
Albumin,B-TE
-,O
3.8,O
Calcium,B-TE
-,O
9.0,O
Phos,B-TE
-,O
2.6,O
*#,O
Mg,B-TE
-,O
1.9,O

2015-04-16,O
07:10,O
PM,O
BLOOD,B-TE
ALT,B-TE
-,O
295,O
*,O
AST,B-TE
-,O
56,O
*,O
CK(CPK),B-TE
-,O
60,O
AlkPhos,B-TE
-,O
208,O
*,O
Amylase,B-TE
-,O
23,O
TotBili,B-TE
-,O
1.6,O
*,O

2015-04-16,O
07:10,O
PM,O
BLOOD,B-TE
Glucose,B-TE
-,O
280,O
*,O
UreaN,B-TE
-,O
18,O
Creat,B-TE
-,O
1.0,O
Na,B-TE
-,O
135,O
K,B-TE
-,O
4.2,O
Cl,B-TE
-,O
98,O
HCO3,B-TE
-,O
22,O
AnGap,B-TE
-,O
19,O

2015-04-16,O
07:10,O
PM,O
BLOOD,B-TE
WBC,B-TE
-,O
18.4,O
*#,O
RBC,B-TE
-,O
4.27,O
Hgb,B-TE
-,O
11.9,O
*,O
Hct,B-TE
-,O
34.8,O
*,O
MCV,B-TE
-,O
82,O
MCH,B-TE
-,O
27.9,O
MCHC,B-TE
-,O
34.1,O
RDW,B-TE
-,O
15.0,O
Plt,B-TE
Ct,I-TE
-,O
317,O

2015-04-24,O
06:35,O
AM,O
BLOOD,B-TE
ALT,B-TE
-,O
82,O
*,O
AST,B-TE
-,O
62,O
*,O
AlkPhos,B-TE
-,O
145,O
*,O
Amylase,B-TE
-,O
51,O
TotBili,B-TE
-,O
0.4,O

2015-04-24,O
06:35,O
AM,O
BLOOD,B-TE
Glucose,B-TE
-,O
134,O
*,O
UreaN,B-TE
-,O
8,O
Creat,B-TE
-,O
0.6,O
Na,B-TE
-,O
144,O
K,B-TE
-,O
3.7,O
Cl,B-TE
-,O
106,O
HCO3,B-TE
-,O
31,O
AnGap,B-TE
-,O
11,O

2015-04-24,O
06:35,O
AM,O
BLOOD,B-TE
WBC,B-TE
-,O
10.5,O
RBC,B-TE
-,O
3.49,O
*,O
Hgb,B-TE
-,O
9.6,O
*,O
Hct,B-TE
-,O
28.0,O
*,O
MCV,B-TE
-,O
80,O
*,O
MCH,B-TE
-,O
27.5,O
MCHC,B-TE
-,O
34.3,O
RDW,B-TE
-,O
15.8,O
*,O
Plt,B-TE
Ct,I-TE
-,O
504,O
*,O

GB,B-TE
US,I-TE
2015-04-16,O

IMPRESSION,O
:,O

1.,O
Distended,B-PR
gallbladder,I-PR
with,O
impacted,B-PR
1.6,I-PR
cm,I-PR
gallstone,I-PR
",",O
focal,B-PR
wall,I-PR
thickening,I-PR
",",O
and,O
positive,B-PR
sonAllan,I-PR
Stephens,I-PR
sign,I-PR
-,O
findings,O
consistent,O
with,O
acute,B-PR
cholecystitis,I-PR
.,O

2.,O
Right,B-PR
renal,I-PR
cysts,I-PR
-,O
lower,B-PR
pole,I-PR
cyst,I-PR
is,O
unchanged,O
from,O
prior,B-TE
exam,I-TE
of,O
2010-10-25,O
and,O
upper,B-PR
pole,I-PR
exophytic,I-PR
cyst,I-PR
was,O
not,O
previously,O
seen,O
sonStacy,O
.,O

ERCP,B-TE
report,O
2015-04-21,O

IMPRESSION,O
:,O

1.,O
Successful,O
removal,B-TR
of,O
CBD,B-PR
stone,I-PR
and,O
placement,O
of,O
plastic,B-TR
biliary,I-TR
stent,I-TR
for,O
confirmed,B-PR
cystic,I-PR
duct,I-PR
leak,I-PR
.,O

Brief,O
Hospital,O
Course,O
:,O

Ms,O
Malek,O
was,O
admitted,O
on,O
2015-04-16,O
due,O
to,O
altered,B-PR
mental,I-PR
status,I-PR
and,O
acute,B-PR
right,I-PR
upper,I-PR
quadrant,I-PR
abdominal,I-PR
pain,I-PR
.,O

Gallbladder,B-TE
ultra,I-TE
sound,I-TE
revealed,O
a,B-PR
distended,I-PR
1.6,I-PR
cm,I-PR

HD,O
#,O
01-20,O
She,O
was,O
monitored,O
closely,O
in,O
the,O
CMED,O
.,O

On,O
2015-04-17,O
she,O
was,O
taken,O
to,O
the,O
OR,O
for,O
lap,B-TR
converted,O
to,O
open,B-TR
cholecystectomy,I-TR
.,O

She,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
",",O
see,O
op,O
report,O
for,O
details,O
.,O

She,O
was,O
extubated,B-TR
and,O
recovered,O
well,O
in,O
PACU,O
.,O

She,O
remained,O
NPO,B-TR
with,O
IV,B-TR
fluids,I-TR
",",O
foley,B-TR
catheter,I-TR
and,O
Dilaudid,B-TR
IV,I-TR
for,O
pain,B-TR
control,I-TR
",",O
Unasyn,B-TR
for,O
antibiotic,B-TR
coverage,I-TR
.,O

She,O
returned,O
to,O
CMED,O
for,O
further,B-TE
monitoring,I-TE
.,O

She,O
was,O
noted,O
to,O
have,O
low,B-PR
urine,I-PR
output,I-PR
at,O
times,O
.,O

She,O
responded,O
well,O
to,O
fluid,B-TR
bolusing,I-TR
.,O

POD#1,O
she,O
was,O
transferred,O
to,O
CC6,O
for,O
further,O
recovery,O
.,O

She,O
remained,O
afebrile,B-PR
",",O
she,O
was,O
given,O
ice,O
chips,O
.,O

Physical,O
therapy,O
was,O
consulted,O
for,O
strength,O
and,O
mobility,O
.,O

POD#2,O
her,B-PR
pain,I-PR
was,O
somewhat,O
uncontrolled,O
",",O
she,O
was,O
placed,O
on,O
Dilaudid,B-TR
PCA,I-TR
with,O
fair,O
effect,O
.,O

Urine,B-TE
output,I-TE
remained,O
adequate,O
.,O

She,O
was,O
monitored,O
on,O
telemetry,B-TE
for,O
mild,B-PR
tachycardia,I-PR
and,O
recieved,O
IV,B-TR
beta,I-TR
blockers,I-TR
.,O

She,O
ambulated,O
with,O
assistance,O
.,O

POD#3,O
she,O
was,O
advanced,O
to,O
sips,B-TR
and,I-TR
clears,I-TR
",",O
foley,B-TR
catheter,I-TR
was,O
discontinued,O
.,O

POD#4,O
",",O
bilious,B-PR
drainage,I-PR
was,O
noted,O
in,O
her,B-TR
JP,I-TR
.,O

She,O
had,O
worsening,B-PR
abdominal,I-PR
pain,I-PR
on,O
exam,B-TE
.,O

She,O
was,O
held,O
NPO,B-TR
.,O

She,O
was,O
taken,O
to,O
ERCP,B-TE
where,O
sphincterotomy,B-TR
was,O
performed,O
and,O
biliary,B-TR
stent,I-TR
was,O
placed,O
.,O

She,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
and,O
returned,O
to,O
CC6,O
post-procedure,O
.,O

JP,B-TR
remained,O
intact,O
with,O
serosainguinous,B-PR
drainage,I-PR
.,O

POD#5,O
she,O
c/o,O
difficulty,B-PR
voiding,I-PR
",",O
pt,O
was,O
straight,B-TR
cathed,I-TR
after,O
bladder,B-TE
scan,I-TE
was,O
obtained,O
and,O
revealed,O
>,O
600,O
ccs,O
urine,O
.,O

POD#,O
05-25,O
she,O
continued,O
with,O
intermittent,O
complaints,O
of,O
urinary,B-PR
retention,I-PR
.,O

However,O
she,O
was,O
able,O
to,O
void,O
.,O

Renal,B-TE
function,I-TE
remained,O
normal,O
.,O

She,O
did,O
not,O
require,O
further,B-TR
straight,I-TR
catheterization,I-TR
.,O

She,O
was,O
advanced,O
to,O
clear,B-TR
liquids,I-TR
again,O
without,O
nausea,B-PR
or,O
vomiting,B-PR
.,O

Her,B-PR
pain,I-PR
was,O
well,O
controlled,O
by,O
Tylenol,B-TR
.,O

Her,O
home,O
regimen,O
of,O
lantus,B-TR
was,O
resumed,O
for,O
elevated,B-PR
blood,I-PR
glucose,I-PR
.,O

POD#6,O
",",O
her,O
diet,O
was,O
advanced,O
to,O
regular,O
.,O

She,O
required,O
disimpaction,B-TR
and,O
had,O
hard,B-PR
stool,I-PR
in,I-PR
the,I-PR
rectum,I-PR
.,O

She,O
was,O
initiated,O
on,O
a,B-TR
bowel,I-TR
regimen,I-TR
and,O
had,O
no,O
further,O
incidents,O
of,O
diarrhea,B-PR
or,O
constipation,B-PR
.,O

POD#7,O
she,O
was,O
discharged,O
to,O
rehab,O
in,O
stable,O
condition,O
.,O

Appropriate,O
follow,O
up,O
appointments,O
are,O
recommended,O
as,O
well,O
as,O
prescriptions,B-TR
.,O

She,O
should,O
return,O
in,O
6,O
weeks,O
for,O
removal,B-TR
of,O
biliary,B-TR
stent,I-TR
.,O

Medications,O
on,O
Admission,O
:,O

Tramadol,B-TR
50,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day),O
.,O

2.,O
Senna,B-TR
8.6,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

3.,O
Nortriptyline,B-TR
25,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

4.,O
Atenolol,B-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

5.,O
Buspirone,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

6.,O
Clonazepam,B-TR
0.5,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

7.,O
Cholecalciferol,B-TR
(,I-TR
Vitamin,I-TR
D3,I-TR
),I-TR
400,O
unit,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

8.,O
Pantoprazole,B-TR
40,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
Q24H,O
(,O
every,O
24,O
hours,O
).,O

9.,O
Docusate,B-TR
Sodium,I-TR
50,O
mg,O
/,O
5,O
mL,O
Liquid,O
Sig,O
:,O
Ten,O
(,O
10,O
),O
mL,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

10.,O
Hexavitamin,B-TR
Tablet,I-TR
Sig,O
:,O
One,O
(,O
1,O
),O
Cap,O
PO,O
DAILY,O
(,O
Daily,O
).,O

11.,O
Dicyclomine,B-TR
10,O
mg,O
Capsule,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

12.,O
Atorvastatin,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

15.,O
Bisacodyl,B-TR
5,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
as,O
needed,O
.,O

16.,O
Acetaminophen,B-TR
325,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
for,O
pain,B-PR
.,O

17.,O
Ibuprofen,B-TR
600,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q8H,O
(,O
every,O
8,O
hours,O
),O
as,O
needed,O
for,O
pain,B-PR
.,O

18.,O
Insulin,B-TR
sliding,I-TR
scale,I-TR
Insulin,B-TR
SC,I-TR
Sliding,I-TR
Scale,I-TR
Q6H,B-TR
Regular,I-TR
Glucose,I-TR
Insulin,I-TR
Dose,I-TR
0-60,O
mg,O
/,O
dL,O
01-20,O
amp,O
D50,O
61-120,O
mg,O
/,O
dL,O
0,O
Units,O
121-140,O
mg,O
/,O
dL,O
3,O
Units,O
141-160,O
mg/dL,O
5,O
Units,O
161-180,O
mg/dL,O
7,O

Units,O
181-200,O
mg,O
/,O
dL,O
9,O
Units,O
201-220,O
mg,O
/,O
dL,O
11,O
Units,O
221-240,O
mg,O
/,O
dL,O
13,O
Units,O
241-260,O
mg,O
/,O
dL,O
15,O
Units,O
261-280,O
mg,O
/,O
dL,O
17,O
Units,O
281-300,O
mg,O
/,O
dL,O
19,O
Units,O
301-320,O
mg,O
/,O
dL,O
21,O
Units,O
>,O
320,O
mg,O
/,O
dL,O
Notify,O
M.D.,O

19.,O
Lantus,B-TR
30,O
units,O
Lantus,B-TR
insulin,I-TR
with,O
breakfast,O

Discharge,O
Medications,O
:,O

1.,O
Tramadol,B-TR
50,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
).,O

2.,O
Senna,B-TR
8.6,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

3.,O
Nortriptyline,B-TR
25,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

4.,O
Atenolol,B-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

5.,O
Buspirone,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

6.,O
Clonazepam,B-TR
0.5,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

7.,O
Cholecalciferol,B-TR
(,I-TR
Vitamin,I-TR
D3,I-TR
),I-TR
400,O
unit,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

8.,O
Pantoprazole,B-TR
40,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
Q24H,O
(,O
every,O
24,O
hours,O
).,O

9.,O
Docusate,B-TR
Sodium,I-TR
50,O
mg,O
/,O
5,O
mL,O
Liquid,O
Sig,O
:,O
Ten,O
(,O
10,O
),O
mL,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

10.,O
Hexavitamin,B-TR
Tablet,I-TR
Sig,O
:,O
One,O
(,O
1,O
),O
Cap,O
PO,O
DAILY,O
(,O
Daily,O
).,O

11.,O
Dicyclomine,B-TR
10,O
mg,O
Capsule,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

12.,O
Atorvastatin,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

13.,O
Amoxicillin-Pot,B-TR
Clavulanate,I-TR
875-125,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
for,O
4,O
days,O
.,O

14.,O
Heparin,B-TR
(,I-TR
Porcine,I-TR
),I-TR
"5,000",O
unit,O
/,O
mL,O
Solution,O
Sig,O
:,O
One,O
(,O
1,O
),O
injection,O
Injection,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

15.,O
Bisacodyl,B-TR
5,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
as,O
needed,O
.,O

16.,O
Acetaminophen,B-TR
325,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
for,O
pain,B-PR
.,O

17.,O
Ibuprofen,B-TR
600,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q8H,O
(,O
every,O
8,O
hours,O
),O
as,O
needed,O
for,O
pain,B-PR
.,O

18.,O
Insulin,B-TR
sliding,I-TR
scale,I-TR

Insulin,B-TR
SC,I-TR
Sliding,I-TR
Scale,I-TR

Q6H,O

Regular,O

Glucose,B-TR
Insulin,I-TR
Dose,I-TR

0-60,O
mg,O
/,O
dL,O
01-20,O
amp,O
D50,O

61-120,O
mg,O
/,O
dL,O
0,O
Units,O

121-140,O
mg,O
/,O
dL,O
3,O
Units,O

141-160,O
mg,O
/,O
dL,O
5,O
Units,O

161-180,O
mg,O
/,O
dL,O
7,O
Units,O

181-200,O
mg,O
/,O
dL,O
9,O
Units,O

201-220,O
mg,O
/,O
dL,O
11,O
Units,O

221-240,O
mg,O
/,O
dL,O
13,O
Units,O

241-260,O
mg,O
/,O
dL,O
15,O
Units,O

261-280,O
mg,O
/,O
dL,O
17,O
Units,O

281-300,O
mg,O
/,O
dL,O
19,O
Units,O

301-320,O
mg,O
/,O
dL,O
21,O
Units,O

>,O
320,O
mg,O
/,O
dL,O
Notify,O
M.D.,O

30,O
units,O
Lantus,B-TR
insulin,I-TR
with,O
breakfast,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Facility,O
:,O

New,O
England,O
Sinai,O
Hospital,O
&,O
Rehab,O
Center,O
-,O
Everett,O

Discharge,O
Diagnosis,O
:,O

Acute,B-PR
Cholecystitis,I-PR

Gangrenous,B-PR
cholecystitis,I-PR
with,O
perforation,B-PR

Discharge,O
Condition,O
:,O

good,O

Discharge,O
Instructions,O
:,O

Please,O
call,O
your,O
surgeon,O
if,O
you,O
develop,O
chest,B-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
fever,B-PR
greater,O
than,O
101.5,O
",",O
foul,B-PR
smelling,I-PR
or,I-PR
colorful,I-PR
drainage,I-PR
from,O
your,B-PR
incisions,I-PR
",",O
redness,B-PR
or,O
swelling,B-PR
",",O
severe,B-PR
abdominal,I-PR
pain,I-PR
or,O
distention,B-PR
",",O
persistent,B-PR
nausea,I-PR
or,O
vomiting,B-PR
",",O
inability,B-PR
to,I-PR
eat,I-PR
or,I-PR
drink,I-PR
",",O
or,O
any,B-PR
other,I-PR
symptoms,I-PR
which,O
are,O
concerning,O
to,O
you,O
.,O

No,O
tub,O
baths,O
or,O
swimming,O
.,O

You,O
may,O
shower,O
.,O

If,O
there,O
is,O
clear,B-PR
drainage,I-PR
from,O
your,B-PR
incisions,I-PR
",",O
cover,O
with,O
a,B-TR
dry,I-TR
dressing,I-TR
.,O

Leave,O
white,B-TR
strips,I-TR
above,O
your,B-PR
incisions,I-PR
in,O
place,O
",",O
allow,O
them,O
to,O
fall,O
off,O
on,O
their,O
own,O
.,O

Activity,O
:,O
No,O
heavy,O
lifting,O
of,O
items,O
11-02,O
pounds,O
until,O
the,O
follow,O
up,O
appointment,O
with,O
your,O
doctor,O
.,O

Medications,O
:,O
Resume,O
your,B-TR
home,I-TR
medications,I-TR
.,O

You,O
should,O
take,O
a,B-TR
stool,I-TR
softener,I-TR
",",O
Colace,B-TR
100,O
mg,O
twice,O
daily,O
as,O
needed,O
for,O
constipation,B-PR
.,O

You,O
will,O
be,O
given,O
pain,B-TR
medication,I-TR
which,O
may,O
make,O
you,O
drowsy,B-PR
.,O

No,O
driving,O
while,O
taking,O
pain,B-TR
medicine,I-TR
.,O

Followup,O
Instructions,O
:,O

Provider,O
:,O
Gregory,O
X,O
Wingard,O
",",O
M.D.,O
Phone,O
:(,O
855,O
),O
651-4418,O

Date,O
/,O
Time,O
:,O
2015-06-03,O
9:30,O

Please,O
call,O
(,O
808,O
),O
246-1373,O
and,O
schedule,O
an,O
appointment,O
to,O
see,O
Dr.,O
Lewis,O
in,O
2,O
weeks,O
.,O

You,O
will,O
be,O
contacted,O
by,O
the,O
gastrointestinal,O
doctors,O
Pat,O
Barrow,O
the,B-TR
removal,I-TR
of,O
your,B-TR
biliary,I-TR
stent,I-TR
in,O
6,O
weeks,O
.,O

Joe,O
Kari,O
MD,O
09-697,O

Completed,O
by,O
:,O
Carol,O
Robert,O
NP,O
80-CIY,O
2015-04-24,O
@,O
1506,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Marion,O
SCHNEIDER,O
on,O
:,O
FRI,O
2015-04-24,O
5:11,O
PM,O

(,O
End,O
of,O
Report,O
),O

791411240,O

PRGH,O

80504780,O

383201,O

9/16/2000,O
12:00:00,O
AM,O

RUPTURED,B-PR
AORTIC,I-PR
ANEURISM,I-PR

Signed,O

DIS,O

Admission,O
Date,O
:,O

09/16/2000,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

11/03/2000,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

RUPTURED,B-PR
PARATHYROID,I-PR
ADENOMA,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Ms.,O
Shuffa,O
is,O
a,O
73-year-old,O
Portuguese,O
speaking,O
woman,O
who,O
was,O
transferred,O
via,O
Med,O
Flight,O
to,O
Verg,O
Medical,O
Center,O
.,O

She,O
arrived,O
intubated,B-TR
and,O
was,O
hemodynamically,O
stable,O
despite,O
concerns,O
of,O
a,B-PR
dissecting,I-PR
aortic,I-PR
arch,I-PR
aneurysm,I-PR
.,O

She,O
initially,O
presented,O
to,O
Brottlake,O
Medical,O
Center,O
on,O
9/15/00,O
complaining,O
of,O
acute,B-PR
onset,I-PR
dysphasia,I-PR
to,O
liquids,O
and,O
solids,O
.,O

While,O
she,O
was,O
in,O
Brottlake,O
Medical,O
Center,O
",",O
she,O
developed,O
new,B-PR
onset,I-PR
stridor,I-PR
",",O
and,O
an,O
ENT,O
consult,O
was,O
obtained,O
.,O

They,O
attempted,O
a,B-TR
fiberoptic,I-TR
intubation,I-TR
with,O
a,B-TR
#,I-TR
6,I-TR
endotracheal,I-TR
tube,I-TR
and,O
found,O
a,B-PR
5,I-PR
mm,I-PR
severely,I-PR
compressed,I-PR
airway,I-PR
.,O

She,O
was,O
also,O
found,O
to,O
have,O
a,B-PR
differential,I-PR
systolic,I-PR
blood,I-PR
pressure,I-PR
and,O
ecchymosis,B-PR
on,I-PR
her,I-PR
anterior,I-PR
chest,I-PR
.,O

Given,O
these,O
findings,O
",",O
she,O
underwent,O
a,B-TE
CT,I-TE
scan,I-TE
which,O
showed,O
a,B-PR
retrotracheal,I-PR
mass,I-PR
that,O
appeared,O
to,O
obliterate,O
the,O
esophagus,O
.,O

This,O
raised,O
concerns,O
for,O
a,B-PR
hemorrhage,I-PR
",",O
and,O
she,O
was,O
transferred,O
to,O
Verg,O
Medical,O
Center,O
emergently,O
.,O

At,O
the,O
Ingree,O
and,O
Ot,O
of,O
Weamanshy,O
Medical,O
Center,O
",",O
she,O
underwent,O
an,B-TE
emergent,I-TE
CT,I-TE
scan,I-TE
with,O
IV,B-TE
contrast,I-TE
.,O

This,O
revealed,O
no,O
extravasation,B-PR
of,I-PR
contrast,I-PR
and,O
no,O
aortic,B-PR
aneurysm,I-PR
.,O

However,O
",",O
it,O
did,O
show,O
an,B-PR
anterior,I-PR
mediastinal,I-PR
mass,I-PR
compressing,O
the,O
trachea,O
with,O
a,O
density,O
consistent,O
with,O
a,B-PR
hematoma,I-PR
.,O

She,O
was,O
admitted,O
to,O
the,O
Thoracic,O
Surgery,O
Service,O
under,O
the,O
care,O
of,O
Dr.,O
Sccrookes,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Severe,B-PR
hypertension,I-PR
",",O
angina,B-PR
",",O
GERD,B-PR
",",O
peptic,B-PR
ulcer,I-PR
disease,I-PR
",",O
status,O
post,O
Billroth,B-TR
II,I-TR
",",O
ovarian,B-PR
cancer,I-PR
",",O
status,O
post,O
TAH-BSO,B-TR
in,O
1987,O
with,O
a,O
negative,O
second,O
look,O
laparotomy,O
in,O
1988,O
",",O
chronic,B-PR
anemia,I-PR
",",O
chronic,B-PR
left,I-PR
ear,I-PR
infection,I-PR
.,O

MEDICATIONS,O
PRIOR,O
TO,O
ADMISSION,O
:,O

Celexa,B-TR
10,O
mg,O
p.o.,O
q.d.;,O
Lasix,B-TR
40,O
mg,O
p.o.,O
q.d.;,O
Capoten,B-TR
50,O
mg,O
p.o.,O
b.i.d.;,O
Pepcid,B-TR
20,O
mg,O
p.o.,O
q.d.;,O
Cardizem,B-TR
180,O
mg,O
p.o.,O
q.d.;,O
Xanax,B-TR
0.5,O
mg,O
tabs,O
.,O

On,O
transfer,O
",",O
she,O
was,O
on,O
her,B-TR
preadmission,I-TR
medications,I-TR
plus,O
Unasyn,B-TR
and,O
Tigan,B-TR
250,O
mg,O
p.o.,O
q.6h.,O
p.r.n.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

She,O
is,O
divorced,O
and,O
retired,O
.,O

She,O
lives,O
with,O
her,O
daughter,O
",",O
and,O
denies,O
any,O
tobacco,O
or,O
alcohol,O
use,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,O
patient,O
is,O
intubated,B-TR
.,O

VITAL,O
SIGNS,O
:,O

Temperature,B-TE
98.6,O
",",O
66,O
.,O

Right,B-TE
arm,I-TE
was,O
180/80,O
",",O
left,B-TE
188/72,O
",",O
and,O
A-line,B-TE
was,O
151/61,O
.,O

Tidal,B-TR
volume,I-TR
is,O
700,O
with,O
a,B-TR
rate,I-TR
of,O
10,O
",",O
10,O
of,O
pressure,B-TR
support,I-TR
",",O
and,O
10,O
of,O
PEEP,B-TR
",",O
and,O
100%,B-TR
FiO2,I-TR
",",O
satting,O
100%,O
.,O

GENERAL,O
:,O

She,O
was,O
sedated,B-TR
and,O
spontaneously,O
moving,O
all,O
four,O
extremities,O
.,O

NECK,O
:,O

Edematous,B-PR
.,O

Trachea,O
was,O
midline,O
.,O

She,O
had,O
bilateral,B-PR
crepitus,I-PR
in,I-PR
the,I-PR
anterior,I-PR
neck,I-PR
.,O

The,O
superior,O
clavicular,O
area,O
showed,O
no,O
signs,O
of,O
central,B-TR
line,I-TR
access,I-TR
attempts,O
.,O

She,O
had,O
a,B-PR
3,I-PR
cm,I-PR
mobile,I-PR
gelatinous,I-PR
well-circumscribed,I-PR
mass,I-PR
in,I-PR
the,I-PR
right,I-PR
supraclavicular,I-PR
region,I-PR
.,O

Her,O
anterior,O
neck,O
and,O
chest,O
had,O
a,B-PR
1,I-PR
cm,I-PR
to,I-PR
2,I-PR
cm,I-PR
area,I-PR
of,I-PR
ecchymosis,I-PR
.,O

LUNGS,O
:,O

She,O
had,O
bilateral,B-PR
expiratory,I-PR
wheezes,I-PR
.,O

ABDOMEN,O
:,O

Soft,O
with,O
good,O
bowel,O
sounds,O
.,O

It,O
was,O
nontender,B-PR
.,O

It,O
was,O
obese,B-PR
with,O
a,B-PR
large,I-PR
midline,I-PR
defect,I-PR
consistent,O
with,O
a,B-PR
ventral,I-PR
hernia,I-PR
",",O
as,O
well,O
as,O
a,B-PR
smaller,I-PR
anterior,I-PR
defect,I-PR
in,I-PR
the,I-PR
left,I-PR
lower,I-PR
quadrant,I-PR
.,O

Both,O
were,O
easily,O
reducible,O
.,O

PULSE,O
:,O

On,O
the,O
right,O
side,O
",",O
2+,B-TE
femoral,I-TE
",",O
popliteal,B-TE
",",O
DP,B-TE
",",O
PT,B-TE
",",O
and,O
radial,B-TE
;,O
on,O
the,O
left,O
side,O
",",O
2+,B-TE
femoral,I-TE
",",O
popliteal,B-TE
",",O
DP,B-TE
",",O
PT,B-TE
",",O
and,O
radial,B-TE
.,O

LABORATORY,O
DATA,O
:,O

CBC,B-TE
was,O
8.7,O
",",O
25.3,O
",",O
and,O
184,O
.,O

Coags,B-TE
12.2,O
",",O
24.8,O
",",O
and,O
1.0,O
.,O

Her,B-TE
gas,I-TE
was,O
7.47/40/332,O
.,O

Electrolytes,B-TE
were,O
143,O
",",O
3.4,O
",",O
105,O
",",O
28,O
",",O
24,O
",",O
3,O
",",O
and,O
131,O
.,O

EKG,B-TE
showed,O
normal,O
sinus,O
rhythm,O
with,O
left,B-PR
ventricular,I-PR
hypertrophy,I-PR
and,O
incomplete,B-PR
left,I-PR
bundle,I-PR
branch,I-PR
block,I-PR
.,O

CT,B-TE
scan,I-TE
showed,O
an,B-PR
anterior,I-PR
mediastinal,I-PR
mass,I-PR
compressing,O
the,O
trachea,O
with,O
air,O
.,O

It,O
was,O
consistent,O
with,O
a,B-PR
hematoma,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

Ms.,O
Shuffa,O
underwent,O
an,B-TE
EGD,I-TE
and,O
flexible,B-TE
bronchoscopy,I-TE
on,O
9/16/00,O
shortly,O
after,O
she,O
arrived,O
.,O

This,O
showed,O
tracheal,B-PR
compressions,I-PR
but,O
no,O
other,B-PR
lesions,I-PR
that,O
were,O
obvious,O
at,O
the,O
time,O
.,O

She,O
was,O
hemodynamically,O
stable,O
and,O
remained,O
on,O
the,B-TR
ventilator,I-TR
.,O

The,O
differential,O
diagnoses,O
at,O
this,O
point,O
consisted,O
of,O
hematoma,B-PR
vs.,O
neoplasm,B-PR
vs.,O
an,B-PR
abscess,I-PR
vs.,O
a,B-PR
thyroid,I-PR
tumor,I-PR
.,O

On,O
9/22/00,O
",",O
she,O
underwent,O
a,B-TE
cervical,I-TE
mediastinoscopy,I-TE
.,O

A,B-TE
biopsy,I-TE
of,O
this,B-PR
mass,I-PR
was,O
consistent,O
with,O
hematoma,B-PR
.,O

The,O
operative,O
report,O
shows,O
that,O
there,O
was,O
an,B-PR
abnormal,I-PR
area,I-PR
below,I-PR
the,I-PR
trachea,I-PR
to,O
the,O
left,O
which,O
represented,O
a,O
cavity,O
between,O
the,O
esophagus,O
",",O
trachea,O
",",O
aorta,O
",",O
and,O
spine,O
that,O
was,O
full,O
of,O
clot,B-PR
.,O

There,O
was,O
no,O
active,B-PR
bleeding,I-PR
at,O
the,O
time,O
.,O

Over,O
the,O
next,O
several,O
days,O
",",O
the,O
patient,O
remained,O
hemodynamically,O
stable,O
on,O
the,B-TR
ventilator,I-TR
.,O

She,O
had,O
an,B-PR
elevated,I-PR
calcium,I-PR
level,I-PR
that,O
raised,O
the,O
suspicion,O
that,O
this,B-PR
mass,I-PR
could,O
be,O
a,B-PR
hematoma,I-PR
coming,O
from,O
a,B-PR
ruptured,I-PR
parathyroid,I-PR
adenoma,I-PR
.,O

The,B-TE
ionized,I-TE
calcium,I-TE
was,O
elevated,B-PR
as,O
was,O
the,B-TE
parathormone,I-TE
level,I-TE
.,O

Given,O
these,O
findings,O
",",O
she,O
underwent,O
a,B-TE
Sestamibi,I-TE
scan,I-TE
.,O

The,B-TE
Sestamibi,I-TE
scan,I-TE
showed,O
findings,O
that,O
were,O
consistent,O
with,O
a,B-PR
parathyroid,I-PR
adenoma,I-PR
in,I-PR
the,I-PR
right,I-PR
lobe,I-PR
of,O
the,O
thyroid,O
.,O

At,O
this,O
time,O
",",O
it,O
was,O
believed,O
that,O
her,B-PR
clot,I-PR
was,O
due,O
to,O
a,B-PR
rupture,I-PR
of,O
this,B-PR
parathyroid,I-PR
adenoma,I-PR
.,O

Dr.,O
Ear,O
brought,O
the,O
patient,O
to,O
the,O
operating,O
room,O
on,O
10/5/00,O
.,O

She,O
underwent,O
a,B-TE
parathyroid,I-TE
exploration,I-TE
with,O
resection,B-TR
of,O
a,B-PR
ruptured,I-PR
ectopic,I-PR
right,I-PR
upper,I-PR
parathyroid,I-PR
adenoma,I-PR
",",O
a,B-TE
biopsy,I-TE
of,I-TE
a,I-TE
normal,I-TE
left,I-TE
and,I-TE
right,I-TE
lower,I-TE
parathyroids,I-TE
",",O
resection,B-TR
of,I-TR
a,I-TR
left,I-TR
upper,I-TR
parathyroid,I-TR
",",O
and,O
tracheostomy,B-TR
.,O

She,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
and,O
was,O
transferred,O
back,O
to,O
the,O
Surgical,O
Intensive,O
Care,O
Unit,O
with,O
her,B-TR
new,I-TR
tracheostomy,I-TR
working,O
well,O
.,O

Her,O
postoperative,O
course,O
was,O
complicated,O
by,O
serosanguineous,B-PR
pleural,I-PR
effusion,I-PR
on,I-PR
the,I-PR
left,I-PR
.,O

This,O
required,O
a,B-TR
chest,I-TR
tube,I-TR
.,O

Her,B-TE
hematocrit,I-TE
continued,O
to,O
drop,O
over,O
the,O
next,O
couple,O
of,O
days,O
despite,O
normal,O
platelet,O
count,O
",",O
normal,O
coags,O
",",O
and,O
no,O
obvious,O
source,O
of,O
bleeding,B-PR
.,O

It,O
was,O
believed,O
that,O
she,O
was,O
continuing,O
to,O
bleed,B-PR
in,I-PR
her,I-PR
chest,I-PR
.,O

However,O
",",O
we,O
are,O
not,O
quite,O
sure,O
why,O
this,O
was,O
occurring,O
.,O

She,O
underwent,O
an,B-TE
extensive,I-TE
workup,I-TE
by,O
Hematology,O
that,O
revealed,O
a,B-PR
bleeding,I-PR
diatheses,I-PR
of,O
unknown,O
etiology,O
.,O

It,O
turns,O
out,O
that,O
several,O
people,O
in,O
her,O
family,O
have,O
a,B-PR
similar,I-PR
bleeding,I-PR
diathesis,I-PR
of,O
unknown,O
etiology,O
.,O

In,O
conclusion,O
",",O
by,O
systems,O
:,O

1.,O
Neuro,O
.,O

The,O
patient,O
became,O
intermittently,B-PR
agitated,I-PR
.,O

We,O
have,O
been,O
giving,O
her,B-TR
Haldol,I-TR
at,O
bedtime,O
as,O
well,O
as,O
Ativan,B-TR
p.r.n.,O
throughout,O
the,O
day,O
.,O

She,O
responds,O
well,O
to,O
this,O
.,O

She,O
speaks,O
some,O
English,O
and,O
seems,O
to,O
understand,O
more,O
than,O
she,O
speaks,O
.,O

She,O
has,O
a,O
family,O
member,O
who,O
is,O
present,O
for,O
approximately,O
12,O
hours,O
each,O
day,O
.,O

She,O
has,O
been,O
very,O
helpful,O
in,O
translating,O
and,O
seems,O
to,O
say,O
that,O
Ms.,O
Shuffa,O
is,O
in,O
good,O
spirits,O
.,O

2.,O
Cardiac,O
.,O

The,B-TE
patient,I-TE
&apos;s,I-TE
blood,I-TE
pressure,I-TE
has,O
been,O
ranging,O
from,O
approximately,O
140,O
to,O
160,O
systolic,O
.,O

This,O
is,O
on,O
a,O
current,O
regimen,O
of,O
Lopressor,B-TR
25,O
mg,O
per,O
NG,B-TR
tube,I-TR
t.i.d.,O
as,O
well,O
as,O
Diltiazem,B-TR
60,O
mg,O
per,O
NG,B-TR
tube,I-TR
t.i.d.,O
",",O
and,O
lisinopril,B-TR
10,O
mg,O
per,O
NG,B-TR
tube,I-TR
q.d.,O
She,O
occasionally,O
gets,O
hypertensive,B-PR
when,O
she,O
is,O
agitated,B-PR
.,O

For,O
this,O
",",O
we,O
have,O
given,O
her,O
10,O
mg,O
of,O
hydralazine,B-TR
.,O

Her,B-TE
blood,I-TE
pressure,I-TE
responds,O
well,O
to,O
this,O
.,O

Otherwise,O
",",O
she,O
is,O
in,O
normal,O
sinus,O
rhythm,O
and,O
has,O
been,O
hemodynamically,O
stable,O
throughout,O
her,O
hospitalization,O
.,O

The,O
patient,O
developed,O
a,B-PR
left,I-PR
femoral,I-PR
artery,I-PR
pseudoaneurysm,I-PR
after,O
placement,B-TR
of,I-TR
a,I-TR
Greenfield,I-TR
filter,I-TR
.,O

This,O
has,O
been,O
followed,O
by,O
the,O
Vascular,O
Surgery,O
Service,O
here,O
at,O
the,O
Ingree,O
and,O
Ot,O
of,O
Weamanshy,O
Medical,O
Center,O
.,O

Dr.,O
Lenni,O
Lung,O
has,O
been,O
consulted,O
.,O

The,B-PR
aneurysm,I-PR
at,O
the,O
time,O
of,O
discharge,O
is,O
approximately,O
2.5,O
cm,O
.,O

They,O
elected,O
not,O
to,O
inject,O
it,O
with,O
thrombin,B-TR
.,O

They,O
asked,O
that,O
the,O
patient,O
follow-up,O
with,O
Dr.,O
Ear,O
in,O
approximately,O
three,O
to,O
four,O
weeks,O
so,O
that,O
this,B-PR
aneurysm,I-PR
can,O
be,O
assessed,O
.,O

They,O
have,O
opted,O
for,O
conservative,O
management,O
given,O
the,O
size,O
.,O

3.,O
Respiratory,O
.,O

At,O
the,O
time,O
of,O
discharge,O
",",O
the,O
patient,O
remained,O
on,O
CPAP,B-TR
with,O
a,B-TR
PEEP,I-TR
of,O
7.5,O
and,O
a,B-TR
pressure,I-TR
support,I-TR
of,O
9,O
.,O

She,O
seems,O
to,O
be,O
tolerating,O
this,O
well,O
as,O
she,O
has,O
an,B-TE
O2,I-TE
sat,I-TE
of,O
100%,O
on,O
40%,B-TR
FIO2,I-TR
.,O

Her,B-TE
chest,I-TE
x-ray,I-TE
shows,O
a,B-PR
left,I-PR
lower,I-PR
lobe,I-PR
hematoma,I-PR
that,O
had,O
greatly,O
improved,O
in,O
the,O
last,O
few,O
days,O
.,O

Her,O
right,O
lung,O
field,O
is,O
clear,O
.,O

Her,B-TR
tracheostomy,I-TR
is,O
functioning,O
well,O
",",O
and,O
we,O
have,O
had,O
no,O
problems,B-PR
with,O
it,O
.,O

She,O
will,O
obviously,O
need,O
to,O
be,O
weaned,O
as,O
tolerated,O
.,O

We,O
had,O
her,O
down,O
to,O
a,B-TR
low,I-TR
pressure,I-TR
support,I-TR
of,O
7,O
in,O
the,O
last,O
week,O
.,O

With,O
the,B-TR
pressure,I-TR
support,I-TR
at,O
7,O
",",O
she,O
became,O
tachypneic,B-PR
and,O
had,O
to,O
be,O
brought,O
back,O
up,O
to,O
10,O
.,O

Her,B-TE
oxygen,I-TE
saturation,I-TE
has,O
always,O
been,O
good,O
.,O

4.,O
GI,O
.,O

The,O
patient,O
is,O
getting,O
tube,B-TR
feeds,I-TR
via,O
her,B-TR
NG,I-TR
tube,I-TR
of,O
full,B-TR
strength,I-TR
Jevity,I-TR
of,O
75,O
cc,O
per,O
hour,O
.,O

This,O
is,O
her,O
goal,O
.,O

She,O
tolerates,O
them,O
very,O
well,O
and,O
has,O
approximately,O
200,O
cc,O
to,O
300,O
cc,O
of,O
stool,O
per,O
day,O
.,O

Last,O
week,O
",",O
she,O
had,O
copious,B-PR
amounts,I-PR
of,I-PR
stool,I-PR
in,O
the,O
range,O
of,O
500,O
cc,O
to,O
1000,O
cc,O
of,O
liquid,O
stool,O
per,O
day,O
.,O

Stool,B-TE
cultures,I-TE
have,O
been,O
sent,O
numerous,O
times,O
as,O
well,O
as,O
analysis,B-TE
for,O
C.,B-PR
difficile,I-PR
toxin,I-PR
.,O

These,O
have,O
all,O
been,O
negative,O
.,O

We,O
believe,O
the,O
this,O
was,O
an,B-PR
osmotic,I-PR
diarrhea,I-PR
.,O

Since,O
her,B-TR
tube,I-TR
feeds,I-TR
have,O
been,O
changed,O
from,O
full,B-TR
strength,I-TR
Nephro,I-TR
to,O
Jevity,B-TR
",",O
her,B-PR
diarrhea,I-PR
has,O
resolved,O
.,O

She,O
has,O
been,O
taking,O
Zantac,B-TR
",",O
and,O
the,B-TE
pH,I-TE
of,I-TE
her,I-TE
NG,I-TE
tube,I-TE
residuals,I-TE
have,O
been,O
in,O
the,O
5,O
to,O
8,O
range,O
.,O

5.,O
GU,O
.,O

The,O
patient,O
has,O
had,O
hypernatremia,B-PR
.,O

She,O
is,O
approximately,O
10,O
kg,O
up,O
her,O
overall,O
body,O
weight,O
.,O

We,O
believe,O
her,O
to,O
still,O
be,O
total,B-PR
body,I-PR
overloaded,I-PR
.,O

Over,O
the,O
last,O
several,O
days,O
",",O
we,O
have,O
been,O
giving,O
her,O
approximately,O
500,O
cc,O
to,O
1000,O
cc,O
of,O
free,B-TR
water,I-TR
through,O
her,B-TR
NG,I-TR
tube,I-TR
.,O

We,O
also,O
have,O
been,O
diuresing,O
her,O
with,O
Bumex,B-TR
.,O

This,O
seems,O
to,O
trend,O
her,B-TE
sodium,I-TE
down,O
.,O

This,O
will,O
need,O
to,O
be,O
monitored,O
closely,O
.,O

Her,B-TE
BUN,I-TE
and,O
creatinine,B-TE
have,O
been,O
normal,O
",",O
and,O
she,O
has,O
always,O
made,O
good,O
urine,O
.,O

6.,O
Heme,O
.,O

As,O
stated,O
before,O
",",O
the,O
patient,O
continued,O
to,O
ooze,O
into,O
her,O
pleural,O
space,O
well,O
after,O
her,B-TR
definitive,I-TR
operation,I-TR
.,O

She,O
had,O
an,B-TE
extensive,I-TE
workup,I-TE
by,O
Hematology,O
which,O
revealed,O
a,B-PR
bleeding,I-PR
diathesis,I-PR
of,O
unknown,O
origin,O
.,O

Before,O
we,O
removed,O
her,B-TR
chest,I-TR
tube,I-TR
",",O
we,O
had,O
to,O
give,O
her,B-TR
platelets,I-TR
.,O

She,O
had,O
no,O
problems,B-PR
with,O
this,O
.,O

At,O
the,O
time,O
of,O
discharge,O
",",O
her,B-TE
hematocrit,I-TE
is,O
stable,O
in,O
the,O
28,O
to,O
33,O
range,O
.,O

I,O
stress,O
that,O
she,O
cannot,O
be,O
anticoagulated,B-TR
.,O

We,O
have,O
given,O
her,B-TR
Lovenox,I-TR
in,O
the,O
past,O
",",O
and,O
she,O
continues,O
to,O
bleed,O
.,O

Therefore,O
",",O
she,O
is,O
on,O
no,O
DVT,B-TR
prophylaxis,I-TR
.,O

She,O
does,O
have,O
a,B-PR
left,I-PR
iliac,I-PR
deep,I-PR
vein,I-PR
thrombosis,I-PR
.,O

She,O
has,O
a,B-TR
Greenfield,I-TR
filter,I-TR
in,O
place,O
",",O
and,O
this,O
is,O
her,O
only,O
DVT,B-TR
prophylaxis,I-TR
.,O

7.,O
ID,O
.,O

At,O
the,O
time,O
of,O
discharge,O
",",O
the,O
patient,O
has,O
a,B-PR
urinary,I-PR
tract,I-PR
infection,I-PR
.,O

She,O
is,O
growing,O
Enterobacter,B-PR
cloacae,I-PR
that,O
is,O
sensitive,O
only,O
to,O
Macrodantin,B-TR
from,O
her,B-TE
urine,I-TE
cultures,I-TE
.,O

Interestingly,O
enough,O
",",O
she,O
also,O
has,O
Enterobacter,B-PR
cloacae,I-PR
growing,O
out,O
of,O
her,O
sputum,O
.,O

This,O
is,O
also,O
sensitive,O
only,O
to,O
Macrodantin,B-TR
.,O

We,O
do,O
not,O
believe,O
that,O
she,O
has,O
any,B-PR
respiratory,I-PR
process,I-PR
going,O
on,O
at,O
the,O
time,O
.,O

She,O
is,O
just,O
begun,O
on,O
Macrodantin,B-TR
at,O
the,O
day,O
of,O
discharge,O
and,O
should,O
continue,O
100,O
mg,O
per,O
NG,B-TR
tube,I-TR
q.i.d.,O
for,O
a,O
ten,O
day,O
course,O
.,O

Her,B-TR
Foley,I-TR
was,O
changed,O
the,O
day,O
before,O
discharge,O
.,O

8.,O
Tubes,B-TR
",",O
lines,B-TR
",",O
and,O
drains,B-TR
.,O

The,O
patient,O
has,O
a,B-TR
tracheostomy,I-TR
",",O
NG,B-TR
tube,I-TR
",",O
and,O
a,B-TR
Foley,I-TR
catheter,I-TR
.,O

Her,B-TR
central,I-TR
line,I-TR
",",O
which,O
was,O
left,B-TR
subclavian,I-TR
quad,I-TR
lumen,I-TR
",",O
was,O
removed,O
on,O
the,O
day,O
of,O
discharge,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Albuterol,B-TR
nebulizers,I-TR
2.5,O
mg,O
q.4h.,O
and,O
Atrovent,B-TR
nebulizers,I-TR
0.5,O
mg,O
q.4h.,O
",",O
please,O
alternate,O
albuterol,B-TR
and,O
Atrovent,B-TR
;,O
Rocaltrol,B-TR
0.25,O
mcg,O
per,O
NG,B-TR
tube,I-TR
q.d.;,O
calcium,B-TR
carbonate,I-TR
1250,O
mg,O
per,O
NG,B-TR
tube,I-TR
q.i.d.;,O
vitamin,B-TR
B12,I-TR
1000,O
mcg,O
IM,O
q.,O
month,O
",",O
next,O
dose,O
is,O
due,O
Nov,O
18,O
;,O
diltiazem,B-TR
60,O
mg,O
per,O
NG,B-TR
tube,I-TR
t.i.d.;,O
ferrous,B-TR
sulfate,I-TR
300,O
mg,O
per,O
NG,B-TR
t.i.d.;,O
Haldol,B-TR
5,O
mg,O
IV,O
q.h.s.;,O
hydralazine,B-TR
10,O
mg,O
IV,O
q.6h.,O
p.r.n.,O
hypertension,B-PR
;,O
lisinopril,B-TR
10,O
mg,O
per,O
NG,B-TR
tube,I-TR
q.d.;,O
Ativan,B-TR
1,O
mg,O
per,O
NG,B-TR
tube,I-TR
q.h.s.;,O
Lopressor,B-TR
25,O
mg,O
per,O
NG,B-TR
tube,I-TR
t.i.d.;,O
Zantac,B-TR
150,O
mg,O
per,O

CONDITION,O
:,O

Stable,O
",",O
with,O
active,B-PR
problems,I-PR
being,O
respiratory,B-PR
failure,I-PR
",",O
urinary,B-PR
tract,I-PR
infection,I-PR
",",O
and,O
bleeding,B-PR
diathesis,I-PR
.,O

DISCHARGE,O
LABS,O
:,O

On,O
the,O
day,O
of,O
discharge,O
",",O
sodium,B-TE
145,O
",",O
potassium,B-TE
4.1,O
",",O
chloride,B-TE
109,O
",",O
bicarb,B-TE
31,O
",",O
creatinine,B-TE
0.7,O
",",O
BUN,B-TE
43,O
",",O
glucose,B-TE
116,O
.,O

CBC,B-TE
14.9,O
",",O
29.2,O
(,O
which,O
is,O
stable,O
),O
",",O
and,O
398,O
.,O

PT,B-TE
12,O
",",O
PTT,B-TE
27,O
",",O
and,O
INR,B-TE
1.0,O
.,O

Magnesium,B-TE
of,O
1.9,O
.,O

Calcium,B-TE
8.1,O
.,O

COMPLICATIONS,O
:,O

None,O
.,O

DISPOSITION,O
:,O

The,O
patient,O
is,O
being,O
discharged,O
to,O
an,O
acute,O
rehab,O
facility,O
.,O

She,O
should,O
follow-up,O
with,O
Dr.,O
Ryna,O
Jescdrig,O
as,O
well,O
as,O
Dr.,O
Lenni,O
Lung,O
in,O
the,O
Vascular,O
Surgery,O
Department,O
in,O
approximately,O
three,O
to,O
four,O
weeks,O
.,O

Please,O
call,O
the,O
Surgical,O
Intensive,O
Care,O
Unit,O
at,O
Verg,O
Medical,O
Center,O
for,O
any,O
further,O
details,O
that,O
may,O
be,O
needed,O
.,O

You,O
can,O
also,O
page,O
Sta,O
Lung,O
",",O
M.D.,O
as,O
I,O
am,O
the,O
dictating,O
physician,O
who,O
has,O
been,O
taking,O
care,O
of,O
Ms.,O
Shuffa,O
for,O
quite,O
some,O
time,O
now,O
.,O

I,O
would,O
be,O
happy,O
to,O
answer,O
any,O
questions,O
.,O

My,O
pager,O
number,O
at,O
Verg,O
Medical,O
Center,O
is,O
number,O
54930,O
.,O

Dictated,O
By,O
:,O

STA,O
LUNG,O
",",O
M.D.,O
HU53,O

Attending,O
:,O

RYNA,O
R.,O
JESCDRIG,O
",",O
M.D.,O
GN3,O
QE555/1531,O

Batch,O
:,O

77428,O

Index,O
No.,O
DXXJ8U8529,O

D,O
:,O

11/03/00,O

T,O
:,O

11/03/00,O

Admission,O
Date,O
:,O

2015-01-19,O

Discharge,O
Date,O
:,O

2015-01-22,O

Date,O
of,O
Birth,O
:,O

1948-02-29,O

Sex,O
:,O

F,O

Service,O
:,O

CCU,O

DISCHARGE,O
SUMMARY,O
ADDENDUM,O
:,O
The,O
patient,O
during,O
her,O
admission,O
from,O
2015-01-19,O
to,O
2015-01-22,O
during,O
that,O
admission,O
she,O
had,O
an,B-TE
echocardiogram,I-TE
which,O
revealed,O
essentially,O
an,B-TE
ejection,I-TE
fraction,I-TE
of,O
40%,O
with,O
a,B-PR
patent,I-PR
foramen,I-PR
ovale,I-PR
mildly,B-PR
dilated,I-PR
left,I-PR
atrium,I-PR
.,O

It,O
also,O
showed,O
intraseptal,B-PR
and,I-PR
inferior,I-PR
akinesis,I-PR
.,O

Additionally,O
because,O
of,O
her,O
history,O
of,O
contrast,B-PR
allergy,I-PR
",",O
she,O
was,O
given,O
Solu-Medrol,B-TR
40,O
milligrams,O
IV,O
prior,O
to,O
the,B-TR
procedure,I-TR
.,O

She,O
did,O
not,O
have,O
any,B-PR
untoward,I-PR
affects,I-PR
or,O
allergic,B-PR
reactions,I-PR
to,O
the,B-TR
procedure,I-TR
.,O

Barbara,O
Gallant,O
",",O
M.D.,O

66-480,O

Dictated,O
By,O
:,O
Troy,O
X.,O
Hall,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2015-03-12,O
18:30,O

T,O
:,O
2015-03-16,O
11:19,O

JOB,O
#:,O
24204,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Barbara,O
Rogers,O
on,O
:,O
WED,O
2015-03-25,O
9:51,O
AM,O

(,O
End,O
of,O
Report,O
),O

801499036,O

FIH,O

3380885,O

04891/6516,O

412982,O

06/06/1993,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

06-06-93,O

DISCHARGE,O
DATE,O
:,O

06-07-93,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
68,O
year,O
old,O
male,O
status,O
post,O
three,O
and,O
a,O
half,O
cycles,O
of,O
adjuvant,B-TR
EAP,I-TR
chemotherapy,I-TR
.,O

He,O
had,O
a,O
good,O
response,O
to,O
preoperative,B-TR
therapy,I-TR
and,O
negative,O
nodes,O
",",O
and,O
is,O
admitted,O
for,O
the,O
final,O
portion,O
of,O
his,B-TR
postoperative,I-TR
cycles,I-TR
.,O

His,B-TR
chemotherapy,I-TR
the,O
week,O
before,O
was,O
decreased,O
because,O
the,B-TE
white,I-TE
blood,I-TE
count,I-TE
dropped,O
to,O
2.8,O
.,O

In,O
the,O
interim,O
",",O
the,B-TE
white,I-TE
blood,I-TE
count,I-TE
rose,O
again,O
to,O
4.2,O
with,O
a,B-TE
hematocrit,I-TE
of,O
30.5,O
",",O
platelet,B-TE
count,I-TE
of,O
196,O
thousand,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
physical,B-TE
examination,I-TE
on,O
admission,O
",",O
the,B-TE
blood,I-TE
pressure,I-TE
was,O
146/80,O
",",O
weight,B-TE
146,O
",",O
temperature,B-TE
98.6,O
",",O
and,O
pulse,B-TE
of,O
92,O
.,O

The,O
skin,O
was,O
normal,O
.,O

The,O
neck,O
was,O
supple,O
.,O

The,B-TE
cardiac,I-TE
examination,I-TE
demonstrated,O
single,O
S1,O
",",O
S2,O
",",O
no,O
murmurs,B-PR
.,O

The,O
lungs,O
were,O
clear,O
.,O

The,B-TE
abdominal,I-TE
examination,I-TE
was,O
within,O
normal,O
limits,O
.,O

The,O
extremities,O
were,O
normal,O
.,O

The,B-TE
neurological,I-TE
examination,I-TE
was,O
nonfocal,O
.,O

LABORATORY,O
DATA,O
:,O

The,B-TE
creatinine,I-TE
was,O
1.3,O
and,O
dropping,O
to,O
1.1,O
.,O

The,B-TE
bilirubin,I-TE
was,O
0.2,O
",",O
SGOT,B-TE
20,O
",",O
magnesium,B-TE
of,O
1.4,O
.,O

The,B-TE
white,I-TE
blood,I-TE
count,I-TE
was,O
4.0,O
",",O
platelet,B-TE
count,I-TE
190,O
",",O
with,O
62%,O
polys,B-TE
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
treated,O
with,O
Adriamycin,B-TR
25,O
mg,O
",",O
Cis-platinum,B-TR
40,O
mg,O
",",O
preceded,O
by,O
Mannitol,B-TR
12.5,O
grams,O
intravenous,O
bolus,O
",",O
and,O
Zofran,B-TR
11,O
mg,O
on,O
two,O
occasions,O
given,O
as,O
an,B-TR
antiemetic,I-TR
.,O

The,B-TR
chemotherapy,I-TR
was,O
well,O
tolerated,O
.,O

DOCTORS,O
DISCHARGE,O
ORDERS,O
:,O

1.,O
Intravenous,B-TR
chemotherapy,I-TR
",",O

2.,O
adenocarcinoma,B-PR
of,I-PR
the,I-PR
distal,I-PR
esophagus,I-PR
",",O

3.,O
mild,B-PR
hypomagnesemia,I-PR
.,O

SPECIAL,O
PROCEDURES,O
AND,O
OPERATIONS,O
:,O

Intravenous,B-TR
antibiotics,I-TR
chemotherapy,I-TR
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Slow-Mag,B-TR
2,O
tablets,O
PO,O
bid,O
",",O
Ativan,B-TR
1,O
mg,O
sublingually,O
q4h,O
prn,O
nausea,B-PR
.,O

GUABENFRANDA,O
D.,O
PO,O
",",O
M.D.,O

TR,O
:,O

ff,O
/,O
bmot,O

DD,O
:,O

06-07-93,O

TD,O
:,O

06/09/93,O

CC,O
:,O

Admission,O
Date,O
:,O

2012-09-26,O

Discharge,O
Date,O
:,O

2012-10-01,O

Date,O
of,O
Birth,O
:,O

2012-09-26,O

Sex,O
:,O

M,O

Service,O
:,O

NEONATOLOGY,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
5235,O
-,O
gram,O
full-term,O
male,O
infant,O
of,O
a,O
diabetic,O
mother,O
born,O
by,O
repeat,B-TR
cesarean,I-TR
section,I-TR
to,O
a,O
29-year-old,O
gravida,O
1,O
",",O
para,O
2,O
",",O
woman,O
.,O

Prenatal,B-TE
screens,I-TE
benign,O
.,O

Group,B-TE
B,I-TE
strep,I-TE
status,I-TE
negative,O
.,O

Pregnancy,O
complicated,O
by,O
insulin-dependent,B-PR
gestational,I-PR
diabetes,I-PR
.,O

Apgar,B-TE
scores,I-TE
were,O
8,O
at,O
1,O
minute,O
and,O
9,O
at,O
5,O
minutes,O
.,O

The,O
infant,O
admitted,O
to,O
the,O
Neonatal,O
Intensive,O
Care,O
Unit,O
for,O
a,B-TE
dextrose,I-TE
stick,I-TE
of,O
20,O
in,O
the,O
delivery,O
room,O
.,O

PHYSICAL,O
EXAMINATION,O
ON,O
ADMISSION,O
:,O

Birth,B-TE
weight,I-TE
was,O
5235,O
grams,O
",",O
length,B-TE
was,O
56,O
cm,O
",",O
and,O
head,B-TE
circumference,I-TE
was,O
37.5,O
cm,O
.,O

Anterior,O
fontanel,O
open,O
and,O
flat,O
.,O

The,O
palate,O
was,O
intact,O
.,O

Nares,O
were,O
patent,O
.,O

Bilateral,B-TE
breath,I-TE
sounds,I-TE
were,O
clear,O
and,O
equal,O
.,O

No,O
grunting,B-PR
",",O
flaring,B-PR
",",O
or,O
retracting,B-PR
.,O

No,O
murmurs,B-PR
.,O

A,O
regular,O
rate,O
and,O
rhythm,O
.,O

Pink,O
and,O
well,O
perfused,O
.,O

The,O
abdomen,O
was,O
soft,O
and,O
nondistended,B-PR
.,O

There,O
was,O
no,O
hepatosplenomegaly,B-PR
.,O

There,O
was,O
a,O
3-vessel,O
cord,O
.,O

The,O
spine,O
was,O
intact,O
.,O

The,O
anus,O
was,O
patent,O
.,O

Normal,O
male,O
genitalia,O
.,O

Tone,O
was,O
appropriate,O
for,O
gestational,O
age,O
.,O

SUMMARY,O
OF,O
HOSPITAL,O
COURSE,O
BY,O
ISSUES-SYSTEM,O
:,O

RESPIRATORY,O
:,O

The,O
infant,O
has,O
remained,O
on,O
room,O
air,O
throughout,O
his,O
hospitalization,O
with,O
oxygen,B-TE
saturations,I-TE
of,O
greater,O
than,O
95,O
percent,O
.,O

Respiratory,B-TE
rates,I-TE
have,O
been,O
40,O
s,O
to,O
60,O
s.,O

The,O
infant,O
has,O
had,O
two,B-PR
spontaneous,I-PR
desaturations,I-PR
which,O
quickly,O
self-resolved,O
on,O
day,O
of,O
life,O
one,O
.,O

No,O
other,O
issues,O
.,O

No,O
apnea,B-PR
or,O
bradycardia,B-PR
.,O

CARDIOVASCULAR,O
:,O

The,O
infant,O
has,O
remained,O
hemodynamically,O
stable,O
with,O
heart,B-TE
rates,I-TE
in,O
the,O
120,O
s,O
to,O
140,O
s,O
and,O
mean,B-TE
blood,I-TE
pressures,I-TE
of,O
57,O
to,O
60,O
.,O

FLUIDS,O
",",O
ELECTROLYTES,O
AND,O
NUTRITION,O
:,O

The,O
infant,O
was,O
admitted,O
to,O
the,O
Neonatal,O
Intensive,O
Care,O
Unit,O
for,O
treatment,B-TR
of,O
hypoglycemia,B-PR
.,O

The,O
infant,O
was,O
started,O
on,O
enteral,B-TR
feedings,I-TR
of,O
Enfamil,B-TR
20,I-TR
calories,I-TR
per,I-TR
ounce,I-TR
by,O
mouth,O
ad,O
lib,O
and,O
maintained,O
glucoses,B-TE
in,O
the,O
middle,O
to,O
high,O
40,O
s,O
taking,O
by,B-TR
mouth,I-TR
feedings,I-TR
every,O
two,O
to,O
three,O
hours,O
by,O
mouth,O
ad,O
lib,O
.,O

On,O
day,O
of,O
life,O
one,O
",",O
the,O
infant,O
had,O
a,B-TE
dextrose,I-TE
stick,I-TE
of,O
34,O
.,O

At,O
that,O
time,O
",",O
an,B-TR
intravenous,I-TR
of,O
D-10-W,B-TR
was,O
started,O
at,O
80,O
cc,O
/,O
kilogram,O
per,O
day,O
.,O

On,O
day,O
of,O
life,O
two,O
",",O
the,O
infant,O
began,O
to,O
wean,O
off,O
intravenous,B-TR
fluids,I-TR
",",O
and,O
this,O
was,O
completed,O
by,O
day,O
of,O
life,O
four,O
.,O

Calories,O
were,O
increased,O
to,O
Similac,B-TR
24,I-TR
calories,I-TR
per,I-TR
ounce,I-TR
.,O

Before,O
discharge,O
to,O
the,O
Newborn,O
Nursery,O
",",O
the,O
infant,O
was,O
taking,O
Similac,B-TR
22,I-TR
calories,I-TR
per,I-TR
ounce,I-TR
by,O
mouth,O
ad,O
lib,O
and,O
maintaining,O
dextrose,B-TE
sticks,I-TE
in,O
the,O
60,O
s.,O

Weight,B-TE
on,O
discharge,O
was,O
5200,O
grams,O
.,O

GASTROINTESTINAL,O
:,O

No,O
issues,O
.,O

HEMATOLOGY,O
:,O

No,O
issues,O
.,O

NEUROLOGY,O
:,O

Normal,O
neurologic,O
examination,O
.,O

SCREENS,O
:,O

A,B-TE
hearing,I-TE
screen,I-TE
was,O
performed,O
with,O
automated,B-TE
auditory,I-TE
brain,I-TE
stem,I-TE
responses,I-TE
and,O
the,O
infant,O
passed,O
on,O
both,O
ears,O
.,O

PSYCHOSOCIAL,O
:,O

The,O
parents,O
are,O
involved,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
on,O
room,O
air,O
.,O

DISCHARGE,O
DISPOSITION,O
:,O

To,O
Newborn,O
Nursery,O
.,O

PRIMARY,O
PEDIATRICIAN,O
:,O

Dr.,O
Tamatha,O
-,O
Cape,O
Cod,O
Hospital,O
.,O

CARE,O
RECOMMENDATIONS,O
:,O

1.,O
Feedings,O
at,O
discharge,O
:,O

Similac,B-TR
22,I-TR
calories,I-TR
per,I-TR
ounce,I-TR
by,O
mouth,O
ad,O
lib,O
with,O
a,O
goal,O
of,O
decreasing,O
to,O
20,B-TR
calories,I-TR
per,I-TR
ounce,I-TR
for,O
dextrose,B-TE
sticks,I-TE
of,O
greater,O
than,O
60,O
.,O

2.,O
Medications,B-TR
:,O

None,O
.,O

3.,O
A,B-TE
state,I-TE
newborn,I-TE
screen,I-TE
was,O
sent,O
on,O
day,O
of,O
life,O
three,O
;,O
the,O
results,O
are,O
pending,O
.,O

4.,O
Received,O
hepatitis,B-TR
B,I-TR
vaccine,I-TR
on,O
2012-09-30,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Large,B-PR
for,I-PR
gestational,I-PR
age,I-PR
.,O

2.,O
Infant,O
of,O
a,O
diabetic,O
mother,O
.,O

3.,O
Hypoglycemia,B-PR
.,O

Reviewed,O
By,O
:,O

Mary,O
Karina,O
",",O
Oregon,O
30621,O

Dictated,O
By,O
:,O
James,O
H.,O
Acosta,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2012-10-02,O
15:46:05,O

T,O
:,O
2012-10-02,O
17:14:44,O

Job,O
#:,O
07783,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Richard,O
Stripling,O
on,O
:,O
Maxine,O
2012-10-25,O
8:30,O
PM,O

(,O
End,O
of,O
Report,O
),O

811533262,O
SC,O

77894566,O

9188280,O

6/30/2006,O
12:00:00,O
AM,O

Primary,B-TR
c,I-TR
/,I-TR
s,I-TR
for,O
breech,B-PR

DIS,O

Admission,O
Date,O
:,O

06/30/2006,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

07/04/2006,O

******,O
FINAL,O
DISCHARGE,O
ORDERS,O
******,O

OBEFYFE,O
",",O
TREE,O

373-78-78-7,O
O38,O

Room,O
:,O

DEALPERSANDERSWAUKE,O
MISSJEANES,O
MACOMTOMA,O
GLANDSTATE,O
MEDICAL,O
CENTER,O

Service,O
:,O

OBS,O

DISCHARGE,O
PATIENT,O
ON,O
:,O

Independence,O
Day,O
AT,O
10:00,O
AM,O

CONTINGENT,O
UPON,O

Attending,B-TE
evaluation,I-TE

WILL,O
D,O
/,O
C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D,O
/,O
C,O
SUMMARY,O
:,O

YES,O

Attending,O
:,O

PO,O
",",O
IEDEARC,O
J,O
",",O
M.D.,O

DISPOSITION,O
:,O

Home,O

DISCHARGE,O
MEDICATIONS,O
:,O

IBUPROFEN,B-TR
400-600,O
MG,O
PO,O
Q6H,O
PRN,O
Pain,B-PR

Food,O
/,O
Drug,O
Interaction,O
Instruction,O

Take,O
with,O
food,O

OXYCODONE,B-TR
5-10,O
MG,O
PO,O
Q3H,O
PRN,O
Pain,B-PR

Instructions,O
:,O

If,O
pt,O
received,O
post,B-TR
partum,I-TR
spinal,I-TR
morphine,I-TR
",",O
DO,O
NOT,O
administer,O
Oxycodone,B-TR
for,O
18,O
hours,O
after,O
morphine,B-TR
administration,I-TR
.,O

PRENATAL,B-TR
MULTIVITAMINS,I-TR
(,I-TR
STUARTNATAL,I-TR
),I-TR
1,O

TAB,O
PO,O
DAILY,O
DIET,O
:,O

No,O
Restrictions,O

ACTIVITY,O
:,O

Resume,O
regular,O
exercise,O

FOLLOW,O
UP,O
APPOINTMENT,O
(,O
S,O
),O
:,O

PH,O
Po,O
6,O
wks,O
",",O

ALLERGY,O
:,O

Penicillins,B-TR

ADMIT,O
DIAGNOSIS,O
:,O

Breech,B-PR
failed,I-PR
version,I-PR
Pregnancy,I-PR

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O

Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O
Primary,B-TR
c,I-TR
/,I-TR
s,I-TR
for,O
breech,B-PR

OTHER,O
DIAGNOSIS,O
;,O

Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O

scheduled,B-TR
c,I-TR
/,I-TR
s,I-TR
for,O
breech,B-PR

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

Vaginal,B-TR
delivery,I-TR
:,O

Undelivered,B-PR

Cesarean,O
Status,O
:,O

Primary,O

Urgency,O
:,O

Scheduled,O

Indications,O
:,O

Breech,B-PR
",",O

Uterine,B-TR
incision,I-TR
type,I-TR
:,O

Transverse,O

Placenta,O
:,O

Delivery,O
:,O

Manual,O

Condition,O
:,O

Normal,O

Staff,O
Obstetrician,O
(,O
supervising,O
),O
:,O

PO,O
",",O
IEDEARC,O
J,O
",",O
M.D.,O
Delivery,O

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O

none,O

BRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

G1,O
T0,O
P0,O
A0,O
L0,O

Estimated,O
EDC,O
:,O

2007-09-06,O

Maternal,O
transfer,O
:,O

No,O

Initial,B-TE
newborn,I-TE
exam,I-TE
:,O

No,O
observed,B-PR
abnormalities,I-PR

ADDITIONAL,O
COMMENTS,O
:,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O

TO,O
DO,O
/,O
PLAN,O
:,O

No,O
dictated,O
summary,O

ENTERED,O
BY,O
:,O

PO,O
",",O
IEDEARC,O
J,O
",",O
M.D.,O
(,O
NH10,O
),O
06/30/06,O
09:55,O
AM,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

1191042,O

Admission,O
Date,O
:,O

2015-04-21,O

Discharge,O
Date,O
:,O

2015-04-29,O

Date,O
of,O
Birth,O
:,O

2015-04-21,O

Sex,O
:,O

M,O

Service,O
:,O

CMED,O

HISTORY,O
:,O

Baby,O
Daniel,O
Holman,O
was,O
born,O
at,O
39,O
and,O
3/7,O
weeks,O
gestation,O
(,O
EDC,O
2015-04-25,O
).,O

His,O
mother,O
is,O
a,O
31-year-old,O
female,O
gravida,O
2,O
",",O
para,O
1,O
",",O
now,O
2,O
.,O

Prenatal,B-TE
screens,I-TE
:,O
blood,B-TE
type,I-TE
A,O
positive,O
",",O
antibody,B-TE
negative,O
",",O
rubella,B-TE
immune,O
",",O
RPR,B-TE
nonreactive,O
",",O
hepatitis,B-TE
B,I-TE
surface,I-TE
antigen,I-TE
negative,O
",",O
GBS,B-TE
unknown,O
.,O

He,O
was,O
born,O
by,O
repeat,B-TR
C-section,I-TR
.,O

There,O
was,O
artificial,B-TR
rupture,I-TR
of,I-TR
membranes,I-TR
was,O
performed,O
at,O
the,B-TR
delivery,I-TR
.,O

Amniotic,O
fluid,O
was,O
clear,O
.,O

Mother,O
received,O
epidural,B-TR
and,O
spinal,B-TR
anesthesia,I-TR
.,O

Baby,O
was,O
vigorous,O
at,O
birth,O
and,O
received,O
routine,O
DR,O
Johnson,O
.,O

Apgars,B-TE
were,O
9,O
and,O
9,O
at,O
1,O
and,O
5,O
minutes,O
.,O

He,O
was,O
transferred,O
to,O
the,O
newborn,O
nursery,O
for,O
further,B-TR
care,I-TR
.,O

In,O
the,O
newborn,O
nursery,O
he,O
was,O
started,O
on,O
PO,B-TR
feedings,I-TR
on,O
demand,O
.,O

He,O
was,O
noted,O
to,O
be,O
large,B-PR
for,I-PR
gestational,I-PR
age,I-PR
with,O
a,B-TE
weight,I-TE
of,O
4525,O
grams,O
.,O

His,B-TE
d-sticks,I-TE
were,O
greater,O
than,O
80,O
.,O

At,O
5,O
hours,O
of,O
life,O
he,O
was,O
noted,O
to,O
have,O
grunting,B-PR
and,O
flaring,B-PR
and,O
E.C.,O
Bovell,O
consult,O
was,O
done,O
.,O

He,O
was,O
in,O
mild,B-PR
respiratory,I-PR
distress,I-PR
and,O
a,O
diagnosis,O
of,O
transient,B-PR
tachypnea,I-PR
of,I-PR
the,I-PR
newborn,I-PR
was,O
made,O
.,O

He,O
was,O
observed,O
in,O
the,O
nursery,O
for,O
progression,B-PR
of,I-PR
symptoms,I-PR
.,O

At,O
16,O
hours,O
of,O
life,O
he,O
was,O
noted,O
to,O
have,O
increased,B-PR
work,I-PR
of,I-PR
breathing,I-PR
with,O
tachypnea,B-PR
",",O
flaring,B-PR
and,O
grunting,B-PR
.,O

He,O
was,O
also,O
noted,O
to,O
have,O
axillary,B-TE
temperature,I-TE
of,O
100.4,O
and,O
a,B-TE
rectal,I-TE
temperature,I-TE
of,O
100.9,O
.,O

At,O
this,O
point,O
CMED,O
was,O
consulted,O
again,O
and,O
he,O
was,O
transferred,O
to,O
the,O
CMED,O
triage,O
for,O
further,B-TR
care,I-TR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Birth,B-TE
weight,I-TE
of,O
4525,O
grams,O
which,O
is,O
greater,O
than,O
90th,O
percentile,O
;,O
length,B-TE
54,O
cm,O
which,O
is,O
greater,O
than,O
90th,O
percentile,O
;,O
head,B-TE
circumference,I-TE
37,O
cm,O
which,O
is,O
greater,O
than,O
90th,O
percentile,O
.,O

D-sticks,B-TE
of,O
117,O
.,O

Large,B-PR
for,I-PR
gestational,I-PR
age,I-PR
appearance,I-PR
of,O
an,O
infant,O
with,O
tachypnea,B-PR
",",O
grunting,B-PR
and,O
flaring,B-PR
.,O

HEENT,O
:,O
Anterior,O
fontanel,O
open,O
and,O
flat,O
.,O

Bilateral,B-TE
red,I-TE
reflexes,I-TE
.,O

Patent,O
nares,O
.,O

Mild,B-PR
flaring,I-PR
.,O

Neck,O
supple,O
.,O

Clavicles,O
stable,O
.,O

RESPIRATORY,O
:,O
Tachypneic,B-PR
with,O
mild,B-PR
retractions,I-PR
",",O
increased,B-PR
work,I-PR
of,I-PR
breathing,I-PR
",",O
clear,O
and,O
equal,O
breath,O
sounds,O
.,O

CARDIOVASCULAR,O
:,O
Normal,O
rate,O
and,O
rhythm,O
.,O

Normal,O
S1,O
and,O
S2,O
without,O
murmur,B-PR
.,O

Brachial,B-TE
pulses,I-TE
equal,O
femoral,B-TE
pulses,I-TE
and,O
are,O
2+,O
.,O

ABDOMEN,O
:,O
Soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
.,O

No,O
hepatosplenomegaly,B-PR
.,O

Patent,O
anus,O
.,O

Umbilical,O
stump,O
dry,O
.,O

GENITALIA,O
:,O
Normal,O
male,O
.,O

Testes,O
distended,O
bilaterally,O
.,O

NEUROLOGIC,O
:,O
Alert,O
and,O
crying,O
.,O

Normal,O
tone,O
and,O
neonatal,B-TE
reflexes,I-TE
.,O

EXTREMITIES,O
:,O
Warm,O
and,O
pink,O
.,O

Moves,O
all,O
extremities,O
well,O
.,O

Hips,O
stable,O
.,O

Skin,O
pink,O
and,O
capillary,B-TE
refill,I-TE
less,O
than,O
2,O
seconds,O
.,O

Spine,O
straight,O
and,O
no,O
abnormalities,B-PR
.,O

SUMMARY,O
OF,O
HOSPITAL,O
COURSE,O
BY,O
SYSTEMS,O
:,O

RESPIRATORY,O
:,O
The,O
infant,O
was,O
placed,O
on,O
CPAP,B-TR
on,O
admission,O
to,O
the,O
CMED,O
and,O
remained,O
on,O
CPAP,B-TR
until,O
day,O
of,O
life,O
2,O
at,O
which,O
time,O
he,O
weaned,O
to,O
nasal,B-TR
cannula,I-TR
and,O
then,O
subsequently,O
to,O
room,O
air,O
on,O
day,O
of,O
life,O
3,O
.,O

He,O
has,O
remained,O
on,O
room,O
air,O
since,O
that,O
time,O
and,O
has,O
had,O
no,O
issues,O
with,O
apnea,B-PR
or,O
desaturation,B-PR
since,O
being,O
on,O
room,O
air,O
.,O

Initial,B-TE
chest,I-TE
x-ray,I-TE
in,O
the,O
CMED,O
showed,O
haziness,B-PR
in,I-PR
the,I-PR
left,I-PR
lower,I-PR
lobe,I-PR
and,O
patchy,B-PR
areas,I-PR
on,I-PR
the,I-PR
right,I-PR
side,I-PR
consistent,O
with,O
concerns,O
for,O
pneumonia,B-PR
.,O

The,O
infant,O
was,O
treated,O
for,O
pneumonia,B-PR
from,O
admission,O
to,O
the,O
CMED,O
.,O

CARDIOVASCULAR,O
:,O
The,O
infant,O
has,O
maintained,O
stable,O
cardiovascular,O
status,O
with,O
normal,O
heart,O
rates,O
and,O
blood,B-TE
pressures,I-TE
and,O
no,O
murmurs,B-PR
.,O

FLUIDS,O
",",O
ELECTROLYTES,O
AND,O
NUTRITION,O
:,O
The,O
infant,O
was,O
started,O
on,O
IV,B-TR
fluids,I-TR
on,O
admission,O
to,O
the,O
CMED,O
.,O

Electrolytes,B-TE
were,O
measured,O
on,O
day,O
of,O
life,O
2,O
and,O
were,O
stable,O
at,O
that,O
time,O
.,O

No,O
further,B-TE
electrolytes,I-TE
have,O
been,O
measured,O
.,O

Enteral,B-TR
feedings,I-TR
were,O
initiated,O
on,O
day,O
of,O
life,O
3,O
and,O
the,O
infant,O
has,O
been,O
ad,B-TR
lib,I-TR
PO,I-TR
feeding,I-TR
on,O
demand,O
since,O
that,O
time,O
.,O

His,B-TE
discharge,I-TE
weight,I-TE
is,O
4180,O
grams,O
.,O

GASTROINTESTINAL,O
:,O

Bilirubin,B-TE
level,I-TE
was,O
peaked,O
on,O
day,O
of,O
life,O
4,O
to,O
10.9/0.3,O
.,O

He,O
has,O
required,O
no,O
phototherapy,B-TR
.,O

HEMATOLOGY,O
:,O
Hematocrit,B-TE
was,O
done,O
on,O
admission,O
to,O
the,O
CMED,O
.,O

Hematocrit,B-TE
was,O
41,O
",",O
platelet,B-TE
count,I-TE
of,O
"404,000",O
.,O

No,O
further,O
hematocrit,B-TE
or,O
platelets,B-TE
have,O
been,O
measured,O
.,O

Blood,B-TE
typing,I-TE
has,O
been,O
done,O
on,O
this,O
infant,O
.,O

The,B-TE
baby,I-TE
's,I-TE
blood,I-TE
type,I-TE
is,O
B,O
negative,O
",",O
antibody,B-TE
negative,O
.,O

INFECTIOUS,O
DISEASE,O
:,O
CBC,B-TE
and,O
blood,B-TE
culture,I-TE
were,O
screened,O
on,O
admission,O
.,O

CBC,B-TE
was,O
benign,O
with,O
"22,000",O
whites,B-TE
",",O
80,O
poly,B-TE
"'s,",I-TE
0,O
bands,B-TE
",",O
15,O
lymphs,B-TE
.,O

Ampicillin,B-TR
and,O
gentamycin,B-TR
were,O
initiated,O
on,O
admission,O
and,O
an,B-TE
LP,I-TE
was,O
done,O
due,O
to,O
the,O
clinical,O
issues,O
of,O
respiratory,B-PR
distress,I-PR
and,O
fever,B-PR
on,O
admission,O
to,O
the,O
CMED,O
.,O

CSF,B-TE
showed,O
white,B-TE
count,I-TE
of,O
7,O
",",O
reds,B-TE
4,O
",",O
protein,B-TE
119,O
",",O
glucose,B-TE
69,O
.,O

The,O
infant,O
was,O
treated,O
for,O
7,O
days,O
of,O
presumed,O
pneumonia,B-PR
with,O
ampicillin,B-TR
and,O
gentamycin,B-TR
.,O

Antibiotics,B-TR
were,O
discontinued,O
on,O
the,O
evening,O
of,O
2015-04-28,O
.,O

NEUROLOGY,O
:,O
The,O
infant,O
has,O
maintained,O
a,O
normal,O
neurologic,O
examination,O
.,O

SENSORY,O
:,O
Hearing,B-TE
screen,I-TE
was,O
performed,O
with,O
automated,B-TE
auditory,I-TE
brain,I-TE
stem,I-TE
responses,I-TE
and,O
the,O
results,O
was,O
the,O
infant,O
passing,O
in,O
both,O
ears,O
.,O

PSYCHOSOCIAL,O
:,O
A,O
Arbour,O
Hospital,O
social,O
worker,O
has,O
been,O
involved,O
with,O
the,O
family,O
.,O

The,O
contact,O
social,O
worker,O
can,O
be,O
reached,O
at,O
(,O
374,O
),O
419-2007,O
.,O

There,O
are,O
no,O
active,B-PR
ongoing,I-PR
issues,I-PR
at,O
this,O
time,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

DISCHARGE,O
DISPOSITION,O
:,O

Home,O
with,O
the,O
parents,O
.,O

NAME,O
OF,O
PRIMARY,O
PEDIATRICIAN,O
:,O

Dr.,O
Gene,O
Hardy,O
from,O
Webster,O
Pediatrics,O
.,O

Telephone,O
No.,O
:,O
(,O
309,O
),O
642-6861,O
fax,O
(,O
515,O
),O
568-6798,O
.,O

CARE,O
RECOMMENDATIONS,O
:,O

1.,O
Ad,B-TR
lib,I-TR
PO,I-TR
feedings,I-TR
of,O
Similac,B-TR
20,I-TR
cal,I-TR
/,I-TR
oz,I-TR
with,I-TR
iron,I-TR
.,O

2.,O
Medications,B-TR
:,O
None,O
.,O

3.,O
State,B-TE
newborn,I-TE
screen,I-TE
was,O
sent,O
on,O
2015-04-24,O
and,O
results,O
are,O
pending,O
.,O

4.,O
Immunizations,B-TR
received,O
:,O
Hepatitis,B-TR
B,I-TR
vaccine,I-TR
was,O
given,O
on,O

5.,O
Immunizations,B-TR
Recommended,O
:,O

6.,O
Synagis,B-TR
RSV,I-TR
prophylaxis,I-TR
should,O
be,O
considered,O
from,O
November,O
through,O
March,O
for,O
infants,O
who,O
meet,O
any,O
of,O
the,O
following,O
three,O
criteria,O
.,O

A.,O
Born,O
at,O
less,O
than,O
32,O
weeks,O
gestation,O
.,O

B.,O
Born,O
between,O
32,O
and,O
35,O
weeks,O
gestation,O
with,O
two,O
of,O
the,O
following,O
:,O

daycare,O
during,O
the,O
RSV,O
season,O
a,O
smoker,O
in,O
the,O
household,O
",",O
neuromuscular,B-PR
disease,I-PR
",",O
airway,B-PR
abnormalities,I-PR
",",O
or,O
school,O
age,O
siblings,O

C.,O
with,O
chronic,B-PR
lung,I-PR
disease,I-PR
.,O

7.,O
Influenza,B-TR
immunization,I-TR
is,O
recommended,O
annually,O
in,O
the,O
fall,O
for,O
all,O
infants,O
once,O
they,O
reach,O
6,O
months,O
of,O
age,O
.,O

Before,O
this,O
age,O
and,O
for,O
the,O
first,O
24,O
months,O
of,O
the,O
child,O
's,O
life,O
",",O
immunization,B-TR
against,O
influenza,B-PR
is,O
recommended,O
for,O
household,O
contacts,O
and,O
out,O
of,O
home,O
caregivers,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Presumed,O
pneumonia,B-PR
",",O
treated,O
.,O

2.,O
Large,B-PR
for,I-PR
gestational,I-PR
age,I-PR
term,O
male,O
.,O

3.,O
Respiratory,B-PR
distress,I-PR
",",O
resolved,O
.,O

4.,O
Mild,B-PR
hyperbilirubinemia,I-PR
",",O
resolving,O
.,O

Claudia,O
Ernest,O
",",O
MD,O
50AAD,O

Dictated,O
By,O
:,O
Stan,O
C.,O
Haaz,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2015-04-28,O
23:50:08,O

T,O
:,O
2015-04-29,O
02:50:40,O

Job,O
#:,O
76623,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Maria,O
L,O
Ulabarro,O
on,O
:,O
WED,O
2015-04-29,O
2:21,O
PM,O

(,O
End,O
of,O
Report,O
),O

825280108,O
PUMC,O

2717701,O

366967,O

8348653,O

9/9/2003,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Report,O
Status,O
:,O

Signed,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

GUYNLORDSMANTDOUET,O
",",O
ARYRISTE,O
T,O

UNIT,O
NUMBER,O
:,O

566-45-49,O

ADMISSION,O
DATE,O
:,O

09/09/2003,O

DISCHARGE,O
DATE,O
:,O

09/12/2003,O

PRINCIPLE,O
DIAGNOSIS,O
:,O

Infrarenal,B-PR
abdominal,I-PR
aortic,I-PR
aneurysm,I-PR
.,O

ASSOCIATED,O
DIAGNOSES,O
:,O

1.,O
Hypertension,B-PR
;,O

2.,O
Gastroesophageal,B-PR
reflux,I-PR
disease,I-PR
;,O

3.,O
Osteoarthritis,B-PR
.,O

PRINCIPLE,O
PROCEDURE,O
:,O

Endovascular,B-TR
repair,I-TR
of,O
abdominal,B-PR
aortic,I-PR
aneurysm,I-PR
with,O
bifurcated,B-TR
device,I-TR
on,O
September,O
9,O
",",O
2003,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
an,O
84,O
year,O
old,O
male,O
",",O
with,O
a,O
history,O
of,O
hypertension,B-PR
",",O
who,O
was,O
discovered,O
to,O
have,O
an,B-PR
asymptomatic,I-PR
7,I-PR
cm,I-PR
abdominal,I-PR
aortic,I-PR
aneurysm,I-PR
on,O
CT,B-TE
scan,I-TE
obtained,O
in,O
the,O
emergency,O
room,O
back,O
in,O
May,O
.,O

At,O
that,O
time,O
he,O
had,O
presented,O
with,O
abdominal,B-PR
pain,I-PR
",",O
and,O
was,O
found,O
to,O
have,O
acute,B-PR
cholecystectomy,I-PR
.,O

He,O
underwent,O
an,B-TR
uncomplicated,I-TR
laparoscopic,I-TR
cholecystectomy,I-TR
.,O

He,O
presents,O
at,O
this,O
time,O
for,O
endovascular,B-TR
repair,I-TR
of,O
this,B-PR
abdominal,I-PR
aortic,I-PR
aneurysm,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Hypertension,B-PR
;,O

2.,O
Gastroesophageal,B-PR
reflux,I-PR
disease,I-PR
;,O

3.,O
H.,B-PR
pylori,I-PR
positive,I-PR
",",O
status,O
post,O
therapy,B-TR
;,O

4.,O
Osteoarthritis,B-PR
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

1.,O
Craniotomy,B-TR
for,O
meningoma,B-PR
",",O
February,O
",",O
1994,O
;,O

2.,O
Laparoscopic,B-TR
cholecystectomy,I-TR
in,O
May,O
",",O
2002,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

1.,O
Aspirin,B-TR
81,O
mg,O
PO,O
qd,O
;,O

2.,O
Atenolol,B-TR
25,O
mg,O
PO,O
qd,O
;,O

3.,O
Protonics,B-TR
40,O
mg,O
PO,O
qd,O
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
quit,O
smoking,O
30,O
years,O
ago,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Blood,B-TE
pressure,I-TE
152/74,O
",",O
pulse,B-TE
60,O
",",O
respirations,B-TE
16,O
.,O

He,O
is,O
71,O
inches,O
tall,O
",",O
196,O
lbs,O
.,O

He,O
has,O
no,O
carotid,B-PR
bruits,I-PR
.,O

Lungs,O
were,O
clear,O
bilaterally,O
.,O

Heart,O
is,O
regular,O
rate,O
and,O
rhythm,O
",",O
without,O
murmur,B-PR
.,O

Abdomen,O
is,O
soft,O
",",O
nontender,B-PR
with,O
a,B-PR
pulsatile,I-PR
mass,I-PR
in,I-PR
the,I-PR
epigastrium,I-PR
.,O

Extremities,O
reveals,O
a,B-TE
2+,I-TE
femoral,I-TE
and,I-TE
pedal,I-TE
pulses,I-TE
bilaterally,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
Vascular,O
Surgery,O
Service,O
as,O
a,O
same,O
day,O
admission,O
",",O
and,O
taken,O
to,O
the,O
operating,O
room,O
for,O
an,B-TR
uncomplicated,I-TR
endovascular,I-TR
repair,I-TR
of,O
his,B-PR
abdominal,I-PR
aortic,I-PR
aneurysm,I-PR
",",O
and,O
Anurx,B-TR
modular,I-TR
bifurcated,I-TR
graft,I-TR
was,O
placed,O
",",O
and,O
both,O
common,O
femoral,O
arteries,O
were,O
repaired,O
in,O
the,O
usual,O
fashion,O
.,O

He,O
had,O
pulsatile,B-TE
pulse,I-TE
volume,I-TE
recordings,I-TE
",",O
in,O
both,O
lower,O
extremities,O
",",O
and,O
both,O
renal,O
arteries,O
were,O
noted,O
to,O
be,O
patent,O
",",O
as,O
were,O
both,O
internal,O
iliac,O
arteries,O
.,O

His,B-TE
angiogram,I-TE
in,O
the,O
operating,O
room,O
",",O
revealed,O
no,O
evidence,O
of,O
an,B-PR
endo,I-PR
leak,I-PR
.,O

Postoperatively,O
",",O
his,O
course,O
was,O
relatively,O
uncomplicated,O
.,O

He,O
did,O
have,O
an,O
episode,O
of,O
a,B-PR
prolonged,I-PR
sinus,I-PR
pause,I-PR
in,O
the,O
recovery,O
room,O
",",O
which,O
resulted,O
in,O
transient,B-PR
loss,I-PR
of,I-PR
consciousness,I-PR
.,O

He,O
responded,O
to,O
a,B-TR
Neo-Synephrine,I-TR
bolus,I-TR
",",O
and,O
had,O
no,O
further,B-PR
complications,I-PR
from,O
this,O
standpoint,O
.,O

Dr.,O
Rosean,O
Fletcher,O
",",O
of,O
the,O
Cardiology,O
Department,O
was,O
consulted,O
",",O
and,O
it,O
was,O
his,O
opinion,O
that,O
the,B-PR
sinus,I-PR
pause,I-PR
was,O
related,O
to,O
increased,B-PR
vagal,I-PR
tone,I-PR
postoperatively,O
",",O
perhaps,O
secondary,O
to,O
the,B-TR
epidural,I-TR
",",O
as,O
well,O
as,O
the,B-TR
patient,I-TR
&apos;s,I-TR
Atenolol,I-TR
use,I-TR
.,O

His,B-TR
Atenolol,I-TR
was,O
held,O
",",O
and,O
he,O
had,O
no,O
further,B-PR
pauses,I-PR
during,O
his,O
stay,O
.,O

His,B-TE
postoperative,I-TE
CT,I-TE
scan,I-TE
showed,O
no,O
evidence,O
of,O
endo,B-PR
leak,I-PR
",",O
or,O
graft,B-PR
kinking,I-PR
.,O

He,O
maintained,O
good,O
peripheral,O
pulses,O
and,O
warm,O
feet,O
postoperatively,O
.,O

However,O
",",O
he,O
did,O
develop,O
significant,B-PR
ecchymosis,I-PR
in,I-PR
both,I-PR
groins,I-PR
",",O
extending,O
down,O
into,O
his,O
scrotum,O
.,O

There,O
was,O
no,O
evidence,O
of,O
significant,B-PR
groin,I-PR
hematomas,I-PR
.,O

He,O
tolerated,O
a,O
regular,O
diet,O
.,O

His,B-PR
pain,I-PR
was,O
adequately,O
controlled,O
with,O
oral,B-TR
medications,I-TR
.,O

Accordingly,O
",",O
the,O
patient,O
was,O
discharged,O
to,O
home,O
on,O
postoperative,O
day,O
2,O
.,O

He,O
will,O
be,O
visited,O
by,O
LDAMC,O
for,O
blood,B-TE
pressure,I-TE
and,O
incision,B-TE
checks,I-TE
.,O

He,O
will,O
follow,O
up,O
with,O
Dr.,O
Dye,O
in,O
the,O
Clinic,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Admission,B-TR
medications,I-TR
.,O

YERTREY,O
TANELI,O
SUMCHIRDKAYSMAVVEINDREPS,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

Electronically,O
Signed,O
ALEN,O
LAA,O
CREDKOTE,O
",",O
M.D.,O

09/30/2003,O
13:34,O

_____________________________,O
ALEN,O
LAA,O
CREDKOTE,O
",",O
M.D.,O

TR,O
:,O

ruw,O

DD,O
:,O

09/11/2003,O

TD,O
:,O

09/12/2003,O
2:23,O
P,O
366967,O

cc,O
:,O

ALEN,O
LAA,O
CREDKOTE,O
",",O
M.D.,O
",",O
ROSEAN,O
FLETCHER,O
",",O
M.D.,O
",",O
VIENNEE,O
BACK,O
",",O
M.D.,O

Admission,O
Date,O
:,O

2011-11-18,O

Discharge,O
Date,O
:,O

2011-11-22,O

Date,O
of,O
Birth,O
:,O

1950-04-21,O

Sex,O
:,O

M,O

Service,O
:,O

CCU,O

REASON,O
FOR,O
ADMISSION,O
:,O

Acute,B-PR
inferior,I-PR
myocardial,I-PR
infarction,I-PR
and,O
right,B-PR
ventricular,I-PR
infarction,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
61,O
-,O
year-old,O
Caucasian-speaking,O
woman,O
with,O
a,O
history,O
of,O
hypercholesterolemia,B-PR
and,O
tobacco,O
use,O
who,O
developed,O
waxing,B-PR
and,I-PR
waning,I-PR
left,I-PR
substernal,I-PR
chest,I-PR
pain,I-PR
with,O
radiation,B-PR
to,I-PR
the,I-PR
left,I-PR
shoulder,I-PR
on,O
2011-11-17,O
which,O
lasted,O
that,O
entire,O
day,O
.,O

Upon,O
waking,O
on,O
the,O
morning,O
of,O
admission,O
",",O
she,O
had,O
10/10,O
chest,B-PR
pain,I-PR
associated,O
with,O
nausea,B-PR
.,O

She,O
presented,O
to,O
Charlton,O
Memorial,O
Hospital,O
Hospital,O
Emergency,O
Department,O
with,O
inferior,B-PR
ST,I-PR
elevations,I-PR
;,O
at,O
which,O
time,O
she,O
became,O
acutely,B-PR
hypotensive,I-PR
to,O
a,B-TE
systolic,I-TE
blood,I-TE
pressure,I-TE
of,O
70,O
to,O
80,O
after,O
receiving,O
one,O
ublingual,B-TR
nitroglycerin,I-TR
.,O

She,O
then,O
became,O
bradycardic,B-PR
which,O
responded,O
to,O
atropine,B-TR
and,O
intravenous,B-TR
fluids,I-TR
.,O

In,O
addition,O
",",O
she,O
was,O
given,O
aspirin,B-TR
",",O
Plavix,B-TR
",",O
heparin,B-TR
",",O
and,O
morphine,B-TR
.,O

Immediately,O
prior,O
to,O
transfer,O
to,O
Worcester,O
State,O
Hospital,O
",",O
she,O
went,O
into,O
ventricular,B-PR
fibrillation,I-PR
arrest,I-PR
at,O
12:30,O
p.m.,O
",",O
at,O
which,O
time,O
she,O
was,O
intubated,B-TR
and,O
defibrillated,B-TR
back,O
to,O
sinus,O
rhythm,O
after,O
five,B-TR
shocks,I-TR
.,O

She,O
received,O
an,B-TR
amiodarone,I-TR
bolus,I-TR
of,O
150,O
mg,O
intravenously,O
and,O
was,O
continued,O
on,O
an,B-TR
amiodarone,I-TR
drip,I-TR
while,O
CMED,O
CSRU-flighted,O
to,O
Boston,O
Regional,O
Medical,O
Centerr,O
where,O
she,O
underwent,O
a,B-TE
catheterization,I-TE
.,O

The,B-TE
cardiac,I-TE
catheterization,I-TE
revealed,O
a,B-PR
total,I-PR
occlusion,I-PR
of,I-PR
the,I-PR
proximal,I-PR
right,I-PR
coronary,I-PR
artery,I-PR
and,O
diffuse,B-PR
right,I-PR
coronary,I-PR
artery,I-PR
disease,I-PR
.,O

She,O
received,O
three,B-TR
stents,I-TR
to,I-TR
the,I-TR
right,I-TR
coronary,I-TR
artery,I-TR
which,O
was,O
complicated,O
by,O
a,B-PR
proximal,I-PR
dissection,I-PR
.,O

She,O
had,O
good,O
post,B-TE
percutaneous,I-TE
coronary,I-TE
intervention,I-TE
angiographic,I-TE
results,I-TE
.,O

Incidentally,O
",",O
an,B-TE
aortogram,I-TE
during,O
the,B-TE
catheterization,I-TE
revealed,O
a,B-PR
Debakey,I-PR
class,I-PR
I,I-PR
aortic,I-PR
ascending,I-PR
aneurysm,I-PR
",",O
and,O
the,O
patient,O
had,O
a,B-TE
pulmonary,I-TE
capillary,I-TE
wedge,I-TE
pressure,I-TE
of,O
20,O
at,O
the,O
time,O
of,O
catheterization,B-TE
.,O

She,O
was,O
transferred,O
to,O
the,O
Coronary,O
Care,O
Unit,O
in,O
stable,O
condition,O
and,O
still,O
intubated,B-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Hypercholesterolemia,B-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

""",O
Flumaran,B-TR
"",O
for,O
circulatory,B-PR
problems,I-PR
.",O

She,O
receives,O
this,B-TR
medication,I-TR
by,O
mail,O
from,O
her,O
relatives,O
in,O
Jill,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
TO,O
CORONARY,O
CARE,O
0408398,O
.,O

Amiodarone,B-TR
drip,I-TR
.,O

2.,O
Integrilin,B-TR
drip,I-TR
.,O

3.,O
Intravenous,B-TR
fluids,I-TR
.,O

ALLERGIES,O
:,O

A,O
question,O
of,O
a,B-TR
SULFA,I-TR
allergy,B-PR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
lives,O
alone,O
in,O
Woburn,O
.,O

She,O
came,O
from,O
Czech,O
Republic,O
14,O
years,O
ago,O
.,O

She,O
works,O
as,O
a,O
nursing,O
assistant,O
in,O
a,O
nursing,O
home,O
.,O

She,O
smokes,O
approximately,O
one,O
and,O
a,O
half,O
packs,O
of,O
cigarettes,O
per,O
day,O
for,O
the,O
last,O
30,O
years,O
.,O

FAMILY,O
HISTORY,O
:,O

Family,O
history,O
is,O
not,O
significant,O
for,O
any,O
early,O
history,O
of,O
coronary,B-PR
artery,I-PR
disease,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
ON,O
PRESENTATION,O
:,O

Examination,B-TE
on,O
admission,O
to,O
the,O
Coronary,O
Care,O
Unit,O
revealed,O
blood,B-TE
pressure,I-TE
was,O
100/57,O
",",O
with,O
a,B-TE
mean,I-TE
arterial,I-TE
pressure,I-TE
of,O
75,O
",",O
heart,B-TE
rate,I-TE
was,O
sinus,O
rhythm,O
at,O
75,O
",",O
temperature,B-TE
was,O
97.6,O
",",O
oxygen,B-TE
saturation,I-TE
was,O
99%,O
on,O
assist,B-TR
control,I-TR
with,O
a,B-TR
tidal,I-TR
volume,I-TR
of,O
600,O
on,O
60%,O
FIO2,B-TR
",",O
5,O
of,O
positive,B-TR
end-expiratory,I-TR
pressure,I-TR
.,O

In,O
general,O
",",O
she,O
was,O
sedated,B-TR
at,O
the,O
time,O
",",O
responsive,O
to,O
stimuli,O
",",O
and,O
was,O
following,O
commands,O
.,O

She,O
had,O
moist,O
mucous,O
membranes,O
.,O

Her,B-TE
carotids,I-TE
were,O
2+,O
bilaterally,O
.,O

Her,O
lungs,O
were,O
clear,O
to,O
auscultation,B-TE
anteriorly,O
.,O

Her,O
heart,O
revealed,O
a,O
regular,O
rate,O
and,O
rhythm,O
with,O
a,B-PR
faint,I-PR
second,I-PR
heart,I-PR
sound,I-PR
and,O
second,O
heart,O
sound,O
.,O

No,O
audible,B-PR
extra,I-PR
heart,I-PR
sounds,I-PR
.,O

Her,O
abdomen,O
was,O
obese,B-PR
and,O
had,O
positive,O
bowel,O
sounds,O
.,O

It,O
was,O
soft,O
and,O
nontender,B-PR
.,O

She,O
had,O
peripheral,B-PR
edema,I-PR
with,O
2+,B-TE
peripheral,I-TE
pulses,I-TE
bilaterally,I-TE
.,O

PERTINENT,O
LABORATORY,O
DATA,O
ON,O
PRESENTATION,O
:,O

Her,B-TE
laboratories,I-TE
at,O
the,O
time,O
of,O
transfer,O
to,O
Saint,O
Vincent,O
Hospital,O
revealed,O
white,B-TE
blood,I-TE
cell,I-TE
count,I-TE
was,O
11.5,O
",",O
hematocrit,B-TE
was,O
42,O
on,O
admission,O
",",O
platelets,B-TE
were,O
242,O
.,O

Chemistry-7,B-TE
was,O
unremarkable,O
.,O

Creatine,B-TE
kinase,I-TE
on,O
admission,O
was,O
309,O
",",O
with,O
a,B-TE
MB,I-TE
of,O
19.6,O
",",O
an,B-TE
index,I-TE
of,O
6.3,O
",",O
and,O
an,B-TE
initial,I-TE
troponin,I-TE
of,O
0.73,O
.,O

RADIOLOGY,O
/,O
IMAGING,O
:,O

A,B-TE
chest,I-TE
x-ray,I-TE
revealed,O
an,B-PR
enlarged,I-PR
mediastinum,I-PR
with,O
clear,O
lung,O
fields,O
bilaterally,O
.,O

Initial,B-TE
electrocardiogram,I-TE
showed,O
a,O
normal,O
sinus,O
rhythm,O
at,O
65,O
",",O
normal,O
axis,O
",",O
2-mm,B-PR
ST,I-PR
elevations,I-PR
in,I-PR
lead,I-PR
III,I-PR
",",O
1-mm,B-PR
ST,I-PR
elevations,I-PR
in,I-PR
aVF,I-PR
and,I-PR
V1,I-PR
",",O
1-mm,B-PR
ST,I-PR
depressions,I-PR
in,I-PR
I,I-PR
and,I-PR
aVL,I-PR
;,O
consistent,O
with,O
an,B-PR
inferior,I-PR
and,I-PR
right,I-PR
ventricular,I-PR
infarction,I-PR
.,O

Right-sided,B-TE
electrocardiograms,I-TE
showed,O
1-mm,B-PR
ST,I-PR
elevations,I-PR
in,I-PR
V4,I-PR
;,O
consistent,O
with,O
a,B-PR
right,I-PR
ventricular,I-PR
infarct,I-PR
.,O

Electrocardiogram,B-TE
status,O
post,O
percutaneous,B-TR
coronary,I-TR
intervention,I-TR
revealed,O
a,O
normal,O
sinus,O
rhythm,O
at,O
84,O
",",O
with,O
a,O

normal,O
axis,O
",",O
and,O
normalizing,O
of,O
the,B-PR
inferior,I-PR
ST,I-PR
segments,I-PR
",",O
with,O
Q,O
waves,O
evolving,O
in,O
leads,O
III,O
and,O
aVF,O
.,O

An,B-TE
echocardiogram,I-TE
status,O
post,O
percutaneous,B-TR
coronary,I-TR
intervention,I-TR
revealed,O
an,B-PR
akinetic,I-PR
inferior,I-PR
wall,I-PR
and,I-PR
right,I-PR
ventricle,I-PR
",",O
mild,B-PR
mitral,I-PR
regurgitation,I-PR
",",O
and,O
ascending,O
aorta,O
measuring,O
5,O
cm,O
.,O

There,O
was,O
no,O
effusion,B-PR
.,O

HOSPITAL,O
COURSE,O
:,O

1.,O
CARDIOVASCULAR,O
SYSTEM,O
:,O

On,O
the,O
night,O
of,O
admission,O
",",O
the,O
patient,O
experienced,O
post,B-PR
catheterization,I-PR
hypotension,I-PR
which,O
required,O
intravenous,B-TR
fluids,I-TR
and,O
dopamine,B-TR
.,O

Electrocardiogram,B-TE
the,O
following,O
morning,O
revealed,O
normalization,O
of,O
her,O
ST,O
segments,O
with,O
evolution,B-PR
of,I-PR
Q,I-PR
waves,I-PR
.,O

Her,B-TR
dopamine,I-TR
was,O
weaned,O
off,O
the,O
following,O
day,O
",",O
and,O
her,B-TR
heparin,I-TR
was,O
discontinued,O
secondary,O
to,O
a,B-PR
right,I-PR
groin,I-PR
hematoma,I-PR
which,O
had,O
developed,O
after,O
the,B-TR
sheath,I-TR
had,O
been,O
pulled,O
out,O
by,O
the,O
fellow,O
.,O

Her,B-TE
creatine,I-TE
kinases,I-TE
climbed,O
;,O
reaching,O
a,O
peak,O
of,O
3523,O
",",O
which,O
was,O
down,O
to,O
1500,O
at,O
the,O
time,O
of,O
discharge,O
.,O

Also,O
noted,O
on,O
the,O
day,O
of,O
11-20,O
",",O
the,O
patient,O
self-extubated,O
herself,O
.,O

For,O
her,B-PR
coronary,I-PR
artery,I-PR
disease,I-PR
",",O
status,O
post,O
catheterization,B-TE
",",O
she,O
was,O
given,O
Integrilin,B-TR
for,O
18,O
hours,O
.,O

She,O
was,O
continued,O
on,O
aspirin,B-TR
",",O
Plavix,B-TR
",",O
and,O
Lipitor,B-TR
.,O

For,O
her,O
rhythm,O
",",O
amiodarone,B-TR
was,O
discontinued,O
as,O
she,O
was,O
maintained,O
in,O
sinus,O
rhythm,O
after,O
moving,O
to,O
the,O
floor,O
.,O

For,O
pump,O
",",O
once,O
transferred,O
out,O
of,O
the,O
Coronary,O
Care,O
Unit,O
on,O
2011-11-20,O
",",O
a,B-TR
beta,I-TR
blocker,I-TR
was,O
begun,O
at,O
12.5,O
mg,O
of,O
Lopressor,B-TR
p.o.,O
b.i.d.,O
which,O
was,O
titrated,O
to,O
25,O
mg,O
at,O
the,O
time,O
of,O
discharge,O
.,O

Also,O
",",O
at,O
the,O
time,O
of,O
discharge,O
",",O
for,O
increased,B-TR
afterload,I-TR
reduction,I-TR
",",O
she,O
was,O
started,O
on,O
lisinopril,B-TR
5,O
mg,O
p.o.,O
q.d.,O

On,O
2011-11-21,O
",",O
the,O
patient,O
experienced,O
atypical,B-PR
chest,I-PR
pain,I-PR
which,O
was,O
made,O
worse,O
with,O
inspiration,O
and,O
movement,O
.,O

It,O
was,O
not,O
associated,O
with,O
any,B-PR
nausea,I-PR
or,O
vomiting,B-PR
.,O

It,O
did,O
not,O
radiate,O
.,O

It,O
was,O
felt,O
to,O
be,O
pain,B-PR
secondary,O
to,O
her,B-PR
self-extubation,I-PR
and,O
noncardiac,B-PR
chest,I-PR
pain,I-PR
.,O

An,B-TE
electrocardiogram,I-TE
was,O
checked,O
which,O
revealed,O
no,O
ST,B-PR
changes,I-PR
",",O
and,O
there,O
was,O
no,O
increase,O
in,O
her,O
downward,O
trending,O
creatine,B-TE
phosphokinases,I-TE
.,O

No,O
further,B-TR
intervention,I-TR
was,O
done,O
.,O

The,O
patient,O
was,O
treated,O
with,O
Tylenol,B-TR
orally,I-TR
as,O
well,O
as,O
Ativan,B-TR
for,O
anxiety,B-PR
that,O
she,O
had,O
about,O
going,O
home,O
.,O

She,O
was,O
pain,B-PR
free,O
on,O
the,O
day,O
of,O
discharge,O
.,O

Regarding,O
her,B-PR
aortic,I-PR
ascending,I-PR
aneurysm,I-PR
",",O
Cardiothoracic,O
Surgery,O
was,O
consulted,O
regarding,O
further,B-TE
workup,I-TE
.,O

At,O
their,O
request,O
",",O
a,B-TE
CT,I-TE
scan,I-TE
of,I-TE
the,I-TE
chest,I-TE
with,O
contrast,B-TE
was,O
performed,O
on,O
the,O
day,O
of,O
discharge,O
.,O

Dr.,O
Streeter,O
from,O
Cardiothoracic,O
Surgery,O
will,O
follow,O
up,O
with,O
the,O
patient,O
for,O
further,B-TR
management,I-TR
in,O
approximately,O
one,O
month,O
as,O
an,O
outpatient,O
.,O

His,O
office,O
will,O
contact,O
her,O
to,O
make,O
that,O
appointment,O
.,O

2.,O
PULMONARY,O
SYSTEM,O
:,O

As,O
stated,O
above,O
",",O
the,O
patient,O
self-extubated,O
herself,O
.,O

She,O
complained,O
of,O
a,B-PR
sore,I-PR
throat,I-PR
which,O
was,O
likely,O
the,O
etiology,O
of,O
her,B-PR
atypical,I-PR
chest,I-PR
complaints,I-PR
.,O

This,O
resolved,O
with,O
Tylenol,B-TR
and,O
as,O
needed,O
doses,O
of,O
oxycodone,B-TR
.,O

Her,O
lungs,O
remained,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
throughout,O
the,O
remainder,O
of,O
her,O
hospital,O
course,O
.,O

At,O
the,O
time,O
of,O
this,O
dictation,O
",",O
the,B-TE
CT,I-TE
of,I-TE
her,I-TE
chest,I-TE
was,O
still,O
pending,O
.,O

The,O
official,O
result,O
was,O
not,O
yet,O
in,O
.,O

3.,O
FLUIDS,O
/,O
ELECTROLYTES,O
/,O
NUTRITION,O
:,O

The,B-TE
patient,I-TE
's,I-TE
electrolytes,I-TE
sere,O
managed,O
daily,O
and,O
repleted,O
on,O
an,O
as,O
needed,O
basis,O
.,O

She,O
did,O
receive,O
intravenous,B-TR
K-Phos,I-TR
for,O
a,B-PR
low,I-PR
phosphorous,I-PR
of,O
1.5,O
.,O

Her,B-TE
phosphorous,I-TE
rose,O
appropriately,O
to,O
3.6,O
at,O
the,O
time,O
of,O
discharge,O
.,O

DISCHARGE,O
FOLLOWUP,O
:,O

1.,O
The,O
patient,O
has,O
an,O
appointment,O
to,O
initiate,O
primary,O
care,O
",",O
as,O
she,O
no,O
longer,O
had,O
a,O
primary,O
care,O
physician,O
.,O

Claire,O
was,O
to,O
see,O
Dr.,O
Michael,O
Majerowski,O
at,O
the,O
Sturdy,O
Memorial,O
Clinic,O
on,O
the,O
east,O
campus,O
",",O
on,O
Bissonette,O
Six,O
",",O
in,O
the,O
South,O
Suite,O
",",O
on,O
31-05-03,O
at,O
11:30,O
a.m.,O

2.,O
In,O
addition,O
",",O
as,O
stated,O
above,O
",",O
Dr.Hastings,O
office,O
from,O
Cardiothoracic,O
Surgery,O
will,O
be,O
in,O
contact,O
with,O
Ms.,O
Williams,O
to,O
arrange,O
followup,O
for,O
her,B-PR
ascending,I-PR
aortic,I-PR
aneurysm,I-PR
in,O
approximately,O
one,O
month,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

1.,O
Lisinopril,B-TR
5,O
mg,O
p.o.,O
q.d.,O

2.,O
Lopressor,B-TR
25,O
mg,O
p.o.,O
b.i.d.,O

3.,O
Plavix,B-TR
75,O
mg,O
p.o.,O
q.d.,O

4.,O
Lipitor,B-TR
10,O
mg,O
p.o.,O
q.d.,O

5.,O
Protonix,B-TR
40,O
mg,O
p.o.,O
q.d.,O

6.,O
Enteric-coated,B-TR
aspirin,I-TR
325,O
mg,O
p.o.,O
q.d.,O

CONDITION,O
AT,O
DISCHARGE,O
:,O

Condition,O
on,O
discharge,O
was,O
stable,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Inferior,B-PR
myocardial,I-PR
infarction,I-PR
and,O
right,B-PR
ventricular,I-PR
infarction,I-PR
.,O

Status,O
post,O
cardiac,B-TE
catheterization,I-TE
and,O
stents,B-TR
times,O
three,O
of,O
the,O
right,O
coronary,O
artery,O
.,O

2.,O
Hypertension,B-PR
.,O

3.,O
Hypercholesterolemia,B-PR
.,O

Rosemary,O
D,O
Mccluskey,O
",",O
M.D.,O
39-696,O

Dictated,O
By,O
:,O
Harriet,O
E.,O
Evans,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2011-11-22,O
14:09,O

T,O
:,O
2011-11-23,O
11:59,O

JOB,O
#:,O
15087,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Sandra,O
BURGER,O
on,O
:,O
WED,O
2011-11-30,O
9:46,O
AM,O

(,O
End,O
of,O
Report,O
),O

846470157,O

FIH,O

2831385,O

45917/em77,O

71794,O

5/13/1992,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

5-13-92,O

DISCHARGE,O
DATE,O
:,O

5-22-92,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
75,O
year,O
old,O
righthanded,O
Caucasian,O
female,O
who,O
was,O
admitted,O
to,O
the,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
because,O
of,O
left,B-PR
facial,I-PR
droop,I-PR
and,O
hand,B-PR
weakness,I-PR
after,O
glaucoma,B-TR
laser,I-TR
surgery,I-TR
.,O

She,O
was,O
transferred,O
to,O
the,O
Sas,O
General,O
Hospital,O
for,O
further,B-TE
evaluation,I-TE
of,O
some,B-PR
weakness,I-PR
in,O
the,O
setting,O
of,O
multiple,B-PR
medical,I-PR
problems,I-PR
.,O

The,O
patient,O
had,O
o.d.,B-TR
glaucoma,I-TR
surgery,I-TR
",",O
1400,O
hours,O
",",O
on,O
May,O
12th,O
",",O
1992,O
.,O

Soon,O
after,O
surgery,B-TR
",",O
the,O
patient,O
noted,O
her,O
left,O
lower,O
face,O
and,O
hand,O
were,O
weak,B-PR
.,O

She,O
was,O
brought,O
to,O
the,O
emergency,O
room,O
where,O
she,O
was,O
evaluated,O
and,O
determined,O
to,O
have,O
had,O
a,B-PR
cerebrovascular,I-PR
accident,I-PR
.,O

She,O
has,O
absolutely,O
no,O
neurologic,B-PR
disease,I-PR
in,O
past,O
.,O

The,B-TE
review,I-TE
of,I-TE
systems,I-TE
is,O
negative,O
.,O

However,O
",",O
two,O
days,O
prior,O
to,O
admission,O
",",O
one,O
family,O
member,O
noted,O
that,O
the,O
patient,O
had,O
a,B-PR
transient,I-PR
left,I-PR
facial,I-PR
droop,I-PR
.,O

A,B-TE
potassium,I-TE
three,O
days,O
prior,O
to,O
surgery,B-TR
was,O
2.8,O
",",O
the,B-TE
level,I-TE
being,O
normalized,O
with,O
p.o.,B-TR
kay,I-TR
ciel,I-TR
prior,O
to,O
admission,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

The,O
patient,O
has,O
a,O
history,O
of,O
MI,B-PR
in,O
1989,O
",",O
no,O
angina,B-PR
before,O
or,O
after,O
.,O

She,O
had,O
a,O
normal,O
exercise,O
thallium,O
test,O
in,O
08/89,O
",",O
per,O
Ona,O
Hospital,O
.,O

The,O
phone,O
no.,O
at,O
the,O
Ona,O
Hospital,O
is,O
337-4296,O
",",O
936,O
area,O
code,O
.,O

#,O
2.,O
History,O
of,O
M.,B-PR
kansasaii,I-PR
with,O
workup,B-TE
by,O
Dr.,O
Screen,O
at,O
Sas,O
General,O
Hospital,O
proceeding,O
currently,O
.,O

#,O
3.,O
History,O
of,O
breast,B-PR
cancer,I-PR
.,O

In,O
December,O
1990,O
she,O
had,O
a,B-TR
lumpectomy,I-TR
",",I-TR
from,I-TR
left,I-TR
breast,I-TR
",",O
and,O
XRT,B-TR
x,O
35,O
.,O

No,O
axillary,B-TR
dissection,I-TR
was,O
done,O
because,O
she,O
was,O
status,O
post,O
MI,B-PR
.,O

She,O
received,O
Tamoxifen,B-TR
briefly,O
.,O

Mammogram,B-TE
was,O
normal,O
7/92,O
",",O
and,O
5/92,O
.,O

She,O
is,O
allergic,B-PR
to,O
Amoxicillin,B-TR
",",O
having,O
developed,O
a,B-PR
rash,I-PR
",",O
does,O
not,O
smoke,O
",",O
does,O
not,O
drink,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Dyazide,B-TR
one,O
p.o.,O
q.d.,O
Propanolol,B-TR
5,O
mg.,O
p.o.,O
t.i.d.,O
Isordil,B-TR
5,O
mg.,O
p.o.,O
t.i.d.,O
Glaucoma,B-TR
drops,I-TR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

blood,B-TE
pressure,I-TE
118/75,O
",",O
pulse,B-TE
88,O
",",O
respirations,B-TE
20,O
",",O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

Head,B-TE
and,I-TE
neck,I-TE
exam,I-TE
was,O
unremarkable,O
",",O
except,O
for,O
the,O
right,O
eye,O
being,O
patched,O
over,O
.,O

Lungs,O
were,O
clear,O
.,O

Breasts,O
were,O
unremarkable,O
.,O

Back,O
was,O
nontender,B-PR
.,O

Heart,O
exam,O
:,O

regular,O
rate,O
and,O
rhythm,O
",",O
jugular,B-TE
venous,I-TE
pressure,I-TE
was,O
normal,O
",",O
no,O
carotid,B-PR
bruit,I-PR
was,O
noted,O
;,O
murmur,B-PR
",",O
rub,B-PR
",",O
gallop,B-PR
",",O
click,B-PR
and,O
ectopy,B-PR
were,O
absent,O
.,O

Abdomen,O
was,O
benign,O
.,O

Rectal,B-TE
tone,I-TE
was,O
normal,O
",",O
guaiac,B-TE
negative,O
stool,O
.,O

Extremities,O
:,O

without,O
clubbing,B-PR
",",O
cyanosis,B-PR
or,O
edema,B-PR
or,O
stigmata,B-PR
of,O
subacute,B-PR
bacterial,I-PR
endocarditis,I-PR
.,O

Normal,O
pulses,O
were,O
palpated,O
.,O

Neurologic,O
exam,O
:,O

the,O
patient,O
was,O
alert,O
and,O
oriented,O
x,O
4,O
.,O

Extensive,B-TE
mental,I-TE
status,I-TE
testing,I-TE
was,O
normal,O
",",O
except,O
for,O
recalling,O
only,O
one,O
out,O
of,O
three,O
objects,O
at,O
five,O
minutes,O
.,O

There,O
was,O
a,O
touch,O
an,B-PR
anosognosia,I-PR
.,O

Cranial,O
nerve,O
exam,O
:,O

visual,O
fields,O
were,O
full,O
o.s.,O
",",O
visual,B-TE
acuity,I-TE
was,O
20/70,O
o.s.,O

Pupil,B-TE
o.s.,I-TE
reacted,O
to,O
light,O
.,O

EOMs,O
with,O
full,O
range,O
of,O
movement,O
",",O
no,O
nystagmus,B-PR
.,O

VIIth,O
cranial,O
nerve,O
:,O

inferior,B-PR
left,I-PR
weak,I-PR
.,O

No,O
gag,B-PR
was,O
present,O
.,O

Otherwise,O
normal,O
CN,O
&apos;s,O
.,O

DTRs,B-TE
showed,O
a,O
mild,O
decrease,O
in,O
left,B-PR
biceps,I-PR
and,I-PR
brachioradialis,I-PR
reflexes,I-PR
",",O
otherwise,O
normal,O
tone,O
",",O
symmetrical,O
reflexes,O
",",O
downgoing,O
toes,O
.,O

Motor,O
exam,O
:,O

5+,O
throughout,O
",",O
except,O
left,O
hand,O
intrinsic,O
muscles,O
were,O
4+,O
",",O
3+,O
in,O
the,O
middle,O
digits,O
.,O

No,O
atrophy,B-PR
was,O
noted,O
.,O

Sensory,B-TE
exam,I-TE
showed,O
some,O
leftsided,B-PR
errors,I-PR
with,O
pinprick,O
and,O
proprioception,O
.,O

Cerebellar,O
exam,O
:,O

finger,B-TE
/,I-TE
to/nose,I-TE
was,O
with,O
mild,B-PR
dysmetria,I-PR
",",O
exaggerated,O
on,O
tracking,O
;,O
rapid,O
alternating,O
movements,O
normal,O
",",O
heel-to-shin,B-TE
was,O
good,O
with,O
few,B-PR
errors,I-PR
.,O

LABORATORY,O
DATA,O
:,O

Chest,B-TE
xray,I-TE
showed,O
expanded,O
lungs,O
with,O
biapical,B-PR
pulmonary,I-PR
opacities,I-PR
.,O

EKG,B-TE
:,O

left,B-PR
bundle,I-PR
branch,I-PR
block,I-PR
.,O

Urinalysis,B-TE
was,O
unremarkable,O
.,O

BUN,B-TE
27,O
",",O
with,O
a,B-TE
creatinine,I-TE
of,O
.9,O
",",O
glucose,B-TE
was,O
182,O
",",O
but,O
otherwise,O
electrolytes,B-TE
were,O
normal,O
.,O

Her,B-TE
admitting,I-TE
hematocrit,I-TE
was,O
45%,O
",",O
white,B-TE
count,I-TE
"7,700",O
",",O
with,O
an,B-TE
MCV,I-TE
of,O
92,O
",",O
platelets,B-TE
were,O
normal,O
at,O
"263,000",O
.,O

Albumin,B-TE
2.5,O
.,O

HOSPITAL,O
COURSE,O
:,O

#,O
1.,O
cerebrovascular,B-PR
accident,I-PR
.,O

The,O
patient,O
suffered,O
some,B-PR
mild,I-PR
weakness,I-PR
which,O
was,O
attributed,O
to,O
stenosis,B-PR
of,I-PR
the,I-PR
distal,I-PR
right,I-PR
internal,I-PR
carotid,I-PR
artery,I-PR
.,O

This,O
was,O
determined,O
by,O
head,B-TE
CT,I-TE
",",O
head,B-TE
MRI,I-TE
",",O
head,B-TE
MRA,I-TE
",",O
carotid,B-TE
noninvasive,I-TE
studies,I-TE
",",O
transcranial,B-TE
Dopplers,I-TE
.,O

The,O
possibility,O
of,O
a,O
cardiac,O
origin,O
was,O
evaluated,O
by,O
echocardiogram,B-TE
and,O
Holter,B-TE
monitor,I-TE
.,O

Her,B-TE
echocardiogram,I-TE
curiously,O
showed,O
a,O
normal,O
left,O
ventricular,O
size,O
and,O
systolic,O
function,O
",",O
a,B-PR
patent,I-PR
foramen,I-PR
ovale,I-PR
",",O
with,O
a,B-PR
trace,I-PR
right,I-PR
to,I-PR
left,I-PR
shunt,I-PR
",",O
as,O
determined,O
by,O
bubble,B-TE
study,I-TE
",",O
trace,B-PR
MR,I-PR
was,O
present,O
.,O

Previous,B-TE
echoes,I-TE
have,O
shown,O
MVP,B-PR
at,O
the,O
Ona,O
Hospital,O
.,O

Her,B-TE
Holter,I-TE
showed,O
up,O
to,O
12,O
beats,O
of,O
SVT,B-PR
",",O
but,O
was,O
otherwise,O
unremarkable,O
.,O

The,O
patient,O
had,O
a,O
normal,O
B12,O
",",O
negative,O
syphilis,O
serologies,O
and,O
normal,O
thyroid,O
function,O
during,O
this,O
hospitalization,O
.,O

She,O
was,O
anticoagulated,O
with,O
heparin,B-TR
and,O
after,O
several,O
days,O
Coumadin,B-TR
was,O
started,O
.,O

Her,B-TR
exact,I-TR
Coumadin,I-TR
dose,I-TR
is,O
undetermined,O
at,O
this,O
point,O
",",O
however,O
it,O
looks,O
like,O
it,O
will,O
be,O
something,O
around,O
5,O
mg,O
a,O
day,O
.,O

Her,B-TE
pro,I-TE
time,I-TE
and,O
PTT,B-TE
have,O
normalized,O
at,O
the,O
time,O
of,O
discharge,O
.,O

She,O
needs,O
to,O
be,O
given,O
5,O
mg,O
of,O
Coumadin,B-TR
tonight,O
",",O
5/22/92,O
.,O

In,O
addition,O
heparin,B-TR
should,O
be,O
started,O
to,O
drip,O
on,O
arrival,O
at,O
400,O
units,O
an,O
hour,O
.,O

It,O
is,O
discontinued,O
at,O
the,O
time,O
of,O
transport,O
.,O

The,O
patient,O
has,O
received,O
physical,B-TR
therapy,I-TR
and,O
occupational,B-TR
therapy,I-TR
and,O
her,O
recovery,O
is,O
near,O
complete,O
.,O

During,O
evaluation,B-TE
of,I-TE
her,I-TE
neurologic,I-TE
status,I-TE
",",O
it,O
was,O
determined,O
that,O
for,O
several,O
months,O
prior,O
to,O
admission,O
",",O
the,O
patient,O
has,O
been,O
too,B-PR
unsteady,I-PR
to,I-PR
ambulate,I-PR
.,O

On,B-TE
our,I-TE
exam,I-TE
she,O
is,O
found,O
to,O
have,O
a,O
significant,O
amount,O
of,O
ataxia,B-PR
",",O
especially,O
in,O
the,O
midline,O
and,O
the,O
exact,O
cause,O
of,O
this,O
is,O
unknown,O
.,O

There,O
are,O
multiple,O
possible,O
contributions,O
and,O
this,O
is,O
where,O
her,O
need,O
for,O
careful,B-TE
internal,I-TE
medical,I-TE
evaluation,I-TE
has,O
arisen,O
.,O

At,O
the,O
time,O
we,O
were,O
to,O
embark,O
on,O
this,B-TE
evaluation,I-TE
",",O
the,O
patient,O
&apos;s,O
family,O
strongly,O
requested,O
that,O
she,O
be,O
transferred,O
to,O
the,O
Sas,O
General,O
Hospital,O
.,O

What,O
follows,O
is,O
a,O
summary,O
of,O
her,B-PR
medical,I-PR
problems,I-PR
and,O
their,O
possible,O
relationship,O
to,O
her,B-PR
ataxia,I-PR
.,O

Her,B-PR
ataxia,I-PR
is,O
likely,O
due,O
to,O
some,O
cerebellar,O
function,O
",",O
though,O
this,O
is,O
not,O
certain,O
.,O

Moreover,O
her,B-TE
MRI,I-TE
did,O
not,O
show,O
any,B-PR
discrete,I-PR
cerebellar,I-PR
lesions,I-PR
.,O

Our,O
leading,O
theory,O
at,O
this,O
point,O
is,O
that,O
her,B-PR
cerebellar,I-PR
dysfunction,I-PR
relates,O
to,O
perineoplastic,B-PR
syndrome,I-PR
",",O
relating,O
to,O
her,O
history,O
of,O
breast,B-PR
Ca,I-PR
.,O

As,O
I,O
mentioned,O
above,O
",",O
her,B-TE
evaluation,I-TE
was,O
limited,O
by,O
her,O
cardiologic,O
status,O
at,O
the,O
time,O
.,O

While,O
mammogram,B-TE
and,O
CA-15.3,B-TE
and,O
breast,B-TE
exam,I-TE
are,O
all,O
normal,O
",",O
the,O
idea,O
of,O
a,B-PR
perineoplastic,I-PR
syndrome,I-PR
with,O
or,O
without,O
concomitant,B-PR
breast,I-PR
Ca,I-PR
has,O
reared,O
its,O
head,O
.,O

Two,O
possible,O
markers,O
are,O
anti-Hu,B-PR
syndrome,I-PR
and,O
anti-Yo,B-TE
antibody,I-TE
.,O

These,B-TE
tests,I-TE
were,O
sent,O
on,O
the,O
18th,O
and,O
are,O
pending,O
at,O
the,O
time,O
of,O
discharge,O
.,O

The,B-TE
results,I-TE
can,O
be,O
obtained,O
by,O
paging,O
me,O
",",O
Do,O
A.,O
Joasscchird,O
",",O
M.D.,O
at,O
834-364-2251,O
.,O

I,O
will,O
be,O
happy,O
to,O
furnish,O
the,B-TE
results,I-TE
.,O

The,O
patient,O
has,O
a,O
history,O
of,O
MI,B-PR
in,O
1989,O
.,O

Echocardiogram,B-TE
no,O
longer,O
shows,O
wall,B-PR
motion,I-PR
abnormalities,I-PR
.,O

EKG,B-TE
",",O
when,O
the,O
patient,O
goes,O
out,O
of,O
left,B-PR
bundle,I-PR
branch,I-PR
block,I-PR
transiently,O
shows,O
an,B-PR
anterolateral,I-PR
Q/wave,I-PR
inversion,I-PR
.,O

We,O
would,O
like,O
to,O
discontinue,O
her,B-TR
Isordil,I-TR
to,O
improve,O
upon,O
some,B-PR
orthostatic,I-PR
hypotension,I-PR
",",O
but,O
we,O
are,O
not,O
certain,O
whether,O
her,O
heart,O
will,O
tolerate,O
this,O
.,O

Persantine,B-TE
thallium,I-TE
is,O
scheduled,O
at,O
this,O
time,O
",",O
but,O
is,O
yet,O
to,O
be,O
performed,O
.,O

The,O
patient,O
has,O
a,O
history,O
of,O
orthostatic,B-PR
hypotension,I-PR
x,O
many,O
years,O
.,O

It,O
has,O
been,O
evaluated,O
in,O
the,O
past,O
without,O
success,O
.,O

During,O
her,O
hospitalization,O
",",O
we,O
confirmed,O
the,O
presence,O
of,O
this,O
",",O
even,O
when,O
she,O
was,O
hydrated,O
with,O
saline,B-TR
",",O
to,O
a,B-TE
fractional,I-TE
excretion,I-TE
of,I-TE
sodium,I-TE
of,O
2%,O
.,O

Studies,B-TE
of,I-TE
her,I-TE
autonomic,I-TE
system,I-TE
did,O
not,O
document,O
any,B-PR
dysautonomia,I-PR
.,O

Studies,B-TE
of,I-TE
skin,I-TE
galvanic,I-TE
conduction,I-TE
were,O
normal,O
and,O
her,B-TE
RR,I-TE
interval,I-TE
evaluation,I-TE
was,O
not,O
abnormal,B-PR
.,O

This,O
is,O
a,B-PR
chronic,I-PR
problem,I-PR
but,O
may,O
be,O
contributing,O
to,O
her,B-PR
current,I-PR
weakness,I-PR
and,O
inability,B-PR
to,I-PR
walk,I-PR
.,O

Florinef,B-TR
is,O
to,O
be,O
considered,O
",",O
however,O
stopping,O
the,B-TR
Isordil,I-TR
is,O
one,O
goal,O
.,O

The,O
patient,O
has,O
a,O
history,O
of,O
bronchiectasis,B-PR
from,O
a,B-PR
childhood,I-PR
pneumonia,I-PR
.,O

In,O
addition,O
there,O
is,O
a,O
distant,O
history,O
of,O
M.,B-PR
kansasaii,I-PR
infection,I-PR
.,O

This,O
has,O
been,O
evaluated,O
by,O
Dr.,O
Screen,O
at,O
Sas,O
General,O
Hospital,O
and,O
probably,O
relates,O
to,O
her,B-TE
lung,I-TE
xray,I-TE
.,O

CT,B-TE
at,O
the,O
Ona,O
Hospital,O
in,O
1989,O
showed,O
similar,O
findings,O
.,O

A,B-TE
chest,I-TE
CT,I-TE
was,O
to,O
be,O
performed,O
and,O
may,O
be,O
yielding,O
.,O

A,B-TE
PPD,I-TE
was,O
placed,O
and,O
is,O
to,O
be,O
read,O
on,O
Saturday,O
",",O
4,O
26th,O
.,O

The,O
left,O
volar,O
forearm,O
has,O
the,B-TE
PPD,I-TE
just,O
proximal,O
to,O
the,O
wrist,O
crease,O
and,O
a,B-TE
candida,I-TE
albicans,I-TE
placed,O
just,O
distal,O
to,O
the,O
antecubital,O
fossa,O
.,O

The,O
patient,O
has,O
a,O
history,O
of,O
deep,B-PR
venous,I-PR
thrombosis,I-PR
in,O
1990,O
",",O
for,O
which,O
she,O
received,O
6,O
months,O
of,O
Coumadin,B-TR
.,O

Dopplers,B-TE
of,I-TE
her,I-TE
lower,I-TE
extremities,I-TE
were,O
negative,O
on,O
this,O
admission,O
.,O

It,O
is,O
doubtful,O
that,O
she,O
has,O
chronic,B-PR
PE,I-PR
",",O
but,O
this,O
is,O
one,O
consideration,O
.,O

It,O
is,O
likely,O
that,O
she,O
has,O
pulmonary,B-PR
hypertension,I-PR
from,O
her,B-PR
lung,I-PR
disease,I-PR
",",O
and,O
so,O
this,O
is,O
a,O
consideration,O
.,O

The,O
patient,O
had,O
mild,B-PR
hyponatremia,I-PR
during,O
this,O
hospitalization,O
with,O
a,B-TE
sodium,I-TE
as,O
low,O
as,O
131,O
.,O

We,O
think,O
this,O
is,O
likely,O
due,O
to,O
an,B-PR
SIADH,I-PR
as,O
she,O
is,O
euvolemic,O
.,O

This,O
can,O
be,O
evaluated,O
further,O
and,O
is,O
not,O
a,O
problem,O
at,O
this,O
time,O
.,O

The,O
patient,O
has,O
glaucoma,B-PR
.,O

Her,B-TR
medications,I-TR
are,O
as,O
listed,O
below,O
.,O

Her,O
ophthalmologist,O
is,O
aware,O
of,O
transfer,O
.,O

His,O
name,O
is,O
Ettrent,O
Can,O
and,O
he,O
can,O
be,O
reached,O
at,O
678-233-5033,O
",",O
b,O
549,O
.,O

DOCTORS,O
DISCHARGE,O
ORDERS,O
:,O

Propanolol,B-TR
5,O
mg.,O
p.o.,O
t.i.d.,O
[,O
hold,O
for,O
SBP,B-TE
less,O
than,O
110,O
],O
",",O
Isosorbide,B-TR
5,O
mg.,O
p.o.,O
t.i.d.,O
",",O
hold,O
for,O
SBP,B-TE
less,O
than,O
110,O
",",O
Colace,B-TR
100,O
mg.,O
p.o.,O
b.i.d.,O
Pilocarpine,B-TR
4%,O
one,O
drop,O
q.i.d.,O
O.D.,O
Pilocarpine,B-TR
2%,O
one,O
drop,O
b.i.d.,O
O.S.,O
Betasan,B-TR
0.5%,O
one,O
drop,O
b.i.d.,O
O.D.,O
.,O

Bacitracin,B-TR
ointment,I-TR
one,O
drop,O
O.D.,O
q.h.s.,O
Ciprofloxacin,B-TR
500,O
mg.,O
one,O
p.o.,O
b.i.d.,O
x,O
four,O
more,O
days,O
[,O
until,O
5/25/92,O
],O
",",O
for,O
recently,B-PR
discovered,I-PR
siderobacter,I-PR
UTI,I-PR
.,O

Coumadin,B-TR
5,O
mg.,O
p.o.,O
q.h.s.,O

She,O
needs,O
her,B-TR
dose,I-TR
on,O
5/22/92,O
.,O

Heparin,B-TR
i.v.,I-TR
drip,I-TR
at,O
400,O
units,O
per,O
hour,O
",",O
on,O
her,O
arrival,O
.,O

In,O
addition,O
the,O
patient,O
requires,O
occupational,B-TR
therapy,I-TR
and,O
physical,B-TR
therapy,I-TR
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

Amoxicillin,B-PR
rash,I-PR
.,O

Small,B-PR
stroke,I-PR
",",O
nearly,O
recovered,O
",",O
likely,O
embolic,B-PR
from,I-PR
carotid,I-PR
artery,I-PR
.,O

Glaucoma,B-PR
",",O
under,O
therapy,B-TR
",",O
status,O
post,O
laser,B-TR
surgery,I-TR
O.D.,I-TR

Orthostatic,B-PR
hypotension,I-PR
.,O

Ataxia,B-PR
with,O
gait,B-PR
abnormality,I-PR
.,O

History,O
of,O
breast,B-PR
cancer,I-PR
.,O

History,O
of,O
atypical,B-PR
mycobacterial,I-PR
colonization,I-PR
.,O

History,O
of,O
DVT,B-PR
.,O

Hyponatremia,B-PR
.,O

Coronary,B-PR
artery,I-PR
disease,I-PR
with,O
MI,B-PR
in,O
1989,O
.,O

DO,O
JOASSCCHIRD,O
",",O
M.D.,O

TR,O
:,O

zg,O
/,O
bmot,O

DD,O
:,O

5-22-92,O

TD,O
:,O

05/22/92,O

CC,O
:,O

MAVIC,O
WORD,O
",",O
M.D.,O
and,O
TOMEDANKELL,O
EAR,O
M.D.,O
",",O
DEPT,O
OF,O
NEUROLOGY,O
.,O

LYNA,O
CAN,O
",",O
M.D.,O
DIVISION,O
OF,O
PULMONARY,O
MEDICINE,O
",",O
JEANES,O
CLINIC,O
",",O
Apem,O
and,O
ETTRENT,O
CAN,O
",",O
C,O
/,O
O,O
Valtawnprinceel,O
Community,O
Memorial,O
Hospital,O

Admission,O
Date,O
:,O

2013-10-27,O

Discharge,O
Date,O
:,O

2013-11-03,O

Date,O
of,O
Birth,O
:,O

1971-05-13,O

Sex,O
:,O

F,O

Service,O
:,O

MEDICINE,B-TR

Allergies,O
:,O

Morphine,B-TR
/,O
Latex,B-TR

Attending,O
:,O
Everett,O
J.,O
Decardo,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

GIB,B-PR
",",O
hematemesis,B-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

EGD,B-TE
with,O
esophageal,B-TR
varices,I-TR
sclerosis,I-TR

History,O
of,O
Present,O
Illness,O
:,O

42,O
year,O
old,O
female,O
with,O
h/o,O
cholangiocarcinoma,B-PR
dx,O
in,O
2009,O
s/p,O
resection,B-TR
",",O
with,O
recent,B-TE
CT,I-TE
showing,O
met,B-PR
cholangiocarcinoma,I-PR
in,O
9/2004,O
.,O

Pt,O
was,O
recently,O
admitted,O
for,O
fever,B-PR
due,O
to,O
cholangitis,B-PR
on,O
10-18,O
and,O
had,O
chemo,B-TR
(,O
CDDP,B-TR
and,O
Gemcitabine,B-TR
),O
on,O
Monday,O
",",O
10-21,O
.,O

Since,O
chemo,B-TR
pt,O
has,O
intermittent,B-PR
nausea,I-PR
adequately,O
controlled,O
by,O
zofran,B-TR
and,O
compazine,B-TR
.,O

Pt,O
was,O
doing,O
well,O
till,O
night,O
of,O
admission,O
when,O
she,O
developed,O
nausea,B-PR
/,O
vomitting,B-PR
and,O
sizable,O
amount,O
of,O
hemoptysis,B-PR
and,O
clots,B-PR
.,O

Has,O
low,B-PR
grade,I-PR
fever,I-PR
since,O
chemo,B-TR
but,O
otherwise,O
ROS,B-TE
was,O
neg,O
for,O
shaking,B-PR
chills,I-PR
",",O
chest,B-PR
pain,I-PR
",",O
SOB,B-PR
",",O
coughing,B-PR
",",O
constipation,B-PR
",",O
diarrhea,B-PR
",",O
tarry,B-PR
stools,I-PR
",",O
abd,B-PR
pain,I-PR
.,O

Pt,O
has,O
reported,O
gaining,O
30,O
lbs,O
since,O
08-31,O
due,O
to,O
ascites,B-PR
.,O

In,O
Monica,O
:,O
vitals,B-TE
:,O
T,B-TE
98.8,O
P,B-TE
98,O
BP,B-TE
136/68,O
R,B-TE
29,O
Sat,B-TE
98%,O
RAPt,O
had,O
NG,B-TR
lavage,I-TR
which,O
evantually,O
cleared,O
up,O
",",O
also,O
was,O
transfused,O
1U,B-TR
PRBC,I-TR
",",O
GI,O
consult,O
called,O
",",O
also,O
got,O
zofran,B-TR
and,O
iv,B-TR
protonix,I-TR
.,O

Past,O
Medical,O
History,O
:,O

1.,O
Ca,O
Hx-Klatskin,B-PR
tumor,I-PR
originally,O
diagnosed,O
2010-08-28,O
after,O
presenting,O
with,O
painless,B-PR
jaundice,I-PR
.,O

2010-10-01,O
pt,O
underwent,O
ex.,B-TE
lap,I-TE
with,O
en,B-TR
bloc,I-TR
resection,I-TR
of,I-TR
L,I-TR
liver,I-TR
lobe,I-TR
",",I-TR
biliary,I-TR
tree,I-TR
",",I-TR
and,I-TR
portal,I-TR
vein,I-TR
.,O

Reconstructed,B-TR
portal,I-TR
vein,I-TR
followed,O
by,O
Roux-en-Y,B-TR
hepaticojejunostomy,I-TR
.,O

Per,O
notes,O
",",O
pathology,B-TE
demonstrated,O
biliary,B-PR
ductal,I-PR
adenocarcinoma,I-PR
(,O
T3N0M0,B-PR
),O
stage,O
Margit,O
.,O

Since,O
presentation,O
",",O
patient,O
had,O
multiple,O
episodes,O
of,O
cholangitis,B-PR
(,O
08-06,O
in,O
past,O
3,O
years,O
with,O
last,O
on,O
10-18,O
"),",O
always,O
short,O
lived,O
and,O
treated,O
with,O
antimicrobial,B-TR
therapy,I-TR
.,O

She,O
has,O
been,O
on,O
ciprofloxacin,B-TR
proph,I-TR
for,O
about,O
1,O
year,O
.,O

Followed,O
with,O
yearly,B-TE
abdominal,I-TE
CT,I-TE
without,O
radiographic,B-PR
progression,I-PR
.,O

CAT,B-TE
scan,I-TE
was,O
performed,O
on,O
2013-09-20,O
at,O
Kindred,O
Park,O
View,O
Specialty,O
Hospital,O
of,O
Springfield,O
",",O
which,O
revealed,O
that,O
she,O
had,O
a,B-PR
recurrence,I-PR
of,I-PR
the,I-PR
tumor,I-PR
with,O
occlusion,B-PR
of,I-PR
her,I-PR
portal,I-PR
vein,I-PR
occluding,B-PR
bile,I-PR
ducts,I-PR
",",O
hepatic,B-PR
artery,I-PR
nearly,I-PR
completely,I-PR
occluded,I-PR
",",O
and,O
much,B-PR
ascites,I-PR
and,O
was,O
started,O
on,O
diuretics,B-TR
.,O

She,O
was,O
was,O
seen,O
at,O
Hallmark,O
Health,O
System,O
heme,O
/,O
on,O
clinic,O
10-09,O
and,O
had,O
repeat,B-TE
CT,I-TE
scan,I-TE
which,O
revealed,O
metastatic,B-PR
cholangiocarcinoma,I-PR
with,O
mets,B-PR
to,I-PR
the,I-PR
ovaries,I-PR
",",O
with,O
tremendous,B-PR
increase,I-PR
in,I-PR
metastatic,I-PR
disease,I-PR
.,O

There,O
was,O
there,O
was,O
obstructive,B-PR
uropathy,I-PR
on,I-PR
the,I-PR
right,I-PR
side,I-PR
",",O
as,O
well,O
as,O
questionable,O
gastric,B-PR
outlet,I-PR
obstruction,I-PR
and,O
peritoneal,B-PR
carcinomatosis,I-PR
.,O

2.,O
cholecystectomy,B-TR
at,O
age,O
25,O

3.,O
MVA-multiple,B-TR
orthopedic,I-TR
procedures,I-TR

4.,O
Strabismus,B-PR

Social,O
History,O
:,O

She,O
is,O
a,O
nurse,O
Damian,O
Mary,O
Lane,O
Hospital,O
.,O

She,O
denies,O
any,O
alcohol,O
",",O
drugs,O
or,O
tobacco,O
.,O

She,O
lives,O
in,O
Tobey,O
Hospital,O
with,O
her,O
mom,O
.,O

She,O
is,O
single,O
",",O
no,O
children,O
.,O

Family,O
History,O
:,O

Her,O
maternal,O
grandmother,O
had,O
breast,B-PR
cancer,I-PR
in,O
her,O
80,O
s,O
and,O
her,O
dad,O
's,O
grandmother,O
had,O
stomach,B-PR
cancer,I-PR
and,O
died,O
in,O
her,O
50,O
s.,O

On,O
her,O
mom,O
's,O
side,O
is,O
an,B-PR
extensive,I-PR
family,I-PR
cardiac,I-PR
history,I-PR
.,O

Physical,O
Exam,O
:,O

VITAL,B-TE
:,O
afebrile,B-PR
",",O
96,O
",",O
108/51,O
",",O
O2sat99%RA,B-TE

GENERAL,O
:,O
pleasant,O
female,O
in,O
no,O
apparent,B-PR
distress,I-PR
",",O
jaundiced,B-PR
skin,I-PR
.,O

HEENT,O
:,O
sclera,B-PR
icteric,I-PR
",",O
OP,O
clear,O
",",O
EOMI,O
",",O
PERRL,O
.,O

NECK,O
:,O
Supple,O
.,O

NODES,O
:,O
No,O
supraclavicular,B-PR
",",I-PR
submandibular,I-PR
",",I-PR
axillary,I-PR
or,I-PR
inguinal,I-PR
lymphadenopathy,I-PR
.,O

LUNGS,O
:,O
Clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

HEART,O
:,O
Regular,O
rate,O
",",O
s1,O
s2,O
.,O

ABDOMEN,O
:,O
soft,O
and,O
distended,B-PR
",",O
but,O
no,O
actual,B-PR
tenderness,I-PR
.,O

Guaiac,B-TE
neg,O
by,O
Monica,O

BACK,O
:,O
No,O
CVA,B-PR
tenderness,I-PR
.,O

EXTREMITIES,O
:,O
No,O
clubbing,B-PR
",",O
cyanosis,B-PR
",",O
but,O
+,O
edema,B-PR
.,O

Pertinent,O
Results,O
:,O

2013-10-27,O
1:30,O

GLUCOSE,B-TE
-,O
112,O
*,O
UREA,B-TE
N,I-TE
-,O
14,O
CREAT,B-TE
-,O
0.8,O
SODIUM,B-TE
-,O
133,O
POTASSIUM,B-TE
-,O
4.0,O
CHLORIDE,B-TE
-,O
97,O
TOTAL,B-TE
CO2,I-TE
-,O
23,O
ANION,B-TE
GAP,I-TE
-,O
17,O

2013-10-27,O
1:30,O

ALT(SGPT),B-TE
-,O
149,O
*,O
AST(SGOT),B-TE
-,O
83,O
*,O
ALK,B-TE
PHOS,I-TE
-,O
663,O
*,O
AMYLASE,B-TE
-,O
37,O
TOT,B-TE
BILI,I-TE
-,O
8.2,O
*,O

2013-10-27,O
1:30,O

LIPASE,B-TE
-,O
42,O

2013-10-27,O
1:30,O

IRON,B-TE
-,O
52,O

2013-10-27,O
1:30,O

calTIBC,B-TE
-,O
230,O
*,O
FERRITIN,B-TE
-,O
197,O
*,O
TRF,B-TE
-,O
177,O
*,O

2013-10-27,O
1:30,O

WBC,B-TE
-,O
3.0,O
*,O
RBC,B-TE
-,O
2.25,O
*,O
HGB,B-TE
-,O
7.2,O
*,O
HCT,B-TE
-,O
20.9,O
*,O
MCV,B-TE
-,O
93,O
MCH,B-TE
-,O
31.8,O
MCHC,B-TE
-,O
34.3,O
RDW,B-TE
-,O
14.7,O

2013-10-27,O
1:30,O

NEUTS,B-TE
-,O
79.7,O
*,O
BANDS,B-TE
-,O
0,O
LYMPHS,B-TE
-,O
13.3,O
*,O
MONOS,B-TE
-,O
4.6,O
EOS,B-TE
-,O
2.2,O
BASOS,B-TE
-,O
0.2,O

2013-10-27,O
1:30,O

HYPOCHROM,B-TE
-,O
1+,O
ANISOCYT,B-TE
-,O
NORMAL,O
POIKILOCY,B-TE
-,O
1+,O
MACROCYT,B-TE
-,O
NORMAL,O
MICROCYT,B-TE
-,O
NORMAL,O
POLYCHROM,B-TE
-,O
NORMAL,O
OVALOCYT,B-TE
-,O
1+,O

2013-10-27,O
1:30,O

PLT,B-TE
COUNT,I-TE
-,O
88,O
*,O

2013-10-27,O
1:30,O

PT,B-TE
-,O
13.4,O
PTT,B-TE
-,O
25.9,O
INR(PT),B-TE
-,O
1.1,O

2013-10-27,O
1:30,O

RET,B-TE
AUT,I-TE
-,O
0.3,O
*,O

2013-10-27,O
01:30,O
AM,O
URINE,B-TE

COLOR,B-TE
-,O
Amber,O
APPEAR,B-TE
-,O
SlHazy,O
SP,B-TE
Barajas,I-TE
-,O
1.025,O

2013-10-27,O
01:30,O
AM,O
URINE,B-TE

BLOOD,B-TE
-,O
NEG,O
NITRITE,B-TE
-,O
POS,O
PROTEIN,B-TE
-,O
30,O
GLUCOSE,B-TE
-,O
NEG,O
KETONE,B-TE
-,O
TR,O
BILIRUBIN,B-TE
-,O
LG,O
UROBILNGN,B-TE
-,O
0.2,O
PH,B-TE
-,O
5.5,O
LEUK,B-TE
-,O
NEG,O

2013-10-27,O
01:30,O
AM,O
URINE,B-TE

RBC,B-TE
-,O
0-2,O
WBC,B-TE
-,O
0-2,O
BACTERIA,B-TE
-,O
MOD,O
YEAST,B-TE
-,O
NONE,O
EPI,B-TE
-,O
03-01,O
RENAL,B-TE
EPI,I-TE
-,O
0-2,O

2013-10-27,O
01:30,O
AM,O
URINE,B-TE

HYALINE,B-TE
-,O
0-2,O

CT,B-TE
abd,I-TE
on,O
2013-10-17,O
showed,O
:,O

1.,O
Recurrent,B-PR
cholangiocarcinoma,I-PR
",",O
with,O
intrahepatic,B-PR
bile,I-PR
duct,I-PR
dilatation,I-PR
and,O
gastric,B-PR
outlet,I-PR
obstruction,I-PR
;,O
exact,O
extent,O
of,O
disease,B-PR
is,O
unclear,O
",",O
but,O
likely,O
extensive,O
.,O

No,O
evidence,O
of,O
portal,B-PR
hypertension,I-PR
is,O
seen,O
.,O

2.,O
Large,B-PR
",",I-PR
cystic,I-PR
",",I-PR
multiseptated,I-PR
mass,I-PR
arising,O
from,O
the,O
adnexa,O
",",O
worrisome,O
for,O
second,B-PR
primary,I-PR
malignancy,I-PR
.,O

3.,O
Ascites,B-PR
",",O
and,O
intraperitoneal,B-PR
carcinomatosis,I-PR
",",O
which,O
can,O
arise,O
from,O
either,O
of,O
the,O
two,O
processes,O
described,O
above,O
.,O

4.,O
Hiatal,B-PR
hernia,I-PR
.,O

2013-11-03,O
7:30,O

BLOOD,B-TE
WBC,B-TE
-,O
2.2,O
*,O
RBC,B-TE
-,O
3.09,O
*,O
Hgb,B-TE
-,O
9.6,O
*,O
Hct,B-TE
-,O
28.7,O
*,O
MCV,B-TE
-,O
93,O
MCH,B-TE
-,O
31.2,O
MCHC,B-TE
-,O
33.6,O
RDW,B-TE
-,O
17.0,O
*,O
Plt,B-TE
Ct,I-TE
-,O
89,O
*,O

2013-10-31,O
6:00,O

BLOOD,B-TE
Neuts,I-TE
-,O
89.7,O
*,O
Bands,B-TE
-,O
0,O
Lymphs,B-TE
-,O
6.9,O
*,O
Monos,B-TE
-,O
2.6,O
Eos,B-TE
-,O
0.2,O
Baso,B-TE
-,O
0.7,O

2013-11-03,O
7:30,O

BLOOD,B-TE
PT,I-TE
-,O
15.2,O
*,O
PTT,B-TE
-,O
29.7,O
INR(PT),B-TE
-,O
1.5,O

2013-11-03,O
7:30,O

BLOOD,B-TE
Glucose,B-TE
-,O
117,O
*,O
UreaN,B-TE
-,O
11,O
Creat,B-TE
-,O
0.9,O
Na,B-TE
-,O
135,O
K,B-TE
-,O
3.5,O
Cl,B-TE
-,O
97,O
HCO3,B-TE
-,O
28,O
AnGap,B-TE
-,O
14,O

2013-11-03,O
7:30,O

BLOOD,B-TE
AlkPhos,B-TE
-,O
431,O
*,O
TotBili,B-TE
-,O
7.8,O
*,O

2013-11-03,O
7:30,O

BLOOD,B-TE
Calcium,B-TE
-,O
8.3,O
*,O
Phos,B-TE
-,O
3.5,O
Mg,B-TE
-,O
1.9,O

2013-10-27,O
1:30,O

BLOOD,B-TE
calTIBC,B-TE
-,O
230,O
*,O
Ferritn,B-TE
-,O
197,O
*,O
TRF,B-TE
-,O
177,O
*,O

Brief,O
Hospital,O
Course,O
:,O

1),O
GI,O
-,O
In,O
the,O
Monica,O
pt,O
had,O
Hct,B-TE
of,O
20,O
and,O
bloody,B-PR
NG,I-PR
lavage,I-PR
which,O
did,O
not,O
clear,O
.,O

She,O
was,O
transfused,O
1U,B-TR
PRBC,I-TR
",",O
GI,O
consult,O
called,O
",",O
also,O
got,O
zofran,B-TR
and,O
iv,B-TR
protonix,I-TR
and,O
admitted,O
to,O
the,O
FICU,O
.,O

On,O
arrival,O
to,O
unit,O
pt,O
had,O
EGD,B-TE
which,O
revealed,O
grade,B-PR
III,I-PR
esophageal,I-PR
varices,I-PR
with,O
signs,O
of,O
old,B-PR
bleeding,I-PR
.,O

She,O
was,O
started,O
on,O
octreotide,B-TR
and,O
nadolol,B-TR
to,O
control,O
portal,B-PR
htn,I-PR
.,O

Pt,O
was,O
stable,O
and,O
had,O
appropriate,O
Hct,B-PR
bump,I-PR
to,O
25,O
after,O
2U,B-TR
PRBC,I-TR
's.,I-TR

She,O
also,O
had,O
climbing,B-PR
bilirubin,I-PR
and,O
low,B-PR
grade,I-PR
temp,I-PR
and,O
was,O
started,O
on,O
Zosyn,B-TR
for,O
suspected,O
biliary,B-PR
obstruction,I-PR
and,O
ascending,B-PR
cholangitis,I-PR
coverage,O
.,O

She,O
was,O
rescoped,O
on,O
10-28,O
and,O
varices,B-PR
were,O
sclerosed,O
(,O
no,O
banding,B-TR
due,O
to,O
latex,B-PR
allergy,I-PR
),O
and,O
diuretics,B-TR
of,O
lasix,B-TR
and,O
aldactone,B-TR
were,O
readded,O
for,O
ascites,B-PR
since,O
BP,B-TE
stable,O
.,O

10-29,O
she,O
was,O
transfused,O
another,O
3U,B-TR
PRBC,I-TR
's,I-TR
with,O
hct,B-PR
bump,I-PR
to,O
31.9,O
and,O
antibiotic,B-TR
coverage,I-TR
broadend,O
to,O
Unasyn,B-TR
",",O
Ceftriaxone,B-TR
",",O
Flagyl,B-TR
because,O
she,O
continued,O
to,O
spike,O
",",O
and,O
for,O
SBP,B-TR
prophylaxis,I-TR
.,O

Preprocedure,O
of,O
PTC,B-TE
on,O
10-30,O
she,O
was,O
transfused,O
1,B-TR
unit,I-TR
PRBC,I-TR
"'s,",I-TR
2,B-TR
platelets,I-TR
and,O
2U,B-TR
FFP,I-TR
and,O
procedure,B-TE
went,O
without,O
complication,B-PR
.,O

ON,O
transfer,O
to,O
the,O
floor,O
she,O
remained,O
hemodynamically,O
stable,O
with,O
stable,O
Hct,O
and,O
declining,B-PR
bilirubin,I-PR
.,O

She,O
remained,O
afebrile,B-PR
so,O
on,O
11-02,O
antibiotic,B-TR
regimen,I-TR
was,O
weaned,O
to,O
only,O
levofloxacin,B-TR
.,O

Liver,O
teams,O
recommended,O
to,O
repeat,B-TE
EGD,I-TE
with,O
non,B-TR
latex,I-TR
banding,I-TR
in,O
7-10,O
days,O
.,O

She,O
also,O
went,O
home,O
on,O
naldolol,B-TR
20,O
mg,O
qd,O
for,O
portal,B-PR
htn,I-PR
",",O
and,O
her,B-TR
home,I-TR
doses,I-TR
of,O
diuretics,B-TR
to,O
control,O
her,B-PR
ascites,I-PR
.,O

2.,O
US,B-TE
finding,O
-,O
Pt,O
was,O
incidentally,O
found,O
to,O
have,O
R,B-PR
hydronephrosis,I-PR
and,O
a,B-PR
R,I-PR
adenexal,I-PR
mass,I-PR
on,O
her,B-TE
US,I-TE
.,O

The,B-PR
hydronephrosis,I-PR
was,O
likely,O
caused,O
by,O
blockage,B-PR
by,O
her,B-PR
tumor,I-PR
.,O

Given,O
her,O
disease,O
prognosis,O
and,O
the,O
fact,O
that,O
her,O
other,O
kidney,O
is,O
functioning,O
well,O
",",O
no,O
intervention,B-TR
was,O
done,O
.,O

Also,O
the,B-PR
adenexal,I-PR
mass,I-PR
may,O
represent,O
a,B-PR
second,I-PR
primary,I-PR
maligancy,I-PR
.,O

This,O
was,O
seen,O
on,O
a,B-TE
prior,I-TE
CT,I-TE
scan,I-TE
and,O
her,O
oncologist,O
is,O
aware,O
.,O

Again,O
given,O
the,B-PR
patient,I-PR
's,I-PR
poor,I-PR
disease,I-PR
prognosis,I-PR
",",O
there,O
was,O
no,O
intervention,B-TR
made,O
at,O
this,O
time,O
.,O

Medications,O
on,O
Admission,O
:,O

MEDICATIONS,O
:,O
She,O
is,O
on,O
Lasix,B-TR
40,O
mg,O
p.o.,O
b.i.d.,O
",",O
Aldactone,B-TR
25,O
mg,O
p.o.,O
b.i.d.,O
",",O
Prilosec,B-TR
20,O
mg,O
p.o.,O
daily,O
",",O
ciprofloxacin,B-TR
250,O
mg,O
p.o.,O
daily,O
",",O
this,O
is,O
for,O
prophylaxis,B-TR
for,O
cholangitis,B-PR
and,O
iron,B-TR
.,O

Discharge,O
Medications,O
:,O

1.,O
Pantoprazole,B-TR
Sodium,I-TR
40,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
Q12H,O
(,O
every,O
12,O
hours,O
).,O

Disp,O
:*,O
60,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
)(s)*,O
Refills,O
:*,O
2,O
*,O

2.,O
Furosemide,B-TR
40,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

Disp,O
:*,O
60,O
Tablet,O
(s)*,O
Refills,O
:*,O
2,O
*,O

3.,O
Spironolactone,B-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

Disp,O
:*,O
60,O
Tablet,O
(s)*,O
Refills,O
:*,O
2,O
*,O

4.,O
Levofloxacin,B-TR
500,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q24H,O
(,O
every,O
24,O
hours,O
).,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

5.,O
Ursodiol,B-TR
300,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
).,O

Disp,O
:*,O
90,O
Capsule,O
(s)*,O
Refills,O
:*,O
2,O
*,O

6.,O
Prochlorperazine,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q6H,O
(,O
every,O
6,O
hours,O
),O
as,O
needed,O
.,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

7.,O
Nystatin,B-TR
"100,000",O
unit,O
/,O
mL,O
Suspension,O
Sig,O
:,O
Five,O
(,O
5,O
),O
mL,O
PO,O
four,O
times,O
a,O
day,O
:,O
Swish,O
and,O
swallow,O
.,O

Disp,O
:*,O
qs,O
mL,O
*,O
Refills,O
:*,O
2,O
*,O

8.,O
Nadolol,B-TR
20,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
once,O
a,O
day,O
.,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
2,O
*,O

9.,O
Outpatient,O
Lab,O
Work,O

Please,O
have,O
CBC,B-TE
and,O
alkaline,B-TE
phosphatase,I-TE
and,O
total,B-TE
bilirubin,I-TE
checked,O
on,O
Monday,O
11-04,O

Discharge,O
Disposition,O
:,O

Home,O
with,O
Service,O

Discharge,O
Diagnosis,O
:,O

Cholangiocarcinoma,B-PR

Biliary,B-PR
obstruction,I-PR

Grade,B-PR
III,I-PR
esophageal,I-PR
varices,I-PR

Discharge,O
Condition,O
:,O

Stable,O
.,O

Discharge,O
Instructions,O
:,O

Call,O
your,O
primary,O
care,O
doctor,O
",",O
oncologist,O
",",O
or,O
return,O
to,O
the,O
Emergency,O
Room,O
if,O
you,O
have,O
increasing,B-PR
nausea,I-PR
",",O
vomiting,B-PR
",",O
leg,B-PR
swelling,I-PR
",",O
confusion,B-PR
",",O
or,O
pain,B-PR
.,O

Followup,O
Instructions,O
:,O

Please,O
follow,O
up,O
at,O
all,O
scheduled,O
appointments,O
including,O
Wednesday,O
in,O
IR,O
clinic,O
.,O

Call,O
the,O
IR,O
clinic,O
on,O
Monday,O
to,O
confirm,O
your,O
appointment,O
:,O
(,O
236,O
),O
672,O
0628,O
.,O

Ask,O
to,O
speak,O
with,O
May,O
Chen,O
",",O
PA.,O

Call,O
your,O
primary,O
care,O
doctor,O
Joanne,O
Dennen,O
for,O
follow,O
up,O
appointments,O
.,O

You,O
will,O
have,O
a,B-TR
banding,I-TR
procedure,I-TR
in,O
9,O
days,O
.,O

Please,O
call,O
the,O
GI,O
clinic,O
and,O
arrange,O
to,O
see,O
Dr.,O
Langton,O
for,O
an,O
appointment,O
:,O
232-2590,O
.,O

Ronald,O
Donna,O
MD,O
19-658,O

Completed,O
by,O
:,O
Neal,O
Robert,O
MD,O
12-904,O
2013-11-04,O
@,O
1405,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Wilson,O
J.,O
Sanchez,O
on,O
:,O
WED,O
2013-11-13,O
9:05,O
AM,O

(,O
End,O
of,O
Report,O
),O

858462183,O

SH,O

20464340,O

11/3/1993,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

11/03/1993,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

11/07/1993,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

1.,O
MYELODYSPLASTIC,B-PR
SYNDROME,I-PR
WITH,O
SYMPTOMATIC,B-PR
ANEMIA,I-PR

OTHER,O
DIAGNOSES,O
:,O

2.,O
RHEUMATOID,B-PR
ARTHRITIS,I-PR

3.,O
DIABETES,B-PR
MELLITUS,I-PR

4.,O
HISTORY,O
OF,O
MULTIPLE,B-PR
FOCAL,I-PR
ATRIAL,I-PR
TACHYCARDIA,I-PR

5.,O
CONGESTIVE,B-PR
HEART,I-PR
FAILURE,I-PR
WITH,O
DILATED,B-PR
CARDIOMYOPATHY,I-PR
",",O
EJECTION,B-TE
FRACTION,I-TE
OF,O
30%,O

6.,O
CORONARY,B-PR
ARTERY,I-PR
DISEASE,I-PR

7.,O
CHRONIC,B-PR
BRONCHIECTASIS,I-PR
ON,O
HOME,B-TR
O2,I-TR

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
69-year-old,O
male,O
with,O
multiple,B-PR
medical,I-PR
problems,I-PR
and,O
known,B-PR
transfusion,I-PR
dependent,I-PR
secondary,O
to,O
myelodysplastic,B-PR
syndrome,I-PR
admitted,O
with,O
decreased,B-PR
hematocrit,I-PR
.,O

The,O
patient,O
has,O
had,O
multiple,O
previous,O
admissions,O
for,O
cardiac,B-PR
and,I-PR
pulmonary,I-PR
disease,I-PR
.,O

He,O
has,O
had,O
chronic,B-PR
anemia,I-PR
since,O
1990,O
",",O
but,O
a,B-TE
bone,I-TE
marrow,I-TE
biopsy,I-TE
in,O
07-92,O
",",O
was,O
consistent,O
with,O
myelodysplastic,B-PR
syndrome,I-PR
.,O

Over,O
the,O
past,O
several,O
months,O
",",O
the,O
patient,O
has,O
had,O
increasing,B-PR
transfusing,I-PR
requirements,I-PR
.,O

His,B-TR
transfusions,I-TR
have,O
been,O
complicated,O
by,O
fluid,B-PR
overload,I-PR
and,O
congestive,B-PR
heart,I-PR
failure,I-PR
",",O
secondary,O
to,O
ischemia,B-PR
cardiomyopathy,I-PR
.,O

His,O
last,O
admission,O
was,O
9-14-93,O
",",O
for,O
a,B-TR
transfusion,I-TR
without,O
complications,B-PR
",",O
and,O
prior,O
to,O
admission,O
the,O
patient,O
reports,O
having,O
several,O
days,O
of,O
increasing,B-PR
weakness,I-PR
",",O
dizziness,B-PR
and,O
fatigue,B-PR
.,O

His,O
wife,O
says,O
his,O
hands,O
and,O
lips,O
have,O
been,O
blue,O
.,O

Apparently,O
",",O
he,O
had,O
had,O
a,B-PR
low,I-PR
hematocrit,I-PR
as,O
an,O
outpatient,O
and,O
was,O
checked,O
two,O
weeks,O
prior,O
to,O
admission,O
but,O
was,O
not,O
given,O
transfusion,B-TR
because,O
the,O
patient,O
did,O
not,O
want,O
to,O
come,O
in,O
at,O
that,O
time,O
.,O

Aside,O
from,O
the,O
above,O
",",O
the,O
patient,O
had,O
felt,O
that,O
baseline,O
without,O
fever,B-PR
and,O
chills,B-PR
or,O
change,B-PR
in,I-PR
chronic,I-PR
cough,I-PR
.,O

He,O
had,O
no,O
increase,O
in,O
his,B-PR
congestive,I-PR
heart,I-PR
failure,I-PR
symptoms,I-PR
",",O
no,O
chest,B-PR
pain,I-PR
",",O
and,O
no,O
hemoptysis,B-PR
or,O
changed,O
in,O
arthritis,B-PR
.,O

The,O
patient,O
did,O
report,O
taking,O
a,B-TR
po,I-TR
antibiotic,I-TR
(,I-TR
Ciprofloxacin,I-TR
),I-TR
for,O
right,B-PR
great,I-PR
toe,I-PR
infection,I-PR
(,O
question,O
of,O
cellulitis,B-PR
vs.,O
paronychia,B-PR
),O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Myelodysplastic,B-PR
syndrome,I-PR
.,O

2.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
/,O
ischemiccardiomyopathy,B-PR
with,O
ejection,B-TE
fraction,I-TE
of,O
30%,O
.,O

3.,O
History,O
of,O
MAT,B-PR
for,O
chronic,B-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
/,O
chronic,B-PR
bronchi,I-PR
ectasis,I-PR
",",O
on,O
home,B-TR
oxygen,I-TR
.,O

4.,O
Non,B-PR
insulin,I-PR
dependent,I-PR
diabetes,I-PR
mellitus,I-PR
.,O

5.,O
Rheumatoid,B-PR
arthritis,I-PR
.,O

6.,O
History,O
of,O
alcohol,O
abuse,O
.,O

7.,O
History,O
of,O
peptic,B-PR
ulcer,I-PR
disease,I-PR
.,O

8.,O
Cataracts,B-PR
",",O
status,O
post,O
bilateral,B-TR
repair,I-TR
.,O

9.,O
C3,B-PR
radiculopathy,I-PR
.,O

10.,O
Psoriasis,B-PR
.,O

11.,O
History,O
of,O
hemoptysis,B-PR
",",O
on,O
Coumadin,B-TR
.,O

12.,O
Status,O
post,O
TURP,B-TR
.,O

ALLERGIES,O
:,O

Quinine,B-TR
",",O
Quinidine,B-TR
",",O
Bactrim,B-TR
",",O
Plaquenil,B-TR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
has,O
a,O
50,O
pack,O
year,O
history,O
of,O
tobacco,O
and,O
quit,O
10,O
years,O
ago,O
;,O
also,O
",",O
a,O
history,O
of,O
ethanol,O
abuse,O
.,O

Still,O
drinks,O
occasionally,O
.,O

The,O
patient,O
lives,O
with,O
his,O
wife,O
and,O
is,O
a,O
retired,O
sardine,O
packer,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Vital,O
signs,O
:,O

Temperature,B-TE
98.8,O
;,O
heart,B-TE
rate,I-TE
88-120,O
and,O
irregular,B-PR
;,O
blood,B-TE
pressure,I-TE
118/78,O
;,O
O2,B-TE
saturation,I-TE
96%,O
on,O
2,B-TR
liters,I-TR
.,O

HEENT,O
:,O

Bilateral,B-PR
cataracts,I-PR
;,O
neck,O
appeared,O
to,O
be,O
somewhat,B-PR
asymmetric,I-PR
thyroid,I-PR
with,O
small,B-PR
nodule,I-PR
barely,O
palpable,O
on,O
the,O
left,O
lobe,O
with,O
the,O
thyroid,O
",",O
otherwise,O
negative,O
.,O

No,O
lymphadenopathy,B-PR
was,O
palpated,O
.,O

Lungs,O
:,O

Rales,B-PR
1/3,O
of,O
the,O
way,O
upbilaterally,O
.,O

Cardiovascular,B-TE
examination,I-TE
revealed,O
jugular,B-PR
venous,I-PR
distention,I-PR
at,O
12,O
cm,O
",",O
no,O
carotid,B-PR
bruits,I-PR
",",O
heart,B-TE
rate,I-TE
was,O
tachycardic,B-PR
and,O
regular,O
",",O
normal,O
S1,O
and,O
S2,O
",",O
palpable,B-PR
S4,I-PR
",",O
no,O
murmur,B-PR
was,O
auscultated,O
.,O

Abdominal,O
examination,O
:,O

Obese,B-PR
",",O
soft,O
",",O
non-tender,B-PR
",",O
bowel,O
sounds,O
were,O
present,O
.,O

Rectal,O
examination,O
:,O

Heme,B-TE
negative,O
.,O

Extremities,O
:,O

Joint,B-PR
deformities,I-PR
consistent,O
with,O
rheumatoid,B-PR
arthritis,I-PR
",",O
right,O
MTP,O
/,O
toe,O
with,O
minimal,B-PR
erythema,I-PR
.,O

Skin,O
examination,O
:,O

Diffuse,B-PR
psoriasis,I-PR
over,I-PR
trunk,I-PR
and,I-PR
arms,I-PR
.,O

Neurological,B-TE
examination,I-TE
was,O
non-focal,O
.,O

LABORATORY,O
DATA,O
:,O

SMA-7,B-TE
was,O
unremarkable,O
aside,O
form,O
a,B-TE
creatinine,I-TE
of,O
1.6,O
and,O
a,B-TE
glucose,I-TE
of,O
207,O
;,O
otherwise,O
",",O
was,O
within,O
normal,O
limits,O
.,O

Hematocrit,B-TE
was,O
22.4,O
;,O
white,B-TE
count,I-TE
.59,O
;,O
platelets,B-TE
84.,O

The,O
patient,O
had,O
an,B-PR
absolute,I-PR
neutropenia,I-PR
with,O
a,B-TE
ANC,I-TE
of,O
318,O
;,O
differential,B-TE
revealed,O
48,O
segs,B-TE
",",O
6,O
bands,B-TE
",",O
40,O
lymphs,B-TE
",",O
4,O
monos,B-TE
.,O

Digoxin,B-TE
level,I-TE
was,O
1.4,O
.,O

Theo-Dur,B-TE
level,I-TE
was,O
15,O
.,O

PT,B-TE
was,O
12.5,O
;,O
PTT,B-TE
27.0,O
.,O

Urinalysis,B-TE
was,O
within,O
normal,O
limits,O
.,O

Chest,B-TE
x-ray,I-TE
showed,O
enlarged,B-PR
heart,I-PR
with,O
mild,B-PR
pulmonary,I-PR
vascular,I-PR
redistribution,I-PR
",",O
no,O
gross,B-PR
congestive,I-PR
heart,I-PR
failure,I-PR
was,O
noted,O
.,O

EKG,B-TE
showed,O
question,O
of,O
MAT,B-PR
vs.,O
atrial,B-PR
fibrillation,I-PR
with,O
a,B-TE
ventricular,I-TE
response,I-TE
of,O
118,O
",",O
axis,B-TE
was,O
0,O
degrees,O
.,O

There,O
was,O
ST,B-PR
scooping,I-PR
in,O
the,O
lateral,O
leads,O
consistent,O
with,O
Dig,B-TR
vs.,O
a,O
question,O
of,O
chronic,B-PR
ischemia,I-PR
changes,I-PR
.,O

There,O
was,O
no,O
significant,B-PR
change,I-PR
from,O
his,B-TE
baseline,I-TE
EKG,I-TE
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
and,O
placed,O
in,O
isolation,B-TR
on,O
neutropenic,B-TR
precautions,I-TR
.,O

He,O
was,O
transfused,O
with,O
1/2,B-TR
units,I-TR
of,I-TR
packed,I-TR
red,I-TR
blood,I-TR
cells,I-TR
and,O
given,O
Lasix,B-TR
periodically,O
to,O
prevent,O
him,O
from,O
going,O
into,O
congestive,B-PR
heart,I-PR
failure,I-PR
has,O
he,O
had,O
on,O
his,B-TR
prior,I-TR
transfusion,I-TR
.,O

Because,O
his,O
need,O
for,O
multiple,B-TR
transfusionsm,I-TR
he,O
was,O
transfused,O
with,O
radiated,B-TR
Leuco,I-TR
four,O
units,O
.,O

The,O
patient,O
had,O
a,O
good,O
bump,O
in,O
his,B-TE
hematocrit,I-TE
",",O
more,O
than,O
expected,O
from,O
22,O
to,O
high,O
20,O
&apos;s,O
range,O
next,O
day,O
after,O
3,O
1/2,O
units,O
",",O
but,O
later,O
that,O
evening,O
had,O
a,B-PR
drop,I-PR
in,O
his,B-TE
hematocrit,I-TE
so,O
was,O
given,O
4,O
more,O
1/2,O
units,O
at,O
this,O
point,O
for,O
a,O
total,O
of,O
4,B-TR
units,I-TR
packed,I-TR
red,I-TR
blood,I-TR
cells,I-TR
.,O

He,O
again,O
did,O
not,O
bump,O
his,B-TE
hematocrit,I-TE
sufficiently,O
and,O
remained,O
in,O
the,O
high,O
20,O
&apos;s,O
after,O
a,O
total,O
of,O
4,O
units,O
",",O
so,O
he,O
was,O
given,O
2,O
more,O
total,O
units,O
in,O
1/2,O
units,O
segments,O
the,O
following,O
day,O
.,O

His,B-TE
hematocrit,I-TE
subsequently,O
bumped,O
to,O
greater,O
than,O
30,O
and,O
was,O
discharged,O
with,O
hematocrit,B-TE
of,O
32,O
on,O
11-7-93,O
.,O

The,O
patient,O
remained,O
asymptomatic,B-PR
from,O
a,B-PR
CHF,I-PR
stand,I-PR
point,I-PR
and,O
felt,O
much,O
better,O
after,O
the,B-TR
transfusions,I-TR
.,O

It,O
is,O
unclear,O
why,O
the,O
patient,O
did,O
not,O
bump,O
his,B-TE
hematocrit,I-TE
more,O
but,O
he,O
did,O
not,O
appear,O
to,O
be,O
hemolyzing,O
from,O
laboratory,O
data,O
",",O
that,O
is,O
his,B-TE
LDH,I-TE
was,O
within,O
normal,O
limits,O
.,O

In,O
addition,O
",",O
multiple,O
stools,O
were,O
guaiaced,O
and,O
were,O
all,O
guaiac,B-TE
negative,O
.,O

The,O
patient,O
was,O
discharged,O
with,O
follow-up,O
with,O
his,O
Hematologist,O
",",O
Dr.,O
Eci,O
Area,O
and,O
Rheumatologist,O
",",O
Dr.,O
Taange,O
Peter,O
",",O
and,O
Cardiologist,O
",",O
Dr.,O
Peter,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Prednisone,B-TR
10,O
mg,O
po,O
q,O
day,O
",",O
Verapamil,B-TR
80,O
mg,O
po,O
t.i.d.,O
",",O
Digoxin,B-TR
0.25,O
mg,O
po,O
q,O
day,O
",",O
Isordil,B-TR
20,O
mg,O
po,O
t.i.d.,O
",",O
Theo-Dur,B-TR
200,O
mg,O
po,O
b.i.d.,O
",",O
Lasix,B-TR
80mg,O
q,O
am,O
",",O
40,O
mg,O
po,O
q,O
pm,O
",",O
Enalapril,B-TR
2.5,O
mg,O
po,O
b.i.d.,O
",",O
Pepcid,B-TR
20,O
mg,O
po,O
b.i.d.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
.,O

FOLLOW,O
UP,O
CARE,O
:,O

Follow-up,O
with,O
his,O
various,O
doctors,O
as,O
noted,O
above,O
.,O

Dictated,O
By,O
:,O

CAGHALA,O
UINTEELE,O
",",O
M.D.,O
HE27,O

Attending,O
:,O

TAANGE,O
Q.,O
PETER,O
",",O
M.D.,O
LX12,O
JL816/3429,O

Batch,O
:,O

2749,O

Index,O
No.,O

BHNZEG2MVV,O

D,O
:,O

12/03/93,O

T,O
:,O

12/05/93,O

CC,O
:,O

1.,O
DR.,O
ECI,O
AREA,O
",",O
HEMOTOLOGY,O
FELLOW,O
AT,O
RWSTMMCO,O

2.,O
DR.,O
PETER,O
",",O
CARDIOLOGY,O

Admission,O
Date:,O

2014-03-31,O

Discharge,O
Date,O
:,O

2014-04-01,O

Date,O
of,O
Birth,O
:,O

2014-03-31,O

Sex,O
:,O

M,O

Service,O
:,O

CMED,O

HISTORY,O
:,O

Baby,O
Alfonso,O
Carroll,O
is,O
a,O
full,O
term,O
infant,O
born,O
at,O
3.325,O
kg,O
to,O
a,O
35-year-old,O
G2,O
",",O
P1,O
",",O
now,O
2,O
mother,O
.,O

Prenatal,B-TE
screens,I-TE
-,O
blood,B-TE
type,I-TE
O,O
positive,O
",",O
antibody,B-TE
screen,I-TE
negative,O
",",O
hepatitis,B-TE
B,I-TE
surface,I-TE
antigen,I-TE
negative,O
",",O
RPR,B-TE
nonreactive,O
",",O
rubella,B-TE
immune,O
.,O

GBS,B-PR
negative,O
.,O

Maternal,O
history,O
notable,O
for,O
hypothyroidism,B-PR
on,O
Levoxyl,B-TR
.,O

Primary,B-TR
cesarean,I-TR
section,I-TR
with,O
previous,O
pregnancy,O
for,O
arrest,B-PR
of,I-PR
descent,I-PR
.,O

Other,B-TR
meds,I-TR
:,O
Paxil,B-TR
.,O

This,O
pregnancy,O
is,O
complicated,O
by,O
a,B-PR
cyst,I-PR
noted,O
on,O
the,O
umbilical,O
cord,O
on,O
fetal,B-TE
ultrasound,I-TE
study,I-TE
at,O
18,O
weeks,O
gestation,O
.,O

Mother,O
presented,O
in,O
spontaneous,O
labor,O
.,O

No,O
perineal,B-PR
sepsis,I-PR
risk,I-PR
factors,I-PR
.,O

No,O
maternal,B-PR
fever,I-PR
.,O

No,O
prolonged,B-PR
rupture,I-PR
of,I-PR
membranes,I-PR
.,O

Clear,O
amniotic,O
fluid,O
.,O

Anesthesia,B-TR
by,O
epidural,B-TR
.,O

Vaginal,O
delivery,O
.,O

Apgars,B-TE
were,O
8,O
and,O
9,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Weight,B-TE
3.325,O
kg,O
",",O
length,B-TE
was,O
20,O
inches,O
i.e.,O
51,O
cm,O
",",O
head,B-TE
circumference,I-TE
34.5,O
cm,O
.,O

Nondysmorphic,B-PR
infant,O
.,O

Active,O
",",O
pink,O
newborn,O
in,O
no,O
distress,B-PR
on,O
radiate,B-TR
warmer,I-TR
.,O

Anterior,O
fontanel,O
soft,O
and,O
flat,O
.,O

Palate,O
and,O
clavicles,O
intact,O
.,O

Neck,O
supple,O
.,O

Lungs,O
clear,O
to,O
apex,O
and,O
equal,O
.,O

CARDIOVASCULAR,O
:,O

Regular,O
rate,O
and,O
rhythm,O
.,O

No,O
murmurs,B-PR
.,O

2+,B-TE
femoral,I-TE
pulses,I-TE
.,O

ABDOMEN,O
:,O
Soft,O
.,O

Positive,O
bowel,O
sounds,O
.,O

Umbilical,O
cord,O
with,O
Braintree,O
jelly,B-PR
cysts,I-PR
but,O
also,O
with,O
pink,B-PR
tubular,I-PR
discoloration,I-PR
at,I-PR
base,I-PR
.,O

Umbilical,O
ring,O
intact,O
.,O

Normal,O
male,O
.,O

Testes,O
down,O
bilaterally,O
.,O

Patent,O
anus,O
.,O

No,O
sacral,B-PR
anomalies,I-PR
.,O

EXTREMITIES,O
:,O
Pink,O
and,O
well,O
perfused,O
.,O

SUMMARY,O
OF,O
HOSPITAL,O
COURSE,O
BY,O
SYSTEMS,O
:,O

RESPIRATORY,O
:,O
He,O
has,O
been,O
stable,O
in,O
room,O
air,O
throughout,O
hospital,O
course,O
.,O

CARDIOVASCULAR,O
:,O
No,O
cardiovascular,B-PR
issues,I-PR
.,O

FLUIDS,O
",",O
ELECTROLYTES,O
AND,O
NUTRITION,O
:,O
Infant,O
initiated,O
on,O
60,O
cc,O
per,O
kg,O
per,O
day,O
of,O
D10W,B-TR
.,O

D-sticks,B-TE
have,O
been,O
stable,O
.,O
Infant,O
is,O
allowed,O
to,O
ad,O
lib,O
breast,O
feed,O
which,O
he,O
is,O
doing,O
vigorously,O
.,O

GASTROINTESTINAL,O
:,O
Infant,O
is,O
ad,O
lib,O
feeding,O
.,O

An,B-TE
abdominal,I-TE
ultrasound,I-TE
was,O
performed,O
.,O

Initial,O
impression,O
included,O
omphalocele,B-PR
with,O
further,B-TE
imaging,I-TE
of,I-TE
the,I-TE
bowel,I-TE
to,O
be,O
done,O
.,O

Surgery,O
was,O
consulted,O
and,O
Dr.,O
Boston,O
took,O
patient,O
to,O
OR,O
for,O
exploration,B-TE
of,I-TE
cord,I-TE
on,O
04-01,O
.,O

Urachal,B-PR
duct,I-PR
remnanr,I-PR
found,O
",",O
removed,O
and,O
bladder,O
repaired,O
.,O

Post,O
op,O
course,O
unremrakable,O
.,O

PAtient,O
began,O
feeding,O
first,O
post,O
op,O
day,O
and,O
has,O
done,O
well,O
.,O

HEMATOLOGY,O
:,O
Hematocrit,B-TE
on,O
admission,O
was,O
52.8,O
.,O

The,O
infant,O
does,O
not,O
require,O
a,B-TR
new,I-TR
blood,I-TR
transfusion,I-TR
.,O

INFECTIOUS,O
DISEASE,O
:,O
CBC,B-TE
and,O
blood,B-TE
culture,I-TE
obtained,O
on,O
admission,O
.,O

Initial,B-TE
CBC,I-TE
had,O
a,B-TE
white,I-TE
count,I-TE
of,O
20,O
",",O
platelet,B-TE
count,I-TE
of,O
386,O
",",O
63,O
polys,B-TE
",",O
2,O
bands,B-TE
",",O
23,O
lymphs,B-TE
.,O

Blood,B-TE
cultures,I-TE
remained,O
negative,O
at,O
this,O
time,O
.,O

Infant,O
has,O
not,O
received,O
any,B-TR
antibiotics,I-TR
.,O

NEUROLOGIC,O
:,O
Infant,O
has,O
been,O
appropriate,O
for,O
gestational,O
age,O
.,O

SENSORY,O
:,O
Hearing,B-TE
screen,I-TE
has,O
not,O
yet,O
been,O
performed,O
but,O
should,O
be,O
done,O
prior,O
to,O
discharge,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
.,O

DISCHARGE,O
DISPOSITION,O
:,O

To,O
Massachusetts,O
General,O
Hospital,O
.,O

NAME,O
OF,O
PRIMARY,O
PEDIATRICIAN,O
:,O

Dr.,O
Joan,O
Derringer,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

Urachal,B-PR
duct,I-PR
remnant,I-PR
.,O

CARE,O
RECOMMENDATIONS,O
:,O

1.,O
Dressing,B-TR
to,O
remain,O
in,O
place,O
for,O
10,O
days,O
unless,O
signs,O
of,O
bleeding,B-PR
",",O
infection,B-PR
or,O
is,O
soiled,O
.,O

2.,O
F/U,O
with,O
primary,O
pediatricians,O
in,O
3-4,O
days,O
or,O
earlier,O
as,O
needed,O
.,O

3.,O
F/U,O
appt,O
with,O
Dr,O
Boston,O
",",O
Massachusetts,O
General,O
Hospital,O
Surgery,O
in,O
approx,O
4,O
weeks,O
.,O

Mother,O
has,O
Dr,O
Fishman's,O
contact,O
information,O
.,O

Emma,O
Nicolas,O
",",O
MD,O
79-770,O

Dictated,O
By,O
:,O
Jerry,O
E,O
Ross,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2014-04-01,O
01:57:51,O

T,O
:,O
2014-04-01,O
02:59:13,O

Job,O
#:,O
96281,O

Signed,O
electronically,O
by,O
:,O
DR.,O
James,O
GRAY,O
on,O
:,O
Roger,O
2014-04-03,O
3:20,O
PM,O

(,O
End,O
of,O
Report,O
),O

860059421,O

SH,O

17511921,O

6/10/1999,O
12:00:00,O
AM,O

GASTROINTESTINAL,B-PR
BLEED,I-PR

Signed,O

DIS,O

Admission,O
Date,O
:,O

06/10/1999,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

06/26/1999,O

DISCHARGE,O
DIAGNOSIS,O
:,O

SEPSIS,B-PR
.,O

SIGNIFICANT,O
PROBLEMS,O
:,O

1,O
),O
GASTROINTESTINAL,B-PR
BLEED,I-PR
.,O

2,O
),O
HEPATIC,B-PR
ENCEPHALOPATHY,I-PR
.,O

3,O
),O
END,B-PR
STAGE,I-PR
RENAL,I-PR
DISEASE,I-PR
ON,O
DIALYSIS,B-TR
.,O

HISTORY,O
OF,O
THE,O
PRESENT,O
ILLNESS,O
:,O

Mr.,O
Vinktlandfreierm,O
was,O
admitted,O
from,O
Owaleharbo,O
Tanaminer,O
Hospital,O
to,O
which,O
he,O
had,O
been,O
discharged,O
approximately,O
four,O
days,O
prior,O
to,O
admission,O
.,O

He,O
was,O
noted,O
to,O
have,O
dark,B-PR
stools,I-PR
per,I-PR
rectum,I-PR
and,O
to,O
be,O
somewhat,B-PR
fluid,I-PR
overloaded,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

He,O
was,O
admitted,O
and,O
found,O
to,O
have,O
a,O
significant,O
hematocrit,B-PR
drop,I-PR
from,O
33.8,O
to,O
24.3,O
.,O

He,O
was,O
found,O
operation,O
be,O
short,B-PR
of,I-PR
breath,I-PR
and,O
was,O
taken,O
to,O
dialysis,B-TR
for,O
apparent,B-PR
fluid,I-PR
overload,I-PR
.,O

His,B-PR
gastrointestinal,I-PR
bleeding,I-PR
issues,I-PR
were,O
investigated,O
with,O
an,B-TE
upper,I-TE
endoscopy,I-TE
which,O
revealed,O
multiple,O
superficial,O
gastric,B-PR
ulcerations,I-PR
consistent,O
with,O
an,B-PR
non-steroidal,I-PR
anti-inflammatory,I-PR
drugs,I-PR
gastropathy,I-PR
.,O

He,O
had,O
been,O
discharged,O
on,O
one,B-TR
aspirin,I-TR
a,O
day,O
with,O
20,O
of,O
Prilosec,B-TR
b.i.d.,O

The,B-TR
aspirin,I-TR
was,O
discontinued,O
and,O
he,O
had,O
no,O
further,O
problems,O
with,O
gastrointestinal,B-PR
bleeding,I-PR
and,O
a,O
stable,O
hematocrit,B-TE
the,O
rest,O
of,O
his,O
hospitalization,O
.,O

During,O
the,O
course,O
of,O
his,O
hospitalization,O
",",O
he,O
became,O
increasingly,B-PR
lethargic,I-PR
.,O

An,B-TE
extensive,I-TE
work-up,I-TE
was,O
done,O
for,O
any,B-PR
metabolic,I-PR
abnormalities,I-PR
which,O
was,O
unrevealing,O
.,O

He,O
responded,O
somewhat,O
to,O
lactulose,B-TR
for,O
hepatic,B-PR
encephalopathy,I-PR
.,O

He,O
had,O
one,B-PR
positive,I-PR
blood,I-PR
culture,I-PR
for,O
Vancomycin,B-PR
resistant,I-PR
enterococcus,I-PR
.,O

In,O
the,O
few,O
days,O
prior,O
to,O
his,O
demise,O
",",O
he,O
was,O
intermittently,O
somewhat,B-PR
lethargic,I-PR
buton,O
the,O
morning,O
of,O
June,O
25,O
",",O
1999,O
",",O
his,B-TE
white,I-TE
count,I-TE
was,O
noted,O
to,O
have,O
increased,O
from,O
8,O
to,O
"13,000",O
.,O

That,O
day,O
",",O
he,O
was,O
found,O
to,O
be,O
acutely,B-PR
short,I-PR
of,I-PR
breath,I-PR
with,O
a,B-TE
respiratory,I-TE
rate,I-TE
of,O
40,O
and,O
oxygen,B-TE
saturations,I-TE
in,O
the,O
mid,O
seventies,O
.,O

He,O
was,O
put,O
on,O
100%,B-TR
nonrebreather,I-TR
and,O
his,B-TE
oxygen,I-TE
saturations,I-TE
improved,O
to,O
the,O
low,O
nineties,O
.,O

Nasal,B-TR
trumpet,I-TR
suction,I-TR
was,O
done,O
and,O
he,O
was,O
found,O
to,O
have,O
food,O
like,O
material,O
that,O
was,O
easily,O
suctioned,O
out,O
.,O

He,O
was,O
also,O
found,O
to,O
havesome,O
pieces,O
of,O
toast,O
in,O
his,O
mouth,O
.,O

Blood,B-TE
gases,I-TE
were,O
done,O
and,O
he,O
was,O
found,O
to,O
have,O
a,B-TE
pH,I-TE
of,O
7.2,O
with,O
a,B-TE
pCO2,I-TE
of,O
21,O
.,O

Fingerstick,B-TE
glucose,I-TE
revealed,O
a,B-TE
sugar,I-TE
of,O
12,O
.,O

A,B-TE
stat,I-TE
panel,I-TE
7,I-TE
confirmed,O
that,O
the,B-TE
sugar,I-TE
was,O
23,O
and,O
that,O
he,O
had,O
a,B-TE
new,I-TE
anion,I-TE
gap,I-TE
of,O
40,O
.,O

Repeat,B-TE
blood,I-TE
gas,I-TE
was,O
done,O
which,O
was,O
almost,O
identical,O
to,O
the,O
first,O
.,O

The,O
family,O
was,O
called,O
and,O
came,O
in,O
to,O
see,O
the,O
patient,O
.,O

An,O
extensive,O
family,O
meeting,O
was,O
held,O
and,O
the,O
family,O
agreed,O
that,O
it,O
did,O
not,O
make,O
sense,O
to,O
intubate,O
the,O
patient,O
and,O
send,O
him,O
to,O
the,O
Intensive,O
Care,O
Unit,O
.,O

In,O
the,O
acute,O
setting,O
",",O
he,O
had,O
been,O
started,O
on,O
levofloxacin,B-TR
",",O
Flagyl,B-TR
",",O
and,O
Vancomycin,B-TR
.,O

These,B-TR
antibiotics,I-TR
were,O
continued,O
but,O
the,O
family,O
decided,O
that,O
they,O
wanted,O
us,O
to,O
emphasize,O
the,O
comfort,O
of,O
the,O
patient,O
and,O
pursue,O
no,O
further,B-TR
invasive,I-TR
measures,I-TR
.,O

The,O
patient,O
was,O
made,O
do,O
not,O
resuscitate,O
/,O
do,O
not,O
intubate,O
.,O

At,O
2:30,O
on,O
June,O
26,O
",",O
1999,O
",",O
I,O
was,O
called,O
to,O
see,O
the,O
patient,O
who,O
had,O
expired,O
.,O

DISPOSITION,O
:,O

The,O
family,O
was,O
notified,O
and,O
came,O
in,O
to,O
see,O
the,O
patient,O
.,O

The,O
family,O
declined,O
an,B-TE
autopsy,I-TE
saying,O
that,O
they,O
felt,O
that,O
the,O
patient,O
had,O
been,O
through,O
enough,O
.,O

The,O
patient,O
&apos;s,O
attending,O
physician,O
",",O
Dr.,O
Erm,O
Neidwierst,O
",",O
was,O
notified,O
as,O
well,O
.,O

Dictated,O
By,O
:,O

CONRELLIE,O
KOTERUDES,O
",",O
M.D.,O
UK0,O

Attending,O
:,O

ERM,O
K.,O
NEIDWIERST,O
",",O
M.D.,O
QQ62,O
OC499/5391,O

Batch,O
:,O

15168,O

Index,O
No.,O

VKRPJQ81J6,O

D,O
:,O

06/26/99,O

T,O
:,O

06/29/99,O

Admission,O
Date,O
:,O

2010-08-30,O

Discharge,O
Date,O
:,O

2010-08-31,O

Date,O
of,O
Birth,O
:,O

1977-03-27,O

Sex,O
:,O

M,O

Service,O
:,O

MEDICINE,B-TR

CHIEF,O
COMPLAINT,O
:,O

Delta,O
MS,O
Rachel,O
Rohrer,O
.,O

HISTORY,O
OF,O
THE,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
33,O
-,O
year-old,O
Asian-Caucasian,O
male,O
with,O
a,O
history,O
of,O
Type,B-PR
1,I-PR
diabetes,I-PR
",",O
asthma,B-PR
",",O
alcohol,O
abuse,O
",",O
and,O
personality,B-PR
disorder,I-PR
/,O
depression,B-PR
admitted,O
on,O
2010-08-28,O
for,O
persistent,B-PR
hypoglycemia,I-PR
.,O

The,O
patient,O
complained,O
of,O
diaphoresis,B-PR
",",O
confusion,B-PR
",",O
dizziness,B-PR
",",O
lightheadedness,B-PR
after,O
drinking,O
a,O
24,O
ounce,O
beer,O
and,O
taking,O
at,O
least,O
an,O
extra,O
15,O
units,O
of,O
NPH,B-TR
insulin,I-TR
the,O
evening,O
of,O
2010-08-27,O
(,O
later,O
reported,O
over,O
70,O
U,O
insulin,B-TR
administered,O
from,O
2.30,O
PM,O
until,O
time,O
of,O
presentation,O
),O
followed,O
by,O
not,O
eating,O
dinner,O
.,O

His,B-PR
symptoms,I-PR
mildly,O
improved,O
after,O
eating,O
a,O
candy,O
bar,O
.,O

The,O
EMS,O
was,O
called,O
and,O
found,O
his,B-TE
blood,I-TE
sugar,I-TE
at,O
the,O
time,O
to,O
be,O
61,O
and,O
noted,O
to,O
be,O
41,O
in,O
the,O
Emergency,O
Department,O
.,O

He,O
denied,O
any,B-PR
seizure,I-PR
activity,I-PR
",",O
loss,B-PR
of,I-PR
consciousness,I-PR
",",O
incontinence,B-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
fevers,B-PR
",",O
or,O
chills,B-PR
",",O
chest,B-PR
pain,I-PR
",",O
change,B-PR
in,I-PR
urinary,I-PR
or,I-PR
bowel,I-PR
habits,I-PR
",",O
or,O
suicidal,B-PR
ideation,I-PR
.,O

He,O
has,O
been,O
depressed,B-PR
recently,O
regarding,O
stress,O
with,O
his,O
home,O
life,O
and,O
on,O
the,O
night,O
of,O
his,B-TR
extra,I-TR
insulin,I-TR
doses,I-TR
",",O
his,O
wife,O
had,O
just,O
kicked,O
him,O
out,O
of,O
the,O
house,O
.,O

He,O
has,O
had,O
four,O
past,O
hospitalizations,O
for,O
attempted,B-PR
suicide,I-PR
with,O
insulin,B-PR
overdosing,I-PR
",",O
usually,O
denied,O
.,O

The,O
wife,O
also,O
states,O
that,O
he,O
drinks,O
more,O
than,O
he,O
states,O
.,O

In,O
the,O
Emergency,O
Department,O
",",O
he,O
received,O
3.5,O
amps,O
of,O
D50,B-TR
and,O
then,O
D5,B-TR
normal,I-TR
saline,I-TR
and,O
D10,B-TR
normal,I-TR
saline,I-TR
with,O
blood,B-TE
sugars,I-TE
that,O
were,O
slow,B-PR
to,I-PR
increase,I-PR
leading,O
the,O
ICU,O
team,O
to,O
suspect,O
that,O
the,O
patient,O
had,O
taken,O
more,O
insulin,B-TR
than,O
he,O
admitted,O
.,O

He,O
also,O
had,O
a,O
very,O
positive,O
tox,B-TE
screen,I-TE
for,O
alcohol,O
.,O

His,B-TE
fingersticks,I-TE
are,O
currently,O
in,O
the,O
200,O
s,O
and,O
his,O
normal,O
blood,O
glucose,O
at,O
home,O
ranges,O
between,O
90-200,O
per,O
the,O
patient,O
.,O

The,O
patient,O
also,O
now,O
complains,O
of,O
increased,B-PR
right,I-PR
upper,I-PR
quadrant,I-PR
/,I-PR
right,I-PR
rib,I-PR
cage,I-PR
pain,I-PR
and,O
new,B-PR
headache,I-PR
.,O

He,O
also,O
complains,O
of,O
chronic,B-PR
photophobia,I-PR
which,O
is,O
unchanged,O
.,O

He,O
denied,O
visual,B-PR
changes,I-PR
",",O
lightheadedness,B-PR
of,O
dizziness,B-PR
currently,O
",",O
neck,B-PR
stiffness,I-PR
",",O
or,O
pain,B-PR
in,I-PR
any,I-PR
other,I-PR
area,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Insulin-dependent,B-PR
diabetes,I-PR
.,O

2.,O
Depression,B-PR
.,O

3.,O
Asthma,B-PR
.,O

4.,O
Alcohol,O
abuse,O
.,O

5.,O
Hypercholesterolemia,B-PR
.,O

MEDICATIONS,O
ON,O
TRANSFER,O
FROM,O
THE,O
INTENSIVE,O
CARE,O
4999801,O
.,O

Humalog,B-TR
sliding,I-TR
scale,I-TR
insulin,I-TR
.,O

2.,O
NPH,B-TR
12,O
units,O
q.a.m.,O
",",O
7,O
units,O
q.p.m.,O
with,O
normal,B-TR
home,I-TR
dose,I-TR
being,O
30,O
units,O
q.a.m.,O
and,O
15,O
units,O
q.p.m.,O

3.,O
Thiamine,B-TR
.,O

4.,O
Folate,B-TR
.,O

5.,O
Multivitamin,B-TR
.,O

6.,O
Fluticasone,B-TR
.,O

7.,O
Albuterol,B-TR
inhaler,I-TR
p.r.n.,O

8.,O
Neutra-Phos,B-TR
.,O

ALLERGIES,O
:,O

The,O
patient,O
has,O
no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

Half,O
pack,O
per,O
day,O
of,O
tobacco,O
times,O
20,O
years,O
",",O
alcohol,O
about,O
two,O
24,O
ounce,O
beers,O
per,O
week,O
.,O

Drugs,O
:,O

Denied,O
IV,O
drug,O
abuse,O
.,O

He,O
lives,O
with,O
his,O
wife,O
who,O
has,O
a,O
baby,O
with,O
another,O
boyfriend,O
of,O
two,O
years,O
.,O

He,O
recently,O
came,O
out,O
as,O
bisexual,O
to,O
his,O
wife,O
.,O

The,O
wife,O
and,O
the,O
patient,O
have,O
two,O
children,O
together,O
.,O

He,O
was,O
fired,O
as,O
a,O
Federal,O
Express,O
worker,O
recently,O
and,O
his,O
wife,O
kicked,O
the,O
patient,O
out,O
of,O
his,O
home,O
on,O
2010-08-27,O
.,O

FAMILY,O
HISTORY,O
:,O

Grandmother,O
with,O
diabetes,B-PR
.,O

Mother,O
with,O
asthma,B-PR
.,O

PHYSICAL,O
EXAMINATION,O
ON,O
TRANSFER,O
:,O
Vital,B-TE
signs,I-TE
:,O

T,B-TE
maximum,I-TE
98.6,O
",",O
blood,B-TE
pressure,I-TE
90s-130s,O
/,O
80s-90s,O
",",O
heart,B-TE
rate,I-TE
70s,O
to,O
80s,O
",",O
respirations,B-TE
18,O
",",O
oxygen,B-TE
saturation,I-TE
98%,O
on,O
room,O
air,O
.,O

General,O
:,O

The,O
patient,O
was,O
a,O
soft-spoken,O
male,O
resting,O
in,O
his,O
bed,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

HEENT,O
:,O

The,O
pupils,O
were,O
equally,O
round,O
and,O
reactive,O
to,O
light,O
.,O

Extraocular,O
muscles,O
were,O
intact,O
.,O

Sclerae,O
were,O
anicteric,B-PR
.,O

Moist,O
mucous,O
membranes,O
",",O
clear,O
oropharynx,O
.,O

Neck,O
:,O

Supple,O
",",O
no,O
masses,B-PR
",",O
no,O
lymphadenopathy,B-PR
.,O

Cardiovascular,O
:,O

Regular,O
rate,O
",",O
no,O
murmurs,B-PR
",",O
rubs,B-PR
",",O
or,O
gallops,B-PR
.,O

Normal,O
S1,O
",",O
S2,O
.,O

Pulmonary,O
:,O

Clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

Abdomen,O
:,O

Normoactive,O
bowel,O
sounds,O
",",O
soft,O
",",O
mildly,B-PR
tender,I-PR
at,I-PR
right,I-PR
upper,I-PR
quadrant,I-PR
just,O
inferior,O
to,O
the,O
lower,O
ribs,O
",",O
no,O
epigastric,B-PR
tenderness,I-PR
.,O

Extremities,O
:,O
Warm,O
and,O
well,O
perfuse,O
.,O

Normal,O
peripheral,O
pulses,O
.,O

Neurologic,O
:,O

Cranial,O
nerves,O
II,O
through,O
XII,O
were,O
intact,O
.,O

Normal,O
sensation,O
.,O

Normal,O
motor,O
strength,O
bilaterally,O
.,O

Psychiatric,O
:,O

Depressed,B-PR
affect,I-PR
.,O

Denied,O
suicidal,B-PR
ideation,I-PR
.,O

LABORATORY,O
/,O
RADIOLOGIC,O
DATA,O
:,O

CBC,B-TE
with,O
a,B-TE
white,I-TE
count,I-TE
of,O
6.2,O
",",O
hemoglobin,B-TE
13.3,O
",",O
hematocrit,B-TE
39.4,O
",",O
platelet,B-TE
"307,000",O
.,O

Sodium,B-TE
142,O
",",O
potassium,B-TE
4.1,O
",",O
chloride,B-TE
104,O
",",O
bicarbonate,B-TE
30,O
",",O
BUN,B-TE
7,O
",",O
creatinine,B-TE
0.7,O
",",O
glucose,B-TE
41,O
.,O

Calcium,B-TE
9.6,O
",",O
magnesium,B-TE
2.2,O
",",O
phosphorus,B-TE
7.4,O
",",O
vitamin,B-TE
B12,I-TE
level,I-TE
320,O
",",O
folate,B-TE
9.5,O
",",O
TSH,B-TE
1.4,O
",",O
acetone,B-TE
negative,O
.,O

Serum,B-TE
tox,I-TE
screen,I-TE
",",O
alcohol,O
32,O
mg,O
per,O
deciliter,O
",",O
negative,O
for,O
aspirin,B-TR
",",O
benzos,B-TR
",",O
barbiturates,B-TR
",",O
and,O
TCA,B-TR
.,O

Urine,B-TE
tox,I-TE
screen,I-TE
negative,O
for,O
benzos,B-TR
",",O
barbiturates,B-TR
",",O
opiates,B-TR
",",O
cocaine,B-TR
",",O
amphetamines,B-TR
",",O
and,O
methadone,B-TR
.,O

Telemetry,B-TE
was,O
notable,O
for,O
episodes,O
of,O
sinus,B-PR
tachycardia,I-PR
to,O
120s,O
to,O
140s,O
only,O
.,O

HOSPITAL,O
COURSE,O
:,O

1.,O
HYPOGLYCEMIA,B-PR
:,O

The,O
patient,O
had,O
been,O
initially,O
very,B-PR
hypoglycemic,I-PR
on,O
admission,O
secondary,O
to,O
overdosing,B-PR
on,I-PR
insulin,I-PR
;,O
however,O
",",O
with,O
glucose,B-TR
repletion,I-TR
both,O
in,O
the,O
Emergency,O
Department,O
and,O
in,O
the,O
ICU,O
",",O
this,O
resolved,O
and,O
the,O
patient,O
also,O
began,O
to,O
eat,O
.,O

We,O
checked,O
fingerstick,B-TE
glucoses,I-TE
q.i.d.,O
and,O
at,O
3:00,O
a.m.,O

His,B-TE
glucose,I-TE
on,O
the,O
morning,O
of,O
discharge,O
was,O
about,O
60,O
so,O
we,O
opted,O
to,O
decrease,O
his,B-TR
p.m.,I-TR
NPH,I-TR
dose,I-TR
slightly,O
for,O
discharge,O
and,O
continue,O
covering,O
him,O
with,O
sliding,B-TR
scale,I-TR
insulin,I-TR
.,O

He,O
should,O
also,O
continue,O
having,O
a,O
snack,O
at,O
midnight,O
if,O
able,O
.,O

It,O
is,O
likely,O
that,O
he,O
required,O
a,O
much,O
greater,O
amount,O
of,O
insulin,B-TR
as,O
an,O
outpatient,O
due,O
to,O
poor,B-PR
compliance,I-PR
with,O
Richard,B-TR
Natalie,I-TR
diet,I-TR
.,O

2.,O
ALCOHOL,O
ABUSE,O
:,O

It,O
is,O
likely,O
that,O
the,O
patient,O
continues,O
to,O
drink,O
more,O
than,O
he,O
admits,O
.,O

He,O
did,O
have,O
past,O
alcoholism,O
consisting,O
of,O
a,O
half,O
a,O
pint,O
of,O
brandy,O
per,O
day,O
for,O
three,O
years,O
but,O
supposedly,O
had,O
quit,O
in,O
2009-09-03,O
.,O

He,O
had,O
been,O
on,O
a,B-TR
diazepam,I-TR
CIWA,I-TR
scale,I-TR
prophylaxis,I-TR
against,O
DT,B-PR
s;,I-PR
however,O
",",O
he,O
had,O
a,B-TE
very,I-TE
low,I-TE
CIWA,I-TE
scale,I-TE
during,O
his,O
entire,O
admission,O
and,O
did,O
not,O
need,O
any,B-TR
benzodiazepines,I-TR
.,O

This,O
alcohol,O
abuse,O
may,O
be,O
further,O
addressed,O
as,O
an,O
inpatient,O
on,O
the,O
Psychiatry,O
Quincy,O
Medical,O
Center,O
.,O

We,O
had,O
also,O
requested,O
a,O
Social,O
Work,O
consult,O
regarding,O
this,O
.,O

3.,O
DEPRESSION,B-PR
vs.,O
Borderline,B-PR
personality,I-PR
disorder,I-PR
:,O

The,O
patient,O
has,O
had,O
several,O
admissions,O
in,O
the,O
past,O
for,O
attempted,B-PR
suicide,I-PR
with,O
overdose,B-PR
of,O
his,B-TR
insulin,I-TR
and,O
though,O
he,O
denied,O
at,O
this,O
time,O
attempting,O
to,O
end,O
his,O
life,O
",",O
it,O
appears,O
that,O
the,O
social,O
situation,O
of,O
increased,B-PR
stressors,I-PR
corresponding,O
to,O
this,O
time,O
suggest,O
that,O
this,O
is,O
not,O
the,O
truth,O
.,O

He,O
received,O
a,O
one-to-one,B-TR
sitter,I-TR
during,O
his,O
admission,O
and,O
will,O
be,O
transferred,O
to,O
the,O
Psychiatry,O
HealthSouth,O
New,O
England,O
Rehab,O
Hospital,O
to,O
ensure,O
the,O
patient,O
's,O
safety,O
and,O
initiate,O
further,B-TR
antidepressant,I-TR
treatment,I-TR
.,O

He,O
will,O
need,O
close,O
follow-up,O
regarding,O
his,B-PR
depression,I-PR
as,O
an,O
outpatient,O
",",O
although,O
apparently,O
this,O
has,O
been,O
set,O
up,O
for,O
him,O
in,O
the,O
past,O
and,O
he,O
had,O
not,O
followed,O
through,O
.,O

4.,O
HISTORY,O
OF,O
HIGH,B-PR
BLOOD,I-PR
PRESSURE,I-PR
:,O

His,B-TE
blood,I-TE
pressure,I-TE
was,O
fairly,O
low,O
with,O
a,O
maximum,O
of,O
130s,O
systolic,O
during,O
his,O
admission,O
",",O
thus,O
we,O
did,O
not,O
continue,O
his,B-TR
lisinopril,I-TR
which,O
he,O
had,O
been,O
on,O
in,O
the,O
past,O
.,O

5.,O
RIGHT,B-PR
UPPER,I-PR
QUADRANT,I-PR
PAIN,I-PR
:,O

We,O
obtained,O
a,B-TE
right,I-TE
upper,I-TE
quadrant,I-TE
ultrasound,I-TE
as,O
well,O
as,O
LFTs,B-TE
",",O
amylase,B-TE
",",O
and,O
lipase,B-TE
which,O
were,O
all,O
normal,O
.,O

He,O
had,O
no,O
evidence,O
of,O
cholecystitis,B-PR
or,O
gallstones,B-PR
or,O
any,B-PR
abnormalities,I-PR
with,I-PR
the,I-PR
liver,I-PR
or,I-PR
kidneys,I-PR
.,O

it,O
is,O
possible,O
that,O
he,O
has,O
had,O
a,B-PR
muscle,I-PR
strain,I-PR
or,O
other,B-PR
musculoskeletal,I-PR
cause,I-PR
.,O

6.,O
PROPHYLAXIS,B-TR
:,O

He,O
was,O
put,O
on,O
Pepcid,B-TR
for,O
GI,B-TR
prophylaxis,I-TR
.,O

7.,O
FLUIDS,O
",",O
ELECTROLYTES,O
",",O
AND,O
NUTRITION,O
:,O

He,O
complied,O
with,O
Linda,B-TR
Chad,I-TR
diet,I-TR
while,O
hospitalized,O
.,O

The,O
patient,O
was,O
hyperphosphatemic,B-PR
secondary,O
to,O
overadministration,O
of,O
Neutra-Phos,B-TR
during,O
his,O
ICU,O
stay,O
.,O

He,O
was,O
given,O
two,O
doses,O
of,O
calcium,B-TR
carbonate,I-TR
1,O
gram,O
",",O
and,O
will,O
most,O
likely,O
normalize,O
secondary,O
to,O
both,O
calcium,O
binding,O
and,O
urinary,O
excretion,O
.,O

He,O
has,O
been,O
asymptomatic,B-PR
.,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

1.,O
Depression,B-PR
.,O

2.,O
Insulin-dependent,B-PR
diabetes,I-PR
mellitus,I-PR
.,O

3.,O
Asthma,B-PR
.,O

4.,O
Alcohol,O
abuse,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Insulin,B-TR
NPH,I-TR
10,O
units,O
q.a.m.,O
",",O
5,O
units,O
q.p.m.,O

2.,O
Humalog,B-TR
sliding,I-TR
scale,I-TR
insulin,I-TR
for,O
fingerstick,B-TE
blood,I-TE
glucose,I-TE
151-200,O
2,O
units,O
;,O
201-250,O
4,O
units,O
;,O
251-300,O
6,O
units,O
;,O
301-350,O
8,O
units,O
;,O
351-400,O
10,O
units,O
;,O
greater,O
than,O
400,O
12,O
units,O
.,O

3.,O
Multivitamin,B-TR
.,O

4.,O
Fluticasone,B-TR
.,O

5.,O
Albuterol,B-TR
p.r.n.,O

6.,O
Pepcid,B-TR
20,O
mg,O
p.o.,O
q.d.,O

FOLLOW-UP,O
PLANS,O
:,O

The,O
patient,O
will,O
be,O
transferred,O
to,O
the,O
Inpatient,O
Psychiatry,O
Unit,O
on,O
Springfield,O
Municipal,O
Hospital,O
IV,O
for,O
further,B-TE
evaluation,I-TE
and,O
treatment,B-TR
of,O
his,B-PR
depression,I-PR
and,O
possible,O
suicidal,B-PR
ideation,I-PR
.,O

He,O
will,O
follow-up,O
with,O
his,O
primary,O
care,O
doctor,O
",",O
Dr.,O
Gillis,O
",",O
after,O
discharge,O
",",O
Johannes,O
for,O
Diabetes,B-TR
management,I-TR
",",O
and,O
Psychiatry,O
for,O
further,B-TR
management,I-TR
of,O
his,B-PR
impulsive,I-PR
behaviors,I-PR
.,O

Patty,O
K.,O
Wagner,O
",",O
M.D.,O
01-820,O

Dictated,O
By,O
:,O
Cora,O
C.,O
Haskett,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2010-08-31,O
09:08,O

T,O
:,O
2010-09-10,O
08:23,O

JOB,O
#:,O
34336,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Elizabeth,O
Gabriele,O
on,O
:,O
FRI,O
2010-09-10,O
3:04,O
PM,O

(,O
End,O
of,O
Report,O
),O

866196074,O
RWH,O

6639378,O

578141,O

325706,O

3/10/2003,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O
/,O
SUMMARY,O

KNOLESA,O
",",O
VIA,O

MRN,O
:,O

6639378,O

Age,O
:,O

39y,O

REGISTRATION,O
DATE,O
:,O

03/10/2003,O
06:42,O
PM,O

Provider,O
:,O

Inachelle,O
Breutzbreunbreuncotfalke,O

PRELMINARY,O
REPORT,O

Benefits,O
Assigned,O
:,O

Y,O

Discharge,O
Date,O
/,O
Time,O
:,O

03/10/2003,O
23:26,O

Discharge,O
Status,O
:,O

Discharged,O

Condition,O
on,O
Discharge,O
:,O

Stable,O

Patient,O
States,O
Complaint,O
:,O

INCREASED,O
ACID,B-PR
REFLUX,I-PR

Standardized,O
Discharge,O
Instructions,O
:,O

The,O
patient,O
was,O
given,O
printed,O
instructions,O
for,O
abdominal,B-PR
pain,I-PR
(,O
Spanish,O
),O
.,O

Diagnosis,O
:,O

GERD,B-PR

Treatment,O
Rendered,O
:,O

h,O
",",O
"p,",B-TE
labs,B-TE
",",O
mylanta,B-TR
/,O
viscous,B-TR
lidocaine,I-TR

Discharge,O
Medications,O
:,O

mylanta,B-TR
15,O
cc,O
mixed,O
with,O
Viscous,B-TR
lidocaine,I-TR
every,O
8,O
hours,O
if,O
needed,O
for,O
severe,O
pain,B-PR
only,O
can,O
use,O
mylanta,B-TR
without,O
lidocaine,B-TR
more,O
frequently,O
bland,B-TR
diet,I-TR
",",O
no,O
caffeine,O
",",O
chilli,O
",",O
or,O
alcohol,O
...,O

Follow,O
up,O
Service,O
:,O

call,O
your,O
PCP,O
to,O
schedule,O
your,O
GI,O
follow,O
up,O
date,O

Disposition,O
",",O
Follow,O
up,O
and,O
Instructions,O
to,O
Patient,O
:,O

return,O
to,O
ED,O
if,O
worsening,B-PR
pain,I-PR
",",O
black,B-PR
stools,I-PR
",",O
blood,B-PR
in,I-PR
stool,I-PR

PCP,O
Name,O
:,O

LEEBKAYSHAUPKERTH,O
",",O
MAENZET,O
N,O

Provider,O
Number,O
:,O

31710,O

This,O
report,O
was,O
created,O
by,O
Breutzbreunbreuncotfalke,O
",",O
Inachelle,O
03/10/2003,O
11:28,O
PM,O

Admission,O
Date,O
:,O

2015-06-10,O

Discharge,O
Date,O
:,O

2015-06-11,O

Date,O
of,O
Birth,O
:,O

1970-12-08,O

Sex,O
:,O

M,O

Service,O
:,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
44,O
-,O
year-old,O
male,O
with,O
a,O
history,O
of,O
coronary,B-PR
artery,I-PR
disease,I-PR
",",O
status,O
post,O
myocardial,B-PR
infarction,I-PR
in,O
9/02,O
",",O
status,O
post,O
stent,B-TR
proximal,B-PR
and,I-PR
mid-RCA,I-PR
lesion,I-PR
and,O
OM,B-PR
lesion,I-PR
.,O

He,O
had,O
a,B-TE
Myoview,I-TE
on,O
05-04,O
which,O
showed,O
fixed,B-PR
inferior,I-PR
wall,I-PR
defect,I-PR
but,O
no,O
evidence,O
of,O
ischemia,B-PR
.,O

He,O
has,O
been,O
getting,O
short,B-PR
of,I-PR
breath,I-PR
with,O
exertion,O
times,O
one,O
month,O
and,O
also,O
has,O
occasional,B-PR
chest,I-PR
tightness,I-PR
.,O

He,O
denies,O
orthopnea,B-PR
",",O
edema,B-PR
",",O
paroxysmal,B-PR
nocturnal,I-PR
dyspnea,I-PR
",",O
diaphoresis,B-PR
",",O
claudication,B-PR
.,O

He,O
also,O
has,O
history,O
of,O
hypertension,B-PR
",",O
high,B-PR
cholesterol,I-PR
and,O
noninsulin,B-PR
dependent,I-PR
diabetes,I-PR
mellitus,I-PR
.,O

He,O
underwent,O
cardiac,B-TE
catheterization,I-TE
today,O
which,O
revealed,O
OM,O
",",O
no,O
obstructive,B-PR
disease,I-PR
",",O
left,B-PR
anterior,I-PR
descending,I-PR
minimal,I-PR
disease,I-PR
",",O
left,B-PR
circumflex,I-PR
40%,I-PR
mid-stenosis,I-PR
.,O

Right,B-PR
coronary,I-PR
artery,I-PR
100%,I-PR
mid-stenosis,I-PR
.,O

Echo,B-TE
in,O
9/02,O
showed,O
LVF,B-TE
of,O
75%,O
with,O
moderate,B-PR
dilatation,I-PR
of,I-PR
the,I-PR
descending,I-PR
aorta,I-PR
.,O

He,O
is,O
now,O
preop,O
for,O
a,B-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Noninsulin,B-PR
dependent,I-PR
diabetes,I-PR
mellitus,I-PR
",",O
hypertension,B-PR
",",O
high,B-PR
cholesterol,I-PR
",",O
coronary,B-PR
artery,I-PR
disease,I-PR
",",O
status,O
post,O
myocardial,B-PR
infarction,I-PR
in,O
9/02,O
.,O

Status,O
post,O
stent,B-TR
.,O

MEDICATIONS,O
:,O

1.,O
Folic,B-TR
Acid,I-TR
.,O

2.,O
Metformin,B-TR
.,O

3.,O
Norvasc,B-TR
.,O

4.,O
Aspirin,B-TR
.,O

5.,O
Lopressor,B-TR
.,O

6.,O
Lipitor,B-TR
.,O

7.,O
Diovan,B-TR
.,O

8.,O
Hydrochlorothiazide,B-TR
.,O

ALLERGIES,O
:,O

Penicillin,B-TR
",",O
sulfa,B-TR
and,O
Codeine,B-TR
.,O

FAMILY,O
HISTORY,O
:,O

Strong,B-PR
coronary,I-PR
artery,I-PR
disease,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

No,O
tobacco,O
",",O
no,O
alcohol,O
",",O
lives,O
with,O
wife,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,O
patient,O
is,O
in,O
no,O
acute,B-PR
distress,I-PR
",",O
vital,B-TE
signs,I-TE
stable,O
.,O

Normocephalic,B-PR
",",O
atraumatic,B-PR
.,O

Pupils,O
are,O
equal,O
",",O
round,O
",",O
and,O
reactive,O
to,O
light,O
and,O
accommodation,O
.,O

Extraocular,O
movements,O
intact,O
.,O

Oropharynx,O
clear,O
.,O

Neck,O
supple,O
.,O

Full,O
range,O
of,O
motion,O
",",O
no,O
lymphadenopathy,B-PR
.,O

No,O
thyromegaly,B-PR
.,O

Carotids,B-TE
2+,O
bilaterally,O
without,O
bruits,B-PR
.,O

Lungs,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

Cardiac,O
:,O

Regular,O
rate,O
and,O
rhythm,O
.,O

No,O
murmurs,B-PR
",",O
rubs,B-PR
or,O
gallops,B-PR
.,O

Abdomen,B-PR
obese,I-PR
",",O
soft,O
",",O
nontender,B-PR
without,O
masses,B-PR
",",O
no,O
hepatosplenomegaly,B-PR
",",O
positive,O
bowel,O
sounds,O
without,O
cyanosis,B-PR
",",O
clubbing,B-PR
or,O
edema,B-PR
.,O

Pulses,B-TE
2+,O
bilaterally,O
throughout,O
.,O

Neurological,O
:,O

Nonfocal,O
.,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
hospital,O
on,O
2015-06-10,O
and,O
taken,O
to,O
the,O
operating,O
room,O
on,O
2015-06-11,O
where,O
coronary,B-TR
artery,I-TR
bypass,I-TR
graft,I-TR
times,O
four,O
was,O
performed,O
.,O

He,O
initially,O
required,O
nitroglycerin,B-TR
drip,I-TR
.,O

He,O
had,O
chest,B-TR
tube,I-TR
and,O
pacing,B-TR
wires,I-TR
in,O
place,O
.,O

Received,O
perioperative,B-TR
Vancomycin,I-TR
.,O

Postoperative,O
day,O
one,O
the,B-TE
chest,I-TE
x-ray,I-TE
showed,O
a,B-PR
collapsed,I-PR
left,I-PR
upper,I-PR
lobe,I-PR
.,O

PEEP,B-TR
was,O
increased,O
and,O
a,B-TE
chest,I-TE
x-ray,I-TE
checked,O
the,O
following,O
morning,O
.,O

The,O
patient,O
subsequently,O
did,O
well,O
",",O
chest,B-TR
tubes,I-TR
were,O
removed,O
at,O
the,O
appropriate,O
time,O
",",O
pacing,B-TR
wires,I-TR
removed,O
at,O
the,O
appropriate,O
time,O
.,O

The,O
patient,O
was,O
discharged,O
to,O
the,O
regular,O
cardiothoracic,O
floor,O
where,O
his,B-TR
anti-hypertensives,I-TR
were,O
manipulated,O
to,O
improve,O
his,B-TE
heart,I-TE
rate,I-TE
and,O
blood,B-TE
pressure,I-TE
.,O

The,O
patient,O
did,O
well,O
on,O
the,O
floor,O
",",O
was,O
seen,O
by,O
physical,O
therapy,O
who,O
quickly,O
cleared,O
him,O
to,O
go,O
home,O
on,O
2015-06-15,O
and,O
the,O
patient,O
was,O
in,O
good,O
condition,O
.,O

Being,O
discharged,O
to,O
home,O
.,O

The,O
patient,O
may,O
shower,O
but,O
should,O
not,O
take,O
baths,O
.,O

Should,O
avoid,O
strenuous,O
activity,O
.,O

Should,O
not,O
drive,O
while,O
on,O
pain,B-TR
medication,I-TR
.,O

He,O
is,O
to,O
follow-up,O
with,O
Dr.,O
Ellis,O
in,O
four,O
weeks,O
",",O
Dr.,O
Joseph,O
Overstreet,O
in,O
one,O
to,O
two,O
weeks,O
.,O

Dr.,O
Iola,O
Alexander,O
in,O
2,O
to,O
3,O
weeks,O
.,O

He,O
is,O
on,O
Lopressor,B-TR
100,O
mg,O
twice,O
a,O
day,O
.,O

Metformin,B-TR
500,O
mg,O
twice,O
a,O
day,O
.,O

Lasix,B-TR
20,O
mg,O
twice,O
a,O
day,O
times,O
seven,O
days,O
.,O

Potassium,B-TR
20,O
mEq,O
twice,O
a,O
day,O
times,O
seven,O
days,O
.,O

Potassium,B-TR
chloride,I-TR
20,O
mEq,O
times,O
seven,O
days,O
",",O
Plavix,B-TR
75,O
mg,O
p.o.,O
q,O
day,O
",",O
Isosorbide,B-TR
60,O
mg,O
q,O
day,O
",",O
Percocet,B-TR
p.r.n.,O
",",O
Entericoated,B-TR
aspirin,I-TR
325,O
mg,O
q,O
day,O
.,O

Colace,B-TR
100,O
mg,O
twice,O
a,O
day,O
p.r.n.,O

Lipitor,B-TR
20,O
mg,O
p.o.,O
q,O
day,O
.,O

Folate,B-TR
1,O
mg,O
q,O
day,O
.,O

DR.,O
Edwards,O
",",O
Brittany,O
92-534,O

Dictated,O
By,O
:,O
William,O
H,O
Centeno,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2015-06-15,O
15:23,O

T,O
:,O
2015-06-15,O
16:16,O

JOB,O
#:,O
83178,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Timothy,O
BZ,O
Holmes,O
on,O
:,O
TUE,O
2015-06-16,O
4:15,O
PM,O

(,O
End,O
of,O
Report,O
),O

892163777,O

TGCHO,O

3997057,O

299593,O

8/5/1998,O
12:00:00,O
AM,O

RULE,O
OUT,O
FOR,O
MYOCARDIAL,B-PR
INFARCTION,I-PR

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

DISCHARGE,O
SUMMARY,O
NAME,O
:,O

FYFEREOSKOTE,O
",",O
CILLMA,O
M,O

UNIT,O
NUMBER,O
:,O

333-10-08,O

ADMISSION,O
DATE,O
:,O

08/05/98,O

DISCHARGE,O
DATE,O
:,O

08/07/98,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Rule,O
out,O
for,O
myocardial,B-PR
infarction,I-PR

ASSOCIATED,O
DIAGNOSIS,O
:,O

1,O
),O
aortic,B-PR
insufficiency,I-PR
;,O
2,O
),O
Parkinson,B-PR
's,I-PR
Disease,I-PR
;,O
3,O
),O
a,O
history,O
of,O
colon,B-PR
carcinoma,I-PR
;,O
4,O
),O
congestive,B-PR
heart,I-PR
failure,I-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

An,B-TE
exercise,I-TE
tolerance,I-TE
test,I-TE
with,O
imaging,B-TE
.,O

CHIEF,O
COMPLAINT,O
:,O

Right,B-PR
sided,I-PR
chest,I-PR
pain,I-PR
by,O
several,O
hours,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Miss,O
Siehjesc,O
is,O
an,O
85-year-old,O
woman,O
with,O
a,O
past,O
medical,O
history,O
significant,O
for,O
Parkinson,B-PR
's,I-PR
Disease,I-PR
of,O
ten,O
years,O
duration,O
",",O
supraventricular,B-PR
tachycardia,I-PR
",",O
and,O
a,O
history,O
of,O
colon,B-PR
carcinoma,I-PR
",",O
who,O
was,O
in,O
her,O
usual,O
state,O
of,O
health,O
until,O
11:30,O
on,O
the,O
morning,O
of,O
admission,O
when,O
she,O
felt,O
the,O
acute,O
on,O
set,O
of,O
5,O
out,O
of,O
10,O
right,B-PR
sided,I-PR
chest,I-PR
pain,I-PR
with,O
radiation,B-PR
to,I-PR
her,I-PR
sternum,I-PR
but,O
not,O
to,O
her,O
neck,O
or,O
arms,O
or,O
back,O
.,O

It,O
was,O
not,O
relieved,O
by,O
2,B-TR
sublingual,I-TR
nitroglycerins,I-TR
.,O

She,O
did,O
state,O
that,O
she,O
experienced,O
some,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
(,O
her,O
usual,O
anginal,O
equivalent,O
),O
and,O
believes,O
she,O
did,O
experience,O
some,B-PR
lightheadedness,I-PR
as,O
well,O
",",O
but,O
denies,O
blacking,O
out,O
or,O
falling,O
.,O

While,O
the,B-PR
pain,I-PR
was,O
initially,O
intermittent,O
",",O
it,O
became,O
steady,O
at,O
about,O
1:00,O
p.m.,O
at,O
which,O
time,O
she,O
presented,O
to,O
the,O
Tecal,O
Galecounxopt,O
Community,O
Hospital,O
Emergency,O
Room,O
and,O
following,O
this,O
experience,O
a,O
spontaneous,O
remission,O
of,O
her,B-PR
right,I-PR
sided,I-PR
pain,I-PR
.,O

Since,O
that,O
time,O
she,O
has,O
experience,O
occasional,O
episodes,O
of,O
the,B-PR
same,I-PR
focal,I-PR
chest,I-PR
pain,I-PR
but,O
finds,O
that,O
it,O
spontaneously,O
remits,O
.,O

It,O
is,O
made,O
better,O
by,O
direct,B-TR
pressure,I-TR
to,I-TR
the,I-TR
point,I-TR
and,O
she,O
recalls,O
no,O
factors,O
which,O
worsened,O
it,O
.,O

She,O
is,O
admitted,O
to,O
rule,O
out,O
myocardial,B-PR
infarction,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1,O
),O
Parkinson,B-PR
's,I-PR
Disease,I-PR
;,O

2,O
),O
hypertension,B-PR
;,O

3,O
),O
aorticsclerosis,B-PR
;,O

4,O
),O
history,O
of,O
colon,B-PR
carcinoma,I-PR
;,O

5,O
),O
severe,B-PR
kyphosis,I-PR
.,O

ALLERGIES,O
:,O

Codeine,B-TR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

1,O
),O
Lasix,B-TR
20,O
mg.,O
PO,O
q.d.,O

2,O
),O
Sinemet,B-TR
25/100,O
1,O
t.i.d.,O

3,O
),O
Cogentin,B-TR
0.5,O
mg.,O
1,O
tabs,O
PO,O
q.a.m.,O
and,O
1,O
q.noon,O
as,O
well,O
as,O
1,O
q.h.s.,O

4,O
),O
Eldepryl,B-TR
5,O
mg.,O
PO,O
b.i.d.,O

5,O
),O
Enteric,B-TR
coated,I-TR
aspirin,I-TR
325,O
mg.,O
PO,O
q.d.,O

6,O
),O
Potassium,B-TR
chloride,I-TR
10,O
mEq.,O
PO,O
q.d.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
smoked,O
one,O
pack,O
of,O
cigarettes,O
per,O
day,O
from,O
age,O
16,O
to,O
50,O
.,O

She,O
quit,O
35,O
years,O
ago,O
.,O

She,O
takes,O
one,O
sip,O
of,O
wine,O
on,O
Fridays,O
.,O

She,O
denies,O
any,O
history,O
of,O
elicit,O
drug,O
use,O
.,O

She,O
did,O
not,O
work,O
after,O
the,O
age,O
of,O
approximately,O
65,O
.,O

The,O
patient,O
is,O
now,O
widowed,O
.,O

She,O
lives,O
with,O
her,O
single,O
daughter,O
.,O

She,O
does,O
have,O
one,O
son,O
who,O
died,O
at,O
the,O
age,O
of,O
21,O
years,O
old,O
.,O

FAMILY,O
HISTORY,O
:,O

Is,O
significant,O
for,O
a,O
father,O
who,O
had,O
a,B-PR
stroke,I-PR
and,O
also,O
suffered,O
from,O
hypertension,B-PR
.,O

She,O
denies,O
any,O
family,O
history,O
of,O
diabetes,B-PR
mellitus,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,B-TE
vital,I-TE
signs,I-TE
showed,O
a,B-TE
temperature,I-TE
of,O
96.8,O
",",O
heart,B-TE
rate,I-TE
80,O
",",O
blood,B-TE
pressure,I-TE
180/78,O
",",O
respiratory,B-TE
rate,I-TE
18,O
",",O
and,O
she,O
was,O
satting,B-TE
95,O
percent,O
on,O
two,B-TR
liters,I-TR
nasal,I-TR
cannula,I-TR
.,O

In,O
general,O
the,O
patient,O
was,O
resting,O
comfortably,O
in,O
bed,O
with,O
a,B-PR
visible,I-PR
tremor,I-PR
of,I-PR
her,I-PR
right,I-PR
hand,I-PR
and,I-PR
foot,I-PR
.,O

The,O
head,O
",",O
eyes,O
",",O
ears,O
",",O
nose,O
and,O
throat,O
",",O
normocephalic,O
",",O
atraumatic,B-PR
",",O
pupils,O
equal,O
",",O
round,O
",",O
reactive,O
to,O
light,O
and,O
accommodation,O
",",O
extraocular,O
muscles,O
intact,O
",",O
sclera,B-PR
anicteric,I-PR
.,O

Neck,O
:,O

supple,O
",",O
no,O
bruits,B-PR
",",O
nodes,B-PR
or,O
thyromegaly,B-PR
.,O

Thorax,O
:,O

crackles,B-PR
at,I-PR
both,I-PR
bases,I-PR
",",O
kyphotic,B-PR
",",O
no,O
costovertebral,B-PR
angle,I-PR
tenderness,I-PR
.,O

Cardiovascular,O
exam,O
:,O

regular,O
rate,O
and,O
rhythm,O
with,O
1,B-PR
out,I-PR
of,I-PR
6,I-PR
systolic,I-PR
ejection,I-PR
murmur,I-PR
.,O

Abdomen,O
:,O

soft,O
",",O
well,B-PR
healed,I-PR
scar,I-PR
",",O
positive,O
bowel,O
sounds,O
",",O
no,O
tenderness,B-PR
or,O
organomegaly,B-PR
noted,O
.,O

Extremities,O
:,O

without,O
clubbing,B-PR
",",O
claudication,B-PR
",",O
or,O
edema,B-PR
.,O

Rectal,O
:,O

negative,O
per,O
the,O
emergency,O
room,O
.,O

Neurologically,O
the,O
patient,O
was,O
alert,O
and,O
oriented,O
x3,O
.,O

Tremors,B-PR
of,I-PR
the,I-PR
right,I-PR
hand,I-PR
and,I-PR
foot,I-PR
at,O
rest,O
.,O

Equivocal,B-PR
cogwheeling,I-PR
on,I-PR
the,I-PR
right,I-PR
",",O
normal,O
tone,O
on,O
the,O
left,O
.,O

LABORATORY,O
DATA,O
:,O

The,B-TE
patient,I-TE
's,I-TE
SMA,I-TE
7,I-TE
was,O
notable,O
for,O
a,B-TE
BUN,I-TE
of,O
28,O
",",O
creatinine,B-TE
1.3,O
",",O
and,O
a,B-TE
glucose,I-TE
of,O
102,O
.,O

Extended,O
chemistries,B-TE
were,O
within,O
normal,O
limits,O
with,O
a,B-TE
creatine,I-TE
kinase,I-TE
of,O
122,O
and,O
no,O
measured,B-TE
methylene,I-TE
blue,I-TE
fraction,I-TE
given,O
the,O
low,O
value,O
.,O

The,B-TE
complete,I-TE
blood,I-TE
count,I-TE
was,O
notable,O
for,O
a,B-TE
white,I-TE
count,I-TE
of,O
"5.3,000",O
",",O
hematocrit,B-TE
39,O
1/2,O
and,O
platelet,B-TE
count,I-TE
of,O
"180,000",O
and,O
normal,O
coags,O
were,O
measured,O
.,O

RADIOLOGY,O
:,O

Portable,B-TE
chest,I-TE
x-ray,I-TE
was,O
without,O
evidence,O
of,O
congestive,B-PR
heart,I-PR
failure,I-PR
or,O
pneumonia,B-PR
.,O

HOSPITAL,O
COURSE,O
AND,O
TREATMENT,O
:,O

The,O
patient,O
proceeded,O
to,O
rule,O
out,O
formyocardial,B-PR
infarction,I-PR
by,O
enzymes,B-TE
.,O

Additionally,O
",",O
the,O
patient,O
underwent,O
a,B-TE
exercise,I-TE
stress,I-TE
test,I-TE
on,O
8/6/98,O
with,O
a,B-TE
heart,I-TE
rate,I-TE
proceeding,O
from,O
76,O
to,O
93,O
beats,O
per,O
minute,O
.,O

There,O
were,O
no,O
electrocardiogram,B-PR
changes,I-PR
noted,O
and,O
there,O
were,O
no,O
arrhythmias,B-PR
noted,O
as,O
well,O
.,O

During,O
the,B-TE
test,I-TE
the,O
patient,O
experienced,O
no,O
chest,B-PR
pressure,I-PR
or,O
pain,B-PR
or,O
dyspnea,B-PR
and,O
nuclear,B-TE
medical,I-TE
imaging,I-TE
was,O
without,O
evidence,O
of,O
ischemia,B-PR
.,O

The,O
patient,O
was,O
in,O
this,O
fashion,O
discharged,O
from,O
the,O
service,O
to,O
continue,O
on,O
her,B-TR
current,I-TR
medications,I-TR
and,O
to,O
call,O
in,O
oneweek,O
to,O
follow,O
up,O
with,O
Dr.,O
Sterpbreutzsterp,O
and,O
Cardiology,O
.,O

The,O
patient,O
already,O
had,O
a,O
follow,O
up,O
appointment,O
with,O
Dr.,O
Sterpbreutzsterp,O
in,O
three,O
weeks,O
",",O
and,O
was,O
instructed,O
to,O
keep,O
that,O
appointment,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Good,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

1),O
Lasix,B-TR
20,O
mg.,O
PO,O
q.d.,O

2),O
Sinemet,B-TR
25/100,O
PO,O
t.i.d.,O

3),O
Cogentin,B-TR
0.5,O
mg.,O
2,O
tabs,O
q.a.m.,O
",",O
1,O
q.lunch,O
time,O
",",O
1,O
q.bed,O
time,O
.,O

4),O
Eldepryl,B-TR
5,O
mg.,O
PO,O
q.d.,O

5),O
Enteric,B-TR
coated,I-TR
aspirin,I-TR
325,O
mg.,O
PO,O
q.d.,O

6),O
Potassium,B-TR
chloride,I-TR
10,O
mEq.,O
PO,O
q.d.,O

7),O
Metoprolol,B-TR
25,O
mg.,O
PO,O
b.i.d.,O

DOCTOR,O
',O
S,O
DISCHARGE,O
ORDERS,O
:,O

The,O
patient,O
will,O
follow,O
up,O
with,O
her,O
primary,O
care,O
physician,O
",",O
Dr.,O
Stoa,O
Sterpbreutzsterp,O
as,O
has,O
already,O
been,O
scheduled,O
three,O
weeks,O
after,O
the,O
discharge,O
date,O
.,O

NILA,O
H.,O
LEFT,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

STOA,O
STERPBREUTZSTERP,O
",",O
M.D.,O

TR,O
:,O

fgz,O

DD,O
:,O

10/12/98,O

TD,O
:,O

10/17/98,O
11:52,O

Acc,O
:,O

NILA,O
H,O
LEFT,O
",",O
M.D.,O
STOA,O
STERPBREUTZSTERP,O
",",O
M.D.,O

895872725,O
ELMVH,O

99080881,O

979718,O

5/25/2002,O
12:00:00,O
AM,O

Chest,B-PR
pain,I-PR

DIS,O

Admission,O
Date,O
:,O

05/25/2002,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

05/27/2002,O

******,O
DISCHARGE,O
ORDERS,O
******,O

FYFEWIERST,O
",",O
MIER,O

799-99-77-2,O
X12,O

Room,O
:,O

33C-139,O

Service,O
:,O

CAR,O

DISCHARGE,O
PATIENT,O
ON,O
:,O

05/27/02,O
AT,O
04:00,O
PM,O

CONTINGENT,O
UPON,O

Not,O
Applicable,O

WILL,O
D,O
/,O
C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D,O
/,O
C,O
SUMMARY,O
:,O

YES,O

Attending,O
:,O

SAGELYSS,O
",",O
TYTUMZE,O
VACHOLLE,O
",",O
M.D.,O

DISPOSITION,O
:,O

Home,O

DISCHARGE,O
MEDICATIONS,O
:,O

LOPRESSOR,B-TR
(,I-TR
METOPROLOL,I-TR
TARTRATE,I-TR
),I-TR
12.5,O
MG,O
PO,O
BID,O

Food,O
/,O
Drug,O
Interaction,O
Instruction,O

Take,O
consistently,O
with,O
meals,O
or,O
on,O
empty,O
stomach,O
.,O

ENALAPRIL,B-TR
MALEATE,I-TR
20,O

MG,O
PO,O
BID,O
DIET,O
:,O

House,O
/,O
Low,O
chol,O
/,O
low,O
sat.,O
fat,O

Activity,O
-,O
As,O
tolerated,O

RETURN,O
TO,O
WORK,O
:,O

After,O
Appt,O
with,O
local,O
physician,O

FOLLOW,O
UP,O
APPOINTMENT,O
(,O
S,O
),O
:,O

Dr.,O
Hashimoto,O
",",O
No,O
Known,B-PR
Allergies,I-PR

ADMIT,O
DIAGNOSIS,O
:,O

chest,B-PR
pressure,I-PR
;,O
r,O
/,O
o,O
mi,B-PR

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O

Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O
Chest,B-PR
pain,I-PR

OTHER,O
DIAGNOSIS,O
;,O

Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O

Chest,B-PR
pain,I-PR
;,O
R,O
/,O
o,O

MI,B-PR

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O

Echocardiogram,B-TE
MRA,B-TE
Kidney,I-TE

BRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

51,O
yo,O
F,O
h,O
/,O
o,O
HTN,B-PR
",",O
hyperchol,B-PR
",",O
p,O
/,O
w,O
SS,B-PR
chest,I-PR
pressure,I-PR
x,O
3,O
days,O
.,O

USOH,O
until,O
3,O
day,O
PTa,O
",",O
dev,O
new,B-PR
SS,I-PR
chest,I-PR
pressure,I-PR
sometimes,O
rad,O
to,O
back,O
and,O
L,O
neck,O
/,O
jaw,O
.,O

Not,O
assoc,O
with,O
exertion,O
(,O
pt,O
has,O
active,O
lifestyle,O
),O
.,O

Pressure,B-PR
lasted,O
for,O
hours,O
at,O
a,O
time,O
.,O

Variably,O
assoc,O
with,O
SOB,B-PR
",",O
nausea,B-PR
",",O
palpitations,B-PR
",",O
tremulousness,B-PR
",",O
diaphoresis,B-PR
.,O

Pt,O
has,O
HTN,B-PR
",",O
measured,O
BP,B-TE
home,O
200/100,O
.,O

Reported,O
to,O
a,O
local,O
ED,O
was,O
found,O
to,O
have,O
BP,B-TE
up,O
to,O
200/100,O
.,O

Put,O
on,O
NTG,B-TR
drip,I-TR
without,O
relief,O
.,O

Pain,B-PR
2/10,O
persisted,O
",",O
relieved,O
by,O
MSO4,B-TR
.,O

At,O
ELMVH,O
ED,O
",",O
BP,B-TE
160/87,O
.,O

Now,O
adm,O
for,O
r,O
/,O
o,O
MI,B-PR
",",O
eval,B-TE
of,O
?,O
demand,B-PR
ischemia,I-PR
",",O
plus,O
w,B-TE
/,I-TE
u,I-TE
of,O
HTN,B-PR
urgency,I-PR
(,O
which,O
may,O
be,O
very,O
new,O
in,O
onset,O
),O
.,O

PE,B-TE
T97.5,B-TE
P59,B-TE
BP,B-TE
(,O
l,O
),O
180/86,O
(,O
r,O
),O
186/98,O
RR20,B-TE
98%,O
2L,B-TR
.,O

Exam,B-TE
only,O
notable,O
for,O
II,B-PR
/,I-PR
VI,I-PR
systolic,I-PR
murmur,I-PR
.,O

Labs,B-TE
only,O
notable,O
for,O
CK,B-TE
54,O
(,O
nl,O
),O
",",O
Trop,B-TE
0.03,O
",",O
Hct,B-TE
35.6,O
MCV,B-TE
79,O
.,O

EKG,B-TE
LBBB,B-PR
NSR,O
.,O

CXR,B-TE
negative,O
.,O

Plan,O
ROMI,B-TE
protocol,I-TE
.,O

CP,B-TR
protocol,I-TR
.,O

Captopril,B-TR
and,O
nitropaste,B-TR
to,O
control,O
pressure,B-PR
.,O

MSO4,B-TR
for,O
CP,B-PR
.,O

Echo,B-TE
",",O
MRA,B-TE
(,O
r,O
/,O
o,O
dissection,B-PR
),O
",",O
urine,B-TE
catecholamines,I-TE
and,O
VMA,B-TE
.,O

Guaiac,B-TE
all,I-TE
stools,I-TE
",",O
check,O
iron,B-TE
studies,I-TE
.,O

HOSPITAL,O
COURSE,O

1.,O
Chest,B-PR
Pain,I-PR

-,O
Pt,O
placed,O
on,O
captopril,B-TR
25,O
tid,O
",",O
lopressor,B-TR
12.5,O
BID,O
and,O
NTG,B-TR
paste,I-TR
SS,O
",",O
achieving,O
normal,O
BP,O
w,O
/,O
in,O
5,O
hrs,O
of,O
adm,O
to,O
floor,O
.,O

Her,B-PR
CPress,I-PR
dissappeared,O
over,O
the,O
same,O
timeframe,O
.,O

-,O
pt,O
r&apos;d,O
/,O
o,O
for,O
mi,B-PR
by,O
CPK,B-TE
(,O
54-&gt;,O
38-&gt;,O
33,O
),O
and,O
TPN,B-TE
(,O
0.03,O
),O
",",O
and,O
stable,O
EKG,O
.,O

2.,O
Hypertension,B-PR

-,O
controlled,O
on,O
captopril,B-TR
+,O
lopressor,B-TR
to,O
110-130s,O
;,O
NTG,B-TR
paste,I-TR
causing,O
30,O
pt,O
drop,O
so,O
d,O
/,O
c&apos;d,O
.,O

-,O
MRA,B-TE
kidney,I-TE
:,O

no,O
stenosis,B-PR
;,O
no,O
parenchymal,B-PR
lesions,I-PR

-,O
CXR,B-TE
:,O

no,O
obvious,B-PR
mediastinal,I-PR
widening,I-PR
",",O
but,O
no,O
comp,B-TE
arison,I-TE
film,I-TE
;,O
wnl,O

-,O
echo,B-TE
:,O

prelim,O
:,O

EF,B-TE
55-60,O
",",O
?,O
septal,B-PR
flattening,I-PR
",",O
mild,B-PR
TR,I-PR
and,O
MR,B-PR
",",O
trace,B-PR
effusion,I-PR
-24h,B-TE
urine,I-TE
study,I-TE
:,O

pending,O
.,O

ADDITIONAL,O
COMMENTS,O
:,O

DISCHARGE,O
CONDITION,O
:,O

Satisfactory,O

TO,O
DO,O
/,O
PLAN,O
:,O

No,O
dictated,O
summary,O

ENTERED,O
BY,O
:,O

MEED,O
",",O
CILE,O
PRILARA,O
",",O
M.D.,O
",",O
PH.D.,O
(,O
RG185,O
),O
05/27/02,O
05:35,O
PM,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

901751538,O

CTMC,O

71624078,O

425615,O

2/3/1992,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

02/03/1992,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

02/07/1992,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

STERNAL,B-PR
WOUND,I-PR
INFECTION,I-PR
.,O

SECONDARY,O
DIAGNOSES,O
:,O

STATUS,O
POST,O
ORTHOTOPIC,B-TR
CARDIAC,I-TR
TRANSPLANT,I-TR
.,O

INSULIN,B-PR
DEPENDENT,I-PR
DIABETES,I-PR
MELLITUS,I-PR
.,O

DILATED,B-PR
CARDIOMYOPATHY,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
48-year-old,O
white,O
man,O
who,O
is,O
20,O
days,O
status,O
post,O
orthotopic,B-TR
cardiac,I-TR
transplant,I-TR
who,O
was,O
readmitted,O
for,O
sternal,B-PR
wound,I-PR
infection,I-PR
.,O

He,O
has,O
insulin,B-PR
dependent,I-PR
diabetes,I-PR
mellitus,I-PR
and,O
a,O
history,O
of,O
a,B-PR
dilated,I-PR
cardiomyopathy,I-PR
.,O

He,O
had,O
progressive,O
symptoms,O
of,O
congestive,B-PR
heart,I-PR
failure,I-PR
which,O
led,O
to,O
his,B-TE
evaluation,I-TE
of,O
his,B-TR
cardiac,I-TR
transplant,I-TR
in,O
March,O
of,O
1991,O
.,O

Preoperatively,O
",",O
he,O
had,O
a,B-PR
severely,I-PR
dilated,I-PR
left,I-PR
ventricle,I-PR
with,O
markedly,B-PR
diminished,I-PR
function,I-PR
.,O

His,O
post,O
transplant,O
course,O
was,O
initially,O
complicated,O
by,O
hyperglycemia,B-PR
and,O
seizure,B-PR
on,O
postoperative,O
day,O
number,O
one,O
.,O

He,O
was,O
",",O
however,O
",",O
extubted,O
without,O
difficulty,O
and,O
after,O
that,O
did,O
quite,O
well,O
.,O

He,O
had,O
a,B-TE
predischarge,I-TE
biopsy,I-TE
.,O

He,O
felt,O
well,O
at,O
home,O
without,O
fevers,B-PR
",",O
chills,B-PR
or,O
rigors,B-PR
.,O

There,O
were,O
no,O
rashes,B-PR
.,O

He,O
had,O
no,O
chest,B-PR
pain,I-PR
or,O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

When,O
he,O
was,O
seen,O
on,O
2/3,O
in,O
the,O
Transplant,O
Clinic,O
",",O
his,B-PR
incision,I-PR
was,O
noted,O
to,O
be,O
more,B-PR
erythematous,I-PR
.,O

He,O
was,O
referred,O
to,O
the,O
Surgical,O
Clinic,O
where,O
the,B-PR
wound,I-PR
was,O
opened,O
and,O
the,O
patient,O
was,O
admitted,O
for,O
intravenous,B-TR
antibiotics,I-TR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,O
revealed,O
a,O
middle,O
aged,O
man,O
in,O
no,O
distress,B-PR
.,O

Blood,B-TE
pressure,I-TE
was,O
152/88,O
.,O

Heart,B-TE
rate,I-TE
90,O
.,O

Respiratory,B-TE
rate,I-TE
14,O
.,O

HEENT,B-TE
exam,I-TE
was,O
within,O
normal,O
limits,O
.,O

Neck,O
was,O
without,O
bruits,B-PR
.,O

Lungs,O
were,O
clear,O
bilaterally,O
.,O

Cardiac,B-TE
exam,I-TE
showed,O
a,O
normal,O
PMI,O
",",O
regular,O
rate,O
and,O
rhythm,O
",",O
normal,O
S1,O
",",O
physiologically,B-PR
split,I-PR
S2,I-PR
.,O

There,O
was,O
an,B-PR
S4,I-PR
.,O

There,O
were,O
no,O
murmurs,B-PR
or,O
rubs,B-PR
.,O

Abdomen,O
was,O
benign,O
.,O

Extremities,O
were,O
2+,B-PR
pedal,I-PR
edema,I-PR
to,O
the,O
knees,O
.,O

Examination,B-TE
of,O
the,B-PR
sternal,I-PR
wound,I-PR
showed,O
an,O
opened,O
area,O
in,O
the,O
mid,O
region,O
of,O
the,B-PR
wound,I-PR
with,O
serosanguineous,B-PR
drainage,I-PR
and,O
a,B-PR
scant,I-PR
amount,I-PR
of,I-PR
thick,I-PR
",",I-PR
yellow,I-PR
pus,I-PR
.,O

There,O
was,O
no,O
induration,B-PR
.,O

LABORATORY,O
DATA,O
:,O

On,O
admission,O
revealed,O
a,B-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
of,O
9.46,O
with,O
89%,O
polys,B-TE
",",O
2%,O
bands,B-TE
",",O
7%,O
lymphocytes,B-TE
",",O
2%,O
monocytes,B-TE
.,O

Cyclosporin,B-TE
A,I-TE
level,I-TE
on,O
admission,O
was,O
179,O
.,O

Microscopic,B-TE
exam,I-TE
showed,O
4+,B-PR
Staph,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
and,O
pancultured,O
.,O

He,O
was,O
treated,O
with,O
vancomycin,B-TR
and,O
ceftazidime,B-TR
while,O
awaiting,O
wound,B-TE
cultures,I-TE
.,O

He,O
had,O
dressing,B-TR
changes,I-TR
twice,O
a,O
day,O
.,O

Surgery,O
was,O
consulted,O
and,O
followed,O
him,O
while,O
he,O
was,O
in,O
house,O
.,O

Cyclosporin,B-TE
levels,I-TE
were,O
followed,O
and,O
his,B-TE
sugars,I-TE
were,O
followed,O
with,O
a,B-TR
sliding,I-TR
scale,I-TR
.,O

During,O
the,O
first,O
two,O
days,O
",",O
he,O
required,O
14,B-TR
and,I-TR
22,I-TR
units,I-TR
of,I-TR
additional,I-TR
coverage,I-TR
.,O

However,O
",",O
by,O
day,O
three,O
he,O
required,O
no,O
additional,B-TR
insulin,I-TR
coverage,I-TR
.,O

On,O
the,O
day,O
prior,O
to,O
discharge,O
",",O
his,B-TR
intravenous,I-TR
antibiotics,I-TR
were,O
discontinued,O
and,O
he,O
was,O
begun,O
on,O
tetracycline,B-TR
.,O

DISPOSITION,O
:,O

The,O
patient,O
was,O
discharged,O
home,O
in,O
stable,O
condition,O
.,O

MEDICATIONS,O
:,O

On,O
discharge,O
included,O
tetracycline,B-TR
",",O
250,O
mg,O
po,O
q.i.d.,O
;,O
cyclosporin,B-TR
",",O
325,O
mg,O
po,O
b.i.d.,O
;,O
prednisone,B-TR
",",O
30,O
mg,O
po,O
q,O
day,O
;,O
Bactrim,B-TR
DS,I-TR
",",O
one,O
po,O
q.o.d.,O
;,O
diltiazem,B-TR
",",O
30,O
mg,O
po,O
q.i.d.,O
;,O
Mycostatin,B-TR
",",O
15,O
cc,O
swish,O
and,O
swallow,O
q.i.d.,O
;,O
Lasix,B-TR
",",O
40,O
mg,O
po,O
q,O
day,O
;,O
Colace,B-TR
",",O
100,O
mg,O
po,O
q.i.d.,O
;,O
Carafate,B-TR
",",O
1,O
gram,O
po,O
q.i.d.,O
;,O
Imuran,B-TR
",",O
50,O
mg,O
po,O
t.i.d.,O
;,O
NPH,B-TR
insulin,I-TR
",",O
44,O
units,O
and,O
10,O
units,O
of,O
regular,O
q,O
a.m.,O
;,O
NPH,B-TR
",",O
22,O
units,O
and,O
8,O
units,O
of,O
regular,O
q,O

PM296/2413,O
RI,O
SEEN,O
",",O
M.D.,O
MC0,O

D,O
:,O

02/26/92,O

Batch,O
:,O

4373,O

Report,O
:,O

O8919E48,O

T,O
:,O

02/27/92,O

Dicatated,O
By,O
:,O

SUSHA,O
I.,O
RHIM,O
",",O
M.D.,O

917563546,O
ELMVH,O

73397283,O

7646550,O

1/23/2003,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

01/23/2003,O

Date,O
of,O
Discharge,O
:,O

01/23/2003,O

ATTENDING,O
:,O

DOTA,O
SPACE,O
M.D.,O

ADMITTING,O
DIAGNOSIS,O
:,O

Lumbar,B-PR
spinal,I-PR
stenosis,I-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

L2,B-TR
to,I-TR
L5,I-TR
laminectomy,I-TR
",",O
L2,B-TR
through,I-TR
L5,I-TR
posterior,I-TR
fusion,I-TR
with,O
segmental,B-TR
instrumentation,I-TR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
50-year-old,O
female,O
with,O
history,O
of,O
low,B-PR
back,I-PR
pain,I-PR
radiating,B-PR
to,I-PR
both,I-PR
legs,I-PR
.,O

She,O
had,O
increasing,B-PR
symptoms,I-PR
overtime,O
",",O
not,O
controlled,O
by,O
conservative,B-TR
management,I-TR
.,O

She,O
therefore,O
elected,O
to,O
undergo,O
surgical,B-TR
treatment,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Her,O
past,O
medical,O
history,O
is,O
notable,O
for,O
bilateral,B-PR
lower,I-PR
extremity,I-PR
venous,I-PR
insufficiency,I-PR
with,O
edema,B-PR
",",O
hypertension,B-PR
.,O

She,O
takes,O
lisinopril,B-TR
/,O
hydrochlorothiazide,B-TR
20/25,O
mg,O
p.o.,O
q.d.,O
",",O
Vioxx,B-TR
50,O
mg,O
p.o.,O
q.d.,O
",",O
Lipitor,B-TR
10,O
mg,O
p.o.,O
q.d.,O
",",O
Nortriptyline,B-TR
25,O
mg,O
p.o.,O
q.h.s.,O
",",O
Neurontin,B-TR
300,O
mg,O
p.o.,O
t.i.d.,O

ALLERGIES,O
:,O

She,O
has,O
nausea,B-PR
with,O
Codeine,B-TR
otherwise,O
no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

Past,O
surgical,O
history,O
is,O
notable,O
of,O
D,B-TE
and,O
C,B-TE
in,O
1980,O
and,O
cyst,B-TR
excision,I-TR
.,O

HABITS,O
:,O

She,O
denies,O
smoking,O
or,O
alcohol,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
examination,B-TE
",",O
her,O
lungs,O
were,O
clear,O
.,O

She,O
had,O
a,O
regular,O
heart,O
rate,O
and,O
rhythm,O
.,O

She,O
had,O
2+,B-TE
bilateral,I-TE
DP,I-TE
and,O
radial,B-TE
pulses,I-TE
.,O

She,O
has,O
mild,B-PR
swelling,I-PR
in,I-PR
both,I-PR
lower,I-PR
extremities,I-PR
.,O

She,O
has,O
pain,B-PR
with,O
straight,O
leg,O
raise,O
",",O
left,O
greater,O
than,O
right,O
and,O
5/5,O
strength,O
in,O
right,O
quads,O
compared,O
to,O
4/5,O
on,O
the,O
left,O
.,O

Please,O
see,O
Dr.,O
Uph,O
&apos;s,O
office,O
note,O
for,O
further,O
details,O
.,O

HOSPITAL,O
COURSE,O
:,O

She,O
was,O
taken,O
to,O
the,O
operating,O
room,O
on,O
01/16/2003,O
for,O
decompression,B-TR
at,I-TR
L2,I-TR
",",I-TR
L5,I-TR
and,O
laminectomy,B-TR
with,O
posterior,B-TR
instrumented,I-TR
fusion,I-TR
at,I-TR
L3,I-TR
to,I-TR
L5,I-TR
.,O

She,O
tolerated,O
the,B-TR
surgery,I-TR
well,O
.,O

She,O
was,O
transferred,O
to,O
recovery,O
room,O
in,O
stable,O
condition,O
.,O

She,O
received,O
blood,B-TR
transfusions,I-TR
intraoperatively,O
and,O
postoperatively,O
in,O
addition,O
to,O
autologous,B-TR
blood,I-TR
.,O

Her,B-TE
hematocrit,I-TE
was,O
stable,O
postoperatively,O
.,O

Her,B-TE
neurologic,I-TE
exam,I-TE
was,O
stable,O
postoperatively,O
with,O
5/5,O
bilaterally,O
",",O
tibial,O
",",O
EHL,O
",",O
FHL,O
",",O
gastroc,O
soleus,O
",",O
and,O
intact,O
quadriceps,O
.,O

She,O
has,O
intact,O
sensation,O
L3,O
to,O
S1,O
and,O
bilateral,O
lower,O
extremities,O
.,O

She,O
was,O
fitted,O
for,O
Verholl,B-TR
Aet,I-TR
over,I-TR
leg,I-TR
brace,I-TR
and,O
mobilized,O
out,O
of,O
the,O
bed,O
in,O
the,B-TR
brace,I-TR
with,O
physical,B-TR
therapy,I-TR
.,O

Her,B-PR
wounds,I-PR
were,O
stable,O
without,O
any,B-PR
erythema,I-PR
or,O
drainage,B-PR
.,O

She,O
reported,O
nausea,B-PR
on,O
pain,B-TR
medications,I-TR
.,O

Her,B-TR
pain,I-TR
medications,I-TR
were,O
changed,O
around,O
until,O
an,O
acceptable,O
regime,O
was,O
accomplished,O
.,O

She,O
is,O
stable,O
for,O
discharge,O
to,O
rehab,O
.,O

DISCHARGE,O
ACTIVITY,O
:,O

She,O
should,O
continue,O
to,O
wear,O
the,B-TR
brace,I-TR
when,O
out,O
of,O
bed,O
and,O
there,O
should,O
be,O
no,O
heavy,O
lifting,O
",",O
twisting,O
or,O
bending,O
activities,O
.,O

She,O
will,O
need,O
to,O
follow,O
up,O
with,O
Dr.,O
Uph,O
on,O
02/21/03,O
at,O
9:30,O
a.m.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Tylenol,B-TR
650,O
mg,O
p.o.,O
q.4h.,O
p.r.n.,O
",",O
Benadryl,B-TR
25,O
mg,O
p.o.,O
q.h.s.,O
p.r.n.,O
",",O
Colace,B-TR
100,O
mg,O
p.o.,O
q.i.d.,O
",",O
Nortriptyline,B-TR
25,O
mg,O
p.o.,O
q.h.s.,O
",",O
Simvastatin,B-TR
10,O
mg,O
p.o.,O
q.h.s.,O
",",O
Metamucil,B-TR
one,O
packet,O
p.o.,O
b.i.d.,O
p.r.n.,O
",",O
Neurontin,B-TR
300,O
mg,O
p.o.,O
t.i.d.,O
",",O
Levsinex,B-TR
0.375,O
mg,O
p.o.,O
q.12h.,O
",",O
Lisinopril,B-TR
/,O
hydrochlorothiazide,B-TR
20/25,O
mg,O
p.o.,O
q.d.,O
",",O
hydrocortisone,B-TR
topical,I-TR
ointment,I-TR
to,O
affected,B-PR
areas,I-PR
",",O
MS,B-TR
Contin,I-TR
30,O
mg,O
p.o.,O
b.i.d.,O
",",O
MSIR,B-TR
15,O
to,O
30,O
mg,O
p.o.,O
q.4h.,O
p.r.n.,O
pain,B-PR
.,O

The,O
patient,O
should,O
continue,O
to,O
have,O
dry,B-TR
sterile,I-TR
dressings,I-TR
to,O
her,B-PR
back,I-PR
and,I-PR
iliac,I-PR
crest,I-PR
wounds,I-PR
until,O
follow,O
up,O
with,O
Dr.,O
Uph,O
.,O

Should,O
there,O
be,O
any,B-PR
wound,I-PR
erythema,I-PR
or,O
drainage,B-PR
",",O
please,O
contact,O
Dr.,O
Uph,O
&apos;s,O
office,O
immediately,O
.,O

eScription,O
document,O
:,O

2-7712488,O
ZNHKjeu,O
Tel,O

Dictated,O
By,O
:,O

MAULPLACKAGNELEEB,O
",",O
INACHELLE,O

Attending,O
:,O

SPACE,O
",",O
DOTA,O
Dictation,O
ID,O
3624752,O

D,O
:,O

01/23/03,O

T,O
:,O

01/23/03,O

948986258,O
YC,O

28079279,O

1027681,O

04/06/2005,O
12:00:00,O
AM,O

abdominal,B-PR
fluid,I-PR
collection,I-PR

DIS,O

Admission,O
Date,O
:,O

04/06/2005,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

04/12/2005,O

******,O
FINAL,O
DISCHARGE,O
ORDERS,O
******,O

LILEY,O
",",O
PEANTSALL,O
885-17-29-8,O
M12,O

Room,O
:,O

5Y-704,O

Service,O
:,O

GGI,O

DISCHARGE,O
PATIENT,O
ON,O
:,O

04/12/05,O
AT,O
01:00,O
PM,O

CONTINGENT,O
UPON,O

HO,B-TE
evaluation,I-TE

WILL,O
D,O
/,O
C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D,O
/,O
C,O
SUMMARY,O
:,O

YES,O

Attending,O
:,O

LILEY,O
",",O
BER,O
",",O
M.D.,O

DISPOSITION,O
:,O

Home,O
w/,O
services,O

DISCHARGE,O
MEDICATIONS,O
:,O

MOTRIN,B-TR
(,I-TR
IBUPROFEN,I-TR
),I-TR
600,O
MG,O
PO,O
Q6H,O
PRN,O
Pain,B-PR
",",O
Headache,B-PR
",",O
Temperature,B-TE
greater,O
than,O
:,O

100,O

Food,O
/,O
Drug,O
Interaction,O
Instruction,O

Take,O
with,O
food,O
FLAGYL,B-TR
(,I-TR
METRONIDAZOLE,I-TR
),I-TR
500,O
MG,O
PO,O
Q8H,O
X,O
10,O
Days,O
Starting,O
Today,O
(,O
04/12,O
),O

Instructions,O
:,O

Take,O
for,O
10,O
days,O
or,O
until,O
drains,B-TR
come,O
out,O
;,O
whichever,O
is,O
of,O
longer,O
duration,O
.,O

Food,O
/,O
Drug,O
Interaction,O
Instruction,O

Take,O
with,O
food,O
OXYCODONE,B-TR
10,O
MG,O
PO,O
Q4H,O
PRN,O
Pain,B-PR
LEVOFLOXACIN,B-TR
500,O
MG,O
PO,O
QD,O
X,O
10,O
Days,O
Starting,O
Today,O
(,O
04/12,O
),O

Instructions,O
:,O

Take,O
for,O
10,O
days,O
or,O
until,O
drains,B-TR
come,O
out,O
;,O
whichever,O
is,O
of,O
longer,O
duration,O
.,O

Food,O
/,O
Drug,O
Interaction,O
Instruction,O

Administer,O
iron,B-TR
products,I-TR
a,O
minimum,O
of,O
2,O
hours,O
before,O
or,O
after,O
a,B-TR
levofloxacin,I-TR
or,O
ciprofloxacin,B-TR
dose,I-TR
dose,O
If,O
on,O
tube,B-TR
feeds,I-TR
",",O
please,O
cycle,O
(,O
hold,O
1,O
hr,O
before,O
to,O
2,O
hr,O
after,O
),O

Take,O
2,O
hours,O
before,O
or,O
2,O
hours,O
after,O
dairy,O
products,O
.,O

MAALOX-TABLETS,B-TR
QUICK,I-TR
DISSOLVE,I-TR
/,I-TR
CHEWABLE,I-TR
2,O
TAB,O
PO,O
Q6H,O
PROTONIX,B-TR
(,I-TR
PANTOPRAZOLE,I-TR
),I-TR
40,O
MG,O
PO,O
QD,O

DIET,O
:,O

House,B-TR
/,I-TR
Low,I-TR
Residue,I-TR
&lt;,O
FDI,O
&gt;,O

ACTIVITY,O
:,O

Walking,O
as,O
tolerated,O

FOLLOW,O
UP,O
APPOINTMENT,O
(,O
S,O
),O
:,O

Dr.,O
Liley,O
",",O
call,O
ASAP,O
to,O
schedule,O
1-2,O
weeks,O
",",O
Your,O
primary,O
care,O
physician,O
1-2,O
weeks,O
",",O
Interventional,O
Radiology,O
",",O
call,O
329-125-0028,O
to,O
schedule,O
an,O
appointment,O
when,O
drain,B-TE
outputs,I-TE
are,O
less,O
than,O
10cc,O
/,O
day,O
.,O
",",O

ALLERGY,O
:,O

NKA,B-PR

ADMIT,O
DIAGNOSIS,O
:,O

abdominal,B-PR
fluid,I-PR
collection,I-PR

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O

Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O
abdominal,B-PR
fluid,I-PR
collection,I-PR

OTHER,O
DIAGNOSIS,O
;,O

Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O
liver,B-PR
hemangioma,I-PR
",",O
bph,B-PR
",",O
gout,B-PR
",",O
meningioma,B-PR
",",O
gerd,B-PR
",",O
episodic,B-PR
vertigo,I-PR
",",O
s,O
/,O
p,O
r,B-TR
colectomy,I-TR
",",O
subtotal,B-TR
colectomy,I-TR

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

NONE,O

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O

IR,B-TR
drainage,I-TR
X2,O

BRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

HPI,O
This,O
is,O
a,O
60,O
yo,O
gentleman,O
who,O
previously,O
had,O
an,B-TR
ileocolic,I-TR
resection,I-TR
for,O
a,B-PR
right,I-PR
colon,I-PR
cancer,I-PR
",",O
and,O
was,O
found,O
to,O
have,O
recurrent,B-PR
disease,I-PR
on,O
colonoscopy,B-TE
.,O

He,O
was,O
also,O
found,O
to,O
have,O
a,B-PR
malignant,I-PR
lesion,I-PR
in,I-PR
his,I-PR
descending,I-PR
colon,I-PR
.,O

He,O
had,O
a,B-TR
subtotal,I-TR
colectomy,I-TR
on,O
03/22/05,O
which,O
was,O
uncomplicated,O
.,O

Postop,O
he,O
has,O
had,O
numerous,O
visits,O
to,O
the,O
ED,O
for,O
co,O
fevers,B-PR
",",O
sweats,B-PR
",",O
and,O
SOB,B-PR
.,O

CTS,B-TE
chest,I-TE
was,O
negative,O
for,O
PE,B-PR
",",O
however,O
it,O
did,O
reveal,O
pulmonary,B-PR
nodules,I-PR
in,I-PR
his,I-PR
RML,I-PR
which,O
need,O
fu,B-TE
imaging,I-TE
in,O
3,O
months,O
.,O

He,O
also,O
had,O
bl,B-PR
atelectasis,I-PR
on,O
cxr,B-TE
.,O

CT,B-TE
of,I-TE
the,I-TE
abdomen,I-TE
showed,O
a,B-PR
collection,I-PR
in,I-PR
the,I-PR
RLQ,I-PR
which,O
appears,O
to,O
be,O
amenable,O
to,O
IR,B-TR
drainage,I-TR
.,O

He,O
also,O
has,O
had,O
urine,B-TE
and,I-TE
blood,I-TE
cultures,I-TE
sent,O
from,O
the,O
ED,O
on,O
04/05,O
and,O
was,O
empirically,O
started,O
on,O
avalox,B-TR
last,O
pm,O
.,O

PMH,O
GERD,B-PR
",",O
HTN,B-PR
",",O
Gout,B-PR
",",O
Meningioma,B-PR
",",O
liver,B-PR
hemangioma,I-PR
",",O
episodic,B-PR
vertigo,I-PR
",",O
colon,B-PR
cancer,I-PR
.,O

MEDS,B-TR

Protonix,B-TR
40,O
qd,O
",",O
Colchicine,B-TR
6,O
mg,O
bid,O
",",O
Meclizine,B-TR
25,O
mg,O
qid,O
prn,O
",",O
glucosamine,B-TR
and,O
oxycodone,B-TR
prn,O
",",O
tessalon,B-TR
prn,O
.,O

ALL,O
NKDA,B-PR
SH,O
No,O
smoking,O
PE,O

GEN,O
-,O
NAD,B-PR

HEENT,O
--,O
perrla,O
",",O
eomi,O
",",O
mmm,O
",",O
tongue,O
midline,O
",",O
op,O
clear,O
",",O
no,O
masses,B-PR

NECK,O
--,O
no,O
jvd,B-PR
/,O
lad/,B-PR
;,O
trachea,O
midline,O
CARD,O
-,O
RRR,O
",",O
S1/S2,O
",",O
no,O
m,B-PR
/,O
r/g,B-PR

PULM,O
-,O
CTAB,O
no,O
w,B-PR
/,I-PR
r,I-PR
/,I-PR
r,I-PR
ABD,O
-nt,B-PR
/,O
nd,B-PR
;,O
incision,B-PR
c,O
/,O
d,O
/,O
I,O
;,O
discrete,B-PR
3x3,I-PR
cm,I-PR
slightly,I-PR
firm,I-PR
protuberant,I-PR
mass,I-PR
to,I-PR
the,I-PR
R,I-PR
of,I-PR
umbilicus,I-PR
;,O
no,O
rebound,B-PR
",",O
no,O
guarding,B-PR
.,O

BACK,O
-,O
no,O
flank,B-PR
tenderness,I-PR

RECTAL,O
--,O
deferred,O

EXT,O
-,O
WWP,O
;,O
no,O
edema,B-PR

On,O
04/06/05,O
Mr.,O
Liley,O
was,O
admitted,O
to,O
Dr.,O
Liley,O
&apos;s,O
service,O
.,O

At,O
that,O
time,O
he,O
was,O
made,O
NPO,B-TR
with,O
IVF,B-TR
",",O
placed,O
on,O
Ampicillin,B-TR
/,O
Levofloxacin,B-TR
/,O
Flagyl,B-TR
and,O
underwent,O
IR,B-TR
placement,I-TR
of,I-TR
a,I-TR
drainage,I-TR
catheter,I-TR
for,O
his,B-PR
abdominopelvic,I-PR
fluid,I-PR
collection,I-PR
.,O

Overnight,O
he,O
spiked,O
a,B-PR
fever,I-PR
to,O
103,O
and,O
his,B-TE
WBC,I-TE
climbed,O
from,O
11,O
to,O
13,O
.,O

As,O
a,O
result,O
",",O
IR,O
reviewed,O
the,B-TE
patient,I-TE
&apos;s,I-TE
post-procedure,I-TE
imaging,I-TE
and,O
felt,O
that,O
the,B-TR
catheter,I-TR
was,O
not,O
adequately,O
draining,O
the,B-PR
patient,I-PR
&apos;s,I-PR
fluid,I-PR
collection,I-PR
.,O

On,O
04/07,O
they,O
took,O
the,O
patient,O
back,O
to,O
the,O
IR,O
suite,O
and,O
placed,O
a,B-TR
second,I-TR
catheter,I-TR
.,O

The,O
location,O
of,O
the,B-TR
second,I-TR
catheter,I-TR
was,O
confirmed,O
that,O
evening,O
by,O
a,B-TE
follow-up,I-TE
scan,I-TE
which,O
revealed,O
good,O
placement,O
.,O

The,O
following,O
day,O
the,O
patient,O
defervesced,O
.,O

Neurologic,O
:,O

The,B-PR
patient,I-PR
&apos;s,I-PR
pain,I-PR
from,O
his,B-TR
catheters,I-TR
was,O
controlled,O
with,O
Oxycodone,B-TR
and,O
Motrin,B-TR
.,O

CV,O
:,O

No,O
active,O
issues,O
.,O

R,O
:,O

The,O
patient,O
received,O
chest,B-TR
PT,I-TR
and,O
was,O
encouraged,O
to,O
ambulate,O
frequently,O
.,O

GI,O
:,O

After,O
catheter,B-TR
placement,I-TR
",",O
the,O
patient,O
was,O
started,O
on,O
sips,B-TR
.,O

He,O
tolerated,O
this,O
well,O
.,O

He,O
was,O
advanced,O
to,O
clears,B-TR
which,O
he,O
tolerated,O
and,O
was,O
restarted,O
on,O
a,B-TR
low,I-TR
residue,I-TR
diet,I-TR
.,O

His,O
bowel,O
function,O
resumed,O
and,O
in,O
fact,O
he,O
had,O
loose,O
stool,O
.,O

He,O
had,O
3,B-TE
specimens,I-TE
sent,O
for,O
C.,B-PR
difficile,I-PR
which,O
were,O
negative,O
.,O

GU,O
:,O

The,O
patient,O
&apos;s,O
electrolytes,O
and,O
fluids,O
were,O
monitored,O
closely,O
during,O
his,O
admission,O
.,O

Heme,O
:,O

The,B-TE
patient,I-TE
&apos;s,I-TE
WBC,I-TE
trended,O
down,O
to,O
10.7,O
at,O
discharge,O
from,O
a,O
peak,O
of,O
13,O
on,O
04/07,O
.,O

His,B-TE
hematocrit,I-TE
remained,O
stable,O
.,O

He,O
received,O
DVT,B-TR
prophylaxis,I-TR
with,O
SC,B-TR
Heparin,I-TR
.,O

ID,O
:,O

Blood,B-TE
cultures,I-TE
04/05,O
revealed,O
Bacteroides,B-PR
fragilis,I-PR
;,O
04/06,O
Fluid,B-TE
collection,I-TE
drainage,I-TE
from,I-TE
IR,I-TE
revealed,O

1),O
4+,B-PR
alpha,I-PR
hemolytic,I-PR
Strep,I-PR
",",O

2),O
2+,B-PR
E.,I-PR
coli,I-PR
sensitive,O
to,O
Ampicillin,B-TR
and,O
Levofloxacin,B-TR
",",O

3),O
3+,B-PR
Enterococci,I-PR
sensitive,O
to,O
Ampicillin,B-TR
and,O
Levofloxacin,B-TR
",",O

4),O
Bacteroides,B-PR
fragilis,I-PR
and,O
Clostridium,B-PR
perfringens,I-PR
.,O

Blood,B-TE
cultures,I-TE
from,O
04/07,O
showed,O
NGTD,B-PR
.,O

Cdiff,B-TE
from,O
04/08,O
",",O
04/09,O
",",O
04/10,O
were,O
negative,O
.,O

Mr.,O
Liley,O
was,O
discharged,O
in,O
stable,O
condition,O
",",O
ambulating,O
and,O
voiding,O
independently,O
",",O
and,O
with,O
adequate,B-TR
pain,I-TR
control,I-TR
.,O

LDAMC,O
services,O
were,O
set-up,O
for,O
care,B-TR
of,O
his,B-TR
IR,I-TR
drains,I-TR
.,O

He,O
was,O
given,O
explicit,O
instructions,O
to,O
follow-up,O
in,O
clinic,O
with,O
Dr.,O
Liley,O
in,O
1-2,O
weeks,O
.,O

ADDENDUM,O
:,O

An,B-TE
abscessogram,I-TE
was,O
performed,O
on,O
04/12/05,O
and,O
revealed,O
no,O
fistula,B-PR
.,O

ADDITIONAL,O
COMMENTS,O
:,O

-,O
Seek,O
medical,O
attention,O
for,O
fevers,B-PR
(,O
temp,B-TE
&gt;,O
101.5,O
),O
",",O
worsening,B-PR
pain,I-PR
",",O
drainage,B-PR
or,O
excessive,B-PR
bleeding,I-PR
from,O
incision,B-PR
",",O
chest,B-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
or,O
any,B-PR
other,I-PR
symptoms,I-PR
of,O
concern,O
.,O

-,O
Follow,O
up,O
with,O
your,O
surgeon,O
in,O
1-2,O
weeks,O
for,O
wound,B-TE
check,I-TE
.,O

-,O
Please,O
do,O
not,O
drive,O
or,O
consume,O
alcohol,O
while,O
taking,O
pain,B-TR
medications,I-TR
.,O

-,O
Resume,O
home,B-TR
medications,I-TR
.,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O

TO,O
DO,O
/,O
PLAN,O
:,O

No,O
dictated,O
summary,O

ENTERED,O
BY,O
:,O

ALIKES,O
",",O
NATO,O
T.,O
",",O
M.D.,O
(,O
FG980,O
),O

2004-12-05,O
11:30,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

957770228,O

FIH,O

408267,O

46769/5v7d,O

237890,O

2/5/1994,O
12:00:00,O
AM,O

TRACHEOESOPHAGEAL,B-PR
FISTULA,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

2-5-94,O

DISCHARGE,O
DATE,O
:,O

4-2-94,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Tracheoesophageal,B-PR
fistula,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

Diabetes,B-PR
mellitus,I-PR
",",O
pneumonia,B-PR
",",O
sepsis,B-PR
",",O
respiratory,B-PR
failure,I-PR
",",O
pleural,B-PR
effusion,I-PR
",",O
postoperative,B-PR
encephalopathy,I-PR
",",O
postoperative,B-PR
myocardial,I-PR
infarction,I-PR
",",O
and,O
thrombocytopenia,B-PR
.,O

SPECIAL,O
PROCEDURES,O
AND,O
OPERATIONS,O
:,O

February,O
6,O
",",O
1994,O
",",O
rigid,B-TE
bronchoscopy,I-TE
with,O
biopsy,B-TE
and,O
upper,B-TE
gastrointestinal,I-TE
endoscopy,I-TE
.,O

ASSOCIATED,O
PROCEDURES,O
:,O

On,O
February,O
10,O
",",O
1994,O
",",O
flexible,B-TE
bronchoscopy,I-TE
",",O
flexible,B-TE
esophagoscopy,I-TE
",",O
rigid,B-TE
bronchoscopy,I-TE
",",O
transhiatal,B-TR
esophagectomy,I-TR
(,I-TR
partial,I-TR
),I-TR
",",O
substernal,B-TR
gastric,I-TR
interposition,I-TR
and,O
jejunostomy,B-TR
.,O

Multiple,B-TE
bronchoscopies,I-TE
",",O
chest,B-TR
tube,I-TR
insertion,I-TR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
was,O
a,O
71,O
year,O
old,O
white,O
female,O
with,O
a,O
history,O
of,O
carcinoid,B-PR
lung,I-PR
cancer,I-PR
who,O
presented,O
for,O
evaluation,B-TE
of,O
a,B-PR
tracheoesophageal,I-PR
fistula,I-PR
.,O

The,O
patient,O
was,O
initially,O
diagnosed,O
in,O
1978,O
with,O
atypical,B-PR
small,I-PR
cell,I-PR
carcinoma,I-PR
of,I-PR
the,I-PR
lung,I-PR
and,O
treated,O
with,O
chemotherapy,B-TR
and,O
radiation,B-TR
therapy,I-TR
until,O
1980,O
.,O

She,O
did,O
well,O
for,O
approximately,O
twelve,O
years,O
until,O
she,O
was,O
diagnosed,O
with,O
carcinoid,B-PR
cancer,I-PR
of,I-PR
the,I-PR
same,I-PR
right,I-PR
upper,I-PR
lobe,I-PR
.,O

This,O
may,O
have,O
been,O
the,B-PR
initial,I-PR
primary,I-PR
cancer,I-PR
although,O
it,O
is,O
unclear,O
at,O
present,O
.,O

Bronchoscopy,B-TE
at,O
that,O
time,O
showed,O
an,B-PR
endobronchial,I-PR
tumor,I-PR
of,I-PR
the,I-PR
right,I-PR
upper,I-PR
lobe,I-PR
bronchus,I-PR
and,O
it,O
was,O
felt,O
to,O
be,O
unresectable,O
.,O

She,O
underwent,O
four,B-TR
treatments,I-TR
of,O
brachytherapy,B-TR
in,O
March,O
through,O
May,O
of,O
1993,O
.,O

She,O
had,O
been,O
doing,O
reasonably,O
well,O
until,O
December,O
of,O
1993,O
when,O
she,O
presented,O
with,O
persistent,B-PR
and,I-PR
worsening,I-PR
cough,I-PR
and,O
near,B-PR
strangulation,I-PR
on,O
attempts,O
at,O
eating,O
solids,O
or,O
drinking,O
liquids,O
.,O

A,B-TE
bronchoscopy,I-TE
showed,O
a,B-PR
tracheoesophageal,I-PR
fistula,I-PR
with,O
an,O
opening,O
into,O
the,O
trachea,O
above,O
the,O
carina,O
and,O
no,O
tumor,B-PR
in,I-PR
the,I-PR
right,I-PR
upper,I-PR
lobe,I-PR
.,O

She,O
has,O
been,O
on,O
total,B-TR
parenteral,I-TR
nutrition,I-TR
and,O
has,O
been,O
nothing,B-TR
by,I-TR
mouth,I-TR
since,O
then,O
.,O

A,B-TE
barium,I-TE
swallow,I-TE
prior,O
to,O
admission,O
showed,O
the,O
presence,O
of,O
a,B-PR
tracheoesophageal,I-PR
fistula,I-PR
with,O
entrance,O
into,O
the,O
right,O
mainstem,O
bronchus,O
below,O
the,O
carina,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Bronchitis,B-PR
",",O
asthma,B-PR
",",O
carcinoid,B-PR
cancer,I-PR
",",O
no,O
history,O
of,O
coronary,B-PR
artery,I-PR
disease,I-PR
or,O
cerebrovascular,B-PR
accident,I-PR
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

The,O
patient,O
is,O
status,O
post,O
appendectomy,B-TR
",",O
hysterectomy,B-TR
and,O
right,B-TR
salpingo-oophorectomy,I-TR
",",O
bladder,B-TR
suspension,I-TR
and,O
a,B-TR
tumor,I-TR
removal,I-TR
from,I-TR
the,I-TR
right,I-TR
neck,I-TR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Cefuroxime,B-TR
1.5,O
grams,O
intravenously,O
q8h,O
",",O
Solu-Medrol,B-TR
62.5,O
mg,O
intravenously,O
q8h,O
",",O
Ventolin,B-TR
metered,I-TR
dose,I-TR
inhaler,I-TR
",",O
2,O
puffs,O
PO,O
q.i.d.,O
",",O
Pepcid,B-TR
20,O
mg,O
intravenously,O
b.i.d.,O

ALLERGIES,O
:,O

The,O
patient,O
is,O
allergic,B-PR
to,O
penicillin,B-TR
",",O
morphine,B-TR
",",O
codeine,B-TR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,O
patient,O
is,O
a,O
pleasant,O
white,O
female,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

She,O
is,O
afebrile,B-PR
with,O
stable,O
vital,O
signs,O
.,O

The,B-TE
head,I-TE
",",I-TE
eyes,I-TE
",",I-TE
ears,I-TE
",",I-TE
nose,I-TE
",",I-TE
throat,I-TE
examination,I-TE
was,O
unremarkable,O
.,O

Neck,O
shows,O
a,B-PR
well,I-PR
healed,I-PR
low,I-PR
collar,I-PR
incision,I-PR
without,O
adenopathy,B-PR
or,O
bruit,B-PR
.,O

The,O
lungs,O
showed,O
mild,B-PR
inspiratory,I-PR
wheeze,I-PR
and,O
moderate,B-PR
expiratory,I-PR
wheezes,I-PR
.,O

Breath,O
sounds,O
are,O
present,O
bilaterally,O
.,O

Cardiovascular,O
exam,O
:,O

regular,O
rate,O
and,O
rhythm,O
.,O

The,O
abdomen,O
was,O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
.,O

Extremities,O
:,O

no,O
clubbing,B-PR
",",O
cyanosis,B-PR
or,O
edema,B-PR
.,O

The,B-TE
rectal,I-TE
examination,I-TE
is,O
guaiac,B-TE
negative,O
with,O
a,O
minimal,O
amount,O
of,O
stool,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
on,O
February,O
5,O
",",O
1994,O
and,O
had,O
a,B-TR
central,I-TR
venous,I-TR
line,I-TR
placed,O
in,O
her,O
right,O
subclavian,O
.,O

The,O
patient,O
was,O
brought,O
to,O
the,O
Operating,O
Room,O
on,O
February,O
6,O
",",O
1994,O
where,O
she,O
underwent,O
rigid,B-TE
and,I-TE
flexible,I-TE
bronchoscopy,I-TE
and,O
upper,B-TE
gastrointestinal,I-TE
endoscopy,I-TE
.,O

Findings,O
included,O
necrotic,B-PR
debris,I-PR
in,I-PR
the,I-PR
distal,I-PR
trachea,I-PR
at,O
the,O
carina,O
and,O
right,O
mainstem,O
bronchus,O
.,O

Esophageal,O
mucosa,O
was,O
visible,O
through,O
the,O
trachea,O
.,O

Her,B-TR
steroids,I-TR
were,O
weaned,O
and,O
the,O
patient,O
was,O
brought,O
to,O
the,O
Operating,O
Room,O
on,O
February,O
10,O
",",O
1994,O
where,O
she,O
underwent,O
once,O
again,O
flexible,B-TE
bronchoscopy,I-TE
and,O
flexible,B-TE
esophagoscopy,I-TE
",",O
as,O
well,O
as,O
rigid,B-TE
bronchoscopy,I-TE
.,O

She,O
then,O
had,O
a,B-TR
transhiatal,I-TR
esophagectomy,I-TR
which,O
was,O
partial,O
",",O
and,O
a,B-TR
substernal,I-TR
gastric,I-TR
interposition,I-TR
as,O
well,O
as,O
a,B-TR
jejunostomy,I-TR
.,O

The,B-TE
pathology,I-TE
report,I-TE
suggested,O
that,O
the,O
area,O
was,O
involved,O
with,O
radiation,B-PR
esophagitis,I-PR
and,O
focal,B-PR
ulceration,I-PR
.,O

She,O
remained,O
ventilator,B-PR
dependent,I-PR
postoperatively,O
and,O
was,O
taken,O
to,O
the,O
Respiratory,O
Intensive,O
Care,O
Unit,O
.,O

The,O
patient,O
was,O
maintained,O
on,O
triple,B-TR
antibiotics,I-TR
which,O
included,O
Vancomycin,B-TR
",",O
ceftazidime,B-TR
and,O
Gentamicin,B-TR
.,O

On,O
postoperative,O
day,O
two,O
",",O
she,O
had,O
an,B-TE
electroencephalogram,I-TE
which,O
showed,O
no,O
evidence,O
of,O
seizure,B-PR
activity,I-PR
but,O
some,B-PR
generalized,I-PR
slowing,I-PR
.,O

The,O
patient,O
was,O
seen,O
in,O
consultation,O
by,O
the,O
Neurology,O
Service,O
for,O
her,B-PR
apparent,I-PR
postoperative,I-PR
encephalopathy,I-PR
and,O
episodes,O
of,O
shaking,B-PR
.,O

An,B-TE
endoscopy,I-TE
was,O
also,O
performed,O
on,O
postoperative,O
day,O
two,O
which,O
showed,O
clean,O
anastomosis,B-TR
.,O

She,O
received,O
multiple,B-TE
bronchoscopies,I-TE
for,O
pulmonary,B-TR
toilet,I-TR
.,O

The,O
patient,O
was,O
maintained,O
on,O
tube,B-TR
feedings,I-TR
and,O
the,B-TR
ventilator,I-TR
.,O

A,B-TE
repeat,I-TE
echocardiogram,I-TE
on,O
February,O
18,O
showed,O
no,O
significant,B-PR
change,I-PR
of,O
her,B-TE
previous,I-TE
echocardiogram,I-TE
on,O
February,O
11,O
",",O
which,O
showed,O
only,O
a,B-PR
small,I-PR
pericardial,I-PR
effusion,I-PR
.,O

A,B-TE
pelvic,I-TE
and,I-TE
abdominal,I-TE
computerized,I-TE
tomography,I-TE
scan,I-TE
on,O
February,O
18,O
also,O
showed,O
no,O
evidence,O
of,O
a,B-PR
focal,I-PR
collection,I-PR
or,O
abscess,B-PR
.,O

She,O
remained,O
intermittently,B-PR
febrile,I-PR
despite,O
numerous,B-TR
antibiotics,I-TR
.,O

Her,B-TE
chest,I-TE
X-ray,I-TE
showed,O
bilateral,B-PR
air,I-PR
space,I-PR
disease,I-PR
",",O
consistent,O
with,O
pneumonia,B-PR
or,O
adult,B-PR
respiratory,I-PR
distress,I-PR
syndrome,I-PR
.,O

She,O
suffered,O
an,O
episode,O
of,O
renal,B-PR
failure,I-PR
which,O
was,O
felt,O
attributable,O
to,O
aminoglycoside,B-PR
toxicity,I-PR
.,O

Her,B-TR
steroids,I-TR
were,O
weaned,O
.,O

Because,O
of,O
her,B-TR
prolonged,I-TR
intubation,I-TR
and,O
inability,B-PR
to,I-PR
wean,I-PR
",",O
on,O
February,O
24,O
",",O
1994,O
",",O
she,O
had,O
a,B-TR
tracheostomy,I-TR
placed,O
.,O

She,O
remained,O
in,O
a,B-PR
coma,I-PR
.,O

The,B-TE
blood,I-TE
cultures,I-TE
on,O
February,O
26,O
",",O
1994,O
grew,O
out,O
Staphylococcus,B-PR
and,O
she,O
was,O
treated,O
for,O
septicemia,B-PR
.,O

Her,B-TE
sputum,I-TE
grew,O
out,O
Pseudomonas,B-PR
aeruginosa,I-PR
as,O
well,O
.,O

The,B-TE
urine,I-TE
contained,O
yeast,B-PR
and,O
she,O
was,O
treated,O
with,O
amphotericin,B-TR
.,O

On,O
March,O
3,O
",",O
1994,O
",",O
a,B-TE
repeat,I-TE
chest,I-TE
and,I-TE
abdominal,I-TE
and,I-TE
pelvis,I-TE
computerized,I-TE
tomography,I-TE
scan,I-TE
showed,O
no,O
evidence,O
of,O
fluid,B-PR
collections,I-PR
.,O

There,O
was,O
a,B-PR
large,I-PR
left,I-PR
pleural,I-PR
effusion,I-PR
however,O
.,O

This,O
was,O
drained,O
with,O
a,B-TR
left,I-TR
chest,I-TR
tube,I-TR
.,O

Her,B-TE
sputum,I-TE
then,O
grew,O
out,O
Klebsiella,B-PR
and,O
she,O
was,O
treated,O
with,O
amikacin,B-TR
and,O
imipenem,B-TR
.,O

She,O
developed,O
a,B-PR
right,I-PR
pleural,I-PR
effusion,I-PR
and,O
had,O
a,B-TR
right,I-TR
chest,I-TR
tube,I-TR
placed,O
.,O

On,O
March,O
13,O
",",O
1994,O
",",O
she,O
regained,O
some,O
level,O
of,O
consciousness,O
.,O

She,O
was,O
able,O
to,O
fix,O
and,O
follow,O
with,O
her,O
eyes,O
",",O
respond,O
to,O
commands,O
.,O

On,O
March,O
14,O
",",O
1994,O
",",O
her,O
right,O
lung,O
was,O
pleurodesed,O
.,O

Attempts,O
were,O
made,O
to,O
facilitate,O
her,B-TR
wean,I-TR
by,O
resting,O
her,O
overnight,O
with,O
a,O
combination,O
of,O
propafol,B-TR
and,O
Fentanyl,B-TR
.,O

This,O
was,O
tried,O
for,O
approximately,O
seven,O
days,O
with,O
no,O
real,O
progress,O
made,O
toward,O
facilitating,O
her,B-TR
vent,I-TR
wean,I-TR
.,O

She,O
continued,O
to,O
require,O
pressor,B-TR
support,I-TR
in,O
the,O
high,O
30,O
&apos;s,O
.,O

She,O
also,O
fell,O
into,O
a,B-PR
coma,I-PR
once,O
again,O
.,O

On,O
March,O
31,O
",",O
1994,O
",",O
her,B-PR
pressor,I-PR
support,I-PR
requirement,I-PR
increased,O
and,O
she,O
continued,O
to,O
have,O
tachypneic,B-PR
episodes,I-PR
.,O

On,O
April,O
2,O
",",O
1994,O
",",O
she,O
had,O
several,O
episodes,O
of,O
bradycardia,B-PR
and,O
asystole,B-PR
",",O
which,O
responded,O
only,O
to,O
manual,B-TR
ventilation,I-TR
.,O

Discussions,O
were,O
held,O
with,O
the,O
patient,O
&apos;s,O
family,O
with,O
regard,O
to,O
her,O
previously,O
expressed,O
wishes,O
not,O
to,O
be,O
maintained,O
on,O
artificial,B-TR
life,I-TR
support,I-TR
for,O
extended,O
period,O
of,O
time,O
with,O
little,O
or,O
no,O
hope,O
for,O
recovery,O
.,O

She,O
had,O
expressed,O
these,O
wishes,O
in,O
writing,O
on,O
several,O
legal,O
forms,O
from,O
the,O
state,O
of,O
Jose,O
Pineston,O
",",O
as,O
well,O
as,O
in,O
discussions,O
with,O
her,O
loved,O
ones,O
.,O

Decision,O
was,O
made,O
in,O
conjunction,O
with,O
the,O
family,O
and,O
Dr.,O
Caslighlourdes,O
to,O
terminate,O
artificial,B-TR
respiratory,I-TR
support,I-TR
.,O

The,O
patient,O
was,O
removed,O
from,O
the,B-TR
ventilator,I-TR
and,O
placed,O
on,O
a,B-TR
T-piece,I-TR
in,I-TR
her,I-TR
trachea,I-TR
only,O
and,O
was,O
made,O
comfortable,O
with,O
narcotics,B-TR
.,O

Her,O
respirations,O
ceased,O
and,O
she,O
died,O
at,O
10:15,O
a.m.,O
on,O
April,O
2,O
",",O
1994,O
.,O

DISPOSITION,O
/,O
PLAN,O
ON,O
DISCHARGE,O
:,O

The,O
family,O
will,O
return,O
the,O
body,O
to,O
Sa,O
for,O
burial,O
.,O

They,O
have,O
declined,O
a,B-TE
post-mortem,I-TE
examination,I-TE
.,O

CA,O
SHUFF,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

RIEMIND,O
CASLIGHLOURDES,O
",",O
M.D.,O

TR,O
:,O

yu,O
/,O
bmot,O

DD,O
:,O

4-2-94,O

TD,O
:,O

04/03/94,O

CC,O
:,O

963005114,O

FIH,O

1704696,O

04773/k096,O

64394,O

5/3/1993,O
12:00:00,O
AM,O

ADULT,B-PR
RESPIRATORY,I-PR
DISTRESS,I-PR
SYNDROME,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

5-3-93,O

DISCHARGE,O
DATE,O
:,O

5-12-93,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Adult,B-PR
respiratory,I-PR
distress,I-PR
syndrome,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

Urinary,B-PR
tract,I-PR
infection,I-PR
",",O
tracheostomy,B-TR
status,O
",",O
diabetes,B-PR
mellitus,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Mr.,O
Stain,O
was,O
transferred,O
from,O
the,O
Oreiewlefell,O
Merkane,O
I,O
Penaltbridgesgreat,O
University,O
Medical,O
Center,O
for,O
progressive,B-PR
respiratory,I-PR
failure,I-PR
and,O
adult,B-PR
respiratory,I-PR
distress,I-PR
syndrome,I-PR
superimposed,O
on,O
a,O
history,O
of,O
chronic,B-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
",",O
perhaps,O
asthma,B-PR
",",O
and,O
ulcerative,B-PR
colitis,I-PR
.,O

His,O
only,O
positive,O
result,O
was,O
a,B-TE
sputum,I-TE
culture,I-TE
for,O
Pseudomonas,B-PR
and,O
this,O
came,O
after,O
he,O
had,O
already,O
been,O
on,O
antibiotics,B-TR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,B-TE
physical,I-TE
examination,I-TE
on,O
transfer,O
showed,O
an,O
alert,O
male,O
with,O
temperature,B-TE
100,O
degrees,O
",",O
blood,B-TE
pressure,I-TE
120/64,O
",",O
heart,B-TE
rate,I-TE
80,O
.,O

He,O
was,O
intubated,B-TR
with,O
pressor,B-TR
support,I-TR
of,O
25,O
",",O
and,O
PEEP,B-TR
of,O
12.5,O
with,O
70%,O
FIO2,B-TR
.,O

Tracheostomy,B-TR
tube,I-TR
was,O
in,O
good,O
position,O
.,O

There,O
was,O
an,B-PR
audible,I-PR
air,I-PR
leak,I-PR
.,O

His,O
chest,O
showed,O
bilateral,B-PR
rhonchi,I-PR
.,O

The,O
abdomen,O
was,O
distended,B-PR
with,O
active,O
bowel,O
sounds,O
.,O

The,B-TE
rectal,I-TE
examination,I-TE
was,O
unremarkable,O
.,O

Extremities,O
showed,O
trace,B-PR
pulmonary,I-PR
edema,I-PR
.,O

LABORATORY,O
DATA,O
:,O

A,B-TE
chest,I-TE
X-ray,I-TE
showed,O
diffuse,B-PR
bilateral,I-PR
alveolar,I-PR
infiltrates,I-PR
",",O
greater,O
in,O
the,O
lower,O
lung,O
fields,O
than,O
in,O
the,O
upper,O
.,O

The,B-TE
EKG,I-TE
showed,O
normal,O
sinus,O
rhythm,O
at,O
83,O
",",O
with,O
an,O
11,O
degree,O
axis,O
",",O
non-specific,B-PR
ST-T,I-PR
wave,I-PR
changes,I-PR
.,O

The,B-TE
sputum,I-TE
Gram,I-TE
stain,I-TE
showed,O
a,B-PR
few,I-PR
polys,I-PR
and,O
no,O
organisms,B-PR
.,O

The,B-TE
blood,I-TE
gas,I-TE
showed,O
a,B-TE
pO2,I-TE
of,O
56,O
",",O
pCO2,B-TE
of,O
48,O
and,O
pH,B-TE
of,O
7.47,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
seen,O
in,O
consultation,O
by,O
Dr.,O
Wire,O
who,O
felt,O
that,O
manipulation,B-TR
of,I-TR
the,I-TR
tracheal,I-TR
tube,I-TR
was,O
the,O
best,O
approach,O
to,O
the,B-PR
air,I-PR
leak,I-PR
since,O
it,O
was,O
a,B-TR
new,I-TR
trach,I-TR
and,O
he,O
was,O
requiring,O
such,O
high,B-TR
ventilator,I-TR
support,I-TR
that,O
it,O
was,O
risky,O
to,O
change,O
it,O
.,O

He,O
also,O
felt,O
that,O
lung,B-TE
biopsy,I-TE
at,O
this,O
time,O
was,O
rather,O
risky,O
.,O

The,O
patient,O
was,O
therefore,O
completely,B-TE
cultured,I-TE
again,O
and,O
begun,O
on,O
antibiotic,B-TR
coverage,I-TR
which,O
would,O
take,O
care,O
of,O
the,B-PR
Pseudomonas,I-PR
he,O
was,O
known,O
to,O
have,O
.,O

The,B-TR
steroids,I-TR
were,O
tapered,O
.,O

He,O
was,O
also,O
begun,O
on,O
anti-Candida,B-TR
regimen,I-TR
for,O
his,B-PR
urinary,I-PR
tract,I-PR
infection,I-PR
with,O
yeast,B-PR
being,O
seen,O
.,O

Because,O
of,O
the,O
story,O
of,O
hemoptysis,B-PR
",",O
he,O
also,O
underwent,O
an,B-TE
exotic,I-TE
bleeding,I-TE
work,I-TE
up,I-TE
for,O
such,O
things,O
as,O
Wegner,B-PR
&apos;s,I-PR
and,O
Goodpasture,B-PR
&apos;s,I-PR
.,O

These,O
results,O
were,O
all,O
negative,O
.,O

He,O
continued,O
to,O
require,O
very,B-TR
high,I-TR
FIO2,I-TR
.,O

He,O
was,O
found,O
to,O
have,O
a,B-PR
DVT,I-PR
by,O
ultrasound,B-TE
.,O

He,O
underwent,O
a,B-TR
trial,I-TR
of,I-TR
TPA,I-TR
followed,O
by,O
heparin,B-TR
.,O

This,O
produced,O
substantially,B-PR
further,I-PR
hemoptysis,I-PR
and,O
the,O
need,O
for,O
transfusion,B-TR
.,O

He,O
stabilized,O
from,O
this,O
",",O
but,O
on,O
the,O
fifth,O
while,O
continuing,O
to,O
have,O
extremely,B-PR
ventilator,I-PR
requirement,I-PR
.,O

In,O
consultation,O
with,O
his,O
family,O
",",O
it,O
was,O
decided,O
that,O
enough,O
support,O
had,O
been,O
done,O
.,O

At,O
that,O
time,O
",",O
therefore,O
",",O
ventilator,B-TR
support,I-TR
was,O
withdrawn,O
under,O
the,B-TR
comfort,I-TR
measures,I-TR
of,O
morphine,B-TR
.,O

STAIN,O
J.,O
A,O
",",O
M.D.,O

TR,O
:,O

sj,O
/,O
bmot,O

DD,O
:,O

6-4-93,O

TD,O
:,O

06/05/93,O

CC,O
:,O

972977292,O

PUOMC,O

9149486,O

13382,O

713336,O

10/14/1996,O
12:00:00,O
AM,O

LEFT,B-PR
ANTERIOR,I-PR
TEMPORAL,I-PR
INTRAPARENCHYMAL,I-PR
HEMORRHAGE,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

CALL,O
",",O
GRANRIVERN,O
S,O

UNIT,O
NUMBER,O
:,O

585-28-96,O

ADMISSION,O
DATE,O
:,O

10/14/96,O

DISCHARGE,O
DATE,O
:,O

10/27/96,O
date,O
of,O
birth,O
;,O
September,O
30,O
",",O
1917,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Left,B-PR
anterior,I-PR
temporal,I-PR
intraparenchymal,I-PR
hemorrhage,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

atrial,B-PR
fibrillation,I-PR
",",O
deep,B-PR
venous,I-PR
thrombosis,I-PR
",",O
pulmonary,B-PR
embolus,I-PR
",",O
right,B-PR
frontal,I-PR
infarct,I-PR
",",O
hypertension,B-PR
",",O
and,O
question,O
progressive,B-PR
supranuclear,I-PR
palsy,I-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

magnetic,B-TE
resonance,I-TE
imaging,I-TE
of,I-TE
the,I-TE
brain,I-TE
on,O
10/18/96,O
.,O

THER,O
PROCEDURES,O
:,O

arterial,B-TE
catheterization,I-TE
on,O
10/14/96,O
",",O
head,B-TE
CT,I-TE
scan,I-TE
on,O
10/14/96,O

HISTORY,O
AND,O
REASON,O
FOR,O
HOSPITALIZATION,O
:,O

Granrivern,O
Call,O
is,O
a,O
79-year-old,O
right,O
handed,O
white,O
male,O
with,O
a,O
history,O
of,O
questionable,O
progressive,B-PR
supranuclear,I-PR
palsy,I-PR
",",O
atrial,B-PR
fibrillation,I-PR
",",O
deep,B-PR
venous,I-PR
thrombosis,I-PR
",",O
and,O
pulmonary,B-PR
embolus,I-PR
who,O
presents,O
with,O
a,B-PR
change,I-PR
in,I-PR
mental,I-PR
status,I-PR
and,O
a,O
fall,O
at,O
home,O
.,O

His,O
family,O
stated,O
that,O
he,O
had,O
a,B-PR
progressive,I-PR
mental,I-PR
decline,I-PR
over,O
the,O
past,O
three,O
years,O
and,O
was,O
initially,O
diagnosed,O
with,O
Parkinson,B-PR
&apos;s,I-PR
disease,I-PR
or,O
features,B-PR
consistent,O
with,O
Parkinsonism,B-PR
.,O

This,O
was,O
poorly,O
responsive,O
to,O
Eldopa,B-TR
.,O

He,O
was,O
later,O
seen,O
by,O
Dr.,O
Flo,O
Cuchkote,O
at,O
the,O
Ph,O
University,O
Of,O
Medical,O
Center,O
and,O
diagnosed,O
with,O
progressive,B-PR
supranuclear,I-PR
palsy,I-PR
.,O

Over,O
the,O
five,O
to,O
six,O
weeks,O
prior,O
to,O
admission,O
he,O
had,O
a,B-PR
drop,I-PR
off,I-PR
in,I-PR
his,I-PR
mental,I-PR
functioning,I-PR
with,O
more,O
frequent,O
episodes,O
of,O
confusion,B-PR
and,O
disorientation,B-PR
and,O
requiring,O
more,O
assistance,B-TR
with,O
his,O
activities,O
of,O
daily,O
living,O
.,O

He,O
also,O
developed,O
a,B-PR
urinary,I-PR
incontinence,I-PR
.,O

He,O
had,O
had,O
two,O
falls,O
to,O
his,O
wife,O
&apos;s,O
recollection,O
",",O
both,O
times,O
slipping,O
off,O
the,O
edge,O
of,O
a,O
chair,O
backwards,O
.,O

On,O
the,O
morning,O
of,O
admission,O
at,O
8,O
o&apos;clock,O
",",O
he,O
was,O
noted,O
to,O
be,O
moving,O
his,O
mouth,O
less,O
and,O
speaking,O
&quot;,O
gibberish,O
&quot;,O
.,O

He,O
was,O
later,O
sitting,O
in,O
a,O
chair,O
making,O
multiple,O
attempts,O
to,O
get,O
up,O
",",O
which,O
he,O
subsequently,O
did,O
and,O
promptly,O
fell,O
directly,O
on,O
his,O
face,O
at,O
approximately,O
11:30,O
a.m.,O

There,O
was,O
no,O
definite,B-PR
clonic,I-PR
activity,I-PR
.,O

There,O
was,O
no,O
known,B-PR
incontinence,I-PR
.,O

He,O
was,O
taken,O
to,O
an,O
outside,O
hospital,O
and,O
nasally,O
intubated,O
and,O
then,O
transferred,O
to,O
the,O
Ph,O
University,O
Of,O
Medical,O
Center,O
Emergency,O
Room,O
where,O
he,O
was,O
orally,O
intubated,O
.,O

A,B-TE
trauma,I-TE
evaluation,I-TE
was,O
negative,O
and,O
thus,O
he,O
was,O
transferred,O
to,O
the,O
Neurology,O
Service,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Coumadin,B-TR
4,O
mgs,O
po,O
qhs,O
",",O
Vasotec,B-TR
5,O
mgs,O
po,O
qd,O
",",O
Lasix,B-TR
prn,O
",",O
Digoxin,B-TR
0.25,O
mgs,O
poqd,O
",",O
Proscar,B-TR
and,O
Sinemet,B-TR
.,O

ALLERGIES,O
:,O

no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1),O
atrial,B-PR
fibrillation,I-PR
on,O
coumadin,B-TR
",",O

2),O
deep,B-PR
venous,I-PR
thrombosis,I-PR
and,O
pulmonary,B-PR
embolus,I-PR
;,O
the,O
wife,O
states,O
since,O
he,O
was,O
in,O
the,O
infantry,O
in,O
World,O
War,O
II,O
.,O

3),O
Question,O
progressive,B-PR
supranuclear,I-PR
palsy,I-PR
.,O

4),O
old,B-PR
right,I-PR
frontal,I-PR
infarct,I-PR
.,O

5),O
hypertension,B-PR
.,O

SOCIAL,O
HISTORY,O
:,O

He,O
lives,O
with,O
his,O
wife,O
who,O
is,O
his,O
primary,O
care,O
giver,O
.,O

He,O
is,O
a,O
former,O
professor,O
at,O
Montana,O
.,O

Tobacco,O
;,O
he,O
has,O
some,O
distant,O
history,O
of,O
some,O
very,O
minimal,O
use,O
.,O

Alcohol,O
;,O
he,O
has,O
no,O
recent,O
use,O
.,O

He,O
was,O
a,O
previous,O
drinker,O
of,O
one,O
&quot;,O
old,O
fashioned,O
&quot;,O
every,O
night,O
.,O

FAMILY,O
HISTORY,O
:,O

He,O
has,O
a,O
father,O
who,O
had,O
dementia,B-PR
.,O

There,O
was,O
no,O
history,O
of,O
strokes,B-PR
or,O
bleeding,B-PR
disorders,I-PR
in,O
the,O
family,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

vital,B-TE
signs,I-TE
in,O
the,O
emergency,O
room,O
were,O
210/100,O
for,O
blood,B-TE
pressure,I-TE
",",O
heart,B-TE
rate,I-TE
70,O
and,O
irregular,B-PR
.,O

He,O
was,O
afebrile,B-PR
.,O

In,O
general,O
he,O
was,O
an,O
intubated,O
elderly,O
frail,O
appearing,O
white,O
male,O
with,O
blood,B-PR
about,I-PR
his,I-PR
face,I-PR
.,O

head,B-TE
",",I-TE
eyes,I-TE
",",I-TE
ears,I-TE
",",I-TE
nose,I-TE
and,I-TE
throat,I-TE
examination,I-TE
;,O
abrasions,B-PR
about,I-PR
his,I-PR
forehead,I-PR
",",O
there,O
was,O
some,B-PR
minimal,I-PR
swelling,I-PR
associated,O
.,O

His,O
neck,O
was,O
rigid,B-PR
;,O
1+,B-TE
carotids,I-TE
without,O
bruits,B-PR
.,O

oropharynx,O
was,O
intubated,B-TR
with,O
blood,B-PR
as,O
well,O
.,O

Lungs,O
;,O
clear,O
to,O
auscultation,B-TE
bilaterally,I-TE
.,O

Cardiovascular,B-TE
examination,I-TE
;,O
regular,O
rate,O
and,O
rhythm,O
with,O
no,O
murmurs,B-PR
",",O
rubs,B-PR
",",O
or,O
gallops,B-PR
.,O

Abdominal,B-TE
examination,I-TE
;,O
soft,O
",",O
non-tender,B-PR
",",O
non-distended,B-PR
",",O
normal,O
active,O
bowel,O
sounds,O
.,O

Extremities,O
:,O

no,O
clubbing,B-PR
",",O
cyanosis,B-PR
",",O
or,O
edema,B-PR
.,O

Neurologically,O
;,O
he,O
opens,O
his,O
eyes,O
to,O
voice,O
.,O

He,O
does,O
not,O
regard,O
the,O
examiner,O
.,O

He,O
had,O
no,B-PR
blink,I-PR
to,O
threat,B-TE
.,O

His,O
pupils,O
were,O
three,O
down,O
to,O
two,O
on,O
the,O
right,O
and,O
five,O
down,O
to,O
four,O
on,O
the,O
left,O
.,O

According,O
to,O
the,O
family,O
this,B-PR
iansicoria,I-PR
was,O
old,O
.,O

He,O
had,O
intact,O
corneals,O
bilaterally,O
and,O
intact,O
horizontal,O
dull,O
movements,O
bilaterally,O
.,O

He,O
had,O
left,O
greater,O
than,O
right,O
nasal,O
stimulation,O
to,O
grimace,O
.,O

He,O
had,O
no,O
gag,B-PR
to,O
tube,B-TR
manipulation,I-TR
.,O

Motor,B-TE
examination,I-TE
he,O
had,O
a,B-PR
weak,I-PR
withdrawal,I-PR
to,O
nail,B-TE
bed,I-TE
pressure,I-TE
in,O
both,O
hands,O
.,O

He,O
triple,O
flexed,O
his,O
bilateral,O
lower,O
extremities,O
to,O
pain,B-PR
.,O

His,B-TE
deep,I-TE
tendon,I-TE
reflexes,I-TE
were,O
2+,O
at,O
the,O
right,O
brachial,O
radialis,O
and,O
right,O
patella,O
;,O
everywhere,O
else,O
his,B-TE
reflexes,I-TE
were,O
1,O
.,O

His,O
toes,O
were,O
down,O
going,O
.,O

SUMMARY,O
OF,O
LABORATORY,O
AND,O
RADIOLOGICAL,O
EXAMINATIONS,O
:,O

sodium,B-TE
141,O
",",O
potassium,B-TE
3.5,O
",",O
chloride,B-TE
107,O
",",O
bicarbonates,B-TE
23.8,O
",",O
BUN,B-TE
23,O
",",O
creatinine,B-TE
1.1,O
",",O
glucose,B-TE
165,O
",",O
PO2,B-TE
377,O
",",O
PCO2,B-TE
32,O
",",O
PH,B-TE
7.50,O
",",O
asomus,B-TE
298,O
",",O
toxic,B-TE
screen,I-TE
negative,O
",",O
white,B-TE
blood,I-TE
cell,I-TE
count,I-TE
11.1,O
",",O
hematocrit,B-TE
39.6,O
",",O
platelet,B-TE
count,I-TE
137,O
",",O
prothrombin,B-TE
time,I-TE
25.2,O
",",O
INR,B-TE
4.3,O
",",O
partial,B-TE
thromboplastin,I-TE
time,I-TE
34.7,O
",",O
urinalysis,B-TE
1+,B-PR
"albumin,",I-PR
0-5,B-PR
high,I-PR
link,I-PR
caths,I-PR
",",O
cervical,B-TE
spine,I-TE
negative,O
",",O
pelvis,B-TE
negative,O
",",O
lumbar,B-TE
spine,I-TE
;,O
negative,O
",",O
thoracic,B-TE
spine,I-TE
negative,O
.,O

chest,B-TE
x-ray,I-TE
clear,O
.,O

electrocardiogram,B-TE
showed,O
2,O
mm,O
of,O
ST,B-PR
depressions,I-PR
in,I-PR
V4-6,I-PR
.,O

Head,B-TE
CT,I-TE
scan,I-TE
showed,O
a,B-PR
2,I-PR
x,I-PR
2,I-PR
x,I-PR
2,I-PR
left,I-PR
anterior,I-PR
temporal,I-PR
hemorrhage,I-PR
with,O
minimal,B-PR
surrounding,I-PR
edema,I-PR
.,O

There,O
was,O
also,O
evidence,O
of,O
an,B-PR
old,I-PR
right,I-PR
frontal,I-PR
infarction,I-PR
.,O

HOSPITAL,O
COURSE,O
AND,O
TREATMENT,O
:,O

1),O
NEUROLOGY,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
Neurology,O
Intensive,O
Care,O
Unit,O
for,O
intensive,B-TE
monitoring,I-TE
due,O
to,O
his,B-PR
frail,I-PR
condition,I-PR
.,O

He,O
had,O
an,B-TE
electroencephalogram,I-TE
performed,O
on,O
his,O
initial,O
admittance,O
to,O
the,O
Intensive,O
Care,O
Unit,O
which,O
did,O
not,O
show,O
any,O
evidence,O
of,O
seizure,B-PR
activity,I-PR
.,O

It,O
did,O
",",O
however,O
",",O
show,O
diffuse,B-PR
slowing,I-PR
.,O

He,O
was,O
given,O
1.5,O
grams,O
of,O
Dilantin,B-TR
in,O
the,O
emergency,O
room,O
as,O
well,O
as,O
2,O
mgs,O
of,O
intravenous,B-TR
Ativan,I-TR
which,O
did,O
little,O
to,O
stop,O
his,B-PR
rhythmic,I-PR
blinking,I-PR
that,O
he,O
showed,O
from,O
time,O
to,O
time,O
on,O
examination,B-TE
.,O

His,B-PR
hypertension,I-PR
;,O
his,B-PR
high,I-PR
blood,I-PR
pressure,I-PR
was,O
controlled,O
with,O
intravenous,B-TR
nitroglycerine,I-TR
in,O
the,O
early,O
going,O
and,O
then,O
he,O
was,O
switched,O
to,O
an,B-TR
oral,I-TR
regimen,I-TR
for,O
better,O
control,O
after,O
he,O
was,O
removed,O
from,O
the,O
Intensive,O
Care,O
Unit,O
.,O

He,O
continued,O
to,O
do,O
well,O
over,O
the,O
next,O
few,O
days,O
and,O
was,O
quite,O
surprisingly,O
intact,O
on,O
both,O
sides,O
of,O
his,O
body,O
in,O
terms,O
of,O
his,O
ability,O
to,O
move,O
.,O

He,O
did,O
consistently,O
have,O
more,O
movement,O
on,O
the,O
left,O
side,O
of,O
his,O
body,O
than,O
on,O
the,O
right,O
",",O
but,O
he,O
gradually,O
became,O
more,O
awake,O
and,O
alert,O
and,O
communicative,O
and,O
his,B-TR
endotracheal,I-TR
tube,I-TR
was,O
removed,O
on,O
the,O
second,O
day,O
of,O
admission,O
.,O

His,O
diagnosis,O
of,O
progressive,B-PR
supranuclear,I-PR
palsy,I-PR
was,O
placed,O
under,O
question,O
on,O
further,B-TE
examination,I-TE
of,I-TE
his,I-TE
eye,I-TE
movement,I-TE
since,O
he,O
was,O
able,O
to,O
have,O
excellent,O
superior,O
gaze,O
especially,O
with,O
the,B-TE
bells,I-TE
phenomenon,I-TE
which,O
would,O
not,O
be,O
seen,O
with,O
progressive,B-PR
supranuclear,I-PR
palsy,I-PR
.,O

It,O
was,O
felt,O
that,O
his,B-PR
dementing,I-PR
illness,I-PR
and,O
rigidity,B-PR
was,O
most,O
likely,O
due,O
to,O
some,O
type,O
of,O
cortico-basal,B-PR
ganglia,I-PR
degeneration,I-PR
process,I-PR
",",O
but,O
this,O
was,O
not,O
clarified,O
during,O
this,O
admission,O
.,O

It,O
was,O
not,O
felt,O
likely,O
to,O
be,O
due,O
to,O
Parkinson,B-PR
&apos;s,I-PR
disease,I-PR
",",O
as,O
he,O
had,O
no,O
significant,O
response,O
to,O
Eldopa,B-TR
in,O
the,O
past,O
and,O
the,O
patient,O
had,O
no,O
evidence,O
of,O
tremor,B-PR
",",O
although,O
he,O
was,O
quite,B-PR
rigid,I-PR
and,O
bradykinetic,B-PR
.,O

He,O
had,O
an,B-TE
magnetic,I-TE
resonance,I-TE
imaging,I-TE
performed,O
on,O
October,O
18,O
",",O
1996,O
.,O

This,O
showed,O
the,B-PR
unchanged,I-PR
left,I-PR
temporal,I-PR
parenchymal,I-PR
interparenchymal,I-PR
hematoma,I-PR
and,O
the,B-PR
old,I-PR
embolic,I-PR
right,I-PR
frontal,I-PR
infarct,I-PR
",",O
but,O
there,O
were,O
no,O
new,B-PR
lesions,I-PR
and,O
no,O
evidence,O
of,O
his,B-TE
susceptibility,I-TE
studies,I-TE
to,O
suggest,O
old,B-PR
bleeds,I-PR
which,O
might,O
have,O
been,O
consistent,O
with,O
amylase,B-PR
angiopathy,I-PR
.,O

In,O
addition,O
",",O
he,O
gadolinium,B-TE
scan,I-TE
did,O
not,O
show,O
enhancement,B-PR
at,O
the,O
area,O
of,O
his,B-PR
hemorrhage,I-PR
",",O
so,O
tumor,B-PR
was,O
felt,O
to,O
be,O
unlikely,O
.,O

However,O
",",O
this,O
issue,O
will,O
need,O
to,O
be,O
re-evaluated,O
in,O
six,O
months,O
time,O
once,O
the,B-PR
hematoma,I-PR
is,O
less,O
prominent,O
to,O
see,O
if,O
there,O
is,O
possibly,O
an,B-PR
underlying,I-PR
tumor,I-PR
or,O
arterial,B-PR
venous,I-PR
malformation,I-PR
that,O
could,O
be,O
currently,O
compressed,O
by,O
the,O
area,O
of,O
hemorrhage,B-PR
.,O

The,O
etiology,O
of,O
his,B-PR
bleed,I-PR
was,O
felt,O
to,O
be,O
most,O
likely,O
secondary,O
to,O
hypertension,B-PR
",",O
but,O
these,O
other,O
causes,O
could,O
also,O
not,O
be,O
ruled,O
out,O
.,O

2),O
CARDIOVASCULAR,O
:,O

His,B-TE
electrocardiogram,I-TE
was,O
concerning,O
for,O
ischemia,B-PR
.,O

He,O
was,O
on,O
intravenous,B-TR
TNG,I-TR
and,O
was,O
supratherapeutic,B-PR
on,O
his,B-TR
anti-coagulation,I-TR
.,O

He,O
did,O
have,O
a,B-PR
slight,I-PR
elevation,I-PR
of,O
his,B-TE
TPK,I-TE
with,O
an,O
additional,O
value,O
of,O
198,O
with,O
a,B-TE
MB,I-TE
fraction,I-TE
of,O
5.7,O
",",O
which,O
makes,O
for,O
a,O
percentage,O
of,O
2.9,O
.,O

That,O
was,O
at,O
the,O
highest,O
percentage,O
that,O
he,O
had,O
and,O
after,O
this,O
his,O
percentage,O
came,O
down,O
to,O
1.6,O
",",O
1.0,O
on,O
subsequent,B-TE
CKMBs,I-TE
and,O
was,O
felt,O
that,O
he,O
had,O
a,B-PR
very,I-PR
small,I-PR
&quot;,I-PR
leaflet,I-PR
&quot;,I-PR
.,O

He,O
remained,O
chest,B-PR
pain,I-PR
free,O
throughout,O
his,O
admission,O
.,O

3),O
PULMONARY,O
:,O

After,O
his,B-TR
initial,I-TR
intubation,I-TR
he,O
remained,O
quite,O
stable,O
.,O

He,O
was,O
found,O
to,O
be,O
at,O
a,B-PR
large,I-PR
aspiration,I-PR
risk,I-PR
given,O
his,B-PR
decreased,I-PR
mental,I-PR
status,I-PR
and,O
the,O
lack,O
of,O
presence,O
of,O
a,B-TE
gag,I-TE
reflex,I-TE
.,O

However,O
",",O
he,O
was,O
given,O
aggressive,B-TR
pulmonary,I-TR
toilets,I-TR
including,O
chest,B-TR
physical,I-TR
therapy,I-TR
and,O
aspiration,B-TR
precautions,I-TR
and,O
the,O
patient,O
did,O
not,O
develop,O
any,B-PR
pulmonary,I-PR
symptoms,I-PR
during,O
his,O
admission,O
.,O

4),O
HEMATOLOGY,O
:,O

He,O
had,O
his,B-TE
prothrombin,I-TE
time,I-TE
reversed,O
with,O
Vitamin,B-TR
K,I-TR
2,O
mgs,O
on,O
admission,O
subcutaneously,O
as,O
well,O
as,O
two,O
units,O
of,O
fresh,B-TR
frozen,I-TR
plasma,I-TR
given,O
in,O
the,O
emergency,O
room,O
.,O

His,O
anticoagulation,O
status,O
had,O
to,O
be,O
monitored,O
very,O
closely,O
due,O
to,O
his,O
history,O
of,O
deep,B-PR
venous,I-PR
thrombosis,I-PR
and,O
pulmonary,B-PR
embolus,I-PR
as,O
well,O
as,O
atrial,B-PR
fibrillation,I-PR
",",O
but,O
he,O
could,O
not,O
be,O
placed,O
on,O
a,O
high,O
amount,O
of,O
anticoagulation,B-TR
because,O
of,O
the,B-PR
new,I-PR
intraparenchymal,I-PR
bleed,I-PR
.,O

It,O
was,O
decided,O
that,O
his,O
goal,O
INR,B-TE
was,O
to,O
be,O
2.0,O
.,O

He,O
did,O
drop,O
below,O
1.5,O
at,O
one,O
time,O
",",O
at,O
which,O
time,O
he,O
was,O
placed,O
on,O
heparin,B-TR
intravenous,I-TR
to,O
carry,O
him,O
through,O
that,O
period,O
",",O
but,O
his,B-TE
discharge,I-TE
INR,I-TE
was,O
around,O
2,O
and,O
he,O
was,O
off,O
of,O
heparin,B-TR
at,O
that,O
time,O
.,O

It,O
was,O
decided,O
that,O
he,O
would,O
have,O
very,O
close,O
monitoring,B-TE
of,O
his,O
anticoagulation,O
status,O
in,O
the,O
future,O
to,O
prevent,O
further,B-PR
problems,I-PR
.,O

5),O
GASTROINTESTINAL,O
:,O

He,O
was,O
evaluated,O
by,O
the,O
speech,O
and,O
swallow,O
pathology,O
group,O
at,O
the,O
Ph,O
University,O
Of,O
Medical,O
Center,O
and,O
it,O
was,O
decided,O
that,O
he,O
was,O
able,O
to,O
swallow,O
on,O
his,O
own,O
with,O
a,B-TR
soft,I-TR
solid,I-TR
diet,I-TR
with,O
supervision,O
.,O

Thus,O
",",O
his,B-TR
nasogastric,I-TR
tube,I-TR
was,O
discontinued,O
on,O
October,O
19,O
",",O
1996,O
and,O
he,O
tolerated,O
feeding,O
quite,O
well,O
.,O

In,O
discussions,O
with,O
the,O
family,O
",",O
given,O
his,O
age,O
and,O
number,O
of,O
medical,B-PR
problems,I-PR
",",O
it,O
was,O
decided,O
that,O
the,O
patient,O
should,O
be,O
do,O
not,O
resuscitate,O
should,O
he,O
have,O
a,B-PR
terminal,I-PR
cardiac,I-PR
event,I-PR
during,O
his,O
admission,O
or,O
during,O
future,O
admissions,O
.,O

However,O
",",O
he,O
was,O
still,O
an,B-TR
intubation,I-TR
candidate,O
if,O
it,O
were,O
felt,O
to,O
be,O
a,B-TR
short,I-TR
term,I-TR
procedure,I-TR
.,O

The,O
family,O
realizes,O
that,O
the,O
long,O
term,O
outlook,O
for,O
this,O
patient,O
is,O
not,O
very,O
good,O
",",O
but,O
they,O
would,O
like,O
to,O
currently,O
continue,O
to,O
provide,O
him,O
with,O
all,B-TR
support,I-TR
necessary,I-TR
",",O
short,O
of,O
resuscitation,B-TR
measures,I-TR
or,O
heroic,B-TR
measures,I-TR
should,O
he,O
have,O
a,B-PR
cardiopulmonary,I-PR
arrest,I-PR
.,O

DISPOSITION,O
/,O
PLAN,O
ON,O
DISCHARGE,O
:,O

Stable,O
.,O

DOCTOR,O
&apos;S,O
DISCHARGE,O
ORDERS,O
:,O

The,O
patient,O
was,O
to,O
be,O
discharged,O
to,O
a,O
rehabilitation,O
hospital,O
",",O
the,O
location,O
of,O
which,O
was,O
undetermined,O
at,O
this,O
time,O
of,O
this,O
discharge,O
summary,O
.,O

The,O
patient,O
is,O
to,O
follow,O
up,O
with,O
Dr.,O
Ria,O
in,O
clinic,O
on,O
one,O
month,O
time,O
and,O
the,O
family,O
is,O
to,O
call,O
me,O
if,O
there,O
were,O
any,O
questions,O
in,O
the,O
interim,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Dilantin,B-TR
100,O
mgs,O
po,O
tid,O
",",O
Carafate,B-TR
1,O
gram,O
po,O
qid,O
",",O
Digoxin,B-TR
0.25,O
mgs,O
po,O
qd,O
",",O
Isordil,B-TR
20,O
mgs,O
po,O
tid,O
",",O
Captopril,B-TR
25,O
mgs,O
po,O
tid,O
",",O
Lopressor,B-TR
50,O
mgs,O
po,O
bid,O
",",O
Colace,B-TR
100,O
mgs,O
po,O
tid,O
",",O
and,O
Coumadin,B-TR
2,O
mgs,O
po,O
qhs,O
.,O

TI,O
CALL,O
",",O
M.D.,O

TR,O
:,O

fcz,O

DD,O
:,O

10/21/96,O

TD,O
:,O

10/21/96,O
2:07,O
A,O

cc,O
:,O

TI,O
SHEMAU,O
CALL,O
",",O
M.D.,O
ASHA,O
E,O
VENGLOAN,O
",",O
M.D.,O
LYDELL,O
R,O
WORCE,O
",",O
M.D.,O
/,O
STAT,O

988183518,O

PUOMC,O

7961198,O

290757,O

137082,O

1/25/1997,O
12:00:00,O
AM,O

CRYPTOGENIC,B-PR
CIRRHOSIS,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

BOEHKOTE,O
",",O
SONA,O
S,O

UNIT,O
NUMBER,O
:,O

457-95-71,O

ADMISSION,O
DATE,O
:,O

01/25/97,O

DISCHARGE,O
DATE,O
:,O

01/30/97,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Cryptogenic,B-PR
cirrhosis,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

Variceal,B-PR
bleeding,I-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

Variceal,B-TR
banding,I-TR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
70-year-old,O
female,O
with,O
cryptogenic,B-PR
cirrhosis,I-PR
.,O

She,O
has,O
a,O
history,O
of,O
esophageal,B-PR
varices,I-PR
and,O
a,O
history,O
of,O
an,B-PR
Upper,I-PR
GI,I-PR
bleed,I-PR
.,O

She,O
has,O
had,O
one,O
pervious,O
episode,O
of,O
variceal,B-PR
bleeding,I-PR
with,O
an,O
unclear,O
date,O
.,O

However,O
she,O
is,O
followed,O
by,O
a,O
Dr.,O
Joasscchird,O
at,O
Vaila,O
Medical,O
Center,O
.,O

She,O
was,O
in,O
her,O
usual,O
state,O
of,O
health,O
until,O
one,O
day,O
prior,O
to,O
admission,O
when,O
she,O
felt,O
increasing,B-PR
fatigue,I-PR
",",O
nausea,B-PR
and,O
vomiting,B-PR
productive,O
of,O
bright,B-PR
red,I-PR
blood,I-PR
and,O
coffee,B-PR
ground,I-PR
emesis,I-PR
.,O

She,O
also,O
had,O
some,B-PR
black,I-PR
",",I-PR
tarry,I-PR
stool,I-PR
in,O
her,B-TR
colostomy,I-TR
bag,I-TR
.,O

At,O
Vaila,O
Medical,O
Center,O
",",O
she,O
had,O
a,B-TE
hematocrit,I-TE
of,O
25,O
and,O
was,O
transfused,O
2,O
units,O
of,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
.,O

She,O
had,O
an,B-TE
upper,I-TE
endoscopy,I-TE
at,O
Va,O
Sit,O
Namar,O
Healthcare,O
showing,O
an,O
esophagus,O
filled,O
with,O
clots,B-PR
and,O
small,O
amount,O
of,O
bleeding,B-PR
varices,I-PR
",",O
clot,B-PR
in,I-PR
the,I-PR
stomach,I-PR
with,O
antral,B-PR
gastritis,I-PR
",",O
and,O
a,O
normal,O
duodenum,O
.,O

She,O
was,O
started,O
on,O
Pitressin,B-TR
",",O
a,B-TR
Blakemore,I-TR
tube,I-TR
was,O
inserted,O
.,O

She,O
was,O
transferred,O
to,O
the,O
Ph,O
University,O
Of,O
Medical,O
Center,O
Intensive,O
Care,O
Unit,O
where,O
on,O
January,O
25,O
in,O
the,O
morning,O
her,B-TE
hematocrit,I-TE
was,O
found,O
to,O
be,O
27.4,O
.,O

She,O
was,O
transfused,O
another,O
2,O
units,O
of,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
over,O
the,O
course,O
of,O
the,O
day,O
and,O
her,B-TE
hematocrit,I-TE
improved,O
to,O
29.4,O
and,O
then,O
31.2,O
.,O

The,O
GI,O
service,O
was,O
consulted,O
and,O
an,B-TE
upper,I-TE
endoscopy,I-TE
study,I-TE
showed,O
grade,B-PR
III,I-PR
varices,I-PR
with,O
no,O
active,B-PR
bleeding,I-PR
and,O
a,B-PR
clean,I-PR
base,I-PR
gastric,I-PR
ulcer,I-PR
possibly,O
secondary,O
to,O
the,B-TR
Blakemore,I-TR
tube,I-TR
.,O

Her,B-PR
varices,I-PR
had,O
stigmata,B-PR
of,O
recent,B-PR
bleeding,I-PR
",",O
were,O
banded,B-TR
successfully,O
.,O

after,O
the,B-TR
procedure,I-TR
and,O
2,O
more,O
units,O
of,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
",",O
the,O
patient,O
was,O
hemodynamically,O
stable,O
and,O
hematocrit,B-TE
was,O
stable,O
at,O
31.2,O
.,O

At,O
that,O
time,O
she,O
was,O
transferred,O
from,O
the,O
Intensive,O
Care,O
Unit,O
to,O
Coden,O
2,O
for,O
the,O
Lemgarson,O
Hospital,O
service,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Cryptogenic,B-PR
cirrhosis,I-PR
with,O
an,B-TE
unclear,I-TE
work,I-TE
up,I-TE
.,O

Diverticular,B-PR
bleed,I-PR
requiring,O
colostomy,B-TR
on,O
May,O
96,O
.,O

Spinal,B-PR
stenosis,I-PR
.,O

Hysterectomy,B-TR
at,O
the,O
age,O
of,O
32,O
.,O

No,O
coronary,B-PR
disease,I-PR
",",O
no,O
diabetes,B-PR
and,O
no,O
hypertension,B-PR
.,O

She,O
had,O
medications,B-TR
on,O
transfer,O
which,O
included,O
Synthroid,B-TR
0.15,O
mg,O
QD,O
",",O
Zoloft,B-TR
50,O
mg,O
QD,O
",",O
Inderal,B-TR
10,O
mg,O
BID,O
",",O
Prilosec,B-TR
20,O
mg,O
QD,O
",",O
Neomycin,B-TR
500,O
TID,O
",",O
Feosol,B-TR
3,O
mg,O
and,O
Darvocet,B-TR
PRN,O
.,O

She,O
has,O
allergies,B-PR
to,O
Morphine,B-TR
",",O
Percocet,B-TR
",",O
Codeine,B-TR
",",O
Penicillin,B-TR
",",O
Xanax,B-TR
and,O
Toradol,B-TR
.,O

SOCIAL,O
HISTORY,O
:,O

She,O
does,O
not,O
smoke,O
tobacco,O
.,O

She,O
uses,O
only,O
occasional,O
alcohol,O
and,O
she,O
is,O
not,O
sexually,O
active,O
.,O

Her,O
husband,O
died,O
of,O
lung,B-PR
cancer,I-PR
.,O

She,O
lives,O
alone,O
in,O
Burg,O
Chi,O
Sternafre,O
",",O
Massachusetts,O
.,O

Her,O
friends,O
check,O
up,O
on,O
her,O
.,O

She,O
does,O
not,O
have,O
a,O
home,O
health,O
aide,O
.,O

She,O
has,O
3,O
kids,O
who,O
live,O
far,O
away,O
.,O

She,O
is,O
able,O
at,O
baseline,O
to,O
walk,O
one,O
flight,O
of,O
stairs,O
",",O
2,O
floor,O
apartment,O
.,O

FAMILY,O
HISTORY,O
:,O

Non,O
contributory,O
and,O
unavailable,O
as,O
she,O
is,O
adopted,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

She,O
is,O
an,O
obese,O
",",O
elderly,O
woman,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

vital,O
signs,O
:,O

158/60,O
with,O
a,B-TE
heart,I-TE
rate,I-TE
of,O
85,O
",",O
temperature,B-TE
99.7,O
",",O
respirations,B-TE
14,O
.,O

Her,O
neck,O
showed,O
no,O
JVD,B-PR
.,O

Lungs,O
clear,O
to,O
auscultation,B-TE
.,O

Her,O
abdomen,O
was,O
obese,B-PR
and,O
distended,B-PR
with,O
good,O
bowel,O
sounds,O
",",O
large,B-PR
ventral,I-PR
hernia,I-PR
.,O

Colostomy,B-TR
with,O
black,B-PR
stool,I-PR
.,O

She,O
had,O
some,B-PR
mid,I-PR
epigastric,I-PR
tenderness,I-PR
and,O
no,O
rebound,B-PR
.,O

Her,O
heart,O
showed,O
a,O
regular,O
rate,O
and,O
rhythm,O
with,O
an,O
S1-S2,O
",",O
no,O
murmur,B-PR
.,O

Her,B-TE
neurological,I-TE
exam,I-TE
was,O
alert,O
and,O
oriented,O
.,O

She,O
had,O
5,O
out,O
of,O
5,O
strength,O
bilaterally,O
and,O
her,O
toes,O
were,O
downgoing,O
.,O

She,O
had,O
no,O
evidence,O
of,O
asterixis,B-PR
.,O

Her,O
skin,O
looked,O
very,O
bronze,O
and,O
tan,O
",",O
especially,O
in,O
the,O
sun,O
exposed,O
areas,O
.,O

She,O
had,O
no,O
spider,B-PR
angiomata,I-PR
",",O
no,O
palmar,B-PR
erythema,I-PR
",",O
no,O
xanthomas,B-PR
and,O
no,O
caput,B-PR
medusae,I-PR
.,O

She,O
did,O
not,O
look,O
teric,B-PR
(,O
???,O
),O
.,O

LABORATORY,O
DATA,O
:,O

Notable,O
for,O
sodium,B-TE
141,O
",",O
potassium,B-TE
4.2,O
",",O
chloride,B-TE
109,O
",",O
bicarb,B-TE
19.8,O
",",O
BUN,B-TE
38,O
",",O
creatinine,B-TE
1.2,O
and,O
glucose,B-TE
388,O
.,O

She,O
had,O
a,B-PR
pneumonia,I-PR
of,O
31,O
",",O
calcium,B-TE
was,O
7.5,O
",",O
phosphorous,B-TE
3.0,O
",",O
magnesium,B-TE
1.3,O
.,O

Her,B-TE
bilirubin,I-TE
was,O
1.4,O
total,O
",",O
0.2,O
direct,B-TE
.,O

alkaline,B-TE
phosphatase,I-TE
101,O
.,O

SGPT,B-TE
22,O
",",O
SGOT,B-TE
41,O
",",O
amylase,B-TE
31,O
",",O
lipase,B-TE
less,O
than,O
1,O
.,O

LDH,B-TE
was,O
38.9,O
",",O
CK,B-TE
was,O
66,O
",",O
her,B-TE
hematocrit,I-TE
was,O
27.4,O
",",O
white,B-TE
count,I-TE
was,O
8.0,O
and,O
her,B-TE
platelets,I-TE
were,O
55,O
.,O

PT,B-TE
was,O
14.5,O
",",O
PTT,B-TE
25.5,O
.,O

HOSPITAL,O
COURSE,O
AND,O
TREATMENT,O
:,O

As,O
described,O
above,O
the,O
patient,O
was,O
transfused,O
an,B-TR
additional,I-TR
2,I-TR
units,I-TR
in,O
the,O
Intensive,O
Care,O
Unit,O
and,O
the,O
patient,O
also,O
received,O
an,B-TE
upper,I-TE
endoscopy,I-TE
study,I-TE
and,O
her,B-PR
varices,I-PR
were,O
banded,B-TR
.,O

On,O
transfer,O
to,O
the,O
Lemgarson,O
Hospital,O
service,O
",",O
her,B-TE
hematocrit,I-TE
was,O
31.2,O
",",O
white,B-TE
count,I-TE
11.1,O
and,O
a,B-TE
platelet,I-TE
count,I-TE
80,O
.,O

Her,B-TE
PT,I-TE
was,O
13.1,O
",",O
PTT,B-TE
26.7,O
.,O

The,O
rest,O
of,O
her,B-TE
labs,I-TE
were,O
unremarkable,O
.,O

She,O
was,O
watched,O
very,O
closely,O
while,O
on,O
the,O
floor,O
.,O

She,O
was,O
on,O
GI,B-TR
bleed,I-TR
precautions,I-TR
at,O
all,O
times,O
",",O
was,O
too,O
large,O
for,O
IV,B-TR
.,O

She,O
had,O
a,B-PR
clot,I-PR
at,O
the,O
blood,O
bank,O
and,O
she,O
had,O
BID,B-TE
hematocrits,I-TE
checked,O
.,O

She,O
was,O
kept,O
NPO,B-TR
until,O
January,O
26,O
when,O
she,O
began,O
to,O
feel,O
hungry,O
.,O

At,O
that,O
time,O
clear,B-TR
liquids,I-TR
were,O
started,O
.,O

All,O
of,O
her,O
stools,O
were,O
guaiaced,O
.,O

She,O
also,O
began,O
Nadolol,B-TR
40,O
mg,O
QD,O
to,O
reduce,O
her,B-PR
portal,I-PR
hypertension,I-PR
.,O

The,O
GI,O
consult,O
team,O
continued,O
to,O
follow,O
her,O
.,O

We,O
also,O
tried,O
to,O
contact,O
her,O
physician,O
at,O
Va,O
Sit,O
Namar,O
Healthcare,O
and,O
was,O
unsuccessful,O
.,O

Therefore,O
we,O
decided,O
to,O
work,B-TE
up,I-TE
her,O
cirrhosis,B-PR
.,O

She,O
was,O
described,O
as,O
having,O
_______,O
cirrhosis,B-PR
and,O
we,O
decided,O
that,O
we,O
wanted,O
to,O
try,O
to,O
figure,O
out,O
the,O
etiology,O
.,O

Her,B-TE
ferritin,I-TE
and,O
iron,B-TE
studies,I-TE
did,O
not,O
reveal,O
any,O
evidence,O
of,O
hemochromatosis,B-PR
and,O
her,B-TE
hep,I-TE
serologies,I-TE
were,O
all,O
negative,O
.,O

She,O
also,O
had,O
negative,O
antimitochondrial,O
antibody,O
and,O
she,O
also,O
had,O
no,O
evidence,O
of,O
ceruloplasmin,B-PR
.,O

Over,O
the,O
course,O
of,O
her,O
admission,O
were,O
also,O
sent,O
an,B-TE
alpha-1-antitrypsin,I-TE
",",O
which,O
was,O
negative,O
.,O

She,O
did,O
very,O
well,O
over,O
the,O
course,O
of,O
her,O
admission,O
with,O
no,O
evidence,O
of,O
further,B-PR
bleeding,I-PR
.,O

Her,B-TE
hematocrit,I-TE
stayed,O
stable,O
at,O
approximately,O
32,O
.,O

We,O
also,O
did,O
an,B-TE
ultrasound,I-TE
guided,I-TE
paracentesis,I-TE
.,O

The,B-TE
peritoneal,I-TE
fluid,I-TE
showed,O
a,B-TE
glucose,I-TE
of,O
244,O
",",O
total,B-TE
protein,I-TE
0.8,O
and,O
a,B-TE
albumin,I-TE
of,O
0.5,O
",",O
globulin,B-TE
0.3,O
",",O
amylase,B-TE
16,O
",",O
LDH,B-TE
of,O
51,O
.,O

The,B-TE
serum,I-TE
albumin,I-TE
gradient,I-TE
was,O
1.8,O
consistent,O
with,O
portal,B-PR
hypertension,I-PR
.,O

The,B-TE
cell,I-TE
count,I-TE
showed,O
a,B-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
of,O
160,O
with,O
16%,B-TE
polys,I-TE
.,O

She,O
therefore,O
_________,O
criteria,O
for,O
a,B-PR
spontaneous,I-PR
bacterial,I-PR
peritonitis,I-PR
.,O

Her,B-TE
platelet,I-TE
count,I-TE
stayed,O
persistently,B-PR
low,I-PR
and,O
we,O
decided,O
that,O
it,O
might,O
be,O
due,O
to,O
Cimetidine,B-TR
.,O

Therefore,O
we,O
switched,O
her,O
Cimetidine,B-TR
to,O
Prilosec,B-TR
.,O

By,O
the,O
2th,O
the,O
patient,O
was,O
feeling,O
very,O
well,O
and,O
desired,O
to,O
transfer,O
or,O
discharge,O
to,O
home,O
.,O

She,O
wanted,O
to,O
be,O
closer,O
to,O
North,O
Dakota,O
.,O

After,O
discussion,O
with,O
her,O
private,O
physician,O
",",O
Dr.,O
Joasscchird,O
",",O
tel.,O
090-249-6079,O
",",O
at,O
Va,O
Sit,O
Namar,O
Healthcare,O
and,O
Dr.,O
Acrookesjo,O
at,O
Do,O
Of,O
Hospital,O
",",O
the,O
patient,O
was,O
judged,O
to,O
be,O
fit,O
for,O
discharge,O
and,O
she,O
was,O
sent,O
home,O
with,O
AH,B-TR
and,O
physical,B-TR
therapy,I-TR
.,O

She,O
was,O
quite,O
able,O
to,O
climb,O
stairs,O
on,O
her,O
own,O
in,O
the,O
hospital,O
.,O

She,O
is,O
to,O
follow,O
up,O
with,O
Dr.,O
Acrookesjo,O
in,O
one,O
week,O
and,O
Dr.,O
Work,O
the,O
gastrointestinal,O
fellow,O
here,O
at,O
PUOMC,O
in,O
2,O
weeks,O
.,O

She,O
may,O
require,O
a,B-TE
repeat,I-TE
upper,I-TE
endoscopy,I-TE
study,I-TE
to,O
see,O
if,O
she,O
needs,O
any,B-TR
rebanding,I-TR
.,O

The,O
patient,O
however,O
complained,O
of,O
a,B-PR
persistent,I-PR
wheeze,I-PR
with,O
beta,B-TR
blocker,I-TR
",",O
therefore,O
it,O
was,O
agreed,O
that,O
we,O
would,O
stop,O
the,B-TR
beta,I-TR
blocker,I-TR
until,O
the,O
patient,O
was,O
followed,O
up,O
as,O
an,O
outpatient,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Zoloft,B-TR
50,O
mg,O
PO,O
QD,O
",",O
Lactulose,B-TR
15,O
g,O
PO,O
BID,O
",",O
Synthroid,B-TR
0.15,O
mg,O
PO,O
QD,O
",",O
Prilosec,B-TR
20,O
mg,O
PO,O
BID,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Good,O
.,O

LENTNY,O
WORK,O
",",O
M.D.,O

TR,O
:,O

zs,O

DD,O
:,O

03/06/97,O

TD,O
:,O

03/10/97,O
2:14,O
P,O

cc,O
:,O

LENTNY,O
MAYLUTYNA,O
WORK,O
",",O
M.D.,O

991070824,O
SC,O

67707063,O

467502,O

9/26/2001,O
12:00:00,O
AM,O

FEVER,B-PR

Signed,O

DIS,O

Admission,O
Date,O
:,O

09/26/2001,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

10/06/2001,O

PRINCIPAL,O
DIAGNOSES,O
:,O

1.,O
NEUTROPENIA,B-PR

2.,O
CELLULITIS,B-PR
.,O

3.,O
FEVER,B-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
60-year-old,O
male,O
with,O
a,O
past,O
medical,O
history,O
notable,O
for,O
coronary,B-PR
artery,I-PR
disease,I-PR
and,O
CABG,B-TR
x2,O
in,O
2001,O
.,O

The,O
patient,O
has,O
felt,O
unwell,B-PR
since,O
7/21,O
after,O
his,B-PR
non-Q,I-PR
wave,I-PR
MI,I-PR
.,O

The,O
patient,O
",",O
at,O
this,O
time,O
",",O
was,O
started,O
on,O
Statin,B-TR
and,O
developed,O
in,O
arthritis,B-PR
approximately,O
one,O
month,O
later,O
with,O
joint,B-PR
pain,I-PR
",",O
myalgia,B-PR
and,O
fatigue,B-PR
.,O

No,O
clear,O
diagnosis,O
was,O
made,O
.,O

The,O
patient,O
was,O
presumed,O
to,O
have,O
a,B-PR
rheumatoid,I-PR
factor,I-PR
negative,I-PR
",",I-PR
rheumatoid,I-PR
arthritis,I-PR
and,O
he,O
was,O
prescribed,O
Naprosyn,B-TR
",",O
prednisone,B-TR
and,O
sulfasalazine,B-TR
.,O

He,O
had,O
a,B-TE
CABG,I-TE
review,I-TE
in,O
2/21,O
.,O

His,B-TR
first,I-TR
CABG,I-TR
was,O
in,O
02/89,O
.,O

Since,O
2/21,O
",",O
he,O
has,O
had,O
increasing,B-PR
weight,I-PR
loss,I-PR
of,O
30-49,O
pounds,O
",",O
night,B-PR
sweats,I-PR
which,O
he,O
attributed,O
to,O
the,B-TR
prednisone,I-TR
and,O
increased,B-PR
fatigue,I-PR
and,O
myalgias,B-PR
.,O

The,O
patient,O
has,O
gradually,O
taken,O
to,O
bed,O
with,O
decreasing,O
activity,O
.,O

In,O
late,O
7/22,O
",",O
sulfasalazine,B-TR
was,O
started,O
at,O
one,O
tab,O
three,O
times,O
a,O
day,O
.,O

The,O
patient,O
subsequently,O
developed,O
diffuse,B-PR
abdominal,I-PR
pain,I-PR
",",O
nausea,B-PR
",",O
vomiting,B-PR
",",O
and,O
decreased,B-PR
p.o.,I-PR
intake,I-PR
.,O

A,B-PR
guaiac,I-PR
positive,I-PR
stool,I-PR
was,O
also,O
noted,O
in,O
the,O
month,O
of,O
July,O
.,O

10,O
days,O
prior,O
to,O
admission,O
",",O
the,O
patient,O
&apos;s,O
primary,O
care,O
physician,O
increased,O
his,B-TR
sulfasalazine,I-TR
dose,I-TR
to,O
two,O
tabs,O
three,O
times,O
a,O
day,O
.,O

The,B-TR
patient,I-TR
&apos;s,I-TR
prednisone,I-TR
was,O
increased,O
to,O
60,O
mg,O
q.d.,O
as,O
the,O
patient,O
was,O
diagnosed,O
with,O
an,B-PR
arthritis,I-PR
flare,I-PR
.,O

The,B-TR
prednisone,I-TR
dose,I-TR
was,O
gradually,O
tapered,O
to,O
20,O
mg,O
q.d.,O

The,O
day,O
before,O
admission,O
",",O
the,O
patient,O
developed,O
a,B-PR
fever,I-PR
to,O
102,O
degrees,O
and,O
increasing,B-PR
abdominal,I-PR
pain,I-PR
.,O

He,O
presented,O
to,O
an,O
outside,O
hops,O
where,O
he,O
was,O
noted,O
to,O
be,O
leukopenic,B-PR
with,O
a,B-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
of,O
0.6,O
",",O
0,O
neutrophils,B-TE
",",O
a,B-TE
hematocrit,I-TE
of,O
32,O
",",O
platelets,B-TE
of,O
326,O
",",O
a,B-TE
MCV,I-TE
of,O
79,O
",",O
and,O
RDW,B-TE
of,O
22,O
.,O

The,O
patient,O
was,O
given,O
IV,B-TR
fluids,I-TR
and,O
treated,O
with,O
imipenem,B-TR
",",O
transferred,O
to,O
Ca,O
Valley,O
Hospital,O
ED,O
",",O
where,O
it,O
was,O
noted,O
that,O
the,O
patient,O
had,O
face,B-PR
and,I-PR
neck,I-PR
swelling,I-PR
",",O
as,O
well,O
as,O
erythema,B-PR
and,O
cervical,B-PR
lymphadenopathy,I-PR
.,O

The,O
patient,O
states,O
that,O
his,B-PR
swelling,I-PR
of,I-PR
his,I-PR
face,I-PR
began,O
two,O
days,O
prior,O
to,O
admission,O
and,O
has,O
doubled,O
since,O
then,O
.,O

In,O
the,O
emergency,O
department,O
",",O
CT,B-TE
of,I-TE
head,I-TE
",",I-TE
neck,I-TE
and,I-TE
abdomen,I-TE
were,O
performed,O
.,O

The,B-TE
CT,I-TE
of,I-TE
the,I-TE
abdomen,I-TE
was,O
without,O
lymphadenopathy,B-PR
",",O
revealed,O
a,B-PR
right,I-PR
renal,I-PR
cyst,I-PR
",",O
otherwise,O
unremarkable,O
.,O

The,B-TE
CT,I-TE
of,I-TE
head,I-TE
and,I-TE
neck,I-TE
was,O
likewise,O
unremarkable,O
showing,O
no,O
evidence,O
of,O
fasciitis,B-PR
or,O
deep,B-PR
tissue,I-PR
thread,I-PR
.,O

No,O
abscesses,B-PR
were,O
noted,O
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

The,O
patient,O
denies,O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
chest,B-PR
pain,I-PR
",",O
orthopnea,B-PR
",",O
no,O
dysuria,B-PR
",",O
hematuria,B-PR
",",O
no,O
visual,B-PR
changes,I-PR
",",O
no,O
rashes,B-PR
",",O
no,O
blurry,B-PR
vision,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Coronary,B-PR
artery,I-PR
disease,I-PR
",",O
status,O
post,O
MI,B-PR
x2,O
",",O
CABG,B-TR
x2,O
in,O
02/89,O
and,O
2/21,O
",",O
history,O
of,O
arthritis,B-PR
",",O
history,O
of,O
bilateral,B-PR
rotator,I-PR
cuff,I-PR
degeneration,I-PR
and,O
tears,B-PR
",",O
history,O
of,O
hypertension,B-PR
",",O
history,O
of,O
hyperlipidemia,B-PR
.,O

MEDICATIONS,O
:,O

Sulfasalazine,B-TR
",",O
prednisone,B-TR
20,O
mg,O
q.d.,O
",",O
Naprosyn,B-TR
500,O
mg,O
t.i.d.,O
",",O
Zestril,B-TR
10,O
mg,O
q.d.,O
",",O
Lopressor,B-TR
50,O
mg,O
b.i.d.,O
and,O
iron,B-TR
supplementation,I-TR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
lives,O
with,O
wife,O
.,O

He,O
is,O
a,O
realtor,O
.,O

The,O
patient,O
has,O
history,O
of,O
heavy,O
cigar,O
smoking,O
",",O
no,O
cigarettes,O
.,O

Social,O
use,O
of,O
alcohol,O
.,O

FAMILY,O
HISTORY,O
:,O

Positive,O
for,O
coronary,B-PR
artery,I-PR
disease,I-PR
and,O
MI,B-PR
.,O

No,O
history,O
of,O
cancer,B-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

VITAL,O
SIGNS,O
:,O

The,B-TE
patient,I-TE
&apos;s,I-TE
temperature,I-TE
was,O
102,O
",",O
heart,B-TE
rate,I-TE
118,O
",",O
blood,B-TE
pressure,I-TE
111/56,O
",",O
respiratory,B-TE
rate,I-TE
28,O
",",O
satting,B-TE
92%,O
on,O
room,O
air,O
.,O

HEENT,O
:,O

Pupils,O
equal,O
",",O
round,O
",",O
and,O
reactive,O
to,O
light,O
",",O
extraocular,O
movements,O
",",O
fundi,O
bilaterally,O
without,O
exudate,B-PR
or,O
hemorrhage,B-PR
.,O

On,O
the,O
left,O
nasolabial,O
",",O
there,O
was,O
a,B-PR
boil,I-PR
with,O
pus,B-PR
and,O
surrounding,B-PR
erythema,I-PR
and,O
tenderness,B-PR
.,O

Left,O
eye,O
with,O
conjunctivae,B-PR
injected,I-PR
",",O
no,O
exudate,B-PR
or,O
pus,B-PR
.,O

Dentition,B-PR
very,I-PR
poor,I-PR
",",O
large,B-PR
bilateral,I-PR
neck,I-PR
and,I-PR
submandibular,I-PR
swelling,I-PR
very,B-PR
tender,I-PR
to,O
palpation,B-TE
.,O

CHEST,O
:,O

Scattered,B-PR
bibasilar,I-PR
rales,I-PR
",",O
no,O
wheezes,B-PR
.,O

CARDIAC,O
:,O

Regular,O
rhythm,O
",",O
tachycardia,B-PR
",",O
no,O
murmurs,B-PR
",",O
no,O
JVD,B-PR
.,O

ABDOMEN,O
:,O

Obese,B-PR
",",O
non-distended,B-PR
",",O
positive,O
bowel,O
sounds,O
",",O
mild,B-PR
diffuse,I-PR
tenderness,I-PR
.,O

EXTREMITIES,O
:,O

No,O
edema,B-PR
",",O
positive,O
dorsalis,O
pedis,O
pulses,O
.,O

NEUROLOGICAL,O
:,O

Non-focal,O
",",O
alert,O
and,O
oriented,O
x3,O
",",O
5/5,O
motor,O
strength,O
in,O
the,O
upper,O
extremities,O
and,O
lower,O
extremities,O
",",O
Babinski,B-TE
reflex,I-TE
",",O
toes,O
are,O
downgoing,O
.,O

LABORATORY,O
DATA,O
:,O

Remarkable,O
for,O
a,B-TE
white,I-TE
cell,I-TE
count,I-TE
of,O
0.4,O
",",O
with,O
0,O
neutrophils,B-TE
",",O
0,O
bands,B-TE
",",O
19,O
lymphs,B-TE
",",O
0,O
monos,B-TE
",",O
hematocrit,B-TE
28.8%,O
",",O
platelets,B-TE
"300,000",O
.,O

ALT,B-TE
141,O
",",O
AST,B-TE
40,O
",",O
alk,B-TE
phos,I-TE
108,O
",",O
and,O
a,B-TE
total,I-TE
bili,I-TE
of,O
1.0.,O
Total,B-TE
protein,I-TE
was,O
5.7,O
",",O
albumin,B-TE
2.5,O
and,O
globulin,B-TE
3.2,O
.,O

His,B-TE
electrolyte,I-TE
panel,I-TE
of,O
sodium,B-TE
135,O
",",O
sodium,B-TE
4.1,O
",",O
chloride,B-TE
99,O
",",O
bicarb,B-TE
30,O
",",O
BUN,B-TE
15,O
",",O
creatinine,B-TE
2.1,O
",",O
blood,B-TE
glucose,I-TE
of,O
196,O
.,O

Iron,B-TE
studies,I-TE
included,O
a,B-TE
ferritin,I-TE
of,O
607,O
",",O
an,B-TE
iron,I-TE
of,O
10,O
",",O
and,O
a,B-TE
TIBC,I-TE
of,O
239,O
.,O

EKG,B-TE
showed,O
tachycardia,B-PR
with,O
a,O
sinus,O
rhythm,O
of,O
103,O
",",O
normal,O
axis,O
",",O
normal,O
intervals,O
",",O
no,O
Q-waves,B-PR
",",O
no,O
ST-T,B-PR
wave,I-PR
changes,I-PR
.,O

The,O
patient,O
had,O
a,O
history,O
from,O
7/12/01,O
of,O
a,O
normal,O
white,O
blood,O
cell,O
count,O
",",O
with,O
a,O
normal,O
absolute,O
neutrophil,O
count,O
.,O

The,B-TE
patient,I-TE
&apos;s,I-TE
chest,I-TE
x-ray,I-TE
at,O
the,O
outside,O
hospital,O
was,O
unremarkable,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
started,O
on,O
ceftazidime,B-TR
",",O
nafcillin,B-TR
and,O
Flagyl,B-TR
for,O
concern,O
of,O
a,B-PR
soft,I-PR
tissue,I-PR
infection,I-PR
.,O

Neutropenic,B-TR
precautions,I-TR
were,O
taken,O
.,O

The,O
patient,O
had,O
a,B-TE
bone,I-TE
marrow,I-TE
biopsy,I-TE
which,O
showed,O
myeloid,B-PR
arrest,I-PR
and,O
probable,O
neutropenia,B-PR
from,O
a,O
drug-related,O
cause,O
presumed,O
to,O
be,O
the,B-TR
sulfasalazine,I-TR
.,O

Over,O
the,O
course,O
of,O
the,O
hospitalization,O
",",O
the,B-TE
patient,I-TE
&apos;s,I-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
rose,O
from,O
0.4,O
to,O
6.3,O
after,O
he,O
was,O
given,O
G-CSF,B-TR
",",O
a,O
course,O
lasting,O
from,O
9/28/01,O
until,O
9/30/01,O
.,O

After,O
the,B-TR
G-CSF,I-TR
",",O
the,B-TE
absolute,I-TE
neutrophil,I-TE
count,I-TE
was,O
greater,O
than,O
8000,O
.,O

On,O
10/3/01,O
",",O
the,O
patient,O
had,O
a,B-TE
repeat,I-TE
head,I-TE
and,I-TE
neck,I-TE
CT,I-TE
",",O
which,O
showed,O
a,B-PR
right,I-PR
parotitis,I-PR
and,O
left,B-PR
submandibular,I-PR
lymphadenopathy,I-PR
with,O
some,B-PR
necrosis,I-PR
.,O

No,O
frank,B-PR
abscesses,I-PR
.,O

The,B-TR
patient,I-TR
&apos;s,I-TR
antibiotics,I-TR
were,O
changed,O
to,O
clindamycin,B-TR
300,O
mg,O
q.i.d.,O
and,O
patient,O
was,O
also,O
put,O
on,O
sialagogue,B-TR
.,O

Over,O
the,O
course,O
of,O
the,O
hospitalization,O
",",O
the,B-PR
swelling,I-PR
and,O
tenderness,B-PR
and,O
erythema,B-PR
have,O
steadily,O
decreased,O
.,O

Recommendations,O
on,O
antibiotics,B-TR
were,O
made,O
by,O
infectious,O
disease,O
team,O
",",O
who,O
was,O
consulted,O
.,O

Rheumatology,O
was,O
also,O
consulted,O
for,O
patient,O
and,O
after,O
workup,B-TE
",",O
it,O
was,O
believed,O
that,O
arthritis,B-PR
may,O
be,O
a,O
rheumatoid,B-PR
factor,I-PR
negative,I-PR
",",I-PR
rheumatoid,I-PR
polyarthritis,I-PR
.,O

Rheumatology,O
recommended,O
a,B-TR
taper,I-TR
of,I-TR
his,I-TR
prednisone,I-TR
to,O
20,O
mg,O
q.d.,O
and,O
the,O
patient,O
will,O
be,O
followed,O
by,O
the,O
rheumatology,O
service,O
.,O

The,O
oncology,O
service,O
was,O
also,O
consulted,O
for,O
patient,O
and,O
performed,O
a,B-TE
bone,I-TE
marrow,I-TE
biopsy,I-TE
.,O

Throughout,O
his,O
course,O
during,O
this,O
hospitalization,O
",",O
the,O
patient,O
was,O
also,O
followed,O
by,O
the,O
ENT,O
service,O
.,O

The,O
ENT,O
physicians,O
did,O
not,O
recommend,O
any,B-TR
procedures,I-TR
",",O
incision,B-TR
and,O
drainage,B-TR
for,O
his,B-PR
right,I-PR
parotitis,I-PR
or,O
left,B-PR
submandibular,I-PR
cervical,I-PR
lymph,I-PR
node,I-PR
necrosis,I-PR
.,O

The,O
ENT,O
team,O
recommended,O
watching,O
patient,O
in-house,O
for,O
two,O
days,O
after,O
his,B-TE
repeat,I-TE
imaging,I-TE
on,O
10/3/01,O
",",O
and,O
to,O
continue,O
antibiotic,B-TR
coverage,I-TR
with,O
clindamycin,B-TR
.,O

The,O
patient,O
had,O
no,O
positive,B-PR
blood,I-PR
cultures,I-PR
during,O
his,O
hospitalization,O
and,O
remained,O
afebrile,B-PR
after,O
the,O
second,O
day,O
of,O
admission,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Topical,B-TR
Bactroban,I-TR
to,O
be,O
applied,O
three,O
times,O
a,O
day,O
to,O
affected,O
naris,O
",",O
prednisone,B-TR
5,O
mg,O
p.o.,O
q.a.m.,O
",",O
K-Dur,B-TR
10,O
mEq,O
x2,O
p.o.,O
q.d.,O
",",O
OxyContin,B-TR
10,O
mg,O
p.o.,O
q.12h.,O
",",O
clindamycin,B-TR
300,O
mg,O
p.o.,O
q.i.d.,O
",",O
lisinopril,B-TR
10,O
mg,O
p.o.,O
q.d.,O
",",O
atenolol,B-TR
25,O
mg,O
p.o.,O
q.d.,O
",",O
trazodone,B-TR
100,O
mg,O
p.o.,O
q.h.s.,O
",",O
Prilosec,B-TR
40,O
mg,O
p.o.,O
q.d,O
",",O
clotrimazole,B-TR
1%,I-TR
cream,I-TR
topical,I-TR
to,O
be,O
applied,O
b.i.d.,O

DISCHARGE,O
FOLLOW-UP,O
:,O

The,O
patient,O
was,O
arranged,O
for,O
follow-up,O
appointment,O
with,O
Dr.,O
Scarvzine,O
of,O
rheumatology,O
on,O
10/11/01,O
.,O

Also,O
",",O
with,O
Dr.,O
Fyfe,O
of,O
ENT,O
scheduled,O
for,O
Halloween,O
.,O

Dr.,O
Twada,O
",",O
his,O
primary,O
care,O
physician,O
at,O
the,O
SBH,O
clinic,O
for,O
10/11/01,O
and,O
Dr.,O
Fyfechird,O
",",O
gastroenterologist,O
",",O
on,O
10/13/01,O
.,O

COMPLICATIONS,O
:,O

There,O
were,O
no,O
complications,B-PR
during,O
the,O
patient,O
&apos;s,O
hospitalization,O
and,O
he,O
was,O
discharged,O
in,O
stable,O
condition,O
.,O

Dictated,O
By,O
:,O

THRYNE,O
ANA,O
",",O
M.D.,O
GN628,O

Attending,O
:,O

DRIS,O
UPHKOTE,O
",",O
M.D.,O
IF67,O
TB150/196806,O

Batch,O
:,O

48373,O

Index,O
No.,O
RYZKWV6XG4,O

D,O
:,O

2010-08-01,O

T,O
:,O

2010-08-01,O

991193550,O

PUOMC,O

1585733,O

16900/0678,O

362005,O

11/30/1995,O
12:00:00,O
AM,O

GASTRIC,B-PR
ULCER,I-PR
AND,O
GASTRIC,B-PR
PERICARDIAL,I-PR
FISTULA,I-PR
",",O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

11-30-95,O

DISCHARGE,O
DATE,O
:,O

12-29-95,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Gastric,B-PR
ulcer,I-PR
and,O
gastric,B-PR
pericardial,I-PR
fistula,I-PR
",",O
constricting,B-PR
pericarditis,I-PR
",",O
adult,B-PR
respiratory,I-PR
distress,I-PR
syndrome,I-PR
",",O
status,O
post,O
gunshot,B-PR
wounds,I-PR
and,O
paraplegia,B-PR
since,O
1991,O
of,O
T4,O
on,O
down,O
.,O

The,O
patient,O
has,O
a,B-TR
Greenfield,I-TR
filter,I-TR
in,O
.,O

He,O
has,O
multiple,B-PR
decubiti,I-PR
on,I-PR
his,I-PR
buttocks,I-PR
and,I-PR
penis,I-PR
.,O

He,O
had,O
a,B-TR
gastric,I-TR
pull,I-TR
up,I-TR
in,O
1992,O
of,O
the,O
stomach,O
into,O
the,O
left,O
thorax,O
and,O
he,O
has,O
a,B-TR
transverse,I-TR
colostomy,I-TR
and,O
a,B-PR
sinus,I-PR
tract,I-PR
on,I-PR
the,I-PR
abdomen,I-PR
.,O

ALLERGIES,O
:,O

Bactrim,B-TR
and,O
Vancomycin,B-TR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Albuterol,B-TR
inhaler,I-TR
.,O

Amphotericin,B-TR
B,I-TR
40,O
mg.,O
qday,O
.,O

Ceftazidime,B-TR
1,O
gram,O
intravenous,O
q,O
8,O
.,O

Ciprofloxacin,B-TR
500,O
mg.,O
po.,O
q12,O
.,O

Cisapride,B-TR
10,O
mg.,O
po.,O
qid,O
.,O

Dakin,B-TR
&apos;s,I-TR
solution,I-TR
1/4,O
strength,O
to,O
ulcer,O
of,O
penis,O
.,O

Benadryl,B-TR
50,O
mg.,O
intravenous,O
tid,O
prn,O
.,O

______________,O
capsule,B-TR
1,O
po.,O
tid,O
.,O

Lasix,B-TR
prn,O
.,O

Nystatin,B-TR
swish,I-TR
and,I-TR
swallow,I-TR
tid,O
.,O

Percocet,B-TR
po.,O
q4,O
to,O
6,O
prn,O
.,O

Trazodone,B-TR
50,O
mg.,O
qhs.,O
multivitamins,B-TR
1,O
po.,O
qd,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
25,O
year,O
old,O
who,O
has,O
a,O
history,O
of,O
a,B-PR
gunshot,I-PR
wound,I-PR
many,O
years,O
ago,O
and,O
has,O
had,O
multiple,B-TR
surgical,I-TR
procedures,I-TR
since,O
then,O
.,O

Most,O
recently,O
he,O
was,O
admitted,O
to,O
an,O
outside,O
hospital,O
with,O
a,B-PR
drug,I-PR
overdose,I-PR
in,O
adult,B-PR
respiratory,I-PR
distress,I-PR
syndrome,I-PR
and,O
ultimately,O
found,O
to,O
have,O
Candidal,B-PR
pericarditis,I-PR
which,O
eventually,O
led,O
to,O
constrictive,B-PR
pericarditis,I-PR
.,O

He,O
had,O
a,B-TR
pericardial,I-TR
window,I-TR
.,O

He,O
had,O
a,B-TE
barium,I-TE
swallow,I-TE
and,O
endoscopy,B-TE
and,O
was,O
said,O
not,O
to,O
have,O
gastric,B-PR
or,I-PR
pericardial,I-PR
ulcer,I-PR
.,O

He,O
had,O
previous,B-TR
substernal,I-TR
gastric,I-TR
bypass,I-TR
because,O
of,O
an,B-PR
interruption,I-PR
of,I-PR
his,I-PR
esophagus,I-PR
at,O
the,O
time,O
of,O
his,B-PR
gunshot,I-PR
wound,I-PR
.,O

He,O
had,O
been,O
noted,O
to,O
have,O
an,B-PR
ulcer,I-PR
and,O
ultimately,O
when,O
he,O
stabilized,O
it,O
was,O
our,O
feeling,O
that,O
he,O
most,O
likely,O
had,O
a,B-PR
gastric,I-PR
pericardial,I-PR
ulcer,I-PR
and,O
he,O
was,O
transferred,O
here,O
for,O
further,B-TR
management,I-TR
.,O

We,O
discussed,O
the,O
risks,O
with,O
his,O
family,O
.,O

It,O
was,O
a,O
very,O
high,O
risk,O
in,O
very,B-PR
poor,I-PR
condition,I-PR
and,O
a,O
cachectic,O
malnourished,O
edematous,O
individuals,O
who,O
have,O
very,B-PR
high,I-PR
venous,I-PR
pressures,I-PR
and,O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

The,O
family,O
understood,O
that,O
this,O
was,O
a,B-TR
life,I-TR
saving,I-TR
procedure,I-TR
and,O
only,O
carried,O
with,O
it,O
approximately,O
50%,O
chance,O
of,O
success,O
.,O

SPECIAL,O
PROCEDURES,O
AND,O
OPERATIONS,O
:,O

esophagoscopy,B-TE
",",O
bronchoscopy,B-TE
",",O
pericardectomy,B-TR
",",O
excision,B-TR
of,O
gastric,B-PR
ulcer,I-PR
",",O
repair,B-TR
of,O
gastric,B-PR
ulcer,I-PR
and,O
pectoralis,B-TR
major,I-TR
myocutaneous,I-TR
flap,I-TR
performed,O
on,O
December,O
4,O
",",O
1995,O
by,O
Dr.,O
Reg,O
Cranka,O
and,O
Dr.,O
Win,O
Shufffyfe,O
.,O

In,O
lieu,O
of,O
a,O
standard,O
discharge,O
summary,O
given,O
this,O
patient,O
&apos;s,O
complicated,O
hospital,O
course,O
and,O
associated,B-PR
illnesses,I-PR
I,O
feel,O
it,O
best,O
to,O
just,O
provide,O
a,O
system,O
summary,O
concerning,O
this,O
patient,O
&apos;s,O
current,O
status,O
.,O

1.,O
Neurologic,O
and,O
Psychologic,O
:,O

The,O
patient,O
is,O
on,O
Nortriptyline,B-TR
for,O
depression,B-PR
.,O

He,O
is,O
a,B-PR
paraplegic,I-PR
from,I-PR
T4,I-PR
down,I-PR
.,O

Otherwise,O
he,O
is,O
awake,O
",",O
alert,O
and,O
appropriate,O
and,O
can,O
respond,O
to,O
questions,O
and,O
can,O
move,O
his,O
upper,O
extremities,O
.,O

The,O
patient,O
however,O
spends,O
most,O
of,O
his,O
time,O
at,O
bedrest,O
due,O
to,O
decubiti,B-PR
ulcer,I-PR
disease,I-PR
.,O

2.,O
Cardiac,O
:,O

The,O
patient,O
had,O
constrictive,B-PR
pericarditis,I-PR
that,O
was,O
relieved,O
by,O
his,B-TR
surgical,I-TR
procedure,I-TR
.,O

He,O
had,O
a,B-TE
cardiac,I-TE
catheterization,I-TE
on,O
December,O
1,O
",",O
1995,O
that,O
showed,O
no,O
complications,B-PR
",",O
elevated,B-PR
right,I-PR
atrial,I-PR
pressure,I-PR
and,O
moderate,B-PR
pulmonary,I-PR
hypertension,I-PR
.,O

The,B-TE
cardiac,I-TE
output,I-TE
was,O
five,O
liters,O
per,O
minute,O
with,O
an,B-TE
index,I-TE
at,O
2.9,O
liters,O
per,O
minute,O
per,O
meter,O
2,O
which,O
is,O
normal,O
.,O

A,O
full,O
copy,O
of,O
the,O
cardiac,O
catheterization,O
report,O
is,O
enclosed,O
with,O
his,O
transfer,O
materials,O
.,O

The,O
patient,O
also,O
underwent,O
cardiac,B-TE
ultrasound,I-TE
on,O
December,O
11,O
",",O
1995,O
that,O
showed,O
abnormal,B-PR
right,I-PR
ventricle,I-PR
wall,I-PR
motion,I-PR
",",O
trace,B-PR
mitral,I-PR
regurgitation,I-PR
",",O
normal,O
left,O
ventricular,O
size,O
and,O
function,O
with,O
an,B-TE
estimated,I-TE
ejection,I-TE
fraction,I-TE
of,O
64%,O
.,O

There,O
is,O
Doppler,B-TE
evidence,O
of,O
tricuspid,B-PR
insufficiency,I-PR
and,O
right,B-PR
atrial,I-PR
dilatation,I-PR
.,O

There,O
is,O
trace,B-PR
pulmonary,I-PR
insufficiency,I-PR
.,O

The,O
right,O
ventricle,O
is,O
dilated,B-PR
and,O
diffusely,B-PR
hypokinetic,I-PR
and,O
there,O
is,O
no,O
evidence,O
of,O
constrictive,B-PR
physiology,I-PR
which,O
was,O
seen,O
on,O
December,O
6,O
",",O
1995,O
.,O

A,O
copy,O
of,O
this,B-TE
ultrasound,I-TE
is,O
also,O
found,O
in,O
his,O
records,O
.,O

The,O
patient,O
is,O
on,O
no,O
specific,B-TR
medications,I-TR
for,O
his,B-PR
cardiac,I-PR
condition,I-PR
.,O

3.,O
Respiratory,O
:,O

the,O
patient,O
is,O
status,O
post,O
thoracotomy,B-TR
and,O
has,O
staples,B-TR
and,O
sutures,B-TR
on,I-TR
his,I-TR
chest,I-TR
.,O

These,O
may,O
be,O
removed,O
when,O
the,B-PR
incisions,I-PR
are,O
noted,O
to,O
be,O
well,O
healed,O
.,O

The,O
patient,O
is,O
approximately,O
three,O
weeks,O
following,O
his,B-TR
procedure,I-TR
and,O
several,O
of,O
these,B-TR
stitches,I-TR
will,O
be,O
removed,O
prior,O
to,O
discharge,O
.,O

The,O
patient,O
is,O
on,O
oxygen,B-TR
by,O
face,B-TR
mask,I-TR
and,O
his,B-TE
saturations,I-TE
have,O
been,O
remaining,O
normal,O
.,O

His,B-TR
medications,I-TR
for,O
his,O
respiratory,O
system,O
are,O
Albuterol,B-TR
nebulizer,I-TR
0.5,O
mg.,O
2.5,O
cc.,O
q4hours,O
.,O

3.,O
GI,O
:,O

The,O
patient,O
has,O
had,O
gastric,B-TR
ulcer,I-TR
repair,I-TR
and,O
also,O
has,O
a,B-TR
colostomy,I-TR
.,O

The,O
patient,O
has,O
a,B-PR
sinus,I-PR
tract,I-PR
that,O
was,O
studied,O
with,O
a,B-TE
fistulogram,I-TE
on,O
December,O
25,O
",",O
1995,O
.,O

This,O
showed,O
no,O
communication,B-PR
with,I-PR
the,I-PR
intestines,I-PR
and,O
was,O
simply,O
a,B-PR
sinus,I-PR
tract,I-PR
.,O

There,O
is,O
no,O
fistula,B-PR
seen,O
.,O

Dr.,O
Asha,O
Vengloan,O
of,O
General,O
Surgery,O
consulted,O
on,O
the,O
patient,O
and,O
concluded,O
the,O
patient,O
does,O
not,O
require,O
any,B-TR
surgical,I-TR
treatment,I-TR
of,O
this,B-PR
problem,I-PR
at,O
the,O
current,O
time,O
and,O
the,B-TR
best,I-TR
treatment,I-TR
for,O
this,O
situation,O
would,O
be,O
to,O
increase,O
the,O
patient,O
&apos;s,O
nutrition,O
.,O

The,O
patient,O
takes,O
poorly,O
his,O
po.,O
diet,O
.,O

However,O
he,O
is,O
able,O
to,O
swallow,O
and,O
tolerate,O
po&apos;s,O
.,O

He,O
just,O
claims,O
to,O
have,O
no,B-PR
appetite,I-PR
and,O
has,O
very,B-PR
poor,I-PR
effort,I-PR
with,O
feeding,O
.,O

The,O
patient,O
is,O
able,O
to,O
tolerate,O
po.,B-TR
medicines,I-TR
.,O

4.,O
GU,O
:,O

The,O
patient,O
has,O
an,B-PR
ulcer,I-PR
on,I-PR
his,I-PR
penis,I-PR
that,O
has,O
been,O
treated,O
with,O
dressing,B-TR
changes,I-TR
.,O

It,O
has,O
been,O
noted,O
to,O
be,O
improving,O
.,O

The,O
patient,O
has,O
a,B-TR
Foley,I-TR
catheter,I-TR
in,O
and,O
when,O
the,O
penile,O
skin,O
is,O
very,O
well,O
healed,O
his,B-TR
Foley,I-TR
catheter,I-TR
may,O
be,O
removed,O
.,O

Until,O
this,O
time,O
he,O
should,O
be,O
kept,O
on,O
three,O
times,O
daily,O
wet,B-TR
to,I-TR
dry,I-TR
dressing,I-TR
changes,I-TR
.,O

5.,O
Skin,O
:,O

The,O
patient,O
has,O
multiple,B-PR
decubiti,I-PR
over,O
his,O
body,O
",",O
in,O
particular,O
his,O
perineum,O
and,O
buttocks,O
have,O
large,B-PR
decubiti,I-PR
.,O

Plastic,O
Surgery,O
was,O
consulted,O
Dr.,O
Ca,O
Shuff,O
who,O
saw,O
the,O
patient,O
and,O
decided,O
that,O
the,O
patient,O
is,O
not,O
a,O
surgical,O
candidate,O
at,O
this,O
point,O
.,O

These,B-PR
wounds,I-PR
should,O
be,O
treated,O
with,O
three,O
times,O
daily,O
wet,B-TR
to,I-TR
dry,I-TR
dressings,I-TR
.,O

The,O
patient,O
&apos;s,O
activity,O
should,O
be,O
limited,O
to,O
being,O
up,O
in,O
a,O
chair,O
only,O
for,O
several,O
minutes,O
per,O
day,O
and,O
sit,O
on,O
a,O
special,O
pad,O
that,O
the,O
family,O
has,O
purchased,O
.,O

6.,O
Infectious,O
Disease,O
:,O

The,B-TE
patient,I-TE
&apos;s,I-TE
white,I-TE
count,I-TE
at,O
the,O
time,O
of,O
discharge,O
is,O
within,O
normal,O
limits,O
.,O

The,O
patient,O
remains,O
on,O
Fluconazole,B-TR
.,O

His,B-TR
other,I-TR
antibiotics,I-TR
were,O
discontinued,O
.,O

His,B-TE
most,I-TE
recent,I-TE
cultures,I-TE
are,O
negative,O
.,O

The,B-TE
chest,I-TE
X-ray,I-TE
shows,O
no,O
evidence,O
of,O
pneumonia,B-PR
.,O

7.,O
Pain,B-PR
.,O

The,O
patient,O
has,O
been,O
very,O
closely,O
with,O
the,O
Pain,O
Service,O
here,O
while,O
admitted,O
.,O

He,O
has,O
been,O
placed,O
on,O
Oxycodone,B-TR
10,O
mg.,O
po.,O
q3hours,O
as,O
needed,O
for,O
pain,B-PR
.,O

The,O
patient,O
had,O
a,B-TR
PCA,I-TR
and,O
several,B-TR
other,I-TR
medications,I-TR
have,O
been,O
discontinued,O
.,O

The,O
patient,O
has,O
strong,O
narcotic,O
seeking,O
behavior,O
.,O

The,O
patient,O
for,O
sleep,O
was,O
given,O
Benadryl,B-TR
25,O
to,O
50,O
mg.,O
qhs.,O
and,O
was,O
not,O
allowed,O
any,O
increases,O
in,O
his,B-TR
narcotics,I-TR
after,O
weaning,O
him,O
down,O
to,O
just,O
requiring,O
the,B-TR
Oxycodone,I-TR
.,O

A,O
complete,O
summary,O
of,O
the,B-TR
patient,I-TR
&apos;s,I-TR
medications,I-TR
are,O
as,O
follows,O
:,O

Cimetidine,B-TR
300,O
mg.,O
intravenous,O
q6hours,O
.,O

Albuterol,B-TR
nebulizer,I-TR
0.5,O
mg.,O
2.5,O
cc.,O
q4hours,O
.,O

Senokot,B-TR
two,O
tablets,O
po.,O
bid,O
or,O
Metamucil,B-TR
one,O
tablespoon,O
po.,O
bid,O
.,O

Nortriptyline,B-TR
25,O
mg.,O
po.,O
qhs,O
.,O

KCL,B-TR
40,O
mEq.,O
po.,O
bid,O
.,O

Saline,B-TR
wet,I-TR
to,I-TR
dry,I-TR
dressing,I-TR
changes,I-TR
three,O
times,O
daily,O
to,O
penis,B-PR
and,I-PR
pelvis,I-PR
decubiti,I-PR
",",O
40%,B-TR
humidified,I-TR
oxygen,I-TR
",",O
Fluconazole,B-TR
200,O
mg.,O
po.,O
bid,O
.,O

Lasix,B-TR
2.5,O
mg.,O
intravenous,O
qid,O
.,O

Prilosec,B-TR
20,O
mg.,O
po.,O
qd,O
.,O

Benadryl,B-TR
25,O
to,O
50,O
mg.,O
po.,O
qhs,O
prn,O
.,O

Oxycodone,B-TR
10,O
mg.,O
po.,O
q3,O
hours,O
prn,O
.,O

Physicians,O
that,O
took,O
care,O
of,O
this,O
patient,O
while,O
at,O
the,O
Ph,O
University,O
Of,O
Medical,O
Center,O
are,O
as,O
follows,O
:,O

Admitting,O
Physician,O
and,O
Thoracic,O
Surgeon,O
:,O

Reg,O
Cranka,O
",",O
M.D.,O

Consulting,O
General,O
Surgeon,O
was,O
Asha,O
Vengloan,O
",",O
M.D.,O

Consulting,O
Urology,O
was,O
Ryna,O
Baker,O
",",O
M.D.,O

Consulting,O
Plastic,O
Surgeon,O
:,O

Ca,O
Shuff,O
",",O
M.D.,O

Consulting,O
Cardiologist,O
:,O

Cealme,O
Maressythe,O
",",O
M.D.,O

Consulting,O
Cardiac,O
Surgeon,O
:,O

Win,O
Shufffyfe,O
",",O
M.D.,O

Infectious,O
Disease,O
Consultant,O
:,O

Dr.,O
Jesc,O
.,O

Psychiatry,O
:,O

Dr.,O
Rencobe,O
and,O
Dr.,O
Saddbeem,O
.,O

Pain,O
Service,O
:,O

Dr.,O
Shuff,O
.,O

In,O
summary,O
this,O
is,O
a,O
25,O
year,O
old,O
male,O
with,O
a,O
very,O
complicated,O
history,O
and,O
a,O
patient,O
of,O
Dr.,O
Breunkays,O
&apos;s,O
.,O

The,O
patient,O
was,O
seen,O
at,O
Ph,O
University,O
Of,O
Medical,O
Center,O
for,O
problem,O
regarding,O
his,B-PR
constrictive,I-PR
pericarditis,I-PR
and,O
underwent,O
a,B-TR
surgical,I-TR
procedure,I-TR
to,O
correct,O
this,O
.,O

Followup,B-TE
cardiac,I-TE
studies,I-TE
showed,O
there,O
was,O
a,O
resolution,O
of,O
his,B-PR
constrictive,I-PR
pericarditis,I-PR
.,O

The,O
patient,O
also,O
had,O
a,B-PR
gastric,I-PR
ulcer,I-PR
repaired,O
at,O
the,O
same,O
time,O
.,O

Other,O
issues,O
of,O
the,O
patient,O
are,O
chronic,O
and,O
most,O
likely,O
will,O
be,O
followed,O
up,O
in,O
hospitals,O
closer,O
to,O
the,O
patient,O
&apos;s,O
home,O
.,O

If,O
there,O
are,O
any,O
questions,O
regarding,O
his,O
care,O
they,O
should,O
be,O
directed,O
to,O
Dr.,O
Cranka,O
&apos;s,O
office,O
at,O
Ph,O
University,O
Of,O
Medical,O
Center,O
and,O
we,O
will,O
be,O
happy,O
to,O
contact,O
any,O
or,O
all,O
of,O
the,O
consultations,O
concerned,O
with,O
Hauth,O
&apos;s,O
care,O
.,O

Hauth,O
is,O
a,O
very,O
complicated,O
patient,O
and,O
it,O
was,O
our,O
pleasure,O
to,O
provide,O
care,O
for,O
him,O
at,O
Ph,O
University,O
Of,O
Medical,O
Center,O
.,O

CA,O
SHUFF,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

REG,O
CRANKA,O
",",O
M.D.,O

TR,O
:,O

fp,O
/,O
bmot,O

DD,O
:,O

12-27-95,O

TD,O
:,O

12/27/95,O

CC,O
:,O

STAT,O
:,O

Goman,O
4,O

Admission,O
Date,O
:,O

2017-06-13,O

Discharge,O
Date,O
:,O

2017-06-17,O

Date,O
of,O
Birth,O
:,O

1956-02-17,O

Sex,O
:,O

M,O

Service,O
:,O

CARDIOTHORACIC,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,O
Drugs,B-TR

Attending:Jordan,O
U,O
Kostohryz,O
",",O
M.D.,O

Chief,O
Complaint:,O
recent,B-PR
mild,I-PR
angina,I-PR
with,O
exertion,O

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

emergency,B-TR
CABG,I-TR
X,O
3,O
(,O
2017-06-13,O
)(,O
LIMA,B-TR
to,I-TR
LAD,I-TR
",",O
SVG,B-TR
to,I-TR
ramus,I-TR
",",O
SVG,B-TR
to,I-TR
OM,I-TR
),O

History,O
of,O
Present,O
Illness,O
:,O

61,O
yo,O
African-American-Hispanic,O
male,O
had,O
abnormal,B-PR
EKG,I-PR
found,O
as,O
part,O
of,O
pre-op,B-TE
eval.,I-TE
for,O
ventral,B-TR
hernia,I-TR
repair,I-TR
.,O

Had,O
subsequent,O
abnormal,B-PR
stress,I-PR
test,I-PR
and,O
pefusion,B-TE
imaging,I-TE
showed,O
EF,B-TE
38%,O
with,O
perfusion,B-PR
defects,I-PR
.,O

Echo,B-TE
prior,O
to,O
scheduled,B-TE
cath,I-TE
showed,O
mild,B-PR
LVH,I-PR
",",O
inferior,B-PR
HK,I-PR
",",O
EF,B-TE
40%,O
",",O
mild,B-PR
MR,I-PR
",",O
mild,B-PR
LAE,I-PR
.,O

Cath,B-TE
at,O
Kindred/North,O
Shore,O
today,O
showed,O
80%,B-PR
LM,I-PR
lesion,I-PR
with,O
normal,O
LAD,O
",",O
CX,O
",",O
RCA,O
.,O

Severe,B-PR
systolic,I-PR
HTN,I-PR
also,O
noted,O
.,O

Transferred,O
in,O
urgently,O
for,O
cabg,B-TR
with,O
Dr.,O
Howard,O
.,O

Past,O
Medical,O
History,O
:,O

ventral,B-PR
hernia,I-PR

HTN,B-PR
elev.,B-PR
chol.,I-PR
right,B-PR
facial,I-PR
droop,I-PR
with,O
metal,B-TR
plate,I-TR
secondary,O
to,O
GSW,B-PR
to,O
face,B-TR
right,I-TR
nephrectomy,I-TR

Social,O
History,O
:,O

current,O
smoker,O

Family,O
History,O
:,O

not,O
given,O

Physical,O
Exam:,O

Not,O
done,O
",",O
taken,O
to,O
OR,O
direct,O
from,O
ambulance,O
transfer,O
.,O

Pertinent,O
Results:,O

2017-06-14,O
02:06AM,O
BLOOD,B-TE

WBC,B-TE
-,O
9.4,O
RBC,B-TE
-,O
3.61*,O
Hgb,B-TE
-,O
10.4*,O
Hct,B-TE
-,O
29.9*,O
MCV,B-TE
-,O
83,O
MCH,B-TE
-,O
28.8,O
MCHC,B-TE
-,O
34.8,O
RDW,B-TE
-,O
14.3,O
Plt,B-TE
Ct,I-TE
-,O
154,O

2017-06-17,O
05:14AM,O
BLOOD,B-TE

Hct,B-TE
-,O
25.2*,O

2017-06-14,O
02:06AM,O
BLOOD,B-TE

Plt,B-TE
Ct,I-TE
-,O
154,O

2017-06-13,O
08:05PM,O
BLOOD,B-TE

PT,B-TE
-,O
13.6*,O
PTT,B-TE
-,O
33.3,O
INR,B-TE
(,O
PT,B-TE
),O
-,O
1.2*,O

2017-06-17,O
05:14AM,O
BLOOD,B-TE

UreaN,B-TE
-,O
25*,O
Creat,B-TE
-,O
1.0,O
K,B-TE
-,O
3.9,O

2017-06-15,O
02:02PM,O
BLOOD,B-TE

Mg,B-TE
-,O
2.1,O

FINAL,O
REPORT,O

TWO,B-TE
VIEW,I-TE
CHEST,I-TE
",",O
2017-06-17,O

COMPARISON,O
:,O

2017-06-14,O
.,O

INDICATION,O
:,O

Status,O
post,O
coronary,B-TR
bypass,I-TR
surgery,I-TR
.,O

There,O
has,O
been,O
removal,O
of,O
a,B-TR
Swan-Ganz,I-TR
catheter,I-TR
and,O
placement,O
of,O
a,B-TR
right,I-TR
internal,I-TR
jugular,I-TR
vascular,I-TR
catheter,I-TR
",",O
with,O
the,O
tip,O
terminating,O
in,O
the,O
proximal,O
right,O
atrium,O
just,O
below,O
the,O
junction,O
with,O
the,O
superior,O
vena,O
cava,O
.,O

Cardiac,O
and,O
mediastinal,O
contours,O
are,O
stable,O
in,O
the,O
postoperative,O
period,O
.,O

Previously,O
reported,O
interstitial,B-PR
edema,I-PR
has,O
resolved,O
.,O

There,O
has,O
been,O
interval,O
improvement,O
in,O
left,B-PR
basilar,I-PR
atelectasis,I-PR
.,O

Right,B-PR
basilar,I-PR
atelectasis,I-PR
has,O
slightly,O
worsened,O
.,O

Bilateral,B-PR
pleural,I-PR
effusions,I-PR
are,O
unchanged,O
.,O

IMPRESSION,O
:,O

1.,O
Vascular,B-TR
catheter,I-TR
tip,I-TR
terminates,O
in,O
proximal,O
right,O
atrium,O
.,O

2.,O
Bibasilar,B-PR
minor,I-PR
atelectasis,I-PR
",",O
worse,O
on,O
the,O
right,O
and,O
improved,O
on,O
the,O
left,O
.,O

Persistent,B-PR
pleural,I-PR
effusions,I-PR
.,O

DR.,O
John,O
S.,O
Beauchamp,O

Approved,O
:,O

SAT,O
2017-06-17,O
8:20,O
PM,O

Procedure,O
Date:2017-06-17,O

PRE-CPB,O
:,O

The,O
left,O
atrium,O
is,O
mildly,B-PR
dilated,I-PR
.,O

No,O
spontaneous,B-PR
echo,I-PR
contrast,I-PR
is,O
seen,O
in,O
the,O
body,O
of,O
the,O
left,O
atrium,O
.,O

No,O
spontaneous,B-PR
echo,I-PR
contrast,I-PR
or,O
thrombus,B-PR
is,O
seen,O
in,O
the,O
body,O
of,O
the,O
left,O
atrium,O
or,O
left,O
atrial,O
appendage,O
.,O

No,O
mass/thrombus,B-PR
is,O
seen,O
in,O
the,O
left,O
atrium,O
or,O
left,O
atrial,O
appendage,O
.,O

No,O
atrial,B-PR
septal,I-PR
defect,I-PR
is,O
seen,O
by,O
2D,B-TE
or,O
color,B-TE
Doppler,I-TE
.,O

There,O
is,O
mild,B-PR
symmetric,I-PR
left,I-PR
ventricular,I-PR
hypertrophy,I-PR
with,O
normal,O
cavity,O
size,O
.,O

There,O
is,O
mild,B-PR
symmetric,I-PR
left,I-PR
ventricular,I-PR
hypertrophy,I-PR
.,O

The,O
left,O
ventricular,O
cavity,O
size,O
is,O
normal,O
.,O

No,O
left,B-PR
ventricular,I-PR
aneurysm,I-PR
is,O
seen,O
.,O

There,O
is,O
mild,B-PR
regional,I-PR
left,I-PR
ventricular,I-PR
systolic,I-PR
dysfunction,I-PR
.,O

Overall,B-TE
left,I-TE
ventricular,I-TE
systolic,I-TE
function,I-TE
is,O
mildly,B-PR
depressed,I-PR
.,O

There,O
is,O
no,O
ventricular,B-PR
septal,I-PR
defect,I-PR
.,O

Resting,B-PR
regional,I-PR
wall,I-PR
motion,I-PR
abnormalities,I-PR
include,O
mild,B-PR
inferior,I-PR
hypokinesis,I-PR
.,O

Right,O
ventricular,O
chamber,O
size,O
and,O
free,O
wall,O
motion,O
are,O
normal,O
.,O

The,O
right,O
ventricular,O
cavity,O
is,O
mildly,B-PR
dilated,I-PR
.,O

There,O
are,O
simple,B-PR
atheroma,I-PR
in,O
the,O
aortic,O
root,O
.,O

There,O
are,O
simple,B-PR
atheroma,I-PR
in,O
the,O
ascending,O
aorta,O
.,O

There,O
are,O
simple,B-PR
atheroma,I-PR
in,O
the,O
aortic,O
arch,O
.,O

There,O
are,O
simple,B-PR
atheroma,I-PR
in,O
the,O
descending,O
thoracic,O
aorta,O
.,O

There,O
are,O
three,O
aortic,O
valve,O
leaflets,O
.,O

The,O
aortic,O
valve,O
leaflets,O
are,O
mildly,B-PR
thickened,I-PR
.,O

No,O
masses,B-PR
or,O
vegetations,B-PR
are,O
seen,O
on,O
the,O
aortic,O
valve,O
.,O

There,O
is,O
no,O
aortic,B-PR
valve,I-PR
stenosis,I-PR
.,O

Trace,B-PR
aortic,I-PR
regurgitation,I-PR
is,O
seen,O
.,O

The,O
mitral,O
valve,O
leaflets,O
are,O
mildly,B-PR
thickened,I-PR
.,O

No,O
mass,B-PR
or,O
vegetation,B-PR
is,O
seen,O
on,O
the,O
mitral,O
valve,O
.,O

Trivial,B-PR
mitral,I-PR
regurgitation,I-PR
is,O
seen,O
.,O

There,O
is,O
no,O
pericardial,B-PR
effusion,I-PR
.,O

POST-CPB,O
:,O

Preserved,O
LV,O
systolic,O
function,O
on,O
phenylephrine,B-TR
.,O

LVEF,B-TE
now,O
50%,O
.,O

Trace,B-PR
MR,I-PR
",",O
AI,B-PR
as,O
described,O
.,O

Normal,O
aortic,O
contours,O
.,O

I,O
certify,O
that,O
I,O
was,O
present,O
for,O
this,B-TR
procedure,I-TR
in,O
compliance,O
with,O
HCFA,O
regulations,O
.,O

Electronically,O
signed,O
by,O
Tracy,O
Kimball,O
",",O
MD,O
",",O
Interpreting,O
physician,O

Brief,O
Hospital,O
Course:,O

Admitted,O
directly,O
to,O
OR,O
from,O
ambulance,O
transfer,O
and,O
underwent,O
cabg,B-TR
x3,O
with,O
Dr.,O
Howard,O
on,O
06-13,O
.,O

Transferred,O
to,O
the,O
CSRU,O
in,O
stable,O
condition,O
on,O
phenylephrine,B-TR
and,O
propofol,B-TR
drips,I-TR
.,O

Extubated,O
early,O
the,O
next,O
morning,O
and,O
chest,B-TR
tubes,I-TR
removed,O
.,O

Gentle,B-TR
diuresis,I-TR
and,O
beta,B-TR
blockade,I-TR
started,O
",",O
and,O
he,O
was,O
transferred,O
to,O
the,O
floor,O
to,O
begin,O
increasing,O
his,O
activity,O
level,O
.,O

Foley,B-TR
removed,O
on,O
POD,O
#2,O
and,O
had,O
scattered,B-PR
rales,I-PR
with,O
temp,B-TE
101.2,O
.,O

Afebrile,B-PR
the,O
next,O
day,O
and,O
pacing,B-TR
wires,I-TR
removed,O
without,O
incident,O
.,O

He,O
made,O
excellent,O
progress,O
and,O
was,O
discharged,O
to,O
home,O
with,O
VNA,O
services,O
on,O
POD,O
#4,O
.,O

He,O
is,O
to,O
follow,O
up,O
with,O
providers,O
as,O
per,O
discharge,O
instructions,O
.,O

Medications,O
on,O
Admission,O
:,O

bisoprolol,B-TR
5,O
mg,O
daily,O
crestor,B-TR
20,O
mg,O
daily,O

HCTZ,B-TR
25,O
mg,O
daily,O
lisinopril,B-TR
40,O
mg,O
daily,O

Discharge,O
Medications:,O

1.,O
Metoprolol,B-TR
Tartrate,I-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

Disp,O
:,O
*60,O
Tablet(,O
s,O
)*,O

Refills,O
:,O
*2*,O

2.,O
Potassium,B-TR
Chloride,I-TR
10,O
mEq,O
Capsule,O
",",O
Sustained,O
Release,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Capsule,O
",",O
Sustained,O
Release,O
PO,O
Q12H,O
(,O
every,O
12,O
hours,O
),O
for,O
7,O
days,O
.,O

Disp,O
:,O
*28,O
Capsule,O
",",O
Sustained,O
Release(,O
s,O
)*,O

Refills,O
:,O
*0*,O

3.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

Disp,O
:,O
*60,O
Capsule(,O
s,O
)*,O

Refills,O
:,O
*2*,O

4.,O
Ranitidine,B-TR
HCl,I-TR
150,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

Disp,O
:,O
*60,O
Tablet(,O
s,O
)*,O

Refills,O
:,O
*2*,O

5.,O
Aspirin,B-TR
81,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

Disp,O
:,O
*30,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
)(,O
s,O
)*,O

Refills,O
:,O
*2*,O

6.,O
Oxycodone-Acetaminophen,B-TR
5-325,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
every,O
4-6,O
hours,O
as,O
needed,O
for,O
pain,B-PR
.,O

Disp,O
:,O
*50,O
Tablet(,O
s,O
)*,O

Refills,O
:,O
*0*,O

7.,O
Rosuvastatin,B-TR
20,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

Disp,O
:,O
*30,O
Tablet(,O
s,O
)*,O

Refills,O
:,O
*2*,O

8.,O
Furosemide,B-TR
20,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
for,O
7,O
days,O
.,O

Disp,O
:,O
*14,O
Tablet(,O
s,O
)*,O

Refills,O
:,O
*0*,O

Discharge,O
Disposition:,O

Home,O
with,O
Service,O

Discharge,O
Diagnosis:,O

CAD,B-PR

HTN,B-PR
ventral,B-PR
hernia,I-PR
right,B-TR
nephrectomy,I-TR
s/p,O
right,B-TR
facial,I-TR
plating,I-TR

Discharge,O
Condition,O
:,O
good,O

Discharge,O
Instructions,O
:,O
may,O
shower,O
",",O
no,O
bathing,O
or,O
swimming,O
for,O
1,O
month,O
no,O
creams,B-TR
",",O
lotions,B-TR
or,O
powders,B-TR
to,O
any,B-PR
incisions,I-PR
no,O
driving,O
for,O
1,O
month,O
no,O
lifting,O
>,O
10,O
#,O
for,O
10,O
weeks,O

A.,O
Instructions,O
:,O
with,O
Dr.,O
Matthew,O
in,O
2-3,O
weeks,O
with,O
Dr.,O
Dellinger,O
in,O
2-3,O
weeks,O
with,O
Dr.,O
les,O
Gokey,O
in,O
4,O
weeks,O

Curtis,O
van,O
den,O
Moreno,O
MD,O
07-506,O

Completed,O
by,O
:,O

Scott,O
Robert,O
NP,O
80-AUM,O
2017-06-29,O
@,O
1121,O

Signed,O
electronically,O
by,O
:,O

DR.,O
Barbara,O
van,O
de,O
Tate,O
on,O
:,O

FRI,O
2017-07-28,O
1:55,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2015-10-05,O

Discharge,O
Date,O
:,O

2015-10-08,O

Date,O
of,O
Birth,O
:,O

1815-10-05,O

Sex,O
:,O

F,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Shellfish,O

Attending,O
:,O

Jacob,O
U.,O
Rolland,O
",",O
M.D.,O

Chief,O
Complaint:,O

Chest,B-PR
pain,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure:,O

None,O

History,O
of,O
Present,O
Illness:,O

The,O
patient,O
is,O
a,O
91,O
yo,O
woman,O
with,O
h/o,O
HTN,B-PR
who,O
came,O
from,O
Bridgewater,O
State,O
Hospital,O
Rehab,O
with,O
substernal,B-PR
chest,I-PR
pain,I-PR
after,O
exercise,O
.,O

Pt,O
had,O
been,O
in,O
her,O
usual,O
state,O
of,O
health,O
and,O
performed,O
here,O
regular,O
exercises,O
.,O

After,O
returning,O
to,O
her,O
room,O
she,O
w,O
noted,O
SSCP,B-PR
without,O
radiation,O
.,O

No,O
nausea,B-PR
",",O
vomiting,B-PR
",",O
diaphoresis,B-PR
.,O

They,O
did,O
an,B-TE
ECG,I-TE
at,O
Bridgewater,O
State,O
Hospital,O
rehab,O
which,O
demonstarted,O
new,B-PR
ST,I-PR
depressions,I-PR
in,I-PR
V1-V4,I-PR
.,O

She,O
received,O
ASA,B-TR
81,O
mg,O
x,O
2,O
and,O
nitro,B-TR
SL,I-TR
x,O
2,O
with,O
partial,O
relief,O
at,O
nursing,O
home,O
.,O

On,O
presentation,O
to,O
Providence,O
Behavioral,O
Health,O
Hospital,O
Amanda,O
",",O
her,B-TE
vitals,I-TE
were,O
HR,B-TE
68,O
",",O
BP,B-TE
142/68,O
",",O
RR,B-TE
28,O
",",O
O2,B-TE
sat,I-TE
100%,O
RA,O
.,O

Exam,B-TE
was,O
notable,O
for,O
RRR,O
with,O
no,O
murmur,B-PR
",",O
bibasilar,B-PR
crackles,I-PR
",",O
guaiac,B-TE
negative,O
.,O

EKG,B-TE
showed,O
sinus,B-PR
brady,I-PR
",",O
with,O
old,B-PR
LAD,I-PR
and,I-PR
new,I-PR
ST,I-PR
depressions,I-PR
in,I-PR
V1-V4,I-PR
.,O

Troponin,B-TE
was,O
0.07,O
.,O

She,O
received,O
ASA,B-TR
",",O
nitro,B-TR
SL,I-TR
then,O
gtt,O
",",O
morphine,B-TR
",",O
metoprolol,B-TR
",",O
and,O
heparin,B-TR
gtt,I-TR
.,O

Cardiology,O
discussed,O
cath,B-TE
however,O
",",O
patient,O
's,O
family,O
turned,O
down,O
.,O

Transferred,O
to,O
CCU,O
for,O
further,B-TR
management,I-TR
and,O
observation,O
.,O

Past,O
Medical,O
History:,O

HTN,B-PR

Hearing,B-PR
difficulty,I-PR

Blindness,B-PR
02-26,O
macular,B-PR
degeneration,I-PR

R,B-PR
ankle,I-PR
fx,I-PR
2002,O

S/p,O
hysterectomy,B-TR

Social,O
History,O
:,O

currently,O
lives,O
at,O
Bridgewater,O
State,O
Hospital,O
Rehab;,O
no,O
tobacco,O
or,O
EtOH,O
use;,O
used,O
to,O
be,O
housewife,O

Family,O
History,O
:,O

n/c,O

Physical,O
Exam:,O

Vitals,O
:,O

T,B-TE
97.8,O
",",O
HR,B-TE
53,O
",",O
BP,B-TE
156/58,O
",",O
RR,B-TE
16,O
",",O
O2,B-TE
sat,I-TE
94%,O
on,O
2.5,O
L,O

Gen,O
:,O

NAD,B-PR
",",O
awake,O
",",O
alert,O
",",O
blind,B-PR
",",O
able,O
to,O
hear,O
loud,O
voices,O
at,O
L,O
ear,O

HEENT,O
:,O

MMM,O
",",O
OP,O
clear,O

Neck,O
:,O

JVP,B-TE
11,O
cm,O

CV,O
:,O

Reg,O
rate,O
",",O
nl,O
S1,O
&,O
S2,O
",",O
no,O
m/r/g,B-PR

Pulm,O
:,O

Crackles,B-PR
at,I-PR
base,I-PR
and,I-PR
mid-lungs,I-PR
bilaterally,I-PR

Abd,O
:,O

Soft,O
",",O
NT,B-PR
",",O
ND,B-PR
",",O
BS,O
present,O
",",O
no,O
masses,B-PR

Ext,O
:,O

Trace,B-PR
ankle,I-PR
edema,I-PR
bilaterally,I-PR

Pertinent,O
Results:,O

LABS,O
on,O
admission:,O

WBC,B-TE
-,O
11.4*,O
RBC,B-TE
-,O
3.61*,O
Hgb,B-TE
-,O
11.4*,O
Hct,B-TE
-,O
32.6*,O
MCV,B-TE
-,O
90,O
MCH,B-TE
-,O
31.7,O

MCHC,B-TE
-,O
35.1*,O
RDW,B-TE
-,O
14.7,O
Plt,B-TE
Ct,I-TE
-,O
281,O

Glucose,B-TE
-,O
124*,O
UreaN,B-TE
-,O
30*,O
Creat,B-TE
-,O
1.3*,O
Na,B-TE
-,O
137,O
K,B-TE
-,O
4.2,O
Cl,B-TE
-,O
102,O
HCO3,B-TE
-,O
27,O

AnGap,B-TE
-,O
12,O

CK,B-TE
(,O
CPK,B-TE
),O
-,O
42,O
cTropnT,B-TE
-,O
0.07*,O

.,O

STUDIES:,O

EKG,B-TE
:,O

sinus,B-PR
brady,I-PR
@,O
48,O
bpm,O
",",O
LAD,O
",",O
LVH,B-PR
",",O
RBBB,B-PR
",",O
Q,B-PR
wave,I-PR
in,I-PR
I,I-PR
",",O
ST,B-PR
depressions,I-PR
in,I-PR
V1-V4,I-PR
",",O
ST,B-PR
elevation,I-PR
in,I-PR
III,I-PR
",",O
aVF,B-PR
",",O
TWI,B-PR
in,I-PR
III,I-PR
",",O
V5,O
.,O

CXR,B-TE
10-07,O
:,O

There,O
is,O
slight,B-PR
worsening,I-PR
of,O
the,B-PR
still,I-PR
mild,I-PR
pulmonary,I-PR
edema,I-PR
.,O

There,O
is,O
no,O
pneumothorax,B-PR
.,O

Small,B-PR
right,I-PR
pleural,I-PR
effusion,I-PR
is,O
stable,O
.,O

Cardiac,O
size,O
is,O
normal,O
.,O

Echo,B-TE
:,O

LVEF,B-TE
>70%,O
",",O
LA,B-TE
6.1,O
cm,O
",",O
no,O
regional,B-PR
wall,I-PR
motion,I-PR
abnormality,I-PR
.,O

Cardiac,B-TE
Enzymes,I-TE

2015-10-05,O
09:00PM,O
BLOOD,B-TE

CK,B-TE
(,O
CPK,B-TE
),O
-,O
1471*,O
CK-MB,B-TE
-,O
207*,O
MB,B-TE
Indx,I-TE
-,O
14.1*,O
cTropnT,B-TE
-,O
6.00*,O

2015-10-06,O
04:47PM,O
BLOOD,B-TE

CK,B-TE
(,O
CPK,B-TE
),O
-,O
1288*,O
CK-MB,B-TE
-,O
158*,O
MB,B-TE
Indx,I-TE
-,O
12.3*,O
cTropnT,B-TE
-,O
6.88*,O

2015-10-07,O
07:30AM,O
BLOOD,B-TE

CK,B-TE
(,O
CPK,B-TE
),O
-,O
627*,O
CK-MB,B-TE
-,O
55*,O
MB,B-TE
Indx,I-TE
-,O
8.8*,O
cTropnT,B-TE
-,O
4.46*,O

.,O

Labs,B-TE
on,O
Discharge,O
2015-10-08,O
08:35AM,O

WBC,B-TE
-,O
13.8*,O
RBC,B-TE
-,O
3.39*,O
Hgb,B-TE
-,O
10.7*,O
Hct,B-TE
-,O
30.2*,O
MCV,B-TE
-,O
89,O
MCH,B-TE
-,O
31.5,O

MCHC,B-TE
-,O
35.3*,O
RDW,B-TE
-,O
14.8,O
Plt,B-TE
Ct,I-TE
-,O
214,O

Glucose,B-TE
-,O
120*,O
UreaN,B-TE
-,O
30*,O
Creat,B-TE
-,O
1.2*,O
Na,B-TE
-,O
134,O
K,B-TE
-,O
4.2,O
Cl,B-TE
-,O
100,O
HCO3,B-TE
-,O
25,O

AnGap,B-TE
-,O
13,O

Calcium,B-TE
-,O
8.7,O
Phos,B-TE
-,O
2.5*,O
Mg,B-TE
-,O
2.1,O

Brief,O
Hospital,O
Course:,O

INITIAL,O
IMPRESSION,O
:,O

90,O
year-old,O
woman,O
with,O
h/o,O
of,O
HTN,B-PR
p/w,O
substernal,B-PR
chest,I-PR
pain,I-PR
shortly,O
after,O
exercise,O
at,O
nursing,O
home,O
",",O
with,O
EKG,B-TE
showing,O
ST,B-PR
depressions,I-PR
in,I-PR
V1-V4,I-PR
and,O
troponin,B-TE
0.07.,O

Likely,O
NSTEMI,B-PR
.,O

.,O

HOSPITAL,O
COURSE,O
BY,O
SYSTEM,O
:,O

.,O

*,O
CV,O
:,O

The,O
patient,O
's,O
family,O
refused,O
coronary,B-TR
artery,I-TR
catheterization,I-TR
.,O

The,O
patient,O
was,O
given,O
ASA,B-TR
",",O
Plavix,B-TR
",",O
heparin,B-TR
drip,I-TR
x,O
24,O
hours,O
",",O
nitro,B-TR
drip,I-TR
",",O
atorvastatin,B-TR
",",O
metoprolol,B-TR
",",O
and,O
lisinopril,B-TR
.,O

Her,B-PR
chest,I-PR
pain,I-PR
was,O
controlled,O
with,O
morphine,B-TR
.,O

Her,B-TE
SBP,I-TE
remained,O
in,O
the,O
160s-170s,O
on,O
hospital,O
day,O
1,O
and,O
she,O
was,O
gently,O
diuresed,O
.,O

On,O
hospital,O
day,O
2,O
she,O
experienced,O
atrial,B-PR
fibrillation,I-PR
with,O
HR,B-TE
in,O
the,O
140s,O
.,O

Her,B-TR
metoprolol,I-TR
dose,I-TR
was,O
increased,O
from,O
25,O
mg,O
PO,O
bid,O
to,O
50,O
mg,O
PO,O
bid,O
then,O
75,O
mg,O
PO,O
tid,O
.,O

Her,B-TE
HR,I-TE
decreased,O
to,O
70s-80s,O
.,O

Her,B-TE
BP,I-TE
remained,O
stable,O
.,O

An,B-TE
ECHO,I-TE
showed,O
that,O
she,O
had,O
preserved,O
EF,O
and,O
no,O
wall,B-PR
motion,I-PR
abnormalities,I-PR
.,O

We,O
decided,O
given,O
her,O
age,O
that,O
she,O
would,O
not,O
be,O
a,O
good,O
candidate,O
for,O
cardioversion,B-TR
for,O
her,B-PR
afib,I-PR
nor,O
would,O
she,O
be,O
a,O
good,O
candidate,O
for,O
coumadin,B-TR
.,O

Therefore,O
we,O
will,O
continue,O
rate,O
control,O
with,O
metoprolol,B-TR
this,O
can,O
be,O
titrated,O
if,O
needed,O
",",O
and,O
aspirin,B-TR
and,O
plavix,B-TR
for,O
anti-coagulation,B-TR
.,O

She,O
should,O
also,O
continue,O
on,O
lipitor,B-TR
and,O
lisinopril,B-TR
.,O

She,O
should,O
have,O
her,B-TE
chem,I-TE
7,I-TE
checked,O
next,O
week,O
given,O
the,O
start,O
of,O
her,B-TR
new,I-TR
meds,I-TR
.,O

Will,O
also,O
need,O
LFT,B-TE
's,I-TE
checked,O
in,O
3-6,O
months,O
.,O

.,O

*,O
Pulmonary,O
:,O

Bilateral,B-PR
crackles,I-PR
at,I-PR
bases,I-PR
and,I-PR
midlungs,I-PR
",",O
elevated,B-PR
JVP,I-PR
",",O
trace,B-PR
bilateral,I-PR
ankle,I-PR
edema,I-PR
",",O
and,O
CXR,B-TE
with,O
diffuse,B-PR
opacities,I-PR
suggest,O
possible,O
pulmonary,B-PR
edema,I-PR
",",O
likely,O
secondary,O
to,O
acute,B-PR
MI,I-PR
.,O

Her,B-TE
O2,I-TE
sat,I-TE
was,O
stable,O
at,O
94-97%,O
on,O
2.5L,O
of,O
supplemental,B-TR
O2,I-TR
.,O

She,O
experienced,O
no,O
respiratory,B-PR
difficulty,I-PR
during,O
the,O
hospital,O
stay,O
.,O

She,O
was,O
diuresed,O
small,O
amount,O
.,O

Her,B-TE
CXR,I-TE
prior,O
to,O
discharge,O
showed,O
mild,B-PR
pulm,I-PR
edema,I-PR
and,O
thus,O
was,O
given,O
40,O
of,O
lasix,B-TR
prior,O
to,O
going,O
to,O
rehab,O
.,O

She,O
can,O
be,O
given,O
prn,O
lasix,B-TR
for,O
weight,B-PR
gain,I-PR
or,O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

.,O

*,O
Leukocytosis-,B-PR
She,O
developed,O
mild,B-PR
elevated,I-PR
WBC,I-PR
.,O

UA,B-TE
had,O
12-14,O

WBC,B-TE
's,I-TE
",",O
few,B-PR
bacteria,I-PR
.,O

She,O
was,O
initially,O
started,O
on,O
Bactrim,B-TR
",",O
but,O
this,O
was,O
stopped,O
as,O
she,O
was,O
afebrile,B-PR
.,O

SHe,O
has,O
a,B-TE
culture,I-TE
pending,O
which,O
needs,O
to,O
be,O
followed,O
up,O
at,O
the,O
nursing,O
home,O
and,O
treated,O
if,O
positive,B-PR
.,O

.,O

*,O
Code,O
:,O

DNR/DNI,O

Medications,O
on,O
Admission,O
:,O

tylenol,B-TR
PRN,O
lisinopril,B-TR
5,O
mg,O
PO,O
qd,O
protonix,B-TR
20,O
mg,O
PO,O
qd,O
artifical,B-TR
tears,I-TR
bid,O
metoprolol,B-TR
25,O
mg,O
PO,O
bid,O

Discharge,O
Medications:,O

1.,O
Senna,B-TR
8.6,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
as,O
needed,O
.,O

2.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
as,O
needed,O
for,O
constipation,B-PR
.,O

3.,O
Aspirin,B-TR
325,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

4.,O
Clopidogrel,B-TR
75,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

5.,O
Atorvastatin,B-TR
80,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

6.,O
Pantoprazole,B-TR
40,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
0.5,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
Q24H,O
(,O
every,O
24,O
hours,O
),O
.,O

7.,O
Polyvinyl,B-TR
Alcohol,I-TR
1.4,O
%,O
Drops,O
Sig,O
:,O
1-2,O
Drops,O
Ophthalmic,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

8.,O
Lisinopril,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

9.,O
Metoprolol,B-TR
Tartrate,I-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
Three,O
(,O
3,O
),O
Tablet,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
.,O

10.,O
Acetaminophen,B-TR
325,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

11.,O
Maalox,B-TR
225-200,O
mg/5,O
mL,O
Suspension,O
Sig,O
:,O
Five,O
(,O
5,O
),O
mL,O
PO,O
every,O
six,O
(,O
6,O
),O
hours,O
as,O
needed,O
for,O
indigestion,B-PR
.,O

12.,O
Lasix,B-TR
40,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
once,O
a,O
day,O
as,O
needed,O
for,O
shortness,B-PR
of,I-PR
breath,I-PR
or,O
wheezing,B-PR
:,O

Can,O
give,O
40,O
lasix,B-TR
PO,O
if,O
having,O
any,O
weight,B-PR
gain,I-PR
or,O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

Discharge,O
Disposition:,O

Extended,O
Care,O

Discharge,O
Diagnosis:,O

NSTEMI,B-PR

Atrial,B-PR
Fibrillation,I-PR

HTN,B-PR

Discharge,O
Condition:,O

Patient,O
without,O
chest,B-PR
pain,I-PR
",",O
heart,B-TE
rate,I-TE
and,O
BP,B-TE
stable,O
.,O

Discharge,O
Instructions:,O

Please,O
take,O
all,B-TR
medications,I-TR
as,O
instructed,O
.,O

She,O
has,O
been,O
started,O
on,O
several,B-TR
new,I-TR
medications,I-TR
which,O
are,O
important,O
to,O
protect,O
her,O
heart,O
.,O

If,O
the,O
patient,O
experiences,O
any,O
chest,B-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
nausea,B-PR
",",O
vomiting,B-PR
",",O
fevers,B-PR
",",O
chills,B-PR
",",O
please,O
return,O
to,O
the,O
emergency,O
room,O
.,O

Followup,O
Instructions:,O

Please,O
call,O
(,O
881-6997,O
to,O
set,O
up,O
follow,O
up,O
cardiology,O
appointment,O
in,O
2-3,O
months,O
.,O

Betty,O
Herbert,O
MD,O
43-075,O

Completed,O
by,O
:,O

Allison,O
Crystal,O
MD,O
52-741,O
2015-10-08,O
@,O
1510,O

Signed,O
electronically,O
by,O
:,O

DR.,O
Dorothy,O
Z.,O
Alderman,O
on,O
:,O

SUN,O
2015-10-11,O
11:49,O
AM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2015-06-05,O

Discharge,O
Date,O
:,O

2015-06-10,O

Date,O
of,O
Birth,O
:,O

2015-06-05,O

Sex,O
:,O

M,O

Service,O
:,O

Neonatology,O

HISTORY,O
:,O

The,O
patient,O
is,O
a,O
"1,770",O
gram,O
male,O
infant,O
born,O
by,O
stat,B-TR
cesarean,I-TR
section,I-TR
for,O
fetal,B-PR
bradycardia,I-PR
at,O
30-6/7,O
weeks,O
gestation,O
to,O
a,O
29-year-old,O
gravida,O
3,O
",",O
para,O
0,O
now,O
1,O
mother,O
.,O

The,O
pregnancy,O
was,O
unremarkable,O
until,O
2015-06-01,O
when,O
the,O
mother,O
presented,O
to,O
Shriner,O
's,O
Hospital,O
for,O
Crippled,O
Children,O
for,O
increased,B-PR
blood,I-PR
pressure,I-PR
and,O
proteinuria,B-PR
.,O

She,O
was,O
transferred,O
to,O
Charles,O
River,O
Hospital,O
and,O
was,O
treated,O
with,O
magnesium,B-TR
sulfate,I-TR
and,O
betamethasone,B-TR
.,O

The,O
morning,O
of,O
admission,O
the,O
mother,O
developed,O
vaginal,B-PR
bleeding,I-PR
and,O
fetal,B-PR
bradycardia,I-PR
was,O
noted,O
.,O

Therefore,O
",",O
a,B-TR
stat,I-TR
cesarean,I-TR
section,I-TR
was,O
performed,O
.,O

The,O
infant,O
emerged,O
limp,B-PR
and,O
without,O
spontaneous,B-PR
respiratory,I-PR
effort,I-PR
.,O

He,O
was,O
given,O
bag,B-TR
mask,I-TR
ventilation,I-TR
with,O
good,O
response,O
.,O

Apgar,B-TE
scores,I-TE
were,O
6,O
at,O
one,O
minute,O
and,O
8,O
at,O
five,O
minutes,O
.,O

PRENATAL,O
SCREENS,O
:,O

O+,O
",",O
hepatitis,B-TE
B,I-TE
surface,I-TE
antigen,I-TE
negative,O
",",O

RPR,B-TE
nonreactive,O
",",O
rubella,B-PR
immune,O
.,O

ADMISSION,O
PHYSICAL,O
EXAMINATION,O
:,O

The,O
birth,O
weight,O
was,O
"1,770",O
grams,O
.,O

The,O
patient,O
was,O
in,O
mild,B-PR
to,I-PR
moderate,I-PR
respiratory,I-PR
distress,I-PR
.,O

He,O
was,O
a,O
nondysmorphic,O
male,O
.,O

Anterior,O
fontanel,O
was,O
soft,O
",",O
open,O
and,O
flat,O
.,O

The,O
ears,O
and,O
eyes,O
were,O
normally,O
placed,O
.,O

The,O
palate,O
was,O
intact,O
.,O

The,O
oropharynx,O
was,O
benign,O
.,O

Neck,O
was,O
supple,O
without,O
masses,B-PR
or,O
defects,B-PR
.,O

The,O
lungs,O
were,O
coarse,B-PR
bilaterally,I-PR
with,O
moderate,B-PR
retractions,I-PR
.,O

The,B-TE
cardiovascular,I-TE
examination,I-TE
revealed,O
S1,B-TE
and,O
S2,B-TE
regular,O
",",O
no,O
murmurs,B-PR
",",O
2+,B-TE
femoral,I-TE
pulses,I-TE
.,O

He,O
was,O
warm,O
and,O
well,O
perfused,O
.,O

The,O
abdomen,O
was,O
benign,O
",",O
flat,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
",",O
no,O
hepatosplenomegaly,B-PR
.,O

He,O
had,O
a,O
normal,O
male,O
phallus,O
and,O
bilaterally,O
descended,O
testes,O
.,O

The,O
anus,O
was,O
patent,O
and,O
normally,O
placed,O
.,O

Hips,O
were,O
stable,O
without,O
clunk,B-PR
.,O

The,O
extremities,O
were,O
normal,O
in,O
appearance,O
.,O

The,O
skin,O
was,O
without,O
lesions,B-PR
.,O

The,B-TE
neurological,I-TE
examination,I-TE
was,O
appropriate,O
for,O
age,O
with,O
normal,O
tone,O
and,O
strength,O
and,O
appropriate,O
reflexes,O
.,O

HOSPITAL,O
COURSE,O
:,O

1.,O
Cardiovascular,O
:,O

The,O
patient,O
remained,O
cardiovascularly,O
stable,O
throughout,O
the,O
admission,O
.,O

He,O
was,O
noted,O
to,O
have,O
some,B-PR
apnea,I-PR
and,O
bradycardic,B-PR
spells,I-PR
of,I-PR
prematurity,I-PR
and,O
was,O
therefore,O
started,O
on,O
caffeine,B-TR
.,O

With,O
the,O
initiation,O
of,O
caffeine,B-TR
therapy,I-TR
the,O
patient,O
has,O
had,O
no,O
more,O
apnea,B-PR
or,O
bradycardic,B-PR
events,I-PR
.,O

2.,O
Respiratory,O
:,O

The,O
patient,O
was,O
initially,O
started,O
on,O
nasal,B-TR
prong,I-TR
CPAP,I-TR
at,O
6,O
and,O
required,O
additional,B-TR
oxygen,I-TR
to,O
35%,O
.,O

However,O
by,O
24,O
hours,O
he,O
transitioned,O
to,O
low-flow,B-TR
nasal,I-TR
cannula,I-TR
and,O
on,O
day,O
of,O
life,O
five,O
transitioned,O
to,O
room,O
air,O
where,O
he,O
currently,O
remains,O
.,O

3.,O
Fluids,O
",",O
electrolytes,O
and,O
nutrition,O
:,O

The,O
patient,O
was,O
initially,O
maintained,O
on,O
intravenous,B-TR
fluids,I-TR
only,O
and,O
when,O
his,B-PR
respiratory,I-PR
distress,I-PR
resolved,O
he,O
was,O
transitioned,O
to,O
enteral,B-TR
feeds,I-TR
.,O

The,O
morning,O
of,O
transfer,O
his,B-TR
IV,I-TR
came,O
out,O
so,O
he,O
has,O
just,O
been,O
advanced,O
to,O
120,O
cc,O
per,O
kg,O
per,O
day,O
of,O
PE-20,B-TR
and,O
his,O
tolerating,O
these,B-TR
PG,I-TR
feedings,I-TR
without,O
difficulty,O
.,O

Last,B-TE
set,I-TE
of,I-TE
electrolytes,I-TE
on,O
06-08,O
",",O
DOL3,O
:,O

Na,B-TE
145,O
",",O
K,B-TE
4.3,O
",",O
Cl,B-TE
110,O
",",O
tCO2,B-TE
25,O
.,O

Discharge,O
Wt,O
1645,O
gms,O
.,O

4.,O
Hematology,O
:,O

His,B-TE
admission,I-TE
complete,I-TE
blood,I-TE
count,I-TE
was,O
notable,O
for,O
a,B-TE
white,I-TE
count,I-TE
of,O
11.8,O
",",O
25,B-TE
polys,I-TE
and,O
no,O
bands,B-PR
.,O

Hematocrit,B-TE
was,O
45,O
",",O
platelet,B-TE
count,I-TE
270,O
.,O

He,O
developed,O
physiologic,B-PR
hyperbilirubinemia,I-PR
(,O
peak,B-TE
bili,I-TE
8.6/0.3,O
on,O
06-08,O
",",O
DOL3,O
),O
for,O
which,O
he,O
was,O
treated,O
with,O
a,B-TR
single,I-TR
phototherapy,I-TR
.,O

His,B-TE
most,I-TE
recent,I-TE
bilirubin,I-TE
was,O
6.6,O
on,O
day,O
of,O
life,O
six,O
",",O
the,O
day,O
of,O
discharge,O
",",O
and,O
his,B-TR
phototherapy,I-TR
was,O
discontinued.,O
He,O
will,O
need,O
a,B-TE
rebound,I-TE
bilirubin,I-TE
level,I-TE
in,O
am,O
.,O

5.,O
Infectious,O
disease,O
:,O

Blood,B-TE
culture,I-TE
was,O
sent,O
but,O
he,O
was,O
never,O
started,O
on,O
antibiotics,B-TR
.,O

The,B-TE
blood,I-TE
culture,I-TE
remained,O
sterile,O
.,O

He,O
was,O
noted,O
to,O
have,O
an,B-PR
erythematous,I-PR
perianal,I-PR
rash,I-PR
and,O
for,O
this,O
was,O
started,O
on,O
Nystatin,B-TR
powder,I-TR
.,O

The,O
parents,O
were,O
updated,O
throughout,O
the,O
admission,O
and,O
a,O
family,O
meeting,O
was,O
held,O
on,O
2015-06-09,O
.,O

6.,O
Sensory,O
:,O

The,O
patient,O
has,O
not,O
had,O
an,O
CMED,B-TE
examination,I-TE
or,O
hearing,B-TE
test,I-TE
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Good,O
.,O

DISPOSITION,O
:,O

To,O
Kindred,O
Hospital,O
Special,O
Care,O
Nursery,O
.,O

NAME,O
OF,O
PEDIATRICIAN,O
:,O

Hale,O
Air,O
Force,O
Base,O
Pediatrics,O
.,O

CARE,O
AND,O
RECOMMENDATIONS,O
:,O

Feeds,B-TR
at,O
discharge,O
are,O
PE-20,B-TR
currently,O
at,O
120,O
cc,O
per,O
kg,O
per,O
day,O
due,O
to,O
advance,O
15,O
cc,O
per,O
kg,O
per,O
day,O
to,O
a,O
total,O
of,O
150,O
cc,O
per,O
kg,O
per,O
day,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Caffeine,B-TR
12,O
mg,O
pg,O
q,O
day.,O
He,O
has,O
not,O
had,O
his,O
06-10,O
dose,O
.,O

STATE,O
NEWBORN,O
SCREENING,O
STATUS,O
:,O

He,O
is,O
due,O
to,O
have,O
his,B-TE
state,I-TE
screen,I-TE
sent,O
today,O
.,O

IMMUNIZATIONS,O
:,O

Not,O
yet,O
received,O
.,O

Synagis,B-TR
RSV,I-TR
prophylaxis,I-TR
should,O
be,O
considered,O
from,O
October,O
through,O
April,O
for,O
infants,O
who,O
meet,O
any,O
of,O
the,O
following,O
criteria,O
:,O

1.,O
Born,O
at,O
less,O
than,O
32,O
weeks,O
.,O

2.,O
Born,O
at,O
32-35,O
weeks,O
with,O
plans,O
for,O
day,O
care,O
during,O
RSV,O
season,O
with,O
a,O
smoker,O
in,O
the,O
household,O
",",O
or,O
with,O
preschool,O
age,O
siblings,O
.,O

3.,O
With,O
chronic,B-PR
lung,I-PR
disease,I-PR
.,O

Influenza,B-TR
vaccination,I-TR
should,O
be,O
considered,O
annually,O
in,O
the,O
fall,O
for,O
preterm,O
infants,O
with,O
chronic,B-PR
lung,I-PR
disease,I-PR
once,O
they,O
reach,O
six,O
months,O
of,O
age,O
.,O

Before,O
this,O
age,O
",",O
the,O
family,O
and,O
other,O
caregivers,O
should,O
be,O
considered,O
for,O
immunization,B-TR
against,O
influenza,B-PR
to,O
protect,O
the,O
infant,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Prematurity,B-PR
at,O
30-6/7,O
weeks,O
.,O

2.,O
Rule,O
out,O
sepsis,B-PR
",",O
off,O
antibiotics,B-TR
.,O

3.,O
Apnea,B-PR
and,O
bradycardia,B-PR
of,O
prematurity,B-PR
.,O

4.,O
Hyperbilirubinemia,B-PR
.,O

5.,O
Feeding,B-PR
immaturity,I-PR
.,O

Freddy,O
Stephen,O
",",O
M.D.,O

55-454,O

Dictated,O
By:Nathan,O
D.,O
Delgadillo,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O

2015-06-10,O

9:35,O

T,O
:,O

2015-06-10,O

9:51,O

JOB#,O
:,O

53951,O

Signed,O
electronically,O
by,O
:,O

DR.,O
Freddy,O
King,O
on,O
:,O

WED,O
2015-06-10,O
11:54,O
AM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2018-03-04,O

Discharge,O
Date,O
:,O

2018-03-09,O

Date,O
of,O
Birth,O
:,O

1957-08-17,O

Sex,O
:,O

M,O

Service,O
:,O

UROLOGY,O

Allergies,O
:,O

Sulfonamides,B-TR
/,O
Penicillins,B-TR
/,O
Tetracyclines,B-TR
/,O
Azithromycin,B-TR
/,O
Iodine,B-TR
/,O
Shellfish,O
/,O
Ace,B-TR
Inhibitors,I-TR
/,O
Ciprofloxacin,B-TR

Attending,O
:,O

Donald,O
E.,O
Jacquet,O
",",O
M.D.,O

Chief,O
Complaint:,O

Chronic,B-PR
prostatitis,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure:,O

TURP,B-TR

History,O
of,O
Present,O
Illness:,O

Justin,O
Searle,O
a,O
60-year-old,O
man,O
with,O
a,O
long,O
history,O
of,O
chronic,B-PR
prostatitis,I-PR
status,O
post,O
two,B-TR
transurethral,I-TR
resection,I-TR
of,I-TR
the,I-TR
prostate,I-TR
procedures,O
in,O
2007,O
and,O
1998,O
.,O

He,O
also,O
has,O
a,O
diagnosis,O
of,O
interstitial,B-PR
cystitis,I-PR
and,O
more,O
significantly,O
has,O
a,O
history,O
of,O
coronary,B-PR
artery,I-PR
disease,I-PR
with,O
a,B-TE
recent,I-TE
catheterization,I-TE
",",O
supraventricular,B-PR
tachycardia,I-PR
",",O
and,O
a,B-PR
progressive,I-PR
mitochondrial,I-PR
myopathy,I-PR
.,O

He,O
has,O
had,O
symptoms,B-PR
of,O
dribbling,B-PR
",",O
stress,B-PR
incontinence,I-PR
",",O
hematuria,B-PR
",",O
but,O
has,O
no,O
dysuria,B-PR
.,O

He,O
was,O
preadmitted,O
for,O
cardiac,O
clearance,O
by,O
Dr.,O
Lair,O
",",O
his,O
cardiologist,O
.,O

Past,O
Medical,O
History:,O

1.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
(,O
s/p,O
stents,B-TR
to,I-TR
LAD,I-TR
and,I-TR
3rd,I-TR
OM,I-TR
),O

2.,O
Supraventricular,B-PR
tachycardia,I-PR
(,O
on,O
a,B-TR
beta,I-TR
blocker,I-TR
),O
.,O

3.,O
Mitochondrial,B-PR
myopathy,I-PR
.,O

4.,O
History,O
of,O
orthostasis,B-PR
with,O
tilt,B-TE
table,I-TE
testing,I-TE
done,O
in,O
the,O
past,O
.,O

5.,O
Status,O
post,O
transurethral,B-TR
resection,I-TR
of,I-TR
prostate,I-TR
times,O
two,O
(,O
in,O
2007,O
and,O
1998,O
),O
.,O

6.,O
Interstitial,B-PR
cystitis,I-PR
.,O

7.,O
Pericarditis,B-PR
.,O

8.,O
Hypertension,B-PR
.,O

9.,O
Hypercholesterolemia,B-PR
.,O

10.,O
Gastrointestinal,B-PR
bleed,I-PR

Social,O
History,O
:,O

denies,O
any,O
tobacco.,O
Divorced,O
",",O
lives,O
in,O
Wisconsin,O

Family,O
History,O
:,O

Father,O
had,O
MI,B-PR
at,O
42,O

Mother,O
died,O
of,O
MI,B-PR
at,O
76,O

Physical,O
Exam,O
:,O

Gen,O
:,O

NAD,B-PR

HEENT,O
:,O

MMM,O

CV,O
:,O

RRR,O
",",O
no,O
m/r/g,B-PR

Lungs,O
:,O

CTAB,O

Abd,O
:,O
soft,O
",",O
+distension,B-PR
with,O
tympany,B-PR
",",O
no,O
HSM,B-PR
",",O
hyperactive,B-PR
BS,I-PR

Ext,O
:,O
no,O
c/c/e,B-PR

Neuro,O
:,O

A&O,O
x3,O
.,O

ECG,B-TE
:,O

NSR,B-TE
at,O
62,O
",",O
nl,O
axis,O
",",O
nl,O
intervals,O
",",O
Q,B-PR
waves,I-PR
in,I-PR
III,I-PR
",",O
avR,B-TE
",",I-TE
V1,B-TE
.,O

TWI,B-PR
's,O
in,O
III,O
",",O
V1,O
.,O

Pertinent,O
Results:,O

2018-03-04,O
01:02PM,O

GLUCOSE,B-TE
-,O
94,O
UREA,B-TE
N,I-TE
-,O
22*,O
CREAT,B-TE
-,O
1.4*,O
SODIUM,B-TE
-,O
142,O

POTASSIUM,B-TE
-,O
5.9*,O
CHLORIDE,B-TE
-,O
108,O
TOTAL,B-TE
CO2,I-TE
-,O
23,O
ANION,B-TE
GAP,I-TE
-,O
17,O

2018-03-04,O
01:02PM,O

CALCIUM,B-TE
-,O
9.7,O
PHOSPHATE,B-TE
-,O
3.9,O
MAGNESIUM,B-TE
-,O
1.9,O

2018-03-04,O
01:02PM,O

WBC,B-TE
-,O
7.5,O
RBC,B-TE
-,O
5.09,O
HGB,B-TE
-,O
15.4,O
HCT,B-TE
-,O
43.7,O
MCV,B-TE
-,O
86,O

MCH,B-TE
-,O
30.2,O
MCHC,B-TE
-,O
35.2*,O
RDW,B-TE
-,O
13.6,O

2018-03-04,O
01:02PM,O

PLT,B-TE
COUNT,I-TE
-,O
257#,O

2018-03-04,O
01:02PM,O

PT,B-TE
-,O
12.2,O
PTT,B-TE
-,O
23.8,O
INR,B-TE
(,I-TE
PT,I-TE
),I-TE
-,O
0.9,O

Brief,O
Hospital,O
Course:,O

On,O
HD2,O
",",O
cardiac,B-TE
clearance,I-TE
was,O
obtained,O
by,O
Dr.,O
Sanchez,O
.,O

Patient,O
tolerated,O
procedure,B-TR
on,O
2018-03-05,O
and,O
was,O
transferred,O
to,O

ICU,O
for,O
24hr,O
post-op,O
cardiac,B-TE
monitoring,I-TE
.,O

Stay,O
was,O
uneventful,O
.,O

On,O
POD1,O
",",O
patient,O
was,O
transferred,O
out,O
of,O
FICU,O
to,O
12R,O
.,O

Catheter,B-TR
was,O
removed,O
.,O

He,O
was,O
started,O
on,O
Pyridium,B-TR
.,O

On,O
POD2,O
",",O
patient,O
was,O
deemed,O
suitable,O
and,O
stable,O
for,O
discharge,O
.,O

On,O
POD4,O
",",O
patient,O
was,O
discharged,O
.,O

Discharge,O
Medications,O
:,O

1.,O
Hydroxyzine,B-TR
HCl,I-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

2.,O
Atorvastatin,B-TR
Calcium,I-TR
20,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

3.,O
Ezetimibe,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

4.,O
Simethicone,B-TR
80,O
mg,O
Tablet,O
",",O
Chewable,O
Sig,O
:,O
0.5-1,O
Tablet,O
",",O
Chewable,O
PO,O
QID,O
(,O
4,O
times,O
a,O
day,O
),O
as,O
needed,O
for,O
indigestion/gas,B-PR
pain,I-PR
.,O

5.,O
Aluminum-Magnesium,B-TR
Hydroxide,I-TR
225-200,O
mg/5,O
mL,O
Suspension,O
Sig,O
:,O
15-30,O
MLs,O
PO,O
QID,O
(,O
4,O
times,O
a,O
day,O
),O
as,O
needed,O
for,O
indigestion,B-PR
.,O

6.,O
Atenolol,B-TR
100,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

7.,O
Hyoscyamine,B-TR
Sulfate,I-TR
0.125,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
QID,O
(,O
4,O
times,O
a,O
day,O
),O
.,O

8.,O
Phenazopyridine,B-TR
HCl,I-TR
100,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
for,O
3,O
days,O
.,O

Discharge,O
Disposition,O
:,O

Home,O

Discharge,O
Diagnosis,O
:,O

Chronic,B-PR
prostatitis,I-PR

Interstitial,B-PR
cystitis,I-PR

Discharge,O
Condition,O
:,O

Good,O

Discharge,O
Instructions,O
:,O

Go,O
to,O
an,O
Emergency,O
Room,O
if,O
you,O
experience,O
symptoms,B-PR
including,O
",",O
but,O
not,O
necessarily,O
limited,O
to,O
:,O
new,B-PR
and,I-PR
continuing,I-PR
nausea,I-PR
",",O
vomiting,B-PR
",",O
fevers,B-PR
(,O
>101.5,O
F,O
),O
",",O
chills,B-PR
",",O
or,O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

Proceed,O
to,O
the,O
ER/EW/Monica,O
if,O
your,B-PR
wound,I-PR
becomes,O
red,B-PR
",",O
swollen,B-PR
",",O
warm,B-PR
",",O
or,O
produces,O
pus,B-PR
.,O

You,O
may,O
remove,O
your,B-TR
dressings,I-TR
2,O
days,O
after,O
your,B-TR
surgery,I-TR
if,O
they,O
were,O
not,O
removed,O
in,O
the,O
hospital,O
.,O

Leave,O
the,B-TR
steri,I-TR
strips,I-TR
on,O
until,O
they,O
begin,O
to,O
peel,O
",",O
then,O
you,O
may,O
remove,O
them.,O
Staples,B-TR
and,O
stitches,B-TR
will,O
remain,O
until,O
your,O
follow-up,O
appointment,O
.,O

If,O
you,O
experience,O
clear,B-PR
drainage,I-PR
from,O
your,B-PR
wounds,I-PR
",",O
cover,O
them,O
with,O
a,B-TR
clean,I-TR
dressing,I-TR
and,O
stop,O
showering,O
until,O
the,B-PR
drainage,I-PR
subsides,O
for,O
at,O
least,O
2,O
days,O
.,O

No,O
heavy,O
lifting,O
or,O
exertion,O
for,O
at,O
least,O
6,O
weeks,O
.,O

No,O
driving,O
while,O
taking,O
pain,B-TR
medications,I-TR
.,O

Narcotics,B-TR
can,O
cause,O
constipation,B-PR
.,O

Please,O
take,O
an,B-TR
over,I-TR
the,I-TR
counter,I-TR
stool,I-TR
softener,I-TR
such,O
as,O
Colace,B-TR
or,O
a,B-TR
gentle,I-TR
laxative,I-TR
such,O
as,O
Milk,B-TR
of,I-TR
Magnesia,I-TR
if,O
you,O
experience,O
constipation,B-PR
.,O

You,O
may,O
resume,O
your,O
regular,O
diet,O
as,O
tolerated,O
.,O

You,O
may,O
take,O
showers,O
(,O
no,O
baths,O
),O
after,O
your,B-TR
dressings,I-TR
have,O
been,O
removed,O
from,O
your,B-PR
wounds,I-PR
.,O

Continue,O
taking,O
your,B-TR
home,I-TR
medications,I-TR
unless,O
otherwise,O
contraindicated,O
and,O
follow,O
up,O
with,O
PCP,O
.,O

Followup,O
Instructions,O
:,O

F/U,O
with,O
Rau,O
.,O

Call,O
for,O
appointment,O

F/U,O
with,O
Dr.,O
Ross,O
in,O
2-3,O
weeks,O
.,O

Michael,O
Morgan,O
MD,O
43-508,O

Completed,O
by,O
:,O

Justin,O
RAO,O
MD,O
71-039,O
2018-03-09,O
@,O
0842,O

Signed,O
electronically,O
by,O
:,O

DR.,O
Freddy,O
Darr,O
on,O
:,O

FRI,O
2018-03-23,O
9:45,O
AM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2016-11-21,O

Discharge,O
Date,O
:,O

2016-11-30,O

Date,O
of,O
Birth,O
:,O

1953-10-19,O

Sex,O
:,O

M,O

Service,O
:,O

CMED,O
CCU,O

CHIEF,O
COMPLAINT,O
AND,O
HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Mr.,O
Jackson,O
is,O
a,O
63-year-old,O
male,O
with,O
squamous,B-PR
cell,I-PR
carcinoma,I-PR
of,O
the,O
floor,O
of,O
mouth,O
(,O
stage,B-PR
T2,I-PR
N0,I-PR
),O
that,O
was,O
biopsied,O
by,O
his,O
dentist,O
.,O

Pathology,B-TE
was,O
reviewed,O
revealing,O
invasive,B-PR
squamous,I-PR
cell,I-PR
carcinoma,I-PR
.,O

He,O
presented,O
on,O
2016-11-21,O
for,O
resection,B-TR
.,O

He,O
was,O
admitted,O
on,O
2016-11-21,O
following,O
his,B-TR
surgery,I-TR
.,O

He,O
underwent,O
a,B-TR
joint,I-TR
procedure,I-TR
by,O
Otolaryngology,O
and,O
Plastic,O
Surgery,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Includes,O
hypertension,B-PR
and,O
chronic,B-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

Polypectomy,B-TR
in,O
2011,O
",",O
tooth,B-TR
extraction,I-TR
(,O
all,O
),O
in,O
1980,O
",",O
and,O
hernia,B-PR
in,O
1977,O
.,O

ALLERGIES,O
:,O

TOMATO,O
(,O
causing,O
anaphylaxis,B-PR
),O
and,O
TETANUS,B-TR
SHOT,I-TR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Triamterene/hydrochlorothiazide,B-TR
37.5/25,O
mg,O
one,O
tablet,O
by,O
mouth,O
once,O
daily,O
and,O
lorazepam,B-TR
1,O
mg,O
three,O
times,O
daily,O
as,O
needed,O
(,O
for,O
anxiety,B-PR
),O
.,O

SOCIAL,O
HISTORY,O
:,O

He,O
has,O
a,O
half-pack,O
per,O
day,O
smoking,O
history,O
and,O
drinks,O
approximately,O
three,O
to,O
four,O
alcoholic,O
beverages,O
per,O
day,O
.,O

PROCEDURES,O
PERFORMED:,O

1.,O
Tracheostomy,B-TR
.,O

2.,O
Diagnostic,B-TE
laryngoscopy,I-TE
and,O
biopsy,B-TE
.,O

3.,O
Bilateral,B-TR
supraomohyoid,I-TR
neck,I-TR
dissection,I-TR
.,O

4.,O
Resection,B-TR
of,O
floor,O
of,O
mouth,B-PR
tumor,I-PR
.,O

SUMMARY,O
OF,O
HOSPITAL,O
COURSE,O
:,O

Surgeon,O
was,O
Dr.,O
Kelsey,O
K,O
Sanchez,O
.,O

Assistant,O
was,O
Dr.,O
Justin,O
K..,O
Velez,O
.,O

Frozen,B-TE
section,I-TE
sent,O
to,O
pathology,O
revealing,O
invasive,B-PR
squamous,I-PR
cell,I-PR
carcinoma,I-PR
.,O

No,O
complications,B-PR
.,O

The,O
Plastic,O
Team,O
then,O
took,O
over,O
for,O
reconstruction,B-TR
consisting,O
of,O
radial,B-TR
forearm,I-TR
free,I-TR
flap,I-TR
to,O
floor,O
of,O
mouth,O
.,O

Surgeon,O
was,O
Dr.,O
Jude.,O
Christopher,O
Swinney,O
.,O

Total,B-TR
intravenous,I-TR
fluids,I-TR
of,O
7300,O
cc,O
.,O

Estimated,B-PR
blood,I-PR
loss,I-PR
of,O
300,O
cc,O
.,O

Urine,B-TE
output,I-TE
of,O
900,O
cc,O
.,O

No,O
complications,B-PR
.,O

In,O
addition,O
",",O
the,O
patient,O
was,O
prepared,O
for,O
an,B-TR
attempted,I-TR
percutaneous,I-TR
endoscopic,I-TR
gastrostomy,I-TR
tube,I-TR
.,O

The,B-TR
percutaneous,I-TR
endoscopic,I-TR
gastrostomy,I-TR
was,O
unsuccessful,O
",",O
and,O
the,B-TR
procedure,I-TR
was,O
converted,O
to,O
an,B-TR
open,I-TR
gastrostomy,I-TR
tube,I-TR
which,O
then,O
proceeded,O
without,O
complications,B-PR
.,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
Surgical,O
Intensive,O
Care,O
Unit,O
postoperatively,O
.,O

He,O
was,O
sedated,O
and,O
ventilated,O
by,O
his,B-TR
tracheostomy,I-TR
6,I-TR
cuff,I-TR
Shiley,I-TR
tube,I-TR
.,O

He,O
had,O
three,O
Westwood-Pocasset,B-TR
drains,I-TR
-,O
two,O
in,O
the,O
neck,O
and,O
one,O
in,O
his,O
right,O
arm,O
.,O

G-tube,B-TR
was,O
to,O
gravity,O
",",O
Foley,B-TR
to,O
gravity,O
",",O
left,B-TR
radial,I-TR
A-line,I-TR
.,O

The,B-TR
flap,I-TR
was,O
pink,O
with,O
a,B-TE
strong,I-TE
Doppler,I-TE
signal,I-TE
.,O

He,O
underwent,O
flap,B-TE
checks,I-TE
every,O
15,O
minutes,O
initially,O
with,O
a,B-TR
dextran,I-TR
infusion,I-TR
.,O

He,O
was,O
placed,O
on,O
Unasyn,B-TR
3,O
grams,O
IV,B-TR
q.6h.,O

Nothing,O
by,O
mouth,O
initially,O
with,O
morphine,B-TR
as,O
needed,O
for,O
pain,B-PR
and,O
Ativan,B-TR
around,O
the,O
clock,O
for,O
delirium,B-TR
tremens,I-TR
prophylaxis,I-TR
.,O

In,O
addition,O
",",O
he,O
received,O
metoprolol,B-TR
q.4.h.,O
",",O
a,B-TR
regular,I-TR
insulin,I-TR
sliding,I-TR
scale,I-TR
",",O
and,O
adequate,O
gastrointestinal,O
prophylaxis,O
with,O
Protonix,B-TR
.,O

Postoperative,B-TE
laboratories,I-TE
revealed,O
sodium,B-TE
was,O
134,O
",",O
potassium,B-TE
was,O
4.1,O
",",O
chloride,B-TE
was,O
102,O
",",O
bicarbonate,B-TE
was,O
28,O
",",O
blood,B-TE
urea,I-TE
nitrogen,I-TE
was,O
18,O
",",O
creatinine,B-TE
was,O
0.8,O
",",O
and,O
glucose,B-TE
was,O
148,O
.,O

Calcium,B-TE
was,O
7.6,O
.,O

Magnesium,B-TE
was,O
2.2,O
.,O

Complete,B-TE
blood,I-TE
count,I-TE
revealed,O
white,B-TE
count,I-TE
was,O
5.4,O
",",O
hematocrit,B-TE
was,O
31.3,O
",",O
and,O
platelets,B-TE
were,O
160,O
.,O

ALT,B-TE
was,O
14,O
",",O
AST,B-TE
was,O
31,O
",",O
alkaline,B-TE
phosphatase,I-TE
was,O
42,O
",",O
total,B-TE
bilirubin,I-TE
was,O
0.9,O
",",O
albumin,B-TE
was,O
2.2,O
.,O

A,B-TE
chest,I-TE
x-ray,I-TE
postoperatively,O
showed,O
clear,O
lung,O
fields,O
.,O

Tracheostomy,B-TR
tube,I-TR
in,O
good,O
position,O
.,O

No,O
pneumothorax,B-PR
.,O

By,O
systems,O
:,O

CMED,O
CSRU,O
and,O
Plastic,O
Surgery,O
flap,B-TE
checks,I-TE
",",O
tracheostomy,B-TR
care,I-TR
",",O
and,O
Westwood-Pocasset,B-TR
management.,I-TR

Cardiovascular,O
:,O

Lopressor,B-TR
5,O
intravenously,O
q.4.h.,O

Respiratory,O
:,O

Nebulizers,B-TR
as,O
needed,O
",",O
weaning,O
from,O
ventilation,B-TR
.,O

Gastrointestinal,O
:,O

Medications,B-TR
per,O
gastrostomy,B-TR
tube,I-TR
on,O
postoperative,O
day,O
one,O
.,O

Genitourinary,O
:,O

Foley,B-TR
catheter,I-TR
for,O
strict,B-TE
monitoring,I-TE
of,I-TE
ins,I-TE
and,I-TE
outs,I-TE
.,O

Hematologic,O
:,O

Hematocrit,B-TE
stable,O
.,O

Infectious,O
Disease,O
:,O

Unasyn,B-TR
for,O
antibiotic,B-TR
coverage,I-TR
.,O

Flap,B-TE
checks,I-TE
carried,O
out,O
q.2h.,O
initially,O
in,O
the,O
Surgical,O
Intensive,O
Care,O
Unit,O
showing,O
positive,B-PR
biphasic,I-PR
Doppler,I-PR
signals,I-PR
.,O

Pink,O
flap,O
with,O
good,O
refill,O
.,O

Right,O
arm,O
neurovascularly,O
intact,O
.,O

He,O
was,O
weaned,O
from,O
ventilation,B-TR
on,O
postoperative,O
day,O
one,O
to,O
pressure,B-TR
support,I-TR
ventilation,I-TR
and,O
then,O
to,O
spontaneous,O
breathing,O
on,O
postoperative,O
day,O
two,O
.,O

His,B-TE
Westwood-Pocasset,I-TE
output,I-TE
for,O
postoperative,O
day,O
one,O
on,O
the,O
left,O
was,O
60,O
",",O
right,O
neck,O
93,O
",",O
in,O
the,O
arm,O
20,O
.,O

Tube,B-TR
feedings,I-TR
were,O
started,O
48,O
hours,O
after,O
the,B-TR
procedure,I-TR
.,O

The,O
cuff,O
on,O
his,B-TR
tracheostomy,I-TR
tube,I-TR
was,O
put,O
down,O
on,O
11-23,O
",",O
postoperative,O
day,O
two,O
which,O
he,O
tolerated,O
well,O
with,O
minimal,B-PR
secretions,I-PR
and,O
a,O
strong,O
adequate,O
cough,O
.,O

Due,O
to,O
bed,O
issues,O
",",O
he,O
was,O
transferred,O
from,O
the,O
Surgical,O
Intensive,O
Care,O
Unit,O
to,O
the,O
Medical,O
Intensive,O
Care,O
Unit,O
on,O
postoperative,O
day,O
three,O
.,O

His,B-TR
tube,I-TR
feedings,I-TR
were,O
advanced,O
.,O

He,O
was,O
out,O
of,O
bed,O
to,O
a,O
chair,O
.,O

He,O
continued,O
with,O
pulmonary,B-TR
toilet,I-TR
and,O
q.2h.,B-TE
flap,I-TE
checks,I-TE
.,O

The,B-TR
Westwood-Pocasset,I-TR
in,I-TR
his,I-TR
right,I-TR
arm,I-TR
was,O
removed,O
on,O
2016-11-25,O
.,O

His,B-TR
tracheostomy,I-TR
was,O
changed,O
to,O
a,B-TR
6,I-TR
cuffless,I-TR
Shiley,I-TR
on,O
2016-11-26,O
and,O
sutures,B-TR
in,O
place,O
with,O
a,B-TR
3-0,I-TR
silk,I-TR
.,O

The,O
patient,O
tolerated,O
this,B-TR
procedure,I-TR
well,O
.,O

This,O
is,O
the,O
end,O
of,O
part,O
1,O
of,O
this,O
dictation,O
summary,O
for,O
Patricia,O
Jackson,O
.,O

To,O
be,O
continued,O
in,O
a,O
separate,O
dictation,O
.,O

Nola,O
Daniel,O
",",O
Hawaii,O
31699,O

Dictated,O
By:Joe,O
C.,O
Roa,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O

2016-11-30,O
10:56,O

T,O
:,O

2016-11-30,O
11:44,O

Job#,O
:,O

77004,O

Signed,O
electronically,O
by,O
:,O

DR.,O
Michael,O
Z,O
Waldroup,O
on,O
:,O

MON,O
2016-12-19,O
10:13,O
AM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2009-12-28,O

Discharge,O
Date,O
:,O

2009-12-31,O

Date,O
of,O
Birth,O
:,O

1964-03-23,O

Sex,O
:,O

F,O

Service,O
:,O

NEUROMEDIC,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Mrs.,O
Wisniewski,O
is,O
a,O
45-year-old,O
woman,O
with,O
multiple,B-PR
familial,I-PR
cavernous,I-PR
hemangiomas,I-PR
.,O

She,O
is,O
right-handed,O
.,O

She,O
was,O
in,O
her,O
usual,O
state,O
of,O
health,O
until,O
one,O
and,O
a,O
half,O
weeks,O
prior,O
to,O
admission,O
.,O

She,O
developed,O
an,B-PR
ear,I-PR
ache,I-PR
",",O
for,O
which,O
she,O
saw,O
her,O
primary,O
care,O
physician,O
",",O
Evelyn,O
was,O
prescribed,O
cortisone,B-TR
drops,I-TR
.,O

A,O
few,O
days,O
later,O
she,O
complained,O
of,O
dizziness,B-PR
.,O

This,O
was,O
mostly,O
described,O
as,O
feeling,O
unsteady,B-PR
on,I-PR
her,I-PR
feet,I-PR
.,O

She,O
stated,O
that,O
she,O
had,O
trouble,O
knowing,O
if,O
her,O
feet,O
were,O
touching,O
the,O
ground,O
.,O

She,O
was,O
seen,O
again,O
by,O
primary,O
care,O
physician,O
",",O
Roderick,O
since,O
she,O
had,O
complaints,O
of,O
dizziness,B-PR
",",O
as,O
well,O
as,O
a,O
new,O
complaint,O
of,O
decreased,B-PR
hearing,I-PR
and,O
the,O
sensation,O
of,O
static,B-PR
in,I-PR
her,I-PR
ears,I-PR
",",O
meniere,B-PR
's,I-PR
disease,I-PR
was,O
considered,O
.,O

She,O
was,O
given,O
an,B-TR
oral,I-TR
prednisone,I-TR
taper,I-TR
.,O

This,B-PR
unsteady,I-PR
gait,I-PR
progressed,O
",",O
and,O
then,O
she,O
subsequently,O
started,O
to,O
develop,O
a,B-PR
pins,I-PR
and,I-PR
needle,I-PR
feeling,I-PR
in,I-PR
the,I-PR
face,I-PR
",",I-PR
hands,I-PR
and,I-PR
feet,I-PR
bilaterally,I-PR
.,O

Her,O
hearing,O
got,O
progressively,B-PR
worse,I-PR
and,O
the,B-PR
sound,I-PR
of,I-PR
static,I-PR
increased,O
.,O

She,O
was,O
very,B-PR
fatigued,I-PR
.,O

At,O
an,O
outside,O
hospital,O
",",O
head,B-TE
CT,I-TE
revealed,O
a,B-PR
1.5,I-PR
cm,I-PR
diameter,I-PR
hyperdense,I-PR
mass,I-PR
in,I-PR
the,I-PR
pons,I-PR
",",O
slightly,O
off,O
center,O
to,O
the,O
right,O
.,O

She,O
was,O
transferred,O
here,O
for,O
further,O
care,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Notable,O
for,O
multiple,B-PR
cavernous,I-PR
hemangiomas,I-PR
.,O

She,O
has,O
had,O
at,B-PR
least,I-PR
two,I-PR
bleeding,I-PR
episodes,I-PR
in,O
the,O
past,O
",",O
mostly,O
described,O
as,O
being,O
accompanied,O
by,O
generalized,B-PR
weakness,I-PR
.,O

She,O
has,O
had,O
at,B-PR
least,I-PR
two,I-PR
generalized,I-PR
seizures,I-PR
in,O
the,O
past,O
",",O
but,O
she,O
has,O
not,O
had,O
one,O
since,O
she,O
was,O
26,O
years,O
old,O
.,O

She,O
was,O
never,O
on,O
an,B-TR
anticonvulsant,I-TR
due,O
to,O
her,O
former,O
beliefs,O
as,O
N.,O
Derk,O
Scientist,O
.,O

She,O
no,O
longer,O
observes,O
that,O
belief,O
system,O
.,O

MEDICATIONS,O
:,O

Prednisone,B-TR
taper,I-TR
as,O
above,O
.,O

ALLERGIES,O
:,O

None,O
.,O

FAMILY,O
HISTORY,O
:,O

Strong,O
maternal,O
history,O
of,O
hemangiomas,B-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Temperature,B-TE
99.2,O
.,O

Pulse,B-TE
60,O
.,O

Blood,B-TE
pressure,I-TE
120/80,O
.,O

Respiratory,B-TE
rate,I-TE
14,O
.,O

In,O
general,O
",",O
she,O
was,O
a,O
thin,O
well-appearing,O
woman,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

Sclera,O
were,O
anicteric,B-PR
.,O

Neck,O
was,O
supple,O
.,O

Chest,O
was,O
clear,O
.,O

Cardiovascular,B-TE
exam,I-TE
revealed,O
a,O
regular,O
rate,O
and,O
rhythm,O
with,O
no,O
murmurs,B-PR
",",O
rubs,B-PR
or,O
gallops,B-PR
.,O

Abdomen,O
soft,O
",",O
nontender,B-PR
and,O
distended,B-PR
.,O

Extremities,O
showed,O
no,O
edema,B-PR
.,O

Neurologically,O
",",O
she,O
was,O
awoken,O
from,O
sleep,O
by,O
voice,O
",",O
cooperative,O
",",O
but,O
mildly,B-PR
drowsy,I-PR
.,O

She,O
became,O
more,O
alert,O
during,O
the,O
remainder,O
of,O
the,B-TE
exam,I-TE
.,O

Speech,O
was,O
fluent,O
but,O
slow,B-PR
",",O
and,O
there,O
was,O
long,B-PR
response,I-PR
latencies,I-PR
before,O
she,O
would,O
initiate,O
speech,O
.,O

She,O
otherwise,O
had,O
normal,O
spontaneous,O
movements,O
and,O
facial,O
expression,O
and,O
did,O
not,O
appear,O
to,O
be,O
abulic,B-PR
.,O

She,O
had,O
normal,O
comprehension,O
.,O

She,O
was,O
able,O
to,O
give,O
a,O
detailed,O
history,O
in,O
an,O
organized,O
manner,O
.,O

There,O
was,O
no,O
dysarthria,B-PR
.,O

Language,O
was,O
normal,O
.,O

There,O
was,O
no,O
evidence,O
of,O
any,B-PR
special,I-PR
neglect,I-PR
.,O

Pupils,O
equal,O
",",O
round,O
and,O
reactive,O
to,O
light,O
.,O

Visual,O
fields,O
were,O
full,O
.,O

Extraocular,O
movements,O
were,O
full,O
with,O
normal,O
smooth,O
pursuit,O
to,O
the,O
left,O
.,O

Pursuit,O
was,O
interrupted,O
by,O
>.....<,O
when,O
tracking,O
from,O
left,O
to,O
right,O
.,O

She,O
had,O
sustained,B-PR
gaze,I-PR
holding,I-PR
nystagmus,I-PR
in,O
both,O
horizontal,O
directions,O
.,O

There,O
was,O
no,O
rotary,B-PR
component,I-PR
.,O

She,O
had,O
a,B-PR
mildly,I-PR
widened,I-PR
right,I-PR
palpable,I-PR
fissure,I-PR
.,O

There,O
was,O
decreased,B-PR
excursion,I-PR
of,I-PR
the,I-PR
right,I-PR
mouth,I-PR
and,O
flattening,B-PR
of,I-PR
the,I-PR
right,I-PR
nasolabial,I-PR
fold,I-PR
(,I-PR
mild,I-PR
),I-PR
.,O

Light,O
touch,O
was,O
subjectively,B-PR
abnormal,I-PR
on,O
both,O
sides,O
of,O
the,O
face,O
.,O

Hearing,O
was,O
diminished,B-PR
for,O
conversational,O
speech,O
.,O

Palate,O
and,O
tongue,O
moved,O
normally,O
in,O
the,O
midline,O
.,O

There,O
was,O
a,B-PR
mild,I-PR
left,I-PR
pronator,I-PR
drift,I-PR
.,O

Finger,B-TE
tapping,I-TE
and,O
rapid,B-TE
alternating,I-TE
movements,I-TE
were,O
slow,B-PR
on,I-PR
the,I-PR
left,I-PR
and,O
she,O
had,O
trouble,B-PR
isolating,I-PR
individual,I-PR
finger,I-PR
movements,I-PR
.,O

There,O
was,O
mild,B-PR
finger-to-nose,I-PR
dysmetria,I-PR
on,I-PR
the,I-PR
left,I-PR
.,O

Power,O
was,O
mildly,B-PR
diminished,I-PR
in,I-PR
the,I-PR
finger,I-PR
extensors,I-PR
and,O
hand,O
intrinsics,O
on,O
the,O
left,O
",",O
otherwise,O
",",O
power,O
was,O
full,O
throughout,O
.,O

Reflexes,B-TE
were,O
brisk,O
in,O
the,O
legs,O
with,O
4-5,O
beats,O
of,O
clonus,B-PR
at,I-PR
the,I-PR
ankles,I-PR
bilaterally,I-PR
.,O

She,O
had,O
bilateral,B-PR
upgoing,I-PR
toes,I-PR
.,O

She,O
made,O
mistakes,B-PR
with,I-PR
position,I-PR
sense,I-PR
",",O
roughly,O
at,O
chance,O
level,O
with,O
both,O
great,O
toes,O
and,O
the,O
left,O
first,O
finger,O
",",O
position,O
sense,O
in,O
the,O
right,O
limb,O
seems,O
preserved,O
.,O

Gait,O
was,O
wide,B-PR
based,I-PR
",",O
very,B-PR
unsteady,I-PR
",",O
veering,O
to,O
the,O
left,O
and,O
to,O
the,O
right,O
.,O

She,O
retropulsed,B-PR
and,O
would,O
have,O
pitched,O
backwards,O
without,O
the,O
assistance,O
of,O
the,O
examiner,O
.,O

LABORATORIES,O
:,O

White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
7.8,O
with,O
86%,O
polymorphonuclear,B-TE
cells,I-TE
",",O
11.1,O
lymphocytes,B-TE
",",O
hemoglobin,B-TE
14.3,O
",",O
hematocrit,B-TE
40.5,O
",",O
MCV,B-TE
88,O
",",O
INR,B-TE
1.0,O
",",O
PTT,B-TE
24.7,O
",",O
PT,B-TE
12.3,O
",",O
platelet,B-TE
count,I-TE
"295,000",O
",",O
glucose,B-TE
81,O
",",O
BUN,B-TE
15,O
",",O
creatinine,B-TE
0.8,O
",",O
sodium,B-TE
142,O
",",O
potassium,B-TE
4.2,O
",",O
chloride,B-TE
104,O
",",O
CO2,B-TE
26,O
",",O
calcium,B-TE
9.3,O
",",O
phosphate,B-TE
4.8,O
",",O
magnesium,B-TE
2.3,O
.,O

MRI,B-TE
of,I-TE
the,I-TE
brain,I-TE
revealed,O
multiple,B-PR
foci,I-PR
susceptibility,I-PR
artifact,I-PR
within,I-PR
the,I-PR
brain,I-PR
.,O

These,O
were,O
seen,O
best,O
in,O
gradient,B-TE
echocardiogram,I-TE
images,I-TE
.,O

There,O
was,O
a,O
large,O
focus,O
of,O
subacute,B-PR
blood,I-PR
products,I-PR
in,I-PR
the,I-PR
mid,I-PR
to,I-PR
low,I-PR
pons,I-PR
suggesting,O
recent,B-PR
hemorrhage,I-PR
into,I-PR
a,I-PR
cavernous,I-PR
angioma,I-PR
.,O

There,O
was,O
some,B-PR
mild,I-PR
surrounding,I-PR
edema,I-PR
.,O

There,O
are,O
also,O
tiny,B-PR
foci,I-PR
artifact,I-PR
within,I-PR
the,I-PR
cerebellum,I-PR
and,I-PR
base,I-PR
of,I-PR
the,I-PR
pons,I-PR
.,O

There,O
was,O
a,O
larger,O
area,O
of,O
susceptibility,B-PR
artifact,I-PR
in,I-PR
the,I-PR
left,I-PR
temporal,I-PR
lobe,I-PR
",",I-PR
right,I-PR
frontal,I-PR
lobe,I-PR
",",I-PR
and,I-PR
the,I-PR
splenius,I-PR
of,I-PR
the,I-PR
corpus,I-PR
collasum,I-PR
.,O

The,O
brain,O
parenchyma,O
was,O
otherwise,O
normal,O
.,O

There,O
was,O
mild,B-PR
enhancement,I-PR
of,I-PR
the,I-PR
pontine,I-PR
hemorrhagic,I-PR
mass,I-PR
but,O
none,O
elsewhere,O
.,O

There,O
was,O
no,O
areas,B-PR
of,I-PR
restricted,I-PR
diffusion,I-PR
to,O
indicate,O
infarction,B-PR
.,O

MRA,B-TE
of,I-TE
the,I-TE
brain,I-TE
was,O
unremarkable,O
.,O

There,O
was,O
no,O
communication,O
>.......<,O
in,O
the,O
visualized,O
vessels,O
and,O
the,O
angiomas,B-PR
.,O

Follow-up,B-TE
CT,I-TE
was,O
obtained,O
the,O
second,O
day,O
of,O
admission,O
.,O

There,O
was,O
no,O
evidence,O
of,O
developing,B-PR
hydrocephalus,I-PR
",",O
which,O
was,O
a,O
concern,O
due,O
to,O
the,B-PR
surrounding,I-PR
edema,I-PR
",",O
and,O
possible,O
suppression,B-PR
of,I-PR
the,I-PR
fourth,I-PR
ventricle,I-PR
.,O

There,O
was,O
no,O
significant,B-PR
change,I-PR
in,I-PR
size,I-PR
of,O
the,B-PR
subacute,I-PR
pontine,I-PR
hemorrhage,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

Mrs.,O
Wisniewski,O
is,O
a,O
45,O
-,O
year-old,O
woman,O
with,O
a,O
strong,O
family,O
history,O
of,O
cavernous,B-PR
angiomas,I-PR
.,O

She,O
has,O
had,O
several,B-PR
prior,I-PR
bleeding,I-PR
events,I-PR
and,O
presented,O
with,O
a,B-PR
subacute,I-PR
bleed,I-PR
in,I-PR
the,I-PR
mid,I-PR
to,I-PR
lower,I-PR
pons,I-PR
.,O

There,O
was,O
relatively,O
central,O
in,O
location,O
",",O
with,O
only,O
a,B-PR
slight,I-PR
right-sided,I-PR
predominance,I-PR
.,O

Her,B-TE
physical,I-TE
examination,I-TE
remained,O
relatively,O
unchanged,O
",",O
with,O
resolution,O
of,O
the,B-PR
subtle,I-PR
left,I-PR
hand,I-PR
weakness,I-PR
and,O
right,B-PR
facial,I-PR
weakness,I-PR
.,O

Her,O
gait,O
remained,O
severely,B-PR
ataxic,I-PR
",",O
likely,O
secondary,O
to,O
sensory,B-PR
deafferentation,I-PR
",",O
as,O
well,O
as,O
involvement,O
of,O
crossing,B-PR
pontine,I-PR
cerebellar,I-PR
fibers,I-PR
.,O

Therefore,O
",",O
it,O
was,O
recommended,O
that,O
she,O
have,O
aggressive,B-TR
Physical,I-TR
Therapy,I-TR
at,O
an,O
Acute,O
Rehabilitation,O
Center,O
.,O

The,O
case,O
was,O
discussed,O
with,O
Dr.,O
Harold,O
from,O
the,O
Falmouth,O
Hospital,O
.,O

He,O
has,O
followed,O
this,O
family,O
in,O
the,O
past,O
and,O
will,O
see,O
her,O
in,O
follow-up,O
.,O

We,O
will,O
arrange,O
to,O
have,O
a,O
copy,O
of,O
the,B-TE
MRI,I-TE
scans,I-TE
sent,O
to,O
him,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Familial,B-PR
cavernous,I-PR
hemangiomas,I-PR
",",O
status,O
post,O
a,B-PR
subacute,I-PR
pontine,I-PR
hemorrhage,I-PR
.,O

2.,O
Severe,B-PR
gait,I-PR
ataxia,I-PR
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Gabapentin,B-TR
100,O
mg,O
po,O
t.i.d.,O
for,O
paresthesias,B-PR
.,O

2.,O
Colace,B-TR
100,O
mg,O
po,O
b.i.d.,O

3.,O
Zantac,B-TR
150,O
mg,O
po,O
b.i.d.,O

4.,O
Prednisone,B-TR
taper,I-TR
completed,O
.,O

Andre,O
R.,O
RATAN,O
",",O
M.D.,O

23-397,O

Dictated,O
By,O
:,O
Maria,O
A,O
Singler,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2009-12-31,O
14:05,O

T,O
:,O
2009-12-31,O
14:57,O

JOB,O
#:,O
71678,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Juan,O
R.,O
RATAN,O
on,O
:,O
TUE,O
2010-03-02,O
8:13,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2016-03-04,O

Discharge,O
Date,O
:,O

2016-03-22,O

Date,O
of,O
Birth,O
:,O

1930-03-23,O

Sex,O
:,O

M,O

Service,O
:,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
an,O
85,O
year,O
old,O
man,O
initially,O
admitted,O
to,O
the,O
Plastic,O
Surgery,O
Service,O
for,O
evaluation,B-TE
of,O
a,B-PR
left,I-PR
facial,I-PR
mass,I-PR
.,O

Subsequently,O
",",O
CMED,O
CCU,O
was,O
consulted,O
and,O
he,O
was,O
transferred,O
to,O
our,O
Service,O
postoperatively,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

His,O
past,O
medical,O
history,O
is,O
significant,O
for,O
prostate,B-PR
cancer,I-PR
",",O
benign,B-PR
prostatic,I-PR
hypertrophy,I-PR
",",O
hypothyroidism,B-PR
",",O
status,O
post,O
radiation,B-TR
for,O
non,B-PR
Hodgkin,I-PR
's,I-PR
lymphoma,I-PR
",",O
chronic,B-PR
painless,I-PR
hematuria,I-PR
",",O
degenerative,B-PR
joint,I-PR
disease,I-PR
and,O
history,O
of,O
a,B-PR
murmur,I-PR
.,O

Last,O
colonoscopy,B-TE
",",O
five,O
years,O
ago,O
.,O

Dementia,B-PR
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

MEDICATIONS,O
:,O

1.,O
Levothyroxine,B-TR
.,O

2.,O
Lasix,B-TR
.,O

3.,O
Proscar,B-TR
.,O

4.,O
Aeroseb,B-TR
.,O

5.,O
Ancef,B-TR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
examination,B-TE
",",O
he,O
is,O
afebrile,B-PR
.,O

Vital,B-TE
signs,I-TE
",",O
stable,O
.,O

Elderly,O
man,O
",",O
somewhat,B-PR
cachectic,I-PR
.,O

Head,O
",",O
eyes,O
",",O
ears,O
",",O
nose,O
and,O
throat,O
",",O
polypoid,B-PR
lesion,I-PR
just,O
inferior,O
to,O
the,O
left,O
zygoma,O
",",O
elevated,O
superiorly,O
",",O
with,O
visible,B-PR
bone,I-PR
.,O

No,O
exudate,B-PR
.,O

Minimal,B-PR
bleeding,I-PR
.,O

Regular,O
rate,O
and,O
rhythm,O
.,O

Clear,O
to,O
auscultation,B-TE
.,O

Nontender,B-PR
",",O
nondistended,B-PR
.,O

HOSPITAL,O
COURSE,O
:,O

He,O
was,O
initially,O
admitted,O
to,O
CMED,O
for,O
resection,B-TR
and,O
repair,B-TR
of,O
this,B-PR
left,I-PR
facial,I-PR
lesion,I-PR
.,O

He,O
also,O
had,O
consults,O
from,O
Urology,O
for,O
his,B-PR
hematuria,I-PR
as,O
well,O
as,O
Medicine,O
preoperatively,O
and,O
CMED,O
CCU,O
.,O

He,O
went,O
to,O
the,O
Operating,O
Room,O
on,O
2016-03-10,O
with,O
Urology,O
for,O
hematuria,B-PR
where,O
he,O
had,O
a,B-TR
cystoscopy,I-TR
transurethral,I-TR
resection,I-TR
of,I-TR
prostate,I-TR
placement,I-TR
.,O

He,O
then,O
went,O
to,O
the,O
Operating,O
Room,O
on,O
2016-03-14,O
where,O
he,O
had,O
resection,B-TR
of,O
the,B-PR
left,I-PR
face,I-PR
squamous,I-PR
cell,I-PR
cancer,I-PR
by,O
Dr.,O
Langhorne,O
and,O
split,B-TR
thickness,I-TR
and,I-TR
full,I-TR
thickness,I-TR
skin,I-TR
grafting,I-TR
of,O
the,B-PR
defects,I-PR
on,O
2016-03-14,O
.,O

He,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
with,O
no,O
complications,B-PR
except,O
postoperatively,O
",",O
his,O
voice,O
was,O
hoarse,B-PR
.,O

On,O
scoping,B-TE
him,O
he,O
had,O
significant,B-PR
supraglottic,I-PR
edema,I-PR
.,O

He,O
was,O
kept,O
in,O
the,O
Unit,O
for,O
observation,B-TE
of,I-TE
his,I-TE
airway,I-TE
and,O
b.i.d.,O
laryngoscopy,B-TE
.,O

This,O
revealed,O
some,B-PR
supraglottic,I-PR
edema,I-PR
which,O
revealed,O
with,O
time,O
",",O
without,O
further,B-TR
intervention,I-TR
.,O

He,O
was,O
followed,O
by,O
Plastic,O
Surgery,O
for,O
his,B-TR
split,I-TR
thickness,I-TR
skin,I-TR
graft,I-TR
and,O
his,B-TR
bolster,I-TR
was,O
discontinued,O
on,O
postoperative,O
day,O
#5,O
with,O
good,O
take,O
up,O
of,O
his,B-TR
skin,I-TR
graft,I-TR
.,O

Urology,O
also,O
followed,O
him,O
and,O
kept,O
him,O
on,O
antibiotics,B-TR
until,O
postoperative,O
day,O
#7,O
at,O
which,O
point,O
antibiotics,B-TR
were,O
discontinued,O
.,O

His,O

Foley,B-TR
was,O
also,O
discontinued,O
.,O

He,O
is,O
being,O
discharged,O
to,O
rehabilitation,O
to,O
follow,O
up,O
for,O
XRT,B-TR
given,O
the,O
fact,O
that,O
his,B-TE
pathology,I-TE
revealed,O
squamous,B-PR
cell,I-PR
cancer,I-PR
extending,O
deep,O
to,O
the,O
margin,O
as,O
well,O
as,O
positive,B-PR
level,I-PR
II,I-PR
nodes,I-PR
.,O

Dr.,O
Navarrete,O
has,O
been,O
e-mailed,O
and,O
his,O
secretary,O
contacted,O
for,O
as,O
soon,O
as,O
possible,O
appointment,O
for,O
XRT,B-TR
follow,O
up,O
.,O

He,O
should,O
also,O
follow,O
up,O
with,O
Dr.,O
Rankin,O
and,O
Dr.,O
Langhorne,O
.,O

He,O
is,O
being,O
discharged,O
",",O
most,O
likely,O
",",O
to,O
Falmouth,O
Hospital,O
.,O

John,O
P,O
Friend,O
",",O
M.D.,O

11-466,O

Dictated,O
By,O
:,O
Frances,O
P,O
Sheets,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2016-03-22,O
12:20,O

T,O
:,O
2016-03-22,O
12:23,O

JOB,O
#,O
:,O
80013,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Jermaine,O
X,O
Reynolds,O
on,O
:,O
Andrea,O
2016-06-30,O
3:46,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2018-05-24,O

Discharge,O
Date,O
:,O

2018-05-29,O

Date,O
of,O
Birth,O
:,O

1964-03-11,O

Sex,O
:,O

M,O

Service,O
:,O

CARDIOTHORACIC,O

Allergies,O
:,O

Keflex,B-TR
/,O
Heparin,B-TR
Agents,I-TR

Attending,O
:,O
James,O
F.,O
Bard,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O
pt,O
sent,O
to,O
ER,O
after,O
routine,O
F/U,O
for,O
UE,B-PR
DVT,I-PR
with,O
vascular,O
surgery,O
.,O

In,O
ER,O
c/o,O
dyspnea,B-PR
and,O
was,O
noted,O
to,O
have,O
mental,B-PR
status,I-PR
changes,I-PR
.,O

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O
none,O
this,O
admission,O

AVR,B-TR
(,I-TR
tissue,I-TR
),I-TR
05-14,O

History,O
of,O
Present,O
Illness,O
:,O

s/p,O
AVR,B-TR
05-14,O
.,O

Postop,O
course,O
c/b,O
right,B-PR
upper,I-PR
extremity,I-PR
DVT,I-PR
and,O
postop,B-PR
Afib,I-PR
.,O

Discharged,O
home,O
05-19,O
with,O
instructions,O
to,O
f/u,O
in,O
vascular,O
clinic,O
.,O

Had,O
vascular,O
clinic,O
f/u,O
on,O
day,O
of,O
admission,O
.,O

At,O
that,O
time,O
had,O
UE,B-TE
duplex,I-TE
which,O
revealed,O
RUE,B-PR
DVT,I-PR
involving,O
IJ,O
",",O
Axillary,O
",",O
subclav,O
",",O
brachial,O
",",O
and,O
basilic,O
veins,O
.,O

Then,O
referred,O
to,O
ER,O
for,O
Tx,B-TR

Past,O
Medical,O
History,O
:,O

s/p,O
AVR,B-TR
(,O
#27,O
pericardial,O
),O

post-op,B-PR
Afib,I-PR

HTN,B-PR

renal,B-PR
calculi,I-PR

?,O
sleep,B-PR
apnea,I-PR

seasonal,B-PR
allergies,I-PR

s/p,O
2,B-TR
surgs.,I-TR
for,O
spermatocele,B-PR

s/p,O
oral,B-TR
surgery,I-TR

Social,O
History,O
:,O
lives,O
with,O
partner,O

professor,O
/,O
Kyra,O
social,O
worker,O

quit,O
smoking,O
20,O
years,O
ago,O

occasional,O
ETOH,O

Family,O
History,O
:,O

non-contributory,O
for,O
premature,B-PR
CAD,I-PR
;,O
father,O
had,O
MI,B-PR
in,O
his,O
70,O
's,O

Physical,O
Exam,O
:,O

admission,B-TE
PE,I-TE

VS,B-TE
:,O
HR,B-TE
103,O
BP,B-TE
162/69,O
RR,B-TE
14,O
Sat,B-TE
92%,O
RA,O

Neuro,O
:,O
MAE,O
",",O
Follows,O
commands,O
",",O
slightly,B-PR
confused,I-PR

Heent,O
:,O
PERRL/EOMI,O
",",O
no,O
JVD,B-PR

Resp,O
:,O
CTAB,O

CV,O
:,O
RRR,O
S1-S2,O
",",O
no,O
murmur,B-PR
.,O

Sternum,O
stable,O

Abdm,O
:,O
soft,O
NT,B-PR
/,O
ND,B-PR
/,O
NABS,O

Ext,O
:,O
+,O
distal,B-TE
pulses,I-TE
",",O
no,O
edema,B-PR

Discharge,B-TE
PE,I-TE

VS,B-TE
:,O
T,B-TE
99,O
HR,B-TE
68,O
BP,B-TE
113/72,O
RR,B-TE
18,O
Sat,B-TE
98%,O
RA,O

Gen,O
:,O
comforable,O

Neuro,O
:,O
A&Ox3,O
",",O
MAE,O
",",O
Follows,O
Commands,O

Resp,O
:,O
CTA-bilat,O

CV:RRR,O
S1-S2,O
",",O
no,O
MRG,B-PR

Resp:CTA-bilat,O

Abdm,O
:,O
soft,O
",",O
NT/ND/NABS,B-PR

Ext,O
:,O
warm,O
well,O
perfused,O
No,O
CCE,B-PR

Pertinent,O
Results,O
:,O

2018-05-24,O
20:55,O

GLUCOSE,B-TE
-,O
193,O
*,O
UREA,B-TE
N,I-TE
-,O
23,O
*,O
CREAT,B-TE
-,O
1.2,O
SODIUM,B-TE
-,O
138,O
POTASSIUM,B-TE
-,O
4.6,O
CHLORIDE,B-TE
-,O
101,O
TOTAL,B-TE
CO2,I-TE
-,O
21,O
*,O
ANION,B-TE
GAP,I-TE
-,O
21,O
*,O

2018-05-24,O
20:55,O

CALCIUM,B-TE
-,O
8.8,O
PHOSPHATE,B-TE
-,O
3.9,O
MAGNESIUM,B-TE
-,O
2.4,O

2018-05-24,O
20:55,O

PT,B-TE
-,O
15.0,O
*,O
PTT,B-TE
-,O
107.1,O
*,O
INR,B-TE
(,I-TE
PT,I-TE
)-,I-TE
1.3,O
*,O

2018-05-24,O
13:25,O

WBC,B-TE
-,O
13.3,O
*#,O
RBC,B-TE
-,O
3.45,O
*,O
HGB,B-TE
-,O
10.6,O
*,O
HCT,B-TE
-,O
30.5,O
*,O
MCV,B-TE
-,O
88,O
MCH,B-TE
-,O
30.6,O
MCHC,B-TE
-,O
34.7,O
RDW,B-TE
-,O
12.7,O

2018-05-28,O
13:40,O

BLOOD,B-TE
WBC,I-TE
-,O
12.9,O
*,O
RBC,B-TE
-,O
3.37,O
*,O
Hgb,B-TE
-,O
10.4,O
*,O
Hct,B-TE
-,O
29.4,O
*,O
MCV,B-TE
-,O
87,O
MCH,B-TE
-,O
30.8,O
MCHC,B-TE
-,O
35.3,O
*,O
RDW,B-TE
-,O
13.3,O
Plt,B-TE
Ct,I-TE
-,O
345,O

2018-05-29,O
11:34,O

BLOOD,B-TE
PT,I-TE
-,O
39.1,O
*,O
INR,B-TE
(,I-TE
PT,I-TE
)-,I-TE
4.4,O
*,O

2018-05-25,O
9:00,O

BLOOD,B-TE
HEPARIN,I-TE
DEPENDENT,I-TE
ANTIBODIES,I-TE
-,O
positive,O

Brief,O
Hospital,O
Course,O
:,O

Pt,O
admitted,O
05-24,O
from,O
ER,O
after,O
positive,B-PR
RUE,I-PR
DVT,I-PR
finding,O
in,O
vascular,O
lab,O
.,O

During,O
ER,B-TE
evaluation,I-TE
pt,O
was,O
noted,O
to,O
have,O
some,O
degree,O
of,O
dyspnea,B-PR
as,O
well,O
as,O
mental,B-PR
status,I-PR
changes,I-PR
",",O
including,O
loss,B-PR
of,I-PR
short,I-PR
term,I-PR
memory,I-PR
and,O
brief,B-PR
unresponsive,I-PR
period,I-PR
after,O
one,O
dose,O
of,O
IV,B-TR
Benadry,I-TR
and,O
steroids,B-TR
prior,O
to,O
CT,B-TE
scan,I-TE
.,O

The,B-TE
CT,I-TE
was,O
negative,O
for,O
CVA,B-PR
but,O
positive,O
for,O
Pulmonary,B-PR
embolism,I-PR
.,O

He,O
was,O
transferred,O
to,O
CSRU,O
for,O
evaluation,B-TE
.,O

Neurology,O
was,O
consulted,O
and,O
the,O
pt,O
also,O
had,O
MRI,B-TE
which,O
was,O
negative,O
.,O

The,O
pt,O
was,O
begun,O
on,O
heparin,B-TR
gtt,I-TR
and,O
was,O
noted,O
to,O
have,O
platelet,B-PR
drop,I-PR
>,O
50%,O
after,O
infusion,B-TR
began,O
",",O
hepain,B-TR
was,O
d/c,O
'd.,O

Argatroban,B-TR
was,O
started,O
abd,O
a,B-TE
HIT,I-TE
panel,I-TE
was,O
sent,O
",",O
HIT,B-TE
panel,I-TE
was,O
positive,B-PR
.,O

Hematology,O
was,O
consulted,O
.,O

By,O
the,O
following,O
mornig,O
all,B-PR
mental,I-PR
status,I-PR
changes,I-PR
had,O
cleared,O
and,O
the,O
pt,O
was,O
transferred,O
to,O
the,O
floors,O
for,O
continued,O
care,O
.,O

Over,O
the,O
next,O
several,O
days,O
the,O
patient,O
was,O
maintained,O
on,O
Argatrobanwhile,B-TR
coumadin,B-TR
therapy,I-TR
was,O
initiated,O
.,O

On,O
HD#6,O
the,O
pt,O
had,O
a,B-TE
therapeudic,I-TE
INR,I-TE
(,O
4.4,O
),O
off,O
Argatroban,B-TR
and,O
wad,O
discharged,O
home,O
.,O

He,O
was,O
to,O
have,O
f/u,O
INR,B-TE
check,I-TE
with,O
Dr,O
Lewis,O
on,O
05-31,O
.,O

Additionally,O
the,O
pt,O
should,O
f/u,O
with,O
the,O
hematology,O
clinic,O
.,O

Medications,O
on,O
Admission,O
:,O

ASA,B-TR
81,O
',O

Atorvastatin,B-TR
10,O
',O

Lisinopril,B-TR
5,O
',O

"Lopressor,B-TR
50,O
""",O

Amiodarone,B-TR
200,O
',O

Discharge,O
Medications,O
:,O

1.,O
Aspirin,B-TR
81,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

2.,O
Atorvastatin,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

3.,O
Metoprolol,B-TR
Tartrate,I-TR
50,O
mg,O
Tablet,O
Sig,O
:One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

4.,O
Amoxicillin-Pot,B-TR
Clavulanate,I-TR
875-125,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
for,O
10,O
days,O
.,O

Disp,O
:*,O
20,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

5.,O
Amiodarone,B-TR
200,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

6.,O
Warfarin,B-TR
2,O
mg,O
Tablet,O
Sig,O
:,O
1.5,O
Tablets,O
PO,O
as,O
directed,O
:,O
3,O
mg,O
1943-05-29,O
and,O
6/1,O
then,O
as,O
directed,O
by,O
Dr,O
Mace,O
.,O

Disp,O
:*,O
100,O
Tablet,O
(s)*,O
Refills,O
:*,O
2,O
*,O

Discharge,O
Disposition,O
:,O

Home,O

Discharge,O
Diagnosis,O
:,O
s/p,O
AVR,B-TR
05-14,O
(,O
tissue,O
),O
readmitted,O
05-24,O
w/,O
pulmonary,B-PR
embolism,I-PR
",",O
RUE,B-PR
DVT,I-PR
",",O
HIT,B-PR
positive,I-PR

PMH,O
:,O
HTN,B-PR
",",O
Renal,B-PR
calculi,I-PR
",",O
sleep,B-PR
apnea,I-PR
",",O

Discharge,O
Condition,O
:,O
good,O

Discharge,O
Instructions,O
:,O
keep,O
wounds,B-PR
clean,O
and,O
dry,O
.,O

OK,O
to,O
shower,O
",",O
no,O
bathing,O
or,O
swimming,O
.,O

Take,O
all,B-TR
medications,I-TR
as,O
prescribed,O
.,O

Follow-up,B-TE
INR,I-TE
to,O
be,O
drawn,O
06-01,O
",",O
by,O
Dr,O
Lewis,O
@,O
597-4427,O

Followup,O
Instructions,O
:,O

Dr,O
Pessolano,O
in,O
3,O
days,O

Dr,O
Arnold,O
in,O
3,O
weeks,O

Hematology,O
clinic,O
in,O
1-2,O
weeks,O

Messersmith,O
della,O
Blore,O
MD,O
27-337,O

Completed,O
by,O
:,O
MARK,O
Yvonne,O
NP,O
80-AUO,O
2018-05-29,O
@,O
1552,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Edward,O
von,O
der,O
Torros,O
on,O
:,O
WED,O
2018-06-20,O
2:58,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2013-12-24,O

Discharge,O
Date,O
:,O

2014-01-13,O

Date,O
of,O
Birth,O
:,O

1959-12-16,O

Sex,O
:,O

F,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Haldol,B-TR
/,O
Compazine,B-TR
/,O
Phenergan,B-TR
/,O
Tigan,B-TR
/,O
Flagyl,B-TR

Attending,O
:,O
David,O
U.,O
Johnson,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Chest,B-PR
Pain,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

Removal,B-TR
of,I-TR
tunneled,I-TR
cath,I-TR
(,O
previously,O
used,O
for,O
tPN,B-TR
),O

History,O
of,O
Present,O
Illness,O
:,O

54,O
yo,O
F,O
with,O
Crohn,B-PR
's,I-PR
s/p,O
ileostomy,B-TR
and,O
subsequent,O
short,B-PR
gut,I-PR
syndrome,I-PR
with,O
port-a-cath,B-TR
placement,I-TR
for,O
TPN,B-TR
who,O
presents,O
with,O
progressive,B-PR
right,I-PR
sided,I-PR
chest,I-PR
pain,I-PR
that,O
comes,O
in,O
waves,O
.,O

The,O
pt,O
reports,O
sharp,B-PR
10/10,I-PR
chest,I-PR
pain,I-PR
under,I-PR
the,I-PR
right,I-PR
breast,I-PR
which,O
is,O
getting,O
progressively,O
worse,O
.,O

The,B-PR
pain,I-PR
is,O
worsened,O
with,O
deep,O
inspiration,O
or,O
movement,O
.,O

It,O
initially,O
started,O
one,O
day,O
previously,O
but,O
has,O
gotten,O
significantly,O
worse,O
over,O
last,O
12,O
hours,O
.,O

It,O
is,O
associated,O
with,O
SOB,B-PR
as,O
well,O
as,O
fevers,B-PR
",",O
chills,B-PR
.,O

The,O
pt,O
denies,O
abd,B-PR
pain,I-PR
",",O
n/v,B-PR
or,O
increased,B-PR
ostomy,I-PR
output,I-PR
.,O

Given,O
her,B-PR
fever,I-PR
",",O
sx,B-PR
of,I-PR
chest,I-PR
pain,I-PR
and,O
SOB,B-PR
as,O
well,O
as,O
an,B-PR
elevated,I-PR
WBC,I-PR
count,I-PR
",",O
she,O
was,O
initially,O
thought,O
to,O
have,O
a,B-PR
PNA,I-PR
.,O

She,O
was,O
therefore,O
given,O
ceftriaxone,B-TR
1,O
g,O
IV,O
x1,O
and,O
azithromycin,B-TR
500,O
mg,O
PO,O
x1,O
in,O
the,O
Deanna,O
.,O

As,O
the,B-TE
CXR,I-TE
was,O
without,O
any,O
evidence,O
of,O
PNA,B-PR
",",O
or,O
PTX,B-PR
",",O
the,O
pt,O
subsequently,O
received,O
a,B-TE
CTA,I-TE
to,O
evaluate,O
for,O
PE,B-PR
which,O
revealed,O
multifocal,B-PR
bilateral,I-PR
PNA,I-PR
but,O
no,O
PE,B-PR
.,O

At,O
this,O
time,O
",",O
she,O
was,O
given,O
Vancomycin,B-TR
1,O
g,O
IV,O
x1,O
.,O

She,O
was,O
also,O
given,O
morphine,B-TR
2,O
mg,O
x3,O
",",O
4,O
mg,O
IV,O
x2,O
",",O
dolasetron,B-TR
12.5,O
mg,O
x2,O
and,O
ativan,B-TR
1,O
mg,O
IV,O
x1,O
.,O

Past,O
Medical,O
History,O
:,O

1.,O
Crohn,B-PR
's,I-PR
disease,I-PR
",",O
dx,O
1974,O
s/p,O
three,B-TR
bowel,I-TR
resections,I-TR
and,O
eventual,B-TR
ileostomy,I-TR
",",O
resulting,O
in,O
short,B-PR
gut,I-PR
syndrome,I-PR

2.,O
Restless,B-PR
leg,I-PR
syndrome,I-PR

3.,O
?,O
Parkinsons,B-PR
vs.,O
EPS,B-PR
side,I-PR
effects,I-PR
from,O
risperdal,B-TR

4.,O
Chronic,B-PR
idiopathic,I-PR
pancreatitis,I-PR
",",O
as,O
demonstrated,O
on,O
CT,B-TE
in,O
09-01,O

"5.,O
Arthritis,B-PR
s/p,O
"",B-TR
pin,I-TR
placement,I-TR
"",I-TR
in,I-TR
left,I-TR
foot,I-TR
05-01",O

6.,O
Degenerative,B-PR
disc,I-PR
disease,I-PR
s/p,O
two,B-TR
back,I-TR
surgeries,I-TR
in,O
80,O
's,O

7.,O
Benzo,B-TR
and,O
opiod,B-TR
addiction,O

8.,O
Paranoia,B-PR
/,O
Depression,B-PR
",",O
h/o,O
auditory,B-PR
hallucinations,I-PR
",",O
?,O
mania,B-PR

9.,O
Port-a-Cath,B-TR
placement,I-TR
for,O
IV,B-TR
hydration,I-TR
in,O
setting,O
of,O
short,B-PR
gut,I-PR
syndrome,I-PR
",",O
complicated,O
by,O
clotting,B-PR
x,O
4,O
",",O
requiring,O
replacement,B-TR

Abd,B-TE
CT,I-TE
performed,O
09-01,O
showed,O
multiple,B-PR
calcifications,I-PR
in,I-PR
the,I-PR
body,I-PR
and,I-PR
tail,I-PR
of,I-PR
the,I-PR
pancreas,I-PR
with,O
a,B-PR
larger,I-PR
cystic,I-PR
lesion,I-PR
in,I-PR
the,I-PR
tail,I-PR
of,I-PR
the,I-PR
pancreas,I-PR
.,O

A,B-PR
second,I-PR
9,I-PR
mm,I-PR
cystic,I-PR
lesion,I-PR
is,O
seen,O
in,O
the,O
head,O
of,O
the,O
pancreas,O
.,O

These,O
findings,O
are,O
consistent,O
with,O
chronic,B-PR
pancreatitis,I-PR
with,O
pseudocyst,B-PR
formation,I-PR

Social,O
History:,O
lives,O
w/,O
her,O
husband,O
in,O
John,O
area,O
;,O
smokes,O
05-04,O
cig,O
/d,O
(,O
30,O
pack,O
year,O
history,O
);,O
no,O
alcohol,O
or,O
recreational,O
drug,O
use,O
",",O
has,O
had,O
addiction,O
to,O
benzodiazepines,B-TR
and,O
opioids,B-TR
in,O
the,O
past,O

Family,O
History,O
:,O

Mother-Crohn,B-PR
's,I-PR
;,O
Daugher-IBS,B-PR
",",O
colitis,B-PR
;,O
Mother,O
--,O
breast,B-PR
CA,I-PR
",;",O

Father,O
-,O
Stephanie,B-PR
tumor,I-PR
",",O
no,O
DM,B-PR
",",O
no,O
CAD,B-PR

Physical,O
Exam,O
:,O

V,B-TE
:,O
101.4,O
",",O
102,O
",",O
167/54,O
->,O
159/77,O
",",O
24,O
->,O
16,O
",",O
98%,O
RA,O
->,O
96%,O
RA,O

Gen,O
:,O
middle,O
aged,O
obese,O
female,O
lying,O
in,O
bed,O
on,O
her,O
left,O
side,O
asleep,O
",",O
speaking,O
slowly,O
.,O

appears,O
younger,O
than,O
stated,O
age,O

HEENT,O
:,O
PERRL,O
",",O
OP,O
clear,O
",",O
MMM,O

CV,O
:,O
RRR,O
",",O
s1,O
",",O
s2,B-PR
distant,I-PR

Chest,O
:,O
crackles,B-PR
at,I-PR
right,I-PR
base,I-PR
with,O
dec.,B-PR
air,I-PR
movement,I-PR
.,O

tender,B-PR
over,I-PR
right,I-PR
chest,I-PR

Abd,O
:,O
obese,B-PR
",",O
multiple,B-PR
surgical,I-PR
scars,I-PR
.,O

Ileostomy,B-TR
bag,I-TR
present,O
with,O
gas,O
and,O
stool,O
.,O

absomen,O
soft,O
",",O
tender,B-PR
to,O
palpation,B-TE
over,I-TE
RUQ,I-TE
",",O
but,O
no,O
guarding,B-PR
or,O
rebound,B-PR

Ext,O
:,O
tr,B-PR
edema,I-PR
",",O
2+,O
DP,B-TE
bilaterally,I-TE

Pertinent,O
Results,O
:,O

2013-12-24,O
1:30,O

GLUCOSE,B-TE
-,O
208,O
*,O
UREA,B-TE
N,I-TE
-,O
21,O
*,O
CREAT,B-TE
-,O
1.3,O
*,O
SODIUM,B-TE
-,O
138,O
POTASSIUM,B-TE
-,O
4.2,O
CHLORIDE,B-TE
-,O
104,O
TOTAL,B-TE
CO2,I-TE
-,O
23,O
ANION,B-TE
GAP,I-TE
-,O
15,O

2013-12-24,O
1:30,O

CK,B-TE
(,I-TE
CPK,I-TE
)-,I-TE
31,O

2013-12-24,O
1:30,O

cTropnT,B-TE
-<,O
0.01,O

2013-12-24,O
1:30,O

WBC,B-TE
-,O
14.4,O
*#,O
RBC,B-TE
-,O
3.82,O
*,O
HGB,B-TE
-,O
11.5,O
*,O
HCT,B-TE
-,O
33.5,O
*,O
MCV,B-TE
-,O
88,O
MCH,B-TE
-,O
30.2,O
MCHC,B-TE
-,O
34.5,O
RDW,B-TE
-,O
14.7,O

2013-12-24,O
1:30,O

NEUTS,B-TE
-,O
78.0,O
*,O
LYMPHS,B-TE
-,O
17.0,O
*,O
MONOS,B-TE
-,O
4.6,O
EOS,B-TE
-,O
0.3,O
BASOS,B-TE
-,O
0.1,O

2013-12-24,O
1:30,O

PLT,B-TE
COUNT,I-TE
-,O
128,O
*,O

2013-12-24,O
1:30,O

PT,B-TE
-,O
12.3,O
PTT,B-TE
-,O
26.1,O
INR,B-TE
(,I-TE
PT,I-TE
)-,I-TE
1.0,O

CTA,B-TE
2013-12-24,O
-,O
IMPRESSION,O
:,O

1.,O
No,O
definite,B-PR
pulmonary,I-PR
embolism,I-PR
is,O
identified,O
.,O

2.,O
Peripheral,B-PR
patchy,I-PR
opacities,I-PR
are,O
seen,O
bilaterally,O
",",O
most,O
consistent,O
with,O
multifocal,B-PR
pneumonia,I-PR
.,O

CXR,B-TE
2013-12-24,O
-,O
There,O
are,O
faint,B-PR
ill-defined,I-PR
opacities,I-PR
within,O
the,O
right,O
lower,O
lung,O
zone,O
and,O
left,O
upper,O
lung,O
zone,O
could,O
represent,O
a,B-PR
multifocal,I-PR
pneumonic,I-PR
process,I-PR
.,O

CXR,B-TE
2014-01-02,O
-,O
IMPRESSION,O
:,O

Multilobar,B-PR
pneumonia,I-PR
with,O
interval,B-PR
worsening,I-PR
in,I-PR
the,I-PR
left,I-PR
lung,I-PR
but,O
slight,O
improvement,O
in,O
the,O
right,O
lower,O
lobe,O
.,O

Head,B-TE
CT,I-TE
2014-01-09,O
-,O
Ordered,O
to,O
evaluate,O
for,O
changes,O
to,O
explain,O
delta,B-PR
MS,I-PR

CONCLUSION,O
:,O

Left,B-PR
parietal,I-PR
subcortical,I-PR
hypodensity,I-PR
",",O
likely,O
ischemic,B-PR
.,O

No,O
definite,B-PR
changes,I-PR
since,O
the,B-TE
MR,I-TE
of,O
in,O
2011-05-15,O
.,O

CXR,B-TE
2014-01-09,O

IMPRESSION,O
:,O

Marked,O
improvement,O
.,O

Brief,O
Hospital,O
Course,O
:,O

54,O
yo,O
F,O
with,O
Crohn,B-PR
's,I-PR
disease,I-PR
s/p,O
ileostomy,B-TR
with,O
subsequent,O
short,B-PR
gut,I-PR
syndrome,I-PR
with,O
port-o-cath,B-TR
for,O
TPN,B-TR
presents,O
with,O
acute,B-PR
onset,I-PR
pleuritic,I-PR
chest,I-PR
pain,I-PR
with,O
fever,B-PR
",",O
chills,B-PR
",",O
and,O
sob,B-PR
.,O

1.,O
Chest,B-PR
pain,I-PR
/,O
Fever,B-PR
/,O
Chills,B-PR
:,O

The,B-PR
acute,I-PR
onset,I-PR
of,I-PR
chest,I-PR
pain,I-PR
was,O
initially,O
very,O
concerning,O
for,O
a,B-PR
PE,I-PR
",",O
however,O
the,B-TE
Chest,I-TE
CT,I-TE
demonstrated,O
multifocal,B-PR
consolidation,I-PR
consistent,O
with,O
a,B-PR
bacterial,I-PR
PNA,I-PR
.,O

This,O
is,O
consistent,O
with,O
the,O
remainder,O
of,O
the,O
pt,O
's,O
history,O
including,O
fever,B-PR
",",O
chills,B-PR
",",O
sob,B-PR
and,O
an,B-PR
elevated,I-PR
WBC,I-PR
count,I-PR
.,O

The,O
pt,O
was,O
given,O
ceftriaxone,B-TR
/,O
azithromycin,B-TR
/,O
vancomycin,B-TR
in,O
Deanna,O
.,O

Blood,B-TE
",",I-TE
urine,I-TE
and,I-TE
sputum,I-TE
culutres,I-TE
were,O
sent,O
.,O

Pt,B-TE
's,I-TE
blood,I-TE
cultures,I-TE
came,O
back,O
positive,O
for,O
Staph,B-PR
Aureus,I-PR
and,O
Enterococcus,B-PR
",",O
both,O
were,O
pansensitive,O
.,O

Sputum,B-TE
culture,I-TE
also,O
returned,O
with,O
Staph.,B-PR
Aureus,I-PR
.,O

Ceftriaxone,B-TR
and,O
azithro,B-TR
were,O
discontinued,O
",",O
and,O
Vacomycin,B-TR
was,O
continued,O
.,O

Pt,O
initially,O
was,O
hypoxic,B-PR
requiring,O
NRB,B-TR
for,O
O2,B-TE
sat,I-TE
of,O
94%,O
",",O
with,O
any,O
attempt,O
to,O
wean,O
she,O
would,O
desat,O
.,O

Pt,O
was,O
intubated,O
prior,O
to,O
tunneled,B-TR
catheter,I-TR
removal,I-TR
",",O
see,O
below,O
.,O

(,O
The,B-TR
tunneled,I-TR
catheter,I-TR
later,O
came,O
back,O
for,O
negative,O
for,O
culture.,B-TE
),O

Earlier,O
that,O
day,O
pt,O
had,O
a,B-TE
chest,I-TE
x,I-TE
ray,I-TE
which,O
showed,O
diffuse,B-PR
infiltrative,I-PR
process,I-PR
concerning,O
for,O
ARDS,B-PR
.,O

Post,O
procedure,B-TR
pt,O
remained,O
intubated,B-TR
on,O
ARDSnet,B-TR
protocol,I-TR
.,O

She,O
self,O
extubated,O
the,O
first,O
day,O
and,O
was,O
reintubated,O
without,O
any,B-PR
complications,I-PR
.,O

Her,B-PR
O2,I-PR
requirement,I-PR
improved,O
on,O
the,B-TR
vent,I-TR
over,O
the,O
next,O
few,O
days,O
and,O
she,O
was,O
weaned,O
off,O
the,B-TR
vent,I-TR
on,O
2013-01-01,O
.,O

After,O
extubation,O
her,B-PR
o2,I-PR
requirement,I-PR
was,O
down,O
to,O
1L,B-TR
NC,I-TR
with,O
sats,B-TE
in,O
mid,O
90s,O
.,O

She,O
was,O
transferred,O
to,O
the,O
floor,O
for,O
further,O
managment,O
.,O

The,O
patient,O
remained,O
afebrile,B-PR
when,O
she,O
transferred,O
to,O
the,O
medicine,O
service,O
.,O

She,O
was,O
weaned,O
off,O
the,B-TR
oxygen,I-TR
and,O
for,O
the,O
remainder,O
of,O
her,O
course,O
her,B-TE
O2sats,I-TE
were,O
stable,O
on,O
room,O
air,O
.,O

The,O
patient,O
had,O
completed,O
her,B-TR
antibiotic,I-TR
course,I-TR
while,O
in,O
house,O
.,O

2.,O
Hx,O
of,O
multiple,B-PR
port-o-cath,I-PR
clots,I-PR
:,O

Although,O
the,O
pt,O
is,O
on,O
warfarin,B-TR
chronically,O
",",O
her,B-TE
INR,I-TE
was,O
subtherapeutic,O
.,O

Goal,O
INR,B-TE
01-31,O
.,O

Initially,O
coumadin,B-TR
was,O
increased,O
",",O
however,O
given,O
concern,O
for,O
infected,B-PR
line,I-PR
",",O
general,O
surgery,O
was,O
consulted,O
who,O
removed,O
the,B-TR
line,I-TR
in,O
the,O
ICU,O
.,O

3.,O
ARF,B-PR
:,O

Pt,O
initially,O
with,O
mild,B-PR
ARI,I-PR
",",O
this,O
was,O
thought,O
to,O
be,O
due,O
to,O
dehydration,B-PR
",",O
after,O
initial,B-TR
volume,I-TR
repletion,I-TR
her,O
renal,O
function,O
improved,O
to,O
her,O
baseline,O
.,O

4.,O
CMED,O
:,O

The,O
pt,O
has,O
a,O
history,O
of,O
paranoia,B-PR
/,O
depression,B-PR
.,O

ON,O
admission,O
she,O
was,O
taking,O
Quetiapine,B-TR
300,O
mg,O
QHS,O
and,O
Clonazepam,B-TR
1,O
mg,O
QAM,O
",",O
1,O
mg,O
Q3PM,O
",",O
2,O
mg,O
PO,O
QHS,O
.,O

Quetiapine,B-TR
was,O
continued,O
however,O
clonipin,B-TR
was,O
initially,O
held,O
when,O
she,O
was,O
intubated,B-TR
on,O
fentynyl,B-TR
/,O
versed,B-TR
.,O

This,O
was,O
restarted,O
post,O
extubation,B-TR
.,O

Intially,O
after,O
being,O
transferred,O
from,O
the,O
ICU,O
to,O
the,O
medicine,O
service,O
the,O
patient,O
was,O
mentating,O
appropriately,O
.,O

Her,O
course,O
later,O
became,O
complicated,O
by,O
visual,B-PR
and,I-PR
auditory,I-PR
hallucinations,I-PR
.,O

She,O
made,O
disturbing,O
comments,O
to,O
the,O
hospital,O
personnel,O
.,O

She,O
was,O
unable,B-PR
to,I-PR
sleep,I-PR
at,O
night,O
",",O
often,O
pacing,O
the,O
halls,O
.,O

She,O
required,O
a,B-TR
1:1,I-TR
sitter,I-TR
.,O

Psychiatry,O
was,O
consulted,O
.,O

They,O
felt,O
that,O
her,O
presentation,O
was,O
secondary,O
to,O
delirium,B-PR
and,O
was,O
multifactorial,O
.,O

They,O
attributed,O
it,O
to,O
polypharmacy,B-PR
",",O
recent,B-PR
infection,I-PR
(,I-PR
pneumonia,I-PR
),I-PR
and,O
insomnia,B-PR
.,O

A,B-TE
head,I-TE
CT,I-TE
was,O
done,O
which,O
ruled,O
out,O
any,B-PR
acute,I-PR
processes,I-PR
.,O

The,O
patient,O
refused,O
an,B-TE
LP,I-TE
.,O

They,O
made,O
recommendations,O
for,O
adjustments,O
to,O
her,B-TR
anti-psychotic,I-TR
medications,I-TR
.,O

At,O
discharge,O
the,O
patient,O
was,O
on,O
clonazepam,B-TR
1,O
mg,O
tid,O
",",O
seroquel,B-TR
300,O
BID,O
and,O
neurontin,B-TR
600,O
QAM,O
",",O
1200,O
QPM,O
and,O
1200,O
QHS,O
.,O

The,O
Kindred,O
Hospital,O
hospital,O
course,O
was,O
prolonged,O
because,O
of,O
her,B-PR
delirium,I-PR
.,O

Once,O
her,O
mental,O
status,O
improved,O
she,O
was,O
discharged,O
.,O

5.,O
?,O
Parkinson,B-PR
's,I-PR
Disease,I-PR
/,O
Akithesia,B-PR
:,O

The,O
patient,O
was,O
maintained,O
Sinemet,B-TR
.,O

6.,O
Pain,B-PR
:,O

In,O
addition,O
to,O
her,B-PR
usual,I-PR
neuropathy,I-PR
pain,I-PR
",",O
the,O
pt,O
initially,O
appeared,O
to,O
have,O
significant,B-PR
pain,I-PR
from,O
the,B-PR
multi-focal,I-PR
PNA,I-PR
as,O
well,O
.,O

(,O
Home,B-TR
regimen,I-TR
",",O
Gabapentin,B-TR
800,O
mg,O
PO,O
QAM,O
",",O
1600,O
mg,O
PO,O
Q3PM,O
",",O
1600,O
mg,O
PO,O
QHS,O
.,O

This,O
was,O
held,O
in,O
the,O
ICU,O
and,O
she,O
was,O
given,O
diluadid,B-TR
prn,O
for,O
pain,B-TR
control,I-TR
.,O

The,B-TR
patient,I-TR
's,I-TR
narcotic,I-TR
and,O
CMED,B-TR
CCU,I-TR
regimen,I-TR
was,O
evaluated,O
by,O
psychiatry,O
during,O
her,B-PR
delirium,I-PR
.,O

Please,O
see,O
above,O
for,O
their,O
recommendations,O
.,O

7.,O
FEN,O
:,O

Given,O
her,O
hx,O
of,O
ileostomy,B-TR
secondary,O
to,O
crohn,B-PR
's,I-PR
disease,I-PR
and,O
resultant,O
short,B-PR
gut,I-PR
syndrome,I-PR
",",O
the,O
pt,O
requires,O
nutritional,B-TR
support,I-TR
via,O
TPN,B-TR
.,O

After,O
removal,O
of,O
tunneled,B-TR
line,I-TR
pt,O
was,O
given,O
tube,B-TR
feeds,I-TR
while,O
she,O
was,O
intubated,B-TR
.,O

The,O
patient,O
was,O
transitioned,O
to,O
a,B-TR
low,I-TR
fat,I-TR
",",I-TR
low,I-TR
residue,I-TR
diet,I-TR
.,O

8,O
.,O

PPX,O
:,O
PPI,B-TR
and,O
heparin,B-TR
SC,I-TR

9.,O
Dispo,O
:,O

The,O
patient,O
was,O
discharged,O
home,O
and,O
instructed,O
to,O
follow,O
up,O
with,O
her,O
PCP,O
.,O

Louis,O
follow,O
up,O
scheduled,O
with,O
psychiatry,O
.,O

Medications,O
on,O
Admission,O
:,O

1.,O
Quetiapine,B-TR
300,O
mg,O
QHS,O

2.,O
Clonazepam,B-TR
1,O
mg,O
QAM,O
",",O
1,O
mg,O
Q3PM,O
",",O
2,O
mg,O
PO,O
QHS,O

3.,O
Ferrous,B-TR
Sulfate,I-TR
325,O
PO,O
Daily,O

4.,O
Carbidopa-Levodopa,B-TR
25-250,O
mg,O
PO,O
5,O
TIMES,O
PER,O
DAY,O
.,O

5.,O
Gabapentin,B-TR
800,O
mg,O
PO,O
QAM,O
",",O
1600,O
mg,O
PO,O
Q3PM,O
",",O
1600,O
mg,O
PO,O
QHS,O

6.,O
Heparin,B-TR
Lock,I-TR
Flush,I-TR
10,O
unit,O
/,O
mL,O
Daily,O
as,O
needed,O
.,O

7.,O
Saline,B-TR
Flush,I-TR

8.,O
Prevacid,B-TR
30,O
mg,O
PO,O
twice,O
a,O
day,O
.,O

9.,O
Vistaril,B-TR
50,O
mg,O
once,O
a,O
day,O
as,O
needed,O
for,O
nausea,B-PR
.,O

10.,O
Zofran,B-TR
4,O
mg,O
PO,O
once,O
a,O
day,O
as,O
needed,O
for,O
nausea,B-PR
.,O

11.,O
Vitamin,B-TR
B-12,I-TR
"1,000",O
mcg,O
/,O
mL,O
One,O
Injection,O
every,O
other,O
week,O
.,O

12.,O
Vicodin,B-TR
5-500,O
mg,O
1-2,O
Tablets,O
PO,O
every,O
six,O
(,O
6,O
),O
hours,O
PRN,O

13.,O
Warfarin,B-TR
1,O
mg,O
PO,O
HS,O
.,O

14.,O
TPN,B-TR

Discharge,O
Medications,O
:,O

1.,O
Amylase-Lipase-Protease,B-TR
"33,200",O
-,O
"10,000",O
-,O
"37,500",O
unit,O
Capsule,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
Four,O
(,O
4,O
),O
Cap,O
PO,O
W/,O
MEALS,O
AND,O
SNACKS,O
(,O

Disp,O
:*,O
120,O
Cap,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

2.,O
Carbidopa-Levodopa,B-TR
25,O
-,O
250,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
5,O
TIMES,O
A,O
DAY,O
(,O

Disp,O
:*,O
150,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

3.,O
Pramipexole,B-TR
0.125,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
.,O

Disp,O
:*,O
90,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

4.,O
Clonazepam,B-TR
1,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
.,O

Disp,O
:*,O
90,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
0,O
*,O

5.,O
Ferrous,B-TR
Sulfate,I-TR
300,O
mg,O
/,O
5,O
mL,O
Liquid,O
Sig,O
:,O
One,O
(,O
1,O
),O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

Disp,O
:*,O
5,O
bottles,O
*,O
Refills,O
:*,O
2,O
*,O

6.,O
Nystatin,B-TR
"100,000",O
unit,O
/,O
g,O
Cream,O
Sig,O
:,O
One,O
(,O
1,O
),O
Appl,O
Topical,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

Disp,O
:*,O
3,O
tubes,O
*,O
Refills,O
:*,O
2,O
*,O

7.,O
Lansoprazole,B-TR
30,O
mg,O
Capsule,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

Disp,O
:*,O
60,O
Capsule,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
)(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

8.,O
Quetiapine,B-TR
100,O
mg,O
Tablet,O
Sig,O
:,O
Three,O
(,O
3,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

Disp,O
:*,O
180,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

9.,O
Propranolol,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

Disp,O
:*,O
60,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

10.,O
Neurontin,B-TR
300,O
mg,O
Capsule,O
Sig,O
:,O
Three,O
(,O
3,O
),O
Capsule,O
PO,O
three,O
times,O
a,O
day,O
:,O
take,O
2,O
tabs,O
in,O
the,O
morining,O
",",O
4,O
tabs,O
in,O
the,O
afternoon,O
",",O
and,O
4,O
tabs,O
in,O
the,O
evening,O
.,O

Disp,O
:*,O
100,O
Capsule,O
(,O
s,O
)*,O
Refills,O
:*,O
0,O
*,O

Discharge,O
Disposition,O
:,O

Home,O
with,O
Service,O

Discharge,O
Diagnosis,O
:,O

Pneumonia,B-PR

Discharge,O
Condition,O
:,O

Good,O

Discharge,O
Instructions,O
:,O

You,O
are,O
to,O
return,O
to,O
the,O
hospital,O
immediately,O
if,O
you,O
should,O
experience,O
any,B-PR
chest,I-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
fevers,B-PR
or,O
any,B-PR
other,I-PR
worrisome,I-PR
symptom,I-PR
.,O

Please,O
continue,O
taking,O
your,B-TR
medications,I-TR
as,O
prescribed,O
.,O

Followup,O
Instructions,O
:,O

Provider,O
:,O

Joyce,O
",",O
Catherine,O
PSYCHIATRY,O
CMED,O
CSRU,O
Phone,O
:(,O
405,O
),O
582-6811,O

Date,O
/,O
Time,O
:,O
2014-01-21,O
3:30,O

Please,O
followup,O
with,O
your,O
primary,O
care,O
physician,O
Todd,O
12-30,O
weeks,O
of,O
discharge,O
.,O

Donna,O
Mcguire,O
MD,O
19-274,O

Completed,O
by,O
:,O

Mark,O
Joseph,O
MD,O
04-104,O
2014-05-18,O
@,O
2128,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Donna,O
Nance,O
on,O
:,O
WED,O
2014-06-04,O
2:21,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2018-10-25,O

Discharge,O
Date,O
:,O

2018-10-31,O

Date,O
of,O
Birth,O
:,O

1951-06-15,O

Sex,O
:,O

M,O

Service,O
:,O

CARDIOTHORACIC,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,O
Drugs,B-TR

Attending,O
:,O
Michael,O
D.,O
Christensen,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Shortness,B-PR
of,I-PR
Breath,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

Coronary,B-TR
Artery,I-TR
Bypass,I-TR
Graft,I-TR
x3,O
(,O
Left,B-TR
internal,I-TR
mammary,I-TR
->,I-TR
left,I-TR
anterior,I-TR
descending,I-TR
",",O
saphaneous,B-TR
vein,I-TR
graft,I-TR
->,I-TR
obtuse,I-TR
marginal,I-TR
",",O
saphaneous,B-TR
vein,I-TR
graft,I-TR
->,I-TR
posterior,I-TR
descending,I-TR
artery,I-TR
),O
2018-10-25,O

History,O
of,O
Present,O
Illness,O
:,O

67,O
y/o,O
male,O
with,O
worsening,B-PR
shortness,I-PR
of,I-PR
breath.,I-PR
Had,O
abnormal,B-PR
ETT,I-PR
and,O
referred,O
for,O
cath,B-TE
.,O

Cath,B-TE
revealed,O
severe,B-PR
3,I-PR
vessel,I-PR
disease,I-PR
.,O

Then,O
referred,O
for,O
surgical,B-TR
intervention,I-TR
.,O

Past,O
Medical,O
History,O
:,O

Carpal,B-PR
tunnel,I-PR
syndrome,I-PR
",",O
Hypertension,B-PR
",",O
Hyperlipidemia,B-PR
",",O
Arthritis,B-PR
",",O
h/o,O
Bell's,B-PR
Palsy,I-PR
",",O
HOH,B-PR
",",O
s/p,O
Tonsillectomy,B-TR

Social,O
History,O
:,O

Denies,O
ETOH,O
",",O
rare,O
Tobacco,O
.,O

Electrician,O
.,O

Family,O
History,O
:,O

Father,O
with,O
MI,B-PR
in,O
50,O
's,O
and,O
underwent,O
CABG,B-TR
.,O

Physical,O
Exam,O
:,O

"VS,B-TE
:,O
65,O
20,O
160/100,O
5,O
',O
7,O
"",O
180,O
#",O

General,O
:,O
WD/WN,O
male,O
in,O
NAD,B-PR

HEENT,O
:,O
EOMI,O
",",O
PERRL,O
",",O
NC/AT,B-PR

Neck,O
:,O
Supple,O
",",O
FROM,O
",",O
-,O
JVD,B-PR
",",O
-,O
carotid,B-PR
bruits,I-PR

Chest,O
:,O
CTAB,O
-,O
w/r/r,B-PR

Heart,O
:,O
RRR,O
-,O
c/r/m/g,B-PR

Abd,O
:,O
Soft,O
",",O
NT/ND,B-PR
+BS,O

Ext,O
:,O
Warm,O
",",O
well-perfused,O
-,O
edema,B-PR
",",O
-,O
varicosities,B-PR

Neuro,O
:,O
A&Ox3,O
",",O
MAE,O
",",O
non-focal,O

Pertinent,O
Results,O
:,O

Echo,B-TE
10-25,O
:,O
PRE-BYPASS,O
:,O
Left,B-TE
ventricular,I-TE
wall,I-TE
thicknesses,I-TE
are,O
normal,O
.,O

The,B-TE
left,I-TE
ventricular,I-TE
cavity,I-TE
size,I-TE
is,O
normal,O
.,O

There,O
is,O
mild,B-PR
inferior,I-PR
wall,I-PR
hypokinesis,I-PR
.,O

There,O
is,O
akinesis,B-PR
/,O
dyskinesis,B-PR
and,O
thinning,B-PR
of,I-PR
the,I-PR
mid,I-PR
to,I-PR
distal,I-PR
inferior,I-PR
septum,I-PR
and,O
the,O
apex,O
.,O

Overall,B-TE
left,I-TE
ventricular,I-TE
systolic,I-TE
function,I-TE
is,O
mildly,B-PR
depressed,I-PR
.,O

Right,B-TE
ventricular,I-TE
chamber,I-TE
size,I-TE
and,O
free,B-TE
wall,I-TE
motion,I-TE
are,O
normal,O
.,O

The,O
descending,O
thoracic,O
aorta,O
is,O
mildly,B-PR
dilated,I-PR
.,O

There,O
are,O
simple,B-PR
atheroma,I-PR
in,I-PR
the,I-PR
descending,I-PR
thoracic,I-PR
aorta,I-PR
.,O

There,O
are,O
three,O
aortic,O
valve,O
leaflets,O
.,O

There,O
is,O
no,O
aortic,B-PR
valve,I-PR
stenosis,I-PR
.,O

No,O
aortic,B-PR
regurgitation,I-PR
is,O
seen,O
.,O

The,O
mitral,O
valve,O
leaflets,O
are,O
mildly,B-PR
thickened,I-PR
.,O

Trivial,B-PR
mitral,I-PR
regurgitation,I-PR
is,O
seen,O
.,O

POST-BYPASS,B-TR
:,O
LV,B-TE
and,I-TE
RV,I-TE
function,I-TE
is,O
unchanged,O
.,O

Aorta,O
is,O
unchanged,O
.,O

Other,O
findings,O
are,O
unchanged,O
.,O

CXR,B-TE
10-30,O
:,O
Left,B-PR
lower,I-PR
lobe,I-PR
atelectasis,I-PR
has,O
partially,O
cleared,O
.,O

Upper,O
lungs,O
are,O
clear,O
.,O

Mild,B-PR
postoperative,I-PR
widening,I-PR
of,I-PR
the,I-PR
cardiomediastinal,I-PR
silhouette,I-PR
is,O
stable,O
.,O

No,O
pneumothorax,B-PR
.,O

2018-10-25,O
11:15,O
AM,O
BLOOD,B-TE
WBC,B-TE
-,O
18.3,O
*#,O
RBC,B-TE
-,O
3.42,O
*,O
Hgb,B-TE
-,O
10.9,O
*,O
Hct,B-TE
-,O
31.6,O
*,O
MCV,B-TE
-,O
92,O
MCH,B-TE
-,O
31.7,O
MCHC,B-TE
-,O
34.4,O
RDW,B-TE
-,O
13.3,O
Plt,B-TE
Ct,I-TE
-,O
134,O
*,O

2018-10-31,O
06:25,O
AM,O
BLOOD,B-TE
WBC,B-TE
-,O
13.6,O
*,O
RBC,B-TE
-,O
2.72,O
*,O
Hgb,B-TE
-,O
8.6,O
*,O
Hct,B-TE
-,O
24.6,O
*,O
MCV,B-TE
-,O
91,O
MCH,B-TE
-,O
31.7,O
MCHC,B-TE
-,O
35.0,O
RDW,B-TE
-,O
14.0,O
Plt,B-TE
Ct,I-TE
-,O
314,O

2018-10-25,O
11:15,O
AM,O
BLOOD,B-TE
PT,B-TE
-,O
13.3,O
*,O
PTT,B-TE
-,O
30.0,O
INR(PT),B-TE
-,O
1.2,O
*,O

2018-10-29,O
06:50,O
AM,O
BLOOD,B-TE
PT,B-TE
-,O
11.9,O
INR(PT),B-TE
-,O
1.0,O

2018-10-25,O
12:36,O
PM,O
BLOOD,B-TE
UreaN,B-TE
-,O
17,O
Creat,B-TE
-,O
0.7,O
Cl,B-TE
-,O
111,O
*,O
HCO3,B-TE
-,O
23,O

2018-10-31,O
06:25,O
AM,O
BLOOD,B-TE
Glucose,B-TE
-,O
91,O
UreaN,B-TE
-,O
19,O
Creat,B-TE
-,O
0.8,O
Na,B-TE
-,O
134,O
K,B-TE
-,O
4.0,O
Cl,B-TE
-,O
98,O
HCO3,B-TE
-,O
26,O
AnGap,B-TE
-,O
14,O

Brief,O
Hospital,O
Course,O
:,O

Mr.,O
Kammerer,O
was,O
a,O
same,O
day,O
admit,O
and,O
on,O
10-25,O
was,O
brought,O
to,O
the,O
operating,O
room,O
where,O
he,O
underwent,O
a,B-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
x,O
3,O
.,O

Please,O
see,O
operative,O
report,O
for,O
surgical,O
details,O
.,O

He,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
and,O
was,O
transferred,O
to,O
the,O
CSRU,O
for,O
invasive,B-TE
monitoring,I-TE
in,O
stable,O
condition,O
.,O

Later,O
on,O
op,O
day,O
he,O
was,O
weaned,O
from,O
sedation,B-TR
",",O
awoke,O
neurologically,O
intact,O
",",O
and,O

extubated,O
.,O

Beta,B-TR
blockers,I-TR
and,O
diuretics,B-TR
were,O
initiated,O
on,O
post-op,O
day,O
one,O
.,O

He,O
was,O
diuresed,B-TR
towards,O
his,B-TE
pre-op,I-TE
weight,I-TE
.,O

He,O
appeared,O
to,O
be,O
doing,O
well,O
and,O
was,O
transferred,O
to,O
the,O
SDU,O
on,O
this,O
day,O
.,O

He,O
did,O
have,O
burst,B-PR
of,I-PR
atrial,I-PR
fibrillation,I-PR
and,O
was,O
started,O
on,O
a,B-TR
Amiodarone,I-TR
gtt,I-TR
.,O

His,B-TR
beta,I-TR
blockers,I-TR
were,O
also,O
titrated,O
for,O
maximal,B-TR
BP,I-TR
and,I-TR
HR,I-TR
control,I-TR
.,O

Chest,B-TR
tubes,I-TR
were,O
removed,O
on,O
post-op,O
day,O
two,O
and,O
epicardial,B-TR
pacing,I-TR
wires,I-TR
on,O
post-op,O
day,O
three,O
.,O

Over,O
the,O
next,O
several,O
days,O
he,O
continued,O
to,O
improve,O
his,O
ambulation,O
and,O
mobility,O
with,O
physical,B-TR
therapy,I-TR
.,O

He,O
had,O
no,O
further,B-PR
episodes,I-PR
of,I-PR
AFIB,I-PR
while,O
on,O
po,B-TR
Amiodarone,I-TR
.,O

On,O
post-op,O
day,O
five,O
he,O
appeared,O
to,O
have,O
left,B-PR
arm,I-PR
phlebitis,I-PR
and,O
was,O
started,O
on,O
antibiotics,B-TR
.,O

He,O
was,O
discharged,O
home,O
on,O
post-op,O
day,O
six,O
with,O
antibiotics,B-TR
and,O
appropriate,B-TR
meds,I-TR
.,O

He,O
will,O
have,O
VNA,B-TR
services,I-TR
and,O
make,O
the,O
appropriate,O
follow-up,O
appointments,O
.,O

Medications,O
on,O
Admission,O
:,O

Aspirin,B-TR
81,O
mg,O
qd,O
",",O
Toprol,B-TR
XL,O
50,O
mg,O
qd,O
",",O
MVI,B-TR
",",O
Flexeril,B-TR
10,O
mg,O
qhs,O
",",O
Plavix,B-TR
75,O
mg,O
qd,O
(,O
last,O
on,O
10-18,O
),O

Discharge,O
Medications,O
:,O

1.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

Disp,O
:*,O
60,O
Capsule,O
(s)*,O
Refills,O
:*,O
0,O
*,O

2.,O
Aspirin,B-TR
81,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp:*,O
30,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
)(s)*,O
Refills,O
:*,O
0,O
*,O

3.,O
Ranitidine,B-TR
HCl,I-TR
150,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

Disp,O
:*,O
60,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

4.,O
Oxycodone,B-TR
-,I-TR
Acetaminophen,I-TR
5-325,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
Q4H,O
(,O
every,O
4,O
hours,O
),O
as,O
needed,O
for,O
pain,B-PR
.,O

Disp,O
:*,O
40,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

5.,O
Atorvastatin,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

6.,O
Amiodarone,B-TR
200,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
):,O
please,O
take,O
400,O
mg,O
twice,O
a,O
day,O
until,O
11-02,O
then,O
decrease,O
to,O
400,O
mg,O
once,O
a,O
day,O
for,O
1,O
week,O
and,O
then,O
decrease,O
to,O
200,O
mg,O
once,O
a,O
day,O
.,O

Disp,O
:*,O
40,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

7.,O
Metoprolol,B-TR
Succinate,I-TR
50,O
mg,O
Tablet,O
Sustained,O
Release,O
24,O
HR,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
Sustained,O
Release,O
24,O
HR,O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Tablet,O
Sustained,O
Release,O
24,O
HR,O
(s)*,O
Refills,O
:*,O
0,O
*,O

8.,O
Ferrous,B-TR
Gluconate,I-TR
300,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

9.,O
Ascorbic,B-TR
Acid,I-TR
500,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

Disp,O
:*,O
60,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

10.,O
Cephalexin,B-TR
500,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
Q6H,O
(,O
every,O
6,O
hours,O
),O
for,O
6,O
days,O
:,O
please,O
complete,O
full,O
course,O
.,O

Disp,O
:*,O
24,O
Capsule,O
(s)*,O
Refills,O
:*,O
0,O
*,O

11.,O
Furosemide,B-TR
20,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
once,O
a,O
day,O
for,O
2,O
weeks,O
.,O

Disp,O
:*,O
14,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

12.,O
Potassium,B-TR
Chloride,I-TR
10,O
mEq,O
Capsule,O
",",O
Sustained,O
Release,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
",",O
Sustained,O
Release,O
PO,O
DAILY,O
(,O
Daily,O
),O
for,O
2,O
weeks,O
.,O

Disp,O
:*,O
14,O
Capsule,O
",",O
Sustained,O
Release,O
(s)*,O
Refills,O
:*,O
0,O
*,O

13.,O
Lisinopril,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
0.5,O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
15,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

Discharge,O
Disposition,O
:,O

Home,O
with,O
Service,O

Discharge,O
Diagnosis,O
:,O

Coronary,B-PR
artery,I-PR
disease,I-PR
s/p,O
Coronary,B-TR
Artery,I-TR
Bypass,I-TR
Graft,I-TR
x3,O

PMH,O
:,O
Carpal,B-PR
tunnel,I-PR
syndrome,I-PR
",",O
Hypertension,B-PR
",",O
Hyperlipidemia,B-PR
",",O
Arthritis,B-PR

Discharge,O
Condition,O
:,O

good,O

Discharge,O
Instructions,O
:,O

May,O
shower,O
",",O
no,O
baths,O
or,O
swimming,O

Monitor,O
wounds,B-PR
for,O
infection,B-PR
-,O
redness,B-PR
",",O
drainage,B-PR
",",O
or,O
increased,B-PR
pain,I-PR

Report,O
any,B-PR
fever,I-PR
greater,I-PR
than,I-PR
101,I-PR

Report,O
any,B-PR
weight,I-PR
gain,I-PR
of,O
greater,O
than,O
2,O
pounds,O
in,O
24,O
hours,O
or,O
5,O
pounds,O
in,O
a,O
week,O

No,O
creams,B-TR
",",O
lotions,B-TR
",",O
powders,B-TR
",",O
or,O
ointments,B-TR
to,O
incisions,B-PR

No,O
driving,O
for,O
approximately,O
one,O
month,O

No,O
lifting,O
more,O
than,O
10,O
pounds,O
for,O
10,O
weeks,O

Please,O
call,O
with,O
any,O
questions,O
or,O
concerns,O

Left,O
Arm,O
continue,O
with,O
elevation,B-TR
",",O
ice,B-TR
",",O
and,O
complete,O
all,B-TR
antibiotics,I-TR

Followup,O
Instructions,O
:,O

Dr,O
Day,O
in,O
4,O
weeks,O
((,O
469,O
),O
587-0462,O
),O
please,O
call,O
for,O
appointment,O

Dr,O
Miller,O
in,O
1,O
week,O
(,O
262-575-0600,O
),O
please,O
call,O
for,O
appointment,O

Dr,O
Scott,O
Raines,O
in,O
2-3,O
weeks,O
please,O
call,O
for,O
appointment,O

Wound,O
check,O
appointment,O
4,O
East,O
as,O
instructed,O
by,O
nurse,O
(,O
280-5326,O
),O

For,O
surgical,B-PR
incision,I-PR
and,O
left,O
arm,O

Craig,O
Douglas,O
MD,O
10-898,O

Completed,O
by,O
:,O
Reyes,O
Marengo,O
PA,O
80,O
-,O
BMD,O
2018-11-19,O
@,O
1536,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Jeffrey,O
Collins,O
on,O
:,O
WED,O
2018-11-21,O
9:28,O
AM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2011-03-10,O

Discharge,O
Date,O
:,O

2011-03-15,O

Date,O
of,O
Birth,O
:,O

1927-10-26,O

Sex,O
:,O

F,O

Service,O
:,O

Medford,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
an,O
83,O
year,O
old,O
woman,O
with,O
a,O
history,O
of,O
hypertension,B-PR
who,O
presents,O
with,O
slurred,B-PR
speech,I-PR
when,O
dehydrated,B-PR
.,O

She,O
has,O
paraplegia,B-PR
secondary,O
to,O
HTLV,B-PR
exposure,I-PR
while,O
on,O
vacation,O
in,O
the,O
Bahamas,O
six,O
years,O
ago,O
.,O

She,O
presented,O
with,O
three,O
days,O
of,O
general,B-PR
malaise,I-PR
",",O
nausea,B-PR
",",O
vomiting,B-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
cough,B-PR
productive,O
of,O
white,B-PR
sputum,I-PR
.,O

She,O
awoke,O
with,O
nausea,B-PR
on,O
the,O
day,O
of,O
admission,O
and,O
pleuritic,B-PR
chest,I-PR
pain,I-PR
.,O

She,O
reports,O
no,O
sick,O
contacts.,O

The,O
patient,O
has,O
some,B-PR
difficulty,I-PR
talking,O
and,O
grasping,O
right,O
hand,O
.,O

She,O
came,O
to,O
the,O
Emergency,O
Department,O
on,O
the,O
2011-03-10,O
",",O
with,O
temperature,B-TE
of,O
99.0,O
F,O
.;,O
blood,B-TE
pressure,I-TE
of,O
97/50,O
;,O
heart,B-TE
rate,I-TE
100,O
;,O
respirations,B-TE
27,O
;,O
O2,B-TE
saturation,I-TE
84%,O
on,O
room,O
air,O
and,O
94%,O
on,O
two,O
liters,O
.,O

The,O
patient,O
had,O
coarse,B-PR
rhonchi,I-PR
on,O
examination,B-TE
.,O

Chest,B-TE
x-ray,I-TE
revealed,O
mild,B-PR
pulmonary,I-PR
edema,I-PR
.,O

Chest,B-TE
CT,I-TE
scan,I-TE
was,O
negative,O
for,O
pulmonary,B-PR
embolism,I-PR
but,O
positive,O
for,O
consolidation,B-PR
.,O

She,O
was,O
started,O
on,O
Levofloxacin,B-TR
but,O
the,O
patient,O
became,O
hypotensive,B-PR
at,O
that,O
point,O
with,O
blood,B-TE
pressure,I-TE
of,O
70/45,O
and,O
received,O
a,B-TR
normal,I-TR
saline,I-TR
bolus,I-TR
to,O
boost,O
her,B-TE
blood,I-TE
pressure,I-TE
to,O
99/60,O
;,O
however,O
the,O
patient,O
was,O
admitted,O
to,O
the,O
Medical,O
Intensive,O
Care,O
Unit,O
for,O
overnight,B-TE
observation,I-TE
because,O
of,O
her,B-PR
somnolence,I-PR
and,O
hypotension,B-PR
.,O

She,O
was,O
transferred,O
to,O
the,O
Everett,O
Firm,O
on,O
the,O
2011-03-11,O
and,O
was,O
mentating,O
well,O
and,O
was,O
stable,O
for,O
transfer,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Positive,B-PR
lupus,I-PR
anti-coagulant,I-PR
.,O

2.,O
Basilar,B-PR
stenosis,I-PR
.,O

3.,O
Prior,B-PR
transient,I-PR
ischemic,I-PR
attacks,I-PR
.,O

4.,O
Right,B-TR
medial,I-TR
malleolus,I-TR
repair,I-TR
in,O
2004-08-05,O
.,O

5.,O
Paraplegia,B-PR
secondary,O
to,O
HTLV,B-PR
from,O
a,O
trip,O
to,O
the,O
Bahamas,O
five,O
to,O
six,O
years,O
ago,O
.,O

6.,O
Hypertension,B-PR
.,O

7.,O
Chronic,B-PR
diarrhea,I-PR
with,O
multiple,O
admissions,O
for,O
dehydration,B-PR
with,O
most,O
recent,O
one,O
on,O
2011-02-26,O
.,O

8.,O
Venous,B-PR
stasis,I-PR
.,O

9.,O
Depression,B-PR
.,O

10.,O
Seizure,B-PR
history,I-PR
on,O
Neurontin,B-TR
.,O

11.,O
Left,B-TR
CMED,I-TR
cataract,I-TR
surgery,I-TR
in,O
2009-10-05,O
.,O

12.,O
Chronic,B-PR
muscle,I-PR
spasms,I-PR
.,O

ALLERGIES,O
:,O

Penicillin,B-TR
for,O
which,O
she,O
reports,O
a,B-PR
rash,I-PR
and,O
dyspepsia,B-PR
when,O
taking,O
uncoated,B-TR
aspirin,I-TR
.,O

She,O
has,O
a,O
questionable,O
sensitivity,B-PR
to,O
iodine,B-TR
.,O

MEDICATIONS,O
AS,O
OUTPATIENT,O
:,O

1.,O
Enteric-coated,B-TR
aspirin,I-TR
.,O

2.,O
Aggrenox,B-TR
.,O

3.,O
Zanaflex,B-TR
.,O

4.,O
Neurontin,B-TR
300,O
mg,O
three,O
times,O
a,O
day,O
.,O

5.,O
Celexa,B-TR
10,O
mg,O
daily,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,B-TE
examination,I-TE
she,O
was,O
a,O
well,O
developed,O
",",O
well,O
nourished,O
female,O
in,O
no,O
apparent,B-PR
distress,I-PR
.,O

She,O
was,O
alert,O
and,O
oriented,O
times,O
three,O
.,O

Speech,O
was,O
fluent,O
.,O

Her,O
lungs,O
revealed,O
coarse,B-PR
bilateral,I-PR
rhonchi,I-PR
from,O
base,O
to,O
midline,O
.,O

Cardiovascular,B-TE
examination,I-TE
is,O
notable,O
for,O
a,O
regular,O
rate,O
and,O
rhythm,O
;,O
no,O
murmurs,B-PR
",",O
rubs,B-PR
or,O
gallops,B-PR
.,O

Abdomen,O
is,O
soft,O
and,O
obese,B-PR
",",O
nontender,B-PR
.,O

Normal,O
bowel,O
sounds,O
present,O
.,O

Extremities,O
notable,O
for,O
two,B-PR
plus,I-PR
lower,I-PR
extremity,I-PR
edema,I-PR
and,O
the,O
ankles,O
were,O
noted,O
to,O
be,O
in,O
pressure,B-TR
stockings,I-TR
.,O

LABORATORY,O
:,O

White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
were,O
11.8,O
",",O
hematocrit,B-TE
31.5,O
",",O
platelets,B-TE
151,O
.,O

Chem-7,B-TE
was,O
a,B-TE
sodium,I-TE
of,O
140,O
",",O
potassium,B-TE
of,O
3.0,O
",",O
chloride,B-TE
108,O
",",O
bicarbonate,B-TE
24,O
",",O
BUN,B-TE
22,O
",",O
creatinine,B-TE
1.0,O
and,O
glucose,B-TE
117,O
.,O

The,O
patient,O
also,O
had,O
a,B-TE
head,I-TE
CT,I-TE
scan,I-TE
in,O
the,O
Emergency,O
Department,O
before,O
coming,O
to,O
the,O
Unit,O
which,O
reported,O
no,O
recent,B-PR
bleed,I-PR
and,O
no,O
change,B-PR
from,O
a,B-TE
prior,I-TE
CT,I-TE
scan,I-TE
done,O
on,O
2011-03-04,O
.,O

EKG,B-TE
is,O
notable,O
for,O
sinus,B-PR
tachycardia,I-PR
at,O
100,O
beats,O
per,O
minute,O
",",O
normal,O
axis,O
.,O

.....,O
done,O
on,O
02-24,O
",",O
notable,O
for,O
mid-basilar,B-PR
artery,I-PR
high-grade,I-PR
stenosis,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

After,O
transfer,O
to,O
the,O
Floor,O
",",O
the,O
patient,O
was,O
continued,O
on,O
Levofloxacin,B-TR
for,O
a,O
ten,O
to,O
14,O
day,O
course,O
for,O
presumptive,O
pneumonia,B-PR
.,O

Due,O
to,O
her,B-PR
chronic,I-PR
diarrhea,I-PR
she,O
was,O
repleted,O
with,O
intravenous,B-TR
fluids,I-TR
.,O

For,O
her,B-PR
depression,I-PR
",",O
continued,O
on,O
Citalopram,B-TR
10,O
mg,O
daily,O
.,O

For,O
her,B-PR
paraplegia,I-PR
and,O
associated,O
muscle,B-PR
spasticity,I-PR
she,O
was,O
continued,O
on,O
her,B-TR
Zanaflex,I-TR
.,O

For,O
deep,B-TR
vein,I-TR
thrombosis,I-TR
prophylaxis,I-TR
she,O
was,O
treated,O
with,O
subcutaneous,B-TR
heparin,I-TR
and,O
for,O
gastrointestinal,B-TR
prophylaxis,I-TR
she,O
was,O
treated,O
with,O
Protonix,B-TR
.,O

She,O
was,O
also,O
evaluated,O
by,O
Physical,B-TR
Therapy,I-TR
and,O
Speech,B-TR
and,O
Swallow,B-TR
because,O
of,O
some,O
report,O
of,O
dysphagia,B-PR
.,O

Physical,B-TR
Therapy,I-TR
felt,O
that,O
the,O
patient,O
was,O
cleared,O
for,O
transfer,O
home,O
with,O
services,O
.,O

Occupational,B-TR
Therapy,I-TR
was,O
also,O
in,O
agreement,O
with,O
the,O
patient,O
's,O
disposition,O
home,O
with,O
services,O
.,O

The,O
patient,O
was,O
able,O
to,O
advance,O
her,O
diet,O
well,O
from,O
liquids,O
to,O
solids,O
",",O
however,O
",",O
she,O
was,O
plagued,O
with,O
a,B-PR
persistent,I-PR
cough,I-PR
and,O
some,B-PR
low,I-PR
grade,I-PR
fevers,I-PR
to,O
99.0,O
F,O
.,O

Speech,B-TR
and,O
Swallow,B-TR
evaluated,O
the,O
patient,O
at,O
bedside,O
and,O
recommended,O
advancing,O
to,O
regular,O
diet,O
with,O
regular,O
consistency,O
and,O
saw,O
no,O
evidence,O
of,O
any,B-PR
dysphagia,I-PR
.,O

There,O
was,O
some,O
question,O
regarding,O
restarting,O
of,O
the,B-TR
patient,I-TR
's,I-TR
Coumadin,I-TR
given,O
her,B-PR
positive,I-PR
lupus,I-PR
anti-coagulant,I-PR
status,I-PR
as,O
well,O
as,O
the,O
presence,O
of,O
her,B-PR
basilar,I-PR
artery,I-PR
stenosis,I-PR
.,O

The,O
patient,O
was,O
discharged,O
on,O
the,O
2011-03-15,O
on,O
the,B-TR
following,I-TR
medications,I-TR
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Levofloxacin,B-TR
250,O
mg,O
q.,O
day,O
for,O
ten,O
days,O
.,O

2.,O
Aspirin,B-TR
/,O
dipyridamole,B-TR
25/200,O
mg,O
capsules,O
taken,O
two,O
times,O
a,O
day,O
.,O

3.,O
Neurontin,B-TR
300,O
mg,O
taken,O
three,O
times,O
a,O
day,O
.,O

4.,O
Subcutaneous,B-TR
heparin,I-TR
taken,O
5000,O
units,O
twice,O
a,O
day,O
.,O

5.,O
Albuterol,B-TR
multiple,I-TR
dose,I-TR
inhalers,I-TR
",",O
one,O
to,O
two,O
puffs,O
q.,O
six,O
hours,O
as,O
needed,O
.,O

6.,O
Atrovent,B-TR
multiple,I-TR
dose,I-TR
inhalers,I-TR
",",O
one,O
to,O
two,O
puffs,O
q.,O
six,O
hours,O
as,O
needed,O
.,O

7.,O
Citalopram,B-TR
10,O
mg,O
q.,O
day,O
.,O

8.,O
Lisinopril,B-TR
2.5,O
mg,O
once,O
a,O
day,O
.,O

9.,O
Trazodone,B-TR
25,O
mg,O
q.,O
h.s.,O
p.r.n.,O

10.,O
Protonix,B-TR
40,O
mg,O
q.,O
day,O
.,O

11.,O
Zanaflex,B-TR
2,O
mg,O
twice,O
a,O
day,O
.,O

12.,O
Tylenol,B-TR
325,O
mg,O
",",O
one,O
to,O
two,O
tablets,O
q.,O
four,O
to,O
six,O
hours,O
p.r.n.,O

13.,O
The,O
patient,O
was,O
also,O
discharged,O
with,O
the,O
restarting,O
of,O
warfarin,B-TR
2,O
mg,O
daily,O
.,O

DISCHARGE,O
INSTRUCTIONS,O
:,O

1.,O
She,O
was,O
instructed,O
to,O
have,O
blood,B-TE
drawn,O
by,O
the,O
Visiting,O
Nurses,O
Association,O
the,O
day,O
after,O
discharge,O
and,O
then,O
a,O
few,O
days,O
after,O
discharge,O
the,O
same,O
week,O
to,O
have,O
INR,B-TE
.,O

Will,O
also,O
have,O
INR,B-TE
checked,O
at,O
once,O
weekly,O
until,O
target,O
of,O
INR,B-TE
of,O
2.0,O
to,O
3.0,O
is,O
reached,O
.,O

2.,O
The,O
patient,O
was,O
instructed,O
to,O
contact,O
Dr.,O
Ralph,O
at,O
(,O
428,O
),O
678-6930,O
",",O
who,O
is,O
covering,O
for,O
her,O
primary,O
care,O
physician,O
",",O
Dr.,O
Erika,O
Witt,O
",",O
to,O
adjust,O
her,B-TR
dosages,I-TR
based,O
on,O
the,B-TE
INR,I-TE
levels,I-TE
.,O

3.,O
The,O
patient,O
also,O
had,O
a,O
Gastrointestinal,O
Clinic,O
follow-up,O
on,O
2011-03-28,O
.,O

She,O
is,O
to,O
follow-up,O
with,O
Dr.,O
Geraldo,O
Davis,O
.,O

4.,O
She,O
was,O
also,O
instructed,O
to,O
follow-up,O
with,O
Dr.,O
Reid,O
from,O
Neurology,O
within,O
a,O
month,O
at,O
(,O
382,O
),O
716,O
4151,O
",",O
given,O
her,B-PR
neurological,I-PR
deficits,I-PR
during,O
this,O
presentation,O
.,O

Brenda,O
L.,O
Nelson,O
",",O
M.D.,O

Dictated,O
By,O
:,O
Rodolfo,O
X,O
Gifford,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2011-04-18,O
16:17,O

T,O
:,O
2011-04-18,O
22:11,O

JOB,O
#:,O

46153,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Dorothy,O
Donahue,O
on,O
:,O
TUE,O
2011-04-19,O
3:15,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2012-11-06,O

Discharge,O
Date,O
:,O

2012-11-11,O

Date,O
of,O
Birth,O
:,O

1965-09-22,O

Sex,O
:,O

M,O

Service,O
:,O

CCU,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
47,O
-,O
year-old,O
male,O
with,O
a,O
past,O
medical,O
history,O
of,O
coronary,B-PR
artery,I-PR
disease,I-PR
",",O
status,B-TR
post,I-TR
2-vessel,I-TR
percutaneous,I-TR
transluminal,I-TR
coronary,I-TR
angioplasty,I-TR
in,O
2005,O
",",O
3-vessel,B-TR
percutaneous,I-TR
transluminal,I-TR
coronary,I-TR
angioplasty,I-TR
in,O
2009,O
",",O
hypertension,B-PR
",",O
new,B-PR
onset,I-PR
type,I-PR
2,I-PR
diabetes,I-PR
",",O
and,O
hypercholesterolemia,B-PR
who,O
presents,O
with,O
the,O
sudden,O
onset,O
of,O
substernal,B-PR
chest,I-PR
pain,I-PR
status,O
post,O
exercise,O
.,O

The,O
patient,O
presented,O
to,O
Bournewood,O
Hospital,O
on,O
the,O
morning,O
of,O
admission,O
with,O
a,O
chief,O
complaint,O
of,O
substernal,B-PR
burning,I-PR
without,O
radiation,O
which,O
developed,O
while,O
doing,O
exercise,O
.,O

Of,O
note,O
",",O
this,O
is,O
the,O
second,O
time,O
the,O
patient,O
has,O
exercised,O
in,O
many,O
months,O
.,O

The,B-PR
pain,I-PR
became,O
worse,O
over,O
the,O
next,O
few,O
minutes,O
to,O
07-12,O
and,O
increased,O
to,O
10-12,O
while,O
he,O
was,O
in,O
the,O
ambulance,O
.,O

His,B-TR
nitroglycerin,I-TR
patch,I-TR
did,O
not,O
help,O
",",O
and,O
he,O
only,O
had,O
slight,O
relief,O
with,O
sublingual,B-TR
nitroglycerin,I-TR
times,O
three,O
.,O

In,O
addition,O
",",O
he,O
had,O
slight,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
but,O
denies,O
headache,B-PR
",",O
change,B-PR
in,I-PR
vision,I-PR
",",O
dizziness,B-PR
",",O
nausea,B-PR
",",O
vomiting,B-PR
",",O
abdominal,B-PR
pain,I-PR
",",O
change,B-PR
in,I-PR
bowel,I-PR
or,I-PR
urinary,I-PR
habits,I-PR
",",O
or,O
fevers,B-PR
",",O
chills,B-PR
",",O
and,O
sweats,B-PR
.,O

Of,O
note,O
",",O
he,O
had,O
a,O
negative,O
stress,O
test,O
in,O
2012-07-03,O
.,O

He,O
was,O
sent,O
to,O
Bournewood,O
Hospital,O
via,O
ambulance,O
.,O

In,O
the,O
Emergency,O
Department,O
he,O
received,O
aspirin,B-TR
",",O
nitroglycerin,B-TR
drip,I-TR
",",O
heparin,B-TR
drip,I-TR
",",O
Dilaudid,B-TR
",",O
and,O
TNK,B-TR
with,O
decreased,O
in,O
his,B-PR
pain,I-PR
but,O
without,O
resolution,O
of,O
symptoms,B-PR
.,O

Electrocardiogram,B-TE
at,O
that,O
time,O
showed,O
ST,B-PR
elevations,I-PR
and,O
J,B-PR
point,I-PR
elevations,I-PR
in,I-PR
V2,I-PR
through,I-PR
V4,I-PR
.,O

The,O
patient,O
was,O
transferred,O
to,O
Sturdy,O
Memorial,O
where,O
he,O
underwent,O
catheterization,B-TE
.,O

Catheterization,B-TE
results,I-TE
showed,O
100%,B-PR
occlusion,I-PR
of,I-PR
the,I-PR
proximal,I-PR
left,I-PR
anterior,I-PR
descending,I-PR
artery,I-PR
and,O
50%,B-PR
stenosis,I-PR
of,I-PR
first,I-PR
diagonal,I-PR
.,O

Angio-Jet,B-TR
percutaneous,I-TR
transluminal,I-TR
coronary,I-TR
angioplasty,I-TR
and,O
stenting,B-TR
was,O
performed,O
on,O
proximal,O
left,O
anterior,O
descending,O
artery,O
and,O
the,B-TR
percutaneous,I-TR
transluminal,I-TR
coronary,I-TR
angioplasty,I-TR
was,O
performed,O
on,O
first,O
diagonal,O
with,O
good,O
results,O
.,O

An,B-TR
intra-aortic,I-TR
balloon,I-TR
pump,I-TR
was,O
placed,O
at,O
this,O
time,O
as,O
well,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
;,O
the,O
patient,O
is,O
status,B-TR
post,I-TR
percutaneous,I-TR
transluminal,I-TR
coronary,I-TR
angioplasty,I-TR
times,O
three,O
in,O
2009,O
at,O
Clinton,O
Hospital,O
;,O
the,O
patient,O
is,O
status,B-TR
post,I-TR
percutaneous,I-TR
transluminal,I-TR
coronary,I-TR
angioplasty,I-TR
times,O
two,O
in,O
2005,O
at,O
Waltham/Weston,O
Hospital,O
.,O

2.,O
Type,B-PR
2,I-PR
diabetes,I-PR
.,O

3.,O
Hypercholesterolemia,B-PR
.,O

4.,O
Hypertension,B-PR
.,O

FAMILY,O
HISTORY,O
:,O

The,O
patient,O
's,O
father,O
died,O
of,O
a,B-PR
myocardial,I-PR
infarction,I-PR
at,O
age,O
40,O
",",O
and,O
a,O
brother,O
who,O
died,O
of,O
a,B-PR
myocardial,I-PR
infarction,I-PR
at,O
age,O
40,O
.,O

SOCIAL,O
HISTORY,O
:,O

No,O
ethanol,O
use,O
.,O

No,O
tobacco,O
at,O
this,O
time,O
;,O
he,O
quit,O
20,O
years,O
ago,O
.,O

The,O
patient,O
is,O
married,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Diltiazem,B-TR
180,O
mg,O
p.o.,O
q.d.,O
",",O
Lipitor,B-TR
10,O
mg,O
p.o.,O
q.d.,O
",",O
Glyset,B-TR
25,O
mg,O
p.o.,O
q.d.,O
",",O
Prevacid,B-TR
30,O
mg,O
p.o.,O
q.d.,O
",",O
metoprolol,B-TR
50,O
mg,O
p.o.,O
b.i.d.,O
",",O
Glucophage,B-TR
500,O
mg,O
p.o.,O
q.d.,O

ALLERGIES,O
:,O

Allergies,B-PR
included,O
PENICILLIN,B-TR
and,O
IODINE,B-TR
.,O

PHYSICAL,O
EXAMINATION,O
ON,O
ADMISSION,O
:,O

Temperature,B-TE
maximum,I-TE
98.7,O
",",O
temperature,B-TE
current,I-TE
98.3,O
",",O
pulse,B-TE
ranged,O
from,O
82,O
to,O
92,O
",",O
blood,B-TE
pressure,I-TE
104,O
to,O
124/67,O
to,O
74,O
with,O
a,O
mean,O
of,O
86,O
to,O
99,O
",",O
respiratory,B-TE
rate,I-TE
of,O
11,O
to,O
16,O
",",O
oxygen,B-TE
saturation,I-TE
94%,O
to,O
98%,O
on,O
2,O
liters,O
.,O

Pulmonary,B-TE
artery,I-TE
pressure,I-TE
was,O
29/15,O
with,O
a,O
mean,O
of,O
22,O
.,O

Cardiac,B-TE
output,I-TE
was,O
7,O
(,O
that,O
was,O
on,O
6,O
of,O
dopamine,B-TR
),O
.,O

Intra-aortic,B-TE
balloon,I-TE
pump,I-TE
augmented,I-TE
systole,I-TE
was,O
109,O
",",O
augmented,B-TE
diastole,I-TE
was,O
111,O
.,O

The,O
patient,O
was,O
lying,O
flat,O
in,O
no,O
apparent,B-PR
distress,I-PR
.,O

HEENT,O
revealed,O
extraocular,O
movements,O
were,O
intact,O
.,O

Pupils,O
were,O
equal,O
",",O
round,O
",",O
and,O
reactive,O
to,O
light,O
and,O
accommodation,O
.,O

The,O
oropharynx,O
was,O
clear,O
with,O
moist,O
mucosa,O
.,O

Neck,O
was,O
supple,O
.,O

No,O
lymphadenopathy,B-PR
.,O

Lungs,O
were,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
",",O
anteriorly,O
and,O
laterally,O
.,O

Cardiovascular,O
revealed,O
jugular,B-PR
venous,I-PR
distention,I-PR
not,O
appreciated,O
.,O

Carotids,O
had,O
normal,O
upstroke,O
and,O
normal,O
volume,O
with,O
bilateral,B-PR
bruits,I-PR
.,O

A,O
regular,O
rate,O
.,O

Normal,O
S1,O
and,O
S2,O
.,O

No,O
S3,B-PR
or,O
S4,B-PR
.,O

No,O
murmurs,B-PR
",",O
rubs,B-PR
or,O
gallops,B-PR
.,O

Abdomen,O
had,O
decreased,B-PR
bowel,I-PR
sounds,I-PR
",",O
soft,O
",",O
nontender,B-PR
",",O
and,O
nondistended,B-PR
.,O

No,O
hepatosplenomegaly,B-PR
.,O

Liver,O
was,O
about,O
5,O
cm,O
.,O

Extremities,O
had,O
no,O
edema,B-PR
.,O

The,O
right,O
groin,O
revealed,O
intra-aortic,B-TR
balloon,I-TR
pump,I-TR
site,O
and,O
pulmonary,B-TR
artery,I-TR
catheterization,I-TR
site,O
were,O
clean,O
",",O
dry,O
and,O
intact,O
without,O
tenderness,B-PR
.,O

Dorsalis,B-TE
pedis,I-TE
pulses,I-TE
were,O
2+,O
bilaterally,O
.,O

Neurologic,B-TE
examination,I-TE
revealed,O
alert,O
and,O
oriented,O
times,O
three,O
.,O

Cranial,O
nerves,O
II,O
through,O
XII,O
were,O
intact,O
.,O

LABORATORY,O
DATA,O
ON,O
ADMISSION,O
:,O

Laboratories,B-TE
on,O
admission,O
revealed,O
white,B-TE
count,I-TE
7.8,O
",",O
hematocrit,B-TE
was,O
41.7,O
",",O
platelets,B-TE
of,O
252,O
",",O
MCV,B-TE
89,O
",",O
RDW,B-TE
12.7,O
.,O

Chem-7,B-TE
revealed,O
sodium,B-TE
of,O
136,O
",",O
potassium,B-TE
4.7,O
",",O
chloride,B-TE
103,O
",",O
bicarbonate,B-TE
22,O
",",O
BUN,B-TE
16,O
",",O
creatinine,B-TE
0.8,O
",",O
glucose,B-TE
284,O
.,O

PT,B-TE
14.2,O
",",O
PTT,B-TE
108.5,O
",",O
INR,B-TE
1.3,O
.,O

Creatine,B-TE
kinase,I-TE
at,O
11,O
a.m.,O
was,O
83,O
",",O
at,O
5,O
p.m.,O
was,O
3021,O
.,O

Arterial,B-TE
blood,I-TE
gas,I-TE
at,O
11,O
a.m.,O
was,O
7.33/46/115,O
.,O

Creatine,B-TE
kinases,I-TE
trended,O
from,O
11:15,O
on,O
the,O
day,O
of,O
admission,O
from,O
83,O
to,O
3021,O
at,O
5,O
p.m.,O
to,O
3450,O
at,O
11,O
p.m.,O
",",O
to,O
1734,O
at,O
5:30,O
a.m.,O
on,O
11-07,O
",",O
to,O
1277,O
at,O
11:30,O
a.m.,O
on,O
11-07,O
",",O
to,O
83,O
at,O
9:30,O
a.m.,O
on,O
11-11,O
.,O

RADIOLOGY,O
/,O
IMAGING,O
:,O

Electrocardiogram,B-TE
post,O
catheterization,B-TE
showed,O
continued,B-PR
ST,I-PR
elevations,I-PR
and,O
J,B-PR
point,I-PR
elevations,I-PR
in,I-PR
V2,I-PR
through,I-PR
V3,I-PR
.,O

Post,B-TE
catheterization,I-TE
echocardiogram,I-TE
showed,O
an,B-TE
ejection,I-TE
fraction,I-TE
of,O
30%,O
",",O
moderate,B-PR
systolic,I-PR
dysfunction,I-PR
",",O
basal,B-PR
anterior,I-PR
hypokinesis,I-PR
",",O
mid,B-PR
anterior,I-PR
akinesis,I-PR
",",O
basal,B-PR
anteroseptal,I-PR
hypokinesis,I-PR
",",O
mid,B-PR
anteroseptal,I-PR
akinesis,I-PR
.,O

Anterior,B-PR
apex,I-PR
akinesis,I-PR
",",O
inferior,B-PR
apex,I-PR
akinesis,I-PR
",",O
and,O
apex,B-PR
akinesis,I-PR
.,O

The,O
was,O
trace,B-PR
mitral,I-PR
regurgitation,I-PR
and,O
trace,B-PR
tricuspid,I-PR
regurgitation,I-PR
.,O

IMPRESSION,O
:,O

This,O
is,O
a,O
47,O
-,O
year-old,O
male,O
with,O
a,O
past,O
medical,O
history,O
of,O
type,B-PR
2,I-PR
diabetes,I-PR
",",O
high,B-PR
cholesterol,I-PR
",",O
hypertension,B-PR
",",O
and,O
coronary,B-PR
artery,I-PR
disease,I-PR
",",O
status,B-TR
post,I-TR
percutaneous,I-TR
transluminal,I-TR
coronary,I-TR
angioplasty,I-TR
times,O
two,O
",",O
who,O
presented,O
with,O
acute,B-PR
coronary,I-PR
syndrome,I-PR
refractory,O
to,O
medical,B-TR
treatment,I-TR
and,O
TNK,B-TR
",",O
now,O
status,B-TR
post,I-TR
Angio-Jet,I-TR
percutaneous,I-TR
transluminal,I-TR
coronary,I-TR
angioplasty,I-TR
and,O
stent,B-TR
of,I-TR
proximal,I-TR
left,I-TR
anterior,I-TR
descending,I-TR
artery,I-TR
and,O
percutaneous,B-TR
transluminal,I-TR
coronary,I-TR
angioplasty,I-TR
of,O
first,O
diagonal,O
with,O
intra-aortic,B-TR
balloon,I-TR
pump,I-TR
placement,I-TR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
Mass.,O
Mental,O
Health,O
Center,O
hospital,O
course,O
was,O
unremarkable,O
.,O

Dopamine,B-TR
was,O
discontinued,O
on,O
day,O
one,O
.,O

The,B-TR
intra-aortic,I-TR
balloon,I-TR
pump,I-TR
was,O
discontinued,O
on,O
day,O
two,O
.,O

The,O
patient,O
was,O
continued,O
on,O
heparin,B-TR
throughout,O
his,O
hospital,O
course,O
and,O
transitioned,O
to,O
Coumadin,B-TR
on,O
hospital,O
day,O
four,O
.,O

The,O
patient,O
was,O
continued,O
on,O
Lipitor,B-TR
and,O
aspirin,B-TR
",",O
and,O
Plavix,B-TR
was,O
added,O
and,O
will,O
be,O
continued,O
for,O
30,O
days,O
post,O
catheterization,B-TE
.,O

The,O
patient,O
was,O
continued,O
on,O
Lopressor,B-TR
and,O
captopril,B-TR
throughout,O
his,O
hospital,O
course,O
",",O
and,O
changed,O
to,O

Zestril,B-TR
10,O
mg,O
q.d.,O
and,O
atenolol,B-TR
25,O
mg,O
q.d.,O
at,O
discharge,O
.,O

The,O
patient,O
was,O
discharged,O
to,O
the,O
medical,O
floor,O
on,O
hospital,O
day,O
three,O
and,O
discharged,O
from,O
the,O
hospital,O
once,O
his,B-TE
INR,I-TE
was,O
within,O
the,O
2,O
to,O
2.5,O
range,O
.,O

CONDITION,O
AT,O
DISCHARGE,O
:,O

The,O
patient,O
's,O
condition,O
on,O
discharge,O
was,O
stable,O
.,O

DISCHARGE,O
STATUS,O
:,O

He,O
was,O
discharged,O
home,O
.,O

DISCHARGE,O
FOLLOWUP,O
:,O

Instructions,O
to,O
follow,O
up,O
with,O
his,O
primary,O
care,O
physician,O
on,O
the,O
Heather,O
after,O
discharge,O
.,O

Primary,O
care,O
physician,O
was,O
to,O
check,O
INR,B-TE
and,O
titrate,O
Zestril,B-TR
up,O
and,O
atenolol,B-TR
as,O
tolerated,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

1.,O
Lipitor,B-TR
10,O
mg,O
p.o.,O
q.d.,O

2.,O
Aspirin,B-TR
325,O
mg,O
p.o.,O
q.d.,O

3.,O
Plavix,B-TR
75,O
mg,O
p.o.,O
q.d.,O
times,O
30,O
days,O
.,O

4.,O
Prevacid,B-TR
30,O
mg,O
p.o.,O
q.d.,O

5.,O
Atenolol,B-TR
25,O
mg,O
p.o.,O
q.d.,O

6.,O
Zestril,B-TR
10,O
mg,O
p.o.,O
q.d.,O

7.,O
Glyset,B-TR
25,O
mg,O
p.o.,O
q.d.,O

8.,O
Glucophage,B-TR
500,O
mg,O
p.o.,O
q.d.,O

9.,O
Coumadin,B-TR
5,O
mg,O
p.o.,O
q.d.,O

Tina,O
Squillace,O
",",O
M.D.,O
30-977,O

Dictated,O
By,O
:,O
Lloyd,O
U.,O
King,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2012-11-12,O
21:57,O

T,O
:,O
2012-11-15,O
14:05,O

JOB,O
#,O
:,O
15711,O

cc,O
:,O
Beau,O
J.,O
Box,O
",",O
M.D.,O

Admission,O
Date,O
:,O

2017-09-03,O

Discharge,O
Date,O
:,O

2017-10-10,O

Date,O
of,O
Birth,O
:,O

1946-12-27,O

Sex,O
:,O

M,O

Service,O
:,O

MEDICINE,B-TR

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,I-PR
Drugs,I-PR

Attending,O
:,O
Donald,O
R,O
Virgil,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Shortness,B-PR
of,I-PR
Breath,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

Endotracheal,B-TR
Intubation,I-TR

Central,B-TR
Venous,I-TR
Catheter,I-TR
and,O
Swan,B-TR
Ganz,I-TR
catheter,I-TR
placement,I-TR

Arterial,B-TR
Line,I-TR
Placement,I-TR

Right,B-TR
sided,I-TR
thoracentesis,I-TR

History,O
of,O
Present,O
Illness,O
:,O

70,O
y/o,O
male,O
with,O
h/o,O
CAD,B-PR
s/p,B-TR
LAD,I-TR
PTCA,I-TR
33,O
yrs,O
ago,O
",",O
COPD,B-PR
",",O
T2DM,B-PR
",",O
and,O
AICD,B-PR
pocket,I-PR
infection,I-PR
who,O
presented,O
to,O
the,O
Juan,O
on,O
2017-09-03,O
with,O
worsening,B-PR
SOB,I-PR
x,O
5,O
days,O
and,O
feeling,O
"",O
cloudy,O
."",O

The,O
patient,O
was,O
currently,O
at,O
Hubbard,O
Regional,O
Hospital,O
and,O
began,O
to,O
develop,O
worsening,B-PR
SOB,I-PR
for,O
the,O
past,O
5,O
days,O
.,O

This,O
AM,O
while,O
talking,O
with,O
his,O
daughter,O
on,O
the,O
phone,O
",",O
he,O
was,O
noted,O
to,O
desaturate,O
into,O
the,O
high,O
80s,O
and,O
he,O
was,O
brought,O
to,O
the,O
The,O
Hospital,O
for,O
Orthopedics,O
Juan,O
for,O
further,B-TE
evaluation,I-TE
.,O

"The,O
patient,O
states,O
that,O
he,O
has,O
felt,O
"",O
cloudy,B-PR
"",O
of,O
late,O
which,O
seems,O
to,O
relate,O
to,O
his,B-PR
worsening,I-PR
SOB,I-PR
.",O

He,O
is,O
not,O
ambulatory,O
and,O
is,O
very,B-PR
deconditioned,I-PR
secondary,O
to,O
several,B-PR
complications,I-PR
within,O
the,O
past,O
two,O
months,O
related,O
to,O
an,B-PR
AICD,I-PR
pocket,I-PR
infection,I-PR
.,O

He,O
denies,O
any,B-PR
CP,I-PR
",",O
N/V/D,B-PR
",",O
abdominal,B-PR
pain,I-PR
",",O
or,O
HA,B-PR
.,O

He,O
states,O
that,O
he,O
only,O
uses,O
one,O
pillow,O
to,O
sleep,O
but,O
admits,O
to,O
sleeping,O
at,O
about,O
30,O
degrees,O
at,O
rehab,O
.,O

In,O
the,O
Juan,O
",",O
his,B-TE
VS,I-TE
were,O
97.8,O
150/80,O
88,O
12,O
89-94%,O
3L,B-TR
NC,I-TR
.,O

He,O
was,O
given,O
Percocet,B-TR
for,O
back,B-PR
pain,I-PR
",",O
Lasix,B-TR
80,O
mg,O
IV,O
",",O
and,O
Combivent,B-TR
neb,I-TR
.,O

For,O
unclear,O
reasons,O
",",O
he,O
was,O
placed,O
on,O
a,B-TR
NRB,I-TR
in,O
the,O
Juan,O
.,O

Upon,O
arrival,O
to,O
the,O
CCU,O
",",O
he,O
was,O
hemodynamically,O
stable,O
.,O

He,O
was,O
quickly,O
weaned,O
to,O
3L,B-TR
O2,I-TR
via,O
NC,B-TR
",",O
O2,B-TE
sats,I-TE
100%,O
.,O

Past,O
Medical,O
History,O
:,O

-,O
AICD,B-PR
Pocket,I-PR
infection,I-PR
c/b,O
MSSA,B-PR
bacteremia,I-PR
",",O
pericardial,B-PR
effusion,I-PR
s/p,B-TE
mediastinal,I-TE
exploration,I-TE
",",O
evacuation,B-TR
of,O
pericardial,B-PR
effusion,I-PR
&,O
hematoma,B-PR
(,O
2017-07-24,O
),O

-,O
Ischemic,B-PR
colitis,I-PR
and,O
ischemic,B-PR
liver,I-PR
2017-06-22,O
(,O
post,O
air,B-PR
embolism,I-PR
from,O
post,O
mediastinal,B-TE
exploration,I-TE
),O

-,O
CAD,B-PR
s/p,B-TR
LAD,I-TR
PTCA,I-TR
33,O
years,O
ago,O

-,O
T2DM,B-PR
c/b,O
neuropathy,B-PR
and,O
nephropathy,B-PR

-,O
s/p,B-TR
Bovine,I-TR
AVR,I-TR
1999,O

Social,O
History,O
:,O

The,O
patient,O
is,O
a,O
retired,O
truck,O
driver,O
.,O

He,O
is,O
currently,O
married,O
",",O
has,O
10,O
children,O
.,O

No,O
smoking,O
for,O
last,O
5,O
years,O
.,O

Prior,O
to,O
that,O
smoked,O
2,O
packs,O
a,O
day,O
.,O

No,O
EtOH,O
or,O
IVDU,O
.,O

Family,O
History,O
:,O

Sister,O
with,O
diabetes,B-PR
.,O

No,O
other,O
known,O
family,O
hx,O
.,O

Physical,O
Exam,O
:,O

Vitals,O
:,O

97.6,O
95/48,O
71,O
98%,O
4L,B-TR
NC,I-TR

General,O
:,O

Oriented,O
to,O
person,O
and,O
time,O
.,O

Slight,B-PR
confustion,I-PR
with,O
place,O
but,O
oriented,O
with,O
some,O
re-direction,O
.,O

HEENT,O
:,O

NC/AT,O
.,O

MM,O
dry,O
.,O

OP,O
clear,O
.,O

PERRLA,O
.,O

EOMI,O
.,O

Neck,O
:,O

JVD,B-PR
difficult,O
to,O
access,O
02-23,O
increased,B-PR
neck,I-PR
girth,I-PR
.,O

CV,O
:,O

S1,O
",",O
S2,O
with,O
Grade,B-PR
II/VI,I-PR
SEM,I-PR
.,O
+S3,B-PR
.,O

Pulm,O
:,O

Crackles,B-PR
halfway,I-PR
up,I-PR
lung,I-PR
fields,I-PR
B/L,I-PR
.,O

Abd,O
:,O

Soft,O
",",O
NT/ND,B-PR
with,O
normoactive,O
BS,O
.,O

Ext,O
:,O

2+,O
pitting,B-PR
edema,I-PR
to,I-PR
knees,I-PR
B/L,I-PR
.,O

Pertinent,O
Results,O
:,O

Admission,O
Labs,O
:,O

2017-09-03,O
PT,B-TE
-,O
13.8,O
*,O
PTT,B-TE
-,O
33.1,O
INR,B-TE
(,I-TE
PT,I-TE
)-,I-TE
1.2,O
*,O

2017-09-03,O
PLT,B-TE
COUNT,I-TE
-,O
124,O
*,O

2017-09-03,O
HYPOCHROM,B-TE
-,O
2+,O
ANISOCYT,B-TE
-,O
1+,O
MACROCYT,B-TE
-,O
2+,O

2017-09-03,O
NEUTS,B-TE
-,O
79.5,O
*,O
LYMPHS,B-TE
-,O
9.9,O
*,O
MONOS,B-TE
-,O
4.9,O
EOS,B-TE
-,O
5.4,O
*,O
BASOS,B-TE
-,O
0.2,O

2017-09-03,O
WBC,B-TE
-,O
9.1,O
RBC,B-TE
-,O
2.77,O
*,O
HGB,B-TE
-,O
8.8,O
*,O
HCT,B-TE
-,O
27.2,O
*,O
MCV,B-TE
-,O
99,O
*,O
MCH,B-TE
-,O
31.9,O
MCHC,B-TE
-,O
32.4,O
RDW,B-TE
-,O
18.0,O
*,O

2017-09-03,O
CK,B-TE
-,I-TE
MB,I-TE
-,O
Not,O
Done,O
proBNP,B-TE
-,O
2656,O
*,O

2017-09-03,O
CK,B-TE
(,I-TE
CPK,I-TE
)-,I-TE
16,O
*,O

2017-09-03,O
GLUCOSE,B-TE
-,O
206,O
*,O
UREA,B-TE
N,I-TE
-,O
28,O
*,O
CREAT,B-TE
-,O
1.8,O
*,O
SODIUM,B-TE
-,O
135,O
POTASSIUM,B-TE
-,O
4.1,O
CHLORIDE,B-TE
-,O
85,O
*,O
TOTAL,B-TE
CO2,I-TE
-,O
42,O
*,O
ANION,B-TE
GAP,I-TE
-,O
12,O

2017-09-03,O
CK,B-TE
-,I-TE
MB,I-TE
-,O
Not,O
Done,O
cTropnT,B-TE
-,O
0.22,O
*,O

2017-09-03,O
CK,B-TE
(,I-TE
CPK,I-TE
)-,I-TE
38,O

Discharge,O
Labs,O
:,O

2017-10-10,O
:,O

INR,B-TE
3.5,O
",",O
PT,B-TE
32.5,O
",",O
PTT,B-TE
41,O

Imaging,O
Studies,O
:,O

1.,O
CXR,B-TE
(,I-TE
PA/Lateral,I-TE
),I-TE
2017-09-03,O

Congestive,B-PR
heart,I-PR
failure,I-PR
with,O
bilateral,B-PR
effusions,I-PR
(,O
R,O
>,O
L,O
),O
",",O
with,O
possible,O
underlying,B-PR
consolidation,I-PR
in,I-PR
the,I-PR
RLL,I-PR
and,O
to,O
a,O
lesser,O
degree,O
the,O
RML,O
and,O
LLL,O
.,O

2.,O
CXR,B-TE
2017-09-04,O

Compared,O
to,O
PA,B-TE
and,I-TE
lateral,I-TE
chest,I-TE
of,O
the,O
prior,O
day,O
.,O

Right-sided,B-TR
PICC,I-TR
line,I-TR
with,O
its,O
tip,O
in,O
the,O
distal,O
SVC,O
.,O

The,O
heart,O
is,O
markedly,B-PR
enlarged,I-PR
.,O

There,O
remains,O
a,B-PR
large,I-PR
right,I-PR
and,I-PR
small,I-PR
left,I-PR
pleural,I-PR
effusion,I-PR
",",O
not,O
significantly,O
changed,O
.,O

Patient,O
remains,O
in,O
congestive,B-PR
heart,I-PR
failure,I-PR
",",O
though,O
it,O
may,O
be,O
slightly,O
improved,O
compared,O
to,O
the,B-TE
prior,I-TE
study,I-TE
.,O

Underlying,B-PR
infectious,I-PR
consolidation,I-PR
in,I-PR
the,I-PR
right,I-PR
lower,I-PR
lobe,I-PR
not,O
excluded,O
.,O

3.,O
Echo,B-TE
2017-09-04,O

The,O
left,O
atrium,O
is,O
mildly,B-PR
dilated,I-PR
.,O

There,O
is,O
mild,B-PR
symmetric,I-PR
left,I-PR
ventricular,I-PR
hypertrophy,I-PR
.,O

The,O
left,O
ventricular,O
cavity,O
size,O
is,O
normal,O
.,O

LV,B-TE
systolic,I-TE
function,I-TE
appears,O
depressed,B-PR
.,O

Resting,B-PR
regional,I-PR
wall,I-PR
motion,I-PR
abnormalities,I-PR
include,O
inferior,B-PR
and,I-PR
inferolateral,I-PR
hypokinesis,I-PR
.,O

Right,O
ventricular,O
chamber,O
size,O
is,O
normal,O
and,O
free,O
wall,O
motion,O
may,O
be,O
mildly,B-PR
impaired,I-PR
.,O

The,O
aortic,O
root,O
is,O
mildly,B-PR
dilated,I-PR
.,O

The,O
ascending,O
aorta,O
is,O
mildly,B-PR
dilated,I-PR
.,O

The,O
aortic,O
valve,O
leaflets,O
are,O
mildly,B-PR
thickened,I-PR
.,O

A,B-TR
bioprosthetic,I-TR
aortic,I-TR
valve,I-TR
prosthesis,I-TR
is,O
present,O
.,O

The,B-TR
aortic,I-TR
prosthesis,I-TR
leaflets,I-TR
appear,O
to,O
move,O
normally,O
.,O

The,O
transaortic,O
gradient,O
is,O
normal,O
for,O
this,B-TR
prosthesis,I-TR
.,O

The,O
mitral,O
valve,O
leaflets,O
are,O
mildly,B-PR
thickened,I-PR
.,O

The,B-TE
left,I-TE
ventricular,I-TE
inflow,I-TE
pattern,I-TE
suggests,O
a,B-PR
restrictive,I-PR
filling,I-PR
abnormality,I-PR
",",O
with,O
elevated,B-PR
left,I-PR
atrial,I-PR
pressure,I-PR
.,O

Transmitral,B-TE
Doppler,I-TE
and,O
tissue,B-TE
velocity,I-TE
imaging,I-TE
are,O
consistent,O
with,O
Grade,B-PR
III/IV,I-PR
(,I-PR
severe,I-PR
),I-PR
left,I-PR
ventricular,I-PR
diastolic,I-PR
dysfunction,I-PR
.,O

The,O
tricuspid,O
valve,O
leaflets,O
are,O
mildly,B-PR
thickened,I-PR
.,O

There,O
is,O
mild,B-PR
pulmonary,I-PR
artery,I-PR
systolic,I-PR
hypertension,I-PR
.,O

There,O
is,O
no,O
pericardial,B-PR
effusion,I-PR
.,O

Compared,O
with,O
the,B-TE
prior,I-TE
study,I-TE
(,O
images,O
reviewed,O
),O
of,O
2017-08-14,O
",",O
ventricular,O
function,O
is,O
now,O
similar.,O

EF,B-TE
35-40%,O
.,O

4.,O
Echo,B-TE
2017-09-14,O

The,O
left,O
atrium,O
is,O
mildly,B-PR
dilated,I-PR
.,O

The,O
left,O
ventricular,O
cavity,O
size,O
is,O
normal,O
.,O

Overall,B-TE
left,I-TE
ventricular,I-TE
systolic,I-TE
function,I-TE
cannot,O
be,O
reliably,O
assessed,O
.,O

3l,O
.,O

The,O
aortic,O
valve,O
leaflets,O
are,O
mildly,B-PR
thickened,I-PR
.,O

The,O
mitral,O
valve,O
leaflets,O
are,O
mildly,B-PR
thickened,I-PR
.,O

There,O
is,O
no,O
pericardial,B-PR
effusion,I-PR
.,O

Compared,O
with,O
the,B-TE
prior,I-TE
study,I-TE
(,O
images,O
reviewed,O
),O
of,O
2017-09-04,O
",",O
there,O
is,O
probably,O
no,O
significant,O
change,O
.,O

All,B-TE
cultures,I-TE
",",O
including,O
BCx,B-TE
",",O
UCx,B-TE
",",O
pleural,B-TE
fluid,I-TE
culture,I-TE
",",O
and,O
wound,B-TE
culture,I-TE
have,O
been,O
negative,O
.,O

5.,O
CT,B-TE
Chest,I-TE
2017-09-16,O
:,O

1.,O
Increasing,B-PR
large,I-PR
right-sided,I-PR
pleural,I-PR
effusion,I-PR
and,O
pulmonary,B-PR
edema,I-PR
.,O

Scattered,B-PR
parenchymal,I-PR
opacities,I-PR
in,I-PR
the,I-PR
left,I-PR
lower,I-PR
lobe,I-PR
represent,O
superimposed,B-PR
infection,I-PR
vs,O
atelectasis,B-PR
.,O

There,O
is,O
no,O
evidence,O
of,O
abscess,B-PR
.,O

6.,O
2017-09-28,O
Chest,B-TE
X,I-TE
Ray,I-TE
:,O

SINGLE,B-TE
AP,I-TE
VIEW,I-TE
OF,I-TE
THE,I-TE
CHEST,I-TE
.,O

There,O
has,O
been,O
almost,O
complete,O
resolution,O
of,O
pulmonary,B-PR
edema,I-PR
.,O

A,B-PR
small,I-PR
right,I-PR
pleural,I-PR
effusion,I-PR
has,O
decreased,O
in,O
size,O
.,O

Mild,B-PR
cardiomegaly,I-PR
is,O
stable,O
.,O

There,O
is,O
no,O
pneumothorax,B-PR
.,O

Right,B-TR
PIC,I-TR
catheter,I-TR
tip,I-TR
ends,O
in,O
the,O
lower,O
SVC,O
.,O

Patient,O
is,O
post,O
median,B-TR
sternotomy,I-TR
.,O

IMPRESSION,O
:,O

Almost,O
complete,O
resolution,O
of,O
pulmonary,B-PR
edema,I-PR
.,O

7.,O
2017-09-29,O
CT,B-TE
Head,I-TE
:,O

FINDINGS,O
:,O

There,O
is,O
no,O
evidence,O
of,O
intraaxial,B-PR
or,I-PR
extraaxial,I-PR
hemorrhage,I-PR
",",O
mass,B-PR
effect,I-PR
",",O
shift,B-PR
of,I-PR
normally,I-PR
midline,I-PR
structures,I-PR
",",O
or,O
acute,B-PR
major,I-PR
or,I-PR
minor,I-PR
vascular,I-PR
territorial,I-PR
infarction,I-PR
.,O

The,O
ventricles,O
and,O
sulci,O
are,O
mildly,B-PR
prominent,I-PR
",",O
but,O
stable,O
in,O
size,O
and,O
appearance,O
.,O

The,O
gray-white,O
matter,O
differentiation,O
is,O
preserved,O
.,O

Again,O
seen,O
are,O
subtle,B-PR
hypodensities,I-PR
within,I-PR
the,I-PR
periventricular,I-PR
white,I-PR
matter,I-PR
which,O
is,O
an,O
indication,O
of,O
chronic,B-PR
microvascular,I-PR
ischemic,I-PR
changes,I-PR
",",O
stable,O
.,O

Extensive,B-PR
carotid,I-PR
artery,I-PR
calcifications,I-PR
are,O
identified,O
.,O

The,O
visualized,O
paranasal,O
sinuses,O
are,O
clear,O
.,O

The,O
surrounding,O
osseous,O
and,O
soft,O
tissue,O
structures,O
are,O
unremarkable,O
.,O

IMPRESSION,O
:,O

No,O
evidence,O
of,O
acute,B-PR
or,I-PR
chronic,I-PR
infarction,I-PR
.,O

Stable,B-PR
microvascular,I-PR
ischemic,I-PR
changes,I-PR
in,I-PR
the,I-PR
periventricular,I-PR
white,I-PR
matter,I-PR
.,O

8.,O
2017-09-30,O
EEG,B-TE
:,O

IMPRESSION,O
:,O

Abnormal,B-PR
EEG,I-PR
due,O
to,O
the,B-PR
moderately,I-PR
slow,I-PR
posterior,I-PR
background,I-PR
and,O
occasional,O
bursts,O
of,O
generalized,B-PR
slowing,I-PR
.,O

These,O
findings,O
indicate,O
a,B-PR
widespread,I-PR
encephalopathic,I-PR
condition,I-PR
affecting,O
both,O
cortical,O
and,O
subcortical,O
structures,O
.,O

Medications,B-TR
",",O
metabolic,B-PR
disturbances,I-PR
",",O
and,O
infection,B-PR
are,O
among,O
the,O
most,O
common,O
causes,O
.,O

No,O
prominent,B-PR
focal,I-PR
abnormalities,I-PR
were,O
evident,O
",",O
and,O
there,O
were,O
no,O
epileptiform,B-PR
features,I-PR
.,O

The,B-TE
cardiac,I-TE
monitor,I-TE
showed,O
occasional,B-PR
irregularities,I-PR
in,O
a,B-TR
PACED,I-TR
rhythm,I-TR
.,O

Brief,O
Hospital,O
Course,O
:,O

A/P,O
:,O

70,O
y/o,O
male,O
with,O
h/o,O
CAD,B-PR
",",O
T2DM,B-PR
",",O
hyperlipidemia,B-PR
",",O
and,O
COPD,B-PR
who,O
presented,O
to,O
the,O
Juan,O
on,O
2017-09-03,O
with,O
worsening,B-PR
SOB,I-PR
x,O
5,O
days,O
from,O
Morton,O
Hospital,O
&,O
Medical,O
Center,O
.,O

Pt.,O
was,O
initially,O
admitted,O
to,O
CCU,O
on,O
2017-09-03,O
",",O
transferred,O
to,O
Pendleton,O
on,O
2017-09-05,O
",",O
triggered,O
on,O
2017-09-10,O
for,O
hypotension,B-PR
with,O
BP,B-TE
67/38,O
and,O
transferred,O
back,O
to,O
CCU,O
on,O
2017-09-10,O
.,O

He,O
remained,O
fluid,B-PR
overloaded,I-PR
and,O
a,B-TR
swan,I-TR
catheter,I-TR
was,O
placed,O
.,O

The,O
following,O
issues,O
were,O
addressed,O
during,O
this,O
hospital,O
admission,O
:,O

1#,O
Cardiac,O
:,O

Pump,B-TR

The,O
patient,O
was,O
initially,O
admitted,O
for,O
likely,O
CHF,B-PR
exacerbation,I-PR
.,O

He,O
was,O
started,O
on,O
a,B-TR
lasix,I-TR
gtt,I-TR
the,O
night,O
of,O
admission,O
with,O
a,O
good,O
response,O
.,O

He,O
continued,O
to,O
diurese,O
and,O
he,O
was,O
moved,O
to,O
the,O
floor,O
since,O
he,O
no,O
longer,O
required,O
intensive,O
level,O
care,O
.,O

While,O
on,O
the,O
floor,O
",",O
he,O
continued,O
to,O
be,O
diuresed,O
.,O

After,O
several,O
days,O
",",O
he,O
became,O
hypotensive,B-PR
and,O
triggered,O
for,O
BPs,B-TE
60s/30s,O
.,O

He,O
was,O
given,O
IVF,B-TR
without,O
an,O
adequate,O
response,O
in,O
his,B-TE
pressures,I-TE
.,O

He,O
was,O
transferred,O
back,O
to,O
the,O
CCU,O
and,O
started,O
on,O
a,B-TR
dopamine,I-TR
gtt,I-TR
.,O

He,O
diuresed,O
well,O
on,O
the,B-TR
dopamine,I-TR
gtt,I-TR
and,O
his,B-TE
BP,I-TE
was,O
supported,O
.,O

Gradually,O
",",O
the,B-TR
dopamine,I-TR
gtt,I-TR
was,O
weaned,O
.,O

However,O
",",O
he,O
still,O
appeared,O
volume,B-PR
overloaded,I-PR
with,O
minimal,O
improvement,O
in,O
his,B-PR
oxygen,I-PR
requirement,I-PR
.,O

A,B-TE
swan,I-TE
was,O
placed,O
for,O
a,O
more,O
accurate,O
picture,O
of,O
his,O
volume,O
status,O
and,O
he,O
was,O
volume,B-PR
overloaded,I-PR
by,O
swan,B-TE
numbers,I-TE
with,O
an,B-PR
elevated,I-PR
PAD,I-PR
and,O
elevated,B-PR
CVP,I-PR
without,O
an,B-TE
obtainable,I-TE
wedge,I-TE
pressure,I-TE
.,O

He,O
also,O
had,O
a,B-PR
high,I-PR
CO,I-PR
and,O
low,B-PR
SVR,I-PR
suggestive,O
of,O
sepsis,B-PR
",",O
but,O
he,O
never,O
had,O
an,B-PR
elevated,I-PR
WBC,I-PR
and,O
was,O
afebrile,B-PR
during,O
his,O
entire,O
hospital,O
admission,O
with,O
negative,O
blood,B-TE
",",I-TE
urine,I-TE
",",I-TE
wound,I-TE
",",I-TE
and,I-TE
pleural,I-TE
fluid,I-TE
cultures,I-TE
.,O

The,B-TR
Lasix,I-TR
drip,I-TR
was,O
eventually,O
changed,O
to,O
IV,B-TR
Lasix,I-TR
boluses,I-TR
",",O
with,O
a,B-TR
net,I-TR
diuresis,I-TR
of,O
over,O
36,O
liters,O
for,O
the,O
hospital,O
stay,O
.,O

He,O
was,O
then,O
transitioned,O
to,O
oral,B-TR
Lasix,I-TR
for,O
maintainence,O
.,O

The,O
patient,O
had,O
an,B-TE
echo,I-TE
on,O
2017-09-04,O
with,O
the,O
results,O
above,O
in,O
detail,O
.,O

It,O
was,O
unchanged,O
in,O
comparison,O
to,O
2017-08-14,O
with,O
similar,O
ventricular,B-TE
function,I-TE
and,O
inferior,B-PR
and,I-PR
inferolateral,I-PR
hypokinesis,I-PR
.,O

The,O
patient,O
had,O
another,B-TE
echo,I-TE
on,O
2017-09-14,O
with,O
no,O
new,O
changes,O
.,O

At,O
discharge,O
the,O
patient,O
was,O
thought,O
to,O
be,O
euvolemic,O
",",O
satting,O
well,O
on,O
room,O
air,O
and,O
without,O
peripheral,B-PR
edema,I-PR
.,O

His,B-TE
dry,I-TE
weight,I-TE
is,O
70.4,O
kg,O
.,O

Ischemia,B-PR

The,O
patient,O
had,O
an,B-PR
initial,I-PR
troponin,I-PR
bump,I-PR
on,O
admission,O
which,O
was,O
most,O
likely,O
secondary,O
to,O
CHF,B-PR
exacerbation,I-PR
.,O

He,O
was,O
continued,O
on,O
Aspirin,B-TR
",",O
Metoprolol,B-TR
and,O
Lipitor,B-TR
with,O
no,O
further,B-PR
issues,I-PR
.,O

Rhythm,B-TE

The,O
patient,O
is,O
completely,B-PR
pacer-dependent,I-PR
",",O
being,O
epicardially,B-TR
paced,I-TR
at,O
70,O
.,O

He,O
is,O
on,O
Amiodarone,B-TR
for,O
post-op,B-PR
afib,I-PR
and,O
this,O
was,O
continued,O
this,O
entire,O
admission,O
.,O

His,B-TE
underlying,I-TE
rhythm,I-TE
is,O
atrial,B-PR
flutter,I-PR
;,O
it,O
was,O
unclear,O
whether,O
he,O
had,O
previously,O
been,O
cardioverted,O
.,O

Anti-coagulation,B-TR
was,O
started,O
with,O
Warfarin,B-TR
5,O
mg,O
with,O
a,O
goal,O
of,O
2-3,O
and,O
a,O
plan,O
for,O
cardioversion,B-TR
in,O
6,O
weeks,O
.,O

The,B-TE
patient,I-TE
's,I-TE
INR,I-TE
became,O
supratherapeutic,B-PR
and,O
Coumadin,B-TR
was,O
held,O
.,O

His,B-TR
coumadin,I-TR
was,O
transitioned,O
to,O
2,O
mg,O
and,O
then,O
1,O
mg,O
.,O

His,B-TE
INR,I-TE
continued,O
to,O
flucuate,O
.,O

He,O
was,O
discharged,O
on,O
1,O
mg,O
",",O
but,O
a,O
stable,O
regimen,O
had,O
not,O
been,O
achieved,O
.,O

His,B-TE
INR,I-TE
will,O
have,O
to,O
be,O
monitored,O
closely,O
unitl,O
his,B-TE
levels,I-TE
are,O
stable,O
.,O

His,O
INR,B-TE
goal,O
is,O
02-24,O
.,O

2#,O
SOB,B-PR
on,O
admission,O
:,O

Likely,O
due,O
to,O
CHF,B-PR
exacerbation,I-PR
",",O
with,O
diuresis,B-TR
of,O
over,O
36,O
L,O
during,O
his,O
admission,O
.,O

He,O
had,O
4,B-TR
surgeries,I-TR
(,O
3,B-TR
cardiac,I-TR
surgeries,I-TR
),O
earlier,O
in,O
the,O
summer,O
",",O
so,O
it,O
is,O
likely,O
that,O
he,O
required,O
copious,B-TR
IVF,I-TR
hydration,I-TR
surrounding,O
these,B-TR
procedures,I-TR
which,O
may,O
have,O
been,O
the,O
cause,O
of,O
his,B-PR
massive,I-PR
fluid,I-PR
overload,I-PR
.,O

It,O
appears,O
that,O
his,O
diet,O
was,O
regulated,O
at,O
rehab,O
but,O
there,O
is,O
concern,O
for,O
medication,B-PR
non-compliance,I-PR
at,O
rehab,O
",",O
per,O
previous,O
discharge,O
summaries,O
.,O

On,O
discharge,O
",",O
the,O
patient,O
was,O
maintained,O
on,O
standing,B-TR
diuretics,I-TR
as,O
well,O
as,O
PRN,B-TR
nebs,I-TR
and,O
INH,B-TR
COPD,I-TR
meds,I-TR
.,O

3#,O
Metabolic,B-PR
Alkalosis,I-PR
/,O
Hypochloremia,B-PR
:,O

Etiology,O
most,O
likely,O
a,O
combination,O
of,O
contraction,B-PR
alkalosis,I-PR
and,O
/,O
or,O
post-hypercapnia,B-PR
.,O

This,O
acutely,O
worsened,O
on,O
2017-09-18,O
",",O
when,O
the,O
patient,O
was,O
found,O
to,O
have,O
mental,B-PR
status,I-PR
changes,I-PR
and,O
an,B-TE
ABG,I-TE
revealed,O
a,B-TE
CO2,I-TE
of,O
over,O
100,O
",",O
likley,O
due,O
to,O
a,B-PR
depressed,I-PR
respiratory,I-PR
drive,I-PR
secondary,O
to,O
sedatives,B-TR
given,O
for,O
agitation,B-PR
on,O
top,O
of,O
a,B-PR
preexisting,I-PR
alkalosis,I-PR
.,O

The,O
patient,O
was,O
therefore,O
intubated,B-TR
for,O
ventilation,B-TR
",",O
and,O
continued,O
to,O
be,O
diuresed,O
.,O

His,B-TE
CO2,I-TE
improved,O
and,O
he,O
was,O
extubated,B-TR
after,O
a,O
few,O
days,O
.,O

All,B-TR
sedating,I-TR
medications,I-TR
were,O
held,O
and,O
serial,B-TE
ABGs,I-TE
were,O
trended,O
to,O
follow,O
the,O
resolution,O
of,O
the,B-PR
metabolic,I-PR
alkalosis,I-PR
.,O

4#,O
Pleural,B-PR
effusions,I-PR
:,O
s/p,B-TR
right,I-TR
thoracentesis,I-TR
on,O
2017-09-06,O
",",O
1600,O
mL,O
of,O
serosanguinous,B-PR
fluid,I-PR
removed,O
from,O
right,O
pleural,O
space,O
.,O

Gram,B-TE
stain,I-TE
and,O
cultures,B-TE
were,O
negative,O
",",O
cytology,B-TE
was,O
negative,O
.,O

The,B-PR
right,I-PR
pleural,I-PR
effusion,I-PR
slowly,O
re-accumulated,O
after,O
tap,B-TR
but,O
resolved,O
after,O
continued,B-TR
diuresis,I-TR
.,O

Repeat,B-TE
CXR,I-TE
showed,O
improvement,O
of,O
the,B-PR
effusion,I-PR
and,O
on,O
discharge,O
he,O
had,O
been,O
breathing,O
well,O
on,O
room,O
air,O
without,O
complications,B-PR

5#,O
T2DM,B-PR
:,O

The,O
patient,O
was,O
started,O
on,O
Glargine,B-TR
for,O
tighter,O
glycemic,O
control,O
and,O
was,O
covered,O
with,O
an,B-TR
insulin,I-TR
sliding,I-TR
scale,I-TR
.,O

He,O
was,O
monitored,O
with,O
QID,B-TE
fingersticks,I-TE
.,O

His,B-TE
blood,I-TE
sugars,I-TE
were,O
in,O
the,O
100s,O
on,O
discharge,O
.,O

6#,O
Hyperlipidemia,B-PR
:,O

The,O
patient,O
was,O
continued,O
on,O
his,B-TR
statin,I-TR
.,O

7#,O
COPD,B-PR
:,O

The,O
patient,O
was,O
continued,O
on,O
nebs,B-TR

8#,O
MS,B-PR
changes,I-PR
:,O

The,O
patient,O
has,O
a,O
history,O
of,O
baseline,B-PR
dementia,I-PR
which,O
was,O
confounded,O
by,O
delerium,B-PR
in,O
the,O
face,O
of,O
metabolic,B-PR
abnormalities,I-PR
.,O

His,O
mental,O
status,O
improved,O
as,O
his,O
metabolic,O
process,O
was,O
resolved,O
as,O
detailed,O
above,O
.,O

Neurology,O
was,O
also,O
consulted,O
and,O
a,B-TE
head,I-TE
CT,I-TE
showed,O
old,B-PR
lacunar,I-PR
infarcts,I-PR
but,O
no,O
acute,O
causes,O
for,O
a,B-PR
change,I-PR
in,I-PR
mental,I-PR
status,I-PR
.,O

An,B-TE
EEG,I-TE
showed,O
mild,B-PR
encephalopathy,I-PR
",",O
but,O
no,O
other,O
findings,O
.,O

His,O
mental,O
status,O
did,O
clear,O
somewhat,O
with,O
the,O
addition,O
of,O
standing,B-TR
lactulose,I-TR
;,O
he,O
was,O
discharged,O
on,O
this,B-TR
medication,I-TR
.,O

9#,O
Hypothyroidism,B-PR
:,O

The,O
patient,O
was,O
continued,O
on,O
his,O
outpatient,O
dose,O
of,O
Levothyroxine,B-TR
.,O

10#,O
?,O
UTI,B-PR
:,O

The,O
patient,O
was,O
started,O
on,O
levofloxacin,B-TR
at,O
Newton-Wellesley,O
Hospital,O
for,O
a,O
question,O
of,O
UTI,B-PR
based,O
on,O
U/A,B-TE
positive,O
for,O
WBC,B-TE
.,O

UCx,B-TE
during,O
this,O
hospitalization,O
were,O
negative,O
and,O
Levofloxacin,B-TR
was,O
d/c,O
'd,O
.,O

11#,O
Chronic,B-PR
lower,I-PR
back,I-PR
pain,I-PR
:,O

The,O
patient,O
was,O
treated,O
with,O
a,B-TR
Lidocaine,I-TR
patch,I-TR
and,O
Percocet,B-TR
prn,O
.,O

Stronger,B-TR
narcotics,I-TR
were,O
avoided,O
given,O
somnolence,B-PR
and,O
MS,B-PR
changes,I-PR
.,O

12#,O
Wound,B-TR
Care,I-TR
:,O

The,O
patient,O
has,O
left,B-PR
chest,I-PR
wound,I-PR
and,O
left,B-PR
gluteal,I-PR
pressure,I-PR
ulcer,I-PR
.,O

Wound,O
care,O
was,O
consulted,O
on,O
2017-09-05,O
and,O
they,O
made,O
several,O
recommendations,O
.,O

For,O
the,B-PR
left,I-PR
gluteal,I-PR
pressure,I-PR
ulcer,I-PR
",",O
they,O
recommended,O
gentle,B-TR
cleansing,I-TR
with,O
normal,B-TR
saline,I-TR
or,O
commercial,B-TR
wound,I-TR
cleaner,I-TR
",",O
thin,O
layer,O
of,O
Duoderm,B-TR
gel,I-TR
",",O
air,O
dry,O
",",O
allevyn,B-TR
foam,I-TR
adhesive,I-TR
over,O
the,O
site,O
",",O
and,O
change,O
every,O
2,O
days,O
or,O
prn,O
.,O

For,O
the,B-PR
left,I-PR
chest,I-PR
wound,I-PR
",",O
they,O
recommended,O
cleansing,O
with,O
commercial,B-TR
wound,I-TR
cleanser,I-TR
",",O
pat,O
dry,O
",",O
pack,B-TR
aquacel,I-TR
AG,I-TR
rope,I-TR
and,O
moisten,O
with,O
saline,B-TR
",",O
cover,O
with,O
dry,B-TR
gauze,I-TR
and,O
change,O
daily,O
.,O

These,O
recommendations,O
were,O
followed,O
throughout,O
the,O
admission,O
.,O

13#,O
Voiding,O
:,O

Pt.,O
failed,O
multiple,O
attempts,O
to,O
void,O
on,O
his,O
own,O
.,O

Case,O
was,O
discussed,O
with,O
neurology,O
.,O

He,O
was,O
started,O
on,O
finsateride,B-TR
on,O
the,O
day,O
prior,O
to,O
admission,O
.,O

He,O
is,O
scheduled,O
to,O
follow,O
up,O
with,O
urology,O
to,O
address,O
this,O
issue,O
.,O

Until,O
then,O
",",O
his,B-TR
foley,I-TR
should,O
remain,O
in,O
place,O
.,O

14#,O
Code,O
:,O

The,O
patient,O
was,O
full,O
code,O
during,O
admission,O
.,O

Medications,O
on,O
Admission,O
:,O

Levothyroxine,B-TR
100,O
mcg,O
PO,O
daily,O

Duloxetine,B-TR
20,O
mg,O
PO,O
QHS,O

Ondansetron,B-TR
PRN,O

Percocet,B-TR
1,O
tab,O
PRN,O

Senna,B-TR
PRN,O

Colace,B-TR
PRN,O

Lasix,B-TR
80,O
mg,O
PO,O
BID,O

Lactulose,B-TR
PRN,O

Lidocaine,B-TR
patch,I-TR

Nystatin,B-TR
powder,I-TR

Gabapentin,B-TR
300,O
mg,O
PO,O
TID,O

Alb,B-TR
nebs,I-TR

Fluticasone,B-TR
/,O
Salmeterol,B-TR

Tiotropium,B-TR
Bromide,I-TR

Spironolactone,B-TR
25,O
mg,O
PO,O
daily,O

Epoetin,B-TR
4000,O
units,O
MWF,O

RISS,B-TR

Amiodarone,B-TR
200,O
mg,O
PO,O
daily,O

Calcium,B-TR
Acetate,I-TR
667,O
mg,O
PO,O
TID,O

SubQ,B-TR
Heparin,I-TR

Pantoprazole,B-TR
40,O
mg,O
PO,O
daily,O

Simvastatin,B-TR
40,O
mg,O
PO,O
QHS,O

ASA,B-TR
81,O
mg,O
PO,O
daily,O

MVI,B-TR

Tylenol,B-TR
PRN,O

Discharge,O
Medications,O
:,O

1.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
as,O
needed,O
for,O
Constipation,B-PR
.,O

Disp,O
:*,O
90,O
Capsule,O
(,O
s,O
)*,O
Refills,O
:*,O
0,O
*,O

2.,O
Levothyroxine,B-TR
100,O
mcg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

Disp,O
:*,O
30,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

3.,O
Duloxetine,B-TR
20,O
mg,O
Capsule,O
",",O
Delayed,O
Release(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
QHS,O
(,O
once,O
a,O
day,O
(,O
at,O
bedtime,O
),O
),O
.,O

4.,O
Lactulose,B-TR
10,O
g,O
/,O
15,O
mL,O
Syrup,O
Sig,O
:,O
Thirty,O
(,O
30,O
),O
ML,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

5.,O
Fluticasone,B-TR
-,O
Salmeterol,B-TR
100-50,O
mcg,O
/,O
Dose,O
Disk,O
with,O
Device,O
Sig,O
:,O
One,O
(,O
1,O
),O
Disk,O
with,O
Device,O
Inhalation,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

Disp,O
:*,O
qs,O
Disk,O
with,O
Device,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

6.,O
Tiotropium,B-TR
Bromide,I-TR
18,O
mcg,O
Capsule,O
",",O
w/,O
Inhalation,B-TR
Device,I-TR
Sig,O
:,O
One,O
(,O
1,O
),O
Cap,O
Inhalation,O
DAILY,O
(,O
Daily,O
),O
.,O

Disp,O
:*,O
qs,O
*,O
Refills,O
:*,O
2,O
*,O

7.,O
Amiodarone,B-TR
200,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

Disp,O
:*,O
30,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

8.,O
Calcium,B-TR
Acetate,I-TR
667,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
TID,O
W/MEALS,O
(,O
3,O
TIMES,O
A,O
DAY,O
WITH,O
MEALS,O
),O
.,O

Disp,O
:*,O
90,O
Capsule,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

9.,O
Oxycodone,B-TR
-,O
Acetaminophen,B-TR
5-325,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
for,O
pain,B-PR
.,O

Disp,O
:*,O
30,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
0,O
*,O

10.,O
Multivitamin,B-TR
Capsule,I-TR
Sig,O
:,O
One,O
(,O
1,O
),O
Cap,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

Disp,O
:*,O
30,O
tablets,O
*,O
Refills,O
:*,O
2,O
*,O

11.,O
Miconazole,B-TR
Nitrate,I-TR
2,O
%,O
Powder,O
Sig,O
:,O
One,O
(,O
1,O
),O
Appl,O
Topical,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

12.,O
Aspirin,B-TR
81,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

Disp,O
:*,O
30,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
)(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

13.,O
Simvastatin,B-TR
40,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
QHS,O
(,O
once,O
a,O
day,O
(,O
at,O
bedtime,O
),O
),O
.,O

Disp,O
:*,O
30,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

14.,O
Pantoprazole,B-TR
40,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

Disp,O
:*,O
30,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
)(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

15.,O
Lidocaine,B-TR
5,O
%(,O
700,O
mg,O
/,O
patch,O
),O
Adhesive,O
Patch,O
",",O
Medicated,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Adhesive,O
Patch,O
",",O
Medicated,O
Topical,O
DAILY,O
(,O
Daily,O
),O
.,O

Disp,O
:*,O
qs,O
Adhesive,O
Patch,O
",",O
Medicated,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

16.,O
Furosemide,B-TR
40,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

Disp,O
:*,O
60,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

17.,O
Ferrous,B-TR
Sulfate,I-TR
325,O
(,O
65,O
),O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

Disp,O
:*,O
30,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

18.,O
Epoetin,B-TR
Alfa,I-TR
"4,000",O
unit/mL,O
Solution,O
Sig,O
:,O
One,O
(,O
1,O
),O
Injection,O
QMOWEFR,O
(,O
Monday,O
-,O
Wednesday,O
-,O
Friday,O
),O
.,O

Disp,O
:*,O
qs,O
*,O
Refills,O
:*,O
2,O
*,O

19.,O
Spironolactone,B-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

Disp,O
:*,O
60,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

20.,O
Albuterol,B-TR
90,O
mcg/Actuation,O
Aerosol,O
Sig,O
:,O
4-6,O
Puffs,O
Inhalation,O
Q6H,O
(,O
every,O
6,O
hours,O
),O
.,O

Disp,O
:*,O
qs,O
*,O
Refills,O
:*,O
2,O
*,O

21.,O
Metoprolol,B-TR
Succinate,I-TR
25,O
mg,O
Tablet,O
Sustained,O
Release,O
24HR,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
Sustained,O
Release,O
24HR,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

22.,O
Finasteride,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

Disp,O
:*,O
30,O
Tablet,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

23.,O
Gabapentin,B-TR
300,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

Disp,O
:*,O
60,O
Capsule,O
(,O
s,O
)*,O
Refills,O
:*,O
2,O
*,O

24.,O
Warfarin,B-TR
1,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
at,O
bedtime,O
:,O
Please,O
monitor,O
INR,B-TE
with,O
goal,O
02-24,O
.,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Discharge,O
Diagnosis,O
:,O

Primary,O
:,O

Congestive,B-PR
Heart,I-PR
Failure,I-PR
exacerbation,I-PR

Secondary,O
:,O

Coronary,B-PR
Artery,I-PR
Disease,I-PR

Hypertension,B-PR

Type,B-PR
2,I-PR
Diabetes,I-PR
Mellitus,I-PR

Chronic,B-PR
Obstructive,I-PR
Pulmonary,I-PR
Disease,I-PR

Discharge,O
Condition,O
:,O

The,O
patient,O
was,O
discharged,O
hemodynamicallly,O
stable,O
",",O
afebrile,B-PR
with,O
appropriate,O
follow,O
up,O
.,O

Discharge,O
Instructions,O
:,O

During,O
this,O
admission,O
you,O
have,O
been,O
treated,O
for,O
a,B-PR
CHF,I-PR
exacerbation,I-PR
.,O

Weigh,O
yourself,O
every,O
morning,O
",",O
call,O
MD,O
if,O
weight,O
increases,O
by,O
>,O
3,O
lbs,O
in,O
2,O
days,O
.,O

Adhere,O
to,O
2,O
gm,O
sodium,O
diet,O

Fluid,O
Restriction,O
:,O

1500,O
mL,O

1.,O
Please,O
take,O
all,B-TR
medications,I-TR
as,O
prescribed,O
.,O

2.,O
Please,O
keep,O
all,O
follow,O
up,O
appointments,O
.,O

3.,O
Please,O
call,O
your,O
PCP,O
C.,O
Lettinga,O
or,O
seek,O
medical,O
attention,O
in,O
the,O
Juan,O
if,O
you,O
experience,O
worsening,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
",",O
chest,B-PR
pain,I-PR
",",O
dizziness,B-PR
",",O
passing,B-PR
out,I-PR
",",O
or,O
any,B-PR
other,I-PR
concerning,I-PR
symptom,I-PR
.,O

Followup,O
Instructions,O
:,O

Please,O
follow,O
up,O
with,O
your,O
PCP,O
C.,O
Lettinga,O
(,O
572,O
8343,O
),O
on,O
10-10,O
at,O
1:00,O
PM,O

Please,O
follow,O
up,O
with,O
Dr.,O
Parker,O
in,O
cardiology,O
(,O
(,O
216,O
),O
660-0019,O
),O
on,O
10-17,O
at,O
4:45,O
PM,O

Please,O
follow,O
up,O
with,O
Dr.,O
Frye,O
in,O
cardiololgy,O
(,O
(,O
216,O
),O
660-0019,O
),O
on,O
10-09,O
at,O
2:15,O
PM,O
.,O

Please,O
follow,O
up,O
with,O
Urology,O
on,O
10-16,O
@,O
1:50,O
PM,O
on,O
the,O
3rd,O
floor,O
of,O
the,O
Maricle,O
Building,O
",",O
east,O
campus,O
of,O
Lahey,O
Clinic,O
-,O
North,O
Shore,O

Ronald,O
Lyman,O
MD,O
77-979,O

Completed,O
by,O
:,O
Bristol,O
MD,O
47-191,O
2017-10-10,O
@,O
1058,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Ronald,O
G.,O
Elston,O
on,O
:,O
WED,O
2017-10-11,O
5:03,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2017-08-14,O

Discharge,O
Date,O
:,O

2017-08-23,O

Date,O
of,O
Birth,O
:,O

1943-08-23,O

Sex,O
:,O

M,O

Service,O
:,O

MEDICINE,B-TR

Allergies,O
:,O

Sulfonamides,B-TR

Attending,O
:,O
Marcus,O
W.,O
Kelley,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Transfer,O
from,O
Athol,O
Memorial,O
Hospital,O
for,O
acute,O
on,O
chronic,B-PR
respiratory,I-PR
distress,I-PR
.,O

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

Lumbar,B-TE
puncture,I-TE
on,O
08-16,O

History,O
of,O
Present,O
Illness,O
:,O

Mr.,O
Lockley,O
is,O
a,O
73,O
yo,O
male,O
with,O
a,O
complicated,O
past,O
medical,O
history,O
",",O
recently,O
discharged,O
from,O
St.,O
Margaret,O
's,O
Center,O
for,O
Women,O
&,O
Infants,O
on,O
08-02,O
following,O
a,O
prolonged,O
admission,O
for,O
STEMI,B-PR
",",O
respiratory,B-PR
failure,I-PR
felt,O
secondary,O
to,O
pulmonary,B-PR
edema,I-PR
requiring,O
intubation,O
and,O
subsequent,B-TR
tracheostomy,I-TR
02-22,O
failure,B-PR
to,I-PR
wean,I-PR
",",O
sepsis,B-PR
and,O
C.difficile,B-PR
colitis,I-PR
treated,O
with,O
Vancomycin,B-TR
and,O
Flagyl,B-TR
with,O
a,O
course,O
of,O
Levophed,B-TR
.,O

He,O
was,O
discharged,O
to,O
Athol,O
Memorial,O
Hospital,O
for,O
continued,B-TR
weaning,I-TR
.,O

Per,O
Dr.,O
John,O
C.,O
Corrigan,O
Mental,O
Health,O
Center,O
",",O
patient,O
remained,O
ventilator,B-PR
dependent,I-PR
",",O
intermittently,O
on,O
PS,B-TR
20/5,O
and,O
back,O
on,O
AC,B-TR
15/5/500/0.35,O
on,O
08-08,O
.,O

At,O
OSH,O
",",O
sputum,B-TE
cultures,I-TE
grew,O
Pseudomonas,B-PR
and,O
MRSA,B-PR
",",O
and,O
he,O
was,O
restarted,O
on,O
Zosyn,B-TR
(,O
08-08,O
),O
and,O
Vancomycin,B-TR
(,O
08-09,O
).,O

He,O
completed,O
his,O
course,O
of,O
Vancomycin,B-TR
on,O
2017-08-10,O
.,O

However,O
",",O
today,O
around,O
17:45,O
",",O
while,O
being,O
moved,O
by,O
the,O
nursing,O
staff,O
",",O
Mr.,O
Lockley,O
Bosche,O
started,O
coughing,B-PR
.,O

Suctioned,O
X,O
1,O
",",O
mucus,O
not,O
cleared,O
.,O

He,O
then,O
became,O
dusky,B-PR
and,O
cyanotic,B-PR
",",O
and,O
stopped,B-PR
breathing,I-PR
on,O
his,O
own,O
.,O

A,O
code,O
was,O
called,O
",",O
+,O
pulse,B-TE
.,O

Patient,O
placed,O
on,O
FiO2,B-TR
100%,O
.,O

Vitals,B-TE
reportedly,O
HR,B-TE
88-98,O
",",O
BP,B-TE
150/80,O
.,O

ABG,B-TE
done,O
on,O
FiO2,B-TR
100%,O
7.36/66/417/98%,O
.,O

At,O
Vencor,O
Hospital,O
",",O
BP,B-PR
dropped,I-PR
to,O
90,O
",",O
and,O
patient,O
was,O
started,O
on,O
NS,B-TR
IVF,I-TR
",",O
with,O
improvement,O
in,O
BP,B-TE
.,O

EKG,B-TE
without,O
acute,B-PR
changes,I-PR
.,O

He,O
was,O
transferred,O
to,O
St.,O
Margaret,O
's,O
Center,O
for,O
Women,O
&,O
Infants,O
John,O
for,O
further,B-TR
management,I-TR
on,O
AC,B-TE
",",O
RR,B-TE
15,O
",",O
PEEP,B-TE
5,O
",",O
Vt,B-TE
500,O
",",O
Fi02,B-TE
1.0,O
.,O

In,O
John,O
",",O
BP,B-TE
80/60,O
",",O
HR,B-TE
80,O
.,O

Continued,O
on,O
IVF,B-TR
(,O
received,O
total,O
2300,O
cc,O
),O
",",O
with,O
improved,O
BP,B-TE
to,O
SBP,B-TE
105-118,O
.,O

Stool,B-TE
sent,O
for,O
C.diff,B-PR
and,O
given,O
Flagyl,B-TR
500,O
mg,O
PO,O
X,O
1,O
dose,O
.,O

Past,O
Medical,O
History,O
:,O

1.,O
Non-small,B-PR
cell,I-PR
lung,I-PR
cancer,I-PR
s/p,B-TR
XRT,I-TR
and,O
chemotherapy,B-TR
in,O
French,O
Guiana,O
",",O
s/p,B-TR
right,I-TR
pneumonectomy,I-TR
in,O
2016-09-21,O
for,O
recurrence,B-PR
.,O

Chronic,B-PR
left,I-PR
pleural,I-PR
effusion,I-PR
.,O

2.,O
SSS,B-PR
status,B-TR
post,I-TR
PM/ICD,I-TR
placement,I-TR

3.,O
COPD/bronchiectasis,B-PR

4.,O
Hypertension,B-PR

5.,O
CAD,B-PR
",",O
with,O
known,O
TO,O
RCA,O
.,O

6.,O
CHF,B-PR
with,O
EF,B-TE
25%,O
on,O
last,B-TE
echo,I-TE
on,O
2017-07-19,O

7.,O
BPH,B-PR

8.,O
Depression,B-PR

9.,O
Left,B-PR
femoral,I-PR
AV,I-PR
fistula,I-PR
2017-04-19,O

10.,O
Recent,B-PR
MRSA,I-PR
pneumonia,I-PR
and,O
sepsis,B-PR
2017-07-21,O
",",O
treated,O
with,O
Vancomycin,B-TR

11.,O
C.,B-PR
difficile,I-PR
colitis,I-PR
treated,O
with,O
Flagyl,B-TR
(,O
completed,O
08-10,O
),O

12.,O
Status,B-TR
post,I-TR
PEG,I-TR
tube,I-TR
placement,I-TR
2017-07-21,O

13.,O
Status,B-TR
post,I-TR
tracheostomy,I-TR
2017-07-21,O
02-22,O
failure,B-PR
to,I-PR
wean,I-PR

14.,O
Status,B-TR
post,I-TR
partial,I-TR
colectomy,I-TR
1972,O

Social,O
History,O
:,O

Son,O
is,O
next,O
of,O
kin,O
.,O

See,O
below,O
for,O
contact,O
information,O
.,O

He,O
has,O
been,O
living,O
at,O
The,O
Cooley,O
Dickinson,O
Hospital,O
House,O
since,O
2017-08-02,O
.,O

Per,O
Dr.,O
John,O
C.,O
Corrigan,O
Mental,O
Health,O
Center,O
",",O
at,O
baseline,O
",",O
patient,O
not,O
interactive,O
.,O

Opens,O
eyes,O
spontaneously,O
",",O
withdraws,O
to,O
painful,B-TE
stimulus,I-TE
.,O

Family,O
History,O
:,O

Non-contributory,O

Physical,O
Exam,O
:,O

PHYSICAL,O
EXAM,O
on,O
admission,O
:,O

VITALS,O
:,O

BP,B-TE
90s-118/47-59,O
",",O
HR,B-TE
80-90s,O
.,O

Vent,O
:,O

AC,B-TE
",",O
RR,B-TE
15,O
",",O
PEEP,B-TE
5,O
",",O
Vt,B-TE
500,O
cc,O
",",O
FiO2,B-TE
1.0,O
.,O

GEN,O
:,O

Intubated,B-TR
",",O
opens,O
eyes,O
",",O
responds,O
to,O
painful,B-TE
stimulus,I-TE
.,O

HEENT,O
:,O

Pupils,B-PR
minimally,I-PR
reactive,I-PR
.,O

Sclera,B-PR
anicteric,I-PR
.,O

NECK,O
:,O

Unable,O
to,O
assess,O
JVP,B-TE
.,O

RESP,O
:,O

Bronchial,B-PR
breathing,I-PR
over,I-PR
right,I-PR
hemithorax,I-PR
.,O

Ronchorous,B-PR
breath,I-PR
sounds,I-PR
left,I-PR
chest,I-PR
.,O

Limited,B-TE
examination,I-TE
.,O

CVS,O
:,O

RRR,O
.,O

Normal,O
S1,O
",",O
S2,O
.,O

+,O
S4,B-PR
.,O

No,O
murmur,B-PR
appreciated,O
.,O

GI,O
:,O

PEG,B-TR
in,O
place,O
",",O
site,O
without,O
drainage,B-PR
.,O

BS,O
present,O
",",O
hypoactive,B-PR
.,O

Abdomen,O
soft,O
.,O

No,O
grimacing,B-PR
with,O
palpation,B-TE
.,O

CMED,O
:,O

Foley,B-TR
in,O
place,O
.,O

EXT,O
:,O

2+,B-PR
edema,I-PR
both,I-PR
upper,I-PR
extremities,I-PR
",",O
sacral,B-PR
edema,I-PR
.,O

Cool,B-PR
extremities,I-PR
.,O

Good,O
pedal,O
pulses,O
peripherally,O
.,O

NEURO,O
:,O

Limited,B-TE
examination,I-TE
.,O

Withdraws,O
to,O
painful,B-TE
stimulus,I-TE
.,O

Moves,O
all,O
4,O
extremities,O
.,O

Pertinent,O
Results,O
:,O

LABS,O
:,O

WBC,B-TE
-,O
4.9,O
RBC,B-TE
-,O
2.92,O
*,O
HGB,B-TE
-,O
8.8,O
*,O
HCT,B-TE
-,O
26.2,O
*,O
MCV,B-TE
-,O
90,O
MCH,B-TE
-,O
30.1,O
MCHC,B-TE
-,O
33.5,O
RDW,B-TE
-,O
18.5,O
*,O
NEUTS,B-TE
-,O
86.5,O
*,O
LYMPHS,B-TE
-,O
7.5,O
*,O
MONOS,B-TE
-,O
4.7,O
EOS,B-TE
-,O
1.2,O
BASOS,B-TE
-,O
0.1,O
PLT,B-TE
COUNT,I-TE
-,O
145,O
*,O
GLUCOSE,B-TE
-,O
91,O
UREA,B-TE
N,I-TE
-,O
21,O
*,O
CREAT,B-TE
-,O
0.6,O
SODIUM,B-TE
-,O
143,O
POTASSIUM,B-TE
-,O
4.2,O
CHLORIDE,B-TE
-,O
106,O
TOTAL,B-TE
CO2,I-TE
-,O
32,O
ANION,B-TE
GAP,I-TE
-,O
9,O
LACTATE,B-TE
-,O
1.4,O
K+,B-TE
-,O
3.9,O

ABG,B-TE
:,O

2017-08-14,O
07:30,O
PM,O
TYPE,O
-,O
ART,B-TE
PO2,I-TE
-,O
468,O
*,O
PCO2,B-TE
-,O
44,O
PH,B-TE
-,O
7.50,O
*,O
TOTAL,B-TE
CO2,I-TE
-,O
36,O
*,O
BASE,B-TE
XS,I-TE
-,O
10,O
INTUBATED,B-TR
-,O
INTUBATED,B-TR

EKG,B-TE
(,O
at,O
Athol,O
Memorial,O
Hospital,O
",",O
17:11,O
),O
:,O

Atrial,B-PR
fibrillation,I-PR
",",O
occasional,B-TR
V-paced,I-TR
",",O
rate,B-TE
74,O
.,O

Normal,O
axis,O
.,O

Old,B-PR
TWI,I-PR
V4-6,I-PR
.,O

EKG,B-TE
in,O
John,O
:,O

Afib,B-PR
",",O
occasional,B-TR
V-paced,I-TR
",",O
rate,B-TE
83,O
bpm,O
.,O

Normal,O
axis,O
.,O

Long,B-PR
QT,I-PR
interval,I-PR
(,O
QTc,B-TE
462,O
ms,O
).,O

ST,B-PR
depressions,I-PR
V4,I-PR
",",I-PR
5,I-PR
.,O

Mild,B-PR
ST,I-PR
elevation,I-PR
in,I-PR
V3,I-PR
.,O

Old,B-PR
TWI,I-PR
V4-6,I-PR
.,O

****************,O

IMAGING,O
:,O

2017-08-14,O
CXR,B-TE
:,O

ETT,B-TR
in,O
correct,O
position,O
.,O

PM,B-TR
wires,I-TR
in,O
good,O
position,O
.,O

S/p,B-TR
right,I-TR
pneumonectomy,I-TR
.,O

Blunting,B-PR
of,I-PR
left,I-PR
CPA,I-PR
likely,O
effusion,B-PR
.,O

New,B-PR
lower,I-PR
left,I-PR
lateral,I-PR
CW,I-PR
opacity,I-PR
",",O
likely,O
loculated,B-PR
pleural,I-PR
fluid,I-PR
.,O

2017-07-19,O
ECHO,B-TE
:,O

Left-to-right,B-PR
shunt,I-PR
across,I-PR
the,I-PR
interatrial,I-PR
septum,I-PR
.,O

LVEF,B-TE
25%,O
.,O

Resting,B-TE
WMA,I-TE
include,O
mid,B-PR
to,I-PR
distal,I-PR
septal,I-PR
akinesis,I-PR
",",O
apical,B-PR
akinesis,I-PR
",",O
inferior,B-PR
akinesis/hypokinesis,I-PR
",",O
and,O
mid,B-PR
to,I-PR
distal,I-PR
anterolateral,I-PR
hypokinesis,I-PR
/,O
akinesis,B-PR
.,O

No,O
definite,O
apical,B-PR
thrombus,I-PR
seen,O
(,O
cannot,O
exclude,O
).,O

01-22+,O
AR,B-PR
.,O

Trivial,B-PR
MR,I-PR
.,O

1+,O
TR,B-PR
.,O

2017-08-16,O
CT,B-TE
head,I-TE
:,O

New,B-PR
rounded,I-PR
low-density,I-PR
area,I-PR
measuring,O
2.5,O
cm,O
in,O
left,O
basal,O
ganglia,O
",",O
which,O
partially,O
extends,O
to,O
the,O
left,O
thalamus,O
",",O
probably,O
representing,O
subacute,B-PR
infarction,I-PR
.,O

On,O
this,B-TE
head,I-TE
CT,I-TE
without,O
contrast,O
",",O
the,B-TE
evaluation,I-TE
is,O
limited,O
.,O

2017-08-16,O
CTA,B-TE
chest,I-TE
:,O

No,O
evidence,O
for,O
pulmonary,B-PR
embolism,I-PR
.,O

Findings,O
consistent,O
with,O
failure,B-PR
or,O
fluid,B-PR
overload,I-PR
.,O

Development,O
of,O
small,B-PR
loculated,I-PR
pleural,I-PR
fluid,I-PR
collection,I-PR
along,I-PR
the,I-PR
periphery,I-PR
of,O
the,O
left,O
major,O
fissure,O
or,O
so-called,B-PR
pseudotumor,I-PR
",",O
consistent,O
with,O
the,B-TE
recent,I-TE
chest,I-TE
x-ray,I-TE
.,O

Unchanged,O
appearance,O
of,O
right,B-TR
pneumonectomy,I-TR
.,O

2017-08-16,O
ECHO,B-TE
:,O

The,O
left,O
atrium,O
is,O
normal,O
in,O
size,O
.,O

Overall,B-TE
LVEF,I-TE
is,O
difficult,O
to,O
assess,O
due,O
to,O
poor,O
echo,B-TE
windows,I-TE
although,O
the,B-TE
basal,I-TE
LV,I-TE
appeas,O
hyperdynamic,B-PR
without,O
regional,B-PR
contraction,I-PR
abnormality,I-PR
(,O
suspect,O
significant,O
improvement,O
compared,O
to,O
prior,B-TE
study,I-TE
dated,O
2017-07-18,O
).,O

No,O
masses,B-PR
or,O
thrombi,B-PR
are,O
seen,O
in,O
the,O
left,O
ventricle,O
(,O
due,O
to,O
poor,O
echo,B-TE
windows,I-TE
cannot,O
fully,O
exclude,O
).,O

The,O
ascending,O
aorta,O
is,O
mildly,B-PR
dilated,I-PR
.,O

There,O
is,O
no,O
aortic,B-PR
valve,I-PR
stenosis,I-PR
.,O

Mild,B-PR
(,I-PR
1+,I-PR
),I-PR
aortic,I-PR
regurgitation,I-PR
is,O
seen,O
.,O

Trivial,B-PR
mitral,I-PR
regurgitation,I-PR
is,O
seen,O
.,O

The,B-TE
left,I-TE
ventricular,I-TE
inflow,I-TE
pattern,I-TE
suggests,O
impaired,B-PR
relaxation,I-PR
.,O

There,O
is,O
a,B-PR
small,I-PR
pericardial,I-PR
effusion,I-PR
.,O

There,O
are,O
no,O
echocardiographic,B-TE
signs,I-TE
of,O
tamponade,B-PR

2017-08-17,O
EEG,B-TE
:,O

Markedly,B-PR
abnormal,I-PR
portable,I-PR
EEG,I-PR
due,O
to,O
the,B-PR
voltage,I-PR
suppression,I-PR
over,I-PR
the,I-PR
left,I-PR
hemisphere,I-PR
and,O
due,O
to,O
the,B-PR
bursts,I-PR
of,I-PR
generalized,I-PR
slowing,I-PR
and,O
right,B-PR
hemisphere,I-PR
slowing,I-PR
.,O

The,B-PR
first,I-PR
abnormality,I-PR
raises,O
the,O
possibility,O
of,O
material,B-PR
(,I-PR
such,I-PR
as,I-PR
subdural,I-PR
fluid,I-PR
),I-PR
interposed,I-PR
between,I-PR
the,I-PR
brain,I-PR
and,O
recording,O
electrodes,O
or,O
widespread,B-PR
cortical,I-PR
dysfunction,I-PR
on,I-PR
that,I-PR
side,I-PR
.,O

Anatomic,O
correlation,O
would,O
be,O
of,O
interest,O
if,O
clinically,O
indicated,O
.,O

The,B-PR
generalized,I-PR
slowing,I-PR
indicates,O
a,B-PR
non,I-PR
specific,I-PR
dysfunction,I-PR
in,I-PR
midline,I-PR
structures,I-PR
.,O

There,O
was,O
also,O
evidence,O
of,O
subcortical,B-PR
dysfunction,I-PR
on,I-PR
the,I-PR
right,I-PR
side,I-PR
.,O

No,O
epileptiform,B-PR
features,I-PR
were,O
seen,O
.,O

MICRO,O
DATA,O
:,O

2017-08-17,O
STOOL,B-TE
CLOSTRIDIUM,I-TE
DIFFICILE,I-TE
TOXIN,I-TE
ASSAY,I-TE
-,O
PENDING,O

2017-08-16,O
CSF,O
;,O
SPINAL,B-TE
FLUID,I-TE
GRAM,I-TE
STAIN,I-TE
-,O
neg,O
FLUID,B-TE
CULTURE,I-TE
-,O
neg,O
;,O
FUNGAL,B-TE
CULTURE,I-TE
-,O
PENDING,O
;,O
ACID,B-TE
FAST,I-TE
CULTURE,I-TE
-,O
PENDING,O
;,O
VIRAL,B-TE
CULTURE,I-TE
-,O
PENDING,O

2017-08-15,O
SPUTUM,B-TE
CULTURE,I-TE
-,O
PRELIMINARY,O
{,O
PSEUDOMONAS,B-PR
AERUGINOSA,I-PR
},O

2017-08-15,O
BLOOD,B-TE
CULTURE,I-TE
NGTD,O

2017-08-15,O
URINE,B-TE
CULTURE,I-TE
-,O
FINAL,O

2017-08-15,O
BLOOD,B-TE
CULTURE,I-TE
NGTD,O

Brief,O
Hospital,O
Course,O
:,O

Mr.,O
Lockley,O
was,O
admitted,O
with,O
respiratory,B-PR
failure,I-PR
",",O
thought,O
to,O
be,O
related,O
to,O
mucus,B-PR
plugging,I-PR
as,O
well,O
as,O
a,B-PR
pseudomonal,I-PR
pneumonia,I-PR
.,O

Both,O
of,O
these,O
etiologies,O
were,O
treated,O
",",O
and,O
he,O
continued,O
to,O
oxygenate,O
and,O
ventilate,O
well,O
on,O
his,O
usual,O
ventilator,O
settings,O
.,O

However,O
",",O
the,O
issue,O
that,O
dominated,O
the,O
admission,O
was,O
his,B-PR
recent,I-PR
acute,I-PR
decline,I-PR
in,I-PR
mental,I-PR
status,I-PR
.,O

He,O
was,O
thoroughly,O
evaluated,O
by,O
neurology,O
and,O
underwent,O
head,B-TE
CT,I-TE
",",O
MRI,B-TE
",",O
LP,B-TE
",",O
and,O
EEG,B-TE
.,O

This,B-TE
work-up,I-TE
demonstrated,O
a,B-PR
small,I-PR
left,I-PR
basal,I-PR
ganglia,I-PR
infarct,I-PR
",",O
likely,O
cardioembolic,B-PR
.,O

However,O
",",O
they,O
felt,O
this,O
event,O
could,O
not,O
account,O
for,O
his,B-PR
new,I-PR
",",I-PR
severe,I-PR
global,I-PR
deficit,I-PR
;,O
this,O
was,O
thought,O
to,O
be,O
secondary,O
to,O
a,B-PR
more,I-PR
pervasive,I-PR
process,I-PR
",",O
likely,O
anoxic,B-PR
encephalopathy,I-PR
",",O
for,O
which,O
the,O
prognosis,O
is,O
extremely,O
grim,O
.,O

This,O
was,O
discussed,O
at,O
length,O
in,O
several,O
family,O
meetings,O
involving,O
the,O
patient,O
's,O
wife,O
",",O
son,O
",",O
primary,O
care,O
doctor,O
",",O
ICU,O
attending,O
",",O
and,O
neurology,O
consultant,O
in,O
the,O
presence,O
of,O
a,O
Asian,O
interpreter,O
.,O

The,O
end,O
result,O
of,O
these,O
discussion,O
was,O
that,O
the,O
patient,O
's,O
wishes,O
would,O
not,O
be,O
consistent,O
with,O
this,O
new,O
level,O
of,O
functioning,O
from,O
which,O
he,O
had,O
little,O
hope,O
of,O
recovery,O
;,O
the,O
family,O
decided,O
to,O
make,O
him,O
comfort,B-TR
measures,I-TR
only,I-TR
.,O

He,O
was,O
disconnected,O
from,O
the,B-TR
ventilator,I-TR
and,O
all,B-TR
medications,I-TR
beyond,O
a,B-TR
morphine,I-TR
drip,I-TR
were,O
stopped,O
",",O
and,O
he,O
expired,O
shortly,O
thereafter,O
.,O

The,O
family,O
was,O
present,O
.,O

Medications,O
on,O
Admission,O
:,O

Jevity,B-TR
1.2,O
65,O
mL,O
/,O
hour,O
continuous,O
with,O
water,O
240,O
cc,O
q,O
8,O
hours,O

Lasix,B-TR
40,O
mg,O
IV,O
QAM,O
(,O
given,O
08-14,O
),O

Vancomycin,B-TR
1,O
gm,O
IV,O
q,O
36,O
hours,O
(,O
last,O
dose,O
at,O
2000,O
on,O
08-13,O
),O
.,O

Started,O
on,O
08-09,O
),O

ASA,B-TR
325,O
mg,O
PO,O
QD,O

Lansoprazole,B-TR
30,O
mg,O
PO,O
QAM,O

Heparin,B-TR
5000,O
units,O
SC,O
TID,O

Zosyn,B-TR
4.5,O
gm,O
IV,O
q,O
8,O
hours,O
(,O
last,O
dose,O
on,O
08-14,O
at,O
1400,O
),O
",",O
started,O
08-08,O
.,O

Metoprolol,B-TR
37.5,O
mg,O
q,O
12,O
hours,O
(,O
last,O
dose,O
07/25,O
in,O
AM,O
),O

Protein,B-TR
/,I-TR
Soy,I-TR
supplement,I-TR
2,O
scoops,O
q,O
12,O
hours,O

Ipratropium,B-TR
/,O
Albuterol,B-TR
inhaler,I-TR
4,O
puffs,O
QID,O

Completed,O
course,O
of,O
Flagyl,B-TR
07-25,O
-->,O
08-10,O
.,O

Discharge,O
Disposition,O
:,O

Expired,O

Discharge,O
Diagnosis,O
:,O

Anoxic,B-PR
encephalopathy,I-PR

Acute,B-PR
respiratory,I-PR
failure,I-PR

Chronic,B-PR
respiratory,I-PR
failure,I-PR

Pseudomonal,B-PR
pneumonia,I-PR

Volume,B-PR
overload,I-PR

Chronic,B-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR

Bronchiectasis,B-PR

Hyponatremia,B-PR

Anemia,B-PR
of,I-PR
chronic,I-PR
disease,I-PR

Secondary,O
:,O

1.,O
Non-small,B-PR
cell,I-PR
lung,I-PR
cancer,I-PR
s/p,B-TR
XRT,I-TR
and,O
chemotherapy,B-TR
in,O
Western,O
Sahara,O
",",O
s/p,B-TR
right,I-TR
pneumonectomy,I-TR
in,O
2016-09-21,O
for,O
recurrence,B-PR
.,O

Chronic,B-PR
left,I-PR
pleural,I-PR
effusion,I-PR
.,O

2.,O
Sick,B-PR
Sinus,I-PR
Syndrome,I-PR
status,B-TR
post,I-TR
PM/ICD,I-TR
placement,I-TR

3.,O
COPD/bronchiectasis,B-PR

4.,O
Hypertension,B-PR

5.,O
CAD,B-PR
",",O
with,O
known,O
TO,O
RCA,O
.,O

6.,O
CHF,B-PR
with,O
EF,B-TE
25%,O
on,O
last,B-TE
echo,I-TE
on,O
2017-07-19,O

7.,O
BPH,B-PR

8.,O
Depression,B-PR

9.,O
Left,B-PR
femoral,I-PR
AV,I-PR
fistula,I-PR
2017-04-19,O

10.,O
Recent,B-PR
MRSA,I-PR
pneumonia,I-PR
and,O
sepsis,B-PR
2017-07-21,O
",",O
treated,O
with,O
Vancomycin,B-TR

11.,O
C.,B-PR
difficile,I-PR
colitis,I-PR
treated,O
with,O
Flagyl,B-TR
(,O
completed,O
08-10,O
),O

12.,O
Status,B-TR
post,I-TR
PEG,I-TR
tube,I-TR
placement,I-TR
2017-07-21,O

13.,O
Status,B-TR
post,I-TR
tracheostomy,I-TR
2017-07-21,O
02-22,O
failure,B-PR
to,I-PR
wean,I-PR

14.,O
Status,B-TR
post,I-TR
partial,I-TR
colectomy,I-TR
1972,O

Discharge,O
Condition,O
:,O

Expired,O

Johnnie,O
Callez,O
MD,O
61-750,O

Completed,O
by,O
:,O
Opal,O
Anne,O
MD,O
40-158,O
2017-08-23,O
@,O
2054,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Teresa,O
Loper,O
on,O
:,O
FRI,O
2017-09-22,O
4:29,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2018-12-26,O

Discharge,O
Date,O
:,O

2019-01-10,O

Date,O
of,O
Birth,O
:,O

1949-02-09,O

Sex,O
:,O

F,O

Service,O
:,O

MEDICINE,B-TR

Allergies,O
:,O

Losartan,B-TR
/,O
Aspirin,B-TR
/,O
Lisinopril-Hctz,B-TR

Attending,O
:,O
Donald,O
I,O
Patrick,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O
fever,B-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

Intubation,B-TR
for,O
airway,B-TR
protection,I-TR
tunneled,B-TR
line,I-TR
change,I-TR
over,I-TR
wire,I-TR
2019-01-08,O

History,O
of,O
Present,O
Illness,O
:,O

69,O
y/o,O
female,O
wtih,O
PMH,O
significant,O
for,O
ESRD,B-PR
on,O
HD,B-TR
",",O
type,B-PR
2,I-PR
DM,I-PR
",",O
and,O
recent,B-PR
PE,I-PR
resulting,O
in,O
PEA,B-PR
arrest,I-PR
admitted,O
through,O
the,O
Juan,O
with,O
sepsis,B-PR
of,O
unknown,O
etiology,O
.,O

Pt,O
was,O
recently,O
admitted,O
to,O
The,O
Hospital,O
for,O
Orthopedics,O
from,O
12-07,O
thorugh,O
12-14,O
with,O
hypotension,B-PR
thought,O
to,O
be,O
secondary,O
to,O
overdiuresis,B-PR
at,O
HD.,B-TR

However,O
",",O
a,B-PR
septic,I-PR
component,I-PR
to,O
the,B-PR
hypotension,I-PR
was,O
also,O
considered,O
as,O
the,O
pt,O
was,O
found,O
to,O
have,O
citrobacter,B-PR
in,I-PR
her,I-PR
urine,I-PR
and,O
C,B-PR
diff,I-PR
in,I-PR
her,I-PR
stool,I-PR
.,O

Pt,O
was,O
then,O
discharged,O
to,O
Arbour-Fuller,O
Hospital,O
Senior,O
Life,O
where,O
she,O
was,O
in,O
her,O
normal,O
state,O
of,O
health,O
until,O
three,O
days,O
ago,O
.,O

Her,O
son,O
reports,O
that,O
she,O
then,O
developed,O
a,B-PR
headache,I-PR
and,O
fevers,B-PR
started,O
three,O
days,O
ago,O
which,O
were,O
treated,O
with,O
tylenol,B-TR
.,O

Then,O
",",O
this,O
morning,O
she,O
developed,O
fatigue,B-PR
and,O
did,O
not,O
eat,O
well,O
.,O

He,O
son,O
also,O
notes,O
that,O
she,O
appeared,O
to,O
be,O
working,B-PR
hard,I-PR
to,I-PR
breath,I-PR
.,O

She,O
was,O
found,O
to,O
be,O
febrile,B-PR
to,O
101.9,O
and,O
received,O
levoflox,B-TR
and,O
vancomycin,B-TR
.,O

Pt,O
was,O
then,O
sent,O
to,O
the,O
The,O
Hospital,O
for,O
Orthopedics,O
Juan,O
for,O
further,B-TE
evaluation,I-TE
.,O

Per,O
notes,O
",",O
pt,O
denied,O
SOB,B-PR
",",O
CP,B-PR
",",O
and,O
abdominal,B-PR
pain,I-PR
prior,O
to,O
intubation,B-TR
.,O

She,O
did,O
complain,O
of,O
a,B-PR
left,I-PR
frontal,I-PR
headache,I-PR
.,O

In,O
the,O
Juan,O
",",O
the,B-TE
pt,I-TE
's,I-TE
VS,I-TE
were,O
singificant,O
for,O
a,B-PR
fever,I-PR
of,O
103.8,O
",",O
tachycardia,B-PR
in,O
the,O
130s-150s,O
",",O
and,O
initial,B-PR
hypertensive,I-PR
in,O
the,O
140s,O
.,O

Her,B-TE
oxygen,I-TE
saturation,I-TE
was,O
96%,O
on,O
RA,O
but,O
she,O
was,O
tachypneic,B-PR
to,O
31,O
.,O

She,O
was,O
obtunded,B-PR
and,O
was,O
thus,O
intubated,B-TR
for,O
airway,B-TR
protection,I-TR
.,O

Post-intubation,O
",",O
the,B-TE
pt,I-TE
's,I-TE
BP,I-TE
acutely,O
dropped,O
to,O
58/19,O
in,O
the,O
setting,O
of,O
propofol,B-TR
.,O

When,O
this,B-TR
medication,I-TR
was,O
discontinued,O
",",O
her,B-TE
BP,I-TE
came,O
back,O
up,O
to,O
the,O
70s-90s,O
/,O
30s-50s,O
.,O

Pt,O
was,O
then,O
initiated,O
on,O
the,B-TR
sepsis,I-TR
protocol,I-TR
.,O

In,O
the,O
Juan,O
",",O
she,O
received,O
vancomycin,B-TR
",",O
levofloxacin,B-TR
",",O
flagyl,B-TR
",",O
and,O
cefepime,B-TR
(,O
2,O
gm,O
).,O

She,O
received,O
a,O
total,O
of,O
4,O
liters,O
of,O
NS,B-TR
then,O
was,O
started,O
on,O
levophed,B-TR
for,O
continued,B-PR
hypotension,I-PR
.,O

Pt,O
is,O
now,O
transferred,O
to,O
the,O
FICU,O
for,O
further,B-TR
care,I-TR
.,O

Per,O
pt,O
's,O
son,O
",",O
she,O
is,O
bedbound,B-PR
at,O
baseline,O
due,O
to,O
her,B-PR
multiple,I-PR
LE,I-PR
femur,I-PR
fractures,I-PR
.,O

Past,O
Medical,O
History,O
:,O

1.,O
Type,B-PR
2,I-PR
diabetes,I-PR
mellitus,I-PR

2.,O
Diabetic,B-PR
nephropathy,I-PR
resulting,O
in,O
ESRD,B-PR
for,O
which,O
she,O
is,O
on,O
HD,B-TR
.,O

Pt,O
was,O
due,O
for,O
HD,B-TR
but,O
missed,O
it,O
secondary,O
to,O
her,B-PR
illness,I-PR
.,O

She,O
normally,O
receives,O
HD,B-TR
on,O
Mon,O
",",O
Wed,O
",",O
and,O
Fri,O
.,O

3.,O
Status,B-PR
post,I-PR
left,I-PR
femur,I-PR
fracture,I-PR

4.,O
Hyponatremia,B-PR

5.,O
Hypercholesterolemia,B-PR

6.,O
Unsteady,B-PR
gait,I-PR

7.,O
Cataracts,B-PR

8.,O
Back,B-PR
pain,I-PR

9.,O
Hypertension,B-PR

10.,O
Anemia,B-PR
of,I-PR
chronic,I-PR
disease,I-PR

11.,O
S/P,B-TR
L,I-TR
shoulder,I-TR
hemiarthroplasty,I-TR
following,O
a,B-PR
left,I-PR
humeral,I-PR
fracuture,I-PR
in,O
2018-11-10-,O
Dumas,O
was,O
complicated,O
by,O
a,B-PR
PEA,I-PR
arrest,I-PR
secondary,O
to,O
PE,B-PR
.,O

12.,O
PE,B-PR
2018-11-17,O
leading,O
to,O
PEA,B-PR
arrest,I-PR

Social,O
History,O
:,O

Lives,O
with,O
son,O
who,O
is,O
very,O
involved,O
and,O
well,O
informed,O
regarding,O
her,O
care,O
needs,O
.,O

Non,O
smoker,O
.,O

No,O
EtOH,O

Family,O
History,O
:,O

Noncontributory,O

Physical,O
Exam,O
:,O

94.5,O

132/50,O

108,O

15,O

100%,O

AC,O
500,O
/,O
15,O
/,O
.50,O
/,O
PEEP,B-TR
5,O

Gen,O
-,O
Sedated,B-TR
and,O
intubated,B-TR
.,O

Grimaces,O
eyes,O
when,O
they,O
are,O
opened,O
.,O

HEENT,O
-,O
NC,O
AT,O
.,O

Right,O
pupil,O
ERRL,O
.,O

Surgical,O
left,O
pupil,O
.,O

Anicteric,B-PR
sclera,I-PR
.,O

MMM,O
.,O

Cardiac,O
-,O
RRR,O
.,O

S1,O
S2,O
.,O

No,O
"m,r,g",B-PR
.,O

Pulm,O
-,O
CTA,O
anteriorlly,O
.,O

Abdomen,O
-,O
Obese,B-PR
.,O

Soft,O
.,O

NT,B-PR
.,O

ND,B-PR
.,O

Positive,O
bowel,O
sounds,O
.,O

Extremities,O
-,O
Feet,B-PR
mildly,I-PR
cool,I-PR
.,O

2+,B-TE
DP,I-TE
pulses,I-TE
bilaterally,I-TE
.,O

2+,B-PR
pitting,I-PR
edema,I-PR
bilateral,I-PR
LE,I-PR
.,O

Skin,B-PR
breakdown,I-PR
between,I-PR
toes,I-PR
.,O

Pressure,B-PR
ulcers,I-PR
under,I-PR
bilateral,I-PR
LE,I-PR
right,O
above,O
the,O
ankles,O
.,O

Do,O
not,O
appear,O
infected,B-PR
.,O

Question,O
mild,B-PR
erythema,I-PR
and,O
warmth,B-PR
of,I-PR
left,I-PR
LE,I-PR
.,O

Neuro,O
-,O
Sedated,B-PR
.,O

Downgoing,O
toes,O
bilaterally,O
.,O

Scruntches,O
eyes,O
closed,O
when,O
try,O
to,O
open,O
them,O
.,O

Pertinent,O
Results,O
:,O

2018-12-26,O
23:10,O

LACTATE,B-TE
-,O
1.8,O

2018-12-26,O
22:53,O

CRP,B-TE
-,O
46.2,O
*,O

2018-12-26,O
22:53,O

SED,B-TE
RATE,I-TE
-,O
33,O
*,O

2018-12-26,O
21:54,O

TYPE,O
-,O
MIX,B-TE
TEMP,I-TE
-,O
35.6,O
RATES,B-TE
-/,O
15,O
TIDAL,B-TE
VOL,I-TE
-,O
500,O
PEEP,B-TR
-,O
5,O
O2,B-TE
-,O
50,O
PO2,B-TE
-,O
34,O
*,O
PCO2,B-TE
-,O
39,O
PH,B-TE
-,O
7.32,O
*,O
TOTAL,B-TE
CO2,I-TE
-,O
21,O
BASE,B-TE
XS,I-TE
-,O
-6,O

2018-12-26,O
21:54,O

LACTATE,B-TE
-,O
1.6,O

2018-12-26,O
21:44,O

GLUCOSE,B-TE
-,O
210,O
*,O
UREA,B-TE
N,I-TE
-,O
29,O
*,O
CREAT,B-TE
-,O
3.2,O
*,O
SODIUM,B-TE
-,O
139,O
POTASSIUM,B-TE
-,O
3.9,O
CHLORIDE,B-TE
-,O
112,O
*,O
TOTAL,B-TE
CO2,I-TE
-,O
17,O
*,O
ANION,B-TE
GAP,I-TE
-,O
14,O

2018-12-26,O
21:44,O

CALCIUM,B-TE
-,O
6.2,O
*,O
PHOSPHATE,B-TE
-,O
1.7,O
*,O
MAGNESIUM,B-TE
-,O
0.9,O
*,O

2018-12-26,O
21:44,O

CORTISOL,B-TE
-,O
10.3,O

2018-12-26,O
21:44,O

WBC,B-TE
-,O
9.0,O
RBC,B-TE
-,O
2.93,O
*,O
HGB,B-TE
-,O
9.0,O
*,O
HCT,B-TE
-,O
29.7,O
*,O
MCV,B-TE
-,O
101,O
*,O
MCH,B-TE
-,O
30.8,O
MCHC,B-TE
-,O
30.4,O
*,O
RDW,B-TE
-,O
24.1,O
*,O

2018-12-26,O
21:44,O

NEUTS,B-TE
-,O
65.2,O
LYMPHS,B-TE
-,O
25.2,O
MONOS,B-TE
-,O
6.0,O
EOS,B-TE
-,O
3.3,O
BASOS,B-TE
-,O
0.4,O

2018-12-26,O
21:44,O

HYPOCHROM,B-TE
-,O
3+,O
ANISOCYT,B-TE
-,O
3+,O
POIKILOCY,B-TE
-,O
1+,O
MACROCYT,B-TE
-,O
3+,O
MICROCYT,B-TE
-,O
1+,O

2018-12-26,O
21:44,O

PLT,B-TE
COUNT,I-TE
-,O
177,O

2018-12-26,O
20:28,O

CORTISOL,B-TE
-,O
9.3,O

2018-12-26,O
08:28,O
PM,B-TE
URINE,I-TE

COLOR,B-TE
-,O
Yellow,O
APPEAR,B-TE
-,O
SlHazy,O
SP,O
Barajas,O
-,O
1.005,O

2018-12-26,O
08:28,O
PM,B-TE
URINE,I-TE

BLOOD,B-TE
-,O
LGE,B-TE
NITRITE,I-TE
-,O
NEG,O
PROTEIN,B-TE
-,O
500,O
GLUCOSE,B-TE
-,O
TR,O
KETONE,B-TE
-,O
NEG,O
BILIRUBIN,B-TE
-,O
NEG,O
UROBILNGN,B-TE
-,O
NEG,O
PH,B-TE
-,O
7.0,O
LEUK,B-TE
-,O
NEG,O

2018-12-26,O
08:28,O
PM,B-TE
URINE,I-TE

RBC,B-TE
-,O
225,O
*,O
WBC,B-TE
-,O
8,O
*,O
BACTERIA,B-TE
-,O
NONE,O
YEAST,B-TE
-,O
NONE,O
EPI,B-TE
-,O
<,O
1,O

2018-12-26,O
14:40,O

CK,B-TE
(,I-TE
CPK,I-TE
)-,I-TE
350,O
*,O

2018-12-26,O
14:40,O

CK,B-TE
-,O
MB,B-TE
-,O
3,O
cTropnT,B-TE
-,O
0.40,O
*,O

MICRO,O
:,O
sputum,B-TE
12-27,O
:,O
grm,B-TE
stn,I-TE
and,O
cx,B-TE
negative,O

infl,B-TE
A,I-TE
and,I-TE
B,I-TE
12-27,O
:,O
negative,O

CSF,B-TE
grm,I-TE
stn,I-TE
/,O
cx,B-TE
:,O
negative,O

urine,B-TE
cx,I-TE
12-26,O
:,O
>,O
100K,O
VRE,B-PR
likely,O
colonized,O
",",O
01-03,O
yest,O
and,O
VRE,B-PR

c,B-TE
diff,I-TE
neg,O
:,O
12-28,O
",",O
12-31,O
",",O
01-01,O
",",O
01-02,O
.,O

bld,B-TE
cx,I-TE
12-26,O
",",O
12-27,O
",",O
12-28,O
",",O
12-31,O
-,O
NG,O
.,O

01-01,O
",",O
01-02,O
X,O
3,O
",",O
01-03,O
",",O
01-04,O
",",O
11/27X,O
2,O
NGTD,O
.,O

Catheter,B-TR
tip,I-TR
01-05,O
",",O
NG,B-TR
.,O

C.,B-TE
Diff,I-TE
B,I-TE
-,O
negative,O

Tunnled,B-TR
catheter,I-TR
tip,I-TR
01-08,O
-,O
ngtd,O

HERPES,B-TE
SIMPLEX,I-TE
VIRUS,I-TE
PCR,I-TE
-,O
PND,O

Brief,O
Hospital,O
Course,O
:,O

A/P,O
:,O

69,O
y/o,O
female,O
wtih,O
PMH,B-PR
significant,O
for,O
ESRD,B-PR
on,O
HD,B-TR
",",O
type,B-PR
2,I-PR
DM,I-PR
",",O
and,O
recent,B-PR
PE,I-PR
resulting,O
in,O
PEA,B-PR
arrest,I-PR
admitted,O
through,O
the,O
Juan,O
with,O
sepsis,B-PR
of,O
unknown,O
etiology,O
.,O

1.,O
Sepsis,B-PR
/,O
ID-,O
Started,O
on,O
sepsis,B-TR
protocol,I-TR
.,O

Unclear,O
etiology,O
headache,B-PR
over,O
the,O
three,O
days,O
prior,O
to,O
admission,O
in,O
association,O
with,O
fever,B-PR
was,O
concerning,O
for,O
a,O
CNS,O
etiology,O
.,O

Covered,O
broadly,O
with,O
vancomycin,B-TR
",",O
flagyl,B-TR
",",O
and,O
cefipime,B-TR
.,O

Given,O
stress,B-TR
dose,I-TR
steroids,I-TR
empirically,O
and,O
Sanchez,B-TE
stim,I-TE
showed,O
cortisol,B-TE
of,O
9.3,O
-->,O
10.3,O
therefore,O
steroids,B-TR
continued,O
.,O

CXR,B-TE
",",O
LP,B-TE
",",O
UA,B-TE
and,O
abdominal,B-TE
CT,I-TE
showed,O
no,O
sign,O
of,O
infection,B-PR
.,O

PICC,B-TR
line,I-TR
was,O
removed,O
empirically,O
.,O

Tip,B-TR
could,O
not,O
be,O
cultured,O
due,O
to,O
contamination,B-PR
.,O

Cultures,B-TE
drawn,O
off,O
the,B-TR
HD,I-TR
cath,I-TR
are,O
negative,O
to,O
date,O
.,O

Patient,B-PR
's,I-PR
LE,I-PR
ulcers,I-PR
appear,O
chronic,O
and,O
do,O
not,O
appear,O
to,O
be,O
the,O
source,O
of,O
infection,B-PR
.,O

Her,O
left,O
knee,O
is,O
slightly,B-PR
erythematous,I-PR
compared,O
to,O
the,O
right,O
but,O
not,O
impressive,O
.,O

Joint,O
is,O
mobile,O
.,O

Nasal,B-TE
washings,I-TE
for,O
influenza,B-PR
were,O
negative,O
;,O
culture,B-TE
pending,O
.,O

Patient,O
improved,O
over,O
the,O
next,O
few,O
days,O
.,O

Steroids,B-TR
were,O
discontinued,O
.,O

On,O
12-18,O
flagyl,B-TR
and,O
cefepime,B-TR
were,O
discontinued,O
as,O
all,B-TE
culture,I-TE
data,I-TE
negative,O
to,O
date,O
.,O

Plan,O
to,O
continue,O
vancomycin,B-TR
for,O
08-19,O
day,O
course,O
to,O
treat,O
empiric,B-PR
line,I-PR
infection,I-PR
.,O

Urine,B-TE
culture,I-TE
came,O
back,O
positive,O
for,O
VRE,B-PR
",",O
however,O
",",O
since,O
patient,O
improved,O
without,O
treatement,B-TR
(,O
ie,O
Linezolid,B-TR
),O
initially,O
.,O

After,O
transfer,O
to,O
the,O
floor,O
when,O
she,O
was,O
stable,O
.,O

On,O
the,O
floor,O
the,B-TR
Vancomycin,I-TR
was,O
discontinued,O
as,O
the,B-TE
catheter,I-TE
tip,I-TE
culture,I-TE
was,O
negative,O
.,O

ID,O
was,O
consulted,O
who,O
suggested,O
broad,B-TR
spectrum,I-TR
antibiotics,I-TR
if,O
she,O
were,O
to,O
spike,B-PR
.,O

When,O
pt,O
spiked,O
a,B-PR
temperature,I-PR
and,O
became,O
hypotensive,B-PR
she,O
was,O
started,O
on,O
Linezolid,B-TR
was,O
started,O
for,O
presumed,O
VRE,B-PR
infection,I-PR
in,I-PR
the,I-PR
urine,I-PR
.,O

She,O
will,O
be,O
treated,O
for,O
total,O
14,O
day,O
course,O
.,O

She,O
was,O
also,O
started,O
on,O
fluconazole,B-TR
for,O
yeast,B-PR
in,I-PR
the,I-PR
urine,I-PR
",",O
to,O
be,O
treated,O
with,O
fluconazole,B-TR
for,O
total,O
7,O
days,O
.,O

She,O
was,O
given,O
Flagyl,B-TR
for,O
presumed,O
C.,B-PR
Diff.,I-PR
Colitis,I-PR
",",O
however,O
this,O
was,O
stopped,O
when,O
C.,B-TE
Diff,I-TE
B,I-TE
toxin,I-TE
came,O
back,O
negative,O
on,O
2019-01-10,O
.,O

The,B-TR
tunneled,I-TR
catheter,I-TR
line,I-TR
was,O
changed,O
over,O
a,B-TR
wire,I-TR
and,O
the,B-TE
tip,I-TE
was,O
also,O
negative,O
.,O

2.,O
Respiratory,O
-,O
Intubated,B-TR
for,O
airway,B-TR
protection,I-TR
due,O
to,O
change,B-PR
in,I-PR
mental,I-PR
status,I-PR
.,O

Extubated,B-TR
12-28,O
with,O
no,O
incident,O
.,O

3.,O
ECG,B-PR
changes,I-PR
-,O
Patient,O
had,O
an,O
episode,O
of,O
chest,B-PR
pain,I-PR
during,O
her,O
hospital,O
stay,O
that,O
was,O
both,O
right,O
and,O
left,O
sided,O
with,O
no,O
radiation,O
and,O
no,O
associated,B-PR
symptoms,I-PR
.,O

ECG,B-TE
showed,O
new,B-PR
diffuse,I-PR
TWI,I-PR
in,I-PR
all,I-PR
leads,I-PR
.,O

Cardiac,B-TE
enzymes,I-TE
were,O
cycled,O
and,O
were,O
normal,O
.,O

Echo,B-TE
was,O
obtained,O
which,O
showed,O
WMA,B-PR
and,O
EF,B-TE
of,O
35-40%,O
.,O

Pt,O
was,O
note,O
started,O
on,O
ASA,B-TR
as,O
she,O
does,O
not,O
tolerate,O
this,O
well,O
",",O
BB,B-TR
was,O
also,O
not,O
started,O
given,O
SBPs,B-TE
in,O
the,O
110s,O
.,O

Statin,B-TR
was,O
also,O
deffered,O
.,O

She,O
may,O
be,O
started,O
on,O
ASA,B-TR
",",O
BB,B-TR
",",O
statin,B-TR
by,O
PCP,O
as,O
Stephen,O
.,O

4.,O
Shoulder,B-PR
fracture,I-PR
-,O
Patient,O
is,O
s/p,B-PR
a,I-PR
left,I-PR
hip,I-PR
fracture,I-PR
(,O
decision,O
not,O
to,O
operate,O
),O
and,O
a,B-PR
left,I-PR
shoulder,I-PR
fracture,I-PR
with,O
hemiarthroplasty,B-TR
11-14,O
.,O

Patient,O
was,O
found,O
to,O
have,O
a,B-PR
new,I-PR
humerus,I-PR
fracture,I-PR
distal,I-PR
to,I-PR
the,I-PR
hardware,I-PR
on,O
film,B-TE
this,O
admission,O
.,O

Assumed,O
to,O
be,O
secondary,O
to,O
trauma,B-PR
when,O
moving,O
patient,O
into,O
ambulance,O
.,O

CMED,O
service,O
was,O
consulted,O
and,O
recommended,O
wtd,B-TR
woulnd,I-TR
care,I-TR
and,O
sling,B-TR
at,O
all,O
times,O
.,O

Wound,B-TR
care,I-TR
should,O
be,O
continued,O
as,O
described,O
after,O
discharge,O
.,O

5.,O
Type,B-PR
2,I-PR
DM,I-PR
-,O
Patient,O
was,O
initially,O
covered,O
with,O
an,B-TR
insulin,I-TR
drip,I-TR
while,O
septic,B-PR
and,O
then,O
transitioned,O
back,O
to,O
insulin,B-TR
sliding,I-TR
scale,I-TR
.,O

6.,O
ESRD,B-PR
on,O
HD,B-TR
-,O
Pt,O
has,O
ESRD,B-PR
secondary,O
to,O
her,B-PR
DM,I-PR
and,O
is,O
on,O
HD,B-TR
.,O

She,O
was,O
dialysed,O
but,O
was,O
slightly,B-PR
limited,I-PR
by,O
hypotension,B-PR
.,O

Dialyzed,O
12-28,O
with,O
plan,O
to,O
dialyze,O
again,O
12-31,O
.,O

Her,B-TR
dialysis,I-TR
was,O
managed,O
by,O
renal,O
service,O
in,O
house,O
.,O

7.,O
PE,B-PR
(,O
11-14,O
)-,O
On,O
heparin,B-TR
drip,I-TR
.,O

Restared,O
coumadin,B-TR
on,O
12-29,O
.,O

Heparin,B-TR
discontinued,O
on,O
01-01,O
when,O
INR,B-TE
was,O
2.0,O
.,O

Coumadin,B-TR
was,O
stopped,O
and,O
she,O
received,O
fFP,B-TR
for,O
tunneled,B-TR
line,I-TR
change,I-TR
over,I-TR
a,I-TR
wire,I-TR
.,O

Coumadin,B-TR
was,O
restarted,O
at,O
a,O
dose,O
of,O
2,O
mg,O
qhs,O
.,O

This,O
should,O
be,O
titrated,O
after,O
discharge,O
for,O
INR,B-TE
goal,I-TE
of,O
2-3,O
.,O

8.,O
PVD,B-PR
:,O

Dry,B-PR
gangrene,I-PR
of,I-PR
toes,I-PR
bilaterally,I-PR
w/,O
necrosis,B-PR
of,I-PR
the,I-PR
heels,I-PR
and,I-PR
posterior,I-PR
calf,I-PR
.,O

Continue,O
to,O
monitor,B-TE
for,O
sign,O
of,O
infection,B-PR
.,O

On,O
vit,B-TR
C.,I-TR
and,O
zinc,B-TR
as,O
well,O
to,O
aid,O
w/,O
wound,O
healing,O
.,O

Wound,O
care,O
consult,O
given,O
anasarca,B-TR
to,O
prevent,O
decub,B-PR
.,O

9.,O
Left,O
UE,O
markedly,O
more,B-PR
edematous,I-PR
than,O
right,O
UE,O
",",O
this,O
could,O
be,O
from,O
fracture,B-PR
",",O
or,O
there,O
could,O
be,O
a,B-PR
clot,I-PR
",",O
an,B-PR
abscess,I-PR
in,I-PR
the,I-PR
area,I-PR
also,O
a,O
possiblity,O
.,O

Ultrasound,B-TE
without,O
clot,B-PR
.,O

Continue,O
elevation,B-TR
and,O
tight,B-TR
dressing,I-TR
to,I-TR
LUE,I-TR
>,O

10.,O
Access,O
-,O
Left,B-TR
IJ,I-TR
placed,O
12-26,O
in,O
Juan,O
was,O
discontinued,O
during,O
the,O
hospitilization,O
.,O

Right,B-TR
dialysis,I-TR
catheter,I-TR
(,O
2018-11-05,O
),O
was,O
changed,O
over,O
a,B-TR
wire,I-TR
2019-01-08,O
.,O

PICC,B-TR
line,I-TR
placed,O
2019-01-08,O
",",O
this,O
should,O
be,O
discontinued,O
immediately,O
after,O
pt,O
finishes,O
the,B-TR
linezolid,I-TR
course,I-TR
.,O

11.,O
Code,O
status,O
-,O
Initially,O
full,O
code,O
then,O
made,O
DNR,O
/,O
DNI,O
after,O
family,O
meeting,O
on,O
02-27,O
.,O

Made,O
full,O
code,O
again,O
on,O
12-30,O
after,O
family,O
meeting,O
with,O
son,O
.,O

Larry,O
would,O
like,O
everything,O
done,O
.,O

12.,O
Communication,O
-,O
With,O
pt,O
's,O
son,O
.,O

His,O
name,O
is,O
Andrea,O
and,O
his,O
phone,O
number,O
is,O
794,O
1029,O
x.,O
1385,O
.,O

Medications,O
on,O
Admission,O
:,O

1.,O
Ascorbic,B-TR
acid,I-TR
500,O
mg,O
BID,O

2.,O
Folic,B-TR
acid,I-TR
1,O
mg,O
daily,O

3.,O
Humulin,B-TR
insulin,I-TR
2,O
units,O
QAM,O

4.,O
RISS,B-TR

5.,O
Pantoprazole,B-TR
40,O
mg,O
BID,O

6.,O
Neutra,B-TR
phos,I-TR
2,O
tabs,O
BID,O

7.,O
Vitamin,B-TR
B,I-TR
complex,I-TR
1,O
tab,O
daily,O

8.,O
Coumadin,B-TR
-,O
Dose,O
unknown,O

9.,O
Tylenol,B-TR
650,O
mg,O
Q4H,O
PRN,O

10.,O
Ondansetron,B-TR
4,O
mg,O
Q6H,O
PRN,O

Discharge,O
Medications,O
:,O

1.,O
Ascorbic,B-TR
Acid,I-TR
500,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

2.,O
Folic,B-TR
Acid,I-TR
1,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

3.,O
Zinc,B-TR
Sulfate,I-TR
220,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

4.,O
Acetaminophen,B-TR
325,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
.,O

5.,O
Papain,B-TR
-,I-TR
Urea,I-TR
544,O
287,O
0616,O
unit,O
-,O
mg,O
/,O
g,O
Ointment,O
Sig,O
:,O
One,O
(,O
1,O
),O
Appl,O
Topical,O
DAILY,O
(,O
Daily,O
),O
.,O

6.,O
Ipratropium,B-TR
Bromide,I-TR
0.02,O
%,O
Solution,O
Sig,O
:,O
One,O
(,O
1,O
),O
Inhalation,O
Q4H,O
(,O
every,O
4,O
hours,O
),O
.,O

7.,O
Calcium,B-TR
Acetate,I-TR
667,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
TID,O
W/,O
MEALS,O
(,O
3,O
TIMES,O
A,O
DAY,O
WITH,O
MEALS,O
),O
.,O

8.,O
Metoprolol,B-TR
Tartrate,I-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
0.5,O
Tablet,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
:,O
Hold,O
for,O
SBP,O
<,O
100,O
",",O
HR,O
<,O
60,O
.,O

9.,O
Fluconazole,B-TR
200,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q24H,O
(,O
every,O
24,O
hours,O
),O
for,O
2,O
days,O
.,O

10.,O
Insulin,B-TR
Regular,I-TR
Human,I-TR
300,O
unit,O
/,O
3,O
mL,O
Insulin,O
Pen,O
Sig,O
:,O
as,O
directed,O
Subcutaneous,O
four,O
times,O
a,O
day,O
:,O
Please,O
administer,O
8,O
units,O
glargine,B-TR
at,O
dinner,O
and,O
regular,B-TR
insulin,I-TR
sliding,I-TR
scale,I-TR
as,O
prescribed,O
.,O

11.,O
Warfarin,B-TR
2,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
HS,O
(,O
at,O
bedtime,O
),O
:,O
Titrate,O
dose,O
to,O
Goal,O
INR,B-TE
03-15,O
.,O

Tablet,O
(,O
s,O
),O

12.,O
Linezolid,B-TR
600,O
mg,O
IV,O
Q12H,O

13.,O
Heparin,B-TR
Flush,I-TR
PICC,I-TR
(,O
100,O
units,O
/,O
ml,O
),O
2,O
ml,O
IV,O
DAILY,O
:,O
PRN,O
10,O
ml,O
NS,O
followed,O
by,O
2,O
ml,O
of,O
100,O
Units,O
/,O
ml,O
heparin,B-TR
(,O
200,O
units,O
heparin,B-TR
),O
each,O
lumen,B-TR
Daily,O
and,O
PRN,O
.,O

Inspect,O
site,O
every,O
shift,O
.,O

14.,O
Heparin,B-TR
Flush,I-TR
CVL,I-TR
(,O
100,O
units,O
/,O
ml,O
),O
1,O
ml,O
IV,O
DAILY,O
:,O
PRN,O

10ml,O
NS,B-TR
followed,O
by,O
1ml,O
of,O
100,O
units/ml,O
heparin,B-TR
(,O
100,O
units,O
heparin,B-TR
),O
each,O
lumen,B-TR
QD,O
and,O
PRN,O
.,O

Inspect,O
site,O
every,O
shift,O

15.,O
Dolasetron,B-TR
Mesylate,I-TR
12.5,O
mg,O
IV,O
Q8H,O
:,O
PRN,O

16.,O
medication,B-TR

Please,O
complete,O
a,O
total,O
14,O
day,O
course,O
of,O
linezolid,B-TR
.,O

Stop,O
linezolid,B-TR
on,O
2019-01-17,O
.,O

The,B-TR
PICC,I-TR
line,I-TR
should,O
be,O
discontinued,O
promptly,O
after,O
the,B-TR
linezolid,I-TR
course,I-TR
is,O
completed,O
.,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Facility,O
:,O

Newton-Wellesley,O
Hospital,O
for,O
the,O
Aged,O
-,O
Acute,O
Rehab,O

Discharge,O
Diagnosis,O
:,O

Sepsis,B-PR
-?,O
source,O

Chronic,B-PR
Kidney,I-PR
disease,I-PR
-,O
on,O
hemodialysis,B-TR
type,B-PR
2,I-PR
diabetes,I-PR
hypercholestrolemia,B-PR
anemia,B-PR
of,I-PR
chornic,I-PR
disease,I-PR
h/o,O
PE,B-PR
",",O
s/p,B-PR
PEA,I-PR
arrest,I-PR
11-14,O

Discharge,O
Condition,O
:,O

Stable,O

Discharge,O
Instructions,O
:,O

You,O
were,O
admitted,O
with,O
low,B-PR
blood,I-PR
pressure,I-PR
and,O
fevers,B-PR
likely,O
due,O
to,O
an,B-PR
infection,I-PR
.,O

Although,O
there,O
was,O
never,O
any,B-PR
bacteria,I-PR
isolated,O
from,O
the,B-TE
blood,I-TE
you,O
had,O
some,B-PR
bacteria,I-PR
in,I-PR
the,I-PR
urine,I-PR
which,O
you,O
are,O
being,O
treated,O
for,O
.,O

It,O
is,O
important,O
that,O
you,O
complete,O
the,B-TR
antibiotic,I-TR
course,I-TR
as,O
prescribed,O
.,O

Please,O
continue,O
to,O
take,O
all,B-TR
medications,I-TR
as,O
prescirbed,O
and,O
follow,O
up,O
with,O
all,O
your,O
appointments,O
.,O

If,O
you,O
have,O
chest,B-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
diahrrea,B-PR
or,O
fevers,B-PR
please,O
contact,O
your,O
PCP,O
.,O

Robert,O
the,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
gets,O
worse,O
please,O
return,O
to,O
emergency,O
room,O
.,O

If,O
you,O
have,O
fevers,B-PR
please,O
contact,O
your,O
PCP,O
or,O
return,O
to,O
the,O
emergency,O
room,O
.,O

Followup,O
Instructions,O
:,O

Please,O
call,O
(,O
664,O
),O
369-9786,O
to,O
set,O
up,O
an,O
appointment,O
with,O
your,O
primary,O
care,O
doctor,O
Dr.,O
Andrew,O
Shelton,O
in,O
1-2,O
wks,O
after,O
discharge,O
.,O

Cleveland,O
Barbara,O
MD,O
00-732,O

Completed,O
by,O
:,O
Sharon,O
Frank,O
MD,O
75-572,O
2019-01-10,O
@,O
1333,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Janice,O
Oconnell,O
on,O
:,O
Kent,O
2019-01-10,O
3:28,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2012-04-20,O

Discharge,O
Date,O
:,O

2012-05-01,O

Date,O
of,O
Birth,O
:,O

1952-06-24,O

Sex,O
:,O

M,O

Service,O
:,O

Medicine,B-TR

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
59,O
year,O
old,O
male,O
with,O
a,O
past,O
medical,O
history,O
significant,O
for,O
an,B-TR
atrioseptal,I-TR
defect,I-TR
repair,I-TR
at,O
age,O
18,O
",",O
congestive,B-PR
heart,I-PR
failure,I-PR
with,O
an,B-TE
ejection,I-TE
fraction,I-TE
of,O
45%,O
and,O
a,B-PR
recent,I-PR
cardiac,I-PR
myocardial,I-PR
infarction,I-PR
",",O
pulmonary,B-PR
hypertension,I-PR
and,O
mitral,B-PR
regurgitation,I-PR
",",O
and,O
atrial,B-PR
fibrillation,I-PR
.,O

He,O
was,O
seen,O
by,O
his,O
primary,O
care,O
physician,O
the,O
day,O
before,O
admission,O
and,O
complained,O
of,O
two,O
weeks,O
of,O
increasing,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
and,O
fatigue,B-PR
",",O
weight,B-PR
gain,I-PR
and,O
abdominal,B-PR
fullness,I-PR
.,O

He,O
was,O
sent,O
to,O
the,O
Emergency,O
Department,O
for,O
further,B-TE
evaluation,I-TE
.,O

The,O
patient,O
reported,O
feeling,O
at,O
his,O
baseline,O
with,O
chronic,B-PR
mild,I-PR
dyspnea,I-PR
on,O
exertion,O
until,O
two,O
weeks,O
prior,O
to,O
admission,O
.,O

During,O
this,O
period,O
he,O
had,O
also,O
been,O
weaned,O
off,O
of,O
his,B-TR
Digoxin,I-TR
starting,O
early,O
in,O
February,O
.,O

Over,O
the,O
two,O
weeks,O
prior,O
to,O
admission,O
he,O
had,O
noticed,O
an,B-PR
increasing,I-PR
heart,I-PR
rate,I-PR
from,O
his,O
baseline,O
in,O
the,O
60s,O
to,O
a,B-TE
heart,I-TE
rate,I-TE
in,O
the,O
120s,O
.,O

He,O
had,O
also,O
some,B-PR
increased,I-PR
shortness,I-PR
of,I-PR
breath,I-PR
and,O
a,B-PR
10,I-PR
pound,I-PR
weight,I-PR
gain,I-PR
and,O
new,O
three,O
to,O
four,O
pillow,B-PR
orthopnea,I-PR
with,O
a,B-PR
dry,I-PR
cough,I-PR
.,O

He,O
denied,O
fevers,B-PR
",",O
chills,B-PR
",",O
nausea,B-PR
or,O
vomiting,B-PR
",",O
chest,B-PR
pain,I-PR
or,O
diaphoresis,B-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Atrioseptal,B-TR
defect,I-TR
repair,I-TR
in,O
1970,O
",",O
cardiomyopathy,B-PR
",",O
right-sided,B-PR
congestive,I-PR
heart,I-PR
failure,I-PR
",",O
pulmonary,B-PR
hypertension,I-PR
",",O
history,O
of,O
atrial,B-PR
fibrillation,I-PR
and,O
atrial,B-PR
flutter,I-PR
",",O
history,O
of,O
prostate,B-PR
cancer,I-PR
",",O
status,B-TR
post,I-TR
brachytherapy,I-TR
",",O
history,O
of,O
rectal,B-PR
bleeding,I-PR
",",O
obstructive,B-PR
sleep,I-PR
apnea,I-PR
on,O
CPAP,B-TR
.,O

ALLERGIES,O
:,O

ACE,B-TR
inhibitors,I-TR
",",O
possible,O
allergy,B-PR
to,O
barium,B-TR
reported,O
by,O
the,O
patient,O
during,O
a,B-TR
barium,I-TR
swallow,I-TR
25,O
years,O
ago,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Digoxin,B-TR
0.125,O
",",O
discontinued,O
one,O
month,O
prior,O
to,O
admission,O
",",O
Toprol,B-TR
XL,I-TR
100,O
mg,O
daily,O
",",O
Trazodone,B-TR
50,O
mg,O
once,O
daily,O
",",O
Lipitor,B-TR
10,O
mg,O
daily,O
",",O
Diovan,B-TR
40,O
mg,O
daily,O
",",O
Atrovent,B-TR
/,O
Albuterol,B-TR
prn,O
",",O
Pulmicort,B-TR
",",O
Coumadin,B-TR
2.5,O
mg,O
daily,O
",",O
Vitamin,B-TR
E,I-TR
",",O
Vitamin,B-TR
C,I-TR
",",O
iron,B-TR
supplement,I-TR
.,O

SOCIAL,O
HISTORY,O
:,O

Remote,O
history,O
of,O
tobacco,O
",",O
occasional,O
alcohol,O
use,O
.,O

He,O
is,O
a,O
retired,O
fire,O
fighter,O
.,O

LABORATORY,O
DATA,O
:,O

White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
10.5,O
",",O
hematocrit,B-TE
38.1,O
",",O
platelets,B-TE
254,O
",",O
INR,B-TE
1.8,O
.,O

Sodium,B-TE
140,O
",",O
potassium,B-TE
5.2,O
",",O
BUN,B-TE
38,O
",",O
creatinine,B-TE
.7,O
",",O
TSH,B-TE
1.8,O
",",O
Digoxin,B-TE
level,I-TE
less,O
than,O
0.2,O
.,O

Serial,B-TE
cardiac,I-TE
enzymes,I-TE
negative,O
.,O

ALT,B-TE
14,O
",",O
AST,B-TE
31,O
",",O
alkaline,B-TE
phosphatase,I-TE
283,O
",",O
total,B-TE
bilirubin,I-TE
1.0,O
",",O
amylase,B-TE
71,O
",",O
glucose,B-TE
tolerance,I-TE
test,I-TE
317,O
.,O

Electrocardiogram,B-TE
showed,O
atrial,B-PR
fibrillation,I-PR
with,O
rapid,B-PR
ventricular,I-PR
response,I-PR
and,O
atrial,B-PR
flutter,I-PR
.,O

Echocardiogram,B-TE
showed,O
moderate,B-PR
dilated,I-PR
left,I-PR
atrium,I-PR
",",O
no,O
atrioseptal,B-PR
defect,I-PR
",",O
severe,B-PR
global,I-PR
left,I-PR
ventricular,I-PR
hypokinesis,I-PR
with,O
severe,B-PR
left,I-PR
ventricular,I-PR
systolic,I-PR
function,I-PR
and,O
moderately,B-PR
dilated,I-PR
right,I-PR
ventricle,I-PR
.,O

There,O
was,O
global,B-PR
hypokinesis,I-PR
apical,I-PR
throughout,I-PR
the,I-PR
right,I-PR
ventricle,I-PR
and,O
abnormal,B-PR
septal,I-PR
motion,I-PR
consistent,O
with,O
right,B-PR
ventricular,I-PR
volume,I-PR
overload,I-PR
.,O

Moderate,B-PR
to,I-PR
severe,I-PR
3+,I-PR
mitral,I-PR
regurgitation,I-PR
and,O
3+,B-PR
tricuspid,I-PR
regurgitation,I-PR
along,O
with,O
moderate,B-PR
pulmonary,I-PR
early,I-PR
systolic,I-PR
hypertension,I-PR
.,O

Of,O
note,O
",",O
this,B-TE
echocardiogram,I-TE
was,O
performed,O
when,O
the,O
patient,O
was,O
tachycardiac,B-PR
.,O

HOSPITAL,O
COURSE,O
:,O

1.,O
Hypotension,B-PR
-,O
The,O
patient,O
was,O
initially,O
mildly,B-PR
hypotensive,I-PR
with,O
systolic,B-TE
blood,I-TE
pressures,I-TE
in,O
the,O
80s,O
.,O

Upon,O
admission,O
it,O
was,O
unclear,O
whether,O
or,O
not,O
the,O
patient,O
was,O
volume,B-PR
overloaded,I-PR
or,O
volume,B-PR
depleted,I-PR
.,O

Initially,O
he,O
was,O
treated,O
with,O
intravenous,B-TR
fluids,I-TR
with,O
a,O
dramatic,O
response,O
in,O
his,B-TE
systolic,I-TE
blood,I-TE
pressure,I-TE
.,O

However,O
",",O
subsequent,O
it,O
was,O
determined,O
that,O
the,B-PR
patient,I-PR
's,I-PR
hypotension,I-PR
may,O
have,O
been,O
related,O
to,O
his,B-PR
rapid,I-PR
ventricular,I-PR
response,I-PR
and,O
right,B-PR
heart,I-PR
failure,I-PR
.,O

Therefore,O
the,O
focus,O
of,O
treatment,B-TR
was,O
changed,O
to,O
controlling,O
his,B-TE
rate,I-TE
.,O

2.,O
Atrial,B-PR
fibrillation,I-PR
-,O
The,B-TR
patient,I-TR
's,I-TR
Digoxin,I-TR
had,O
been,O
weaned,O
off,O
prior,O
to,O
his,O
admission,O
.,O

It,O
was,O
felt,O
that,O
this,O
potentially,O
had,O
lead,O
to,O
his,B-PR
atrial,I-PR
flutter,I-PR
and,O
atrial,B-PR
fibrillation,I-PR
with,O
rapid,B-PR
ventricular,I-PR
response,I-PR
.,O

The,O
patient,O
was,O
loaded,O
once,O
again,O
with,O
Digoxin,B-TR
and,O
his,B-TR
beta,I-TR
blocker,I-TR
was,O
increased,O
to,O
100,O
mg,O
of,O
Lopressor,B-TR
",",O
three,O
times,O
a,O
day,O
.,O

In,O
addition,O
the,O
patient,O
was,O
started,O
on,O
Verapamil,B-TR
since,O
his,B-TE
heart,I-TE
rate,I-TE
had,O
remained,O
mildly,B-PR
tachycardiac,I-PR
in,O
the,O
low,O
100s,O
.,O

3.,O
Congestive,B-PR
heart,I-PR
failure,I-PR
-,O
During,O
the,O
initial,O
course,O
of,O
the,O
patient,O
's,O
admission,O
",",O
it,O
was,O
unclear,O
as,O
to,O
whether,O
or,O
not,O
he,O
was,O
volume,B-PR
overloaded,I-PR
or,O
volume,B-PR
depleted,I-PR
.,O

The,O
patient,O
was,O
initially,O
treated,O
with,O
intravenous,B-TR
fluids,I-TR
",",O
however,O
",",O
subsequently,O
he,O
was,O
diuresed,O
when,O
he,O
became,O
symptomatic,B-PR
and,O
short,B-PR
of,I-PR
breath,I-PR
.,O

Chest,B-TE
x-rays,I-TE
revealed,O
evidence,O
of,O
congestive,B-PR
heart,I-PR
failure,I-PR
.,O

The,O
decision,O
was,O
made,O
to,O
have,O
the,O
patient,O
undergo,O
a,B-TE
cardiac,I-TE
catheterization,I-TE
to,O
fully,O
evaluate,O
the,O
hemodynamics,O
to,O
determine,O
the,O
etiology,O
of,O
the,B-PR
patient,I-PR
's,I-PR
heart,I-PR
failure,I-PR
.,O

In,O
addition,O
",",O
plans,O
were,O
made,O
to,O
evaluate,O
the,O
patient,O
's,O
cardiac,O
arteries,O
to,O
determine,O
if,O
he,O
had,O
any,O
component,O
of,O
ischemic,B-PR
cardiomyopathy,I-PR
.,O

4.,O
Abnormal,B-TE
liver,I-TE
function,I-TE
tests,I-TE
-,O
The,O
patient,O
had,O
an,B-PR
isolated,I-PR
",",I-PR
elevated,I-PR
alkaline,I-PR
phosphatase,I-PR
with,O
a,B-PR
confirmatory,I-PR
elevation,I-PR
in,O
his,B-TE
gamma,I-TE
glutamyl,I-TE
transferase,I-TE
.,O

An,B-TE
ultrasound,I-TE
of,I-TE
the,I-TE
right,I-TE
upper,I-TE
quadrant,I-TE
did,O
not,O
reveal,O
any,B-PR
cholelithiasis,I-PR
or,O
cholecystitis,B-PR
",",O
however,O
",",O
an,B-PR
irregular,I-PR
hepatic,I-PR
contour,I-PR
was,O
seen,O
which,O
is,O
suggestive,O
of,O
underlying,B-PR
chronic,I-PR
liver,I-PR
disease,I-PR
.,O

There,O
was,O
some,O
concern,O
that,O
the,O
patient,O
may,O
have,O
a,B-PR
partial,I-PR
biliary,I-PR
obstruction,I-PR
and,O
the,O
patient,O
was,O
sent,O
for,O
an,B-TE
magnetic,I-TE
resonance,I-TE
cholangiopancreatography,I-TE
to,O
further,O
evaluate,O
the,O
biliary,O
system,O
.,O

Magnetic,B-TE
resonance,I-TE
cholangiopancreatography,I-TE
did,O
not,O
reveal,O
any,O
evidence,O
of,O
biliary,B-PR
dilatation,I-PR
or,O
of,O
any,B-PR
obstructing,I-PR
pancreatic,I-PR
mass,I-PR
.,O

Again,O
seen,O
was,O
a,B-PR
slightly,I-PR
irregular,I-PR
contour,I-PR
of,I-PR
the,I-PR
liver,I-PR
with,O
dilated,B-PR
hepatic,I-PR
veins,I-PR
suggesting,O
chronic,B-PR
hepatic,I-PR
vascular,I-PR
congestion,I-PR
.,O

The,O
patient,O
also,O
revealed,O
a,O
prior,O
history,O
of,O
heavy,O
alcohol,O
use,O
for,O
approximately,O
20,O
years,O
",",O
during,O
the,O
mid,O
1950s,O
to,O
mid,O
1970s,O
.,O

It,O
was,O
felt,O
that,O
he,O
may,O
have,O
had,O
some,O
component,O
of,O
vascular,B-PR
congestion,I-PR
from,O
his,B-PR
congestive,I-PR
heart,I-PR
failure,I-PR
as,O
well,O
as,O
possibly,O
some,B-PR
mild,I-PR
cirrhotic,I-PR
changes,I-PR
secondary,O
to,O
his,O
previous,O
alcohol,O
use,O
.,O

5.,O
Fall,O
-,O
The,O
patient,O
had,O
a,O
mechanical,O
fall,O
during,O
his,O
admission,O
.,O

He,O
did,O
not,O
sleep,O
at,O
all,O
the,O
night,O
before,O
and,O
was,O
extremely,B-PR
fatigued,I-PR
.,O

He,O
was,O
walking,O
in,O
the,O
hall,O
",",O
dragging,O
his,B-TR
intravenous,I-TR
pole,I-TR
when,O
he,O
tripped,O
over,O
the,O
foot,O
of,O
the,O
pole,O
and,O
lost,O
his,O
balance,O
.,O

He,O
fell,O
backwards,O
",",O
landing,O
on,O
his,O
buttocks,O
and,O
bumped,O
his,O
head,O
.,O

His,B-TE
neurological,I-TE
examination,I-TE
at,O
that,O
time,O
was,O
nonfocal,O
and,O
the,O
head,O
was,O
atraumatic,B-PR
without,O
any,O
evidence,O
of,O
a,B-PR
hematoma,I-PR
.,O

A,B-TE
computerized,I-TE
axial,I-TE
tomography,I-TE
scan,I-TE
of,I-TE
his,I-TE
head,I-TE
at,O
that,O
time,O
did,O
not,O
reveal,O
any,B-PR
extra,I-PR
or,I-PR
intracranial,I-PR
hemorrhage,I-PR
.,O

6.,O
Rectal,B-PR
bleeding,I-PR
-,O
The,O
patient,O
has,O
a,O
history,O
of,O
rectal,B-PR
bleeding,I-PR
",",O
ever,O
since,O
his,B-TR
brachytherapy,I-TR
for,O
his,B-PR
prostate,I-PR
cancer,I-PR
.,O

The,O
patient,O
has,O
been,O
treated,O
with,O
Argon,B-TR
laser,I-TR
therapy,I-TR
in,O
the,O
past,O
for,O
his,B-PR
rectal,I-PR
bleeding,I-PR
and,O
it,O
is,O
recommended,O
that,O
he,O
follow,O
up,O
with,O
his,O
gastroenterologist,O
for,O
repeat,B-TR
Argon,I-TR
laser,I-TR
therapy,I-TR
.,O

The,O
remainder,O
of,O
the,O
hospital,O
course,O
will,O
be,O
dictated,O
by,O
the,O
covering,O
intern,O
.,O

Sheila,O
Providence,O
",",O
M.D.,O
50-442,O

Dictated,O
By,O
:,O
Marjorie,O
I.,O
Taylor,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2012-05-01,O
22:34,O

T,O
:,O
2012-05-02,O
06:55,O

JOB,O
#:,O
79270,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Jane,O
Nix,O
on,O
:,O
MON,O
2012-05-07,O
9:28,O
AM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

Discharge,O
Date,O
:,O

2014-01-24,O

Date,O
of,O
Birth,O
:,O

1928-11-23,O

Sex,O
:,O

F,O

Service,O
:,O

Internal,B-TR
Medicine,I-TR

During,O
the,O
last,O
four,O
hospital,O
days,O
",",O
the,O
continued,O
to,O
do,O
relatively,O
well,O
.,O

Her,O
renal,O
function,O
significantly,O
improved,O
",",O
and,O
her,B-TE
discharge,I-TE
creatinine,I-TE
was,O
3.1,O
.,O

Of,O
note,O
",",O
her,B-TE
blood,I-TE
pressure,I-TE
significantly,O
improved,O
in,O
the,O
120s-130s,O
which,O
assured,O
better,O
perfusion,O
in,O
her,O
kidneys,O
.,O

She,O
received,O
intermittent,O
doses,O
of,O
Lasix,B-TR
to,O
assure,O
overall,O
negative,O
intakes,O
and,O
outputs,O
.,O

She,O
progressed,O
beautifully,O
with,O
physical,B-TR
therapy,I-TR
and,O
occupational,B-TR
therapy,I-TR
and,O
was,O
able,O
to,O
ambulate,O
with,O
assistance,O
.,O

She,O
has,O
very,B-PR
mild,I-PR
left,I-PR
lower,I-PR
extremity,I-PR
pain,I-PR
which,O
is,O
largely,O
unchanged,O
.,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
.,O

2.,O
Congestive,B-PR
heart,I-PR
failure,I-PR
.,O

3.,O
Acute,B-PR
renal,I-PR
failure,I-PR
.,O

4.,O
Acute,B-PR
myocardial,I-PR
infarction,I-PR
.,O

5.,O
Osteomyelitis,B-PR
.,O

6.,O
Diabetes,B-PR
mellitus,I-PR
.,O

DISPOSITION,O
:,O

Discharged,O
to,O
a,O
rehabilitation,O
facility,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Amiodarone,B-TR
200,O
mg,O
p.o.,O
q,O
day,O
.,O

2.,O
Warfarin,B-TR
3,O
mg,O
p.o.,O
q,O
h.s.,O

3.,O
Renagel,B-TR
1600,O
mg,O
p.o.,O
t.i.d.,O

4.,O
Aspirin,B-TR
325,O
mg,O
p.o.,O
q,O
day,O
.,O

5.,O
Miconazole,B-TR
powder,I-TR
2%,O
t.i.d.,O

6.,O
Levofloxacin,B-TR
250,O
mg,O
p.o.,O
q48,O
hours,O
for,O
the,O
next,O
five,O
weeks,O
for,O
osteomyelitis,B-PR
.,O

7.,O
Flagyl,B-TR
500,O
mg,O
p.o.,O
t.i.d.,O
for,O
the,O
next,O
five,O
weeks,O
for,O
osteomyelitis,B-PR
.,O

8.,O
Protonix,B-TR
40,O
mg,O
p.o.,O
q,O
day,O
.,O

9.,O
Magnesium,B-TR
Oxide,I-TR
800,O
mg,O
p.o.,O
b.i.d.,O

10.,O
Epogen,B-TR
5000,O
units,O
two,O
times,O
weekly,O
",",O
on,O
Monday,O
and,O
Thursday,O
.,O

11.,O
Colace,B-TR
100,O
mg,O
p.o.,O
b.i.d.,O

12.,O
Lasix,B-TR
80,O
mg,O
p.o.,O
b.i.d.,O

13.,O
NPH,B-TR
insulin,I-TR
7,O
units,O
in,O
the,O
morning,O
and,O
5,O
units,O
at,O
night,O
.,O

14.,O
Regular,B-TR
insulin,I-TR
sliding,I-TR
scale,I-TR
.,O

Richard,O
U.,O
Walker,O
",",O
M.D.,O

36-781,O

Dictated,O
By,O
:,O
Levi,O
G.,O
Savage,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2014-01-24,O
13:13,O

T,O
:,O
2014-01-24,O
13:45,O

JOB,O
#:,O

12151,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Kelly,O
Hunter,O
YANG,O
on,O
:,O
FRI,O
2014-01-31,O
2:04,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2015-10-28,O

Discharge,O
Date,O
:,O

2015-11-13,O

Date,O
of,O
Birth,O
:,O

1941-08-30,O

Sex,O
:,O

F,O

Service,O
:,O
CARDIOTHORACIC,O

Allergies,O
:,O

Tape,O
/,O
Benadryl,B-TR

Attending,O
:Jordan,O
U,O
Kostohryz,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Chest,B-PR
discomfort,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

2015-10-30,O
Left,B-TR
Carotid,I-TR
Stenting,I-TR

2015-11-02,O
Coronary,B-TR
Artery,I-TR
Bypass,I-TR
Graft,I-TR
x,O
2,O
(,O
Lima,B-TR
to,I-TR
LAD,I-TR
",",O
SVG,B-TR
to,I-TR
OM,I-TR
),O

History,O
of,O
Present,O
Illness,O
:,O

Ms.,O
Bridge,O
is,O
a,O
74,O
y/o,O
female,O
admitted,O
to,O
outside,O
hospital,O
on,O
2015-10-21,O
with,O
chest,B-PR
discomfort,I-PR
",",O
vomiting,B-PR
and,O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

Initial,B-TE
EKG,I-TE
showed,O
ST,B-PR
depressions,I-PR
",",O
but,O
cardiac,B-TE
enzymes,I-TE
were,O
not,O
elevated,B-PR
.,O

She,O
eventually,O
underwent,O
a,B-TE
cardiac,I-TE
cath,I-TE
to,O
assess,O
coronary,B-PR
disease,I-PR
which,O
revealed,O
three,B-PR
vessel,I-PR
coronary,I-PR
artery,I-PR
disease,I-PR
.,O

She,O
was,O
then,O
transferred,O
to,O
The,O
Hospital,O
for,O
Orthopedics,O
for,O
surgical,B-TR
intervention,I-TR
.,O

Past,O
Medical,O
History,O
:,O

Coronary,B-PR
Artery,I-PR
Disease,I-PR
",",O
Hypertension,B-PR
",",O
Hyperlipidemia,B-PR
",",O
Diabetes,B-PR
Mellitus,I-PR
",",O
Hypothyroid,B-PR
",",O
h/o,O
Bilateral,B-PR
DVT,I-PR
's,I-PR
(,O
on,O
chronic,B-TR
coumadin,I-TR
therapy,I-TR
"),",O
Pleural,B-PR
disorder,I-PR
?,O
Sarcoidosis,B-PR
",",O
Gastritis,B-PR
",",O
B12,B-PR
deficiency,I-PR
",",O
Chronic,B-PR
renal,I-PR
insufficiency,I-PR
",",O
s/p,O
Appendectomy,B-TR
",",O
s/p,O
Lap,B-TR
cholectomy,I-TR
",",O
s/p,O
Total,B-TR
abdominal,I-TR
hysterectomy,I-TR

Social,O
History,O
:,O

Denies,O
tobacco,O
or,O
ETOH,O
use,O
.,O

Lives,O
wth,O
husband,O
.,O

Family,O
History,O
:,O

Mother,O
died,O
of,O
MI,B-PR
at,O
age,O
55,O
.,O

Brother,O
w/,O
CAD,B-PR
since,O
age,O
40,O
and,O
died,O
in,O
70,O
's,O
after,O
cardiac,B-TR
surgery,I-TR
.,O

Son,O
died,O
at,O
14,O
d/t,O
ASD,B-PR
.,O

Physical,O
Exam,O
:,O

Gen,O
:,O
NAD,B-PR

Neck,O
:,O
Supple,O
",",O
-,O
JVD,B-PR
",",O
-,O
Bruits,B-PR

Heart,O
:,O
RRR,O
-,O
c/r/m/g,B-PR

Lungs,O
:,O
CTAB,O
",",O
coarse,B-PR

Abd,O
:,O
Soft,O
",",O
NT/NT,B-PR
+,O
BS,O

Ext,O
:,O
Cool,O
",",O
1,O
+,O
pedal,B-TE
pulses,I-TE
",",O
-,O
varicosities,B-PR
",",O
-,O
edema,B-PR

Neuro,O
:,O
A&O,O
x,O
3,O
",",O
MAE,O
",",O
non-focal,O

Some,B-PR
rashes,I-PR
on,I-PR
ACW,I-PR
around,O
EKG,B-TR
leads,I-TR

Pertinent,O
Results,O
:,O

CNIS,B-TE
10-29,O
:,O

1.,O
60-69%,B-PR
stenosis,I-PR
of,I-PR
the,I-PR
right,I-PR
internal,I-PR
carotid,I-PR
artery,I-PR
.,O

2.,O
80-99%,B-PR
stenosis,I-PR
of,I-PR
the,I-PR
left,I-PR
internal,I-PR
carotid,I-PR
artery,I-PR
.,O

Echo,B-TE
11-02,O
:,O
PRE-BYPASS,O
:,O
Left,O
ventricular,O
wall,O
thickness,O
",",O
cavity,O
size,O
",",O
and,O
systolic,O
function,O
are,O
normal,O
(,O
LVEF>55%,B-TE
).,O

Resting,B-PR
regional,I-PR
wall,I-PR
motion,I-PR
abnormalities,I-PR
include,O
mild,B-PR
apical,I-PR
hypokinesis,I-PR
.,O

The,O
aortic,O
valve,O
leaflets,O
(,O
3,O
),O
appear,O
structurally,O
normal,O
with,O
good,O
leaflet,O
excursion,O
and,O
no,O
aortic,B-PR
regurgitation,I-PR
.,O

The,O
mitral,O
valve,O
appears,O
structurally,O
normal,O
with,O
trivial,B-PR
mitral,I-PR
regurgitation,I-PR
.,O

There,O
are,O
complex,B-PR
(>,I-PR
4,I-PR
mm,I-PR
),I-PR
atheroma,I-PR
in,I-PR
the,I-PR
descending,I-PR
thoracic,I-PR
aorta,I-PR
.,O

Mild,B-PR
tricuspid,I-PR
regurgitation,I-PR
.,O

POST-BYPASS,O
:,O
Preserved,O
Kindred,O
/,O
North,O
Shore,O
-,O
ventricular,O
systolic,O
fxn,O
.,O

Trivial,B-PR
MR,I-PR
.,O

Edith,O
AI,O
.,O

Aorta,O
intact,O
.,O

CT,B-TE
11-04,O
:,O
No,O
acute,B-PR
intracranial,I-PR
hemorrhage,I-PR
.,O

Findings,O
consistent,O
with,O
small,B-PR
vessel,I-PR
ischemic,I-PR
changes,I-PR
.,O

MRI,B-TE
would,O
be,O
more,O
sensitive,O
for,O
the,O
detection,O
of,O
acute,B-PR
infarction,I-PR
.,O

CT,B-TE
angiogram,I-TE
demonstrates,O
no,O
stenosis,B-PR
or,O
aneurysm,B-PR
in,I-PR
the,I-PR
intracranial,I-PR
circulation,I-PR
.,O

Slight,B-PR
irregularity,I-PR
of,O
the,O
origin,O
of,O
the,O
right,O
vertebral,O
artery,O
may,O
be,O
atherosclerotic,B-PR
in,O
nature,O
.,O

Normal,O
contrast,O
enhancement,O
seen,O
in,O
the,B-TR
left,I-TR
common/internal,I-TR
carotid,I-TR
artery,I-TR
stent,I-TR
.,O

Mild,B-PR
stenosis,I-PR
of,I-PR
the,I-PR
proximal,I-PR
right,I-PR
internal,I-PR
carotid,I-PR
artery,I-PR
.,O

4,B-PR
mm,I-PR
left,I-PR
upper,I-PR
lobe,I-PR
lung,I-PR
nodule,I-PR
.,O

In,O
the,O
absence,O
of,O
history,O
of,O
malignancy,B-PR
",",O
this,O
is,O
statistically,O
benign,O
.,O

One-year,O
followup,O
may,O
be,O
considered,O
.,O

CXR,B-TE
11-06,O
:,O
Allowing,O
for,O
technical,O
changes,O
",",O
no,O
major,B-PR
adverse,I-PR
interval,I-PR
change,I-PR
has,O
occurred,O
.,O

Bibasilar,B-PR
subsegmental,I-PR
atelectasis,I-PR
together,O
with,O
bilateral,B-PR
pleural,I-PR
effusions,I-PR
appear,O
relatively,O
unchanged,O
.,O

The,O
mediastinum,O
appears,O
unchanged,O
.,O

Left-sided,B-TR
subclavian,I-TR
line,I-TR
is,O
unchanged,O
in,O
position,O
.,O

There,O
is,O
evidence,O
of,O
prior,B-TR
cardiac,I-TR
surgery,I-TR
.,O

2015-11-13,O
06:15,O
AM,O
BLOOD,O
WBC,B-TE
-,O
8.8,O
RBC,B-TE
-,O
2.79,O
*,O
Hgb,B-TE
-,O
8.6,O
*,O
Hct,B-TE
-,O
25.4,O
*,O
MCV,B-TE
-,O
91,O
MCH,B-TE
-,O
30.9,O
MCHC,B-TE
-,O
33.8,O
RDW,B-TE
-,O
15.6,O
*,O
Plt,B-TE
Ct,I-TE
-,O
583,O
*,O

2015-11-12,O
06:00,O
AM,O
BLOOD,O
WBC,B-TE
-,O
7.7,O
RBC,B-TE
-,O
2.73,O
*,O
Hgb,B-TE
-,O
8.3,O
*,O
Hct,B-TE
-,I-TE
25.1,O
*,O
MCV,B-TE
-,O
92,O
MCH,B-TE
-,O
30.4,O
MCHC,B-TE
-,O
33.1,O
RDW,B-TE
-,O
15.5,O
Plt,B-TE
Ct,I-TE
-,O
528,O
*,O

2015-11-13,O
06:15,O
AM,O
BLOOD,O
Plt,B-TE
Ct,I-TE
-,O
583,O
*,O

2015-11-13,O
06:15,O
AM,O
BLOOD,O
PT,B-TE
-,O
18.0,O
*,O
PTT,B-TE
-,O
62.3,O
*,O
INR(PT),B-TE
-,O
1.7,O
*,O

2015-11-12,O
06:00,O
AM,O
BLOOD,O
PT,B-TE
-,O
15.5,O
*,O
PTT,B-TE
-,O
62.4,O
*,O
INR(PT),B-TE
-,O
1.4,O
*,O

2015-11-11,O
05:45,O
AM,O
BLOOD,O
PT,B-TE
-,O
14.5,O
*,O
PTT,B-TE
-,O
51.4,O
*,O
INR(PT),B-TE
-,O
1.3,O
*,O

2015-11-13,O
06:15,O
AM,O
BLOOD,O
Glucose,B-TE
-,O
96,O
UreaN,B-TE
-,O
20,O
Creat,B-TE
-,O
1.6,O
*,O
Na,B-TE
-,O
141,O
K,B-TE
-,O
4.3,O
Cl,B-TE
-,O
106,O
HCO3,B-TE
-,O
24,O
AnGap,B-TE
-,O
15,O

2015-11-12,O
06:00,O
AM,O
BLOOD,O
Glucose,B-TE
-,O
85,O
UreaN,B-TE
-,O
19,O
Creat,B-TE
-,O
1.6,O
*,O
Na,B-TE
-,O
140,O
K,B-TE
-,I-TE
4.4,O
Cl,B-TE
-,O
105,O
HCO3,B-TE
-,O
24,O
AnGap,B-TE
-,I-TE
15,O

2015-11-11,O
05:45,O
AM,O
BLOOD,O
Creat,B-TE
-,O
1.6,O
*,O
K,B-TE
-,O
4.7,O

2015-10-28,O
03:30,O
PM,O
BLOOD,O
Glucose,B-TE
-,O
98,O
UreaN,B-TE
-,O
26,O
*,O
Creat,B-TE
-,O
1.6,O
*,O
Na,B-TE
-,O
140,O
K,B-TE
-,O
4.6,O
Cl,B-TE
-,O
104,O
HCO3,B-TE
-,O
27,O
AnGap,B-TE
-,O
14,O

Brief,O
Hospital,O
Course,O
:,O

Ms.,O
Bridge,O
was,O
admitted,O
from,O
OSH,O
for,O
coronary,B-TR
artery,I-TR
bypass,I-TR
surgery,I-TR
.,O

She,O
underwent,O
usual,B-TE
pre-operative,I-TE
testing,I-TE
along,O
with,O
carotid,B-TE
ultrasound,I-TE
.,O

CNIS,B-TE
revealed,O
carotid,B-PR
stenosis,I-PR
and,O
she,O
ultimately,O
underwent,O
left,B-TR
carotid,I-TR
stenting,I-TR
by,O
vascular,O
surgery,O
on,O
10-30,O
.,O

Please,O
see,O
report,O
for,O
details,O
.,O

On,O
11-02,O
she,O
was,O
brought,O
to,O
the,O
operating,O
room,O
where,O
she,O
underwent,O
a,B-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
x,O
2,O
.,O

Please,O
see,O
operative,O
report,O
for,O
surgical,O
details,O
.,O

She,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
and,O
was,O
transferred,O
to,O
the,O
CSRU,O
for,O
invasive,B-TE
monitoring,I-TE
in,O
stable,O
condition,O
.,O

Later,O
on,O
op,O
day,O
sedation,B-TR
was,O
weaned,O
",",O
she,O
awoke,O
neurologically,O
intact,O
and,O
was,O
extubated,B-TR
.,O

On,O
post-op,O
day,O
one,O
chest,B-TR
tubes,I-TR
were,O
removed,O
and,O
beta,B-TR
blockers,I-TR
and,O
diuretics,B-TR
were,O
initiated,O
.,O

She,O
was,O
gently,O
diuresed,O
towards,O
her,O
pre-op,O
weight,O
.,O

Also,O
on,O
this,O
day,O
she,O
was,O
transferred,O
to,O
the,O
SDU,O
.,O

Early,O
on,O
post-op,O
day,O
two,O
Ms.,O
Bridge,O
had,O
an,O
episode,O
of,O
aphasia,B-PR
.,O

She,O
underwent,O
an,B-TE
immediate,I-TE
head,I-TE
CT,I-TE
and,O
Neuro,O
consult,O
and,O
was,O
transferred,O
back,O
to,O
the,O
CSRU,O
.,O

CT,B-TE
was,O
negative,O
and,O
she,O
returned,O
to,O
baseline,O
neuro,O
status,O
without,O
deficits,B-PR
by,O
arrival,O
to,O
CSRU,O
.,O

Neurology,O
concluded,O
episode,B-PR
was,O
most,O
concerning,O
for,O
TIA,B-PR
.,O

Epicardial,B-TR
pacing,I-TR
wires,I-TR
were,O
removed,O
on,O
post-op,O
day,O
four,O
.,O

After,O
remaining,O
stable,O
in,O
the,O
CSRU,O
for,O
several,O
days,O
without,O
change,B-PR
in,I-PR
neuro,I-PR
status,I-PR
she,O
was,O
transferred,O
back,O
to,O
the,O
SDU,O
on,O
post-op,O
day,O
four,O
.,O

She,O
was,O
then,O
started,O
on,O
Heparin,B-TR
with,O
transition,O
to,O
Coumadin,B-TR
(,O
goal,O
INR,B-TE
of,O
2-3,O
secondary,O
to,O
h/o,O
bilateral,B-PR
DVT,I-PR
's).,O

During,O
entire,O
post-op,O
course,O
she,O
was,O
followed,O
by,O
physical,O
therapy,O
for,O
strength,O
and,O
mobility,O
.,O

She,O
continued,O
to,O
improve,O
steadily,O
over,O
the,O
next,O
several,O
days,O
without,O
any,O
other,O
post-op,O

complications,B-PR
.,O

She,O
was,O
discharged,O
on,O
post-op,O
day,O
11,O
.,O

Medications,O
on,O
Admission,O
:,O

Meds,B-TR
at,O
home,O
:,O
Coumadin,B-TR
",",O
Levoxyl,B-TR
",",O
Folate,B-TR
",",O
Colace,B-TR
",",O
Byetta,B-TR
",",O
Verapamil,B-TR
",",O
Lisinopril,B-TR
",",O
Pravachol,B-TR
",",O
Nexium,B-TR
",",O
Lasix,B-TR
",",O
Celexa,B-TR

Meds,B-TR
at,O
transfer,O
:,O
Levoxyl,B-TR
",",O
Celexa,B-TR
",",O
Folate,B-TR
",",O
Lopressor,B-TR
",",O
Colace,B-TR
",",O
RISS,B-TR
",",O
B12,B-TR
",",O
Protonix,B-TR
",",O
Lasix,B-TR
",",O
Zocor,B-TR
",",O
Verapamil,B-TR
",",O
Lovenox,B-TR
",",O
Lisinopril,B-TR

Discharge,O
Medications,O
:,O

1.,O
Aspirin,B-TR
81,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
)(s)*,O
Refills,O
:*,O
0,O
*,O

2.,O
Pantoprazole,B-TR
40,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
Q24H,O
(,O
every,O
24,O
hours,O
).,O

Disp,O
:*,O
30,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
)(s)*,O
Refills,O
:*,O
0,O
*,O

3.,O
Levothyroxine,B-TR
125,O
mcg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

4.,O
Simvastatin,B-TR
40,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

5.,O
Citalopram,B-TR
20,O
mg,O
Tablet,O
Sig,O
:,O
0.5,O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

6.,O
Clopidogrel,B-TR
75,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

7.,O
Ferrous,B-TR
Gluconate,I-TR
300,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

8.,O
Ascorbic,B-TR
Acid,I-TR
500,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

9.,O
Folic,B-TR
Acid,I-TR
1,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

10.,O
Metoprolol,B-TR
Tartrate,I-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

Disp,O
:*,O
60,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

11.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

Disp,O
:*,O
30,O
Capsule,O
(s)*,O
Refills,O
:*,O
0,O
*,O

12.,O
Coumadin,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
once,O
a,O
day,O
:,O
Check,O
INR,B-TE
11-15,O
with,O
results,O
called,O
to,O
Dr.,O
Lynn,O
.,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

13.,O
Tramadol,B-TR
50,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
.,O

Disp,O
:*,O
50,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

14.,O
Lasix,B-TR
40,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
once,O
a,O
day,O
:,O
40,O
mg,O
daily,O
x,O
1,O
week,O
then,O
40,O
mg,O
every,O
other,O
day,O
as,O
prior,O
to,O
surgery,B-TR
.,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Discharge,O
Diagnosis,O
:,O

Coronary,B-PR
Artery,I-PR
Disease,I-PR
s/p,O
Coronary,B-TR
Artery,I-TR
Bypass,I-TR
Graft,I-TR
x,O
2,O

Post-operative,B-PR
Transient,I-PR
Ischemic,I-PR
Attack,I-PR

Carotid,B-PR
Stenosis,I-PR
s/p,O
Left,B-TR
Carotid,I-TR
Stenting,I-TR

PMH,O
:,O
Hypertension,B-PR
",",O
Hyperlipidemia,B-PR
",",O
Diabetes,B-PR
Mellitus,I-PR
",",O
Hypothyroid,B-PR
",",O
h/o,O
Bilateral,B-PR
DVT,I-PR
"'s,",I-PR
Pleural,B-PR
disorder,I-PR
?,O
Sarcoidosis,B-PR
",",O
Gastritis,B-PR
",",O
B12,B-PR
deficiency,I-PR
",",O
Chronic,B-PR
renal,I-PR
insufficiency,I-PR
",",O
s/p,O
Appendectomy,B-TR
",",O
s/p,O
Lap,B-TR
cholectomy,I-TR
",",O
s/p,O
Total,B-TR
abdominal,I-TR
hysterectomy,I-TR

Discharge,O
Condition,O
:,O

good,O

Discharge,O
Instructions,O
:,O

Patient,O
may,O
shower,O
",",O
no,O
baths,O
.,O

No,O
creams,B-TR
",",O
lotions,B-TR
or,O
ointments,B-TR
to,O
incisions,B-PR
.,O

No,O
driving,O
for,O
at,O
least,O
one,O
month,O
.,O

No,O
lifting,O
more,O
than,O
10,O
lbs,O
for,O
at,O
least,O
10,O
weeks,O
from,O
the,O
date,O
of,O
surgery,B-TR
.,O

Monitor,O
wounds,B-PR
for,O
signs,B-PR
of,I-PR
infection,I-PR
.,O
Please,O
call,O
with,O
any,O
concerns,O
or,O
questions,O
.,O

VVp,O
Instructions,O
:,O

Dr.,O
von,O
Sampson,O
in,O
4,O
weeks,O

Dr,O
Royer,O
in,O
2-3,O
weeks,O

Dr.,O
Lynn,O
in,O
1-2,O
weeks,O

Peterson,O
ver,O
Vasquez,O
MD,O
07-506,O

Completed,O
by,O
:,O
Theresa,O
Leonore,O
NP,O
80-BXH,O
2015-11-13,O
@,O
1100,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Ruby,O
von,O
der,O
Smith,O
on:,O
WED,O
2015-12-09,O
3:34,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date:,O

2011-02-08,O

Discharge,O
Date,O
:,O

2011-02-14,O

Date,O
of,O
Birth,O
:,O

1953-05-15,O

Sex,O
:,O

M,O

Service,O
:,O

CMED,O

HISTORY,O
OF,O
THE,O
PRESENT,O
ILLNESS,O
:,O

Briefly,O
",",O
this,O
is,O
a,O
57-year-old,O
gentleman,O
with,O
a,O
history,O
of,O
COPD,B-PR
",",O
status,O
post,O
intubation,B-TR
six,O
years,O
ago,O
but,O
not,O
on,O
home,B-TR
02,I-TR
with,O
recent,O
FEV1,B-TE
27%,O
of,O
predicted,O
value,O
",",O
and,O
FEV1/FVC,B-TE
ratio,I-TE
56%,O
of,O
hypercholesterolemia,B-PR
",",O
who,O
was,O
admitted,O
for,O
COPD,B-PR
exacerbation,I-PR
and,O
worsening,O
of,O
upper,B-PR
respiratory,I-PR
tract,I-PR
infection,I-PR
symptoms,I-PR
for,O
a,O
week,O
prior,O
to,O
admission,O
.,O

He,O
was,O
afebrile,B-PR
with,O
stable,O
vital,O
signs,O
on,O
presentation,O
to,O

HOSPITAL,O
COURSE,O
:,O

He,O
was,O
started,O
on,O
p.o.,B-TR
steroids,I-TR
and,O
to,O
CMED,O
for,O
management,B-TR
of,O
COPD,B-PR
exacerbation,I-PR
but,O
he,O
appeared,O
in,O
more,B-PR
respiratory,I-PR
distress,I-PR
overnight,O
and,O
was,O
started,O
on,O
IV,B-TR
Solu-Medrol,I-TR
and,O
more,B-TR
frequent,I-TR
nebulizers,I-TR
for,O
COPD,B-PR
.,O

He,O
was,O
also,O
started,O
on,O
antibiotics,B-TR
for,O
possible,O
bronchitis,B-PR
or,O
community-acquired,B-PR
pneumonia,I-PR
.,O

Given,O
his,B-PR
tenuous,I-PR
respiratory,I-PR
status,I-PR
",",O
he,O
was,O
transferred,O
to,O
the,O
FICU,O
with,O
closer,B-TE
observation,I-TE
.,O

He,O
did,O
not,O
require,O
intubation,B-TR
and,O
improved,O
with,O
q.,O
two,O
hour,O
nebulizers,B-TR
and,O
chest,B-TR
PT,I-TR
.,O

He,O
was,O
again,O
transferred,O
to,O
the,O
CMED,O
Service,O
for,O
further,B-TR
management,I-TR
of,O
his,B-PR
COPD,I-PR
exacerbation,I-PR
.,O

He,O
was,O
continued,O
on,O
p.o.,B-TR
prednisone,I-TR
and,O
frequent,B-TR
nebulizers,I-TR
for,O
COPD,B-PR
.,O

He,O
was,O
evaluated,O
by,O
the,O
physical,O
therapist,O
in,O
the,O
hospital,O
and,O
was,O
found,O
to,O
desaturate,B-PR
to,O
84%,O
with,O
ambulating,O
on,O
room,O
air,O
.,O

Therefore,O
",",O
home,B-TR
02,I-TR
was,O
recommended,O
on,O
discharge,O
.,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O
.,O

DISCHARGE,O
STATUS,O
:,O

To,O
home,O
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

1.,O
Chronic,B-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
exacerbation,I-PR
.,O

2.,O
Bronchitis,B-PR
.,O

3.,O
Community-acquired,B-PR
pneumonia,I-PR
.,O

4.,O
Rule,O
out,O
myocardial,B-PR
infarction,I-PR
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Flovent,B-TR
two,O
puffs,O
b.i.d.,O

2.,O
Levofloxacin,B-TR
500,O
mg,O
p.o.,O
q.d.,O
for,O
another,O
11,O
days,O
for,O
a,O
total,O
of,O
a,O
14,O
day,O
course,O
.,O

3.,O
Albuterol,B-TR
inhaler,I-TR
one,O
to,O
two,O
puffs,O
q.,O
four,O
to,O
six,O
hours,O
p.r.n.,O

4.,O
Aspirin,B-TR
81,O
mg,O
p.o.,O
q.d.,O

5.,O
Salmeterol,B-TR
one,O
to,O
two,O
puffs,O
b.i.d.,O

6.,O
Oxygen,B-TR
2,I-TR
liters,I-TR
nasal,I-TR
cannula,I-TR
with,O
ambulating,O
as,O
needed,O
.,O

7.,O
Prednisone,B-TR
taper,I-TR
with,O
40,O
mg,O
p.o.,O
q.d.,O
for,O
two,O
days,O
",",O
30,O
mg,O
p.o.,O
q.d.,O
for,O
two,O
days,O
",",O
20,O
mg,O
p.o.,O
q.d.,O
for,O
two,O
days,O
",",O
10,O
mg,O
p.o.,O
q.d.,O
for,O
two,O
days,O
.,O

DISCHARGE,O
FOLLOW-UP,O
:,O

The,O
patient,O
will,O
see,O
his,O
PCP,O
in,O
one,O
to,O
two,O
weeks,O
.,O

The,O
patient,O
will,O
also,O
see,O
his,O
pulmonologist,O
",",O
Dr.,O
Daniel,O
Bell,O
",",O
appointment,O
was,O
made,O
on,O
discharge,O
.,O

John,O
C,O
Stalnaker,O
",",O
M.D.,O

35-693,O

Dictated,O
By,O
:,O
Margaret,O
BT,O
Mahaffey,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2011-02-19,O
10:21,O

T,O
:,O
2011-02-21,O
18:42,O

JOB,O
#:,O

74873,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Kate,O
Gentry,O
on,O
:,O
MON,O
2011-03-07,O
4:08,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2013-05-09,O

Discharge,O
Date,O
:,O

2013-06-02,O

Date,O
of,O
Birth,O
:,O

1966-03-19,O

Sex,O
:,O

M,O

Service,O
:,O

Scott,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
47,O
year,O
old,O
male,O
",",O
with,O
end,B-PR
stage,I-PR
liver,I-PR
disease,I-PR
secondary,O
to,O
hepatitis,B-PR
C,I-PR
cirrhosis,I-PR
diagnosed,O
about,O
5,O
years,O
prior,O
to,O
admission,O
.,O

The,O
patient,O
had,O
undergone,O
treatment,B-TR
with,O
interferon,B-TR
and,O
Ribavirin,B-TR
.,O

He,O
had,O
been,O
admitted,O
to,O
the,O
St.,O
Margaret,O
's,O
Center,O
for,O
Women,O
&,O
Infants,O
multiple,O
times,O
early,O
in,O
2013,O
for,O
management,B-TR
of,O
encephalopathy,B-PR
and,O
ascites,B-PR
.,O

The,O
patient,O
had,O
been,O
discharged,O
from,O
the,O
St.,O
Margaret,O
's,O
Center,O
for,O
Women,O
&,O
Infants,O
on,O
2013-05-06,O
",",O
but,O
was,O
readmitted,O
on,O
2013-05-09,O
when,O
noted,O
to,O
have,O
worsening,B-PR
renal,I-PR
function,I-PR
.,O

The,B-TE
patient,I-TE
's,I-TE
serum,I-TE
creatinine,I-TE
on,O
the,O
day,O
of,O
discharge,O
",",O
on,O
2013-05-06,O
",",O
was,O
1.9,O
",",O
but,O
was,O
noted,O
to,O
increase,O
to,O

3.2,O
on,O
2013-05-08,O
",",O
and,O
was,O
further,B-PR
elevated,I-PR
to,O
3.6,O
on,O
2013-05-09,O
.,O

The,O
patient,O
was,O
admitted,O
with,O
concern,O
for,O
hepatorenal,B-PR
syndrome,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Hepatitis,B-PR
C,I-PR
cirrhosis,I-PR
for,O
which,O
the,O
patient,O
was,O
on,O
the,O
liver,O
transplant,O
list,O
.,O

2.,O
Hypertension,B-PR
.,O

3.,O
Nephrolithiasis,B-PR
.,O

4.,O
Hemorrhoids,B-PR
.,O

5.,O
Knee,B-TR
surgeries,I-TR
.,O

6.,O
Back,B-TR
surgery,I-TR
.,O

MEDICATIONS,O
:,O

1.,O
Miconazole,B-TR
nitrate,I-TR
powder,I-TR
tid,O
prn,O
for,O
groin,B-PR
rash,I-PR
.,O

2.,O
Protonix,B-TR
40,O
mg,O
po,O
bid,O
.,O

3.,O
Lactulose,B-TR
30,O
ml,O
tid,O
(,O
titrated,O
to,O
4,O
to,O
5,O
bowel,O
movements,O
qd,O
),O
.,O

4.,O
Vancomycin,B-TR
1,O
gm,O
IV,O
bid,O
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
is,O
married,O
with,O
no,O
children,O
.,O

He,O
works,O
as,O
a,O
counselor,O
at,O
an,O
alcohol,O
and,O
drug,O
treatment,O
facility,O
for,O
teenagers,O
.,O

The,O
patient,O
was,O
previously,O
a,O
heavy,O
alcohol,O
user,O
",",O
but,O
had,O
been,O
sober,O
since,O
1996,O
.,O

The,O
patient,O
had,O
also,O
used,O
cocaine,O
in,O
the,O
past,O
",",O
but,O
had,O
also,O
stopped,O
in,O
1996,O
.,O

HOSPITAL,O
COURSE,O
:,O

(,O
Part,O
of,O
the,O
patient,O
's,O
chart,O
from,O
the,O
period,O
2013-05-09,O
to,O
2013-05-23,O
is,O
currently,O
unavailable,O
",",O
and,O
this,O
dictation,O
will,O
mainly,O
cover,O
the,O
period,O
from,O
2013-05-23,O
to,O
2013-06-02,O
),O

As,O
previously,O
mentioned,O
",",O
the,B-TE
patient,I-TE
's,I-TE
creatinine,I-TE
at,O
the,O
time,O
of,O
admission,O
was,O
up,O
to,O
3.6,O
from,O
1.9,O
at,O
the,O
time,O
of,O
his,O
discharge,O
3,O
days,O
prior,O
.,O

Over,O
the,O
following,O
5,O
days,O
",",O
the,B-TE
patient,I-TE
's,I-TE
creatinine,I-TE
improved,O
marginally,O
to,O
2.7,O
.,O

Optimization,O
of,O
his,B-TE
fluid,I-TE
balance,I-TE
was,O
managed,O
by,O
the,O
medical,O
service,O
in,O
consultation,O
with,O
hepatology,O
and,O
renal,O
.,O

The,B-TE
patient,I-TE
's,I-TE
INR,I-TE
on,O
admission,O
was,O
2.4,O
",",O
with,O
his,B-TE
PT,I-TE
level,I-TE
being,O
18.9,O
.,O

The,O
patient,O
periodically,O
required,O
transfusions,B-TR
of,O
fresh,B-TR
frozen,I-TR
plasma,I-TR
",",O
as,O
well,O
as,O
platelets,B-TR
and,O
red,B-TR
cells,I-TR
.,O

The,O
patient,O
was,O
thrombocytopenic,B-PR
with,O
a,B-TE
platelet,I-TE
count,I-TE
of,O
49,O
on,O
the,O
23,O
.,O

The,O
patient,O
was,O
continued,O
on,O
vancomycin,B-TR
therapy,I-TR
for,O
his,B-PR
previously,I-PR
diagnosed,I-PR
Methicillin,I-PR
resistant,I-PR
",",I-PR
coagulase,I-PR
negative,I-PR
Staph,I-PR
bacteremia,I-PR
.,O

The,O
patient,O
's,O
nutrition,O
was,O
suboptimal,O
",",O
and,O
the,O
patient,O
was,O
started,O
on,O
tube,B-TR
feeding,I-TR
.,O

The,O
patient,O
underwent,O
diagnostic,O
and,O
therapeutic,B-TR
paracentesis,I-TR
on,O
2013-05-16,O
",",O
2013-05-21,O
",",O
and,O
2013-05-24,O
.,O

He,O
had,O
no,O
evidence,O
of,O
spontaneous,B-PR
bacterial,I-PR
peritonitis,I-PR
.,O

On,O
2013-05-25,O
",",O
a,O
liver,O
became,O
available,O
for,O
transplant,B-TR
to,O
the,O
patient,O
.,O

The,O
patient,O
was,O
taken,O
to,O
the,O
operating,O
room,O
and,O
underwent,O
an,B-TR
orthotopic,I-TR
liver,I-TR
transplant,I-TR
.,O

In,O
order,O
to,O
aid,O
in,O
optimization,O
of,O
the,B-TE
patient,I-TE
's,I-TE
fluid,I-TE
status,I-TE
",",O
the,O
patient,O
was,O
on,O
continuous,B-TR
Baker,I-TR
Baker,I-TR
dialysis,I-TR
during,O
the,B-TR
procedure,I-TR
.,O

His,B-PR
estimated,I-PR
blood,I-PR
loss,I-PR
was,O
2,O
liters,O
.,O

The,O
patient,O
received,O
5,O
liters,O
of,O
crystalloid,B-TR
",",O
9,O
units,O
of,O
fresh,B-TR
frozen,I-TR
plasma,I-TR
",",O
9,O
units,O
of,O
red,B-TR
cells,I-TR
",",O
6,O
units,O
of,O
platelets,B-TR
",",O
as,O
well,O
as,O
1,O
liter,O
of,O
Cell,B-TR
Saver,I-TR
.,O

The,B-TR
procedure,I-TR
proceeded,O
without,O
complications,B-PR
",",O
and,O
the,O
patient,O
was,O
transferred,O
to,O
the,O
intensive,O
care,O
unit,O
while,O
still,O
intubated,B-TR
following,O
the,B-TR
procedure,I-TR
.,O

The,O
patient,O
underwent,O
an,O
uncomplicated,O
recovery,O
in,O
the,O
intensive,O
care,O
unit,O
.,O

By,O
postop,O
day,O
1,O
",",O
the,O
patient,O
was,O
awake,O
",",O
in,O
no,O
distress,B-PR
",",O
and,O
appeared,O
lucid,O
prior,O
to,O
extubation,O
.,O

The,O
patient,O
was,O
extubated,O
on,O
postop,O
day,O
1,O
without,O
any,B-PR
problems,I-PR
.,O

The,O
patient,O
was,O
on,O
a,B-TR
Lasix,I-TR
drip,I-TR
to,O
aid,O
in,O
diuresis,B-TR
",",O
and,O
was,O
ultimately,O
converted,O
to,O
oral,B-TR
Lasix,I-TR
on,O
postop,O
day,O
1,O
.,O

The,B-TR
patient,I-TR
's,I-TR
pain,I-TR
control,I-TR
was,O
with,O
morphine,B-TR
.,O

The,O
patient,O
required,O
2,O
units,O
of,O
fresh,B-TR
frozen,I-TR
plasma,I-TR
on,O
the,O
night,O
following,O
surgery,B-TR
",",O
and,O
1,O
unit,O
of,O
platelets,B-TR
on,O
postop,O
day,O
1,O
",",O
but,O
otherwise,O
required,O
no,O
blood,B-TR
products,I-TR
following,O
the,B-TR
liver,I-TR
transplant,I-TR
.,O

The,O
patient,O
was,O
started,O
on,O
sips,O
on,O
postop,O
day,O
2,O
",",O
and,O
advanced,O
to,O
clear,O
liquids,O
on,O
postop,O
day,O
3,O
.,O

He,O
was,O
advanced,O
to,O
a,O
regular,O
house,O
diet,O
later,O
on,O
postop,O
day,O
3,O
.,O

The,O
patient,O
was,O
advanced,O
per,O
protocol,O
to,O
an,B-TR
immunosuppressive,I-TR
regimen,I-TR
of,O
prednisone,B-TR
",",O
Neoral,B-TR
",",O
and,O
CellCept,B-TR
.,O

The,O
patient,O
's,O
mental,O
status,O
remained,O
essentially,O
clear,O
throughout,O
the,O
entire,O
postoperative,O
period,O
.,O

The,O
patient,O
started,O
ambulating,O
with,O
the,O
assistance,O
of,O
physical,B-TR
therapy,I-TR
following,O
transfer,O
to,O
the,O
surgical,O
floor,O
.,O

At,O
the,O
time,O
of,O
discharge,O
",",O
the,O
patient,O
was,O
independent,O
",",O
ambulating,O
",",O
and,O
functioning,O
well,O
.,O

The,O
patient,O
's,O
appetite,O
improved,O
significantly,O
",",O
and,O
at,O
the,O
time,O
of,O
discharge,O
the,O
patient,O
was,O
on,O
a,O
regular,O
diet,O
with,O
no,O
tube,B-TR
feed,I-TR
supplements,I-TR
deemed,O
necessary,O
.,O

The,B-TE
patient,I-TE
's,I-TE
liver,I-TE
function,I-TE
tests,I-TE
all,O
improved,O
appropriately,O
by,O
the,O
time,O
of,O
discharge,O
.,O

The,B-PR
patient,I-PR
's,I-PR
surgical,I-PR
incision,I-PR
was,O
also,O
healing,O
well,O
by,O
the,O
time,O
of,O
discharge,O
with,O
no,O
evidence,O
of,O
infection,B-PR
.,O

The,O
patient,O
was,O
ultimately,O
deemed,O
ready,O
for,O
discharge,O
on,O
postoperative,O
day,O
8,O
.,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Bactrim,B-TR
single,I-TR
strength,I-TR
1,O
tablet,O
po,O
qd,O
.,O

2.,O
Protonix,B-TR
40,O
mg,O
po,O
qd,O
.,O

3.,O
Metoprolol,B-TR
25,O
mg,O
po,O
bid,O
.,O

4.,O
Fluconazole,B-TR
200,O
mg,O
po,O
qd,O
.,O

5.,O
CellCept,B-TR
1,O
gm,O
po,O
bid,O
.,O

6.,O
Prednisone,B-TR
20,O
mg,O
po,O
qd,O
.,O

7.,O
Dilaudid,B-TR
prn,O
.,O

8.,O
Neoral,B-TR
500,O
mg,O
po,O
bid,O
.,O

9.,O
Valcyte,B-TR
450,O
mg,O
po,O
qod,O
.,O

10.,O
Lasix,B-TR
40,O
mg,O
bid,O
x,O
21,O
days,O
.,O

11.,O
Colace,B-TR
100,O
mg,O
po,O
bid,O
.,O

FOLLOW,O
UP,O
:,O

1.,O
The,O
patient,O
was,O
to,O
follow-up,O
with,O
Dr.,O
Ronald,O
in,O
the,O
Transplant,O
Center,O
3,O
days,O
following,O
discharge,O
.,O

2.,O
The,O
patient,O
was,O
to,O
follow-up,O
with,O
Dr.,O
Lueras,O
of,O
hepatology,O
following,O
discharge,O
.,O

MAJOR,O
SURGICAL,O
PROCEDURES,O
:,O

Liver,B-TR
transplant,I-TR
on,O
2013-05-25,O
.,O

Elinor,O
Nicole,O
",",O
New,O
York,O
12428,O

Dictated,O
By,O
:,O
Elizabeth,O
F.,O
Wells,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2013-06-05,O
08:29:54,O

T,O
:,O
2013-06-06,O
10:40:21,O

Job,O
#,O
:,O
34705,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Charles,O
Y.S.,O
Warnock,O
on,O
:,O
Maxine,O
2013-06-20,O
5:29,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2016-08-08,O

Discharge,O
Date,O
:,O

2016-08-15,O

Date,O
of,O
Birth,O
:,O

1978-08-02,O

Sex,O
:,O

F,O

Service:,O

PROCEDURE,O
:,O

Cadaveric,B-TR
pancreas,I-TR
transplantation,I-TR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
37,O
year,O
old,O
lady,O
with,O
type,B-PR
1,I-PR
diabetes,I-PR
mellitus,I-PR
",",O
who,O
is,O
four,O
months,O
postcadaveric,B-TR
kidney,I-TR
transplantation,I-TR
and,O
now,O
has,O
good,O
graft,O
function,O
.,O

She,O
presents,O
for,O
cadaveric,B-TR
pancreas,I-TR
transplantation,I-TR
.,O

Her,B-PR
diabetes,I-PR
mellitus,I-PR
has,O
been,O
complicated,O
by,O
retinopathy,B-PR
and,O
nephropathy,B-PR
as,O
well,O
as,O
peripheral,B-PR
neuropathy,I-PR
.,O

She,O
takes,O
14,O
units,O
of,O
NPH,B-TR
insulin,I-TR
twice,O
a,O
day,O
supplementing,O
with,O
a,B-TR
sliding,I-TR
scale,I-TR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
examination,B-TE
",",O
she,O
is,O
in,O
no,O
apparent,B-PR
distress,I-PR
and,O
is,O
alert,O
and,O
oriented,O
.,O

Her,B-TE
chest,I-TE
and,I-TE
cardiovascular,I-TE
examinations,I-TE
are,O
unremarkable,O
.,O

She,O
is,O
afebrile,B-PR
with,O
stable,O
vital,O
signs,O
.,O

Her,O
abdomen,O
is,O
soft,O
and,O
nontender,B-PR
with,O
a,B-PR
well,I-PR
healed,I-PR
left,I-PR
lower,I-PR
quadrant,I-PR
incision,I-PR
from,O
her,B-TR
kidney,I-TR
transplantation,I-TR
.,O

She,O
has,O
good,O
femoral,O
pulses,O
bilaterally,O
.,O

HOSPITAL,O
COURSE,O
:,O

She,O
underwent,O
cadaveric,B-TR
pancreas,I-TR
transplantation,I-TR
without,O
complication,B-PR
.,O

She,O
received,O
induction,B-TR
therapy,I-TR
with,O
thymoglobulin,B-TR
intraoperative,O
and,O
postoperatively,O
for,O
five,O
days,O
.,O

She,O
was,O
kept,O
on,O
a,B-TR
similar,I-TR
immunosuppressive,I-TR
regimen,I-TR
as,O
with,O
her,B-TR
kidney,I-TR
transplant,I-TR
.,O

She,O
had,O
excellent,O
pancreas,O
graft,O
function,O
immediately,O
.,O

Her,O
renal,O
function,O
also,O
remained,O
stable,O
in,O
the,O
perioperative,O
period,O
.,O

She,O
was,O
quickly,O
placed,O
on,O
a,O
diet,O
and,O
advanced,O
to,O
regular,O
diet,O
.,O

She,O
was,O
discharged,O
home,O
in,O
stable,O
condition,O
on,O
postoperative,O
day,O
six,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
.,O

DISCHARGE,O
INSTRUCTIONS,O
:,O

She,O
will,O
begin,O
weekly,O
follow-up,O
in,O
the,O
Transplant,O
Center,O
.,O

She,O
is,O
to,O
not,O
lift,O
anything,O
greater,O
than,O
ten,O
pounds,O
for,O
six,O
weeks,O
.,O

She,O
is,O
to,O
continue,O
monitoring,O
her,B-TE
blood,I-TE
sugar,I-TE
twice,O
a,O
day,O
.,O

She,O
has,O
undergone,O
full,O
teaching,O
in,O
regards,O
to,O
immunosuppressant,B-TR
medications,I-TR
.,O

In,O
addition,O
",",O
she,O
will,O
take,O
Valganciclovir,B-TR
for,O
three,O
months,O
posttransplant,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Status,O
post,O
cadaveric,B-TR
pancreas,I-TR
transplant,I-TR
.,O

2.,O
Type,B-PR
1,I-PR
diabetes,I-PR
mellitus,I-PR
.,O

3.,O
End,B-PR
stage,I-PR
renal,I-PR
disease,I-PR
",",O
status,O
post,O
kidney,B-TR
transplantation,I-TR
.,O

Dictated,O
By,O
:,O
Jon,O
O,O
Shappy,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2016-11-10,O
18:28,O

T,O
:,O
2016-11-12,O
11:51,O

JOB,O
#,O
:,O
63429,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Jacob,O
Butler,O
on,O
:,O
WED,O
2016-11-16,O
7:45,O
AM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2014-04-23,O

Discharge,O
Date,O
:,O

2014-04-28,O

Date,O
of,O
Birth,O
:,O

1980-02-05,O

Sex,O
:,O

F,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Penicillins,B-TR
/,O
Sulfonamides,B-TR

Attending,O
:,O
Louie,O
A.,O
Keith,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Benzo,B-PR
overdose,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

Intubation,B-TR
for,I-TR
airway,I-TR
protection,I-TR

History,O
of,O
Present,O
Illness,O
:,O

HPI,O
:,O

Ms.,O
Franklin,O
is,O
a,O
34,O
-,O
year-old,O
woman,O
with,O
Bipolar,B-PR
disorder,I-PR
and,O
group,O
home,O
resident,O
who,O
by,O
way,O
of,O
EMS,O
for,O
apparent,B-PR
alprazolam,I-PR
overdose,I-PR
.,O

In,O
the,O
St.,O
Margaret,O
's,O
Center,O
for,O
Women,O
&,O
Infants,O
",",O
the,O
patient,O
was,O
lethargic,B-PR
and,O
unable,O
to,O
give,O
a,O
history,O
.,O

She,O
was,O
promptly,O
intubated,O
for,O
airway,O
protection,O
and,O
in,O
order,O
to,O
administer,O
charcoal,B-TR
.,O

Patient,O
was,O
found,O
at,O
group,O
home,O
in,O
am,O
laying,O
on,O
floor,O
by,O
bed,O
unresponsive,B-PR
",",O
last,O
seen,O
awake,O
8,O
hours,O
prior,O
at,O
dinner,O
.,O

"Group,O
home,O
states,O
that,O
patient,O
"",O
may,O
have,O
taken,O
too,O
many,O
Xanax,B-TR
.",O

Patient,O
has,O
a,O
history,O
of,O
suicidal,B-PR
ideations,I-PR
and,O
self,B-PR
mutilation,I-PR
.,O

Later,O
patient,O
told,O
CMED,O
CCU,O
that,O
she,O
was,O
feeling,O
down,O
and,O
impulsively,O
ingested,O
5,O
days,O
worth,O
of,O
medications,B-TR
",",O
she,O
states,O
that,O
her,O
intent,O
at,O
that,O
time,O
was,O
to,O
end,O
her,O
life,O
.,O

Past,O
Medical,O
History,O
:,O

1.,O
Bipolar,B-PR
disorder,I-PR
.,O

2.,O
Asthma,B-PR
.,O

3.,O
Posttraumatic,B-PR
stress,I-PR
disorder,I-PR
.,O

4.,O
GERD,B-PR

5.,O
Chronic,B-PR
constipation,I-PR
from,O
laxative,B-PR
abuse,I-PR
.,O

Social,O
History,O
:,O

Denies,O
any,O
recent,O
use,O
of,O
EtOH,O
or,O
illicit,O
drugs,O
.,O

Per,O
OMR,O
",",O
h/o,O
sporadic,O
marijuana,O
use,O
.,O

Now,O
living,O
at,O
the,O
DBT,O
House,O
on,O
Treva,O
Williamson,O
in,O
Westborough,O
.,O

In,O
currently,O
in,O
a,O
relationship,O
with,O
a,O
man,O
whom,O
she,O
met,O
during,O
a,O
previous,O
inpt,O
admission,O
.,O

Per,O
OMR,O
",",O
the,O
patient,O
is,O
currently,O
not,O
in,O
contact,O
with,O
her,O
family,O
.,O

She,O
was,O
raised,O
in,O
multiple,O
foster,O
care,O
homes,O
because,O
her,O
mother,O
could,O
not,O
care,O
for,O
her,O
.,O

She,O
was,O
physically,O
abused,O
and,O
severely,O
neglected,O
as,O
a,O
child,O
and,O
been,O
sexually,O
assaulted,O
.,O

She,O
has,O
no,O
current,O
romantic,O
relationship,O
.,O

She,O
has,O
never,O
been,O
married,O
.,O

She,O
has,O
completed,O
up,O
to,O
the,O
tenth,O
grade,O
of,O
high,O
school,O
.,O

She,O
has,O
no,O
current,O
legal,O
issues,O
.,O

Family,O
History,O
:,O

Substance,O
abuse,O
in,O
mother,O
and,O
brother,O
.,O

Two,O
sisters,O
with,O
h/o,O
depression,B-PR
and,O
suicidality,B-PR
.,O

Physical,O
Exam,O
:,O

VS,B-TE
95.4,O
HR,B-TE
62,O
BP,B-TE
99/70,O
RR,B-TE
20,O
O2Sat,B-TE
100%,O

Gen,O
:,O

Intubated,B-TR
and,O
sedated,B-TR

HEENT,O
:,O

ATNC,B-PR
",",O
Pupils,O
dialted,O
at,O
5,O
mm,O
but,O
minimally,B-PR
reactive,I-PR
",",O
anicteric,B-PR

Chest,O
:,O

CTA,O
ant/lat,O

Cor,O
:,O

RR,O
nl,O
S1,O
S2,O
no,O
m,B-PR

Abd,O
:,O

Soft,O
",",O
nd,B-PR
",",O
hypoactive,B-PR
bowel,I-PR
sounds,I-PR

Ext,O
:,O

WWP,B-PR
",",O
multiple,B-PR
linear,I-PR
scars,I-PR
and,O
burns,B-PR
on,I-PR
hands,I-PR
and,I-PR
arms,I-PR

Neuro,O
:,O

Sedated,B-TR
",",O
DTRs,B-TE
:,O

Skin,O
:,O

No,O
rashes,B-PR
or,O
petechiae,B-PR
",",O
linear,B-PR
and,I-PR
burn,I-PR
scars,I-PR
as,O
above,O

Pertinent,O
Results,O
:,O

2014-04-23,O
7:56,O

WBC,B-TE
-,O
9.4,O
#,O
RBC,B-TE
-,O
4.75,O
HGB,B-TE
-,O
14.7,O
HCT,B-TE
-,O
42.2,O
MCV,B-TE
-,O
89,O
MCH,B-TE
-,O
30.9,O
MCHC,B-TE
-,O
34.8,O
RDW,B-TE
-,O
13.6,O

2014-04-23,O
7:56,O

PLT,B-TE
COUNT,I-TE
-,O
330,O

2014-04-23,O
7:56,O

NEUTS,B-TE
-,O
73.0,O
*,O
LYMPHS,B-TE
-,O
21.8,O
MONOS,B-TE
-,O
3.8,O
EOS,B-TE
-,O
1.1,O
BASOS,B-TE
-,O
0.3,O

2014-04-23,O
7:56,O

ASA,B-TE
-,O
NEG,O
ETHANOL,B-TE
-,O
NEG,O
ACETMNPHN,B-TE
-,O
NEG,O
bnzodzpn,B-TE
-,O
NEG,O
barbitrt,B-TE
-,O
NEG,O
tricyclic,B-TE
-,O
POS,O

2014-04-23,O
7:56,O

LITHIUM,B-TE
-,O
LESS,O
THAN,O

2014-04-23,O
7:56,O

DIGOXIN,B-TE
-<,O
0.2,O
*,O

2014-04-23,O
7:56,O

GLUCOSE,B-TE
-,O
116,O
*,O
UREA,B-TE
N,I-TE
-,O
14,O
CREAT,B-TE
-,O
1.0,O
SODIUM,B-TE
-,O
137,O
POTASSIUM,B-TE
-,O
4.5,O
CHLORIDE,B-TE
-,O
105,O
TOTAL,B-TE
CO2,I-TE
-,O
20,O
*,O
ANION,B-TE
GAP,I-TE
-,O
17,O

2014-04-23,O
7:56,O

CALCIUM,B-TE
-,O
9.7,O
PHOSPHATE,B-TE
-,O
3.7,O
MAGNESIUM,B-TE
-,O
2.1,O

2014-04-23,O
7:56,O

ALT,B-TE
(,I-TE
SGPT,I-TE
)-,I-TE
21,O
AST,B-TE
(,I-TE
SGOT,I-TE
)-,O
40,O
ALK,B-TE
PHOS,I-TE
-,O
70,O
AMYLASE,B-TE
-,O
59,O
TOT,B-TE
BILI,I-TE
-,O
0.4,O

2014-04-23,O
7:56,O

LIPASE,B-TE
-,O
66,O
*,O

2014-04-23,O
08:00,O
AM,O
URINE,B-TE

BLOOD,B-TE
-,O
NEG,O
NITRITE,B-TE
-,O
NEG,O
PROTEIN,B-TE
-,O
NEG,O
GLUCOSE,B-TE
-,O
NEG,O
KETONE,B-TE
-,O
TR,O
BILIRUBIN,B-TE
-,O
NEG,O
UROBILNGN,B-TE
-,O
NEG,O
PH,B-TE
-,O
6.5,O
LEUK,B-TE
-,O
NEG,O

2014-04-23,O
08:13,O
AM,O
URINE,B-TE
bnzodzpn,B-TE
-,O
POS,O
barbitrt,B-TE
-,O
NEG,O
opiates,B-TE
-,O
NEG,O
cocaine,B-TE
-,O
NEG,O
amphetmn,B-TE
-,O
NEG,O
mthdone,B-TE
-,O
NEG,O

2014-04-23,O
13:38,O

CK,B-TE
(,I-TE
CPK,I-TE
)-,I-TE
4713,O
*,O

2014-04-23,O
03:45,O
PM,O
URINE,B-TE

UCG,B-TE
-,O
NEGATIVE,O

2014-04-23,O
15:56,O

D-DIMER,B-TE
-,O
7998,O
*,O

CXR,B-TE
:,O

Probable,O
ateletasis,B-PR
of,I-PR
lingula,I-PR
",",O
consistent,O
with,O
pneumonitis,B-PR

EKG,B-TE
:,O

NSR,O
R,B-TE
60,O
Normal,O
axis,O
",",O
intervals,O
",",O
incomplete,B-PR
RBBB,I-PR
",",O
flat,B-PR
T,I-PR
aVL,I-PR
",",O
V2,O
",",O
TWI,B-PR
V1,I-PR

CT,B-TE
Chest,I-TE
-,O
shows,O
bilateral,B-PR
segmental,I-PR
",",I-PR
subsegmental,I-PR
PEs,I-PR

B/L,B-TE
LE,I-TE
LENIs,I-TE
-,O
negative,O

Brief,O
Hospital,O
Course,O
:,O

CMED,O
CSRU,O
Course,O
:,O

Patient,O
was,O
intubated,O
in,O
John,O
for,O
airway,O
protection,O
and,O
administation,O
of,O
charcoal,B-TR
.,O

Toxicology,O
consulted,O
and,O
felt,O
that,O
patient,O
most,O
likely,O
had,O
benzo,B-PR
overdose,I-PR
.,O

ABG,B-TE
revealed,O
widened,B-PR
A-a,I-PR
gradient,I-PR
so,O
a,B-TE
d-dimer,I-TE
was,O
sent,O
which,O
was,O
elevated,B-PR
.,O

Patient,O
had,O
CTA,B-TE
which,O
showed,O
bilateral,B-PR
pulmonary,I-PR
embolisms,I-PR
.,O

Patient,O
was,O
started,O
on,O
heparin,B-TR
drip,I-TR
and,O
bilateral,B-TE
lower,I-TE
extremeties,I-TE
were,O
done,O
which,O
were,O
negative,O
for,O
DVT,B-PR
.,O

Patient,O
was,O
exubated,O
after,O
1,O
day,O
in,O
ICU,O
after,O
waking,O
up,O
.,O

Overnight,O
in,O
the,O
ICU,O
patient,O
was,O
noticed,O
to,O
have,O
painful,B-PR
bullae,I-PR
on,I-PR
hands,I-PR
and,I-PR
arm,I-PR
along,O
with,O
swelling,B-PR
.,O

Dermatology,O
and,O
plastic,O
surgery,O
were,O
consulted,O
who,O
felt,O
that,O
symptoms,B-PR
were,O
due,O
to,O
trauma,B-PR
;,O
it,O
was,O
not,O
felt,O
that,O
patient,O
had,O
compartment,B-PR
syndrome,I-PR
.,O

Patient,O
was,O
splinted,O
and,O
UE,O
were,O
kept,O
elevated,O
.,O

Patient,O
was,O
gradually,O
put,O
back,O
on,O
her,B-TR
outpatient,I-TR
xanax,I-TR
dose,I-TR
of,O
1,O
mg,O
qid,O
and,O
clozaril,B-TR
was,O
restarted,O
.,O

Patient,O
was,O
transferred,O
to,O
floor,O
after,O
spending,O
1,O
day,O
in,O
the,O
ICU,O
.,O

Once,O
on,O
the,O
floor,O
patient,O
stable,O
.,O

Plastic,O
did,O
not,O
feel,O
that,O
patient,O
had,O
any,B-PR
compartment,I-PR
syndrome,I-PR
and,O
recommended,O
aggresive,B-TR
upper,I-TR
extremity,I-TR
elevation,I-TR
for,O
swelling,B-TR
reduction,I-TR
.,O

While,O
on,O
the,O
floor,O
patient,O
's,O
hands,O
improved,O
with,O
good,O
range,O
of,O
motion,O
of,O
left,O
hand,O
",",O
however,O
Jones,O
some,B-PR
poor,I-PR
range,I-PR
of,I-PR
motion,I-PR
of,O
right,O
.,O

X-ray,B-TE
of,I-TE
the,I-TE
hands,I-TE
and,I-TE
wrist,I-TE
were,O
obtained,O
which,O
were,O
negative,O
.,O

Patient,O
seen,O
by,O
PT,O
and,O
OT,O
who,O
recommended,O
hand,B-TR
exercises,I-TR
and,O
splints,B-TR
for,O
patient,O
.,O

Patient,O
was,O
put,O
on,O
coumadin,B-TR
that,O
was,O
bridged,O
with,O
lovenox,B-TR
unti,O
lINR,B-TR
theraputic,I-TR
01-23,O
.,O

Patient,O
conitnued,O
to,O
have,O
SI,B-PR
while,O
on,O
floor,O
and,O
was,O
transferred,O
to,O
psychiatry,O
.,O

While,O
on,O
the,O
floor,O
patient,B-TE
's,I-TE
urinalysis,I-TE
suggestive,O
of,O
UTI,B-PR
and,O
was,O
put,O
on,O
6,O
day,O
course,O
of,O
levofloxacin,B-TR
.,O

Medications,O
on,O
Admission,O
:,O

Propanolol,B-TR
XL,I-TR
80,O
mg,O
qd,O

Modifinal,B-TR
100,O
mg,O
po,O
qd,O

Lamictal,B-TR
100,O
mg,O
po,O
bid,O

Alprazolam,B-TR
1,O
mg,O
po,O
qid,O

Senna,B-TR

Trazadone,B-TR
200,O
mg,O
po,O
qhs,O

Clomipramine,B-TR
100,O
mg,O
po,O
qhs,O

Pantopraozle,B-TR
40,O
mg,O
po,O
qd,O

Clozapine,B-TR
300,O
mg,O
po,O
qhs,O

Folate,B-TR
1,O
mg,O
po,O
qd,O

Multivitamin,B-TR

Discharge,O
Medications,O
:,O

1.,O
Acetaminophen,B-TR
325,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
.,O

2.,O
Lamotrigine,B-TR
100,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

3.,O
Pantoprazole,B-TR
Sodium,I-TR
40,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
Q24H,O
(,O
every,O
24,O
hours,O
),O
.,O

4.,O
Folic,B-TR
Acid,I-TR
1,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

5.,O
Multivitamin,B-TR
Capsule,I-TR
Sig,O
:,O
One,O
(,O
1,O
),O
Cap,O
PO,O
DAILY,O
(,O
Daily,O
),O
.,O

6.,O
Senna,B-TR
8.6,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

7.,O
Clozapine,B-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
HS,O
(,O
at,O
bedtime,O
),O
.,O

8.,O
Warfarin,B-TR
Sodium,I-TR
3,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
at,O
bedtime,O
.,O

9.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
.,O

10.,O
Trazodone,B-TR
HCl,I-TR
100,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
HS,O
(,O
at,O
bedtime,O
),O
as,O
needed,O
.,O

11.,O
Alprazolam,B-TR
1,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
QID,O
(,O
4,O
times,O
a,O
day,O
),O
.,O

12.,O
Levofloxacin,B-TR
500,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q24H,O
(,O
every,O
24,O
hours,O
),O
for,O
3,O
days,O
.,O

13.,O
Bisacodyl,B-TR
5,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
DAILY,O
(,O
Daily,O
),O
as,O
needed,O
.,O

14.,O
Nicotine,B-TR
14,O
mg,O
/,O
24,O
hr,O
Patch,O
24,O
HR,O
Sig,O
:,O
One,O
(,O
1,O
),O
Patch,O
24,O
HR,O
Transdermal,O
DAILY,O
(,O
Daily,O
),O
.,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Discharge,O
Diagnosis,O
:,O

Benzodiazapine,B-PR
Overdose,I-PR

Traumatic,B-PR
/,I-PR
pressure,I-PR
bullae,I-PR

Bipolar,B-PR
Disorder,I-PR

Discharge,O
Condition,O
:,O

Stable,O
-,O
Swelling,B-PR
in,I-PR
hands,I-PR
reduced,O
and,O
range,O
of,O
motion,O
continue,O
to,O
improve,O
.,O

Discharge,O
Instructions,O
:,O

Please,O
continue,O
to,O
take,O
coumadin,B-TR
as,O
directed,O
by,O
your,O
doctors,O
until,O
told,O
to,O
stop,O
for,O
clots,B-PR
found,O
in,O
your,O
lungs,O
.,O

Please,O
continue,O
to,O
take,O
antibiotics,B-TR
as,O
directed,O
for,O
urinary,B-PR
tract,I-PR
infection,I-PR
for,O
3,O
more,O
days,O
.,O

Please,O
conitnue,O
to,O
keep,O
hands,O
elevated,O
in,O
bed,O
until,O
follow,O
up,O
appointment,O
with,O
plastic,O
surgery,O
.,O

Followup,O
Instructions,O
:,O

Patient,O
will,O
be,O
admitted,O
to,O
psychiatry,O
service,O

Patient,O
should,O
follow,O
up,O
with,O
at,O
plastic,O
surgery,O
clinic,O
in,O
2,O
weeks,O
.,O

Appointment,O
setup,O
for,O
Tues.,O
05-13,O
at,O
10,O
am,O
.,O

3rd,O
floor,O
Henderson,O
Building,O
with,O
Dr.,O
Black,O
(,O
650,O
),O
866-1361,O

Raymond,O
William,O
MD,O
50-154,O

Completed,O
by,O
:,O
Simon,O
Claudine,O
Audrey,O
MD,O
82-812,O
2014-04-28,O
@,O
1227,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Tracey,O
Mccourtney,O
on,O
:,O
MON,O
2014-05-05,O
10:26,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2012-04-30,O

Discharge,O
Date,O
:,O

2012-05-14,O

Date,O
of,O
Birth,O
:,O

1956-11-04,O

Sex,O
:,O

M,O

Service,O
:,O

O-CMED,O
CCU,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
55,O
-,O
year-old,O
male,O
with,O
recently,B-PR
diagnosed,I-PR
abdominal,I-PR
carcinomatosis,I-PR
.,O

The,O
patient,O
presented,O
with,O
abdominal,B-PR
pain,I-PR
and,O
bloating,B-PR
and,O
was,O
found,O
to,O
have,O
a,B-PR
large,I-PR
omental,I-PR
mass,I-PR
.,O

Biopsy,B-TE
revealed,O
adenocarcinoma,B-PR
.,O

Histochemical,B-TE
stains,I-TE
are,O
consistent,O
with,O
hepatobiliary,O
origin,O
.,O

Endoscopies,B-TE
were,O
negative,O
except,O
for,O
an,B-PR
extrinsic,I-PR
mass,I-PR
present,I-PR
on,I-PR
the,I-PR
stomach,I-PR
.,O

The,O
patient,O
presents,O
with,O
increased,B-PR
abdominal,I-PR
pain,I-PR
and,O
poor,B-PR
oral,I-PR
intake,I-PR
as,O
well,O
as,O
generalized,B-PR
weakness,I-PR
.,O

On,O
presentation,O
",",O
the,O
patient,O
denied,O
chest,B-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
and,O
cough,B-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Benign,B-PR
prostatic,I-PR
hypertrophy,I-PR
.,O

2.,O
Osteoarthritis,B-PR
.,O

3.,O
Gastrointestinal,B-PR
adenocarcinoma,I-PR
(,O
as,O
noted,O
in,O
History,O
of,O
Present,O
Illness,O
),O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Colace,B-TR
",",O
Senna,B-TR
",",O
Dulcolax,B-TR
",",O
Tylenol,B-TR
",",O
oxycodone,B-TR
as,O
needed,O
",",O
Ambien,B-TR
",",O
and,O
Protonix,B-TR
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

FAMILY,O
HISTORY,O
:,O

Mother,O
had,O
adrenal,B-PR
cancer,I-PR
.,O

Father,O
had,O
coronary,B-PR
artery,I-PR
disease,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
was,O
employed,O
as,O
a,O
salesman,O
.,O

He,O
denied,O
the,O
use,O
of,O
tobacco,O
and,O
drugs,O
.,O

He,O
uses,O
alcohol,O
occasionally,O
.,O

The,O
patient,O
is,O
married,O
with,O
two,O
children,O
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

Review,B-TE
of,I-TE
systems,I-TE
was,O
significant,O
for,O
progressive,B-PR
abdominal,I-PR
discomfort,I-PR
",",O
decreased,B-PR
oral,I-PR
intake,I-PR
",",O
and,O
weakness,B-PR
in,O
the,O
past,O
nine,O
weeks,O
.,O

PHYSICAL,O
EXAMINATION,O
ON,O
PRESENTATION,O
:,O

Physical,B-TE
examination,I-TE
revealed,O
temperature,B-TE
was,O
96.9,O
",",O
heart,B-TE
rate,I-TE
was,O
121,O
",",O
blood,B-TE
pressure,I-TE
was,O
122/86,O
",",O
respiratory,B-TE
rate,I-TE
was,O
22,O
",",O
and,O
oxygen,B-TE
saturation,I-TE
was,O
96%,O
on,O
room,O
air,O
.,O

In,O
general,O
",",O
the,O
patient,O
looked,O
acutely,B-PR
and,I-PR
chronically,I-PR
ill,I-PR
.,O

Head,B-TE
",",I-TE
eyes,I-TE
",",I-TE
ears,I-TE
",",I-TE
nose,I-TE
",",I-TE
and,I-TE
throat,I-TE
examination,I-TE
revealed,O
the,O
oropharynx,O
was,O
clear,O
.,O

Sclerae,O
were,O
anicteric,B-PR
.,O

Mucous,O
membranes,O
were,O
moist,O
.,O

Cardiovascular,B-TE
examination,I-TE
revealed,O
tachycardic,B-PR
first,I-PR
heart,I-PR
sound,I-PR
and,I-PR
second,I-PR
heart,I-PR
sound,I-PR
.,O

No,O
murmurs,B-PR
",",O
rubs,B-PR
",",O
or,O
gallops,B-PR
.,O

Lungs,O
revealed,O
decreased,B-PR
breath,I-PR
sounds,I-PR
and,O
dullness,B-PR
to,O
percussion,B-TE
in,O
the,O
left,O
lung,O
base,O
.,O

The,O
abdomen,O
was,O
distended,B-PR
and,O
firm,B-PR
.,O

Positive,O
bowel,O
sounds,O
.,O

Extremity,B-TE
examination,I-TE
revealed,O
no,O
clubbing,B-PR
",",O
cyanosis,B-PR
",",O
or,O
edema,B-PR
.,O

IMPRESSION,O
:,O

This,O
was,O
a,O
55,O
-,O
year-old,O
gentleman,O
with,O
recently,B-PR
diagnosed,I-PR
abdominal,I-PR
carcinomatosis,I-PR
admitted,O
with,O
increased,B-PR
abdominal,I-PR
pain,I-PR
and,O
poor,B-PR
oral,I-PR
intake,I-PR
.,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
O-CMED,O
Service,O
for,O
further,B-TR
management,I-TR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
O-CMED,O

Service,O
.,O

He,O
was,O
placed,O
on,O
a,B-TR
patient-controlled,I-TR
analgesia,I-TR
for,O
pain,B-TR
control,I-TR
.,O

He,O
was,O
administered,O
intravenous,B-TR
fluids,I-TR
and,O
oral,O
diet,O
as,O
tolerated,O
.,O

On,O
the,O
night,O
of,O
05-01,O
",",O
the,O
patient,O
complained,O
of,O
increased,B-PR
vomiting,I-PR
.,O

"He,O
also,O
complained,O
of,O
increased,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
and,O
"",O
difficulty,B-PR
catching,I-PR
his,I-PR
breath,I-PR
.""",O

On,O
room,O
air,O
",",O
the,B-TE
patient,I-TE
's,I-TE
oxygen,I-TE
saturation,I-TE
was,O
80%,O
.,O

His,B-TE
saturation,I-TE
increased,O
to,O
87%,O
on,O
a,B-TR
nonrebreather,I-TR
.,O

A,B-TE
chest,I-TE
x-ray,I-TE
disclosed,O
a,B-PR
left,I-PR
pleural,I-PR
effusion,I-PR
.,O

The,O
patient,O
was,O
bolused,O
with,O
intravenous,B-TR
heparin,I-TR
due,O
to,O
concern,O
for,O
pulmonary,B-PR
embolism,I-PR
.,O

The,O
patient,O
expressed,O
a,O
desire,O
to,O
be,O
full,O
code,O
",",O
so,O
he,O
was,O
transferred,O
to,O
the,O
Intensive,O
Care,O
Unit,O
.,O

The,O
patient,O
became,O
more,O
comfortable,O
being,O
seated,O
upright,O
with,O
nebulizer,B-TR
treatments,I-TR
.,O

An,B-TE
angiogram,I-TE
was,O
done,O
which,O
disclosed,O
possible,O
subsegmental,B-PR
pulmonary,I-PR
emboli,I-PR
of,I-PR
the,I-PR
upper,I-PR
lobes,I-PR
as,O
well,O
as,O
infiltrates,B-PR
consistent,O
with,O
aspiration,B-PR
pneumonia,I-PR
.,O

The,O
patient,O
was,O
placed,O
on,O
Flagyl,B-TR
and,O
Levaquin,B-TR
for,O
treatment,B-TR
of,O
pneumonia,B-PR
.,O

He,O
was,O
continued,O
on,O
heparin,B-TR
for,O
treatment,B-TR
of,O
the,B-PR
pulmonary,I-PR
emboli,I-PR
.,O

While,O
in,O
the,O
Intensive,O
Care,O
Unit,O
",",O
the,O
patient,O
was,O
noted,O
to,O
have,O
increasing,B-PR
abdominal,I-PR
distention,I-PR
.,O

On,O
05-03,O
the,O
patient,O
underwent,O
an,B-TE
abdominal,I-TE
ultrasound,I-TE
with,O
paracentesis,B-TR
",",O
and,O
5,O
liters,O
of,O
fluid,B-PR
were,O
removed,O
.,O

On,O
05-04,O
",",O
the,O
patient,O
was,O
transferred,O
back,O
to,O
the,O
O-CMED,O
CSRU,O

Service,O
.,O

Due,O
to,O
persistent,B-PR
gastric,I-PR
secretions,I-PR
",",O
an,B-TR
nasogastric,I-TR
tube,I-TR
was,O
placed,O
for,O
decompression,B-TR
.,O

The,O
patient,O
was,O
noted,O
to,O
have,O
a,O
functional,O
ileus,O
.,O

Octreotide,B-TR
was,O
initiated,O
in,O
an,O
attempt,O
to,O
decrease,O
the,B-PR
gastric,I-PR
secretions,I-PR
.,O

On,O
05-13,O
",",O
the,O
patient,O
's,O
respiratory,O
status,O
declined,O
further,O
.,O

He,O
was,O
noted,O
not,O
have,O
an,B-PR
increasing,I-PR
left-sided,I-PR
pleural,I-PR
effusion,I-PR
.,O

A,B-TR
thoracentesis,I-TR
was,O
done,O
with,O
removal,B-TR
of,O
1.5,O
liters,O
of,O
fluid,B-PR
.,O

A,B-TR
paracentesis,I-TR
was,O
repeated,O
with,O
removal,B-TR
of,O
2.5,O
liters,O
of,O
fluid,B-PR
.,O

On,O
the,O
night,O
of,O
05-13,O
",",O
the,O
patient,O
continued,O
to,O
decline,O
.,O

The,O
family,O
decided,O
to,O
pursue,O
comfort,B-TR
measures,I-TR
.,O

Morphine,B-TR
was,O
administered,O
to,O
insure,O
patient,O
's,O
comfort,O
.,O

The,O
patient,O
expired,O
at,O
6,O
p.m.,O
on,O
05-14,O
.,O

FINAL,O
DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Gastrointestinal,B-PR
adenocarcinoma,I-PR
;,O
primary,O
unknown,O
(,O
likely,O
hepatobiliary,O
),O
.,O

2.,O
Aspiration,B-PR
pneumonia,I-PR
.,O

3.,O
Pulmonary,B-PR
emboli,I-PR
.,O

4.,O
Hypoxia,B-PR
.,O

5.,O
Dehydration,B-PR
.,O

6.,O
Ileus,B-PR
.,O

Pearl,O
Y.,O
Simmons,O
",",O
M.D.,O
68-957,O

Dictated,O
By,O
:,O
Lynn,O
J,O
Crump,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2012-05-14,O
19:24,O

T,O
:,O
2012-05-19,O
05:00,O

JOB,O
#,O
:,O
79196,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Catherine,O
GOLDSTEIN,O
on,O
:,O
Andrea,O
2012-06-07,O
8:18,O
AM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2019-01-09,O

Discharge,O
Date,O
:,O

2019-01-15,O

Date,O
of,O
Birth,O
:,O

1973-11-18,O

Sex,O
:,O

M,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Erythromycin,B-TR
Base,I-TR

Attending,O
:,O
Stephanie,O
I,O
Sept,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Syncope,B-PR
.,O

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

None,O
.,O

History,O
of,O
Present,O
Illness,O
:,O

45M,O
w/no,O
PMH,O
presented,O
to,O
Chelseahospital,O
after,O
a,B-PR
syncopal,I-PR
episode,I-PR
on,O
the,O
morning,O
of,O
admission,O
.,O

Pt,O
was,O
preparing,O
lunch,O
when,O
suddenly,O
felt,O
lightheaded,B-PR
/,O
faint,B-PR
and,O
immediately,O
fell,O
to,O
the,O
kitchen,O
floor,O
face,O
first,O
.,O

He,O
denies,O
LOC,B-PR
.,O

Immediately,O
there,O
after,O
he,O
was,O
very,B-PR
short,I-PR
of,I-PR
breath,I-PR
",",O
felt,O
lightheaded,B-PR
again,O
and,O
called,O
911,O
.,O

At,O
Springfield,O
",",O
CT,B-TE
chest,I-TE
was,O
positive,O
for,O
saddle,B-PR
PE,I-PR
.,O

VS,B-TE
were,O
with,O
stable,O
BPs,O
",",O
tachy,B-PR
to,O
110-120,O
",",O
sat,B-TE
98%,O
RA,O
.,O

He,O
received,O
Lovenox,B-TR
91,O
mg,O
SC,O
prior,O
to,O
transport,O
and,O
was,O
transferred,O
to,O
Arbour,O
Hospital,O
for,O
further,O
care,O
.,O

Mr.,O
Anders,O
states,O
that,O
2,O
weeks,O
prior,O
to,O
his,O
presentation,O
he,O
hurt,O
his,O
left,O
knee,O
.,O

He,O
was,O
sitting,O
on,O
the,O
floor,O
legs,O
crossed,O
and,O
stood,O
up,O
when,O
he,O
heard,O
his,O
knee,O
CMED,O
CCU,O
.,O

Then,O
again,O
on,O
Sunday,O
",",O
3,O
days,O
PTA,O
",",O
again,O
from,O
sitting,O
to,O
standing,O
heard,O
his,O
knee,O
CMED,O
CCU,O
.,O

He,O
was,O
essentially,B-PR
bed,I-PR
bound,I-PR
for,O
3,O
days,O
prior,O
to,O
admission,O
",",O
unable,B-PR
to,I-PR
ambulate,I-PR
.,O

He,O
started,O
to,O
notice,O
inflammation,B-PR
of,I-PR
his,I-PR
L,I-PR
calf,I-PR
/,I-PR
leg,I-PR
worse,O
2,O
days,O
prior,O
to,O
presentation,O
.,O

In,O
this,O
2,O
week,O
interval,O
he,O
denied,O
having,O
CP,B-PR
/,O
chest,B-PR
discomfort,I-PR
or,O
difficulty,B-PR
breathing,I-PR
",",O
no,O
cough,B-PR
or,O
hemoptysis,B-PR
.,O

No,O
f/c/,B-PR
sweats,B-PR
.,O

Pt,O
denied,O
any,B-PR
bleeding,I-PR
or,I-PR
clotting,I-PR
disorders,I-PR
and,O
has,O
never,O
had,O
a,B-PR
clot,I-PR
in,O
the,O
past,O
.,O

Past,O
Medical,O
History,O
:,O

Left,B-PR
knee,I-PR
injury,I-PR
.,O

Seasonal,B-PR
allergies,I-PR
.,O

Social,O
History,O
:,O

Family,O
History,O
:,O

-,O
M,O
:,O

HTN,B-PR
",",O
DM,B-PR

-,O
F,O
:,O

COPD,B-PR
",",O
Prostate,B-PR
CA,I-PR

-,O
Grandfather,O
died,O
of,O
MI,B-PR
at,O
age,O
75,O

Physical,O
Exam,O
:,O

VS,B-TE
:,O
99.4,O
HR,B-TE
111,O
BP,B-TE
110/64,O
RR16,B-TE
97%,O
2LNC,B-TR

GEN,O
:,O
NAD,B-PR
",",O
pleasant,O
speaking,O
in,O
full,O
sentences,O

HEENT,O
:,O
MMM,O
",",O
OP,O
clear,O
",",O
dried,B-PR
blood,I-PR
in,I-PR
nasal,I-PR
mucosa,I-PR

RESP,O
:,O
CTABL,O
",",O
no,O
crackles,B-PR
",",O
no,O
wheezing,B-PR
or,O
rhonchi,B-PR

CV,O
:,O
Reg,O
",",O
tachy,B-PR
Nml,O
S1,O
",",O
S2,O
",",O
no,O
M/R/G,B-PR

ABD,O
:,O
soft,O
ND/NT,B-PR
+BS,O

EXT,O
:,O
L,B-PR
leg/calf,I-PR
swollen,I-PR
",",O
+,O
Johnson,B-TE
sign,I-TE
",",O
not,O
tense,B-PR
",",O
no,O
cord,O
palpable,O
",",O
L,O
knee,O
w/,O
medial,B-PR
meniscus,I-PR
area,I-PR
inflammed,I-PR
",",O
not,O
warm,B-PR
",",O
no,O
crepitus,B-PR
",",O
feet-2+DP,B-TE
pulses,I-TE
b/l,O

Pertinent,O
Results,O
:,O

1.,O
CT,B-TE
OF,I-TE
HEAD,I-TE
WITHOUT,I-TE
CONTRAST,I-TE
:,O

No,O
evidence,O
of,O
acute,B-PR
intracranial,I-PR
hemorrhage,I-PR
or,O
fractures,B-PR
.,O

2.,O
ECHO,B-TE

Conclusions,O
:,O

The,O
left,O
atrium,O
is,O
normal,O
in,O
size,O
.,O

The,B-TE
estimated,I-TE
right,I-TE
atrial,I-TE
pressure,I-TE
is,O
16-20,O
mmHg,O
.,O

Left,B-TE
ventricular,I-TE
wall,I-TE
thicknesses,I-TE
are,O
normal,O
.,O

The,B-TE
left,I-TE
ventricular,I-TE
cavity,I-TE
is,O
small,O
.,O

Left,B-TE
ventricular,I-TE
systolic,I-TE
function,I-TE
is,O
hyperdynamic,B-PR
(,O
EF,B-TE
>,O
75%,O
),O
.,O

There,O
is,O
no,O
ventricular,B-PR
septal,I-PR
defect,I-PR
.,O

The,O
right,O
ventricular,O
cavity,O
is,O
mildly,B-PR
dilated,I-PR
.,O

Right,B-TE
ventricular,I-TE
systolic,I-TE
function,I-TE
is,O
borderline,O
normal,O
.,O

The,O
aortic,O
valve,O
leaflets,O
(,O
3,O
),O
appear,O
structurally,O
normal,O
with,O
good,O
leaflet,O
excursion,O
and,O
no,O
aortic,B-PR
regurgitation,I-PR
.,O

The,O
mitral,O
valve,O
leaflets,O
are,O
structurally,O
normal,O
.,O

There,O
is,O
no,O
mitral,B-PR
valve,I-PR
prolapse,I-PR
.,O

There,O
is,O
moderate,B-PR
pulmonary,I-PR
artery,I-PR
systolic,I-PR
hypertension,I-PR
.,O

There,O
is,O
no,O
pericardial,B-PR
effusion,I-PR
.,O

Impression,O
:,O
mildly,B-PR
dilated,I-PR
right,I-PR
ventricle,I-PR
;,O
small,B-PR
",",I-PR
hyperdynamic,I-PR
left,I-PR
ventricle,I-PR
;,O
at,O
least,O
moderate,B-PR
pulmonary,I-PR
hypertension,I-PR

3.,O
BILATERAL,B-TE
LENI,I-TE
's,I-TE

IMPRESSION,O
:,O

No,O
evidence,O
of,O
DVT,B-PR
in,I-PR
either,I-PR
lower,I-PR
limb,I-PR
.,O

OSH,B-TE
IMAGING,I-TE
:,O

EKG,B-TE
:,O

-,O
Sinus,B-PR
Tach,I-PR
",",O
normal,O
axis,O
HR,B-TE
119,O
ST,B-PR
Depression,I-PR
V3-V5,I-PR
;,O
S1Q3T3,B-PR
",",O
p-pulmonale,B-PR
.,O

01-11,O
MRI,B-TE
Left,I-TE
Knee,I-TE
w/o,I-TE
Contrast,I-TE

1.,O
Bucket,B-PR
handle,I-PR
medial,I-PR
meniscal,I-PR
tear,I-PR
with,O
flipped,B-PR
fragment,I-PR
in,I-PR
the,I-PR
intercondylar,I-PR
notch,I-PR
.,O

Complex,B-PR
tear,I-PR
involving,O
the,O
posterior,O
Ellison,O
and,O
body,O
.,O

2.,O
Moderate,B-PR
knee,I-PR
joint,I-PR
effusion,I-PR
with,O
possible,O
ganglion,B-PR
cyst,I-PR
at,I-PR
the,I-PR
insertion,I-PR
of,I-PR
the,I-PR
PCL,I-PR
.,O

3.,O
Discoid,B-PR
lateral,I-PR
meniscus,I-PR
.,O

Brief,O
Hospital,O
Course,O
:,O

Mr.,O
Anders,O
was,O
admitted,O
for,O
anticoagulation,B-TR
and,O
hemodynamic,B-TE
monitoring,I-TE
in,O
the,O
setting,O
of,O
saddle,B-PR
pulmonary,I-PR
embolus,I-PR
and,O
left,B-PR
knee,I-PR
injury,I-PR
.,O

#.,O
PE,B-PR
:,O

Given,O
no,O
other,O
risk,O
factors,O
or,O
likely,O
causes,O
",",O
the,O
most,O
likely,O
etiology,O
for,O
his,B-PR
embolus,I-PR
is,O
DVT,B-PR
from,I-PR
the,I-PR
left,I-PR
leg,I-PR
.,O

He,O
has,O
no,O
known,B-PR
clotting,I-PR
disorder,I-PR
but,O
did,O
have,O
trauma,B-PR
to,I-PR
leg,I-PR
prompting,O
immobility,B-PR
and,O
stasis,B-PR
.,O

He,O
remained,O
hemodynmically,O
stable,O
throughout,O
his,O
hospitalization,O
and,O
did,O
not,O
have,O
an,B-PR
oxygen,I-PR
requirement,I-PR
upon,O
discharge,O
.,O

Given,O
no,O
evidence,O
of,O
hemodynamic,B-PR
instability,I-PR
",",O
lysis,B-TR
was,O
not,O
required,O
.,O

He,O
was,O
anticoagulated,O
with,O
heparin,B-TR
and,O
coumadin,B-TR
.,O

He,O
will,O
need,O
to,O
follow,O
up,O
with,O
hematology,O
for,O
an,B-TE
outpatient,I-TE
thrombophilia,I-TE
work-up,I-TE
(,O
not,O
done,O
as,O
inpatient,O
as,O
results,O
would,O
not,O
change,O
acute,B-TR
management,I-TR
of,O
PE,B-PR
).,O

He,O
will,O
also,O
require,O
close,O
follow,O
up,O
with,O
his,O
primary,O
care,O
provider,O
for,O
coumadin,B-TR
management,I-TR
.,O

Duration,O
of,O
his,B-TR
coumadin,I-TR
therapy,I-TR
to,O
be,O
determined,O
by,O
hematology,O
",",O
but,O
likely,O
to,O
be,O
at,O
least,O
6,O
months,O
in,O
duration,O
.,O

#.,O
Syncope,B-PR
:,O

In,O
setting,O
of,O
PE,B-PR
.,O

Remainder,O
of,O
his,B-TE
cardiac,I-TE
workup,I-TE
was,O
negative,O
.,O

He,O
did,O
have,O
a,B-PR
small,I-PR
troponin,I-PR
leak,I-PR
",",O
felt,O
to,O
be,O
related,O
to,O
right,B-PR
heart,I-PR
strain,I-PR
in,O
the,O
setting,O
of,O
P-pulmonale,B-PR
related,O
to,O
clot,B-PR
burden,I-PR
.,O

His,B-TE
tronponin,I-TE
quickly,O
trended,O
down,O
and,O
he,O
did,O
not,O
have,O
EKG,B-TE
evidence,O
of,O
ischemia,B-PR
.,O

An,B-TE
ECHO,I-TE
did,O
not,O
reveal,O
any,B-PR
wall,I-PR
motion,I-PR
abnormalities,I-PR
related,O
to,O
ischemia,B-PR
.,O

#.,O
Hematocrit,B-TE
:,O

Dropped,O
from,O
42.7,O
to,O
36,O
in,O
setting,O
of,O
anticoagulation,B-TR
for,O
saddle,B-PR
PE,I-PR
and,O
IV,B-TR
fluids,I-TR
.,O

No,O
active,B-PR
bleeding,I-PR
noted,O
.,O

Pt,O
asymptomatic,B-PR
.,O

#.,O
L,B-PR
knee,I-PR
injury,I-PR
:,O

Given,O
his,O
history,O
and,O
physical,B-TE
exam,I-TE
",",O
Mr.,O
Anders,O
presented,O
with,O
an,B-PR
injury,I-PR
most,O
consistent,O
with,O
meniscal,B-PR
tear,I-PR
.,O

In,O
order,O
to,O
facilitate,O
therapy,B-TR
and,O
to,O
promote,O
mobility,O
",",O
an,B-TE
MRI,I-TE
of,I-TE
the,I-TE
knee,I-TE
was,O
done,O
.,O

He,O
was,O
seen,O
by,O
physical,O
therapy,O
and,O
will,O
need,O
to,O
follow,O
up,O
with,O
orthopaedics,O
upon,O
discharge,O
for,O
repeat,B-TE
evaluation,I-TE
.,O

#.,O
CODE,O
:,O

FULL,O
CODE,O
.,O

Medications,O
on,O
Admission,O
:,O

Discharge,O
Disposition,O
:,O

Home,O

Discharge,O
Diagnosis,O
:,O

Pulmonary,B-PR
embolus,I-PR

Left,B-PR
knee,I-PR
meniscal,I-PR
tear,I-PR

Discharge,O
Condition,O
:,O

Stable,O

Discharge,O
Instructions,O
:,O

You,O
were,O
admitted,O
to,O
the,O
hospital,O
for,O
a,B-PR
pulmonary,I-PR
embolism,I-PR
.,O

You,O
were,O
treated,O
with,O
blood,B-TR
thinners,I-TR
.,O

You,O
have,O
been,O
started,O
on,O
an,B-TR
oral,I-TR
blood,I-TR
thinner,I-TR
called,O
Coumadin,B-TR
(,I-TR
Warfarin,I-TR
).,O

Please,O
continue,O
to,O
take,O
this,B-TR
medication,I-TR
as,O
prescribed,O
.,O

You,O
must,O
have,O
your,B-TE
INR,I-TE
(,O
blood,B-TE
levels,I-TE
),O
checked,O
on,O
a,O
regular,O
basis,O
until,O
your,B-TE
INR,I-TE
levels,I-TE
remain,O
01-19,O
.,O

The,B-TE
MRI,I-TE
of,I-TE
your,I-TE
knee,I-TE
showed,O
a,B-PR
meniscal,I-PR
tear,I-PR
.,O

Please,O
schedule,O
an,O
appointment,O
with,O
your,O
orthopedic,O
surgeon,O
to,O
determine,O
a,O
plan,O
for,O
treatment,B-TR
.,O

Please,O
follow-up,O
with,O
your,O
Primary,O
Care,O
doctor,O
Marion,O
Bock,O
as,O
below,O
.,O

Please,O
return,O
to,O
the,O
hospital,O
if,O
you,O
experience,O
chest,B-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
lightheadedness,B-PR
or,O
dizziness,B-PR
.,O

Followup,O
Instructions,O
:,O

Please,O
follow-up,O
with,O
your,O
Primary,O
care,O
doctor,O
Larry,O
Bock,O
2019-01-16,O
at,O
8:30,O
AM,O
.,O

At,O
this,O
appointment,O
",",O
you,O
should,O
confirm,O
orthopedic,O
follow-up,O
and,O
request,O
a,O
hematology,O
referral,O
.,O

Call,O
to,O
reschedule,O
.,O

Heidi,O
Laura,O
MD,O
44-725,O

Completed,O
by,O
:,O
Daniel,O
Tapaha,O
MD,O
73-060,O
2019-01-15,O
@,O
0918,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Steven,O
W.,O
Weekley,O
on,O
:,O
Sandra,O
2019-01-15,O
10:22,O
AM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2012-05-21,O

Discharge,O
Date,O
:,O

2012-05-25,O

Date,O
of,O
Birth,O
:,O

1957-01-05,O

Sex,O
:,O

F,O

Service,O
:,O

CMED,O
CCU,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
55-year-old,O
female,O
with,O
multiple,O
prior,O
admissions,O
for,O
pneumonia,B-PR
",",O
COPD,B-PR
",",O
asthma,B-PR
exacerbation,I-PR
",",O
over,O
3,O
weeks,O
of,O
upper,B-PR
respiratory,I-PR
like,I-PR
infection,I-PR
unremitting,O
with,O
increased,B-TR
nebulizer,I-TR
treatments,I-TR
at,O
home,O
.,O

The,O
patient,O
saw,O
her,O
PCP,O
and,O
was,O
known,O
to,O
have,O
an,B-TE
oxygen,I-TE
saturation,I-TE
of,O
82,O
to,O
85,O
percent,O
on,O
room,O
air,O
.,O

She,O
was,O
referred,O
to,O
the,O
Emergency,O
Department,O
.,O

In,O
the,O
Emergency,O
Department,O
",",O
the,O
patient,O
received,O
Zithromax,B-TR
",",O
ceftriaxone,B-TR
",",O
and,O
Flagyl,B-TR
.,O

Chest,B-TE
x-ray,I-TE
was,O
remarkable,O
for,O
a,O
questionable,O
left,B-PR
lower,I-PR
lobe,I-PR
infiltrate,I-PR
.,O

The,O
patient,O
received,O
nebulizer,B-TR
treatment,I-TR
with,O
oxygen,B-TE
saturations,I-TE
increasing,O
up,O
to,O
98,O
percent,O
on,O
room,O
air,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Asthma,B-PR
/,O
COPD,B-PR
on,O
BiPAP,B-TR
",",O
history,O
of,O
intubation,B-TR
.,O

Restrictive,B-PR
lung,I-PR
disease,I-PR
.,O

Chronic,B-PR
inflammatory,I-PR
demyelinating,I-PR
polyradiculopathy,I-PR
.,O

Gastritis,B-PR
and,O
duodenitis,B-PR
.,O

Question,O
of,O
Tyrone,B-PR
esophagus,I-PR
.,O

Chronic,B-PR
abdominal,I-PR
pain,I-PR
.,O

Neurogenic,B-PR
bladder,I-PR
.,O

Chronic,B-PR
muscle,I-PR
spasms,I-PR
.,O

Coronary,B-PR
artery,I-PR
disease,I-PR
status,O
post,O
negative,O
stress,B-TE
echo,I-TE
on,O
10-12,O
.,O

History,O
of,O
syncope,B-PR
.,O

Adrenal,B-PR
insufficiency,I-PR
.,O

Hypercholesterolemia,B-PR
.,O

Depression,B-PR
and,O
anxiety,B-PR
.,O

Hyperthyroidism,B-PR
.,O

IgG,B-PR
deficiency,I-PR
.,O

Status,O
post,O
cholecystectomy,B-TR
and,O
appendectomy,B-TR
.,O

Anemia,B-PR
of,O
chronic,B-PR
disease,I-PR
.,O

ALLERGIES,O
:,O

AZMACORT,B-TR
",",O
CLINDAMYCIN,B-TR
",",O
VERSED,B-TR
",",O
FENTANYL,B-TR
",",O
and,O
MORPHINE,B-TR
.,O

SOCIAL,O
HISTORY,O
:,O

History,O
of,O
20-to-30-pack-year,O
smoking,O
",",O
quit,O
approximately,O
15,O
years,O
ago,O
.,O

She,O
denies,O
any,O
alcohol,O
or,O
drug,O
use,O
.,O

Married,O
with,O
children,O
",",O
wheelchair,B-PR
bound,I-PR
mostly,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

From,O
admission,O
",",O
vital,B-TE
signs,I-TE
98.3,O
",",O
blood,B-TE
pressure,I-TE
128/74,O
",",O
68,O
to,O
112,O
is,O
her,B-TE
heart,I-TE
rate,I-TE
",",O
respiratory,B-TE
rate,I-TE
24,O
",",O
100,O
percent,O
on,O
room,O
air,O
.,O

General,O
:,O

She,O
is,O
a,O
chronically,O
ill-appearing,O
female,O
",",O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

HEENT,O
:,O

Benign,O
.,O

Cardiac,B-TE
exam,I-TE
:,O

Normal,O
.,O

Pulmonary,B-TE
exam,I-TE
:,O

Diffuse,B-PR
bronchial,I-PR
breath,I-PR
sounds,I-PR
",",O
no,O
wheezes,B-PR
.,O

Abdominal,B-TE
exam,I-TE
:,O

Benign,O
.,O

Extremity,B-TE
exam,I-TE
:,O

No,O
edema,B-PR
.,O

Left,B-PR
lower,I-PR
extremity,I-PR
and,I-PR
left,I-PR
upper,I-PR
extremity,I-PR
weaker,I-PR
at,O
3/5,O
compared,O
to,O
right,O
upper,O
extremity,O
and,O
right,O
lower,O
extremity,O
",",O
chronic,O
according,O
to,O
the,O
patient,O
.,O

MEDICATIONS,O
:,O

On,O
admission,O

1.,O
Vitamin,B-TR
D,I-TR
400,O
mg,O
q.d.,O

2.,O
Levoxyl,B-TR
50,O
mcg,O
q.d.,O

3.,O
Baclofen,B-TR
20,O
mg,O
p.o.,O
t.i.d.,O

4.,O
Florinef,B-TR
0.1,O
mg,O
p.o.,O
q.a.m.,O

5.,O
Klonopin,B-TR
2,O
mg,O
t.i.d.,O

6.,O
BuSpar,B-TR
10,O
mg,O
t.i.d.,O

7.,O
Zanaflex,B-TR
8,O
mg,O
q.4,O
h.,O

8.,O
Oxazepam,B-TR
30,O
mg,O
p.r.n.,O

9.,O
Singulair,B-TR
10,O
mg,O
q.p.m.,O

10.,O
Lipitor,B-TR
10,O
mg,O
q.p.m.,O

11.,O
Ativan,B-TR
2,O
mg,O
p.r.n.,O

12.,O
Protonix,B-TR
20,O
mg,O
p.o.,O
b.i.d.,O

13.,O
Sucralfate,B-TR
2,O
mg,O
b.i.d.,O

14.,O
Albuterol,B-TR
nebulizer,I-TR
q.03-14,O
h.,O
p.r.n.,O

15.,O
Pamidronate,B-TR
30,O
mg,O
IV,O
every,O
month,O
.,O

HOSPITAL,O
COURSE,O
:,O

Shortness,B-PR
of,I-PR
breath,I-PR
.,O

The,O
patient,O
was,O
maintained,O
on,O
albuterol,B-TR
nebulizer,I-TR
treatments,I-TR
and,O
Ipratropium,B-TR
nebulizer,I-TR
treatments,I-TR
",",O
as,O
this,O
was,O
apparently,O
thought,O
to,O
be,O
related,O
to,O
her,B-PR
chronic,I-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
.,O

Given,O
the,O
presence,O
of,O
consolidation,B-PR
on,O
chest,B-TE
x-ray,I-TE
",",O
however,O
",",O
and,O
previous,O
history,O
of,O
pneumonia,B-PR
",",O
the,O
patient,O
was,O
maintained,O
on,O
antibiotics,B-TR
of,O
Zithromax,B-TR
500,O
mg,O
daily,O
and,O
ceftriaxone,B-TR
.,O

The,O
patient,O
was,O
also,O
started,O
on,O
Solu-Medrol,B-TR
IV,I-TR
for,O
active,B-PR
airway,I-PR
disease,I-PR
component,I-PR
of,O
her,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
.,O

The,O
patient,O
was,O
maintained,O
on,O
supplemental,B-TR
oxygen,I-TR
and,O
sputum,O
production,O
was,O
maximized,O
with,O
the,O
help,O
of,O
an,B-TR
Acapella,I-TR
device,I-TR
and,O
respiratory,B-TR
therapy,I-TR
.,O

Mucomyst,B-TR
was,O
also,O
considered,O
as,O
a,B-TR
mucolytic,I-TR
component,I-TR
towards,O
secretions,B-PR
.,O

Adrenal,B-PR
insufficiency,I-PR
.,O

The,O
patient,O
was,O
maintained,O
on,O
IV,B-TR
Solu,I-TR
-,I-TR
Medrol,I-TR
60,O
mg,O
q.,O
8,O
h.,O

Chest,B-PR
soreness,I-PR
.,O

The,O
patient,O
describes,O
chest,B-PR
discomfort,I-PR
without,O
any,B-PR
significant,I-PR
EKG,I-PR
changes,I-PR
.,O

The,O
patient,O
was,O
maintained,O
on,O
Percocet,B-TR
p.r.n.,O
for,O
pain,B-TR
relief,I-TR
.,O

This,O
was,O
thought,O
to,O
be,O
related,O
to,O
musculoskeletal,O
.,O

There,O
was,O
no,O
evidence,O
of,O
acute,B-PR
rib,I-PR
factors,I-PR
on,O
her,B-TE
chest,I-TE
x-ray,I-TE
.,O

GI,O
.,O

The,O
patient,O
was,O
maintained,O
on,O
PPI,B-TR
for,O
reflux,B-PR
disease,I-PR
and,O
known,B-PR
gastritis,I-PR
.,O

CMED,O
.,O

The,O
patient,O
has,O
a,O
history,O
of,O
neurogenic,B-PR
bladder,I-PR
and,O
",",O
therefore,O
",",O
she,O
required,O
a,B-TR
Foley,I-TR
catheterization,I-TR
.,O

Endocrine,O
.,O

The,O
patient,O
was,O
on,O
Levoxyl,B-TR
at,O
home,O
as,O
her,O
home,O
dose,O
for,O
hyperthyroidism,B-PR
.,O

CMED,O
CSRU,O
transfer,O
.,O

The,O
patient,O
was,O
transferred,O
on,O
the,O
evening,O
of,O
2012-05-22,O
to,O
the,O
ICU,O
given,O
persistent,B-PR
carbon,I-PR
dioxide,I-PR
retention,I-PR
and,O
respiratory,B-PR
acidosis,I-PR
and,O
the,B-PR
intermittent,I-PR
mental,I-PR
status,I-PR
changes,I-PR
.,O

The,O
patient,O
had,O
had,O
ABG,B-TE
on,O
the,O
floor,O
",",O
which,O
prompted,O
her,O
to,O
transfer,O
to,O
the,O
ICU,O
.,O

Her,B-TE
pH,I-TE
was,O
7.23,O
",",O
PCO2,B-TE
73,O
",",O
PO2,B-TE
146,O
on,O
a,B-TR
nonrebreather,I-TR
.,O

The,O
patient,O
had,O
BiPAP,B-TR
initiated,O
once,O
she,O
reached,O
the,O
unit,O
",",O
but,O
did,O
not,O
tolerate,O
it,O
",",O
becoming,O
apneic,B-PR
and,O
obstructing,B-PR
.,O

The,O
patient,O
was,O
switched,O
to,O
2,B-TR
liters,I-TR
nasal,I-TR
cannula,I-TR
and,O
oxygen,O
saturating,O
at,O
98,O
to,O
100,O
percent,O
.,O

After,O
BiPAP,B-TR
was,O
initiated,O
",",O
the,O
patient,O
became,O
hypotensive,B-PR
down,O
to,O
75/28,O
and,O
bradycardiac,B-PR
",",O
responding,O
to,O
3,B-TR
fluid,I-TR
boluses,I-TR
over,O
the,O
course,O
of,O
the,O
night,O
.,O

The,O
patient,O
was,O
started,O
on,O
Florinef,B-TR
for,O
concern,O
of,O
adrenal,B-PR
insufficiency,I-PR
;,O
however,O
",",O
she,O
was,O
hemodynamically,O
stable,O
that,O
morning,O
and,O
was,O
transferred,O
back,O
out,O
to,O
the,O
floor,O
.,O

It,O
was,O
thought,O
that,O
the,O
patient,O
may,O
have,O
been,O
mucous,B-PR
plugging,I-PR
during,O
her,O
stay,O
in,O
the,O
ICU,O
.,O

Hematologic,O
.,O

The,O
patient,O
has,O
a,O
history,O
of,O
high,B-PR
MCV,I-PR
and,O
megaloblastic,B-PR
cells,I-PR
on,O
smear,B-TE
in,O
the,O
setting,O
of,O
anemia,B-PR
;,O
question,O
B12,B-PR
deficiency,I-PR
",",O
the,O
patient,O
also,O
has,O
a,O
history,O
of,O
borderline,B-PR
low,I-PR
B12,I-PR
levels,I-PR
.,O

The,O
patient,O
was,O
diagnosed,O
for,O
B12,B-PR
deficiency,I-PR
due,O
to,O
her,O
long,O
history,O
of,O
poor,B-PR
p.o.,I-PR
intake,I-PR
.,O

Methylmalonic,B-TE
acid,I-TE
levels,I-TE
were,O
sent,O
",",O
the,O
results,O
are,O
pending,O
at,O
the,O
time,O
of,O
discharge,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

Asthma,B-PR
flare,I-PR
and,O
bronchitis,B-PR
.,O

Chronic,B-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
.,O

Demyelinating,B-PR
polyradiculopathy,I-PR
.,O

Anxiety,B-PR
disorder,I-PR
.,O

Chronic,B-PR
abdominal,I-PR
pain,I-PR
.,O

DISCHARGE,O
STATUS,O
:,O

The,O
patient,O
will,O
be,O
discharged,O
to,O
home,O
.,O

DISCHARGE,O
CONDITION,O
:,O

The,O
patient,O
is,O
stable,O
without,O
an,B-PR
oxygen,I-PR
requirement,I-PR
.,O

DISCHARGE,O
FOLLOWUP,O
:,O

The,O
patient,O
is,O
instructed,O
to,O
followup,O
with,O
her,O
doctor,O
in,O
1,O
to,O
2,O
weeks,O
of,O
discharge,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Cholecalciferol,B-TR
.,O

2.,O
Vitamin,B-TR
D,I-TR
.,O

3.,O
Levothyroxine,B-TR
50,O
mcg,O
p.o.,O
q.d.,O

4.,O
Baclofen,B-TR
10,O
mg,O
p.o.,O
t.i.d.,O

5.,O
Clonazepam,B-TR
1,O
mg,O
p.o.,O
t.i.d.,O

6.,O
Buspirone,B-TR
10,O
mg,O
p.o.,O
t.i.d.,O

7.,O
Montelukast,B-TR
sodium,I-TR
10,O
mg,O
p.o.,O
q.h.s.,O

8.,O
Atorvastatin,B-TR
10,O
mg,O
p.o.,O
q.h.s.,O

9.,O
Protonix,B-TR
40,O
mg,O
p.o.,O
q.d.,O

10.,O
Albuterol,B-TR
sulfate,I-TR
solution,I-TR
q.05-15,O
h.,O
p.r.n.,O
for,O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

11.,O
Tizanidine,B-TR
8,O
mg,O
p.o.,O
q.6,O
h.,O

12.,O
Acetaminophen,B-TR
p.r.n.,O

13.,O
Prednisone,B-TR
taper,I-TR
for,O
3,O
days,O
.,O

14.,O
Levofloxacin,B-TR
500,O
mg,O
p.o.,O
q.d.,O
for,O
10,O
more,O
days,O
.,O

15.,O
Florinef,B-TR
Acetate,I-TR
0.1,O
mg,O
p.o.,O
q.d.,O

James,O
Grunow,O
",",O
M.D.,O
53-506,O

Dictated,O
By,O
:,O
Elizabeth,O
A,O
Eaton,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2012-08-01,O
12:27:33,O

T,O
:,O
2012-08-01,O
20:27:59,O

Job,O
#:,O

33698,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Kenneth,O
Wilford,O
on,O
:,O
Maxine,O
2012-08-16,O
12:22,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2019-06-14,O

Discharge,O
Date,O
:,O

2019-06-19,O

Date,O
of,O
Birth,O
:,O

1968-01-21,O

Sex,O
:,O

M,O

Service,O
:,O

MEDICINE,B-TR

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,O
Drugs,B-TR

Attending,O
:,O
Michael,O
A.E.,O
Adkins,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Shortness,B-PR
of,I-PR
breath,I-PR
",",O
fever,B-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

None,O

History,O
of,O
Present,O
Illness,O
:,O

Mr.,O
Mcelveen,O
is,O
a,O
51,O
year-old,O
male,O
with,O
metastatic,B-PR
RCC,I-PR
status,O
post,O
left,B-TR
radical,I-TR
nephrectomy,I-TR
in,O
2018-03-21,O
",",O
status,O
post,O
Avastin,B-TR
and,O
sorafenib,B-TR
",",O
most,O
recently,O
on,O
Sutent,B-TR
monotherapy,I-TR
since,O
2018-12-21,O
",",O
with,O
mild,B-PR
renal,I-PR
insufficiency,I-PR
",",O
who,O
presented,O
from,O
home,O
on,O
2019-06-14,O
with,O
shortness,B-PR
of,I-PR
breath,I-PR
and,O
fever,B-PR
.,O

Of,O
note,O
",",O
he,O
was,O
hospitalized,O
at,O
Dana-Farber,O
Cancer,O
Institute,O
from,O
9/25-10/6,O
with,O
chest,B-PR
pain,I-PR
",",O
at,O
which,O
time,O
he,O
reportedly,O
had,O
cardiac,B-TE
enzymes,I-TE
",",O
an,B-TE
echocardiogram,I-TE
and,O
a,B-TE
pharmacological,I-TE
stress,I-TE
test,I-TE
performed,O
.,O

It,O
is,O
unclear,O
from,O
history,O
what,O
these,B-TE
studies,I-TE
revealed,O
.,O

He,O
reports,O
that,O
he,O
felt,O
fatigued,B-PR
during,O
the,O
week,O
prior,O
to,O
the,O
current,O
admission,O
.,O

On,O
the,O
day,O
of,O
admission,O
",",O
he,O
felt,O
"",O
congested,B-PR
"",O
in,O
his,O
chest,O
",",O
and,O
had,O
a,B-PR
new,I-PR
fever,I-PR
.,O

He,O
was,O
taken,O
to,O
the,O
Deanna,O
by,O
his,O
wife,O
.,O

Patrick,O
reports,O
a,B-PR
mild,I-PR
cough,I-PR
for,O
2,O
days,O
PTA,O
",",O
non-productive,B-PR
.,O

He,O
denies,O
a,O
history,O
of,O
aspiration,B-PR
events,I-PR
or,O
choking,B-PR
with,O
food,O
intake,O
.,O

He,O
describes,O
mild,B-PR
reflux,I-PR
symptoms,I-PR
at,O
night,O
.,O

Further,B-TE
ROS,I-TE
reveals,O
mild,B-PR
SOB,I-PR
in,O
the,O
days,O
preceding,O
admission,O
",",O
but,O
he,O
tells,O
me,O
that,O
he,O
was,O
surprised,O
to,O
find,O
out,O
about,O
his,B-PR
low,I-PR
oxygen,I-PR
saturation,I-PR
because,O
he,O
did,O
not,O
feel,O
that,O
bad,O
.,O

He,O
denies,O
chills,B-PR
",",O
no,O
chest,B-PR
pain,I-PR
",",O
no,O
LE,B-PR
swelling,I-PR
.,O

In,O
the,O
Deanna,O
",",O
Tmax,B-TE
102.8,O
",",O
BP,B-TE
100,O
-,O
140/60,O
"s,",O
HR,B-TE
80,O
"s,",O
RR,B-TE
20,O
"s,",O
Sat,B-TE
75%,O
on,O
RA,B-TR
in,O
triage,O
",",O
up,O
to,O
100%,O
on,O
NRB,B-TR
.,O

CXR,B-TE
with,O
bibasilar,B-PR
consolidations,I-PR
.,O

He,O
was,O
given,O
Levo,B-TR
750,O
mg,O
PO,O
X1,O
",",O
and,O
Flagyl,B-TR
500,O
mg,O
PO,O
X1,O
.,O

His,B-TE
BP,I-TE
decreased,O
to,O
100,O
systolic,O
despite,O
hydration,B-TR
with,O
2L,O
of,O
NS,B-TR
.,O

He,O
was,O
subsquently,O
admitted,O
to,O
the,O
ICU,O
for,O
further,B-TR
care,I-TR
.,O

He,O
was,O
placed,O
on,O
Levo,B-TR
and,O
Ceftriaxone,B-TR
.,O

A,B-TE
cosyntropin,I-TE
stimulation,I-TE
test,I-TE
revealed,O
cortisol,B-TE
32.1,O
-->,O
36.4,O
.,O

His,B-PR
oxygen,I-PR
requirement,I-PR
decreased,O
",",O
and,O
his,O
overall,O
status,O
improved,O
quickly,O
.,O

He,O
is,O
being,O
transferred,O
to,O
the,O
floor,O
for,O
ongoing,B-TR
care,I-TR
.,O

Past,O
Medical,O
History,O
:,O

1.,O
Metastatic,B-PR
renal,I-PR
cell,I-PR
carcinoma,I-PR
",",O
diagnosed,O
in,O
2018-03-21,O
",",O
status,O
post,O
left,B-TR
radical,I-TR
nephrectomy,I-TR
at,O
St.,O
Margaret's,O
Center,O
for,O
Women,O
&,O
Infants,O
in,O
03/2006,O
.,O

Path,O
consistent,O
with,O
renal,B-PR
cell,I-PR
carcinoma,I-PR
of,I-PR
chromophobe,I-PR
type,I-PR
with,O
Carter,B-PR
nuclear,I-PR
grade,I-PR
of,O
4/4,O
.,O

Lymphovascular,B-PR
invasion,I-PR
was,O
present,O
.,O

He,O
later,O
presented,O
with,O
increasing,B-PR
back,I-PR
pain,I-PR
",",O
and,O
metastatic,B-PR
disease,I-PR
was,O
documented,O
.,O

He,O
is,O
status,O
post,O
Avastin,B-TR
plus,O
sorafenib,B-TR
",",O
protocol,O
#04-393,O
",",O
discontinued,O
in,O
the,O
setting,O
of,O

ongoing,B-PR
grade,I-PR
III,I-PR
rash,I-PR
",",O
involving,O
the,O
hands,O
and,O
feet,O
in,O
addition,O
proteinuria,B-PR
secondary,O
to,O
the,O
Avastin,B-TR
.,O

He,O
has,O
been,O
maintained,O
on,O
single,B-TR
Timlin,I-TR
therapy,I-TR
with,O
Sutent,B-TR
50,O
mg,O
daily,O
as,O
of,O
2018-12-21,O
and,O
has,O
completed,O
nearly,O
6,O
cycles,O
.,O

He,O
has,O
mild,B-PR
renal,I-PR
insufficiency,I-PR
in,O
the,O
setting,O
of,O
Sutent,B-TR
.,O

2.,O
Seasonal,B-PR
allergies,I-PR

Social,O
History,O
:,O

He,O
lives,O
at,O
home,O
with,O
his,O
wife,O
and,O
son,O
",",O
who,O
is,O
7,O
years,O
old,O
.,O

He,O
works,O
in,O
real,O
estate,O
development,O
and,O
invests,O
in,O
stockmarket,O
.,O

HE,O
is,O
a,O
lifelong,O
non-smoker,O
.,O

Family,O
History,O
:,O

Not,O
reviewed,O
with,O
patient,O
.,O

Physical,O
Exam,O
:,O

VITALS,B-TE
:,O
T,B-TE
96.9,O
",",O
BP,B-TE
110/70,O
",",O
HR,B-TE
84,O
",",O
RR,B-TE
20,O
",",O
Sat,B-TE
97%,O
on,O
4L,O
.,O

GEN,O
:,O
In,O
NAD,B-PR
.,O

HEENT,O
:,O
Flushed,B-PR
cheeks,I-PR
.,O

Slightly,B-PR
dry,I-PR
MM,I-PR
.,O

NECK,O
:,O
JVP,B-TE
not,O
elevated,B-PR
.,O

RESP,O
:,O
Decreased,B-PR
air,I-PR
entry,I-PR
and,O
crackles,B-PR
at,I-PR
both,I-PR
lung,I-PR
bases,I-PR
.,O

+,O
Egophony,B-PR
.,O

CVS,O
:,O
RRR,O
.,O
Normal,O
S1,O
",",O
S2,O
.,O

No,O
S3,B-PR
",",O
S4,B-PR
.,O

No,O
murmur,B-PR
or,O
rub,B-PR
.,O

GI,O
:,O
BS,O
NA,O
.,O

Abdomen,O
soft,O
and,O
non-tender,B-PR
.,O

EXT,O
:,O
Without,O
edema,B-PR
.,O

Good,O
pedal,O
pulses,O
.,O

Pertinent,O
Results,O
:,O

Laboratory,O
results,O
:,O

2019-06-14,O
10:30,O
AM,O
BLOOD,O
WBC,B-TE
-,O
8.0,O
RBC,B-TE
-,O
4.22,O
*,O
Hgb,B-TE
-,O
12.9,O
*,O
Hct,B-TE
-,O
41.7,O
MCV,B-TE
-,O
99,O
*,O
MCH,B-TE
-,O
30.5,O
MCHC,B-TE
-,O
30.8,O
*,O
RDW,B-TE
-,O
16.8,O
*,O
Plt,B-TE
Ct,I-TE
-,O
797,O
*#,O

2019-06-19,O
07:20,O
AM,O
BLOOD,O
WBC,B-TE
-,O
11.1,O
*,O
RBC,B-TE
-,O
3.47,O
*,O
Hgb,B-TE
-,O
10.9,O
*,O
Hct,B-TE
-,O
34.1,O
*,O
MCV,B-TE
-,O
98,O
MCH,B-TE
-,O
31.3,O
MCHC,B-TE
-,O
31.9,O
RDW,B-TE
-,O
16.7,O
*,O
Plt,B-TE
Ct,I-TE
-,O
604,O
*,O

2019-06-14,O
10:30,O
AM,O
BLOOD,O
PT,B-TE
-,O
11.2,O
PTT,B-TE
-,O
23.9,O
INR(PT),B-TE
-,O
0.9,O

2019-06-14,O
10:30,O
AM,O
BLOOD,O
Plt,B-TE
Ct,I-TE
-,O
797,O
*#,O

2019-06-14,O
10:30,O
AM,O
BLOOD,O
Glucose,B-TE
-,O
134,O
*,O
UreaN,B-TE
-,O
39,O
*,O
Creat,B-TE
-,O
2.1,O
*,O
Na,B-TE
-,O
133,O
K,B-TE
-,O
7.9,O
*,O
Cl,B-TE
-,O
94,O
*,O
HCO3,B-TE
-,O
28,O
AnGap,B-TE
-,O
19,O

2019-06-19,O
07:20,O
AM,O
BLOOD,O
Glucose,B-TE
-,O
73,O
UreaN,B-TE
-,O
20,O
Creat,B-TE
-,O
1.1,O
Na,B-TE
-,O
136,O
K,B-TE
-,O
5.0,O
Cl,B-TE
-,O
101,O
HCO3,B-TE
-,O
27,O
AnGap,B-TE
-,O
13,O

2019-06-14,O
10:30,O
AM,O
BLOOD,O
ALT,B-TE
-,O
34,O
AST,B-TE
-,O
167,O
*,O
CK(CPK),B-TE
-,O
313,O
*,O
AlkPhos,B-TE
-,O
383,O
*,O
Amylase,B-TE
-,O
44,O
TotBili,B-TE
-,O
0.7,O

2019-06-14,O
06:03,O
PM,O
BLOOD,O
CK(CPK),B-TE
-,O
194,O
*,O

2019-06-14,O
10:30,O
AM,O
BLOOD,O
CK-MB,B-TE
-,O
3,O
cTropnT,B-TE
-,O
0.05,O
*,O

2019-06-14,O
06:03,O
PM,O
BLOOD,O
CK-MB,B-TE
-4,O
cTropnT,B-TE
-,O
0.03,O
*,O

2019-06-17,O
05:30,O
AM,O
BLOOD,O
proBNP,B-TE
-,O
258,O
*,O

2019-06-14,O
06:03,O
PM,O
BLOOD,O
Calcium,B-TE
-,O
8.3,O
*,O
Phos,B-TE
-,O
4.3,O
Mg,B-TE
-,O
1.9,O

2019-06-18,O
07:55,O
AM,O
BLOOD,O
calTIBC,B-TE
-,O
229,O
Ferritn,B-TE
-,O
GREATER,O
TH,O
TRF,O
-,O
176,O
*,O

2019-06-16,O
07:35,O
AM,O
BLOOD,O
TSH,B-TE
-,O
43,O
*,O

2019-06-16,O
07:35,O
AM,O
BLOOD,O
Free,B-TE
T4,I-TE
-,O
0.36,O
*,O

2019-06-19,O
07:20,O
AM,O
BLOOD,O
WBC,B-TE
-,O
11.1,O
*,O
RBC,B-TE
-,O
3.47,O
*,O
Hgb,B-TE
-,O
10.9,O
*,O
Hct,B-TE
-,O
34.1,O
*,O
MCV,B-TE
-,O
98,O
MCH,B-TE
-,O
31.3,O
MCHC,B-TE
-,O
31.9,O
RDW,B-TE
-,O
16.7,O
*,O
Plt,B-TE
Ct,I-TE
-,O
604,O
*,O

2019-06-19,O
07:20,O
AM,O
BLOOD,O
Neuts,B-TE
-,O
77.0,O
*,O
Bands,B-TE
-,O
5.0,O
Lymphs,B-TE
-,O
11.0,O
*,O
Monos,B-TE
-,O
3.0,O
Eos,B-TE
-,O
0,O
Baso,B-TE
-,O
0,O
Atyps,B-TE
-,O
1.0,O
*,O
Metas,B-TE
-,O
2.0,O
*,O
Myelos,B-TE
-,O
1.0,O
*,O

2019-06-18,O
07:55,O
AM,O
BLOOD,O
PT,B-TE
-,O
11.5,O
INR(PT),B-TE
-,O
1.0,O

2019-06-19,O
07:20,O
AM,O
BLOOD,O
Glucose,B-TE
-,O
73,O
UreaN,B-TE
-,O
20,O
Creat,B-TE
-,O
1.1,O
Na,B-TE
-,O
136,O
K,B-TE
-,O
5.0,O
Cl,B-TE
-,O
101,O
HCO3,B-TE
-,O
27,O
AnGap,B-TE
-,O
13,O

2019-06-19,O
07:20,O
AM,O
BLOOD,O
Calcium,B-TE
-,O
8.0,O
*,O
Phos,B-TE
-,O
3.3,O
Mg,B-TE
-,O
2.0,O

Relevant,O
Imaging,O
:,O

1),O
Bilateral,B-TE
LE,I-TE
doppler,I-TE
(,O
06-14,O
):,O
No,O
evidence,O
of,O
deep,B-PR
venous,I-PR
thrombosis,I-PR
in,I-PR
the,I-PR
lower,I-PR
extremities,I-PR
bilaterally,I-PR
.,O

2),O
Cxray,B-TE
(,O
06-14,O
):,O
New,B-PR
bibasilar,I-PR
consolidations,I-PR
are,O
demonstrated,O
accompanied,O
by,O
bilateral,B-PR
small,I-PR
pleural,I-PR
effusion,I-PR
.,O

The,O
lung,O
volumes,O
are,O
slightly,B-PR
increased,I-PR
.,O

There,O
is,O
no,O
pneumothorax,B-PR
identified,O
.,O

3),O
CT,B-TE
Torso,I-TE
(,O
06-17,O
):,O

1.,O
Marked,B-PR
interval,I-PR
enlargement,I-PR
of,I-PR
the,I-PR
cardiac,I-PR
silhouette,I-PR
.,O

Together,O
with,O
the,O
interval,O
development,O
of,O
bilateral,B-PR
pleural,I-PR
effusions,I-PR
",",O
this,O
indicates,O
cardiac,B-PR
insufficiency,I-PR
(,O
or,O
alternatively,O
volume,B-PR
overload,I-PR
),O
and,O
an,B-TE
echocardiogram,I-TE
may,O
be,O
indicated,O
for,O
further,B-TE
evaluation,I-TE
.,O

2.,O
Bilateral,B-PR
basilar,I-PR
compressive,I-PR
atelectasis,I-PR
.,O

Superimposed,B-PR
infectious,I-PR
consolidation,I-PR
is,O
likely,O
.,O

3.,O
Interval,O
development,O
of,O
tree-in-Eric,B-PR
nodular,I-PR
opacities,I-PR
and,O
scattered,B-PR
ground,I-PR
glass,I-PR
opacities,I-PR
involving,I-PR
the,I-PR
right,I-PR
lung,I-PR
",",O
concerning,O
for,O
an,B-PR
infectious,I-PR
process,I-PR
.,O

The,O
differential,O
diagnosis,O
of,O
this,O
is,O
wide,O
including,O
viral,B-PR
",",I-PR
fungal,I-PR
and,I-PR
atypical,I-PR
mycobacterial,I-PR
infections,I-PR
.,O

Drug,B-PR
toxicity,I-PR
would,O
be,O
a,O
consideration,O
",",O
although,O
somewhat,O
less,O
likely,O
given,O
the,O
unilaterality,O
of,O
the,O
findings,O
.,O

4.,O
New,B-PR
jejunal,I-PR
wall,I-PR
thickening,I-PR
with,O
persistent,B-PR
distal,I-PR
ileal,I-PR
wall,I-PR
thickening,I-PR
and,O
diffuse,B-PR
mesenteric,I-PR
stranding,I-PR
",",O
most,O
likely,O
reflecting,O
an,B-PR
infectious,I-PR
etiology,I-PR
.,O

5.,O
Overall,O
stability,O
in,O
metastatic,B-PR
burden,I-PR
.,O

4),O
ECHO,B-TE
(,O
06-18,O
):,O
Mild,B-PR
symmetric,I-PR
left,I-PR
ventricular,I-PR
hypertrophy,I-PR
with,O
preserved,O
biventricular,O
systolic,O
function,O
.,O

Mild,B-PR
posterior,I-PR
mitral,I-PR
valve,I-PR
prolapse,I-PR
with,O
mild,B-PR
mitral,I-PR
regurgitation,I-PR
.,O

Small,B-PR
(,I-PR
0.6,I-PR
cm,I-PR
),I-PR
circumferential,I-PR
pericardial,I-PR
effusion,I-PR
",",O
largest,O
around,O
the,O
left,O
atrium,O
.,O

5),O
L,B-TE
femur,I-TE
xray,I-TE
(,O
06-18,O
):,O
Predominantly,B-PR
sclerotic,I-PR
lesion,I-PR
with,O
interval,B-PR
periosteal,I-PR
new,I-PR
bone,I-PR
formation,I-PR
involving,O
the,O
intertrochanteric,O
and,O
subtrochanteric,O
regions,O
.,O

No,O
displaced,B-PR
fracture,I-PR
is,O
demonstrated,O
.,O

Brief,O
Hospital,O
Course,O
:,O

Mr.,O
Mcelveen,O
51,O
year-old,O
male,O
with,O
metastatic,B-PR
RCC,I-PR
on,O
Sutent,B-TR
since,O
2018-12-21,O
",",O
admitted,O
with,O
fever,B-PR
",",O
hypoxemia,B-PR
",",O
and,O
bibasilar,B-PR
pneumonia,I-PR
.,O

1),O
Bibasilar,B-PR
pneumonia,I-PR
:,O
Patient,O
was,O
treated,O
for,O
community-acquired,B-PR
pneumonia,I-PR
.,O

He,O
was,O
initially,O
placed,O
on,O
Ceftriaxone,B-TR
",",O
Levaquin,B-TR
",",O
and,O
Flagyl,B-TR
in,O
the,O
ICU,O
but,O
then,O
changed,O
to,O

Azithromycin,B-TR
&,O
CTX,B-TR
at,O
time,O
of,O
transfer,O
to,O
the,O
oncology,O
service,O
.,O

He,O
continued,O
to,O
have,O
an,B-PR
oxygen,I-PR
requirement,I-PR
and,O
CT,B-TE
scan,I-TE
suggested,O
ground,B-PR
glass,I-PR
opacities,I-PR
",",O
suggestive,O
of,O
an,B-PR
underlying,I-PR
infectious,I-PR
process,I-PR
.,O

ECHO,B-TE
was,O
done,O
and,O
confirmed,O
normal,O
ejection,O
fraction,O
.,O

His,O
respiratory,O
status,O
improved,O
slowly,O
",",O
oxygen,B-TR
was,O
weaned,O
off,O
",",O
and,O
he,O
was,O
discharged,O
on,O
course,O
of,O
Levaquin,B-TR
.,O

2),O
Metastatic,B-PR
RCC,I-PR
:,O
Sutent,B-TR
was,O
held,O
on,O
admission,O
in,O
light,O
of,O
acute,B-PR
infection,I-PR
.,O

He,O
underwent,O
a,B-TE
staging,I-TE
CT,I-TE
scan,I-TE
torso,I-TE
which,O
suggested,O
no,O
significant,B-PR
increase,I-PR
in,I-PR
tumor,I-PR
burden,I-PR
.,O

Patient,O
was,O
also,O
found,O
to,O
have,O
abnormal,B-PR
TFTs,I-PR
on,O
Sutent,B-TR
and,O
was,O
started,O
on,O
replacement,B-TR

therapy,B-TR
.,O

He,O
will,O
need,O
follow-up,B-TE
bloodwork,I-TE
as,O
an,O
outpatient,O
.,O

Recent,B-TE
CT,I-TE
scan,I-TE
showed,O
destruction,B-PR
of,I-PR
L,I-PR
femoral,I-PR
neck,I-PR
.,O

He,O
underwent,O
an,B-TE
xray,I-TE
of,I-TE
the,I-TE
L,I-TE
femur,I-TE
which,O
did,O
not,O
suggest,O
an,B-PR
acute,I-PR
fracture,I-PR
.,O

No,O
limitations,O
were,O
placed,O
in,O
regards,O
to,O
weightbearing,O
status,O
.,O

Patient,O
was,O
instructed,O
to,O
restart,O
Sutent,B-TR
next,O
Monday,O
.,O

3),O
Renal,B-PR
insufficiency,I-PR
:,O
Creatinine,B-TE
improved,O
from,O
2.1,O
to,O
1.3,O
at,O
time,O
of,O
discharge,O
.,O

Likely,O
related,O
to,O
underlying,B-PR
malignancy,I-PR
as,O
well,O
as,O
prerenal,B-PR
component,I-PR
given,O
improvement,O
with,O
gentle,B-TR
hydration,I-TR
.,O

Medications,O
on,O
Admission,O
:,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O
He,O
takes,O
Imodium,B-TR
and,O
Lomotil,B-TR
while,O
on,O
Sutent,B-TR
for,O
diarrhea,B-PR
.,O

He,O
has,O
not,O
had,O
a,O
BM,O
in,O
3,O
days,O
now,O
.,O

He,O
is,O
also,O
on,O
MS,B-TR
Contin,I-TR
45,O
mg,O
PO,O
q12,O
hours,O
(,O
confirmed,O
with,O
wife,O
),O
and,O
MSIR,B-TR
15,O
mg,O
every,O
4,O
hours,O
as,O
needed,O
.,O

MEDICATIONS,O
ON,O
TRANSFER,O
:,O

Heparin,B-TR
5000,O
UNIT,O
SC,O
TID,O

Albuterol,B-TR
0.083%,O
Neb,O
Soln,O
1,O
NEB,O
IH,O
Q6H,O

Ipratropium,B-TR
Bromide,I-TR
Neb,I-TR
1,O
NEB,O
IH,O
Q6H,O

CeftriaXONE,B-TR
1,O
gm,O
IV,O
Q24H,O

Levofloxacin,B-TR
500,O
mg,O
PO,O
Q24H,O

Morphine,B-TR
Sulfate,I-TR
2-4,O
mg,O
IV,O
Q4H,O
:,O
PRN,O

Docusate,B-TR
Sodium,I-TR
100,O
mg,O
PO,O
BID,O

Pantoprazole,B-TR
40,O
mg,O
PO,O
Q24H,O

Fluticasone,B-TR
Propionate,I-TR
110mcg,O
2,O
PUFF,O
IH,O
BID,O

Discharge,O
Medications,O
:,O

1.,O
Levothyroxine,B-TR
50,O
mcg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
2,O
*,O

2.,O
Levofloxacin,B-TR
500,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q24H,O
(,O
every,O
24,O
hours,O
),O
for,O
4,O
days,O
:,O
last,O
dose,O
will,O
be,O
Nolen,O
",",O
06-23,O
.,O

Disp,O
:*,O
4,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

3.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
):,O
Take,O
as,O
necessary,O
for,O
constipation,B-PR
.,O

4.,O
SUTENT,B-TR
50,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
Every,O
other,O
day,O
:,O
Please,O
restart,O
on,O
Wallace,O
",",O
06-24,O
.,O

5.,O
Morphine,B-TR
15,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
for,O
Pain,B-PR
.,O

Disp,O
:*,O
60,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

6.,O
Morphine,B-TR
15,O
mg,O
Tablet,O
Sustained,O
Release,O
Sig,O
:,O
Three,O
(,O
3,O
),O
Tablet,O
Sustained,O
Release,O
PO,O
Q12H,O
(,O
every,O
12,O
hours,O
).,O

Disp,O
:*,O
90,O
Tablet,O
Sustained,O
Release,O
(s)*,O
Refills,O
:*,O
0,O
*,O

Discharge,O
Disposition,O
:,O

Home,O

Discharge,O
Diagnosis,O
:,O

Primary,O
diagnoses,O
:,O

1),O
Pneumonia,B-PR

2),O
Acute,B-PR
renal,I-PR
failure,I-PR

3),O
Metastatic,B-PR
renal,I-PR
cell,I-PR
carcinoma,I-PR

4),O
Hypoxemia,B-PR

Discharge,O
Condition,O
:,O

Stable,O

Discharge,O
Instructions,O
:,O

1),O
Please,O
take,O
all,B-TR
medications,I-TR
as,O
listed,O
in,O
the,O
discharge,O
instructions,O
.,O

2),O
You,O
were,O
admitted,O
to,O
the,O
hospital,O
and,O
started,O
on,O
an,B-TR
antibiotic,I-TR
called,O
Levaquin,B-TR
for,O
a,B-PR
pneumonia,I-PR
.,O

You,O
should,O
continue,O
taking,O
this,B-TR
medication,I-TR
and,O
your,O
last,O
day,O
will,O
be,O
Nolen,O
",",O
06-23,O
.,O

3),O
When,O
you,O
were,O
admitted,O
to,O
the,O
hospital,O
your,B-TR
Sutent,I-TR
was,O
stopped,O
.,O

You,O
should,O
resume,O
this,B-TR
medication,I-TR
starting,O
Wallace,O
",",O
06-24,O
.,O

You,O
should,O
take,O
this,B-TR
medication,I-TR
every,O
other,O
day,O
.,O

4),O
During,O
your,O
hospital,O
stay,O
you,O
were,O
also,O
found,O
to,O
have,O
low,B-PR
thyroid,I-PR
hormone,I-PR
levels,I-PR
.,O

As,O
a,O
result,O
",",O
you,O
were,O
started,O
on,O
thyroid,B-TR
supplements,I-TR
.,O

You,O
should,O
have,O
follow-up,B-TE
blood,I-TE
tests,I-TE
by,O
your,O
primary,O
care,O
physician,O
B,O
3,O
months,O
.,O

5),O
Please,O
attend,O
all,O
appointments,O
as,O
listed,O
below,O
.,O

6),O
If,O
you,O
experience,O
any,O
fevers,B-PR
",",O
chills,B-PR
",",O
chest,B-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
dizziness,B-PR
or,O
any,B-PR
other,I-PR
concerning,I-PR
symptoms,I-PR
please,O
return,O
to,O
the,O
emergency,O
department,O
.,O

Followup,O
Instructions,O
:,O

1),O
Provider,O
:,O
Yolanda,O
Joyce,O
",",O
MD,O
Phone,O
:,O
337,O
2567,O

Date,O
/,O
Time,O
:,O
2019-07-03,O
3:30,O

2),O
Provider,O
:,O
Peter,O
Helen,O
Braddy,O
",",O
MD,O
Phone,O
:,O
337,O
2567,O

Date,O
/,O
Time,O
:,O
2019-07-03,O
3:30,O

Philip,O
Glenn,O
MD,O
60-385,O

Completed,O
by,O
:,O
Eva,O
Susan,O
MD,O
54-940,O
2019-07-27,O
@,O
1700,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Patrick,O
B,O
Santiago,O
on,O
:,O
MON,O
2019-07-29,O
9:27,O
AM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2013-06-12,O

Discharge,O
Date,O
:,O

2013-06-25,O

Date,O
of,O
Birth,O
:,O

1943-03-31,O

Sex,O
:,O

M,O

Service,O
:,O

TRA,O

ADDENDUM,O
:,O

This,O
is,O
a,O
discharge,O
summary,O
addendum,O
for,O
Discharge,O
Summary,O
number,O
554108,O
.,O

As,O
follows,O
.,O

Patient,O
was,O
discharged,O
to,O
rehabilitation,B-TR
on,O
2013-06-25,O
.,O

Discharge,O
was,O
delayed,O
by,O
one,O
day,O
to,O
ensure,O
patient,O
could,O
tolerate,O
P.O.,O
which,O
patient,O
did,O
without,O
difficulty,B-PR
.,O

Please,O
see,O
original,O
Discharge,O
Summary,O
for,O
discharge,B-TR
medications,I-TR
.,O

Josh,O
Harry,O
",",O
Missouri,O
43478,O

Dictated,O
By,O
:,O
Joe,O
J.,O
T.,O
Gochenour,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2013-06-25,O
07:58:05,O

T,O
:,O
2013-06-25,O
08:07:03,O

Job,O
#:,O

79141,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Clara,O
M.,O
Odell,O
on,O
:,O
WED,O
2013-06-26,O
9:58,O
AM,O

(,O
End,O
of,O
Report,O
),O

1909607,O

Admission,O
Date,O
:,O

2010-06-28,O

Discharge,O
Date,O
:,O

2010-07-01,O

Date,O
of,O
Birth,O
:,O

1990-02-01,O

Sex,O
:,O

F,O

Service,O
:,O

ORTHOPEDIC,O

HISTORY,O
OF,O
THE,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
20-year-old,O
female,O
with,O
no,O
significant,O
past,O
medical,O
history,O
",",O
who,O
was,O
the,O
unrestrained,O
passenger,O
in,O
a,O
high,O
speed,O
rollover,O
motor,O
vehicle,O
accident,O
on,O
2010-06-27,O
.,O

By,O
report,O
",",O
the,O
patient,O
was,O
ejected,O
from,O
the,O
vehicle,O
on,O
impact,O
and,O
found,O
curled,O
in,O
the,O
fetal,O
position,O
at,O
the,O
rear,O
of,O
the,O
vehicle,O
at,O
the,O
scene,O
.,O

The,O
vehicle,O
was,O
noted,O
to,O
be,O
extensively,O
damaged,O
.,O

By,O
report,O
",",O
the,O
patient,O
was,O
noted,O
to,O
be,O
awake,O
",",O
but,O
confused,B-PR
at,O
the,O
scene,O
of,O
the,O
accident,O
with,O
no,O
memory,O
of,O
the,O
incident,O
.,O

She,O
was,O
immobilized,O
in,O
the,B-TR
C-spine,I-TR
collar,I-TR
at,O
the,O
scene,O
of,O
the,O
accident,O
and,O
subsequently,O
transported,O
by,O
EMS,O
to,O
the,O
New,O
England,O
Sinai,O
Hospital,O
&,O
Rehab,O
Center,O
Emergency,O
Department,O
for,O
further,B-TR
management,I-TR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Examination,B-TE
on,O
presentation,O
to,O
the,O
emergency,O
room,O
revealed,O
the,O
following,O
:,O

Temperature,B-TE
35.4,O
Celsius,O
",",O
blood,B-TE
pressure,I-TE
116/63,O
",",O
pulse,B-TE
105,O
",",O
respiratory,B-TE
rate,I-TE
18,O
",",O
oxygen,B-TE
saturation,I-TE
98%,O
on,O
room,O
air,O
.,O

The,O
patient,O
was,O
alert,O
and,O
oriented,O
times,O
three,O
in,O
no,O
apparent,B-PR
distress,I-PR
.,O

Boston,B-TE
Coma,I-TE
Scale,I-TE
of,O
15,O
.,O

Tympanic,O
membranes,O
were,O
noted,O
to,O
be,O
clear,O
.,O

Pupils,O
were,O
equal,O
",",O
round,O
",",O
reactive,O
to,O
light,O
at,O
approximately,O
4,O
mm,O
.,O

The,O
patient,O
's,O
trachea,O
was,O
noted,O
to,O
be,O
midline,O
.,O

The,B-TE
patient,I-TE
's,I-TE
lung,I-TE
examination,I-TE
revealed,O
the,O
lungs,O
to,O
be,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
",",O
no,O
crepitus,B-PR
",",O
and,O
a,B-PR
left,I-PR
clavicular,I-PR
deformity,I-PR
was,O
grossly,O
apparent,O
on,O
examination,B-TE
.,O

CARDIAC,O
:,O

Cardiac,B-TE
examination,I-TE
demonstrated,O
regular,O
rate,O
and,O
rhythm,O
",",O
no,O
murmurs,B-PR
",",O
rubs,B-PR
",",O
or,O
gallops,B-PR
.,O

ABDOMEN,O
:,O

Soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
.,O

RECTAL,O
:,O

Examination,B-TE
was,O
guaiac,B-TE
negative,O
with,O
good,O
rectal,O
tone,O
.,O

The,O
patient,O
's,O
pelvis,O
was,O
stable,O
to,O
AP,B-TE
and,I-TE
lateral,I-TE
compression,I-TE
.,O

A,B-PR
5,I-PR
cm,I-PR
laceration,I-PR
was,O
noted,O
over,O
the,O
patient,O
's,O
occiput,O
on,O
further,B-TE
inspection,I-TE
with,O
no,O
exposed,B-PR
underlying,I-PR
bone,I-PR
.,O

Right,B-TE
upper,I-TE
extremity,I-TE
examination,I-TE
demonstrated,O
intact,O
motor,O
",",O
sensory,O
",",O
and,O
vascular,O
function,O
.,O

Left,B-TE
upper,I-TE
extremity,I-TE
examination,I-TE
demonstrated,O
no,O
gross,B-PR
deformities,I-PR
",",O
tenderness,B-PR
to,O
palpation,B-TE
in,I-TE
the,I-TE
mid,I-TE
forearm,I-TE
",",O
intact,O
motor,O
function,O
in,O
the,O
median,O
",",O
radial,O
",",O
and,O
ulnar,O
nerve,O
distributions,O
",",O
intact,O
sensation,O
to,O
light,B-TE
touch,I-TE
in,O
the,O
median,O
and,O
radial,O
nerve,O
distributions,O
",",O
decreased,B-PR
sensation,I-PR
in,I-PR
the,I-PR
ulnar-nerve,I-PR
distribution,I-PR
",",O
warm,O
and,O
well,O
perfused,O
limb,O
with,O
2+,O
radial,B-TE
pulses,I-TE
.,O

Right,B-TE
lower,I-TE
extremity,I-TE
examination,I-TE
demonstrated,O
mild,B-PR
swelling,I-PR
and,O
ecchymosis,B-PR
of,I-PR
the,I-PR
right,I-PR
posterior,I-PR
thigh,I-PR
and,O
approximately,O
a,B-PR
3,I-PR
cm,I-PR
laceration,I-PR
in,I-PR
the,I-PR
lower,I-PR
leg,I-PR
",",O
expressive,O
of,O
moderate,O
amounts,O
of,O
standard,O
sterile,O

fashion,O
.,O

No,O
gross,B-PR
deformities,I-PR
.,O

Motor,B-TE
",",I-TE
sensory,I-TE
",",I-TE
and,I-TE
vascular,I-TE
examinations,I-TE
were,O
intact,O
in,O
all,O
distributions,O
.,O

Left,B-TE
lower,I-TE
extremity,I-TE
examination,I-TE
demonstrated,O
no,O
gross,B-PR
deformities,I-PR
and,O
intact,O
motor,O
",",O
sensory,O
",",O
and,O
vascular,O
examinations,O
in,O
all,O
distributions,O
.,O

Radiographic,B-TE
studies,I-TE
demonstrated,O
an,B-PR
inferior,I-PR
displaced,I-PR
left,I-PR
midclavicular,I-PR
fracture,I-PR
",",O
no,O
evidence,O
of,O

pneumothorax,B-PR
.,O

Trauma,B-TE
series,I-TE
demonstrated,O
no,O
evidence,O
of,O
a,B-PR
pelvic,I-PR
fracture,I-PR
.,O

Head,B-TE
CT,I-TE
demonstrated,O
no,O
evidence,O
of,O
intracranial,B-PR
bleeding,I-PR
.,O

Trauma,B-TE
CT,I-TE
demonstrated,O
mild,B-PR
pulmonary,I-PR
contusions,I-PR
",",O
but,O
no,O
pelvic,B-PR
fracture,I-PR
.,O

Cervical,B-TE
spine,I-TE
imaging,I-TE
demonstrated,O
no,O
evidence,O
of,O
cervical,B-PR
spine,I-PR
injury,I-PR
.,O

Right,B-TE
tibial-fibular,I-TE
film,I-TE
series,I-TE
demonstrated,O
no,O
evidence,O
of,O
fracture,B-PR
displacement,I-PR
.,O

Left,B-TE
humerus,I-TE
film,I-TE
series,I-TE
demonstrated,O
no,O
evidence,O
of,O
fracture,B-PR
or,O
displacement,B-PR
.,O

Right,B-TE
foot,I-TE
and,I-TE
femur,I-TE
series,I-TE
demonstrated,O
no,O
evidence,O
of,O
fracture,B-PR
displacement,I-PR
.,O

Left,B-TE
forearm,I-TE
and,I-TE
wrist,I-TE
series,I-TE
demonstrated,O
transverse,B-PR
mid,I-PR
shaft,I-PR
radial,I-PR
fracture,I-PR
with,O
ulnar,B-PR
displacement,I-PR
.,O

Diagnosis,B-TE
peritoneum,I-TE
lavage,I-TE
times,O
two,O
was,O
negative,O
for,O
any,O
signs,O
of,O
intra-abdominal,B-PR
bleeding,I-PR
.,O

LABORATORY,O
DATA,O
:,O

Studies,B-TE
on,O
admission,O
revealed,O
the,O
following,O
:,O

White,B-TE
blood,I-TE
cell,I-TE
12.9,O
",",O
hemoglobin,B-TE
11.5,O
",",O
hematocrit,B-TE
32.8,O
",",O
platelet,B-TE
count,I-TE
"197,000",O
",",O
sodium,B-TE
141,O
",",O
potassium,B-TE
3.6,O
",",O
chloride,B-TE
110,O
",",O
bicarbonate,B-TE
21,O
",",O
BUN,B-TE
20,O
",",O
creatinine,B-TE
0.7,O
",",O
glucose,B-TE
189,O
",",O
PT,B-TE
13.3,O
",",O
INR,B-TE
1.2,O
",",O
PTT,B-TE
30.0,O
",",O
amylase,B-TE
57,O
",",O
arterial,B-TE
blood,I-TE
gas,I-TE
7.32,O
",",O
35,O
",",O
159,O
",",O
19,O
",",O
-7,O
.,O

Urinalysis,B-TE
was,O
within,O
normal,O
limits,O
with,O
6,O
to,O
10,O
red,B-TE
blood,I-TE
cells,I-TE
.,O

Toxicology,B-TE
screen,I-TE
was,O
negative,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
evaluated,O
by,O
the,O
Trauma,O
Service,O
in,O
the,O
emergency,O
room,O
",",O
where,O
she,O
received,O
four,O
liters,O

crystalloid,B-TR
and,O
four,O
units,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
with,O
good,O
response,O
.,O

In,O
addition,O
",",O
the,O
patient,O
received,O
the,O
above-described,O
diagnostic,B-TE
procedures,I-TE
",",O
which,O
demonstrated,O
injuries,B-PR
limited,O
to,O
a,B-PR
posterior,I-PR
scalp,I-PR
laceration,I-PR
",",O
left,B-PR
fractured,I-PR
clavicle,I-PR
",",O
left,B-PR
fractured,I-PR
radius,I-PR
",",O
right,B-PR
thigh,I-PR
hematoma,I-PR
",",O
and,O
right,B-PR
leg,I-PR
laceration,I-PR
.,O

The,O
patient,O
was,O
subsequently,O
admitted,O
to,O
the,O
Trauma,O
Service,O
on,O
2010-06-28,O
under,O
the,O
direction,O
of,O
Dr.,O
Lowery,O
.,O

Given,O
the,B-PR
patient,I-PR
's,I-PR
right,I-PR
thigh,I-PR
hematoma,I-PR
",",O
a,B-TE
duplex,I-TE
evaluation,I-TE
of,I-TE
the,I-TE
right,I-TE
lower,I-TE
extremity,I-TE
was,O
performed,O
on,O
2010-06-28,O
and,O
demonstrated,O
no,O
evidence,O
of,O
major,B-PR
arterial,I-PR
or,I-PR
venous,I-PR
injury,I-PR
in,O
the,O
level,O
of,O

the,O
right,O
inguinal,O
region,O
.,O

On,O
06-28,O
",",O
the,O
patient,O
was,O
also,O
cleared,O
for,O
removal,O
of,O
her,B-TR
C-spine,I-TR
collar,I-TR
and,O
deemed,O
stable,O
for,O
transfer,O
to,O
the,O
Orthopedic,O
Service,O
under,O
the,O
direction,O
of,O
Dr.,O
Ronda,O
Lopez,O
.,O

The,O
patient,O
remained,O
stable,O
through,O
2010-06-29,O
at,O
which,O
point,O
she,O
was,O
sent,O
to,O
the,O
operating,O
room,O
to,O
undergo,O
a,B-TR
left,I-TR
radial,I-TR
fracture,I-TR
open,I-TR
reduction,I-TR
and,O
internal,B-TR
fixation,I-TR
procedure,I-TR
.,O

The,O
patient,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
and,O
demonstrated,O
a,B-TE
postoperative,I-TE
hematocrit,I-TE
of,O
40.9,O
.,O

Of,O
note,O
",",O
the,B-PR
scalp,I-PR
and,I-PR
right,I-PR
lower,I-PR
leg,I-PR
lacerations,I-PR
were,O
closed,O
primarily,O
by,O
the,O
trauma,O
team,O
on,O
admission,O
and,O
on,O
hospital,O
day,O
#1,O
were,O
noted,O
to,O
be,O
clean,O
",",O
dry,O
",",O
and,O
intact,O
.,O

Nonoperative,B-TR
treatment,I-TR
was,O
elected,O
for,O
the,B-PR
patient,I-PR
's,I-PR
left,I-PR
clavicular,I-PR
fracture,I-PR
.,O

On,O
postoperative,O
day,O
#1,O
",",O
2010-06-30,O
",",O
the,O
patient,O
was,O
noted,O
to,O
be,O
clinically,O
stable,O
",",O
tolerating,O
oral,O
intake,O
",",O
and,O
expressive,O
of,O
adequate,O
amounts,O
of,O
urine,O
independent,O
of,O
a,B-TR
Foley,I-TR
catheter,I-TR
.,O

The,B-PR
patient,I-PR
's,I-PR
head,I-PR
wound,I-PR
laceration,I-PR
was,O
noted,O
to,O
be,O
clean,O
and,O
dry,O
with,O
intact,B-TR
staples,I-TR
.,O

There,O
was,O
no,O
erythema,B-PR
or,O
purulence,B-PR
.,O

The,O
left,O
clavicle,O
was,O
noted,O
to,O
have,O
continued,B-PR
ecchymosis,I-PR
decreased,O
from,O
prior,B-TE
examination,I-TE
with,O
a,B-PR
minor,I-PR
stepoff,I-PR
and,O
mild,B-PR
tenderness,I-PR
to,O
palpation,B-TE
decreased,O
from,O
prior,B-TE
examinations,I-TE
.,O

The,B-TR
left,I-TR
forearm,I-TR
dressing,I-TR
was,O
noted,O
to,O
be,O
in,O
place,O
",",O
clean,O
",",O
dry,O
",",O
and,O
intact,O
with,O
no,O
saturation,B-PR
.,O

The,O
patient,O
was,O
noted,O
to,O
be,O
able,O
to,O
wiggle,O
her,O
fingers,O
with,O
intact,O
flexor,O
",",O
extensor,O
",",O
abductor,O
",",O
and,O
adductor,O
function,O
.,O

Mild,B-PR
swelling,I-PR
was,O
noted,O
in,O
the,O
left,O
hand,O
.,O

Sensation,O
was,O
intact,O
in,O
the,O
median,O
",",O
radius,O
",",O
and,O
ulnar-nerve,O
distributions,O
.,O

Fingers,O
were,O
warm,O
and,O
well,O
perfused,O
with,O
capillary,B-TE
refill,I-TE
less,O
than,O
3,O
seconds,O
.,O

The,B-PR
patient,I-PR
's,I-PR
right,I-PR
anterior,I-PR
tibial,I-PR
wound,I-PR
was,O
noted,O
to,O
be,O
clean,O
",",O
dry,O
",",O
and,O
intact,O
with,O
sutures,B-TR
intact,O
and,O
no,O
erythema,B-PR
or,O
purulence,B-PR
noted,O
.,O

On,O
06-30,O
",",O
the,O
patient,O
was,O
evaluated,O
by,O
Occupational,O
Therapy,O
and,O
fitted,O
for,O
a,B-TR
left,I-TR
upper,I-TR
extremity,I-TR
splint,I-TR
.,O

The,O
patient,O
was,O
also,O
administered,O
adaptive,B-TR
training,I-TR
for,O
activities,B-TR
of,I-TR
daily,I-TR
life,I-TR
and,O
advised,O
regarding,O
wound,B-TR
care,I-TR
.,O

In,O
addition,O
",",O
the,O
patient,O
was,O
also,O
fitted,O
with,O
a,B-TR
figure-of-eight,I-TR
clavicular,I-TR
splint,I-TR
and,O
instructed,O
in,O
its,O

proper,O
use,O
.,O

On,O
2010-07-01,O
",",O
the,O
patient,O
was,O
discharged,O
from,O
the,O
hospital,O
with,O
instructions,O
for,O
follow,O
up,O
care,O
on,O
return,O
to,O
the,O
United,O
Kingdom,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

The,O
patient,O
is,O
to,O
be,O
discharged,O
to,O
home,O
.,O

DISCHARGE,O
STATUS,O
:,O

Stable,O
.,O

DIAGNOSIS,O
:,O

1.,O
Left,B-PR
transverse,I-PR
mid,I-PR
shaft,I-PR
radial,I-PR
fracture,I-PR
with,O
ulnar,B-PR
displacement,I-PR
status,O
post,O
left,B-TR
radial,I-TR
open,I-TR
reduction,I-TR
and,O
internal,B-TR
fixation,I-TR
.,O

2.,O
Left,B-PR
midclavicular,I-PR
fracture,I-PR
managed,O
nonoperatively,O
.,O

3.,O
Occipital,B-PR
scalp,I-PR
laceration,I-PR
.,O

4.,O
Right,B-PR
anterior,I-PR
tibial,I-PR
laceration,I-PR
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Percocet,B-TR
one,O
to,O
two,O
tablets,O
PO,O
q.4h.,O
to,O
6h.p.r.n.,O
pain,B-PR
.,O

FOLLOW-UP,O
CARE,O
:,O

The,O
patient,O
is,O
medically,O
cleared,O
for,O
a,O
flight,O
to,O
return,O
to,O
her,O
home,O
in,O
the,O
United,O
Kingdom,O
.,O

The,O
patient,O
is,O
to,O
maintain,O
her,B-TR
figure-of-eight,I-TR
clavicular,I-TR
splint,I-TR
and,O
left,B-TR
posterior,I-TR
forearm,I-TR
splint,I-TR
in,O
place,O
for,O
fourteen,O
days,O
following,O
discharge,O
.,O

The,B-PR
left,I-PR
forearm,I-PR
and,I-PR
right,I-PR
lower,I-PR
leg,I-PR
wound,I-PR
should,O
be,O
kept,O
clean,O
and,O
dry,O
with,O
regular,B-TR
dressing,I-TR
changes,I-TR
with,O
dry,B-TR
gauze,I-TR
once,O
per,O
day,O
.,O

Scalp,B-PR
laceration,I-PR
should,O
be,O
kept,O
clean,O
and,O
dry,O
for,O
five,O
days,O
following,O
discharge,O
after,O
which,O
point,O
the,O
patient,O
may,O
once,O
wash,O
her,O
hair,O
.,O

Percocet,B-TR
for,O
pain,B-PR
as,O
needed,O
.,O

The,O
patient,O
is,O
to,O
followup,O
with,O
an,O
orthopedist,O
in,O
the,O
United,O
Kingdom,O
fourteen,O
days,O
following,O
discharge,O
at,O
which,O
point,O
repeat,B-TE
x-rays,I-TE
of,I-TE
her,I-TE
left,I-TE
forearm,I-TE
should,O
be,O
obtained,O
and,O
her,B-TR
left,I-TR
forearm,I-TR
scalp,I-TR
and,I-TR
right,I-TR
lower,I-TR
leg,I-TR
sutures,I-TR
and,O
staples,B-TR
may,O
be,O
removed,O
.,O

Questions,O
regarding,O
follow,O
up,O
may,O
be,O
referred,O
to,O
Dr.,O
Ronda,O
Lopez,O
at,O
the,O
Ayer,O
Orthopedic,O
Group,O
.,O

Telephone,O
#:,O

(,O
658,O
),O
842-8661,O
.,O

Ortiz,O
V,O
Baugher,O
",",O
M.D.,O

75-285,O

Dictated,O
By,O
:,O
Catherine,O
K,O
Thomas,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2010-06-30,O
17:18,O

T,O
:,O
2010-06-30,O
17:39,O

JOB,O
#:,O

3326,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Kisha,O
Jones,O
on,O
:,O
Jose,O
2010-07-01,O
8:27,O
AM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2018-10-25,O

Discharge,O
Date,O
:,O

2018-11-01,O

Date,O
of,O
Birth,O
:,O

1943-11-06,O

Sex,O
:,O

M,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,I-PR
Drugs,I-PR

Attending,O
:,O
Kelly,O
L.,O
Bradley,O
",",O
M.D.,O

Addendum,O
:,O

Explained,O
to,O
pt,O
which,O
of,O
the,B-TR
meds,I-TR
he,O
should,O
no,O
longer,O
take,O
that,O
he,O
was,O
taking,O
pre-admission,O
.,O

Also,O
",",O
explained,O
which,O
meds,B-TR
are,O
new,O
.,O

Wife,O
verbally,O
agrees,O
to,O
understanding,O
.,O

Discharge,O
Medications,O
:,O

1.,O
Diltiazem,B-TR
HCl,O
240,O
mg,O
Capsule,O
",",O
Sustained,O
Release,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
",",O
Sustained,O
Release,O
PO,O
DAILY,O
(,O
Daily,O
).,O

2.,O
Simvastatin,B-TR
40,O
mg,O
Tablet,O
Sig:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

3.,O
Albuterol-Ipratropium,B-TR
103-18,O
mcg,O
/,O
Actuation,O
Aerosol,O
Sig,O
:,O
02-26,O
Puffs,O
Inhalation,O
Q6H,O
(,O
every,O
6,O
hours,O
),O
as,O
needed,O
.,O

4.,O
Fluticasone-Salmeterol,B-TR
250-50,O
mcg,O
/,O
Dose,O
Disk,O
with,O
Device,O
Sig,O
:,O
One,O
(,O
1,O
),O
Disk,O
with,O
Device,O
Inhalation,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

5.,O
Terazosin,B-TR
1,O
mg,O
Capsule,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Capsule,O
PO,O
HS,O
(,O
at,O
bedtime,O
).,O

6.,O
Acetaminophen,B-TR
325,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
.,O

7.,O
Nimodipine,B-TR
30,O
mg,O
Capsule,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Capsule,O
PO,O
Q4H,O
(,O
every,O
4,O
hours,O
),O
for,O
2,O
weeks,O
.,O

Disp,O
:*,O
168,O
Capsule,O
(s)*,O
Refills,O
:*,O
0,O
*,O

8.,O
Ferrous,B-TR
Sulfate,I-TR
325,O
(,O
65,O
),O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
2,O
*,O

9.,O
Aspirin,B-TR
81,O
mg,O
Tablet,O
",",O
Chewable,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Chewable,O
PO,O
DAILY,O
(,O
Daily,O
).,O

10.,O
Ipratropium,B-TR
Bromide,I-TR
0.02,O
%,O
Solution,O
Sig,O
:,O
One,O
(,O
1,O
),O
Inhalation,O
Q6H,O
(,O
every,O
6,O
hours,O
).,O

11.,O
Simvastatin,B-TR
40,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

12.,O
Hydralazine,B-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
1.5,O
Tablets,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
).,O

Disp,O
:*,O
135,O
Tablet,O
(s)*,O
Refills,O
:*,O
2,O
*,O

13.,O
Metoprolol,B-TR
Tartrate,I-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
1.5,O
Tablets,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

Disp,O
:*,O
90,O
Tablet,O
(s)*,O
Refills,O
:*,O
2,O
*,O

14.,O
Isosorbide,B-TR
Dinitrate,I-TR
20,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
).,O

Disp,O
:*,O
90,O
Tablet,O
(s)*,O
Refills,O
:*,O
2,O
*,O

15.,O
Clopidogrel,B-TR
75,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

16.,O
Glipizide,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
once,O
a,O
day,O
.,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
2,O
*,O

Discharge,O
Disposition,O
:,O

Home,O
with,O
Service,O

Jacob,O
Montegut,O
MD,O
71-786,O

Completed,O
by,O
:,O
Oscar,O
Jerome,O
Julian,O
MD,O
39-824,O
2018-11-01,O
@,O
1610,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Joyce,O
Arney,O
on,O
:,O
MON,O
2018-12-03,O
10:55,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2012-01-07,O

Discharge,O
Date,O
:,O

2012-03-10,O

Date,O
of,O
Birth,O
:,O

Sex,O
:,O

M,O

Service,O
:,O

Since,O
2012-02-26,O
",",O
the,O
patient,O
has,O
been,O
stable,O
.,O

The,O
Whidden,O
Memorial,O
Hospital,O
hospital,O
course,O
has,O
been,O
smooth,O
with,O
the,O
patient,O
progressively,O
improving,O
.,O

The,O
patient,O
was,O
initially,O
on,O
several,B-TR
antibiotics,I-TR
included,O
Cefepime,B-TR
",",O
Vancomycin,B-TR
",",O
Ciprofloxacin,B-TR
",",O
Ambazone,B-TR
and,O
Flagyl,B-TR
.,O

The,B-TE
patient,I-TE
's,I-TE
HSV,I-TE
antibody,I-TE
titer,I-TE
was,O
found,O
to,O
be,O
negative,O
and,O
the,O
patient,O
's,O
Acyclovir,B-TR
was,O
not,O
restarted,O
.,O

Infectious,O
disease,O
continued,O
to,O
follow,O
and,O
on,O
2012-02-29,O
",",O
the,O
patient,O
spiked,O
again,O
which,O
at,O
that,O
time,O
was,O
felt,O
to,O
be,O
due,O
to,O
his,B-TR
central,I-TR
line,I-TR
and,O
the,B-TR
central,I-TR
line,I-TR
was,O
resited,O
on,O
the,O
left,O
side,O
and,O
the,O
patient,O
was,O
started,O
on,O
intravenous,B-TR
Vancomycin,I-TR
.,O

Over,O
the,O
following,O
days,O
until,O
discharge,O
",",O
the,O
patient,O
remained,O
afebrile,B-PR
and,O
on,O
2012-03-09,O
",",O
in,O
fact,O
all,O
the,B-TR
patient,I-TR
's,I-TR
antibiotics,I-TR
were,O
discontinued,O
.,O

As,O
for,O
the,O
patient,O
's,O
ALL,B-PR
and,O
AML,B-PR
",",O
the,O
patient,O
was,O
started,O
on,O
a,B-TR
new,I-TR
chemotherapy,I-TR
protocol,I-TR
called,O
hyper-CVAD,B-TR
on,O
2012-03-06,O
.,O

After,O
the,O
patient,O
began,O
on,O
this,B-TR
protocol,I-TR
",",O
his,B-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
steadily,O
began,O
to,O
climb,O
.,O

The,O
patient,O
became,O
no,O
longer,O
neutropenic,B-PR
.,O

The,O
patient,O
's,O
also,O
began,O
to,O
climb,O
and,O
the,B-TE
percent,I-TE
blasts,I-TE
in,O
his,B-TE
differential,I-TE
decreased,O
significantly,O
.,O

The,O
patient,O
had,O
no,O
further,B-PR
complaints,I-PR
and,O
on,O
2012-03-10,O
",",O
his,B-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
was,O
2.3,O
",",O
neutrophils,B-TE
50%,O
",",O
bands,B-TE
2%,O
",",O
lymphocytes,B-TE
5%,O
",",O
monocytes,B-TE
40%,O
",",O
and,O
blasts,B-TE
1%,O
.,O

Platelet,B-TE
count,I-TE
was,O
"759,000",O
.,O

The,O
patient,O
was,O
discharged,O
to,O
home,O
with,O
instructions,O
to,O
return,O
to,O
the,O
hospital,O
on,O
Monday,O
",",O
2012-03-12,O
",",O
for,O
follow-up,O
and,O
laboratory,B-TE
checks,I-TE
.,O

The,O
patient,O
was,O
also,O
given,O
instructions,O
to,O
be,O
prudent,O
and,O
stay,O
away,O
from,O
public,O
places,O
as,O
well,O
as,O
small,O
children,O
.,O

The,O
patient,O
was,O
also,O
told,O
to,O
continue,O
on,O
a,B-TR
neutropenic,I-TR
diet,I-TR
.,O

The,O
patient,O
was,O
also,O
told,O
that,O
he,O
would,O
have,O
to,O
be,O
admitted,O
for,O
several,O
days,O
during,O
his,B-TR
next,I-TR
cycle,I-TR
of,I-TR
CVAD,I-TR
.,O

The,O
patient,O
was,O
discharged,O
to,O
home,O
in,O
good,O
condition,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

1.,O
Bactrim,B-TR
double,I-TR
strength,I-TR
one,O
tablet,O
q.,O
Monday,O
",",O
Wednesday,O
and,O
Friday,O
.,O

2.,O
Compazine,B-TR
10,O
mg,O
p.o.,O
q,O
6hours,O
p.r.n.,O
nausea,B-PR
.,O

3.,O
Anzemet,B-TR
100,O
mg,O
p.o.,O
once,O
daily,O
p.r.n.,O
nausea,B-PR
.,O

The,O
patient,O
is,O
to,O
return,O
to,O
the,O
hospital,O
on,O
Monday,O
for,O
follow-up,O
.,O

DR.,O
Esparza,O
",",O
Gail,O
18-714,O

Dictated,O
By,O
:,O
Cristobal,O
C.,O
Reid,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2012-03-10,O
22:44,O

T,O
:,O
2012-03-11,O
10:08,O

JOB,O
#:,O

24313,O

1,O

1,O

1,O

OMR,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Brenda,O
C.,O
Massey,O
on,O
:,O
MON,O
2012-04-23,O
1:02,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2010-08-26,O

Discharge,O
Date,O
:,O

2010-09-02,O

Date,O
of,O
Birth,O
:,O

1961-06-26,O

Sex,O
:,O

M,O

Service,O
:,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Mr.,O
Robert,O
Mackey,O
is,O
a,O
49,O
year,O
old,O
gentleman,O
with,O
a,O
22,O
year,O
history,O
of,O
diabetes,B-PR
mellitus,I-PR
.,O

He,O
has,O
a,O
history,O
of,O
peripheral,B-PR
neuropathy,I-PR
",",O
kidney,B-TR
transplantation,I-TR
in,O
2003,O
secondary,O
to,O
diabetic,B-PR
nephropathy,I-PR
",",O
as,O
well,O
as,O
throat,B-PR
cancer,I-PR
in,O
2004,O
treated,O
with,O
local,B-TR
resection,I-TR
and,O
radical,B-TR
neck,I-TR
dissection,I-TR
on,I-TR
the,I-TR
left,I-TR
as,O
well,O
as,O
postoperative,B-TR
radiation,I-TR
.,O

Mr.,O

Therefore,O
",",O
he,O
was,O
admitted,O
for,O
C4-C5,B-TR
and,I-TR
C5-C6,I-TR
anterior,I-TR
diskectomy,I-TR
with,O
autologous,B-TR
bone,I-TR
graft,I-TR
and,O
instrumented,B-TR
fusion,I-TR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Postoperative,B-TE
physical,I-TE
examination,I-TE
demonstrated,O
that,O
he,O
was,O
afebrile,B-PR
at,O
97,O
degrees,O
;,O
blood,B-TE
pressure,I-TE
145/80,O
;,O
pulse,B-TE
60,O
;,O
respiratory,B-TE
rate,I-TE
10,O
;,O
100%,O
on,O
a,B-TR
non-rebreather,I-TR
.,O

He,O
was,O
awake,O
",",O
alert,O
",",O
uncomfortable,B-PR
secondary,O
to,O
incisional,B-PR
tenderness,I-PR
at,O
neck,B-PR
site,I-PR
as,O
well,O
as,O
right,B-PR
iliac,I-PR
graft,I-PR
site,I-PR
.,O

The,B-PR
wounds,I-PR
were,O
clean,O
",",O
dry,O
and,O
intact,O
",",O
and,O
flat,O
.,O

HOSPITAL,O
COURSE,O
:,O

While,O
in,O
the,O
PACU,O
",",O
Anesthesia,O
was,O
called,O
because,O
the,O
patient,O
became,O
dyspneic,B-PR
and,O
tachypneic,B-PR
and,O
his,B-TE
SAO2,I-TE
dropped,O
to,O
89%,O
.,O

His,B-TE
respiratory,I-TE
rate,I-TE
was,O
30,O
on,O
face,B-TR
mask,I-TR
.,O

Interoperatively,O
",",O
he,O
was,O
positive,O
two,O
liters,O
with,O
a,O
stable,O
blood,O
pressure,O
and,O
heart,B-TE
rate,I-TE
",",O
although,O
requiring,O
some,B-TR
neo-synephrine,I-TR
interoperatively,O
.,O

He,O
responded,O
to,O
intravenous,B-TR
Lasix,I-TR
with,O
3.2,O
liters,O
of,O
urine,B-TE
output,I-TE
as,O
well,O
as,O
marked,O
clinical,O
improvement,O
.,O

The,O
etiology,O
for,O
his,B-PR
congestive,I-PR
heart,I-PR
failure,I-PR
was,O
determined,O
likely,O
to,O
be,O
diastolic,B-PR
dysfunction,I-PR
from,O
increased,B-PR
heart,I-PR
rate,I-PR
as,O
well,O
as,O
excess,B-PR
volume,I-PR
.,O

No,O
definite,O
evidence,O
for,O
significant,B-PR
myocardial,I-PR
ischemia,I-PR
",",O
although,O
cardiac,B-TE
enzymes,I-TE
were,O
sent,O
and,O
he,O
ruled,O
out,O
for,O
myocardial,B-PR
infarction,I-PR
.,O

He,O
was,O
admitted,O
to,O
the,O
Surgical,O
Intensive,O
Care,O
Unit,O
where,O
his,O
respiratory,O
and,O
cardiac,O
status,O
was,O
monitored,O
carefully,O
.,O

He,O
was,O
given,O
Lasix,B-TR
to,O
continue,O
to,O
diurese,O
the,B-PR
excess,I-PR
volume,I-PR
.,O

He,O
was,O
also,O
put,O
on,O
Lopressor,B-TR
150,O
mg,O
twice,O
a,O
day,O
.,O

Also,O
in,O
the,O
Intensive,O
Care,O
Unit,O
",",O
O2,B-TE
saturation,I-TE
was,O
closely,O
monitored,O
.,O

The,O
patient,O
became,O
agitated,B-PR
with,O
both,O
tent,B-TR
and,O
Bi-PAP,B-TR
machine,I-TR
",",O
although,O
continued,O
to,O
saturate,O
well,O
.,O

He,O
was,O
transferred,O
to,O
Medicine,O
the,O
morning,O
of,O
2010-08-30,O
",",O
for,O
continued,B-TR
medical,I-TR
management,I-TR
post,O
surgery,O
.,O

On,O
the,O
day,O
of,O
transfer,O
",",O
the,O
patient,O
was,O
noted,O
to,O
be,O
confused,B-PR
with,O
waxing,B-PR
and,I-PR
waning,I-PR
sensorium,I-PR
;,O
thus,O
",",O
a,B-TE
delirium,I-TE
work-up,I-TE
was,O
initiated,O
looking,O
for,O
precipitants,O
.,O

1.,O
When,O
his,B-TE
O2,I-TE
saturation,I-TE
was,O
monitored,O
",",O
his,B-TE
pulse,I-TE
oximetry,I-TE
remained,O
in,O
the,O
90s,O
during,O
his,O
stay,O
.,O

2.,O
His,B-TR
non-essential,I-TR
medications,I-TR
that,O
may,O
have,O
been,O
contributing,O
to,O
his,B-PR
change,I-PR
in,I-PR
mental,I-PR
status,I-PR
were,O
discontinued,O
;,O
those,O
included,O
Temocillin,B-TR
",",O
Nortriptyline,B-TR
",",O
Haldol,B-TR
",",O
Lorazepam,B-TR
",",O
Venlafaxine,B-TR
",",O
Bupropion,B-TR
",",O
and,O
Gabapentin,B-TR
.,O

In,O
addition,O
",",O
his,B-TE
cyclosporin,I-TE
levels,I-TE
were,O
checked,O
.,O

3.,O
Hypo,B-PR
or,I-PR
hyperglycemia,I-PR
:,O

Mahoney,O
had,O
been,O
following,O
with,O
their,O
appreciated,O
recommendations,O
on,O
glucose,B-TR
control,I-TR
.,O

Finger,B-TE
sticks,I-TE
were,O
in,O
the,O
150,O
s,O
when,O
acutely,B-PR
agitated,I-PR
",",O
therefore,O
",",O
it,O
was,O
not,O
determined,O
that,O
glucose,B-TE
levels,I-TE
were,O
contributory,O
.,O

4.,O
Infectious,B-PR
causes,I-PR
were,O
evaluated,O
.,O

He,O
was,O
febrile,B-PR
in,O
the,O
Intensive,O
Care,O
Unit,O
to,O
101.0,O
F.,O
;,O
yet,O
",",O
chest,B-TE
x-ray,I-TE
",",O
blood,B-TE
cultures,I-TE
",",O
urinalysis,B-TE
and,O
urine,B-TE
cultures,I-TE
were,O
all,O
negative,O
for,O
sources,O
.,O

A,B-TE
lumbar,I-TE
puncture,I-TE
was,O
considered,O
",",O
although,O
not,O
performed,O
due,O
to,O
the,O
fact,O
that,O
the,O
cerebrospinal,O
fluid,O
was,O
not,O
breached,O
during,O
the,B-TR
procedure,I-TR
.,O

5.,O
Mass,B-PR
effect,I-PR
was,O
considered,O
",",O
although,O
no,O
focal,B-PR
deficits,I-PR
were,O
ever,O
noted,O
on,O
examination,B-TE
and,O
due,O
to,O
the,B-PR
fluctuating,I-PR
sensorium,I-PR
",",O
it,O
was,O
determined,O
that,O
there,O
was,O
no,O
severe,B-PR
underlying,I-PR
structural,I-PR
abnormality,I-PR
.,O

A,B-TE
head,I-TE
and,I-TE
neck,I-TE
CT,I-TE
scan,I-TE
",",I-TE
non-contrast,I-TE
",",O
were,O
ordered,O
though,O
to,O
evaluate,O
for,O
such,B-PR
processes,I-PR
.,O

No,O
acute,B-PR
intracranial,I-PR
hemorrhages,I-PR
or,O
midline,B-PR
shifts,I-PR
were,O
noted,O
",",O
although,O
a,B-PR
soft,I-PR
tissue,I-PR
mass,I-PR
was,O
noted,O
at,O
the,O
level,O
of,O
C2,O
.,O

This,O
was,O
determined,O
to,O
be,O
within,O
the,O
normal,O
expected,O
changes,O
post,O
surgery,O
.,O

6.,O
Trauma,B-PR
was,O
also,O
considered,O
.,O

The,O
patient,O
was,O
found,O
out,O
of,O
bed,O
but,O
no,O
signs,O
of,O
head,B-PR
trauma,I-PR
",",O
no,O
loss,B-PR
of,I-PR
consciousness,I-PR
.,O

Throughout,O
his,O
stay,O
",",O
Chem-10,B-TE
was,O
monitored,O
.,O

There,O
were,O
no,O
electrolytes,B-PR
or,I-PR
mineral,I-PR
abnormalities,I-PR
that,O
could,O
explain,O
his,B-PR
delirium,I-PR
.,O

Liver,B-TE
function,I-TE
tests,I-TE
were,O
checked,O
",",O
only,O
total,B-TE
bilirubin,I-TE
was,O
slightly,B-PR
elevated,I-PR
at,O
1.6,O
.,O

TSH,B-TE
was,O
within,O
normal,O
limits,O
as,O
was,O
B12,B-TE
and,O
folate,B-TE
.,O

RPR,B-TE
evaluating,I-TE
for,O
possible,O
neurologic,B-PR
syphilis,I-PR
was,O
also,O
checked,O
.,O

The,B-TE
assay,I-TE
was,O
nonreactive,O
.,O

An,B-TE
EEG,I-TE
was,O
also,O
considered,O
to,O
rule,O
out,O
non-convulsive,B-PR
status,I-PR
epilepticus,I-PR
",",O
although,O
again,O
this,O
did,O
not,O
seem,O
to,O
be,O
a,O
likely,O
cause,O
.,O

On,O
the,O
evening,O
of,O
the,O
22nd,O
",",O
the,O
patient,O
became,O
acutely,B-PR
agitated,I-PR
",",O
threatening,O
to,O
leave,O
",",O
and,O
also,O
threatening,O
to,O
harm,O
those,O
nurses,O
and,O
physicians,O
that,O
were,O
attempting,O
to,O
prevent,O
him,O
from,O
leaving,O
.,O

Security,O
was,O
notified,O
who,O
then,O
arrived,O
to,O
the,O
room,O
and,O
helped,O
to,O
place,O
the,O
patient,O
in,O
four-point,O

restraints,B-TR
",",O
for,O
the,O
safety,O
of,O
both,O
the,O
patient,O
and,O
the,O
staff,O
of,O
the,O
hospital,O
.,O

The,B-TR
restraints,I-TR
were,O
weaned,O
off,O
overnight,O
although,O
he,O
became,O
acutely,B-PR
agitated,I-PR
and,O
they,O
were,O
replaced,O
early,O
on,O
08-31,O
.,O

Later,O
in,O
the,O
morning,O
on,O
08-31,O
",",O
the,O
patient,O
was,O
more,O
oriented,O
and,O
alert,O
",",O
and,O
asked,O
to,O
have,O
the,B-TR
restraints,I-TR
removed,O
.,O

They,O
were,O
taken,O
off,O
two,O
at,O
a,O
time,O
.,O

The,O
patient,O
continued,O
to,O
do,O
well,O
and,O
did,O
not,O
require,O
restraints,B-TR
after,O
that,B-PR
event,I-PR
.,O

Intramuscular,B-TR
as,O
well,O
as,O
intravenous,B-TR
Haldol,I-TR
were,O
ordered,O
p.r.n.,O
for,O
emergency,O
use,O
should,O
he,O
become,O
acutely,B-PR
agitated,I-PR
.,O

haldol,B-TR
as,O
well,O
as,O
the,B-TR
restraints,I-TR
were,O
not,O
required,O
after,O
the,O
morning,O
of,O
the,O
23rd,O
.,O

Each,O
progressive,O
"day,",O

The,O
likely,O
cause,O
of,O
the,B-PR
delirium,I-PR
was,O
a,O
combination,O
of,O
surgery,B-TR
and,O
Intensive,O
Care,O
Unit,O
stay,O
in,O
addition,O
to,O
poly-pharmacy,B-TR
.,O

Other,O
concerns,O
during,O
his,O
stay,O
was,O
his,B-TE
kidney,I-TE
function,I-TE
",",O
due,O
to,O
his,B-TR
renal,I-TR
transplant,I-TR
in,O
2003,O
.,O

His,B-TR
immunosuppressive,I-TR
therapy,I-TR
was,O
continued,O
throughout,O
his,O
stay,O
;,O
his,B-TE
creatinine,I-TE
remained,O
approximately,O
2.3,O
to,O
2.4,O
;,O
he,O
has,O
a,B-PR
baseline,I-PR
renal,I-PR
insufficiency,I-PR
.,O

With,O
this,O
in,O
mind,O
",",O
when,O
obtaining,O
a,B-TE
CT,I-TE
scan,I-TE
it,O
was,O
determined,O
that,O
contrast,B-TR
would,O
not,O
be,O
the,O
best,O
option,O
.,O

While,O
the,O
patient,O
was,O
in,O
restraints,B-TR
",",O
gentle,B-TR
hydration,I-TR
was,O
initiated,O
since,O
p.o.,B-TE
intake,I-TE
was,O
not,B-PR
adequate,I-PR
.,O

As,O
for,O
his,B-PR
diabetes,I-PR
mellitus,I-PR
",",O
the,O
Mahoney,O
Team,O
provided,O
updated,O
recommendations,O
each,O
day,O
",",O
adjusting,O
for,O
the,O
changing,O
p.o.,O
intake,O
.,O

The,O
only,O
other,B-PR
complaints,I-PR
from,O
Mr.,O
Mackey,O
during,O
his,O
stay,O
were,O
:,O

Soreness,B-PR
at,O
his,B-PR
operative,I-PR
sites,I-PR
",",O
for,O
which,O
he,O
was,O
given,O
p.r.n.,B-TR
Tylenol,I-TR
once,O
his,B-PR
delirium,I-PR
had,O
resolved,O
.,O

In,O
addition,O
",",O
he,O
also,O
complained,O
of,O
difficulty,B-PR
with,I-PR
swallowing,I-PR
",",O
necessitating,O
only,O
soft,B-TR
and,I-TR
liquid,I-TR
diet,I-TR
.,O

This,O
was,O
attributed,O
to,O
postoperative,B-PR
swelling,I-PR
and,O
changes,O
from,O
his,B-TR
diskectomy,I-TR
performed,O
2010-08-27,O
.,O

DISPOSITION,O
:,O

The,O
patient,O
was,O
discharged,O
on,O
09-02,O
.,O

DISCHARGE,O
INSTRUCTIONS,O
:,O

1.,O
Follow-up,O
with,O
Dr.,O
Williams,O
on,O
Tuesday,O
",",O
09-07,O
",",O
at,O
noon,O
.,O

2.,O
Follow-up,O
with,O
Dr.,O
Michael,O
",",O
his,O
psychiatrist,O
",",O
on,O
Wednesday,O
",",O
09-08,O
.,O

3.,O
He,O
was,O
also,O
discharged,O
home,O
with,O
Visiting,O
Nurse,O
Association,O
for,O
Physical,B-TE
Therapy,I-TE
evaluation,I-TE
of,O
home,O
safety,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Venlafaxine,B-TR
XR,I-TR
75,O
mg,O
q.,O
a.m.,O

2.,O
Furosemide,B-TR
20,O
mg,O
q.o.d.,O

3.,O
Metoprolol,B-TR
100,O
mg,O
twice,O
a,O
day,O
.,O

4.,O
Nitroglycerin,B-TR
sublingual,I-TR
0.3,O
mg,O
p.r.n.,O

5.,O
Cyclosporin,B-TR
microemulsion,I-TR
.,O

6.,O
Neoral,B-TR
100,O
mg,O
twice,O
a,O
day,O
.,O

7.,O
Zithropren,B-TR
50,O
mg,O
q.,O
day,O
.,O

8.,O
Prednisone,B-TR
10,O
mg,O
q.,O
day,O
.,O

9.,O
Minoxidil,B-TR
10,O
mg,O
twice,O
a,O
day,O
.,O

10.,O
Prilosec,B-TR
20,O
mg,O
q.,O
day,O
.,O

11.,O
NPH,B-TR
30,O
units,O
q.,O
a.m.,O
",",O
5,O
to,O
6,O
units,O
q.,O
p.m.,O

12.,O
Regular,B-TR
insulin,I-TR
5,O
units,O
q.,O
a.m.,O
and,O
3,O
to,O
5,O
units,O
q.,O
p.m.,O

13.,O
Wellbutrin,B-TR
100,O
mg,O
q.,O
day,O
.,O

14.,O
Zocor,B-TR
60,O
mg,O
q.,O
day,O
.,O

15.,O
Nitroglycerin,B-TR
SR,I-TR
2.5,O
mg,O
twice,O
a,O
day,O
.,O

He,O
was,O
instructed,O
to,O
hold,O
the,O
following,O
three,O
medications,B-TR
that,O
he,O
took,O
prior,O
to,O
admission,O
:,O

Nortriptyline,B-TR
10,O
mg,O
q.,O
h.s.,O
;,O
Flomax,B-TR
0.4,O
mg,O
q.,O
h.s.,O
;,O
Neurontin,B-TR
600,O
mg,O
three,O
times,O
a,O
day,O
.,O

He,O
was,O
instructed,O
not,O
to,O
restart,O
these,O
until,O
seen,O
by,O
Dr.,O
Ercek,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
C4-C5,B-TR
",",I-TR
C5-C6,I-TR
",",I-TR
anterior,I-TR
microdiscectomy,I-TR
and,I-TR
fusion,I-TR
with,O
right,B-TR
iliac,I-TR
bone,I-TR
graft,I-TR
.,O

For,O
completeness,O
",",O
the,O
patient,O
's,O
complete,O
past,O
medical,O
history,O
:,O

1.,O
End-stage,B-PR
renal,I-PR
disease,I-PR
secondary,O
to,O
type,B-PR
1,I-PR
diabetes,I-PR
mellitus,I-PR
;,O
status,O
post,O
renal,B-TR
transplant,I-TR
in,O
2003,O
.,O

2.,O
History,O
of,O
multiple,B-PR
urinary,I-PR
tract,I-PR
infections,I-PR
.,O

3.,O
Pyelonephritis,B-PR
.,O

4.,O
Creatinine,B-TE
2.2,O
to,O
2.5,O
.,O

5.,O
Right,B-TR
coronary,I-TR
artery,I-TR
stent,I-TR
in,O
2008,O
;,O
ejection,B-TE
fraction,I-TE
60,O
to,O
65%,O
.,O

6.,O
Type,B-PR
1,I-PR
diabetes,I-PR
mellitus,I-PR
with,O
triopathy,B-PR
",",O
retinopathy,B-PR
",",O
neuropathy,B-PR
",",O
nephropathy,B-PR
.,O

7.,O
Benign,B-PR
prostatic,I-PR
hypertrophy,I-PR
status,O
post,O
transurethral,B-TR
resection,I-TR
of,I-TR
the,I-TR
prostate,I-TR
;,O
self,B-TR
catheterization,I-TR
.,O

8.,O
Hypertension,B-PR
.,O

9.,O
Hypercholesterolemia,B-PR
.,O

10.,O
Hepatitis,B-PR
B,I-PR
.,O

11.,O
Throat,B-PR
cancer,I-PR
status,O
post,O
right,B-TR
neck,I-TR
dissection,I-TR
and,O
XRT,B-TR
in,O
2004,O
.,O

12.,O
Cerebral,B-PR
aneurysm,I-PR
.,O

13.,O
Left,B-TR
prosthetic,I-TR
CMED,O
CCU,O
.,O

ALLERGIES,O
:,O

Gentamicin,B-TR
",",O
and,O
ibuprofen,B-TR
.,O

Kenneth,O
Jeffrey,O
",",O
MD,O

Dictated,O
By,O
:,O
Michael,O
S,O
Bonham,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2010-09-02,O
18:23,O

T,O
:,O
2010-09-07,O
16:04,O

JOB,O
#:,O

36814,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Victoria,O
Williams,O
on,O
:,O
MON,O
2010-11-08,O
3:18,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2009-08-17,O

Discharge,O
Date,O
:,O

2009-09-10,O

Date,O
of,O
Birth,O
:,O

1951-04-02,O

Sex,O
:,O

M,O

Service,O
:,O

BLUE,O
GENERAL,O
SURGERY,O

Attending,O
:,O
Terry,O
U,O
Cheatom,O
",",O
M.D.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Mr.,O
Cordano,O
is,O
a,O
58-year-old,O
gentlemen,O
with,O
a,O
past,O
medical,O
history,O
significant,O
for,O
primary,B-PR
sclerosing,I-PR
cholangitis,I-PR
who,O
presented,O
with,O
a,O
chief,O
complaint,O
of,O
endoscopic,B-TE
retrograde,I-TE
cholangiopancreatography,I-TE
endoscopic,B-TE
retrograde,I-TE
cholangiopancreatography,I-TE
and,O
percutaneous,B-TE
transhepatic,I-TE
cholangiogram,I-TE
.,O

The,B-TR
most,I-TR
recent,I-TR
percutaneous,I-TR
transluminal,I-TR
coronary,I-TR
angioplasty,I-TR
was,O
done,O
in,O
2009-07-25,O
.,O

At,O
the,O
time,O
an,B-TR
8,I-TR
Caucasian,I-TR
catheter,I-TR
was,O
placed,O
in,O
the,O
common,O
hepatic/bioduct,O
for,O
external,B-TR
drainage,I-TR
.,O

The,B-TE
endoscopic,I-TE
retrograde,I-TE
cholangiopancreatography,I-TE
also,O
showed,O
the,O
presence,O
proximal,O
common,O
bile,O
duct,O
.,O

Nodularities,B-PR
in,I-PR
the,I-PR
common,I-PR
bile,I-PR
duct,I-PR
visualized,O
by,O
endoscopic,B-TE
retrograde,I-TE
cholangiopancreatography,I-TE
was,O
also,O
worrisome,O
for,O
cholangiocarcinoma,B-PR
and,O
the,O
patient,O
was,O
admitted,O
to,O
the,O
Blue,O
General,O
Surgery,O
Service,O
for,O
possible,O
surgical,B-TR
interventions,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Ulcerative,B-PR
colitis,I-PR
",",O
primary,B-PR
sclerosing,I-PR
cholangitis,I-PR
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

Status,O
post,O
placement,B-TR
of,I-TR
percutaneous,I-TR
transhepatic,I-TR
biliary,I-TR
drainage,I-TR
with,O
placement,B-TR
of,I-TR
8,I-TR
Caucasian,I-TR
nephrostomy,I-TR
catheter,I-TR
in,O
the,O
common,O
bile,O
duct,O
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

1.,O
Ursodiol,B-TR
600,O
mg,O
t.i.d.,O

2.,O
Ambien,B-TR
5,O
mg,O
q.h.s.,O

PHYSICAL,O
EXAMINATION,O
ON,O
ADMISSION,O
:,O

The,O
patient,O
is,O
a,O
jaundiced,O
looking,O
gentlemen,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

The,O
head,O
is,O
normocephalic,O
",",O
atraumatic,B-PR
and,O
eyes,O
are,O
icteric,B-PR
.,O

The,O
neck,O
is,O
supple,O
with,O
no,O
lymphadenopathy,B-PR
.,O

The,O
chest,O
is,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

The,O
heart,O
has,O
a,O
regular,O
rate,O
and,O
rhythm,O
with,O
normal,O
S1,O
",",O
S2,O
.,O

There,O
is,O
no,O
murmurs,B-PR
.,O

The,O
abdomen,O
was,O
soft,O
",",O
nontender,B-PR
",",O
no,O
masses,B-PR
and,O
nondistended,B-PR
.,O

There,O
is,O
no,O
hepatosplenomegaly,B-PR
.,O

Rectal,B-TE
exam,I-TE
showed,O
no,O
masses,B-PR
and,O
is,O
guaiac,B-TE
negative,O
.,O

The,O
extremities,O
have,O
distal,O
pulses,O
and,O
were,O
warm,O
and,O
well,O
perfused,O
.,O

Neurological,B-TE
exam,I-TE
was,O
grossly,O
intact,O
.,O

LABORATORY,O
STUDIES,O
AT,O
ADMISSION,O
:,O

A,B-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
of,O
14.2,O
",",O
hematocrit,B-TE
of,O
35.3,O
",",O
platelet,B-TE
count,I-TE
of,O
"449,000",O
.,O

Sodium,B-TE
of,O
130,O
",",O
potassium,B-TE
3.5,O
",",O
chloride,B-TE
93,O
",",O
bicarbonate,B-TE
28,O
",",O
BUN,B-TE
15,O
",",O
creatinine,B-TE
"1.1,",O
prothrombin,B-TE
time,I-TE
14.1,O
",",O
partial,B-TE
thrombin,I-TE
time,I-TE
29.7,O
.,O

INR,B-TE
1.4,O
.,O

ALT,B-TE
106,O
",",O
AST,B-TE
149,O
",",O
alkaline,B-TE
phosphatase,I-TE
242,O
.,O

Total,B-TE
bilirubin,I-TE
10.1,O
",",O
amylase,B-TE
90,O
and,O
lipase,B-TE
112,O
.,O

RADIOLOGICAL,O
STUDIES,O
AT,O
TIME,O
OF,O
ADMISSION,O
:,O

Chest,B-TE
x-ray,I-TE
revealed,O
minimal,B-PR
left,I-PR
base,I-PR
atelectasis,I-PR
and,O
elevation,B-PR
of,I-PR
left,I-PR
hemidiaphragm,I-PR
.,O

A,B-TE
CT,I-TE
scan,I-TE
with,I-TE
po,I-TE
contrast,I-TE
showed,O
dilation,B-PR
of,I-PR
intrahepatic,I-PR
common,I-PR
bile,I-PR
duct,I-PR
which,O
is,O
improved,O
from,O
previous,B-TE
studies,I-TE
.,O

It,O
is,O
also,O
noted,O
that,O
there,O
was,O
splenomegaly,B-PR
.,O

HOSPITAL,O
COURSE,O
:,O

Mr.,O
Cordano,O
was,O
admitted,O
on,O
2009-08-17,O
for,O
a,B-TR
replacement,I-TR
of,I-TR
transhepatic,I-TR
biliary,I-TR
drainage,I-TR
catheter,I-TR
.,O

At,O
that,O
time,O
",",O
cholangiogram,B-TE
confirmed,O
that,O
there,O
was,O
a,B-PR
distal,I-PR
stricture,I-PR
of,I-PR
the,I-PR
common,I-PR
bile,I-PR
duct,I-PR
.,O

An,B-TE
endoscopic,I-TE
retrograde,I-TE
cholangiopancreatography,I-TE
also,O
demonstrated,O
similar,O
findings,O

and,O
it,O
is,O
noted,O
there,O
was,O
nodularity,B-PR
in,I-PR
the,I-PR
common,I-PR
bile,I-PR
duct,I-PR
which,O
is,O
worrisome,O
for,O
cholangiocarcinoma,B-PR
.,O

Therefore,O
",",O
the,O
patient,O
was,O
taken,O
to,O
the,O
Operating,O
Room,O
on,O
2009-08-24,O
for,O
a,B-TR
Whipple,I-TR
procedure,I-TR
versus,O
hepaticojejunostomy,B-TR
.,O

On,O
exploration,B-TE
of,I-TE
the,I-TE
abdomen,I-TE
revealed,O
significant,B-PR
nodularity,I-PR
of,I-PR
the,I-PR
liver,I-PR
indicating,O
of,O
advanced,B-PR
cirrhosis,I-PR
.,O

Intraoperative,O
frozen,O
section,O
of,O
the,O
distal,O
and,O
proximal,O
common,O
bile,O
duct,O
in,O
the,O

region,B-PR
nodularity,I-PR
",",O
which,O
is,O
identified,O
previously,O
by,O
endoscopic,B-TE
retrograde,I-TE
cholangiopancreatography,I-TE
",",O
and,O
regional,O
lymph,O
nodes,O
were,O
all,O
sent,O
to,O
pathology,B-TE
.,O

They,O
were,O
all,O
negative,O
for,O
malignancy,B-PR
and,O
therefore,O
a,B-TR
hepaticojejunostomy,I-TR

was,O
performed,O
.,O

Cholangiogram,B-TE
on,O
postoperative,O
day,O
number,O
two,O
showed,O
no,O
evidence,O
of,O
leakage,B-PR
at,I-PR
the,I-PR
anastomosis,I-PR
site,I-PR
.,O

The,O
patient,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
and,O
he,O
was,O
sent,O
to,O
the,O
floor,O
in,O
stable,O
condition,O
.,O

The,O
patient,O
's,O
postoperative,O
course,O
was,O
notable,O
for,O
an,B-PR
elevation,I-PR
in,O
white,B-TE
blood,I-TE
cell,I-TE
count,O
peaking,O
at,O
30.0,O
on,O
postoperative,O
day,O
number,O
two,O
.,O

He,O
was,O
given,O
Unasyn,B-TR
for,O
empiric,B-TR
antibiotic,I-TR
treatment,I-TR
.,O

At,O
the,O
time,O
",",O
blood,O
",",O
urine,O
and,O
bile,O
was,O
sent,O
for,O
culture,B-TE
",",O
which,O
were,O
all,O
negative,O
.,O

A,B-TE
chest,I-TE
x-ray,I-TE
was,O
also,O
negative,O
for,O
any,B-PR
pneumonia,I-PR
.,O

Postoperatively,O
",",O
Mr.,O
Cordano,O
also,O
suffered,O
from,O
low,B-PR
urine,I-PR
output,I-PR
ranges,O
between,O
25,O
to,O
30,O
cc,O
per,O
hour,O
.,O

Fractional,B-TE
excretion,I-TE
of,I-TE
sodium,I-TE
was,O
less,O
than,O
1%,O
suggesting,O
a,B-PR
prerenal,I-PR
etiology,I-PR
.,O

The,B-TE
sodium,I-TE
creatinine,I-TE
peaked,O
at,O
2.0,O
and,O
the,O
patient,O
was,O
treated,O
with,O
boluses,B-TR
of,I-TR
intravenous,I-TR
fluid,I-TR
and,O
intravenous,B-TR
albumin,I-TR
infusion,I-TR
was,O
also,O
administered,O
.,O

He,O
responded,O
well,O
to,O
this,B-TR
regimen,I-TR
and,O
made,O
adequate,O
urine,O
output,O
.,O

At,O
the,O
same,O
time,O
",",O
the,O
patient,O
also,O
developed,O
distentions,B-PR
of,I-PR
the,I-PR
abdomen,I-PR
consistent,O
with,O
accumulation,B-PR
of,I-PR
ascitic,I-PR
fluid,I-PR
.,O

He,O
also,O
had,O
significant,B-PR
lower,I-PR
extremity,I-PR
and,I-PR
scrotum,I-PR
edema,I-PR
.,O

On,O
postoperative,O
day,O
number,O
eight,O
",",O
the,B-TE
patient,I-TE
's,I-TE
oxygen,I-TE
saturation,I-TE
dropped,O
to,O
85%,O
on,O
room,O
air,O
and,O
he,O
was,O
transferred,O
to,O
the,O
Surgical,O
Intensive,O
Care,O
Unit,O
for,O
fluid,B-TR
management,I-TR
.,O

Chest,B-TE
x-ray,I-TE
and,O
sputum,B-TE
culture,I-TE
obtained,O
at,O
the,O
time,O
were,O
negative,O
and,O
the,O
patient,O
was,O
treated,O
with,O
100%,B-TR
nonrebreather,I-TR
which,O
improved,O
his,B-TE
oxygenation,I-TE
.,O

While,O
he,O
is,O
in,O
the,O
Surgical,O
Intensive,O
Care,O
Unit,O
",",O
paracentesis,B-TE
was,O
performed,O
and,O
it,O

revealed,O
greater,O
than,O
"24,000",O
white,B-TE
blood,I-TE
cell,I-TE
count,I-TE
in,O
the,B-PR
ascites,I-PR
which,O
is,O
consistent,O
with,O
SVT,B-PR
.,O

He,O
was,O
given,O
Zosyn,B-TR
for,O
empiric,B-TR
treatment,I-TR
.,O

Gram,B-TE
stain,I-TE
and,O
culture,B-TE
of,O
the,B-PR
ascites,I-PR
failed,O
to,O
identify,O
any,B-PR
organism,I-PR
.,O

He,O
was,O
weaned,O
from,O
oxygen,B-PR
requirement,I-PR
and,O
was,O
continued,O
on,O
normal,B-TR
saline,I-TR
boluses,I-TR
and,O

intravenous,B-TR
albumin,I-TR
for,O
treatment,O
of,O
prerenal,B-PR
azotemia,I-PR
.,O

Somatostatin,B-TR
and,O
midodrine,B-TR
were,O
also,O
given,O
for,O
this,B-PR
condition,I-PR
and,O
he,O
also,O
received,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
.,O

On,O
postoperative,O
day,O
number,O
ten,O
",",O
the,O
patient,O
returned,O
to,O
the,O
floor,O
with,O
improved,O
renal,O
function,O
and,O
without,O
oxygen,B-PR
requirement,I-PR
.,O

The,B-TR
somatostatin,I-TR
and,O
the,B-TR
midodrine,I-TR
were,O
discontinued,O
and,O
the,O
regimen,O
of,O
Lasix,B-TR
and,O
spironolactone,B-TR
was,O
started,O
for,O
diuresis,B-TR
.,O

His,B-TE
creatinine,I-TE
levels,I-TE
trended,O
toward,O
normal,O
and,O
the,B-TE
fractional,I-TE
excretion,I-TE
of,I-TE
sodium,I-TE
also,O
increased,O
indicating,O
a,O
resolution,O
of,O
the,B-PR
prerenal,I-PR
kidney,I-PR
failure,I-PR
.,O

On,O
postoperative,O
day,O
number,O
17,O
",",O
the,O
patient,O
was,O
discharged,O
.,O

At,O
the,O
time,O
he,O
took,O
good,O
po,O
.,O

He,O
has,O
a,B-TR
PICC,I-TR
line,I-TR
in,O
place,O
for,O
continued,O
treatment,O
with,O
Rocephin,B-TR
and,O
he,O
will,O
have,O
a,O
visiting,O
nurse,O
to,O
help,O
him,O
to,O
administer,O
these,B-TR
medications,I-TR
.,O

While,O
in,O
the,O
hospital,O
",",O
the,O
patient,O
received,O
initial,B-TE
work-up,I-TE
including,O
echocardiogram,B-TE
",",O
electrocardiogram,B-TE
and,O
serology,B-TE
studies,I-TE
to,O
be,O
listed,O
for,O
liver,B-TR
transplant,I-TR
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

1.,O
Rocephin,B-TR
1,O
gram,O
q.d.,O

2.,O
Furosemide,B-TR
10,O
mg,O
q.d.,O

3.,O
Spironolactone,B-TR
100,O
mg,O
q.d.,O

4.,O
Ursodiol,B-TR
600,O
mg,O
po,O
t.i.d.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
.,O

DISCHARGE,O
STATUS,O
:,O

To,O
home,O
with,O
services,O
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

PSC,B-PR
",",O
status,O
post,O
hepaticojejunostomy,B-TR
.,O

Hope,O
Raymond,O
",",O
M.D.,O
",",O
Ph.D.,O

02-366,O

Dictated,O
By,O
:,O
Alden,O
B.,O
Edwards,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2009-10-02,O
09:08,O

T,O
:,O
2009-10-02,O
09:08,O

JOB,O
#:,O

86749,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Mary,O
Jones,O
on,O
:,O
SUN,O
2009-10-04,O
1:08,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2016-12-30,O

Discharge,O
Date,O
:,O

2017-01-13,O

Date,O
of,O
Birth,O
:,O

1960-09-05,O

Sex,O
:,O

M,O

Service,O
:,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
56,O
year,O
old,O
man,O
with,O
history,O
of,O
hypercholesterolemia,B-PR
and,O
type,B-PR
II,I-PR
diabetes,I-PR
mellitus,I-PR
.,O

He,O
has,O
a,O
recent,O
history,O
of,O
dyspnea,B-PR
on,O
exertion,O
on,O
exertional,B-PR
chest,I-PR
pain,I-PR
which,O
has,O
increased,O
over,O
the,O
last,O
several,O
weeks,O
and,O
is,O
relieved,O
by,O
sublingual,B-TR
nitroglycerin,I-TR
.,O

On,O
2016-06-26,O
",",O
he,O
had,O
a,B-PR
positive,I-PR
exercise,I-PR
tolerance,I-PR
test,I-PR
.,O

Cardiac,B-TE
catheterization,I-TE
at,O
the,O
end,O
of,O
October,O
revealed,O
a,B-PR
dilated,I-PR
aortic,I-PR
root,I-PR
to,O
4.4,O
cm,O
and,O
80%,B-PR
stenosis,I-PR
of,I-PR
the,I-PR
mid,I-PR
left,I-PR
anterior,I-PR
descending,I-PR
at,O
the,O
bifurcation,O
involving,O
the,O
diagonal,O
branch,O
",",O
70%,B-PR
stenoses,I-PR
of,I-PR
the,I-PR
left,I-PR
circumflex,I-PR
and,I-PR
oblique,I-PR
marginal,I-PR
artery,I-PR
and,O
90%,B-PR
stenosis,I-PR
of,I-PR
the,I-PR
posterior,I-PR
descending,I-PR
artery,I-PR
.,O

His,B-TE
atrioventricular,I-TE
valve,I-TE
gradient,I-TE
was,O
27,O
with,O
an,B-TE
AV,I-TE
surface,I-TE
area,I-TE
of,O
.91,O
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

Review,B-TE
of,I-TE
systems,I-TE
shows,O
that,O
the,O
patient,O
denies,O
any,B-PR
orthopnea,I-PR
",",O
paroxysmal,B-PR
nocturnal,I-PR
dyspnea,I-PR
.,O

He,O
has,O
no,O
bleeding,B-PR
or,O
clotting,B-PR
problems,I-PR
.,O

Juanita,O
does,O
not,O
feel,O
any,B-PR
palpitations,I-PR
.,O

He,O
does,O
not,O
have,O
wheezing,B-PR
",",O
claudication,B-PR
or,O
gastrointestinal,B-PR
bleeding,I-PR
.,O

Nor,O
does,O
he,O
have,O
any,O
history,O
of,O
stroke,B-PR
like,I-PR
symptoms,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Hypercholesterolemia,B-PR
.,O

Type,B-PR
II,I-PR
diabetes,I-PR
.,O

Recent,B-PR
pneumonia,I-PR
.,O

Remote,O
tobacco,O
use,O
.,O

Recent,B-PR
weight,I-PR
loss,I-PR
associated,O
with,O
the,B-PR
pneumonia,I-PR
.,O

Gastroesophageal,B-PR
reflux,I-PR
disease,I-PR
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

One,O
aspirin,B-TR
a,O
day,O
.,O

Nexium,B-TR
40,O
mg,O
a,O
day,O
.,O

Carvedilol,B-TR
6.125,O
mg,O
a,O
day,O
.,O

Glucophage,B-TR
25,O
mg,O
once,O
a,O
day,O
.,O

Lipitor,B-TR
10,O
mg,O
once,O
a,O
day,O
.,O

SOCIAL,O
HISTORY,O
:,O

He,O
lives,O
with,O
his,O
wife,O
and,O
works,O
as,O
a,O
drug,O
representative,O
for,O
Carvedilol,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
physical,B-TE
examination,I-TE
",",O
the,O
patient,O
is,O
afebrile,B-PR
.,O

Weight,B-TE
is,O
82,O
kilograms,O
.,O

Blood,B-TE
pressure,I-TE
126/66,O
.,O

General,O
:,O

Active,O
",",O
well-developed,O
",",O
well-nourished,O
male,O
.,O

Head,B-TE
and,I-TE
neck,I-TE
examination,I-TE
:,O

No,O
bruits,B-PR
appreciated,O
.,O

Lungs,O
are,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

Heart,O
was,O
regular,O
rate,O
and,O
rhythm,O
.,O

S1,O
and,O
S2,O
.,O

3/6,B-PR
systolic,I-PR
ejection,I-PR
murmur,I-PR
throughout,O
his,O
precordium,O
.,O

His,O
abdomen,O
is,O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
.,O

No,O
hepatosplenomegaly,B-PR
and,O
no,O
CVA,B-PR
tenderness,I-PR
.,O

Extremities,O
are,O
warm,O
",",O
well,O
perfused,O
",",O
no,O
cyanosis,B-PR
",",O
clubbing,B-PR
or,O

edema,B-PR
.,O

Palpable,O
dorsalis,O
pedis,O
pulses,O
.,O

No,O
varicosities,B-PR
noted,O
.,O

The,O
patient,O
was,O
also,O
noted,O
to,O
be,O
right,O
handed,O
.,O

HOSPITAL,O
COURSE,O
:,O

He,O
was,O
admitted,O
to,O
the,O
cardiac,O
surgery,O
service,O
for,O
an,B-TR
elected,I-TR
Bental,I-TR
procedure,I-TR
with,O
homograft,B-TR
and,O
coronary,B-TR
artery,I-TR
bypass,I-TR
graft,I-TR
.,O

Once,O
consent,O
and,O
preoperative,B-TE
evaluation,I-TE
was,O
complete,O
",",O
he,O
was,O
taken,O
to,O
the,O
operating,O
room,O
.,O

Please,O
refer,O
to,O
the,O
previously,O
dictated,O
operative,O
note,O
of,O
2016-12-30,O
by,O
Dr.,O
Lawrence,O
.,O

Briefly,O
",",O
the,O
patient,O
was,O
taken,O
to,O
the,O
operating,O
room,O
to,O
repair,B-TR
his,B-PR
critical,I-PR
aortic,I-PR
stenosis,I-PR
",",O
his,B-PR
coronary,I-PR
artery,I-PR
disease,I-PR
and,O
his,B-PR
significantly,I-PR
dilated,I-PR
ascending,I-PR
aortic,I-PR
aneurysm,I-PR
.,O

The,B-TR
procedure,I-TR
was,O
an,B-TR
aortic,I-TR
valve,I-TR
replacement,I-TR
with,O
a,B-TR
tissue,I-TR
valve,I-TR
",",O
a,B-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
procedure,I-TR
where,O
five,B-TR
grafts,I-TR
were,O
performed,O
.,O

The,O
left,O
internal,O
mammary,O
artery,O
was,O
connected,O
to,O
the,O
proximal,O
left,O
anterior,O
descending,O
and,O
saphenous,B-TR
vein,I-TR
grafts,I-TR
were,O
connected,O
to,O
the,O
posterior,O
descending,O
artery,O
",",O
diagonal,O
branch,O
",",O
obtuse,O
marginal,O
and,O
distal,O
left,O
anterior,O
descending,O
.,O

Finally,O
",",O
a,B-TR
super,I-TR
coronary,I-TR
arch,I-TR
graft,I-TR
was,O
implanted,O
.,O

This,O
was,O
a,B-TR
....................,I-TR
graft,I-TR
.,O

Cardiopulmonary,B-TR
bypass,I-TR
time,O
was,O
234,O
minutes,O
.,O

His,O
aorta,O
was,O
cross,B-TR
clamped,I-TR
for,O
168,O
minutes,O
.,O

He,O
had,O
pharmacologic,B-TR
circulatory,I-TR
arrest,I-TR
for,O
18,O
minutes,O
.,O

The,O
patient,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
and,O
was,O
transferred,O
to,O
the,O
unit,O
",",O
intubated,B-TR
on,O
Milrinone,B-TR
",",O
Levophed,B-TR
and,O
Propofol,B-TR
drips,I-TR
.,O

The,O
rest,O
of,O
the,O
hospital,O
stay,O
can,O
be,O
discussed,O
in,O
terms,O
of,O
system,O
based,O
approach,O
.,O

Pulmonary,O
:,O

The,O
patient,O
remained,O
intubated,B-TR
until,O
postoperative,O
day,O
number,O
five,O
.,O

After,O
that,O
",",O
the,O
patient,O
had,O
no,O
major,B-PR
problems,I-PR
with,I-PR
his,I-PR
lungs,I-PR
.,O

His,B-TE
oxygen,I-TE
saturations,I-TE
remained,O
good,O
and,O
he,O
did,O
not,O
require,O
supplemental,B-TR
oxygen,I-TR
more,O
than,O
a,O
couple,O
of,O
days,O
after,O
his,O
extubation,O
.,O

He,O
was,O
sent,O
to,O
the,O
floor,O
from,O
the,O
cardiac,O
surgery,O
recovery,O
unit,O
on,O
postoperative,O
day,O
number,O
seven,O
.,O

After,O
an,O
extended,O
stay,O
for,O
hemodynamic,B-TE
monitoring,I-TE
and,O
pressor,B-TR
support,I-TR
to,O
maintain,O
his,O
perfusion,O
.,O

Neurologic,O
:,O

The,B-PR
major,I-PR
neurologic,I-PR
event,I-PR
of,O
this,O
hospital,O
course,O
was,O
that,O
the,O
patient,O
was,O
slow,B-PR
to,I-PR
awake,I-PR
after,O
his,B-TR
Propofol,I-TR
drip,I-TR
was,O
discontinued,O
.,O

Because,O
of,O
his,B-PR
confusion,I-PR
",",O
a,O
neurology,O
consult,O
was,O
obtained,O
and,O
subsequent,B-TE
radiographic,I-TE
imaging,I-TE
revealed,O
chronic,B-PR
appearing,I-PR
infarcts,I-PR
in,I-PR
the,I-PR
right,I-PR
occipital,I-PR
lobe,I-PR
as,O
well,O
as,O
both,O
cerebellar,O
hemispheres,O
",",O
suggestive,O
of,O
more,B-PR
chronic,I-PR
infarcts,I-PR
",",O
as,O
well,O
as,O
an,O
area,O
in,O
the,O
left,O
corona,O
radiata,O
",",O
adjacent,O
to,O
the,O
left,O
lateral,O
ventricle,O
which,O
may,O
or,O
may,O
not,O
be,O
an,B-PR
acute,I-PR
infarct,I-PR
.,O

This,O
was,O
seen,O
on,O
the,B-TE
CAT,I-TE
scan,I-TE
on,O
postoperative,O
day,O
number,O
one,O
",",O
12-31,O
.,O

As,O
the,O
patient,O
became,O
more,O
awake,O
",",O
he,O
still,O
remained,O
somewhat,B-PR
confused,I-PR
and,O
a,B-PR
little,I-PR
bit,I-PR
out,I-PR
of,I-PR
it,I-PR
.,O

In,O
addition,O
",",O
he,O
was,O
noted,O
to,O
have,O
a,B-PR
right,I-PR
sided,I-PR
hemiplegia,I-PR
.,O

Over,O
his,O
postoperative,O
course,O
",",O
Mr.,O
Douglass,O
has,O
gradually,O
been,O
able,O
to,O
utilize,O
more,O
and,O
more,O
of,O
his,O
right,O
side,O
and,O
with,O
the,O
assistance,O
of,O
physical,B-TR
therapy,I-TR
and,O
occupational,B-TR
therapy,I-TR
",",O
he,O
has,O
4,O
to,O
5,O
+,O
strength,O
in,O
his,O
right,O
hand,O
and,O
arm,O
and,O
about,O
4,O
+,O
strength,O
in,O
his,O
right,O
leg,O
.,O

He,O
is,O
able,O
to,O
walk,O
about,O
the,O
floor,O
on,O
the,O
days,O
prior,O
to,O
discharge,O
",",O
with,O
the,O
assistance,O
of,O
the,O
physical,O
therapist,O
and,O
nurses,O
.,O

In,O
addition,O
",",O
Mr.,O
Douglass,O
is,O
given,O
Trazodone,B-TR
to,O
help,O
him,O
sleep,O
at,O
night,O
.,O

A,O
psychiatric,O
consult,O
was,O
also,O
obtained,O
due,O
to,O
his,O
mental,O
status,O
and,O
confusion,B-PR
postoperatively,O
but,O
his,B-PR
psychiatric,I-PR
issues,I-PR
are,O
mostly,O
related,O
to,O
his,B-PR
neurologic,I-PR
insults,I-PR
and,O
he,O
has,O
no,O
distinctive,B-PR
psychiatric,I-PR
disorder,I-PR
",",O
except,O
for,O
perhaps,O
postoperative,B-PR
delirium,I-PR
.,O

Cardiovascularly,O
",",O
the,O
patient,O
did,O
extremely,O
well,O
following,O
the,B-TR
surgery,I-TR
.,O

The,B-TR
Levophed,I-TR
drip,I-TR
was,O
continued,O
until,O
postoperative,O
day,O
number,O
one,O
.,O

Milrinone,B-TR
was,O
continued,O
until,O
postoperative,O
day,O
number,O
three,O
",",O
at,O
which,O
point,O
he,O
was,O
having,O
good,O
enough,O
cardiac,O
output,O
that,O
he,O
did,O
not,O
need,O
these,B-TR
drips,I-TR
to,O
help,O
maintain,O
his,B-TE
blood,I-TE
pressure,I-TE
anymore,O
.,O

He,O
has,O
remained,O
without,O
any,B-PR
chest,I-PR
pain,I-PR
following,O
this,B-TR
procedure,I-TR
and,O
his,B-PR
sternal,I-PR
wound,I-PR
is,O
clean,O
",",O
dry,O
and,O
intact,O
at,O
the,O
end,O
of,O
the,B-TR
procedure,I-TR
.,O

In,O
addition,O
",",O
he,O
has,O
hypertension,B-PR
",",O
for,O
which,O
he,O
receives,O
Metoprolol,B-TR
and,O
he,O
has,O
hypercholesterolemia,B-PR
",",O
for,O
which,O
he,O
receives,O
nothing,O
at,O
this,O
time,O
.,O

Pulmonary,O
:,O

The,O
patient,O
remained,O
intubated,B-TR
until,O
postoperative,O
day,O
number,O
five,O
.,O

He,O
was,O
diuresed,O
and,O
was,O
soon,O
saturating,O
very,O
well,O
on,O
room,O
air,O
.,O

Gastrointestinal,O
:,O

The,O
patient,O
has,O
gastroesophageal,B-PR
reflux,I-PR
disease,I-PR
",",O
for,O
which,O
he,O
has,O
been,O
receiving,O
Zantac,B-TR
as,O
an,O
inpatient,O
.,O

We,O
will,O
put,O
him,O
back,O
on,O
his,B-TR
Nexium,I-TR
.,O

In,O
addition,O
",",O
over,O
the,O
last,O
couple,O
of,O
days,O
prior,O
to,O
discharge,O
",",O
the,O
patient,O
did,O
appear,O
a,B-PR
little,I-PR
bit,I-PR
icteric,I-PR
.,O

Liver,B-TE
function,I-TE
tests,I-TE
were,O
obtained,O
and,O
they,O
were,O
slightly,B-PR
elevated,I-PR
liver,I-PR
function,I-PR
tests,I-PR
and,O
ALT,B-TE
was,O
44,O
",",O
AST,B-TE
was,O
34,O
;,O
alkaline,B-TE
phosphatase,I-TE
was,O
199,O
",",O
within,O
normal,O
limits,O
.,O

Total,B-TE
bilirubin,I-TE
was,O
2.8,O
.,O

Amylase,B-TE
was,O
108,O
and,O
lipase,B-TE
was,O
213,O
.,O

A,B-TE
right,I-TE
upper,I-TE
quadrant,I-TE
ultrasound,I-TE
did,O
not,O
reveal,O
any,B-PR
gallstones,I-PR
or,O
common,B-PR
bile,I-PR
duct,I-PR
dilatation,I-PR
indicative,O
of,O
cholecystitis,B-PR
or,O
cholelithiasis,B-PR
.,O

In,O
addition,O
",",O
the,O
patient,O
did,O
have,O
slightly,B-PR
elevated,I-PR
blood,I-PR
sugars,I-PR
over,O
the,O
last,O
couple,O
of,O
days,O
and,O
has,O
required,O
an,B-TR
insulin,I-TR
sliding,I-TR
scale,I-TR
and,O
basal,B-TR
insulin,I-TR
to,O
maintain,O
his,B-TE
blood,I-TE
sugars,I-TE
at,O
a,O
more,O
appropriate,O
level,O
.,O

The,O
ideal,O
blood,O
sugar,O
levels,O
for,O
Mr.,O
Douglass,O
in,O
this,O
postoperative,O
period,O
should,O
be,O
less,O
than,O
140,O
.,O

Please,O
stay,O
on,O
top,O
of,O
the,B-TR
sliding,I-TR
scale,I-TR
so,O
that,O
the,O
patient,O
can,O
keep,O
a,O
euglycemic,O
level,O
.,O

Hematologic,O
:,O

The,O
patient,O
",",O
during,O
this,O
admission,O
",",O
required,O
transfusion,O
of,O
three,O
units,O
of,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
to,O
maintain,O
adequate,O
hematocrit,O
.,O

At,O
the,O
time,O
of,O
discharge,O
",",O
Mr.,O
Norman,O
hematocrit,B-TE
is,O
at,O
40.7,O
.,O

Fluids,O
",",O
electrolytes,O
and,O
nutrition,O
:,O

The,O
patient,O
did,O
receive,O
a,O
significant,O
amount,O
of,O
diuresis,B-TR
postoperatively,O
and,O
is,O
well,O
below,O
his,O
baseline,O
with,O
weight,B-TE
",",O
most,O
likely,O
because,O
of,O
his,B-PR
inability,I-PR
to,I-PR
eat,I-PR
because,O
of,O
his,B-PR
stroke,I-PR
.,O

Once,O
he,O
was,O
coherent,O
enough,O
",",O
the,O
patient,O
was,O
evaluated,O
by,O
the,O
swallow,O
team,O
who,O

declared,O
him,O
at,O
first,O
an,B-PR
aspiration,I-PR
risk,I-PR
.,O

As,O
Mr.,O
Douglass,O
has,O
improved,O
from,O
his,B-PR
initial,I-PR
stroke,I-PR
",",O
he,O
has,O
become,O
more,O
lucid,O

and,O
is,O
less,O
of,O
an,B-PR
aspiration,I-PR
risk,I-PR
.,O

On,O
01-12,O
",",O
one,O
day,O
prior,O
to,O
discharge,O
",",O
he,O
was,O
cleared,O
by,O
the,O
swallow,O
team,O
to,O
eat,O

a,O
diet,O
as,O
he,O
wishes,O
.,O

He,O
is,O
going,O
out,O
on,O
a,B-TR
cardiac,I-TR
healthy,I-TR
",",I-TR
diabetic,I-TR
diet,I-TR
",",O
as,O
tolerated,O
with,O
Boost,B-TR
supplements,I-TR
.,O

Infectious,O
disease,O
:,O

The,O
patient,O
had,O
positive,B-PR
blood,I-PR
and,I-PR
urine,I-PR
cultures,I-PR
on,O
01-05,O
for,O
history,O
of,O
Methicillin,B-PR
resistant,I-PR
Staphylococcus,I-PR
aureus,I-PR
",",O
which,O
was,O
pan,B-TE
sensitive,I-TE
.,O

He,O
was,O
started,O
on,O
Oct.,O
25,O
for,O
this,B-PR
bug,I-PR
.,O

On,O
01-08,O
",",O
the,B-TR
patient,I-TR
's,I-TR
central,I-TR
venous,I-TR
line,I-TR
was,O
discontinued,O
.,O

The,B-TE
catheterization,I-TE
tip,I-TE
also,O
grew,O
out,O
Serratia,B-PR
.,O

On,O
the,O
16th,O
",",O
a,B-TE
urine,I-TE
culture,I-TE
was,O
obtained,O
and,O
did,O
grow,O
out,O
greater,O
than,O
"100,000",O
colonies,O
of,O
E.,B-PR
coli,I-PR
which,O
was,O
intermittently,B-PR
resistant,I-PR
to,O
Ciprofloxacin,B-TR
.,O

He,O
was,O
started,O
on,O
Bactrim,B-TR
for,O
that,O
.,O

Please,O
continue,O
Mr.,O
David,O
Montero,O
for,O
one,O
month,O
to,O
fight,O
his,B-PR
blood,I-PR
borne,I-PR
infection,I-PR
",",O
to,O
prevent,O
seeding,O
of,O
his,B-TR
aortic,I-TR
graft,I-TR
and,O
continue,O
Bactrim,B-TR
for,O
ten,O
days,O
after,O
discharge,O
to,O
treat,O
the,B-PR
E.,I-PR
coli,I-PR
in,I-PR
his,I-PR
urine,I-PR
.,O

DISPOSITION,O
:,O

Mr.,O
Douglass,O
is,O
being,O
discharged,O
on,O
2017-01-13,O
to,O
a,O
rehabilitation,O
facility,O
in,O
good,O
condition,O
.,O

FOLLOW-UP,O
:,O

One,O
to,O
two,O
weeks,O
with,O
his,O
primary,O
care,O
physician,O
and,O
two,O
to,O
three,O
weeks,O
with,O
his,O
cardiologist,O
and,O
at,O
one,O
month,O
with,O
Dr.,O
Costello,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

Coronary,B-PR
artery,I-PR
disease,I-PR
",",O
status,O
post,O
coronary,B-TR
artery,I-TR
bypass,I-TR
graft,I-TR
.,O

Critical,B-PR
aortic,I-PR
stenosis,I-PR
",",O
status,O
post,O
aortic,B-TR
valve,I-TR
replacement,I-TR
.,O

Aortic,B-PR
arch,I-PR
aneurysm,I-PR
",",O
status,O
post,O
aortic,B-TR
arch,I-TR
graft,I-TR
.,O

Acute,B-PR
postoperative,I-PR
delirium,I-PR
.,O

Perioperative,B-PR
stroke,I-PR
.,O

Chronic,B-PR
blood,I-PR
loss,I-PR
anemia,I-PR
and,O
chronic,B-TR
RBC,I-TR
transfusion,I-TR
.,O

Urinary,B-PR
tract,I-PR
infection,I-PR
.,O

Hypercholesterolemia,B-PR
.,O

Type,B-PR
II,I-PR
diabetes,I-PR
.,O

Gastroesophageal,B-PR
reflux,I-PR
disease,I-PR
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Metoprolol,B-TR
75,O
mg,O
p.o.,O
twice,O
a,O
day,O
.,O

Captopril,B-TR
12.5,O
mg,O
p.o.,O
three,O
times,O
a,O
day,O
.,O

Aspirin,B-TR
81,O
mg,O
p.o.,O
q.,O
day,O
.,O

Plavix,B-TR
75,O
mg,O
p.o.,O
q.,O
day,O
.,O

Heparin,B-TR
5000,O
units,O
subcutaneous,O
twice,O
a,O
day,O
.,O

Metformin,B-TR
1000,O
mg,O
extended,O
release,O
p.o.,O
q.,O
day,O
.,O

Humalog,B-TR
Max,I-TR
75/25,O
",",O
20,O
units,O
subcutaneous,O
once,O
a,O
day,O
in,O
the,O
morning,O
.,O

Levofloxacin,B-TR
500,O
mg,O
p.o.,O
q.,O
day,O
.,O

Bactrim,B-TR
DS,I-TR
tabs,I-TR
",",O
one,O
tablet,O
p.o.,O
q.,O
day,O
for,O
ten,O
days,O
.,O

Colace,B-TR
100,O
mg,O
p.o.,O
twice,O
a,O
day,O
.,O

Hold,O
for,O
loose,B-PR
stools,I-PR
.,O

Nexium,B-TR
40,O
mg,O
p.o.,O
q.,O
day,O
.,O

Trazodone,B-TR
25,O
mg,O
p.o.,O
q,O
h.s.,O
as,O
needed,O
for,O
sleep,O
.,O

Lasix,B-TR
20,O
mg,O
p.o.,O
q.,O
day,O
for,O
one,O
week,O
.,O

KCl,B-TR
20,O
mg,O
p.o.,O
q.,O
day,O
for,O
one,O
week,O
.,O

Dolly,O
V,O
Blevins,O
",",O
M.D.,O

04-100,O

Dictated,O
By,O
:,O
Kenneth,O
O.,O
Hogan,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2017-01-12,O
11:35,O

T,O
:,O
2017-01-13,O
05:30,O

JOB,O
#:,O

92344,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Dolly,O
D.F.,O
Sipes,O
on:,O
Roxane,O
2017-02-21,O
11:52,O
AM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2014-02-21,O

Discharge,O
Date,O
:,O

2014-03-25,O

Date,O
of,O
Birth,O
:,O

1928-07-25,O

Sex,O
:,O

F,O

Service,O
:,O

SURGERY,O

Allergies,O
:,O

Sulfa,B-TR
(,I-TR
Sulfonamides,I-TR
),I-TR

Attending,O
:,O
Mattie,O
R.,O
A.,O
Hamilton,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Nausea,B-PR
",",O
vomiting,B-PR
",",O
Abdominal,B-PR
pain,I-PR
",",O
distention,B-PR
.,O

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

1.,O
Subtotal,B-TR
colectomy,I-TR
",",O
end,B-TR
ileostomy,I-TR
",",O
Hartmann's,B-TR
pouch,I-TR
",",O
G-tube,B-TR

2.,O
Completion,B-TR
sigmoid,I-TR
colectomy,I-TR
",",O
repair,B-TR
of,O
colovesicular,B-PR
fistula,I-PR
",",O
small,B-TR
bowel,I-TR
repair,I-TR

History,O
of,O
Present,O
Illness,O
:,O

Ms,O
Crossman,O
is,O
an,O
84,O
year,O
old,O
female,O
with,O
complaints,O
of,O
abdominal,B-PR
pain,I-PR
",",O
diarrhea,B-PR
",",O
nausea,B-PR
and,O
vomiting,B-PR
x,O
1,O
week,O
",",O
who,O
presented,O
to,O
an,O
outside,O
hospital,O
.,O

She,O
was,O
transferred,O
to,O
Arbour,O
Hospital,O
on,O
2015-02-21,O
for,O
bowel,B-PR
obstruction,I-PR
",",O
ischemia,B-PR
and,O
worsening,B-PR
abdominal,I-PR
distention,I-PR
and,O
pain,B-PR
.,O

Past,O
Medical,O
History,O
:,O

CAD,B-PR
s/p,O
MI,B-PR
",",O
HTN,B-PR
",",O
DMII,B-PR

Social,O
History,O
:,O

Lives,O
independently,O
",",O
but,O
in,O
the,O
same,O
building,O
with,O
daughter,O
.,O

Amy,O
3,O
children,O
",",O
2,O
daughters,O
and,O
1,O
son,O
.,O

Daughter,O
Lurline,O
is,O
Durable,O
Power,O
of,O
Attorney,O
.,O

The,O
other,O
daughter,O
was,O
recently,O
in,O
a,O
car,O
accident,O
and,O
underwent,O
surgery,B-TR
at,O
Saint,O
Vincent,O
Hospital,O
.,O

Family,O
History,O
:,O

NC,O

Physical,O
Exam,O
:,O

At,O
time,O
of,O
discharge,O
:,O

Afebrile,B-PR
",",O
VSS,O

A&O,O
X,O
3,O
",",O
NAD,B-PR

RRR,O

CTAB,O
",",O
mildly,B-PR
decreased,I-PR
breath,I-PR
sounds,I-PR
b/l,I-PR

Abd,O
soft,O
",",O
NT/ND,B-PR
",",O
+,O
bs,O
",",O
no,O
masses,B-PR
",",O
ostomy,B-TR
in,I-TR
RLQ,I-TR
pink,O
",",O
with,O
stool,O

G-tube,B-TR
in,O
place,O

LE,B-PR
trace,I-PR
edema,I-PR

Pertinent,O
Results,O
:,O

2014-02-21,O
12:20,O
PM,O
BLOOD,B-TE
WBC,B-TE
-,O
10.2,O
RBC,B-TE
-,O
5.32,O
Hgb,B-TE
-,O
14.9,O
Hct,B-TE
-,O
43.4,O
MCV,B-TE
-,O
82,O
MCH,B-TE
-,O
28.0,O
MCHC,B-TE
-,O
34.4,O
RDW,B-TE
-,O
16.0,O
*,O
Plt,B-TE
Ct,I-TE
-,O
204,O

2014-02-21,O
12:20,O
PM,O
BLOOD,B-TE
PT,B-TE
-,O
12.9,O
PTT,B-TE
-,O
32.5,O
INR(PT),B-TE
-,O
1.1,O

2014-02-21,O
12:20,O
PM,O
BLOOD,B-TE
Glucose,B-TE
-,O
345,O
*,O
UreaN,B-TE
-,O
34,O
*,O
Creat,B-TE
-,O
1.0,O
Na,B-TE
-,O
137,O
K,B-TE
-,O
4.3,O
Cl,B-TE
-,O
99,O
HCO3,B-TE
-,O
24,O
AnGap,B-TE
-,O
18,O

2014-02-21,O
12:20,O
PM,O
BLOOD,B-TE
ALT,B-TE
-,O
17,O
AST,B-TE
-,O
27,O
AlkPhos,B-TE
-,O
119,O
*,O
Amylase,B-TE
-,O
27,O
TotBili,B-TE
-,O
0.9,O

2014-02-21,O
12:20,O
PM,O
BLOOD,B-TE
Lipase,B-TE
-,O
11,O

2014-02-21,O
12:20,O
PM,O
BLOOD,B-TE
CK-MB,B-TE
-,O
7,O
cTropnT,B-TE
-<,O
0.01,O

2014-03-09,O
02:59,O
AM,O
BLOOD,B-TE
cTropnT,B-TE
-,O
0.21,O
*,O

2014-03-09,O
11:29,O
AM,O
BLOOD,B-TE
CK-MB,B-TE
-,O
35,O
*,O
MB,B-TE
Indx,I-TE
-,O
25.5,O
*,O
cTropnT,B-TE
-,O
0.45,O
*,O

2014-03-09,O
07:52,O
PM,O
BLOOD,B-TE
CK-MB,B-TE
-,O
NotDone,O
cTropnT,B-TE
-,O
0.55,O
*,O

2014-03-10,O
05:25,O
PM,O
BLOOD,B-TE
cTropnT,B-TE
-,O
0.42,O
*,O

2014-03-11,O
02:00,O
AM,O
BLOOD,B-TE
cTropnT,B-TE
-,O
0.45,O
*,O

2014-03-19,O
07:13,O
AM,O
BLOOD,B-TE
CK-MB,B-TE
-,O
3,O
cTropnT,B-TE
-,O
0.19,O
*,O

2014-03-19,O
01:33,O
PM,O
BLOOD,B-TE
CK-MB,B-TE
-,O
NotDone,O
cTropnT,B-TE
-,O
0.17,O
*,O

2014-03-21,O
09:58,O
AM,O
BLOOD,B-TE
CK-MB,B-TE
-,O
NotDone,O
cTropnT,B-TE
-,O
0.06,O
*,O

03-07,O
wound,B-TE
swab,I-TE
:,O
VRE,B-PR

CT,B-TE
Abd,I-TE
02-21,O
:,O

1.,O
Markedly,B-PR
dilated,I-PR
colon,I-PR
throughout,O
ascending,O
",",O
transverse,O
",",O
and,O
descending,O
colon,O
with,O
air-fluid,B-PR
levels,I-PR
",",O
overall,O
unchanged,O
since,O
prior,B-TE
study,I-TE
performed,O
on,O
the,O
same,O
day,O
with,O
pneumatosis,B-PR
in,I-PR
the,I-PR
ascending,I-PR
colon,I-PR
.,O

Sigmoid,B-PR
diverticulosis,I-PR
with,O
focal,B-PR
narrowing,I-PR
of,I-PR
the,I-PR
sigmoid,I-PR
colon,I-PR
just,O
distal,O
to,O
the,B-PR
dilatation,I-PR
with,O
wall,B-PR
thickening,I-PR
",",O
due,O
to,O
diverticulitis,B-PR
.,O

This,O
area,O
can,O
be,O
a,O
leading,O
point,O
of,O
obstruction,B-PR
.,O

An,B-PR
underlying,I-PR
mass,I-PR
lesion,I-PR
or,O
cancer,B-PR
cannot,O
be,O
excluded,O
in,O
this,O
area,O
",",O
and,O
further,B-TE
clinical,I-TE
investigation,I-TE
is,O
recommended,O
.,O

2.,O
Limited,B-TE
evaluation,I-TE
for,O
known,B-PR
sigmoid-vesicle,I-PR
fistula,I-PR
.,O

3.,O
Small,B-PR
amount,I-PR
of,I-PR
ascites,I-PR
",",O
somewhat,O
increased,O
anterior,O
to,O
the,O
liver,O
.,O

4.,O
Bilateral,B-PR
renal,I-PR
cysts,I-PR
.,O

5.,O
Heavy,B-PR
calcification,I-PR
of,I-PR
the,I-PR
aorta,I-PR
and,I-PR
SMA,I-PR
and,I-PR
its,I-PR
branches,I-PR
.,O

Due,O
to,O
atherosclerosis,B-PR
",",O
assessment,B-TE
of,I-TE
the,I-TE
intraluminal,I-TE
process,I-TE
of,O
these,O
branches,O
is,O
limited,O
.,O

CTA/CT,B-TE
abd,I-TE
03-07,O
:,O

1.,O
No,O
evidence,O
of,O
pulmonary,B-PR
embolism,I-PR
.,O

Small,B-PR
bilateral,I-PR
pleural,I-PR
effusions,I-PR
with,O
compressive,B-PR
atelectasis,I-PR
.,O

2.,O
Left,B-PR
lower,I-PR
quadrant,I-PR
thick-walled,I-PR
peripherally,I-PR
enhancing,I-PR
fluid,I-PR
collection,I-PR
",",O
which,O
appears,O
to,O
communicate,O
with,O
the,O
sutured,O
end,O
of,O
the,O
proximal,O
sigmoid,O
colon,O
via,O
a,B-PR
small,I-PR
collection,I-PR
of,I-PR
extraluminal,I-PR
gas,I-PR
.,O

In,O
the,O
correct,O
clincial,O
setting,O
",",O
this,O
could,O
be,O
consistent,O
with,O
an,B-PR
abscess,I-PR
.,O

3.,O
Moderate,B-PR
intraabdominal,I-PR
ascites,I-PR
.,O

4.,O
Status,O
post,O
ileostomy,B-TR
without,O
evidence,O
of,O
small-bowel,B-PR
obstruction,I-PR
.,O

5.,O
Distended,B-PR
gallbladder,I-PR
.,O

6.,O
Diverticulosis,B-PR
within,I-PR
the,I-PR
right,I-PR
remnant,I-PR
sigmoid,I-PR
colon,I-PR
.,O

03-21,O
VCUG,B-TE
-,O
no,O
leak,B-PR

Brief,O
Hospital,O
Course,O
:,O

Ms,O
Crossman,O
was,O
admitted,O
on,O
2015-02-21,O
from,O
an,O
outside,O
hospital,O
to,O
the,O
ICU,O
.,O

Neuro,O
:,O
Developed,O
confusion,B-PR
during,O
her,O
first,O
5,O
days,O
in,O
the,O
ICU,O
.,O

Post-operatively,O
mental,O
status,O
improved,O
.,O

Intermitent,B-PR
delirium,I-PR
throughout,O
admission,O
.,O

Required,O
restraints,B-TR
to,O
prevent,O
DC,O
of,O
pertinent,B-TR
therapies,I-TR
while,O
in,O
the,O
ICU,O
.,O

Currently,O
AAOx3,O
.,O

Cardiovascular,O
:,O
Complained,O
of,O
chest,B-PR
pain,I-PR
during,O
first,O
few,O
days,O
of,O
admission,O
",",O
a,O
cardiology,O
consult,O
was,O
obtained,O
.,O

She,O
recieved,O
serial,B-TE
enzymes,I-TE
and,O
EKGs,B-TE
.,O

Troponins,B-TE
remained,O
mildly,B-PR
elevated,I-PR
as,O
high,O
as,O
0.6,O
throughout,O
her,O
admission,O
",",O
and,O
most,O
recent,O
result,O
now,O
0.1,O
.,O

She,O
was,O
treated,O
in,O
IUC,O
for,O
unstable,B-PR
angina,I-PR
with,O
nitroglycerin,B-TR
.,O

It,O
was,O
recommended,O
to,O
maximize,O
her,B-TR
medical,I-TR
treatment,I-TR
with,O
Beta,B-TR
blockers,I-TR
",",O
aspirin,B-TR
",",O
a,B-TR
statin,I-TR
and,O
an,B-TR
ACE,I-TR
Inhibitor,I-TR
.,O

Required,O
diuresis,B-TR
of,O
>,O
9,O
L,O
while,O
in,O
the,O
ICU,O
",",O
after,O
2nd,B-TR
surgery,I-TR
.,O

Continues,O
to,O
have,O
trace,B-PR
lower,I-PR
extremity,I-PR
edema,I-PR
",",O
and,O
recieves,O
lasix,B-TR
po,I-TR
.,O

Respiratory,O
:,O
She,O
was,O
intubated,B-TR
briefly,O
post-op,O
subtotal,B-TR
colectomy,I-TR
and,O
again,O
for,O
several,O
days,O
after,O
second,B-TR
surgery,I-TR
.,O

Recieved,O
nebulizer,B-TR
treatments,I-TR
post-op,O
in,O
the,O
ICU,O
",",O
after,O
successfully,O
extubated,O
.,O

Gastrointestinal,O
:,O
Her,B-TE
initial,I-TE
CT,I-TE
scan,I-TE
showed,O
dilated,B-PR
Turner,I-PR
colon,I-PR
",",O
wall,B-PR
thickening,I-PR
and,O
pneumatosis,B-PR
see,O
pertinent,O
results,O
.,O

She,O
was,O
initially,O
treated,O
nonoperatively,O
with,O
IV,B-TR
fluids,I-TR
",",O
antibiotics,B-TR
",",O
serial,B-TE
exams,I-TE
and,O
NGT,B-TR
decompression,I-TR
.,O

On,O
HD#5,O
flexible,B-TE
sigmoidoscopy,I-TE
was,O
performed,O
for,O
colonic,B-TR
decompression,I-TR
.,O

On,O
HD#6,O
",",O
colonscopy,B-TE
was,O
performed,O
for,O
decompression,B-TR
",",O
and,O
revealed,O
pseudomembrane,B-PR
and,O
friable,B-PR
colonic,I-PR
tissue,I-PR
.,O

Her,O
abdomen,O
remained,O
tender,B-PR
and,O
distended,B-PR
despite,O
attempted,O
decompression,B-TR
.,O

She,O
was,O
taken,O
to,O
the,O
OR,O
for,O
Subtotal,B-TR
Colectomy,I-TR
",",O
G,B-TR
tube,I-TR
and,O
ileostomy,B-TR
due,O
to,O
unresponsiveness,B-PR
to,O
non-operative,B-TR
treatment,I-TR
.,O

Ileostomy,B-TR
remains,O
pink,O
and,O
intact,O
",",O
draining,O
green-brown,O
soft,O
stool,O
.,O

Her,O
post-operative,O
course,O
continued,O
uneventfully,O
in,O
the,O
ICU,O
",",O
and,O
she,O
was,O
transferred,O
to,O
the,O
floor,O
POD#6,O
.,O

She,O
developed,O
additional,B-PR
abdominal,I-PR
tenderness,I-PR
and,O
distention,B-PR
.,O

Her,B-TE
HCT,I-TE
dropped,O
and,O
she,O
recieved,O
1,B-TR
unit,I-TR
PRBCs,I-TR
.,O

Geriatric,O
consult,O
was,O
obtained,O
to,O
assist,O
with,O
management,O
.,O

On,O
POD#8,O
a,B-TE
CT,I-TE
scan,I-TE
was,O
obtained,O
which,O
revealed,O
an,B-PR
abcess,I-PR
with,O
a,B-PR
colovesicular,I-PR
fistula,I-PR
.,O

She,O
was,O
taken,O
to,O
the,O
OR,O
for,O
exploration,B-TE
and,O
drainage,B-TR
.,O

She,O
recieved,O
further,B-TR
resection,I-TR
of,I-TR
remaining,I-TR
colon,I-TR
",",O
repair,B-TR
of,O
a,B-PR
leak,I-PR
from,I-PR
Relaford,I-PR
pouch,I-PR
and,O
repair,B-TR
of,O
colovesicular,B-PR
fistula,I-PR
.,O

After,O
her,B-TR
2nd,I-TR
surgery,I-TR
she,O
returned,O
to,O
the,O
ICU,O
and,O
improved,O
steadily,O
.,O

Abdomen,O
remained,O
soft,O
and,O
nontender,B-PR
.,O

She,O
remained,O
on,O
IV,B-TR
antibiotics,I-TR
x,O
14,O
days,O
and,O
required,O
pressors,B-TR
for,O
the,O
first,O
few,O
days,O
post-op,O
.,O

Her,B-PR
incision,I-PR
has,O
remained,O
clean,O
",",O
dry,O
",",O
intact,O
",",O
with,O
staples,B-TR
removed,O
on,O
POD#,O
27/18,O
.,O

Genitourinary,O
:,O
She,O
had,O
a,B-TR
foley,I-TR
catheter,I-TR
from,O
the,O
time,O
of,O
admission,O
.,O

POD#,O
23/14,O
she,O
recieved,O
a,B-TE
cystoscopy,I-TE
which,O
revealed,O
no,O
leak,B-PR
.,O

Her,B-TR
foley,I-TR
was,O
subsequently,O
dc,O
'd,O
.,O

Musculoskeletal,O
:,O
Has,O
suffered,O
significant,B-PR
deconditioning,I-PR
since,O
admission,O
",",O
but,O
has,O
consisitently,O
recieved,O
PT,B-TR
.,O

See,O
PT,O
note,O
for,O
further,B-TE
assessment,I-TE
and,O
discussion,O
.,O

Nutrition,O
:,O
She,O
was,O
held,O
NPO,B-TR
at,O
admission,O
",",O
and,O
initiated,O
on,O
TPN,B-TR
by,O
HD#3,O
.,O

Post-operatively,O
she,O
began,O
on,O
TF,B-TR
"s,",I-TR
and,O
the,B-TR
TPN,I-TR
was,O
weaned,O
down,O
.,O

By,O
POD#,O
05-29,O
she,O
was,O
having,O
high,B-PR
residuals,I-PR
on,O
TF,B-TR
"s,",I-TR
so,O
TPN,B-TR
was,O
reinitiated,O
.,O

Tf,B-TR
's,I-TR
were,O
dc,O
'ed,O
prior,O
to,O
second,B-TR
surgery,I-TR
.,O

POD#,O
15/6,O
",",O
she,O
resumed,O
TF,B-TR
's,I-TR
and,O
TPN,B-TR
was,O
tapered,O
again,O
.,O

TF,O
goals,O
were,O
achieved,O
and,O
TPN,B-TR
dc,O
'ed.,O

A,O
diet,O
by,O
mouth,O
was,O
initiated,O
.,O

At,O
time,O
of,O
discharge,O
she,O
is,O
tolerating,O
a,O
regular,O
diet,O
with,O
TF,B-TR
's,I-TR
at,O
goal,O
.,O

Patient,O
is,O
an,B-PR
insulin,I-PR
dependent,I-PR
diabetic,I-PR
.,O

She,O
was,O
followed,O
by,O
Cape,O
Cod,O
Hospital,O
Clinic,O
for,O
treatment,B-TR
of,O
persistent,B-PR
hyperglycemia,I-PR
.,O

Pain,B-PR
:,O
Her,B-PR
pain,I-PR
was,O
controlled,O
with,O
IV,B-TR
pain,I-TR
medicines,I-TR
while,O
in,O
ICU,O
.,O

She,O
has,O
been,O
adequately,O
controlled,O
with,O
Tylenol,B-TR
",",O
Motrin,B-TR
&,O
Oxycodone,B-TR
by,O
mouth,O
",",O
per,O
recommendations,O
by,O
Geriatrics,O
.,O

POD#,O
22/15,O
Ms,O
Crossman,O
was,O
transferred,O
to,O
3,O
North,O
where,O
she,O
continued,O
to,O
progress,O
well,O
with,O
PT,B-TR
",",O
increasing,O
PO,O
intake,O
",",O
tolerating,O
TF,B-TR
"s,",I-TR
and,O
weaning,O
from,O
nasal,B-TR
cannula,I-TR
oxygen,I-TR
.,O

She,O
has,O
remained,O
stable,O
with,O
no,O
acute,B-PR
events,I-PR
.,O

She,O
is,O
discharged,O
to,O
rehab,O
on,O
POD#,O
27/18,O
.,O

Medications,O
on,O
Admission,O
:,O

Norvasc,B-TR

Atenolol,B-TR

Isosorbide,B-TR

Lasix,B-TR

Insulin,B-TR

Discharge,O
Medications,O
:,O

1.,O
Heparin,B-TR
(,I-TR
Porcine,I-TR
),I-TR
"5,000",O
unit,O
/,O
mL,O
Solution,O
Sig,O
:,O
One,O
(,O
1,O
),O
mL,O
Injection,O
TID,O
(,O
3,O
times,O
a,O
day,O
).,O

2.,O
Acetaminophen,B-TR
325,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
.,O

3.,O
Polyvinyl,B-TR
Alcohol,I-TR
-,O
Povidone,B-TR
1.4-0.6,O
%,O
Dropperette,O
Sig,O
:,O
02-25,O
Drops,O
Ophthalmic,O
PRN,O
(,O
as,O
needed,O
).,O

4.,O
Metoprolol,B-TR
Tartrate,I-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
).,O

5.,O
Aspirin,B-TR
81,O
mg,O
Tablet,O
",",O
Chewable,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Chewable,O
PO,O
DAILY,O
(,O
Daily,O
).,O

6.,O
Atorvastatin,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

7.,O
Lisinopril,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
0.5,O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

8.,O
Furosemide,B-TR
40,O
mg,O
Tablet,O
Sig,O
:,O
1.5,O
Tablets,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

9.,O
Ipratropium,B-TR
Bromide,I-TR
17,O
mcg,O
/,O
Actuation,O
Aerosol,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Puff,O
Inhalation,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
.,O

10.,O
Albuterol,B-TR
90,O
mcg,O
/,O
Actuation,O
Aerosol,O
Sig,O
:,O
1-2,O
Puffs,O
Inhalation,O
Q6H,O
(,O
every,O
6,O
hours,O
),O
as,O
needed,O
.,O

11.,O
Oxycodone,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q4-6H,O
(,O
every,O
4,O
to,O
6,O
hours,O
),O
as,O
needed,O
for,O
pain,B-PR
.,O

12.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

13.,O
Potassium,B-TR
Chloride,I-TR
20,O
mEq,O
Tab,O
Sust,O
.,O
Rel,O
.,O
Particle,O
/,O
Crystal,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tab,O
Sust,O
.,O
Rel,O
.,O
Particle,O
/,O
Crystal,O
PO,O
once,O
a,O
day,O
.,O

14.,O
Glargine,B-TR

15.,O
Miconazole,B-TR
Nitrate,I-TR
2,O
%,O
Powder,O
Sig,O
:,O
One,O
(,O
1,O
),O
Appl,O
Topical,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
as,O
needed,O
.,O

16.,O
Miconazole,B-TR
Nitrate,I-TR
2,O
%,O
Cream,O
Sig,O
:,O
One,O
(,O
1,O
),O
Appl,O
Topical,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

17.,O
Ibuprofen,B-TR
100,O
mg/5,O
mL,O
Suspension,O
Sig,O
:,O
Twenty,O
(,O
20,O
),O
mL,O
PO,O
Q8H,O
(,O
every,O
8,O
hours,O
),O
as,O
needed,O
.,O

18.,O
Debrox,B-TR
6.5,O
%,O
Drops,O
Sig,O
:,O
Five,O
(,O
5,O
),O
Drop,O
Otic,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
for,O
5,O
days,O
:,O
both,O
ears,O
.,O

19.,O
Trazodone,B-TR
50,O
mg,O
Tablet,O
Sig,O
:,O
1,O
/,O
2-1,O
Tablet,O
PO,O
HS,O
(,O
at,O
bedtime,O
).,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Discharge,O
Diagnosis,O
:,O

Hurtado,B-PR
Colon,I-PR

Diverticulitis,B-PR

S/P,O
Subtotal,B-TR
Colectomy,I-TR
",",O
Ileostomy,B-TR
",",O
Gastrostomy,B-TR
tube,I-TR

S/P,O
Exploratory,B-TE
laparotomy,I-TE
",",O
resection,B-TR
of,I-TR
small,I-TR
intestine,I-TR
with,O
primary,B-TR
anastomosis,I-TR
",",O
Sigmoid,B-TR
colectomy,I-TR
",",O
repair,B-TR
of,O
colovesicular,B-PR
fistula,I-PR

Unstable,B-PR
Angina,I-PR

Discharge,O
Condition,O
:,O

stable,O

Discharge,O
Instructions,O
:,O

Please,O
call,O
the,O
surgeon,O
or,O
return,O
to,O
the,O
Emergency,O
Department,O
if,O
you,O
develop,O
chest,B-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
fever,B-PR
greater,I-PR
than,I-PR
101.5,I-PR
",",O
foul,B-PR
smelling,I-PR
or,I-PR
colorful,I-PR
drainage,I-PR
from,O
your,B-PR
incisions,I-PR
",",O
redness,B-PR
or,O
swelling,B-PR
",",O
severe,B-PR
abdominal,I-PR
pain,I-PR
or,O
distention,B-PR
",",O
persistent,B-PR
nausea,I-PR
or,O
vomiting,B-PR
",",O
inability,B-PR
to,I-PR
eat,I-PR
or,I-PR
drink,I-PR
",",O
or,O
any,O

other,B-PR
symptoms,I-PR
which,O
are,O
concerning,O
to,O
you,O
.,O

No,O
tub,O
baths,O
or,O
swimming,O
.,O

You,O
may,O
shower,O
.,O

If,O
there,O
is,O
clear,B-PR
drainage,I-PR
from,O
your,B-PR
incisions,I-PR
",",O
cover,O
with,O
a,B-TR
dry,I-TR
dressing,I-TR
.,O

Leave,O
white,B-TR
strips,I-TR
above,O
your,B-PR
incisions,I-PR
in,O
place,O
",",O
allow,O
them,O
to,O
fall,O
off,O
on,O
their,O
own,O
.,O

Activity,O
:,O
No,O
heavy,O
lifting,O
of,O
items,O
12-08,O
pounds,O
until,O
the,O
follow,O
up,O
appointment,O
with,O
your,O
doctor,O
.,O

Medications,O
:,O
Resume,O
your,O
home,B-TR
medications,I-TR
.,O

You,O
should,O
take,O
a,B-TR
stool,I-TR
softener,I-TR
",",O
Colace,B-TR
100,O
mg,O
twice,O
daily,O
as,O
needed,O
for,O
constipation,B-PR
.,O

You,O
will,O
be,O
given,O
pain,B-TR
medication,I-TR
which,O
may,O
make,O
you,O
drowsy,B-PR
.,O

Followup,O
Instructions,O
:,O

Provider,O
:,O
Joe,O
Kari,O
",",O
MD,O
Phone,O
:(,O
625,O
),O
747-8259,O

Date,O
/,O
Time,O
:,O
2014-04-11,O
1:15,O

Joe,O
Kari,O
MD,O
09-697,O

Completed,O
by,O
:,O
Carol,O
Robert,O
NP,O
80-CIY,O
2014-03-25,O
@,O
0837,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Marion,O
SCHNEIDER,O
on,O
:,O
Sandra,O
2014-03-25,O
12:56,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2012-06-07,O

Discharge,O
Date,O
:,O

2012-06-09,O

Date,O
of,O
Birth,O
:,O

1963-12-03,O

Sex,O
:,O

M,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,I-PR
Drugs,I-PR

Attending,O
:,O
Christopher,O
KJ,O
Cater,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Overdose,B-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

NG,B-TR
tube,I-TR

History,O
of,O
Present,O
Illness,O
:,O

Mr.,O
Vazquez,O
is,O
a,O
48,O
year,O
old,O
man,O
with,O
a,O
history,O
of,O
hepatitis,B-PR
C,I-PR
",",O
bipolar,B-PR
disorder,I-PR
with,O
suicide,O
attempts,O
in,O
the,O
past,O
",",O
recent,O
CMED,O
admit,O
earlier,O
in,O
4/05,O
who,O
was,O
found,O
alert,O
approximately,O
one,O
hour,O
after,O
taking,O
an,O
unspecified,O
number,O
of,O
pills,B-TR
.,O

Per,O
report,O
",",O
there,O
were,O
empty,O
bottles,O
of,O
Inderal,B-TR
and,O
Klonopin,B-TR
found,O
at,O
bedside,O
",",O
as,O
well,O
as,O
02-26,O
full,O
bottles,O
of,O
geodon,B-TR
",",O
gabapentin,B-TR
",",O
Lescol,B-TR
and,O
paroxitine,B-TR
.,O

The,O
patient,O
was,O
reportedly,O
alert,O
at,O
scene,O
",",O
and,O
then,O
became,O
unresponsive,B-PR
in,O
route,O
to,O
the,O
hospital,O
.,O

In,O
the,O
Rita,O
",",O
the,O
patient,O
was,O
intubated,O
and,O
given,O
activated,B-TR
charcoal,I-TR
.,O

His,B-TE
initial,I-TE
BP,I-TE
was,O
60/P,O
with,O
a,B-TE
pulse,I-TE
in,O
the,O
60,O
s.,O

He,O
was,O
given,O
4,O
amps,O
of,O
calcium,B-TR
gluconate,I-TR
",",O
and,O
started,O
on,O
a,B-TR
Calcium,I-TR
gtt,I-TR
.,O

He,O
was,O
also,O
given,O
5mg,O
of,O
glucagon,B-TR
and,O
started,O
on,O
a,B-TR
glucagon,I-TR
drip,I-TR
with,O
good,O
response,O
.,O

His,B-TE
urine,I-TE
and,O
serum,B-TE
tox,I-TE
screens,I-TE
were,O
notable,O
only,O
for,O
benzos,B-TR
",",O
otherwise,O
negative,O
.,O

He,O
was,O
seen,O
by,O
cardiology,O
",",O
and,O
toxicology,O
was,O
consulted,O
via,O
telephone,O
.,O

He,O
was,O
admitted,O
to,O
the,O
CMED,O
",",O
intubated,O
for,O
airway,B-TR
protection,I-TR
and,O
started,O
on,O
both,O
a,B-TR
calcium,I-TR
and,I-TR
glucagon,I-TR
drip,I-TR
.,O

There,O
was,O
evidence,O
of,O
possible,O
aspiration,B-PR
pneumonia,I-PR
on,O
CXR,B-TE
",",O
though,O
he,O
was,O
extubated,O
without,O
incident,O
on,O
the,O
AM,O
of,O
transfer,O
to,O
the,O
medicine,O
floor,O
.,O

CMED,O
was,O
made,O
aware,O
",",O
and,O
they,O
are,O
actively,O
involved,O
in,O
his,O
care,O
.,O

Past,O
Medical,O
History,O
:,O

Hep,B-PR
C,I-PR

Bipolar,B-PR
D/O,I-PR
with,O
one,O
suicide,O
attempt,O
by,O
overdose,B-PR
several,O
years,O
ago,O

Agoraphobia,B-PR

Panic,B-PR
disorder,I-PR

Narcissism,B-PR

No,O
history,O
of,O
head,B-PR
trauma,I-PR
or,O
seizure,B-PR
disorder,I-PR

Social,O
History,O
:,O

Denies,O
alcohol,O
use,O
.,O

Has,O
a,O
history,O
of,O
cocaine,O
abuse,O
-,O
in,O
remission,O
for,O
6,O
years,O
",",O
with,O
one,O
relapse,O
2.5,O
years,O
ago,O
.,O

Has,O
a,O
history,O
of,O
qualude,O
use,O
since,O
high,O
school,O
",",O
also,O
in,O
remission,O
.,O

Denies,O
use,O
of,O
AA/NA,O
.,O
Smokes,O
1ppd,O
.,O

Patient,O
lives,O
at,O
home,O
with,O
his,O
mother,O
",",O
father,O
and,O
brother,O
.,O

Reports,O
that,O
he,O
has,O
suffered,O
from,O
anxiety,B-PR
since,O
childhood,O
and,O
needed,O
to,O
drop,O
out,O
of,O
college,O
.,O

Unemployed,O
and,O
on,O
disability,O
.,O

Waiting,O
for,O
a,O
subsidized,O
apartment,O
.,O

No,O
current,O
relationship,O
.,O

Family,O
History,O
:,O

Denies,O
.,O

Physical,O
Exam,O
:,O

Vitals,B-TE
:,O
99.3,O

Gen,O
:,O
caucasian,O
man,O
lying,O
in,O
bed,O
",",O
NAD,B-PR

HEENT,O
:,O
NCAT,O
",",O
PERRL,O
",",O
EOMI,O
",",O
no,O
icterus,B-PR
",",O
OP,O
clear,O
",",O
MMM,O
",",O
no,O
tongue,B-PR
fasciculations,I-PR

Neck,O
:,O
supple,O
",",O
no,O
LAD,B-PR
",",O
no,O
JVD,B-PR

CV,O
:,O
RRR,O
",",O
nl,O
s1,O
s2,O
",",O
no,O
m/g/r,B-PR

Lungs,O
:,O
?,O
decreased,B-PR
BS,I-PR
over,I-PR
left,I-PR
middle,I-PR
lung,I-PR
",",O
otherwise,O
CTA,O

Abd,O
:,O
normal,O
size,O
",",O
nd,B-PR
",",O
no,O
scars,B-PR
",",O
nl,O
bs,O
",",O
soft,O
",",O
nt,B-PR
",",O
palp,O
liver,O

Ext,O
:,O
no,O
c/c/e,B-PR
",",O
no,O
edema,B-PR

Neuro,O
:,O
no,O
asterixis,B-PR
",",O
CN,O
II-XII,O
intact,O
",",O
5/5,O
strength,O
throughout,O
",",O
sensation,O
to,O
LT,B-TE
intact,O
throughout,O
",",O
gait,O
deferred,O

CMED,O
:,O
A+Ox3,O
",",O
mood,O
"",O
great,O
",""",O
affect,O
approp,O
",",O
speech,B-PR
stuttering,I-PR
",",O
linear,O
TP,O
",",O
no,O
SI,B-PR
or,O
HI,B-PR

Pertinent,O
Results,O
:,O

Labs,O
on,O
admit,O
:,O

2012-06-07,O
09:55,O
PM,O
BLOOD,B-TE
WBC,B-TE
-,O
8.9,O
RBC,B-TE
-,O
4.94,O
Hgb,B-TE
-,O
15.8,O
Hct,B-TE
-,O
45.3,O
MCV,B-TE
-,O
92,O
MCH,B-TE
-,O
31.9,O
MCHC,B-TE
-,O
34.8,O
RDW,B-TE
-,O
12.4,O
Plt,B-TE
Ct,I-TE
-,O
175,O

2012-06-07,O
09:55,O
PM,O
BLOOD,B-TE
Neuts,B-TE
-,O
49.9,O
*,O
Lymphs,B-TE
-,O
42.4,O
*,O
Monos,B-TE
-,O
5.5,O
Eos,B-TE
-,O
1.6,O
Baso,B-TE
-,O
0.6,O

2012-06-07,O
09:55,O
PM,O
BLOOD,B-TE
Plt,B-TE
Ct,I-TE
-,O
175,O

2012-06-07,O
09:55,O
PM,O
BLOOD,B-TE
PT,B-TE
-,O
12.8,O
PTT,B-TE
-,O
25.7,O
INR(PT),B-TE
-,O
1.0,O

2012-06-07,O
09:55,O
PM,O
BLOOD,B-TE
Glucose,B-TE
-,O
108,O
*,O
UreaN,B-TE
-,O
13,O
Creat,B-TE
-,O
0.7,O
Na,B-TE
-,O
146,O
*,O
K,B-TE
-,O
3.7,O
Cl,B-TE
-,O
109,O
*,O
HCO3,B-TE
-,O
30,O
*,O
AnGap,B-TE
-,O
11,O

2012-06-07,O
09:55,O
PM,O
BLOOD,B-TE
Albumin,B-TE
-,O
3.9,O
Calcium,B-TE
-,O
8.5,O
Phos,B-TE
-,O
4.2,O
Mg,B-TE
-,O
2.0,O

2012-06-07,O
09:55,O
PM,O
BLOOD,B-TE
ALT,B-TE
-,O
44,O
*,O
AST,B-TE
-,O
31,O
AlkPhos,B-TE
-,O
36,O
*,O
TotBili,B-TE
-,O
0.2,O

2012-06-07,O
09:55,O
PM,O
BLOOD,B-TE
ASA,B-TE
-,O
NEG,O
Ethanol,B-TE
-,O
NEG,O
Acetmnp,B-TE
-,O
NEG,O
Bnzodzp,B-TE
-,O
NEG,O
Barbitr,B-TE
-,O
NEG,O
Tricycl,B-TE
-,O
NEG,O

Labs,O
today,O
:,O

2012-06-08,O
09:30,O
AM,O
BLOOD,B-TE
WBC,B-TE
-,O
10.1,O
RBC,B-TE
-,O
4.35,O
*,O
Hgb,B-TE
-,O
14.2,O
Hct,B-TE
-,O
39.9,O
*,O
MCV,B-TE
-,O
92,O
MCH,B-TE
-,O
32.6,O
*,O
MCHC,B-TE
-,O
35.6,O
*,O
RDW,B-TE
-,O
12.4,O
Plt,B-TE
Ct,I-TE
-,O
151,O

2012-06-08,O
09:30,O
AM,O
BLOOD,B-TE
Glucose,B-TE
-,O
115,O
*,O
UreaN,B-TE
-,O
14,O
Creat,B-TE
-,O
0.8,O
Na,B-TE
-,O
142,O
K,B-TE
-,O
4.1,O
Cl,B-TE
-,O
112,O
*,O
HCO3,B-TE
-,O
26,O
AnGap,B-TE
-,O
8,O

2012-06-08,O
09:30,O
AM,O
BLOOD,B-TE
Calcium,B-TE
-,O
10.4,O
*,O
Phos,B-TE
-,O
2.8,O
Mg,B-TE
-,O
1.8,O

2012-06-08,O

CXR,B-TE
:,O

An,B-TR
endotracheal,I-TR
tube,I-TR
terminates,O
just,O
above,O
the,O
thoracic,O
inlet,O
approximately,O
6.5,O
cm,O
above,O
the,O
carina,O
.,O

The,B-TR
nasogastric,I-TR
tube,I-TR
terminates,O
within,O
the,O
stomach,O
.,O

Cardiac,O
and,O
mediastinal,O
contours,O
are,O
within,O
normal,O
limits,O
.,O

There,O
is,O
a,B-PR
patchy,I-PR
area,I-PR
of,I-PR
increased,I-PR
opacity,I-PR
in,O
the,O
left,O
retrocardiac,O
region,O
",",O
which,O
was,O
not,O
seen,O
on,O
the,B-TE
earlier,I-TE
study,I-TE
.,O

Right,O
lung,O
is,O
clear,O
.,O

Left,O
costophrenic,O
angle,O
has,O
been,O
excluded,O
from,O
the,B-TE
study,I-TE
and,O
cannot,O
be,O
assessed,O
.,O

There,O
is,O
no,O
evidence,O
of,O
right,B-PR
pleural,I-PR
effusion,I-PR
or,O
right,B-PR
pneumothorax,I-PR
.,O

IMPRESSION,O
:,O

1),O
Endotracheal,B-TR
tube,I-TR
is,O
slightly,O
proximal,O
in,O
location,O
",",O
and,O
could,O
be,O
advanced,O
approximately,O
1.5,O
cm,O
for,O
more,O
optimal,O
placement,O
.,O

2),O
Patchy,B-PR
left,I-PR
retrocardiac,I-PR
opacity,I-PR
which,O
may,O
be,O
due,O
to,O
patchy,B-PR
atelectasis,I-PR
",",O
aspiration,B-PR
",",O
or,O
early,B-PR
pneumonia,I-PR
.,O

Followup,B-TE
radiograph,I-TE
suggested,O

Brief,O
Hospital,O
Course,O
:,O

A/P,O
:,O
48yo,O
man,O
with,O
h/o,O
HCV,B-PR
",",O
bipolar,B-PR
DO,I-PR
",",O
h/o,O
suicide,O
attempts,O
",",O
a/w,O
overdose,B-PR
of,O
Inderal,B-TR
",",O
Klonopin,B-TR
",",O
Geodon,B-TR
",",O
s/T,O
Jackson,O
stay,O
with,O
intubation,B-TR
for,O
airway,B-TR
protection,I-TR
",",O
with,O
question,O
of,O
L,B-PR
retrocardiac,I-PR
infiltrate,I-PR
",",O
now,O
doing,O
well,O
.,O

Overdose,O
:,O

Bipolar,B-PR
disorder,I-PR
:,O

-,O
appreciate,O
CMED,O
consult,O
;,O
patient,O
to,O
be,O
discharged,O
to,O
inpatient,O
CMED,O
facility,O
once,O
stable,O

Activity,O
:,O
OOB,O
with,O
assist,O

FEN,O
:,O
house,O
diet,O

PPX,O
:,O
SC,B-TR
heparin,I-TR
",",O
bowel,B-TR
regimen,I-TR
",",O
nicotine,B-TR
patch,I-TR

CODE,O
:,O
full,O

DISPO,O
:,O
transfer,O
to,O
inpatient,O
CMED,O
likely,O
tomorrow,O

Medications,O
on,O
Admission,O
:,O

Neurontin,B-TR
800,O
mg,O
tid,O

Ziprasidone,B-TR
bid,O

Propanolol,B-TR
20,O
mg,O
tid,O

Klonopin,B-TR
2,O
mg,O
tid,O

Paxil,B-TR
30,O
mg,O
qd,O

Protonix,B-TR
40,O
mg,O
qd,O

Folate,B-TR
1,O
mg,O
qd,O

Lescol,B-TR
40,O
qd,O

Discharge,O
Disposition,O
:,O

Home,O

Discharge,O
Diagnosis,O
:,O

Depression,B-PR

Discharge,O
Condition,O
:,O

Depressed,B-PR

Discharge,O
Instructions,O
:,O

Going,O
to,O
UMass,O
Memorial,O
Medical,O
Center,O
4,O
.,O

Followup,O
Instructions,O
:,O

Please,O
f,O
/,O
u,O
with,O
PCP,O
D,O
2,O
weeks,O
.,O

Joseph,O
Judy,O
MD,O
35-943,O

Completed,O
by,O
:,O
John,O
Konderla,O
MD,O
01-196,O
2012-06-09,O
@,O
1707,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Felix,O
Garcia,O
on,O
:,O
FRI,O
2012-06-15,O
4:29,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2013-02-12,O

Discharge,O
Date,O
:,O

2013-02-16,O

Date,O
of,O
Birth,O
:,O

1937-03-25,O

Sex,O
:,O

F,O

Service,O
:,O

CARDIOTHORACIC,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
was,O
referred,O
from,O
an,O
outside,O
hospital,O
with,O
a,O
chief,O
complaint,O
of,O
increasing,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
and,O
tires,B-PR
easily,I-PR
with,O
exertion,O
.,O

Admitted,O
to,O
Bay,O
State,O
Medical,O
Center,O
Hospital,O
in,O
2012-10-22,O
in,O
congestive,B-PR
heart,I-PR
failure,I-PR
at,O
that,O
time,O
.,O

Via,O
echocardiogram,B-TE
",",O
found,O
to,O
have,O
aortic,B-PR
stenosis,I-PR
.,O

Referred,O
to,O
Memorial,O
Hospital,O
(,O
Worcester,O
),O
for,O
cardiac,B-TE
catheterization,I-TE
to,O
further,O
evaluate,O
her,B-PR
aortic,I-PR
stenosis,I-PR
.,O

Cardiac,B-TE
catheterization,I-TE
done,O
on,O
01-07,O
showed,O
an,B-TE
aortic,I-TE
valve,I-TE
area,I-TE
of,O
.38,O
cm.sq.,O
",",O
with,O
a,B-TE
mean,I-TE
gradient,I-TE
of,O
62,O
",",O
and,O
a,B-TE
peak,I-TE
gradient,I-TE
of,O
85,O
.,O

Moderate,B-PR
pulmonary,I-PR
hypertension,I-PR
",",O
PA,B-TE
pressure,I-TE
48/24,O
",",O
1+,B-PR
mitral,I-PR
regurgitation,I-PR
",",O
severe,B-PR
aortic,I-PR
stenosis,I-PR
with,O
an,B-TE
LVEDP,I-TE
of,O
19,O
and,O
an,B-TE
ejection,I-TE
fraction,I-TE
of,O
43%,O
.,O

She,O
was,O
then,O
referred,O
to,O
Cardiothoracic,O
Surgery,O
for,O
aortic,B-TR
valve,I-TR
replacement,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Aortic,B-PR
stenosis,I-PR

2.,O
Diabetes,B-PR
mellitus,I-PR
Type,I-PR
2,I-PR

3.,O
Right,B-TR
hip,I-TR
replacement,I-TR

4.,O
Noninsulin,B-PR
dependent,I-PR
diabetes,I-PR
mellitus,I-PR

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Include,O
Glucovance,B-TR
5/500,O
one,O
tablet,O
twice,O
a,O
day,O
",",O
Univasc,B-TR
7.5,O
mg,O
once,O
daily,O
",",O
lasix,B-TR
20,O
mg,O
every,O
other,O
day,O
",",O
and,O
aspirin,B-TR
325,O
mg,O
once,O
daily,O
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

FAMILY,O
HISTORY,O
:,O

Significant,O
for,O
her,O
father,O
",",O
who,O
died,O
at,O
50,O
years,O
from,O
myocarditis,B-PR
.,O

SOCIAL,O
HISTORY,O
:,O

She,O
lives,O
alone,O
in,O
Methuen,O
with,O
five,O
stairs,O
.,O

She,O
has,O
a,O
remote,O
tobacco,O
history,O
",",O
quit,O
in,O
October,O
",",O
one,O
pack,O
per,O
day,O
for,O
50,O
years,O
.,O

No,O
alcohol,O
use,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Vital,O
signs,O
:,O

Heart,B-TE
rate,I-TE
108,O
and,O
regular,O
",",O
blood,B-TE
pressure,I-TE
145/76,O
",",O
respiratory,B-TE
rate,I-TE
20,O
",",O
height,B-TE
5'2"",O
",",O
weight,B-TE
141,O
pounds,O
.,O

General,O
:,O

Healthy-appearing,O
woman,O
",",O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

Skin,O
:,O

No,O
lesions,B-PR
or,O
rashes,B-PR
.,O

Head,O
",",O
eyes,O
",",O
ears,O
",",O
nose,O
and,O
throat,O
:,O

Pupils,O
equal,O
",",O
round,O
and,O
reactive,O
to,O
light,O
",",O
extraocular,O
movements,O
intact,O
",",O
anicteric,B-PR
",",O
not,O
injected,B-PR
.,O

Oropharynx,O
:,O

Mucous,O
membranes,O
moist,O
.,O

Neck,O
:,O

Supple,O
",",O
no,O
lymphadenopathy,B-PR
",",O
no,O
jugular,B-PR
venous,I-PR
distention,I-PR
",",O
no,O
thyromegaly,B-PR
.,O

Chest,O
:,O

Clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

Heart,O
:,O

Regular,O
rate,O
and,O
rhythm,O
",",O
S1,O
",",O
S2,O
",",O
with,O
III/VI,B-PR
blowing,I-PR
murmur,I-PR
.,O

Abdomen,O
:,O

Soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
",",O
normal,O
active,O
bowel,O
sounds,O
",",O
no,O
hepatosplenomegaly,B-PR
.,O

Extremities,O
:,O

Warm,O
and,O
well,O
perfused,O
",",O
with,O
no,O
cyanosis,B-PR
",",O
clubbing,B-PR
or,O
edema,B-PR
",",O
no,O
varicosities,B-PR
.,O

Neurological,O
:,O

Cranial,O
nerves,O
II,O
through,O
XII,O
grossly,O
intact,O
.,O

Moves,O
all,O
extremities,O
.,O

Strength,B-TE
5/5,O
in,O
upper,O
and,O
lower,O
extremities,O
.,O

Sensation,O
intact,O
in,O
all,O
dermatomes,O
.,O

Pulses,B-TE
:,O

Femoral,B-TE
2,O
+,O
bilaterally,O
",",O
dorsalis,B-TE
pedis,I-TE
1,O
+,O
bilaterally,O
",",O
posterior,B-TE
tibial,I-TE
1,O
+,O
bilaterally,O
",",O
and,O
radial,B-TE
2,O
+,O
bilaterally,O
.,O

No,O
carotid,B-PR
bruits,I-PR
were,O
noted,O
.,O

LABORATORY,O
DATA,O
:,O

White,B-TE
count,I-TE
5.3,O
",",O
hematocrit,B-TE
43,O
",",O
platelets,B-TE
200,O
.,O

Sodium,B-TE
138,O
",",O
potassium,B-TE
4.9,O
",",O
chloride,B-TE
102,O
",",O
CO2,B-TE
25,O
",",O
BUN,B-TE
24,O
",",O
creatinine,B-TE
0.9,O
",",O
glucose,B-TE
309,O
.,O

Electrocardiogram,B-TE
:,O

Rate,B-TE
of,O
91,O
",",O
first,B-PR
degree,I-PR
AV,I-PR
block,I-PR
",",O
intervals,B-TE
.22,O
",",O
.92,O
",",O
.36,O
",",O
with,O
left,B-PR
ventricular,I-PR
hypertrophy,I-PR
.,O

Chest,B-TE
x-ray,I-TE
is,O
pending,O
at,O
the,O
time,O
of,O
physical,B-TE
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
a,O
direct,O
admission,O
to,O
the,O
operating,O
room,O
on,O
02-12,O
",",O
at,O
which,O
time,O
she,O
underwent,O
an,O

aortic,B-TR
valve,I-TR
replacement,I-TR
.,O

Please,O
see,O
the,O
operative,O
report,O
for,O
full,O
details,O
.,O

In,O
summary,O
",",O
she,O
had,O
an,B-TR
aortic,I-TR
valve,I-TR
replacement,I-TR
with,O
a,B-TR
#21,I-TR
mosaic,I-TR
porcine,I-TR
valve,I-TR
.,O

She,O
tolerated,O
the,B-TR
operation,I-TR
well,O
",",O
and,O
was,O
transferred,O
from,O
the,O
operating,O
room,O
to,O
the,O
Cardiothoracic,O
Intensive,O
Care,O
Unit,O
.,O

The,O
patient,O
did,O
well,O
in,O
the,O
immediate,O
postoperative,O
period,O
",",O
however,O
",",O
her,B-TE
blood,I-TE
pressure,I-TE
remained,O
somewhat,B-PR
labile,I-PR
.,O

Therefore,O
",",O
she,O
was,O
continued,O
on,O
a,B-TR
Neo-Synephrine,I-TR
drip,I-TR
to,O
maintain,O
a,B-TE
systolic,I-TE
blood,I-TE
pressure,I-TE
greater,O
than,O
110,O
.,O

In,O
addition,O
",",O
she,O
was,O
slow,O
to,O
awaken,O
after,O
her,B-TR
anesthesia,I-TR
was,O
reversed,O
",",O
and,O
in,O
several,O
attempts,O
to,O
wean,O
from,O
the,B-TR
ventilator,I-TR
",",O
she,O
developed,O
a,B-PR
respiratory,I-PR
acidosis,I-PR
.,O

She,O
therefore,O
remained,O
on,O
the,B-TR
ventilator,I-TR
throughout,O
the,O
day,O
of,O
postoperative,O
day,O
one,O
.,O

On,O
postoperative,O
day,O
two,O
",",O
the,O
patient,O
remained,O
hemodynamically,O
stable,O
.,O

Her,B-TR
Neo-Synephrine,I-TR
drip,I-TR
was,O
weaned,O
to,O
off,O
.,O

She,O
was,O
again,O
weaned,O
from,O
the,B-TR
ventilator,I-TR
",",O
and,O
successfully,O
extubated,O
.,O

Her,B-TR
chest,I-TR
tubes,I-TR
were,O
discontinued,O
and,O
",",O
at,O
the,O
end,O
of,O
the,O
day,O
",",O
she,O
was,O
transferred,O
from,O
the,O
Cardiothoracic,O
Intensive,O
Care,O
Unit,O
to,O
the,O
floor,O
for,O
continuing,B-TR
postoperative,I-TR
care,I-TR
and,O
cardiac,B-TR
rehabilitation,I-TR
.,O

After,O
being,O
transferred,O
to,O
the,O
floor,O
",",O
the,O
patient,O
did,O
well,O
.,O

Over,O
the,O
next,O
several,O
days,O
",",O
her,O
activity,O
level,O
was,O
increased,O
with,O
the,O
assistance,O
of,O
Physical,O
Therapy,O
and,O
the,O
nursing,O
staff,O
.,O

She,O
remained,O
hemodynamically,O
stable,O
.,O

Her,O
respiratory,O
condition,O
remained,O
stable,O
and,O
",",O
on,O
postoperative,O
day,O
four,O
",",O
she,O
was,O
deemed,O
stable,O
and,O
ready,O
to,O
be,O
transferred,O
to,O
rehabilitation,O
for,O
continuing,B-TR
postoperative,I-TR
care,I-TR
and,O
physical,O

therapy,B-TR
.,O

At,O
the,O
time,O
of,O
transfer,O
",",O
the,B-TE
patient,I-TE
's,I-TE
physical,I-TE
examination,I-TE
is,O
as,O
follows,O
:,O

Vital,O
signs,O
:,O

Temperature,B-TE
98.4,O
",",O
heart,B-TE
rate,I-TE
78,O
and,O
sinus,B-TE
rhythm,I-TE
",",O
blood,B-TE
pressure,I-TE
106/50,O
",",O
respiratory,B-TE
rate,I-TE
18,O
",",O
oxygen,B-TE
saturation,I-TE
97%,O
on,O
room,O
air,O
.,O

Weight,B-TE
preoperatively,O
was,O
67,O
kg,O
",",O
at,O
discharge,O
is,O
70.9,O
kg,O
.,O

Laboratory,B-TE
data,I-TE
on,O
02-15,O
:,O

White,B-TE
count,I-TE
4.1,O
",",O
hematocrit,B-TE
23,O
",",O
platelets,B-TE
144,O
.,O

Sodium,B-TE
141,O
",",O
potassium,B-TE
4.3,O
",",O
chloride,B-TE
108,O
",",O
CO2,B-TE
25,O
",",O
BUN,B-TE
24,O
",",O
creatinine,B-TE
0.8,O
",",O
glucose,B-TE
140,O
.,O

Physical,O
examination,O
:,O

Alert,O
and,O
oriented,O
x,O
3,O
",",O
moves,O
all,O
extremities,O
",",O
conversant,O
.,O

Respiratory,O
:,O

Scattered,B-PR
rhonchi,I-PR
with,O
diminished,B-PR
breath,I-PR
sounds,I-PR
in,I-PR
the,I-PR
bases,I-PR
.,O

Cor,O
:,O

Regular,O
rate,O
and,O
rhythm,O
",",O
S1,O
",",O
S2,O
",",O
with,O
soft,B-PR
systolic,I-PR
ejection,I-PR
murmur,I-PR
.,O

Sternum,O
is,O
stable,O
.,O

Incision,B-PR
with,O
staples,B-TR
",",O
open,O
to,O
air,O
",",O
clean,O
and,O
dry,O
.,O

Abdomen,O
:,O

Soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
",",O
normal,O
active,O
bowel,O
sounds,O
.,O

Extremities,O
:,O

Warm,O
and,O
well,O
perfused,O
",",O
with,O
no,O
cyanosis,B-PR
",",O
clubbing,B-PR
or,O
edema,B-PR
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Ranitidine,B-TR
150,O
mg,O
twice,O
a,O
day,O
",",O
enteric-coated,B-TR
aspirin,I-TR
325,O
mg,O
once,O
daily,O
",",O
Glucovance,B-TR
5/500,O
one,O
tablet,O
twice,O
a,O
day,O
",",O
metoprolol,B-TR
25,O
mg,O
twice,O
a,O
day,O
",",O
Furosemide,B-TR
20,O
mg,O
once,O
daily,O
for,O
14,O
days,O
",",O
potassium,B-TR
chloride,I-TR
20,O
mEq,O
once,O
daily,O
for,O
14,O
days,O
",",O
Colace,B-TR
100,O
mg,O
twice,O
a,O
day,O
",",O
Niferex,B-TR
150,O
mg,O
once,O
daily,O
",",O
Percocet,B-TR
5/325,O
one,O
to,O
two,O
tablets,O
every,O
four,O
hours,O
as,O
needed,O
",",O
ibuprofen,B-TR
400,O
mg,O
every,O
six,O
hours,O
as,O
needed,O
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

1.,O
Aortic,B-PR
stenosis,I-PR
status,O
post,O
aortic,B-TR
valve,I-TR
replacement,I-TR
with,O
a,B-TR
#21,I-TR
mosaic,I-TR
porcine,I-TR
valve,I-TR

2.,O
Diabetes,B-PR
mellitus,I-PR
Type,I-PR
2,I-PR

3.,O
Right,B-TR
hip,I-TR
replacement,I-TR

CONDITION,O
ON,O
TRANSFER,O
:,O

Stable,O
.,O

DISCHARGE,O
INSTRUCTIONS,O
:,O

She,O
is,O
to,O
have,O
follow,O
up,O
with,O
Dr.,O
Bloomfield,O
in,O
one,O
month,O
",",O
and,O
follow,O
up,O
in,O
the,O
Wound,O
Clinic,O
in,O
two,O

weeks,O
.,O

Alice,O
S.,O
Shadle,O
",",O
M.D.,O

37-538,O

Dictated,O
By,O
:,O
James,O
F.,O
Buchanan,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2013-02-15,O
18:35,O

T,O
:,O
2013-02-16,O
01:03,O

JOB,O
#:,O

59205,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Richard,O
Gray,O
on,O
:,O
Tommy,O
2013-02-17,O
12:05,O
AM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2015-09-16,O

Discharge,O
Date,O
:,O

2015-09-21,O

Date,O
of,O
Birth,O
:,O

1962-09-26,O

Sex,O
:,O

M,O

Service,O
:,O

CARDIOTHOR,O

REASON,O
FOR,O
ADMISSION,O
:,O

Mitral,B-TR
valve,I-TR
repair,I-TR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
52,O
year,O
old,O
Czech,O
speaking,O
gentleman,O
with,O
a,O
history,O
of,O
severe,B-PR
mitral,I-PR
regurgitation,I-PR
.,O

For,O
the,O
past,O
several,O
years,O
",",O
the,O
patient,O
has,O
continued,O
to,O
have,O
significant,B-PR
exercise,I-PR
intolerance,I-PR
which,O
has,O
limited,O
his,O
ability,O
to,O
work,O
.,O

He,O
reports,O
severe,B-PR
dyspnea,I-PR
on,O
exertion,O
.,O

The,O
patient,O
had,O
a,O
recent,O
admission,O
earlier,O
in,O
the,O
month,O
and,O
he,O
was,O
discharged,O
on,O
2015-09-10,O
",",O
after,O
undergoing,O
cardiac,B-TE
catheterization,I-TE
.,O

This,O
was,O
significant,O
for,O
demonstrating,O
no,O
flow-limited,B-PR
disease,I-PR
in,I-PR
the,I-PR
coronaries,I-PR
but,O
several,B-PR
fistulae,I-PR

from,O
the,O
left,O
anterior,O
descending,O
to,O
the,O
PA,O
.,O

Several,O
of,O
these,O
were,O
coil,B-TR
embolized,I-TR
during,O
this,O
admission,O
.,O

He,O
tolerated,O
this,O
well,O
",",O
was,O
sent,O
home,O
",",O
and,O
now,O
returns,O
for,O
his,B-TR
mitral,I-TR
valve,I-TR
repair,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Mitral,B-PR
valve,I-PR
regurgitation,I-PR
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

None,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

1.,O
Atenolol,B-TR
25,O
mg,O
p.o.,O
q.,O
day,O
.,O

2.,O
Enteric-coated,B-TR
aspirin,I-TR
325,O
mg,O
p.o.,O
q.,O
day,O
.,O

3.,O
Nitroglycerin,B-TR
sublingual,I-TR
p.r.n.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
is,O
currently,O
on,O
Disability,O
and,O
lives,O
at,O
home,O
with,O
his,O
wife,O
.,O

Kimberly,O
was,O
born,O
in,O
Great,O
Britain,O
.,O

He,O
denies,O
any,O
ETOH,O
or,O
tobacco,O
use,O
.,O

FAMILY,O
HISTORY,O
:,O

Negative,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,O
patient,O
is,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

Temperature,B-TE
is,O
98.3,O
F.,O
;,O
pulse,B-TE
is,O
76,O
;,O
blood,B-TE
pressure,I-TE
113/52,O
;,O
breathing,B-TE
18,O
;,O
98%,O
on,O
room,O
air,O
.,O

HEENT,O
:,O

The,O
patient,O
is,O
missing,B-PR
many,I-PR
teeth,I-PR
.,O

Oropharynx,O
is,O
clear,O
.,O

There,O
is,O
no,O
cervical,B-PR
lymphadenopathy,I-PR
.,O

Supple,O
neck,O
.,O

Heart,O
is,O
regular,O
rate,O
and,O
rhythm,O
with,O
a,B-PR
III/VI,I-PR
systolic,I-PR
ejection,I-PR
murmur,I-PR
.,O

His,O
lungs,O
are,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

Abdomen,O
is,O
soft,O
and,O
nontender,B-PR
.,O

The,O
patient,O
has,O
no,O
cyanosis,B-PR
",",O
clubbing,B-PR
or,O
edema,B-PR
in,I-PR
extremities,I-PR
.,O

LABORATORY,O
:,O

On,O
admission,O
include,O
a,B-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
of,O
5.6,O
",",O
hematocrit,B-TE
of,O
32.5,O
",",O
platelets,B-TE
of,O
202,O
.,O

Sodium,B-TE
of,O
140,O
",",O
potassium,B-TE
of,O
3.5,O
",",O
BUN,B-TE
of,O
4,O
",",O
creatinine,B-TE
of,O
0.6,O
",",O
glucose,B-TE
of,O
137,O
.,O

Chest,B-TE
x-ray,I-TE
shows,O
no,O
infiltrate,B-PR
or,O
pneumothorax,B-PR
.,O

Cardiac,B-TE
catheterization,I-TE
demonstrates,O
no,O
significant,B-PR
disease,I-PR
in,I-PR
the,I-PR
coronary,I-PR
arteries,I-PR
.,O

Two,O
branches,O
of,O
an,B-PR
left,I-PR
anterior,I-PR
descending,I-PR
to,I-PR
PA,I-PR
fistula,I-PR
which,O
was,O
successfully,O
coiled,O
.,O

There,O
is,O
a,B-PR
persistent,I-PR
flow,I-PR
through,O
an,O
inferior,O
branch,O
of,O
the,O
left,O
anterior,O
descending,O
to,O
PA,B-PR
fistula,I-PR
and,O
a,O
persistent,O
branch,O
of,O
the,B-PR
circumflex,I-PR
to,I-PR
PA,I-PR
branch,I-PR
fistula,I-PR
which,O
anatomically,O
were,O
not,O
suitable,O
for,O
coil,B-TR
embolization,I-TR
.,O

Ejection,B-TE
fraction,I-TE
was,O
60%,O
.,O

HOSPITAL,O
COURSE,O
:,O

On,O
the,O
day,O
of,O
admission,O
",",O
the,O
patient,O
went,O
to,O
the,O
Operating,O
Room,O
and,O
underwent,O
a,O
minimally,O
invasive,O

mitral,B-TR
valve,I-TR
repair,I-TR
.,O

He,O
tolerated,O
this,B-TR
procedure,I-TR
well,O
.,O

The,O
patient,O
was,O
brought,O
to,O
the,O
cardiothoracic,O
Intensive,O
Care,O
Unit,O
in,O
stable,O
condition,O
on,O
minimal,B-TR
pressor,I-TR
support,I-TR
.,O

He,O
was,O
successfully,O
weaned,O
off,O
this,B-TR
support,I-TR
.,O

The,O
patient,O
was,O
fully,O
weaned,O
from,O
ventilatory,B-TR
support,I-TR
secondary,O
to,O
a,B-PR
persistent,I-PR
acidemia,I-PR
.,O

This,O
was,O
treated,O
with,O
sodium,B-TR
bicarbonate,I-TR
and,O
a,B-TR
Swan-Ganz,I-TR
was,O
placed,O
to,O
provide,O
close,B-TE
hemodynamic,I-TE
monitoring,I-TE
.,O

The,O
patient,O
was,O
found,O
to,O
have,O
stable,O
hemodynamics,O
with,O
appropriate,O
mixed,O
venous,B-TE
saturations,I-TE
in,O
the,O
70%,O
range,O
.,O

The,O
patient,O
was,O
corrected,O
to,O
a,O
normal,O
pH,O
of,O
7.41,O
by,O
the,O
first,O
postoperative,O
night,O
and,O
remained,O
stable,O
.,O

He,O
was,O
then,O
weaned,O
off,O
of,O
ventilatory,B-TR
support,I-TR
and,O
was,O
successfully,O
extubated,O
.,O

The,O
patient,O
did,O
have,O
a,B-PR
slight,I-PR
bit,I-PR
of,I-PR
confusion,I-PR
early,O
in,O
post-extubation,O
course,O
which,O
cleared,O
.,O

This,O
was,O
also,O
compounded,O
by,O
a,O
language,O
barrier,O
since,O
the,O
patient,O
cannot,O
speak,O
English,O
.,O

In,O
addition,O
",",O
the,O
patient,O
's,O
early,O
postoperative,O
course,O
had,O
a,O
tremendous,O
urine,B-TE
output,I-TE
.,O

It,O
was,O
equally,O
up,O
to,O
700,O
cc.,O
an,O
hour,O
and,O
a,B-TE
renal,I-TE
consultation,I-TE
was,O
obtained,O
.,O

He,O
underwent,O
a,B-TE
head,I-TE
CT,I-TE
scan,I-TE
to,O
rule,O
out,O
intracranial,B-PR
pathology,I-PR
leading,O
to,O
diabetes,B-PR
insipidus,I-PR
.,O

This,O
was,O
negative,O
.,O

The,B-TE
patient,I-TE
's,I-TE
serum,I-TE
and,O
urine,B-TE
electrolytes,I-TE
indicated,O
that,O
this,B-TR
diuresis,I-TR
was,O
appropriate,O
.,O

The,B-TE
patient,I-TE
's,I-TE
urine,I-TE
output,I-TE
has,O
decreased,O
and,O
his,B-TE
BUN,I-TE
and,O
creatinine,B-TE
remained,O
normal,O
.,O

The,B-TR
patient,I-TR
's,I-TR
Foley,I-TR
was,O
discontinued,O
.,O

He,O
had,O
developed,O
some,B-PR
hematuria,I-PR
which,O
has,O
resolved,O
.,O

The,O
patient,O
has,O
remained,O
stable,O
and,O
is,O
now,O
ready,O
for,O
discharge,O
to,O
home,O
with,O
follow-up,O
in,O
approximately,O
four,O
weeks,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Mitral,B-PR
regurgitation,I-PR
status,O
post,O
minimally,B-TR
invasive,I-TR
mitral,I-TR
valve,I-TR
repair,I-TR
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Lopressor,B-TR
75,O
mg,O
p.o.,O
twice,O
a,O
day,O
.,O

2.,O
Colace,B-TR
100,O
mg,O
p.o.,O
twice,O
a,O
day,O
.,O

3.,O
Percocet,B-TR
one,O
to,O
two,O
p.o.,O
q.,O
four,O
hours,O
p.r.n.,O

4.,O
Aspirin,B-TR
325,O
mg,O
p.o.,O
q.,O
day,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
.,O

DIGibsonE,O
INSTRUCTIONS,O
:,O

1.,O
The,O
patient,O
will,O
follow-up,O
with,O
Dr.,O
de,O
las,O
Grau,O
in,O
four,O
weeks,O
.,O

2.,O
He,O
will,O
follow-up,O
with,O
his,O
primary,O
care,O
physician,O
",",O
Dr.,O
Blake,O
",",O
in,O
two,O
weeks,O
.,O

3.,O
The,O
patient,O
will,O
call,O
for,O
any,B-PR
fevers,I-PR
or,O
difficulties,B-PR
with,I-PR
the,I-PR
wound,I-PR
care,I-PR
",",O
and,O
will,O
be,O
instructed,O
with,O
an,O
interpreter,O
present,O
.,O

Bruce,O
lou,O
Murphy,O
",",O
M.D.,O

07-760,O

Dictated,O
By,O
:,O
Ellen,O
V,O
Wise,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2015-09-21,O
08:34,O

T,O
:,O
2015-09-26,O
15:44,O

JO,O
B#:,O

18430,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Mary,O
van,O
den,O
Mosley,O
on,O
:,O
WED,O
2015-10-14,O
7:16,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2013-10-29,O

Discharge,O
Date,O
:,O

2013-11-04,O

Date,O
of,O
Birth,O
:,O

1943-01-06,O

Sex,O
:,O

M,O

Service,O
:,O

CARDIOTHORACIC,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,I-PR
Drugs,I-PR

Attending,O
:,O
Angie,O
CM,O
Johnson,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Coronary,B-PR
artery,I-PR
disease,I-PR
requiring,O
surgical,B-TR
intervention,I-TR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

CABG,B-TR
x,O
5,O

History,O
of,O
Present,O
Illness,O
:,O

Mr.,O
Andersen,O
is,O
a,O
71-year-old,O
male,O
with,O
worsening,B-PR
anginal,I-PR
symptoms,I-PR
who,O
underwent,O
catheterization,B-TE
that,O
showed,O
severe,B-PR
three-vessel,I-PR
disease,I-PR
.,O

He,O
is,O
presenting,O
for,O
revascularization,B-TR
.,O

Past,O
Medical,O
History,O
:,O

DM2,B-PR
-,O
dx,O
'd,O
at,O
the,O
age,O
of,O
48,O

Arthritis,B-PR

HTN,B-PR

Tonsillectomy,B-TR
around,O
the,O
age,O
of,O
10,O

Social,O
History,O
:,O

Quit,O
smoking,O
23,O
years,O
ago,O
",",O
occasional,O
ETOH,O
",",O
denies,O
illicit,O
drug,O
use,O
.,O

Lives,O
with,O
wife,O
",",O
retired,O
12,O
years,O
ago,O
after,O
working,O
as,O
electrician,O
for,O
Attleboro,O
Donald,O

Family,O
History,O
:,O

Father,O
died,O
of,O
colon,B-PR
cancer,I-PR
.,O

Mother,O
with,O
pacemaker,B-TR
",",O
alive,O
at,O
91,O
years,O
old,O
.,O

Physical,O
Exam,O
:,O

Awake,O
and,O
alert,O
",",O
NAD,B-PR

HEENT,O
:,O
PERRLA,O
",",O
no,O
carotid,B-PR
bruits,I-PR

CV,O
:,O
RRR,O
",",O
no,O
M/R/G,B-PR

Lungs,O
:,O
CTA,O
b/l,O

Abd,O
:,O
Soft,O
",",O
NT/ND,B-PR
",",O
NABS,O

Ext,O
:,O
cool,O
",",O
no,O
varicosities,B-PR
",",O
1+,O
pedal,B-TE
pulses,I-TE

Pertinent,O
Results,O
:,O

2013-10-29,O
11:37,O
AM,O
BLOOD,B-TE
WBC,B-TE
-,O
11.4,O
*#,O
RBC,B-TE
-,O
3.09,O
*#,O
Hgb,B-TE
-,O
9.1,O
*#,O
Hct,B-TE
-,O
27.5,O
*#,O
MCV,B-TE
-,O
89,O
MCH,B-TE
-,O
29.5,O
MCHC,B-TE
-,O
33.3,O
RDW,B-TE
-,O
14.6,O
Plt,B-TE
Ct,I-TE
-,O
180,O

2013-10-29,O
11:37,O
AM,O
BLOOD,B-TE
PT,B-TE
-,O
16.2,O
*,O
PTT,B-TE
-,O
29.0,O
INR(PT),B-TE
-,O
1.7,O

2013-10-29,O
11:37,O
AM,O
BLOOD,B-TE
Plt,B-TE
Ct,I-TE
-,O
180,O

2013-10-29,O
01:09,O
PM,O
BLOOD,B-TE
Glucose,B-TE
-,O
172,O
*,O
UreaN,B-TE
-,O
11,O
Creat,B-TE
-,O
0.9,O
Na,B-TE
-,O
142,O
Cl,B-TE
-,O
111,O
*,O
HCO3,B-TE
-,O
22,O

2013-10-29,O
01:09,O
PM,O
BLOOD,B-TE
Mg,B-TE
-,O
2.6,O

Brief,O
Hospital,O
Course,O
:,O

The,O
patient,O
was,O
taken,O
to,O
the,O
operating,O
room,O
on,O
2013-10-29,O
for,O
a,B-TR
CABG,I-TR
x5,O
.,O

Please,O
see,O
operative,O
note,O
for,O
full,O
details,O
.,O

The,O
patient,O
tolerated,O
this,B-TR
procedure,I-TR
well,O
.,O

He,O
was,O
taken,O
immediately,O
post-operatively,O
to,O
the,O
CSRU,O
.,O

He,O
was,O
extubated,O
that,O
night,O
.,O

The,O
did,O
well,O
in,O
the,O
ICU,O
.,O

His,B-TR
central,I-TR
line,I-TR
and,O
chest,B-TR
tubes,I-TR
were,O
removed,O
on,O
post-op,O
day,O
#2,O
and,O
was,O
transferred,O
to,O
the,O
floor,O
in,O
stable,O
condition,O
.,O

On,O
post-op,O
day,O
#3,O
",",O
the,B-TR
patient,I-TR
's,I-TR
pacing,I-TR
wires,I-TR
were,O
removed,O
",",O
and,O
his,B-TR
lopressor,I-TR
was,O
started,O
.,O

On,O
post-op,O
day,O
#4,O
",",O
the,O
patient,O
failed,O
the,O
first,O
of,O
his,B-TE
void,I-TE
trials,I-TE
.,O

He,O
was,O
seen,O
and,O
cleared,O
by,O
physical,O
therapy,O
.,O

He,O
was,O
discharged,O
home,O
on,O
post-op,O
day,O
#6,O
in,O
stable,O
condition,O
with,O
a,B-TR
foley,I-TR
catheter,I-TR
and,O
leg,B-TR
bag,I-TR
.,O

Medications,O
on,O
Admission,O
:,O

Avandia,B-TR
8,O
mg,O
daily,O

Glipizide,B-TR
10,O
mg,O
bid,O

Diovan,B-TR
160,O
mg,O
daily,O

Metformin,B-TR
500,O
mg,O
two,O
tabs,O
bid,O

Omeprazole,B-TR
20,O
mg,O
q,O
PM,O

Discharge,O
Medications,O
:,O

1.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
as,O
needed,O
for,O
constipation,B-PR
.,O

Disp,O
:*,O
60,O
Capsule,O
(s)*,O
Refills,O
:*,O
2,O
*,O

2.,O
Aspirin,B-TR
81,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
)(s)*,O
Refills,O
:*,O
2,O
*,O

3.,O
Oxycodone,B-TR
-,O
Acetaminophen,B-TR
5-325,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
Q4H,O
(,O
every,O
4,O
hours,O
),O
as,O
needed,O
for,O
pain,B-PR
for,O
30,O
doses,O
.,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

4.,O
Atorvastatin,B-TR
Calcium,I-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
2,O
*,O

5.,O
Rosiglitazone,B-TR
Maleate,I-TR
8,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

6.,O
Glipizide,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

7.,O
Tamsulosin,B-TR
0.4,O
mg,O
Capsule,O
",",O
Sust.,O
Release,O
24,O
HR,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
",",O
Sust,O
.,O
Release,O
24,O
HR,O
PO,O
HS,O
(,O
at,O
bedtime,O
).,O

Disp,O
:*,O
30,O
Capsule,O
",",O
Sust.,O
Release,O
24,O
HR,O
(s)*,O
Refills,O
:*,O
0,O
*,O

8.,O
Metoprolol,B-TR
Tartrate,I-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
0.5,O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
2,O
*,O

9.,O
Furosemide,B-TR
20,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
every,O
twelve,O
(,O
12,O
),O
hours,O
.,O

Disp,O
:*,O
60,O
Tablet,O
(s)*,O
Refills,O
:*,O
2,O
*,O

10.,O
Pantoprazole,B-TR
Sodium,I-TR
40,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
Q24H,O
(,O
every,O
24,O
hours,O
).,O

Disp,O
:*,O
30,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
)(s)*,O
Refills,O
:*,O
2,O
*,O

11.,O
Potassium,B-TR
Chloride,I-TR
10,O
mEq,O
Capsule,O
",",O
Sustained,O
Release,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Capsule,O
",",O
Sustained,O
Release,O
PO,O
Q12H,O
(,O
every,O
12,O
hours,O
).,O

Disp,O
:*,O
120,O
Capsule,O
",",O
Sustained,O
Release,O
(s)*,O
Refills,O
:*,O
2,O
*,O

Discharge,O
Disposition,O
:,O

Home,O
with,O
Service,O

Discharge,O
Diagnosis,O
:,O

Coronary,B-PR
artery,I-PR
disease,I-PR

Discharge,O
Condition,O
:,O

Stable,O

Discharge,O
Instructions,O
:,O

Please,O
return,O
to,O
the,O
hospital,O
or,O
call,O
Dr.,O
Alvarado,O
's,O
office,O
if,O
you,O
experience,O
chills,B-PR
or,O
fever,B-PR
greater,I-PR
than,I-PR
101,I-PR
degrees,I-PR
F.,I-PR

Please,O
call,O
if,O
you,O
notice,O
redness,B-PR
",",O
swelling,B-PR
",",O
or,O
tenderness,B-PR
of,O
your,B-PR
chest,I-PR
wound,I-PR
",",O
or,O
if,O
it,O
begins,O
to,O
drain,O
pus,B-PR
.,O

No,O
heavy,O
lifting,O
or,O
driving,O
until,O
follow,O
up,O
with,O
Dr.,O
Mullins,O
.,O

You,O
may,O
shower,O
.,O

Wash,O
incision,B-PR
with,O
mild,O
soap,O
and,O
water,O
",",O
then,O
pat,O
dry,O
.,O

You,O
will,O
need,O
to,O
follow,O
up,O
with,O
your,O
primary,O
care,O
physician,O
/,O
urologist,O
prior,O
to,O
removal,O
of,O
your,B-TR
urinary,I-TR
catheter,I-TR
.,O

Followup,O
Instructions,O
:,O

Provider,O
:,O
Mary,O
",",O
Francis,O
Z.,O
739-488-1975,O
Call,O
to,O
schedule,O
appointment,O
.,O

Please,O
follow,O
up,O
in,O
1,O
month,O
.,O

Provider,O
:,O
Laurie,O
",",O
Paul,O
G.,O
(,O
858,O
),O
481-2816,O
Call,O
to,O
schedule,O
appointment,O
.,O

Please,O
follow,O
up,O
in,O
1,O
week,O
.,O

Bernice,O
Jessica,O
MD,O
95-512,O

Completed,O
by,O
:,O
Carol,O
Lydia,O
MD,O
27-960,O
2013-11-05,O
@,O
0029,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Elizabeth,O
GS,O
Vega,O
on,O
:,O
FRI,O
2013-12-06,O
12:28,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2020-03-11,O

Discharge,O
Date,O
:,O

2020-03-23,O

Date,O
of,O
Birth,O
:,O

1946-04-03,O

Sex,O
:,O

M,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Penicillins,B-TR

Attending,O
:,O
Ross,O
Z,O
Kenmore,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Transfer,O
from,O
Newton-Wellesley,O
Hospital,O
hospital,O
for,O
epidural,B-PR
abscess,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

1.,O
Partial,B-TR
vertebrectomy,I-TR
of,I-TR
L3,I-TR
and,I-TR
L4,I-TR
.,O

2.,O
Fusion,B-TR
at,I-TR
L3-L4,I-TR
.,O

3.,O
Vertebral,B-TR
Spacer,I-TR
at,I-TR
L3-L4,I-TR
.,O

4.,O
Anterior,B-TR
instrumentation,I-TR
L3-L4,I-TR
.,O

5.,O
Autograft,B-TR
",",O
bone,B-TR
morphogenic,I-TR
protein,I-TR
",",O
and,O
allograft,B-TR
.,O

6.,O
Debridement,B-TR

7.,O
Incision,B-TR
and,O
drainage,B-TR

8.,O
Echocardiogram,B-TE

History,O
of,O
Present,O
Illness,O
:,O

73,O
yo,O
M,O
transferred,O
from,O
Newton-Wellesley,O
Hospital,O
hospital,O
for,O
epidural,B-PR
abscess,I-PR
.,O

Pt,O
has,O
h/o,O
colon,B-PR
can,I-PR
to,I-PR
liver,I-PR
",",O
s/p,O
resxn,B-TR
with,O
serosal,B-PR
implants,I-PR
in,O
9/03,O
.,O

Pt,O
states,O
he,O
has,O
been,O
receiving,O
chemotherapy,B-TR
up,O
until,O
1,O
week,O
ago,O
.,O

States,O
he,O
first,O
developed,O
back,B-PR
pain,I-PR
5,O
weeks,O
ago,O
but,O
was,O
still,O
able,O
to,O
ambulate,O
with,O
his,B-TR
cane,I-TR
.,O

Last,O
week,O
it,O
was,O
worse,O
and,O
he,O
was,O
seen,O
in,O
clinic,O
.,O

An,B-TE
MRI,I-TE
was,O
done,O
and,O
this,O
showed,O
a,B-PR
signal,I-PR
abno,I-PR
in,I-PR
L3,I-PR
L4,I-PR
?,O
disciitis,B-PR
vs,O
osteo,B-PR
without,O
a,B-PR
definitive,I-PR
epidural,I-PR
abscess,I-PR
.,O

Initially,O
on,O
Vanc,B-TR
and,O
Cipro,B-TR
on,O
Friday,O
but,O
then,O
seen,O
by,O
ID,O
who,O
reccommended,O
no,O
abx,B-TR
but,O
a,B-TE
bone,I-TE
biopsy,I-TE
",",O
blood,B-TE
cx,I-TE
.,O

He,O
was,O
also,O
seen,O
by,O
spine,O
who,O
repeated,O
the,B-TE
MRI,I-TE
and,O
this,O
showed,O
L3-4,B-PR
osteomyelitis,I-PR
and,O
discitis,B-PR
and,O
an,B-PR
epidural,I-PR
abscess,I-PR
",",O
5cm,O
.,O

He,O
was,O
subsequently,O
restared,O
on,O
Vancomycin,B-TR
for,O
Corynebacterium,B-PR
in,O
blood,B-TE
cx,I-TE
from,O
Fri,O
;,O
Followup,B-TE
cx,I-TE
has,O
been,O
NGTD,O
.,O

CXR,B-TE
also,O
showed,O
small,B-PR
pleural,I-PR
effusion,I-PR
and,O
attempt,O
was,O
made,O
to,O
tap,B-TR
it,O
",",O
but,O
pt,O
did,O
not,O
tolerate,O
the,B-TR
procedure,I-TR
and,O
asked,O
that,O
it,O
be,O
deferred,O
.,O

He,O
did,O
undergo,O
a,B-TE
CT-guided,I-TE
aspiration,I-TE
/,I-TE
biopsy,I-TE
at,I-TE
the,I-TE
L3-4,I-TE
disc,I-TE
space,I-TE
on,O
2020-03-11,O
and,O
the,O
pt,O
was,O
transferred,O
to,O
Mediplex,O
Rehab,O
Hospital,O
immediately,O
following,O
this,O
.,O

No,O
results,O
from,O
this,O
were,O
sent,O
.,O

Currently,O
pt,O
denies,O
sensory,B-PR
deficits,I-PR
or,O
weakness,B-PR
.,O

States,O
he,O
is,O
not,O
able,O
to,O
walk,O
because,O
of,O
severe,B-PR
pain,I-PR
.,O

States,O
pain,B-PR
is,O
worst,O
when,O
he,O
sits,O
up,O
or,O
twists,O
his,O
back,O
.,O

No,O
bowel,B-PR
or,I-PR
bladder,I-PR
incontinence,I-PR
.,O

Past,O
Medical,O
History,O
:,O

-,O
colon,B-PR
cancer,I-PR
with,O
mets,B-PR
to,I-PR
liver,I-PR
s/p,O
resection,B-TR
09-07,O
.,O

Oncologist,O
is,O
Dr.,O
Rowles,O
.,O

-,O
CAD,B-PR
s/p,O
CABG,B-TR
x4,O
in,O
',O
03,O
.,O

-,O
DM,B-PR
with,O
neuropathy,B-PR
.,O

-,O
persistent,B-PR
R,I-PR
foot,I-PR
ulcer,I-PR

Social,O
History,O
:,O

Lives,O
alone,O
in,O
apartment,O
in,O
Boston,O
.,O

Is,O
married,O
but,O
"",O
separated,O
"",O
from,O
his,O
wife,O
",",O
although,O
they,O
still,O
help,O
each,O
other,O
-,O

he,O
states,O
he,O
gives,O
her,O
one,O
of,O
his,O
pensions,O
and,O
she,O
helps,O
him,O
with,O
medicines,B-TR
etc,O
.,O

"Quit,O
tobacco,O
in,O
2003,O
after,O
smoking,O
1,O
ppd,O
for,O
"",O
a,O
very,O
long,O
time,O
"".",O

Drank,O
ETOH,O
heavily,O
until,O
8,O
years,O
ago,O
when,O
he,O
quit,O
.,O

Denies,O
IVDU,O
.,O

Has,O
children,O
but,O
they,O
are,O
not,O
nearby,O
.,O

Family,O
History,O
:,O

NC,O

Physical,O
Exam,O
:,O

98.6,O
",",O
104/50,O
",",O
96,O
",",O
20,O
",",O
96%,O
RA,O

Gen,O
:,O
in,O
NAD,B-PR
",",O
but,O
winces,O
in,O
pain,B-PR
with,O
movements,O
of,O
his,O
back,O
.,O

HEENT,O
:,O
Clear,O
OP,O
",",O
MM,B-PR
very,I-PR
dry,I-PR
.,O

NECK,O
:,O
Supple,O
",",O
No,O
LAD,B-PR
",",O
No,O
JVD,B-PR

CHEST,O
:,O
Port,B-TR
a,I-TR
cath,I-TR
in,I-TR
R,I-TR
chest,I-TR
",",O
no,O
erythema,B-PR
or,O
tenderness,B-PR
.,O

CV,O
:,O
RR,O
",",O
NL,O
rate,O
.,O

NL,O
S1,O
",",O
S2,O
.,O

II/VI,B-PR
SEM,I-PR
at,I-PR
LSB,I-PR
with,O
radiation,B-PR
to,I-PR
apex,I-PR
.,O

LUNGS,O
:,O
+,O
crackles,B-PR
at,I-PR
L,I-PR
base,I-PR
>,O
R,O
base,O
.,O

ABD,O
:,O
Pt,O
very,B-PR
tense,I-PR
in,I-PR
abdomen,I-PR
(,O
states,O
belly,O
is,O
fine,O
",",O
but,O
he,O
is,O
weary,O
of,O
his,O
back,O
).,O

Well,B-PR
healed,I-PR
midline,I-PR
scar,I-PR
from,O
chest,O
down,O
to,O
pubis,O
.,O

No,O
HSM,B-PR
.,O

EXT,O
:,O
No,O
edema,B-PR
.,O

Dressing,B-TR
c/d/i,O
over,O
R,B-PR
LE,I-PR
ulcer,I-PR
.,O

1,O
+,O
DP,B-TE
pulses,I-TE
BL,O

NEURO,O
:,O
A&Ox3,O
.,O

Appropriate,O
.,O

CN,O
02-17,O
grossly,O
intact,O
.,O

Preserved,O
sensation,O
throughout,O
.,O

5/5,O
strength,O
throughout,O
",",O
though,O
weary,O
of,O
moving,O
back,O
.,O

Back,O
:,O
+,O
ttp,B-PR
of,I-PR
lumbar,I-PR
spine,I-PR
and,I-PR
paraspinal,I-PR
muscles,I-PR
",",O
R,O
>,O
L,O
.,O

No,O
erythema,B-PR
or,O
swelling,B-PR
noted,O
.,O

CMED,O
CSRU,O
:,O
Listens,O
and,O
responds,O
to,O
questions,O
appropriately,O
",",O
pleasant,O

Pertinent,O
Results,O
:,O

Na,B-TE
:,O
135,O
",",O
K,B-TE
4.5,O
",",O
Cl,B-TE
96,O
",",O
CO2,B-TE
27,O
",",O
BUN,B-TE
12,O
",",O
Cr,B-TE
0.7,O
",",O
Glu,B-TE
167,O
",",O
Ca,B-TE
8.4,O
",",O
Vanco,B-TE
trough,I-TE
13,O
",",O
WBC,B-TE
5.3,O
",",O
Hct,B-TE
32.0,O
",",O
plt,B-TE
330,O
",",O
INR,B-TE
1.0,O
.,O

No,O
culture,B-TE
data,I-TE
was,O
sent,O
.,O

STUDIES,O
:,O

MRI,B-TE
lumbar,I-TE
spine,I-TE
(,O
Youville,O
Hospital,O
2020-03-10,O
):,O
L3-4,B-PR
osteomyelitis,I-PR
",",O
discitis,B-PR
",",O
and,O
epidural,B-PR
abscess,I-PR
.,O

Degenerative,B-PR
changes,I-PR
including,O
multilevel,B-PR
central,I-PR
spinal,I-PR
stenosis,I-PR
.,O

Impression,B-PR
on,I-PR
the,I-PR
anterior,I-PR
aspect,I-PR
of,I-PR
the,I-PR
lower,I-PR
spinal,I-PR
cord,I-PR
at,I-PR
T11-12,I-PR
by,O
disc,B-PR
bulge,I-PR
.,O

Addendum,O
:,O
Findings,O
are,O
c/w,O
paraspinous,B-PR
extension,I-PR
of,I-PR
infection,I-PR
anteriorly,O
and,O
laterally,O
into,O
the,O
medial,O
aspects,O
of,O
the,O
psoas,O
muscles,O
bilaterally,O
at,O
the,O
L3,O
and,O
L4,O
levels,O
.,O

CXR,B-TE
(,O
Youville,O
Hospital,O
2020-03-09,O
):,O
Persistent,B-PR
unchanged,I-PR
L,I-PR
mid,I-PR
and,I-PR
lower,I-PR
lung,I-PR
field,I-PR
airspace,I-PR
disease,I-PR
with,O
moderate,B-PR
L,I-PR
pleural,I-PR
effusion,I-PR
.,O

Brief,O
Hospital,O
Course,O
:,O

73,O
yo,O
M,O
transferred,O
from,O
Youville,O
Hospital,O
with,O
h/o,O
colon,B-PR
cancer,I-PR
with,O
known,B-PR
liver,I-PR
mets,I-PR
now,O
with,O
epidural,B-PR
abscess,I-PR
and,O
corynebacterium,B-PR
bacteremia,I-PR
:,O

#,O
Epidural,B-PR
abscess,I-PR
:,O
The,O
patient,O
was,O
evaluated,O
by,O
orthopedic,O
spine,O
consult,O
service,O
and,O
ID,O
.,O

He,O
was,O
continued,O
on,O
IV,B-TR
vancomycin,I-TR
throughout,O
his,O
course,O
and,O
had,O
therapeutic,O
troughs,B-TE
.,O

The,O
patient,O
was,O
taken,O
to,O
the,O
OR,O
twice,O
with,O
orthopaedics,O
.,O

Please,O
see,O
the,O
operation,O
notes,O
for,O
details,O
about,O
the,B-TR
surgeries,I-TR
.,O

The,O
patient,O
was,O
briefly,O
admitted,O
to,O
the,O
ICU,O
for,O
low,B-PR
hematocrit,I-PR
and,O
hyponatremia,B-PR
immediately,O
following,O
the,B-TR
surgery,I-TR
but,O
was,O
then,O
transferred,O
back,O
to,O
the,O
floor,O
in,O
stable,O
condition,O
.,O

The,O
patient,O
had,O
a,B-TR
PICC,I-TR
line,I-TR
placed,O
and,O
will,O
continue,O
a,B-TR
8,I-TR
week,I-TR
course,I-TR
of,I-TR
antibiotics,I-TR
.,O

The,O
patient,O
will,O
also,O
wear,O
a,B-TR
back,I-TR
brace,I-TR
at,O
all,O
times,O
while,O
out,O
of,O
bed,O
.,O

#,O
Candidemia,B-PR
:,O

The,O
patient,O
was,O
started,O
on,O
Diflucan,B-TR
.,O

Ophthalmology,O
was,O
consulted,O
and,O
ruled,O
out,O
ocular,B-PR
spread,I-PR
.,O

The,B-TR
patient,I-TR
's,I-TR
portocath,I-TR
was,O
removed,O
.,O

The,O
tip,O
was,O
culture,B-TE
negative,O
.,O

The,O
patient,O
will,O
get,O
a,O
total,O
of,O
a,B-TR
two,I-TR
week,I-TR
course,I-TR
of,I-TR
Diflucan,I-TR
.,O

#,O
Corynebacterium,B-PR
bacteremia,I-PR
:,O
presumably,O
Corynebacterium,B-PR
in,O
epidural,B-PR
abscess,I-PR
as,O
well,O
.,O

The,O
patient,O
had,O
no,O
blood,B-TE
cultures,I-TE
to,O
grow,O
corynebacterium,B-PR
while,O
hospitalized,O
.,O

#,O
Pleural,B-PR
effusion,I-PR
:,O
The,O
patient,O
was,O
noted,O
have,O
an,B-PR
effusion,I-PR
on,O
CXR,B-TE
.,O

IP,O
was,O
consulted,O
and,O
did,O
a,B-TE
thoracentesis,I-TE
.,O

The,B-TE
tap,I-TE
was,O
negative,O
for,O
malignant,B-PR
cells,I-PR
.,O

A,B-TE
repeat,I-TE
CT,I-TE
was,O
done,O
showing,O
nodular,B-PR
thickening,I-PR
along,O
the,O
right,O
major,O
and,O
minor,O
fissure,O
",",O
concerning,O
for,O
intrapleural,B-PR
tumor,I-PR
implants,I-PR
.,O

IP,O
reviewed,O
the,B-TE
films,I-TE
and,O
recommended,O
continue,O
oncologic,B-TR
care,I-TR
according,O
to,O

outpatient,O
course,O
and,O
pleurodesis,B-TR
if,O
the,O
pt,O
becomes,O
symptomatic,B-PR
02-07,O
fluid,B-PR
accumulation,I-PR
.,O

The,O
patient,O
will,O
follow,O
up,O
with,O
his,O
oncologist,O
.,O

#,O
Foot,B-PR
ulcer,I-PR
:,O
diabetic,B-PR
ulcer,I-PR
s/p,O
surgery,B-TR
but,O
never,O
healed,O
.,O

Wound,O
care,O
was,O
consulted,O
and,O
made,O
recommendations,O
for,O
ulcer,B-TR
care,I-TR
.,O

His,B-TR
dressings,I-TR
were,O
changed,O
by,O
the,O
nursing,O
staff,O
accordingly,O
.,O

#,O
Anemia,B-PR
:,O
His,B-TE
HCT,I-TE
remained,O
stable,O
post-surgery,O
.,O

The,O
patient,O
was,O
continued,O
on,O
his,B-TR
iron,I-TR
supplements,I-TR
.,O

Medications,O
on,O
Admission,O
:,O

-,O
Iron,B-TR
Sulfate,I-TR
300,O
mg,O
po,O
tid,O

-,O
Procrit,B-TR
"40,000",O
units,O
SC,O
q,O
Friday,O

-,O
Lovenox,B-TR
40,O
mg,O
SC,O
q24,O
for,O
DVT,O
ppx,O

-,O
Morphine,B-TR
2-4,O
mg,O
IV,O
q3-4,O
prn,O

-,O
Mylanta,B-TR
30,O
cc,O
po,O
q6,O
prn,O

-,O
Pepcid,B-TR
20,O
mg,O
po,O
daily,O

-,O
glipizide,B-TR
5,O
mg,O
po,O
bid,O

-,O
metformin,B-TR
500,O
mg,O
po,O
bid,O

-,O
metoprolol,B-TR
50,O
mg,O
po,O
daily,O

-,O
Vancomycin,B-TR
1.5,O
gm,O
q,O
12,O
hours,O

Discharge,O
Medications,O
:,O

1.,O
Albuterol,B-TR
Sulfate,I-TR
0.083,O
%,O
Solution,O
Sig,O
:,O
One,O
(,O
1,O
),O
Inhalation,O
Q4H,O
(,O
every,O
4,O
hours,O
),O
as,O
needed,O
.,O

2.,O
Ipratropium,B-TR
Bromide,I-TR
0.02,O
%,O
Solution,O
Sig,O
:,O
One,O
(,O
1,O
),O
Inhalation,O
Q6H,O
(,O
every,O
6,O
hours,O
),O
as,O
needed,O
.,O

3.,O
Aluminum-Magnesium,B-TR
Hydroxide,I-TR
225-200,O
mg,O
/,O
5,O
mL,O
Suspension,O
Sig,O
:,O
15-30,O
MLs,O
PO,O
QID,O
(,O
4,O
times,O
a,O
day,O
),O
as,O
needed,O
.,O

4.,O
Glipizide,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

5.,O
Miconazole,B-TR
Nitrate,I-TR
2,O
%,O
Powder,O
Sig,O
:,O
One,O
(,O
1,O
),O
Appl,O
Topical,O
TID,O
(,O
3,O
times,O
a,O
day,O
),O
as,O
needed,O
.,O

6.,O
Acetaminophen,B-TR
325,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
Q6H,O
(,O
every,O
6,O
hours,O
),O
as,O
needed,O
for,O
fever,B-PR
or,O
pain,B-PR
.,O

7.,O
Metoprolol,B-TR
Tartrate,I-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
1.5,O
Tablets,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

8.,O
Cepacol,B-TR
2,O
mg,O
Lozenge,O
Sig,O
:,O
One,O
(,O
1,O
),O
Lozenge,O
Mucous,O
membrane,O
PRN,O
(,O
as,O
needed,O
).,O

9.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

10.,O
Senna,B-TR
8.6,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
as,O
needed,O
.,O

11.,O
Oxycodone,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
every,O
4-6,O
hours,O
as,O
needed,O
for,O
pain,B-PR
for,O
14,O
days,O
.,O

12.,O
Fluconazole,B-TR
200,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
Q24H,O
(,O
every,O
24,O
hours,O
),O
for,O
7,O
days,O
.,O

13.,O
Oxycodone,B-TR
10,O
mg,O
Tablet,O
Sustained,O
Release,O
12,O
HR,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
Sustained,O
Release,O
12HR,O
PO,O
Q12H,O
(,O
every,O
12,O
hours,O
).,O

14.,O
Bisacodyl,B-TR
5,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
as,O
needed,O
.,O

15.,O
Aspirin,B-TR
81,O
mg,O
Tablet,O
",",O
Chewable,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Chewable,O
PO,O
DAILY,O
(,O
Daily,O
).,O

16.,O
Vancomycin,B-TR
in,I-TR
Dextrose,I-TR
1,O
g,O
/,O
200,O
mL,O
Piggyback,O
Sig,O
:,O
One,O
(,O
1,O
),O
Intravenous,O
Q,O
12H,O
(,O
Every,O
12,O
Hours,O
):,O
To,O
finish,O
on,O
2020-05-12,O
.,O

17.,O
Pepcid,B-TR
20,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
once,O
a,O
day,O
.,O

18.,O
Heparin,B-TR
Lock,I-TR
Flush,I-TR
(,I-TR
Porcine,I-TR
),I-TR
100,O
unit,O
/,O
mL,O
Syringe,O
Sig,O
:,O
Two,O
(,O
2,O
),O
ML,O
Intravenous,O
DAILY,O
(,O
Daily,O
),O
as,O
needed,O
:,O
10,O
ml,O
NS,B-TR
followed,O
by,O
2,O
ml,O
of,O
100,O
Units,O
/,O
ml,O
heparin,B-TR
(,O
200,O
units,O
heparin,B-TR
),O
each,O
lumen,O
Daily,O
and,O
PRN,O
.,O

Inspect,O
site,O
every,O
shift,O
.,O

19.,O
Insulin,B-TR
Glargine,I-TR
100,O
unit,O
/,O
mL,O
Solution,O
Sig,O
:,O
Four,O
(,O
4,O
),O
units,O
Subcutaneous,O
at,O
dinner,O
time,O
.,O

20.,O
Insulin,B-TR
Lispro,I-TR
(,I-TR
Human,I-TR
),I-TR
100,O
unit,O
/,O
mL,O
Cartridge,O
Sig,O
:,O
One,O
(,O
1,O
),O
Subcutaneous,O
four,O
times,O
a,O
day,O
:,O
As,O
directed,O
by,O
sliding,B-TR
scale-please,I-TR
see,O
attached,O
scale,O
.,O

Discharge,O
Disposition,O
:,O

Home,O

Discharge,O
Diagnosis,O
:,O

Primary,O
diagnosis,O
:,O
Epidural,B-PR
abscess,I-PR

Secondary,O
diagnosis,O
:,O

-,O
colon,B-PR
cancer,I-PR
with,O
mets,B-PR
to,I-PR
liver,I-PR
s/p,O
resection,B-TR
09-07,O
.,O

-,O
CAD,B-PR
s/p,O
CABG,B-TR
x4,O
in,O
',O
03,O
.,O

-,O
DM,B-PR
with,O
neuropathy,B-PR
.,O

-,O
persistent,B-PR
R,I-PR
foot,I-PR
ulcer,I-PR

Discharge,O
Condition,O
:,O

Stable,O
",",O
afebrile,B-PR

Discharge,O
Instructions,O
:,O

You,O
were,O
diagnosed,O
with,O
an,B-PR
epidural,I-PR
abscess,I-PR
.,O

Continue,O
to,O
take,O
the,B-TR
antibiotics,I-TR
as,O
directed,O
.,O

Take,O
the,B-TR
pain,I-TR
medication,I-TR
as,O
directed,O
and,O
do,O
not,O
drive,O
while,O
taking,O
this,B-TR
medication,I-TR
.,O

Call,O
the,O
doctor,O
or,O
return,O
to,O
the,O
Thomas,O
for,O
:,O

-,O
worsening,B-PR
pain,I-PR
or,O
weakness,B-PR
in,I-PR
your,I-PR
legs,I-PR
",",O
loss,B-PR
of,I-PR
bowel,I-PR
or,I-PR
bladder,I-PR
function,I-PR
or,O
any,B-PR
other,I-PR
concerning,I-PR
symptoms,I-PR
.,O

Followup,O
Instructions,O
:,O

Please,O
follow,O
up,O
with,O
Dr.,O
Scott,O
Ann,O
",",O
MD,O
Phone,O
:(,O
921,O
),O
538,O
8079,O
on,O
2020-04-30,O
at,O
11:00am,O
.,O

Please,O
follow,O
up,O
with,O
Dr,O
Erb,O
-,O
3/30/07,O
at,O
10:00am,O
.,O

Please,O
follow,O
up,O
with,O
Dr.,O
Rowles,O
",",O
your,O
oncologist,O
",",O
in,O
2-3,O
weeks,O

Brooke,O
Donna,O
MD,O
37-421,O

Completed,O
by,O
:,O
Jessica,O
POPE,O
MD,O
58-704,O
2020-03-23,O
@,O
1515,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Maryjane,O
WS,O
Hammond,O
on,O
:,O
FRI,O
2020-05-01,O
12:36,O
AM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2015-03-26,O

Discharge,O
Date,O
:,O

2015-03-30,O

Date,O
of,O
Birth,O
:,O

1967-03-08,O

Sex,O
:,O

F,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Morphine,B-TR
/,O
Histamine,B-TR
H2,I-TR
Inhibitors,I-TR
/,O
Heparin,B-TR
Agents,I-TR

Attending,O
:,O
Terry,O
T,O
Trott,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Increasing,B-PR
abdominal,I-PR
girth,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

4u,B-TR
FFP,I-TR

Paracentesis,B-TR

History,O
of,O
Present,O
Illness,O
:,O

47,O
female,O
with,O
h/o,O
HCV,B-PR
cirrhosis,I-PR
compocated,O
by,O
encephalopathy,B-PR
",",O
ascites,B-PR
",",O
and,O
h/o,O
portal,B-PR
vein,I-PR
thrombosis,I-PR
(,O
right,O
anterior,O
portal,O
vein,O
),O
and,O
portalcaval,B-TR
shunt,I-TR
(,O
reversed,O
flow,O
in,O
main,O
portal,O
vein,O
),O
presents,O
from,O
liver,O
clinic,O
with,O
increasing,B-PR
abdominal,I-PR
girth,I-PR
.,O

She,O
also,O
described,O
sob,B-PR
",",O
nausea,B-PR
",",O
worsening,B-PR
lower,I-PR
ext,I-PR
edema,I-PR
.,O

She,O
denied,O
abd,B-PR
pain,I-PR
",",O
fevers,B-PR
",",O
chills,B-PR
.,O

She,O
was,O
admitted,O
for,O
a,B-TR
large,I-TR
volume,I-TR
paracentesis,I-TR
but,O
her,B-TE
INR,I-TE
on,O
admission,O
was,O
3.8,O
.,O

She,O
received,O
4units,O
of,O
FFP,B-TR
which,O
decreased,O
her,B-TE
INR,I-TE
to,O
2.2,O
and,O
then,O
2,O
more,O
units,O
during,O
the,B-TR
tap,I-TR
.,O

She,O
then,O
had,O
6L,O
of,O
non-bloody,B-PR
ascitic,I-PR
fluid,I-PR
removed,O
without,O
complication,B-PR
.,O

She,O
received,O
36gm,O
of,O
albumin,B-TR
following,O
the,B-TR
tap,I-TR
.,O

Her,B-TE
BP,I-TE
on,O
admission,O
was,O
120/70,O
and,O
remained,O
stable,O
following,O
the,B-TR
tap,I-TR
.,O

Over,O
the,O
next,O
several,O
hours,O
",",O
pt,O
complained,O
of,O
abd,B-PR
pain,I-PR
but,O
this,O
resolved,O
on,O
its,O
own,O
without,O
medication,B-TR
.,O

In,O
the,O
am,O
",",O
she,O
was,O
found,O
to,O
have,O
a,B-TE
hct,I-TE
of,O
24,O
",",O
down,O
from,O
32,O
and,O
plts,B-TE
35,O
",",O
down,O
from,O
72,O
.,O

She,O
received,O
2,O
units,O
of,O
plts,B-TR
and,O
1,O
unit,O
of,O
PRBC,B-TR
s.,I-TR

Her,B-TE
BP,I-TE
was,O
then,O
noted,O
to,O
be,O
decreased,B-PR
at,O
80/40,O
which,O
improved,O
mildly,O
to,O
90/30,O
with,O
1.5L,O
of,O
NS,B-TR
.,O

Temp,B-TE
noted,O
to,O
be,O
low,B-PR
at,O
94,O
and,O
she,O
was,O
placed,O
on,O
bear,B-TR
hugger,I-TR
which,O
improved,O
temp,B-TE
to,O
96.7,O
.,O

Her,O
mental,O
status,O
also,O
had,O
decreased,B-PR
from,O
admission,O
and,O
her,B-TE
urine,I-TE
output,I-TE
was,O
minimal,B-PR
",",O
225cc,O
over,O
the,O
past,O
12,O
hours,O
.,O

Creatinine,B-TE
this,O
am,O
was,O
1.9,O
from,O
0.9,O
yesterday,O
.,O

Previous,O
hospital,O
course,O
(,O
per,O
H&P,O
):,O

She,O
was,O
recently,O
hospitalised,O
from,O
02-23,O
/,O
03-04,O
for,O
abdominal,B-PR
discomfort,I-PR
at,O
which,O
time,O
she,O
underwent,O
paracentesis,B-TR
that,O
ruled,O
out,O
SBP,B-PR
and,O
relieved,O
her,B-PR
abdominal,I-PR
pain,I-PR
.,O

She,O
also,O
underwent,O
US,B-TE
that,O
revealed,O
patent,O
portal,O
and,O
hepatic,O
vessels,O
.,O

While,O
her,O
discharge,O
summary,O
maintains,O
that,O
she,O
was,O
continued,O
on,O
Furosemide,B-TR
/,O
Spirinolactone,B-TR
/,O
Propranolol,B-TR
",",O
the,O
patient,O
did,O
not,O
receive,O
any,O
scripts,O
on,O
discharge,O
and,O
as,O
a,O
result,O
did,O
not,O
take,O
these,B-TR
medications,I-TR
.,O

Also,O
",",O
due,O
to,O
worsening,B-PR
renal,I-PR
function,I-PR
",",O
she,O
was,O
started,O
on,O
octreotide,B-TR
/,O
midodrine,B-TR
/,O
albumin,B-TR
for,O
hepatorenal,O

syndrome,B-PR
(,O
Cr,B-TE
3.3,O
at,O
its,O
worst,O
),O
which,O
resolved,O
prior,O
to,O
her,O
discharge,O
.,O

The,O
hospitalisation,O
was,O
also,O
significant,O
for,O
mild,B-PR
DIC,I-PR
for,O
which,O
she,O
received,O
cryoglobulins,B-TR
and,O
UTI,B-PR
(+,O
Enterococcus,B-PR
and,O
+,O
Klebsiella,B-PR
).,O

She,O
received,O
a,O
7,O
day,O
course,O
of,O
amoxicillin,B-TR
for,O
which,O
Enterococcus,B-PR
was,O
sensitive,O
but,O
Klebsiella,B-PR
unknown,O
.,O

Past,O
Medical,O
History,O
:,O

HCV,B-PR
cirrhosis,I-PR
c/b,O
esophageal,B-PR
varices,I-PR
",",O
ascites,B-PR
",",O
partial,B-PR
portal,I-PR
vein,I-PR
thrombosis,I-PR

h/o,O
gastritis,B-PR

morbid,B-PR
obesity,I-PR

recent,O
cholecystitis,B-PR
08-10,O

h/o,O
EtOH,O
abuse,O

sickle,B-PR
cell,I-PR
trait,I-PR

Social,O
History,O
:,O

Patient,O
denies,O
etoh,O
and,O
tobacco,O
use,O
.,O

She,O
has,O
a,O
history,O
of,O
heavy,O
alcohol,O
use,O
.,O

Lives,O
alone,O
second,O
floor,O
apartment,O
;,O
son,O
and,O
mother,O
nearby,O

Family,O
History,O
:,O

None,O

Physical,O
Exam,O
:,O

Physical,O
Exam,O
:,O
T,B-TE
95,O
",",O
BP,B-TE
120/70,O
",",O
HR,B-TE
82,O
",",O
RR,B-TE
20,O
",",O
96%,O
RA,O
Wt,B-TE
301.6,O
lb,O

HEENT,O
:,O
+,O
scleral,B-PR
icterus,I-PR
.,O

No,O
thrush,B-PR
.,O

Neck,O
:,O
No,O
Donna,O
",",O
normal,O
thyroid,O
contour,O

Lungs,O
:,O
CTAB,O

Cardiac,O
:,O
RRR,O
",",O
no,O
murmurs,B-PR

Abdomen,O
:,O
obese,B-PR
",",O
soft,O
",",O
mildly,B-PR
distended,I-PR
dull,B-PR
to,O
percussion,B-TE
throughout,O
",",O
no,O
tenderness,B-PR
",",O
liver,B-PR
non-palpable,I-PR
due,O
to,O
large,B-PR
volume,I-PR
of,I-PR
ascited,I-PR

Extremities,O
:,O
05-09,O
+,O
pretibial,B-PR
edema,I-PR
extending,O
above,O
knee,O
R,O
>,O
L,O
",",O
no,O
asterixis,B-PR
.,O

No,O
palmar,B-PR
erythema,I-PR

Pertinent,O
Results,O
:,O

2015-03-26,O
10:10,O
AM,O
BLOOD,B-TE
WBC,B-TE
-,O
8.1,O
RBC,B-TE
-,O
3.69,O
*,O
Hgb,B-TE
-,O
11.0,O
*,O
Hct,B-TE
-,O
32.4,O
*,O
MCV,B-TE
-,O
88,O
MCH,B-TE
-,O
29.8,O
MCHC,B-TE
-,O
33.9,O
RDW,B-TE
-,O
26.0,O
*,O
Plt,B-TE
Ct,I-TE
-,O
72,O
*#,O

2015-03-26,O
10:10,O
AM,O
BLOOD,B-TE
Neuts,B-TE
-,O
68.3,O
Bands,B-TE
-,O
0,O
Lymphs,B-TE
-,O
19.8,O
Monos,B-TE
-,O
10.6,O
Eos,B-TE
-,O
1.1,O
Baso,B-TE
-,O
0.2,O

2015-03-26,O
10:10,O
AM,O
BLOOD,B-TE
Hypochr,B-TE
-,O
1,O
+,O
Anisocy,B-TE
-,O
2,O
+,O
Poiklo,B-TE
-,O
2,O
+,O
Macrocy,B-TE
-,O
2,O
+,O
Microcy,B-TE
-,O
NORMAL,O
Polychr,B-TE
-,O
NORMAL,O
Ovalocy,B-TE
-,O
OCCASIONAL,O
Target,B-TE
-,O
OCCASIONAL,O
Schisto,B-TE
-,O
OCCASIONAL,O
Tear,O
Dr,O
Clark,O

2015-03-26,O
10:10,O
AM,O
BLOOD,B-TE
PT,B-TE
-,O
23.0,O
*,O
PTT,B-TE
-,O
63.2,O
*,O
INR(PT),B-TE
-,O
3.8,O

2015-03-26,O
10:10,O
AM,O
BLOOD,B-TE
Glucose,B-TE
-,O
76,O
UreaN,B-TE
-,O
17,O
Creat,B-TE
-,O
0.8,O
Na,B-TE
-,O
129,O
*,O
K,B-TE
-,O
3.9,O
Cl,B-TE
-,O
101,O
HCO3,B-TE
-,O
19,O
*,O
AnGap,B-TE
-,O
13,O

2015-03-26,O
10:10,O
AM,O
BLOOD,B-TE
ALT,B-TE
-,O
33,O
AST,B-TE
-,O
65,O
*,O
AlkPhos,B-TE
-,O
70,O
TotBili,B-TE
-,O
30.3,O
*,O
DirBili,B-TE
-,O
20.8,O
*,O
IndBili,B-TE
-,O
9.5,O

2015-03-26,O
10:10,O
AM,O
BLOOD,B-TE
Albumin,B-TE
-,O
3.1,O
*,O

2015-03-26,O
10:10,O
AM,O
BLOOD,B-TE
Ammonia,B-TE
-,O
39,O

RADIOLOGY,O

1.,O
Small,B-PR
cirrhotic,I-PR
liver,I-PR
with,O
what,O
appears,O
to,O
be,O
a,B-TR
portocaval,I-TR
shunt,I-TR
.,O

2.,O
Moderate,B-PR
ascites,I-PR
.,O

3.,O
Cholelithiasis,B-PR
without,O
evidence,O
of,O
acute,B-PR
cholecystitis,I-PR
.,O

4.,O
No,O
hydronephrosis,B-PR
.,O

5.,O
Borderline,B-PR
splenomegaly,I-PR
.,O

Brief,O
Hospital,O
Course,O
:,O

A/P,O
:,O
48,O
yo,O
morbidly,O
obese,O
woman,O
with,O
HCV,B-PR
cirrhosis,I-PR
c/b,O
encephalopathy,B-PR
",",O
esophageal,B-PR
varices,I-PR
and,O
partial,B-PR
vein,I-PR
thrombosis,I-PR
(,O
but,O
no,O
hx,O
of,O
SBP,B-PR
),O
presents,O
with,O
increasing,B-PR
abdominal,I-PR
girth,I-PR
likely,O
secondary,O
to,O
ascites,B-PR
.,O

Admitted,O
for,O
diagnostic,B-TR
/,I-TR
therapeutic,I-TR
paracentesis,I-TR
and,O
then,O
transferred,O
to,O
the,O
ICU,O
for,O
hypotension,B-PR
",",O
confusion,B-PR
and,O
anemia,B-PR
.,O

#,O
Liver,B-PR
cirrhosis,I-PR
:,O
MELD,B-TE
score,I-TE
of,O
34,O
on,O
admission,O
.,O

Pt,O
became,O
more,B-PR
encephalopathic,I-PR
during,O
her,O
hospital,O
course,O
.,O

She,O
was,O
not,O
a,O
transplant,O
candidate,O
due,O
to,O
her,B-PR
obesity,I-PR
.,O

A,O
family,O
meeting,O
was,O
held,O
on,O
hospital,O
day,O
#4,O
which,O
included,O
the,O
pt,O
's,O
closest,O
family,O
members,O
",",O
her,O
hepatologist,O
",",O
Dr.,O
Steidl,O
",",O
her,O
PCP,O
",",O
Dr.,O
Popoff,O
and,O
the,O
ICU,O
team,O
.,O

After,O
it,O
was,O
explained,O
that,O
the,B-PR
pt,I-PR
's,I-PR
prognosis,I-PR
was,O
very,O
poor,O
given,O
that,O
she,O
was,O
not,O
a,B-TR
transplant,I-TR
candidate,O
",",O
the,O

decision,O
was,O
made,O
by,O
the,O
family,O
and,O
the,O
medical,O
team,O
to,O
withdraw,O
care,B-TR
.,O

The,O
pt,O
was,O
made,O
comfortable,O
and,O
she,O
expired,O
several,O
hours,O
later,O
.,O

#,O
Recurrent,B-PR
ascites,I-PR
:,O
On,O
the,O
medical,O
floor,O
",",O
pt,O
had,O
a,B-TR
large,I-TR
volume,I-TR
paracentesis,I-TR
(,O
6,O
liters,O
),O
followed,O
by,O
replacement,B-TR
with,I-TR
albumin,I-TR
.,O

She,O
had,O
no,O
evidence,O
of,O
SBP,B-PR
.,O

#,O
Hypotension,B-PR
:,O
Pt,O
became,O
hypotensive,B-PR
following,O
the,B-TR
large,I-TR
volume,I-TR
paracentesis,I-TR
despite,O
replacement,B-TR
with,I-TR
albumin,I-TR
.,O

This,O
was,O
thought,O
to,O
be,O
04-09,O
the,B-TR
large,I-TR
volume,I-TR
tap,I-TR
verses,O
sepsis,B-PR
though,O
she,O
had,O
no,O
other,O
evidence,O
of,O
sepsis,B-PR
.,O

She,O
was,O
placed,O
on,O
pressors,B-TR
to,O
maintain,O
a,B-TE
MAP,I-TE
>,O
55,O
.,O

Once,O
the,O
decision,O
was,O
made,O
to,O
withdraw,O
care,O
",",O
the,B-TR
pressors,I-TR
were,O
discontinued,O
.,O

#,O
Anemia,B-PR
:,O
Hct,B-PR
dropped,I-PR
following,O
the,B-TR
tap,I-TR
and,O
there,O
was,O
concern,O
for,O
bleed,B-PR
into,I-PR
her,I-PR
abdomen,I-PR
.,O

She,O
received,O
one,O
unit,O
of,O
PRBC,B-TR
s.,I-TR

CT,B-TE
of,I-TE
the,I-TE
abdomen,I-TE
and,I-TE
pelvis,I-TE
showed,O
no,O
evidence,O
of,O
bleed,B-PR
.,O

Her,B-TE
hematocrit,I-TE
remained,O
stable,O
at,O
24-26,O
following,O
the,B-PR
acute,I-PR
drop.,I-PR

#,O
ARF,B-PR
:,O
Creatinine,B-TE
has,O
increased,O
from,O
0.9,O
on,O
admission,O
to,O
1.9,O
on,O
admission,O
to,O
ICU,O
.,O

Urine,B-TE
lytes,I-TE
with,O
Na,B-TE
of,O
10,O
indicating,O
either,O
pre-renal,B-PR
or,O
hepatorenal,B-PR
.,O

Fluid,B-TE
challenge,I-TE
with,O
36gm,O
of,O
albumin,B-TR
",",O
one,O
unit,O
of,O
PRBCs,B-TR
and,O
2L,O
of,O
NS,B-TR
.,O

Will,O
check,O
creatinine,B-TE
this,O
afternoon,O
.,O

Pt,O
previously,O
diagnosed,O
with,O
hepatorenal,B-PR
and,O
was,O
started,O
on,O
midodrine,B-TR
",",O
octreotide,B-TR
and,O
albumin,B-TR
;,O
these,O
were,O

continued,O
.,O

Her,B-TE
creatinine,I-TE
continued,O
to,O
increase,O
",",O
likely,O
due,O
to,O
her,B-PR
worsening,I-PR
liver,I-PR
failure,I-PR
.,O

Pt,O
expired,O
during,O
this,O
admission,O
after,O
family,O
discussion,O
to,O
make,O
her,O
comfort,O
care,O
only,O
.,O

Medications,O
on,O
Admission,O
:,O

Rifaximine,B-TR
200,O
mg,O
tid,O

Lactulose,B-TR
30,O
cc,O
qid,O
titrated,O
to,O
3-4,O
BM,O
/,O
day,O

Protonix,B-TR
40,O
mg,O
po,O
qd,O

Discharge,O
Medications,O
:,O

none,O

Discharge,O
Disposition,O
:,O

Home,O

Discharge,O
Diagnosis,O
:,O

none,O

Discharge,O
Condition,O
:,O

expired,B-PR

Discharge,O
Instructions,O
:,O

none,O

Followup,O
Instructions,O
:,O

none,O

Tracy,O
Doris,O
MD,O
79-274,O

Completed,O
by,O
:,O
Melvin,O
Thomas,O
MD,O
50-805,O
2015-06-22,O
@,O
1413,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Micheal,O
J.,O
Rozzi,O
on,O
:,O
MON,O
2015-07-20,O
1:53,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2008-12-24,O

Discharge,O
Date,O
:,O

2009-02-06,O

Date,O
of,O
Birth,O
:,O

2008-12-24,O

Sex,O
:,O

F,O

Service,O
:,O

Neonatology,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Gerardo,O
is,O
the,O
1400,O
gm,O
product,O
of,O
a,O
32,O
05-03,O
week,O
twin,O
gestation,O
born,O
to,O
a,O
37,O
year,O
old,O
gravida,O
1,O
",",O
para,O
0,O
mother,O
.,O

Prenatal,O
laboratory,O
values,O
:,O

Maternal,B-TE
blood,I-TE
type,I-TE
0-positive,O
",",O
DAT,B-TE
negative,O
",",O
negative,O
",",O
RPR,B-TE
nonreactive,O
.,O

The,O
mother,O
's,O
past,O
medical,O
history,O
is,O
significant,O
for,O
:,O

1.,O
Tuberculosis,B-PR
",",O
mother,O
was,O
treated,O
in,O
2001,O
according,O
to,O
chart,O
with,O
subsequent,O
negative,O
chest,B-TE
x-ray,I-TE
",",O
and,O

2.,O
Infertility,B-PR
.,O

The,O
pregnancy,O
was,O
complicated,O
by,O
twin,B-PR
gestation,I-PR
and,O
by,O
polyhydramnios,B-PR
with,O
apparent,O
duodenal,B-PR
atresia,I-PR
and,O
nuchal,O

thickening,B-PR
consistent,O
with,O
Trisomy,B-PR
21,I-PR
in,O
the,O
B,O
co-twin,O
.,O

Amniocentesis,B-TE
was,O
not,O
performed,O
.,O

Maternal,B-PR
hypertension,I-PR
was,O
noted,O
in,O
the,O
doctor,O
's,O
office,O
and,O
Mom,O
was,O
referred,O
to,O
nonreassuring,B-TE
fetal,I-TE
tracing,I-TE
",",O
necessitating,O
an,B-TR
urgent,I-TR
cesarean,I-TR
section,I-TR
.,O

Twin,O
#1,O
cried,O
spontaneously,O
at,O
birth,O
",",O
was,O
bulb,B-TR
suctioned,I-TR
and,O
received,O
Blow-by,B-TR
oxygen,I-TR
.,O

Apgars,B-TE
were,O
8,O
at,O
one,O
minute,O
and,O
8,O
at,O
five,O
minutes,O
.,O

Twin,O
#1,O
was,O
noted,O
to,O
be,O
in,O
a,B-PR
breech,I-PR
presentation,I-PR
.,O

Sepsis,B-PR
risk,I-PR
factors,I-PR
:,O

No,O
fever,B-PR
",",O
no,O
fetal,B-PR
tachycardia,I-PR
",",O
rupture,B-PR
of,I-PR
membranes,I-PR
at,O
delivery,O
.,O

Group,B-TE
B,I-TE
Streptococcus,I-TE
status,I-TE
unknown,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Well-appearing,O
female,O
without,O
distress,B-PR
on,O
admission,O
to,O
the,O
Newborn,O
Intensive,O
Care,O
Unit,O
.,O

The,O
patient,O
had,O
a,B-TE
weight,I-TE
of,O
1400,O
gm,O
",",O
length,B-TE
41.5,O
cm,O
and,O
head,B-TE
circumference,I-TE
of,O
29.25,O
cm,O
.,O

Anterior,O
fontanelle,O
",",O
soft,O
and,O
flat,O
",",O
palate,O
intact,O
",",O
nondysmorphic,B-PR
features,I-PR
.,O

Lungs,O
:,O
breath,B-TE
sounds,I-TE
clear,O
and,O
equal,O
bilaterally,O
",",O
no,O
retractions,B-PR
.,O

Heart,O
:,O
regular,O
rate,O
and,O
rhythm,O
",",O
no,O
murmur,B-PR
",",O
normal,O
S1,O
and,O
S2,O
",",O
pulses,B-TE
2,O
+.,O

Abdomen,O
:,O
soft,O
",",O
nondistended,B-PR
.,O

Without,O
hepatosplenomegaly,B-PR
",",O
without,O
masses,B-PR
.,O

Normal,O
female,O
genitalia,O
.,O

Anus,O
patent,O
.,O

Positive,O
suck,B-TE
",",O
positive,O
grasp,B-TE
.,O

Skin,O
intact,O
.,O

Size,O
appropriate,O
for,O
gestational,O
age,O
",",O
32,O
week,O
female,O
.,O

SUMMARY,O
OF,O
HOSPITAL,O
COURSE,O
:,O

1.,O
Respiratory,O
-,O
Gerardo,O
was,O
initially,O
placed,O
in,O
nasal,B-TR
cannula,I-TR
oxygen,I-TR
to,O
maintain,O
oxygen,B-TE
saturation,I-TE
greater,O
than,O
94,O
.,O

On,O
day,O
of,O
life,O
#1,O
",",O
caffeine,B-TR
was,O
started,O
.,O

Gerardo,O
weaned,O
to,O
room,O
air,O
on,O
day,O
of,O
life,O
#6,O
.,O

Caffeine,B-TR
was,O
discontinued,O
on,O
day,O
of,O
life,O
#19,O
.,O

Breath,B-TE
sounds,I-TE
",",O
clear,O
and,O
equal,O
",",O
without,O
retractions,B-PR
",",O
respiratory,B-TE
rate,I-TE
30,O
s,O
to,O
60,O
s.,O

2.,O
Cardiovascular,O
-,O
The,O
patient,O
has,O
been,O
cardiovascularly,O
stable,O
without,O
murmur,B-PR
.,O

3.,O
Fluids,O
",",O
electrolytes,O
and,O
nutrition,O
-,O
Birthweight,B-TE
was,O
1400,O
gm,O
",",O
25th,O
percentile,O
.,O

The,O
patient,O
was,O
initially,O
started,O
on,O
D10,B-TR
/,I-TR
W,I-TR
at,O
80,O
cc,O
/,O
kg,O
/,O
day,O
.,O

She,O
began,O
enteral,B-TR
feeds,I-TR
on,O
day,O
of,O
life,O
#2,O
advancing,O
to,O
mother,O
's,O
breastmilk,O
30,O
with,O
ProMod,B-TR
at,O
150,O
cc,O
/,O
kg,O
/,O
day,O
.,O

Baby,O
received,O
parenteral,B-TR
nutrition,I-TR
and,O
lipids,B-TR
for,O
four,O
days,O
.,O

No,O
hypoglycemia,B-PR
issues,I-PR
noted,O
.,O

Baby,O
is,O
presently,O
tolerating,O
mother,O
's,O
breastmilk,O
with,O
Enfamil,B-TR
powder,I-TR
to,O
make,O
24,O
cal,O
/,O
oz,O
at,O
130,O
cc,O
/,O
kg,O
/,O
day,O
.,O

The,O
baby,O
is,O
breastfeeding,O
well,O
.,O

The,O
plan,O
is,O
for,O
alternating,O
feeds,O
.,O

4.,O
Gastrointestinal,O
",",O
genitourinary,O
-,O
Peak,B-TE
bilirubin,I-TE
8.5,O
",",O
phototherapy,B-TR
times,O
24,O
hours,O
.,O

Rebound,B-TE
bilirubin,I-TE
6.4,O
.,O

5.,O
Hematology,O
-,O
Most,O
recent,O
hematocrit,B-TE
was,O
42.8,O
on,O
50-05-25,O
.,O

The,O
baby,O
received,O
no,O
blood,B-TR
products,I-TR
.,O

6.,O
Infectious,O
disease,O
-,O
No,O
sepsis,B-PR
risk,I-PR
factors,I-PR
.,O

Initial,B-TE
complete,I-TE
blood,I-TE
count,I-TE
with,O
white,B-TE
blood,I-TE
cell,I-TE
count,I-TE
14,O
",",O
hemoglobin,B-TE
21.6,O
",",O
hematocrit,B-TE
62.9,O
",",O
65,O
neutrophils,B-TE
",",O
no,O
bands,B-TE
",",O
28,O
lymphocytes,B-TE
.,O

Blood,B-TE
cultures,I-TE
negative,O
.,O

7.,O
Neurology,O
-,O
Normal,O
head,O
ultrasound,O
on,O
2009-01-08,O
.,O

8.,O
Sensory,O
-,O
Audiology,O
",",O
hearing,B-TE
screening,I-TE
was,O
performed,O
with,O
automated,O
auditory,O
brain,O
stem,O
responses,O
.,O

Baby,O
passed,O
hearing,B-TE
test,I-TE
on,O
2009-01-21,O
.,O

Follow,O
up,O
recommended,O
in,O
eight,O
months,O
.,O

Ophthalmology,O
:,O

A,B-TE
follow,I-TE
up,I-TE
examination,I-TE
is,O
recommended,O
in,O
six,O
to,O
eight,O
months,O
.,O

9.,O
Psychosocial,O
-,O
Bridgewater,O
State,O
Hospital,O
Center,O
's,O
social,O
work,O
involved,O
with,O
family,O
.,O

The,O
contact,O
social,O
worker,O
is,O
Barbara,O
Cole,O
and,O
she,O
can,O
be,O
reached,O
at,O
(,O
972,O
),O
433-8086,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
.,O

DISCHARGE,O
DISPOSITION,O
:,O
Home,O
.,O

PRIMARY,O
PEDIATRICIAN,O
:,O

Dr.,O
Vito,O
Dotzler,O
",",O
phone,O
(,O
259,O
),O
579-8396,O
",",O
fax,O
898-3942,O
.,O

RECOMMENDATIONS,O
:,O

1.,O
Feeds,O
-,O
Breastfeeding,O
ad,O
lib,O
",",O
supplementing,O
with,O
Enfamil,B-TR
24,O
or,O
breastmilk,O
24,O
cal,O
/,O
oz,O
made,O
with,O
1,O
tsp,O
of,O
Enfamil,B-TR
powder,I-TR
per,O
100,O
cc,O
of,O
breastmilk,O
.,O

2.,O
Medications,B-TR
-,O
Poly-Vi-James,B-TR
1,O
cc,O
p.o.,O
q.,O
day,O
;,O
Iron,B-TR
or,O
Fer-In-James,B-TR
0.2,O
cc,O
p.o.,O
q.,O
day,O
to,O
give,O
2,O
mg,O
/,O
kg,O
/,O
day,O

3.,O
Car,B-TE
seat,I-TE
screening,I-TE
-,O
Passed,O
.,O

4.,O
State,B-TE
newborn,I-TE
screening,I-TE
-,O
Last,O
on,O
2009-01-07,O
",",O
all,O
within,O
normal,O
range,O
.,O

5.,O
Immunizations,B-TR
received,O
-,O
Hepatitis,B-TR
B,I-TR
vaccine,I-TR
given,O
2009-01-22,O
.,O

6.,O
Immunizations,B-TR
recommended,O
-,O

Synagis,B-TR
respiratory,I-TR
syncytial,I-TR
virus,I-TR
prophylaxis,I-TR
should,O
be,O
considered,O
from,O
October,O
through,O
April,O
for,O
infants,O
who,O
meet,O

any,O
of,O
the,O
following,O
three,O
criteria,O
-,O

1.,O
Born,O
at,O
less,O
than,O
32,O
weeks,O
;,O

2.,O
Born,O
between,O
32,O
and,O
35,O
weeks,O
with,O
plans,O
for,O
daycare,O
during,O
respiratory,O
syncytial,O
virus,O
season,O
",",O
with,O
a,O
smoker,O
in,O
the,O
household,O
or,O
with,O
preschool,O
siblings,O
;,O
or,O

3.,O
With,O
chronic,B-PR
lung,I-PR
disease,I-PR
.,O

After,O
some,O
debate,O
",",O
we,O
concluded,O
that,O
Vetrano,O
was,O
not,O
at,O
unusually,O
high,O
risk,O
from,O
RSV,B-PR
",",O
but,O
that,O
her,O
sister,O
might,O
be,O
.,O

Vetrano,O
probably,O
does,O
not,O
need,O
Synagis,B-TR
at,O
least,O
until,O
her,O
sibling,O
is,O
discharged,O
from,O
the,O
hospital,O
.,O

It,O
may,O
then,O
be,O
reasonable,O
to,O
treat,O
both,O
for,O
the,O
balance,O
of,O
the,O
RSV,O
season,O
.,O

Influenza,B-TR
immunization,I-TR
should,O
be,O
considered,O
annually,O
in,O
the,O
fall,O
for,O
preterm,O
infants,O
with,O
chronic,B-PR
lung,I-PR
disease,I-PR
once,O
they,O

reach,O
six,O
months,O
of,O
age,O
",",O
before,O
this,O
age,O
the,O
family,O
and,O
other,O
caregivers,O
should,O
be,O
considered,O
for,O
immunization,B-TR
against,O

influenza,B-PR
to,O
protect,O
the,O
infant,O
.,O

7.,O
Follow,O
up,O
-,O
Follow,O
up,O
appointment,O
with,O
primary,O
pediatrician,O
within,O
five,O
days,O
of,O
discharge,O
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

1.,O
Prematurity,B-PR
",",O
former,O
32,O
4/7,O
weeks,O
",",O
Twin,O
#1,O

2.,O
Rule,O
out,O
sepsis,B-PR

Beverly,O
Q.,O
Bailey,O
",",O
M.D.,O
02-131,O

Dictated,O
By,O
:,O
Carmen,O
Y.R.,O
Martinez,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2009-02-05,O
18:20,O

T,O
:,O
2009-02-05,O
18:39,O

JOB,O
#:,O

17371,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Lizzie,O
Calkins,O
on,O
:,O
Adeline,O
2009-02-06,O
10:27,O
AM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2009-03-27,O

Discharge,O
Date,O
:,O

2009-04-03,O

Date,O
of,O
Birth,O
:,O

1960-03-06,O

Sex,O
:,O

F,O

Service,O
:,O

GYNECOLOGY,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
49-year-old,O
gravida,O
III,O
",",O
para,O
II,O
",",O
who,O
was,O
sent,O
from,O
her,O
primary,O
care,O
physician,O
's,O
office,O
secondary,O
to,O
lower,B-PR
abdominal,I-PR
pain,I-PR
.,O

The,O
patient,O
is,O
status,O
post,O
uterine,B-TR
artery,I-TR
embolization,I-TR
on,O
2009-01-07,O
secondary,O
to,O
fibroids,B-PR
.,O

She,O
has,O
had,O
continuing,B-PR
vaginal,I-PR
discharge,I-PR
",",O
and,O
was,O
diagnosed,O
with,O
bacterial,B-PR
vaginosis,I-PR
one,O
day,O
prior,O
to,O
admission,O
",",O
and,O
was,O
given,O
a,O
prescription,O
for,O
Flagyl,B-TR
.,O

She,O
noted,O
increasing,B-PR
abdominal,I-PR
pain,I-PR
two,O
days,O
prior,O
to,O
admission,O
",",O
which,O
became,O
more,O
severe,O
on,O
the,O
day,O
prior,O
to,O
admission,O
.,O

She,O
went,O
to,O
her,O
primary,O
care,O
physician,O
's,O
office,O
on,O
the,O
day,O
of,O
admission,O
complaining,O
of,O
abdominal,B-PR
pain,I-PR
",",O
which,O
she,O
stated,O
was,O
constant,O
but,O
intermittently,O
sharper,O
at,O
times,O
.,O

The,O
location,O
was,O
variable,O
.,O

She,O
also,O
complained,O
of,O
some,B-PR
loose,I-PR
stools,I-PR
on,O
the,O
day,O
of,O
admission,O
",",O
no,O
nausea,B-PR
or,O
vomiting,B-PR
.,O

Her,B-TE
temperature,I-TE
was,O
100.4,O
in,O
the,O
office,O
",",O
and,O
she,O
had,O
no,O
chills,B-PR
.,O

She,O
was,O
sent,O
for,O
a,B-TE
CT,I-TE
scan,I-TE
of,I-TE
her,I-TE
abdomen,I-TE
",",O
which,O
revealed,O
fluid,B-PR
and,O
question,O
of,O
gas,B-PR
in,I-PR
the,I-PR
endometrial,I-PR
cavity,I-PR
",",O
and,O
she,O
was,O
sent,O
to,O
Pinewood,O
",",O
Norfolk,O
for,O
treatment,B-TR
and,O
admission,B-TR
.,O

PAST,O
OBSTETRICAL,O
HISTORY,O
:,O

Cesarean,B-TR
section,I-TR
x,O
2,O
",",O
spontaneous,B-PR
abortion,I-PR
x,O
1,O
.,O

PAST,O
GYNECOLOGIC,O
HISTORY,O
:,O

Last,O
menstrual,O
period,O
2009-02-21,O
.,O

Some,B-PR
spotting,I-PR
on,O
the,O
day,O
prior,O
to,O
admission,O
",",O
but,O
not,O
a,O
normal,O
period,O
.,O

Periods,O
regular,O
.,O

Lupron,B-TR
x,O
three,O
months,O
prior,O
to,O
embolization,B-TR
.,O

Fibroid,B-PR
uterus,I-PR
status,O
post,O
embolization,B-TR
on,O
2009-01-07,O
.,O

Dilatation,B-TR
and,I-TR
curettage,I-TR
x,O
1,O
for,O
SAB,B-PR
.,O

History,O
of,O
herpes,B-PR
simplex,I-PR
virus,I-PR
",",O
last,O
outbreak,O
in,O
2000,O
.,O

No,O
history,O
of,O
abnormal,B-PR
Pap,I-PR
smears,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

None,O
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

Cesarean,B-TR
section,I-TR
x,O
2,O
",",O
dilatation,B-TR
and,I-TR
curettage,I-TR
x,O
1,O
",",O
neck,B-TR
fusion,I-TR
after,O
motor,O
vehicle,O
accident,O
",",O
shoulder,B-TR
surgery,I-TR
after,O
motor,O
vehicle,O
accident,O
.,O

MEDICATIONS,O
:,O

Flagyl,B-TR
.,O

ALLERGIES,O
:,O

None,O
.,O

SOCIAL,O
HISTORY,O
:,O

No,O
smoking,O
",",O
alcohol,O
or,O
drugs,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Temperature,B-TE
100.4,O
",",O
pulse,B-TE
108,O
",",O
respirations,B-TE
20,O
",",O
blood,B-TE
pressure,I-TE
110/70,O
",",O
oxygen,B-TE
saturation,I-TE
100%,O
on,O
room,O
air,O
.,O

In,O
general,O
",",O
she,O
was,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

Her,O
abdomen,O
was,O
notable,O
for,O
voluntary,B-PR
guarding,I-PR
but,O
no,O
involuntary,B-PR
guarding,I-PR
or,O
rebound,B-PR
",",O
mild,B-PR
right,I-PR
lower,I-PR
quadrant,I-PR
tenderness,I-PR
greater,O
than,O
left,O
lower,O
quadrant,O
",",O
nondistended,B-PR
.,O

Her,B-TE
pelvic,I-TE
examination,I-TE
was,O
notable,O
for,O
some,B-PR
brownish,I-PR
discharge,I-PR
.,O

Her,O
uterus,O
and,O
adnexa,O
were,O
difficult,O
to,O
assess,O
secondary,O
to,O
voluntary,B-PR
tensing,I-PR
of,I-PR
her,I-PR
abdomen,I-PR
.,O

ASSESSMENT,O
:,O

This,O
is,O
a,O
49-year-old,O
gravida,O
III,O
",",O
para,O
II,O
",",O
status,B-TR
post,I-TR
uterine,I-TR
artery,I-TR
embolization,I-TR
on,O
2009-01-07,O
due,O
to,O
uterine,B-PR
fibroids,I-PR
",",O
with,O
continued,B-PR
abdominal,I-PR
pain,I-PR
and,O
CT,B-TE
scan,I-TE
revealing,O
fluid,B-PR
and,I-PR
gas,I-PR
in,I-PR
the,I-PR
endometrial,I-PR
cavity,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
and,O
was,O
initially,O
started,O
on,O
intravenous,B-TR
ampicillin,I-TR
",",O
gentamicin,B-TR
and,O
clindamycin,B-TR
.,O

Her,B-TE
initial,I-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
was,O
11.3,O
",",O
with,O
a,O
normal,O
differential,O
.,O

Her,B-TE
sedimentation,I-TE
rate,I-TE
was,O
elevated,B-PR
at,O
110,O
.,O

Her,B-TE
electrolytes,I-TE
were,O
within,O
normal,O
limits,O
.,O

She,O
was,O
maintained,O
on,O
intravenous,B-TR
antibiotics,I-TR
.,O

On,O
hospital,O
day,O
number,O
three,O
",",O
her,B-TE
blood,I-TE
cultures,I-TE
came,O
back,O
positive,B-PR
in,O
the,B-TE
anaerobic,I-TE
culture,I-TE
for,O
gram-positive,B-PR
cocci,I-PR
in,I-PR
pairs,I-PR
and,I-PR
clusters,I-PR
.,O

Further,B-TE
identification,I-TE
revealed,O
staphylococcus,B-PR
coag-negative,I-PR
",",O
which,O
was,O
sensitive,O
to,O
gentamicin,B-TR
and,O
clindamycin,B-TR
.,O

She,O
was,O
continued,O
on,O
her,B-TR
antibiotics,I-TR
",",O
and,O
was,O
afebrile,B-PR
until,O
hospital,O
day,O
number,O
five,O
",",O
when,O
she,O
had,O
a,B-PR
temperature,I-PR
spike,I-PR
to,O
102.3,O
.,O

Repeat,B-TE
blood,I-TE
cultures,I-TE
were,O
sent,O
.,O

Her,B-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
was,O
12.8,O
",",O
with,O
a,O
normal,O
differential,O
.,O

At,O
this,O
time,O
",",O
an,O
Infectious,O
Disease,O
consult,O
was,O
obtained,O
",",O
and,O
the,O
recommendation,O
was,O
to,O
discontinue,O
the,B-TR
ampicillin,I-TR
",",O
gentamicin,B-TR
and,O
clindamycin,B-TR
",",O
and,O
start,O
her,O
on,O
intravenous,B-TR
Unasyn,I-TR
.,O

She,O
underwent,O
a,B-TE
pelvic,I-TE
ultrasound,I-TE
and,O
an,B-TE
abdomen,I-TE
and,I-TE
pelvis,I-TE
CT,I-TE
",",O
which,O
revealed,O
continued,B-PR
air,I-PR
in,I-PR
the,I-PR
endometrial,I-PR
cavity,I-PR
vs.,O
in,O
the,B-PR
fundal,I-PR
fibroid,I-PR
.,O

Discussion,O
was,O
had,O
at,O
this,O
time,O
with,O
the,O
patient,O
regarding,O
whether,O
or,O
not,O
this,O
represented,O
an,B-PR
infected,I-PR
abscess,I-PR
vs.,O
post-surgical,B-PR
change,I-PR
.,O

Extensive,O
discussion,O
was,O
held,O
",",O
and,O
second,O
opinion,O
was,O
obtained,O
regarding,O
the,O
need,O
for,O

possible,O
drainage,B-TR
of,O
the,B-PR
abscess,I-PR
vs.,O
hysterectomy,B-TR
.,O

The,O
patient,O
requested,O
an,O
outside,O
second,O
opinion,O
",",O
as,O
she,O
was,O
reluctant,O
to,O
undergo,O
hysterectomy,B-TR
at,O
this,O
time,O
.,O

She,O
was,O
discharged,O
to,O
home,O
on,O
hospital,O
day,O
number,O
eight,O
",",O
on,O
oral,B-TR
antibiotics,I-TR
.,O

The,O
patient,O
was,O
to,O
have,O
a,B-TE
repeat,I-TE
CT,I-TE
scan,I-TE
in,O
one,O
week,O
.,O

She,O
was,O
also,O
to,O
obtain,O
a,O
second,O
opinion,O
regarding,O
the,O
question,O
of,O
possible,O
surgical,B-TR
management,I-TR
.,O

Claude,O
U,O
Bolanos,O
",",O
M.D.,O

95-182,O

Dictated,O
By,O
:,O
William,O
MP,O
Lajoie,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2009-04-02,O
22:09,O

T,O
:,O
2009-04-03,O
01:26,O

JOB,O
#:,O

61261,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Suzanne,O
Simpson,O
on,O
:,O
FRI,O
2009-04-24,O
12:48,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2013-11-21,O

Discharge,O
Date,O
:,O

2013-11-26,O

Date,O
of,O
Birth,O
:,O

1949-07-18,O

Sex,O
:,O

F,O

Service,O
:,O

PLASTIC,O

Allergies,O
:,O

Trazodone,B-TR
/,O
Ambien,B-TR
/,O
Sinequan,B-TR

Attending,O
:,O
Bobby,O
Z.S.,O
Ruiz,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

ACQUIRED,B-PR
DEFECT,I-PR
FROM,O
BASAL,B-TR
CELL,I-TR
CARCINOMA,I-TR
RESECTION,I-TR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

RIGHT,B-TR
NOSE,I-TR
/,I-TR
ALA,I-TR
RECONSTRUCTION,I-TR
USING,O
RIGHT,B-TR
CHEEK,I-TR
ADVANCEMENT,I-TR
AND,O
FOREHEAD,B-TR
LOCAL,I-TR
FLAP,I-TR

History,O
of,O
Present,O
Illness,O
:,O

MS.,O
Marshall,O
IS,O
A,O
64-YEAR,O
OLD,O
",",O
MENTALLY,B-PR
RETARDED,I-PR
",",O
FEMALE,O
WHO,O
PRESENTED,O
WITH,O
AN,B-PR
AQUIRED,I-PR
DEFECT,I-PR
OF,I-PR
THE,I-PR
RIGHT,I-PR
NASAL,I-PR
ALA,I-PR
AND,I-PR
MEDIAL,I-PR
CHEEK,I-PR
REGION,I-PR
AFTER,O
BASAL,B-PR
CELL,I-PR
CARCINOMA,I-PR
WAS,O
RESECTED,O
BY,O
DERMATOLOGY,O
.,O

Past,O
Medical,O
History,O
:,O

MENTAL,B-PR
RETARDATION,I-PR

DIABETES,B-PR

BIPOLAR,B-PR
DISORDER,I-PR

Social,O
History,O
:,O

LIVES,O
IN,O
A,O
NURSING,O
HOME,O
",",O
HAS,O
A,O
BROTHER,O
WHO,O
IS,O
THE,O
HEALTH,O
CARE,O
PROXY,O
.,O

NO,O
Tifany,O
",",O
ETOH,O
",",O
OR,O
REC,O
DRUG,O
USE,O
.,O

Physical,O
Exam,O
:,O

ON,O
PRESENTATION,O
",",O
PT,O
WAS,O
AFEBRILE,B-PR
WITH,O
NORMAL,O
VITAL,O
SIGNS,O

GEN,O
:,O
NO,O
ACUTE,B-PR
DISTRESS,I-PR
",",O
ABLE,O
TO,O
COMMUNICATE,O
AND,O
FOLLOW,O
ORDERS,O

HEAD,O
AND,O
NECK,O
:,O
5,B-PR
CM,I-PR
CIRCULAR,I-PR
FULL,I-PR
THICKNESS,I-PR
DEFECT,I-PR
AT,O
THE,O
JUNCTION,O
OF,O
THE,O
RIGHT,O
ALA,O
AND,O
CHEEK,O

HEART,O
:,O
REGULAR,O
RATE,O
AND,O
RHYTHM,O

LUNGS,O
:,O
CLEAR,O
TO,O
ASCULATION,B-TE

ABDOMEN,O
:,O
SOFT,O
",",O
NON-TENDER,B-PR
",",O
NON-DISTENDED,B-PR

EXTREMITIES,O
:,O
NO,O
EDEMA,B-PR
",",O
CYANOSIS,B-PR
",",O
FULL,O
RANGE,O
OF,O
MOTION,O

Brief,O
Hospital,O
Course,O
:,O

UPON,O
ADMISSION,O
",",O
THE,O
PATIENT,O
WAS,O
PRE-OP,O
'D,O
AND,O
MADE,O
NPO,B-TR
/,O
IVF,B-TR
.,O

SHE,O
WENT,O
TO,O
SURGERY,B-TR
THE,O
NEXT,O
MORNING,O
AND,O
TOLERATED,O
THE,B-TR
SURGERY,I-TR
WELL,O
.,O

HOWEVER,O
",",O
SHE,O
WAS,O
SLOW,O
TO,O
AWAKE,O
FROM,O
ANESTHESIA,B-TR
",",O
AND,O
WAS,O
ADMITTED,O
TO,O
THE,O
CMED,O
CCU,O
OBSERVATION,B-TE
.,O

SHE,O
WAS,O
TRANSFERED,O
TO,O
THE,O
FLOOR,O
POST-OP,O
DAY,O
2,O
WHERE,O
SHE,O
HAD,O
BEEN,O
AFEBRILE,B-PR
WITH,O
NORMAL,O
VITALS,O
",",O
MAKING,O
GOOD,O
URINE,O
",",O
AND,O
TOLERATING,O
A,O
REGULAR,O
DIET,O
.,O

HER,B-PR
WOUND,I-PR
HAS,O
REMAIND,O
DRY,O
AND,O
CLOSED,O
",",O
WITHOUT,O
EVIDENCE,O
OF,O
INFECTION,B-PR
OR,O
BREAKDOWN,B-PR
.,O

SHE,O
HAS,O
BEEN,O
WATCHED,O
BY,O
A,O
SITTER,O
AT,O
ALL,O
TIMES,O
.,O

SHE,O
WILL,O
BE,O
DISCHARGED,O
TODAY,O
BACK,O
TO,O
HER,O
NURSING,O
HOME,O
IN,O
GOOD,O
CONDITION,O
",",O
ON,O
PAIN,B-TR
MEDS,I-TR
",",O
ANTIBIOTICS,B-TR
",",O
AND,O
WITH,O
ANTICIPATED,O
1:1,O
WATCH,O
.,O

SHE,O
WILL,O
FOLLOW,O
UP,O
WITH,O
DR.,O
Karen,O
IN,O
1,O
WEEK,O
.,O

STAGE,O
TWO,O
OF,O
HER,B-TR
SURGERY,I-TR
WILL,O
BE,O
DONE,O
IN,O
3,O
WEEKS,O
.,O

Discharge,O
Medications,O
:,O

1.,O
Paroxetine,B-TR
HCl,I-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
AM,O
().,O

2.,O
Multivitamin,B-TR
Capsule,I-TR
Sig,O
:,O
One,O
(,O
1,O
),O
Cap,O
PO,O
QAM,O
(,O
once,O
a,O
day,O
(,O
in,O
the,O
morning,O
)).,O

3.,O
Divalproex,B-TR
Sodium,I-TR
500,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
QAM,O
(,O
once,O
a,O
day,O
(,O
in,O
the,O
morning,O
)).,O

4.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
as,O
needed,O
:,O
constipation,B-PR
.,O

Disp,O
:*,O
30,O
Capsule,O
(s)*,O
Refills,O
:*,O
0,O
*,O

5.,O
Triamcinolone,B-TR
Acetonide,I-TR
0.1,O
%,O
Cream,O
Sig,O
:,O
One,O
(,O
1,O
),O
Appl,O
Topical,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

6.,O
Divalproex,B-TR
Sodium,I-TR

7.,O
Atorvastatin,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
HS,O
(,O
at,O
bedtime,O
).,O

8.,O
Oxybutynin,B-TR
Chloride,I-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
QPM,O
(,O
once,O
a,O
day,O
(,O
in,O
the,O
evening,O
)).,O

9.,O
Hydrocodone-Acetaminophen,B-TR
5-500,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
Q4H,O
(,O
every,O
4,O
hours,O
).,O

Disp,O
:*,O
40,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

10.,O
Bacitracin-Polymyxin-Neosp,B-TR
HC,I-TR
Ointment,I-TR
Sig,O
:,O
One,O
(,O
1,O
),O
Topical,O
three,O
times,O
a,O
day,O
.,O

Disp,O
:*,O
1,O
500,O
/,O
gram,O
*,O
Refills,O
:*,O
2,O
*,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Discharge,O
Diagnosis,O
:,O

AQUIRED,B-PR
DEFORMITY,I-PR
OF,I-PR
THE,I-PR
RIGHT,I-PR
ALA,I-PR
/,I-PR
NOSE,I-PR
AND,I-PR
MEDIAL,I-PR
CHEEK,I-PR
FROM,O
BASAL,B-TR
CELL,I-TR
CARCINOMA,I-TR
RESECTION,I-TR

Discharge,O
Condition,O
:,O

GOOD,O

Discharge,O
Instructions,O
:,O

PLEASE,O
GIVE,O
PATIENT,O
MEDICATIONS,B-TR
AS,O
PRESCRIBED,O
AND,O
READ,O
WARNING,O
LABELS,O
CAREFULLY,O
.,O

IF,O
SIGNS,B-PR
AND,I-PR
SYMPTOMS,I-PR
OF,O
INFECTION,B-PR
",",O
SUCH,O
AS,O
FEVERS,B-PR
/,O
CHILLS,B-PR
",",O
PURULENT,B-PR
DISCHARGE,I-PR
FROM,I-PR
WOUND,I-PR
/,I-PR
INCISION,I-PR
SITE,I-PR
",",O
INCREASED,B-PR
REDNESS,I-PR
",",O
INCREASED,B-PR
PAIN,I-PR
",",O
PLEASE,O
CALL,O
OR,O
GO,O
TO,O
THE,O
EMERGENCY,O
ROOM,O
.,O

REMEMBER,O
TO,O
CALL,O
TO,O
SCHEDULE,O
HER,O
FOLLOW,O
UP,O
APPOINTMENT,O
(,O
BELOW,O
).,O

LIGHT,O
ACTIVITIES,O
UNTIL,O
SEEN,O
IN,O
CLINIC,O
.,O

STAGE,O
2,O
OF,O
THE,B-TR
SURGERY,I-TR
WILL,O
BE,O
DONE,O
IN,O
3,O
WEEKS,O
.,O

MAY,O
SHOWER,O
--,O
DAB,O
DRY,O
",",O
DO,O
NOT,O
SCRUB,O
.,O

PLEASE,O
CLEAN,O
INCISION,B-PR
SITE,I-PR
WITH,O
NORMAL,B-TR
SALINE,I-TR
OR,O
CLEAN,O
WATER,O
THREE,O
TIMES,O
A,O
DAY,O
AND,O
PLACE,O
ANTIBIOTIC,B-TR
OINTMENT,I-TR
(,O
GIVEN,O
),O
ON,O
TOP,O
OF,O
WOUND,B-PR
.,O

PLEASE,O
KEEP,O
PATIENT,O
AWAY,O
FROM,O
THE,O
SUN,O
.,O

MOST,O
IMPORTANTLY,O
",",O
THE,O
PATIENT,O
MUST,O
BE,O
WATCH,O
ONE-ON-ONE,O
SO,O
THAT,O
SHE,O
DOES,O
NOT,O
PICK,O
AT,O
HER,B-PR
WOUND,I-PR
.,O

Followup,O
Instructions,O
:,O

PLEASE,O
CALL,O
DR.Parson,O
OFFICE,O
FOR,O
A,O
FOLLOW,O
UP,O
(,O
989-5361,O
Mauricio,O
(,O
540-4644,O

Nancy,O
Lois,O
MD,O
88-449,O

Completed,O
by,O
:,O
Mary,O
Lisa,O
MD,O
53-914,O
2013-11-26,O
@,O
1134,O

Signed,O
electronically,O
by,O
:,O
DR.,O
David,O
Randazzo,O
on,O
:,O
MON,O
2013-12-16,O
7:25,O
AM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2013-05-18,O

Discharge,O
Date,O
:,O

2013-05-24,O

Date,O
of,O
Birth,O
:,O

1811-08-19,O

Sex,O
:,O

F,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,I-PR
Drugs,I-PR

Attending,O
:,O
Sarah,O
Q.,O
George,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Hip,B-PR
fracture,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

OPERATIVE,O
PROCEDURE,O
:,O

1.,O
Closed,B-TR
reduction,I-TR
of,I-TR
right,I-TR
hip,I-TR
with,O
open,B-TR
placement,I-TR
of,I-TR
dynamic,I-TR
hip,I-TR
screw,I-TR
",",I-TR
right,I-TR
hip,I-TR
.,O

2.,O
Examination,B-TE
under,I-TE
anesthesia,I-TE
with,O
placement,B-TR
of,I-TR
splint,I-TR
",",I-TR
right,I-TR
elbow,I-TR
.,O

PROCEDURE,O
#2,O
:,O

1.,O
Exploratory,B-TE
laparotomy,I-TE
with,O
drainage,B-TR
of,O
intra-abdominal,B-PR
abscess,I-PR
and,O
peritonitis,B-PR
with,O
gross,B-PR
soilage,I-PR
with,I-PR
bile,I-PR
and,I-PR
gastric,I-PR
contents,I-PR
.,O

2.,O
Exposure,B-TR
and,O
wide,B-TR
drainage,I-TR
of,O
perforated,B-PR
posterior,I-PR
duodenal,I-PR
ulcer,I-PR
with,O
internal,B-TR
and,I-TR
external,I-TR
drainage,I-TR
.,O

3.,O
Feeding,B-TR
jejunostomy,I-TR
.,O

4.,O
Tube,B-TR
gastrostomy,I-TR
.,O

5.,O
Placement,O
of,O
a,B-TR
right,I-TR
femoral,I-TR
arterial,I-TR
line,I-TR
.,O

History,O
of,O
Present,O
Illness,O
:,O

90,O
yo,O
F,O
with,O
MMP,B-PR
(,O
see,O
below,O
),O
who,O
sustained,O
a,B-PR
mechanical,I-PR
fall,I-PR
down,O
stairs,O
resulting,O
in,O
a,B-PR
hip,I-PR
and,I-PR
arm,I-PR
fracture,I-PR
.,O

Fall,B-PR
was,O
witnessed,O
by,O
daughter,O
.,O

Nicholas,B-PR
seizures,I-PR
",",O
no,O
LOC,B-PR
",",O
no,O
head,B-PR
or,I-PR
neck,I-PR
trauma,I-PR
.,O

Patient,O
denies,O
CP,B-PR
",",O
SOB,B-PR
",",O
light,B-PR
headedness,I-PR
",",O
or,O
dizziness,B-PR
prior,O
to,O
of,O
after,O
the,B-PR
fall,I-PR
.,O

She,O
fell,O
on,O
her,O
R,O
side,O
and,O
had,O
a,O
great,O
deal,O
of,O
pain,B-PR
in,I-PR
her,I-PR
R,I-PR
arm,I-PR
and,I-PR
hip,I-PR
.,O

Presented,O
to,O
Taunton,O
and,O
found,O
to,O
have,O
R,B-PR
humerus,I-PR
and,I-PR
R,I-PR
hip,I-PR
fx,I-PR
.,O

Ct,B-TE
of,I-TE
head,I-TE
and,I-TE
neck,I-TE
neg,O
for,O
fx,B-PR
",",O
bleed,B-PR
",",O
and,O
dislocation,B-PR
.,O

Past,O
Medical,O
History,O
:,O

1.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
status,O
post,O
non-ST-elevation,B-PR
myocardial,I-PR
infarction,I-PR
in,O
2009-05-05,O
",",O
status,O
post,O
cardiac,B-TE
catheterization,I-TE
with,O
left,B-TR
anterior,I-TR
descending,I-TR
artery,I-TR
stent,I-TR
placement,I-TR
in,O
05/2001,O
.,O

2.,O
CHF,B-PR
with,O
an,B-TE
ejection,I-TE
fraction,I-TE
of,O
40-45%,O
02-09,O

3.,O
Diabetes,B-PR
type,I-PR
2,I-PR
.,O

4.,O
Anemia,B-PR
",",O
transfusion,B-PR
dependent,I-PR
every,O
three,O
months,O
.,O

Hct,B-TE
28,O
b/l,O

5.,O
Polymyalgia,B-PR
rheumatica,I-PR
.,O

6.,O
Hypertension,B-PR
.,O

7.,O
Hypothyroidism,B-PR
.,O

8.,O
Chronic,B-PR
renal,I-PR
insufficiency,I-PR
with,O
a,B-TE
b/l,I-TE
creatinine,I-TE
of,O
1.4,O
.,O

9.,O
History,O
of,O
syncope,B-PR
and,O
first,B-PR
degree,I-PR
A-V,I-PR
heart,I-PR
block,I-PR
with,O
beta,B-TR
blocker,I-TR
therapy,I-TR
.,O

10.,O
History,O
of,O
lower,B-PR
gastrointestinal,I-PR
bleed,I-PR
in,O
2009-06-05,O
.,O

11.,O
spinal,B-PR
stenosis,I-PR

12.,O
Pacemaker,B-TR
-,O
DDD,B-TR
dual,I-TR
chamber,I-TR
rate,I-TR
response,I-TR
pacemaker,I-TR
2011-08-22,O
for,O
symptomatic,B-PR
bradycardia,I-PR

Social,O
History,O
:,O

Lives,O
alone,O
in,O
elderly,O
housing,O
",",O
a,O
daughter,O
in,O
the,O
area,O
",",O
two,O
children,O
and,O
exercises,O
two,O
times,O
a,O
week,O
by,O
walking,O
and,O
stretching,O
.,O

no,O
",",O
tob,O
",",O
no,O
etoh,O
",",O
no,O
drugs,O

Family,O
History,O
:,O

Noncontributory,O

Physical,O
Exam,O
:,O

at,O
admission,O

T,B-TE
96.0,O
BP,B-TE
177/61,O
P,B-TE
70,O
R,B-TE
18,O
O2,B-TE
97,O
on,O
RA,O

Gen,O
-,O
somnolent,B-PR
",",O
confused,B-PR

HEENT,O
-,O
PERRL,O
",",O
OP,O
clear,O
",",O
EOMI,O

Cor,O
-,O
rrr,O
",",O
no,O
m/r/g,B-PR

Chest,O
-,O
CTAB,O
anteriorly,O

Abd,O
-,O
s/nt/nd,B-PR
+BS,O

Ext,O
-,O
2,O
+,O
edema,B-PR
to,I-PR
knees,I-PR
",",O
warm,O
2,O
+,O
pulses,B-TE
",",O
pain,B-PR
in,I-PR
R,I-PR
arm,I-PR
and,I-PR
R,I-PR
hip,I-PR

Pertinent,O
Results,O
:,O

2013-05-18,O
06:00,O
PM,O
GLUCOSE,B-TE
-,O
188,O
*,O
UREA,B-TE
N,I-TE
-,O
48,O
*,O
CREAT,B-TE
-,O
1.3,O
*,O
SODIUM,B-TE
-,O
138,O
POTASSIUM,B-TE
-,O
4.0,O
CHLORIDE,B-TE
-,O
106,O
TOTAL,B-TE
CO2,I-TE
-,O
21,O
*,O
ANION,B-TE
GAP,I-TE
-,O
15,O

2013-05-18,O
06:00,O
PM,O
CK(CPK),B-TE
-,O
32,O

2013-05-18,O
06:00,O
PM,O
CK-MB,B-TE
-,O
NotDone,O

2013-05-18,O
06:00,O
PM,O
WBC,B-TE
-,O
14.9,O
*#,O
RBC,B-TE
-,O
2.91,O
*,O
HGB,B-TE
-,O
8.5,O
*,O
HCT,B-TE
-,O
24.7,O
*,O
MCV,B-TE
-,O
85,O
MCH,B-TE
-,O
29.3,O
MCHC,B-TE
-,O
34.5,O
RDW,B-TE
-,O
14.6,O

2013-05-18,O
06:00,O
PM,O
NEUTS,B-TE
-,O
87.9,O
*,O
BANDS,B-TE
-,O
0,O
LYMPHS,B-TE
-,O
6.3,O
*,O
MONOS,B-TE
-,O
5.7,O
EOS,B-TE
-,O
0.1,O
BASOS,B-TE
-,O
0,O

2013-05-18,O
06:00,O
PM,O
HYPOCHROM,B-TE
-,O
1,O
+,O
ANISOCYT,B-TE
-,O
NORMAL,O
POIKILOCY,B-TE
-,O
NORMAL,O
MACROCYT,B-TE
-,O
NORMAL,O
MICROCYT,B-TE
-,O
NORMAL,O
POLYCHROM,B-TE
-,O
NORMAL,O

2013-05-18,O
06:00,O
PM,O
PLT,B-TE
SMR,I-TE
-,O
NORMAL,O
PLT,B-TE
COUNT,I-TE
-,O
216,O

2013-05-18,O
06:00,O
PM,O
PT,B-TE
-,O
13.3,O
PTT,B-TE
-,O
26.4,O
INR(PT),B-TE
-,O
1.2,O
EKG,B-TE
-,O
NSR,O
64,O
",",O
1st,B-PR
deg,I-PR
block,I-PR
",",O
LAD,B-PR
",",O
new,B-PR
TWI,I-PR
inf/lat,I-PR
leads,I-PR
",",O
new,B-PR
ST,I-PR
depressions,I-PR
V4-6,I-PR

Echo,B-TE
02-09,O

1.,O
The,O
left,O
atrium,O
is,O
moderately,B-PR
dilated,I-PR
.,O

The,O
left,O
atrium,O
is,O
elongated,B-PR
.,O

2.,O
The,B-TE
left,I-TE
ventricular,I-TE
wall,I-TE
thicknesses,I-TE
are,O
normal,O
.,O

The,B-TE
left,I-TE
ventricular,I-TE
cavity,I-TE
size,I-TE
is,O
normal,O
.,O

There,O
is,O
mild,B-PR
regional,I-PR
left,I-PR
ventricular,I-PR
systolic,I-PR
dysfunction,I-PR
.,O

Overall,O
left,B-TE
ventricular,I-TE
systolic,I-TE
function,I-TE
is,O
mildly,B-PR
depressed,I-PR
.,O

Resting,B-PR
regional,I-PR
wall,I-PR
motion,I-PR
abnormalities,I-PR
include,O
inferolateral,B-PR
",",I-PR
inferior,I-PR
and,I-PR
mid,I-PR
septal,I-PR
hypokinesis,I-PR
.,O

3.,O
Right,B-TE
ventricular,I-TE
chamber,I-TE
size,I-TE
is,O
normal,O
.,O

Right,B-TE
ventricular,I-TE
systolic,I-TE
function,I-TE
is,O
normal,O
.,O

4.,O
The,O
aortic,O
valve,O
leaflets,O
(,O
3,O
),O
are,O
mildly,B-PR
thickened,I-PR
.,O

No,O
aortic,B-PR
regurgitation,I-PR
present,O
.,O

5.,O
The,O
mitral,O
valve,O
leaflets,O
are,O
mildly,B-PR
thickened,I-PR
.,O

Moderate,B-PR
(,I-PR
2,I-PR
+),I-PR
mitral,I-PR
regurgitation,I-PR
is,O
seen,O
.,O

6.,O
There,O
is,O
moderate,B-PR
pulmonary,I-PR
artery,I-PR
systolic,I-PR
hypertension,I-PR
.,O

7.,O
There,O
is,O
no,O
pericardial,B-PR
effusion,I-PR
.,O

Compared,O
with,O
the,O
findings,O
of,O
the,B-TE
prior,I-TE
study,I-TE
(,O
tape,O
reviewed,O
),O
of,O
2009-06-05,O
",",O
the,B-TE
LV,I-TE
function,I-TE
has,O
improved,O
with,O
an,O
improvementt,O
in,O
function,O
of,O
the,O
apex,O
",",O
septal,O
and,O
anterior,O
walls,O
.,O

New,B-PR
inferior,I-PR
and,I-PR
inferolateral,I-PR
wall,I-PR
motion,I-PR
abnormalities,I-PR
with,O
more,B-PR
severe,I-PR
mitral,I-PR
regurgitation,I-PR
present,O
.,O

Cath,B-TE
2001,O

1.,O
Coronary,B-TE
angiography,I-TE
demonstrated,O
single,B-PR
vessel,I-PR
disease,I-PR
in,I-PR
a,I-PR
right,I-PR
dominant,I-PR
system,I-PR
.,O

The,O
left,O
main,O
was,O
normal,O
.,O

The,O
LAD,O
had,O
serial,B-PR
90%,I-PR
lesions,I-PR
proximally,I-PR
",",O
involving,O
the,O
origin,O
of,O
the,O
first,O
diagonal,O
",",O
which,O
was,O
occluded,B-PR
and,O
filled,O
via,O
left,O
to,O
left,O
collaterals,O
.,O

The,O
mid-distal,O
LAD,O
was,O
underfilled,B-PR
initially,O
but,O
was,O
without,O
obstructive,B-PR
disease,I-PR
.,O

The,O
non-dominant,O
circumflex,O
system,O
had,O
no,O
hemodynamically,B-PR
significant,I-PR
stenoses,I-PR
.,O

The,O
dominant,O
RCA,O
was,O
a,O
large,O
vessel,O
with,O
no,O
significant,B-PR
disease,I-PR
.,O

2.,O
Resting,B-TE
hemodynamics,I-TE
revealed,O
elevated,B-PR
right,I-PR
and,I-PR
left,I-PR
sided,I-PR
filling,I-PR
pressures,I-PR
with,O
a,B-TE
mean,I-TE
RA,I-TE
pressure,I-TE
of,O
12,O
mm,O
Hg,O
and,O
a,B-TE
mean,I-TE
wedge,I-TE
pressure,I-TE
24,O
mm,O
Hg,O
.,O

Moderate,B-PR
pulmonary,I-PR
hypertension,I-PR
was,O
present,O
with,O
a,B-TE
PA,I-TE
of,O
52/28,O
.,O

The,B-TE
cardiac,I-TE
index,I-TE
was,O
preserved,O
at,O
3.0,O
L,O
/,O
min,O
/,O
m2,O
.,O

3.,O
Left,B-TE
ventriculography,I-TE
was,O
not,O
performed,O
due,O
to,O
the,O
presence,O
of,O
moderate,B-PR
renal,I-PR
insufficiency,I-PR
(,O
creatinine,B-TE
1.6,O
).,O

4.,O
Successful,B-TR
PTCA,I-TR
and,O
stenting,B-TR
of,I-TR
the,I-TR
proximal,I-TR
LAD,I-TR
with,O
overlapping,B-TR
2.25,I-TR
x,I-TR
13,I-TR
mm,I-TR
and,I-TR
2.25,I-TR
x,I-TR
18,I-TR
mm,I-TR
Hepacoat,I-TR
stents,I-TR
with,O
no,O
residual,B-PR
stenosis,I-PR
or,O
dissection,B-PR
and,O
normal,O
flow,O
(,O
see,O
PTCA,B-TR
comments,O
).,O

FINAL,O
DIAGNOSIS,O
:,O

1.,O
One,B-PR
vessel,I-PR
coronary,I-PR
artery,I-PR
disease,I-PR
.,O

2.,O
Moderately,B-PR
elevated,I-PR
right,I-PR
and,I-PR
left,I-PR
sided,I-PR
filling,I-PR
pressures,I-PR
.,O

3.,O
Successful,B-TR
stenting,I-TR
of,I-TR
the,I-TR
proximal,I-TR
LAD,I-TR
.,O

Hematology,O

COMPLETE,B-TE
BLOOD,I-TE
COUNT,I-TE
WBC,B-TE
RBC,B-TE
Hgb,B-TE
Hct,B-TE
MCV,B-TE
MCH,B-TE
MCHC,B-TE
RDW,B-TE
Plt,B-TE
Ct,I-TE

2013-05-24,O
09:40,O
AM,O
19.3,O
*,O
4.46,O
13.1,O
39.2,O
88,O
29.4,O
33.5,O
14.4,O
159,O

2013-05-24,O
12:52,O
AM,O
19.8,O
*#,O
4.73,O
13.8,O
42.1,O
#,O
89,O
29.3,O
32.9,O
14.3,O
147,O
*,O

DIFFERENTIAL,B-TE
Neuts,B-TE
Bands,B-TE
Lymphs,B-TE
Monos,B-TE
Eos,B-TE
Baso,B-TE
Atyps,B-TE
Metas,B-TE

2013-05-22,O
06:15,O
AM,O
90.0,O
*,O
0,O
5.6,O
*,O
4.2,O
0.1,O
0.2,O

RED,B-TE
CELL,I-TE
MORPHOLOGY,I-TE
Hypochr,B-TE
Anisocy,B-TE
Poiklo,B-TE
Macrocy,B-TE
Microcy,B-TE
Polychr,B-TE

2013-05-22,O
06:15,O
AM,O
NORMAL,O
NORMAL,O
NORMAL,O
NORMAL,O
NORMAL,O
NORMAL,O

BASIC,B-TE
COAGULATION,I-TE
(,O
PT,B-TE
",",O
PTT,B-TE
",",O
PLT,B-TE
",",O
INR,B-TE
),O
PT,B-TE
PTT,B-TE
Plt,B-TE
Smr,I-TE
Plt,B-TE
Ct,I-TE
INR(PT),B-TE
LPlt,B-TE

2013-05-24,O
09:40,O
AM,O
159,O
1,O
+,O

2013-05-24,O
09:40,O
AM,O
14.9,O
*,O
1,O
31.9,O
1.5,O

1,O
NOTE,O
NEW,O
NORMAL,O
RANGE,O
AS,O
OF,O
12,O
AM,O
2013-05-04,O

2013-05-24,O
12:52,O
AM,O
147,O
*,O

2013-05-24,O
12:52,O
AM,O
14.6,O
*,O
1,O
33.8,O
1.4,O

1,O
NOTE,O
NEW,O
NORMAL,O
RANGE,O
AS,O
OF,O
12,O
AM,O
2013-05-04,O

Chemistry,B-TE

RENAL,O
&,O
GLUCOSE,O
Glucose,B-TE
UreaN,B-TE
Creat,B-TE
Na,B-TE
K,B-TE
Cl,B-TE
HCO3,B-TE
AnGap,B-TE

2013-05-24,O
09:40,O
AM,O
192,O
*,O
87,O
*,O
2.4,O
*,O
146,O
*,O
5.1,O
114,O
*,O
16,O
*,O
21,O
*,O

2013-05-24,O
12:52,O
AM,O
160,O
*,O
86,O
*,O
2.6,O
*,O
148,O
*,O
4.4,O
115,O
*,O
14,O
*,O
1,O
23,O
*,O

1,O
VERIFIED,O
BY,O
DILUTION,O

NOTIFIED,O
Y.,O
Welch,O
-,O
TSICU,O
140,O
AM,O
2013-05-24,O

ENZYMES,B-TE
&,O
BILIRUBIN,B-TE
ALT,B-TE
AST,B-TE
LD(LDH),B-TE
CK(CPK),B-TE
AlkPhos,B-TE
Amylase,B-TE
TotBili,B-TE
DirBili,B-TE

2013-05-24,O
07:40,O
AM,O
628,O
*,O

2013-05-24,O
12:52,O
AM,O
22,O
65,O
*,O
739,O
*,O
52,O
81,O
1.0,O

OTHER,B-TE
ENZYMES,I-TE
&,O
BILIRUBINS,B-TE
Lipase,B-TE

2013-05-24,O
0:52,O

CPK,B-TE
ISOENZYMES,B-TE
CK-MB,B-TE
MB,B-TE
Indx,I-TE
cTropnT,B-TE

2013-05-24,O
07:40,O
AM,O
15,O
*,O
2.4,O

2013-05-24,O
12:52,O
AM,O
14,O
*,O
1.9,O
0.12,O
*,O
1,O

1,O
CTROPNT,B-TE
>,O
0.10,O
NG/ML,O
SUGGESTS,O
ACUTE,B-PR
MI,I-PR

CHEMISTRY,B-TE
TotProt,B-TE
Albumin,B-TE
Globuln,B-TE
Calcium,B-TE
Phos,B-TE
Mg,B-TE
UricAcd,B-TE
Iron,B-TE
Cholest,B-TE

2013-05-24,O
09:40,O
AM,O
8.3,O
*,O
5.4,O
*,O
2.1,O

2013-05-24,O
12:52,O
AM,O
2.1,O
*,O
7.7,O
*,O
5.1,O
*#,O
1.6,O

LIPID,B-TE
/,O
CHOLESTEROL,B-TE
Triglyc,B-TE
HDL,B-TE
CHOL/HD,B-TE
LDLcalc,B-TE

2013-05-19,O
09:20,O
AM,O
1603,O
-,O
5419,O
LDL(CALC),B-TE
INVALID,O
IF,O
TRIG,B-TE
>,O
400,O
OR,O
NON-FASTING,O
SAMPLE,O
LAB,O
USE,O
ONLY,O
GreenHd,O

2013-05-18,O
06:00,O
PM,O
HOLD1,O

1,O
HOLD,O

DISCARD,O
GREATER,O
THAN,O
4,O
HOURS,O
OLD,O

Blood,B-TE
Gas,I-TE

BLOOD,B-TE
GASES,I-TE
Type,B-TE
Temp,B-TE
Rates,B-TE
Tidal,B-TE
V,I-TE
PEEP,B-TE
FiO2,B-TE
O2,B-TE
Flow,B-TE
pO2,B-TE
pCO2,B-TE
pH,B-TE
calHCO3,B-TE
Base,B-TE
XS,I-TE
AADO2,B-TE
REQ,B-TR
O2,I-TR
Intubat,B-TR
Vent,B-TR

2013-05-24,O
07:58,O
AM,O
ART,B-TE
102,O
36,O
7.26,O
*,O
17,O
*,O
-9,O

2013-05-24,O
04:31,O
AM,O
ART,B-TE
36.4,O
16,O
/,O
662-15484,O
*,O
7.26,O
*,O
16,O
*,O
-10,O

ASSIST,O
/,O
CON1,O
INTUBATED,B-TR

1,O
ASSIST,O
/,O
CONTROL,O

2013-05-24,O
12:58,O
AM,O
ART,O
147,O
*,O
39,O
7.22,O
*,O
1,O
17,O
*,O
-11,O

1,O
VERIFIED,O

PROVIDER,O
NOTIFIED,O
PER,O
CURRENT,O
LAB,O
POLICY,O

WHOLE,O
BLOOD,O
",",O
MISCELLANEOUS,B-TE
CHEMISTRY,I-TE
Glucose,B-TE
Lactate,B-TE
Na,B-TE
K,B-TE
Cl,B-TE
calHCO3,B-TE

2013-05-24,O
07:58,O
AM,O
4.5,O
*,O
1,O

1,O
VERIFIED,O

2013-05-24,O
04:31,O
AM,O
5.1,O
*,O
1,O

1,O
VERIFIED,O

2013-05-24,O
12:58,O
AM,O
6.2,O
*,O
1,O

1,O
VERIFIED,O

HEMOGLOBLIN,B-TE
FRACTIONS,I-TE
(,O
COOXIMETRY,B-TE
),O
Hgb,B-TE
calcHCT,B-TE
O2,B-TE
Sat,I-TE
COHgb,B-TE
MetHgb,B-TE

2013-05-23,O
09:36,O
PM,O
11.4,O
*,O
34,O
73,O
1,O
1,O

2013-05-23,O
01:08,O
PM,O
10.9,O
*,O
33,O
96,O

CALCIUM,B-TE
freeCa,B-TE

2013-05-23,O
09:36,O
PM,O
1.00,O
*,O

2013-05-23,O
01:08,O
PM,O
1.22,O

RADIOLOGY,O
Final,O
Report,O

CT,B-TE
ABDOMEN,I-TE
W/O,I-TE
CONTRAST,I-TE
2013-05-23,O
5:46,O
PM,O

CT,B-TE
ABDOMEN,I-TE
W/O,I-TE
CONTRAST,I-TE
;,O
CT,B-TE
PELVIS,I-TE
W/O,I-TE
CONTRAST,I-TE

Reason,O
:,O
Please,O
eval,O
for,O
perf,B-PR
/,I-PR
ischemic,I-PR
bowel,I-PR

UNDERLYING,O
MEDICAL,O
CONDITION,O
:,O

92,O
year,O
old,O
woman,O
with,O
MS,B-PR
changes,I-PR
",",O
abd,B-PR
pain,I-PR
hypotension,B-PR
and,O
bloody,B-PR
lavage,I-PR
on,O
Lovenox+ASA,B-TR

REASON,O
FOR,O
THIS,O
EXAMINATION,O
:,O

Please,O
eval,O
for,O
perf,B-PR
/,I-PR
ischemic,I-PR
bowel,I-PR

CONTRAINDICATIONS,O
for,O
IV,B-TE
CONTRAST,I-TE
:,O
renal,B-PR
failure,I-PR

INDICATION,O
:,O
94-year-old,O
woman,O
with,O
mental,B-PR
status,I-PR
changes,I-PR
",",O
now,O
with,O
abdominal,B-PR
pain,I-PR
and,O
hypertension,B-PR
.,O

TECHNIQUE,O
:,O
A,O
multidetector,O
scanner,O
was,O
used,O
to,O
obtain,O
contiguous,B-TE
axial,I-TE
images,I-TE
from,O
the,O
lung,O
bases,O
to,O
the,O
pubic,O
symphysis,O
.,O

Neither,O
IV,B-TE
nor,I-TE
oral,I-TE
contrast,I-TE
were,O
used,O
.,O

CT,B-TE
OF,I-TE
THE,I-TE
ABDOMEN,I-TE
WITHOUT,I-TE
IV,I-TE
CONTRAST,I-TE
:,O
There,O
are,O
bilateral,B-PR
pleural,I-PR
effusions,I-PR
",",O
right,O
greater,O
the,O
left,O
;,O
there,O
is,O
compressive,B-PR
atelectasis,I-PR
at,I-PR
the,I-PR
left,I-PR
lung,I-PR
base,I-PR
.,O

There,O
are,O
coronary,B-PR
vascular,I-PR
calcifications,I-PR
.,O

A,B-TR
nasogastric,I-TR
tube,I-TR
is,O
seen,O
coiling,O
in,O
the,O
stomach,O
.,O

A,B-TR
dual,I-TR
chamber,I-TR
pacemaker,I-TR
is,O
seen,O
with,O
leads,O
terminating,O
in,O
the,O
right,O
atrium,O
and,O
right,O
ventricle,O
.,O

Nasogastric,B-TR
tube,I-TR
is,O
seen,O
coiling,O
in,O
the,O
stomach,O
",",O
with,O
its,O
tip,O
at,O
the,O
pylorus,O
.,O

Allowing,O
for,O
the,O
limitations,O
of,O
this,B-TE
noncontrast,I-TE
study,I-TE
",",O
the,O
liver,O
",",O
pancreas,O
",",O
adrenals,O
",",O
stomach,O
are,O
unremarkable,O
.,O

A,B-PR
1.8,I-PR
cm,I-PR
exophytic,I-PR
renal,I-PR
cyst,I-PR
is,O
seen,O
on,O
the,O
left,O
.,O

A,B-PR
similar,I-PR
lesion,I-PR
is,O
seen,O
on,O
the,O
right,O
",",O
measuring,O
2.2,O
cm,O
.,O

The,O
aorta,O
is,O
normal,O
in,O
caliber,O
",",O
with,O
vascular,B-PR
calcifications,I-PR
.,O

A,B-PR
small,I-PR
amount,I-PR
of,I-PR
free,I-PR
fluid,I-PR
is,O
seen,O
tracking,O
around,O
the,O
liver,O
",",O
right,O
pericolic,O
gutter,O
",",O
along,O
the,O
mesentery,O
and,O
surrounding,O
the,O
right,O
colon,O
",",O
which,O
is,O
collapsed,O
.,O

A,B-PR
small,I-PR
amount,I-PR
of,I-PR
nondependent,I-PR
free,I-PR
air,I-PR
is,O
seen,O
in,O
the,O
anterior,O
aspect,O
of,O
the,O
abdomen,O
.,O

The,O
remainder,O
of,O
the,O
bowel,O
loops,O
are,O
fluid,O
filled,O
",",O
and,O
nondilated,B-PR
.,O

CT,B-TE
OF,I-TE
THE,I-TE
PELVIS,I-TE
WITHOUT,I-TE
IV,I-TE
CONTRAST,I-TE
:,O
As,O
previously,O
noted,O
",",O
there,O
is,O
a,B-PR
small,I-PR
amount,I-PR
of,I-PR
free,I-PR
fluid,I-PR
surrounding,O
the,O
right,O
colon,O
",",O
tracking,O
along,O
the,O
mesentery,O
and,O
into,O
the,O
pelvis,O
.,O

A,B-PR
small,I-PR
amount,I-PR
of,I-PR
free,I-PR
air,I-PR
is,O
seen,O
in,O
the,O
nondependent,O
portion,O
of,O
the,O
pelvis,O
.,O

Vascular,B-PR
calcifications,I-PR
are,O
seen,O
in,O
the,O
abdominal,O
aorta,O
and,O
iliac,O
arteries,O
.,O

Subcutaneous,B-PR
edema,I-PR
is,O
noted,O
in,O
the,O
lower,O
abdomen,O
and,O
pelvis,O
.,O

A,B-TR
catheter,I-TR
is,O
seen,O
entering,O
the,O
left,O
inguinal,O
region,O
and,O
coursing,O
along,O
the,O
iliac,O
vessels,O
",",O
terminating,O
in,O
the,O
left,O
pelvis,O
.,O

Osseous,O
structures,O
are,O
remarkable,O
for,O
degenerative,B-PR
changes,I-PR
of,I-PR
the,I-PR
spine,I-PR
",",O
and,O
a,B-PR
fracture,I-PR
of,I-PR
the,I-PR
proximal,I-PR
right,I-PR
humerus,I-PR
",",O
with,O
orthopedic,B-TR
hardware,I-TR
causing,O
beam,B-PR
hardening,I-PR
artifact,I-PR
.,O

IMPRESSION,O
:,O

1.,O
A,O
small,O
amount,O
of,O
free,B-PR
air,I-PR
and,I-PR
free,I-PR
fluid,I-PR
in,I-PR
the,I-PR
pelvis,I-PR
and,I-PR
abdomen,I-PR
",",O
mostly,O
along,O
the,O
right,O
pericolic,O
gutter,O
and,O
surrounding,O
the,O
ascending,O
colon,O
",",O
concerning,O
for,O
perforation,B-PR
.,O

Other,O
bowel,O
loops,O
are,O
unremarkable,O
on,O
this,B-TE
limited,I-TE
study,I-TE
.,O

This,O
was,O
discussed,O
with,O
Dr.,O
Jason,O
Long,O
at,O
approximately,O
6:30,O
p.m.,O
",",O
2013-05-23,O
.,O

2.,O
Bilateral,B-PR
pleural,I-PR
effusions,I-PR
",",O
right,O
greater,O
than,O
left,O
",",O
with,O
left-sided,B-PR
compressive,I-PR
atelectasis,I-PR
.,O

3.,O
Right,B-PR
proximal,I-PR
humeral,I-PR
fracture,I-PR
status,O
post,O
fixation,B-TR
.,O

The,B-TE
study,I-TE
and,O
the,O
report,O
were,O
reviewed,O
by,O
the,O
staff,O
radiologist,O
.,O

DR.,O
Billy,O
L.,O
Boender,O

DR.,O
Pat,O
K.,O
Walton,O

Approved,O
:,O
FRI,O
2013-05-24,O
4:01,O
PM,O

Brief,O
Hospital,O
Course,O
:,O

95,O
yo,O
F,O
with,O
MMP,B-PR
who,O
sustained,O
a,B-PR
mechanical,I-PR
fall,I-PR
down,O
stairs,O
resulting,O
in,O
a,B-PR
hip,I-PR
and,I-PR
arm,I-PR
fracture,I-PR
.,O

1),O
s/p,O
Fall,B-PR
-,O
unlikely,O
to,O
be,O
mechanical,O
in,O
nature,O
.,O

Patient,O
has,O
injuries,B-PR
to,I-PR
her,I-PR
shoulder,I-PR
and,I-PR
hip,I-PR
.,O

2),O
CV,O
-,O
Patient,O
has,O
CAD,B-PR
and,O
CHF,B-PR
with,O
a,B-PR
low,I-PR
hct,I-PR
and,O
major,B-PR
trauma,I-PR
.,O

She,O
also,O
has,O
new,B-PR
changes,I-PR
on,I-PR
EKG,I-PR
.,O

On,O
pressor,B-TR
to,O
hold,O
mean,O
60,O
.,O

3),O
Anemia,B-PR
-,O
patient,O
transfusion,B-PR
dependant,I-PR
with,O
a,O
baseline,O
of,O
28,O
.,O

-,O
transfuse,O
2,O
units,O
today,O
",",O
with,O
lasix,B-TR

4),O
GERD,B-PR
-,O
PPI,B-TR

5),O
DM,B-PR
-,O
glipizide,B-TR
",",O
ISS,B-TR

6),O
PMR,B-PR
-,O
cont,O
prednisone,B-TR

7),O
GI,O
:,O
Ms.,O
Pimental,O
is,O
an,O
unfortunate,O
95,O
year,O
old,O
woman,O
",",O
status,O
post,O
a,B-PR
recent,I-PR
fall,I-PR
necessitating,O
right,B-TR
ORIF,I-TR
of,I-TR
the,I-TR
hip,I-TR
and,O
right,B-PR
wrist,I-PR
fracture,I-PR
ORIF,B-TR
",",O
who,O
was,O
in,O
the,O
hospital,O
for,O
this,O
event,O
",",O
when,O
it,O
was,O
noted,O
that,O
she,O
had,O
abdominal,B-PR
pain,I-PR
",",O
distention,B-PR
and,O
coffee,B-PR
ground,I-PR
emesis,I-PR
with,O
worsening,B-PR
mental,I-PR
status,I-PR
and,O
renal,B-PR
failure,I-PR
.,O

CT,B-TE
scan,I-TE
was,O
obtained,O
and,O
this,O
revealed,O
free,B-PR
air,I-PR
and,O
massive,B-PR
ascites,I-PR
.,O

Pt,O
underwent,O
surgery,B-TR
on,O
05-23,O

1.,O
Exploratory,B-TE
laparotomy,I-TE
with,O
drainage,B-TR
of,O
intra-abdominal,B-PR
abscess,I-PR
and,O
peritonitis,B-PR
with,O
gross,B-PR
soilage,I-PR
with,I-PR
bile,I-PR
and,I-PR
gastric,I-PR
contents,I-PR
.,O

2.,O
Exposure,B-TR
and,O
wide,B-TR
drainage,I-TR
of,O
perforated,B-PR
posterior,I-PR
duodenal,I-PR
ulcer,I-PR
with,O
internal,B-TR
and,I-TR
external,I-TR
drainage,I-TR
.,O

3.,O
Feeding,B-TR
jejunostomy,I-TR
.,O

4.,O
Tube,B-TR
gastrostomy,I-TR
.,O

Continue,O
to,O
deteriorate,O
spiking,B-PR
fevers,I-PR
with,O
ventilatory,B-TR
support,I-TR
on,O
pressors,B-TR
to,O
hold,O
the,B-TE
bp.,I-TE
with,O
no,O
improvement,O
in,O
mental,O
staus,O
was,O
made,O
CMO,O
5/20/5,O
.,O

Expired,O
at,O
5,O
pm,O

Medications,O
on,O
Admission,O
:,O

lasix,B-TR
alt,O
40,O
mg,O
and,O
20,O
mg,O
qday,O

levothyrox,B-TR
50,O
mcg,O
qday,O

lisinopril,B-TR
5,O
mg,O
qday,O

famotidine,B-TR
20,O
mg,O
qday,O

fe,B-TR
so4,I-TR
325,O
mg,O
qday,O

asa,B-TR
325,O
mg,O
qday,O

toprol,B-TR
xl,I-TR
25,O
mg,O
qday,O

glipizide,B-TR
5,O
mg,O
qday,O

imdur,B-TR
60,O
mg,O
qdau,O

prednisone,B-TR
5,O
mg,O
qday,O

tylenol,B-TR

Discharge,O
Disposition,O
:,O

Expired,B-PR

Discharge,O
Diagnosis,O
:,O

MULTIORGAN,B-PR
FAILURE,I-PR

DUODENAL,B-PR
PERFORATION,I-PR

MULTIPLE,B-PR
TRAUMA,I-PR

Discharge,O
Condition,O
:,O

deceased,O

Followup,O
Instructions,O
:,O

none,O

Frank,O
Linda,O
MD,O
44-897,O

Completed,O
by,O
:,O
Deanna,O
Patague,O
MD,O
48-130,O
2013-05-24,O
@,O
1820,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Marta,O
Keever,O
on,O
:,O
FRI,O
2013-06-21,O
9:40,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2013-05-14,O

Discharge,O
Date,O
:,O

2013-05-18,O

Date,O
of,O
Birth,O
:,O

1953-07-27,O

Sex,O
:,O

F,O

Service,O
:,O

CMED,O
CSRU,O

CHIEF,O
COMPLAINT,O
:,O

The,O
patient,O
was,O
admitted,O
originally,O
for,O
airway,B-TE
monitoring,I-TE
status,O
post,O
endoscopic,O
retrograde,O

cholangiopancreatography,B-TE
with,O
adverse,B-PR
reaction,I-PR
to,O
Fentanyl,B-TR
and,O
tongue,B-PR
injury,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
59,O
year-old,O
female,O
status,O
post,O
endoscopic,B-TE
retrograde,I-TE
cholangiopancreatography,I-TE
on,O
the,O
day,O
of,O
admission,O
",",O
which,O
had,O
been,O
done,O
to,O
evaluate,O
for,O
possible,O
bile,B-PR
leak,I-PR
after,O
cholecystectomy,B-TR
was,O
performed,O
four,O
days,O
ago,O
.,O

The,O
patient,O
was,O
in,O
her,O
usual,O
state,O
of,O
health,O
until,O
four,O
days,O
prior,O
to,O
admission,O
when,O
she,O
had,O
a,B-TR
cholecystectomy,I-TR
.,O

Her,O
postop,O
course,O
was,O
uneventful,O
until,O
one,O
day,O
prior,O
to,O
admission,O
when,O
she,O
developed,O
abdominal,B-PR
pain,I-PR
.,O

She,O
went,O
to,O
an,O
outside,O
hospital,O
Emergency,O
Room,O
and,O
was,O
reassured,O
and,O
sent,O
home,O
.,O

On,O
the,O
day,O
of,O
admission,O
she,O
returned,O
to,O
the,O
outside,O
hospital,O
Emergency,O
Room,O
where,O
an,B-TE
abdominal,I-TE
CT,I-TE
was,O
performed,O
",",O
which,O
showed,O
"",O
thickened,B-PR
stomach,I-PR
and,O
free,B-PR
air,I-PR
."",O

She,O
was,O
sent,O
to,O
New,O
England,O
Sinai,O
Hospital,O
&,O
Rehab,O
Center,O
for,O
an,B-TE
endoscopic,I-TE
retrograde,I-TE
cholangiopancreatography,I-TE
and,O
possible,O
stent,B-TR
placement,I-TR
.,O

She,O
had,O
a,B-TE
successful,I-TE
endoscopic,I-TE
retrograde,I-TE
cholangiopancreatography,I-TE
",",O
which,O
showed,O
a,B-PR
bile,I-PR
leak,I-PR
at,I-PR
the,I-PR
duct,I-PR
of,I-PR
Luschka,I-PR
.,O

A,B-TR
stent,I-TR
was,O
placed,O
successfully,O
.,O

After,O
her,B-TE
endoscopic,I-TE
retrograde,I-TE
cholangiopancreatography,I-TE
the,O
patient,O
developed,O
"",O
jaw,B-PR
clenching,I-PR
",",O
biting,B-PR
tongue,I-PR
",",O
rigidity,B-PR
and,O
cold,B-PR
/,I-PR
chills,I-PR
."",O

The,O
patient,O
received,O
ampicillin,B-TR
",",O
Gentamycin,B-TR
and,O
Flagyl,B-TR
empirically,O
as,O
well,O
as,O
Narcan,B-TR
to,O
reverse,O
fentanyl,B-TR
.,O

Because,O
of,O
the,B-PR
tongue,I-PR
injury,I-PR
and,O
tachycardia,B-PR
as,O
well,O
as,O
possible,O
infection,B-PR
given,O
her,B-PR
fevers,I-PR
or,O
chills,B-PR
the,O
GI,O
Service,O
transferred,O
the,O
patient,O
to,O
the,O
CMED,O
CCU,O
for,O
close,O
observation,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Hiatal,B-PR
hernia,I-PR
.,O

2.,O
Status,O
post,O
cholecystectomy,B-TR
four,O
days,O
prior,O
to,O
admission,O
.,O

3.,O
Urinary,B-PR
frequency,I-PR
secondary,O
to,O
interstitial,B-PR
cystitis,I-PR
.,O

4.,O
Mitral,B-PR
valve,I-PR
prolapse,I-PR
.,O

5.,O
Tubal,B-TR
ligation,I-TR
many,O
years,O
ago,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

1.,O
Prempro,B-TR
.,O

2.,O
CMED,B-TR
CCU,I-TR
drops,I-TR
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
at,O
the,O
time,O
of,O
admission,O
",",O
however,O
",",O
it,O
is,O
assumed,O
that,O
her,B-PR
rigidity,I-PR
and,O
jaw,B-PR
clenching,I-PR
was,O
secondary,O
to,O
Fentanyl,B-TR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
is,O
married,O
.,O

She,O
works,O
as,O
a,O
teacher,O
's,O
aid,O
in,O
Cambridge,O
.,O

She,O
denies,O
tobacco,O
or,O
alcohol,O
use,O
.,O

PHYSICAL,O
EXAMINATION,O
ON,O
ADMISSION,O
TO,O
THE,O
CMED,O
CCU,O
:,O

Vital,B-TE
signs,I-TE
temperature,B-TE
100.6,O
.,O

Heart,B-TE
rate,I-TE
105,O
.,O

Blood,B-TE
pressure,I-TE
162/76,O
.,O

Respiratory,B-TE
rate,I-TE
18,O
.,O

Sating,B-TE
98%,O
on,O
3,O
liters,O
.,O

In,O
general,O
",",O
the,O
patient,O
was,O
groggy,B-PR
status,O
post,O
anesthesia,B-TR
",",O
shivering,B-PR
",",O
but,O
awake,O
.,O

HEENT,O
showed,O
tongue,O
with,O
laceration,B-PR
on,I-PR
the,I-PR
right,I-PR
edge,I-PR
.,O

Mucous,O
membranes,O
are,O
moist,O
.,O

Pupils,O
are,O
equal,O
",",O
round,O
and,O
reactive,O
to,O
light,O
.,O

Extraocular,O
movements,O
intact,O
.,O

Lungs,O
were,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

Heart,O
regular,O
rate,O
and,O
rhythm,O
.,O

No,O
murmurs,B-PR
",",O
rubs,B-PR
or,O
gallops,B-PR
.,O

Abdomen,O
was,O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
.,O

There,O
were,O
normoactive,O
bowel,O
sounds,O
.,O

There,O
was,O
no,O
rebound,B-PR
or,O
guarding,B-PR
.,O

There,O
were,O
post,B-PR
laparoscopic,I-PR
incisions,I-PR
without,O
erythema,B-PR
with,O
Steri-Strips,B-TR
in,O
place,O
.,O

The,O
extremities,O
were,O
without,O
edema,B-PR
.,O

Dorsalis,B-TE
pedis,I-TE
pulses,I-TE
were,O
intact,O
bilaterally,O
.,O

There,O
were,O
no,O
rashes,B-PR
.,O

LABORATORIES,O
ON,O
ADMISSION,O
:,O

White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
9.0,O
",",O
hematocrit,B-TE
39.3,O
",",O
platelets,B-TE
296,O
",",O
neutrophil,B-TE
count,I-TE
82,O
",",O
lymphocytes,B-TE
14,O
",",O
4,O
monocytes,B-TE
",",O
troponin,B-TE
was,O
less,O
then,O
0.3,O
.,O

Sodium,B-TE
139,O
",",O
potassium,B-TE
3.8,O
",",O
chloride,B-TE
101,O
",",O
bicarb,B-TE
26,O
",",O
BUN,B-TE
9,O
",",O
creatinine,B-TE
0.7,O
",",O
glucose,B-TE
141,O
",",O
albumin,B-TE
4.1,O
",",O
calcium,B-TE
8.9,O
",",O
LDH,B-TE
665,O
",",O
AST,B-TE
44,O
",",O
ALT,B-TE
of,O
57,O
",",O
amylase,B-TE
41,O
",",O
CK,B-TE
32,O
.,O

Electrocardiogram,B-TE
showed,O
normal,O
sinus,O
rhythm,O
at,O
73,O
beats,O
per,O
minute,O
.,O

There,O
was,O
normal,O
axis,O
.,O

Normal,O
intervals,O
.,O

There,O
were,O
no,O
ST,B-PR
or,I-PR
T,I-PR
wave,I-PR
changes,I-PR
.,O

Abdominal,B-TE
CT,I-TE
showed,O
inflammation,B-PR
in,I-PR
the,I-PR
right,I-PR
upper,I-PR
quadrant,I-PR
",",O
small,B-PR
fluid,I-PR
in,I-PR
the,I-PR
circumferential,I-PR
thickening,I-PR
of,I-PR
the,I-PR
distal,I-PR
stomach,I-PR
.,O

There,O
was,O
a,O
question,O
of,O
a,B-PR
small,I-PR
ulcer,I-PR
.,O

There,O
was,O
a,O
tiny,O
amount,O
of,O
free,B-PR
air,I-PR
.,O

This,O
was,O
per,O
report,O
of,O
Vencor,O
Hospital,O
.,O

HOSPITAL,O
COURSE,O
:,O

In,O
summary,O
the,O
patient,O
is,O
a,O
59,O
year-old,O
female,O
who,O
was,O
admitted,O
to,O
Quincy,O
Medical,O
Center,O
for,O
an,B-TE
endoscopic,I-TE
retrograde,I-TE
cholangiopancreatography,I-TE
for,O
possible,O
stent,B-TR
placement,I-TR
for,O
a,B-PR
bile,I-PR
leak,I-PR
secondary,O
to,O
cholecystectomy,B-TR
performed,O
four,O
days,O
prior,O
to,O
admission,O
.,O

She,O
then,O
suffered,O
rigidity,B-PR
with,O
jaw,B-PR
clenching,I-PR
and,O
tongue,B-PR
biting,I-PR
secondary,O
to,O
Fentanyl,B-TR
administration,O
and,O
was,O
transferred,O
to,O
the,O
CMED,O
CCU,O
for,O
close,O
observation,O
.,O

She,O
did,O
well,O
overnight,O
in,O
the,O
CMED,O
CCU,O
.,O

She,O
was,O
started,O
on,O
Ampicillin,B-TR
",",O
Gentamycin,B-TR
and,O
Flagyl,B-TR
.,O

Her,B-TE
liver,I-TE
function,I-TE
tests,I-TE
and,O
amylase,B-TE
and,O
lipase,B-TE
were,O
followed,O
closely,O
.,O

On,O
the,O
second,O
hospital,O
day,O
the,O
patient,O
was,O
doing,O
much,O
better,O
and,O
was,O
stable,O
from,O
an,O
airway,O
perspective,O
",",O
so,O
she,O
was,O
transferred,O
to,O
the,O
General,O
Medical,O
Floor,O
.,O

1.,O
Gastrointestinal,O
:,O

As,O
stated,O
the,O
patient,O
was,O
status,O
post,O
endoscopic,B-TE
retrograde,I-TE
cholangiopancreatography,I-TE
with,O
stent,O

placement,B-TR
for,O
a,B-PR
bile,I-PR
leak,I-PR
from,I-PR
the,I-PR
duct,I-PR
of,I-PR
Luschka,I-PR
.,O

The,O
patient,O
was,O
continued,O
on,O
Ampicillin,B-TR
",",O
Gentamycin,B-TR
and,O
Flagyl,B-TR
",",O
which,O
had,O
been,O
started,O
at,O
the,O
time,O
of,O
transfer,O
to,O
the,O
CMED,O
CCU,O
.,O

She,O
had,O
waxing,B-PR
and,I-PR
waning,I-PR
fevers,I-PR
.,O

However,O
",",O
her,B-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
was,O
never,O
really,B-PR
elevated,I-PR
and,O
she,O
did,O
not,O
have,O
a,B-PR
bandemia,I-PR
.,O

On,O
the,O
day,O
of,O
transfer,O
to,O
the,O
General,O
Medical,O
Floor,O
the,O
patient,O
had,O
received,O
clear,B-TR
liquids,I-TR
.,O

She,O
did,O
not,O
tolerate,O
this,O
very,O
well,O
.,O

Her,B-TE
amylase,I-TE
and,O
lipase,B-TE
on,O
the,O
day,O
following,O
the,B-TE
endoscopic,I-TE
retrograde,I-TE
cholangiopancreatography,I-TE

were,O
elevated,B-PR
.,O

Amylase,B-TE
was,O
2304,O
with,O
lipase,B-TE
being,O
7116,O
.,O

Therefore,O
she,O
was,O
made,O
NPO,B-TR
and,O
given,O
aggressive,B-TR
intravenous,I-TR
hydration,I-TR
.,O

On,O
the,O
second,O
hospital,O
day,O
on,O
the,O
General,O
Medical,O
Floor,O
the,O
patient,O
had,O
marked,B-PR
rebound,I-PR
to,O
palpation,B-TE
of,I-TE
her,I-TE
abdomen,I-TE
.,O

She,O
was,O
followed,O
closely,O
with,O
serial,B-TE
abdominal,I-TE
examinations,I-TE
.,O

Her,B-TE
amylase,I-TE
and,O
lipase,B-TE
were,O
trending,O
down,O
",",O
however,O
.,O

An,B-TE
abdominal,I-TE
CT,I-TE
was,O
obtained,O
",",O
which,O
showed,O
only,O
mild,B-PR
pancreatitis,I-PR
.,O

There,O
were,O
no,O
intra-abdominal,B-PR
fluid,I-PR
collections,I-PR
",",O
which,O
required,O
any,B-TR
drainage,I-TR
.,O

On,O
the,O
third,O
hospital,O
day,O
the,B-PR
patient,I-PR
's,I-PR
pain,I-PR
was,O
improving,O
and,O
the,B-PR
rebound,I-PR
was,O
decreasing,O
.,O

Her,B-TE
enzymes,I-TE
continued,O
to,O
trend,O
down,O
.,O

She,O
received,O
clear,B-TR
liquids,I-TR
in,O
the,O
evening,O
and,O
tolerated,O
these,O
well,O
.,O

On,O
the,O
day,O
of,O
discharge,O
the,O
patient,O
was,O
tolerating,O
a,B-TR
BRAT,I-TR
diet,I-TR
without,O
significant,O
abdominal,O

pain,B-PR
.,O

She,O
had,O
no,O
further,B-PR
rebound,I-PR
.,O

She,O
had,O
no,O
temperature,B-PR
spikes,I-PR
in,O
greater,O
then,O
24,O
hours,O
at,O
the,O
time,O
of,O
discharge,O
.,O

2.,O
Hematology,O
:,O

The,B-TE
patient,I-TE
's,I-TE
hematocrit,I-TE
was,O
34.8,O
at,O
the,O
time,O
of,O
admission,O
.,O

It,O
decreased,O
to,O
30,O
in,O
the,O
setting,O
of,O
aggressive,B-TR
hydration,I-TR
.,O

It,O
remained,O
stable,O
at,O
the,O
time,O
of,O
discharge,O
and,O
it,O
was,O
29.5,O
on,O
the,O
day,O
of,O
discharge,O
.,O

3.,O
FEN,O
:,O

The,O
patient,O
was,O
aggressively,B-TR
hydrated,I-TR
given,O
that,O
she,O
was,O
NPO,B-TR
.,O

She,O
required,O
periodic,B-TR
repletion,I-TR
of,I-TR
her,I-TR
potassium,I-TR
.,O

Her,B-TE
bicarb,I-TE
began,O
to,O
drop,O
and,O
she,O
developed,O
an,B-PR
anion,I-PR
gap,I-PR
acidosis,I-PR
.,O

This,O
was,O
most,O
likely,O
secondary,O
to,O
ketoacidosis,B-PR
as,O
she,O
had,O
no,O
dextrose,B-TR
in,O
her,B-TR
intravenous,I-TR
fluids,I-TR
.,O

This,O
was,O
added,O
on,O
the,O
evening,O
prior,O
to,O
discharge,O
and,O
on,O
the,O
day,O
of,O
discharge,O
her,B-PR
anion,I-PR
gap,I-PR
acidosis,I-PR
had,O
resolved,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

1.,O
Levaquin,B-TR
500,O
mg,O
one,O
po,O
q,O
day,O
times,O
seven,O
days,O
.,O

2.,O
Protonix,B-TR
40,O
mg,O
po,O
q,O
day,O
.,O

3.,O
Percocet,B-TR
one,O
to,O
two,O
tablets,O
po,O
q,O
4,O
to,O
6,O
hours,O
prn,O
.,O

The,O
patient,O
was,O
given,O
a,B-TR
prescription,I-TR
for,I-TR
ten,I-TR
pills,I-TR
.,O

4.,O
Prempro,B-TR
as,O
the,O
patient,O
was,O
formerly,O
taking,O
.,O

5.,O
Trazodone,B-TR
at,O
bedtime,O
.,O

DISCHARGE,O
FOLLOW,O
UP,O
:,O

The,O
patient,O
was,O
to,O
make,O
an,O
appointment,O
with,O
Dr.,O
Nicholson,O
within,O
one,O
to,O
two,O
months,O
after,O
discharge,O
for,O
removal,B-TR
of,I-TR
the,I-TR
stent,I-TR
.,O

In,O
addition,O
",",O
she,O
would,O
follow,O
up,O
with,O
her,O
primary,O
care,O
physician,O
within,O
one,O
to,O
two,O
weeks,O
following,O
discharge,O
.,O

She,O
was,O
to,O
continue,O
on,O
a,B-TR
BRAT,I-TR
diet,I-TR
over,O
the,O
weekend,O
and,O
two,O
days,O
after,O
discharge,O
she,O
could,O
advance,O
to,O
a,B-TR
low,I-TR
fat,I-TR
no,I-TR
dairy,I-TR
diet,I-TR
.,O

She,O
could,O
slowly,O
advance,O
back,O
to,O
a,O
normal,O
diet,O
over,O
the,O
next,O
week,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Post,B-PR
endoscopic,I-PR
retrograde,I-PR
cholangiopancreatography,I-PR
pancreatitis,I-PR
.,O

2.,O
Anemia,B-PR
.,O

3.,O
Hypokalemia,B-PR
.,O

4.,O
Anion,B-PR
gap,I-PR
acidosis,I-PR
.,O

5.,O
Bile,B-PR
leak,I-PR
.,O

Thompson,O
MING,O
LI,O
",",O
M.D.,O

44-725,O

Dictated,O
By,O
:,O
Marcelene,O
R.,O
Brennan,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2013-05-18,O
13:49,O

T,O
:,O
2013-05-20,O
08:16,O

JOB,O
#:,O

23220,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Ruth,O
O.,O
Black,O
on,O
:,O
WED,O
2013-05-22,O
7:10,O
AM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2011-10-28,O

Discharge,O
Date,O
:,O

2011-12-01,O

Date,O
of,O
Birth,O
:,O

1964-04-14,O

Sex,O
:,O

F,O

Service,O
:,O

Bone,O
marrow,O
transplant,O
service,O

Again,O
",",O
this,O
was,O
a,O
47-year-old,O
female,O
admitted,O
with,O
Berkitt's,B-PR
lymphoma,I-PR
.,O

HOSPITAL,O
COURSE,O
OVER,O
THESE,O
PREVIOUS,O
DAYS,O
:,O

1.,O
Liver,B-PR
lesions,I-PR
:,O

The,O
patient,O
went,O
for,O
a,B-TE
repeat,I-TE
MRI,I-TE
which,O
showed,O
no,O
change,O
in,O
the,B-PR
previously,I-PR
noted,I-PR
enumerable,I-PR
hepatic,I-PR
cyst,I-PR
in,I-PR
her,I-PR
liver,I-PR
.,O

A,O
Hepatology,O
consult,O
was,O
obtained,O
who,O
felt,O
that,O
the,O
most,O
likely,O
etiology,O
of,O
these,B-PR
cysts,I-PR
were,O
from,O
hepatic,B-PR
candidiasis,I-PR
",",O
although,O
one,O
could,O
not,O
rule,O
out,O
lymphoma,B-PR
involving,O
from,O
Burkitt's,B-PR
.,O

She,O
will,O
be,O
discharged,O
on,O
AmBisome,B-TR
300,O
mg,O
IV,O
q.d.,O
for,O
treatment,O
of,O
her,B-PR
hepatic,I-PR
candidiasis,I-PR
.,O

This,O
regimen,O
",",O
that,O
being,O
AmBisome,B-TR
",",O
was,O
recommended,O
by,O
the,O
Infectious,O
Disease,O
physicians,O
",",O
who,O
felt,O
that,O
AmBisome,B-TR
was,O
a,O
better,O
drug,O
of,O
choice,O
as,O
compared,O
to,O
fluconazole,B-TR
.,O

2.,O
Heme,O
:,O

The,B-TE
patient,I-TE
's,I-TE
platelets,I-TE
",",O
white,B-TE
count,I-TE
",",O
and,O
hematocrit,B-TE
have,O
all,O
been,O
stable,O
.,O

Her,B-TE
white,I-TE
count,I-TE
remained,O
elevated,B-PR
despite,O
discontinuing,O
her,B-TR
G-CSF,I-TR
.,O

However,O
",",O
the,O
patient,O
is,O
not,O
febrile,B-PR
and,O
her,B-TE
white,I-TE
count,I-TE
should,O
be,O
continued,O
to,O
be,O
watched,O
.,O

3.,O
On,O
the,O
morning,O
of,O
12-01,O
",",O
the,O
patient,O
had,O
some,O
transient,O
episodes,O
of,O
hypotension,B-PR
with,O
SBP,B-TE
s,I-TE
in,O
the,O
70,O
s.,O

Her,B-TR
captopril,I-TR
was,O
discontinued,O
",",O
and,O
she,O
was,O
given,O
two,B-TR
IV,I-TR
fluid,I-TR
boluses,I-TR
with,O
appropriate,O
response,O
.,O

Her,B-TE
blood,I-TE
pressures,I-TE
and,O
all,O
of,O
her,B-TE
vital,I-TE
signs,I-TE
are,O
stable,O
.,O

4.,O
FEN,O
:,O

The,O
patient,O
was,O
continued,O
on,O
TPN,B-TR
over,O
the,O
past,O
couple,O
days,O
.,O

She,O
is,O
also,O
started,O
on,O
marinol,B-TR
2.5,O
mg,O
p.o.,O
b.i.d.,O
and,O
encouraged,O
p.o.,O
intake,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Guarded,B-PR
",",O
but,O
stable,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Burkitt's,B-PR
lymphoma,I-PR
.,O

2.,O
Hepatic,B-PR
candidiasis,I-PR
.,O

DISCHARGE,O
STATUS,O
:,O

The,O
patient,O
will,O
be,O
discharged,O
to,O
an,O
outside,O
hospital,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
AmBisome,B-TR
300,O
mg,O
IV,O
q.d.,O

2.,O
Marinol,B-TR
2.5,O
mg,O
p.o.,O
b.i.d.,O
before,O
breakfast,O
and,O
dinner,O
.,O

3.,O
Atarax,B-TR
25,O
mg,O
IV,O
/,O
p.o.,O
q.,O
4-6,O
h.,O
prn,O
for,O
itching,B-PR
.,O

4.,O
Colace,B-TR
100,O
mg,O
p.o.,O
b.i.d.,O

5.,O
Protonix,B-TR
40,O
mg,O
p.o.,O
/,O
IV,O
q.d.,O

6.,O
Nystatin,B-TR
06-18,O
mL,O
swish,O
and,O
swallow,O
q.6.,O
prn,O
.,O

7.,O
Peridex,B-TR
15,O
mL,O
swish,O
and,O
swallow,O
prn,O
.,O

Maria,O
Scheer,O
",",O
M.D.12.699,O

Dictated,O
By,O
:,O
Inez,O
Q,O
Hubbard,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2011-12-01,O
13:09,O

T,O
:,O
2011-12-01,O
13:20,O

JOB,O
#:,O

66182,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Richard,O
Blakey,O
on,O
:,O
FRI,O
2011-12-23,O
9:54,O
AM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2011-01-19,O

Discharge,O
Date,O
:,O

2011-01-25,O

Date,O
of,O
Birth,O
:,O

1943-01-22,O

Sex,O
:,O

M,O

Service,O
:,O

MEDICINE,O

INDICATION,O
FOR,O
ADMISSION,O
:,O

Transfer,O
from,O
Rehab,O
Hospital,O
of,O
the,O
Cape,O
&,O
Islands,O
Hospital,O
for,O
an,B-TE
endoscopic,I-TE
retrogram,I-TE
cholangiopancreatography,I-TE
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Mr.,O
Eugene,O
is,O
a,O
67,O
year,O
old,O
male,O
with,O
a,O
remote,O
history,O
of,O
chronic,B-PR
pancreatitis,I-PR
due,O
to,O
alcohol,O
abuse,O
30,O
years,O
ago,O
",",O
who,O
is,O
transferred,O
now,O
from,O
Rehab,O
Hospital,O
of,O
the,O
Cape,O
&,O
Islands,O
Hospital,O
for,O
an,B-TE
ERCP,I-TE
and,O
work-up,B-TE
for,O
a,B-PR
cystic,I-PR
lesion,I-PR
at,O
the,O
head,O
of,O
his,O
pancreas,O
on,O
CT,B-TE
scan,I-TE
shown,O
at,O
the,O
outside,O
hospital,O
.,O

The,O
patient,O
presented,O
initially,O
to,O
Rehab,O
Hospital,O
of,O
the,O
Cape,O
&,O
Islands,O
Hospital,O
at,O
the,O
end,O
of,O
December,O
for,O
abdominal,B-PR
pain,I-PR
",",O
and,O
was,O
found,O
to,O
have,O
pancreatitis,B-PR
.,O

During,O
this,O
admission,O
",",O
two,B-TE
CT,I-TE
scans,I-TE
had,O
shown,O
a,O
question,O
of,O
an,B-PR
enlargement,I-PR
of,I-PR
the,I-PR
head,I-PR
of,I-PR
his,I-PR
pancreas,I-PR

versus,O
early,B-PR
pseudocyst,I-PR
.,O

The,O
patient,O
was,O
discharged,O
home,O
early,O
from,O
this,O
admission,O
due,O
to,O
family,O
needs,O
.,O

While,O
at,O
home,O
",",O
the,O
patient,O
did,O
not,O
do,O
well,O
and,O
could,O
tolerate,O
minimal,O
food,O
intake,O
and,O
lost,O
about,O
20,O
pounds,O
in,O
one,O
month,O
.,O

On,O
an,O
office,O
visit,O
on,O
01-14,O
",",O
the,O
patient,O
was,O
found,O
to,O
have,O
significantly,B-PR
elevated,I-PR
alkaline,I-PR
phosphatase,I-PR
.,O

That,O
evening,O
",",O
the,O
patient,O
again,O
developed,O
abdominal,B-PR
pain,I-PR
"",O
like,O
his,B-PR
pancreatitis,I-PR
"",O
with,O
nausea,B-PR
and,O
vomiting,B-PR
",",O
for,O
which,O
he,O
was,O
admitted,O
to,O
the,O
Rehab,O
Hospital,O
of,O
the,O
Cape,O
&,O
Islands,O
Hospital,O
.,O

In,O
the,O
Emergency,O
Department,O
at,O
the,O
Rehab,O
Hospital,O
of,O
the,O
Cape,O
&,O
Islands,O
Hospital,O
",",O
the,O
patient,O
was,O
noted,O
to,O
have,O
vomited,O
some,O
heme,O
positive,O
material,O
.,O

His,B-TE
complete,I-TE
blood,I-TE
count,I-TE
showed,O
11%,B-PR
bandemia,I-PR
with,O
a,B-TE
total,I-TE
white,I-TE
count,I-TE
of,O
10,O
.,O

A,B-TE
HIDA,I-TE
scan,I-TE
showed,O
no,B-PR
flow,I-PR
",",O
question,O
of,O
pancreatitis,B-PR
versus,O
common,B-PR
bile,I-PR
duct,I-PR
obstruction,I-PR
.,O

His,B-TE
electrocardiogram,I-TE
showed,O
a,O
normal,O
sinus,O
rhythm,O
.,O

A,B-TE
chest,I-TE
x-ray,I-TE
was,O
unremarkable,O
.,O

During,O
his,O
admission,O
to,O
Rehab,O
Hospital,O
of,O
the,O
Cape,O
&,O
Islands,O
Hospital,O
",",O
the,O
patient,O
had,O
dropped,O
his,B-TE
hematocrit,I-TE
to,O
the,O
30,O
s,O
with,O
recorded,B-PR
melena,I-PR
.,O

He,O
received,O
an,B-TE
MRCP,I-TE
which,O
was,O
negative,O
for,O
evidence,O
of,O
stones,B-PR
.,O

An,B-TE
ultrasound,I-TE
showed,O
normal,O
gallbladder,O
with,O
no,O
wall,B-PR
thickening,I-PR
but,O
a,B-PR
dilated,I-PR
common,I-PR
bile,I-PR
duct,I-PR
of,O
8,O
mm,O
measured,O
on,O
CT,B-TE
scan,I-TE
.,O

The,O
patient,O
had,O
an,B-TE
attempted,I-TE
ERCP,I-TE
on,O
01-18,O
",",O
which,O
was,O
unsuccessful,O
due,O
to,O
a,B-PR
long,I-PR
nipple,I-PR
like,I-PR
papilla,I-PR
.,O

He,O
was,O
therefore,O
transferred,O
to,O
Saints,O
Medical,O
Center,O
for,O
endoscopic,B-TE
retrogram,I-TE
cholangiopancreatography,I-TE
.,O

The,B-TE
patient,I-TE
's,I-TE
blood,I-TE
cultures,I-TE
at,O
outside,O
hospital,O
grew,O
out,O
Streptococcus,B-PR
sanguis-gordonii,I-PR
on,O
01-18,O
.,O

This,O
was,O
sensitive,O
to,O
Clindamycin,B-TR
",",O
Erythromycin,B-TR
",",O
penicillin,B-TR
S,I-TR
and,O
Vancomycin,B-TR
.,O

Prior,O
to,O
this,O
result,O
",",O
the,O
patient,O
had,O
already,O
been,O
on,O
Ampicillin,B-TR
",",O
Sulbactam,B-TR
and,O
Gentamycin,B-TR
.,O

It,O
appears,O
from,O
the,O
Discharge,O
summary,O
that,O
the,O
patient,O
was,O
placed,O
on,O
Unasyn,B-TR
3,O
grams,O
intravenously,O
every,O
six,O
hours,O
after,O
his,B-TE
ERCP,I-TE
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Type,B-PR
2,I-PR
diabetes,I-PR
mellitus,I-PR
.,O

2.,O
Right,B-PR
rotator,I-PR
cuff,I-PR
injury,I-PR
.,O

3.,O
Gastroesophageal,B-PR
reflux,I-PR
disease,I-PR
with,O
esophageal,B-TR
dilatation,I-TR
for,O
stricture,B-PR
.,O

4.,O
Recent,B-PR
pancreatitis,I-PR
;,O
prior,O
history,O
for,O
recurrent,B-PR
pancreatitis,I-PR
30,O
years,O
ago,O
from,O
alcohol,O
.,O

5.,O
History,O
of,O
Streptococcemia,B-PR
in,O
the,O
year,O
2008,O
;,O
source,O
was,O
unclear,O
but,O
presumed,O
to,O
be,O
urinary,O
.,O

6.,O
Status,O
post,O
tonsillectomy,B-TR
as,O
a,O
child,O
.,O

MEDICATIONS,O
AT,O
HOME,O
:,O

1.,O
Prilosec,B-TR
20,O
mg,O
p.o.,O
q.,O
day,O
.,O

2.,O
Flomax,B-TR
4,O
mg,O
p.o.,O
q.,O
day,O
.,O

3.,O
Humalog,B-TR
75/25,O
",",O
subcutaneously,O
.,O

4.,O
Regular,B-TR
insulin,I-TR
15,O
units,O
q.,O
a.m.,O
and,O
14,O
units,O
q.,O
p.m.,O

MEDICATIONS,O
ON,O
ADMISSION,O
FROM,O
TRANSFER,O
:,O

1.,O
Unasyn,B-TR
3,O
grams,O
intravenous,O
every,O
six,O
hours,O
.,O

2.,O
NPH,B-TR
10,O
units,O
subcutaneously,O
every,O
morning,O
and,O
8,O
units,O
subcutaneously,O
every,O
evening,O
.,O

3.,O
Flomax,B-TR
0.4,O
mg,O
p.o.,O
q.,O
day,O
.,O

4.,O
Prilosec,B-TR
30,O
mg,O
p.o.,O
q.,O
day,O
.,O

5.,O
Regular,B-TR
insulin,I-TR
sliding,I-TR
scale,I-TR
.,O

6.,O
Tylenol,B-TR
.,O

ALLERGIES,O
:,O

The,O
patient,O
is,O
allergic,B-PR
to,O
Ciprofloxacin,B-TR
",",O
morphine,B-TR
sulfate,I-TR
and,O
Droperidol,B-TR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
lives,O
with,O
his,O
disabled,O
wife,O
who,O
has,O
a,B-PR
psychiatric,I-PR
condition,I-PR
.,O

He,O
had,O
a,O
history,O
of,O
alcohol,O
abuse,O
but,O
has,O
been,O
sober,O
for,O
30,O
years,O
.,O

He,O
is,O
a,O
retired,O
painter,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,O
showed,O
a,B-TE
temperature,I-TE
of,O
97.1,O
F.,O
;,O
heart,B-TE
rate,I-TE
of,O
65,O
;,O
blood,B-TE
pressure,I-TE
of,O
146/74,O
;,O
respiratory,B-TE
rate,I-TE
of,O
20,O
;,O
oxygen,B-TE
saturation,I-TE
98%,O
on,O
three,O
liters,O
and,O
95%,O
on,O
room,O
air,O
.,O

The,O
patient,O
was,O
alert,O
",",O
awake,O
and,O
oriented,O
",",O
pleasant,O
",",O
and,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

Head,B-TE
",",I-TE
eyes,I-TE
",",I-TE
ears,I-TE
",",I-TE
nose,I-TE
and,I-TE
throat,I-TE
examination,I-TE
revealed,O
mucous,O
membranes,O
that,O
were,O
moist,O
.,O

The,O
patient,O
has,O
two,O
teeth,O
.,O

He,O
has,O
fine,O
dental,O
hygiene,O
.,O

He,O
had,O
no,O
icterus,B-PR
.,O

Cardiovascular,O
system,O
revealed,O
normal,O
S1,O
and,O
S2,O
",",O
no,O
murmurs,B-PR
or,O
gallops,B-PR
and,O
regular,O
rate,O
and,O
rhythm,O
.,O

Pulmonary,B-TE
examination,I-TE
revealed,O
lungs,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

Abdominal,B-TE
examination,I-TE
revealed,O
an,O
abdomen,O
that,O
is,O
nondistended,B-PR
",",O
nontender,B-PR
.,O

He,O
had,O
normoactive,O
bowel,O
sounds,O
.,O

His,B-TE
liver,I-TE
span,I-TE
was,O
8,O
cm,O
.,O

The,O
antrum,O
was,O
palpable,O
3,O
cm,O
below,O
the,O
costal,O
margin,O
.,O

The,O
spleen,O
tip,O
was,O
palpable,O
.,O

There,O
was,O
no,O
rebound,B-PR
;,O
no,O
Munos,B-PR
sign,I-PR
.,O

Extremities,O
reveal,O
no,O
edema,B-PR
",",O
no,O
swelling,B-PR
.,O

Neurologic,B-TE
examination,I-TE
revealed,O
an,O
alert,O
and,O
oriented,O
individual,O
.,O

His,O
face,O
was,O
symmetric,O
;,O
tongue,O
was,O
midline,O
.,O

His,O
language,O
was,O
fluent,O
and,O
normal,O
.,O

The,O
patient,O
was,O
moving,O
all,O
four,O
extremities,O
with,O
ease,O
.,O

There,O
was,O
no,O
formal,B-TE
strength,I-TE
test,I-TE
done,O
.,O

LABORATORY,O
:,O

Studies,O
revealed,O
a,B-TE
hematocrit,I-TE
of,O
32.6,O
",",O
white,B-TE
count,I-TE
of,O
6.0,O
.,O

His,B-TE
platelet,I-TE
count,I-TE
was,O
267,O
.,O

His,B-TE
MCV,I-TE
was,O
88,O
",",O
red,B-TE
cell,I-TE
distribution,I-TE
was,O
13.4,O
.,O

Chemistry,O
on,O
admission,O
showed,O
a,B-TE
sodium,I-TE
of,O
141,O
",",O
potassium,B-TE
of,O
4.3,O
",",O
chloride,B-TE
of,O
107,O
",",O
bicarbonate,B-TE
of,O
25,O
",",O
BUN,B-TE
of,O
4,O
",",O
creatinine,B-TE
of,O
0.6,O
and,O
a,B-TE
sugar,I-TE
of,O
177,O
.,O

Liver,B-TE
function,I-TE
tests,I-TE
revealed,O
an,B-TE
ALT,I-TE
of,O
31,O
",",O
AST,B-TE
of,O
36,O
",",O
alkaline,B-TE
phosphatase,I-TE
of,O
509,O
.,O

Total,B-TE
bilirubin,I-TE
was,O
0.8,O
.,O

Albumin,B-TE
was,O
2.6,O
.,O

His,B-TE
blood,I-TE
cultures,I-TE
were,O
drawn,O
and,O
pending,O
.,O

Urinalysis,B-TE
revealed,O
trace,B-PR
glucose,I-PR
",",O
no,O
ketones,B-PR
",",O
no,O
red,B-PR
cells,I-PR
",",O
no,O
white,B-PR
cells,I-PR
and,O
less,O
than,O
one,O
epithelial,O
cells,O
.,O

COURSE,O
IN,O
HOSPITAL,O
:,O

The,O
patient,O
was,O
taken,O
down,O
to,O
the,B-TE
endoscopic,I-TE
retrogram,I-TE
cholangiopancreatogram,I-TE
upon,O
admission,O
.,O

On,O
this,B-TE
examination,I-TE
",",O
the,O
patient,O
was,O
found,O
to,O
have,O
mild,B-PR
biliary,I-PR
stricture,I-PR
most,O
likely,O
secondary,O
to,O
chronic,B-PR
pancreatitis,I-PR
.,O

Cytology,B-TE
was,O
obtained,O
.,O

He,O
was,O
also,O
found,O
to,O
have,O
dilated,B-PR
pancreatic,I-PR
ducts,I-PR
with,O
calcifications,B-PR
consistent,O
with,O
chronic,B-PR
pancreatitis,I-PR
.,O

The,O
patient,O
underwent,O
a,B-TR
percutaneous,I-TR
sphincterotomy,I-TR
extended,O
to,O
a,B-TR
full,I-TR
sphincterectomy,I-TR
.,O

He,O
also,O
had,O
successful,B-TR
extraction,I-TR
of,O
stone,B-PR
fragments,I-PR
.,O

The,O
patient,O
tolerated,O
this,B-TR
procedure,I-TR
well,O
and,O
had,O
no,O
complications,B-PR
.,O

The,O
patient,O
subsequently,O
underwent,O
a,B-TE
CT,I-TE
scan,I-TE
angiogram,I-TE
with,O
Pancreas,B-TE
protocol,I-TE
to,O
assess,O
the,O
pseudocyst,B-PR
versus,O
enlarged,B-PR
pancreas,I-PR
head,I-PR
.,O

The,O
results,O
of,O
this,B-TE
study,I-TE
indicated,O
that,O
this,O
structure,O
at,O
the,O
head,O
of,O
his,O
pancreas,O
is,O
most,O
likely,O
a,B-PR
forming,I-PR
pseudocyst,I-PR
;,O
however,O
",",O
the,O
suspicion,O
of,O
malignancy,B-PR
is,O
still,O
possible,O
and,O
the,O
patient,O
underwent,O
an,B-TE
ultrasound,I-TE
guided,I-TE
biopsy,I-TE
of,O
this,B-PR
mass,I-PR
on,O
2011-01-20,O
.,O

The,O
cytology,O
for,O
this,B-TE
biopsy,I-TE
is,O
still,O
pending,O
.,O

The,O
patient,O
recovered,O
well,O
status,O
post,O
these,B-TE
two,I-TE
procedures,I-TE
.,O

He,O
had,O
no,O
complications,B-PR
and,O
no,O
subsequently,B-PR
pancreatitis,I-PR
.,O

His,B-TE
alkaline,I-TE
phosphatase,I-TE
and,O
all,B-PR
the,I-PR
other,I-PR
abnormal,I-PR
liver,I-PR
function,I-PR
tests,I-PR
were,O
resolving,O
.,O

He,O
had,O
no,O
pain,B-PR
and,O
did,O
not,O
require,O
any,B-TR
pain,I-TR
medications,I-TR
.,O

He,O
was,O
tolerating,O
food,O
very,O
well,O
and,O
was,O
afebrile,B-PR
throughout,O
admission,O
.,O

With,O
regards,O
to,O
the,B-PR
patient,I-PR
's,I-PR
documented,I-PR
Strep,I-PR
septicemia,I-PR
in,O
the,O
outside,O
hospital,O
",",O
the,O
Infectious,O
Disease,O
Team,O
was,O
formally,O
consulted,O
.,O

Upon,O
obtaining,O
more,O
information,O
from,O
Rehab,O
Hospital,O
of,O
the,O
Cape,O
&,O
Islands,O
Hospital,O
",",O
it,O
appears,O
that,O
the,O
patient,O
had,O
two,O
out,O
of,O
four,O
bottles,O
growing,O
out,O
Streptococcus,B-PR
sanguis,I-PR
in,O
the,O
outside,O
hospital,O
.,O

The,O
patient,O
appeared,O
to,O
have,O
been,O
covered,O
by,O
Ampicillin,B-TR
",",O
Gentamycin,B-TR
and,O
then,O
Unasyn,B-TR
in,O
the,O
outside,O
hospital,O
.,O

The,O
patient,O
",",O
on,O
admission,O
",",O
was,O
placed,O
on,O
Ampicillin,B-TR
",",O
Gentamycin,B-TR
and,O
Flagyl,B-TR
.,O

With,O
repeated,B-TE
blood,I-TE
cultures,I-TE
that,O
were,O
negative,O
",",O
the,O
patient,O
was,O
reduced,O
to,O
single,O
Mckenzie,O
of,O
intravenous,B-TR
Ampicillin,I-TR
.,O

For,O
this,B-PR
documented,I-PR
septicemia,I-PR
",",O
this,O
patient,O
went,O
for,O
a,B-TE
endocarditis,I-TE
work-up,I-TE
.,O

He,O
had,O
a,B-TE
transthoracic,I-TE
echocardiogram,I-TE
which,O
revealed,O
no,O
vegetations,B-PR
.,O

On,O
this,B-TE
echocardiogram,I-TE
",",O
he,O
was,O
found,O
to,O
have,O
mildly,B-PR
dilated,I-PR
left,I-PR
atrium,I-PR
",",O
mild,B-PR
symmetric,I-PR
left,I-PR
ventricular,I-PR
hypertrophy,I-PR
",",O
and,O
a,O
normal,O
ejection,O
fraction,O
of,O
greater,O
than,O
55%,O
.,O

There,O
were,O
no,O
other,B-PR
abnormalities,I-PR
noted,O
on,O
this,B-TE
study,I-TE
.,O

The,O
patient,O
then,O
underwent,O
a,B-TE
transesophageal,I-TE
echocardiogram,I-TE
on,O
01-24,O
.,O

On,O
this,B-TE
echocardiogram,I-TE
",",O
he,O
was,O
again,O
noted,O
to,O
not,O
have,O
any,O
evidence,O
for,O
valvular,B-PR
vegetations,I-PR
.,O

A,B-PR
complex,I-PR
plaque,I-PR
was,O
found,O
in,O
the,O
aortic,O
arch,O
in,O
the,O
descending,O
thoracic,O
aorta,O
",",O
although,O
this,B-PR
plaque,I-PR
is,O
non-mobile,O
.,O

There,O
was,O
focal,B-PR
mitral,I-PR
valve,I-PR
prolapse,I-PR
noted,O
without,O
pathologic,B-PR
mitral,I-PR
regurgitation,I-PR
.,O

The,O
patient,O
was,O
noted,O
to,O
have,O
trace,B-PR
aortic,I-PR
regurgitation,I-PR
.,O

A,B-TE
Panorex,I-TE
x-ray,I-TE
of,O
his,O
two,O
teeth,O
were,O
obtained,O
and,O
a,B-TE
Dental,I-TE
Consultation,I-TE
was,O
done,O
.,O

The,O
patient,O
was,O
thought,O
to,O
have,O
normal,O
dental,O
hygiene,O
and,O
low,O
suspicion,O
for,O
a,O
source,O
of,O
his,B-PR
alpha,I-PR
septicemia,I-PR
from,I-PR
his,I-PR
mouth,I-PR
.,O

Infectious,O
Disease,O
Department,O
as,O
well,O
as,O
Cardiology,O
had,O
recommended,O
a,O
formal,O
14,O
-,O
day,O
course,O
of,O
intravenous,B-TR
antibiotics,I-TR
to,O
treat,O
a,B-PR
documented,I-PR
alpha,I-PR
Streptococcal,I-PR
septicemia,I-PR
from,O
outside,O
hospital,O
blood,B-TE
cultures,I-TE
.,O

The,O
patient,O
's,O
insurance,O
company,O
",",O
however,O
",",O
would,O
not,O
pay,O
for,O
home,B-TR
antibiotics,I-TR
.,O

After,O
much,O
discussion,O
with,O
the,O
patient,O
",",O
the,O
patient,O
was,O
informed,O
of,O
the,O
risks,O
of,O
not,O
finishing,O
a,O
14,O
day,O
course,O
of,O
intravenous,B-TR
antibiotics,I-TR
and,O
chose,O
to,O
go,O
home,O
.,O

He,O
had,O
three,O
days,O
of,O
antibiotics,B-TR
remaining,O
at,O
the,O
time,O
of,O
discharge,O
.,O

It,O
was,O
discussed,O
with,O
the,O
patient,O
to,O
send,O
him,O
out,O
on,O
Augmentin,B-TR
500,O
mg,O
three,O
times,O
a,O
day,O
for,O
ten,O
more,O
days,O
.,O

He,O
was,O
to,O
follow-up,O
with,O
his,O
primary,O
care,O
physician,O
within,O
two,O
to,O
three,O
days,O
for,O
repeat,B-TE
laboratory,I-TE
studies,I-TE
and,O
blood,B-TE
cultures,I-TE
.,O

He,O
was,O
to,O
return,O
to,O
the,O
hospital,O
with,O
any,O
signs,O
of,O
shaking,B-PR
chills,B-PR
or,O
fever,B-PR
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Pancreatitis,B-PR
status,O
post,O
endoscopic,B-TE
retrogram,I-TE
cholangiopancreatography,I-TE
and,O
sphincterotomy,B-TR
.,O

2.,O
Alpha,B-PR
Streptococcus,I-PR
septicemia,I-PR
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Augmentin,B-TR
500,O
mg,O
p.o.,O
three,O
times,O
a,O
day,O
times,O
ten,O
days,O
.,O

2.,O
Flomax,B-TR
0.4,O
mg,O
p.o.,O
q.,O
day,O
.,O

3.,O
Prilosec,B-TR
20,O
mg,O
p.o.,O
q.,O
day,O
.,O

4.,O
Humalog,B-TR
and,O
Regular,B-TR
insulin,I-TR
subcutaneously,O
.,O

Hallo,O
MING,O
LI,O
",",O
M.D.,O

40-963,O

Dictated,O
By,O
:,O
Annie,O
D.,O
Martinez,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2011-01-25,O
14:08,O

T,O
:,O
2011-01-26,O
11:30,O

JOB,O
#:,O

9167,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Dorothy,O
L.,O
Brennan,O
on,O
:,O
Russell,O
2011-01-27,O
11:38,O
AM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2010-10-04,O

Discharge,O
Date,O
:,O

2010-10-17,O

Date,O
of,O
Birth,O
:,O

1929-11-09,O

Sex,O
:,O

F,O

Service,O
:,O

There,O
will,O
be,O
further,O
addendum,O
.,O

Respiratory,B-PR
distress,I-PR
-,O
On,O
10-12,O
",",O
the,O
patient,O
was,O
transferred,O
to,O
Medicine,O
Intensive,O
Care,O
Unit,O
secondary,O
to,O
respiratory,B-PR
distress,I-PR
.,O

In,O
the,O
Medicine,O
Intensive,O
Care,O
Unit,O
",",O
the,O
patient,O
was,O
initially,O
placed,O
on,O
high-flow,B-TR
60%,I-TR
oxygen,I-TR
face,I-TR
mask,I-TR
and,O
they,O
diuresed,O
approximately,O
5,O
liters,O
off,O
into,O
the,B-TR
intravenous,I-TR
Lasix,I-TR
.,O

The,O
patient,O
actually,O
was,O
improved,O
.,O

She,O
came,O
back,O
to,O
the,O
floor,O
on,O
10-14,O
.,O

Since,O
then,O
the,O
patient,O
's,O
oxygenation,O
has,O
been,O
improving,O
and,O
today,O
",",O
10-17,O
",",O
she,O
is,O
requiring,O
.5,O
liters,O
of,O
keep,O
her,B-TE
saturations,I-TE
above,O
94,O
.,O

The,O
patient,O
continues,O
to,O
be,O
diuresed,O
with,O
approximately,O
20,O
mg,O
of,O
Lasix,B-TR
a,O
day,O
and,O
she,O
has,O
had,O
good,O
urine,O
output,O
.,O

Anemia,B-PR
-,O
The,B-TE
patient,I-TE
's,I-TE
hematocrit,I-TE
dropped,O
in,O
the,O
Intensive,O
Care,O
Unit,O
to,O
the,O
mid,O
20s,O
and,O
she,O
received,O
one,O
unit,O
of,O
packed,O

red,B-TR
blood,I-TR
cells,I-TR
with,O
a,O
good,O
response,O
up,O
to,O
30,O
.,O

Hypotension,B-PR
-,O
On,O
the,O
night,O
of,O
10-16,O
",",O
the,O
patient,O
was,O
diuresed,O
with,O
20,O
mg,O
of,O
intravenous,B-TR
Lasix,I-TR
.,O

This,O
is,O
the,O
normal,O
dose,O
that,O
she,O
puts,O
out,O
too,O
.,O

The,O
patient,O
became,O
hypotensive,B-PR
into,O
the,O
70,O
s,O
without,O
any,B-PR
symptoms,I-PR
.,O

Her,B-TE
oxygen,I-TE
saturations,I-TE
were,O
greater,O
than,O
94%,O
at,O
the,O
time,O
.,O

The,O
patient,O
was,O
given,O
250,O
cc,O
of,O
normal,B-TR
saline,I-TR
and,O
her,B-TE
blood,I-TE
pressure,I-TE
responded,O
coming,O
back,O
up,O
to,O
the,O
high,O
90,O
s.,O

No,O
further,O
episodes,O
of,O
hypotension,B-PR
were,O
noted,O
.,O

As,O
of,O
the,O
time,O
of,O
this,O
dictation,O
",",O
on,O
2010-10-17,O
",",O
the,O
patient,O
appears,O
to,O
be,O
getting,O
better,O
.,O

Recent,B-TE
chest,I-TE
x-ray,I-TE
shows,O
resolving,B-PR
right,I-PR
lower,I-PR
lobe,I-PR
pneumonia,I-PR
.,O

She,O
continues,O
on,O
her,B-TR
Prednisone,I-TR
taper,I-TR
for,O
her,B-PR
asthma,I-PR
and,O
this,O
is,O
day,O
#,O
14,O
of,O
antibiotics,B-TR
.,O

MARK,O
Shorter,O
",",O
M.D.,O

94-264,O

Dictated,O
By,O
:,O
Donna,O
Q,O
Fisher,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2010-10-17,O
12:22,O

T,O
:,O
2010-10-17,O
17:21,O

JOB,O
#:,O

33371,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2019-01-19,O

Discharge,O
Date,O
:,O

2019-01-24,O

Date,O
of,O
Birth,O
:,O

1981-03-17,O

Sex,O
:,O

M,O

Service,O
:,O
MEDICINE,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,O
Drugs,B-TR

Attending,O
:,O
Antonio,O
I,O
Staples,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

nausea,B-PR
and,O
vomiting,B-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

01-23,O
PORT,B-TR
line,I-TR
removal,I-TR
.,O

01-23,O
PICC,B-TR
placement,I-TR
.,O

01-24,O
PICC,B-TR
removal,I-TR
.,O

History,O
of,O
Present,O
Illness,O
:,O

This,O
is,O
a,O
37,O
y/o,O
male,O
patient,O
with,O
PMH,O
Type,B-PR
I,I-PR
DM,I-PR
",",O
HTN,B-PR
",",O
gastroparesis,B-PR
",",O
ESRD,B-PR
on,O
HD,B-TR
(,O
last,O
in,O
12/26,O
per,O
patient,O
),O
who,O
presents,O
to,O
CMED,O
CCU,O
with,O
hypertensive,B-PR
urgency,I-PR
unable,O
from,O
the,O
Larry,O
.,O

The,O
patient,O
early,O
this,O
morning,O
to,O
the,O
Ruthie,O
with,O
his,B-PR
usual,I-PR
nausea,I-PR
",",O
vomiting,B-PR
",",O
abdominal,B-PR
pain,I-PR
and,O
was,O
found,O
to,O
be,O
hypertensive,B-PR
to,O
256/110,O
",",O
HR,B-TE
102,O
",",O
T,B-TE
99.2,O
",",O
RR,B-TE
22,O
",",O
92%,O
RA,O
.,O

History,O
is,O
difficult,O
to,O
obtain,O
from,O
patient,O
d/t,O
somnolence,B-PR
and,O
lack,B-PR
of,I-PR
desire,I-PR
to,O
participate,O
in,O
interview,O
",",O
but,O
per,O
Frank,O
note,O
he,O
was,O
diaphoretic,B-PR
and,O
',O
writing,O
in,O
pain,B-PR
"',",O
vomiting,O
clear,O
substance,O
.,O

He,O
was,O
given,O
ativan,B-TR
a,O
total,O
of,O
4,O
mg,O
of,O
ativan,B-TR
",",O
6,O
mg,O
of,O
dilaudid,B-TR
",",O
labetolol,B-TR
20,O
mg,O
IV,O
x,O
1,O
and,O
hydralazine,B-TR
10,O
mg,O
IV,O
x,O
1,O
without,O
good,O
response,O
(,O
200/99,O
).,O

He,O
recieved,O
2L,B-TR
NS,I-TR
and,O
was,O
started,O
on,O
labetolol,B-TR
gtt,I-TR
and,O
BP,B-TE
decreased,O
to,O
161/79,O
.,O

Tranferred,O
to,O
CMED,O
CCU,O
for,O
further,O
management,O
while,O
on,O
labetolol,B-TR
gtt,I-TR
.,O

Of,O
note,O
",",O
the,O
patient,O
is,O
admitted,O
to,O
hospital,O
3,O
times,O
every,O
month,O
for,O
similar,O
complaints,O
with,O
last,O
admission,O
1/20-2/1/07,O
.,O

At,O
that,O
time,O
BP,B-TE
was,O
attributed,O
to,O
abdominal,B-PR
pain,I-PR
and,O
inability,O
to,O
take,O
PO,O
meds,O
d/t,O
nausea,B-PR
/,O
vomiting,B-PR
.,O

Also,O
had,O
labile,B-PR
blood,I-PR
sugars,I-PR
with,O
repeated,O
episodes,O
of,O
hypoglycemia,B-PR
",",O
and,O
Strickland,O
recommended,O
sugars,B-TE
in,O
the,O
range,O
of,O
150-200,O
.,O

He,O
eloped,O
prior,O
to,O
formal,O
discharge,O
when,O
his,B-TE
FS,I-TE
was,O
found,O
to,O
be,O
critically,B-PR
high,I-PR
-,O
recommended,O
to,O
patient,O
that,O
he,O
stay,O
for,O
repeat,O
",",O
but,O
left,O
AMA,O
without,O
signing,O
any,O
forms,O
.,O

Upon,O
transfer,O
to,O
the,O
CMED,O
CCU,O
the,O
patient,O
appears,O
somewhat,B-PR
uncomfortable,I-PR
",",O
reporting,O
nausea,B-PR
and,O
abdominal,B-PR
pain,I-PR
",",O
but,O
when,O
questioned,O
he,O
was,O
unable,O
/,O
unwilling,O
to,O
participate,O
in,O
HPI,O
or,O
exam,B-TE
d/t,O
sleepiness,B-PR
.,O

He,O
denied,O
CP,B-PR
",",O
SOB,B-PR
",",O
HA,B-PR
",",O
vision,B-PR
changes,I-PR
",",O
neck,B-PR
stiffness,I-PR
",",O
dysuria,B-PR
",",O
or,O
other,B-PR
symptoms,I-PR
.,O

In,O
the,O
CMED,O
CCU,O
he,O
became,O
hypotensive,B-PR
to,O
SBP,B-TE
80,O
s.,O

Labetalol,B-TR
was,O
stopped,O
and,O
he,O
received,O
a,B-TR
500,I-TR
cc,I-TR
fluid,I-TR
bolus,I-TR
and,O
his,B-TE
blood,I-TE
pressure,I-TE
rose,O
to,O
SBP,B-TE
90,O
s.,O

Cardiac,O
and,O
infectious,O
sources,O
of,O
hypotension,B-PR
were,O
considered,O
",",O
but,O
cardiac,B-TE
enzymes,I-TE
were,O
not,O
changed,O
from,O
prior,O
studies,O
and,O
he,O
had,O
no,O
localizing,B-PR
signs,I-PR
of,I-PR
infection,I-PR
;,O
blood,B-TE
cultures,I-TE
were,O
sent,O
and,O
a,B-TE
ultrasound,I-TE
of,O
the,B-TR
L,I-TR
arm,I-TR
AVF,I-TR
ordered,O
to,O
rule,O
out,O
abscess,B-PR
at,I-PR
the,I-PR
site,I-PR
.,O

He,O
received,O
a,B-TR
partial,I-TR
HD,I-TR
session,I-TR
",",O
limited,O
by,O
hypotension,B-PR
.,O

Over,O
night,O
",",O
his,B-TE
blood,I-TE
pressure,I-TE
trended,O
up,O
to,O
130,O
s,O
systolic,O
.,O

He,O
was,O
restarted,O
on,O
his,B-TR
home,I-TR
blood,I-TR
pressure,I-TR
regimen,I-TR
.,O

Renal,O
consult,O
team,O
saw,O
him,O
2019-01-20,O
and,O
plan,O
to,O
next,O
dialyze,O
him,O
on,O
2019-01-21,O
.,O

He,O
was,O
to,O
be,O
called,O
out,O
to,O
the,O
medical,O
floor,O
on,O
2019-01-20,O
but,O
became,O
somnolent,B-PR
after,O
receiving,O
pain,B-TR
and,I-TR
anti-nausea,I-TR
meds,I-TR
",",O
so,O
he,O
stayed,O
in,O
the,O
ICU,O
for,O
closer,O
monitoring,O
of,O
respiratory,O
status,O
",",O
which,O
spontaneously,O
improved,O
.,O

His,B-TE
blood,I-TE
sugar,I-TE
at,O
10,O
pm,O
was,O
low,O
at,O
22,O
and,O
he,O
was,O
disoriented,B-PR
",",O
which,O
resolved,O
with,O
two,O
glasses,O
of,O
juice,O
;,O
he,O
did,O
not,O
receive,O
his,O
standing,O
dose,O
of,O
NPH,B-TR
that,O
evening,O
.,O

Blood,B-TE
cultures,I-TE
returned,O
positive,O
with,O
GPC,B-PR
in,I-PR
pairs,I-PR
and,I-PR
clusters,I-PR
",",O
so,O
a,B-TE
TTE,I-TE
and,O
surveillance,B-TE
cultures,I-TE
were,O
ordered,O
and,O
vancomycin,B-TR
was,O
started,O
.,O

He,O
was,O
then,O
called,O
out,O
to,O
the,O
medical,O
floor,O
on,O
01-21,O
.,O

Past,O
Medical,O
History,O
:,O

1.,O
DM,B-PR
type,I-PR
I,O

2.,O
ESRD,B-PR
on,O
hemodialysis,B-TR
started,O
2017-01-07,O
on,O
Tu,O
",",O
Th,O
",",O
Sat,O

3.,O
Severe,B-PR
autonomic,I-PR
dysfunction,I-PR
with,O
multiple,O
hospitalizations,O
for,O
hypertensive,B-PR
emergency,I-PR
",",O
gastroparesis,B-PR
",",O
and,O
orthostatic,B-PR
hypotension,I-PR
.,O

4.,O
History,O
of,O
esophageal,B-PR
erosion,I-PR
",",O
MW,B-PR
tear,I-PR

5.,O
CAD,B-PR
with,O
1-vessel,B-PR
disease,I-PR
(,O
50%,B-PR
stenosis,I-PR
D1,I-PR
in,O
2014-06-07,O
"),",O
normal,O
stress,O

2015-10-07,O

6.,O
hx,O
of,O
Foot,B-PR
Ulcer,I-PR

7.,O
h/o,O
clot,B-PR
in,O
AV,B-TR
graft,I-TR
x2,O
(,O
March,O
and,O
2018-07-07,O
),O

Social,O
History,O
:,O

Denies,O
alcohol,O
or,O
tobacco,O
use,O
.,O

Endorses,O
occassional,O
marijuana,O
use,O
.,O

Lives,O
with,O
his,O
Carney,O
Hospital,O
mother,O
and,O
their,O
three,O
children,O
.,O

Family,O
History,O
:,O

His,O
father,O
recently,O
died,O
of,O
ESRD,B-PR
and,O
diabetes,B-PR
.,O

His,O
mother,O
is,O
in,O
her,O
50,O
s,O
and,O
has,O
hypertension,B-PR
.,O

He,O
has,O
two,O
sisters,O
",",O
one,O
with,O
diabetes,B-PR
",",O
and,O
six,O
brothers,O
",",O
one,O
with,O
diabetes,B-PR
.,O

Physical,O
Exam,O
:,O

Vitals,B-TE
:,O
97.4,O
",",O
164/90,O
",",O
102,O
",",O
10,O
",",O
97%,O
4L,O

General,O
:,O
sleepy,B-PR
",",O
arouses,O
to,O
voice,O
but,O
limited,O
participation,O
with,O
physical,B-TE
exam,I-TE

HEENT,O
:,O
PERRL,O
",",O
left,B-PR
pupil,I-PR
smaller,I-PR
than,I-PR
right,I-PR
",",O
pt,O
will,O
not,O
participate,O
in,O
EOMI,O
",",O
sclera,O
anicteric,B-PR
",",O
MM,B-PR
dry,I-PR
",",O
No,O
OP,B-PR
lesions,I-PR

Neck,O
:,O
Supple,O
",",O
no,O
JVD,B-PR

CV,O
:,O
RRR,O
",",O
nl,O
S1,O
",",O
S2,O
",",O
2/6,B-PR
systolic,I-PR
murmur,I-PR
at,I-PR
LUSB,I-PR

Lungs,O
:,O
CTAB,O
post,O

Chest,O
:,O
HD,B-TR
line,I-TR
in,O
place,O
without,O
erythema,B-PR

Abd,O
:,O
Soft,O
",",O
ND,B-PR
",",O
nontender,B-PR
",",O
+,O
BS,O
",",O
no,O
guarding,B-PR
",",O
no,O
rebound,B-PR
",",O
multiple,B-PR
well,I-PR
healed,I-PR
scars,I-PR

Ext,O
:,O
no,O
c/c/e,B-PR
",",O
left,B-PR
arm,I-PR
with,I-PR
fistula,I-PR
with,O
good,O
thrill,O

Skin,O
:,O
no,O
rashes,B-PR

Brief,O
Hospital,O
Course,O
:,O

Pt,O
admitted,O
to,O
medical,O
floor,O
in,O
hemodynamically,O
stable,O
condition,O
without,O
specific,B-PR
complaints,I-PR
.,O

#,O
hypertensive,B-PR
urgency,I-PR
:,O

Upon,O
presentation,O
it,O
was,O
unclear,O
when,O
last,O
time,O
was,O
that,O
patient,O
took,O
meds,B-TR
",",O
but,O
hypertension,B-PR
likely,O
d/t,O
inability,B-PR
to,I-PR
take,I-PR
meds,I-PR
in,O
setting,O
of,O
N/V,B-PR
.,O

Also,O
contribution,O
of,O
autonomic,B-PR
dysfunction,I-PR
.,O

No,O
evidence,O
of,O
active,B-PR
end,I-PR
organ,I-PR
damage,I-PR
.,O

Pt,O
was,O
treated,O
with,O
labetalol,B-TR
gtt,I-TR
in,O
CMED,O
CCU,O
which,O
was,O
weaned,O
off,O
on,O
01-20,O
.,O

carduac,B-PR
enzymes,I-PR
mildly,I-PR
elevated,I-PR
",",O
felt,O
02-08,O
demand,B-PR
ischemia,I-PR
in,O
setting,O
of,O
hypertensive,B-PR
urgency,I-PR
",",O
CK,B-TE
and,O
MB,B-TE
trended,O
Mcewen,O
at,O
time,O
of,O
admission,O
to,O
medical,O
floor,O
.,O

Pt,B-PR
's,I-PR
hypertensive,I-PR
urgency,I-PR
was,O
resolved,O
upon,O
admission,O
to,O
the,O
medical,O
floor,O
.,O

His,B-TE
SBP,I-TE
s,I-TE
ranged,O
140,O
s-,O
170,O
s,O
.,O

He,O
was,O
restarted,O
on,O
his,O
home,O
regimen,O
of,O
antihypertensives,B-TR
without,O
difficulty,O
(,O
metoprolol,B-TR
75,O
tid,O
",",O
clonidine,B-TR
patch,I-TR
and,I-TR
oral,I-TR
",",O
nifedipine,B-TR
30,O
SR,O
q,O
daily,O
).,O

he,O
was,O
discharged,O
home,O
with,O
change,O
in,O
his,O
regimen,O
.,O

#,O
bacteremia,B-PR
:,O

pt,O
with,O
2/4,O
bottles,O
coag,B-PR
neg,I-PR
staph,I-PR
on,O
01-19,O
and,O
again,O
on,O
01-20,O
.,O

PORT,B-TR
was,O
felt,O
most,O
likely,O
source,O
",",O
and,O
pt,O
has,O
had,O
at,O
least,O
2,O
sets,O
of,O
+,B-PR
blood,I-PR
cultures,I-PR
since,O
it,O
was,O
placed,O
.,O

TTE,B-TE
was,O
obtained,O
which,O
was,O
not,O
concerning,O
for,O
endocarditis,B-PR
.,O

pt,O
without,O
stigmata,B-PR
of,I-PR
SBE,I-PR
.,O

ID,O
consult,O
obtained,O
which,O
recommended,O
removal,B-TR
of,I-TR
PORT,I-TR
",",O
which,O
was,O
taken,O
out,O
on,O
01-23,O
.,O

Pt,O
will,O
compelete,O
a,O
2,O
week,O
course,O
of,O
vancomycin,B-TR
at,O
hemodialysis,B-TR
",",O
which,O
has,O
been,O
arranged,O
by,O
renal,O
service,O
.,O

A,B-TR
PICC,I-TR
was,O
breifly,O
placed,O
",",O
however,O
removed,O
as,O
it,O
is,O
unclear,O
if,O
pt,O
can,O
reliably,O
flush,O
this,O
.,O

PORT,B-TR
will,O
be,O
replaced,O
on,O
2019-02-11,O
per,O
IR,O
(,O
Dr.,O
Welsh,O
placed,O
last,O
PORT,B-TR
",",O
then,O
removed,O
it,O
on,O
01-23,O
"),",O
ordered,O
placed,O
in,O
OMR,O
.,O

Indication,O
:,O

diabetic,B-PR
gastropathy,I-PR
causing,O
inability,B-PR
to,I-PR
toleral,I-PR
oral,I-PR
antihypertensive,I-PR
medication,I-PR
prompting,O
repeated,O
Donald,O
presentation,O
for,O
hypertensive,B-PR
urgency,I-PR
.,O

Pt,O
with,O
surveillance,B-TE
cultures,I-TE
and,O
port,B-TE
tip,I-TE
cultures,I-TE
showing,O
NGTD,O
on,O
01-24,O
",",O
he,O
will,O
have,O
futher,B-TE
surveillance,I-TE
cultures,I-TE
drawn,O
at,O
hemodialysis,B-TR
and,O
followed,O
by,O
his,O
nephrologist,O
.,O

#,O
n/v/,B-PR
abdominal,B-PR
pain,I-PR
:,O
pt,O
with,O
multiple,O
admissions,O
with,O
similar,B-PR
complaints,I-PR
",",O
etiology,O
02-08,O
gastroparesis,B-PR
",",O
improves,O
considerably,O
with,O
ativan,B-TR
",",O
dilaudid,B-TR
",",O
reglan,B-TR
",",O
pt,O
was,O
tolerating,O
PO,B-TR
meds,I-TR
/,O
diet,O
at,O
time,O
of,O
admission,O
to,O
medical,O
service,O
and,O
was,O
restarted,O
on,O
oral,B-TR
reglan,I-TR
.,O

#,O
DMI,B-PR
:,O
Pt,O
on,O
sliding,B-TR
scale,I-TR
as,O
inpatient,O
and,O
taking,O
NPH,B-TR
2,O
units,O
BID,O
at,O
home,O
.,O

pt,O
with,O
two,O
episodes,O
of,O
hypoglycemia,B-PR
(,O
FSBS,B-TE
22,O
and,O
27,O
"),",O
etiology,O
unclear,O
",",O
pt,O
followed,O
by,O
Strickland,O
",",O
who,O
recommend,O
no,O
changes,O
to,O
current,B-TR
insulin,I-TR
regimen,I-TR
.,O

will,O
discharge,O
pt,O
with,O
instructions,O
to,O
continue,O
NPH,B-TR
2,O
UNITS,O
BID,O
as,O
Frederick,O
Tracey,O
recs,O
.,O

#,O
CAD,B-PR
-,O
pt,O
denied,O
cp,B-PR
/,O
sob,B-PR
throughout,O
hospitalization,O
.,O

Troponins,B-TE
rose,O
at,O
admission,O
",",O
however,O
CK,B-TE
and,O
MB,B-TE
trending,O
Mcewen,O
wat,O
time,O
of,O
admission,O
to,O
medical,O
service,O
.,O

Etiology,O
felt,O
most,O
likely,O
demand,B-PR
ischemia,I-PR
in,O
setting,O
of,O
original,B-PR
hypertensive,I-PR
urgency,I-PR
with,O
persistent,B-PR
elevation,I-PR
of,I-PR
trop,I-PR
02-08,O
ESRD,B-PR
.,O

Pt,O
was,O
continued,O
on,O
aspirin,B-TR
",",O
metoprolol,B-TR
",",O
nifedipine,B-TR
.,O

#,O
ESRD,B-PR
:,O
etiology,O
likely,O
02-08,O
DM,B-PR
and,O
HTN,B-PR
",",O
pt,O
tolerating,O
HD,B-TR
well,O
",",O
and,O
underwent,O
dialysis,B-TR
without,O
difficulty,B-PR
on,O
01-24,O
.,O

pt,O
will,O
be,O
discharged,O
home,O
with,O
plan,O
to,O
continue,O
current,B-TR
dialysis,I-TR
schedule,I-TR
(,O
Tue,O
/,O
Th,O
/,O
Sat,O
).,O

In,O
addition,O
pt,O
will,O
be,O
given,O
vancomycin,B-TR
at,O
dialysis,O
x,O
2,O
week,O
course,O
(,O
last,O
day,O
2019-02-05,O
),O
given,O
his,B-PR
PORT,I-PR
line,I-PR
infection,I-PR
.,O

He,O
will,O
have,O
levels,B-TE
drawn,O
at,O
dialysis,B-TR
and,O
be,O
dosed,O
with,O
vancomycin,B-TR
as,O
appropriate,O
.,O

Plan,O
is,O
for,O
surveillance,B-TE
cultures,I-TE
to,O
be,O
drawn,O
at,O
dialysis,B-TR
.,O

If,O
negative,O
",",O
pt,O
is,O
scheduled,O
for,O
presumptively,B-TR
replacement,I-TR
of,I-TR
PORT,I-TR
on,O
2019-02-11,O
with,O
interventional,B-TR
radiology,I-TR
(,O
dr.,O
Arevalo,O
).,O

Pt,O
continued,O
on,O
home,O
regimen,O
of,O
calcium,B-TR
acetate,I-TR
667,O
mg,O
",",O
3,O
capsules,O
TID,O
.,O

#,O
AV,B-TR
fistula,I-TR
:,O
pt,O
with,O
h/o,O
numerous,B-PR
clots,I-PR
in,O
AV,B-TR
fistula,I-TR
.,O

No,O
signs,O
of,O
infection,B-PR
presently,O
",",O
and,O
tolerating,O
dialysis,B-TR
without,O
difficulty,B-PR
.,O

Pt,O
was,O
subtherapeuticon,B-PR
INR,I-PR
on,O
admission,O
",",O
thus,O
treated,O
with,O
heparin,B-TR
gtt,I-TR
.,O

coumadin,B-TR
held,O
on,O
01-22,O
for,O
PORT,B-TR
removal,I-TR
",",O
and,O
restarted,O
on,O
01-24,O
.,O

Pt,O
discharged,O
with,O
instructions,O
to,O
continue,O
coumadin,B-TR
1.5,O
mg,O
po,O
q,O
daily,O
with,O
goal,B-TE
INR,I-TE
02-09,O
.,O

#,O
DISPO,O
:,O

pt,O
discharged,O
home,O
on,O
01-24,O
with,O
instructions,O
to,O
complete,O
2,O
week,O
course,O
of,O
vancomycin,B-TR
at,O
hemodialysis,B-TR
for,O
his,B-PR
PORT,I-PR
line,I-PR
infection,I-PR
.,O

an,O
appointment,O
was,O
made,O
with,O
interventional,O
radiology,O
on,O
2019-02-11,O
to,O
replace,O
his,B-TR
PORT,I-TR
",",O
under,O
the,O
assumption,O
that,O
his,B-TE
surveillance,I-TE
cultures,I-TE
from,O
dialysis,B-TR
remain,O
negative,O
.,O

discussed,O
this,O
plan,O
with,O
renal,O
service,O
(,O
Anthony,O
Mcknight,O
),O
who,O
will,O
communicate,O
with,O
pt,O
's,O
outpatient,O
dialysis,O
service,O
.,O

Medications,O
on,O
Admission,O
:,O

Metoclopramide,B-TR
10,O
mg,O
PO,O
Q6,O

Metoprolol,B-TR
Tartrate,I-TR
75,O
mg,O
PO,O
TID,O

Calcium,B-TR
Acetate,I-TR
1340,O
mg,O
tid,O
with,O
meals,O

Anzemet,B-TR
12.5,O
IV,O
prn,O

Prochlorperazine,B-TR
10,O
mg,O
IV,O
Q6H,O
prn,O

Ativan,B-TR
1,O
mg,O
PO,O
Q6H,O
prn,O

Dilaudid,B-TR
4mg,O
PO,O
Q3-4H,O
prn,O

Insulin,B-TR
NPH,I-TR
2,O
units,O
Subcutaneous,O
twice,O
a,O
day,O
.,O

Clonidine,B-TR
0.3,O
mg,O
/,O
24,O
hr,O
Patch,O
Weekly,O
Transdermal,O
QTHUR,O

Clonidine,B-TR
0.2,O
mg,O
PO,O
TID,O

Prochlorperazine,B-TR
10,O
mg,O
q,O
6,O
h,O

Coumadin,B-TR
1.5,O
mg,O
PO,O
QHS,O

Nifedipine,B-TR
30,O
SR,O
mg,O
PO,O
QD,O

Bisacodyl,B-TR
prn,O

Protonix,B-TR
40,O
QD,O

Discharge,O
Medications,O
:,O

1.,O
Metoclopramide,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q6H,O
(,O
every,O
6,O
hours,O
).,O

2.,O
Metoprolol,B-TR
Tartrate,I-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
Three,O
(,O
3,O
),O
Tablet,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
).,O

3.,O
Calcium,B-TR
Acetate,I-TR
667,O
mg,O
Capsule,O
Sig,O
:,O
Three,O
(,O
3,O
),O
Capsule,O
PO,O
TID,O
W/,O
MEALS,O
(,O
3,O
TIMES,O
A,O
DAY,O
WITH,O
MEALS,O
).,O

4.,O
Ativan,B-TR
1,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
q6h,O
prn,O
.,O

5.,O
Dilaudid,B-TR
4,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
q3-4hr,O
prn,O
.,O

6.,O
Clonidine,B-TR
0.3,O
mg,O
/,O
24,O
hr,O
Patch,O
Weekly,O
Sig,O
:,O
One,O
(,O
1,O
),O
Patch,O
Weekly,O
Transdermal,O
Q,O
WED,O
(,O
every,O
Wednesday,O
).,O

7.,O
Clonidine,B-TR
0.2,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
).,O

8.,O
Warfarin,B-TR
1,O
mg,O
Tablet,O
Sig,O
:,O
1.5,O
Tablets,O
PO,O
DAILY,O
(,O
Daily,O
).,O

9.,O
Nifedipine,B-TR
30,O
mg,O
Tablet,O
Sustained,O
Release,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
Sustained,O
Release,O
PO,O
DAILY,O
(,O
Daily,O
).,O

10.,O
Pantoprazole,B-TR
40,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
Q24H,O
(,O
every,O
24,O
hours,O
).,O

11.,O
Bisacodyl,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
once,O
a,O
day,O
as,O
needed,O
for,O
constipation,B-PR
.,O

12.,O
Vancomycin,B-TR
in,I-TR
Dextrose,I-TR
1,O
g,O
/,O
200,O
mL,O
Piggyback,O
Sig,O
:,O
One,O
(,O
1,O
),O
Intravenous,O
QHD,O
(,O
each,O
hemodialysis,B-TR
):,O
2,O
week,O
course,O
to,O
be,O
given,O
at,O
dialysis,O
",",O
last,O
day,O
2019-02-05,O
.,O

Disp,O
:*,O
qs,O
*,O
Refills,O
:*,O
2,O
*,O

13.,O
Aspirin,B-TR
81,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
once,O
a,O
day,O
.,O

14.,O
Humalog,B-TR
100,O
unit,O
/,O
mL,O
Solution,O
Sig,O
:,O
USE,O
AS,O
DIRECTED,O
Subcutaneous,O
four,O
times,O
a,O
day,O
:,O
please,O
use,O
attached,O
sliding,B-TR
scale,I-TR
.,O

Disp,O
:*,O
qs,O
*,O
Refills,O
:*,O
2,O
*,O

15.,O
Insulin,B-TR
NPH,I-TR
Human,I-TR
Recomb,I-TR
100,O
unit,O
/,O
mL,O
Suspension,O
Sig,O
:,O
2,O
UNITS,O
Subcutaneous,O
twice,O
a,O
day,O
.,O

Disp,O
:*,O
qs,O
*,O
Refills,O
:*,O
2,O
*,O

Discharge,O
Disposition,O
:,O

Home,O

Discharge,O
Diagnosis,O
:,O

primary,O
:,O

bacteremia,B-PR
02-08,O
PORT,B-PR
line,I-PR
infection,I-PR

hypertensive,B-PR
urgency,I-PR

diabetic,B-PR
gastropathy,I-PR

Discharge,O
Condition,O
:,O

stable,O
.,O

Discharge,O
Instructions,O
:,O

please,O
continue,O
to,O
take,O
all,O
of,O
your,B-TR
medications,I-TR
as,O
prescribed,O
.,O

you,O
were,O
started,O
on,O
a,O
2,O
week,O
course,O
of,O
vancomycin,B-TR
to,O
be,O
given,O
at,O
hemodialysis,B-TR
for,O
your,B-PR
line,I-PR
infection,I-PR
.,O

you,O
will,O
have,O
your,B-TR
PORT,I-TR
replaced,O
after,O
2,O
weeks,O
of,O
antibiotics,B-TR
if,O
your,B-TE
blood,I-TE
cultures,I-TE
remain,O
negative,O
.,O

if,O
you,O
have,O
recurrent,B-PR
fevers,I-PR
",",O
chills,B-PR
",",O
naseau,B-PR
",",O
vomitting,B-PR
",",O
chest,B-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
or,O
other,B-PR
worrisome,I-PR
symptoms,I-PR
",",O
please,O
contact,O
your,O
primary,O
care,O
physician,O
or,O
the,O
emergency,O
department,O
.,O

Followup,O
Instructions,O
:,O

please,O
follow,O
up,O
with,O
your,O
primary,O
care,O
doctor,O
within,O
4,O
weeks,O
.,O

please,O
follow-up,O
with,O
your,O
dialysis,O
physician,O
regarding,O
replacing,O
your,B-TR
PORT,I-TR
.,O

please,O
follow-up,O
with,O
dr.,O
Lillian,O
becker,O
in,O
gastroenterology,O
within,O
1-2,O
weeks,O
",",O
an,O
appointment,O
has,O
been,O
made,O
for,O
on,O
you,O
2019-02-11,O
at,O
3PM,O
.,O

(,O
447,O
),O
671-2034,O
(,O
Caldwell,O
building,O
",",O
1st,O
floor,O
",",O
1718,O
S.,O
Sixth,O
Blvd.,O
).,O

upon,O
arriving,O
home,O
please,O
contact,O
the,O
King,O
and,O
arrange,O
to,O
be,O
seen,O
within,O
1-2,O
weeks,O
.,O

Adam,O
Ruth,O
MD,O
61-358,O

Completed,O
by,O
:,O
Elwood,O
Edmond,O
MD,O
68-884,O
2019-01-31,O
@,O
1141,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Pamula,O
Pugh,O
on,O
:,O
Russell,O
2019-01-31,O
12:12,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2011-12-26,O

Discharge,O
Date,O
:,O

2012-01-26,O

Date,O
of,O
Birth,O
:,O

1958-04-03,O

Sex,O
:,O

F,O

Service,O
:,O

NOTE,O
:,O

This,O
is,O
an,O
addendum,O
to,O
the,O
discharge,O
summary,O
for,O
the,O
admission,O
starting,O
2012-01-05,O
.,O

The,O
patient,O
was,O
discharged,O
on,O
2012-01-26,O
.,O

ADDENDUM,O
HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
had,O
stage,B-PR
1,I-PR
sacral,I-PR
decubitus,I-PR
on,I-PR
her,I-PR
buttocks,I-PR
.,O

This,O
was,O
treated,O
with,O
wound,B-TR
care,I-TR
using,O
Eucerin,B-TR
cream,I-TR
and,O
also,O
patient,O
was,O
treated,O
with,O
lidocaine,B-TR
jelly,I-TR
for,O
pain,B-TR
control,I-TR
.,O

The,O
patient,O
was,O
seen,O
by,O
the,O
wound,O
care,O
nurse,O
and,O
the,B-PR
decubitus,I-PR
ulcer,I-PR
was,O
felt,O
to,O
be,O
mild,O
",",O
but,O
was,O
causing,O
the,O
patient,O
a,O
lot,O
of,O
discomfort,B-PR
and,O
the,O
wound,O
care,O
nurse,O
Ivy,O
Rose,O
lidocaine,B-TR
jelly,I-TR
.,O

With,O
regard,O
to,O
the,B-PR
patient,I-PR
's,I-PR
chronic,I-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
",",O
the,O
patient,O
's,O
respiratory,O
status,O
improved,O
throughout,O
the,O
remainder,O
of,O
her,O
hospital,O
course,O
.,O

The,O
patient,O
had,O
no,O
shortness,B-PR
of,I-PR
breath,I-PR
or,O
cough,B-PR
on,O
discharge,O
.,O

The,O
patient,O
was,O
oxygenating,O
well,O
on,O
her,B-TR
home,I-TR
O2,I-TR
dose,I-TR
of,O
2,O
liters,O
per,O
minute,O
.,O

The,O
patient,O
overall,O
continued,O
to,O
improve,O
",",O
but,O
remained,O
physically,B-PR
decompensated,I-PR
and,O
the,O
patient,O
was,O
transferred,O
to,O
Waltham/Weston,O
Hospital,O
Rehabilitation,O
Hospital,O
for,O
intensive,B-TR
physical,I-TR
therapy,I-TR
.,O

DISCHARGE,B-TR
MEDICATIONS,I-TR
are,O
the,O
same,O
with,O
the,O
addition,O
of,O
viscous,B-TR
lidocaine,I-TR
jelly,I-TR
to,O
be,O
applied,O
to,O
buttock,O
prn,O
and,O
viscous,B-TR
lidocaine,I-TR
swish,I-TR
and,I-TR
swallow,I-TR
tid,O
prn,O
before,O
meals,O
.,O

Timothy,O
E,O
Woolfolk,O
",",O
M.D.,O

18-858,O

Dictated,O
By,O
:,O
Robert,O
C.,O
Warren,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2012-01-26,O
09:56,O

T,O
:,O
2012-01-26,O
09:58,O

JOB,O
#:,O

48146,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Kevin,O
Arthur,O
on,O
:,O
Tony,O
2012-01-27,O
6:52,O
AM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2010-05-17,O

Discharge,O
Date,O
:,O

2010-05-29,O

Date,O
of,O
Birth,O
:,O

1923-11-09,O

Sex,O
:,O

F,O

Service,O
:,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
an,O
86-year-old,O
female,O
with,O
a,O
past,O
medical,O
history,O
of,O
diabetes,B-PR
and,O
hypertension,B-PR
who,O
presented,O
to,O
the,O
Emergency,O
Department,O
with,O
a,O
two,O
day,O
history,O
of,O
shortness,B-PR
of,I-PR
breath,I-PR
and,O
easy,B-PR
fatigability,I-PR
.,O

She,O
also,O
noted,O
increased,B-PR
dyspnea,I-PR
on,O
exertion,O
.,O

Prior,O
to,O
this,O
patient,O
could,O
walk,O
upstairs,O
but,O
now,O
cannot,O
.,O

She,O
denies,O
chest,B-PR
pain,I-PR
",",O
orthopnea,B-PR
",",O
paroxysmal,B-PR
nocturnal,I-PR
dyspnea,I-PR
.,O

However,O
",",O
the,O
patient,O
has,O
noted,O
some,B-PR
abdominal,I-PR
pain,I-PR
",",O
intermittent,O
times,O
a,O
couple,O
of,O
days,O
",",O
none,O
on,O
the,O
day,O
of,O
admission,O
.,O

Denied,O
nausea,B-PR
",",O
vomiting,B-PR
",",O
diaphoresis,B-PR
",",O
bowel,B-PR
movement,I-PR
changes,I-PR
.,O

She,O
has,O
noted,O
increased,B-PR
urinary,I-PR
frequency,I-PR
.,O

Denies,O
fever,B-PR
or,O
chills,B-PR
.,O

Of,O
note,O
",",O
she,O
has,O
had,O
recent,B-TR
medication,I-TR
changes,I-TR
which,O
included,O
discontinuing,O
Diovan,B-TR
and,O
starting,O
terazosin,B-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Diabetes,B-PR
mellitus,I-PR
.,O

2.,O
Hypertension,B-PR
.,O

3.,O
Osteoarthritis,B-PR
.,O

4.,O
_______________,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

HOME,O
MEDICATIONS,O
:,O

1.,O
Aspirin,B-TR
325,O
mg,O
p.o.,O
q.,O
day,O
.,O

2.,O
Norvasc,B-TR
10,O
mg,O
p.o.,O
q.,O
day,O
.,O

3.,O
Isosorbide,B-TR
mononitrate,I-TR
30,O
q.,O
day,O
.,O

4.,O
Terazosin,B-TR
1,O
mg,O
p.o.,O
q.,O
day,O
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
lives,O
alone,O
.,O

Has,O
a,O
remote,O
tobacco,O
history,O
.,O

No,O
ethanol,O
.,O

FAMILY,O
HISTORY,O
:,O

Positive,O
for,O
diabetes,B-PR
.,O

No,O
coronary,B-PR
artery,I-PR
disease,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,O
",",O
blood,B-TE
pressure,I-TE
151/61,O
",",O
heart,B-TE
rate,I-TE
75,O
",",O
SaO2,B-TE
93%,O
on,O
room,O
air,O
.,O

In,O
general,O
",",O
patient,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

Speaks,O
in,O
full,O
sentences,O
.,O

Neck,O
:,O

Jugular,B-TE
venous,I-TE
pressure,I-TE
notable,O
at,O
the,O
mid,O
neck,O
upright,O
about,O
80,O
degree,O
angles,O
.,O

Cardiovascular,O
regular,O
rate,O
and,O
rhythm,O
with,O
a,B-PR
1-2/6,I-PR
holosystolic,I-PR
murmur,I-PR
.,O

Pulmonary,O
:,O

Crackles,B-PR
bilaterally,I-PR
one-third,O
to,O
one-half,O
the,O
way,O
up,O
.,O

Abdomen,O
:,O

Bowel,B-TE
sounds,I-TE
positive,O
",",O
soft,O
",",O
non-tender,B-PR
",",O
non-distended,B-PR
.,O

Extremities,O
:,O

1+,B-PR
lower,I-PR
extremity,I-PR
edema,I-PR
.,O

LABORATORIES,O
ON,O
ADMISSION,O
:,O

Included,O
normal,O
CBC,O
",",O
BUN,B-TE
47,O
",",O
creatinine,B-TE
2.4,O
up,O
from,O
baseline,O
of,O
about,O
1.5,O
.,O

Troponin,B-TE
4.7,O
",",O
CK,B-TE
101,O
",",O
MB,B-TE
3,O
.,O

RADIOLOGY,O
:,O

Chest,B-TE
x-ray,I-TE
showed,O
patient,O
was,O
in,O
congestive,B-PR
heart,I-PR
failure,I-PR
.,O

ELECTROCARDIOGRAM,B-TE
:,O

Showed,O
normal,O
sinus,O
rhythm,O
at,O
107,O
beats,O
per,O
minute,O
with,O
left,B-PR
axis,I-PR
deviation,I-PR
and,O
poor,B-PR
R-wave,I-PR
progression,I-PR
.,O

However,O
",",O
no,O
acute,B-PR
changes,I-PR
were,O
apparent,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
Cardiac,O
Medicine,O
Service,O
and,O
treated,O
for,O
presumed,O
diastolic,B-PR
and,I-PR
systolic,I-PR
dysfunction,I-PR
.,O

Echocardiogram,B-TE
was,O
obtained,O
which,O
showed,O
moderately,B-PR
depressed,I-PR
left,I-PR
ventricular,I-PR
systolic,I-PR
function,I-PR
as,O
well,O
as,O
hypokinesis,B-PR
of,I-PR
the,I-PR
lower,I-PR
half,I-PR
of,I-PR
septum,I-PR
and,I-PR
apex,I-PR
.,O

Also,O
of,O
note,O
was,O
the,B-PR
distal,I-PR
lateral,I-PR
wall,I-PR
hypokinesis,I-PR
.,O

The,B-PR
wall,I-PR
motion,I-PR
abnormalities,I-PR
were,O
noted,O
to,O
be,O
new,O
.,O

It,O
was,O
believed,O
that,O
a,B-TE
troponin,I-TE
on,O
admission,O
in,O
addition,O
to,O
the,B-PR
wall,I-PR
motion,I-PR
abnormalities,I-PR
she,O
underwent,O
a,B-PR
non-Q,I-PR
wave,I-PR
myocardial,I-PR
infarction,I-PR
prior,O
to,O
resulted,O
in,O
her,B-PR
current,I-PR
cardiac,I-PR
failure,I-PR
.,O

Throughout,O
hospital,O
course,O
patient,B-TE
's,I-TE
troponin,I-TE
trended,O
down,O
to,O
less,O
than,O
0.3,O
.,O

Heart,O
Failure,O
Service,O
was,O
involved,O
.,O

She,O
was,O
continued,O
with,O
aggressive,B-TR
diuresis,I-TR
.,O

She,O
was,O
started,O
on,O
_________,O
with,O
excellent,O
diuresis,O
",",O
however,O
",",O
her,B-PR
renal,I-PR
functioning,I-PR
worsening,I-PR
.,O

A,B-TE
cardiac,I-TE
catheterization,I-TE
was,O
deferred,O
until,O
the,B-PR
renal,I-PR
issue,I-PR
could,O
be,O
resolved,O
.,O

However,O
",",O
her,B-TE
creatinine,I-TE
continued,O
to,O
increase,O
.,O

Diuresis,B-TR
was,O
halted,O
and,O
without,O
improvement,O
in,O
creatinine,B-TE
.,O

Renal,O
was,O
consulted,O
.,O

A,B-TE
renal,I-TE
ultrasound,I-TE
was,O
obtained,O
.,O

It,O
showed,O
a,B-TE
right,I-TE
kidney,I-TE
size,I-TE
of,O
6.3,O
cm,O
and,O
a,B-TE
left,I-TE
kidney,I-TE
size,I-TE
of,O
8.4,O
cm,O
.,O

Given,O
her,B-PR
hypertension,I-PR
which,O
was,O
very,O
difficult,O
to,O
control,O
",",O
it,O
was,O
felt,O
that,O
she,O
had,O
renal,B-PR
artery,I-PR
stenosis,I-PR
and,O
thus,O
she,O
underwent,O
MRA,B-TE
of,I-TE
the,I-TE
kidney,I-TE
which,O
showed,O
severe,B-PR
right,I-PR
renal,I-PR
artery,I-PR
stenosis,I-PR
at,I-PR
its,I-PR
origin,I-PR
.,O

There,O
was,O
also,O
moderate,B-PR
to,I-PR
severe,I-PR
focal,I-PR
stenosis,I-PR
of,I-PR
the,I-PR
left,I-PR
renal,I-PR
artery,I-PR
approximately,O
1.3,O
cm,O
from,O
its,O
origin,O
.,O

Dr.,O
______________,O
consulted,O
on,O
the,O
case,O
.,O

She,O
was,O
transferred,O
to,O
the,O
unit,O
overnight,O
to,O
assess,O
volume,B-TE
which,O
was,O
noted,O
to,O
be,O
optimal,O
.,O

On,O
05-25,O
she,O
underwent,O
catheterization,B-TE
and,O
subsequent,B-TR
stenting,I-TR
of,I-TR
the,I-TR
left,I-TR
renal,I-TR
artery,I-TR
.,O

Due,O
to,O
dye,B-TR
load,I-TR
required,O
to,O
assess,O
the,B-PR
coronary,I-PR
disease,I-PR
were,O
not,O
visualized,O
.,O

After,O
the,B-TR
procedure,I-TR
the,O
patient,O
did,O
well,O
.,O

However,O
",",O
her,B-TE
creatinine,I-TE
has,O
worsened,B-PR
up,O
to,O
4.2,O
.,O

However,O
",",O
her,B-TE
urine,I-TE
output,I-TE
has,O
improved,O
.,O

She,O
has,O
not,O
required,O
hemodialysis,B-TR
at,O
this,O
time,O
.,O

She,O
will,O
need,O
close,O
follow,O
up,O
of,O
her,O
renal,O
functioning,O
.,O

The,O
patient,O
is,O
discharged,O
to,O
an,O
extended,O
discharge,O
facility,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Non-Q,B-PR
wave,I-PR
myocardial,I-PR
infarction,I-PR
.,O

2.,O
Systolic,B-PR
and,I-PR
diastolic,I-PR
congestive,I-PR
heart,I-PR
failure,I-PR
.,O

3.,O
Bilateral,B-PR
renal,I-PR
artery,I-PR
stenosis,I-PR
status,O
post,O
stent,B-TR
left,I-TR
renal,I-TR
artery,I-TR
.,O

4.,O
Acute,B-PR
renal,I-PR
failure,I-PR
.,O

5.,O
Hypertension,B-PR
.,O

FOLLOW,O
UP,O
:,O

She,O
is,O
to,O
follow,O
up,O
with,O
her,O
primary,O
care,O
physician,O
in,O
one,O
week,O
.,O

She,O
is,O
to,O
follow,O
up,O
Heart,O
Failure,O
and,O
Cardiology,O
in,O
one,O
week,O
as,O
well,O
.,O

In,O
addition,O
",",O
patient,O
is,O
to,O
have,O
her,O
own,O
appointment,O
with,O
Podiatry,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Aspirin,B-TR
325,O
mg,O
p.o.,O
q.,O
day,O
.,O

2.,O
Norvasc,B-TR
10,O
mg,O
p.o.,O
q.,O
day,O
.,O

3.,O
Atorvastatin,B-TR
10,O
mg,O
p.o.,O
q.,O
day,O
.,O

4.,O
Protonix,B-TR
20,O
mg,O
p.o.,O
q.,O
day,O
.,O

5.,O
Multivitamin,B-TR
one,O
p.o.,O
q.,O
day,O
.,O

6.,O
Carvedilol,B-TR
3.125,O
p.o.,O
b.i.d.,O

7.,O
___________,O
dinitrate,B-TR
20,O
mg,O
p.o.,O
t.i.d.,O

8.,O
Erythropoietin,B-TR
"10,000",O
units,O
two,O
times,O
a,O
week,O
Tuesday,O
and,O
Saturday,O
.,O

9.,O
Calcium,B-TR
acetate,I-TR
Tums,I-TR
one,O
p.o.,O
t.i.d.,O
with,O
meals,O
.,O

10.,O
Tylenol,B-TR
325,O
mg,O
p.o.,O
q.,O
4-6,O
h.,O
p.r.n.,O

11.,O
Iron,B-TR
sulfate,I-TR
325,O
mg,O
p.o.,O
q.,O
day,O
.,O

12.,O
Colace,B-TR
100,O
mg,O
p.o.,O
b.i.d.,O

13.,O
Hydralazine,B-TR
10,O
mg,O
p.o.,O
q.,O
6h.,O

14.,O
Plavix,B-TR
75,O
mg,O
p.o.,O
q.,O
day,O
times,O
30,O
days,O
.,O

Kathy,O
Tillis,O
",",O
M.D.,O

85-987,O

Dictated,O
By,O
:,O
John,O
V.E.,O
Jameson,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2010-05-27,O
14:29,O

T,O
:,O
2010-05-27,O
14:10,O

JOB,O
#:,O

80987,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Kathy,O
Tillis,O
on,O
:,O
MON,O
2010-06-07,O
4:00,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2017-08-12,O

Discharge,O
Date,O
:,O

2017-08-16,O

Date,O
of,O
Birth,O
:,O

1995-02-03,O

Sex,O
:,O

F,O

Service,O
:,O
SURGERY,O

Allergies,O
:,O

Shellfish,O

Attending,O
:,O
Maria,O
X,O
White,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Motor,O
vehicle,O
accident,O

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

None,O

History,O
of,O
Present,O
Illness,O
:,O

22,O
year,O
old,O
female,O
transfer,O
from,O
outside,O
hospital,O
after,O
a,O
motor,O
vehicle,O
accident,O
with,O
diagnosed,B-PR
liver,I-PR
laceration,I-PR
by,O
CT,B-TE
scan,I-TE
.,O

Past,O
Medical,O
History,O
:,O

None,O

Social,O
History,O
:,O

Social,O
alcohol,O

Family,O
History,O
:,O

Non,O
pertinent,O
to,O
admission,O

Physical,O
Exam,O
:,O

Patient,O
was,O
alert,O
",",O
oriented,O
x3,O
.,O

Neck,O
with,O
cervical,B-TR
collar,I-TR
.,O

Left,B-PR
forarm,I-PR
and,I-PR
right,I-PR
knee,I-PR
abrasions,I-PR
.,O

Chest,O
clear,O
to,O
auscultation,B-TE
bilateral,O
",",O
S1,O
S2,O
normal,O
and,O
with,O
no,O
murmors,B-PR
.,O

Abdominal,B-PR
pain,I-PR
predominally,O
on,O
the,O
right,O
upper,O
quadrant,O
",",O
no,O
signs,O
of,O
peritoneal,B-PR
irritation,I-PR
.,O

Pertinent,O
Results,O
:,O

2017-08-12,O
23:41,O

GLUCOSE,B-TE
-,O
74,O
UREA,B-TE
N,I-TE
-,O
9,O
CREAT,B-TE
-,O
0.7,O
SODIUM,B-TE
-,O
139,O
POTASSIUM,B-TE
-,O
3.5,O
CHLORIDE,B-TE
-,O
106,O
TOTAL,B-TE
CO2,I-TE
-,O
23,O
ANION,B-TE
GAP,I-TE
-,O
14,O

2017-08-12,O
11:41PM,O

ALT(SGPT),B-TE
-,O
241,O
*,O
AST(SGOT),B-TE
-,O
207,O
*,O
ALK,B-TE
PHOS,I-TE
-,O
51,O
TOT,B-TE
BILI,I-TE
-,O
0.8,O

2017-08-12,O
23:41,O

CALCIUM,B-TE
-,O
8.2,O
*,O
PHOSPHATE,B-TE
-,O
3.1,O
MAGNESIUM,B-TE
-,O
2.2,O

2017-08-12,O
15:15,O

GLUCOSE,B-TE
-,O
75,O
UREA,B-TE
N,I-TE
-,O
10,O
CREAT,B-TE
-,O
0.6,O
SODIUM,B-TE
-,O
137,O
POTASSIUM,B-TE
-,O
3.7,O
CHLORIDE,B-TE
-,O
103,O
TOTAL,B-TE
CO2,I-TE
-,O
23,O
ANION,B-TE
GAP,I-TE
-,O
15,O

2017-08-12,O
15:15,O

ALT(SGPT),B-TE
-,O
318,O
*,O
AST(SGOT),B-TE
-,O
307,O
*,O
ALK,B-TE
PHOS,I-TE
-,O
61,O
TOT,B-TE
BILI,I-TE
-,O
0.9,O

2017-08-12,O
15:15,O

WBC,B-TE
-,O
8.3,O
RBC,B-TE
-,O
3.64,O
*,O
HGB,B-TE
-,O
12.6,O
HCT,B-TE
-,O
36.1,O
MCV,B-TE
-,O
99,O
*,O
MCH,B-TE
-,O
34.7,O
*,O
MCHC,B-TE
-,O
35.0,O
RDW,B-TE
-,O
12.4,O

2017-08-12,O
15:15,O

PT,B-TE
-,O
11.6,O
PTT,B-TE
-,O
26.0,O
INR(PT),B-TE
-,O
0.9,O

Brief,O
Hospital,O
Course,O
:,O

Patient,O
was,O
admited,O
",",O
pain,B-PR
was,O
managed,O
with,O
a,B-TR
PCA,I-TR
and,O
later,O
with,O
PO,B-TR
medication,I-TR
.,O

The,B-PR
liver,I-PR
laceration,I-PR
was,O
stable,O
",",O
no,O
sign,O
of,O
rupture,B-PR
or,O
further,B-PR
complication,I-PR
",",O
did,O
not,O
required,O
surgical,B-TR
managment,I-TR
.,O

The,B-TE
liver,I-TE
enzimes,I-TE
come,O
down,O
",",O
no,O
signs,O
of,O
biliary,B-PR
stasis,I-PR
.,O

She,O
was,O
able,O
to,O
tolerate,O
diet,O
",",O
ambulate,O
",",O
having,O
a,O
bowel,O
movement,O
and,O
dischargo,O
home,O
in,O
good,O
conditions,O
.,O

Medications,O
on,O
Admission,O
:,O

None,O

Discharge,O
Medications,O
:,O

1.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
for,O
4,O
days,O
.,O

Disp,O
:*,O
8,O
Capsule,O
(s)*,O
Refills,O
:*,O
0,O
*,O

2.,O
Hydromorphone,B-TR
2,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q2H,O
(,O
every,O
2,O
hours,O
),O
as,O
needed,O
for,O
Pain,B-PR
for,O
4,O
days,O
.,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

Discharge,O
Disposition,O
:,O

Home,O

Discharge,O
Diagnosis,O
:,O

Motor,O
vehicle,O
accident,O

Discharge,O
Condition,O
:,O

Good,O

Discharge,O
Instructions,O
:,O

-,O
Call,O
for,O
appointment,O
to,O
(,O
289,O
),O
411-5387,O
for,O
the,O
Trauma,O
Clinic,O
and,O
Abdominal,B-TE
CT,I-TE
scan,I-TE
of,I-TE
the,I-TE
Abdomen,I-TE
in,O
4,O
weeks,O

Followup,O
Instructions,O
:,O

-,O
Trauma,O
Surgery,O
Clinic,O
in,O
four,O
weeks,O
with,O
CT,B-TE
abdomen,I-TE
results,O
.,O

Call,O
Trauma,O
Clinic,O
to,O
coordinate,O
the,B-TE
study,I-TE
",",O
result,O
and,O
appointment,O
dates,O
((,O
289,O
),O
411-5387,O
).,O

Ida,O
Doris,O
MD,O
79-274,O

Completed,O
by,O
:,O
Jane,O
Ashmore,O
MD,O
50-063,O
2017-08-16,O
@,O
0950,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Jennifer,O
Green,O
on,O
:,O
FRI,O
2017-09-01,O
1:04,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2009-05-01,O

Discharge,O
Date,O
:,O

Date,O
of,O
Birth,O
:,O

1969-05-19,O

Sex,O
:,O

M,O

Service,O
:,O

Surgery,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
39,O
year-old,O
gentleman,O
admitted,O
on,O
2009-05-01,O
to,O
the,O
Jewish,O
Memorial,O
Hospital,O
referred,O
from,O
South,O
Cove,O
Community,O
Health,O
Center,O
.,O

He,O
is,O
a,O
39,O
year-old,O
gentleman,O
with,O
hyperlipidemia,B-PR
and,O
smoking,O
who,O
presented,O
with,O
acute,O
onset,O
of,O
chest,B-PR
pain,I-PR
since,O
five,O
in,O
the,O
morning,O
with,O
radiation,O
to,O
the,O
left,O
arm,O
and,O
nausea,B-PR
.,O

Symptoms,B-PR
resolved,O
spontaneously,O
.,O

He,O
was,O
taken,O
to,O
the,O

Cath,O
Lab,O
at,O
the,O
Pinewood,O
",",O
Norfolk,O
that,O
evening,O
where,O
a,B-TR
stent,I-TR
procedure,I-TR
to,I-TR
the,I-TR
RCA,I-TR
was,O
complicated,O
by,O
guidewire,O
entrapment,O
inside,O
of,O
a,B-TR
stent,I-TR
requiring,O
CT,B-TR
surgery,I-TR
to,O
do,O
a,B-TR
thoracotomy,I-TR
with,O
bypass,B-TR
and,O
excision,B-TR
of,I-TR
the,I-TR
wire,I-TR
.,O

The,O
case,O
was,O
complicated,O
by,O
an,O
episode,O
of,O
coffee,B-PR
ground,I-PR
emesis,I-PR
and,O
a,B-PR
bleed,I-PR
from,I-PR
femoral,I-PR
access,I-PR
site,I-PR
prior,O
to,O
CT,B-TR
surgery,I-TR
.,O

Gastroenterology,O
was,O
consulted,O
and,O
they,O
recommended,O
Protonix,B-TR
and,O
felt,O
it,O
was,O
due,O
to,O
peptic,B-PR
ulcer,I-PR
disease,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Hepatitis,B-PR
B,I-PR
.,O

2.,O
Hypercholesterolemia,B-PR
.,O

3.,O
Fatty,B-PR
liver,I-PR
resolved,O
.,O

MEDICATIONS,O
AT,O
HOME,O
:,O

Relatively,O
unknown,O
other,O
than,O
Lipitor,B-TR
.,O

ALLERGIES,O
:,O
He,O
had,O
no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

He,O
smokes,O
one,O
pack,O
per,O
day,O
.,O

He,O
works,O
as,O
a,O
jeweler,O
.,O

He,O
lives,O
at,O
home,O
with,O
his,O
wife,O
.,O

FAMILY,O
HISTORY,O
:,O
Not,O
significant,O
for,O
coronary,B-PR
artery,I-PR
disease,I-PR
.,O

Please,O
note,O
the,O
patient,O
is,O
only,O
Caucasian,O
speaking,O
and,O
information,O
is,O
second,O
hand,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
diagnosed,O
as,O
having,O
an,B-PR
acute,I-PR
myocardial,I-PR
infarction,I-PR
.,O

The,O
patient,O
was,O
taken,O
emergently,O
to,O
the,O
operating,O
room,O
on,O
2009-05-02,O
for,O
his,B-TR
CABG,I-TR
",",O
right,B-TR
coronary,I-TR
endarterectomy,I-TR
",",O
removal,B-TR
of,I-TR
RCA,I-TR
stents,I-TR
and,O
retrieval,B-TR
of,I-TR
the,I-TR
aortic,I-TR
guidewire,I-TR
.,O

Postoperatively,O
he,O
did,O
well,O
and,O
was,O
transferred,O
to,O
the,O
Cardiac,O
Surgery,O
Intensive,O
Care,O
Unit,O
where,O
he,O
was,O
on,O
pressor,B-TR
support,I-TR
of,O
Neo-Synephrine,B-TR
and,O
he,O
was,O
extubated,O
.,O

The,O
patient,O
slowly,O
weaned,O
off,O
Neo-Synephrine,B-TR
as,O
tolerated,O
.,O

He,O
was,O
transferred,O
to,O
the,O
floor,O
on,O
2009-05-04,O
.,O

His,B-TR
chest,I-TR
tube,I-TR
had,O
been,O
discontinued,O
.,O

Upon,O
arrival,O
to,O
the,O
floor,O
the,B-TR
patient,I-TR
's,I-TR
wires,I-TR
were,O
discontinued,O
on,O
2009-05-05,O
and,O
his,B-TR
Foley,I-TR
catheter,I-TR
was,O
discontinued,O
.,O

The,O
patient,O
was,O
seen,O
by,O
Physical,O
Therapy,O
.,O

His,B-TE
electrolytes,I-TE
were,O
repleted,O
and,O
the,O
patient,O
was,O
discharged,O
home,O
on,O
2009-05-06,O
after,O
tolerating,O
a,O
level,O
V,O
.,O

MEDICATIONS,O
:,O
His,B-TR
prescriptions,I-TR
shall,O
include,O

1.,O
Lopressor,B-TR
25,O
milligrams,O
po,O
bid,O
.,O

2.,O
Lipitor,B-TR
20,O
milligrams,O
po,O
q,O
HS,O
.,O

3.,O
Niferex,B-TR
150,O
milligrams,O
caplet,O
one,O
cap,O
per,O
day,O
.,O

4.,O
Protonix,B-TR
40,O
milligrams,O
po,O
q,O
day,O
.,O

5.,O
Colace,B-TR
100,O
milligrams,O
po,O
bid,O
.,O

6.,O
Percocet,B-TR
one,O
to,O
two,O
tablets,O
q,O
four,O
H,O
prn,O
for,O
pain,B-PR
.,O

He,O
will,O
get,O
60,O
of,O
those,O
.,O

7.,O
Plavix,B-TR
75,O
milligrams,O
po,O
q,O
day,O
times,O
three,O
months,O
.,O

8.,O
Aspirin,B-TR
325,O
milligrams,O
po,O
q,O
day,O
.,O

9.,O
Lasix,B-TR
20,O
milligrams,O
po,O
times,O
30,O
days,O
.,O

10.,O
KCL,B-TR
20,O
milliequivalents,O
po,O
q,O
d,O
times,O
three,O
days,O
.,O

DISCHARGE,O
FOLLOW,O
UP,O
:,O
The,O
patient,O
is,O
to,O
follow,O
up,O
with,O
Dr.,O
Debra,O
Oneal,O
",",O
his,O
PCP,O
and,O
his,O
cardiologist,O
in,O
3,O
weeks,O
.,O

Saul,O
N.,O
Keehne,O
",",O
M.D.,O

Dictated,O
By,O
:,O
Shirley,O
Y,O
Waler,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2009-05-06,O
11:12,O

T,O
:,O
2009-05-06,O
11:34,O

JOB,O
#:,O

20629,O

Signed,O
electronically,O
by,O
:,O
DR.,O
William,O
Spencer,O
on,O
:,O
WED,O
2009-05-06,O
12:20,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2012-01-20,O

Discharge,O
Date,O
:,O

2012-01-23,O

Date,O
of,O
Birth,O
:,O

1947-09-21,O

Sex,O
:,O

M,O

Service,O
:,O

UROLOGY,O

PREOPERATIVE,O
DIAGNOSIS,O
:,O

Prostate,B-PR
cancer,I-PR
.,O

ADMITTING,O
DIAGNOSIS,O
:,O

Status,O
post,O
radical,B-TR
retropubic,I-TR
prostatectomy,I-TR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
64,O
year,O
old,O
gentleman,O
with,O
a,O
history,O
of,O
elevated,B-PR
PSA,I-PR
",",O
prostate,B-PR
cancer,I-PR
.,O

He,O
was,O
diagnosed,O
with,O
needle,B-TE
biopsy,I-TE
on,O
either,O
side,O
of,O
the,O
prostate,O
with,O
3+3,O
equals,O
6,O
on,O
the,O
right,O
side,O
and,O
3+4,O
equals,O
7,O
on,O
the,O
left,O
side,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
underwent,O
radical,B-TR
retropubic,I-TR
prostatectomy,I-TR
on,O
2012-01-20,O
.,O

Dr.,O
Marie,O
Anderson,O
performed,O
the,B-TR
surgery,I-TR
.,O

The,O
patient,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
.,O

On,O
postoperative,O
day,O
number,O
one,O
",",O
he,O
was,O
administered,O
1,B-TR
mg,I-TR
Coumadin,I-TR
per,O
protocol,O
as,O
well,O
as,O
on,O
the,O
operative,O
day,O
1,O
mg,O
of,O
Coumadin,B-TR
.,O

The,O
patient,O
was,O
advanced,O
to,O
regular,O
diet,O
on,O
postoperative,O
day,O
one,O
.,O

His,B-TE
laboratories,I-TE
were,O
checked,O
and,O
his,B-TE
hematocrit,I-TE
was,O
noted,O
to,O
be,O
stable,O
.,O

He,O
was,O
made,O
to,O
ambulate,O
on,O
postoperative,O
day,O
one,O
.,O

His,B-PR
pain,I-PR
was,O
well,O
controlled,O
with,O
oral,B-TR
medication,I-TR
at,O
this,O
time,O
.,O

On,O
postoperative,O
day,O
two,O
",",O
he,O
continued,O
to,O
convalesce,O
as,O
planned,O
.,O

His,B-TR
intravenous,I-TR
fluids,I-TR
were,O
discontinued,O
at,O
this,O
time,O
.,O

He,O
was,O
on,O
a,O
house,O
diet,O
and,O
tolerating,O
it,O
well,O
at,O
this,O
time,O
as,O
well,O
.,O

His,B-TR
Penrose,I-TR
drain,I-TR
was,O
discontinued,O
at,O
this,O
time,O
.,O

He,O
was,O
ready,O
for,O
discharge,O
home,O
on,O
postoperative,O
day,O
three,O
.,O

He,O
was,O
discharged,O
home,O
with,O
a,B-TR
Foley,I-TR
catheter,I-TR
and,O
he,O
will,O
follow-up,O
with,O
Dr.,O
Ross,O
in,O
one,O
to,O
two,O
weeks,O
.,O

COMPLICATIONS,O
DURING,O
STAY,O
:,O

None,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
.,O

DISCHARGE,O
STATUS,O
:,O

To,O
home,O
.,O

Terry,O
CR,O
Dennis,O
",",O
M.D.,O

68-233,O

Dictated,O
By,O
:,O
Tracy,O
C,O
Rea,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2012-04-28,O
17:18,O

T,O
:,O
2012-05-01,O
20:32,O

JOB,O
#:,O

21454,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Antonio,O
Hall,O
on,O
:,O
FRI,O
2012-05-04,O
7:48,O
AM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2014-10-21,O

Discharge,O
Date,O
:,O

2014-11-21,O

Date,O
of,O
Birth,O
:,O

1942-03-10,O

Sex,O
:,O

M,O

Service,O
:,O
SURGERY,O

Allergies,O
:,O

Iodine,B-TR
;,O
Iodine,B-TR
Containing,I-TR

Attending,O
:,O
Dona,O
J.,O
O.,O
Anderson,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

s/p,O
Fall,O

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

Tracheostomy,B-TR
2014-11-11,O

Bronchoscopy,B-TE
2014-11-05,O

Past,O
Medical,O
History,O
:,O

Atrial,B-PR
fibrillation,I-PR
(,O
on,O
Coumadin,B-TR
),O

Coronary,B-PR
Artery,I-PR
Disease,I-PR

Ulcerative,B-PR
Colitis,I-PR
w/,O
colostomy,B-TR

Hypertension,B-PR

Pacemaker,B-TR

CVA,B-PR
2012,O
w/,O
right,B-PR
sided,I-PR
weakness,I-PR

Cataracts,B-PR
",",O
s/p,O
cataract,B-TR
surgery,I-TR

s/p,O
TURP,B-TR

Social,O
History,O
:,O

Lives,O
with,O
wife,O
;,O
+ETOH,O
use,O

Family,O
History,O
:,O

Noncontributory,O

Pertinent,O
Results,O
:,O

2014-10-21,O
20:10,O

GLUCOSE,B-TE
-,O
126,O
*,O
UREA,B-TE
N,I-TE
-,O
9,O
CREAT,B-TE
-,O
0.8,O
SODIUM,B-TE
-,O
135,O
POTASSIUM,B-TE
-,O
3.4,O
CHLORIDE,B-TE
-,O
99,O
TOTAL,B-TE
CO2,I-TE
-,O
25,O
ANION,B-TE
GAP,I-TE
-,O
14,O

2014-10-21,O
20:10,O

CALCIUM,B-TE
-,O
8.2,O
*,O
PHOSPHATE,B-TE
-,O
2.1,O
*,O
MAGNESIUM,B-TE
-,O
1.9,O

2014-10-21,O
20:10,O

WBC,B-TE
-,O
6.5,O
RBC,B-TE
-,O
3.68,O
*,O
HGB,B-TE
-,O
11.6,O
*,O
HCT,B-TE
-,O
32.5,O
*,O
MCV,B-TE
-,O
88,O
MCH,B-TE
-,O
31.5,O
MCHC,B-TE
-,O
35.6,O
*,O
RDW,B-TE
-,O
13.6,O

2014-10-21,O
20:10,O

PLT,B-TE
COUNT,I-TE
-,O
207,O

2014-10-21,O
20:10,O

PT,B-TE
-,O
15.0,O
*,O
PTT,B-TE
-,O
31.3,O
INR(PT),B-TE
-,O
1.5,O

2014-10-21,O
14:56,O

TYPE,O
-,O
ART,O
TEMP,B-TE
-,O
36.6,O
RATES,B-TE
-,O
14,O
/,O
TIDAL,B-TE
VOL,I-TE
-,O
550,O
PEEP,B-TR
-,O
5,O
O2,B-TR
-,O
100,O
PO2,B-TE
-,O
416,O
*,O
PCO2,B-TE
-,O
39,O
PH,B-TE
-,O
7.41,O
TOTAL,B-TE
CO2,I-TE
-,O
26,O
BASE,B-TE
XS,I-TE
-,O
0,O
AADO2,B-TE
-,O
279,O
REQ,B-TE
O2,I-TE
-,O
52,O
-,O
ASSIST,O
/,O
CON,O
INTUBATED,O
-,O
INTUBATED,O

2014-10-21,O
9:35,O

ASA,B-TE
-,O
NEG,O
ETHANOL,B-TE
-,O
NEG,O
ACETMNPHN,B-TE
-,O
NEG,O
bnzodzpn,B-TE
-,O
NEG,O
barbitrt,B-TE
-,O
NEG,O
tricyclic,B-TE
-,O
NEG,O

2014-10-21,O
09:35,O
AM,O
URINE,B-TE

bnzodzpn,B-TE
-,O
NEG,O
barbitrt,B-TE
-,O
NEG,O
opiates,B-TE
-,O
NEG,O
cocaine,B-TE
-,O
NEG,O
amphetmn,B-TE
-,O
NEG,O
mthdone,B-TE
-,O
NEG,O

CT,B-TE
C,I-TE
-,I-TE
SPINE,I-TE
W/O,I-TE
CONTRAST,I-TE

2014-10-21,O
9:59,O

CT,B-TE
C,I-TE
-,I-TE
SPINE,I-TE
W/O,I-TE
CONTRAST,I-TE
;,O
CT,O
RECONSTRUCTION,O

Reason,O
:,O
72,O
male,O
s/p,O
fall,O
down,O
20,O
stairs,O

UNDERLYING,O
MEDICAL,O
CONDITION,O
:,O

72,O
year,O
old,O
man,O
with,O

REASON,O
FOR,O
THIS,O
EXAMINATION,O
:,O

72,O
male,O
s/p,O
fall,O
down,O
20,O
stairs,O

CONTRAINDICATIONS,O
for,O
IV,O
CONTRAST,O
:,O
None,O
.,O

INDICATIONS,O
:,O
Fall,O
down,O
20,O
stairs,O
.,O

TECHNIQUE,O
:,O
Noncontrast,B-TE
cervical,I-TE
spine,I-TE
CT,I-TE
.,O

COMPARISON,O
:,O
None,O
.,O

NOTE,O
:,O
This,B-TE
study,I-TE
was,O
initially,O
performed,O
on,O
2014-10-21,O
.,O

Findings,O
were,O
discussed,O
with,O
Dr.,O
Leanne,O
Vazquez,O
at,O
the,O
time,O
this,B-TE
study,I-TE
was,O
performed,O
",",O
but,O
the,B-TE
study,I-TE
was,O
not,O
dictated,O
until,O
the,O
morning,O
of,O
2014-10-22,O
",",O
due,O
to,O
PACS,O
malfunction,O
.,O

NONCONTRAST,B-TE
CERVICAL,I-TE
SPINE,I-TE
CT,I-TE
:,O
There,O
are,O
minimally,B-PR
displaced,I-PR
and,I-PR
comminuted,I-PR
fractures,I-PR
through,I-PR
the,I-PR
left,I-PR
C7,I-PR
and,I-PR
T1,I-PR
transverse,I-PR
processes,I-PR
.,O

The,O
margins,O
do,O
not,O
appear,O
to,O
extend,O
into,O
the,O
foramina,O
transversaria,O
.,O

Positioning,O
limits,O
assessment,B-TE
of,I-TE
alignment,I-TE
due,O
to,O
extreme,B-PR
head,I-PR
tilting,I-PR
to,I-PR
the,I-PR
right,I-PR
",",O
but,O
this,O
is,O
likely,O
the,O
best,O
obtainable,O
secondary,O
to,O
intubation,B-TR
and,O
nasogastric,B-TR
tube,I-TR
placement,I-TR
.,O

Allowing,O
for,O
the,O
limitations,O
",",O
the,O
vertebral,O
bodies,O
are,O
normal,O
in,O
height,O
and,O
normally,O
aligned,O
.,O

There,O
is,O
no,O
atlantoaxial,B-PR
subluxation,I-PR
.,O

The,O
lateral,O
masses,O
of,O
C1,O
articulate,O
normally,O
about,O
the,O
odontoid,O
process,O
.,O

Prevertebral,B-PR
soft,I-PR
tissue,I-PR
swelling,I-PR
cannot,O
be,O
excluded,O
secondary,O
to,O
intubation,B-TR
.,O

Extensive,B-PR
carotid,I-PR
arterial,I-PR
calcifications,I-PR
are,O
present,O
in,O
the,O
bulb,O
regions,O
bilaterally,O
.,O

Biapical,B-PR
lung,I-PR
scarring,I-PR
and,O
mild,B-PR
bronchiectasis,I-PR
are,O
present,O
.,O

Also,O
noted,O
is,O
sclerosis,B-PR
and,O
opacification,B-PR
of,I-PR
the,I-PR
visualized,I-PR
left,I-PR
mastoid,I-PR
air,I-PR
cells,I-PR
and,I-PR
mastoid,I-PR
tip,I-PR
",",O
likely,O
chronic,O
inflammatory,O

disease,B-PR
.,O

IMPRESSION,O
:,O
Minimally,B-PR
displaced,I-PR
",",I-PR
comminuted,I-PR
fractures,I-PR
of,I-PR
the,I-PR
left,I-PR
C7,I-PR
and,I-PR
T1,I-PR
transverse,I-PR
processes,I-PR
.,O

No,O
evidence,O
of,O
extension,B-PR
into,I-PR
the,I-PR
foramina,I-PR
transversaria,I-PR
.,O

CT,B-TE
HEAD,I-TE
W/O,I-TE
CONTRAST,I-TE

2014-10-21,O
9:42,O

CT,B-TE
HEAD,I-TE
W/O,I-TE
CONTRAST,I-TE

Reason,O
:,O
bleed,B-PR
?,O

UNDERLYING,O
MEDICAL,O
CONDITION,O
:,O

72,O
year,O
old,O
man,O
with,O
intraparenchymal,B-PR
bleed,I-PR
s/p,O
fall,O

REASON,O
FOR,O
THIS,O
EXAMINATION,O
:,O

bleed,B-PR
?,O

CONTRAINDICATIONS,O
for,O
IV,O
CONTRAST,O
:,O
None,O
.,O

INDICATION,O
:,O
Intraparenchymal,B-PR
hemorrhage,I-PR
after,O
fall,O
.,O

Assess,O
for,O
hemorrhage,B-PR
.,O

TECHNIQUE,O
:,O
Non-contrast,B-TE
head,I-TE
CT,I-TE
.,O

COMPARISON,O
:,O
No,O
prior,B-TE
studies,I-TE
are,O
available,O
.,O

By,O
report,O
",",O
the,O
patient,O
has,O
an,B-TE
outside,I-TE
study,I-TE
.,O

Should,O
this,O
become,O
available,O
",",O
an,O
addendum,O
will,O
be,O
issued,O
to,O
this,O
report,O
following,O
the,O
comparison,O
with,O
the,B-TE
outside,I-TE
examination,I-TE
.,O

NOTE,O
:,O
This,B-TE
study,I-TE
was,O
initially,O
performed,O
on,O
the,O
morning,O
of,O
10-21,O
",",O
and,O
is,O
being,O
dictated,O
on,O
the,O
morning,O
of,O
10-22,O
due,O
to,O
PACS,O
malfunction,O
.,O

Findings,O
were,O
called,O
to,O
Dr.,O
Leanne,O
Vazquez,O
on,O
the,O
morning,O
of,O
10-21,O
.,O

NON-CONTRAST,B-TE
HEAD,I-TE
CT,I-TE
:,O
There,O
is,O
a,B-PR
small,I-PR
amount,I-PR
of,I-PR
hemorrhage,I-PR
within,O
the,O
occipital,O
horns,O
of,O
both,O
lateral,O
ventricles,O
",",O
right,O
greater,O
than,O
left,O
.,O

Located,O
within,O
the,O
atrium,O
of,O
the,O
right,O
lateral,O
ventricle,O
is,O
an,B-PR
18,I-PR
x,I-PR
10,I-PR
mm,I-PR
nodular,I-PR
area,I-PR
of,I-PR
increased,I-PR
density,I-PR
which,O
is,O
separate,O
from,O
the,O
choroid,O
plexus,O
.,O

There,O
is,O
no,O
evidence,O
of,O
surrounding,B-PR
edema,I-PR
.,O

There,O
is,O
diffuse,B-PR
brain,I-PR
atrophy,I-PR
and,O
chronic,B-PR
microvascular,I-PR
infarction,I-PR
throughout,I-PR
the,I-PR
white,I-PR
matter,I-PR
.,O

There,O
is,O
a,B-PR
remote,I-PR
right,I-PR
frontal,I-PR
infarct,I-PR
.,O

There,O
is,O
no,O
evidence,O
of,O
subarachnoid,B-PR
hemorrhage,I-PR
or,O
acute,B-PR
major,I-PR
vascular,I-PR
territorial,I-PR
infarction,I-PR
.,O

The,O
ventricles,O
do,O
not,O
appear,O
dilated,O
relative,O
to,O
the,O
sulci,O
",",O
and,O
there,O
is,O
no,O
shift,B-PR
of,I-PR
normally,I-PR
midline,I-PR
structures,I-PR
.,O

There,O
is,O
no,O
skull,B-PR
fracture,I-PR
.,O

There,O
is,O
opacification,B-PR
of,I-PR
the,I-PR
posterior,I-PR
nasal,I-PR
cavity,I-PR
and,I-PR
nasopharynx,I-PR
but,O
an,B-TR
NG,I-TR
tube,I-TR
is,O
present,O
",",O
and,O
the,O
patient,O
is,O
intubated,O
.,O

Opacified,B-PR
and,I-PR
sclerotic,I-PR
left,I-PR
mastoid,I-PR
air,I-PR
cells,I-PR
are,O
noted,O
.,O

IMPRESSION,O
:,O

1.,O
Small,O
amount,O
of,O
intraventricular,B-PR
hemorrhage,I-PR
.,O

2.,O
Ovoid,B-PR
18,I-PR
-,I-PR
mm,I-PR
density,I-PR
within,I-PR
the,I-PR
atrium,I-PR
of,O
the,O
right,O
lateral,O
ventricle,O
.,O

This,O
could,O
represent,O
either,O
an,B-PR
atypically,I-PR
located,I-PR
blood,I-PR
clot,I-PR
or,O
an,B-PR
intraventricular,I-PR
mass,I-PR
",",O
and,O
further,O
evaluation,O
with,O
contrast,B-TE
-,I-TE
enhanced,I-TE
MRI,I-TE
of,I-TE
the,I-TE
brain,I-TE
",",O
when,O
clinically,O
feasible,O
",",O
is,O
recommended,O
.,O

Results,O
were,O
discussed,O
with,O
Dr.,O
Leanne,O
Vazquez,O
in,O
the,O
early,O
afternoon,O
on,O
2014-10-21,O
.,O

CT,B-TE
HEAD,I-TE
W/O,I-TE
CONTRAST,I-TE

2014-11-14,O
12:34,O

CT,B-TE
HEAD,I-TE
W/O,I-TE
CONTRAST,I-TE

Reason,O
:,O
altered,B-PR
mental,I-PR
status,I-PR

UNDERLYING,O
MEDICAL,O
CONDITION,O
:,O

72,O
year,O
old,O
man,O
with,O

REASON,O
FOR,O
THIS,O
EXAMINATION,O
:,O

altered,B-PR
mental,I-PR
status,I-PR

CONTRAINDICATIONS,O
for,O
IV,O
CONTRAST,O
:,O
None,O
.,O

INDICATION,O
:,O
72-year-old,O
male,O
with,O
altered,B-PR
mental,I-PR
status,I-PR
.,O

TECHNIQUE,O
:,O
Axial,B-TE
noncontrast,I-TE
CT,I-TE
scans,I-TE
of,I-TE
the,I-TE
brain,I-TE
were,O
obtained,O
.,O

Comparison,O
is,O
made,O
to,O
a,B-TE
previous,I-TE
study,I-TE
from,O
2014-10-27,O
.,O

FINDINGS,O
:,O

There,O
are,O
numerous,O
areas,O
of,O
decreased,B-PR
attenuation,I-PR
in,I-PR
the,I-PR
periventricular,I-PR
and,I-PR
subcortical,I-PR
white,I-PR
matter,I-PR
of,O
both,O
cerebral,O
hemispheres,O
",",O
indicating,O
chronic,B-PR
microvascular,I-PR
infarction,I-PR
.,O

There,O
is,O
also,O
an,B-PR
old,I-PR
right,I-PR
frontal,I-PR
lobe,I-PR
cortical,I-PR
infarction,I-PR
.,O

A,B-PR
small,I-PR
right,I-PR
occipital,I-PR
lobe,I-PR
chronic,I-PR
infarction,I-PR
is,O
also,O
evident,O
.,O

There,O
is,O
a,B-PR
small,I-PR
amount,I-PR
of,I-PR
blood,I-PR
layering,I-PR
in,I-PR
both,I-PR
lateral,I-PR
ventricles,I-PR
",",O
and,O
this,O
has,O
decreased,O
since,O
the,B-TE
previous,I-TE
study,I-TE
.,O

The,O
size,O
and,O
shape,O
of,O
the,O
ventricles,O
is,O
unchanged,O
.,O

No,O
new,B-PR
hemorrhage,I-PR
is,O
observed,O
.,O

There,O
is,O
opacification,B-PR
of,I-PR
the,I-PR
mastoid,I-PR
air,I-PR
cells,I-PR
",",O
greater,O
on,O
the,O
left,O
than,O
the,O
right,O
.,O

There,O
is,O
some,B-PR
fluid,I-PR
or,O
mucosal,B-PR
thickening,I-PR
in,I-PR
the,I-PR
ethmoid,I-PR
and,I-PR
sphenoid,I-PR
sinuses,I-PR
.,O

IMPRESSION,O
:,O
No,O
new,B-PR
cortical,I-PR
territorial,I-PR
infarction,I-PR
or,O
hemorrhage,B-PR
is,O
identified,O
.,O

There,O
is,O
decreased,B-PR
intraventricular,I-PR
blood,I-PR
",",O
compared,O
to,O
the,B-TE
previous,I-TE
study,I-TE
",",O
and,O
there,O
are,O
no,O
signs,O
of,O
hydrocephalus,B-PR
.,O

CHEST,B-TE
(,I-TE
PORTABLE,I-TE
AP,I-TE
),I-TE

2014-11-12,O
9:10,O

CHEST,B-TE
(,I-TE
PORTABLE,I-TE
AP,I-TE
),I-TE

Reason,O
:,O
Fever,B-PR
",",O
f/u,O
infiltrte,B-PR

UNDERLYING,O
MEDICAL,O
CONDITION,O
:,O

72,O
yo,O
M,O
with,O
rib,B-PR
fx,I-PR
s/p,O
trauma,B-PR
",",O
failure,O
on,O
previous,B-TE
CXR,I-TE
",",O
now,O
with,O
fever,B-PR
.,O

REASON,O
FOR,O
THIS,O
EXAMINATION,O
:,O

Fever,B-PR
",",O
f/u,O
infiltrte,B-PR

HISTORY,O
:,O
Trauma,B-PR
",",O
congestive,B-PR
heart,I-PR
failure,I-PR
",",O
fever,B-PR
",",O
pneumonia,B-PR
.,O

Portable,B-TE
supine,I-TE
chest,I-TE
radiograph,I-TE
shows,O
improvement,O
in,O
edema,B-PR
compared,O
to,O
studies,B-TE
from,O
four,O
and,O
five,O
days,O
earlier,O
with,O
no,O
significant,B-PR
radiographic,I-PR
change,I-PR
in,O
right,B-PR
upper,I-PR
lobe,I-PR
consolidation,I-PR
consistent,O
with,O
pneumonia,B-PR
.,O

Some,B-PR
interstitial,I-PR
edema,I-PR
still,O
persists,O
",",O
but,O
there,O
is,O
no,O
central,B-PR
pulmonary,I-PR
vascular,I-PR
congestion,I-PR
.,O

Cardiac,B-TE
size,I-TE
is,O
unchanged,O
.,O

The,O
amount,O
of,O
fluid,B-PR
layering,I-PR
at,I-PR
the,I-PR
apices,I-PR
and,I-PR
the,I-PR
pleural,I-PR
spaces,I-PR
appear,O
slightly,O
decreased,O
.,O

Multiple,B-PR
left-sided,I-PR
rib,I-PR
fractures,I-PR
are,O
seen,O
.,O

Supporting,B-TR
tubes,I-TR
and,I-TR
lines,I-TR
are,O
in,O
unchanged,O
position,O
and,O
the,O
patient,O
has,O
a,B-TR
single,I-TR
lead,I-TR
pacemaker,I-TR
projected,O
on,O
the,O
left,O
.,O

Calcification,B-PR
is,O
seen,O
at,O
both,O
carotid,O
bifurcations,O
.,O

CONCLUSION,O
:,O
Improvement,O
in,O
congestion,B-PR
from,O
edema,B-PR
with,O
no,O
worsening,O
",",O
but,O
no,O
significant,O
improvement,O
",",O
in,O
the,B-PR
right,I-PR
upper,I-PR
lobe,I-PR
pneumonia,I-PR
.,O

Supporting,B-TR
lines,I-TR
and,I-TR
tubes,I-TR
in,O
unchanged,O
position,O
.,O

Brief,O
Hospital,O
Course,O
:,O

Admitted,O
to,O
TSICU,O
for,O
subarachnoid,B-PR
hemorrhage,I-PR
and,O
multiple,B-PR
spinal,I-PR
fractures,I-PR
.,O

Intubated,B-TR
and,O
sedated,B-TR
for,O
desats,B-PR
on,O
2014-10-27,O
.,O

Evaluated,O
by,O
neurosurgery,O
and,O
deemed,O
stable,O
on,O
2014-10-22,O
.,O

CT,B-TE
head,I-TE
remained,O
stable,O
for,O
SAH,B-PR
.,O

Evaluated,O
by,O
orthopedic,O
spine,O
surgeons,O
with,O
recommendations,O
for,O
soft,B-TR
c-collar,I-TR
for,O
comfort,O
.,O

In,O
TSICU,O
",",O
developed,O
MRSA,B-PR
pneumonia,I-PR
with,O
question,O
of,O
aspiration,B-PR
",",O
treated,O
Zosyn,B-TR
-->,O
vanc,B-TR
/,O
levo,B-TR
-->,O
then,O
2,O
week,O
course,O
of,O
Linazolid,B-TR
with,O
resolution,O
of,O
fevers,B-PR
and,O
decreased,B-PR
pulmonary,I-PR
secretions,I-PR
.,O

2014-11-11,O
:,O
Tracheostomy,B-TR
performed,O
without,O
complication,B-PR
.,O

Patient,O
tolerated,O
decreasing,B-TR
ventillary,I-TR
support.,I-TR

Mental,O
status,O
improved,O
with,O
the,O
discontinuation,O
of,O
his,B-TR
bensodiazapines,I-TR
.,O

Failed,B-PR
swallow,I-PR
study,I-PR
x,O
2,O
in,O
early,O
November,O
.,O

Decision,O
to,O
continue,O
Dobhoff,B-TR
at,O
rehab,O
given,O
continued,O
clinical,O
improvement,O
and,O
his,O
poor,O
candidacy,O
for,O
G/J,B-TR
tube,I-TR
.,O

Communicating,O
by,O
speech,O
s/p,O
PMV,B-TR
placement,I-TR
.,O

Continued,O
in,O
Melrose-J,O
for,O
comfort,O
per,O
orthopedics,O
.,O

Stable,O
during,O
his,O
course,O
on,O
the,O
surgical,O
Beth,O
Israel,O
Deaconess,O
Hospital-Needham,O
.,O

Occasionally,O
required,O
Haldol,B-TR
/,O
ativan,B-TR
at,O
night,O
for,O
agitation,B-PR
.,O

Progressed,O
adequately,O
with,O
physical,B-TR
/,I-TR
occupational,I-TR
therapy,I-TR
",",O
however,O
was,O
noted,O
to,O
develop,O
an,B-PR
early,I-PR
bilateral,I-PR
upper,I-PR
extermity,I-PR
contracture,I-PR
at,I-PR
the,I-PR
elbows,I-PR
and,I-PR
wrists,I-PR
.,O

Serial,B-TE
CT,I-TE
head,I-TE
revealed,O
decreased,B-PR
blood,I-PR
through,O
2014-11-14,O
.,O

Discharge,O
Medications,O
:,O

1.,O
Heparin,B-TR
(,I-TR
Porcine,I-TR
),I-TR
"5,000",O
unit/mL,O
Solution,O
Sig,O
:,O
One,O
(,O
1,O
),O
Injection,O
TID,O
(,O
3,O
times,O
a,O
day,O
).,O

2.,O
Lisinopril,B-TR
15,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

3.,O
Lansoprazole,B-TR
30,O
mg,O
Susp,O
",",O
Delayed,O
Release,O
for,O
Recon,O
Sig,O
:,O
One,O
(,O
1,O
),O
PO,O
DAILY,O
(,O
Daily,O
).,O

4.,O
Linezolid,B-TR
600,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q12H,O
(,O
every,O
12,O
hours,O
):,O
Last,O
dose,O
2014-11-20,O
.,O

5.,O
Metoprolol,B-TR
Tartrate,I-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
TID,O
(,O
3,O
times,O
a,O
day,O
).,O

6.,O
Digoxin,B-TR
125,O
mcg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

7.,O
Docusate,B-TR
Sodium,I-TR
150,O
mg,O
/,O
15,O
mL,O
Liquid,O
Sig,O
:,O
One,O
(,O
1,O
),O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

8.,O
Bisacodyl,B-TR
5,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
DAILY,O
(,O
Daily,O
),O
as,O
needed,O
for,O
constipation,B-PR
.,O

9.,O
Magnesium,B-TR
Hydroxide,I-TR
400,O
mg,O
/,O
5,O
mL,O
Suspension,O
Sig,O
:,O
Thirty,O
(,O
30,O
),O
ML,O
PO,O
Q6H,O
(,O
every,O
6,O
hours,O
),O
as,O
needed,O
for,O
consitpation,B-PR
.,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Facility,O
:,O

Children,O
's,O
Hospital,O
of,O
Waltham,O

Discharge,O
Diagnosis,O
:,O

s/p,O
Fall,O

Subarachnoid,B-PR
hemorrhage,I-PR
w/,O
bilateral,B-PR
intraventricular,I-PR
hemorrhage,I-PR

Left,B-PR
T1,I-PR
transverse,I-PR
process,I-PR
fracture,I-PR

C7,B-PR
&,I-PR
T1,I-PR
mimimally,I-PR
displaced,I-PR
transverse,I-PR
process,I-PR
fracture,I-PR

Left,B-PR
rib,I-PR
fractures,I-PR
05-22,O

Discharge,O
Condition,O
:,O

Stable,O

Discharge,O
Instructions,O
:,O

You,O
must,O
continue,O
to,O
wear,O
your,B-TR
cervical,I-TR
collar,I-TR
for,O
the,O
next,O
4,O
weeks,O
(,O
through,O
12-11,O
).,O

Follow,O
up,O
with,O
Trauma,O
in,O
3-4,O
weeks,O
after,O
your,O
discharge,O
.,O

Follow,O
up,O
Instructions,O
:,O

Call,O
(,O
909,O
),O
566-1185,O
to,O
schedule,O
appointment,O
in,O
Trauma,O
Clinic,O
in,O
3-4,O
weeks,O
.,O

Follow,O
up,O
with,O
Dr.,O
Topping,O
after,O
your,O
discharge,O
from,O
rehabilitation,O

Call,O
887,O
415,O
4220,O
to,O
schedule,O
an,O
appointment,O
with,O
Orthopedics,O
for,O
late,O
November,O
.,O

David,O
Thomas,O
MD,O
60-008,O

Completed,O
by,O
:,O
Russell,O
Anthony,O
Conner,O
MD,O
87-672,O
2014-11-21,O
@,O
1110,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Melissa,O
Higuera,O
on,O
:,O
SUN,O
2014-11-23,O
6:13,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2015-10-26,O

Discharge,O
Date,O
:,O

2015-10-30,O

Date,O
of,O
Birth,O
:,O

1998-01-05,O

Sex,O
:,O

M,O

Service,O
:,O

SURGERY,B-TR

Allergies,O
:,O

Sulfa,B-TR
(,I-TR
Sulfonamides,I-TR
),I-TR
/,O
Penicillins,B-TR

Attending,O
:,O
Mary,O
T,O
Davis,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

s/p,O
Pedestrian,O
struck,O
by,O
auto,O

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

2015-10-27,O
Open,B-TR
reduction,I-TR
and,O
internal,B-TR
fixation,I-TR
of,O
right,B-PR
tib/fib,I-PR
fractures,I-PR

History,O
of,O
Present,O
Illness,O
:,O

17,O
yo,O
male,O
pedestrian,O
who,O
was,O
struck,O
by,O
auto,O
at,O
unknown,O
speed,O
;,O
+LOC,B-PR
.,O

He,O
was,O
medflighted,O
to,O
The,O
Hospital,O
for,O
Orthopedics,O
for,O
ongoing,B-TR
trauma,I-TR
care,I-TR
.,O

Upon,O
arrival,O
GCS,B-TE
15,O
",",O
alert,O
and,O
oriented,O
x3,O
.,O

Past,O
Medical,O
History,O
:,O

Attention,B-PR
deficit,I-PR
disorder,I-PR
(,O
diagnosed,O
@,O
14,O
yrs,O
of,O
age,O
),O

Social,O
History,O
:,O

High,O
school,O
student,O

Resides,O
with,O
parents,O
and,O
siblings,O

Family,O
History,O
:,O

Noncontributory,O

Pertinent,O
Results,O
:,O

2015-10-26,O
20:48,O

GLUCOSE,B-TE
-,O
101,O
LACTATE,B-TE
-,O
2.9,O
*,O
NA+,B-TE
-,O
142,O
K+,B-TE
-,O
3.6,O
CL-,B-TE
-,O
102,O
TCO2,B-TE
-,O
26,O

2015-10-26,O
20:34,O

UREA,B-TE
N,I-TE
-,O
12,O
CREAT,B-TE
-,O
1.0,O

2015-10-26,O
20:34,O

AMYLASE,B-TE
-,O
44,O

2015-10-26,O
20:34,O

ASA,B-TE
-,O
NEG,O
ETHANOL,B-TE
-,O
NEG,O
ACETMNPHN,B-TE
-,O
NEG,O
bnzodzpn,B-TE
-,O
NEG,O
barbitrt,B-TE
-,O
NEG,O
tricyclic,B-TE
-,O
NEG,O

2015-10-26,O
20:34,O

WBC,B-TE
-,O
16.0,O
*,O
RBC,B-TE
-,O
4.89,O
HGB,B-TE
-,O
14.5,O
HCT,B-TE
-,O
40.4,O
MCV,B-TE
-,O
83,O
MCH,B-TE
-,O
29.7,O
MCHC,B-TE
-,O
35.9,O
*,O
RDW,B-TE
-,O
13.4,O

2015-10-26,O
20:34,O

PLT,B-TE
COUNT,I-TE
-,O
247,O

2015-10-26,O
20:34,O

PT,B-TE
-,O
12.7,O
PTT,B-TE
-,O
23.8,O
INR(PT),B-TE
-,O
1.1,O

CT,B-TE
HEAD,I-TE
W/O,I-TE
CONTRAST,I-TE

Reason,O
:,O
STUCK,O
BY,O
AUTO,O

UNDERLYING,O
MEDICAL,O
CONDITION,O
:,O

56,O
year,O
old,O
man,O
s/p,O
struck,O
by,O
auto,O

REASON,O
FOR,O
THIS,O
EXAMINATION,O
:,O

eval,B-TE
for,O
bleed,B-PR

CONTRAINDICATIONS,O
for,O
IV,O
CONTRAST,O
:,O
None,O
.,O

INDICATION,O
:,O
Struck,O
by,O
car,O
.,O

COMPARISONS,O
:,O
None,O
.,O

TECHNIQUE,O
:,O
Axial,B-TE
MDCT,I-TE
images,I-TE
of,I-TE
the,I-TE
brain,I-TE
without,O
IV,O
contrast,O
.,O

FINDINGS,O
:,O
There,O
is,O
a,B-PR
linear,I-PR
nondepressed,I-PR
right,I-PR
temporal,I-PR
calvarial,I-PR
fracture,I-PR
extending,O
into,O
the,O
mastoid,O
process,O
.,O

There,O
is,O
a,B-PR
small,I-PR
subdural,I-PR
hematoma,I-PR
with,O
components,O
of,O
pneumocephalus,B-PR
tracking,O
from,O
the,O
mastoid,O
air,O
cells,O
.,O

There,O
is,O
no,O
shift,B-PR
of,I-PR
normally,I-PR
midline,I-PR
structures,I-PR
.,O

There,O
is,O
also,O
a,B-PR
left,I-PR
occipital,I-PR
scalp,I-PR
contusion,I-PR
but,O
no,O
associated,B-PR
skull,I-PR
fracture,I-PR
.,O

Prominent,B-TR
sutures,I-TR
in,O
this,O
young,O
patient,O
",",O
the,B-TR
right,I-TR
calvarial,I-TR
suture,I-TR
extending,O
into,O
the,O
right,O
temporal,O
bones,O
appears,O
more,O
prominent,O
than,O
its,O
counterpart,O
on,O
the,O
left,O
",",O
however,O
",",O
does,O
not,O
appear,O
to,O
represent,O
an,B-PR
acute,I-PR
fracture,I-PR
.,O

No,O
other,B-PR
acute,I-PR
fractures,I-PR
are,O
appreciated,O
.,O

There,O
is,O
small,O
amount,O
of,O
mucosal,B-PR
thickening,I-PR
in,I-PR
the,I-PR
sphenoid,I-PR
sinuses,I-PR
.,O

No,O
air-fluid,B-TE
levels,I-TE
to,O
suggest,O
occult,B-PR
facial,I-PR
fractures,I-PR
.,O

Orbits,O
are,O
unremarkable,O
.,O

IMPRESSION,O
:,O
Linear,B-PR
right,I-PR
temporal,I-PR
calvarial,I-PR
fracture,I-PR
extending,O
into,O
the,O
mastoid,O
process,O
with,O
small,B-PR
associated,I-PR
right,I-PR
posterior,I-PR
convexity,I-PR
subdural,I-PR
hematoma,I-PR
and,O
pneumocephalus,B-PR
.,O

Discussed,O
with,O
trauma,O
team,O
during,O
the,B-TE
study,I-TE
.,O

CT,B-TE
C-SPINE,I-TE
W/O,O
CONTRAST,O

Reason,O
:,O
STUCK,O
BY,O
AUTO,O

UNDERLYING,O
MEDICAL,O
CONDITION,O
:,O

56,O
year,O
old,O
man,O
s/p,O
struck,O
by,O
auto,O

REASON,O
FOR,O
THIS,O
EXAMINATION,O
:,O

eval,B-TE
for,O
fx,B-PR

CONTRAINDICATIONS,O
for,O
IV,O
CONTRAST,O
:,O
None,O
.,O

INDICATION,O
:,O
18-year-old,O
hit,O
by,O
car,O
.,O

Head,B-PR
injury,I-PR
to,I-PR
the,I-PR
occiput,I-PR
.,O

COMPARISONS,O
:,O
None,O
.,O

TECHNIQUE,O
:,O
Axial,B-TE
MDCT,I-TE
images,I-TE
of,I-TE
the,I-TE
cervical,I-TE
spine,I-TE
with,O
coronal,O
and,O
sagittal,O
reformats,O
without,O
IV,O
contrast,O
.,O

FINDINGS,O
:,O
C1,O
through,O
T1,O
are,O
well,O
visualized,O
.,O

There,O
is,O
normal,O
alignment,O
of,O
the,O
cervical,O
vertebral,O
bodies,O
without,O
acute,B-PR
fracture,I-PR
or,O
traumatic,B-PR
malalignment,I-PR
.,O

The,O
posterior,O
elements,O
are,O
intact,O
.,O

There,O
is,O
no,O
significant,B-PR
prevertebral,I-PR
soft,I-PR
tissue,I-PR
swelling,I-PR
.,O

The,O
C1-C2,O
relationship,O
is,O
within,O
normal,O
limits,O
.,O

The,O
dens,O
is,O
intact,O
.,O

The,O
lung,O
apices,O
are,O
clear,O
without,O
pneumothorax,B-PR
.,O

The,O
upper,O
ribs,O
are,O
intact,O
.,O

There,O
is,O
a,B-PR
linear,I-PR
right,I-PR
temporal,I-PR
calvarial,I-PR
fracture,I-PR
extending,O
into,O
the,O
right,O
temporal,O
bones,O
.,O

This,O
appears,O
to,O
stop,O
short,O
of,O
the,O
carotid,O
canal,O
.,O

Multiple,O
posterior,O
right,O
-,O
sided,O
mastoid,O
air,O
cells,O
are,O
opacified,B-PR
with,I-PR
blood,I-PR
.,O

IMPRESSION,O
:,O

1),O
No,O
acute,B-PR
cervical,I-PR
spine,I-PR
fracture,I-PR
.,O

2),O
Linear,B-PR
right,I-PR
temporal,I-PR
calvarial,I-PR
fracture,I-PR
extending,O
into,O
the,O
mastoid,O
with,O
a,B-PR
small,I-PR
right,I-PR
posterior,I-PR
convexity,I-PR
subdural,I-PR
hematoma,I-PR
and,O
pneumocephalus,B-PR
;,O
see,O
head,B-TE
CT,I-TE
report,O
.,O

CHEST,B-TE
(,I-TE
PA,I-TE
&,I-TE
LAT,I-TE
),I-TE

Reason,O
:,O
Please,O
r/o,O
acute,B-PR
process,I-PR
.,O

UNDERLYING,O
MEDICAL,O
CONDITION,O
:,O

17,O
year,O
old,O
man,O
with,O
post-op,B-PR
fever,I-PR
.,O

REASON,O
FOR,O
THIS,O
EXAMINATION,O
:,O

Please,O
r/o,O
acute,B-PR
process,I-PR
.,O

INDICATION,O
:,O
Postoperative,B-PR
fever,I-PR
.,O

COMPARISONS,O
:,O
Comparison,O
is,O
made,O
to,O
2015-10-27,O
.,O

TECHNIQUE,O
:,O
PA,B-TE
and,I-TE
lateral,I-TE
views,I-TE
of,I-TE
the,I-TE
chest,I-TE
.,O

FINDINGS,O
:,O
The,O
heart,O
is,O
of,O
normal,O
size,O
.,O

Mediastinal,O
and,O
hilar,O
contours,O
are,O
within,O
normal,O
limits,O
.,O

The,O
lung,O
fields,O
are,O
clear,O
.,O

There,O
are,O
no,O
pleural,B-PR
effusions,I-PR
or,O
focal,B-PR
consolidations,I-PR
.,O

There,O
is,O
no,O
evidence,O
of,O
CHF,B-PR
.,O

IMPRESSION,O
:,O
No,O
evidence,O
of,O
significant,B-PR
abnormality,I-PR
.,O

TIB,B-TE
/,I-TE
FIB,I-TE
(,I-TE
AP,I-TE
&,I-TE
LAT,I-TE
),I-TE
SOFT,O
TISSUE,O

Reason,O
:,O
eval,B-TE
for,I-TE
alignment,I-TE
",",I-TE
post,I-TE
op,I-TE
changes,I-TE

UNDERLYING,O
MEDICAL,O
CONDITION,O
:,O

56,O
year,O
old,O
man,O
with,O
open,B-PR
RLE,I-PR
fx,I-PR
now,O
s/p,B-TR
fixation,I-TR

REASON,O
FOR,O
THIS,O
EXAMINATION,O
:,O

eval,B-TE
for,I-TE
alignment,I-TE
",",I-TE
post,I-TE
op,I-TE
changes,I-TE

INDICATION,O
:,O
Fracture,B-PR
.,O
Assess,O
for,O
alignment,O
.,O

RIGHT,B-TE
TIBIA,I-TE
/,I-TE
FIBULA,I-TE
",",I-TE
AP,I-TE
AND,I-TE
LATERAL,I-TE
VIEWS,I-TE
:,O
An,B-TR
intramedullary,I-TR
rod,I-TR
is,O
seen,O
fixating,O
a,B-PR
proximal,I-PR
diaphyseal,I-PR
comminuted,I-PR
tibial,I-PR
fracture,I-PR
with,O
six,B-TR
proximal,I-TR
and,I-TR
two,I-TR
distal,I-TR
screws,I-TR
.,O

Additionally,O
",",O
a,B-TR
side,I-TR
plate,I-TR
is,O
seen,O
medially,O
fixating,O
the,B-PR
fracture,I-PR
.,O

There,O
is,O
a,B-PR
non-displaced,I-PR
comminuted,I-PR
fracture,I-PR
of,I-PR
the,I-PR
proximal,I-PR
fibular,I-PR
diaphysis,I-PR
.,O

There,O
is,O
surrounding,O
soft,B-PR
tissue,I-PR
swelling,I-PR
.,O

Os,O
trigonum,O
is,O
visualized,O
.,O

IMPRESSION,O
:,O
Comminuted,B-PR
proximal,I-PR
tibiofibular,I-PR
fractures,I-PR
status,B-TR
post,I-TR
ORIF,I-TR
of,I-TR
the,I-TR
tibia,I-TR
with,O
an,B-TR
intramedullary,I-TR
rod,I-TR
and,I-TR
side,I-TR
plate,I-TR
.,O

No,O
evidence,O
of,O
immediate,B-PR
hardware,I-PR
complication,I-PR
.,O

CT,B-TE
HEAD,I-TE
W/O,O
CONTRAST,O

Reason,O
:,O
follow,B-TE
up,I-TE
ct,I-TE

UNDERLYING,O
MEDICAL,O
CONDITION,O
:,O

17,O
year,O
old,O
man,O
with,O
pneumocephalus,B-PR
s/p,O
CMED,O
CCU,O
v.,O
mvc,O

REASON,O
FOR,O
THIS,O
EXAMINATION,O
:,O

follow,B-TE
up,I-TE
ct,I-TE

CONTRAINDICATIONS,O
for,O
IV,O
CONTRAST,O
:,O
None,O
.,O

CLINICAL,O
HISTORY,O
:,O
History,O
of,O
pneumocephalus,B-PR
status,O
post,O
pedestrian,O
versus,O
motor,O
vehicle,O
collision,O
.,O

Follow,B-TE
up,I-TE
CT,I-TE
scan,I-TE
.,O

COMPARISON,O
:,O
Non-contrast,B-TE
head,I-TE
CT,I-TE
from,O
2015-10-27,O
.,O

TECHNIQUE,O
:,O
Non-contrast,B-TE
head,I-TE
CT,I-TE
.,O

FINDINGS,O
:,O
The,O
previously,O
noted,O
subdural,B-PR
hemorrhage,I-PR
in,I-PR
the,I-PR
right,I-PR
posterior,I-PR
fossa,I-PR
appears,O
less,O
conspicuous,O
.,O

The,O
pneumocephalus,B-PR
adjacent,O
to,O
the,B-PR
linear,I-PR
skull,I-PR
fracture,I-PR
appears,O
to,O
have,O
decreased,O
in,O
size,O
.,O

There,O
are,O
persistent,B-PR
bifrontal,I-PR
and,I-PR
right,I-PR
parietal,I-PR
hemorrhagic,I-PR
contusions,I-PR
with,O
surrounding,B-PR
edema,I-PR
and,O
possible,O
small,B-PR
left,I-PR
frontal,I-PR
subarachnoid,I-PR
hemorrhage,I-PR
(,O
adjacent,O
to,O
falx,O
),O
which,O
are,O
largely,O
unchanged,O
.,O

There,O
is,O
no,O
shift,B-PR
of,I-PR
normally,I-PR
midline,I-PR
structures,I-PR
or,O
hydrocephalus,B-PR
.,O

The,O
ventricles,O
",",O
cisterns,O
and,O
sulci,O
are,O
normal,O
.,O

The,B-TE
air-,I-TE
fluid,I-TE
level,I-TE
in,I-TE
the,I-TE
right,I-TE
sphenoid,I-TE
sinus,I-TE
and,O
bilateral,B-PR
opacification,I-PR
of,I-PR
the,I-PR
mastoid,I-PR
air,I-PR
cells,I-PR
are,O
unchanged,O
.,O

IMPRESSION,O
:,O

1.,O
Decreased,O
size,O
of,O
right,B-PR
posterior,I-PR
subdural,I-PR
hemorrhage,I-PR
.,O

2.,O
Multifocal,B-PR
hemorrhagic,I-PR
contusions,I-PR
and,O
surrounding,B-PR
edema,I-PR
are,O
largely,O
unchanged,O
.,O

Brief,O
Hospital,O
Course,O
:,O

He,O
was,O
admitted,O
to,O
the,O
trauma,O
service,O
.,O
Orthopedics,O
and,O
Neurosurgery,O
were,O
consulted,O
because,O
of,O
his,B-PR
injuries,I-PR
.,O

His,B-PR
Neurosurgical,I-PR
issues,I-PR
were,O
nonoperative,O
;,O
he,O
was,O
loaded,O
with,O
Dilantin,B-TR
;,O
serial,B-TE
head,I-TE
CT,I-TE
scans,I-TE
were,O
performed,O
and,O
were,O
stable,O
.,O

He,O
will,O
need,O
to,O
follow,O
up,O
with,O
Dr.,O
Mckinney,O
in,O
4,O
weeks,O
for,O
repeat,B-TE
head,I-TE
imaging,I-TE
and,O
continue,O
with,O
Dilantin,B-TR
for,O
one,O
month,O
.,O

His,B-PR
right,I-PR
tib,I-PR
/,I-PR
fib,I-PR
fracture,I-PR
was,O
repaired,O
by,O
Orthopedics,O
on,O
10-27,O
;,O
postoperatively,O
there,O
were,O
no,O
complications,B-PR
.,O

Weight,O
bearing,O
status,O
was,O
increased,O
to,O
weight,O
bearing,O
as,O
tolerated,O
.,O

He,O
was,O
fitted,O
with,O
a,B-TR
hinged,I-TR
Mcdonald,I-TR
brace,I-TR
for,O
his,B-PR
LLE,I-PR
.,O

He,O
will,O
need,O
to,O
continue,O
on,O
Lovenox,B-TR
injections,I-TR
for,O
at,O
least,O
4-6,O
weeks,O
.,O

He,O
was,O
transfused,O
with,O
3,B-TR
u,I-TR
packed,I-TR
cells,I-TR
for,O
a,B-TE
hematocrit,I-TE
of,O
21,O
",",O
post,B-TE
transfusion,I-TE
HCT,I-TE
was,O
26.1,O
;,O
there,O
was,O
a,O
questionable,O
transfusion,B-PR
reaction,I-PR
at,O
the,O
end,O
of,O
his,B-TR
first,I-TR
unit,I-TR
of,I-TR
packed,I-TR
cells,I-TR
;,O
he,O
did,O
subsequently,O
receive,O
the,B-TR
remaining,I-TR
2,I-TR
units,I-TR
without,O
any,B-PR
further,I-PR
reaction,I-PR
.,O

Physical,O
and,O
Occupational,O
therapy,O
were,O
consulted,O
and,O
have,O
recommended,O
home,O
with,O
services,O
.,O

Medications,O
on,O
Admission,O
:,O

None,O

Allergic,B-PR
to,O
PCN,B-TR
and,O
Sulfa,B-TR

Discharge,O
Medications,O
:,O

1.,O
Phenytoin,B-TR
50,O
mg,O
Tablet,O
",",O
Chewable,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
",",O
Chewable,O
PO,O
three,O
times,O
a,O
day,O
for,O
1,O
months,O
.,O

Disp,O
:*,O
180,O
Tablet,O
",",O
Chewable,O
(s)*,O
Refills,O
:*,O
0,O
*,O

2.,O
Oxycodone,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
Q4H,O
(,O
every,O
4,O
hours,O
),O
as,O
needed,O
for,O
pain,B-PR
.,O

Disp,O
:*,O
75,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

3.,O
Docusate,B-TR
Sodium,I-TR
100,O
mg,O
Capsule,O
Sig,O
:,O
One,O
(,O
1,O
),O
Capsule,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

4.,O
Magnesium,B-TR
Hydroxide,I-TR
400,O
mg,O
/,O
5,O
mL,O
Suspension,O
Sig,O
:,O
Thirty,O
(,O
30,O
),O
ML,O
PO,O
Q6H,O
(,O
every,O
6,O
hours,O
),O
as,O
needed,O
for,O
constipation,B-PR
.,O

5.,O
Lovenox,B-TR
40,O
mg,O
/,O
0.4,O
mL,O
Syringe,O
Sig,O
:,O
0.4,O
ML,O
's,O
Subcutaneous,O
once,O
a,O
day,O
for,O
30,O
days,O
.,O

Disp,O
:*,O
30,O
*,O
Refills,O
:*,O
0,O
*,O

Discharge,O
Disposition,O
:,O

Home,O
with,O
Service,O

Discharge,O
Diagnosis,O
:,O

s/p,O
Pedestrian,O
Struck,O
by,O
Auto,O

Subdural,B-PR
hematoma,I-PR

Skull,B-PR
fracture,I-PR

Right,B-PR
comminuted,I-PR
tibia,I-PR
/,I-PR
fibula,I-PR
fracture,I-PR

Discharge,O
Condition,O
:,O

Good,O

Discharge,O
Instructions,O
:,O

Return,O
to,O
the,O
emergency,O
room,O
if,O
you,O
develop,O
fevers,B-PR
",",O
chills,B-PR
",",O
severe,B-PR
headaches,I-PR
",",O
visual,B-PR
disturbances,I-PR
",",O
nause,B-PR
",",O
vomiting,B-PR
and,O
/,O
or,O
any,B-PR
other,I-PR
symptoms,I-PR
that,O
are,O
concerning,O
to,O
you,O
.,O

You,O
will,O
need,O
to,O
conrtinue,O
with,O
your,B-TR
Lovenox,I-TR
injections,I-TR
for,O
at,O
least,O
4-6,O
weeks,O
as,O
instructed,O
by,O
Orthopedics,O

Followup,O
Instructions,O
:,O

Follow,O
up,O
with,O
Dr.,O
Garza,O
",",O
Orthopaedics,O
in,O
10-14,O
days,O
",",O
call,O
953,O
6923,O
for,O
an,O
appointment,O
.,O

Follow,O
up,O
with,O
Dr.,O
Melendez,O
",",O
Neurosurgery,O
in,O
4,O
weeks,O
;,O
call,O
745,O
8256,O
ext,O
-,O
6468,O
for,O
an,O
appointment,O
.,O

Inform,O
the,O
office,O
that,O
you,O
will,O
need,O
a,B-TE
repeat,I-TE
head,I-TE
CT,I-TE
scan,I-TE
for,O
this,O
appointment,O
.,O

Lori,O
Dorothy,O
MD,O
79-290,O

Completed,O
by,O
:,O
Christopher,O
Sandy,O
NP,O
80-BYL,O
2015-11-03,O
@,O
1526,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Muriel,O
Zech,O
on,O
:,O
WED,O
2015-11-04,O
11:30,O
AM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2014-03-31,O

Discharge,O
Date,O
:,O

2014-04-09,O

Date,O
of,O
Birth,O
:,O

1964-04-26,O

Sex,O
:,O

M,O

Service,O
:,O

Liver,B-TR
Transplant,I-TR
Surgery,I-TR
Service,O

ADMISSION,O
DIAGNOSIS,O
:,O

Hepatitis,B-PR
C,I-PR
cirrhosis,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
49,O
year-old,O
man,O
with,O
hepatitis,B-PR
C,I-PR
cirrhosis,I-PR
complicated,O
by,O
encephalopathy,B-PR
",",O
positive,B-PR
esophageal,I-PR
varices,I-PR
",",O
now,O
with,O
worsening,B-PR
confusion,I-PR
and,O
lethargy,B-PR
.,O

The,O
patient,O
has,O
been,O
admitted,O
5,O
x,O
in,O
the,O
past,O
to,O
Nantucket,O
Cottage,O
Hospital,O
since,O
11-30,O
for,O
encephalopathy,B-PR
.,O

Most,O
recently,O
admitted,O
on,O
2014-03-19,O
to,O
2014-03-22,O
.,O

Infectious,B-TE
work-up,I-TE
was,O
negative,O
.,O

Trazodone,B-TR
stopped,O
.,O

Patient,O
was,O
started,O
on,O
Lactulose,B-TR
and,O
Rifaximine,B-TR
which,O
improved,O
his,O
mental,O
status,O
.,O

Today,O
",",O
on,O
2014-03-03,O
",",O
the,O
patient,O
was,O
seen,O
in,O
clinic,O
with,O
increased,B-PR
lethargy,I-PR
",",O
confusion,B-PR
.,O

Wife,O
reports,O
that,O
the,O
patient,O
has,O
a,O
history,O
of,O
lethargy,B-PR
and,O
confusion,B-PR
",",O
similar,O
to,O
the,B-PR
symptoms,I-PR
for,O
which,O
the,O
patient,O
was,O
recently,O
admitted,O
.,O

The,O
patient,O
also,O
reports,O
that,O
he,O
has,O
had,O
"",O
yellowish,B-PR
eyes,I-PR
",",O
some,B-PR
shaking,I-PR
and,O
his,O
breath,O
smelled,O
more,O
like,O
ammonia,O
over,O
the,O
past,O
3,O
days,O
."",O

The,O
patient,O
has,O
been,O
compliant,O
with,O
his,B-TR
medications,I-TR
.,O

He,O
has,O
had,O
one,O
bowel,O
movement,O
today,O
which,O
is,O
on,O
2014-03-31,O
.,O

He,O
has,O
had,O
night,B-PR
sweats,I-PR
for,O
the,O
past,O
2,O
weeks,O
.,O

He,O
denies,O
any,B-PR
abdominal,I-PR
pain,I-PR
.,O

He,O
gets,O
cold,B-PR
easily,O
but,O
denies,O
fevers,B-PR
.,O

His,O
stools,O
have,O
been,O
brown,O
to,O
green,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

HCV,B-PR
cirrhosis,I-PR
.,O

Underwent,O
treatment,B-TR
with,O
Interferon,B-TR
10,O
years,O
ago,O
.,O

He,O
stopped,O
secondary,O
to,O
aggressive,B-PR
behavior,I-PR
.,O

History,O
of,O
hepatic,B-PR
encephalopathy,I-PR
.,O

Esophageal,B-PR
varices,I-PR
.,O

EGD,B-TE
on,O
2013-12-08,O
demonstrated,O
5,B-PR
cores,I-PR
of,I-PR
varices,I-PR
",",O
grade,O
1,O
to,O
2,O
at,O
the,O
lower,O
third,O
of,O
the,O
esophagus,O
.,O

Four,B-TR
bands,I-TR
were,O
placed,O
without,O
difficulty,O
.,O

Also,O
",",O
the,O
patient,O
has,O
a,O
past,O
medical,O
history,O
of,O
hypertension,B-PR
",",O
glucose,B-PR
intolerance,I-PR
",",O
peripheral,B-PR
neuropathy,I-PR
.,O

The,O
patient,O
was,O
taken,O
off,O
of,O
Neurontin,B-TR
because,O
it,O
started,O
to,O
worsen,O
his,O
mental,O
status,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Nadolol,B-TR
20,O
mg,O
q.,O
Day,O
.,O

Protonix,B-TR
20,O
mg,O
q.,O
24,O
hours,O
.,O

Osamine,B-TR
200,O
mg,O
t.i.d.,O

Lactulose,B-TR
30,O
mg,O
q.i.d.,O

Lasix,B-TR
40,O
mg,O
q.,O
Day,O
.,O

Insulin,B-TR
regular,I-TR
.,O

Amlodipine,B-TR
5,O
mg,O
q.,O
Day,O
.,O

Retazepine,B-TR
50,O
mg,O
q,O
h.s.,O

Testosterone,B-TR
4,O
mg,O
q.,O
24,O
hours,O
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
is,O
married,O
and,O
lives,O
with,O
his,O
wife,O
.,O

Previously,O
employed,O
as,O
a,O
security,O
guard,O
at,O
a,O
nuclear,O
power,O
plant,O
.,O

Quit,O
tobacco,O
20,O
years,O
ago,O
and,O
currently,O
denies,O
any,O
cigarette,O
.,O

Alcohol,O
:,O
No,O
alcohol,O
use,O
.,O

The,O
patient,O
contracted,O
HCV,B-PR
20,O
years,O
ago,O
secondary,O
to,O
IV,O
drug,O
use,O
.,O

FAMILY,O
HISTORY,O
:,O

Mother,O
died,O
of,O
end,B-PR
stage,I-PR
renal,I-PR
disease,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Vital,B-TE
signs,I-TE
were,O
stable,O
.,O

Weight,B-TE
was,O
122.5,O
.,O

General,O
:,O
Patient,O
is,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

Lethargic,B-PR
",",O
occasionally,O
falling,O
asleep,O
.,O

HEENT,O
:,O
Pupils,O
equal,O
",",O
round,O
and,O
reactive,O
to,O
light,O
.,O

Sclera,B-PR
mildly,I-PR
icteric,I-PR
.,O

Neck,O
:,O
No,O
LAD,B-PR
.,O

Lungs,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

CV,O
:,O
Regular,O
rate,O
and,O
rhythm,O
.,O

Normal,O
S1,O
and,O
S2,O
without,O
murmurs,B-PR
or,O
rubs,B-PR
.,O

Positive,B-PR
gynecomastia,I-PR
.,O

Abdomen,O
:,O
Positive,O
bowel,O
sounds,O
",",O
soft,O
",",O
nondistended,B-PR
",",O
nontender,B-PR
.,O

Obvious,B-PR
ascites,I-PR
.,O

1+,B-PR
edema,I-PR
bilaterally,I-PR
.,O

Neurologic,O
:,O
Awake,O
",",O
alert,O
and,O
oriented,O
x3,O
.,O

Cranial,O
nerves,O
2,O
through,O
12,O
intact,O
.,O

There,O
was,O
mild,B-PR
asterixis,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
.,O

Patient,O
continued,O
on,O
Lactulose,B-TR
.,O

The,O
goal,O
was,O
3,O
to,O
4,O
stools,O
per,O
day,O
.,O

Continue,O
on,O
Rifaximine,B-TR
.,O

Continue,O
Lasix,B-TR
.,O

Physical,O
therapy,O
was,O
consulted,O
on,O
2014-04-01,O
.,O

On,O
2014-04-02,O
",",O
the,O
patient,O
was,O
awake,O
",",O
alert,O
and,O
oriented,O
",",O
taking,O
Lactulose,B-TR
.,O

Difficulty,B-PR
with,I-PR
word,I-PR
finding,I-PR
at,O
times,O
.,O

Denies,O
any,B-PR
pain,I-PR
or,O
discomfort,B-PR
.,O

Abdomen,O
:,O
Slightly,B-PR
distended,I-PR
",",O
nontender,B-PR
.,O

Positive,O
bowel,O
sounds,O
.,O

Positive,O
flatus,O
.,O

Good,O
op,O
site,O
.,O

Ultrasound,B-TE
was,O
performed,O
on,O
2014-04-01,O
demonstrating,O
severe,B-PR
portal,I-PR
hypertension,I-PR
with,O
massive,B-PR
peri,I-PR
splenic,I-PR
varices,I-PR
and,O
splenorenal,B-TR
shunt,I-TR
.,O

Portal,O
vein,O
was,O
fully,O
patent,O
.,O

Repeat,B-PR
hepato,I-PR
fungal,I-PR
flare,I-PR
.,O

On,O
2014-04-04,O
",",O
the,O
transplant,O
service,O
was,O
consulted,O
because,O
the,O
patient,O
was,O
possibly,O
going,O
to,O
the,O
operating,O
room,O
for,O
transplant,B-TR
on,O
2014-04-04,O
.,O

The,O
patient,O
did,O
go,O
to,O
operating,O
room,O
on,O
2014-04-04,O
and,O
the,O
patient,O
had,O
cadaveric,B-TR
liver,I-TR
transplant,I-TR
performed,O
by,O
Dr.,O
Michael,O
Sanders,O
.,O

Please,O
see,O
detailed,O
operative,O
note,O
for,O
more,O
information,O
about,O
the,B-TR
procedure,I-TR
.,O

Postoperatively,O
",",O
the,O
patient,O
was,O
transferred,O
to,O
the,O
ICU,O
.,O

The,O
patient,O
received,O
MMF,B-TR
1,O
gram,O
b.i.d.,O
",",O
Flagyl,B-TR
500,O
mg,O
IV,O
x1,O
.,O

The,O
patient,O
also,O
received,O
Unasyn,B-TR
for,O
2,O
days,O
",",O
Fluconazole,B-TR
",",O
heparin,B-TR
",",O
Protonix,B-TR
",",O
insulin,B-TR
",",O
morphine,B-TR
",",O
Bactrim,B-TR
.,O

The,O
patient,O
was,O
on,O
Propofol,B-TR
for,O
2,O
days,O
.,O

LABORATORY,O
DATA,O
:,O

On,O
2014-04-04,O
",",O
labs,B-TE
were,O
as,O
follows,O
:,O

WBC,B-TE
of,O
8.3,O
;,O
hematocrit,B-TE
of,O
30.6,O
;,O
platelets,B-TE
69,O
;,O
sodium,B-TE
132,O
;,O
3.9,O
",",O
102,O
",",O
22,O
",",O
serum,B-TE
creatinine,I-TE
of,O
13,O
and,O
1.1,O
.,O

Glucose,B-TE
114,O
.,O

AST,B-TE
87,O
.,O

ALT,B-TE
44,O
.,O

Alkaline,B-TE
phosphatase,I-TE
169,O
.,O

PT,B-TE
of,O
20.6,O
.,O

PTT,B-TE
of,O
38.7,O
.,O

INR,B-TE
of,O
2.0,O
.,O

On,O
postoperative,O
day,O
number,O
1,O
",",O
duplex,B-TE
ultrasound,I-TE
of,I-TE
the,I-TE
patient,I-TE
's,I-TE
liver,I-TE
was,O
performed,O
demonstrating,O
normal,O
appearing,O
portal,O
veins,O
and,O
hepatic,O
arteries,O
.,O

There,O
was,O
normal,O
flow,O
within,O
the,O
middle,O
hepatic,O
vein,O
.,O

There,O
appears,O
to,O
be,O
a,B-PR
decreased,I-PR
and,I-PR
sluggish,I-PR
flow,I-PR
within,I-PR
the,I-PR
right,I-PR
and,I-PR
left,I-PR
hepatic,I-PR
veins,I-PR
with,O
loss,B-PR
of,I-PR
normal,I-PR
respiratory,I-PR
variations,I-PR
",",I-PR
wave,I-PR
forms,I-PR
and,I-PR
the,I-PR
intrahepatic,I-PR
portion,I-PR
.,O

Additionally,O
",",O
there,O
is,O
diminished,B-PR
color,I-PR
flow,I-PR
with,O
confluence,O
of,O
the,O
hepatic,O
veins,O
.,O

These,O
findings,O
may,O
reflect,O
thrombus,B-PR
within,I-PR
the,I-PR
left,I-PR
and,I-PR
right,I-PR
hepatic,I-PR
veins,I-PR
.,O

Caval,B-PR
narrowing,I-PR
is,O
seen,O
",",O
most,O
likely,O
correlation,O
to,O
clinical,O
history,O
is,O
recommended,O
and,O
further,O
evaluation,O
of,O
the,B-TE
CT,I-TE
or,O
short-term,B-TE
ultrasounds,I-TE
for,O
follow-up,O
was,O
recommended,O
.,O

The,B-TR
Feeney,I-TR
Gann-Burlington,I-TR
drain,I-TR
on,O
postoperative,O
day,O
number,O
demonstrated,O
medial,B-TE
output,I-TE
of,O
780,O
with,O
lateral,B-TE
output,I-TE
of,O
150,O
.,O

Patient,O
went,O
to,O
the,O
floor,O
and,O
patient,O
was,O
on,O
the,O
floor,O
on,O
2014-04-07,O
.,O

Patient,O
continued,O
getting,O
Acyclovir,B-TR
",",O
Prednisone,B-TR
",",O
MMF,B-TR
one,O
gram,O
b.i.d,O
.,O

The,O
patient,O
was,O
on,O
FK,B-TR
2,I-TR
and,O
2,O
that,O
was,O
started,O
on,O
postoperative,O
day,O
number,O
2,O
.,O

Diet,O
was,O
advanced,O
.,O

Patient,O
was,O
ambulating,O
.,O

Waltham-Ludlow,B-TR
drains,I-TR
put,O
out,O
on,O
the,O
13th,O
620,O
and,O
380,O
.,O

Physical,O
therapy,O
was,O
re,O
consulted,O
.,O

Omalley,O
was,O
consulted,O
on,O
2014-04-08,O
for,O
better,O
glucose,B-TR
control,I-TR
since,O
the,O
patient,O
was,O
on,O
steroids,B-TR
.,O

Social,O
work,O
was,O
consulted,O
.,O

Patient,O
continued,O
to,O
do,O
very,O
well,O
",",O
ambulating,O
",",O
following,O
the,O
diet,O
.,O

Patient,O
was,O
transfused,O
1,B-TR
unit,I-TR
of,I-TR
platelets,I-TR
on,O
2014-04-08,O
for,O
platelet,B-TE
count,I-TE
of,O
66,O
.,O

A,B-TE
heparin,I-TE
independent,I-TE
antibody,I-TE
was,O
sent,O
off,O
on,O
2014-04-07,O
which,O
was,O
unremarkable,O
.,O

On,O
2014-04-09,O
",",O
patient,O
continued,O
to,O
do,O
very,O
well,O
",",O
ambulating,O
",",O
tolerating,O
a,O
diet,O
",",O
urinating,O
without,O
difficulty,B-PR
.,O

Drains,B-TR
continued,O
to,O
put,O
out,O
significant,O
amount,O
of,O
fluid,O
.,O

Patient,B-TE
's,I-TE
labs,I-TE
from,O
2014-04-10,O
were,O
the,O
following,O
:,O

7.1,O
",",O
hematocrit,B-TE
of,O
30.8,O
",",O
platelets,B-TE
90,O
.,O

Sodium,B-TE
of,O
138,O
;,O
potassium,B-TE
3.5,O
;,O
106,O
",",O
28,O
",",O
31,O
",",O
1.0,O
",",O
glucose,B-TE
134,O
.,O

AST,B-TE
82,O
.,O

ALT,B-TE
176,O
.,O

Alkaline,B-TE
phosphatase,I-TE
78,O
which,O
all,O
have,O
significantly,O
decreased,O
since,O
postoperative,O
day,O
number,O
1,O
.,O

Total,B-TE
bilirubin,I-TE
was,O
0.9,O
.,O

On,O
2014-04-09,O
",",O
FK,B-TE
level,I-TE
was,O
10.3,O
.,O

Patient,O
left,O
on,O
2014-04-09,O
with,O
VNA,O
to,O
home,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Protonix,B-TR
40,O
mg,O
q.,O
24,O
.,O

Moltipine,B-TR
5,O
mg,O
q.,O
Day,O
.,O

Fluconazole,B-TR
400,O
mg,O
q.,O
24,O
hours,O
.,O

Prednisone,B-TR
20,O
mg,O
q.,O
Day,O
.,O

MMF,B-TR
1000,O
mg,O
b.i.d.,O
.,O

Lopressor,B-TR
50,O
m,O
b.i.d.,O

Percocet,B-TR
1,O
to,O
2,O
tabs,O
q.,O
4,O
to,O
6,O
hours,O
prn,O
.,O

Colace,B-TR
100,O
mg,O
b.i.d.,O

Bactrim,B-TR
SS,O
1,O
tab,O
q.,O
Day,O
.,O

Tacrolimus,B-TR
3,O
mg,O
b.i.d.,O

Lasix,B-TR
20,O
mg,O
b.i.d.,O

Valcyte,B-TR
900,O
mg,O
q.,O
Day,O
.,O

Patient,O
is,O
on,O
insulin,B-TR
sliding,I-TR
scale,I-TR
with,O
fixed,O
dose,O
.,O

FOLLOW,O
UP,O
:,O

The,O
patient,O
is,O
to,O
follow-up,O
with,O
Dr.,O
Amanda,O
Pepper,O
on,O
the,O
following,O
dates,O
:,O

2014-04-14,O
at,O
9,O
a.m.,O
",",O
2014-04-24,O
at,O
10:20,O
a.m.,O
and,O
2014-05-01,O
at,O
10:20,O
a.m.,O

If,O
the,O
patient,O
can,O
not,O
make,O
those,O
appointments,O
or,O
has,O
any,O
questions,O
about,O
the,O
appointments,O
",",O
please,O
call,O
787-984-9608,O
.,O

The,O
patient,O
is,O
to,O
call,O
787-984-9608,O
if,O
any,O
fevers,B-PR
",",O
chills,B-PR
",",O
nausea,B-PR
and,O
vomiting,B-PR
",",O
abdominal,B-PR
pain,I-PR
",",O
inability,B-PR
to,I-PR
take,I-PR
medications,I-PR
",",O
inability,B-PR
to,I-PR
eat,I-PR
or,I-PR
drink,I-PR
.,O

Patient,O
needs,O
to,O
have,O
labs,B-TE
every,O
Monday,O
and,O
Thursday,O
including,O
a,B-TE
CBC,I-TE
",",O
chem-10,B-TE
",",O
AST,B-TE
",",O
ALT,B-TE
",",O
alkaline,B-TE
phosphatase,I-TE
",",O
albumin,B-TE
",",O
total,B-TE
bilirubin,I-TE
and,O
Prograf,B-TE
level,I-TE
need,O
to,O
be,O
obtained,O
.,O

Please,O
fax,O
results,O
to,O
(,O
728,O
),O
250-3265,O
.,O

All,B-TE
cultures,I-TE
have,O
been,O
unremarkable,O
.,O

Cultures,B-TE
were,O
obtained,O
on,O
2014-03-31,O
.,O

Urine,B-TE
culture,I-TE
and,O
blood,B-TE
culture,I-TE
have,O
been,O
unremarkable,O
on,O
2014-04-03,O
.,O

Hepatitis,B-TE
viral,I-TE
load,I-TE
was,O
"76,500",O
.,O

Pathology,O
demonstrates,O
that,O
the,B-TE
pathology,I-TE
results,I-TE
of,I-TE
the,I-TE
liver,I-TE
were,O
not,O
finalized,O
.,O

Darrell,O
Diiorio,O
",",O
MD,O
",",O
PHD,O
02-366,O

Dictated,O
By,O
:,O
Deborah,O
JP,O
Allen,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2014-04-11,O
14:30:39,O

T,O
:,O
2014-04-11,O
15:05:40,O

Job,O
#:,O

88167,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Greg,O
Jones,O
on,O
:,O
FRI,O
2014-04-25,O
2:37,O
PM,O

(,O
End,O
of,O
Report,O
),O

242460787,O
DH,O

5950242,O

67766054,O

86004855,O

09/26/2004,O
12:00:00,O
AM,O

Face,O
Sheet,O
/,O
Discharge,O
Order,O

SIGNED,O

DIS,O

[,O
report,O
_,O
end,O
],O

Admission,O
Date,O
:,O

2015-11-09,O

Discharge,O
Date,O
:,O

2015-11-16,O

Date,O
of,O
Birth,O
:,O

2015-11-09,O

Sex,O
:,O

F,O

Service,O
:,O

CMED,O
CCU,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Baby,O
girl,O
Fritsche,O
is,O
the,O
1670,O
gram,O
product,O
of,O
a,O
31,O
and,O
06-17,O
week,O
gestation,O
born,O
to,O
a,O
34,O
-,O
year-old,O
G2,O
P1,O
now,O
2,O
woman,O
.,O

Fetal,B-TE
screens,I-TE
",",O
O,O
positive,O
",",O
antibody,B-TE
negative,O
",",O
RPR,B-TE
nonreactive,O
",",O
rubella,B-TE
immune,O
",",O
hepatitis,B-TE
surface,I-TE
antigen,I-TE
negative,O
",",O
GBS,B-TE
unknown,O
.,O

IVF,B-PR
pregnancy,I-PR
complicated,O
by,O
IUGR,B-PR
",",O
2,B-PR
vessel,I-PR
cord,I-PR
",",O
normal,O
fetal,O
echo,O
reverse,O
diastolic,O
flow,O
and,O
demise,B-PR
of,I-PR
twin,I-PR
A,I-PR
at,O
27,O
weeks,O
.,O

Twin,O
B,O
with,O
normal,O
fetal,O
survey,O
was,O
transferred,O
to,O
Boston,O
Medical,O
Center,O
at,O
26,O
and,O
2/7,O
weeks,O
with,O
IUGR,B-PR
of,I-PR
twin,I-PR
A,I-PR
was,O
first,O
noted,O
",",O
presented,O
with,O
preterm,B-PR
labor,I-PR
at,O
31,O
weeks,O
.,O

Betamethasone,B-TR
complete,O
at,O
approximately,O
26,O
weeks,O
and,O
31,O
weeks,O
.,O

Mother,O
was,O
on,O
clindamycin,B-TR
since,O
11-04,O
.,O

PPROM,B-PR
with,O
bleeding,B-PR
and,O
transverse,B-PR
lie,I-PR
prompted,O
cesarean,B-TR
section,I-TR
.,O

Abruption,B-PR
noted,O
.,O

Apgars,B-TE
were,O
6,O
and,O
9,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,O
weight,B-TE
1670,O
grams,O
approximately,O
50,O
th,O
percentile,O
",",O
length,B-TE
43,O
cm,O
50,O
th,O
percentile,O
",",O
head,B-TE
circumference,I-TE
not,O
done,O
.,O

Anterior,O
fontanel,O
soft,O
",",O
flat,O
",",O
cap,O
and,O
prong,B-TR
CPAP,I-TR
in,O
place,O
.,O

Nondysmorphic,B-PR
intact,O
Veliz,O
.,O

Comfortable,O
with,O
good,O
aeration,O
",",O
clear,O
breath,O
sounds,O
",",O
does,O
grunt,O
intermittently,O
when,O
disturbed,O
.,O

No,O
murmur,B-PR
.,O

Normal,O
pulses,O
.,O

Soft,O
abdomen,O
",",O
3,O
vessel,O
cord,O
.,O

No,O
hepatosplenomegaly,B-PR
.,O

Normal,O
female,O
genitalia,O
.,O

Positive,O
vaginal,B-PR
tag,I-PR
.,O

Patent,O
anus,O
.,O

No,O
hip,B-PR
click,I-PR
.,O

No,O
sacral,B-PR
dimple,I-PR
.,O

Moves,O
all,O
extremities,O
.,O

Decrease,B-PR
tone,I-PR
",",O
ruddy,O
",",O
warm,O
",",O
well,O
perfused,O
with,O
peripheral,B-TR
IV,I-TR
in,I-TR
left,I-TR
hand,I-TR
.,O

HOSPITAL,O
COURSE,O
:,O

Respiratory,O
.,O

Mills,O
was,O
admitted,O
to,O
the,O
newborn,O
intensive,O
care,O
unit,O
with,O
moderate,B-PR
respiratory,I-PR
distress,I-PR
.,O

Infant,O
placed,O
on,O
CPAP,B-TR
.,O

X-ray,B-TE
revealed,O
mild,B-PR
respiratory,I-PR
distress,I-PR
syndrome,I-PR
.,O

She,O
remained,O
on,O
CPAP,B-TR
for,O
a,O
total,O
of,O
24,O
hours,O
at,O
which,O
time,O
she,O
transitioned,O
to,O
room,O
air,O
and,O
continues,O
to,O
be,O
stable,O
in,O
room,O
air,O
.,O

Caffeine,B-TR
citrate,I-TR
was,O
initiated,O
on,O
11-14,O
for,O
apnea,B-PR
and,O
bradycardia,B-PR
of,I-PR
prematurity,I-PR
.,O

She,O
is,O
currently,O
receiving,O
11,O
mg,O
po,O
every,O
day,O
.,O

Cardiovascular,O
.,O

Has,O
been,O
cardiovascular,O
stable,O
throughout,O
hospital,O
course,O
.,O

Heart,B-TE
ranges,I-TE
130,O
s,O
to,O
160,O
s.,O

Blood,B-TE
pressure,I-TE
most,O
recently,O
60/37,O
with,O
a,O
mean,O
of,O
44,O
.,O

Fluid,O
and,O
electrolyte,O
.,O

Birth,B-TE
weight,I-TE
was,O
1670,O
grams,O
50,O
th,O
percentile,O
",",O
length,B-TE
43,O
cm,O
50,O
th,O
percentile,O
.,O

Head,B-TE
circumference,I-TE
not,O
done,O
.,O

Infant,O
was,O
initially,O
started,O
on,O
80,O
cc,O
per,O
kilo,O
per,O
day,O
of,O
D10W,B-TR
.,O

Enteral,B-TR
feedings,I-TR
were,O
initiated,O
on,O
day,O
of,O
life,O
#1,O
.,O

Infant,O
achieved,O
full,B-TR
enteral,I-TR
feedings,I-TR
by,O
day,O
of,O
life,O
6,O
.,O

She,O
is,O
currently,O
receiving,O
150,O
cc,O
per,O
kilo,O
per,O
day,O
of,O
Special,B-TR
Care,I-TR
20,I-TR
.,O

Her,B-TE
discharge,I-TE
weight,I-TE
is,O
1477,O
gm,O
.,O

Her,O
most,O
recent,O
set,O
of,O
electrolytes,O
were,O
on,O
2015-11-13,O
with,O
a,B-TE
sodium,I-TE
of,O
143,O
",",O
a,B-TE
potassium,I-TE
of,O
6.3,O
hemolyzed,O
",",O
a,B-TE
chloride,I-TE
of,O
113,O
and,O
a,B-TE
total,I-TE
CO2,I-TE
of,O
17,O
.,O

She,O
will,O
need,O
advance,B-TR
calorie,I-TR
density,I-TR
for,O
better,O
growth,O
.,O

GI,B-TE
.,I-TE
Bilirubin,I-TE
peaked,O
on,O
day,O
of,O
life,O
#2,O
of,O
9.0,O
/,O
0.3,O
.,O

Infant,O
is,O
under,O
phototherapy,B-TR
",",O
which,O
was,O
discontinued,O
on,O
11-13,O
.,O

Most,B-TE
recent,I-TE
bilirubin,I-TE
was,O
on,O
11-14,O
of,O
4.8,O
/,O
0.3,O
.,O

Hematology,O
.,O

Hematocrit,B-TE
on,O
admission,O
was,O
53.7,O
.,O

She,O
has,O
not,O
required,O
any,B-TR
blood,I-TR
transfusions,I-TR
.,O

Infectious,O
disease,O
.,O

A,B-TE
CBC,I-TE
and,O
blood,B-TE
culture,I-TE
obtained,O
on,O
admission,O
.,O

CBC,B-TE
had,O
a,B-TE
white,I-TE
blood,I-TE
cell,I-TE
count,I-TE
of,O
9,O
",",O
17,O
polys,B-TE
",",O
0,O
bands,B-TE
",",O
platelets,B-TE
of,O
326,O
.,O

She,O
received,O
48,O
hours,O
of,O
ampicillin,B-TR
and,O
gentamycin,B-TR
with,O
negative,O
blood,B-TE
cultures,I-TE
and,O
antibiotics,B-TR
were,O
discontinued,O
.,O

Neurological,O
.,O

She,O
has,O
been,O
appropriate,O
for,O
gestational,O
age,O
.,O

Head,B-TE
ultrasound,I-TE
was,O
performed,O
on,O
2015-11-16,O
and,O
was,O
normal,O
.,O

Sensory,B-TE
",",I-TE
hearing,I-TE
screen,I-TE
has,O
not,O
yet,O
been,O
performed,O
",",O
but,O
should,O
be,O
done,O
prior,O
to,O
discharge,O
.,O

CONDITION,O
AT,O
DISCHARGE,O
:,O

Stable,O
.,O

DISCHARGE,O
DISPOSITION,O
:,O

To,O
Boston,O
Medical,O
Center,O
.,O

PRIMARY,O
PEDIATRICIAN,O
:,O

Dr.,O
Kim,O
Adams,O
.,O

Telephone,O
number,O
is,O
(,O
261,O
),O
564-6894,O
.,O

CARE,O
AND,O
RECOMMENDATIONS,O
:,O

Continue,O
150,O
cc,O
per,O
kilo,O
per,O
day,O
of,O
Special,B-TR
Care,I-TR
20,I-TR
calories,I-TR
advancing,O
caloric,O
intake,O
as,O
required,O
to,O
maintain,O
weight,O
gain,O
of,O
3,O
grams,O
per,O
kilogram,O
per,O
day,O
.,O

Medications,B-TR
",",O
continue,O
caffeine,B-TR
citrate,I-TR
of,O
11,O
mg,O
po,O
every,O
day,O
.,O

Car,B-TE
seat,I-TE
position,I-TE
screening,I-TE
has,O
not,O
yet,O
been,O
done,O
.,O

State,B-TE
newborn,I-TE
screen,I-TE
was,O
sent,O
on,O
day,O
of,O
life,O
#3,O
and,O
at,O
discharge,O
.,O

Initial,O
results,O
were,O
within,O
normal,O
limits,O
.,O

Immunizations,B-TR
received,O
",",O
infant,O
has,O
not,O
received,O
any,B-TR
immunizations,I-TR
to,O
date,O
.,O

State,B-TE
newborn,I-TE
screen,I-TE
was,O
sent,O
on,O
2015-11-12,O
.,O

Immunizations,B-TR
:,O
recommended,O
Synagis,B-TR
RSV,I-TR
prophylaxis,I-TR
should,O
be,O
considered,O
from,O
November,O
through,O
March,O
for,O
infants,O
who,O
meet,O
any,O
of,O
the,O
following,O
3,O
criteria,O
",",O
born,O
at,O
less,O
than,O
32,O
weeks,O
",",O
born,O
between,O
32,O
and,O
35,O
weeks,O
with,O
2,O
of,O
the,O
following,O
",",O
daycare,O
during,O
RSV,O
season,O
",",O
a,O
smoker,O
in,O
the,O
household,O
",",O
neuromuscular,B-PR
disease,I-PR
and,O
weight,B-PR
abnormalities,I-PR
or,O
school,O
age,O
siblings,O
with,O
chronic,B-PR
lung,I-PR
disease,I-PR
.,O

Influenza,B-TR
immunization,I-TR
is,O
recommended,O
annually,O
in,O
the,O
fall,O
for,O
all,O
infants,O
once,O
they,O
reach,O
6,O
months,O
of,O
age,O
.,O

Before,O
this,O
age,O
and,O
for,O
the,O
first,O
24,O
months,O
of,O
the,B-TR
child,I-TR
's,I-TR
life,I-TR
immunizations,I-TR
against,O
influenza,B-PR
is,O
recommended,O
for,O
household,O
contacts,O
and,O
out,O
of,O
home,O
care,O
givers,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

Premature,B-PR
infant,I-PR
born,O
at,O
31,O
and,O
6/7,O
weeks,O
gestation,O
",",O
resolved,O
respiratory,B-PR
distress,I-PR
syndrome,I-PR
.,O

Rule,O
out,O
sepsis,B-PR
with,O
antibiotic,B-TR
.,O

Hyperbilirubinemia,B-PR
resolving,O
.,O

Apnea,B-PR
and,O
bradycardia,B-PR
of,I-PR
prematurity,I-PR
.,O

Tai,O
Pamela,O
Wendell,O
",",O
Oklahoma,O
05158,O

Dictated,O
By,O
:,O
Kurt,O
S,O
Imperato,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2015-11-15,O
21:17:13,O

T,O
:,O
2015-11-16,O
06:38:42,O

Job,O
#:,O

82694,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Debbie,O
TRAN,O
on,O
:,O
MON,O
2015-11-16,O
9:57,O
AM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2018-05-26,O

Discharge,O
Date,O
:,O

2018-05-31,O

Date,O
of,O
Birth,O
:,O

1935-11-10,O

Sex,O
:,O

F,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Codeine,B-TR
/,O
Iodine,B-TR

Attending,O
:,O
Derrick,O
L.,O
Mayo,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

large,B-PR
pericardial,I-PR
effusion,I-PR
",",O
transfer,O
from,O
OSH,O

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

Thoracentesis,B-TR
2018-05-27,O

History,O
of,O
Present,O
Illness,O
:,O

82,O
F,O
with,O
h/o,O
COPD,B-PR
",",O
CAD,B-PR
",",O
pafib,B-PR
and,O
SSS,B-PR
s/p,O
pacer,B-TR
on,O
05-08,O
for,O
symptomatic,B-PR
pauses,I-PR
is,O
transferred,O
for,O
large,B-PR
pericardial,I-PR
effusion,I-PR
?,O
needing,O
drainage,B-TR
and,O
CHF,B-PR
.,O

She,O
was,O
admitted,O
to,O
Cambridge,O
Hospital,O
2018-05-24,O
with,O
ARF,B-PR
(,O
Cr,B-TE
3.5,O
up,O
from,O
0.9,O
),O
and,O
SOB,B-PR
.,O

According,O
to,O
her,O
guardian,O
she,O
was,O
discharged,O
to,O
her,O
NH,O
for,O
a,O
few,O
days,O
after,O
her,B-TR
pacer,I-TR
was,O
placed,O
05-08,O
",",O
which,O
was,O
complicated,O
by,O
a,B-PR
PTX,I-PR
requiring,O
CT,B-TR
placement,I-TR
which,O
had,O
been,O
d/c,O
'd,O
in,O
the,O
hospital,O
after,O
resolution,O
of,O
her,B-PR
PTX,I-PR
.,O

She,O
had,O
some,O
nausea,B-PR
/,O
vomiting,B-PR
and,O
generally,O
was,O
taking,O
poor,O
pos,O
at,O
her,O
NH,O
.,O

There,O
had,O
been,O
some,O
concern,O
her,B-PR
nausea,I-PR
was,O
due,O
to,O
her,B-TR
amiodarone,I-TR
which,O
had,O
been,O
discontinued,O
about,O
1,O
week,O
ago,O
.,O

She,O
was,O
then,O
sent,O
to,O
Franklin,O
Medical,O
Center,O
05-24,O
with,O
lethargy,B-PR
and,O
n/v,B-PR
.,O

At,O
Erich,O
Lindemann,O
Mental,O
Health,O
Center,O
she,O
was,O
discovered,O
to,O
have,O
ARF,B-PR
",",O
a,B-PR
large,I-PR
pericardial,I-PR
effusion,I-PR
",",O
and,O
bilateral,B-PR
pleural,I-PR
effusions,I-PR
.,O

She,O
was,O
treated,O
with,O
IVF,B-TR
for,O
her,B-PR
ARF,I-PR
.,O

She,O
underwent,O
a,B-TE
TTE,I-TE
at,O
Erich,O
Lindemann,O
Mental,O
Health,O
Center,O
today,O
(,O
05-26,O
),O
showing,O
mod-lg,B-PR
circumferential,I-PR
pericardial,I-PR
effusion,I-PR
without,O
evidence,O
of,O
RV,B-PR
diastolic,I-PR
collapse,I-PR
and,O
no,O
MV,O
inflow,O
evidence,O
of,O
tamponade,B-PR
",",O
pacer,B-TR
wire,I-TR
located,O
in,O
RV,O
apex,O
.,O

There,O
was,O
still,O
concern,O
for,O
her,B-PR
effusion,I-PR
contributing,O
to,O
her,B-PR
SOB,I-PR
at,O
the,O
OSH,O
so,O
she,O
was,O
transferred,O
for,O
drainage,B-TR
and,O
treatment,B-TR
of,O
CHF,B-PR
.,O

Today,O
she,O
only,O
complains,O
of,O
some,B-PR
SOB,I-PR
",",O
which,O
she,O
says,O
remains,O
largely,O
unchanged,O
over,O
the,O
past,O
few,O
days,O
.,O

She,O
denies,O
any,B-PR
CP,I-PR
/,O
cough,B-PR
/,O
fever,B-PR
/,O
abd,B-PR
pain,I-PR
/,O
diarrhea,B-PR
/,O
black,B-PR
or,I-PR
bloody,I-PR
stools,I-PR
/,O
headache,B-PR
.,O

Past,O
Medical,O
History,O
:,O

htn,B-PR

afib,B-PR
",",O
SSS,B-PR

COPD,B-PR

CAD,B-PR

pacer,B-TR
DDDR,I-TR
(,I-TR
Vitatron,I-TR
CL860,I-TR
),I-TR
placed,O
05-08,O
for,O
SSS,B-PR
with,O
symptomatic,B-PR
bradycardia,I-PR
",",O
c/b,O
R,B-PR
PTX,I-PR
requiring,O
chest,B-TR
tube,I-TR

GERD,B-PR

CVA,B-PR

hypothyroidism,B-PR

legally,B-PR
blind,I-PR

Social,O
History,O
:,O

NH,O
resident,O
",",O
guardian,O
Robert,O
Murrell,O

Family,O
History,O
:,O

NC,O

Physical,O
Exam,O
:,O

Exam,O
:,O
T,B-TE
96.2,O
HR,B-TE
70,O
BP,B-TE
118/46,O
R,B-TE
24,O
sat,B-TE
90%,O
on,O
60%FM,B-TR

pulsus,B-PR
parodoxus,I-PR
=,O
6-8,O
mm,O

gen,O
:,O
mild,B-PR
resp,I-PR
distress,I-PR
speaking,O
in,O
full,O
sentences,O
but,O
using,O
accessory,O
muscles,O

HEENT,O
:,O
mmm,O
",",O
JVP,B-TE
at,O
14,O
cm,O
",",O
no,O
bruits,B-PR
",",O
supple,O

CV,O
:,O
RRR,O
",",O
02-19,O
sys,O
m,O
at,O
RUSB,O

pulm,O
:,O
no,O
BS,B-TE
01-15,O
way,O
up,O
bilat,O
",",O
no,O
consolidation,B-PR

abd,O
:,O
s/nt/slightly,O
distended,B-PR
",",O
dec,B-PR
BS,I-PR
",",O
no,O
CVA,B-PR
tenderness,I-PR

ext,O
:,O
1+,B-PR
LE,I-PR
edema,I-PR

Pertinent,O
Results,O
:,O

ECG,B-TE
:,O
a,O
paced,O
at,O
70,O
bpm,O
/,O
nml,O
axis,O
",",O
LBBB,B-PR
",",O
no,O
ST,B-PR
or,I-PR
TW,I-PR
changes,I-PR

CXR,B-TE
at,O
Erich,O
Lindemann,O
Mental,O
Health,O
Center,O
05-26,O
:,O
bilateral,B-PR
pleural,I-PR
eff,I-PR
and,O
pericardial,B-PR
eff,I-PR

CT,B-TE
chest,I-TE
at,O
Erich,O
Lindemann,O
Mental,O
Health,O
Center,O
05-25,O
:,O
large,B-PR
pericardial,I-PR
effusion,I-PR
",",O
bilat,B-PR
pleural,I-PR
eff,I-PR
with,O
underlying,B-PR
consolidation,I-PR
which,O
could,O
represent,O
PNA,B-PR
vs.,O
atelectasis,B-PR

TTE,B-TE
at,O
Erich,O
Lindemann,O
Mental,O
Health,O
Center,O
05-26,O
:,O
mod-lg,B-PR
circumferential,I-PR
pericardial,I-PR
eff,I-PR
",",O
no,O
evidence,O
of,O
RV,B-PR
diastolic,I-PR
collapse,I-PR
",",O
no,O
MV,O
inflow,O
evidence,O
of,O
tamponade,B-PR
",",O
pacer,B-TR
lead,I-TR
located,O
in,O
RV,O
apex,O

head,B-TE
CT,I-TE
at,O
Erich,O
Lindemann,O
Mental,O
Health,O
Center,O
05-24,O
:,O
atrophy,B-PR
",",O
dense,B-PR
calcification,I-PR
of,I-PR
the,I-PR
tentorium,I-PR
",",O
most,O
likely,O
of,O
metabolic,O
etiology,O

IMAGING,B-TE
AT,O
Providence,O
Behavioral,O
Health,O
Hospital,O
:,O

ECHO,B-TE
2018-05-28,O

IMPRESSION,O
:,O
Moderate,B-PR
to,I-PR
large,I-PR
pericardial,I-PR
effusion,I-PR
(,O
minimal,B-PR
fluid,I-PR
anteriorly,I-PR
(,O
1cm,O
"),",O
?,O
bloody,B-PR
).,O

No,O
definite,B-PR
tamponade,I-PR
physiology,I-PR
.,O

Pacer,B-TR
seen,O
in,O
RV,O
apex,O
",",O
but,O
cannot,O
exclude,O
perforation,B-PR
.,O

CXR,B-TE
2018-05-30,O

FINDINGS,O
:,O
The,B-TE
lung,I-TE
volumes,I-TE
are,O
Moderate,O
bilateral,B-PR
pleural,I-PR
effusions,I-PR
are,O
unchanged,O
.,O

Mild,B-PR
pulmonary,I-PR
edema,I-PR
is,O
unchanged,O
.,O

Lung,B-TE
volumes,I-TE
are,O
low,B-PR
.,O

Bibasilar,B-PR
atelectasis,I-PR
is,O
unchanged,O
.,O

IMPRESSION,O
:,O
Unchanged,B-PR
moderate,I-PR
bilateral,I-PR
pleural,I-PR
effusions,I-PR
and,O
mild,B-PR
CHF,I-PR
.,O

RENAL,B-TE
US,I-TE
2018-05-28,O

FINDINGS,O
:,O
The,O
right,O
kidney,O
measures,O
11,O
cm,O
in,O
length,B-TE
",",O
the,O
left,O
kidney,O
measures,O
9.7,O
cm,O
in,O
length,B-TE
.,O

No,O
hydronephrosis,B-PR
is,O
seen,O
.,O

No,O
urinary,B-PR
calculi,I-PR
are,O
seen,O
.,O

The,O
bladder,O
appears,O
unremarkable,O
and,O
contains,O
a,B-TR
Foley,I-TR
catheter,I-TR
.,O

IMPRESSION,O
:,O
No,O
evidence,O
of,O
hydronephrosis,B-PR
.,O

Brief,O
Hospital,O
Course,O
:,O

A/P,O
:,O

82,O
y/o,O
f,O
w,O
h/o,O
afib,B-PR
",",O
SSS,B-PR
s/p,O
pacer,B-TR
05-08,O
c/b,O
PTX,B-PR
requiring,O
CT,B-TR
",",O
CAD,B-PR
",",O
who,O
was,O
readmitted,O
05-24,O
with,O
ARF,B-PR
and,O
lethargy,B-PR
",",O
found,O
to,O
have,O
a,B-PR
large,I-PR
pericardial,I-PR
effusion,I-PR
and,O
bilateral,B-PR
pleural,I-PR
effusions,I-PR
",",O
with,O
echo,B-TE
showing,O
no,O
evidence,O
of,O
tamponade,B-PR
",",O
who,O
is,O
transferred,O
for,O
possible,O
pericardial,B-TR
effusion,I-TR
drainage,I-TR
and,O
treatment,B-TR
of,O
CHF,B-PR
",",O
as,O
well,O
as,O
drainage,B-TR
of,O
bilateral,B-PR
pleural,I-PR
effusions,I-PR
.,O

She,O
had,O
a,B-TE
BNP,I-TE
of,O
>,O
5000,O
on,O
admission,O
.,O

Since,O
admission,O
",",O
she,O
ruled,O
out,O
for,O
MI,B-PR
by,O
enzymes,B-TE
",",O
and,O
had,O
a,B-TE
right,I-TE
sided,I-TE
thoracentesis,I-TE
which,O
yielded,O
transudative,B-PR
fluid,I-PR
.,O

WBC,B-TE
s,I-TE
since,O
admission,O
were,O
as,O
high,O
as,O
"14,000",O
but,O
normalized,O
.,O

She,O
also,O
had,O
2,B-TE
echocardiograms,I-TE
which,O
revealed,O
persistent,B-PR
pericardial,I-PR
effusions,I-PR
.,O

She,O
has,O
been,O
gently,O
diuresed,O
but,O
has,O
worsening,B-PR
ARF,I-PR
.,O

Her,B-PR
O2,I-PR
requirement,I-PR
has,O
increased,O
despite,O
diuresis,B-TR
.,O

She,O
denies,O
any,O
CP,B-PR
/,O
cough,B-PR
/,O
fever,B-PR
",",O
abdominal,B-PR
pain,I-PR
/,O
diarrhea,B-PR
",",O
black,B-PR
or,I-PR
bloody,I-PR
stools,I-PR
or,O
headache,B-PR
.,O

Her,B-TE
urine,I-TE
output,I-TE
decreased,B-PR
to,O
nearly,O
zero,O
.,O

In,O
the,O
setting,O
of,O
her,B-PR
ongoing,I-PR
pericardial,I-PR
effusion,I-PR
",",O
she,O
was,O
transferred,O
for,O
closer,O
observation,O
to,O
the,O
CCU,O
.,O

The,O
CCU,O
fellow,O
and,O
team,O
declined,O
to,O
do,O
pericardial,B-TR
drainage,I-TR
",",O
as,O
the,O
pt,O
was,O
hemodynamically,O
stable,O
",",O
without,O
change,B-PR
in,I-PR
appearance,I-PR
of,I-PR
effusion,I-PR
by,O
echo,B-TE
performed,O
at,O
bedside,O
by,O
cards,O
fellow,O
.,O

As,O
she,O
was,O
felt,O
by,O
the,O
CCU,O
to,O
be,O
a,O
poor,O
candidate,O
for,O
right,B-TE
heart,I-TE
cath,I-TE
",",O
was,O
hemodynamically,O
stable,O
with,O
blood,B-TE
pressure,I-TE
110,O
s-,O
120,O
s,O
systolic,B-TE
and,O
pulse,B-TE
70,O
s-,O
80,O
s,O
",",O
she,O
was,O
called,O
out,O
of,O
the,O
CCU,O
and,O
back,O
to,O
the,O
cardiac,O
floor,O
without,O
intervention,B-TR
.,O

The,O
procedure,O
team,O
was,O
called,O
to,O
consider,O
doing,O
a,B-TR
left,I-TR
thoracentesis,I-TR
",",O
but,O
she,O
was,O
declined,O
because,O
it,O
was,O
felt,O
that,O
her,B-PR
effusions,I-PR
were,O
transudative,B-PR
",",O
secondary,O
to,O
CHF,B-PR
",",O
and,O
it,O
was,O
recommended,O
to,O
treat,O
CHF,B-PR
.,O

The,O
pt,O
continued,O
to,O
have,O
low,B-PR
urine,I-PR
output,I-PR
.,O

She,O
was,O
given,O
a,B-TR
lasix,I-TR
drip,I-TR
IV,I-TR
upon,O
call-out,O
of,O
the,O
ICU,O
",",O
and,O
additional,O
boluses,B-TR
of,I-TR
IV,I-TR
lasix,I-TR
",",O
200,O
mg,O
then,O
300,O
mg,O
IV,O
were,O
given,O
with,O
a,O
good,O
response,O
",",O
however,O
",",O
she,O
remained,O
net,B-PR
positive,I-PR
fluid,I-PR
balance,I-PR
.,O

Renal,O
consultants,O
did,O
not,O
feel,O
there,O
was,O
an,O
emergent,O
need,O
for,O
dialysis,B-TR
.,O

A,B-TR
nitro,I-TR
drip,I-TR
was,O
started,O
in,O
an,O
effort,O
to,O
decrease,O
her,O
preload,B-TE
and,O
afterload,B-TE
.,O

On,O
call,O
out,O
from,O
the,O
CCU,O
",",O
the,O
pt,O
was,O
satting,B-TE
93%,O
on,O
4-5L,O
NC,B-TR
",",O
and,O
through,O
the,O
following,O
night,O
",",O
her,B-PR
oxygen,I-PR
requirement,I-PR
increased,O
to,O
NRB,B-TR
",",O
wherein,O
she,O
was,O
satting,B-TE
upper,O
80,O
s-,O
low,O
90,O
s.,O

ABG,B-TE
that,O
evening,O
was,O
7.29/51/56,O
on,O
4L,O
NC,B-TR
and,O
early,O
the,O
next,O
morning,O
",",O
was,O
7.25/62/64,O
on,O
NRB,B-TR
.,O

A,B-TE
CXR,I-TE
was,O
performed,O
the,O
evening,O
of,O
5/16,O
",",O
showing,O
moderate,B-PR
sized,I-PR
bilateral,I-PR
pleural,I-PR
effusions,I-PR
",",O
stable,B-PR
cardiomegaly,I-PR
and,O
a,O
possible,O
RLL,B-PR
infiltrate,I-PR
.,O

Vancomycin,B-TR
and,O
Zosyn,B-TR
were,O
started,O
.,O

She,O
was,O
afebrile,B-PR
.,O

The,O
morning,O
of,O
5/17,O
",",O
her,B-TE
pulsus,I-TE
parodoxicus,I-TE
was,O
12,O
.,O

Because,O
of,O
her,B-TE
ABG,I-TE
",",O
and,O
declining,O
clinical,O
status,O
",",O
the,O
CCU,O
was,O
notified,O
for,O
possible,O
transfer,O
.,O

The,O
CMED,O
CSRU,O
Intern,O
called,O
the,O
Murphy,O
",",O
Robert,O
Leigh,O
",",O
to,O
give,O
her,O
the,O
update,O
with,O
regards,O
to,O
the,O
pt,O
's,O
deteriorating,O
clinical,O
status,O
.,O

It,O
was,O
felt,O
that,O
given,O
her,O
age,O
",",O
multiple,B-PR
co-morbidities,I-PR
",",O
that,O
her,O
prognosis,O
was,O
poor,O
even,O
prior,O
to,O
CCU,O
admission,O
",",O
possible,O
pericardial,B-TR
drainage,I-TR
or,O
repeat,B-TR
thoracenteses,I-TR
.,O

Goals,O
of,O
care,O
were,O
clarified,O
with,O
her,O
Murphy,O
",",O
Robert,O
Sanchez,O
.,O

Explained,O
to,O
Lewin,O
that,O
pt,O
will,O
likely,O
need,O
to,O
be,O
intubated,O
",",O
as,O
she,O
cannot,O
lie,O
flat,O
",",O
and,O
most,O
likely,O
cannot,O
undergo,O
pericardial,B-TR
drainage,I-TR
",",O
thoracentesis,B-TR
",",O
or,O
right,B-TR
heart,I-TR
cath,I-TR
with,O
BiPAP,B-TR
(,O
which,O
would,O
have,O
been,O
the,O
next,O
measure,O
after,O
NRB,B-TR
",",O
and,O
prior,O
to,O
intubation,B-TR
).,O

Explained,O
that,O
despite,O
these,B-TR
invasive,I-TR
measures,I-TR
",",O
she,O
still,O
has,O
a,O
very,O
poor,O
prognosis,O
.,O

Odell,O
stated,O
she,O
had,O
been,O
thinking,O
about,O
this,O
all,O
night,O
of,O
2018-05-30,O
",",O
and,O
agreed,O
that,O
this,O
is,O
not,O
what,O
the,O
pt,O
would,O
have,O
wanted,O
.,O

Odell,O
does,O
not,O
believe,O
the,O
pt,O
would,O
want,O
to,O
be,O
intubated,O
",",O
with,O
central,B-TR
line,I-TR
",",O
right,B-TR
heart,I-TR
cath,I-TR
",",O
in,O
the,O
CCU,O
.,O

She,O
requested,O
the,O
patient,O
be,O
made,O
Comfort,B-TR
Measures,I-TR
Only,O
.,O

She,O
was,O
DNR/DNI,O
on,O
admission,O
.,O

This,O
was,O
documented,O
in,O
the,O
computer,O
",",O
confirmed,O
with,O
Cardiology,O
attending,O
and,O
fellow,O
",",O
and,O
conveyed,O
to,O
the,O
CCU,O
staff,O
",",O
who,O
were,O
informed,O
she,O
may,O
need,O
to,O
go,O
for,O
transfer,O
(,O
which,O
was,O
subsequently,O
cancelled,O
).,O

The,O
pt,O
will,O
be,O
made,O
comfortable,O
",",O
with,O
goals,O
of,O
care,O
shifted,O
towards,O
suppressing,O
her,B-PR
air,I-PR
hunger,I-PR
and,O
pain,B-PR
.,O

#.,O
SOB,B-PR
:,O
Most,O
consistent,O
with,O
CHF,B-PR
by,O
exam,B-TE
",",O
although,O
unknown,O
what,O
the,O
severity,O
of,O
her,B-PR
COPD,I-PR
is,O
currently,O
.,O

TTE,B-TE
revealed,O
large,B-PR
pericardial,I-PR
effusion,I-PR
.,O

Pt,O
is,O
now,O
s/p,O
drainage,B-TR
of,O
right,B-PR
pleural,I-PR
effusion,I-PR
",",O
diagnostic,O
and,O
therapeutic,O
",",O
with,O
studies,B-TE
consistent,O
with,O
transudate,B-PR
",",O
etiology,O
most,O
likely,O
02-15,O
CHF,B-PR
.,O

We,O
continued,O
her,B-TR
albuterol,I-TR
/,O
atrovent,B-TR
nebs,I-TR
",",O
diuresis,B-TR
with,O
IV,B-TR
lasix,I-TR
drip,I-TR
and,O
boluses,B-TR
.,O

Her,B-TE
05-27,I-TE
CXR,I-TE
post,O
procedure,O
w/o,O
PNX,B-PR
",",O
effusion,B-PR
much,O
improved,O
",",O
yet,O
her,B-TE
05-28,I-TE
CXR,I-TE
worse,O
than,O
05-27,O
with,O
some,O
reaccumulation,O
of,O
right,B-PR
pleural,I-PR
effusion,I-PR
.,O

Then,O
",",O
on,O
05-29,O
",",O
she,O
demonstrated,O
bilateral,B-PR
pleural,I-PR
effusions,I-PR
(,O
reaccumulated,O
"),",O
right,B-PR
lower,I-PR
lobe,I-PR
infiltrate,I-PR
(,O
started,O
on,O
vanco,B-TR
/,O
zosyn,B-TR
)->,O
put,O
on,O
face,B-TR
mask,I-TR
",",O
given,O
lasix,B-TR
x,O
1,O
bolus,O
100,O
mg,O
",",O
responded,O
somewhat,O
and,O
o2,B-TE
sat,I-TE
stable,O
in,O
low,O
90,O
s.,O

She,O
was,O
given,O
200,B-TR
mg,I-TR
IV,I-TR
lasix,I-TR
X,O
1,O
with,O
an,O
additional,O
100,O
cc,O
of,O
urine,B-TE
output,I-TE
the,O
evening,O
of,O
5/16,O
.,O

Her,B-TR
lasix,I-TR
gtt,I-TR
continued,O
during,O
this,O
time,O
.,O

Her,B-TE
oxygen,I-TE
sats,I-TE
did,O
not,O
improve,O
.,O

She,O
was,O
then,O
made,O
CMO,O
.,O

See,O
above,O
.,O

#.,O
Pericardial,B-PR
effusion,I-PR
:,O
unclear,O
etiology,O
",",O
OSH,O
had,O
raised,O
question,O
of,O
RV,B-PR
perforation,I-PR
from,O
pacer,B-TR
",",O
however,O
she,O
had,O
a,O
normal,O
echo,O
appearance,O
of,O
lead,O
",",O
no,O
tamponade,B-PR
by,O
exam,B-TE
.,O

This,O
has,O
still,O
be,O
known,O
to,O
occur,O
during,O
the,B-TR
placement,I-TR
of,I-TR
pacemaker,I-TR
.,O

It,O
was,O
felt,O
posthumously,O
that,O
her,B-PR
large,I-PR
pericardial,I-PR
effusion,I-PR
was,O
most,O
likely,O
secondary,O
to,O
a,B-PR
complication,I-PR
of,O
pacer,B-TR
placement,I-TR
",",O
although,O
this,O
was,O
not,O
seen,O
on,O
imaging,B-TE
.,O

In,O
the,O
last,O
12,O
hours,O
of,O
her,O
life,O
",",O
her,B-TE
pulsus,I-TE
was,O
12,O
",",O
and,O
she,O
was,O
felt,O
to,O
likely,O
to,O
have,O
aspect,O
of,O
tamponade,B-PR
physiology,I-PR
",",O
since,O
her,B-TE
preload,I-TE
was,O
reduced,O
.,O

#.,O
CHF,B-PR
:,O
normal,O
EF,O
on,O
TTE,B-TE
so,O
possibly,O
with,O
diastolic,B-PR
dysfunction,I-PR
",",O
ruled,O
out,O
for,O
MI,B-PR

-,O
See,O
course,O
of,O
diuresis,B-TR
above,O
.,O

-,O
We,O
continued,O
ASA,B-TR
/,O
imdur,B-TR
/,O
CCB,B-TR
/,O
hold,O
diovan,B-TR
until,O
pt,O
was,O
made,O
CMO,O
.,O

#.,O
Pleural,B-PR
effusions,I-PR
:,O
Likely,O
due,O
to,O
CHF,B-PR
although,O
had,O
some,B-PR
leukocytosis,I-PR
at,O
admission,O
to,O
OSH,O
.,O

Mary,B-TE
studies,I-TE
c/w,O
transudate,B-PR
.,O

-,O
After,O
she,O
was,O
made,O
CMO,O
",",O
the,O
pt,O
was,O
started,O
on,O
Morphine,B-TR
gtt,I-TR
to,O
maximize,O
comfort,O
and,O
minimize,O
air,B-PR
hunger,I-PR
.,O

#.,O
Afib/SSS,B-PR
:,O
She,O
was,O
A-paced,B-TR
",",O
pacer,B-TR
placed,O
05-08,O
in,O
DDDR,B-TR
mode,I-TR
",",O
complicated,O
by,O
PTX,B-PR
requiring,O
chest,B-TR
tube,I-TR
which,O
resolved,O
and,O
tube,B-TR
was,O
removed,O
during,O
admit,O
for,O
pacer,B-TR
",",O
no,O
evidence,O
of,O
PTX,B-PR
on,O
most,B-TE
recent,I-TE
CXR,I-TE
.,O

Her,B-TR
pacer,I-TR
wires,I-TR
in,O
correct,O
position,O
.,O

We,O
continued,O
amiodarone,B-TR
until,O
pt,O
was,O
made,O
CMO,O
.,O

Anticoagulation,B-TR
has,O
not,O
been,O
given,O
this,O
admission,O
.,O

She,O
was,O
a,O
poor,O
anticoagulation,O
candidate,O
.,O

We,O
started,O
her,O
on,O
dilt,B-TR
for,O
additional,B-TR
a,I-TR
fib,I-TR
control,I-TR
(,O
revert,O
back,O
to,O
a,B-PR
fib,I-PR
on,O
05-29,O
"),",O
which,O
was,O
stopped,O
when,O
the,O
pt,O
was,O
made,O
CMO,O
.,O

#.,O
Oliguric,B-PR
ARF,I-PR
:,O
likely,O
prerenal,O
due,O
to,O
n/v,B-PR
poor,B-PR
po,I-PR
intake,I-PR
and,O
poor,B-PR
forward,I-PR
flow,I-PR
",",O
However,O
",",O
need,O
to,O
continue,O
diuresis,B-TR
.,O

Her,B-TE
urine,I-TE
lytes,I-TE
consistent,O
with,O
ATN,B-PR
",",O
FENA,B-TE
4%,O
.,O

Renal,B-TE
u/s,I-TE
negative,O
for,O
hydronephrosis,B-PR
.,O

Renal,O
consultants,O
did,O
not,O
feel,O
that,O
there,O
was,O
an,O
indication,O
for,O
urgent,B-TR
hemodialysis,I-TR
.,O

She,O
continued,O
to,O
put,O
out,O
low,B-PR
amounts,I-PR
of,I-PR
urine,I-PR
throughout,O
the,O
admission,O
",",O
despite,O
aggressive,B-TR
diuresis,I-TR
with,O
IV,B-TR
lasix,I-TR
gtt,I-TR
and,O
boluses,B-TR
.,O

See,O
above,O
.,O

#.,O
ID,O
:,O
initially,O
had,O
leukocytosis,B-PR
at,O
admission,O
",",O
with,O
chest,B-TE
CT,I-TE
showing,O
possible,O
underlying,B-PR
consolidations,I-PR
vs.,O
atelectasis,B-PR
",",O
levoflox,B-TR
started,O
05-24,O
and,O
subsequently,O
stopped,O
(,O
no,O
consolidations,B-PR
on,O
CXR,B-TE
and,O
afebrile,B-PR
).,O

U/A,B-TE
on,O
05-27,O
c/w,O
UTI,B-PR
.,O

Pt,O
now,O
on,O
IV,B-TR
Ceftriaxone,I-TR
(,O
was,O
on,O
levoflox,B-TR
since,O
05-24,O
however,O
UA,B-TE
now,O
floridly,B-PR
positive,I-PR
(,O
more,O
so,O
than,O
UA,B-TE
at,O
OSH,O
),O
so,O
felt,O
possibly,O
levo-resistant,B-PR
.,O

Pt,O
started,O
on,O
CTX,B-TR
05-27,O
.,O

She,O
was,O
empirically,O
started,O
on,O
vanco/zosyn,B-TR
for,O
empiric,B-TR
hosp,I-TR
acquired,I-TR
pna,I-TR
coverage,I-TR

-,O
possible,O
opacity,B-PR
on,O
CXR,B-TE
-,O
along,O
w/,O
leukocytosis,B-PR
.,O

#.,O
Anemia,B-PR
:,O
Unclear,O
source,O
.,O

She,O
was,O
guiaic,B-TE
negative,O
.,O

#.,O
FEN,O
:,O
check,O
lytes,B-TE
",",O
most,O
recently,O
normal,O
.,O

cardiac/renal,B-TR
diet,I-TR

#.,O
Access,O
:,O
PIV,B-TR

#.,O
Code,O
:,O
DNR/DNI/CMO,O
verified,O
with,O
Robert,O
Marks,O
2018-05-29,O

#.,O
Communication,O
:,O
Guardian,O
Robert,O
Fitzgerald,O
(,O
520,O
),O
328,O
5499,O
.,O

Medications,O
on,O
Admission,O
:,O

aranesp,B-TR
100,O
mcg,O
(,O
X1,O
05-26,O
),O

diltiazem,B-TR
CD,I-TR
240,O
mg,O

paxil,B-TR
20,O
mg,O
daily,O

detrol,B-TR
LA,I-TR
4,O
mg,O
daily,O

EC,B-TR
ASA,I-TR
81,O
mg,O
daily,O

pepcid,B-TR
20,O
mg,O
daily,O

amiodarone,B-TR
200,O
mg,O
daily,O

levofloxacin,B-TR
250,O
mg,O
IV,O
daily,O
(,O
started,O
05-24,O
),O

levothyroxine,B-TR
50,O
mcg,O
daily,O

diovan,B-TR
160,O
mg,O
daily,O

imdur,B-TR
60,O
mg,O
daily,O

albuterol-ipratroprium,B-TR
INH,O
2,O
sprays,O
tid,O
prn,O

Discharge,O
Disposition,O
:,O

Expired,O

Discharge,O
Diagnosis,O
:,O

1.,O
Pulmonary,B-PR
Edema,I-PR
and,O
Hypoxic,B-PR
Respiratory,I-PR
Failure,I-PR

2.,O
Large,B-PR
pericardial,I-PR
effusion,I-PR

3.,O
Moderate,B-PR
bilateral,I-PR
pleural,I-PR
effusions,I-PR

4.,O
Congestive,B-PR
Heart,I-PR
Failure,I-PR

5.,O
Paroxysmal,B-PR
Atrial,I-PR
Fibrillation,I-PR

6.,O
Sick,B-PR
sinus,I-PR
syndrome,I-PR
status,O
post,O
pacer,B-TR
placement,I-TR

7.,O
Coronary,B-PR
Artery,I-PR
Disease,I-PR

Discharge,O
Condition,O
:,O

Expired,O

Discharge,O
Instructions,O
:,O

Not,O
applicable,O

Followup,O
Instructions,O
:,O

Not,O
applicable,O

Jessica,O
Ashley,O
MD,O
19-617,O

Completed,O
by,O
:,O
James,O
Weishaar,O
MD,O
01-503,O
2018-05-31,O
@,O
1428,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Barry,O
Smith,O
on,O
:,O
FRI,O
2018-06-01,O
8:26,O
AM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2016-07-18,O

Discharge,O
Date,O
:,O

2016-07-21,O

Date,O
of,O
Birth,O
:,O

1969-11-05,O

Sex,O
:,O

M,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Penicillins,B-TR

Attending,O
:,O
Daniel,O
Z.,O
H.,O
Walton,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

Dyspnea,B-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

None,O

History,O
of,O
Present,O
Illness,O
:,O

46,O
-,O
yo-man,O
w/,O
active,O
cocaine,O
use,O
presents,O
w/,O
LE,B-PR
edema,I-PR
.,O

10,O
days,O
ago,O
",",O
he,O
developed,O
b/l,B-PR
LE,I-PR
edema,I-PR
that,O
has,O
gotten,O
progressively,O
worse,O
until,O
now,O
.,O

Three,O
days,O
ago,O
",",O
he,O
developed,O
dyspnea,B-PR
on,O
exertion,O
when,O
climbing,O
stairs,O
",",O
assoc,O
w/,O
2-pillow,B-PR
orthopnea,I-PR
and,O
PND,B-PR
.,O

He,O
denies,O
any,B-PR
recent,I-PR
chest,I-PR
pain,I-PR
",",O
palpitations,B-PR
",",O
headache,B-PR
",",O
confusion,B-PR
",",O
weakness,B-PR
",",O
numbness,B-PR
",",O
abd,B-PR
pain,I-PR
",",O
or,O
hematuria,B-PR
.,O

No,O
recent,B-PR
viral,I-PR
syndromes,I-PR
or,O
URI,B-PR
s.,I-PR

He,O
does,O
admit,O
to,O
cocaine,O
use,O
last,O
night,O
.,O

Today,O
",",O
his,O
wife,O
convinced,O
him,O
to,O
present,O
to,O
the,O
Deanna,O
for,O
evaluation,B-TE
.,O

In,O
the,O
Deanna,O
",",O
his,B-TE
BP,I-TE
was,O
230/170,O
.,O

BNP,B-TE
was,O
elevated,O
at,O
7500,O
.,O

CXR,B-TE
revealed,O
evidence,O
of,O
cardiomegaly,B-PR
and,O
pulm,B-PR
edema,I-PR
.,O

He,O
was,O
treated,O
w/,O
ASA,B-TR
325,O
mg,O
",",O
lasix,B-TR
10,O
mg,O
IV,O
",",O
and,O
hydralazine,B-TR
10,O
mg,O
IV,O
x,O
2,O
.,O

He,O
responded,O
well,O
to,O
lasix,B-TR
w/,O
good,O
UOP,B-TE
",",O
but,O
diastolic,B-TE
BP,I-TE
remained,O
elevated,B-PR
at,O
170,O
",",O
prompting,O
initiation,O
of,O
nitroprusside,B-TR
gtt,I-TR
.,O

He,O
is,O
now,O
admitted,O
to,O
the,O
CCU,O
for,O
further,O
care,O
.,O

Past,O
Medical,O
History,O
:,O

none,O

Social,O
History,O
:,O

significant,O
for,O
current,O
tobacco,O
use,O
.,O

Drinks,O
3-4,O
beers,O
a,O
few,O
times,O
weekly,O
",",O
no,O
h/o,O
withdrawal,B-PR
symptoms,I-PR
",",O
seizures,B-PR
or,O
DT,B-PR
s.,I-PR

Snorts,O
cocaine,O
1-2,O
times,O
monthly,O
.,O

Never,O
injected,O
drugs,O
.,O

Family,O
History,O
:,O

There,O
is,O
no,O
family,O
history,O
of,O
premature,B-PR
coronary,I-PR
artery,I-PR
disease,I-PR
or,O
sudden,B-PR
death,I-PR
.,O

Physical,O
Exam,O
:,O

VS,B-TE
:,O
"T,",B-TE
BP,B-TE
181/122,O
",",O
HR,B-TE
84,O
",",O
RR,B-TE
12,O
",",O
O2,B-TE
98%,O
2L/m,O

Gen,O
:,O
lying,O
flat,O
in,O
bed,O
",",O
pleasant,O
and,O
conversational,O
",",O
NAD,B-PR

HEENT,O
:,O
NCAT,B-PR
.,O

Sclera,B-PR
anicteric,I-PR
.,O

PERRL,O
",",O
EOMI,O
.,O

OP,O
clear,O
w/,O
MMM,O
.,O

Neck,O
:,O
Supple,O
with,O
JVP,B-TE
of,O
8,O
cm,O
.,O

CV,O
:,O
reg,O
s1,O
",",O
loud,B-PR
s2,I-PR
",",O
+,O
2/6,B-PR
systolic,I-PR
murmur,I-PR
radiating,I-PR
to,I-PR
axilla,I-PR
",",O
no,O
s3/s4/r,B-PR

Pulm,O
:,O
CTA,O
b/l,O
w/,O
no,O
crackles,B-PR
or,O
wheezing,B-PR

Abd,O
:,O
obese,B-PR
",",O
+BS,O
",",O
soft,O
",",O
NTND,B-PR
.,O

Ext,O
:,O
warm,O
",",O
2+,O
DP,B-TE
b/l,O
",",O
2+,B-PR
pitting,I-PR
edema,I-PR
to,I-PR
knees,I-PR
b/l,I-PR

Neuro,O
:,O
a/o,O
x,O
3,O
",",O
CN,O
04-04,O
intact,O

Pertinent,O
Results,O
:,O

2016-07-18,O
17:30,O

WBC,B-TE
-,O
7.7,O
RBC,B-TE
-,O
5.00,O
HGB,B-TE
-,O
15.0,O
HCT,B-TE
-,O
42.8,O
MCV,B-TE
-,O
86,O
MCH,B-TE
-,O
30.0,O
MCHC,B-TE
-,O
35.0,O
RDW,B-TE
-,O
14.6,O

2016-07-18,O
17:30,O

PLT,B-TE
COUNT,I-TE
-,O
315,O

2016-07-18,O
17:30,O

CK-MB,B-TE
-,O
4,O
proBNP,B-TE
-,O
7489,O
*,O

2016-07-18,O
17:30,O

cTropnT,B-TE
-,O
0.02,O
*,O

2016-07-18,O
17:30,O

ALT(SGPT),B-TE
-,O
77,O
*,O
AST(SGOT),B-TE
-,O
60,O
*,O
CK(CPK),B-TE
-,O
195,O
*,O
ALK,B-TE
PHOS,I-TE
-,O
104,O
AMYLASE,B-TE
-,O
100,O
TOT,B-TE
BILI,I-TE
-,O
0.4,O

EKG,B-TE
demonstrated,O
NSR,O
at,O
87,O
bpm,O
",",O
nl,O
axis,O
",",O
nl,O
int,O
",",O
LVH,B-PR
w/,O
strain,B-PR
pattern,I-PR
",",O
no,O
ischemic,B-PR
changes,I-PR
.,O

CXR,B-TE
:,O

Moderate,B-PR
to,I-PR
severe,I-PR
enlargement,I-PR
of,I-PR
the,I-PR
cardiac,I-PR
silhouette,I-PR
",",O
and,O

Conclusions,O
:,O

The,O
left,O
atrium,O
is,O
moderately,B-PR
dilated,I-PR
.,O

There,O
is,O
moderate,B-PR
symmetric,I-PR
left,I-PR
ventricular,I-PR
hypertrophy,I-PR
with,O
mild,B-PR
cavity,I-PR
dilation,I-PR
and,O
severe,B-PR
global,I-PR
hypokinesis,I-PR
.,O

No,O
left,B-PR
ventricular,I-PR
thrombus,I-PR
is,O
seen,O
.,O

Tissue,B-TE
Doppler,I-TE
imaging,I-TE
suggests,O
an,B-PR
increased,I-PR
left,I-PR
ventricular,I-PR
filling,I-PR
pressure,I-PR
(,O
PCWP,B-TE
>,O
18,O
mmHg,O
).,O

The,O
right,O
ventricular,O
cavity,O
is,O
mildly,B-PR
dilated,I-PR
with,O
severe,B-PR
free,I-PR
wall,I-PR
hypokinesis,I-PR
.,O

The,O
aortic,O
valve,O
leaflets,O
(,O
3,O
),O
are,O
minimally,B-PR
thickened,I-PR
.,O

No,O
aortic,B-PR
stenosis,I-PR
or,O
aortic,B-PR
regurgitation,I-PR
is,O
seen,O
.,O

The,O
mitral,O
valve,O
leaflets,O
are,O
structurally,O
normal,O
.,O

There,O
is,O
no,O
mitral,B-PR
valve,I-PR
prolapse,I-PR
.,O

Mild,B-PR
(,I-PR
1+,I-PR
),I-PR
mitral,I-PR
regurgitation,I-PR
is,O
seen,O
.,O

There,O
is,O
moderate,B-PR
pulmonary,I-PR
artery,I-PR
systolic,I-PR
hypertension,I-PR
.,O

There,O
is,O
a,B-PR
very,I-PR
small,I-PR
circumferential,I-PR
pericardial,I-PR
effusion,I-PR
.,O

IMPRESSION,O
:,O
Moderate,B-PR
symmetric,I-PR
eft,I-PR
ventricular,I-PR
hypertrophy,I-PR
with,O
severe,B-PR
global,I-PR
biventricular,I-PR
hypokinesis,I-PR
c/w,O
diffuse,B-PR
process,I-PR
(,O
toxin,B-PR
",",O
metabolic,O
",",O
cannot,O
exclude,O
myocarditis,B-PR
;,O
in,O
the,O
absence,O
of,O
LVH,B-PR
on,O
ECG,B-TE
",",O
an,B-PR
infiltrative,I-PR
process,I-PR
should,O
also,O
be,O
considered,O
).,O

Mild,B-PR
mitral,I-PR
regurgitation,I-PR
.,O

Moderate,B-PR
pulmonary,I-PR
arterial,I-PR
hypertension,I-PR
.,O

Very,B-PR
small,I-PR
circumferential,I-PR
pericardial,I-PR
effusion,I-PR
.,O

Possible,O
abnormality,B-PR
on,I-PR
the,I-PR
aortic,I-PR
valve,I-PR
as,O
described,O
above,O
without,O
aortic,B-PR
regurgitation,I-PR
.,O

If,O
clinically,O
indicated,O
a,B-TE
TEE,I-TE
would,O
be,O
better,O
able,O
to,O
define,O
an,B-PR
abnormality,I-PR
of,I-PR
the,I-PR
aortic,I-PR
valve,I-PR
.,O

Brief,O
Hospital,O
Course,O
:,O

46,O
-,O
yo-man,O
w/,O
cocaine,O
abuse,O
presents,O
w/,O
LE,B-PR
edema,I-PR
and,O
DOE,B-PR
likely,O
from,O
diastolic,B-PR
heart,I-PR
failure,I-PR
in,O
the,O
setting,O
of,O
cocaine,O
use,O
complicated,O
by,O
hypertensive,B-PR
urgency,I-PR
.,O

Hypertensive,B-PR
urgency,I-PR
:,O

BP,B-TE
230/170,O
on,O
presentation,O
",",O
most,O
likely,O
from,O
chronic,B-PR
HTN,I-PR
exacerbated,O
by,O
cocaine,O
use,O
.,O

No,O
signs,O
of,O
end-organ,B-PR
damage,I-PR
at,O
present,O
except,O
for,O
elevated,B-PR
creatinine,I-PR
",",O
which,O
is,O
more,O
likely,O
a,B-PR
chronic,I-PR
problem,I-PR
.,O

The,O
patient,O
was,O
started,O
on,O
labetalol,B-TR
and,O
Lisinopril,B-TR
.,O

His,B-TE
blood,I-TE
pressure,I-TE
was,O
taken,O
down,O
from,O
230,O
systolic,B-TE
to,O
approx,O
160,O
systolic,B-TE
/,O
100,O
diastolic,B-TE
on,O
discharge,O
.,O

His,B-PR
lower,I-PR
extremity,I-PR
edema,I-PR
improved,O
with,O
diuresis,B-TR
.,O

An,B-TE
echo,I-TE
performed,O
on,O
admission,O
showed,O
an,B-TE
LF,I-TE
EF,I-TE
of,O
25%,O
.,O

It,O
is,O
hoped,O
with,O
good,B-TR
blood,I-TR
pressure,I-TR
control,I-TR
and,O
use,O
of,O
an,B-TR
ACE-I,I-TR
with,O
follow,O
up,O
in,O
addition,O
to,O
cocaine,O
abstaining,O
will,O
improved,O
his,O
cardiac,O
function,O
.,O

Renal,B-PR
Failure,I-PR
:,O
creatinine,B-TE
on,O
admission,O
was,O
1.6,O
Likely,O
acute,B-PR
hypertensive,I-PR
nephropathy,I-PR
plus,O
probalbe,O
long-standing,B-PR
hypertensive,I-PR
disease,I-PR
.,O

discharged,O
on,O
ACE-I,B-TR
.,O

Substance,O
Use,O
:,O
Social,O
work,O
saw,O
patient,O
and,O
counceled,O
him,O
regarding,O
substance,O
abuse,O
.,O

Discharged,O
with,O
Margaret,O
Hallock,O
",",O
cardiology,O
follow,O
up,O
as,O
well,O
as,O
scheduled,O
appointment,O
with,O
a,O
new,O
PCP,O
@,O
Newton,O
Health,O
Center,O
.,O

Medications,O
on,O
Admission,O
:,O

none,O

Discharge,O
Medications,O
:,O

1.,O
Aspirin,B-TR
325,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

2.,O
Hydrochlorothiazide,B-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
2,O
*,O

3.,O
Labetalol,B-TR
200,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

Disp,O
:*,O
120,O
Tablet,O
(s)*,O
Refills,O
:*,O
2,O
*,O

4.,O
Lisinopril,B-TR
20,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
2,O
*,O

Discharge,O
Disposition,O
:,O

Home,O

Discharge,O
Diagnosis,O
:,O

Primary,O
:,O

-,O
mild,B-PR
transaminitis,I-PR
likely,O
03-25,O
etoh,O
and,O
cocaine,O
abuse,O

Discharge,O
Condition,O
:,O

well,O

Discharge,O
Instructions,O
:,O

You,O
came,O
in,O
with,O
hypertensive,B-PR
emergency,I-PR
.,O

You,O
were,O
treated,O
with,O
medications,B-TR
to,O
improve,O
your,B-TE
blood,I-TE
pressure,I-TE
.,O

Notably,O
you,O
were,O
discharged,O
on,O
:,O

1.,O
Lisinopril,B-TR
20,O
mg,O
daily,O

2.,O
HCTZ,B-TR
25,O
mg,O
daily,O

3.,O
Labetalol,B-TR
400,O
mg,O
bid,O

4.,O
ASA,B-TR
162mg,O
daily,O

It,O
is,O
extremely,O
important,O
for,O
you,O
to,O
take,O
these,B-TR
medications,I-TR
.,O

It,O
is,O
very,O
important,O
that,O
you,O
followup,O
with,O
your,O
cardiology,O
.,O

Please,O
return,O
to,O
the,O
Deanna,O
if,O
you,O
experience,O
SOB,B-PR
",",O
chest,B-PR
pain,I-PR
",",O
fevers,B-PR
",",O
chills,B-PR
",",O
dizziness,B-PR
",",O
decreased,B-PR
urine,I-PR
output,I-PR
.,O

It,O
is,O
also,O
very,O
important,O
that,O
you,O
abstain,O
from,O
cocaine,O
use,O
.,O

Followup,O
Instructions,O
:,O

Please,O
see,O
Dr.,O
Villani,O
on,O
Monday,O
2016-07-25,O
at,O
10:00,O
in,O
Smith,O
7th,O
.,O

It,O
is,O
extremely,O
important,O
for,O
you,O
to,O
keep,O
this,O
appointment,O
.,O

You,O
have,O
a,O
Primary,O
Care,O
Physician,O
B.,O
Schumacher,O
on,O
07-29,O
@,O
1:45,O
pm,O
.,O

Please,O
arrive,O
1,O
hour,O
prior,O
to,O
the,O
appointment,O
to,O
complete,O
the,O
Free,O
Care,O
Application,O
there,O
.,O

You,O
need,O
to,O
bring,O
a,O
picture,O
ID,O
",",O
proof,O
of,O
citizenship,O
",",O
proof,O
of,O
address,O
.,O

The,O
Clinci,O
phone,O
number,O
is,O
(,O
754,O
),O
280-1011,O

Please,O
followup,O
with,O
Dr.,O
Lesha,O
Lefebvre,O
on,O
08-15,O
at,O
10:30,O
am,O
.,O

His,O
number,O
is,O
(,O
532-803-1162,O
.,O

His,O
secretary,O
can,O
help,O
you,O
clarify,O
your,O
insurance,O
.,O

Ralph,O
Katherine,O
MD,O
31-164,O

Completed,O
by,O
:,O
Terry,O
Smith,O
MD,O
12-201,O
2016-07-21,O
@,O
1848,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Jennifer,O
Applebee,O
on,O
:,O
Sandra,O
2016-07-21,O
9:54,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2011-09-23,O

Discharge,O
Date,O
:,O

2011-10-06,O

Date,O
of,O
Birth,O
:,O

2011-09-23,O

Sex,O
:,O

M,O

Service,O
:,O

NEONATOLOGY,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Ken,O
Nansteel-Miller,O
is,O
the,O
triplet,O
#3,O
of,O
a,B-PR
spontaneous,I-PR
triamniotic-trichorionic,I-PR
triplet,I-PR
pregnancy,I-PR
born,O
to,O
a,O
39-year-old,O
G4,O
P1,O
spontaneous,O
abortion,O
2,O
woman,O
.,O

Prenatal,O
screens,O
:,O

Blood,B-TE
type,I-TE
A,O
positive,O
",",O
antibody,B-TE
negative,O
",",O
rubella,B-TE
immune,O
",",O
RPR,B-TE
nonreactive,O
",",O
hepatitis,B-TE
B,I-TE
surface,I-TE
antigen,I-TE
negative,O
",",O
group,B-TE
beta,I-TE
Strep,I-TE
status,I-TE
unknown,O
.,O

The,O
mother,O
was,O
followed,O
closely,O
and,O
received,O
betamethasone,B-TR
2011-08-22,O
.,O

She,O
was,O
admitted,O
on,O
2011-08-25,O
for,O
nausea,B-PR
",",O
vomiting,B-PR
",",O
and,O
a,B-PR
shortened,I-PR
cervix,I-PR
.,O

She,O
was,O
treated,O
with,O
bed,B-TR
rest,I-TR
and,O
prn,O
terbutaline,B-TR
.,O

Other,B-TR
medications,I-TR
including,O
Prozac,B-TR
.,O

The,O
babies,O
were,O
born,O
by,O
elective,B-TR
cesarean,I-TR
section,I-TR
at,O
34,O
weeks,O
gestation,O
.,O

This,O
triplet,O
#3,O
emerged,O
with,O
spontaneous,O
respirations,O
",",O
and,O
required,O
blow-by,B-TR
oxygen,I-TR
in,O
the,O
delivery,O
room,O
.,O

Apgars,B-TE
were,O
seven,O
at,O
one,O
minute,O
and,O
eight,O
at,O
five,O
minutes,O
.,O

He,O
was,O
admitted,O
to,O
the,O
Neonatal,O
Intensive,O
Care,O
Unit,O
for,O
treatment,B-TR
of,O
prematurity,B-PR
.,O

PHYSICAL,O
EXAM,O
UPON,O
ADMISSION,O
TO,O
THE,O
NEONATAL,O
INTENSIVE,O
CARE,O
UNIT,O
:,O

Weight,B-TE
1.7,O
kg,O
",",O
length,B-TE
41.5,O
cm,O
",",O
head,B-TE
circumference,I-TE
29,O
cm,O
",",O
all,O
10th-25th,O
percentile,O
for,O
34,O
weeks,O
.,O

General,O
:,O
Nondysmorphic,B-PR
preterm,O
male,O
in,O
mild,B-PR
respiratory,I-PR
distress,I-PR
.,O

Head,O
",",O
eyes,O
",",O
ears,O
",",O
nose,O
",",O
and,O
throat,O
:,O

Anterior,O
fontanel,O
open,O
and,O
flat,O
.,O

Symmetric,O
facial,O
features,O
.,O

Positive,O
red,B-TE
reflex,I-TE
bilaterally,O
.,O

Palate,O
intact,O
.,O

Chest,O
:,O
Mild,B-PR
intercostal,I-PR
and,I-PR
sternal,I-PR
retractions,I-PR
.,O

Breath,B-TE
sounds,I-TE
equal,O
with,O
fair,O
aeration,O
.,O

Cardiovascular,O
:,O
Regular,O
",",O
rate,O
",",O
and,O
rhythm,O
",",O
no,O
murmur,B-PR
.,O

Femoral,B-TE
pulses,I-TE
+2,O
.,O

Abdomen,O
is,O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
",",O
no,O
masses,B-PR
",",O
positive,O
bowel,O
sounds,O
.,O

Genitourinary,O
:,O
Normal,O
preterm,O
male,O
.,O

Testes,O
descended,O
bilaterally,O
.,O

Spine,O
straight,O
with,O
normal,O
sacrum,O
.,O

Hips,O
stable,O
.,O

Neurologic,O
:,O
Appropriate,O
tone,O
and,O
reflexes,O
.,O

HOSPITAL,O
COURSE,O
BY,O
SYSTEMS,O
INCLUDING,O
PERTINENT,O
LABORATORY,O
DATA,O
:,O

1.,O
Respiratory,O
:,O
Lincoln,O
required,O
nasal,B-TR
cannula,I-TR
O2,I-TR
for,O
approximately,O
the,O
first,O
8-12,O
hours,O
of,O
life,O
.,O

He,O
weaned,O
to,O
room,O
air,O
and,O
remained,O
on,O
room,O
air,O
the,O
rest,O
of,O
his,O
Neonatal,O
Intensive,O
Care,O
Unit,O
admission,O
.,O

He,O
has,O
had,O
no,O
episodes,O
of,O
spontaneous,B-PR
apnea,I-PR
during,O
admission,O
.,O

2.,O
Cardiovascular,O
:,O
Falmouth,O
has,O
maintained,O
normal,O
heart,O
rates,O
and,O
blood,B-TE
pressures,I-TE
.,O

No,O
murmurs,B-PR
have,O
been,O
noted,O
.,O

3.,O
Fluids,O
",",O
electrolytes,O
",",O
and,O
nutrition,O
:,O

Beverly,O
was,O
initially,O
NPO,B-TR
and,O
maintained,O
on,O
intravenous,B-TR
fluids,I-TR
.,O

Enteral,B-TR
feeds,I-TR
were,O
started,O
on,O
day,O
of,O
life,O
#1,O
",",O
and,O
gradually,O
advanced,O
to,O
full,O
volume,O
.,O

His,O
maximum,O
caloric,O
intake,O
was,O
24,O
calories,O
per,O
ounce,O
.,O

At,O
the,O
time,O
of,O
discharge,O
",",O
he,O
is,O
breastfeeding,O
or,O
taking,O
Enfamil,O
fortified,O
to,O
24,O
calories,O
/,O
ounce,O
with,O
intake,O
approximately,O
150,O
cc,O
/,O
kg,O
/,O
day,O
.,O

Discharge,B-TE
weight,I-TE
is,O
1.89,O
kg,O
.,O

4.,O
Gastrointestinal,O
:,O
Boston,O
required,O
treatment,B-TR
for,O
unconjungated,B-PR
hyperbilirubinemia,I-PR
with,O
phototherapy,B-TR
.,O

His,B-TE
peak,I-TE
serum,I-TE
bilirubin,I-TE
occurred,O
on,O
day,O
of,O
life,O
three,O
with,O
a,O
total,O
of,O
8.3,O
/,O
0.2,O
direct,O
",",O
8.1,O
indirect,O
mg/dl,O
.,O

He,O
received,O
phototherapy,B-TR
for,O
approximately,O
72,O
hours,O
.,O

Rebound,B-TE
bilirubin,I-TE
on,O
day,O
of,O
life,O
#7,O
was,O
6.6,O
",",O
and,O
total,O
was,O
0.2,O
direct,O
.,O

5.,O
Neurological,O
:,O
Wellesley,O
has,O
maintained,O
a,O
normal,O
neurological,O
examination,O
.,O

Throughout,O
admission,O
",",O
there,O
are,O
no,O
neurological,B-PR
concerns,I-PR
at,O
the,O
time,O
of,O
discharge,O
.,O

6.,O
Sensory,O
:,O

Audiology,O
:,O
Hearing,B-TE
screening,I-TE
was,O
performed,O
with,O
automated,O
auditory,O
brain,O
stem,O
responses,O
.,O

Nantucket,O
passed,O
in,O
both,O
ears,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O
Good,O
.,O

DISCHARGE,O
/,O
DISPOSITION,O
:,O
Home,O
with,O
parents,O
.,O

PRIMARY,O
PEDIATRICIAN,O
:,O
Dr.,O
Penny,O
Scott,O
",",O
8400,O
S.,O
Maple,O
Blvd.,O
",",O
Arbour-Fuller,O
Hospital,O
",",O
New,O
Hampshire,O
25344,O
",",O
phone,O
number,O
617-6198,O
.,O

Fax,O
number,O
(,O
317,O
),O
497-7408,O
.,O

CARE,O
AND,O
RECOMMENDATIONS,O
AT,O
THE,O
TIME,O
OF,O
DISCHARGE,O
:,O

1.,O
Feeding,O
:,O
Breast,O
feeding,O
or,O
Enfamil,O
24,O
calories,O
/,O
ounce,O
.,O

2.,O
Medications,B-TR
:,O
Ferrous,B-TR
sulfate,I-TR
0.15,O
cc,O
po,O
q,O
day,O
25,O
mg,O
/,O
ml,O
dilution,O
.,O

3.,O
Car,B-TE
seat,I-TE
position,I-TE
screening,I-TE
was,O
performed,O
.,O

Waltham,O
was,O
monitored,O
for,O
90,O
minutes,O
without,O
any,O
episodes,O
of,O
apnea,B-PR
or,O
oxygen,B-PR
desaturation,I-PR
.,O

4.,O
State,B-TE
Newborn,I-TE
Screens,I-TE
were,O
sent,O
on,O
09-27,O
and,O
2011-10-05,O
with,O
no,O
notification,O
of,O
abnormal,B-PR
results,I-PR
to,O
date,O
.,O

5.,O
No,O
immunizations,B-TR
administered,O
.,O

Plan,O
is,O
to,O
receive,O
hepatitis,B-TR
B,I-TR
in,O
the,O
pediatrician,O
's,O
office,O
",",O
once,O
he,O
reaches,O
a,O
weight,O
of,O
2,O
kg,O
.,O

6.,O
Immunizations,B-TR
recommended,O
:,O
Synagis,B-TR
RSV,I-TR
prophylaxis,I-TR
should,O
be,O
considered,O
from,O
October,O
through,O
April,O
for,O
infants,O
who,O
meet,O
any,O
of,O
the,O
following,O
three,O
criteria,O
:,O

1),O
Born,O
at,O
less,O
than,O
32,O
weeks,O
",",O

2),O
born,O
between,O
32,O
and,O
35,O
weeks,O
with,O
plans,O
for,O
daycare,O
during,O
RSV,O
season,O
",",O
with,O
a,O
smoker,O
in,O
the,O
household,O
",",O
or,O
with,O
preschool,O
siblings,O
",",O
or,O

3),O
with,O
chronic,B-PR
lung,I-PR
disease,I-PR
.,O

Influenza,B-TR
immunization,I-TR
should,O
be,O
considered,O
annually,O
in,O
the,O
fall,O
for,O
preterm,O
infants,O
with,O
chronic,B-PR
lung,I-PR
disease,I-PR
once,O
they,O
reach,O
six,O
months,O
of,O
age,O
.,O

Before,O
this,O
age,O
",",O
the,O
family,O
and,O
other,O
caregivers,O
should,O
be,O
considered,O
for,O
immunization,B-TR
against,O
influenza,B-PR
to,O
protect,O
the,O
infant,O
.,O

FOLLOW-UP,O
APPOINTMENTS,O
:,O
Dr.,O
Parramore,O
on,O
10-10,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Prematurity,B-PR
at,I-PR
34,I-PR
weeks,I-PR
gestation,I-PR
.,O

2.,O
Triplet,O
#3,O
of,O
triplet,O
gestation,O
.,O

3.,O
Unconjugated,B-PR
hyperbilirubinemia,I-PR
.,O

Reviewed,O
By,O
:,O
Janna,O
L.,O
Desorbo,O
",",O
M.D.,O

00-112,O

Dictated,O
By,O
:,O
Jeannette,O
D.,O
Rede,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2011-10-06,O
04:03,O

T,O
:,O
2011-10-06,O
06:19,O

JOB,O
#:,O

2566,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Bernice,O
Jenkins,O
on,O
:,O
FRI,O
2011-10-07,O
4:01,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2019-09-27,O

Discharge,O
Date,O
:,O

2019-10-07,O

Date,O
of,O
Birth,O
:,O

1959-01-27,O

Sex,O
:,O

M,O

Service,O
:,O

CARDIOTHORACIC,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,I-PR
Drugs,I-PR

Attending,O
:,O
Luis,O
JG,O
Lavoie,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

exertional,B-PR
angina,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

10-01,O
CABG,B-TR
x,O
3,O

History,O
of,O
Present,O
Illness,O
:,O

60,O
yo,O
M,O
with,O
exertional,B-PR
angina,I-PR
->,O
positive,B-PR
ETT,I-PR
->,O
cath,B-TE
with,O
severe,B-PR
3VD,I-PR

Past,O
Medical,O
History,O
:,O

HTN,B-PR

DM,B-PR

cataracts,B-PR
s/p,O
removal,B-TR
of,O
in,O
Mayotte,O
c/b,O
enucleated,O
CMED,O
CSRU,O

urinary,B-PR
incontinence,I-PR

Social,O
History,O
:,O

farmer,O
in,O
Mayotte,O

lives,O
with,O
wife,O
and,O
oldest,O
son,O

Family,O
History,O
:,O

father,O
with,O
?,O
Mi,B-PR
at,O
unknown,O
age,O

Physical,O
Exam,O
:,O

NAD,B-TE
76,O
184/87,O
18,O

Teeth,B-PR
in,I-PR
poor,I-PR
repair,I-PR

lungs,O
ctab,O
ant,O
/,O
lat,O

distant,B-PR
heart,I-PR
sounds,I-PR
",",O
RRR,O

Abdomen,O
benign,O

extrem,B-PR
warm,I-PR
",",O
no,O
edema,B-PR
",",O
no,O
varicosities,B-PR
",",O
2+,O
pedal,B-TE
pulses,I-TE

Pertinent,O
Results,O
:,O

2019-10-07,O
05:30,O
AM,O
BLOOD,B-TE
WBC,B-TE
-,O
6.5,O
RBC,B-TE
-,O
3.23,O
*,O
Hgb,B-TE
-,O
9.5,O
*,O
Hct,B-TE
-,O
27.6,O
*,O
MCV,B-TE
-,O
86,O
MCH,B-TE
-,O
29.4,O
MCHC,B-TE
-,O
34.4,O
RDW,B-TE
-,O
14.0,O
Plt,B-TE
Ct,I-TE
-,O
356,O
#,O

2019-10-07,O
05:30,O
AM,O
BLOOD,B-TE
Plt,B-TE
Ct,I-TE
-,O
356,O
#,O

2019-10-04,O
06:50,O
AM,O
BLOOD,B-TE
PT,B-TE
-,O
13.2,O
*,O
PTT,B-TE
-,O
32.1,O
INR(PT),B-TE
-,O
1.2,O
*,O

2019-10-07,O
05:30,O
AM,O
BLOOD,B-TE
Glucose,B-TE
-,O
156,O
*,O
UreaN,B-TE
-,O
20,O
Creat,B-TE
-,O
1.0,O
Na,B-TE
-,O
140,O
K,B-TE
-,O
3.8,O
Cl,B-TE
-,O
99,O
HCO3,B-TE
-,O
31,O
AnGap,B-TE
-,O
14,O

Brief,O
Hospital,O
Course,O
:,O

He,O
was,O
taken,O
to,O
the,O
operating,O
room,O
on,O
2019-10-01,O
where,O
he,O
underwent,O
a,B-TR
CABG,I-TR
x,O
3,O
.,O

He,O
was,O
transferred,O
to,O
the,O
CMED,O
CCU,O
in,O
critical,O
but,O
stable,O
condition,O
.,O

He,O
was,O
extubated,O
by,O
POD,O
#1,O
.,O

He,O
was,O
weaned,O
from,O
his,B-TR
vasoactive,I-TR
drips,I-TR
and,O
transferred,O
to,O
the,O
floor,O
on,O
POD,O
#2,O
.,O

He,O
was,O
seen,O
by,O
speech,O
and,O
swallowing,O
who,O
recommended,O
NPO,B-TR
",",O
he,O
then,O
underwent,O
a,B-TE
video,I-TE
swallow,I-TE
after,O
which,O
he,O
was,O
changed,O
to,O
a,B-TR
diet,I-TR
of,I-TR
thin,I-TR
liquids,I-TR
and,I-TR
soft,I-TR
solids,I-TR
",",O
and,O
felt,O
that,O
his,O
eeating,O
may,O
be,O
limited,O
by,O
his,B-PR
loose,I-PR
teeth,I-PR
.,O

Dentistry,O
and,O
OMFS,O
were,O
consulted,O
",",O
and,O
he,O
had,O
four,O
front,O
teeth,O
removed,O
on,O
10-04,O
.,O

He,O
did,O
well,O
post,O
operatively,O
and,O
he,O
was,O
ready,O
for,O
discharge,O
on,O
2019-10-07,O
.,O

Medications,O
on,O
Admission,O
:,O

lisinopril,B-TR
",",O
protonix,B-TR
",",O
glipizide,B-TR
",",O
metformin,B-TR
",",O
asa,B-TR

Discharge,O
Medications,O
:,O

1.,O
Aspirin,B-TR
81,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
)(s)*,O
Refills,O
:*,O
0,O
*,O

2.,O
Pantoprazole,B-TR
40,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
Q24H,O
(,O
every,O
24,O
hours,O
).,O

Disp,O
:*,O
30,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
)(s)*,O
Refills,O
:*,O
0,O
*,O

3.,O
Metoprolol,B-TR
Tartrate,I-TR
50,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

Disp,O
:*,O
60,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

4.,O
Docusate,B-TR
Sodium,I-TR
150,O
mg,O
/,O
15,O
mL,O
Liquid,O
Sig,O
:,O
One,O
(,O
1,O
),O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

Disp,O
:*,O
QS,O
1,O
month,O
*,O
Refills,O
:*,O
0,O
*,O

5.,O
Oxycodone,B-TR
-,O
Acetaminophen,B-TR
5-325,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
every,O
4-6,O
hours,O
as,O
needed,O
for,O
pain,B-PR
.,O

Disp,O
:*,O
50,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

6.,O
Clopidogrel,B-TR
75,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

7.,O
Atorvastatin,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

8.,O
Glipizide,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

Disp,O
:*,O
60,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

9.,O
Lisinopril,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

10.,O
Hydrochlorothiazide,B-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
once,O
a,O
day,O
.,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

Discharge,O
Disposition,O
:,O

Home,O
with,O
Service,O

Discharge,O
Diagnosis,O
:,O

CAD,B-PR

HTN,B-PR

DM,B-PR

cataracts,B-PR
s/p,O
removal,B-TR
c/b,O
enucleated,O
left,O
CMED,O
CSRU,O

urinary,B-PR
incontinence,I-PR

?,O
TIA,B-PR

Discharge,O
Condition,O
:,O

Good,O
.,O

Discharge,O
Instructions,O
:,O

Call,O
with,O
fever,B-PR
",",O
redness,B-PR
or,O
drainage,B-PR
from,I-PR
incision,I-PR
or,O
weight,B-PR
gain,I-PR
more,O
than,O
2,O
pounds,O
in,O
one,O
day,O
or,O
five,O
in,O
one,O
week,O
.,O

Shower,O
",",O
no,O
baths,O
",",O
no,O
lotions,B-TR
",",O
creams,B-TR
or,O
powders,B-TR
to,O
incisions,B-PR
.,O

No,O
lifting,O
more,O
than,O
10,O
pounds,O
or,O
driving,O
until,O
follow,O
up,O
with,O
surgeon,O
.,O

Followup,O
Instructions,O
:,O

Dr.,O
Dewhurst,O
2,O
weeks,O

Dr.,O
Burns,O
4,O
weeks,O

Chad,O
Barbara,O
MD,O
49-703,O

Completed,O
by,O
:,O
Theresa,O
Leonore,O
NP,O
80-BXH,O
2019-10-07,O
@,O
1229,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Eugene,O
Offutt,O
on,O
:,O
MON,O
2019-10-07,O
12:44,O
PM,O

(,O
End,O
of,O
Report,O
),O

655488444,O

BH,O

7432347,O

65055,O

2/10/2000,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O

FREIREKOTE,O
",",O
SONYLA,O

MRN,O
:,O

7432347,O

Age,O
:,O

35y,O

REGISTRATION,O
DATE,O
:,O

02/10/2000,O
03:19,O
PM,O

PRELIMINARY,O
REPORT,O

This,O
is,O
to,O
notify,O
you,O
that,O
your,O
patient,O
",",O
FREIREKOTE,O
",",O
SONYLA,O
arrived,O
in,O
the,O
Emergency,O
Department,O
at,O
Bri,O
Health,O
on,O
02/10/2000,O
03:19,O
PM,O
.,O

The,O
patient,O
presented,O
with,O
a,O
chief,O
complaint,O
of,O
FOUND,B-PR
DOWN,I-PR
.,O

Following,O
evaluation,B-TE
and,O
treatment,B-TR
",",O
the,O
patient,O
's,O
disposition,O
at,O
the,O
end,O
of,O
the,O
visit,O
was,O
ADMITTED,O
AS,O
AN,O
INPATIENT,O
TO,O
BRI,O
HEALTH,O
.,O

Your,O
patient,O
was,O
admitted,O
under,O
the,O
care,O
of,O
REEFRAUP,O
",",O
JA,O
Y,O
with,O
a,O
preliminary,O
diagnosis,O
of,O
SYNCOPE,B-PR
.,O

If,O
you,O
need,O
additional,O
information,O
please,O
call,O
442-025-0303,O
.,O

[,O
report,O
_,O
end,O
],O

Admission,O
Date,O
:,O

2015-06-04,O

Discharge,O
Date,O
:,O

2015-06-08,O

Date,O
of,O
Birth,O
:,O

1958-03-17,O

Sex,O
:,O

F,O

Service,O
:,O

CCU,O

HISTORY,O
OF,O
THE,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
57,O
-,O
year-old,O
female,O
with,O
a,O
history,O
of,O
hypertension,B-PR
and,O
hypercholesterolemia,B-PR
but,O
no,O
prior,B-PR
coronary,I-PR
artery,I-PR
disease,I-PR
history,I-PR
who,O
presented,O
with,O
chest,B-PR
pain,I-PR
.,O

The,O
patient,O
reports,O
the,B-PR
pain,I-PR
began,O
at,O
4:00,O
p.m.,O
on,O
the,O
day,O
of,O
admission,O
.,O

She,O
reports,O
that,O
it,O
had,O
essentially,O
started,O
earlier,O
in,O
the,O
day,O
with,O
some,B-PR
GERD-like,I-PR
symptoms,I-PR
.,O

She,O
had,O
taken,O
Maalox,B-TR
but,O
had,O
no,O
relief,O
with,O
this,O
.,O

The,B-PR
pain,I-PR
was,O
intermittent,O
through,O
the,O
day,O
and,O
then,O
at,O
4:00,O
p.m.,O
increased,O
and,O
was,O
also,O
associated,O
with,O
nausea,B-PR
and,O
diaphoresis,B-PR
.,O

She,O
reports,O
that,O
the,B-PR
pain,I-PR
shot,O
through,O
her,O
back,O
.,O

The,O
patient,O
has,O
never,O
had,O
these,B-PR
symptoms,I-PR
in,O
the,O
past,O
.,O

She,O
arrived,O
in,O
the,O
Emergency,O
Room,O
at,O
8:00,O
p.m.,O

At,O
that,O
time,O
",",O
the,B-PR
pain,I-PR
was,O
unremitting,O
.,O

In,O
the,O
Emergency,O
Room,O
",",O
the,O
patient,O
was,O
given,O
Lopressor,B-TR
",",O
nitroglycerin,B-TR
",",O
and,O
aspirin,B-TR
.,O

A,B-TR
TP3A,I-TR
inhibitor,I-TR
was,O
not,O
given,O
for,O
concern,O
for,O
dissection,B-PR
.,O

The,O
patient,O
was,O
found,O
to,O
have,O
5057,O
E.,O
Sixth,O
Blvd.,O
elevations,B-PR
in,I-PR
I,I-PR
",",I-PR
aVL,I-PR
",",I-PR
and,I-PR
V1,I-PR
through,I-PR
V2,I-PR
and,O
ST,B-PR
depressions,I-PR
in,I-PR
II,I-PR
",",I-PR
III,I-PR
",",I-PR
and,I-PR
aVF,I-PR
.,O

The,O
patient,O
was,O
taken,O
emergently,O
to,O
the,O
Cardiac,O
Catheterization,O
Laboratory,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Hypertension,B-PR
.,O

2.,O
Hypercholesterolemia,B-PR
.,O

3.,O
Chondrocalcinosis,B-PR
.,O

4.,O
Carpal,B-PR
tunnel,I-PR
syndrome,I-PR
.,O

5.,O
GERD,B-PR
.,O

ADMISSION,O
MEDICATIONS,O
:,O

1.,O
Atenolol,B-TR
25,O
.,O

2.,O
Crestor,B-TR
10,O
q.d.,O

3.,O
Uniretic,B-TR
15/25,O
.,O

ALLERGIES,O
:,O
The,O
patient,O
has,O
no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O
The,O
patient,O
denied,O
tobacco,O
.,O

The,O
patient,O
denied,O
alcohol,O
or,O
other,O
drug,O
use,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O
Vital,O
signs,O
:,O

On,O
admission,O
",",O
the,O
patient,O
was,O
afebrile,B-PR
",",O
blood,B-TE
pressure,I-TE
146/88,O
",",O
pulse,B-TE
71,O
",",O
respirations,B-TE
18,O
.,O

General,O
:,O
The,O
patient,O
was,O
a,O
well,O
appearing,O
female,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

Cardiac,O
:,O
Regular,O
rate,O
and,O
rhythm,O
",",O
normal,O
S1,O
",",O
S2,O
.,O

No,O
murmurs,B-PR
were,O
appreciated,O
.,O

Lungs,O
:,O
Clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

Abdomen,O
:,O
Soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
",",O
good,O
bowel,O
sounds,O
.,O

Extremities,O
:,O
There,O
was,O
no,O
edema,B-PR
in,I-PR
the,I-PR
extremities,I-PR
.,O

The,B-TE
dorsalis,I-TE
pedis,I-TE
pulses,I-TE
were,O
2+,O
bilaterally,O
.,O

LABORATORY,O
AND,O
RADIOLOGIC,O
DATA,O
:,O
On,O
admission,O
",",O
white,B-TE
count,I-TE
10.8,O
",",O
hematocrit,B-TE
38.2,O
",",O
platelets,B-TE
"324,000",O
.,O

HOSPITAL,O
COURSE,O
:,O

1.,O
CORONARY,B-PR
ARTERY,I-PR
DISEASE,I-PR
:,O
The,O
patient,O
was,O
taken,O
to,O
Cardiac,B-TE
Catheterization,I-TE
where,O
she,O
was,O
found,O
to,O
have,O
two,B-PR
vessel,I-PR
disease,I-PR
.,O

The,O
proximal,O
LAD,O
was,O
found,O
to,O
have,O
a,B-PR
90%,I-PR
lesion,I-PR
with,O
a,O
septal,O
branch,O
with,O
a,B-PR
95%,I-PR
stenosis,I-PR
and,O
a,O
diagonal,O
branch,O
with,O
99%,B-PR
stenosis,I-PR
.,O

The,O
patient,O
had,O
twin,B-TR
LAD,I-TR
stents,I-TR
to,O
the,O
LAD,O
diagonal,O
and,O
LAD,O
septal,O
branches,O
with,O
Taxus,B-TR
stents,I-TR
.,O

This,O
restored,O
flow,O
appropriately,O
.,O

The,O
patient,O
also,O
had,O
proximal,B-PR
RCA,I-PR
lesion,I-PR
of,I-PR
80%,I-PR
and,O
a,B-PR
mid,I-PR
RCA,I-PR
lesion,I-PR
of,I-PR
80-90%,I-PR
which,O
were,O
not,O
intervened,O
upon,O
.,O

The,O
patient,O
was,O
given,O
an,B-TR
aspirin,I-TR
and,O
Plavix,B-TR
and,O
in,O
addition,O
started,O
on,O
a,B-TR
beta,I-TR
Elmore,I-TR
",",O
Maxine,B-TR
ACE,I-TR
inhibitor,I-TR
",",O
and,O
these,O
were,O
titrated,O
up,O
as,O
her,B-TE
blood,I-TE
pressure,I-TE
tolerated,O
.,O

Given,O
the,O
fact,O
that,O
the,O
patient,O
had,O
issues,O
with,O
muscle,B-PR
cramping,I-PR
with,O
Atorvastatin,B-TR
in,O
the,O
past,O
",",O
she,O
was,O
started,O
on,O
Pravastatin,B-TR
which,O
should,O
give,O
less,O
of,O
these,B-PR
side,I-PR
effects,I-PR
.,O

The,O
patient,O
will,O
follow-up,O
with,O
Cardiology,O
in,O
one,O
months,O
time,O
for,O
further,B-TR
management,I-TR
of,O
her,B-PR
coronary,I-PR
artery,I-PR
disease,I-PR
and,O
further,B-TE
evaluation,I-TE
of,O
her,B-PR
remaining,I-PR
RCA,I-PR
lesions,I-PR
.,O

2.,O
PUMP,O
:,O
The,O
patient,O
had,O
an,B-TE
echocardiogram,I-TE
to,O
assess,O
her,O
LV,O
function,O
.,O

She,O
was,O
found,O
to,O
have,O
an,B-TE
ejection,I-TE
fraction,I-TE
of,O
30-35%,O
as,O
well,O
as,O
an,B-PR
akinetic,I-PR
apex,I-PR
and,O
apical,B-PR
mid,I-PR
and,I-PR
septal,I-PR
akinesis,I-PR
.,O

Given,O
the,O
fact,O
that,O
the,O
patient,O
had,O
significant,B-PR
apical,I-PR
akinesis,I-PR
",",O
she,O
was,O
started,O
on,O
heparin,B-TR
with,O
a,O
transition,O
to,O
Coumadin,B-TR
for,O
anticoagulation,B-TR
for,O
stroke,B-TR
prevention,I-TR
in,O
the,O
setting,O
of,O
apical,B-PR
akinesis,I-PR
.,O

On,O
discharge,O
",",O
the,O
patient,O
was,O
given,O
Lovenox,B-TR
injections,I-TR
which,O
should,O
be,O
continued,O
until,O
the,O
patient,O
reaches,O
a,O
therapeutic,O
dose,O
of,O
Coumadin,B-TR
.,O

3.,O
RHYTHM,O
:,O
The,O
patient,O
was,O
monitored,O
on,O
telemetry,B-TE
throughout,O
her,O
hospitalization,O
with,O
no,O
significant,B-PR
events,I-PR
.,O

The,O
patient,O
had,O
an,B-TE
EP,I-TE
evaluation,I-TE
and,O
will,O
be,O
followed-up,O
by,O
Dr.,O
Welch,O
.,O

14-087,O
",",O
the,O
patient,O
had,O
a,B-TE
signal-averaged,I-TE
EKG,I-TE
.,O

She,O
will,O
follow-up,O
with,O
Dr.,O
Welch,O
with,O
an,B-TE
echocardiogram,I-TE
on,O
2015-07-24,O
in,O
a,O
meeting,O
to,O
discuss,O
risk,O
stratification,O
for,O
sudden,B-PR
cardiac,I-PR
death,I-PR
and,O
possible,O
ICD,B-TR
placement,I-TR
.,O

4.,O
NEUROLOGY,O
:,O
The,O
patient,O
complained,O
of,O
left,B-PR
lower,I-PR
extremity,I-PR
weakness,I-PR
with,O
ambulation,O
two,O
days,O
after,O
her,B-TE
cardiac,I-TE
catheterization,I-TE
.,O

The,O
patient,O
had,O
no,O
evidence,O
for,O
weakness,B-PR
on,O
examination,B-TE
with,O
good,O
proximal,O
and,O
distal,O
strength,O
in,O
the,O
lower,O
extremities,O
as,O
well,O
as,O
intact,O
sensation,O
.,O

The,O
patient,O
worked,O
with,O
Physical,O
Therapy,O
and,O
was,O
able,O
to,O
ambulate,O
without,O
difficulty,O
.,O

She,O
was,O
also,O
able,O
to,O
ascend,O
stairs,O
without,O
difficulty,B-PR
.,O

The,O
patient,O
was,O
already,O
on,O
an,B-TR
aspirin,I-TR
and,O
Plavix,B-TR
should,O
this,O
represent,O
a,B-PR
small,I-PR
stroke,I-PR
.,O

However,O
",",O
there,O
was,O
no,O
evidence,O
for,O
neurologic,B-PR
deficit,I-PR
on,O
examination,B-TE
and,O
this,O
will,O
be,O
followed-up,O
by,O
her,O
primary,O
care,O
physician,O
.,O

5.,O
HEMATOLOGY,O
:,O
The,O
patient,O
was,O
discharged,O
on,O
Coumadin,B-TR
for,O
apical,B-PR
akinesis,I-PR
and,O
stroke,B-PR
risk,I-PR
.,O

This,O
will,O
be,O
further,O
monitored,O
by,O
her,O
primary,O
care,O
physician,O
",",O
Dr.,O
Banks,O
",",O
who,O
will,O
adjust,O
her,B-TR
Coumadin,I-TR
dose,I-TR
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O
Stable,O
.,O

DISCHARGE,O
STATUS,O
:,O
To,O
home,O
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O
ST,B-PR
elevation,I-PR
myocardial,I-PR
infarction,I-PR
",",O
status,O
post,O
left,B-TR
anterior,I-TR
descending,I-TR
artery,I-TR
stent,I-TR
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Aspirin,B-TR
325,O
q.d.,O

2.,O
Lisinopril,B-TR
5,O
q.d.,O

3.,O
Toprol,B-TR
XL,I-TR
100,O
q.d.,O

4.,O
Coumadin,B-TR
5,O
q.d.,O

5.,O
Plavix,B-TR
75,O
q.d.,O

6.,O
Lovenox,B-TR
60,O
mg,O
b.i.d.,O
until,O
therapeutic,O
on,O
Coumadin,B-TR
.,O

7.,O
Pravastatin,B-TR
80,O
q.d.,O

FOLLOW-UP,O
PLANS,O
:,O
The,O
patient,O
will,O
follow-up,O
with,O
her,O
primary,O
care,O
physician,O
in,O
the,O
week,O
following,O
discharge,O
for,O
further,O
monitoring,O
of,O
her,B-TE
INR,I-TE
and,O
adjustment,O
of,O
her,B-TR
Coumadin,I-TR
dose,I-TR
.,O

The,O
patient,O
will,O
also,O
follow-up,O
with,O
Electrophysiology,O
with,O
Dr.,O
Welch,O
on,O
2015-07-24,O
.,O

In,O
addition,O
to,O
this,O
",",O
the,O
patient,O
will,O
follow-up,O
with,O
Cardiology,O
",",O
Dr.,O
Foster,O
",",O
and,O
Dr.,O
Upshaw,O
",",O
on,O
2015-07-06,O
for,O
further,B-TE
monitoring,I-TE
.,O

Joshua,O
PINTO,O
",",O
M.D.,O
12.932,O

Dictated,O
By,O
:,O
Greg,O
E.,O
Riordan,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2015-06-10,O
09:17,O

T,O
:,O
2015-06-12,O
16:28,O

JOB,O
#:,O

74717,O

Signed,O
electronically,O
by,O
:,O
DR.,O
David,O
PINTO,O
on,O
:,O
FRI,O
2015-06-19,O
5:36,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2013-04-24,O

Discharge,O
Date,O
:,O

2013-05-11,O

Date,O
of,O
Birth,O
:,O

2013-04-24,O

Sex,O
:,O

F,O

Service,O
:,O

NEONATOLOGY,O

HISTORY,O
:,O

Richard,O
Williams,O
",",O
Twin,O
number,O
II,O
",",O
was,O
born,O
at,O
31-6/7,O
weeks,O
gestation,O
by,O
cesarean,B-TR
section,I-TR
for,O
rupture,B-PR
of,I-PR
membranes,I-PR
of,O
Twin,O
number,O
I,O
and,O
progressive,B-PR
preterm,I-PR
labor,I-PR
.,O

Mother,O
is,O
a,O
37,O
year,O
old,O
Gravida,O
1,O
",",O
Para,O
0,O
now,O
2,O
woman,O
whose,O
blood,B-TE
type,I-TE
is,O
A,O
negative,O
",",O
antibody,B-TE
negative,O
",",O
rubella,B-TE
immune,O
",",O
RPR,B-TE
nonreactive,O
",",O
hepatitis,B-TE
B,I-TE
surface,I-TE
antigen,I-TE
negative,O
and,O
Group,B-TE
B,I-TE
Streptococcus,I-TE
unknown,O
.,O

The,O
mother,O
had,O
received,O
a,O
complete,O
course,O
of,O
betamethasone,B-TR
prior,O
to,O
delivery,O
.,O

This,O
pregnancy,O
was,O
achieved,O
with,O
in,O
Bartley,B-TR
fertilization,I-TR
.,O

A,B-TR
cerclage,I-TR
was,O
placed,O
at,O
18,O
weeks,O
gestation,O
.,O

Cesarean,B-TR
section,I-TR
was,O
performed,O
under,O
spinal,B-TR
anesthesia,I-TR
.,O

This,O
infant,O
emerged,O
with,O
Apgars,B-TE
of,O
8,O
at,O
one,O
minute,O
and,O
8,O
at,O
five,O
minutes,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,O
",",O
revealed,O
a,O
vigorous,O
non-dysmorphic,O
premature,O
infant,O
",",O
with,O
moderate,B-PR
subcostal,I-PR
retractions,I-PR
and,O
some,B-PR
occasional,I-PR
grunting,I-PR
",",O
normal,O
S1,O
",",O
S2,O
heart,O
sounds,O
",",O
no,O
murmur,B-PR
.,O

Pink,O
and,O
well,O
perfused,O
.,O

Normal,O
hip,O
examination,O
and,O
age,O
appropriate,O
tone,O
and,O
reflexes,O
.,O

The,B-TE
birth,I-TE
weight,I-TE
was,O
"1,980",O
grams,O
",",O
80th,O
percentile,O
.,O

The,B-TE
birth,I-TE
length,I-TE
was,O
44,O
centimeters,O
",",O
the,O
75th,O
percentile,O
and,O
the,B-TE
birth,I-TE
head,I-TE
circumference,I-TE
was,O
30.6,O
centimeters,O
",",O
in,O
the,O
65th,O
percentile,O

HOSPITAL,O
COURSE,O
BY,O
SYSTEMS,O
:,O

1.,O
Respiratory,O
Status,O
:,O

The,O
infant,O
was,O
intubated,O
soon,O
after,O
admission,O
to,O
the,O
CMED,O
CSRU,O
and,O
received,O
two,O
doses,O
of,O
surfactant,B-TR
.,O

She,O
weaned,O
to,O
room,O
air,O
on,O
day,O
of,O
life,O
one,O
where,O
she,O
has,O
remained,O
since,O
that,O
time,O
.,O

Her,B-TE
respirations,I-TE
are,O
comfortable,O
.,O

Her,B-TE
lung,I-TE
sounds,I-TE
are,O
clear,O
and,O
equal,O
.,O

She,O
has,O
had,O
no,O
apnea,B-PR
",",O
bradycardia,B-PR
or,O
desaturation,B-PR
.,O

2.,O
Cardiovascular,O
Status,O
:,O

She,O
had,O
remained,O
normotensive,O
throughout,O
her,O
CMED,O
CSRU,O
stay,O
.,O

She,O
has,O
a,O
normal,O
S1,O
",",O
S2,O
heart,O
sound,O
and,O
no,O
murmur,B-PR
.,O

She,O
is,O
pink,O
and,O
well,O
perfused,O
.,O

3.,O
Fluids,O
",",O
Electrolytes,O
and,O
Nutrition,O
Status,O
:,O

She,O
started,O
on,O
enteral,B-TR
feeds,I-TR
on,O
day,O
of,O
life,O
number,O
two,O
and,O
progressed,O
without,O
difficulty,O
to,O
full,B-TR
volume,I-TR
feedings,I-TR
by,O
day,O
of,O
life,O
five,O
and,O
then,O
was,O
advanced,O
to,O
calorie,B-TR
enhanced,I-TR
breast,I-TR
milk,I-TR
of,O
24,O
calories,O
per,O
ounce,O
.,O

She,O
has,O
been,O
taking,O
from,O
130,O
to,O
160,O
cc.,O
per,O
kilo,O
per,O
day,O
on,O
an,B-TR
ad,I-TR
lib,I-TR
feeding,I-TR
plan,I-TR
.,O

At,O
the,O
time,O
of,O
discharge,O
",",O
her,B-TE
weight,I-TE
is,O
"2,200",O
grams,O
;,O
her,B-TE
length,I-TE
is,O
49.5,O
centimeters,O
(,O
19.5,O
inches,O
),O
and,O
her,B-TE
head,I-TE
circumference,I-TE
is,O
30.5,O
centimeters,O
.,O

4.,O
Gastrointestinal,O
Status,O
:,O

Her,B-TE
peak,I-TE
bilirubin,I-TE
occurred,O
on,O
day,O
of,O
life,O
five,O
and,O
was,O
total,B-TE
12.1,O
",",O
direct,B-TE
0.3,O
;,O
the,B-TE
last,I-TE
bilirubin,I-TE
on,O
day,O
of,O
life,O
six,O
was,O
total,B-TE
11.1,O
",",O
direct,B-TE
0.4,O
.,O

She,O
never,O
required,O
phototherapy,B-TR
.,O

5.,O
Hematological,O
Status,O
:,O

Her,B-TE
hematocrit,I-TE
at,O
the,O
time,O
of,O
admission,O
was,O
45.4,O
",",O
platelets,B-TE
were,O
"360,000",O
.,O

She,O
is,O
receiving,O
supplemental,B-TR
iron,I-TR
to,O
provide,O
2,O
mg,O
per,O
kilo,O
per,O
day,O
as,O
elemental,B-TR
iron,I-TR
.,O

She,O
has,O
never,O
received,O
any,O
blood,B-TR
products,I-TR
during,O
this,O
CMED,O
CSRU,O
stay,O
.,O

6.,O
Infectious,O
Disease,O
Status,O
:,O

The,O
infant,O
was,O
started,O
on,O
Ampicillin,B-TR
and,O
Gentamycin,B-TR
at,O
the,O
time,O
of,O
admission,O
for,O
sepsis,B-PR
risk,I-PR
factor,I-PR
.,O

The,B-TR
antibiotics,I-TR
were,O
discontinued,O
after,O
48,O
hours,O
when,O
the,O
infant,O
was,O
clinically,O
well,O
and,O
the,B-TE
blood,I-TE
cultures,I-TE
remained,O
negative,O
.,O

7.,O
Neurological,O
Status,O
:,O

She,O
had,O
a,B-TE
head,I-TE
ultrasound,I-TE
on,O
2013-05-02,O
",",O
that,O
was,O
completely,O
within,O
normal,O
limits,O
.,O

8.,O
Psychosocial,O
:,O

The,O
parents,O
have,O
been,O
very,O
involved,O
in,O
the,O
infant,O
's,O
care,O
throughout,O
her,O
CMED,O
CSRU,O
stay,O
.,O

She,O
is,O
the,O
first,O
twin,O
to,O
go,O
home,O
.,O

The,O
infant,O
's,O
first,O
name,O
is,O
Ralph,O
and,O
after,O
discharge,O
the,O
infant,O
's,O
last,O
name,O
will,O
be,O
Neoma,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Good,O
.,O

DISPOSITION,O
:,O

The,O
infant,O
is,O
being,O
discharged,O
home,O
with,O
her,O
parents,O
.,O

Primary,O
pediatric,O
care,O
will,O
be,O
provided,O
by,O
Dr.,O
Hortencia,O
Conner,O
of,O
Milton,O
Hospital,O
Pediatric,O
Group,O
",",O
3408,O
E.,O
Fifth,O
Rd.,O
",",O
Bridgewater,O
State,O
Hospital,O
",",O
Tennessee,O
06546,O
",",O
telephone,O
number,O
is,O
433-0531,O
.,O

CARE,O
AND,O
RECOMMENDATIONS,O
:,O

1.,O
Feedings,O
:,O

The,O
infant,O
is,O
on,O
breast,B-TR
milk,I-TR
with,I-TR
Enfamil,I-TR
Powder,I-TR
to,O
provide,O
24,O
calories,O
per,O
ounce,O
and,O
on,O
an,B-TR
ad,I-TR
lib,I-TR
feeding,I-TR
schedule,I-TR
.,O

2.,O
Medications,O
:,O

Ferinsol,B-TR
0.2,O
cc.,O
to,O
provide,O
5,O
mg,O
a,O
day,O
.,O

3.,O
The,O
infant,O
passed,O
a,B-TE
car,I-TE
seat,I-TE
positioning,I-TE
test,I-TE
on,O
2013-05-11,O
.,O

4.,O
State,B-TE
Screens,I-TE
were,O
sent,O
on,O
04-27,O
and,O
2013-05-08,O
.,O

5.,O
The,O
infant,O
received,O
the,B-TR
hepatitis,I-TR
B,I-TR
vaccine,I-TR
on,O
2013-05-09,O
",",O
and,O
Synagis,B-TR
on,O
2013-05-11,O
.,O

Immunization,O
recommended,O
:,O

1),O
Synagis,B-TR
RSV,I-TR
prophylaxis,I-TR
should,O
be,O
considered,O
from,O
October,O
through,O
April,O
for,O
infants,O
who,O
meet,O
any,O
of,O
the,O
following,O
three,O
criteria,O
:,O

Born,O
at,O
less,O
than,O
32,O
weeks,O
;,O
born,O
between,O
32,O
and,O
35,O
weeks,O
with,O
plans,O
for,O
day,O
care,O
during,O
the,O
RSV,O
season,O
",",O
with,O
a,O

smoker,O
in,O
the,O
household,O
",",O
with,O
preschool,O
siblings,O
",",O
or,O
with,O
chronic,B-PR
lung,I-PR
disease,I-PR
;,O

2),O
Influenza,B-TR
immunization,I-TR
should,O
be,O
considered,O
annually,O
in,O
the,O
Fall,O
for,O
preterm,O
infants,O
with,O
chronic,B-PR
lung,I-PR
disease,I-PR
once,O
they,O
reach,O
six,O
months,O
of,O
age,O
.,O

Before,O
this,O
age,O
",",O
the,O
family,O
and,O
other,O
care,O
givers,O
should,O
be,O
considered,O
for,O
immunization,B-TR
against,O
influenza,B-PR
to,O
protect,O
the,O
infant,O
.,O

DISCHARGE,O
INSTRUCTIONS,O
:,O

1.,O
Follow-up,O
appointments,O
",",O
the,O
parents,O
have,O
an,O
appointment,O
with,O
Dr.,O
Avon,O
on,O
Tuesday,O
",",O
05-14,O
.,O

2.,O
Visiting,O
Nurses,O
Association,O
of,O
the,O
L.F.,O
Quigley,O
Memorial,O
Hospital,O
will,O
visit,O
on,O
Sunday,O
",",O
2013-05-12,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Prematurity,B-PR
at,O
31-6/7,O
weeks,O
gestation,O
.,O

2.,O
Twin,O
II,O
.,O

3.,O
Sepsis,B-PR
",",O
ruled,O
out,O
.,O

4.,O
Status,O
post,O
respiratory,B-PR
distress,I-PR
syndrome,I-PR
.,O

Brian,O
LT,O
Wentzel,O
",",O
M.D.,O

96-131,O

Dictated,O
By,O
:,O
Tammy,O
T.K.,O
Farless,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2013-05-11,O
17:49,O

T,O
:,O
2013-05-11,O
18:43,O

JOB,O
#:,O

6197,O

Signed,O
electronically,O
by,O
:,O
DR.,O
John,O
Bonilla,O
on,O
:,O
MON,O
2013-05-13,O
4:49,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2015-12-03,O

Discharge,O
Date,O
:,O

2015-12-08,O

Date,O
of,O
Birth,O
:,O

1960-04-22,O

Sex,O
:,O

M,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Patient,O
recorded,O
as,O
having,O
No,O
Known,B-PR
Allergies,I-PR
to,O
Drugs,B-TR

Attending,O
:,O
Geoffrey,O
F,O
Corney,O
",",O
M.D.,O

Chief,O
Complaint,O
:,O

bright,B-PR
red,I-PR
blood,I-PR
per,I-PR
rectum,I-PR

Major,O
Surgical,O
or,O
Invasive,O
Procedure,O
:,O

Colonoscopy,B-TR

Virtual,B-TR
colonoscopy,I-TR

History,O
of,O
Present,O
Illness,O
:,O

55,O
yo,O
M,O
w/,O
h/o,O
recurrent,B-PR
bladder,I-PR
ca,I-PR
s/p,O
cystectomy,B-TR
w/,O
ileal,B-TR
conduit,I-TR
p/w,O
BRBPR,B-PR
to,O
OSH,O
.,O

Hct,B-TE
dropped,O
34,O
->,O
22,O
.,O

EGD,B-TE
normal,O
.,O

Cscope,B-TE
unable,O
to,O
complete,O
due,O
to,O
blood,B-PR
but,O
tics,B-PR
seen,O
.,O

Tagged,O
RBC,B-TE
+,O
activity,O
in,O
RLQ,O
.,O

Transferred,O
to,O
Mediplex,O
Rehab,O
Hospital,O
ICU,O
where,O
Hct,B-TE
has,O
remained,O
stable,O
.,O

Seen,O
by,O
GI,O
and,O
plan,O
is,O
to,O
continue,O
holding,O
anticoagulation,B-TR
and,O
repeat,B-TE
scope,I-TE
on,O
Monday,O
.,O

Pt,O
feeling,O
well,O
",",O
denies,O
abd,B-PR
pain,I-PR
",",O
N/V,B-PR
",",O
LH,B-PR
",",O
SOB,B-PR
",",O
CP,B-PR
.,O

Past,O
Medical,O
History,O
:,O

Metastatic,B-PR
bladder,I-PR
CA,I-PR
now,O
in,O
remission,O
s/p,O
chemo/xrt,B-TR
s/p,O
cystectomy,B-TR
and,O
ileal,B-TR
loop,I-TR
urinary,I-TR
diversion,I-TR
and,O
also,O
radical,B-TR
prstatectomy,I-TR
with,O
bilateral,B-TR
pelvic,I-TR
lymph,I-TR
node,I-TR
dissection,I-TR
.,O

b/l,B-PR
DVT,I-PR
"s,",O
most,O
recent,O
seen,O
in,O
IVC,O
to,O
right,O
femoral,O
vein,O
s/p,O
IVC,B-TR
filter,I-TR
2015-01-15,O

Nephrolithiasis,B-PR
.,O

Anemia,B-PR
-,O
baseline,O
mid,O
30,O
s.,O

Social,O
History,O
:,O

From,O
Sao,O
Tome,O
originally,O
.,O

denies,O
smoking,O

works,O
at,O
a,O
deli,O
in,O
beaconhill,O
.,O

Family,O
History,O
:,O

denies,O
fh,O
of,O
bleeding,B-PR
or,O
clotting,B-PR
disorders,I-PR
.,O

Physical,O
Exam,O
:,O

per,O
admitting,O
resident,O
:,O

T,B-TE
97.4,O
BP,B-TE
100/62,O
P,B-TE
56,O
RR,B-TE
16,O

Mid,O
aged,O
man,O
in,O
NAD,B-PR

sclera,B-PR
anicteric,I-PR
",",O
MMM,O

supple,O
",",O
no,O
LAD,B-PR

CTAB,O

RRR,O
S1/S2,O
no,O
M,B-PR

soft,O
",",O
+BS,O
",",O
NT,B-PR
",",O
Midline,B-PR
surgical,I-PR
scar,I-PR
",",O
nephrostomy,B-TR
bag,I-TR
draining,O

yellowish,B-PR
urine,I-PR
in,I-PR
RLQ,I-PR

no,O
edema,B-PR
",",O
no,O
clubbing,B-PR

Pertinent,O
Results,O
:,O

2015-12-03,O
10:27,O
PM,O
GLUCOSE,B-TE
-,O
88,O
UREA,B-TE
N,I-TE
-,O
12,O
CREAT,B-TE
-,O
1.0,O
SODIUM,B-TE
-,O
138,O
POTASSIUM,B-TE
-,O
3.3,O
CHLORIDE,B-TE
-,O
107,O
TOTAL,B-TE
CO2,I-TE
-,O
25,O
ANION,B-TE
GAP,I-TE
-,O
9,O

2015-12-03,O
10:27,O
PM,O
estGFR,B-TE
-,O
Using,O
this,O

2015-12-03,O
10:27,O
PM,O
CALCIUM,B-TE
-,O
8.7,O
PHOSPHATE,B-TE
-,O
2.4,O
*,O
MAGNESIUM,B-TE
-,O
1.5,O
*,O

2015-12-03,O
10:27,O
PM,O
WBC,B-TE
-,O
8.4,O
RBC,B-TE
-,O
2.98,O
*,O
HGB,B-TE
-,O
9.3,O
*,O
HCT,B-TE
-,O
26.3,O
*,O
MCV,B-TE
-,O
88,O
MCH,B-TE
-,O
31.1,O
MCHC,B-TE
-,O
35.3,O
*,O
RDW,B-TE
-,O
14.4,O

2015-12-03,O
10:27,O
PM,O
PLT,B-TE
COUNT,I-TE
-,O
164,O

2015-12-03,O
10:27,O
PM,O
PT,B-TE
-,O
11.4,O
PTT,B-TE
-,O
27.5,O
INR(PT),B-TE
-,O
1.0,O

Brief,O
Hospital,O
Course,O
:,O

55,O
year,O
old,O
man,O
with,O
history,O
of,O
metastatic,B-PR
bladder,I-PR
cancer,I-PR
and,O
recurrent,B-PR
DVT,I-PR
s,I-PR
on,O
Lovenox,B-TR
admitted,O
with,O
lower,B-PR
GI,I-PR
bleeding,I-PR
.,O

Right,B-PR
lower,I-PR
quadrant,I-PR
source,I-PR
of,I-PR
bleed,I-PR
on,O
red,B-TE
blood,I-TE
cell,I-TE
scan,I-TE
.,O

Attempts,O
to,O
visualize,O
colon,O
by,O
conventional,B-TE
and,I-TE
CT,I-TE
virtual,I-TE
colonoscopy,I-TE
failed,O
because,O
of,O
sigmoid,B-PR
angulation,I-PR
and,O
inadequate,O
preparation,O
",",O
respectively,O
.,O

On,O
Ct,B-TE
scan,I-TE
",",O
a,B-PR
right,I-PR
psoas,I-PR
mass,I-PR
",",O
most,O
consistent,O
with,O
a,B-PR
hematoma,I-PR
",",O
was,O
seen,O
.,O

Since,O
the,B-TE
hematocrit,I-TE
of,O
the,O
patient,O
was,O
stable,O
and,O
outside,O
records,O
from,O
2015-03-28,O
mentioned,O
a,B-PR
mass,I-PR
in,I-PR
the,I-PR
right,I-PR
pelvis,I-PR
",",O
the,O
patient,O
was,O
discharged,O
.,O

Lovenox,B-TR
was,O
held,O
until,O
follow-up,O
with,O
primary,O
care,O
doctor,O
.,O

Also,O
",",O
a,B-TE
repeat,I-TE
outpatient,I-TE
CT,I-TE
colonoscopy,I-TE
with,O
better,O
preparation,O
should,O
be,O
considered,O
.,O

Medications,O
on,O
Admission,O
:,O

Lovenox,B-TR
0.6,O
mg,O
/,O
kg,O
SC,O
BID,O

Discharge,O
Medications,O
:,O

1.,O
Pantoprazole,B-TR
40,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
once,O
a,O
day,O
.,O

2.,O
Outpatient,O
Lab,O
Work,O

cbc,B-TE
",",O
creatinine,B-TE

Discharge,O
Disposition,O
:,O

Home,O

Discharge,O
Diagnosis,O
:,O

Primary,O
diagnosis,O
:,O

GIB,B-PR

Secondary,O
diagnosis,O
:,O

Metastatic,B-PR
",",I-PR
recurrent,I-PR
bladder,I-PR
cancer,I-PR

h/o,O
DVT,B-PR
s,I-PR

Discharge,O
Condition,O
:,O

Good,O
.,O

Stable,O
Hct,O
of,O
31,O
.,O

Discharge,O
Instructions,O
:,O

We,O
recommend,O
that,O
you,O
do,O
NOT,O
resume,O
your,B-TR
lovenox,I-TR
until,O
talking,O
to,O
your,O
PCP,O
",",O
Dr.,O
Jessie,O
.,O

You,O
likely,O
have,O
a,B-PR
bleeding,I-PR
source,I-PR
in,I-PR
your,I-PR
colon,I-PR
that,O
we,O
have,O
been,O
unable,O
to,O
visualize,O
.,O

The,B-PR
bleeding,I-PR
has,O
stopped,O
and,O
you,O
have,O
remained,O
hemodynamically,O
stable,O
and,O
your,B-TE
hematocrit,I-TE
is,O
stable,O
",",O
but,O
you,O
are,O
at,O
risk,O
of,O
bleeding,B-PR
from,O
this,O
source,O
again,O
with,O
anticoagulation,B-TR
.,O

A,B-TE
CT,I-TE
scan,I-TE
of,I-TE
your,I-TE
abdomen,I-TE
showed,O
a,B-PR
right,I-PR
pelvic,I-PR
mass,I-PR
",",O
most,O
likely,O
a,B-PR
hematoma,I-PR
",",O
which,O
had,O
been,O
described,O
previously,O
in,O
2015-03-28,O
.,O

Please,O
continue,O
to,O
take,O
your,B-TR
other,I-TR
medications,I-TR
as,O
prescribed,O
.,O

Please,O
follow,O
up,O
with,O
your,O
PCP,O
as,O
scheduled,O
.,O

Please,O
bring,O
your,O
outpatient,O
lab,O
results,O
to,O
your,O
PCP,O
(,O
Dr.,O
Hemler,O
),O

Please,O
see,O
a,O
doctor,O
if,O
you,O
feel,O
dizzy,B-PR
",",O
or,O
have,O
blood,B-PR
in,I-PR
your,I-PR
stool,I-PR
again,O
.,O

Followup,O
Instructions,O
:,O

Please,O
follow,O
up,O
with,O
your,O
PCP,O
S.,O
Saracino,O
on,O
2015-12-30,O
at,O
8:00,O
AM,O
.,O

Her,O
number,O
is,O
(,O
512,O
),O
677-6547,O
.,O

Please,O
go,O
to,O
Dr.,O
Colombo,O
office,O
later,O
this,O
week,O
to,O
have,O
your,B-TE
labs,I-TE
drawn,O
and,O
sent,O
to,O
Dr.,O
Powell,O
.,O

James,O
Jennifer,O
MD,O
",",O
PHD,O
12-944,O

Completed,O
by,O
:,O
Kimberly,O
Sarah,O
MD,O
97-625,O
2015-12-08,O
@,O
1543,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Joanne,O
Gilbert,O
YANG,O
on,O
:,O
MON,O
2016-02-08,O
9:27,O
AM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2016-04-05,O

Discharge,O
Date,O
:,O

2016-04-11,O

Date,O
of,O
Birth,O
:,O

1948-10-18,O

Sex,O
:,O

M,O

Service,O
:,O

Cardiothoracic,B-TR
Surgery,I-TR

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
67,O
-,O
year-old,O
male,O
with,O
a,O
history,O
of,O
high,B-PR
cholesterol,I-PR
who,O
was,O
in,O
his,O
usual,O
state,O
of,O
health,O
until,O
2016-04-03,O
.,O

He,O
was,O
raking,O
leaves,O
on,O
04-02,O
and,O
then,O
developed,O
episodes,O
of,O
mid,B-PR
chest,I-PR
pain,I-PR
and,O
burning,B-PR
which,O
radiated,O
to,O
the,O
left,O
arm,O
.,O

That,O
night,O
he,O
reportedly,O
stopped,O
breathing,B-PR
and,O
was,O
unresponsive,B-PR
.,O

His,O
wife,O
gave,O
him,O
mouth-to-mouth,B-TR
resuscitation,I-TR
and,O
he,O
regained,O
consciousness,O
.,O

He,O
presented,O
to,O
an,O
outside,O
hospital,O
with,O
an,B-PR
acute,I-PR
inferior,I-PR
myocardial,I-PR
infarction,I-PR
and,O
was,O
treated,O
with,O
thrombolytic,B-TR
therapy,I-TR
.,O

His,B-TE
troponin,I-TE
was,O
20,O
and,O
he,O
had,O
EKG,B-PR
changes,I-PR
.,O

He,O
underwent,O
catheterization,B-TE
on,O
2016-04-05,O
which,O
revealed,O
a,B-TE
left,I-TE
ventricular,I-TE
ejection,I-TE
fraction,I-TE
of,O
50%,O
",",O
no,O
mitral,B-PR
regurgitation,I-PR
",",O
insufficiency,B-PR
or,O
hypokinesis,B-PR
.,O

Left,O
main,O
coronary,O
artery,O
was,O
narrowed,B-PR
50-60%,O
",",O
left,O
anterior,O
descending,O
coronary,O
artery,O
70%,O
proximally,O
",",O
right,B-PR
coronary,I-PR
artery,I-PR
dominant,I-PR
diseased,I-PR
up,O
to,O
90%,O
proximally,O
in,O
the,O
midportion,O
",",O
70%,O
distally,O
.,O

The,O
left,O
circumflex,O
coronary,O
artery,O
was,O
50%,O
proximally,O
",",O
90%,O
obtuse,O
marginal,O
#3,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
History,O
of,O
high,B-PR
cholesterol,I-PR
.,O

2.,O
Hemorrhoidectomy,B-TR
.,O

3.,O
Carotid,B-PR
disease,I-PR
.,O

MEDICATIONS,O
AT,O
HOME,O
:,O

1.,O
Lipitor,B-TR
20,O
mg,O
p.o.,O
q.d.,O

2.,O
Aspirin,B-TR
325,O
mg,O
p.o.,O
q.d.,O

3.,O
Lopressor,B-TR
25,O
mg,O
p.o.,O
b.i.d.,O

4.,O
Plavix,B-TR
75,O
mg,O
p.o.,O
q.d.,O
which,O
has,O
been,O
discontinued,O
prior,O
to,O
surgery,B-TR
.,O

FAMILY,O
HISTORY,O
:,O

Positive,O
for,O
coronary,B-PR
artery,I-PR
disease,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

No,O
cigarettes,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

In,O
general,O
the,O
patient,O
was,O
in,O
no,O
acute,B-PR
distress,I-PR
",",O
afebrile,B-PR
",",O
vital,B-TE
signs,I-TE
stable,O
.,O

HEENT,O
:,O
Normocephalic,O
",",O
atraumatic,B-PR
.,O

Pupils,O
equal,O
",",O
round,O
and,O
reactive,O
to,O
light,O
.,O

Extraocular,O
movements,O
intact,O
.,O

Nasopharynx,O
benign,O
.,O

Neck,O
:,O
Supple,O
with,O
full,O
range,O
of,O
motion,O
",",O
no,O
lymphadenopathy,B-PR
nor,O
thyromegaly,B-PR
.,O

Carotids,B-TE
were,O
1+,O
bilaterally,O
.,O

Positive,O
right,B-PR
carotid,I-PR
bruits,I-PR
.,O

Lungs,O
:,O
Clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

Cardiovascular,O
:,O
Regular,O
rate,O
and,O
rhythm,O
",",O
no,O
murmurs,B-PR
.,O

Abdomen,O
:,O
Positive,O
bowel,O
sounds,O
",",O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
",",O
no,O
masses,B-PR
",",O
no,O
hepatosplenomegaly,B-PR
.,O

Extremities,O
:,O
Without,O
cyanosis,B-PR
",",O
clubbing,B-PR
or,O
edema,B-PR
.,O

Pulses,B-TE
were,O
2+,O
bilaterally,O
throughout,O
.,O

Neurologic,O
:,O
Nonfocal,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
hospital,O
and,O
on,O
2016-04-06,O
the,O
patient,O
underwent,O
coronary,B-TR
artery,I-TR
bypass,I-TR
grafting,I-TR
x,O
4,O
with,O
left,O
internal,O
mammary,O
artery,O
to,O
the,O
left,O
anterior,O
descending,O
coronary,O
artery,O
",",O
saphenous,B-TR
vein,I-TR
graft,I-TR
to,I-TR
the,I-TR
diagonal,I-TR
",",O
saphenous,B-TR
vein,I-TR
graft,I-TR
to,I-TR
obtuse,I-TR
marginal,I-TR
",",O
saphenous,B-TR
vein,I-TR
graft,I-TR
to,I-TR
right,I-TR
coronary,I-TR
artery,I-TR
",",O
posterior,O
descending,O
coronary,O
artery,O
.,O

The,O
patient,O
appeared,O
to,O
have,O
tolerated,O
the,B-TR
procedure,I-TR
and,O
was,O
transferred,O
to,O
the,O
cardiac,O
intensive,O
care,O
unit,O
for,O
postoperative,B-TR
management,I-TR
.,O

He,O
was,O
started,O
on,O
beta,B-TR
blockers,I-TR
.,O

The,O
patient,O
had,O
pacing,B-TR
wires,I-TR
and,O
chest,B-TR
tubes,I-TR
in,O
place,O
",",O
both,O
of,O
which,O
over,O
the,O
course,O
of,O
his,O
stay,O
were,O
removed,O
successfully,O
.,O

The,O
patient,O
did,O
well,O
postoperatively,O
and,O
was,O
transported,O
to,O
the,O
regular,O
cardiac,O
surgery,O
floor,O
where,O
he,O
tolerated,O
a,O
regular,O
diet,O
",",O
ambulated,O
well,O
",",O
did,O
well,O
with,O
his,O
activities,O
of,O
daily,O
living,O
.,O

He,O
was,O
seen,O
by,O
physical,O
therapy,O
and,O
cleared,O
.,O

They,O
requested,O
that,O
he,O
follow,O
up,O
in,O
three,O
to,O
five,O
weeks,O
for,O
endurance,B-TR
training,I-TR
",",O
however,O
then,O
physical,O
therapy,O
followed,O
him,O
a,O
number,O
of,O
times,O
afterward,O
and,O
decided,O
that,O
he,O
was,O
in,O
good,O
condition,O
and,O
did,O
not,O
need,O
further,O
physical,B-TR
therapy,I-TR
.,O

On,O
2016-04-11,O
the,O
patient,O
was,O
in,O
good,O
condition,O
and,O
he,O
is,O
being,O
discharged,O
on,O
a,O
regular,O
heart-healthy,O
diet,O
.,O

He,O
may,O
observe,O
regular,O
activity,O
although,O
he,O
should,O
avoid,O
strenuous,O
activity,O
and,O
should,O
not,O
drive,O
while,O
on,O
pain,B-TR
medications,I-TR
.,O

He,O
should,O
follow,O
up,O
with,O
Dr.,O
Dushaj,O
in,O
four,O
weeks,O
.,O

He,O
should,O
follow,O
up,O
with,O
his,O
cardiologist,O
in,O
two,O
to,O
three,O
weeks,O
and,O
he,O
should,O
follow,O
up,O
with,O
his,O
primary,O
care,O
physician,O
in,O
one,O
to,O
two,O
weeks,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Lasix,B-TR
20,O
mg,O
p.o.,O
q.,O
12,O
.,O

2.,O
Potassium,B-TR
20,O
mEq,O
p.o.,O
q.,O
12,O
.,O

3.,O
Colace,B-TR
100,O
mg,O
p.o.,O
b.i.d.,O

4.,O
Aspirin,B-TR
325,O
mg,O
p.o.,O
q.d.,O

5.,O
Percocet,B-TR
1-2,O
tablets,O
p.o.,O
q.,O
4,O
p.r.n.,O
pain,B-PR
.,O

6.,O
Lopressor,B-TR
12.5,O
mg,O
p.o.,O
b.i.d.,O

Alexander,O
S.,O
Young,O
",",O
M.D.,O
29-418,O

Dictated,O
By,O
:,O
Lila,O
I,O
Morgan,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2016-04-11,O
10:48,O

T,O
:,O
2016-04-11,O
10:59,O

JOB,O
#:,O
75073,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Jose,O
Kines,O
on,O
:,O
TUE,O
2016-04-12,O
7:03,O
AM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2017-09-22,O

Discharge,O
Date,O
:,O

2017-09-27,O

Date,O
of,O
Birth,O
:,O

2017-09-22,O

Sex,O
:,O

M,O

Service,O
:,O

CMED,O
CSRU,O

HISTORY,O
:,O

Peggy,O
Hammock,O
is,O
a,O
full,O
term,O
baby,O
boy,O
born,O
at,O
38,O
1/7,O
weeks,O
by,O
repeat,B-TR
cesarean,I-TR
section,I-TR
to,O
a,O
34,O
year,O
old,O
gravida,O
III,O
",",O
now,O
para,O
II,O
mother,O
.,O

Serologies,B-TE
include,O
blood,B-TE
type,I-TE
O,O
negative,O
",",O
antibody,B-TE
negative,O
",",O
RPR,B-TE
nonreactive,O
.,O

Hepatitis,B-TE
B,I-TE
surface,I-TE
antigen,I-TE
negative,O
",",O
rubella,B-TE
immune,O
.,O

Group,B-TE
B,I-TE
strep,I-TE
screening,I-TE
was,O
negative,O
.,O

Pregnancy,O
was,O
uncomplicated,B-PR
until,O
an,O
occurrence,O
of,O
HSV,B-PR
outbreak,I-PR
occurred,O
on,O
2017-09-13,O
approximately,O
one,O
week,O
prior,O
to,O
delivery,B-TR
.,O

Pregnancy,O
was,O
also,O
complicated,O
by,O
maternal,O
history,O
of,O
depression,B-PR
for,O
which,O
mother,O
received,O
Zoloft,B-TR
.,O

On,O
day,O
of,O
delivery,B-TR
mother,O
presented,O
in,O
spontaneous,B-PR
labor,I-PR
.,O

There,O
were,O
no,O
sepsis,B-PR
risk,I-PR
factors,I-PR
.,O

GBS,B-TE
negative,O
.,O

No,O
maternal,B-PR
fever,I-PR
.,O

Rupture,B-PR
of,I-PR
membranes,I-PR
at,O
time,O
of,O
delivery,B-TR
.,O

Delivery,B-TR
was,O
by,O
repeat,B-TR
cesarean,I-TR
section,I-TR
and,O
Apgars,B-TE
of,O
8,O
and,O
9,O
were,O
given,O
at,O
one,O
and,O
five,O
minutes,O
respectively,O
.,O

Baby,O
appeared,O
well,O
and,O
went,O
to,O
the,O
newborn,O
nursery,O
and,O
was,O
breast,O
feeding,O
and,O
undergoing,O
routine,B-TR
newborn,I-TR
care,I-TR
.,O

On,O
the,O
newborn,O
nursery,O
the,O
mother,O
called,O
the,O
nurse,O
for,O
concern,O
of,O
baby,O
turning,O
dusky,B-PR
while,O
feeding,O
.,O

She,O
called,O
the,O
nurses,O
and,O
patted,O
the,O
infant,O
on,O
the,O
back,O
.,O

This,B-PR
episode,I-PR
was,O
also,O
accompanied,O
by,O
gagging,B-PR
motions,I-PR
noted,O
of,O
the,O
infant,O
.,O

A,B-PR
second,I-PR
episode,I-PR
occurred,O
where,O
the,O
baby,O
turned,O
pale,B-PR
.,O

Mother,O
thought,O
the,O
baby,O
just,O
did,O
not,O
look,O
right,O
.,O

The,O
baby,O
did,O
not,O
turn,O
blue,B-PR
at,O
that,O
time,O
.,O

The,O
Neonatal,O
Intensive,O
Care,O
Unit,O
was,O
notified,O
and,O
the,O
baby,O
was,O
transferred,O
to,O
the,O
Newborn,O
Intensive,O
Care,O
Unit,O
for,O
further,B-TE
evaluation,I-TE
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,O
to,O
the,O
Neonatal,O
Intensive,O
Care,O
Unit,O
:,O

Full,O
term,O
well,O
appearing,O
infant,O
with,O
some,B-PR
facial,I-PR
jaundice,I-PR
",",O
overall,O
pink,O
",",O
warm,O
and,O
well,O
perfused,O
",",O
alert,O
and,O
responsive,O
.,O

Anterior,O
fontanelle,O
is,O
soft,O
",",O
open,O
and,O
flat,O
.,O

Ears,O
are,O
normally,O
set,O
.,O

Red,B-TE
reflexes,I-TE
noted,O
bilaterally,O
.,O

He,O
had,O
a,O
left,O
pupil,O
that,O
was,O
in,O
unequal,B-PR
in,I-PR
size,I-PR
with,O
a,B-PR
keyhole,I-PR
appearance,I-PR
consistent,O
with,O
a,B-PR
coloboma,I-PR
.,O

The,O
nares,O
were,O
patent,O
.,O

Palate,O
was,O
intact,O
.,O

Mucous,O
membranes,O
were,O
moist,O
and,O
pink,O
.,O

His,O
neck,O
was,O
supple,O
without,O
masses,B-PR
or,O
bruits,B-PR
.,O

Lungs,O
were,O
clear,O
to,O
auscultation,B-TE
and,O
equal,O
.,O

Comfortable,O
respiratory,O
pattern,O
.,O

Cardiovascular,O
:,O

Regular,O
rate,O
and,O
rhythm,O
",",O
no,O
murmur,B-PR
.,O

2,O
plus,O
femoral,B-TE
pulses,I-TE
were,O
noted,O
.,O

Abdomens,O
oft,O
with,O
positive,O
bowel,O
sounds,O
.,O

Genitourinary,O
:,O

Infant,O
was,O
circumcised,B-TR
in,O
the,O
newborn,O
nursery,O
which,O
was,O
healing,O
well,O
.,O

Testes,O
were,O
descended,O
bilaterally,O
.,O

Extremities,O
were,O
pink,O
and,O
well,O
perfused,O
.,O

Neurologic,O
:,O

Tone,B-TE
was,O
appropriate,O
for,O
gestational,O
age,O
with,O
equal,O
strength,B-TE
",",O
symmetric,O
reflexes,B-TE
.,O

HOSPITAL,O
COURSE,O
BY,O
SYSTEMS,O
:,O

Respiratory,O
:,O

The,O
infant,O
was,O
placed,O
on,O
a,B-TE
cardiopulmonary,I-TE
monitor,I-TE
upon,O
admission,O
to,O
the,O
Newborn,O
Intensive,O
Care,O
Unit,O
with,O
pulse,B-TE
oximetry,I-TE
.,O

He,O
was,O
noted,O
to,O
have,O
an,O
episode,O
of,O
desaturation,B-PR
related,O
to,O
feeding,O
with,O
desaturations,B-PR
in,O
the,O
70,O
percent,O
.,O

This,O
resolved,O
spontaneously,O
when,O
the,O
bottle,O
was,O
pulled,O
from,O
the,O
baby,O
's,O
mouth,O
.,O

Jule,O
remained,O
in,O
room,O
air,O
without,O
any,O
evidence,O
of,O
respiratory,B-PR
distress,I-PR
and,O
was,O
without,O
any,B-PR
further,I-PR
dusky,I-PR
spells,I-PR
or,O
pale,B-PR
episodes,I-PR
in,O
the,O
48,O
hours,O
prior,O
to,O
discharge,O
.,O

Cardiovascular,O
:,O

Renee,O
remained,O
cardiovascularly,O
stable,O
with,O
AP,B-TE
s,I-TE
noted,O
to,O
be,O
120,O
to,O
130,O
s.,O

Blood,B-TE
pressure,I-TE
84/43,O
with,O
a,B-TE
mean,I-TE
of,O
59,O
.,O

Fluid,O
",",O
electrolytes,O
and,O
nutritions,O
:,O

The,O
baby,O
had,O
been,O
breast,O
feeding,O
ad,O
lib,O
in,O
the,O
Newborn,O
Nursery,O
.,O

He,O
continued,O
to,O
feed,O
ad,O
lib,O
while,O
a,O
patient,O
in,O
the,O
Newborn,O
Intensive,O
Care,O
Unit,O
.,O

He,O
was,O
fed,O
with,O
a,O
bottle,O
occasionally,O
by,O
his,O
dad,O
and,O
had,O
a,O
vigorous,O
suck,O
and,O
was,O
noted,O
to,O
have,O
some,B-PR
discoordination,I-PR
of,I-PR
his,I-PR
suck,I-PR
while,O
breathing,O
at,O
the,O
initial,O
onset,O
of,O
feeding,O
time,O
.,O

This,O
resolved,O
with,O
removal,O
of,O
the,O
bottle,O
from,O
the,O
baby,O
's,O
mouth,O
.,O

Breast,O
feeding,O
was,O
limited,O
to,O
four,O
to,O
five,O
minutes,O
on,O
each,O
side,O
per,O
recommendation,O
of,O
neurology,O
after,O
their,B-TE
evaluation,I-TE
to,O
try,O
and,O
minimize,O
incidence,O
of,O
gastroesophageal,B-PR
reflux,I-PR
.,O

Weight,B-TE
at,O
time,O
of,O
discharge,O
is,O
3.13,O
kilograms,O
.,O

Birth,B-TE
weight,I-TE
was,O
3.29,O
kilograms,O
in,O
the,O
75th,O
percentile,O
.,O

Head,B-TE
circumference,I-TE
was,O
34.5,O
cm,O
",",O
75th,O
percentile,O
",",O
and,O
length,B-TE
was,O
50.7,O
cm,O
",",O
also,O
the,O
75th,O
percentile,O
.,O

Gastrointestinal,O
:,O

Baby,O
was,O
noted,O
to,O
have,O
frequent,B-PR
spitting,I-PR
episodes,I-PR
.,O

This,O
was,O
minimized,O
with,O
limitation,B-TR
of,I-TR
volume,I-TR
at,I-TR
each,I-TR
feed,I-TR
with,O
frequent,B-TR
feeding,I-TR
.,O

He,O
had,O
normal,O
voiding,O
and,O
stooling,O
patterns,O
.,O

The,O
baby,O
demonstrated,O
mild,B-PR
physiologic,I-PR
jaundice,I-PR
with,O
a,B-TE
serum,I-TE
bilirubin,I-TE
obtained,O
on,O
day,O
of,O
life,O
three,O
which,O
was,O
6.7,O
with,O
a,O
direct,O
of,O
0.2,O
.,O

Mother,B-TE
's,I-TE
blood,I-TE
type,I-TE
is,O
O,O
negative,O
.,O

Infant,B-TE
's,I-TE
blood,I-TE
type,I-TE
was,O
O,O
positive,O
and,O
Coombs,B-TE
was,O
noted,O
to,O
be,O
negative,O
.,O

Hematologic,O
:,O

In,O
addition,O
a,B-TE
complete,I-TE
blood,I-TE
count,I-TE
was,O
obtained,O
on,O
admission,O
with,O
a,B-TE
white,I-TE
count,I-TE
of,O
10.1,O
with,O
43,O
polys,B-TE
and,O
0,O
bands,B-TE
.,I-TE

Hematocrit,B-TE
was,O
noted,O
to,O
47.5,O
with,O
platelets,B-TE
of,O
"257,000",O
.,O

There,O
were,O
no,O
blood,B-TR
products,I-TR
received,O
during,O
hospitalization,O
.,O

Infectious,O
disease,O
:,O

A,B-TE
blood,I-TE
culture,I-TE
was,O
obtained,O
upon,O
admission,O
and,O
Ampicillin,B-TR
and,O
Gentamicin,B-TR
were,O
given,O
for,O
48,O
hours,O
with,O
blood,B-TE
cultures,I-TE
remaining,O
sterile,O
.,O

Antibiotics,B-TR
were,O
discontinued,O
on,O
day,O
of,O
life,O
three,O
and,O
infant,O
has,O
remained,O
clinically,O
well,O
off,O
antibiotics,B-TR
.,O

Neurology,O
:,O

Neurology,O
was,O
consulted,O
due,O
to,O
the,O
concern,O
for,O
seizures,B-PR
in,O
the,O
setting,O
of,O
dusky,B-PR
episodes,I-PR
.,O

Neurology,O
evaluated,O
the,O
baby,O
and,O
found,O
the,O
baby,O
to,O
have,O
a,O
normal,O
neurological,O
examination,O
.,O

An,B-TE
EEG,I-TE
was,O
performed,O
.,O

The,B-TE
EEG,I-TE
showed,O
transient,B-PR
sharp,I-PR
waves,I-PR
in,I-PR
the,I-PR
left,I-PR
front,I-PR
",",O
left,O
occipital,O
and,O
right,O
parietal,O
regions,O
.,O

There,O
was,O
no,O
electrographic,B-TE
evidence,I-TE
of,O
seizure,B-PR
activity,I-PR
noted,O
.,O

Sensory,O
:,O

Hearing,B-TE
screening,I-TE
was,O
performed,O
with,O
automated,O
auditory,O
brain,O
stem,O
responses,O
.,O

Baby,O
passed,O
in,O
both,O
ears,O
on,O
09-23,O
.,O

Ophthalmology,O
:,O

Ophthalmology,O
was,O
consulted,O
due,O
to,O
the,O
presence,O
of,O
a,B-PR
coloboma,I-PR
into,O
the,O
left,O
CMED,O
.,O

Ophthalmology,O
noted,O
that,O
this,B-PR
left,I-PR
Martha,I-PR
coloboma,I-PR
was,O
likely,O
an,B-PR
isolated,I-PR
anomaly,I-PR
in,O
the,O
absence,O
of,O
other,B-PR
pathology,I-PR
.,O

Follow,O
up,O
as,O
below,O
.,O

Psychosocial,O
:,O

Cambridge,O
Health,O
Alliance,O
social,O
worker,O
was,O
involved,O
with,O
this,O
family,O
.,O

She,O
may,O
be,O
reached,O
at,O
(,O
756,O
),O
599-4849,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Good,O
.,O

DISCHARGE,O
DISPOSITION,O
:,O

To,O
home,O
with,O
parents,O
.,O

Primary,O
pediatrician,O
is,O
Dr.,O
Satterlund,O
of,O
Westborough,O
Pediatrics,O
.,O

Telephone,O
number,O
is,O
(,O
739,O
),O
520-0347,O
.,O

Fax,O
number,O
is,O
(,O
617,O
),O
455-4585,O
.,O

Appointment,O
is,O
on,O
Lyon,O
",",O
10-30,O
.,O

CARE,O
AND,O
RECOMMENDATIONS,O
:,O

Feeds,O
are,O
breast,O
feeding,O
P.O.,O
ad,O
lib,O
.,O

Medications,B-TR
are,O
Tri-Vi-Michael,B-TR
1,O
cc,O
by,O
mouth,O
each,O
day,O
.,O

Newborn,B-TE
state,I-TE
screen,I-TE
was,O
sent,O
on,O
day,O
of,O
life,O
three,O
.,O

Results,O
are,O
pending,O
.,O

Immunizations,B-TR
received,O
are,O
hepatitis,B-TR
B,I-TR
vaccine,I-TR
given,O
on,O
09-26,O
.,O

Follow,O
up,O
appointments,O
scheduled,O
:,O

Neurology,O
follow,O
up,O
with,O
Dr.,O
Workman,O
is,O
scheduled,O
for,O
2017-10-20,O
at,O
12:30,O
pm,O

Phone,O
number,O
is,O
209-604-1402,O
.,O

Follow,O
up,O
ophthalmology,O
appointment,O
is,O
with,O
Dr.,O
Jundt,O
on,O
Ison,O
4,O
at,O
the,O
Addison,O
Gilbert,O
Hospital,O
of,O
Oak,O
Bluffs,O
in,O
three,O
months,O
.,O

Appointment,O
to,O
be,O
scheduled,O
by,O
mom,O
.,O

Telephone,O
number,O
is,O
444,O
7700,O
.,O

Boston,O
Regional,O
Medical,O
Centerr,O
Visiting,O
Nurse,O
Association,O
has,O
been,O
asked,O
to,O
visit,O
this,O
family,O
at,O
home,O
to,O
follow,O
up,O
on,O
feeding,O
and,O

parenting,O
.,O

DISCHARGE,O
DIAGNOSES,O
:,O

Full,O
term,O
male,O
infant,O
with,O
cyanosis,B-PR
episodes,I-PR
.,O

Rule,O
out,O
sepsis,B-PR
.,O

Left,B-PR
coloboma,I-PR
.,O

Rule,O
out,O
seizures,B-PR
.,O

Lucile,O
Virgina,O
",",O
MD,O
50AAD,O

Dictated,O
By,O
:,O
Sherry,O
G,O
Christie,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2017-09-27,O
17:51:44,O

T,O
:,O
2017-09-27,O
18:26:21,O

Job,O
#:,O
75510,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Marcus,O
N,O
Schartz,O
on,O
:,O
Maxine,O
2017-09-28,O
9:34,O
AM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2011-02-06,O

Discharge,O
Date,O
:,O

2011-02-08,O

Date,O
of,O
Birth,O
:,O

Sex,O
:,O

M,O

Service,O
:,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Mr.,O
Pohl,O
is,O
a,O
53,O
-,O
year-old,O
male,O
with,O
history,O
of,O
alcohol,O
use,O
and,O
hypertension,B-PR
.,O

"He,O
was,O
found,O
in,O
his,O
apartment,O
lobby,O
"",O
shouting,O
"",O
and,O
very,B-PR
agitated,I-PR
.",O

The,O
patient,O
states,O
that,O
he,O
recalls,O
going,O
out,O
alone,O
to,O
a,O
cafe,O
the,O
evening,O
prior,O
to,O
admission,O
.,O

There,O
he,O
recalls,O
having,O
pizza,O
and,O
two,O
glasses,O
of,O
red,O
wine,O
.,O

The,O
patient,O
told,O
other,O
staff,O
that,O
he,O
had,O
a,O
few,O
cocktails,O
and,O
drinking,O
a,O
few,O
more,O
glasses,O
of,O
wine,O
when,O
he,O
ran,O
into,O
some,O
friends,O
at,O
a,O
bar,O
.,O

He,O
denies,O
any,O
other,O
drug,O
or,O
toxin,O
ingestion,O
.,O

He,O
does,O
not,O
recall,O
walking,O
home,O
",",O
but,O
he,O
states,O
that,O
the,O
way,O
is,O
well,O
known,O
to,O
him,O
.,O

He,O
has,O
no,O
further,O
recollection,O
",",O
until,O
he,O
presented,O
to,O
the,O
emergency,O
room,O
.,O

He,O
by,O
emergency,O
room,O
report,O
",",O
was,O
found,O
in,O
his,O
apartment,O
lobby,O
agitated,B-PR
.,O

EMS,O
was,O
called,O
and,O
the,O
patient,O
was,O
taken,O
to,O
the,O
emergency,O
room,O
.,O

Blood,B-TE
alcohol,I-TE
level,I-TE
was,O
383,O
.,O

Agitated,B-PR
in,O
emergency,O
room,O
requiring,O
4,B-TR
leather,I-TR
restraints,I-TR
",",O
received,O
5,O
mg,O
of,O
Haldol,B-TR
",",O
2,O
mg,O
of,O
Ativan,B-TR
.,O

He,O
became,O
hypotensive,B-PR
in,O
the,O
emergency,O
room,O
with,O
a,B-TE
systolic,I-TE
blood,I-TE
pressure,I-TE
in,O
the,O
80,O
's,O
and,O
had,O
decreased,B-PR
respiratory,I-PR
rate,I-PR
.,O

He,O
received,O
a,B-TR
normal,I-TR
saline,I-TR
bolus,I-TR
of,O
2,O
liters,O
of,O
good,O
blood,O
pressure,O
response,O
.,O

The,O
patient,O
was,O
then,O
admitted,O
to,O
the,O
medical,O
Intensive,O
Care,O
Unit,O
for,O
observation,O
of,O
his,B-TE
blood,I-TE
pressure,I-TE
and,O
then,O
transferred,O
to,O
our,O
service,O
on,O
medicine,O
when,O
the,B-TE
blood,I-TE
pressures,I-TE
remained,O
stable,O
overnight,O
.,O

The,O
patient,O
denies,O
any,B-PR
chest,I-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
dysuria,B-PR
",",O
diarrhea,B-PR
",",O
bright,B-PR
red,I-PR
blood,I-PR
per,I-PR
rectum,I-PR
.,O

He,O
does,O
complain,O
of,O
cold,B-PR
symptoms,I-PR
times,O
one,O
week,O
.,O

The,O
patient,O
states,O
in,O
the,O
past,O
that,O
he,O
has,O
participated,O
in,O
several,O
alcohol,B-TR
treatment,I-TR
programs,I-TR
",",O
most,O
recently,O
Star,O
which,O
is,O
similar,O
Alcoholics,O
Anonymous,O
.,O

The,O
patient,O
admits,O
that,O
he,O
has,O
had,O
many,O
stressors,O
in,O
his,O
life,O
lately,O
.,O

His,O
job,O
as,O
a,O
computer,O
programmer,O
is,O
unstable,O
.,O

His,O
brother,O
is,O
mentally,B-PR
handicapped,I-PR
and,O
might,O
be,O
sent,O
away,O
from,O
his,O
instate,O
institution,O
.,O

"He,O
is,O
also,O
concerned,O
about,O
the,O
threat,O
of,O
war,O
and,O
is,O
ready,O
to,O
"",O
move,O
to,O
Madagascar,O
"".",O

He,O
states,O
that,O
he,O
primarily,O
relies,O
on,O
friends,O
.,O

In,O
the,O
past,O
",",O
he,O
has,O
been,O
very,B-PR
depressed,I-PR
and,O
has,O
seen,O
a,B-TR
counselor,I-TR
at,O
Greenfield,O
Community,O
College,O
Community,O
Health,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Hypertension,B-PR
.,O

2.,O
History,O
of,O
colonic,B-PR
polyps,I-PR
times,O
3,O
",",O
benign,O
in,O
2007,O
",",O
repeat,B-TE
colonoscopy,I-TE
due,O
to,O
in,O
2010,O
.,O

3.,O
History,O
of,O
right,B-PR
inguinal,I-PR
hernia,I-PR
in,O
2002,O
.,O

FAMILY,O
HISTORY,O
:,O

Noncontributory,O
.,O

SOCIAL,O
HISTORY,O
:,O

Positive,O
tobacco,O
",",O
10,O
pack,O
year,O
history,O
",",O
quit,O
for,O
8,O
years,O
in,O
his,O
40,O
's,O
and,O
now,O
no,O
cigarettes,O
for,O
one,O
week,O
using,O
no,O
pharmacal,B-TR
therapy,I-TR
.,O

Positive,O
for,O
ETOH,O
(,O
10,O
glasses,O
a,O
week,O
"),",O
positive,O
for,O
drugs,O
",",O
marijuana,O
in,O
college,O
.,O

He,O
denies,O
any,O
IV,O
drug,O
use,O
.,O

The,O
patient,O
currently,O
lives,O
lone,O
in,O
Malden,O
.,O

He,O
came,O
out,O
here,O
for,O
college,O
at,O
BU,O
and,O
works,O
as,O
a,O
computer,O
programmer,O
.,O

Primarily,O
the,O
family,O
lives,O
in,O
Wisconsin,O
.,O

The,O
patient,O
has,O
only,O
male,O
sexual,O
partners,O
and,O
in,O
the,O
last,O
six,O
months,O
has,O
two,O
regular,O
partners,O
who,O
reportedly,O
are,O
human,B-PR
immunodeficiency,I-PR
virus,I-PR
negative,O
and,O
no,O
IV,O
drug,O
use,O
.,O

He,O
uses,O
condoms,B-TR
consistently,O
.,O

Major,O
stressors,O
in,O
his,O
life,O
include,O
unstable,O
job,O
",",O
brother,O
is,O
mentally,B-PR
handicapped,I-PR
",",O
war,O
.,O

ALLERGIES,O
:,O
No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

MEDICATIONS,O
AT,O
HOME,O
:,O

1.,O
Lisinopril,B-TR
5,O
mg,O
p.o.,O
q.d.,O

2.,O
Mavik,B-TR
question,O
of,O
dosage,O
.,O

3.,O
Hydrochlorothiazide,B-TR
question,O
of,O
dosage,O
.,O

MEDICATIONS,O
ON,O
TRANSFER,O
:,O

1.,O
Ranitidine,B-TR
150,O
mg,O
b.i.d.,O

2.,O
Thiamine,B-TR
100,O
mg,O
q.d.,O

3.,O
Folic,B-TR
acid,I-TR
1,O
mg,O
q.,O
d.,O

4.,O
Multivitamin,B-TR

PHYSICAL,O
EXAMINATION,O
:,O

Vitals,B-TE
on,I-TE
admission,I-TE
:,O
Please,O
refer,O
to,O
addendum,O
.,O

Vital,B-TE
signs,I-TE
were,O
stable,O
.,O

Systolic,B-TE
blood,I-TE
pressure,I-TE
in,O
the,O
120,O
's,O
to,O
130,O
's.,O

Pulse,B-TE
in,O
the,O
60,O
's,O
to,O
70,O
's.,O

The,O
patient,O
was,O
a,O
thin,O
well-appearing,O
man,O
who,O
was,O
visibly,B-PR
restless,I-PR
in,O
bed,O
.,O

Neurological,O
:,O

He,O
was,O
alert,O
and,O
oriented,O
times,O
3,O
and,O
with,O
slightly,B-PR
pressured,I-PR
speech,I-PR
.,O

He,O
states,O
that,O
mood,O
is,O
depressed,B-PR
.,O

He,O
denies,O
auditory,B-PR
",",I-PR
visual,I-PR
or,I-PR
tactile,I-PR
hallucinations,I-PR
.,O

Cranial,B-TE
nerves,I-TE
II-XII,I-TE
are,O
grossly,O
intact,O
",",O
5/5,O
strength,B-TE
in,I-TE
all,I-TE
extremities,I-TE
",",O
sensation,B-TE
is,O
intact,O
in,O
all,O
extremities,O
.,O

Head,B-TE
",",I-TE
ears,I-TE
",",I-TE
eyes,I-TE
",",I-TE
nose,I-TE
and,I-TE
throat,I-TE
:,O
Atraumatic,B-PR
and,O
normocephalic,O
.,O

Sclerae,O
were,O
anicteric,B-PR
.,O

Oropharynx,O
was,O
benign,O
without,O
exudate,B-PR
.,O

Neck,O
:,O

Supple,O
.,O

Cardiovascular,O
:,O

Regular,O
rate,O
and,O
rhythm,O
with,O
normal,O
S1,O
and,O
S2,O
.,O

NO,O
murmurs,B-PR
",",O
rubs,B-PR
or,O
gallops,B-PR
.,O

Chest,O
:,O

Rare,B-PR
crackles,I-PR
on,I-PR
the,I-PR
right,I-PR
base,I-PR
",",O
otherwise,O
clear,O
to,O
auscultation,B-TE
bilaterally,I-TE
.,O

Abdomen,O
:,O

Positive,O
bowel,O
sounds,O
",",O
nontender,B-PR
and,O
nondistended,B-PR
.,O

No,O
hepatosplenomegaly,B-PR
.,O

Extremities,O
:,O

He,O
had,O
Dorsalis,B-TE
pedis,I-TE
in,O
radial,B-TE
pulses,I-TE
",",O
hands,B-PR
and,I-PR
feet,I-PR
notably,I-PR
tremulous,I-PR
without,O
asterixis,B-PR
.,O

No,O
stigmata,B-PR
of,O
IV,O
drug,O
use,O
.,O

LABORATORY,O
DATA,O
:,O

CBC,B-TE
:,O
White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
is,O
8.8,O
",",O
hematocrit,B-TE
35.5,O
platelets,B-TE
266,O
",",O
PT,B-TE
13,O
",",O
PT-T,B-TE
23.3,O
",",O
INR,B-TE
was,O
1.1,O
.,O

Chem-7,B-TE
:,O
Sodium,B-TE
145,O
",",O
potassium,B-TE
3.4,O
",",O
chloride,B-TE
116,O
",",O
bicarb,B-TE
21,O
",",O
BUN,B-TE
12,O
",",O
creatinine,B-TE
0.6,O
",",O
glucose,B-TE
96,O
",",O
calcium,B-TE
7.2,O
",",O
phos,B-TE
3.6,O
",",O
magnesium,B-TE
1.7,O
.,O

Liver,B-TE
function,I-TE
tests,I-TE
:,O
ALT,B-TE
38,O
",",O
AST,B-TE
34,O
",",O
alk,B-TE
phos,I-TE
is,I-TE
107,O
",",O
albumin,B-TE
is,O
3.2,O
",",O
peak,B-TE
bili,I-TE
is,I-TE
0.3,O
",",O
amylase,B-TE
31,O
",",O
and,O
lipase,B-TE
is,O
32,O
.,O

UA,B-TE
was,O
negative,O
.,O

Urine,B-TE
tox,I-TE
was,O
negative,O
.,O

Serum,B-TE
tox,I-TE
was,O
positive,O
for,O
ETOH,B-TE
at,O
383,O
",",O
otherwise,O
negative,O
.,O

Serum,B-TE
osmolality,I-TE
was,O
38397,O
",",O
calculated,B-TE
osmolality,I-TE
gap,I-TE
was,O
21,O
.,O

Radiology,O
:,O

chest,B-TE
x-ray,I-TE
from,O
02-07,O
had,O
linear,B-PR
atelectasis,I-PR
in,I-PR
right,I-PR
lower,I-PR
lobe,I-PR
with,O
no,O
evidence,O
of,O
a,B-PR
band-like,I-PR
opacity,I-PR
in,I-PR
the,I-PR
left,I-PR
lower,I-PR
lobe,I-PR
which,O
was,O
evident,O
on,O
the,B-TE
chest,I-TE
x-ray,I-TE
on,O
02-06,O
.,O

CT,B-TE
of,I-TE
the,I-TE
head,I-TE
on,O
02-06,O
was,O
negative,O
for,O
hemorrhage,B-PR
.,O

There,O
was,O
bran,B-PR
atrophy,I-PR
and,O
right,B-PR
temporal,I-PR
encephalomalacia,I-PR
.,O

ASSESSMENT,O
AND,O
PLAN,O
:,O

Mr.,O
Pohl,O
is,O
a,O
53,O
-,O
year-old,O
male,O
with,O
a,O
history,O
of,O
ETOH,O
",",O
hypertension,B-PR
who,O
presented,O
int,O
he,O
emergency,O
room,O
with,O
increased,B-PR
agitation,I-PR
",",O
like,O
secondary,O
to,O
ETOH,B-PR
intoxication,I-PR
and,O
developed,O
subsequent,B-PR
hypotension,I-PR
",",O
systolic,B-TE
blood,I-TE
pressures,I-TE
in,O
the,O
80,O
"'s,",O
status,O
post,O
Ativan,B-TR
and,O
Haldol,B-TR
",",O
but,O
was,O
responsive,O

to,O
fluid,B-TR
resuscitation,I-TR
at,O
4,O
liters,O
and,O
was,O
admitted,O
to,O
the,O
CMED,O
CCU,O
for,O
hemodynamic,B-TE
monitoring,I-TE
.,O

On,O
hospital,O
day,O
#2,O
",",O
the,O
patient,O
was,O
transferred,O
to,O
the,O
Medicine,O
Ludlow,O
Team,O
.,O

Plan,O
for,O
patient,O
regarding,O
cardiac,O
",",O
unlike,O
hypotension,B-PR
of,I-PR
cardiac,I-PR
origin,I-PR
.,O

The,O
patient,O
responded,O
well,O
to,O
fluid,B-TR
resuscitation,I-TR
.,O

Elevated,B-PR
CK,I-PR
on,O
02-07,O
is,O
likely,O
secondary,O
to,O
mild,B-PR
rhabdomyolysis,I-PR
.,O

The,O
patient,O
was,O
hemodynamically,O
stable,O
overnight,O
in,O
the,O
CMED,O
CCU,O
.,O

We,O
decided,O
to,O
discontinue,O
telemetry,B-TE
and,O
held,O
all,B-TR
hypertension,I-TR
medications,I-TR
including,O
Lisinopril,B-TR
",",O
Mavik,B-TR
",",O
hydrochlorothiazide,B-TR
.,O

2.,O
For,O
pulmonary,O
",",O
the,O
patient,O
had,O
a,O
good,O
O2,B-TE
saturations,I-TE
on,O
room,O
air,O
.,O

He,O
had,O
atelectasis,B-PR
in,I-PR
the,I-PR
right,I-PR
lower,I-PR
lobe,I-PR
by,O
chest,B-TE
x-ray,I-TE
.,O

We,O
encouraged,O
activity,O
and,O
patient,O
out,O
of,O
bed,O
.,O

3.,O
Gastrointestinal,O
:,O

The,O
patient,O
on,O
ranitidine,B-TR
150,O
mg,O
p.o.,O
b.i.d.,O
for,O
gastrointestinal,B-TR
prophylaxis,I-TR
.,O

4.,O
Urology,O
:,O
Foley,B-TR
was,O
discontinued,O
in,O
the,O
CMED,O
CCU,O
at,O
12,O
p.m.,O

The,O
patient,O
was,O
urinating,O
without,O
difficulty,B-PR
.,O

We,O
gave,O
the,O
patient,O
bathroom,O
privileges,O
.,O

5.,O
FEN,O
:,O

We,O
continued,O
IV,B-TR
fluids,I-TR
at,O
100,O
cc,O
per,O
hour,O
for,O
one,O
liter,O
secondary,O
to,O
a,O
concern,O
for,O
rhabdomyolysis,B-PR
plus,O
kidney,B-TR
protective,I-TR
effects,I-TR
.,O

K,B-TE
was,O
3.4,O
",",O
repleted,O
",",O
potassium,B-TR
chloride,I-TR
40,O
mEq,O
times,O
1,O
dose,O
p.o.,O

Calcium,B-TE
with,O
7.2,O
corrected,O
to,O
less,O
than,O
"8.0,",O
completed,O
calcium,B-TR
carbonate,I-TR
at,O
500,O
mg,O
blood,B-TE
pressure.o.,I-TE
t.i.d.,O
while,O
in,O
the,O
hospital,O
.,O

Mag,B-TE
was,O
1.7,O
",",O
repleted,O
with,O
magnesium,B-TR
oxide,I-TR
with,O
400,O
mg,O
p.o.,O
times,O
one,O
dose,O
.,O

Diet,O
as,O
tolerated,O
.,O

6.,O
Substance,O
use,O

The,O
patient,O
states,O
that,O
he,O
was,O
willing,O
to,O
speak,O
with,O
someone,O
from,O
addiction,O
services,O
.,O

We,O
were,O
concerned,O
regarding,O
possibly,O
binge,O
drinking,O
or,O
ETOH,O
abuse,O
.,O

The,O
patient,O
seemed,O
notably,B-PR
anxious,I-PR
and,O
depressed,B-PR
.,O

It,O
is,O
possible,O
that,O
the,O
patient,O
is,O
self,O
medicating,O
for,O
underlying,B-PR
psychiatric,I-PR
disorder,I-PR
.,O

We,O
will,O
monitor,B-TE
for,O
signs,O
of,O
alcohol,B-PR
withdrawal,I-PR
according,O
to,O
the,B-TE
CIWA,I-TE
scale,I-TE
.,O

We,O
will,O
given,O
valium,B-TR
5,O
mg,O
p.o.,O
q.,O
3,O
hours,O
for,O
withdrawal,B-PR
.,O

We,O
will,O
consult,O
addiction,O
service,O
in,O
the,O
a.m.,O

We,O
will,O
consider,O
psychiatry,O
consult,O
in,O
the,O
future,O
to,O
assess,O
for,O
underlying,B-PR
anxiety,I-PR
disorder,I-PR
or,O
depression,B-PR
.,O

DISPOSITION,O
:,O

The,O
patient,O
may,O
be,O
discharge,O
Harry,O
02-08,O
pending,O
observations,B-TE
for,O
delirium,B-PR
tremens,I-PR
after,O
discussion,O
with,O
primary,O
care,O
physician,O
",",O
Dr.,O
Blue,O
who,O
knows,O
the,O
patient,O
well,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
transferred,O
to,O
medicine,O
service,O
on,O
hospital,O
day,O
#2,O
after,O
remaining,O
hemodynamically,O
stable,O
in,O
the,O
CMED,O
CCU,O
overnight,O
.,O

1.,O
Blood,B-TE
pressure,I-TE
:,O

The,B-TE
patient,I-TE
's,I-TE
blood,I-TE
pressure,I-TE
remained,O
stable,O
on,O
hospital,O
day,O
#2,O
through,O
hospital,O
day,O
#3,O
status,O
post,O
IV,B-TR
hydration,I-TR
with,O
systolic,B-TE
blood,I-TE
pressures,I-TE
in,O
the,O
120,O
's,O
to,O
130,O
's.,O

We,O
continued,O
to,O
hold,O
the,O
patient,O
's,O
home,B-TR
blood,I-TR
pressure,I-TR
medications,I-TR
.,O

The,O
patient,O
was,O
asymptomatic,B-PR
without,O
chest,B-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
and,O
no,O
mental,B-PR
status,I-PR
changes,I-PR
.,O

2.,O
Substance,O
abuse,O
:,O

On,O
Hospital,O
day,O
#2,O
through,O
hospital,O
day,O
#3,O
",",O
the,O
patient,O
had,O
mild,B-PR
tremor,I-PR
on,I-PR
hands,I-PR
",",O
but,O
improved,O
over,O
hospital,O
course,O
.,O

The,O
patient,O
became,O
notably,B-PR
less,I-PR
anxious,I-PR
throughout,O
hospital,O
stay,O
.,O

CIWA,B-TE
scale,I-TE
over,O
night,O
was,O
1,O
for,O
tremor,B-PR
and,O
the,O
patient,O
did,O
not,O
require,O
any,O
Valium,B-TR
for,O
alcohol,B-PR
withdrawal,I-PR
.,O

We,O
believe,O
that,O
the,O
patient,O
is,O
able,O
to,O
be,O
discharged,O
and,O
to,O
follow,O
up,O
with,O
Dr.,O
Sandra,O
Rose,O
",",O
addiction,O
services,O
as,O
an,O
outpatient,O
.,O

Call,O
for,O
further,O
referral,O
.,O

3.,O
FEN,O
:,O

Calcium,B-TR
carbonate,I-TR
500,O
mg,O
p.o.,O
t.i.d.,O
",",O
Mag,B-TR
oxide,I-TR
400,O
mg,O
p.o.,O
times,O
one,O
dose,O
",",O
potassium,B-TR
chloride,I-TR
repleted,O
40,O
mEq,O
times,O
one,O
dose,O
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

1.,O
ETOH,B-PR
intoxication,I-PR
.,O

2.,O
Hypertension,B-PR
.,O

3.,O
History,O
of,O
colonic,B-PR
polyp,I-PR
times,O
3,O
",",O
benign,O
in,O
2007,O
",",O
repeat,B-TE
colonoscopy,I-TE
due,O
in,O
2010,O
.,O

4.,O
History,B-PR
of,I-PR
right,I-PR
inguinal,I-PR
hernia,I-PR
in,O
2002,O
.,O

DISCHARGE,O
STATUS,O
:,O

Home,O
.,O

FOLLOW,O
UP,O
:,O

Follow,O
up,O
with,O
Dr.,O
Marcia,O
Bender,O
to,O
be,O
arranged,O
by,O
the,O
patient,O
.,O

The,O
patient,O
will,O
also,O
call,O
clinical,O
nurse,O
specialist,O
",",O
Sandra,O
Rose,O
at,O
(,O
968,O
),O
347-9868,O
for,O
further,O
referral,O
to,O
addiction,O
services,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Return,O
to,O
home,B-TR
medications,I-TR
:,O

1.,O
Lisinopril,B-TR
5,O
mg,O
p.o.q.d.,O

2.,O
Mavik,B-TR
unknown,O
dosage,O
.,O

3.,O
Hydrochlorothiazide,B-TR
unknown,O
dosage,O
.,O

MARK,O
T,O
Ragin,O
",",O
M.D.,O
34-329,O

Dictated,O
By,O
:,O
Alice,O
T.,O
Mahoney,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2011-02-08,O
12:05,O

T,O
:,O
2011-02-08,O
12:15,O

JOB,O
#:,O
77892,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Richard,O
Carlson,O
on,O
:,O
SUN,O
2011-02-20,O
1:40,O
PM,O

(,O
End,O
of,O
Report,O
),O

7901625,O

Admission,O
Date,O
:,O

2015-03-16,O

Discharge,O
Date,O
:,O

2015-03-19,O

Date,O
of,O
Birth,O
:,O

Sex,O
:,O

Service,O
:,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
an,O
82,O
-,O
year-old,O
male,O
with,O
a,O
history,O
of,O
hypertension,B-PR
",",O
remote,O
tobacco,O
abuse,O
",",O
chronic,B-PR
renal,I-PR
insufficiency,I-PR
",",O
and,O
a,O
history,O
of,O
a,B-PR
TIA,I-PR
who,O
was,O
in,O
his,O
usual,O
state,O
of,O
health,O
until,O
five,O
nights,O
prior,O
to,O
admission,O
when,O
he,O
awoke,O
at,O
midnight,O
with,O
severe,B-PR
epigastric,I-PR
pain,I-PR
radiating,O
to,O
both,O
arms,O
.,O

He,O
also,O
had,O
bilateral,B-PR
arm,I-PR
numbness,I-PR
.,O

The,B-PR
symptoms,I-PR
were,O
associated,O
with,O
diaphoresis,B-PR
and,O
shortness,B-PR
of,I-PR
breath,I-PR
but,O
no,O
nausea,B-PR
or,O
vomiting,B-PR
.,O

After,O
approximately,O
one,O
hour,O
",",O
he,O
presented,O
to,O
the,O
Bristol,O
County,O
Tuberculosis,O
Hospital,O
Dana-Farber,O
Cancer,O
Institute,O
Campus,O
where,O
he,O
ruled,O
in,O
for,O
a,B-PR
non-ST,I-PR
elevation,I-PR
MI,I-PR
with,O
a,B-TE
CK,I-TE
of,O
438,O
with,O
a,B-TE
peak,I-TE
CK,I-TE
MB,I-TE
of,O
19.8,O
and,O
troponin,B-TE
that,O
peaked,O
at,O
10.2,O
.,O

He,O
was,O
started,O
on,O
nitrates,B-TR
there,O
as,O
well,O
as,O
heparin,B-TR
and,O
Integrelin,B-TR
and,O
remained,O
pain-free,B-PR
.,O

He,O
denied,O
any,O
history,O
of,O
similar,B-PR
symptoms,I-PR
in,O
the,O
past,O
and,O
has,O
had,O
no,O
prior,O
history,O
of,O
angina,B-PR
or,O
myocardial,B-PR
infarction,I-PR
.,O

The,O
patient,O
was,O
subsequently,O
transferred,O
to,O
Youville,O
Hospital,O
for,O
cardiac,B-TE
catheterization,I-TE
.,O

At,O
the,O
time,O
of,O
transfer,O
",",O
he,O
was,O
initially,O
admitted,O
to,O
the,O
CMI,O
Service,O
after,O
undergoing,O
cardiac,B-TE
catheterization,I-TE
which,O
revealed,O
a,B-PR
long,I-PR
LAD,I-PR
lesion,I-PR
that,O
was,O
angioplastied,O
without,O
stent,B-TR
placement,I-TR
",",O
and,O
a,B-PR
total,I-PR
occlusion,I-PR
of,I-PR
the,I-PR
RCA,I-PR
with,O
collaterals,O
.,O

He,O
subsequently,O
became,O
hypotensive,B-PR
and,O
bradycardiac,B-PR
in,O
the,O
Catheterization,O
Laboratory,O
which,O
responded,O
to,O
IV,B-TR
fluids,I-TR
",",O
dopamine,B-TR
",",O
Atropine,B-TR
",",O
and,O
he,O
was,O
then,O
transferred,O
to,O
the,O
CCU,O
for,O
further,B-TE
monitoring,I-TE
.,O

He,O
had,O
a,B-TE
bedside,I-TE
transthoracic,I-TE
echocardiogram,I-TE
done,O
in,O
the,O
Cardiac,O
Catheterization,O
laboratory,O
without,O
evidence,O
of,O
an,B-PR
effusion,I-PR
.,O

A,B-TR
Swan,I-TR
was,O
also,O
placed,O
.,O

There,O
were,O
no,O
stents,B-TR
deployed,O
at,O
all,O
throughout,O
the,B-TE
catheterization,I-TE
.,O

By,O
the,O
time,O
he,O
was,O
admitted,O
",",O
he,O
was,O
off,O
pressors,B-TR
and,O
hemodynamically,O
stable,O
and,O
pain-free,B-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

TIA,B-PR
in,O
1998,O
.,O

COPD,B-PR
with,O
2,O
liters,O
dependence,O
of,O
home,B-TR
02,I-TR
.,O

BPH,B-PR
.,O

Chronic,B-PR
renal,I-PR
insufficiency,I-PR
.,O

Gastritis,B-PR
.,O

Asthma,B-PR
.,O

SOCIAL,O
HISTORY,O
:,O

He,O
lis,O
currently,O
widowed,O
.,O

He,O
lives,O
in,O
senior,O
apartment,O
housing,O
in,O
Cambridge,O
on,O
the,O
second,O
floor,O
.,O

He,O
is,O
very,O
active,O
.,O

He,O
uses,O
a,B-TR
cane,I-TR
p.r.n.,O
for,O
walking,O
.,O

He,O
denied,O
any,O
falls,O
at,O
home,O
.,O

His,O
only,O
family,O
member,O
is,O
a,O
niece,O
in,O
Missouri,O
.,O

He,O
is,O
currently,O
retired,O
.,O

He,O
has,O
a,O
remote,O
tobacco,O
history,O
and,O
reports,O
occasional,O
alcohol,O
use,O
.,O

He,O
denied,O
any,O
other,O
drug,O
use,O
.,O

FAMILY,O
HISTORY,O
:,O

Noncontributory,O
.,O

ALLERGIES,O
:,O

The,O
patient,O
has,O
no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

1.,O
Aspirin,B-TR
325,O
mg,O
q.d.,O

2.,O
Metoprolol,B-TR
50,O
mg,O
b.i.d.,O

3.,O
Lipitor,B-TR
10,O
mg,O
q.d.,O

4.,O
MDI,B-TR
p.r.n.,O

5.,O
Heparin,B-TR
drip,I-TR
on,O
transfer,O
.,O

6.,O
Integrelin,B-TR
drip,I-TR
on,O
transfer,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Vital,B-TE
signs,I-TE
:,O

Heart,B-TE
rate,I-TE
91,O
",",O
regular,O
",",O
blood,B-TE
pressure,I-TE
169/81,O
from,O
a,B-TR
right,I-TR
groin,I-TR
A,I-TR
line,I-TR
",",O
respirations,B-TE
12,O
",",O
oxygen,B-TE
saturation,I-TE
of,O
97,O
percent,O
on,O
2,B-TR
liters,I-TR
nasal,I-TR
cannula,I-TR
.,O

General,O
:,O

He,O
was,O
a,O
well,O
appearing,O
male,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

HEENT,O
:,O

Crusting,B-PR
around,I-PR
the,I-PR
right,I-PR
eyelid,I-PR
but,O
the,O
pupils,O
were,O
equal,O
",",O
round,O
",",O
and,O
reactive,O
to,O
light,O
.,O

He,O
was,O
edentulous,B-PR
.,O

Neck,O
:,O

The,O
neck,O
was,O
supple,O
without,O
lymphadenopathy,B-PR
or,O
thyromegaly,B-PR
.,O

Cardiovascular,O
:,O

His,O
heart,O
was,O
regular,O
with,O
a,O
normal,O
S1,O
and,O
S2,O
.,O

He,O
had,O
no,O
murmurs,B-PR
",",O
rubs,B-PR
",",O
or,O
gallops,B-PR
.,O

Lungs,O
:,O

His,O
lungs,O
were,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
Anteriorly,O
and,O
laterally,O
.,O

Abdomen,O
:,O

Soft,O
",",O
obese,B-PR
",",O
nontender,B-PR
",",O
nondistended,B-PR
.,O

He,O
had,O
normoactive,O
bowel,B-TE
sounds,I-TE
.,O

Extremities,O
:,O

There,O
was,O
a,B-TR
right,I-TR
groin,I-TR
A,I-TR
line,I-TR
and,O
a,B-TR
left,I-TR
groin,I-TR
venous,I-TR
sheath,I-TR
with,O
a,B-TR
Swan,I-TR
.,O

He,O
had,O
no,O
evident,B-PR
edema,I-PR
.,O

He,O
had,O
2+,O
dorsalis,B-TE
pedis,I-TE
and,O
posterior,B-TE
tibial,I-TE
pulses,I-TE
bilaterally,O
.,O

Neurologic,O
:,O

He,O
was,O
alert,O
and,O
oriented,O
times,O
three,O
",",O
moving,O
all,O
extremities,O
.,O

LABORATORY,O
DATA,O
:,O

On,O
admission,O
",",O
the,B-TE
CBC,I-TE
revealed,O
a,B-TE
white,I-TE
count,I-TE
of,O
7.4,O
",",O
hematocrit,B-TE
39.7,O
",",O
and,O
platelets,B-TE
of,O
"217,000",O
.,O

Serum,B-TE
chemistries,I-TE
revealed,O
a,B-TE
sodium,I-TE
of,O
"135,",O
potassium,B-TE
4.0,O
",",O
chloride,B-TE
102,O
",",O
bicarbonate,B-TE
26,O
",",O
BUN,B-TE
29,O
",",O
creatinine,B-TE
1.6,O
",",O
and,O
glucose,B-TE
of,O
111,O
.,O

The,B-TE
initial,I-TE
EKG,I-TE
showed,O
normal,O
sinus,B-TE
rhythm,I-TE
at,O
a,B-TE
rate,I-TE
of,O
71,O
with,O
a,O
normal,O
axis,B-TE
and,O
evidence,O
of,O
first-degree,B-PR
AV,I-PR
block,I-PR
with,O
prolonged,B-PR
PR,I-PR
interval,I-PR
of,O
238,O
milliseconds,O
.,O

He,O
also,O
had,O
a,B-PR
widened,I-PR
QRS,I-PR
of,O
153,O
milliseconds,O
",",O
an,B-PR
old,I-PR
right,I-PR
bundle,I-PR
branch,I-PR
block,I-PR
",",O
and,O
no,O
acute,B-PR
ST,I-PR
or,I-PR
T,I-PR
wave,I-PR
changes,I-PR
.,O

The,B-TE
EKG,I-TE
was,O
prior,O
to,O
catheterization,B-TE
and,O
the,O
one,O
post,O
PTCA,B-TR
was,O
no,O
different,O
.,O

He,O
had,O
a,B-TE
bedside,I-TE
echocardiogram,I-TE
done,O
in,O
the,O
Catheterization,O
Laboratory,O
which,O
showed,O
normal,O
LV,O
wall,O
thickness,O
and,O
normal,O
LV,O
cavity,O
size,O
.,O

There,O
was,O
no,O
evidence,O
of,O
effusion,B-PR
.,O

It,O
was,O
difficult,O
to,O
assess,O
free,O
wall,O
motion,O
.,O

Cardiac,B-TE
catheterization,I-TE
revealed,O
a,B-PR
totally,I-PR
occluded,I-PR
RCA,I-PR
with,O
collaterals,O
",",O
an,B-PR
80,I-PR
percent,I-PR
LAD,I-PR
lesion,I-PR
extending,O
distally,O
which,O
was,O
angioplastied,O
but,O
no,O
stent,B-TR
was,O
placed,O
.,O

Hemodynamics,O
:,O

The,B-TE
right,I-TE
heart,I-TE
catheterization,I-TE
revealed,O
pulmonary,B-TE
capillary,I-TE
wedge,I-TE
pressure,I-TE
of,O
4,O
",",O
cardiac,B-TE
output,I-TE
of,O
8,O
",",O
and,O
cardiac,B-TE
index,I-TE
of,O
3.8,O
",",O
he,O
had,O
an,B-TE
RA,I-TE
pressure,I-TE
of,O
10,O
",",O
RV,B-TE
pressure,I-TE
of,O
43/4,O
",",O
PA,B-TE
pressure,I-TE
of,O
37/10,O
.,O

ASSESSMENT,O
:,O

This,O
is,O
an,O
82,O
-,O
year-old,O
male,O
with,O
a,O
history,O
of,O
prior,O
tobacco,O
use,O
",",O
hypertension,B-PR
",",O
chronic,B-PR
renal,I-PR
insufficiency,I-PR
",",O
COPD,B-PR
",",O
gastritis,B-PR
",",O
and,O
TIA,B-PR
who,O
initially,O
presented,O
to,O
Braintree,O
with,O
a,B-PR
non-ST,I-PR
elevation,I-PR
MI,I-PR
and,O
Guaiac,B-PR
positive,I-PR
stools,I-PR
",",O
transferred,O
to,O
St.,O
Margaret's,O
Center,O
for,O
Women,O
&,O
Infants,O
for,O
cardiac,B-TE
catheterization,I-TE
with,O
PTCA,B-TR
to,O
mid,B-PR
LAD,I-PR
lesion,I-PR
complicated,O
by,O
hypotension,B-PR
and,O
bradycardia,B-PR
requiring,O
Atropine,B-TR
",",O
IV,B-TR
fluids,I-TR
and,O
transient,B-TR
dopamine,I-TR
possibly,O
secondary,O
to,O
vagal,B-PR
reaction,I-PR
",",O
subsequently,O
transferred,O
to,O
CCU,O
for,O
close,B-TE
monitoring,I-TE
",",O
hemodynamically,O
stable,O
at,O
the,O
time,O
of,O
admission,O
to,O
the,O
CCU,O
.,O

HOSPITAL,O
COURSE,O
:,O

1.,O
CARDIOVASCULAR,O
:,O

As,O
summarized,O
above,O
",",O
the,O
patient,O
had,O
a,B-PR
non-ST,I-PR
elevation,I-PR
MI,I-PR
with,O
evidence,O
of,O
an,B-PR
80,I-PR
percent,I-PR
mid,I-PR
LAD,I-PR
lesion,I-PR
for,O
which,O
he,O
underwent,O
angioplasty,B-TR
without,O
stent,B-TR
placement,I-TR
.,O

He,O
was,O
initially,O
continued,O
on,O
aspirin,B-TR
",",O
Plavix,B-TR
",",O
beta,B-TR
blocker,I-TR
",",O
statin,B-TR
",",O
and,O
ACE,B-TR
inhibitor,I-TR
.,O

At,O
the,O
time,O
of,O
discharge,O
",",O
his,B-TR
Plavix,I-TR
was,O
held,O
due,O
to,O
Guaiac,B-PR
positive,I-PR
stools,I-PR
and,O
hematocrit,B-PR
drop,I-PR
throughout,O
admission,O
.,O

He,O
had,O
a,B-TE
transthoracic,I-TE
echocardiogram,I-TE
the,O
day,O
after,O
admission,O
showing,O
an,B-TE
ejection,I-TE
fraction,I-TE
of,O
greater,O
than,O
60,O
percent,O
.,O

No,O
focal,B-PR
wall,I-PR
motion,I-PR
abnormalities,I-PR
.,O

He,O
had,O
no,O
recurrent,B-PR
chest,I-PR
pain,I-PR
or,O
shortness,B-PR
of,I-PR
breath,I-PR
throughout,O
admission,O
.,O

In,O
regards,O
to,O
his,O
rhythm,O
",",O
he,O
has,O
an,B-PR
underlying,I-PR
right,I-PR
bundle,I-PR
branch,I-PR
block,I-PR
and,O
first-degree,B-PR
AV,I-PR
block,I-PR
which,O
were,O
stable,O
throughout,O
this,O
admission,O
.,O

He,O
will,O
be,O
followed-up,O
by,O
his,O
cardiologist,O
after,O
discharge,O
.,O

1.,O
PULMONARY,O
:,O

He,O
had,O
a,O
history,O
of,O
COPD,B-PR
for,O
which,O
he,O
is,O
on,O
baseline,O
2,O
liters,O
of,O
02,B-TR
by,O
nasal,B-TR
cannula,I-TR
at,O
home,O
and,O
Albuterol,B-TR
and,O
Atrovent,B-TR
MDI,I-TR
s,O
p.r.n.,O
at,O
home,O
.,O

He,O
is,O
also,O
on,O
Flovent,B-TR
MDI,I-TR
at,O
home,O
as,O
well,O
.,O

He,O
was,O
continued,O
on,O
his,B-TR
MDI,I-TR
and,O
was,O
at,O
his,B-PR
baseline,I-PR
02,I-PR
requirement,I-PR
throughout,O
admission,O
.,O

1.,O
RENAL,O
:,O

He,O
has,O
a,O
history,O
of,O
chronic,B-PR
renal,I-PR
insufficiency,I-PR
likely,O
secondary,O
to,O
hypertension,B-PR
and,O
was,O
admitted,O
with,O
a,B-TE
creatinine,I-TE
of,O
1.6,O
.,O

His,B-TR
ACE,I-TR
inhibitor,I-TR
post,O
MI,B-PR
was,O
initially,O
held,O
due,O
to,O
his,B-TE
creatinine,I-TE
.,O

However,O
",",O
this,O
responded,O
to,O
IV,B-TR
fluids,I-TR
and,O
his,B-TR
ACE,I-TR
inhibitor,I-TR
was,O
restarted,O
at,O
the,O
time,O
of,O
discharge,O
.,O

He,O
will,O
need,O
close,B-TE
monitoring,I-TE
of,O
his,B-TE
creatinine,I-TE
post,O
discharge,O
in,O
the,O
setting,O
of,O
reinstitution,O
of,O
his,B-TR
ACE,I-TR
inhibitor,I-TR
.,O

1.,O
GASTROINTESTINAL,O
:,O

His,O
stools,O
were,O
noted,O
to,O
be,O
Guaiac,B-PR
positive,I-PR
at,O
the,O
outside,O
hospital,O
and,O
there,O
was,O
still,O
concern,O
for,O
possible,O
GI,B-PR
bleed,I-PR
given,O
continued,O
Guaiac,B-PR
positive,I-PR
stools,I-PR
during,O
this,O
admission,O
and,O
a,B-PR
slight,I-PR
drop,I-PR
in,I-PR
his,I-PR
hematocrit,I-PR
from,O
39,O
to,O
33,O
.,O

It,O
was,O
felt,O
most,O
appropriate,O
for,O
him,O
to,O
have,O
an,B-TE
outpatient,I-TE
GI,I-TE
workup,I-TE
",",O
and,O
his,O
PCP,O
was,O
contacted,O
and,O
will,O
arrange,O
for,O
outpatient,B-TE
colonoscopy,I-TE
.,O

His,B-TR
Plavix,I-TR
was,O
held,O
at,O
the,O
time,O
of,O
discharge,O
due,O
to,O
a,O
question,O
of,O
GI,B-PR
bleed,I-PR
and,O
in,O
the,O
setting,O
of,O
not,O
having,O
a,B-TR
stent,I-TR
placed,O
at,O
the,O
time,O
of,O
catheterization,B-TE
.,O

He,O
was,O
continued,O
on,O
his,B-TR
aspirin,I-TR
",",O
however,O
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

Coronary,B-PR
artery,I-PR
disease,I-PR
",",O
status,O
post,O
non-ST,B-PR
elevation,I-PR
myocardial,I-PR
infarction,I-PR
with,O
80,B-PR
percent,I-PR
mid,I-PR
LAD,I-PR
lesion,I-PR
",",O
now,O
status,O
post,O
angioplasty,B-TR
.,O

Hypertension,B-PR
.,O

Chronic,B-PR
renal,I-PR
insufficiency,I-PR
.,O

Chronic,B-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
.,O

Guaiac,B-PR

Anemia,B-PR
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Lipitor,B-TR
10,O
mg,O
q.d.,O

2.,O
Lisinopril,B-TR
2.5,O
mg,O
q.d.,O

3.,O
Flovent,B-TR
110,O
micrograms,O
aerosol,O
two,O
puffs,O
b.i.d.,O

4.,O
Aspirin,B-TR
325,O
mg,O
q.d.,O

5.,O
Combivent,B-TR
MDI,O
p.r.n.,O

6.,O
Toprol,B-TR
XL,I-TR
100,O
mg,O
q.d.,O

DISPOSITION,O
:,O

At,O
the,O
time,O
of,O
discharge,O
",",O
the,B-TE
patient,I-TE
's,I-TE
vital,I-TE
signs,I-TE
were,O
stable,O
and,O
he,O
was,O
without,O
complaints,B-PR
.,O

DISCHARGE,O
STATUS,O
:,O

He,O
will,O
be,O
discharged,O
to,O
home,O
and,O
was,O
cleared,O
by,O
Physical,O
Therapy,O
.,O

FOLLOW,O
UP,O
:,O

He,O
has,O
been,O
scheduled,O
for,O
follow-up,O
with,O
Dr.,O
Martha,O
on,O
2015-03-25,O
at,O
11:00,O
a.m.,O

It,O
was,O
discussed,O
with,O
him,O
the,O
need,O
to,O
schedule,O
follow-up,O
for,O
colonoscopy,B-TE
with,O
his,O
PCP,O
as,O
well,O
.,O

He,O
will,O
call,O
the,O
Cardiology,O
Division,O
at,O
Addison,O
Gilbert,O
Hospital,O
Greenfield,O
to,O
schedule,O
a,O
follow-up,O
with,O
his,O
cardiologist,O
there,O
within,O
the,O
next,O
week,O
.,O

Lucile,O
Minor,O
Etta,O
",",O
MD,O

12ADA,O

Dictated,O
By,O
:,O
Emily,O
M.,O
Cassidy,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2015-07-29,O
17:03:53,O

T,O
:,O
2015-07-29,O
22:08:30,O

Job,O
#:,O
81504,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Brenda,O
JM.,O
Espinosa,O
on,O
:,O
Maxine,O
2015-09-10,O
1:57,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2013-11-04,O

Discharge,O
Date,O
:,O

2013-11-16,O

Date,O
of,O
Birth,O
:,O

1930-12-19,O

Sex,O
:,O

F,O

Service,O
:,O

MEDICINE,O

Allergies,O
:,O

Sulfa,B-TR
(,I-TR
Sulfonamides,I-TR
),O
/,O
Penicillins,B-TR
/,O
Macrodantin,B-TR
/,O
Ivp,B-TR
Dye,I-TR
",",O
Iodine,B-TR
Containing,I-TR

Attending,O
:,O
Robert,O
E,O
Goldschmidt,O
",",O
M.D.,O

Addendum,O
:,O

Just,O
prior,O
to,O
discharge,O
on,O
11-14,O
",",O
pt,B-TE
's,I-TE
BP,I-TE
was,O
found,O
to,O
be,O
70/40,O
P70,O
s,O
just,O
after,O
receiving,O
her,B-TR
am,I-TR
BP,I-TR
meds,I-TR
.,O

She,O
was,O
asymptomatic,B-PR
.,O

The,O
patient,O
was,O
kept,O
in,O
the,O
hospital,O
and,O
the,O
following,O
issues,O
were,O
addressed,O
:,O

1.,O
Hypotension,B-PR
:,O
The,B-TR
patient,I-TR
'd,I-TR
pm,I-TR
BP,I-TR
meds,I-TR
were,O
held,O
11-14,O
and,O
she,O
was,O
administered,O
1.5L,O
NS,B-TR
over,O
the,O
course,O
of,O
the,O
day,O
with,O
subsequent,O
SBP,B-TE
s,I-TE
in,O
the,O
high,O
90,O
"s,",O
low,O
100,O
"s,.",O

The,B-PR
hypotension,I-PR
was,O
likely,O
due,O
to,O
volume,B-PR
depletion,I-PR
caused,O
by,O
her,B-PR
diarrhea,I-PR
/,O
loose,B-PR
stools,I-PR
in,O
addition,O
to,O
decreased,B-PR
PO,I-PR
intake,I-PR
secondary,O
to,O
her,B-PR
GERD,I-PR
and,O
thrush,B-PR
.,O

All,O
of,O
this,O
occurred,O
in,O
the,O
setting,O
of,O
aggressive,B-TR
BP,I-TR
management,I-TR
with,O
metoprolol,B-TR
25,O
BID,O
",",O
HCTZ,B-TR
/,O
Triampterene,B-TR
(,O
as,O
a,O
replacment,O
for,O
lasix,B-TR
due,O
to,O
recurrent,B-PR
hypokalemia,I-PR
"),",O
Benicar,B-TR
20,O
mg,O
QD,O
",",O
and,O
Imdur,B-TR
30,O
mg,O
QD,O
.,O

Infection,B-PR
/,O
sepsis,B-PR
was,O
not,O
likely,O
given,O
she,O
was,O
afebrile,B-PR
and,O
had,O
no,O
localizing,B-PR
sx,I-PR
with,O
an,O
improving,O
lung,B-TE
exam,I-TE
and,O
02,B-PR
requirement,I-PR
.,O

Given,O
the,B-PR
patient,I-PR
's,I-PR
recent,I-PR
RP,I-PR
bleed,I-PR
",",O
there,O
was,O
concern,O
for,O
a,B-PR
recurrent,I-PR
bleed,I-PR
.,O

Her,B-TE
groin,I-TE
exam,I-TE
was,O
unchanged,O
.,O

Her,B-TE
Hct,I-TE
dropped,O
from,O
Hct,B-TE
38.9,O
before,O
fluids,B-TR
to,O
35.5,O
s/p,O
1.5L,O
NS,B-TR
and,O
was,O
thought,O
to,O
be,O
dilutional,O
.,O

Repeat,B-TE
hcts,I-TE
were,O
stable,O
.,O

The,O
patient,O
was,O
kept,O
an,O
additional,O
two,O
days,O
to,O
follow,O
her,B-TE
hcts,I-TE
and,O
titrate,O
her,B-TR
BP,I-TR
meds,I-TR
.,O

As,O
volume,B-PR
depletion,I-PR
was,O
thought,O
to,O
be,O
the,O
cause,O
of,O
her,B-PR
low,I-PR
BP,I-PR
",",O
only,O
the,B-TR
BBlocker,I-TR
was,O
restarted,O
.,O

She,O
was,O
also,O
placed,O
on,O
on,O
low,B-TR
dose,I-TR
spironolactone,I-TR
as,O
a,B-TR
K,I-TR
sparing,I-TR
diuretic,I-TR
and,O
for,O
BP,B-TR
control,I-TR
in,O
addition,O
to,O
Toprol,B-TR
XL,I-TR
25,O
mg,O
QD,O
for,O
her,B-PR
coronary,I-PR
disease,I-PR
.,O

She,O
tolerated,O
these,B-TR
meds,I-TR
with,O
SBP,B-TE
s,I-TE
in,O
the,O
high,O
90,O
s,O
to,O
100,O
s,O
and,O
was,O
therefore,O
discharged,O
on,O
this,B-TR
regimen,I-TR
.,O

She,O
will,O
need,O
follow,O
up,O
with,O
her,O
PCP,O
within,O
B,O
week,O
after,O
discharge,O
from,O
the,O
extended,O
care,O
facility,O
for,O
further,B-TR
BP,I-TR
titration,I-TR
and,O
monitoring,B-TE
of,I-TE
her,I-TE
electrolytes,I-TE
.,O

2.,O
Thrush,B-PR
:,O
This,O
is,O
likely,O
secondary,O
to,O
her,B-TR
steroid,I-TR
inhalers,I-TR
and,O
PO,B-TR
prednisone,I-TR
for,O
COPD,B-PR
exacerbation,I-PR
.,O

She,O
was,O
started,O
on,O
nystatin,B-TR
swish,O
and,O
swallow,O
QID,O
.,O

The,O
patient,O
was,O
encouraged,O
to,O
take,B-TR
PO,I-TR
liquids,I-TR
to,O
prevent,O
volume,B-PR
depletion,I-PR
.,O

3.,O
diarrhea,B-PR
:,O
The,O
patient,O
has,O
been,O
having,O
loose,B-PR
stools,I-PR
at,O
night,O
and,O
was,O
guiac,B-PR
pos,I-PR
x,O
2,O
.,O

Stool,B-TE
for,I-TE
C.diff,I-TE
toxin,I-TE
was,O
sent,O
x,O
1,O
and,O
was,O
negative,O
.,O

Her,B-TR
bowel,I-TR
regimen,I-TR
is,O
prn,O
.,O

Gastroenteritis,B-PR
is,O
possible,O
but,O
she,O
has,O
no,O
vomiting,B-PR
and,O
only,O
occ,B-PR
nausea,I-PR
with,O
meds,B-TR
.,O

There,O
is,O
no,O
evidence,O
of,O
obstruction,B-PR
on,O
AXR,B-TE
.,O

Therefore,O
",",O
the,O
cause,O
of,O
her,B-PR
mild,I-PR
diarrhea,I-PR
(,O
few,B-PR
loose,I-PR
BM,I-PR
/,O
liquid,B-PR
stool,I-PR
/,O
night,O
),O
may,O
be,O
either,O
viral,B-PR
or,O
secondary,O
to,O
resolving,B-PR
abdominal,I-PR
hematoma,I-PR
with,O
resultant,O
irritation,B-PR
of,I-PR
GI,I-PR
system,I-PR
.,O

We,O
have,O
advised,O
a,B-TR
BRAT,I-TR
diet,I-TR
.,O

4.,O
guiac,B-PR
pos,I-PR
stool,I-PR
:,O
Given,O
the,O
patient,O
's,O
sx,O
of,O
GERD,B-PR
",",O
current,O
PO,B-TR
steroid,I-TR
regimen,I-TR
",",O
and,O
ASA,B-TR
for,O
her,B-TR
stents,I-TR
",",O
the,O
ddx,O
for,O
her,B-PR
guiac,I-PR
positive,I-PR
stools,I-PR
would,O
include,O
gastritis,B-PR
/,O
gastric,B-PR
ulcer,I-PR
in,O
addition,O
to,O
lower,B-PR
GI,I-PR
pathology,I-PR
.,O

However,O
",",O
she,O
has,O
no,O
vomiting,B-PR
and,O
only,B-PR
mild,I-PR
nausea,I-PR
with,O
medications,B-TR
.,O

She,O
also,O
has,O
no,O
gross,B-PR
blood,I-PR
per,I-PR
rectum,I-PR
and,O
her,B-TE
hct,I-TE
is,O
stable,O
.,O

Upon,O
discharge,O
the,O
patient,O
was,O
changed,O
to,O
a,B-TR
BID,I-TR
protonix,I-TR
regimen,I-TR
.,O

Dr.,O
Valerio,O
office,O
was,O
notified,O
about,O
the,O
patient,O
's,O
discharge,O
plans,O
and,O
status,O
.,O

She,O
will,O
need,O
outpatient,O
follow,O
up,O
for,O
her,B-PR
guiac,I-PR
pos,I-PR
stools,I-PR
with,O
endoscopy,B-TE
vs,O
EGD,B-TE
+/-,O
H.pylori,B-TE
serologies,I-TE
.,O

A,O
copy,O
of,O
this,O
dc,O
summary,O
will,O
be,O
faxed,O
to,O
her,O
PCP,O
to,O
ensure,O
proper,O
follow,O
up,O
.,O

Discharge,O
Medications,O
:,O

1.,O
Atorvastatin,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

2.,O
Pantoprazole,B-TR
40,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
twice,O
a,O
day,O
.,O

3.,O
Acetaminophen,B-TR
500,O
mg,O
Tablet,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Tablet,O
PO,O
Q6H,O
(,O
every,O
6,O
hours,O
).,O

Disp,O
:*,O
240,O
Tablet,O
(s)*,O
Refills,O
:*,O
2,O
*,O

4.,O
Oxycodone,B-TR
5,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
Q4H,O
(,O
every,O
4,O
hours,O
),O
as,O
needed,O
for,O
pain,B-PR
.,O

Disp,O
:*,O
90,O
Tablet,O
(s)*,O
Refills,O
:*,O
0,O
*,O

5.,O
Fluticasone,B-TR
50,O
mcg,O
/,O
Actuation,O
Aerosol,O
",",O
Spray,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Spray,O
Nasal,O
DAILY,O
(,O
Daily,O
).,O

6.,O
Fluticasone,B-TR
110,O
mcg,O
/,O
Actuation,O
Aerosol,O
Sig,O
:,O
Two,O
(,O
2,O
),O
Puff,O
Inhalation,O
BID,O
(,O
2,O
times,O
a,O
day,O
).,O

7.,O
Tiotropium,B-TR
Bromide,I-TR
18,O
mcg,O
Capsule,O
",",O
w/,O
Inhalation,O
Device,O
Sig,O
:,O
One,O
(,O
1,O
),O
Cap,O
Inhalation,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Cap,O
(s)*,O
Refills,O
:*,O
2,O
*,O

8.,O
Clopidogrel,B-TR
75,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

Disp,O
:*,O
30,O
Tablet,O
(s)*,O
Refills,O
:*,O
2,O
*,O

9.,O
Albuterol,B-TR
Sulfate,I-TR
0.083,O
%,O
Solution,O
Sig,O
:,O
One,O
(,O
1,O
),O
puff,O
Inhalation,O
Q6H,O
(,O
every,O
6,O
hours,O
),O
as,O
needed,O
for,O
shortness,B-PR
of,I-PR
breath,I-PR
or,O
wheezing,B-PR
.,O

Disp,O
:*,O
1,O
inhaler,O
*,O
Refills,O
:*,O
1,O
*,O

10.,O
Aluminum,B-TR
-,I-TR
Magnesium,I-TR
Hydroxide,I-TR
225-200,O
mg,O
/,O
5,O
mL,O
Suspension,O
Sig,O
:,O
15-30,O
ML,O
s,O
PO,O
PRN,O
(,O
as,O
needed,O
).,O

11.,O
Senna,B-TR
8.6,O
mg,O
Tablet,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
PO,O
BID,O
(,O
2,O
times,O
a,O
day,O
),O
as,O
needed,O
.,O

12.,O
Prednisone,B-TR
10,O
mg,O
Tablet,O
Sig,O
:,O
1-2,O
Tablets,O
PO,O
DAILY,O
(,O
Daily,O
),O
for,O
4,O
days,O
:,O
Please,O
take,O
two,O
pills,O
for,O
one,O
day,O
starting,O
11-17,O
",",O
then,O
take,O
one,O
pill,O
for,O
three,O
days,O
.,O

Disp,O
:*,O
5,O
Tablet,O
(s)*,O
Refills,O
:,O
*,O
0,O
*,O

13.,O
oxygen,B-TR
continue,O
02,B-TR
at,O
1L/min,O
continuous,O
to,O
keep,O
sats,B-TE
in,O
90,O
's.,O

14.,O
Spironolactone,B-TR
25,O
mg,O
Tablet,O
Sig,O
:,O
0.5,O
Tablet,O
PO,O
DAILY,O
(,O
Daily,O
).,O

15.,O
Metoprolol,B-TR
Succinate,I-TR
25,O
mg,O
Tablet,O
Sustained,O
Release,O
24HR,O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
Sustained,O
Release,O
24HR,O
PO,O
DAILY,O
(,O
Daily,O
).,O

16.,O
Nystatin,B-TR
"100,000",O
unit,O
/,O
mL,O
Suspension,O
Sig,O
:,O
Ten,O
(,O
10,O
),O
ML,O
PO,O
QID,O
(,O
4,O
times,O
a,O
day,O
),O
for,O
7,O
days,O
.,O

17.,O
Aspirin,B-TR
325,O
mg,O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
Sig,O
:,O
One,O
(,O
1,O
),O
Tablet,O
",",O
Delayed,O
Release,O
(,O
E.C.,O
),O
PO,O
DAILY,O
(,O
Daily,O
).,O

Discharge,O
Disposition,O
:,O

Extended,O
Care,O

Facility,O
:,O

3133,O
W.,O
Third,O
Ave.,O
Rehab,O
&,O
Nursing,O
Center,O
-,O
Westwood,O
Lodge,O
Hospital,O

Discharge,O
Diagnosis,O
:,O

1),O
Rapid,B-PR
atrial,I-PR
fibrillation,I-PR
with,O
demand,B-PR
ischemia,I-PR

2),O
Retroperitoneal,B-PR
bleed,I-PR

Discharge,O
Condition,O
:,O

Stable,O

Discharge,O
Instructions,O
:,O

Please,O
follow,O
up,O
with,O
your,O
PCP,O
Richard,O
",",O
Kevin,O
Robinson,O
(,O
771,O
),O
937-5400,O
upon,O
discharge,O
.,O

If,O
you,O
experience,O
CP,B-PR
",",O
SOB,B-PR
",",O
dizzyness,B-PR
",",O
or,O
any,B-PR
other,I-PR
symptoms,I-PR
that,O
concern,O
you,O
please,O
call,O
your,O
PCP,O
or,O
return,O
to,O
the,O
ER,O
.,O

Note,O
:,O
you,O
have,O
had,O
a,B-TR
cardiac,I-TR
stent,I-TR
placed,O
during,O
this,O
admission,O
.,O

You,O
must,O
take,O
your,B-TR
aspirin,I-TR
and,O
plavix,B-TR
every,O
day,O
to,O
prevent,O
failure,B-PR
of,I-PR
these,I-PR
stents,I-PR
which,O
could,O
be,O
life,O
threatening,O
.,O

Please,O
take,O
all,B-TR
medications,I-TR
as,O
prescribed,O
.,O

Followup,O
Instructions,O
:,O

1),O
Please,O
follow,O
up,O
with,O
your,O
PCP,O
and,O
cardiologist,O
",",O
David,O
",",O
Larry,O
Robinson,O
(,O
771,O
),O
937-5400,O
",",O
upon,O
discharge,O
.,O

2),O
You,O
are,O
scheduled,O
to,O
have,O
your,B-TR
staples,I-TR
removed,O
on,O
2013-11-20,O
3:00,O
with,O
provider,O
:,O
Leah,O
",",O
Paula,O
G.,O
Wilson,O
SURGERY,O
(,O
NHB,O
),O

Date,O
/,O
Time,O
:,O
2013-11-20,O
3:00,O
.,O

Lashonda,O
Christopher,O
MD,O
48-669,O

Completed,O
by,O
:,O
Jill,O
Kelly,O
MD,O
47-482,O
2013-11-16,O
@,O
1550,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Lee,O
V.,O
Young,O
on,O
:,O
FRI,O
2013-12-20,O
4:59,O
PM,O

(,O
End,O
of,O
Report,O
),O

Admission,O
Date,O
:,O

2014-10-14,O

Discharge,O
Date,O
:,O

2014-10-17,O

Date,O
of,O
Birth,O
:,O

1959-12-09,O

Sex,O
:,O

M,O

Service,O
:,O

CCU,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
55,O
-,O
year-old,O
Caucasian,O
speaking,O
male,O
who,O
is,O
a,O
smoker,O
and,O
has,O
a,O
family,O
history,O
of,O
coronary,B-PR
artery,I-PR
disease,I-PR
",",O
as,O
well,O
as,O
a,O
personal,O
history,O
of,O
hypertension,B-PR
",",O
who,O
experienced,O
multiple,O
episodes,O
of,O
10/10,B-PR
substernal,I-PR
chest,I-PR
pain,I-PR
radiating,O
down,O
his,O
left,O
arm,O
last,O
night,O
with,O
his,O
daily,O
activities,O
.,O

Each,B-PR
episode,I-PR
lasted,O
approximately,O
15,O
minutes,O
in,O
duration,O
and,O
resolved,O
on,O
their,O
own,O
.,O

This,O
morning,O
while,O
landscaping,O
the,O
patient,O
had,O
unremitting,B-PR
12-05,I-PR
pain,I-PR
with,O
shortness,B-PR
of,I-PR
breath,I-PR
and,O
diaphoresis,B-PR
.,O

He,O
presented,O
to,O
Deaconess-Nashoba,O
Hospital,O
Hospital,O
and,O
the,B-TE
first,I-TE
EKG,I-TE
was,O
found,O
to,O
have,O
ST,B-PR
elevations,I-PR
in,I-PR
V1-V3,I-PR
of,O
1-2,O
mm,O
with,O
T,B-PR
wave,I-PR
inversions,I-PR
in,O
V4-6,O
",",O
I,O
and,O
L,O
",",O
which,O
progressed,O
to,O
3-0167,O
W.,O
Seventh,O
Ave.,O
elevations,O
within,O
20,O
minutes,O
.,O

Heparin,B-TR
and,O
nitroglycerin,B-TR
drip,I-TR
were,O
started,O
with,O
10,O
mg,O
of,O
IV,B-TR
Retavase,I-TR
half,O
dose,O
.,O

He,O
was,O
transferred,O
to,O
the,O
North,O
Adams,O
Regional,O
Hospital,O
for,O
catheterization,B-TE
.,O

Once,O
at,O
Hahnemann,O
General,O
Hospital,O
he,O
received,O
heparin,B-TR
and,O
Integrilin,B-TR
.,O

Coronary,B-TE
angiography,I-TE
revealed,O
left,O
main,O
",",O
left,O
circumflex,O
and,O
RCA,O
normal,O
and,O
left,B-PR
LAD,I-PR
with,I-PR
99%,I-PR
midstenosis,I-PR
.,O

A,B-TR
Hepacoat,I-TR
stent,I-TR
was,O
placed,O
with,O
no,O
residuals,B-TE
but,O
good,O
flow,O
after,O
nitroglycerin,B-TR
and,O
diltiazem,B-TR
.,O

The,B-PR
chest,I-PR
pain,I-PR
persisted,O
afterwards,O
and,O
a,B-TE
relook,I-TE
catheterization,I-TE
was,O
performed,O
that,O
revealed,O
no,O
occlusions,B-PR
.,O

The,B-TE
right,I-TE
heart,I-TE
catheterization,I-TE
revealed,O
a,B-TE
cardiac,I-TE
output,I-TE
index,I-TE
of,O
4.11,O
and,O
2.15,O
respectively,O
.,O

RA,B-TE
pressure,I-TE
was,O
13,O
",",O
RV,B-TE
pressure,I-TE
45/7,O
",",O
wedge,B-TE
27,O
and,O
PA,B-TE
pressures,I-TE
of,O
42/21,O
.,O

He,O
was,O
transferred,O
to,O
the,O
CC,O
for,O
monitoring,B-TE
and,O
he,O
denied,O
having,O
further,B-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
nausea,B-PR
or,O
vomiting,B-PR
.,O

At,O
baseline,O
the,O
patient,O
denies,O
any,O
previous,B-PR
chest,I-PR
pain,I-PR
",",O
pressure,B-PR
",",O
dyspnea,B-PR
on,O
exertion,O
",",O
orthopnea,B-PR
",",O
PND,B-PR
or,O
palpitations,B-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Only,O
hypertension,B-PR
.,O

MEDICATIONS,O
:,O

Antihypertensive,B-TR
medications,I-TR
that,O
the,O
patient,O
could,O
not,O
identify,O
.,O

ALLERGIES,O
:,O

The,O
patient,O
denies,O
having,O
any,B-PR
drug,I-PR
allergies,I-PR
.,O

FAMILY,O
HISTORY,O
:,O

Significant,O
for,O
a,O
brother,O
who,O
had,O
an,B-PR
MI,I-PR
at,O
age,O
61,O
.,O

SOCIAL,O
HISTORY,O
:,O

He,O
has,O
two,O
kids,O
",",O
works,O
as,O
a,O
landscaper,O
and,O
as,O
a,O
school,O
custodian,O
in,O
Ware,O
.,O

He,O
has,O
a,O
15,O
to,O
20,O
pack-year,O
history,O
.,O

Smokes,O
1,O
pack-per-day,O
for,O
15,O
years,O
but,O
had,O
quit,O
for,O
20,O
years,O
and,O
recently,O
restarted,O
.,O

He,O
drinks,O
two,O
glasses,O
of,O
wine,O
per,O
day,O
and,O
denies,O
any,O
use,O
of,O
illicit,O
substances,O
.,O

PHYSICAL,O
EXAMINATION,O
ON,O
ADMISSION,O
:,O

The,O
patient,O
was,O
afebrile,B-PR
.,O

Blood,B-TE
pressure,I-TE
156/67,O
",",O
pulse,B-TE
80,O
and,O
respiratory,B-TE
rate,I-TE
14,O
.,O

Appearance,O
:,O

He,O
was,O
laying,O
flat,O
",",O
very,B-PR
tense,I-PR
.,O

Skin,O
was,O
strong,O
build,O
and,O
was,O
in,O
no,O
apparent,B-PR
distress,I-PR
.,O

HEENT,O
:,O

He,O
was,O
anicteric,B-PR
with,O
moist,O
mucous,O
membranes,O
.,O

No,O
JVD,B-PR
or,O
increased,B-PR
JVP,I-PR
was,O
appreciated,O
at,O
0,O
degrees,O
.,O

The,O
patient,O
did,O
not,O
have,O
any,B-PR
carotid,I-PR
bruits,I-PR
",",O
abdominal,B-PR
bruits,I-PR
or,O
femoral,B-PR
bruits,I-PR
.,O

His,B-TE
PMI,I-TE
was,O
two,O
finger,B-TE
breath,I-TE
width,I-TE
in,O
the,O
fifth,O
intercostal,O
space,O
lateral,O
to,O
the,O
midclavicular,O
line,O
.,O

There,O
were,O
no,O
lifts,B-PR
or,O
heaves,B-PR
on,O
examination,B-TE
.,O

His,O
heart,O
was,O
regular,O
with,O
no,O
murmurs,B-PR
",",O
rubs,B-PR
or,O
gallops,B-PR
and,O
his,B-TE
radial,I-TE
and,I-TE
DP,I-TE
pulses,I-TE
were,O
both,O
2+,O
bilaterally,O
and,O
equal,O
.,O

His,O
lungs,O
were,O
clear,O
to,O
auscultation,B-TE
.,O

His,O
abdomen,O
was,O
scaphoid,B-PR
",",O
nondistended,B-PR
",",O
nontender,B-PR
with,O
positive,O
bowel,O
sounds,O
.,O

His,O
extremities,O
were,O
warm,O
",",O
pink,O
with,O
no,O
edema,B-PR
.,O

The,O
right,O
calf,O
site,O
had,O
minimal,B-PR
ooze,I-PR
and,O
no,O
hematomas,B-PR
or,O
bruits,B-PR
.,O

ELECTROCARDIOGRAM,O
:,O

Significant,O
for,O
what,O
was,O
stated,O
in,O
the,O
HPI,O
.,O

OVERALL,O
IMPRESSION,O
:,O

This,O
is,O
a,O
54,O
-,O
year-old,O
man,O
with,O
significant,B-PR
coronary,I-PR
artery,I-PR
disease,I-PR
risk,I-PR
factors,I-PR
",",O
positive,O
family,O
history,O
",",O
smoking,O
history,O
",",O
hypertension,B-PR
and,O
gender,O
who,O
presented,O
with,O
an,B-PR
ST,I-PR
elevation,I-PR
MI,I-PR
status,O
post,O
LAD,B-TR
stent,I-TR
",",O
complicated,O
by,O
no,O
residuals,B-PR
requiring,O
nitroglycerin,B-TR
and,O
diltiazem,B-TR
for,O
good,O
flow,O
.,O

The,O
patient,O
was,O
pain,B-PR
free,O
and,O
doing,O
well,O
.,O

HOSPITAL,O
COURSE,O
:,O

For,O
his,B-PR
coronary,I-PR
artery,I-PR
disease,I-PR
",",O
aspirin,B-TR
was,O
started,O
at,O
325,O
.,O

Plavix,B-TR
was,O
started,O
at,O
75,O
mg,O
a,O
day,O
",",O
Lipitor,B-TR
20,O
mg,O
per,O
day,O
",",O
metoprolol,B-TR
25,O
mg,O
twice,O
a,O
day,O
to,O
be,O
titrated,O
up,O
as,O
tolerated,O
and,O
on,O
day,O
two,O
of,O
admission,O
an,B-TR
ACE,I-TR
inhibitor,I-TR
was,O
started,O
.,O

Captopril,B-TR
6.2,O
3,O
x,O
a,O
day,O
and,O
titrated,O
up,O
.,O

A,B-TE
lipid,I-TE
panel,I-TE
was,O
checked,O
and,O
found,O
to,O
be,O
within,O
normal,O
limits,O
",",O
although,O
it,O
was,O
noted,O
this,O
was,O
in,O
the,O
post,O
MI,O
setting,O
and,O
the,B-TE
lipid,I-TE
panel,I-TE
could,O
be,O
falsely,O
low,O
.,O

Serial,B-TE
CK,I-TE
s,I-TE
were,O
followed,O
with,O
a,B-TE
CK,I-TE
peak,I-TE
of,O
433,O
.,O

Hypertension,B-PR
was,O
managed,O
with,O
beta,B-TR
blocker,I-TR
and,O
ACE,B-TR
inhibitor,I-TR
and,O
Integrilin,B-TR
was,O
continued,O
post,O
MI,B-PR
for,O
18,O
hours,O
.,O

Rhythm,O
was,O
maintained,O
at,O
normal,O
sinus,O
",",O
monitored,O
on,O
telemetry,B-TE
without,O
ectopy,B-PR
.,O

EKG,B-TE
s,I-TE
were,O
followed,O
for,O
normalization,O
.,O

The,O
patient,O
had,O
an,B-TE
echocardiogram,I-TE
on,O
day,O
two,O
of,O
admission,O
",",O
which,O
revealed,O
a,B-PR
mildly,I-PR
dilated,I-PR
left,I-PR
atrium,I-PR
",",O
mild,B-PR
symmetric,I-PR
LVH,I-PR
",",O
normal,O
LV,O
cavity,O
size,O
",",O
mild,B-PR
region,I-PR
LV,I-PR
systolic,I-PR
dysfunction,I-PR
",",O
arresting,B-PR
regional,I-PR
wall,I-PR
motion,I-PR
abnormality,I-PR
including,O
focal,B-PR
apical,I-PR
hypokinesis,I-PR
",",O
a,O
normal,O
right,O
ventricular,O
chamber,O
size,O
and,O
free,O
wall,O
motion,O
",",O
a,B-PR
moderately,I-PR
dilated,I-PR
aortic,I-PR
root,I-PR
",",O
a,B-PR
mildly,I-PR
dilated,I-PR
ascending,I-PR
aorta,I-PR
",",O
normal,O
aortic,O
valve,O
leaflet,O
",",O
normal,O
mitral,O
valve,O
leaflet,O
and,O
no,O
pericardial,B-PR
effusions,I-PR
.,O

The,O
patient,O
was,O
normal,O
volume,O
and,O
displayed,O
no,O
evidence,O
CHF,B-PR
signs,I-PR
or,I-PR
symptoms,I-PR
.,O

The,B-PR
risk,I-PR
factors,I-PR
were,O
addressed,O
.,O

The,O
patient,O
was,O
told,O
repeatedly,O
that,O
he,O
needed,O
to,O
stop,O
smoking,O
and,O
was,O
given,O
a,B-TR
nicotine,I-TR
patch,I-TR
and,O
his,O
primary,O
care,O
provider,O
was,O
called,O
to,O
discuss,O
outpatient,O
plans,O
to,O
help,O
the,O
patient,O
stop,O
smoking,O
.,O

The,O
patient,O
was,O
advised,O
to,O
have,O
a,B-TR
low,I-TR
fat,I-TR
/,I-TR
low,I-TR
cholesterol,I-TR
diet,I-TR
",",O
was,O
cleared,O
by,O
PT,O
and,O
advised,O
to,O
do,O
cardiac,B-TR
rehabilitation,I-TR
.,O

He,O
was,O
advised,O
the,O
importance,O
of,O
each,O
of,O
his,O
and,O
compliance,O
with,O
each,O
of,O
these,B-TR
medications,I-TR
and,O
was,O
told,O
he,O
needed,O
close,O
followup,O
with,O
a,O
cardiologist,O
.,O

For,O
renal,O
",",O
his,B-TE
creatinine,I-TE
was,O
monitored,O
and,O
the,B-TE
dye,I-TE
load,I-TE
and,O
the,B-TE
catheterization,I-TE
.,O

It,O
was,O
normal,O
and,O
did,O
not,O
increase,O
.,O

Gastrointestinal,O
:,O

The,O
patient,O
was,O
given,O
a,B-TR
low,I-TR
fat,I-TR
/,I-TR
low,I-TR
cholesterol,I-TR
diet,I-TR
.,O

His,B-TE
electrolytes,I-TE
were,O
monitored,O
and,O
repleted,O
carefully,O
.,O

He,O
had,O
normal,O
bowel,O
movements,O
and,O
had,O
GI,B-TR
prophylaxis,I-TR
throughout,O
his,O
stay,O
.,O

For,O
hematology,O
",",O
the,B-TE
patient,I-TE
's,I-TE
hematocrit,I-TE
and,O
platelets,B-TE
were,O
monitored,O
after,O
the,B-TE
catheterization,I-TE
.,O

They,O
were,O
normal,O
and,O
did,O
not,O
change,O
and,O
the,O
patient,O
received,O
pneumatic,B-TR
boots,I-TR
for,O
DVT,B-TR
prophylaxis,I-TR
.,O

On,O
day,O
two,O
of,O
admission,O
",",O
the,O
patient,O
ambulated,O
with,O
PT,B-TR
and,O
was,O
moved,O
to,O
the,O
regular,O
floor,O
.,O

On,O
day,O
three,O
of,O
admission,O
",",O
the,O
patient,O
felt,O
that,O
his,O
strength,O
was,O
back,O
to,O
baseline,O
.,O

He,O
denied,O
ever,O
having,O
any,B-PR
chest,I-PR
pain,I-PR
",",O
chest,B-PR
pressure,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
dyspnea,B-PR
on,O
exertion,O
and,O
he,O
was,O
discharged,O
to,O
home,O
.,O

He,O
was,O
told,O
to,O
return,O
to,O
the,O
emergency,O
department,O
if,O
he,O
had,O
any,B-PR
chest,I-PR
pain,I-PR
",",O
pressure,B-PR
",",O
difficulty,B-PR
breathing,I-PR
",",O
nausea,B-PR
",",O
light-headiness,B-PR
or,O
dizziness,B-PR
.,O

He,O
was,O
advised,O
to,O
take,O
all,O
of,O
his,B-TR
medications,I-TR
.,O

An,O
appointment,O
was,O
established,O
for,O
him,O
to,O
see,O
his,O
primary,O
care,O
doctor,O
",",O
Dr.,O
Stella,O
Booth,O
on,O
Maynard,O
",",O
2014-10-20,O
and,O
the,O
patient,O
was,O
referred,O
to,O
Dr.,O
Granville,O
Hamers,O
",",O
at,O
Ware,O
in,O
cardiology,O
to,O
be,O
seen,O
in,O
two,O
weeks,O
.,O

Dr,O
Marcus,O
assistant,O
was,O
called,O
and,O
she,O
stated,O
that,O
she,O
would,O
call,O
the,O
patient,O
with,O
an,O
appointment,O
.,O

FINAL,O
DIAGNOSES,O
:,O

1.,O
ST,B-PR
elevation,I-PR
myocardial,I-PR
infarction,I-PR
.,O

2.,O
Hypertension,B-PR
.,O

MAJOR,O
SURGICAL,O
AND,O
INVASIVE,O
PROCEDURES,O
:,O

Cardiac,B-TE
catheterization,I-TE
and,O
stent,B-TR
placement,I-TR
in,I-TR
the,I-TR
mid,I-TR
left,I-TR
anterior,I-TR
descending,I-TR
artery,I-TR
.,O

DISCHARGE,O
CONDITION,O
:,O

Good,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Aspirin,B-TR
325,O
mg,O
q.d.,O
",",O
Plavix,B-TR
75,O
mg,O
q.d.,O
",",O
Lipitor,B-TR
20,O
mg,O
q.d.,O
",",O
nitroglycerin,B-TR
0.3,O
mg,O
sublingually,O
p.r.n.,O
chest,B-PR
pain,I-PR
or,O
pressure,B-PR
or,O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
lisinopril,B-TR
hydrochlorothiazide,B-TR
20,O
/,O
12.5,O
mg,O
q.d.,O
",",O
atenolol,B-TR
25,O
mg,O
q.d.,O

The,O
patient,O
was,O
told,O
he,O
could,O
return,O
to,O
work,O
after,O
two,O
weeks,O
of,O
rest,B-TR
",",O
given,O
that,O
his,O
work,O
required,O
a,O
high,O
level,O
of,O
exertion,O
and,O
the,O
patient,O
was,O
also,O
given,O
a,O
prescription,O
for,O
a,B-TR
transdermal,I-TR
nicotine,I-TR
patch,I-TR
14,O
mg,O
the,O
be,O
used,O
for,O
up,O
to,O
2,O
weeks,O
until,O
cravings,B-PR
remitted,O
.,O

Antonio,O
PINTO,O
",",O
M.D.,O
52-057,O

Dictated,O
By,O
:,O
Salvador,O
BX,O
Hernandez,O
",",O
M.D.,O

MEDQUIST36,O

D,O
:,O
2014-10-18,O
12:39,O

T,O
:,O
2014-10-21,O
12:42,O

JOB,O
#:,O
78572,O

Signed,O
electronically,O
by,O
:,O
DR.,O
Steve,O
PINTO,O
on,O
:,O
SUN,O
2014-11-02,O
8:39,O
PM,O

(,O
End,O
of,O
Report,O
),O

018636330,O
DH,O

5425710,O

123524,O

144918,O

6/2/2005,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Report,O
Status,O
:,O

Signed,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

KOTE,O
",",O
OA,O

UNIT,O
NUMBER,O
:,O

509-22-30,O

ADMISSION,O
DATE,O
:,O

06/02/2005,O

DISCHARGE,O
DATE,O
:,O

06/05/2005,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

C5-6,B-PR
disc,I-PR
herniation,I-PR
with,O
cord,B-PR
compression,I-PR
and,O
myelopathy,B-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

Microscopic,B-TR
anterior,I-TR
cervical,I-TR
diskectomy,I-TR
at,I-TR
C5-6,I-TR
and,O
fusion,B-TR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
63-year-old,O
female,O
with,O
a,O
three-year,O
history,O
of,O
bilateral,B-PR
hand,I-PR
numbness,I-PR
and,O
occasional,B-PR
weakness,I-PR
.,O

Within,O
the,O
past,O
year,O
",",O
these,B-PR
symptoms,I-PR
have,O
progressively,O
gotten,O
worse,O
",",O
to,O
encompass,O
also,O
her,O
feet,O
.,O

She,O
had,O
a,B-TE
workup,I-TE
by,O
her,O
neurologist,O
and,O
an,B-TE
MRI,I-TE
revealed,O
a,B-PR
C5-6,I-PR
disc,I-PR
herniation,I-PR
with,O
cord,B-PR
compression,I-PR
and,O
a,B-PR
T2,I-PR
signal,I-PR
change,I-PR
at,O
that,O
level,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Significant,O
for,O
hypertension,B-PR
",",O
hyperlipidemia,B-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Lipitor,B-TR
",",O
Flexeril,B-TR
",",O
hydrochlorothiazide,B-TR
and,O
Norvasc,B-TR
.,O

ALLERGIES,O
:,O

She,O
has,O
no,O
known,B-PR
drug,I-PR
allergy,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

She,O
smokes,O
one,O
pack,O
per,O
day,O
x45,O
years,O
.,O

She,O
occasionally,O
drinks,O
alcohol,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

She,O
had,O
5/5,O
strength,O
in,O
bilateral,O
upper,O
and,O
lower,O
extremities,O
.,O

She,O
had,O
a,B-TE
Hoffman,I-TE
&apos;s,I-TE
sign,I-TE
greater,O
on,O
the,O
right,O
than,O
the,O
left,O
and,O
she,O
had,O
10,B-PR
beats,I-PR
of,I-PR
clonus,I-PR
in,O
the,O
right,O
foot,O
and,O
3-5,B-PR
beats,I-PR
in,I-PR
the,I-PR
left,I-PR
foot,I-PR
.,O

She,O
had,O
hyperreflexia,B-PR
in,O
both,O
the,O
bilateral,O
upper,O
and,O
lower,O
extremities,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
tolerated,O
a,B-TR
C5-6,I-TR
ACDF,I-TR
by,O
Dr.,O
Miezetri,O
Gach,O
quite,O
well,O
.,O

She,O
had,O
a,B-TE
postoperative,I-TE
CT,I-TE
scan,I-TE
that,O
revealed,O
partial,B-PR
decompression,I-PR
of,I-PR
the,I-PR
spinal,I-PR
canal,I-PR
and,O
good,O
placement,O
of,O
her,B-TR
hardware,I-TR
.,O

Immediately,O
postop,O
",",O
her,B-TE
exam,I-TE
only,O
improved,O
slightly,O
in,O
her,B-PR
hyperreflexia,I-PR
.,O

She,O
was,O
ambulating,O
by,O
postoperative,O
day,O
number,O
two,O
.,O

She,O
tolerated,O
a,O
regular,O
diet,O
.,O

Her,B-PR
pain,I-PR
was,O
under,O
good,O
control,O
with,O
PO,B-TR
pain,I-TR
medications,I-TR
and,O
she,O
was,O
deemed,O
suitable,O
for,O
discharge,O
.,O

DISCHARGE,O
ORDERS,O
:,O

The,O
patient,O
was,O
asked,O
to,O
call,O
Dr.,O
Miezetri,O
Gach,O
&apos;s,O
office,O
for,O
a,O
follow-up,O
appointment,O
and,O
wound,B-TE
check,I-TE
.,O

She,O
is,O
asked,O
to,O
call,O
with,O
any,O
fevers,B-PR
",",O
chills,B-PR
",",O
increasing,B-PR
weakness,I-PR
or,O
numbness,B-PR
or,O
any,O
bowel,B-PR
and,I-PR
bladder,I-PR
disruption,I-PR
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

She,O
was,O
discharged,O
on,O
the,O
following,O
medications,O
.,O

1.,O
Colace,B-TR
",",O
100,O
mg,O
PO,O
bid,O
.,O

2.,O
Zantac,B-TR
",",O
150,O
mg,O
PO,O
bid,O
.,O

3.,O
Percocet,B-TR
",",O
5/325,O
",",O
1-2,O
tabs,O
PO,O
q4-6h,O
prn,O
pain,B-PR
.,O

4.,O
Lipitor,B-TR
",",O
10,O
mg,O
PO,O
daily,O
.,O

5.,O
Hydrochlorothiazide,B-TR
",",O
25,O
mg,O
PO,O
daily,O
.,O

6.,O
Norvasc,B-TR
",",O
5,O
mg,O
PO,O
daily,O
.,O

LALIND,O
KOTE,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

Electronically,O
Signed,O
MIEZETRI,O
NIMIRY,O
POP,O
",",O
M.D.,O
08/01/2005,O
18:50,O

_____________________________,O
MIEZETRI,O
NIMIRY,O
POP,O
",",O
M.D.,O

TR,O
:,O

qg,O

DD,O
:,O

07/30/2005,O

TD,O
:,O

07/31/2005,O
9:43,O
A,O
123524,O

cc,O
:,O

MIEZETRI,O
NIMIRY,O
POP,O
",",O
M.D.,O

026350193,O
RWH,O

7093319,O

549304,O

8417371,O

6/5/2002,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O
/,O
SUMMARY,O

AASCOLESLENT,O
",",O
DIROD,O

MRN,O
:,O

7093319,O

Age,O
:,O

50y,O

REGISTRATION,O
DATE,O
:,O

06/05/2002,O
02:46,O
PM,O

Provider,O
:,O

RYBAM,O
SHOULDER,O

PRELIMINARY,O
REPORT,O

PCP,O
notified,O
by,O
MD,O
:,O

Left,O
message,O
with,O
answering,O
service,O
or,O
PCP,O
office,O

Benefits,O
Assigned,O
:,O

Y,O

Discharge,O
Date,O
/,O
Time,O
:,O

06/05/2002,O
16:17,O

Discharge,O
Status,O
:,O

Discharged,O

Condition,O
on,O
Discharge,O
:,O

Stable,O

Patient,O
States,O
Complaint,O
:,O

L,B-PR
SHOULDER,I-PR
INJ,I-PR

Standardized,O
Discharge,O
Instructions,O
:,O

The,O
patient,O
was,O
given,O
printed,O
instructions,O
for,O
neck,B-PR
strains,I-PR
(,O
English,O
),O
.,O

Diagnosis,O
:,O

Left,B-PR
Shoulder,I-PR
/,I-PR
Neck,I-PR
strain,I-PR
/,I-PR
sprain,I-PR
.,O

Treatment,O
Rendered,O
:,O

Dilaudid,B-TR
2mg,O
PO,O
x,O
1,O
Flexeril,B-TR
10,O
mg,O
x,O
1,O

Discharge,O
Medications,O
:,O

Flexeril,B-TR
10mg,O
TID,O

Disposition,O
",",O
Follow,O
up,O
and,O
Instructions,O
to,O
Patient,O
:,O

Please,O
follow-up,O
with,O
your,O
Orthopaedic,O
physician,O
on,O
Wednesday,O
6/9/02,O
as,O
previously,O
arranged,O
by,O
patient,O
.,O

Please,O
follow-up,O
with,O
PCP,O
.,O

Take,O
codeine,B-TR
prescribed,O
by,O
PCP,O
with,O
food,O
and,O
water,O
to,O
prevent,O
nausea,B-PR
and,O
constipation,B-PR
.,O

Do,O
not,O
drive,O
if,O
taking,O
flexeril,B-TR
and,O
codeine,B-TR
.,O

PCP,O
Name,O
:,O

DOUET,O
",",O
LAH,O

Provider,O
Number,O
:,O

19061,O

This,O
report,O
was,O
created,O
by,O
SHOULDER,O
",",O
RYBAM,O
06/05/2002,O
04:26,O
PM,O

037945397,O
RWH,O

2690633,O

194867,O

151887,O

10/17/2001,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O
/,O
SUMMARY,O

FYFEVAIA,O
",",O
LORERINDIL,O

MRN,O
:,O

2690633,O

Age,O
:,O

77y,O

REGISTRATION,O
DATE,O
:,O

10/17/2001,O
01:36,O
PM,O

Provider,O
:,O

CH,O
KOTEKOLL,O

PRELIMINARY,O
REPORT,O

PCP,O
notified,O
by,O

MD,O
:,O

Yes,O
-,O
Direct,O
contact,O
with,O
PCP,O

Benefits,O
Assigned,O
:,O

N,O

Discharge,O
Date,O
/,O
Time,O
:,O

10/17/2001,O
16:28,O

Discharge,O
Status,O
:,O

Discharged,O

Condition,O
on,O
Discharge,O
:,O

Stable,O

Patient,O
States,O
Complaint,O
:,O

NEAR,B-PR
SYNCOPE,I-PR
Standardized,O
Discharge,O
Instructions,O
:,O

The,O
patient,O
was,O
given,O
printed,O
instructions,O
for,O
dizziness,B-PR
(,O
English,O
),O
.,O

Diagnosis,O
:,O

near,B-PR
syncope,I-PR
",",O
dehydration,B-PR
vs,O
cardiogenic,B-PR

Treatment,O
Rendered,O
:,O

IVF,B-TR
",",O
cbc,B-TE
(,O
hct,B-TE
36,O
),O
",",O
normal,O
chem,O
7,O
",",O
negative,O
cardiac,O
enzymes,O
",",O
negative,O
stool,O
guaiac,O
",",O
normal,O
CXR,O

Discharge,O
Medications,O
:,O

none,O

Disposition,O
",",O
Follow,O
up,O
and,O
Instructions,O
to,O
Patient,O
:,O

Patient,O
will,O
follow-up,O
with,O
his,O
PCP,O
",",O
Dr.,O
Foutchner,O
",",O
on,O
Monday,O
.,O

Dr.,O
Foutchner,O
will,O
arrange,O
for,O
an,B-TE
outpatient,I-TE
Holter,I-TE
monitor,I-TE
.,O

The,O
patient,O
is,O
to,O
return,O
to,O
the,O
ED,O
for,O
recurrent,B-PR
dizziness,I-PR
",",O
chest,B-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
or,O
weakness,B-PR
.,O

PCP,O
Name,O
:,O

SUMCHIRDKAYSMAVVEINDREPS,O
",",O
YERTREY,O

Provider,O
Number,O
:,O

12298,O

This,O
report,O
was,O
created,O
by,O
KOTEKOLL,O
",",O
CH,O
10/17/2001,O
07:08,O
PM,O

044687343,O
ELMVH,O

1719921,O

1626859,O

3/13/2006,O
12:00:00,O
AM,O

COPD,B-PR
flare,I-PR

DIS,O

Admission,O
Date,O
:,O

03/13/2006,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

03/19/2006,O

******,O
FINAL,O
DISCHARGE,O
ORDERS,O
******,O

FREIERMLINKENEIGHCAABLINFARST,O
",",O
ANEA,O

770-09-54-2,O
O32,O

Room,O
:,O

39K-128,O

Service,O
:,O

MED,O

DISCHARGE,O
PATIENT,O
ON,O
:,O

03/19/06,O
AT,O
01:00,O
PM,O

CONTINGENT,O
UPON,O

Not,O
Applicable,O

WILL,O
D,O
/,O
C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D,O
/,O
C,O
SUMMARY,O
:,O

YES,O

Attending,O
:,O

ALBFYFEAYLES,O
",",O
LORRE,O
EZO,O
",",O
M.D.,O

CODE,O
STATUS,O
:,O

Full,O
code,O

DISPOSITION,O
:,O

Villeflardsbroo,O
Ands,O
Tho,O
Cardhako,O
General,O
Hospital,O

DISCHARGE,O
MEDICATIONS,O
:,O

ACETYLSALICYLIC,B-TR
ACID,I-TR
81,O
MG,O
PO,O
DAILY,O
ALBUTEROL,B-TR
NEBULIZER,I-TR
2.5,O
MG,O
NEB,O
Q4H,O
Starting,O
Today,O
(,O
03/17,O
),O
PRN,O
Shortness,B-PR
of,I-PR
Breath,I-PR
LISINOPRIL,B-TR
10,O
MG,O
PO,O
DAILY,O
NIFEREX-150,B-TR
150,O
MG,O
PO,O
BID,O
PREDNISONE,B-TR
Taper,I-TR
PO,I-TR
Give,O
50,O
mg,O
q,O
24,O
h,O
X,O
1,O
dose,O
(,O
s,O
),O
",",O
then,O
Give,O
40,O
mg,O
q,O
24,O
h,O
X,O
1,O
dose,O
(,O
s,O
),O
",",O
then,O
Give,O
30,O
mg,O
q,O
24,O
h,O
X,O
1,O
dose,O
(,O
s,O
),O
",",O
then,O
Give,O
20,O
mg,O
q,O
24,O
h,O
X,O
1,O
dose,O
(,O
s,O
),O
",",O
then,O
Give,O
10,O
mg,O
q,O
24,O
h,O
X,O
1,O
dose,O
(,O

Food,O
/,O
Drug,O
Interaction,O
Instruction,O

Avoid,O
grapefruit,O
unless,O
MD,O
instructs,O
otherwise,O
.,O

Give,O
on,O
an,O
empty,O
stomach,O
(,O
give,O
1hr,O
before,O
or,O
2hr,O
after,O
food,O
),O
SINGULAIR,B-TR
(,I-TR
MONTELUKAST,I-TR
),I-TR
10,O
MG,O
PO,O
BEDTIME,O
ADVAIR,B-TR
DISKUS,I-TR
500/50,I-TR
(,I-TR
FLUTICASONE,I-TR
PROPIONATE/...,I-TR
),I-TR
1,O
PUFF,O
INH,O
BID,O
CALTRATE,B-TR
+,I-TR
D,I-TR
1,O
TAB,O
PO,O
BID,O
LANTUS,B-TR
(,I-TR
INSULIN,I-TR
GLARGINE,I-TR
),I-TR
35,O
UNITS,O
SC,O
QAM,O
DUONEB,B-TR
(,I-TR
ALBUTEROL,I-TR
AND,I-TR
IPRATROPIUM,I-TR
NEBULIZER,I-TR
),I-TR
3/0.5,O
MG,O
NEB,O
Q6H,O
Starting,O
Today,O
(,O
03/17,O
),O
PRN,O
Shortness,B-PR
of,I-PR
Breath,I-PR
",",O
Wheezing,B-PR
NOVOLOG,B-TR
(,I-TR
INSULIN,I-TR
ASPART,I-TR
),I-TR
4,O
UNITS,O
SC,O
AC,O

Instructions,O
:,O

standing,B-TR
pre-meal,I-TR
novolog,I-TR
.,O

give,O
when,O
patient,O
will,O
eat,O
and,O
food,O
is,O
in,O
the,O
room,O
.,O

NOVOLOG,B-TR
(,I-TR
INSULIN,I-TR
ASPART,I-TR
),I-TR
Sliding,O
Scale,O
(,O
subcutaneously,O
),O
SC,O
AC,O

Instructions,O
:,O

pre-meal,O
correction,O
dose,O
.,O

give,O
in,O
addition,O
to,O
standing,B-TR
pre-meal,I-TR
novolog,I-TR
when,O
patient,O
will,O
eat,O
and,O
food,O
is,O
in,O
the,O
room,O
.,O

If,O
BS,B-TE
is,O
less,O
than,O
125,O
",",O
then,O
give,O
0,O
units,O
subcutaneously,O
If,O
BS,B-TE
is,O
125-150,O
",",O
then,O
give,O
2,O
units,O
subcutaneously,O
If,O
BS,B-TE
is,O
151-200,O
",",O
then,O
give,O
3,O
units,O
subcutaneously,O
If,O
BS,B-TE
is,O
201-250,O
",",O
then,O
give,O
4,O
units,O
subcutaneously,O
If,O
BS,B-TE
is,O
251-300,O
",",O
then,O
give,O
6,O
units,O
subcutaneously,O
If,O
BS,B-TE
is,O
301-350,O
",",O
then,O
give,O
8,O
units,O
subcutaneously,O
If,O
BS,B-TE
is,O
351-400,O
",",O
then,O
give,O
10,O
units,O
subcutaneously,O
and,O
call,O
HO,O
Call,O
HO,O
if,O
BS,B-TE
is,O
greater,O
than,O
400,O
PROTONIX,B-TR
(,I-TR
PANTOPRAZOLE,I-TR
),I-TR
40,O
MG,O
PO,O
DAILY,O
COMBIVENT,B-TR
(,I-TR
IPRATROPIUM,I-TR
AND,I-TR
ALBUTEROL,I-TR
SULFATE,I-TR
),I-TR
2,O
PUFF,O

Food,O
/,O
Drug,O
Interaction,O
Instruction,O

Give,O
on,O
an,O
empty,O
stomach,O
(,O
give,O
1hr,O
before,O
or,O
2hr,O
after,O
food,O
),O

Take,O
with,O
8,O
oz,O
of,O
plain,O
water,O
SPIRIVA,B-TR
(,I-TR
TIOTROPIUM,I-TR
),I-TR
18,O

MCG,O
INH,O
DAILY,O
DIET,O
:,O

House,O
/,O
Low,O
chol,O
/,O
low,O
sat.,O
fat,O

DIET,O
:,O

House,O
/,O
ADA,O
1800,O
cals,O
/,O
dy,O

ACTIVITY,O
:,O

walk,O
with,O
assist,O
per,O
PT,B-TE
eval,I-TE

FOLLOW,O
UP,O
APPOINTMENT,O
(,O
S,O
),O
:,O

Dr,O
Zuknocegrend,O
PCP,O
4/24,O
130,O
",",O

Dr.,O
Pump,O
3/25/05,O
1:30,O
",",O

ALLERGY,O
:,O

NKA,O
ADMIT,O
DIAGNOSIS,O
:,O

COPD,B-PR
flare,I-PR

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O

Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O
COPD,B-PR
flare,I-PR

OTHER,O
DIAGNOSIS,O
;,O

Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O

COPD,B-PR
(,I-PR
chronic,I-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
),I-PR
DM,B-PR
cervical,B-PR
DJD,I-PR
(,O
),O
iron,B-PR
deficiency,I-PR
anemia,I-PR
(,I-PR
iron,I-PR
deficiency,I-PR
anemia,I-PR
),I-PR
cervical,B-PR
and,I-PR
lumbar,I-PR
djd,I-PR
(,O
12,O
),O
osa,B-PR
(,I-PR
sleep,I-PR
apnea,I-PR
),I-PR
s,O
/,O
p,O
tb,B-TR
treatment,I-TR
(,O
5,O
),O

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O

na,O

BRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

CC,O
:,O

weakness,B-PR

HPI,O
:,O

75,O
y,O
/,O
o,O
F,O
with,O
DM,B-PR
",",O
COPD,B-PR
on,O
2L,B-TR
NC,I-TR
and,O
Bipap,B-TR
at,O
night,O
p,O
/,O
w,O
generalized,B-PR
weakness,I-PR
and,O
fatigue,B-PR
",",O
urinary,B-PR
incontinence,I-PR
and,O
shaking,B-PR
as,O
well,O
as,O
increased,B-PR
sputum,I-PR
production,I-PR
.,O

Per,O
daughter,O
these,B-PR
symptoms,I-PR
are,O
typical,O
of,O
COPD,B-PR
flare,I-PR
.,O

ROS,O
otherwise,O
negative,O
.,O

Admission,O
Status,O
:,O

ED,O
:,O

REc&apos;d,O
duonebs,B-TR
",",O
solumedrol,B-TR
125,O

Vitals,O
:,O

t97.5,O
",",O
hr,B-TE
117,O
",",O
bp156/81,O
",",O
rr28,O
",",O
o2,B-TE
sats,I-TE
87%,O
RA,O
;,O
95%,O
4L,O

Exam,O
:,O

NAD,B-PR
",",O
pleasant,O
",",O
speaking,O
in,O
complete,O
sentences,O
",",O
poor,B-PR
air,I-PR
movement,I-PR
bilaterally,I-PR
",",O
L,O
&gt;,O
R,O
",",O
no,O
wheezes,B-PR
or,O
rales,B-PR
",",O
rrr,O
",",O
distant,O
",",O
abd,O
benign,O
",",O
no,O
edema,B-PR
",",O
alert,O
and,O
oriented,O
times,O
three,O
",",O
no,O
focal,B-PR
deficits,I-PR
",",O
conversant,O
Studies,O
:,O

-,O
EKG,B-TE
sinus,O
92,O
",",O
no,O
ST,B-PR
changes,I-PR

-,O
CXR,B-TE
no,O
focal,B-PR
consolidation,I-PR
or,O
edema,B-PR
",",O
old,B-PR
biapical,I-PR
scarring,I-PR
ABG,B-TE
7.34/79/74,O
U,B-TE
/,I-TE
A,I-TE
negative,O

Daily,O
Status,O
:,O

improving,O
",",O
but,O
still,B-PR
poor,I-PR
air,I-PR
movement,I-PR
",",O
diffusely,B-PR
wheezy,I-PR
on,O
exam,B-TE
",",O
at,O
baseline,O
2L,B-TR
o2,I-TR
requirement,I-TR

A,O
/,O
P,O
:,O

75,O
y,O
/,O
o,O
F,O
with,O
h,O
/,O
o,O
COPD,B-PR
c,O
/,O
b,O
frequent,B-PR
exacerbations,I-PR
p,O
/,O
w,O
typical,B-PR
flare,I-PR
symptoms,I-PR
.,O

Problem,O
List,O
:,O

CV,O
-,O
Ischemia,B-PR
ASA,B-TR
",",O
lisinopril,B-TR
Pump,I-TR
no,O
evidence,O
of,O
failure,B-PR

Rhythm,O
Resp,O
-,O
COPD,B-PR

flare,B-PR
-,O
steroids,B-TR
",",O
cont,O
prednisone,B-TR
60,O
",",O
taper,O
slowly,O
as,O
tolerated,O
",",O
duonebs,B-TR
",",O
advair,B-TR
",",O
singulair,B-TR
",",O
spiriva,B-TR
",",O
claritin,B-TR
azithromycin,B-TR
for,O
atypical,B-PR
bronchitis,I-PR
to,O
complete,O
a,O
5,O
day,O
course,O
",",O
keep,O
o2,B-TE
sat,I-TE
90-94,O
",",O
home,B-TR
nocturnal,I-TR
CPAP,I-TR
not,O
tolerated,O
in,O
house,O
",",O
does,O
well,O
on,O
nc,B-TR
",",O
appears,O
ato,O
be,O
at,O
baseline,O

Renal,O
-,O

Cr,B-TE
0.8,O
",",O
stress,B-PR
incontinence,I-PR
by,O
symptoms,B-PR
with,O
increased,B-PR
cough,I-PR
",",O
no,O
evidence,O
of,O
uti,B-PR
",",O
cont,O
to,O
closely,O
monitor,O

GI,O
-,O
Bowel,B-TR
regimen,I-TR

Heme,O
-,O
Chronic,B-PR
Fe,I-PR
deficiency,I-PR
anemia,I-PR
",",O
cont,O
iron,B-TR

Endo,O
-,O
DM,B-PR
on,O
insulin,B-TR
with,O
steroids,B-TR

ID,O
-,O
afebrile,B-PR
",",O
no,O
wbc,B-TE
",",O
started,O
on,O
Azithromycin,B-TR
for,O
COPD,B-PR
flare,I-PR

FEN,O
-,O
ADA,O
diet,O

PPx,O
-,O
Lovenox,B-TR
",",O
PPI,B-TR

Dispo,O
-,O
to,O
rehab,O
when,O
resp,B-PR
status,I-PR
improved,O
",",O
PT,O
consulted,O

Code,O
-,O
FC,O

ADDITIONAL,O
COMMENTS,O
:,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O

TO,O
DO,O
/,O
PLAN,O
:,O

f,O
/,O
u,O
with,O
PCP,O
and,O
Dr.,O
Pump,O
as,O
scheduled,O
",",O
return,O
to,O
ED,O
with,O
worsening,B-PR
sob,I-PR
or,O
increased,B-PR
cough,I-PR
or,O
sputum,B-PR
production,I-PR

No,O
dictated,O
summary,O

ENTERED,O
BY,O
:,O

TIKWELD,O
",",O
WILLAIDE,O
V.,O
",",O
M.D.,O
(,O
QT296,O
),O
03/19/06,O
10:53,O
AM,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

060376519,O
DH,O

649031,O

323495,O

3838556,O

4/5/2003,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O
/,O
SUMMARY,O

SELCFARST,O
",",O
NAORLY,O

MRN,O
:,O

649031,O

Age,O
:,O

49y,O

REGISTRATION,O
DATE,O
:,O

04/05/2003,O
11:47,O
AM,O

Provider,O
:,O

STIEGE,O
",",O
M.D.,O
TLANDJESC,O

PRELIMINARY,O
REPORT,O

PCP,O
notified,O
by,O
MD,O
:,O

E-mail,O
PCP,O

Discharge,O
Date,O
/,O
Time,O
:,O

04/05/2003,O
22:06,O

Discharge,O
Status,O
:,O

Discharged,O

Condition,O
on,O
Discharge,O
:,O

Stable,O

Patient,O
States,O
Complaint,O
:,O

DIZZINESS,B-PR

Standardized,O
Discharge,O
Instructions,O
:,O

The,O
patient,O
was,O
given,O
printed,O
instructions,O
for,O
dizziness,B-PR
(,O
English,O
),O
.,O

Diagnosis,O
:,O

Benign,B-PR
positional,I-PR
vertigo,I-PR
vs,O
labyrinthitis,B-PR

Treatment,O
Rendered,O
:,O

Head,B-TE
CT,I-TE
negative,O
.,O

Discharge,O
Medications,O
:,O

Meclizine,B-TR
25,O
mg,O
po,O
bid,O
.,O

Disposition,O
",",O
Follow,O
up,O
and,O
Instructions,O
to,O
Patient,O
:,O

Return,O
to,O
ED,O
or,O
call,O
PCP,O
if,O
symptoms,B-PR
worsen,O
or,O
if,O
fever,B-PR
with,O
headache,B-PR
.,O

Pt,O
d,O
/,O
c&apos;d,O
home,O
in,O
stable,O
condition,O
.,O

PCP,O
Name,O
:,O

GUYNLORDSMANTDOUET,O
",",O
RYLA,O
B,O

Provider,O
Number,O
:,O

26596,O

This,O
report,O
was,O
created,O
by,O
TLANDJESC,O
",",O
IECELANE,O
",",O
M.D.,O
04/05/2003,O
10:09,O
PM,O

095889687,O
WGH,O

9786774,O

224527,O

311732,O

10/24/2001,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O
/,O
SUMMARY,O

SOURS,O
",",O
NANONIFF,O
ELLMI,O

MRN,O
:,O

9786774,O

Age,O
:,O

31y,O

REGISTRATION,O
DATE,O
:,O

10/24/2001,O
07:57,O
AM,O

Provider,O
:,O

LICHEREANYVE,O
CHIRDKOTEKERTH,O

PRELIMINARY,O
REPORT,O

Benefits,O
Assigned,O
:,O

Y,O

Discharge,O
Date,O
/,O
Time,O
:,O

10/24/2001,O
10:07,O

Discharge,O
Status,O
:,O

Discharged,O
Condition,O
on,O
Discharge,O
:,O

Stable,O
Patient,O
States,O
Complaint,O
:,O

SWOLLEN,B-PR
PAINFUL,I-PR
L,I-PR
SIDE,I-PR
FC,I-PR

Diagnosis,O
:,O

L,B-PR
upper,I-PR
lip,I-PR
/,I-PR
L,I-PR
nostril,I-PR
abscess,I-PR

Treatment,O
Rendered,O
:,O

5,O
cc,O
of,O
purulent,B-PR
material,I-PR
drained,O
by,O
needle,B-TR
aspiration,I-TR

Discharge,O
Medications,O
:,O

Augmentin,B-TR
875,O
mg,O
twice,O
a,O
day,O
for,O
10,O
days,O
.,O

Follow,O
up,O
Service,O
:,O

Please,O
see,O
your,O
PCP,O
in,O
follow,O
up,O
.,O

Disposition,O
",",O
Follow,O
up,O
and,O
Instructions,O
to,O
Patient,O
:,O

Return,O
immediately,O
for,O
worsening,O
signs,O
of,O
infection,B-PR
(,O
increased,B-PR
swelling,I-PR
",",O
pain,B-PR
",",O
redness,B-PR
),O
or,O
for,O
any,B-PR
neurologic,I-PR
changes,I-PR
(,O
blurry,B-PR
or,I-PR
double,I-PR
vision,I-PR
",",O
headaches,B-PR
",",O
trouble,B-PR
walking,I-PR
",",O
etc,O
),O
.,O

PCP,O
Name,O
:,O

CLEV,O
",",O
NISHA,O

Provider,O
Number,O
:,O

53476,O

This,O
report,O
was,O
created,O
by,O
CHIRDKOTEKERTH,O
",",O
LICHEREANYVE,O
10/24/2001,O
10:09,O
AM,O

101407944,O
PUMC,O

3925529,O

441763,O

2345939,O

4/30/2005,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Report,O
Status,O
:,O

Signed,O

DISCHARGE,O
SUMMARY,O
NAME,O
:,O

CAUGH,O
",",O
DI,O
K,O

UNIT,O
NUMBER,O
:,O

569-82-26,O

ADMISSION,O
DATE,O
:,O

04/30/2005,O

DISCHARGE,O
DATE,O
:,O

5/14/05,O
05/14/2005,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Right,B-PR
parietal,I-PR
occipital,I-PR
temporal,I-PR
tumor,I-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

5/5/05,O
right,B-TR
parietal,I-TR
occipital,I-TR
craniotomy,I-TR
and,O
debulking,B-TR
of,I-TR
tumor,I-TR
using,O
stulz,B-TR
neuro,I-TR
navigation,I-TR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
pleasant,O
83-year-old,O
retired,O
psychiatrist,O
who,O
presents,O
with,O
a,O
chief,O
complaint,O
of,O
gait,B-PR
difficulty,I-PR
for,O
the,O
last,O
five,O
to,O
six,O
months,O
.,O

The,O
patient,O
has,O
a,O
history,O
of,O
laryngeal,B-PR
cancer,I-PR
in,O
2000,O
and,O
2001,O
",",O
CVA,B-PR
in,O
2001,O
to,O
2002,O
and,O
hypertension,B-PR
",",O
who,O
has,O
a,O
six,O
month,O
history,O
of,O
progressive,B-PR
difficulty,I-PR
in,I-PR
ambulation,I-PR
.,O

The,O
patient,O
was,O
in,O
previously,O
good,O
health,O
when,O
he,O
reports,O
starting,O
to,O
notice,O
problems,B-PR
ambulating,I-PR
about,O
six,O
months,O
ago,O
.,O

His,O
partner,O
also,O
reports,O
that,O
he,O
has,O
been,O
having,O
more,B-PR
difficulty,I-PR
with,I-PR
ADLs,I-PR
.,O

He,O
reported,O
that,O
he,O
began,O
with,O
difficulty,B-PR
buttoning,I-PR
his,I-PR
shirt,I-PR
for,O
many,O
years,O
since,O
after,O
a,B-PR
stroke,I-PR
but,O
now,O
reports,O
that,O
on,O
occasion,O
she,O
would,O
ask,O
him,O
why,O
he,O
was,O
doing,O
certain,O
things,O
and,O
he,O
could,O
not,O
give,O
a,O
concrete,O
example,O
.,O

The,O
patient,O
was,O
having,O
a,B-PR
hard,I-PR
time,I-PR
walking,I-PR
and,O
reports,O
that,O
he,O
has,O
felt,O
weaker,O
.,O

He,O
has,O
had,O
uncoordination,B-PR
of,I-PR
his,I-PR
feet,I-PR
and,O
began,O
having,O
a,B-TR
cane,I-TR
four,O
to,O
five,O
months,O
ago,O
with,O
the,B-PR
increasing,I-PR
weakness,I-PR
.,O

This,O
was,O
especially,O
bad,O
when,O
trying,O
to,O
arise,O
.,O

The,O
patient,O
has,O
seen,O
his,O
primary,O
care,O
physician,O
who,O
referred,O
him,O
to,O
physical,O
therapy,O
for,O
his,B-PR
gait,I-PR
weakness,I-PR
but,O
his,B-PR
symptoms,I-PR
failed,O
to,O
improve,O
.,O

He,O
continued,O
to,O
progress,O
until,O
two,O
weeks,O
prior,O
to,O
admission,O
when,O
he,O
was,O
found,O
in,O
the,O
bathtub,O
",",O
unsteady,B-PR
and,O
fell,O
trying,O
to,O
steady,O
himself,O
.,O

The,O
patient,O
could,O
not,O
be,O
moved,O
and,O
had,O
to,O
have,O
911,O
called,O
for,O
help,O
.,O

Since,O
that,O
time,O
he,O
had,O
been,O
ambulating,O
with,O
a,B-TR
walker,I-TR
and,O
has,O
had,O
increasing,B-PR
difficulty,I-PR
with,I-PR
falls,I-PR
in,O
the,O
last,O
two,O
weeks,O
.,O

The,O
patient,O
was,O
again,O
seen,O
by,O
his,O
primary,O
care,O
physician,O
and,O
a,B-TE
CG,I-TE
scan,I-TE
revealed,O
a,B-PR
mass,I-PR
in,I-PR
the,I-PR
right,I-PR
parietal,I-PR
lobe,I-PR
.,O

The,O
patient,O
was,O
referred,O
to,O
the,O
Neurology,O
Service,O
for,O
further,B-TE
workup,I-TE
of,O
the,B-PR
mass,I-PR
.,O

The,O
patient,O
denied,O
blurry,B-PR
vision,I-PR
",",O
headache,B-PR
",",O
nausea,B-PR
",",O
vomiting,B-PR
",",O
paresthesias,B-PR
",",O
pain,B-PR
in,I-PR
mental,I-PR
status,I-PR
",",O
confusion,B-PR
or,O
seizures,B-PR
.,O

The,O
patient,O
is,O
status,O
post,O
radiation,B-TR
therapy,I-TR
and,O
resection,B-TR
and,O
reconstruction,B-TR
for,O
his,B-PR
laryngeal,I-PR
cancer,I-PR
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

Positive,B-PR
weakness,I-PR
",",O
otherwise,O
negative,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Hypertension,B-PR
",",O
CVA,B-PR
2001,O
",",O
2002,O
diabetes,B-PR
",",O
laryngeal,B-PR
cancer,I-PR
",",O
right,B-TR
CEA,I-TR
",",O
prostatectomy,B-TR
for,O
BPH,B-PR
",",O
total,B-TR
knee,I-TR
replacement,I-TR
",",O
status,O
post,O
appendectomy,B-TR
.,O

MEDICATIONS,O
PRIOR,O
TO,O
ADMISSION,O
:,O

Plavix,B-TR
75,O
mg,O
every,O
day,O
",",O
Lipitor,B-TR
40,O
mg,O
every,O
day,O
",",O
HCTZ,B-TR
50,O
mg,O
",",O
Monopril,B-TR
10,O
mg,O
every,O
day,O
",",O
Viagra,B-TR
100,O
mg,O
prn,O
.,O

ALLERGIES,O
:,O

NKDA,B-PR
.,O

FAMILY,O
HISTORY,O
:,O

Father,O
with,O
CAD,B-PR
at,O
90,O
",",O
diabetes,B-PR
",",O
CVA,B-PR
",",O
hypercholesterolemia,B-PR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
has,O
one,O
to,O
two,O
pack,O
x20,O
year,O
history,O
of,O
smoking,O
that,O
was,O
30,O
years,O
ago,O
.,O

He,O
reports,O
occasional,O
alcohol,O
use,O
and,O
no,O
illicits,O
.,O

The,O
patient,O
is,O
a,O
retired,O
psychiatrist,O
who,O
lives,O
in,O
Ph,O
.,O

PHYSICAL,O
EXAM,O
:,O

Afebrile,B-PR
",",O
vital,B-TE
signs,I-TE
stable,O
but,O
notable,O
for,O
a,B-TE
blood,I-TE
pressure,I-TE
of,O
164/80,O
.,O

Generally,O
a,O
well,O
developed,O
elderly,O
man,O
in,O
no,O
apparent,B-PR
distress,I-PR
sitting,O
in,O
bed,O
.,O

HEENT,O
;,O

extraocular,O
movements,O
intact,O
.,O

Pupils,O
equally,O
round,O
and,O
reactive,O
to,O
light,O
.,O

No,O
nystagmus,B-PR
.,O

No,O
retinal,B-PR
hemorrhages,I-PR
.,O

External,O
ears,O
normal,O
.,O

Moist,O
buccal,O
mucosa,O
",",O
poor,B-PR
dentition,I-PR
",",O
no,O
erythema,B-PR
or,I-PR
exudates,I-PR
in,I-PR
the,I-PR
posterior,I-PR
pharynx,I-PR
.,O

Neck,O
supple,O
.,O

Prominent,B-PR
salivary,I-PR
glands,I-PR
bilaterally,I-PR
.,O

No,O
other,B-PR
masses,I-PR
or,O
thyromegaly,B-PR
noted,O
.,O

No,O
cervical,B-PR
",",I-PR
para-auricular,I-PR
or,I-PR
clavicular,I-PR
lymphadenopathy,I-PR
.,O

Chest,O
:,O

Crackles,B-PR
in,I-PR
the,I-PR
right,I-PR
lung,I-PR
field,I-PR
.,O

No,O
egophony,B-PR
.,O

Heart,O
:,O

no,O
palpable,B-PR
thrill,I-PR
or,O
heave,B-PR
.,O

S1,O
",",O
S2,O
.,O

3/6,B-PR
systolic,I-PR
ejection,I-PR
murmur,I-PR
heard,O
best,O
at,O
the,O
apex,O
.,O

Pulses,O
2+,O
carotids,O
bilaterally,O
",",O
2+,O
radial,O
pulses,O
",",O
2+,O
DP,O
pulses,O
bilaterally,O
.,O

The,O
abdomen,O
was,O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
",",O
positive,O
bowel,O
sounds,O
.,O

No,O
hepato,B-PR
or,O
splenomegaly,B-PR
.,O

Right,B-PR
lower,I-PR
quadrant,I-PR
scar,I-PR
and,O
inferior,B-PR
midline,I-PR
scar,I-PR
that,O
are,O
well,O
healed,O
.,O

Back,O
:,O

No,O
CVA,B-PR
tenderness,I-PR
.,O

Skin,O
:,O

No,O
petechiae,B-PR
.,O

Cranial,O
nerves,O
II,O
through,O
XII,O
grossly,O
intact,O
with,O
a,B-PR
slight,I-PR
deviation,I-PR
of,I-PR
the,I-PR
uvula,I-PR
and,I-PR
tongue,I-PR
to,O
the,O
right,O
.,O

There,O
is,O
increased,B-PR
tone,I-PR
in,I-PR
his,I-PR
right,I-PR
upper,I-PR
extremity,I-PR
with,O
a,B-PR
slight,I-PR
left,I-PR
pronator,I-PR
drift,I-PR
.,O

On,O
the,O
right,O
side,O
his,O
strength,O
was,O
5,O
out,O
5,O
.,O

On,O
the,O
left,O
side,O
it,O
is,O
4,O
out,O
of,O
5,O
in,O
the,O
lower,O
extremities,O
.,O

The,O
patient,O
has,O
an,B-PR
intention,I-PR
tremor,I-PR
with,I-PR
the,I-PR
left,I-PR
hand,I-PR
.,O

His,O
reflexes,O
were,O
symmetric,O
with,O
upgoing,O
toes,O
.,O

There,O
was,O
a,O
plantar,O
grasp,O
present,O
on,O
the,O
left,O
hand,O
.,O

Graphesthesia,O
was,O
poor,O
in,O
both,O
hands,O
.,O

His,O
gait,O
was,O
unsteady,O
and,O
he,O
was,O
unable,O
to,O
stand,O
on,O
his,O
own,O
.,O

Mental,O
status,O
:,O

he,O
was,O
alert,O
and,O
oriented,O
x3,O
.,O

RELEVANT,O
LABORATORY,O
DATA,O
:,O

White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
on,O
admission,O
6.1,O
",",O
INR,B-TE
on,O
admission,O
1.0,O
",",O
relevant,B-TE
imaging,I-TE
.,O

Echocardiogram,B-TE
June,O
2004,O
showed,O
an,B-TE
EF,I-TE
of,O
77%,O
.,O

Chest,B-TE
xray,I-TE
reveals,O
no,O
consolidation,B-PR
or,O
signs,B-PR
of,I-PR
edema,I-PR
.,O

CT,B-TE
shows,O
a,B-PR
right,I-PR
parietal,I-PR
hyperdense,I-PR
and,I-PR
heterogenously,I-PR
enhancing,I-PR
mass,I-PR
measuring,O
6.5,O
x,O
5,O
cm,O
with,O
the,B-PR
surrounding,I-PR
vasogenic,I-PR
edema,I-PR
in,O
effacement,O
of,O
the,O
right,O
lateral,O
ventricle,O
.,O

The,O
finding,O
was,O
most,O
consistent,O
with,O
metastatic,B-PR
disease,I-PR
and,O
less,O
likely,O
primary,B-PR
CNS,I-PR
neoplasm,I-PR
such,O
as,O
glioblastoma,B-PR
.,O

MRI,B-TE
showed,O
a,B-PR
large,I-PR
heterogenous,I-PR
enhancing,I-PR
right,I-PR
parietal,I-PR
mass,I-PR
lesion,I-PR
with,O
a,O
possible,O
ependymal,B-PR
spread,I-PR
.,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
Neurologic,O
Service,O
for,O
workup,B-TE
of,O
his,B-PR
tumor,I-PR
.,O

The,O
neuro-oncologist,O
felt,O
that,O
because,O
of,O
the,B-PR
tremendous,I-PR
tumor,I-PR
burden,I-PR
that,O
was,O
likely,O
causing,O
his,B-PR
symptoms,I-PR
the,O
patient,O
will,O
require,O
open,B-TR
debulking,I-TR
as,O
well,O
as,O
obtaining,O
issue,O
for,O
a,B-TE
pathologic,I-TE
diagnosis,I-TE
.,O

Thea,O
patient,O
was,O
referred,O
to,O
Dr.,O
Coma,O
of,O
the,O
Eragnes,O
Houseco,O
Ardbay,O
Memorial,O
Hospital,O
.,O

On,O
May,O
5,O
",",O
2005,O
the,O
patient,O
was,O
taken,O
to,O
the,O
operating,O
room,O
for,O
a,B-TR
right,I-TR
parietal,I-TR
occipital,I-TR
craniotomy,I-TR
and,O
debulking,B-TR
of,O
the,B-PR
tumor,I-PR
using,O
stulz,B-TR
neuro,I-TR
navigation,I-TR
.,O

Please,O
see,O
the,O
separately,O
dictated,O
operative,O
report,O
for,O
further,O
details,O
of,O
the,B-TR
procedure,I-TR
.,O

The,O
patient,O
was,O
taken,O
to,O
the,O
recovery,O
room,O
and,O
then,O
to,O
the,O
postoperative,O
floor,O
in,O
stable,O
condition,O
.,O

Of,O
note,O
the,O
patient,O
was,O
seen,O
by,O
cardiology,O
for,O
preoperative,B-TE
assessment,I-TE
.,O

The,O
patient,O
was,O
also,O
seen,O
by,O
physical,O
and,O
occupational,O
therapy,O
during,O
his,O
postoperative,O
course,O
and,O
they,O
recommended,O
that,O
he,O
go,O
to,O
a,O
rehabilitation,O
facility,O
for,O
his,O
recovery,O
.,O

A,B-TE
postoperative,I-TE
MRI,I-TE
was,O
obtained,O
which,O
revealed,O
no,O
remarkable,B-PR
findings,I-PR
but,O
only,O
post,B-PR
surgical,I-PR
changes,I-PR
.,O

Transcranial,B-TE
Dopplers,I-TE
were,O
checked,O
following,O
surgery,B-TR
and,O
the,O
patient,O
was,O
started,O
on,O
Decadron,B-TR
4,O
mg,O
q6,O
to,O
prevent,O
swelling,B-PR
.,O

The,O
patient,O
was,O
started,O
on,O
Fragmin,B-TR
for,O
DVT,B-TR
prophylaxis,I-TR
and,O
the,O
patient,O
was,O
also,O
started,O
on,O
Dilantin,B-TE
levels,I-TE
.,O

Of,O
note,O
on,O
5/9/05,O
the,O
patient,O
was,O
seen,O
by,O
Urology,O
due,O
to,O
an,B-PR
inability,I-PR
to,I-PR
void,I-PR
and,O
a,B-TR
16,I-TR
French,I-TR
Coude,I-TR
catheter,I-TR
was,O
placed,O
.,O

The,O
patient,O
then,O
was,O
given,O
voiding,B-TR
trials,I-TR
but,O
eventually,O
he,O
needed,O
to,O
be,O
straight,O
cathed,O
prn,O
.,O

At,O
the,O
time,O
of,O
transfer,O
",",O
a,B-TR
16,I-TR
Coude,I-TR
catheter,I-TR
was,O
in,O
place,O
and,O
draining,O
well,O
.,O

The,O
patient,O
can,O
have,O
voiding,B-TR
trials,I-TR
at,O
rehab,O
and,O
he,O
is,O
being,O
maintained,O
on,O
Flomax,B-TR
.,O

The,O
patient,O
had,O
a,O
relatively,O
unremarkable,O
course,O
and,O
his,O
neurologic,O
status,O
continued,O
to,O
improve,O
following,O
the,B-TR
operation,I-TR
.,O

At,O
the,O
time,O
of,O
discharge,O
the,O
patient,O
was,O
alert,O
and,O
oriented,O
x3,O
and,O
able,O
to,O
swallow,O
pureed,O
and,O
thick,O
diet,O
without,O
a,O
problem,O
.,O

On,O
5/11/05,O
repeat,B-TE
imaging,I-TE
revealed,O
some,B-PR
edema,I-PR
and,O
mass,B-PR
affect,I-PR
.,O

The,O
patient,O
was,O
given,O
an,B-TR
IV,I-TR
load,I-TR
of,I-TR
Decadron,I-TR
and,O
restarted,O
on,O
IV,B-TR
Decadron,I-TR
which,O
was,O
eventually,O
transferred,O
to,O
po,B-TR
Decadron,I-TR
.,O

The,O
patient,O
was,O
also,O
started,O
on,O
Mannitol,B-TR
.,O

His,B-TE
pathology,I-TE
came,O
back,O
as,O
a,B-PR
large,I-PR
grade,I-PR
IV,I-PR
glioma,I-PR
.,O

The,B-PR
patient,I-PR
&apos;s,I-PR
pain,I-PR
was,O
initially,O
controlled,O
with,O
IV,B-TR
pain,I-TR
medications,I-TR
but,O
at,O
the,O
time,O
of,O
discharge,O
to,O
the,O
rehab,O
facility,O
he,O
was,O
able,O
to,O
control,O
his,B-PR
pain,I-PR
on,O
po,B-TR
pain,I-TR
medications,I-TR
.,O

The,O
patient,O
did,O
have,O
a,B-TE
postoperative,I-TE
serum,I-TE
sodium,I-TE
in,O
the,O
120s,O
from,O
the,O
130s,O
three,O
days,O
postoperatively,O
.,O

An,O
endocrine,O
consult,O
was,O
obtained,O
to,O
help,O
manage,O
his,B-TE
serum,I-TE
electrolytes,I-TE
.,O

The,O
patient,O
was,O
started,O
on,O
three,O
grams,O
of,O
sodium,B-TR
",",O
3x,O
a,O
day,O
with,O
fluid,B-TR
restriction,I-TR
.,O

Over,O
the,O
next,O
several,O
days,O
his,B-TE
sodium,I-TE
levels,I-TE
were,O
followed,O
and,O
by,O
5/12/05,O
his,B-TE
plasma,I-TE
sodium,I-TE
was,O
back,O
to,O
136,O
.,O

The,O
patient,O
was,O
taken,O
off,O
fluid,B-TR
restriction,I-TR
.,O

On,O
5/14/05,O
Mannitol,B-TR
was,O
tapered,O
and,O
then,O
d,O
/,O
c&apos;d.,O

At,O
the,O
time,O
of,O
transfer,O
the,O
patient,O
was,O
stable,O
and,O
needed,O
only,O
physical,B-TR
and,I-TR
occupational,I-TR
therapy,I-TR
.,O

The,O
patient,O
was,O
oriented,O
to,O
person,O
",",O
place,O
and,O
time,O
and,O
opened,O
eyes,O
appropriately,O
to,O
speech,O
when,O
asked,O
.,O

The,O
patient,O
is,O
hard,B-PR
of,I-PR
hearing,I-PR
.,O

The,O
patient,O
had,O
no,O
complaints,B-PR
of,I-PR
pain,I-PR
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Lipitor,B-TR
40,O
mg,O
po,O
every,O
day,O
.,O

2.,O
Captopril,B-TR
12.5,O
mg,O
po,O
tid,O
.,O

3.,O
Nexium,B-TR
40,O
mg,O
po,O
every,O
day,O
.,O

4.,O
Colace,B-TR
100,O
mg,O
po,O
bid,O
.,O

5.,O
Ativan,B-TR
0.5,O
mg,O
po,O
q4,O
hours,O
prn,O
for,O
anxiety,B-PR
.,O

6.,O
Allegra,B-TR
60,O
mg,O
po,O
bid,O
.,O

7.,O
Dilantin,B-TR
100,O
mg,O
IV,O
tid,O
which,O
can,O
be,O
changed,O
to,O
a,B-TR
po,I-TR
regimen,I-TR
in,O
seven,O
days,O
.,O

8.,O
Zinc,B-TR
220,O
mg,O
po,O
every,O
day,O
.,O

9.,O
Vitamin,B-TR
C,I-TR
500,O
mg,O
po,O
bid,O
.,O

10.,O
Flomax,B-TR
0.4,O
mg,O
po,O
every,O
day,O
.,O

11.,O
Fragmin,B-TR
2500,O
units,O
subcut,O
every,O
day,O
.,O

12.,O
Levofloxacin,B-TR
500,O
mg,O
po,O
q,O
daily,O
x10,O
days,O
.,O

13.,O
Dexamethasone,B-TR
4,O
mg,O
po,O
q6,O
hours,O
.,O

14.,O
The,B-TR
steroid,I-TR
will,O
be,O
kept,O
for,O
now,O
and,O
tapered,O
at,O
a,O
later,O
date,O
on,O
follow,O
up,O
with,O
Dr.,O
Coma,O
.,O

15.,O
Regular,B-TR
insulin,I-TR
sliding,I-TR
scale,I-TR
with,O
finger,O
sticks,O
qac,O
and,O
qhs,O
.,O

16.,O
Neutra-Phos,B-TR
1.25,O
grams,O
po,O
as,O
needed,O
.,O

DISCHARGE,O
INSTRUCTIONS,O
:,O

The,O
patient,O
is,O
instructed,O
to,O
not,O
shower,O
or,O
bath,O
until,O
one,O
week,O
.,O

The,B-TR
staples,I-TR
were,O
removed,O
prior,O
to,O
discharge,O
.,O

The,O
patient,O
is,O
instructed,O
not,O
to,O
drive,O
.,O

The,O
patient,O
is,O
asked,O
to,O
see,O
a,O
physician,O
immediately,O
or,O
go,O
to,O
the,O
nearest,O
emergency,O
room,O
if,O
any,B-PR
bleeding,I-PR
",",O
wound,B-PR
infection,I-PR
",",O
fever,B-PR
greater,O
than,O
100.8,O
",",O
intractable,B-PR
nausea,I-PR
and,I-PR
vomiting,I-PR
",",O
headache,B-PR
",",O
dizziness,B-PR
",",O
numbness,B-PR
",",O
pain,B-PR
or,O
weakness,B-PR
occurs,O
.,O

The,O
patient,O
instructed,O
to,O
call,O
Dr.,O
Coma,O
&apos;s,O
office,O
at,O
496-260-3297,O
to,O
arrange,O
for,O
a,O
follow,O
up,O
appointment,O
in,O
the,O
Saintaelfoote,O
Hospital,O
at,O
the,O
first,O
available,O
time,O
",",O
one,O
to,O
two,O
months,O
after,O
surgery,B-TR
.,O

The,O
patient,O
is,O
also,O
asked,O
to,O
call,O
the,O
Neuro,O
/,O
Oncology,O
Service,O
",",O
the,O
office,O
of,O
Dr.,O
Britts,O
at,O
430-884-2917,O
for,O
a,O
follow,O
up,O
appointment,O
in,O
three,O
weeks,O
.,O

The,O
patient,O
is,O
asked,O
to,O
take,O
a,O
course,O
of,O
Dilantin,B-TR
for,O
ten,O
more,O
days,O
.,O

The,O
patient,O
is,O
instructed,O
not,O
to,O
undergo,O
any,O
heavy,O
lifting,O
until,O
seen,O
in,O
clinic,O
.,O

HOPETAMEMY,O
K.,O
THOREDUHEDREPS,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

Electronically,O
Signed,O
ERIN,O
KENGEKOTE,O
",",O
M.D.,O

05/14/2005,O
16:02,O

_____________________________,O
ERIN,O
KENGEKOTE,O
",",O
M.D.,O

TR,O
:,O

wy,O

DD,O
:,O

05/14/2005,O

TD,O
:,O

05/14/2005,O
1:10,O
P,O
441763,O

cc,O
:,O

ERIN,O
KENGEKOTE,O
",",O
M.D.,O

105732749,O

FIH,O

7017973,O

715894,O

55714,O

9/10/1999,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

DISCHARGE,O
SUMMARY,O
NAME,O
:,O

STERPKOTENEISH,O
",",O
LYDELL,O
A,O

UNIT,O
NUMBER,O
:,O

712-67-96,O

ADMISSION,O
DATE,O
:,O

09/10/1999,O

DISCHARGE,O
DATE,O
:,O

09/14/1999,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Pancreatic,B-PR
carcinoma,I-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

Laparoscopy,B-TE
with,O
biopsy,B-TE
for,O
diagnosis,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Ms.,O
Sterpkoteneish,O
is,O
a,O
69-year-old,O
woman,O
",",O
who,O
over,O
the,O
past,O
six,O
months,O
has,O
noted,O
increasing,B-PR
pain,I-PR
in,I-PR
her,I-PR
left,I-PR
upper,I-PR
quadrant,I-PR
radiating,O
to,O
the,O
back,O
.,O

She,O
described,O
the,B-PR
pain,I-PR
as,O
being,O
exacerbated,O
by,O
eating,O
and,O
described,O
an,B-PR
associated,I-PR
weight,I-PR
loss,I-PR
.,O

She,O
presented,O
to,O
her,O
primary,O
care,O
physician,O
",",O
Dr.,O
Tlandtaze,O
",",O
in,O
Aersing,O
Rocuch,O
Sun,O
",",O
who,O
obtained,O
a,B-TE
CT,I-TE
scan,I-TE
",",O
which,O
demonstrated,O
a,B-PR
mass,I-PR
in,O
the,O
tail,O
of,O
the,O
pancreas,O
.,O

She,O
was,O
then,O
referred,O
to,O
the,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
under,O
the,O
El,O
Memorial,O
and,O
was,O
seen,O
by,O
Dr.,O
Blinjesc,O
",",O
who,O
scheduled,O
her,O
for,O
an,B-TE
exploratory,I-TE
laparoscopy,I-TE
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Is,O
significant,O
for,O
spinal,B-PR
stenosis,I-PR
and,O
a,O
series,O
of,O
operations,B-TR
including,O
repair,B-TR
of,O
a,B-PR
ureteral,I-PR
stricture,I-PR
;,O
cataract,B-TR
implants,I-TR
;,O
two,B-TR
partial,I-TR
hysterectomies,I-TR
;,O
and,O
an,B-TR
appendectomy,I-TR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Oxycontin,B-TR
10,O
mg,O
PO,O
q.day,O
.,O

Darvocet,B-TR
.,O

Estratab,B-TR
.,O

Aspirin,B-TR
325,O
mg,O
PO,O
q.day,O
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,B-TE
blood,I-TE
pressure,I-TE
was,O
150/86,O
;,O
pulse,B-TE
82,O
;,O
respirations,B-TE
16,O
.,O

Lungs,O
were,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

Heart,O
:,O

regular,O
S1,O
and,O
S2,O
;,O
no,O
murmurs,B-PR
.,O

Abdomen,O
:,O

soft,O
;,O
nontender,O
;,O
no,O
palpable,B-PR
masses,I-PR
.,O

HOSPITAL,O
COURSE,O
AND,O
TREATMENT,O
:,O

The,O
patient,O
was,O
admitted,O
through,O
same,O
day,O
surgery,O
and,O
taken,O
to,O
the,O
operating,O
room,O
where,O
Dr.,O
Blinjesc,O
",",O
assisted,O
by,O
Dr.,O
Zockbeathe,O
",",O
performed,O
a,B-TE
diagnostic,I-TE
laparoscopy,I-TE
with,O
peritoneal,B-TR
washings,I-TR
.,O

Findings,O
included,O
no,B-PR
gross,I-PR
evidence,I-PR
seating,I-PR
in,I-PR
the,I-PR
abdominal,I-PR
wall,I-PR
;,O
one,B-PR
nodule,I-PR
on,O
the,O
posterior,O
surface,O
of,O
the,O
right,O
lobe,O
of,O
the,O
liver,O
;,O
one,B-PR
nodule,I-PR
in,O
the,O
inferior,O
edge,O
of,O
the,O
falciform,O
ligament,O
.,O

Specimens,B-TE
sent,O
to,O
pathology,O
included,O
peritoneal,B-TE
washings,I-TE
and,O
permanent,B-TE
specimens,I-TE
from,I-TE
the,I-TE
liver,I-TE
and,O
falciform,B-PR
nodules,I-PR
.,O

There,O
were,O
no,O
complications,B-PR
",",O
and,O
the,O
patient,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
.,O

Postoperatively,O
",",O
the,O
patient,O
had,O
some,B-PR
abdominal,I-PR
bloating,I-PR
with,O
evidence,O
of,O
subcutaneous,B-PR
emphysema,I-PR
over,I-PR
the,I-PR
abdomen,I-PR
.,O

She,O
was,O
uncomfortable,B-PR
and,O
slow,O
to,O
have,O
bowel,O
movements,O
",",O
although,O
she,O
did,O
have,O
flatus,O
.,O

She,O
tolerated,O
a,O
full,O
diet,O
well,O
",",O
but,O
continued,O
to,O
have,O
abdominal,B-PR
cramping,I-PR
and,O
a,B-PR
mild,I-PR
ileus,I-PR
for,O
the,O
following,O
three,O
days,O
.,O

She,O
was,O
treated,O
with,O
repeated,B-TR
Fleet,I-TR
&apos;s,I-TR
enemas,I-TR
",",O
and,O
on,O
postoperative,O
day,O
three,O
",",O
she,O
had,O
a,O
number,O
of,O
bowel,O
movements,O
",",O
was,O
considerably,O
more,O
comfortable,O
",",O
and,O
deemed,O
ready,O
for,O
discharge,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Was,O
excellent,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Included,O
aspirin,B-TR
325,O
mg,O
PO,O
q.day,O
.,O

Percocet,B-TR
one,O
to,O
two,O
whenever,O
necessary,O
q.,O
four,O
to,O
six,O
hours,O
for,O
pain,B-PR
.,O

Estratab,B-TR
one,O
PO,O
q.day,O
.,O

At,O
the,O
time,O
of,O
discharge,O
",",O
cytopathology,B-TE
specimens,I-TE
had,O
been,O
negative,O
",",O
and,O
surgical,B-TE
pathology,I-TE
specimens,I-TE
were,O
still,O
pending,O
.,O

She,O
was,O
instructed,O
to,O
call,O
Dr.,O
Blinjesc,O
for,O
the,O
results,O
of,O
these,B-TE
tests,I-TE
and,O
to,O
follow,O
up,O
with,O
him,O
for,O
further,O
management,O
if,O
necessary,O
.,O

STA,O
BODEJOVE,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

______________________________,O
LONSHI,O
OCK,O
",",O
M.D.,O

TR,O
:,O

hjr,O

DD,O
:,O

09/14/1999,O

TD,O
:,O

09/17/1999,O
2:26,O
P,O

cc,O
:,O

LONSHI,O
OCK,O
",",O
M.D.,O

cc,O
:,O

Telshey,O
K.,O
Swatlleebtik,O
",",O
M.D.,O
Rinime,O
Hawnspantkote,O
Arkansas,O

115026438,O
SC,O

23754357,O

49885,O

8/25/2002,O
12:00:00,O
AM,O

s,O
/,O
p,O
NSVD,O

DIS,O

Admission,O
Date,O
:,O

08/25/2002,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

08/27/2002,O

******,O
DISCHARGE,O
ORDERS,O
******,O

HEMPWIERST,O
",",O
E,O

904-74-17-7,O
Z57,O

Room,O
:,O

FXP2-288,O

Service,O
:,O

OBS,O

DISCHARGE,O
PATIENT,O
ON,O
:,O

08/27/02,O
AT,O
10:00,O
AM,O

CONTINGENT,O
UPON,O

HO,B-TE
evaluation,I-TE

WILL,O
D,O
/,O
C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D,O
/,O
C,O
SUMMARY,O
:,O

YES,O

Attending,O
:,O

BAWNREEF,O
",",O
CENTEKANEELD,O
",",O
M.D.,O

DISPOSITION,O
:,O

Home,O

DISCHARGE,O
MEDICATIONS,O
:,O

DOCUSATE,B-TR
SODIUM,I-TR
100,O
MG,O
PO,O
BID,O
PRN,O
IBUPROFEN,B-TR
200-600,O
MG,O
PO,O
Q4-6H,O
PRN,O
PAIN,B-PR

DIET,O
:,O

No,O
Restrictions,O

Activity,O
-,O
As,O
tolerated,O

FOLLOW,O
UP,O
APPOINTMENT,O
(,O
S,O
),O
:,O

OB,O
Clinic,O
2,O
weeks,O
and,O
6,O
weeks,O
",",O
No,O
Known,B-PR
Allergies,I-PR

ADMIT,O
DIAGNOSIS,O
:,O

postdates,B-PR
pregnancy,I-PR

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O

Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O
s,O
/,O
p,O
NSVD,B-PR

OTHER,O
DIAGNOSIS,O
;,O

Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O

none,O

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

Primary,O
Anesthesia,O
:,O

Epidural,O
Secondary,O
Anesthesia,O
:,O

Local,O
Vaginal,O
delivery,O
:,O

Spontaneous,O
Episiotomy,O
:,O

Median,O
Placenta,O
:,O

Delivery,O
:,O

Manual,O
Condition,O
:,O

Normal,O
Delivering,O
Resident,O
/,O
Staff,O
:,O

GOINGNETHBUMPS,O
",",O
NANSO,O
R.,O
",",O
M.D.,O

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O

BRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

G2,O
T0,O
P0,O
A1,O
L0,O
Estimated,O
EDC,O
:,O

2002-03-02,O

Indications,O
for,O
induction,O
:,O

Post,B-PR
dates,I-PR

Maternal,O
transfer,O
:,O

No,O

Initial,B-TE
newborn,I-TE
exam,I-TE
:,O

No,O
observed,B-PR
abnormalities,I-PR

Baby,O
1,O

MRN,O
:,O

70632019,O

Delivery,O
date,O
:,O

02/13/02,O
01:20,O
AM,O

Apgars,B-TE
"8,9",O

Weight,B-TE
:,O

9lb,O
4,O
oz,O
4196,O
grams,O

Sex,O
:,O

Female,O

ADDITIONAL,O
COMMENTS,O
:,O

Nothing,O
in,O
the,O
vagina,O
for,O
6,O
weeks,O
-,O
no,O
tampons,B-TR
",",O
no,O
douching,B-TR
",",O
no,O
intercourse,O
.,O

If,O
you,O
experience,O
fever,B-PR
&gt;,O
100.4,O
",",O
bleeding,B-PR
&gt;,O
1,O
pad,O
/,O
hour,O
",",O
foul,B-PR
smelling,I-PR
discharge,I-PR
",",O
abdominal,B-PR
pain,I-PR
",",O
or,O
other,B-PR
worrisome,I-PR
symptoms,I-PR
",",O
please,O
call,O
your,O
doctor,O
or,O
return,O
to,O
the,O
hospital,O
.,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O

TO,O
DO,O
/,O
PLAN,O
:,O

No,O
dictated,O
summary,O

ENTERED,O
BY,O
:,O

GOINGNETHBUMPS,O
",",O
NANSO,O
R.,O
",",O
M.D.,O
(,O
HK18,O
),O
02/14/02,O
08:39,O
AM,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

130959255,O

FIH,O

1431063,O

10119/hy66,O

738478,O

6/15/1994,O
12:00:00,O
AM,O

RIGHT,B-PR
OCCIPITAL,I-PR
HEMORRHAGIC,I-PR
STROKE,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

6-15-94,O

DISCHARGE,O
DATE,O
:,O

6-26-94,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Right,B-PR
occipital,I-PR
hemorrhagic,I-PR
stroke,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Ms.,O
Tlandkotesmitskote,O
is,O
a,O
patient,O
who,O
came,O
complaining,O
of,O
feeling,O
dizzy,B-PR
and,O
bumping,O
into,O
objects,O
on,O
her,O
left,O
side,O
.,O

She,O
is,O
a,O
seventy-one,O
year,O
old,O
female,O
with,O
a,O
history,O
of,O
hypertension,B-PR
who,O
is,O
in,O
otherwise,O
good,O
health,O
.,O

This,O
morning,O
while,O
on,O
a,O
cruise,O
ship,O
",",O
she,O
was,O
eating,O
breakfast,O
when,O
she,O
suddenly,O
noticed,O
she,O
could,O
not,O
see,O
a,O
roll,O
on,O
her,O
plate,O
although,O
she,O
knew,O
that,O
it,O
was,O
there,O
.,O

She,O
also,O
felt,O
dizzy,B-PR
and,O
the,O
room,O
was,O
spinning,O
.,O

While,O
walking,O
",",O
she,O
kept,O
bumping,O
into,O
object,O
on,O
her,O
left,O
side,O
.,O

She,O
also,O
complained,O
of,O
a,B-PR
dull,I-PR
",",I-PR
right,I-PR
sided,I-PR
headache,I-PR
over,I-PR
the,I-PR
right,I-PR
eyebrow,I-PR
.,O

Symptoms,B-PR
lasted,O
about,O
five,O
hours,O
and,O
then,O
gradually,O
resolved,O
except,O
for,O
the,B-PR
change,I-PR
in,I-PR
vision,I-PR
.,O

She,O
denied,O
having,O
any,O
weakness,B-PR
",",O
numbness,B-PR
",",O
or,O
pain,B-PR
.,O

She,O
also,O
denies,O
having,O
hoarseness,B-PR
",",O
difficulties,B-PR
in,I-PR
finding,I-PR
words,I-PR
",",O
speaking,O
",",O
hiccups,B-PR
",",O
or,O
diplopia,B-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

The,O
past,O
medical,O
history,O
is,O
significant,O
for,O
hypertension,B-PR
.,O

The,O
past,O
surgical,O
history,O
is,O
negative,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Atenolol,B-TR
",",O
25,O
mg,O
PO,O
qd,O
.,O

ALLERGIES,O
:,O

The,O
patient,O
has,O
no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

On,O
review,O
of,O
systems,O
",",O
the,O
patient,O
denied,O
any,O
history,O
of,O
transient,B-PR
ischemic,I-PR
attacks,I-PR
.,O

FAMILY,O
HISTORY,O
:,O

Father,O
and,O
mother,O
died,O
in,O
their,O
eighties,O
of,O
heart,B-PR
disease,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
denied,O
using,O
tobacco,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
physical,B-TE
examination,I-TE
",",O
she,O
was,O
a,O
very,O
pleasant,O
",",O
moderately,O
obese,O
female,O
in,O
no,O
apparent,B-PR
distress,I-PR
.,O

She,O
was,O
afebrile,B-PR
and,O
her,B-TE
vital,I-TE
signs,I-TE
were,O
stable,O
.,O

The,O
head,O
was,O
normocephalic,O
and,O
atraumatic,B-PR
.,O

The,O
pupils,O
were,O
equal,O
",",O
round,O
",",O
reactive,O
to,O
light,O
.,O

The,O
tympanic,O
membranes,O
were,O
gray,O
.,O

The,O
fundi,O
were,O
sharp,O
.,O

The,O
neck,O
was,O
supple,O
with,O
full,O
range,O
of,O
movement,O
.,O

The,O
lungs,O
were,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
",",O
without,O
rales,B-PR
or,O
wheezes,B-PR
.,O

The,O
heart,O
had,O
a,O
recovery,O
regular,O
rate,O
and,O
rhythm,O
.,O

The,O
abdomen,O
was,O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
.,O

Extremities,O
revealed,O
2+,B-PR
pitting,I-PR
edema,I-PR
in,I-PR
the,I-PR
knees,I-PR
bilaterally,I-PR
.,O

The,B-TE
neurological,I-TE
examination,I-TE
revealed,O
that,O
the,O
patient,O
was,O
awake,O
",",O
alert,O
and,O
oriented,O
to,O
person,O
",",O
place,O
and,O
time,O
.,O

She,O
was,O
able,O
to,O
subtract,O
serial,O
sevens,O
",",O
remember,O
three,O
out,O
of,O
three,O
objects,O
after,O
five,O
minutes,O
",",O
and,O
there,O
was,O
notable,B-PR
aphasia,I-PR
or,O
word,B-PR
finding,I-PR
difficulty,I-PR
.,I-PR

The,O
cranial,O
nerves,O
showed,O
pupils,O
were,O
bilaterally,O
active,O
from,O
3,O
to,O
2,O
mm,O
.,O

There,O
was,O
a,B-PR
dense,I-PR
hemianopsia,I-PR
on,I-PR
the,I-PR
left,I-PR
side,I-PR
.,O

The,O
extra,O
ocular,O
muscles,O
were,O
intact,O
bilaterally,O
.,O

Corneals,O
were,O
present,O
bilaterally,O
.,O

Sensation,O
was,O
intact,O
to,O
light,B-TE
touch,I-TE
and,O
pin,B-TE
prick,I-TE
bilaterally,O
.,O

Face,O
was,O
symmetric,O
.,O

Eye,O
closing,O
was,O
tight,O
.,O

Hearing,O
was,O
intact,O
bilaterally,O
.,O

Palate,O
was,O
midline,O
.,O

Gag,O
was,O
intact,O
.,O

The,O
sternocleidomastoid,O
and,O
trapezius,O
had,O
good,O
strength,O
.,O

Tongue,O
was,O
midline,O
.,O

Strength,O
was,O
5/5,O
in,O
bilateral,O
upper,O
extremities,O
and,O
bilateral,O
lower,O
extremities,O
in,O
detail,O
.,O

There,O
was,O
no,O
pronator,B-PR
drift,I-PR
.,O

Sensation,O
was,O
intact,O
to,O
light,B-TE
touch,I-TE
",",O
pin,B-TE
prick,I-TE
",",O
and,O
proprioception,B-TE
.,O

Cerebellar,B-TE
examination,I-TE
revealed,O
in,O
intention,B-PR
tremor,I-PR
on,I-PR
the,I-PR
right,I-PR
side,I-PR
.,O

The,O
patient,O
had,O
considerable,B-PR
difficulty,I-PR
with,I-PR
left,I-PR
finger-to-nose,I-PR
movement,I-PR
",",O
most,O
likely,O
secondary,O
to,O
hemianopsia,B-PR
.,O

There,O
was,O
no,O
nystagmus,B-PR
",",O
except,O
for,O
some,B-PR
fine,I-PR
fast,I-PR
beat,I-PR
nystagmus,I-PR
bilateral,I-PR
extremes,I-PR
of,I-PR
abduction,I-PR
.,O

Reflexes,O
were,O
symmetric,O
and,O
2+,O
bilaterally,O
at,O
the,O
biceps,O
tendon,O
",",O
2+,O
bilaterally,O
at,O
brachial,O
radialis,O
",",O
2+,O
bilaterally,O
at,O
the,O
patellar,O
tendon,O
",",O
1+,O
bilaterally,O
Achilles,O
tendon,O
.,O

The,O
toes,O
were,O
downgoing,O
bilaterally,O
.,O

Gait,O
:,O

patient,O
had,O
difficulty,B-PR
with,I-PR
tandem,I-PR
gait,I-PR
and,O
fell,O
forward,O
while,O
standing,O
on,O
his,O
his,O
toes,O
.,O

Otherwise,O
",",O
the,O
gait,O
was,O
normal,O
.,O

LABORATORY,O
DATA,O
:,O

Laboratory,O
studies,O
on,O
admission,O
demonstrated,O
a,B-TE
sodium,I-TE
of,O
144,O
",",O
potassium,B-TE
4.1,O
",",O
chloride,B-TE
106,O
",",O
bicarbonate,B-TE
20.0,O
",",O
BUN,B-TE
and,O
creatinine,B-TE
12/0.7,O
",",O
glucose,B-TE
99,O
",",O
white,B-TE
blood,I-TE
count,I-TE
of,O
5.7,O
",",O
hematocrit,B-TE
of,O
40.6,O
",",O
platelet,B-TE
count,I-TE
of,O
226,O
",",O
prothrombin,B-TE
time,I-TE
was,O
9.4,O
",",O
partial,B-TE
thromboplastin,I-TE
time,I-TE
was,O
29,O
.,O

The,B-TE
computerized,I-TE
tomography,I-TE
scan,I-TE
was,O
performed,O
and,O
showed,O
a,B-PR
right,I-PR
occipital,I-PR
hemorrhage,I-PR
.,O

SUMMARY,O
:,O

The,O
patient,O
is,O
a,O
seventy-one,O
year,O
old,O
female,O
with,O
a,O
history,O
of,O
hypertension,B-PR
who,O
now,O
presents,O
with,O
a,B-PR
right,I-PR
occipital,I-PR
hemorrhagic,I-PR
stroke,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
hospital,O
for,O
further,B-TE
evaluation,I-TE
and,O
work,B-TE
up,I-TE
.,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
Intermediate,O
Care,O
Unit,O
in,O
the,O
Neurology,O
Intensive,O
Care,O
Unit,O
.,O

However,O
",",O
she,O
was,O
soon,O
moved,O
out,O
of,O
there,O
as,O
her,B-TE
examination,I-TE
appeared,O
to,O
be,O
stable,O
.,O

A,O
Neurosurgery,O
Service,O
consultation,O
was,O
obtained,O
and,O
they,O
felt,O
that,O
no,O
surgical,B-TR
intervention,I-TR
was,O
required,O
.,O

The,O
patient,O
underwent,O
a,O
number,O
of,O
tests,B-TE
.,O

She,O
had,O
a,B-TE
magnetic,I-TE
resonance,I-TE
imaging,I-TE
study,I-TE
and,O
magnetic,B-TE
resonance,I-TE
imaging,I-TE
angiogram,I-TE
performed,O
which,O
showed,O
a,B-PR
large,I-PR
hemorrhagic,I-PR
lesion,I-PR
on,I-PR
the,I-PR
occipital,I-PR
lobe,I-PR
.,O

There,O
was,O
no,O
clear,B-PR
enhancing,I-PR
mass,I-PR
",",O
but,O
follow,O
up,O
was,O
suggested,O
.,O

So,O
an,B-TE
magnetic,I-TE
resonance,I-TE
imaging,I-TE
angiogram,I-TE
was,O
obtained,O
and,O
showed,O
the,B-PR
right,I-PR
parietal,I-PR
occipital,I-PR
hemorrhage,I-PR
.,O

The,B-TE
MRA,I-TE
showed,O
mild,B-PR
narrowing,I-PR
of,I-PR
the,I-PR
left,I-PR
ICA,I-PR
just,O
distal,O
to,O
the,O
bifurcation,O
.,O

There,O
was,O
also,O
scattered,B-PR
T2,I-PR
hyperintense,I-PR
foci,I-PR
within,I-PR
the,I-PR
periventricular,I-PR
and,I-PR
left,I-PR
frontal,I-PR
white,I-PR
matter,I-PR
consistent,O
with,O
small,B-PR
vessel,I-PR
disease,I-PR
",",O
gliosis,B-PR
or,O
demyelination,B-PR
.,O

A,B-TE
Holter,I-TE
monitor,I-TE
was,O
obtained,O
and,O
showed,O
that,O
the,O
patient,O
was,O
in,O
normal,O
sinus,O
rhythm,O
.,O

The,B-TE
heart,I-TE
rate,I-TE
was,O
53,O
to,O
106,O
.,O

There,O
were,O
some,B-PR
very,I-PR
rare,I-PR
atrial,I-PR
premature,I-PR
contractions,I-PR
.,O

There,O
were,O
no,O
ventricular,B-PR
premature,I-PR
contractions,I-PR
.,O

An,B-TE
echocardiogram,I-TE
was,O
obtained,O
and,O
showed,O
that,O
the,B-TE
ejection,I-TE
fraction,I-TE
was,O
60%,O
and,O
there,O
was,O
no,O
thrombus,B-PR
.,O

It,O
was,O
felt,O
to,O
be,O
within,O
normal,O
limits,O
.,O

Over,O
the,O
ensuing,O
days,O
",",O
the,O
patient,O
had,O
several,O
episodes,O
of,O
confusion,B-PR
at,O
night,O
.,O

However,O
",",O
these,O
gradually,O
resolved,O
.,O

She,O
also,O
developed,O
what,O
appeared,O
to,O
be,O
urinary,B-PR
tract,I-PR
infection,I-PR
and,O
was,O
placed,O
on,O
PO,B-TR
Bactrim,I-TR
.,O

By,O
6-26-94,O
",",O
the,O
patient,O
was,O
felt,O
to,O
be,O
ready,O
for,O
discharge,O
.,O

At,O
that,O
time,O
",",O
she,O
was,O
afebrile,B-PR
and,O
her,B-TE
vital,I-TE
signs,I-TE
were,O
stable,O
.,O

She,O
was,O
tolerating,O
a,O
regular,O
diet,O
.,O

She,O
was,O
awake,O
",",O
alert,O
and,O
oriented,O
to,O
person,O
",",O
place,O
",",O
and,O
time,O
.,O

She,O
continued,O
to,O
have,O
a,B-PR
dense,I-PR
left,I-PR
hemianopsia,I-PR
",",O
but,O
otherwise,O
was,O
neurologically,O
intact,O
.,O

The,O
patient,O
was,O
discharged,O
home,O
with,O
Santea,O
Gehawhi,O
General,O
Hospital,O
care,O
and,O
instructed,O
to,O
follow,O
up,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

The,O
patient,O
was,O
discharged,O
on,O
Tenormin,B-TR
",",O
25,O
mg,O
PO,O
qd,O
;,O
Bactrim,B-TR
DS,I-TR
",",O
one,O
PO,O
bid,O
x5,O
days,O
.,O

TATAJO,O
SEE,O
",",O
M.D.,O

TR,O
:,O

ba,O
/,O
bmot,O

DD,O
:,O

8-4-94,O

TD,O
:,O

08/06/94,O

CC,O
:,O

134300717,O

FIH,O

9099750,O

22777/5p0t,O

355178,O

2/23/1993,O
12:00:00,O
AM,O

DEEP,B-PR
VENOUS,I-PR
THROMBOSIS,I-PR
OF,I-PR
RIGHT,I-PR
LOWER,I-PR
EXTREMITY,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

2-23-93,O

DISCHARGE,O
DATE,O
:,O

2-24-93,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Deep,B-PR
venous,I-PR
thrombosis,I-PR
of,I-PR
right,I-PR
lower,I-PR
extremity,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

Metastatic,B-PR
melanoma,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
the,O
second,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
admission,O
for,O
Taroby,O
Patient,O
",",O
a,O
70,O
year,O
old,O
male,O
with,O
a,O
history,O
of,O
metastatic,B-PR
melanoma,I-PR
.,O

His,B-PR
melanoma,I-PR
was,O
originally,O
diagnosed,O
last,O
fall,O
when,O
he,O
presented,O
with,O
lesions,B-PR
in,I-PR
the,I-PR
liver,I-PR
and,I-PR
spleen,I-PR
",",O
and,O
a,B-TE
chest,I-TE
CT,I-TE
showed,O
left,B-PR
upper,I-PR
lobe,I-PR
nodules,I-PR
.,O

A,B-TE
head,I-TE
CT,I-TE
scan,I-TE
was,O
negative,O
",",O
but,O
an,B-TE
MRI,I-TE
scan,I-TE
of,I-TE
the,I-TE
spine,I-TE
showed,O
an,O
L5,B-PR
metastasis,I-PR
with,O
a,B-PR
fracture,I-PR
and,O
had,O
with,O
epidural,B-PR
and,I-PR
paraspinal,I-PR
extension,I-PR
.,O

In,O
addition,O
",",O
there,O
was,O
a,B-PR
T11,I-PR
metastasis,I-PR
with,O
cord,B-PR
compression,I-PR
.,O

Approximately,O
one,O
week,O
ago,O
",",O
he,O
was,O
admitted,O
to,O
the,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
for,O
chemotherapy,B-TR
with,O
DTIC,B-TR
and,O
Tamoxifen,B-TR
.,O

At,O
that,O
time,O
",",O
he,O
also,O
began,O
radiation,B-TR
therapy,I-TR
to,O
his,O
lumbosacral,O
spine,O
.,O

He,O
is,O
continuing,O
on,O
the,B-TR
radiation,I-TR
therapy,I-TR
to,O
date,O
.,O

On,O
February,O
23,O
",",O
Mr.,O
Patient,O
presented,O
to,O
Dr.,O
Patient,O
&apos;s,O
office,O
with,O
two,B-PR
major,I-PR
symptoms,I-PR
.,O

First,O
",",O
he,O
had,O
right,B-PR
lower,I-PR
extremity,I-PR
swelling,I-PR
and,O
lower,B-TE
extremity,I-TE
noninvasives,I-TE
confirmed,O
the,O
diagnosis,O
of,O
a,B-PR
femoral,I-PR
deep,I-PR
venous,I-PR
thrombosis,I-PR
.,O

Second,O
",",O
he,O
had,O
a,B-PR
witnessed,I-PR
episode,I-PR
in,O
which,O
his,O
eyes,O
rolled,O
to,O
the,O
back,O
of,O
his,O
head,O
and,O
there,O
was,O
a,O
question,O
of,O
some,B-PR
seizure,I-PR
activity,I-PR
.,O

In,O
the,O
past,O
",",O
he,O
has,O
not,O
been,O
known,O
to,O
have,O
a,O
history,O
of,O
CNS,B-PR
metastases,I-PR
.,O

The,O
episode,O
of,O
potential,B-PR
seizure,I-PR
activity,I-PR
occurred,O
in,O
the,O
setting,O
of,O
a,O
bowel,O
movement,O
and,O
may,O
have,O
been,O
associated,O
with,O
vasovagal,B-PR
activity,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

The,O
past,O
medical,O
history,O
is,O
as,O
above,O
.,O

FAMILY,O
HISTORY,O
:,O

Noncontributory,O
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

The,B-TE
review,I-TE
of,I-TE
systems,I-TE
is,O
negative,O
",",O
except,O
as,O
above,O
.,O

ALLERGIES,O
:,O

The,O
patient,O
has,O
no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,B-TE
physical,I-TE
examination,I-TE
reveals,O
a,O
pleasant,O
70,O
year,O
old,O
male,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

The,B-TE
blood,I-TE
pressure,I-TE
was,O
113/70,O
",",O
pulse,B-TE
66,O
",",O
respirations,B-TE
20,O
",",O
and,O
a,B-TE
temperature,I-TE
of,O
96.8,O
.,O

HEENT,B-TE
showed,O
pupils,O
equal,O
",",O
round,O
",",O
reactive,O
to,O
light,O
and,O
accommodation,O
",",O
and,O
extra,O
ocular,O
movements,O
intact,O
.,O

The,O
sclerae,O
were,O
anicteric,O
.,O

The,O
neck,O
was,O
supple,O
",",O
without,O
jugular,B-PR
venous,I-PR
distention,I-PR
or,O
increased,B-PR
thyroid,I-PR
.,O

Nodes,O
:,O

There,O
was,O
no,O
appreciable,B-PR
cervical,I-PR
",",I-PR
supraclavicular,I-PR
",",I-PR
axillary,I-PR
",",I-PR
or,I-PR
inguinal,I-PR
adenopathy,I-PR
.,O

The,O
chest,O
was,O
clear,O
to,O
auscultation,B-TE
and,O
percussion,B-TE
.,O

Cardiac,O
:,O

regular,O
rate,O
and,O
rhythm,O
",",O
with,O
a,B-PR
I,I-PR
/,I-PR
VI,I-PR
systolic,I-PR
ejection,I-PR
murmur,I-PR
.,O

The,O
abdomen,O
showed,O
a,O
10,O
cm,O
liver,O
with,O
the,O
edge,O
palpable,O
2,O
fingerbreadths,O
below,O
the,O
right,O
costal,O
margin,O
.,O

The,B-TE
extremity,I-TE
exam,I-TE
was,O
notable,O
for,O
2+,B-PR
pitting,I-PR
edema,I-PR
in,I-PR
the,I-PR
right,I-PR
lower,I-PR
extremity,I-PR
extending,O
to,O
the,O
knee,O
.,O

The,B-TE
neurological,I-TE
examination,I-TE
was,O
nonfocal,O
.,O

HOSPITAL,O
COURSE,O
:,O

Mr.,O
Patient,O
underwent,O
venogram,B-TE
and,O
inferior,B-TR
vena,I-TR
cava,I-TR
filter,I-TR
placement,I-TR
on,O
February,O
23,O
",",O
1993,O
and,O
was,O
then,O
he,O
was,O
admitted,O
to,O
the,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
for,O
postoperative,B-TR
care,I-TR
.,O

He,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
.,O

In,O
addition,O
",",O
the,O
second,O
major,O
event,O
that,O
had,O
occurred,O
yesterday,O
was,O
a,B-PR
neurologic,I-PR
event,I-PR
of,O
some,O
kind,O
.,O

Over,O
the,O
24,O
hours,O
of,O
in,O
house,O
hospitalization,O
",",O
he,O
did,O
not,O
have,O
any,B-PR
further,I-PR
neurologic,I-PR
activity,I-PR
and,O
was,O
able,O
to,O
ambulate,O
without,O
assistance,O
prior,O
to,O
discharge,O
.,O

He,O
will,O
be,O
scheduled,O
for,O
an,B-TE
MRI,I-TE
scan,I-TE
",",O
Neurology,B-TE
consult,I-TE
",",O
and,O
an,B-TE
EEG,I-TE
next,O
week,O
as,O
an,O
out,O
patient,O
.,O

Mr.,O
Patient,O
was,O
a,O
poor,O
candidate,O
for,O
anticoagulation,B-TR
because,O
of,O
his,O
history,O
of,O
metastatic,B-PR
melanoma,I-PR
and,O
the,O
question,O
of,O
CNS,B-PR
metastases,I-PR
.,O

An,B-TR
IVC,I-TR
filter,I-TR
placement,I-TR
was,O
accomplished,O
without,O
complication,B-PR
.,O

He,O
is,O
stable,O
on,O
February,O
24,O
and,O
ready,O
for,O
discharge,O
to,O
home,O
.,O

PROCEDURES,O
:,O

IVC,B-TR
filter,I-TR
placement,I-TR
.,O

COMPLICATIONS,O
:,O

None,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Decadron,B-TR
4,O
mg,O
PO,O
bid,O
",",O
Dilantin,B-TR
100,O
mg,O
PO,O
tid,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
.,O

DISPOSITION,O
:,O

Mr.,O
Patient,O
will,O
be,O
discharged,O
to,O
home,O
.,O

He,O
will,O
have,O
follow,O
up,O
arranged,O
with,O
Dr.,O
Guabenfranda,O
Patient,O
.,O

ESTIMATED,O
DISABILITY,O
AND,O
PROBABLE,O
DURATION,O
:,O

Permanent,O
.,O

CA,O
SHUFF,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

GUABENFRANDA,O
PATIENT,O
",",O
M.D.,O

TR,O
:,O

it,O
/,O
bmot,O

DD,O
:,O

2-24-93,O

TD,O
:,O

02/26/93,O

CC,O
:,O

143748600,O
SC,O

43243309,O

95342,O

09/30/2000,O
12:00:00,O
AM,O

atypical,B-PR
chest,I-PR
pain,I-PR

DIS,O

Admission,O
Date,O
:,O

09/30/2000,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

10/01/2000,O

******,O
DISCHARGE,O
ORDERS,O
******,O

FALC,O
",",O
COLL,O
891-57-52-0,O
T37,O

Room,O
:,O

53X-785,O

Service,O
:,O

CAR,O

DISCHARGE,O
PATIENT,O
ON,O
:,O

10/01/00,O
AT,O
03:30,O
PM,O

CONTINGENT,O
UPON,O

ETT,O

WILL,O
D,O
/,O
C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D,O
/,O
C,O
SUMMARY,O
:,O

YES,O

Attending,O
:,O

KOTEZUSTLEEB,O
",",O
LIJO,O
LIFLE,O
",",O
M.D.,O

CODE,O
STATUS,O
:,O

Full,O
code,O

DISPOSITION,O
:,O

Home,O

DISCHARGE,O
MEDICATIONS,O
:,O

ALBUTEROL,B-TR
INHALER,I-TR
2,O
PUFF,O
INH,O
QID,O

Instructions,O
:,O

PLEASE,O
USE,O
WITH,O
SPACER,B-TR
(,O
PLEASE,O
INSTRUCT,O
PATIENT,O
),O
ECASA,B-TR
(,I-TR
ASPIRIN,I-TR
ENTERIC,I-TR
COATED,I-TR
),I-TR
325,O
MG,O
PO,O
QD,O
WELLBUTRIN,B-TR
(,I-TR
BUPROPION,I-TR
HCL,I-TR
),I-TR
150,O
MG,O
PO,O
BID,O
GEMFIBROZIL,B-TR
600,O
MG,O
PO,O
BID,O
ZESTRIL,B-TR
(,I-TR
LISINOPRIL,I-TR
),I-TR
20,O
MG,O
PO,O
QD,O
ZANTAC,B-TR
(,I-TR
RANITIDINE,I-TR
HCL,I-TR
),I-TR
150,O
MG,O
PO,O
BID,O
SERZONE,B-TR
(,I-TR
NEFAZODONE,I-TR
),I-TR
300,O
MG,O
PO,O
QHS,O
ZYPREXA,B-TR
(,I-TR
OLANZAPINE,I-TR
),I-TR
5,O
MG,O
PO,O
QHS,O

Number,O
of,O
Doses,O
Required,O
(,O
approximate,O
),O
:,O

4,O

GLUCOPHAGE,B-TR
(,I-TR
METFORMIN,I-TR
),I-TR
850,O
MG,O
PO,O
TID,O
Starting,O
ON,O
10/03/00,O
(,O
10/03,O
),O
ACTOS,B-TR
30,O
MG,O
PO,O
QD,O

DIET,O
:,O

House,O
/,O
ADA,O
2100,O
cals,O
/,O
dy,O

RETURN,O
TO,O
WORK,O
:,O

Immediately,O

FOLLOW,O
UP,O
APPOINTMENT,O
(,O
S,O
),O
:,O

Dr.,O
Rotrysbreunkorc,O
1-2,O
weeks,O
",",O

ALLERGY,O
:,O

Penicillins,B-TR

ADMIT,O
DIAGNOSIS,O
:,O

atypical,B-PR
cp,I-PR

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O
Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O
atypical,B-PR
chest,I-PR
pain,I-PR

OTHER,O
DIAGNOSIS,O
;,O
Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O
dm,B-PR
(,I-PR
diabetes,I-PR
mellitus,I-PR
),I-PR
anxiety,B-PR
(,I-PR
anxiety,I-PR
),I-PR
htn,B-PR
(,I-PR
hypertension,I-PR
),I-PR
gerd,B-PR
(,I-PR
esophageal,I-PR
reflux,I-PR
),I-PR

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O

BRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

41,O
yo,O
man,O
with,O
CRFs,B-PR
of,O
DM,B-PR
Type,I-PR
II,I-PR
",",O
high,B-PR
cholesterol,I-PR
",",O
smoking,O
history,O
",",O
family,O
hx,O
",",O
HTN,B-PR
p,O
/,O
w,O
episodes,B-PR
of,I-PR
atypical,I-PR
CP,I-PR
x,I-PR
1,I-PR
week,I-PR
",",O
with,O
rest,O
and,O
exertion,O
.,O

also,O
has,O
h,O
/,O
o,O
anxiety,B-PR
and,O
GERD,B-PR
.,O

No,O
assoicated,B-PR
Sx,I-PR
.,O

Here,O
",",O
had,O
T,B-PR
wave,I-PR
flattening,I-PR
laterally,I-PR
and,I-PR
inferiorly,I-PR
with,O
pain,B-PR
that,O
resolved,O
pain,B-PR
free,O
",",O
but,O
not,O
clear,O
that,O
lead,B-TE
placement,I-TE
is,O
the,O
same,O
.,O

Had,O
Chest,B-TE
CT,I-TE
to,O
r,O
/,O
o,O
dissection,B-PR
(,O
due,O
to,O
back,B-PR
pain,I-PR
),O
which,O
was,O
neg.,O

Ruled,O
out,O
for,O
MI,B-PR
.,O

Will,O
plan,O
on,O
ETT,B-TE
.,O

Holding,O
Metformin,B-TR
until,O
Friday,O
due,O
to,O
CT,B-TE
with,I-TE
contrast,I-TE
.,O

ADDITIONAL,O
COMMENTS,O
:,O

smoking,O
cessation,O
group,O
will,O
contact,O
you,O
at,O
home,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O

TO,O
DO,O
/,O
PLAN,O
:,O

you,O
will,O
be,O
contacted,O
at,O
home,O
by,O
the,O
smoking,O
cessation,O
program,O

No,O
dictated,O
summary,O

ENTERED,O
BY,O
:,O

WIERST,O
",",O
STO,O
L.,O
",",O
M.D.,O
(,O
RR86,O
),O
10/01/00,O
02:33,O
PM,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

145980160,O

FIH,O

6382196,O

94916/ly7e,O

289653,O

06/30/1993,O
12:00:00,O
AM,O

PROSTATE,B-PR
CANCER,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

06-30-93,O

DISCHARGE,O
DATE,O
:,O

07-06-93,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Prostate,B-PR
cancer,I-PR
.,O

SPECIAL,O
PROCEDURES,O
AND,O
OPERATIONS,O
:,O

Radical,B-TR
retropubic,I-TR
prostatectomy,I-TR
",",O
bilateral,B-TR
lymph,I-TR
node,I-TR
dissection,I-TR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
67,O
year,O
old,O
white,O
male,O
with,O
a,O
recent,O
history,O
of,O
urinary,B-PR
frequency,I-PR
Q2-3H,O
",",O
stranguria,B-PR
",",O
nocturia,B-PR
x,O
3-4,O
per,O
night,O
.,O

He,O
was,O
found,O
on,O
physical,B-TE
exam,I-TE
to,O
have,O
an,B-PR
asymmetric,I-PR
prostate,I-PR
with,O
prominence,B-PR
on,I-PR
the,I-PR
left,I-PR
and,O
a,O
question,O
of,O
a,B-PR
nodule,I-PR
.,O

Repeat,B-TE
exam,I-TE
one,O
month,O
later,O
showed,O
a,B-PR
firm,I-PR
left-sided,I-PR
lobe,I-PR
.,O

Transrectal,B-TE
ultrasound,I-TE
showed,O
a,B-PR
hypoechoic,I-PR
left-sided,I-PR
mass,I-PR
in,I-PR
the,I-PR
peripheral,I-PR
zone,I-PR
.,O

A,B-TE
biopsy,I-TE
showed,O
moderately,B-PR
to,I-PR
poorly,I-PR
differentiated,I-PR
Grade,I-PR
III-IV,I-PR
adenocarcinoma,I-PR
on,I-PR
the,I-PR
left,I-PR
.,O

The,O
right,O
lobe,O
was,O
within,O
normal,O
limits,O
.,O

This,O
was,O
done,O
on,O
05/05/93,O
at,O
FIH,O
.,O

He,O
also,O
had,O
a,O
3-4,O
year,O
history,O
of,O
impotence,B-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Significant,O
for,O
non-insulin,B-PR
diabetes,I-PR
mellitus,I-PR
",",O
for,O
which,O
he,O
takes,O
Diabeta,B-TR
",",O
one,O
QD,O
;,O
right,B-PR
eye,I-PR
cataract,I-PR
",",O
operated,O
on,O
three,O
years,O
ago,O
.,O

ALLERGIES,O
:,O

He,O
is,O
allergic,B-PR
to,O
Motrin,B-TR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Diabeta,B-TR
",",O
one,O
QD,O
.,O

SOCIAL,O
HISTORY,O
:,O

No,O
smoking,O
history,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

He,O
was,O
a,O
well,O
developed,O
",",O
well,O
nourished,O
white,O
male,O
.,O

HEENT,O
:,O

within,O
normal,O
limits,O
.,O

His,O
neck,O
was,O
supple,O
with,O
no,O
jugular,B-PR
venous,I-PR
distention,I-PR
or,O
thyromegaly,B-PR
.,O

Chest,O
was,O
clear,O
to,O
percussion,B-TE
and,O
auscultation,B-TE
.,O

Heart,O
:,O

regular,O
rate,O
and,O
rhythm,O
with,O
normal,O
S1,O
and,O
S2,O
",",O
no,O
murmurs,B-PR
.,I-PR

The,O
abdomen,O
was,O
soft,O
and,O
non-tender,B-PR
with,O
no,O
masses,B-PR
or,O
organomegaly,B-PR
.,O

No,O
costovertebral,B-PR
angle,I-PR
tenderness,I-PR
.,O

His,B-TE
genitourinary,I-TE
exam,I-TE
showed,O
an,O
uncircumcised,O
male,O
with,O
normal,O
scrotal,O
contents,O
.,O

Rectal,O
:,O

There,O
was,O
a,B-PR
firm,I-PR
nodule,I-PR
in,O
the,O
left,O
lobe,O
of,O
the,O
prostate,O
in,O
the,O
lateral,O
aspect,O
.,O

Extremities,O
:,O

No,O
clubbing,B-PR
",",I-PR
cyanosis,B-PR
or,O
edema,B-PR
.,O

Pulses,B-TE
2+,O
.,O

Neurological,O
:,O

Nonfocal,O
.,O

LABORATORY,O
DATA,O
:,O

Sodium,B-TE
141,O
",",O
potassium,B-TE
4.1,O
",",O
chloride,B-TE
104,O
",",O
bicarbonate,B-TE
28.8,O
",",O
BUN,B-TE
17,O
",",O
creatinine,B-TE
0.9,O
",",O
glucose,B-TE
118,O
.,O

His,B-TE
white,I-TE
blood,I-TE
count,I-TE
was,O
7100,O
",",O
hematocrit,B-TE
35.9,O
",",O
platelet,B-TE
count,I-TE
"258,000",O
.,O

PT,B-TE
9.4/10.3,O
",",O
PTT,B-TE
27,O
.,O

His,B-TE
urinalysis,I-TE
showed,O
marked,B-PR
occult,I-PR
blood,I-PR
and,O
positive,B-PR
white,I-PR
blood,I-PR
cell,I-PR
screen,I-PR
but,O
was,O
otherwise,O
negative,O
.,O

His,B-TE
chest,I-TE
X-ray,I-TE
was,O
normal,O
.,O

EKG,B-TE
:,O

normal,O
sinus,O
rhythm,O
at,O
73,O
beats,O
per,O
minute,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
brought,O
to,O
the,O
operating,O
room,O
on,O
06/30/93,O
after,O
informed,O
consent,O
was,O
obtained,O
.,O

A,B-TR
radical,I-TR
retropubic,I-TR
prostatectomy,I-TR
with,O
bilateral,B-TR
lymph,I-TR
node,I-TR
dissection,I-TR
was,O
done,O
.,O

He,O
was,O
afebrile,B-PR
postoperatively,O
with,O
vital,B-TE
signs,I-TE
stable,O
.,O

His,B-TE
potassium,I-TE
was,O
3.7,O
and,O
his,B-TE
hematocrit,I-TE
33,O
.,O

His,O
postoperative,O
course,O
was,O
remarkable,O
for,O
a,B-PR
low,I-PR
grade,I-PR
temperature,I-PR
to,O
101.7,O
.,O

His,B-TE
blood,I-TE
cultures,I-TE
and,O
chest,B-TE
X-ray,I-TE
were,O
negative,O
.,O

He,O
had,O
flatus,O
on,O
postoperative,O
day,O
#,O
3,O
.,O

His,B-TR
Jackson-Pratt,I-TR
drained,O
about,O
35-40,O
cc,O
per,O
day,O
and,O
was,O
discontinued,O
on,O
postoperative,O
day,O
#,O
3,O
.,O

His,B-TE
hematocrit,I-TE
on,O
07/03,O
was,O
28.1,O
.,O

On,O
that,O
day,O
he,O
was,O
slightly,B-PR
diaphoretic,I-PR
with,O
some,B-PR
tachycardia,I-PR
to,O
100,O
.,O

The,O
remaining,O
unit,O
of,O
autologous,B-TR
packed,I-TR
red,I-TR
blood,I-TR
cells,I-TR
was,O
transfused,O
.,O

A,B-TE
cardiology,I-TE
consult,I-TE
was,O
obtained,O
for,O
this,O
episode,O
of,O
diaphoresis,B-PR
with,O
tachycardia,B-PR
",",O
as,O
well,O
as,O
for,O
an,B-TE
EKG,I-TE
being,O
read,O
as,O
having,O
anterolateral,B-PR
changes,I-PR
.,O

He,O
had,O
no,O
symptoms,B-PR
of,O
chest,B-PR
pain,I-PR
or,O
myocardial,B-PR
ischemia,I-PR
.,O

A,B-TE
repeat,I-TE
EKG,I-TE
showed,O
no,O
changes,B-PR
.,O

He,O
subsequently,O
did,O
well,O
",",O
with,O
a,B-TE
repeat,I-TE
hematocrit,I-TE
of,O
34.3,O
after,O
the,B-TE
transfusion,I-TE
.,O

His,B-TE
creatinine,I-TE
was,O
1.2,O
on,O
postoperative,O
day,O
#,O
5,O
.,O

On,O
postoperative,O
day,O
#,O
6,O
his,B-PR
low,I-PR
grade,I-PR
temperature,I-PR
resolved,O
.,O

His,B-TE
vital,I-TE
signs,I-TE
were,O
stable,O
.,O

He,O
was,O
discharged,O
home,O
on,O
Percocet,B-TR
and,O
Keflex,B-TR
.,O

He,O
was,O
discharged,O
in,O
good,O
condition,O
.,O

He,O
will,O
follow,O
up,O
with,O
Dr.,O
Iechalette,O
Cancer,O
in,O
his,O
office,O
.,O

SIE,O
ROOM,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

IECHALETTE,O
ROOM,O
",",O
M.D.,O

TR,O
:,O

btt,O
/,O
bmot,O

DD,O
:,O

07-07-93,O

TD,O
:,O

07/08/93,O

CC,O
:,O

Dr.,O
Na,O
Dussmum,O

156406283,O

HLGMC,O

7213645,O

64723/51cy,O

5/28/1993,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

5-28-93,O

DISCHARGE,O
DATE,O
:,O

6-4-93,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
58,O
year,O
old,O
right,O
hand,O
dominant,O
white,O
male,O
with,O
a,O
long,O
history,O
of,O
hypertension,B-PR
",",O
changed,O
his,B-TR
medications,I-TR
from,O
Aldomet,B-TR
to,O
Clonidine,B-TR
six,O
weeks,O
ago,O
.,O

The,O
patient,O
has,O
a,O
history,O
of,O
adult,B-PR
onset,I-PR
diabetes,I-PR
mellitus,I-PR
",",O
ankylosing,B-PR
spondylitis,I-PR
",",O
status,O
post,O
myocardial,B-PR
infarction,I-PR
in,O
&apos;96,O
(,O
?,O
),O
now,O
with,O
acute,O
onset,O
of,O
left,B-PR
face,I-PR
and,I-PR
arm,I-PR
greater,I-PR
than,I-PR
leg,I-PR
hemiplegia,I-PR
and,O
primary,B-PR
hemisensory,I-PR
loss,I-PR
on,I-PR
the,I-PR
left,I-PR
.,O

Briefly,O
",",O
he,O
was,O
talking,O
to,O
a,O
friend,O
at,O
5:30,O
p.m.,O
the,O
day,O
prior,O
to,O
admission,O
",",O
when,O
he,O
had,O
to,O
grab,O
his,O
locker,O
and,O
sit,O
down,O
.,O

His,O
voice,O
became,O
slurred,B-PR
and,O
he,O
had,O
a,B-PR
mild,I-PR
central,I-PR
dull,I-PR
headache,I-PR
.,O

He,O
was,O
unable,O
to,O
move,O
the,O
left,O
side,O
of,O
his,O
body,O
and,O
felt,O
numb,B-PR
on,I-PR
that,I-PR
side,I-PR
.,O

He,O
was,O
taken,O
to,O
Wayskemedcalltown,O
Talmi,O
and,O
transferred,O
to,O
Heaonboburg,O
Linpack,O
Grant,O
Medical,O
Center,O
with,O
a,B-TE
computerized,I-TE
tomography,I-TE
scan,I-TE
showing,O
a,B-PR
1x2,I-PR
thalamic,I-PR
capsular,I-PR
hemorrhage,I-PR
without,O
superficial,B-PR
mass,I-PR
effect,I-PR
.,O

His,B-TE
blood,I-TE
pressure,I-TE
was,O
220/110,O
there,O
.,O

He,O
denies,O
any,O
visual,B-PR
symptoms,I-PR
or,O
cortical-type,B-PR
symptoms,I-PR
.,O

He,O
is,O
a,O
heavy,O
smoker,O
and,O
drinks,O
2-3,O
shots,O
per,O
day,O
at,O
times,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Vasotec,B-TR
40,O
mg,O
q.day,O
",",O
Soma,B-TR
1,O
tablet,O
q.day,O
",",O
Demerolprn,B-TR
",",O
Clonidine,B-TR
.,O

ALLERGIES,O
:,O

The,O
patient,O
has,O
no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

As,O
described,O
above,O
.,O

FAMILY,O
HISTORY,O
:,O

The,O
family,O
history,O
is,O
positive,O
for,O
diabetes,B-PR
mellitus,I-PR
",",O
positive,O
for,O
cancer,B-PR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
lives,O
with,O
two,O
people,O
in,O
Cinglendda,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,B-TE
physical,I-TE
examination,I-TE
",",O
patient,O
is,O
in,O
no,O
acute,B-PR
distress,I-PR
",",O
afebrile,B-PR
",",O
blood,B-TE
pressure,I-TE
134/80,O
",",O
heart,B-TE
rate,I-TE
80,O
and,O
regular,O
",",O
no,O
bruits,B-PR
.,O

Cardiovascular,B-TE
exam,I-TE
:,O

regular,O
rate,O
and,O
rhythm,O
with,O
a,B-PR
I/VI,I-PR
systolic,I-PR
ejection,I-PR
murmur,I-PR
.,O

His,O
lungs,O
were,O
clear,O
to,O
auscultation,B-TE
and,O
percussion,B-TE
.,O

The,O
abdomen,O
was,O
soft,O
and,O
non-tender,B-PR
",",O
obese,B-PR
",",O
with,O
normal,O
bowel,O
sounds,O
.,O

Back,O
and,O
neck,O
were,O
stiff,B-PR
and,O
sore,B-PR
",",O
without,O
localizing,B-PR
tenderness,I-PR
.,O

On,O
neurological,B-TE
examination,I-TE
",",O
mental,O
status,O
alert,O
and,O
oriented,O
x,O
three,O
",",O
good,O
memory,O
",",O
fluent,O
speech,O
",",O
good,O
repetition,O
and,O
naming,O
.,O

Able,O
to,O
describe,O
two,O
routes,O
from,O
house,O
to,O
the,O
CMH,O
.,O

The,O
cranial,O
nerves,O
showed,O
full,O
visual,O
fields,O
without,O
extinction,B-PR
",",O
pupils,O
5,O
to,O
3,O
bilaterally,O
and,O
equal,O
",",O
disks,O
flat,O
",",O
lower,B-PR
left,I-PR
facial,I-PR
decreased,I-PR
sensation,I-PR
to,I-PR
temperature,I-PR
",",O
pin,B-TE
prick,I-TE
on,O
the,O
left,O
V1,O
through,O
V3,O
",",O
tongue,O
deviates,O
to,O
the,O
left,O
",",O
good,O
gag,O
",",O
decreased,B-PR
shrug,I-PR
on,I-PR
the,I-PR
left,I-PR
.,O

Motor,B-TE
examination,I-TE
showed,O
full,O
power,O
on,O
the,O
right,O
arm,O
and,O
leg,O
",",O
could,O
barely,O
flex,O
fingers,O
of,O
the,O
left,O
hand,O
",",O
pulls,O
left,O
arm,O
medially,O
only,O
.,O

Left,O
leg,O
could,O
flex,O
2/5,O
and,O
wiggle,O
toes,O
.,O

On,O
sensory,B-TE
examination,I-TE
",",O
had,O
decreased,O
pin,O
prick,O
",",O
temperature,O
",",O
vibration,O
in,O
the,O
left,O
side,O
of,O
the,O
body,O
.,O

The,B-TE
finger-to-nose,I-TE
was,O
okay,O
on,O
the,O
right,O
.,O

On,O
reflex,B-TE
examination,I-TE
",",O
2,O
on,O
the,O
right,O
upper,O
extremity,O
",",O
2+,O
on,O
the,O
left,O
upper,O
extremity,O
",",O
2,O
on,O
the,O
right,O
knee,O
",",O
0,O
on,O
the,O
right,O
ankle,O
",",O
with,O
down,O
going,O
toe,O
on,O
the,O
right,O
.,O

Three,O
on,O
the,O
left,O
knee,O
",",O
4,O
on,O
the,O
left,O
ankle,O
with,O
upgoing,O
toe,O
and,O
clonus,B-PR
on,O
the,O
left,O
.,O

LABORATORY,O
DATA,O
:,O

Electrolytes,B-TE
were,O
within,O
normal,O
limits,O
",",O
glucose,B-TE
192,O
",",O
BUN,B-TE
and,O
creatinine,B-TE
9/0.7,O
",",O
hematocrit,B-TE
49.5,O
",",O
white,B-TE
blood,I-TE
count,I-TE
7.9,O
",",O
platelet,B-TE
count,I-TE
"166,000",O
",",O
65%,O
polys,B-TE
",",O
3,O
bands,B-TE
",",O
24%,O
lymphs,B-TE
.,O

The,B-TE
electrocardiogram,I-TE
showed,O
normal,O
sinus,O
rhythm,O
with,O
old,B-PR
Q,I-PR
wave,I-PR
inferior,I-PR
myocardial,I-PR
infarction,I-PR
.,O

Head,B-TE
computerized,I-TE
tomography,I-TE
scan,I-TE
showed,O
1.5,B-PR
to,I-PR
2,I-PR
centimeter,I-PR
bleed,I-PR
in,I-PR
the,I-PR
right,I-PR
thalamus,I-PR
extending,O
to,O
the,O
internal,O
capsule,O
with,O
mild,B-PR
distortion,I-PR
only,O
",",O
no,O
shift,B-PR
.,O

The,B-TE
chest,I-TE
X-ray,I-TE
was,O
clear,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
floor,O
for,O
observation,O
.,O

The,B-TE
neurological,I-TE
examination,I-TE
on,O
discharge,O
was,O
no,O
movement,B-PR
in,I-PR
the,I-PR
hand,I-PR
on,O
the,O
left,O
or,O
arm,O
.,O

Slight,O
abductive,O
and,O
adductive,O
movement,O
on,O
the,O
left,O
only,O
in,O
the,O
upper,O
extremity,O
.,O

On,O
the,O
lower,O
extremity,O
",",O
could,O
wiggle,B-TE
toes,I-TE
",",O
flexor,B-TE
and,O
plantar,B-TE
",",O
3+/5,O
",",O
quadriceps,O
4/5,O
on,O
the,O
left,O
.,O

2.,O
hypertension,B-PR
.,O

The,O
patient,O
was,O
managed,O
with,O
Vasotec,B-TR
",",O
Nifedipine,B-TR
and,O
Clonidine,B-TR
with,O
blood,B-TE
pressure,I-TE
under,O
good,O
control,O
at,O
the,O
time,O
of,O
discharge,O
",",O
average,O
125,O
systolic,B-TE
",",O
70,O
diastolic,B-TE
",",O
heart,B-TE
rate,I-TE
of,O
72,O
.,O

Also,O
managed,O
with,O
Valium,B-TR
5,O
mg,O
PO,O
t.i.d.,O

Muscle,B-PR
spasms,I-PR
were,O
managed,O
with,O
Flexeril,B-TR
10,O
PO,O
t.i.d.,O

3.,O
diabetes,B-PR
mellitus,I-PR
.,O

The,O
patient,O
was,O
started,O
on,O
2.5,O
of,O
Micronase,B-TR
with,O
resulting,B-TE
sugars,I-TE
as,O
low,O
as,O
63,O
",",O
decreased,O
to,O
1.25,O
mg,O
q.day,O
.,O

The,O
patient,O
is,O
discharged,O
in,O
fair,O
condition,O
with,O
medical,O
approval,O
to,O
the,O
Pasi,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Vasotec,B-TR
20,O
mg,O
PO,O
b.i.d.,O
",",O
Clonidine,B-TR
0.2,O
mg,O
PO,O
b.i.d.,O
",",O
Nifedipine,B-TR
20,O
mg,O
PO,O
t.i.d.,O
",",O
Flexeril,B-TR
10,O
mg,O
PO,O
t.i.d.,O
",",O
Valium,B-TR
5,O
mg,O
PO,O
t.i.d.,O
",",O
Micronase,B-TR
1.25,O
mg,O
q.day,O
.,O

ADVERSE,O
DRUG,O
REACTIONS,O
:,O

The,O
patient,O
was,O
found,O
to,O
be,O
allergic,B-PR
to,O
Percocet,B-TR
and,O
Percodan,B-TR
during,O
his,O
hospital,O
course,O
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

Right,B-PR
thalamic,I-PR
hemorrhage,I-PR
",",O
hypertension,B-PR
",",O
diabetes,B-PR
mellitus,I-PR
.,O

ROBTHER,O
TIMES,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

SHAA,O
LEFT,O
",",O
M.D.,O

TR,O
:,O

nj,O
/,O
bmot,O

DD,O
:,O

6-4-93,O

TD,O
:,O

06/04/93,O

CC,O
:,O

Dr.,O
Namarce,O
Aldridge,O
Pasi,O
STAT,O

176318078_a,O

FIH,O

4189699,O

28872/d70h,O

94756,O

11/03/1993,O
12:00:00,O
AM,O

MITRAL,B-PR
STENOSIS,I-PR

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

11-03-93,O

DISCHARGE,O
DATE,O
:,O

11-06-93,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Mitral,B-PR
stenosis,I-PR

ASSOCIATED,O
DIAGNOSIS,O
:,O

Tricuspid,B-PR
regurgitation,I-PR
",",O
heart,B-PR
failure,I-PR
",",O
chronic,B-PR
atrial,I-PR
fibrillation,I-PR
",",O
chronic,B-PR
ventricular,I-PR
ectopy,I-PR
",",O
chronic,B-PR
obstructive,I-PR
lung,I-PR
disease,I-PR
.,O

ADVERSE,O
DRUG,O
REACTIONS,O
:,O

Epistaxis,B-PR
to,O
Coumadin,B-TR
in,O
the,O
past,O
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

Cardiac,B-TE
catheterization,I-TE
11/03,O
.,O

OTHER,O
PROCEDURE,O
:,O

Pulmonary,B-TE
function,I-TE
test,I-TE
11/04,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
68-year-old,O
patient,O
of,O
Dr.,O
Naka,O
Jesc,O
had,O
two,O
episodes,O
of,O
rheumatic,B-PR
fever,I-PR
as,O
a,O
teenager,O
.,O

She,O
has,O
had,O
chronic,B-PR
atrial,I-PR
fibrillation,I-PR
.,O

Coumadin,B-TR
has,O
caused,O
bleeding,B-PR
from,I-PR
the,I-PR
mouth,I-PR
and,I-PR
nose,I-PR
on,O
two,O
occasions,O
",",O
on,O
one,O
occasion,O
with,O
prothrombin,B-TE
time,I-TE
13,O
",",O
and,O
has,O
been,O
replaced,O
by,O
anti-platelet,B-TR
agents,I-TR
.,O

She,O
has,O
had,O
recurrent,B-PR
syncope,I-PR
since,O
age,O
6,O
.,O

She,O
has,O
now,O
had,O
progressive,B-PR
heart,I-PR
failure,I-PR
.,O

A,B-TE
Holter,I-TE
showed,O
atrial,B-PR
fibrillation,I-PR
with,O
period,O
of,O
ventricular,B-PR
bigemini,I-PR
.,O

She,O
cut,O
down,O
dramatically,O
on,O
smoking,O
two,O
years,O
ago,O
",",O
but,O
has,O
continued,O
to,O
smoke,O
",",O
although,O
",",O
very,O
recently,O
",",O
she,O
admits,O
to,O
only,O
&quot;,O
two,O
puffs,O
&quot;,O
per,O
day,O
.,O

She,O
has,O
not,O
had,O
hypertension,B-PR
or,O
diabetes,B-PR
",",O
and,O
says,O
he,O
has,O
lowered,O
her,B-TE
cholesterol,I-TE
from,O
333,O
to,O
197,O
by,O
changing,O
her,O
diet,O
.,O

There,O
is,O
no,O
family,O
history,O
of,O
heart,B-PR
disease,I-PR
.,O

She,O
has,O
been,O
treated,O
with,O
Vanceril,B-TR
for,O
chronic,B-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
.,O

She,O
has,O
had,O
one,O
gram,O
per,O
day,O
proteinuria,B-TR
with,O
normal,O
creatinine,O
.,O

She,O
had,O
a,B-TR
partial,I-TR
gastrectomy,I-TR
in,O
1972,O
for,O
a,B-PR
&quot;,I-PR
tumor,I-PR
&quot;,I-PR
.,O

She,O
has,O
had,O
an,B-TR
appendectomy,I-TR
and,O
cholecystectomy,B-TR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Digoxin,B-TR
0.125,O
mg,O
po,O
q.d.,O
",",O
Lasix,B-TR
40,O
mg,O
b.i.d.,O
",",O
aspirin,B-TR
held,O
",",O
and,O
Vanceril,B-TR
three,O
puffs,O
b.i.d.,O

ALLERGIES,O
:,O

Transdermal,B-TR
nitroglycerin,I-TR
caused,O
headache,B-PR
.,O

SOCIAL,O
HISTORY,O
:,O

She,O
does,O
not,O
drink,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Heart,B-TE
rate,I-TE
86,O
",",O
irregularly,O
irregular,O
",",O
blood,B-TE
pressure,I-TE
142/86,O
.,O

Neck,B-PR
veins,I-PR
distended,I-PR
.,O

Carotids,O
normal,O
.,O

Chest,O
clear,O
.,O

Apical,B-TE
impulse,I-TE
not,O
palpable,O
.,O

Right,B-PR
ventricular,I-PR
heave,I-PR
.,O

S1,O
normal,O
.,O

S2,O
narrowly,B-PR
physiologically,I-PR
split,I-PR
with,O
accentuation,B-PR
of,O
P2,O
.,O

No,O
S3,B-PR
or,O
opening,B-PR
snap,I-PR
.,O

Grade,B-PR
II,I-PR
systolic,I-PR
murmur,I-PR
at,I-PR
the,I-PR
left,I-PR
lower,I-PR
sternal,I-PR
border,I-PR
.,O

Grade,B-PR
II,I-PR
decrescendo,I-PR
diastolic,I-PR
murmur,I-PR
at,I-PR
the,I-PR
left,I-PR
lower,I-PR
sternal,I-PR
border,I-PR
.,O

Diastolic,B-PR
rumble,I-PR
at,I-PR
the,I-PR
apex,I-PR
.,O

Liver,B-PR
slightly,I-PR
pulsatile,I-PR
but,O
no,O
enlarged,B-PR
.,O

Pulses,B-TE
normal,O
to,O
the,O
femorals,O
with,O
weak,B-PR
dorsalis,I-PR
pedis,I-PR
pulses,I-PR
.,O

Superficial,B-PR
varicose,I-PR
veins,I-PR
.,O

No,O
edema,B-PR
.,O

LABORATORY,O
DATA,O
:,O

Hematocrit,B-TE
44,O
",",O
potassium,B-TE
4.0,O
",",O
BUN,B-TE
23,O
",",O
creatinine,B-TE
1.2,O
",",O
blood,B-TE
sugar,I-TE
115,O
",",O
Digoxin,B-TE
1.4,O
.,O

Electrocardiogram,B-TE
showed,O
atrial,B-PR
fibrillation,I-PR
",",O
moderate,B-PR
ventricular,I-PR
response,I-PR
",",O
incomplete,B-PR
right,I-PR
bundle,I-PR
branch,I-PR
block,I-PR
",",O
right,B-PR
axis,I-PR
deviation,I-PR
",",O
right,B-PR
ventricular,I-PR
hypertrophy,I-PR
and,O
possible,O
apical,B-PR
infarction,I-PR
.,O

Chest,B-TE
x-ray,I-TE
showed,O
left,B-PR
atrial,I-PR
",",I-PR
right,I-PR
ventricular,I-PR
and,I-PR
pulmonary,I-PR
arterial,I-PR
enlargement,I-PR
and,O
interstitial,B-PR
edema,I-PR
with,O
small,B-PR
",",I-PR
bilateral,I-PR
effusions,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

Cardiac,B-TR
catheterization,I-TR
was,O
performed,O
without,O
complication,B-PR
from,O
the,O
right,O
neck,O
and,O
right,O
groin,O
on,O
the,O
day,O
of,O
admission,O
.,O

Right,B-TE
atrial,I-TE
pressure,I-TE
was,O
12,O
with,O
a,O
wave,O
form,O
consistent,O
with,O
tricuspid,B-PR
regurgitation,I-PR
.,O

There,O
was,O
no,O
tricuspid,B-PR
valve,I-PR
gradient,I-PR
.,O

Pulmonary,B-TE
artery,I-TE
pressure,I-TE
was,O
markedly,B-PR
elevated,I-PR
at,O
120/60,O
.,O

Pulmonary,B-TE
capillary,I-TE
wedge,I-TE
pressure,I-TE
was,O
markedly,B-PR
elevated,I-PR
at,O
38,O
",",O
with,O
a,B-PR
very,I-PR
large,I-PR
mitral,I-PR
valve,I-PR
gradient,I-PR
.,O

There,O
was,O
little,O
or,O
no,O
aortic,B-PR
valve,I-PR
gradient,I-PR
.,O

Fich,B-TE
cardiac,I-TE
output,I-TE
was,O
3.0,O
and,O
indexed,O
2.0,O
.,O

Arterial,B-TE
oxygen,I-TE
saturation,I-TE
was,O
85,O
percent,O
.,O

There,O
was,O
minimal,B-PR
mitral,I-PR
valve,I-PR
calcification,I-PR
",",O
normal,O
left,O
ventricular,O
contraction,O
",",O
and,O
2+,B-PR
mitral,I-PR
regurgitation,I-PR
into,I-PR
a,I-PR
large,I-PR
left,I-PR
atrium,I-PR
.,O

There,O
was,O
minimal,B-PR
aortic,I-PR
valve,I-PR
calcification,I-PR
",",O
mild,B-PR
______________,I-PR
thickening,I-PR
",",O
normal,O
open,O
",",O
and,O
mild,B-PR
aortic,I-PR
regurgitation,I-PR
.,O

There,O
was,O
mild,B-PR
atherosclerosis,I-PR
of,I-PR
the,I-PR
mid,I-PR
left,I-PR
anterior,I-PR
descending,I-PR
.,O

FVC,B-TE
was,O
1.6,O
or,O
58,O
percent,O
of,O
predicted,O
and,O
FEV1,B-TE
0.95,O
or,O
45,O
percent,O
of,O
predicted,O
.,O

Room,B-TE
air,I-TE
arterial,I-TE
blood,I-TE
gas,I-TE
was,O
56/40/7.45,O
.,O

Because,O
it,O
would,O
be,O
ideal,O
to,O
place,O
a,B-TR
mechanical,I-TR
valve,I-TR
if,O
valve,B-TR
replacement,I-TR
rather,O
that,O
commissurotomy,B-TR
is,O
needed,O
",",O
she,O
was,O
seen,O
by,O
Dr.,O
Ca,O
Shuff,O
of,O
ENT,O
for,O
her,O
history,O
of,O
epistaxis,B-PR
.,O

He,O
identified,O
no,O
bleeding,B-PR
source,I-PR
",",O
but,O
felt,O
that,O
the,O
risk,O
of,O
nasal,B-PR
hemorrhage,I-PR
on,O
Coumadin,B-TR
could,O
be,O
minimized,O
interventional,B-TR
neuroradiology,I-TR
occlusion,I-TR
of,O
the,O
arteries,O
to,O
the,O
nose,O
bilaterally,O
.,O

The,O
patient,O
was,O
therefore,O
referred,O
to,O
the,O
Dr.,O
A,O
Eu,O
Wave,O
.,O

The,B-TR
procedure,I-TR
could,O
not,O
be,O
scheduled,O
during,O
this,O
admission,O
.,O

The,O
patient,O
is,O
",",O
therefore,O
",",O
discharged,O
after,O
a,O
three,O
day,O
hospitalization,O
",",O
with,O
plans,O
for,O
re-admission,O
for,O
the,B-TR
neuroradiology,I-TR
procedure,I-TR
.,O

This,O
will,O
be,O
followed,O
by,O
a,O
trial,O
of,O
Coumadin,B-TR
",",O
and,O
then,O
by,O
mitral,B-TR
commissurotomy,I-TR
or,O
replacement,B-TR
and,O
probable,O
tricuspid,B-TR
annuloplasty,I-TR
by,O
Dr.,O
Riemund,O
C.,O
Wave,O
.,O

In,O
the,O
meantime,O
",",O
Lasix,B-TR
dosage,O
is,O
increased,O
.,O

Potassium,B-TR
replacement,I-TR
has,O
caused,O
",",O
according,O
to,O
the,O
patient,O
",",O
marked,B-PR
hyperkalemia,I-PR
in,O
the,O
past,O
.,O

DISCHARGE,O
REGIMEN,O
:,O

Digoxin,B-TR
0.125,O
mg,O
q.d.,O
",",O
Lasix,B-TR
80,O
mg,O
q.a.m.,O
and,O
40,O
mg,O
q.p.m.,O
aspirin,B-TR
1,O
q.d.,O
",",O
and,O
Vanceril,B-TR
three,O
puffs,O
b.i.d.,O

CA,O
SHUFF,O
",",O
M.D.,O

TR,O
:,O

vw,O
/,O
bmot,O

DD,O
:,O

11-06-93,O

TD,O
:,O

11/07/93,O

CC,O
:,O

Copies,O
to,O
Dr.,O
Bodejove,O
at,O
Valtawnprinceel,O
Community,O
Memorial,O
Hospital,O
",",O
Dr.,O
A,O
Eu,O
Wave,O
",",O
Dr.,O
Riemund,O
C.,O
Wave,O
",",O
and,O
three,O
copies,O
to,O
Dr.,O
Ca,O
Shuff,O
edited,O
12/31/93,O
qm,O

176746010,O
WGH,O

14633,O

546385,O

8603421,O

12/7/2004,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O
/,O
SUMMARY,O

GLOTZASRHALT,O
",",O
SHIRLH,O

MRN,O
:,O

14633,O

Age,O
:,O

25y,O

REGISTRATION,O
DATE,O
:,O

12/07/2004,O
10:08,O
PM,O

Provider,O
:,O

Gram,O
Meedner,O

PRELIMINARY,O
REPORT,O

Benefits,O
Assigned,O
:,O

Y,O

Discharge,O
Date,O
/,O
Time,O
:,O

12/07/2004,O
22:57,O

Discharge,O
Status,O
:,O

Discharged,O

Condition,O
on,O
Discharge,O
:,O

Stable,O

Patient,O
States,O
Complaint,O
:,O

FLANK,B-PR
PAIN,I-PR
URI,B-PR
?,O

Standardized,O
Discharge,O
Instructions,O
:,O

The,O
patient,O
was,O
given,O
printed,O
instructions,O
for,O
urinary,B-PR
tract,I-PR
infection,I-PR
(,O
Portugese,O
),O
.,O

Diagnosis,O
:,O

Urinary,B-PR
Tract,I-PR
Infection,I-PR

Treatment,O
Rendered,O
:,O

Exam,B-TE
",",O
urinalysis,B-TE
",",O
medication,B-TR

Discharge,O
Medications,O
:,O

Levofloxacin,B-TR
500,O
mg,O
every,O
day,O
for,O
7,O
days,O

Follow,O
up,O
Service,O
:,O

If,O
you,O
do,O
not,O
have,O
a,O
primary,O
care,O
physician,O
",",O
it,O
is,O
recommended,O
that,O
you,O
select,O
one,O
.,O

If,O
you,O
would,O
like,O
an,O
WGH,O
primary,O
care,O
physician,O
",",O
please,O
call,O
the,O
Eghelas,O
Medical,O
Centers,O
at,O
265-573-2272,O
.,O

Disposition,O
",",O
Follow,O
up,O
and,O
Instructions,O
to,O
Patient,O
:,O

Return,O
to,O
the,O
ER,O
for,O
high,B-PR
fevers,I-PR
",",O
vomiting,B-PR
",",O
uncontrolled,B-PR
pains,I-PR
or,O
other,B-PR
concerns,I-PR
as,O
needed,O
.,O

PCP,O
Name,O
:,O

NONE,O
",",O
PHYSICIAN,O

Provider,O
Number,O
:,O

51669,O

This,O
report,O
was,O
created,O
by,O
Meedner,O
",",O
Shaza,O
12/07/2004,O
10:59,O
PM,O

188543380,O

NVH,O

24217709,O

06/07/2000,O
12:00:00,O
AM,O

CHRONIC,B-PR
MYELOGENOUS,I-PR
LEUKEMIA,I-PR

Signed,O

DIS,O

Admission,O
Date,O
:,O

06/07/2000,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

07/02/2000,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

CML,B-PR
.,O

OTHER,O
DIAGNOSES,O
:,O

1.,O
STATUS,O
POST,O
BONE,B-TR
MARROW,I-TR
TRANSPLANT,I-TR
.,O

2.,O
INTRAPARENCHYMAL,B-PR
BLEED,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Mr.,O
Larsen,O
was,O
a,O
50-year-old,O
salesman,O
who,O
in,O
12/26,O
was,O
noted,O
to,O
have,O
an,B-PR
elevated,I-PR
platelet,I-PR
count,I-PR
of,O
"778,000",O
.,O

He,O
was,O
found,O
to,O
have,O
CML,B-PR
.,O

He,O
was,O
admitted,O
on,O
06/07/00,O
for,O
a,B-TR
matched,I-TR
",",I-TR
unrelated,I-TR
donor,I-TR
bone,I-TR
marrow,I-TR
transplant,I-TR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Unremarkable,O
.,O

LABORATORY,O
DATA,O
:,O

White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
of,O
24.409,O
and,O
platelets,B-TE
of,O
"956,000",O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
received,O
his,B-TR
bone,I-TR
marrow,I-TR
transplant,I-TR
on,O
06/12/00,O
.,O

His,O
course,O
was,O
then,O
complicated,O
by,O
fevers,B-PR
and,O
neutropenia,B-PR
which,O
were,O
treated,O
with,O
antibiotics,B-TR
and,O
a,B-PR
diffuse,I-PR
erythroderm,I-PR
felt,O
to,O
be,O
a,B-PR
drug,I-PR
reaction,I-PR
.,O

On,O
06/24/00,O
the,O
patient,O
was,O
found,O
to,O
have,O
pulmonary,B-PR
infiltrates,I-PR
and,O
some,B-PR
hemoptysis,I-PR
.,O

A,B-TE
bronchoscopy,I-TE
was,O
done,O
and,O
there,O
was,O
blood,B-PR
found,O
in,O
the,O
upper,O
airways,O
but,O
no,O
evidence,O
of,O
blood,B-PR
in,I-PR
alveoli,I-PR
so,O
it,O
was,O
not,O
felt,O
to,O
be,O
DAH,B-PR
.,O

On,O
06/26/00,O
due,O
to,O
agitation,B-PR
",",O
change,B-PR
in,I-PR
mental,I-PR
status,I-PR
and,O
increased,B-PR
respiratory,I-PR
distress,I-PR
",",O
the,O
patient,O
was,O
intubated,B-TR
.,O

It,O
was,O
felt,O
at,O
that,O
time,O
that,O
the,B-PR
changing,I-PR
mental,I-PR
status,I-PR
and,O
respiratory,B-PR
distress,I-PR
might,O
be,O
due,O
to,O
a,O
combination,O
of,O
medication,B-TR
and,O
worsening,B-PR
mucositis,I-PR
.,O

Although,O
the,B-TR
patient,I-TR
&apos;s,I-TR
pain,I-TR
and,I-TR
sedation,I-TR
meds,I-TR
were,O
adjusted,O
he,O
continued,O
to,O
be,O
agitated,B-PR
and,O
there,O
was,O
difficulty,O
weaning,O
him,O
off,O
the,B-TR
vent,I-TR
.,O

Because,O
of,O
this,B-PR
continued,I-PR
agitation,I-PR
",",O
a,B-TE
head,I-TE
CT,I-TE
was,O
performed,O
on,O
07/01/00,O
and,O
it,O
revealed,O
an,B-PR
intraparenchymal,I-PR
hemorrhage,I-PR
.,O

Neurosurgery,O
was,O
consulted,O
but,O
due,O
to,O
the,B-PR
severity,I-PR
of,I-PR
the,I-PR
bleed,I-PR
surgery,B-TR
was,O
not,O
considered,O
an,O
option,O
.,O

The,O
patient,O
gradually,O
lost,O
brain,O
systolic,O
ejection,O
murmur,O
function,O
and,O
was,O
pronounced,O
dead,B-PR
on,O
07/02/00,O
.,O

Dictated,O
By,O
:,O

LAYMIE,O
LARSEN,O
",",O
M.D.,O
EM08,O

Attending,O
:,O

ANA,O
V.,O
A,O
",",O
M.D.,O
ZM0,O
LB414/6537,O

Batch,O
:,O

67043,O

Index,O
No.,O

EZCDQ560N8,O

D,O
:,O

07/19/00,O

T,O
:,O

07/20/00,O

194442600,O
RWH,O

1642008,O

83328/rh01,O

61509,O

10/19/1993,O
12:00:00,O
AM,O

RIGHT,B-PR
CAPSULAR,I-PR
PUTAMENAL,I-PR
HEMORRHAGE,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

10/19/93,O

DISCHARGE,O
DATE,O
:,O

10/25/93,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Right,B-PR
capsular,I-PR
putamenal,I-PR
hemorrhage,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

hypertension,B-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Mrs.,O
Dua,O
is,O
a,O
34,O
year,O
old,O
white,O
female,O
with,O
an,O
unclear,O
history,O
of,O
hypertension,B-PR
for,O
at,O
least,O
five,O
years,O
.,O

She,O
was,O
in,O
her,O
usual,O
state,O
of,O
health,O
until,O
around,O
12:40,O
on,O
October,O
19,O
",",O
when,O
while,O
on,O
the,O
phone,O
",",O
started,O
to,O
have,O
difficulty,B-PR
in,I-PR
talking,I-PR
.,O

Her,O
speech,O
became,O
slurred,B-PR
",",O
this,O
was,O
followed,O
a,O
few,O
seconds,O
after,O
by,O
weakness,B-PR
and,I-PR
numbness,I-PR
of,I-PR
her,I-PR
arm,I-PR
and,I-PR
leg,I-PR
.,O

She,O
did,O
not,O
complain,O
of,O
headache,B-PR
",",O
diplopia,B-PR
",",O
or,O
any,B-PR
other,I-PR
neurological,I-PR
symptoms,I-PR
.,O

She,O
was,O
seen,O
at,O
A,O
Memorial,O
Hospital,O
where,O
her,B-TE
blood,I-TE
pressure,I-TE
was,O
measured,O
at,O
240/120,O
and,O
was,O
found,O
to,O
have,O
a,B-PR
mild,I-PR
left,I-PR
hemiparesis,I-PR
.,O

She,O
was,O
then,O
transferred,O
to,O
Ro,O
Woodma,O
Healthcare,O
for,O
further,B-TR
management,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

negative,O
.,O

HABITS,O
:,O

She,O
does,O
not,O
smoke,O
",",O
does,O
not,O
use,O
birth,B-TR
control,I-TR
pills,I-TR
",",O
does,O
not,O
use,O
drugs,O
.,O

Denies,O
any,O
abuse,O
of,O
alcohol,O
.,O

FAMILY,O
HISTORY,O
:,O

Father,O
and,O
brother,O
died,O
of,O
PE,B-PR
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

negative,O
.,O

SOCIAL,O
HISTORY,O
:,O

She,O
works,O
at,O
TackyMart,O
",",O
is,O
single,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

A,O
34,O
year,O
old,O
white,O
female,O
lying,O
in,O
bed,O
",",O
anxious,B-PR
;,O
blood,B-TE
pressure,I-TE
of,O
220/120,O
",",O
afebrile,B-PR
.,O

Skin,O
:,O

no,O
lesions,B-PR
.,O

HEENT,O
:,O

normocephalic,O
",",O
atraumatic,B-PR
",",O
anicteric,B-PR
.,O

Neck,O
:,O

supple,O
",",O
no,O
bruits,B-PR
.,O

Heart,O
:,O

regular,O
rhythm,O
with,O
no,O
murmur,B-PR
",",O
rub,B-PR
or,O
gallop,B-PR
.,O

Lungs,O
:,O

clear,O
to,O
auscultation,B-TE
.,O

Abdomen,O
:,O

bowel,O
sounds,O
present,O
",",O
soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
",",O
guaiac,O
negative,O
",",O
no,O
hepatosplenomegaly,B-PR
.,O

Extremities,O
:,O

no,O
clubbing,B-PR
",",I-PR
cyanosis,B-PR
or,O
edema,B-PR
.,O

Neurological,O
:,O

she,O
was,O
alert,O
and,O
oriented,O
times,O
three,O
.,O

Her,O
speech,O
was,O
fluent,O
with,O
no,O
phasic,B-PR
or,I-PR
praxic,I-PR
problems,I-PR
",",O
dysarthric,B-PR
.,O

Memory,O
and,O
attention,O
span,O
good,O
.,O

Visual,O
fields,O
were,O
full,O
to,O
confrontation,B-TE
.,O

Fundi,O
were,O
flat,O
.,O

Pupils,O
were,O
2,O
millimeters,O
down,O
to,O
1,O
millimeter,O
by,O
direct,B-TE
and,I-TE
consensual,I-TE
stimuli,I-TE
.,O

Extra,O
ocular,O
movements,O
were,O
full,O
.,O

Corneals,O
diminished,O
on,O
the,O
left,O
side,O
.,O

V1,O
through,O
V3,O
",",O
diminished,O
light,B-TE
touch,I-TE
and,O
pinprick,B-TE
in,O
the,O
left,O
side,O
.,O

There,O
was,O
a,B-PR
left,I-PR
central,I-PR
facial,I-PR
paresis,I-PR
.,O

Gag,B-TE
was,O
symmetric,O
.,O

Tongue,O
deviated,O
to,O
the,O
left,O
.,O

There,O
was,O
a,B-PR
left,I-PR
arm,I-PR
pronator,I-PR
.,O

The,O
______________,O
was,O
normal,O
.,O

Strength,O
was,O
5/5,O
on,O
the,O
right,O
side,O
",",O
4/5,O
on,O
the,O
left,O
side,O
.,O

The,B-TE
deep,I-TE
tendon,I-TE
reflexes,I-TE
were,O
2+,O
on,O
the,O
left,O
side,O
",",O
1+,O
on,O
the,O
right,O
side,O
.,O

The,O
plantar,O
was,O
upgoing,O
on,O
the,O
left,O
side,O
.,O

On,O
sensory,B-TE
exam,I-TE
there,O
was,O
a,B-PR
mild,I-PR
diminution,I-PR
of,I-PR
light,I-PR
touch,I-PR
",",I-PR
pinprick,I-PR
",",I-PR
position,I-PR
",",I-PR
and,I-PR
vibration,I-PR
sense,I-PR
in,I-PR
the,I-PR
left,I-PR
side,I-PR
.,O

Cerebella,O
:,O

the,O
fine,O
motor,O
movements,O
of,O
the,O
left,O
hand,O
were,O
diminished,B-PR
",",O
there,O
was,O
a,B-PR
mild,I-PR
dysmetria,I-PR
on,I-PR
the,I-PR
left,I-PR
side,I-PR
to,O
finger,B-TE
/,I-TE
nose,I-TE
and,O
heel,B-TE
/,I-TE
shin,I-TE
.,O

The,B-PR
walk,I-PR
was,I-PR
paretic,I-PR
in,I-PR
the,I-PR
left,I-PR
side,I-PR
.,O

LABORATORY,O
DATA,O
:,O

sodium,B-TE
140,O
",",O
potassium,B-TE
4,O
",",O
chloride,B-TE
107,O
",",O
CO2,B-TE
25.4,O
",",O
BUN,B-TE
9,O
",",O
creatinine,B-TE
.8,O
",",O
blood,B-TE
sugar,I-TE
130,O
.,O

Uric,B-TE
acid,I-TE
4.7,O
",",O
cholesterol,B-TE
150,O
",",O
triglycerides,B-TE
74,O
",",O
HDL,B-TE
44,O
",",O
LDL,B-TE
91,O
.,O

Normal,O
liver,O
function,O
tests,O
.,O

Urine,B-TE
and,I-TE
serum,I-TE
toxicology,I-TE
screen,I-TE
negative,O
.,O

Thyroid,B-TE
stimulation,I-TE
hormone,I-TE
1.9,O
.,O

Dexamethasone,B-TE
suppression,I-TE
test,I-TE
negative,O
with,O
a,B-TE
cortisol,I-TE
level,I-TE
at,O
8,O
a.m.,O
of,O
1.7,O
.,O

Twenty-four,B-TE
urine,I-TE
for,O
catecholamine,B-TE
",",O
metanephrines,B-TE
",",O
and,O
VMA,B-TE
pending,O
at,O
the,O
time,O
of,O
discharge,O
.,O

White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
9.8,O
",",O
hematocrit,B-TE
44.1,O
",",O
platelets,B-TE
262,O
",",O
prothrombin,B-TE
time,I-TE
10.4/,O
10.3,O
",",O
partial,B-TE
thromboplastin,I-TE
time,I-TE
25.9,O
.,O

urinalysis,B-TE
:,O

specific,B-TE
gravity,I-TE
125,O
",",O
PH,O
6,O
.,O

Urine,B-TE
culture,I-TE
negative,O
.,O

Sedimentation,B-TE
rate,I-TE
2,O
",",O
antithrombin,B-TE
3,O
.,O

Protein,B-TE
C,I-TE
",",O
protein,B-TE
S,I-TE
and,O
plasminogen,B-TE
level,I-TE
within,O
normal,O
limits,O
.,O

Electrocardiogram,B-TE
:,O

sinus,B-TE
rhythm,I-TE
at,O
116,O
",",O
axis,B-TE
of,O
23,O
",",O
intervals,B-TE
of,O
.14/,O
.07/,O
.42,O
",",O
no,O
ST-segment,B-PR
abnormalities,I-PR
.,O

Chest,B-TE
x-ray,I-TE
negative,O
.,O

Head,B-TE
computerized,I-TE
tomography,I-TE
scan,I-TE
on,O
10/19,O
:,O
3,B-PR
centimeter,I-PR
hyperdensity,I-PR
within,O
the,O
right,O
putamenal,O
area,O
in,O
the,O
right,O
external,O
capsusle,O
consistent,O
with,O
intra-parenchymal,B-PR
hematoma,I-PR
with,O
mild,B-PR
local,I-PR
mass,I-PR
effect,I-PR
and,O
surrounding,B-PR
edema,I-PR
.,O

No,O
other,O
areas,O
of,O
hemorrhage,B-PR
identified,O
.,O

Head,B-TE
computerized,I-TE
tomography,I-TE
scan,I-TE
of,O
10/23,O
:,O

the,O
area,O
of,O
hemorrhage,B-PR
the,O
same,O
",",O
slightly,B-PR
more,I-PR
edema,I-PR
and,I-PR
mass,I-PR
effect,I-PR
.,O

Pulmonary,B-TE
angiogram,I-TE
:,O

no,O
evidence,O
of,O
pulmonary,B-PR
emboli,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

Given,O
the,O
localization,O
of,O
the,B-PR
hematoma,I-PR
and,O
the,O
history,O
of,O
hypertension,B-PR
",",O
the,O
most,O
likely,O
cause,O
for,O
Mrs.,O
Dua,O
&apos;s,O
cerebellar,B-PR
hemorrhage,I-PR
is,O
hypertension,B-PR
.,O

A,B-TE
magnetic,I-TE
resonance,I-TE
imaging,I-TE
study,I-TE
will,O
be,O
scheduled,O
as,O
an,O
outpatient,O
in,O
three,O
months,O
to,O
rule,O
out,O
a,B-PR
small,I-PR
vascular,I-PR
malformation,I-PR
if,O
responsible,O
for,O
the,B-PR
hemorrhage,I-PR
.,O

At,O
the,O
time,O
of,O
discharge,O
",",O
Mrs.,O
Dua,O
has,O
had,O
a,O
remarkable,O
recovery,O
.,O

She,O
is,O
now,O
able,O
to,O
walk,O
fitfully,O
and,O
use,O
her,O
left,O
hand,O
with,O
no,O
problem,B-PR
.,O

The,B-TE
exam,I-TE
is,O
remarkable,O
for,O
a,B-PR
mild,I-PR
leftsided,I-PR
face,I-PR
",",O
arm,B-PR
and,I-PR
leg,I-PR
weakness,I-PR
and,O
sensory,B-PR
deficit,I-PR
that,O
should,O
further,O
improve,O
with,O
physical,B-TR
therapy,I-TR
and,O
occupational,B-TR
therapy,I-TR
help,O
.,O

She,O
will,O
be,O
followed,O
by,O
the,O
OT,O
/,O
PT,O
dept.,O
for,O
that,O
.,O

Her,B-PR
hypertension,I-PR
was,O
difficult,O
to,O
manage,O
initially,O
and,O
required,O
three,O
days,O
of,O
Intensive,O
Care,O
Unit,O
with,O
A-line,B-TR
and,O
Nipride,B-TR
intravenously,I-TR
.,O

It,O
was,O
finally,O
under,O
control,O
with,O
high,O
doses,O
of,O
Captopril,B-TR
",",O
Nifedipine,B-TR
",",O
and,O
hydrochlorothiazide,B-TR
.,O

The,B-TE
workup,I-TE
to,O
rule,O
out,O
secondary,B-PR
cause,I-PR
of,O
hypertension,B-PR
given,O
the,O
patient,O
&apos;s,O
young,O
age,O
and,O
the,O
difficulty,O
controlling,O
the,O
blood,O
pressure,O
was,O
started,O
as,O
an,O
inpatient,O
and,O
will,O
be,O
completed,O
by,O
Dr.,O
______________as,O
an,O
outpatient,O
.,O

So,O
far,O
no,O
secondary,B-PR
causes,I-PR
of,O
hypertension,B-PR
were,O
identified,O
but,O
causes,O
like,O
lymphocytic,B-PR
?,I-PR
chromocytoma,I-PR
or,O
renal,B-PR
artery,I-PR
stenosis,I-PR
have,O
not,O
been,O
ruled,O
out,O
yet,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

hydrochlorothiazide,B-TR
25,O
mg.,O
po,O
q.day,O
",",O
Captopril,B-TR
75,O
mg.,O
po,O
three,O
times,O
a,O
day,O
",",O
Nifedipine,B-TR
40,O
mg.,O
po,O
three,O
times,O
a,O
day,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
.,O

FOLLOWUP,O
:,O

The,O
patient,O
will,O
followup,O
with,O
Dr.,O
______________at,O
Omend,O
Hospital,O
and,O
with,O
Dr.,O
Deep,O
at,O
the,O
Barb,O
Memorial,O
Hospital,O
.,O

DISABILITY,O
:,O

100%,O
for,O
now,O
.,O

Will,O
be,O
reassessed,O
after,O
a,O
month,O
of,O
intensive,B-TR
physical,I-TR
therapy,I-TR
and,O
occupational,B-TR
therapy,I-TR
.,O

MATAANRE,O
TAG,O
",",O
M.D.,O

TR,O
:,O

ee,O
/,O
bihn,O

DD,O
:,O

10/25/93,O

TD,O
:,O

10/27/93,O

CC,O
:,O

212512774,O
WGH,O

6218589,O

29021,O

9923207,O

10/31/2004,O
12:00:00,O
AM,O

OB,O
Discharge,O
Summary,O

Signed,O

DIS,O

Report,O
Status,O
:,O

Signed,O
OB,O
EMR,O
L,O
and,O
D,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

RIASHWAN,O
BERLNI,O
VALLEY,O

UNIT,O
NUMBER,O
:,O

130-93-91,O

ADMISSION,O
DATE,O
:,O

20041031,O

DISCHARGE,O
DATE,O
:,O

20041103,O

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
:,O

Vaginal,B-TR
Delivery,I-TR
With,O
Second,B-PR
Degree,I-PR
Laceration,I-PR

ASSOCIATED,O
DIAGNOSES,O
:,O

Abnormal,B-PR
Laboratory,I-PR
Result,I-PR
;,O
Abnormal,B-PR
Pap,I-PR
Test,I-PR
;,O
Monilial,B-PR
Vaginitis,I-PR

PRINCIPAL,O
PROCEDURE,O
OR,O
OPERATION,O
:,O

Spontaneous,B-TR
Vertex,I-TR
Vaginal,I-TR
Delivery,I-TR

ASSOCIATED,O
PROCEDURES,O
OR,O
OPERATIONS,O
:,O

POSTPARTUM,O
DIAGNOSTIC,O
PROCEDURES,O
:,O

None,O

POSTPARTUM,O
THERAPEUTIC,O
PROCEDURES,O
:,O

None,O

OTHER,O
POSTPARTUM,O
THERAPIES,O
:,O

Routine,B-TR
Post,I-TR
Partum,I-TR
Care,I-TR

HISTORY,O
AND,O
REASON,O
FOR,O
HOSPITALIZATION,O
:,O

Premature,B-PR
Rupture,I-PR
Of,I-PR
Membranes,I-PR

PHYSICAL,O
EXAMINATION,O
:,O

HEIGHT,O
63,O
HEENT,B-TE
NORMAL,O
MOUTH,O
NORMAL,O
NECK,O
NORMAL,O
BREASTS,O
NORMAL,O
No,O
masses,B-PR
NIPPLES,O
NORMAL,O
CHEST,O
NORMAL,O
CTA,B-TE
bilat,O
",",O
neg,O
wheezing,B-PR
COR,O
NORMAL,O
NSR,O
",",O
no,O
murmur,B-PR
ABDOMEN,O
Gravid,B-PR
",",O
vtx,O
.,O

EFW,B-TE
=,O
7#,O
.,O

FHTs,B-TE
140s,O
w/,O
reactivity,O
.,O

Mild,B-PR
irreg.,I-PR
ctx,I-PR
.,O

EXTREM,B-TE
NORMAL,O
SKIN,O
NORMAL,O
NODES,O
NORMAL,O
VULVA,O
NORMAL,O
VAGINA,O
Leaking,O
copious,B-PR
amounts,I-PR
clear,I-PR
fluid,I-PR
.,O

Fluid,B-TE
amnioswab,I-TE
and,O
fern,B-PR
positive,I-PR
.,O

SSE,B-TE
and,O
digital,B-TE
exam,I-TE
deferred,O
CERVIX,B-TE
digital,I-TE
exam,I-TE
deferred,O
at,O
time,O
of,O
admission,O
OS,B-TE
NORMAL,O
see,O
above,O
ADNEXAE,B-TE
NORMAL,O
non-palp,O
d,O
/,O
t,O
advanced,B-PR
gest,I-PR
UTERUS,I-PR
Gravid,I-PR
",",O
vtx,O
.,O

EFW,B-TE
=,O
7#,O
.,O

FHTs,B-TE
140s,O
w/,O
reactivity,O
.,O

Ctx,B-TE
q,O
6,O
&apos;,O
.,O

UTERINE,B-TE
SIZE,I-TE
IN,O
WEEKS,O
38,O

HOSPITAL,O
COURSE,O
(,O
include,O
complications,O
if,O
any,O
),O
:,O

This,O
27,O
year,O
old,O
Gravida,O
1,O
Para,O
0000,O
was,O
admitted,O
to,O
the,O
Life,O
Valley,O
Medical,O
Center,O
Obstetrical,O
service,O
on,O
10/31/2004,O
at,O
08:45,O
pm,O
for,O
the,O
indication,O
(,O
s,O
),O
:,O

premature,B-PR
rupture,I-PR
of,I-PR
membranes,I-PR
.,O

She,O
delivered,O
a,O
3235,O
gram,O
male,O
infant,O
on,O
11/01/2004,O
at,O
09:31,O
am,O
with,O
apgar,B-TE
scores,I-TE
of,O
9,O
and,O
9,O
at,O
one,O
and,O
five,O
minutes,O
respectively,O
at,O
39.0,O
weeks,O
gestation,O
via,O
spontaneous,B-TR
vertex,I-TR
vaginal,I-TR
delivery,I-TR
.,O

During,O
her,O
labor,O
she,O
encountered,O
the,O
following,O
complication,O
(,O
s,O
),O
:,O

none,O
.,O

During,O
her,O
delivery,O
she,O
encountered,O
the,O
following,O
complication,O
(,O
s,O
),O
:,O

none,O
.,O

Postpartum,O
she,O
encountered,O
the,O
following,O
complication,O
(,O
s,O
),O
:,O

none,O
.,O

She,O
was,O
discharged,O
on,O
11/03/2004,O
at,O
11:18,O
am,O
in,O
good,O
condition,O
.,O

DISCHARGE,O
ORDERS,O
(,O
medications,O
instructions,O
to,O
patient,O
",",O
follow-up,O
care,O
),O
:,O

DISCHARGE,O
ACTIVITY,O
:,O

No,O
Restrictions,O

DISCHARGE,O
DIET,O
:,O

No,O
Restrictions,O

POSTPARTUM,O
DISPOSITION,O
:,O

Home,O
With,O
Self-Care,O
(,O
Routine,O
Discharge,O
),O

POSTPARTUM,O
CARE,O
SITE,O
:,O

La,O
Community,O
Hospital,O

POSTPARTUM,O
RETURN,O
APPOINTMENT,O
(,O
DAYS,O
),O
:,O

42,O

BREAST,O
FEEDING,O
AT,O
DISCHARGE,O
:,O

Yes,O

POSTPARTUM,O
RH,O
IMMUNE,O
GLOBULIN,O
:,O

Not,O
Indicated,O

POSTPARTUM,O
MEASLES,O
/,O
MUMPS,O
/,O
RUBELLA,O
VACCINE,O
:,O

Not,O
Indicated,O

MEDICATION,O
(,O
S,O
),O
ON,O
DISCHARGE,O
:,O

Multivitamins,B-TR
And,O
Folate,B-TR

Electronically,O
Signed,O
:,O

Fyfe,O
",",O
Lan,O
S,O
11/03/2004,O
11:19:27,O
AM,O

223159990,O

PUOMC,O

3546292,O

181083,O

366324,O

7/31/2000,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O

AKOTEBONTKAYS,O
",",O
JUANQUINTLEO,O

MRN,O
:,O

3546292,O

Age,O
:,O

37y,O

REGISTRATION,O
DATE,O
:,O

07/31/2000,O
07:36,O
PM,O

PRELIMINARY,O
REPORT,O

This,O
is,O
to,O
notify,O
you,O
that,O
your,O
patient,O
",",O
AKOTEBONTKAYS,O
",",O
JUANQUINTLEO,O
arrived,O
in,O
the,O
Emergency,O
Department,O
at,O
Ph,O
University,O
Of,O
Medical,O
Center,O
on,O
07/31/2000,O
07:36,O
PM,O
.,O

The,O
patient,O
presented,O
with,O
a,O
chief,O
complaint,O
of,O
FEVER,B-PR
.,O

Following,O
evaluation,B-TE
and,O
treatment,B-TR
",",O
the,O
patient,O
&apos;s,O
disposition,O
at,O
the,O
end,O
of,O
the,O
visit,O
was,O
ADMITTED,O
AS,O
AN,O
INPATIENT,O
TO,O
PH,O
UNIVERSITY,O
OF,O
MEDICAL,O
CENTER,O
.,O

Your,O
patient,O
was,O
admitted,O
under,O
the,O
care,O
of,O
ANER,O
",",O
AEA,O
M,O
with,O
a,O
preliminary,O
diagnosis,O
of,O
LINE,B-PR
SEPSIS,I-PR
.,O

If,O
you,O
need,O
additional,O
information,O
please,O
call,O
639-873-2993,O
.,O

245096078,O

FIH,O

9174858,O

12-Feb,O

997359,O

11/3/1992,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

11/3/92,O

DISCHARGE,O
DATE,O
:,O

12/6/92,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
68,O
year,O
old,O
",",O
right,O
handed,O
caucasian,O
female,O
",",O
former,O
R.N.,O
who,O
complained,O
of,O
several,O
days,O
of,O
vertigo,B-PR
",",O
one,O
day,O
of,O
double,B-PR
vision,I-PR
",",O
dysarthria,B-PR
and,O
worsening,O
of,O
vertigo,B-PR
.,O

She,O
was,O
seen,O
at,O
the,O
outside,O
hospital,O
and,O
put,O
on,O
aspirin,B-TR
for,O
two,O
days,O
.,O

An,B-TE
magnetic,I-TE
resonance,I-TE
imaging,I-TE
study,I-TE
showed,O
basilar,B-PR
artery,I-PR
disease,I-PR
",",O
questionable,O
aneurysm,B-PR
.,O

The,O
patient,O
was,O
transferred,O
to,O
the,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
.,O

An,B-TE
angiogram,I-TE
on,O
11/3,O
was,O
consistent,O
with,O
thrombosis,B-PR
at,I-PR
the,I-PR
mid,I-PR
basilar,I-PR
artery,I-PR
.,O

The,O
patient,O
was,O
put,O
on,O
heparin,B-TR
and,O
was,O
stable,O
since,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Hypertension,B-PR
for,O
20,O
years,O
",",O
high,B-PR
cholesterol,I-PR
",",O
coronary,B-PR
artery,I-PR
disease,I-PR
with,O
episodes,O
of,O
angina,B-PR
",",O
no,O
history,O
of,O
myocardial,B-PR
infarction,I-PR
",",O
exercise,B-TE
treadmill,I-TE
or,O
evaluation,B-TE
.,O

She,O
has,O
had,O
an,B-TR
inguinal,I-TR
hernia,I-TR
repair,I-TR
.,O

A,B-TR
left,I-TR
breast,I-TR
lumpectomy,I-TR
was,O
reportedly,O
benign,B-TE
.,O

ALLERGIES,O
:,O

The,O
patient,O
has,O
no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Mevicor,B-TR
60,O
mg.,O
PO,O
q.d.,O
",",O
Cardizem,B-TR
90,O
mg.,O
w,O
release,O
PO,O
q.d.,O
",",O
Questran,B-TR
one,O
pack,O
q.i.d.,O
",",O
Niacin,B-TR
500,O
mg.,O
PO,O
b.i.d.,O

SOCIAL,O
HISTORY,O
:,O

She,O
is,O
a,O
one,O
pack,O
per,O
day,O
smoker,O
for,O
the,O
last,O
forty,O
years,O
",",O
denies,O
alcohol,O
",",O
is,O
a,O
former,O
nurse,O
with,O
the,O
Storm,O
Mor,O
Hospital,O
And,O
Medical,O
Center,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Her,B-TE
blood,I-TE
pressure,I-TE
was,O
190/90,O
when,O
I,O
first,O
saw,O
her,O
on,O
her,O
second,O
hospital,O
day,O
.,O

She,O
was,O
afebrile,B-PR
",",O
in,O
sinus,O
rhythm,O
",",O
pulse,O
60,O
.,O

Neck,O
supple,O
.,O

Lungs,O
clear,O
.,O

Heart,O
:,O

regular,O
rate,O
and,O
rhythm,O
",",O
without,O
ectopy,B-PR
.,O

A,B-PR
II,I-PR
/,I-PR
VI,I-PR
systolic,I-PR
ejection,I-PR
murmur,I-PR
is,O
at,O
the,O
base,O
",",O
minimal,B-PR
radiation,I-PR
to,I-PR
the,I-PR
carotids,I-PR
.,O

Abdomen,O
:,O

soft,O
",",O
without,O
hepatosplenomegaly,B-PR
.,O

Extremities,O
:,O

normal,O
pulses,O
",",O
no,O
clubbing,B-PR
",",O
cyanosis,B-PR
or,O
edema,B-PR
.,O

The,B-TE
neurological,I-TE
examination,I-TE
:,O

post,O
angiogram,B-TE
her,O
eyes,O
were,O
closed,O
.,O

She,O
was,O
very,O
responsive,O
",",O
somewhat,O
sleepy,O
",",O
she,O
complained,O
of,O
chest,B-PR
pain,I-PR
",",O
which,O
was,O
diffuse,O
",",O
non-localizing,O
without,O
electrocardiogram,O
changes,O
and,O
persisted,O
for,O
several,O
days,O
and,O
then,O
went,O
away,O
completely,O
.,O

She,O
was,O
oriented,O
to,O
person,O
",",O
place,O
",",O
time,O
and,O
purpose,O
",",O
she,O
recalled,O
three,O
out,O
of,O
three,O
objects,O
at,O
five,O
minutes,O
",",O
she,O
is,O
able,O
to,O
do,O
calculations,O
.,O

She,O
maintained,O
her,O
fixation,O
on,O
the,O
conversation,O
well,O
.,O

The,B-TE
cranial,I-TE
nerve,I-TE
exam,I-TE
:,O

pupils,O
reactive,O
to,O
light,O
",",O
extra,B-TE
ocular,I-TE
movements,I-TE
show,O
good,O
upgaze,O
up,O
to,O
3,O
mm.,O
",",O
good,O
down,O
gaze,O
.,O

Right,B-TE
lateral,I-TE
gaze,I-TE
",",O
the,O
right,O
eye,O
had,O
2,O
mm.,O
of,O
sclera,O
showing,O
",",O
the,O
left,O
eye,O
was,O
normal,O
",",O
and,O
there,O
are,O
a,O
few,O
beats,O
of,O
right,B-PR
beading,I-PR
nystagmus,I-PR
.,O

The,B-TE
left,I-TE
lateral,I-TE
gaze,I-TE
",",O
the,O
left,O
eye,O
had,O
1,O
mm.,O
of,O
lateral,O
sclera,O
showing,O
.,O

Disks,O
were,O
flat,O
.,O

Sensory,O
limb,O
of,O
the,O
right,O
eye,O
corneal,B-TE
reflex,I-TE
is,O
slowed,O
",",O
otherwise,O
normal,O
.,O

Seventh,B-PR
nerve,I-PR
weakness,I-PR
on,O
the,O
right,O
in,O
a,O
central,O
pattern,O
is,O
present,O
.,O

Soft,O
palate,O
was,O
in,O
the,O
midline,O
and,O
moved,O
upward,O
nicely,O
",",O
but,O
did,O
not,O
respond,O
to,O
gag,O
.,O

Tongue,O
protrudes,O
2,O
cm.,O
with,O
slight,O
deviation,O
to,O
the,O
right,O
.,O

Sensory,B-TE
exam,I-TE
was,O
not,O
remarkable,O
",",O
cerebellar,B-TE
exam,I-TE
was,O
not,O
possible,O
.,O

Motor,B-TE
exam,I-TE
showed,O
greater,O
than,O
4+,O
strength,O
bilateral,O
upper,O
extremities,O
and,O
psoas,O
unable,O
to,O
lift,O
off,O
bed,O
.,O

Quadraceps,B-TE
2+,O
on,O
the,O
left,O
and,O
3+,O
on,O
the,O
right,O
.,O

Gastroc.,B-TE
3,O
on,O
the,O
left,O
and,O
4+,O
on,O
the,O
right,O
.,O

Tibialis,B-TE
3,O
on,O
the,O
left,O
",",O
5+,O
on,O
the,O
right,O
.,O

Reflexes,B-TE
were,O
diffuse,O
3+,O
",",O
toes,O
upgoing,O
bilaterally,O
.,O

LABORATORY,O
DATA,O
:,O

On,O
admission,O
",",O
electrocardiogram,B-TE
showed,O
less,O
than,O
1,O
mm.,O
of,O
ST,B-PR
depression,I-PR
in,I-PR
V4,I-PR
to,I-PR
V6,I-PR
",",O
which,O
is,O
likely,O
the,O
patient,O
&apos;s,O
baseline,O
.,O

CK,B-TE
&apos;s,I-TE
were,O
mildly,B-PR
elevated,I-PR
but,O
the,B-TE
MB,I-TE
fractions,I-TE
were,O
not,O
remarkable,O
.,O

A,B-TE
chest,I-TE
X-ray,I-TE
showed,O
some,B-PR
left,I-PR
lower,I-PR
lobe,I-PR
atelectasis,I-PR
.,O

Admitting,B-TE
creatinine,I-TE
was,O
.7,O
",",O
glucose,B-TE
131,O
",",O
white,B-TE
blood,I-TE
count,I-TE
was,O
"10,000",O
",",O
hematocrit,B-TE
was,O
40,O
",",O
liver,B-TE
enzymes,I-TE
normal,O
range,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
taken,O
to,O
the,O
Intensive,O
Care,O
Unit,O
after,O
her,B-TE
angiogram,I-TE
.,O

She,O
was,O
aggressively,O
anticoagulated,O
with,O
heparin,B-TR
.,O

A,B-PR
small,I-PR
intimal,I-PR
tear,I-PR
in,O
the,O
arch,O
of,O
the,O
aorta,O
during,O
the,B-TE
angiogram,I-TE
",",O
was,O
without,O
sequelae,B-PR
.,O

She,O
was,O
doing,O
well,O
with,O
at,O
least,O
4+,O
strength,O
in,O
all,O
of,O
her,O
extremities,O
",",O
when,O
on,O
11/13,O
",",O
she,O
had,O
an,B-PR
acute,I-PR
drop,I-PR
in,O
her,B-TE
systolic,I-TE
blood,I-TE
pressure,I-TE
to,O
70,O
for,O
unclear,O
reasons,O
and,O
without,O
evidence,O
of,O
acute,B-PR
sepsis,I-PR
.,O

This,O
was,O
accompanied,O
by,O
substantial,B-PR
decrement,I-PR
in,I-PR
neurologic,I-PR
function,I-PR
.,O

For,O
a,O
short,O
time,O
",",O
she,O
seemed,O
&quot;,B-PR
locked,I-PR
in,I-PR
&quot;,I-PR
.,O

She,O
has,O
made,O
slow,O
progress,O
since,O
then,O
and,O
at,O
the,O
time,O
of,O
discharge,O
has,O
4-strength,O
at,O
the,O
left,O
elbow,O
and,O
4+,O
in,O
the,O
left,O
wrist,O
and,O
hand,O
.,O

Trace,O
movement,O
of,O
the,O
right,O
elbow,O
and,O
4-strength,O
of,O
the,O
right,O
wrist,O
and,O
hand,O
.,O

4-to,O
4+,O
strength,O
at,O
the,O
left,O
ankle,O
",",O
4+,O
strength,O
at,O
the,O
right,O
knee,O
and,O
right,O
ankle,O
.,O

She,O
is,O
unable,O
to,O
lift,O
either,O
foot,O
off,O
the,O
bed,O
.,O

The,O
extra,O
ocular,O
movements,O
are,O
full,O
.,O

Tongue,O
protrudes,O
4,O
cm,O
.,O

She,O
is,O
drowsy,B-PR
at,O
times,O
",",O
but,O
generally,O
alert,O
",",O
responsive,O
",",O
interactive,O
",",O
able,O
to,O
talk,O
in,O
two,O
to,O
three,O
word,O
sentences,O
when,O
she,O
wants,O
to,O
.,O

She,O
has,O
severe,B-PR
memory,I-PR
deficits,I-PR
",",O
but,O
nevertheless,O
",",O
is,O
able,O
to,O
engage,O
in,O
conversation,O
",",O
answers,O
questions,O
",",O
names,O
things,O
well,O
",",O
does,O
calculations,O
and,O
recognizes,O
family,O
members,O
and,O
states,O
preferences,O
.,O

She,O
has,O
been,O
working,O
with,O
Speech,B-TR
Therapy,I-TR
",",O
occupational,B-TR
therapy,I-TR
and,O
physical,B-TR
therapy,I-TR
closely,O
and,O
should,O
continue,O
to,O
show,O
improvement,O
.,O

She,O
is,O
anticoagulated,O
on,O
Coumadin,B-TR
and,O
this,O
has,O
been,O
stable,O
.,O

She,O
is,O
do,O
not,O
resuscitate,O
in,O
agreement,O
with,O
the,O
wishes,O
of,O
her,O
multiple,O
family,O
members,O
.,O

Follow,O
up,O
computerized,B-TE
tomography,I-TE
scans,I-TE
and,O
magnetic,B-TE
resonance,I-TE
imaging,I-TE
studies,I-TE
have,O
shown,O
infarction,B-PR
in,I-PR
bilateral,I-PR
basis,I-PR
pontis,I-PR
",",I-PR
mid,I-PR
brain,I-PR
",",I-PR
the,I-PR
superior,I-PR
cerebellar,I-PR
areas,I-PR
",",I-PR
left,I-PR
thalamus,I-PR
",",I-PR
bilateral,I-PR
temporal,I-PR
lobes,I-PR
medially,I-PR
and,I-PR
inferiorly,I-PR
and,I-PR
left,I-PR
posterior,I-PR
communicating,I-PR
artery,I-PR
.,O

The,O
patient,O
had,O
fevers,B-PR
sporadically,O
during,O
this,O
hospitalization,O
with,O
rising,B-PR
white,I-PR
blood,I-PR
counts,I-PR
.,O

A,B-TE
chest,I-TE
X-ray,I-TE
documented,O
a,B-PR
progressing,I-PR
left,I-PR
lower,I-PR
lobe,I-PR
infiltrate,I-PR
.,O

Initially,O
this,O
improved,O
on,O
Clindamycin,B-TR
and,O
Cefotetan,B-TR
",",O
but,O
fevers,B-PR
recurred,O
on,O
this,B-TR
antibiotic,I-TR
regimen,I-TR
.,O

Sputum,B-TE
grew,O
out,O
Klebsiella,B-PR
pneumoniae,I-PR
",",O
and,O
she,O
was,O
treated,O
with,O
Gentamicin,B-TR
and,O
Ancef,B-TR
for,O
14,O
days,O
intravenous,O
(,O
bug,B-PR
being,O
sensitive,O
to,O
these,B-TR
two,I-TR
drugs,I-TR
),O
.,O

A,B-PR
left,I-PR
pleural,I-PR
effusion,I-PR
developed,O
and,O
this,O
was,O
tapped,O
with,O
ultrasound,B-TE
guidance,I-TE
",",O
and,O
found,O
to,O
be,O
sterile,O
",",O
and,O
without,O
evidence,O
of,O
empyema,B-PR
.,O

The,O
patient,O
is,O
on,O
Ciprofloxacin,B-TR
.,O

The,O
day,O
of,O
discharge,O
is,O
day,O
#3,O
of,O
7,O
",",O
after,O
which,O
antibiotics,B-TR
should,O
be,O
totally,O
discontinued,O
.,O

She,O
has,O
developed,O
bad,B-PR
thrush,I-PR
in,O
this,O
setting,O
",",O
she,O
is,O
not,O
yet,O
able,O
to,O
swallow,O
and,O
so,O
she,O
is,O
on,O
Nystatin,B-TR
swish,I-TR
and,I-TR
spit,I-TR
five,O
times,O
a,O
day,O
.,O

She,O
also,O
gets,O
Peridex,B-TR
to,O
clean,O
out,O
her,O
mouth,O
.,O

Once,O
her,B-TE
liver,I-TE
enzymes,I-TE
are,O
completely,O
normal,O
",",O
a,O
seven,O
day,O
course,O
of,O
Fluconazol,B-TR
may,O
be,O
helpful,O
if,O
the,B-PR
thrush,I-PR
is,O
not,O
spontaneously,O
resolving,O
off,O
of,O
antibiotics,B-TR
.,O

She,O
has,O
been,O
afebrile,B-PR
for,O
greater,O
than,O
10,O
days,O
",",O
including,O
several,O
days,O
on,O
oral,B-TR
antibiotics,I-TR
.,O

The,B-TE
patient,I-TE
&apos;s,I-TE
liver,I-TE
enzymes,I-TE
were,O
noted,O
to,O
be,O
elevated,O
mid,O
way,O
through,O
her,B-TR
hospital,I-TR
course,I-TR
",",O
to,O
about,O
three,O
times,O
normal,O
",",O
especially,O
the,O
SGOT,B-TE
and,O
SGPT,B-TE
.,O

These,O
have,O
spontaneously,O
reversed,O
",",O
and,O
are,O
nearly,O
normal,O
at,O
the,O
time,O
of,O
discharge,O
.,O

A,B-TE
right,I-TE
upper,I-TE
quadrant,I-TE
ultrasound,I-TE
documented,O
gallstones,B-PR
",",O
without,O
evidence,O
of,O
common,B-PR
bile,I-PR
duct,I-PR
dilatation,I-PR
or,O
active,B-PR
cholecystitis,I-PR
.,O

The,O
exact,O
cause,O
of,O
her,B-PR
liver,I-PR
enzyme,I-PR
elevation,I-PR
is,O
unclear,O
",",O
but,O
we,O
are,O
being,O
careful,O
about,O
administering,O
drugs,B-TR
",",O
which,O
might,O
irritate,O
the,O
liver,O
.,O

The,O
patient,O
had,O
a,B-PR
steady,I-PR
decline,I-PR
in,O
her,B-TE
hematocrit,I-TE
during,O
this,B-TR
hospitalization,I-TR
.,O

Iron,B-TE
studies,I-TE
are,O
all,O
entirely,O
normal,O
",",O
her,B-PR
anemia,I-PR
is,O
attributed,O
to,O
anemia,B-PR
or,O
chronic,B-PR
disease,I-PR
with,O
hypoproliferation,B-PR
as,O
well,O
as,O
multiple,B-TE
phlebotomies,I-TE
.,O

The,O
plan,O
is,O
to,O
give,O
her,O
folic,B-TR
acid,I-TR
",",O
but,O
not,O
iron,B-TR
.,O

The,B-TE
patient,I-TE
&apos;s,I-TE
potassiums,I-TE
have,O
been,O
repeatedly,O
low,O
and,O
require,O
daily,B-TE
checks,I-TE
and,O
repletion,B-TR
.,O

This,O
is,O
thought,O
due,O
to,O
the,O
extensive,O
course,O
of,O
Gentamicin,B-TR
which,O
she,O
received,O
.,O

This,O
must,O
be,O
carefully,O
checked,O
despite,O
the,O
standing,O
order,O
for,O
potassium,B-TR
.,O

The,O
patient,O
has,O
had,O
low,B-PR
sodiums,I-PR
during,O
this,B-TR
hospitalization,I-TR
.,O

This,O
may,O
due,O
to,O
her,B-PR
central,I-PR
nervous,I-PR
system,I-PR
process,I-PR
or,O
her,B-PR
pulmonary,I-PR
process,I-PR
",",O
with,O
fluids,B-TR
administered,I-TR
as,O
described,O
",",O
she,O
should,O
not,O
have,O
any,B-PR
problems,I-PR
from,O
this,O
.,O

Her,B-TE
sodiums,I-TE
were,O
never,O
below,O
130,O
.,O

She,O
does,O
well,O
with,O
tube,B-TR
feeds,I-TR
.,O

Her,B-TR
tube,I-TR
feeds,I-TR
orders,O
are,O
as,O
follow,O
:,O

full,O
strength,O
Replete,O
with,O
fiber,B-TR
at,O
70,O
cc.,O
per,O
hour,O
.,O

In,O
addition,O
",",O
the,O
patient,O
gets,O
250,O
cc.,O
of,O
juice,B-TR
(,O
not,O
water,O
),O
three,O
times,O
a,O
day,O
.,O

She,O
also,O
gets,O
Lactinex,B-TR
granules,I-TR
three,O
packages,O
in,O
each,O
bottle,O
of,O
tube,B-TR
feeds,I-TR
.,O

She,O
also,O
gets,O
Metamucil,B-TR
one,O
teaspoon,O
with,O
the,O
first,O
bolus,O
of,O
juice,B-TR
each,O
day,O
.,O

Please,O
note,O
that,O
evaluation,B-TE
by,I-TE
the,I-TE
swallowing,I-TE
therapist,I-TE
",",O
showed,O
that,O
the,O
patient,O
is,O
aspirating,O
at,O
this,O
time,O
",",O
but,O
there,O
is,O
great,O
hope,O
from,O
the,O
nature,O
of,O
her,B-PR
deficit,I-PR
and,O
the,O
good,O
movements,O
of,O
her,O
tongue,O
that,O
normal,O
swallowing,O
should,O
return,O
soon,O
.,O

It,O
is,O
for,O
this,O
reason,O
that,O
she,O
is,O
discharged,O
with,O
an,B-TR
nasogastric,I-TR
tube,I-TR
and,O
that,O
no,O
plans,O
for,O
G,B-TR
tube,I-TR
placement,I-TR
are,O
made,O
at,O
this,O
time,O
.,O

She,O
has,O
a,O
history,O
of,O
of,O
angina,B-PR
without,O
myocardial,B-PR
infarction,I-PR
that,O
has,O
not,O
been,O
worked,O
up,O
.,O

She,O
did,O
have,O
brief,B-PR
chest,I-PR
pain,I-PR
twice,O
during,O
this,O
admission,O
that,O
did,O
not,O
correlate,O
with,O
electrocardiogram,O
changes,O
.,O

In,O
the,O
first,O
week,O
of,O
November,O
",",O
her,B-TE
electrocardiogram,I-TE
showed,O
T,B-PR
wave,I-PR
inversions,I-PR
in,I-PR
the,I-PR
lateral,I-PR
leads,I-PR
",",O
correlating,O
with,O
an,B-PR
increase,I-PR
in,O
the,B-TE
LDH,I-TE
",",O
but,O
not,O
CK,B-TE
.,O

This,O
did,O
not,O
normalize,O
with,O
administration,O
of,O
Isordil,B-TR
and,O
the,O
patient,O
denied,O
chest,B-PR
pain,I-PR
at,O
this,O
time,O
.,O

As,O
of,O
4/7,O
",",O
her,B-TE
electrocardiogram,I-TE
had,O
reverted,O
back,O
to,O
normal,O
and,O
there,O
is,O
no,O
evidence,O
of,O
congestive,B-PR
heart,I-PR
failure,I-PR
or,O
continued,O
electrocardiogram,O
changes,O
",",O
and,O
chest,B-PR
pain,I-PR
is,O
absent,O
.,O

Her,B-TE
cholesterol,I-TE
was,O
350,O
here,O
.,O

She,O
has,O
been,O
off,O
of,O
her,B-TR
hypercholesterol,I-TR
medicines,I-TR
.,O

These,O
can,O
be,O
restarted,O
when,O
it,O
is,O
deemed,O
reasonable,O
",",O
in,O
view,O
of,O
her,B-PR
acute,I-PR
disease,I-PR
and,O
recently,B-PR
elevated,I-PR
liver,I-PR
enzymes,I-PR
.,O

Note,O
that,O
the,B-TE
liver,I-TE
enzymes,I-TE
were,O
normal,O
on,O
admission,O
",",O
at,O
which,O
time,O
she,O
was,O
taking,O
all,O
of,O
the,B-TR
above,I-TR
cholesterol,I-TR
medicines,I-TR
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Metamucil,B-TR
1,O
teaspoon,O
q.d.,O
",",O
with,O
first,O
bolus,O
of,O
juice,B-TR
",",O
juice,B-TR
250,O
cc.,O
down,O
nasogastric,B-TR
tube,I-TR
t.i.d.,O
",",O
tube,B-TR
feeds,I-TR
as,O
above,O
",",O
Lactinex,B-TR
as,O
above,O
",",O
Tagamet,B-TR
800,O
mg.,O
nasogastric,B-TR
tube,I-TR
qhs,O
",",O
Nystatin,B-TR
swish,I-TR
and,I-TR
spit,I-TR
10,O
cc.,O
five,O
times,O
a,O
day,O
",",O
Cardizem,B-TR
slow,I-TR
release,I-TR
90,O
mg.,O
PO,O
q.d.,O
",",O
Folic,B-TR
Acid,I-TR
1,O
mg.,O
PO,O
q.d.,O
",",O
Ciprofloxacin,B-TR
500,O
mg.,O
PO,O
b.i.d.,O
",",O
discontinue,O
on,O
12/10/92,O
KayCiel,B-TR
30,O
mEq.,O
down,O
nasogastric,B-TR
tube,I-TR
q.d.,O
",",O
Peridex,B-TR
10,O
cc.,O
swish,O
and,O
spit,O
q.i.d.,O
",",O
Coumadin,B-TR
4,O
mg.,O
nasogastric,O
tube,O
on,O
odd,O
days,O
",",O
alternating,O
with,O
5,O
mg.,O
nasogastric,O

DISCHARGE,O
DIAGNOSIS,O
:,O

Basilar,B-PR
artery,I-PR
stenosis,I-PR
with,O
basilar,B-PR
thrombosis,I-PR
and,O
&quot;,B-PR
top,I-PR
of,I-PR
the,I-PR
basilar,I-PR
&quot;,I-PR
syndrome,I-PR
.,O

Includes,O
recent,B-PR
infarct,I-PR
to,I-PR
pons,I-PR
",",I-PR
mid,I-PR
brain,I-PR
",",I-PR
left,I-PR
thalamus,I-PR
",",I-PR
bilateral,I-PR
temporal,I-PR
lobes,I-PR
and,I-PR
left,I-PR
visual,I-PR
cortex,I-PR
",",O
on,O
Coumadin,B-TR
.,O

The,O
patient,O
is,O
do,O
not,O
resuscitate,O
at,O
family,O
&apos;s,O
request,O
.,O

Left,B-PR
lower,I-PR
lobe,I-PR
pneumonia,I-PR
",",O
resolving,O
now,O
on,O
oral,B-TR
antibiotics,I-TR
.,O

Gallstones,B-PR
",",O
thought,O
to,O
be,O
inactive,O
.,O

Improving,O
liver,B-PR
enzyme,I-PR
elevation,I-PR
.,O

Anemia,B-PR
",",O
discharge,B-TE
hematocrit,I-TE
28,O
",",O
not,O
iron,B-PR
deficient,I-PR
.,O

Low,B-PR
potassium,I-PR
",",O
thought,O
due,O
to,O
Gentamicin,B-TR
.,O

Low,B-PR
sodium,I-PR
",",O
responsive,O
to,O
fluid,B-TR
restriction,I-TR
.,O

History,O
of,O
coronary,B-PR
artery,I-PR
disease,I-PR
.,O

Thrush,B-PR
.,O

High,B-PR
cholesterol,I-PR
.,O

The,O
patient,O
needs,O
prothrombin,B-TE
time,I-TE
checked,O
daily,O
",",O
patient,O
needs,O
potassium,B-TE
checked,O
daily,O
",",O
patient,O
needs,O
sodium,B-TE
checked,O
at,O
least,O
every,O
other,O
day,O
.,O

DO,O
JOASSCCHIRD,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

NAREA,O
SWALLOW,O
",",O
M.D.,O

TR,O
:,O

sw,O
/,O
bmot,O

DD,O
:,O

12/6/92,O

TD,O
:,O

12/06/92,O

CC,O
:,O

Dr.,O
Namarce,O
May,O
STAT,O

245317863,O
WGH,O

9156109,O

780576,O

720567,O

04/20/2005,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O
/,O
SUMMARY,O

KOORSKOTE,O
",",O
RETCO,O

MRN,O
:,O

9156109,O

Age,O
:,O

26y,O

REGISTRATION,O
DATE,O
:,O

04/20/2005,O
10:30,O
PM,O

Provider,O
:,O

HE,O
HERDES,O

PRELIMINARY,O
REPORT,O

PCP,O
notified,O
by,O
MD,O
:,O

E-mail,O
PCP,O

Benefits,O
Assigned,O
:,O

Y,O

Discharge,O
Note,O
Date,O
/,O
Time,O
:,O

04/21/2005,O
05:25,O

Discharge,O
Status,O
:,O

Discharged,O

Condition,O
on,O
Discharge,O
:,O

Stable,O

Patient,O
States,O
Complaint,O
:,O

RLQ,B-PR
PAIN,I-PR

Standardized,O
Discharge,O
Instructions,O
:,O

The,O
patient,O
was,O
given,O
printed,O
instructions,O
for,O
kidney,B-PR
stones,I-PR
(,O
English,O
),O
.,O

Diagnosis,O
:,O

likely,O
recently,B-PR
passed,I-PR
kidney,I-PR
stone,I-PR

Treatment,O
Rendered,O
:,O

history,O
",",O
physical,B-TE
",",O
lab,B-TE
",",O
Abdominal,B-TE
CT,I-TE
scan,I-TE

Discharge,O
Medications,O
:,O

Motrin,B-TR
as,O
needed,O

Follow,O
up,O
Service,O
:,O

Please,O
follow,O
up,O
with,O
your,O
primary,O
care,O
physician,O
within,O
the,O
next,O
week,O
.,O

Also,O
please,O
follow,O
up,O
with,O
urology,O
regarding,O
management,B-TR
of,O
your,B-PR
kidney,I-PR
stones,I-PR
.,O

Disposition,O
",",O
Follow,O
up,O
and,O
Instructions,O
to,O
Patient,O
:,O

Please,O
return,O
if,O
your,B-PR
symptoms,I-PR
return,O
",",O
you,O
develop,O
a,B-PR
fever,I-PR
.,O

PCP,O
Name,O
:,O

KOTEKOTEPRUESS,O
",",O
SUSNUM,O

Provider,O
Number,O
:,O

43264,O

This,O
report,O
was,O
created,O
by,O
HERDES,O
",",O
NEWSHALIE,O
04/21/2005,O
06:47,O
AM,O

262182942,O

BH,O

2513486,O

923091,O

05/08/2000,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O

JEM,O
",",O
ON,O

MRN,O
:,O

2513486,O

Age,O
:,O

74y,O

REGISTRATION,O
DATE,O
:,O

05/08/2000,O
07:57,O
PM,O

PRELIMINARY,O
REPORT,O

This,O
is,O
to,O
notify,O
you,O
that,O
your,O
patient,O
",",O
JEM,O
",",O
ON,O
arrived,O
in,O
the,O
Emergency,O
Department,O
at,O
Bri,O
Health,O
on,O
05/08/2000,O
07:57,O
PM,O
.,O

The,O
patient,O
presented,O
with,O
a,O
chief,O
complaint,O
of,O
IV,B-TR
FLUIDS,I-TR
.,O

Following,O
triage,B-TE
",",O
the,O
patient,O
LEFT,O
WITHOUT,O
TREATMENT,B-TR
.,O

If,O
you,O
need,O
additional,O
information,O
please,O
call,O
442-025-0303,O
.,O

PCP,O
Name,O
:,O

ACKCA,O
",",O
SLAINEAEE,O
L,O

Provider,O
Number,O
:,O

78369,O

262912613,O

CTMC,O

43279523,O

551881,O

6/25/1990,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

06/25/1990,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

07/05/1990,O

PRINCIPLE,O
DIAGNOSIS,O
:,O

LEFT,B-PR
KNEE,I-PR
OSTEOARTHRITIS,I-PR
.,O

PROCEDURE,O
:,O

LEFT,B-TR
TOTAL,I-TR
KNEE,I-TR
ARTHROPLASTY,I-TR
ON,O
6/26/90,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
78-year-old,O
female,O
who,O
has,O
had,O
osteoarthritis,B-PR
and,O
noted,O
the,O
sudden,O
onset,O
of,O
left,B-PR
knee,I-PR
pain,I-PR
in,O
09/89,O
.,O

Since,O
that,O
time,O
",",O
she,O
has,O
used,O
a,B-TR
cane,I-TR
and,O
she,O
was,O
referred,O
to,O
Dr.,O
Koors,O
.,O

MRI,B-TE
demonstrated,O
a,B-PR
left,I-PR
femoral,I-PR
condyle,I-PR
osteonecrotic,I-PR
defect,I-PR
and,O
degenerative,B-PR
meniscus,I-PR
.,O

She,O
climbs,O
stairs,O
one,O
at,O
a,O
time,O
and,O
denied,O
rest,B-PR
pain,I-PR
.,O

She,O
can,O
one,O
walk,O
without,O
difficulties,B-PR
.,O

She,O
presented,O
for,O
an,B-TR
elective,I-TR
left,I-TR
total,I-TR
knee,I-TR
arthroplasty,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Pneumonia,B-PR
one,O
and,O
a,O
half,O
years,O
ago,O
.,O

Hepatitis,B-PR
35,O
years,O
ago,O
.,O

Anxiety,B-PR
neurosis,I-PR
for,O
which,O
she,O
has,O
received,O
shock,B-TR
therapy,I-TR
in,O
the,O
past,O
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

Total,B-TR
abdominal,I-TR
hysterectomy,I-TR
.,O

MEDICATIONS,O
:,O

On,O
admission,O
included,O
Tylenol,B-TR
.,O

ALLERGIES,O
:,O

DOXEPIN,B-TR
CAUSES,O
ITCHING,B-PR
.,O

HABITS,O
:,O

The,O
patient,O
does,O
not,O
smoke,O
.,O

She,O
drinks,O
one,O
to,O
two,O
glasses,O
of,O
scotch,O
per,O
day,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,O
was,O
only,O
significant,O
for,O
her,B-TE
orthopaedic,I-TE
exam,I-TE
.,O

Her,O
left,O
knee,O
had,O
5,O
degrees,O
of,O
valgus,B-PR
",",O
120,O
degrees,O
of,O
flexion,O
",",O
full,O
extension,O
and,O
slight,B-PR
valgus,I-PR
instability,I-PR
.,O

She,O
had,O
no,O
Lachmann,O
or,O
anterior,O
drawer,O
",",O
she,O
did,O
have,O
a,B-PR
mild,I-PR
effusion,I-PR
.,O

She,O
had,O
normal,O
sensation,O
and,O
pulses,O
in,O
both,O
legs,O
.,O

LABORATORY,O
DATA,O
:,O

On,O
admission,O
included,O
a,B-TE
hematocrit,I-TE
of,O
34.2,O
.,O

Potassium,B-TE
4.4,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
cleared,O
for,O
surgery,B-TR
by,O
Dr.,O
Lupevickette,O
Ca,O
.,O

Her,B-TE
EKG,I-TE
was,O
normal,O
.,O

She,O
was,O
therefore,O
taken,O
to,O
the,O
Operating,O
Room,O
on,O
6/26,O
and,O
underwent,O
a,B-TR
left,I-TR
total,I-TR
knee,I-TR
arthroplasty,I-TR
losing,O
200,O
cc,O
of,O
blood,O
in,O
the,B-TR
procedure,I-TR
with,O
two,B-TR
drains,I-TR
left,O
in,O
which,O
were,O
removed,O
on,O
the,O
first,O
postoperative,O
day,O
.,O

She,O
was,O
slightly,B-PR
agitated,I-PR
on,O
the,O
first,O
postoperative,O
day,O
but,O
this,O
resolved,O
by,O
the,O
second,O
postoperative,O
day,O
.,O

Her,B-TR
epidural,I-TR
catheter,I-TR
was,O
removed,O
on,O
6/29,O
.,O

The,B-TR
Foley,I-TR
catheter,I-TR
was,O
removed,O
on,O
6/29,O
and,O
she,O
had,O
no,O
difficulties,B-PR
voiding,I-PR
.,O

Psychiatry,O
Service,O
saw,O
her,O
on,O
6/28,O
and,O
recommended,O
avoiding,O
benzodiazepines,B-TR
and,O
Haldol,B-TR
for,O
agitation,B-PR
.,O

She,O
was,O
prophylaxed,O
with,O
Kefzol,B-TR
perioperatively,O
and,O
with,O
Coumadin,B-TR
postoperatively,O
.,O

She,O
was,O
also,O
given,O
whiskey,B-TR
spirits,I-TR
because,O
of,O
the,O
fact,O
that,O
she,O
drank,O
one,O
to,O
two,O
drinks,O
of,O
scotch,O
per,O
day,O
.,O

Her,B-TE
hematocrit,I-TE
was,O
31.4,O
on,O
6/29,O
with,O
a,B-TE
PT,I-TE
of,O
18.2,O

Her,B-TE
PT,I-TE
drifted,O
down,O
to,O
a,O
level,O
of,O
12.9,O
by,O
7/3,O
and,O
therefore,O
she,O
will,O
be,O
discharged,O
with,O
4,O
mg,O
of,O
Coumadin,B-TR
per,O
day,O
to,O
be,O
followed,O
by,O
the,O
Coumadin,O
Clinic,O
at,O
Cowerin,O
Tonli,O
Medical,O
Center,O
.,O

She,O
was,O
discharged,O
with,O
a,O
prescription,O
for,O
Tylenol,B-TR
#3,I-TR
with,O
Physical,B-TR
Therapy,I-TR
.,O

She,O
did,O
quite,O
well,O
with,O
Physical,B-TR
Therapy,I-TR
and,O
was,O
ambulating,O
with,O
a,B-TR
walker,I-TR
and,O
crutches,B-TR
by,O
7/3/90,O
.,O

She,O
was,O
able,O
to,O
flex,O
her,O
knees,O
to,O
90,O
degrees,O
by,O
that,O
time,O
.,O

She,O
developed,O
no,O
problems,O
with,O
edema,B-PR
or,O
with,O
her,B-PR
wound,I-PR
during,O
her,O
hospital,O
stay,O
.,O

She,O
will,O
follow-up,O
with,O
Dr.,O
Koors,O
in,O
approximately,O
five,O
weeks,O
.,O

________________________________,O

IA605/6041,O
DE,O
KOORS,O
",",O
M.D.,O
CU2,O

D,O
:,O

07/03/90,O

Batch,O
:,O

1726,O

Report,O
:,O

J0929X49,O

T,O
:,O

07/04/90,O

Dicatated,O
By,O
:,O

LENTNY,O
FARSTNAPPSSHEE,O
",",O
M.D.,O

270045381,O

BH,O

6676757,O

650129,O

10/10/1997,O
12:00:00,O
AM,O

LEFT,B-PR
PROXIMAL,I-PR
HUMERUS,I-PR
FRACTURE,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

DISCHARGE,O
SUMMARY,O
NAME,O
:,O

JUNK,O
",",O
KACHOLERA,O

UNIT,O
NUMBER,O
:,O

482-31-51,O

ADMISSION,O
DATE,O
:,O

10/10/97,O

DISCHARGE,O
DATE,O
:,O

10/23/97,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Left,B-PR
proximal,I-PR
humerus,I-PR
fracture,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

Adult-onset,B-PR
diabetes,I-PR
mellitus,I-PR
x,O
40,O
years,O
",",O
history,O
of,O
silent,B-PR
myocardial,I-PR
infarction,I-PR
",",O
coronary,B-TR
artery,I-TR
bypass,I-TR
graft,I-TR
(,O
three,O
vessels,O
in,O
1987,O
),O
",",O
history,O
of,O
chronic,B-PR
",",I-PR
stable,I-PR
angina,I-PR
pectoris,I-PR
",",O
Fournier,B-PR
&apos;s,I-PR
gangrene,I-PR
versus,O
necrotizing,B-PR
fasciitis,I-PR
",",O
congestive,B-PR
heart,I-PR
failure,I-PR
in,O
03/97,O
while,O
in,O
the,O
hospital,O
for,O
a,B-PR
rib,I-PR
fracture,I-PR
",",O
glaucoma,B-PR
",",O
diabetic,B-PR
retinopathy,I-PR
with,O
blindness,B-PR
in,I-PR
the,I-PR
right,I-PR
eye,I-PR
",",O
history,O
of,O
gastric,B-TR
stapling,I-TR
",",O
left,B-PR
rib,I-PR
fracture,I-PR
",",O
right,B-TR
femur,I-TR
surgery,I-TR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

Left,B-TR
shoulder,I-TR
hemiarthroplasty,I-TR
.,O

OTHER,O
PROCEDURES,O
:,O

Upper,B-TR
endoscopy,I-TR
x,O
2,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
65-year-old,O
male,O
with,O
a,O
past,O
medical,O
history,O
of,O
diabetes,B-PR
mellitus,I-PR
",",O
three-vessel,B-TR
coronary,I-TR
artery,I-TR
bypassgraft,I-TR
",",O
congestive,B-PR
heart,I-PR
failure,I-PR
",",O
who,O
presents,O
with,O
a,B-PR
humeral,I-PR
fracture,I-PR
.,O

The,O
patient,O
is,O
admitted,O
for,O
preoperative,B-TE
and,I-TE
orthopedic,I-TE
evaluations,I-TE
.,O

The,O
patient,O
presented,O
with,O
a,B-PR
comminuted,I-PR
fracture,I-PR
of,I-PR
the,I-PR
proximal,I-PR
left,I-PR
humerus,I-PR
when,O
he,O
slipped,O
over,O
the,O
stairs,O
",",O
about,O
to,O
board,O
an,O
airplane,O
back,O
to,O
Jeglas,O
Blvd.,O
",",O
Jolouisrowarlihis,O
",",O
Alabama,O
86071,O
.,O

The,B-PR
fracture,I-PR
was,O
seen,O
by,O
Orthopedics,O
and,O
was,O
reduced,O
.,O

During,O
conscious,B-TR
sedation,I-TR
",",O
the,O
patient,O
developed,O
bigeminy,B-PR
(,O
the,O
patient,O
was,O
sedated,O
",",O
did,O
not,O
feel,O
chest,B-PR
pain,I-PR
or,O
shortness,B-PR
of,I-PR
breath,I-PR
),O
.,O

The,O
patient,O
presented,O
to,O
Bri,O
Health,O
in,O
order,O
to,O
be,O
evaluated,O
for,O
preoperative,B-TE
clearance,I-TE
.,O

He,O
was,O
reported,O
to,O
have,O
had,O
a,B-PR
myocardial,I-PR
infarction,I-PR
in,O
the,O
past,O
(,O
EKG,B-TE
positive,O
for,O
ischemia,B-PR
",",O
exercise,B-TE
tolerance,I-TE
test,I-TE
positive,O
",",O
cardiac,B-TE
catheterization,I-TE
positive,O
",",O
the,O
patient,O
is,O
now,O
status,O
posta,O
three-vessel,B-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
in,O
1987,O
),O
.,O

The,O
patient,O
also,O
hada,O
history,O
of,O
arrhythmia,B-PR
",",O
found,O
approximately,O
ten,O
years,O
ago,O
",",O
unknown,O
what,O
type,O
.,O

The,O
patient,O
was,O
on,O
coumadin,B-TR
recently,O
",",O
?,O
whether,O
for,O
the,O
arrhythmia,B-PR
.,O

Coumadin,B-TR
was,O
reportedly,O
discontinued,O
approximately,O
six,O
months,O
ago,O
secondary,O
to,O
planned,O
surgery,B-TR
for,O
diabetic,B-PR
retinopathy,I-PR
and,O
glaucoma,B-PR
.,O

The,O
patient,O
did,O
not,O
have,O
chest,B-PR
pain,I-PR
until,O
approximately,O
1-1/2,O
years,O
ago,O
",",O
when,O
he,O
began,O
to,O
have,O
chest,B-PR
tightness,I-PR
(,I-PR
pressure,I-PR
),I-PR
approximately,O
every,O
three,O
months,O
with,O
stress,B-PR
.,O

The,O
patient,O
has,O
no,O
chest,B-PR
pain,I-PR
when,O
walking,O
slowly,O
and,O
can,O
walk,O
approximately,O
1.5,O
miles,O
.,O

He,O
can,O
climb,O
approximately,O
three,O
flights,O
of,O
stairs,O
before,O
becoming,O
short,B-PR
of,I-PR
breath,I-PR
.,O

He,O
does,O
become,O
slightly,B-PR
short,I-PR
of,I-PR
breath,I-PR
when,O
lifting,O
furniture,O
.,O

On,O
the,O
day,O
of,O
admission,O
",",O
when,O
he,O
fell,O
",",O
the,O
patient,O
was,O
experiencing,O
no,O
chest,B-PR
pain,I-PR
",",O
no,O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
and,O
had,O
no,O
loss,B-PR
of,I-PR
consciousness,I-PR
",",O
no,O
head,B-PR
trauma,I-PR
with,I-PR
fall,I-PR
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

No,O
fevers,B-PR
or,O
chills,B-PR
",",O
no,O
chest,B-PR
pain,I-PR
",",O
no,O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

The,O
patient,O
has,O
stable,B-PR
three-pillow,I-PR
orthopnea,I-PR
and,O
occasional,B-PR
paroxysmal,I-PR
nocturnal,I-PR
dyspnea,I-PR
.,O

He,O
has,O
a,B-PR
chronic,I-PR
cough,I-PR
with,O
clear,B-PR
sputum,I-PR
.,O

No,O
hemoptysis,B-PR
",",O
hematemesis,B-PR
",",O
abdominal,B-PR
pain,I-PR
",",O
black,B-PR
or,I-PR
tarry,I-PR
stools,I-PR
",",O
dysuria,B-PR
/,O
frequency/urgency,B-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Some,O
type,O
of,O
cardiac,B-PR
arrhythmia,I-PR
",",O
diagnosed,O
approximately,O
ten,O
years,O
ago,O
.,O

History,O
of,O
coronary,B-PR
artery,I-PR
disease,I-PR
status,O
post,O
silent,B-PR
myocardial,I-PR
infarction,I-PR
in,O
the,O
past,O
and,O
three-vessel,B-TR
coronary,I-TR
artery,I-TR
bypass,I-TR
graft,I-TR
in,O
1987,O
.,O

The,O
patient,O
has,O
been,O
experiencing,O
chronic,B-PR
",",I-PR
stable,I-PR
angina,I-PR
pectoris,I-PR
over,O
the,O
past,O
one,O
to,O
one,O
and,O
a,O
half,O
years,O
approximately,O
once,O
every,O
three,O
months,O
.,O

History,O
of,O
congestive,B-PR
heart,I-PR
failure,I-PR
",",O
diagnosed,O
approximately,O
eight,O
years,O
ago,O
.,O

Diabetes,B-PR
mellitus,I-PR
for,O
approximately,O
40,O
years,O
.,O

Fournier,B-PR
&apos;s,I-PR
gangrene,I-PR
versus,O
necrotizing,B-PR
fasciitis,I-PR
.,O

Glaucoma,B-PR
.,O

Diabetic,B-PR
retinopathy,I-PR
with,O
the,O
patient,O
blind,B-PR
in,I-PR
right,I-PR
eye,I-PR
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

Cholecystectomy,B-TR
.,O

Status,O
post,O
gastric,B-TR
stapling,I-TR
.,O

Left,B-PR
rib,I-PR
fracture,I-PR
.,O

Right,B-TR
femur,I-TR
surgery,I-TR
approximately,O
two,O
years,O
ago,O
.,O

Righteye,B-TR
surgery,I-TR
for,O
glaucoma,B-PR
in,O
05/97,O
.,O

Laser,B-TR
surgery,I-TR
for,O
retinopathy,B-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Humulin,B-TR
70/30,O
with,O
30,O
units,O
subq.q.a.m.,O
and,O
20,O
units,O
subq.q.p.m.,O
Vasotec,B-TR
20,O
mg.,O
q.,O
a.m.,O
Prozac,B-TR
40,O
mg.,O
q.d.,O
Lasix,B-TR
40,O
mg.,O
q.d.,O
K-Dur,B-TR
approximately,O
28,O
?,O
mEq,O
q.d.,O
Atropine,B-TR
1%,O
1,O
GTT,O
OD,O
b.i.d.,O
Ocufen,B-TR
0.03%,O
1,O
GTT,O
OD,O
t.i.d.,O
Ventolin,B-TR
metered-dose,O
inhaler,O
.,O

ALLERGIES,O
:,O

no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

TOBACCO,O
:,O

Formerly,O
smoked,O
3,O
packs,O
per,O
day,O
x,O
25,O
years,O
;,O
2,O
cigars,O
per,O
day,O
x,O
approximately,O
6,O
months,O
.,O

He,O
quit,O
all,O
tobacco,O
approximately,O
27,O
years,O
ago,O
.,O

ETOH,O
:,O

Rare,O
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
is,O
retired,O
",",O
lives,O
with,O
his,O
wife,O
and,O
one,O
son,O
",",O
who,O
is,O
47,O
years,O
old,O
and,O
had,O
multiple,B-PR
myeloma,I-PR
and,O
renal,B-PR
failure,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,O
patient,O
is,O
alert,O
and,O
oriented,O
and,O
has,O
a,B-TR
sling,I-TR
for,O
his,B-PR
left,I-PR
humeral,I-PR
fracture,I-PR
.,O

Blood,B-TE
pressure,I-TE
120/70,O
",",O
temperature,B-TE
97.8,O
F,O
",",O
pulse,B-TE
68,O
",",O
respirations,B-TE
22,O
",",O
Sa02,B-TE
on,O
2,O
L,O
94%,O
.,O

HEENT,O
:,O

Right-sided,B-PR
ptosis,I-PR
",",O
right,O
eye,O
not,O
reactive,O
to,O
light,O
",",O
cataract,B-PR
present,O
",",O
patient,O
blind,B-PR
in,I-PR
that,I-PR
eye,I-PR
",",O
left,O
eye,O
reactive,O
to,O
light,O
",",O
cataract,B-PR
also,O
present,O
in,O
that,O
eye,O
.,O

Extraocular,B-TE
movements,I-TE
-,O
conjugated,O
eye,O
movement,O
intact,O
.,O

Oropharynx,O
moist,O
",",O
without,O
lesions,B-PR
.,O

Mild,B-PR
right,I-PR
facial,I-PR
droop,I-PR
.,O

Sensation,O
intact,O
.,O

No,O
slurred,B-PR
speech,I-PR
.,O

Cardiac,O
:,O

regular,O
rate,O
and,O
rhythm,O
",",O
no,O
murmur,B-PR
appreciated,O
",",O
normal,O
S1,O
and,O
S2,O
.,O

Chest,O
/,O
lungs,O
:,O

The,O
patient,O
is,O
diffusely,B-PR
wheezy,I-PR
upon,O
presentation,O
.,O

Abdomen,B-PR
distended,I-PR
",",O
mild,B-PR
tenderness,I-PR
on,I-PR
the,I-PR
left,I-PR
",",O
bowel,B-TE
sounds,I-TE
present,O
",",O
nohepatosplenomegaly,B-PR
.,O

Extremities,O
:,O

1+,B-PR
edema,I-PR
of,I-PR
the,I-PR
ankles,I-PR
",",O
pulses,B-TE
present,O
bilaterally,O
.,O

No,O
calf,B-PR
tenderness,I-PR
.,O

Rectal,O
:,O

Guaiac,B-TE
negative,O
.,O

Neurological,O
:,O

Non-focal,O
",",O
except,O
unable,O
to,O
assess,O
left,O
upper,O
extremity,O
secondary,O
to,O
the,B-PR
patient,I-PR
&apos;s,I-PR
broken,I-PR
humeral,I-PR
fracture,I-PR
.,O

LABORATORY,O
DATA,O
:,O

sodium,B-TE
135,O
",",O
potassium,B-TE
4.1,O
",",O
chloride,B-TE
101,O
",",O
C02,B-TE
28.4,O
",",O
BUN,B-TE
17,O
",",O
creatinine,B-TE
1.0,O
",",O
glucose,B-TE
302,O
",",O
calcium,B-TE
8.6,O
",",O
phosphorus,B-TE
2.5,O
",",O
magnesium,B-TE
1.6,O
",",O
total,B-TE
protein,I-TE
6.7,O
",",O
albumin,B-TE
3.3,O
",",O
globulin,B-TE
3.4,O
",",O
uric,B-TE
acid,I-TE
6.3,O
",",O
totalbilirubin,B-TE
.7,O
",",O
alkaline,B-TE
phosphatase,I-TE
93,O
",",O
SGOT,B-TE
20,O
",",O
LDH,B-TE
258,O
",",O
CPK,B-TE
95,O
",",O
whiteblood,B-TE
count,I-TE
15.3,O
",",O
hematocrit,B-TE
49.7,O
",",O
platelet,B-TE
count,I-TE
159,O
",",O
MCV,B-TE
98,O
.,O

RADIOLOGIC,O
STUDIES,O
:,O

Chest,B-TE
x-ray,I-TE
10/10/97,O
:,O

Elevated,B-PR
left,I-PR
hemidiaphragm,I-PR
of,O
uncertain,O
etiology,O
or,O
duration,O
.,O

Postoperative,B-PR
changes,I-PR
of,I-PR
the,I-PR
sternum,I-PR
and,I-PR
media,I-PR
stinum,I-PR
were,O
seen,O
and,O
no,O
acute,B-PR
pulmonary,I-PR
disease,I-PR
was,O
visualized,O
.,O

The,O
patient,O
also,O
had,O
a,B-TE
shoulder,I-TE
film,I-TE
done,O
on,O
10/10/97,O
that,O
showed,O
a,B-PR
severely,I-PR
comminuted,I-PR
fracture,I-PR
of,I-PR
the,I-PR
proximal,I-PR
left,I-PR
humerus,I-PR
with,O
proximal,B-PR
distraction,I-PR
.,O

A,B-PR
lucency,I-PR
and,I-PR
irregularity,I-PR
of,I-PR
the,I-PR
glenoid,I-PR
",",O
possibly,O
representing,O
a,B-PR
fracture,I-PR
",",O
was,O
also,O
seen,O
",",O
and,O
a,B-TE
CT,I-TE
scan,I-TE
was,O
therefore,O
obtained,O
in,O
order,O
to,O
evaluate,O
this,O
area,O
.,O

This,B-TE
CT,I-TE
scan,I-TE
",",O
done,O
also,O
on,O
10/10/97,O
",",O
again,O
showed,O
the,B-PR
severely,I-PR
comminuted,I-PR
fracture,I-PR
of,I-PR
the,I-PR
proximal,I-PR
left,I-PR
humerus,I-PR
.,O

Two,B-PR
major,I-PR
fracture,I-PR
fragments,I-PR
were,O
seen,O
at,O
the,O
humeral,O
head,O
",",O
articulating,O
with,O
the,O
glenoid,O
fossa,O
.,O

The,B-PR
fracture,I-PR
fragments,I-PR
retained,O
their,O
proper,O
site,O
of,O
articulation,O
with,O
the,O
glenoid,O
fossa,O
.,O

Innumerable,B-PR
smaller,I-PR
fracture,I-PR
fragments,I-PR
were,O
interposed,O
between,O
the,B-PR
fracture,I-PR
fragment,I-PR
and,O
the,O
distal,O
humeral,O
shaft,O
.,O

The,O
glenoid,O
fossa,O
was,O
intact,O
.,O

No,O
scapular,B-PR
fractures,I-PR
were,O
present,O
.,O

EKG,B-TE
:,O

normal,O
sinus,O
rhythm,O
at,O
72,O
beats,B-TE
/,I-TE
minute,I-TE
",",O
intraventricular,B-PR
conduction,I-PR
delay,I-PR
",",O
Q,O
-,O
waves,O
seen,O
in,O
II,O
",",O
III,O
",",O
and,O
AVF,O
with,O
probable,O
old,B-PR
inferior,I-PR
myocardial,I-PR
infarction,I-PR
.,O

T,O
-,O
waves,O
were,O
also,O
noted,O
to,O
be,O
inverted,O
in,O
I,O
and,O
AVL,O
.,O

Ventricular,B-PR
bigeminy,I-PR
was,O
also,O
seen,O
.,O

HOSPITAL,O
COURSE,O
AND,O
TREATMENT,O
:,O

1.,O
ORTHOPEDICS,O
:,O

The,O
patient,O
has,O
a,B-PR
severely,I-PR
comminuted,I-PR
fracture,I-PR
of,I-PR
the,I-PR
proximal,I-PR
left,I-PR
humerus,I-PR
.,O

He,O
is,O
status,O
post,O
a,B-TR
hemiarthroplasty,I-TR
on,O
10/17/97,O
.,O

He,O
received,O
Ancef,B-TR
preoperatively,O
.,O

Physical,O
Therapy,O
has,O
been,O
seeing,O
the,O
patient,O
and,O
putting,O
him,O
through,O
passive,B-TR
external,I-TR
rotation,I-TR
to,O
the,O
neutral,O
position,O
of,O
the,O
left,O
shoulder,O
and,O
forward,O
flexion,O
with,O
physical,B-TR
therapy,I-TR
assistance,I-TR
.,O

Brittle,B-PR
bones,I-PR
were,O
noted,O
during,O
the,B-TR
operation,I-TR
.,O

A,B-TE
bone,I-TE
density,I-TE
scan,I-TE
would,O
be,O
recommended,O
as,O
an,O
outpatient,O
",",O
in,O
order,O
to,O
evaluate,O
this,O
.,O

2.,O
NEUROLOGICAL,O
:,O

The,O
patient,O
has,O
right,B-PR
facial,I-PR
droop,I-PR
",",O
right,B-PR
ptosis,I-PR
",",O
stable,O
and,O
present,O
for,O
greater,O
than,O
one,O
year,O
.,O

3.,O
CARDIOVASCULAR,O
:,O

No,O
chest,B-PR
pain,I-PR
",",O
no,O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
1+,B-PR
ankle,I-PR
edema,I-PR
.,O

The,O
patient,O
was,O
ruled,O
out,O
for,O
a,B-PR
myocardial,I-PR
infarction,I-PR
",",O
given,O
his,B-PR
fall,I-PR
at,O
the,O
airport,O
and,O
bigeminy,B-PR
seen,O
on,O
electrocardiogram,B-TE
that,O
he,O
developed,O
during,O
conscious,B-TR
sedation,I-TR
during,O
reduction,B-TR
of,I-TR
the,I-TR
fracture,I-TR
.,O

Cardiology,O
was,O
consulted,O
and,O
aspirin,B-TR
and,O
beta,B-TR
blocker,I-TR
added,O
to,O
his,B-TR
regimen,I-TR
",",O
as,O
well,O
as,O
chest,B-TR
wall,I-TR
nitroglycerin,I-TR
around,O
the,O
time,O
of,O
surgery,B-TR
",",O
which,O
was,O
subsequently,O
discontinued,O
.,O

An,B-TE
adenosine,I-TE
SESTAMIBI,I-TE
was,O
performed,O
on,O
10/12/97,O
",",O
which,O
showed,O
a,O
negative,O
electrocardiogram,O
for,O
ischemia,B-PR
and,O
cardiac,B-TE
perfusion,I-TE
scans,I-TE
",",O
with,O
a,B-PR
moderate-sized,I-PR
",",I-PR
dense,I-PR
",",I-PR
fixed,I-PR
inferior,I-PR
defect,I-PR
indicative,O
of,O
scar,B-PR
.,O

A,B-PR
small,I-PR
/,I-PR
moderate-sized,I-PR
",",I-PR
mild-intensity,I-PR
",",I-PR
reversible,I-PR
posterior,I-PR
lateral,I-PR
defect,I-PR
was,O
also,O
seen,O
",",O
indicative,O
of,O
mild,B-PR
/,I-PR
moderate,I-PR
ischemia,I-PR
.,O

An,B-TE
echocardiogram,I-TE
was,O
performed,O
on,O
Columbus,O
Day,O
which,O
showed,O
an,B-TE
ejection,I-TE
fraction,I-TE
of,O
50%,O
",",O
left,B-PR
atrial,I-PR
enlargement,I-PR
",",O
thickening,B-PR
of,I-PR
the,I-PR
aortic,I-PR
wall,I-PR
consistent,O
with,O
atherosclerotic,B-PR
changes,I-PR
",",O
left,O
ventricle,O
size,O
",",O
and,O
systolic,O
function,O
within,O
normal,O
limits,O
.,O

Cardiac,B-TE
monitor,I-TE
was,O
placed,O
on,O
the,O
patient,O
",",O
given,O
the,B-PR
bigeminy,I-PR
",",O
and,O
he,O
did,O
rule,O
out,O
for,O
myocardial,B-PR
infarction,I-PR
.,O

Cardiology,O
recommended,O
that,O
in,O
addition,O
to,O
the,B-TR
medications,I-TR
already,O
stated,O
above,O
",",O
his,B-TE
hematocrit,I-TE
be,O
kept,O
greater,O
than,O
30,O
.,O

After,O
his,B-TR
procedure,I-TR
on,O
10/17/97,O
",",O
elevated,B-PR
CPKs,I-PR
were,O
noted,O
on,O
10/19/97,O
to,O
10/20/97,O
",",O
and,O
the,O
first,O
level,O
was,O
744,O
",",O
CPK,B-TE
#,O
2,O
635,O
",",O
and,O
CPK,B-TE
#,O
3,O
461,O
.,O

MB,B-PR
fractionations,I-PR
of,O
the,B-TE
CPKs,I-TE
were,O
all,O
negative,O
and,O
were,O
thought,O
to,O
be,O
secondary,O
to,O
the,O
patient,O
&apos;s,O
beginning,O
physical,O
therapy,O
on,O
10/19/97,O
",",O
and,O
all,O
muscular,O
in,O
origin,O
.,O

4.,O
GASTROENTEROLOGY,O
:,O

GI,O
was,O
consulted,O
on,O
10/15/97,O
for,O
melena,B-PR
",",O
decreased,B-PR
hematocrit,I-PR
prior,O
to,O
his,B-TR
humeral,I-TR
fixation,I-TR
surgery,I-TR
.,O

Upper,B-TE
endoscopy,I-TE
x,I-TE
2,I-TE
were,O
done,O
.,O

The,O
first,O
was,O
on,O
10/15/97,O
",",O
which,O
showed,O
clotted,B-PR
blood,I-PR
in,I-PR
the,I-PR
esophagus,I-PR
.,O

The,O
stomach,O
had,O
evidence,O
of,O
prior,B-TR
surgery,I-TR
and,O
old,B-PR
blood,I-PR
in,I-PR
the,I-PR
stomach,I-PR
.,O

It,O
was,O
thought,O
that,O
the,B-PR
blood,I-PR
in,I-PR
the,I-PR
esophagus,I-PR
was,O
secondary,O
to,O
a,O
possible,O
Mallory-Weiss,B-PR
tear,I-PR
.,O

A,B-TE
second,I-TE
endoscopy,I-TE
was,O
also,O
performed,O
several,O
days,O
later,O
",",O
in,O
order,O
to,O
rule,O
out,O
a,B-PR
gastric,I-PR
ulcer,I-PR
",",O
and,O
also,O
because,O
the,O
patient,O
had,O
had,O
another,O
episode,O
of,O
melena,B-PR
.,O

A,B-PR
gastric,I-PR
ulcer,I-PR
was,O
found,O
and,O
this,O
was,O
biopsied,O
and,O
pathology,B-TE
is,O
pending,O
at,O
this,O
time,O
.,O

This,O
report,O
needs,O
to,O
be,O
followed,O
up,O
",",O
and,O
will,O
be,O
available,O
at,O
Bri,O
Health,O
in,O
the,O
Pathology,O
Department,O
some,O
time,O
within,O
the,O
next,O
three,O
to,O
seven,O
days,O
.,O

The,O
patient,O
also,O
needs,O
a,B-TE
repeat,I-TE
endoscopy,I-TE
and,O
a,B-TE
GI,I-TE
follow-up,I-TE
appointment,O
inapproximately,O
two,O
months,O
.,O

I,O
have,O
spoken,O
with,O
the,O
patient,O
in,O
detail,O
",",O
and,O
he,O
will,O
be,O
getting,O
in,O
touch,O
with,O
his,O
primary-care,O
physician,O
",",O
Dr.,O
Fordwoodall,O
Stick,O
",",O
in,O
Ranegei,O
Pkwy,O
",",O
Verertliet,O
",",O
South,O
Carolina,O
62156,O
.,O

The,O
patient,O
is,O
to,O
arrange,O
follow,O
up,O
with,O
a,O
GI,O
doctor,O
in,O
Jotar,O
Boulevard,O
",",O
Cunahtampfordama,O
",",O
South,O
Dakota,O
62848,O
through,O
his,O
primary-care,O
physician,O
.,O

The,O
patient,O
was,O
initially,O
on,O
Cimetidine,B-TR
and,O
Carafate,B-TR
here,O
at,O
Bri,O
Health,O
",",O
and,O
then,O
switched,O
to,O
Prilosec,B-TR
20,O
mg,O
bid,O
.,O

5.,O
PULMONARY,O
:,O

The,B-TE
patient,I-TE
&apos;s,I-TE
admitting,I-TE
chest,I-TE
x-ray,I-TE
showed,O
an,B-PR
elevated,I-PR
left,I-PR
hemidiaphragm,I-PR
consistent,O
with,O
atelectasis,B-PR
versus,O
splinting,B-PR
on,I-PR
that,I-PR
side,I-PR
.,O

Incentive,B-TR
spirometry,I-TR
was,O
started,O
.,O

Albuterol,B-TR
and,I-TR
Atrovent,I-TR
nebulizers,I-TR
were,O
done,O
.,O

The,O
patient,O
received,O
chest,B-TR
physical,I-TR
therapy,I-TR
bid,O
.,O

6.,O
ENDOCRINE,O
:,O

The,O
patient,O
needs,O
still,O
better,O
diabetes,B-TR
control,I-TR
.,O

He,O
has,O
been,O
somewhat,O
noncompliant,O
with,O
his,O
diet,O
(,O
eating,O
Pringle,O
&apos;s,O
in,O
the,O
room,O
),O
.,O

His,B-TR
NPH,I-TR
was,O
recently,O
increased,O
today,O
(,O
10/23/97,O
),O
to,O
24,O
units,O
in,O
the,O
a.m.,O
and,O
14,O
units,O
in,O
the,O
p.m.,O
with,O
CZI,B-TR
sliding-scale,I-TR
coverage,I-TR
.,O

7.,O
INFECTIOUS,O
DISEASE,O
:,O

The,B-TE
patient,I-TE
urinalysis,I-TE
on,O
10/19/97,O
showed,O
moderate,B-PR
occult,I-PR
blood,I-PR
",",O
pH,B-TE
5,O
",",O
albumin,B-TE
1+,O
",",O
white,B-TE
blood,I-TE
cells,I-TE
present,O
",",O
2-50,O
red,B-TE
blood,I-TE
cell,I-TE
",",O
10-20,O
white,B-TE
blood,I-TE
cells,I-TE
",",O
few,B-PR
bacteria,I-PR
",",O
and,O
moderate,B-PR
bladder,I-PR
epithelial,I-PR
cells,I-PR
.,O

Floxin,B-TR
200,O
mg,O
po,O
bid,O
was,O
begun,O
.,O

However,O
",",O
his,B-TE
urine,I-TE
culture,I-TE
from,O
the,O
same,O
day,O
remained,O
negative,O
",",O
and,O
this,O
was,O
discontinued,O
two,O
days,O
later,O
.,O

A,B-TE
repeat,I-TE
urinalysis,I-TE
on,O
10/22/97,O
was,O
negative,O
.,O

8.,O
RENAL,O
:,O

After,O
the,B-TR
patient,I-TR
&apos;s,I-TR
procedure,I-TR
",",O
he,O
was,O
felt,O
to,O
be,O
volume,B-PR
overloaded,I-PR
.,O

He,O
was,O
given,O
Lasix,B-TR
40,O
mg,O
IV,O
x,O
1,O
and,O
also,O
had,O
Nitro,B-TR
paste,I-TR
around,O
the,O
time,O
of,O
his,B-TR
surgery,I-TR
and,O
beta,B-TR
blocker,I-TR
.,O

The,O
patient,O
became,O
slightly,B-PR
hypotensive,I-PR
on,O
the,O
night,O
of,O
10/18/97,O
with,O
systolic,B-TE
blood,I-TE
pressures,I-TE
in,O
the,O
80s,O
to,O
90s.,O

His,B-TE
BUN/,I-TE
creatinine,I-TE
rose,O
from,O
16/1.2,O
on,O
10/18/97,O
to,O
25/1.9,O
on,O
10/18/97,O
to,O
22/9.1,O
to,O
today,O
&apos;s,O
labs,O
",",O
which,O
are,O
15/0.7,O
on,O
10/23/97,O
.,O

9.,O
HEMATOLOGY,O
:,O

The,O
patient,O
transfused,O
2,O
units,O
on,O
10/15/97,O
for,O
a,B-TE
hematocrit,I-TE
of,O
27.6,O
.,O

The,O
patient,O
transfused,O
2,O
units,O
of,O
10/16/97,O
for,O
a,B-TE
hematocrit,I-TE
of,O
30.03,O
.,O

The,O
patient,O
transfused,O
1,O
unit,O
on,O
10/18/97,O
for,O
a,B-TE
hematocrit,I-TE
of,O
29.4,O
.,O

The,O
patient,O
transfused,O
1,O
unit,O
on,O
10/19/97,O
for,O
a,B-TE
hematocrit,I-TE
of,O
27.9,O
.,O

The,O
patient,O
transfused,O
2,O
units,O
on,O
10/20/97,O
for,O
a,B-TE
hematocrit,I-TE
of,O
28.2.10,O
.,O

FEN,O
:,O

Repleting,O
potassium,B-TR
",",O
magnesium,B-TR
",",O
phosphorus,B-TR
as,O
needed,O
.,O

The,O
patient,O
was,O
noted,O
to,O
be,O
slightly,B-PR
hyponatremic,I-PR
over,O
the,O
past,O
few,O
days,O
",",O
with,O
sodiums,B-TE
in,O
the,O
128-132,O
range,O
",",O
but,O
this,O
was,O
secondary,O
to,O
elevated,B-PR
glucose,I-PR
fingerstick,I-PR
blood,I-PR
sugars,I-PR
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
",",O
good,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

NPH,B-TR
insulin,I-TR
24,O
units,O
subq.,O
q.,O
a.m.,O
NPH,B-TR
insulin,I-TR
14,O
units,O
subq.,O
q.,O
p.m.,O
CZI,B-TR
sliding,O
scale,O
on,O
a,O
q.,O
a.c.,O
and,O
q.,O
h.s.,O
fingerstick,O
basis,O
with,O
the,O
following,O
scale,O
:,O

FBS,B-TE
less,O
than,O
200,O
=,O
0,O
units,O
of,O
CZI,B-TR
FBS,B-TE
201-250,O
=,O
2,O
units,O
of,O
CZI,B-TR
FBS,B-TE
251-300,O
=,O
4,O
units,O
of,O
CZI,B-TR
FBS,B-TE
301-350,O
=,O
6,O
units,O
of,O
CZI,B-TR
FBS,B-TE
351-400,O
=,O
8,O
units,O
of,O
CZI,B-TR
FBS,B-TE
greater,O
than,O
400,O
=,O
10,O
units,O
of,O
CZI,B-TR
.,O

Atropine,B-TR
sulfate,I-TR
1,O
GTT,O
1%,O
OD,O
b.i.d.,O

Ocufen,B-TR
0.03%,O
1,O
GTT,O
OD,O
t.i.d.,O
Vasotec,B-TR
20,O
mg.,O
p.o.q.,O
a.m.,O
Prozac,B-TR
40,O
mg.p.o.q.,O
a.m.,O

Oxygen,B-TR
2-4,O
L,O
to,O
keep,O
Sa02,B-TE
greater,O
than,O
or,O
equal,O
to,O
94-95%,O
and,O
wean,O
as,O
tolerated,O
.,O

Colace,B-TR
100,O
mg.,O
p.o.,O
t.i.d.,O
Senokot,B-TR
1,O
p.o.,O
q.,O
h.s.,O
Nystatin,B-TR
powder,O
to,O
affected,B-PR
area,I-PR
t.i.d.,O
Lopressor,B-TR
25,O
mg.,O
p.o.,O
b.i.d.,O
Atrovent,B-TR
0.8/2.5,O
c.c.,O
normal,B-TR
saline,I-TR
nebulizers,I-TR
q.,O
8,O
h.,O
Albuterol,B-TR
2.5/5,O
c.c.,O
normal,B-TR
saline,I-TR
nebulizers,I-TR
q.,O
4,O
h.,O
with,O
q.,O
2,O
h.,O
p.r.n.,O
Percocet,B-TR
1-2,O
p.o.,O
q.,O
4,O
h.,O
p.r.n.,O
pain,B-PR
.,O

Prilosec,B-TR
20,O
mg.,O
p.o.,O
b.i.d.,O
Vexol,B-TR
1%,O
1,O
GTT,O
OD,O
b.i.d.,O
Lasix,B-TR
40,O
mg.,O
p.o.,O
q.d.,O
KCl,B-TR
20,O
mEq,O
p.o.,O
q.d.,O
Tylenol,B-TR
650,O
mg.,O
p.o.,O
q.,O
12,O
h.,O
p.r.n.,O
Ativan,B-TR
1,O
mg.,O
p.o.,O
q.,O
h.s.,O
p.r.n.,O

SAY,O
REKE,O
",",O
M.D.,O

TR,O
:,O

vr,O

DD,O
:,O

TD,O
:,O

10/23/97,O
3:05,O

Pcc,O
:,O

NABETH,O
NA,O
GLYNCRED,O
",",O
M.D.,O
MI,O
T,O
THULRO,O
",",O
M.D.,O
/,O
Fordwoodall,O
Stick,O
",",O
M.D.,O
7922,O

Fordknoxtall,O
Illinois,O

274230067,O
EH,O

11456974,O

175762,O

02/04/1990,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

02/04/1990,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

02/13/1990,O

PRINCIPLE,O
DIAGNOSIS,O
:,O

LEFT,B-PR
ROTATOR,I-PR
CUFF,I-PR
TEAR,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
52-year-old,O
right,O
handed,O
male,O
with,O
a,O
many,O
year,O
history,O
of,O
bilateral,B-PR
shoulder,I-PR
pain,I-PR
",",O
right,O
greater,O
than,O
left,O
.,O

He,O
has,O
steroid,B-TR
injections,I-TR
in,O
the,O
right,O
and,O
in,O
the,O
left,O
four,O
times,O
.,O

Arthrogram,B-TE
in,O
the,O
distant,O
past,O
showed,O
a,B-PR
right,I-PR
rotator,I-PR
cuff,I-PR
tear,I-PR
and,O
he,O
now,O
has,O
increased,B-PR
pain,I-PR
in,I-PR
his,I-PR
left,I-PR
shoulder,I-PR
.,O

MRI,B-TE
by,O
report,O
showed,O
bilateral,B-TR
rotator,I-TR
cuff,I-TR
repairs,I-TR
and,O
he,O
was,O
admitted,O
for,O
repair,B-TR
of,I-TR
the,I-TR
left,I-TR
rotator,I-TR
cuff,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Back,B-PR
pain,I-PR
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

Ankle,B-TR
surgery,I-TR
times,O
two,O
on,O
the,O
right,O
.,O

Pilonidal,B-TR
cyst,I-TR
removal,I-TR
.,O

MEDICATIONS,O
:,O

On,O
admission,O
included,O
Naprosyn,B-TR
.,O

ALLERGIES,O
:,O

NO,O
KNOWN,B-PR
DRUG,I-PR
ALLERGIES,I-PR
.,O

HABITS,O
:,O

The,O
patient,O
smokes,O
two,O
packs,O
per,O
day,O
and,O
has,O
an,O
approximately,O
a,O
75-pack-year,O
history,O
of,O
smoking,O
.,O

He,O
has,O
a,O
history,O
of,O
drinking,O
which,O
he,O
discontinued,O
in,O
May,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,O
revealed,O
a,O
white,O
male,O
with,O
no,O
palpable,B-PR
adenopathy,I-PR
.,O

HEENT,B-TE
exam,I-TE
was,O
within,O
normal,O
limits,O
.,O

Lungs,O
revealed,O
occasional,B-PR
wheezing,I-PR
bilaterally,I-PR
at,O
both,O
bases,O
.,O

Heart,O
was,O
regular,O
with,O
a,B-PR
I,I-PR
/,I-PR
VI,I-PR
systolic,I-PR
ejection,I-PR
murmur,I-PR
without,O
jugular,B-PR
venous,I-PR
distention,I-PR
.,O

Pulses,B-TE
were,O
2+,O
bilaterally,O
.,O

Abdomen,O
was,O
obese,B-PR
with,O
positive,O
bowel,O
sounds,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
.,O

Examination,B-TE
of,I-TE
his,I-TE
shoulder,I-TE
revealed,O
the,O
patient,O
to,O
be,O
able,O
to,O
flex,O
his,O
right,O
arm,O
to,O
170,O
degrees,O
",",O
internally,O
rotate,O
to,O
10,O
degrees,O
and,O
externally,O
rotate,O
to,O
40,O
degrees,O
with,O
positive,B-PR
joint,I-PR
tenderness,I-PR
.,O

All,O
range,O
of,O
motion,O
with,O
his,O
right,O
shoulder,O
was,O
painful,O
.,O

The,O
left,O
shoulder,O
was,O
identical,O
in,O
range,O
of,O
motion,O
and,O
was,O
also,O
painful,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
with,O
the,B-TE
assessment,I-TE
of,O
left,B-TR
rotator,I-TR
cuff,I-TR
repair,I-TR
and,O
he,O
was,O
taken,O
to,O
the,O
Operating,O
Room,O
on,O
the,O
day,O
of,O
admission,O
where,O
he,O
underwent,O
left,B-TR
rotator,I-TR
cuff,I-TR
repair,I-TR
under,O
general,B-TR
endotracheal,I-TR
tube,I-TR
anesthesia,I-TR
.,O

There,O
were,O
no,O
intraoperative,B-PR
complications,I-PR
.,O

His,O
postoperative,O
course,O
was,O
generally,O
unremarkable,O
except,O
for,O
a,O
prolonged,O
course,O
of,O
advancement,O
with,O
range,O
of,O
motion,O
of,O
his,O
left,O
shoulder,O
.,O

Occupational,O
therapy,O
became,O
involved,O
initially,O
and,O
he,O
remained,O
on,O
patient,B-TR
controlled,I-TR
analgesia,I-TR
secondary,O
to,O
problems,O
with,O
left,B-PR
shoulder,I-PR
pain,I-PR
.,O

He,O
was,O
kept,O
in,O
the,O
hospital,O
for,O
an,O
extended,O
period,O
to,O
improve,O
his,O
postoperative,O
range,O
of,O
motion,O
.,O

However,O
",",O
he,O
was,O
eventually,O
able,O
to,O
achieve,O
forward,O
flexion,O
of,O
135,O
degrees,O
and,O
external,O
rotation,O
of,O
30,O
degrees,O
by,O
postoperative,O
day,O
number,O
eight,O
.,O

His,B-PR
wound,I-PR
remained,O
clean,O
and,O
dry,O
and,O
showed,O
no,O
signs,B-PR
of,I-PR
infection,I-PR
and,O
healed,O
well,O
.,O

However,O
",",O
his,O
course,O
was,O
otherwise,O
complicated,O
by,O
discovery,O
of,O
persistently,B-PR
elevated,I-PR
blood,I-PR
sugars,I-PR
and,O
Endocrinology,O
was,O
consulted,O
to,O
rule,O
out,O
possible,O
newly,B-PR
diagnosed,I-PR
diabetes,I-PR
.,O

His,B-TE
hemoglobin,I-TE
A1C,I-TE
levels,I-TE
actually,O
came,O
back,O
within,O
normal,O
limits,O
",",O
however,O
",",O
the,B-PR
wide,I-PR
excursions,I-PR
of,O
his,B-TE
sugars,I-TE
were,O
consistent,O
with,O
possible,O
diabetes,B-PR
.,O

He,O
was,O
placed,O
on,O
a,B-TR
diabetic,I-TR
diet,I-TR
and,O
his,B-TE
sugars,I-TE
did,O
show,O
some,O
improvement,O
.,O

It,O
was,O
not,O
necessary,O
to,O
start,O
him,O
on,O
oral,B-TR
hypoglycemics,I-TR
or,O
insulin,B-TR
.,O

He,O
also,O
complained,O
of,O
occasional,B-PR
spells,I-PR
and,O
jitteriness,B-PR
and,O
some,B-PR
orthostatic,I-PR
dizziness,I-PR
and,O
thus,O
Neurology,O
was,O
consulted,O
and,O
EMG,B-TE
&apos;s,I-TE
were,O
performed,O
which,O
were,O
normal,O
.,O

His,O
neurologist,O
was,O
contacted,O
",",O
Dr.,O
Cap,O
",",O
and,O
the,O
exact,O
of,O
his,O
problems,O
was,O
not,O
demonstrated,O
during,O
this,O
hospitalization,O
",",O
however,O
",",O
they,O
felt,O
that,O
this,O
could,O
possibly,O
be,O
an,B-PR
autonomic,I-PR
type,I-PR
neuropathy,I-PR
maybe,O
secondary,O
to,O
some,B-PR
underlying,I-PR
diabetic,I-PR
process,I-PR
.,O

Further,B-TE
work-up,I-TE
of,O
his,B-PR
neurologic,I-PR
conditions,I-PR
were,O
planned,O
as,O
an,O
outpatient,O
.,O

Thus,O
",",O
he,O
was,O
discharged,O
on,O
postoperative,O
day,O
number,O
eight,O
in,O
good,O
condition,O
with,O
a,B-PR
well,I-PR
healed,I-PR
left,I-PR
shoulder,I-PR
wound,I-PR
and,O
doing,O
well,O
with,O
occupational,B-TR
therapy,I-TR
with,O
plans,O
for,O
him,O
to,O
follow-up,O
with,O
Dr.,O
Necessary,O
.,O

DISPOSITION,O
:,O

MEDICATIONS,O
:,O

On,O
discharge,O
included,O
Valium,B-TR
",",O
2,O
mg,O
po,O
t.i.d.;,O
Naprosyn,B-TR
",",O
500,O
mg,O
po,O
b.i.d.,O
________________________________,O
ZV061/6138,O
TICENA,O
NECESSARY,O
",",O
M.D.,O
WO00,O

D,O
:,O

03/12/90,O

Batch,O
:,O

2280,O

Report,O
:,O

V1412C43,O

T,O
:,O

03/14/89,O

Dictated,O
By,O
:,O

VITA,O
THOSTERWEN,O
LINKEKOTEMONES,O
",",O
M.D.,O

284487129,O

CTMC,O

42669672,O

466333,O

01/16/1996,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

01/16/1996,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

01/20/1996,O

PROBLEM,O
LIST,O
:,O

1.,O
INSULIN,B-PR
DEPENDENT,I-PR
DIABETES,I-PR
MELLITUS,I-PR

2.,O
PRIOR,O
HISTORY,O
OF,O
ANTERIOR,B-PR
MYOCARDIAL,I-PR
INFARCTION,I-PR

3.,O
EPISODE,O
OF,O
PULMONARY,B-PR
EDEMA,I-PR

4.,O
HYPERCHOLESTEROLEMIA,B-PR

CHIEF,O
COMPLAINT,O
:,O

The,O
patient,O
is,O
a,O
40,O
year,O
old,O
male,O
with,O
a,O
history,O
of,O
prior,B-PR
anterior,I-PR
myocardial,I-PR
infarction,I-PR
and,O
insulin,B-PR
dependent,I-PR
diabetes,I-PR
mellitus,I-PR
who,O
was,O
transferred,O
from,O
an,O
outside,O
hospital,O
after,O
an,O
episode,O
of,O
acute,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
and,O
pulmonary,B-PR
edema,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
has,O
a,O
history,O
four,O
years,O
ago,O
of,O
being,O
admitted,O
to,O
the,O
Etearal,O
Etsystems/,O
Hospital,O
after,O
suffering,O
an,B-PR
acute,I-PR
anterior,I-PR
myocardial,I-PR
infarction,I-PR
.,O

The,O
course,O
had,O
multiple,B-PR
complications,I-PR
requiring,O
pressors,B-TR
.,O

He,O
had,O
a,B-TE
cardiac,I-TE
catheterization,I-TE
performed,O
which,O
revealed,O
a,B-PR
three,I-PR
vessel,I-PR
coronary,I-PR
artery,I-PR
disease,I-PR
with,O
an,B-PR
occluded,I-PR
RCA,I-PR
",",O
70%-80%,B-PR
proximal,I-PR
LAD,I-PR
",",O
and,O
a,B-PR
high,I-PR
grade,I-PR
left,I-PR
circumflex,I-PR
lesion,I-PR
after,I-PR
the,I-PR
OM,I-PR
with,O
distal,B-PR
left,I-PR
circumflex,I-PR
occlusion,I-PR
.,O

The,O
patient,O
was,O
subsequently,O
medically,O
management,O
after,O
this,B-TR
hospitalization,I-TR
and,O
has,O
done,O
very,O
well,O
.,O

His,B-TE
most,I-TE
recent,I-TE
echocardiogram,I-TE
in,O
April,O
of,O
1996,O
showed,O
an,B-TE
ejection,I-TE
fraction,I-TE
of,O
20%,O
with,O
a,B-PR
thin,I-PR
fibrotic,I-PR
septum,I-PR
with,O
akinesis,B-PR
and,O
moderately,B-PR
severe,I-PR
hypokinesis,I-PR
in,I-PR
all,I-PR
other,I-PR
regions,I-PR
except,O
for,O
the,O
lateral,O
wall,O
.,O

The,O
patient,O
also,O
had,O
an,B-TE
electrocardiogram,I-TE
in,O
April,O
of,O
1996,O
which,O
was,O
negative,O
following,O
",",O
however,O
was,O
at,O
a,O
low,O
workload,O
.,O

The,O
patient,O
&apos;s,O
was,O
most,O
recently,O
admitted,O
to,O
Centdick,O
Naco,O
Hospital,O
Medical,O
Center,O
on,O
Martin,O
Luther,O
King,O
Day,O
after,O
becoming,O
acutely,B-PR
short,I-PR
of,I-PR
breath,I-PR
after,O
a,O
five,O
minute,O
walk,O
.,O

He,O
had,O
no,O
chest,B-PR
pain,I-PR
",",O
palpitations,B-PR
",",O
diaphoresis,B-PR
",",O
or,O
nausea,B-PR
.,O

He,O
called,O
the,O
EMT,O
&apos;s,O
and,O
was,O
found,O
to,O
be,O
in,O
pulmonary,B-PR
edema,I-PR
by,O
chest,B-TE
x-ray,I-TE
at,O
Centdick,O
Naco,O
Hospital,O
Medical,O
Center,O
.,O

He,O
was,O
diuresed,B-TR
and,O
ruled,O
out,O
for,O
myocardial,B-PR
infarction,I-PR
.,O

His,B-TE
ECG,I-TE
showed,O
no,O
ischemic,B-PR
changes,I-PR
.,O

He,O
was,O
then,O
transferred,O
to,O
the,O
Retelk,O
County,O
Medical,O
Center,O
for,O
further,B-TR
management,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

(1),O
Insulin,B-PR
dependent,I-PR
diabetes,I-PR
mellitus,I-PR
x,O
15,O
years,O
with,O
no,O
retinopathy,B-PR
or,O
foot,B-PR
lesions,I-PR
.,O

(2),O
Bilateral,B-PR
cataracts,I-PR
.,O

(3),O
In,O
1967,O
he,O
had,O
an,B-TR
orchiopexy,I-TR
for,O
undescended,B-PR
testicle,I-PR
.,O

(4),O
Coronary,B-PR
artery,I-PR
disease,I-PR
as,O
above,O
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Aspirin,B-TR
325,O
mg,O
p.o.,O
q.,O
day,O
",",O
Capoten,B-TR
25,O
mg,O
p.o.,O
q.8h.,O
",",O
NPH,B-TR
insulin,I-TR
28,O
units,O
q.a.m.,O
and,O
10,O
units,O
q.p.m.,O
",",O
Regular,B-TR
insulin,I-TR
4,O
units,O
q.a.m.,O
and,O
4,O
units,O
q.p.m.,O
",",O
simvastatin,B-TR
20,O
mg,O
p.o.,O
q.,O
day,O
",",O
digoxin,B-TR
0.25,O
mg.,O

SOCIAL,O
HISTORY,O
:,O

He,O
lives,O
with,O
his,O
two,O
brothers,O
and,O
is,O
on,O
disability,O
.,O

He,O
has,O
a,O
ten,O
pack,O
year,O
history,O
of,O
smoking,O
",",O
quit,O
in,O
1990,O
.,O

He,O
does,O
not,O
drink,O
alcohol,O
.,O

FAMILY,O
HISTORY,O
:,O

His,O
mother,O
and,O
father,O
both,O
died,O
secondary,O
to,O
myocardial,B-PR
infarction,I-PR
.,O

One,O
of,O
his,O
brothers,O
has,O
had,O
a,B-PR
myocardial,I-PR
infarction,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Temperature,B-TE
100.3,O
",",O
heart,B-TE
rate,I-TE
76,O
",",O
blood,B-TE
pressure,I-TE
100/78,O
",",O
respiratory,B-TE
rate,I-TE
16,O
",",O
and,O
an,B-TE
oxygen,I-TE
saturation,I-TE
of,O
96%,O
on,O
two,O
liters,O
.,O

NECK,O
:,O

No,O
jugular,B-PR
venous,I-PR
distention,I-PR
.,O

CHEST,O
:,O

Clear,O
to,O
auscultation,B-TE
with,O
no,O
wheezes,B-PR
or,O
rales,B-PR
.,O

CARDIOVASCULAR,O
:,O

Regular,O
rate,O
and,O
rhythm,O
with,O
no,O
extra,B-PR
heart,I-PR
sounds,I-PR
and,O
no,O
murmurs,B-PR
.,O

ABDOMEN,O
:,O

Benign,O
.,O

EXTREMITIES,O
:,O

No,O
edema,B-PR
with,O
2+,O
pulses,O
.,O

LABORATORY,O
DATA,O
:,O

BUN,B-TE
25,O
and,O
creatinine,B-TE
1.4,O
.,O

White,B-TE
count,I-TE
6,O
and,O
hematocrit,B-TE
41.5,O
.,O

PT,B-TE
14.1,O
with,O
an,B-TE
INR,I-TE
of,O
1.4,O
",",O
PTT,B-TE
36.7,O
.,O

Chest,B-TE
x-ray,I-TE
showed,O
no,O
infiltrates,B-PR
and,O
no,O
pulmonary,B-PR
edema,I-PR
.,O

Urinalysis,B-TE
was,O
negative,O
.,O

Electrocardiogram,B-TE
showed,O
normal,O
sinus,O
rhythm,O
at,O
63,O
with,O
normal,O
intervals,O
.,O

He,O
had,O
flat,B-PR
T,I-PR
waves,I-PR
in,I-PR
I,I-PR
and,I-PR
aVL,I-PR
",",O
which,O
were,O
unchanged,O
from,O
previous,B-TE
ECG,I-TE
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
for,O
further,B-TR
management,I-TR
of,O
his,B-PR
pulmonary,I-PR
edema,I-PR
.,O

It,O
was,O
felt,O
that,O
the,O
patient,O
possibly,O
had,O
a,O
worsening,O
of,O
his,B-PR
coronary,I-PR
artery,I-PR
disease,I-PR
and,O
therefore,O
underwent,O
cardiac,B-TE
catheterization,I-TE
on,O
01/17/96,O
.,O

At,O
cardiac,B-TE
catheterization,I-TE
he,O
had,O
an,B-TE
RA,I-TE
pressure,I-TE
of,O
8,O
",",O
an,B-TE
RV,I-TE
pressure,I-TE
of,O
52/10,O
",",O
PA,B-TE
pressure,I-TE
of,O
60/25,O
",",O
and,O
wedge,B-TE
of,O
26,O
.,O

His,O
coronary,O
arteries,O
revealed,O
an,B-PR
80%,I-PR
stenosis,I-PR
and,O
a,B-PR
large,I-PR
OM,I-PR
.,O

The,O
dominant,O
left,O
circumflex,O
was,O
occluded,B-PR
with,O
left-to-left,B-PR
filling,I-PR
.,O

He,O
also,O
had,O
a,B-PR
50%,I-PR
LAD,I-PR
stenosis,I-PR
",",O
a,B-PR
100%,I-PR
large,I-PR
DT,I-PR
stenosis,I-PR
and,O
a,O
nondominant,O
RCA,O
with,O
left,O
RCA,O
collaterals,O
.,O

It,O
was,O
felt,O
that,O
this,B-TE
cardiac,I-TE
catheterization,I-TE
was,O
not,O
significantly,O
changed,O
from,O
his,B-TE
previous,I-TE
catheterization,I-TE
.,O

Given,O
his,B-PR
high,I-PR
right-sided,I-PR
filling,I-PR
pressure,I-PR
",",O
he,O
was,O
started,O
on,O
Lasix,B-TR
for,O
diuresis,B-TR
and,O
his,B-TR
Captopril,I-TR
was,O
increased,O
for,O
greater,B-TR
afterload,I-TR
reduction,I-TR
.,O

It,O
was,O
felt,O
that,O
the,O
patient,O
should,O
have,O
an,B-TR
augmented,I-TR
medical,I-TR
regimen,I-TR
and,O
as,O
an,O
outpatient,O
undergo,O
an,B-TE
exercise,I-TE
tolerance,I-TE
test,I-TE
with,O
viability,B-TE
evaluation,I-TE
to,O
determine,O
whether,O
he,O
would,O
benefit,O
from,O
revascularization,B-TR
.,O

He,O
was,O
restarted,O
on,O
Coumadin,B-TR
for,O
his,B-PR
low,I-PR
ejection,I-PR
fraction,I-PR
and,O
started,O
on,O
diuresis,B-TR
with,O
IV,B-TR
Lasix,I-TR
for,O
two,O
days,O
and,O
then,O
switched,O
to,O
an,B-TR
oral,I-TR
Lasix,I-TR
regimen,I-TR
.,O

DISPOSITION,O
:,O

He,O
was,O
discharged,O
to,O
home,O
in,O
stable,O
condition,O
and,O
feeling,O
well,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Insulin,B-TR
NPH,I-TR
10,O
units,O
q.p.m.,O
and,O
28,O
units,O
q.a.m.,O
",",O
insulin,B-TR
Regular,I-TR
4,O
units,O
q.a.m.,O
and,O
4,O
units,O
q.p.m.,O
",",O
aspirin,B-TR
325,O
mg,O
p.o.,O
q.,O
day,O
",",O
digoxin,B-TR
0.25,O
mg,O
p.o.,O
q.,O
day,O
",",O
simvastatin,B-TR
20,O
mg,O
p.o.,O
q.,O
day,O
",",O
captopril,B-TR
37.5,O
mg,O
p.o.,O
t.i.d.,O
",",O
Coumadin,B-TR
5,O
mg,O
p.o.,O
q.h.s.,O
",",O
Lasix,B-TR
20,O
mg,O
p.o.,O
q.,O
day,O
.,O

FOLLOW-UP,O
:,O

He,O
is,O
to,O
see,O
Dr.,O
Ench,O
in,O
two,O
weeks,O
to,O
check,O
his,B-TE
PT,I-TE
and,O
INR,B-TE
",",O
also,O
to,O
check,O
for,O
potassium,B-TE
.,O

Dictated,O
By,O
:,O

CA,O
X.,O
SCGACH,O
",",O
M.D.,O
YG59,O

Attending,O
:,O

JEMALKYLE,O
J.,O
EHKOTE,O
",",O
M.D.,O
BI7,O
PJ387/3762,O

Batch,O
:,O

37377,O

Index,O
No.,O
WDXZUZ7Y9B,O

D,O
:,O

01/20/96,O

T,O
:,O

01/20/96,O

289811204,O

FIH,O

2696998,O

22684/ukjj,O

819579,O

4/16/1993,O
12:00:00,O
AM,O

RIGHT,B-PR
HIP,I-PR
",",I-PR
OSTEOARTHRITIS,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

4/16/93,O

DISCHARGE,O
DATE,O
:,O

4/23/93,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Right,B-PR
hip,I-PR
",",I-PR
osteoarthritis,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
generally,O
healthy,O
85,O
year,O
old,O
female,O
",",O
who,O
has,O
had,O
a,O
five,O
year,O
history,O
of,O
right,B-PR
hip,I-PR
pain,I-PR
",",O
worsening,O
over,O
the,O
past,O
several,O
months,O
.,O

Her,B-PR
pain,I-PR
is,O
located,O
in,O
the,O
groin,O
and,O
thigh,O
.,O

It,O
is,O
aggravated,O
by,O
activity,O
and,O
improved,O
by,O
sitting,O
or,O
lying,O
down,O
.,O

It,O
is,O
associated,O
with,O
rest,B-PR
pain,I-PR
as,O
well,O
.,O

She,O
uses,O
a,B-TR
cane,I-TR
or,O
walker,B-TR
for,O
ambulation,O
",",O
and,O
is,O
limited,O
to,O
one,O
to,O
two,O
blocks,O
.,O

She,O
does,O
stairs,O
one,O
at,O
a,O
time,O
and,O
only,O
with,O
help,O
.,O

She,O
has,O
difficulty,B-PR
with,I-PR
shoes,I-PR
and,I-PR
socks,I-PR
and,I-PR
foot,I-PR
care,I-PR
.,O

The,B-PR
patient,I-PR
&apos;s,I-PR
pain,I-PR
has,O
not,O
been,O
relieved,O
by,O
Darvocet,B-TR
and,O
Advil,B-TR
.,O

Radiographs,B-TE
demonstrate,O
right,B-PR
hip,I-PR
osteoarthritis,I-PR
.,O

Having,O
failed,O
conservative,B-TR
management,I-TR
",",O
the,O
patient,O
presented,O
for,O
elective,B-TR
right,I-TR
total,I-TR
hip,I-TR
replacement,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Hypertension,B-PR
",",O
possible,O
peptic,B-PR
ulcer,I-PR
disease,I-PR
1959,O
",",O
history,O
of,O
left,B-PR
ankle,I-PR
and,I-PR
knee,I-PR
fractures,I-PR
",",O
1980,O
.,O

Recent,B-PR
urinary,I-PR
tract,I-PR
infection,I-PR
",",O
E.,B-PR
coli,I-PR
03/93,O
.,O

Recent,B-PR
herpes,I-PR
zoster,I-PR
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

cholecystectomy,B-TR
",",O
total,B-TR
abdominal,I-TR
hysterectomy,I-TR
",",O
cataract,B-TR
excision,I-TR
.,O

MEDICATIONS,B-TR
ON,I-TR
ADMISSION,I-TR
:,O

hydrochlorothiazide,B-TR
50,O
mg.,O
PO,O
qday,O
",",O
KayCiel,B-TR
.,O

ALLERGIES,O
:,O

The,O
patient,O
has,O
no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

HABITS,O
:,O

The,O
patient,O
does,O
not,O
smoke,O
or,O
drink,O
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

Negative,O
in,O
detail,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,O
patient,O
was,O
an,O
elderly,O
woman,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

The,B-TE
head,I-TE
and,I-TE
neck,I-TE
exam,I-TE
was,O
within,O
normal,O
limits,O
.,O

The,O
lungs,O
were,O
clear,O
to,O
auscultation,B-TE
.,O

Cardiac,O
:,O

regular,O
rate,O
and,O
rhythm,O
without,O
murmur,B-PR
.,O

The,O
abdomen,O
was,O
soft,O
",",O
nontender,O
",",O
nondistended,O
",",O
with,O
normal,O
active,O
bowel,O
sounds,O
.,O

Extremities,O
:,O

left,O
hip,O
110,O
degrees,O
of,O
flexion,B-TE
",",O
0,O
degrees,O
of,O
extension,B-TE
",",O
30,O
degrees,O
of,O
abduction,B-TE
",",O
45,O
degrees,O
of,O
adduction,B-TE
",",O
10,O
degrees,O
of,O
internal,B-TE
rotation,I-TE
and,I-TE
flexion,I-TE
",",O
45,O
degrees,O
of,O
external,B-TE
rotation,I-TE
and,I-TE
flexion,I-TE
.,O

Right,O
hip,O
90,O
degrees,O
of,O
flexion,B-TE
",",O
minus,O
30,O
degrees,O
of,O
extension,B-TE
",",O
20,O
degrees,O
of,O
abduction,B-TE
",",O
30,O
degrees,O
of,O
adduction,B-TE
",",O
less,O
than,O
5,O
degrees,O
of,O
internal,B-TE
rotation,I-TE
and,I-TE
flexion,I-TE
and,O
less,O
than,O
5,O
degrees,O
of,O
external,B-TE
rotation,I-TE
and,I-TE
flexion,I-TE
.,O

There,O
was,O
no,O
leg,B-PR
length,I-PR
discrepancy,I-PR
.,O

The,O
patient,O
&apos;s,O
gait,O
was,O
halting,O
",",O
stooped,O
and,O
slow,O
.,O

The,O
patient,O
used,O
the,B-TR
cane,I-TR
in,O
her,O
left,O
hand,O
.,O

The,B-TE
patient,I-TE
&apos;s,I-TE
neurovascular,I-TE
examination,I-TE
was,O
intact,O
.,O

LABORATORY,O
DATA,O
:,O

the,B-TE
sodium,I-TE
was,O
140,O
",",O
potassium,B-TE
3.7,O
",",O
chloride,B-TE
96,O
",",O
bicarbonate,B-TE
30,O
",",O
BUN,B-TE
and,O
creatinine,B-TE
14/0.9,O
",",O
glucose,B-TE
105,O
",",O
hematocrit,B-TE
42,O
",",O
white,B-TE
blood,I-TE
count,I-TE
8.6,O
",",O
platelet,B-TE
count,I-TE
"644,000",O
",",O
prothrombin,B-TE
time,I-TE
10.4,O
",",O
partial,B-TE
thromboplastin,I-TE
time,I-TE
28.7,O
",",O
urinalysis,B-TE
trace,B-PR
white,I-PR
blood,I-PR
cells,I-PR
",",O
slight,B-PR
occult,I-PR
red,I-PR
blood,I-PR
cells,I-PR
.,O

The,B-TE
electrocardiogram,I-TE
showed,O
normal,O
sinus,O
rhythm,O
at,O
a,B-TE
rate,I-TE
of,O
80,O
with,O
intraventricular,B-PR
conduction,I-PR
delay,I-PR
and,O
poor,B-PR
R,I-PR
wave,I-PR
progression,I-PR
.,O

There,O
were,O
no,O
acute,B-PR
ischemic,I-PR
changes,I-PR
.,O

The,B-TE
chest,I-TE
X-ray,I-TE
showed,O
borderline,B-PR
cardiomegaly,I-PR
but,O
no,O
acute,B-PR
cardiac,I-PR
or,I-PR
pulmonary,I-PR
disease,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
Orthopedic,O
Service,O
on,O
4/16/93,O
.,O

On,O
that,O
day,O
she,O
underwent,O
clearance,O
from,O
the,O
Cardiology,O
Service,O
",",O
Dr.,O
Shuff,O
.,O

It,O
was,O
his,O
impression,O
that,O
the,B-PR
patient,I-PR
&apos;s,I-PR
hypertension,I-PR
was,O
controlled,O
on,O
hydrochlorothiazide,B-TR
.,O

Given,O
the,B-PR
patient,I-PR
&apos;s,I-PR
low,I-PR
potassium,I-PR
level,I-PR
of,O
2.4,O
on,O
the,O
day,O
of,O
admission,O
",",O
he,O
suggested,O
supplementation,O
with,O
potassium,B-TR
.,O

The,O
patient,O
was,O
cleared,O
from,O
surgery,O
from,O
a,O
cardiology,O
standpoint,O
.,O

On,O
the,O
following,O
morning,O
4/17/93,O
",",O
the,O
patient,O
was,O
taken,O
to,O
the,O
operating,O
room,O
where,O
she,O
underwent,O
a,B-TR
right,I-TR
total,I-TR
hip,I-TR
replacement,I-TR
",",O
using,O
a,B-TR
hybrid,I-TR
S-ROM,I-TR
system,I-TR
.,O

Postoperatively,O
",",O
the,O
patient,O
did,O
extremely,O
well,O
.,O

The,O
patient,O
was,O
seen,O
in,O
consultation,O
with,O
the,O
physical,O
therapy,O
service,O
initially,O
for,O
routine,B-TR
rehabilitation,I-TR
after,O
a,B-TR
total,I-TR
hip,I-TR
replacement,I-TR
.,O

Her,B-TR
hemovac,I-TR
drains,I-TR
were,O
removed,O
on,O
postoperative,O
day,O
#,O
2,O
as,O
was,O
her,B-TR
Foley,I-TR
catheter,I-TR
.,O

Her,B-TE
hematocrit,I-TE
remained,O
stable,O
in,O
the,O
low,O
to,O
mid,O
30,O
&apos;s,O
and,O
she,O
did,O
not,O
require,O
a,B-TR
transfusion,I-TR
.,O

The,O
patient,O
did,O
have,O
postoperatively,B-PR
hypokalemia,I-PR
to,O
a,O
level,O
of,O
2.7,O
and,O
subsequently,O
was,O
corrected,O
with,O
oral,B-TR
and,I-TR
intravenous,I-TR
potassium,I-TR
on,O
4/22/93,O
",",O
the,O
patient,O
underwent,O
a,B-TE
duplex,I-TE
ultrasound,I-TE
examination,I-TE
",",O
which,O
showed,O
no,O
evidence,O
of,O
of,O
deep,B-PR
venous,I-PR
thrombosis,I-PR
.,O

The,B-TR
patient,I-TR
&apos;s,I-TR
Coumadin,I-TR
was,O
thus,O
stopped,O
and,O
she,O
was,O
switched,O
to,O
Bufferin,B-TR
.,O

The,O
patient,O
&apos;s,O
hospitalization,O
was,O
uncomplicated,O
.,O

She,O
was,O
discharged,O
to,O
the,O
Encharlea,O
Il,O
Medical,O
Center,O
in,O
New,O
Hampshire,O
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

Right,B-PR
hip,I-PR
osteoarthritis,I-PR
",",O
status,O
post,O
right,B-TR
total,I-TR
hip,I-TR
replacement,I-TR
on,O
4/17/93,O
.,O

Hypertension,B-PR
.,O

Postoperative,B-PR
hypokalemia,I-PR
",",O
resolved,O
.,O

Postoperative,B-PR
confusion,I-PR
",",O
transient,O
and,O
resolved,O
spontaneously,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Satisfactory,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

hydrochlorothiazide,B-TR
50,O
mg.,O
PO,O
qday,O
",",O
KayCiel,B-TR
40,O
mEq.,O
b.i.d.,O
",",O
Ecotrin,B-TR
1,O
tablet,O
qday,O
",",O
Ferrous,B-TR
sulfate,I-TR
325,O
mg.,O
PO,O
b.i.d.,O
",",O
Folate,B-TR
1,O
mg.,O
PO,O
qday,O
",",O
multivitamins,B-TR
one,O
tablet,O
qday,O
",",O
Tylenol,B-TR
#,I-TR
3,I-TR
1,O
to,O
2,O
PO,O
q3hours,O
PRN,O
.,O

DISPOSITION,O
/,O
PLAN,O
ON,O
DISCHARGE,O
:,O

The,O
patient,O
is,O
discharged,O
to,O
the,O
Encharlea,O
Il,O
Medical,O
Center,O
.,O

There,O
she,O
should,O
received,O
physical,B-TR
therapy,I-TR
to,O
consist,O
of,O
a,B-TR
routine,I-TR
post,I-TR
total,I-TR
hip,I-TR
replacement,I-TR
rehabilitation,I-TR
protocol,I-TR
",",O
with,O
emphasis,O
on,O
gait,B-TR
training,I-TR
",",O
partial,O
weight,O
bearing,O
on,O
the,O
right,O
lower,O
extremity,O
",",O
using,O
a,O
walker,B-TR
or,O
crutches,B-TR
.,O

The,O
patient,O
should,O
also,O
have,O
her,B-TE
potassium,I-TE
levels,I-TE
checked,O
two,O
times,O
per,O
week,O
to,O
insure,O
that,O
she,O
is,O
not,O
becoming,O
hypokalemic,B-PR
.,O

The,O
patient,O
should,O
have,O
a,O
follow,O
up,O
appointment,O
arranged,O
with,O
Dr.,O
Level,O
.,O

LAYMIE,O
M,O
HE,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

LILLBI,O
SERVICE,O
",",O
M.D.,O

TR,O
:,O

il,O
/,O
bmot,O

DD,O
:,O

4/22/93,O

TD,O
:,O

04/22/93,O

CC,O
:,O

Dr.,O
Lako,O
Service,O
STAT,O

297228405,O
DH,O

595721,O

777098,O

4177257,O

2/3/2004,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O
/,O
SUMMARY,O

CHIRDVOLN,O
",",O
IENA,O

MRN,O
:,O

595721,O

Age,O
:,O

46y,O

REGISTRATION,O
DATE,O
:,O

02/03/2004,O
11:14,O
AM,O

Provider,O
:,O

AGE,O
SHUFF,O

PRELIMINARY,O
REPORT,O

Discharge,O
Date,O
/,O
Time,O
:,O

02/03/2004,O
19:12,O

Discharge,O
Status,O
:,O

Discharged,O

Condition,O
on,O
Discharge,O
:,O

Stable,O

Patient,O
States,O
Complaint,O
:,O

VAG,B-PR
BLEEDING,I-PR

Diagnosis,O
:,O

dysfunctional,B-PR
uterine,I-PR
bleeding,I-PR

Treatment,O
Rendered,O
:,O

pelvic,B-TE
ultrasound,I-TE
-,O
normal,O
ovaries,O
",",O
thickened,B-PR
endometrium,I-PR
hematocrit,B-TE
-,O
33,O

Discharge,O
Medications,O
:,O

percocet,B-TR
as,O
directed,O
for,O
pain,B-PR

Follow,O
up,O
Service,O
:,O

Please,O
follow,O
up,O
with,O
gynecology,O
-,O
you,O
will,O
need,O
to,O
have,O
your,B-PR
uterine,I-PR
bleeding,I-PR
evaluted,O

Please,O
call,O
gynecology,O
clinic,O
at,O
150-5825,O
to,O
arrange,O
for,O
follow,O
up,O
.,O

Disposition,O
",",O
Follow,O
up,O
and,O
Instructions,O
to,O
Patient,O
:,O

Please,O
return,O
to,O
the,O
ED,O
if,O
you,O
develop,O
any,B-PR
worsening,I-PR
pain,I-PR
",",O
vomiting,B-PR
or,O
fevers,B-PR
&gt;,O
101,O
.,O

If,O
you,O
are,O
unable,O
to,O
keep,O
down,O
liquids,O
or,O
have,O
any,B-PR
fainting,I-PR
episodes,I-PR
we,O
should,O
see,O
you,O
again,O
as,O
well,O
.,O

Otherwise,O
you,O
need,O
to,O
see,O
a,O
gynecologist,O
to,O
evaluate,O
this,B-PR
bleeding,I-PR
.,O

PCP,O
Name,O
:,O

REKE,O
",",O
ATOTA,O
S,O

Provider,O
Number,O
:,O

26024,O

This,O
report,O
was,O
created,O
by,O
SHUFF,O
",",O
RONRIN,O
02/03/2004,O
07:23,O
PM,O

306968218,O
YC,O

24803748,O

3232251,O

1/20/2003,O
12:00:00,O
AM,O

IUP,O
at,O
36,O
weeks,O
",",O
delivered,O

DIS,O

Admission,O
Date,O
:,O

01/20/2003,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

01/24/2003,O

******,O
DISCHARGE,O
ORDERS,O
******,O

KOTEROSTREUKOTE,O
",",O
ARO,O
MA,O
O.,O
965-81-64-6,O
U94,O

Room,O
:,O

HSN28-1050,O

Service,O
:,O

OBS,O

DISCHARGE,O
PATIENT,O
ON,O
:,O

01/24/03,O
AT,O
10:00,O
AM,O

CONTINGENT,O
UPON,O

Attending,B-TE
evaluation,I-TE

WILL,O
D,O
/,O
C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D,O
/,O
C,O
SUMMARY,O
:,O

YES,O

Attending,O
:,O

HOUGHTBREUN,O
",",O
TESANT,O
E.,O
",",O
M.D.,O

DISPOSITION,O
:,O

Home,O

DISCHARGE,O
MEDICATIONS,O
:,O

TYLENOL,B-TR
(,I-TR
ACETAMINOPHEN,I-TR
),I-TR
650,O
MG,O
PO,O
Q4H,O
PRN,O
PAIN,B-PR
COLACE,B-TR
(,I-TR
DOCUSATE,I-TR
SODIUM,I-TR
),I-TR
100,O
MG,O
PO,O
BID,O
PRN,O
Constipation,B-PR
IBUPROFEN,B-TR
600,O
MG,O
PO,O
Q4-6H,O
PRN,O
PAIN,B-PR
MILK,B-TR
OF,I-TR
MAGNESIA,I-TR
(,I-TR
MAGNESIUM,I-TR
HYDROXIDE,I-TR
),I-TR
30,O
MILLILITERS,O
PO,O
QD,O
PRN,O
Constipation,B-PR
PERCOCET,B-TR
1-2,O
TAB,O
PO,O
Q4H,O
PRN,O
PAIN,B-PR

DIET,O
:,O

No,O
Restrictions,O

ACTIVITY,O
:,O

Walking,O
as,O
tolerated,O

FOLLOW,O
UP,O
APPOINTMENT,O
(,O
S,O
),O
:,O

Houghtbreun,O
6,O
weeks,O
",",O
No,O
Known,B-PR
Allergies,I-PR

ADMIT,O
DIAGNOSIS,O
:,O

Repeat,B-PR
C,I-PR
/,I-PR
S,I-PR
PPS,I-PR

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O

Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O
IUP,B-PR
at,O
36,O
weeks,O
",",O
delivered,O

OTHER,O
DIAGNOSIS,O
;,O

Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O
IUP,B-PR
at,O
36,O
weeks,O
.,O

insulin,B-PR
dependent,I-PR
gestational,I-PR
diabetic,I-PR
",",O
prior,B-PR
C,I-PR
/,I-PR
S,I-PR
",",O
RSAP,B-PR

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

Primary,O

Anesthesia,O
:,O

Spinal,O

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O

NONE,O

BRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

G4,O
T2,O
P0,O
A1,O
L2,O
Estimated,O

EDC,O
:,O

Maternal,O
transfer,O
:,O

No,O

Baby,O
1,O

MRN,O
:,O

23548875,O

Delivery,O
date,O
:,O

01/20/03,O
10:49,O
AM,O

Apgars,B-TE
"9,9",O

Weight,B-TE
:,O

6lb,O
5,O
oz,O
2863,O
grams,O

Sex,O
:,O

Female,O

ADDITIONAL,O
COMMENTS,O
:,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O

TO,O
DO,O
/,O
PLAN,O
:,O

No,O
dictated,O
summary,O

ENTERED,O
BY,O
:,O

HOUGHTBREUN,O
",",O
TESANT,O
E.,O
",",O
M.D.,O
(,O
EV89,O
),O
01/20/03,O
12:26,O
PM,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

320422564,O

CTMC,O

9300549,O

340424,O

06/16/1997,O
12:00:00,O
AM,O

BILIARY,B-PR
OBSTRUCTION,I-PR

Signed,O

DIS,O

Admission,O
Date,O
:,O

06/16/1997,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

06/18/1997,O

PROBLEM,O
LIST,O
:,O

1.,O
RECTAL,B-PR
CARCINOMA,I-PR
",",O
STATUS,O
POST,O
PARTIAL,B-TR
COLECTOMY,I-TR
.,O

2.,O
METASTATIC,B-PR
COLON,I-PR
CARCINOMA,I-PR
.,O

3.,O
HYPERTENSION,B-PR
.,O

4.,O
AORTIC,B-PR
STENOSIS,I-PR
WITH,O
PORCINE,B-TR
VALVE,I-TR
.,O

5.,O
URINARY,B-PR
TRACT,I-PR
INFECTION,I-PR
.,O

6.,O
CHOLANGITIS,B-PR
.,O

7.,O
ANEMIA,B-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
70,O
year,O
old,O
gentleman,O
with,O
metastatic,B-PR
rectal,I-PR
cancer,I-PR
who,O
presented,O
with,O
biliary,B-PR
obstruction,I-PR
.,O

In,O
the,O
past,O
",",O
he,O
had,O
biliary,B-TR
stents,I-TR
placed,O
which,O
clotted,O
off,O
.,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
Short,O
Stay,O
Unit,O
for,O
further,B-TE
evaluation,I-TE
.,O

The,O
day,O
prior,O
",",O
the,O
patient,O
had,O
endoscopic,B-TE
retrograde,I-TE
cholangiopancreatography,I-TE
done,O
with,O
dilated,B-PR
ducts,I-PR
times,O
two,O
and,O
eventually,O
had,O
interventional,B-TR
radiology,I-TR
attempt,O
to,O
place,O
percutaneous,B-TR
drains,I-TR
to,O
decompress,O
his,B-PR
biliary,I-PR
tree,I-PR
.,O

The,O
patient,O
had,O
two,B-TR
drains,I-TR
placed,O
after,O
a,B-TR
prolonged,I-TR
course,I-TR
and,O
difficult,B-TR
procedure,I-TR
.,O

After,O
being,O
transferred,O
from,O
the,O
interventional,O
radiology,O
table,O
to,O
the,O
stretcher,O
",",O
one,O
of,O
his,B-TR
lateral,I-TR
percutaneous,I-TR
drains,I-TR
had,O
been,O
pulled,O
out,O
inadvertently,O
.,O

He,O
was,O
admitted,O
to,O
the,O
Short,O
Stay,O
Unit,O
",",O
given,O
Ancef,B-TR
and,O
Gentamicin,B-TR
per,O
the,O
team,O
for,O
antibiotic,B-TR
prophylaxis,I-TR
and,O
observed,O
overnight,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

As,O
above,O
.,O

ALLERGIES,O
:,O

None,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Cipro,B-TR
500,O
mg,O
p.o.,O
b.i.d.,O
",",O
Vasotec,B-TR
10,O
mg,O
q.d.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
denies,O
any,O
alcohol,O
or,O
tobacco,O
.,O

FAMILY,O
HISTORY,O
:,O

Significant,O
for,O
colon,B-PR
carcinoma,I-PR
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

Unremarkable,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Temperature,B-TE
was,O
99.1,O
",",O
blood,B-TE
pressure,I-TE
132/74,O
",",O
heart,B-TE
rate,I-TE
80,O
",",O
respirations,B-TE
18,O
",",O
02,B-TE
sat,I-TE
99%,O
on,O
room,O
air,O
.,O

The,O
patient,O
was,O
an,O
alert,O
",",O
jaundiced,O
gentleman,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

LUNGS,O
:,O

were,O
clear,O
to,O
auscultation,B-TE
.,O

HEART,O
:,O

had,O
a,O
regular,O
rate,O
and,O
rhythm,O
with,O
a,B-PR
II,I-PR
/,I-PR
VI,I-PR
systolic,I-PR
murmur,I-PR
at,I-PR
the,I-PR
right,I-PR
sternal,I-PR
border,I-PR
.,O

ABDOMEN,O
:,O

was,O
soft,O
",",O
nontender,B-PR
",",O
with,O
good,O
bowel,O
sounds,O
.,O

He,O
had,O
midline,B-TR
catheter,I-TR
that,O
was,O
still,O
in,O
place,O
and,O
was,O
draining,O
bile,O
.,O

EXTREMITIES,O
:,O

were,O
without,O
edema,B-PR
.,O

NEUROLOGICAL,O
:,O

exam,B-TE
within,O
normal,O
limits,O
.,O

LABORATORY,O
:,O

White,B-TE
count,I-TE
was,O
8.2,O
",",O
hematocrit,B-TE
35,O
.,O

AST,B-TE
was,O
175,O
",",O
ALT,B-TE
76,O
",",O
LDH,B-TE
454,O
.,O

Total,B-TE
bilirubin,I-TE
was,O
12,O
and,O
direct,B-TE
bilirubin,I-TE
8,O
.,O

Alkaline,B-TE
phosphatase,I-TE
was,O
372,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
Short,O
Stay,O
Unit,O
and,O
continued,O
to,O
receive,O
antibiotics,B-TR
overnight,O
.,O

The,O
next,O
morning,O
",",O
he,O
was,O
doing,O
well,O
with,O
the,B-TR
intact,I-TR
drain,I-TR
draining,O
bilious,B-PR
material,I-PR
without,O
any,O
difficulty,O
.,O

The,O
patient,O
was,O
doing,O
well,O
with,O
minimal,O
to,O
no,O
belly,B-PR
pain,I-PR
and,O
no,O
nausea,B-PR
or,O
vomiting,B-PR
.,O

The,O
patient,O
was,O
taken,O
back,O
to,O
surgery,O
by,O
the,O
interventional,O
radiology,O
team,O
and,O
had,O
a,B-TR
second,I-TR
drain,I-TR
placed,O
without,O
any,O
difficulty,O
and,O
was,O
transferred,O
back,O
to,O
the,O
Short,O
Stay,O
Unit,O
.,O

The,O
patient,O
was,O
observed,O
overnight,O
without,O
any,B-PR
problems,I-PR
.,O

He,O
was,O
tolerating,O
p.o.,O
and,O
feeling,O
back,O
to,O
his,O
baseline,O
.,O

He,O
was,O
discharged,O
in,O
stable,O
condition,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Same,O
as,O
admission,O
.,O

He,O
will,O
continue,O
Cipro,B-TR
p.o.,I-TR
for,O
prophylaxis,B-TR
.,O

FOLLOW-UP,O
:,O

Follow-up,O
with,O
Dr.,O
Loydsadd,O
in,O
one,O
to,O
two,O
weeks,O
.,O

He,O
is,O
also,O
to,O
have,O
AH,B-TR
for,O
his,B-TR
home,I-TR
stent,I-TR
care,I-TR
.,O

Dictated,O
By,O
:,O

Attending,O
:,O

LILLBI,O
FYFEBREUN,O
",",O
M.D.,O
KE15,O
TB326/0625,O

Batch,O
:,O

56777,O

Index,O
No.,O
M2ZRS51Y3Q,O

D,O
:,O

06/18/97,O

T,O
:,O

06/21/97,O

332803550,O

PUOMC,O

6548851,O

97371/52b3,O

854510,O

6/22/1993,O
12:00:00,O
AM,O

CHRONIC,B-PR
OBSTRUCTIVE,I-PR
PULMONARY,I-PR
DISEASE,I-PR

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

06-22-93,O

DISCHARGE,O
DATE,O
:,O

06-27-93,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Chronic,B-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR

ASSOCIATED,O
DIAGNOSES,O
:,O

Steroid,B-PR
complications,I-PR
",",O
including,O
cataract,B-PR
",",O
osteoporosis,B-PR
",",O
diffuse,B-PR
fibrocystic,I-PR
breast,I-PR
disease,I-PR
",",O
trigeminal,B-PR
neuralgia,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Mrs.,O
Cast,O
is,O
a,O
50,O
year,O
old,O
white,O
female,O
with,O
a,O
history,O
of,O
chronic,B-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
and,O
evidence,O
of,O
severe,B-PR
lobular,I-PR
emphysema,I-PR
",",O
who,O
has,O
progressive,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
and,O
inability,O
to,O
carry,O
on,O
with,O
activities,O
of,O
daily,O
living,O
without,O
assistance,O
.,O

She,O
was,O
admitted,O
to,O
the,O
hospital,O
for,O
a,B-TE
pre,I-TE
lung,I-TE
transplant,I-TE
evaluation,I-TE
.,O

The,O
patient,O
has,O
been,O
steroid,B-PR
dependent,I-PR
for,O
two,O
years,O
and,O
has,O
been,O
intubated,B-TR
in,O
the,O
past,O
only,O
once,O
for,O
a,B-TR
surgical,I-TR
repair,I-TR
of,I-TR
trigeminal,I-TR
neuralgia,I-TR
.,O

Her,O
previous,O
occupation,O
was,O
an,O
executive,O
secretary,O
",",O
home,O
trainer,O
/,O
nurse,O
",",O
rental,O
aide,O
.,O

She,O
has,O
no,O
history,O
of,O
asbestos,B-PR
exposure,I-PR
or,O
tuberculosis,B-PR
exposure,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Notable,O
for,O
a,O
history,O
of,O
trigeminal,B-PR
neuralgia,I-PR
",",O
left,B-TR
shoulder,I-TR
surgery,I-TR
",",O
fibrocystic,B-PR
breast,I-PR
disease,I-PR
",",O
endometriosis,B-PR
and,O
status,O
post,O
total,B-PR
abdominal,I-PR
hysterectomy,I-PR
.,O

ALLERGIES,O
:,O

History,O
of,O
gastrointestinal,B-PR
intolerance,I-PR
to,O
Tetracycline,B-TR
",",O
Erythromycin,B-TR
",",O
declomycin,B-TR
associated,O
with,O
edema,B-PR
and,O
rash,B-PR
",",O
Talwin,B-TR
associated,O
with,O
disorientation,B-PR
and,O
gastrointestinal,B-PR
symptoms,I-PR
",",O
Dilantin,B-TR
has,O
caused,O
rash,B-PR
and,O
edema,B-PR
",",O
morphine,B-TR
associated,O
with,O
itching,B-PR
and,O
gastrointestinal,B-PR
symptoms,I-PR
",",O
Demerol,B-TR
unclear,O
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
is,O
a,O
divorced,O
mother,O
of,O
two,O
on,O
Medicaid,O
.,O

FAMILY,O
HISTORY,O
:,O

Non,O
contributory,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Notable,O
for,O
her,B-PR
diffuse,I-PR
expiratory,I-PR
wheezes,I-PR
and,O
scattered,B-PR
expiratory,I-PR
crackles,I-PR
.,O

Cranial,O
nerves,O
were,O
intact,O
except,O
for,O
paresthesias,B-PR
on,O
the,O
left,O
in,O
the,O
VII,O
and,O
VIII,O
distribution,O
.,O

The,O
breasts,O
were,O
notable,O
for,O
fibrocystic,B-PR
changes,I-PR
.,O

LABORATORY,O
DATA,O
:,O

Serum,B-TE
sodium,I-TE
141,O
",",O
potassium,B-TE
4.0,O
",",O
chloride,B-TE
106,O
",",O
C02,B-TE
29.6,O
",",O
calcium,B-TE
9.2,O
",",O
phosphorus,B-TE
3.6,O
.,O

Magnesium,B-TE
1.7,O
.,O

BUN,B-TE
12,O
",",O
creatinine,B-TE
0.6,O
",",O
glucose,B-TE
92,O
",",O
uric,B-TE
acid,I-TE
3.3.,O
Cholesterol,B-TE
236,O
",",O
triglycerides,B-TE
115,O
",",O
HDL,B-TE
99,O
",",O
LDL,B-TE
114,O
",",O
total,B-TE
protein,I-TE
6.2,O
",",O
globulin,B-TE
2.6,O
",",O
direct,B-TE
bilirubin,I-TE
0,O
",",O
total,B-TE
bilirubin,I-TE
0.2,O
",",O
alkaline,B-TE
phosphatase,I-TE
59,O
",",O
amylase,B-TE
64,O
",",O
SGOT,B-TE
16,I-TE
",",O
LDH,B-TE
141,I-TE
",",O
CPK,B-TE
57,O
.,O

The,B-TE
LH,I-TE
was,O
4.9,O
",",O
FSH,B-TE
3.3,O
.,O

TSH,B-TE
was,O
124,O
",",O
cortisol,B-TE
2.1,O
",",O
25,B-TE
hydroxy,I-TE
vitamin,I-TE
D,I-TE
",",I-TE
and,I-TE
125,I-TE
dihydroxy,I-TE
vitamin,I-TE
D,I-TE
levels,I-TE
were,O
pending,O
.,O

Urine,B-TE
cotenine,I-TE
level,O
none,O
detected,O
.,O

Estradialol,B-TE
pending,O
.,O

White,B-TE
blood,I-TE
count,I-TE
9.6,O
",",O
hematocrit,B-TE
38.8,O
",",O
platelet,B-TE
"348,000",O
",",O
mean,B-TE
corpuscular,I-TE
volume,I-TE
85,O
and,O
86,O
",",O
MCH,B-TE
29,O
",",O
MCHC,B-TE
34,O
.,O

PT,B-TE
9.5/10.0,O
",",O
PTT,B-TE
23.9,O
.,O

Urinalysis,B-TE
was,O
normal,O
.,O

Sed,B-TE
rate,I-TE
6,O
.,O

Varicella,B-TE
antibody,I-TE
positive,O
",",O
CMV,B-TE
antibody,I-TE
positive,O
",",O
toxo,B-TE
negative,O
",",O
RPR,B-TE
non,O
reactive,O
.,O

The,O
patient,O
was,O
A+,O
.,O

FEV1,B-TE
0.78,O
liters,O
",",O
vital,B-TE
capacity,I-TE
2.12,O
liters,O
",",O
total,B-TE
lung,I-TE
capacity,I-TE
5.51,O
liters,O
",",O
single,B-TE
breath,I-TE
DLCO,I-TE
5.3,O
(,O
25%,O
predicted,O
),O
.,O

Cardiopulmonary,B-TE
exercise,I-TE
study,I-TE
results,O
are,O
pending,O
.,O

Echocardiogram,B-TE
showed,O
normal,O
right,O
ventricular,O
and,O
left,O
ventricular,O
size,O
and,O
systolic,O
function,O
.,O

A,B-TE
left,I-TE
and,I-TE
right,I-TE
heart,I-TE
catheterization,I-TE
and,O
coronary,B-TE
angiogram,I-TE
revealed,O
aortic,B-TE
120/70,O
",",O
mean,B-TE
95,O
",",O
PA,B-TE
26/10,O
",",O
mean,B-TE
17,O
",",O
PC,B-TE
7,O
",",O
RV,B-TE
26/6,O
",",O
RA,B-TE
4,O
",",O
cardiac,B-TE
output,I-TE
5.7,O
",",O
index,B-TE
3.8,O
.,O

Systemic,B-TE
arterial,I-TE
resistance,I-TE
12/81,O
.,O

The,B-TE
electrocardiogram,I-TE
showed,O
a,B-PR
short,I-PR
PR,I-PR
interval,I-PR
with,O
no,O
delta,B-PR
wave,I-PR
",",O
clockwise,B-PR
rotation,I-PR
present,I-PR
.,O

A,B-TE
quantitative,I-TE
VQ,I-TE
scan,I-TE
of,O
the,O
lung,O
showed,O
42%,O
ventilation,B-TE
to,I-TE
the,I-TE
left,I-TE
",",O
57%,O
ventilation,B-TE
to,I-TE
the,I-TE
right,I-TE
",",O
42%,O
perfusion,B-TE
to,I-TE
the,I-TE
left,I-TE
",",O
57%,O
perfusion,B-TE
to,I-TE
the,I-TE
right,I-TE
.,O

Abdominal,B-TE
ultrasound,I-TE
was,O
unremarkable,O
.,O

HIV,B-TE
testing,I-TE
results,O
pending,O
.,O

Hepatitis,B-TE
serologies,I-TE
pending,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
seen,O
in,O
consultation,O
by,O
a,O
variety,O
of,O
consultants,O
including,O
Infectious,O
Disease,O
",",O
Cardiology,O
",",O
Endocrine,O
",",O
Psychiatry,O
",",O
ENT,O
",",O
and,O
Neuro-ophthalmology,O
.,O

She,O
was,O
noted,O
to,O
have,O
mild,B-PR
cataracts,I-PR
",",O
possibly,O
due,O
to,O
chronic,B-TR
steroids,I-TR
",",O
as,O
well,O
as,O
a,B-PR
subtle,I-PR
temporal,I-PR
disc,I-PR
pallor,I-PR
OD,I-PR
",",O
possibly,O
due,O
to,O
previous,O
episode,O
of,O
optic,B-PR
neuritis,I-PR
.,O

No,O
acute,B-PR
pathology,I-PR
was,O
noted,O
and,O
no,O
treatment,B-PR
was,O
necessary,O
at,O
this,O
time,O
.,O

Dr.,O
Koteelks,O
indicated,O
that,O
the,O
patient,O
did,O
not,O
have,O
sinus,B-PR
problems,I-PR
currently,O
but,O
thought,O
that,O
the,B-PR
trigeminal,I-PR
pain,I-PR
might,O
be,O
investigated,O
further,O
and,O
that,O
the,B-PR
sphenoid,I-PR
might,O
account,O
for,O
some,O
of,O
the,B-PR
patient,I-PR
&apos;s,I-PR
discomfort,I-PR
.,O

If,O
so,O
",",O
he,O
considers,O
the,O
possibility,O
that,O
this,O
could,O
be,O
opened,O
.,O

This,O
is,O
left,O
for,O
further,O
follow,O
up,O
as,O
an,O
outpatient,O
.,O

Dr.,O
Tikkerth,O
felt,O
that,O
the,O
patient,O
had,O
mild,B-PR
adjustment,I-PR
related,I-PR
anxiety,I-PR
under,O
good,O
control,O
with,O
a,O
history,O
of,O
tobacco,O
abuse,O
in,O
the,O
past,O
.,O

The,O
patient,O
completed,O
the,B-TE
studies,I-TE
and,O
to,O
be,O
informed,O
of,O
the,O
results,O
as,O
an,O
outpatient,O
.,O

She,O
knows,O
to,O
return,O
to,O
her,O
local,O
physician,O
for,O
her,B-TR
routine,I-TR
care,I-TR
with,O
her,B-PR
condition,I-PR
unchanged,O
at,O
the,O
time,O
of,O
discharge,O
.,O

I,O
L.,O
STERPSKOLK,O
",",O
M.D.,O

TR,O
:,O

bg,O
/,O
bmot,O

DD,O
:,O

09-08-93,O

TD,O
:,O

09/09/93,O

CC,O
:,O

333521954,O

FIH,O

9558642,O

616751,O

7916543,O

2/23/2005,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O
/,O
SUMMARY,O

WIEGNEIGH,O
",",O
YLA,O

MRN,O
:,O

9558642,O

Age,O
:,O

53y,O

REGISTRATION,O
DATE,O
:,O

02/23/2005,O
05:41,O
AM,O

Provider,O
:,O

GETZSIEH,O
",",O
M.D.,O
WORK,O

PRELIMINARY,O
REPORT,O
PCP,O
notified,O
by,O

MD,O
:,O

Yes-Direct,O
contact,O
with,O
PCP,O

Discharge,O
Date,O
/,O
Time,O
:,O

02/23/2005,O
13:38,O

Discharge,O
Status,O
:,O

Discharged,O
Condition,O
on,O
Discharge,O
:,O

Stable,O

Patient,O
States,O
Complaint,O
:,O

CHEST,B-PR
PAIN,I-PR
/,O
SOB,B-PR

Diagnosis,O
:,O

R,B-PR
Lung,I-PR
Mass,I-PR
",",O
likely,O
cancer,B-PR

Treatment,O
Rendered,O
:,O

Physical,B-TE
Examination,I-TE
",",O
Laboratory,B-TE
Evaluation,I-TE
",",O
CXR,B-TE
",",O
Chest,B-TE
CT,I-TE

Discharge,O
Medications,O
:,O

Vicodin,B-TR
1-2,O
TABS,O
PO,O
Q6H,O
PRN,O
pain,B-PR
",",O
#,O
50,O
",",O
no,O
refills,O

Disposition,O
",",O
Follow,O
up,O
and,O
Instructions,O
to,O
Patient,O
:,O

Oncologist,O
",",O
Dr.,O
Ala,O
Aixknoleskaysneighslemteelenortkote,O
",",O
will,O
call,O
you,O
will,O
your,O
appt,O
.,O

You,O
can,O
call,O
576-598-7570,O
if,O
you,O
need,O
to,O
reschedule,O
.,O

We,O
are,O
scheduling,O
you,O
for,O
a,B-TE
needle,I-TE
biopsy,I-TE
by,O
interventional,O
radiology,O
for,O
some,O
time,O
in,O
the,O
next,O
week,O
.,O

they,O
will,O
call,O
you,O
to,O
set,O
up,O
appt,O
.,O

PCP,O
Name,O
:,O

NIQUE,O
",",O
TOYA,O
N,O

Provider,O
Number,O
:,O

21636,O

This,O
report,O
was,O
created,O
by,O
WORK,O
",",O
SHELLBETHA,O
",",O
M.D.,O
02/23/2005,O
01:59,O
PM,O

337702516,O
WGH,O

9387380,O

310695,O

271735,O

9/15/2000,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Report,O
Status,O
:,O

Signed,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

FREIERMLINKENEIGHCAABLINFARST,O
",",O
ANEA,O

UNIT,O
NUMBER,O
:,O

008-08-33,O

ADMISSION,O
DATE,O
:,O

09/15/2000,O

DISCHARGE,O
DATE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
hospital,O
on,O
July,O
12th,O
for,O
a,B-TR
chole,I-TR
with,O
a,O
principle,O
diagnosis,O
of,O
recurrent,B-PR
biliary,I-PR
colic,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
42,O
year,O
old,O
with,O
recurrent,B-PR
biliary,I-PR
colic,I-PR
.,O

She,O
has,O
had,O
ultrasound,B-PR
proven,I-PR
gallstones,I-PR
for,O
ten,O
years,O
",",O
seen,O
on,O
an,B-TE
earlier,I-TE
obstetric,I-TE
ultrasound,I-TE
.,O

The,O
patient,O
has,O
had,O
no,O
symptoms,B-PR
until,O
approximately,O
two,O
years,O
ago,O
when,O
she,O
began,O
having,O
classic,B-PR
biliary,I-PR
colic,I-PR
pain,I-PR
with,O
right,B-PR
upper,I-PR
quadrant,I-PR
epigastric,I-PR
pain,I-PR
radiating,O
to,O
midback,O
with,O
nausea,B-PR
",",O
but,O
without,O
vomiting,B-PR
.,O

Onset,O
was,O
an,O
hour,O
to,O
1,O
hour,O
after,O
meals,O
",",O
worse,O
with,O
greasy,O
meals,O
",",O
lasting,O
five,O
minutes,O
to,O
two,O
hours,O
.,O

Episodes,B-PR
have,O
been,O
increasing,O
in,O
frequency,O
over,O
the,O
last,O
few,O
months,O
.,O

She,O
has,O
had,O
no,O
fevers,B-PR
",",O
chills,B-PR
",",O
respiratory,B-PR
symptoms,I-PR
",",O
diarrhea,B-PR
",",O
bright,B-PR
red,I-PR
blood,I-PR
per,I-PR
rectum,I-PR
or,O
melena,B-PR
.,O

She,O
has,O
not,O
found,O
any,O
relieve,O
with,O
any,O
over,B-TR
the,I-TR
counter,I-TR
medications,I-TR
.,O

She,O
has,O
no,O
family,O
history,O
of,O
gallbladder,B-PR
or,O
pancreatic,B-PR
disease,I-PR
.,O

She,O
has,O
had,O
no,O
significant,O
weight,B-PR
loss,I-PR
.,O

No,O
anorexia,B-PR
.,O

An,B-TE
ultrasound,I-TE
on,O
1/25/00,O
showed,O
six,B-PR
gallstones,I-PR
without,O
cholecystitis,B-PR
.,O

She,O
has,O
no,O
history,O
of,O
liver,B-PR
disease,I-PR
",",O
hepatitis,B-PR
.,O

The,O
patient,O
is,O
from,O
45,O
Sidewonly,O
Blvd,O
",",O
Fresa,O
Loharanleah,O
",",O
Maryland,O
.,O

Has,O
lived,O
in,O
896,O
Lokatspur,O
Pkwy,O
",",O
Ingrich,O
Vepobuffh,O
",",O
Indiana,O
for,O
25,O
years,O
and,O
works,O
as,O
a,O
teaching,O
assistant,O
in,O
a,O
second,O
grade,O
in,O
Satlnonew,O
Rollglend,O
Pabridrham,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Significant,O
for,O
a,B-TR
left,I-TR
ear,I-TR
operation,I-TR
approximately,O
30,O
years,O
ago,O
with,O
left,B-TR
TM,I-TR
reconstruction,I-TR
in,O
December,O
1999,O
at,O
Hitch,O
Hospital,O
.,O

MEDS,O
ON,O
ADMISSION,O
:,O

Only,O
multivitamins,B-TR
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
denies,O
tobacco,O
and,O
/,O
or,O
alcohol,O
use,O
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

Noncontributory,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,O
patient,O
is,O
a,O
healthy,O
appearing,O
female,O
looking,O
her,O
stated,O
age,O
in,O
no,O
apparent,B-PR
distress,I-PR
.,O

She,O
is,O
anicteric,B-PR
without,O
rash,B-PR
or,O
HEENT,O
.,O

Significant,O
for,O
left,B-PR
TM,I-PR
scarring,I-PR
without,O
acute,B-PR
inflammation,I-PR
or,O
drainage,B-PR
.,O

Oropharynx,O
is,O
moist,O
.,O

No,O
lymphadenopathy,B-PR
is,O
noted,O
.,O

Thyroid,O
is,O
nonpalpable,O
.,O

She,O
is,O
without,O
bruits,B-PR
or,O
JVD,B-PR
.,O

Lungs,O
are,O
bilaterally,O
clear,O
to,O
auscultation,B-TE
.,O

Cardiac,B-TE
exam,I-TE
;,O
she,O
has,O
positive,O
S1,O
",",O
S2,O
without,O
murmur,B-PR
",",O
rub,B-PR
or,O
gallop,B-PR
.,O

Rate,B-TE
was,O
75,O
.,O

Abdomen,O
is,O
soft,O
and,O
nontender,B-PR
without,O
hepatosplenomegaly,B-PR
or,O
mass,B-PR
.,O

She,O
has,O
no,O
rebound,B-PR
or,O
guarding,B-PR
.,O

Her,B-TE
rectal,I-TE
exam,I-TE
is,O
guaiac,O
negative,O
.,O

Her,O
extremities,O
are,O
without,O
normal,O
limits,O
with,O
+2,O
pulses,O
throughout,O
.,O

She,O
is,O
neurologically,O
intact,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
for,O
the,B-TR
lap,I-TR
coli,I-TR
with,O
an,B-TE
intraoperative,I-TE
cholangiogram,I-TE
by,O
Dr.,O
Sterp,O
under,O
general,B-TR
anesthesia,I-TR
.,O

A,O
separate,O
operative,O
note,O
has,O
been,O
dictated,O
.,O

Operative,O
course,O
and,O
recovery,O
were,O
without,O
complication,B-PR
.,O

The,O
patient,O
was,O
admitted,O
to,O
floor,O
.,O

The,O
patient,O
was,O
afebrile,B-PR
",",O
vital,B-TE
signs,I-TE
were,O
stable,O
.,O

She,O
is,O
taking,O
po,O
&apos;s,O
.,O

She,O
is,O
ambulatory,O
.,O

The,O
patient,O
will,O
be,O
discharged,O
to,O
home,O
in,O
stable,O
condition,O
with,O
a,O
follow,O
up,O
appointment,O
with,O
Dr.,O
Sterp,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Percocet,B-TR
5,O
mg,O
in,O
325,O
mg,O
one,O
to,O
two,O
tabs,O
po,O
q4,O
to,O
6,O
prn,O
pain,B-PR
.,O

The,O
patient,O
will,O
be,O
discharged,O
in,O
stable,O
condition,O
.,O

Follow,O
up,O
as,O
mentioned,O
will,O
be,O
with,O
Dr.,O
Sterp,O
.,O

______________________,O
SANTDEL,O
GLOTZRHALT,O
",",O
M.D.,O

TR,O
:,O

sxu,O

DD,O
:,O

09/15/2000,O

TD,O
:,O

09/21/2000,O
10:58,O
P,O

cc,O
:,O

MINAQUEENALT,O
MASHINEUSSHA,O
STERP,O
",",O
M.D.,O

346176858,O
SC,O

29574503,O

4164300,O

12/9/2005,O
12:00:00,O
AM,O

SVD,O

DIS,O

Admission,O
Date,O
:,O

12/09/2005,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

12/12/2005,O

******,O
DISCHARGE,O
ORDERS,O
******,O

CHAFFBITZ,O
",",O
LI,O
183-67-53-0,O
U69,O

Room,O
:,O

DEALPERSANDERSWAUKE,O
MISSJEANES,O
MACOMTOMA,O
GLANDSTATE,O
MEDICAL,O
CENTER,O

Service,O
:,O

OBS,O

DISCHARGE,O
PATIENT,O
ON,O
:,O

12/12/05,O
AT,O
10:00,O
AM,O

CONTINGENT,O
UPON,O

Not,O
Applicable,O

WILL,O
D,O
/,O
C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D,O
/,O
C,O
SUMMARY,O
:,O

YES,O

Attending,O
:,O

GRENDZISKLEEB,O
",",O
DELMRU,O
CENI,O
",",O
M.D.,O

DISPOSITION,O
:,O

Home,O

DISCHARGE,O
MEDICATIONS,O
:,O

DERMOPLAST,B-TR
TOPICAL,I-TR
TP,O
Q12H,O
PRN,O
Pain,B-PR
DOCUSATE,B-TR
SODIUM,I-TR
100,O
MG,O
PO,O
BID,O
PRN,O
Constipation,B-PR
IBUPROFEN,B-TR
400-600,O
MG,O
PO,O
Q6H,O
PRN,O
Pain,B-PR

Food,O
/,O
Drug,O
Interaction,O
Instruction,O

Take,O
with,O
food,O
PRENATAL,B-TR
MULTIVITAMINS,I-TR
(,I-TR
STUARTNATAL,I-TR
1+1,I-TR
),I-TR
1,O
TAB,O
PO,O
QD,O
TUCKS,B-TR
(,I-TR
WITCH,I-TR
HAZEL,I-TR
),I-TR
TOPICAL,O
TP,O
Q4H,O
PRN,O
Pain,B-PR

DIET,O
:,O

No,O
Restrictions,O

ACTIVITY,O
:,O

Walking,O
as,O
tolerated,O

FOLLOW,O
UP,O
APPOINTMENT,O
(,O
S,O
),O
:,O

Dr,O
Grendziskleeb,O
6,O
weeks,O
",",O

ALLERGY,O
:,O

NKA,B-PR

ADMIT,O
DIAGNOSIS,O
:,O

labor,B-PR
at,I-PR
term,I-PR

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O
Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O

SVD,O
OTHER,O
DIAGNOSIS,O
;,O
Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O

SVD,O
OPERATIONS,O
AND,O
PROCEDURES,O
:,O

Primary,O
Anesthesia,O
:,O

Epidural,O
Vaginal,O
delivery,O
:,O

Spontaneous,O
Episiotomy,O
:,O

Median,O
Placenta,O
:,O

Delivery,O
:,O

Spontaneous,O
Condition,O
:,O

Normal,O

Staff,O
Obstetrician,O
(,O
supervising,O
),O
:,O

BOORMKAYSSCAJE,O
",",O
PA,O
A.,O
",",O
M.D.,O
Delivery,O

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O

none,O

BRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

G3,O
T1,O
P0,O
A1,O
L1,O

Estimated,O
EDC,O
:,O

2012-09-05,O

Maternal,O
transfer,O
:,O

No,O

Initial,B-TE
newborn,I-TE
exam,I-TE
:,O

No,O
observed,B-PR
abnormalities,I-PR

ADDITIONAL,O
COMMENTS,O
:,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O

TO,O
DO,O
/,O
PLAN,O
:,O

No,O
dictated,O
summary,O

ENTERED,O
BY,O
:,O

BOORMKAYSSCAJE,O
",",O
PA,O
A.,O
",",O
M.D.,O
(,O
TI84,O
),O
12/10/05,O
02:58,O
AM,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

348301810,O

CTMC,O

65055310,O

421501,O

2/19/1991,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Unsigned,O

DIS,O

Admission,O
Date,O
:,O

02/19/1991,O

Report,O
Status,O
:,O

Unsigned,O

Discharge,O
Date,O
:,O

02/25/1991,O

ADMISSION,O
DIAGNOSIS,O
:,O

ENDOMETRIAL,B-PR
CANCER,I-PR
.,O

OPERATION,O
:,O

Total,B-TR
abdominal,I-TR
hysterectomy,I-TR
",",O
bilateral,B-TR
salpingo,I-TR
oophorectomy,I-TR
2-19-91,O
by,O
Dr.,O
Lako,O
Coma,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
an,O
81-year-old,O
who,O
presented,O
with,O
postmenopausal,B-PR
spotting,I-PR
and,O
had,O
an,B-TE
endometrial,I-TE
biopsy,I-TE
which,O
was,O
read,O
at,O
the,O
Etearal,O
Etsystems/,O
Hospital,O
as,O
showing,O
grade,B-PR
I,I-PR
adenocarcinoma,I-PR
.,O

Accordingly,O
she,O
presents,O
for,O
operative,B-TR
therapy,I-TR
at,O
this,O
time,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Negative,O
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

None,O
.,O

MEDICATIONS,O
:,O

None,O
.,O

ALLERGIES,O
:,O

None,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

She,O
is,O
somewhat,O
obese,O
elderly,O
female,O
.,O

HEENT,O
unremarkable,O
.,O

Lungs,O
clear,O
.,O

Abdomen,B-PR
obese,I-PR
",",O
no,O
scars,B-PR
.,O

Pelvic,B-TE
exam,I-TE
showed,O
a,O
small,O
mobile,O
uterus,O
.,O

Extremities,O
show,O
no,O
edema,B-PR
.,O

LABORATORY,O
DATA,O
:,O

All,O
within,O
normal,O
limits,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
brought,O
to,O
the,O
Operating,O
Room,O
on,O
2-19-91,O
where,O
she,O
had,O
an,B-TE
exploratory,I-TE
laparotomy,I-TE
",",O
TAH,B-TR
/,I-TR
BSO,I-TR
",",O
and,O
omental,B-TE
biopsy,I-TE
.,O

She,O
had,O
a,B-TE
normal,I-TE
abdominal,I-TE
exploration,I-TE
of,O
a,O
small,O
uterus,O
with,O
superficial,B-PR
invasion,I-PR
on,O
gross,B-TE
examination,I-TE
",",O
normal,O
ovaries,O
.,O

Washings,B-TE
were,O
sent,O
.,O

A,B-TR
subfascial,I-TR
J-P,I-TR
was,O
left,O
.,O

The,O
patient,O
did,O
well,O
postoperatively,O
and,O
had,O
a,O
regular,O
diet,O
by,O
the,O
third,O
postoperative,O
day,O
.,O

Subfascia,B-TR
drain,I-TR
was,O
discontinued,O
.,O

The,O
patient,O
&apos;s,O
postoperative,B-TE
Hct,I-TE
was,O
34,O
.,O

DISPOSITION,O
:,O

She,O
will,O
have,O
follow-up,O
with,O
Dr.,O
Lako,O
Coma,O
.,O

YM263/3597,O
LAKO,O
C.,O
COMA,O
",",O
M.D.,O
TH0,O

D,O
:,O

02/25/91,O

Batch,O
:,O

4620,O

Report,O
:,O

A5427C65,O

T,O
:,O

02/27/91,O

Dicatated,O
By,O
:,O

TA,O
K.,O
JESC,O
",",O
M.D.,O

351853846,O
WGH,O

8921553,O

92855,O

715722,O

3/24/1997,O
12:00:00,O
AM,O

GAIT,B-PR
DISORDER,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

DISCHARGE,O
SUMMARY,O
NAME,O
:,O

PREHEPRIOR,O
",",O
NIENEMILEISELE,O

UNIT,O
NUMBER,O
:,O

372-41-54,O

ADMISSION,O
DATE,O
:,O

03/24/97,O

DISCHARGE,O
DATE,O
:,O

03/28/97,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Gait,B-PR
disorder,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
31-year-old,O
right-handed,O
female,O
with,O
right-sided,B-PR
greater,I-PR
than,I-PR
left-sided,I-PR
weakness,I-PR
and,O
difficulty,B-PR
walking,I-PR
for,O
several,O
days,O
.,O

She,O
was,O
in,O
her,O
usual,O
state,O
of,O
health,O
until,O
3/20/97,O
when,O
she,O
experienced,O
the,O
fairly,O
sudden,O
onset,O
of,O
predominantly,O
right-sided,B-PR
arm,I-PR
and,I-PR
leg,I-PR
weakness,I-PR
and,O
ataxia,B-PR
.,O

She,O
was,O
standing,O
and,O
walking,O
with,O
her,O
friend,O
",",O
who,O
&quot;,O
had,O
to,O
catch,O
her,O
from,O
falling,O
down,O
&quot;,O
as,O
she,O
toppled,O
towards,O
the,O
right,O
.,O

She,O
evidently,O
recovered,O
from,O
the,B-PR
episode,I-PR
after,O
a,O
number,O
of,O
minutes,O
.,O

The,O
following,O
day,O
",",O
she,O
remained,O
in,O
bed,O
through,O
essentially,O
all,O
of,O
the,O
day,O
due,O
to,O
malaise,B-PR
with,O
no,O
specific,B-PR
deficits,I-PR
being,O
noted,O
.,O

In,O
the,O
subsequent,O
two,O
days,O
",",O
she,O
had,O
several,O
small,B-PR
spells,I-PR
of,I-PR
&quot;,I-PR
imbalance,I-PR
&quot;,O
",",O
particularly,O
towards,O
the,O
right,O
",",O
and,O
other,B-PR
symptoms,I-PR
included,O
diffuse,B-PR
and,I-PR
mainly,I-PR
frontal,I-PR
headaches,I-PR
and,O
mild,B-PR
neck,I-PR
soreness,I-PR
.,O

There,O
was,O
no,O
diplopia,B-PR
",",O
visual,B-PR
loss,I-PR
",",O
speech,B-PR
abnormality,I-PR
or,O
sensory,B-PR
change,I-PR
in,O
her,O
history,O
.,O

She,O
was,O
initially,O
evaluated,O
at,O
an,O
outside,O
hospital,O
emergency,O
room,O
",",O
and,O
then,O
transferred,O
to,O
Well,O
General,O
Hospital,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Is,O
notable,O
for,O
depression,B-PR
",",O
and,O
she,O
has,O
been,O
followed,O
regularly,O
by,O
Dr.,O
Freiermchird,O
of,O
Nash,O
Health,O
for,O
several,O
months,O
with,O
pharmacologic,B-TR
treatment,I-TR
",",O
which,O
is,O
apparently,O
working,O
well,O
.,O

Her,B-TR
Doxepin,I-TR
has,O
recently,O
been,O
increased,O
.,O

She,O
is,O
status,O
post,O
appendectomy,B-TR
and,O
otherwise,O
has,O
no,O
remarkable,O
past,O
medical,O
history,O
.,O

ALLERGIES,O
:,O

Quinine,B-TR
gives,O
her,O
a,B-PR
rash,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

The,O
only,O
medications,B-TR
she,O
is,O
on,O
are,O
Paxil,B-TR
30,O
mg,O
p.o.,O
q.day,O
",",O
Doxepin,B-TR
25,O
mg,O
p.o.,O
q.day,O
",",O
and,O
Klonopin,B-TR
2,O
mg,O
p.o.,O
q.h.s.,O

SOCIAL,O
HISTORY,O
:,O

She,O
is,O
currently,O
unemployed,O
",",O
but,O
until,O
recently,O
",",O
she,O
was,O
employed,O
at,O
a,O
bank,O
.,O

She,O
was,O
born,O
and,O
raised,O
in,O
Atonlaremont,O
Rockpo,O
.,O

There,O
is,O
a,O
history,O
of,O
childhood,O
abuse,O
.,O

She,O
does,O
not,O
drink,O
.,O

She,O
is,O
a,O
former,O
tobacco,O
user,O
and,O
takes,O
no,O
illicit,O
drugs,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

She,O
was,O
pleasant,O
",",O
in,O
no,O
acute,B-PR
distress,I-PR
;,O
blood,B-TE
pressure,I-TE
130/60,O
;,O
heart,B-TE
rate,I-TE
66,O
;,O
respirations,B-TE
18,O
;,O
temperature,B-TE
98,O
.,O

Her,O
thyroid,O
was,O
within,O
normal,O
limits,O
.,O

There,O
were,O
no,O
carotid,B-PR
or,I-PR
cervical,I-PR
bruits,I-PR
.,O

She,O
had,O
a,O
normal,O
S1,O
and,O
S2,O
and,O
regular,O
rate,O
and,O
rhythm,O
with,O
no,O
murmurs,B-PR
.,O

Her,O
lungs,O
were,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

Her,O
abdomen,O
was,O
benign,O
.,O

Her,O
extremities,O
were,O
without,O
clubbing,B-PR
",",O
cyanosis,B-PR
",",O
edema,B-PR
",",O
or,O
rash,B-PR
;,O
there,O
were,O
some,O
older,O
hematomas,B-PR
in,I-PR
the,I-PR
bilaterally,I-PR
shins,I-PR
.,O

Mental,O
status,O
-,O
her,O
speech,O
was,O
fluent,O
without,O
errors,O
.,O

Her,O
affect,O
was,O
slightly,B-PR
inappropriate,I-PR
at,O
times,O
;,O
for,O
example,O
",",O
singing,B-PR
or,I-PR
humming,I-PR
along,I-PR
while,O
performing,O
some,O
of,O
the,B-TE
motor,I-TE
tasks,I-TE
and,O
giving,O
the,O
impression,O
of,O
indifference,B-PR
to,O
the,B-PR
deficits,I-PR
that,O
were,O
demonstrated,O
on,O
the,B-TE
examination,I-TE
.,O

Her,O
memory,O
was,O
fully,O
intact,O
for,O
short-term,O
recollection,O
of,O
three,O
out,O
of,O
three,O
objects,O
at,O
five,O
minutes,O
with,O
excellent,O
naming,O
",",O
repetition,O
",",O
proverb,O
interpretation,O
",",O
and,O
ability,O
to,O
follow,O
commands,O
.,O

Visual,O
fields,O
were,O
full,O
to,O
confrontation,O
.,O

Her,O
left,O
pupil,O
was,O
7,O
mm,O
reacting,O
to,O
5,O
mm,O
.,O

Her,O
right,O
pupil,O
was,O
5.5,O
mm,O
reacting,O
to,O
4,O
mm,O
.,O

Her,O
extraocular,O
movements,O
were,O
intact,O
for,O
horizontal,O
and,O
vertical,O
pursuits,O
.,O

There,O
was,O
no,O
nystagmus,B-PR
and,O
no,O
ptosis,B-PR
.,O

Her,O
saccades,O
were,O
normal,O
.,O

Facial,O
strength,O
and,O
sensation,O
were,O
full,O
and,O
symmetric,O
.,O

Her,O
tongue,O
",",O
uvula,O
and,O
palate,O
were,O
midline,O
.,O

Shoulder,O
shrug,O
was,O
5/5,O
power,O
.,O

Motor,B-TE
examination,I-TE
revealed,O
5/5,O
power,O
in,O
all,O
groups,O
in,O
the,O
proximal,O
and,O
distal,O
upper,O
and,O
lower,O
extremities,O
.,O

There,O
was,O
no,O
drift,B-PR
.,O

There,O
was,O
normal,O
bulk,O
and,O
tone,O
.,O

She,O
had,O
slightly,B-PR
slow,I-PR
fine,I-PR
finger,I-PR
motility,I-PR
approximately,O
equal,O
bilaterally,O
",",O
although,O
this,O
was,O
extremely,O
difficult,O
to,O
reproduce,O
.,O

Sensory,O
-,O
intact,O
light,O
touch,O
",",O
temperature,O
",",O
and,O
vibration,O
overall,O
.,O

Reflexes,B-TE
were,O
2+,O
throughout,O
in,O
the,O
upper,O
and,O
lower,O
extremities,O
",",O
and,O
toes,O
were,O
downgoing,O
.,O

There,O
was,O
no,O
jaw,B-PR
jerk,I-PR
and,O
no,O
Hoffman,O
&apos;s,O
sign,O
.,O

Coordination,O
-,O
toe,B-TE
tap,I-TE
was,O
slow,B-PR
bilaterally,I-PR
",",O
although,O
difficult,O
to,O
reproduce,O
",",O
and,O
at,O
best,O
",",O
was,O
essentially,O
within,O
normal,O
limits,O
.,O

On,O
standing,O
",",O
she,O
tended,O
to,O
fall,O
to,O
the,O
front,O
",",O
back,O
or,O
sides,O
without,O
trying,O
to,O
stop,O
her,O
fall,O
initially,O
",",O
and,O
extensive,B-TE
gait,I-TE
testing,I-TE
was,O
deferred,O
due,O
to,O
concerns,O
for,O
safety,O
.,O

Her,B-TE
heel-to-shin,I-TE
and,I-TE
finger-to-nose,I-TE
testing,I-TE
was,O
fully,O
intact,O
bilaterally,O
without,O
ataxia,B-PR
or,O
tremor,B-PR
.,O

LABORATORY,O
DATA,O
:,O

Were,O
unremarkable,O
with,O
normal,O
electrolytes,B-TE
and,O
complete,B-TE
blood,I-TE
count,I-TE
parameters,I-TE
.,O

Her,B-TE
erythrocyte,I-TE
sedimentation,I-TE
rate,I-TE
was,O
12,O
.,O

Her,B-TE
coagulation,I-TE
parameters,I-TE
were,O
normal,O
.,O

Head,B-TE
CT,I-TE
scan,I-TE
without,I-TE
contrast,I-TE
showed,O
normal,O
brain,O
parenchyma,O
and,O
no,O
intracranial,B-PR
process,I-PR
.,O

HOSPITAL,O
COURSE,O
AND,O
TREATMENT,O
:,O

The,O
patient,O
was,O
admitted,O
for,O
her,B-PR
gait,I-PR
disorder,I-PR
with,O
other,O
notable,B-PR
findings,I-PR
on,O
examination,B-TE
including,O
anisocoria,B-PR
",",O
which,O
",",O
by,O
the,O
patient,O
&apos;s,O
report,O
",",O
had,O
been,O
noted,O
several,O
months,O
earlier,O
.,O

A,B-TE
magnetic,I-TE
resonance,I-TE
imaging,I-TE
and,O
magnetic,B-TE
resonance,I-TE
angiogram,I-TE
study,I-TE
was,O
obtained,O
",",O
which,O
showed,O
no,O
clear,O
evidence,O
of,O
arterial,B-PR
dissections,I-PR
or,O
infarction,B-PR
or,O
other,B-PR
pathologic,I-PR
processes,I-PR
.,O

She,O
had,O
been,O
placed,O
on,O
heparin,B-TR
initially,O
",",O
but,O
this,O
was,O
discontinued,O
after,O
the,B-TE
magnetic,I-TE
resonance,I-TE
imaging,I-TE
results,O
were,O
obtained,O
.,O

Posterior,B-TE
transcranial,I-TE
Doppler,I-TE
studies,I-TE
showed,O
normal,O
studies,O
of,O
both,O
vertebral,O
arteries,O
",",O
and,O
carotid,B-TE
non-invasive,I-TE
studies,I-TE
showed,O
normal,O
right,O
and,O
left,O
carotid,O
bifurcations,O
.,O

On,O
the,O
second,O
hospital,O
day,O
",",O
her,B-PR
gait,I-PR
continued,O
to,O
be,O
markedly,B-PR
unstable,I-PR
",",O
although,O
with,O
no,O
consistent,O
pattern,O
in,O
terms,O
of,O
weakness,B-PR
or,O
directionality,O
of,O
falling,O
",",O
and,O
she,O
continued,O
to,O
have,O
no,O
reproducible,B-PR
upper,I-PR
extremity,I-PR
or,I-PR
lower,I-PR
extremity,I-PR
ataxia,I-PR
or,O
dysmetria,B-PR
.,O

She,O
was,O
seen,O
by,O
the,O
Psychiatry,B-TR
Service,I-TR
.,O

She,O
was,O
not,O
felt,O
to,O
be,O
acutely,B-PR
suicidal,I-PR
or,O
otherwise,O
in,O
need,O
of,O
acute,B-TR
psychiatric,I-TR
treatment,I-TR
.,O

The,O
psychiatrist,O
also,O
noted,O
the,O
indifference,O
the,O
patient,O
evinced,O
regarding,O
her,B-PR
own,I-PR
symptomatology,I-PR
.,O

The,O
patient,O
was,O
evaluated,O
in,O
one,O
of,O
the,O
neurology,O
conferences,O
for,O
several,O
hours,O
",",O
and,O
during,O
this,O
time,O
",",O
showed,O
significant,O
improvement,O
while,O
receiving,O
gait,B-TR
training,I-TR
as,O
well,O
as,O
evaluation,B-TE
;,O
in,O
particular,O
",",O
she,O
became,O
more,O
stable,O
with,O
counter-balancing,B-TR
methods,I-TR
.,O

This,O
trend,O
of,O
improvement,O
continued,O
",",O
and,O
she,O
was,O
discharged,O
in,O
stable,O
condition,O
.,O

She,O
will,O
follow,O
up,O
with,O
her,O
psychiatrist,O
",",O
Dr.,O
Freiermchird,O
(,O
Sone,O
Memorial,O
Hospital,O
),O
on,O
a,O
regular,O
basis,O
",",O
and,O
she,O
can,O
follow,O
up,O
with,O
the,O
Neurology,O
Service,O
on,O
a,O
p.r.n.,O
basis,O
if,O
needed,O
.,O

She,O
will,O
continue,O
on,O
her,B-TR
previous,I-TR
outpatient,I-TR
medical,I-TR
regimen,I-TR
.,O

NIREGE,O
MEMORY,O
",",O
M.D.,O

TR,O
:,O

bzo,O

DD,O
:,O

03/29/97,O

TD,O
:,O

03/31/97,O
12:36,O
P,O

cc,O
:,O

NYRI,O
A,O
MEMORY,O
",",O
M.D.,O

ASHELLRIETTE,O
NESSASU,O
THREATSVOT,O
",",O
M.D.,O

EJEAN,O
NADARC,O
FREIERMCHIRD,O
",",O
M.D.,O

373254497,O
PUMC,O

6211697,O

433913,O

209987,O

3/5/2002,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O
/,O
SUMMARY,O

SHUFFJESC,O
",",O
NANORA,O

MRN,O
:,O

6211697,O

Age,O
:,O

36y,O

REGISTRATION,O
DATE,O
:,O

03/05/2002,O
10:11,O
PM,O

Provider,O
:,O

QUELOISEVIER,O
DREWEILLTRIEVKEMME,O

PRELIMINARY,O
REPORT,O

PCP,O
notified,O
by,O
MD,O
:,O

E-mail,O
PCP,O

Benefits,O
Assigned,O
:,O

Y,O

Discharge,O
Date,O
/,O
Time,O
:,O

03/06/2002,O
06:23,O

Discharge,O
Status,O
:,O

Discharged,O

Condition,O
on,O
Discharge,O
:,O

Stable,O

Patient,O
States,O
Complaint,O
:,O

ABD,B-PR
PAIN/,I-PR
PELVIC,B-PR
PAIN,I-PR

Standardized,O
Discharge,O
Instructions,O
:,O

The,O
patient,O
was,O
given,O
printed,O
instructions,O
for,O
abdominal,B-PR
pain,I-PR
(,O
English,O
),O
.,O

Diagnosis,O
:,O

Abdominal,B-PR
pain,I-PR
Treatment,O
Rendered,O
:,O

Ct,B-TE
scan,I-TE
shows,O
ovarian,B-PR
cyst,I-PR

Discharge,O
Medications,O
:,O

Vicodin,B-TR

Disposition,O
",",O
Follow,O
up,O
and,O
Instructions,O
to,O
Patient,O
:,O

Please,O
follow,O
up,O
with,O
Dr.,O
Wires,O
on,O
Monday,O
.,O

If,O
you,O
have,O
continued,O
fevers,B-PR
",",O
worsening,B-PR
abdominal,I-PR
pain,I-PR
",",O
discharge,B-PR
or,O
other,B-PR
worrisome,I-PR
symptoms,I-PR
",",O
please,O
return,O
to,O
the,O
emergency,O
department,O
.,O

PCP,O
Name,O
:,O

WIRES,O
",",O
PEANTSALL,O
A,O

Provider,O
Number,O
:,O

16986,O

This,O
report,O
was,O
created,O
by,O
DREWEILLTRIEVKEMME,O
",",O
QUELOISEVIER,O
03/06/2002,O
06:28,O
AM,O

384729825,O

FIH,O

670582,O

899158,O

790156,O

11/20/2002,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O

BREUNDAIL,O
",",O
NETFA,O

MRN,O
:,O

670582,O

Age,O
:,O

91y,O

REGISTRATION,O
DATE,O
:,O

11/20/2002,O
02:02,O
AM,O

PRELIMINARY,O
REPORT,O

This,O
is,O
to,O
notify,O
you,O
that,O
your,O
patient,O
",",O
BREUNDAIL,O
",",O
NETFA,O
arrived,O
in,O
the,O
Emergency,O
Department,O
at,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
on,O
11/20/2002,O
02:02,O
AM,O
.,O

The,O
patient,O
presented,O
with,O
a,O
chief,O
complaint,O
of,O
SDH,B-PR
.,O

Following,O
evaluation,B-TE
and,O
treatment,B-TR
",",O
the,O
patient,O
&apos;s,O
disposition,O
at,O
the,O
end,O
of,O
the,O
visit,O
was,O
ADMITTED,O
AS,O
AN,O
INPATIENT,O
TO,O
FAIRM,O
OF,O
IJORDCOMPMAC,O
HOSPITAL,O
.,O

The,O
patient,O
&apos;s,O
preliminary,O
admitting,O
physician,O
is,O
GLYNCRED,O
",",O
NABETH,O
N,O
and,O
the,O
preliminary,O
diagnosis,O
is,O
SDH,B-PR
.,O

Please,O
note,O
this,O
information,O
may,O
have,O
been,O
updated,O
on,O
the,O
inpatient,O
unit,O
.,O

If,O
you,O
need,O
additional,O
information,O
please,O
call,O
834-226-3369,O
.,O

PCP,O
Name,O
:,O

TRIEVA,O
",",O
WINGENE,O
R,O

Provider,O
Number,O
:,O

3519,O

388755206,O
SC,O

28741969,O

9895112,O

12/1/2003,O
12:00:00,O
AM,O

s,O
/,O
p,O
cesarean,B-TR

DIS,O

Admission,O
Date,O
:,O

12/01/2003,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

12/06/2003,O

******,O
DISCHARGE,O
ORDERS,O
******,O

STENOBE,O
",",O
LANDEM,O
847-02-84-0,O
J73,O

Room,O
:,O

GHA74-9086,O

Service,O
:,O

OBS,O

DISCHARGE,O
PATIENT,O
ON,O
:,O

12/06/03,O
AT,O
10:00,O
AM,O

CONTINGENT,O
UPON,O

Attending,B-TE
evaluation,I-TE

WILL,O
D,O
/,O
C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D,O
/,O
C,O
SUMMARY,O
:,O

YES,O

Attending,O
:,O

CLOZPLU,O
",",O
A,O
A,O
",",O
M.D.,O

DISPOSITION,O
:,O

Home,O

DISCHARGE,O
MEDICATIONS,O
:,O

COLACE,B-TR
(,I-TR
DOCUSATE,I-TR
SODIUM,I-TR
),I-TR
100,O
MG,O
PO,O
BID,O
IBUPROFEN,B-TR
600,O
MG,O
PO,O
Q6H,O
PRN,O
PAIN,O
ALDOMET,B-TR
(,I-TR
METHYLDOPA,I-TR
),I-TR
250,O
MG,O
PO,O
BID,O
PERCOCET,B-TR
1-2,O
TAB,O
PO,O
Q4H,O
PRN,O
PAIN,B-PR

DIET,O
:,O

No,O
Restrictions,O

ACTIVITY,O
:,O

Resume,O
regular,O
exercise,O

FOLLOW,O
UP,O
APPOINTMENT,O
(,O
S,O
),O
:,O

Your,O
obstetrician,O
6,O
weeks,O
",",O
No,O
Known,B-PR
Allergies,I-PR

ADMIT,O
DIAGNOSIS,O
:,O

s,O
/,O
p,O
cesarean,B-TR

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O
Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O
s,O
/,O
p,O
cesarean,B-TR

OTHER,O
DIAGNOSIS,O
;,O
Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O
s,O
/,O
p,O
cesarean,B-TR

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

Primary,O
Anesthesia,O
:,O

Epidural,B-TR
Vaginal,O
delivery,O
:,O

Undelivered,O
Cesarean,O
Status,O
:,O

Primary,O
Urgency,O
:,O

Emergent,O
Indications,O
:,O

Non-reassuring,B-PR
fetal,I-PR
status,I-PR
",",O
Uterine,O

incision,O
type,O
:,O

Transverse,O

Placenta,O
:,O

Delivery,O
:,O

Manual,O
Condition,O
:,O

Normal,O
Staff,O
Obstetrician,O
(,O
supervising,O
),O
:,O

CLOZPLU,O
",",O
A,O
A,O
",",O
M.D.,O
Delivery,O

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O

IV,B-TR
ABX,I-TR

BRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

G9,O
T3,O
P0,O
A5,O
L3,O

Estimated,O
EDC,O
:,O

11/28/03,O

Indications,O
for,O
induction,O
:,O

Post,B-PR
dates,I-PR

Complications,O
of,O
labor,O
:,O

",",O
Other,O
-,O
bradycardia,B-PR

Maternal,O
transfer,O
:,O

No,O

Initial,O
newborn,O
exam,O
:,O

No,O
observed,B-PR
abnormalities,I-PR

Baby,O
1,O

MRN,O
:,O

32859272,O

Delivery,O
date,O
:,O

12/02/03,O
03:20,O
PM,O
Apgars,B-TE
"7,8",O

Weight,B-TE
:,O

9lb,O
15,O
oz,O
4508,O
grams,O

Sex,O
:,O

Male,O

ADDITIONAL,O
COMMENTS,O
:,O

no,O
heavy,O
lifting,O
;,O
nothing,O
in,O
the,O
vagina,O
for,O
6,O
weeks,O
--,O
no,O
intercourse,O
",",O
no,O
douching,O
",",O
no,O
tampons,O
;,O
call,O
for,O
fever,B-PR
above,I-PR
100.5,I-PR
",",O
worsening,B-PR
abdominal,I-PR
pain,I-PR
",",O
heavy,B-PR
bleeding,I-PR
",",O
or,O
any,B-PR
other,I-PR
concern,I-PR
;,O
no,O
driving,O
while,O
taking,O
percocet,B-TR

DISCHARGE,O
CONDITION,O
:,O

Stable,O

TO,O
DO,O
/,O
PLAN,O
:,O

No,O
dictated,O
summary,O

ENTERED,O
BY,O
:,O

HAXKOTE,O
",",O
A,O
N.,O
",",O
M.D.,O
(,O
ZL69,O
),O
12/06/03,O
09:04,O
AM,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

402389409,O
WGH,O

2852246,O

946048,O

3205820,O

10/18/2005,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O
/,O
SUMMARY,O

SLENTPEASEBUMPS,O
",",O
LISSSOND,O

MRN,O
:,O

2852246,O

Age,O
:,O

52y,O

REGISTRATION,O
DATE,O
:,O

10/18/2005,O
02:43,O
PM,O

Provider,O
:,O

APT,O
SHUFF,O

PRELIMINARY,O
REPORT,O

Benefits,O
Assigned,O
:,O

N,O

Discharge,O
Note,O
Date,O
/,O
Time,O
:,O

10/18/2005,O
15:50,O

Discharge,O
Status,O
:,O

Discharged,O

Condition,O
on,O
Discharge,O
:,O

Stable,O

Patient,O
States,O
Complaint,O
:,O

S,O
/,O
P,O
MVA,O

Standardized,O
Discharge,O
Instructions,O
:,O

The,O
patient,O
was,O
given,O
printed,O
instructions,O
for,O
motor,O
vehicle,O
accident,O
-,O
trauma,B-PR
(,O
English,O
),O
.,O

The,O
patient,O
was,O
given,O
printed,O
instructions,O
for,O
sprains,B-PR
",",O
fractures,B-PR
and,O
bruises,B-PR
(,O
English,O
),O
.,O

Diagnosis,O
:,O

s,O
/,O
p,O
motor,O
vehicle,O
accident,O
",",O
muscle,B-PR
contusions,I-PR

Treatment,O
Rendered,O
:,O

xray,B-TE
-,O
no,O
evidence,O
of,O
fracture,B-PR

Discharge,O
Medications,O
:,O

motrin,B-TR
600,O
mg,O
every,O
8,O
hours,O
for,O
pain,B-PR
-,O
please,O
take,O
with,O
food,O
in,O
your,O
stomach,O

Follow,O
up,O
Service,O
:,O

Please,O
call,O
your,O
primary,O
care,O
doctor,O
next,O
week,O
and,O
arrange,O
for,O
follow,O
up,O
next,O
week,O
.,O

Disposition,O
",",O
Follow,O
up,O
and,O
Instructions,O
to,O
Patient,O
:,O

Please,O
use,O
ice,B-TR
to,O
sore,B-PR
areas,I-PR
for,O
the,O
next,O
few,O
days,O
.,O

If,O
you,O
develop,O
trouble,B-PR
breathing,I-PR
",",O
worsening,B-PR
pain,I-PR
",",O
vomiting,B-PR
or,O
any,B-PR
other,I-PR
concerns,I-PR
please,O
return,O
to,O
the,O
ED,O
for,O
further,B-TE
evaluation,I-TE
.,O

Do,O
no,O
strenuous,O
activity,O
or,O
heavy,O
lifting,O
for,O
the,O
next,O
few,O
days,O
.,O

PCP,O
Name,O
:,O

CLOPKOORSFONGAYLES,O
",",O
NORBMADE,O

Provider,O
Number,O
:,O

26318,O

This,O
report,O
was,O
created,O
by,O
SHUFF,O
",",O
RONRIN,O
10/18/2005,O
03:53,O
PM,O

405507617,O

FIH,O

2887168,O

132052,O

543394,O

11/12/2002,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

DISCHARGE,O
SUMMARY,O
NAME,O
:,O

SPALDFREIERMPLCA,O
",",O
IEOLY,O
E,O

UNIT,O
NUMBER,O
:,O

251-62-95,O

ADMISSION,O
DATE,O
:,O

11/12/2002,O

DISCHARGE,O
DATE,O
:,O

11/15/2002,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Alzheimer,B-PR
&apos;s,I-PR
disease,I-PR
secondary,O
to,O
Down,B-PR
&apos;s,I-PR
syndrome,I-PR
.,O

CHIEF,O
COMPLAINT,O
:,O

This,O
is,O
a,O
44,O
year-old,O
right,O
handed,O
woman,O
with,O
Down,B-PR
&apos;s,I-PR
syndrome,I-PR
who,O
presents,O
with,O
falling,B-PR
and,O
a,B-PR
decrease,I-PR
in,I-PR
her,I-PR
activities,I-PR
of,O
daily,O
living,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
44,O
year-old,O
right,O
handed,O
woman,O
with,O
Down,B-PR
&apos;s,I-PR
syndrome,I-PR
who,O
presents,O
with,O
increased,B-PR
falling,I-PR
and,O
gait,B-PR
unsteadiness,I-PR
and,O
an,B-PR
increased,I-PR
inability,I-PR
to,O
perform,O
her,O
activities,O
of,O
daily,O
living,O
over,O
the,O
past,O
three,O
years,O
.,O

The,O
diagnosis,O
of,O
Alzheimer,B-PR
&apos;s,I-PR
was,O
made,O
in,O
1998,O
.,O

The,O
patient,O
had,O
an,B-TE
MRI,I-TE
at,O
an,O
outside,O
hospital,O
which,O
showed,O
enlarged,B-PR
lateral,I-PR
ventricles,I-PR
and,O
the,O
possible,O
diagnosis,O
of,O
normal,B-PR
pressure,I-PR
hydrocephalus,I-PR
was,O
entertained,O
and,O
the,O
patient,O
was,O
admitted,O
for,O
diagnostic,B-TE
lumbar,I-TE
puncture,I-TE
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Notable,O
for,O
Down,B-PR
&apos;s,I-PR
syndrome,I-PR
",",O
Altzheimer,B-PR
&apos;s,I-PR
disease,I-PR
secondary,O
to,O
Down,B-PR
&apos;s,I-PR
syndrome,I-PR
diagnosed,O
in,O
1998,O
",",O
status,O
post,O
multiple,B-PR
falls,I-PR
",",O
no,O
heart,B-PR
disease,I-PR
",",O
ankle,B-TR
surgery,I-TR
and,O
an,B-PR
abnormal,I-PR
EEG,I-PR
.,O

MEDICATIONS,O
:,O

Include,O
Lamictal,B-TR
50,O
mgs,O
bid,O
",",O
Aricept,B-TR
10,O
mgs,O
qhs,O
",",O
BuSpar,B-TR
15,O
mgs,O
bid,O
",",O
Trazodone,B-TR
100,O
mgs,O
qhs,O
.,O

ALLERGIES,O
:,O

There,O
are,O
no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
lives,O
at,O
home,O
with,O
her,O
family,O
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

Notable,O
for,O
decreased,B-PR
ability,I-PR
to,O
do,O
her,O
activities,O
of,O
daily,O
living,O
",",O
a,B-PR
decrease,I-PR
in,I-PR
her,I-PR
language,I-PR
",",O
some,B-PR
urinary,I-PR
accidents,I-PR
",",O
increased,B-PR
falls,I-PR
and,O
a,B-PR
poor,I-PR
gait,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Noted,O
for,O
friendly,O
",",O
jovial,O
44,O
year-old,O
woman,O
with,O
Down,B-PR
&apos;s,I-PR
.,O

Vital,O
signs,O
:,O

Blood,B-TE
pressure,I-TE
150/82,O
",",O
heart,B-TE
rate,I-TE
88,O
",",O
respiratory,B-TE
rate,I-TE
18,O
.,O

HEENT,B-TE
examination,I-TE
is,O
notable,O
for,O
bilateral,B-PR
esotropia,I-PR
.,O

Chest,O
was,O
clear,O
to,O
auscultation,B-TE
.,O

Cardiac,B-TE
examination,I-TE
was,O
regular,O
rate,O
and,O
rhythm,O
.,O

Abdominal,B-TE
examination,I-TE
was,O
soft,O
",",O
non-tender,B-PR
",",O
positive,O
bowel,O
sounds,O
.,O

Extremities,O
:,O

Left,O
ankle,O
was,O
notable,O
for,O
swelling,B-PR
secondary,O
to,O
status,O
post,O
left,B-TR
ankle,I-TR
surgery,I-TR
.,O

Skin,O
:,O

The,O
patient,O
had,O
back,B-PR
folliculitis,I-PR
.,O

Neuro,B-TE
examination,I-TE
was,O
notable,O
for,O
a,O
patient,O
who,O
was,O
alert,O
and,O
oriented,O
x,O
1,O
.,O

She,O
could,O
identify,O
her,O
siblings,O
.,O

She,O
can,O
name,O
several,O
words,O
such,O
as,O
thumb,O
",",O
watch,O
and,O
knuckle,O
.,O

She,O
was,O
unable,O
to,O
name,O
glasses,O
.,O

Cranial,O
nerves,O
notable,O
for,O
bilateral,B-PR
esotropia,I-PR
.,O

Her,O
extraocular,O
motions,O
were,O
full,O
.,O

The,O
face,O
was,O
symmetrical,O
.,O

The,O
motor,O
tone,O
was,O
within,O
normal,O
limits,O
in,O
the,O
upper,O
and,O
lower,O
extremities,O
.,O

The,O
strength,O
was,O
5,O
out,O
of,O
5,O
.,O

Reflexes,B-TE
were,O
2+,O
bilaterally,O
with,O
down,O
going,O
toes,O
.,O

Her,O
gait,O
was,O
notable,O
for,O
requiring,O
assist,O
.,O

The,O
patient,O
walked,O
with,O
her,B-PR
feet,I-PR
externally,I-PR
rotated,I-PR
with,O
a,B-PR
wide,I-PR
based,I-PR
gait,I-PR
with,O
shuffling,B-PR
short,I-PR
steps,I-PR
with,O
a,B-PR
tendency,I-PR
to,I-PR
fall,I-PR
back,I-PR
and,O
she,O
was,O
unable,O
to,O
walk,O
without,O
assist,O
.,O

MRI,B-TE
",",O
as,O
discussed,O
",",O
was,O
done,O
at,O
outside,O
hospital,O
and,O
demonstrated,O
large,B-PR
ventricles,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
Arkzie-,O
Memorial,O
for,O
lumbar,B-TE
puncture,I-TE
.,O

On,O
the,O
night,O
of,O
admission,O
lumbar,B-TE
puncture,I-TE
was,O
attempted,O
on,O
the,O
floor,O
",",O
but,O
we,O
were,O
unable,O
to,O
get,O
cerebral,O
spinal,O
fluid,O
due,O
to,O
difficulty,O
with,O
compliance,O
with,O
the,O
patient,O
who,O
was,O
severely,B-PR
agitated,I-PR
and,O
would,O
not,O
comply,O
with,O
the,B-TE
examination,I-TE
.,O

On,O
hospital,O
day,O
the,O
patient,O
underwent,O
conscious,B-TR
sedation,I-TR
in,O
the,O
operating,O
room,O
where,O
lumbar,B-TE
puncture,I-TE
was,O
performed,O
.,O

Opening,B-TE
pressure,I-TE
was,O
17,O
and,O
approximately,O
20-25,O
cc,O
of,O
CSF,O
was,O
removed,O
.,O

CSF,B-TE
was,O
notable,O
for,O
sugar,B-TE
level,I-TE
of,O
65,O
and,O
total,B-TE
protein,I-TE
level,I-TE
of,O
56,O
.,O

OTHER,O
LABORATORIES,O
THAT,O
WERE,O
NOTABLE,O
:,O

Vitamin,B-TE
B12,I-TE
of,O
855,O
",",O
folic,B-TE
acid,I-TE
of,O
15.4,O
.,O

Chem-7,B-TE
was,O
within,O
normal,O
limits,O
.,O

Tube,O
and,O
requisition,O
of,O
the,O
CSF,B-TE
labeled,I-TE
tube,I-TE
#,I-TE
1,I-TE
was,O
notable,O
for,O
color,B-TE
pink,O
",",O
turbidity,B-TE
slight,O
",",O
xanthochromia,B-TE
yes,O
",",O
red,B-TE
blood,I-TE
cells,I-TE
"3,800",O
",",O
white,B-TE
blood,I-TE
cells,I-TE
3,O
",",O
neutrophils,B-TE
58,O
",",O
bands,B-TE
4,O
",",O
lymphs,B-TE
29,O
",",O
monos,B-TE
6,O
",",O
eos,B-TE
2,O
and,O
basos,B-TE
1,O
.,O

CSF,B-TE
tube,I-TE
labeled,I-TE
#,I-TE
4,I-TE
was,O
notable,O
for,O
CSF,B-TE
color,I-TE
pink,O
",",O
CSF,B-TE
turbidity,I-TE
slight,O
",",O
CSF,B-TE
xanthochromia,I-TE
yes,O
",",O
CSF,B-TE
RBCs,I-TE
"3,900",O
",",O
CSF,B-TE
white,I-TE
blood,I-TE
cells,I-TE
3,O
",",O
CSF,B-TE
neutrophils,I-TE
61,O
",",O
CSF,B-TE
bands,I-TE
3,O
",",O
CSF,B-TE
lymphs,I-TE
31,O
",",O
CSF,B-TE
monos,I-TE
1,O
",",O
CSF,B-TE
eos,I-TE
3,O
",",O
CSF,B-TE
basos,I-TE
1,O
.,O

CSF,B-TE
gram,I-TE
stain,I-TE
was,O
notable,O
for,O
no,O
polys,B-PR
and,O
no,O
organisms,B-PR
seen,O
.,O

The,B-TE
fluid,I-TE
culture,I-TE
was,O
no,O
growth,O
to,O
date,O
.,O

One,O
day,O
prior,O
to,O
lumbar,B-TE
puncture,I-TE
",",O
an,B-TE
aerobic,I-TE
culture,I-TE
was,O
similarly,O
pending,O
.,O

Lyme,B-TE
capture,I-TE
was,O
pending,O
and,O
at,O
the,O
time,O
of,O
discharge,O
.,O

Other,O
notable,O
tests,O
:,O

RPR,B-TE
card,I-TE
test,I-TE
was,O
negative,O
.,O

Because,O
of,O
poor,O
compliance,O
with,O
the,B-TE
gait,I-TE
examination,I-TE
it,O
was,O
very,O
difficult,O
to,O
assess,O
changing,B-PR
gait,I-PR
post,O
lumbar,B-TE
puncture,I-TE
.,O

The,O
patient,O
&apos;s,O
gait,O
remained,O
wide,O
based,O
and,O
shuffling,O
and,O
requiring,O
assist,O
.,O

Her,O
mental,O
status,O
remained,O
similarly,O
to,O
her,B-TE
admission,I-TE
examination,I-TE
.,O

The,O
patient,O
was,O
discharged,O
to,O
home,O
on,O
11/15/02,O
with,O
instructions,O
to,O
the,O
family,O
to,O
observe,O
her,O
gait,O
in,O
her,O
home,O
environment,O
and,O
to,O
observe,O
her,O
behavior,O
in,O
her,O
home,O
environment,O
over,O
the,O
next,O
day,O
and,O
to,O
report,O
back,O
to,O
the,O
primary,O
neurologist,O
",",O
Dr.,O
Flythegach,O
",",O
as,O
to,O
changes,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Were,O
as,O
they,O
were,O
on,O
admission,O
.,O

The,B-TE
patient,I-TE
&apos;s,I-TE
neuro,I-TE
examination,I-TE
was,O
largely,O
unchanged,O
from,O
the,B-TE
admission,I-TE
neuro,I-TE
examination,I-TE
.,O

LATO,O
TIKFREIERM,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

_____________________________,O
LATO,O
TIKFREIERM,O
",",O
M.D.,O

TR,O
:,O

yh,O

DD,O
:,O

11/14/2002,O

TD,O
:,O

11/19/2002,O
3:35,O
P,O

cc,O
:,O

SIE,O
FLYTHEGACH,O
",",O
M.D.,O
TIFFILL,O
SAPNINS,O
",",O
M.D.,O
STA,O
THERNLIN,O
BALLOON,O
",",O
M.D.,O
LATO,O
TIKFREIERM,O
",",O
M.D.,O
/PCP,O
",",O
Jofredd,O
Mones,O
",",O
M.D.,O

405868244,O
YC,O

70449076,O

5586564,O

11/16/2005,O
12:00:00,O
AM,O

POSTPARTUM,O

DIS,O

Admission,O
Date,O
:,O

11/16/2005,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

11/19/2005,O

******,O
FINAL,O
DISCHARGE,O
ORDERS,O
******,O

WARESIN,O
",",O
SAGAY,O
702-84-43-7,O
L06,O

Room,O
:,O

DBM62-8758,O

Service,O
:,O

OBS,O

DISCHARGE,O
PATIENT,O
ON,O
:,O

11/18/05,O
AT,O
02:00,O
PM,O

CONTINGENT,O
UPON,O

cnm,B-TE
evaluation,I-TE

WILL,O
D,O
/,O
C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D,O
/,O
C,O
SUMMARY,O
:,O

YES,O

Attending,O
:,O

OBSTETRICS,O
SERVICE,O
",",O
YC,O
",",O
M.D.,O

DISPOSITION,O
:,O

Home,O

DISCHARGE,O
MEDICATIONS,O
:,O

DOCUSATE,B-TR
SODIUM,I-TR
100,O
MG,O
PO,O
BID,O
PRN,O
Constipation,B-PR
IBUPROFEN,B-TR
400-600,O
MG,O
PO,O
Q6H,O
PRN,O
Pain,B-PR

Food,O
/,O
Drug,O
Interaction,O
Instruction,O

Take,O
with,O
food,O
PRENATAL,B-TR
MULTIVITAMINS,I-TR
(,I-TR
STUARTNATAL,I-TR
),I-TR
1,O
TAB,O
PO,O
QD,O
MAALOX-TABLETS,B-TR
QUICK,I-TR
DISSOLVE,I-TR
/,I-TR
CHEWABLE,I-TR
1-2,O
TAB,O
PO,O
Q6H,O
PRN,O
Upset,B-PR
Stomach,I-PR

DIET,O
:,O

No,O
Restrictions,O

ACTIVITY,O
:,O

Resume,O
regular,O
exercise,O

FOLLOW,O
UP,O
APPOINTMENT,O
(,O
S,O
),O
:,O

BROOKSIDE,O
2,O
wks,O
",",O

ALLERGY,O
:,O

NKA,O
ADMIT,O
DIAGNOSIS,O
:,O

pregnancy,B-PR
",",I-PR
term,I-PR

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O

Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O

POSTPARTUM,O
OTHER,O
DIAGNOSIS,O
;,O

Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O
postpartum,O

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

Vaginal,O
delivery,O
:,O

Spontaneous,O

Laceration,B-PR
:,O

Perineal,B-PR
",",I-PR
1st,I-PR
degree,I-PR

Placenta,O
:,O

Delivery,O
:,O

Spontaneous,O

Condition,O
:,O

Normal,O

Certified,O
Nurse,O
Midwife,O
:,O

NEAD,O
",",O
MANERTNY,O
",",O
CNM,O

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O

repair,B-TR
of,O
first,B-PR
degree,I-PR
perineal,I-PR
laceration,I-PR

BRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

G2,O
T1,O
P0,O
A0,O
L1,O
Estimated,O

EDC,O
:,O

2012-02-05,O

Maternal,O
transfer,O
:,O

No,O

Initial,O
newborn,O
exam,O
:,O

No,O
observed,B-PR
abnormalities,I-PR

Baby,O
1,O

MRN,O
:,O

26793023,O

Delivery,O
date,O
:,O

11/16/05,O
02:21,O
PM,O

Apgars,B-TE
"9,9",O

Weight,B-TE
:,O

7lb,O
4.8,O
oz,O
3311,O
grams,O

Sex,O
:,O

Female,O

ADDITIONAL,O
COMMENTS,O
:,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O

TO,O
DO,O
/,O
PLAN,O
:,O

No,O
dictated,O
summary,O

ENTERED,O
BY,O
:,O

JESCCOT,O
",",O
LA,O
P.,O
",",O
C.N.M,O
(,O
YW8,O
),O

11/17/05,O
08:24,O
AM,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

412141256,O

FIH,O

3833231,O

39626/6vf7,O

817292,O

10/3/1994,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

10-03-94,O

DISCHARGE,O
DATE,O
:,O

10-06-94,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
85,O
year,O
old,O
man,O
was,O
admitted,O
because,O
of,O
the,O
new,O
onset,O
of,O
focal,B-PR
left-sided,I-PR
seizure,I-PR
and,O
unresponsiveness,B-PR
.,O

He,O
had,O
a,O
past,O
history,O
of,O
ischemic,B-PR
cardiomyopathy,I-PR
with,O
an,B-TE
ejection,I-TE
fraction,I-TE
of,O
10,O
",",O
mild,B-PR
aortic,I-PR
stenosis,I-PR
and,O
a,B-PR
right,I-PR
middle,I-PR
cerebral,I-PR
artery,I-PR
territory,I-PR
stroke,I-PR
in,O
07/94,O
.,O

He,O
was,O
at,O
Orlak,O
on,O
the,O
day,O
of,O
admission,O
and,O
was,O
found,O
unresponsive,B-PR
with,O
left,B-PR
tonic-clonic,I-PR
movements,I-PR
",",O
greater,O
in,O
the,O
arms,O
than,O
in,O
the,O
legs,O
.,O

He,O
was,O
transferred,O
to,O
Fairm,O
of,O
Ijordcompmac,O
Hospital,O
",",O
where,O
seizures,B-PR
were,O
stopped,O
with,O
2,O
mg,O
of,O
Ativan,B-TR
.,O

He,O
was,O
loaded,O
with,O
IV,B-TR
Dilantin,I-TR
.,O

He,O
remained,O
unresponsive,B-PR
with,O
poor,B-PR
airway,I-PR
protection,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Eyes,O
were,O
deviated,O
to,O
the,O
left,O
.,O

He,O
was,O
flaccid,B-PR
bilaterally,I-PR
.,O

He,O
had,O
no,O
oculocephalic,B-PR
reflexes,I-PR
.,O

After,O
one,O
hour,O
his,O
eyes,O
were,O
midline,O
and,O
he,O
remained,O
unresponsive,B-PR
.,O

HOSPITAL,O
COURSE,O
:,O

By,O
the,O
patient,O
and,O
his,O
family,O
&apos;s,O
prior,O
wishes,O
",",O
the,O
patient,O
was,O
extubated,O
.,O

An,B-TE
electroencephalogram,I-TE
revealed,O
generalized,B-PR
slowing,I-PR
without,I-PR
ictal,I-PR
events,I-PR
.,O

He,O
had,O
no,O
carotid,B-PR
bruits,I-PR
.,O

He,O
had,O
stertorous,B-PR
breathing,I-PR
",",O
positional,B-PR
tremors,I-PR
of,I-PR
the,I-PR
left,I-PR
upper,I-PR
extremity,I-PR
",",O
a,B-PR
spastic,I-PR
left,I-PR
hemiparesis,I-PR
in,I-PR
flexion,I-PR
.,O

He,O
withdrew,O
both,O
legs,O
to,O
painful,B-TE
stimuli,I-TE
.,O

The,O
right,O
upper,O
extremity,O
was,O
flaccid,B-PR
and,O
paresthetic,B-PR
.,O

Again,O
",",O
comfort,O
measures,O
only,O
were,O
undertaken,O
as,O
per,O
the,O
patient,O
&apos;s,O
previous,O
wishes,O
and,O
the,O
family,O
&apos;s,O
current,O
insistence,O
.,O

At,O
1:15,O
PM,O
on,O
10/06/94,O
",",O
the,O
patient,O
was,O
found,O
unresponsive,B-PR
with,O
no,O
heart,B-PR
sounds,I-PR
",",O
carotid,B-PR
pulse,I-PR
",",O
respiratory,B-PR
excursions,I-PR
",",O
or,O
pupillary,B-PR
reactions,I-PR
.,O

His,O
family,O
was,O
notified,O
.,O

Consent,O
for,O
autopsy,B-TE
was,O
denied,O
.,O

DISCHARGE,O
DIAGNOSIS,O
:,O

1.,O
Left,B-PR
middle,I-PR
cerebral,I-PR
artery,I-PR
territory,I-PR
cerebral,I-PR
infarction,I-PR
.,O

2.,O
Cardiomyopathy,B-PR
.,O

3.,O
Residual,O
of,O
previous,B-PR
right,I-PR
middle,I-PR
cerebral,I-PR
artery,I-PR
stroke,I-PR
.,O

RE,O
RHALTFETHFONGPOCE,O
",",O
M.D.,O

TR,O
:,O

cnm,O
/,O
bmot,O

DD,O
:,O

10-18-94,O

TD,O
:,O

10/19/94,O

CC,O
:,O

424729395,O
DH,O

11649,O

7013,O

908447,O

6/14/2001,O
12:00:00,O
AM,O

OB,O
Discharge,O
Summary,O

Signed,O

DIS,O

Report,O
Status,O
:,O

Signed,O
OB,O
EMR,O
L,O
and,O
D,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

XARAH,O
RATIA,O
SERVICE,O

UNIT,O
NUMBER,O
:,O

642-07-90,O

ADMISSION,O
DATE,O
:,O

20010614,O

DISCHARGE,O
DATE,O
:,O

20010616,O

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
:,O

Abnormal,B-PR
Fetal,I-PR
Heart,I-PR
Rate,I-PR
/,I-PR
Rhythm,I-PR
-,O
Delivered,O

ASSOCIATED,O
DIAGNOSES,O
:,O

Abnormal,B-PR
Pap,I-PR
Test,I-PR
",",O
history,O
of,O

PRINCIPAL,O
PROCEDURE,O
OR,O
OPERATION,O
:,O

Vacuum,B-TR
Extraction,I-TR

ASSOCIATED,O
PROCEDURES,O
OR,O
OPERATIONS,O
:,O

POSTPARTUM,O
DIAGNOSTIC,O
PROCEDURES,O
:,O

None,O

POSTPARTUM,O
THERAPEUTIC,O
PROCEDURES,O
:,O

None,O

OTHER,O
POSTPARTUM,O
THERAPIES,O
:,O

Routine,B-TR
Post,I-TR
Partum,I-TR
Care,I-TR

HISTORY,O
AND,O
REASON,O
FOR,O
HOSPITALIZATION,O
:,O

Active,B-PR
Labor,I-PR

PHYSICAL,O
EXAMINATION,O
:,O

HEIGHT,B-TE
49,O
HEENT,B-TE
NORMAL,O
MOUTH,O
NORMAL,O
NECK,O
NORMAL,O
BREASTS,O
NORMAL,O
NIPPLES,O
NORMAL,O
CHEST,O
NORMAL,O
COR,O
NORMAL,O
ABDOMEN,O
NORMAL,O
gravid,O
",",O
+,O
FHR,O
",",O
NT,O
EXTREM,O
NORMAL,O
SKIN,O
NORMAL,O
NODES,O
NORMAL,O
VULVA,O
NORMAL,O
VAGINA,O
NORMAL,O
CERVIX,O
NORMAL,O
4-5/100%,O
OS,O
NORMAL,O
closed,O
",",O
firm,O
",",O
-CMT,O
ADNEXAE,O
NORMAL,O
UTERUS,O
NORMAL,O
term,O
7-7.5,O
#,O
vtx,O
UTERINE,O
SIZE,O
IN,O
WEEKS,O
NORMAL,O
term,O

HOSPITAL,O
COURSE,O
(,O
include,O
complications,O
if,O
any,O
),O
:,O

This,O
23,O
year,O
old,O
Gravida,O
2,O
Para,O
1001,O
was,O
admitted,O
to,O
the,O
Naliheall,O
County,O
Memorial,O
Hospital,O
Obstetrical,O
service,O
on,O
06/14/2001,O
at,O
01:29,O
pm,O
for,O
the,O
indication,O
(,O
s,O
),O
:,O

active,B-PR
labor,I-PR
.,O

She,O
delivered,O
a,O
3263,O
gram,O
female,O
infant,O
at,O
06/14/2001,O
at,O
06:40,O
pm,O
with,O
apgar,B-TE
scores,I-TE
of,O
8,O
and,O
8,O
at,O
one,O
and,O
five,O
minutes,O
respectively,O
at,O
40.3,O
weeks,O
gestation,O
via,O
vacuum,B-TR
extraction,I-TR
.,O

During,O
her,O
labor,O
she,O
encountered,O
the,O
following,O
complication,O
(,O
s,O
),O
:,O

fetal,B-PR
bradycardia,I-PR
.,O

During,O
her,O
delivery,O
she,O
encountered,O
the,O
following,O
complication,O
(,O
s,O
),O
:,O

nuchal,B-PR
cord,I-PR
",",O
times,O
two,O
.,O

Postpartum,O
she,O
encountered,O
the,O
following,O
complication,O
(,O
s,O
),O
:,O

none,O
.,O

She,O
was,O
discharged,O
on,O
06/16/2001,O
at,O
12:00,O
pm,O
in,O
stable,O
condition,O
.,O

DISCHARGE,O
ACTIVITY,O
:,O

No,O
Restrictions,O

DISCHARGE,O
DIET,O
:,O

No,O
Restrictions,O

POSTPARTUM,O
DISPOSITION,O
:,O

Home,O
With,O
Self-Care,O
(,O
Routine,O
Discharge,O
),O

POSTPARTUM,O
CARE,O
SITE,O
:,O

Burnrise,O
Memorial,O
Hospital,O

POSTPARTUM,O
RETURN,O
APPOINTMENT,O
(,O
DAYS,O
),O
:,O

42,O

BREAST,O
FEEDING,O
AT,O
DISCHARGE,O
:,O

Yes,O

POSTPARTUM,O
MEASLES,O
/,O
MUMPS/RUBELLA,O
VACCINE,O
:,O

Not,O
Indicated,O

Electronically,O
Signed,O
:,O

American,O
",",O
06/16/2001,O
5:14:05,O
PM,O

425680098,O
SC,O

55925443,O

867222,O

8/7/1992,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Unsigned,O

DIS,O

Admission,O
Date,O
:,O

08/07/1992,O

Report,O
Status,O
:,O

Unsigned,O

Discharge,O
Date,O
:,O

08/10/1992,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
an,O
81,O
year,O
old,O
female,O
with,O
a,B-PR
right,I-PR
breast,I-PR
mass,I-PR
with,O
a,B-PR
discharge,I-PR
.,O

A,B-TE
mammogram,I-TE
of,I-TE
the,I-TE
right,I-TE
breast,I-TE
with,O
shadow,B-TE
biopsy,I-TE
was,O
negative,O
.,O

In,O
the,O
fall,O
of,O
1991,O
",",O
nipple,B-PR
changes,I-PR
and,O
discomfort,B-PR
was,O
again,O
noted,O
.,O

A,B-TE
mmamogram,I-TE
showed,O
no,O
change,O
on,O
right,O
",",O
but,O
new,B-TE
biopsy,I-TE
was,O
positive,O
.,O

On,O
the,O
left,O
",",O
there,O
was,O
a,B-PR
new,I-PR
shawdown,I-PR
but,O
the,B-TE
biopsy,I-TE
was,O
negative,O
.,O

The,O
patient,O
presents,O
now,O
for,O
right,B-TR
modified,I-TR
radical,I-TR
mastectomy,I-TR
with,O
impant,B-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Unremarkable,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

None,O
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

HABITS,O
:,O

Smoked,O
twenty,O
years,O
ago,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Clear,O
lungs,O
",",O
normal,O
heart,O
",",O
Pagett,B-TE
&apos;s,I-TE
type,O
changes,O
on,O
the,O
right,O
breast,O
and,O
left,O
breast,O
without,O
apparent,B-PR
masses,I-PR
with,O
scarring,B-PR
supra-areolar,I-PR
and,I-PR
infra-areolar,I-PR
.,O

A,B-PR
biopsy,I-PR
scar,I-PR
on,I-PR
the,I-PR
right,I-PR
breast,I-PR
from,O
1990,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
taken,O
to,O
the,O
Operting,O
Room,O
on,O
8/7/92,O
",",O
where,O
a,B-TR
right,I-TR
modified,I-TR
radical,I-TR
mastectomy,I-TR
was,O
performed,O
.,O

Subsequently,O
a,B-TR
saline-filled,I-TR
right,I-TR
breast,I-TR
implant,I-TR
was,O
performed,O
.,O

The,O
patient,O
tolerated,O
the,B-TR
procedure,I-TR
extremely,O
well,O
.,O

Two,B-TR
drains,I-TR
were,O
used,O
.,O

One,B-TR
drain,I-TR
was,O
removed,O
on,O
postoperative,O
day,O
number,O
two,O
",",O
and,O
the,B-TR
second,I-TR
drain,I-TR
she,O
will,O
be,O
discharged,O
to,O
home,O
with,O
.,O

DISPOSITION,O
:,O

The,O
patient,O
is,O
discharged,O
to,O
home,O
in,O
good,O
condiiton,O
.,O

Discharge,B-TR
medications,I-TR
include,O
Percocet,B-TR
and,O
Colace,B-TR
.,O

Folloowup,O
is,O
in,O
one,O
week,O
with,O
Dr.,O
Ralekote,O
.,O

DP337/1857,O
DETIASAIRE,O
KAYSJARDUHE,O
",",O
M.D.,O
PQ01,O

D,O
:,O

08/08/92,O

Batch,O
:,O

9736,O

Report,O
:,O

J3725F1,O

T,O
:,O

08/10/92,O

Dictated,O
By,O
:,O

LA,O
JESCCOT,O
",",O
M.D.,O
KC44,O

433651389,O

CTMC,O

81247987,O

625670,O

08/16/1998,O
12:00:00,O
AM,O

MENTAL,B-PR
STATUS,I-PR
CHANGE,I-PR
",",O
CELLULITIS,B-PR

Signed,O

DIS,O

Admission,O
Date,O
:,O

08/16/1998,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

08/18/1998,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

MENTAL,B-PR
STATUS,I-PR
CHANGES,I-PR
.,O

OTHER,O
DIAGNOSES,O
:,O

1),O
AORTIC,B-PR
STENOSIS,I-PR
.,O

2),O
MITRAL,B-PR
REGURGITATION,I-PR
.,O

3),O
STATUS,O
POST,O
FALL,B-PR
.,O

4),O
HISTORY,O
OF,O
TRANSIENT,B-PR
ISCHEMIC,I-PR
ATTACK,I-PR
/,O
CEREBROVASCULAR,B-PR
ACCIDENT,I-PR
.,O

5),O
RIGHT,B-PR
LOWER,I-PR
EXTREMITY,I-PR
WOUND,I-PR
.,O

6),O
ATRIAL,B-PR
FIBRILLATION,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
an,O
88,O
year-old,O
woman,O
undergoing,O
treatment,B-TR
for,O
a,B-PR
right,I-PR
lower,I-PR
extremity,I-PR
cellulitis,I-PR
who,O
was,O
transferred,O
from,O
Child,O
for,O
worsening,B-PR
cellulitis,I-PR
and,O
new,B-PR
confusion,I-PR
.,O

The,O
patient,O
has,O
a,O
history,O
of,O
severe,B-PR
aortic,I-PR
stenosis,I-PR
and,O
was,O
recently,O
admitted,O
to,O
the,O
Retelk,O
County,O
Medical,O
Center,O
for,O
a,O
Nafcillin,B-PR
sensitive,I-PR
Staphylococcus,I-PR
aureus,I-PR
cellulitis,I-PR
of,I-PR
the,I-PR
right,I-PR
leg,I-PR
treated,O
with,O
a,B-TR
course,I-TR
of,I-TR
Nafcillin,I-TR
and,O
Levofloxacin,B-TR
.,O

There,O
was,O
also,O
a,B-PR
right,I-PR
leg,I-PR
fluid,I-PR
collection,I-PR
that,O
was,O
incised,O
and,O
drained,O
on,O
August,O
1,O
",",O
1998,O
.,O

The,O
patient,O
was,O
sent,O
to,O
rehabilitation,B-TR
on,O
Levofloxacin,B-TR
orally,O
.,O

Although,O
details,O
were,O
not,O
available,O
at,O
the,O
time,O
of,O
admission,O
",",O
apparently,O
",",O
she,O
had,O
done,O
well,O
until,O
the,O
24,O
hours,O
proceeding,O
admission,O
when,O
the,B-PR
cellulitis,I-PR
was,O
felt,O
to,O
be,O
worsening,O
.,O

She,O
had,O
also,O
been,O
noted,O
to,O
be,O
confused,B-PR
and,O
combative,B-PR
during,O
that,O
24,O
hour,O
period,O
.,O

As,O
her,O
baseline,O
mental,O
status,O
is,O
completely,O
alert,O
and,O
oriented,O
",",O
this,O
caused,O
concern,O
amongst,O
the,O
staff,O
of,O
the,O
rehabilitation,O
center,O
and,O
the,O
patient,O
was,O
transferred,O
to,O
the,O
Retelk,O
County,O
Medical,O
Center,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1),O
Aortic,B-PR
stenosis,I-PR
",",I-PR
severe,I-PR
",",O
echocardiogram,B-TE
in,O
July,O
of,O
1998,O
with,O
a,B-TE
peak,I-TE
gradient,I-TE
of,O
6-8,O
mm,O
of,O
mercury,O
",",O
aortic,B-TE
valve,I-TE
area,I-TE
calculated,O
to,O
be,O
0.5,O
cm,O
squared,O
by,O
the,O
continuity,B-TE
equation,I-TE
.,O

The,O
patient,O
has,O
a,O
history,O
of,O
congestive,B-PR
heart,I-PR
failure,I-PR
.,O

Calculated,B-TE
ejection,I-TE
fraction,I-TE
was,O
45-50%,O
.,O

2),O
Mitral,B-PR
regurgitation,I-PR
",",O
2+,O
on,O
July,O
of,O
1998,O
echocardiogram,B-TE
.,O

3),O
History,O
of,O
atrial,B-PR
fibrillation,I-PR
.,O

4),O
History,O
of,O
cerebrovascular,B-PR
disease,I-PR
.,O

5),O
Hypertension,B-PR
.,O

6),O
History,O
of,O
temporal,B-PR
arteritis,I-PR
on,O
chronic,B-TR
steroids,I-TR
.,O

7),O
History,O
of,O
colitis,B-PR
.,O

8),O
History,O
of,O
vertebral,B-PR
body,I-PR
fractures,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

1),O
Digoxin,B-TR
0.125,O
mg,O
p.o.,O
q.,O
day,O
.,O

2),O
Lasix,B-TR
80,O
mg,O
p.o.,O
b.i.d.,O

3),O
Aspirin,B-TR
81,O
mg,O
p.o.,O
q.,O
day,O
.,O

4),O
Coumadin,B-TR
2,O
mg,O
p.o.,O
q.h.s.,O

5),O
Zaroxolyn,B-TR
2.5,O
mg,O
p.o.,O
q.,O
day,O
.,O

6),O
Toprol,B-TR
XL,I-TR
50,O
mg,O
p.o.,O
q.,O
day,O
.,O

7),O
Potassium,B-TR
20,O
mEq,O
p.o.,O
q.,O
day,O
.,O

8),O
Prednisone,B-TR
5,O
mg,O
p.o.,O
q.o.d.,O

9),O
Fosamax,B-TR
10,O
mg,O
p.o.,O
q.,O
day,O
.,O

10),O
Levofloxacin,B-TR
250,O
mg,O
p.o.,O
q.,O
day,O
.,O

11),O
Axid,B-TR
150,O
mg,O
p.o.,O
b.i.d.,O

12),O
Buspar,B-TR
5,O
mg,O
p.o.,O
t.i.d.,O

13),O
Zyrtec,B-TR
10,O
mg,O
p.o.,O
q.,O
day,O
.,O

ALLERGIES,O
:,O

The,O
patient,O
had,O
no,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
is,O
presently,O
staying,O
at,O
the,O
Gangistown,O
Hospital,O
Center,O
.,O

She,O
has,O
a,O
son,O
who,O
is,O
actively,O
involved,O
in,O
her,O
care,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Physical,B-TE
examination,I-TE
on,O
admission,O
revealed,O
an,O
elderly,O
woman,O
",",O
sleeping,O
",",O
responsive,O
only,O
to,O
noxious,B-TE
stimuli,I-TE
after,O
having,O
received,O
some,B-TR
sedation,I-TR
in,O
the,O
emergency,O
department,O
.,O

Vital,B-TE
signs,I-TE
:,O

Heart,B-TE
rate,I-TE
60,O
",",O
respiratory,B-TE
rate,I-TE
18,O
",",O
blood,B-TE
pressure,I-TE
116/80,O
",",O
temperature,B-TE
97.1,O
degrees,O
",",O
oxygen,B-TE
saturation,I-TE
93%,O
on,O
room,O
air,O
.,O

Head,B-TE
and,I-TE
neck,I-TE
examination,I-TE
was,O
benign,O
.,O

Skin,B-TE
examination,I-TE
was,O
notable,O
for,O
a,B-PR
leg,I-PR
ulcer,I-PR
and,O
cellulitis,B-PR
to,O
be,O
delineated,O
below,O
.,O

There,O
were,O
no,O
spider,B-PR
angiomata,I-PR
.,O

Neck,O
was,O
supple,O
with,O
no,O
thyromegaly,B-PR
.,O

Lungs,O
were,O
clear,O
to,O
auscultation,B-TE
bilaterally,I-TE
.,O

The,B-TE
heart,I-TE
examination,I-TE
revealed,O
that,O
the,O
patient,O
had,O
a,B-PR
sustained,I-PR
PMI,I-PR
which,O
was,O
located,O
in,O
the,O
left,O
mid,O
clavicular,O
line,O
",",O
S1,O
",",O
near,B-PR
complete,I-PR
obliteration,I-PR
of,I-PR
the,I-PR
second,I-PR
heart,I-PR
sound,I-PR
by,O
a,B-PR
two,I-PR
out,I-PR
of,I-PR
six,I-PR
high,I-PR
pitched,I-PR
murmur,I-PR
peaking,O
at,O
mid,O
to,O
late,O
systole,O
and,O
heard,O
across,O
the,O
precordium,O
.,O

It,O
radiates,O
to,O
both,O
carotids,O
bilaterally,O
.,O

There,O
was,O
also,O
a,B-PR
blowing,I-PR
holosystolic,I-PR
murmur,I-PR
heard,O
at,O
the,O
patient,O
&apos;s,O
apex,O
to,O
axilla,O
.,O

There,O
was,O
no,O
S3,B-PR
appreciated,O
.,O

Vascular,B-TE
examination,I-TE
was,O
notable,O
for,O
1+,B-PR
carotid,I-PR
impulses,I-PR
which,O
were,O
diminished,O
and,O
delayed,O
and,O
the,O
above,O
mentioned,O
transmitted,B-PR
cardiac,I-PR
murmurs,I-PR
.,O

Abdominal,B-TE
examination,I-TE
revealed,O
that,O
the,O
abdomen,O
was,O
soft,O
",",O
non-tender,B-PR
",",O
non-distended,B-PR
",",O
no,O
organomegaly,B-PR
",",O
no,O
masses,B-PR
",",O
normal,O
active,O
bowel,O
sounds,O
.,O

The,B-TE
patient,I-TE
&apos;s,I-TE
extremity,I-TE
examination,I-TE
was,O
notable,O
for,O
erythema,B-PR
of,I-PR
the,I-PR
right,I-PR
calf,I-PR
with,O
a,B-PR
small,I-PR
ulcer,I-PR
with,O
a,O
relatively,O
clean,O
base,O
.,O

Neurological,B-TE
examination,I-TE
revealed,O
that,O
the,O
patient,O
was,O
quite,B-PR
sedated,I-PR
at,O
this,O
time,O
having,O
received,O
some,O
medications,B-TR
.,O

She,O
was,O
arousable,O
only,O
to,O
painful,B-TE
stimuli,I-TE
.,O

Her,O
pupils,O
were,O
reactive,O
bilaterally,O
.,O

Her,O
face,O
was,O
symmetric,O
.,O

She,O
had,O
an,O
intact,O
gag,O
reflex,O
.,O

She,O
was,O
able,O
to,O
move,O
all,O
four,O
of,O
her,O
extremities,O
in,O
response,O
to,O
pain,B-TE
.,O

Her,B-TE
deep,I-TE
tendon,I-TE
reflexes,I-TE
were,O
slightly,O
diminished,O
at,O
1+,O
bilaterally,O
",",O
but,O
symmetric,O
.,O

LABORATORY,O
:,O

The,O
patient,O
&apos;s,O
laboratory,O
data,O
on,O
admission,O
is,O
as,O
follows,O
:,O

Sodium,B-TE
was,O
142,O
",",O
potassium,B-TE
3.3,O
",",O
chloride,B-TE
99,O
",",O
BUN,B-TE
23,O
",",O
creatinine,B-TE
1.1,O
.,O

AST,B-TE
was,O
25,O
",",O
alkaline,B-TE
phosphatase,I-TE
130,O
",",O
total,B-TE
bilirubin,I-TE
3.2,O
",",O
albumin,B-TE
3.4,O
",",O
calcium,B-TE
8.8,O
.,O

Digoxin,B-TE
level,I-TE
was,O
0.8,O
.,O

Hematocrit,B-TE
was,O
33.0,O
",",O
platelet,B-TE
count,I-TE
627,O
",",O
white,B-TE
blood,I-TE
cell,I-TE
count,I-TE
"10,000",O
",",O
MCV,B-TE
79.8,O
.,O

Coagulation,B-TE
studies,I-TE
revealed,O
a,O
PT,B-TE
of,O
17.4,O
seconds,O
with,O
an,B-TE
INR,I-TE
of,O
2.1,O
",",O
PTT,B-TE
25.5,O
.,O

The,B-TE
patient,I-TE
&apos;s,I-TE
admission,I-TE
chest,I-TE
x-ray,I-TE
revealed,O
no,O
infiltrate,B-PR
",",O
no,O
congestive,B-PR
heart,I-PR
failure,I-PR
.,O

Head,B-TE
CT,I-TE
scan,I-TE
performed,O
in,O
the,O
emergency,O
department,O
revealed,O
no,O
bleed,B-PR
.,O

Urinalysis,B-TE
revealed,O
trace,B-PR
microscopic,I-PR
hematuria,I-PR
with,O
47,O
red,O
blood,O
cells,O
per,O
high,O
powered,O
field,O
",",O
1+,B-PR
bacteria,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

1),O
Mental,O
status,O
changes,O
:,O

On,O
admission,O
to,O
the,O
emergency,O
room,O
",",O
the,O
patient,O
was,O
somewhat,O
argumentative,B-PR
and,O
confused,B-PR
as,O
well,O
as,O
uncooperative,B-PR
with,I-PR
procedures,I-PR
.,O

A,B-TE
neurologic,I-TE
work-up,I-TE
was,O
undertaken,O
which,O
included,O
a,B-TE
CT,I-TE
scan,I-TE
of,I-TE
the,I-TE
head,I-TE
which,O
revealed,O
no,O
acute,B-PR
bleed,I-PR
and,O
a,B-TE
lumbar,I-TE
puncture,I-TE
which,O
revealed,O
a,B-TE
glucose,I-TE
of,O
72,O
",",O
protein,B-TE
65,O
",",O
white,B-TE
blood,I-TE
cell,I-TE
count,I-TE
19,O
",",O
red,B-TE
blood,I-TE
cell,I-TE
count,I-TE
"11,500",O
with,O
no,O
evidence,O
of,O
xanthrochromasia,B-PR
.,O

The,O
Neurology,O
Service,O
evaluated,O
the,O
patient,O
who,O
felt,O
that,O
her,B-PR
agitation,I-PR
was,O
most,O
likely,O
due,O
to,O
infection,B-PR
",",O
her,B-TR
multiple,I-TR
medications,I-TR
",",O
or,O
her,B-PR
metabolic,I-PR
condition,I-PR
.,O

The,O
patient,O
&apos;s,O
mental,O
status,O
slowly,O
began,O
to,O
recover,O
",",O
however,O
on,O
the,O
morning,O
of,O
the,O
first,O
day,O
of,O
admission,O
",",O
August,O
16,O
",",O
1998,O
",",O
the,O
patient,O
was,O
found,O
after,O
having,O
fallen,O
.,O

A,B-TE
neurological,I-TE
examination,I-TE
was,O
performed,O
which,O
revealed,O
no,O
abnormality,B-PR
and,O
imaging,B-TE
included,O
a,B-TE
head,I-TE
scan,I-TE
which,O
revealed,O
no,O
bleed,B-PR
and,O
a,B-TE
cervical,I-TE
spine,I-TE
series,I-TE
which,O
revealed,O
degenerative,B-PR
joint,I-PR
disease,I-PR
but,O
no,O
obvious,B-PR
fracture,I-PR
.,O

The,O
patient,O
decided,O
not,O
to,O
pursue,O
further,B-TE
testing,I-TE
with,O
a,B-TE
neck,I-TE
CT,I-TE
scan,I-TE
.,O

At,O
the,O
time,O
of,O
discharge,O
",",O
the,O
patient,O
&apos;s,O
mental,O
status,O
is,O
back,O
to,O
its,O
baseline,O
.,O

2),O
Right,B-PR
lower,I-PR
extremity,I-PR
cellulitis,I-PR
:,O

The,O
patient,O
was,O
evaluated,O
by,O
the,O
Surgical,O
Service,O
who,O
felt,O
that,O
the,B-PR
wound,I-PR
was,O
clean,O
with,O
some,B-PR
erythema,I-PR
but,O
without,O
evidence,O
of,O
true,B-PR
cellulitis,I-PR
.,O

The,O
patient,O
&apos;s,O
antibiotics,B-TR
were,O
discontinued,O
with,O
the,O
thought,O
that,O
prolonged,B-TR
antibiotics,I-TR
only,O
put,O
her,O
at,O
more,O
risk,O
for,O
infection,B-PR
.,O

3),O
Cardiac,O
:,O

The,O
patient,O
has,O
a,O
history,O
of,O
critical,B-PR
aortic,I-PR
stenosis,I-PR
and,O
mitral,B-PR
regurgitation,I-PR
.,O

Fortunately,O
",",O
these,O
issues,O
were,O
not,O
active,O
during,O
the,O
present,O
admission,O
.,O

4),O
Status,O
post,O
fall,B-PR
:,O

The,O
patient,O
did,O
fall,O
while,O
inhouse,O
.,O

A,B-TE
head,I-TE
CT,I-TE
scan,I-TE
and,O
cervical,B-TE
spine,I-TE
series,I-TE
were,O
negative,O
.,O

The,O
patient,O
appeared,O
to,O
have,O
no,O
deficits,B-PR
at,O
the,O
time,O
of,O
discharge,O
.,O

5),O
Atrial,B-PR
fibrillation,I-PR
:,O

The,B-TR
patient,I-TR
&apos;s,I-TR
Coumadin,I-TR
was,O
continued,O
.,O

6),O
Abnormal,B-PR
liver,I-PR
function,I-PR
tests,I-PR
:,O

On,O
admission,O
",",O
the,O
patient,O
was,O
noted,O
to,O
have,O
elevated,B-PR
bilirubins,I-PR
in,O
the,O
3,O
range,O
and,O
mildly,B-PR
elevated,I-PR
alkaline,I-PR
phosphatase,I-PR
consistent,O
with,O
a,O
cholestatic,B-PR
picture,I-PR
.,O

These,B-TE
liver,I-TE
function,I-TE
tests,I-TE
will,O
be,O
followed,O
closely,O
as,O
an,O
outpatient,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

1),O
Aspirin,B-TR
81,O
mg,O
p.o.,O
q.,O
day,O
.,O

2),O
Digoxin,B-TR
0.125,O
mg,O
p.o.,O
q.,O
AM,O
.,O

3),O
Lasix,B-TR
40,O
mg,O
p.o.,O
b.i.d.,O

4),O
Zaroxolyn,B-TR
0.25,O
mg,O
p.o.,O
q.,O
day,O
.,O

5),O
Prednisone,B-TR
5,O
mg,O
p.o.,O
q.o.d.,O

6),O
Coumadin,B-TR
2,O
mg,O
p.o.,O
q.h.s.,O

7),O
Kay,B-TR
Ciel,I-TR
20,O
mEq,O
p.o.,O
q.,O
day,O
.,O

8),O
Fosamax,B-TR
10,O
mg,O
p.o.,O
q.,O
day,O
.,O

9),O
Amitriptyline,B-TR
10,O
mg,O
p.o.,O
q.h.s.,O

10),O
Buspar,B-TR
5,O
mg,O
p.o.,O
t.i.d.,O

FOLLOW-UP,O
:,O

The,O
patient,O
will,O
be,O
followed,O
at,O
rehabilitation,B-TR
by,O
her,O
primary,O
care,O
physician,O
",",O
Dr.,O
Both,O
.,O

Dictated,O
By,O
:,O

TIA,O
BREUNMULL,O
",",O
M.D.,O
OH29,O

Attending,O
:,O

RA,O
S.,O
BOTH,O
",",O
M.D.,O
YT79,O
WH234/2364,O

Batch,O
:,O

4025,O

Index,O
No.,O
FSYAMR79X6,O

D,O
:,O

08/18/98,O

T,O
:,O

08/18/98,O

455343475,O
PUMC,O

4322324,O

195078,O

781135,O

6/15/2000,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O

KOTE,O
",",O
YGA,O

MRN,O
:,O

4322324,O

Age,O
:,O

43y,O

REGISTRATION,O
DATE,O
:,O

06/15/2000,O
01:09,O
PM,O

PRELIMINARY,O
REPORT,O

This,O
is,O
to,O
notify,O
you,O
that,O
your,O
patient,O
",",O
KOTE,O
",",O
YGA,O
arrived,O
in,O
the,O
Emergency,O
Department,O
at,O
"Ponta,itri-",O
University,O
Medical,O
Center,O
on,O
06/15/2000,O
01:09,O
PM,O
.,O

The,O
patient,O
presented,O
with,O
a,O
chief,O
complaint,O
of,O
R,B-PR
THUMB,I-PR
INJURY,I-PR
.,O

Following,O
triage,B-TE
",",O
the,O
patient,O
LEFT,O
WITHOUT,O
TREATMENT,B-TR
.,O

If,O
you,O
need,O
additional,O
information,O
please,O
call,O
937-599-6520,O
.,O

493597270,O

CMC,O

86164445,O

3/17/1998,O
12:00:00,O
AM,O

ACUTE,B-PR
LEUKEMIA,I-PR

Signed,O

DIS,O

Admission,O
Date,O
:,O

03/17/1998,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

04/12/1998,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
68,O
year,O
old,O
with,O
acute,B-PR
leukemia,I-PR
.,O

The,O
patient,O
was,O
in,O
her,O
usual,O
state,O
of,O
health,O
until,O
about,O
three,O
weeks,O
prior,O
to,O
admission,O
when,O
she,O
began,O
to,O
notice,O
increased,B-PR
weakness,I-PR
and,O
bruising,B-PR
.,O

She,O
presented,O
to,O
a,O
Wood,O
Emergency,O
Department,O
six,O
days,O
prior,O
to,O
admission,O
.,O

Platelets,B-TE
were,O
"9,000",O
",",O
hemoglobin,B-TE
9.5,O
",",O
temperature,B-TE
was,O
100.4,O
.,O

The,O
patient,O
had,O
a,B-TE
smear,I-TE
there,O
consistent,O
with,O
ALL,B-PR
.,O

The,O
patient,O
was,O
transferred,O
to,O
Norri,O
Hospital,O
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

No,O
headache,B-PR
",",O
no,O
nausea,B-PR
",",O
vomiting,B-PR
or,O
diarrhea,B-PR
.,O

Some,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
with,O
allergies,B-PR
",",O
particularly,O
cats,O
.,O

No,O
chest,B-PR
pain,I-PR
.,O

The,O
patient,O
had,O
been,O
doing,O
aerobics,O
three,O
times,O
a,O
week,O
until,O
a,O
couple,O
of,O
weeks,O
before,O
admission,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

The,O
patient,O
&apos;s,O
past,O
medical,O
history,O
is,O
significant,O
for,O
allergies,B-PR
",",O
depression,B-PR
and,O
anxiety,B-PR
",",O
pleural,B-PR
thickening,I-PR
/,O
asbestosis,B-PR
",",O
chronic,B-PR
left,I-PR
bundle,I-PR
branch,I-PR
block,I-PR
",",O
tonsillectomy,B-TR
",",O
adenoidectomy,B-TR
",",O
vein,B-TR
stripping,I-TR
(,O
1968,O
),O
",",O
left,B-PR
wrist,I-PR
fracture,I-PR
(,O
1994,O
),O
",",O
and,O
hypercholesterolemia,B-PR
.,O

ALLERGIES,O
:,O

The,B-PR
patient,I-PR
&apos;s,I-PR
allergies,I-PR
include,O
a,O
questionable,O
penicillin,B-PR
reaction,I-PR
;,O
however,O
",",O
the,O
patient,O
tolerated,O
Ampicillin,B-TR
well,O
.,O

The,O
patient,O
does,O
not,O
recollect,O
what,O
her,B-PR
reaction,I-PR
to,O
penicillin,B-TR
was,O
.,O

The,O
patient,O
also,O
had,O
a,O
history,O
of,O
platelet,B-PR
reaction,I-PR
.,O

FAMILY,O
HISTORY,O
:,O

The,O
patient,O
&apos;s,O
family,O
history,O
was,O
significant,O
for,O
a,O
brother,O
with,O
colon,B-PR
cancer,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
lives,O
with,O
her,O
husband,O
and,O
she,O
has,O
three,O
children,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,B-TE
patient,I-TE
&apos;s,I-TE
physical,I-TE
examination,I-TE
revealed,O
a,O
well-developed,O
",",O
well-nourished,O
white,O
female,O
in,O
no,O
apparent,B-PR
distress,I-PR
.,O

Vital,O
signs,O
:,O

Temperature,B-TE
98.2,O
",",O
blood,B-TE
pressure,I-TE
134/80,O
",",O
respiratory,B-TE
rate,I-TE
22,O
",",O
pulse,B-TE
102,O
.,O

HEENT,B-TE
examination,I-TE
was,O
normocephalic,O
and,O
atraumatic,B-PR
.,O

Cranial,O
nerves,O
II-XII,O
were,O
grossly,O
intact,O
.,O

There,O
was,O
decreased,B-PR
hearing,I-PR
bilaterally,I-PR
.,O

The,O
oropharynx,O
was,O
within,O
normal,O
limits,O
with,O
fillings,O
and,O
a,B-PR
partial,I-PR
upper,I-PR
plate,I-PR
.,O

The,O
neck,O
had,O
a,O
full,O
range,O
of,O
motion,O
",",O
no,O
lymphadenopathy,B-PR
.,O

The,B-TE
chest,I-TE
exam,I-TE
was,O
clear,O
to,O
auscultation,B-TE
.,O

Cardiac,B-TE
exam,I-TE
revealed,O
an,O
S1,O
and,O
an,O
S2,O
and,O
a,B-PR
diffuse,I-PR
2/6,I-PR
systolic,I-PR
murmur,I-PR
.,O

The,O
abdomen,O
was,O
soft,O
",",O
nontender,B-PR
and,O
nondistended,B-PR
with,O
no,O
guarding,B-PR
and,O
no,O
hepatosplenomegaly,B-PR
.,O

Bowel,O
sounds,O
were,O
present,O
.,O

The,B-TE
skin,I-TE
examination,I-TE
revealed,O
the,O
right,O
breast,O
had,O
a,B-PR
dark,I-PR
two,I-PR
centimeter,I-PR
ecchymosis,I-PR
and,O
the,O
left,O
medial,O
thigh,O
had,O
two,O
pale,B-PR
blue,I-PR
two,I-PR
centimeter,I-PR
macules,I-PR
.,O

LABORATORY,O
DATA,O
:,O

Admitting,B-TE
labs,I-TE
were,O
:,O

Sodium,B-TE
138,O
",",O
potassium,B-TE
4.2,O
",",O
chloride,B-TE
98,O
",",O
BUN,B-TE
21,O
",",O
creatinine,B-TE
0.7,O
",",O
glucose,B-TE
117,O
",",O
white,B-TE
blood,I-TE
cell,I-TE
count,I-TE
"13,200",O
",",O
hematocrit,B-TE
22.5,O
",",O
platelet,B-TE
count,I-TE
"40,000",O
.,O

AST,B-TE
29,O
",",O
ALK,B-TE
151,O
",",O
total,B-TE
bilirubin,I-TE
0.2,O
",",O
total,B-TE
protein,I-TE
7.2,O
",",O
albumin,B-TE
4.3,O
",",O
globulins,B-TE
2.9,O
",",O
calcium,B-TE
8.9,O
.,O

PT,B-TE
12.8,O
",",O
PTT,B-TE
19.1,O
.,O

Peripheral,B-TE
smear,I-TE
revealed,O
blasts,B-TE
of,O
62%,O
.,O

HOSPITAL,O
COURSE,O
:,O

A,B-TR
Hickman,I-TR
catheter,I-TR
was,O
placed,O
and,O
the,O
patient,O
was,O
begun,O
on,O
chemotherapy,B-TR
.,O

The,B-TR
regimen,I-TR
included,O
cyclophosphamide,B-TR
",",O
daunorubicin,B-TR
",",O
prednisone,B-TR
",",O
Vincristine,B-TR
and,O
PEG-asparaginase,B-TR
.,O

The,O
patient,O
tolerated,O
the,B-TR
chemotherapy,I-TR
regimen,I-TR
well,O
.,O

The,O
patient,O
began,O
neutropenic,B-PR
on,O
day,O
five,O
of,O
induction,O
.,O

The,B-TE
patient,I-TE
&apos;s,I-TE
liver,I-TE
function,I-TE
tests,I-TE
began,O
to,O
rise,O
and,O
she,O
began,O
to,O
experience,O
pulmonary,B-PR
symptoms,I-PR
including,O
increased,B-PR
crackles,I-PR
.,O

The,O
patient,O
began,O
to,O
spike,O
and,O
a,B-TE
blood,I-TE
culture,I-TE
grew,O
out,O
Staphylococcusaureus,B-PR
.,O

The,O
patient,O
was,O
begun,O
on,O
Gentamicin,B-TR
",",O
Vancomycin,B-TR
and,O
Piperacillin,B-TR
",",O
which,O
was,O
changed,O
to,O
Gentamicin,B-TR
and,O
Ceftazidime,B-TR
.,O

The,O
patient,O
continued,O
to,O
spike,O
and,O
was,O
enrolled,O
in,O
a,O
randomized,O
trial,O
",",O
the,O
patient,O
was,O
randomized,O
to,O
AmBisome,B-TR
antifungal,I-TR
treatment,I-TR
.,O

An,B-TE
abdominal,I-TE
MRI,I-TE
was,O
performed,O
to,O
assess,O
continued,O
elevated,B-PR
liver,I-PR
enzymes,I-PR
;,O
however,O
",",O
the,B-TE
MRI,I-TE
was,O
negative,O
.,O

The,O
patient,O
was,O
begun,O
on,O
Nafcillin,B-TR
due,O
to,O
continued,O
spiking,O
.,O

The,O
patient,O
began,O
to,O
experience,O
urinary,B-PR
retention,I-PR
and,O
was,O
straight,O
catheterized,O
.,O

Thepatient,O
developed,O
a,O
possible,O
drug,B-PR
rash,I-PR
and,O
Nafcillin,B-TR
was,O
changed,O
to,O
Ancef,B-TR
.,O

The,O
patient,O
became,O
constipated,B-PR
;,O
this,O
resolved,O
with,O
laxatives,B-TR
.,O

The,O
patient,O
improved,O
significantly,O
and,O
was,O
thought,O
to,O
be,O
ready,O
for,O
discharge,O
by,O
the,O
11th,O
of,O
April,O
.,O

She,O
will,O
follow,O
up,O
with,O
her,O
primary,O
oncologists,O
",",O
Dr,O
A,O
and,O
Dr,O
Dark,O
",",O
at,O
IVMC,O
",",O
after,O
her,O
discharge,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

The,B-TR
patient,I-TR
&apos;s,I-TR
discharge,I-TR
medications,I-TR
include,O
the,O
following,O
:,O

1),O
Albuterol,B-TR
inhaler,I-TR
two,O
puffs,O
q.i.d.,O
p.r.n.,O
breathing,B-PR
difficulties,I-PR
.,O

2),O
Calcium,B-TR
gluconate,I-TR
1000,O
mg,O
p.o.,O
q,O
day,O
.,O

3),O
Cefazolin,B-TR
one,O
gram,O
IV,O
q.8h.,O
x,O
13days,O
.,O

4),O
Colace,B-TR
100,O
mg,O
p.o.,O
b.i.d.,O

5),O
Lasix,B-TR
40,O
mg,O
p.o.,O
q,O
day,O
.,O

6),O
Lactulose,B-TR
30,O
milliliters,O
p.o.,O
q.2h.,O
p.r.n.,O
constipation,B-PR
.,O

7),O
Magnesium,B-TR
hydroxide,I-TR
30,O
milliliters,O
p.o.,O
q,O
day,O
.,O

8),O
Miracle,B-TR
Creamtopical,I-TR
q,O
day,O
p.r.n.,O
skin,B-PR
irritation,I-PR
.,O

9),O
Sarna,B-TR
topical,I-TR
b.i.d.,O
p.r.n.,O
itching,B-PR
.,O

10),O
Senna,B-TR
tablets,I-TR
",",O
two,O
tablets,O
p.o.,O
b.i.d.,O

11),O
Simethicone,B-TR
80,O
mg,O
p.o.,O
q.i.d.,O
p.r.n.,O
gas,B-PR
pain,I-PR
.,O

12),O
Citrucel,B-TR
one,O
tablespoon,O
p.o.,O
q,O
day,O
.,O

13),O
K-Dur,B-TR
10,O
mEq,O
x,O
three,O
",",O
p.o.,O
b.i.d.,O

14),O
Zoloft,B-TR
25,O
mg,O
p.o.,O
q,O
day,O
.,O

15),O
Peridex,B-TR
30,O
cc,O
p.o.,O
b.i.d.,O
x,O
14,O
days,O
.,O

16),O
Robituss,B-TR
in,I-TR
AC,I-TR
five,O
to,O
ten,O
milliliters,O
p.o.,O
q.h.s.,O
p.r.n.,O
cough,B-PR
.,O

Dictated,O
By,O
:,O

AZEL,O
HIBBSKAYS,O
",",O
M.D.,O
CF66,O

Attending,O
:,O

TELSHEY,O
K.,O
SWATLLEEBTIK,O
",",O
M.D.,O
NJ38,O
ME089/6922,O

Batch,O
:,O

43792,O

Index,O
No.,O
CHDNIR25,O
OK,O

D,O
:,O

05/13/98,O

T,O
:,O

05/13/98,O

498710998,O

CMC,O

14172445,O

04/29/1992,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

04/29/1992,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

05/28/1992,O

DISCHARGE,O
DIAGNOSES,O
:,O

1.,O
Carotid,B-PR
stenosis,I-PR
.,O

2.,O
Aortic,B-PR
stenosis,I-PR
.,O

3.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
.,O

PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
76-year-old,O
female,O
who,O
was,O
admitted,O
to,O
the,O
medicine,O
service,O
on,O
04-29-92,O
with,O
a,O
past,O
history,O
significant,O
for,O
aortic,B-PR
stenosis,I-PR
and,O
chest,B-PR
pain,I-PR
who,O
presented,O
for,O
evaluation,B-TE
for,O
aortic,B-TR
valve,I-TR
replace-ment,I-TR
.,O

The,O
patient,O
has,O
a,O
history,O
of,O
exertional,B-PR
angina,I-PR
and,O
chest,B-PR
pain,I-PR
associated,O
with,O
light-headedness,B-PR
for,O
nine,O
years,O
which,O
was,O
noted,O
to,O
increase,O
in,O
frequency,O
over,O
the,O
past,O
year,O
",",O
then,O
upon,O
admission,O
had,O
light-headedness,B-PR
and,O
chest,B-PR
pain,I-PR
with,O
a,B-PR
dull,I-PR
pressure,I-PR
in,I-PR
her,I-PR
neck,I-PR
to,O
her,O
substernal,O
area,O
",",O
with,O
only,O
minimal,O
exertion,O
such,O
as,O
&quot;,O
walking,O
across,O
the,O
room,O
&quot;,O
.,O

She,O
states,O
this,O
light-headedness,B-PR
is,O
often,O
associated,O
with,O
shortness,B-PR
of,I-PR
breath,I-PR
and,O
diaphoresis,B-PR
occasionally,O
with,O
nausea,B-PR
.,O

She,O
denies,O
any,O
vomiting,B-PR
",",O
states,O
that,O
the,B-PR
episodes,I-PR
usually,O
last,O
about,O
five,O
minutes,O
and,O
are,O
relieved,O
with,O
rest,O
.,O

The,B-PR
pain,I-PR
and,O
light-headedness,B-PR
is,O
now,O
severely,O
lifestyle,O
limiting,O
and,O
the,O
patient,O
requested,O
evaluation,B-TE
for,O
possible,O
aortic,B-TR
valve,I-TR
replacement,I-TR
.,O

Cardiac,O
risk,O
factors,O
hypercholesterolemia,B-PR
",",O
hypertension,B-PR
",",O
no,O
history,O
of,O
tobacco,O
use,O
",",O
diabetes,B-PR
or,O
family,O
history,O
.,O

Past,O
medical,O
history,O
is,O
as,O
stated,O
above,O
",",O
aortic,B-PR
stenosis,I-PR
",",O
found,O
to,O
be,O
critical,O
on,O
echocardiogram,B-TE
on,O
4-13-92,O
",",O
done,O
in,O
Otte,O
A,O
",",O
New,O
Jersey,O
and,O
was,O
found,O
to,O
have,O
left,B-PR
ventricular,I-PR
hypertrophy,I-PR
and,O
ejection,B-TE
fraction,I-TE
of,O
58%,O
",",O
no,O
right,B-PR
heart,I-PR
wall,I-PR
motion,I-PR
abnormali-ties,I-PR
and,O
an,B-TE
aortic,I-TE
valve,I-TE
gradient,I-TE
of,O
greater,O
than,O
100,O
.,O

She,O
also,O
has,O
a,O
history,O
of,O
uterine,B-PR
fibroids,I-PR
",",O
status,O
post,O
total,B-TR
abdominal,I-TR
hysterectomy,I-TR
.,O

She,O
has,O
known,B-PR
bilateral,I-PR
carotid,I-PR
disease,I-PR
",",O
stated,O
to,O
be,O
greater,O
than,O
70%,O
bilaterally,O
.,O

She,O
has,O
a,O
history,O
of,O
glaucoma,B-PR
and,O
a,O
questionable,O
history,O
of,O
claudication,B-PR
in,I-PR
her,I-PR
legs,I-PR
as,O
well,O
as,O
a,O
history,O
of,O
hypertension,B-PR
.,O

Medications,B-TR
on,I-TR
admission,I-TR
were,O
only,O
aspirin,B-TR
p.r.n.,O
and,O
Timoptic,B-TR
solution,I-TR
0.5%,I-TR
to,O
the,O
left,O
eye,O
twice,O
a,O
day,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
physical,B-TE
examination,I-TE
she,O
was,O
afebrile,B-PR
with,O
a,O
blood,B-TE
pressure,I-TE
of,O
170/100,O
",",O
heart,B-TE
rate,I-TE
of,O
70,O
.,O

HEENT,B-TE
examination,I-TE
notable,O
for,O
bilateral,B-PR
arcussenilis,I-PR
but,O
otherwise,O
unremarkable,O
.,O

Her,O
neck,O
showed,O
no,O
JVD,B-PR
",",O
there,O
was,O
a,B-PR
slow,I-PR
carotid,I-PR
upstroke,I-PR
bilaterally,I-PR
",",O
there,O
were,O
bilateral,B-PR
carotid,I-PR
bruits,I-PR
versus,O
transmitted,B-PR
murmur,I-PR
.,O

Chest,O
was,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

Cardiac,B-TE
examination,I-TE
revealed,O
a,O
regular,O
rate,O
and,O
rhythm,O
with,O
a,O
normal,O
S1,O
and,O
S2,O
",",O
3/6,O
systolic,B-PR
murmur,I-PR
at,I-PR
the,I-PR
right,I-PR
upper,I-PR
sternal,I-PR
border,I-PR
",",O
no,O
gallop,B-PR
was,O
detected,O
.,O

Her,O
abdomen,O
was,O
soft,O
",",O
nontender,B-PR
with,O
good,O
bowel,O
sounds,O
.,O

Extremi-ties,O
:,O

There,O
is,O
no,O
clubbing,B-PR
",",O
cyanosis,B-PR
or,O
edema,B-PR
and,O
her,B-TE
peripheral,I-TE
pulses,I-TE
were,O
trace,O
palpable,O
.,O

LAB,O
/,O
X-RAY,O
DATA,O
:,O

Labs,O
on,O
admission,O
:,O

Sodium,B-TE
141,O
",",O
potassium,B-TE
5.0,O
",",O
BUN,B-TE
18,O
",",O
creatinine,B-TE
1.0,O
",",O
PT,B-TE
12.3,O
",",O
PTT,B-TE
24,O
",",O
WBC,B-TE
7.6,O
",",O
hematocrit,B-TE
41,O
",",O
platelets,B-TE
"278,000",O
.,O

EKG,B-TE
revealed,O
a,O
normal,O
sinus,O
rhythm,O
with,O
a,O
rate,O
of,O
69,O
",",O
left,B-PR
ventricular,I-PR
hyper-trophy,I-PR
with,O
poor,B-PR
anterior,I-PR
progression,I-PR
of,I-PR
R-waves,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

She,O
was,O
admitted,O
and,O
evaluated,O
by,O
the,O
cardiac,O
surgery,O
service,O
after,O
having,O
undergone,O
cardiac,B-TE
catheterization,I-TE
which,O
revealed,O
a,O
70%,B-PR
stenosis,I-PR
of,I-PR
her,I-PR
left,I-PR
circumflex,I-PR
artery,I-PR
",",O
50%,B-PR
stenosis,I-PR
of,I-PR
the,I-PR
left,I-PR
anterior,I-PR
descending,I-PR
and,O
10%,B-PR
stenosis,I-PR
of,I-PR
the,I-PR
right,I-PR
coronary,I-PR
artery,I-PR
.,O

Carotid,B-TE
angiography,I-TE
revealed,O
left,B-PR
internal,I-PR
carotid,I-PR
stenosis,I-PR
of,I-PR
90%,I-PR
",",O
right,B-PR
internal,I-PR
carotid,I-PR
artery,I-PR
&quot;,I-PR
critical,I-PR
stenosis,I-PR
&quot;,I-PR
.,O

On,O
05-01-92,O
she,O
was,O
taken,O
to,O
the,O
operating,O
room,O
at,O
which,O
time,O
she,O
underwent,O
an,B-TR
aortic,I-TR
valve,I-TR
replacement,I-TR
with,O
a,O
#,B-TR
19,I-TR
St.,I-TR
Jude,I-TR
valve,I-TR
",",O
coronary,B-TR
artery,I-TR
bypass,I-TR
graft,I-TR
times,O
one,O
with,O
saphenous,B-TR
vein,I-TR
graft,I-TR
from,O
the,O
posterior,O
descending,O
artery,O
to,O
the,O
obtuse,O
marginal,O
and,O
right,B-TR
carotid,I-TR
endarterectomy,I-TR
.,O

This,O
was,O
performed,O
by,O
Dr.,O
Medicine,O
and,O
Dr.,O
Room,O
.,O

The,O
patient,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
and,O
was,O
found,O
postoperatively,O
to,O
have,O
some,B-PR
left,I-PR
upper,I-PR
extremity,I-PR
weakness,I-PR
on,O
proximal,O
greater,O
than,O
distal,O
musculature,O
.,O

She,O
was,O
extubated,O
on,O
postoperative,O
day,O
number,O
one,O
and,O
otherwise,O
had,O
an,O
unremarkable,O
postoperative,O
course,O
with,O
the,O
exception,O
of,O
her,B-PR
left,I-PR
upper,I-PR
extremity,I-PR
weakness,I-PR
.,O

On,O
05-04-92,O
she,O
was,O
evaluated,O
by,O
the,O
neurology,O
service,O
",",O
who,O
recommended,O
a,B-TE
CT,I-TE
scan,I-TE
",",O
however,O
no,O
evidence,O
of,O
infarction,B-PR
was,O
detected,O
.,O

There,O
was,O
only,O
diffuse,B-PR
small,I-PR
vessel,I-PR
disease,I-PR
noted,O
.,O

On,O
05-05-92,O
she,O
was,O
noted,O
to,O
convert,O
to,O
atrial,B-PR
fibrillation,I-PR
which,O
resolved,O
spontaneously,O
a,O
few,O
days,O
later,O
.,O

However,O
",",O
on,O
05-07-92,O
there,O
was,O
a,O
a,O
question,O
of,O
a,B-PR
new,I-PR
event,I-PR
with,O
addition,O
to,O
the,B-PR
left,I-PR
upper,I-PR
extremity,I-PR
weakness,I-PR
",",O
some,B-PR
noted,I-PR
right,I-PR
upper,I-PR
and,I-PR
right,I-PR
lower,I-PR
extremity,I-PR
discoordination,I-PR
.,O

She,O
was,O
begun,O
on,O
a,B-TR
heparin,I-TR
drip,I-TR
.,O

On,O
5-9-92,O
the,B-PR
right-sided,I-PR
symptoms,I-PR
worsened,O
and,O
she,O
also,O
had,O
some,B-PR
elements,I-PR
of,I-PR
aphasia,I-PR
.,O

She,O
underwent,O
angiography,B-TE
on,O
5-9-92,O
which,O
showed,O
the,O
right,O
internal,O
carotid,O
artery,O
to,O
be,O
patent,O
",",O
however,O
there,O
was,O
highly,O
significant,B-PR
stenosis,I-PR
of,I-PR
the,I-PR
left,I-PR
carotid,I-PR
artery,I-PR
and,O
she,O
was,O
taken,O
to,O
the,O
operating,O
room,O
later,O
that,O
day,O
for,O
a,B-TR
left,I-TR
carotid,I-TR
endarterectomy,I-TR
.,O

She,O
was,O
taken,O
postoperatively,O
the,O
ICU,O
where,O
she,O
was,O
extubated,O
on,O
postoperative,O
day,O
number,O
one,O
and,O
by,O
5-11-92,O
she,O
was,O
noted,O
to,O
have,O
markedly,O
increased,O
use,O
of,O
her,O
right,O
side,O
",",O
resolving,O
aphasia,B-PR
and,O
she,O
was,O
transferred,O
to,O
the,O
floor,O
with,O
the,B-PR
residual,I-PR
deficit,I-PR
only,O
noted,O
to,O
be,O
some,B-PR
left,I-PR
upper,I-PR
extremity,I-PR
weakness,I-PR
.,O

She,O
was,O
worked,O
up,O
aggressively,O
with,O
the,O
physical,O
therapy,O
and,O
occupational,O
services,O
",",O
made,O
good,O
progress,O
and,O
began,O
ambulating,O
with,O
assistance,O
with,O
a,B-TR
walker,I-TR
but,O
with,O
minimal,O
assistance,O
from,O
an,O
aid,O
.,O

She,O
was,O
feeding,O
herself,O
and,O
was,O
very,O
enthusiastic,O
and,O
energetic,O
in,O
her,O
participation,O
in,O
her,B-TR
rehabilitation,I-TR
activities,I-TR
.,O

She,O
was,O
maintained,O
on,O
heparin,B-TR
therapy,I-TR
initially,O
but,O
this,O
was,O
quickly,O
switched,O
over,O
to,O
Coumadin,B-TR
anticoagulation,I-TR
therapy,I-TR
which,O
she,O
will,O
need,O
to,O
be,O
on,O
long-term,O
for,O
her,B-TR
aortic,I-TR
valve,I-TR
replacement,I-TR
.,O

DISPOSITION,O
:,O

She,O
is,O
transferred,O
to,O
Rockdempbanri,O
Hospital,O
on,O
05-28-92,O
to,O
continue,O
her,B-TR
rehabilitation,I-TR
.,O

Discharge,O
medications,O
:,O

Lopressor,B-TR
100,O
mg,O
p.o.,O
b.i.d.,O
;,O
Nifedipine,B-TR
10,O
mg,O
p.o.,O
t.i.d.,O
;,O
Timoptic,B-TR
solution,I-TR
0.5%,O
OS,O
b.i.d.,O
;,O
Coumadin,B-TR
1,O
mg,O
alternating,O
with,O
1.5,O
mg,O
q.o.d.,O
at,O
q.h.s.,O
and,O
Haldol,B-TR
2,O
mg,O
p.o.,O
q.h.s.,O
p.r.n.,O
in,O
the,O
evening,O
",",O
only,O
for,O
agitation,B-PR
associated,O
with,O
confusion,B-PR
.,O

Upon,O
discharge,O
it,O
was,O
the,O
recommendation,O
of,O
the,O
cardiology,O
team,O
that,O
the,B-TE
patient,I-TE
&apos;s,I-TE
prothrombin,I-TE
time,I-TE
be,O
monitored,O
weekly,O
and,O
be,O
kept,O
at,O
a,O
ratio,O
of,O
3-4,O
IU,O
.,O

Dictated,O
By,O
:,O

NIEIE,O
FREIERM,O
",",O
M.D.,O
ZX,O
681,O
/,O
0201,O
/,O
RISHAN,O
MISHON,O
ROOM,O
",",O
M.D.,O

BREUNTIK,O

D,O
:,O

05/26/92,O

T,O
:,O

05/27/92,O

Batch,O
:,O

U886,O

Report,O
:,O

LH486L9,O

500472963,O

PUOMC,O

9506800,O

464389,O

651486,O

9/20/2000,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O

FYFEUARDFEL,O
",",O
TADE,O

MRN,O
:,O

9506800,O

Age,O
:,O

65y,O

REGISTRATION,O
DATE,O
:,O

09/20/2000,O
12:41,O
PM,O

PRELIMINARY,O
REPORT,O

This,O
is,O
to,O
notify,O
you,O
that,O
your,O
patient,O
",",O
FYFEUARDFEL,O
",",O
TADE,O
arrived,O
in,O
the,O
Emergency,O
Department,O
at,O
Ph,O
University,O
Of,O
Medical,O
Center,O
on,O
09/20/2000,O
12:41,O
PM,O
.,O

The,O
patient,O
presented,O
with,O
a,O
chief,O
complaint,O
of,O
ABD,B-PR
PAIN,I-PR
.,O

Following,O
evaluation,B-TE
and,O
treatment,B-TR
",",O
the,O
patient,O
&apos;s,O
disposition,O
at,O
the,O
end,O
of,O
the,O
visit,O
was,O
ADMITTED,O
AS,O
AN,O
INPATIENT,O
TO,O
PH,O
UNIVERSITY,O
OF,O
MEDICAL,O
CENTER,O
.,O

Your,O
patient,O
was,O
admitted,O
under,O
the,O
care,O
of,O
FONG,O
",",O
CONEY,O
N,O
with,O
a,O
preliminary,O
diagnosis,O
of,O
PERFORATION,B-PR
.,O

If,O
you,O
need,O
additional,O
information,O
please,O
call,O
639-873-2993,O
.,O

503651854,O
WGH,O

4959433,O

288418,O

2823104,O

7/31/2004,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O
/,O
SUMMARY,O

A,O
",",O
WALINA,O

MRN,O
:,O

4959433,O

Age,O
:,O

32y,O

REGISTRATION,O
DATE,O
:,O

07/31/2004,O
11:24,O
AM,O

Provider,O
:,O

PADA,O
MEEDHUANG,O

PRELIMINARY,O
REPORT,O

PCP,O
notified,O
by,O
MD,O
:,O

E-mail,O
PCP,O

Benefits,O
Assigned,O
:,O

Y,O

Discharge,O
Date,O
/,O
Time,O
:,O

07/31/2004,O
12:58,O

Discharge,O
Status,O
:,O

Discharged,O

Condition,O
on,O
Discharge,O
:,O

Stable,O

Patient,O
States,O
Complaint,O
:,O

S,O
/,O
P,O
MVA,O

Diagnosis,O
:,O

head,B-PR
trauma,I-PR
-,O
mva,O

Treatment,B-TR
Rendered,O
:,O

history,O
",",O
physical,B-TE
",",O
neuro,B-TE
exam,I-TE
normal,O

Discharge,O
Medications,O
:,O

tylenol,B-TR
as,O
needed,O
.,O

refrain,O
from,O
motrin,B-TR
at,O
this,O
time,O
.,O

Follow,O
up,O
Service,O
:,O

f,O
/,O
u,O
with,O
dr.,O
white,O

Disposition,O
",",O
Follow,O
up,O
and,O
Instructions,O
to,O
Patient,O
:,O

monitor,O
/,O
return,O
for,O
nausea,B-PR
/,O
vomiting,B-PR
",",O
headache,B-PR
",",O
visual,B-PR
/,I-PR
mental,I-PR
status,I-PR
changes,I-PR
or,O
other,B-PR
concerns,I-PR
.,O

PCP,O
Name,O
:,O

WHITE,O
",",O
ELVNO,O
R,O

Provider,O
Number,O
:,O

70468,O

This,O
report,O
was,O
created,O
by,O
MEEDHUANG,O
",",O
PADA,O
07/31/2004,O
12:59,O
PM,O

517414339,O

PUOMC,O

4351342,O

88500,O

99515,O

12/26/1996,O
12:00:00,O
AM,O

HYPERPARATHYROIDISM,B-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

HOUGHTJESCSLEM,O
",",O
RIESHINJIN,O
R,O

UNIT,O
NUMBER,O
:,O

948-14-32,O

ADMISSION,O
DATE,O
:,O

12/26/96,O

DISCHARGE,O
DATE,O
:,O

01/01/97,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

hyperparathyroidism,B-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

1.,O
status,O
post,O
mitral,B-TR
valve,I-TR
replacement,I-TR
",",O

2.,O
hypertension,B-PR
",",O

3.,O
atrial,B-PR
fibrillation,I-PR
",",O

4.,O
hypertrophic,B-PR
obstructive,I-PR
cardiomyopathy,I-PR
",",O

5.,O
osteoarthritis,B-PR
",",O

6.,O
right,B-PR
cheek,I-PR
basal,I-PR
cell,I-PR
carcinoma,I-PR
",",O

7.,O
glaucoma,B-PR
",",O

8.,O
non-insulin,B-PR
dependent,I-PR
diabetes,I-PR
mellitus,I-PR
",",O

9.,O
status,O
post,O
laparoscopic,B-TR
cholecystectomy,I-TR
",",O

10.,O
status,O
post,O
dilation,B-TR
and,I-TR
curettage,I-TR
",",O

11.,O
status,O
post,O
cataract,B-TR
surgery,I-TR
",",O

12.,O
status,O
post,O
left,B-TE
breast,I-TE
biopsy,I-TE
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

Parathyroidectomy,B-TR
on,O
12-27-96,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
an,O
83-year-old,O
female,O
who,O
presents,O
for,O
surgical,B-TE
evaluation,I-TE
for,O
her,B-PR
hyperparathyroidism,I-PR
.,O

This,O
is,O
an,O
83-year-old,O
female,O
with,O
a,O
history,O
of,O
hypertrophic,B-PR
obstructive,I-PR
cardiomyopathy,I-PR
",",O
status,O
post,O
mitral,B-TR
valve,I-TR
replacement,I-TR
in,O
1988,O
",",O
chronic,B-PR
atrial,I-PR
fibrillation,I-PR
",",O
hypertension,B-PR
",",O
who,O
presents,O
for,O
parathyroidectomy,B-TR
.,O

In,O
August,O
of,O
1996,O
while,O
the,O
patient,O
was,O
at,O
Retelk,O
County,O
Medical,O
Center,O
for,O
replacement,B-TR
of,I-TR
her,I-TR
knees,I-TR
bilaterally,I-TR
",",O
and,O
on,O
preoperative,B-TE
evaluation,I-TE
she,O
was,O
noted,O
to,O
have,O
a,B-PR
high,I-PR
calcium,I-PR
and,O
therefore,O
the,B-TR
surgery,I-TR
was,O
canceled,O
.,O

Further,B-TE
testing,I-TE
revealed,O
hyperparathyroidism,B-PR
as,O
evidenced,O
by,O
an,B-PR
elevated,I-PR
PTH,I-PR
.,O

The,O
patient,O
reports,O
no,O
masses,B-PR
in,I-PR
her,I-PR
neck,I-PR
.,O

She,O
has,O
noticed,O
some,O
generalized,B-PR
hoarseness,I-PR
in,I-PR
her,I-PR
voice,I-PR
for,O
the,O
past,O
5-6,O
months,O
.,O

In,O
addition,O
",",O
she,O
has,O
some,B-PR
dysphagia,I-PR
",",O
particularly,O
has,O
had,O
some,B-PR
difficulties,I-PR
with,I-PR
swallowing,I-PR
.,O

She,O
has,O
been,O
seen,O
by,O
Dr.,O
Tokbelb,O
",",O
her,O
primary,O
care,O
physician,O
in,O
Itgreenredan,O
Hospital,O
",",O
and,O
also,O
Dr.,O
Kotefyfechird,O
",",O
her,O
cardiologist,O
",",O
and,O
also,O
an,O
endocrinologist,O
at,O
Retelk,O
County,O
Medical,O
Center,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
status,O
post,O
mitral,B-TR
valve,I-TR
replacement,I-TR
in,O
1988,O
.,O

She,O
has,O
a,B-TR
St.,I-TR
Jude,I-TR
&apos;s,I-TR
mechanical,I-TR
valve,I-TR
and,O
has,O
been,O
on,O
Coumadin,B-TR
since,O
then,O
",",O

2.,O
hypertension,B-PR
",",O
she,O
has,O
had,O
hypertension,B-PR
for,O
15,O
years,O
",",O

3.,O
atrial,B-PR
fibrillation,I-PR
",",O
she,O
is,O
status,O
post,O
cardioversion,B-TR
3-25-94,O
",",O

4.,O
hypertrophic,B-PR
obstructive,I-PR
cardiomyopathy,I-PR
",",O

5.,O
osteoarthritis,B-PR
;,O
she,O
is,O
to,O
receive,O
bilateral,B-TR
total,I-TR
knee,I-TR
replacements,I-TR
at,O
some,O
time,O
in,O
the,O
near,O
future,O
",",O

6.,O
right,B-PR
cheek,I-PR
basal,I-PR
cell,I-PR
carcinoma,I-PR
to,O
be,O
removed,O
in,O
the,O
future,O
",",O

7.,O
history,O
of,O
glaucoma,B-PR
",",O

8.,O
non,B-PR
insulin,I-PR
dependent,I-PR
diabetes,I-PR
mellitus,I-PR
which,O
was,O
diagnosed,O
in,O
March,O
",",O
1995,O
",",O

9.,O
shingles,B-PR
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

1.,O
laparoscopic,B-TR
cholecystectomy,I-TR
03/93,O
by,O
Dr.,O
Sapmal,O
",",O

2.,O
dilation,B-TR
and,I-TR
curettage,I-TR
in,O
1992,O
for,O
polyps,B-PR
",",O

3.,O
left,B-TE
breast,I-TE
biopsy,I-TE
which,O
was,O
benign,O
",",O

4.,O
cataract,B-TR
surgery,I-TR
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

1.,O
Lopid,B-TR
600,O
mg,O
PO,O
b.i.d.,O
",",O

2.,O
K-Dur,B-TR
20,O
mg,O
PO,O
q.day,O
",",O

3.,O
Lasix,B-TR
40,O
mg,O
PO,O
q.day,O
",",O

4.,O
Coumadin,B-TR
2.5,O
mg,O
PO,O
q.day,O
which,O
was,O
last,O
taken,O
two,O
days,O
prior,O
to,O
admission,O
",",O

5.,O
Norvasc,B-TR
500,O
mg,O
PO,O
q.day,O
",",O

6.,O
Digoxin,B-TR
.25,O
mg,O
PO,O
q.day,O
",",O

7.,O
Lopressor,B-TR
50,O
mg,O
PO,O
b.i.d.,O
",",O

8.,O
Glucotrol,B-TR
10,O
XL,O
qam,O
",",O

9.,O
Timoptic,B-TR
0.5%,O
b.i.d.,O
to,O
both,O
eyes,O
",",O

10.,O
Pilocarpine,B-TR
gel,I-TR
qhs,O
to,O
both,O
eyes,O
.,O

FAMILY,O
HISTORY,O
:,O

There,O
is,O
no,O
family,O
history,O
of,O
parathyroid,B-PR
or,I-PR
thyroid,I-PR
diseases,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
is,O
widowed,O
.,O

She,O
lives,O
alone,O
but,O
is,O
completely,O
independent,O
.,O

She,O
visits,O
her,O
daughter,O
once,O
a,O
week,O
.,O

No,O
ethanol,O
or,O
tobacco,O
use,O
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

The,B-TE
review,I-TE
of,I-TE
systems,I-TE
is,O
significant,O
for,O
a,O
history,O
of,O
dyspnea,B-PR
on,I-PR
exertion,I-PR
.,O

At,O
present,O
",",O
she,O
can,O
walk,O
one,O
to,O
two,O
blocks,O
before,O
having,O
to,O
stop,O
because,O
of,O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

When,O
walking,O
outside,O
",",O
she,O
stops,O
multiple,O
times,O
because,O
of,O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

She,O
sleeps,O
with,O
two,O
pillows,O
at,O
night,O
.,O

She,O
gets,O
short,B-PR
of,I-PR
breath,I-PR
walking,O
up,O
steps,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
physical,B-TE
examination,I-TE
",",O
she,O
is,O
a,O
pleasant,O
woman,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

Her,B-TE
pulse,I-TE
is,O
72,O
",",O
irregularly,O
irregular,O
",",O
blood,B-TE
pressure,I-TE
96/60,O
",",O
temperature,B-TE
97.9,O
",",O
respirations,B-TE
18,O
.,O

The,B-TE
head,I-TE
",",I-TE
eyes,I-TE
",",I-TE
ears,I-TE
",",I-TE
nose,I-TE
and,I-TE
throat,I-TE
examination,I-TE
is,O
notable,O
for,O
pupils,O
which,O
have,O
irregular,B-PR
border,I-PR
and,O
are,O
very,B-PR
sluggishly,I-PR
reactive,I-PR
.,O

The,O
patient,O
reports,O
that,O
she,O
will,O
have,O
revision,B-TR
of,I-TR
cataract,I-TR
surgery,I-TR
.,O

Neck,O
and,O
lungs,O
are,O
unremarkable,O
.,O

Cardiovascular,B-TE
exam,I-TE
:,O

III,B-PR
/,I-PR
VI,I-PR
systolic,I-PR
click,I-PR
and,O
irregularly,B-PR
irregular,I-PR
rhythm,I-PR
.,O

The,O
abdomen,O
was,O
benign,O
.,O

She,O
is,O
guaiac,O
negative,O
on,O
rectal,B-TE
examination,I-TE
.,O

Extremities,O
:,O

unremarkable,O
.,O

LABORATORY,O
DATA,O
:,O

Admission,O
white,B-TE
blood,I-TE
count,I-TE
4.3,O
",",O
hematocrit,B-TE
31.0,O
",",O
electrolytes,B-TE
were,O
all,O
within,O
normal,O
limits,O
",",O
glucose,B-TE
218,O
",",O
prothrombin,B-TE
time,I-TE
on,O
admission,O
was,O
15.1,O
with,O
INR,B-TE
of,O
1.5,O
",",O
partial,B-TE
thromboplastin,I-TE
time,I-TE
23.3,O
.,O

The,B-TE
electrocardiogram,I-TE
showed,O
atrial,B-PR
fibrillation,I-PR
with,O
slow,B-PR
ventricular,I-PR
response,I-PR
and,O
digitalis,B-PR
effect,I-PR
as,O
well,O
as,O
left,B-PR
ventricular,I-PR
hypertrophy,I-PR
.,O

IMPRESSION,O
ON,O
ADMISSION,O
:,O

Impression,O
was,O
that,O
this,O
was,O
an,O
83-year-old,O
female,O
with,O
cardiac,B-PR
history,I-PR
",",O
dyspnea,B-PR
on,I-PR
exertion,I-PR
",",O
increased,B-PR
calcium,I-PR
and,O
hyperparathyroidism,B-PR
who,O
presents,O
for,O
parathyroidectomy,B-TR
.,O

HOSPITAL,O
COURSE,O
AND,O
TREATMENT,O
:,O

On,O
the,O
day,O
of,O
admission,O
",",O
the,O
patient,O
was,O
brought,O
to,O
the,O
operating,O
room,O
for,O
parathyroidectomy,B-TR
.,O

The,O
right,O
superior,O
parathyroid,O
gland,O
was,O
found,O
to,O
be,O
markedly,B-PR
enlarged,I-PR
and,O
consistent,O
with,O
an,B-PR
adenoma,I-PR
.,O

Her,O
right,O
superior,O
parathyroid,O
gland,O
was,O
removed,O
and,O
the,O
rest,O
of,O
her,O
parathyroid,O
glands,O
were,O
left,O
in,O
place,O
.,O

Postoperatively,O
",",O
the,O
patient,O
did,O
well,O
and,O
was,O
able,O
to,O
cough,O
and,O
phonate,O
completely,O
with,O
no,O
changes,B-PR
from,O
preoperative,O
.,O

The,O
plan,O
was,O
to,O
start,O
her,O
on,O
heparin,B-TR
and,O
Coumadin,B-TR
and,O
discontinue,O
her,B-TR
heparin,I-TR
when,O
her,B-TE
Coumadin,I-TE
levels,I-TE
became,O
therapeutic,O
as,O
judged,O
by,O
the,B-TE
prothrombin,I-TE
time,I-TE
/,O
INR,B-TE
.,O

However,O
",",O
on,O
postoperative,O
day,O
number,O
two,O
",",O
the,O
patient,O
in,O
the,O
afternoon,O
noticed,O
some,B-PR
tingling,I-PR
in,I-PR
her,I-PR
hands,I-PR
and,O
also,O
some,B-PR
tingling,I-PR
hear,I-PR
her,I-PR
perioral,I-PR
region,I-PR
.,O

She,O
had,O
a,O
negative,O
Chvostek,O
&apos;s,O
and,O
negative,O
Trousseau,O
&apos;s,O
sign,O
.,O

She,O
had,O
no,O
muscular,B-PR
weakness,I-PR
noted,O
.,O

An,B-TE
ionized,I-TE
calcium,I-TE
was,O
drawn,O
which,O
was,O
low,O
at,O
1.0,O
.,O

As,O
a,O
result,O
",",O
the,O
patient,O
was,O
started,O
on,O
Os-Cal,B-TR
250,O
mg,O
PO,O
q.i.d.,O
On,O
postoperative,O
day,O
number,O
three,O
",",O
her,B-TE
ionized,I-TE
calcium,I-TE
was,O
1.06,O
and,O
her,B-TR
Os-Cal,I-TR
was,O
increased,O
to,O
500,O
q.i.d.,O

However,O
",",O
her,B-PR
ionized,I-PR
calcium,I-PR
decreased,I-PR
to,O
0.97,O
and,O
she,O
was,O
given,O
one,O
amp,O
of,O
calcium,B-TR
gluconate,I-TR
.,O

On,O
postoperative,O
day,O
number,O
five,O
",",O
the,O
patient,O
felt,O
fine,O
and,O
had,O
an,B-TE
INR,I-TE
of,O
1.9,O
with,O
a,B-TE
prothrombin,I-TE
time,I-TE
of,O
16.6,O
.,O

Her,B-TE
calcium,I-TE
was,O
8.5,O
",",O
albumin,B-TE
3.6,O
",",O
and,O
phosphate,B-TE
4.5,O
.,O

She,O
had,O
had,O
no,O
further,O
episodes,O
of,O
tingling,B-PR
in,I-PR
her,I-PR
fingers,I-PR
after,O
the,O
initial,O
episode,O
which,O
had,O
prompted,O
us,O
originally,O
to,O
draw,O
the,B-TE
ionized,I-TE
calcium,I-TE
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Good,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

1.,O
Coumadin,B-TR
5,O
mg,O
PO,O
q.day,O
",",O
then,O
she,O
will,O
follow,O
up,O
with,O
her,O
primary,O
care,O
physician,O
and,O
decide,O
the,O
dosage,O
thereafter,O
",",O

2.,O
Lopid,B-TR
600,O
mg,O
PO,O
b.i.d.,O
",",O

3.,O
K-Dur,B-TR
20,O
mg,O
PO,O
q.day,O
",",O

4.,O
Os-Cal,B-TR
500,O
mg,O
PO,O
q.i.d.,O
",",O

5.,O
Rocaltrol,B-TR
0.25,O
mg,O
PO,O
b.i.d.,O
",",O

6.,O
Lasix,B-TR
40,O
mg,O
PO,O
q.day,O
",",O

7.,O
Norvasc,B-TR
5,O
mg,O
PO,O
q.day,O
",",O

8.,O
Digoxin,B-TR
.25,O
mg,O
PO,O
q.day,O
",",O

9.,O
Lopressor,B-TR
50,O
mg,O
PO,O
b.i.d.,O
",",O

10.,O
Glucotrol,B-TR
10,O
mg,O
qam,O
.,O

FOLLOW,O
UP,O
:,O

For,O
follow,O
up,O
",",O
the,O
patient,O
is,O
to,O
call,O
for,O
an,O
appointment,O
with,O
Dr.,O
Sapmal,O
.,O

In,O
addition,O
",",O
she,O
is,O
to,O
follow,O
up,O
with,O
her,O
primary,O
care,O
physician,O
to,O
check,O
her,B-TE
prothrombin,I-TE
time,I-TE
/,O
INR,B-TE
as,O
well,O
as,O
calcium,B-TE
",",I-TE
albumin,I-TE
and,I-TE
phosphate,I-TE
levels,I-TE
.,O

She,O
will,O
be,O
sent,O
home,O
with,O
home,O
Arnsperni,O
Health,O
.,O

LENNI,O
BREUTZOLN,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

_____________________,O
RIEEA,O
SAPMAL,O
",",O
M.D.,O

TR,O
:,O

hzu,O

DD,O
:,O

New,O
Years,O
Day,O

TD,O
:,O

01/06/97,O
2:48,O
P,O

cc,O
:,O

RIEEA,O
ODEE,O
SAPMAL,O
",",O
M.D.,O
CEALME,O
LEOE,O
MARESSYTHE,O
Dr.,O
Tokbelb,O
Welle,O
Health,O
Sonsant,O
.,O

523704694,O

PRGH,O

67119280,O

480282,O

10/23/1999,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

10/23/1999,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

11/02/1999,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Left,B-PR
sided,I-PR
spastic,I-PR
hemiparesis,I-PR
",",O
status,O
post,O
surgical,B-TR
correction,I-TR
of,I-TR
C-1,I-TR
",",I-TR
C-2,I-TR
dural,I-TR
AVM,I-TR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Ms.,O
Breunlinke,O
is,O
a,O
69,O
year-old,O
right,O
handed,O
woman,O
",",O
status,O
post,O
surgical,B-TR
correction,I-TR
of,I-TR
a,I-TR
C-1,I-TR
to,I-TR
C-2,I-TR
dural,I-TR
AVM,I-TR
in,O
January,O
",",O
1998,O
",",O
now,O
presenting,O
with,O
a,O
one,O
month,O
history,O
of,O
increasing,B-PR
left,I-PR
sided,I-PR
weakness,I-PR
and,O
pain,B-PR
with,O
spasticity,B-PR
",",O
occasional,O
difficulty,B-PR
swallowing,I-PR
and,O
abdominal,B-PR
pain,I-PR
.,O

She,O
was,O
originally,O
admitted,O
to,O
the,O
Verg,O
Medical,O
Center,O
in,O
January,O
",",O
1998,O
",",O
because,O
of,O
a,O
one,O
year,O
history,O
of,O
left,B-PR
sided,I-PR
weakness,I-PR
and,O
spasticity,B-PR
.,O

She,O
was,O
found,O
to,O
have,O
intermedullary,B-PR
lesion,I-PR
at,I-PR
C1-2,I-PR
level,I-PR
which,O
on,O
biopsy,B-TE
showed,O
abnormal,B-PR
vasculature,I-PR
",",O
hemosiderin,B-PR
deposit,I-PR
",",O
leading,O
in,O
turn,O
to,O
the,O
discovery,O
of,O
a,B-PR
dural,I-PR
arteriovenous,I-PR
malformation,I-PR
at,O
that,O
level,O
which,O
was,O
surgically,O
corrected,O
.,O

The,O
postoperative,O
period,O
was,O
complicated,O
by,O
transient,B-PR
swallowing,I-PR
difficulty,I-PR
",",O
increasing,B-PR
left,I-PR
sided,I-PR
weakness,I-PR
and,O
urinary,B-PR
retention,I-PR
.,O

She,O
was,O
discharged,O
to,O
inpatient,O
rehabilitation,O
where,O
she,O
made,O
significant,O
progress,O
toward,O
recovery,O
.,O

As,O
of,O
the,O
beginning,O
of,O
September,O
",",O
1999,O
",",O
she,O
was,O
able,O
to,O
swallow,O
without,O
difficulty,O
",",O
urinate,O
without,O
difficulty,O
(,O
although,O
bowel,O
movements,O
have,O
been,O
problematic,B-PR
),O
.,O

Functionally,O
",",O
she,O
was,O
at,O
the,O
level,O
of,O
pre-gait,B-TR
training,I-TR
and,O
able,O
to,O
stand,O
and,O
take,O
several,O
steps,O
with,O
upper,B-TR
body,I-TR
support,I-TR
.,O

Over,O
the,O
past,O
4-5,O
weeks,O
her,B-PR
functional,I-PR
level,I-PR
has,O
progressively,O
deteriorated,O
.,O

She,O
is,O
now,O
unable,O
to,O
stand,O
and,O
needs,O
assistance,O
to,O
sit,O
up,O
.,O

Her,O
left,O
arm,O
has,O
developed,O
a,B-PR
flexure,I-PR
contraction,I-PR
and,O
she,O
reports,O
intermitttent,B-PR
pain,I-PR
in,I-PR
the,I-PR
left,I-PR
arm,I-PR
and,I-PR
leg,I-PR
which,O
occurs,O
both,O
spontaneously,O
and,O
is,O
also,O
triggered,O
by,O
contact,O
.,O

She,O
has,O
developed,O
some,O
new,B-PR
swallowing,I-PR
difficulty,I-PR
and,O
since,O
her,O
transfer,O
to,O
a,O
long,O
term,O
inpatient,O
care,O
facility,O
",",O
she,O
has,O
lost,O
ten,O
pounds,O
.,O

She,O
denies,O
dysuria,B-PR
or,O
excessive,B-PR
urinary,I-PR
frequency,I-PR
.,O

Over,O
the,O
past,O
several,O
weeks,O
she,O
has,O
also,O
developed,O
severe,B-PR
intermittent,I-PR
abdominal,I-PR
pain,I-PR
",",O
localized,O
to,O
the,O
suprapubic,O
area,O
",",O
left,O
greater,O
than,O
right,O
",",O
occurring,O
intermittently,O
.,O

The,O
patient,O
feels,O
this,O
is,O
secondary,O
to,O
her,B-PR
hemorrhoids,I-PR
",",O
although,O
it,O
does,O
not,O
clearly,O
localize,O
to,O
the,O
rectum,O
.,O

This,B-PR
pain,I-PR
often,O
follows,O
bowel,O
movement,O
but,O
does,O
occur,O
spontaneously,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Significant,O
for,O
Insulin,B-PR
dependent,I-PR
diabetes,I-PR
mellitus,I-PR
",",O
atrial,B-PR
fibrillation,I-PR
",",O
hypothyroidism,B-PR
",",O
hypertension,B-PR
",",O
depression,B-PR
",",O
frequent,B-PR
urinary,I-PR
tract,I-PR
infections,I-PR
",",O
neuropathic,B-PR
pain,I-PR
syndrome,I-PR
and,O
osteoporosis,B-PR
.,O

MEDICATION,O
:,O

On,O
admission,O
include,O
Cozaar,B-TR
75,O
mg,O
q.d.,O
",",O
Coumadin,B-TR
2,O
mg/1,O
mg,O
alternate,O
days,O
",",O
Synthroid,B-TR
175,O
mcg,O
q.d.,O
",",O
Zoloft,B-TR
50,O
mg,O
q.d.,O
",",O
Zantac,B-TR
150,O
mg,O
b.i.d.,O
",",O
Diabeta,B-TR
25,O
mg,O
q.d.,O
",",O
Proctofoam,B-TR
1%,O
q.i.d.,O
",",O
Demerol,B-TR
100,O
mg,O
q,O
6,O
p.r.n.,O
",",O
OsCal,B-TR
2,O
tabs,O
t.i.d.,O
",",O
multivitamins,B-TR
and,O
KCl,B-TR
supplements,I-TR
",",O
Dulcolax,B-TR
5,O
mg,O
q.d.,O
",",O
Senokot,B-TR
2,O
tabs,O
q,O
h.s.,O
",",O
Metamucil,B-TR
1,O
tablespoon,O
b.i.d.,O
",",O
Detrol,B-TR
2,O
mg,O
b.i.d.,O
",",O
Neurontin,B-TR
200,O
mg,O
t.i.d.,O
",",O
HydroDIURIL,B-TR
12.5,O
mg,O
q.d.,O
",",O
Valium,B-TR
10,O
mg,O
q,O
8,O
p.r.n.,O
muscle,B-PR
spasm,I-PR
",",O
Insulin,B-TR
by,O
sliding,O
scale,O

ALLERGIES,O
:,O

The,O
patient,O
is,O
allergic,B-PR
to,O
Hydralazine,B-TR
",",O
codeine,B-TR
",",O
ace,B-TR
inhibitors,I-TR
",",O
Nifedipine,B-TR
and,O
Percocet,B-TR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,O
",",O
heart,O
is,O
regular,O
rate,O
and,O
rhythm,O
without,O
murmur,B-PR
.,O

Lungs,O
are,O
clear,O
to,O
auscultation,B-TE
bilaterally,I-TE
.,O

Abdomen,O
is,O
soft,O
",",O
with,O
marked,B-PR
suprapubic,I-PR
tenderness,I-PR
and,O
reduced,B-PR
bowel,I-PR
sounds,I-PR
.,O

Anal,O
tone,O
is,O
reduced,B-PR
.,O

Rectal,B-TE
examination,I-TE
is,O
nontender,B-PR
and,O
stool,O
is,O
guaiac,O
negative,O
.,O

Neurologically,O
",",O
the,O
patient,O
is,O
alert,O
and,O
oriented,O
times,O
three,O
with,O
normal,O
speech,O
",",O
language,O
and,O
repetition,O
.,O

Cranial,O
nerves,O
:,O

pupils,O
are,O
4-6,O
mm,O
bilaterally,O
",",O
extraocular,O
movements,O
were,O
full,O
without,O
nystagmus,B-PR
.,O

Eye,O
closure,O
and,O
smile,O
are,O
symmetric,O
.,O

Tongue,O
is,O
midline,O
.,O

Facial,O
sensation,O
is,O
sensation,O
.,O

Strength,O
:,O

The,O
tone,O
is,O
markedly,B-PR
increased,I-PR
in,I-PR
bot,I-PR
legs,I-PR
with,O
left,O
greater,O
than,O
right,O
.,O

Left,O
arm,O
shows,O
a,B-PR
flexor,I-PR
contracture,I-PR
and,O
markedly,B-PR
increased,I-PR
tone,I-PR
.,O

The,O
right,O
arm,O
shows,O
moderate,B-PR
increased,I-PR
tone,I-PR
.,O

Power,O
:,O

The,O
left,O
upper,O
extremity,O
shows,O
reduction,B-PR
in,I-PR
motor,I-PR
power,I-PR
ranging,O
from,O
2/5,O
in,O
the,O
triceps,O
",",O
4/5,O
in,O
the,O
biceps,O
",",O
and,O
3-4/5,O
in,O
the,O
wrists,O
and,O
hand,O
intrinsics,O
.,O

The,O
right,O
upper,O
extremity,O
shows,O
generalized,B-PR
reduction,I-PR
in,I-PR
strength,I-PR
",",O
4/5,O
in,O
all,O
joints,O
.,O

In,O
the,O
lower,O
extremities,O
on,O
the,O
left,O
hip,O
flexor,O
is,O
1/5,O
",",O
knee,O
flexion,O
and,O
extension,O
is,O
3/5,O
and,O
4/5,O
respectively,O
and,O
plantar,O
and,O
dorsiflexion,O
is,O
4/5,O
.,O

The,O
right,O
lower,O
extremity,O
shows,O
a,O
3/5,O
on,O
hip,O
flexion,O
",",O
4/5,O
at,O
knee,O
flexion,O
and,O
extension,O
and,O
full,O
power,O
on,O
dorsi,O
and,O
plantar,O
flexion,O
.,O

Reflexes,O
:,O

Upper,O
extremities,O
are,O
very,O
brisk,O
bilaterally,O
and,O
symmetrical,O
3+.,O
There,O
is,O
positive,B-PR
tremor,I-PR
reflex,I-PR
on,I-PR
the,I-PR
left,I-PR
and,O
absent,B-PR
on,I-PR
the,I-PR
right,I-PR
.,O

Lower,O
extremities,O
show,O
patellar,B-TE
reflexes,I-TE
3+,O
left,O
",",O
4+,O
right,O
",",O
no,O
cross,B-TE
deductor,I-TE
reflexes,I-TE
and,O
absent,O
ankle,O
jerks,O
.,O

There,O
is,O
no,O
clonus,B-PR
on,I-PR
the,I-PR
right,I-PR
but,O
sustained,B-PR
clonus,I-PR
(,I-PR
10-12,I-PR
beats,I-PR
),I-PR
on,I-PR
the,I-PR
left,I-PR
.,O

Plantar,O
responses,O
:,O

toes,O
are,O
upgoing,O
on,O
the,O
left,O
",",O
down,O
going,O
on,O
the,O
right,O
.,O

Sensory,O
:,O

The,O
patient,O
has,O
diminished,B-PR
vibration,I-PR
and,I-PR
propioception,I-PR
in,I-PR
the,I-PR
left,I-PR
upper,I-PR
and,I-PR
lower,I-PR
extremity,I-PR
and,O
decreased,B-PR
temperature,I-PR
",",O
light,B-TE
touch,I-TE
and,O
pinprick,B-TE
sensation,I-TE
in,O
the,O
right,O
upper,O
and,O
lower,O
extremity,O
consistent,O
with,O
a,B-PR
high,I-PR
cervical,I-PR
spinal,I-PR
sensory,I-PR
level,I-PR
.,O

Cerebellar,O
;,O
The,O
patient,O
demonstrates,O
an,B-PR
intention,I-PR
tremor,I-PR
on,O
finger,B-TE
to,I-TE
nose,I-TE
with,O
the,O
left,O
hand,O
.,O

Fine,O
motor,O
movements,O
are,O
slow,B-PR
but,O
accurate,O
in,O
the,O
left,O
and,O
right,O
hands,O
.,O

LABORATORY,O
DATA,O
:,O

Sodium,B-TE
140,O
",",O
potassium,B-TE
3.8,O
",",O
chloride,B-TE
100,O
",",O
bicarbonate,B-TE
of,O
30,O
",",O
BUN,B-TE
of,O
13,O
",",O
creatinine,B-TE
0.8,O
",",O
serum,B-TE
glucose,I-TE
228,O
.,O

White,B-TE
blood,I-TE
count,I-TE
is,O
"7,000",O
.,O

Hematocrit,B-TE
is,O
37.6,O
",",O
platelet,B-TE
count,I-TE
is,O
"148,000",O
.,O

Prothrombin,B-TE
time,I-TE
is,O
15.9,O
with,O
an,B-TE
INR,I-TE
of,O
1.7,O
.,O

PTT,B-TE
is,O
24,O
.,O

Urinalysis,B-TE
from,O
October,O
21,O
",",O
is,O
positive,O
for,O
Citrobacter,B-PR
susceptible,O
to,O
ciprofloxacin,B-TR
",",O
gentamycin,B-TR
",",O
nitrofurantoin,B-TR
",",O
tetracycline,B-TR
and,O
Bactrim,B-TR
.,O

Electrocardiogram,B-TE
shows,O
no,O
P-waves,B-PR
.,O

The,O
patient,O
is,O
fully,O
paced,O
.,O

HOSPITAL,O
COURSE,O
:,O

On,O
admission,O
",",O
a,B-TE
CT,I-TE
scan,I-TE
of,I-TE
the,I-TE
head,I-TE
with,O
and,O
without,O
contrast,O
was,O
performed,O
",",O
showing,O
a,B-PR
missing,I-PR
posterior,I-PR
arch,I-PR
at,I-PR
C-1,I-PR
and,O
metallic,B-TR
clips,I-TR
at,I-TR
the,I-TR
craniocervical,I-TR
junction,I-TR
consistent,O
with,O
prior,B-TR
surgical,I-TR
intervention,I-TR
.,O

No,O
arteriovenous,B-PR
malformations,I-PR
are,O
identified,O
;,O
there,O
is,O
no,O
evidence,O
of,O
recurrence,B-PR
of,O
her,B-PR
former,I-PR
vascular,I-PR
malformation,I-PR
.,O

No,O
intraspinal,B-PR
lesions,I-PR
are,O
identified,O
.,O

Upon,O
further,O
review,O
of,O
Dr.,O
Laymie,O
Fields,O
",",O
Department,O
of,O
Neuroradiology,O
",",O
review,O
of,O
the,O
cervical,O
spine,O
on,O
CT,B-TE
reveals,O
no,O
extrinsic,B-PR
compressive,I-PR
lesions,I-PR
impacting,O
the,O
spinal,O
cord,O
and,O
no,O
enhancing,B-PR
lesions,I-PR
of,I-PR
the,I-PR
spinal,I-PR
cord,I-PR
with,O
contrast,B-TE
.,O

Angiography,B-TE
performed,O
on,O
October,O
31,O
",",O
1999,O
",",O
showed,O
normal,B-PR
vascular,I-PR
distribution,I-PR
of,I-PR
the,I-PR
head,I-PR
and,I-PR
neck,I-PR
with,O
no,O
recurrence,B-PR
of,I-PR
arteriovenous,I-PR
malformation,I-PR
.,O

During,O
this,O
admission,O
",",O
the,O
patient,O
was,O
started,O
on,O
Baclofen,B-TR
10,O
mg,O
p.o.,O
t.i.d.,O
for,O
spasticity,B-PR
.,O

Coumadin,B-TR
was,O
discontinued,O
.,O

The,O
patient,O
was,O
given,O
aspirin,B-TR
325,O
mg,O
p.o.,O
q.d.,O

The,O
patient,O
was,O
also,O
given,O
Valium,B-TR
5-10,O
mg,O
p.o.,O
t.i.d.,O
for,O
muscle,B-PR
spasm,I-PR
.,O

She,O
was,O
continued,O
on,O
Demerol,B-TR
50,O
mg,O
q,O
6-8,O
hours,O
p.r.n.,O
for,O
left,B-PR
arm,I-PR
and,I-PR
leg,I-PR
pain,I-PR
.,O

Upon,O
further,O
review,O
of,O
CT,B-TE
and,O
angiography,B-TE
results,O
with,O
Neuroradiology,O
and,O
Neurology,O
service,O
",",O
it,O
was,O
decided,O
that,O
CT,B-TE
myelography,I-TE
was,O
not,O
indicated,O
at,O
this,O
time,O
.,O

Note,O
",",O
the,O
patient,O
is,O
not,O
a,O
candidate,O
for,O
magnetic,B-TE
resonance,I-TE
imaging,I-TE
secondary,O
to,O
ferromagnetic,B-TR
intracardiac,I-TR
pacing,I-TR
device,I-TR
.,O

DISPOSITION,O
:,O

The,O
patient,O
was,O
discharged,O
back,O
to,O
Raka,O
St,O
",",O
Mcape,O
Garl,O
",",O
long,O
term,O
facility,O
.,O

We,O
recommend,O
daily,O
physical,B-TR
therapy,I-TR
and,O
occupational,B-TR
therapy,I-TR
to,O
maximize,O
functional,B-PR
capacity,I-PR
with,O
optimization,O
of,O
pharmacological,B-TR
regimen,I-TR
for,O
spasticity,B-PR
including,O
Baclofen,B-TR
",",O
Valium,B-TR
and,O
adequate,B-TR
analgesia,I-TR
.,O

The,O
patient,O
is,O
to,O
followup,O
in,O
Neurology,O
clinic,O
",",O
Verg,O
Medical,O
Center,O
with,O
Dr.,O
Deida,O
K.,O
Areke,O
and,O
/,O
or,O
Dr.,O
Istranmuna,O
Cord,O
in,O
4-6,O
weeks,O
time,O
.,O

Dictated,O
By,O
:,O

DEIDA,O
K.,O
LONG,O
",",O
M.D.,O

Attending,O
:,O

ISTRANMUNA,O
B.,O
CORD,O
",",O
M.D.,O
VR52,O
PH501/3560,O

Batch,O
:,O

1445,O

Index,O
No.,O
MUZHFDOZK0,O

D,O
:,O

11/02/99,O

T,O
:,O

11/02/99,O
KE9,O

544907529,O
RWH,O

2746299,O

6349,O

700114,O

4/4/2002,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O

JESCWIERST,O
",",O
MA,O

MRN,O
:,O

2746299,O

Age,O
:,O

55y,O

REGISTRATION,O
DATE,O
:,O

04/04/2002,O
01:09,O
AM,O

PRELIMINARY,O
REPORT,O

This,O
is,O
to,O
notify,O
you,O
that,O
your,O
patient,O
",",O
JESCWIERST,O
",",O
MA,O
arrived,O
in,O
the,O
Emergency,O
Department,O
at,O
Ro,O
Woodma,O
Healthcare,O
on,O
04/04/2002,O
01:09,O
AM,O
.,O

The,O
patient,O
presented,O
with,O
a,O
chief,O
complaint,O
of,O
EPIGASTRIC,B-PR
PAIN,I-PR
/,O
ABD,B-PR
PAIN,I-PR
.,O

Following,O
evaluation,B-TE
and,O
treatment,B-TR
",",O
the,O
patient,O
&apos;s,O
disposition,O
at,O
the,O
end,O
of,O
the,O
visit,O
was,O
ADMITTED,O
AS,O
AN,O
INPATIENT,O
TO,O
RO,O
WOODMA,O
HEALTHCARE,O
.,O

The,O
patient,O
&apos;s,O
preliminary,O
admitting,O
physician,O
is,O
PRIESDOUET,O
",",O
CH,O
J,O
and,O
the,O
preliminary,O
diagnosis,O
is,O
CHOLECYSTITIS,B-PR
.,O

Please,O
note,O
this,O
information,O
may,O
have,O
been,O
updated,O
on,O
the,O
inpatient,O
unit,O
.,O

If,O
you,O
need,O
additional,O
information,O
please,O
call,O
662-747-1199,O
.,O

PCP,O
Name,O
:,O

GRENDZISKLEEB,O
",",O
FACISA,O
T,O

Provider,O
Number,O
:,O

11181,O

555509347,O
PUMC,O

7264645,O

16649,O

8815716,O

8/31/2004,O
12:00:00,O
AM,O

OB,O
Discharge,O
Summary,O

Signed,O

DIS,O

Report,O
Status,O
:,O

Signed,O
OB,O
EMR,O
L,O
and,O
D,O

DISCHARGE,O
SUMMARY,O
NAME,O
:,O

THON,O
MERI,O
CINKGUAY,O

UNIT,O
NUMBER,O
:,O

069-81-00,O

ADMISSION,O
DATE,O
:,O

20040831,O

DISCHARGE,O
DATE,O
:,O

20040903,O

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
:,O

Vaginal,B-TR
Delivery,I-TR
With,O
Second,B-PR
Degree,I-PR
Laceration,I-PR

ASSOCIATED,O
DIAGNOSES,O
:,O

Low,B-PR
Lying,I-PR
Placenta,I-PR
;,O
Past,O
Medical,O
History,O
",",O
history,O
of,O
;,O
Urinary,B-PR
Tract,I-PR
Infection,I-PR
",",O
history,O
of,O

PRINCIPAL,O
PROCEDURE,O
OR,O
OPERATION,O
:,O

Spontaneous,B-TR
Vertex,I-TR
Vaginal,I-TR
Delivery,I-TR

ASSOCIATED,O
PROCEDURES,O
OR,O
OPERATIONS,O
:,O

POSTPARTUM,O
DIAGNOSTIC,O
PROCEDURES,O
:,O

None,O

POSTPARTUM,O
THERAPEUTIC,O
PROCEDURES,O
:,O

None,O

OTHER,O
POSTPARTUM,O
THERAPIES,O
:,O

Routine,B-TR
Post,I-TR
Partum,I-TR
Care,I-TR

HISTORY,O
AND,O
REASON,O
FOR,O
HOSPITALIZATION,O
:,O

Active,B-PR
Labor,I-PR

PHYSICAL,O
EXAMINATION,O
:,O

HEIGHT,B-TE
66,O
HEENT,B-TE
NORMAL,O
NECK,O
NORMAL,O
BREASTS,O
NORMAL,O
NIPPLES,O
NORMAL,O
CHEST,O
NORMAL,O
COR,O
NORMAL,O
ABDOMEN,O
NORMAL,O
EXTREM,O
NORMAL,O
SKIN,O
NORMAL,O
NODES,O
NORMAL,O
VULVA,O
NORMAL,O
VAGINA,O
NORMAL,O
CERVIX,O
NORMAL,O
OS,O
NORMAL,O
ADNEXAE,O
NORMAL,O
UTERUS,O
NORMAL,O
UTERINE,O
SIZE,O
IN,O
WEEKS,O
NORMAL,O
12,O

HOSPITAL,O
COURSE,O
(,O
include,O
complications,O
if,O
any,O
),O
:,O

This,O
34,O
year,O
old,O
Gravida,O
1,O
Para,O
0000,O
was,O
admitted,O
to,O
the,O
Bap,O
Spald,O
Hospital,O
Obstetrical,O
service,O
on,O
08/31/2004,O
at,O
06:00,O
am,O
for,O
the,O
indication,O
(,O
s,O
),O
:,O

active,B-PR
labor,I-PR
.,O

She,O
delivered,O
a,O
3550,O
gram,O
male,O
infant,O
on,O
08/31/2004,O
at,O
09:33,O
pm,O
with,O
apgar,B-TE
scores,I-TE
of,O
9,O
and,O
9,O
at,O
one,O
and,O
five,O
minutes,O
respectively,O
at,O
41.0,O
weeks,O
gestation,O
via,O
spontaneous,B-TR
vertex,I-TR
vaginal,I-TR
delivery,I-TR
.,O

During,O
her,O
labor,O
she,O
encountered,O
the,O
following,O
complication,O
(,O
s,O
),O
:,O

chorioamnionitis,B-PR
.,O

During,O
her,O
delivery,O
she,O
encountered,O
the,O
following,O
complication,O
(,O
s,O
),O
:,O

nuchal,B-PR
cord,I-PR
.,O

Postpartum,O
she,O
encountered,O
the,O
following,O
complication,O
(,O
s,O
),O
:,O

none,O
.,O

She,O
was,O
discharged,O
on,O
09/03/2004,O
at,O
12:07,O
pm,O
in,O
good,O
condition,O
.,O

DISCHARGE,O
ACTIVITY,O
:,O

No,O
Restrictions,O

DISCHARGE,O
DIET,O
:,O

No,O
Restrictions,O

POSTPARTUM,O
DISPOSITION,O
:,O

Home,O
With,O
Self-Care,O
(,O
Routine,O
Discharge,O
),O

POSTPARTUM,O
CARE,O
SITE,O
:,O

Cinpipecoursspi,O
Hospital,O
Health,O
Center,O

POSTPARTUM,O
RETURN,O
APPOINTMENT,O
(,O
DAYS,O
),O
:,O

42,O

BREAST,O
FEEDING,O
AT,O
DISCHARGE,O
:,O

Yes,O

POSTPARTUM,O
MEASLES,O
/,O
MUMPS/RUBELLA,O
VACCINE,O
:,O

Not,O
Indicated,O

MEDICATION,O
(,O
S,O
),O
ON,O
DISCHARGE,O
:,O

Multivitamins,B-TR
And,O
Folate,B-TR
(,I-TR
Fam,I-TR
Pren,I-TR
Forte,I-TR
),I-TR

Electronically,O
Signed,O
:,O

Pada,O
Post,O
",",O
MD,O

09/03/2004,O
9:51:35,O
PM,O

574700124,O
RWH,O

587585,O

896338,O

996098,O

11/26/2000,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O

CHAFFBITZ,O
",",O
TESSMONDMARV,O

MRN,O
:,O

587585,O

Age,O
:,O

26y,O

REGISTRATION,O
DATE,O
:,O

11/26/2000,O
06:47,O
PM,O

PRELIMINARY,O
REPORT,O

This,O
is,O
to,O
notify,O
you,O
that,O
your,O
patient,O
",",O
CHAFFBITZ,O
",",O
TESSMONDMARV,O
arrived,O
in,O
the,O
Emergency,O
Department,O
at,O
Ro,O
Woodma,O
Healthcare,O
on,O
11/26/2000,O
06:47,O
PM,O
.,O

The,O
patient,O
presented,O
with,O
a,O
chief,O
complaint,O
of,O
ABD,B-PR
PAIN,I-PR
.,O

Following,O
evaluation,B-TE
and,O
treatment,B-TR
",",O
the,O
patient,O
&apos;s,O
disposition,O
at,O
the,O
end,O
of,O
the,O
visit,O
was,O
TREATED,O
AND,O
RELEASED,O
.,O

If,O
you,O
need,O
additional,O
information,O
please,O
call,O
662-747-1199,O
.,O

596437842,O

CTMC,O

63056604,O

547591,O

02/08/1991,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

02/08/1991,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

02/18/1991,O

DISCHARGE,O
DIAGNOSES,O
:,O

1),O
ACQUIRED,B-PR
IMMUNODEFICIENCY,I-PR
SYNDROME,I-PR
.,O

2),O
PNEUMOCYSTIS,B-PR
CARINII,I-PR
PNEUMONIA,I-PR
.,O

3),O
ADULT,B-PR
RESPIRATORY,I-PR
DISTRESS,I-PR
SYNDROME,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Mr.,O
Breutzfarstxei,O
is,O
a,O
30,O
year,O
old,O
man,O
with,O
recently,O
diagnosed,O
acquired,B-PR
immunodeficiency,I-PR
syndrome,I-PR
and,O
Pneumocystis,B-PR
carinii,I-PR
pneumonia,I-PR
who,O
presented,O
with,O
pneumonia,B-PR
",",O
developed,O
adult,B-PR
respiratory,I-PR
distress,I-PR
syndrome,I-PR
",",O
and,O
died,O
in,O
the,O
hospital,O
after,O
failed,O
efforts,O
of,O
ventilatory,B-TR
support,I-TR
.,O

Mr.,O
Breutzfarstxei,O
was,O
recently,O
diagnosed,O
with,O
acquired,B-PR
immunodeficiency,I-PR
syndrome,I-PR
when,O
he,O
had,O
Pneumocystis,B-PR
carinii,I-PR
pneumonia,I-PR
on,O
01/17/91,O
.,O

He,O
was,O
admitted,O
to,O
the,O
Retelk,O
County,O
Medical,O
Center,O
at,O
that,O
time,O
and,O
was,O
treated,O
with,O
Bactrim,B-TR
and,O
steroids,B-TR
.,O

He,O
was,O
actually,O
intubated,O
and,O
underwent,O
bronchoscopy,B-TR
where,O
the,O
diagnosis,O
was,O
made,O
with,O
a,B-PR
positive,I-PR
toluidine,I-PR
blue,I-PR
study,I-PR
.,O

He,O
initially,O
did,O
well,O
after,O
extubation,B-TR
and,O
completed,O
approximately,O
two,O
weeks,O
of,O
Bactrim,B-TR
and,O
a,B-TR
steroid,I-TR
taper,I-TR
.,O

At,O
discharge,O
after,O
about,O
two,O
weeks,O
post-extubation,O
",",O
he,O
had,O
an,O
O2,B-TE
saturation,I-TE
of,O
approximately,O
95%,O
on,O
room,O
air,O
.,O

He,O
was,O
seen,O
by,O
Dr.,O
Seen,O
and,O
Dr.,O
Seen,O
as,O
an,O
out-patient,O
.,O

On,O
02/06/91,O
",",O
he,O
was,O
seen,O
in,O
FLFDMC,O
and,O
at,O
that,O
point,O
",",O
his,B-TE
temperature,I-TE
was,O
noted,O
to,O
be,O
101.4,O
and,O
he,O
had,O
malaise,B-PR
and,O
diarrhea,B-PR
.,O

He,O
was,O
evaluated,O
in,O
the,O
Emergency,O
Room,O
.,O

At,O
that,O
time,O
",",O
his,B-TE
oxygen,I-TE
saturation,I-TE
was,O
only,O
90%,O
on,O
room,O
air,O
and,O
his,B-TE
chest,I-TE
X-Ray,I-TE
showed,O
no,O
change,O
.,O

Cultures,B-TE
were,O
taken,O
and,O
he,O
was,O
sent,O
out,O
.,O

On,O
02/08/91,O
",",O
the,O
patient,O
called,O
Dr.,O
Seen,O
because,O
of,O
increased,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
and,O
malaise,B-PR
.,O

He,O
was,O
seen,O
in,O
FLFDMC,O
where,O
he,O
was,O
noted,O
to,O
have,O
jaundice,B-PR
and,O
newly,B-PR
palpable,I-PR
liver,I-PR
edge,I-PR
.,O

Review,O
of,O
liver,B-TE
function,I-TE
tests,I-TE
revealed,O
a,B-PR
cholestatic,I-PR
picture,I-PR
which,O
was,O
not,O
previously,O
found,O
and,O
it,O
was,O
felt,O
that,O
this,O
was,O
secondary,O
to,O
the,B-TR
Bactrim,I-TR
which,O
had,O
been,O
recently,O
stopped,O
anyway,O
.,O

His,B-TE
oxygen,I-TE
saturation,I-TE
at,O
that,O
time,O
was,O
only,O
86%,O
on,O
room,O
air,O
and,O
he,O
was,O
admitted,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1),O
HIV,B-PR
positive,I-PR
with,O
a,B-TE
CD4,I-TE
count,I-TE
of,O
74,O
.,O

2),O
Recent,B-PR
PCP,I-PR
.,O

3),O
Status,O
post,O
right,B-TR
elbow,I-TR
surgery,I-TR
.,O

4),O
Venereal,B-PR
disease,I-PR
history,I-PR
.,O

5),O
PPD,B-PR
anergic,I-PR
.,O

The,O
patient,O
&apos;s,O
HIV,O
risk,O
factors,O
include,O
history,O
of,O
intravenous,O
drug,O
abuse,O
",",O
prostitution,O
",",O
and,O
a,O
former,O
prisoner,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
presentation,O
",",O
the,O
patient,O
was,O
a,O
young,O
appearing,O
Hispanic,O
male,O
in,O
mild,B-PR
respiratory,I-PR
distress,I-PR
with,O
a,B-TE
blood,I-TE
pressure,I-TE
of,O
140/90,O
",",O
heart,B-TE
rate,I-TE
120,O
",",O
respirations,B-TE
32,O
",",O
and,O
temperature,B-TE
101,O
.,O

SKIN,O
:,O

Jaundiced,O
.,O

HEENT,O
:,O

Revealed,O
icteric,B-PR
sclerae,I-PR
",",O
the,B-PR
oropharynx,I-PR
with,I-PR
extensive,I-PR
thrush,I-PR
",",O
and,O
an,B-PR
ulcer,I-PR
under,I-PR
his,I-PR
tongue,I-PR
.,O

NECK,O
:,O

He,O
had,O
no,O
cervical,B-PR
adenopathy,I-PR
and,O
his,O
neck,O
was,O
supple,O
.,O

LUNGS,O
:,O

Had,O
tubular,B-PR
breath,I-PR
sounds,I-PR
especially,O
in,O
the,O
lower,O
lung,O
fields,O
.,O

CARDIAC,O
:,O

Showed,O
regular,O
rate,O
and,O
rhythm,O
without,O
murmurs,B-PR
",",O
rubs,B-PR
",",O
or,O
gallops,B-PR
.,O

There,O
was,O
no,O
costovertebral,B-PR
angle,I-PR
tenderness,I-PR
.,O

ABDOMEN,O
:,O

Soft,O
with,O
bowel,O
sounds,O
and,O
there,O
was,O
mid,B-PR
epigastric,I-PR
and,I-PR
right,I-PR
upper,I-PR
quadrant,I-PR
tenderness,I-PR
.,O

His,O
liver,O
was,O
10,O
cm,O
and,O
was,O
felt,O
three,O
finger,O
breadths,O
below,O
the,O
costal,O
margin,O
.,O

His,O
spleen,O
was,O
not,O
palpable,O
.,O

RECTAL,O
:,O

He,O
had,O
guaiac,B-PR
positive,I-PR
stools,I-PR
.,O

EXTREMITIES,O
:,O

Unremarkable,O
.,O

GENITOURINARY,O
:,O

His,O
penis,O
had,O
a,O
1/2,B-PR
cm,I-PR
ulcer,I-PR
with,O
yellowish,B-PR
discharge,I-PR
.,O

NEUROLOGICAL,O
:,O

Non-focal,O
.,O

LABORATORY,O
EXAMINATION,O
:,O

On,O
admission,O
",",O
white,B-TE
count,I-TE
was,O
7.2,O
with,O
57%,O
neutrophils,B-TE
",",O
40%,O
lymphocytes,B-TE
",",O
l,O
mononuclear,B-TE
cell,I-TE
",",O
and,O
1.6,O
eosinophils,B-TE
.,O

PT,B-TE
was,O
12.6,O
and,O
PTT,B-TE
was,O
29,O
.,O

Sodium,B-TE
was,O
133,O
",",O
potassium,B-TE
was,O
4.2,O
",",O
chloride,B-TE
100,O
",",O
CO2,B-TE
19,O
",",O
BUN,B-TE
21,O
",",O
creatinine,B-TE
1.2,O
",",O
and,O
glucose,B-TE
122,O
.,O

ALT,B-TE
was,O
181,O
",",O
AST,B-TE
was,O
156,O
",",O
LDH,B-TE
was,O
336,O
",",O
alkaline,B-TE
phosphatase,I-TE
was,O
214,O
",",O
and,O
bilirubin,B-TE
was,O
12.7,O
total,O
.,O

(,O
On,O
02/06,O
",",O
his,B-TE
bilirubin,I-TE
had,O
been,O
7.2,O
with,O
6,O
direct,O
),O
.,O

His,B-TE
arterial,I-TE
blood,I-TE
gas,I-TE
on,O
50%,O
was,O
pO2,B-TE
92,O
",",O
pCO2,B-TE
24,O
",",O
and,O
pH,B-TE
7.46,O
.,O

His,B-TE
chest,I-TE
X-Ray,I-TE
showed,O
bilateral,B-PR
nodular,I-PR
infiltrates,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
for,O
work-up,B-TE
of,O
his,B-PR
cholestatic,I-PR
jaundice,I-PR
picture,I-PR
along,O
with,O
work-up,B-TE
for,O
his,B-PR
pulmonary,I-PR
process,I-PR
and,O
treatment,B-TR
of,O
both,O
.,O

In,O
terms,O
of,O
pulmonary,O
function,O
",",O
it,O
was,O
felt,O
that,O
one,O
possibility,O
was,O
that,O
the,O
patient,O
was,O
a,B-PR
Bactrim,I-PR
failure,I-PR
for,O
PCP,B-PR
although,O
this,O
was,O
unusual,O
.,O

He,O
was,O
started,O
on,O
Pentamidine,B-TR
",",O
especially,O
in,O
light,O
of,O
the,O
fact,O
that,O
it,O
was,O
felt,O
that,O
his,B-TE
liver,I-TE
function,I-TE
tests,I-TE
were,O
due,O
possibly,O
to,O
Bactrim,B-TR
.,O

The,O
patient,O
was,O
also,O
covered,O
with,O
Erythromycin,B-TR
and,O
Gentamicin,B-TR
for,O
coverage,O
of,O
community,B-PR
acquired,I-PR
pneumonias,I-PR
and,O
gram,B-PR
negative,I-PR
rods,I-PR
.,O

He,O
was,O
given,O
supplemental,B-TR
oxygen,I-TR
.,O

In,O
terms,O
of,O
his,B-PR
liver,I-PR
abnormalities,I-PR
",",O
it,O
was,O
felt,O
that,O
viral,B-PR
hepatitis,I-PR
was,O
in,O
the,O
differential,O
as,O
well,O
as,O
several,B-PR
opportunistic,I-PR
infections,I-PR
of,I-PR
the,I-PR
liver,I-PR
but,O
also,O
was,O
felt,O
that,O
Bactrim,B-TR
could,O
be,O
a,O
cause,O
of,O
these,B-PR
abnormalities,I-PR
.,O

Titers,B-TE
for,O
CMV,B-PR
and,O
Epstein-Barr,B-PR
virus,I-PR
were,O
sent,O
and,O
a,B-TE
titer,I-TE
for,O
toxoplasma,B-PR
was,O
sent,O
.,O

Stool,B-TE
was,O
sent,O
for,O
ova,B-PR
and,O
parasites,B-PR
.,O

Gastrointestinal,O
was,O
consulted,O
.,O

Initially,O
",",O
the,O
patient,O
did,O
well,O
in,O
terms,O
of,O
his,O
pre-status,O
and,O
required,O
less,O
oxygen,B-TR
.,O

However,O
",",O
on,O
02/10/91,O
",",O
his,B-TE
respiratory,I-TE
rate,I-TE
increased,O
and,O
his,B-TE
oxygen,I-TE
saturation,I-TE
decreased,O
.,O

Actually,O
in,O
reviewing,O
the,O
records,O
at,O
this,O
point,O
",",O
it,O
appears,O
that,O
Pentamidine,B-TR
was,O
not,O
started,O
initially,O
so,O
on,O
the,B-TR
antibiotics,I-TR
of,O
Erythromycin,B-TR
and,O
Gentamicin,B-TR
",",O
the,O
patient,O
&apos;s,O
respiratory,O
status,O
worsened,O
and,O
his,B-TE
LDH,I-TE
climbed,O
so,O
he,O
began,O
Pentamidine,B-TR
on,O
02/10/91,O
.,O

On,O
02/11/91,O
",",O
the,O
patient,O
again,O
appeared,O
more,O
comfortable,O
this,O
time,O
with,O
50%,B-TR
facemask,I-TR
but,O
then,O
required,O
more,O
oxygen,B-TR
",",O
dropped,O
his,B-TE
O2,I-TE
saturations,I-TE
",",O
and,O
was,O
intubated,O
on,O
02/11/91,O
.,O

He,O
was,O
transferred,O
to,O
the,O
Intensive,O
Care,O
Unit,O
on,O
12/12/90,O
on,O
Gentamicin,B-TR
",",O
Vancomycin,B-TR
",",O
Pentamidine,B-TR
",",O
and,O
Prednisone,B-TR
.,O

Also,O
of,O
note,O
at,O
that,O
point,O
",",O
hepatitis,B-TE
C,I-TE
virus,I-TE
serologies,I-TE
had,O
come,O
back,O
positive,O
.,O

However,O
",",O
at,O
this,O
point,O
",",O
his,B-PR
liver,I-PR
function,I-PR
test,I-PR
abnormalities,I-PR
appeared,O
more,O
consistent,O
with,O
a,B-PR
cholestatic,I-PR
picture,I-PR
with,O
his,B-TE
direct,I-TE
bilirubin,I-TE
being,O
12.1,O
and,O
total,B-TE
being,O
14.1,O
.,O

The,B-TE
patient,I-TE
&apos;s,I-TE
abdominal,I-TE
CT,I-TE
scan,I-TE
showed,O
no,O
liver,B-PR
disease,I-PR
and,O
no,O
obstruction,B-PR
.,O

The,B-TE
patient,I-TE
&apos;s,I-TE
liver,I-TE
function,I-TE
tests,I-TE
appeared,O
to,O
improve,O
.,O

The,B-PR
patient,I-PR
&apos;s,I-PR
penile,I-PR
ulcer,I-PR
was,O
cultured,O
and,O
grew,O
positive,B-PR
herpes,I-PR
simplex,I-PR
virus,I-PR
and,O
the,O
patient,O
was,O
started,O
on,O
Acyclovir,B-TR
.,O

On,O
02/13/91,O
",",O
the,O
patient,O
had,O
a,B-TE
bronchoalveolar,I-TE
lavage,I-TE
performed,O
which,O
showed,O
a,B-PR
toluidine,I-PR
blue,I-PR
with,O
many,B-PR
pneumocysts,I-PR
noted,O
.,O

No,O
other,B-TE
cultures,I-TE
grew,O
out,O
and,O
the,O
patient,O
&apos;s,O
clinical,O
status,O
deteriorated,O
.,O

The,O
patient,O
required,O
100%,B-TR
oxygen,I-TR
to,O
maintain,O
adequate,O
oxygen,O
saturations,O
on,O
the,B-TR
ventilator,I-TR
.,O

He,O
required,O
elevated,B-TR
ventilatory,I-TR
pressures,I-TR
with,O
PIPS,B-TE
often,O
above,O
60,O
.,O

Fortunately,O
",",O
no,O
evidence,O
of,O
baratroma,B-PR
was,O
ever,O
discerned,O
.,O

However,O
",",O
the,O
patient,O
&apos;s,O
respiratory,O
status,O
continued,O
to,O
decline,O
and,O
we,O
were,O
unable,O
to,O
maintain,O
oxygen,B-TE
saturations,I-TE
above,O
80%,O
even,O
using,O
reverse,B-TR
I,I-TR
to,I-TR
E,I-TR
ventilation,I-TR
",",O
paralysis,B-TR
",",O
sedation,B-TR
",",O
and,O
other,B-TR
modes,I-TR
of,I-TR
ventilation,I-TR
.,O

Patient,O
underwent,O
liver,B-TE
biopsy,I-TE
on,O
02/16/91,O
and,O
the,O
results,O
of,O
this,O
were,O
pending,O
when,O
the,O
patient,O
died,O
.,O

The,O
patient,O
actually,O
developed,O
decreasing,B-PR
counts,I-PR
with,O
white,B-TE
count,I-TE
as,O
low,O
as,O
1.75,O
",",O
hematocrit,B-TE
as,O
low,O
as,O
26,O
",",O
and,O
platelets,B-TE
as,O
low,O
as,O
68,O
noted,O
on,O
02/15/91,O
.,O

These,O
were,O
supported,O
with,O
blood,B-TR
products,I-TR
and,O
Hematology,O
was,O
consulted,O
.,O

They,O
felt,O
that,O
it,O
was,O
most,O
likely,O
secondary,O
to,O
Bactrim,B-TR
and,O
these,O
actually,O
were,O
getting,O
better,O
when,O
the,O
patient,O
died,O
.,O

Bone,B-TE
marrow,I-TE
biopsy,I-TE
was,O
not,O
attempted,O
.,O

Discussions,O
were,O
begun,O
with,O
the,O
family,O
regarding,O
limits,O
of,O
supportive,B-TR
care,I-TR
.,O

Due,O
to,O
continued,B-PR
worsening,I-PR
pulmonary,I-PR
status,I-PR
and,O
an,O
overall,O
grim,O
prognosis,O
",",O
the,O
family,O
decided,O
",",O
in,O
consultation,O
with,O
the,O
Medical,O
Team,O
",",O
to,O
withdraw,O
ventilatory,B-TR
support,I-TR
.,O

This,O
was,O
done,O
on,O
the,O
evening,O
of,O
02/18/91,O
.,O

Patient,O
expired,O
after,O
the,B-TR
endotracheal,I-TR
tube,I-TR
was,O
withdrawn,O
at,O
6:40,O
p.m.,O

DISPOSITION,O
:,O

The,O
patient,O
died,O
in,O
hospital,O
.,O

An,B-TE
autopsy,I-TE
will,O
be,O
performed,O
.,O

An,B-TE
autopsy,I-TE
was,O
performed,O
as,O
per,O
the,O
family,O
&apos;s,O
wishes,O
.,O

WE221/9850,O
TAKO,O
C.,O
INSKE,O
",",O
M.D.,O
",",O
PH.,O
JT2,O
FF2,O

D,O
:,O

02/18/91,O

Batch,O
:,O

8600,O

Report,O
:,O

V7238B57,O

T,O
:,O

02/20/91,O

Dicatated,O
By,O
:,O

LATO,O
L.,O
TIKFREIERM,O
",",O
M.D.,O

cc,O
:,O

1.,O
LERMA,O
N.,O
WYNBRANTESXELL,O
",",O
M.D.,O

2.,O
ANA,O
V.,O
A,O
",",O
M.D.,O

3.,O
DALLI,O
A.,O
SEEN,O
",",O
M.D,O

4.,O
ARC,O
N.,O
SEEN,O
",",O
M.D.,O

598403789,O
DH,O

8993683,O

816711,O

963035,O

02/25/2001,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O

GLYN,O
",",O
AEA,O

MRN,O
:,O

8993683,O

Age,O
:,O

67y,O

REGISTRATION,O
DATE,O
:,O

02/25/2001,O
12:20,O
PM,O

PRELIMINARY,O
REPORT,O

This,O
is,O
to,O
notify,O
you,O
that,O
your,O
patient,O
",",O
GLYN,O
",",O
AEA,O
arrived,O
in,O
the,O
Emergency,O
Department,O
at,O
Daughtersvillshamen&apos;s,O
Hospital,O
on,O
02/25/2001,O
12:20,O
PM,O
.,O

The,O
patient,O
presented,O
with,O
a,O
chief,O
complaint,O
of,O
HEMATURIA,B-PR
.,O

Following,O
evaluation,B-TE
and,O
treatment,B-TR
",",O
the,O
patient,O
&apos;s,O
disposition,O
at,O
the,O
end,O
of,O
the,O
visit,O
was,O
ADMITTED,O
AS,O
AN,O
INPATIENT,O
TO,O
DAUGHTERSVILLSHAMEN&apos;S,O
HOSPITAL,O
.,O

The,O
patient,O
&apos;s,O
preliminary,O
admitting,O
physician,O
is,O
LINKETHORE,O
",",O
HANSVERLLEN,O
G,O
and,O
the,O
preliminary,O
diagnosis,O
is,O
HEMATURIA,B-PR
.,O

Please,O
note,O
this,O
information,O
may,O
have,O
been,O
updated,O
on,O
the,O
inpatient,O
unit,O
.,O

If,O
you,O
need,O
additional,O
information,O
please,O
call,O
613-870-0699,O
.,O

PCP,O
Name,O
:,O

SWANKEMANDESSKIAIS,O
",",O
SANTCINET,O
E,O

Provider,O
Number,O
:,O

42283,O

614746156,O

CTMC,O

48720920,O

513332,O

7/3/1999,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

07/03/1999,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

EHC9,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
71-year-old,O
police,O
chief,O
who,O
presents,O
with,O
painless,B-PR
jaundice,I-PR
x1,O
day,O
.,O

The,O
patient,O
was,O
generally,O
in,O
excellent,O
health,O
with,O
a,O
past,O
medical,O
history,O
significant,O
only,O
for,O
noninsulin,B-PR
dependent,I-PR
diabetes,I-PR
mellitus,I-PR
who,O
was,O
presented,O
with,O
painless,B-PR
jaundice,I-PR
x2,O
days,O
.,O

He,O
also,O
noted,O
a,B-PR
23,I-PR
pound,I-PR
weight,I-PR
loss,I-PR
in,O
the,O
past,O
11,O
months,O
despite,O
having,O
an,B-PR
increased,I-PR
appetite,I-PR
.,O

The,O
patient,O
also,O
complained,O
of,O
fatigue,B-PR
and,O
&quot;,B-PR
feeling,I-PR
down,I-PR
&quot;,I-PR
.,O

His,O
wife,O
noted,O
personality,B-PR
changes,I-PR
with,O
increased,B-PR
irritability,I-PR
.,O

Patient,O
denies,O
night,B-PR
sweats,I-PR
in,O
the,O
past,O
month,O
.,O

The,O
patient,O
denies,O
melena,B-PR
",",O
hematochezia,B-PR
",",O
nausea,B-PR
",",O
and,O
abdominal,B-PR
pain,I-PR
.,O

The,O
patient,O
states,O
that,O
he,O
is,O
occasionally,B-PR
constipated,I-PR
.,O

Also,O
denies,O
tenesmus,B-PR
.,O

On,O
the,O
day,O
prior,O
to,O
admission,O
",",O
the,O
patient,O
&apos;s,O
family,O
noted,O
that,O
&quot;,O
he,O
looked,O
yellow,B-PR
&quot;,O
and,O
presented,O
to,O
the,O
Lorough,O
Medical,O
Center,O
&apos;s,O
Emergency,O
Department,O
this,O
after,O
noon,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1.,O
Type,B-PR
II,I-PR
diabetes,I-PR
mellitus,I-PR
diagnosed,O
06/94,O
",",O
well-controlled,O
with,O
last,B-TE
hemoglobin,I-TE
A1C,I-TE
6.2,O

2.,O
Vocal,B-PR
cord,I-PR
polyps,I-PR

3.,O
Question,O
of,O
history,O
of,O
AVN,B-PR
or,O
osseous,B-PR
necrosis,I-PR

4.,O
History,O
of,O
hyperkalemia,B-PR
.,O

Question,O
RTA,B-PR
type,I-PR
4,I-PR

MEDICATIONS,O
:,O

Glucotrol,B-TR
10,O
q.a.m.,O
and,O
vitamins,B-TR

ALLERGIES,O
:,O

The,O
patient,O
is,O
allergic,B-PR
to,O
MSG,O
from,O
which,O
he,O
gets,O
hives,B-PR
.,O

SOCIAL,O
HISTORY,O
:,O

No,O
ethanol,O
use,O
",",O
remote,O
pipe,O
smoking,O
use,O
which,O
he,O
discontinued,O
20,O
years,O
ago,O
",",O
no,O
illicit,O
drug,O
use,O
.,O

FAMILY,O
HISTORY,O
:,O

Noncontributory,O
.,O

The,O
patient,O
&apos;s,O
father,O
died,O
at,O
the,O
age,O
of,O
83,O
of,O
CHF,B-PR
.,O

The,O
patient,O
&apos;s,O
mother,O
is,O
alive,O
at,O
the,O
age,O
of,O
114y,O
.,O

The,O
patient,O
has,O
six,O
children,O
and,O
10,O
grandchildren,O
",",O
all,O
in,O
excellent,O
health,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
presented,O
to,O
the,O
Emergency,O
Department,O
with,O
a,O
complaint,O
of,O
painless,B-PR
jaundice,I-PR
",",O
weight,B-PR
loss,I-PR
",",O
and,O
fatigue,B-PR
.,O

Abdominal,B-TE
CT,I-TE
while,O
in,O
the,O
Emergency,O
Department,O
revealed,O
likely,O
primary,B-PR
colorectal,I-PR
adenocarcinoma,I-PR
with,O
multiple,B-PR
liver,I-PR
metastases,I-PR
.,O

Hematocrit,B-TE
was,O
24,O
in,O
the,O
Emergency,O
Department,O
.,O

The,O
patient,O
received,O
two,O
units,O
of,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
and,O
the,B-TE
hematocrit,I-TE
rose,O
to,O
30,O
the,O
following,O
day,O
.,O

The,O
patient,O
was,O
seen,O
by,O
both,O
Gastroenterology,O
and,O
Oncology,O
.,O

Biopsy,B-TE
was,O
taken,O
at,O
colonoscopy,B-TE
on,O
7/5/99,O
.,O

Head,B-TE
CT,I-TE
was,O
done,O
with,O
final,O
results,O
pending,O
on,O
discharge,O
.,O

The,O
patient,O
was,O
to,O
follow-up,O
with,O
the,O
Petersly,O
Hospital,O
And,O
Medical,O
Center,O
as,O
an,O
outpatient,O
for,O
further,B-TR
treatment,I-TR
.,O

The,O
patient,O
is,O
discharged,O
to,O
home,O
.,O

His,O
condition,O
is,O
stable,O
and,O
he,O
was,O
discharged,O
with,O
the,B-TR
following,I-TR
medications,I-TR
:,O

Iron,B-TR
300,O
mg,O
p.o.,O
t.i.d.,O
",",O
Glucotrol,B-TR
",",O
Acel,B-TR
10,O
mg,O
p.o.,O
q.d.,O
",",O
and,O
Bactrim,B-TR
SS,I-TR
1,O
tablet,O
p.o.,O
b.i.d.,O

Dicatated,O
By,O
:,O

STEPH,O
ALEA,O
",",O
M.D.,O

Attending,O
:,O

BREANA,O
G.,O
CORNEA,O
",",O
M.D.,O
IS68,O
ON208/5303,O

Batch,O
:,O

31863,O

Index,O
No.,O
MIEQVK9Q4Z,O

D,O
:,O

07/05/99,O

T,O
:,O

07/05/99,O

CC,O
:,O

1.,O
BREANA,O
G.,O
CORNEA,O
",",O
M.D.*,O
CONFORD,O
GHACOLL,O
HEALTHCARE,O

622086964,O

BH,O

8245338,O

356492,O

05/16/2004,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Report,O
Status,O
:,O

Signed,O

DISCHARGE,O
SUMMARY,O
NAME,O
:,O

WIERSTUPH,O
",",O
NORNAME,O
H,O

UNIT,O
NUMBER,O
:,O

370-15-25,O

ADMISSION,O
DATE,O
:,O

05/16/2004,O

DISCHARGE,O
DATE,O
:,O

05/26/2004,O

PRIMARY,O
DIAGNOSIS,O
:,O

Ovarian,B-PR
cancer,I-PR
.,O

ASSOCIATED,O
DIAGNOSES,O
:,O

Hypertension,B-PR
",",O
asthma,B-PR
",",O
obesity,B-PR
",",O
history,O
of,O
heart,B-PR
murmur,I-PR
",",O
hemorrhoids,B-PR
",",O
whooping,B-PR
cough,I-PR
as,O
a,O
child,O
.,O

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

Total,B-TR
abdominal,I-TR
hysterectomy,I-TR
",",O
bilateral,B-TR
salpingooophorectomy,I-TR
",",O
bilateral,B-TR
lymph,I-TR
node,I-TR
dissection,I-TR
",",O
omentectomy,B-TR
",",O
lysis,B-TR
of,O
adhesions,B-PR
",",O
removal,B-TR
of,O
mass,B-PR
from,O
surface,O
of,O
transverse,O
colon,O
.,O

HISTORY,O
OF,O
THE,O
PRESENT,O
ILLNESS,O
AND,O
REASON,O
FOR,O
HOSPITALIZATION,O
:,O

64-year-old,O
G5P5,O
postmenopausal,O
for,O
10,O
years,O
with,O
a,O
history,O
of,O
two,O
months,O
of,O
progressive,B-PR
abdominal,I-PR
distention,I-PR
",",O
crampy,B-PR
abdominal,I-PR
pain,I-PR
",",O
urinary,B-PR
frequency,I-PR
and,O
diarrhea,B-PR
.,O

The,O
patient,O
has,O
not,O
obtained,O
gynecologic,B-TR
care,I-TR
for,O
32,O
years,O
until,O
April,O
2004,O
when,O
an,O
increase,O
in,O
abdominal,B-PR
GERD,I-PR
and,O
urinary,B-PR
symptoms,I-PR
lead,O
her,O
to,O
initial,O
consultation,O
with,O
Dr.,O
Lentny,O
Farstnappsshee,O
in,O
Gobrew,O
Street,O
",",O
Denlandcobridclevena,O
",",O
West,O
Virginia,O
28880,O
.,O

At,O
that,O
time,O
a,B-TE
pelvic,I-TE
ultrasound,I-TE
was,O
performed,O
showing,O
extensive,B-PR
fluid,I-PR
and,O
clear,B-PR
mass,I-PR
within,O
the,O
pelvi-abdominal,O
cavity,O
.,O

MRI,B-TE
showed,O
a,B-PR
large,I-PR
fluid,I-PR
filled,I-PR
abdomen,I-PR
with,O
a,B-PR
relatively,I-PR
small,I-PR
mass,I-PR
measuring,O
about,O
5,O
to,O
6,O
cm,O
in,O
the,O
right,O
pelvis,O
.,O

At,O
this,O
point,O
she,O
had,O
an,B-PR
elevated,I-PR
CA,I-PR
125,O
at,O
440,O
and,O
came,O
to,O
Dr.,O
Chabechird,O
for,O
further,O
consultation,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Hypertension,B-PR
",",O
asthma,B-PR
for,O
10,O
years,O
",",O
no,O
hospitalizations,B-TR
",",O
obesity,B-PR
",",O
history,O
of,O
heart,B-PR
murmur,I-PR
",",O
hemorrhoids,B-PR
and,O
whooping,B-PR
cough,I-PR
as,O
a,O
child,O
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

Tonsillectomy,B-TR
in,O
1947,O
",",O
removal,B-TR
of,O
a,B-PR
renal,I-PR
calculus,I-PR
in,O
1979,O
",",O
cholecystectomy,B-TR
in,O
1986,O
.,O

OB-GYN,O
HISTORY,O
:,O

G5,O
",",O
P5,O
normal,O
Pap,O
smears,O
",",O
sexual,O
active,O
without,O
dyspareunia,B-PR
.,O

No,O
regular,B-TE
breast,I-TE
self,I-TE
examination,I-TE
",",O
has,O
not,O
had,O
a,B-TE
mammogram,I-TE
.,O

MEDICATIONS,O
AT,O
HOME,O
:,O

Included,O
Prinzide,B-TR
12.5,O
mg,O
po,O
daily,O
",",O
albuterol,B-TR
inhaler,I-TR
prn,O

ALLERGIES,O
:,O

Demerol,B-TR
.,O

The,O
patient,O
developed,O
ulceration,B-PR
after,O
IM,B-TR
injection,I-TR
.,O

She,O
also,O
has,O
food,B-PR
allergies,I-PR
to,O
raw,O
vegetables,O
as,O
well,O
as,O
some,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
and,O
throat,B-PR
constriction,I-PR
with,O
shrimp,O
.,O

FAMILY,O
HISTORY,O
:,O

Remarkable,O
for,O
colon,B-PR
cancer,I-PR
in,O
her,O
mother,O
and,O
maternal,O
grandfather,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
on,O
05/16/2004,O
for,O
bowel,B-TR
preparation,I-TR
before,O
the,B-TR
surgery,I-TR
.,O

On,O
05/17/2004,O
the,O
patient,O
underwent,O
atotal,B-TR
abdominal,I-TR
hysterectomy,I-TR
",",O
bilateral,B-TR
salpingooophorectomy,I-TR
",",O
bilateral,B-TR
node,I-TR
dissection,I-TR
",",O
omentectomy,B-TR
",",O
lysis,B-TR
of,O
adhesions,B-PR
",",O
removal,B-TR
of,O
mass,B-PR
from,O
surface,O
of,O
transverse,O
colon,O
.,O

The,O
report,O
from,O
the,B-TE
frozen,I-TE
section,I-TE
sent,O
in,O
the,B-TR
surgery,I-TR
came,O
back,O
with,O
poorly,B-PR
differentiated,I-PR
adenocarcinoma,I-PR
",",O
possibly,O
serous,B-PR
carcinoma,I-PR
of,I-PR
the,I-PR
ovary,I-PR
.,O

In,O
the,O
postoperative,O
recovery,O
room,O
the,O
patient,O
had,O
a,B-TE
hematocrit,I-TE
of,O
29.2,O
with,O
low,B-PR
urine,I-PR
output,I-PR
.,O

She,O
was,O
given,O
1,O
unit,O
of,O
packed,B-TR
red,I-TR
blood,I-TR
cell,I-TR
.,O

Her,B-TE
urine,I-TE
output,I-TE
subsequently,O
increased,O
.,O

The,O
patient,O
was,O
transferred,O
to,O
the,O
floor,O
without,O
any,B-PR
complications,I-PR
.,O

She,O
had,O
an,O
uneventful,O
night,O
.,O

On,O
postoperative,O
day,O
one,O
",",O
the,B-TE
patient,I-TE
&apos;s,I-TE
urine,I-TE
culture,I-TE
came,O
back,O
with,O
moderate,B-PR
E.,I-PR
coli,I-PR
.,O

She,O
was,O
started,O
on,O
Levofloxacin,B-TR
500,O
mg,O
po,O
daily,O
.,O

The,O
patient,O
was,O
also,O
started,O
on,O
a,O
clear,O
diet,O
.,O

On,O
postoperative,O
day,O
two,O
",",O
her,B-TR
Foley,I-TR
was,O
discontinued,O
.,O

The,O
patient,O
was,O
out,O
of,O
bed,O
.,O

She,O
was,O
tolerating,O
liquids,O
.,O

On,O
postoperative,O
day,O
three,O
",",O
the,O
patient,O
had,O
a,B-TR
port,I-TR
placed,O
.,O

She,O
also,O
had,O
one,O
episode,O
of,O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

Achest,B-TE
x-ray,I-TE
done,O
at,O
that,O
time,O
showed,O
left,B-PR
pleural,I-PR
effusion,I-PR
and,O
small,B-PR
right,I-PR
pleural,I-PR
effusion,I-PR
",",O
not,O
pulmonary,B-PR
edema,I-PR
and,O
left,B-PR
lower,I-PR
lobe,I-PR
consolidations,I-PR
.,O

The,O
patient,O
was,O
afebrile,B-PR
",",O
her,B-TE
vital,I-TE
signs,I-TE
were,O
stable,O
and,O
she,O
maintained,O
a,O
good,O
urine,B-TE
output,I-TE
.,O

She,O
also,O
had,O
an,O
episode,O
of,O
nausea,B-PR
with,O
some,B-PR
emesis,I-PR
",",O
after,O
being,O
treated,O
with,O
Zofran,B-TR
with,O
no,B-PR
relief,I-PR
",",O
a,B-TR
nasogastric,I-TR
tube,I-TR
was,O
placed,O
which,O
drained,O
1200,O
cc,O
of,O
bilious,B-PR
fluid,I-PR
.,O

On,O
postoperative,O
day,O
four,O
",",O
the,O
patient,O
continued,O
to,O
have,O
nasogastric,B-TR
tube,I-TR
in,O
place,O
.,O

A,B-TE
repeat,I-TE
chest,I-TE
x-ray,I-TE
done,O
for,O
dyspnea,B-PR
showed,O
persistent,B-PR
pleural,I-PR
effusion,I-PR
with,O
atelectasis,B-PR
versus,O
pneumonia,B-PR
.,O

Her,B-TR
levofloxacin,I-TR
was,O
continued,O
.,O

The,O
patient,O
tolerated,O
nasogastric,B-TE
tube,I-TE
clamping,I-TE
trials,I-TE
with,O
high,B-PR
residuals,I-PR
in,O
the,O
600,O
cc,O
range,O
.,O

The,O
patient,O
did,O
well,O
on,O
postoperative,O
day,O
five,O
and,O
six,O
.,O

She,O
was,O
started,O
on,O
clear,O
fluids,O
with,O
a,B-TR
nasogastric,I-TR
clamped,O
.,O

On,O
postoperative,O
day,O
seven,O
the,O
patient,O
diet,O
was,O
slowly,O
advanced,O
as,O
tolerated,O
.,O

She,O
was,O
also,O
started,O
on,O
Decadron,B-TR
in,O
preparation,O
for,O
her,B-TR
chemotherapy,I-TR
.,O

On,O
postoperative,O
day,O
eight,O
which,O
is,O
Memorial,O
Day,O
the,O
patient,O
was,O
started,O
on,O
Carboplatin-Taxolchemo,B-TR
therapy,I-TR
",",O
which,O
she,O
tolerated,O
without,O
complication,B-PR
.,O

On,O
postoperative,O
nine,O
",",O
her,B-TR
JP,I-TR
drain,I-TR
was,O
discontinued,O
.,O

The,O
patient,O
was,O
discharged,O
home,O
that,O
afternoon,O
in,O
stable,O
condition,O
in,O
the,O
afternoon,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Dilaudid,B-TR
2,O
to,O
4,O
mg,O
po,O
q3h,O
prn,O
pain,B-PR
",",O
Ativan,B-TR
1,O
mg,O
po,O
q12h,O
prn,O
anxiety,B-PR
",",O
Zofran,B-TR
8,O
mg,O
po,O
q8h,O
prn,O
nausea,B-PR
",",O
Compazine,B-TR
10,O
mg,O
po,O
q6h,O
prn,O
nausea,B-PR
",",O
Decadron,B-TR
20,O
mg,O
po,O
q6h,O
x,O
2,O
doses,O
.,O

The,O
patient,O
was,O
instructed,O
to,O
take,O
20,O
mg,O
at,O
11,O
pm,O
the,O
night,O
before,O
her,B-TR
next,I-TR
chemotherapy,I-TR
and,O
8,O
am,O
on,O
the,O
morning,O
of,O
chemotherapy,B-TR
.,O

Colace,B-TR
100,O
mg,O
po,O
bid,O
",",O
Albuterol,B-TR
inhalers,I-TR
two,O
puffs,O
inhaled,O
qid,O
prn,O
wheezing,B-PR
and,O
asthma,B-PR
symptoms,I-PR
.,O

DISCHARGE,O
INSTRUCTIONS,O
:,O

The,O
patient,O
was,O
instructed,O
to,O
follow,O
up,O
with,O
Dr.,O
Slaineaee,O
Chabechird,O
.,O

She,O
was,O
told,O
to,O
make,O
an,O
appointment,O
two,O
weeks,O
after,O
her,B-TR
surgery,I-TR
for,O
removal,B-TR
of,O
her,B-TR
retention,I-TR
sutures,I-TR
.,O

The,O
patient,O
was,O
discharged,O
home,O
in,O
stable,O
condition,O
.,O

NAUNGDAPHBERE,O
T.,O
BUMPSFOOKS,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

Electronically,O
Signed,O

SLAINEAEE,O
S,O
CHABECHIRD,O
",",O
JR,O
",",O
M.D.,O

06/04/2004,O
15:45,O

_____________________________,O
SLAINEAEE,O
S,O
CHABECHIRD,O
",",O
JR,O
",",O
M.D.,O

TR,O
:,O

fk,O

DD,O
:,O

05/26/2004,O

TD,O
:,O

05/27/2004,O
4:01,O
A,O
356492,O

cc,O
:,O

SLAINEAEE,O
S,O
CHABECHIRD,O
",",O
JR,O
",",O
M.D.,O

627258104,O

GH,O

56900479,O

1/8/2001,O
12:00:00,O
AM,O

PANCREATIC,B-PR
CANCER,I-PR

Signed,O

DIS,O

Admission,O
Date,O
:,O

01/08/2001,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

01/30/2001,O

CHIEF,O
COMPLAINT,O
:,O

The,O
patient,O
was,O
transferred,O
from,O
an,O
outside,O
hospital,O
for,O
a,O
second,O
opinion,O
regarding,O
workup,B-TE
of,O
his,B-PR
pancreatic,I-PR
cancer,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
61,O
year,O
old,O
male,O
with,O
a,O
history,O
of,O
diabetes,B-PR
",",O
coronary,B-PR
artery,I-PR
disease,I-PR
",",O
hepatitis,B-PR
C,I-PR
",",O
and,O
asthma,B-PR
who,O
was,O
diagnosed,O
recently,O
with,O
pancreatic,B-PR
cancer,I-PR
after,O
he,O
presented,O
to,O
Seph&apos;sju,O
Memorial,O
after,O
a,O
motor,O
vehicle,O
accident,O
.,O

Chest,B-TE
CT,I-TE
revealed,O
a,B-PR
pulmonary,I-PR
nodule,I-PR
.,O

Abdominal,B-TE
CT,I-TE
revealed,O
a,B-PR
3.0,I-PR
to,I-PR
4.0,I-PR
centimeter,I-PR
lesion,I-PR
in,I-PR
the,I-PR
pancreatic,I-PR
head,I-PR
.,O

An,B-TE
ERCP,I-TE
performed,O
there,O
showed,O
a,B-PR
long,I-PR
segment,I-PR
of,I-PR
distal,I-PR
narrowing,I-PR
of,I-PR
the,I-PR
common,I-PR
bileduct,I-PR
and,O
a,B-TR
transhepatic,I-TR
biliary,I-TR
drain,I-TR
was,O
placed,O
there,O
on,O
December,O
29,O
.,O

On,O
January,O
1,O
",",O
a,B-TR
chest,I-TR
tube,I-TR
was,O
placed,O
for,O
a,B-PR
loculated,I-PR
pleural,I-PR
effusion,I-PR
.,O

On,O
January,O
2,O
",",O
pleurodesis,B-TR
was,O
performed,O
.,O

On,O
January,O
4,O
",",O
he,O
had,O
a,B-PR
desaturation,I-PR
.,O

VQ,B-TE
was,O
indeterminate,O
.,O

LENIs,B-TE
were,O
negative,O
at,O
that,O
time,O
.,O

On,O
January,O
5,O
",",O
he,O
had,O
a,B-TE
chest,I-TE
xray,I-TE
with,O
a,B-PR
left,I-PR
apicalpneumothorax,I-PR
but,O
was,O
stable,O
on,O
chest,B-TE
xray,I-TE
of,O
January,O
7,O
.,O

Brain,B-TE
CT,I-TE
was,O
negative,O
",",O
as,O
was,O
a,B-TE
bronchoscopy,I-TE
with,O
lavage,B-TR
.,O

His,B-TE
CA99,I-TE
was,O
normal,O
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

The,O
patient,O
had,O
reported,O
an,O
approximately,O
30,B-PR
pound,I-PR
weight,I-PR
loss,I-PR
in,I-PR
six,I-PR
weeks,I-PR
.,O

He,O
had,O
experienced,O
some,B-PR
constipation,I-PR
for,O
the,O
few,O
months,O
prior,O
with,O
lighter,B-PR
colored,I-PR
stools,I-PR
",",O
darkened,B-PR
urine,I-PR
and,O
fatigue,B-PR
for,O
months,O
with,O
increased,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
",",O
orthopnea,B-PR
and,O
dyspnea,B-PR
on,O
exertion,O
.,O

He,O
denied,O
any,O
fevers,B-PR
",",O
chills,B-PR
or,O
night,B-PR
sweats,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Significant,O
for,O
recently,B-PR
diagnosed,I-PR
pancreatic,I-PR
cancer,I-PR
.,O

Diabetes,B-PR
.,O

Hypertension,B-PR
.,O

Gout,B-PR
.,O

Hypercholesterolemia,B-PR
.,O

Coronary,B-PR
artery,I-PR
disease,I-PR
with,O
congestive,B-PR
heart,I-PR
failure,I-PR
.,O

Asthma,B-PR
.,O

Hepatitis,B-PR
C,I-PR
.,O

Psoriasis,B-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Lasix,B-TR
",",O
80,O
;,O
Avandia,B-TR
",",O
4,O
b.i.d.,O
;,O
Glipizide,B-TR
",",O
10,O
b.i.d.;,O
Imdur,B-TR
",",O
30,O
;,O
Allopurinol,B-TR
;,O
Zocor,B-TR
",",O
20,O
;,O
Prilosec,B-TR
",",O
20,O
",",O
potassium,B-TR
",",O
40,O
;,O
Oxycontin,B-TR
",",O
30,O
b.i.d.;,O
subcutaneous,B-TR
heparin,I-TR
;,O
Unasyn,B-TR
",",O
1.5,O
grams,O
q,O
6,O
;,O
Combivent,B-TR
and,O
morphine,B-TR
prn,O
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
is,O
a,O
hair,O
stylist,O
.,O

He,O
lives,O
by,O
himself,O
in,O
Tennessee,O
.,O

No,O
tobacco,O
.,O

Seldom,O
ETOH,O
.,O

No,O
drug,O
use,O
.,O

Heis,O
single,O
with,O
no,O
children,O
.,O

He,O
has,O
a,O
very,O
supportive,O
family,O
with,O
numerous,O
siblings,O
.,O

FAMILY,O
HISTORY,O
:,O

Mother,O
and,O
father,O
died,O
of,O
heart,B-PR
failure,I-PR
.,O

Theyalso,O
had,O
diabetes,B-PR
and,O
hypertension,B-PR
.,O

Sister,O
with,O
stomach,B-PR
cancer,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
ON,O
ADMISSION,O
:,O

The,O
patient,O
was,O
afebrile,B-PR
.,O

Heart,B-TE
rate,I-TE
was,O
78,O
",",O
blood,B-TE
pressure,I-TE
98/50,O
",",O
respiratory,B-TE
rate,I-TE
of,O
32,O
",",O
satting,B-TE
91%,O
on,O
four,B-TR
liters,I-TR
.,O

In,O
general,O
",",O
this,O
is,O
an,O
obese,O
male,O
in,O
mild,B-PR
respiratory,I-PR
distress,I-PR
.,O

Neck,O
was,O
supple,O
with,O
no,O
lymphadenopathy,B-PR
.,O

HEENT,O
-,O
normocephalic,O
/,O
atraumatic,B-PR
",",O
extraocular,O
movements,O
are,O
intact,O
",",O
pupils,O
equal,O
",",O
round,O
and,O
reactive,O
to,O
light,O
and,O
accommodation,O
.,O

Chest,O
had,O
diffuse,B-PR
crackles,I-PR
bilaterally,I-PR
halfway,O
up,O
.,O

Coronary,O
-,O
irregular,B-PR
PVCs,I-PR
",",O
S1,O
",",O
S2,O
normal,O
",",O
positive,B-PR
systolic,I-PR
murmur,I-PR
at,I-PR
the,I-PR
left,I-PR
upper,I-PR
sternal,I-PR
border,I-PR
radiating,O
throughout,O
.,O

Abdomen,O
was,O
distended,B-PR
",",O
tympanitic,B-PR
",",O
mildly,B-PR
tender,I-PR
epigastrium,I-PR
and,I-PR
right,I-PR
lower,I-PR
quadrant,I-PR
.,O

No,O
rebound,B-PR
or,O
guarding,B-PR
.,O

Extremities,O
had,O
2+,B-PR
bilateral,I-PR
lower,I-PR
extremity,I-PR
edema,I-PR
to,I-PR
knees,I-PR
.,O

No,O
clubbing,B-PR
or,O
cyanosis,B-PR
.,O

Neurologic,B-TE
examination,I-TE
-,O
alert,O
and,O
oriented,O
x,O
3,O
",",O
slurred,B-PR
and,I-PR
slow,I-PR
speech,I-PR
",",O
distractable,B-PR
.,O

Cranial,O
nerves,O
II,O
through,O
XII,O
are,O
intact,O
.,O

Sensory,O
is,O
intact,O
to,O
soft,O
touch,O
throughout,O
.,O

Strength,O
is,O
5/5,O
throughout,O
.,O

LABORATORY,O
DATA,O
:,O

White,B-TE
blood,I-TE
count,I-TE
4.36,O
",",O
hematocrit,B-TE
26.1,O
with,O
platelets,B-TE
of,O
"107,000",O
",",O
MCV,B-TE
81,O
.,O

Sodium,B-TE
137,O
",",O
potassium,B-TE
4.5,O
",",O
chloride97,B-TE
",",O
bicarb,B-TE
24,O
",",O
BUN,B-TE
124,O
",",O
creatinine,B-TE
4.1,O
",",O
glucose,B-TE
144,O
",",O
AST,B-TE
49,O
",",O
ALT33,B-TE
",",O
alkaline,B-TE
phosphatase,I-TE
253,O
",",O
total,B-TE
bili,I-TE
1.6,O
",",O
calcium,B-TE
9.2,O
",",O
magnesium,B-TE
2.3,O
",",O
albumin,B-TE
3.4,O
.,O

HOSPITAL,O
COURSE,O
:,O

1.,O
Gastrointestinal,O
.,O

The,O
patient,O
had,O
an,B-PR
elevated,I-PR
bilirubin,I-PR
on,O
admission,O
with,O
decreased,B-PR
output,I-PR
of,O
biliary,B-TR
drain,I-TR
.,O

The,B-TR
drain,I-TR
was,O
replaced,O
over,O
the,O
wire,O
",",O
8-10,O
by,O
IR,O
",",O
when,O
it,O
was,O
accidentally,O
removed,O
.,O

Increased,O
flow,O
again,O
.,O

The,O
patient,O
had,O
signs,B-PR
and,O
symptoms,B-PR
develop,O
of,O
SBP,B-PR
",",O
also,O
with,O
an,B-PR
elevated,I-PR
white,I-PR
count,I-PR
.,O

He,O
was,O
treated,O
broadly,O
with,O
amp,B-TR
",",O
levo,B-TR
and,O
Flagyl,B-TR
.,O

Cultures,B-TE
were,O
negative,O
and,O
onlyon,O
one,B-TE
gram,I-TE
stain,I-TE
did,O
it,O
show,O
rare,B-PR
gram,I-PR
negative,I-PR
rods,I-PR
.,O

The,B-TE
patient,I-TE
&apos;s,I-TE
abdominal,I-TE
fluid,I-TE
cell,I-TE
counts,I-TE
showed,O
2400,O
white,B-TE
blood,I-TE
cells,I-TE
",",O
500,O
red,B-TE
cells,I-TE
with,O
82,O
polyps,B-TE
",",O
11,O
lymphs,B-TE
",",O
7,O
monos,B-TE
.,O

Clinically,O
",",O
this,O
was,O
consistent,O
with,O
SBP,B-PR
",",O
although,O
unfortunately,O
",",O
fluid,O
was,O
never,O
sent,O
for,O
cytology,B-TE
and,O
a,O
lot,O
of,O
those,B-PR
white,I-PR
cells,I-PR
are,O
most,O
likely,O
due,O
to,O
his,B-PR
cancer,I-PR
.,O

He,B-TR
underwent,I-TR
abdominal,I-TR
paracentesis,I-TR
approximately,O
two,O
times,O
a,O
week,O
for,O
therapeutic,O
.,O

This,O
had,O
to,O
be,O
performed,O
by,O
IR,O
because,O
the,B-PR
pocket,I-PR
was,O
too,O
deep,O
to,O
access,O
from,O
the,O
bedside,O
.,O

He,O
received,O
a,O
two,O
week,O
course,O
of,O
broad,B-TR
spectrum,I-TR
antibiotics,I-TR
and,O
will,O
be,O
maintained,O
on,O
Levofloxacin,B-TR
IV,I-TR
for,O
prophylaxis,B-TR
against,O
SBP,B-PR
.,O

2.,O
Pulmonary,O
.,O

From,O
a,O
pulmonary,O
standpoint,O
",",O
he,O
continued,O
to,O
complain,O
of,O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

His,B-PR
apical,I-PR
pneumothorax,I-PR
from,O
the,O
outside,O
hospital,O
had,O
resolved,O
.,O

Chest,B-TE
xray,I-TE
was,O
consistent,O
with,O
pleurodesis,B-PR
.,O

However,O
",",O
with,O
persistent,B-PR
abdomen,I-PR
distention,I-PR
",",O
there,O
is,O
likely,O
restrictive,B-PR
deficit,I-PR
and,O
",",O
in,O
addition,O
",",O
after,O
each,O
tap,B-TE
",",O
he,O
at,O
times,O
became,O
hypotensive,B-PR
and,O
with,O
some,B-TR
mild,I-TR
fluid,I-TR
resuscitation,I-TR
decompensated,O
with,O
pulmonary,B-PR
edema,I-PR
",",O
requiring,O
both,O
albumin,B-TR
and,O
Lasix,B-TR
to,O
try,O
to,O
mobilize,O
third,B-PR
space,I-PR
fluids,I-PR
.,O

On,O
the,O
day,O
of,O
discharge,O
",",O
he,O
is,O
stating,O
approximately,O
91,O
to,O
92%,O
on,O
three,O
to,O
four,O
liters,O
.,O

Chest,B-TE
xray,I-TE
is,O
still,O
consistent,O
with,O
volume,B-PR
overload,I-PR
.,O

The,O
plan,O
will,O
be,O
to,O
continue,O
to,O
try,O
to,O
alternate,O
albumin,B-TR
and,O
Lasix,B-TR
to,O
mobilize,O
his,B-PR
fluid,I-PR
.,O

3.,O
Cardiovascular,O
.,O

He,O
had,O
episodes,O
of,O
bradycardia,B-PR
without,O
subsequent,B-PR
fall,I-PR
in,I-PR
blood,I-PR
pressure,I-PR
at,O
the,O
beginning,O
of,O
his,O
admission,O
.,O

He,O
was,O
ruled,O
out,O
for,O
a,B-PR
myocardial,I-PR
infarction,I-PR
.,O

Echocardiogram,B-TE
showed,O
50%,O
ejection,O
fraction,O
with,O
mild,B-PR
mitral,I-PR
regurgitation,I-PR
.,O

He,O
did,O
not,O
show,O
any,O
episodes,O
of,O
bradycardia,B-PR
throughout,O
the,O
remainder,O
of,O
his,B-TR
hospital,I-TR
course,I-TR
.,O

4.,O
Endocrine,O
.,O

Diabetes,B-PR
.,O

His,B-TR
Avandia,I-TR
was,O
discontinued,O
secondary,O
to,O
the,B-PR
side,I-PR
effect,I-PR
profile,I-PR
.,O

He,O
is,O
being,O
maintained,O
on,O
glipizide,B-TR
and,O
sliding,B-TR
scale,I-TR
insulin,I-TR
.,O

5.,O
Heme,O
.,O

From,O
a,O
heme,O
standpoint,O
",",O
he,O
presented,O
anemic,B-PR
and,O
with,O
an,B-PR
elevated,I-PR
PT,I-PR
INR,I-PR
.,O

He,O
required,O
a,B-TR
few,I-TR
transfusions,I-TR
during,O
his,B-TR
hospital,I-TR
course,I-TR
.,O

He,O
also,O
required,O
FFP,B-TR
initially,O
to,O
reverse,O
his,B-PR
coagulopathy,I-PR
.,O

However,O
",",O
this,O
resolved,O
on,O
its,O
own,O
over,O
the,B-TR
hospital,I-TR
course,I-TR
.,O

His,B-TE
INR,I-TE
normalized,O
",",O
however,O
",",O
unfortunately,O
",",O
he,O
developed,O
bilateral,B-PR
deep,I-PR
venous,I-PR
thromboses,I-PR
during,O
his,B-TR
hospital,I-TR
course,I-TR
and,O
will,O
be,O
maintained,O
on,O
Lovenox,B-TR
.,O

6.,O
Renal,O
.,O

He,O
had,O
a,B-TE
creatinine,I-TE
of,O
4.0,O
on,O
admission,O
and,O
this,O
decreased,O
down,O
to,O
the,O
mid,O
ones,O
with,O
fluid,B-TR
",",O
currently,O
at,O
1.7,O
on,O
discharge,O
.,O

From,O
his,B-TE
urinalysis,I-TE
",",O
he,O
has,O
mostly,O
a,B-PR
prerenal,I-PR
state,I-PR
.,O

However,O
",",O
he,O
does,O
require,O
diuresis,B-TR
to,O
prevent,O
increased,B-PR
volume,I-PR
overload,I-PR
in,O
his,O
lungs,O
from,O
his,B-PR
hypoalbunemic,I-PR
state,I-PR
.,O

At,O
the,O
time,O
",",O
Nutrition,O
was,O
following,O
",",O
initially,O
with,O
a,O
low,O
fat,O
",",O
low,O
cholesterol,O
",",O
low,O
sugar,O
diet,O
.,O

His,O
appetite,O
is,O
decreasing,O
somewhat,O
as,O
his,B-PR
disease,I-PR
process,I-PR
progresses,O
",",O
therefore,O
",",O
we,O
have,O
liberalized,O
his,O
diet,O
for,O
him,O
to,O
take,O
what,O
he,O
wishes,O
.,O

7.,O
ID,O
.,O

Please,O
see,O
GI,O
.,O

He,O
was,O
treated,O
with,O
broad,B-TR
spectrum,I-TR
antibiotics,I-TR
for,O
a,O
14,O
day,O
course,O
for,O
clinical,B-PR
SBP,I-PR
.,O

He,O
will,O
be,O
maintained,O
on,O
Levofloxacin,B-TR
for,O
prophylaxis,B-TR
against,O
SBP,B-PR
.,O

Given,O
that,O
he,O
will,O
need,O
continued,B-TE
"taps,",I-TE

8.,O
Oncology,O
.,O

The,O
patient,O
initially,O
came,O
for,O
workup,B-TE
of,O
pancreatic,B-PR
cancer,I-PR
with,O
a,O
questions,O
of,O
palliative,B-TR
chemotherapy,I-TR
.,O

However,O
",",O
given,O
his,B-PR
rapid,I-PR
clinical,I-PR
decline,I-PR
",",O
this,O
was,O
deferred,O
and,O
I,O
do,O
not,O
suspect,O
that,O
he,O
will,O
be,O
a,O
candidate,O
for,O
this,O
",",O
as,O
the,O
degree,O
of,O
his,B-PR
decline,I-PR
bodes,O
a,O
poor,O
prognosis,O
for,O
him,O
.,O

His,B-PR
pain,I-PR
here,O
has,O
been,O
controlled,O
",",O
initially,O
on,O
Oxycontin,B-TR
with,O
morphine,B-TR
for,O
breakthrough,B-PR
pain,I-PR
.,O

As,O
he,O
becomes,O
progressively,B-PR
more,I-PR
somnolent,I-PR
",",O
this,O
will,O
likely,O
need,O
to,O
be,O
switched,O
to,O
IV,B-TR
pain,I-TR
medications,I-TR
only,O
.,O

Discussion,O
",",O
at,O
that,O
point,O
in,O
time,O
",",O
should,O
occur,O
with,O
the,O
family,O
about,O
comfort,B-TR
measures,I-TR
and,O
about,O
weaning,O
him,O
from,O
his,B-TR
medications,I-TR
to,O
make,O
him,O
more,O
comfortable,O
.,O

Code,O
status,O
-,O
the,O
patient,O
is,O
a,O
DNR,O
/,O
DNI,O
.,O

This,O
is,O
an,O
unfortunate,O
case,O
but,O
Mr.,O
Po,O
does,O
have,O
an,O
incredibly,O
supportive,O
family,O
who,O
have,O
been,O
here,O
consistently,O
to,O
visit,O
him,O
and,O
that,O
offers,O
him,O
an,O
important,O
source,O
of,O
comfort,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Tylenol,B-TR
",",O
650,O
mg,O
p.o.,O
q,O
4,O
prn,O
;,O
Allopurinol,B-TR
",",O
100,O
mg,O
p.o.,O
q.d.,O
;,O
Peridex,B-TR
mouthwash,I-TR
",",O
10,O
ml,O
b.i.d.;,O
cholysteramineresin,B-TR
",",O
4,O
grams,O
p.o.,O
q.d.,O
;,O
clotrimazole,B-TR
",",O
one,O
troche,O
p.o.,O
q.i.d.,O
;,O
Fentanyl,B-TR
patch,I-TR
",",O
100,O
mcg,O
per,O
hour,O
topical,O
q,O
72,O
hours,O
;,O
glipizide,B-TR
",",O
10,O
mg,O
p.o.,O
q.d.;,O
Atarax,B-TR
",",O
25,O
operating,O
table,O
50,O
mg,O
p.o.,O
q,O
6,O
to,O
8,O
hours,O
prn,O
itching,B-PR
;,O
regular,B-TR
sliding,I-TR
scale,I-TR
insulin,I-TR
;,O
KBL,B-TR
mouthwash,I-TR
",",O
15,O
ccp,O
.o.,O
q.d.,O
prn,O
mouth,B-PR
discomfort,I-PR
;,O
Lactulose,B-TR
",",O
30,O
ml,O
p.o.,O
q.i.d.,O
that,O
was,O
started,O
on,O
January,O
30,O
",",O
for,O

The,O
patient,O
gets,O
very,B-PR
somnolent,I-PR
with,O
Ativan,B-TR
.,O

Maalox,B-TR
Plus,I-TR
",",I-TR
Extra,I-TR
Strength,I-TR
",",O
15,O
cc,O
p.o.,O
q,O
6,O
hours,O
prn,O
indigestion,B-PR
;,O
magnesium,B-TR
sulfate,I-TR
;,O
sliding,O
scale,O
IV,O
and,O
potassium,B-TR
chloride,I-TR
",",O
sliding,O
scale,O
IV,O
.,O

He,O
is,O
also,O
on,O
Reglan,B-TR
",",O
10,O
mg,O
p.o.,O
q,O
h,O
;,O
Miracle,B-TR
topical,I-TR
cream,I-TR
to,O
affected,B-PR
area,I-PR
;,O
also,O
Sarna,B-TR
",",I-TR
topical,I-TR
cream,I-TR
",",O
b.i.d.,O

He,O
has,O
Nystatin,B-TR
suspension,I-TR
mouthwash,I-TR
",",O
10,O
cc,O
swish,O
and,O
swallow,O
q.i.d.,O
He,O
gets,O
Serax,B-TR
",",O
15,O
to,O
30,O
mg,O
p.o.,O
q,O
h.s.,O
prni,O
nsomnia,B-PR
.,O

Ocean,B-TR
Spray,I-TR
q.i.d.,O
to,O
nares,O
prn,O
nasal,B-PR
dryness,I-PR
.,O

Multivitamin,B-TR
",",O
one,O
tab,O
q.d.,O
Morphine,B-TR
immediate,I-TR
release,I-TR
",",O
MSIR,B-TR
",",O
15,O
to,O
30,O
mg,O
p.o.,O
q,O
2,O
to,O
3,O
hours,O
prn,O
pain,B-PR
.,O

He,O
is,O
also,O
on,O
a,B-TR
Fentanyl,I-TR
patch,I-TR
",",O
100,O
mcg,O
q,O
72,O
hours,O
.,O

The,B-TR
morphine,I-TR
is,O
for,O
breakthrough,B-PR
pain,I-PR
.,O

Hydrocortisone,B-TR
",",O
1%,O
topical,O
cream,O
q,O
6,O
to,O
8,O
hours,O
prn,O
itching,B-PR
.,O

Levofloxacin,B-TR
",",O
250,O
mg,O
p.o.,O
q.d.,O
;,O
Albuterol,B-TR
and,I-TR
Atrovent,I-TR
nebs,I-TR
q,O
4,O
to6,O
hours,O
as,O
needed,O
prn,O
wheeze,B-PR
.,O

PLAN,O
FOR,O
FOLLOWUP,O
:,O

Follow,O
up,O
will,O
be,O
with,O
Dr.,O
A,O
Flow,O
from,O
Stromware,O
St.,O
",",O
Balt,O
who,O
is,O
the,O
patient,O
&apos;s,O
primary,O
oncologist,O
there,O
.,O

Dictated,O
By,O
:,O

JIMCHARL,O
B.,O
VERGEFLOW,O
",",O
M.D.,O
XX14,O

Attending,O
:,O

LUPEVICKETTE,O
FLOW,O
",",O
M.D.,O
YA80,O
QO567/192247,O

Batch,O
:,O

8798,O

Index,O
No.,O

QFQYRB7,O
AGG,O

D,O
:,O

01/30/01,O

T,O
:,O

01/30/01,O

638157550,O
SC,O

97308722,O

6261929,O

1/22/2005,O
12:00:00,O
AM,O

gastritis,B-PR

DIS,O

Admission,O
Date,O
:,O

01/22/2005,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

01/24/2005,O

******,O
DISCHARGE,O
ORDERS,O
******,O

AKOTE,O
",",O
NAO,O
630-65-64-5,O
Q39,O

Room,O
:,O

70B-157,O

Service,O
:,O

GGI,O

DISCHARGE,O
PATIENT,O
ON,O
:,O

01/24/05,O
AT,O
07:00,O
PM,O

CONTINGENT,O
UPON,O

Not,O
Applicable,O

WILL,O
D,O
/,O
C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D,O
/,O
C,O
SUMMARY,O
:,O

YES,O

Attending,O
:,O

GAETZFREIERM,O
",",O
DENA,O
DA,O
",",O
M.D.,O

CODE,O
STATUS,O
:,O

Full,O
code,O

DISPOSITION,O
:,O

Home,O

DISCHARGE,O
MEDICATIONS,O
:,O

AMOXICILLIN,B-TR
"1,000",O
MG,O
PO,O
BID,O
X,O
28,O
doses,O

Instructions,O
:,O

for,O
H.Pylori,B-PR
.,O

Food,O
/,O
Drug,O
Interaction,O
Instruction,O

May,O
be,O
taken,O
without,O
regard,O
to,O
meals,O

CLARITHROMYCIN,B-TR
500,O
MG,O
PO,O
BID,O
X,O
28,O
doses,O

Instructions,O
:,O

h.pylori,B-TR
tx,I-TR
.,O

Food,O
/,O
Drug,O
Interaction,O
Instruction,O

Take,O
with,O
food,O

Alert,O
overridden,O
:,O

Override,O
added,O
on,O
01/23/05,O
by,O
DAINSAYLESNOORT,O
",",O
AGER,O
",",O
M.D.,O
",",O
PH.D.,O

SERIOUS,O
INTERACTION,O
:,O

SIMVASTATIN,B-TR
and,O
CLARITHROMYCIN,B-TR

POTENTIALLY,O
SERIOUS,O
INTERACTION,O
:,O

SIMVASTATIN,B-TR
and,O
CLARITHROMYCIN,B-TR

Reason,O
for,O
override,O
:,O

will,O
monitor,O
.,O

HYDROCHLOROTHIAZIDE,B-TR
25,O
MG,O
PO,O
QD,O
ZOCOR,B-TR
(,I-TR
SIMVASTATIN,I-TR
),I-TR
40,O
MG,O
PO,O
QHS,O

Food,O
/,O
Drug,O
Interaction,O
Instruction,O

Avoid,O
grapefruit,O
unless,O
MD,O
instructs,O
otherwise,O
.,O

Override,O
Notice,O
:,O

Override,O
added,O
on,O
01/23/05,O
by,O
DAINSAYLESNOORT,O
",",O
AGER,O
",",O
M.D.,O
",",O
PH.D.,O
on,O
order,O
for,O
CLARITHROMYCIN,B-TR
PO,I-TR
(,O
ref,O
#,O
99052380,O
),O

SERIOUS,O
INTERACTION,O
:,O

SIMVASTATIN,B-TR
and,O
CLARITHROMYCIN,B-TR

POTENTIALLY,O
SERIOUS,O
INTERACTION,O
:,O

SIMVASTATIN,B-TR
and,O
CLARITHROMYCIN,B-TR

Reason,O
for,O
override,O
:,O

will,O
monitor,O
.,O

POTASSIUM,B-TR
CHLORIDE,I-TR
SLOW,I-TR
REL.,I-TR
(,I-TR
KCL,I-TR
SLOW,I-TR
RELEASE,I-TR
),I-TR
40,O
MEQ,O
PO,O
QD,O
As,O
per,O
SC,O

Potassium,O
Chloride,O
Policy,O
:,O

each,O
20,O
mEq,O
dose,O
to,O
be,O
given,O
with,O
4,O
oz,O
of,O
fluid,O
COZAAR,B-TR
(,I-TR
LOSARTAN,I-TR
),I-TR
50,O
MG,O
PO,O
QD,O

Number,O
of,O
Doses,O
Required,O
(,O
approximate,O
),O
:,O

2,O

LAMICTAL,B-TR
(,I-TR
LAMOTRIGINE,I-TR
),I-TR
150,O
MG,O
PO,O
BID,O

Number,O
of,O
Doses,O
Required,O
(,O
approximate,O
),O
:,O

5,O

WELLBUTRIN,B-TR
SR,I-TR
(,I-TR
BUPROPION,I-TR
HCL,I-TR
SUSTAINED,I-TR
RELEASE,I-TR
),I-TR
200,O
MG,O
PO,O
BID,O

Number,O
of,O
Doses,O
Required,O
(,O
approximate,O
),O
:,O

4,O

ESOMEPRAZOLE,B-TR
20,O
MG,O
PO,O
BID,O
X,O
28,O
doses,O

Instructions,O
:,O

H.,B-TR
Pylori,I-TR
tx,I-TR
.,O

DIET,O
:,O

No,O
Restrictions,O

ACTIVITY,O
:,O

Resume,O
regular,O
exercise,O

FOLLOW,O
UP,O
APPOINTMENT,O
(,O
S,O
),O
:,O

Dr.,O
Gaetzfreierm,O
1-2,O
weeks,O
",",O

ALLERGY,O
:,O

PERCOCET,B-TR
",",O
IV,B-TR
Contrast,I-TR
",",O
LISINOPRIL,B-TR
",",O
ATENOLOL,B-TR

ADMIT,O
DIAGNOSIS,O
:,O

Gastritis,B-PR

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O
Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O
gastritis,B-PR

OTHER,O
DIAGNOSIS,O
;,O
Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O
Obesity,B-PR
HTN,B-PR
High,B-PR
Cholesterol,I-PR
Tobacco,O
Fhx,O
of,O
CAD,B-PR
ETT,B-TR
12/94,O
(,O
-,O
),O
ischemia,B-PR
ECHO,B-TE
02/89,O
nl,B-TE
ETT,I-TE
03/89,O
",",O
07/90,O
c,O
/,O
w,O
ND,B-PR
ische,I-PR

Takes,O
hubby,O
&apos;s,O
sl,B-TR
ntg,I-TR
Barium,B-TE
Swallow,I-TE
04/89,O
(,O
-,O
),O
UGI,B-TE
06/91,O
(,O
-,O
),O

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O

MRI,B-TE
HIDA,B-TE
CT,B-TE

BRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

The,O
pt,O
is,O
a,O
55yo,O
F,O
s,O
/,O
p,O
Roux,B-TR
en,I-TR
Y,I-TR
GBP,I-TR
in,O
12/20,O
presenting,O
to,O
the,O
ED,O
this,O
AM,O
c,O
/,O
o,O
mod,B-PR
severe,I-PR
midepigastric,I-PR
pain,I-PR
.,O

She,O
notes,O
that,O
she,O
has,O
had,O
this,B-PR
pain,I-PR
since,O
Thursday,O
",",O
and,O
that,O
it,O
becomes,O
much,O
worse,O
within,O
15,O
min,O
of,O
consuming,O
a,O
meal,O
.,O

She,O
has,O
also,O
had,O
intermittent,B-PR
post-prandial,I-PR
nausea,I-PR
/,I-PR
satiety,I-PR
for,O
which,O
she,O
had,O
been,O
scheduled,O
for,O
an,B-TE
outpt,I-TE
EGD,I-TE
with,O
GI,B-TE
on,O
2/8,O
.,O

She,O
describes,O
the,B-PR
pain,I-PR
as,O
band-like,O
/,O
radiating,O
to,O
both,O
sides,O
but,O
not,O
the,O
back,O
.,O

Her,B-PR
pain,I-PR
currently,O
is,O
5/10,O
.,O

ROS,O
(,O
-,O
),O
emesis,B-PR
/,O
BRBPR/melena,B-PR
/,O
fever/chills,B-PR
/,O
sob,B-PR
.,O

Pt,O
was,O
seen,O
by,O
GI,O
on,O
13,O
EGD,B-TE
was,O
performed,O
HD2,O
which,O
was,O
negative,O
for,O
gastritis,B-PR
",",O
stricture,B-PR
or,O
ulcer,B-PR
.,O

Pt,O
was,O
found,O
to,O
be,O
H.,B-PR
Pylori,I-PR
positive,I-PR
and,O
therefore,O
was,O
started,O
on,O
empiric,B-TR
treatment,I-TR
.,O

Afferent,O
limb,O
of,O
the,O
roux,B-TR
en,I-TR
y,I-TR
anastamosis,I-TR
was,O
visualized,O
however,O
the,O
efferent,O
limb,O
could,O
not,O
be,O
explored,O
.,O

Pt,O
had,O
HIDA,B-TE
scan,I-TE
which,O
was,O
negative,O
for,O
obstruction,B-PR
",",O
and,O
CT,B-TE
was,O
unremarkable,O
.,O

Pt,O
was,O
tolerating,O
regular,O
diet,O
by,O
HD4,O
",",O
and,O
GI,O
felt,O
that,O
further,B-TE
workup,I-TE
could,O
be,O
continued,O
as,O
an,O
outpatient,O
.,O

Pt,O
was,O
therefore,O
discharged,O
home,O
in,O
stable,O
condition,O
",",O
voiding,O
",",O
ambulating,O
and,O
eating,O
without,O
difficulty,O
.,O

Plans,O
to,O
follow,O
up,O
with,O
outpatient,B-TE
MRA,I-TE
to,O
rule,O
out,O
ischemic,O
causes,O
of,O
post,B-PR
prandial,I-PR
pain,I-PR
",",O
as,O
well,O
as,O
HIDA,B-TE
with,I-TE
CK,I-TE
challenge,I-TE
to,O
evaluate,O
for,O
biliary,B-PR
dyskinesia,I-PR
without,O
stasis,O
.,O

Pt,O
will,O
finish,O
course,O
of,O
H.,B-TR
pylori,I-TR
treatment,I-TR
as,O
well,O
.,O

ADDITIONAL,O
COMMENTS,O
:,O

If,O
fevers,B-PR
",",O
chills,B-PR
",",O
nausea,B-PR
",",O
vomiting,B-PR
",",O
diarrhea,B-PR
",",O
increasing,B-PR
pain,I-PR
with,I-PR
food,I-PR
please,O
call,O
Dr.,O
Gaetzfreierm,O
&apos;s,O
office,O
or,O
PCP,O
.,O

If,O
severe,O
",",O
then,O
proceed,O
to,O
ER,O
for,O
evaluation,B-TE
.,O

Will,O
need,O
to,O
call,O
for,O
outpatient,O
MRA,B-TE
and,O
HIDA,B-TE
with,I-TE
CCK,I-TE
challenge,I-TE
to,O
evaluate,O
biliary,O
system,O
and,O
mesenteric,O
vasculature,O
.,O

Please,O
continue,O
taking,O
the,B-TR
antibiotics,I-TR
for,O
H.,B-PR
Pylori,I-PR
for,O
full,O
course,O
(,O
26,O
more,O
days,O
),O
.,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O

TO,O
DO,O
/,O
PLAN,O
:,O

No,O
dictated,O
summary,O

ENTERED,O
BY,O
:,O

DOUETSHUFF,O
",",O
DE,O
CLEEE,O
",",O
M.D.,O
(,O
CP85,O
),O
01/24/05,O
06:53,O
PM,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

641557794,O
WGH,O

1460214,O

715884,O

957382,O

5/29/2000,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Report,O
Status,O
:,O

Signed,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

FREIERMPRATL,O
",",O
NI,O
L,O

UNIT,O
NUMBER,O
:,O

794-23-29,O

ADMISSION,O
DATE,O
:,O

05/29/2000,O

DISCHARGE,O
DATE,O
:,O

05/30/2000,O

PRINCIPAL,O
DIAGNOSIS,O
:,O
:,O

Non-toxic,B-PR
multinodular,I-PR
goiter,I-PR
.,O

ASSOCIATED,O
DIAGNOSES,O
;,O

Left,B-PR
thyroid,I-PR
occult,I-PR
papillary,I-PR
carcinoma,I-PR
.,O

Chronic,B-PR
lymphocytic,I-PR
thyroiditis,I-PR
",",O
status,O
post,O
right,B-TR
total,I-TR
and,I-TR
left,I-TR
subtotal,I-TR
oophorectomy,I-TR
",",O
asthma,B-PR
",",O
migraine,B-PR
",",O
history,O
of,O
Droperidol,B-PR
allergy,I-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O
:,O

5-29-00,O
:,O

Thyroidectomy,B-TR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
51,O
year-old,O
female,O
",",O
with,O
a,B-PR
non-toxic,I-PR
multinodular,I-PR
goiter,I-PR
.,O

She,O
has,O
developed,O
symptoms,B-PR
from,O
a,B-PR
right,I-PR
lower,I-PR
dominant,I-PR
nodule,I-PR
with,O
pressure,B-PR
discomfort,I-PR
in,I-PR
the,I-PR
neck,I-PR
.,O

She,O
has,O
no,O
dyspnea,B-PR
or,O
dysphagia,B-PR
.,O

She,O
is,O
euthyroid,O
.,O

There,O
is,O
no,O
family,O
history,O
of,O
thyroid,B-PR
cancer,I-PR
.,O

She,O
has,O
not,O
received,O
prior,B-TR
radiation,I-TR
exposure,I-TR
.,O

PHYSICAL,O
EXAMINATION,O
:,O
:,O

On,O
physical,B-TE
exam,I-TE
",",O
she,O
is,O
a,O
healthy-appearing,O
female,O
with,O
a,O
normal,O
voice,O
and,O
no,O
exophthalmos,B-PR
.,O

Vital,B-TE
Signs,I-TE
:,O

include,O
a,B-TE
blood,I-TE
pressure,I-TE
of,O
174/84,O
",",O
respirations,B-TE
14,O
",",O
pulse,B-TE
89,O
",",O
temperature,B-TE
98.9,O
",",O
O2,B-TE
sat,I-TE
98%,O
.,O

Pupils,O
equal,O
",",O
round,O
",",O
reactive,O
to,O
light,O
and,O
accommodation,O
",",O
and,O
extraocular,O
movements,O
intact,O
.,O
",",O
with,O
a,O
benign,O
oropharynx,O
.,O

Palpation,B-TE
of,O
the,O
neck,O
discloses,O
a,B-PR
multinodular,I-PR
goiter,I-PR
",",O
larger,O
on,O
the,O
right,O
side,O
",",O
with,O
no,O
associated,B-PR
cervical,I-PR
lymphadenopathy,I-PR
.,O

Carotid,O
pulsations,O
are,O
normal,O
without,O
bruit,B-PR
.,O

Lungs,O
:,O

clear,O
to,O
auscultation,B-TE
and,O
percussion,B-TE
.,O

Bilaterally,O
without,O
stridor,B-PR
.,O

Her,B-TE
heart,I-TE
rhythm,I-TE
is,O
regular,O
with,O
a,O
normal,O
S1-S2,O
",",O
and,O
no,O
murmur,B-PR
.,O

Abdomen,O
is,O
soft,O
",",O
non-tender,B-PR
",",O
with,O
no,O
organomegaly,B-PR
or,O
masses,B-PR
.,O

Her,B-TE
deep,I-TE
tendon,I-TE
reflexes,I-TE
are,O
symmetric,O
.,O

HOSPITAL,O
COURSE,O
:,O

On,O
5-29-00,O
",",O
she,O
underwent,O
thyroidectomy,B-TR
with,O
removal,B-TR
of,O
a,B-PR
3.3,I-PR
centimeter,I-PR
right,I-PR
lobe,I-PR
microfollicular,I-PR
adenoma,I-PR
and,O
left,O
lobe,O
6,O
mm,O
.,O

papillary,B-PR
carcinoma,I-PR
.,O

There,O
was,O
no,O
evidence,O
of,O
any,B-PR
middle,I-PR
compartment,I-PR
lymphadenopathy,I-PR
or,O
spread,O
of,O
the,B-PR
tumor,I-PR
outside,O
the,O
thyroid,O
.,O

She,O
had,O
an,O
uncomplicated,O
postoperative,O
recovery,O
period,O
.,O

Her,B-TR
sutures,I-TR
were,O
removed,O
on,O
postoperative,O
day,O
#,O
one,O
",",O
at,O
which,O
time,O
she,O
went,O
home,O
in,O
satisfactory,O
condition,O
.,O

DOCTOR,O
&apos;S,O
DISCHARGE,O
ORDERS,O
:,O

1.,O
Synthroid,B-TR
0.125,O
mg.,O
daily,O
.,O

2.,O
She,O
will,O
see,O
Dr.,O
Days,O
in,O
his,O
office,O
in,O
two,O
weeks,O
.,O

3.,O
She,O
will,O
remove,O
the,B-TR
neck,I-TR
suture,I-TR
lines,I-TR
Steri-Strips,I-TR
in,O
10,O
days,O
.,O

STELLRISH,O
L.,O
LIGHT,O
",",O
M.D.,O

Cc,O
:,O

Stellrish,O
L.,O
Days,O
",",O
M.D.,O
(,O
3,O
copies,O
),O

Electronically,O
Signed,O
STELLRISH,O
LOISRA,O
LIGHT,O
",",O
M.D.,O
09/06/2000,O
04:20,O

TR,O
:,O

jrn,O

DD,O
:,O

08/16/2000,O

TD,O
:,O

08/20/2000,O
9:25,O
A,O

cc,O
:,O

STELLRISH,O
LOISRA,O
LIGHT,O
",",O
M.D.,O

655358166,O
WGH,O

5367777,O

33714,O

8114836,O

10/12/2004,O
12:00:00,O
AM,O

OB,O
Discharge,O
Summary,O

Signed,O

DIS,O

Report,O
Status,O
:,O

Signed,O
OB,O
EMR,O
L,O
and,O
D,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

JUARISY,O
DUHESMITRE,O

UNIT,O
NUMBER,O
:,O

683-54-33,O

ADMISSION,O
DATE,O
:,O

20041012,O

DISCHARGE,O
DATE,O
:,O

20041015,O

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
:,O

Vaginal,B-TR
Delivery,I-TR
With,O
Second,B-PR
Degree,I-PR
Laceration,I-PR

ASSOCIATED,O
DIAGNOSES,O
:,O

Abnormal,B-PR
Pap,I-PR
Test,I-PR
",",O
history,O
of,O
;,O
Bacterial,B-PR
Vaginitis,I-PR
;,O
Contraception,B-TR
Management,I-TR
;,O
Hiv,O
Counseled,O

PRINCIPAL,O
PROCEDURE,O
OR,O
OPERATION,O
:,O

Spontaneous,B-TR
Vertex,I-TR
Vaginal,I-TR
Delivery,I-TR

ASSOCIATED,O
PROCEDURES,O
OR,O
OPERATIONS,O
:,O

POSTPARTUM,O
DIAGNOSTIC,O
PROCEDURES,O
:,O

None,O

OTHER,O
POSTPARTUM,O
THERAPIES,O
:,O

Antimicrobial,B-TR
Therapy,I-TR

HISTORY,O
AND,O
REASON,O
FOR,O
HOSPITALIZATION,O
:,O

Srom,B-PR
In,O
Labor,B-PR

PHYSICAL,O
EXAMINATION,O
:,O

MOUTH,O
NORMAL,O
NECK,O
NORMAL,O
thyroid,O
wnl,O
BREASTS,O
NORMAL,O
no,O
distinct,B-PR
masses,I-PR
NIPPLES,O
NORMAL,O
inverted,B-PR
[,O
b,O
],O
",",O
evert,B-TR
w,I-TR
/,I-TR
stimulation,I-TR
CHEST,O
NORMAL,O
LCTA,O
COR,O
NORMAL,O
RRR,O
ABDOMEN,O
NORMAL,O
gravid,O
EXTREM,O
NORMAL,O
SKIN,O
NORMAL,O
NODES,O
NORMAL,O
VULVA,O
NORMAL,O
no,O
lesions,B-PR
",",O
white,B-PR
d,I-PR
/,I-PR
c,I-PR
at,I-PR
introitus,I-PR
VAGINA,O
NORMAL,O
sml,B-PR
amt,I-PR
thin,I-PR
white,I-PR
d,I-PR
/,I-PR
c,I-PR
ph,B-TE
4.5,O
",",O
koh,B-TE
+amine,O
",",O
NS,B-TE
+clue,O
",",O
neg,O
trich,O
CERVIX,O
NORMAL,O
1/100/0,O
srom,B-PR
clear,O
OS,O
NORMAL,O
closed,O
ADNEXAE,O
NORMAL,O
no,O
palp,B-PR
masses,I-PR
",",O
NT,O
UTERUS,O
NORMAL,O
gravid,O
UTERINE,O
SIZE,O
IN,O
WEEKS,O
NORMAL,O
term,O
RECTUM,O
NORMAL,O
no,O
ext,B-PR
lesions,I-PR

HOSPITAL,O
COURSE,O
(,O
include,O
complications,O
if,O
any,O
),O
:,O

This,O
21,O
year,O
old,O
Gravida,O
2,O
Para,O
0010,O
was,O
admitted,O
to,O
the,O
Life,O
Valley,O
Medical,O
Center,O
Obstetrical,O
service,O
on,O
10/12/2004,O
at,O
08:41,O
am,O
for,O
the,O
indication,O
(,O
s,O
),O
:,O

srom,B-PR
in,O
labor,B-PR
.,O

She,O
delivered,O
a,O
3680,O
gram,O
male,O
infant,O
on,O
10/12/2004,O
at,O
10:17,O
pm,O
with,O
apgar,B-TE
scores,I-TE
of,O
9,O
and,O
9,O
at,O
one,O
and,O
five,O
minutes,O
respectively,O
at,O
40.0,O
weeks,O
gestation,O
via,O
spontaneous,B-TR
vertex,I-TR
vaginal,I-TR
delivery,I-TR
.,O

During,O
her,O
labor,O
she,O
encountered,O
the,O
following,O
complication,O
(,O
s,O
),O
:,O

srom,B-PR
.,O

During,O
her,O
delivery,O
she,O
encountered,O
the,O
following,O
complication,O
(,O
s,O
),O
:,O

none,O
.,O

Postpartum,O
she,O
encountered,O
the,O
following,O
complication,O
(,O
s,O
),O
:,O

none,O
.,O

She,O
was,O
discharged,O
on,O
10/15/2004,O
at,O
01:52,O
pm,O
in,O
good,O
condition,O
.,O

DISCHARGE,O
ACTIVITY,O
:,O

No,O
Restrictions,O

DISCHARGE,O
DIET,O
:,O

No,O
Restrictions,O

POSTPARTUM,O
DISPOSITION,O
:,O

Home,O
Under,O
Care,O
Of,O
Home,O
Health,O
Agency,O

POSTPARTUM,O
CARE,O
SITE,O
:,O

Alle,O
Rehabilitation,O
Hospital,O

POSTPARTUM,O
RETURN,O
APPOINTMENT,O
(,O
DAYS,O
),O
:,O

42,O

BREAST,O
FEEDING,O
AT,O
DISCHARGE,O
:,O

Yes,O

MEDICATION,O
(,O
S,O
),O
ON,O
DISCHARGE,O
:,O

Metronidazole,B-TR
Tablets,I-TR
(,I-TR
Flagyl,I-TR
),I-TR
;,O
Multivitamins,B-TR
And,I-TR
Folate,I-TR
Capsules,I-TR
(,I-TR
Stuart,I-TR
Prenatal,I-TR
With,I-TR
Folate,I-TR
),I-TR

Electronically,O
Signed,O
:,O

Thorerogodlethrelf,O
",",O
Cisperna,O
M,O
10/17/2004,O
6:01:02,O
PM,O

688127038,O
EH,O

47449520,O

204512,O

3/5/2002,O
12:00:00,O
AM,O

TCA,B-PR
overdose,I-PR

DIS,O

Admission,O
Date,O
:,O

03/05/2002,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

03/07/2002,O

******,O
DISCHARGE,O
ORDERS,O
******,O

HULLEKOTE,O
",",O
AU,O
329-72-53-3,O
Z23,O

Room,O
:,O

29Z-191,O

Service,O
:,O

MED,O

DISCHARGE,O
PATIENT,O
ON,O
:,O

03/07/02,O
AT,O
11:00,O
AM,O

CONTINGENT,O
UPON,O

Not,O
Applicable,O

WILL,O
D,O
/,O
C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D,O
/,O
C,O
SUMMARY,O
:,O

YES,O

Attending,O
:,O

UPHMADRE,O
",",O
CIOUSALE,O
N.,O
",",O
M.D.,O

CODE,O
STATUS,O
:,O

Full,O
code,O

DISPOSITION,O
:,O

Rehabilitation,B-TR

DISCHARGE,O
MEDICATIONS,O
:,O

FOLATE,B-TR
(,I-TR
FOLIC,I-TR
ACID,I-TR
),I-TR
1,O
MG,O
PO,O
QD,O
ZANTAC,B-TR
(,I-TR
RANITIDINE,I-TR
HCL,I-TR
),I-TR
150,O
MG,O
PO,O
BID,O
MVI,B-TR
THERAPEUTIC,I-TR
W,I-TR
/,I-TR
MINERALS,I-TR
(,I-TR
THERAP,I-TR
VITS,I-TR
/,I-TR
MINERALS,I-TR
),I-TR
1,O
TAB,O
PO,O
QD,O
THIAMINE,B-TR
HCL,I-TR
100,O
MG,O
PO,O
QD,O

DIET,O
:,O

No,O
Restrictions,O
Activity,O
-,O
As,O
tolerated,O

FOLLOW,O
UP,O
APPOINTMENT,O
(,O
S,O
),O
:,O

Dr.,O
Ee,O
",",O
patient,O
to,O
arrange,O
",",O
No,O
Known,B-PR
Allergies,I-PR

ADMIT,O
DIAGNOSIS,O
:,O

TCA,B-PR
overdose,I-PR

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O
Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O
TCA,B-PR
overdose,I-PR

OTHER,O
DIAGNOSIS,O
;,O
Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O
depression,B-PR
(,I-PR
depression,I-PR
),I-PR

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O

None,O

BRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

32,O
y,O
/,O
o,O
woman,O
with,O
h,O
/,O
o,O
anxiety,B-PR
and,O
depression,B-PR
and,O
prior,B-PR
suicide,I-PR
attempt,I-PR
presents,O
with,O
TCA,B-PR
and,I-PR
celexa,I-PR
overdose,I-PR
",",O
tremulous,B-PR
/,O
light-headed,B-PR
",",O
felt,O
better,O
post,O
charcoal,B-TR
.,O

No,O
EKG,O
changes,O
",",O
marijuana,B-TE
in,I-TE
urine,I-TE
",",O
HCO3,B-TE
22,O
.,O

Transferred,O
to,O
floor,O
on,O
day,O
of,O
admission,O
with,O
no,O
acute,B-PR
medical,I-PR
issues,I-PR
;,O
awaiting,O
psych,B-TE
eval,I-TE
.,O

Not,O
actively,B-PR
suicidal,I-PR
.,O

3/7,O
--,O
repeat,B-TE
HCO3,I-TE
24,O
and,O
26,O
without,O
bicarb,B-TR
drip,I-TR
.,O

EKG,B-TE
without,O
changes,O
.,O

Patient,O
felt,O
well,O
",",O
tolerating,O
POs,O
.,O

BEST,B-TE
team,I-TE
eval,I-TE
found,O
bed,O
at,O
psych,O
rehab,O
facility,O
.,O

OF,O
NOTE,O
",",O
Nortriptyline,B-TE
level,I-TE
came,O
back,O
as,O
43,O
(,O
SUBTHERAPEUTIC,O
--,O
NORMAL,O
50-150,O
),O
.,O

ADDITIONAL,O
COMMENTS,O
:,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O

TO,O
DO,O
/,O
PLAN,O
:,O

No,O
dictated,O
summary,O

ENTERED,O
BY,O
:,O

KOTEKEESECRANKBERF,O
",",O
LA,O
A.,O
",",O
M.D.,O
(,O
JG92,O
),O
03/07/02,O
10:56,O
AM,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

693008750,O

HLGMC,O

6001356,O

14235,O

9/18/2001,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O

HUHTLAND,O
",",O
CIE,O

MRN,O
:,O

6001356,O

Age,O
:,O

82y,O

REGISTRATION,O
DATE,O
:,O

09/18/2001,O
10:52,O
AM,O

PRELIMINARY,O
REPORT,O

This,O
is,O
to,O
notify,O
you,O
that,O
your,O
patient,O
",",O
HUHTLAND,O
",",O
CIE,O
arrived,O
in,O
the,O
Emergency,O
Department,O
at,O
Heaonboburg,O
Linpack,O
Grant,O
Medical,O
Center,O
on,O
09/18/2001,O
10:52,O
AM,O
.,O

The,O
patient,O
presented,O
with,O
a,O
chief,O
complaint,O
of,O
WHEEZES,B-PR
.,O

Following,O
evaluation,B-TE
and,O
treatment,B-TR
",",O
the,O
patient,O
&apos;s,O
disposition,O
at,O
the,O
end,O
of,O
the,O
visit,O
was,O
ADMITTED,O
AS,O
AN,O
INPATIENT,O
TO,O
HEAONBOBURG,O
LINPACK,O
GRANT,O
MEDICAL,O
CENTER,O
.,O

Your,O
patient,O
was,O
admitted,O
under,O
the,O
care,O
of,O
SAPSCLYSS,O
",",O
LEO,O
R,O
with,O
a,O
preliminary,O
diagnosis,O
of,O
PNEUMONIA,B-PR
",",O
.,O

If,O
you,O
need,O
additional,O
information,O
please,O
call,O
605-304-8547,O
.,O

PCP,O
Name,O
:,O

SC,O
",",O
JUSONKIM,O
N,O

Provider,O
Number,O
:,O

96078,O

699905656,O
SC,O

6100044,O

921737,O

1/17/1993,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

01/17/1993,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

01/21/1993,O

DISCHARGE,O
DIAGNOSIS,O
:,O

1.,O
RIGHT,B-TR
SIDED,I-TR
SCIATICA,I-TR
PROCEDURE,I-TR
:,O

Right,B-TR
laminectomy,I-TR
and,O
discectomy,B-TR
by,O
Dr.,O
Small,O
",",O
Neurosurgery,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
42,O
year,O
old,O
gentleman,O
who,O
suffered,O
lower,B-PR
back,I-PR
pain,I-PR
during,O
an,O
accident,O
at,O
work,O
in,O
1990,O
.,O

This,O
gradually,O
increased,O
until,O
June,O
1992,O
where,O
he,O
had,O
recurrent,B-PR
severe,I-PR
right,I-PR
sided,I-PR
sciatica,I-PR
.,O

In,O
September,O
1992,O
CT,B-TE
myelogram,I-TE
showed,O
a,B-PR
lateral,I-PR
L-1,I-PR
S-1,I-PR
disc,I-PR
bulge,I-PR
and,O
small,B-PR
L-4-4,I-PR
bulge,I-PR
.,O

He,O
has,O
had,O
no,O
change,O
in,O
pain,B-PR
in,O
the,O
last,O
few,O
months,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Negative,O
.,O

ALLERGIES,O
:,O

None,O
.,O

MEDICATIONS,O
:,O

None,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

He,O
was,O
found,O
to,O
be,O
healthy,O
.,O

His,B-TE
examination,I-TE
was,O
completely,O
unremarkable,O
.,O

He,O
had,O
5,O
out,O
of,O
5,O
strength,O
diffusely,O
",",O
normal,O
deep,O
tendon,O
reflexes,O
and,O
normal,O
sensation,O
.,O

HOSPITAL,O
COURSE,O
:,O

He,O
was,O
admitted,O
",",O
taken,O
to,O
the,O
operating,O
room,O
where,O
he,O
underwent,O
L5-S1,B-TR
right,I-TR
hemilaminectomy,I-TR
and,O
discectomy,B-TR
.,O

He,O
tolerated,O
the,O
procedure,O
well,O
",",O
was,O
taken,O
to,O
the,O
floor,O
in,O
stable,O
condition,O
.,O

Over,O
the,O
next,O
three,O
days,O
he,O
increased,O
his,O
activity,O
gradually,O
",",O
was,O
able,O
to,O
do,O
stairs,O
with,O
Physical,B-TR
Therapy,I-TR
and,O
had,O
pain,B-PR
which,O
could,O
be,O
controlled,O
with,O
oral,B-TR
analgesics,I-TR
.,O

DISPOSITION,O
:,O

MEDICATIONS,O
:,O

He,O
is,O
discharged,O
on,O
Percocet,B-TR
",",O
Colace,B-TR
and,O
Motrin,B-TR
.,O

Dictated,O
By,O
:,O

NASA,O
R.,O
SMALL,O
",",O
M.D.,O
IX97,O

Attending,O
:,O

VIENNIEZUTACHANT,O
WAVE,O
",",O
M.D.,O
NN08,O
QM838/6096,O

Batch,O
:,O

8704,O

Index,O
No.,O
AFUFB928WZ,O

D,O
:,O

01/20/93,O

T,O
:,O

01/22/93,O

708739405,O
DH,O

606127,O

65761,O

4209641,O

10/29/2003,O
12:00:00,O
AM,O

OB,O
Discharge,O
Summary,O

Signed,O

DIS,O

Report,O
Status,O
:,O

Signed,O
OB,O
EMR,O
L,O
and,O
D,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

SYSCO,O
TAMARCE,O
DOSE,O

UNIT,O
NUMBER,O
:,O

372-13-02,O

ADMISSION,O
DATE,O
:,O

20031029,O

DISCHARGE,O
DATE,O
:,O

20041101,O

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
:,O

Normal,B-TR
Vaginal,I-TR
Delivery,I-TR

ASSOCIATED,O
DIAGNOSES,O
:,O

Current,O
Smoker,O
",",O
history,O
of,O
;,O
Depression,B-PR
",",O
history,O
of,O
;,O
Isoimmunization,B-PR
",",I-PR
Rh,I-PR
;,O
Undesired,B-PR
Fertility,I-PR

PRINCIPAL,O
PROCEDURE,O
OR,O
OPERATION,O
:,O

Spontaneous,B-TR
Vertex,I-TR
Vaginal,I-TR
Delivery,I-TR

ASSOCIATED,O
PROCEDURES,O
OR,O
OPERATIONS,O
:,O

POSTPARTUM,O
DIAGNOSTIC,O
PROCEDURES,O
:,O

None,O

POSTPARTUM,O
THERAPEUTIC,O
PROCEDURES,O
:,O

None,O

OTHER,O
POSTPARTUM,O
THERAPIES,O
:,O

Pp,B-TR
Sterilization,I-TR

HISTORY,O
AND,O
REASON,O
FOR,O
HOSPITALIZATION,O
:,O

Early,B-PR
Labor,I-PR
/,O
Rule,O
Out,O
Labor,B-PR

PHYSICAL,O
EXAMINATION,O
:,O

HEIGHT,O
HOSPITAL,O
COURSE,O
(,O
include,O
complications,O
if,O
any,O
),O
:,O

This,O
22,O
year,O
old,O
Gravida,O
4,O
Para,O
2012,O
was,O
admitted,O
to,O
the,O
Naliheall,O
County,O
Memorial,O
Hospital,O
Obstetrical,O
service,O
on,O
10/29/2003,O
at,O
11:14,O
pm,O
for,O
the,O
indication,O
(,O
s,O
),O
:,O
early,B-PR
labor,I-PR
/,O
rule,O
out,O
labor,B-PR
.,O

She,O
delivered,O
a,O
3263,O
gram,O
female,O
infant,O
on,O
10/30/2003,O
at,O
05:03,O
am,O
with,O
apgar,B-TE
scores,I-TE
of,O
8,O
and,O
9,O
at,O
one,O
and,O
five,O
minutes,O
respectively,O
at,O
40.1,O
weeks,O
gestation,O
via,O
spontaneous,B-TR
vertex,I-TR
vaginal,I-TR
delivery,I-TR
.,O

During,O
her,O
labor,O
she,O
encountered,O
the,O
following,O
complication,O
(,O
s,O
),O
:,O

none,O
.,O

During,O
her,O
delivery,O
she,O
encountered,O
the,O
following,O
complication,O
(,O
s,O
),O
:,O

nuchal,B-PR
cord,I-PR
",",O
x,O
1-,O
reduced,O
prior,O
to,O
delivery,B-TR
.,O

Postpartum,O
she,O
encountered,O
the,O
following,O
complication,O
(,O
s,O
),O
:,O

none,O
.,O

She,O
was,O
discharged,O
on,O
11/01/2004,O
at,O
12:00,O
pm,O
in,O
good,O
condition,O
.,O

DISCHARGE,O
ORDERS,O
(,O
medications,B-TR
instructions,O
to,O
patient,O
",",O
follow-up,O
care,O
),O
:,O

DISCHARGE,O
ACTIVITY,O
:,O

No,O
Restrictions,O

DISCHARGE,O
DIET,O
:,O

No,O
Restrictions,O

POSTPARTUM,O
DISPOSITION,O
:,O

Home,O
With,O
Self-Care,B-TR
(,O
Routine,O
Discharge,O
),O

POSTPARTUM,O
CARE,O
SITE,O
:,O

Uval,O
General,O
Hospital,O

POSTPARTUM,O
RETURN,O
APPOINTMENT,O
(,O
DAYS,O
),O
:,O

42,O

BREAST,O
FEEDING,O
AT,O
DISCHARGE,O
:,O

No,O

POSTPARTUM,O
RH,O
IMMUNE,O
GLOBULIN,O
:,O

Given,O

POSTPARTUM,O
MEASLES,O
/,O
MUMPS/RUBELLA,O
VACCINE,O
:,O

Not,O
Indicated,O

MEDICATION,O
(,O
S,O
),O
ON,O
DISCHARGE,O
:,O

Multivitamins,B-TR
And,O
Folate,B-TR

Electronically,O
Signed,O
:,O

Ockgiernruss,O
",",O
Riret,O
R,O
12/18/2003,O
7:53:30,O
PM,O

723989226,O

OMH,O

6410178,O

996067,O

3/30/1999,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Report,O
Status,O
:,O

Signed,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

NETSHUFFSCARVTRACE,O
",",O
RIRA,O

UNIT,O
NUMBER,O
:,O

005-27-20,O

ADMISSION,O
DATE,O
:,O

03/30/1999,O

DISCHARGE,O
DATE,O
:,O

09/16/2006,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Severe,B-PR
chronic,I-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
.,O

Respiratory,B-PR
failure,I-PR
.,O

Congestive,B-PR
heart,I-PR
failure,I-PR
.,O

Right,B-PR
lower,I-PR
lobe,I-PR
pneumonia,I-PR
.,O

Atonic,B-PR
bladder,I-PR
with,O
suprapubic,B-TR
catheter,I-TR
.,O

Anxiety,B-PR
.,O

Coronary,B-PR
artery,I-PR
disease,I-PR
.,O

History,O
of,O
colon,B-PR
cancer,I-PR
status,O
post,O
hemicolectomy,B-TR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
76,O
year,O
old,O
white,O
male,O
with,O
severe,B-PR
chronic,I-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
who,O
has,O
had,O
several,O
recent,O
admissions,O
to,O
Oaksgekesser/,O
Memorial,O
Hospital,O
for,O
respiratory,B-PR
insuffiencey,I-PR
most,O
often,O
secondary,O
to,O
pneumonia,B-PR
.,O

He,O
was,O
most,O
recently,O
discharged,O
from,O
Oaksgekesser/,O
Memorial,O
Hospital,O
on,O
03/06/99,O
and,O
was,O
then,O
transferred,O
to,O
Linghs,O
County,O
Medical,O
Center,O
from,O
which,O
he,O
was,O
discharged,O
on,O
03/20/99,O
.,O

The,O
patient,O
was,O
doing,O
relatively,O
at,O
home,O
until,O
one,O
day,O
prior,O
to,O
admission,O
he,O
complained,O
discomfort,B-PR
over,O
a,B-TR
suprapubic,I-TR
catheter,I-TR
area,I-TR
.,O

The,O
patient,O
had,O
missed,O
his,O
usual,O
monthly,O
change,O
of,O
his,B-TR
suprapubic,I-TR
catheter,I-TR
and,O
felt,O
discomfort,B-PR
and,O
noticed,O
some,B-PR
blood,I-PR
at,I-PR
the,I-PR
site,I-PR
of,O
the,O
catheter,O
.,O

The,O
patient,O
was,O
brought,O
to,O
the,O
Emergency,O
Room,O
one,O
day,O
prior,O
to,O
admission,O
where,O
he,O
was,O
evaluated,O
by,O
Urology,O
and,O
had,O
his,B-TR
catheter,I-TR
changed,O
.,O

The,O
patient,O
at,O
that,O
time,O
noted,O
slight,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
but,O
was,O
sent,O
home,O
anyway,O
.,O

On,O
the,O
day,O
of,O
admission,O
the,O
patient,O
noticed,O
increasing,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
.,O

The,O
patient,O
was,O
noted,O
to,O
be,O
confused,B-PR
and,O
to,O
be,O
disoriented,B-PR
toward,O
the,O
end,O
of,O
the,O
day,O
after,O
complaining,O
of,O
shortness,B-PR
of,I-PR
breath,I-PR
for,O
most,O
of,O
the,O
day,O
.,O

The,O
patient,O
denies,O
any,O
recent,B-PR
upper,I-PR
respiratory,I-PR
infections,I-PR
",",O
no,O
fevers,B-PR
",",O
no,O
chills,B-PR
",",O
no,O
change,B-PR
in,I-PR
cough,I-PR
",",O
sputum,B-PR
.,O

He,O
also,O
denies,O
any,O
chest,B-PR
pain,I-PR
.,O

No,O
orthopnea,B-PR
.,O

No,O
paroxysmal,B-PR
nocturnal,I-PR
dyspnea,I-PR
.,O

The,O
patient,O
had,O
been,O
taking,O
his,B-TR
usual,I-TR
medications,I-TR
and,O
using,O
his,B-TR
nasal,I-TR
oxygen,I-TR
at,I-TR
home,I-TR
.,O

By,O
the,O
time,O
the,O
patient,O
arrived,O
at,O
the,O
Oaksgekesser/,O
Memorial,O
Hospital,O
Emergency,O
Room,O
he,O
was,O
in,O
moderate,B-PR
respiratory,I-PR
distress,I-PR
.,O

His,B-TE
initial,I-TE
blood,I-TE
gases,I-TE
on,O
40%,B-TR
02,I-TR
was,O
P02,B-TE
102,O
",",O
PC02,B-TE
115,O
",",O
PH,B-TE
7.11,O
.,O

The,O
patient,O
was,O
given,O
respiratory,B-TR
therapy,I-TR
in,O
the,O
way,O
of,O
nebulizer,B-TR
treatments,I-TR
in,O
the,O
Oaksgekesser/,O
Memorial,O
Hospital,O
Emergency,O
Room,O
because,O
of,O
a,O
longstanding,O
desire,O
by,O
patient,O
and,O
family,O
to,O
refrain,O
from,O
intubation,B-TR
to,O
be,O
considered,O
Do,O
Not,O
Resuscitate,O
.,O

The,O
patient,O
was,O
not,O
intubated,O
.,O

However,O
he,O
was,O
transferred,O
to,O
the,O
Medical,O
Intensive,O
Care,O
Unit,O
where,O
he,O
received,O
continuous,B-TR
respiratory,I-TR
therapy,I-TR
in,O
theway,O
of,O
Albuterol,B-TR
nebulizers,I-TR
as,O
well,O
as,O
nasal,B-TR
oxygen,I-TR
",",O
intravenous,B-TR
steroids,I-TR
and,O
intravenous,B-TR
antibiotics,I-TR
.,O

A,B-TE
chest,I-TE
x-ray,I-TE
in,O
the,O
Oaksgekesser/,O
Memorial,O
Hospital,O
Emergency,O
Room,O
showed,O
new,B-PR
changes,I-PR
on,O
his,B-TE
chest,I-TE
x-ray,I-TE
on,O
top,O
of,O
his,B-PR
usual,I-PR
severe,I-PR
bilateral,I-PR
emphysema_____,I-PR
with,O
scarring,B-PR
in,I-PR
both,I-PR
lungs,I-PR
.,O

There,O
were,O
new,B-PR
air,I-PR
space,I-PR
opacifications,I-PR
in,I-PR
the,I-PR
left,I-PR
apex,I-PR
and,I-PR
the,I-PR
right,I-PR
lower,I-PR
lobe,I-PR
.,O

These,O
were,O
thought,O
to,O
be,O
consistent,O
either,O
with,O
pneumonia,B-PR
or,O
asymmetric,B-PR
pulmonary,I-PR
edema,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Associated,B-PR
medical,I-PR
problems,I-PR
include,O
:,O

1.,O
Atonic,B-PR
bladder,I-PR
with,O
a,B-TR
suprapubic,I-TR
tube,I-TR
.,O

2.,O
Anxiety,B-PR
.,O

3.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
with,O
a,O
history,O
of,O
angina,B-PR
in,O
the,O
distant,O
past,O
.,O

4.,O
History,O
of,O
colon,B-PR
cancer,I-PR
with,O
a,B-TR
colectomy,I-TR
in,O
the,O
past,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

1.,O
Ativan,B-TR
1,O
mg,O
po,O
twice,O
a,O
day,O
.,O

2.,O
Trusopt,B-TR
1,O
gtt,O
left,O
eye,O
three,O
times,O
a,O
day,O
.,O

3.,O
Xalatan,B-TR
0.005%,O
one,O
gtt,O
left,O
eye,O
qhs,O
.,O

4.,O
Brimonidine,B-TR
1,O
gtt,O
left,O
eye,O
three,O
times,O
a,O
day,O
.,O

5.,O
Combivent,B-TR
3,O
puffs,O
four,O
times,O
per,O
day,O
.,O

6.,O
Aerobid,B-TR
three,O
puffs,O
twice,O
a,O
day,O
.,O

7.,O
Sorbitol,B-TR
30,O
cc,O
every,O
other,O
day,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

He,O
was,O
an,O
elderly,O
frail,O
gentleman,O
in,O
moderate,B-PR
respiratory,I-PR
distress,I-PR
.,O

He,O
had,O
a,B-TE
blood,I-TE
pressure,I-TE
110/70,O
",",O
heart,B-TE
rate,I-TE
110,O
beats,O
per,O
minute,O
and,O
regular,O
",",O
respiratory,B-TE
rate,I-TE
25,O
.,O

He,O
was,O
in,O
moderate,B-PR
respiratory,I-PR
distress,I-PR
.,O

His,B-TE
temperature,I-TE
was,O
98F,O
.,O

He,O
had,O
a,O
normal,O
head,B-TE
",",I-TE
eyes,I-TE
",",I-TE
ears,I-TE
",",I-TE
nose,I-TE
and,I-TE
throat,I-TE
exam,I-TE
.,O

Neck,B-TE
exam,I-TE
revealed,O
no,O
jugular,B-PR
venous,I-PR
distention,I-PR
and,O
no,O
masses,B-PR
.,O

Lung,B-TE
exam,I-TE
revealed,O
decreased,B-PR
breath,I-PR
sounds,I-PR
as,O
well,O
as,O
crackles,B-PR
in,I-PR
the,I-PR
bases,I-PR
.,O

There,O
were,O
no,O
wheezes,B-PR
or,O
rhonchi,B-PR
.,O

Heart,B-TE
exam,I-TE
revealed,O
a,O
soft,O
S1,O
and,O
S2,O
",",O
no,O
murmur,B-PR
was,O
heard,O
",",O
no,O
S3,B-PR
.,O

Abdomen,O
was,O
soft,O
",",O
nontender,B-PR
with,O
no,O
masses,B-PR
palpable,I-PR
.,O

Rectal,B-TE
exam,I-TE
was,O
unremarkable,O
with,O
stool,B-TE
heme,I-TE
negative,O
.,O

Neurological,B-TE
exam,I-TE
revealed,O
an,O
alert,O
and,O
oriented,O
x,O
3,O
elderly,O
male,O
.,O

He,O
moved,O
all,O
extremities,O
.,O

Deep,B-TE
tendon,I-TE
reflexes,I-TE
were,O
symmetrical,O
in,O
all,O
extremities,O
.,O

LABORATORY,O
AND,O
RADIOLOGIC,O
DATA,O
:,O

Sodium,B-TE
148,O
",",O
potassium,B-TE
3.4,O
",",O
glucose,B-TE
174,O
",",O
P02,B-TE
102,O
",",O
PC02,B-TE
115,O
",",O
PH,B-TE
7.11,O
on,O
40%,B-TR
02,I-TR
.,O

Blood,B-TE
urea,I-TE
nitrogen,I-TE
11,O
",",O
creatinine,B-TE
.6,O
",",O
uric,B-TE
acid,I-TE
3.0,O
",",O
alkaline,B-TE
phosphatase,I-TE
78,O
",",O
creatinine,B-PR
phosphokinase,I-PR
isoenzymes,I-PR
too,I-PR
low,I-PR
",",O
hematocrit,B-TE
41,O
",",O
white,B-TE
blood,I-TE
cell,I-TE
count,I-TE
11.6,O
.,O

Urine,B-TE
analysis,I-TE
showed,O
20-50,O
white,B-TE
blood,I-TE
cells,I-TE
and,O
3-5,O
red,B-TE
blood,I-TE
cells,I-TE
.,O

Electrocardiogram,B-TE
showed,O
sinus,B-PR
tachycardia,I-PR
at,O
a,O
rate,O
of,O
123,O
beats,O
per,O
minute,O
compared,O
to,O
previous,B-TE
electrocardiogram,I-TE
of,O
1/29,O
there,O
were,O
no,O
significant,B-PR
changes,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
stabilized,O
in,O
the,O
Medical,O
Intensive,O
Care,O
Unit,O
.,O

He,O
stayed,O
in,O
the,O
unit,O
for,O
about,O
one,O
day,O
.,O

During,O
that,O
period,O
of,O
time,O
he,O
received,O
nebulizer,B-TR
treatments,I-TR
with,O
Albuterol,B-TR
.,O

He,O
was,O
also,O
started,O
on,O
intravenous,B-TR
Ticarcillin,I-TR
for,O
possible,O
gram,B-PR
negative,I-PR
pneumonia,I-PR
.,O

He,O
was,O
diuresed,O
with,O
intravenous,B-TR
Lasix,I-TR
to,O
which,O
he,O
responded,O
with,O
at,O
lease,O
a,O
2L,O
urine,B-TE
output,I-TE
on,O
the,O
first,O
day,O
and,O
1.5L,O
the,O
second,O
day,O
.,O

After,O
one,O
day,O
in,O
the,O
Medical,O
Intensive,O
Care,O
Unit,O
the,O
patient,O
was,O
stable,O
enough,O
to,O
go,O
to,O
the,O
floor,O
where,O
he,O
continued,O
the,O
rest,O
of,O
his,B-TR
treatment,I-TR
.,O

This,O
consisted,O
of,O
continued,O
nebulizer,B-TR
treatments,I-TR
as,O
well,O
as,O
intravenous,B-TR
antibiotics,I-TR
and,O
intravenous,B-TR
Solu-Medrol,I-TR
.,O

As,O
the,B-TR
patient,I-TR
&apos;s,I-TR
diuresis,I-TR
continued,O
his,B-PR
respiratory,I-PR
status,I-PR
improved,O
.,O

A,B-TE
chest,I-TE
x-ray,I-TE
showed,O
clearing,O
of,O
the,B-PR
opacities,I-PR
in,O
the,B-TE
chest,I-TE
x-ray,I-TE
that,O
were,O
consistent,O
with,O
pulmonary,B-PR
edema,I-PR
because,O
he,O
continued,O
to,O
have,O
some,B-PR
abnormality,I-PR
in,I-PR
the,I-PR
right,I-PR
lower,I-PR
lobe,I-PR
.,O

The,O
patient,O
was,O
continued,O
on,O
antibiotics,B-TR
for,O
possible,O
pneumonia,B-PR
.,O

The,B-TR
antibiotic,I-TR
chosen,O
was,O
Levaquin,B-TR
500,O
mg,O
1,O
tab,O
per,O
day,O
.,O

This,O
was,O
started,O
on,O
4/2/99,O
and,O
should,O
be,O
continued,O
for,O
ten,O
days,O
.,O

The,B-TR
Ticarcillin,I-TR
was,O
stopped,O
after,O
two,O
days,O
when,O
it,O
was,O
felt,O
that,O
he,O
did,O
not,O
have,O
a,B-PR
serious,I-PR
pneumonia,I-PR
.,O

The,B-PR
patient,I-PR
&apos;s,I-PR
respiratory,I-PR
status,I-PR
continued,O
to,O
improve,O
but,O
towards,O
the,O
last,O
2-3,O
days,O
of,O
his,O
hospitalization,O
the,O
amount,O
of,O
improvement,O
was,O
minimal,O
.,O

It,O
was,O
felt,O
that,O
his,B-PR
respiratory,I-PR
status,I-PR
has,O
been,O
maximally,O
treated,O
by,O
then,O
.,O

The,O
patient,O
&apos;s,O
major,O
improvement,O
came,O
after,O
the,O
first,O
two,O
days,O
with,O
brisk,B-TR
diuresis,I-TR
with,O
Lasix,B-TR
.,O

While,O
in,O
the,O
Oaksgekesser/,O
Memorial,O
Hospital,O
the,O
patient,O
on,O
4/4/99,O
complained,O
of,O
mild,B-PR
epigastric,I-PR
discomfort,I-PR
because,O
he,O
was,O
put,O
in,O
Cimetidine,B-TR
while,O
in,O
the,O
Intensive,O
Care,O
Unit,O
for,O
prophylaxis,B-TR
against,O
peptic,B-PR
ulcer,I-PR
disease,I-PR
.,O

The,O
patient,O
was,O
upgraded,O
to,O
Prilosec,B-TR
20,O
mg,O
per,O
day,O
for,O
possible,O
treatment,O
of,O
gastritis,B-PR
or,O
gastroesophageal,B-PR
reflux,I-PR
disease,I-PR
.,O

The,O
patient,O
did,O
have,O
any,O
nausea,B-PR
",",O
vomiting,B-PR
or,O
evidence,O
of,O
gastrointestinal,B-PR
bleeding,I-PR
.,O

The,B-PR
patient,I-PR
&apos;s,I-PR
abdominal,I-PR
pain,I-PR
should,O
be,O
followed,O
over,O
the,O
next,O
week,O
or,O
so,O
in,O
case,O
it,O
does,O
not,O
respond,O
to,O
Prilosec,B-TR
.,O

While,O
in,O
Oaksgekesser/,O
Memorial,O
Hospital,O
the,O
patient,O
was,O
never,O
able,O
to,O
get,O
out,O
of,O
bed,O
and,O
walk,O
independently,O
.,O

It,O
is,O
hoped,O
that,O
when,O
he,O
is,O
transferred,O
to,O
a,O
rehab,O
facility,O
that,O
he,O
will,O
continue,O
with,O
physical,B-TR
therapy,I-TR
to,O
regain,O
his,O
strength,O
and,O
regain,O
independence,O
in,O
activities,O
of,O
daily,O
living,O
.,O

Discussion,O
with,O
the,O
family,O
regarding,O
the,O
possibility,O
of,O
sending,O
him,O
to,O
a,O
nursing,O
home,O
was,O
entertained,O
however,O
the,O
family,O
strongly,O
refused,O
to,O
allow,O
him,O
to,O
go,O
a,O
nursing,O
home,O
.,O

They,O
wanted,O
the,O
patient,O
to,O
return,O
to,O
his,O
home,O
after,O
a,O
stay,O
at,O
a,B-TR
rehab,I-TR
facility,I-TR
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

The,O
patient,O
&apos;s,O
respiratory,O
status,O
was,O
stable,O
.,O

I,O
think,O
his,O
breathing,O
was,O
as,O
good,O
as,O
to,O
be,O
expected,O
with,O
the,O
amount,O
of,O
severe,B-PR
chronic,I-PR
obstructive,I-PR
pulmonary,I-PR
disease,I-PR
he,O
had,O
.,O

He,O
needed,O
to,O
go,O
to,O
a,B-TR
rehab,I-TR
facility,I-TR
for,O
continued,B-TR
respiratory,I-TR
therapy,I-TR
and,O
for,O
Physical,B-TR
Therapy,I-TR
to,O
increase,O
his,O
muscle,O
strength,O
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

1.,O
Albuterol,B-TR
2.5,O
mg,O
in,O
2.5,B-TR
normal,I-TR
saline,I-TR
q4h,O
.,O

2.,O
Heparin,B-TR
5000,O
units,O
subcutaneously,O
twice,O
a,O
day,O
.,O

3.,O
Ativan,B-TR
.5,O
mg,O
twice,O
a,O
day,O
.,O

4.,O
Nasal,B-TR
oxygen,I-TR
3L,O
per,O
minute,O
.,O

5.,O
Levaquin,B-TR
500,O
mg,O
per,O
day,O
to,O
be,O
continued,O
until,O
4/12/99,O
.,O

6.,O
Lasix,B-TR
40,O
mg,O
per,O
day,O
.,O

7.,O
Prednisone,B-TR
40,O
mg,O
per,O
day,O
to,O
be,O
tapered,O
over,O
two,O
weeks,O
.,O

8.,O
Xalatan,B-TR
eyedrops,I-TR
1,O
gtt,O
in,O
left,O
eye,O
per,O
day,O
.,O

9.,O
Alphagan,B-TR
1,O
gtt,O
in,O
left,O
eye,O
three,O
times,O
a,O
day,O
.,O

10.,O
Trusopt,B-TR
1gtt,O
in,O
left,O
eye,O
three,O
times,O
a,O
day,O
.,O

11.,O
Prilosec,B-TR
20,O
mg,O
per,O
day,O
.,O

FOLLOWUP,O
:,O

The,O
patient,O
should,O
have,O
follow,O
up,O
with,O
his,O
primary,O
care,O
physician,O
Dr.,O
Rod,O
Linkeboltshieltrus,O
at,O
the,O
TRE,O
453,O
about,O
one,O
week,O
after,O
discharge,O
from,O
rehab,O
facility,O
.,O

The,O
telephone,O
number,O
at,O
his,O
office,O
is,O
236-4518,O
.,O

ROD,O
END,O
",",O
M.D.,O

TR,O
:,O

lh,O

DD,O
:,O

04/05/1999,O

TD,O
:,O

04/05/1999,O
3:06,O

Pcc,O
:,O

ROD,O
END,O
",",O
M.D.,O

C.R.TRYGLO,O
HOSPITAL,O
OF,O
STAT,O

745431641,O
WGH,O

2464448,O

333887,O

3473372,O

9/16/2004,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O
/,O
SUMMARY,O

KOTEA,O
",",O
TORTHEOA,O

MRN,O
:,O

2464448,O

Age,O
:,O

59y,O

REGISTRATION,O
DATE,O
:,O

09/16/2004,O
09:22,O
AM,O

Provider,O
:,O

YERTREY,O
SUMCHIRDKAYSMAVVEINDREPS,O

PRELIMINARY,O
REPORT,O

PCP,O
notified,O
by,O
MD,O
:,O

Yes,O
-,O
Direct,O
contact,O
with,O
PCP,O

Benefits,O
Assigned,O
:,O

N,O

Discharge,O
Date,O
/,O
Time,O
:,O

09/16/2004,O
17:48,O

Discharge,O
Status,O
:,O

Discharged,O

Condition,O
on,O
Discharge,O
:,O

Stable,O

Patient,O
States,O
Complaint,O
:,O

CP,B-PR

Standardized,O
Discharge,O
Instructions,O
:,O

The,O
patient,O
was,O
given,O
printed,O
instructions,O
for,O
chest,B-PR
pain,I-PR
(,O
English,O
),O
.,O

Diagnosis,O
:,O

Noncardiac,B-PR
chest,I-PR
pain,I-PR

Treatment,O
Rendered,O
:,O

Labs,B-TE
stable,O
",",O
NTG,B-TR
sublingual,I-TR
",",O
stress,B-TE
MIBI,I-TE
was,O
negative,O
for,O
ischemia,B-PR
.,O

Discharge,O
Medications,O
:,O

Continue,O
current,B-TR
medication,I-TR

Disposition,O
",",O
Follow,O
up,O
and,O
Instructions,O
to,O
Patient,O
:,O

Follow,O
up,O
as,O
scheduled,O
with,O
Dr.,O
Fyfechird,O
.,O

Return,O
to,O
the,O
ED,O
for,O
worsening,B-PR
chest,I-PR
pain,I-PR
",",O
shortness,B-PR
of,I-PR
breath,I-PR
",",O
nausea,B-PR
/,O
vomiting,B-PR
",",O
fever,B-PR
/,O
chills,B-PR
",",O
weakness,B-PR
/,O
dizziness/numbness,B-PR
",",O
or,O
any,B-PR
other,I-PR
problems,I-PR
.,O

PCP,O
Name,O
:,O

SLANDTIF,O
",",O
ASTHEO,O
D,O

Provider,O
Number,O
:,O

49422,O

This,O
report,O
was,O
created,O
by,O
SUMCHIRDKAYSMAVVEINDREPS,O
",",O
YERTREY,O
09/16/2004,O
05:53,O
PM,O

745701560,O
WGH,O

2217927,O

991462,O

4257841,O

10/23/2005,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O
/,O
SUMMARY,O

SMANTVERGE,O
",",O
TAWNEN,O

MRN,O
:,O

2217927,O

Age,O
:,O

78y,O

REGISTRATION,O
DATE,O
:,O

10/23/2005,O
09:30,O
AM,O

Provider,O
:,O

VONNELIBRY,O
POUSSCROOKESSEILLE,O

PRELIMINARY,O
REPORT,O

PCP,O
notified,O
by,O
MD,O
:,O

E-mail,O
PCP,O

Benefits,O
Assigned,O
:,O

Y,O

Discharge,O
Note,O

Date,O
/,O
Time,O
:,O

10/23/2005,O
10:35,O

Discharge,O
Status,O
:,O

Discharged,O

Condition,O
on,O
Discharge,O
:,O

Stable,O

Patient,O
States,O
Complaint,O
:,O

APPT,O
VONNELIBRY,O
POUSSCROOKESSEILLE,O

Diagnosis,O
:,O

Anxiety,B-PR
NOS,I-PR

Treatment,O
Rendered,O
:,O

psychological,B-TE
assessment,I-TE
",",O
past,O
medication,O
responses,O
discussed,O
.,O

No,O
new,B-TR
meds,I-TR
for,O
now,O

Discharge,O
Medications,O
:,O

None,O
today,O
Disposition,O
",",O

Follow,O
up,O
and,O
Instructions,O
to,O
Patient,O
:,O

Keep,O
follow-up,O
medical,O
appointments,O
with,O
Dr,O
Trosgaugh,O
.,O

Continuing,O
taking,O
meds,B-TR
she,O
prescribed,O
.,O

PCP,O
Name,O
:,O

TROSGAUGH,O
",",O
NACOLE,O

Provider,O
Number,O
:,O

16660,O

This,O
report,O
was,O
created,O
by,O
POUSSCROOKESSEILLE,O
",",O
VONNELIBRY,O
10/23/2005,O
10:51,O
AM,O

767751445,O
ELMVH,O

45154940,O

6035801,O

12/6/2005,O
12:00:00,O
AM,O

COPD,B-PR
exacerbation,I-PR
with,O
NSTEMI,B-PR

DIS,O

Admission,O
Date,O
:,O

12/06/2005,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

12/10/2005,O

******,O
FINAL,O
DISCHARGE,O
ORDERS,O
******,O

SCHOELLSULLKOTEFONG,O
",",O
MAUSTINIE,O

161-66-98-5,O
W53,O

Room,O
:,O

66R-249,O

Service,O
:,O

MED,O

DISCHARGE,O
PATIENT,O
ON,O
:,O

12/09/05,O
AT,O
08:00,O
PM,O

CONTINGENT,O
UPON,O

Attending,B-TE
evaluation,I-TE

WILL,O
D,O
/,O
C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D,O
/,O
C,O
SUMMARY,O
:,O

YES,O

Attending,O
:,O

FREIERMFUSC,O
",",O
SHAIGAYDONA,O
",",O
M.D.,O
",",O
M.DIV.,O

CODE,O
STATUS,O
:,O

Full,O
code,O

DISPOSITION,O
:,O

Home,O
w/,O
services,O

DISCHARGE,O
MEDICATIONS,O
:,O

VITAMIN,B-TR
C,I-TR
(,I-TR
ASCORBIC,I-TR
ACID,I-TR
),I-TR
"1,000",O
MG,O
PO,O
QD,O
ECASA,B-TR
(,I-TR
ASPIRIN,I-TR
ENTERIC,I-TR
COATED,I-TR
),I-TR
81,O
MG,O
PO,O
QD,O
CALCIUM,B-TR
CARBONATE,I-TR
(,I-TR
500,I-TR
MG,I-TR
ELEMENTAL,I-TR
CA++,I-TR
),I-TR
500,O
MG,O
PO,O
BID,O
PREDNISONE,B-TR
20,O
MG,O
PO,O
QAM,O
Starting,O
Today,O
(,O
12/09,O
),O

Instructions,O
:,O

taper,O
over,O
2,O
weeks,O
MULTIVITAMIN,B-TR
THERAPEUTIC,I-TR
(,I-TR
THERAPEUTIC,I-TR
MULTIVI,I-TR
...,I-TR
),I-TR
5,O
MILLILITERS,O
PO,O
QD,O

Override,O
Notice,O
:,O

Override,O
added,O
on,O
12/07/05,O
by,O
BELB,O
",",O
BRITHERL,O
",",O
M.D.,O
on,O
order,O
for,O
ATORVASTATIN,B-TR
PO,I-TR
(,O
ref,O
#,O
33823759,O
),O

POTENTIALLY,O
SERIOUS,O
INTERACTION,O
:,O

NIACIN,B-TR
",",O
VIT,B-TR
.,O

B-3,B-TR
and,O
ATORVASTATIN,B-TR
CALCIUM,I-TR

Reason,O
for,O
override,O
:,O

md,O
aware,O

Previous,O
override,O
information,O
:,O

Override,O
added,O
on,O
12/06/05,O
by,O
BELB,O
",",O
BRITHERL,O
",",O
M.D.,O
on,O
order,O
for,O
ZOCOR,B-TR
PO,I-TR
(,O
ref,O
#,O
33033281,O
),O

POTENTIALLY,O
SERIOUS,O
INTERACTION,O
:,O

NIACIN,B-TR
",",O
VIT,B-TR
.,O

B-3,B-TR
and,O
SIMVASTATIN,B-TR

Reason,O
for,O
override,O
:,O

md,O
aware,O

FLOVENT,B-TR
(,I-TR
FLUTICASONE,I-TR
PROPIONATE,I-TR
),I-TR
44,O
MCG,O
INH,O
BID,O
Starting,O
Today,O
(,O
12/09,O
),O
LEVAQUIN,B-TR
(,I-TR
LEVOFLOXACIN,I-TR
),I-TR
500,O
MG,O
PO,O
QD,O

Food,O
/,O
Drug,O
Interaction,O
Instruction,O

Administer,O
iron,B-TR
products,I-TR
a,O
minimum,O
of,O
2,O
hours,O
before,O
or,O
after,O
a,O
levofloxacin,B-TR
or,O
ciprofloxacin,B-TR
dose,O
dose,O

If,O
on,O
tube,B-TR
feeds,I-TR
",",O
please,O
cycle,O
(,O
hold,O
1,O
hr,O
before,O
to,O
2,O
hr,O
after,O
),O

Take,O
2,O
hours,O
before,O
or,O
2,O
hours,O
after,O
dairy,O
products,O
.,O

Alert,O
overridden,O
:,O

Override,O
added,O
on,O
12/06/05,O
by,O
BELB,O
",",O
BRITHERL,O
",",O
M.D.,O

POTENTIALLY,O
SERIOUS,O
INTERACTION,O
:,O

SALMETEROL,B-TR
XINAFOATE,I-TR
and,O
LEVOFLOXACIN,B-TR

Reason,O
for,O
override,O
:,O

md,O
aware,O

SEREVENT,B-TR
DISKUS,I-TR
(,I-TR
SALMETEROL,I-TR
DISKUS,I-TR
),I-TR
1,O
PUFF,O
INH,O
BID,O

Override,O
Notice,O
:,O

Override,O
added,O
on,O
12/06/05,O
by,O
BELB,O
",",O
BRITHERL,O
",",O
M.D.,O
on,O
order,O
for,O
LEVAQUIN,B-TR
PO,I-TR
(,O
ref,O
#,O
57095042,O
),O

POTENTIALLY,O
SERIOUS,O
INTERACTION,O
:,O

SALMETEROL,B-TR
XINAFOATE,I-TR
and,O
LEVOFLOXACIN,B-TR

Reason,O
for,O
override,O
:,O

md,O
aware,O

LISINOPRIL,B-TR
5,O
MG,O
PO,O
QD,O

Alert,O
overridden,O
:,O

Override,O
added,O
on,O
12/08/05,O
by,O
:,O

POTENTIALLY,O
SERIOUS,O
INTERACTION,O
:,O

POTASSIUM,B-TR
CHLORIDE,I-TR
and,O
LISINOPRIL,B-TR

Reason,O
for,O
override,O
:,O

md,O
aware,O

TOPROL,B-TR
XL,I-TR
(,I-TR
METOPROLOL,I-TR
SUCCINATE,I-TR
EXTENDED,I-TR
RELEASE,I-TR
),I-TR
25,O
MG,O
PO,O
QD,O
Starting,O
Today,O
(,O
12/09,O
),O

Food,O
/,O
Drug,O
Interaction,O
Instruction,O

Take,O
consistently,O
with,O
meals,O
or,O
on,O
empty,O
stomach,O
.,O

ALENDRONATE,B-TR
70,O
MG,O
PO,O
QWEEK,O

Food,O
/,O
Drug,O
Interaction,O
Instruction,O

Give,O
on,O
an,O
empty,O
stomach,O
(,O
give,O
1hr,O
before,O
or,O
2hr,O
after,O
food,O
),O

Take,O
with,O
8,O
oz,O
of,O
plain,O
water,O
ALBUTEROL,B-TR
INHALER,I-TR
2,O
PUFF,O
INH,O
QID,O
Starting,O
Today,O
(,O
12/09,O
),O
ATROVENT,B-TR
INHALER,I-TR
(,I-TR
IPRATROPIUM,I-TR
INHALER,I-TR
),I-TR
2,O
PUFF,O
INH,O
QID,O
Starting,O
Today,O
(,O
12/09,O
),O

DIET,O
:,O

No,O
Restrictions,O

ACTIVITY,O
:,O

Resume,O
regular,O
exercise,O

FOLLOW,O
UP,O
APPOINTMENT,O
(,O
S,O
),O
:,O

Gento,O
Yaneslaunt,O
03/17/06,O
scheduled,O
",",O

Arois,O
Maillliepslighsint,O
02/18/06,O
scheduled,O
",",O

ALLERGY,O
:,O

NKA,B-PR
ADMIT,O
DIAGNOSIS,O
:,O

COPD,B-PR
exacerbation,I-PR

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O

Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O
COPD,B-PR
exacerbation,I-PR
with,O
NSTEMI,B-PR

OTHER,O
DIAGNOSIS,O
;,O

Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O

severe,B-PR
COPD,I-PR
Pneumonia,B-PR
recovering,O
alcoholic,O
recovering,O
barbituate,O
abuse,O
unexplained,B-PR
hct,I-PR
drop,I-PR
poor,B-PR
appetite,I-PR
x,O
1,O
week,O

STEROID,B-PR
PSYCHOSIS,I-PR
NO,O
BENZOS,B-TR

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

none,O

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O

Heparin,B-TR
while,O
having,O
a,B-PR
demand,I-PR
ischemic,I-PR
episode,I-PR

BRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

*,O
CC,O
:,O

82F,O
with,O
COPD,B-PR
exacerpation,I-PR

*,O
DDx,O
:,O

COPD,B-PR
exacerpation,I-PR
with,O
troponin,B-PR
leak,I-PR
likely,O
NSTEMI,B-PR
secondary,O
to,O
demand,B-PR
ischemia,I-PR
.,O

*,O
HPI,O
:,O

4,O
days,O
of,O
worsening,B-PR
SOB,I-PR
with,O
sore,B-PR
throat,I-PR
and,O
cough,B-PR
productive,I-PR
of,I-PR
yellow,I-PR
/,I-PR
green,I-PR
sputum,I-PR
.,O

Fatigue,B-PR
secondary,O
to,O
worsening,B-PR
dyspnea,I-PR
.,O

took,O
Prednisone,B-TR
40,I-TR
at,O
home,O
and,O
presented,O
to,O
ED,O
where,O
found,O
to,O
have,O
1mm,B-PR
lateral,I-PR
ST,I-PR
depressions,I-PR
and,O
slight,B-PR
troponin,I-PR
and,I-PR
MB,I-PR
leak,I-PR
.,O

no,O
N,B-PR
/,O
V/HA,B-PR
/,O
D,B-PR
no,O
sweats,B-PR
",",O
no,O
chills,B-PR
",",O
of,O
abdominal,B-PR
pain,I-PR
",",O
no,O
chest,B-PR
pain,I-PR
",",O
no,O
pleuricy,B-PR
",",O
no,O
LEE,B-PR
",",O
no,O
paresthesias,B-PR
",",O
no,O
numbness,B-PR
",",O
no,O
shoulder,B-PR
pain,I-PR
",",O
no,O
jaw,B-PR
pain,I-PR
.,O

*,O
PMH,O
:,O

COPD,B-PR
(,O
s,O
/,O
p,O
lung,B-TR
resection,I-TR
FEV1,B-TE
25%,O
),O
",",O
chronic,B-PR
pericardial,I-PR
effusion,I-PR
",",O
PVD,B-PR
",",O
R,B-PR
renal,I-PR
artery,I-PR
stenosis,I-PR
",",O
osteoporosis,B-PR
",",O
presbylaryngis,B-PR

**************,O
PATIENT,O
STATUS,O
********************,O

98.4,O
",",O
94,O
",",O
22,O
",",O
120/96,O
",",O
98%,O
on,O
2L.,O
NAD,B-PR
",",O
using,O
scalenes,B-TE
",",O
AT,O
/,O
NC,O
",",O
no,O
oral,B-PR
lesions,I-PR
",",O
Bibasilar,B-PR
rales,I-PR
otherwise,O
clear,O
",",O
good,O
air,O
movement,O
",",O
RRR,O
",",O
no,O
MRG,O
",",O
NTND,O
+BS,O
",",O
no,O
CCE,O
",",O
2+,O
DPs,O
.,O

Guiac,O
negative,O

***************,O
STUDIES,O
***********************,O

LABS,O
:,O

WBC,B-TE
12.91,O

CXR,O
:,O

small,B-PR
pleural,I-PR
effusion,I-PR
",",O
flat,O
diaphrams,O
no,O
acute,B-PR
changes,I-PR

Echo,B-TE
-,O

***********,O
HOSPITAL,O
COURSE,O
****************,O

1.,O
CV,O
:,O

likely,O
having,O
a,B-PR
NSTEMI,I-PR
secondary,O
to,O
demand,B-PR
.,O

Cardiac,B-TE
enzymes,I-TE
trending,O
down,O
on,O
12.7.05,O
",",O
anticoagulated,O
while,O
having,O
leak,B-TE
.,O

I,O
-,O
heparin,B-TR
for,O
PTT,B-PR
50-70,O
durin,O
enzyme,B-PR
leak,I-PR
.,O
metoprolol,B-TR
12,O
QID,O
.,O

Cardiac,B-TE
enzymes,I-TE
BID,O
while,O
actively,O
having,O
leak,B-PR
",",O
ASA,B-TR

R,O
-,O
monitor,O
on,O
telemetry,B-TR

P,O
-,O
no,O
evidence,B-PR
of,I-PR
failure,I-PR

-,O
Echo,O
:,O

2.,O
COPD,O
:,O

likely,O
exacerbation,B-PR
possibly,O
from,O
URI,B-PR
/,O
pneumonia,B-PR
.,O

Aputum,B-TE
cultures,I-TE
pending,O
.,O

Treated,O
with,O
:,O

atrovent,B-TR
NEB,I-TR
QID,O
",",O
albuterol,B-TR
Neb,I-TR
QID,O
",",O
ipratropium,B-TR
NEB,I-TR
BID,O
",",O
flovent,B-TR
INH,I-TR
BID,O
",",O
Serevent,B-TR
INH,I-TR
BID,O
",",O
and,O
prednisone,B-TR
30,O
QD,O
taper,O
.,O

Levaquin,B-TR
500,O
QD,O
empirically,O

3.,O
GI,O
:,O

PPI,B-TR
prophylaxis,I-TR

4.,O
FEN,O
:,O

MVI,B-PR
",",O
Cardiac,O
diet,O

ADDITIONAL,O
COMMENTS,O
:,O

Please,O
make,O
an,O
appointment,O
to,O
see,O
dr.,O
Arois,O
Maillliepslighsint,O
within2-3,O
weeks,O
after,O
you,O
leave,O
the,O
hospital,O

Please,O
taper,O
off,O
your,O
prednisone,B-TR
within,O
2,O
weeks,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O

TO,O
DO,O
/,O
PLAN,O
:,O

PT,O
:,O

please,O
evaluate,O
ambutlation,O
ability,O
and,O
O2,B-TE
requirement,I-TE

Please,O
evaluate,O
resolution,O
of,O
cardiac,B-PR
troponin,I-PR
leak,I-PR
and,O
stable,O
EKG,O
.,O

Please,O
evaluate,O
resolution,O
of,O
COPD,B-PR
exacerbation,I-PR
and,O
need,O
for,O
any,B-TR
further,I-TR
antibiocis,I-TR

No,O
dictated,O
summary,O

ENTERED,O
BY,O
:,O

BELB,O
",",O
BRITHERL,O
",",O
M.D.,O
(,O
IL35,O
),O
12/10/05,O
02:50,O
PM,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

779878634,O

TGCHO,O

9260099,O

612765,O

12/11/2003,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Report,O
Status,O
:,O

Signed,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

A,O
",",O
REBAY,O
J,O

UNIT,O
NUMBER,O
:,O

984-98-62,O

ADMISSION,O
DATE,O
:,O

12/11/2003,O

DISCHARGE,O
DATE,O
:,O

01/08/2004,O

The,O
patient,O
has,O
a,O
known,O
history,O
of,O
pancreatic,B-PR
adenocarcinoma,I-PR
.,O

He,O
is,O
admitted,O
at,O
this,O
time,O
because,O
of,O
significant,B-PR
GI,I-PR
bleeding,I-PR
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

Significant,O
for,O
fatigue,B-PR
and,O
increased,B-PR
abdominal,I-PR
discomfort,I-PR
.,O

MEDICATIONS,O
AT,O
THE,O
TIME,O
OF,O
ADMISSION,O
:,O

Insulin,B-TR
",",O
Celexa,B-TR
",",O
Protonix,B-TR
",",O
Ambien,B-TR
and,O
Pancreas,B-TR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Vital,B-TE
signs,I-TE
showed,O
his,B-TE
blood,I-TE
pressure,I-TE
to,O
be,O
slightly,B-PR
decreased,I-PR
at,O
120/60,O
",",O
pulse,B-TE
64,O
",",O
respirations,B-TE
16,O
",",O
temperature,B-TE
98.8,O
",",O
O2,B-TE
sat,I-TE
95,O
.,O

HEENT,O
:,O

Evidence,B-PR
of,I-PR
anemia,I-PR
with,O
being,B-PR
pale,I-PR
",",O
but,O
anicteric,O
",",O
no,O
oral,B-PR
lesions,I-PR
.,O

Neck,O
supple,O
.,O

Lungs,O
clear,O
.,O

Back,O
without,O
CVA,B-PR
or,I-PR
spinal,I-PR
tenderness,I-PR
.,O

Heart,O
regular,O
rate,O
and,O
rhythm,O
.,O

Abdomen,O
:,O

Bowel,O
sounds,O
positive,O
",",O
soft,O
",",O
mildly,B-PR
tender,I-PR
in,I-PR
the,I-PR
epigastrium,I-PR
without,O
hepatosplenomegaly,B-PR
",",O
mass,B-PR
or,O
tenderness,B-PR
.,O

Extremities,O
:,O

Trace,B-PR
edema,I-PR
without,O
cyanosis,B-PR
or,O
clubbing,B-PR
.,O

His,B-TE
hematocrit,I-TE
at,O
the,O
time,O
of,O
admission,O
was,O
20.5,O
",",O
after,O
having,O
been,O
32,O
one,O
week,O
earlier,O
.,O

ASSESSMENT,O
:,O

The,B-TE
assessment,I-TE
was,O
that,O
he,O
had,O
a,B-PR
GI,I-PR
bleed,I-PR
.,O

He,O
was,O
transfused,O
and,O
then,O
evaluated,O
by,O
GI,O
.,O

Endoscopy,B-TE
showed,O
multiple,B-PR
angio,I-PR
ectasias,I-PR
throughout,I-PR
the,I-PR
stomach,I-PR
.,O

He,O
received,O
multiple,B-TR
treatments,I-TR
for,O
this,O
over,O
the,O
succeeding,O
weeks,O
.,O

In,O
addition,O
",",O
he,O
was,O
transfused,O
.,O

His,B-TE
platelet,I-TE
count,I-TE
was,O
maintained,O
with,O
platelet,B-TR
transfusion,I-TR
as,O
necessary,O
.,O

He,O
was,O
treated,O
with,O
Octreotide,B-TR
to,O
try,O
to,O
slow,O
down,O
the,B-PR
bleeding,I-PR
.,O

Despite,O
all,O
these,O
measures,O
",",O
his,B-PR
bleeding,I-PR
was,O
never,O
totally,O
controlled,O
.,O

He,O
then,O
had,O
an,B-TR
angiogram,I-TR
with,I-TR
Gel,I-TR
foam,I-TR
to,O
try,O
to,O
control,O
his,B-PR
GI,I-PR
bleed,I-PR
.,O

Again,O
",",O
this,O
was,O
unsuccessful,O
.,O

At,O
that,O
point,O
he,O
had,O
a,B-PR
change,I-PR
in,I-PR
mental,I-PR
status,I-PR
and,O
was,O
no,B-PR
longer,I-PR
responsive,I-PR
.,O

Given,O
this,O
",",O
the,O
decision,O
was,O
made,O
to,O
make,O
his,O
care,O
comfort,O
measures,O
only,O
.,O

At,O
this,O
point,O
",",O
he,O
was,O
made,O
comfort,O
measures,O
and,O
expired,O
comfortably,O
.,O

The,O
cause,O
of,O
death,B-PR
was,O
a,O
combination,O
of,O
GI,B-PR
bleeding,I-PR
felt,O
to,O
be,O
ultimately,O
related,O
to,O
his,B-PR
known,I-PR
metastatic,I-PR
pancreatic,I-PR
cancer,I-PR
.,O

TA,O
KO,O
FOSSA,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

Electronically,O
Signed,O
TA,O
KO,O
FOSSA,O
",",O
M.D.,O

02/05/2004,O
17:03,O

_____________________________,O
TA,O
KO,O
FOSSA,O
",",O
M.D.,O

TR,O
:,O

mb,O

DD,O
:,O

01/23/2004,O

TD,O
:,O

01/26/2004,O
2:16,O
A,O
612765,O

cc,O
:,O

TA,O
KO,O
FOSSA,O
",",O
M.D.,O

788268693,O
DH,O

7258512,O

20586,O

831510,O

4/30/2005,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O
/,O
SUMMARY,O

FREIERMDREPS,O
",",O
RI,O

MRN,O
:,O

7258512,O

Age,O
:,O

44y,O

REGISTRATION,O
DATE,O
:,O

04/30/2005,O
02:55,O
PM,O

Provider,O
:,O

RONRIN,O
SHUFF,O

PRELIMINARY,O
REPORT,O

Benefits,O
Assigned,O
:,O

Y,O

Discharge,O
Note,O
Date,O
/,O
Time,O
:,O

04/30/2005,O
15:49,O

Discharge,O
Status,O
:,O

Discharged,O

Condition,O
on,O
Discharge,O
:,O

Stable,O

Patient,O
States,O
Complaint,O
:,O

R,B-PR
ELBOW,I-PR
INJURY,I-PR

Standardized,O
Discharge,O
Instructions,O
:,O

The,O
patient,O
was,O
given,O
printed,O
instructions,O
for,O
sprains,B-PR
",",O
fractures,B-PR
and,O
bruises,B-PR
(,O
English,O
),O
.,O

The,O
patient,O
was,O
given,O
a,O
work,O
note,O
(,O
English,O
),O
.,O

Diagnosis,O
:,O

R,B-PR
elbow,I-PR
strain,I-PR

Treatment,O
Rendered,O
:,O

xray,B-TE
-,O
no,O
evidence,O
of,O
effusion,B-PR
or,O
fracture,B-PR

Discharge,O
Medications,O
:,O

motrin,B-TR
400-600,O
mg,O
every,O
8,O
hours,O
as,O
needed,O
for,O
pain,B-PR

Follow,O
up,O
Service,O
:,O

It,O
is,O
recommended,O
that,O
you,O
receive,O
follow-up,O
care,O
with,O
the,O
Department,O
of,O
Orthopaedics,O
if,O
your,B-PR
symptoms,I-PR
are,O
not,O
improved,O
in,O
5-7,O
days,O
.,O

Please,O
call,O
(,O
890,O
),O
541-3008,O
to,O
schedule,O
an,O
appointment,O
.,O

For,O
managed,O
care,O
plans,O
",",O
check,O
with,O
your,O
PCP,O
before,O
making,O
this,O
appointment,O
.,O

Disposition,O
",",O
Follow,O
up,O
and,O
Instructions,O
to,O
Patient,O
:,O

Use,O
ice,B-TR
to,O
sore,B-PR
areas,I-PR
for,O
the,O
next,O
few,O
days,O
.,O

Do,O
no,O
strenuous,O
activity,O
until,O
your,B-PR
symptoms,I-PR
are,O
improved,O
.,O

Do,O
gentle,B-TR
range,I-TR
of,I-TR
motion,I-TR
exercises,I-TR
for,O
the,O
next,O
few,O
days,O
.,O

PCP,O
Name,O
:,O

CREDKOTE,O
",",O
ALEN,O

Provider,O
Number,O
:,O

18160,O

This,O
report,O
was,O
created,O
by,O
SHUFF,O
",",O
RONRIN,O
04/30/2005,O
03:52,O
PM,O

814743340,O
RWH,O

3393103,O

501370,O

9041109,O

5/13/2006,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

TRICHEPRAKEJESC,O
",",O
BETLA,O

UNIT,O
NUMBER,O
:,O

381-75-78,O

ADMISSION,O
DATE,O
:,O

05/13/2006,O

DISCHARGE,O
DATE,O
:,O

05/16/2006,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Chest,B-PR
pain,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

Coronary,B-PR
artery,I-PR
disease,I-PR
;,O
hypertension,B-PR
;,O
hyperlipidemia,B-PR
;,O
sleep,B-PR
apnea,I-PR
;,O
diabetes,B-PR
type,I-PR
2,I-PR
.,O

PROCEDURES,O
:,O

Adenosine,B-TE
stress,I-TE
test,I-TE
.,O

Part,B-TE
1,I-TE
of,I-TE
a,I-TE
sleep,I-TE
study,I-TE
.,O

Coronary,B-TE
angiogram,I-TE
.,O

Chest,B-TE
CT,I-TE
.,O

Chest,B-TE
x-ray,I-TE
.,O

HISTORY,O
AND,O
REASON,O
FOR,O
HOSPITALIZATION,O
:,O

The,O
patient,O
is,O
a,O
55-year-old,O
gentleman,O
with,O
a,O
history,O
of,O
CAD,B-PR
status,O
post,O
non,B-PR
ST,I-PR
elevation,I-PR
MI,I-PR
in,O
11/17,O
who,O
presents,O
with,O
chest,B-PR
pain,I-PR
X,O
48,O
hours,O
.,O

He,O
went,O
to,O
Padrugmoff,O
Hospital,O
Emergency,O
Room,O
.,O

He,O
has,O
a,O
history,O
of,O
hypertension,B-PR
",",O
diabetes,B-PR
",",O
and,O
high,B-PR
cholesterol,I-PR
.,O

In,O
2003,O
",",O
he,O
had,O
a,B-PR
non,I-PR
ST,I-PR
elevation,I-PR
MI,I-PR
",",O
came,O
to,O
the,O
RWH,O
",",O
and,O
had,O
a,B-TE
cath,I-TE
done,O
",",O
which,O
showed,O
a,B-PR
40%,I-PR
RCA,I-PR
",",O
which,O
was,O
hazy,B-PR
.,O

An,B-TE
IVUS,I-TE
was,O
done,O
",",O
and,O
it,O
was,O
felt,O
that,O
it,O
was,O
more,O
severe,O
.,O

He,O
underwent,O
a,B-TR
PTC,I-TR
stenting,I-TR
of,I-TR
an,I-TR
RCA,I-TR
with,O
a,B-TR
Vision,I-TR
stent,I-TR
",",O
3,O
x,O
18,O
.,O

Diagonal,O
1,O
also,O
had,O
a,B-PR
99%,I-PR
stenosis,I-PR
.,O

There,O
was,O
no,O
other,B-PR
noted,I-PR
disease,I-PR
.,O

Since,O
then,O
",",O
the,O
patient,O
has,O
occasional,B-PR
chest,I-PR
pain,I-PR
with,O
emotional,B-PR
stress,I-PR
",",O
when,O
he,O
is,O
angry,O
or,O
upset,O
.,O

Yesterday,O
morning,O
",",O
he,O
developed,O
intermittent,B-PR
substernal,I-PR
chest,I-PR
pain,I-PR
with,O
radiation,B-PR
to,I-PR
the,I-PR
left,I-PR
shoulder,I-PR
that,O
worsened,O
with,O
any,O
activity,O
and,O
any,O
motion,O
of,O
his,O
shoulders,O
.,O

It,O
progressed,O
over,O
the,O
course,O
of,O
the,O
day,O
requiring,O
less,O
movement,O
.,O

He,O
also,O
became,O
short,B-PR
of,I-PR
breath,I-PR
with,O
climbing,O
a,O
flight,O
of,O
stairs,O
.,O

He,O
denies,O
diaphoresis,B-PR
or,O
nausea,B-PR
.,O

He,O
went,O
to,O
the,O
Padrugmoff,O
Hospital,O
Emergency,O
Room,O
after,O
trying,O
nitroglycerin,B-TR
at,O
home,O
.,O

However,O
",",O
his,B-TR
nitroglycerin,I-TR
was,O
old,O
and,O
the,B-TR
script,I-TR
was,O
expired,O
.,O

In,O
the,O
ER,O
",",O
he,O
received,O
3,B-TR
sublingual,I-TR
nitroglycerins,I-TR
and,O
1,O
mg,O
of,O
Dilaudid,B-TR
.,O

After,O
that,O
",",O
he,O
was,O
pain-free,B-PR
.,O

Lopressor,B-TR
IV,I-TR
was,O
given,O
to,O
control,O
his,B-TE
heart,I-TE
rate,I-TE
.,O

He,O
also,O
received,O
Lipitor,B-TR
80,O
mg,O
",",O
Plavix,B-TR
300,O
",",O
heparin,B-TR
IV,I-TR
",",O
integrelin,B-TR
double,I-TR
bolus,I-TR
",",O
followed,O
by,O
a,B-TR
drip,I-TR
.,O

Apparently,O
once,O
his,B-PR
pain,I-PR
was,O
free,O
",",O
his,B-TE
EKG,I-TE
was,O
noted,O
to,O
have,O
hyperacute,B-PR
T-wave,I-PR
anteriorly,I-PR
without,O
progression,B-PR
.,O

He,O
was,O
transferred,O
to,O
the,O
Ro,O
Woodma,O
Healthcare,O
for,O
further,B-TR
cardiac,I-TR
care,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Diabetes,B-PR
;,O
hypertension,B-PR
;,O
hyperlipidemia,B-PR
.,O

MEDICATIONS,O
AT,O
HOME,O
:,O

Include,O
Lisinopril,B-TR
5,O
mg,O
p.o.,O
every,O
day,O
;,O
nitroglycerin,B-TR
sublingual,I-TR
p.r.n.;,O
Toprol,B-TR
XL,I-TR
100,O
mg,O
p.o.,O
every,O
day,O
;,O
Plavix,B-TR
75,O
mg,O
p.o.,O
every,O
day,O
;,O
Avandia,B-TR
4,O
mg,O
p.o.,O
every,O
day,O
;,O
Lipitor,B-TR
40,O
mg,O
p.o.,O
every,O
day,O
;,O
TriCor,B-TR
145,O
mg,O
p.o.,O
every,O
day,O
.,O

SOCIAL,O
HISTORY,O
:,O

He,O
is,O
married,O
.,O

He,O
does,O
have,O
a,O
lot,O
of,O
anxiety,B-PR
.,O

Socially,O
he,O
drinks,O
alcohol,O
.,O

He,O
does,O
not,O
smoke,O
.,O

He,O
has,O
2,O
daughters,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
ruled,O
out,O
for,O
an,B-PR
MI,I-PR
with,O
negative,O
CK,O
X4,O
and,O
negative,O
troponin,O
X4,O
.,O

He,O
was,O
taken,O
to,O
the,O
Cardiac,O
Catheterization,O
Lab,O
where,O
cath,B-TE
showed,O
top-normal,O
LVEDP,O
at,O
12,O
;,O
no,O
AF,B-PR
;,O
widely,B-PR
patent,I-PR
RCA,I-PR
stent,I-PR
;,O
mild,B-PR
CAD,I-PR
in,I-PR
the,I-PR
left,I-PR
coronary,I-PR
artery,I-PR
symptom,I-PR
;,O
widely,B-PR
patent,I-PR
diagonal,I-PR
1,I-PR
at,O
the,O
site,O
of,O
prior,B-TR
PTCA,I-TR
.,O

He,O
received,O
an,B-TR
Angio-Seal,I-TR
to,I-TR
the,I-TR
right,I-TR
common,I-TR
femoral,I-TR
artery,I-TR
.,O

He,O
then,O
underwent,O
a,B-TE
CT,I-TE
scan,I-TE
to,O
rule,O
out,O
a,B-PR
PE,I-PR
.,O

That,O
test,O
was,O
negative,O
.,O

He,O
underwent,O
lower,B-TE
extremity,I-TE
study,I-TE
to,O
rule,O
out,O
a,B-PR
DVT,I-PR
in,I-PR
both,I-PR
legs,I-PR
.,O

That,O
was,O
negative,O
.,O

He,O
was,O
noted,O
to,O
have,O
an,O
episode,O
of,O
desaturation,B-PR
into,I-PR
the,I-PR
80%,I-PR
range,I-PR
while,O
sleeping,O
.,O

Pulmonary,B-TE
consult,I-TE
was,O
done,O
",",O
and,O
it,O
was,O
felt,O
that,O
the,O
patient,O
should,O
undergo,O
a,B-TE
formal,I-TE
sleep,I-TE
study,I-TE
",",O
full,B-TE
PFTs,I-TE
",",O
and,O
a,B-TE
repeat,I-TE
CT,I-TE
scan,I-TE
in,O
1,O
year,O
to,O
assess,O
for,O
pulmonary,B-PR
nodule,I-PR
that,O
was,O
seen,O
.,O

However,O
",",O
please,O
note,O
that,O
this,B-PR
nodule,I-PR
has,O
been,O
stable,O
over,O
time,O
.,O

The,O
patient,O
also,O
complained,O
of,O
intermittent,B-PR
right,I-PR
neck,I-PR
swelling,I-PR
",",O
and,O
recommendations,O
are,O
to,O
consider,O
a,B-TE
CT,I-TE
scan,I-TE
with,I-TE
contrast,I-TE
to,O
evaluate,O
nodes,B-PR
in,I-PR
his,I-PR
neck,I-PR
.,O

On,O
physical,B-TE
exam,I-TE
today,O
",",O
the,O
patient,O
did,O
not,O
have,O
any,B-PR
swelling,I-PR
",",O
and,O
he,O
states,O
that,O
he,O
did,O
not,O
feel,O
the,B-PR
swelling,I-PR
was,O
present,O
.,O

The,O
patient,O
underwent,O
an,B-TE
adenosine,I-TE
stress,I-TE
test,I-TE
",",O
where,O
he,O
exercised,O
for,O
4,O
minutes,O
",",O
reaching,O
65%,O
of,O
predicted,O
heart,O
rate,O
.,O

He,O
did,O
not,O
have,O
chest,B-PR
pain,I-PR
.,O

EKG,B-TE
was,O
negative,O
for,O
ischemia,B-PR
.,O

The,B-TE
myocardial,I-TE
perfusion,I-TE
images,I-TE
show,O
no,O
definite,O
evidence,O
of,O
ischemia,B-PR
.,O

The,B-TE
LV,I-TE
contractile,I-TE
function,I-TE
was,O
normal,O
.,O

There,O
was,O
mild,B-PR
posterior,I-PR
vasal,I-PR
thinning,I-PR
.,O

It,O
is,O
not,O
clearly,O
outside,O
normal,O
limits,O
.,O

He,O
underwent,O
an,B-TE
echocardiogram,I-TE
",",O
which,O
showed,O
an,B-TE
EF,I-TE
of,O
60%,O
.,O

There,O
was,O
no,O
evidence,O
of,O
MVP,B-PR
.,O

There,O
was,O
trace,B-PR
mitral,I-PR
regurgitation,I-PR
.,O

There,O
was,O
no,O
evidence,O
of,O
LA,B-PR
dilatation,I-PR
.,O

There,O
was,O
no,O
aortic,B-PR
stenosis,I-PR
.,O

There,O
was,O
trace,B-PR
aortic,I-PR
insufficiency,I-PR
.,O

The,O
LV,O
cavity,O
size,O
was,O
normal,O
.,O

The,B-TE
systolic,I-TE
function,I-TE
was,O
within,O
normal,O
limits,O
.,O

There,O
was,O
no,O
evidence,O
of,O
LV,B-PR
hypertrophy,I-PR
.,O

There,O
was,O
no,O
obvious,O
segmental,B-PR
wall-motion,I-PR
abnormality,I-PR
.,O

There,O
was,O
no,O
evidence,O
of,O
pericardial,B-PR
effusion,I-PR
.,O

The,O
right,O
ventricle,O
was,O
not,O
dilated,B-PR
.,O

The,B-TE
systolic,I-TE
function,I-TE
was,O
within,O
normal,O
limits,O
.,O

The,O
patient,O
underwent,O
a,B-TE
sleep,I-TE
study,I-TE
",",O
the,O
first,O
part,O
",",O
which,O
showed,O
that,O
he,O
had,O
75,B-PR
respiratory,I-PR
events,I-PR
observed,O
with,O
apnea,B-PR
",",O
hypopnea,B-TE
index,I-TE
of,O
11,O
an,O
hour,O
.,O

The,B-TE
mean,I-TE
heart,I-TE
rate,I-TE
was,O
68,O
.,O

They,O
felt,O
that,O
there,O
was,O
obstruction,B-PR
and,O
possible,O
obstruction,B-PR
to,I-PR
airflow,I-PR
generating,O
some,B-PR
obstructive,I-PR
apnea,I-PR
",",O
as,O
well,O
as,O
partial,B-PR
obstructive,I-PR
events,I-PR
.,O

They,O
recommended,O
that,O
the,O
patient,O
may,O
benefit,O
from,O
a,O
trial,O
of,O
continuous,B-TR
positive,I-TR
pressure,I-TR
at,I-TR
the,I-TR
bedside,I-TR
.,O

The,O
patient,O
has,O
been,O
scheduled,O
to,O
have,O
the,O
second,O
part,O
of,O
the,B-TE
sleep,I-TE
study,I-TE
done,O
on,O
June,O
18,O
",",O
2006,O
",",O
at,O
8:30,O
p.m.,O
at,O
RWH,O
in,O
the,O
Esley,O
Community,O
Hospital,O
",",O
10th,O
floor,O
sleep,O
lab,O
",",O
phone,O
number,O
133-225-1257,O
.,O

Prior,O
to,O
discharge,O
today,O
",",O
he,O
underwent,O
PFTs,B-TE
.,O

The,O
results,O
of,O
the,B-TE
PFTs,I-TE
are,O
unavailable,O
at,O
the,O
time,O
of,O
this,O
dictation,O
.,O

Based,O
on,O
all,B-TE
the,I-TE
tests,I-TE
above,I-TE
",",O
it,O
was,O
felt,O
that,O
the,O
patient,O
was,O
stable,O
for,O
discharge,O
home,O
.,O

His,B-TE
blood,I-TE
pressure,I-TE
was,O
114,O
to,O
123/62,O
.,O

Heart,B-TE
rate,I-TE
69,O
to,O
80,O
.,O

Room,B-TE
air,I-TE
saturation,I-TE
96%,O
.,O

Temperature,B-TE
97.9,O
.,O

Lung,B-TE
sounds,I-TE
clear,O
bilaterally,O
.,O

Heart,O
sounds,O
:,O

Regular,O
rate,O
and,O
rhythm,O
;,O
S1-S2,O
;,O
positive,O
S4,O
;,O
no,O
murmur,B-PR
.,O

Abdomen,O
:,O

Soft,O
",",O
nontender,O
",",O
nondistended,O
;,O
no,O
guarding,B-PR
;,O
no,O
masses,B-PR
;,O
positive,O
bowel,B-TE
sounds,I-TE
X4,O
.,O

Right,O
groin,O
status,B-PR
post,I-PR
catheterization,I-PR
showed,O
no,O
hematoma,B-PR
or,O
bruit,B-PR
.,O

Lower,B-TE
extremity,I-TE
pulses,I-TE
were,O
intact,O
without,O
any,O
edema,B-PR
.,O

Lab,O
values,O
:,O

Sodium,B-TE
139,O
;,O
potassium,B-TE
4.1,O
;,O
BUN,B-TE
15,O
;,O
creatinine,B-TE
1.1,O
;,O
magnesium,B-TE
1.6,O
;,O
SGPT,B-TE
19,O
;,O
SGOT,B-TE
20,O
;,O
alkaline,B-TE
phosphatase,I-TE
66,O
;,O
total,B-TE
bilirubin,I-TE
0.6,O
;,O
direct,B-TE
bilirubin,I-TE
0.2,O
;,O
total,B-TE
cholesterol,I-TE
234,O
;,O
triglycerides,B-TE
274,O
;,O
HDL,B-TE
44,O
;,O
LDL,B-TE
135,O
;,O
hemoglobin,B-TE
A1c,B-TE
6.7,O
;,O
white,B-TE
cell,I-TE
count,I-TE
6.1,O
;,O
hematocrit,B-TE
36.4,O
;,O
platelet,B-TE
count,I-TE
201,O
.,O

During,O
the,O
hospital,O
course,O
",",O
the,O
patient,O
was,O
started,O
on,O
a,B-TR
PPI,I-TR
",",O
Nexium,B-TR
",",O
for,O
concerns,O
of,O
acid,B-PR
reflux,I-PR
.,O

Also,O
",",O
a,O
long,O
discussion,O
was,O
taken,O
with,O
the,O
patient,O
as,O
most,O
of,O
his,B-PR
chest,I-PR
discomfort,I-PR
happens,O
when,O
he,O
is,O
quite,O
anxious,B-PR
.,O

He,O
used,O
Ativan,B-TR
in,O
the,O
hospital,O
",",O
which,O
helped,O
him,O
.,O

The,O
patient,O
was,O
advised,O
that,O
he,O
needs,O
to,O
speak,O
with,O
his,O
PCP,O
about,O
medication,B-TR
for,I-TR
antianxiety,I-TR
and,O
/,O
or,O
further,B-TE
testing,I-TE
or,O
counseling,B-TR
to,O
help,O
control,O
his,B-PR
anxiety,I-PR
level,I-PR
.,O

MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Nitroglycerin,B-TR
1,O
tablet,O
sublingual,O
q.,O
5,O
minutes,O
X3,O
p.r.n.,O
chest,B-PR
pain,I-PR
.,O

TriCor,B-TR
145,O
mg,O
p.o.,O
every,O
day,O
.,O

Lipitor,B-TR
40,O
mg,O
p.o.,O
every,O
day,O
.,O

Plavix,B-TR
75,O
mg,O
p.o.,O
every,O
day,O
.,O

Aspirin,B-TR
325,O
mg,O
p.o.,O
every,O
day,O
.,O

Lisinopril,B-TR
5,O
mg,O
p.o.,O
every,O
day,O
.,O

Avandia,B-TR
4,O
mg,O
p.o.,O
every,O
day,O
.,O

Toprol,B-TR
XL,I-TR
100,O
mg,O
p.o.,O
every,O
day,O
.,O

Prilosec,B-TR
20,O
mg,O
p.o.,O
every,O
day,O
.,O

Ativan,B-TR
0.5,O
mg,O
p.o.,O
b.i.d.,O
p.r.n.,O
anxiety,B-PR
.,O

The,O
patient,O
was,O
asked,O
to,O
follow,O
up,O
with,O
his,O
PCP,O
",",O
Dr.,O
Cora,O
Belbsnil,O
",",O
at,O
Necrestneysagiles,O
Medical,O
Center,O
in,O
a,O
period,O
of,O
1,O
to,O
2,O
weeks,O
.,O

He,O
was,O
asked,O
to,O
follow,O
up,O
with,O
Dr.,O
Riale,O
Tables,O
",",O
his,O
cardiologist,O
",",O
in,O
a,O
period,O
of,O
1,O
to,O
2,O
weeks,O
;,O
he,O
also,O
works,O
at,O
Necrestneysagiles,O
Medical,O
Center,O
.,O

The,O
patient,O
was,O
told,O
that,O
he,O
should,O
discus,O
with,O
his,O
PCP,O
further,B-TE
GI,I-TE
testing,I-TE
",",O
as,O
well,O
as,O
medications,B-TR
for,O
anxiety,B-PR
.,O

The,O
patient,O
will,O
need,O
to,O
have,O
a,B-TE
followup,I-TE
sleep,I-TE
study,I-TE
done,O
as,O
above,O
per,O
the,O
recommendations,O
based,O
on,O
the,O
results,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Stable,O
.,O

RYROL,O
DALEDAE,O
",",O
NP,O

DICTATING,O
FOR,O
:,O

Unreviewed,O

_____________________________,O
NAA,O
NARICHA,O
EARLY,O
",",O
M.D.,O

TR,O
:,O

so,O

DD,O
:,O

05/16/2006,O

TD,O
:,O

05/17/2006,O
7:29,O
A,O
501370,O

cc,O
:,O

NAA,O
NARICHA,O
EARLY,O
",",O
M.D.,O

817406016,O
RWH,O

3154334,O

554691,O

3547577,O

7/6/2005,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O

JEMSKOP,O
",",O
COT,O

MRN,O
:,O

3154334,O

Age,O
:,O

54y,O

REGISTRATION,O
DATE,O
:,O

07/06/2005,O
11:11,O
AM,O

PRELIMINARY,O
REPORT,O

This,O
is,O
to,O
notify,O
you,O
that,O
your,O
patient,O
",",O
JEMSKOP,O
",",O
COT,O
arrived,O
in,O
the,O
Emergency,O
Department,O
at,O
Ro,O
Woodma,O
Healthcare,O
on,O
07/06/2005,O
11:11,O
AM,O
.,O

The,O
patient,O
presented,O
with,O
a,O
chief,O
complaint,O
of,O
CP,B-PR
.,O

Following,O
evaluation,B-TE
and,O
treatment,B-TR
",",O
the,O
patient,O
&apos;s,O
disposition,O
at,O
the,O
end,O
of,O
the,O
visit,O
was,O
admitted,O
as,O
an,O
inpatient,O
to,O
Ro,O
Woodma,O
Healthcare,O
.,O

The,O
patient,O
&apos;s,O
preliminary,O
admitting,O
physician,O
is,O
KOTEDAIZREKE,O
",",O
LILA,O
and,O
the,O
preliminary,O
admitting,O
diagnosis,O
is,O
CP,B-PR
.,O

Please,O
note,O
this,O
information,O
may,O
have,O
been,O
updated,O
on,O
the,O
inpatient,O
unit,O
.,O

If,O
you,O
need,O
additional,O
information,O
please,O
call,O
662-747-1199,O
.,O

PCP,O
Name,O
:,O

TITCHEAGNERO,O
",",O
TO,O

Provider,O
Number,O
:,O

98076,O

825330116,O

HLGMC,O

6051380,O

10615/2646,O

8/15/1993,O
12:00:00,O
AM,O

ACUTE,B-PR
MYOCARDIAL,I-PR
INFARCTION,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ADMISSION,O
DATE,O
:,O

8-15-93,O

DISCHARGE,O
DATE,O
:,O

08-22-93,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Acute,B-PR
myocardial,I-PR
infarction,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

1.,O
Coronary,B-PR
artery,I-PR
disease,I-PR
",",O

2.,O
unstable,B-PR
angina,I-PR
(,I-PR
postmyocardial,I-PR
infarction,I-PR
angina,I-PR
),I-PR
",",O

3.,O
Parkinson,B-PR
&apos;s,I-PR
disease,I-PR
.,O

SPECIAL,O
PROCEDURES,O
AND,O
OPERATIONS,O
:,O

1.,O
Percutaneous,B-TR
transluminal,I-TR
coronary,I-TR
angioplasty,I-TR
and,O
coronary,B-TR
atherectomy,I-TR
of,I-TR
the,I-TR
left,I-TR
anterior,I-TR
descending,I-TR
",",O
8-17-93,O
",",O

2.,O
relook,O
coronary,B-TE
angiogram,I-TE
",",O
08-18-93,O
.,O

DOCTORS,O
DISCHARGE,O
ORDERS,O
AND,O
MEDICATIONS,O
ON,O
DISCHARGE,O
:,O

Ecotrin,B-TR
1,O
tablet,O
PO,O
qd,O
",",O
Captopril,B-TR
6.25,O
mg,O
PO,O
tid,O
",",O
K-Dur,B-TR
20,O
mEq.,O
PO,O
qd,O
",",O
Lasix,B-TR
20,O
mg,O
PO,O
qd,O
",",O
Isordil,B-TR
10,O
mg,O
PO,O
tid,O
",",O
Sinemet,B-TR
1/2,O
tablet,O
PO,O
bid,O
",",O
Symmetrel,B-TR
100,O
mg,O
PO,O
bid,O
",",O
Parloder,B-TR
2.5mg,O
PO,O
qd,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
58,O
year,O
old,O
female,O
with,O
a,O
history,O
of,O
Parkinson,B-PR
&apos;s,I-PR
disease,I-PR
for,O
more,O
than,O
twenty,O
years,O
who,O
presented,O
to,O
the,O
Gemenadentoolpai,O
Medical,O
Center,O
with,O
a,B-PR
revolving,I-PR
anterolateral,I-PR
wall,I-PR
myocardial,I-PR
infarction,I-PR
on,O
08-01-93,O
.,O

She,O
has,O
been,O
under,O
the,O
care,O
of,O
Dr.,O
Aalv,O
Manual,O
and,O
was,O
referred,O
here,O
for,O
further,B-TR
therapy,I-TR
.,O

She,O
had,O
no,O
prior,O
significant,O
cardiac,O
history,O
and,O
presented,O
to,O
her,O
local,O
medical,O
doctor,O
&apos;s,O
office,O
with,O
an,O
episode,O
of,O
severe,B-PR
retrosternal,I-PR
chest,I-PR
pain,I-PR
.,O

Her,B-TE
electrocardiogram,I-TE
showed,O
a,B-PR
new,I-PR
right,I-PR
bundle,I-PR
branch,I-PR
block,I-PR
and,O
left,B-PR
anterior,I-PR
hemiblock,I-PR
.,O

The,O
patient,O
was,O
transferred,O
to,O
the,O
Gemenadentoolpai,O
Medical,O
Center,O
and,O
was,O
admitted,O
.,O

Her,B-TR
hospital,I-TR
course,I-TR
was,O
remarkable,O
for,O
ruling,O
in,O
for,O
a,B-PR
myocardial,I-PR
infarction,I-PR
with,O
a,B-TE
peak,I-TE
CPK,I-TE
of,O
"9,379",O
units,O
with,O
a,O
5.9%,O
MB,O
fraction,O
.,O

In,O
addition,O
",",O
on,O
telemetry,B-TE
she,O
developed,O
complete,B-PR
heart,I-PR
block,I-PR
and,O
hypotension,B-PR
requiring,O
temporary,B-TR
pacing,I-TR
wire,I-TR
and,O
then,O
a,B-TR
permanent,I-TR
pacemaker,I-TR
implantation,I-TR
on,O
08-03-93,O
.,O

She,O
developed,O
congestive,B-PR
heart,I-PR
failure,I-PR
and,O
required,O
pressor,B-TR
support,I-TR
.,O

She,O
underwent,O
cardiac,B-TE
catheterization,I-TE
on,O
8-15-93,O
and,O
was,O
found,O
to,O
have,O
a,B-TE
left,I-TE
ventricular,I-TE
end,I-TE
diastolic,I-TE
pressure,I-TE
of,O
28,O
millimeters,O
of,O
mercury,O
.,O

She,O
had,O
a,B-PR
dominant,I-PR
right,I-PR
coronary,I-PR
artery,I-PR
with,O
minor,B-PR
disease,I-PR
.,O

The,O
main,O
left,O
coronary,O
artery,O
had,O
a,B-PR
20%,I-PR
stenosis,I-PR
.,O

The,O
left,O
anterior,O
descending,O
had,O
a,B-PR
severe,I-PR
80%,I-PR
proximal,I-PR
stenosis,I-PR
with,O
a,B-PR
filling,I-PR
defect,I-PR
consistent,O
with,O
intraluminal,B-PR
thrombus,I-PR
.,O

The,O
circumflex,O
artery,O
had,O
a,B-PR
minor,I-PR
40%,I-PR
stenosis,I-PR
.,O

Cine,B-TE
left,I-TE
ventriculogram,I-TE
revealed,O
a,B-PR
dilated,I-PR
left,I-PR
ventricle,I-PR
with,O
an,B-PR
area,I-PR
of,I-PR
anterolateral,I-PR
",",I-PR
apical,I-PR
",",I-PR
and,I-PR
septal,I-PR
akinesis,I-PR
.,O

The,B-TE
left,I-TE
ventricular,I-TE
ejection,I-TE
fraction,I-TE
was,O
estimated,O
to,O
38%,O
.,O

The,O
patient,O
was,O
transferred,O
to,O
the,O
Heaonboburg,O
Linpack,O
Grant,O
Medical,O
Center,O
for,O
consideration,O
of,O
coronary,B-TR
angioplasty,I-TR
.,O

CARDIAC,O
RISK,O
FACTORS,O
:,O

Her,B-PR
risk,I-PR
factors,I-PR
for,O
coronary,B-PR
artery,I-PR
disease,I-PR
included,O
a,B-PR
positive,I-PR
family,I-PR
history,I-PR
and,O
an,B-PR
elevated,I-PR
cholesterol,I-PR
level,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Her,O
past,O
medical,O
history,O
is,O
remarkable,O
for,O
a,O
history,O
of,O
Parkinson,B-PR
&apos;s,I-PR
disease,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Her,B-TE
physical,I-TE
examination,I-TE
at,O
the,O
time,O
of,O
admission,O
revealed,O
a,O
pleasant,O
lady,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

The,B-TE
blood,I-TE
pressure,I-TE
was,O
120/70,O
millimeters,O
of,O
mercury,O
.,O

Her,B-TE
pulse,I-TE
was,O
regular,O
at,O
80,O
beats,O
per,O
minute,O
.,O

The,B-TE
jugular,I-TE
venous,I-TE
pressure,I-TE
was,O
elevated,O
at,O
6,O
cm,O
above,O
the,O
sternal,O
angle,O
.,O

The,O
carotids,O
were,O
normal,O
.,O

The,O
chest,O
was,O
clear,O
.,O

The,B-TE
cardiac,I-TE
examination,I-TE
revealed,O
anapical,B-PR
impulse,I-PR
in,I-PR
the,I-PR
fifth,I-PR
left,I-PR
intercostal,I-PR
space,I-PR
",",O
left,O
to,O
mid,O
clavicular,O
line,O
.,O

The,O
first,O
sound,O
was,O
normal,O
.,O

The,O
second,O
sound,O
was,O
normally,O
split,O
.,O

She,O
had,O
no,O
murmurs,B-PR
and,O
no,O
gallops,B-PR
.,O

The,B-TE
examination,I-TE
the,I-TE
abdomen,I-TE
was,O
benign,O
.,O

The,B-TE
examination,I-TE
of,I-TE
the,I-TE
extremities,I-TE
showed,O
no,O
edema,B-PR
.,O

She,O
had,O
good,O
pulses,O
bilaterally,O
.,O

LABORATORY,O
DATA,O
:,O

Her,B-TE
electrocardiogram,I-TE
revealed,O
normal,O
sinus,O
rhythm,O
",",O
left,B-PR
atrial,I-PR
enlargement,I-PR
",",O
left,B-PR
axis,I-PR
deviation,I-PR
",",O
poor,B-PR
R-wave,I-PR
progression,I-PR
in,O
V1,O
through,O
V4,O
",",O
consistent,O
with,O
marked,O
clockwise,O
rotation,O
",",O
cannot,O
rule,O
out,O
an,B-PR
old,I-PR
anteroseptal,I-PR
wall,I-PR
myocardial,I-PR
infarction,I-PR
.,O

There,O
were,O
prominent,B-PR
Q-waves,I-PR
in,I-PR
AVL,I-PR
",",O
consistent,O
with,O
lateral,B-PR
myocardial,I-PR
infarction,I-PR
.,O

There,O
were,O
non-specific,B-PR
ST-T,I-PR
wave,I-PR
abnormalities,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
Medical,O
Service,O
.,O

The,O
patient,O
was,O
seen,O
in,O
consultation,O
by,O
the,O
Neurology,O
Department,O
because,O
of,O
the,O
history,O
of,O
Parkinson,B-PR
&apos;s,I-PR
disease,I-PR
.,O

The,O
patient,O
was,O
maintained,O
on,O
intravenous,B-TR
heparin,I-TR
.,O

On,O
8-17-93,O
",",O
she,O
was,O
taken,O
to,O
the,O
cardiac,O
catheterization,O
laboratory,O
where,O
she,O
underwent,O
percutaneous,B-TR
transluminal,I-TR
coronary,I-TR
angioplasty,I-TR
of,I-TR
the,I-TR
proximal,I-TR
left,I-TR
anterior,I-TR
descending,I-TR
.,O

Following,O
balloon,B-TR
angioplasty,I-TR
",",O
there,O
was,O
a,B-TR
local,I-TR
dissection,I-TR
with,O
evidence,O
of,O
intraluminal,B-PR
thrombus,I-PR
",",O
with,O
a,B-PR
greater,I-PR
than,I-PR
10%,I-PR
loss,I-PR
in,I-PR
the,I-PR
initial,I-PR
gain,I-PR
following,O
coronary,B-TR
angioplasty,I-TR
.,O

Therefore,O
",",O
directional,B-TR
coronary,I-TR
atherectomy,I-TR
was,O
performed,O
with,O
an,O
excellent,O
angiographic,O
outcome,O
",",O
and,O
a,B-PR
less,I-PR
than,I-PR
10%,I-PR
residual,I-PR
narrowing,I-PR
.,O

The,O
patient,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
.,O

She,O
was,O
maintained,O
on,O
intravenous,B-TR
heparin,I-TR
and,O
was,O
brought,O
back,O
to,O
the,B-TE
cardiac,I-TE
catheterization,I-TE
laboratory,I-TE
on,O
08-18-93,O
for,O
a,B-TE
relook,I-TE
coronary,I-TE
angiography,I-TE
.,O

Coronary,B-TE
angiography,I-TE
demonstrated,O
ongoing,O
benefit,O
of,O
the,B-TR
initial,I-TR
coronary,I-TR
atherectomy,I-TR
.,O

Specifically,O
",",O
there,O
was,O
no,O
decrease,O
in,O
the,O
initial,O
gain,O
that,O
she,O
achieved,O
after,O
directional,B-TR
atherectomy,I-TR
.,O

The,O
patient,O
remained,O
stable,O
during,O
the,O
rest,O
of,O
the,O
hospitalization,O
.,O

She,O
was,O
transferred,O
in,O
stable,O
condition,O
to,O
the,O
Pasi,O
for,O
further,B-TR
rehabilitation,I-TR
therapy,I-TR
.,O

RENLAN,O
FYFEZEIS,O
",",O
M.D.,O

Dr.,O
Aalv,O
Lorjes,O
Salv,O
Manual,O
Pasi,O

TR,O
:,O

jb,O
/,O
bmot,O

DD,O
:,O

9-17-93,O

TD,O
:,O

09/19/93,O

CC,O
:,O

837898389,O

CTMC,O

88360969,O

394521,O

11/24/1994,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

11/24/1994,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

1),O
RIGHT,B-PR
LOWER,I-PR
EXTREMITY,I-PR
PSEUDOMONAS,I-PR
CELLULITIS,I-PR
.,O

2),O
PAROXYSMAL,B-PR
ATRIAL,I-PR
FIBRILLATION,I-PR
.,O

3),O
CORD,B-PR
COMPRESSION,I-PR
.,O

4),O
STEROID,B-PR
INDUCED,I-PR
DIABETES,I-PR
MELLITUS,I-PR
.,O

5),O
PLASMACYTOMA,B-PR
.,O

6),O
POOR,B-PR
NUTRITIONAL,I-PR
STATUS,I-PR
.,O

7),O
THROMBOCYTOPENIA,B-PR
STATUS,O
POST,O
BONE,B-TR
MARROW,I-TR
TRANSPLANT,I-TR
.,O

8),O
MULTIPLE,B-PR
MYELOMA,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
is,O
a,O
59-year-old,O
white,O
male,O
.,O

The,O
patient,O
has,O
had,O
multiple,B-PR
myeloma,I-PR
since,O
1990,O
.,O

He,O
underwent,O
an,B-TR
autologous,I-TR
bone,I-TR
marrow,I-TR
transplant,I-TR
in,O
10/92,O
at,O
Petersly,O
Hospital,O
And,O
Medical,O
Center,O
.,O

At,O
that,O
time,O
he,O
received,O
total,B-TR
body,I-TR
irradiation,I-TR
of,O
1400,O
cGy,O
.,O

This,B-TR
bone,I-TR
marrow,I-TR
transplant,I-TR
did,O
not,O
produce,O
remission,O
and,O
then,O
he,O
was,O
treated,O
with,O
three,B-TR
cycles,I-TR
of,I-TR
VAD,I-TR
subsequently,O
.,O

In,O
08/94,O
",",O
the,O
patient,O
developed,O
lower,B-PR
back,I-PR
pain,I-PR
.,O

A,B-TE
workup,I-TE
done,O
in,O
DE,O
is,O
not,O
available,O
at,O
the,O
time,O
of,O
this,O
dictation,O
.,O

According,O
to,O
her,O
scanty,O
records,O
",",O
an,B-TE
MRI,I-TE
of,I-TE
the,I-TE
spine,I-TE
showed,O
diffuse,B-PR
spinal,I-PR
column,I-PR
involvement,I-PR
with,O
lesions,B-PR
in,I-PR
T4,I-PR
and,I-PR
T8,I-PR
with,O
no,O
cord,B-PR
compression,I-PR
at,O
that,O
time,O
.,O

He,O
was,O
then,O
treated,O
with,O
radiation,B-TR
therapy,I-TR
from,O
T3,O
to,O
T9,O
receiving,O
2500,O
cGy,O
from,O
08/94,O
to,O
09/94,O
.,O

He,O
has,O
been,O
on,O
Decadron,B-TR
since,O
08/94,O
.,O

About,O
two,O
weeks,O
prior,O
to,O
admission,O
the,O
patient,O
developed,O
mid,B-PR
back,I-PR
pain,I-PR
",",O
burning,O
in,O
nature,O
with,O
radiation,O
around,O
the,O
right,O
lower,O
ribs,O
.,O

He,O
also,O
began,O
to,O
develop,O
noticeably,B-PR
increasing,I-PR
bilateral,I-PR
lower,I-PR
extremity,I-PR
weakness,I-PR
and,O
possibly,O
numbness,B-PR
in,I-PR
the,I-PR
lower,I-PR
extremities,I-PR
.,O

He,O
stated,O
that,O
he,O
had,O
difficulty,B-PR
rising,I-PR
from,I-PR
a,I-PR
chair,I-PR
.,O

An,B-TE
MRI,I-TE
without,I-TE
gadolinium,I-TE
done,O
on,O
11/20/94,O
of,O
the,O
spine,O
showed,O
a,B-PR
right,I-PR
posterior,I-PR
lateral,I-PR
epidural,I-PR
mass,I-PR
extending,O
from,O
T9,O
to,O
T12,O
.,O

There,O
was,O
evidence,O
of,O
cord,B-PR
compression,I-PR
.,O

The,B-TR
patient,I-TR
&apos;s,I-TR
Decadron,I-TR
dose,I-TR
was,O
increased,O
to,O
12,O
mg,O
q,O
day,O
and,O
he,O
was,O
also,O
started,O
on,O
MS,B-TR
Contin,I-TR
and,O
radiation,B-TR
therapy,I-TR
was,O
being,O
planned,O
and,O
arranged,O
at,O
the,O
Petersly,O
Hospital,O
And,O
Medical,O
Center,O
.,O

However,O
",",O
one,O
day,O
prior,O
to,O
admission,O
the,O
patient,O
developed,O
right,B-PR
lower,I-PR
extremity,I-PR
pain,I-PR
and,O
could,O
not,O
walk,O
secondary,O
to,O
the,B-PR
pain,I-PR
.,O

Over,O
the,O
next,O
12,O
hours,O
while,O
in,O
transit,O
to,O
the,O
hospital,O
",",O
the,O
patient,O
&apos;s,O
right,O
lower,O
extremity,O
became,O
red,B-PR
",",O
swollen,B-PR
",",O
and,O
increasingly,B-PR
painful,I-PR
.,O

He,O
has,O
had,O
chronic,B-PR
bilateral,I-PR
lower,I-PR
extremity,I-PR
swelling,I-PR
since,O
his,B-TR
transplant,I-TR
but,O
the,B-PR
right,I-PR
lower,I-PR
extremity,I-PR
swelling,I-PR
was,O
noticeably,O
increased,O
.,O

He,O
also,O
complained,O
of,O
some,B-PR
fecal,I-PR
incontinence,I-PR
the,O
day,O
prior,O
to,O
admission,O
without,O
urinary,B-PR
incontinence,I-PR
.,O

At,O
the,O
time,O
of,O
presentation,O
the,O
patient,O
denied,O
headache,B-PR
",",O
arm,B-PR
weakness,I-PR
",",O
changes,B-PR
in,I-PR
vision,I-PR
",",O
dysarthria,B-PR
",",O
abdominal,B-PR
pain,I-PR
",",O
nausea,B-PR
or,O
vomiting,B-PR
",",O
chest,B-PR
pain,I-PR
or,O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

He,O
was,O
taken,O
to,O
Huyychestleme,O
Health,O
Of,O
in,O
Scoo,O
",",O
Utah,O
where,O
he,O
had,O
a,B-TE
temperature,I-TE
of,O
99.9,O
",",O
blood,B-TE
pressure,I-TE
90/50,O
",",O
heart,B-TE
rate,I-TE
128,O
",",O
and,O
O2,B-TE
sat,I-TE
of,O
91%,O
on,O
room,O
air,O
.,O

Blood,B-TE
cultures,I-TE
",",O
urine,B-TE
culture,I-TE
",",O
and,O
UA,B-TE
were,O
all,O
done,O
.,O

Blood,B-TE
cultures,I-TE
drawn,O
on,O
admission,O
subsequently,O
grew,O
Pseudomonas,B-PR
aeruginosa,I-PR
.,O

He,O
was,O
treated,O
with,O
Ceftazidime,B-TR
",",O
gentamicin,B-TR
",",O
and,O
Vancomycin,B-TR
and,O
also,O
was,O
started,O
on,O
a,B-TR
Dopamine,I-TR
drip,I-TR
for,O
treatment,O
of,O
his,B-PR
sepsis,I-PR
.,O

A,B-TE
Swan,I-TE
was,O
placed,O
and,O
initial,O
readings,O
were,O
CVP,B-TE
of,O
6,O
",",O
wedge,B-TE
pressure,I-TE
of,O
10,O
to,O
12,O
",",O
cardiac,B-TE
index,I-TE
of,O
4.7,O
",",O
and,O
SVR,B-TE
of,O
438,O
all,O
consistent,O
with,O
a,B-PR
Pseudomonas,I-PR
sepsis,I-PR
picture,I-PR
.,O

He,O
was,O
given,O
stress,B-TR
steroids,I-TR
and,O
was,O
subsequently,O
transferred,O
to,O
Lorough,O
Medical,O
Center,O
&apos;s,O
Intensive,O
Care,O
Unit,O
for,O
further,B-TR
management,I-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1),O
Multiple,B-PR
myeloma,I-PR
.,O

2),O
Paroxysmal,B-PR
atrial,I-PR
fibrillation,I-PR
.,O

3),O
Plasmacytoma,B-PR
of,I-PR
T9,I-PR
through,I-PR
T12,I-PR
.,O

4),O
Chronic,B-PR
renal,I-PR
insufficiency,I-PR
.,O

5),O
Chronically,B-PR
low,I-PR
platelet,I-PR
count,I-PR
.,O

6),O
Failed,B-TR
autologous,I-TR
bone,I-TR
marrow,I-TR
transplant,I-TR
in,O
10/92,O
.,O

7),O
Hypothyroidism,B-PR
.,O

FAMILY,O
HISTORY,O
:,O

Positive,O
for,O
diabetes,B-PR
mellitus,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

Married,O
to,O
a,O
very,O
supportive,O
wife,O
.,O

ALLERGIES,O
:,O

Question,O
of,O
penicillin,B-TR
and,O
sulfa,B-TR
drugs,I-TR
leading,O
to,O
a,B-PR
rash,I-PR
.,O

MEDICATIONS,O
:,O

On,O
transfer,O
include,O
Vancomycin,B-TR
",",O
Ceftazidime,B-TR
",",O
gentamicin,B-TR
",",O
Solu,B-TR
Cortef,I-TR
100,O
mg,O
q8h,O
",",O
Lasix,B-TR
",",O
Synthroid,B-TR
",",O
insulin,B-TR
",",O
MS,B-TR
Contin,I-TR
60,O
mg,O
b.i.d.,O
",",O
MSO4,B-TR
2,O
mg,O
p.r.n.,O
pain,B-PR
IV,O
",",O
Dopamine,B-TR
12,O
mcg,O
per,O
minute,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,O
showed,O
a,O
non-toxic,O
appearing,O
male,O
with,O
temperature,B-TE
99.5,O
",",O
blood,B-TE
pressure,I-TE
82/50,O
",",O
heart,B-TE
rate,I-TE
118,O
",",O
respiratory,B-TE
rate,I-TE
15,O
.,O

HEENT,B-TE
exam,I-TE
atraumatic,B-PR
",",O
no,O
oral,B-PR
lesions,I-PR
.,O

Neck,O
supple,O
",",O
carotids,O
without,O
bruits,B-PR
.,O

Cardiac,B-TE
exam,I-TE
was,O
regular,O
S1,O
and,O
S2,O
",",O
no,O
murmur,B-PR
.,O

Chest,O
clear,O
to,O
auscultation,B-TE
with,O
a,B-PR
few,I-PR
fine,I-PR
crackles,I-PR
at,I-PR
the,I-PR
left,I-PR
base,I-PR
.,O

Abdomen,O
non-distended,B-PR
",",O
positive,O
bowel,O
sounds,O
",",O
soft,O
",",O
non-tender,B-PR
",",O
no,O
hepatosplenomegaly,B-PR
or,O
masses,B-PR
.,O

Rectal,O
normal,O
tone,O
",",O
guaiac,B-PR
positive,I-PR
brown,I-PR
stool,I-PR
",",O
no,O
perirectal,B-PR
lesions,I-PR
or,O
erythema,B-PR
.,O

Extremities,O
reveal,O
the,O
right,O
lower,O
extremity,O
was,O
tense,B-PR
",",O
purple-red,B-PR
",",O
swollen,B-PR
",",O
and,O
was,O
warm,O
from,O
the,O
knee,O
to,O
the,O
ankle,O
and,O
extremely,B-PR
tender,I-PR
.,O

There,O
was,O
pitting,B-PR
edema,I-PR
of,I-PR
both,I-PR
lower,I-PR
extremities,I-PR
but,O
no,O
evidence,O
of,O
cellulitis,B-PR
of,I-PR
the,I-PR
left,I-PR
lower,I-PR
extremity,I-PR
.,O

Neurological,B-TE
exam,I-TE
on,I-TE
admission,I-TE
revealed,O
he,O
was,O
drowsy,B-PR
but,O
easily,O
arousable,O
to,O
voice,O
",",O
oriented,O
to,O
person,O
",",O
Retelk,O
County,O
Medical,O
Center,O
",",O
and,O
date,O
",",O
able,O
to,O
say,O
no,O
but,O
mildly,B-PR
inattentive,I-PR
during,O
examination,B-TE
.,O

Cranial,O
nerves,O
intact,O
.,O

Motor,B-TE
exam,I-TE
normal,O
tone,O
",",O
positive,B-PR
asterixis,I-PR
",",O
no,O
drift,O
.,O

Strength,O
was,O
decreased,O
in,O
both,O
lower,O
extremities,O
.,O

Coordination,O
was,O
normal,O
with,O
good,O
finger,O
to,O
nose,O
",",O
gait,O
was,O
not,O
tested,O
.,O

Deep,B-TE
tendon,I-TE
reflexes,I-TE
were,O
2+,O
in,O
the,O
upper,O
extremities,O
",",O
1+,O
in,O
the,O
patella,B-TE
reflexes,I-TE
",",O
no,B-PR
reflexes,I-PR
at,I-PR
the,I-PR
ankles,I-PR
",",O
upgoing,O
Babinski,O
toes,O
bilaterally,O
.,O

LABORATORY,O
DATA,O
:,O

On,O
admission,O
revealed,O
white,B-TE
blood,I-TE
cell,I-TE
count,I-TE
4.2,O
",",O
Hct,B-TE
27,O
",",O
platelet,B-TE
count,I-TE
28,O
.,O

Glucose,B-TE
191,O
.,O

PT,B-TE
17.6,O
",",O
PTT,B-TE
48.7,O
",",O
fibrinogen,B-TE
686,O
",",O
TT,B-TE
39.2,O
.,O

Magnesium,B-TE
1.7,O
.,O

UA,B-TE
showed,O
no,O
white,O
blood,O
cells,O
",",O
positive,B-PR
granular,I-PR
casts,I-PR
.,O

Chest,B-TE
x-ray,I-TE
was,O
without,O
infiltrates,B-PR
",",O
wand,O
in,O
good,O
position,O
.,O

An,B-TE
MRI,I-TE
was,O
performed,O
upon,O
admission,O
and,O
showed,O
an,B-PR
epidural,I-PR
mass,I-PR
at,O
the,O
right,O
posterior,O
lateral,O
T9,O
to,O
T12,O
area,O
invading,O
the,O
neural,O
foramina,O
.,O

There,O
was,O
no,O
CSF,B-PR
density,I-PR
.,O

These,B-PR
findings,I-PR
were,O
consistent,O
with,O
the,B-PR
cord,I-PR
compression,I-PR
.,O

HOSPITAL,O
COURSE,O
:,O

By,O
problems,O
-,O

1),O
INFECTIOUS,O
DISEASE,O
/,O
CELLULITIS,O
:,O

The,B-PR
patient,I-PR
&apos;s,I-PR
clinical,I-PR
situation,I-PR
was,O
most,O
consistent,O
with,O
a,B-PR
Pseudomonas,I-PR
cellulitis,I-PR
and,O
subsequent,B-PR
sepsis,I-PR
.,O

Blood,B-TE
cultures,I-TE
drawn,O
at,O
the,O
outside,O
hospital,O
grew,O
out,O
Pseudomonas,B-PR
that,O
was,O
sensitive,O
to,O
Imipenem,B-TR
and,O
Tobramycin,B-TR
.,O

There,O
were,O
cultures,B-TE
obtained,O
seeping,O
from,O
the,B-PR
wound,I-PR
at,O
Retelk,O
County,O
Medical,O
Center,O
and,O
those,O
also,O
grew,O
out,O
Pseudomonas,B-PR
aeruginosa,I-PR
.,O

The,B-PR
organism,I-PR
grown,O
at,O
this,O
institution,O
was,O
sensitive,O
to,O
Imipenem,B-TR
",",O
Ceftazidime,B-TR
",",O
Amikacin,B-TR
",",O
gentamicin,B-TR
",",O
Ciprofloxacin,B-TR
",",O
Tobramycin,B-TR
but,O
was,O
resistant,O
to,O
Cefotetan,B-TR
",",O
Ceftriaxone,B-TR
",",O
Mezlocillin,B-TR
",",O
Bactrim,B-TR
",",O
Ampicillin,B-TR
",",O
chloramphenicol,B-TR
",",O
and,O
sulbactam,B-TR
.,O

He,O
was,O
treated,O
initially,O
with,O
Ceftazidime,B-TR
and,O
gentamicin,B-TR
but,O
there,O
was,O
a,O
question,O
about,O
the,B-PR
organism,I-PR
&apos;s,I-PR
susceptibility,I-PR
from,O
lab,B-TE
studies,I-TE
done,O
at,O
the,O
outside,O
hospital,O
.,O

He,O
was,O
subsequently,O
switched,O
to,O
Imipenem,B-TR
and,O
Tobramycin,B-TR
and,O
was,O
maintained,O
on,O
those,B-TR
medications,I-TR
throughout,O
the,O
hospital,O
course,O
.,O

The,B-TR
Tobramycin,I-TR
and,O
Imipenem,B-TR
were,O
started,O
on,O
11/25/94,O
.,O

In,O
addition,O
",",O
the,O
patient,O
received,O
a,O
five,O
day,O
course,O
of,O
intravenous,B-TR
IgG,I-TR
to,O
improve,O
infection,B-TR
control,I-TR
.,O

Vancomycin,B-TR
was,O
also,O
added,O
to,O
his,B-TR
regimen,I-TR
on,O
11/28/94,O
and,O
this,O
was,O
primarily,O
to,O
provide,O
improved,B-TR
MRSA,I-TR
coverage,I-TR
as,O
he,O
continued,O
to,O
have,O
erythema,B-PR
along,I-PR
the,I-PR
lateral,I-PR
right,I-PR
lower,I-PR
extremity,I-PR
.,O

He,O
was,O
evaluated,O
by,O
the,O
Surgery,O
Department,O
and,O
it,O
is,O
there,O
feeling,O
that,O
there,O
is,O
no,O
indication,O
for,O
surgical,B-TR
intervention,I-TR
/,O
amputation,B-TR
at,O
this,O
time,O
.,O

He,O
is,O
being,O
maintained,O
with,O
twice,O
daily,O
Xeroform,B-TR
with,O
Betadine,B-TR
changes,O
.,O

These,B-TR
dressing,I-TR
changes,I-TR
are,O
applied,O
by,O
applying,O
the,O
Xeroform,B-TR
on,O
Betadine,B-TR
initially,O
and,O
then,O
changing,O
it,O
with,O
sterile,B-TR
dry,I-TR
bandages,I-TR
.,O

Of,O
note,O
",",O
the,O
patient,O
has,O
extreme,B-PR
pain,I-PR
with,O
these,B-TR
dressing,I-TR
changes,I-TR
and,O
requires,O
parenteral,B-TR
morphine,I-TR
sulfate,I-TR
for,O
pain,B-PR
control,I-PR
during,I-PR
dressing,I-PR
changes,I-PR
.,O

The,O
plan,O
is,O
to,O
complete,O
a,O
full,O
course,O
of,O
Imipenem,B-TR
and,O
Tobramycin,B-TR
for,O
his,B-PR
Pseudomonas,I-PR
cellulitis,I-PR
.,O

As,O
mentioned,O
earlier,O
he,O
continues,O
to,O
have,O
erythema,B-PR
tracking,O
up,O
his,O
leg,O
and,O
up,O
to,O
his,O
lateral,O
thigh,O
.,O

The,O
cause,O
of,O
this,B-PR
erythema,I-PR
is,O
not,O
know,O
at,O
this,O
time,O
but,O
has,O
not,O
shown,O
extensive,O
progression,O
.,O

2),O
CARDIOVASCULAR,O
:,O

The,O
patient,O
was,O
initially,O
treated,O
with,O
Dopamine,B-TR
which,O
was,O
subsequently,O
weaned,O
off,O
after,O
his,B-PR
sepsis,I-PR
improved,O
.,O

He,O
was,O
noted,O
to,O
be,O
in,O
rapid,B-PR
AF,I-PR
on,O
several,O
episodes,O
receiving,O
5,B-TR
mg,I-TR
IV,I-TR
Lopressor,I-TR
each,O
time,O
with,O
improvement,O
.,O

He,O
has,O
been,O
in,O
and,O
out,O
of,O
atrial,B-PR
fibrillation,I-PR
and,O
normal,O
sinus,O
rhythm,O
.,O

An,B-TE
echocardiogram,I-TE
performed,O
at,O
the,O
outside,O
hospital,O
while,O
he,O
was,O
septic,B-PR
showed,O
decreased,B-PR
global,I-PR
EF,I-PR
.,O

The,O
patient,O
is,O
being,O
maintained,O
on,O
Digoxin,B-TR
for,O
his,B-PR
paroxysmal,I-PR
atrial,I-PR
fibrillation,I-PR
.,O

He,O
has,O
had,O
no,O
significant,O
episode,O
of,O
tachycardia,B-PR
or,O
blood,B-PR
pressure,I-PR
alteration,I-PR
during,O
the,O
final,O
days,O
of,O
hospitalization,O
.,O

The,O
plan,O
is,O
to,O
continue,O
the,B-TR
Digoxin,I-TR
and,O
to,O
recheck,O
an,B-TE
echocardiogram,I-TE
to,O
assess,O
his,B-TE
ejection,I-TE
fraction,I-TE
when,O
he,O
is,O
clinically,O
better,O
.,O

3),O
ONCOLOGY,O
:,O

The,O
patient,O
has,O
a,B-PR
plasmacytoma,I-PR
affecting,O
the,O
spine,O
.,O

He,O
has,O
been,O
receiving,O
radiation,B-TR
therapy,I-TR
to,O
that,O
area,O
during,O
the,O
hospital,O
stay,O
.,O

The,O
plan,O
is,O
to,O
complete,O
a,O
full,O
course,O
of,O
XRT,B-TR
to,I-TR
the,I-TR
spinal,I-TR
region,I-TR
for,O
the,B-PR
plasmacytoma,I-PR
.,O

The,B-PR
patient,I-PR
&apos;s,I-PR
lesion,I-PR
compressing,O
his,O
thoracic,O
spine,O
was,O
never,O
biopsied,O
",",O
however,O
",",O
the,B-TE
MRI,I-TE
appearance,O
does,O
not,O
seem,O
to,O
be,O
infectious,B-PR
and,O
is,O
most,O
consistent,O
with,O
plasmacytoma,B-PR
for,O
which,O
he,O
is,O
receiving,O
the,B-TR
radiation,I-TR
therapy,I-TR
.,O

4),O
NEUROLOGIC,O
:,O

As,O
mentioned,O
above,O
he,O
has,O
a,B-PR
cord,I-PR
compression,I-PR
and,O
is,O
on,O
steroids,B-TR
.,O

He,O
was,O
initially,O
treated,O
with,O
IV,B-TR
Decadron,I-TR
10,O
mg,O
up,O
front,O
and,O
then,O
6,O
mg,O
q6h.,O

His,B-TE
neurological,I-TE
exam,I-TE
remained,O
stable,O
with,O
no,O
evidence,O
of,O
increasing,B-PR
lower,I-PR
extremity,I-PR
edema,I-PR
.,O

His,B-TR
Decadron,I-TR
dose,I-TR
was,O
titrated,O
down,O
to,O
5,O
mg,O
IV,O
q6h,O
on,O
12/3/94,O
.,O

His,B-TR
Decadron,I-TR
dose,I-TR
will,O
be,O
slowly,O
titrated,O
down,O
over,O
time,O
following,O
his,B-TE
neurological,I-TE
exam,I-TE
closely,O
.,O

5),O
BLOOD,O
SUGARS,O
:,O

The,O
patient,O
has,O
steroid,B-PR
induced,I-PR
diabetes,I-PR
mellitus,I-PR
.,O

He,O
has,O
been,O
on,O
increasing,B-TR
doses,I-TR
of,I-TR
insulin,I-TR
receiving,O
NPH,B-TR
in,O
the,O
morning,O
and,O
night,O
in,O
addition,O
to,O
a,B-TR
CZI,I-TR
sliding,I-TR
scale,I-TR
on,O
a,O
q6h,O
basis,O
.,O

The,O
plan,O
is,O
to,O
continue,O
the,B-TR
supplemental,I-TR
insulin,I-TR
while,O
he,O
is,O
on,O
steroids,B-TR
and,O
while,O
his,B-TE
sugars,I-TE
remain,O
high,O
.,O

6),O
RESPIRATORY,O
:,O

He,O
initially,O
required,O
a,B-TR
face,I-TR
mask,I-TR
to,O
keep,O
his,B-TE
saturation,I-TE
above,O
90%,O
.,O

However,O
",",O
with,O
increasing,B-TR
diuresis,I-TR
and,O
improving,B-PR
septic,I-PR
pictures,I-PR
his,B-TE
O2,I-TE
saturations,I-TE
have,O
improved,O
and,O
he,O
is,O
now,O
on,O
nasal,B-TR
cannula,I-TR
and,O
will,O
be,O
maintained,O
on,O
nasal,B-TR
cannula,I-TR
to,O
keep,O
his,B-TE
sat,I-TE
above,O
93%,O
.,O

He,O
can,O
be,O
given,O
intravenous,B-TR
Lasix,I-TR
as,O
needed,O
for,O
any,O
evidence,O
of,O
respiratory,B-PR
compromise,I-PR
or,O
increasing,B-PR
pulmonary,I-PR
edema,I-PR
.,O

7),O
NUTRITION,O
:,O

The,O
patient,O
has,O
a,B-PR
poor,I-PR
nutritional,I-PR
status,I-PR
with,O
hypoalbuminemia,B-PR
.,O

He,O
has,O
been,O
maintained,O
on,O
tube,B-TR
feeds,I-TR
and,O
that,O
should,O
be,O
continued,O
.,O

He,O
should,O
also,O
be,O
encouraged,O
to,O
eat,O
as,O
much,O
as,O
possible,O
orally,O
in,O
addition,O
to,O
this,B-TR
tube,I-TR
feeds,I-TR
and,O
aspiration,B-TR
precaution,I-TR
should,O
be,O
maintained,O
.,O

8),O
ELEVATED,B-PR
PT,I-PR
and,I-PR
PTT,I-PR
:,O

Both,O
of,O
these,O
responded,O
to,O
three,O
day,O
course,O
of,O
vitamin,B-TR
K,I-TR
10,O
mg,O
each,O
day,O
.,O

His,B-TE
PT,I-TE
and,O
PTT,B-TE
are,O
now,O
normal,O
",",O
however,O
",",O
he,O
continues,O
to,O
run,O
a,B-PR
low,I-PR
platelet,I-PR
count,I-PR
.,O

This,O
has,O
been,O
evident,O
since,O
the,O
time,O
of,O
his,B-TR
bone,I-TR
marrow,I-TR
transplant,I-TR
.,O

We,O
have,O
been,O
transfusing,O
him,O
with,O
platelets,B-TR
to,O
keep,O
his,B-TE
counts,I-TE
above,O
"20,000",O
to,O
reduce,O
his,B-PR
bleeding,I-PR
risk,I-PR
.,O

He,O
also,O
received,O
several,B-TR
blood,I-TR
transfusions,I-TR
while,O
here,O
to,O
maintain,O
his,B-TE
Hct,I-TE
around,O
30,O
.,O

Thrombocytopenic,B-TR
inducing,I-TR
drugs,I-TR
should,O
be,O
avoided,O
if,O
possible,O
on,O
this,O
patient,O
.,O

DISPOSITION,O
:,O

DISCHARGE,O
MEDICATIONS,O
:,O

Tylenol,B-TR
650,O
mg,O
po,O
q4h,O
p.r.n.,O
",",O
Dulcolax,B-TR
10,O
mg,O
per,O
rectum,O
b.i.d.,O
p.r.n.,O
",",O
Decadron,B-TR
5,O
mg,O
IV,O
q6h,O
",",O
Digoxin,B-TR
0.25,O
mg,O
po,O
q,O
day,O
",",O
Colace,B-TR
100,O
mg,O
po,O
t.i.d.,O
",",O
Florinef,B-TR
0.1,O
mg,O
po,O
q,O
day,O
for,O
presumed,O
adrenal,B-PR
insufficiency,I-PR
",",O
Imipenem,B-TR
500,O
mg,O
IV,O
q6h,O
",",O
insulin,B-TR
NPH,I-TR
60,O
units,O
subcu,O
q,O
a.m.,O
",",O
insulin,B-TR
NPH,I-TR
20,O
units,O
subcu,O
q,O
p.m.,O
",",O
insulin,B-TR
CZI,I-TR
sliding,I-TR
scale,I-TR
regular,I-TR
",",O
Synthroid,B-TR
125,O
mcg,O
po,O
q,O
day,O
",",O
magnesium,B-TR
sliding,I-TR
scale,I-TR
",",O
potassium,B-TR
sliding,I-TR
scale,I-TR
today,O
",",O
morphine,B-TR
sulfate,I-TR
IV,I-TR
p.r.n.,O
dressing,B-TR
changes,I-TR
and,O
breakthrough,B-PR
pain,I-PR
",",O
Carafate,B-TR

Dicatated,O
By,O
:,O

LAYMIE,O
WHITE,O
",",O
M.D.,O
WE01,O

Attending,O
:,O

TAMYRCLEO,O
N.,O
BACK,O
",",O
M.D.,O
GP0,O
EA855/4665,O

Batch,O
:,O

669,O

Index,O
No.,O
FXZQ7B8JJX,O

D,O
:,O

12/03/94,O

T,O
:,O

12/03/94,O

839999049,O
YC,O

59242403,O

431924,O

11/01/2000,O
12:00:00,O
AM,O

Obstructive,B-PR
Sleep,I-PR
Apnea,I-PR

DIS,O

Admission,O
Date,O
:,O

11/01/2000,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

11/04/2000,O

******,O
DISCHARGE,O
ORDERS,O
******,O

BREUNCLONTSTREAUAYLES,O
",",O
BINTRIREE,O

766-50-79-4,O
H55,O

Room,O
:,O

42Z-770,O

Service,O
:,O

MED,O

DISCHARGE,O
PATIENT,O
ON,O
:,O
11/04/00,O
AT,O
03:00,O
PM,O

CONTINGENT,O
UPON,O

Not,O
Applicable,O

WILL,O
D,O
/,O
C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D,O
/,O
C,O
SUMMARY,O
:,O

YES,O

Attending,O
:,O

AISTAKEFLICHSKI,O
",",O
TAINE,O
D.,O
",",O
M.D.,O

CODE,O
STATUS,O
:,O

Full,O
code,O

DISPOSITION,O
:,O

Home,O

DISCHARGE,O
MEDICATIONS,O
:,O

WELLBUTRIN,B-TR
(,I-TR
BUPROPION,I-TR
HCL,I-TR
),I-TR
150,O
MG,O
PO,O
BID,O
FOLATE,B-TR
(,I-TR
FOLIC,I-TR
ACID,I-TR
),I-TR
1,O
MG,O
PO,O
QD,O
ATIVAN,B-TR
(,I-TR
LORAZEPAM,I-TR
),I-TR
1,O
MG,O
PO,O
Q12H,O
X,O
1,O
Days,O
ATIVAN,B-TR
(,I-TR
LORAZEPAM,I-TR
),I-TR
1,O
MG,O
PO,O
QHS,O
X,O
7,O
Days,O
Starting,O
on,O
11/5,O
MVI,B-TR
THERAPEUTIC,I-TR
W,I-TR
/,I-TR
MINERALS,I-TR
(,I-TR
THERAP,I-TR
VITS,I-TR
/,I-TR
MINERALS,I-TR
),I-TR
1,O
TAB,O
PO,O
QD,O

Alert,O
overridden,O
:,O

Override,O
added,O
on,O
11/03/00,O
by,O
TWADA,O
",",O
STASTERL,O
ETHESHI,O
",",O
M.D.,O

POTENTIALLY,O
SERIOUS,O
INTERACTION,O
:,O

SIMVASTATIN,B-TR
and,O
NIACIN,B-TR
",",O
VIT.,B-TR

B-3,B-TR
Reason,O
for,O
override,O
:,O

indicated,O
THIAMINE,B-TR
(,I-TR
THIAMINE,I-TR
HCL,I-TR
),I-TR
100,O
MG,O
PO,O
QD,O
SIMVASTATIN,B-TR
40,O
MG,O
PO,O
QHS,O

Override,O
Notice,O
:,O

Override,O
added,O
on,O
11/03/00,O
by,O
TWADA,O
",",O
STASTERL,O
ETHESHI,O
",",O
M.D.,O
on,O
order,O
for,O
MVI,B-TR
THERAPEUTIC,I-TR
W,I-TR
/,I-TR
MINERALS,I-TR
PO,I-TR
(,O
ref,O
#,O
90299469,O
),O

POTENTIALLY,O
SERIOUS,O
INTERACTION,O
:,O

SIMVASTATIN,B-TR
and,O
NIACIN,B-TR
",",O
VIT.,B-TR
B-3,I-TR

Reason,O
for,O
override,O
:,O

indicated,O
LISINOPRIL,B-TR
10,O
MG,O
PO,O
QD,O
NICOTINE,B-TR
PATCH,I-TR
(,I-TR
NICOTINE,I-TR
),I-TR
21,O
MG/DAY,O
TP,O
Q24H,O

DIET,O
:,O

House,O
/,O
NAS,O
/,O
Low,O
chol,O
/,O
low,O
sat.,O
fat,O
&lt;,O
FDI,O
&gt;,O

RETURN,O
TO,O
WORK,O
:,O

Immediately,O

FOLLOW,O
UP,O
APPOINTMENT,O
(,O
S,O
),O
:,O

Firmert,O
Hospital,O
11/6,O
at,O
9am,O
scheduled,O
",",O
Cialneinsisters,O
Hospital,O
And,O
Medical,O
Center,O
11/16,O
at,O
8:15pm,O
scheduled,O
",",O
Dr.,O
Condnort,O
12/04,O
at,O
2pm,O
scheduled,O
",",O
Dr.,O
Lila,O
Spielbjaque,O
12/01,O
at,O
1:50pm,O
scheduled,O
",",O
No,O
Known,B-PR
Allergies,I-PR

ADMIT,O
DIAGNOSIS,O
:,O

r,O
/,O
o,O
MI,B-PR

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O

Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O
Obstructive,B-PR
Sleep,I-PR
Apnea,I-PR

OTHER,O
DIAGNOSIS,O
;,O

Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O
HTN,B-PR
tobacco,O
EtOh,O
abuse,O
sinus,B-PR
bradycardia,I-PR

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O

BRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

50,O
yo,O
M,O
from,O
Taheimpromong,O
admitted,O
w,O
/,O
CP,B-PR
for,O
r,O
/,O
o,O
MI,B-PR
.,O

Has,O
significant,B-PR
cardiac,I-PR

RF,O
:,O

FH,O
",",O
HTN,B-PR
",",O
tobacco,O
.,O

Presented,O
w,O
/,O
epigastric,B-PR
pain,I-PR
",",O
SOB,B-PR
at,O
work,O
.,O

ETT,B-TE
was,O
negative,O
for,O
ischemia,B-PR
.,O

Echo,B-TE
showed,O
ef,B-TE
45-50%,O
",",O
with,O
mild,B-PR
dilatation,I-PR
and,O
no,O
significant,B-PR
valvular,I-PR
disease,I-PR
",",O
and,O
nl,O
PAP,O
.,O

ACE,O
team,O
consulted,O
who,O
arranged,O
for,O
pt,O
to,O
have,O
outpt,O
follow,O
up,O
.,O

During,O
this,O
hospitalization,O
",",O
pt,O
was,O
noted,O
to,O
have,O
sinus,B-PR
bradycardia,I-PR
and,O
pauses,B-PR
",",O
associated,O
with,O
desaturations,B-PR
in,I-PR
the,I-PR
70,I-PR
&apos;s,I-PR
.,O

CPAP,B-TR
at,O
5,O
was,O
attempted,O
",",O
but,O
pt,O
did,O
not,O
tolerate,O
this,O
.,O

He,O
will,O
have,O
outpt,B-TR
fitting,I-TR
at,O
the,O
sleep,O
center,O
in,O
Sabo,O
.,O

Pt,O
also,O
counselled,O
re,O
:,O

quitting,O
smoking,O
",",O
and,O
he,O
appears,O
motivated,O
to,O
do,O
so,O
",",O
as,O
well,O
as,O
to,O
cut,O
down,O
on,O
his,O
drinking,O
.,O

ADDITIONAL,O
COMMENTS,O
:,O

1.,O
llame,O
a,O
su,O
doctor,O
y,O
haga,O
cita,O
para,O
verlo,O
dentro,O
de,O
1,O
semana,O
.,O

2.,O
llame,O
a,O
la,O
clinica,O
the,O
Wake,O
Valley,O
Hospital,O
442/961-2446,O
",",O
si,O
tiene,O
que,O
cambiar,O
la,O
cita,O
.,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O

TO,O
DO,O
/,O
PLAN,O
:,O

No,O
dictated,O
summary,O

ENTERED,O
BY,O
:,O

LARDES,O
",",O
COLNKAY,O
",",O
M.D.,O
(,O
IP09,O
),O
11/04/00,O
03:34,O
PM,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

843566350,O
RWH,O

25596,O

526208,O

555812,O

1/12/2005,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O
/,O
SUMMARY,O

KOTEA,O
",",O
TORTHEOA,O

MRN,O
:,O

25596,O

Age,O
:,O

47y,O

REGISTRATION,O
DATE,O
:,O

01/12/2005,O
06:07,O
AM,O

Provider,O
:,O

THAA,O
WAGES,O

PRELMINARY,O
REPORT,O

Benefits,O
Assigned,O
:,O

N,O

Discharge,O
Note,O

Date,O
/,O
Time,O
:,O

01/12/2005,O
09:17,O

Discharge,O
Status,O
:,O

Discharged,O

Condition,O
on,O
Discharge,O
:,O

Stable,O

Patient,O
States,O
Complaint,O
:,O

MIGRAINES,B-PR
FOR,O
10,O
DAYS,O

Standardized,O
Discharge,O
Instructions,O
:,O

The,O
patient,O
was,O
given,O
printed,O
instructions,O
for,O
headache,B-PR
(,O
English,O
),O
.,O

Diagnosis,O
:,O

Headache,B-PR

Treatment,O
Rendered,O
:,O

MD,B-TR
evaluation,I-TR
",",O
head,B-TE
CT,I-TE

Discharge,O
Medications,O
:,O

None,O

Follow,O
up,O
Service,O
:,O

Please,O
follow,O
up,O
with,O
Dr.,O
Ner,O

PCP,O
Name,O
:,O

ANERM,O
",",O
CHRETTA,O

Provider,O
Number,O
:,O

25911,O

This,O
report,O
was,O
created,O
by,O
WAGES,O
",",O
THAA,O
01/12/2005,O
09:18,O
AM,O

853262744,O

OMH,O

8223316,O

121051,O

7/10/2002,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O

SCOBE,O
",",O
RYLALON,O

MRN,O
:,O

8223316,O

Age,O
:,O

87y,O

REGISTRATION,O
DATE,O
:,O

07/10/2002,O
11:45,O
AM,O

PRELIMINARY,O
REPORT,O

This,O
is,O
to,O
notify,O
you,O
that,O
your,O
patient,O
",",O
SCOBE,O
",",O
RYLALON,O
arrived,O
in,O
the,O
Emergency,O
Department,O
at,O
Oaksgekesser/,O
Memorial,O
Hospital,O
on,O
07/10/2002,O
11:45,O
AM,O
.,O

The,O
patient,O
presented,O
with,O
a,O
chief,O
complaint,O
of,O
SOB,B-PR
.,O

Following,O
evaluation,B-TE
and,O
treatment,B-TR
",",O
the,O
patient,O
&apos;s,O
disposition,O
at,O
the,O
end,O
of,O
the,O
visit,O
was,O
ADMITTED,O
AS,O
AN,O
INPATIENT,O
TO,O
OAKSGEKESSER/,O
MEMORIAL,O
HOSPITAL,O
.,O

The,O
patient,O
&apos;s,O
preliminary,O
admitting,O
physician,O
is,O
BRITTSFYFEAST,O
",",O
SHER,O
T,O
and,O
the,O
preliminary,O
diagnosis,O
is,O
S,O
/,O
SOB,B-PR
.,O

Please,O
note,O
this,O
information,O
may,O
have,O
been,O
updated,O
on,O
the,O
inpatient,O
unit,O
.,O

If,O
you,O
need,O
additional,O
information,O
please,O
call,O
187-715-4303.,O

PCP,O
Name,O
:,O

NEIGHROBLIN,O
",",O
RETTE,O
R,O

Provider,O
Number,O
:,O

74337,O

869436718,O
SC,O

64806295,O

6613471,O

10/1/2003,O
12:00:00,O
AM,O

post,O
partum,O

DIS,O

Admission,O
Date,O
:,O

10/01/2003,O

Report,O
Status,O
:,O

Discharge,O
Date,O
:,O

10/04/2003,O

******,O
DISCHARGE,O
ORDERS,O
******,O

KULRINNE,O
",",O
RYYELEGE,O
N,O

386-85-38-0,O
X32,O

Room,O
:,O

JQL5-545,O

Service,O
:,O

OBS,O

DISCHARGE,O
PATIENT,O
ON,O
:,O

10/04/03,O
AT,O
10:00,O
AM,O

CONTINGENT,O
UPON,O

Not,O
Applicable,O

WILL,O
D,O
/,O
C,O
ORDER,O
BE,O
USED,O
AS,O
THE,O
D,O
/,O
C,O
SUMMARY,O
:,O

YES,O

Attending,O
:,O

KOTEJOASTHOREUPHKAYS,O
",",O
GAI,O
",",O
M.D.,O

DISPOSITION,O
:,O

Home,O

DISCHARGE,O
MEDICATIONS,O
:,O

TYLENOL,B-TR
(,I-TR
ACETAMINOPHEN,I-TR
),I-TR
650,O
MG,O
PO,O
Q4H,O
PRN,O
PAIN,B-PR

Alert,O
overridden,O
:,O

Override,O
added,O
on,O
10/01/03,O
by,O
KOTEJOASTHOREUPHKAYS,O
",",O
GAI,O
",",O
M.D.,O

POTENTIALLY,O
SERIOUS,O
INTERACTION,O
:,O

ACETAMINOPHEN,B-TR
and,O
ACETAMINOPHEN,B-TR

Reason,O
for,O
override,O
:,O

ok,O

COLACE,B-TR
(,I-TR
DOCUSATE,I-TR
SODIUM,I-TR
),I-TR
100,O
MG,O
PO,O
BID,O
IBUPROFEN,B-TR
600,O
MG,O
PO,O
Q4H,O
PRN,O
PAIN,B-PR

Food,O
/,O
Drug,O
Interaction,O
Instruction,O

Take,O
with,O
food,O
MILK,B-TR
OF,I-TR
MAGNESIA,I-TR
(,I-TR
MAGNESIUM,I-TR
HYDROXIDE,I-TR
),I-TR
30,O
MILLILITERS,O
PO,O
BID,O
PRN,O
Constipation,B-PR
PERCOCET,B-TR
1-2,O
TAB,O
PO,O
Q4H,O
PRN,O
PAIN,B-PR

Override,O
Notice,O
:,O

Override,O
added,O
on,O
10/01/03,O
by,O
KOTEJOASTHOREUPHKAYS,O
",",O
GAI,O
",",O
M.D.,O
on,O
order,O
for,O
TYLENOL,B-TR
PO,O
650,O
MG,O
Q4H,O
(,O
ref,O
#,O
85225311,O
),O

POTENTIALLY,O
SERIOUS,O
INTERACTION,O
:,O

ACETAMINOPHEN,B-TR
and,O
ACETAMINOPHEN,B-TR

Reason,O
for,O
override,O
:,O

ok,O

DIET,O
:,O

No,O
Restrictions,O

ACTIVITY,O
:,O

Resume,O
regular,O
exercise,O

FOLLOW,O
UP,O
APPOINTMENT,O
(,O
S,O
),O
:,O

kotejoasthoreuphkays,O
6,O
weeks,O
",",O

ALLERGY,O
:,O

Sulfa,B-TR
",",O
Bactrim,B-TR

ADMIT,O
DIAGNOSIS,O
:,O

Pregnancy,B-PR

PRINCIPAL,O
DISCHARGE,O
DIAGNOSIS,O
;,O

Responsible,O
After,O
Study,O
for,O
Causing,O
Admission,O
),O

post,O
partum,O

OTHER,O
DIAGNOSIS,O
;,O

Conditions,O
",",O
Infections,O
",",O
Complications,O
",",O
affecting,O
Treatment,O
/,O
Stay,O

twins,O

OPERATIONS,O
AND,O
PROCEDURES,O
:,O

Primary,O
Anesthesia,O
:,O

Spinal,O

Vaginal,O
delivery,O
:,O

Undelivered,B-PR

Cesarean,O
Status,O
:,O

Primary,O

Urgency,O
:,O

Scheduled,O

Indications,O
:,O

Breech,B-PR
",",O
Multiple,B-PR
gestation,I-PR
",",O

Uterine,O
incision,O
type,O
:,O

Transverse,O

Placenta,O
:,O

Delivery,O
:,O

Spontaneous,O

Condition,O
:,O

Normal,O

Staff,O
Obstetrician,O
(,O
supervising,O
),O
:,O

KOTEJOASTHOREUPHKAYS,O
",",O
GAI,O
",",O
M.D.,O
Delivery,O

OTHER,O
TREATMENTS,O
/,O
PROCEDURES,O
(,O
NOT,O
IN,O
O.R.,O
),O

none,O

BRIEF,O
RESUME,O
OF,O
HOSPITAL,O
COURSE,O
:,O

G3,O
T1,O
P0,O
A1,O
L1,O

Estimated,O
EDC,O
:,O

10/14/03,O

Maternal,O
transfer,O
:,O

No,O

Initial,O
newborn,O
exam,O
:,O

No,O
observed,B-PR
abnormalities,I-PR

Baby,O
1,O

MRN,O
:,O

76306248,O

Delivery,O
date,O
:,O

2010-01-03,O
9:06,O

Apgars,B-TE
"8,9",O

Weight,B-TE
:,O

7lb,O
1,O
oz,O
3204,O
grams,O

Sex,O
:,O

Male,O

Baby,O
2,O

MRN,O
:,O

62685780,O

Delivery,O
date,O
:,O

2010-01-03,O
9:08,O

Apgars,B-TE
"8,8",O

Weight,B-TE
:,O

7lb,O
0,O
oz,O
3175,O
grams,O

Sex,O
:,O

Female,O

ADDITIONAL,O
COMMENTS,O
:,O

DISCHARGE,O
CONDITION,O
:,O

Stable,O

TO,O
DO,O
/,O
PLAN,O
:,O

No,O
dictated,O
summary,O

ENTERED,O
BY,O
:,O

KOTEJOASTHOREUPHKAYS,O
",",O
GAI,O
",",O
M.D.,O
(,O
CT17,O
),O
10/04/03,O
07:11,O
AM,O

******,O
END,O
OF,O
DISCHARGE,O
ORDERS,O
******,O

879492218,O
YC,O

53470378,O

3210349,O

6/26/2004,O
12:00:00,O
AM,O

PNEUMONIA,B-PR

Signed,O

DIS,O

Admission,O
Date,O
:,O

06/26/2004,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

07/08/2004,O

ATTENDING,O
:,O

MALTA,O
FYFEZEISLEITZ,O
MD,O

CHIEF,O
COMPLAINT,O
:,O

Shortness,B-PR
of,I-PR
breath,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
38-year-old,O
gentleman,O
",",O
Spanish-speaking,O
",",O
from,O
the,O
Taheimpromong,O
",",O
with,O
no,O
significant,O
past,O
medical,O
history,O
",",O
who,O
presents,O
with,O
shortness,B-PR
of,I-PR
breath,I-PR
x,O
2,O
months,O
as,O
well,O
as,O
a,B-PR
dry,I-PR
cough,I-PR
x,O
1,O
month,O
.,O

The,O
patient,O
was,O
in,O
his,O
usual,O
state,O
of,O
health,O
until,O
two,O
months,O
prior,O
to,O
admission,O
when,O
he,O
began,O
to,O
notice,O
shortness,B-PR
of,I-PR
breath,I-PR
on,O
climbing,O
flights,O
of,O
stairs,O
.,O

He,O
stated,O
that,O
this,O
became,O
worse,O
over,O
the,O
last,O
month,O
until,O
he,O
was,O
noted,O
to,O
be,O
short,B-PR
of,I-PR
breath,I-PR
at,O
rest,O
.,O

He,O
also,O
states,O
that,O
he,O
has,O
had,O
a,B-PR
dry,I-PR
and,I-PR
nonproductive,I-PR
cough,I-PR
for,O
one,O
month,O
.,O

He,O
denied,O
any,O
fevers,B-PR
",",O
chills,B-PR
",",O
or,O
night,B-PR
sweats,I-PR
.,O

No,O
nausea,B-PR
",",O
vomiting,B-PR
",",O
or,O
diarrhea,B-PR
.,O

He,O
did,O
note,O
some,B-PR
weight,I-PR
loss,I-PR
over,O
the,O
past,O
several,O
months,O
",",O
though,O
the,O
amount,O
was,O
unknown,O
.,O

He,O
denied,O
any,O
contact,O
with,O
TB,O
positive,O
patients,O
.,O

He,O
describes,O
a,O
negative,O
PPD,O
one,O
year,O
prior,O
to,O
admission,O
when,O
he,O
was,O
in,O
prison,O
for,O
one,O
week,O
.,O

He,O
did,O
travel,O
to,O
the,O
Taheimpromong,O
",",O
last,O
in,O
01/2004,O
for,O
three,O
weeks,O
.,O

He,O
did,O
note,O
multiple,O
female,O
sexual,O
partners,O
",",O
although,O
described,O
using,O
condoms,O
except,O
with,O
his,O
wife,O
.,O

He,O
denies,O
any,O
IV,O
drug,O
use,O
",",O
did,O
describe,O
cocaine,O
use,O
last,O
two,O
months,O
ago,O
.,O

He,O
did,O
drink,O
alcohol,O
three,O
drinks,O
per,O
day,O
",",O
no,O
withdrawal,B-PR
symptoms,I-PR
.,O

In,O
emergency,O
room,O
",",O
he,O
was,O
noted,O
to,O
be,O
afebrile,O
with,O
stable,O
vital,O
signs,O
",",O
was,O
treated,O
with,O
IV,B-TR
fluids,I-TR
",",O
azithromycin,B-TR
",",O
and,O
cefuroxime,B-TR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

None,O
.,O

MEDICATIONS,O
:,O

None,O
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
lives,O
currently,O
with,O
a,O
friend,O
",",O
he,O
is,O
from,O
the,O
Taheimpromong,O
and,O
has,O
lived,O
here,O
for,O
13,O
years,O
",",O
he,O
does,O
note,O
multiple,O
sexual,O
partners,O
",",O
although,O
he,O
notes,O
using,O
condoms,O
with,O
everyone,O
except,O
his,O
wife,O
",",O
he,O
reportedly,O
had,O
a,O
negative,O
PPD,O
during,O
his,O
prison,O
stay,O
one,O
year,O
ago,O
for,O
one,O
week,O
.,O

He,O
traveled,O
to,O
the,O
Taheimpromong,O
last,O
in,O
01/2004,O
for,O
one,O
month,O
.,O

He,O
does,O
drink,O
alcohol,O
three,O
drinks,O
per,O
day,O
",",O
denies,O
any,O
current,O
tobacco,O
use,O
.,O

FAMILY,O
HISTORY,O
:,O

Sister,O
with,O
bone,B-PR
cancer,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
UPON,O
ADMISSION,O
:,O

Temperature,B-TE
97.4,O
",",O
heart,B-TE
rate,I-TE
100,O
",",O
blood,B-TE
pressure,I-TE
142/89,O
",",O
and,O
O2,B-TE
saturation,I-TE
94%,O
on,O
room,O
air,O
.,O

General,B-TE
exam,I-TE
revealed,O
a,O
well-developed,O
",",O
well-nourished,O
gentleman,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

HEENT,B-TE
exam,I-TE
revealed,O
sclerae,B-PR
to,O
be,O
injected,O
.,O

Pupils,O
equal,O
",",O
round,O
",",O
and,O
reactive,O
to,O
light,O
.,O

No,O
lymphadenopathy,B-PR
was,O
noted,O
in,O
the,O
neck,O
",",O
there,O
was,O
a,O
question,O
of,O
right,B-PR
axillary,I-PR
lymphadenopathy,I-PR
.,O

Chest,B-TE
exam,I-TE
reveals,O
coarse,B-PR
rhonchi,I-PR
with,O
some,B-PR
bibasilar,I-PR
crackles,I-PR
.,O

Abdominal,B-TE
exam,I-TE
revealed,O
soft,O
",",O
nontender,O
",",O
and,O
nondistended,O
abdomen,O
.,O

Heart,B-TE
exam,I-TE
was,O
regular,O
rate,O
and,O
rhythm,O
",",O
tachycardic,B-PR
",",O
with,O
a,B-PR
flat,I-PR
jugular,I-PR
venous,I-PR
pressure,I-PR
.,O

His,O
extremities,O
were,O
without,O
cyanosis,B-PR
",",O
clubbing,B-PR
",",O
or,O
edema,B-PR
.,O

His,O
skin,O
was,O
clear,O
",",O
without,O
rashes,B-PR
.,O

There,O
is,O
no,O
hepatosplenomegaly,B-PR
noted,O
on,O
abdominal,B-TE
exam,I-TE
.,O

Neuro,B-TE
exam,I-TE
was,O
alert,O
and,O
oriented,O
x,O
3,O
.,O

LABORATORY,O
DATA,O
UPON,O
ADMISSION,O
:,O

Sodium,B-TE
139,O
",",O
potassium,B-TE
3.5,O
",",O
chloride,B-TE
103,O
",",O
bicarbonate,B-TE
25,O
",",O
BUN,B-TE
9,O
",",O
creatinine,B-TE
0.9,O
",",O
and,O
glucose,B-TE
83,O
.,O

White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
11.2,O
",",O
hematocrit,B-TE
43.2,O
",",O
and,O
platelets,B-TE
"447,000",O
.,O

EKG,O
upon,O
admission,O
:,O

Sinus,B-PR
tachycardia,I-PR
at,O
100,O
.,O

Chest,O
x-ray,O
upon,O
admission,O
:,O

Diffuse,B-PR
interstitial,I-PR
process,I-PR
/,O
consolidation,B-PR
.,O

HOSPITAL,O
COURSE,O
BY,O
SYSTEM,O
:,O

1.,O
Pulmonary,O
/,O
Infectious,O
Disease,O
:,O

The,O
patient,O
&apos;s,O
differential,O
diagnosis,O
included,O
initially,O
a,O
question,O
of,O
an,B-PR
atypical,I-PR
pneumonia,I-PR
or,O
PCP,B-PR
.,O

His,B-TE
PPD,I-TE
has,O
been,O
negative,O
one,O
year,O
prior,O
to,O
admission,O
",",O
PPD,B-TE
was,O
rechecked,O
during,O
this,O
admission,O
and,O
was,O
negative,O
.,O

He,O
was,O
ruled,O
out,O
for,O
tuberculosis,B-PR
with,O
an,B-TE
induced,I-TE
sputum,I-TE
x,O
3,O
",",O
which,O
showed,O
no,O
AFB,B-PR
.,O

Chest,B-TE
CT,I-TE
showed,O
bibasilar,B-PR
diffuse,I-PR
infiltrates,I-PR
",",O
PCP,B-TE
was,O
negative,O
.,O

Thus,O
initially,O
he,O
had,O
been,O
started,O
on,O
prednisone,B-TR
and,O
Bactrim,B-TR
",",O
this,O
was,O
discontinued,O
.,O

He,O
was,O
continued,O
on,O
azithromycin,B-TR
and,O
cefuroxime,B-TR
until,O
bronchoscopy,O
results,O
were,O
known,O
",",O
negative,O
.,O

Thus,O
they,O
were,O
discontinued,O
.,O

He,O
initially,O
had,O
refused,O
HIV,B-TE
testing,I-TE
",",O
however,O
",",O
was,O
finally,O
consented,O
",",O
HIV,B-PR
was,O
noted,O
to,O
be,O
negative,O
.,O

Pulmonary,O
consult,O
was,O
invited,O
",",O
initially,O
the,O
patient,O
refused,O
bronchoscopy,B-TE
",",O
however,O
",",O
did,O
agree,O
to,O
it,O
during,O
his,O
hospital,O
stay,O
.,O

The,O
results,O
were,O
negative,O
for,O
Micro,B-PR
",",O
most,O
likely,O
diagnosis,O
as,O
per,O
review,B-TE
of,I-TE
pathology,I-TE
is,O
organizing,B-PR
pneumonia,I-PR
with,O
possible,O
diagnosis,O
of,O
BOOP,B-PR
and,O
chronic,B-PR
inhalational,I-PR
injury,I-PR
was,O
a,O
possibility,O
.,O

The,O
patient,O
required,O
supplemental,B-TR
oxygen,I-TR
to,O
keep,O
his,B-TE
oxygen,I-TE
saturation,I-TE
greater,O
than,O
93%,O
.,O

Ambulatory,B-TE
saturation,I-TE
was,O
82%,O
on,O
room,O
air,O
.,O

He,O
was,O
treated,O
with,O
supportive,B-TR
medical,I-TR
therapy,I-TR
for,O
his,B-PR
cough,I-PR
.,O

He,O
was,O
to,O
follow,O
up,O
with,O
pulmonary,O
as,O
an,O
outpatient,O
.,O

2.,O
Cardiovascular,O
:,O

Echocardiogram,B-TE
was,O
checked,O
to,O
rule,O
out,O
CHF,B-PR
",",O
showed,O
LVH,B-PR
and,O
trace,B-PR
TR,I-PR
",",O
ejection,B-TE
fraction,I-TE
of,O
60%,O
without,O
any,O
pulmonary,B-PR
hypertension,I-PR
.,O

3.,O
Heme,O

/ID,O
:,O

Hepatitis,B-TE
serologies,I-TE
were,O
negative,O
.,O

4.,O
FEN,O
:,O

The,O
patient,O
was,O
kept,O
on,O
a,O
house,O
diet,O
.,O

His,B-TE
electrolytes,I-TE
were,O
repeated,O
p.r.n.,O

5.,O
Prophylaxis,O
:,O

Lovenox,B-TR
.,O

6.,O
Code,O
status,O
:,O

Full,O
.,O

7.,O
Disposition,O
:,O

The,O
patient,O
was,O
discharged,O
to,O
home,O
in,O
satisfactory,O
condition,O
with,O
home,B-TR
oxygen,I-TR
.,O

Multiple,O
conversations,O
were,O
had,O
with,O
the,O
patient,O
as,O
well,O
as,O
an,O
interpreter,O
stating,O
the,O
importance,O
of,O
not,O
smoking,O
and,O
keeping,O
flames,O
away,O
from,O
his,B-TR
oxygen,I-TR
tank,I-TR
.,O

He,O
was,O
sent,O
home,O
with,O
LDAMC,O
services,O
to,O
help,O
with,O
his,B-TR
medications,I-TR
as,O
well,O
as,O
oxygen,O
education,O
.,O

He,O
was,O
told,O
to,O
call,O
a,O
doctor,O
or,O
come,O
to,O
the,O
emergency,O
room,O
should,O
he,O
have,O
any,B-PR
further,I-PR
troubles,I-PR
",",O
breathing,O
",",O
chest,B-PR
pain,I-PR
",",O
or,O
fevers,B-PR
.,O

He,O
was,O
to,O
follow,O
up,O
with,O
Dr.,O
Malta,O
at,O
Firmert,O
Hospital,O
on,O
07/23/04,O
at,O
3:00,O
p.m.,O
",",O
as,O
well,O
as,O
Dr.,O
Shawn,O
Leick,O
at,O
the,O
Stonho,O
Health,O
Care,O
pulmonary,O
division,O
as,O
directed,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Prednisone,B-TR
60,O
mg,O
p.o.,O
q.a.m.,O

2.,O
Bactrim,B-TR
double,I-TR
strength,I-TR
one,O
tablet,O
p.o.,O
q.d.,O
for,O
PCP,B-TR
prophylaxis,I-TR
during,O
his,B-TR
steroid,I-TR
course,I-TR
.,O

eScription,O
document,O
:,O

0-3054851,O
WEBCtug,O
Tel,O

CC,O
:,O

Mata,O
Fyfezeisleitz,O
MD,O
Verla,O

Dictated,O
By,O
:,O

KOTEHARBE,O
",",O
THRYNE,O

Attending,O
:,O

FYFEZEISLEITZ,O
",",O
MATA,O
Dictation,O
ID,O
5149122,O

D,O
:,O

2011-06-04,O

T,O
:,O

2011-07-04,O

888428725,O
RWH,O

712675,O

695770,O

6153969,O

11/4/2006,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O

CRITCHE,O
",",O
NIFREDEDRHET,O

MRN,O
:,O

712675,O

Age,O
:,O

40y,O

REGISTRATION,O
DATE,O
:,O

11/04/2006,O
12:17,O
PM,O

PRELIMINARY,O
REPORT,O

This,O
is,O
to,O
notify,O
you,O
that,O
your,O
patient,O
",",O
CRITCHE,O
",",O
NIFREDEDRHET,O
arrived,O
in,O
the,O
Emergency,O
Department,O
at,O
Ro,O
Woodma,O
Healthcare,O
on,O
11/04/2006,O
12:17,O
PM,O
.,O

The,O
patient,O
presented,O
with,O
a,O
chief,O
complaint,O
of,O
CP,B-PR
SOB,B-PR
.,O

Following,O
evaluation,B-TE
and,O
treatment,B-TR
",",O
the,O
patient,O
&apos;s,O
disposition,O
at,O
the,O
end,O
of,O
the,O
visit,O
was,O
admitted,O
as,O
an,O
inpatient,O
to,O
Ro,O
Woodma,O
Healthcare,O
.,O

The,O
patient,O
&apos;s,O
preliminary,O
admitting,O
physician,O
is,O
DREISSNEIGH,O
",",O
LIRU,O
and,O
the,O
preliminary,O
admitting,O
diagnosis,O
is,O
CP,B-PR
",",O
R,O
/,O
O,O
MI,B-PR
.,O

Please,O
note,O
this,O
information,O
may,O
have,O
been,O
updated,O
on,O
the,O
inpatient,O
unit,O
.,O

If,O
you,O
need,O
additional,O
information,O
please,O
call,O
662-747-1199,O
.,O

PCP,O
Name,O
:,O

DREISSNEIGH,O
",",O
LIRU,O

Provider,O
Number,O
:,O

33616,O

891864133,O
RWH,O

4713221,O

93061,O

136986,O

3/17/2000,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O
/,O
SUMMARY,O

CUCHSPARDCAMPMOTTELAMN,O
",",O
LARIN,O

MRN,O
:,O

4713221,O

Age,O
:,O

47y,O

REGISTRATION,O
DATE,O
:,O

03/17/2000,O
01:25,O
PM,O

Provider,O
:,O

VA,O
LARDESPRABLEYL,O

PRELIMINARY,O
REPORT,O

Benefits,O
Assigned,O
:,O

Y,O

Discharge,O
Date,O
/,O
Time,O
:,O

03/17/2000,O
16:31,O

Discharge,O
Status,O
:,O

Discharged,O

Patient,O
States,O
Complaint,O
:,O

R,O
/,O
O,O
HEMMOROIDS,B-PR

Diagnosis,O
:,O

perianal,B-PR
and,I-PR
perivaginal,I-PR
pruritis,I-PR

Treatment,O
Rendered,O
:,O

pelvic,B-TE
exam,I-TE

Discharge,O
Medications,O
:,O

none,O

Disposition,O
",",O
Follow,O
up,O
and,O
Instructions,O
to,O
Patient,O
:,O

Please,O
call,O
(,O
994,O
),O
944-4238,O
in,O
2-3,O
days,O
to,O
obtain,O
results,O
of,O
the,B-TE
lab,I-TE
tests,I-TE
that,O
were,O
ordered,O
.,O

If,O
tests,O
are,O
positive,B-PR
",",O
follow,O
up,O
with,O
your,O
primary,O
care,O
doctor,O
of,O
gynecologist,O
.,O

This,O
report,O
was,O
created,O
by,O
LARDESPRABLEYL,O
",",O
VA,O
03/17/2000,O
04:33,O
PM,O

910458031,O

NVH,O

23238893,O

1/12/1991,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Admission,O
Date,O
:,O

01/12/1991,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

01/20/1991,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

METASTATIC,B-PR
ADENOCARCINOMA,I-PR
OF,I-PR
UNKNOWN,I-PR
PRIMARY,I-PR
.,O

SECONDARY,O
DIAGNOSIS,O
:,O

INTRAUTERINE,B-PR
PREGNANCY,I-PR
AT,I-PR
23,I-PR
WEEKS,I-PR
.,O

HYPERCALCEMIA,B-PR
.,O

INFERIOR,B-PR
VENA,I-PR
CAVA,I-PR
OBSTRUCTION,I-PR
.,O

IMPENDING,B-PR
SPINAL,I-PR
CORD,I-PR
COMPRESSION,I-PR
.,O

IDENTIFICATION,O
DATA,O
:,O

The,O
patient,O
is,O
a,O
34-year-old,O
female,O
with,O
a,B-PR
22,I-PR
week,I-PR
intrauterine,I-PR
pregnancy,I-PR
who,O
was,O
transferred,O
from,O
Bri,O
Health,O
with,O
diffuse,B-PR
metastatic,I-PR
adenocarcinoma,I-PR
of,I-PR
unknown,I-PR
primary,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
was,O
in,O
her,O
usual,O
state,O
of,O
excellent,O
health,O
until,O
July,O
of,O
1991,O
when,O
she,O
first,O
noted,O
a,B-PR
left,I-PR
clavicular,I-PR
mass,I-PR
.,O

Subsequently,O
",",O
the,B-PR
mass,I-PR
continued,O
to,O
increase,O
in,O
size,O
.,O

On,O
12/23,O
",",O
she,O
was,O
seen,O
by,O
Dr.,O
Stonge,O
at,O
Bri,O
Health,O
where,O
a,B-PR
3,I-PR
x,I-PR
7,I-PR
cm,I-PR
left,I-PR
mid,I-PR
clavicular,I-PR
mass,I-PR
was,O
noted,O
.,O

A,B-TE
fine,I-TE
needle,I-TE
aspirate,I-TE
of,O
this,B-PR
mass,I-PR
reportedly,O
revealed,O
giant,B-PR
cell,I-PR
tumor,I-PR
.,O

The,O
patient,O
was,O
initially,O
told,O
that,O
this,O
was,O
a,B-PR
benign,I-PR
tumor,I-PR
and,O
that,O
it,O
could,O
simply,O
be,O
watched,O
and,O
definitively,O
treated,O
after,O
the,B-TR
delivery,I-TR
of,I-TR
her,I-TR
baby,I-TR
.,O

Subsequently,O
",",O
the,B-PR
mass,I-PR
progressively,O
increased,O
in,O
size,O
and,O
the,O
patient,O
had,O
developed,O
significant,B-PR
discomfort,I-PR
in,I-PR
this,I-PR
region,I-PR
.,O

On,O
1/5,O
",",O
the,O
patient,O
underwent,O
a,B-TR
local,I-TR
tumor,I-TR
debulking,I-TR
at,O
Bri,O
Health,O
under,O
local,B-TR
anesthesia,I-TR
.,O

The,B-TE
pathology,I-TE
",",O
unfortunately,O
",",O
revealed,O
an,B-PR
aggressive,I-PR
adenocarcinoma,I-PR
(,O
micropapillary,O
type,O
;,O
mucin,O
producing,O
),O
.,O

This,O
prompted,O
further,B-TE
staging,I-TE
work-up,I-TE
.,O

The,O
patient,O
subsequently,O
had,O
a,B-TE
limited,I-TE
chest,I-TE
CT,I-TE
at,O
Bri,O
Health,O
which,O
showed,O
diffuse,B-PR
bilateral,I-PR
pulmonary,I-PR
metastases,I-PR
",",O
metastases,B-PR
to,I-PR
the,I-PR
sternum,I-PR
",",I-PR
rib,I-PR
",",I-PR
multiple,I-PR
spinal,I-PR
levels,I-PR
;,O
internal,B-PR
mammary,I-PR
lymphadenopathy,I-PR
.,O

The,O
poor,O
prognosis,O
for,O
the,O
patient,O
and,O
child,O
were,O
discussed,O
and,O
after,O
the,O
patient,O
decided,O
to,O
have,O
an,B-TR
elective,I-TR
abortion,I-TR
",",O
an,B-TE
abdominal,I-TE
CT,I-TE
scan,I-TE
was,O
obtained,O
which,O
revealed,O
diffuse,B-PR
metastatic,I-PR
lesions,I-PR
of,I-PR
the,I-PR
liverspine,I-PR
",",I-PR
ribs,I-PR
and,I-PR
most,I-PR
of,I-PR
the,I-PR
lymph,I-PR
nodes,I-PR
.,O

There,O
was,O
no,O
obvious,B-PR
GIor,I-PR
pancreatic,I-PR
tumor,I-PR
identified,O
.,O

The,O
patient,O
had,O
a,B-PR
very,I-PR
firm,I-PR
nodule,I-PR
at,O
the,O
vertex,O
of,O
her,O
calvarium,O
.,O

A,O
specimen,O
was,O
obtained,O
by,O
fine,B-TE
needle,I-TE
aspiration,I-TE
and,O
the,B-TE
pathology,I-TE
of,O
this,O
was,O
consistent,O
with,O
adenocarcinoma,B-PR
.,O

The,O
patient,O
was,O
transferred,O
to,O
Nimaconwood,O
Valley,O
Hospital,O
for,O
management,B-TR
of,O
her,B-PR
cancer,I-PR
and,O
termination,B-TR
of,O
the,B-PR
pregnancy,I-PR
.,O

Over,O
the,O
past,O
four,O
weeks,O
",",O
the,O
patient,O
reported,O
progressive,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
and,O
mid,B-PR
thoracic,I-PR
back,I-PR
pain,I-PR
.,O

She,O
has,O
had,O
no,O
motor,B-PR
weakness,I-PR
",",O
abnormal,B-PR
sensation,I-PR
",",O
numbness,B-PR
",",O
tingling,B-PR
or,O
incontinence,B-PR
of,I-PR
bowel,I-PR
or,I-PR
bladder,I-PR
.,O

She,O
denied,O
fevers,B-PR
",",O
chills,B-PR
or,O
sweats,B-PR
.,O

There,O
has,O
been,O
no,O
GI,B-PR
or,I-PR
GU,I-PR
symptoms,I-PR
except,O
for,O
constipation,B-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Unremarkable,O
.,O

MEDICATIONS,O
:,O

On,O
admission,O
included,O
Percocet,B-TR
for,O
pain,B-PR
and,O
multivitamins,B-TR
.,O

ALLERGIES,O
:,O

NO,O
KNOWN,B-PR
DRUG,I-PR
ALLERGIES,I-PR
.,O

FAMILY,O
HISTORY,O
:,O

The,O
patient,O
&apos;s,O
father,O
died,O
at,O
age,O
69,O
with,O
metastatic,B-PR
prostate,I-PR
cancer,I-PR
.,O

The,O
patient,O
&apos;s,O
sister,O
has,O
a,O
history,O
of,O
cervical,B-PR
cancer,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
is,O
married,O
and,O
lives,O
with,O
her,O
husband,O
.,O

She,O
has,O
no,O
children,O
.,O

She,O
is,O
a,O
nonsmoker,O
.,O

She,O
drinks,O
socially,O
.,O

She,O
has,O
not,O
had,O
any,O
alcoholic,O
beverages,O
during,O
this,B-PR
pregnancy,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,O
revealed,O
a,O
pleasant,O
",",O
comfortable,O
",",O
tired,O
appearing,O
female,O
.,O

The,O
patient,O
was,O
afebrile,O
.,O

Blood,B-TE
pressure,I-TE
was,O
98/64,O
.,O

Pulse,B-TE
82,O
.,O

Respiratory,B-TE
rate,I-TE
20,O
.,O

Skin,B-TE
exam,I-TE
revealed,O
a,B-PR
right,I-PR
posterior,I-PR
parietal,I-PR
scalp,I-PR
nodle,I-PR
measuring,O
2,O
x,O
3,O
cm,O
which,O
was,O
very,O
firm,O
.,O

There,O
was,O
a,B-PR
1,I-PR
cm,I-PR
firm,I-PR
nodule,I-PR
at,I-PR
the,I-PR
left,I-PR
upper,I-PR
thoracic,I-PR
region,I-PR
of,O
the,O
back,O
between,O
the,O
midline,O
and,O
the,O
scapula,O
.,O

There,O
was,O
a,B-PR
1,I-PR
cm,I-PR
firm,I-PR
nodule,I-PR
in,O
the,O
right,O
upper,O
quadrant,O
of,O
the,O
abdomen,O
.,O

HEENT,B-TE
exam,I-TE
was,O
unremarkable,O
.,O

Neck,O
was,O
supple,O
.,O

There,O
was,O
no,O
jugular,B-PR
venous,I-PR
distention,I-PR
.,O

There,O
was,O
no,O
lymphadenopathy,B-PR
.,O

Back,O
was,O
without,O
CVA,B-PR
tenderness,I-PR
.,O

There,O
was,O
no,O
scapular,B-PR
tenderness,I-PR
.,O

There,O
was,O
mild,B-PR
lower,I-PR
thoracic,I-PR
tenderness,I-PR
.,O

Lungs,O
were,O
clear,O
to,O
auscultation,B-TE
.,O

There,O
were,O
no,O
rales,B-PR
or,O
wheezes,B-PR
.,O

There,O
was,O
no,O
egophony,B-PR
.,O

Cardiac,B-TE
exam,I-TE
was,O
tachycardic,B-PR
and,O
regular,O
",",O
normal,O
S1,O
and,O
S2,O
.,O

There,O
was,O
a,B-PR
II,I-PR
/,I-PR
VI,I-PR
systolic,I-PR
ejection,I-PR
murmur,I-PR
loudest,O
at,O
the,O
left,O
upper,O
sternal,O
border,O
.,O

There,O
was,O
no,O
heave,B-PR
.,O

Abdomen,O
was,O
gravid,B-PR
.,O

Bowel,O
sounds,O
were,O
present,O
.,O

The,O
abdomen,O
was,O
tympanitic,O
and,O
nontender,B-PR
.,O

The,O
liver,O
was,O
11,O
cm,O
by,O
percussion,B-TE
.,O

There,O
was,O
no,O
liver,O
edge,O
palpable,O
",",O
no,O
spleen,O
tip,O
palpable,O
.,O

Rectal,O
revealed,O
normal,O
muscle,O
tone,O
",",O
heme,O
negative,O
stool,O
.,O

Extremities,O
revealed,O
1+,B-PR
bipedal,I-PR
edema,I-PR
on,O
admission,O
.,O

Neurological,B-TE
examination,I-TE
revealed,O
the,O
patient,O
to,O
be,O
alert,O
and,O
oriented,O
times,O
three,O
.,O

Cranial,O
nerves,O
II,O
-,O
XII,O
were,O
intact,O
.,O

Motor,O
was,O
5/5,O
.,O

Sensation,O
was,O
intact,O
to,O
light,B-TE
touch,I-TE
.,O

Deep,B-TE
tendon,I-TE
reflexes,I-TE
were,O
1-2+,O
and,O
symmetric,O
bilaterally,O
.,O

Toes,O
were,O
downgoing,O
.,O

LABORATORY,O
DATA,O
:,O

On,O
admission,O
included,O
an,B-TE
ALT,I-TE
of,O
108,O
",",O
AST,B-TE
of,O
286,O
.,O

Total,B-TE
bilirubin,I-TE
3.0,O
",",O
direct,B-TE
bilirubin,I-TE
of,O
2.0,O
.,O

Alkaline,B-TE
phosphatase,I-TE
1148,O
.,O

LDH,B-TE
806,O
.,O

Calcium,B-TE
11.8,O
.,O

Albumin,B-TE
2.3,O
.,O

Hematocrit,B-TE
was,O
30.6,O
.,O

White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
was,O
11.14,O
.,O

PT,B-TE
was,O
13.2,O
.,O

PTT,B-TE
was,O
29.8,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
had,O
an,B-TR
elective,I-TR
termination,I-TR
of,O
her,B-PR
pregnancy,I-PR
on,O
1/13/91,O
.,O

The,B-TE
work-up,I-TE
for,O
the,O
extent,O
of,O
the,B-PR
patient,I-PR
&apos;s,I-PR
disease,I-PR
included,O
MRI,B-TE
scan,I-TE
of,I-TE
the,I-TE
cervical,I-TE
and,I-TE
thoracic,I-TE
spine,I-TE
which,O
revealed,O
multiple,B-PR
metastatic,I-PR
lesions,I-PR
in,I-PR
the,I-PR
vertebral,I-PR
bodies,I-PR
;,O
a,B-PR
T3,I-PR
lesion,I-PR
extending,O
from,O
the,O
body,O
to,O
the,O
right,O
neural,O
for,O
amina,O
with,O
foraminal,B-PR
obstruction,I-PR
.,O

An,B-PR
epidural,I-PR
mass,I-PR
was,O
present,O
at,O
T10,O
which,O
was,O
extending,O
from,O
the,O
lamina,O
or,O
spinous,O
process,O
anteriorly,O
and,O
almost,O
compressing,O
the,O
spinal,O
cord,O
.,O

An,B-TE
abdominal,I-TE
and,I-TE
pelvic,I-TE
CT,I-TE
scan,I-TE
with,I-TE
IV,I-TE
contrast,I-TE
revealed,O
bilateral,B-PR
pulmonary,I-PR
nodules,I-PR
and,O
bilateral,B-PR
pleural,I-PR
effusions,I-PR
",",O
extensive,B-PR
liver,I-PR
metastases,I-PR
",",O
narrowing,B-PR
of,I-PR
the,I-PR
intra,I-PR
hepatic,I-PR
IVC,I-PR
and,O
distention,B-PR
of,I-PR
the,I-PR
azygous,I-PR
system,I-PR
suggestive,O
of,O
IVC,B-PR
obstruction,I-PR
by,O
liver,B-PR
metastases,I-PR
;,O
ascites,B-PR
;,O
multiple,B-PR
bony,I-PR
metastases,I-PR
;,O
and,O
an,B-PR
isolated,I-PR
splenic,I-PR
metastases,I-PR
.,O

A,B-TE
bone,I-TE
scan,I-TE
revealed,O
increased,B-PR
uptake,I-PR
in,I-PR
the,I-PR
left,I-PR
chest,I-PR
wall,I-PR
",",I-PR
left,I-PR
anterior,I-PR
ribs,I-PR
four,I-PR
to,I-PR
six,I-PR
",",O
and,O
increased,B-PR
uptake,I-PR
in,I-PR
the,I-PR
left,I-PR
and,I-PR
right,I-PR
lateral,I-PR
skull,I-PR
in,O
the,O
area,O
of,O
the,O
parotids,O
.,O

Ahead,B-TE
CT,I-TE
scan,I-TE
revealed,O
a,B-PR
metastatic,I-PR
lesion,I-PR
in,O
the,O
right,O
vertex,O
of,O
the,O
calvarium,O
but,O
no,O
intracranial,B-PR
abnormalities,I-PR
.,O

Work-up,B-TE
for,O
the,O
source,O
of,O
the,B-PR
primary,I-PR
tumor,I-PR
which,O
is,O
still,O
unknown,O
included,O
a,B-TE
mammogram,I-TE
which,O
identified,O
no,O
suspicious,B-PR
microcalcifications,I-PR
and,O
no,O
dominant,B-PR
masses,I-PR
.,O

The,B-TE
abdominal,I-TE
and,I-TE
pelvic,I-TE
CT,I-TE
scans,I-TE
showed,O
no,O
suspicious,B-PR
GI,I-PR
masses,I-PR
",",O
no,O
pancreatic,B-PR
mass,I-PR
;,O
a,B-PR
2,I-PR
cm,I-PR
ovarian,I-PR
cyst,I-PR
.,O

The,O
review,O
of,O
the,B-TE
pathology,I-TE
from,O
Bri,O
Health,O
confirmed,O
a,B-PR
high,I-PR
grade,I-PR
adenocarcinoma,I-PR
.,O

Erica,B-TE
and,I-TE
basic,I-TE
cystic,I-TE
protein,I-TE
stains,I-TE
are,O
still,O
pending,O
.,O

Serum,B-TE
markers,I-TE
were,O
normal,O
.,O

The,B-TE
CEA,I-TE
was,O
less,O
than,O
0.7,O
.,O

The,B-TE
hCG,I-TE
on,I-TE
admission,I-TE
was,O
"30,710",O
and,O
on,O
1/19,O
was,O
805,O
.,O

The,B-TE
CA-125,I-TE
was,O
still,O
pending,O
and,O
alphafeto,B-TE
protein,I-TE
is,O
still,O
pending,O
.,O

Hypercalcemia,B-PR
:,O

The,O
patient,O
presented,O
with,O
a,B-TE
serum,I-TE
calcium,I-TE
of,O
11.8,O
and,O
an,B-TE
albumin,I-TE
of,O
2.3,O
on,O
admission,O
.,O

She,O
received,O
three,O
days,O
of,O
intravenous,B-TR
etidronate,I-TR
with,O
normal,B-TR
saline,I-TR
diuresis,I-TR
and,O
the,B-TE
serum,I-TE
calcium,I-TE
subsequently,O
decreased,O
to,O
9.0,O
.,O

The,O
patient,O
was,O
then,O
switched,O
to,O
po,B-TR
etidronate,I-TR
.,O

IVC,B-PR
obstruction,I-PR
:,O

The,O
patient,O
has,O
extensive,B-PR
hepatic,I-PR
metastases,I-PR
and,O
by,O
CT,B-TE
scan,I-TE
there,O
is,O
obstruction,B-PR
of,I-PR
the,I-PR
intrahepatic,I-PR
IVC,I-PR
.,O

This,O
has,O
resulted,O
in,O
marked,B-PR
bilateral,I-PR
lower,I-PR
extremity,I-PR
and,I-PR
presacral,I-PR
edema,I-PR
with,O
ascites,B-PR
.,O

The,B-PR
patient,I-PR
&apos;s,I-PR
low,I-PR
serum,I-PR
albumin,I-PR
is,O
also,O
contributing,O
to,O
her,B-PR
extensive,I-PR
edema,I-PR
.,O

Hypoxia,B-PR
and,O
shortness,B-PR
of,I-PR
breath,I-PR
:,O

Although,O
the,B-TE
patient,I-TE
&apos;s,I-TE
room,I-TE
air,I-TE
saturation,I-TE
was,O
96%,O
during,O
this,O
admission,O
",",O
she,O
subjectively,O
complained,O
of,O
increased,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
.,O

It,O
was,O
felt,O
that,O
the,B-PR
patient,I-PR
&apos;s,I-PR
extensive,I-PR
pulmonary,I-PR
metastases,I-PR
and,O
bilateral,B-PR
pleural,I-PR
effusions,I-PR
resulted,O
in,O
increased,B-PR
work,I-PR
of,I-PR
respiration,I-PR
and,O
a,O
sensation,O
of,O
shortness,B-PR
of,I-PR
breath,I-PR
.,O

Impending,B-PR
spinal,I-PR
cord,I-PR
compression,I-PR
:,O

The,O
patient,O
had,O
back,B-PR
pain,I-PR
on,O
admission,O
without,O
any,B-PR
focal,I-PR
neurological,I-PR
signs,I-PR
.,O

The,B-TE
MRI,I-TE
scan,I-TE
on,I-TE
admission,I-TE
revealed,O
an,B-PR
impending,I-PR
cord,I-PR
compression,I-PR
at,O
the,O
level,O
of,O
T10,O
.,O

She,O
was,O
started,O
on,O
Decadron,B-TR
and,O
on,O
1/17,O
began,O
the,O
first,O
of,O
ten,B-TR
radiation,I-TR
treatments,I-TR
to,O
two,O
fields,O
(,O
T2,O
to,O
T5,O
and,O
T9,O
to,O
T11,O
),O
.,O

Per,O
the,O
patient,O
&apos;s,O
wishes,O
",",O
Dr.,O
Dalywoo,O
Droreite,O
the,O
Windgo,O
Hospital,O
was,O
consulted,O
for,O
a,O
second,O
opinion,O
regarding,O
the,B-TR
management,I-TR
of,O
her,B-PR
malignancy,I-PR
.,O

Dr.,O
Linke,O
recommended,O
chemotherapy,B-TR
with,I-TR
PFL,I-TR
.,O

Per,O
the,O
patient,O
&apos;s,O
wishes,O
",",O
she,O
was,O
transferred,O
to,O
the,O
Windgo,O
Hospital,O
for,O
chemotherapy,B-TR
.,O

ALT,B-TE
was,O
53,O
.,O

AST,B-TE
was,O
89,O
.,O

Her,B-TE
LDH,I-TE
was,O
394,O
.,O

Her,B-TE
alkaline,I-TE
phosphatase,I-TE
was,O
1514,O
.,O

Total,B-TE
bilirubin,I-TE
was,O
2.1,O
.,O

Direct,B-TE
bilirubin,I-TE
was,O
1.4,O
.,O

Albumin,B-TE
was,O
2.3,O
.,O

Calcium,B-TE
9.1,O
.,O

Hematocrit,B-TE
was,O
32.5,O
.,O

White,B-TE
blood,I-TE
cell,I-TE
count,I-TE
was,O
16.89,O
.,O

PT,B-TE
was,O
12.9,O
.,O

PTT,B-TE
was,O
27.3,O
.,O

DISPOSITION,O
:,O

MEDICATIONS,O
:,O

On,O
discharge,O
included,O
etidronate,B-TR
",",O
475,O
mg,O
IV,O
q,O
day,O
;,O
heparin,B-TR
",",O
5000,O
units,O
subcutaneously,O
b.i.d.,O
;,O
Decadron,B-TR
",",O
4,O
mg,O
po,O
q,O
six,O
hours,O
;,O
MS,B-TR
Contin,I-TR
",",O
45,O
mg,O
po,O
b.i.d.,O
;,O
Pepcid,B-TR
",",O
20,O
mg,O
po,O
b.i.d.,O
;,O
Senekot,B-TR
",",O
one,O
tablet,O
po,O
t.i.d.,O
;,O
Bronkosol,B-TR
",",O
0.25,O
cc,O
q,O
four,O
hours,O
.,O

It,O
was,O
decided,O
to,O
have,O
the,B-PR
patient,I-PR
&apos;s,I-PR
medical,I-PR
and,I-PR
oncological,I-PR
issues,I-PR
managed,O
at,O
Windgo,O
Hospital,O
.,O

At,O
the,O
time,O
of,O
discharge,O
",",O
the,B-TE
patient,I-TE
&apos;s,I-TE
electrolytes,I-TE
were,O
within,O
normal,O
limits,O
.,O

BD452/5255,O

RUTHU,O
PAIN,O
",",O
M.D.,O
KW25,O

D,O
:,O

01/20/91,O

Batch,O
:,O

8050,O

Report,O
:,O

H7691U2,O

T,O
:,O

01/24/91,O

Dictated,O
By,O
:,O

CEALME,O
PAIN,O
",",O
M.D.,O

915093496,O
RWH,O

802338,O

45989,O

2923113,O

12/13/2002,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Report,O
Status,O
:,O

Signed,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

GIENGBEENEA,O
",",O
NAA,O

UNIT,O
NUMBER,O
:,O

799-54-08,O

ADMISSION,O
DATE,O
:,O

12/13/2002,O

DISCHARGE,O
DATE,O
:,O

12/14/2002,O

ADMITTING,O
DIAGNOSIS,O
:,O

1.,O
Undesired,B-PR
fertility,I-PR
.,O

2.,O
Undesired,B-PR
adiposity,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
30,O
-year-old,O
Gravida,O
III,O
",",O
Para,O
II,O
who,O
presented,O
desiring,O
definitive,B-TR
surgical,I-TR
sterilization,I-TR
.,O

She,O
was,O
extensively,O
counseled,O
regarding,O
other,O
methods,O
of,O
birth,B-TR
control,I-TR
and,O
desired,O
to,O
proceed,O
with,O
definitive,B-TR
surgical,I-TR
therapy,I-TR
.,O

In,O
addition,O
",",O
the,O
patient,O
desired,O
liposuction,B-TR
of,I-TR
varying,I-TR
areas,I-TR
as,O
well,O
.,O

The,O
patient,O
was,O
consented,O
for,O
both,B-TR
procedures,I-TR
and,O
brought,O
to,O
the,O
Operating,O
Room,O
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

None,O
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

Appendectomy,B-TR
at,O
the,O
age,O
of,O
14,O
",",O
open,O
.,O

PAST,O
OBSTETRIC,O
HISTORY,O
:,O

Spontaneous,B-PR
vaginal,I-PR
delivery,I-PR
x,O
2,O
.,O

PAST,O
GYN,O
HISTORY,O
:,O

Regular,O
menses,O
",",O
on,O
Ortho-Tri-Cyclen,B-TR
.,O

No,O
history,O
of,O
sexually,B-PR
transmitted,I-PR
disease,I-PR
",",O
no,O
history,O
of,O
domestic,O
violence,O
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

1.,O
Ortho,B-TR
Tri-Cyclen,I-TR
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

Height,B-TE
5,O
&apos;,O
1,O
&quot;,O
",",O
weight,B-TE
138,O
lb.,O

Blood,B-TE
pressure,I-TE
:,O

130/82,O
and,O
heart,B-TE
rate,I-TE
80,O
.,O

Breasts,O
:,O

no,O
masses,B-PR
.,O

Lungs,O
:,O

clear,O
to,O
auscultation,B-TE
and,O
percussion,B-TE
bilaterally,O
.,O

Heart,O
:,O

regular,O
rate,O
and,O
rhythm,O
",",O
S1-S2,O
.,O

Abdomen,O
:,O

soft,O
",",O
nontender,B-PR
",",O
nondistended,B-PR
.,O

Extremities,O
:,O

within,O
normal,O
.,O

Pelvic,B-TE
exam,I-TE
revealed,O
normal,O
vulva,O
",",O
vagina,O
normal,O
",",O
cervix,O
normal,O
",",O
uterus,O
anteverted,O
",",O
small,O
",",O
nontender,B-PR
.,O

Adnexa,O
:,O

no,O
masses,B-PR
or,O
tenderness,B-PR
.,O

Rectal,O
:,O

deferred,O
.,O

HOSPITAL,O
COURSE,O
AND,O
TREATMENT,O
:,O

The,O
patient,O
was,O
admitted,O
to,O
the,O
Operating,O
Room,O
where,O
she,O
underwent,O
an,B-TR
unremarkable,I-TR
laparoscopic,I-TR
tubal,I-TR
ligation,I-TR
.,O

This,O
was,O
done,O
with,O
Falope,B-TR
rings,I-TR
.,O

The,B-PR
estimated,I-PR
blood,I-PR
loss,I-PR
was,O
minimal,O
and,O
the,O
patient,O
received,O
600,O
cc.,O
of,O
intravenous,B-TR
fluid,I-TR
.,O

Of,O
note,O
",",O
the,O
patient,O
had,O
a,O
negative,O
urine,O
pregnancy,O
test,O
prior,O
to,O
the,B-TR
surgery,I-TR
.,O

The,O
patient,O
then,O
underwent,O
liposuction,B-TR
of,I-TR
her,I-TR
abdomen,I-TR
",",I-TR
inner,I-TR
thighs,I-TR
",",I-TR
hips,I-TR
",",I-TR
flanks,I-TR
",",I-TR
chest,I-TR
and,I-TR
arms,I-TR
with,O
Dr.,O
Chain,O
.,O

She,O
did,O
well,O
and,O
was,O
admitted,O
to,O
the,O
GYN,O
Service,O
postoperatively,O
because,O
the,O
patient,O
had,O
persistent,B-PR
pain,I-PR
.,O

On,O
postoperative,O
day,O
#one,O
",",O
she,O
was,O
then,O
stable,O
with,O
no,O
complaints,B-PR
.,O

She,O
remained,O
afebrile,B-PR
.,O

Her,B-TR
Foley,I-TR
was,O
removed,O
.,O

Her,O
diet,O
was,O
advanced,O
without,O
difficulty,O
and,O
the,O
patient,O
was,O
stable,O
for,O
discharge,O
.,O

The,O
patient,O
was,O
to,O
follow,O
up,O
in,O
several,O
days,O
time,O
with,O
Dr.,O
Chain,O
of,O
the,O
Plastics,O
Clinic,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Motrin,B-TR
and,O
Percocet,B-TR
as,O
needed,O
.,O

PADA,O
MARONNESSGRE,O
CHAIN,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

Electronically,O
Signed,O
PADA,O
MARONNESSGRE,O
CHAIN,O
",",O
M.D.,O
04/25/2003,O
09:50,O

_____________________________,O
PADA,O
MARONNESSGRE,O
CHAIN,O
",",O
M.D.,O

TR,O
:,O

wwi,O

DD,O
:,O

04/17/2003,O

TD,O
:,O

04/18/2003,O
8:28,O
A,O
045989,O

cc,O
:,O

PADA,O
MARONNESSGRE,O
CHAIN,O
",",O
M.D.,O

917989835,O
RWH,O

5427551,O

405831,O

9660879,O

01/09/2002,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O
/,O
SUMMARY,O

STERPMOONE,O
",",O
NY,O

MRN,O
:,O

5427551,O

Age,O
:,O

37y,O

REGISTRATION,O
DATE,O
:,O

01/09/2002,O
01:27,O
PM,O

Provider,O
:,O

NONOK,O
AYREKEMPE,O

PRELIMINARY,O
REPORT,O

PCP,O
notified,O
by,O
MD,O
:,O

Left,O
message,O
with,O
answering,O
service,O
or,O
PCP,O
office,O

Benefits,O
Assigned,O
:,O

Y,O

Discharge,O
Date,O
/,O
Time,O
:,O

01/09/2002,O
17:02,O

Discharge,O
Status,O
:,O

Discharged,O

Condition,O
on,O
Discharge,O
:,O

Stable,O

Patient,O
States,O
Complaint,O
:,O

EVAL,B-TE

Standardized,O
Discharge,O
Instructions,O
:,O

Schedule,O
outpatient,O
psychiatry,O
appointment,O
Necrestneysagiles,O
Medical,O
Center,O
.,O

Contact,O
BRIDC,O
BRESCA,O
DENONE,O
HEALTH,O
CARE,O
(,O
558-927-7217,O
),O
for,O
appointment,O
w/,O
therapist,O
.,O

Needs,O
to,O
speak,O
w/,O
PCP,O
in,O
order,O
to,O
switch,O
provider,O
Diagnosis,O
:,O

PTSD,B-PR

Discharge,O
Medications,O
:,O

.5,B-TR
Risperdal,I-TR

Disposition,O
",",O
Follow,O
up,O
and,O
Instructions,O
to,O
Patient,O
:,O

Continue,O
w/,O
Risperdal,B-TR
per,O
new,O
psychiatrist,O

B,B-TR
and,I-TR
W,I-TR
and,O
work,O
w/,O
therapist,O
re:,O
historical,O
issues,O
.,O

If,O
symptoms,B-PR
continue,O
to,O
be,O
overwhelming,B-PR
return,O
to,O
V,O
or,O
call,O
1-903-263-5797,O

PCP,O
Name,O
:,O

SHUFFNEG,O
",",O
SOA,O
W,O

Provider,O
Number,O
:,O

80157,O

This,O
report,O
was,O
created,O
by,O
AYREKEMPE,O
",",O
NONOK,O
01/09/2002,O
05:09,O
PM,O

920798564,O

CTMC,O

70160673,O

840502,O

3/3/1999,O
12:00:00,O
AM,O

PROSTATE,B-PR
CANCER,I-PR
AND,O
RENAL,B-PR
FAILURE,I-PR

Signed,O

DIS,O

Admission,O
Date,O
:,O

03/03/1999,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

03/08/1999,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

ACUTE,B-PR
RENAL,I-PR
FAILURE,I-PR
.,O

SIGNIFICANT,B-PR
PROBLEMS,I-PR
:,O

1.,O
METASTATIC,B-PR
PROSTATE,I-PR
CA,I-PR
.,O

2.,O
OBSTRUCTIVE,B-PR
UROPATHY,I-PR
",",O
STATUS,B-PR
POST,I-PR
LEFT,I-PR
NEPHROSTOMY,I-PR
.,O

3.,O
HYPERTENSION,B-PR
.,O

4.,O
ANEMIA,B-PR
.,O

5.,O
GASTROESOPHAGEAL,B-PR
REFLUX,I-PR
DISEASE,I-PR
.,O

CHIEF,O
COMPLAINT,O
:,O

This,O
88-year-old,O
male,O
with,O
history,O
of,O
prostate,B-PR
CA,I-PR
was,O
admitted,O
from,O
an,O
outside,O
hospital,O
secondary,O
to,O
persistent,B-PR
hematuria,I-PR
status,O
post,O
nephrostomy,B-TR
tube,I-TR
placement,I-TR
transferred,O
to,O
Retelk,O
County,O
Medical,O
Center,O
for,O
further,B-TR
management,I-TR
.,O

HISTORY,O
OF,O
PRESENT,B-PR
ILLNESS,I-PR
:,O

Mr.,O
Prehekote,O
is,O
an,O
88-year-old,O
Portuguese,O
speaking,O
only,O
male,O
who,O
was,O
diagnosed,O
with,O
adenocarcinoma,B-PR
of,I-PR
the,I-PR
prostate,I-PR
in,O
1998,O
.,O

He,O
received,O
transurethral,B-TR
resection,I-TR
of,I-TR
the,I-TR
prostate,I-TR
one,O
year,O
ago,O
because,O
of,O
persistent,B-PR
urinary,I-PR
retention,I-PR
.,O

After,O
that,O
",",O
he,O
was,O
on,O
Lupron,B-TR
and,O
Nilandron,B-TR
hormone,I-TR
therapy,I-TR
.,O

The,O
patient,O
was,O
admitted,O
on,O
February,O
23,O
",",O
1999,O
to,O
Eifro,O
Medical,O
Center,O
because,O
of,O
failure,B-PR
to,I-PR
thrive,I-PR
and,O
decreased,B-PR
hematocrit,I-PR
.,O

He,O
was,O
noted,O
to,O
have,O
elevated,B-PR
BUN,I-PR
and,O
creatinine,B-TE
.,O

BUN,B-TE
was,O
34,O
and,O
creatinine,B-TE
was,O
2.6,O
",",O
up,O
from,O
his,O
baseline,O
of,O
1.0,O
.,O

Prostate,B-TE
specific,I-TE
antigen,I-TE
increased,O
from,O
77.9,O
to,O
88,O
",",O
and,O
the,O
patient,O
also,O
had,O
urinary,B-PR
incontinence,I-PR
and,O
body,B-PR
weight,I-PR
loss,I-PR
.,O

Further,B-TE
evaluation,I-TE
of,O
his,B-PR
renal,I-PR
failure,I-PR
showed,O
that,O
the,O
patient,O
has,O
bilateral,B-PR
hydronephrosis,I-PR
",",O
most,O
likely,O
obstructive,B-PR
uropathy,I-PR
due,O
to,O
prostate,B-PR
CA,I-PR
in,I-PR
the,I-PR
pelvic,I-PR
area,I-PR
.,O

Because,O
of,O
the,B-PR
increasing,I-PR
creatinine,I-PR
to,O
8.0,O
on,O
February,O
28,O
",",O
1999,O
",",O
a,B-TR
left,I-TR
nephrostomy,I-TR
tube,I-TR
was,O
placed,O
.,O

However,O
after,O
the,B-TR
procedure,I-TR
",",O
the,B-PR
patient,I-PR
&apos;s,I-PR
hematocrit,I-PR
dropped,I-PR
to,O
24,O
and,O
he,O
was,O
transfused,O
two,B-TR
units,I-TR
of,I-TR
packed,I-TR
red,I-TR
blood,I-TR
cells,I-TR
.,O

His,B-TE
hematocrit,I-TE
increased,O
to,O
about,O
30,O
",",O
but,O
he,O
continued,O
to,O
have,O
hematuria,B-PR
and,O
his,B-TE
renal,I-TE
function,I-TE
only,O
improved,O
very,O
slowly,O
.,O

He,O
also,O
received,O
Kayexalate,B-TR
for,O
hyperkalemia,B-PR
.,O

Due,O
to,O
the,B-PR
persistent,I-PR
blood,I-PR
in,I-PR
the,I-PR
urine,I-PR
",",O
he,O
was,O
transferred,O
from,O
Eifro,O
Medical,O
Center,O
to,O
the,O
Retelk,O
County,O
Medical,O
Center,O
for,O
angiographic,B-TE
studies,I-TE
to,O
rule,O
out,O
any,O
vascular,B-PR
injuries,I-PR
.,O

The,O
patient,O
was,O
transferred,O
to,O
Genearocktemp,O
Ry,O
Health,O
on,O
March,O
3,O
",",O
1999,O
.,O

REVIEW,O
OF,O
SYSTEMS,O
:,O

The,O
patient,O
had,O
constipation,B-PR
with,O
dysuria,B-PR
",",O
but,O
no,O
fever,B-PR
or,O
chills,B-PR
.,O

No,O
cough,B-PR
.,O

No,O
chest,B-PR
pain,I-PR
.,O

No,O
palpitations,B-PR
",",O
history,O
of,O
epigastric,B-PR
pain,I-PR
and,O
body,B-PR
weight,I-PR
loss,I-PR
.,O

No,O
headache,B-PR
.,O

No,O
bone,B-PR
pain,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

1),O
Hypertension,B-PR
.,O

2),O
Gastroesophageal,B-PR
reflux,I-PR
disease,I-PR
.,O

3),O
Anemia,B-PR
.,O

4),O
Prostate,B-PR
CA,I-PR
.,O

ALLERGIES,B-PR
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

MEDICATIONS,O
:,O

Clonidine,B-TR
2.5,O
milligrams,O
topical,O
q.,O
week,O
",",O
Nitropaste,B-TR
2,O
inches,O
q.4h.,O
",",O
Nilandron,B-TR
50,O
milligrams,O
p.o.,O
q.d.,O
",",O
Lupron,B-TR
",",O
Dulcolax,B-TR
p.r.n.,O
",",O
Colace,B-TR
100,O
milligrams,O
p.o.,O
b.i.d.,O
",",O
Ferrous,B-TR
sulfate,I-TR
300,O
milligrams,O
p.o.,O
b.i.d.,O
",",O
Lansopiacole,B-TR
15,O
milligrams,O
p.o.,O
q.d.,O
",",O
bethanechol,B-TR
25,O
milligrams,O
p.o.,O
t.i.d.,O

SOCIAL,O
HISTORY,O
:,O

The,O
patient,O
has,O
been,O
living,O
in,O
the,O
Kansas,O
for,O
more,O
than,O
20,O
years,O
.,O

He,O
was,O
originally,O
from,O
Wark,O
and,O
he,O
speaks,O
Portuguese,O
only,O
.,O

He,O
is,O
now,O
living,O
with,O
his,O
son,O
and,O
daughter,O
",",O
and,O
five,O
other,O
children,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
admission,O
",",O
the,O
patient,O
was,O
a,O
frail,O
looking,O
elderly,O
male,O
lying,O
in,O
bed,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

Temperature,B-TE
95.4,O
",",O
pulse,B-TE
120,O
",",O
blood,B-TE
pressure,I-TE
150/80,O
",",O
respiratory,B-TE
rate,I-TE
24,O
",",O
95%,O
on,O
room,O
air,O
.,O

Conjunctiva,O
were,O
not,O
pale,O
.,O

Sclera,O
nonicteric,O
.,O

Pupils,O
:,O

Isocoric,B-PR
cataract,I-PR
bilaterally,I-PR
.,O

Mouth,O
:,O

Mucous,B-PR
membranes,I-PR
slightly,I-PR
dry,I-PR
.,O

No,O
oral,B-PR
ulcers,I-PR
.,O

Neck,O
:,O

Supple,O
.,O

Jugular,O
vein,O
not,O
engorged,O
.,O

Carotid,O
pulses,O
bounding,O
very,O
strongly,O
.,O

No,O
thyromegaly,B-PR
.,O

Chest,B-TE
examination,I-TE
showed,O
some,B-PR
basilar,I-PR
crackles,I-PR
at,I-PR
the,I-PR
right,I-PR
lung,I-PR
base,I-PR
.,O

Heart,O
initially,O
tachycardia,B-PR
",",O
grade,B-PR
II,I-PR
/,I-PR
VI,I-PR
systolic,I-PR
ejection,I-PR
murmur,I-PR
at,I-PR
the,I-PR
left,I-PR
sternal,I-PR
border,I-PR
.,O

Abdomen,O
:,O

Soft,O
.,O

Liver,O
and,O
spleen,O
were,O
not,O
palpable,O
.,O

Bowel,O
sounds,O
normoactive,O
.,O

Extremities,O
:,O

Traced,B-PR
pitting,I-PR
edema,I-PR
.,O

No,O
cyanosis,B-PR
and,O
no,O
clubbing,B-PR
.,O

Peripheral,B-TE
pulses,I-TE
were,O
very,O
strong,O
and,O
bounding,O
.,O

No,O
calf,B-PR
tenderness,I-PR
.,O

Homan,B-TE
&apos;s,I-TE
sign,I-TE
negative,O
.,O

Neurologic,O
:,O

Examination,B-TE
was,O
limited,O
because,O
the,O
patient,O
speaks,O
only,O
Portuguese,O
.,O

LABORATORY,O
DATA,O
:,O

On,O
admission,O
the,O
patient,O
&apos;s,O
biochemistry,O
showed,O
sodium,B-TE
of,O
140,O
",",O
potassium,B-TE
4.0,O
",",O
chloride,B-TE
107,O
",",O
bicarb,B-TE
14,O
",",O
BUN,B-TE
63,O
",",O
creatinine,B-TE
5.8,O
",",O
blood,B-TE
sugar,I-TE
133,O
.,O

Liver,B-TE
function,I-TE
test,I-TE
showed,O
AST,B-TE
21,O
",",O
alkaline,B-TE
phosphatase,I-TE
70,O
",",O
total,B-TE
bilirubin,I-TE
0.3,O
",",O
total,B-TE
protein,I-TE
6.5,O
",",O
albumin,B-TE
3.9,O
",",O
globulin,B-TE
2.6,O
.,O

CBC,B-TE
:,O

WBC,B-TE
8.4,O
",",O
hematocrit,B-TE
32.6,O
",",O
platelet,B-TE
count,I-TE
"194,000",O
.,O

PT,B-TE
11.9,O
",",O
INR,B-TE
1.0,O
",",O
PTT,B-TE
28.4,O
.,O

Chest,B-TE
x-ray,I-TE
showed,O
no,O
evidence,O
of,O
cardiomegaly,B-PR
.,O

No,O
lung,B-PR
infiltrate,I-PR
.,O

CT,B-TE
scan,I-TE
of,I-TE
the,I-TE
renal,I-TE
area,I-TE
showed,O
right,B-PR
hydronephrosis,I-PR
which,O
extends,O
to,O
an,B-PR
asymmetrically,I-PR
thickened,I-PR
urinary,I-PR
bladder,I-PR
wall,I-PR
.,O

A,B-PR
mass,I-PR
like,I-PR
thickening,I-PR
of,I-PR
the,I-PR
urinary,I-PR
bladder,I-PR
suggestive,O
of,O
either,O
detrusor,B-PR
hypertrophy,I-PR
or,O
possibly,O
tumor,B-PR
.,O

The,B-TE
CT,I-TE
scan,I-TE
showed,O
a,B-PR
cavitary,I-PR
lung,I-PR
lesion,I-PR
in,I-PR
the,I-PR
right,I-PR
lower,I-PR
lobe,I-PR
compatible,O
with,O
metastatic,O
or,O
septic,B-PR
embolus,I-PR
.,O

EKG,B-TE
showed,O
atrial,B-PR
fibrillation,I-PR
",",O
left,B-PR
axis,I-PR
deviation,I-PR
",",O
LVH,B-PR
",",O
nonspecific,B-PR
ST-T,I-PR
changes,I-PR
either,O
due,O
to,O
digitalis,B-PR
affect,I-PR
.,O

CK,B-TE
enzymes,I-TE
146,O
.,O

Repeated,O
three,O
times,O
and,O
remained,O
flat,O
.,O

Troponin,B-TE
I,I-TE
on,O
the,O
second,O
day,O
of,O
admission,O
was,O
1.18,O
.,O

HOSPITAL,O
COURSE,O
:,O

After,O
admission,O
",",O
urology,O
",",O
nephrology,O
as,O
well,O
as,O
interventional,O
radiology,O
was,O
consulted,O
about,O
the,O
management,O
of,O
this,O
patient,O
.,O

The,O
specialist,O
concluded,O
that,O
because,O
the,B-PR
patient,I-PR
&apos;s,I-PR
hematuria,I-PR
seemed,O
to,O
be,O
stable,O
and,O
hematocrit,B-TE
to,O
maintain,O
at,O
about,O
29-30,O
",",O
there,O
is,O
no,O
urgent,O
need,O
to,O
do,O
an,B-TE
arteriogram,I-TE
which,O
may,O
cause,O
further,B-PR
damage,I-PR
to,I-PR
the,I-PR
patient,I-PR
&apos;s,I-PR
kidney,I-PR
.,O

Urology,B-TE
consultation,I-TE
thinks,O
that,O
cystoscopy,B-TR
would,O
not,O
add,O
any,O
benefit,O
to,O
the,O
management,O
and,O
only,O
would,O
consider,O
a,B-TR
right,I-TR
nephrostomy,I-TR
if,O
renal,B-PR
function,I-PR
failed,O
to,O
improve,O
.,O

After,O
admission,O
",",O
the,O
patient,O
was,O
treated,O
conservatively,O
to,O
correct,O
his,B-PR
electrolyte,I-PR
and,I-PR
metabolic,I-PR
acidosis,I-PR
.,O

He,O
was,O
given,O
blood,B-TR
transfusion,I-TR
",",O
two,O
units,O
when,O
his,B-TE
hematocrit,I-TE
dropped,O
to,O
29.4,O
.,O

After,O
transfusion,B-TR
",",O
the,B-TE
patient,I-TE
&apos;s,I-TE
hematocrit,I-TE
rose,O
to,O
37.7,O
on,O
the,O
day,O
of,O
discharge,O
.,O

The,O
patient,O
was,O
also,O
given,O
sodium,B-TR
bicarbonate,I-TR
to,O
correct,O
his,B-PR
metabolic,I-PR
acidosis,I-PR
.,O

He,O
continued,O
to,O
pass,O
about,O
1500-2000,O
cc,O
of,O
urine,O
a,O
day,O
and,O
his,B-TE
renal,I-TE
function,I-TE
improved,O
slowly,O
with,O
creatinine,B-TE
decreased,O
to,O
4.2,O
on,O
the,O
day,O
of,O
discharge,O
.,O

During,O
this,O
admission,O
",",O
the,O
patient,O
also,O
developed,O
atrial,B-PR
fibrillation,I-PR
with,O
ventricular,B-TE
rate,I-TE
of,O
about,O
70-80,O
.,O

CPK,B-TE
was,O
tracked,O
",",O
but,O
was,O
totally,O
normal,O
.,O

No,O
beta,B-TR
blockers,I-TR
were,O
given,O
.,O

A,O
long,O
discussion,O
amongst,O
the,O
specialist,O
",",O
nephrology,O
",",O
urology,O
",",O
interventional,O
radiology,O
",",O
primary,O
oncology,O
as,O
well,O
with,O
the,O
family,O
lead,O
to,O
the,O
conclusion,O
that,O
conservative,B-TR
management,I-TR
may,O
give,O
the,O
patient,O
more,O
comfort,O
than,O
crisis,B-TR
treatment,I-TR
in,O
this,B-PR
well,I-PR
advanced,I-PR
prostate,I-PR
CA,I-PR
.,O

Dr.,O
Lucreamull,O
discussed,O
the,O
patient,O
&apos;s,O
clinical,O
status,O
and,O
overall,O
situation,O
with,O
the,O
patient,O
&apos;s,O
family,O
and,O
the,O
family,O
decided,O
that,O
Mr.,O
Prehekote,O
could,O
return,O
home,O
with,O
hospice,B-TR
.,O

The,O
patient,O
&apos;s,O
primary,O
care,O
physician,O
",",O
Dr.,O
Tomedankell,O
Flowayles,O
will,O
manage,O
the,B-TR
hospice,I-TR
issues,O
.,O

The,O
patient,O
was,O
discharged,O
to,O
home,O
for,O
hospice,B-TR
on,O
March,O
8,O
",",O
1999,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Bethanechol,B-TR
25,O
milligrams,O
p.o.,O
t.i.d.,O
",",O
Clonidine,B-TR
2.5,O
milligrams,O
topical,O
q.,O
week,O
",",O
apply,O
every,O
Sunday,O
",",O
Colace,B-TR
100,O
milligrams,O
p.o.,O
b.i.d.,O
",",O
Haldol,B-TR
0.5-1,O
milligrams,O
p.o.,O
q.6-8h.,O
p.r.n.,O
agitation,B-PR
",",O
Niferex,B-TR
150,O
milligrams,O
p.o.,O
b.i.d.,O
",",O
nitroglycerin,B-TR
paste,I-TR
2%,O
",",O
2,O
inches,O
topical,O
q.8h.,O
",",O
Prilosec,B-TR
20,O
milligrams,O
p.o.,O
q.d.,O
",",O
Senna,B-TR
tablets,I-TR
2,O
tablets,O
b.i.d.,O
",",O
sodium,B-TR
bicarbonate,I-TR
650,O
milligrams,O
p.o.,O
t.i.d.,O
for,O
five,O
days,O
",",O
Proscar,B-TR
5,O
milligrams,O
p.o.,O
q.d.,O
",",O
Casodex,B-TR
50,O
milligrams,O
p.o.,O
q.d.,O
",",O
Nephrocaps,B-TR
1,O
tablets,O
p.o.,O
q.d.,O

COMPLICATIONS,O
:,O

None,O
.,O

CONDITION,O
ON,O
DISCHARGE,O
:,O

Fair,O
.,O

DISPOSITION,O
:,O

Home,O
with,O
hospice,B-TR
.,O

Dictated,O
By,O
:,O

KYMBELL,O
SPARDJEB,O
",",O
M.D.,O
BJ43,O

Attending,O
:,O

LAGEORG,O
LUCREAMULL,O
",",O
M.D.,O
MR28,O
PN199/1242,O

Batch,O
:,O

14667,O

Index,O
No.,O
UDFTTQ73N9,O

D,O
:,O

03/08/99,O

T,O
:,O

03/09/99,O

932057504,O
DH,O

5898830,O

809200,O

356490,O

11/25/2000,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O

AGACHBRAUCH,O
",",O
RENSIAANARC,O

MRN,O
:,O

5898830,O

Age,O
:,O

44y,O

REGISTRATION,O
DATE,O
:,O

11/25/2000,O
01:36,O
AM,O

PRELIMINARY,O
REPORT,O

This,O
is,O
to,O
notify,O
you,O
that,O
your,O
patient,O
",",O
AGACHBRAUCH,O
",",O
RENSIAANARC,O
arrived,O
in,O
the,O
Emergency,O
Department,O
at,O
Daughtersvillshamen&apos;s,O
Hospital,O
on,O
11/25/2000,O
01:36,O
AM,O
.,O

The,O
patient,O
presented,O
with,O
a,O
chief,O
complaint,O
of,O
AF-RESOLVED,B-PR
.,O

Following,O
evaluation,B-TE
and,O
treatment,B-TR
",",O
the,O
patient,O
&apos;s,O
disposition,O
at,O
the,O
end,O
of,O
the,O
visit,O
was,O
TREATED,O
AND,O
RELEASED,O
.,O

If,O
you,O
need,O
additional,O
information,O
please,O
call,O
613-870-0699,O
.,O

950452368,O

CTMC,O

25445040,O

808386,O

5/9/1998,O
12:00:00,O
AM,O

EXTERNAL,B-PR
WOUND,I-PR
INFECTIONS,I-PR

Signed,O

DIS,O

Admission,O
Date,O
:,O

05/09/1998,O

Report,O
Status,O
:,O

Signed,O

Discharge,O
Date,O
:,O

05/25/1998,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

STERNAL,B-PR
WOUND,I-PR
INFECTION,I-PR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
a,O
74-year-old,O
woman,O
",",O
well,O
known,O
to,O
the,O
cardiac,O
surgery,O
service,O
",",O
readmitted,O
from,O
Glasmif/putdi,O
Health,O
Network,O
with,O
sternal,B-PR
wound,I-PR
infection,I-PR
.,O

She,O
has,O
been,O
previously,O
hospitalized,O
on,O
12,O
April,O
1998,O
for,O
the,B-PR
same,I-PR
diagnosis,I-PR
.,O

She,O
is,O
now,O
coming,O
for,O
surgical,B-TR
treatment,I-TR
",",O
wound,B-TR
debridement,I-TR
",",O
and,O
possible,O
wound,B-TR
closure,I-TR
with,I-TR
bilateral,I-TR
pectoralis,I-TR
flap,I-TR
.,O

She,O
underwent,O
coronary,B-TR
artery,I-TR
bypass,I-TR
graft,I-TR
times,O
two,O
with,O
saphenous,B-TR
vein,I-TR
graft,I-TR
on,O
29,O
March,O
1998,O
.,O

Of,O
note,O
",",O
the,O
patient,O
is,O
status,B-PR
post,I-PR
lymphoma,I-PR
with,O
treatment,O
of,O
chemotherapy,B-TR
and,O
radiation,B-TR
six,O
years,O
ago,O
",",O
and,O
is,O
an,B-PR
insulin-dependent,I-PR
diabetic,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Insulin-dependent,B-PR
diabetes,I-PR
mellitus,I-PR
",",O
lymphoma,B-PR
as,O
above,O
",",O
ulcerative,B-PR
colitis,I-PR
",",O
melanoma,B-PR
status,O
post,O
excision,B-TR
in,I-TR
right,I-TR
upper,I-TR
extremity,I-TR
",",O
hypertension,B-PR
",",O
hypothyroidism,B-PR
",",O
congestive,B-PR
heart,I-PR
failure,I-PR
",",O
and,O
coronary,B-PR
artery,I-PR
disease,I-PR
with,O
bypass,B-TR
grafting,I-TR
.,O

PAST,O
SURGICAL,O
HISTORY,O
:,O

She,O
is,O
status,O
post,O
left,B-TR
knee,I-TR
replacement,I-TR
and,O
status,O
post,O
multiple,B-TR
prior,I-TR
surgeries,I-TR
and,O
reconstruction,B-TR
of,I-TR
the,I-TR
knee,I-TR
.,O

Status,O
post,O
cholecystectomy,B-TR
",",O
lumbar,B-TR
diskectomy,I-TR
",",O
and,O
tonsillectomy,B-TR
with,O
adenoidectomy,B-TR
.,O

ALLERGIES,O
:,O

Erythromycin,B-TR
",",O
vancomycin,B-TR
",",O
and,O
Bacitracin,B-TR
.,O

ADMISSION,O
MEDICATIONS,O
:,O

Elavil,B-TR
50,O
mg,O
p.o.,O
q.h.s.,O
",",O
coated,B-TR
aspirin,I-TR
325,O
mg,O
p.o.,O
p.day,O
",",O
Tegretol,B-TR
100,O
mg,O
p.o.,O
b.i.d.,O
",",O
Ancef,B-TR
1,O
gm,O
IV,O
q.12h.,O
times,O
seven,O
days,O
",",O
Vasotec,B-TR
5,O
mg,O
p.o.,O
q.day,O
",",O
Synthroid,B-TR
0.025,O
mg,O
p.o.,O
q.day,O
",",O
Asacol,B-TR
400,O
mg,O
q.a.m.,O
and,O
800,O
mg,O
q.p.m.,O
",",O
Lopressor,B-TR
25,O
mg,O
p.o.,O
b.i.d.,O
",",O
Prilosec,B-TR
20,O
mg,O
p.o.,O
q.day,O
",",O
and,O
insulin,B-TR
70/30,O
26,O
units,O
in,O
the,O
morning,O
and,O
12,O
units,O
at,O
night,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

The,O
patient,O
was,O
admitted,O
with,O
a,O
blood,B-TE
pressure,I-TE
of,O
140/80,O
",",O
temperature,B-TE
101.3,O
",",O
pulse,B-TE
84,O
",",O
and,O
respiratory,B-TE
rate,I-TE
22,O
.,O

The,O
patient,O
is,O
obese,B-PR
with,O
unremarkable,O
physical,O
examination,O
except,O
for,O
a,B-PR
systolic,I-PR
murmur,I-PR
",",O
I,B-PR
/,I-PR
VI,I-PR
and,I-PR
erythema,I-PR
over,I-PR
the,I-PR
sternal,I-PR
wound,I-PR
and,O
upper,O
third,O
.,O

The,B-PR
wound,I-PR
had,O
a,B-PR
beefy,I-PR
red,I-PR
cellulitic,I-PR
area,I-PR
surrounding,O
an,O
open,O
area,O
",",O
blanching,O
to,O
touch,O
.,O

There,O
was,O
no,O
purulence,B-PR
or,O
discharge,B-PR
noted,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
placed,O
on,O
IV,B-TR
antibiotics,I-TR
",",O
Ancef,B-TR
1,O
gm,O
q.8h.,O

On,O
10,O
May,O
1998,O
",",O
she,O
underwent,O
sternal,B-TR
wound,I-TR
debridement,I-TR
and,I-TR
closure,I-TR
",",O
performed,O
by,O
Dr.,O
Falccouette,O
and,O
Dr.,O
Shuffzeln,O
.,O

The,O
patient,O
was,O
switched,O
to,O
ampicillin,B-TR
",",O
gentamicin,B-TR
",",O
and,O
clindamycin,B-TR
",",O
according,O
to,O
the,B-TE
culture,I-TE
",",O
Enterococci,B-PR
and,O
Staphylococcus,B-PR
in,O
the,B-PR
wound,I-PR
.,O

Due,O
to,O
the,B-PR
persistent,I-PR
fevers,I-PR
",",O
the,O
patient,O
underwent,O
vancomycin,B-TR
desensitization,I-TR
in,O
the,O
surgical,O
Intensive,O
Care,O
Unit,O
followed,O
by,O
a,B-TR
change,I-TR
of,I-TR
antibiotics,I-TR
to,O
vancomycin,B-TR
and,O
levofloxacin,B-TR
.,O

Further,B-TE
cultures,I-TE
from,I-TE
sputum,I-TE
and,I-TE
urine,I-TE
revealed,O
yeast,B-PR
sensitive,O
to,O
Diflucan,B-TR
",",O
which,O
was,O
administered,O
shortly,O
after,O
.,O

Because,O
of,O
expected,B-TR
long,I-TR
term,I-TR
antibiotic,I-TR
administration,I-TR
",",O
a,B-TR
PICC,I-TR
line,I-TR
was,O
placed,O
and,O
the,O
patient,O
was,O
prepared,O
for,O
transfer,O
back,O
to,O
Fo,O
Hospital,O
.,O

As,O
a,B-PR
small,I-PR
complication,I-PR
",",O
the,O
patient,O
opened,O
a,B-PR
left,I-PR
ankle,I-PR
wound,I-PR
post,O
saphenous,B-TR
vein,I-TR
harvest,I-TR
",",O
which,O
persists,O
up,O
until,O
now,O
and,O
is,O
of,O
a,O
size,O
2,O
x,O
1,O
cm,O
.,O

Due,O
to,O
difficult,B-PR
ambulation,I-PR
",",O
the,O
patient,O
developed,O
a,B-PR
small,I-PR
ulcer,I-PR
in,I-PR
the,I-PR
sacral,I-PR
area,I-PR
",",O
which,O
was,O
treated,O
with,O
Duoderm,B-TR
dressing,I-TR
.,O

During,O
the,O
course,O
of,O
hospitalization,O
",",O
the,O
patient,O
was,O
followed,O
by,O
cardiac,O
surgery,O
",",O
cardiology,O
",",O
infectious,O
disease,O
",",O
allergy,O
",",O
and,O
medicine,O
",",O
including,O
GI,O
teams,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

Elavil,B-TR
by,O
mouth,O
15,O
mg,O
every,O
night,O
",",O
Dulcolax,B-TR
rectally,O
10,O
mg,O
once,O
a,O
day,O
",",O
Tegretol,B-TR
by,O
mouth,O
100,O
mg,O
twice,O
a,O
day,O
",",O
Benadryl,B-TR
by,O
mouth,O
25,O
mg,O
three,O
times,O
a,O
day,O
",",O
Colace,B-TR
by,O
mouth,O
200,O
mg,O
twice,O
a,O
day,O
",",O
Vasotec,B-TR
by,O
mouth,O
10,O
mg,O
twice,O
a,O
day,O
",",O
EOC,B-TR
/,I-TR
LOC,I-TR
p.r./p.o.,O
one,O
each,O
once,O
a,O
day,O
as,O
needed,O
for,O
constipation,B-PR
",",O
Lasix,B-TR
by,O
mouth,O
80,O
mg,O
every,O
morning,O
",",O
insulin,B-TR
regular,O
according,O
to,O
insulin,O
scale,O
",",O
Synthroid,B-TR
by,O
mouth,O
25,O
mcg,O
once,O
a,O
day,O
",",O
Maalox,B-TR
Plus,I-TR
Extra,I-TR
Strength,I-TR
by,O
mouth,O
15,O
ml,O
every,O

Note,O
",",O
please,O
draw,O
blood,O
for,O
vancomycin,B-TE
levels,I-TE
on,O
25,O
May,O
1998,O
",",O
before,O
the,O
next,O
dose,O
",",O
to,O
get,O
the,B-TE
trough,I-TE
level,I-TE
.,O

Keep,O
vancomycin,B-TE
trough,I-TE
between,O
10-20,O
",",O
but,O
not,O
less,O
due,O
to,O
desensitization,B-PR
.,O

Vancomycin,B-TE
levels,I-TE
should,O
be,O
checked,O
every,O
third,O
day,O
for,O
four,O
to,O
six,O
weeks,O
",",O
according,O
to,O
IMD,O
.,O

Nizatidine,B-TR
by,O
mouth,O
150,O
mg,O
twice,O
a,O
day,O
",",O
insulin,B-TR
70/30,O
human,O
injection,O
under,O
skin,O
12,O
units,O
every,O
night,O
",",O
insulin,B-TR
70/30,O
human,O
injection,O
subcutaneous,O
26,O
units,O
every,O
morning,O
",",O
Lovenox,B-TR
injection,O
under,O
skin,O
40,O
mg,O
once,O
a,O
day,O
",",O
and,O
levofloxacin,B-TR
by,O
mouth,O
250,O
mg,O
once,O
a,O
day,O
.,O

Dictated,O
By,O
:,O

NALA,O
BEST,O
",",O
M.D.,O
KJ76,O

Attending,O
:,O

JOFREDD,O
N.,O
FALCCOUETTE,O
",",O
M.D.,O
CA8,O
XX584/6088,O

Batch,O
:,O

3679,O

Index,O
No.,O
W9YYL76XV1,O

D,O
:,O

05/25/98,O

T,O
:,O

05/25/98,O

CC,O
:,O

1.,O
LAELK,O
MEMORIAL,O
HOSPITAL,O

959086752,O

PUOMC,O

6824024,O

94907,O

812890,O

2/1/2000,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Report,O
Status,O
:,O

Signed,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

RATHELIFE,O
",",O
TIEANAKI,O
B,O

UNIT,O
NUMBER,O
:,O

342-07-28,O

ADMISSION,O
DATE,O
:,O

02/01/2000,O

DISCHARGE,O
DATE,O
:,O

02/08/2000,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Non-healing,B-PR
ulcer,I-PR
on,I-PR
the,I-PR
right,I-PR
leg,I-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

Right,B-TR
fem,I-TR
to,I-TR
below,I-TR
knee,I-TR
pop,I-TR
bypass,I-TR
graft,I-TR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

This,O
patient,O
is,O
an,O
seventy,O
eight,O
year,O
old,O
female,O
with,O
history,O
of,O
peripheral,B-PR
vascular,I-PR
disease,I-PR
who,O
is,O
status,O
post,O
above,B-TR
knee,I-TR
to,I-TR
fem,I-TR
pop,I-TR
bypass,I-TR
graft,I-TR
with,O
6,B-TR
millimeter,I-TR
PTFE,I-TR
.,O

This,B-TR
operation,I-TR
was,O
performed,O
for,O
two,O
months,O
of,O
increased,B-PR
rest,I-PR
pain,I-PR
.,O

Her,B-PR
pain,I-PR
resolved,O
after,O
surgery,B-TR
and,O
she,O
has,O
been,O
doing,O
well,O
since,O
",",O
although,O
at,O
baseline,O
now,O
she,O
is,O
minimally,B-PR
ambulatory,I-PR
from,O
bed,O
to,O
commode,O
.,O

For,O
the,O
past,O
couple,O
of,O
months,O
the,O
patient,O
has,O
had,O
a,B-PR
non-healing,I-PR
right,I-PR
dorsal,I-PR
foot,I-PR
ulcer,I-PR
which,O
has,O
been,O
increasing,O
in,O
size,O
and,O
started,O
as,O
a,B-PR
pin,I-PR
hole,I-PR
and,O
she,O
does,O
not,O
recollect,O
any,B-PR
trauma,I-PR
",",O
as,O
similar,B-PR
small,I-PR
ulcers,I-PR
developed,O
on,O
the,O
left,O
foot,O
as,O
well,O
around,O
the,O
same,O
time,O
",",O
but,O
that,O
has,O
subsequently,O
healed,O
.,O

The,B-PR
ulcer,I-PR
was,O
managed,O
conservatively,O
at,O
Har,O
Hospital,O
by,O
Dr.,O
Holes,O
with,O
Silvadene,B-TR
b.i.d.,O
lower,B-TE
extremity,I-TE
non-invasive,I-TE
study,I-TE
obtained,O
at,O
that,O
time,O
showed,O
poor,B-PR
distal,I-PR
right,I-PR
extremity,I-PR
perfusion,I-PR
.,O

The,O
patient,O
was,O
referred,O
back,O
to,O
Dr.,O
Pop,O
for,O
the,O
possibility,O
of,O
a,B-TR
revascularization,I-TR
procedure,I-TR
.,O

She,O
is,O
status,O
post,O
angiography,B-TE
today,O
.,O

She,O
has,O
just,O
finished,O
a,O
ten,O
day,O
course,O
of,O
Ciprofloxacin,B-TR
.,O

She,O
denies,O
any,O
fevers,B-PR
or,O
chills,B-PR
.,O

She,O
does,O
have,O
rest,B-PR
pain,I-PR
in,I-PR
the,I-PR
right,I-PR
foot,I-PR
and,I-PR
ankle,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Significant,O
for,O
Guillain-Barr,B-PR
syndrome,I-PR
",",O
Lupus,B-PR
",",O
status,O
post,O
multiple,B-PR
decubiti,I-PR
",",O
peripheral,B-PR
vascular,I-PR
disease,I-PR
",",O
status,O
post,O
right,B-TR
total,I-TR
knee,I-TR
replacement,I-TR
and,O
status,O
post,O
cholecystectomy,B-TR
",",O
status,O
post,O
hysterectomy,B-TR
",",O
status,O
post,O
goiter,B-PR
and,O
left,B-PR
lung,I-PR
fibrosis,I-PR
",",O
status,O
post,O
methicillin,B-PR
resistant,I-PR
Staphylococcus,I-PR
aureus,I-PR
pneumonia,I-PR
.,O

MEDICATIONS,O
ON,O
ADMISSION,O
:,O

Prednisone,B-TR
5,O
every,O
other,O
day,O
",",O
alternating,O
with,O
ten,O
every,O
other,O
day,O
.,O

Trental,B-TR
400,O
milligrams,O
t.i.d.,O
",",O
Cytotec,B-TR
100,O
milligrams,O
t.i.d.,O
",",O
Ativan,B-TR
2,O
milligrams,O
q.h.s.,O
Darvon,B-TR
65,O
milligrams,O
two,O
q.i.d,O
",",O
Relafen,B-TR
500,O
milligrams,O
b.i.d,O
",",O
Vitamin,B-TR
E,I-TR
",",O
Prilosec,B-TR
20,O
milligrams,O
once,O
a,O
day,O
",",O
Zantac,B-TR
150,O
milligrams,O
b.i.d,O
",",O
Lasix,B-TR
120,O
milligrams,O
every,O
other,O
day,O
PRN,O
edema,B-PR
.,O

Didronel,B-TR
1,O
q,O
day,O
which,O
has,O
been,O
on,O
hold,O
.,O

Proventil,B-TR
inhaler,I-TR
via,I-TR
nebulizers,I-TR
0.5,O
milligrams,O
with,O
Atrovent,B-TR
.,O

ALLERGIES,O
:,O

The,O
patient,O
is,O
allergic,B-PR
Ampicillin,B-TR
",",O
Tylenol,B-TR
",",O
Clinoril,B-TR
",",O
Biaxin,B-TR
",",O
Codeine,B-TR
",",O
Sulfa,B-TR
and,O
Aminophylline,B-TR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

She,O
is,O
afebrile,O
",",O
her,B-TE
vital,I-TE
signs,I-TE
are,O
stable,O
.,O

Her,O
pupils,O
equal,O
round,O
reactive,O
to,O
light,O
and,O
accomodation,O
",",O
normocephalic,O
",",O
atraumatic,O
",",O
extraocular,O
muscles,O
intact,O
.,O

Neck,O
",",O
she,O
has,O
II+,O
bilateral,O
carotids,O
",",O
no,O
bruits,B-PR
",",O
no,O
jugular,B-PR
venous,I-PR
distention,I-PR
.,O

Lungs,O
decreased,B-PR
breath,I-PR
sounds,I-PR
at,I-PR
bilateral,I-PR
bases,I-PR
with,O
minimal,B-PR
expiratory,I-PR
crackles,I-PR
on,I-PR
the,I-PR
right,I-PR
.,O

Abdomen,O
",",O
soft,O
",",O
non-tender,B-PR
",",O
non-distended,B-PR
",",O
normal,O
active,O
bowel,O
sounds,O
.,O

Extremities,O
on,O
the,O
right,O
",",O
she,O
has,O
a,O
II+,O
femoral,O
",",O
no,O
distal,B-PR
pulses,I-PR
beyond,O
that,O
.,O

On,O
the,O
left,O
she,O
has,O
a,O
II+,O
femoral,O
and,O
II+,O
popliteal,O
",",O
no,O
distal,B-PR
pulses,I-PR
beyond,O
that,O
.,O

She,O
has,O
on,O
her,O
right,O
ankle,O
anteriorly,O
a,B-PR
four,I-PR
centimeter,I-PR
ulcer,I-PR
with,I-PR
necrotic,I-PR
base,I-PR
.,O

Minimal,B-PR
surrounding,I-PR
erythema,I-PR
.,O

She,O
is,O
able,O
to,O
wiggle,O
her,O
toes,O
bilaterally,O
.,O

Sensation,O
is,O
intact,O
bilaterally,O
.,O

Her,O
legs,O
are,O
tender,O
to,O
touch,O
bilaterally,O
.,O

Her,B-TE
angiography,I-TE
showed,O
a,B-PR
right,I-PR
proximal,I-PR
popliteal,I-PR
occlusion,I-PR
",",O
anterior,B-PR
tibial,I-PR
dominant,I-PR
foot,I-PR
vessel,I-PR
.,O

Small,B-PR
posterior,I-PR
tibial,I-PR
occlusion,I-PR
on,I-PR
the,I-PR
distal,I-PR
calf,I-PR
and,O
a,B-PR
small,I-PR
peroneal,I-PR
goes,O
down,O
to,O
the,O
ankle,O
.,O

On,O
a,B-TE
rectal,I-TE
examination,I-TE
she,O
is,O
guaiac,O
negative,O
",",O
no,O
masses,B-PR
and,O
no,O
gluteal,B-PR
ulcers,I-PR
or,O
decubiti,B-PR
.,O

HOSPITAL,O
COURSE,O
AND,O
TREATMENT,O
:,O

The,O
patient,O
was,O
admitted,O
and,O
taken,O
to,O
the,O
operating,O
room,O
on,O
the,O
following,O
day,O
and,O
she,O
underwent,O
a,B-TR
right,I-TR
fem,I-TR
to,I-TR
below,I-TR
knee,I-TR
popliteal,I-TR
bypass,I-TR
graft,I-TR
using,O
a,B-TR
six,I-TR
millimeter,I-TR
ring,I-TR
PTFE,I-TR
.,O

She,O
had,O
a,O
strong,O
popliteal,O
doppler,O
pulse,O
intraoperatively,O
and,O
good,O
PVR,O
on,O
the,O
right,O
postoperatively,O
.,O

The,O
patient,O
did,O
well,O
in,O
the,O
postoperative,O
period,O
.,O

She,O
was,O
afebrile,O
",",O
her,B-TE
vital,I-TE
signs,I-TE
were,O
stable,O
.,O

She,O
was,O
making,O
adequate,O
urine,O
output,O
anywhere,O
between,O
20,O
to,O
50,O
ccs,O
an,O
hour,O
.,O

Her,B-TE
hematocrit,I-TE
was,O
26.8,O
and,O
she,O
was,O
transfused,O
1,O
unit,O
of,O
packed,B-TR
red,I-TR
blood,I-TR
cells,I-TR
.,O

Her,O
diet,O
was,O
advanced,O
from,O
clears,O
to,O
a,O
diet,O
as,O
tolerated,O
.,O

On,O
postoperative,O
day,O
two,O
the,O
patient,O
was,O
noted,O
to,O
have,O
some,B-PR
swelling,I-PR
in,I-PR
her,I-PR
left,I-PR
lower,I-PR
extremity,I-PR
and,O
this,O
was,O
felt,O
to,O
be,O
a,B-PR
hematoma,I-PR
secondary,O
to,O
her,B-TE
PVR,I-TE
cuff,I-TE
.,O

There,O
is,O
mild,O
amount,O
of,O
surrounding,B-PR
erythema,I-PR
and,O
the,O
patient,O
was,O
started,O
on,O
Ancef,B-TR
at,O
that,O
time,O
.,O

The,O
patient,O
was,O
seen,O
by,O
physical,O
therapy,O
.,O

The,O
area,O
of,O
erythema,B-PR
on,I-PR
her,I-PR
left,I-PR
leg,I-PR
enlarged,O
slightly,O
and,O
the,O
patient,O
was,O
placed,O
on,O
Vancomycin,B-TR
for,O
several,O
days,O
after,O
which,O
time,O
her,B-PR
erythema,I-PR
again,O
began,O
to,O
decrease,O
.,O

Her,O
right,O
foot,O
remained,O
warm,O
.,O

She,O
had,O
wounds,B-PR
which,O
were,O
clean,O
",",O
dry,O
and,O
intact,O
and,O
the,O
patient,O
was,O
stable,O
from,O
a,O
respiratory,O
standpoint,O
using,O
her,B-TR
respirator,I-TR
at,O
night,O
.,O

The,O
patient,O
required,O
an,B-TR
additional,I-TR
blood,I-TR
transfusion,I-TR
during,O
her,O
hospital,O
stay,O
as,O
her,B-TE
hematocrit,I-TE
had,O
decreased,O
to,O
27,O
on,O
postoperative,O
day,O
three,O
.,O

The,O
patient,O
while,O
in,O
bed,O
had,O
her,O
legs,O
elevated,O
.,O

The,O
patient,O
was,O
tolerating,O
a,O
general,O
diet,O
",",O
she,O
was,O
voiding,O
on,O
her,O
own,O
and,O
the,O
patient,O
was,O
discharged,O
to,O
home,O
as,O
her,O
daughter,O
is,O
a,O
nurse,O
.,O

She,O
was,O
discharged,O
with,O
PO,B-TR
Keflex,I-TR
that,O
she,O
was,O
to,O
take,O
for,O
the,O
next,O
ten,O
days,O
.,O

The,O
patient,O
is,O
to,O
follow,O
up,O
with,O
Dr.,O
Pop,O
in,O
one,O
week,O
and,O
the,O
patient,O
was,O
afebrile,O
with,O
stable,O
vital,O
signs,O
at,O
the,O
time,O
of,O
discharge,O
.,O

LAYMIE,O
ASLINKE,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

Electronically,O
Signed,O
EDRY,O
R,O
YELLOW,O
",",O
M.D.,O

03/16/2000,O
13:21,O

_____________________________,O
EDRY,O
YELLOW,O
",",O
M.D.,O

TR,O
:,O

nw,O

DD,O
:,O

02/09/2000,O

TD,O
:,O

02/12/2000,O
1:41,O
P,O

cc,O
:,O

EDRY,O
R,O
YELLOW,O
",",O
M.D.,O

965367286,O
WGH,O

4025213,O

465655,O

9246470,O

12/19/2006,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O

CIENNE,O
",",O
GUTAOI,O

MRN,O
:,O

4025213,O

Age,O
:,O

42y,O

REGISTRATION,O
DATE,O
:,O

12/19/2006,O
08:13,O
PM,O

PRELIMINARY,O
REPORT,O

This,O
is,O
to,O
notify,O
you,O
that,O
your,O
patient,O
",",O
CIENNE,O
",",O
GUTAOI,O
arrived,O
in,O
the,O
Emergency,O
Department,O
at,O
Well,O
General,O
Hospital,O
on,O
12/19/2006,O
08:13,O
PM,O
.,O

The,O
patient,O
presented,O
with,O
a,O
chief,O
complaint,O
of,O
SOB,B-PR
.,O

Following,O
triage,B-TE
",",O
the,O
patient,O
left,O
without,O
being,O
seen,O
.,O

If,O
you,O
need,O
additional,O
information,O
please,O
call,O
366-686-5449,O
.,O

PCP,O
Name,O
:,O

ELKSOBEBEUCH,O
",",O
IEVE,O

Provider,O
Number,O
:,O

66130,O

974381789,O

PUOMC,O

520610,O

70648,O

390115,O

12/25/1996,O
12:00:00,O
AM,O

ATRIAL,B-PR
FIBRILLATION,I-PR
.,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

LENKPRUSKIHKOOGLEKIH,O
",",O
NIEKERO,O
C,O

UNIT,O
NUMBER,O
:,O

449-50-82,O

ADMISSION,O
DATE,O
:,O

12/25/96,O

DISCHARGE,O
DATE,O
:,O

12/29/96,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Atrial,B-PR
fibrillation,I-PR
.,O

ASSOCIATED,O
DIAGNOSIS,O
:,O

History,O
of,O
multinodular,B-PR
goiter,I-PR
;,O
history,O
of,O
hypertension,B-PR
;,O
history,O
of,O
subtotal,B-TR
thyroidectomy,I-TR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

Electrical,B-TR
cardioversion,I-TR
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

Ms.,O
Lenkpruskihkooglekih,O
is,O
a,O
63-year-old,O
lady,O
with,O
a,O
history,O
of,O
frequent,B-PR
premature,I-PR
ventricular,I-PR
contractions,I-PR
and,O
infrequent,B-PR
short,I-PR
runs,I-PR
of,I-PR
non-sustained,I-PR
ventricular,I-PR
tachycardia,I-PR
(,O
one,O
four-beat,O
run,O
),O
in,O
1991,O
",",O
for,O
which,O
several,O
antiarrhythmic,O
agents,O
including,O
Propranolol,B-TR
",",O
Quinidine,B-TR
",",O
Procainamide,B-TR
",",O
Tenormin,B-TR
",",O
Norpace,B-TR
",",O
Corgard,B-TR
",",O
and,O
Flecainide,B-TR
were,O
used,O
",",O
but,O
were,O
stopped,O
because,O
of,O
intolerance,B-PR
.,O

At,O
that,O
time,O
",",O
she,O
had,O
clear,O
coronary,O
arteries,O
on,O
coronary,B-TE
angiography,I-TE
and,O
an,B-TE
ejection,I-TE
fraction,I-TE
greater,O
than,O
50%,O
.,O

She,O
did,O
well,O
off,O
antiarrhythmic,B-TR
agents,I-TR
until,O
October,O
of,O
this,O
year,O
when,O
she,O
was,O
noted,O
to,O
have,O
atrial,B-PR
fibrillation,I-PR
with,O
a,B-PR
rapid,I-PR
ventricular,I-PR
rate,I-PR
after,O
several,O
days,O
of,O
decreased,B-PR
exercise,I-PR
tolerance,I-PR
.,O

She,O
was,O
started,O
on,O
Coumadin,B-TR
and,O
had,O
a,O
failed,O
attempt,O
at,O
DC,B-TR
electrical,I-TR
cardioversion,I-TR
on,O
11/16/96,O
.,O

She,O
has,O
been,O
on,O
Coumadin,B-TR
since,O
and,O
has,O
continued,O
to,O
have,O
occasional,B-PR
palpitations,I-PR
and,O
mild,B-PR
shortness,I-PR
of,I-PR
breath,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Includes,O
a,O
history,O
of,O
hypertension,B-PR
;,O
multinodular,B-PR
goiter,I-PR
;,O
subtotal,B-TR
thyroidectomy,I-TR
.,O

MEDICATIONS,O
:,O

Include,O
Cardizem,B-TR
CD,I-TR
180,O
mg,O
daily,O
;,O
Monopril,B-TR
10,O
mg,O
daily,O
;,O
Digoxin,B-TR
.25,O
mg,O
daily,O
;,O
and,O
Lasix,B-TR
40,O
mg,O
every,O
other,O
day,O
.,O

ALLERGIES,O
:,O

To,O
Quinidine,B-TR
",",O
Procardia,B-TR
",",O
and,O
sulfa,B-TR
antibiotics,I-TR
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
examination,B-TE
",",O
blood,B-TE
pressure,I-TE
was,O
200/100,O
;,O
heart,B-TE
rate,I-TE
120,O
per,O
minute,O
(,O
atrial,B-PR
fibrillation,I-PR
),O
.,O

The,O
patient,O
was,O
noted,O
to,O
be,O
anxious,B-PR
.,O

There,O
was,O
no,O
neck,B-PR
vein,I-PR
distension,I-PR
or,O
carotid,B-PR
bruits,I-PR
.,O

Heart,O
sounds,O
were,O
normal,O
.,O

The,O
lungs,O
were,O
clear,O
.,O

The,B-TE
abdominal,I-TE
examination,I-TE
was,O
benign,O
.,O

There,O
was,O
no,O
peripheral,B-PR
edema,I-PR
.,O

Pulses,O
were,O
all,O
easily,O
palpable,O
.,O

LABORATORY,O
DATA,O
:,O

A,B-TE
12-lead,I-TE
electrocardiogram,I-TE
showed,O
atrial,B-PR
fibrillation,I-PR
with,O
a,O
QT,O
interval,O
of,O
.46,O
seconds,O
.,O

There,O
were,O
diffuse,B-PR
ST,I-PR
segment,I-PR
and,I-PR
T-wave,I-PR
abnormalities,I-PR
",",O
which,O
were,O
nonspecific,O
.,O

A,B-TE
complete,I-TE
blood,I-TE
count,I-TE
",",O
electrolytes,B-TE
",",O
BUN,B-TE
and,O
creatinine,B-TE
were,O
within,O
normal,O
limits,O
.,O

INR,B-TE
was,O
elevated,O
at,O
2.5,O
.,O

An,B-TE
echocardiogram,I-TE
was,O
performed,O
",",O
which,O
showed,O
completely,O
normal,O
left,O
ventricular,O
systolic,O
function,O
with,O
an,O
ejection,O
fraction,O
calculated,O
at,O
.74,O
.,O

There,O
was,O
no,O
evidence,O
of,O
left,B-PR
ventricular,I-PR
hypertrophy,I-PR
or,O
asymmetric,B-PR
septal,I-PR
hypertrophy,I-PR
",",O
which,O
had,O
been,O
an,O
issue,O
that,O
had,O
been,O
raised,O
on,O
an,B-TE
echocardiogram,I-TE
in,O
Ownra,O
Cin,O
",",O
New,O
Mexico,O
on,O
12/06/96,O
.,O

HOSPITAL,O
COURSE,O
AND,O
TREATMENT,O
:,O

The,O
patient,O
was,O
started,O
on,O
Propafenone,B-TR
300,O
mg,O
three,O
times,O
a,O
day,O
and,O
underwent,O
an,O
attempt,O
at,O
electrical,B-TR
cardioversion,I-TR
after,O
seven,O
doses,O
of,O
this,O
.,O

This,O
failed,O
",",O
despite,O
one,O
shock,O
at,O
300,O
joules,O
and,O
two,O
shocks,O
at,O
360,O
joules,O
.,O

The,O
Propafenone,B-TR
was,O
stopped,O
",",O
and,O
the,O
patient,O
was,O
changed,O
to,O
Amiodarone,B-TR
400,O
mg,O
t.i.d.,O
",",O
which,O
was,O
continued,O
for,O
two,O
days,O
.,O

The,O
patient,O
was,O
discharged,O
to,O
home,O
on,O
Amiodarone,B-TR
200,O
mg,O
daily,O
on,O
12/29/96,O
.,O

An,B-TE
electrocardiogram,I-TE
showed,O
no,O
evidence,O
of,O
QT,B-PR
prolongation,I-PR
prior,O
to,O
discharge,O
",",O
and,O
pulmonary,B-TE
function,I-TE
tests,I-TE
will,O
be,O
performed,O
before,O
the,O
patient,O
goes,O
home,O
today,O
.,O

The,O
patient,O
will,O
follow,O
up,O
with,O
Dr.,O
Ther,O
Ludzjesc,O
at,O
Shiekeu,O
Hospital,O
Medical,O
Centers,O
in,O
Connecticut,O
.,O

In,O
addition,O
",",O
she,O
will,O
return,O
to,O
this,O
hospital,O
in,O
early,O
February,O
for,O
repeat,O
attempt,O
at,O
electrical,B-TR
cardioversion,I-TR
on,O
Amiodarone,B-TR
.,O

She,O
will,O
continue,O
her,O
Coumadin,B-TR
until,O
then,O
and,O
arrangements,O
for,O
her,O
readmission,O
can,O
be,O
made,O
through,O
Dr.,O
Iceca,O
Rhaltkaaispehbreun,O
's,O
office,O
here,O
.,O

MEDICATIONS,O
:,O

Other,O
than,O
the,O
addition,O
of,O
Amiodarone,B-TR
200,O
mg,O
daily,O
",",O
will,O
be,O
the,O
same,O
as,O
her,B-TR
admission,I-TR
medications,I-TR
.,O

STA,O
BODEJOVE,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

ICECA,O
RHALTKAAISPEHBREUN,O
",",O
M.D.,O

cc,O
:,O

Dr.,O
Ther,O
Ludzjesc,O
Director,O
",",O
Section,O
of,O
Cardiology,O
Shiekeu,O
Hospital,O
Medical,O
Centers,O
NC,O

TR,O
:,O

sip,O

DD,O
:,O

12/29/96,O

TD,O
:,O

12/29/96,O
10:03,O
A,O

cc,O
:,O

ICECA,O
RHALTKAAISPEHBREUN,O
",",O
M.D.,O

979440029,O
RWH,O

2027705,O

618070,O

3030191,O

06/11/2005,O
12:00:00,O
AM,O

ED,O
Discharge,O
Summary,O

Unsigned,O

DIS,O

Report,O
Status,O
:,O

Unsigned,O

ED,O
DISCHARGE,O
NOTIFICATION,O
/,O
SUMMARY,O

ELKSFALCBAINKIH,O
",",O
ON,O

MRN,O
:,O

2027705,O

Age,O
:,O

47y,O

REGISTRATION,O
DATE,O
:,O

06/11/2005,O
12:08,O
PM,O

Provider,O
:,O

BURLTIS,O
TROWELKS,O

PRELIMINARY,O
REPORT,O

PCP,O
notified,O
by,O
MD,O
:,O

E-mail,O

PCP,O
Benefits,O
Assigned,O
:,O

Y,O

Discharge,O
Note,O
Date,O
/,O
Time,O
:,O

06/11/2005,O
21:46,O

Discharge,O
Status,O
:,O

Discharged,O

Condition,O
on,O
Discharge,O
:,O

Stable,O

Patient,O
States,O
Complaint,O
:,O

BODY,B-PR
SHAKING,I-PR

Standardized,O
Discharge,O
Instructions,O
:,O

The,O
patient,O
was,O
given,O
printed,O
instructions,O
for,O
back,B-PR
pain,I-PR
(,O
English,O
),O
.,O

Diagnosis,O
:,O

back,B-PR
pain/,I-PR
mechanical,B-PR
fall,I-PR

Treatment,O
Rendered,O
:,O

Pt,B-TE
&apos;s,I-TE
labs,I-TE
were,O
checked,O
",",O
he,O
was,O
seen,O
by,O
Neurology,O
",",O
and,O
he,O
received,O
a,B-TE
spine,I-TE
MRI,I-TE
which,O
was,O
negative,O
.,O

He,O
received,O
Rx,B-TR
for,O
potassium,B-TR
to,O
help,O
with,O
cramps,B-PR
.,O

Advised,O
to,O
contact,O
Pain,O
service,O
for,O
repeat,B-TR
injections,I-TR
",",O
F,O
/,O
U,O
with,O
Neurology,O
",",O
explore,O
PT,B-TR
",",O
massage,B-TR
therapy,I-TR
.,O

Discharge,O
Medications,O
:,O

K-Dur,B-TR
20meq,O
PO,O
QD,O

Disposition,O
",",O
Follow,O
up,O
and,O
Instructions,O
to,O
Patient,O
:,O

F,O
/,O
U,O
with,O
Dr.,O
Wierstkotea,O
within,O
1,O
week,O
.,O

F,O
/,O
U,O
with,O
Neurology,O
",",O
pain,O
service,O
to,O
schedule,O
an,O
appt,O
.,O

PCP,O
Name,O
:,O

WIERSTKOTEA,O
",",O
JETA,O

Provider,O
Number,O
:,O

50927,O

This,O
report,O
was,O
created,O
by,O
TROWELKS,O
",",O
BURLTIS,O
06/11/2005,O
09:52,O
PM,O

989519730,O
WGH,O

4708487,O

265076,O

4927849,O

05/09/2004,O
12:00:00,O
AM,O

Discharge,O
Summary,O

Signed,O

DIS,O

Report,O
Status,O
:,O

Signed,O

DISCHARGE,O
SUMMARY,O

NAME,O
:,O

GINSLENT,O
",",O
A,O
L,O

UNIT,O
NUMBER,O
:,O

537-43-35,O

ADMISSION,O
DATE,O
:,O

05/09/2004,O

DISCHARGE,O
DATE,O
:,O

05/16/2004,O

PRINCIPAL,O
DIAGNOSIS,O
:,O

Colon,B-PR
cancer,I-PR
.,O

ASSOCIATED,O
DIAGNOSES,O
:,O

History,O
of,O
diverticulitis,B-PR
",",O
status,O
post,O
cholecystectomy,B-TR
",",O
status,O
post,O
appendectomy,B-TR
",",O
and,O
hypertension,B-PR
.,O

PRINCIPAL,O
PROCEDURE,O
:,O

Transverse,B-TR
colectomy,I-TR
for,O
tumor,B-PR
.,O

ASSOCIATED,O
PROCEDURES,O
:,O

None,O
.,O

HISTORY,O
OF,O
PRESENT,O
ILLNESS,O
:,O

The,O
patient,O
is,O
an,O
84-year-old,O
woman,O
with,O
a,O
history,O
of,O
diverticulitis,B-PR
who,O
was,O
found,O
to,O
have,O
colon,B-PR
cancer,I-PR
on,O
colonoscopy,B-TE
",",O
which,O
was,O
performed,O
in,O
March,O
of,O
2004,O
.,O

An,B-PR
invasive,I-PR
moderately,I-PR
differentiated,I-PR
adenocarcinoma,I-PR
was,O
noted,O
in,O
the,O
transverse,O
colon,O
at,O
80,O
cm,O
.,O

The,O
patient,O
reports,O
a,O
history,O
of,O
bloating,B-PR
and,O
flatulence,B-PR
as,O
well,O
as,O
increased,B-PR
fatigue,I-PR
.,O

She,O
has,O
also,O
had,O
some,B-PR
discomfort,I-PR
in,I-PR
her,I-PR
left,I-PR
lower,I-PR
abdomen,I-PR
and,O
notes,O
diarrhea,B-PR
every,O
4-5,O
days,O
.,O

She,O
says,O
that,O
her,O
appetite,O
is,O
good,O
and,O
has,O
noted,O
no,O
weight,B-PR
loss,I-PR
.,O

PAST,O
MEDICAL,O
HISTORY,O
:,O

Cholecystectomy,B-TR
in,O
1994,O
",",O
colonoscopy,B-TR
2004,O
",",O
status,O
post,O
tonsillectomy,B-TR
",",O
status,O
post,O
appendectomy,B-TR
",",O
status,O
post,O
ORIF,B-TR
of,I-TR
left,I-TR
wrist,I-TR
",",O
status,O
post,O
left,B-TR
ear,I-TR
surgery,I-TR
",",O
NSVD,B-TR
x5,O
",",O
and,O
hypertension,B-PR
.,O

MEDICATIONS,O
:,O

Premarin,B-TR
vaginal,I-TR
once,O
a,O
month,O
",",O
enalapril,B-TR
",",O
Tylenol,B-TR
",",O
vitamins,B-TR
",",O
and,O
Halcion,B-TR
at,O
night,O
.,O

ALLERGIES,O
:,O

No,O
known,B-PR
drug,I-PR
allergies,I-PR
.,O

SOCIAL,O
HISTORY,O
:,O

She,O
is,O
married,O
and,O
lives,O
in,O
an,O
assisted,O
living,O
facility,O
with,O
her,O
husband,O
.,O

She,O
has,O
five,O
grown,O
children,O
.,O

PHYSICAL,O
EXAMINATION,O
:,O

On,O
exam,B-TE
she,O
is,O
afebrile,B-PR
.,O

Her,B-TE
vital,I-TE
signs,I-TE
are,O
stable,O
.,O

Baseline,B-TE
blood,I-TE
pressure,I-TE
of,O
144/61,O
",",O
heart,B-TE
rate,I-TE
of,O
73,O
",",O
and,O
oxygen,B-TE
saturation,I-TE
of,O
96%,O
on,O
room,O
air,O
.,O

She,O
is,O
a,O
pleasant,O
well,O
appearing,O
elderly,O
woman,O
in,O
no,O
acute,B-PR
distress,I-PR
.,O

Lungs,O
are,O
clear,O
to,O
auscultation,B-TE
bilaterally,O
.,O

Heart,O
is,O
regular,O
without,O
murmurs,B-PR
",",O
rubs,B-PR
",",O
or,O
gallops,B-PR
.,O

Abdomen,O
is,O
soft,O
",",O
nontender,B-PR
",",O
and,O
nondistended,B-PR
.,O

Her,O
extremities,O
are,O
without,O
edema,B-PR
and,O
are,O
warm,O
.,O

HOSPITAL,O
COURSE,O
:,O

The,O
patient,O
was,O
consented,O
for,O
surgery,B-TR
and,O
on,O
the,O
day,O
of,O
admission,O
was,O
taken,O
to,O
the,O
operating,O
room,O
for,O
transverse,B-TR
colectomy,I-TR
for,O
tumor,B-PR
.,O

The,O
patient,O
tolerated,O
the,B-TR
procedure,I-TR
well,O
and,O
there,O
are,O
no,O
complications,B-PR
.,O

Her,O
postoperative,O
course,O
was,O
unremarkable,O
.,O

She,O
was,O
maintained,O
on,O
an,B-TR
epidural,I-TR
and,O
PCA,B-TR
for,O
pain,B-PR
control,I-PR
.,O

She,O
was,O
kept,O
NPO,B-TR
initially,O
and,O
her,O
diet,O
was,O
slowly,O
advanced,O
as,O
tolerated,O
.,O

When,O
she,O
was,O
taking,O
clear,B-TR
liquids,I-TR
",",O
her,B-TR
pain,I-TR
medication,I-TR
was,O
switched,O
to,O
p.o.,B-TR
pain,I-TR
regimen,I-TR
with,O
good,O
affect,O
.,O

For,O
blood,B-TR
pressure,I-TR
control,I-TR
she,O
was,O
maintained,O
on,O
metoprolol,B-TR
at,O
the,O
request,O
of,O
her,O
primary,O
care,O
physician,O
and,O
enalapril,B-TR
was,O
discontinued,O
.,O

With,O
the,O
help,O
of,O
physical,B-TR
therapy,I-TR
the,O
patient,O
was,O
ambulated,O
and,O
on,O
postoperative,O
seven,O
",",O
with,O
the,O
patient,O
tolerating,O
a,B-TR
post,I-TR
surgical,I-TR
soft,I-TR
diet,I-TR
and,O
with,O
pain,B-PR
well,O
controlled,O
on,O
oral,B-TR
pain,I-TR
medications,I-TR
",",O
she,O
was,O
discharged,O
to,O
rehabilitation,O
facility,O
.,O

DISCHARGE,O
MEDICATIONS,O
:,O

1.,O
Tylenol,B-TR
650,O
mg,O
p.o.,O
q.4.h.,O
p.r.n.,O
pain,B-PR
.,O

2.,O
Metoprolol,B-TR
25,O
mg,O
p.o.,O
b.i.d.,O

3.,O
Motrin,B-TR
400,O
mg,O
p.o.,O
b.i.d.,O
p.r.n.,O
pain,B-PR
.,O

4.,O
Halcion,B-TR
0.25,O
mg,O
p.o.,O
at,O
night,O
.,O

5.,O
Dulcolax,B-TR
10,O
to,O
20,O
mg,O
PR,O
b.i.d.,O
p.r.n.,O
constipation,B-PR
.,O

6.,O
Senna,B-TR
2,O
tablets,O
p.o.,O
b.i.d.,O

DISCHARGE,O
INSTRUCTIONS,O
:,O

Consume,O
a,O
diet,O
as,O
tolerated,O
avoiding,O
carbonated,O
beverages,O
.,O

Her,O
activity,O
level,O
is,O
as,O
tolerated,O
.,O

She,O
is,O
to,O
contact,O
Dr.,O
Warm,O
&apos;s,O
office,O
to,O
schedule,O
a,O
follow,O
up,O
appointment,O
.,O

She,O
is,O
to,O
also,O
call,O
the,O
office,O
if,O
she,O
has,O
any,O
fever,B-PR
greater,I-PR
than,I-PR
101,I-PR
",",O
bleeding,B-PR
from,I-PR
the,I-PR
surgical,I-PR
wounds,I-PR
",",O
or,O
pus,B-PR
from,I-PR
the,I-PR
wounds,I-PR
.,O

She,O
is,O
to,O
be,O
maintained,O
on,O
metoprolol,B-TR
for,O
blood,B-TR
pressure,I-TR
control,I-TR
and,O
the,O
restarting,O
of,O
her,B-TR
ACE,I-TR
inhibitor,I-TR
is,O
to,O
be,O
decided,O
by,O
her,O
primary,O
care,O
physician,O
.,O

ALEN,O
L,O
CREDKOTE,O
",",O
M.D.,O

DICTATING,O
FOR,O
:,O

Electronically,O
Signed,O
OIE,O
LIMOR,O
WARM,O
",",O
M.D.,O
05/18/2004,O
11:28,O

_____________________________,O
OIE,O
LIMOR,O
WARM,O
",",O
M.D.,O

TR,O
:,O

ep,O

DD,O
:,O

05/16/2004,O

TD,O
:,O

05/16/2004,O
7:28,O
A,O
265076,O

cc,O
:,O

OIE,O
LIMOR,O
WARM,O
",",O
M.D.,O
CH,O
GILD,O
WARM,O
",",O
M.D.,O